PMC - PMC5042925
IS  - 2197-425X (Electronic)
VI  - 4
IP  - Suppl 1
DP  - 2016 Sep
TI  - ESICM LIVES 2016: part three: Milan, Italy. 1–5 October 2016.
LID - 28
FAU - Velasquez, T.
AU  - Velasquez T
AD  - Texas Children’s Hospital, Clinical Nutriiton, Houston, USA
FAU - Mackey, G.
AU  - Mackey G
AD  - Texas Children’s Hospital, Intensive Care, Houston, USA
FAU - Lusk, J.
AU  - Lusk J
AD  - Texas Children’s Hospital, Intensive Care, Houston, USA
FAU - Kyle, U. G.
AU  - Kyle UG
AD  - Texas Children’s Hospital, Intensive Care, Houston, USA
FAU - Fontenot, T.
AU  - Fontenot T
AD  - Texas Children’s Hospital, Intensive Care, Houston, USA
FAU - Marshall, P.
AU  - Marshall P
AD  - Texas Children’s Hospital, Intensive Care, Houston, USA
FAU - Shekerdemian, L. S.
AU  - Shekerdemian LS
AD  - Texas Children’s Hospital, Intensive Care, Houston, USA
FAU - Coss-Bu, J. A.
AU  - Coss-Bu JA
AD  - Texas Children’s Hospital, Intensive Care, Houston, USA
FAU - Nishigaki, A.
AU  - Nishigaki A
AD  - Kochi Medical School, Department of Anesthesiology and Intensive Care Medicine,
      Nankoku, Japan
FAU - Yatabe, T.
AU  - Yatabe T
AD  - Kochi Medical School, Department of Anesthesiology and Intensive Care Medicine,
      Nankoku, Japan
FAU - Tamura, T.
AU  - Tamura T
AD  - Kochi Medical School, Department of Anesthesiology and Intensive Care Medicine,
      Nankoku, Japan
FAU - Yamashita, K.
AU  - Yamashita K
AD  - Kochi Medical School, Department of Anesthesiology and Intensive Care Medicine,
      Nankoku, Japan
FAU - Yokoyama, M.
AU  - Yokoyama M
AD  - Kochi Medical School, Department of Anesthesiology and Intensive Care Medicine,
      Nankoku, Japan
FAU - Ruiz-Rodriguez, J. C.
AU  - Ruiz-Rodriguez JC
AD  - Vall d’ Hebron University Hospital, Critical Care Department, Barcelona, Spain
FAU - Encina, B.
AU  - Encina B
AD  - Vall d’ Hebron University Hospital, Critical Care Department, Barcelona, Spain
FAU - Belmonte, R.
AU  - Belmonte R
AD  - Vall d’ Hebron University Hospital, Critical Care Department, Barcelona, Spain
FAU - Troncoso, I.
AU  - Troncoso I
AD  - Vall d’ Hebron University Hospital, Critical Care Department, Barcelona, Spain
FAU - Tormos, P.
AU  - Tormos P
AD  - Vall d’ Hebron University Hospital, Anesthesia & Reanimation Department,
      Barcelona, Spain
FAU - Riveiro, M.
AU  - Riveiro M
AD  - Vall d’ Hebron University Hospital, Neurocritical Care Department, Barcelona,
      Spain
FAU - Baena, J.
AU  - Baena J
AD  - Vall d’ Hebron University Hospital, Neurocritical Care Department, Barcelona,
      Spain
FAU - Sanchez, A.
AU  - Sanchez A
AD  - Vall d’ Hebron University Hospital, Critical Care Department, Barcelona, Spain
FAU - Bañeras, J.
AU  - Bañeras J
AD  - Vall d’ Hebron University Hospital, Coronary Care Unit, Barcelona, Spain
FAU - Cordón, J.
AU  - Cordón J
AD  - Vall d’ Hebron University Hospital, Critical Care Department, Barcelona, Spain
FAU - Duran, N.
AU  - Duran N
AD  - Sagrat Cor University Hospital, Critical Care Department, Barcelona, Spain
FAU - Ruiz, A.
AU  - Ruiz A
AD  - Vall d’ Hebron University Hospital, Critical Care Department, Barcelona, Spain
FAU - Caballero, J.
AU  - Caballero J
AD  - Vall d’ Hebron University Hospital, Critical Care Department, Barcelona, Spain
FAU - Nuvials, X.
AU  - Nuvials X
AD  - Vall d’ Hebron University Hospital, Critical Care Department, Barcelona, Spain
FAU - Riera, J.
AU  - Riera J
AD  - Vall d’ Hebron University Hospital, Critical Care Department, Barcelona, Spain
FAU - Serra, J.
AU  - Serra J
AD  - Vall d’ Hebron University Hospital, Critical Care Department, Barcelona, Spain
FAU - Rutten, A. M. F.
AU  - Rutten AMF
AD  - St Elisabeth Twee Steden Hospital, ICU, Tilburg, Netherlands
FAU - van Ieperen, S. N. M.
AU  - van Ieperen SNM
AD  - St Elisabeth Twee Steden Hospital, ICU, Tilburg, Netherlands
FAU - Der Kinderen, E. P. H. M.
AU  - Der Kinderen EPHM
AD  - St Elisabeth Twee Steden Hospital, ICU, Tilburg, Netherlands
FAU - Van Logten, T.
AU  - Van Logten T
AD  - St Elisabeth Twee Steden Hospital, ICU, Tilburg, Netherlands
FAU - Kovacikova, L.
AU  - Kovacikova L
AD  - National Institute of Cardiovascular Diseases, PCICU, Bratislava, Slovakia
FAU - Skrak, P.
AU  - Skrak P
AD  - National Institute of Cardiovascular Diseases, Bratislava, Slovakia
FAU - Zahorec, M.
AU  - Zahorec M
AD  - National Institute of Cardiovascular Diseases, Pediatric Cardiac Intensive Care
      Unit, Bratislava, Slovakia
FAU - Kyle, U. G.
AU  - Kyle UG
AD  - Texas Children’s Hospital, Intensive Care, Houston, USA
FAU - Akcan-Arikan, A.
AU  - Akcan-Arikan A
AD  - Texas Children’s Hospital, Intensive Care, Houston, USA
FAU - Silva, J. C.
AU  - Silva JC
AD  - Texas Children’s Hospital, Intensive Care, Houston, USA
FAU - Mackey, G.
AU  - Mackey G
AD  - Texas Children’s Hospital, Intensive Care, Houston, USA
FAU - Lusk, J.
AU  - Lusk J
AD  - Texas Children’s Hospital, Intensive Care, Houston, USA
FAU - Goldsworthy, M.
AU  - Goldsworthy M
AD  - Texas Children’s Hospital, Intensive Care, Houston, USA
FAU - Shekerdemian, L. S.
AU  - Shekerdemian LS
AD  - Texas Children’s Hospital, Intensive Care, Houston, USA
FAU - Coss-Bu, J. A.
AU  - Coss-Bu JA
AD  - Texas Children’s Hospital, Intensive Care, Houston, USA
FAU - Wood, D.
AU  - Wood D
AD  - Bristol Royal Hospital for Children, Paediatric Intensive Care Unit, Bristol, UK
FAU - Harrison, D.
AU  - Harrison D
AD  - Intensive Care National Audit & Research Centre (ICNARC), London, UK
FAU - Parslow, R.
AU  - Parslow R
AD  - University of Leeds, Leeds, UK
FAU - Davis, P.
AU  - Davis P
AD  - Bristol Royal Hospital for Children, Paediatric Intensive Care Unit, Bristol, UK
FAU - Pappachan, J.
AU  - Pappachan J
AD  - Southampton University Hospitals NHS Trust, Southampton, UK
FAU - Goodwin, S.
AU  - Goodwin S
AD  - Bristol Royal Hospital for Children, Paediatric Intensive Care Unit, Bristol, UK
FAU - Ramnarayan, P.
AU  - Ramnarayan P
AD  - Great Ormond Street Hospital, London, UK
FAU - Chernyshuk, S.
AU  - Chernyshuk S
AD  - UCCC, ICU, Kyiv, Ukraine
FAU - Yemets, H.
AU  - Yemets H
AD  - UCCC, ICU, Kyiv, Ukraine
FAU - Zhovnir, V.
AU  - Zhovnir V
AD  - UCCC, ICU, Kyiv, Ukraine
FAU - Pulitano’, S. M.
AU  - Pulitano’ SM
AD  - Catholic University, Department of Anesthesia and Intensive Care, Rome, Italy
FAU - De Rosa, S.
AU  - De Rosa S
AD  - Catholic University, Department of Anesthesia and Intensive Care, Rome, Italy
FAU - Mancino, A.
AU  - Mancino A
AD  - Catholic University, Department of Anesthesia and Intensive Care, Rome, Italy
FAU - Villa, G.
AU  - Villa G
AD  - International Renal Research Institute of Vicenza (IRRIV), Department of
      Nephrology, Dialysis and Transplantation, Vicenza, Italy
FAU - Tosi, F.
AU  - Tosi F
AD  - Catholic University, Department of Anesthesia and Intensive Care, Rome, Italy
FAU - Franchi, P.
AU  - Franchi P
AD  - Catholic University, Department of Anesthesia and Intensive Care, Rome, Italy
FAU - Conti, G.
AU  - Conti G
AD  - Catholic University, Department of Anesthesia and Intensive Care, Rome, Italy
FAU - Patel, B.
AU  - Patel B
AD  - The Children’s Hospital at Montefiore, Pediatric Critical Care, Bronx, USA
FAU - Khine, H.
AU  - Khine H
AD  - The Children’s Hospital at Montefiore, Bronx, USA
FAU - Shah, A.
AU  - Shah A
AD  - The Children’s Hospital at Montefiore, Bronx, USA
FAU - Sung, D.
AU  - Sung D
AD  - The Children’s Hospital at Montefiore, Bronx, USA
FAU - Singer, L.
AU  - Singer L
AD  - The Children’s Hospital at Montefiore, Bronx, USA
FAU - Haghbin, S.
AU  - Haghbin S
AD  - Shiraz University of Medical Sciences, Pediatric intensive Care, Shiraz, Islamic 
      Republic of Iran
FAU - Inaloo, S.
AU  - Inaloo S
AD  - Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran
FAU - Serati, Z.
AU  - Serati Z
AD  - Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran
FAU - Idei, M.
AU  - Idei M
AD  - Yokohama City University Hospital, Intensive Care Unit, Yokohama, Japan
FAU - Nomura, T.
AU  - Nomura T
AD  - Yokohama City University Hospital, Department of Anesthesiology, Yokohama, Japan
FAU - Yamamoto, N.
AU  - Yamamoto N
AD  - Yokohama City University Hospital, Intensive Care Unit, Yokohama, Japan
FAU - Sakai, Y.
AU  - Sakai Y
AD  - Yokohama City University Hospital, Intensive Care Unit, Yokohama, Japan
FAU - Yoshida, T.
AU  - Yoshida T
AD  - Yokohama City University Hospital, Intensive Care Unit, Yokohama, Japan
FAU - Matsuda, Y.
AU  - Matsuda Y
AD  - Yokohama City University Hospital, Intensive Care Unit, Yokohama, Japan
FAU - Yamaguchi, Y.
AU  - Yamaguchi Y
AD  - Yokohama City University Hospital, Intensive Care Unit, Yokohama, Japan
FAU - Takaki, S.
AU  - Takaki S
AD  - Yokohama City University Hospital, Intensive Care Unit, Yokohama, Japan
FAU - Yamaguchi, O.
AU  - Yamaguchi O
AD  - Yokohama City University Hospital, Intensive Care Unit, Yokohama, Japan
FAU - Goto, T.
AU  - Goto T
AD  - Yokohama City University Hospital, Department of Anesthesiology, Yokohama, Japan
FAU - Longani, N.
AU  - Longani N
AD  - The Children’s Hospital at Montefiore, Pediatric Critical Care, Bronx, USA
FAU - Medar, S.
AU  - Medar S
AD  - The Children’s Hospital at Montefiore, Pediatric Critical Care, Bronx, USA
FAU - Abdel-Aal, I. R.
AU  - Abdel-Aal IR
AD  - Cairo University/Kasr Alainy Medical School, Anesthesia, Pain and Surgical ICU,
      Cairo, Egypt
FAU - El Adawy, A. S.
AU  - El Adawy AS
AD  - Cairo University/Kasr Alainy Medical School, Cairo, Egypt
FAU - Mohammed, H. M. E. H.
AU  - Mohammed HMEH
AD  - Cairo University/Kasr Alainy Medical School, Cairo, Egypt
FAU - Mohamed, A. N.
AU  - Mohamed AN
AD  - Cairo University/Kasr Alainy Medical School, Cairo, Egypt
FAU - Parry, S. M.
AU  - Parry SM
AD  - The University of Melbourne, Department of Physiotherapy, Melbourne, Australia
FAU - Knight, L. D.
AU  - Knight LD
AD  - Royal Melbourne Hospital, Department of Physiotherapy, Melbourne, Australia
FAU - Denehy, L.
AU  - Denehy L
AD  - The University of Melbourne, Department of Physiotherapy, Melbourne, Australia
FAU - De Morton, N.
AU  - De Morton N
AD  - Peter MacCallum Cancer Centre, Department of Physiotherapy, Melbourne, Australia
FAU - Baldwin, C. E.
AU  - Baldwin CE
AD  - Flinders Medical Centre, Department of Physiotherapy, Adelaide, Australia
FAU - Sani, D.
AU  - Sani D
AD  - National University Hospital, Department of Rehabilitation, Singapore, Singapore
FAU - Kayambu, G.
AU  - Kayambu G
AD  - National University Hospital, Department of Rehabilitation, Singapore, Singapore
FAU - da Silva, V. Z. M.
AU  - da Silva VZM
AD  - Escola Superior da Saude, Health Sciences Program, Brasilia, Brazil
FAU - Phongpagdi, P.
AU  - Phongpagdi P
AD  - The University of Melbourne, Department of Physiotherapy, Melbourne, Australia
FAU - Puthucheary, Z. A.
AU  - Puthucheary ZA
AD  - University College London Hospitals, Division of Critical Care, London, UK
FAU - Granger, C. L.
AU  - Granger CL
AD  - The University of Melbourne, Department of Physiotherapy, Melbourne, Australia
FAU - Rydingsward, J. E.
AU  - Rydingsward JE
AD  - Brigham and Women’s Hospital, Department of Rehabilitation, Boston, USA
FAU - Horkan, C. M.
AU  - Horkan CM
AD  - Brigham and Women’s Hospital, Department of Medicine, Boston, USA
FAU - Christopher, K. B.
AU  - Christopher KB
AD  - Brigham and Women’s Hospital, Renal Division, Boston, USA
FAU - McWilliams, D.
AU  - McWilliams D
AD  - Queen Elizabeth Hospital NHS FT, Birmingham, UK
FAU - Jones, C.
AU  - Jones C
AD  - Queen Elizabeth Hospital NHS FT, Birmingham, UK
FAU - Reeves, E.
AU  - Reeves E
AD  - Queen Elizabeth Hospital NHS FT, Birmingham, UK
FAU - Atkins, G.
AU  - Atkins G
AD  - Queen Elizabeth Hospital NHS FT, Birmingham, UK
FAU - Snelson, C.
AU  - Snelson C
AD  - Queen Elizabeth Hospital NHS FT, Birmingham, UK
FAU - Aitken, L. M.
AU  - Aitken LM
AD  - City University London, School of Health Sciences, London, UK
FAU - Rattray, J.
AU  - Rattray J
AD  - University of Dundee, Dundee, UK
FAU - Kenardy, J.
AU  - Kenardy J
AD  - University of Queensland, Brisbane, Australia
FAU - Hull, A. M.
AU  - Hull AM
AD  - NHS Tayside, Dundee, UK
FAU - Ullman, A.
AU  - Ullman A
AD  - Griffith University, NHMRC Centre of Research Excellence in Nursing, Menzies
      Health Institute Queensland, Brisbane, Australia
FAU - Le Brocque, R.
AU  - Le Brocque R
AD  - University of Queensland, Brisbane, Australia
FAU - Mitchell, M.
AU  - Mitchell M
AD  - Griffith University, NHMRC Centre of Research Excellence in Nursing, Menzies
      Health Institute Queensland, Brisbane, Australia
FAU - Davis, C.
AU  - Davis C
AD  - Princess Alexandra Hospital, Intensive Care Unit, Brisbane, Australia
FAU - Macfarlane, B.
AU  - Macfarlane B
AD  - Griffith University, NHMRC Centre of Research Excellence in Nursing, Menzies
      Health Institute Queensland, Brisbane, Australia
FAU - Azevedo, J. C.
AU  - Azevedo JC
AD  - Hospital Israelita Albert Einstein, São Paulo, Brazil
FAU - Rocha, L. L.
AU  - Rocha LL
AD  - Hospital Israelita Albert Einstein, São Paulo, Brazil
FAU - De Freitas, F. F. M.
AU  - De Freitas FFM
AD  - Hospital Israelita Albert Einstein, São Paulo, Brazil
FAU - Cavalheiro, A. M.
AU  - Cavalheiro AM
AD  - Hospital Israelita Albert Einstein, São Paulo, Brazil
FAU - Lucinio, N. M.
AU  - Lucinio NM
AD  - Hospital Israelita Albert Einstein, São Paulo, Brazil
FAU - Lobato, M. S.
AU  - Lobato MS
AD  - Hospital Israelita Albert Einstein, São Paulo, Brazil
FAU - Ebeling, G.
AU  - Ebeling G
AD  - Odense University Hospital, Anesthesiology and Intensive Care Medicine, Odense,
      Denmark
FAU - Kraegpoeth, A.
AU  - Kraegpoeth A
AD  - Odense University Hospital, Anesthesiology and Intensive Care Medicine, Odense,
      Denmark
FAU - Laerkner, E.
AU  - Laerkner E
AD  - Odense University Hospital, University of Southern Denmark, Odense, Denmark
FAU - De Brito-Ashurst, I.
AU  - De Brito-Ashurst I
AD  - Royal Brompton and Harefield NHS Foundation Trust, Rehabilitation and Therapies, 
      London, UK
FAU - White, C.
AU  - White C
AD  - Royal Surrey County Hospital, ICU and SPACeR research group, Guildford, UK
FAU - Gregory, S.
AU  - Gregory S
AD  - Royal Surrey County Hospital, Guildford, UK
FAU - Forni, L. G.
AU  - Forni LG
AD  - Royal Surrey County Hospital, ICU and SPACeR research group, Guildford, UK
FAU - Flowers, E.
AU  - Flowers E
AD  - Guys and St Thomas NHS Foundation Trust, London, UK
FAU - Curtis, A.
AU  - Curtis A
AD  - Guys and St Thomas NHS Foundation Trust, London, UK
FAU - Wood, C. A.
AU  - Wood CA
AD  - Guys and St Thomas NHS Foundation Trust, London, UK
FAU - Siu, K.
AU  - Siu K
AD  - Khoo Teck Puat Hospital, Rehabilitation Services, Singapore, Singapore
FAU - Venkatesan, K.
AU  - Venkatesan K
AD  - Khoo Teck Puat Hospital, Anaesthesia & Surgical Intensive Care, Singapore,
      Singapore
FAU - Muhammad, J. B. H.
AU  - Muhammad JBH
AD  - Khoo Teck Puat Hospital, Rehabilitation Services, Singapore, Singapore
FAU - Ng, L.
AU  - Ng L
AD  - Khoo Teck Puat Hospital, Rehabilitation Services, Singapore, Singapore
FAU - Seet, E.
AU  - Seet E
AD  - Khoo Teck Puat Hospital, Anaesthesia & Surgical Intensive Care, Singapore,
      Singapore
FAU - Baptista, N.
AU  - Baptista N
AD  - Clinica Sagrada Esperança, Luanda, Angola
FAU - Escoval, A.
AU  - Escoval A
AD  - Escola Nacional de Saude Publica/UNL, Lisboa, Portugal
FAU - Tomas, E.
AU  - Tomas E
AD  - Clinica Sagrada Esperança, Luanda, Angola
FAU - Agrawal, R.
AU  - Agrawal R
AD  - Fortis Escorts Heart Institute, Critical Care Medicine, New Delhi, India
FAU - Mathew, R.
AU  - Mathew R
AD  - Fortis Escorts Heart Institute, Critical Care Medicine, New Delhi, India
FAU - Varma, A.
AU  - Varma A
AD  - Fortis Escorts Heart Institute, Critical Care Medicine, New Delhi, India
FAU - Dima, E.
AU  - Dima E
AD  - University of Athens, Medical School, Evangelismos Hospital, Athens, Greece
FAU - Charitidou, E.
AU  - Charitidou E
AD  - National Technical University of Athens, Athens, Greece
FAU - Perivolioti, E.
AU  - Perivolioti E
AD  - Evangelismos Hospital, Athens, Greece
FAU - Pratikaki, M.
AU  - Pratikaki M
AD  - Evangelismos Hospital, Athens, Greece
FAU - Vrettou, C.
AU  - Vrettou C
AD  - Evangelismos Hospital, Athens, Greece
FAU - Giannopoulos, A.
AU  - Giannopoulos A
AD  - Evangelismos Hospital, Athens, Greece
FAU - Zakynthinos, S.
AU  - Zakynthinos S
AD  - Evangelismos Hospital, Athens, Greece
FAU - Routsi, C.
AU  - Routsi C
AD  - Evangelismos Hospital, Athens, Greece
FAU - Atchade, E.
AU  - Atchade E
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Houzé, S.
AU  - Houzé S
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Jean-Baptiste, S.
AU  - Jean-Baptiste S
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Thabut, G.
AU  - Thabut G
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Genève, C.
AU  - Genève C
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Tanaka, S.
AU  - Tanaka S
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Lortat-Jacob, B.
AU  - Lortat-Jacob B
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Augustin, P.
AU  - Augustin P
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Desmard, M.
AU  - Desmard M
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Montravers, P.
AU  - Montravers P
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - de Molina, F. J. González
AU  - de Molina FJG
AD  - Hospital Universitari Mútua de Terrassa, Intensive Care Department, Terrassa,
      Spain
FAU - Barbadillo, S.
AU  - Barbadillo S
AD  - Hospital General de Catalunya, Intensive Care Department, Sant Cugat del Vallés, 
      Spain
FAU - Alejandro, R.
AU  - Alejandro R
AD  - Hospital Universitari de Tarragona Joan XXIII, Intensive Care Department,
      Tarragona, Spain
FAU - Álvarez-Lerma, F.
AU  - Álvarez-Lerma F
AD  - Hospital del Mar, Intensive Care Department, Barcelona, Spain
FAU - Vallés, J.
AU  - Vallés J
AD  - Hospital Parc Taulí, Intensive Care Department, Sabadell, Spain
FAU - Catalán, R. M.
AU  - Catalán RM
AD  - Hospital General de Vic, Intensive Care Department, Vic, Spain
FAU - Palencia, E.
AU  - Palencia E
AD  - Hospital Infanta Leonor, Intensive Care Department, Madrid, Spain
FAU - Jareño, A.
AU  - Jareño A
AD  - Hospital del SAS de Jerez, Intensive Care Department, Jerez de la Frontera, Spain
FAU - Granada, R. M.
AU  - Granada RM
AD  - Hospital de Bellvitge, Intensive Care Department, Barcelona, Spain
FAU - Ignacio, M. L.
AU  - Ignacio ML
AD  - St James’s University Hospital, Dublin, Ireland
CN  - GETGAG Working Group
FAU - Cui, N.
AU  - Cui N
AD  - Peking Union Medical College Hospital, Critical Care Medicine, Beijing, China
FAU - Liu, D.
AU  - Liu D
AD  - Peking Union Medical College Hospital, Critical Care Medicine, Beijing, China
FAU - Wang, H.
AU  - Wang H
AD  - Peking Union Medical College Hospital, Critical Care Medicine, Beijing, China
FAU - Su, L.
AU  - Su L
AD  - Peking Union Medical College Hospital, Critical Care Medicine, Beijing, China
FAU - Qiu, H.
AU  - Qiu H
AD  - Nanjing Zhongda Hospital, Southeast University School of Medicine, Critical Care 
      Medicine, Nanjing, China
FAU - Li, R.
AU  - Li R
AD  - Peking University First Hospital, Peking University, Research Center for Medical 
      Mycology, Beijing, China
FAU - Jaffal, K.
AU  - Jaffal K
AD  - Lille University Hospital, ICU, Lille, France
FAU - Rouzé, A.
AU  - Rouzé A
AD  - Lille University Hospital, ICU, Lille, France
FAU - Poissy, J.
AU  - Poissy J
AD  - Lille University Hospital, ICU, Lille, France
FAU - Sendid, B.
AU  - Sendid B
AD  - Lille University Hospital, Mycology and Parasitology Lab, Lille, France
FAU - Nseir, S.
AU  - Nseir S
AD  - Lille University Hospital, ICU, Lille, France
FAU - Paramythiotou, E.
AU  - Paramythiotou E
AD  - Attikon University Hospital, Athens, Greece
FAU - Rizos, M.
AU  - Rizos M
AD  - Attikon University Hospital, Athens, Greece
FAU - Frantzeskaki, F.
AU  - Frantzeskaki F
AD  - Attikon University Hospital, Athens, Greece
FAU - Antoniadou, A.
AU  - Antoniadou A
AD  - Attikon University Hospital, Athens, Greece
FAU - Vourli, S.
AU  - Vourli S
AD  - Attikon University Hospital, Athens, Greece
FAU - Zerva, L.
AU  - Zerva L
AD  - Attikon University Hospital, Athens, Greece
FAU - Armaganidis, A.
AU  - Armaganidis A
AD  - Attikon University Hospital, Athens, Greece
FAU - Riera, J.
AU  - Riera J
AD  - Vall d’Hebron University Hospital, Critical Care, Barcelona, Spain
FAU - Gottlieb, J.
AU  - Gottlieb J
AD  - Hannover Medical School, Department of Respiratory Medicine, Hannover, Germany
FAU - Greer, M.
AU  - Greer M
AD  - Hannover Medical School, Department of Respiratory Medicine, Hannover, Germany
FAU - Wiesner, O.
AU  - Wiesner O
AD  - Hannover Medical School, Department of Respiratory Medicine, Hannover, Germany
FAU - Martínez, M.
AU  - Martínez M
AD  - Vall d’Hebron University Hospital, Critical Care, Barcelona, Spain
FAU - Acuña, M.
AU  - Acuña M
AD  - Vall d’Hebron University Hospital, Critical Care, Barcelona, Spain
FAU - Rello, J.
AU  - Rello J
AD  - Vall d’Hebron University Hospital, Critical Care, Barcelona, Spain
FAU - Welte, T.
AU  - Welte T
AD  - Hannover Medical School, Department of Respiratory Medicine, Hannover, Germany
FAU - Atchade, E.
AU  - Atchade E
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Mignot, T.
AU  - Mignot T
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Houzé, S.
AU  - Houzé S
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Jean-Baptiste, S.
AU  - Jean-Baptiste S
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Thabut, G.
AU  - Thabut G
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Lortat-Jacob, B.
AU  - Lortat-Jacob B
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Tanaka, S.
AU  - Tanaka S
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Augustin, P.
AU  - Augustin P
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Desmard, M.
AU  - Desmard M
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Montravers, P.
AU  - Montravers P
AD  - Hopital Bichat Claude Bernard, Paris, France
FAU - Soussi, S.
AU  - Soussi S
AD  - AP-HP, GH St-Louis-Lariboisière, Department of Anesthesiology and Critical Care
      and SMUR and Burn Unit, Paris, France
FAU - Dudoignon, E.
AU  - Dudoignon E
AD  - AP-HP, GH St-Louis-Lariboisière, Department of Anesthesiology and Critical Care
      and SMUR and Burn Unit, Paris, France
FAU - Ferry, A.
AU  - Ferry A
AD  - AP-HP, GH St-Louis-Lariboisière, Department of Anesthesiology and Critical Care
      and SMUR and Burn Unit, Paris, France
FAU - Chaussard, M.
AU  - Chaussard M
AD  - AP-HP, GH St-Louis-Lariboisière, Department of Anesthesiology and Critical Care
      and SMUR and Burn Unit, Paris, France
FAU - Benyamina, M.
AU  - Benyamina M
AD  - AP-HP, GH St-Louis-Lariboisière, Department of Anesthesiology and Critical Care
      and SMUR and Burn Unit, Paris, France
FAU - Alanio, A.
AU  - Alanio A
AD  - AP-HP, GH St-Louis-Lariboisière, Mycology Unit, Paris, France
FAU - Touratier, S.
AU  - Touratier S
AD  - AP-HP, GH St-Louis-Lariboisière, Pharmacy Unit, Paris, France
FAU - Chaouat, M.
AU  - Chaouat M
AD  - AP-HP, GH St-Louis-Lariboisière, Plastic Surgery and Burn Unit, Paris, France
FAU - Lafaurie, M.
AU  - Lafaurie M
AD  - AP-HP, GH St-Louis-Lariboisière, Department of Infectious Diseases, Paris, France
FAU - Mimoun, M.
AU  - Mimoun M
AD  - AP-HP, GH St-Louis-Lariboisière, Plastic Surgery and Burn Unit, Paris, France
FAU - Mebazaa, A.
AU  - Mebazaa A
AD  - AP-HP, GH St-Louis-Lariboisière, Department of Anesthesiology and Critical Care
      and SMUR and Burn Unit, Paris, France
FAU - Legrand, M.
AU  - Legrand M
AD  - AP-HP, GH St-Louis-Lariboisière, Department of Anesthesiology and Critical Care
      and SMUR and Burn Unit, Paris, France
FAU - Sheils, M. A.
AU  - Sheils MA
AD  - Dudley Group of Hospitals NHS Foundation Trust, Anaesthetics, Dudley, UK
FAU - Patel, C.
AU  - Patel C
AD  - Dudley Group of Hospitals NHS Foundation Trust, Anaesthetics, Dudley, UK
FAU - Mohankumar, L.
AU  - Mohankumar L
AD  - Dudley Group of Hospitals NHS Foundation Trust, Microbiology, Dudley, UK
FAU - Akhtar, N.
AU  - Akhtar N
AD  - Dudley Group of Hospitals NHS Foundation Trust, Anaesthetics, Dudley, UK
FAU - Noriega, S. K. Pacheco
AU  - Noriega SKP
AD  - Hospital Simón Bolívar, Burn ICU, Bogotá, Colombia
FAU - Aldana, N. Navarrete
AU  - Aldana NN
AD  - Hospital Simón Bolívar, Burn ICU, Bogotá, Colombia
FAU - León, J. L. Ávila
AU  - León JLÁ
AD  - Hospital Simón Bolívar, Burn ICU, Bogotá, Colombia
FAU - Baquero, J. Durand
AU  - Baquero JD
AD  - Hospital Simón Bolívar, Burn ICU, Bogotá, Colombia
FAU - Bernal, F. Fernández
AU  - Bernal FF
AD  - Hospital Simón Bolívar, Burn ICU, Bogotá, Colombia
FAU - Ahmadnia, E.
AU  - Ahmadnia E
AD  - Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London, 
      UK
FAU - Hadley, J. S.
AU  - Hadley JS
AD  - Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London, 
      UK
FAU - Millar, M.
AU  - Millar M
AD  - Royal London Hospital, Barts Health NHS Trust, Microbiology Department, London,
      UK
FAU - Hall, D.
AU  - Hall D
AD  - Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London, 
      UK
FAU - Hewitt, H.
AU  - Hewitt H
AD  - Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London, 
      UK
FAU - Yasuda, H.
AU  - Yasuda H
AD  - Japanese Red Cross Musashino Hospital, Emergency And Critical Care Medicine,
      Tokyo, Japan
FAU - Sanui, M.
AU  - Sanui M
AD  - Saitama Medical Center, Jichi Medical University, Department of Anesthesiology
      and Critical Care Medicine, Saitama, Japan
FAU - Komuro, T.
AU  - Komuro T
AD  - Japanese Society of Education for Physicians and Trainees in Intensive Care,
      Tokyo, Japan
FAU - Kawano, S.
AU  - Kawano S
AD  - Japanese Society of Education for Physicians and Trainees in Intensive Care,
      Tokyo, Japan
FAU - Andoh, K.
AU  - Andoh K
AD  - Japanese Society of Education for Physicians and Trainees in Intensive Care,
      Tokyo, Japan
FAU - Yamamoto, H.
AU  - Yamamoto H
AD  - Japanese Society of Education for Physicians and Trainees in Intensive Care,
      Tokyo, Japan
FAU - Noda, E.
AU  - Noda E
AD  - Japanese Society of Education for Physicians and Trainees in Intensive Care,
      Tokyo, Japan
FAU - Hatakeyama, J.
AU  - Hatakeyama J
AD  - Japanese Society of Education for Physicians and Trainees in Intensive Care,
      Tokyo, Japan
FAU - Saitou, N.
AU  - Saitou N
AD  - Japanese Society of Education for Physicians and Trainees in Intensive Care,
      Tokyo, Japan
FAU - Okamoto, H.
AU  - Okamoto H
AD  - Japanese Society of Education for Physicians and Trainees in Intensive Care,
      Tokyo, Japan
FAU - Kobayashi, A.
AU  - Kobayashi A
AD  - Japanese Society of Education for Physicians and Trainees in Intensive Care,
      Tokyo, Japan
FAU - Takei, T.
AU  - Takei T
AD  - Japanese Society of Education for Physicians and Trainees in Intensive Care,
      Tokyo, Japan
FAU - Matsukubo, S.
AU  - Matsukubo S
AD  - Japanese Society of Education for Physicians and Trainees in Intensive Care,
      Tokyo, Japan
CN  - JSEPTIC (Japanese Society of Education for Physicians and Trainees in Intensive
      Care) Clinical Trial Group
FAU - Rotzel, H. B.
AU  - Rotzel HB
AD  - Hospital Clinic Universitari Valencia, Valencia, Spain
FAU - Lázaro, A. Serrano
AU  - Lázaro AS
AD  - Hospital Clinic Universitari Valencia, Valencia, Spain
FAU - Prada, D. Aguillón
AU  - Prada DA
AD  - Hospital Clinic Universitari Valencia, Valencia, Spain
FAU - Gimillo, M. Rodriguez
AU  - Gimillo MR
AD  - Hospital Clinic Universitari Valencia, Valencia, Spain
FAU - Barinas, O. Diaz
AU  - Barinas OD
AD  - Hospital Clinic Universitari Valencia, Valencia, Spain
FAU - Cortes, M. L. Blasco
AU  - Cortes MLB
AD  - Hospital Clinic Universitari Valencia, Valencia, Spain
FAU - Franco, J. Ferreres
AU  - Franco JF
AD  - Hospital Clinic Universitari Valencia, Valencia, Spain
FAU - Roca, J. M. Segura
AU  - Roca JMS
AD  - Hospital Clinic Universitari Valencia, Valencia, Spain
FAU - Carratalá, A.
AU  - Carratalá A
AD  - Hospital Clinic Universitari Valencia, Valencia, Spain
FAU - Gonçalves, B.
AU  - Gonçalves B
AD  - Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil
FAU - Turon, R.
AU  - Turon R
AD  - Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil
FAU - Mendes, A.
AU  - Mendes A
AD  - Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil
FAU - Miranda, F.
AU  - Miranda F
AD  - Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil
FAU - Mata, P. J.
AU  - Mata PJ
AD  - Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil
FAU - Cavalcanti, D.
AU  - Cavalcanti D
AD  - Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil
FAU - Melo, N.
AU  - Melo N
AD  - Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil
FAU - Lacerda, P.
AU  - Lacerda P
AD  - Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil
FAU - Kurtz, P.
AU  - Kurtz P
AD  - Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil
FAU - Righy, C.
AU  - Righy C
AD  - Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil
FAU - Rosario, L. E. de la Cruz
AU  - Rosario LEde la C
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Lesmes, S. P. Gómez
AU  - Lesmes SPG
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Romero, J. C. García
AU  - Romero JCG
AD  - Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain
FAU - Herrera, A. N. García
AU  - Herrera ANG
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Pertuz, E. D. Díaz
AU  - Pertuz EDD
AD  - Complejo Hospitalario de Navarra, Neurology, Pamplona, Navarra Spain
FAU - Sánchez, M. J. Gómez
AU  - Sánchez MJG
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Sanz, E. Regidor
AU  - Sanz ER
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Hualde, J. Barado
AU  - Hualde JB
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Hernández, A. Ansotegui
AU  - Hernández AA
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Irazabal, J. M. Guergué
AU  - Irazabal JMG
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Spatenkova, V.
AU  - Spatenkova V
AD  - Regional Hospital, Neurocenter, Neurointensive Care Unit, Liberec, Czech Republic
FAU - Bradac, O.
AU  - Bradac O
AD  - Military University Hospital and First Medical School, Charles University,
      Department of Neurosurgery, Prague, Czech Republic
FAU - Suchomel, P.
AU  - Suchomel P
AD  - Regional Hospital, Neurocenter, Department of Neurosurgery, Liberec, Czech
      Republic
FAU - Urli, T.
AU  - Urli T
AD  - IRCCS Istituto delle Scienze Neurologiche, Anesthesia and Intensive Care,
      Bellaria Hospital, Bologna, Italy
FAU - Lazzeri, E. Heusch
AU  - Lazzeri EH
AD  - University of Bologna, Bologna, Italy
FAU - Aspide, R.
AU  - Aspide R
AD  - IRCCS Istituto delle Scienze Neurologiche, Anesthesia and Intensive Care,
      Bellaria Hospital, Bologna, Italy
FAU - Zanello, M.
AU  - Zanello M
AD  - IRCCS Istituto delle Scienze Neurologiche, Anesthesia and Intensive Care,
      Bellaria Hospital, Bologna, Italy
FAU - Perez-Borrero, L.
AU  - Perez-Borrero L
AD  - Hospital Serrania, Ronda, Spain
FAU - Garcia-Alvarez, J. M.
AU  - Garcia-Alvarez JM
AD  - Hospital Serrania, Ronda, Spain
FAU - Arias-Verdu, M. D.
AU  - Arias-Verdu MD
AD  - Hospital Regional, Intensive Care, Malaga, Spain
FAU - Aguilar-Alonso, E.
AU  - Aguilar-Alonso E
AD  - Hospital Infanta Margarita, Intensive Care, Cabra, Spain
FAU - Rivera-Fernandez, R.
AU  - Rivera-Fernandez R
AD  - Hospital Serrania, Ronda, Spain
FAU - Mora-Ordoñez, J.
AU  - Mora-Ordoñez J
AD  - Hospital Regional, Intensive Care, Malaga, Spain
FAU - De La Fuente-Martos, C.
AU  - De La Fuente-Martos C
AD  - Hospital Infanta Margarita, Intensive Care, Cabra, Spain
FAU - Castillo-Lorente, E.
AU  - Castillo-Lorente E
AD  - Hospital Neurotraumatologico, Jaen, Spain
FAU - Guerrero-Lopez, F.
AU  - Guerrero-Lopez F
AD  - Hospital Virgen de las Nieves, Intensive Care, Granada, Spain
FAU - Lesmes, S. P. Gómez
AU  - Lesmes SPG
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain
FAU - Rosario, L. E. De la Cruz
AU  - Rosario LEDla C
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain
FAU - Pertuz, E. D. Díaz
AU  - Pertuz EDD
AD  - Complejo Hospitalario de Navarra, Neurology, Pamplona, Spain
FAU - Hernández, A. Ansotegui
AU  - Hernández AA
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain
FAU - Romero, J. C. García
AU  - Romero JCG
AD  - Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Spain
FAU - Sánchez, M. J. Gómez
AU  - Sánchez MJG
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain
FAU - Herrera, A. N. García
AU  - Herrera ANG
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain
FAU - Ramírez, J. Roldán
AU  - Ramírez JR
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain
FAU - Sanz, E. Regidor
AU  - Sanz ER
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain
FAU - Hualde, J. Barado
AU  - Hualde JB
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain
FAU - León, J. P. Tirapu
AU  - León JPT
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain
FAU - Navarro-Guillamón, L.
AU  - Navarro-Guillamón L
AD  - Complejo Hospitalario de Granada, Granada, Spain
FAU - Cordovilla-Guardia, S.
AU  - Cordovilla-Guardia S
AD  - Complejo Hospitalario de Granada, Granada, Spain
FAU - Iglesias-Santiago, A.
AU  - Iglesias-Santiago A
AD  - Complejo Hospitalario de Granada, Granada, Spain
FAU - Guerrero-López, F.
AU  - Guerrero-López F
AD  - Complejo Hospitalario de Granada, Granada, Spain
FAU - Fernández-Mondéjar, E.
AU  - Fernández-Mondéjar E
AD  - Complejo Hospitalario de Granada, Granada, Spain
FAU - Vidal, A.
AU  - Vidal A
AD  - Fundación Jiménez Díaz, Madrid, Spain
FAU - Perez, M.
AU  - Perez M
AD  - Hospital Rey Juan Carlos, Móstoles, Spain
FAU - Juez, A.
AU  - Juez A
AD  - Hospital Rey Juan Carlos, Móstoles, Spain
FAU - Arias, N.
AU  - Arias N
AD  - Fundación Jiménez Díaz, Madrid, Spain
FAU - Colino, L.
AU  - Colino L
AD  - Fundación Jiménez Díaz, Madrid, Spain
FAU - Perez, J. L.
AU  - Perez JL
AD  - Fundación Jiménez Díaz, Madrid, Spain
FAU - Pérez, H.
AU  - Pérez H
AD  - Fundación Jiménez Díaz, Madrid, Spain
FAU - Calpe, P.
AU  - Calpe P
AD  - Fundación Jiménez Díaz, Madrid, Spain
FAU - Alcala, M. A.
AU  - Alcala MA
AD  - Fundación Jiménez Díaz, Madrid, Spain
FAU - Robaglia, D.
AU  - Robaglia D
AD  - Fundación Jiménez Díaz, Madrid, Spain
FAU - Perez, C.
AU  - Perez C
AD  - Fundación Jiménez Díaz, Madrid, Spain
FAU - Lan, S. K.
AU  - Lan SK
AD  - Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan,
      Province of China
FAU - Cunha, M. M.
AU  - Cunha MM
AD  - Centro Hospitalar Tâmega e Sousa, Intensive Care, Penafiel, Portugal
FAU - Moreira, T.
AU  - Moreira T
AD  - Centro Hospitalar Tâmega e Sousa, Intensive Care, Penafiel, Portugal
FAU - Santos, F.
AU  - Santos F
AD  - Centro Hospitalar Tâmega e Sousa, Intensive Care, Penafiel, Portugal
FAU - Lafuente, E.
AU  - Lafuente E
AD  - Centro Hospitalar Tâmega e Sousa, Intensive Care, Penafiel, Portugal
FAU - Fernandes, M. J.
AU  - Fernandes MJ
AD  - Centro Hospitalar Tâmega e Sousa, Intensive Care, Penafiel, Portugal
FAU - Silva, J. G.
AU  - Silva JG
AD  - Centro Hospitalar Tâmega e Sousa, Intensive Care, Penafiel, Portugal
FAU - Rosario, L. E. de la Cruz
AU  - Rosario LEde la C
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Lesmes, S. P. Gómez
AU  - Lesmes SPG
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Herrera, A. N. García
AU  - Herrera ANG
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Romero, J. C. García
AU  - Romero JCG
AD  - Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain
FAU - Pertuz, E. D. Díaz
AU  - Pertuz EDD
AD  - Complejo Hospitalario de Navarra, Neurology, Pamplona, Navarra Spain
FAU - Sánchez, M. J. Gómez
AU  - Sánchez MJG
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Sanz, E. Regidor
AU  - Sanz ER
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Echeverría, J. G. Armando
AU  - Echeverría JGA
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Hernández, A. Ansotegui
AU  - Hernández AA
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Hualde, J. Barado
AU  - Hualde JB
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Podlepich, V.
AU  - Podlepich V
AD  - Burdenko Neurosurgery Institute, Moscow, Russian Federation
FAU - Sokolova, E.
AU  - Sokolova E
AD  - Burdenko Neurosurgery Institute, Moscow, Russian Federation
FAU - Alexandrova, E.
AU  - Alexandrova E
AD  - Burdenko Neurosurgery Institute, Moscow, Russian Federation
FAU - Lapteva, K.
AU  - Lapteva K
AD  - Burdenko Neurosurgery Institute, Moscow, Russian Federation
FAU - Kurtz, P.
AU  - Kurtz P
AD  - Fiocruz, Rio de Janeiro, Brazil
FAU - Shuinotsuka, C.
AU  - Shuinotsuka C
AD  - D’Or Institute for Research and Education, Rio de Janeiro, Brazil
FAU - Rabello, L.
AU  - Rabello L
AD  - D’Or Institute for Research and Education, Rio de Janeiro, Brazil
FAU - Vianna, G.
AU  - Vianna G
AD  - D’Or Institute for Research and Education, Rio de Janeiro, Brazil
FAU - Reis, A.
AU  - Reis A
AD  - D’Or Institute for Research and Education, Rio de Janeiro, Brazil
FAU - Cairus, C.
AU  - Cairus C
AD  - D’Or Institute for Research and Education, Rio de Janeiro, Brazil
FAU - Salluh, J.
AU  - Salluh J
AD  - D’Or Institute for Research and Education, Rio de Janeiro, Brazil
FAU - Bozza, F.
AU  - Bozza F
AD  - D’Or Institute for Research and Education, Rio de Janeiro, Brazil
FAU - Torres, J. C. Barrios
AU  - Torres JCB
AD  - Hospital Gregorio Marañon, Intensive Care Unit, Madrid, Spain
FAU - Araujo, N. J. Fernández
AU  - Araujo NJF
AD  - Hospital Gregorio Marañon, Intensive Care Unit, Madrid, Spain
FAU - García-Olivares, P.
AU  - García-Olivares P
AD  - Hospital Gregorio Marañon, Intensive Care Unit, Madrid, Spain
FAU - Keough, E.
AU  - Keough E
AD  - Hospital Gregorio Marañon, Intensive Care Unit, Madrid, Spain
FAU - Dalorzo, M.
AU  - Dalorzo M
AD  - Hospital Gregorio Marañon, Intensive Care Unit, Madrid, Spain
FAU - Tang, L. K.
AU  - Tang LK
AD  - Hospital Gregorio Marañon, Intensive Care Unit, Madrid, Spain
FAU - De Sousa, I.
AU  - De Sousa I
AD  - Hospital Gregorio Marañon, Intensive Care Unit, Madrid, Spain
FAU - Díaz, M.
AU  - Díaz M
AD  - Hospital Gregorio Marañon, Intensive Care Unit, Madrid, Spain
FAU - Marcos-Zambrano, L. J.
AU  - Marcos-Zambrano LJ
AD  - Hospital Gregorio Marañon, Microbiology, Madrid, Spain
FAU - Guerrero, J. E.
AU  - Guerrero JE
AD  - Hospital Gregorio Marañon, Intensive Care Unit, Madrid, Spain
FAU - Gomez, S. E. Zamora
AU  - Gomez SEZ
AD  - Hospital Juarez de México, ICU, Mexico City, Mexico
FAU - Lopez, G. D. Hernandez
AU  - Lopez GDH
AD  - Hospital Juarez de México, ICU, Mexico City, Mexico
FAU - Cuellar, A. I. Vazquez
AU  - Cuellar AIV
AD  - Hospital Juarez de México, ICU, Mexico City, Mexico
FAU - Nieto, O. R. Perez
AU  - Nieto ORP
AD  - Hospital Juarez de México, ICU, Mexico City, Mexico
FAU - Gonzalez, J. A. Castanon
AU  - Gonzalez JAC
AD  - Hospital Juarez de México, ICU, Mexico City, Mexico
FAU - Bhasin, D.
AU  - Bhasin D
AD  - Max Superspeciality Hospital, Critical Care, Pulmonary and Sleep Medicine,
      Mohali, India
FAU - Rai, S.
AU  - Rai S
AD  - Max Superspeciality Hospital, Critical Care, Pulmonary and Sleep Medicine,
      Mohali, India
FAU - Singh, H.
AU  - Singh H
AD  - Max Superspeciality Hospital, Critical Care, Pulmonary and Sleep Medicine,
      Mohali, India
FAU - Gupta, O.
AU  - Gupta O
AD  - Max Superspeciality Hospital, Critical Care, Pulmonary and Sleep Medicine,
      Mohali, India
FAU - Bhattal, M. K.
AU  - Bhattal MK
AD  - Max Superspeciality Hospital, Critical Care, Pulmonary and Sleep Medicine,
      Mohali, India
FAU - Sampley, S.
AU  - Sampley S
AD  - Max Superspeciality Hospital, Critical Care, Pulmonary and Sleep Medicine,
      Mohali, India
FAU - Sekhri, K.
AU  - Sekhri K
AD  - Dr. H.S.J Institute of Dental Sciences, Pharmacology, Chandigarh, India
FAU - Nandha, R.
AU  - Nandha R
AD  - Dr. H.S.J Institute of Dental Sciences, Pharmacology, Chandigarh, India
FAU - Aliaga, F. A.
AU  - Aliaga FA
AD  - Instituto Nacional del Tórax, Fellow Respiratory Medicine, Santiago, Chile
FAU - Olivares, F.
AU  - Olivares F
AD  - Hospital Militar de Santiago, Intensive Care, Santiago, Chile
FAU - Appiani, F.
AU  - Appiani F
AD  - Hospital Militar de Santiago, Intensive Care, Santiago, Chile
FAU - Farias, P.
AU  - Farias P
AD  - Hospital Militar de Santiago, Intensive Care, Santiago, Chile
FAU - Alberto, F.
AU  - Alberto F
AD  - Hospital Militar de Santiago, Intensive Care, Santiago, Chile
FAU - Hernández, A.
AU  - Hernández A
AD  - Hospital Militar de Santiago, Intensive Care, Santiago, Chile
FAU - Pons, S.
AU  - Pons S
AD  - Bichat University Hospital, Medical ICU, Paris, France
FAU - Sonneville, R.
AU  - Sonneville R
AD  - Bichat University Hospital, Medical ICU, Paris, France
FAU - Bouadma, L.
AU  - Bouadma L
AD  - Bichat University Hospital, Medical ICU, Paris, France
FAU - Neuville, M.
AU  - Neuville M
AD  - Bichat University Hospital, Medical ICU, Paris, France
FAU - Mariotte, E.
AU  - Mariotte E
AD  - Bichat University Hospital, Medical ICU, Paris, France
FAU - Radjou, A.
AU  - Radjou A
AD  - Bichat University Hospital, Medical ICU, Paris, France
FAU - Lebut, J.
AU  - Lebut J
AD  - Bichat University Hospital, Medical ICU, Paris, France
FAU - Chemam, S.
AU  - Chemam S
AD  - Bichat University Hospital, Medical ICU, Paris, France
FAU - Voiriot, G.
AU  - Voiriot G
AD  - Bichat University Hospital, Medical ICU, Paris, France
FAU - Dilly, M. P.
AU  - Dilly MP
AD  - Bichat University Hospital, Anaesthesiology, Paris, France
FAU - Mourvillier, B.
AU  - Mourvillier B
AD  - Bichat University Hospital, Medical ICU, Paris, France
FAU - Dorent, R.
AU  - Dorent R
AD  - Bichat University Hospital, Cardiovascular surgery, Paris, France
FAU - Nataf, P.
AU  - Nataf P
AD  - Bichat University Hospital, Cardiovascular surgery, Paris, France
FAU - Wolff, M.
AU  - Wolff M
AD  - Bichat University Hospital, Medical ICU, Paris, France
FAU - Timsit, J. F.
AU  - Timsit JF
AD  - Bichat University Hospital, Medical ICU, Paris, France
FAU - Ediboglu, O.
AU  - Ediboglu O
AD  - Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit,
      Izmir, Turkey
FAU - Ataman, S.
AU  - Ataman S
AD  - Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit,
      Izmir, Turkey
FAU - Ozkarakas, H.
AU  - Ozkarakas H
AD  - Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit,
      Izmir, Turkey
FAU - Kirakli, C.
AU  - Kirakli C
AD  - Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit,
      Izmir, Turkey
FAU - Vakalos, A.
AU  - Vakalos A
AD  - Xanthi General Hospital, ICU, Xanthi, Greece
FAU - Avramidis, V.
AU  - Avramidis V
AD  - Xanthi General Hospital, ICU, Xanthi, Greece
FAU - Obukhova, O.
AU  - Obukhova O
AD  - N.N. Blokhin Russian Cancer Research Center, Medical ICU, Moscow, Russian
      Federation
FAU - Kurmukov, I. A.
AU  - Kurmukov IA
AD  - N.N. Blokhin Russian Cancer Research Center, Medical ICU, Moscow, Russian
      Federation
FAU - Kashiya, S.
AU  - Kashiya S
AD  - N.N. Blokhin Russian Cancer Research Center, Medical ICU, Moscow, Russian
      Federation
FAU - Golovnya, E.
AU  - Golovnya E
AD  - N.N. Blokhin Russian Cancer Research Center, Express Laboratory, Moscow, Russian 
      Federation
FAU - Baikova, V. N.
AU  - Baikova VN
AD  - N.N. Blokhin Russian Cancer Research Center, Express Laboratory, Moscow, Russian 
      Federation
FAU - Ageeva, T.
AU  - Ageeva T
AD  - N.N. Blokhin Russian Cancer Research Center, Biochemical Laboratory, Moscow,
      Russian Federation
FAU - Haritydi, T.
AU  - Haritydi T
AD  - N.N. Blokhin Russian Cancer Research Center, Biochemical Laboratory, Moscow,
      Russian Federation
FAU - Kulaga, E. V.
AU  - Kulaga EV
AD  - N.N. Blokhin Russian Cancer Research Center, Microbiology Department, Moscow,
      Russian Federation
FAU - Rios-Toro, J. J.
AU  - Rios-Toro JJ
AD  - Hospital Serrania, Ronda, Spain
FAU - Perez-Borrero, L.
AU  - Perez-Borrero L
AD  - Hospital Serrania, Ronda, Spain
FAU - Aguilar-Alonso, E.
AU  - Aguilar-Alonso E
AD  - Hospital Infanta Margarita, Intensive Care, Cabra, Spain
FAU - Arias-Verdu, M. D.
AU  - Arias-Verdu MD
AD  - Hospital Regional, Intensive Care, Malaga, Spain
FAU - Garcia-Alvarez, J. M.
AU  - Garcia-Alvarez JM
AD  - Hospital Serrania, Ronda, Spain
FAU - Lopez-Caler, C.
AU  - Lopez-Caler C
AD  - Hospital Regional, Intensive Care, Malaga, Spain
FAU - De La Fuente-Martos, C.
AU  - De La Fuente-Martos C
AD  - Hospital Infanta Margarita, Intensive Care, Cabra, Spain
FAU - Rodriguez-Fernandez, S.
AU  - Rodriguez-Fernandez S
AD  - Hospital Serrania, Ronda, Spain
FAU - Sanchez-Orézzoli, M. Gomez
AU  - Sanchez-Orézzoli MG
AD  - Hospital Serrania, Ronda, Spain
FAU - Martin-Gallardo, F.
AU  - Martin-Gallardo F
AD  - Hospital Serrania, Ronda, Spain
FAU - Nikhilesh, J.
AU  - Nikhilesh J
AD  - CHL Hospitals, Dept of Critical Care Services, Indore, India
FAU - Joshi, V.
AU  - Joshi V
AD  - Shalby Hospital, Dept of Critical Care Services, Indore, India
FAU - Villarreal, E.
AU  - Villarreal E
AD  - Hospital la Fe, Intensive Care Unit, Valencia, Spain
FAU - Ruiz, J.
AU  - Ruiz J
AD  - Hospital la Fe, Valencia, Spain
FAU - Gordon, M.
AU  - Gordon M
AD  - Hospital la Fe, Valencia, Spain
FAU - Quinza, A.
AU  - Quinza A
AD  - Hospital la Fe, Valencia, Spain
FAU - Gimenez, J.
AU  - Gimenez J
AD  - Hospital la Fe, Valencia, Spain
FAU - Piñol, M.
AU  - Piñol M
AD  - Hospital la Fe, Valencia, Spain
FAU - Castellanos, A.
AU  - Castellanos A
AD  - Hospital la Fe, Valencia, Spain
FAU - Ramirez, P.
AU  - Ramirez P
AD  - Hospital la Fe, Valencia, Spain
FAU - Jeon, Y. D.
AU  - Jeon YD
AD  - Yonsei Wonju University College of Medicine, Department of Internal Medicine,
      Wonju, Republic of Korea
FAU - Jeong, W. Y.
AU  - Jeong WY
AD  - Yonsei University College of Medicine, Department of Internal Medicine, Seoul,
      Republic of Korea
FAU - Kim, M. H.
AU  - Kim MH
AD  - Yonsei University College of Medicine, Department of Internal Medicine, Seoul,
      Republic of Korea
FAU - Jeong, I. Y.
AU  - Jeong IY
AD  - Yonsei University College of Medicine, Department of Internal Medicine, Seoul,
      Republic of Korea
FAU - Ahn, M. Y.
AU  - Ahn MY
AD  - Yonsei University College of Medicine, Department of Internal Medicine, Seoul,
      Republic of Korea
FAU - Ahn, J. Y.
AU  - Ahn JY
AD  - Yonsei University College of Medicine, Department of Internal Medicine, Seoul,
      Republic of Korea
FAU - Han, S. H.
AU  - Han SH
AD  - Yonsei University College of Medicine, Department of Internal Medicine, Seoul,
      Republic of Korea
FAU - Choi, J. Y.
AU  - Choi JY
AD  - Yonsei University College of Medicine, Department of Internal Medicine, Seoul,
      Republic of Korea
FAU - Song, Y. G.
AU  - Song YG
AD  - Yonsei University College of Medicine, Department of Internal Medicine, Seoul,
      Republic of Korea
FAU - Kim, J. M.
AU  - Kim JM
AD  - Yonsei University College of Medicine, Department of Internal Medicine, Seoul,
      Republic of Korea
FAU - Ku, N. S.
AU  - Ku NS
AD  - Yonsei University College of Medicine, Department of Internal Medicine, Seoul,
      Republic of Korea
FAU - Shah, H.
AU  - Shah H
AD  - Saint Barnabas Medical Center, Department of Medicine, Livingston, USA
FAU - Kellner, F.
AU  - Kellner F
AD  - Saint Barnabas Medical Center, Department of Medicine, Livingston, USA
FAU - Rezai, F.
AU  - Rezai F
AD  - Saint Barnabas Medical Center, Department of Medicine, Livingston, USA
FAU - Mistry, N.
AU  - Mistry N
AD  - Saint Barnabas Medical Center, Department of Medicine, Livingston, USA
FAU - Yodice, P.
AU  - Yodice P
AD  - Saint Barnabas Medical Center, Department of Medicine, Livingston, USA
FAU - Ovnanian, V.
AU  - Ovnanian V
AD  - Saint Barnabas Medical Center, Department of Medicine, Livingston, USA
FAU - Fless, K.
AU  - Fless K
AD  - Saint Barnabas Medical Center, Department of Medicine, Livingston, USA
FAU - Handler, E.
AU  - Handler E
AD  - Saint Barnabas Medical Center, Department of Medicine, Livingston, USA
FAU - Alejos, R. Martínez
AU  - Alejos RM
AD  - CHU Bordeaux, Bordeaux, France
FAU - Romeu, J. D. Martí
AU  - Romeu JDM
AD  - Hospital Clínic, Barcelona, Spain
FAU - Antón, D. González
AU  - Antón DG
AD  - CHU Bordeaux, Bordeaux, France
FAU - Quinart, A.
AU  - Quinart A
AD  - CHU Bordeaux, Bordeaux, France
FAU - Martí, A. Torres
AU  - Martí AT
AD  - Hospital Clínic, Barcelona, Spain
FAU - Llaurado-Serra, M.
AU  - Llaurado-Serra M
AD  - Rovira i Virgili University, Nursing Department, Tarragona, Spain
FAU - Lobo-Civico, A.
AU  - Lobo-Civico A
AD  - Dr Josep Trueta University Hospital, Intensive Care Unit, Girona, Spain
FAU - Ventura-Rosado, A.
AU  - Ventura-Rosado A
AD  - Quiron Salud-Hospital General de Catalunya, Intensive Care Unit, Barcelona, Spain
FAU - Piñol-Tena, A.
AU  - Piñol-Tena A
AD  - Verge de la Cinta University Hospital, Intensive Care Unit, Tortosa, Spain
FAU - Pi-Guerrero, M.
AU  - Pi-Guerrero M
AD  - Hospital de Sant Joan Despí Moissès Broggi, Intensive Care Unit, Barcelona, Spain
FAU - Paños-Espinosa, C.
AU  - Paños-Espinosa C
AD  - Sant Pau I Santa Tecla University Hospital, Intensive Care Unit, Tarragona, Spain
FAU - Peralvo-Bernat, M.
AU  - Peralvo-Bernat M
AD  - Joan XXIII University Hospital, Intensive Care Unit, Tarragona, Spain
FAU - Marine-Vidal, J.
AU  - Marine-Vidal J
AD  - University Hospital Vall d’Hebron, Medical Transplant Coordination Department,
      Barcelona, Spain
FAU - Gonzalez-Engroba, R.
AU  - Gonzalez-Engroba R
AD  - Quiron Salud-Hospital General de Catalunya, Intensive Care Unit, Barcelona, Spain
FAU - Montesinos-Cerro, N.
AU  - Montesinos-Cerro N
AD  - Dr Josep Trueta University Hospital, Intensive Care Unit, Girona, Spain
FAU - Treso-Geira, M.
AU  - Treso-Geira M
AD  - Verge de la Cinta University Hospital, Intensive Care Unit, Tortosa, Spain
FAU - Valeiras-Valero, A.
AU  - Valeiras-Valero A
AD  - Hospital de Sant Joan Despí Moissès Broggi, Intensive Care Unit, Barcelona, Spain
FAU - Martinez-Reyes, L.
AU  - Martinez-Reyes L
AD  - Sant Pau I Santa Tecla University Hospital, Intensive Care Unit, Tarragona, Spain
FAU - Sandiumenge, A.
AU  - Sandiumenge A
AD  - University Hospital Vall d’Hebron, Medical Transplant Coordination Department,
      Barcelona, Spain
FAU - Jimenez-Herrera, M. F.
AU  - Jimenez-Herrera MF
AD  - Rovira i Virgili University, Nursing Department, Tarragona, Spain
CN  - CAPCRI Study
FAU - Helyar, S.
AU  - Helyar S
AD  - King’s College Hospital, ACET Research Team, London, UK
FAU - Riozzi, P.
AU  - Riozzi P
AD  - King’s College Hospital, ACET Research Team, London, UK
FAU - Noon, A.
AU  - Noon A
AD  - King’s College Hospital, ACET Research Team, London, UK
FAU - Hallows, G.
AU  - Hallows G
AD  - King’s College Hospital, ACET Research Team, London, UK
FAU - Cotton, H.
AU  - Cotton H
AD  - King’s College Hospital, ACET Research Team, London, UK
FAU - Keep, J.
AU  - Keep J
AD  - King’s College Hospital, ACET Research Team, London, UK
FAU - Hopkins, P. A.
AU  - Hopkins PA
AD  - King’s College Hospital, ACET Research Team, London, UK
FAU - Taggu, A.
AU  - Taggu A
AD  - St. Johns Medical College Hospital, Critical Care Medicine, Bangalore, India
FAU - Renuka, S.
AU  - Renuka S
AD  - St. Johns Medical College Hospital, Bangalore, India
FAU - Sampath, S.
AU  - Sampath S
AD  - St. Johns Medical College Hospital, Bangalore, India
FAU - Rood, P. J. T.
AU  - Rood PJT
AD  - Radboud University Nijmegen Medical Centre, Intensive Care, Nijmegen, Netherlands
FAU - Frenzel, T.
AU  - Frenzel T
AD  - Radboud University Nijmegen Medical Centre, Intensive Care, Nijmegen, Netherlands
FAU - Verhage, R.
AU  - Verhage R
AD  - Radboud University Nijmegen Medical Centre, Intensive Care, Nijmegen, Netherlands
FAU - Bonn, M.
AU  - Bonn M
AD  - Radboud University Nijmegen Medical Centre, Intensive Care, Nijmegen, Netherlands
FAU - Pickkers, P.
AU  - Pickkers P
AD  - Radboud University Nijmegen Medical Centre, Intensive Care, Nijmegen, Netherlands
FAU - van der Hoeven, J. G.
AU  - van der Hoeven JG
AD  - Radboud University Nijmegen Medical Centre, Intensive Care, Nijmegen, Netherlands
FAU - van den Boogaard, M.
AU  - van den Boogaard M
AD  - Radboud University Nijmegen Medical Centre, Intensive Care, Nijmegen, Netherlands
FAU - Corradi, F.
AU  - Corradi F
AD  - Ente Ospedaliero Ospedali Galliera, Anestesia e Rianimazione, Genova, Italy
FAU - Melnyk, L.
AU  - Melnyk L
AD  - Ente Ospedaliero Ospedali Galliera, Anestesia e Rianimazione, Genova, Italy
FAU - Moggia, F.
AU  - Moggia F
AD  - Ente Ospedaliero Ospedali Galliera, Anestesia e Rianimazione, Genova, Italy
FAU - Pienovi, R.
AU  - Pienovi R
AD  - Ente Ospedaliero Ospedali Galliera, Anestesia e Rianimazione, Genova, Italy
FAU - Adriano, G.
AU  - Adriano G
AD  - Ente Ospedaliero Ospedali Galliera, Anestesia e Rianimazione, Genova, Italy
FAU - Brusasco, C.
AU  - Brusasco C
AD  - Ente Ospedaliero Ospedali Galliera, Anestesia e Rianimazione, Genova, Italy
FAU - Mariotti, L.
AU  - Mariotti L
AD  - Ente Ospedaliero Ospedali Galliera, Anestesia e Rianimazione, Genova, Italy
FAU - Lattuada, M.
AU  - Lattuada M
AD  - Ente Ospedaliero Ospedali Galliera, Anestesia e Rianimazione, Genova, Italy
FAU - Bloomer, M. J.
AU  - Bloomer MJ
AD  - Deakin University, School of Nursing and Midwifery, Melbourne, Australia
FAU - Coombs, M.
AU  - Coombs M
AD  - Victoria University, Wellington, Graduate School of Nursing Midwifery and Health,
      Wellington, New Zealand
FAU - Ranse, K.
AU  - Ranse K
AD  - University of Canberra, Faculty of Health, Canberra, Australia
FAU - Endacott, R.
AU  - Endacott R
AD  - Royal Devon and Exeter Hospital, Royal Devon and Exeter Clinical School, Exeter, 
      UK
FAU - Maertens, B.
AU  - Maertens B
AD  - Ghent University, Faculty of Medicine and Health Sciences, Ghent, Belgium
FAU - Blot, K.
AU  - Blot K
AD  - Ghent University, Faculty of Medicine and Health Sciences, Ghent, Belgium
FAU - Blot, S.
AU  - Blot S
AD  - Ghent University, Dept. of Internal Medicine, Ghent, Belgium
FAU - Amerongen, M. P. van Nieuw
AU  - Amerongen MPvan N
AD  - VU University Medical Center, Intensive Care, Amsterdam, Netherlands
FAU - van der Heiden, E. S.
AU  - van der Heiden ES
AD  - VU University Medical Center, Intensive Care, Amsterdam, Netherlands
FAU - Twisk, J. W. R.
AU  - Twisk JWR
AD  - VU University Medical Center, Epidemiology and Biostatistics, Amsterdam,
      Netherlands
FAU - Girbes, A. R. J.
AU  - Girbes ARJ
AD  - VU University Medical Center, Intensive Care, Amsterdam, Netherlands
FAU - Spijkstra, J. J.
AU  - Spijkstra JJ
AD  - VU University Medical Center, Intensive Care, Amsterdam, Netherlands
FAU - Riozzi, P.
AU  - Riozzi P
AD  - King’s College Hospital, ACET Research Team, London, UK
FAU - Helyar, S.
AU  - Helyar S
AD  - King’s College Hospital, ACET Research Team, London, UK
FAU - Cotton, H.
AU  - Cotton H
AD  - King’s College Hospital, ACET Research Team, London, UK
FAU - Hallows, G.
AU  - Hallows G
AD  - King’s College Hospital, ACET Research Team, London, UK
FAU - Noon, A.
AU  - Noon A
AD  - King’s College Hospital, ACET Research Team, London, UK
FAU - Bell, C.
AU  - Bell C
AD  - King’s College Hospital, Audit Team, King’s Critical Care, London, UK
FAU - Peters, K.
AU  - Peters K
AD  - King’s College Hospital, Audit Team, King’s Critical Care, London, UK
FAU - Feehan, A.
AU  - Feehan A
AD  - King’s College Hospital, Audit Team, King’s Critical Care, London, UK
FAU - Keep, J.
AU  - Keep J
AD  - King’s College Hospital, ACET Research Team, London, UK
FAU - Hopkins, P. A.
AU  - Hopkins PA
AD  - King’s College Hospital, ACET Research Team, London, UK
FAU - Churchill, K.
AU  - Churchill K
AD  - Royal Devon and Exeter Hospital, ICU, Exeter, UK
FAU - Hawkins, K.
AU  - Hawkins K
AD  - Royal Devon and Exeter Hospital, ICU, Exeter, UK
FAU - Brook, R.
AU  - Brook R
AD  - Royal Devon and Exeter Hospital, ICU, Exeter, UK
FAU - Paver, N.
AU  - Paver N
AD  - Royal Devon and Exeter Hospital, ICU, Exeter, UK
FAU - Endacott, R.
AU  - Endacott R
AD  - Plymouth University/Royal Devon and exeter Hospital Clinical School, Exeter, UK
FAU - Maistry, N.
AU  - Maistry N
AD  - Royal Brompton and Harefield NHS Foundation Trust, Rehabilitation and Therapies, 
      London, UK
FAU - van Wijk, A.
AU  - van Wijk A
AD  - Senior ICU Nurse Quality and Safety VU University Medical Center, Amsterdam,
      Netherlands
FAU - Rouw, N.
AU  - Rouw N
AD  - Senior ICU Nurse Quality and Safety VU University Medical Center, Amsterdam,
      Netherlands
FAU - van Galen, T.
AU  - van Galen T
AD  - ICU Nursing, VU University Medical Center, Amsterdam, Netherlands
FAU - Evelein-Brugman, S.
AU  - Evelein-Brugman S
AD  - VU University Medical Center, Amsterdam, Netherlands
FAU - Taggu, A.
AU  - Taggu A
AD  - St. Johns Medical College Hospital, Critical Care Medicine, Bangalore, India
FAU - Krishna, B.
AU  - Krishna B
AD  - St. Johns Medical College Hospital, Bangalore, India
FAU - Sampath, S.
AU  - Sampath S
AD  - St. Johns Medical College, Bangalore, India
FAU - Putzu, A.
AU  - Putzu A
AD  - Fondazione Cardiocentro Ticino, Cardiac Anesthesia and Intensive Care, Lugano,
      Switzerland
FAU - Fang, M.
AU  - Fang M
AD  - IRCCS San Raffaele Scientific Institute, Department of Anesthesia and Intensive
      Care, Milan, Italy
FAU - Berto, M. Boscolo
AU  - Berto MB
AD  - Fondazione Cardiocentro Ticino, Cardiac Anesthesia and Intensive Care, Lugano,
      Switzerland
FAU - Belletti, A.
AU  - Belletti A
AD  - IRCCS San Raffaele Scientific Institute, Department of Anesthesia and Intensive
      Care, Milan, Italy
FAU - Cassina, T.
AU  - Cassina T
AD  - Fondazione Cardiocentro Ticino, Cardiac Anesthesia and Intensive Care, Lugano,
      Switzerland
FAU - Cabrini, L.
AU  - Cabrini L
AD  - IRCCS San Raffaele Scientific Institute, Department of Anesthesia and Intensive
      Care, Milan, Italy
FAU - Mistry, M.
AU  - Mistry M
AD  - University of Liverpool, Institute of Ageing and Chronic Disease, Liverpool, UK
FAU - Alhamdi, Y.
AU  - Alhamdi Y
AD  - University of Liverpool, Institute of Infection and Global Health, Liverpool, UK
FAU - Welters, I.
AU  - Welters I
AD  - University of Liverpool, Institute of Infection and Global Health, Liverpool, UK
FAU - Abrams, S. T.
AU  - Abrams ST
AD  - University of Liverpool, Institute of Infection and Global Health, Liverpool, UK
FAU - Toh, C. H.
AU  - Toh CH
AD  - University of Liverpool, Institute of Infection and Global Health, Liverpool, UK
FAU - Han, H. S.
AU  - Han HS
AD  - Samsung Medical Center, Surgery, Seoul, Republic of Korea
FAU - Gil, E. M.
AU  - Gil EM
AD  - Samsung Medical Center, Critical Care Medicine, Seoul, Republic of Korea
FAU - Lee, D. S.
AU  - Lee DS
AD  - Samsung Medical Center, Critical Care Medicine, Seoul, Republic of Korea
FAU - Park, C. M.
AU  - Park CM
AD  - Samsung Medical Center, Surgery, Seoul, Republic of Korea
FAU - Winder-Rhodes, S.
AU  - Winder-Rhodes S
AD  - Royal Surrey County Hospital NHS Foundation Trust, Department of Intensive Care
      Medicine and Surrey Peri-Operative Anaesthesia and Critical Care Collaborative
      Research Group (SPACER), Guildford, UK
FAU - Lotay, R.
AU  - Lotay R
AD  - Royal Surrey County Hospital NHS Foundation Trust, Department of Intensive Care
      Medicine and Surrey Peri-Operative Anaesthesia and Critical Care Collaborative
      Research Group (SPACER), Guildford, UK
FAU - Doyle, J.
AU  - Doyle J
AD  - Royal Surrey County Hospital NHS Foundation Trust, Department of Intensive Care
      Medicine and Surrey Peri-Operative Anaesthesia and Critical Care Collaborative
      Research Group (SPACER), Guildford, UK
FAU - Ke, M. W.
AU  - Ke MW
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Huang, W. C.
AU  - Huang WC
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Chiang, C. H.
AU  - Chiang CH
AD  - Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Hung, W. T.
AU  - Hung WT
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Cheng, C. C.
AU  - Cheng CC
AD  - Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Lin, K. C.
AU  - Lin KC
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Lin, S. C.
AU  - Lin SC
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Chiou, K. R.
AU  - Chiou KR
AD  - Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Wann, S. R.
AU  - Wann SR
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Shu, C. W.
AU  - Shu CW
AD  - Kaohsiung Veterans General Hospital, Department of Medical Education and
      Research, Kaohsiung City, Taiwan, Province of China
FAU - Kang, P. L.
AU  - Kang PL
AD  - Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Mar, G. Y.
AU  - Mar GY
AD  - Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Liu, C. P.
AU  - Liu CP
AD  - Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Dubó, S.
AU  - Dubó S
AD  - Universidad de Concepción, Facultad de Medicina, Departamento de Kinesiología,
      Concepcion, Chile
FAU - Aquevedo, A.
AU  - Aquevedo A
AD  - Hospital Dr. Sótero del Río, Unidad de Pacientes Críticos, Santiago, Chile
FAU - Jibaja, M.
AU  - Jibaja M
AD  - Hospital Eugenio Espejo, Unidad de Cuidados Intensivos, Quito, Ecuador
FAU - Berrutti, D.
AU  - Berrutti D
AD  - Universidad de la República, Hospital de Clínicas, Centro de Terapia Intensiva,
      Montevideo, Uruguay
FAU - Labra, C.
AU  - Labra C
AD  - Pontificia Universidad Catolica de Chile, Facultad de Medicina, Departamento de
      Medicina Intensiva, Santiago, Chile
FAU - Lagos, R.
AU  - Lagos R
AD  - Pontificia Universidad Catolica de Chile, Facultad de Medicina, Departamento de
      Medicina Intensiva, Santiago, Chile
FAU - García, M. F.
AU  - García MF
AD  - Hospital Eugenio Espejo, Unidad de Cuidados Intensivos, Quito, Ecuador
FAU - Ramirez, V.
AU  - Ramirez V
AD  - Hospital Eugenio Espejo, Unidad de Cuidados Intensivos, Quito, Ecuador
FAU - Tobar, M.
AU  - Tobar M
AD  - Hospital Eugenio Espejo, Unidad de Cuidados Intensivos, Quito, Ecuador
FAU - Picoita, F.
AU  - Picoita F
AD  - Hospital Eugenio Espejo, Unidad de Cuidados Intensivos, Quito, Ecuador
FAU - Peláez, C.
AU  - Peláez C
AD  - Hospital Eugenio Espejo, Unidad de Cuidados Intensivos, Quito, Ecuador
FAU - Carpio, D.
AU  - Carpio D
AD  - Pontificia Universidad Catolica de Chile, Facultad de Medicina, Departamento de
      Medicina Intensiva, Santiago, Chile
FAU - Alegría, L.
AU  - Alegría L
AD  - Pontificia Universidad Catolica de Chile, Facultad de Medicina, Departamento de
      Medicina Intensiva, Santiago, Chile
FAU - Hidalgo, C.
AU  - Hidalgo C
AD  - Hospital Guillermo Grant Benavente, Concepcion, Chile
FAU - Godoy, K.
AU  - Godoy K
AD  - Hospital Guillermo Grant Benavente, Concepcion, Chile
FAU - Bakker, J.
AU  - Bakker J
AD  - Pontificia Universidad Catolica de Chile, Facultad de Medicina, Departamento de
      Medicina Intensiva, Santiago, Chile
FAU - Hernández, G.
AU  - Hernández G
AD  - Pontificia Universidad Catolica de Chile, Facultad de Medicina, Departamento de
      Medicina Intensiva, Santiago, Chile
FAU - Sadamoto, Y.
AU  - Sadamoto Y
AD  - Hokkaido University Graduate School of Medicine, Emergency and Critical Care
      Medicine, Sapporo, Japan
FAU - Katabami, K.
AU  - Katabami K
AD  - Hokkaido University Graduate School of Medicine, Emergency and Critical Care
      Medicine, Sapporo, Japan
FAU - Wada, T.
AU  - Wada T
AD  - Hokkaido University Graduate School of Medicine, Emergency and Critical Care
      Medicine, Sapporo, Japan
FAU - Ono, Y.
AU  - Ono Y
AD  - Hokkaido University Graduate School of Medicine, Emergency and Critical Care
      Medicine, Sapporo, Japan
FAU - Maekawa, K.
AU  - Maekawa K
AD  - Hokkaido University Graduate School of Medicine, Emergency and Critical Care
      Medicine, Sapporo, Japan
FAU - Hayakawa, M.
AU  - Hayakawa M
AD  - Hokkaido University Graduate School of Medicine, Emergency and Critical Care
      Medicine, Sapporo, Japan
FAU - Sawamura, A.
AU  - Sawamura A
AD  - Hokkaido University Graduate School of Medicine, Emergency and Critical Care
      Medicine, Sapporo, Japan
FAU - Gando, S.
AU  - Gando S
AD  - Hokkaido University Graduate School of Medicine, Emergency and Critical Care
      Medicine, Sapporo, Japan
FAU - Marin-Mateos, H.
AU  - Marin-Mateos H
AD  - Hospital 12 de Octubre, Medicina Intensiva, Madrid, Spain
FAU - Perez-Vela, J. L.
AU  - Perez-Vela JL
AD  - Hospital 12 de Octubre, Medicina Intensiva, Madrid, Spain
FAU - Garcia-Gigorro, R.
AU  - Garcia-Gigorro R
AD  - Hospital 12 de Octubre, Medicina Intensiva, Madrid, Spain
FAU - Peiretti, M. A. Corres
AU  - Peiretti MAC
AD  - Hospital 12 de Octubre, Medicina Intensiva, Madrid, Spain
FAU - Lopez-Gude, M. J.
AU  - Lopez-Gude MJ
AD  - Hospital 12 de Octubre, Medicina Intensiva, Madrid, Spain
FAU - Chacon-Alves, S.
AU  - Chacon-Alves S
AD  - Hospital 12 de Octubre, Medicina Intensiva, Madrid, Spain
FAU - Renes-Carreño, E.
AU  - Renes-Carreño E
AD  - Hospital 12 de Octubre, Medicina Intensiva, Madrid, Spain
FAU - Montejo-González, J. C.
AU  - Montejo-González JC
AD  - Hospital 12 de Octubre, Medicina Intensiva, Madrid, Spain
FAU - Parlevliet, K. L.
AU  - Parlevliet KL
AD  - VU University Medical Center, Intensive Care Medicine, Amsterdam, Netherlands
FAU - Touw, H. R. W.
AU  - Touw HRW
AD  - VU University Medical Center Amsterdam, Anaesthesiology, Amsterdam, Netherlands
FAU - Beerepoot, M.
AU  - Beerepoot M
AD  - VU University Medical Center, Intensive Care Medicine, Amsterdam, Netherlands
FAU - Boer, C.
AU  - Boer C
AD  - VU University Medical Center Amsterdam, Anaesthesiology, Amsterdam, Netherlands
FAU - Elbers, P. W. G.
AU  - Elbers PWG
AD  - VU University Medical Center, Intensive Care Medicine, Amsterdam, Netherlands
FAU - Tuinman, P. R.
AU  - Tuinman PR
AD  - VU University Medical Center, Intensive Care Medicine, Amsterdam, Netherlands
FAU - Abdelmonem, S. A.
AU  - Abdelmonem SA
AD  - University of Alexandria, Critical Care, Alexandria, Egypt
FAU - Helmy, T. A.
AU  - Helmy TA
AD  - University of Alexandria, Critical Care, Alexandria, Egypt
FAU - El Sayed, I.
AU  - El Sayed I
AD  - Medical Research Institute, Biomedical Informatics & Medical Statistics,
      Alexandria, Egypt
FAU - Ghazal, S.
AU  - Ghazal S
AD  - University of Alexandria, Critical Care, Alexandria, Egypt
FAU - Akhlagh, S. H.
AU  - Akhlagh SH
AD  - Shiraz University of Medical Sciences, Anesthesia and Intensive Care Department, 
      Shiraz, Islamic Republic of Iran
FAU - Masjedi, M.
AU  - Masjedi M
AD  - Shiraz University of Medical Sciences, Anesthesia and Intensive Care Department, 
      Shiraz, Islamic Republic of Iran
FAU - Hozhabri, K.
AU  - Hozhabri K
AD  - Shiraz University of Medical Sciences, Anesthesia and Intensive Care Department, 
      Shiraz, Islamic Republic of Iran
FAU - Kamali, E.
AU  - Kamali E
AD  - Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran
FAU - Zýková, I.
AU  - Zýková I
AD  - Regional Hospital Liberec, Department of Anesthesia and intensive Care, Liberec, 
      Czech Republic
FAU - Paldusová, B.
AU  - Paldusová B
AD  - Regional Hospital Liberec, Department of Anesthesia and intensive Care, Liberec, 
      Czech Republic
FAU - Sedlák, P.
AU  - Sedlák P
AD  - Regional Hospital Liberec, Department of Anesthesia and intensive Care, Liberec, 
      Czech Republic
FAU - Morman, D.
AU  - Morman D
AD  - Regional Hospital Liberec, Department of Anesthesia and intensive Care, Liberec, 
      Czech Republic
FAU - Youn, A. M.
AU  - Youn AM
AD  - Chungnam National University Hospital, Anesthesiology and Pain Medicine, Daejon, 
      Republic of Korea
FAU - Ohta, Y.
AU  - Ohta Y
AD  - Hyogo College of Medicine, General Internal Medicine, Nishinomiya, Japan
FAU - Sakuma, M.
AU  - Sakuma M
AD  - Hyogo College of Medicine, Clinical Epidemiology, Nishinomiya, Japan
FAU - Bates, D.
AU  - Bates D
AD  - Brigham and Women’s Hospital, General Internal Medicine, Boston, USA
FAU - Morimoto, T.
AU  - Morimoto T
AD  - Hyogo College of Medicine, Clinical Epidemiology, Nishinomiya, Japan
FAU - Su, P. L.
AU  - Su PL
AD  - National Cheng Kung University Hospital, Department of Internal Medicine, Tainan,
      Taiwan, Province of China
FAU - Chang, W. Y.
AU  - Chang WY
AD  - National Cheng Kung University Hospital, Department of Internal Medicine, Tainan,
      Taiwan, Province of China
FAU - Lin, W. C.
AU  - Lin WC
AD  - National Cheng Kung University Hospital, Department of Internal Medicine, Tainan,
      Taiwan, Province of China
FAU - Chen, C. W.
AU  - Chen CW
AD  - National Cheng Kung University Hospital, Department of Internal Medicine, Tainan,
      Taiwan, Province of China
FAU - Facchin, F.
AU  - Facchin F
AD  - University of Padova, Department of Medicine (DIMED), Padova, Italy
FAU - Zarantonello, F.
AU  - Zarantonello F
AD  - University of Padova, Department of Medicine (DIMED), Padova, Italy
FAU - Panciera, G.
AU  - Panciera G
AD  - University of Padova, Department of Medicine (DIMED), Padova, Italy
FAU - De Cassai, A.
AU  - De Cassai A
AD  - University of Padova, Department of Medicine (DIMED), Padova, Italy
FAU - Venrdramin, A.
AU  - Venrdramin A
AD  - University of Padova, Department of Medicine (DIMED), Padova, Italy
FAU - Ballin, A.
AU  - Ballin A
AD  - University of Padova, Department of Medicine (DIMED), Padova, Italy
FAU - Tonetti, T.
AU  - Tonetti T
AD  - University of Padova, Department of Medicine (DIMED), Padova, Italy
FAU - Persona, P.
AU  - Persona P
AD  - Azienda Ospedaliera di Padova, Emergency Department, Padova, Italy
FAU - Ori, C.
AU  - Ori C
AD  - University of Padova, Department of Medicine (DIMED), Padova, Italy
FAU - Del Sorbo, L.
AU  - Del Sorbo L
AD  - University of Toronto, Interdepartmental Division of Critical Care Medicine,
      Toronto, Canada
FAU - Rossi, S.
AU  - Rossi S
AD  - Azienda Ospedaliera di Padova, Emergency Department, Padova, Italy
FAU - Vergani, G.
AU  - Vergani G
AD  - Università degli Studi di Milano, Dipartimento di Fisiopatologia Medico
      Chirurgica e dei Trapianti, Milano, Italy
FAU - Cressoni, M.
AU  - Cressoni M
AD  - Università degli Studi di Milano, Dipartimento di Fisiopatologia Medico
      Chirurgica e dei Trapianti, Milano, Italy
FAU - Chiumello, D.
AU  - Chiumello D
AD  - Policlinico Di Milano, Dipartimento di Anestesia, Rianimazione, Urgenza ed
      Emergenza, Milano, Italy
FAU - Chiurazzi, C.
AU  - Chiurazzi C
AD  - Università degli Studi di Milano, Dipartimento di Fisiopatologia
      Medico-Chirurgica e dei Trapianti, Milano, Italy
FAU - Brioni, M.
AU  - Brioni M
AD  - Università degli Studi di Milano, Dipartimento di Fisiopatologia Medico
      Chirurgica e dei Trapianti, Milano, Italy
FAU - Algieri, I.
AU  - Algieri I
AD  - Università degli Studi di Milano, Dipartimento di Fisiopatologia Medico
      Chirurgica e dei Trapianti, Milano, Italy
FAU - Tonetti, T.
AU  - Tonetti T
AD  - Georg-August-University Goettingen, Anesthesiology and Intensive Care Medicine,
      Goettingen, Germany
FAU - Guanziroli, M.
AU  - Guanziroli M
AD  - Università degli Studi di Milano, Dipartimento di Fisiopatologia Medico
      Chirurgica e dei Trapianti, Milano, Italy
FAU - Colombo, A.
AU  - Colombo A
AD  - Policlinico Di Milano, Dipartimento di Anestesia, Rianimazione, Urgenza ed
      Emergenza, Milano, Italy
FAU - Tomic, I.
AU  - Tomic I
AD  - Univesity of Zagreb, Department of Intensive Care Medicine, Rebro, Croatia
FAU - Colombo, A.
AU  - Colombo A
AD  - Università degli Studi di Milano, Dipartimento di Fisiopatologia Medico
      Chirurgica e dei Trapianti, Milano, Italy
FAU - Crimella, F.
AU  - Crimella F
AD  - Università degli Studi di Milano, Dipartimento di Fisiopatologia Medico
      Chirurgica e dei Trapianti, Milano, Italy
FAU - Carlesso, E.
AU  - Carlesso E
AD  - Università degli Studi di Milano, Dipartimento di Fisiopatologia Medico
      Chirurgica e dei Trapianti, Milano, Italy
FAU - Gasparovic, V.
AU  - Gasparovic V
AD  - Univesity of Zagreb, Department of Intensive Care Medicine, Rebro, Croatia
FAU - Gattinoni, L.
AU  - Gattinoni L
AD  - Georg-August-University Goettingen, Anesthesiology and Intensive Care Medicine,
      Goettingen, Germany
FAU - Neto, A. Serpa
AU  - Neto AS
AD  - Hospital Israelita Albert Einstein, Critical Care Medicine, São Paulo, Brazil
FAU - Schmidt, M.
AU  - Schmidt M
AD  - Australian and New Zealand Intensive Care Research Centre, School of Public
      Health, Monash University, Department of Epidemiology and Preventive Medicine,
      Melbourne, Australia
FAU - Pham, T.
AU  - Pham T
AD  - Groupe Hospitalier Henri Mondor; Assistance Publique-Hôpitaux de Paris, Service
      de Réanimation Médicale, Créteil, France
FAU - Combes, A.
AU  - Combes A
AD  - Institute of Cardiometabolism and Nutrition (iCAN); Hôpital de la
      Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Medical-Surgical
      Intensive Care Unit, Paris, France
FAU - de Abreu, M. Gama
AU  - de Abreu MG
AD  - University Hospital Carl Gustav Carus, Technische Universität Dresden,
      21Pulmonary Engineering Group, Department of Anesthesiology and Intensive Care
      Medicine, Dresden, Germany
FAU - Pelosi, P.
AU  - Pelosi P
AD  - IRCCS San Martino IST, University of Genoa, Surgical Sciences and Integrated
      Diagnostics, Genoa, Italy
FAU - Schultz, M. J.
AU  - Schultz MJ
AD  - Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam,
      Netherlands
CN  - for the ReVA Research Network and the PROVE Network Investigators
FAU - Katira, B. H.
AU  - Katira BH
AD  - Hospital for Sick Children, Physiology and Experimental Medicine, Toronto, Canada
FAU - Engelberts, D.
AU  - Engelberts D
AD  - Hospital for Sick Children, Physiology and Experimental Medicine, Toronto, Canada
FAU - Giesinger, R. E.
AU  - Giesinger RE
AD  - Hospital for Sick Children, University of Toronto, Neonatal Medicine, Toronto,
      Canada
FAU - Ackerley, C.
AU  - Ackerley C
AD  - Hospital for Sick Children, Division of Electron Microscopy, Toronto, Canada
FAU - Yoshida, T.
AU  - Yoshida T
AD  - Hospital for Sick Children, Physiology and Experimental Medicine, Toronto, Canada
FAU - Zabini, D.
AU  - Zabini D
AD  - Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, 
      Toronto, Canada
FAU - Otulakowski, G.
AU  - Otulakowski G
AD  - Hospital for Sick Children, Physiology and Experimental Medicine, Toronto, Canada
FAU - Post, M.
AU  - Post M
AD  - Hospital for Sick Children, Physiology and Experimental Medicine, Toronto, Canada
FAU - Kuebler, W. M.
AU  - Kuebler WM
AD  - Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, 
      Toronto, Canada
FAU - McNamara, P. J.
AU  - McNamara PJ
AD  - Hospital for Sick Children, University of Toronto, Neonatal Medicine, Toronto,
      Canada
FAU - Kavanagh, B. P.
AU  - Kavanagh BP
AD  - Hospital for Sick Children, Physiology and Experimental Medicine, Toronto, Canada
FAU - Pirracchio, R.
AU  - Pirracchio R
AD  - Hopital Europeen Georges Pompidou, Anesthesiology and Intensive Care Medicine,
      Paris, France
FAU - Rigon, M. Resche
AU  - Rigon MR
AD  - Université Paris Diderot, Paris, France
FAU - Carone, M.
AU  - Carone M
AD  - University of Washington, Seattle, USA
FAU - Chevret, S.
AU  - Chevret S
AD  - Université Paris Diderot, Paris, France
FAU - Annane, D.
AU  - Annane D
AD  - Université de Versailles Saint-Quentin-en-Yvelines, Garches, France
FAU - Eladawy, S.
AU  - Eladawy S
AD  - Faculty of Pharmacy-Ain Shams University, Cairo, Egypt
FAU - El-Hamamsy, M.
AU  - El-Hamamsy M
AD  - Faculty of Pharmacy-Ain Shams University, Cairo, Egypt
FAU - Bazan, N.
AU  - Bazan N
AD  - Critical Care Medicine Department Cairo University Hospitals, Cairo, Egypt
FAU - Elgendy, M.
AU  - Elgendy M
AD  - Faculty of Medicine - Ain Shams University, Cairo, Egypt
FAU - De Pascale, G.
AU  - De Pascale G
AD  - Sacro Cuore Catholic University, A. Gemelli Hospital, Department of
      Anesthesiology and Intensive Care, Rome, Italy
FAU - Vallecoccia, M. S.
AU  - Vallecoccia MS
AD  - Sacro Cuore Catholic University, A. Gemelli Hospital, Department of
      Anesthesiology and Intensive Care, Rome, Italy
FAU - Cutuli, S. L.
AU  - Cutuli SL
AD  - Sacro Cuore Catholic University, A. Gemelli Hospital, Department of
      Anesthesiology and Intensive Care, Rome, Italy
FAU - Di Gravio, V.
AU  - Di Gravio V
AD  - Sacro Cuore Catholic University, A. Gemelli Hospital, Department of
      Anesthesiology and Intensive Care, Rome, Italy
FAU - Pennisi, M. A.
AU  - Pennisi MA
AD  - Sacro Cuore Catholic University, A. Gemelli Hospital, Department of
      Anesthesiology and Intensive Care, Rome, Italy
FAU - Conti, G.
AU  - Conti G
AD  - Sacro Cuore Catholic University, A. Gemelli Hospital, Department of
      Anesthesiology and Intensive Care, Rome, Italy
FAU - Antonelli, M.
AU  - Antonelli M
AD  - Sacro Cuore Catholic University, A. Gemelli Hospital, Department of
      Anesthesiology and Intensive Care, Rome, Italy
FAU - Andreis, D. T.
AU  - Andreis DT
AD  - Bloomsbury Institute of Intensive Care Medicine, University College London,
      London, UK
FAU - Khaliq, W.
AU  - Khaliq W
AD  - Bloomsbury Institute of Intensive Care Medicine, University College London,
      London, UK
FAU - Singer, M.
AU  - Singer M
AD  - Bloomsbury Institute of Intensive Care Medicine, University College London,
      London, UK
FAU - Hartmann, J.
AU  - Hartmann J
AD  - Danube University, Department for Health Sciences and Biomedicine, Krems, Austria
FAU - Harm, S.
AU  - Harm S
AD  - Danube University, Department for Health Sciences and Biomedicine, Krems, Austria
FAU - Carmona, S. Alcantara
AU  - Carmona SA
AD  - Hospital Universtario Puerta de Hierro Majadahonda, Intensive Care Unit, Madrid, 
      Spain
FAU - Almudevar, P. Matia
AU  - Almudevar PM
AD  - Hospital Universtario Puerta de Hierro Majadahonda, Intensive Care Unit, Madrid, 
      Spain
FAU - Abellán, A. Naharro
AU  - Abellán AN
AD  - Hospital Universtario Puerta de Hierro Majadahonda, Intensive Care Unit, Madrid, 
      Spain
FAU - Ramos, J. Veganzones
AU  - Ramos JV
AD  - Hospital Universtario Puerta de Hierro Majadahonda, Intensive Care Unit, Madrid, 
      Spain
FAU - Pérez, L. Pérez
AU  - Pérez LP
AD  - Hospital Universtario Puerta de Hierro Majadahonda, Intensive Care Unit, Madrid, 
      Spain
FAU - Valbuena, B. Lobo
AU  - Valbuena BL
AD  - Hospital Universtario Puerta de Hierro Majadahonda, Intensive Care Unit, Madrid, 
      Spain
FAU - Sanz, N. Martínez
AU  - Sanz NM
AD  - Hospital Universtario Puerta de Hierro Majadahonda, Intensive Care Unit, Madrid, 
      Spain
FAU - Simón, I. Fernández
AU  - Simón IF
AD  - Hospital Universtario Puerta de Hierro Majadahonda, Intensive Care Unit, Madrid, 
      Spain
FAU - Arrigo, M.
AU  - Arrigo M
AD  - AP-HP, Saint Louis and Lariboisière University Hospitals, Department of
      Anesthesiology and Critical Care Medicine, Paris, France
FAU - Feliot, E.
AU  - Feliot E
AD  - AP-HP, Saint Louis and Lariboisière University Hospitals, Department of
      Anesthesiology and Critical Care Medicine, Paris, France
FAU - Deye, N.
AU  - Deye N
AD  - AP-HP, Saint Louis and Lariboisière University Hospitals, Department of
      Anesthesiology and Critical Care Medicine, Paris, France
FAU - Cariou, A.
AU  - Cariou A
AD  - AP-HP, Hôpital Cochin, Medical Intensive Care Unit, Paris, France
FAU - Guidet, B.
AU  - Guidet B
AD  - AP-HP, Hôpital Saint-Antoine, Medical Intensive Care Unit, Paris, France
FAU - Jaber, S.
AU  - Jaber S
AD  - Saint-Eloi University Hospital, Department of Anesthesiology and Critical Care
      Medicine, Montpellier, France
FAU - Leone, M.
AU  - Leone M
AD  - AP-HM, Hôpital Nord, Department of Anesthesiology and Critical Care Medicine,
      Marseille, France
FAU - Resche-Rigon, M.
AU  - Resche-Rigon M
AD  - AP-HP, Saint Louis University Hospital, Biostatistics and Clinical Epidemiology
      Research Unit Department, Paris, France
FAU - Baron, A. Vieillard
AU  - Baron AV
AD  - AP-HP, Hôpital Ambroise Paré, Department of Anesthesiology and Critical Care
      Medicine, Paris, France
FAU - Legrand, M.
AU  - Legrand M
AD  - AP-HP, Saint Louis and Lariboisière University Hospitals, Department of
      Anesthesiology and Critical Care Medicine, Paris, France
FAU - Gayat, E.
AU  - Gayat E
AD  - AP-HP, Saint Louis and Lariboisière University Hospitals, Department of
      Anesthesiology and Critical Care Medicine, Paris, France
FAU - Mebazaa, A.
AU  - Mebazaa A
AD  - AP-HP, Saint Louis and Lariboisière University Hospitals, Department of
      Anesthesiology and Critical Care Medicine, Paris, France
CN  - from the FROG ICU Investigators
FAU - Balik, M.
AU  - Balik M
AD  - 1st Medical Faculty, Charles University, Prague, Czech Republic
FAU - Kolnikova, I.
AU  - Kolnikova I
AD  - 1st Medical Faculty, Charles University, Prague, Czech Republic
FAU - Maly, M.
AU  - Maly M
AD  - 1st Medical Faculty, Charles University, Prague, Czech Republic
FAU - Waldauf, P.
AU  - Waldauf P
AD  - 3rd Medical Faculty, Charles University, Prague, Czech Republic
FAU - Tavazzi, G.
AU  - Tavazzi G
AD  - University of Pavia, Pavia, Italy
FAU - Kristof, J.
AU  - Kristof J
AD  - 1st Medical Faculty, Charles University, Prague, Czech Republic
FAU - Herpain, A.
AU  - Herpain A
AD  - Erasme University Hospital, Université Libre de Bruxelles, Intensive Care Unit,
      Bruxelles, Belgium
FAU - Su, F.
AU  - Su F
AD  - Experimental Laboratory of Intensive Care, Université Libre de Bruxelles,
      Bruxelles, Belgium
FAU - Post, E.
AU  - Post E
AD  - Experimental Laboratory of Intensive Care, Université Libre de Bruxelles,
      Bruxelles, Belgium
FAU - Taccone, F.
AU  - Taccone F
AD  - Erasme University Hospital, Université Libre de Bruxelles, Intensive Care Unit,
      Bruxelles, Belgium
FAU - Vincent, J. L.
AU  - Vincent JL
AD  - Erasme University Hospital, Université Libre de Bruxelles, Intensive Care Unit,
      Bruxelles, Belgium
FAU - Creteur, J.
AU  - Creteur J
AD  - Erasme University Hospital, Université Libre de Bruxelles, Intensive Care Unit,
      Bruxelles, Belgium
FAU - Lee, C.
AU  - Lee C
AD  - Edwards Lifesciences, Critical Care, Irvine, USA
FAU - Hatib, F.
AU  - Hatib F
AD  - Edwards Lifesciences, Critical Care, Irvine, USA
FAU - Jian, Z.
AU  - Jian Z
AD  - Edwards Lifesciences, Critical Care, Irvine, USA
FAU - Buddi, S.
AU  - Buddi S
AD  - Edwards Lifesciences, Critical Care, Irvine, USA
FAU - Cannesson, M.
AU  - Cannesson M
AD  - University of California Los Angeles, Anesthesiology, Los Angeles, USA
FAU - Fileković, S.
AU  - Fileković S
AD  - University Medical Centre Ljubljana, Department of Anaesthesiology and Surgical
      Intensive Therapy, Ljubljana, Slovenia
FAU - Turel, M.
AU  - Turel M
AD  - University Medical Center Ljubljana, Department of Pulmonary Diseases and
      Allergy, Ljubljana, Slovenia
FAU - Knafelj, R.
AU  - Knafelj R
AD  - University Medical Center Ljubljana, Center for Intensive Internal Medicin,
      Ljubljana, Slovenia
FAU - Gorjup, V.
AU  - Gorjup V
AD  - University Medical Center Ljubljana, Center for Intensive Internal Medicin,
      Ljubljana, Slovenia
FAU - Stanić, R.
AU  - Stanić R
AD  - University Medical Centre Ljubljana, Department of Anaesthesiology and Surgical
      Intensive Therapy, Ljubljana, Slovenia
FAU - Gradišek, P.
AU  - Gradišek P
AD  - University Medical Centre Ljubljana, Department of Anaesthesiology and Surgical
      Intensive Therapy, Ljubljana, Slovenia
FAU - Cerović, O.
AU  - Cerović O
AD  - University Medical Centre Ljubljana, Department of Anaesthesiology and Surgical
      Intensive Therapy, Ljubljana, Slovenia
FAU - Mirković, T.
AU  - Mirković T
AD  - University Medical Centre Ljubljana, Department of Anaesthesiology and Surgical
      Intensive Therapy, Ljubljana, Slovenia
FAU - Noč, M.
AU  - Noč M
AD  - University Medical Center Ljubljana, Center for Intensive Internal Medicin,
      Ljubljana, Slovenia
FAU - Tirkkonen, J.
AU  - Tirkkonen J
AD  - Seinäjoki Central Hospital, Department of Anaesthesiology and Intensive Care
      Medicine, Seinäjoki, Finland
FAU - Hellevuo, H.
AU  - Hellevuo H
AD  - Tampere University Hospital, Department of Emergency Medicine, Tampere, Finland
FAU - Olkkola, K. T.
AU  - Olkkola KT
AD  - Helsinki University Hospital, Department of Anaesthesiology, Intensive Care,
      Emergency Care and Pain Medicine, Helsinki, Finland
FAU - Hoppu, S.
AU  - Hoppu S
AD  - Tampere University Hospital, Department of Intensive Care Medicine, Tampere,
      Finland
FAU - Lin, K. C.
AU  - Lin KC
AD  - Kaohsiung Veterans General Hospital, Department of Critical Care Medicine,
      Kaohsiung City, Taiwan, Province of China
FAU - Hung, W. T.
AU  - Hung WT
AD  - Kaohsiung Veterans General Hospital, Department of Critical Care Medicine,
      Kaohsiung City, Taiwan, Province of China
FAU - Chiang, C. C.
AU  - Chiang CC
AD  - Kaohsiung Veterans General Hospital, Cardiovascular division, Kaohsiung City,
      Taiwan, Province of China
FAU - Huang, W. C.
AU  - Huang WC
AD  - Kaohsiung Veterans General Hospital, Department of Critical Care Medicine,
      Kaohsiung City, Taiwan, Province of China
FAU - Juan, W. C.
AU  - Juan WC
AD  - Kaohsiung Veterans General Hospital, Department of Emergency, Kaohsiung City,
      Taiwan, Province of China
FAU - Lin, S. C.
AU  - Lin SC
AD  - Kaohsiung Veterans General Hospital, Department of Critical Care Medicine,
      Kaohsiung City, Taiwan, Province of China
FAU - Cheng, C. C.
AU  - Cheng CC
AD  - Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Lin, P. H.
AU  - Lin PH
AD  - Kaohsiung Veterans General Hospital, Department of Emergency, Kaohsiung City,
      Taiwan, Province of China
FAU - Fong, K. Y.
AU  - Fong KY
AD  - Kaohsiung Veterans General Hospital, Department of Emergency, Kaohsiung City,
      Taiwan, Province of China
FAU - Hou, D. S.
AU  - Hou DS
AD  - Kaohsiung Veterans General Hospital, Department of Emergency, Kaohsiung City,
      Taiwan, Province of China
FAU - Kang, P. L.
AU  - Kang PL
AD  - Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Wann, S. R.
AU  - Wann SR
AD  - Kaohsiung Veterans General Hospital, Department of Emergency, Kaohsiung City,
      Taiwan, Province of China
FAU - Chen, Y. S.
AU  - Chen YS
AD  - Kaohsiung Veterans General Hospital, Department of Internal Medicine, Kaohsiung
      City, Taiwan, Province of China
FAU - Mar, G. Y.
AU  - Mar GY
AD  - Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Liu, C. P.
AU  - Liu CP
AD  - Kaohsiung Veterans General Hospital, Cardiovascular division, Kaohsiung City,
      Taiwan, Province of China
FAU - Paul, M.
AU  - Paul M
AD  - ICU Cochin Hospital, Paris, France
FAU - Bougouin, W.
AU  - Bougouin W
AD  - ICU Cochin Hospital, Paris, France
FAU - Geri, G.
AU  - Geri G
AD  - ICU Cochin Hospital, Paris, France
FAU - Dumas, F.
AU  - Dumas F
AD  - Emergency Department, Cochin Hospital, Paris, France
FAU - Champigneulle, B.
AU  - Champigneulle B
AD  - ICU Cochin Hospital, Paris, France
FAU - Legriel, S.
AU  - Legriel S
AD  - ICU Mignot Hospital, Versailles, France
FAU - Charpentier, J.
AU  - Charpentier J
AD  - ICU Cochin Hospital, Paris, France
FAU - Mira, J. P.
AU  - Mira JP
AD  - ICU Cochin Hospital, Paris, France
FAU - Sandroni, C.
AU  - Sandroni C
AD  - Anesthesiology and Intensive Care, Catholic University School of Medicine, Rome, 
      Italy
FAU - Cariou, A.
AU  - Cariou A
AD  - ICU Cochin Hospital, Paris, France
FAU - Zimmerman, J.
AU  - Zimmerman J
AD  - University of Washington School of Medicine, Seattle Children’s Hospital,
      Pediatric Critical Care Medicine, Seattle, USA
FAU - Sullivan, E.
AU  - Sullivan E
AD  - University of Washington School of Medicine, Seattle Children’s Hospital,
      Pediatric Critical Care Medicine, Seattle, USA
FAU - Noursadeghi, M.
AU  - Noursadeghi M
AD  - University College London, Faculty of Medical Sciences, Division of Infection &
      Immunity, London, UK
FAU - Fox, B.
AU  - Fox B
AD  - Immunexpress, Seattle, USA
FAU - Sampson, D.
AU  - Sampson D
AD  - Immunexpress, Seattle, USA
FAU - McHugh, L.
AU  - McHugh L
AD  - Immunexpress, Seattle, USA
FAU - Yager, T.
AU  - Yager T
AD  - Immunexpress, Seattle, USA
FAU - Cermelli, S.
AU  - Cermelli S
AD  - Immunexpress, Seattle, USA
FAU - Seldon, T.
AU  - Seldon T
AD  - Immunexpress, Seattle, USA
FAU - Bhide, S.
AU  - Bhide S
AD  - Immunexpress, Seattle, USA
FAU - Brandon, R. A.
AU  - Brandon RA
AD  - Immunexpress, Seattle, USA
FAU - Brandon, R. B.
AU  - Brandon RB
AD  - Immunexpress, Seattle, USA
FAU - Zwaag, J.
AU  - Zwaag J
AD  - Radboud University Medical Center, Intensive Care Research, Nijmegen, Netherlands
FAU - Beunders, R.
AU  - Beunders R
AD  - Radboud University Medical Center, Intensive Care Research, Nijmegen, Netherlands
FAU - Pickkers, P.
AU  - Pickkers P
AD  - Radboud University Medical Center, Intensive Care Research, Nijmegen, Netherlands
FAU - Kox, M.
AU  - Kox M
AD  - Radboud University Medical Center, Intensive Care Research, Nijmegen, Netherlands
FAU - Gul, F.
AU  - Gul F
AD  - Marmara University, Anaesthesiology and Reanimation, Istanbul, Turkey
FAU - Arslantas, M. K.
AU  - Arslantas MK
AD  - Marmara University, Anaesthesiology and Reanimation, Istanbul, Turkey
FAU - Genc, D.
AU  - Genc D
AD  - Marmara University, Pediatric Immunology, Istanbul, Turkey
FAU - Zibandah, N.
AU  - Zibandah N
AD  - Marmara University, Pediatric Immunology, Istanbul, Turkey
FAU - Topcu, L.
AU  - Topcu L
AD  - Marmara University, Anaesthesiology and Reanimation, Istanbul, Turkey
FAU - Akkoc, T.
AU  - Akkoc T
AD  - Marmara University, Pediatric Immunology, Istanbul, Turkey
FAU - Cinel, I.
AU  - Cinel I
AD  - Marmara University, Anaesthesiology and Reanimation, Istanbul, Turkey
FAU - Greco, E.
AU  - Greco E
AD  - Bloomsbury Institute of Intensive Care Medicine, University College London,
      London, UK
FAU - Lauretta, M. P.
AU  - Lauretta MP
AD  - Bloomsbury Institute of Intensive Care Medicine, University College London,
      London, UK
FAU - Andreis, D. T.
AU  - Andreis DT
AD  - Bloomsbury Institute of Intensive Care Medicine, University College London,
      London, UK
FAU - Singer, M.
AU  - Singer M
AD  - Bloomsbury Institute of Intensive Care Medicine, University College London,
      London, UK
FAU - Garcia, I. Palacios
AU  - Garcia IP
AD  - Hospital Virgen del Rocio, Sevilla, Spain
FAU - Cordero, M.
AU  - Cordero M
AD  - Hospital Virgen del Rocio, Sevilla, Spain
FAU - Martin, A. Diaz
AU  - Martin AD
AD  - Hospital Virgen del Rocio, Sevilla, Spain
FAU - Pallás, T. Aldabó
AU  - Pallás TA
AD  - Hospital Virgen del Rocio, Sevilla, Spain
FAU - Montero, J. Garnacho
AU  - Montero JG
AD  - Hospital Virgen del Rocio, Sevilla, Spain
FAU - Rey, J. Revuelto
AU  - Rey JR
AD  - Hospital Virgen del Rocio, Sevilla, Spain
FAU - Malo, L. Roman
AU  - Malo LR
AD  - Hospital Virgen del Rocio, Sevilla, Spain
FAU - Montoya, A. A. Tanaka
AU  - Montoya AAT
AD  - ABC Medical Center, Critical Care Unit, Mexico, Mexico
FAU - Martinez, A. D. C. Amador
AU  - Martinez ADCA
AD  - ABC Medical Center, Mexico, Mexico
FAU - Ayala, L. Y. Delgado
AU  - Ayala LYD
AD  - ABC Medical Center, Mexico, Mexico
FAU - Zepeda, E. Monares
AU  - Zepeda EM
AD  - ABC Medical Center, Mexico, Mexico
FAU - Granillo, J. Franco
AU  - Granillo JF
AD  - ABC Medical Center, Mexico, Mexico
FAU - Sanchez, J. Aguirre
AU  - Sanchez JA
AD  - ABC Medical Center, Mexico, Mexico
FAU - Alejo, G. Camarena
AU  - Alejo GC
AD  - ABC Medical Center, Mexico, Mexico
FAU - Cabrera, A. Rugerio
AU  - Cabrera AR
AD  - ABC Medical Center, Mexico, Mexico
FAU - Montenegro, A. Pedraza
AU  - Montenegro AP
AD  - ABC Medical Center, Mexico, Mexico
FAU - Pham, T.
AU  - Pham T
AD  - Hôpital Tenon, APHP, Medical and Surgical ICU, Paris, France
FAU - Beduneau, G.
AU  - Beduneau G
AD  - Rouen University Hospital, Medical Intensive Care, Rouen, France
FAU - Schortgen, F.
AU  - Schortgen F
AD  - CHU Henri Mondor, Medical ICU, Créteil, France
FAU - Piquilloud, L.
AU  - Piquilloud L
AD  - University Hospital of Lausanne, Intensive Care and Burn Unit, Lausanne,
      Switzerland
FAU - Zogheib, E.
AU  - Zogheib E
AD  - CHU d’Amiens, Cardiothoracic and Vascular ICU, Amiens, France
FAU - Jonas, M.
AU  - Jonas M
AD  - CHU Hotel Dieu, Medical ICU, Nantes, France
FAU - Grelon, F.
AU  - Grelon F
AD  - Hospital Le Mans, Intensive Care Unit, Le Mans, France
FAU - Runge, I.
AU  - Runge I
AD  - CHR d’Orleans, Medical ICU, Orleans, France
FAU - Terzi, N.
AU  - Terzi N
AD  - CHU Grenoble Alpes, Medical ICU, Grenoble, France
FAU - Grangé, S.
AU  - Grangé S
AD  - Université Grenoble-Alpes, Inserm U1042, Grenoble, France
FAU - Barberet, G.
AU  - Barberet G
AD  - CHR de Mulhouse, Medical ICU, Mulhouse, France
FAU - Guitard, P. G.
AU  - Guitard PG
AD  - Rouen University Hospital, Surgical Intensive Care, Rouen, France
FAU - Frat, J. P.
AU  - Frat JP
AD  - CHU de Poitiers, Medical ICU, Poitiers, France
FAU - Constan, A.
AU  - Constan A
AD  - CHU Henri Mondor and ReVA Network, Medical ICU, Créteil, France
FAU - Chrétien, J. M.
AU  - Chrétien JM
AD  - CHU d’Angers, Clinical Research Institute, Angers, France
FAU - Mancebo, J.
AU  - Mancebo J
AD  - Hospital de Sant Pau, Servei de Medicina Intensiva, Barcelona, Spain
FAU - Mercat, A.
AU  - Mercat A
AD  - CHU d’Angers, Medical ICU, Angers, France
FAU - Richard, J. C. M.
AU  - Richard JCM
AD  - Annecy Genevois General Hospital, Annecy, France
FAU - Brochard, L.
AU  - Brochard L
AD  - University of Toronto Saint Michael’s Hospital and Keenan Research Centre,
      Interdepartmental Division of Critical Care, Toronto, Canada
CN  - The WIND study group
FAU - Soilemezi, E.
AU  - Soilemezi E
AD  - ‘Papageorgiou’ General Hospital, ICU, Thessaloniki, Greece
FAU - Koco, E.
AU  - Koco E
AD  - ‘Papageorgiou’ General Hospital, ICU, Thessaloniki, Greece
FAU - Savvidou, S.
AU  - Savvidou S
AD  - ‘Papageorgiou’ General Hospital, ICU, Thessaloniki, Greece
FAU - Nouris, C.
AU  - Nouris C
AD  - ‘Papageorgiou’ General Hospital, ICU, Thessaloniki, Greece
FAU - Matamis, D.
AU  - Matamis D
AD  - ‘Papageorgiou’ General Hospital, ICU, Thessaloniki, Greece
CN  - Plug Working Group
FAU - Di Mussi, R.
AU  - Di Mussi R
AD  - Dipartimento dell‘Emergenza e dei Trapianti d‘Organo, Università degli Studi
      “Aldo Moro”, Bari, Italy
FAU - Spadaro, S.
AU  - Spadaro S
AD  - Ferrara University, Ferrara, Italy
FAU - Volta, C. A.
AU  - Volta CA
AD  - Ferrara University, Ferrara, Italy
FAU - Mariani, M.
AU  - Mariani M
AD  - Dipartimento dell‘Emergenza e dei Trapianti d‘Organo, Università degli Studi
      “Aldo Moro”, Bari, Italy
FAU - Colaprico, A.
AU  - Colaprico A
AD  - Dipartimento dell‘Emergenza e dei Trapianti d‘Organo, Università degli Studi
      “Aldo Moro”, Bari, Italy
FAU - Antonio, C.
AU  - Antonio C
AD  - Dipartimento dell‘Emergenza e dei Trapianti d‘Organo, Università degli Studi
      “Aldo Moro”, Bari, Italy
FAU - Bruno, F.
AU  - Bruno F
AD  - Dipartimento dell‘Emergenza e dei Trapianti d‘Organo, Università degli Studi
      “Aldo Moro”, Bari, Italy
FAU - Grasso, S.
AU  - Grasso S
AD  - Dipartimento dell‘Emergenza e dei Trapianti d‘Organo, Università degli Studi
      “Aldo Moro”, Bari, Italy
FAU - Rodriguez, A.
AU  - Rodriguez A
AD  - Hospital Universitari Joan XXIII, Critical Care Medicine, Tarragona, Spain
FAU - Martín-Loeches, I.
AU  - Martín-Loeches I
AD  - St James’s University Hospital. Trinity Center for Health Sciences, Anaesthesia
      and Critical Care, Dublin, Ireland
FAU - Díaz, E.
AU  - Díaz E
AD  - Hospital Parc Tauli, Critical Care Medicine, Sabadell, Spain
FAU - Masclans, J. R.
AU  - Masclans JR
AD  - Hospital del Mar/CIBERES/UPF, Critical Care Medicine, Barcelona, Spain
FAU - Gordo, F.
AU  - Gordo F
AD  - Hospital del Henares, Critical Care Medicine, Madrid, Spain
FAU - Solé-Violán, J.
AU  - Solé-Violán J
AD  - Hospital Dr. Negrín, Critical Care Medicine, Las Palmas de Gran Canaria, Spain
FAU - Bodí, M.
AU  - Bodí M
AD  - Hospital Universitari Joan XXIII, Critical Care Medicine, Tarragona, Spain
FAU - Avilés-Jurado, F. X.
AU  - Avilés-Jurado FX
AD  - Universitat Rovira i Virgili/IISPV, Tarragona, Spain
FAU - Trefler, S.
AU  - Trefler S
AD  - Hospital Universitari Joan XXIII, Critical Care Medicine, Tarragona, Spain
FAU - Magret, M.
AU  - Magret M
AD  - Hospital Universitari Joan XXIII, Critical Care Medicine, Tarragona, Spain
FAU - Reyes, L. F.
AU  - Reyes LF
AD  - UT Heatlh Science Center at San Antonio and South Texas Veterans Health Care
      System, Pulmonary Disease and Critical Care, San Antonio, USA
FAU - Marín-Corral, J.
AU  - Marín-Corral J
AD  - Hospital del Mar/CIBERES/UPF, Critical Care Medicine, Barcelona, Spain
FAU - Yebenes, J. C.
AU  - Yebenes JC
AD  - Hospital de Mataró, Critical Care Medicine, Mataró, Spain
FAU - Esteban, A.
AU  - Esteban A
AD  - Hospital de Getafe, Critical Care Medicine, Madrid, Spain
FAU - Anzueto, A.
AU  - Anzueto A
AD  - UT Heatlh Science Center at San Antonio and South Texas Veterans Health Care
      System, Pulmonary Disease and Critical Care, San Antonio, USA
FAU - Aliberti, S.
AU  - Aliberti S
AD  - University of Milan - Biocca San Genaro Hospital, School of Medicine and Surgery,
      Monza, Italy
FAU - Restrepo, M. I.
AU  - Restrepo MI
AD  - UT Heatlh Science Center at San Antonio and South Texas Veterans Health Care
      System, Pulmonary Disease and Critical Care, San Antonio, USA
CN  - GETGAG/SEMICYUC
FAU - Larsson, J. Skytte
AU  - Larsson JS
AD  - University of Gothenburg, Department of Anesthesia and Intensive Care,
      Sahlgrenska University Hospital, Göteborg, Sweden
FAU - Redfors, B.
AU  - Redfors B
AD  - University of Gothenburg, Department of Cardiothoracic Anesthesia and Intensive
      Care, Sahlgrenska University Hospital, Göteborg, Sweden
FAU - Ricksten, S. E.
AU  - Ricksten SE
AD  - University of Gothenburg, Department of Anesthesia and Intensive Care,
      Sahlgrenska University Hospital, Göteborg, Sweden
FAU - Haines, R.
AU  - Haines R
AD  - Guy’s & St Thomas Hospital, London, UK
FAU - Powell-Tuck, J.
AU  - Powell-Tuck J
AD  - Guy’s & St Thomas Hospital, London, UK
FAU - Leonard, H.
AU  - Leonard H
AD  - Guy’s & St Thomas Hospital, London, UK
FAU - Ostermann, M.
AU  - Ostermann M
AD  - Guy’s & St Thomas Hospital, London, UK
FAU - Berthelsen, R. E.
AU  - Berthelsen RE
AD  - Nordsjællands Hospital, Dept. of Anaesthesiology and Intensive Care, Hillerød,
      Denmark
FAU - Itenov, T. S.
AU  - Itenov TS
AD  - Nordsjællands Hospital, Dept. of Anaesthesiology and Intensive Care, Hillerød,
      Denmark
FAU - Perner, A.
AU  - Perner A
AD  - Rigshospitalet, Copenhagen University Hospital, Dept. of intensive Care,
      Copenhagen, Denmark
FAU - Jensen, J. U.
AU  - Jensen JU
AD  - Rigshospitalet, Copenhagen University Hospital, CHIP & PERSIMUNE, Dept. of
      Infectious Diseases, Copenhagen, Denmark
FAU - Ibsen, M.
AU  - Ibsen M
AD  - Nordsjællands Hospital, Dept. of Anaesthesiology and Intensive Care, Hillerød,
      Denmark
FAU - Jensen, A. E. K.
AU  - Jensen AEK
AD  - University of Copenhagen, Dept. of Biostatistics, Copenhagen, Denmark
FAU - Bestle, M. H.
AU  - Bestle MH
AD  - Nordsjællands Hospital, Dept. of Anaesthesiology and Intensive Care, Hillerød,
      Denmark
FAU - Bucknall, T.
AU  - Bucknall T
AD  - St George’s, University of London, London, UK
FAU - Dixon, J.
AU  - Dixon J
AD  - St Georges NHS Foundation Trust, General Intensive Care, London, UK
FAU - Boa, F.
AU  - Boa F
AD  - St Georges NHS Foundation Trust, Clinical Blood Sciences, London, UK
FAU - MacPhee, I.
AU  - MacPhee I
AD  - St George’s, University of London, Renal Medicine, London, UK
FAU - Philips, B. J.
AU  - Philips BJ
AD  - St George’s, University of London, General Intensive Care, London, UK
CN  - AKI Research Group
CN  - St George’s University of London
FAU - Doyle, J.
AU  - Doyle J
AD  - Department of Intensive Care Medicine and Surrey Peri-Operative Anaesthesia and
      Critical Care Collaborative Research Group (SPACER), Guildford, UK
FAU - Saadat, F.
AU  - Saadat F
AD  - Department of Intensive Care Medicine and Surrey Peri-Operative Anaesthesia and
      Critical Care Collaborative Research Group (SPACER), Guildford, UK
FAU - Samuels, T.
AU  - Samuels T
AD  - Department of Intensive Care Medicine and Surrey Peri-Operative Anaesthesia and
      Critical Care Collaborative Research Group (SPACER), Guildford, UK
FAU - Huddart, S.
AU  - Huddart S
AD  - Department of Anaesthesia, Royal Surrey County Hospital NHS Foundation Trust,
      Guildford, UK
FAU - McCormick, B.
AU  - McCormick B
AD  - Royal Devon and Exeter Hospital, Exeter, UK
FAU - DeBrunnar, R.
AU  - DeBrunnar R
AD  - Royal Devon and Exeter Hospital, Exeter, UK
FAU - Preece, J.
AU  - Preece J
AD  - Royal Devon and Exeter Hospital, Exeter, UK
FAU - Swart, M.
AU  - Swart M
AD  - South Devon Healthcare NHS Foundation Trust, Torquay, UK
FAU - Peden, C.
AU  - Peden C
AD  - Department of Anaesthesia and Intensive Care, Royal United Hospital Bath NHS
      Trust, Bath, UK
FAU - Richardson, S.
AU  - Richardson S
AD  - Department of Surgery, Royal United Hospital Bath NHS Trust, Bath, UK
FAU - Forni, L.
AU  - Forni L
AD  - Department of Intensive Care Medicine and Surrey Peri-Operative Anaesthesia and
      Critical Care Collaborative Research Group (SPACER), Guildford, UK
FAU - Kalfon, P.
AU  - Kalfon P
AD  - CH Chartres, Réanimation, Chartres, France
FAU - Baumstarck, K.
AU  - Baumstarck K
AD  - Aix-Marseille Université, Unité de Recherche EA 3279, Marseille, France
FAU - Estagnasie, P.
AU  - Estagnasie P
AD  - Clinique Ambroise Paré, Réanimation, Neuilly/Seine, France
FAU - Geantot, M. A.
AU  - Geantot MA
AD  - CHU Dijon Bourgogne, Anesthésie Réanimation, Dijon, France
FAU - Berric, A.
AU  - Berric A
AD  - CHI Toulon/La Seyne sur Mer, Réanimation Polyvalente, Toulon, France
FAU - Simon, G.
AU  - Simon G
AD  - CH Troyes, Réanimation, Troyes, France
FAU - Floccard, B.
AU  - Floccard B
AD  - CHU Edouard Herriot, Hospices Civils de Lyon, Réanimation Polyvalente, Lyon,
      France
FAU - Signouret, T.
AU  - Signouret T
AD  - Hôpital Européen de Marseille, Réanimation, Marseille, France
FAU - Boucekine, M.
AU  - Boucekine M
AD  - Aix-Marseille Université, Unité de Recherche EA 3279, Marseille, France
FAU - Fromentin, M.
AU  - Fromentin M
AD  - CHU Cochin, AP-HP, Réanimation Chirurgicale, Paris, France
FAU - Nyunga, M.
AU  - Nyunga M
AD  - CH Victor Provo, Réanimation Polyvalente, Roubaix, France
FAU - Sossou, A.
AU  - Sossou A
AD  - CH Emile Roux, Réanimation, Le Puy-en-Velay, France
FAU - Venot, M.
AU  - Venot M
AD  - CHU Saint-Louis, Réanimation Médicale, Paris, France
FAU - Robert, R.
AU  - Robert R
AD  - CHU La Milétrie, Réanimation Médicale, Poitiers, France
FAU - Follin, A.
AU  - Follin A
AD  - Hôpital Européen Georges Pompidou, AP-HP, Réanimation Chirugicale, Paris, France
FAU - Renault, A.
AU  - Renault A
AD  - CHU Brest, Réanimation Médicale, Brest, France
FAU - Garrouste, M.
AU  - Garrouste M
AD  - Groupe Hospitalier Paris Saint-Joseph, Médecine Intensive et Réanimation, Paris, 
      France
FAU - Collange, O.
AU  - Collange O
AD  - CHU Strasbourg, Hôpital Civil, Réanimation Chirugicale Polyvalente, Strasbourg,
      France
FAU - Levrat, Q.
AU  - Levrat Q
AD  - Groupe Hospitalier de La Rochelle - Ré - Aunis, Réanimation, La Rochelle, France
FAU - Villard, I.
AU  - Villard I
AD  - CHU Beaujon, AP-HP, Anesthésie Réanimation, Clichy, France
FAU - Thévenin, D.
AU  - Thévenin D
AD  - CH Lens, Réanimation, Lens, France
FAU - Pottecher, J.
AU  - Pottecher J
AD  - CHU Strasbourg, Hôpital Hautepierre, Réanimation Chirugicale, Strasbourg, France
FAU - Patrigeon, R. G.
AU  - Patrigeon RG
AD  - CH Auxerre, Réanimation, Auxerre, France
FAU - Revel, N.
AU  - Revel N
AD  - CHU Nice, Hôpital Pasteur, Réanimation Médico-Chirurgicale, Nice, France
FAU - Vigne, C.
AU  - Vigne C
AD  - CHU Hôpital Nord, AP-HM, Réanimation Chirugicale, Marseille, France
FAU - Mimoz, O.
AU  - Mimoz O
AD  - CHU La Milétrie, Réanimation Chirugicale, Poitiers, France
FAU - Auquier, P.
AU  - Auquier P
AD  - Aix-Marseille Université, Unité de Recherche EA 3279, Marseille, France
CN  - IPREA Study Group
FAU - Pawar, S.
AU  - Pawar S
AD  - St George Hospital, Intensive Care, Sydney, Australia
FAU - Jacques, T.
AU  - Jacques T
AD  - St George Hospital, Sydney, Australia
FAU - Deshpande, K.
AU  - Deshpande K
AD  - St George Hospital, Sydney, Australia
FAU - Pusapati, R.
AU  - Pusapati R
AD  - St George Hospital, Sydney, Australia
FAU - Wood, B.
AU  - Wood B
AD  - St George Hospital, Sydney, Australia
FAU - Pulham, R. A.
AU  - Pulham RA
AD  - Great Ormond Street Hospital, Critical Care and Cardiorespiratory Division,
      London, UK
FAU - Wray, J.
AU  - Wray J
AD  - Great Ormond Street Hospital, Critical Care and Cardiorespiratory Division,
      London, UK
FAU - Brown, K.
AU  - Brown K
AD  - Great Ormond Street Hospital, Critical Care and Cardiorespiratory Division,
      London, UK
FAU - Pierce, C.
AU  - Pierce C
AD  - Great Ormond Street Hospital, Paediatric Intensive Care Unit, London, UK
FAU - Nadel, S.
AU  - Nadel S
AD  - St Mary’s Hospital and Charing Cross Hospital Imperial College NHS trust,
      Paediatric Intensive Care Unit, London, UK
FAU - Ramnarayan, P.
AU  - Ramnarayan P
AD  - Great Ormond Street Hospital, Children’s Acute Transport Service, London, UK
FAU - Azevedo, J. R.
AU  - Azevedo JR
AD  - Hospital Sao Domingos, ICU, Sao Luis, Brazil
FAU - Montenegro, W. S.
AU  - Montenegro WS
AD  - Hospital Sao Domingos, ICU, Sao Luis, Brazil
FAU - Rodrigues, D. P.
AU  - Rodrigues DP
AD  - Hospital Sao Domingos, Sao Luis, Brazil
FAU - Sousa, S. C.
AU  - Sousa SC
AD  - Hospital Sao Domingos, ICU, Sao Luis, Brazil
FAU - Araujo, V. F.
AU  - Araujo VF
AD  - Hospital Sao Domingos, ICU, Sao Luis, Brazil
FAU - Leitao, A. L.
AU  - Leitao AL
AD  - Hospital Sao Domingos, ICU, Sao Luis, Brazil
FAU - Prazeres, P. H.
AU  - Prazeres PH
AD  - Hospital Sao Domingos, ICU, Sao Luis, Brazil
FAU - Mendonca, A. V.
AU  - Mendonca AV
AD  - Hospital Sao Domingos, ICU, Sao Luis, Brazil
FAU - Paula, M. P.
AU  - Paula MP
AD  - Hospital Sao Domingos, Sao Luis, Brazil
FAU - Das Neves, A.
AU  - Das Neves A
AD  - HIGA Gral San Martin, La Plata, Argentina
FAU - Loudet, C. I.
AU  - Loudet CI
AD  - HIGA Gral San Martin, La Plata, Argentina
FAU - Busico, M.
AU  - Busico M
AD  - Hospital de Trauma F Abete, Municipio Islas Malvinas, Argentina
FAU - Vazquez, D.
AU  - Vazquez D
AD  - Sanatorio Anchorena, Buenos Aires, Argentina
FAU - Villalba, D.
AU  - Villalba D
AD  - Hospital Municipal Chivilcoy, Chivilcoy, Argentina
FAU - Lischinsky, A.
AU  - Lischinsky A
AD  - Instituto De Neurología Cognitiva-INECO, Buenos Aires, Argentina
FAU - Veronesi, M.
AU  - Veronesi M
AD  - Instituto Fleni, Escobar, Argentina
FAU - Emmerich, M.
AU  - Emmerich M
AD  - Sanatorio Güemes, Buenos Aires, Argentina
FAU - Descotte, E.
AU  - Descotte E
AD  - Hospital Británico de Buenos Aires, Buenos Aires, Argentina
FAU - Juliarena, A.
AU  - Juliarena A
AD  - Hospital Austral, Pilar, Argentina
FAU - Bisso, M. Carboni
AU  - Bisso MC
AD  - Hospital San Antonio, Gualeguay, Argentina
FAU - Grando, M.
AU  - Grando M
AD  - Clinica Bazterrica, Buenos Aires, Argentina
FAU - Tapia, A.
AU  - Tapia A
AD  - Hospital Domingo Funes, Santa Maria de Punilla, Argentina
FAU - Camargo, M.
AU  - Camargo M
AD  - Hospital San Luis, San Luis, Argentina
FAU - Ulla, D. Villani
AU  - Ulla DV
AD  - HIGA San José, Pergamino, Argentina
FAU - Corzo, L.
AU  - Corzo L
AD  - Hospital Artemides Zatti, Viedma, Argentina
FAU - dos Santos, H. Placido
AU  - dos Santos HP
AD  - Hospital de Gastroenterologia Udaondo, Buenos Aires, Argentina
FAU - Ramos, A.
AU  - Ramos A
AD  - Sanatorio Parque, Rosario, Argentina
FAU - Doglia, J. A.
AU  - Doglia JA
AD  - Hospital Dr. Carlos Macías, Mar de Ajó, Argentina
FAU - Estenssoro, E.
AU  - Estenssoro E
AD  - HIGA San José, Pergamino, Argentina
FAU - Carbonara, M.
AU  - Carbonara M
AD  - Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico, Department of
      Anaesthesiology and Intensive Care, Milan, Italy
FAU - Magnoni, S.
AU  - Magnoni S
AD  - Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico, Department of
      Anaesthesiology and Intensive Care, Milano, Italy
FAU - Donald, C. L. Mac
AU  - Donald CLM
AD  - University of Washington School of Medicine, Department of Neurological Surgery, 
      Seattle, USA
FAU - Shimony, J. S.
AU  - Shimony JS
AD  - Washington University, Mallinckrodt Institute of Radiology, St. Louis, USA
FAU - Conte, V.
AU  - Conte V
AD  - Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico, Department of
      Anaesthesiology and Intensive Care, Milano, Italy
FAU - Triulzi, F.
AU  - Triulzi F
AD  - Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico, Department of
      Neuroradiology, Milano, Italy
FAU - Stretti, F.
AU  - Stretti F
AD  - Milan University, Milano, Italy
FAU - Macrì, M.
AU  - Macrì M
AD  - Milan University, Milano, Italy
FAU - Snyder, A. Z.
AU  - Snyder AZ
AD  - Washington University, Mallinckrodt Institute of Radiology, St. Louis, USA
FAU - Stocchetti, N.
AU  - Stocchetti N
AD  - Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico, Department of
      Anaesthesiology and Intensive Care, Milano, Italy
FAU - Brody, D. L.
AU  - Brody DL
AD  - Washington University, Department of Neurology, St. Louis, USA
FAU - Podlepich, V.
AU  - Podlepich V
AD  - Burdenko Neurosurgery Institute, Moscow, Russian Federation
FAU - Shimanskiy, V.
AU  - Shimanskiy V
AD  - Burdenko Neurosurgery Institute, Moscow, Russian Federation
FAU - Savin, I.
AU  - Savin I
AD  - Burdenko Neurosurgery Institute, Moscow, Russian Federation
FAU - Lapteva, K.
AU  - Lapteva K
AD  - Burdenko Neurosurgery Institute, Moscow, Russian Federation
FAU - Chumaev, A.
AU  - Chumaev A
AD  - Burdenko Neurosurgery Institute, Moscow, Russian Federation
FAU - Tjepkema-Cloostermans, M. C.
AU  - Tjepkema-Cloostermans MC
AD  - Medisch Spectrum Twente, Clinical Neurophysiology and Neurology, Enschede,
      Netherlands
FAU - Hofmeijer, J.
AU  - Hofmeijer J
AD  - Rijnstate Hospital, Neurology, Arnhem, Netherlands
FAU - Beishuizen, A.
AU  - Beishuizen A
AD  - Medisch Spectrum Twente, Intensive Care Medicine, Enschede, Netherlands
FAU - Hom, H.
AU  - Hom H
AD  - Medisch Spectrum Twente, Intensive Care Medicine, Enschede, Netherlands
FAU - Blans, M. J.
AU  - Blans MJ
AD  - Rijnstate Hospital, Intensive Care Medicine, Arnhem, Netherlands
FAU - van Putten, M. J. A. M.
AU  - van Putten MJAM
AD  - Medisch Spectrum Twente, Clinical Neurophysiology and Neurology, Enschede,
      Netherlands
FAU - Longhi, L.
AU  - Longhi L
AD  - Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Anesthesia and Critical
      Care Medicine, Bergamo, Italy
FAU - Frigeni, B.
AU  - Frigeni B
AD  - Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Neurology, Bergamo,
      Italy
FAU - Curinga, M.
AU  - Curinga M
AD  - University of Milan, Milano, Italy
FAU - Mingone, D.
AU  - Mingone D
AD  - University of Milan - Bicocca, Monza, Italy
FAU - Beretta, S.
AU  - Beretta S
AD  - Ospedale San Gerardo, Neurology, Monza, Italy
FAU - Patruno, A.
AU  - Patruno A
AD  - Ospedale San Gerardo, Anesthesia and Critical Care Medicine, Monza, Italy
FAU - Gandini, L.
AU  - Gandini L
AD  - Ospedale San Gerardo, Anesthesia and Critical Care Medicine, Monza, Italy
FAU - Vargiolu, A.
AU  - Vargiolu A
AD  - Ospedale San Gerardo, Anesthesia and Critical Care Medicine, Monza, Italy
FAU - Ferri, F.
AU  - Ferri F
AD  - Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Anesthesia and Critical
      Care Medicine, Bergamo, Italy
FAU - Ceriani, R.
AU  - Ceriani R
AD  - Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Anesthesia and Critical
      Care Medicine, Bergamo, Italy
FAU - Rottoli, M. R.
AU  - Rottoli MR
AD  - Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Neurology, Bergamo,
      Italy
FAU - Lorini, L.
AU  - Lorini L
AD  - Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Anesthesia and Critical
      Care Medicine, Bergamo, Italy
FAU - Citerio, G.
AU  - Citerio G
AD  - University of Milan - Bicocca, Monza, Italy
FAU - Pifferi, S.
AU  - Pifferi S
AD  - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Neuroscience Intensive
      Care Unit, Milan, Italy
FAU - Battistini, M.
AU  - Battistini M
AD  - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Neuroscience Intensive
      Care Unit, Milan, Italy
FAU - Cordolcini, V.
AU  - Cordolcini V
AD  - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Neuroscience Intensive
      Care Unit, Milan, Italy
FAU - Agarossi, A.
AU  - Agarossi A
AD  - Università degli Studi di Milano, Milan, Italy
FAU - Di Rosso, R.
AU  - Di Rosso R
AD  - Università degli Studi di Milano, Milan, Italy
FAU - Ortolano, F.
AU  - Ortolano F
AD  - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Neuroscience Intensive
      Care Unit, Milan, Italy
FAU - Stocchetti, N.
AU  - Stocchetti N
AD  - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Neuroscience Intensive
      Care Unit, Milan, Italy
FAU - Lourido, C. Mora
AU  - Lourido CM
AD  - Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain
FAU - Cabrera, J. L. Santana
AU  - Cabrera JLS
AD  - Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain
FAU - Santana, J. D. Martín
AU  - Santana JDM
AD  - Hospital Insular Las Palmas GC, Department of Economy, University of Las Palmas
      de Gran Canaria, Las Palmas de Gran Canaria, Spain
FAU - Alzola, L. Melián
AU  - Alzola LM
AD  - Hospital Insular Las Palmas GC, Department of Economy, University of Las Palmas
      de Gran Canaria, Las Palmas de Gran Canaria, Spain
FAU - del Rosario, C. García
AU  - del Rosario CG
AD  - Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain
FAU - Pérez, H. Rodríguez
AU  - Pérez HR
AD  - Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain
FAU - Torrent, R. Lorenzo
AU  - Torrent RL
AD  - Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain
FAU - Eslami, S.
AU  - Eslami S
AD  - Academic Medical Center, University of Amsterdam, Medical Informatics, Amsterdam,
      Netherlands
FAU - Dalhuisen, A.
AU  - Dalhuisen A
AD  - Gelre Hospitals Apeldoorn, Intensive Care Medicine, Apeldoorn, Netherlands
FAU - Fiks, T.
AU  - Fiks T
AD  - Gelre Hospitals Apeldoorn, Intensive Care Medicine, Apeldoorn, Netherlands
FAU - Schultz, M. J.
AU  - Schultz MJ
AD  - Academic Medical Center, University of Amsterdam, Intensive Care Medicine,
      Amsterdam, Netherlands
FAU - Hanna, A. Abu
AU  - Hanna AA
AD  - Academic Medical Center, University of Amsterdam, Medical Informatics, Amsterdam,
      Netherlands
FAU - Spronk, P. E.
AU  - Spronk PE
AD  - Gelre Hospitals Apeldoorn, Intensive Care Medicine, Apeldoorn, Netherlands
FAU - Wood, M.
AU  - Wood M
AD  - Queen’s University, Centre for Neuroscience Studies, Kingston, Canada
FAU - Maslove, D.
AU  - Maslove D
AD  - Queen’s University, Medicine and Critical Care, Kingston, Canada
FAU - Muscedere, J.
AU  - Muscedere J
AD  - Queen’s University, Medicine and Critical Care, Kingston, Canada
FAU - Scott, S. H.
AU  - Scott SH
AD  - Queen’s University, Centre for Neuroscience Studies, Kingston, Canada
FAU - Saha, T.
AU  - Saha T
AD  - Queen’s University, Anaesthesia and Perioperative Medicine, Kingston, Canada
FAU - Hamilton, A.
AU  - Hamilton A
AD  - Queen’s University, Surgery, Kingston, Canada
FAU - Petsikas, D.
AU  - Petsikas D
AD  - Queen’s University, Surgery, Kingston, Canada
FAU - Payne, D.
AU  - Payne D
AD  - Queen’s University, Surgery, Kingston, Canada
FAU - Boyd, J. G.
AU  - Boyd JG
AD  - Queen’s University, Centre for Neuroscience Studies, Kingston, Canada
FAU - Puthucheary, Z. A.
AU  - Puthucheary ZA
AD  - University College London Hospitals NHS Foundation Trust, Division of Critical
      Care, London, UK
FAU - McNelly, A. S.
AU  - McNelly AS
AD  - University College London Hospitals, NIHR Biomedical Research Centre, London, UK
FAU - Rawal, J.
AU  - Rawal J
AD  - UCL/University College London Hospitals NHS Foundation Trust, Institute of Sport,
      Exercise and Health, London, UK
FAU - Connolly, B.
AU  - Connolly B
AD  - Guy’s & St Thomas’ NHS Foundation Trust and King’s College London, NIHR
      Biomedical Research Centre, London, UK
FAU - McPhail, M. J.
AU  - McPhail MJ
AD  - St Mary’s Hospital and Imperial College London, Hepatology & Gastroenterology,
      London, UK
FAU - Sidhu, P.
AU  - Sidhu P
AD  - Kings College Hospital NHS Foundation Trust, Department of Radiology, London, UK
FAU - Rowlerson, A.
AU  - Rowlerson A
AD  - Kings College London, Centre of Human and Aerospace Physiological Sciences,
      London, UK
FAU - Moxham, J.
AU  - Moxham J
AD  - King’s College London, Department of Asthma, Allergy and Lung Biology, London, UK
FAU - Harridge, S. D.
AU  - Harridge SD
AD  - Kings College London, Centre of Human and Aerospace Physiological Sciences,
      London, UK
FAU - Hart, N.
AU  - Hart N
AD  - Guy’s & St Thomas’ NHS Foundation Trust, Lane Fox Clinical Respiratory Physiology
      Research Centre, London, UK
FAU - Montgomery, H. E.
AU  - Montgomery HE
AD  - University College London Hospitals, NIHR Biomedical Research Centre, London, UK
FAU - Jovaisa, T.
AU  - Jovaisa T
AD  - Queen’s Hospital, Critical Care Department, Romford, UK
FAU - Thomas, B.
AU  - Thomas B
AD  - Queen’s Hospital, Critical Care Department, Romford, UK
FAU - Gupta, D.
AU  - Gupta D
AD  - Queen’s Hospital, Pharmacy Service, Romford, UK
FAU - Wijayatilake, D. S.
AU  - Wijayatilake DS
AD  - Queen’s Hospital, Critical Care Department, Romford, UK
FAU - Shum, H. P.
AU  - Shum HP
AD  - Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong China
FAU - King, H. S.
AU  - King HS
AD  - Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong China
FAU - Chan, K. C.
AU  - Chan KC
AD  - Tuen Mun Hospital, Hong Kong, Hong Kong China
FAU - Tang, K. B.
AU  - Tang KB
AD  - Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong China
FAU - Yan, W. W.
AU  - Yan WW
AD  - Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong China
FAU - Arias, C. Castro
AU  - Arias CC
AD  - Hospital Universitario La Paz, Madrid, Spain
FAU - Latorre, J.
AU  - Latorre J
AD  - Hospital Universitario La Paz, Madrid, Spain
FAU - De La Rica, A. Suárez
AU  - De La Rica AS
AD  - Hospital Universitario La Paz, Madrid, Spain
FAU - Garrido, E. Maseda
AU  - Garrido EM
AD  - Hospital Universitario La Paz, Madrid, Spain
FAU - Feijoo, A. Montero
AU  - Feijoo AM
AD  - Hospital Universitario La Paz, Madrid, Spain
FAU - Gancedo, C. Hernández
AU  - Gancedo CH
AD  - Hospital Universitario La Paz, Madrid, Spain
FAU - Tofiño, A. López
AU  - Tofiño AL
AD  - Hospital Universitario La Paz, Madrid, Spain
FAU - Rodríguez, F. Gilsanz
AU  - Rodríguez FG
AD  - Hospital Universitario La Paz, Madrid, Spain
FAU - Gemmell, L. K.
AU  - Gemmell LK
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Campbell, R.
AU  - Campbell R
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Doherty, P.
AU  - Doherty P
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - MacKay, A.
AU  - MacKay A
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Singh, N.
AU  - Singh N
AD  - Royal Berkshire Hospital, Critical Care Unit, Reading, UK
FAU - Vitaller, S.
AU  - Vitaller S
AD  - Hospital Costa del Sol Marbella, Malaga, Spain
FAU - Nagib, H.
AU  - Nagib H
AD  - Hospital Costa del Sol Marbella, Malaga, Spain
FAU - Prieto, J.
AU  - Prieto J
AD  - Hospital Costa del Sol Marbella, Malaga, Spain
FAU - Del Arco, A.
AU  - Del Arco A
AD  - Hospital Costa del Sol Marbella, Malaga, Spain
FAU - Zayas, B.
AU  - Zayas B
AD  - Hospital Costa del Sol Marbella, Malaga, Spain
FAU - Gomez, C.
AU  - Gomez C
AD  - Hospital Costa del Sol Marbella, Malaga, Spain
FAU - Tirumala, S.
AU  - Tirumala S
AD  - NRI Medical College and Hospital, Department of Critical Care, Guntur, India
FAU - Pasha, S. A.
AU  - Pasha SA
AD  - NRI Medical College and Hospital, Department of Critical Care, Guntur, India
FAU - Kumari, B. K.
AU  - Kumari BK
AD  - NRI Medical College and Hospital, Department of Critical Care, Guntur, India
FAU - Martinez-Lopez, P.
AU  - Martinez-Lopez P
AD  - Hospital Universitario Virgen de la Victoria, Malaga, Spain
FAU - Puerto-Morlán, A.
AU  - Puerto-Morlán A
AD  - Hospital Universitario Virgen de la Victoria, Malaga, Spain
FAU - Nuevo-Ortega, P.
AU  - Nuevo-Ortega P
AD  - Hospital Universitario Virgen de la Victoria, Malaga, Spain
FAU - Pujol, L. Martinez
AU  - Pujol LM
AD  - Hospital Universitari Mutua Terrassa, Intensive Care Medicine, Terrassa, Spain
FAU - Dolset, R. Algarte
AU  - Dolset RA
AD  - Hospital Universitari Mutua Terrassa, Intensive Care Medicine, Terrassa, Spain
FAU - González, B. Sánchez
AU  - González BS
AD  - Hospital Universitari Mutua Terrassa, Intensive Care Medicine, Terrassa, Spain
FAU - Riera, S. Quintana
AU  - Riera SQ
AD  - Hospital Universitari Mutua Terrassa, Intensive Care Medicine, Terrassa, Spain
FAU - Álvarez, J. Trenado
AU  - Álvarez JT
AD  - Hospital Universitari Mutua Terrassa, Intensive Care Medicine, Terrassa, Spain
FAU - Quintana, S.
AU  - Quintana S
AD  - Hospital Universitari Mutua Terrassa, Critical Care Department, Terrassa, Spain
FAU - Martínez, L.
AU  - Martínez L
AD  - Hospital Universitari Mutua Terrassa, Critical Care Department, Terrassa, Spain
FAU - Algarte, R.
AU  - Algarte R
AD  - Hospital Universitari Mutua Terrassa, Critical Care Department, Terrassa, Spain
FAU - Sánchez, B.
AU  - Sánchez B
AD  - Hospital Universitari Mutua Terrassa, Critical Care Department, Terrassa, Spain
FAU - Trenado, J.
AU  - Trenado J
AD  - Hospital Universitari Mutua Terrassa, Critical Care Department, Terrassa, Spain
FAU - Tomas, E.
AU  - Tomas E
AD  - Clinica Sagrada Esperança, Luanda, Angola
FAU - Brock, N.
AU  - Brock N
AD  - Clinica Sagrada Esperança, Luanda, Angola
FAU - Viegas, E.
AU  - Viegas E
AD  - Clinica Sagrada Esperança, Luanda, Angola
FAU - Filipe, E.
AU  - Filipe E
AD  - Clinica Sagrada Esperança, Luanda, Angola
FAU - Cottle, D.
AU  - Cottle D
AD  - Lancashire Teaching Hospitals Trust, Critical Care, Preston, UK
FAU - Traynor, T.
AU  - Traynor T
AD  - Lancashire Teaching Hospitals Trust, Critical Care, Preston, UK
FAU - Martínez, M. V. Trasmonte
AU  - Martínez MVT
AD  - Fundación Jiménez Díaz, Madrid, Spain
FAU - Márquez, M. Pérez
AU  - Márquez MP
AD  - Fundación Jiménez Díaz, Madrid, Spain
FAU - Gómez, L. Colino
AU  - Gómez LC
AD  - Fundación Jiménez Díaz, Madrid, Spain
FAU - Martínez, N. Arias
AU  - Martínez NA
AD  - Fundación Jiménez Díaz, Madrid, Spain
FAU - Muñoz, J. M. Milicua
AU  - Muñoz JMM
AD  - Fundación Jiménez Díaz, Madrid, Spain
FAU - Bellver, B. Quesada
AU  - Bellver BQ
AD  - Fundación Jiménez Díaz, Madrid, Spain
FAU - Varea, M. Muñoz
AU  - Varea MM
AD  - Fundación Jiménez Díaz, Madrid, Spain
FAU - Llorente, M. Á. Alcalá
AU  - Llorente MÁA
AD  - Fundación Jiménez Díaz, Madrid, Spain
FAU - Calvo, C. Pérez
AU  - Calvo CP
AD  - Fundación Jiménez Díaz, Madrid, Spain
FAU - Hillier, S. D.
AU  - Hillier SD
AD  - Broomfield Hospital, Intensive Care Unit, Chelmsford, UK
FAU - Faulds, M. C.
AU  - Faulds MC
AD  - Broomfield Hospital, Intensive Care Unit, Chelmsford, UK
FAU - Hendra, H.
AU  - Hendra H
AD  - Hokkaido University Hospital, Emergency and Critical Care Center, Sapporo, Japan
FAU - Lawrence, N.
AU  - Lawrence N
AD  - Hokkaido University Hospital, Emergency and Critical Care Center, Sapporo, Japan
FAU - Maekawa, K.
AU  - Maekawa K
AD  - University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France
FAU - Hayakawa, M.
AU  - Hayakawa M
AD  - University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France
FAU - Ono, Y.
AU  - Ono Y
AD  - University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France
FAU - Kodate, A.
AU  - Kodate A
AD  - University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France
FAU - Sadamoto, Y.
AU  - Sadamoto Y
AD  - University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France
FAU - Tominaga, N.
AU  - Tominaga N
AD  - University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France
FAU - Mizugaki, A.
AU  - Mizugaki A
AD  - University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France
FAU - Murakami, H.
AU  - Murakami H
AD  - University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France
FAU - Yoshida, T.
AU  - Yoshida T
AD  - University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France
FAU - Katabami, K.
AU  - Katabami K
AD  - University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France
FAU - Wada, T.
AU  - Wada T
AD  - University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France
FAU - Sawamura, A.
AU  - Sawamura A
AD  - University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France
FAU - Gando, S.
AU  - Gando S
AD  - University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France
FAU - Silva, S.
AU  - Silva S
AD  - INSERM 1214, Toulouse NeuroImaging Center (TONIC), Toulouse, France
FAU - Kerhuel, L.
AU  - Kerhuel L
AD  - School of Medicine and Surgery, University Milano Bicocca and Hospital San
      Gerardo, Department of Anaesthesiology and Critical Care, Monza, Italy
FAU - Malagurski, B.
AU  - Malagurski B
AD  - University Teaching Hospital of Purpan, Toulouse, France
FAU - Citerio, G.
AU  - Citerio G
AD  - University Hospital of Clermont-Ferrand, Critical Care Unit, Clermont-Ferrand,
      France
FAU - Chabanne, R.
AU  - Chabanne R
AD  - University Hospital and University of Liège, Cyclotron Research Center and
      Department of Neurology, Liège, Belgium
FAU - Laureys, S.
AU  - Laureys S
AD  - Groupe Hospitalier Pitié-Salpétrière, APHP, Critical Care and Anaesthesiology
      Department, Paris, France
FAU - Puybasset, L.
AU  - Puybasset L
AD  - Hôpital Erasme, Université Libre de Bruxelles, Department of Intensive Care,
      Brussels, Belgium
FAU - Nobile, L.
AU  - Nobile L
AD  - Ospedali Riuniti, Department of Perioperative Medicine, Trieste, Italy
FAU - Pognuz, E. R.
AU  - Pognuz ER
AD  - CHUV, Department of Neurology, Lausanne, Switzerland
FAU - Rossetti, A. O.
AU  - Rossetti AO
AD  - Hopital Erasme, Université Libre de Bruxelles, Department of Neurology, Brussels,
      Belgium
FAU - Verginella, F.
AU  - Verginella F
AD  - CHUV, Department of Neurology, Lausanne, Switzerland
FAU - Gaspard, N.
AU  - Gaspard N
AD  - CHUV, Department of Intensive Care, Lausanne, Switzerland
FAU - Creteur, J.
AU  - Creteur J
AD  - Ospedali Riuniti, Department of Perioperative Medicine, Trieste, Italy
FAU - Ben-Hamouda, N.
AU  - Ben-Hamouda N
AD  - Hokkaido University Hospital, Emergency and Critical Care Medicine, Sapporo,
      Japan
FAU - Oddo, M.
AU  - Oddo M
AD  - Hokkaido University Hospital, Emergency and Critical Care Medicine, Sapporo,
      Japan
FAU - Taccone, F. S.
AU  - Taccone FS
AD  - Ospedali Riuniti, Department of Perioperative Medicine, Trieste, Italy
FAU - Ono, Y.
AU  - Ono Y
AD  - Hokkaido University Hospital, Clinical Research and Medical Innovation Center,
      Sapporo, Japan
FAU - Hayakawa, M.
AU  - Hayakawa M
AD  - Hokkaido University Hospital, Clinical Research and Medical Innovation Center,
      Sapporo, Japan
FAU - Iijima, H.
AU  - Iijima H
AD  - Hokkaido University Graduate School of Medicine, Division of Acute and Critical
      Care Medicine, Sapporo, Japan
FAU - Maekawa, K.
AU  - Maekawa K
AD  - Hokkaido University Hospital, Clinical Research and Medical Innovation Center,
      Sapporo, Japan
FAU - Kodate, A.
AU  - Kodate A
AD  - Hokkaido University Hospital, Clinical Research and Medical Innovation Center,
      Sapporo, Japan
FAU - Sadamoto, Y.
AU  - Sadamoto Y
AD  - Hokkaido University Hospital, Clinical Research and Medical Innovation Center,
      Sapporo, Japan
FAU - Mizugaki, A.
AU  - Mizugaki A
AD  - Hokkaido University Hospital, Clinical Research and Medical Innovation Center,
      Sapporo, Japan
FAU - Murakami, H.
AU  - Murakami H
AD  - Hokkaido University Hospital, Clinical Research and Medical Innovation Center,
      Sapporo, Japan
FAU - Katabami, K.
AU  - Katabami K
AD  - Hokkaido University Hospital, Clinical Research and Medical Innovation Center,
      Sapporo, Japan
FAU - Wada, T.
AU  - Wada T
AD  - Hokkaido University Hospital, Clinical Research and Medical Innovation Center,
      Sapporo, Japan
FAU - Sawamura, A.
AU  - Sawamura A
AD  - Hokkaido University Hospital, Clinical Research and Medical Innovation Center,
      Sapporo, Japan
FAU - Gando, S.
AU  - Gando S
AD  - Hokkaido University Hospital, Clinical Research and Medical Innovation Center,
      Sapporo, Japan
FAU - Kodate, A.
AU  - Kodate A
AD  - Aarhus University Hospital, Anesthesiology, Aarhus, Denmark
FAU - Katabami, K.
AU  - Katabami K
AD  - Aarhus University Hospital, Anesthesiology, Aarhus, Denmark
FAU - Wada, T.
AU  - Wada T
AD  - Aarhus University Hospital, Anesthesiology, Aarhus, Denmark
FAU - Ono, Y.
AU  - Ono Y
AD  - Aarhus University Hospital, Anesthesiology, Aarhus, Denmark
FAU - Maekawa, K.
AU  - Maekawa K
AD  - Aarhus University Hospital, Anesthesiology, Aarhus, Denmark
FAU - Hayakawa, M.
AU  - Hayakawa M
AD  - Aarhus University Hospital, Anesthesiology, Aarhus, Denmark
FAU - Sawamura, A.
AU  - Sawamura A
AD  - Aarhus University Hospital, Anesthesiology, Aarhus, Denmark
FAU - Gando, S.
AU  - Gando S
AD  - Aarhus University Hospital, Anesthesiology, Aarhus, Denmark
FAU - Andersen, L. W.
AU  - Andersen LW
AD  - Beth Israel Deaconess Medical Center, Harvard Medical School, Emergency Medicine,
      Boston, USA
FAU - Raymond, T.
AU  - Raymond T
AD  - The Children’s Hospital of Philadelphia, Philadelphia, USA
FAU - Berg, R.
AU  - Berg R
AD  - University of Pennsylvania, Philadelphia, USA
FAU - Nadkarni, V.
AU  - Nadkarni V
AD  - University of Pennsylvania, Philadelphia, USA
FAU - Grossestreuer, A.
AU  - Grossestreuer A
AD  - Institute of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany
FAU - Kurth, T.
AU  - Kurth T
AD  - Beth Israel Deaconess Medical Center, Harvard Medical School, Critical Care,
      Boston, USA
FAU - Donnino, M.
AU  - Donnino M
AD  - Medical City Children’s Hospital, Dallas, USA
FAU - Krüger, A.
AU  - Krüger A
AD  - Chulalongkorn University, Pulmonary and Critical Care Medicine, Bangkok, Thailand
FAU - Ostadal, P.
AU  - Ostadal P
AD  - Chulalongkorn University, Pulmonary and Critical Care Medicine, Bangkok, Thailand
FAU - Janotka, M.
AU  - Janotka M
AD  - Chulalongkorn University, Pulmonary and Critical Care Medicine, Bangkok, Thailand
FAU - Vondrakova, D.
AU  - Vondrakova D
AD  - Chulalongkorn University, Pulmonary and Critical Care Medicine, Bangkok, Thailand
FAU - Kongpolprom, N.
AU  - Kongpolprom N
AD  - King Chulalongkorn Memmorial Hospital, Bangkok, Thailand
FAU - Cholkraisuwat, J.
AU  - Cholkraisuwat J
AD  - Chulalongkorn University, Medicine, Bangkok, Thailand
FAU - Pekkarinen, P. T.
AU  - Pekkarinen PT
AD  - IRCCS - Istituto di Ricerche Farmacologiche ‘Mario Negri’, Department of
      Cardiovascular Research, Milan, Italy
FAU - Ristagno, G.
AU  - Ristagno G
AD  - Kuopio University Hospital, Division of Intensive Care Medicine, Kuopio, Finland
FAU - Masson, S.
AU  - Masson S
AD  - Kuopio University Hospital, Division of Intensive Care Medicine, Kuopio, Finland
FAU - Latini, R.
AU  - Latini R
AD  - Kuopio University Hospital, Division of Intensive Care Medicine, Kuopio, Finland
FAU - Bendel, S.
AU  - Bendel S
AD  - Oulu University Hospital, Medical Research Center Oulu, Department of
      Anaesthesiology, University of Oulu and Division of Intensive Care Medicine,
      Oulu, Finland
FAU - Ala-Kokko, T.
AU  - Ala-Kokko T
AD  - Tampere University Hospital, Department of Intensive Care, Tampere, Finland
FAU - Varpula, T.
AU  - Varpula T
AD  - IRCCS - Istituto di Ricerche Farmacologiche ‘Mario Negri’, Department of
      Cardiovascular Research, Milan, Italy
FAU - Vaahersalo, J.
AU  - Vaahersalo J
AD  - IRCCS - Istituto di Ricerche Farmacologiche ‘Mario Negri’, Department of
      Cardiovascular Research, Milan, Italy
FAU - Hoppu, S.
AU  - Hoppu S
AD  - Helsinki University Hospital, Department of Neurology, Helsinki, Finland
FAU - Tiainen, M.
AU  - Tiainen M
AD  - University-Hospital of Padova, Department of Laboratory Medicine, Padova, Italy
FAU - Mion, M. M.
AU  - Mion MM
AD  - Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea
FAU - Plebani, M.
AU  - Plebani M
AD  - Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea
FAU - Pettilä, V.
AU  - Pettilä V
AD  - IRCCS - Istituto di Ricerche Farmacologiche ‘Mario Negri’, Department of
      Cardiovascular Research, Milan, Italy
FAU - Skrifvars, M.B.
AU  - Skrifvars M
AD  - IRCCS - Istituto di Ricerche Farmacologiche ‘Mario Negri’, Department of
      Cardiovascular Research, Milan, Italy
CN  - FINNRESUSCI Study Group
FAU - Son, Y.
AU  - Son Y
AD  - Université Libre de Bruxelles - Erasme University Hospital, Department of
      Intensive Care, Bruxelles, Belgium
FAU - Kim, K. S.
AU  - Kim KS
AD  - Université Libre de Bruxelles - Erasme University Hospital, Department of
      Intensive Care, Bruxelles, Belgium
FAU - Suh, G. J.
AU  - Suh GJ
AD  - Université Libre de Bruxelles - Erasme University Hospital, Department of
      Intensive Care, Bruxelles, Belgium
FAU - Kwon, W. Y.
AU  - Kwon WY
AD  - Université Libre de Bruxelles - Erasme University Hospital, Department of
      Intensive Care, Bruxelles, Belgium
FAU - Ko, J. I.
AU  - Ko JI
AD  - Université Libre de Bruxelles - Erasme University Hospital, Department of
      Intensive Care, Bruxelles, Belgium
FAU - Park, M. J.
AU  - Park MJ
AD  - Université Libre de Bruxelles - Erasme University Hospital, Department of
      Intensive Care, Bruxelles, Belgium
FAU - Cavicchi, F. Zama
AU  - Cavicchi FZ
AD  - St Luke’s International Hospital, Emergency, Tokyo, Japan
FAU - Iesu, E.
AU  - Iesu E
AD  - St Luke’s International Hospital, Emergency, Tokyo, Japan
FAU - Nobile, L.
AU  - Nobile L
AD  - St Luke’s International Hospital, Emergency, Tokyo, Japan
FAU - Vincent, J. L.
AU  - Vincent JL
AD  - St Luke’s International Hospital, Emergency, Tokyo, Japan
FAU - Creteur, J.
AU  - Creteur J
AD  - St Luke’s International Hospital, Emergency, Tokyo, Japan
FAU - Taccone, F. S.
AU  - Taccone FS
AD  - St Luke’s International Hospital, Emergency, Tokyo, Japan
FAU - Tanaka, H.
AU  - Tanaka H
AD  - St Luke’s International Hospital, Tokyo, Japan
FAU - Otani, N.
AU  - Otani N
AD  - Hospital Universitari Mutua Terrassa, Critical Care Department, Terrassa, Spain
FAU - Ode, S.
AU  - Ode S
AD  - Hospital Universitari Mutua Terrassa, Critical Care Department, Terrassa, Spain
FAU - Ishimatsu, S.
AU  - Ishimatsu S
AD  - Hospital Universitari Mutua Terrassa, Critical Care Department, Terrassa, Spain
FAU - Martínez, L.
AU  - Martínez L
AD  - Hospital Universitari Mutua Terrassa, Terrassa, Spain
FAU - Algarte, R.
AU  - Algarte R
AD  - Hospital Universitari Mutua Terrassa, Terrassa, Spain
FAU - Sánchez, B.
AU  - Sánchez B
AD  - Hospital Universitari Mutua Terrassa, Terrassa, Spain
FAU - Romero, I.
AU  - Romero I
AD  - Na Homolce Hospital, Prague, Czech Republic
FAU - Martínez, F.
AU  - Martínez F
AD  - Hospital Universitari Mutua Terrassa, Terrassa, Spain
FAU - Quintana, S.
AU  - Quintana S
AD  - Hospital Universitari Mutua Terrassa, Terrassa, Spain
FAU - Trenado, J.
AU  - Trenado J
AD  - Hospital Universitari Mutua Terrassa, Terrassa, Spain
FAU - Vondrakova, D.
AU  - Vondrakova D
AD  - National Taiwan University Hospital, Department of Anesthesiology, Taipei,
      Taiwan, Province of China
FAU - Ostadal, P.
AU  - Ostadal P
AD  - National Taiwan University Hospital, Department of Anesthesiology, Taipei,
      Taiwan, Province of China
FAU - Kruger, A.
AU  - Kruger A
AD  - National Taiwan University Hospital, Department of Anesthesiology, Taipei,
      Taiwan, Province of China
FAU - Janotka, M.
AU  - Janotka M
AD  - National Taiwan University Hospital, Department of Anesthesiology, Taipei,
      Taiwan, Province of China
FAU - Malek, F.
AU  - Malek F
AD  - National Taiwan University Hospital, Department of Anesthesiology, Taipei,
      Taiwan, Province of China
FAU - Neuzil, P.
AU  - Neuzil P
AD  - National Taiwan University Hospital, Department of Anesthesiology, Taipei,
      Taiwan, Province of China
FAU - Yeh, Y. C.
AU  - Yeh YC
AD  - National Taiwan University Hospital, Department of Surgery, Taipei, Taiwan,
      Province of China
FAU - Chen, Y. S.
AU  - Chen YS
AD  - Far Eastern Memorial Hospital, Department of Anesthesiology, New Taipei, Taiwan, 
      Province of China
FAU - Wang, C. H.
AU  - Wang CH
AD  - Far Eastern Memorial Hospital, Department of Anesthesiology, New Taipei, Taiwan, 
      Province of China
FAU - Huang, C. H.
AU  - Huang CH
AD  - National Taiwan University Hospital, Department of Surgery, Taipei, Taiwan,
      Province of China
FAU - Chao, A.
AU  - Chao A
AD  - National Taiwan University Hospital, Department of Surgery, Taipei, Taiwan,
      Province of China
FAU - Lee, C. T.
AU  - Lee CT
AD  - National Taiwan University Hospital, Department of Surgery, Taipei, Taiwan,
      Province of China
FAU - Lai, C. H.
AU  - Lai CH
AD  - Far Eastern Memorial Hospital, Department of Anesthesiology, New Taipei, Taiwan, 
      Province of China
FAU - Chan, W. S.
AU  - Chan WS
AD  - Division of Electrophysiology, Department of Cardiovascular Medicine, University 
      of Münster, Münster, Germany
FAU - Cheng, Y. J.
AU  - Cheng YJ
AD  - National Taiwan University Hospital, Department of Surgery, Taipei, Taiwan,
      Province of China
FAU - Sun, W. Z.
AU  - Sun WZ
AD  - National Taiwan University Hospital, Department of Surgery, Taipei, Taiwan,
      Province of China
FAU - Kaese, S.
AU  - Kaese S
AD  - Division of Cardiology, Department of Cardiovascular Medicine, University of
      Münster, Münster, Germany
FAU - Horstmann, C.
AU  - Horstmann C
AD  - CHU Montpellier, Montpellier, France
FAU - Lebiedz, P.
AU  - Lebiedz P
AD  - CHU Montpellier, Montpellier, France
FAU - Mourad, M.
AU  - Mourad M
AD  - Na Homolce Hospital, Prague, Czech Republic
FAU - Gaudard, P.
AU  - Gaudard P
AD  - Na Homolce Hospital, Prague, Czech Republic
FAU - Eliet, J.
AU  - Eliet J
AD  - Na Homolce Hospital, Prague, Czech Republic
FAU - Zeroual, N.
AU  - Zeroual N
AD  - Na Homolce Hospital, Prague, Czech Republic
FAU - Colson, P.
AU  - Colson P
AD  - Na Homolce Hospital, Prague, Czech Republic
FAU - Ostadal, P.
AU  - Ostadal P
AD  - Charles University in Prague, Prague, Czech Republic
FAU - Mlcek, M.
AU  - Mlcek M
AD  - Cantonal Hospital Winterthur, Winterthur, Switzerland
FAU - Hrachovina, M.
AU  - Hrachovina M
AD  - Cantonal Hospital Winterthur, Winterthur, Switzerland
FAU - Kruger, A.
AU  - Kruger A
AD  - Charles University in Prague, Prague, Czech Republic
FAU - Vondrakova, D.
AU  - Vondrakova D
AD  - Charles University in Prague, Prague, Czech Republic
FAU - Janotka, M.
AU  - Janotka M
AD  - Charles University in Prague, Prague, Czech Republic
FAU - Mates, M.
AU  - Mates M
AD  - Charles University in Prague, Prague, Czech Republic
FAU - Hala, P.
AU  - Hala P
AD  - Charles University in Prague, Prague, Czech Republic
FAU - Kittnar, O.
AU  - Kittnar O
AD  - Cantonal Hospital Winterthur, Winterthur, Switzerland
FAU - Neuzil, P.
AU  - Neuzil P
AD  - Charles University in Prague, Prague, Czech Republic
FAU - Jacky, A.
AU  - Jacky A
AD  - University Hospital Zurich, Institute for Anaesthesiology, Cardio-surgical
      Intensive Care Unit, Zurich, Switzerland
FAU - Rudiger, A.
AU  - Rudiger A
AD  - Erasmus Medical Center, Rotterdam, Netherlands
FAU - Spahn, D. R.
AU  - Spahn DR
AD  - Erasmus Medical Center, Rotterdam, Netherlands
FAU - Bettex, D. A.
AU  - Bettex DA
AD  - Erasmus Medical Center, Rotterdam, Netherlands
FAU - Kara, A.
AU  - Kara A
AD  - University Hospital Erasme, Université Libre de Bruxelles, Critical Care,
      Brussels, Belgium
FAU - Akin, S.
AU  - Akin S
AD  - University Hospital Erasme, Université Libre de Bruxelles, Critical Care,
      Brussels, Belgium
FAU - Dos reis Miranda, D.
AU  - Dos reis Miranda D
AD  - University Hospital Erasme, Université Libre de Bruxelles, Critical Care,
      Brussels, Belgium
FAU - Struijs, A.
AU  - Struijs A
AD  - University Hospital Erasme, Université Libre de Bruxelles, Critical Care,
      Brussels, Belgium
FAU - Caliskan, K.
AU  - Caliskan K
AD  - University Hospital Erasme, Université Libre de Bruxelles, Critical Care,
      Brussels, Belgium
FAU - van Thiel, R. J.
AU  - van Thiel RJ
AD  - University Hospital Erasme, Université Libre de Bruxelles, Critical Care,
      Brussels, Belgium
FAU - Dubois, E. A.
AU  - Dubois EA
AD  - University Hospital Erasme, Université Libre de Bruxelles, Critical Care,
      Brussels, Belgium
FAU - de Wilde, W.
AU  - de Wilde W
AD  - University Hospital Erasme, Université Libre de Bruxelles, Critical Care,
      Brussels, Belgium
FAU - Zijlstra, F.
AU  - Zijlstra F
AD  - University Hospital Erasme, Université Libre de Bruxelles, Critical Care,
      Brussels, Belgium
FAU - Gommers, D.
AU  - Gommers D
AD  - University Hospital Erasme, Université Libre de Bruxelles, Critical Care,
      Brussels, Belgium
FAU - Ince, C.
AU  - Ince C
AD  - University Hospital Erasme, Université Libre de Bruxelles, Critical Care,
      Brussels, Belgium
FAU - Marca, L.
AU  - Marca L
AD  - Texas Children’s Hospital, Clinical Nutriiton, Houston, USA
FAU - Xini, A.
AU  - Xini A
AD  - National Taiwan University Hospital, Taipei, Taiwan, Province of China
FAU - Mongkolpun, W.
AU  - Mongkolpun W
AD  - National Taiwan University Hospital, Taipei, Taiwan, Province of China
FAU - Cordeiro, C. P. R.
AU  - Cordeiro CPR
AD  - National Taiwan University Hospital, Taipei, Taiwan, Province of China
FAU - Leite, R. T.
AU  - Leite RT
AD  - National Taiwan University Hospital, Taipei, Taiwan, Province of China
FAU - Lheureux, O.
AU  - Lheureux O
AD  - National Taiwan University Hospital, Taipei, Taiwan, Province of China
FAU - Bader, A.
AU  - Bader A
AD  - National Taiwan University Hospital, Taipei, Taiwan, Province of China
FAU - Rincon, L.
AU  - Rincon L
AD  - National Taiwan University Hospital, Taipei, Taiwan, Province of China
FAU - Santacruz, C.
AU  - Santacruz C
AD  - National Taiwan University Hospital, Taipei, Taiwan, Province of China
FAU - Preiser, J. C.
AU  - Preiser JC
AD  - National Taiwan University Hospital, Taipei, Taiwan, Province of China
FAU - Chao, A.
AU  - Chao A
AD  - Chang Gung Memorial Hospital, Linkou, Taoyaun Taiwan, Province of China
FAU - Chao, A. S.
AU  - Chao AS
AD  - National Taiwan University Hospital, Department of Surgery, Taipei, Taiwan,
      Province of China
FAU - Chen, Y. S.
AU  - Chen YS
AD  - Hallym University, Emergency Medicine, Seoul, Republic of Korea
FAU - Kim, W.
AU  - Kim W
AD  - Hanyang University, Emergency Medicine, Seoul, Republic of Korea
FAU - Ahn, C.
AU  - Ahn C
AD  - Hanyang University, Neurosurgery, Seoul, Republic of Korea
FAU - Cho, Y.
AU  - Cho Y
AD  - Hanyang University, Emergency Medicine, Seoul, Republic of Korea
FAU - Lim, T. H.
AU  - Lim TH
AD  - Hanyang University, Neurosurgery, Seoul, Republic of Korea
FAU - Oh, J.
AU  - Oh J
AD  - Hanyang University, Neurosurgery, Seoul, Republic of Korea
FAU - Choi, K. S.
AU  - Choi KS
AD  - Kyung Hee University, Preventive Medicine, Seoul, Republic of Korea
FAU - Jang, B. H.
AU  - Jang BH
AD  - University Medical Center Hamburg-Eppendorf, Intensive Care Medicine, Hamburg,
      Germany
FAU - Ha, J. K.
AU  - Ha JK
AD  - Hanyang University, Emergency Medicine, Seoul, Republic of Korea
FAU - Mecklenburg, A.
AU  - Mecklenburg A
AD  - University Heart Center Hamburg-Eppendorf, General and Interventional Cardiology,
      Hamburg, Germany
FAU - Stamm, J.
AU  - Stamm J
AD  - University Heart Center Hamburg-Eppendorf, General and Interventional Cardiology,
      Hamburg, Germany
FAU - Soeffker, G.
AU  - Soeffker G
AD  - University Heart Center Hamburg-Eppendorf, General and Interventional Cardiology,
      Hamburg, Germany
FAU - Kubik, M.
AU  - Kubik M
AD  - University Heart Center Hamburg-Eppendorf, General and Interventional Cardiology,
      Hamburg, Germany
FAU - Sydow, K.
AU  - Sydow K
AD  - University Heart Center Hamburg-Eppendorf, Cardiovascular Surgery, Hamburg,
      Germany
FAU - Reichenspurner, H.
AU  - Reichenspurner H
AD  - St. Franziskus Hospital Münster, Pneumology and Intensive Care Medicine, Münster,
      Germany
FAU - Kluge, S.
AU  - Kluge S
AD  - University Heart Center Hamburg-Eppendorf, General and Interventional Cardiology,
      Hamburg, Germany
FAU - Braune, S.
AU  - Braune S
AD  - Università La Sapienza di Roma, UOD Terapia Intensiva nei Trapianti d’Organo,
      Policlinico Umberto I, Roma, Italy
FAU - Bergantino, B.
AU  - Bergantino B
AD  - University of Turin, Dept. of Surgical Sciences, Turin, Italy
FAU - Ruberto, F.
AU  - Ruberto F
AD  - University of Turin, Dept. of Surgical Sciences, Turin, Italy
FAU - Magnanimi, E.
AU  - Magnanimi E
AD  - University of Turin, Dept. of Surgical Sciences, Turin, Italy
FAU - Privato, E.
AU  - Privato E
AD  - University of Turin, Dept. of Surgical Sciences, Turin, Italy
FAU - Zullino, V.
AU  - Zullino V
AD  - University of Turin, Dept. of Surgical Sciences, Turin, Italy
FAU - Bruno, K.
AU  - Bruno K
AD  - University of Turin, Dept. of Surgical Sciences, Turin, Italy
FAU - Pugliese, F.
AU  - Pugliese F
AD  - University of Turin, Dept. of Surgical Sciences, Turin, Italy
FAU - Sales, G.
AU  - Sales G
AD  - Città della Salute e della Scienza Hospital, Dept. of Anesthesiology, Turin,
      Italy
FAU - Girotto, V.
AU  - Girotto V
AD  - Città della Salute e della Scienza Hospital, Dept. of Anesthesiology, Turin,
      Italy
FAU - Vittone, F.
AU  - Vittone F
AD  - INSERM, U1116, Vandoeuvre-les-Nancy, France
FAU - Brazzi, L.
AU  - Brazzi L
AD  - Città della Salute e della Scienza Hospital, Dept. of Anesthesiology, Turin,
      Italy
FAU - Fritz, C.
AU  - Fritz C
AD  - Ecole de Chirurgie de Nancy, Vandoeuvre-les-Nancy, France
FAU - Kimmoun, A.
AU  - Kimmoun A
AD  - Ecole de Chirurgie de Nancy, Vandoeuvre-les-Nancy, France
FAU - Vanhuyse, F.
AU  - Vanhuyse F
AD  - Ecole de Chirurgie de Nancy, Vandoeuvre les Nancy, France
FAU - Trifan, B.
AU  - Trifan B
AD  - CHU de Nancy, Plateforme d’Aide à la Recherche Clinique, Vandoeuvre-les-Nancy,
      France
FAU - Orlowski, S.
AU  - Orlowski S
AD  - Ecole de Chirurgie de Nancy, Vandoeuvre-les-Nancy, France
FAU - Albuisson, E.
AU  - Albuisson E
AD  - Hopital Europeen Georges Pompidou, Paris, France
FAU - Tran, N.
AU  - Tran N
AD  - CHU de Nancy, Plateforme d’Aide à la Recherche Clinique, Vandoeuvre-les-Nancy,
      France
FAU - Levy, B.
AU  - Levy B
AD  - Ecole de Chirurgie de Nancy, Vandoeuvre-les-Nancy, France
FAU - Chhor, V.
AU  - Chhor V
AD  - Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain
FAU - Joachim, J.
AU  - Joachim J
AD  - Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain
FAU - Follin, A.
AU  - Follin A
AD  - Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain
FAU - Champigneulle, B.
AU  - Champigneulle B
AD  - Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain
FAU - Chatelon, J.
AU  - Chatelon J
AD  - Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain
FAU - Fave, G.
AU  - Fave G
AD  - Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain
FAU - Mantz, J.
AU  - Mantz J
AD  - Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain
FAU - Pirracchio, R.
AU  - Pirracchio R
AD  - Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain
FAU - Diaz, D. Díaz
AU  - Diaz DD
AD  - Glasgow Royal Infirmary, Anaesthesia, Glasgow, UK
FAU - Villanova, M.
AU  - Villanova M
AD  - Glasgow Royal Infirmary, Anaesthesia, Glasgow, UK
FAU - Aguirregabyria, M.
AU  - Aguirregabyria M
AD  - Glasgow Royal Infirmary, Anaesthesia, Glasgow, UK
FAU - Andrade, G.
AU  - Andrade G
AD  - Glasgow Royal Infirmary, Anaesthesia, Glasgow, UK
FAU - López, L.
AU  - López L
AD  - Glasgow Royal Infirmary, Anaesthesia, Glasgow, UK
FAU - Palencia, E.
AU  - Palencia E
AD  - Glasgow Royal Infirmary, Anaesthesia, Glasgow, UK
FAU - John, G.
AU  - John G
AD  - Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic
      of Korea
FAU - Cowan, R.
AU  - Cowan R
AD  - Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic
      of Korea
FAU - Hart, R.
AU  - Hart R
AD  - Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic
      of Korea
FAU - Lake, K.
AU  - Lake K
AD  - Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic
      of Korea
FAU - Litchfield, K.
AU  - Litchfield K
AD  - Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic
      of Korea
FAU - Song, J. W.
AU  - Song JW
AD  - Ghent University Hospital, General Internal Medicin, Gent, Belgium
FAU - Lee, Y. J.
AU  - Lee YJ
AD  - Ghent University Hospital, General Internal Medicin, Gent, Belgium
FAU - Cho, Y. J.
AU  - Cho YJ
AD  - Ghent University Hospital, General Internal Medicin, Gent, Belgium
FAU - Choi, S.
AU  - Choi S
AD  - Ghent University Hospital, General Internal Medicin, Gent, Belgium
FAU - Vermeir, P.
AU  - Vermeir P
AD  - Ghent University, Public Health, Gent, Belgium
FAU - Vandijck, D.
AU  - Vandijck D
AD  - Ghent University, Internal Medicin, Gent, Belgium
FAU - Blot, S.
AU  - Blot S
AD  - Ghent University, General Internal Medicine, Gent, Belgium
FAU - Mariman, A.
AU  - Mariman A
AD  - Ghent University, Family Medicine and Primary Health Care, Gent, Belgium
FAU - Verhaeghe, R.
AU  - Verhaeghe R
AD  - Ghent University, Internal Medicin, Gent, Belgium
FAU - Deveugele, M.
AU  - Deveugele M
AD  - Ghent University Hospital, Internal Medicine, Gent, Belgium
FAU - Vogelaers, D.
AU  - Vogelaers D
AD  - University Hospital Zurich, University Zurich, Zürich, Switzerland
FAU - Chok, L.
AU  - Chok L
AD  - Hospital Uster, Department of Internal Medicine, Uster, Switzerland
FAU - Bachli, E. B.
AU  - Bachli EB
AD  - University Hospital Zurich, University Zurich, Heart and Vascular Surgical
      Intensive Care Unit, Zurich, Switzerland
FAU - Bettex, D.
AU  - Bettex D
AD  - University Hospital Zurich, University Zurich, Surgical Intensive Care Unit,
      Zurich, Switzerland
FAU - Cottini, S. R.
AU  - Cottini SR
AD  - University Hospital Zurich, University Zurich, Neurosurgical Intensive Care Unit,
      Zurich, Switzerland
FAU - Keller, E.
AU  - Keller E
AD  - University Hospital Zurich, University Zurich, Medical Intensive Care Unit,
      Zurich, Switzerland
FAU - Maggiorini, M.
AU  - Maggiorini M
AD  - University Hospital Zurich, University Zurich, Surgical Intensive Care Unit,
      Zürich, Switzerland
FAU - Schuepbach, R.
AU  - Schuepbach R
AD  - Gelre Hospitals Apeldoorn, Intensive Care Medicine, Apeldoorn, Netherlands
FAU - Fiks, T.
AU  - Fiks T
AD  - Gelre Hospitals Apeldoorn, Physiotherapy, Apeldoorn, Netherlands
FAU - Stiphout, C.
AU  - Stiphout C
AD  - Gelre Hospitals Apeldoorn, Physiotherapy, Apeldoorn, Netherlands
FAU - Grevelink, M.
AU  - Grevelink M
AD  - Gelre Hospitals Apeldoorn, Physiotherapy, Apeldoorn, Netherlands
FAU - Vaneker, I.
AU  - Vaneker I
AD  - Gelre Hospitals Apeldoorn, Physiotherapy, Apeldoorn, Netherlands
FAU - Ruijter, A.
AU  - Ruijter A
AD  - Catharina Hospital, Intensive Care Medicine, Eindhoven, Netherlands
FAU - Buise, M.
AU  - Buise M
AD  - Academic Medical Center, University of Amsterdam, Intensive Care Medicine,
      Amsterdam, Netherlands
FAU - Spronk, P. E.
AU  - Spronk PE
AD  - Gelre Hospitals Apeldoorn, Physiotherapy, Apeldoorn, Netherlands
FAU - Tena, S. Altaba
AU  - Tena SA
AD  - Imperial College Healthcare NHS Trust, General Intensive Care Unit, London, UK
FAU - Barrachina, L. Galarza
AU  - Barrachina LG
AD  - Imperial College Healthcare NHS Trust, General Intensive Care Unit, London, UK
FAU - Portillo, J. H. Rodriguez
AU  - Portillo JHR
AD  - Imperial College Healthcare NHS Trust, General Intensive Care Unit, London, UK
FAU - Aznar, G. Pagés
AU  - Aznar GP
AD  - Imperial College Healthcare NHS Trust, General Intensive Care Unit, London, UK
FAU - Campos, L. Mateu
AU  - Campos LM
AD  - Imperial College Healthcare NHS Trust, General Intensive Care Unit, London, UK
FAU - Sellés, M. D. Ferrándiz
AU  - Sellés MDF
AD  - Imperial College Healthcare NHS Trust, General Intensive Care Unit, London, UK
FAU - Tomás, M. Arlandis
AU  - Tomás MA
AD  - Imperial College Healthcare NHS Trust, General Intensive Care Unit, London, UK
FAU - Muncharaz, A. Belenguer
AU  - Muncharaz AB
AD  - Imperial College Healthcare NHS Trust, General Intensive Care Unit, London, UK
FAU - Skinner, L.
AU  - Skinner L
AD  - Imperial College Healthcare NHS Trust, Haematology, London, UK
FAU - Monsalvo, S.
AU  - Monsalvo S
AD  - Samsung Medical Center, Seoul, Republic of Korea
FAU - Olavarria, E.
AU  - Olavarria E
AD  - Samsung Medical Center, Seoul, Republic of Korea
FAU - Stümpfle, R.
AU  - Stümpfle R
AD  - Imperial College Healthcare NHS Trust, Haematology, London, UK
FAU - Na, S. J.
AU  - Na SJ
AD  - Dalhousie University, Critical Care Medicine, Halifax, Canada
FAU - Park, J.
AU  - Park J
AD  - Dalhousie University, Critical Care Medicine, Halifax, Canada
FAU - Chung, C. R.
AU  - Chung CR
AD  - Dalhousie University, Critical Care Medicine, Halifax, Canada
FAU - Park, C. M.
AU  - Park CM
AD  - Dalhousie University, Critical Care Medicine, Halifax, Canada
FAU - Suh, G. Y.
AU  - Suh GY
AD  - Dalhousie University, Critical Care Medicine, Halifax, Canada
FAU - Yang, J. H.
AU  - Yang JH
AD  - Dalhousie University, Critical Care Medicine, Halifax, Canada
FAU - Witter, T.
AU  - Witter T
AD  - Dalhousie University, Anesthesiology, Pain Management and Perioperative Medicine,
      Halifax, Canada
FAU - Brousseau, C.
AU  - Brousseau C
AD  - Dalhousie University, Emergency Medicine, Halifax, Canada
FAU - Butler, M. B.
AU  - Butler MB
AD  - Dalhousie University, Anesthesiology, Pain Management and Perioperative Medicine,
      Halifax, Canada
FAU - Erdogan, M.
AU  - Erdogan M
AD  - Queen Mary University of London, William Harvey Research Institute, London, UK
FAU - Dougall, P. C. Mac
AU  - Dougall PCM
AD  - Dalhousie University, Respiratory Therapy, Halifax, Canada
FAU - Green, R. S.
AU  - Green RS
AD  - Dalhousie University, Anesthesiology, Pain Management and Perioperative Medicine,
      Halifax, Canada
FAU - Abbott, T. E. F.
AU  - Abbott TEF
AD  - London School of Economics, London, UK
FAU - Torrance, H. D. T.
AU  - Torrance HDT
AD  - London School of Economics, London, UK
FAU - Cron, N.
AU  - Cron N
AD  - Northwick Park Hospital, London, UK
FAU - Vaid, N.
AU  - Vaid N
AD  - Barts Health NHS Trust, London, UK
FAU - Emmanuel, J.
AU  - Emmanuel J
AD  - Tata Memorial Hospital, Anaesthesia, Critical Care and Pain, Mumbai, India
FAU - Siddiqui, S. S.
AU  - Siddiqui SS
AD  - Erasme University Hospital, Université Libre de Bruxelles, Department of
      Intensive Care, Brussels, Belgium
FAU - Prabu, N.
AU  - Prabu N
AD  - Erasme University Hospital, Université Libre de Bruxelles, Department of
      Intensive Care, Brussels, Belgium
FAU - Chaudhari, H. K.
AU  - Chaudhari HK
AD  - Erasme University Hospital, Université Libre de Bruxelles, Department of
      Intensive Care, Brussels, Belgium
FAU - Patil, V. P.
AU  - Patil VP
AD  - Erasme University Hospital, Université Libre de Bruxelles, Department of
      Intensive Care, Brussels, Belgium
FAU - Divatia, J. V.
AU  - Divatia JV
AD  - Erasme University Hospital, Université Libre de Bruxelles, Department of
      Intensive Care, Brussels, Belgium
FAU - Solanki, S.
AU  - Solanki S
AD  - Erasme University Hospital, Université Libre de Bruxelles, Department of
      Intensive Care, Brussels, Belgium
FAU - Kulkarni, A. P.
AU  - Kulkarni AP
AD  - Erasme University Hospital, Université Libre de Bruxelles, Department of
      Intensive Care, Brussels, Belgium
FAU - Gutierrez, L. A. Rincon
AU  - Gutierrez LAR
AD  - Insituto Mexicano del Seguro Social, Internal Medicine, Celaya, Mexico
FAU - Bader, A.
AU  - Bader A
AD  - Insituto Mexicano del Seguro Social, Internal Medicine, Celaya, Mexico
FAU - Brasseur, A.
AU  - Brasseur A
AD  - Insituto Mexicano del Seguro Social, Internal Medicine, Celaya, Mexico
FAU - Lheureux, O.
AU  - Lheureux O
AD  - Insituto Mexicano del Seguro Social, Internal Medicine, Celaya, Mexico
FAU - Vincent, J. L.
AU  - Vincent JL
AD  - Insituto Mexicano del Seguro Social, Internal Medicine, Celaya, Mexico
FAU - Creteur, J.
AU  - Creteur J
AD  - Insituto Mexicano del Seguro Social, Internal Medicine, Celaya, Mexico
FAU - Taccone, F. S.
AU  - Taccone FS
AD  - Insituto Mexicano del Seguro Social, Internal Medicine, Celaya, Mexico
FAU - Hempel, D.
AU  - Hempel D
AD  - University of Frankfurt, Frankfurt, Germany
FAU - Stauffert, N.
AU  - Stauffert N
AD  - University Bonn, Bonn, Germany
FAU - Recker, F.
AU  - Recker F
AD  - Hospital Frankfurt Hoechst, Frankfurt, Germany
FAU - Schröder, T.
AU  - Schröder T
AD  - KfH Bad Soden, Bad Soden, Germany
FAU - Reusch, S.
AU  - Reusch S
AD  - Ultrasound Network in Acute and Critical Care, Frankfurt, Germany
FAU - Schleifer, J.
AU  - Schleifer J
AD  - Hospital Frankfurt Hoechst, Frankfurt, Germany
FAU - Breitkreutz, R.
AU  - Breitkreutz R
AD  - Rigshospitalet, Copenhagen University Hospital, Intensive Care Unit 4131,
      Copenhagen, Denmark
FAU - Sjövall, F.
AU  - Sjövall F
AD  - Lund University, Dep. of Clinical Sciences, Lund, Sweden
FAU - Perner, A.
AU  - Perner A
AD  - Lund University, Dep. of Clinical Sciences, Lund, Sweden
FAU - Møller, M. Hylander
AU  - Møller MH
AD  - Lund University, Dep. of Clinical Sciences, Lund, Sweden
FAU - Moraes, R. B.
AU  - Moraes RB
AD  - Hospital Femina Grupo Hopsitalar Conceição, Intensive Care, Porto Alegre, Brazil
FAU - Borges, F. K.
AU  - Borges FK
AD  - Hospital Universitari i Politècnic la Fe, Intensive Care Unit, Valencia, Spain
FAU - Guillen, J. A. V.
AU  - Guillen JAV
AD  - Hospital Universitari i Politècnic la Fe, Intensive Care Unit, Valencia, Spain
FAU - Zabaletta, W. J. C.
AU  - Zabaletta WJC
AD  - Hospital Universitari i Politècnic la Fe, Intensive Care Unit, Valencia, Spain
CN  - PICS- HCPA: Programa Intrahospitalar de Combate à Sepse do Hospital de Clínicas
      de Porto Alegre
FAU - Ruiz-Ramos, J.
AU  - Ruiz-Ramos J
AD  - Hospital Universitari i Politècnic la Fe, Pharmacy, Valencia, Spain
FAU - Ramirez, P.
AU  - Ramirez P
AD  - Hospital Universitari i Politècnic la Fe, Pharmacy, Valencia, Spain
FAU - Marqués-Miñana, M. R.
AU  - Marqués-Miñana MR
AD  - Hospital Universitari i Politècnic la Fe, Pneumology, Valencia, Spain
FAU - Villarreal, E.
AU  - Villarreal E
AD  - Hospital Universitari i Politècnic la Fe, Pharmacy, Valencia, Spain
FAU - Gordon, M.
AU  - Gordon M
AD  - Hospital Universitari i Politècnic la Fe, Pharmacy, Valencia, Spain
FAU - Sosa, M.
AU  - Sosa M
AD  - Hospital Universitari i Politècnic la Fe, Pharmacy, Valencia, Spain
FAU - Concha, P.
AU  - Concha P
AD  - Hospital Universitari i Politècnic la Fe, Pharmacy, Valencia, Spain
FAU - Castellanos, A.
AU  - Castellanos A
AD  - Hospital Universitari i Politècnic la Fe, Pharmacy, Valencia, Spain
FAU - Menendez, R.
AU  - Menendez R
AD  - University Hospital of Gran Canaria Dr. Negrín, Intensive Care Unit, Las Palmas
      de Gran Canaria, Spain
FAU - Ramírez, C. Sánchez
AU  - Ramírez CS
AD  - University Hospital of Gran Canaria Dr. Negrín, Microbiology Department, Las
      Palmas de Gran Canaria, Spain
FAU - Santana, M. Cabrera
AU  - Santana MC
AD  - University Hospital of Gran Canaria Dr. Negrín, Microbiology Department, Las
      Palmas de Gran Canaria, Spain
FAU - Balcázar, L. Caipe
AU  - Balcázar LC
AD  - University Hospital of Gran Canaria Dr. Negrín, Microbiology Department, Las
      Palmas de Gran Canaria, Spain
FAU - Escalada, S. Hípola
AU  - Escalada SH
AD  - University Hospital of Gran Canaria Dr. Negrín, Microbiology Department, Las
      Palmas de Gran Canaria, Spain
FAU - Viera, M. A. Hernández
AU  - Viera MAH
AD  - University Hospital of Gran Canaria Dr. Negrín, Microbiology Department, Las
      Palmas de Gran Canaria, Spain
FAU - Vázquez, C. F. Lübbe
AU  - Vázquez CFL
AD  - University Hospital of Gran Canaria Dr. Negrín, Microbiology Department, Las
      Palmas de Gran Canaria, Spain
FAU - Díaz, J. J. Díaz
AU  - Díaz JJD
AD  - University Hospital of Gran Canaria Dr. Negrín, Microbiology Department, Las
      Palmas de Gran Canaria, Spain
FAU - Campelo, F. Artiles
AU  - Campelo FA
AD  - University Hospital of Gran Canaria Dr. Negrín, Pharmacy Department, Las Palmas
      de Gran Canaria, Spain
FAU - Monroy, N. Sangil
AU  - Monroy NS
AD  - University of Las Palmas de Gran Canaria, Mathematics and Informatics Deparment, 
      Las Palmas de Gran Canaria, Spain
FAU - Santana, P. Saavedra
AU  - Santana PS
AD  - Hospital Virgen del Rocio, Seville, Spain
FAU - Santana, S. Ruiz
AU  - Santana SR
AD  - University Hospital of Gran Canaria Dr. Negrín, Microbiology Department, Las
      Palmas de Gran Canaria, Spain
FAU - Gutiérrez-Pizarraya, A.
AU  - Gutiérrez-Pizarraya A
AD  - Hospital Virgen Macarena, Seville, Spain
FAU - Garnacho-Montero, J.
AU  - Garnacho-Montero J
AD  - Aix Marseille Université, Assistance Publique-Hôpitaux de Marseille, Hôpital
      Nord, Service d’Anesthésie et de Réanimation, Marseille, France
FAU - Martin, C.
AU  - Martin C
AD  - EA 3279 Research Unit, Aix Marseille University & Assistance Publique-Hôpitaux de
      Marseille, Marseille, France
FAU - Baumstarck, K.
AU  - Baumstarck K
AD  - Department of Clinical Medicine, Trinity College, Wellcome Trust-HRB Clinical
      Research Facility, St James Hospital, Dublin, Ireland
FAU - Leone, M.
AU  - Leone M
AD  - EA 3279 Research Unit, Aix Marseille University & Assistance Publique-Hôpitaux de
      Marseille, Marseille, France
FAU - Martín-Loeches, I.
AU  - Martín-Loeches I
AD  - Hopital Europeen Georges Pompidou, Anesthesiology and Intensive Care Medicine,
      Paris, France
FAU - Pirracchio, R.
AU  - Pirracchio R
AD  - University of California Berkeley, Biostatistics, Berkeley, USA
FAU - Legrand, M.
AU  - Legrand M
AD  - Hopital Europeen Georges Pompidou, Paris, France
FAU - Mainardi, J. L.
AU  - Mainardi JL
AD  - University of California Berkeley, Berkeley, USA
FAU - Mantz, J.
AU  - Mantz J
AD  - Hospital Universitario Miguel Servet, ICU, Zaragoza, Spain
FAU - Cholley, B.
AU  - Cholley B
AD  - Hospital Universitario Miguel Servet, Microbiology, Zaragoza, Spain
FAU - Hubbard, A.
AU  - Hubbard A
AD  - Hospital de Barbastro, Barbastro, Spain
FAU - Frontera, P. Ruiz
AU  - Frontera PR
AD  - Hospital Universitario Miguel Servet, Microbiology, Zaragoza, Spain
FAU - Vega, L. M. Claraco
AU  - Vega LMC
AD  - Hospital Universitario Miguel Servet, Microbiology, Zaragoza, Spain
FAU - Miguelena, P. Ruiz de Gopegui
AU  - Miguelena PRde G
AD  - Hospital Universitario Miguel Servet, Microbiology, Zaragoza, Spain
FAU - Usón, M. C. Villuendas
AU  - Usón MCV
AD  - Hospital Universitario Miguel Servet, Microbiology, Zaragoza, Spain
FAU - López, A. Rezusta
AU  - López AR
AD  - Hospital de Barbastro, Barbastro, Spain
FAU - Clemente, E. Aurensanz
AU  - Clemente EA
AD  - HU Arnau de Vilanova, Lleida, Spain
FAU - Ibañes, P. Gutiérrez
AU  - Ibañes PG
AD  - Hospital Universitario Miguel Servet, Microbiology, Zaragoza, Spain
FAU - Aguilar, A. L. Ruiz
AU  - Aguilar ALR
AD  - Hospital Universitario Miguel Servet, Microbiology, Zaragoza, Spain
FAU - Palomar, M.
AU  - Palomar M
AD  - H Galdakao, Bilbao, Spain
FAU - Olaechea, P.
AU  - Olaechea P
AD  - HU Vall d’Hebron, Barcelona, Spain
FAU - Uriona, S.
AU  - Uriona S
AD  - HU Doce de Octubre, Madrid, Spain
FAU - Vallverdu, M.
AU  - Vallverdu M
AD  - H Galdakao, Bilbao, Spain
FAU - Catalan, M.
AU  - Catalan M
AD  - HU Malaga, Malaga, Spain
FAU - Nuvials, X.
AU  - Nuvials X
AD  - H Galdakao, Bilbao, Spain
FAU - Aragon, C.
AU  - Aragon C
AD  - Parc de Salut Mar. IMIM (Mar Medical Research Institut), Barcelona, Spain
FAU - Lerma, F. Alvarez
AU  - Lerma FA
AD  - Yonsei Wonju University College of Medicine, Department of Internal Medicine,
      Wonju, Republic of Korea
CN  - ENVIN-HELICS Study Group
FAU - Jeon, Y. D.
AU  - Jeon YD
AD  - Yonsei University College of Medicine, Department of Internal Medicine, Seoul,
      Republic of Korea
FAU - Jeong, W. Y.
AU  - Jeong WY
AD  - Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic
      of Korea
FAU - Kim, M. H.
AU  - Kim MH
AD  - Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic
      of Korea
FAU - Jeong, I. Y.
AU  - Jeong IY
AD  - Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic
      of Korea
FAU - Ahn, M. Y.
AU  - Ahn MY
AD  - Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic
      of Korea
FAU - Ahn, J. Y.
AU  - Ahn JY
AD  - Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic
      of Korea
FAU - Han, S. H.
AU  - Han SH
AD  - Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic
      of Korea
FAU - Choi, J. Y.
AU  - Choi JY
AD  - Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic
      of Korea
FAU - Song, Y. G.
AU  - Song YG
AD  - Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic
      of Korea
FAU - Kim, J. M.
AU  - Kim JM
AD  - Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic
      of Korea
FAU - Ku, N. S.
AU  - Ku NS
AD  - Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic
      of Korea
FAU - Bassi, G. Li
AU  - Bassi GL
AD  - University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano,
      Italy
FAU - Xiol, E. Aguilera
AU  - Xiol EA
AD  - University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano,
      Italy
FAU - Senussi, T.
AU  - Senussi T
AD  - University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano,
      Italy
FAU - Idone, F. A.
AU  - Idone FA
AD  - University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano,
      Italy
FAU - Motos, A.
AU  - Motos A
AD  - University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano,
      Italy
FAU - Chiurazzi, C.
AU  - Chiurazzi C
AD  - University of Milan, Fisiopatologia medico-chirurgica e dei trapianti, Milano,
      Italy
FAU - Travierso, C.
AU  - Travierso C
AD  - Hospital Virgen de la Arrixaca, ICU, El Palmar, Spain
FAU - Fernández-Barat, L.
AU  - Fernández-Barat L
AD  - University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano,
      Italy
FAU - Amaro, R.
AU  - Amaro R
AD  - University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano,
      Italy
FAU - Hua, Y.
AU  - Hua Y
AD  - University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano,
      Italy
FAU - Ranzani, O. T.
AU  - Ranzani OT
AD  - University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano,
      Italy
FAU - Bobi, Q.
AU  - Bobi Q
AD  - University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano,
      Italy
FAU - Rigol, M.
AU  - Rigol M
AD  - University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano,
      Italy
FAU - Torres, A.
AU  - Torres A
AD  - University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano,
      Italy
FAU - Fernández, I. Fuentes
AU  - Fernández IF
AD  - Hospital Virgen de la Arrixaca, Pharmacy, El Palmar, Spain
FAU - Soler, E. Andreu
AU  - Soler EA
AD  - Hospital Virgen de la Arrixaca, Pharmacy, El Palmar, Spain
FAU - de Vera, A. Pareja Rodríguez
AU  - de Vera APR
AD  - University of Murcia, Faculty of Veterinary, Murcia, Spain
FAU - Pastor, E. Escudero
AU  - Pastor EE
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - Hernandis, V.
AU  - Hernandis V
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - Ros Martínez, J.
AU  - Ros Martínez J
AD  - Hospital Virgen de la Arrixaca, Pharmacy, El Palmar, Spain
FAU - Rubio, R. Jara
AU  - Rubio RJ
AD  - Hospital Virgen de la Arrixaca, Pharmacy, El Palmar, Spain
FAU - Torner, M. Miralbés
AU  - Torner MM
AD  - Institut de Recerca Biomédica de Lleida, Lleida, Spain
FAU - Brugger, S. Carvalho
AU  - Brugger SC
AD  - Institut de Recerca Biomédica de Lleida, Lleida, Spain
FAU - Eroles, A. Aragones
AU  - Eroles AA
AD  - University of Foggia, Anaesthesia and Intensive Care, Foggia, Italy
FAU - Moles, S. Iglesias
AU  - Moles SI
AD  - Institut de Recerca Biomédica de Lleida, Lleida, Spain
FAU - Cabello, J. Trujillano
AU  - Cabello JT
AD  - Institut de Recerca Biomédica de Lleida, Lleida, Spain
FAU - Schoenenberger, J. A.
AU  - Schoenenberger JA
AD  - Institut de Recerca Biomédica de Lleida, Lleida, Spain
FAU - Casals, X. Nuvials
AU  - Casals XN
AD  - Institut de Recerca Biomédica de Lleida, Lleida, Spain
FAU - Vidal, M. Vallverdu
AU  - Vidal MV
AD  - Institut de Recerca Biomédica de Lleida, Lleida, Spain
FAU - Garrido, B. Balsera
AU  - Garrido BB
AD  - Institut de Recerca Biomédica de Lleida, Lleida, Spain
FAU - Martinez, M. Palomar
AU  - Martinez MP
AD  - Institut de Recerca Biomédica de Lleida, Lleida, Spain
FAU - Mirabella, L.
AU  - Mirabella L
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Cotoia, A.
AU  - Cotoia A
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Tullo, L.
AU  - Tullo L
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Stella, A.
AU  - Stella A
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Di Bello, F.
AU  - Di Bello F
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Di Gregorio, A.
AU  - Di Gregorio A
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Dambrosio, M.
AU  - Dambrosio M
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Cinnella, G.
AU  - Cinnella G
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra
      Spain
FAU - Rosario, L. E. de la Cruz
AU  - Rosario LEde la C
AD  - Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain
FAU - Lesmes, S. P. Gómez
AU  - Lesmes SPG
AD  - Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain
FAU - Romero, J. C. García
AU  - Romero JCG
AD  - Complejo Hospitalario de Navarra, Neurology, Pamplona, Navarra Spain
FAU - Herrera, A. N. García
AU  - Herrera ANG
AD  - Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain
FAU - Pertuz, E. D. Díaz
AU  - Pertuz EDD
AD  - Juntendo University School of Medicine, General Medicine, Tokyo, Japan
FAU - Sánchez, M. J. Gómez
AU  - Sánchez MJG
AD  - Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain
FAU - Sanz, E. Regidor
AU  - Sanz ER
AD  - Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain
FAU - Hualde, J. Barado
AU  - Hualde JB
AD  - Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain
FAU - Hernández, A. Ansotegui
AU  - Hernández AA
AD  - Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain
FAU - Ramirez, J. Roldán
AU  - Ramirez JR
AD  - Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain
FAU - Takahashi, H.
AU  - Takahashi H
AD  - Niijima, Tokyo National Health Insurance Clinic, Tokyo, Japan
FAU - Kazutoshi, F.
AU  - Kazutoshi F
AD  - Niijima, Tokyo National Health Insurance Clinic, Tokyo, Japan
FAU - Okada, Y.
AU  - Okada Y
AD  - Tokyo Metropolitan Government, Emergency Medical Services and Disaster Response
      Section, Tokyo, Japan
FAU - Oobayashi, W.
AU  - Oobayashi W
AD  - All India Institute of Medical Sciences, Anesthesiology Critical Care and Pain
      Medicine, New Delhi, India
FAU - Naito, T.
AU  - Naito T
AD  - Niijima, Tokyo National Health Insurance Clinic, Tokyo, Japan
FAU - Baidya, D. K.
AU  - Baidya DK
AD  - ASST Sacco Fatebenefratelli, Milano, Italy
FAU - Maitra, S.
AU  - Maitra S
AD  - ASST Sacco Fatebenefratelli, Milano, Italy
FAU - Anand, R. K.
AU  - Anand RK
AD  - ASST Sacco Fatebenefratelli, Milano, Italy
FAU - Ray, B. R.
AU  - Ray BR
AD  - ASST Sacco Fatebenefratelli, Milano, Italy
FAU - Arora, M. K.
AU  - Arora MK
AD  - ASST Sacco Fatebenefratelli, Milano, Italy
FAU - Ruffini, C.
AU  - Ruffini C
AD  - ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
FAU - Rota, L.
AU  - Rota L
AD  - ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
FAU - Corona, A.
AU  - Corona A
AD  - ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
FAU - Sesana, G.
AU  - Sesana G
AD  - NIHR Surgical Reconstruction and Microbiology Research Centre, Birmingham, UK
FAU - Ravasi, S.
AU  - Ravasi S
AD  - NIHR Surgical Reconstruction and Microbiology Research Centre, Birmingham, UK
FAU - Catena, E.
AU  - Catena E
AD  - ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
FAU - Naumann, D. N.
AU  - Naumann DN
AD  - Kings College Hospital, London, UK
FAU - Mellis, C.
AU  - Mellis C
AD  - Heartfelt Technologies Ltd, Cambridge, UK
FAU - Husheer, S. L.
AU  - Husheer SL
AD  - Ente Ospedaliero Ospedali Galliera, Anestesia e Rianimazione, Genova, Italy
FAU - Bishop, J.
AU  - Bishop J
AD  - Kings College Hospital, London, UK
FAU - Midwinter, M. J.
AU  - Midwinter MJ
AD  - Kings College Hospital, London, UK
FAU - Hutchings, S.
AU  - Hutchings S
AD  - Heartfelt Technologies Ltd, Cambridge, UK
FAU - Corradi, F.
AU  - Corradi F
AD  - Azienda Ospedaliero-Universitaria di Parma, Dipartimento Cardio-Nefro-Polmonare, 
      UO di Cardiochirurgia, Parma, Italy
FAU - Brusasco, C.
AU  - Brusasco C
AD  - Azienda Ospedaliero-Universitaria di Parma, Dipartimento Cardio-Nefro-Polmonare, 
      UO di Cardiochirurgia, Parma, Italy
FAU - Manca, T.
AU  - Manca T
AD  - Royal Brompton and Harefield Trust, Speech and Language Therapy, London, UK
FAU - Ramelli, A.
AU  - Ramelli A
AD  - Royal Brompton and Harefield Trust, Speech and Language Therapy, London, UK
FAU - Lattuada, M.
AU  - Lattuada M
AD  - Azienda Ospedaliero-Universitaria di Parma, Dipartimento Cardio-Nefro-Polmonare, 
      UO di Cardiochirurgia, Parma, Italy
FAU - Nicolini, F.
AU  - Nicolini F
AD  - Royal Brompton and Harefield Trust, Speech and Language Therapy, London, UK
FAU - Gherli, T.
AU  - Gherli T
AD  - Royal Brompton and Harefield Trust, Speech and Language Therapy, London, UK
FAU - Vezzani, A.
AU  - Vezzani A
AD  - Royal Brompton and Harefield Trust, Speech and Language Therapy, London, UK
FAU - Young, A.
AU  - Young A
AD  - Complejo Hospitalario de Granada, Intensive Care Unit, Granada, Spain
FAU - Carmona, A. Fernández
AU  - Carmona AF
AD  - Hospital Regional Málaga, Málaga, Spain
FAU - Santiago, A. Iglesias
AU  - Santiago AI
AD  - Hospital Regional Málaga, Málaga, Spain
FAU - Guillamon, L. Navarro
AU  - Guillamon LN
AD  - Hospital Regional Málaga, Málaga, Spain
FAU - Delgado, M. J. García
AU  - Delgado MJG
AD  - Hospital Regional Málaga, Málaga, Spain
FAU - Delgado-Amaya, M.
AU  - Delgado-Amaya M
AD  - Complejo Hospitalario de Jaén, Jaen, Spain
FAU - Curiel-Balsera, E.
AU  - Curiel-Balsera E
AD  - Complejo Hospitalario de Jaén, Jaen, Spain
FAU - Rivera-Romero, L.
AU  - Rivera-Romero L
AD  - Complejo Hospitalario de Jaén, Jaen, Spain
FAU - Castillo-Lorente, E.
AU  - Castillo-Lorente E
AD  - Hospital Puerta del Mar, Cadiz, Spain
FAU - Carrero-Gómez, F.
AU  - Carrero-Gómez F
AD  - Hospital Virgen de las Nieves, Granada, Spain
FAU - Aguayo-DeHoyos, E.
AU  - Aguayo-DeHoyos E
AD  - Hammersmith Hospital, Imperial College Healthcare NHS Trust, Department of
      Surgery and Cancer, London, UK
CN  - ARIAM registry of adult cardiac surgery
FAU - Healey, A. J.
AU  - Healey AJ
AD  - Hospital Rio Hortega, Valladolid, Spain
FAU - Cameron, C.
AU  - Cameron C
AD  - Hospital Rio Hortega, Valladolid, Spain
FAU - Jiao, L.R.
AU  - Jiao L
AD  - Hospital Rio Hortega, Valladolid, Spain
FAU - Stümpfle, R.
AU  - Stümpfle R
AD  - Hospital Rio Hortega, Valladolid, Spain
FAU - Pérez, A.
AU  - Pérez A
AD  - Istanbul University Cerrahpasa Medical Faculty, Anesthesiology and Intensive
      Care, Istanbul, Turkey
FAU - Martin, S.
AU  - Martin S
AD  - Istanbul University Cerrahpasa Medical Faculty, Anesthesiology and Intensive
      Care, Istanbul, Turkey
FAU - del Moral, O. Lopez
AU  - del Moral OL
AD  - Istanbul University Cerrahpasa Medical Faculty, Anesthesiology and Intensive
      Care, Istanbul, Turkey
FAU - Toval, S.
AU  - Toval S
AD  - Istanbul University Cerrahpasa Medical Faculty, Anesthesiology and Intensive
      Care, Istanbul, Turkey
FAU - Rico, J.
AU  - Rico J
AD  - Istanbul University Cerrahpasa Medical Faculty, Anesthesiology and Intensive
      Care, Istanbul, Turkey
FAU - Aldecoa, C.
AU  - Aldecoa C
AD  - Istanbul University Cerrahpasa Medical Faculty, Anesthesiology and Intensive
      Care, Istanbul, Turkey
FAU - Oguzhan, K.
AU  - Oguzhan K
AD  - University of Southampton, Faculty of Medicine, Southampton, UK
FAU - Demirkiran, O.
AU  - Demirkiran O
AD  - University of Southampton, Faculty of Medicine, Southampton, UK
FAU - Kirman, M.
AU  - Kirman M
AD  - University of Southampton, Faculty of Medicine, Southampton, UK
FAU - Bozbay, S.
AU  - Bozbay S
AD  - University of Southampton, Faculty of Medicine, Southampton, UK
FAU - Kosuk, M. E.
AU  - Kosuk ME
AD  - University of Southampton, Faculty of Medicine, Southampton, UK
FAU - Asyralyyeva, G.
AU  - Asyralyyeva G
AD  - University of Southampton, Faculty of Medicine, Southampton, UK
FAU - Dilek, M.
AU  - Dilek M
AD  - University of Southampton, Faculty of Medicine, Southampton, UK
FAU - Duzgun, M.
AU  - Duzgun M
AD  - University of Southampton, Faculty of Medicine, Southampton, UK
FAU - Telli, S.
AU  - Telli S
AD  - University of Southampton, Faculty of Medicine, Southampton, UK
FAU - Aydin, M.
AU  - Aydin M
AD  - University of Southampton, Faculty of Medicine, Southampton, UK
FAU - Yilmazer, F.
AU  - Yilmazer F
AD  - University of Southampton, Faculty of Medicine, Southampton, UK
FAU - Hodgson, L. E.
AU  - Hodgson LE
AD  - Western Sussex Hospitals NHS FT, Worthing, UK
FAU - Dimitrov, B. D.
AU  - Dimitrov BD
AD  - Western Sussex Hospitals NHS FT, Worthing, UK
FAU - Stubbs, C.
AU  - Stubbs C
AD  - Royal Surrey County Hospital, Intensive Care, Guildford, UK
FAU - Forni, L. G.
AU  - Forni LG
AD  - University of Surrey, Guildford, UK
FAU - Venn, R.
AU  - Venn R
AD  - University of Brighton, Brighton, UK
FAU - Vedage, D.
AU  - Vedage D
AD  - University of Southampton, Faculty of Medicine, Southampton, UK
FAU - Shawaf, S.
AU  - Shawaf S
AD  - University of Southampton, Faculty of Medicine, Southampton, UK
FAU - Naran, P.
AU  - Naran P
AD  - University of Southampton, Faculty of Medicine, Southampton, UK
FAU - Sirisena, N.
AU  - Sirisena N
AD  - University of Southampton, Faculty of Medicine, Southampton, UK
FAU - Kinnear, J.
AU  - Kinnear J
AD  - University of Southampton, Faculty of Medicine, Southampton, UK
FAU - Dimitrov, B. D.
AU  - Dimitrov BD
AD  - Western Sussex Hospitals NHS FT, Worthing, UK
FAU - Hodgson, L. E.
AU  - Hodgson LE
AD  - Western Sussex Hospitals NHS FT, Worthing, UK
FAU - Stubbs, C.
AU  - Stubbs C
AD  - Royal Surrey County Hospital, Intensive Care, Guildford, UK
FAU - Forni, L. G.
AU  - Forni LG
AD  - University of Surrey, Guildford, UK
FAU - Venn, R.
AU  - Venn R
AD  - University of Brighton, Brighton, UK
FAU - Londoño, J. Gonzalez
AU  - Londoño JG
AD  - Dr Josep Trueta University Hospital, Clinical laboratory, Girona, Spain
FAU - Cardenas, C. Lorencio
AU  - Cardenas CL
AD  - Dr Josep Trueta University Hospital, Clinical laboratory, Girona, Spain
FAU - Ginés, A. Sánchez
AU  - Ginés AS
AD  - Dr Josep Trueta University Hospital, Clinical laboratory, Girona, Spain
FAU - Gubianas, C. Murcia
AU  - Gubianas CM
AD  - Dr Josep Trueta University Hospital, Clinical laboratory, Girona, Spain
FAU - Sánchez, E. Clapes
AU  - Sánchez EC
AD  - Pavlov First Saint-Petersburg State Medical University, Anesthesiology and
      Intensive Care, Saint-Petersburg, Russian Federation
FAU - Sirvent, J. M.
AU  - Sirvent JM
AD  - Dr Josep Trueta University Hospital, Clinical laboratory, Girona, Spain
FAU - Panafidina, V.
AU  - Panafidina V
AD  - Saint-Petersburg I. I. Dzhanelidze Research institute of Emergency Medicine,
      Saint-Petersburg, Russian Federation
FAU - Shlyk, I.
AU  - Shlyk I
AD  - Saint-Petersburg I. I. Dzhanelidze Research institute of Emergency Medicine,
      Saint-Petersburg, Russian Federation
FAU - Ilyina, V.
AU  - Ilyina V
AD  - Vilnius University, Clinic of Anaesthesiology and Intensive Care, Vilnius,
      Lithuania
FAU - Judickas, S.
AU  - Judickas S
AD  - Vilnius University, Faculty of Medicine, Vilnius, Lithuania
FAU - Kezyte, G.
AU  - Kezyte G
AD  - Hadassah Hebrew University Medical Center, Jerusalem, Israel
FAU - Urbanaviciute, I.
AU  - Urbanaviciute I
AD  - Hadassah Hebrew University Medical Center, Jerusalem, Israel
FAU - Serpytis, M.
AU  - Serpytis M
AD  - Vilnius University, Faculty of Medicine, Vilnius, Lithuania
FAU - Gaizauskas, E.
AU  - Gaizauskas E
AD  - Vilnius University, Faculty of Medicine, Vilnius, Lithuania
FAU - Sipylaite, J.
AU  - Sipylaite J
AD  - Vilnius University, Faculty of Medicine, Vilnius, Lithuania
FAU - Sprung, C. L.
AU  - Sprung CL
AD  - LeukoDx, Jerusalem, Israel
FAU - Munteanu, G.
AU  - Munteanu G
AD  - LeukoDx, Jerusalem, Israel
FAU - Morales, R. C.
AU  - Morales RC
AD  - LeukoDx, Jerusalem, Israel
FAU - Kasdan, H.
AU  - Kasdan H
AD  - Regional University Hospital in Málaga, Intensive Care Medicine, Málaga, Spain
FAU - Volker, T.
AU  - Volker T
AD  - Regional University Hospital in Málaga, Intensive Care Medicine, Málaga, Spain
FAU - Reiter, A.
AU  - Reiter A
AD  - Regional University Hospital in Málaga, Intensive Care Medicine, Málaga, Spain
FAU - Cohen, Y.
AU  - Cohen Y
AD  - Regional University Hospital in Málaga, Intensive Care Medicine, Málaga, Spain
FAU - Himmel, Y.
AU  - Himmel Y
AD  - Regional University Hospital in Málaga, Intensive Care Medicine, Málaga, Spain
FAU - Meissonnier, J.
AU  - Meissonnier J
AD  - Regional University Hospital in Málaga, Intensive Care Medicine, Málaga, Spain
FAU - Banderas-Bravo, M. E.
AU  - Banderas-Bravo ME
AD  - Queen Mary University of London, William Harvey Research Institute, London, UK
FAU - Gómez-Jiménez, C.
AU  - Gómez-Jiménez C
AD  - Queen Mary University of London, William Harvey Research Institute, London, UK
FAU - García-Martínez, M. V.
AU  - García-Martínez MV
AD  - Queen Mary University of London, William Harvey Research Institute, London, UK
FAU - Martínez-Carmona, J. F.
AU  - Martínez-Carmona JF
AD  - Queen Mary University of London, William Harvey Research Institute, London, UK
FAU - Fernández-Ortega, J. F.
AU  - Fernández-Ortega JF
AD  - Queen Mary University of London, William Harvey Research Institute, London, UK
FAU - O‘Dwyer, M. J.
AU  - O‘Dwyer MJ
AD  - The Royal London Hospital, Adult Critical Care Unit, London, UK
FAU - Starczewska, M.
AU  - Starczewska M
AD  - Queen Mary University of London, London, UK
FAU - Wilks, M.
AU  - Wilks M
AD  - Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium
FAU - Vincent, J. L.
AU  - Vincent JL
AD  - Nord University, Faculty of Health Science, Levanger, Norway
CN  - The Rapid Diagnosis of Infections in the Critically Ill Team
FAU - Torsvik, M.
AU  - Torsvik M
AD  - Nord-Trøndelag Hospital Trust, Levanger Hospital, Internal Medicine, Levanger,
      Norway
FAU - Gustad, L. T.
AU  - Gustad LT
AD  - Norwegian University of Technology and Science (NTNU), Department of Neuroscience
      (INM), Trondheim, Norway
FAU - Bangstad, I. L.
AU  - Bangstad IL
AD  - Norwegian University of Technology and Science (NTNU), Department of Neuroscience
      (INM), Trondheim, Norway
FAU - Vinje, L. J.
AU  - Vinje LJ
AD  - Norwegian University of Technology and Science (NTNU), Department of Neuroscience
      (INM), Trondheim, Norway
FAU - Damås, J. K.
AU  - Damås JK
AD  - Norwegian University of technology and Science (NTNU), Centre of Molecular
      Inflammation Research, Department of Cancer Research and Molecular Medicine,
      Trondheim, Norway
FAU - Solligård, E.
AU  - Solligård E
AD  - St Olavs University Hospital, Clinic of Anesthesia and Intensive Care, Trondheim,
      Norway
FAU - Mehl, A.
AU  - Mehl A
AD  - Nord-Trøndelag Hospital Trust, Levanger Hospital, Internal Medicine, Levanger,
      Norway
FAU - Tsunoda, M.
AU  - Tsunoda M
AD  - Attikon University Hospital, 2nd Department of Critical Care, Athens, Greece
FAU - Kang, M.
AU  - Kang M
AD  - Attikon University Hospital, 2nd Department of Critical Care, Athens, Greece
FAU - Saito, M.
AU  - Saito M
AD  - Attikon University Hospital, 2nd Department of Critical Care, Athens, Greece
FAU - Saito, N.
AU  - Saito N
AD  - Attikon University Hospital, 2nd Department of Critical Care, Athens, Greece
FAU - Akizuki, N.
AU  - Akizuki N
AD  - Attikon University Hospital, 2nd Department of Critical Care, Athens, Greece
FAU - Namiki, M.
AU  - Namiki M
AD  - Attikon University Hospital, 2nd Department of Critical Care, Athens, Greece
FAU - Takeda, M.
AU  - Takeda M
AD  - Attikon University Hospital, 2nd Department of Critical Care, Athens, Greece
FAU - Yuzawa, J.
AU  - Yuzawa J
AD  - Attikon University Hospital, 2nd Department of Critical Care, Athens, Greece
FAU - Yaguchi, A.
AU  - Yaguchi A
AD  - Attikon University Hospital, 2nd Department of Critical Care, Athens, Greece
CN  - Tokyo Womens Medical University
FAU - Frantzeskaki, F.
AU  - Frantzeskaki F
AD  - Attikon University Hospital, 2nd Department of Internal Medicine, Athens, Greece
FAU - Tsirigotis, P.
AU  - Tsirigotis P
AD  - National and Kapodistrian University of Athens, Department of Experimental
      Physiology, Athens, Greece
FAU - Chondropoulos, S.
AU  - Chondropoulos S
AD  - National and Kapodistrian University of Athens, Department of Experimental
      Physiology, Athens, Greece
FAU - Paramythiotou, E.
AU  - Paramythiotou E
AD  - Attikon University Hospital, 2nd Department of Internal Medicine, Athens, Greece
FAU - Theodorakopoulou, M.
AU  - Theodorakopoulou M
AD  - Attikon University Hospital, 2nd Department of Internal Medicine, Athens, Greece
FAU - Stamouli, M.
AU  - Stamouli M
AD  - National and Kapodistrian University of Athens, Department of Experimental
      Physiology, Athens, Greece
FAU - Gkirkas, K.
AU  - Gkirkas K
AD  - National and Kapodistrian University of Athens, Department of Experimental
      Physiology, Athens, Greece
FAU - Dimopoulou, I. K.
AU  - Dimopoulou IK
AD  - Tokyo Women’s Medical University, Tokyo, Japan
FAU - Makiko, S.
AU  - Makiko S
AD  - University College London, Faculty of Medical Sciences, London, UK
FAU - Tsunoda, M.
AU  - Tsunoda M
AD  - University College London, Faculty of Medical Sciences, London, UK
FAU - Kang, M.
AU  - Kang M
AD  - University College London, Faculty of Medical Sciences, London, UK
FAU - Yuzawa, J.
AU  - Yuzawa J
AD  - University College London, Faculty of Medical Sciences, London, UK
FAU - Akiduki, N.
AU  - Akiduki N
AD  - University College London, Faculty of Medical Sciences, London, UK
FAU - Namiki, M.
AU  - Namiki M
AD  - University College London, Faculty of Medical Sciences, London, UK
FAU - Takeda, M.
AU  - Takeda M
AD  - University College London, Faculty of Medical Sciences, London, UK
FAU - Yaguchi, A.
AU  - Yaguchi A
AD  - University College London, Faculty of Medical Sciences, London, UK
FAU - Preau, S.
AU  - Preau S
AD  - Lille Univ Hospital, Lille, France
FAU - Ambler, M.
AU  - Ambler M
AD  - Lille Univ Hospital, Lille, France
FAU - Sigurta, A.
AU  - Sigurta A
AD  - Lille Univ Hospital, Lille, France
FAU - Saeed, S.
AU  - Saeed S
AD  - Lille Univ Hospital, Lille, France
FAU - Singer, M.
AU  - Singer M
AD  - Lille Univ Hospital, Lille, France
FAU - Jochmans, S.
AU  - Jochmans S
AD  - Melun Hospital, Clinical Research Unit, Melun, France
FAU - Chelly, J.
AU  - Chelly J
AD  - Melun Hospital, Clinical Research Unit, Melun, France
FAU - Vong, L. V. P.
AU  - Vong LVP
AD  - Melun Hospital, Clinical Research Unit, Melun, France
FAU - Sy, O.
AU  - Sy O
AD  - Melun Hospital, Clinical Research Unit, Melun, France
FAU - Serbource-Goguel, J.
AU  - Serbource-Goguel J
AD  - Melun Hospital, Clinical Research Unit, Melun, France
FAU - Rolin, N.
AU  - Rolin N
AD  - Melun Hospital, Clinical Research Unit, Melun, France
FAU - Weyer, C. M.
AU  - Weyer CM
AD  - Melun Hospital, Clinical Research Unit, Melun, France
FAU - Abdallah, R. I.
AU  - Abdallah RI
AD  - Melun Hospital, Clinical Research Unit, Melun, France
FAU - Adrie, C.
AU  - Adrie C
AD  - Melun Hospital, Clinical Research Unit, Melun, France
FAU - Vinsonneau, C.
AU  - Vinsonneau C
AD  - Melun Hospital, Clinical Research Unit, Melun, France
FAU - Monchi, M.
AU  - Monchi M
AD  - Melun Hospital, Clinical Research Unit, Melun, France
FAU - Mayr, U.
AU  - Mayr U
AD  - Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit,
      Izmir, Turkey
FAU - Huber, W.
AU  - Huber W
AD  - Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit,
      Izmir, Turkey
FAU - Karsten, E.
AU  - Karsten E
AD  - Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit,
      Izmir, Turkey
FAU - Lahmer, T.
AU  - Lahmer T
AD  - Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit,
      Izmir, Turkey
FAU - Thies, P.
AU  - Thies P
AD  - Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit,
      Izmir, Turkey
FAU - Henschel, B.
AU  - Henschel B
AD  - Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit,
      Izmir, Turkey
FAU - Fischer, G.
AU  - Fischer G
AD  - Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit,
      Izmir, Turkey
FAU - Schmid, R. M.
AU  - Schmid RM
AD  - Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit,
      Izmir, Turkey
FAU - Ediboglu, O.
AU  - Ediboglu O
AD  - National Cheng Kung University Hospital, Department of Internal Medicine, Tainan,
      Taiwan, Province of China
FAU - Ataman, S.
AU  - Ataman S
AD  - National Cheng Kung University Hospital, Department of Internal Medicine, Tainan,
      Taiwan, Province of China
FAU - Naz, I.
AU  - Naz I
AD  - National Cheng Kung University Hospital, Department of Internal Medicine, Tainan,
      Taiwan, Province of China
FAU - Yaman, G.
AU  - Yaman G
AD  - National Cheng Kung University Hospital, Department of Internal Medicine, Tainan,
      Taiwan, Province of China
FAU - Kirakli, C.
AU  - Kirakli C
AD  - National Cheng Kung University Hospital, Department of Internal Medicine, Tainan,
      Taiwan, Province of China
FAU - Su, P. L.
AU  - Su PL
AD  - National Cheng Kung University, Medical Device Innovation Center, Tainan, Taiwan,
      Province of China
FAU - Kou, P. S.
AU  - Kou PS
AD  - National Cheng Kung University, Medical Device Innovation Center, Tainan, Taiwan,
      Province of China
FAU - Lin, W. C.
AU  - Lin WC
AD  - National Cheng Kung University, Medical Device Innovation Center, Tainan, Taiwan,
      Province of China
FAU - Chen, C. W.
AU  - Chen CW
AD  - National Cheng Kung University, Medical Device Innovation Center, Tainan, Taiwan,
      Province of China
FAU - Lozano, J. A. Benítez
AU  - Lozano JAB
AD  - Hospital Universitario Reina Sofia, Intensive Care Unit, Córdoba, Spain
FAU - Sánchez, P. Carmona
AU  - Sánchez PC
AD  - Hospital of Manises, Intensive Care Unit, Valencia, Spain
FAU - Francioni, J. E. Barrueco
AU  - Francioni JEB
AD  - Complejo Hospitalario de Jaén, Intensive Care Unit, Jaén, Spain
FAU - Ferrón, F. Ruiz
AU  - Ferrón FR
AD  - Réanimation Médicale, Hôpital de la Croix-Rousse, Lyon, France
FAU - Simón, J. M. Serrano
AU  - Simón JMS
AD  - Hospital of Manises, Intensive Care Unit, Valencia, Spain
FAU - Riad, Z.
AU  - Riad Z
AD  - IMRB, INSERM 955, Créteil, France
FAU - Mezidi, M.
AU  - Mezidi M
AD  - IMRB, INSERM 955, Créteil, France
FAU - Aublanc, M.
AU  - Aublanc M
AD  - IMRB, INSERM 955, Créteil, France
FAU - Perinel, S.
AU  - Perinel S
AD  - IMRB, INSERM 955, Créteil, France
FAU - Lissonde, F.
AU  - Lissonde F
AD  - IMRB, INSERM 955, Créteil, France
FAU - Louf-Durier, A.
AU  - Louf-Durier A
AD  - IMRB, INSERM 955, Créteil, France
FAU - Yonis, H.
AU  - Yonis H
AD  - IMRB, INSERM 955, Créteil, France
FAU - Tapponnier, R.
AU  - Tapponnier R
AD  - IMRB, INSERM 955, Créteil, France
FAU - Richard, J. C.
AU  - Richard JC
AD  - IMRB, INSERM 955, Créteil, France
FAU - Louis, B.
AU  - Louis B
AD  - Hôpital de la Croix-Rousse, Réanimation Médicale, Lyon, France
FAU - Guérin, C.
AU  - Guérin C
AD  - IMRB, INSERM 955, Créteil, France
CN  - PLUG working group
FAU - Mezidi, M.
AU  - Mezidi M
AD  - INSERM 955, Equipe 13, Créteil, France
FAU - Yonis, H.
AU  - Yonis H
AD  - INSERM 955, Equipe 13, Créteil, France
FAU - Aublanc, M.
AU  - Aublanc M
AD  - INSERM 955, Equipe 13, Créteil, France
FAU - Lissonde, F.
AU  - Lissonde F
AD  - INSERM 955, Equipe 13, Créteil, France
FAU - Louf-Durier, A.
AU  - Louf-Durier A
AD  - INSERM 955, Equipe 13, Créteil, France
FAU - Perinel, S.
AU  - Perinel S
AD  - INSERM 955, Equipe 13, Créteil, France
FAU - Tapponnier, R.
AU  - Tapponnier R
AD  - INSERM 955, Equipe 13, Créteil, France
FAU - Richard, J. C.
AU  - Richard JC
AD  - INSERM 955, Equipe 13, Créteil, France
FAU - Guérin, C.
AU  - Guérin C
AD  - INSERM 955, Equipe 13, Créteil, France
FAU - Marmanidou, K.
AU  - Marmanidou K
AD  - Cyprus University of Technology, Department of Electrical Engineering, Computer
      Engineering and Informatics, Limassol, Cyprus
FAU - Oikonomou, M.
AU  - Oikonomou M
AD  - Cyprus University of Technology, Department of Electrical Engineering, Computer
      Engineering and Informatics, Limassol, Cyprus
FAU - Nouris, C.
AU  - Nouris C
AD  - Cyprus University of Technology, Department of Electrical Engineering, Computer
      Engineering and Informatics, Limassol, Cyprus
FAU - Loizou, C.
AU  - Loizou C
AD  - Erasmus Medical Center, Intensive Care Adults, Rotterdam, Netherlands
FAU - Soilemezi, E.
AU  - Soilemezi E
AD  - Cyprus University of Technology, Department of Electrical Engineering, Computer
      Engineering and Informatics, Limassol, Cyprus
FAU - Matamis, D.
AU  - Matamis D
AD  - Cyprus University of Technology, Department of Electrical Engineering, Computer
      Engineering and Informatics, Limassol, Cyprus
FAU - Somhorst, P.
AU  - Somhorst P
AD  - Okayama University Hospital, Department of Clinical Engineering, Okayama City,
      Japan
FAU - Gommers, D.
AU  - Gommers D
AD  - Okayama University Hospital, Department of Clinical Engineering, Okayama City,
      Japan
FAU - Hayashi, K.
AU  - Hayashi K
AD  - Okayama University Hospital, Advanced Emergency and Critical Care Center, Okayama
      City, Japan
FAU - Hirayama, T.
AU  - Hirayama T
AD  - Okayama University Hospital, Advanced Emergency and Critical Care Center, Okayama
      City, Japan
FAU - Yumoto, T.
AU  - Yumoto T
AD  - Kawasaki Medical School, Department of Acute Care & Primary Care Medicine,
      Kurashiki City, Japan
FAU - Tsukahara, K.
AU  - Tsukahara K
AD  - Kawasaki Medical School, Department of Acute Care & Primary Care Medicine,
      Kurashiki City, Japan
FAU - Iida, A.
AU  - Iida A
AD  - Kawasaki Medical School, Department of Acute Care & Primary Care Medicine,
      Kurashiki City, Japan
FAU - Nosaka, N.
AU  - Nosaka N
AD  - Kawasaki Medical School, Department of Acute Care & Primary Care Medicine,
      Kurashiki City, Japan
FAU - Sato, K.
AU  - Sato K
AD  - Kawasaki Medical School, Department of Acute Care & Primary Care Medicine,
      Kurashiki City, Japan
FAU - Ugawa, T.
AU  - Ugawa T
AD  - Kawasaki Medical School, Department of Acute Care & Primary Care Medicine,
      Kurashiki City, Japan
FAU - Nakao, A.
AU  - Nakao A
AD  - Kawasaki Medical School, Department of Acute Care & Primary Care Medicine,
      Kurashiki City, Japan
FAU - Ujike, Y.
AU  - Ujike Y
AD  - Okayama University, Department of Medical Technology Graduate School of Health
      Sciences, Okayama City, Japan
FAU - Hirohata, S.
AU  - Hirohata S
AD  - Fondazione IRCCS Policlinico S. Matteo, Anesthesia and Intensive Care, University
      of Pavia, Pavie, Italy
FAU - Mojoli, F.
AU  - Mojoli F
AD  - University of Chieti, School of residency in Anesthesia, Intensive Care and Pain 
      Therapy, Chieti, Italy
FAU - Torriglia, F.
AU  - Torriglia F
AD  - University of Chieti, School of residency in Anesthesia, Intensive Care and Pain 
      Therapy, Chieti, Italy
FAU - Giannantonio, M.
AU  - Giannantonio M
AD  - Radboudumc, Intensive Care, Nijmegen, Netherlands
FAU - Orlando, A.
AU  - Orlando A
AD  - University of Chieti, School of residency in Anesthesia, Intensive Care and Pain 
      Therapy, Chieti, Italy
FAU - Bianzina, S.
AU  - Bianzina S
AD  - University of Chieti, School of residency in Anesthesia, Intensive Care and Pain 
      Therapy, Chieti, Italy
FAU - Tavazzi, G.
AU  - Tavazzi G
AD  - University of Chieti, School of residency in Anesthesia, Intensive Care and Pain 
      Therapy, Chieti, Italy
FAU - Mongodi, S.
AU  - Mongodi S
AD  - University of Chieti, School of residency in Anesthesia, Intensive Care and Pain 
      Therapy, Chieti, Italy
FAU - Pozzi, M.
AU  - Pozzi M
AD  - University of Chieti, School of residency in Anesthesia, Intensive Care and Pain 
      Therapy, Chieti, Italy
FAU - Iotti, G. A.
AU  - Iotti GA
AD  - University of Chieti, School of residency in Anesthesia, Intensive Care and Pain 
      Therapy, Chieti, Italy
FAU - Braschi, A.
AU  - Braschi A
AD  - University of Chieti, School of residency in Anesthesia, Intensive Care and Pain 
      Therapy, Chieti, Italy
CN  - PLUG Working Group
FAU - Jansen, D.
AU  - Jansen D
AD  - Beijing Tiantan Hospital, Capital Medical University, Department of Critical Care
      Medicine, Beijing, China
FAU - Gadgil, S.
AU  - Gadgil S
AD  - Beijing Tiantan Hospital, Capital Medical University, Department of Critical Care
      Medicine, Beijing, China
FAU - Doorduin, J.
AU  - Doorduin J
AD  - Beijing Tiantan Hospital, Capital Medical University, Department of Critical Care
      Medicine, Beijing, China
FAU - Roesthuis, L.
AU  - Roesthuis L
AD  - Beijing Tiantan Hospital, Capital Medical University, Department of Critical Care
      Medicine, Beijing, China
FAU - van der Hoeven, J. G.
AU  - van der Hoeven JG
AD  - Beijing Tiantan Hospital, Capital Medical University, Department of Critical Care
      Medicine, Beijing, China
FAU - Heunks, L. M. A.
AU  - Heunks LMA
AD  - Beijing Tiantan Hospital, Capital Medical University, Department of Critical Care
      Medicine, Beijing, China
FAU - Chen, G. Q.
AU  - Chen GQ
AD  - University of Sao Paulo, Faculty of Medicine, Hospital das Clínicas, Anesthesia, 
      Critical Care and Pain, Sao Paulo, Brazil
FAU - Sun, X. M.
AU  - Sun XM
AD  - University of Sao Paulo, Faculty of Medicine, Hospital das Clínicas, Anesthesia, 
      Critical Care and Pain, Sao Paulo, Brazil
FAU - He, X.
AU  - He X
AD  - University of Sao Paulo, Faculty of Medicine, Hospital das Clínicas, Anesthesia, 
      Critical Care and Pain, Sao Paulo, Brazil
FAU - Yang, Y. L.
AU  - Yang YL
AD  - University of Sao Paulo, Faculty of Medicine, Hospital das Clínicas, Anesthesia, 
      Critical Care and Pain, Sao Paulo, Brazil
FAU - Shi, Z. H.
AU  - Shi ZH
AD  - University of Sao Paulo, Faculty of Medicine, Hospital das Clínicas, Anesthesia, 
      Critical Care and Pain, Sao Paulo, Brazil
FAU - Xu, M.
AU  - Xu M
AD  - University of Sao Paulo, Faculty of Medicine, Hospital das Clínicas, Anesthesia, 
      Critical Care and Pain, Sao Paulo, Brazil
FAU - Zhou, J. X.
AU  - Zhou JX
AD  - University of Sao Paulo, Faculty of Medicine, Hospital das Clínicas, Anesthesia, 
      Critical Care and Pain, Sao Paulo, Brazil
FAU - Pereira, S. M.
AU  - Pereira SM
AD  - University of Sao Paulo, Faculty of Medicine, Hospital das Clínicas, Pulmonary
      and Critical Care, Sao Paulo, Brazil
FAU - Tucci, M. R.
AU  - Tucci MR
AD  - Hospital Sirio Libanes, Anesthesia, Critical Care and Pain, Sao Paulo, Brazil
FAU - Tonelotto, B. F. F.
AU  - Tonelotto BFF
AD  - University of Sao Paulo, Faculty of Medicine, Hospital das Clínicas, Radiology,
      Sao Paulo, Brazil
FAU - Simoes, C. M.
AU  - Simoes CM
AD  - University of Sao Paulo, Faculty of Medicine, Hospital das Clínicas, Pulmonary
      and Critical Care, Sao Paulo, Brazil
FAU - Morais, C. C. A.
AU  - Morais CCA
AD  - Hospital Sirio Libanes, Anesthesia, Critical Care and Pain, Sao Paulo, Brazil
FAU - Pompeo, M. S.
AU  - Pompeo MS
AD  - University of Sao Paulo, Faculty of Medicine, Hospital das Clínicas, Pulmonary
      and Critical Care, Sao Paulo, Brazil
FAU - Kay, F. U.
AU  - Kay FU
AD  - Okayama University Hospital, Department of Intensive Care, Okayama, Japan
FAU - Amato, M. B. P.
AU  - Amato MBP
AD  - Hospital Sirio Libanes, Anesthesia, Critical Care and Pain, Sao Paulo, Brazil
FAU - Vieira, J. E.
AU  - Vieira JE
AD  - University of Sao Paulo, Faculty of Medicine, Hospital das Clínicas, Pulmonary
      and Critical Care, Sao Paulo, Brazil
FAU - Suzuki, S.
AU  - Suzuki S
AD  - Okayama University Medical School, Department of Anesthesiology and
      Resuscitology, Okayama, Japan
FAU - Mihara, Y.
AU  - Mihara Y
AD  - Asan Medical Center, University of Ulsan College of Medicine, Department of
      Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul, 
      Republic of Korea
FAU - Hikasa, Y.
AU  - Hikasa Y
AD  - Asan Medical Center, University of Ulsan College of Medicine, Department of
      Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul, 
      Republic of Korea
FAU - Okahara, S.
AU  - Okahara S
AD  - Asan Medical Center, University of Ulsan College of Medicine, Department of
      Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul, 
      Republic of Korea
FAU - Morimatsu, H.
AU  - Morimatsu H
AD  - Asan Medical Center, University of Ulsan College of Medicine, Department of
      Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul, 
      Republic of Korea
CN  - On behalf of Okayama Research Investigation Organizing Network
      (ORION)investigators
FAU - Kwon, H. M.
AU  - Kwon HM
AD  - Asan Medical Center, University of Ulsan College of Medicine, Department of
      Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul, 
      Republic of Korea
FAU - Moon, Y. J.
AU  - Moon YJ
AD  - Asan Medical Center, University of Ulsan College of Medicine, Department of
      Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul, 
      Republic of Korea
FAU - Lee, S. H.
AU  - Lee SH
AD  - Asan Medical Center, University of Ulsan College of Medicine, Department of
      Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul, 
      Republic of Korea
FAU - Jung, K. W.
AU  - Jung KW
AD  - Asan Medical Center, University of Ulsan College of Medicine, Department of
      Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul, 
      Republic of Korea
FAU - Shin, W. J.
AU  - Shin WJ
AD  - Asan Medical Center, University of Ulsan College of Medicine, Department of
      Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul, 
      Republic of Korea
FAU - Jun, I. G.
AU  - Jun IG
AD  - Asan Medical Center, University of Ulsan College of Medicine, Department of
      Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul, 
      Republic of Korea
FAU - Song, J. G.
AU  - Song JG
AD  - Asan Medical Center, University of Ulsan College of Medicine, Department of
      Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul, 
      Republic of Korea
FAU - Hwang, G. S.
AU  - Hwang GS
AD  - Asan Medical Center, University of Ulsan College of Medicine, Department of
      Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul, 
      Republic of Korea
FAU - Lee, S.
AU  - Lee S
AD  - University Hospital of Parma, Parma, Italy
FAU - Moon, Y. J.
AU  - Moon YJ
AD  - University Hospital of Parma, Parma, Italy
FAU - Kwon, H. M.
AU  - Kwon HM
AD  - University Hospital of Parma, Parma, Italy
FAU - Jung, K.
AU  - Jung K
AD  - University Hospital of Parma, Parma, Italy
FAU - Shin, W. J.
AU  - Shin WJ
AD  - University Hospital of Parma, Parma, Italy
FAU - Jun, I. G.
AU  - Jun IG
AD  - University Hospital of Parma, Parma, Italy
FAU - Song, J. G.
AU  - Song JG
AD  - University Hospital of Parma, Parma, Italy
FAU - Hwang, G. S.
AU  - Hwang GS
AD  - University Hospital of Parma, Parma, Italy
FAU - Ramelli, A.
AU  - Ramelli A
AD  - E.O. Ospedali Galliera, Genoa, Italy
FAU - Manca, T.
AU  - Manca T
AD  - E.O. Ospedali Galliera, Genoa, Italy
FAU - Corradi, F.
AU  - Corradi F
AD  - Medical University of Vienna, Department of Anesthesiology, General Intensive
      Care and Pain Medicine, Vienna, Austria
FAU - Brusasco, C.
AU  - Brusasco C
AD  - Medical University of Vienna, Department of Anesthesiology, General Intensive
      Care and Pain Medicine, Vienna, Austria
FAU - Nicolini, F.
AU  - Nicolini F
AD  - E.O. Ospedali Galliera, Genoa, Italy
FAU - Gherli, T.
AU  - Gherli T
AD  - E.O. Ospedali Galliera, Genoa, Italy
FAU - Brianti, R.
AU  - Brianti R
AD  - E.O. Ospedali Galliera, Genoa, Italy
FAU - Fanzaghi, P.
AU  - Fanzaghi P
AD  - E.O. Ospedali Galliera, Genoa, Italy
FAU - Vezzani, A.
AU  - Vezzani A
AD  - E.O. Ospedali Galliera, Genoa, Italy
FAU - Tudor, B. A.
AU  - Tudor BA
AD  - Medical University of Vienna, Department of Surgery/Div. of General Surgery,
      Vienna, Austria
FAU - Klaus, D. A.
AU  - Klaus DA
AD  - Medical University of Vienna, Department of Surgery/Div. of General Surgery,
      Vienna, Austria
FAU - Lebherz-Eichinger, D.
AU  - Lebherz-Eichinger D
AD  - Medical University of Vienna, Department of Surgery/Div. of General Surgery,
      Vienna, Austria
FAU - Lechner, C.
AU  - Lechner C
AD  - Medical University of Vienna, Department of Surgery/Div. of General Surgery,
      Vienna, Austria
FAU - Schwarz, C.
AU  - Schwarz C
AD  - Medical University of Vienna, Department of Cranio-, Maxillofacial and Oral
      Surgery, Vienna, Austria
FAU - Bodingbauer, M.
AU  - Bodingbauer M
AD  - Medical University of Vienna, Department of Cranio-, Maxillofacial and Oral
      Surgery, Vienna, Austria
FAU - Seemann, R.
AU  - Seemann R
AD  - Pirogov Russian National Research Medical University, Anesthesiology and
      Intensive Care Medicine, Moscow, Russian Federation
FAU - Kaczirek, K.
AU  - Kaczirek K
AD  - Medical University of Vienna, Department of Cranio-, Maxillofacial and Oral
      Surgery, Vienna, Austria
FAU - Fleischmann, E.
AU  - Fleischmann E
AD  - Medical University of Vienna, Department of Surgery/Div. of General Surgery,
      Vienna, Austria
FAU - Roth, G. A.
AU  - Roth GA
AD  - Medical University of Vienna, Department of Surgery/Div. of General Surgery,
      Vienna, Austria
FAU - Krenn, C. G.
AU  - Krenn CG
AD  - Medical University of Vienna, Department of Surgery/Div. of General Surgery,
      Vienna, Austria
FAU - Malyshev, A.
AU  - Malyshev A
AD  - Yokohama City University Graduate school of Medicine, Department of
      Anesthesiology and Critical Care, Yokohama, Japan
FAU - Sergey, S.
AU  - Sergey S
AD  - Yokohama City University Graduate school of Medicine, Department of
      Anesthesiology and Critical Care, Yokohama, Japan
FAU - Yamaguchi, Y.
AU  - Yamaguchi Y
AD  - Yamato Municipal Hospital, Department of Anesthesia, Yamato, Japan
FAU - Nomura, T.
AU  - Nomura T
AD  - Yamato Municipal Hospital, Department of Anesthesia, Yamato, Japan
FAU - Yoshitake, E.
AU  - Yoshitake E
AD  - CHU Antoine Béclère APHP, Intensive Care Unit, Clamart, France
FAU - Idei, M.
AU  - Idei M
AD  - Yamato Municipal Hospital, Department of Anesthesia, Yamato, Japan
FAU - Yoshida, T.
AU  - Yoshida T
AD  - Yamato Municipal Hospital, Department of Anesthesia, Yamato, Japan
FAU - Takaki, S.
AU  - Takaki S
AD  - Yamato Municipal Hospital, Department of Anesthesia, Yamato, Japan
FAU - Yamaguchi, O.
AU  - Yamaguchi O
AD  - Yamato Municipal Hospital, Department of Anesthesia, Yamato, Japan
FAU - Kaneko, M.
AU  - Kaneko M
AD  - CHU Antoine Béclère APHP, Intensive Care Unit, Clamart, France
FAU - Goto, T.
AU  - Goto T
AD  - Yamato Municipal Hospital, Department of Anesthesia, Yamato, Japan
FAU - Tencé, N.
AU  - Tencé N
AD  - CHU Antoine Béclère APHP, Department of Hematology, Clamart, France
FAU - Zaien, I.
AU  - Zaien I
AD  - CHU Antoine Béclère APHP, Department of Hematology, Clamart, France
FAU - Wolf, M.
AU  - Wolf M
AD  - University Hospitals Birmingham NHS Trust, Critical Care, Birmingham, UK
FAU - Trouiller, P.
AU  - Trouiller P
AD  - CHU Antoine Béclère APHP, Department of Hematology, Clamart, France
FAU - Jacobs, F. M.
AU  - Jacobs FM
AD  - CHU Antoine Béclère APHP, Department of Hematology, Clamart, France
FAU - Kelly, J. M.
AU  - Kelly JM
AD  - University of Toronto, Toronto, Canada
FAU - Veigas, P.
AU  - Veigas P
AD  - Royal College of Surgeons in Ireland, Dublin, Ireland
FAU - Hollands, S.
AU  - Hollands S
AD  - Royal College of Surgeons in Ireland, Dublin, Ireland
FAU - Min, A.
AU  - Min A
AD  - St Michael’s Hospital, Toronto, Canada
FAU - Rizoli, S.
AU  - Rizoli S
AD  - Royal College of Surgeons in Ireland, Dublin, Ireland
FAU - Robles, C. M. Coronado
AU  - Robles CMC
AD  - Odessa National Medical University, Anesthesiology and Intensive Care, Odessa,
      Ukraine
FAU - de Oca Sandoval, M. A. Montes
AU  - de Oca Sandoval MAM
AD  - Odessa National Medical University, Anesthesiology and Intensive Care, Odessa,
      Ukraine
FAU - Tarabrin, O.
AU  - Tarabrin O
AD  - Odessa National Medical University, Odessa, Ukraine
FAU - Gavrychenko, D.
AU  - Gavrychenko D
AD  - Odessa National Medical University, Odessa, Ukraine
FAU - Mazurenko, G.
AU  - Mazurenko G
AD  - Odessa National Medical University, Odessa, Ukraine
FAU - Tarabrin, P.
AU  - Tarabrin P
AD  - Hospital Virgen del Rocio, Sevilla, Spain
FAU - Garcia, I. Palacios
AU  - Garcia IP
AD  - Royal Alexandra Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Martin, A. Diaz
AU  - Martin AD
AD  - Royal Alexandra Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Mendez, M. Casado
AU  - Mendez MC
AD  - Royal Alexandra Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - orden, V. Arellano
AU  - orden VA
AD  - Royal Alexandra Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Noval, R. Leal
AU  - Noval RL
AD  - Royal Alexandra Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - McCue, C.
AU  - McCue C
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Gemmell, L.
AU  - Gemmell L
AD  - Hospital Universitario Príncipe de Asturias, Intensive Care Unit, Madrid, Spain
FAU - MacKay, A.
AU  - MacKay A
AD  - Hospital Universitario Príncipe de Asturias, Intensive Care Unit, Madrid, Spain
FAU - Luján, J.
AU  - Luján J
AD  - Hospital Universitario Príncipe de Asturias, Madrid, Spain
FAU - Villa, P.
AU  - Villa P
AD  - Hospital Universitario Príncipe de Asturias, Madrid, Spain
FAU - Llorente, B.
AU  - Llorente B
AD  - Hospital Universitario Príncipe de Asturias, Madrid, Spain
FAU - Molina, R.
AU  - Molina R
AD  - Hospital Universitario Príncipe de Asturias, Hematology, Madrid, Spain
FAU - Alcázar, L.
AU  - Alcázar L
AD  - Hospital Universitario Príncipe de Asturias, Madrid, Spain
FAU - Juanas, C. Arenillas
AU  - Juanas CA
AD  - Hospital Universitario Príncipe de Asturias, Madrid, Spain
FAU - Rogero, S.
AU  - Rogero S
AD  - Hospital Universitario Príncipe de Asturias, Madrid, Spain
FAU - Pascual, T.
AU  - Pascual T
AD  - Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
FAU - Cambronero, J. A.
AU  - Cambronero JA
AD  - Hospital Universitario Príncipe de Asturias, Madrid, Spain
FAU - Almudévar, P. Matía
AU  - Almudévar PM
AD  - Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran
FAU - Domínguez, J. Palamidessi
AU  - Domínguez JP
AD  - Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran
FAU - Carmona, S. Alcántara
AU  - Carmona SA
AD  - Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran
FAU - Castañeda, D. Palacios
AU  - Castañeda DP
AD  - Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran
FAU - Abellán, A. Naharro
AU  - Abellán AN
AD  - Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran
FAU - Lucendo, A. Pérez
AU  - Lucendo AP
AD  - Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran
FAU - Pérez, L. Pérez
AU  - Pérez LP
AD  - Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran
FAU - Rivas, R. Fernández
AU  - Rivas RF
AD  - Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran
FAU - Sanz, N. Martínez
AU  - Sanz NM
AD  - Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran
FAU - Ramos, J. Veganzones
AU  - Ramos JV
AD  - Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran
FAU - Villamizar, P. Rodríguez
AU  - Villamizar PR
AD  - Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran
FAU - Javadpour, S.
AU  - Javadpour S
AD  - University of Franche-Comté, Laboratory of Psychology EA 3188, Besançon, France
FAU - Kalani, N.
AU  - Kalani N
AD  - University of Franche-Comté, Laboratory of Psychology EA 3188, Besançon, France
FAU - Amininejad, T.
AU  - Amininejad T
AD  - University of Franche-Comté, Laboratory of Psychology EA 3188, Besançon, France
FAU - Jamali, S.
AU  - Jamali S
AD  - University of Franche-Comté, Laboratory of Psychology EA 3188, Besançon, France
FAU - Sobhanian, S.
AU  - Sobhanian S
AD  - University of Franche-Comté, Laboratory of Psychology EA 3188, Besançon, France
FAU - Laurent, A.
AU  - Laurent A
AD  - CR CHUM, Montreal, Canada
FAU - Bonnet, M.
AU  - Bonnet M
AD  - CR CHUM, Montreal, Canada
FAU - Rigal, R.
AU  - Rigal R
AD  - CHRU Minjoz, Besançon, France
FAU - Aslanian, P.
AU  - Aslanian P
AD  - CHRU Minjoz, Besançon, France
FAU - Hebert, P.
AU  - Hebert P
AD  - CHRU Minjoz, Besançon, France
FAU - Capellier, G.
AU  - Capellier G
AD  - Complejo Hospitalario de Granada, Granada, Spain
CN  - PS-ICU Group
FAU - Contreras, M. R. Diaz
AU  - Contreras MRD
AD  - Hospital del SAS de Jerez, Intensive Care Unit, Jerez de la Frontera, Spain
FAU - Mejías, C. Rodriguez
AU  - Mejías CR
AD  - Hospital del SAS de Jerez, Intensive Care Unit, Jerez de la Frontera, Spain
FAU - Ruiz, F. C. Santiago
AU  - Ruiz FCS
AD  - Hospital del SAS de Jerez, Intensive Care Unit, Jerez de la Frontera, Spain
FAU - Lombardo, M. Duro
AU  - Lombardo MD
AD  - Hospital del SAS de Jerez, Intensive Care Unit, Jerez de la Frontera, Spain
FAU - Perez, J. Castaño
AU  - Perez JC
AD  - Hospital del SAS de Jerez, Intensive Care Unit, Jerez de la Frontera, Spain
FAU - de Hoyos, E. Aguayo
AU  - de Hoyos EA
AD  - Hospital del SAS de Jerez, Intensive Care Unit, Jerez de la Frontera, Spain
FAU - Estella, A.
AU  - Estella A
AD  - Hospital del SAS de Jerez, Jerez de la Frontera, Spain
FAU - Viciana, R.
AU  - Viciana R
AD  - University Hospital Vall d’Hebron, Transplant Coordination, Barcelona, Spain
FAU - Fontaiña, L. Perez
AU  - Fontaiña LP
AD  - Hospital del SAS de Jerez, Jerez de la Frontera, Spain
FAU - Rico, T.
AU  - Rico T
AD  - Hospital del SAS de Jerez, Jerez de la Frontera, Spain
FAU - Madueño, V. Perez
AU  - Madueño VP
AD  - Hospital del SAS de Jerez, Jerez de la Frontera, Spain
FAU - Recuerda, M.
AU  - Recuerda M
AD  - Hospital del SAS de Jerez, Jerez de la Frontera, Spain
FAU - Fernández, L.
AU  - Fernández L
AD  - Hospital del SAS de Jerez, Jerez de la Frontera, Spain
FAU - Sandiumenge, A.
AU  - Sandiumenge A
AD  - University Hospital Vall d’Hebron, Stroke Unit, Neurology, Barcelona, Spain
FAU - Bonet, S.
AU  - Bonet S
AD  - University Hospital Vall d’Hebron, Barcelona, Spain
FAU - Mazo, C.
AU  - Mazo C
AD  - St Elisabeth Twee Steden Hospital, Intensive Care Medicine, Tilburg, Netherlands
FAU - Rubiera, M.
AU  - Rubiera M
AD  - University Hospital Vall d’Hebron, Barcelona, Spain
FAU - Ruiz-Rodríguez, J. C.
AU  - Ruiz-Rodríguez JC
AD  - St Elisabeth Twee Steden Hospital, Intensive Care Medicine, Tilburg, Netherlands
FAU - Gracia, R. M.
AU  - Gracia RM
AD  - St Elisabeth Twee Steden Hospital, Intensive Care Medicine, Tilburg, Netherlands
FAU - Espinel, E.
AU  - Espinel E
AD  - University Hospital Vall d’Hebron, Stroke Unit, Neurology, Barcelona, Spain
FAU - Pont, T.
AU  - Pont T
AD  - University Hospital Vall d’Hebron, Stroke Unit, Neurology, Barcelona, Spain
FAU - Kotsopoulos, A.
AU  - Kotsopoulos A
AD  - The Dutch Transplant Foundation, Leiden, Netherlands
FAU - Jansen, N.
AU  - Jansen N
AD  - Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
FAU - Abdo, W. F.
AU  - Abdo WF
AD  - Clinical Hospital Center Sestre Milosrdnice, Anaesthesiology and Intensive Care, 
      Zagreb, Croatia
FAU - Gopcevic, A.
AU  - Gopcevic A
AD  - Hospital Universitario Virgen del Rocio, Coordinación de Trasplantes, Seville,
      Spain
FAU - Gavranovic, Z.
AU  - Gavranovic Z
AD  - Hospital Universitario Virgen del Rocio, Coordinación de Trasplantes, Seville,
      Spain
FAU - Vucic, M.
AU  - Vucic M
AD  - Hospital Universitario Virgen del Rocio, Coordinación de Trasplantes, Seville,
      Spain
FAU - Glogoski, M. Zlatic
AU  - Glogoski MZ
AD  - Hospital Universitario Virgen del Rocio, Coordinación de Trasplantes, Seville,
      Spain
FAU - Penavic, L. Videc
AU  - Penavic LV
AD  - Hospital Universitario Virgen del Rocio, Coordinación de Trasplantes, Seville,
      Spain
FAU - Horvat, A.
AU  - Horvat A
AD  - Hospital Universitario Virgen del Rocio, Coordinación de Trasplantes, Seville,
      Spain
FAU - Martin-Villen, L.
AU  - Martin-Villen L
AD  - Hospital Universitario Virgen del Rocio, Critical Care, Seville, Spain
FAU - Egea-Guerero, J. J.
AU  - Egea-Guerero JJ
AD  - Hospital Universitario Virgen del Rocio, Critical Care, Seville, Spain
FAU - Revuelto-Rey, J.
AU  - Revuelto-Rey J
AD  - Université Paris Diderot, Sorbonne Paris Cité, INSERM UMR1160, Paris, France
FAU - Aldabo-Pallas, T.
AU  - Aldabo-Pallas T
AD  - Hospital Universitario Juan XXII, Critical Care, Tarragona, Spain
FAU - Correa-Chamorro, E.
AU  - Correa-Chamorro E
AD  - Hospital Universitario Virgen del Rocio, Critical Care, Seville, Spain
FAU - Gallego-Corpa, A. I.
AU  - Gallego-Corpa AI
AD  - Hospital Universitario Virgen del Rocio, Critical Care, Seville, Spain
FAU - Granados, P. Ruiz del Portal-Ruiz
AU  - Granados PRdel PR
AD  - Hospital Universitario Virgen del Rocio, Critical Care, Seville, Spain
FAU - Faivre, V.
AU  - Faivre V
AD  - APHP, Lariboisiere University Hospital, Surgical ICU, Paris, France
FAU - Wildenberg, L.
AU  - Wildenberg L
AD  - APHP, Lariboisiere University Hospital, Surgical ICU, Paris, France
FAU - Huot, B.
AU  - Huot B
AD  - APHP, Lariboisiere University Hospital, Surgical ICU, Paris, France
FAU - Lukaszewicz, A. C.
AU  - Lukaszewicz AC
AD  - APHP, Lariboisiere University Hospital, Surgical ICU, Paris, France
FAU - Simsir, M.
AU  - Simsir M
AD  - APHP, Lariboisiere University Hospital, Surgical ICU, Paris, France
FAU - Mengelle, C.
AU  - Mengelle C
AD  - APHP, Lariboisiere University Hospital, Surgical ICU, Paris, France
FAU - Payen, D.
AU  - Payen D
AD  - APHP, Lariboisiere University Hospital, Surgical ICU, Paris, France
FAU - Sanz, N. Martinez
AU  - Sanz NM
AD  - Puerta de Hierro Hospital, Intensive Care Unit, Majadahonda, Spain
FAU - Valbuena, B. Lobo
AU  - Valbuena BL
AD  - Puerta de Hierro Hospital, Intensive Care Unit, Majadahonda, Spain
FAU - de la Fuente, M. Valdivia
AU  - de la Fuente MV
AD  - Puerta de Hierro Hospital, Intensive Care Unit, Majadahonda, Spain
FAU - Almudena, P. Matía
AU  - Almudena PM
AD  - Puerta de Hierro Hospital, Intensive Care Unit, Majadahonda, Spain
FAU - Pérez, L. Pérez
AU  - Pérez LP
AD  - Puerta de Hierro Hospital, Intensive Care Unit, Majadahonda, Spain
FAU - Carmona, S. Alcántara
AU  - Carmona SA
AD  - Puerta de Hierro Hospital, Intensive Care Unit, Majadahonda, Spain
FAU - Abellán, A. Navarro
AU  - Abellán AN
AD  - Puerta de Hierro Hospital, Intensive Care Unit, Majadahonda, Spain
FAU - Simón, I. Fernández
AU  - Simón IF
AD  - Puerta de Hierro Hospital, Intensive Care Unit, Majadahonda, Spain
FAU - Muñoz, J. J. Rubio
AU  - Muñoz JJR
AD  - Puerta de Hierro Hospital, Intensive Care Unit, Majadahonda, Spain
FAU - Ramos, J. Veganzones
AU  - Ramos JV
AD  - Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Pain and
      Intensive Care, Singapore, Singapore
FAU - Carmona, S. Alcantara
AU  - Carmona SA
AD  - Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Pain and
      Intensive Care, Singapore, Singapore
FAU - Almudevar, P. Matia
AU  - Almudevar PM
AD  - Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Pain and
      Intensive Care, Singapore, Singapore
FAU - Abellan, A. Naharro
AU  - Abellan AN
AD  - Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Pain and
      Intensive Care, Singapore, Singapore
FAU - Lucendo, M. A. Perez
AU  - Lucendo MAP
AD  - Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Pain and
      Intensive Care, Singapore, Singapore
FAU - Perez, L. Perez
AU  - Perez LP
AD  - Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Pain and
      Intensive Care, Singapore, Singapore
FAU - Dominguez, J. Palamidessi
AU  - Dominguez JP
AD  - Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Pain and
      Intensive Care, Singapore, Singapore
FAU - Rivas, R. Fernandez
AU  - Rivas RF
AD  - Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Pain and
      Intensive Care, Singapore, Singapore
FAU - Villamizar, P. Rodriguez
AU  - Villamizar PR
AD  - Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Pain and
      Intensive Care, Singapore, Singapore
FAU - Wee, S.
AU  - Wee S
AD  - Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore
FAU - Ong, C.
AU  - Ong C
AD  - Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore
FAU - Lau, Y. H.
AU  - Lau YH
AD  - Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore
FAU - Wong, Y.
AU  - Wong Y
AD  - Regional University Hospital in Málaga, Intensive Care Medicine, Málaga, Spain
FAU - Banderas-Bravo, M. E.
AU  - Banderas-Bravo ME
AD  - Hosiptal Son Llàtzer, Intensive Care Department, Palma de Mallorca, Spain
FAU - Olea-Jiménez, V.
AU  - Olea-Jiménez V
AD  - Hosiptal Son Llàtzer, Intensive Care Department, Palma de Mallorca, Spain
FAU - Mora-Ordóñez, J. M.
AU  - Mora-Ordóñez JM
AD  - Hosiptal Son Llàtzer, Intensive Care Department, Palma de Mallorca, Spain
FAU - Gómez-Jiménez, C.
AU  - Gómez-Jiménez C
AD  - Hosiptal Son Llàtzer, Intensive Care Department, Palma de Mallorca, Spain
FAU - Muñoz-Muñoz, J. L.
AU  - Muñoz-Muñoz JL
AD  - Hosiptal Son Llàtzer, Intensive Care Department, Palma de Mallorca, Spain
FAU - Vallejo-Báez, J.
AU  - Vallejo-Báez J
AD  - Hosiptal Son Llàtzer, Intensive Care Department, Palma de Mallorca, Spain
FAU - Daga-Ruiz, D.
AU  - Daga-Ruiz D
AD  - Hosiptal Son Llàtzer, Intensive Care Department, Palma de Mallorca, Spain
FAU - Lebrón-Gallardo, M.
AU  - Lebrón-Gallardo M
AD  - Hosiptal Son Llàtzer, Intensive Care Department, Palma de Mallorca, Spain
FAU - Rialp, G.
AU  - Rialp G
AD  - Hospital Son Espases, Intensive Care Department, Palma de Mallorca, Spain
FAU - Raurich, J. M.
AU  - Raurich JM
AD  - Hospital de la Santa Creu i Sant Pau, Intensive Care Department, Barcelona, Spain
FAU - Morán, I.
AU  - Morán I
AD  - Hospital Torrejón de Ardoz, Intensive Care Department, Madrid, Spain
FAU - Martín, M. C.
AU  - Martín MC
AD  - Hospital Infanta Leonor, Intensive Care Department, Madrid, Spain
FAU - Heras, G.
AU  - Heras G
AD  - Hospital de Sant Joan Despí Moissès Broggi, Intensive Care Department, Sant Joan 
      Despí, Spain
FAU - Mas, A.
AU  - Mas A
AD  - Hospital Sant Joan de Déu, Intensive Care Department, Reus, Spain
FAU - Vallverdú, I.
AU  - Vallverdú I
AD  - APHM, CHU Nord, Medical ICU, Marseilles, France
FAU - Hraiech, S.
AU  - Hraiech S
AD  - APHM, CHU Timone, Medical ICU, Marseilles, France
FAU - Bourenne, J.
AU  - Bourenne J
AD  - Mayo Clinic, Pulmonary and Critical Care, Rochester, USA
FAU - Guervilly, C.
AU  - Guervilly C
AD  - APHM, CHU Timone, Medical ICU, Marseilles, France
FAU - Forel, J. M.
AU  - Forel JM
AD  - APHM, CHU Timone, Medical ICU, Marseilles, France
FAU - Adda, M.
AU  - Adda M
AD  - APHM, CHU Timone, Medical ICU, Marseilles, France
FAU - Sylla, P.
AU  - Sylla P
AD  - APHM, CHU Timone, Medical ICU, Marseilles, France
FAU - Mouaci, A.
AU  - Mouaci A
AD  - APHM, CHU Timone, Medical ICU, Marseilles, France
FAU - Gainnier, M.
AU  - Gainnier M
AD  - Mayo Clinic, Pulmonary and Critical Care, Rochester, USA
FAU - Papazian, L.
AU  - Papazian L
AD  - APHM, CHU Timone, Medical ICU, Marseilles, France
FAU - Bauer, P. R.
AU  - Bauer PR
AD  - Mayo Clinic, Center for the Science of Health Care Delivery, Rochester, USA
FAU - Kumbamu, A.
AU  - Kumbamu A
AD  - Mayo Clinic, Mayo Foundation for Medical Education and Research, Rochester, USA
FAU - Wilson, M. E.
AU  - Wilson ME
AD  - Mayo Clinic, Center for the Science of Health Care Delivery, Rochester, USA
FAU - Pannu, J. K.
AU  - Pannu JK
AD  - Mayo Clinic, Anesthesia Clinical Research, Rochester, USA
FAU - Egginton, J. S.
AU  - Egginton JS
AD  - Mayo Clinic, Mayo Foundation for Medical Education and Research, Rochester, USA
FAU - Kashyap, R.
AU  - Kashyap R
AD  - JA Hiroshima General Hospital, Pharmaceutical Department, Hatsukaiti-shi,
      Hiroshima Japan
FAU - Gajic, O.
AU  - Gajic O
AD  - Mayo Clinic, Center for the Science of Health Care Delivery, Rochester, USA
FAU - Yoshihiro, S.
AU  - Yoshihiro S
AD  - JA Hiroshima General Hospital, Division of Emergency and Critical Care Medicine, 
      Hatsukaiti-shi, Hiroshima Japan
FAU - Sakuraya, M.
AU  - Sakuraya M
AD  - Hokkaido University Hospital, Emergency and Critical Care Center, Sapporo,
      Hokkaido Japan
FAU - Hayakawa, M.
AU  - Hayakawa M
AD  - Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China
FAU - Hirata, A.
AU  - Hirata A
AD  - Hokkaido University Hospital, Emergency and Critical Care Center, Sapporo,
      Hokkaido Japan
FAU - Kawamura, N.
AU  - Kawamura N
AD  - Hokkaido University Hospital, Emergency and Critical Care Center, Sapporo,
      Hokkaido Japan
FAU - Tsutui, T.
AU  - Tsutui T
AD  - Hokkaido University Hospital, Emergency and Critical Care Center, Sapporo,
      Hokkaido Japan
FAU - Yoshida, K.
AU  - Yoshida K
AD  - Hokkaido University Hospital, Emergency and Critical Care Center, Sapporo,
      Hokkaido Japan
FAU - Hashimoto, Y.
AU  - Hashimoto Y
AD  - JA Hiroshima General Hospital, Division of Emergency and Critical Care Medicine, 
      Hatsukaiti-shi, Hiroshima Japan
CN  - Japan Septic Disseminated Intravascular Coagulation (JSEPTIC DIC) study group
FAU - Chang, C. H.
AU  - Chang CH
AD  - Chang Gung Memorial Hospital, Linkou, Taoyuan City, Taiwan, Province of China
FAU - Hu, H. C.
AU  - Hu HC
AD  - Queen’s University, Critical Care Medicine, Kingston, Canada
FAU - Chiu, L. C.
AU  - Chiu LC
AD  - Queen’s University, Critical Care Medicine, Kingston, Canada
FAU - Hung, C. Y.
AU  - Hung CY
AD  - Queen’s University, Critical Care Medicine, Kingston, Canada
FAU - Li, S. H.
AU  - Li SH
AD  - Queen’s University, Critical Care Medicine, Kingston, Canada
FAU - Kao, K. C.
AU  - Kao KC
AD  - Queen’s University, Critical Care Medicine, Kingston, Canada
FAU - Sibley, S.
AU  - Sibley S
AD  - University of Western Ontario, Critical Care Medicine, London, Canada
FAU - Drover, J.
AU  - Drover J
AD  - University of Western Ontario, Critical Care Medicine, London, Canada
FAU - D’Arsigny, C.
AU  - D’Arsigny C
AD  - University of Western Ontario, Critical Care Medicine, London, Canada
FAU - Parker, C.
AU  - Parker C
AD  - University of Western Ontario, Critical Care Medicine, London, Canada
FAU - Howes, D.
AU  - Howes D
AD  - University of Western Ontario, Critical Care Medicine, London, Canada
FAU - Moffatt, S.
AU  - Moffatt S
AD  - University of Western Ontario, Critical Care Medicine, London, Canada
FAU - Erb, J.
AU  - Erb J
AD  - University of Western Ontario, Critical Care Medicine, London, Canada
FAU - Ilan, R.
AU  - Ilan R
AD  - University of Western Ontario, Critical Care Medicine, London, Canada
FAU - Messenger, D.
AU  - Messenger D
AD  - University of Western Ontario, Critical Care Medicine, London, Canada
FAU - Ball, I.
AU  - Ball I
AD  - Hospital Municipal Moyses Deutsch, ICU, São Paulo, Brazil
FAU - Boyd, J. G.
AU  - Boyd JG
AD  - University of Western Ontario, Critical Care Medicine, London, Canada
FAU - Harrison, M.
AU  - Harrison M
AD  - University of Western Ontario, Critical Care Medicine, London, Canada
FAU - Ridi, S.
AU  - Ridi S
AD  - University of Western Ontario, Critical Care Medicine, London, Canada
FAU - Muscedere, J.
AU  - Muscedere J
AD  - University of Western Ontario, Critical Care Medicine, London, Canada
FAU - Andrade, A. H.
AU  - Andrade AH
AD  - Hospital Municipal Moyses Deutsch, Quality Sector, São Paulo, Brazil
FAU - Costa, R. C.
AU  - Costa RC
AD  - Hospital Municipal Moyses Deutsch, Quality Sector, São Paulo, Brazil
FAU - Souza, V. A.
AU  - Souza VA
AD  - Hospital Municipal Moyses Deutsch, Quality Sector, São Paulo, Brazil
FAU - Gonzalez, V.
AU  - Gonzalez V
AD  - Hospital Municipal Moyses Deutsch, Quality Sector, São Paulo, Brazil
FAU - Amorim, V.
AU  - Amorim V
AD  - Hospital Municipal Moyses Deutsch, Quality Sector, São Paulo, Brazil
FAU - Rolla, F.
AU  - Rolla F
AD  - Hospital Municipal Moyses Deutsch, Quality Sector, São Paulo, Brazil
FAU - Filho, C. A. C. Abreu
AU  - Filho CACA
AD  - Hospital Municipal Moyses Deutsch, Quality Sector, São Paulo, Brazil
FAU - Miranda, R.
AU  - Miranda R
AD  - KCMH, Nursing Department, Bangkok, Thailand
FAU - Atchasiri, S.
AU  - Atchasiri S
AD  - Université Pierre et Marie Curie, UMR_S 1158 and Hôpital Pitié-Salpêtrière,
      Respiratory Division and Medical ICU, Paris, France
FAU - Buranavanich, P.
AU  - Buranavanich P
AD  - Université Pierre et Marie Curie, UMR_S 1158 and Hôpital Pitié-Salpêtrière,
      Respiratory Division and Medical ICU, Paris, France
FAU - Wathanawatthu, T.
AU  - Wathanawatthu T
AD  - Université Pierre et Marie Curie, UMR_S 1158 and Hôpital Pitié-Salpêtrière,
      Respiratory Division and Medical ICU, Paris, France
FAU - Suwanpasu, S.
AU  - Suwanpasu S
AD  - Université Pierre et Marie Curie, UMR_S 1158 and Hôpital Pitié-Salpêtrière,
      Respiratory Division and Medical ICU, Paris, France
FAU - Bureau, C.
AU  - Bureau C
AD  - Hôpital Dupuytren, Limoges, France
FAU - Rolland-Debord, C.
AU  - Rolland-Debord C
AD  - Hôpital Dupuytren, Limoges, France
FAU - Poitou, T.
AU  - Poitou T
AD  - Hôpital Dupuytren, Limoges, France
FAU - Clavel, M.
AU  - Clavel M
AD  - CHU de Clermont-Ferrand and Université d’Auvergne, Clermont-Ferrand, France
FAU - Perbet, S.
AU  - Perbet S
AD  - Université Grenoble-Alpes and CHU Grenoble Alpes, Grenoble, France
FAU - Terzi, N.
AU  - Terzi N
AD  - CHU d’Angers, Angers, France
FAU - Kouatchet, A.
AU  - Kouatchet A
AD  - Hospital Dr. Nélio Mendonça, Serviço de Medicina Intensiva, Funchal, Portugal
FAU - Similowski, T.
AU  - Similowski T
AD  - Hôpital Dupuytren, Limoges, France
FAU - Demoule, A.
AU  - Demoule A
AD  - Hôpital Dupuytren, Limoges, France
FAU - Diaz, P.
AU  - Diaz P
AD  - Chia Nan University of Pharmacy and Science, Recreation and Health-Care
      Management, Tainan, Taiwan, Province of China
FAU - Nunes, J.
AU  - Nunes J
AD  - Chia Nan University of Pharmacy and Science, Recreation and Health-Care
      Management, Tainan, Taiwan, Province of China
FAU - Escórcio, S.
AU  - Escórcio S
AD  - Chia Nan University of Pharmacy and Science, Recreation and Health-Care
      Management, Tainan, Taiwan, Province of China
FAU - Silva, G.
AU  - Silva G
AD  - Chia Nan University of Pharmacy and Science, Recreation and Health-Care
      Management, Tainan, Taiwan, Province of China
FAU - Chaves, S.
AU  - Chaves S
AD  - Chia Nan University of Pharmacy and Science, Recreation and Health-Care
      Management, Tainan, Taiwan, Province of China
FAU - Jardim, M.
AU  - Jardim M
AD  - Chia Nan University of Pharmacy and Science, Recreation and Health-Care
      Management, Tainan, Taiwan, Province of China
FAU - Câmara, M.
AU  - Câmara M
AD  - Chia Nan University of Pharmacy and Science, Recreation and Health-Care
      Management, Tainan, Taiwan, Province of China
FAU - Fernandes, N.
AU  - Fernandes N
AD  - Chia Nan University of Pharmacy and Science, Recreation and Health-Care
      Management, Tainan, Taiwan, Province of China
FAU - Duarte, R.
AU  - Duarte R
AD  - Chia Nan University of Pharmacy and Science, Recreation and Health-Care
      Management, Tainan, Taiwan, Province of China
FAU - Jardim, J. J.
AU  - Jardim JJ
AD  - Chia Nan University of Pharmacy and Science, Recreation and Health-Care
      Management, Tainan, Taiwan, Province of China
FAU - Pereira, C. A.
AU  - Pereira CA
AD  - Chia Nan University of Pharmacy and Science, Recreation and Health-Care
      Management, Tainan, Taiwan, Province of China
FAU - Nóbrega, J. J.
AU  - Nóbrega JJ
AD  - Chia Nan University of Pharmacy and Science, Recreation and Health-Care
      Management, Tainan, Taiwan, Province of China
FAU - Chen, C. M.
AU  - Chen CM
AD  - Chi-Mei Medical Center, Intensive Care Medicine, Tainan, Taiwan, Province of
      China
FAU - Lai, C. C.
AU  - Lai CC
AD  - Chi Mei Medical Center, Internal Medicine, Tainan, Taiwan, Province of China
FAU - Cheng, K. C.
AU  - Cheng KC
AD  - Chi-Mei Medical Center, Tainan, Taiwan, Province of China
FAU - Chou, W.
AU  - Chou W
AD  - Chi-Mei Medical Center, Intensive Care Medicine, Tainan, Taiwan, Province of
      China
FAU - Lee, S. J.
AU  - Lee SJ
AD  - Yonsei University Wonju College of Medicine, Emergency Medicine, Wonju, Republic 
      of Korea
FAU - Cha, Y. S.
AU  - Cha YS
AD  - Tokushima University Graduate School, Critical Care and Emergency Medicine,
      Tokushima, Japan
FAU - Lee, W. Y.
AU  - Lee WY
AD  - Yonsei University Wonju College of Medicine, Emergency Medicine, Wonju, Republic 
      of Korea
FAU - Onodera, M.
AU  - Onodera M
AD  - Takarazuka City Hospital, Intensive Care Unit, Takarazuka, Japan
FAU - Nakataki, E.
AU  - Nakataki E
AD  - Takarazuka City Hospital, Intensive Care Unit, Takarazuka, Japan
FAU - Oto, J.
AU  - Oto J
AD  - Takarazuka City Hospital, Intensive Care Unit, Takarazuka, Japan
FAU - Imanaka, H.
AU  - Imanaka H
AD  - Uzbekistan Research Center of Emergency Medicine, Tashkent, Uzbekistan
FAU - Nishimura, M.
AU  - Nishimura M
AD  - Takarazuka City Hospital, Intensive Care Unit, Takarazuka, Japan
FAU - Khadjibaev, A.
AU  - Khadjibaev A
AD  - Tashkent Institute of Postgraduate Medical Education, Tashkent, Uzbekistan
FAU - Sabirov, D.
AU  - Sabirov D
AD  - Guglielmo da Saliceto Hospital, Intermediate Care Unit, Piacenza, Italy
FAU - Rosstalnaya, A.
AU  - Rosstalnaya A
AD  - Guglielmo da Saliceto Hospital, Intermediate Care Unit, Piacenza, Italy
FAU - Akalaev, R.
AU  - Akalaev R
AD  - Tashkent Institute of Postgraduate Medical Education, Tashkent, Uzbekistan
FAU - Parpibaev, F.
AU  - Parpibaev F
AD  - Tashkent Institute of Postgraduate Medical Education, Tashkent, Uzbekistan
FAU - Antonucci, E.
AU  - Antonucci E
AD  - Guglielmo da Saliceto Hospital, Local Health Care Unit, Piacenza, Italy
FAU - Rossini, P.
AU  - Rossini P
AD  - Guglielmo da Saliceto Hospital, Local Health Care Unit, Piacenza, Italy
FAU - Gandolfi, S.
AU  - Gandolfi S
AD  - Stellenbosch University, Stellenbsoch, South Africa
FAU - Montini, E.
AU  - Montini E
AD  - Guglielmo da Saliceto Hospital, Local Health Care Unit, Piacenza, Italy
FAU - Orlando, S.
AU  - Orlando S
AD  - Guglielmo da Saliceto Hospital, Local Health Care Unit, Piacenza, Italy
FAU - van Nes, M.
AU  - van Nes M
AD  - University of the Western Cape, Cape Town, South Africa
FAU - Karachi, F.
AU  - Karachi F
AD  - University of the Western Cape, Cape Town, South Africa
FAU - Hanekom, S.
AU  - Hanekom S
AD  - Hospital Municipal Moyses Deutsch, ICU, Sao Paulo, Brazil
FAU - Andrade, A. H.
AU  - Andrade AH
AD  - St Georges NHS Foundation Trust, Cardiothoracic Intensive Care, London, UK
FAU - Pereira, U. V.
AU  - Pereira UV
AD  - St Georges NHS Foundation Trust, Cardiothoracic Intensive Care, London, UK
FAU - Filho, C. A. C. Abreu
AU  - Filho CACA
AD  - St Georges NHS Foundation Trust, Cardiothoracic Intensive Care, London, UK
FAU - Costa, R. C.
AU  - Costa RC
AD  - St Georges NHS Foundation Trust, Cardiothoracic Intensive Care, London, UK
FAU - Parkin, M. S. W.
AU  - Parkin MSW
AD  - Hospital Municipal Moyses Deutsch, ICU, São Paulo, Brazil
FAU - Moore, M.
AU  - Moore M
AD  - Hospital Municipal Moyses Deutsch, ICU, São Paulo, Brazil
FAU - Andrade, A. H.
AU  - Andrade AH
AD  - Seoul National University Bundang Hospital, Critical Care Medicine, Seongnam,
      Republic of Korea
FAU - Costa, R. C.
AU  - Costa RC
AD  - Seoul National University Bundang Hospital, Critical Care Medicine, Seongnam,
      Republic of Korea
FAU - Carvalho, K. V. Silva
AU  - Carvalho KVS
AD  - Seoul National University Bundang Hospital, Critical Care Medicine, Seongnam,
      Republic of Korea
FAU - Filho, C. A. C. Abreu
AU  - Filho CACA
AD  - Seoul National University Bundang Hospital, Critical Care Medicine, Seongnam,
      Republic of Korea
FAU - Min, H. J.
AU  - Min HJ
AD  - Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic
      of Korea
FAU - Kim, H. J.
AU  - Kim HJ
AD  - Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic
      of Korea
FAU - Lee, D. S.
AU  - Lee DS
AD  - Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic
      of Korea
FAU - Choi, Y. Y.
AU  - Choi YY
AD  - Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic
      of Korea
FAU - Lee, E. Y.
AU  - Lee EY
AD  - Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic
      of Korea
FAU - Song, I.
AU  - Song I
AD  - Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic
      of Korea
FAU - Kim, D. J.
AU  - Kim DJ
AD  - Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic
      of Korea
FAU - E, Y. Y.
AU  - E YY
AD  - Seoul National University Bundang Hospital, Anesthesiology, Seongnam, Republic of
      Korea
FAU - Kim, J. W.
AU  - Kim JW
AD  - Seoul National University Bundang Hospital, Anesthesiology, Seongnam, Republic of
      Korea
FAU - Park, J. S.
AU  - Park JS
AD  - Seoul National University Bundang Hospital, Anesthesiology, Seongnam, Republic of
      Korea
FAU - Cho, Y. J.
AU  - Cho YJ
AD  - Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic
      of Korea
FAU - Lee, J. H.
AU  - Lee JH
AD  - Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic
      of Korea
FAU - Suh, J. W.
AU  - Suh JW
AD  - Seoul National University Bundang Hospital, Anesthesiology, Seongnam, Republic of
      Korea
FAU - Jo, Y. H.
AU  - Jo YH
AD  - Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic
      of Korea
FAU - Kim, K. S.
AU  - Kim KS
AD  - Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic
      of Korea
FAU - Lee, Y. J.
AU  - Lee YJ
AD  - Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic
      of Korea
FAU - Ferrero-Calleja, J.
AU  - Ferrero-Calleja J
AD  - Hospital Sírio-Libanês, Intensive Care Unit, São Paulo, Brazil
FAU - Merino-Vega, D.
AU  - Merino-Vega D
AD  - Hospital Sírio-Libanês, Intensive Care Unit, São Paulo, Brazil
FAU - González-Jiménez, A. I.
AU  - González-Jiménez AI
AD  - Hospital Sírio-Libanês, Intensive Care Unit, São Paulo, Brazil
FAU - Sigcha, M. Sigcha
AU  - Sigcha MS
AD  - Hospital Sírio-Libanês, Intensive Care Unit, São Paulo, Brazil
FAU - Hernández-Tejedor, A.
AU  - Hernández-Tejedor A
AD  - Hospital Sírio-Libanês, Intensive Care Unit, São Paulo, Brazil
FAU - Martin-Vivas, A.
AU  - Martin-Vivas A
AD  - Hospital Sírio-Libanês, Intensive Care Unit, São Paulo, Brazil
FAU - Gabán-Díez, Á.
AU  - Gabán-Díez Á
AD  - Hospital Sírio-Libanês, Intensive Care Unit, São Paulo, Brazil
FAU - Luna, R. Ruiz-de
AU  - Luna RRd
AD  - Hospital Sírio-Libanês, Intensive Care Unit, São Paulo, Brazil
FAU - De la Calle-Pedrosa, N.
AU  - De la Calle-Pedrosa N
AD  - Hospital Sírio-Libanês, Intensive Care Unit, São Paulo, Brazil
FAU - Temprano-Gómez, I.
AU  - Temprano-Gómez I
AD  - Hospital Sírio-Libanês, Intensive Care Unit, São Paulo, Brazil
FAU - Afonso-Rivero, D.
AU  - Afonso-Rivero D
AD  - Hospital Sírio-Libanês, Intensive Care Unit, São Paulo, Brazil
FAU - Pellin-Ariño, J. I.
AU  - Pellin-Ariño JI
AD  - Hospital Sírio-Libanês, Intensive Care Unit, São Paulo, Brazil
FAU - Algora-Weber, A.
AU  - Algora-Weber A
AD  - Hospital Sírio-Libanês, Intensive Care Unit, São Paulo, Brazil
FAU - Fumis, R. R. L.
AU  - Fumis RRL
AD  - Hospital Geral do Grajau, Intensive Care Unit, Sao Paulo, Brazil
FAU - Ferraz, A. B.
AU  - Ferraz AB
AD  - Hospital Sírio Libanes, Intensive Care Unit, São Paulo, Brazil
FAU - Junior, J. M. Vieira
AU  - Junior JMV
AD  - Akdeniz University, Antalya, Turkey
FAU - Kirca, H.
AU  - Kirca H
AD  - Ribeirão Preto Medical School, University of São Paulo, Division of Intensive
      Care, Department of Surgery and Anatomy, Ribeirão Preto, Brazil
FAU - Cakin, O.
AU  - Cakin O
AD  - Ribeirão Preto Medical School, University of São Paulo, Division of Intensive
      Care, Department of Surgery and Anatomy, Ribeirão Preto, Brazil
FAU - Unal, M.
AU  - Unal M
AD  - Ribeirão Preto Medical School, University of São Paulo, Division of Intensive
      Care, Department of Surgery and Anatomy, Ribeirão Preto, Brazil
FAU - Mutlu, H.
AU  - Mutlu H
AD  - Ribeirão Preto Medical School, University of São Paulo, Division of Intensive
      Care, Department of Surgery and Anatomy, Ribeirão Preto, Brazil
FAU - Ramazanoglu, A.
AU  - Ramazanoglu A
AD  - Ribeirão Preto Medical School, University of São Paulo, Division of Intensive
      Care, Department of Surgery and Anatomy, Ribeirão Preto, Brazil
FAU - Cengiz, M.
AU  - Cengiz M
AD  - Ribeirão Preto Medical School, University of São Paulo, Division of Intensive
      Care, Department of Surgery and Anatomy, Ribeirão Preto, Brazil
FAU - Nicolini, E. A.
AU  - Nicolini EA
AD  - Intensive Care Unit of São Francisco Hospital, Ribeirão Preto, Brazil
FAU - Pelisson, F. G. F.
AU  - Pelisson FGF
AD  - Ribeirão Preto Medical School, University of São Paulo, Social Medicine
      Department, Ribeirão Preto, Brazil
FAU - Nunes, R. S.
AU  - Nunes RS
AD  - Ribeirão Preto Medical School, University of São Paulo, Social Medicine
      Department, Ribeirão Preto, Brazil
FAU - da Silva, S. L.
AU  - da Silva SL
AD  - Ribeirão Preto Medical School, University of São Paulo, Social Medicine
      Department, Ribeirão Preto, Brazil
FAU - Carreira, M. M.
AU  - Carreira MM
AD  - Ribeirão Preto Medical School, University of São Paulo, Social Medicine
      Department, Ribeirão Preto, Brazil
FAU - Bellissimo-Rodrigues, F.
AU  - Bellissimo-Rodrigues F
AD  - Chi Mei Medical Center, Intensive Care Medicine, Tainan, Taiwan, Province of
      China
FAU - Ferez, M. A.
AU  - Ferez MA
AD  - Ribeirão Preto Medical School, University of São Paulo, Social Medicine
      Department, Ribeirão Preto, Brazil
FAU - Basile-Filho, A.
AU  - Basile-Filho A
AD  - Intensive Care Unit of São Francisco Hospital, Ribeirão Preto, Brazil
FAU - Chao, H. C.
AU  - Chao HC
AD  - Carnegie Mellon University, Robotics Institute, Pittsburgh, USA
FAU - Chen, C. M.
AU  - Chen CM
AD  - Carnegie Mellon University, Robotics Institute, Pittsburgh, USA
FAU - Chen, L.
AU  - Chen L
AD  - University of Pittsburgh, School of Nursing, Pittsburgh, USA
FAU - Hravnak, M.
AU  - Hravnak M
AD  - University of Pittsburgh, Department of Critical Care Medicine, School of
      Medicine, Pittsburgh, USA
FAU - Clermont, G.
AU  - Clermont G
AD  - Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid Spain
FAU - Pinsky, M.
AU  - Pinsky M
AD  - Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid Spain
FAU - Dubrawski, A.
AU  - Dubrawski A
AD  - University of Pittsburgh, School of Nursing, Pittsburgh, USA
FAU - Varas, J. Luján
AU  - Varas JL
AD  - Cairo University, Critical Care Medicine, Cairo, Egypt
FAU - Montero, R. Molina
AU  - Montero RM
AD  - Cairo University, Critical Care Medicine, Cairo, Egypt
FAU - Sánchez-Elvira, L. Alcázar
AU  - Sánchez-Elvira LA
AD  - Cairo University, Critical Care Medicine, Cairo, Egypt
FAU - Díaz, P. Villa
AU  - Díaz PV
AD  - Cairo University, Critical Care Medicine, Cairo, Egypt
FAU - Delgado, C. Pintado
AU  - Delgado CP
AD  - Cairo University, Critical Care Medicine, Cairo, Egypt
FAU - Ruiz, B. Llorente
AU  - Ruiz BL
AD  - Cairo University, Critical Care Medicine, Cairo, Egypt
FAU - Guerrero, A. Pardo
AU  - Guerrero AP
AD  - Cairo University, Critical Care Medicine, Cairo, Egypt
FAU - Galache, J. A. Cambronero
AU  - Galache JAC
AD  - Cairo University, Critical Care Medicine, Cairo, Egypt
FAU - Sherif, H.
AU  - Sherif H
AD  - Clinique du Millénaire, Hérault, Montpellier, France
FAU - Hassanin, H.
AU  - Hassanin H
AD  - Clinique du Millénaire, Hérault, Montpellier, France
FAU - El Hossainy, R.
AU  - El Hossainy R
AD  - Clinique du Millénaire, Hérault, Montpellier, France
FAU - Samy, W.
AU  - Samy W
AD  - Clinique du Millénaire, Hérault, Montpellier, France
FAU - Ly, H.
AU  - Ly H
AD  - Clinique du Millénaire, Montpellier, France
FAU - David, H.
AU  - David H
AD  - CHU Grenoble, Anesthesiology and Intensive Care, Grenoble, France
FAU - Burtin, P.
AU  - Burtin P
AD  - CHU Grenoble, Anesthesiology and Intensive Care, Grenoble, France
FAU - Charpentier, C.
AU  - Charpentier C
AD  - CHU Grenoble, Anesthesiology and Intensive Care, Grenoble, France
FAU - Barral, M.
AU  - Barral M
AD  - CHU Grenoble, Anesthesiology and Intensive Care, Grenoble, France
FAU - Courant, P.
AU  - Courant P
AD  - CHU Grenoble, Anesthesiology and Intensive Care, Grenoble, France
FAU - Fournel, E.
AU  - Fournel E
AD  - CHU Grenoble, Cardiac Surgery, Grenoble, France
FAU - Gaide-Chevronnay, L.
AU  - Gaide-Chevronnay L
AD  - CHU Grenoble, Cardiac Surgery, Grenoble, France
FAU - Durand, M.
AU  - Durand M
AD  - CHU Grenoble, Cardiac Surgery, Grenoble, France
FAU - Albaladejo, P.
AU  - Albaladejo P
AD  - CHU Grenoble, Cardiac Surgery, Grenoble, France
FAU - Payen, J. F.
AU  - Payen JF
AD  - CHU Grenoble, Cardiac Surgery, Grenoble, France
FAU - Chavanon, O.
AU  - Chavanon O
AD  - Erasme University Hospital, Université Libre de Bruxelles, Department of
      Intensive Care, Brussels, Belgium
FAU - Ortiz, A. Blandino
AU  - Ortiz AB
AD  - IRCCS - Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
FAU - Pozzebon, S.
AU  - Pozzebon S
AD  - IRCCS - Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
FAU - Lheureux, O.
AU  - Lheureux O
AD  - IRCCS - Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
FAU - Brasseur, A.
AU  - Brasseur A
AD  - IRCCS - Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
FAU - Vincent, J. L.
AU  - Vincent JL
AD  - IRCCS - Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
FAU - Creteur, J.
AU  - Creteur J
AD  - IRCCS - Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
FAU - Taccone, F. S.
AU  - Taccone FS
AD  - IRCCS - Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
FAU - Fumagalli, F.
AU  - Fumagalli F
AD  - University of Milan, Milan, Italy
FAU - Scala, S.
AU  - Scala S
AD  - University of Milan, Milan, Italy
FAU - Affatato, R.
AU  - Affatato R
AD  - University of Milan, Milan, Italy
FAU - De Maglie, M.
AU  - De Maglie M
AD  - Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia, Lodi, Italy
FAU - Zani, D.
AU  - Zani D
AD  - Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia, Lodi, Italy
FAU - Novelli, D.
AU  - Novelli D
AD  - University of Milan, Milan, Italy
FAU - Marra, C.
AU  - Marra C
AD  - University of Milan, Milan, Italy
FAU - Luciani, A.
AU  - Luciani A
AD  - University of Milan, Milan, Italy
FAU - De Zani, D.
AU  - De Zani D
AD  - Sacco Hospital, Milan, Italy
FAU - Luini, M.
AU  - Luini M
AD  - Sacco Hospital, Milan, Italy
FAU - Letizia, T.
AU  - Letizia T
AD  - VHS Medical Center, Emergency Medicine, Seoul, Republic of Korea
FAU - Pravettoni, D.
AU  - Pravettoni D
AD  - Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia, Lodi, Italy
FAU - Staszewsky, L.
AU  - Staszewsky L
AD  - University of Milan, Milan, Italy
FAU - Masson, S.
AU  - Masson S
AD  - University of Milan, Milan, Italy
FAU - Belloli, A.
AU  - Belloli A
AD  - Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia, Lodi, Italy
FAU - Di Giancamillo, M.
AU  - Di Giancamillo M
AD  - Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia, Lodi, Italy
FAU - Scanziani, E.
AU  - Scanziani E
AD  - Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia, Lodi, Italy
FAU - Latini, R.
AU  - Latini R
AD  - University of Milan, Milan, Italy
FAU - Ristagno, G.
AU  - Ristagno G
AD  - University of Milan, Milan, Italy
FAU - Kye, Y. C.
AU  - Kye YC
AD  - Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea
FAU - Suh, G. J.
AU  - Suh GJ
AD  - IRCCS - Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
FAU - Kwon, W. Y.
AU  - Kwon WY
AD  - IRCCS - Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
FAU - Kim, K. S.
AU  - Kim KS
AD  - IRCCS - Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
FAU - Yu, K. M.
AU  - Yu KM
AD  - IRCCS - Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
FAU - Babini, G.
AU  - Babini G
AD  - Texas Children’s Hospital, Clinical Nutriiton, Houston, USA
FAU - Ristagno, G.
AU  - Ristagno G
AD  - Kuopio University Hospital, Kuopio, Finland
FAU - Grassi, L.
AU  - Grassi L
AD  - Kuopio University Hospital, Kuopio, Finland
FAU - Fumagalli, F.
AU  - Fumagalli F
AD  - Kuopio University Hospital, Kuopio, Finland
FAU - Bendel, S.
AU  - Bendel S
AD  - University of Milan, Milan, Italy
FAU - De Maglie, M.
AU  - De Maglie M
AD  - North Karelia Central Hospital, Karelia, Finland
FAU - Affatato, R.
AU  - Affatato R
AD  - Kuopio University Hospital, Kuopio, Finland
FAU - Masson, S.
AU  - Masson S
AD  - Kuopio University Hospital, Kuopio, Finland
FAU - Latini, R.
AU  - Latini R
AD  - Kuopio University Hospital, Kuopio, Finland
FAU - Scanziani, E.
AU  - Scanziani E
AD  - North Karelia Central Hospital, Karelia, Finland
FAU - Reinikainen, M.
AU  - Reinikainen M
AD  - Helsinki University Hospital, Helsinki, Finland
FAU - Skrifvars, M.
AU  - Skrifvars M
AD  - Technische Universität München, Klinik für Anaesthesiologie, Munich, Germany
FAU - Kappler, F.
AU  - Kappler F
AD  - Cardinal Massaia Hospital, Anesthesia and Intensive Care Unit, Asti, Italy
FAU - Blobner, M.
AU  - Blobner M
AD  - Cardinal Massaia Hospital, Anesthesia and Intensive Care Unit, Asti, Italy
FAU - Schaller, S. J.
AU  - Schaller SJ
AD  - Cardinal Massaia Hospital, Anesthesia and Intensive Care Unit, Asti, Italy
FAU - Roasio, A.
AU  - Roasio A
AD  - ULB Université Libre de Bruxelles, Department of Intensive Care, Erasme
      University Hospital, Bruxelles, Belgium
FAU - Costanzo, E.
AU  - Costanzo E
AD  - ULB Université Libre de Bruxelles, Department of Intensive Care, Erasme
      University Hospital, Bruxelles, Belgium
FAU - Cardellino, S.
AU  - Cardellino S
AD  - ULB Université Libre de Bruxelles, Department of Intensive Care, Erasme
      University Hospital, Bruxelles, Belgium
FAU - Iesu, E.
AU  - Iesu E
AD  - Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea
FAU - Cavicchi, F. Zama
AU  - Cavicchi FZ
AD  - Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea
FAU - Fontana, V.
AU  - Fontana V
AD  - Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea
FAU - Nobile, L.
AU  - Nobile L
AD  - Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea
FAU - Vincent, J. L.
AU  - Vincent JL
AD  - Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea
FAU - Creteur, J.
AU  - Creteur J
AD  - Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea
FAU - Taccone, F. S.
AU  - Taccone FS
AD  - Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea
FAU - Park, M.
AU  - Park M
AD  - Seoul National University, Neurology, Seoul, Republic of Korea
FAU - You, K. M.
AU  - You KM
AD  - Seoul National University, Neurology, Seoul, Republic of Korea
FAU - Suh, G. J.
AU  - Suh GJ
AD  - Seoul National University, Neurology, Seoul, Republic of Korea
FAU - Kwon, W. Y.
AU  - Kwon WY
AD  - Seoul National University, Neurology, Seoul, Republic of Korea
FAU - Ko, S. B.
AU  - Ko SB
AD  - Erasme Hospital, Brussels, Belgium
FAU - Kim, K. S.
AU  - Kim KS
AD  - Seoul National University, Neurology, Seoul, Republic of Korea
FAU - Xini, A.
AU  - Xini A
AD  - Network for Improving Critical Care Systems and Training (NICST), Colombo, Sri
      Lanka
FAU - Marca, L.
AU  - Marca L
AD  - Network for Improving Critical Care Systems and Training (NICST), Colombo, Sri
      Lanka
FAU - Lheureux, O.
AU  - Lheureux O
AD  - Network for Improving Critical Care Systems and Training (NICST), Colombo, Sri
      Lanka
FAU - Brasseur, A.
AU  - Brasseur A
AD  - Network for Improving Critical Care Systems and Training (NICST), Colombo, Sri
      Lanka
FAU - Vincent, J. L.
AU  - Vincent JL
AD  - Network for Improving Critical Care Systems and Training (NICST), Colombo, Sri
      Lanka
FAU - Creteur, J.
AU  - Creteur J
AD  - Network for Improving Critical Care Systems and Training (NICST), Colombo, Sri
      Lanka
FAU - Taccone, F. S.
AU  - Taccone FS
AD  - Network for Improving Critical Care Systems and Training (NICST), Colombo, Sri
      Lanka
FAU - Beane, A.
AU  - Beane A
AD  - National Intensive Care Surveillance, Quality Secretariat Building, Castle Street
      Hospital for Women, Colombo, Sri Lanka
FAU - Thilakasiri, M. C. K. T.
AU  - Thilakasiri MCKT
AD  - National Intensive Care Surveillance, Quality Secretariat Building, Castle Street
      Hospital for Women, Colombo, Sri Lanka
FAU - De Silva, A. P.
AU  - De Silva AP
AD  - National Intensive Care Surveillance, Quality Secretariat Building, Castle Street
      Hospital for Women, Colombo, Sri Lanka
FAU - Stephens, T.
AU  - Stephens T
AD  - National Intensive Care Surveillance, Quality Secretariat Building, Castle Street
      Hospital for Women, Colombo, Sri Lanka
FAU - Sigera, C. S.
AU  - Sigera CS
AD  - National Intensive Care Surveillance, Quality Secretariat Building, Castle Street
      Hospital for Women, Colombo, Sri Lanka
FAU - Athapattu, P.
AU  - Athapattu P
AD  - Royal London Hospital, Barts Health, Adult Critical Care Unit, London, UK
FAU - Jayasinghe, S.
AU  - Jayasinghe S
AD  - Royal London Hospital, Barts Health, Adult Critical Care Unit, London, UK
FAU - Padeniya, A.
AU  - Padeniya A
AD  - Lady Ridgeway Hospital for Children, Colombo, Sri Lanka
FAU - Haniffa, R.
AU  - Haniffa R
AD  - Royal London Hospital, Barts Health, Adult Critical Care Unit, London, UK
FAU - Santiago, A. Iglesias
AU  - Santiago AI
AD  - University Medical Centre Göttingen, Department for Anaesthesiology, Göttingen,
      Germany
FAU - Sáez, V. Chica
AU  - Sáez VC
AD  - University Medical Centre Göttingen, Department for Anaesthesiology, Göttingen,
      Germany
FAU - Ruiz-Ruano, R. de la Chica
AU  - Ruiz-Ruano Rde la C
AD  - University Medical Centre Göttingen, Department for Anaesthesiology, Göttingen,
      Germany
FAU - González, A. Sánchez
AU  - González AS
AD  - University Medical Centre Göttingen, Department for Anaesthesiology, Göttingen,
      Germany
FAU - Kunze-Szikszay, N.
AU  - Kunze-Szikszay N
AD  - University Medical Centre Göttingen, Department for Oral and Maxillofacial
      Surgery, Göttingen, Germany
FAU - Wand, S.
AU  - Wand S
AD  - University Medical Centre Göttingen, Department for Oral and Maxillofacial
      Surgery, Göttingen, Germany
FAU - Klapsing, P.
AU  - Klapsing P
AD  - University Medical Centre Göttingen, Department for Oral and Maxillofacial
      Surgery, Göttingen, Germany
FAU - Wetz, A.
AU  - Wetz A
AD  - University Medical Centre Göttingen, Department for Oral and Maxillofacial
      Surgery, Göttingen, Germany
FAU - Heyne, T.
AU  - Heyne T
AD  - University Medical Centre Göttingen, Department for Oral and Maxillofacial
      Surgery, Göttingen, Germany
FAU - Schwerdtfeger, K.
AU  - Schwerdtfeger K
AD  - University Medical Centre Göttingen, Department for Oral and Maxillofacial
      Surgery, Göttingen, Germany
FAU - Troeltzsch, M.
AU  - Troeltzsch M
AD  - Sunnybrook Health Sciences Centre, Critical Care, Toronto, Canada
FAU - Bauer, M.
AU  - Bauer M
AD  - University Medical Centre Göttingen, Department for Oral and Maxillofacial
      Surgery, Göttingen, Germany
FAU - Quintel, M.
AU  - Quintel M
AD  - University Medical Centre Göttingen, Department for Oral and Maxillofacial
      Surgery, Göttingen, Germany
FAU - Moerer, O.
AU  - Moerer O
AD  - University Medical Centre Göttingen, Department for Oral and Maxillofacial
      Surgery, Göttingen, Germany
FAU - Cook, D. J.
AU  - Cook DJ
AD  - Yokohama City Minato Red Cross Hospital, Department of Emergency and Critical
      Care Medicine, Yokohama, Japan
FAU - Rutherford, W. B.
AU  - Rutherford WB
AD  - Yokohama City Minato Red Cross Hospital, Department of Emergency and Critical
      Care Medicine, Yokohama, Japan
FAU - Scales, D. C.
AU  - Scales DC
AD  - Yokohama City Minato Red Cross Hospital, Department of Emergency and Critical
      Care Medicine, Yokohama, Japan
FAU - Adhikari, N. K.
AU  - Adhikari NK
AD  - Yokohama City Minato Red Cross Hospital, Department of Emergency and Critical
      Care Medicine, Yokohama, Japan
FAU - Cuthbertson, B. H.
AU  - Cuthbertson BH
AD  - Yokohama City Minato Red Cross Hospital, Department of Emergency and Critical
      Care Medicine, Yokohama, Japan
FAU - Suzuki, T.
AU  - Suzuki T
AD  - Tokyo Medical and Dental University, Health Policy and Informatics Section,
      Department of Health Policy, Tokyo, Japan
FAU - Takei, T.
AU  - Takei T
AD  - Tokyo Medical and Dental University, Health Policy and Informatics Section,
      Department of Health Policy, Tokyo, Japan
FAU - Fushimi, K.
AU  - Fushimi K
AD  - Center for Cancer Control and Information Services, Division of Health Services
      Research, Tokyo, Japan
FAU - Iwamoto, M.
AU  - Iwamoto M
AD  - National Center for Child Health and Development, Department of Critical Care,
      Tokyo, Japan
FAU - Nakagawa, S.
AU  - Nakagawa S
AD  - Intermed Hospital, Intensive Care Department, Ulaanbaatar, Mongolia
FAU - Mendsaikhan, N.
AU  - Mendsaikhan N
AD  - Health Sciences University of Mongolia, Division of Emergency Medicine and
      Anaesthesia, Ulaanbaatar, Mongolia
FAU - Begzjav, T.
AU  - Begzjav T
AD  - Health Sciences University of Mongolia, Division of Emergency Medicine and
      Anaesthesia, Ulaanbaatar, Mongolia
FAU - Lundeg, G.
AU  - Lundeg G
AD  - University Hospital Salzburg and Paracelsus Private Medical University,
      Department of Anesthesiology, Perioperative and General Intensive Care Medicine, 
      Salzburg, Austria
FAU - Dünser, M. W.
AU  - Dünser MW
AD  - Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain
FAU - Romero, D. González
AU  - Romero DG
AD  - Hospital Insular Las Palmas GC, Department of Economy. University of Las Palmas
      de Gran Canaria, Las Palmas de Gran Canaria, Spain
FAU - Cabrera, J. L. Santana
AU  - Cabrera JLS
AD  - Hospital Insular Las Palmas GC, Department of Economy. University of Las Palmas
      de Gran Canaria, Las Palmas de Gran Canaria, Spain
FAU - Santana, J. D. Martín
AU  - Santana JDM
AD  - Rush University Medical Center, Chicago, USA
FAU - Padilla, Y. Santana
AU  - Padilla YS
AD  - Hospital Insular Las Palmas GC, Department of Economy. University of Las Palmas
      de Gran Canaria, Las Palmas de Gran Canaria, Spain
FAU - Pérez, H. Rodríguez
AU  - Pérez HR
AD  - Hospital Insular Las Palmas GC, Department of Economy. University of Las Palmas
      de Gran Canaria, Las Palmas de Gran Canaria, Spain
FAU - Torrent, R. Lorenzo
AU  - Torrent RL
AD  - Hospital Insular Las Palmas GC, Department of Economy. University of Las Palmas
      de Gran Canaria, Las Palmas de Gran Canaria, Spain
FAU - Kleinpell, R.
AU  - Kleinpell R
AD  - Giannitsa General Hospital, Intensive Care Unit, Giannitsa, Greece
FAU - Chouris, I.
AU  - Chouris I
AD  - G. Papanikolaou Hospital, A’ Intensive Care Unit, Thessaloniki, Greece
FAU - Radu, V.
AU  - Radu V
AD  - G. Papanikolaou Hospital, A’ Intensive Care Unit, Thessaloniki, Greece
FAU - Stougianni, M.
AU  - Stougianni M
AD  - G. Papanikolaou Hospital, A’ Intensive Care Unit, Thessaloniki, Greece
FAU - Lavrentieva, A.
AU  - Lavrentieva A
AD  - Heart of England NHS Foundation Trust, Birmingham, UK
FAU - Lagonidis, D.
AU  - Lagonidis D
AD  - G. Papanikolaou Hospital, A’ Intensive Care Unit, Thessaloniki, Greece
FAU - Price, R. D. T.
AU  - Price RDT
AD  - Queen Elizabeth University Hospital, NHS GG&C, Intensive Care Unit, Glasgow, UK
FAU - Day, A.
AU  - Day A
AD  - Queen Elizabeth University Hospital, NHS GG&C, Intensive Care Unit, Glasgow, UK
FAU - Arora, N.
AU  - Arora N
AD  - Queen Elizabeth University Hospital, NHS GG&C, Intensive Care Unit, Glasgow, UK
FAU - Henderson, M. A.
AU  - Henderson MA
AD  - Golden Jubilee National Hospital, Department of Anaesthesia, Clydebank, UK
FAU - Hickey, S.
AU  - Hickey S
AD  - Centro Hospitalar de S.João, Porto, Portugal
FAU - Costa, M. I. Almeida
AU  - Costa MIA
AD  - University of Porto, Porto, Portugal
FAU - Carvalho, J. P.
AU  - Carvalho JP
AD  - Centro Hospitalar de São João/University of Porto, Porto, Portugal
FAU - Gomes, A. A.
AU  - Gomes AA
AD  - University of Porto, Porto, Portugal
FAU - Mergulhão, P. J.
AU  - Mergulhão PJ
AD  - Tuen Mun Hospital, Anaesthesia & Intensive Care, Hong Kong, Hong Kong, China
FAU - Chan, K. K. C.
AU  - Chan KKC
AD  - Pamela Youde Nethersole Eastern Hospital, Intensive Care, Hong Kong, Hong Kong
      China
FAU - Shum, H. P.
AU  - Shum HP
AD  - Shiraz University of Medical Sciences, Shiraz, Iran, Shiraz Anesthesiology and
      Critical Care Research Center, Shiraz, Islamic Republic of Iran
FAU - Yan, W. W.
AU  - Yan WW
AD  - Shiraz University of Medical Sciences, Shiraz, Iran, Shiraz Anesthesiology and
      Critical Care Research Center, Shiraz, Islamic Republic of Iran
FAU - Maghsoudi, B.
AU  - Maghsoudi B
AD  - Shiraz University of Medical Sciences, Shiraz Anesthesiology and Critical Care
      Research Center, Shiraz, Islamic Republic of Iran
FAU - Tabei, S. H.
AU  - Tabei SH
AD  - Department of Epidemiology, School of Public Health - Shiraz University of
      Medical Sciences, Shiraz, Islamic Republic of Iran
FAU - Masjedi, M.
AU  - Masjedi M
AD  - Shiraz University of Medical Sciences, Shiraz Anesthesiology and Critical Care
      Research Center, Shiraz, Islamic Republic of Iran
FAU - Sabetian, G.
AU  - Sabetian G
AD  - Shiraz University of Medical Sciences, Shiraz Anesthesiology and Critical Care
      Research Center, Shiraz, Islamic Republic of Iran
FAU - Tabatabaei, H. R.
AU  - Tabatabaei HR
AD  - Student Research Committee - Shiraz University of Medical Sciences, Shiraz,
      Islamic Republic of Iran
FAU - Akbarzadeh, A.
AU  - Akbarzadeh A
AD  - AIIMS Bhopal, Department of Trauma & Emergency, Bhopal, India
CN  - Student Research Committee - Shiraz University of Medical Sciences
FAU - Saigal, S.
AU  - Saigal S
AD  - AIIMS Bhopal, Community and Family Medicine, Bhopal, India
FAU - Pakhare, A.
AU  - Pakhare A
AD  - AIIMS Bhopal, Medicine, Bhopal, India
FAU - Joshi, R.
AU  - Joshi R
AD  - Apollo Hospitals, Critical Care Unit, Bhubaneswar, India
FAU - Pattnaik, S. K.
AU  - Pattnaik SK
AD  - Apollo Hospitals, Bhubaneswar, India
FAU - Ray, B.
AU  - Ray B
AD  - University Hospital of Liège, General Intensive Care Unit and Burn Centre, Liège,
      Belgium
FAU - Rousseau, A. F.
AU  - Rousseau AF
AD  - University of Liège, Liège, Belgium
FAU - Michel, L.
AU  - Michel L
AD  - University Hospital of Liège, Clinical Chemistry Department, Liège, Belgium
FAU - Bawin, M.
AU  - Bawin M
AD  - University Hospital of Liège, Clinical Chemistry Department, Liège, Belgium
FAU - Cavalier, E.
AU  - Cavalier E
AD  - University of Liège, Department of Public Health, Epidemiology and Health
      Economics, Liège, Belgium
FAU - Reginster, J. Y.
AU  - Reginster JY
AD  - Sir Run Run Shaw Hospital, Intensive Care Medicine, Hanghzou, China
FAU - Damas, P.
AU  - Damas P
AD  - University of Liège, Liège, Belgium
FAU - Bruyere, O.
AU  - Bruyere O
AD  - Sir Run Run Shaw Hospital, Intensive Care Medicine, Hanghzou, China
FAU - Zhou, J. C.
AU  - Zhou JC
AD  - ZNA Middelheim General Hospital, Department of Anaesthesiology, Antwerp, Belgium
FAU - Cauwenberghs, H.
AU  - Cauwenberghs H
AD  - University of Antwerp, Department of Pharmaceutic Sciences, Antwerp, Belgium
FAU - De Backer, A.
AU  - De Backer A
AD  - University of Antwerp, Department of Pharmaceutic Sciences, Antwerp, Belgium
FAU - Neels, H.
AU  - Neels H
AD  - ZNA Middelheim General Hospital, Department of Cardiac Surgery, Antwerp, Belgium
FAU - Deblier, I.
AU  - Deblier I
AD  - Hospital 12 de Octubre, Cardiac Intensive Care Unit, Critical Care Department,
      Madrid, Spain
FAU - Berghmans, J.
AU  - Berghmans J
AD  - University of Antwerp, Department of Pharmaceutic Sciences, Antwerp, Belgium
FAU - Himpe, D.
AU  - Himpe D
AD  - University of Antwerp, Department of Pharmaceutic Sciences, Antwerp, Belgium
FAU - Barea-Mendoza, J. A.
AU  - Barea-Mendoza JA
AD  - Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan,
      Province of China
FAU - Portillo, I. Prieto
AU  - Portillo IP
AD  - Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan,
      Province of China
FAU - Fernández, M. Valiente
AU  - Fernández MV
AD  - Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan,
      Province of China
FAU - Gigorro, R. Garcia
AU  - Gigorro RG
AD  - Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan,
      Province of China
FAU - Vela, J. L. Perez
AU  - Vela JLP
AD  - Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan,
      Province of China
FAU - Mateos, H. Marín
AU  - Mateos HM
AD  - Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan,
      Province of China
FAU - Alves, S. Chacón
AU  - Alves SC
AD  - Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan,
      Province of China
FAU - Varas, G. Morales
AU  - Varas GM
AD  - Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan,
      Province of China
FAU - Rodriguez-Biendicho, A.
AU  - Rodriguez-Biendicho A
AD  - Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan,
      Province of China
FAU - Carreño, E. Renes
AU  - Carreño ER
AD  - Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan,
      Province of China
FAU - González, J. C. Montejo
AU  - González JCM
AD  - Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan,
      Province of China
FAU - Yang, J. S.
AU  - Yang JS
AD  - Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Chiang, C. H.
AU  - Chiang CH
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Hung, W. T.
AU  - Hung WT
AD  - Sir Run Run Shaw Hospital, Intensive Care Medicine, Hanghzou, China
FAU - Huang, W. C.
AU  - Huang WC
AD  - Sir Run Run Shaw Hospital, Intensive Care Medicine, Hanghzou, China
FAU - Cheng, C. C.
AU  - Cheng CC
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Lin, K. C.
AU  - Lin KC
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Lin, S. C.
AU  - Lin SC
AD  - Sir Run Run Shaw Hospital, Intensive Care Medicine, Hanghzou, China
FAU - Chiou, K. R.
AU  - Chiou KR
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Wann, S. R.
AU  - Wann SR
AD  - Sir Run Run Shaw Hospital, Intensive Care Medicine, Hanghzou, China
FAU - Lin, K. L.
AU  - Lin KL
AD  - Sir Run Run Shaw Hospital, Intensive Care Medicine, Hanghzou, China
FAU - Kang, P. L.
AU  - Kang PL
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Mar, G. Y.
AU  - Mar GY
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Liu, C. P.
AU  - Liu CP
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Zhou, J. C.
AU  - Zhou JC
AD  - Pusan National University Yangsan Hospital, Anesthesia and Pain Medicine,
      Yangsan-si, Republic of Korea
FAU - Choi, Y. J.
AU  - Choi YJ
AD  - Korea University Anam Hospital, Anaesthesiology and Pain Medicine, Seoul,
      Republic of Korea
FAU - Yoon, S. Z.
AU  - Yoon SZ
AD  - Hospital Puerta del Mar, Cadiz, Spain
FAU - Gordillo-Brenes, A.
AU  - Gordillo-Brenes A
AD  - Hospital Regional, Intensive Care, Malaga, Spain
FAU - Fernandez-Zamora, M. D.
AU  - Fernandez-Zamora MD
AD  - Hospital Serrania, Ronda, Spain
FAU - Perez-Borrero, L.
AU  - Perez-Borrero L
AD  - Hospital Regional, Intensive Care, Málaga, Spain
FAU - Arias-Verdu, M. D.
AU  - Arias-Verdu MD
AD  - Hospital Infanta Margarita, Intensive Care, Cabra, Spain
FAU - Aguilar-Alonso, E.
AU  - Aguilar-Alonso E
AD  - Hospital Virgen del Rocio, Intensive Care, Sevilla, Spain
FAU - Herruzo-Aviles, A.
AU  - Herruzo-Aviles A
AD  - Hospital Virgen de las Nieves, Intensive Care, Granada, Spain
FAU - Garcia-Delgado, M.
AU  - Garcia-Delgado M
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain
FAU - Hinojosa-Perez, R.
AU  - Hinojosa-Perez R
AD  - Hospital Virgen de las Nieves, Intensive Care, Granada, Spain
FAU - Curiel-Balsera, E.
AU  - Curiel-Balsera E
AD  - Hospital Serrania, Ronda, Spain
FAU - Rivera-Fernandez, R.
AU  - Rivera-Fernandez R
AD  - Hospital Regional, Intensive Care, Málaga, Spain
CN  - ARIAM-ANDALUCIA
FAU - Lesmes, S. P. Gómez
AU  - Lesmes SPG
AD  - Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain
FAU - Rosario, L. E. De la Cruz
AU  - Rosario LEDla C
AD  - Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain
FAU - Hernández, A. Ansotegui
AU  - Hernández AA
AD  - Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain
FAU - Herrera, A. N. García
AU  - Herrera ANG
AD  - Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain
FAU - Sanz, E. Regidor
AU  - Sanz ER
AD  - Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain
FAU - Sánchez, M. J. Gómez
AU  - Sánchez MJG
AD  - Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain
FAU - Hualde, J. Barado
AU  - Hualde JB
AD  - Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain
FAU - Pascual, O. Agudo
AU  - Pascual OA
AD  - Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain
FAU - León, J. P. Tirapu
AU  - León JPT
AD  - Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain
FAU - Irazabal, J. M. Guergue
AU  - Irazabal JMG
AD  - Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain
FAU - Pérez, A. González
AU  - Pérez AG
AD  - Hospital Universitario Central de Asturias, ICU 3, Oviedo, Spain
FAU - Fernández, P. Alvarez
AU  - Fernández PA
AD  - Hospital Universitario Central de Asturias, Oviedo, Spain
FAU - Amor, L. Lopéz
AU  - Amor LL
AD  - Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain
FAU - Albaiceta, G. Muñiz
AU  - Albaiceta GM
AD  - Hospital Universitario Central de Asturias, ICU 3, Oviedo, Spain
FAU - Lesmes, S. P. Gómez
AU  - Lesmes SPG
AD  - ASST Sacco Fatebenefratelli, Milano, Italy
FAU - Rosario, L. E. De la Cruz
AU  - Rosario LEDla C
AD  - ASST Sacco Fatebenefratelli, Milano, Italy
FAU - Hernández, A. Ansotegui
AU  - Hernández AA
AD  - ASST Sacco Fatebenefratelli, Milano, Italy
FAU - Sanz, E. Regidor
AU  - Sanz ER
AD  - ASST Sacco Fatebenefratelli, Milano, Italy
FAU - Sánchez, M. J. Gómez
AU  - Sánchez MJG
AD  - ASST Sacco Fatebenefratelli, Milano, Italy
FAU - Calvo, S. Aldunate
AU  - Calvo SA
AD  - ASST Sacco Fatebenefratelli, Milano, Italy
FAU - Herrera, A. N. García
AU  - Herrera ANG
AD  - ASST Sacco Fatebenefratelli, Milano, Italy
FAU - Hualde, J. Barado
AU  - Hualde JB
AD  - ASST Sacco Fatebenefratelli, Milano, Italy
FAU - Pascual, O. Agudo
AU  - Pascual OA
AD  - ASST Sacco Fatebenefratelli, Milano, Italy
FAU - León, J. P. Tirapu
AU  - León JPT
AD  - ASST Sacco Fatebenefratelli, Milano, Italy
FAU - Corona, A.
AU  - Corona A
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Ruffini, C.
AU  - Ruffini C
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Spazzadeschi, A.
AU  - Spazzadeschi A
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Marrazzo, F.
AU  - Marrazzo F
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Gandola, A.
AU  - Gandola A
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Sciurti, R.
AU  - Sciurti R
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Savi, C.
AU  - Savi C
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Catena, E.
AU  - Catena E
AD  - Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Ke, M. W.
AU  - Ke MW
AD  - Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Cheng, C. C.
AU  - Cheng CC
AD  - Kaohsiung Veterans General Hospital, Department of Medical Education and
      Research, Kaohsiung City, Taiwan, Province of China
FAU - Huang, W. C.
AU  - Huang WC
AD  - Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Chiang, C. H.
AU  - Chiang CH
AD  - Kaohsiung Veterans General Hospital, Department of Medical Education and
      Research, Kaohsiung City, Taiwan, Province of China
FAU - Hung, W. T.
AU  - Hung WT
AD  - Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Lin, K. C.
AU  - Lin KC
AD  - Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Lin, S. C.
AU  - Lin SC
AD  - Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Wann, S. R.
AU  - Wann SR
AD  - Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City,
      Taiwan, Province of China
FAU - Chiou, K. R.
AU  - Chiou KR
AD  - Kaohsiung Veterans General Hospital, Department of Medical Education and
      Research, Kaohsiung City, Taiwan, Province of China
FAU - Tseng, C. J.
AU  - Tseng CJ
AD  - University Hospital of Pisa, Department of Anaesthesia and Critical Care
      Medicine, Cardiothoracic and Vascular Anaesthesia, Pisa, Italy
FAU - Kang, P. L.
AU  - Kang PL
AD  - Kaohsiung Veterans General Hospital, Department of Medical Education and
      Research, Kaohsiung City, Taiwan, Province of China
FAU - Mar, G. Y.
AU  - Mar GY
AD  - Kaohsiung Veterans General Hospital, Department of Medical Education and
      Research, Kaohsiung City, Taiwan, Province of China
FAU - Liu, C. P.
AU  - Liu CP
AD  - Kaohsiung Veterans General Hospital, Department of Medical Education and
      Research, Kaohsiung City, Taiwan, Province of China
FAU - Bertini, P.
AU  - Bertini P
AD  - University of Pisa, Scuola di Specializzazione in Malattie del l’Apparato
      Cardiovascolare, Pisa, Italy
FAU - De Sanctis, F.
AU  - De Sanctis F
AD  - University Hospital of Pisa, Department of Anaesthesia and Critical Care
      Medicine, Cardiothoracic and Vascular Anaesthesia, Pisa, Italy
FAU - Guarracino, F.
AU  - Guarracino F
AD  - University of Pisa, Scuola di Specializzazione in Malattie del l’Apparato
      Cardiovascolare, Pisa, Italy
FAU - Bertini, P.
AU  - Bertini P
AD  - OLVG Hospital, Department of Intensive Care, Amsterdam, Netherlands
FAU - Baldassarri, R.
AU  - Baldassarri R
AD  - OLVG Hospital, Department of Intensive Care, Amsterdam, Netherlands
FAU - Guarracino, F.
AU  - Guarracino F
AD  - OLVG Hospital, Department of Intensive Care, Amsterdam, Netherlands
FAU - Buitinck, S. H.
AU  - Buitinck SH
AD  - Tilburg University; TIAS School for Business and Society, Tilburg, Netherlands
FAU - van der Voort, P. H. J.
AU  - van der Voort PHJ
AD  - Tilburg University; TIAS School for Business and Society, Tilburg, Netherlands
FAU - Oto, J.
AU  - Oto J
AD  - Tokushima University Graduate School, Emergency and Critical Care Medicine,
      Tokushima, Japan
FAU - Nakataki, E.
AU  - Nakataki E
AD  - Fortis Escorts Hospital, Critical Care Medicine, Faridabad, India
FAU - Tsunano, Y.
AU  - Tsunano Y
AD  - Fortis Escorts Hospital, Critical Care Medicine, Faridabad, India
FAU - Izawa, M.
AU  - Izawa M
AD  - Fortis Escorts Hospital, Critical Care Medicine, Faridabad, India
FAU - Tane, N.
AU  - Tane N
AD  - Tokushima University Graduate School, Emergency and Critical Care Medicine,
      Tokushima, Japan
FAU - Onodera, M.
AU  - Onodera M
AD  - Fortis Escorts Hospital, Critical Care Medicine, Faridabad, India
FAU - Nishimura, M.
AU  - Nishimura M
AD  - Fortis Escorts Hospital, Critical Care Medicine, Faridabad, India
FAU - Ghosh, S.
AU  - Ghosh S
AD  - Fortis Escorts Hospital, Microbiology, Faridabad, India
FAU - Gupta, A.
AU  - Gupta A
AD  - Niguarda Ca Granda Hospital, Anesthesia CCM 2, Milan, Italy
FAU - De Gasperi, A.
AU  - De Gasperi A
AD  - Niguarda Ca Granda Hospital, Milan, Italy
FAU - Mazza, E.
AU  - Mazza E
AD  - National Scientific Medical Research Center, Clinical Microbiology, Astana,
      Kazakhstan
FAU - Limuti, R.
AU  - Limuti R
AD  - National Scientific Medical Research Center, Clinical Microbiology, Astana,
      Kazakhstan
FAU - Prosperi, M.
AU  - Prosperi M
AD  - National Scientific Medical Research Center, Clinical Microbiology, Astana,
      Kazakhstan
FAU - Bissenova, N.
AU  - Bissenova N
AD  - Ankara University Faculty of Medicine, Department of Internal Medicine Division
      of Intensive Care, Ankara, Turkey
FAU - Yergaliyeva, A.
AU  - Yergaliyeva A
AD  - Ankara University Faculty of Medicine, Department of Internal Medicine Division
      of Intensive Care, Ankara, Turkey
FAU - Talan, L.
AU  - Talan L
AD  - Ankara University Faculty of Medicine, Clinical Microbiology and Infection
      Disease, Ankara, Turkey
FAU - Yılmaz, G.
AU  - Yılmaz G
AD  - Woodlands Multispeciality Hospital, Clinical Microbiology Dept, Kolkata, India
FAU - Güven, G.
AU  - Güven G
AD  - Ankara University Faculty of Medicine, Clinical Microbiology and Infection
      Disease, Ankara, Turkey
FAU - Yoruk, F.
AU  - Yoruk F
AD  - Woodlands Multispeciality Hospital, Clinical Microbiology Dept, Kolkata, India
FAU - Altıntas, N. D.
AU  - Altıntas ND
AD  - Ankara University Faculty of Medicine, Clinical Microbiology and Infection
      Disease, Ankara, Turkey
FAU - Mukherjee, D. N.
AU  - Mukherjee DN
AD  - Woodlands Multispeciality Hospital, Nephrology Dept, Kolkata, India
FAU - Agarwal, L. K.
AU  - Agarwal LK
AD  - Cure Clinic Nursing Home, Kolkata, India
FAU - Mandal, K.
AU  - Mandal K
AD  - HU Arnau de Vilanova, Lleida, Spain
FAU - Palomar, M.
AU  - Palomar M
AD  - IRBLL, Lleida, Spain
FAU - Balsera, B.
AU  - Balsera B
AD  - IRBLL, Lleida, Spain
FAU - Vallverdu, M.
AU  - Vallverdu M
AD  - IRBLL, Lleida, Spain
FAU - Martinez, M.
AU  - Martinez M
AD  - Hospital Universitario de Fuenlabrada, Intensive Care Unit, Madrid, Spain
FAU - Garcia, M.
AU  - Garcia M
AD  - IRBLL, Lleida, Spain
FAU - Castellana, D.
AU  - Castellana D
AD  - IRBLL, Lleida, Spain
FAU - Lopez, R.
AU  - Lopez R
AD  - IRBLL, Lleida, Spain
FAU - Barcenilla, F.
AU  - Barcenilla F
AD  - IRBLL, Lleida, Spain
FAU - Kaminsky, G. E.
AU  - Kaminsky GE
AD  - Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil
FAU - Carreño, R.
AU  - Carreño R
AD  - Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil
FAU - Escribá, A.
AU  - Escribá A
AD  - Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil
FAU - Fuentes, M.
AU  - Fuentes M
AD  - Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil
FAU - Gálvez, V.
AU  - Gálvez V
AD  - Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil
FAU - Del Olmo, R.
AU  - Del Olmo R
AD  - Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil
FAU - Nieto, B.
AU  - Nieto B
AD  - Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil
FAU - Vaquerizo, C.
AU  - Vaquerizo C
AD  - Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil
FAU - Alvarez, J.
AU  - Alvarez J
AD  - Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil
FAU - De la Torre, M. A.
AU  - De la Torre MA
AD  - Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil
FAU - Torres, E.
AU  - Torres E
AD  - Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil
FAU - Bogossian, E.
AU  - Bogossian E
AD  - Universidade Federal do Rio de Janeiro, Infectious Diseases, Rio de Janeiro,
      Brazil
FAU - Nouer, S. Aranha
AU  - Nouer SA
AD  - Hospital Universitario Arnau de Vilanova, Lleida, Spain
FAU - Salgado, D. Ribeiro
AU  - Salgado DR
AD  - Universidade Federal do Rio de Janeiro, Infectious Diseases, Rio de Janeiro,
      Brazil
FAU - Brugger, S. Carvalho
AU  - Brugger SC
AD  - Yildirim Beyazit University, Anesthesiology and Reanimation, Ankara, Turkey
FAU - Jiménez, G. Jiménez
AU  - Jiménez GJ
AD  - Yildirim Beyazit University, Anesthesiology and Reanimation, Ankara, Turkey
FAU - Torner, M. Miralbés
AU  - Torner MM
AD  - Yildirim Beyazit University, Anesthesiology and Reanimation, Ankara, Turkey
FAU - Vidal, M. Vallverdú
AU  - Vidal MV
AD  - Yildirim Beyazit University, Anesthesiology and Reanimation, Ankara, Turkey
FAU - Garrido, B. Balsera
AU  - Garrido BB
AD  - Yildirim Beyazit University, Anesthesiology and Reanimation, Ankara, Turkey
FAU - Casals, X. Nuvials
AU  - Casals XN
AD  - Yildirim Beyazit University, Anesthesiology and Reanimation, Ankara, Turkey
FAU - Gaite, F. Barcenilla
AU  - Gaite FB
AD  - Yildirim Beyazit University, Anesthesiology and Reanimation, Ankara, Turkey
FAU - Cabello, J. Trujillano
AU  - Cabello JT
AD  - Yildirim Beyazit University, Anesthesiology and Reanimation, Ankara, Turkey
FAU - Martínez, M. Palomar
AU  - Martínez MP
AD  - Yildirim Beyazit University, Anesthesiology and Reanimation, Ankara, Turkey
FAU - Doganci, M.
AU  - Doganci M
AD  - Yildirim Beyazit University, Biostatistics and Medical Informatics, Ankara,
      Turkey
FAU - Izdes, S.
AU  - Izdes S
AD  - Yildirim Beyazit University, Biostatistics and Medical Informatics, Ankara,
      Turkey
FAU - Besevli, S. Guzeldag
AU  - Besevli SG
AD  - Yildirim Beyazit University, Biostatistics and Medical Informatics, Ankara,
      Turkey
FAU - Alkan, A.
AU  - Alkan A
AD  - Yildirim Beyazit University, Infectious Diseases and Microbiology, Ankara, Turkey
FAU - Kayaaslan, B.
AU  - Kayaaslan B
AD  - University Hospital of Gran Canaria Dr. Negrín, Intensive Care Unit, Las Palmas
      de Gran Canaria, Spain
FAU - Ramírez, C. Sánchez
AU  - Ramírez CS
AD  - University Hospital of Gran Canaria Dr. Negrín, Pharmacy Department, Las Palmas
      de Gran Canaria, Spain
FAU - Balcázar, L. Caipe
AU  - Balcázar LC
AD  - University Hospital of Gran Canaria Dr. Negrín, Pharmacy Department, Las Palmas
      de Gran Canaria, Spain
FAU - Santana, M. Cabrera
AU  - Santana MC
AD  - University Hospital of Gran Canaria Dr. Negrín, Pharmacy Department, Las Palmas
      de Gran Canaria, Spain
FAU - Viera, M. A. Hernández
AU  - Viera MAH
AD  - University Hospital of Gran Canaria Dr. Negrín, Pharmacy Department, Las Palmas
      de Gran Canaria, Spain
FAU - Escalada, S. Hípola
AU  - Escalada SH
AD  - University Hospital of Gran Canaria Dr. Negrín, Pharmacy Department, Las Palmas
      de Gran Canaria, Spain
FAU - Vázquez, C. F. Lübbe
AU  - Vázquez CFL
AD  - University Hospital of Gran Canaria Dr. Negrín, Pharmacy Department, Las Palmas
      de Gran Canaria, Spain
FAU - Penichet, S. M. Marrero
AU  - Penichet SMM
AD  - University Hospital of Gran Canaria Dr. Negrín, Microbiology Department, Las
      Palmas de Gran Canaria, Spain
FAU - Campelo, F. Artiles
AU  - Campelo FA
AD  - Hospital of Getafe, Intensive Care Unit, Madrid, Spain
FAU - López, M. A. De La Cal
AU  - López MADLC
AD  - University of Las Palmas de Gran Canaria, Mathematics and Informatcs Deparment,
      Las Palmas de Gran Canaria, Spain
FAU - Santana, P. Saavedra
AU  - Santana PS
AD  - Intensive Care Unit, Ambroise Paré University Hospital, Assistance Publique,
      Hôpitaux de Paris, Boulogne-Billancourt, France
FAU - Santana, S. Ruíz
AU  - Santana SR
AD  - University Hospital of Gran Canaria Dr. Negrín, Pharmacy Department, Las Palmas
      de Gran Canaria, Spain
FAU - Repessé, X.
AU  - Repessé X
AD  - Infection control Unit, Ambroise Paré University Hospital, Assistance Publique,
      Hôpitaux de Paris, Boulogne-Billancourt, France
FAU - Artiguenave, M.
AU  - Artiguenave M
AD  - Infection control Unit, Ambroise Paré University Hospital, Assistance Publique,
      Hôpitaux de Paris, Boulogne-Billancourt, France
FAU - Paktoris-Papine, S.
AU  - Paktoris-Papine S
AD  - Infection control Unit, Ambroise Paré University Hospital, Assistance Publique,
      Hôpitaux de Paris, Boulogne-Billancourt, France
FAU - Espinasse, F.
AU  - Espinasse F
AD  - Infectious Diseases Unit, Ambroise Paré University Hospital, Assistance Publique,
      Hôpitaux de Paris, Boulogne-Billancourt, France
FAU - Dinh, A.
AU  - Dinh A
AD  - Microbiology Unit, Section Biology Pathology and Health Products, Ambroise Paré
      University Hospital, Assistance Publique, Hôpitaux de Paris,
      Boulogne-Billancourt, France
FAU - El Sayed, F.
AU  - El Sayed F
AD  - Intensive Care Unit, Ambroise Paré University Hospital, Assistance publique,
      Hôpitaux de Paris, Boulogne-Billancourt, France
FAU - Charron, C.
AU  - Charron C
AD  - Intensive Care Unit, Ambroise Paré University Hospital, Assistance Publique -
      Hôpitaux de Paris, Boulogne-Billancourt, France
FAU - Géri, G.
AU  - Géri G
AD  - Rescu, Li Ka Shing Institute at St Michael‘s Hospital, Toronto, Canada
FAU - Vieillard-Baron, A.
AU  - Vieillard-Baron A
AD  - University of Versailles Saint-Quentin en Yvelines, Faculty of Medicine Paris
      Ile-de-France Ouest, Saint-Quentin en Yvelines, France
FAU - Marmanidou, K.
AU  - Marmanidou K
AD  - Hôpital de Bicêtre, Hôpitaux universitaires Paris-Sud, Université Paris-Sud,
      Service de réanimation médicale, Inserm UMR_S999, Le Kremlin Bicêtre, France
FAU - Oikonomou, M.
AU  - Oikonomou M
AD  - Hôpital de Bicêtre, Hôpitaux universitaires Paris-Sud, Université Paris-Sud,
      Service de réanimation médicale, Inserm UMR_S999, Le Kremlin Bicêtre, France
FAU - Nouris, C.
AU  - Nouris C
AD  - Hôpital de Bicêtre, Hôpitaux universitaires Paris-Sud, Université Paris-Sud,
      Service de réanimation médicale, Inserm UMR_S999, Le Kremlin Bicêtre, France
FAU - Dimitroulakis, K.
AU  - Dimitroulakis K
AD  - Hôpital de Bicêtre, Hôpitaux universitaires Paris-Sud, Université Paris-Sud,
      Service de réanimation médicale, Inserm UMR_S999, Le Kremlin Bicêtre, France
FAU - Soilemezi, E.
AU  - Soilemezi E
AD  - Hôpital de Bicêtre, Hôpitaux universitaires Paris-Sud, Université Paris-Sud,
      Service de réanimation médicale, Inserm UMR_S999, Le Kremlin Bicêtre, France
FAU - Matamis, D.
AU  - Matamis D
AD  - Hôpital de Bicêtre, Hôpitaux universitaires Paris-Sud, Université Paris-Sud,
      Service de réanimation médicale, Inserm UMR_S999, Le Kremlin Bicêtre, France
FAU - Ferré, A.
AU  - Ferré A
AD  - Hôpital Ambroise Paré, Hôpitaux universitaires Paris-Ile-de-France-Ouest,
      Université de Versailles Saint Quentin en Yvelines, Service de réanimation
      polyvalente, Boulogne-Billancourt, France
FAU - Guillot, M.
AU  - Guillot M
AD  - Hôpital Ambroise Paré, Hôpitaux universitaires Paris-Ile-de-France-Ouest,
      Université de Versailles Saint Quentin en Yvelines, Service de réanimation
      polyvalente, Boulogne-Billancourt, France
FAU - Teboul, J. L.
AU  - Teboul JL
AD  - Hôpital Ambroise Paré, Hôpitaux universitaires Paris-Ile-de-France-Ouest,
      Université de Versailles Saint Quentin en Yvelines, Service de réanimation
      polyvalente, Boulogne-Billancourt, France
FAU - Lichtenstein, D.
AU  - Lichtenstein D
AD  - Centre hospitalier de Sens, Service de réanimation polyvalente, Sens, France
FAU - Mézière, G.
AU  - Mézière G
AD  - CHU Tenon, APHP, Medical and Surgical ICU, Paris, France
FAU - Richard, C.
AU  - Richard C
AD  - Hôpital Ambroise Paré, Hôpitaux universitaires Paris-Ile-de-France-Ouest,
      Université de Versailles Saint Quentin en Yvelines, Service de réanimation
      polyvalente, Boulogne-Billancourt, France
FAU - Monnet, X.
AU  - Monnet X
AD  - Hôpital Ambroise Paré, Hôpitaux universitaires Paris-Ile-de-France-Ouest,
      Université de Versailles Saint Quentin en Yvelines, Service de réanimation
      polyvalente, Boulogne-Billancourt, France
FAU - Pham, T.
AU  - Pham T
AD  - University of Toronto, Interdepartmental Division of Critical Care, Toronto,
      Canada
FAU - Beduneau, G.
AU  - Beduneau G
AD  - Rouen University Hospital, UPRES EA3830 IRIB, Rouen, France
FAU - Schortgen, F.
AU  - Schortgen F
AD  - University Hospital of Lausanne, Intensive Care and Burn Unit, Lausanne,
      Switzerland
FAU - Piquilloud, L.
AU  - Piquilloud L
AD  - CHU d’Amiens, Cardiothoracic and Vascular ICU, Amiens, France
FAU - Zogheib, E.
AU  - Zogheib E
AD  - Université Jules Verne, Picardie, INSERM U1088 - CURS, Amiens, France
FAU - Jonas, M.
AU  - Jonas M
AD  - Hospital Le Mans, Intensive Care Unit, Le Mans, France
FAU - Grelon, F.
AU  - Grelon F
AD  - CHR d’Orleans, Medical ICU, Orleans, France
FAU - Runge, I.
AU  - Runge I
AD  - CHU Grenoble Alpes, Medical ICU, Grenoble, France
FAU - Terzi, N.
AU  - Terzi N
AD  - Université Grenoble-Alpes, Inserm U1042, Grenoble, France
FAU - Grangé, S.
AU  - Grangé S
AD  - Rouen University Hospital, UPRES EA3830 IRIB, Rouen, France
FAU - Barberet, G.
AU  - Barberet G
AD  - Rouen University Hospital, Surgical Intensive Care, Rouen, France
FAU - Guitard, P. G.
AU  - Guitard PG
AD  - CHU de Poitiers, Medical ICU, Poitiers, France
FAU - Frat, J. P.
AU  - Frat JP
AD  - Université de Poitiers, INSERM, CIC- 1402, Équipe 5 ALIVE, Poitiers, France
FAU - Constan, A.
AU  - Constan A
AD  - CHU d’Angers, Clinical Research Institute, Angers, France
FAU - Chrétien, J. M.
AU  - Chrétien JM
AD  - Hospital de Sant Pau, Servei de Medicina Intensiva, Barcelona, Spain
FAU - Mancebo, J.
AU  - Mancebo J
AD  - CHU d’Angers, Medical ICU, Angers, France
FAU - Mercat, A.
AU  - Mercat A
AD  - Annecy Genevois General Hospital, Annecy, France
FAU - Richard, J. C. M.
AU  - Richard JCM
AD  - Saint Michael’s Hospital and Keenan Research Centre, Interdepartmental Division
      of Critical Care, Toronto, Canada
FAU - Brochard, L.
AU  - Brochard L
AD  - Rīga Stradiņš University, Faculty of Continuing Education, Residency Section,
      Riga, Latvia
CN  - The WIND study group
FAU - Prīdāne, S.
AU  - Prīdāne S
AD  - Rīga Stradiņš University, Department of Anaesthesiology & Intensive Care, Riga,
      Latvia
FAU - Sabeļņikovs, O.
AU  - Sabeļņikovs O
AD  - Pauls Stradins Clinical University Hospital, Department of Intensive Care, Riga, 
      Latvia
FAU - Mojoli, F.
AU  - Mojoli F
AD  - Rouen University Hospital, Medical Intensive Care, Rouen, France
FAU - Orlando, A.
AU  - Orlando A
AD  - Rouen University Hospital, Medical Intensive Care, Rouen, France
FAU - Bianchi, I.
AU  - Bianchi I
AD  - Rouen University Hospital, Medical Intensive Care, Rouen, France
FAU - Torriglia, F.
AU  - Torriglia F
AD  - Rouen University Hospital, Medical Intensive Care, Rouen, France
FAU - Bianzina, S.
AU  - Bianzina S
AD  - Rouen University Hospital, Medical Intensive Care, Rouen, France
FAU - Pozzi, M.
AU  - Pozzi M
AD  - Rouen University Hospital, Medical Intensive Care, Rouen, France
FAU - Iotti, G. A.
AU  - Iotti GA
AD  - Rouen University Hospital, Medical Intensive Care, Rouen, France
FAU - Braschi, A.
AU  - Braschi A
AD  - Rouen University Hospital, Medical Intensive Care, Rouen, France
CN  - PLUG Working Group
FAU - Beduneau, G.
AU  - Beduneau G
AD  - Rouen University Hospital, UPRES EA3830 IRIB, Rouen, France
FAU - Pham, T.
AU  - Pham T
AD  - University of Toronto, Interdepartmental Division of Critical Care, Toronto,
      Canada
FAU - Schortgen, F.
AU  - Schortgen F
AD  - University Hospital of Lausanne, Intensive Care and Burn Unit, Lausanne,
      Switzerland
FAU - Piquilloud, L.
AU  - Piquilloud L
AD  - CHU d’Amiens, Cardiothoracic and Vascular ICU, Amiens, France
FAU - Zogheib, E.
AU  - Zogheib E
AD  - Université Jules Verne, Picardie, INSERM U1088 - CURS, Amiens, France
FAU - Jonas, M.
AU  - Jonas M
AD  - Hospital Le Mans, Intensive Care Unit, Le Mans, France
FAU - Grelon, F.
AU  - Grelon F
AD  - CHR d’Orleans, Medical ICU, Orleans, France
FAU - Runge, I.
AU  - Runge I
AD  - CHU Grenoble Alpes, Medical ICU, Grenoble, France
FAU - Terzi, N.
AU  - Terzi N
AD  - Université Grenoble-Alpes, Inserm U1042, Grenoble, France
FAU - Grangé, S.
AU  - Grangé S
AD  - Rouen University Hospital, UPRES EA3830 IRIB, Rouen, France
FAU - Barberet, G.
AU  - Barberet G
AD  - Rouen University Hospital, Surgical Intensive Care, Rouen, France
FAU - Guitard, P. G.
AU  - Guitard PG
AD  - CHU de Poitiers, Medical ICU, Poitiers, France
FAU - Frat, J. P.
AU  - Frat JP
AD  - Université de Poitiers, INSERM, CIC- 1402, Équipe 5 ALIVE, Poitiers, France
FAU - Constan, A.
AU  - Constan A
AD  - CHU d’Angers, Clinical Research Institute, Angers, France
FAU - Chrétien, J. M.
AU  - Chrétien JM
AD  - Hospital de Sant Pau, Servei de Medicina Intensiva, Barcelona, Spain
FAU - Mancebo, J.
AU  - Mancebo J
AD  - CHU d’Angers, Medical ICU, Angers, France
FAU - Mercat, A.
AU  - Mercat A
AD  - Annecy Genevois General Hospital, Annecy, France
FAU - Richard, J. C. M.
AU  - Richard JCM
AD  - Saint Michael’s Hospital and Keenan Research Centre, Interdepartmental Division
      of Critical Care, Toronto, Canada
FAU - Brochard, L.
AU  - Brochard L
AD  - University of Crete, School of Medicine, Intensive Care, Heraklio, Crete Greece
CN  - The WIND study group
FAU - Kondili, E.
AU  - Kondili E
AD  - University Hospital of Heraklio, Intensive Care, Heraklio, Crete Greece
FAU - Psarologakis, C.
AU  - Psarologakis C
AD  - General Hospital of Larissa, Intensive Care, Larissa, Greece
FAU - Kokkini, S.
AU  - Kokkini S
AD  - General Hospital of Larissa, Intensive Care, Larissa, Greece
FAU - Amargianitakis, V.
AU  - Amargianitakis V
AD  - General Hospital of Larissa, Intensive Care, Larissa, Greece
FAU - Babalis, D.
AU  - Babalis D
AD  - University Hospital of Heraklio, Intensive Care, Heraklio, Crete Greece
FAU - Chytas, A.
AU  - Chytas A
AD  - Asklepios Schlossberg Klinik, Early Neurological Rehabilitation, Bad König,
      Germany
FAU - Chouvarda, I.
AU  - Chouvarda I
AD  - Asklepios Schlossberg Klinik, Early Neurological Rehabilitation, Bad König,
      Germany
FAU - Vaporidi, K.
AU  - Vaporidi K
AD  - University Hospital of Heraklio, Intensive Care, Heraklio, Crete Greece
FAU - Georgopoulos, D.
AU  - Georgopoulos D
AD  - University Hospital of Heraklio, Intensive Care, Heraklio, Crete Greece
FAU - Trapp, O.
AU  - Trapp O
AD  - University Heidelberg, Anaesthesiology and Intensiv Care Medicine, Heppenheim,
      Germany
FAU - Kalenka, A.
AU  - Kalenka A
AD  - Fondazione IRCCS Policlinico S. Matteo, Anesthesia and Intensive Care, University
      of Pavia, Pavie, Italy
FAU - Mojoli, F.
AU  - Mojoli F
AD  - Hospital Quirón de Málaga, Intensive Care Unit, Málaga, Spain
FAU - Orlando, A.
AU  - Orlando A
AD  - Hospital Quirón de Málaga, Intensive Care Unit, Málaga, Spain
FAU - Bianchi, I.
AU  - Bianchi I
AD  - Hospital Quirón de Málaga, Intensive Care Unit, Málaga, Spain
FAU - Torriglia, F.
AU  - Torriglia F
AD  - Hospital Quirón de Málaga, Intensive Care Unit, Málaga, Spain
FAU - Bianzina, S.
AU  - Bianzina S
AD  - Hospital Quirón de Málaga, Intensive Care Unit, Málaga, Spain
FAU - Pozzi, M.
AU  - Pozzi M
AD  - Hospital Quirón de Málaga, Intensive Care Unit, Málaga, Spain
FAU - Iotti, G. A.
AU  - Iotti GA
AD  - Hospital Quirón de Málaga, Intensive Care Unit, Málaga, Spain
FAU - Braschi, A.
AU  - Braschi A
AD  - Hospital Quirón de Málaga, Intensive Care Unit, Málaga, Spain
CN  - PLUG Working Group
FAU - Lozano, J. A. Benítez
AU  - Lozano JAB
AD  - Hospital Universitario Reina Sofía, Intensive Care Unit, Córdoba, Spain
FAU - Sánchez, P. Carmona
AU  - Sánchez PC
AD  - Hospital de Manises, Valencia, Spain
FAU - Francioni, J. E. Barrueco
AU  - Francioni JEB
AD  - Complejo Hospitalario de Jaén, Jaén, Spain
FAU - Ferrón, F. Ruiz
AU  - Ferrón FR
AD  - University of Ferrara/Intensive Care Unit, Morphology, Surgery and Experimental
      Medicine, Ferrara, Italy
FAU - Simón, J. M. Serrano
AU  - Simón JMS
AD  - Hospital de Manises, Valencia, Spain
FAU - Spadaro, S.
AU  - Spadaro S
AD  - Aalborg University, Respiratory and Critical Care group (rcare) Center for
      Model-based Medical Decision Support (MMDS) Department of Health Science and
      Technology, Aalborg, Denmark
FAU - Karbing, D. S.
AU  - Karbing DS
AD  - University of Milan, Department of Anesthesia, Critical Care and Emergency
      Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
FAU - Gioia, A.
AU  - Gioia A
AD  - Aalborg University, Respiratory and Critical Care group (rcare) Center for
      Model-based Medical Decision Support (MMDS) Department of Health Science and
      Technology, Aalborg, Denmark
FAU - Moro, F.
AU  - Moro F
AD  - Aalborg University, Respiratory and Critical Care group (rcare) Center for
      Model-based Medical Decision Support (MMDS) Department of Health Science and
      Technology, Aalborg, Denmark
FAU - Corte, F. Dalla
AU  - Corte FD
AD  - Aalborg University, Respiratory and Critical Care group (rcare) Center for
      Model-based Medical Decision Support (MMDS) Department of Health Science and
      Technology, Aalborg, Denmark
FAU - Mauri, T.
AU  - Mauri T
AD  - Peoples’ Friendship University of Russia, Anesthesiology & Intensive Care,
      Moscow, Russian Federation
FAU - Volta, C. A.
AU  - Volta CA
AD  - Aalborg University, Respiratory and Critical Care group (rcare) Center for
      Model-based Medical Decision Support (MMDS) Department of Health Science and
      Technology, Aalborg, Denmark
FAU - Rees, S. E.
AU  - Rees SE
AD  - University of Milan, Department of Anesthesia, Critical Care and Emergency
      Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
CN  - Plug working group
FAU - Petrova, M. V.
AU  - Petrova MV
AD  - Hospices Civils de Lyon, Hôpital de la Croix Rousse, Service de Reanimation
      Médicale, Lyon, France
FAU - Mohan, R.
AU  - Mohan R
AD  - Hospices Civils de Lyon, Hôpital de la Croix Rousse, Service de Reanimation
      Médicale, Lyon, France
FAU - Butrov, A. V.
AU  - Butrov AV
AD  - Hospices Civils de Lyon, Hôpital de la Croix Rousse, Service de Reanimation
      Médicale, Lyon, France
FAU - Beeharry, S. D.
AU  - Beeharry SD
AD  - Hospices Civils de Lyon, Hôpital de la Croix Rousse, Service de Reanimation
      Médicale, Lyon, France
FAU - Vatsik, M. V.
AU  - Vatsik MV
AD  - Hospices Civils de Lyon, Hôpital de la Croix Rousse, Service de Reanimation
      Médicale, Lyon, France
FAU - Sakieva, F. I.
AU  - Sakieva FI
AD  - Hospices Civils de Lyon, Hôpital de la Croix Rousse, Service de Reanimation
      Médicale, Lyon, France
FAU - Gobert, F.
AU  - Gobert F
AD  - Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France
FAU - Yonis, H.
AU  - Yonis H
AD  - Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France
FAU - Tapponnier, R.
AU  - Tapponnier R
AD  - Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France
FAU - Fernandez, R.
AU  - Fernandez R
AD  - Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France
FAU - Labaune, M. A.
AU  - Labaune MA
AD  - Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France
FAU - Burle, J. F.
AU  - Burle JF
AD  - Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France
FAU - Barbier, J.
AU  - Barbier J
AD  - Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France
FAU - Vincent, B.
AU  - Vincent B
AD  - Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France
FAU - Cleyet, M.
AU  - Cleyet M
AD  - Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France
FAU - Richard, J. C.
AU  - Richard JC
AD  - Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France
FAU - Guérin, C.
AU  - Guérin C
AD  - Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France
FAU - Shinotsuka, C. Righy
AU  - Shinotsuka CR
AD  - University of Helsinki and Helsinki University Hospital, Helsinki, Finland
FAU - Creteur, J.
AU  - Creteur J
AD  - University of Helsinki and Helsinki University Hospital, Helsinki, Finland
FAU - Taccone, F. S.
AU  - Taccone FS
AD  - University of Helsinki and Helsinki University Hospital, Helsinki, Finland
FAU - Törnblom, S.
AU  - Törnblom S
AD  - Lapland Central Hospital, Rovaniemi, Finland
FAU - Nisula, S.
AU  - Nisula S
AD  - Lapland Central Hospital, Rovaniemi, Finland
FAU - Vaara, S.
AU  - Vaara S
AD  - Lapland Central Hospital, Rovaniemi, Finland
FAU - Poukkanen, M.
AU  - Poukkanen M
AD  - West China Hospital, Sichuan University, Department of Critical Care Medicine,
      Chengdu, China
FAU - Andersson, S.
AU  - Andersson S
AD  - Lapland Central Hospital, Rovaniemi, Finland
FAU - Pettilä, V.
AU  - Pettilä V
AD  - Lapland Central Hospital, Rovaniemi, Finland
FAU - Pesonen, E.
AU  - Pesonen E
AD  - Lapland Central Hospital, Rovaniemi, Finland
FAU - Xie, Z.
AU  - Xie Z
AD  - Kobe University Hospital, Anesthesiology, Kobe, Japan
FAU - Liao, X.
AU  - Liao X
AD  - Kobe University Hospital, Anesthesiology, Kobe, Japan
FAU - Kang, Y.
AU  - Kang Y
AD  - Kobe University Hospital, Anesthesiology, Kobe, Japan
FAU - Zhang, J.
AU  - Zhang J
AD  - Kobe University Hospital, Anesthesiology, Kobe, Japan
FAU - Kubota, K.
AU  - Kubota K
AD  - Alexandria University, Critical Care Medicine, Alexandria, Egypt
FAU - Egi, M.
AU  - Egi M
AD  - Alexandria University, Critical Care Medicine, Alexandria, Egypt
FAU - Mizobuchi, S.
AU  - Mizobuchi S
AD  - Alexandria University, Critical Care Medicine, Alexandria, Egypt
FAU - Hegazy, S.
AU  - Hegazy S
AD  - Alexandria University, Internal Medicine-Nephrology Unit, Alexandria, Egypt
FAU - El-Keraie, A.
AU  - El-Keraie A
AD  - Alexandria University, Clinical and Chemical Pathology, Alexandria, Egypt
FAU - El Sayed, E.
AU  - El Sayed E
AD  - Centro Hospitalar Lisboa Norte, Nephrology and Renal Transplantation, Lisbon,
      Portugal
FAU - El Hamid, M. Abd
AU  - El Hamid MA
AD  - Alexandria University, Internal Medicine-Nephrology Unit, Alexandria, Egypt
FAU - Rodrigues, N. J.
AU  - Rodrigues NJ
AD  - Centro Hospitalar Lisboa Norte, Intensive Care Medicine, Lisbon, Portugal
FAU - Pereira, M.
AU  - Pereira M
AD  - Centro Hospitalar Lisboa Norte, Intensive Care Medicine, Lisbon, Portugal
FAU - Godinho, I.
AU  - Godinho I
AD  - Centro Hospitalar Lisboa Norte, Intensive Care Medicine, Lisbon, Portugal
FAU - Gameiro, J.
AU  - Gameiro J
AD  - Centro Hospitalar Lisboa Norte, Intensive Care Medicine, Lisbon, Portugal
FAU - Neves, M.
AU  - Neves M
AD  - Centro Hospitalar Lisboa Norte, Intensive Care Medicine, Lisbon, Portugal
FAU - Gouveia, J.
AU  - Gouveia J
AD  - Royal Surrey County Hospital, ICU and SPACeR research group, Guildford, UK
FAU - e Silva, Z. Costa
AU  - e Silva ZC
AD  - Royal Surrey County Hospital, ICU and SPACeR research group, Guildford, UK
FAU - Lopes, J. A.
AU  - Lopes JA
AD  - Centro Hospitalar Lisboa Norte, Intensive Care Medicine, Lisbon, Portugal
FAU - Mckinlay, J.
AU  - Mckinlay J
AD  - University of Surrey, Guildford, UK
FAU - Kostalas, M.
AU  - Kostalas M
AD  - University of Surrey, Guildford, UK
FAU - Kooner, G.
AU  - Kooner G
AD  - University of Surrey, Guildford, UK
FAU - Dudas, G.
AU  - Dudas G
AD  - University of Surrey, Guildford, UK
FAU - Horton, A.
AU  - Horton A
AD  - Aomori Jekeikai Hospiyal, Clinical Engineer, Aomori, Japan
FAU - Kerr, C.
AU  - Kerr C
AD  - Aomori Jekeikai Hospiyal, Clinical Engineer, Aomori, Japan
FAU - Karanjia, N.
AU  - Karanjia N
AD  - University of Semmelweis, Budapest, Hungary
FAU - Creagh-Brown, B.
AU  - Creagh-Brown B
AD  - University of Surrey, Guildford, UK
FAU - Forni, L.
AU  - Forni L
AD  - University of Surrey, Guildford, UK
FAU - Yamazaki, A.
AU  - Yamazaki A
AD  - Clinica Universidad de Navarra, Anesthesia and Critical Care Unit, Pamplona,
      Spain
FAU - Ganuza, M. Sanz
AU  - Ganuza MS
AD  - Clinica Universidad de Navarra, Nephrology, Pamplona, Spain
FAU - Molina, J. A. Martinez
AU  - Molina JAM
AD  - Clinica Universidad de Navarra, Nephrology, Pamplona, Spain
FAU - Martinez, F. Hidalgo
AU  - Martinez FH
AD  - Clinica Universidad de Navarra, Nephrology, Pamplona, Spain
FAU - Freile, M. T. Chiquito
AU  - Freile MTC
AD  - Clinica Universidad de Navarra, Nephrology, Pamplona, Spain
FAU - Fernandez, N. Garcia
AU  - Fernandez NG
AD  - Uppsala University, Surgical Sciencies, Uppsala, Sweden
FAU - Travieso, P. Medrano
AU  - Travieso PM
AD  - Clinica Universidad de Navarra, Nephrology, Pamplona, Spain
FAU - Bandert, A.
AU  - Bandert A
AD  - Centre Hospitalier Universitaire Vaudois, Adult Intensive Care Unit, Lausanne,
      Switzerland
FAU - Frithiof, R.
AU  - Frithiof R
AD  - Centre Hospitalier Universitaire Vaudois, Adult Intensive Care Unit, Lausanne,
      Switzerland
FAU - Lipcsey, M.
AU  - Lipcsey M
AD  - Centre Hospitalier Universitaire Vaudois, Adult Intensive Care Unit, Lausanne,
      Switzerland
FAU - Smekal, D.
AU  - Smekal D
AD  - Centre Hospitalier Universitaire Vaudois, Adult Intensive Care Unit, Lausanne,
      Switzerland
FAU - Schlaepfer, P.
AU  - Schlaepfer P
AD  - Centre Hospitalier Universitaire Vaudois, Anaesthesiology Department, Lausanne,
      Switzerland
FAU - Durovray, J. D.
AU  - Durovray JD
AD  - Centre Hospitalier Universitaire Vaudois, Anaesthesiology Department, Lausanne,
      Switzerland
FAU - Plouhinec, V.
AU  - Plouhinec V
AD  - Centre Hospitalier Universitaire Vaudois, Adult Intensive Care Unit, Lausanne,
      Switzerland
FAU - Chiappa, C.
AU  - Chiappa C
AD  - Centre Hospitalier Universitaire Vaudois, Adult Intensive Care Unit, Lausanne,
      Switzerland
FAU - Bellomo, R.
AU  - Bellomo R
AD  - Royal Brompton and Harefield NHS Foundation Trust, London, UK
FAU - Schneider, A. G.
AU  - Schneider AG
AD  - Centre Hospitalier Universitaire Vaudois, Adult Intensive Care Unit, Lausanne,
      Switzerland
FAU - Mitchell, S.
AU  - Mitchell S
AD  - Barts Health NHS Trust, Adult Critical Care, London, UK
FAU - Durrant, J.
AU  - Durrant J
AD  - Barts Health NHS Trust, Adult Critical Care, London, UK
FAU - Street, H.
AU  - Street H
AD  - Barts Health NHS Trust, Adult Critical Care, London, UK
FAU - Dunthorne, E.
AU  - Dunthorne E
AD  - Barts Health NHS Trust, Adult Critical Care, London, UK
FAU - Shears, J.
AU  - Shears J
AD  - Barts Health NHS Trust, Adult Critical Care, London, UK
FAU - Caballero, C. Hernandez
AU  - Caballero CH
AD  - Barts Health NHS Trust, Adult Critical Care, London, UK
FAU - Hutchison, R.
AU  - Hutchison R
AD  - Nikisso Medical, London, UK
FAU - Schwarze, S.
AU  - Schwarze S
AD  - Nikisso Medical, London, UK
FAU - Ghabina, S.
AU  - Ghabina S
AD  - Nikisso Medical, London, UK
FAU - Thompson, E.
AU  - Thompson E
AD  - Hospital Universitario San Ignacio, Internal Medicine, Nephrology, Bogota,
      Colombia
FAU - Prowle, J. R.
AU  - Prowle JR
AD  - Nikisso Medical, London, UK
FAU - Kirwan, C. J.
AU  - Kirwan CJ
AD  - Nikisso Medical, London, UK
FAU - Gonzalez, C. A.
AU  - Gonzalez CA
AD  - Pontificia Universidad Javeriana, Nefrology, Bogota, Colombia
FAU - Pinto, J. L.
AU  - Pinto JL
AD  - Pontificia Universidad Javeriana, Internal Medicine, Bogota, Colombia
FAU - Orozco, V.
AU  - Orozco V
AD  - Hospital Militar Central, Nephrology, Bogota, Colombia
FAU - Patiño, J. A.
AU  - Patiño JA
AD  - Hospital Militar Central, Nephrology, Bogota, Colombia
FAU - Garcia, P. K.
AU  - Garcia PK
AD  - Pontificia Universidad Javeriana, Nefrology, Bogota, Colombia
FAU - Contreras, K. M.
AU  - Contreras KM
AD  - Pontificia Universidad Javeriana, Nefrology, Bogota, Colombia
FAU - Rodriguez, P.
AU  - Rodriguez P
AD  - Pontificia Universidad Javeriana, Nefrology, Bogota, Colombia
FAU - Echeverri, J. E.
AU  - Echeverri JE
AD  - Pontificia Universidad Javeriana, Nefrology, Bogota, Colombia
LA  - eng
PT  - Journal Article
DEP - 20160929
TA  - Intensive Care Med Exp
JT  - Intensive Care Medicine Experimental
AID - 100 [pii]
AID - 10.1186/s40635-016-0100-7 [doi]
SO  - Intensive Care Med Exp. 2016 Sep 29;4(Suppl 1):. doi:10.1186/s40635-016-0100-7.

PMC - PMC4672311
PMID- 26632287
IS  - 0893-133X (Print)
IS  - 1740-634X (Electronic)
VI  - 40
IP  - Suppl 1
DP  - 2015 Dec
TI  - Poster Session II Tuesday, December 8, 2015.
PG  - S272-442
LA  - eng
PT  - Journal Article
DEP - 20151203
PHST- 2015/12/03 [aheadofprint]
TA  - Neuropsychopharmacology
JT  - Neuropsychopharmacology
AID - npp2015326 [pii]
AID - 10.1038/npp.2015.326 [doi]
SO  - Neuropsychopharmacology. 2015 Dec;40(Suppl 1):S272-442. Epub 2015 Dec 03
      doi:10.1038/npp.2015.326.

PMC - PMC4672310
PMID- 26632286
IS  - 0893-133X (Print)
IS  - 1740-634X (Electronic)
VI  - 40
IP  - Suppl 1
DP  - 2015 Dec
TI  - Poster Session I Monday, December 7, 2015.
PG  - S106-271
LA  - eng
PT  - Journal Article
DEP - 20151203
PHST- 2015/12/03 [aheadofprint]
TA  - Neuropsychopharmacology
JT  - Neuropsychopharmacology
AID - npp2015325 [pii]
AID - 10.1038/npp.2015.325 [doi]
SO  - Neuropsychopharmacology. 2015 Dec;40(Suppl 1):S106-271. Epub 2015 Dec 03
      doi:10.1038/npp.2015.325.

PMC - PMC4927905
PMID- 26599473
IS  - 0922-6028 (Print)
IS  - 1878-3627 (Electronic)
VI  - 34
IP  - 1
TI  - Other ways of seeing: From behavior to neural mechanisms in the online
      “visual” control of action with sensory substitution.
PG  - 29-44
AB  - Vision is the dominant sense for perception-for-action in humans and other higher
      primates. Advances in sight restoration now utilize the other intact senses to
      provide information that is normally sensed visually through sensory substitution
      to replace missing visual information. Sensory substitution devices translate
      visual information from a sensor, such as a camera or ultrasound device, into a
      format that the auditory or tactile systems can detect and process, so the
      visually impaired can see through hearing or touch. Online control of action is
      essential for many daily tasks such as pointing, grasping and navigating, and
      adapting to a sensory substitution device successfully requires extensive
      learning. Here we review the research on sensory substitution for vision
      restoration in the context of providing the means of online control for action in
      the blind or blindfolded. It appears that the use of sensory substitution devices
      utilizes the neural visual system; this suggests the hypothesis that sensory
      substitution draws on the same underlying mechanisms as unimpaired visual control
      of action. Here we review the current state of the art for sensory substitution
      approaches to object recognition, localization, and navigation, and the potential
      these approaches have for revealing a metamodal behavioral and neural basis for
      the online control of action.
FAU - Proulx, Michael J.
AU  - Proulx MJ
AD  - Crossmodal Cognition Lab, Department of Psychology, University of Bath, Bath, UK
FAU - Gwinnutt, James
AU  - Gwinnutt J
AD  - Crossmodal Cognition Lab, Department of Psychology, University of Bath, Bath, UK
FAU - Dell’Erba, Sara
AU  - Dell’Erba S
AD  - Crossmodal Cognition Lab, Department of Psychology, University of Bath, Bath, UK
FAU - Levy-Tzedek, Shelly
AU  - Levy-Tzedek S
AD  - Cognition, Aging and Rehabilitation Lab, Recanati School for Community Health
      Professions, Department of Physical Therapy & Zlotowski Center for Neuroscience, 
      Ben Gurion University of the Negev, Beer-Sheva, Israel
FAU - de Sousa, Alexandra A.
AU  - de Sousa AA
AD  - Crossmodal Cognition Lab, Department of Psychology, University of Bath, Bath, UK
FAU - Brown, David J.
AU  - Brown DJ
AD  - Crossmodal Cognition Lab, Department of Psychology, University of Bath, Bath, UK
LA  - eng
PT  - Journal Article
TA  - Restor Neurol Neurosci
JT  - Restorative Neurology and Neuroscience
AID - RNN150541 [pii]
AID - 10.3233/RNN-150541 [doi]
SO  - Restor Neurol Neurosci. ;34(1):29-44. doi:10.3233/RNN-150541.

PMC - PMC4669991
IS  - 2050-6406 (Print)
IS  - 2050-6414 (Electronic)
VI  - 3
IP  - 5 Suppl
DP  - 2015 Oct
DP  - 2015 Oct
TI  - UEG Week 2015 Poster Presentations.
PG  - 146-687
LA  - eng
PT  - Journal Article
TA  - United European Gastroenterol J
JT  - United European Gastroenterology Journal
AID - 10.1177/2050640615601623 [doi]
AID - 10.1177_2050640615601623 [pii]
SO  - United European Gastroenterol J. 2015 Oct;3(5 Suppl):146-687.
      doi:10.1177/2050640615601623.

PMC - PMC4506766
PMID- 26188929
IS  - 1743-0003 (Electronic)
VI  - 12
DP  - 2015
TI  - Haptic wearables as sensory replacement, sensory augmentation and trainer – a
      review.
LID - 59
AB  - Sensory impairments decrease quality of life and can slow or hinder
      rehabilitation. Small, computationally powerful electronics have enabled the
      recent development of wearable systems aimed to improve function for individuals 
      with sensory impairments. The purpose of this review is to synthesize current
      haptic wearable research for clinical applications involving sensory impairments.
      We define haptic wearables as untethered, ungrounded body worn devices that
      interact with skin directly or through clothing and can be used in natural
      environments outside a laboratory. Results of this review are categorized by
      degree of sensory impairment. Total impairment, such as in an amputee, blind, or 
      deaf individual, involves haptics acting as sensory replacement; partial
      impairment, as is common in rehabilitation, involves haptics as sensory
      augmentation; and no impairment involves haptics as trainer. This review found
      that wearable haptic devices improved function for a variety of clinical
      applications including: rehabilitation, prosthetics, vestibular loss,
      osteoarthritis, vision loss and hearing loss. Future haptic wearables development
      should focus on clinical needs, intuitive and multimodal haptic displays, low
      energy demands, and biomechanical compliance for long-term usage.
FAU - Shull, Peter B.
AU  - Shull PB
AD  - State Key Laboratory of Mechanical System and Vibration, School of Mechanical
      Engineering, Shanghai Jiao Tong University, Room 930, Mechanical Engineering Bld,
      800 Dong Chuan Road, Shanghai, 200240 China
FAU - Damian, Dana D.
AU  - Damian DD
AD  - Boston Children’s Hospital, Harvard University, 330 Longwood Avenue, Boston,
      Massachusetts 02115 USA
LA  - eng
PT  - Journal Article
DEP - 20150720
PHST- 2015/01/13 [received]
PHST- 2015/07/13 [accepted]
TA  - J Neuroeng Rehabil
JT  - Journal of NeuroEngineering and Rehabilitation
AID - 55 [pii]
AID - 10.1186/s12984-015-0055-z [doi]
SO  - J Neuroeng Rehabil. 2015 Jul 20;12:. doi:10.1186/s12984-015-0055-z.

PMC - PMC4405523
PMID- 25869016
IS  - 0884-8734 (Print)
IS  - 1525-1497 (Electronic)
VI  - 30
IP  - Suppl 2
DP  - 2015 Apr
TI  - Abstracts from the 38th Annual Meeting of the Society of General Internal
      Medicine.
PG  - 45-551
LA  - eng
PT  - Journal Article
DEP - 20150414
TA  - J Gen Intern Med
JT  - Journal of General Internal Medicine
AID - 3271 [pii]
AID - 10.1007/s11606-015-3271-0 [doi]
SO  - J Gen Intern Med. 2015 Apr;30(Suppl 2):45-551. Epub 2015 Apr 14
      doi:10.1007/s11606-015-3271-0.

PMC - PMC4364461
PMID- 26305006
IS  - 0586-7614 (Print)
IS  - 1745-1701 (Electronic)
VI  - 41
IP  - Suppl 1
DP  - 2015 Mar
TI  - Abstracts for the 15th International Congress on Schizophrenia Research (ICOSR).
PG  - S1-S341
LA  - eng
PT  - Journal Article
DEP - 20150316
PHST- 2015/03/16 [aheadofprint]
TA  - Schizophr Bull
JT  - Schizophrenia Bulletin
AID - 10.1093/schbul/sbv010 [doi]
SO  - Schizophr Bull. 2015 Mar;41(Suppl 1):S1-S341. Epub 2015 Mar 16
      doi:10.1093/schbul/sbv010.

PMC - PMC4261149
IS  - 0893-133X (Print)
IS  - 1740-634X (Electronic)
VI  - 39
IP  - Suppl 1
DP  - 2014 Dec
TI  - Poster Session III Wednesday, December 10, 2014.
PG  - S473-647
LA  - eng
PT  - Journal Article
DEP - 20141203
PHST- 2014/12/03 [aheadofprint]
TA  - Neuropsychopharmacology
JT  - Neuropsychopharmacology
AID - npp2014282 [pii]
AID - 10.1038/npp.2014.282 [doi]
SO  - Neuropsychopharmacology. 2014 Dec;39(Suppl 1):S473-647. Epub 2014 Dec 03
      doi:10.1038/npp.2014.282.

PMC - PMC4261148
IS  - 0893-133X (Print)
IS  - 1740-634X (Electronic)
VI  - 39
IP  - Suppl 1
DP  - 2014 Dec
TI  - Poster Session II Tuesday, December 09, 2014.
PG  - S291-472
LA  - eng
PT  - Journal Article
DEP - 20141203
PHST- 2014/12/03 [aheadofprint]
TA  - Neuropsychopharmacology
JT  - Neuropsychopharmacology
AID - npp2014281 [pii]
AID - 10.1038/npp.2014.281 [doi]
SO  - Neuropsychopharmacology. 2014 Dec;39(Suppl 1):S291-472. Epub 2014 Dec 03
      doi:10.1038/npp.2014.281.

PMC - PMC4202795
PMID- 25368587
IS  - 1664-1078 (Electronic)
VI  - 5
DP  - 2014
TI  - Tactile feedback improves auditory spatial localization.
LID - 1121
AB  - Our recent studies suggest that congenitally blind adults have severely impaired 
      thresholds in an auditory spatial bisection task, pointing to the importance of
      vision in constructing complex auditory spatial maps (Gori et al., 2014). To
      explore strategies that may improve the auditory spatial sense in visually
      impaired people, we investigated the impact of tactile feedback on spatial
      auditory localization in 48 blindfolded sighted subjects. We measured auditory
      spatial bisection thresholds before and after training, either with tactile
      feedback, verbal feedback, or no feedback. Audio thresholds were first measured
      with a spatial bisection task: subjects judged whether the second sound of a
      three sound sequence was spatially closer to the first or the third sound. The
      tactile feedback group underwent two audio-tactile feedback sessions of 100
      trials, where each auditory trial was followed by the same spatial sequence
      played on the subject’s forearm; auditory spatial bisection thresholds were
      evaluated after each session. In the verbal feedback condition, the positions of 
      the sounds were verbally reported to the subject after each feedback trial. The
      no feedback group did the same sequence of trials, with no feedback. Performance 
      improved significantly only after audio-tactile feedback. The results suggest
      that direct tactile feedback interacts with the auditory spatial localization
      system, possibly by a process of cross-sensory recalibration. Control tests with 
      the subject rotated suggested that this effect occurs only when the tactile and
      acoustic sequences are spatially congruent. Our results suggest that the tactile 
      system can be used to recalibrate the auditory sense of space. These results
      encourage the possibility of designing rehabilitation programs to help blind
      persons establish a robust auditory sense of space, through training with the
      tactile modality.
FAU - Gori, Monica
AU  - Gori M
AD  - Robotics Brain and Cognitive Sciences Department, Istituto Italiano di
      TecnologiaGenoa, Italy
FAU - Vercillo, Tiziana
AU  - Vercillo T
AD  - Robotics Brain and Cognitive Sciences Department, Istituto Italiano di
      TecnologiaGenoa, Italy
FAU - Sandini, Giulio
AU  - Sandini G
AD  - Robotics Brain and Cognitive Sciences Department, Istituto Italiano di
      TecnologiaGenoa, Italy
FAU - Burr, David
AU  - Burr D
AD  - Department of Neuroscience, Psychology, Pharmacology and Child Health, University
      of FlorenceFlorence, Italy
LA  - eng
PT  - Journal Article
DEP - 20141020
PHST- 2014/07/11 [received]
PHST- 2014/09/15 [accepted]
TA  - Front Psychol
JT  - Frontiers in Psychology
AID - 10.3389/fpsyg.2014.01121 [doi]
SO  - Front Psychol. 2014 Oct 20;5:. doi:10.3389/fpsyg.2014.01121.

PMC - PMC4212306
IS  - 2050-6406 (Print)
IS  - 2050-6414 (Electronic)
VI  - 2
IP  - 1 Suppl
DP  - 2014 Oct
DP  - 2014 Oct
TI  - UEG Week 2014 Poster Presentations.
PG  - A132-605
LA  - eng
PT  - Journal Article
TA  - United European Gastroenterol J
JT  - United European Gastroenterology Journal
AID - 10.1177/2050640614548980 [doi]
AID - 10.1177_2050640614548980 [pii]
SO  - United European Gastroenterol J. 2014 Oct;2(1 Suppl):A132-605.
      doi:10.1177/2050640614548980.

PMC - PMC4244175
PMID- 25205049
IS  - 1352-4585 (Print)
IS  - 1477-0970 (Electronic)
VI  - 20
IP  - 1 Suppl
DP  - 2014 Sep
DP  - 2014 Sep
TI  - ACTRIMS-ECTRIMS MSBoston 2014: Poster Sessions 2.
PG  - 285-496
LA  - eng
PT  - Journal Article
TA  - Mult Scler
JT  - Multiple Sclerosis (Houndmills, Basingstoke, England)
AID - 10.1177/1352458514547846 [doi]
AID - 10.1177_1352458514547846 [pii]
SO  - Mult Scler. 2014 Sep;20(1 Suppl):285-496. doi:10.1177/1352458514547846.

PMC - PMC4244172
PMID- 25205048
IS  - 1352-4585 (Print)
IS  - 1477-0970 (Electronic)
VI  - 20
IP  - 1 Suppl
DP  - 2014 Sep
DP  - 2014 Sep
TI  - 2014 Joint ACTRIMS-ECTRIMS Meeting (MSBoston 2014) MS Journal Online: Poster
      Session 1.
PG  - 67-284
LA  - eng
PT  - Journal Article
TA  - Mult Scler
JT  - Multiple Sclerosis (Houndmills, Basingstoke, England)
AID - 10.1177/1352458514546077 [doi]
AID - 10.1177_1352458514546077 [pii]
SO  - Mult Scler. 2014 Sep;20(1 Suppl):67-284. doi:10.1177/1352458514546077.

PMC - PMC5350815
IS  - 1752-8054 (Print)
IS  - 1752-8062 (Electronic)
VI  - 7
IP  - 3
DP  - 2014 Jun
TI  - ACTS Abstracts.
PG  - 202-76
LA  - eng
PT  - Journal Article
DEP - 20140610
TA  - Clin Transl Sci
JT  - Clinical and Translational Science
AID - 10.1111/cts.12171 [doi]
AID - CTS12171 [pii]
SO  - Clin Transl Sci. 2014 Jun;7(3):202-76. Epub 2014 Jun 10 doi:10.1111/cts.12171.

PMC - PMC4429500
PMID- 24737224
IS  - 0884-8734 (Print)
IS  - 1525-1497 (Electronic)
VI  - 29
IP  - Suppl 1
DP  - 2014 Apr
TI  - Abstracts from the 37th Annual Meeting of the Society of General Internal
      Medicine.
PG  - 1-545
LA  - eng
PT  - Journal Article
DEP - 20140416
TA  - J Gen Intern Med
JT  - Journal of General Internal Medicine
AID - 2834 [pii]
AID - 10.1007/s11606-014-2834-9 [doi]
SO  - J Gen Intern Med. 2014 Apr;29(Suppl 1):1-545. Epub 2014 Apr 16
      doi:10.1007/s11606-014-2834-9.

PMC - PMC4070603
IS  - 2050-6406 (Print)
IS  - 2050-6414 (Electronic)
VI  - 1
IP  - 1 Suppl
DP  - 2013 Oct
DP  - 2013 Oct
TI  - UEG Week 2013 Poster Presentations.
PG  - A135-587
LA  - eng
PT  - Journal Article
TA  - United European Gastroenterol J
JT  - United European Gastroenterology Journal
AID - 10.1177/2050640613502900 [doi]
AID - 10.1177_2050640613502900 [pii]
SO  - United European Gastroenterol J. 2013 Oct;1(1 Suppl):A135-587.
      doi:10.1177/2050640613502900.

PMC - PMC3654146
PMID- 23625304
IS  - 0884-8734 (Print)
IS  - 1525-1497 (Electronic)
VI  - 28
IP  - Suppl 1
DP  - 2013 Jun
TI  - Abstracts from the 36th Annual Meeting of the Society of General Internal
      Medicine.
PG  - 1-489
LA  - eng
PT  - Journal Article
PT  - News
DEP - 20130428
TA  - J Gen Intern Med
JT  - Journal of General Internal Medicine
AID - 2436 [pii]
AID - 10.1007/s11606-013-2436-y [doi]
SO  - J Gen Intern Med. 2013 Jun;28(Suppl 1):1-489. Epub 2013 Apr 28
      doi:10.1007/s11606-013-2436-y.

PMC - PMC3864668
PMID- 24353744
IS  - 1754-9450 (Print)
IS  - 2042-8723 (Electronic)
VI  - 6
IP  - 1
DP  - 2012
TI  - A Virtual Environment for People Who Are Blind – A Usability Study.
LID - 10.1108/17549451211214346
AB  - For most people who are blind, exploring an unknown environment can be
      unpleasant, uncomfortable, and unsafe. Over the past years, the use of virtual
      reality as a learning and rehabilitation tool for people with disabilities has
      been on the rise. This research is based on the hypothesis that the supply of
      appropriate perceptual and conceptual information through compensatory sensorial 
      channels may assist people who are blind with anticipatory exploration. In this
      research we developed and tested the BlindAid system, which allows the user to
      explore a virtual environment. The two main goals of the research were: (a)
      evaluation of different modalities (haptic and audio) and navigation tools, and
      (b) evaluation of spatial cognitive mapping employed by people who are blind. Our
      research included four participants who are totally blind. The preliminary
      findings confirm that the system enabled participants to develop comprehensive
      cognitive maps by exploring the virtual environment.
FAU - Lahav, O.
AU  - Lahav O
AD  - Laboratory for Human and Machine Haptics (The Touch Lab), Research Laboratory of 
      Electronics, Massachusetts Institute of Technology, Cambridge, MA, USA
FAU - Schloerb, D. W.
AU  - Schloerb DW
AD  - Laboratory for Human and Machine Haptics (The Touch Lab), Research Laboratory of 
      Electronics, Massachusetts Institute of Technology, Cambridge, MA, USA
FAU - Kumar, S.
AU  - Kumar S
AD  - Laboratory for Human and Machine Haptics (The Touch Lab), Research Laboratory of 
      Electronics, Massachusetts Institute of Technology, Cambridge, MA, USA
FAU - Srinivasan, M. A.
AU  - Srinivasan MA
AD  - Laboratory for Human and Machine Haptics (The Touch Lab), Research Laboratory of 
      Electronics, Massachusetts Institute of Technology, Cambridge, MA, USA
LA  - eng
PT  - Journal Article
GR  - R21 EY016601 || EY
TA  - J Assist Technol
JT  - Journal of assistive technologies
AID - 10.1108/17549451211214346 [doi]
MID - NIHMS529941
SO  - J Assist Technol. 2012;6(1):. doi:10.1108/17549451211214346.

PMC - PMC3044641
PMID- 21355132
IS  - 0586-7614 (Print)
IS  - 1745-1701 (Electronic)
VI  - 37
IP  - Suppl 1
DP  - 2011 Mar
TI  - Abstracts for the 13th International Congress on Schizophrenia Research (ICOSR).
PG  - 1-327
LA  - eng
PT  - Journal Article
TA  - Schizophr Bull
JT  - Schizophrenia Bulletin
AID - 10.1093/schbul/sbq173 [doi]
SO  - Schizophr Bull. 2011 Mar;37(Suppl 1):1-327. doi:10.1093/schbul/sbq173.

PMC - PMC5522881
IS  - 1662-5218 (Electronic)
VI  - 11
DP  - 2017
TI  - Hybrid Brain–Computer Interface Techniques for Improved Classification Accuracy
      and Increased Number of Commands: A Review.
LID - 35
AB  - In this article, non-invasive hybrid brain–computer interface (hBCI) technologies
      for improving classification accuracy and increasing the number of commands are
      reviewed. Hybridization combining more than two modalities is a new trend in
      brain imaging and prosthesis control. Electroencephalography (EEG), due to its
      easy use and fast temporal resolution, is most widely utilized in combination
      with other brain/non-brain signal acquisition modalities, for instance,
      functional near infrared spectroscopy (fNIRS), electromyography (EMG),
      electrooculography (EOG), and eye tracker. Three main purposes of hybridization
      are to increase the number of control commands, improve classification accuracy
      and reduce the signal detection time. Currently, such combinations of EEG + fNIRS
      and EEG + EOG are most commonly employed. Four principal components (i.e.,
      hardware, paradigm, classifiers, and features) relevant to accuracy improvement
      are discussed. In the case of brain signals, motor imagination/movement tasks are
      combined with cognitive tasks to increase active brain–computer interface (BCI)
      accuracy. Active and reactive tasks sometimes are combined: motor imagination
      with steady-state evoked visual potentials (SSVEP) and motor imagination with
      P300. In the case of reactive tasks, SSVEP is most widely combined with P300 to
      increase the number of commands. Passive BCIs, however, are rare. After
      discussing the hardware and strategies involved in the development of hBCI, the
      second part examines the approaches used to increase the number of control
      commands and to enhance classification accuracy. The future prospects and the
      extension of hBCI in real-time applications for daily life scenarios are
      provided.
FAU - Hong, Keum-Shik
AU  - Hong KS
AD  - School of Mechanical Engineering, Pusan National University, Busan, South Korea
FAU - Khan, Muhammad Jawad
AU  - Khan MJ
AD  - School of Mechanical Engineering, Pusan National University, Busan, South Korea
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170724
GR  - NRF-2014 -R1A2A1A10049727
PHST- 2017/04/24 [received]
PHST- 2017/07/03 [accepted]
TA  - Front Neurorobot
JT  - Frontiers in Neurorobotics
AID - 10.3389/fnbot.2017.00035 [doi]
SO  - Front Neurorobot. 2017 Jul 24;11:. doi:10.3389/fnbot.2017.00035.

PMC - PMC5498867
IS  - 1472-6882 (Electronic)
VI  - 17
IP  - Suppl 1
DP  - 2017
TI  - World Congress Integrative Medicine & Health 2017: part two: Berlin, Germany. 3–5
      May 2017.
LID - 317
FAU - Ee, Carolyn
AU  - Ee C
AD  - 0000 0004 1936 834Xgrid.1013.3National Institute of Complementary Medicine,
      Western Sydney University, Sydney, Australia
FAU - Thuraisingam, Sharmala
AU  - Thuraisingam S
AD  - 0000 0001 2179 088Xgrid.1008.9Department of General Practice, University of
      Melbourne, Melbourne, Australia
FAU - Pirotta, Marie
AU  - Pirotta M
AD  - 0000 0001 2179 088Xgrid.1008.9Department of General Practice, University of
      Melbourne, Melbourne, Australia
FAU - French, Simon
AU  - French S
AD  - 0000 0004 1936 8331grid.410356.5School of Rehabilitation Therapy, Queens
      University, Ontario, Canada
FAU - Xue, Charlie
AU  - Xue C
AD  - 0000 0001 2163 3550grid.1017.7School of Health and Biomedical Sciences, RMIT
      University, Melbourne, Australia
FAU - Teede, Helena
AU  - Teede H
AD  - 0000 0004 1936 7857grid.1002.3School of Public Health and Preventive Medicine,
      Monash University, Melbourne, Australia
FAU - Kristoffersen, Agnete E.
AU  - Kristoffersen AE
AD  - 0000000122595234grid.10919.30NAFKAM, UiT, The Arctic University of Norway,
      Tromsø, 9019 Norway
FAU - Sirois, Fuschia
AU  - Sirois F
AD  - 0000 0004 1936 9262grid.11835.3eDepartment of Psychology, University of
      Sheffield, Sheffield, S1 1HD UK
FAU - Stub, Trine
AU  - Stub T
AD  - 0000000122595234grid.10919.30Department of Community Medicine, UiT The Arctic
      University of Norway, Tromsø, 9019 Norway
FAU - Engler, Jennifer
AU  - Engler J
AD  - 0000 0004 1936 9721grid.7839.5Institue of General Practice, Goethe University
      Frankfurt, Frankfurt, 60590 Germany
FAU - Joos, Stefanie
AU  - Joos S
AD  - 0000 0001 2190 1447grid.10392.39Department of General Practice, University of
      Tübingen, Tübingen, Germany
FAU - Güthlin, Corina
AU  - Güthlin C
AD  - 0000 0004 1936 9721grid.7839.5Institue of General Practice, Goethe University
      Frankfurt, Frankfurt, 60590 Germany
FAU - Felenda, Jennifer
AU  - Felenda J
AD  - Med.-pharm. Information/Klinische Forschung, WALA Heilmittel GmbH, Bad Boll/
      Eckwälden, 73087 Germany
FAU - Beckmann, Christiane
AU  - Beckmann C
AD  - Med.-pharm. Information/Klinische Forschung, WALA Heilmittel GmbH, Bad Boll/
      Eckwälden, 73087 Germany
FAU - Stintzing, Florian
AU  - Stintzing F
AD  - Ressortleitung Wissenschaft, WALA Heilmittel GmbH, Bad Boll/Eckwälden, 73087
      Germany
FAU - Evans, Roni
AU  - Evans R
AD  - 0000000419368657grid.17635.36University of Minnnesota, Minneapolis, 55455 MN USA
FAU - Bronfort, Gert
AU  - Bronfort G
AD  - 0000000419368657grid.17635.36University of Minnnesota, Minneapolis, 55455 MN USA
FAU - Keefe, Daniel
AU  - Keefe D
AD  - 0000000419368657grid.17635.36University of Minnnesota, Minneapolis, 55455 MN USA
FAU - Taberko, Anna
AU  - Taberko A
AD  - grid.454628.9Minneapolis College of Art and Design, Minneapolis, MN USA
FAU - Hanson, Linda
AU  - Hanson L
AD  - 0000000419368657grid.17635.36University of Minnnesota, Minneapolis, 55455 MN USA
FAU - Haley, Alex
AU  - Haley A
AD  - 0000000419368657grid.17635.36University of Minnnesota, Minneapolis, 55455 MN USA
FAU - Ma, Haiwei
AU  - Ma H
AD  - 0000000419368657grid.17635.36University of Minnnesota, Minneapolis, 55455 MN USA
FAU - Jolton, Joseph
AU  - Jolton J
AD  - grid.454628.9Minneapolis College of Art and Design, Minneapolis, MN USA
FAU - Yarosh, Lana
AU  - Yarosh L
AD  - 0000000419368657grid.17635.36University of Minnnesota, Minneapolis, 55455 MN USA
FAU - Keefe, Francis
AU  - Keefe F
AD  - 0000000419368657grid.17635.36University of Minnnesota, Minneapolis, 55455 MN USA
FAU - Nam, Jung
AU  - Nam J
AD  - 0000000419368657grid.17635.36University of Minnnesota, Minneapolis, 55455 MN USA
FAU - Evans, Roni
AU  - Evans R
AD  - 0000000419368657grid.17635.36University of Minnesota, Minneapolis, 55455 MN USA
FAU - Ojala, Liwanag
AU  - Ojala L
AD  - Caring Bridge, Minneapolis, MN USA
FAU - Kreitzer, Mary J.
AU  - Kreitzer MJ
AD  - 0000000419368657grid.17635.36University of Minnesota, Minneapolis, 55455 MN USA
FAU - Hanson, Linda
AU  - Hanson L
AD  - 0000000419368657grid.17635.36University of Minnesota, Minneapolis, 55455 MN USA
FAU - Fink, Careen
AU  - Fink C
AD  - Phytomedicines Supply and Development Center, Innovation & Development, Bayer
      Consumer Health Steigerwald Arzneimittelwerk GmbH, Darmstadt, 68526 Germany
FAU - Kraft, Karin
AU  - Kraft K
AD  - 0000000121858338grid.10493.3fUniversity Medicine of Rostock, Rostock, 18055
      Germany
FAU - Flower, Andrew
AU  - Flower A
AD  - 0000 0004 1936 9297grid.5491.9Primary Care and Population Sciences, University of
      Southampton, Southampton, UK
FAU - Lewith, George
AU  - Lewith G
AD  - 0000 0004 1936 9297grid.5491.9Primary Care and Population Sciences, University of
      Southampton, Southampton, UK
FAU - Harman, Kim
AU  - Harman K
AD  - 0000 0004 1936 9297grid.5491.9Primary Care and Population Sciences, University of
      Southampton, Southampton, UK
FAU - Stuart, Beth
AU  - Stuart B
AD  - 0000 0004 1936 9297grid.5491.9Primary Care and Population Sciences, University of
      Southampton, Southampton, UK
FAU - Bishop, Felicity L.
AU  - Bishop FL
AD  - 0000 0004 1936 9297grid.5491.9Psychology, University of Southampton, Southampton,
      UK
FAU - Frawley, Jane
AU  - Frawley J
AD  - 0000 0004 1936 7611grid.117476.2Faculty of Health, University of Technology
      Sydney, Sydney, 2007 Australia
FAU - Füleki, Lilla
AU  - Füleki L
AD  - 0000 0001 0942 9821grid.11804.3c1st Department of Pathology and Experimental
      Cancer Research, Semmelweis University, Budapest, 1085 Hungary
FAU - Kiss, Eva
AU  - Kiss E
AD  - 0000 0001 0942 9821grid.11804.3c1st Department of Pathology and Experimental
      Cancer Research, Semmelweis University, Budapest, 1085 Hungary
FAU - Vancsik, Tamas
AU  - Vancsik T
AD  - 0000 0001 0942 9821grid.11804.3c1st Department of Pathology and Experimental
      Cancer Research, Semmelweis University, Budapest, 1085 Hungary
FAU - Krenacs, Tibor
AU  - Krenacs T
AD  - 0000 0001 0942 9821grid.11804.3c1st Department of Pathology and Experimental
      Cancer Research, Semmelweis University, Budapest, 1085 Hungary
FAU - Funabashi, Martha
AU  - Funabashi M
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Pohlman, Katherine A.
AU  - Pohlman KA
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Mior, Silvano
AU  - Mior S
AD  - 0000 0004 0473 5995grid.418591.0Canadian Memorial Chiropractic College, Toronto, 
      Canada
FAU - Thiel, Haymo
AU  - Thiel H
AD  - 0000 0004 0489 9631grid.417783.eAnglo-European College of Chiropractic,
      Bournemouth, UK
FAU - Hill, Michael D.
AU  - Hill MD
AD  - 0000 0004 1936 7697grid.22072.35University of Calgary, Calgary, Canada
FAU - Cassidy, David J.
AU  - Cassidy DJ
AD  - 0000 0001 2157 2938grid.17063.33University of Toronto, Toronto, Canada
FAU - Westaway, Michael
AU  - Westaway M
AD  - 0000 0004 1936 7697grid.22072.35University of Calgary, Calgary, Canada
FAU - Yager, Jerome
AU  - Yager J
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Hurwitz, Eric
AU  - Hurwitz E
AD  - 0000 0001 2188 0957grid.410445.0University of Hawaii at Manoa, Honolulu, Hawai’I 
      USA
FAU - Kawchuk, Gregory N.
AU  - Kawchuk GN
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - O’Beirne, Maeve
AU  - O’Beirne M
AD  - 0000 0004 1936 7697grid.22072.35University of Calgary, Calgary, Canada
FAU - Vohra, Sunita
AU  - Vohra S
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Gaboury, Isabelle
AU  - Gaboury I
AD  - 0000 0000 9064 6198grid.86715.3dFamily Medicine, Universite de Sherbrooke,
      Sherbrooke, J1H 5N4 Canada
FAU - Morin, Chantal
AU  - Morin C
AD  - 0000 0000 9064 6198grid.86715.3dFamily Medicine, Universite de Sherbrooke,
      Sherbrooke, J1H 5N4 Canada
FAU - Gaertner, Katharina
AU  - Gaertner K
AD  - 0000 0001 0726 5157grid.5734.5Institute for Complementary Medicine, University of
      Bern, Bern, 3008 Switzerland
FAU - Torchetti, Loredana
AU  - Torchetti L
AD  - 0000 0001 0726 5157grid.5734.5Institute for Complementary Medicine, University of
      Bern, Bern, 3008 Switzerland
FAU - Frei-Erb, Martin
AU  - Frei-Erb M
AD  - 0000 0001 0726 5157grid.5734.5Institute for Complementary Medicine, University of
      Bern, Bern, 3008 Switzerland
FAU - Kundi, Michael
AU  - Kundi M
AD  - 0000 0000 9259 8492grid.22937.3dInstitute of Environmental Health, Medical
      University of Vienna, Vienna, 1090 Austria
FAU - Frass, Michael
AU  - Frass M
AD  - 0000 0000 9259 8492grid.22937.3dDepartment of Medicine I, Clinical Division of
      Oncology, Medical University of Vienna, Vienna, 1090 Austria
FAU - Gallo, Eugenia
AU  - Gallo E
AD  - 0000 0004 1757 2304grid.8404.8Department of Experimental and Clinical Medicine,
      University of Florence, Florence, Italy
FAU - Maggini, Valentina
AU  - Maggini V
AD  - 0000 0004 1757 2304grid.8404.8Department of Experimental and Clinical Medicine,
      University of Florence, Florence, Italy
FAU - Comite, Mattia
AU  - Comite M
AD  - 0000 0004 1759 9494grid.24704.35Center for Integrative Medicine, Careggi
      Universtary Hospital, Florence, Italy
FAU - Sofi, Francesco
AU  - Sofi F
AD  - 0000 0004 1757 2304grid.8404.8Department of Experimental and Clinical Medicine,
      University of Florence, Florence, Italy
FAU - Baccetti, Sonia
AU  - Baccetti S
AD  - Tuscan Network of Integrative Medicine, Region of Tuscany, Florence, Italy
FAU - Vannacci, Alfredo
AU  - Vannacci A
AD  - 0000 0004 1757 2304grid.8404.8Department of Experimental and Clinical Medicine,
      University of Florence, Florence, Italy
FAU - Di Stefano, Mariella
AU  - Di Stefano M
AD  - Tuscan Network of Integrative Medicine, Region of Tuscany, Florence, Italy
FAU - Monechi, Maria V.
AU  - Monechi MV
AD  - Tuscan Network of Integrative Medicine, Region of Tuscany, Florence, Italy
FAU - Gori, Luigi
AU  - Gori L
AD  - 0000 0004 1759 9494grid.24704.35Center for Integrative Medicine, Careggi
      Universtary Hospital, Florence, Italy
FAU - Rossi, Elio
AU  - Rossi E
AD  - Tuscan Network of Integrative Medicine, Region of Tuscany, Florence, Italy
FAU - Firenzuoli, Fabio
AU  - Firenzuoli F
AD  - 0000 0004 1759 9494grid.24704.35Center for Integrative Medicine, Careggi
      Universtary Hospital, Florence, Italy
FAU - Mediati, Rocco D.
AU  - Mediati RD
AD  - 0000 0004 1759 9494grid.24704.35Cure Palliative e Terapia Del Dolore, Careggi
      Universitary Hospital, Florence, Italy
FAU - Ballerini, Giovanna
AU  - Ballerini G
AD  - 0000 0004 1759 9494grid.24704.35Cure Palliative e Terapia Del Dolore, Careggi
      Universitary Hospital, Florence, Italy
FAU - Gardiner, Paula
AU  - Gardiner P
AD  - 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical
      Center, Boston, 02118 MA USA
FAU - Lestoquoy, Anna S.
AU  - Lestoquoy AS
AD  - 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical
      Center, Boston, 02118 MA USA
FAU - Negash, Lily
AU  - Negash L
AD  - 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical
      Center, Boston, 02118 MA USA
FAU - Stillman, Sarah
AU  - Stillman S
AD  - 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical
      Center, Boston, 02118 MA USA
FAU - Shah, Prachi
AU  - Shah P
AD  - 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical
      Center, Boston, 02118 MA USA
FAU - Liebschutz, Jane
AU  - Liebschutz J
AD  - 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical
      Center, Boston, 02118 MA USA
FAU - Adelstein, Pamela
AU  - Adelstein P
AD  - grid.475621.3Codman Square Health Center, Dorchester, MA USA
FAU - Farrell-Riley, Christine
AU  - Farrell-Riley C
AD  - grid.475621.3Codman Square Health Center, Dorchester, MA USA
FAU - Brackup, Ivy
AU  - Brackup I
AD  - grid.475621.3Dothouse Health Center, Dorchester, MA USA
FAU - Penti, Brian
AU  - Penti B
AD  - 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical
      Center, Boston, 02118 MA USA
FAU - Saper, Robert
AU  - Saper R
AD  - 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical
      Center, Boston, 02118 MA USA
FAU - Sampedro, Isabel Giralt
AU  - Sampedro IG
AD  - ENERGIMED, Barcelona, 08007 Spain
FAU - Carvajal, Gilda
AU  - Carvajal G
AD  - ENERGIMED, Barcelona, 08007 Spain
FAU - Gleiss, Andreas
AU  - Gleiss A
AD  - 0000 0000 9259 8492grid.22937.3dCenter for Medical Statistics, Informatics, and
      Intelligent Systems, Medical University of Vienna, Vienna, 1090 Austria
FAU - Gross, Marie M.
AU  - Gross MM
AD  - 0000 0001 2218 4662grid.6363.0AG für Integrative Medizin in der Pädiatrischen
      Onkologie, Charité Universitätsmedizin, Berlin, 13353 Germany
FAU - Brendlin, Dorothea
AU  - Brendlin D
AD  - 0000 0001 2218 4662grid.6363.0AG für Integrative Medizin in der Pädiatrischen
      Onkologie, Charité Universitätsmedizin, Berlin, 13353 Germany
FAU - Röttger, Jonas
AU  - Röttger J
AD  - 0000 0001 2218 4662grid.6363.0AG für Integrative Medizin in der Pädiatrischen
      Onkologie, Charité Universitätsmedizin, Berlin, 13353 Germany
FAU - Stritter, Wiebke
AU  - Stritter W
AD  - 0000 0001 2218 4662grid.6363.0AG für Integrative Medizin in der Pädiatrischen
      Onkologie, Charité Universitätsmedizin, Berlin, 13353 Germany
FAU - Seifert, Georg
AU  - Seifert G
AD  - 0000 0001 2218 4662grid.6363.0AG für Integrative Medizin in der Pädiatrischen
      Onkologie, Charité Universitätsmedizin, Berlin, 13353 Germany
FAU - Grzanna, Noelle
AU  - Grzanna N
AD  - 0000 0004 0593 1824grid.440934.eComplementary Medicine, Hochschule Fresenius,
      München, 80798 Germany
FAU - Stange, Rainer
AU  - Stange R
AD  - 0000 0004 0415 8446grid.473656.5Naturheilkunde, Immanuel-Krankenhaus, Berlin,
      14109 Germany
FAU - Guendling, Peter W.
AU  - Guendling PW
AD  - 0000 0004 0593 1824grid.440934.eComplementary Medicine, Hochschule Fresenius,
      München, 80798 Germany
FAU - Gu, Wen
AU  - Gu W
AD  - grid.459365.8Beijing Hospital of Traditional Chinese Medicine, Rheumatism,
      Beijing, China
FAU - Lu, Yan
AU  - Lu Y
AD  - grid.464481.bEmergency Department, Xiyuan Hospital, Beijing, China
FAU - Wang, Jie
AU  - Wang J
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Rheumatism, Beijing, China
FAU - Zhang, Chengcheng
AU  - Zhang C
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Nephrology, Beijing, China
FAU - Bai, Hua
AU  - Bai H
AD  - Rehabilitation Department, Xiluoyuan Community Health Service Centre, Beijing,
      China
FAU - He, Yuxi
AU  - He Y
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Rheumatism, Beijing, China
FAU - Zhang, Xiaoxu
AU  - Zhang X
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Rheumatism, Beijing, China
FAU - Zhang, Zhengju
AU  - Zhang Z
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Rheumatism, Beijing, China
FAU - Wang, Dali
AU  - Wang D
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Rheumatism, Beijing, China
FAU - Meng, Fengxian
AU  - Meng F
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Rheumatism, Beijing, China
FAU - Hagel, Alexander
AU  - Hagel A
AD  - 0000 0001 2107 3311grid.5330.5University of Erlangen, Erlangen, 91054 Germany
FAU - Albrecht, Heinz
AU  - Albrecht H
AD  - 0000 0001 2107 3311grid.5330.5University of Erlangen, Erlangen, 91054 Germany
FAU - Vollbracht, Claudia
AU  - Vollbracht C
AD  - Pascoe Naturmedizin, Gießen, 35394 Germany
FAU - Dauth, Wolfgang
AU  - Dauth W
AD  - Institute of Employment Research, Nuremberg, Germany
FAU - Hagel, Wolfgang
AU  - Hagel W
AD  - 0000 0004 0380 0396grid.416464.5Martha Maria, Nuremberg, Germany
FAU - Vitali, Francesco
AU  - Vitali F
AD  - 0000 0001 2107 3311grid.5330.5University of Erlangen, Erlangen, 91054 Germany
FAU - Ganzleben, Ingo
AU  - Ganzleben I
AD  - 0000 0001 2107 3311grid.5330.5University of Erlangen, Erlangen, 91054 Germany
FAU - Schultis, Hans
AU  - Schultis H
AD  - 0000 0004 0572 0285grid.461810.aSynlab, Weiden, Germany
FAU - Konturek, Peter
AU  - Konturek P
AD  - Thuringia Clinic, Saalfeld, Germany
FAU - Stein, Jürgen
AU  - Stein J
AD  - Department of Nutritional Medicine, Sachsenhausen, Germany
FAU - Neurath, Markus
AU  - Neurath M
AD  - 0000 0001 2107 3311grid.5330.5University of Erlangen, Erlangen, 91054 Germany
FAU - Raithel, Martin
AU  - Raithel M
AD  - 0000 0001 2107 3311grid.5330.5University of Erlangen, Erlangen, 91054 Germany
FAU - Hagel, Alexander
AU  - Hagel A
AD  - 0000 0001 2107 3311grid.5330.5University of Erlangen, Erlangen, 91054 Germany
FAU - Vollbracht, Claudia
AU  - Vollbracht C
AD  - Pascoe Naturmedizin, Gießen, 35394 Germany
FAU - Raithel, Martin
AU  - Raithel M
AD  - 0000 0001 2107 3311grid.5330.5University of Erlangen, Erlangen, 91054 Germany
FAU - Konturek, Peter
AU  - Konturek P
AD  - Thuringia Clinic, Saalfeld, Germany
FAU - Krick, Bianka
AU  - Krick B
AD  - Pascoe Naturmedizin, Gießen, 35394 Germany
FAU - Haller, Heidemarie
AU  - Haller H
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany
FAU - Klose, Petra
AU  - Klose P
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany
FAU - Dobos, Gustav
AU  - Dobos G
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany
FAU - Kümmel, Sherko
AU  - Kümmel S
AD  - 0000 0001 0006 4176grid.461714.1Breast Unit, Kliniken Essen-Mitte, Essen, Germany
FAU - Cramer, Holger
AU  - Cramer H
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany
FAU - Haller, Heidemarie
AU  - Haller H
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany
FAU - Saha, Felix J.
AU  - Saha FJ
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany
FAU - Kowoll, Anna
AU  - Kowoll A
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany
FAU - Ebner, Barbara
AU  - Ebner B
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany
FAU - Berger, Bettina
AU  - Berger B
AD  - 0000 0000 9024 6397grid.412581.bDepartment of Health, Institute for Integrative
      Medicine, Witten/Herdecke University, Herdecke, Germany
FAU - Dobos, Gustav
AU  - Dobos G
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany
FAU - Choi, Kyung-Eun
AU  - Choi KE
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany
FAU - He, Lisha
AU  - He L
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - Wang, Han
AU  - Wang H
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - He, X.
AU  - He X
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - Gu, C.
AU  - Gu C
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - Zhang, Y.
AU  - Zhang Y
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - Zhao, Linhua
AU  - Zhao L
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - Tong, Xiaolin
AU  - Tong X
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - He, Lisha
AU  - He L
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - Wang, Han
AU  - Wang H
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - He, Xinhui
AU  - He X
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - Gu, Chengjuan
AU  - Gu C
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - Zhang, Ying
AU  - Zhang Y
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - Zhao, Linhua
AU  - Zhao L
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - Tong, Xiaolin
AU  - Tong X
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - He, Lisha
AU  - He L
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - Wang, Han
AU  - Wang H
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - He, Xinhui
AU  - He X
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - Gu, Chengjuan
AU  - Gu C
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - Zhang, Ying
AU  - Zhang Y
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - Zhao, Linhua
AU  - Zhao L
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - Tong, Xiaolin
AU  - Tong X
AD  - grid.464297.aGuang’anmen Hospital, China Acadamy of Chinese Medicine Sciences,
      Beijing, China
FAU - Ho, Robin S. T.
AU  - Ho RST
AD  - 0000 0004 1937 0482grid.10784.3aJockey Club School of Public Health and Primary
      Care, The Chinese University of Hong Kong, Hong Kong, 852 Hong Kong
FAU - Chung, Vincent C. H.
AU  - Chung VCH
AD  - 0000 0004 1937 0482grid.10784.3aJockey Club School of Public Health and Primary
      Care, The Chinese University of Hong Kong, Hong Kong, 852 Hong Kong
FAU - Wu, Xinyin
AU  - Wu X
AD  - 0000 0004 1937 0482grid.10784.3aHong Kong Institute of Integrative Medicine, The 
      Chinese University of Hong Kong, Hong Kong, 852 Hong Kong
FAU - Wong, Charlene H. L.
AU  - Wong CHL
AD  - 0000 0004 1937 0482grid.10784.3aHong Kong Institute of Integrative Medicine, The 
      Chinese University of Hong Kong, Hong Kong, 852 Hong Kong
FAU - Wu, Justin C. Y.
AU  - Wu JCY
AD  - 0000 0004 1937 0482grid.10784.3aHong Kong Institute of Integrative Medicine, The 
      Chinese University of Hong Kong, Hong Kong, 852 Hong Kong
FAU - Wong, Samuel Y. S.
AU  - Wong SYS
AD  - 0000 0004 1937 0482grid.10784.3aJockey Club School of Public Health and Primary
      Care, The Chinese University of Hong Kong, Hong Kong, 852 Hong Kong
FAU - Lau, Alexander Y. L.
AU  - Lau AYL
AD  - 0000 0004 1937 0482grid.10784.3aHong Kong Institute of Integrative Medicine, The 
      Chinese University of Hong Kong, Hong Kong, 852 Hong Kong
FAU - Sit, Regina W. S.
AU  - Sit RWS
AD  - 0000 0004 1937 0482grid.10784.3aJockey Club School of Public Health and Primary
      Care, The Chinese University of Hong Kong, Hong Kong, 852 Hong Kong
FAU - Wong, Wendy
AU  - Wong W
AD  - 0000 0004 1937 0482grid.10784.3aHong Kong Institute of Integrative Medicine, The 
      Chinese University of Hong Kong, Hong Kong, 852 Hong Kong
FAU - Holmes, Michelle
AU  - Holmes M
AD  - 0000 0004 1936 9297grid.5491.9Psychology, University of Southampton, Southampton,
      SO17 1BJ UK
FAU - Bishop, Felicity
AU  - Bishop F
AD  - 0000 0004 1936 9297grid.5491.9Psychology, University of Southampton, Southampton,
      SO17 1BJ UK
FAU - Calman, Lynn
AU  - Calman L
AD  - 0000 0004 1936 9297grid.5491.9Faculty of Health Sciences, University of
      Southampton, Southampton, SO17 1BJ UK
FAU - Holmes, Michelle
AU  - Holmes M
AD  - 0000 0004 1936 9297grid.5491.9Psychology, University of Southampton, Southampton,
      SO17 1BJ UK
FAU - Bishop, Felicity
AU  - Bishop F
AD  - 0000 0004 1936 9297grid.5491.9Psychology, University of Southampton, Southampton,
      SO17 1BJ UK
FAU - Lewith, George
AU  - Lewith G
AD  - 0000 0004 1936 9297grid.5491.9Primary Medical Care, University of Southampton,
      Southampton, SO16 5ST UK
FAU - Newell, Dave
AU  - Newell D
AD  - 0000 0004 0489 9631grid.417783.eAnglo-European College of Chiropractic,
      Bournemouth, BH5 2DF UK
FAU - Field, Jonathan
AU  - Field J
AD  - Back2Health, Southsea, PO4 0DW UK
FAU - Htut, Win L.
AU  - Htut WL
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, 133-791 South Korea
FAU - Han, Dongwoon
AU  - Han D
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, 133-791 South Korea
FAU - Choi, Da I.
AU  - Choi DI
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, 133-791 South Korea
FAU - Choi, Soo J.
AU  - Choi SJ
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, 133-791 South Korea
FAU - Kim, Ha Y.
AU  - Kim HY
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, 133-791 South Korea
FAU - Hwang, Jung H.
AU  - Hwang JH
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, 133-791 South Korea
FAU - Huang, Ching W.
AU  - Huang CW
AD  - 0000 0001 2171 7818grid.289247.2Department of Preventive Medicine, College of
      Korean Medicine, Kyung Hee University, Seoul, 02447 South Korea
FAU - Jang, Bo H.
AU  - Jang BH
AD  - 0000 0001 2171 7818grid.289247.2Department of Preventive Medicine, College of
      Korean Medicine, Kyung Hee University, Seoul, 02447 South Korea
FAU - Chen, Fang P.
AU  - Chen FP
AD  - 0000 0004 0604 5314grid.278247.cTaipei Veterans General Hospital, Taipei, Taiwan
FAU - Ko, Seong G.
AU  - Ko SG
AD  - 0000 0001 2171 7818grid.289247.2Department of Preventive Medicine, College of
      Korean Medicine, Kyung Hee University, Seoul, 02447 South Korea
FAU - Huang, Wenjing
AU  - Huang W
AD  - grid.464297.aDepartment of Endocrinology, Guang’anmen Hospital China Academy of
      Chinese Medical Sciences, Beijing, 100053 China
FAU - Jin, De
AU  - Jin D
AD  - grid.464297.aDepartment of Endocrinology, Guang’anmen Hospital China Academy of
      Chinese Medical Sciences, Beijing, 100053 China
FAU - Lian, Fengmei
AU  - Lian F
AD  - grid.464297.aDepartment of Endocrinology, Guang’anmen Hospital China Academy of
      Chinese Medical Sciences, Beijing, 100053 China
FAU - Jang, Soobin
AU  - Jang S
AD  - 0000 0001 2171 7818grid.289247.2Kyung Hee University, Seoul, 02447 South Korea
FAU - Kim, Kyeong H.
AU  - Kim KH
AD  - 0000 0001 2171 7818grid.289247.2Kyung Hee University, Seoul, 02447 South Korea
FAU - Lee, Eun K.
AU  - Lee EK
AD  - 0000 0001 2171 7818grid.289247.2Kyung Hee University, Seoul, 02447 South Korea
FAU - Sun, Seung H.
AU  - Sun SH
AD  - 0000 0004 0533 2258grid.412417.5Sangji University Korean Medicine Hospital,
      Wonju, South Korea
FAU - Go, Ho Y.
AU  - Go HY
AD  - 0000 0004 0533 259Xgrid.443977.aSemyung University, Jecheon, South Korea
FAU - Ko, Youme
AU  - Ko Y
AD  - 0000 0001 2171 7818grid.289247.2Kyung Hee University, Seoul, 02447 South Korea
FAU - Park, Sunju
AU  - Park S
AD  - 0000 0001 0523 5122grid.411948.1Daejeon University, Daejeon, South Korea
FAU - Jang, Bo H.
AU  - Jang BH
AD  - 0000 0001 2171 7818grid.289247.2Kyung Hee University, Seoul, 02447 South Korea
FAU - Shin, Yong C.
AU  - Shin YC
AD  - 0000 0001 2171 7818grid.289247.2Kyung Hee University, Seoul, 02447 South Korea
FAU - Ko, Seong G.
AU  - Ko SG
AD  - 0000 0001 2171 7818grid.289247.2Kyung Hee University, Seoul, 02447 South Korea
FAU - Janik, Hubert
AU  - Janik H
AD  - 0000000121858338grid.10493.3fComplementary Medicine, University of Medicine
      Rostock, Rostock, 18057 Germany
FAU - Greiffenhagen, Natalie
AU  - Greiffenhagen N
AD  - 0000000121858338grid.10493.3fComplementary Medicine, University of Medicine
      Rostock, Rostock, 18057 Germany
FAU - Bolte, Jürgen
AU  - Bolte J
AD  - Strandklinik Boltenhagen, Boltenhagen, Germany
FAU - Kraft, Karin
AU  - Kraft K
AD  - 0000000121858338grid.10493.3fComplementary Medicine, University of Medicine
      Rostock, Rostock, 18057 Germany
FAU - Jaworski, Mariusz
AU  - Jaworski M
AD  - 0000000113287408grid.13339.3bDepartment of Medical Psychology, Medical University
      of Warsaw, Warsaw, 02-091 Poland
FAU - Adamus, Miroslawa
AU  - Adamus M
AD  - 0000000113287408grid.13339.3bDepartment of Medical Psychology, Medical University
      of Warsaw, Warsaw, 02-091 Poland
FAU - Dobrzynska, Aleksandra
AU  - Dobrzynska A
AD  - 0000000113287408grid.13339.3bDepartment of Medical Psychology, Medical University
      of Warsaw, Warsaw, 02-091 Poland
FAU - Jeitler, Michael
AU  - Jeitler M
AD  - Department of Internal and Complementary Medicine, Immanuel Hospital Berlin,
      Berlin, 14109 Germany
FAU - Jaspers, Jessica
AU  - Jaspers J
AD  - 0000 0001 2218 4662grid.6363.0Charité - University Medical Center, Berlin, 10117 
      Germany
FAU - von Scheidt, Christel
AU  - von Scheidt C
AD  - Department of Internal and Complementary Medicine, Immanuel Hospital Berlin,
      Berlin, 14109 Germany
FAU - Koch, Barbara
AU  - Koch B
AD  - Department of Internal and Complementary Medicine, Immanuel Hospital Berlin,
      Berlin, 14109 Germany
FAU - Michalsen, Andreas
AU  - Michalsen A
AD  - Department of Internal and Complementary Medicine, Immanuel Hospital Berlin,
      Berlin, 14109 Germany
FAU - Steckhan, Nico
AU  - Steckhan N
AD  - 0000 0001 2218 4662grid.6363.0Charité - University Medical Center, Berlin, 10117 
      Germany
FAU - Kessler, Christian
AU  - Kessler C
AD  - Department of Internal and Complementary Medicine, Immanuel Hospital Berlin,
      Berlin, 14109 Germany
FAU - Jin, De
AU  - Jin D
AD  - 0000 0004 0632 3409grid.410318.fGuang An Men Hospital of China Academy of Chinese
      Medical Sciences, Beijing, 100053 China
FAU - Huang, Wen-jing
AU  - Huang Wj
AD  - 0000 0004 0632 3409grid.410318.fGuang An Men Hospital of China Academy of Chinese
      Medical Sciences, Beijing, 100053 China
FAU - Pang, Bing
AU  - Pang B
AD  - 0000 0004 0632 3409grid.410318.fGuang An Men Hospital of China Academy of Chinese
      Medical Sciences, Beijing, 100053 China
FAU - Lian, Feng-Mei
AU  - Lian FM
AD  - 0000 0004 0632 3409grid.410318.fGuang An Men Hospital of China Academy of Chinese
      Medical Sciences, Beijing, 100053 China
FAU - Jong, Miek
AU  - Jong M
AD  - Louis Bolk Institute, Driebergen, 3972LA Netherlands
FAU - Baars, Erik
AU  - Baars E
AD  - Louis Bolk Institute, Driebergen, 3972LA Netherlands
FAU - Glockmann, Anja
AU  - Glockmann A
AD  - IFAEMM at the Witten/Herdecke University, Freiburg, Germany
FAU - Hamre, Harald
AU  - Hamre H
AD  - IFAEMM at the Witten/Herdecke University, Freiburg, Germany
FAU - Kainuma, Mosaburo
AU  - Kainuma M
AD  - 0000 0001 2242 4849grid.177174.3Community Medicine Education Unit, Graduate
      School Of Medical Science, Kyushu University, Fukuoka, 812-8582 Japan
FAU - Murakami, Aya
AU  - Murakami A
AD  - 0000 0001 2242 4849grid.177174.3Community Medicine Education Unit, Graduate
      School Of Medical Science, Kyushu University, Fukuoka, 812-8582 Japan
FAU - Kubota, Toshio
AU  - Kubota T
AD  - 0000 0001 2242 4849grid.177174.3Community Medicine Education Unit, Graduate
      School Of Medical Science, Kyushu University, Fukuoka, 812-8582 Japan
FAU - Kobayashi, Daisuke
AU  - Kobayashi D
AD  - 0000 0001 2242 4849grid.177174.3Community Medicine Education Unit, Graduate
      School Of Medical Science, Kyushu University, Fukuoka, 812-8582 Japan
FAU - Sumoto, Yasuhiro
AU  - Sumoto Y
AD  - 0000 0001 2242 4849grid.177174.3Community Medicine Education Unit, Graduate
      School Of Medical Science, Kyushu University, Fukuoka, 812-8582 Japan
FAU - Furusyo, Norihiro
AU  - Furusyo N
AD  - 0000 0001 2242 4849grid.177174.3Department of General Internal Medicine, Kyushu
      University, Fukuoka, Japan
FAU - Ando, Shin-Ichi
AU  - Ando SI
AD  - 0000 0004 0404 8415grid.411248.aSleep Apnea Center, Kyushu University Hospital,
      Fukuoka, Japan
FAU - Shimazoe, Takao
AU  - Shimazoe T
AD  - 0000 0001 2242 4849grid.177174.3Community Medicine Education Unit, Graduate
      School Of Medical Science, Kyushu University, Fukuoka, 812-8582 Japan
FAU - Kelber, Olaf
AU  - Kelber O
AD  - Innovation & Development, Phytomedicines Supply and development Center,
      Steigerwald Arzneimittelwerk GmbH, Bayer Consumer Health, Darmstadt, 64295
      Germany
FAU - Verjee, S.
AU  - Verjee S
AD  - 0000 0001 2155 0333grid.7645.0Food Chemistry and Toxicology, University of
      Kaiserslautern, Kaiserslautern, 67663 Germany
FAU - Gorgus, Eva
AU  - Gorgus E
AD  - 0000 0001 2155 0333grid.7645.0Food Chemistry and Toxicology, University of
      Kaiserslautern, Kaiserslautern, 67663 Germany
FAU - Schrenk, Dieter
AU  - Schrenk D
AD  - 0000 0001 2155 0333grid.7645.0Food Chemistry and Toxicology, University of
      Kaiserslautern, Kaiserslautern, 67663 Germany
FAU - Kemper, Kathi
AU  - Kemper K
AD  - OSU, Blacklick, 43004 OH USA
FAU - Hill, Ellie
AU  - Hill E
AD  - OSU, Blacklick, 43004 OH USA
FAU - Kemper, Kathi
AU  - Kemper K
AD  - OSU, Blacklick, 43004 OH USA
FAU - Rao, Nisha
AU  - Rao N
AD  - 0000 0001 2285 7943grid.261331.4College of Medicine, OSU, Columbus, 43210 OH USA
FAU - Gascon, Gregg
AU  - Gascon G
AD  - OSU, Blacklick, 43004 OH USA
FAU - Mahan, John
AU  - Mahan J
AD  - OSU, Blacklick, 43004 OH USA
FAU - Kienle, Gunver
AU  - Kienle G
AD  - 0000 0000 9428 7911grid.7708.8Center for Complementary Medicine, Institute for
      Environmental Health Sciences and Hospital Infection Control, Medical Center –
      University of Freiburg, Freiburg, 79106 Germany
FAU - Dietrich, Jörg
AU  - Dietrich J
AD  - 0000 0004 0386 9924grid.32224.35Massachusetts General Hospital, Boston, MA USA
FAU - Schmoor, Claudia
AU  - Schmoor C
AD  - 0000 0000 9428 7911grid.7708.8Clinical Trials Unit Freiburg, Medical Center –
      University of Freiburg, Freiburg, Germany
FAU - Huber, Roman
AU  - Huber R
AD  - 0000 0000 9428 7911grid.7708.8Center for Complementary Medicine, Institute for
      Environmental Health Sciences and Hospital Infection Control, Medical Center –
      University of Freiburg, Freiburg, 79106 Germany
FAU - Kim, Weon H.
AU  - Kim WH
AD  - 0000 0001 1364 9317grid.49606.3dGraduate School of Public Policy, Hanyang
      University, Seoul, 133-791 South Korea
FAU - Han, Dongwoon
AU  - Han D
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, 04763 South Korea
FAU - Ahmed, Mansoor
AU  - Ahmed M
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, 04763 South Korea
FAU - He, Luzhu
AU  - He L
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, 04763 South Korea
FAU - Hwang, Jung Hye
AU  - Hwang JH
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, 04763 South Korea
FAU - Kiss, Eva
AU  - Kiss E
AD  - 0000 0001 0942 9821grid.11804.3c1st Department of Pathology and Experimental
      Cancer Research, Semmelweis University, Budapest, 1085 Hungary
FAU - Vancsik, Tamas
AU  - Vancsik T
AD  - 0000 0001 0942 9821grid.11804.3c1st Department of Pathology and Experimental
      Cancer Research, Semmelweis University, Budapest, 1085 Hungary
FAU - Meggyeshazi, Nora
AU  - Meggyeshazi N
AD  - 0000 0001 0942 9821grid.11804.3c1st Department of Pathology and Experimental
      Cancer Research, Semmelweis University, Budapest, 1085 Hungary
FAU - Kovago, Csaba
AU  - Kovago C
AD  - 0000 0001 1015 7851grid.129553.9Department of Pharmacology and Toxicology, Szent 
      Istvan University Faculty of Veterinary Science, Budapest, 1078 Hungary
FAU - Krenacs, Tibor
AU  - Krenacs T
AD  - 0000 0001 0942 9821grid.11804.3c1st Department of Pathology and Experimental
      Cancer Research, Semmelweis University, Budapest, 1085 Hungary
FAU - Klaus, Anne K.
AU  - Klaus AK
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Zerm, Roland
AU  - Zerm R
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Pranga, Danilo
AU  - Pranga D
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Ostermann, Thomas
AU  - Ostermann T
AD  - 0000 0000 9024 6397grid.412581.bIntegrative Medicine, Witten/Herdecke University,
      Witten/Herdecke, Germany
FAU - Reif, Marcus
AU  - Reif M
AD  - Society for Clinical Research, Berlin, Germany
FAU - von Laue, Hans Broder
AU  - von Laue HB
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Brinkhaus, Benno
AU  - Brinkhaus B
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité University, Berlin, 10117 Germany
FAU - Kröz, Matthias
AU  - Kröz M
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Klaus, Anne K.
AU  - Klaus AK
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Zerm, Roland
AU  - Zerm R
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Pranga, Danilo
AU  - Pranga D
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Recchia, Daniela Rodrigues
AU  - Recchia DR
AD  - 0000 0000 9024 6397grid.412581.bIntegrative Medicine, Witten/Herdecke University,
      Witten/Herdecke, Germany
FAU - Ostermann, Thomas
AU  - Ostermann T
AD  - 0000 0000 9024 6397grid.412581.bIntegrative Medicine, Witten/Herdecke University,
      Witten/Herdecke, Germany
FAU - Reif, Marcus
AU  - Reif M
AD  - Society for Clinical Research, Berlin, Germany
FAU - von Laue, Hans B.
AU  - von Laue HB
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Brinkhaus, Benno
AU  - Brinkhaus B
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité University, Berlin, Germany
FAU - Kröz, Matthias
AU  - Kröz M
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Klein-Laansma, Christien T.
AU  - Klein-Laansma CT
AD  - Health Care and Nutrition, Louis Bolk Institute, Driebergen, 3972LA Netherlands
FAU - Jong, Mats
AU  - Jong M
AD  - 0000 0001 1530 0805grid.29050.3eNursing, Mid-Sweden University, Sundsvall, Sweden
FAU - von Hagens, Cornelia
AU  - von Hagens C
AD  - Naturopathy and Integrative Medicine, Department of Gynaecological Endocrinology 
      and Reproductive Medicine, University Women’s Hospital Heidelberg, Heidelberg,
      Germany
FAU - Jansen, Jean P.
AU  - Jansen JP
AD  - Health Care and Nutrition, Louis Bolk Institute, Driebergen, 3972LA Netherlands
FAU - van Wietmarschen, Herman
AU  - van Wietmarschen H
AD  - Health Care and Nutrition, Louis Bolk Institute, Driebergen, 3972LA Netherlands
FAU - Jong, Miek C.
AU  - Jong MC
AD  - Health Care and Nutrition, Louis Bolk Institute, Driebergen, 3972LA Netherlands
FAU - Ko, Youme
AU  - Ko Y
AD  - 0000 0001 2171 7818grid.289247.2Preventive Medicine, Kyung Hee University, Seoul,
      02447 South Korea
FAU - Sun, Seung-Ho
AU  - Sun SH
AD  - 0000 0004 0533 2258grid.412417.5Korean Internal Medicine, Sangji University,
      Wonju, South Korea
FAU - Go, Ho-Yeon
AU  - Go HY
AD  - 0000 0004 0533 259Xgrid.443977.aKorean Internal Medicine, Semyung University,
      Jecheon, South Korea
FAU - Jeon, Chan-Yong
AU  - Jeon CY
AD  - 0000 0004 0647 2973grid.256155.0Korean Internal Medicine, Gachon University,
      Seongnam, South Korea
FAU - Song, Yun-Kyung
AU  - Song YK
AD  - 0000 0004 0647 2973grid.256155.0Rehabilitation Medicine, Gachon University,
      Seongnam, South Korea
FAU - Ko, Seong-Gyu
AU  - Ko SG
AD  - 0000 0001 2171 7818grid.289247.2Preventive Medicine, Kyung Hee University, Seoul,
      02447 South Korea
FAU - Koch, Anna K.
AU  - Koch AK
AD  - 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine, 
      Kliniken Essen-Mitte, Essen, 45276 Germany
FAU - Rabsilber, Sybille
AU  - Rabsilber S
AD  - grid.459714.aDepartment of Gynecology, Malteser Hospital St. Anna, Duisburg,
      Germany
FAU - Lauche, Romy
AU  - Lauche R
AD  - 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine, 
      Kliniken Essen-Mitte, Essen, 45276 Germany
FAU - Kümmel, Sherko
AU  - Kümmel S
AD  - 0000 0001 0006 4176grid.461714.1Interdisclipinary Breast Cancer Center, Kliniken 
      Essen-Mitte, Essen, Germany
FAU - Dobos, Gustav
AU  - Dobos G
AD  - 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine, 
      Kliniken Essen-Mitte, Essen, 45276 Germany
FAU - Langhorst, Jost
AU  - Langhorst J
AD  - 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine, 
      Kliniken Essen-Mitte, Essen, 45276 Germany
FAU - Cramer, Holger
AU  - Cramer H
AD  - 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine, 
      Kliniken Essen-Mitte, Essen, 45276 Germany
FAU - Koch, Anna K.
AU  - Koch AK
AD  - 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine, 
      Kliniken Essen-Mitte, Essen, 45276 Germany
FAU - Trifunovic-Koenig, Milena
AU  - Trifunovic-Koenig M
AD  - 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine, 
      Kliniken Essen-Mitte, Essen, 45276 Germany
FAU - Klose, Petra
AU  - Klose P
AD  - 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine, 
      Kliniken Essen-Mitte, Essen, 45276 Germany
FAU - Cramer, Holger
AU  - Cramer H
AD  - 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine, 
      Kliniken Essen-Mitte, Essen, 45276 Germany
FAU - Dobos, Gustav
AU  - Dobos G
AD  - 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine, 
      Kliniken Essen-Mitte, Essen, 45276 Germany
FAU - Langhorst, Jost
AU  - Langhorst J
AD  - 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine, 
      Kliniken Essen-Mitte, Essen, 45276 Germany
FAU - Koster, Evi
AU  - Koster E
AD  - grid.449761.9University of Applied Sciences Leiden, Leiden, 2333CK Netherlands
FAU - Baars, Erik
AU  - Baars E
AD  - grid.449761.9University of Applied Sciences Leiden, Leiden, 2333CK Netherlands
FAU - Delnoij, Diana
AU  - Delnoij D
AD  - 0000 0001 0943 3265grid.12295.3dScientific Centre for Transformation in Care and 
      Welfare (Tranzo), Tilburg University, Leiden, Netherlands
FAU - Kroll, Lena
AU  - Kroll L
AD  - 0000 0001 2108 9006grid.7307.3Sport sciences, University of Augsburg, Augsburg,
      86135 Germany
FAU - Weiss, Kathrin
AU  - Weiss K
AD  - 0000 0001 2108 9006grid.7307.3Sport sciences, University of Augsburg, Augsburg,
      86135 Germany
FAU - Kubo, Ai
AU  - Kubo A
AD  - 0000 0000 9957 7758grid.280062.eDivision of Research, Kaiser Permanente, Oakland,
      CA 94612 USA
FAU - Hendlish, Sarah
AU  - Hendlish S
AD  - 0000 0000 9957 7758grid.280062.eDivision of Research, Kaiser Permanente, Oakland,
      CA 94612 USA
FAU - Altschuler, Andrea
AU  - Altschuler A
AD  - 0000 0000 9957 7758grid.280062.eDivision of Research, Kaiser Permanente, Oakland,
      CA 94612 USA
FAU - Connolly, Nancy
AU  - Connolly N
AD  - 0000 0000 9957 7758grid.280062.eDivision of Research, Kaiser Permanente, Oakland,
      CA 94612 USA
FAU - Avins, Andy
AU  - Avins A
AD  - 0000 0000 9957 7758grid.280062.eDivision of Research, Kaiser Permanente, Oakland,
      CA 94612 USA
FAU - Lauche, Romy
AU  - Lauche R
AD  - 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and
      Integrative Medicine (ARCCIM), University of Technology Sydney, Ultimo, 2007
      Australia
FAU - Recchia, Daniela Rodrigues
AU  - Recchia DR
AD  - 0000 0000 9024 6397grid.412581.bDepartment of Psychology and Psychotherapy,
      University of Witten/Herdecke, Witten, Germany
FAU - Cramer, Holger
AU  - Cramer H
AD  - 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and
      Integrative Medicine (ARCCIM), University of Technology Sydney, Ultimo, 2007
      Australia
FAU - Wardle, Jon
AU  - Wardle J
AD  - 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and
      Integrative Medicine (ARCCIM), University of Technology Sydney, Ultimo, 2007
      Australia
FAU - Lee, David
AU  - Lee D
AD  - 0000 0004 1936 8606grid.26790.3aDepartment of Public Health Sciences, University 
      of Miami, Miami, FL USA
FAU - Sibbritt, David
AU  - Sibbritt D
AD  - 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and
      Integrative Medicine (ARCCIM), University of Technology Sydney, Ultimo, 2007
      Australia
FAU - Adams, Jon
AU  - Adams J
AD  - 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and
      Integrative Medicine (ARCCIM), University of Technology Sydney, Ultimo, 2007
      Australia
FAU - Ostermann, Thomas
AU  - Ostermann T
AD  - 0000 0000 9024 6397grid.412581.bDepartment of Psychology and Psychotherapy,
      University of Witten/Herdecke, Witten, Germany
FAU - Lauche, Romy
AU  - Lauche R
AD  - 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and
      Integrative Medicine (ARCCIM), University of Technology Sydney, Ultimo, 2007
      Australia
FAU - Sibbritt, David
AU  - Sibbritt D
AD  - 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and
      Integrative Medicine (ARCCIM), University of Technology Sydney, Ultimo, 2007
      Australia
FAU - Park, Crystal
AU  - Park C
AD  - 0000 0001 0860 4915grid.63054.34Department of Psychology, University of
      Connecticut, Storrs, CT USA
FAU - Mishra, Gita
AU  - Mishra G
AD  - 0000 0000 9320 7537grid.1003.2School of Public Health, University of Queensland, 
      Herston, QLD Australia
FAU - Adams, Jon
AU  - Adams J
AD  - 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and
      Integrative Medicine (ARCCIM), University of Technology Sydney, Ultimo, 2007
      Australia
FAU - Cramer, Holger
AU  - Cramer H
AD  - 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and
      Integrative Medicine (ARCCIM), University of Technology Sydney, Ultimo, 2007
      Australia
FAU - Lechner, Johann
AU  - Lechner J
AD  - Praxisklinik München, Munich, 81547 Germany
FAU - Lee, Inseon
AU  - Lee I
AD  - 0000 0001 0196 8249grid.411544.1Abt. Innere Medizin VI - Psychosomatische Medizin
      und Psychotherapie, Universitätsklinikum Tübingen, Tübingen, 72076 Germany
FAU - Chae, Younbyoung
AU  - Chae Y
AD  - Acupuncture & Meridian Science Research Center, Seoul, 130-701 South Korea
FAU - Lee, Jisu
AU  - Lee J
AD  - 0000 0001 2171 7818grid.289247.2Kyung Hee University, College of Korean Medicine,
      Seoul, South Korea
FAU - Cho, Seung H.
AU  - Cho SH
AD  - 0000 0001 2171 7818grid.289247.2Department of Clinical Korean Medicine, Kyung Hee
      University, Graduate School, Seoul, South Korea
FAU - Choi, Yujin
AU  - Choi Y
AD  - 0000 0001 2171 7818grid.289247.2Department of Clinical Korean Medicine, Kyung Hee
      University, Graduate School, Seoul, South Korea
FAU - Lee, Jee Y.
AU  - Lee JY
AD  - 0000 0001 0357 1464grid.411231.4Kyung Hee University Hospital at Gangdong, Korean
      Internal Medicine, Seoul, South Korea
FAU - Ryu, Han S.
AU  - Ryu HS
AD  - 0000 0001 0357 1464grid.411231.4Kyung Hee University Hospital at Gangdong, Korean
      Internal Medicine, Seoul, South Korea
FAU - Yoon, Sung S.
AU  - Yoon SS
AD  - 0000 0001 0357 1464grid.411231.4Kyung Hee University Hospital at Gangdong, Korean
      Internal Medicine, Seoul, South Korea
FAU - Oh, Hye K.
AU  - Oh HK
AD  - 0000 0001 0357 1464grid.411231.4Kyung Hee University Hospital at Gangdong, Korean
      Internal Medicine, Seoul, South Korea
FAU - Hyun, Lyun K.
AU  - Hyun LK
AD  - 0000 0001 0357 1464grid.411231.4Kyung Hee University Hospital at Gangdong, Korean
      Internal Medicine, Seoul, South Korea
FAU - Kim, Jin O.
AU  - Kim JO
AD  - 0000 0001 0357 1464grid.411231.4Kyung Hee University Hospital at Gangdong, Korean
      Internal Medicine, Seoul, South Korea
FAU - Yoon, Seong W.
AU  - Yoon SW
AD  - 0000 0001 0357 1464grid.411231.4Kyung Hee University Hospital at Gangdong, Korean
      Internal Medicine, Seoul, South Korea
FAU - Lee, Ju-Yeon
AU  - Lee JY
AD  - 0000 0000 8653 1507grid.412301.5Cardiovascular Engineering, Helmholtz Institute
      of RWTH Aachen University & Hospital, Aachen, 52074 Germany
FAU - Shin, Sang-Hoon
AU  - Shin SH
AD  - 0000 0004 0533 2258grid.412417.5Oriental biomedical engineering, Sangji
      University, Wonju, 26339 South Korea
FAU - Jang, Min
AU  - Jang M
AD  - 0000 0004 0533 2258grid.412417.5Oriental biomedical engineering, Sangji
      University, Wonju, 26339 South Korea
FAU - Müller, Indra
AU  - Müller I
AD  - 0000 0000 8653 1507grid.412301.5Cardiovascular Engineering, Helmholtz Institute
      of RWTH Aachen University & Hospital, Aachen, 52074 Germany
FAU - Park, So-Hyun Janson
AU  - Park SHJ
AD  - 0000 0000 8653 1507grid.412301.5Cardiovascular Engineering, Helmholtz Institute
      of RWTH Aachen University & Hospital, Aachen, 52074 Germany
FAU - Lestoquoy, Anna S.
AU  - Lestoquoy AS
AD  - 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical
      Center, Boston, 02118 USA
FAU - Laird, Lance
AU  - Laird L
AD  - 0000 0004 0367 5222grid.475010.7Boston University School of Medicine, Boston, USA
FAU - Negash, Lily
AU  - Negash L
AD  - 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical
      Center, Boston, 02118 USA
FAU - Mitchell, Suzanne
AU  - Mitchell S
AD  - 0000 0004 0367 5222grid.475010.7Boston University School of Medicine, Boston, USA
FAU - Gardiner, Paula
AU  - Gardiner P
AD  - 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical
      Center, Boston, 02118 USA
FAU - Li, Xiaofei
AU  - Li X
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Wang, Yunhui
AU  - Wang Y
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Zhen, Jianhua
AU  - Zhen J
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Yu, He
AU  - Yu H
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Liu, Tiegang
AU  - Liu T
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Gu, Xiaohong
AU  - Gu X
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Liu, Hui
AU  - Liu H
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine Dong Fang 
      Hospital, Chinese Medicine, Beijing, China
FAU - Ma, Weiguo
AU  - Ma W
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine Dong Fang 
      Hospital, Chinese Medicine, Beijing, China
FAU - Zhang, Chengcheng
AU  - Zhang C
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine Dong Fang 
      Hospital, Chinese Medicine, Beijing, China
FAU - Shang, Xuezheng
AU  - Shang X
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine Dong Fang 
      Hospital, Chinese Medicine, Beijing, China
FAU - Bai, Yu
AU  - Bai Y
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine Dong Fang 
      Hospital, Chinese Medicine, Beijing, China
FAU - Meng, Fengxian
AU  - Meng F
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine Dong Fang 
      Hospital, Chinese Medicine, Beijing, China
FAU - Liu, Wei
AU  - Liu W
AD  - 0000 0000 8550 1509grid.418737.eEdward Via College of Osteopathic Medicine,
      Auburn, AL USA
FAU - Rooney, Collin
AU  - Rooney C
AD  - 0000 0001 2299 3507grid.16753.36Northwestern University, Evanston, IL USA
FAU - Smith, Amos
AU  - Smith A
AD  - 0000 0001 2297 8753grid.252546.2Auburn University, Auburn, AL USA
FAU - Lopes, Shirlene
AU  - Lopes S
AD  - 0000 0004 1937 0722grid.11899.38Internal Medicine-General Internal Medicine and
      Semiology, University of São Paulo-School of Medicine, São Paulo, 01218011 Brazil
FAU - Demarzo, Marcelo
AU  - Demarzo M
AD  - 0000 0001 0514 7202grid.411249.bPublic Health, Brazilian Center for Mindfulness
      and Health Promotion – UNIFESP, São Paulo, 04753-060 Brazil
FAU - do Patrocínio Nunes, Maria
AU  - do Patrocínio Nunes M
AD  - 0000 0004 1937 0722grid.11899.38Internal Medicine-General Internal Medicine and
      Semiology, University of São Paulo-School of Medicine, São Paulo, 01218011 Brazil
FAU - Lorenz, Peter
AU  - Lorenz P
AD  - Department of Analytical Development and Research, Wala Heilmittel GmbH, Bad
      Boll/Eckwaelden, 73087 Germany
FAU - Gründemann, Carsten
AU  - Gründemann C
AD  - 0000 0000 9428 7911grid.7708.8Center for Complementary Medicine, Institute for
      Environmental Health Sciences and Hospital Infection Control, University Medical 
      Center, Freiburg, 79106 Germany
FAU - Heinrich, Miriam
AU  - Heinrich M
AD  - Department of Analytical Development and Research, Wala Heilmittel GmbH, Bad
      Boll/Eckwaelden, 73087 Germany
FAU - Garcia-Käufer, Manuel
AU  - Garcia-Käufer M
AD  - 0000 0000 9428 7911grid.7708.8Center for Complementary Medicine, Institute for
      Environmental Health Sciences and Hospital Infection Control, University Medical 
      Center, Freiburg, 79106 Germany
FAU - Grunewald, Franziska
AU  - Grunewald F
AD  - 0000 0000 9428 7911grid.7708.8Center for Complementary Medicine, Institute for
      Environmental Health Sciences and Hospital Infection Control, University Medical 
      Center, Freiburg, 79106 Germany
FAU - Messerschmidt, Silke
AU  - Messerschmidt S
AD  - Department of Analytical Development and Research, Wala Heilmittel GmbH, Bad
      Boll/Eckwaelden, 73087 Germany
FAU - Herrick, Anja
AU  - Herrick A
AD  - Department of Pharmacology and Clinical Research, Wala Heilmittel GmbH, Bad
      Boll/Eckwaelden, 73087 Germany
FAU - Gruber, Kim
AU  - Gruber K
AD  - Department of Pharmacology and Clinical Research, Wala Heilmittel GmbH, Bad
      Boll/Eckwaelden, 73087 Germany
FAU - Beckmann, Christiane
AU  - Beckmann C
AD  - Department of Pharmacology and Clinical Research, Wala Heilmittel GmbH, Bad
      Boll/Eckwaelden, 73087 Germany
FAU - Knödler, Matthias
AU  - Knödler M
AD  - Department of Analytical Development and Research, Wala Heilmittel GmbH, Bad
      Boll/Eckwaelden, 73087 Germany
FAU - Huber, Roman
AU  - Huber R
AD  - 0000 0000 9428 7911grid.7708.8Center for Complementary Medicine, Institute for
      Environmental Health Sciences and Hospital Infection Control, University Medical 
      Center, Freiburg, 79106 Germany
FAU - Steinborn, Carmen
AU  - Steinborn C
AD  - 0000 0000 9428 7911grid.7708.8Center for Complementary Medicine, Institute for
      Environmental Health Sciences and Hospital Infection Control, University Medical 
      Center, Freiburg, 79106 Germany
FAU - Stintzing, Florian
AU  - Stintzing F
AD  - Department of Analytical Development and Research, Wala Heilmittel GmbH, Bad
      Boll/Eckwaelden, 73087 Germany
FAU - Lu, Taoying
AU  - Lu T
AD  - 0000 0000 8848 7685grid.411866.cThe Second Affiliated Hospital of Guangzhou
      University of Chinese Medicine, Guangzhou, 510120 China
FAU - Wang, Lixin
AU  - Wang L
AD  - 0000 0004 1757 641Xgrid.440665.5The Affiliated Hospital of Changchun University
      of Chinese Medicine, Changchun, China
FAU - Wu, Darong
AU  - Wu D
AD  - 0000 0000 8848 7685grid.411866.cThe Second Affiliated Hospital of Guangzhou
      University of Chinese Medicine, Guangzhou, 510120 China
FAU - Luberto, Christina M
AU  - Luberto CM
AD  - 0000 0004 0386 9924grid.32224.35Harvard Medical School/ Massachusetts General
      Hospital, Boston, 02114 MA USA
FAU - Hall, Daniel L.
AU  - Hall DL
AD  - 0000 0004 0386 9924grid.32224.35Harvard Medical School/ Massachusetts General
      Hospital, Boston, 02114 MA USA
FAU - Chad-Friedman, Emma
AU  - Chad-Friedman E
AD  - 0000 0004 0386 9924grid.32224.35Benson-Henry Institute for Mind-Body Medicine,
      Massachusetts General Hospital, Boston, MA USA
FAU - Lechner, Suzanne
AU  - Lechner S
AD  - 0000 0004 1936 8606grid.26790.3aUniversity of Miami, Miami, FL USA
FAU - Park, Elyse R.
AU  - Park ER
AD  - 0000 0004 0386 9924grid.32224.35Harvard Medical School/ Massachusetts General
      Hospital, Boston, 02114 MA USA
FAU - Luberto, Christina M.
AU  - Luberto CM
AD  - 0000 0004 0386 9924grid.32224.35Harvard Medical School/Massachusetts General
      Hospital, Boston, 02114 MA USA
FAU - Park, Elyse
AU  - Park E
AD  - 0000 0004 0386 9924grid.32224.35Harvard Medical School/Massachusetts General
      Hospital, Boston, 02114 MA USA
FAU - Goodman, Janice
AU  - Goodman J
AD  - 0000 0004 0386 9924grid.32224.35Harvard Medical School/Massachusetts General
      Hospital, Boston, 02114 MA USA
FAU - Luer, Sonja
AU  - Luer S
AD  - grid.412353.2Division of Pediatric Hematology/Oncology, University Children’s
      Hospital, Bern, Switzerland
FAU - Heri, Matthias
AU  - Heri M
AD  - 0000 0001 0726 5157grid.5734.5Institute of Complementary Medicine, University,
      Bern, Switzerland
FAU - von Ammon, Klaus
AU  - von Ammon K
AD  - 0000 0001 0726 5157grid.5734.5Institute of Complementary Medicine, University,
      Bern, Switzerland
FAU - Frei-Erb, Martin
AU  - Frei-Erb M
AD  - 0000 0001 0726 5157grid.5734.5Institute of Complementary Medicine, University,
      Bern, Switzerland
FAU - Ma, Weiguo
AU  - Ma W
AD  - Dongfang Hospital of Beijing University of Traditional Medicine, Clinical,
      Beijing, China
FAU - Meng, Fengxian
AU  - Meng F
AD  - Dongfang Hospital of Beijing University of Traditional Medicine, Clinical,
      Beijing, China
FAU - Maggini, Valentina
AU  - Maggini V
AD  - 0000 0004 1757 2304grid.8404.8Department of Experimental and Clinical Medicine,
      University of Florence, Florence, viale Pieraccini 6, 50139 Florence, Italy
FAU - Gallo, Eugenia
AU  - Gallo E
AD  - 0000 0004 1757 2304grid.8404.8Department of Experimental and Clinical Medicine,
      University of Florence, Florence, viale Pieraccini 6, 50139 Florence, Italy
FAU - Landini, Ida
AU  - Landini I
AD  - 0000 0004 1757 2304grid.8404.8Department of Experimental and Clinical Medicine,
      University of Florence, Florence, viale Pieraccini 6, 50139 Florence, Italy
FAU - Lapucci, Andrea
AU  - Lapucci A
AD  - 0000 0004 1757 2304grid.8404.8Department of Experimental and Clinical Medicine,
      University of Florence, Florence, viale Pieraccini 6, 50139 Florence, Italy
FAU - Nobili, Stefania
AU  - Nobili S
AD  - 0000 0004 1757 2304grid.8404.8Department of Health Sciences, University of
      Florence, viale Pieraccini 6, 50139 Florence, Italy
FAU - Mini, Enrico
AU  - Mini E
AD  - 0000 0004 1757 2304grid.8404.8Department of Experimental and Clinical Medicine,
      University of Florence, Florence, viale Pieraccini 6, 50139 Florence, Italy
FAU - Firenzuoli, Fabio
AU  - Firenzuoli F
AD  - Referring Center for Phytotherapy, Centre for Integrative Medicine - Careggi,
      Universitary Hospital, 50139 Florence, Italy
FAU - McDermott, Clare
AU  - McDermott C
AD  - 0000 0004 1936 9297grid.5491.9Primary Care and Population Science, University of 
      Southampton, Southampton, SO16 5ST UK
FAU - Lewith, George
AU  - Lewith G
AD  - 0000 0004 1936 9297grid.5491.9Primary Care and Population Science, University of 
      Southampton, Southampton, SO16 5ST UK
FAU - Richards, Selwyn
AU  - Richards S
AD  - 0000 0000 8761 3918grid.266218.9University of Cumbria, Carlisle, UK
FAU - Cox, Diane
AU  - Cox D
AD  - 0000 0000 8761 3918grid.266218.9University of Cumbria, Carlisle, UK
FAU - Frossell, Sarah
AU  - Frossell S
AD  - Rebuilding Your Life Project, Oxford, UK
FAU - Leydon, Geraldine
AU  - Leydon G
AD  - 0000 0004 1936 9297grid.5491.9Primary Care and Population Science, University of 
      Southampton, Southampton, SO16 5ST UK
FAU - Eyles, Caroline
AU  - Eyles C
AD  - 0000 0004 1936 9297grid.5491.9Primary Care and Population Science, University of 
      Southampton, Southampton, SO16 5ST UK
FAU - Raphael, Hilly
AU  - Raphael H
AD  - Rebuilding Your Life Project, Oxford, UK
FAU - Rogers, Rachael
AU  - Rogers R
AD  - Oxfordshire CFS/ME Service, Oxford, UK
FAU - Selby, Michelle
AU  - Selby M
AD  - 0000 0000 8761 3918grid.266218.9University of Cumbria, Carlisle, UK
FAU - Adler, Charlotte
AU  - Adler C
AD  - 0000 0000 8761 3918grid.266218.9University of Cumbria, Carlisle, UK
FAU - Allam, Jo
AU  - Allam J
AD  - 0000 0000 8761 3918grid.266218.9University of Cumbria, Carlisle, UK
FAU - Meng, Fengxian
AU  - Meng F
AD  - 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Gu, Wen
AU  - Gu W
AD  - grid.459365.8Department of Rheumatology, Beijing Hospital of Traditional Chinese 
      Medicine, Beijing, China
FAU - Zhang, Chengcheng
AU  - Zhang C
AD  - 0000 0001 1431 9176grid.24695.3cDepartment of Nephrology, Dongfang Hospital,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Bai, Hua
AU  - Bai H
AD  - Department of Traditional Chinese Medicine, Xiluoyuan Community Health Service
      Center of Fengtai Distict, Beijing, China
FAU - Zhang, Zhengju
AU  - Zhang Z
AD  - 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Wang, Dali
AU  - Wang D
AD  - 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Bu, Xiangwei
AU  - Bu X
AD  - 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Zhang, Honghong
AU  - Zhang H
AD  - 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Zhang, Jianpeng
AU  - Zhang J
AD  - 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Liu, Hui
AU  - Liu H
AD  - 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Mikolasek, Michael
AU  - Mikolasek M
AD  - 0000 0004 0478 9977grid.412004.3Institute for Complementary and Integrative
      Medicine, UniversityHospital Zurich, Zurich, 8091 Switzerland
FAU - Berg, Jonas
AU  - Berg J
AD  - 0000 0004 0478 9977grid.412004.3Institute for Complementary and Integrative
      Medicine, UniversityHospital Zurich, Zurich, 8091 Switzerland
FAU - Witt, Claudia
AU  - Witt C
AD  - 0000 0004 0478 9977grid.412004.3Institute for Complementary and Integrative
      Medicine, UniversityHospital Zurich, Zurich, 8091 Switzerland
FAU - Barth, Jürgen
AU  - Barth J
AD  - 0000 0004 0478 9977grid.412004.3Institute for Complementary and Integrative
      Medicine, UniversityHospital Zurich, Zurich, 8091 Switzerland
FAU - Miskulin, Ivan
AU  - Miskulin I
AD  - 0000 0001 1015 399Xgrid.412680.9Institute for Integrative Medicine, Faculty of
      Medicine Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, 31000
      Croatia
FAU - Lalic, Zdenka
AU  - Lalic Z
AD  - APIPHARMA Ltd., Zagreb, Croatia
FAU - Miskulin, Maja
AU  - Miskulin M
AD  - 0000 0001 1015 399Xgrid.412680.9Institute for Integrative Medicine, Faculty of
      Medicine Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, 31000
      Croatia
FAU - Dumic, Albina
AU  - Dumic A
AD  - 0000 0001 1015 399Xgrid.412680.9Department of Internal Medicine, Family Medicine 
      and Medical History, Faculty of Medicine Osijek, Josip Juraj Strossmayer
      University of Osijek, Osijek, Croatia
FAU - Sebo, Damir
AU  - Sebo D
AD  - 0000 0001 1015 399Xgrid.412680.9Institute for Integrative Medicine, Faculty of
      Medicine Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, 31000
      Croatia
FAU - Vcev, Aleksandar
AU  - Vcev A
AD  - 0000 0001 1015 399Xgrid.412680.9Department of Internal Medicine, Family Medicine 
      and Medical History, Faculty of Medicine Osijek, Josip Juraj Strossmayer
      University of Osijek, Osijek, Croatia
FAU - Mohammed, Nasr A. A.
AU  - Mohammed NAA
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, 04763 South Korea
FAU - Han, Dongwoon
AU  - Han D
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, 04763 South Korea
FAU - Ahmed, Mansoor
AU  - Ahmed M
AD  - 0000 0001 1364 9317grid.49606.3dHanyang University, College of Medicine, Seoul,
      133-791 South Korea
FAU - Choi, Soo Jeung
AU  - Choi SJ
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, Seoul, South Korea
FAU - Im, Hyea Bin
AU  - Im HB
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, Seoul, South Korea
FAU - Hwang, Jung Hye
AU  - Hwang JH
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, Seoul, South Korea
FAU - Mukherjee, Anwesha
AU  - Mukherjee A
AD  - 0000 0004 0503 0903grid.411681.bDepartment of Pharmacology, Poona College of
      Pharmacy, BVDU, Pune, India
FAU - Kandhare, Amit
AU  - Kandhare A
AD  - 0000 0004 0503 0903grid.411681.bDepartment of Pharmacology, Poona College of
      Pharmacy, BVDU, Pune, India
FAU - Bodhankar, Subhash
AU  - Bodhankar S
AD  - 0000 0004 0503 0903grid.411681.bDepartment of Pharmacology, Poona College of
      Pharmacy, BVDU, Pune, India
FAU - Mukherjee, Anwesha
AU  - Mukherjee A
AD  - 0000 0004 0503 0903grid.411681.bDepartment of Pharmacology, Poona College of
      Pharmacy, BVDU, Pune, India
FAU - Kandhare, Amit
AU  - Kandhare A
AD  - 0000 0004 0503 0903grid.411681.bDepartment of Pharmacology, Poona College of
      Pharmacy, BVDU, Pune, India
FAU - Thakurdesai, Prasad
AU  - Thakurdesai P
AD  - Indus Biotech Private Limited, Pune, India
FAU - Bodhankar, Subhash
AU  - Bodhankar S
AD  - 0000 0004 0503 0903grid.411681.bDepartment of Pharmacology, Poona College of
      Pharmacy, BVDU, Pune, India
FAU - Munk, Niki
AU  - Munk N
AD  - 0000 0001 2287 3919grid.257413.6Health Sciences, Indiana University School of
      Health and Rehabilitation Sciences, Indianapolis, 46202 IN USA
FAU - Evans, Erica
AU  - Evans E
AD  - 0000 0001 2287 3919grid.257413.6Health Sciences, Indiana University School of
      Health and Rehabilitation Sciences, Indianapolis, 46202 IN USA
FAU - Froman, Amanda
AU  - Froman A
AD  - 0000 0000 9681 3540grid.280828.8Roudebush VA Medical Center, Indianapolis, IN USA
FAU - Kline, Matthew
AU  - Kline M
AD  - 0000 0000 9681 3540grid.280828.8Roudebush VA Medical Center, Indianapolis, IN USA
FAU - Bair, Matthew J.
AU  - Bair MJ
AD  - 0000 0001 2287 3919grid.257413.6Health Sciences, Indiana University School of
      Health and Rehabilitation Sciences, Indianapolis, 46202 IN USA
FAU - Musial, Frauke
AU  - Musial F
AD  - 0000000122595234grid.10919.30Department of Community Medicine, National Research 
      Center in Complementary and Alternative Medicine, NAFKAM, The Arctic University
      of Norway, UiT, Tromsø, 9037 Norway
FAU - Kristoffersen, Agnete E.
AU  - Kristoffersen AE
AD  - 0000000122595234grid.10919.30Department of Community Medicine, National Research 
      Center in Complementary and Alternative Medicine, NAFKAM, The Arctic University
      of Norway, UiT, Tromsø, 9037 Norway
FAU - Alræk, Terje
AU  - Alræk T
AD  - 0000 0004 1936 834Xgrid.1013.3National Institute of Complementary Medicine,
      Western Sydney University, Sydney, Australia
FAU - Hamre, Harald J.
AU  - Hamre HJ
AD  - 0000 0000 9024 6397grid.412581.bInstitute for Applied Epistemology and Medical
      Methodology, University of Witten-Herdecke, Herdecke, Germany
FAU - Stub, Trine
AU  - Stub T
AD  - 0000000122595234grid.10919.30Department of Community Medicine, National Research 
      Center in Complementary and Alternative Medicine, NAFKAM, The Arctic University
      of Norway, UiT, Tromsø, 9037 Norway
FAU - Björkman, Lars
AU  - Björkman L
AD  - Dental Biomaterials Adverse Reaction Unit, Uni Health, Uni Research, Bergen,
      Norway
FAU - Fønnebø, Vinjar M.
AU  - Fønnebø VM
AD  - 0000000122595234grid.10919.30Department of Community Medicine, National Research 
      Center in Complementary and Alternative Medicine, NAFKAM, The Arctic University
      of Norway, UiT, Tromsø, 9037 Norway
FAU - Pang, Bing
AU  - Pang B
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Lian, Feng-mei
AU  - Lian Fm
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Ni, Qing
AU  - Ni Q
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Tong, Xiao-lin
AU  - Tong Xl
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Li, Xin-long
AU  - Li Xl
AD  - 0000 0004 0632 3409grid.410318.fInstitute of Basic Research in Clinical Medicine,
      China Academy of Chinese Medical Sciences, Beijing, China
FAU - Liu, Wen-ke
AU  - Liu Wk
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Feng, Shuo
AU  - Feng S
AD  - 0000 0001 1431 9176grid.24695.3cCentre for Evidence-Based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Zhao, Xi-yan
AU  - Zhao Xy
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Zheng, Yu-jiao
AU  - Zheng Yj
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Zhao, Xue-min
AU  - Zhao Xm
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Lin, Yi-qun
AU  - Lin Yq
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Pang, Bing
AU  - Pang B
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Lian, Feng-mei
AU  - Lian Fm
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Tong, Xiao-lin
AU  - Tong Xl
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Zhao, Tian-yu
AU  - Zhao Ty
AD  - 0000 0004 1799 2712grid.412635.7Endocrinology, First Teaching Hospital of Tianjin
      University of Traditional Chinese Medicine, Tianjin, China
FAU - Zhao, Xi-Yan
AU  - Zhao XY
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Phd, Hui Che
AU  - Phd HC
AD  - grid.464481.bDigestion, Xiyuan Hospital of China Academy of Chinese Medical
      Sciences, Beijing, China
FAU - Zhang, Chen
AU  - Zhang C
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Pang, Bing
AU  - Pang B
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Liu, Feng
AU  - Liu F
AD  - Obesity Research Center, Beijing Wuguanda Biological Technology co., LTD.,
      Beijing, 100053 China
FAU - Tong, Xiao-lin
AU  - Tong Xl
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Zhao, Lin-hua
AU  - Zhao Lh
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Zhao, Xue-min
AU  - Zhao Xm
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Ye, Ru
AU  - Ye R
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Gu, Cheng-juan
AU  - Gu Cj
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Pang, Bing
AU  - Pang B
AD  - 0000 0001 1431 9176grid.24695.3cTraditional Chinese Medicine, Centre for
      Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing,
      Beijing, China
FAU - Ni, Qing
AU  - Ni Q
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Tong, Xiao-lin
AU  - Tong Xl
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Lian, Feng-mei
AU  - Lian Fm
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Zhao, Xi-yan
AU  - Zhao Xy
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Jin, De
AU  - Jin D
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Zhao, Xue-min
AU  - Zhao Xm
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Zheng, Yu-jiao
AU  - Zheng Yj
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Lin, Yi-qun
AU  - Lin Yq
AD  - 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital
      of China Academy of Chinese Medical Sciences, Beijing, 100053 China
FAU - Peng, Wenbo
AU  - Peng W
AD  - 0000 0004 1936 7611grid.117476.2Faculty of Health, University of Technology
      Sydney, Sydney, 2007 Australia
FAU - Lauche, Romy
AU  - Lauche R
AD  - 0000 0004 1936 7611grid.117476.2Faculty of Health, University of Technology
      Sydney, Sydney, 2007 Australia
FAU - Sibbritt, David
AU  - Sibbritt D
AD  - 0000 0004 1936 7611grid.117476.2Faculty of Health, University of Technology
      Sydney, Sydney, 2007 Australia
FAU - Adams, Jon
AU  - Adams J
AD  - 0000 0004 1936 7611grid.117476.2Faculty of Health, University of Technology
      Sydney, Sydney, 2007 Australia
FAU - Peng, Wenbo
AU  - Peng W
AD  - 0000 0004 1936 7611grid.117476.2Faculty of Health, University of Technology
      Sydney, Sydney, 2007 Australia
FAU - Wardle, Jon
AU  - Wardle J
AD  - 0000 0004 1936 7611grid.117476.2Faculty of Health, University of Technology
      Sydney, Sydney, 2007 Australia
FAU - Cramer, Holger
AU  - Cramer H
AD  - 0000 0001 2187 5445grid.5718.bFaculty of Medicine, University of Duisburg-Essen, 
      Essen, Germany
FAU - Mishra, Gita
AU  - Mishra G
AD  - 0000 0000 9320 7537grid.1003.2School of Public Health, University of Queensland, 
      Brisbane, Australia
FAU - Lauche, Romy
AU  - Lauche R
AD  - 0000 0004 1936 7611grid.117476.2Faculty of Health, University of Technology
      Sydney, Sydney, 2007 Australia
FAU - Pohlman, Katherine A.
AU  - Pohlman KA
AD  - grid.17089.37University of Alberta, Edmonton, T6G 2C8 Canada
FAU - Mior, Silvano
AU  - Mior S
AD  - 0000 0004 0473 5995grid.418591.0Canadian Memorial Chiropractic College, Toronto, 
      Canada
FAU - Funabashi, Martha
AU  - Funabashi M
AD  - grid.17089.37University of Alberta, Edmonton, T6G 2C8 Canada
FAU - De Carvalho, Diana
AU  - De Carvalho D
AD  - 0000 0000 9130 6822grid.25055.37Memorial University of Newfoundland, St. John’s, 
      Canada
FAU - El-Bayoumi, Mohamed
AU  - El-Bayoumi M
AD  - New Brunswick Chiropractors’ Association, Fredericton, Canada
FAU - Haig, Bob
AU  - Haig B
AD  - Ontario Chiropractic Association, Toronto, Canada
FAU - Kelly, Kimbalin
AU  - Kelly K
AD  - Ontario Chiropractic Association, Toronto, Canada
FAU - Wade, Darrell J.
AU  - Wade DJ
AD  - Newfoundland & Labrador Chiropractic Association, St. John’s, Canada
FAU - O’Beirne, Maeve
AU  - O’Beirne M
AD  - 0000 0004 1936 7697grid.22072.35University of Calgary, Calgary, Canada
FAU - Vohra, Sunita
AU  - Vohra S
AD  - grid.17089.37University of Alberta, Edmonton, T6G 2C8 Canada
FAU - Portalupi, Emanuela
AU  - Portalupi E
AD  - ARESMA, Milano, Italy
FAU - Gobo, Giampietro
AU  - Gobo G
AD  - 0000 0004 1757 2822grid.4708.bDepartment of Philosophy, University of Milano,
      Milano, Italy
FAU - Bellavita, Luigi
AU  - Bellavita L
AD  - ARESMA, Milano, Italy
FAU - Guglielmetti, Chiara
AU  - Guglielmetti C
AD  - 0000 0004 1757 2822grid.4708.bDepartment of Economics, Management and
      Quantitative Methods, University of Milano, DEMM, Milano, Italy
FAU - Raak, Christa
AU  - Raak C
AD  - 0000 0000 9024 6397grid.412581.bInstitute for Integrative Medicine,
      Witten/Herdecke University, Herdecke, 58313 Germany
FAU - Teuber, Myriam
AU  - Teuber M
AD  - H:G - Hochschule für Gesundheit und Sport GmbH, Berlin, 10367 Germany
FAU - Molsberger, Friedrich
AU  - Molsberger F
AD  - H:G - Hochschule für Gesundheit und Sport GmbH, Berlin, 10367 Germany
FAU - von Rath, Ulrich
AU  - von Rath U
AD  - grid.37828.36Institute of Family Medicine, University Hospital
      Schleswig-Holstein, Campus Luebeck, Luebeck, 23570 Germany
FAU - Reichelt, Ulrike
AU  - Reichelt U
AD  - 0000 0001 2111 7257grid.4488.0Technische Universität Dresden, Medizinische
      Fakultät Carl Gustav Carus, Dresden, Germany
FAU - Schwanebeck, Uta
AU  - Schwanebeck U
AD  - Koordinierungszentrum für klinische Studien, Dresden, Germany
FAU - Zeil, Sabine
AU  - Zeil S
AD  - 0000 0001 1091 2917grid.412282.fUniversitätsklinikum Carl Gustav Carus, Klinik
      und Poliklinik für Kinder- und Jugendmedizin, Dresden, Germany
FAU - Vogelberg, Christian
AU  - Vogelberg C
AD  - 0000 0001 1091 2917grid.412282.fUniversitätsklinikum Carl Gustav Carus, Klinik
      und Poliklinik für Kinder- und Jugendmedizin, Dresden, Germany
FAU - Veintimilla, Dolores Rodríguez
AU  - Veintimilla DR
AD  - Clinical Nutrition and Dietetics, SOLCA Cancer Hospital, Guayaquil, 000 Ecuador
FAU - Vollbracht, Claudia
AU  - Vollbracht C
AD  - Pascoe Naturmedizin, Gießen, 35394 Germany
FAU - Mery, Guerrero Tapia
AU  - Mery GT
AD  - Clinical Nutrition and Dietetics, SOLCA Cancer Hospital, Guayaquil, 000 Ecuador
FAU - Villavicencio, Marisol Maldonado
AU  - Villavicencio MM
AD  - Clinical Nutrition and Dietetics, SOLCA Cancer Hospital, Guayaquil, 000 Ecuador
FAU - Moran, Sandra Herrera
AU  - Moran SH
AD  - Clinical Nutrition and Dietetics, SOLCA Cancer Hospital, Guayaquil, 000 Ecuador
FAU - Sachse, Christian
AU  - Sachse C
AD  - Department of Natural Medicine, Immanuel Krankenhaus Berlin-Wannsee, Berlin,
      14109 Germany
FAU - Gündlin, Peter W
AU  - Gündlin PW
AD  - 0000 0004 0593 1824grid.440934.eNaturheilkunde und Komplementäre Medizin,
      Hochschule Fresenius, Idstein (Taunus), Germany
FAU - Stange, Rainer
AU  - Stange R
AD  - Department of Natural Medicine, Immanuel Krankenhaus Berlin-Wannsee, Berlin,
      14109 Germany
FAU - Sahebkarkhorasani, Monirsadat
AU  - Sahebkarkhorasani M
AD  - Iranian Traditional Medicine, Mashhad Medical University, Mashhad, 9172314
      Islamic Republic of Iran
FAU - Azizi, Hoda
AU  - Azizi H
AD  - 0000 0001 2198 6209grid.411583.aDepartment of Complementary Medicine, Mashhad
      University of Medical Sciences, Mashhad, 9135913556 Islamic Republic of Iran
FAU - Schumann, Dania
AU  - Schumann D
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen,
      45276 Germany
FAU - Lauche, Romy
AU  - Lauche R
AD  - 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and
      Integrative Medicine (ARCCIM), Faculty of Health, University of Technology
      Sydney, Sydney, New South Wales Australia
FAU - Sundberg, Tobias
AU  - Sundberg T
AD  - 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and
      Integrative Medicine (ARCCIM), Faculty of Health, University of Technology
      Sydney, Sydney, New South Wales Australia
FAU - Leach, Matthew J.
AU  - Leach MJ
AD  - 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and
      Integrative Medicine (ARCCIM), Faculty of Health, University of Technology
      Sydney, Sydney, New South Wales Australia
FAU - Cramer, Holger
AU  - Cramer H
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen,
      45276 Germany
FAU - Seca, Susana
AU  - Seca S
AD  - Chinese Medicine, Heidelberg School of Chinese Medicine, Heidelberg, Germany
FAU - Greten, Henry
AU  - Greten H
AD  - 0000 0001 1503 7226grid.5808.5Traditional Chinese Medicine, Institute of
      Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal
FAU - Selliah, Sugir
AU  - Selliah S
AD  - 0000 0004 1937 0650grid.7400.3Department of Systematic and Evolutionary Botany,
      University of Zurich, Zürich, 8008 Switzerland
FAU - Shakya, Anu
AU  - Shakya A
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, 04763 South Korea
FAU - Han, Dongwoon
AU  - Han D
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, 04763 South Korea
FAU - Kim, Ha Yun
AU  - Kim HY
AD  - 0000 0001 1364 9317grid.49606.3dHealthcare Administration, Hanyang University,
      Seoul, 133-791 South Korea
FAU - Choi, Da I.
AU  - Choi DI
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, Seoul, South Korea
FAU - Im, Hyea B.
AU  - Im HB
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, Seoul, South Korea
FAU - Choi, Soo J.
AU  - Choi SJ
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, Seoul, South Korea
FAU - Sherbakova, Anna
AU  - Sherbakova A
AD  - 0000 0001 2240 3300grid.10388.32Medizinische Klinik III, UKB, Friedrich
      Wilhelms-Universität Bonn, Bonn, 53127 Germany
FAU - Ulrich-Merzenich, Gudrun
AU  - Ulrich-Merzenich G
AD  - 0000 0001 2240 3300grid.10388.32Medizinische Klinik III, UKB, Friedrich
      Wilhelms-Universität Bonn, Bonn, 53127 Germany
FAU - Kelber, Olaf
AU  - Kelber O
AD  - Phytomeidines Supply and Development Center, Steigerwald Arzneimittelwerk GmbH,
      Bayer Consumer Health, Darmstadt, 64295 Germany
FAU - Abdel-Aziz, Heba
AU  - Abdel-Aziz H
AD  - Bayer Consumer Health, Medicial Affairs, Phytomedicines Supply and Development
      Center, Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany
FAU - Sibinga, Erica
AU  - Sibinga E
AD  - 0000 0001 2171 9311grid.21107.35Pediatrics, Johns Hopkins School of Medicine,
      Baltimore, 21224 MD USA
FAU - Webb, Lindsey
AU  - Webb L
AD  - 0000 0001 2171 9311grid.21107.35Mental Health, Johns Hopkins School of Public
      Health, Baltimore, MD USA
FAU - Ellen, Jonathan
AU  - Ellen J
AD  - 0000 0001 2171 9311grid.21107.35Johns Hopkins School of Public Health, Baltimore,
      MD USA
FAU - Skrautvol, Kari
AU  - Skrautvol K
AD  - 0000 0000 9151 4445grid.412414.6Faculty of Health Sciences, Oslo and Akershus
      University College of Applied Sciences, Oslo, 0130 Norway
FAU - Nåden, Dagfinn
AU  - Nåden D
AD  - 0000 0000 9151 4445grid.412414.6Faculty of Health Sciences, Oslo and Akershus
      University College of Applied Sciences, Oslo, 0130 Norway
FAU - Song, Rhayun
AU  - Song R
AD  - 0000 0001 0722 6377grid.254230.2Department of Nursing, Chungnam National
      University, Daejeon, 301747 South Korea
FAU - Grabowska, Weronika
AU  - Grabowska W
AD  - 0000 0004 0378 8294grid.62560.37Osher Center for Integrative Medicine, Harvard
      Medical School and Brigham and Women’s Hospital, Boston, MA 02215 USA
FAU - Osypiuk, Kamila
AU  - Osypiuk K
AD  - 0000 0004 0378 8294grid.62560.37Osher Center for Integrative Medicine, Harvard
      Medical School and Brigham and Women’s Hospital, Boston, MA 02215 USA
FAU - Diaz, Gloria V.
AU  - Diaz GV
AD  - 000000041936754Xgrid.38142.3cPhysical Medicine & Rehabilitation, Harvard Medical 
      School, Boston, MA USA
FAU - Bonato, Paolo
AU  - Bonato P
AD  - 000000041936754Xgrid.38142.3cPhysical Medicine & Rehabilitation, Harvard Medical 
      School, Boston, MA USA
FAU - Park, Moonkyoung
AU  - Park M
AD  - Nursing, Woosong College, Daejeon, South Korea
FAU - Hausdorff, Jeffrey
AU  - Hausdorff J
AD  - 0000 0004 1937 0546grid.12136.37Sackler Faculty of Medicine, Tel Aviv University,
      Tel Aviv-Yafo, Israel
FAU - Fox, Michael
AU  - Fox M
AD  - 000000041936754Xgrid.38142.3cNeurology, Harvard Medical School, Boston, MA USA
FAU - Sudarsky, Lewis R.
AU  - Sudarsky LR
AD  - 0000 0004 0378 8294grid.62560.37Neurology, Brigham and Women’s Hospital, Boston, 
      MA USA
FAU - Tarsy, Daniel
AU  - Tarsy D
AD  - 000000041936754Xgrid.38142.3cNeurology, Harvard Medical School, Boston, MA USA
FAU - Novakowski, James
AU  - Novakowski J
AD  - 0000 0004 0378 8294grid.62560.37Osher Center for Integrative Medicine, Harvard
      Medical School and Brigham and Women’s Hospital, Boston, MA 02215 USA
FAU - Macklin, Eric A.
AU  - Macklin EA
AD  - 0000 0004 0386 9924grid.32224.35Massachusetts General Hospital, Boston, MA USA
FAU - Wayne, Peter M.
AU  - Wayne PM
AD  - 0000 0004 0378 8294grid.62560.37Osher Center for Integrative Medicine, Harvard
      Medical School and Brigham and Women’s Hospital, Boston, MA 02215 USA
FAU - Song, Rhayun
AU  - Song R
AD  - 0000 0001 0722 6377grid.254230.2Department of Nursing, Chungnam National
      University, Daejeon, 301747 South Korea
FAU - Hwang, Inok
AU  - Hwang I
AD  - 0000 0004 0647 2279grid.411665.1Chungnam National University Hospital, Daejeon,
      South Korea
FAU - Ahn, Sukhee
AU  - Ahn S
AD  - 0000 0001 0722 6377grid.254230.2Department of Nursing, Chungnam National
      University, Daejeon, 301747 South Korea
FAU - Lee, Myung-Ah
AU  - Lee MA
AD  - 0000 0001 2293 5761grid.257409.dKinesiology, Recreation and Sport, Indiana State 
      University, Terre Haute, IN USA
FAU - Wayne, Peter M.
AU  - Wayne PM
AD  - 000000041936754Xgrid.38142.3cHarvard Medical School, Boston, MA 02215 USA
FAU - Sohn, Min K.
AU  - Sohn MK
AD  - 0000 0004 0647 2279grid.411665.1Chungnam National University Hospital, Daejeon,
      South Korea
FAU - Sorokin, Oleg
AU  - Sorokin O
AD  - National Ayurvedic Medical Association of Russia, Novosibirsk, 630108 Russian
      Federation
FAU - Steckhan, Nico
AU  - Steckhan N
AD  - Clinical Naturopathy, Charité Institute of Social Medicine, Epidemiologiy and
      Health Economics, Berlin, 14109 Germany
FAU - Heydeck, Dagmar
AU  - Heydeck D
AD  - Charité Institute of Biochemistry, Berlin, 10117 Germany
FAU - Borchert, Astrid
AU  - Borchert A
AD  - Charité Institute of Biochemistry, Berlin, 10117 Germany
FAU - Hohmann, Christoph-Daniel
AU  - Hohmann CD
AD  - Clinical Naturopathy, Charité Institute of Social Medicine, Epidemiologiy and
      Health Economics, Berlin, 14109 Germany
FAU - Kühn, Harmut
AU  - Kühn H
AD  - Charité Institute of Biochemistry, Berlin, 10117 Germany
FAU - Michalsen, Andreas
AU  - Michalsen A
AD  - Clinical Naturopathy, Charité Institute of Social Medicine, Epidemiologiy and
      Health Economics, Berlin, 14109 Germany
FAU - Kessler, Christian
AU  - Kessler C
AD  - Clinical Naturopathy, Charité Institute of Social Medicine, Epidemiologiy and
      Health Economics, Berlin, 14109 Germany
FAU - Steckhan, Nico
AU  - Steckhan N
AD  - 0000 0001 2218 4662grid.6363.0Institute of Social medicine, Epidemiologiy and
      Health Economics, Charité University Hospital, Berlin, 14109 Germany
FAU - Hohmann, Christoph-Daniel
AU  - Hohmann CD
AD  - 0000 0001 2218 4662grid.6363.0Institute of Social medicine, Epidemiologiy and
      Health Economics, Charité University Hospital, Berlin, 14109 Germany
FAU - Cramer, Holger
AU  - Cramer H
AD  - 0000 0001 2218 4662grid.6363.0Institute of Social medicine, Epidemiologiy and
      Health Economics, Charité University Hospital, Berlin, 14109 Germany
FAU - Michalsen, Andreas
AU  - Michalsen A
AD  - 0000 0001 2218 4662grid.6363.0Institute of Social medicine, Epidemiologiy and
      Health Economics, Charité University Hospital, Berlin, 14109 Germany
FAU - Dobos, Gustav
AU  - Dobos G
AD  - 0000 0001 2218 4662grid.6363.0Institute of Social medicine, Epidemiologiy and
      Health Economics, Charité University Hospital, Berlin, 14109 Germany
FAU - von Scheidt, Christel
AU  - von Scheidt C
AD  - 0000 0001 2218 4662grid.6363.0Institute of Social medicine, Epidemiologiy and
      Health Economics, Charité University Hospital, Berlin, 14109 Germany
FAU - Kirschbaum, Clemens
AU  - Kirschbaum C
AD  - 0000 0001 2218 4662grid.6363.0Institute of Social medicine, Epidemiologiy and
      Health Economics, Charité University Hospital, Berlin, 14109 Germany
FAU - Stalder, Tobias
AU  - Stalder T
AD  - 0000 0001 2218 4662grid.6363.0Institute of Social medicine, Epidemiologiy and
      Health Economics, Charité University Hospital, Berlin, 14109 Germany
FAU - Stöckigt, Barbara
AU  - Stöckigt B
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité - Universitätsmedizin Berlin, Berlin, 10117 Germany
FAU - Teut, Michael
AU  - Teut M
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité - Universitätsmedizin Berlin, Berlin, 10117 Germany
FAU - Suhr, Ralf
AU  - Suhr R
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité - Universitätsmedizin Berlin, Berlin, 10117 Germany
FAU - Sulmann, Daniela
AU  - Sulmann D
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité - Universitätsmedizin Berlin, Berlin, 10117 Germany
FAU - Brinkhaus, Benno
AU  - Brinkhaus B
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité - Universitätsmedizin Berlin, Berlin, 10117 Germany
FAU - Streeter, Chris
AU  - Streeter C
AD  - 0000 0004 1936 7558grid.189504.1Psychiatry, Boston University School of
      Mediicine, Boston, 02118 MA USA
FAU - Gerbarg, Patrica
AU  - Gerbarg P
AD  - 0000 0001 0728 151Xgrid.260917.bPsychiatry, New York Medical College, Valhalla,
      10955 NY USA
FAU - Silveri, Marisa
AU  - Silveri M
AD  - 0000 0004 1936 7558grid.189504.1Psychiatry, Boston University School of
      Mediicine, Boston, 02118 MA USA
FAU - Brown, Richard
AU  - Brown R
AD  - Psychiatry, Columbia College of Surgeon, New York, NY USA
FAU - Jensen, John
AU  - Jensen J
AD  - 000000041936754Xgrid.38142.3cPsychiatry, Harvard University, Belmont, CA USA
FAU - Stritter, Wiebke
AU  - Stritter W
AD  - 0000 0001 2218 4662grid.6363.0Department of Pediatrics, Division of Oncology and 
      Hematology, Charité Universitätsmedizin Berlin, Berlin, 13353 Germany
FAU - Rutert, Britta
AU  - Rutert B
AD  - 0000 0001 2218 4662grid.6363.0Department of Pediatrics, Division of Oncology and 
      Hematology, Charité Universitätsmedizin Berlin, Berlin, 13353 Germany
FAU - Eggert, Angelika
AU  - Eggert A
AD  - 0000 0001 2218 4662grid.6363.0Department of Pediatrics, Division of Oncology and 
      Hematology, Charité Universitätsmedizin Berlin, Berlin, 13353 Germany
FAU - Längler, Alfred
AU  - Längler A
AD  - 0000 0000 9024 6397grid.412581.bInstitute for Integrative Medicine,
      Gemeinschaftskrankenhaus Herdecke, Witten/Herdecke University, Witten/Herdecke,
      Germany
FAU - Seifert, Georg
AU  - Seifert G
AD  - 0000 0001 2218 4662grid.6363.0Department of Pediatrics, Division of Oncology and 
      Hematology, Charité Universitätsmedizin Berlin, Berlin, 13353 Germany
FAU - Holmberg, Christine
AU  - Holmberg C
AD  - 0000 0001 2218 4662grid.6363.0Institute of Public Health, Charité
      Universitätsmedizin Berlin, Berlin, Germany
FAU - Sun, Jin
AU  - Sun J
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence-Based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, 100029 China
FAU - Deng, Xin
AU  - Deng X
AD  - 0000 0004 1759 3543grid.411858.1Guangxi university of Chinese Medicine Affiliated
      Hospital, Guangxi, China
FAU - Li, Wen-Yuan
AU  - Li WY
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence-Based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, 100029 China
FAU - Wen, Bin
AU  - Wen B
AD  - 0000 0004 1759 3543grid.411858.1Guangxi university of Chinese Medicine Affiliated
      Hospital, Guangxi, China
FAU - Robinson, Nicola
AU  - Robinson N
AD  - 0000 0001 2112 2291grid.4756.0Faculty of Health and Social Care, London South
      Bank University, London, UK
FAU - Liu, Jian-Ping
AU  - Liu JP
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence-Based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, 100029 China
FAU - Sung, Hyun K.
AU  - Sung HK
AD  - Institute for Integrative Medicine, Catholic Kwandong University International
      St. Mary’s Hospital, Incheon, South Korea
FAU - Yang, Narae
AU  - Yang N
AD  - Institute for Integrative Medicine, Catholic Kwandong University International
      St. Mary’s Hospital, Incheon, South Korea
FAU - Go, Ho Y.
AU  - Go HY
AD  - 0000 0004 0533 259Xgrid.443977.aInternal Medicine, Semyung University, Chungju,
      South Korea
FAU - Shin, Seon M.
AU  - Shin SM
AD  - 0000 0004 0533 259Xgrid.443977.aInternal Medicine, Semyung University, Jecheon,
      South Korea
FAU - Jung, Hee
AU  - Jung H
AD  - 0000 0001 0098 1097grid.453028.8Korean Medicine, Korea Health Industry
      Development Institute, Osong, South Korea
FAU - Kim, Young J.
AU  - Kim YJ
AD  - 0000 0004 0533 259Xgrid.443977.aInternal Medicine, Semyung University, Chungju,
      South Korea
FAU - Jung, Woo S.
AU  - Jung WS
AD  - 0000 0001 2171 7818grid.289247.2Internal Medicine, Kyunghee University, Seoul,
      South Korea
FAU - Park, Tae Y.
AU  - Park TY
AD  - Institute for Integrative Medicine, Catholic Kwandong University International
      St. Mary’s Hospital, Incheon, South Korea
FAU - Suzuki, Kiyoshi
AU  - Suzuki K
AD  - MOA Health Science Foundation, President, Tokyo, Japan
FAU - Ito, Toshinori
AU  - Ito T
AD  - 0000 0004 0373 3971grid.136593.bOsaka University School of Medicine, Integrative 
      Medicine, Osaka, Japan
FAU - Uchida, Seiya
AU  - Uchida S
AD  - MOA Health Science Foundation, Tokyo, Japan
FAU - Kamohara, Seika
AU  - Kamohara S
AD  - Japan Society of Integrative Medicine, Tokyo, Japan
FAU - Ono, Naoya
AU  - Ono N
AD  - Japan Society of Integrative Medicine, Tokyo, Japan
FAU - Takamura, Mitsuyuki
AU  - Takamura M
AD  - 0000 0004 1769 2015grid.412075.5Kampo medicine outpatient clinic, Mie University 
      Hospital, Tsu, 24201 Japan
FAU - Yokochi, Ayumu
AU  - Yokochi A
AD  - 0000 0004 1769 2015grid.412075.5Pain Clinic, Mie University Hospital, Tsu, 24201 
      Japan
FAU - Maruyama, Kazuo
AU  - Maruyama K
AD  - 0000 0004 1769 2015grid.412075.5Kampo medicine outpatient clinic, Mie University 
      Hospital, Tsu, 24201 Japan
FAU - Tapia, Patricio
AU  - Tapia P
AD  - Department of Family Medicine, School of Medicine, Pontifica Cniversidad Católica
      de Chile, Santiago, 8330077 Chile
FAU - Thabaut, Katarzyna
AU  - Thabaut K
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany
FAU - Brinkhaus, Benno
AU  - Brinkhaus B
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany
FAU - Stöckigt, Barbara
AU  - Stöckigt B
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany
FAU - Thronicke, Anja
AU  - Thronicke A
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Kröz, Matthias
AU  - Kröz M
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Steele, Megan
AU  - Steele M
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Matthes, Harald
AU  - Matthes H
AD  - Hospital Havelhöhe, Berlin, Germany
FAU - Herbstreit, Cornelia
AU  - Herbstreit C
AD  - Hospital Havelhöhe, Berlin, Germany
FAU - Schad, Friedemann
AU  - Schad F
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Tian, Jiaxing
AU  - Tian J
AD  - grid.464297.aGuang’anmen Hospital, China Academy of Chinese Medical Sciences,
      Beijing, 100053 China
FAU - Lian, Fengmei
AU  - Lian F
AD  - grid.464297.aGuang’anmen Hospital, China Academy of Chinese Medical Sciences,
      Beijing, 100053 China
FAU - Yang, Libo
AU  - Yang L
AD  - grid.256883.2Hebei Medical University Pharmaceutical Research Institute,
      Shijiazhuang, 050017 China
FAU - Tong, Xiaolin
AU  - Tong X
AD  - grid.464297.aGuang’anmen Hospital, China Academy of Chinese Medical Sciences,
      Beijing, 100053 China
FAU - Tian, Tian
AU  - Tian T
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, The
      Preclinical medicine Institute, Beijing, China
FAU - Zhang, Hewei
AU  - Zhang H
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, The
      Preclinical medicine Institute, Beijing, China
FAU - Tian, Xia
AU  - Tian X
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Wang, CongCong
AU  - Wang C
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Chai, Qian Yun
AU  - Chai QY
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Zhang, Lijuan
AU  - Zhang L
AD  - 0000 0004 0632 3409grid.410318.fAcupuncture, Xiyuan Hospital CACMS, Beijing,
      China
FAU - Xia, Ruyu
AU  - Xia R
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Huang, Na
AU  - Huang N
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Fei, Yutong
AU  - Fei Y
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Liu, Jianpin
AU  - Liu J
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Trent, Natalie
AU  - Trent N
AD  - 0000 0004 0378 8294grid.62560.37Brigham and Women’s Hospital, Medicine, Boston,
      MA USA
FAU - Miraglia, Mindy
AU  - Miraglia M
AD  - Kripalu Center for Yoga & Health, Stockbridge, MA USA
FAU - Dusek, Jeffrey
AU  - Dusek J
AD  - 0000 0000 8739 9261grid.413636.5Allina Health, Minneapolis, MN USA
FAU - Pasalis, Edi
AU  - Pasalis E
AD  - Kripalu Center for Yoga & Health, Stockbridge, MA USA
FAU - Khalsa, Sat B.
AU  - Khalsa SB
AD  - 0000 0004 0378 8294grid.62560.37Brigham and Women’s Hospital, Medicine, Boston,
      MA USA
FAU - Trifunovic-König, Milena
AU  - Trifunovic-König M
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Centre of Integrative Gastroenterology, Kliniken Essen-Mitte, Faculty of
      Medicine, University of Duisburg-Essen, Essen, Germany
FAU - Klose, Petra
AU  - Klose P
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen,
      Germany
FAU - Cramer, Holger
AU  - Cramer H
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen,
      Germany
FAU - Lauche, Romy
AU  - Lauche R
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen,
      Germany
FAU - Koch, Anna
AU  - Koch A
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Centre of Integrative Gastroenterology, Kliniken Essen-Mitte, Faculty of
      Medicine, University of Duisburg-Essen, Essen, Germany
FAU - Dobos, Gustav
AU  - Dobos G
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen,
      Germany
FAU - Langhorst, Jost
AU  - Langhorst J
AD  - 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine,
      Centre of Integrative Gastroenterology, Kliniken Essen-Mitte, Faculty of
      Medicine, University of Duisburg-Essen, Essen, Germany
FAU - Uebelacker, Lisa
AU  - Uebelacker L
AD  - 0000 0000 8593 9332grid.273271.2Psychosocial Research, Butler Hospital,
      Providence, 02906 RL USA
FAU - Tremont, Geoffrey
AU  - Tremont G
AD  - 0000 0004 1936 9094grid.40263.33Brown University, Providence, RL USA
FAU - Gillette, Lee
AU  - Gillette L
AD  - Independent Yoga Consultant, Providence, RL USA
FAU - Epstein-Lubow, Gary
AU  - Epstein-Lubow G
AD  - 0000 0000 8593 9332grid.273271.2Psychosocial Research, Butler Hospital,
      Providence, 02906 RL USA
FAU - Strong, David
AU  - Strong D
AD  - 0000 0001 2107 4242grid.266100.3UCSD, San Diego, CA USA
FAU - Abrantes, Ana
AU  - Abrantes A
AD  - 0000 0000 8593 9332grid.273271.2Psychosocial Research, Butler Hospital,
      Providence, 02906 RL USA
FAU - Tyrka, Audrey
AU  - Tyrka A
AD  - 0000 0000 8593 9332grid.273271.2Psychosocial Research, Butler Hospital,
      Providence, 02906 RL USA
FAU - Tran, Tanya
AU  - Tran T
AD  - 0000 0001 0557 9478grid.240588.3Rhode Island Hospital, Providence, RL USA
FAU - Gaudiano, Brandon
AU  - Gaudiano B
AD  - 0000 0000 8593 9332grid.273271.2Psychosocial Research, Butler Hospital,
      Providence, 02906 RL USA
FAU - Miller, Ivan
AU  - Miller I
AD  - 0000 0000 8593 9332grid.273271.2Psychosocial Research, Butler Hospital,
      Providence, 02906 RL USA
FAU - Ullmann, Gerhild
AU  - Ullmann G
AD  - 0000 0000 9560 654Xgrid.56061.34Social and Behavioral Sciences, School of Public 
      Health, University of Memphis, Memphis, 38152 TN USA
FAU - Ullmann, Gerhild
AU  - Ullmann G
AD  - 0000 0000 9560 654Xgrid.56061.34Social and Behavioral Sciences, University of
      Memphis, School of Public Health, Memphis, 38152 TN USA
FAU - Li, Yuhua
AU  - Li Y
AD  - 0000 0000 9560 654Xgrid.56061.34Exercise, Sport and Movement Science, University 
      of Memphis, School of Health Studies, Memphis, TN USA
FAU - Vaidya, Sujata
AU  - Vaidya S
AD  - Health Solutions, Pune, India
FAU - Marathe, Vinod
AU  - Marathe V
AD  - Health Solutions, Pune, India
FAU - Vale, Ana C.
AU  - Vale AC
AD  - Clinic, Vila Velha, 29102010 Brazil
FAU - Motta, Jacquelyne
AU  - Motta J
AD  - Clinic, Vila Velha, 29102010 Brazil
FAU - Donadão, Fabíola
AU  - Donadão F
AD  - Clinic, Vila Velha, 29102010 Brazil
FAU - Valente, Angela C.
AU  - Valente AC
AD  - 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do Câncer Infantil –
      Department of Pediatric Oncology, Faculdade de Medicina da Universidade de São
      Paulo, Sao Paulo, 05410-03 Brazil
FAU - Valente, Luana C. Carvalho
AU  - Valente LCC
AD  - 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do Câncer Infantil –
      Department of Pediatric Oncology, Faculdade de Medicina da Universidade de São
      Paulo, Sao Paulo, 05410-03 Brazil
FAU - Ghelman, Ricardo
AU  - Ghelman R
AD  - 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do Câncer Infantil –
      Department of Pediatric Oncology, Faculdade de Medicina da Universidade de São
      Paulo, Sao Paulo, 05410-03 Brazil
FAU - Vesovic, Dusan
AU  - Vesovic D
AD  - VISAN - Sanitary Medical School of Applied Sciences, Belgrade, 11000 Serbia
FAU - Jevdic, Dragan
AU  - Jevdic D
AD  - Private Practice “Astrocit”, Vrsac, Serbia
FAU - Jevdic, Aleksandar
AU  - Jevdic A
AD  - Private Practice “Dr Jevdic”, Vrsac, Serbia
FAU - Jevdic, Katarina
AU  - Jevdic K
AD  - Special Neuropsychiatric Hospital “Dr S. Bakalovic”, Vrsac, Serbia
FAU - Djacic, Mihael
AU  - Djacic M
AD  - Special Neuropsychiatric Hospital “Dr S. Bakalovic”, Vrsac, Serbia
FAU - Letic, Dragica
AU  - Letic D
AD  - Health care Center “1. Oktobar”, Plandiste, Serbia
FAU - Bozic, Drago
AU  - Bozic D
AD  - Health care Center “1. Oktobar”, Plandiste, Serbia
FAU - Markovic, Marija
AU  - Markovic M
AD  - Health care Center “1. Oktobar”, Plandiste, Serbia
FAU - Dunjic, Slobodan
AU  - Dunjic S
AD  - Center for Integrative Procedures and Supplements “Dr Dunjic”, Belgrade, Serbia
FAU - Vesovic, Dusan
AU  - Vesovic D
AD  - VISAN - Sanitary Medical School of Applied Sciences, Belgrade, 11000 Serbia
FAU - Jevdic, Dragan
AU  - Jevdic D
AD  - Private Practice “Astrocit”, Vrsac, Serbia
FAU - Jevdic, Aleksandar
AU  - Jevdic A
AD  - Private Practice “Dr Jevdic”, Vrsac, Serbia
FAU - Jevdic, Katarina
AU  - Jevdic K
AD  - Special Neuropsychiatric Hospital “Dr S. Bakalovic”, Vrsac, Serbia
FAU - Djacic, Mihael
AU  - Djacic M
AD  - Special Neuropsychiatric Hospital “Dr S. Bakalovic”, Vrsac, Serbia
FAU - Letic, Dragica
AU  - Letic D
AD  - Health Care Center “1. Oktobar”, Plandiste, Serbia
FAU - Bozic, Drago
AU  - Bozic D
AD  - Health Care Center “1. Oktobar”, Plandiste, Serbia
FAU - Markovic, Marija
AU  - Markovic M
AD  - Health Care Center “1. Oktobar”, Plandiste, Serbia
FAU - Ruscuklic, Gordana
AU  - Ruscuklic G
AD  - “Planet Zdravja”, Ljubljana, Slovenia
FAU - Baksa, Dezire
AU  - Baksa D
AD  - “Planet Zdravja”, Ljubljana, Slovenia
FAU - Dunjic, Slobodan
AU  - Dunjic S
AD  - Center for Integrative Procedures and Supplements “Dr Dunjic”, Belgrade, Serbia
FAU - Vesovic, Dusan
AU  - Vesovic D
AD  - VISAN - Sanitary Medical School of Applied Sciences, Belgrade, 11000 Serbia
FAU - Jevdic, Dragan
AU  - Jevdic D
AD  - Private Practice “Astrocit”, Vrsac, Serbia
FAU - Jevdic, Aleksandar
AU  - Jevdic A
AD  - Private Practice “Dr Jevdic”, Vrsac, Serbia
FAU - Jevdic, Katarina
AU  - Jevdic K
AD  - Special Neuropsychiatric Hospital “Dr S. Bakalovic”, Vrsac, Serbia
FAU - Djacic, Mihael
AU  - Djacic M
AD  - Special Neuropsychiatric Hospital “Dr S. Bakalovic”, Vrsac, Serbia
FAU - Letic, Dragica
AU  - Letic D
AD  - Health Care Center “1. Oktobar”, Plandiste, Serbia
FAU - Bozic, Drago
AU  - Bozic D
AD  - Health Care Center “1. Oktobar”, Plandiste, Serbia
FAU - Markovic, Marija
AU  - Markovic M
AD  - Health Care Center “1. Oktobar”, Plandiste, Serbia
FAU - Ruscuklic, Gordana
AU  - Ruscuklic G
AD  - “Planet Zdravja”, Ljubljana, Slovenia
FAU - Baksa, Dezire
AU  - Baksa D
AD  - “Planet Zdravja”, Ljubljana, Slovenia
FAU - Dunjic, Slobodan
AU  - Dunjic S
AD  - Center for Integrative Procedures and Supplements “Dr Dunjic”, Belgrade, Serbia
FAU - Vesovic, Dusan
AU  - Vesovic D
AD  - VISAN - Sanitary Medical School of Applied Sciences, Belgrade, 11000 Serbia
FAU - Jevdic, Dragan
AU  - Jevdic D
AD  - Private Practice “Astrocit”, Vrsac, Serbia
FAU - Jevdic, Aleksandar
AU  - Jevdic A
AD  - Private Practice “Dr Jevdic”, Vrsac, Serbia
FAU - Jevdic, Katarina
AU  - Jevdic K
AD  - Special Neuropsychiatric Hospital “Dr S. Bakalovic”, Vrsac, Serbia
FAU - Djacic, Mihael
AU  - Djacic M
AD  - Special Neuropsychiatric Hospital “Dr S. Bakalovic”, Vrsac, Serbia
FAU - Letic, Dragica
AU  - Letic D
AD  - Health Care Center “1. Oktobar”, Plandiste, Serbia
FAU - Bozic, Drago
AU  - Bozic D
AD  - Health Care Center “1. Oktobar”, Plandiste, Serbia
FAU - Markovic, Marija
AU  - Markovic M
AD  - Health Care Center “1. Oktobar”, Plandiste, Serbia
FAU - Ruscuklic, Gordana
AU  - Ruscuklic G
AD  - “Planet Zdravja”, Ljubljana, Slovenia
FAU - Baksa, Dezire
AU  - Baksa D
AD  - “Planet Zdravja”, Ljubljana, Slovenia
FAU - Dunjic, Slobodan
AU  - Dunjic S
AD  - Center for Integrative Procedures and Supplements “Dr Dunjic”, Belgrade, Serbia
FAU - Vesovic, Dusan
AU  - Vesovic D
AD  - VISAN - Sanitary Medical School of Applied Sciences, Belgrade, 11000 Serbia
FAU - Jevdic, Dragan
AU  - Jevdic D
AD  - Private Practice “Astrocit”, Vrsac, Serbia
FAU - Jevdic, Aleksandar
AU  - Jevdic A
AD  - Private Practice “Dr Jevdic”, Vrsac, Serbia
FAU - Jevdic, Katarina
AU  - Jevdic K
AD  - Special Neuropsychiatric Hospital “Dr S. Bakalovic”, Vrsac, Serbia
FAU - Djacic, Mihael
AU  - Djacic M
AD  - Special Neuropsychiatric Hospital “Dr S. Bakalovic”, Vrsac, Serbia
FAU - Letic, Dragica
AU  - Letic D
AD  - Health Care Center “1. Oktobar”, Plandiste, Serbia
FAU - Bozic, Drago
AU  - Bozic D
AD  - Health Care Center “1. Oktobar”, Plandiste, Serbia
FAU - Markovic, Marija
AU  - Markovic M
AD  - Health Care Center “1. Oktobar”, Plandiste, Serbia
FAU - Vrca, Kenan
AU  - Vrca K
AD  - “Planet Zdravja”, Sarajevo, Bosnia and Herzegovina
FAU - Dunjic, Slobodan
AU  - Dunjic S
AD  - Center for Integrative Procedures and Supplements “Dr Dunjic”, Belgrade, Serbia
FAU - Vincent, Ann
AU  - Vincent A
AD  - 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, Rochester, 55905 NY USA
FAU - Wahner-Roedler, Dietlind
AU  - Wahner-Roedler D
AD  - 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, Rochester, 55905 NY USA
FAU - Whipple, Mary
AU  - Whipple M
AD  - 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, Rochester, 55905 NY USA
FAU - Vogelius, Maria M.
AU  - Vogelius MM
AD  - 0000 0001 0674 042Xgrid.5254.6Institute of Public Health, University of
      Copenhagen, Copenhagen, 1353 Denmark
FAU - Vollbracht, Claudia
AU  - Vollbracht C
AD  - Naturopathy & Complementary Medicine, Carl Remigius Medical School, Idstein,
      65510 Germany
FAU - Friesecke, Iris
AU  - Friesecke I
AD  - Naturopathy & Complementary Medicine, Carl Remigius Medical School, Idstein,
      65510 Germany
FAU - Gündling, Peter W.
AU  - Gündling PW
AD  - Naturopathy & Complementary Medicine, Carl Remigius Medical School, Idstein,
      65510 Germany
FAU - Wahner-Roedler, Dietlind
AU  - Wahner-Roedler D
AD  - 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, General Internal Medicine,
      Rochester, NY USA
FAU - Mahapatra, Saswati
AU  - Mahapatra S
AD  - 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, General Internal Medicine,
      Rochester, NY USA
FAU - Hynes, Rebecca
AU  - Hynes R
AD  - 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, General Internal Medicine,
      Rochester, NY USA
FAU - Van Rooy, Kimberly
AU  - Van Rooy K
AD  - 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, General Internal Medicine,
      Rochester, NY USA
FAU - Looker, Sherry
AU  - Looker S
AD  - 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, General Internal Medicine,
      Rochester, NY USA
FAU - Ghosh, Aditya
AU  - Ghosh A
AD  - 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, General Internal Medicine,
      Rochester, NY USA
FAU - Bauer, Brent
AU  - Bauer B
AD  - 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, General Internal Medicine,
      Rochester, NY USA
FAU - Cutshall, Susanne
AU  - Cutshall S
AD  - 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, General Internal Medicine,
      Rochester, NY USA
FAU - Walach, Harald
AU  - Walach H
AD  - 0000 0001 2205 0971grid.22254.33Pediatric Gastroenterology, Poznan Medical
      University, Poznan, 60-572 Poland
FAU - Flores, Ana Borges
AU  - Flores AB
AD  - 0000 0004 1936 7988grid.4305.2Department of Psychology, University of Edinburgh, 
      Edinburgh, UK
FAU - Walach, Harald
AU  - Walach H
AD  - 0000 0001 2205 0971grid.22254.33Pediatric Gastroenterology, Poznan Medical
      University, Poznan, 60-572 Poland
FAU - Ofner, Michael
AU  - Ofner M
AD  - 0000 0000 8988 2476grid.11598.34Institute of Pathophysiology, Medical University 
      Graz, Graz, Austria
FAU - Kastner, Andreas
AU  - Kastner A
AD  - 0000 0001 1941 5140grid.9970.7Department of Traumatology, University of Linz,
      Linz, Austria
FAU - Schwarzl, Gerhard
AU  - Schwarzl G
AD  - 0000 0001 1941 5140grid.9970.7Department of Radiology, University of Linz, Linz, 
      Austria
FAU - Schwameder, Hermann
AU  - Schwameder H
AD  - 0000000110156330grid.7039.dSports Science, University of Salzburg, Salzburg,
      Austria
FAU - Alexander, Nathalie
AU  - Alexander N
AD  - 0000000110156330grid.7039.dSports Science, University of Salzburg, Salzburg,
      Austria
FAU - Strutzenberger, Gerda
AU  - Strutzenberger G
AD  - 0000000110156330grid.7039.dSports Science, University of Salzburg, Salzburg,
      Austria
FAU - Wang, Jie
AU  - Wang J
AD  - 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Lu, Yan
AU  - Lu Y
AD  - 0000 0004 0632 3409grid.410318.fEmergency Department, Xiyuan Hospital, China
      Academy of Chinese Medical Science, Beijing, China
FAU - Gu, Wen
AU  - Gu W
AD  - grid.459365.8Department of Rheumatology, Beijing Hospital of Traditional Chinese 
      Medicine, Beijing, China
FAU - Zhang, Chengcheng
AU  - Zhang C
AD  - 0000 0001 1431 9176grid.24695.3cDepartment of Nephrology, Dongfang Hospital,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Bu, Xianwei
AU  - Bu X
AD  - 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Zhang, Honghong
AU  - Zhang H
AD  - 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Zhang, Jianping
AU  - Zhang J
AD  - 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital,
      Beijing University of Chinese Medicine, Beijing, China
FAU - He, Yuxi
AU  - He Y
AD  - 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Zhang, Xiaoxu
AU  - Zhang X
AD  - 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Meng, Fengxian
AU  - Meng F
AD  - 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Wang, Shang
AU  - Wang S
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Yu, He
AU  - Yu H
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Shi, Jinfeng
AU  - Shi J
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Hao, Yu
AU  - Hao Y
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Liu, Tiegang
AU  - Liu T
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Wu, Jun
AU  - Wu J
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Qiu, Zeji
AU  - Qiu Z
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Gu, Xiaohong
AU  - Gu X
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Wang, Yuh-Hai
AU  - Wang YH
AD  - grid.445029.eNatural Biotechnology, Nanhua University, Dalin, 622 Taiwan
FAU - Lou, Chi-Jung
AU  - Lou CJ
AD  - grid.445029.eNatural Biotechnology, Nanhua University, Dalin, 622 Taiwan
FAU - Watts, Sam
AU  - Watts S
AD  - 0000 0004 1936 9297grid.5491.9Primary Care, University of Southampton,
      Southhampton, SO16 5ST UK
FAU - Wayne, Peter
AU  - Wayne P
AD  - 0000 0004 0378 8294grid.62560.37Osher Center for Integrative Medicine, BWH/HMS,
      Boston, MA USA
FAU - Osypiuk, Kamila
AU  - Osypiuk K
AD  - 0000 0004 0378 8294grid.62560.37Osher Center for Integrative Medicine, BWH/HMS,
      Boston, MA USA
FAU - Vergara-Diaz, Gloria
AU  - Vergara-Diaz G
AD  - 000000041936754Xgrid.38142.3cPhysical Medicine & Rehabilitation, Spaulding
      Rehabilitation Hospital, Harvard Medical School, Boston, MA USA
FAU - Bonato, Paolo
AU  - Bonato P
AD  - 000000041936754Xgrid.38142.3cPhysical Medicine & Rehabilitation, Spaulding
      Rehabilitation Hospital, Harvard Medical School, Boston, MA USA
FAU - Gow, Brian
AU  - Gow B
AD  - 0000 0004 0378 8294grid.62560.37Osher Center for Integrative Medicine, BWH/HMS,
      Boston, MA USA
FAU - Hausdorff, Jeffrey
AU  - Hausdorff J
AD  - 0000 0004 1937 0546grid.12136.37Sackler Faculty of Medicine, Tel Aviv University,
      Tel Aviv, Israel
FAU - Miranda, Jose
AU  - Miranda J
AD  - 0000 0004 0451 8771grid.416228.bSpaulding Rehabilitation Hospital, Physical
      Medicine & Rehabilitation, Boston, MA USA
FAU - Sudarsky, Lewis
AU  - Sudarsky L
AD  - 0000 0004 0378 8294grid.62560.37Neurology, Brigham and Women’s Hospital, Boston, 
      MA USA
FAU - Tarsy, Daniel
AU  - Tarsy D
AD  - 0000 0000 9011 8547grid.239395.7Beth Israel Deaconess Medical Center, Boston, MA 
      USA
FAU - Fox, Michael
AU  - Fox M
AD  - 0000 0000 9011 8547grid.239395.7Laboratory of Brain Network Imaging and
      Modulation, Beth Israel Deaconess Medical Center, Boston, MA USA
FAU - Macklin, Eric
AU  - Macklin E
AD  - 0000 0004 0386 9924grid.32224.35Massachusetts General Hospital, Boston, MA USA
FAU - Wode, Kathrin
AU  - Wode K
AD  - Regional Cancer Center Stockholm Gotland, Stockholm, Sweden
FAU - Bergqvist, Jenny
AU  - Bergqvist J
AD  - 0000 0004 0623 9776grid.440104.5St Görans Hospital, Stockholm, Sweden
FAU - Bernhardsson, Britt-Marie
AU  - Bernhardsson BM
AD  - 0000 0004 1937 0626grid.4714.6Karolinska Institutet, Stockholm, Sweden
FAU - Nordberg, Johanna Hök
AU  - Nordberg JH
AD  - Regional Cancer Center Stockholm Gotland, Stockholm, Sweden
FAU - Kienle, Gunver
AU  - Kienle G
AD  - 0000 0000 9428 7911grid.7708.8Center for Complementary Medicine, Institute for
      Environmental Health Sciences and Hospital Infection Control, Medical Center –
      University of Freiburg, Freiburg, Germany
FAU - Sharp, Lena
AU  - Sharp L
AD  - Regional Cancer Center Stockholm Gotland, Stockholm, Sweden
FAU - Henriksson, Roger
AU  - Henriksson R
AD  - Regional Cancer Center Stockholm Gotland, Stockholm, Sweden
FAU - Woo, Yeonju
AU  - Woo Y
AD  - 0000 0001 0671 5021grid.255168.dPreventive Medicine, College of Korean Medicine, 
      Dongguk University Graduate School, Seoul, South Korea
FAU - Hyun, Min K.
AU  - Hyun MK
AD  - 0000 0001 0671 5021grid.255168.dPreventive medicine, College of Korean Medicine, 
      Dongguk University, Gyeongju-si, South Korea
FAU - Wu, Hao
AU  - Wu H
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, TCM
      Diagnostics, Beijing, China
FAU - Wang, Tian-Fang
AU  - Wang TF
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, TCM
      Diagnostics, Beijing, China
FAU - Zhao, Yan
AU  - Zhao Y
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, TCM
      Diagnostics, Beijing, China
FAU - Wei, Yu
AU  - Wei Y
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, TCM
      Diagnostics, Beijing, China
FAU - Tian, Lei
AU  - Tian L
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, TCM
      Diagnostics, Beijing, China
FAU - He, Lei
AU  - He L
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, TCM
      Diagnostics, Beijing, China
FAU - Wang, Xue
AU  - Wang X
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, TCM
      Diagnostics, Beijing, China
FAU - Wu, Ruohan
AU  - Wu R
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Feng, Shuo
AU  - Feng S
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Han, Mei
AU  - Han M
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Caldwell, Patrina H. Y.
AU  - Caldwell PHY
AD  - 0000 0004 1936 834Xgrid.1013.3The Children’s Hospital at Westmead and Discipline 
      of Paediatrics and Child Health, University of Sydney, Sydney, Australia
FAU - Liu, Shigang
AU  - Liu S
AD  - grid.464297.aGuang’anmen Hospital, China Academy of Chinese Medical Sciences,
      Beijing, China
FAU - Zhang, Jing
AU  - Zhang J
AD  - 0000 0004 1936 8972grid.25879.31Department of Biostatistics and Epidemiology,
      University of Pennsylvania, Philadelphia, USA
FAU - Liu, Jianping
AU  - Liu J
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Xia, Ruyu
AU  - Xia R
AD  - 0000 0001 1431 9176grid.24695.3cCentre for Evidence-Based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Chai, Qianyun
AU  - Chai Q
AD  - Journal of Traditional Chinese Medicine, Beijing, China
FAU - Fei, Yutong
AU  - Fei Y
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      China
FAU - Guo, Zhongning
AU  - Guo Z
AD  - grid.464481.bDepartment of Oncology, Xiyuan Hospital, China Academy of Chinese
      Medical Sciences, Beijing, China
FAU - Wang, Congcong
AU  - Wang C
AD  - China Association of Traditional Chinese Medicine, Beijing, China
FAU - Liu, Zhijun
AU  - Liu Z
AD  - Beijing Kawin Technology Share-holding CO., Ltd, Beijing, China
FAU - Li, Xun
AU  - Li X
AD  - 0000 0001 1431 9176grid.24695.3cCentre for Evidence-Based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Zhang, Ying
AU  - Zhang Y
AD  - 0000 0001 1431 9176grid.24695.3cCentre for Evidence-Based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Liu, Jianping
AU  - Liu J
AD  - 0000 0001 1431 9176grid.24695.3cCentre for Evidence-Based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Yang, I. J.
AU  - Yang IJ
AD  - 0000 0001 0671 5021grid.255168.dDongguk University College of Korean Medicine,
      Physiology, Gyeongju-si, South Korea
FAU - Lincha, V. Ruberio
AU  - Lincha VR
AD  - 0000 0001 0671 5021grid.255168.dDongguk University College of Korean Medicine,
      Physiology, Gyeongju-si, South Korea
FAU - Ahn, S. H.
AU  - Ahn SH
AD  - 0000 0001 0671 5021grid.255168.dDongguk University College of Korean Medicine,
      Anatomy, Gyeongju-si, South Korea
FAU - Lee, D. U.
AU  - Lee DU
AD  - 0000 0001 0671 5021grid.255168.dDongguk University, Division of Bioscience,
      Gyeongju-si, South Korea
FAU - Shin, H. M.
AU  - Shin HM
AD  - 0000 0001 0671 5021grid.255168.dDongguk University College of Korean Medicine,
      Physiology, Gyeongju-si, South Korea
FAU - Yang, Lu
AU  - Yang L
AD  - 0000 0004 1936 7611grid.117476.2University of Technology Sydney, Ultimo, 2007
      Australia
FAU - Sibbritt, David
AU  - Sibbritt D
AD  - 0000 0004 1936 7611grid.117476.2University of Technology Sydney, Ultimo, 2007
      Australia
FAU - Peng, Wenbo
AU  - Peng W
AD  - 0000 0004 1936 7611grid.117476.2University of Technology Sydney, Ultimo, 2007
      Australia
FAU - Adams, Jon
AU  - Adams J
AD  - 0000 0004 1936 7611grid.117476.2University of Technology Sydney, Ultimo, 2007
      Australia
FAU - Yang, N.
AU  - Yang N
AD  - Catholic Kwandong University Int St.Mary’s Hospital, Integrative Medicine,
      Incheon, South Korea
FAU - Sung, H.
AU  - Sung H
AD  - 0000 0004 0533 259Xgrid.443977.aCollege of Korean Medicine, Semyung University,
      Korean Internal Medicine, Chungju, South Korea
FAU - Shin, S. M.
AU  - Shin SM
AD  - 0000 0004 0533 259Xgrid.443977.aCollege of Korean Medicine, Semyung University,
      Korean Internal Medicine, Jecheon, South Korea
FAU - Go, H. Y.
AU  - Go HY
AD  - 0000 0004 0533 259Xgrid.443977.aCollege of Korean Medicine, Semyung University,
      Korean Internal Medicine, Chungju, South Korea
FAU - Jung, H.
AU  - Jung H
AD  - 0000 0001 0098 1097grid.453028.8Korea Health Industry Development Institute,
      Korean Medicine, Osong, South Korea
FAU - Kim, Y.
AU  - Kim Y
AD  - 0000 0004 0533 259Xgrid.443977.aCollege of Korean Medicine, Semyung University,
      Korean Internal Medicine, Chungju, South Korea
FAU - Park, T. Y.
AU  - Park TY
AD  - Catholic Kwandong University Int St.Mary’s hospital, Incheon, South Korea
FAU - Yap, Angela
AU  - Yap A
AD  - 0000 0004 0385 0924grid.428397.3Duke-NUS Medical School, Singapore, Singapore
FAU - Kwan, Yu H.
AU  - Kwan YH
AD  - 0000 0004 0385 0924grid.428397.3Duke-NUS Medical School, Singapore, Singapore
FAU - Tan, Chuen S.
AU  - Tan CS
AD  - 0000 0001 2180 6431grid.4280.eNational University of Singapore, Singapore,
      Singapore
FAU - Ibrahim, Syed
AU  - Ibrahim S
AD  - OneHeartBeat Percussions, Singapore, Singapore
FAU - Ang, Seng B.
AU  - Ang SB
AD  - 0000 0000 8958 3388grid.414963.dKK Women’s and Children’s Hospital, Singapore,
      Singapore
FAU - Yayi, Alfred
AU  - Yayi A
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, South Korea
FAU - Han, Dongwoon
AU  - Han D
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, South Korea
FAU - Im, Hyea Bin
AU  - Im HB
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, South Korea
FAU - Hwang, Jung Hye
AU  - Hwang JH
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, South Korea
FAU - Choi, Soo Jeung
AU  - Choi SJ
AD  - 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang
      University, College of Medicine, Seoul, South Korea
FAU - Yoo, Jeong E.
AU  - Yoo JE
AD  - 0000 0001 0523 5122grid.411948.1Daejeon University, Obstetrics and Gynecology,
      Daejeon, South Korea
FAU - Yoo, Ho R.
AU  - Yoo HR
AD  - 0000 0001 0523 5122grid.411948.1Daejeon University, Daejeon, South Korea
FAU - Jang, Sae B.
AU  - Jang SB
AD  - 0000 0001 0523 5122grid.411948.1Daejeon University, Obstetrics and Gynecology,
      Daejeon, South Korea
FAU - Lee, Hye L.
AU  - Lee HL
AD  - 0000 0004 0647 2973grid.256155.0Gachon University, College of Korean Medicine,
      Seongnam, South Korea
FAU - Youssef, Ala’a
AU  - Youssef A
AD  - Heliopolis University for Sustainable Development, Medicinal Plants, Nasr City,
      Egypt
FAU - Ezzat, Shahira
AU  - Ezzat S
AD  - 0000 0004 0639 9286grid.7776.1Cairo University, Medicinal Plants, Cairo, Egypt
FAU - Motaal, Amira Abdel
AU  - Motaal AA
AD  - 0000 0004 0639 9286grid.7776.1Cairo University, Medicinal Plants, Cairo, Egypt
FAU - El-Askary, Hesham
AU  - El-Askary H
AD  - 0000 0004 0639 9286grid.7776.1Cairo University, Medicinal Plants, Cairo, Egypt
FAU - Yu, Xiaotong
AU  - Yu X
AD  - grid.464297.aGuang’anmen Hospital, China Academy of Chinese Medical Sciences,
      Beijing, China
FAU - Cui, Yashan
AU  - Cui Y
AD  - grid.464297.aGuang’anmen Hospital, China Academy of Chinese Medical Sciences,
      Beijing, China
FAU - Zhang, Ying
AU  - Zhang Y
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      China
FAU - Lian, Fengmei
AU  - Lian F
AD  - grid.464297.aGuang’anmen Hospital, China Academy of Chinese Medical Sciences,
      Beijing, China
FAU - Yun, Younghee
AU  - Yun Y
AD  - 0000 0001 0357 1464grid.411231.4Department of Korean Medicine Dermatology, Kyung 
      Hee University Hospital at Gangdong, Seoul, South Korea
FAU - Ko, Youme
AU  - Ko Y
AD  - 0000 0001 2171 7818grid.289247.2Department of Preventive Medicine, Graduate
      School, Kyung Hee University, Seoul, South Korea
FAU - Ahn, Jin-Hyang
AU  - Ahn JH
AD  - 0000 0001 0357 1464grid.411231.4Department of Korean Medicine Dermatology, Kyung 
      Hee University Hospital at Gangdong, Seoul, South Korea
FAU - Jang, Bo-Hyung
AU  - Jang BH
AD  - 0000 0001 2171 7818grid.289247.2Department of Preventive Medicine, Graduate
      School, Kyung Hee University, Seoul, South Korea
FAU - Kim, Kyu-Seok
AU  - Kim KS
AD  - 0000 0001 2171 7818grid.289247.2Department of Dermatology of Korean Medicine,
      Kyung Hee University, Seoul, South Korea
FAU - Ko, Seong-Gyu
AU  - Ko SG
AD  - 0000 0001 2171 7818grid.289247.2Department of Preventive Medicine, Graduate
      School, Kyung Hee University, Seoul, South Korea
FAU - Choi, Inhwa
AU  - Choi I
AD  - 0000 0001 0357 1464grid.411231.4Department of Korean Medicine Dermatology, Kyung 
      Hee University Hospital at Gangdong, Seoul, South Korea
FAU - Zerm, Roland
AU  - Zerm R
AD  - FIH-Berlin, Berlin, Germany
FAU - Glinz, Augustina
AU  - Glinz A
AD  - FIH-Berlin, Berlin, Germany
FAU - Pranga, Danilo
AU  - Pranga D
AD  - FIH-Berlin, Berlin, Germany
FAU - Berger, Bettina
AU  - Berger B
AD  - 0000 0000 9024 6397grid.412581.bInstitute for Integrative Medicine, University
      Witten/Herdecke, Witten, Germany
FAU - ten Brink, Fadime
AU  - ten Brink F
AD  - 0000 0000 9529 9877grid.10423.34Hannover Medical School, Clinic for
      Rehabilitative Medicine, Hannover, Germany
FAU - Reif, Marcus
AU  - Reif M
AD  - Society for Clinical Research, Berlin, Germany
FAU - Büssing, Arnd
AU  - Büssing A
AD  - Internal Medicine, Gemeinschaftskrankenhaus Havelhöne, Berlin, Germany
FAU - Gutenbrunner, Christoph
AU  - Gutenbrunner C
AD  - Society for Clinical Research, Berlin, Germany
FAU - Kröz, Matthias
AU  - Kröz M
AD  - FIH-Berlin, Berlin, Germany
FAU - Zerm, Roland
AU  - Zerm R
AD  - FIH-Berlin, Berlin, Germany
FAU - Helbrecht, Bert
AU  - Helbrecht B
AD  - FIH-Berlin, Berlin, Germany
FAU - Pranga, Danilo
AU  - Pranga D
AD  - FIH-Berlin, Berlin, Germany
FAU - Brinkhaus, Benno
AU  - Brinkhaus B
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité University Hospital, Berlin, Germany
FAU - Michalsen, Andreas
AU  - Michalsen A
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité University Hospital, Berlin, Germany
FAU - Kröz, Matthias
AU  - Kröz M
AD  - FIH-Berlin, Berlin, Germany
FAU - Zhang, Honghong
AU  - Zhang H
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Rheumatology, Beijing, China
FAU - Fang, Tiesheng
AU  - Fang T
AD  - Community Health Service Center of Yangsong Town, Traditional Chinese Medicine,
      Beijing, China
FAU - Wang, Jie
AU  - Wang J
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Rheumatology, Beijing, China
FAU - Zhang, Chengcheng
AU  - Zhang C
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Nephrology, Beijing, China
FAU - He, Yuxi
AU  - He Y
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Rheumatology, Beijing, China
FAU - Zhang, Xiaoxu
AU  - Zhang X
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Rheumatology, Beijing, China
FAU - Zhang, Zhengju
AU  - Zhang Z
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Rheumatology, Beijing, China
FAU - Wang, Dali
AU  - Wang D
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Rheumatology, Beijing, China
FAU - Meng, Fengxion
AU  - Meng F
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Rheumatology, Beijing, China
FAU - Zhang, Jianping
AU  - Zhang J
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Beijing China, Rheumatology, Beijing, China
FAU - Zhang, Chengcheng
AU  - Zhang C
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Beijing China, Rheumatology, Beijing, China
FAU - Bai, Hua
AU  - Bai H
AD  - Xiluoyuan Community Health Service Center, Fengtai District, Beijing, China,
      Traditional Chinese Medicin, Beijing, China
FAU - Shen, Zhiming
AU  - Shen Z
AD  - Jingzhou Central Hospital of Hubei Province, China, Hubei, China
FAU - Ma, Weiguo
AU  - Ma W
AD  - Jingzhou Central Hospital of Hubei Province, China, Hubei, China
FAU - Liu, Hui
AU  - Liu H
AD  - Jingzhou Central Hospital of Hubei Province, China, Hubei, China
FAU - Bai, Yu
AU  - Bai Y
AD  - Jingzhou Central Hospital of Hubei Province, China, Hubei, China
FAU - Shang, Xuezheng
AU  - Shang X
AD  - Jingzhou Central Hospital of Hubei Province, China, Hubei, China
FAU - Meng, Fengxian
AU  - Meng F
AD  - Jingzhou Central Hospital of Hubei Province, China, Hubei, China
FAU - Zhang, Ruixin
AU  - Zhang R
AD  - Center for Integrative Medicine, University of Maryland, Baltimore, MD USA
FAU - Wu, Fan
AU  - Wu F
AD  - 0000 0001 2372 7462grid.412540.6Shanghai University of Traditional Chinese
      Medicine, Shanghai, China
FAU - Li, Ming
AU  - Li M
AD  - 0000 0001 2372 7462grid.412540.6Shanghai University of Traditional Chinese
      Medicine, Shanghai, China
FAU - Xuan, Xinyun
AU  - Xuan X
AD  - Center for Integrative Medicine, University of Maryland, Baltimore, MD USA
FAU - Shen, Xueyong
AU  - Shen X
AD  - 0000 0001 2372 7462grid.412540.6Shanghai University of Traditional Chinese
      Medicine, Shanghai, China
FAU - Ren, Ke
AU  - Ren K
AD  - Department of Neural and Pain Sciences, Dental School, University of Maryland,
      Baltimore, MD USA
FAU - Berman, Brian
AU  - Berman B
AD  - Center for Integrative Medicine, University of Maryland, Baltimore, MD USA
FAU - Zhen, Jianhua
AU  - Zhen J
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Li, Xiaofei
AU  - Li X
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Gu, Xiaohong
AU  - Gu X
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Yu, He
AU  - Yu H
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Zheng, Zian
AU  - Zheng Z
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Wan, Yuxiang
AU  - Wan Y
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Wang, Yunhui
AU  - Wang Y
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Ma, Xueyan
AU  - Ma X
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Dong, Fei
AU  - Dong F
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Liu, Tiegang
AU  - Liu T
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Zhen, Jianhua
AU  - Zhen J
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Li, Xiaofei
AU  - Li X
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Gu, Xiaohong
AU  - Gu X
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Yu, He
AU  - Yu H
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Zheng, Zian
AU  - Zheng Z
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Wan, Yuxiang
AU  - Wan Y
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Wang, Yunhui
AU  - Wang Y
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Ma, Xueyan
AU  - Ma X
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Dong, Fei
AU  - Dong F
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Liu, Tiegang
AU  - Liu T
AD  - 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of
      Chinese Medicine, Beijing, 100029 China
FAU - Zick, Suzie
AU  - Zick S
AD  - 0000000086837370grid.214458.eFamily Medicine, University of Michigan, Ann Arbor, 
      MI 48105 USA
FAU - Harris, Richard
AU  - Harris R
AD  - 0000000086837370grid.214458.eFamily Medicine, University of Michigan, Ann Arbor, 
      MI 48105 USA
FAU - Bae, Go E.
AU  - Bae GE
AD  - 0000 0001 0719 8572grid.262229.fPusan National University Korean Medicine
      Hospital, Internal Medicine, Yangsan-si, South Korea
FAU - Kwon, Jung N.
AU  - Kwon JN
AD  - 0000 0001 0719 8572grid.262229.fPusan National University Korean Medicine
      Hospital, Internal Medicine, Yangsan-si, South Korea
FAU - Lee, Hye Y.
AU  - Lee HY
AD  - 0000 0001 0719 8572grid.262229.fPusan National University Korean Medicine
      Hospital, Internal Medicine, Yangsan-si, South Korea
FAU - Nam, Jong K.
AU  - Nam JK
AD  - 0000 0004 0442 9883grid.412591.aDepartment of Urology, Pusan National University 
      Yangsan Hospital, Yangsan, South Korea
FAU - Lee, Sang D.
AU  - Lee SD
AD  - 0000 0004 0442 9883grid.412591.aDepartment of Urology, Pusan National University 
      Yangsan Hospital, Yangsan, South Korea
FAU - Lee, Dong H.
AU  - Lee DH
AD  - 0000 0004 0442 9883grid.412591.aDepartment of Urology, Pusan National University 
      Yangsan Hospital, Yangsan, South Korea
FAU - Han, Ji Y.
AU  - Han JY
AD  - 0000 0004 0442 9883grid.412591.aDepartment of Urology, Pusan National University 
      Yangsan Hospital, Yangsan, South Korea
FAU - Yun, Young J.
AU  - Yun YJ
AD  - 0000 0001 0719 8572grid.262229.fPusan National University Korean Medicine
      Hospital, Internal Medicine, Yangsan-si, South Korea
FAU - Lee, Ji H.
AU  - Lee JH
AD  - 0000 0001 0719 8572grid.262229.fPusan National University Korean Medicine
      Hospital, Internal Medicine, Yangsan-si, South Korea
FAU - Park, Hye L.
AU  - Park HL
AD  - 0000 0001 0719 8572grid.262229.fPusan National University Korean Medicine
      Hospital, Internal Medicine, Yangsan-si, South Korea
FAU - Park, Seong H.
AU  - Park SH
AD  - 0000 0001 0719 8572grid.262229.fPusan National University Korean Medicine
      Hospital, Internal Medicine, Yangsan-si, South Korea
FAU - Bocci, Chiara
AU  - Bocci C
AD  - S. Maugeri Fondation, Pavia, 27100 Italy
FAU - Ivaldi, Giovanni B.
AU  - Ivaldi GB
AD  - S. Maugeri Fondation, Pavia, 27100 Italy
FAU - Vietti, Ilaria
AU  - Vietti I
AD  - S. Maugeri Fondation, Pavia, 27100 Italy
FAU - Meaglia, Ilaria
AU  - Meaglia I
AD  - S. Maugeri Fondation, Pavia, 27100 Italy
FAU - Guffi, Marta
AU  - Guffi M
AD  - S. Maugeri Fondation, Pavia, 27100 Italy
FAU - Ruggiero, Rubina
AU  - Ruggiero R
AD  - S. Maugeri Fondation, Pavia, 27100 Italy
FAU - Gualea, Marita
AU  - Gualea M
AD  - S. Maugeri Fondation, Pavia, 27100 Italy
FAU - Longa, Emanuela
AU  - Longa E
AD  - S. Maugeri Fondation, Pavia, 27100 Italy
FAU - Bonucci, Massimo
AU  - Bonucci M
AD  - S. Feliciano Hospital, Outpatient Oncology, Rome, Italy
FAU - Croke, Sarah
AU  - Croke S
AD  - 0000 0004 1936 8403grid.9909.9School of Heathcare, University of Leeds Alumnus,
      Rochdale, OL12 7RX UK
FAU - Rodriguez, Lourdes Diaz
AU  - Rodriguez LD
AD  - Nursing, Faculty of Health Sciences/University of Granada, Granada, 18971 Spain
FAU - Caracuel-Martínez, Juan C.
AU  - Caracuel-Martínez JC
AD  - Physiotherapy Unit, University Hospital San Cecilio/Health Andalusian Service,
      Granada, Spain
FAU - Fajardo-Rodríguez, Manuel F.
AU  - Fajardo-Rodríguez MF
AD  - Physiotherapy Unit, University Hospital San Cecilio/Health Andalusian Service,
      Granada, Spain
FAU - Ariza-García, Angélica
AU  - Ariza-García A
AD  - Physiotherapy Unit, University Hospital San Cecilio/Health Andalusian Service,
      Granada, Spain
FAU - la Fuente, Francisca García-De
AU  - la Fuente FGD
AD  - Physiotherapy Unit, University Hospital San Cecilio/Health Andalusian Service,
      Granada, Spain
FAU - Arroyo-Morales, Manuel
AU  - Arroyo-Morales M
AD  - Nursing, Faculty of Health Sciences/University of Granada, Granada, 18971 Spain
FAU - Estrems, Maria S.
AU  - Estrems MS
AD  - Fundació Sànitaria de Mollet, Surgery, Barcelona, Spain
FAU - Gómez, Vicente G.
AU  - Gómez VG
AD  - 0000 0004 1767 5311grid.459594.0Hospital de Viladecans, Barcelona, Spain
FAU - Estrems, Maria S.
AU  - Estrems MS
AD  - Fundació Sànitaria de Mollet, Surgery, Barcelona, Spain
FAU - Sabater, Mónica Valero
AU  - Sabater MV
AD  - 0000 0004 1764 9746grid.413293.eHospital Royo Villanova, Zaragoza, Spain
FAU - Ferreri, Rosaria
AU  - Ferreri R
AD  - Hospital Centre of Integrated Medicine, Hospital of Pitigliano ASL Sudest
      Toscana, Grosseto, 58100 Italy
FAU - Bernardini, Simonetta
AU  - Bernardini S
AD  - Hospital Centre of Integrated Medicine, Hospital of Pitigliano ASL Sudest
      Toscana, Grosseto, 58100 Italy
FAU - Pulcri, Roberto
AU  - Pulcri R
AD  - Hospital Centre of Integrated Medicine, Hospital of Pitigliano ASL Sudest
      Toscana, Grosseto, 58100 Italy
FAU - Cracolici, Franco
AU  - Cracolici F
AD  - Hospital Centre of Integrated Medicine, Hospital of Pitigliano ASL Sudest
      Toscana, Grosseto, 58100 Italy
FAU - Rinaldi, Massimo
AU  - Rinaldi M
AD  - Hospital Centre of Integrated Medicine, Hospital of Pitigliano ASL Sudest
      Toscana, Grosseto, 58100 Italy
FAU - Porciani, Claudio
AU  - Porciani C
AD  - Hospital Centre of Integrated Medicine, Hospital of Pitigliano ASL Sudest
      Toscana, Grosseto, 58100 Italy
FAU - Firenzuoli, Fabio
AU  - Firenzuoli F
AD  - 0000 0004 1759 9494grid.24704.35Referring Centre for Phytotherapy, Center for
      Integrative Medicine, Careggi Universitary Hospital, Florence, 50139 Italy
FAU - Baccetti, Sonia
AU  - Baccetti S
AD  - Tuscan Network of Integrative Medicine, Florence, Italy
FAU - Di Stefano, Mariella
AU  - Di Stefano M
AD  - Tuscan Network of Integrative Medicine, Florence, Italy
FAU - Monechi, Maria V.
AU  - Monechi MV
AD  - Tuscan Network of Integrative Medicine, Florence, Italy
FAU - Gallo, Eugenia
AU  - Gallo E
AD  - 0000 0004 1759 9494grid.24704.35Referring Centre for Phytotherapy, Center for
      Integrative Medicine, Careggi Universitary Hospital, Florence, 50139 Italy
FAU - Maggini, Valentina
AU  - Maggini V
AD  - 0000 0004 1759 9494grid.24704.35Referring Centre for Phytotherapy, Center for
      Integrative Medicine, Careggi Universitary Hospital, Florence, 50139 Italy
FAU - Gori, Luigi
AU  - Gori L
AD  - 0000 0004 1759 9494grid.24704.35Referring Centre for Phytotherapy, Center for
      Integrative Medicine, Careggi Universitary Hospital, Florence, 50139 Italy
FAU - Rossi, Elio
AU  - Rossi E
AD  - Tuscan Network of Integrative Medicine, Florence, Italy
FAU - Fisher, Peter
AU  - Fisher P
AD  - grid.439673.cRoyal London Hospital for Integrated Medicine, UCLH NHS Trust,
      London, WC1N 3HR UK
FAU - Hughes, John
AU  - Hughes J
AD  - grid.439673.cRoyal London Hospital for Integrated Medicine, UCLH NHS Trust,
      London, WC1N 3HR UK
FAU - Mendoza, Ariadna
AU  - Mendoza A
AD  - 0000 0004 0612 2754grid.439749.4UCH Cancer Clinical Trials Unit, London, UK
FAU - MacPherson, Hugh
AU  - MacPherson H
AD  - 0000 0004 1936 9668grid.5685.eUniversity of York, York, UK
FAU - Witt, Claudia
AU  - Witt C
AD  - 0000 0004 0478 9977grid.412004.3University Hospital Zurich, Zurich, Switzerland
FAU - Filshie, Jacqueline
AU  - Filshie J
AD  - 0000 0004 0417 0461grid.424926.fRoyal Marsden Hospital, London, UK
FAU - Lewith, George
AU  - Lewith G
AD  - 0000 0004 1936 9297grid.5491.9University of Southampton, Southampton, UK
FAU - Di Francesco, Antonia
AU  - Di Francesco A
AD  - IOMED, Lecce, Italy
FAU - Bernardini, Alberto
AU  - Bernardini A
AD  - IOMED, Lecce, Italy
FAU - Messe, Monica
AU  - Messe M
AD  - IOMED, Lecce, Italy
FAU - Primitivo, Vincenzo
AU  - Primitivo V
AD  - IOMED, Lecce, Italy
FAU - Iasella, Piera A.
AU  - Iasella PA
AD  - IOMED, Lecce, Italy
FAU - Ghelman, Ricardo
AU  - Ghelman R
AD  - 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do Câncer Infantil –
      Department of Pediatric Oncology, Faculdade de Medicina da Universidade de São
      Paulo, Sao Paulo, 05410-030 Brazil
FAU - Taminato, Monica
AU  - Taminato M
AD  - 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do Câncer Infantil –
      Department of Pediatric Oncology, Faculdade de Medicina da Universidade de São
      Paulo, Sao Paulo, 05410-030 Brazil
FAU - Alcantara, Jaqueline Do Carmo
AU  - Alcantara JDC
AD  - 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do Câncer Infantil –
      Department of Pediatric Oncology, Faculdade de Medicina da Universidade de São
      Paulo, Sao Paulo, 05410-030 Brazil
FAU - De Oliveira, Katia R.
AU  - De Oliveira KR
AD  - 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do Câncer Infantil –
      Department of Pediatric Oncology, Faculdade de Medicina da Universidade de São
      Paulo, Sao Paulo, 05410-030 Brazil
FAU - Rodrigues, Debora C. De Azevedo
AU  - Rodrigues DCDA
AD  - 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do Câncer Infantil –
      Department of Pediatric Oncology, Faculdade de Medicina da Universidade de São
      Paulo, Sao Paulo, 05410-030 Brazil
FAU - Mumme, Juliana R. Campana
AU  - Mumme JRC
AD  - 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do Câncer Infantil –
      Department of Pediatric Oncology, Faculdade de Medicina da Universidade de São
      Paulo, Sao Paulo, 05410-030 Brazil
FAU - Sunakozawa, Olga K. Matsumoto
AU  - Sunakozawa OKM
AD  - 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do Câncer Infantil –
      Department of Pediatric Oncology, Faculdade de Medicina da Universidade de São
      Paulo, Sao Paulo, 05410-030 Brazil
FAU - Filho, Vicente Odone
AU  - Filho VO
AD  - 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do Câncer Infantil –
      Department of Pediatric Oncology, Faculdade de Medicina da Universidade de São
      Paulo, Sao Paulo, 05410-030 Brazil
FAU - Seifert, Georg
AU  - Seifert G
AD  - 0000 0001 2218 4662grid.6363.0Department of Pediatric Oncology, Charité
      University Medicine, Berlin, Germany
FAU - Goldenberg, Joshua
AU  - Goldenberg J
AD  - 0000 0004 0415 7072grid.252865.eBastyr University, Kenmore, WA 98028-4966 USA
FAU - Day, Andrew
AU  - Day A
AD  - 0000 0004 0415 7072grid.252865.eBastyr University, Kenmore, WA 98028-4966 USA
FAU - Sasagawa, Masa
AU  - Sasagawa M
AD  - 0000 0004 0415 7072grid.252865.eBastyr University, Kenmore, WA 98028-4966 USA
FAU - Ward, Lesley
AU  - Ward L
AD  - 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and
      Integrative Medicine, University of Technology, Sydney, Australia
FAU - Cooley, Kieran
AU  - Cooley K
AD  - 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and
      Integrative Medicine, University of Technology, Sydney, Australia
FAU - Gunnarsdottir, Thora
AU  - Gunnarsdottir T
AD  - 0000 0004 0640 0021grid.14013.37Faculty of Nursing, University of Iceland,
      Reykjavik, 105 Iceland
FAU - Hjaltadottir, Ingibjorg
AU  - Hjaltadottir I
AD  - 0000 0004 0640 0021grid.14013.37Faculty of Nursing, University of Iceland,
      Reykjavik, 105 Iceland
FAU - Hajimonfarednejad, Mahdie
AU  - Hajimonfarednejad M
AD  - 0000 0000 8819 4698grid.412571.4Shiraz University of Medical Sciences, Shiraz,
      71747637 Islamic Republic of Iran
FAU - Hannan, Nicole
AU  - Hannan N
AD  - Alchemy Health & Wellbeing, Miami, 4220 Australia
FAU - Hellsing, Rut
AU  - Hellsing R
AD  - Regional Cancer Center Stockholm/Gotland, Stockholm, SE-102 39 Sweden
FAU - Wode, Kathrin
AU  - Wode K
AD  - Regional Cancer Center Stockholm/Gotland, Stockholm, SE-102 39 Sweden
FAU - Nordberg, Johanna Hök
AU  - Nordberg JH
AD  - 0000 0004 1937 0626grid.4714.6Department of Neurobiology, Caring Sciences &
      Society, Karolinska Institutet, Huddinge, SE-14183 Sweden
FAU - Nordberg, Johanna Hök
AU  - Nordberg JH
AD  - 0000 0004 1937 0626grid.4714.6Department of Neurobiology, Caring Sciences &
      Society, Karolinska Institute, Huddinge, SE-14183 Sweden
FAU - Andermo, Susanne
AU  - Andermo S
AD  - 0000 0004 1937 0626grid.4714.6Department of Neurobiology, Caring Sciences &
      Society, Karolinska Institute, Huddinge, SE-14183 Sweden
FAU - Arman, Maria
AU  - Arman M
AD  - 0000 0004 1937 0626grid.4714.6Department of Neurobiology, Caring Sciences &
      Society, Karolinska Institute, Huddinge, SE-14183 Sweden
FAU - von Hörsten, Iris
AU  - von Hörsten I
AD  - grid.413361.2Hospital San Juan de Dios, Internal Medicine, Santiago de Chile,
      Chile
FAU - Torrielo, Patricia Vásquez
AU  - Torrielo PV
AD  - grid.413361.2Hospital San Juan de Dios, Internal Medicine, Santiago de Chile,
      Chile
FAU - Vilaró, Carmen L. Andrade
AU  - Vilaró CLA
AD  - grid.413361.2Hospital San Juan de Dios, Internal Medicine, Santiago de Chile,
      Chile
FAU - Cabrera, Francisco Cerda
AU  - Cabrera FC
AD  - Centro de Estudios e Investigación Terapéutica, Santiago de Chile, Chile
FAU - Huber, Roman
AU  - Huber R
AD  - 0000 0000 9428 7911grid.7708.8Center for Complementary Medicine, University
      Medical Center Freiburg, Freiburg, 79106 Germany
FAU - Hui, Henny
AU  - Hui H
AD  - 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority, 
      Hong Kong, Hong Kong
FAU - Ziea, Eric
AU  - Ziea E
AD  - 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority, 
      Hong Kong, Hong Kong
FAU - Tsui, Dora
AU  - Tsui D
AD  - 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority, 
      Hong Kong, Hong Kong
FAU - Hsieh, Joyce
AU  - Hsieh J
AD  - 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority, 
      Hong Kong, Hong Kong
FAU - Lam, Christine
AU  - Lam C
AD  - 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority, 
      Hong Kong, Hong Kong
FAU - Chan, Edith
AU  - Chan E
AD  - 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority, 
      Hong Kong, Hong Kong
FAU - Jensen, Mark P.
AU  - Jensen MP
AD  - 0000000122986657grid.34477.33University of Washington, Seattle, WA USA
FAU - Battalio, Samuel L.
AU  - Battalio SL
AD  - 0000000122986657grid.34477.33University of Washington, Seattle, WA USA
FAU - Chan, Joy
AU  - Chan J
AD  - 0000000122986657grid.34477.33University of Washington, Seattle, WA USA
FAU - Edwards, Karlyn A.
AU  - Edwards KA
AD  - 0000000122986657grid.34477.33University of Washington, Seattle, WA USA
FAU - Gertz, Kevin J.
AU  - Gertz KJ
AD  - 0000000122986657grid.34477.33University of Washington, Seattle, WA USA
FAU - Day, Melissa A.
AU  - Day MA
AD  - 0000 0000 9320 7537grid.1003.2University of Queensland, Brisbane, Australia
FAU - Sherlin, Leslie H.
AU  - Sherlin LH
AD  - 0000 0004 0384 0646grid.419438.3Southwest College of Naturopathic Medicine,
      Tempe, AZ USA
FAU - Ehde, Dawn M.
AU  - Ehde DM
AD  - 0000000122986657grid.34477.33University of Washington, Seattle, WA USA
FAU - Kim, Kyeong H.
AU  - Kim KH
AD  - Management Policy, National Development Institute of Korean Medicine,
      Gyeongsan-si, 38540 South Korea
FAU - Jang, Soobin
AU  - Jang S
AD  - Management Policy, National Development Institute of Korean Medicine,
      Gyeongsan-si, 38540 South Korea
FAU - Jang, Bo-Hyoung
AU  - Jang BH
AD  - Management Policy, National Development Institute of Korean Medicine,
      Gyeongsan-si, 38540 South Korea
FAU - Go, Ho-Yeon
AU  - Go HY
AD  - Management Policy, National Development Institute of Korean Medicine,
      Gyeongsan-si, 38540 South Korea
FAU - Park, Sunju
AU  - Park S
AD  - Management Policy, National Development Institute of Korean Medicine,
      Gyeongsan-si, 38540 South Korea
FAU - Ko, Seong-Gyu
AU  - Ko SG
AD  - Management Policy, National Development Institute of Korean Medicine,
      Gyeongsan-si, 38540 South Korea
FAU - Kraft, Karin
AU  - Kraft K
AD  - Naturopathy, University of Medicine, Rostock, 18057 Germany
FAU - Janik, Hubert
AU  - Janik H
AD  - Naturopathy, University of Medicine, Rostock, 18057 Germany
FAU - Börner, Anja
AU  - Börner A
AD  - Urology, University of Medicine, Rostock, 18057 Germany
FAU - Lee, Jihong
AU  - Lee J
AD  - 0000 0001 0357 1464grid.411231.4Pediatrics of Korean Medicine, Kyung Hee
      University Hospital at Gangdong, Seoul, South Korea
FAU - Lee, Boram
AU  - Lee B
AD  - 0000 0001 0357 1464grid.411231.4Pediatrics of Korean Medicine, Kyung Hee
      University Hospital at Gangdong, Seoul, South Korea
FAU - Chang, Gyu T.
AU  - Chang GT
AD  - 0000 0001 0357 1464grid.411231.4Pediatrics of Korean Medicine, Kyung Hee
      University Hospital at Gangdong, Seoul, South Korea
FAU - Menassa, Alejandra
AU  - Menassa A
AD  - Mental Health, CMI (Clinica Medicina Integrativa), Madrid, 28015 Spain
FAU - Motoo, Yoshiharu
AU  - Motoo Y
AD  - 0000 0001 0265 5359grid.411998.cDepartment of Medical Oncology, Kanazawa Medical 
      University, Uchinada, Ishikawa 920-0293 Japan
FAU - Müller, Jürgen
AU  - Müller J
AD  - Phytomedicines Supply and Development Center, Steigerwald Arzneimittelwerk GmbH, 
      Bayer Consumer Health, Darmstadt, 64295 Germany
FAU - Rabini, Sabine
AU  - Rabini S
AD  - 0000 0004 1936 9756grid.10253.35Department of Medical Cell Biology,
      Philipps-University Marburg, Marburg, Germany
FAU - Vinson, Bettina
AU  - Vinson B
AD  - Phytomedicines Supply and Development Center, Steigerwald Arzneimittelwerk GmbH, 
      Bayer Consumer Health, Darmstadt, 64295 Germany
FAU - Kelber, Olaf
AU  - Kelber O
AD  - Phytomedicines Supply and Development Center, Steigerwald Arzneimittelwerk GmbH, 
      Bayer Consumer Health, Darmstadt, 64295 Germany
FAU - Storr, Martin
AU  - Storr M
AD  - Center for Endoscopy Starnberg, Starnberg, Germany
FAU - Kraft, Karin
AU  - Kraft K
AD  - Naturopathy, Center for Internal Medicine, University of Medicine, Rostock,
      Germany
FAU - Niemeijer, Martin
AU  - Niemeijer M
AD  - 0000000120346234grid.5477.1University of Applied Sciences, Leiden, 2333CK
      Netherlands
FAU - Baars, Erik
AU  - Baars E
AD  - 0000000120346234grid.5477.1University of Applied Sciences, Leiden, 2333CK
      Netherlands
FAU - Hoekman, Joop
AU  - Hoekman J
AD  - 0000000120346234grid.5477.1University of Applied Sciences, Leiden, 2333CK
      Netherlands
FAU - Ruijssenaaars, Wied
AU  - Ruijssenaaars W
AD  - 0000000120346234grid.5477.1University of Applied Sciences, Leiden, 2333CK
      Netherlands
FAU - Njoku, Faith C.
AU  - Njoku FC
AD  - 0000 0001 0668 7243grid.266093.8Irvine School of Medicine, Irvine, University of 
      California, Irvine, CA USA
FAU - Klose, Petra
AU  - Klose P
AD  - 0000 0001 2187 5445grid.5718.bInternal Medicine and Integrative Medicine,
      University of Duisburg-Essen, Essen, Germany
FAU - Brinkhaus, Benno
AU  - Brinkhaus B
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité University Hospital, Berlin, Germany
FAU - Michalsen, Andreas
AU  - Michalsen A
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité University Hospital, Berlin, Germany
FAU - Dobos, Gustav
AU  - Dobos G
AD  - 0000 0001 2187 5445grid.5718.bInternal Medicine and Integrative Medicine,
      University of Duisburg-Essen, Essen, Germany
FAU - Cramer, Holger
AU  - Cramer H
AD  - 0000 0001 2187 5445grid.5718.bInternal Medicine and Integrative Medicine,
      University of Duisburg-Essen, Essen, Germany
FAU - Norheim, Arne J.
AU  - Norheim AJ
AD  - 0000000122595234grid.10919.30National Research Center in Complementary and
      Alternative Medicine (NAFKAM), Department of Community Medicine, Faculty of
      Health Sciences, The Arctic University of Tromsø, Tromsø, 9037 Norway
FAU - Alræk, Terje
AU  - Alræk T
AD  - 0000000122595234grid.10919.30National Research Center in Complementary and
      Alternative Medicine (NAFKAM), Department of Community Medicine, Faculty of
      Health Sciences, The Arctic University of Tromsø, Tromsø, 9037 Norway
FAU - Okumus, Filiz
AU  - Okumus F
AD  - 0000 0004 0471 9346grid.411781.aDepartment of Midwifery, Istanbul Medipol
      University, Istanbul, 34083 Turkey
FAU - Oncu-Celik, Halime
AU  - Oncu-Celik H
AD  - Delivery Room, Istanbul Bahcelievler Public Hospital, Istanbul, 34180 Turkey
LA  - eng
PT  - Journal Article
DEP - 20170630
TA  - BMC Complement Altern Med
JT  - BMC Complementary and Alternative Medicine
AID - 1783 [pii]
AID - 10.1186/s12906-017-1783-3 [doi]
SO  - BMC Complement Altern Med. 2017 Jun 30;17(Suppl 1):.
      doi:10.1186/s12906-017-1783-3.

PMC - PMC5042924
IS  - 2197-425X (Electronic)
VI  - 4
IP  - Suppl 1
DP  - 2016 Sep
TI  - ESICM LIVES 2016: part one: Milan, Italy. 1-5 October 2016.
LID - 27
FAU - Bos, L.
AU  - Bos L
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - Schouten, L.
AU  - Schouten L
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - van Vught, L.
AU  - van Vught L
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - Wiewel, M.
AU  - Wiewel M
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - Ong, D.
AU  - Ong D
AD  - UMCU, Utrecht, Netherlands
FAU - Cremer, O.
AU  - Cremer O
AD  - UMCU, Utrecht, Netherlands
FAU - Artigas, A.
AU  - Artigas A
AD  - Autonomous University of Barcelona, Barcelona, Spain
FAU - Martin-Loeches, I.
AU  - Martin-Loeches I
AD  - Hospital São Francisco Xavier, Lisbon, Portugal
FAU - Hoogendijk, A.
AU  - Hoogendijk A
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - van der Poll, T.
AU  - van der Poll T
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - Horn, J.
AU  - Horn J
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - Juffermans, N.
AU  - Juffermans N
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - Schultz, M.
AU  - Schultz M
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - de Prost, N.
AU  - de Prost N
AD  - CHU Henri Mondor, Medical ICU, Créteil, France
FAU - Pham, T.
AU  - Pham T
AD  - Hôpital Tenon, APHP, Medical and Surgical ICU, Paris, France
FAU - Carteaux, G.
AU  - Carteaux G
AD  - CHU Henri Mondor, Medical ICU, Créteil, France
FAU - Dessap, A. Mekontso
AU  - Dessap AM
AD  - CHU Henri Mondor, Medical ICU, Créteil, France
FAU - Brun-Buisson, C.
AU  - Brun-Buisson C
AD  - CHU Henri Mondor, Medical ICU, Créteil, France
FAU - Fan, E.
AU  - Fan E
AD  - University Health Network, University of Toronto, Critical Care Medicine,
      Toronto, Canada
FAU - Bellani, G.
AU  - Bellani G
AD  - University of Milan - Bicocca, Health Sciences, School of Medicine and Surgery,
      Monza, Italy
FAU - Laffey, J.
AU  - Laffey J
AD  - St Michael’s Hospital, University of Toronto, Anesthesia, Toronto, Canada
FAU - Mercat, A.
AU  - Mercat A
AD  - CHU d’Angers, Medical ICU, Angers, France
FAU - Brochard, L.
AU  - Brochard L
AD  - Interdepartmental Division of Critical Care, University of Toronto Saint
      Michael’s Hospital and Keenan Research Centre, Toronto, Canada
FAU - Maitre, B.
AU  - Maitre B
AD  - CHU Henri Mondor, Medical ICU, Créteil, France
CN  - LUNG SAFE investigators and the ESICM study group
FAU - Howells, P. A.
AU  - Howells PA
AD  - University of Birmingham, Institute for Inflammation and Ageing, Birmingham, UK
FAU - Thickett, D. R.
AU  - Thickett DR
AD  - University of Birmingham, Institute for Inflammation and Ageing, Birmingham, UK
FAU - Knox, C.
AU  - Knox C
AD  - University of Sheffield, Mathematics and Statistics Help Centre, Sheffield, UK
FAU - Park, D. P.
AU  - Park DP
AD  - Heart of England NHS Foundation Trust, Intensive Care Medicine, Birmingham, UK
FAU - Gao, F.
AU  - Gao F
AD  - University of Birmingham, Institute for Inflammation and Ageing, Birmingham, UK
FAU - Tucker, O.
AU  - Tucker O
AD  - Department of Surgery, University Hospitals Birmingham NHS Trust, Birmingham, UK
FAU - Whitehouse, T.
AU  - Whitehouse T
AD  - University Hospitals Birmingham NHS Trust, Anaesthesia and Critical Care
      Medicine, Birmingham, UK
FAU - McAuley, D. F.
AU  - McAuley DF
AD  - Queen’s University of Belfast, Wellcome-Wolfson Institute for Experimental
      Medicine, Belfast, UK
FAU - Perkins, G. D.
AU  - Perkins GD
AD  - Heart of England NHS Foundation Trust, Intensive Care Medicine, Birmingham, UK
FAU - Pham, T.
AU  - Pham T
AD  - St Michael’s Hospital, University of Toronto, Critical Care, Toronto, Canada
FAU - Laffey, J.
AU  - Laffey J
AD  - St Michael’s Hospital, University of Toronto, Anesthesia, Toronto, Canada
FAU - Bellani, G.
AU  - Bellani G
AD  - University of Milan-Bicocca, Health Sciences, School of Medicine and Surgery,
      Monza, Italy
FAU - Fan, E.
AU  - Fan E
AD  - University Health Network, University of Toronto, Critical Care Medicine,
      Toronto, Canada
CN  - LUNG SAFE Investigators and the ESICM Trials Group
FAU - Pisani, L.
AU  - Pisani L
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - Roozeman, J. P.
AU  - Roozeman JP
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - Simonis, F. D.
AU  - Simonis FD
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - Giangregorio, A.
AU  - Giangregorio A
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - Schouten, L. R.
AU  - Schouten LR
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - Van der Hoeven, S. M.
AU  - Van der Hoeven SM
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - Horn, J.
AU  - Horn J
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - Neto, A. Serpa
AU  - Neto AS
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - Festic, E.
AU  - Festic E
AD  - Mayo Clinic, Jacksonville, USA
FAU - Dondorp, A. M.
AU  - Dondorp AM
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - Grasso, S.
AU  - Grasso S
AD  - University of Bari ‘Aldo Moro’, Bari, Italy
FAU - Bos, L. D.
AU  - Bos LD
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - Schultz, M. J.
AU  - Schultz MJ
AD  - Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
FAU - Koster-Brouwer, M.
AU  - Koster-Brouwer M
AD  - University Medical Center Utrecht, Intensive Care, Utrecht, Netherlands
FAU - Verboom, D.
AU  - Verboom D
AD  - University Medical Center Utrecht, Intensive Care, Utrecht, Netherlands
FAU - Scicluna, B.
AU  - Scicluna B
AD  - Academic Medical Center, University of Amsterdam, Center for Experimental and
      Molecular Medicine, Amsterdam, Netherlands
FAU - van de Groep, K.
AU  - van de Groep K
AD  - University Medical Center Utrecht, Intensive Care, Utrecht, Netherlands
FAU - Frencken, J.
AU  - Frencken J
AD  - University Medical Center Utrecht, Intensive Care, Utrecht, Netherlands
FAU - Schultz, M.
AU  - Schultz M
AD  - Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam,
      Netherlands
FAU - van der Poll, T.
AU  - van der Poll T
AD  - Academic Medical Center, University of Amsterdam, Center for Experimental and
      Molecular Medicine, Amsterdam, Netherlands
FAU - Bonten, M.
AU  - Bonten M
AD  - University Medical Center Utrecht, Julius Center for Health Sciences and Primary 
      Care, Utrecht, Netherlands
FAU - Cremer, O.
AU  - Cremer O
AD  - University Medical Center Utrecht, Intensive Care, Utrecht, Netherlands
FAU - Ko, J. I.
AU  - Ko JI
AD  - Seoul National University Hospital, Seoul, Republic of Korea
FAU - Kim, K. S.
AU  - Kim KS
AD  - Seoul National University Hospital, Seoul, Republic of Korea
FAU - Suh, G. J.
AU  - Suh GJ
AD  - Seoul National University Hospital, Seoul, Republic of Korea
FAU - Kwon, W. Y.
AU  - Kwon WY
AD  - Seoul National University Hospital, Seoul, Republic of Korea
FAU - Kim, K.
AU  - Kim K
AD  - Department of Emergency Medicine, Seoul National University Bundang Hospital,
      Seongnam-si, Republic of Korea
FAU - Shin, J. H.
AU  - Shin JH
AD  - Department of Emergency Medicine, Seoul National University Boramae Hospital,
      Seoul, Republic of Korea
FAU - Ranzani, O. T.
AU  - Ranzani OT
AD  - Department of Pulmonology, Hospital Clinic of Barcelona, University of Barcelona,
      Institut D’investigacions August Pi I Sunyer (IDIBAPS), Barcelona, Spain
FAU - Prina, E.
AU  - Prina E
AD  - Department of Pulmonology, Hospital Clinic of Barcelona, University of Barcelona,
      Institut D’investigacions August Pi I Sunyer (IDIBAPS), Barcelona, Spain
FAU - Menendez, R.
AU  - Menendez R
AD  - Pneumology Department, ISS/Hospital Universitario y Politecnico La Fe, CIBER
      Enfermedades Respiratorias (CIBERES), Valencia, Spain
FAU - Ceccato, A.
AU  - Ceccato A
AD  - Department of Pulmonology, Hospital Clinic of Barcelona, University of Barcelona,
      Institut D’investigacions August Pi I Sunyer (IDIBAPS), Barcelona, Spain
FAU - Mendez, R.
AU  - Mendez R
AD  - Pneumology Department, ISS/Hospital Universitario y Politecnico La Fe, CIBER
      Enfermedades Respiratorias (CIBERES), Valencia, Spain
FAU - Cilloniz, C.
AU  - Cilloniz C
AD  - Department of Pulmonology, Hospital Clinic of Barcelona, University of Barcelona,
      Institut D’investigacions August Pi I Sunyer (IDIBAPS), Barcelona, Spain
FAU - Gabarrus, A.
AU  - Gabarrus A
AD  - Department of Pulmonology, Hospital Clinic of Barcelona, University of Barcelona,
      Institut D’investigacions August Pi I Sunyer (IDIBAPS), Barcelona, Spain
FAU - Ferrer, M.
AU  - Ferrer M
AD  - Department of Pulmonology, Hospital Clinic of Barcelona, University of Barcelona,
      Institut D’investigacions August Pi I Sunyer (IDIBAPS), Barcelona, Spain
FAU - Torres, A.
AU  - Torres A
AD  - Department of Pulmonology, Hospital Clinic of Barcelona, University of Barcelona,
      Institut D’investigacions August Pi I Sunyer (IDIBAPS), Barcelona, Spain
FAU - Urbano, A.
AU  - Urbano A
AD  - Department of Mathematics, University of Pittsburgh, Pittsburgh, USA
FAU - Zhang, L. A.
AU  - Zhang LA
AD  - Department of Chemical and Petroleum Engineering, University of Pittsburgh,
      Pittsburgh, USA
FAU - Swigon, D.
AU  - Swigon D
AD  - Department of Mathematics, University of Pittsburgh, Pittsburgh, USA
FAU - Pike, F.
AU  - Pike F
AD  - University of Pittsburgh, Biostatistics, Pittsburgh, USA
FAU - Parker, R. S.
AU  - Parker RS
AD  - Department of Chemical and Petroleum Engineering, University of Pittsburgh,
      Pittsburgh, USA
FAU - Clermont, G.
AU  - Clermont G
AD  - Department of Chemical and Petroleum Engineering, University of Pittsburgh,
      Pittsburgh, USA
FAU - Scheer, C.
AU  - Scheer C
AD  - Department of Anesthesiology, University of Greifswald, Greifswald, Germany
FAU - Kuhn, S. O.
AU  - Kuhn SO
AD  - Department of Anesthesiology, University of Greifswald, Greifswald, Germany
FAU - Modler, A.
AU  - Modler A
AD  - University of Greifswald, Greifswald, Germany
FAU - Vollmer, M.
AU  - Vollmer M
AD  - University of Greifswald, Institute of Bioinfomatics, University Medicine
      Greifswald, Greifswald, Germany
FAU - Fuchs, C.
AU  - Fuchs C
AD  - Department of Anesthesiology, University of Greifswald, Greifswald, Germany
FAU - Hahnenkamp, K.
AU  - Hahnenkamp K
AD  - Department of Anesthesiology, University of Greifswald, Greifswald, Germany
FAU - Rehberg, S.
AU  - Rehberg S
AD  - Department of Anesthesiology, University of Greifswald, Greifswald, Germany
FAU - Gründling, M.
AU  - Gründling M
AD  - Department of Anesthesiology, University of Greifswald, Greifswald, Germany
FAU - Taggu, A.
AU  - Taggu A
AD  - St. Johns Medical College, Bangalore, India
FAU - Darang, N.
AU  - Darang N
AD  - Yashoda Hospials, Secundrabad, India
FAU - Öveges, N.
AU  - Öveges N
AD  - University of Szeged Faculty of Medicine, Anaesthesiology and Intensive Therapy, 
      Szeged, Hungary
FAU - László, I.
AU  - László I
AD  - University of Szeged Faculty of Medicine, Anaesthesiology and Intensive Therapy, 
      Szeged, Hungary
FAU - Tánczos, K.
AU  - Tánczos K
AD  - University of Szeged Faculty of Medicine, Anaesthesiology and Intensive Therapy, 
      Szeged, Hungary
FAU - Németh, M.
AU  - Németh M
AD  - University of Szeged Faculty of Medicine, Anaesthesiology and Intensive Therapy, 
      Szeged, Hungary
FAU - Lebák, G.
AU  - Lebák G
AD  - University of Szeged Faculty of Medicine, Anaesthesiology and Intensive Therapy, 
      Szeged, Hungary
FAU - Tudor, B.
AU  - Tudor B
AD  - Medical University of Vienna, Anaesthesiology and General Intensive Care
      Medicine, Vienna, Austria
FAU - Érces, D.
AU  - Érces D
AD  - University of Szeged Faculty of Medicine, Surgical Research, Szeged, Hungary
FAU - Kaszaki, J.
AU  - Kaszaki J
AD  - University of Szeged Faculty of Medicine, Surgical Research, Szeged, Hungary
FAU - Huber, W.
AU  - Huber W
AD  - Technische Universität München, Gastroenterology, Munich, Germany
FAU - Trásy, D.
AU  - Trásy D
AD  - University of Szeged Faculty of Medicine, Anaesthesiology and Intensive Therapy, 
      Szeged, Hungary
FAU - Molnár, Z.
AU  - Molnár Z
AD  - University of Szeged Faculty of Medicine, Anaesthesiology and Intensive Therapy, 
      Szeged, Hungary
FAU - Ferrara, G.
AU  - Ferrara G
AD  - Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Cátedra de
      Farmacología Aplicada, La Plata, Argentina
FAU - Edul, V. S. Kanoore
AU  - Edul VSK
AD  - Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Cátedra de
      Farmacología Aplicada, La Plata, Argentina
FAU - Canales, H. S.
AU  - Canales HS
AD  - Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Cátedra de
      Farmacología Aplicada, La Plata, Argentina
FAU - Martins, E.
AU  - Martins E
AD  - Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Cátedra de
      Farmacología Aplicada, La Plata, Argentina
FAU - Canullán, C.
AU  - Canullán C
AD  - Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Cátedra de
      Farmacología Aplicada, La Plata, Argentina
FAU - Murias, G.
AU  - Murias G
AD  - Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Cátedra de
      Farmacología Aplicada, La Plata, Argentina
FAU - Pozo, M. O.
AU  - Pozo MO
AD  - Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Cátedra de
      Farmacología Aplicada, La Plata, Argentina
FAU - Eguillor, J. F. Caminos
AU  - Eguillor JFC
AD  - Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Cátedra de
      Farmacología Aplicada, La Plata, Argentina
FAU - Buscetti, M. G.
AU  - Buscetti MG
AD  - Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Cátedra de
      Farmacología Aplicada, La Plata, Argentina
FAU - Ince, C.
AU  - Ince C
AD  - Academic Medical Center, University of Amsterdam, Translational Physiology,
      Amsterdam, Netherlands
FAU - Dubin, A.
AU  - Dubin A
AD  - Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Cátedra de
      Farmacología Aplicada, La Plata, Argentina
FAU - Aya, H. D.
AU  - Aya HD
AD  - St George’s University Hospitals NHS Foundation Trust, Adult Critical Care
      Directorate, London, UK
FAU - Rhodes, A.
AU  - Rhodes A
AD  - St George’s University Hospitals NHS Foundation Trust, Adult Critical Care
      Directorate, London, UK
FAU - Fletcher, N.
AU  - Fletcher N
AD  - St George’s University Hospitals NHS Foundation Trust, Adult Critical Care
      Directorate, London, UK
FAU - Grounds, R. M.
AU  - Grounds RM
AD  - St George’s University Hospitals NHS Foundation Trust, Adult Critical Care
      Directorate, London, UK
FAU - Cecconi, M.
AU  - Cecconi M
AD  - St George’s University Hospitals NHS Foundation Trust, Adult Critical Care
      Directorate, London, UK
FAU - Jacquet-Lagrèze, M.
AU  - Jacquet-Lagrèze M
AD  - Hôpital Louis Pradel, Anesthésie Réanimation, Bron, France
FAU - Riche, M.
AU  - Riche M
AD  - Hôpital Louis Pradel, Anesthésie Réanimation, Bron, France
FAU - Schweizer, R.
AU  - Schweizer R
AD  - Hôpital Louis Pradel, Anesthésie Réanimation, Bron, France
FAU - Portran, P.
AU  - Portran P
AD  - Hôpital Louis Pradel, Anesthésie Réanimation, Bron, France
FAU - Fornier, W.
AU  - Fornier W
AD  - Hôpital Louis Pradel, Anesthésie Réanimation, Bron, France
FAU - Lilot, M.
AU  - Lilot M
AD  - Hôpital Femme Mère Enfant, Lyon, France
FAU - Neidecker, J.
AU  - Neidecker J
AD  - Hôpital Louis Pradel, Anesthésie Réanimation, Bron, France
FAU - Fellahi, J. L.
AU  - Fellahi JL
AD  - Hôpital Louis Pradel, Anesthésie Réanimation, Bron, France
FAU - Escoresca-Ortega, A.
AU  - Escoresca-Ortega A
AD  - Intensive Care Unit, Hospital Virgen del Rocio, Sevilla, Spain
FAU - Gutiérrez-Pizarraya, A.
AU  - Gutiérrez-Pizarraya A
AD  - Intensive Care Unit, Hospital Virgen del Rocio, Sevilla, Spain
FAU - Charris-Castro, L.
AU  - Charris-Castro L
AD  - Intensive Care Unit, Hospital Virgen del Rocio, Sevilla, Spain
FAU - Corcia-Palomo, Y.
AU  - Corcia-Palomo Y
AD  - Intensive Care Unit, Hospital Virgen del Rocio, Sevilla, Spain
FAU - Fernandez-Delgado, E.
AU  - Fernandez-Delgado E
AD  - Intensive Care Unit, Hospital Virgen del Rocio, Sevilla, Spain
FAU - Garnacho-Montero, J.
AU  - Garnacho-Montero J
AD  - Intensive Care Unit, Hospital Virgen del Rocio, Sevilla, Spain
FAU - Roger, C.
AU  - Roger C
AD  - Department of Anaesthesiology, Critical Care, Pain and Emergency Medicine, Nimes 
      University Hospital, Nimes, France
FAU - Muller, L.
AU  - Muller L
AD  - Department of Anaesthesiology, Critical Care, Pain and Emergency Medicine, Nimes 
      University Hospital, Nimes, France
FAU - Elotmani, L.
AU  - Elotmani L
AD  - Department of Anaesthesiology, Critical Care, Pain and Emergency Medicine, Nimes 
      University Hospital, Nimes, France
FAU - Lipman, J.
AU  - Lipman J
AD  - University of Queensland, Burns Trauma Critical Care Research Centre, Brisbane,
      Australia
FAU - Lefrant, J. Y.
AU  - Lefrant JY
AD  - Department of Anaesthesiology, Critical Care, Pain and Emergency Medicine, Nimes 
      University Hospital, Nimes, France
FAU - Roberts, J. A.
AU  - Roberts JA
AD  - University of Queensland, Burns Trauma Critical Care Research Centre, Brisbane,
      Australia
FAU - Muñoz-Bermúdez, R.
AU  - Muñoz-Bermúdez R
AD  - Hospital del Mar-IMIM, Critical Care, Barcelona, Spain
FAU - Samper, M.
AU  - Samper M
AD  - Hospital del Mar-IMIM, Critical Care, Barcelona, Spain
FAU - Climent, C.
AU  - Climent C
AD  - Hospital del Mar-IMIM, Critical Care, Barcelona, Spain
FAU - Vasco, F.
AU  - Vasco F
AD  - Hospital del Mar-IMIM, Critical Care, Barcelona, Spain
FAU - Sara, V.
AU  - Sara V
AD  - Hospital del Mar-IMIM, Critical Care, Barcelona, Spain
FAU - Luque, S.
AU  - Luque S
AD  - Hospital del Mar, Pharmacy, Barcelona, Spain
FAU - Campillo, N.
AU  - Campillo N
AD  - Hospital del Mar, Pharmacy, Barcelona, Spain
FAU - Cerrato, S. Grau
AU  - Cerrato SG
AD  - Hospital del Mar, Pharmacy, Barcelona, Spain
FAU - Masclans, J. R.
AU  - Masclans JR
AD  - Hospital del Mar-IMIM, Critical Care, Barcelona, Spain
FAU - Alvarez-Lerma, F.
AU  - Alvarez-Lerma F
AD  - Hospital del Mar-IMIM, Critical Care, Barcelona, Spain
FAU - Brugger, S. Carvalho
AU  - Brugger SC
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - Jimenez, G. Jimenez
AU  - Jimenez GJ
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - Torner, M. Miralbés
AU  - Torner MM
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - Cabello, J. Trujillano
AU  - Cabello JT
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - Garrido, B. Balsera
AU  - Garrido BB
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - Casals, X. Nuvials
AU  - Casals XN
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - Gaite, F. Barcenilla
AU  - Gaite FB
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - Vidal, M. Vallverdú
AU  - Vidal MV
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - Martínez, M. Palomar
AU  - Martínez MP
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - Gusarov, V.
AU  - Gusarov V
AD  - N.I. Pirogov National Medical Surgical Center, Anestesiology and Intensive Care, 
      Moscow, Russian Federation
FAU - Shilkin, D.
AU  - Shilkin D
AD  - N.I. Pirogov National Medical Surgical Center, Anestesiology and Intensive Care, 
      Moscow, Russian Federation
FAU - Dementienko, M.
AU  - Dementienko M
AD  - N.I. Pirogov National Medical Surgical Center, Anestesiology and Intensive Care, 
      Moscow, Russian Federation
FAU - Nesterova, E.
AU  - Nesterova E
AD  - N.I. Pirogov National Medical Surgical Center, Anestesiology and Intensive Care, 
      Moscow, Russian Federation
FAU - Lashenkova, N.
AU  - Lashenkova N
AD  - N.I. Pirogov National Medical Surgical Center, Microbiology Laboratory, Moscow,
      Russian Federation
FAU - Kuzovlev, A.
AU  - Kuzovlev A
AD  - N.I. Pirogov National Medical Surgical Center, Anestesiology and Intensive Care, 
      Moscow, Russian Federation
FAU - Zamyatin, M.
AU  - Zamyatin M
AD  - N.I. Pirogov National Medical Surgical Center, Anestesiology and Intensive Care, 
      Moscow, Russian Federation
FAU - Demoule, A.
AU  - Demoule A
AD  - Pitie-Salpetriere Hospital and Pierre and Marie Curie University, Paris, France
FAU - Carreira, S.
AU  - Carreira S
AD  - Pitie-Salpetriere Hospital and Pierre and Marie Curie University, Paris, France
FAU - Lavault, S.
AU  - Lavault S
AD  - Pitie-Salpetriere Hospital and Pierre and Marie Curie University, Paris, France
FAU - Palancca, O.
AU  - Palancca O
AD  - Pitie-Salpetriere Hospital and Pierre and Marie Curie University, Paris, France
FAU - Morawiec, E.
AU  - Morawiec E
AD  - Pitie-Salpetriere Hospital and Pierre and Marie Curie University, Paris, France
FAU - Mayaux, J.
AU  - Mayaux J
AD  - Pitie-Salpetriere Hospital and Pierre and Marie Curie University, Paris, France
FAU - Arnulf, I.
AU  - Arnulf I
AD  - Pitie-Salpetriere Hospital and Pierre and Marie Curie University, Paris, France
FAU - Similowski, T.
AU  - Similowski T
AD  - Pitie-Salpetriere Hospital and Pierre and Marie Curie University, Paris, France
FAU - Rasmussen, B. S.
AU  - Rasmussen BS
AD  - Department of Anaesthesia and Intensive Care Medicine, Aalborg University
      Hospital, Aalborg, Denmark
FAU - Maltesen, R. G.
AU  - Maltesen RG
AD  - Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
FAU - Hanifa, M.
AU  - Hanifa M
AD  - Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
FAU - Pedersen, S.
AU  - Pedersen S
AD  - Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
FAU - Kristensen, S. R.
AU  - Kristensen SR
AD  - Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
FAU - Wimmer, R.
AU  - Wimmer R
AD  - Department of Chemistry and Bioscience, Section of Biotechnology, Aalborg
      University, Aalborg, Denmark
FAU - Panigada, M.
AU  - Panigada M
AD  - Policlinico Di Milano, Milan, Italy
FAU - Bassi, G. Li
AU  - Bassi GL
AD  - Hospital Clinic, Barcelona, Spain
FAU - Ranzani, O. T.
AU  - Ranzani OT
AD  - Hospital Clinic, Barcelona, Spain
FAU - Kolobow, T.
AU  - Kolobow T
AD  - National Institutes of Health, Bethesda, USA
FAU - Zanella, A.
AU  - Zanella A
AD  - Policlinico Di Milano, Milan, Italy
FAU - Cressoni, M.
AU  - Cressoni M
AD  - Policlinico Di Milano, Milan, Italy
FAU - Berra, L.
AU  - Berra L
AD  - Massachusetts General Hospital, Boston, USA
FAU - Parrini, V.
AU  - Parrini V
AD  - Ospedale Nuovo del Mugello, Borgo San Lorenzo (FI), Italy
FAU - Kandil, H.
AU  - Kandil H
AD  - Gruppo Ospedaliero San Donato, San Donato M.se, Italy
FAU - Salati, G.
AU  - Salati G
AD  - Arcispedale S. Maria Nuova, Reggio Emilia, Italy
FAU - Livigni, S.
AU  - Livigni S
AD  - Ospedale San Giovanni Bosco, Torino, Italy
FAU - Amatu, A.
AU  - Amatu A
AD  - Policlinico San Matteo, Pavia, Italy
FAU - Andreotti, A.
AU  - Andreotti A
AD  - Policlinico di Modena, Modena, Italy
FAU - Tagliaferri, F.
AU  - Tagliaferri F
AD  - Azienda Ospedaliero - Universitaria di Parma, Parma, Italy
FAU - Moise, G.
AU  - Moise G
AD  - Ospedale Città di Sesto San Giovanni, Sesto San Giovanni, Italy
FAU - Mercurio, G.
AU  - Mercurio G
AD  - Policlinico Gemelli, Roma, Italy
FAU - Costa, A.
AU  - Costa A
AD  - Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
FAU - Vezzani, A.
AU  - Vezzani A
AD  - Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
FAU - Lindau, S.
AU  - Lindau S
AD  - University Hospital Frankfurt, Frankfurt, Germany
FAU - Babel, J.
AU  - Babel J
AD  - University Hospital Center Zagreb, Zagreb, Croatia
FAU - Cavana, M.
AU  - Cavana M
AD  - Ospedale Santa Chiara, Trento, Italy
FAU - Consonni, D.
AU  - Consonni D
AD  - Policlinico Di Milano, Milan, Italy
FAU - Pesenti, A.
AU  - Pesenti A
AD  - Policlinico Di Milano, Milan, Italy
FAU - Gattinoni, L.
AU  - Gattinoni L
AD  - University of Göttingen, Göttingen, Germany
FAU - Torres, A.
AU  - Torres A
AD  - Hospital Clinic, Barcelona, Spain
CN  - for the GRAVITY-VAP TRIAL NETWORK
FAU - Mansouri, P.
AU  - Mansouri P
AD  - School of Nursing, Shiraz University of Medical Science, Shiraz, Islamic Republic
      of Iran
FAU - Zand, F.
AU  - Zand F
AD  - Shiraz University of Medical Sciences, Anesthesiology and Critical Care Research 
      Center, Shiraz, Islamic Republic of Iran
FAU - Zahed, L.
AU  - Zahed L
AD  - Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran
FAU - Dehghanrad, F.
AU  - Dehghanrad F
AD  - Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran
FAU - Bahrani, M.
AU  - Bahrani M
AD  - Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran
FAU - Ghorbani, M.
AU  - Ghorbani M
AD  - Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran
FAU - Cambiaghi, B.
AU  - Cambiaghi B
AD  - University of Milan - Bicocca, Monza, Italy
FAU - Moerer, O.
AU  - Moerer O
AD  - University of Goettingen, Goettingen, Germany
FAU - Mauri, T.
AU  - Mauri T
AD  - Fondazione IRCCS Ospedale Maggiore Policlinico, Anesthesia and Critical Care,
      Milan, Italy
FAU - Kunze-Szikszay, N.
AU  - Kunze-Szikszay N
AD  - University of Goettingen, Goettingen, Germany
FAU - Ritter, C.
AU  - Ritter C
AD  - University of Goettingen, Goettingen, Germany
FAU - Pesenti, A.
AU  - Pesenti A
AD  - University of Milan, Milan, Italy
FAU - Quintel, M.
AU  - Quintel M
AD  - University of Goettingen, Goettingen, Germany
FAU - Vilander, L. M.
AU  - Vilander LM
AD  - University of Helsinki and Helsinki University Hospital, Intensive Care Medicine,
      Helsinki, Finland
FAU - Kaunisto, M. A.
AU  - Kaunisto MA
AD  - Institute for Molecular Medicine Finland (FIMM), University of Helsinki,
      Helsinki, Finland
FAU - Vaara, S. T.
AU  - Vaara ST
AD  - University of Helsinki and Helsinki University Hospital, Intensive Care Medicine,
      Helsinki, Finland
FAU - Pettilä, V.
AU  - Pettilä V
AD  - University of Helsinki and Helsinki University Hospital, Intensive Care Medicine,
      Helsinki, Finland
CN  - FINNAKI Study Group
FAU - Mulier, J. L. G. Haitsma
AU  - Mulier JLGH
AD  - VU Medical Centre, Intensive Care Adults, Amsterdam, Netherlands
FAU - Rozemeijer, S.
AU  - Rozemeijer S
AD  - VU Medical Centre, Intensive Care Adults, Amsterdam, Netherlands
FAU - Spoelstra-de Man, A. M. E.
AU  - Spoelstra-de Man AME
AD  - VU Medical Centre, Intensive Care Adults, Amsterdam, Netherlands
FAU - Elbers, P. E.
AU  - Elbers PE
AD  - VU Medical Centre, Intensive Care Adults, Amsterdam, Netherlands
FAU - Tuinman, P. R.
AU  - Tuinman PR
AD  - VU Medical Centre, Intensive Care Adults, Amsterdam, Netherlands
FAU - de Waard, M. C.
AU  - de Waard MC
AD  - VU Medical Centre, Intensive Care Adults, Amsterdam, Netherlands
FAU - Oudemans-van Straaten, H. M.
AU  - Oudemans-van Straaten HM
AD  - VU Medical Centre, Intensive Care Adults, Amsterdam, Netherlands
FAU - Liberatore, A. M. A.
AU  - Liberatore AMA
AD  - Federal University of São Paulo, Surgery, São Paulo, Brazil
FAU - Souza, R. B.
AU  - Souza RB
AD  - Universidade Federal de São Paulo, Morphology and Genetics, São Paulo, Brazil
FAU - Martins, A. M. C. R. P. F.
AU  - Martins AMCRPF
AD  - Biological Institute of São Paulo, São Paulo, Brazil
FAU - Vieira, J. C. F.
AU  - Vieira JCF
AD  - Federal University of São Paulo, Surgery, São Paulo, Brazil
FAU - Koh, I. H. J.
AU  - Koh IHJ
AD  - Federal University of São Paulo, Surgery, São Paulo, Brazil
FAU - Martínez, M. Galindo
AU  - Martínez MG
AD  - Hospital Santa Lucía, Intensive Care, Cartagena, Spain
FAU - Sánchez, R. Jiménez
AU  - Sánchez RJ
AD  - Hospital Santa Lucía, Intensive Care, Cartagena, Spain
FAU - Gascón, L. Martínez
AU  - Gascón LM
AD  - Hospital Santa Lucía, Análisis Clínicos, Cartagena, Spain
FAU - Mulero, M. D. Rodríguez
AU  - Mulero MDR
AD  - Hospital Santa Lucía, Intensive Care, Cartagena, Spain
FAU - Freire, A. Ortín
AU  - Freire AO
AD  - Hospital Santa Lucía, Intensive Care, Cartagena, Spain
FAU - Muñoz, A. Ojados
AU  - Muñoz AO
AD  - Hospital Santa Lucía, Intensive Care, Cartagena, Spain
FAU - Acebes, S. Rebollo
AU  - Acebes SR
AD  - Hospital Santa Lucía, Intensive Care, Cartagena, Spain
FAU - Martínez, Á. Fernández
AU  - Martínez ÁF
AD  - Hospital Santa Lucía, Intensive Care, Cartagena, Spain
FAU - Aliaga, S. Moreno
AU  - Aliaga SM
AD  - Hospital Santa Lucía, Cartagena, Spain
FAU - Para, L. Herrera
AU  - Para LH
AD  - Hospita Santa Lucía, Intensive Care, Cartagena, Spain
FAU - Payá, J. Murcia
AU  - Payá JM
AD  - Hospital Santa Lucía, Intensive Care, Cartagena, Spain
FAU - Mulero, F. Rodríguez
AU  - Mulero FR
AD  - Department of Physiology, School of Medicine Murcia, Murcia, Spain
FAU - Guerci, P.
AU  - Guerci P
AD  - Department of Translational Physiology, Academic Medical Center, University of
      Amsterdam, Amsterdam, Netherlands
FAU - Ince, Y.
AU  - Ince Y
AD  - Department of Translational Physiology, Academic Medical Center, University of
      Amsterdam, Amsterdam, Netherlands
FAU - Heeman, P.
AU  - Heeman P
AD  - Department of Medical Technical Innovation & Development (MIO), Academic Medical 
      Center, University of Amsterdam, Amsterdam, Netherlands
FAU - Ergin, B.
AU  - Ergin B
AD  - Department of Translational Physiology, Academic Medical Center, University of
      Amsterdam, Amsterdam, Netherlands
FAU - Ince, C.
AU  - Ince C
AD  - Department of Translational Physiology, Academic Medical Center, University of
      Amsterdam, Amsterdam, Netherlands
FAU - Uz, Z.
AU  - Uz Z
AD  - Academic Medical Centre Amsterdam, Translational Physiology, Amsterdam,
      Netherlands
FAU - Massey, M.
AU  - Massey M
AD  - Department of Energency Medicine, Harvard Medical School, Boston, USA
FAU - Ince, Y.
AU  - Ince Y
AD  - Academic Medical Center, University of Amsterdam, Transaltional Physiology,
      Amsterdam, Netherlands
FAU - Papatella, R.
AU  - Papatella R
AD  - Academic Medical Center, University of Amsterdam, Transaltional Physiology,
      Amsterdam, Netherlands
FAU - Bulent, E.
AU  - Bulent E
AD  - Academic Medical Center, University of Amsterdam, Transaltional Physiology,
      Amsterdam, Netherlands
FAU - Guerci, P.
AU  - Guerci P
AD  - Academic Medical Center, University of Amsterdam, Transaltional Physiology,
      Amsterdam, Netherlands
FAU - Toraman, F.
AU  - Toraman F
AD  - Department of Cardio-thoracic Surgery, Acibadem University, Istanbul, Turkey
FAU - Ince, C.
AU  - Ince C
AD  - Academic Medical Center, University of Amsterdam, Transaltional Physiology,
      Amsterdam, Netherlands
FAU - Longbottom, E. R.
AU  - Longbottom ER
AD  - Queen Mary University of London, WHRI, Translational Medicine and Therapeutics,
      London, UK
FAU - Torrance, H. D.
AU  - Torrance HD
AD  - Queen Mary University of London, WHRI, Translational Medicine and Therapeutics,
      London, UK
FAU - Owen, H. C.
AU  - Owen HC
AD  - Queen Mary University of London, WHRI, Translational Medicine and Therapeutics,
      London, UK
FAU - Hinds, C. J.
AU  - Hinds CJ
AD  - Queen Mary University of London, WHRI, Translational Medicine and Therapeutics,
      London, UK
FAU - Pearse, R. M.
AU  - Pearse RM
AD  - Queen Mary University of London, WHRI, Translational Medicine and Therapeutics,
      London, UK
FAU - O’Dywer, M. J.
AU  - O’Dywer MJ
AD  - Queen Mary University of London, WHRI, Translational Medicine and Therapeutics,
      London, UK
FAU - Trogrlic, Z.
AU  - Trogrlic Z
AD  - Department of Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands
FAU - van der Jagt, M.
AU  - van der Jagt M
AD  - Department of Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands
FAU - Lingsma, H.
AU  - Lingsma H
AD  - Department of Public Health, Erasmus Medical Centre, Rotterdam, Netherlands
FAU - Ponssen, H. H.
AU  - Ponssen HH
AD  - Department of Intensive Care, Albert Schweitzer Hospital, Dordrecht, Netherlands
FAU - Schoonderbeek, J. F.
AU  - Schoonderbeek JF
AD  - Department of Intensive Care, Ikazia Hospital, Rotterdam, Netherlands
FAU - Schreiner, F.
AU  - Schreiner F
AD  - Department of Intensive Care, IJsselland Hospital, Rotterdam, Netherlands
FAU - Verbrugge, S. J.
AU  - Verbrugge SJ
AD  - Department of Intensive Care, Sint Franciscus Gasthuis, Rotterdam, Netherlands
FAU - Duran, S.
AU  - Duran S
AD  - Department of Intensive Care, Maasstad Hospital, Rotterdam, Netherlands
FAU - van Achterberg, T.
AU  - van Achterberg T
AD  - KU Leuven, Academic Centre for Nursing and Midwifery, Leuven, Belgium
FAU - Bakker, J.
AU  - Bakker J
AD  - Department of Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands
FAU - Gommers, D. A. M. P. J.
AU  - Gommers DAMPJ
AD  - Department of Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands
FAU - Ista, E.
AU  - Ista E
AD  - Department of Pediatric Surgery, Intensive Care Unit, Erasmus Medical Center -
      Sophia Children’s Hospital, Rotterdam, Netherlands
FAU - Krajčová, A.
AU  - Krajčová A
AD  - Third Faculty of Medicine, Charles University in Prague, Laboratory for
      Metabolism and Bioenergetics, Prague, Czech Republic
FAU - Waldauf, P.
AU  - Waldauf P
AD  - Department of Anaesthesiology and Intensive Care, Third Faculty of Medicine,
      Charles University in Prague, Prague, Czech Republic
FAU - Duška, F.
AU  - Duška F
AD  - Third Faculty of Medicine, Charles University in Prague, Laboratory for
      Metabolism and Bioenergetics, Prague, Czech Republic
FAU - Shah, A.
AU  - Shah A
AD  - Nuffield Division of Anaesthetics, Oxford University Hospitals NHS Foundation
      Trust, Oxford, UK
FAU - Roy, N.
AU  - Roy N
AD  - University of Oxford, Weatherall Institute of Molecular Medicine, Oxford, UK
FAU - McKechnie, S.
AU  - McKechnie S
AD  - Nuffield Division of Anaesthetics, Oxford University Hospitals NHS Foundation
      Trust, Oxford, UK
FAU - Doree, C.
AU  - Doree C
AD  - Oxford University Hospitals NHS Foundation Trust, Systematic Review Initiative
      NHS Blood & Transplant, Oxford, UK
FAU - Fisher, S.
AU  - Fisher S
AD  - Oxford University Hospitals NHS Foundation Trust, Systematic Review Initiative
      NHS Blood & Transplant, Oxford, UK
FAU - Stanworth, S. J.
AU  - Stanworth SJ
AD  - Department of Haematology, Oxford University Hospitals NHS Foundation Trust,
      Oxford, UK
FAU - Jensen, J. F.
AU  - Jensen JF
AD  - Department of Anesthesiology, Nordsjællands Hospital, University of Copenhagen,
      Hillerød, Denmark
FAU - Overgaard, D.
AU  - Overgaard D
AD  - Department of Nursing, Metropolitan University, Copenhagen, Denmark
FAU - Bestle, M. H.
AU  - Bestle MH
AD  - Department of Anesthesiology, Nordsjællands Hospital, University of Copenhagen,
      Hillerød, Denmark
FAU - Christensen, D. F.
AU  - Christensen DF
AD  - Department of Anesthesiology, Nordsjællands Hospital, University of Copenhagen,
      Hillerød, Denmark
FAU - Egerod, I.
AU  - Egerod I
AD  - Department of Neuroanesthesiology, University of Copenhagen, Rigshospitalet,
      Copenhagen, Denmark
CN  - The RAPIT Group
FAU - Pivkina, A.
AU  - Pivkina A
AD  - N.I. Pirogov National Medical Surgical Center, Anestesiology and Intensive Care, 
      Moscow, Russian Federation
FAU - Gusarov, V.
AU  - Gusarov V
AD  - N.I. Pirogov National Medical Surgical Center, Anestesiology and Intensive Care, 
      Moscow, Russian Federation
FAU - Zhivotneva, I.
AU  - Zhivotneva I
AD  - N.I. Pirogov National Medical Surgical Center, Moscow, Russian Federation
FAU - Pasko, N.
AU  - Pasko N
AD  - N.I. Pirogov National Medical Surgical Center, Anestesiology and Intensive Care, 
      Moscow, Russian Federation
FAU - Zamyatin, M.
AU  - Zamyatin M
AD  - N.I. Pirogov National Medical Surgical Center, Moscow, Russian Federation
FAU - Jensen, J. F.
AU  - Jensen JF
AD  - Department of Anesthesiology, Nordsjællands Hospital, University of Copenhagen,
      Hillerød, Denmark
FAU - Egerod, I.
AU  - Egerod I
AD  - University of Copenhagen, Health & Medical Sciences, Copenhagen, Denmark
FAU - Bestle, M. H.
AU  - Bestle MH
AD  - Department of Anesthesiology, Nordsjællands Hospital, University of Copenhagen,
      Hillerød, Denmark
FAU - Christensen, D. F.
AU  - Christensen DF
AD  - Department of Anesthesiology, Nordsjællands Hospital, University of Copenhagen,
      Hillerød, Denmark
FAU - Alklit, A.
AU  - Alklit A
AD  - Department of Psychology, University of Southern Denmark, Odense, Denmark
FAU - Hansen, R. L.
AU  - Hansen RL
AD  - Department of Anesthesiology, Nordsjællands Hospital, University of Copenhagen,
      Hillerød, Denmark
FAU - Knudsen, H.
AU  - Knudsen H
AD  - Department of Anesthesiology, Herlev Hospital, University of Copenhagen, Herlev, 
      Denmark
FAU - Grode, L. B.
AU  - Grode LB
AD  - Department of Anesthesiology, Hospital of Horsens, Horsens, Denmark
FAU - Overgaard, D.
AU  - Overgaard D
AD  - Department of Nursing, Metropolitan University, Copenhagen, Denmark
CN  - The RAPIT group
FAU - Hravnak, M.
AU  - Hravnak M
AD  - University of Pittsburgh, School of Nursing, Pittsburgh, USA
FAU - Chen, L.
AU  - Chen L
AD  - Carnegie Mellon University, Robotics Institute, Auton Lab, Pittsburgh, USA
FAU - Dubrawski, A.
AU  - Dubrawski A
AD  - Carnegie Mellon University, Robotics Institute, Auton Lab, Pittsburgh, USA
FAU - Clermont, G.
AU  - Clermont G
AD  - University of Pittsburgh, Critical Care Medicine, Pittsburgh, Pennsylvania USA
FAU - Pinsky, M. R.
AU  - Pinsky MR
AD  - University of Pittsburgh, Critical Care Medicine, Pittsburgh, Pennsylvania USA
FAU - Parry, S. M.
AU  - Parry SM
AD  - Department of Physiotherapy, The University of Melbourne, Melbourne, Australia
FAU - Knight, L. D.
AU  - Knight LD
AD  - Department of Physiotherapy, Royal Melbourne Hospital, Melbourne, Australia
FAU - Connolly, B. C.
AU  - Connolly BC
AD  - Guy’s and St Thomas’ NHS Foundation Trust and Kings College, London, UK
FAU - Baldwin, C. E.
AU  - Baldwin CE
AD  - University of South Australia, Member of the International Centre for Allied
      Health Evidence (iCAHE) and the Sansom Institute, Adelaide, Australia
FAU - Puthucheary, Z. A.
AU  - Puthucheary ZA
AD  - Division of Respiratory and Critical Care, National University Hospital,
      Singapore, Singapore
FAU - Denehy, L.
AU  - Denehy L
AD  - Department of Physiotherapy, The University of Melbourne, Melbourne, Australia
FAU - Hart, N.
AU  - Hart N
AD  - Guy’s and St Thomas’ NHS Foundation Trust and Kings College, London, UK
FAU - Morris, P. E.
AU  - Morris PE
AD  - Division of Critical Care and Pulmonology, University of Kentucky, Kentucky, USA
FAU - Mortimore, J.
AU  - Mortimore J
AD  - Guy’s & St Thomas’ NHS Foundation Trust, Lane Fox Respiratory Unit, London, UK
FAU - Granger, C. L.
AU  - Granger CL
AD  - Department of Physiotherapy, The University of Melbourne, Melbourne, Australia
FAU - Jensen, H. I.
AU  - Jensen HI
AD  - Department of Anaesthesiology and Intensive Care, Lillebaelt Hospital, Vejle and 
      Kolding, Denmark
FAU - Piers, R.
AU  - Piers R
AD  - Department of Geriatrics, Ghent University Hospital, Gent, Belgium
FAU - Van den Bulcke, B.
AU  - Van den Bulcke B
AD  - Department of Intensive Care, Ghent University Hospital, Gent, Belgium
FAU - Malmgren, J.
AU  - Malmgren J
AD  - Department of Anaesthesiology and Intensive Care, Sahlgrenska University
      Hospital, Gothenburg, Sweden
FAU - Metaxa, V.
AU  - Metaxa V
AD  - King’s College Hospital, Critical Care and Major Trauma, London, UK
FAU - Reyners, A. K.
AU  - Reyners AK
AD  - Department of Internal Medicine, University of Groningen, University Medical
      Center Groningen, Groningen, Netherlands
FAU - Darmon, M.
AU  - Darmon M
AD  - Saint-Etienne University Hospital and Jacques Lisfranc Medical School,
      Saint-Etienne, France
FAU - Rusinova, K.
AU  - Rusinova K
AD  - Department of Anaesthesia and Intensive Care Medicine, General University
      Hospital, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech
      Republic
FAU - Talmor, D.
AU  - Talmor D
AD  - Department of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess
      Medical Center and Harvard Medical School, Boston, USA
FAU - Meert, A. P.
AU  - Meert AP
AD  - Institut Jules Bordet, ULB, Service des soins Intensifs et Ergences Oncologiques,
      Bruxelles, Belgium
FAU - Cancelliere, L.
AU  - Cancelliere L
AD  - Dipartimento Emergenza Urgenza Anestesia e Rianimazione, Ospedale Maggiore della 
      Carità Novara, Novara, Italy
FAU - Zubek, L.
AU  - Zubek L
AD  - Semmelweis University, Budapest, Hungary
FAU - Maia, P.
AU  - Maia P
AD  - Intensive Care Department, Hospital S.António, Porto, Portugal
FAU - Michalsen, A.
AU  - Michalsen A
AD  - Department of Anesthesiology and Critical Care, Tettnang Hospital, Tettnang,
      Germany
FAU - Decruyenaere, J.
AU  - Decruyenaere J
AD  - Department of Intensive Care, Ghent University Hospital, Gent, Belgium
FAU - Kompanje, E.
AU  - Kompanje E
AD  - Department of Intensive Care, Erasmus Hospital, Rotterdam, Netherlands
FAU - Vanheule, S.
AU  - Vanheule S
AD  - Department of Psychoanalysis and Clinical Consulting, Ghent University, Gent,
      Belgium
FAU - Azoulay, E.
AU  - Azoulay E
AD  - Hôpital Saint Louis, Service de Reanimation Médicale, Paris, France
FAU - Vansteelandt, S.
AU  - Vansteelandt S
AD  - Department of Applied Mathematics and Computer Science and Statistics, Ghent
      University, Gent, Belgium
FAU - Benoit, D.
AU  - Benoit D
AD  - Department of Intensive Care, Ghent University Hospital, Gent, Belgium
FAU - Van den Bulcke, B.
AU  - Van den Bulcke B
AD  - Department of Intensive Care, Ghent University Hospital, Gent, Belgium
FAU - Piers, R.
AU  - Piers R
AD  - Department of Geriatrics, Ghent University Hospital, Gent, Belgium
FAU - Jensen, H. I.
AU  - Jensen HI
AD  - Department of Anaestesiology and Intensive Care, Lillebaelt Hospital, Veijle and 
      Kolding, Denmark
FAU - Malmgren, J.
AU  - Malmgren J
AD  - Department of Anaesthesiology and Intensive Care, Sahlgrenska University
      Hospital, Gothenburg, Sweden
FAU - Metaxa, V.
AU  - Metaxa V
AD  - King’s College Hospital, Critical Care and Major Trauma, London, UK
FAU - Reyners, A. K.
AU  - Reyners AK
AD  - Department of Internal Medicine, University of Groningen, University Medical
      Center Groningen, Groningen, Netherlands
FAU - Darmon, M.
AU  - Darmon M
AD  - Saint-Etienne University Hospital and Jacques Lisfranc Medical School,
      Saint-Etienne, France
FAU - Rusinova, K.
AU  - Rusinova K
AD  - Department of Anaesthesia and Intensive Care, General University Hospital, 1st
      Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
FAU - Talmor, D.
AU  - Talmor D
AD  - Department of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess
      Medical Center and Harvard Medical School, Boston, USA
FAU - Meert, A. P.
AU  - Meert AP
AD  - Institut Jules Bordet, ULB, Service des Soins Intensifs et Urgences Oncologiques,
      Bruxelles, Belgium
FAU - Cancelliere, L.
AU  - Cancelliere L
AD  - Dipartimento Emergenza Urgenza Anestesia e Rianimazione, Ospedale maggiore della 
      carità Novara, Novara, Italy
FAU - Zubek, L.
AU  - Zubek L
AD  - Semmelweis University, Budapest, Hungary
FAU - Maia, P.
AU  - Maia P
AD  - Department of Intensive Care, Hospital S. António, Porto, Portugal
FAU - Michalsen, A.
AU  - Michalsen A
AD  - Department of Anesthesiology and Critical Care, Tettnang Hospital, Tettnang,
      Germany
FAU - Decruyenaere, J.
AU  - Decruyenaere J
AD  - Department of Intensive Care, Ghent University Hospital, Gent, Belgium
FAU - Kompanje, E.
AU  - Kompanje E
AD  - Department of Intensive Care, Erasmus Hospital, Rotterdam, Netherlands
FAU - Vanheule, S.
AU  - Vanheule S
AD  - Department of Psychoanalysis and Clinical Consulting, Ghent University, Gent,
      Belgium
FAU - Azoulay, E.
AU  - Azoulay E
AD  - Hopital Saint Louis, Service de Reanimation Médicale, Paris, France
FAU - Vansteelandt, S.
AU  - Vansteelandt S
AD  - Department of Applied Mathematics and Computer Science and Statistics, Ghent
      University, Gent, Belgium
FAU - Benoit, D.
AU  - Benoit D
AD  - Department of Intensive Care, Ghent University Hospital, Gent, Belgium
FAU - Ryan, C.
AU  - Ryan C
AD  - St Georges NHS Foundation Trust, General Intensive Care, London, UK
FAU - Dawson, D.
AU  - Dawson D
AD  - St Georges NHS Foundation Trust, General Intensive Care, London, UK
FAU - Ball, J.
AU  - Ball J
AD  - St Georges NHS Foundation Trust, General Intensive Care, London, UK
FAU - Noone, K.
AU  - Noone K
AD  - St Georges NHS Foundation Trust, General Intensive Care, London, UK
FAU - Aisling, B.
AU  - Aisling B
AD  - St Georges NHS Foundation Trust, General Intensive Care, London, UK
FAU - Prudden, S.
AU  - Prudden S
AD  - St Georges NHS Foundation Trust, General Intensive Care, London, UK
FAU - Ntantana, A.
AU  - Ntantana A
AD  - Papageorgiou General Hospital, ICU, Thessaloniki, Greece
FAU - Matamis, D.
AU  - Matamis D
AD  - Papageorgiou General Hospital, ICU, Thessaloniki, Greece
FAU - Savvidou, S.
AU  - Savvidou S
AD  - Papageorgiou General Hospital, ICU, Thessaloniki, Greece
FAU - Giannakou, M.
AU  - Giannakou M
AD  - AHEPA University Hospital, ICU, Thessaloniki, Greece
FAU - Gouva, M.
AU  - Gouva M
AD  - Technological Educational Institutes of Ipeirus, Ioannina, Greece
FAU - Nakos, G.
AU  - Nakos G
AD  - University Hospital of Ioannina, ICU, Ioannina, Greece
FAU - Koulouras, V.
AU  - Koulouras V
AD  - University Hospital of Ioannina, ICU, Ioannina, Greece
FAU - Aron, J.
AU  - Aron J
AD  - Royal Free Hospital, Intensive Care Unit, London, UK
FAU - Lumley, G.
AU  - Lumley G
AD  - Royal Free Hospital, Intensive Care Unit, London, UK
FAU - Milliken, D.
AU  - Milliken D
AD  - Royal Free Hospital, Intensive Care Unit, London, UK
FAU - Dhadwal, K.
AU  - Dhadwal K
AD  - Royal Free Hospital, Intensive Care Unit, London, UK
FAU - McGrath, B. A.
AU  - McGrath BA
AD  - University Hospital South Manchester, Manchester, UK
FAU - Lynch, S. J.
AU  - Lynch SJ
AD  - University Hospital South Manchester, Manchester, UK
FAU - Bovento, B.
AU  - Bovento B
AD  - University Hospital South Manchester, Manchester, UK
FAU - Sharpe, G.
AU  - Sharpe G
AD  - University Hospital South Manchester, Manchester, UK
FAU - Grainger, E.
AU  - Grainger E
AD  - University Hospital South Manchester, Manchester, UK
FAU - Pieri-Davies, S.
AU  - Pieri-Davies S
AD  - University Hospital South Manchester, Manchester, UK
FAU - Wallace, S.
AU  - Wallace S
AD  - University Hospital South Manchester, Manchester, UK
FAU - McGrath, B.
AU  - McGrath B
AD  - University Hospital South Manchester, Manchester, UK
FAU - Lynch, S. J.
AU  - Lynch SJ
AD  - University Hospital South Manchester, Manchester, UK
FAU - Bovento, B.
AU  - Bovento B
AD  - University Hospital South Manchester, Manchester, UK
FAU - Grainger, E.
AU  - Grainger E
AD  - University Hospital South Manchester, Manchester, UK
FAU - Pieri-Davies, S.
AU  - Pieri-Davies S
AD  - University Hospital South Manchester, Manchester, UK
FAU - Sharpe, G.
AU  - Sharpe G
AD  - University Hospital South Manchester, Manchester, UK
FAU - Wallace, S.
AU  - Wallace S
AD  - University Hospital South Manchester, Manchester, UK
FAU - Jung, M.
AU  - Jung M
AD  - Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan
      University School of Medicine, Seoul, Republic of Korea
FAU - Cho, J.
AU  - Cho J
AD  - Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan
      University School of Medicine, Seoul, Republic of Korea
FAU - Park, H.
AU  - Park H
AD  - Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan
      University School of Medicine, Seoul, Republic of Korea
FAU - Suh, G.
AU  - Suh G
AD  - Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan
      University School of Medicine, Seoul, Republic of Korea
FAU - Kousha, O.
AU  - Kousha O
AD  - Royal Cornwall Hospital, Intensive Care Unit, Truro, UK
FAU - Paddle, J.
AU  - Paddle J
AD  - Royal Cornwall Hospital, Intensive Care Unit, Truro, UK
FAU - Gripenberg, L. Gamrin
AU  - Gripenberg LG
AD  - Karolinska University Hospital Huddinge, Stockholm, Sweden
FAU - Rehal, M. Sundström
AU  - Rehal MS
AD  - Karolinska University Hospital Huddinge, Stockholm, Sweden
FAU - Wernerman, J.
AU  - Wernerman J
AD  - Karolinska University Hospital Huddinge, Stockholm, Sweden
FAU - Rooyackers, O.
AU  - Rooyackers O
AD  - Karolinska University Hospital Huddinge, Stockholm, Sweden
FAU - de Grooth, H. J.
AU  - de Grooth HJ
AD  - Department of Intensive Care, VU University Medical Center, Amsterdam,
      Netherlands
FAU - Choo, W. P.
AU  - Choo WP
AD  - Department of Clinical Pharmacology and Pharmacy, VU University Medical Center,
      Amsterdam, Netherlands
FAU - Spoelstra-de Man, A. M.
AU  - Spoelstra-de Man AM
AD  - Department of Intensive Care, VU University Medical Center, Amsterdam,
      Netherlands
FAU - Swart, E. L.
AU  - Swart EL
AD  - Department of Clinical Pharmacology and Pharmacy, VU University Medical Center,
      Amsterdam, Netherlands
FAU - Oudemans-van Straaten, H. M.
AU  - Oudemans-van Straaten HM
AD  - Department of Intensive Care, VU University Medical Center, Amsterdam,
      Netherlands
FAU - Talan, L.
AU  - Talan L
AD  - Department of Internal Medicine Division of Intensive Care, Ankara University
      Faculty of Medicine, Ankara, Turkey
FAU - Güven, G.
AU  - Güven G
AD  - Department of Internal Medicine Division of Intensive Care, Ankara University
      Faculty of Medicine, Ankara, Turkey
FAU - Altıntas, N. D.
AU  - Altıntas ND
AD  - Department of Internal Medicine Division of Intensive Care, Ankara University
      Faculty of Medicine, Ankara, Turkey
FAU - Padar, M.
AU  - Padar M
AD  - Department of Anaesthesiology and Intensive Care, Tartu University Hospital,
      Tartu, Estonia
FAU - Uusvel, G.
AU  - Uusvel G
AD  - Department of Anaesthesiology and Intensive Care, Tartu University Hospital,
      Tartu, Estonia
FAU - Starkopf, L.
AU  - Starkopf L
AD  - University of Copenhagen, Faculty of Health and Medical Sciences, Section of
      Biostatistics, Institute of Public Health, Copenhagen, Denmark
FAU - Starkopf, J.
AU  - Starkopf J
AD  - Department of Anaesthesiology and Intensive Care, Tartu University Hospital,
      Tartu, Estonia
FAU - Blaser, A. Reintam
AU  - Blaser AR
AD  - Department of Anaesthesiology and Intensive Care, University of Tartu, Tartu,
      Estonia
FAU - Kalaiselvan, M. S.
AU  - Kalaiselvan MS
AD  - Department of Critical Care Medicine, Sri Ramachandra University, Chennai, India
FAU - Arunkumar, A. S.
AU  - Arunkumar AS
AD  - Department of Critical Care Medicine, Sri Ramachandra University, Chennai, India
FAU - Renuka, M. K.
AU  - Renuka MK
AD  - Department of Anesthesiology, Sri Ramachandra University, Chennai, India
FAU - Shivkumar, R. L.
AU  - Shivkumar RL
AD  - Department of Critical Care Medicine, Sri Ramachandra University, Chennai, India
FAU - Volbeda, M.
AU  - Volbeda M
AD  - Department of Intensive Care, University Medical Center Groningen, University of 
      Groningen, Groningen, Netherlands
FAU - ten Kate, D.
AU  - ten Kate D
AD  - Department of Intensive Care, University Medical Center Groningen, University of 
      Groningen, Groningen, Netherlands
FAU - Hoekstra, M.
AU  - Hoekstra M
AD  - Department of Intensive Care, University Medical Center Groningen, University of 
      Groningen, Groningen, Netherlands
FAU - van der Maaten, J. M.
AU  - van der Maaten JM
AD  - Departments of Intensive Care and Anesthesiology, University Medical Center
      Groningen, University of Groningen, Groningen, Netherlands
FAU - Nijsten, M. W.
AU  - Nijsten MW
AD  - Department of Intensive Care, University Medical Center Groningen, University of 
      Groningen, Groningen, Netherlands
FAU - Komaromi, A.
AU  - Komaromi A
AD  - Karolinska University Hospital Huddinge, Stockholm, Sweden
FAU - Rooyackers, O.
AU  - Rooyackers O
AD  - Karolinska University Hospital Huddinge, Stockholm, Sweden
FAU - Wernerman, J.
AU  - Wernerman J
AD  - Karolinska University Hospital Huddinge, Stockholm, Sweden
FAU - Norberg, Å.
AU  - Norberg Å
AD  - Karolinska University Hospital Huddinge, Stockholm, Sweden
FAU - Smedberg, M.
AU  - Smedberg M
AD  - Karolinska University Hospital Huddinge, Stockholm, Sweden
FAU - Mori, M.
AU  - Mori M
AD  - Karolinska University Hospital Huddinge, Stockholm, Sweden
FAU - Pettersson, L.
AU  - Pettersson L
AD  - Karolinska University Hospital Huddinge, Stockholm, Sweden
FAU - Norberg, Å.
AU  - Norberg Å
AD  - Karolinska University Hospital Huddinge, Stockholm, Sweden
FAU - Rooyackers, O.
AU  - Rooyackers O
AD  - Karolinska University Hospital Huddinge, Stockholm, Sweden
FAU - Wernerman, J.
AU  - Wernerman J
AD  - Karolinska University Hospital Huddinge, Stockholm, Sweden
FAU - Theodorakopoulou, M.
AU  - Theodorakopoulou M
AD  - Attikon University Hospital, ICU, Athens, Greece
FAU - Christodoulopoulou, T.
AU  - Christodoulopoulou T
AD  - Attikon University Hospital, ICU, Athens, Greece
FAU - Diamantakis, A.
AU  - Diamantakis A
AD  - Attikon University Hospital, ICU, Athens, Greece
FAU - Frantzeskaki, F.
AU  - Frantzeskaki F
AD  - Attikon University Hospital, ICU, Athens, Greece
FAU - Kontogiorgi, M.
AU  - Kontogiorgi M
AD  - Attikon University Hospital, ICU, Athens, Greece
FAU - Chrysanthopoulou, E.
AU  - Chrysanthopoulou E
AD  - Attikon University Hospital, ICU, Athens, Greece
FAU - Lygnos, M.
AU  - Lygnos M
AD  - Attikon University Hospital, ICU, Athens, Greece
FAU - Diakaki, C.
AU  - Diakaki C
AD  - Attikon University Hospital, ICU, Athens, Greece
FAU - Armaganidis, A.
AU  - Armaganidis A
AD  - Attikon University Hospital, ICU, Athens, Greece
FAU - Gundogan, K.
AU  - Gundogan K
AD  - Erciyes University, Intensive Care Unit, Kayseri, Turkey
FAU - Dogan, E.
AU  - Dogan E
AD  - Internal Medicine Department, Erciyes University, Kayseri, Turkey
FAU - Coskun, R.
AU  - Coskun R
AD  - Erciyes University, Intensive Care Unit, Kayseri, Turkey
FAU - Muhtaroglu, S.
AU  - Muhtaroglu S
AD  - Clinical Biochemistry Department, Erciyes University, Kayseri, Turkey
FAU - Sungur, M.
AU  - Sungur M
AD  - Erciyes University, Intensive Care Unit, Kayseri, Turkey
FAU - Ziegler, T.
AU  - Ziegler T
AD  - Department of Medicine, Division of Endocrinology, Metabolism and Lipids, Emory
      University, Atlanta, USA
FAU - Guven, M.
AU  - Guven M
AD  - Erciyes University, Intensive Care Unit, Kayseri, Turkey
FAU - Kleyman, A.
AU  - Kleyman A
AD  - University College London, Bloomsbury Institute of Intensive Care Medicine,
      London, UK
FAU - Khaliq, W.
AU  - Khaliq W
AD  - University College London, Bloomsbury Institute of Intensive Care Medicine,
      London, UK
FAU - Andreas, D.
AU  - Andreas D
AD  - University College London, Bloomsbury Institute of Intensive Care Medicine,
      London, UK
FAU - Singer, M.
AU  - Singer M
AD  - University College London, Bloomsbury Institute of Intensive Care Medicine,
      London, UK
FAU - Meierhans, R.
AU  - Meierhans R
AD  - University Hospital Zurich, University Zurich, Surgical Intensive Care Unit,
      Zurich, Switzerland
FAU - Schuepbach, R.
AU  - Schuepbach R
AD  - University Hospital Zurich, University Zurich, Surgical Intensive Care Unit,
      Zurich, Switzerland
FAU - De Brito-Ashurst, I.
AU  - De Brito-Ashurst I
AD  - Royal Brompton and Harefield NHS Foundation Trust, London, UK
FAU - Zand, F.
AU  - Zand F
AD  - Anesthesiology and Critical Care Research Center, Shiraz University of Medical
      Sciences, Shiraz, Islamic Republic of Iran
FAU - Sabetian, G.
AU  - Sabetian G
AD  - Shiraz University of Medical Sciences, Trauma Research Center, Shiraz, Islamic
      Republic of Iran
FAU - Nikandish, R.
AU  - Nikandish R
AD  - Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran
FAU - Hagar, F.
AU  - Hagar F
AD  - Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran
FAU - Masjedi, M.
AU  - Masjedi M
AD  - Anesthesiology and Critical Care Research Center, Shiraz University of Medical
      Sciences, Shiraz, Islamic Republic of Iran
FAU - Maghsudi, B.
AU  - Maghsudi B
AD  - Anesthesiology and Critical Care Research Center, Shiraz University of Medical
      Sciences, Shiraz, Islamic Republic of Iran
FAU - Vazin, A.
AU  - Vazin A
AD  - Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran
FAU - Ghorbani, M.
AU  - Ghorbani M
AD  - Anesthesiology and Critical Care Research Center, Shiraz University of Medical
      Sciences, Shiraz, Islamic Republic of Iran
FAU - Asadpour, E.
AU  - Asadpour E
AD  - Anesthesiology and Critical Care Research Center, Shiraz University of Medical
      Sciences, Shiraz, Islamic Republic of Iran
FAU - Kao, K. C.
AU  - Kao KC
AD  - Chang Gung Memorial Hospital, Thoacic Medicine, Kwei-Shan, Taoyuan, Taiwan,
      Province of China
FAU - Chiu, L. C.
AU  - Chiu LC
AD  - Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China
FAU - Hung, C. Y.
AU  - Hung CY
AD  - Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China
FAU - Chang, C. H.
AU  - Chang CH
AD  - Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China
FAU - Li, S. H.
AU  - Li SH
AD  - Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China
FAU - Hu, H. C.
AU  - Hu HC
AD  - Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China
FAU - El Maraghi, S.
AU  - El Maraghi S
AD  - Critical Care Department, Faculty of Medicine - Beni Suef University, Cairo,
      Egypt
FAU - Ali, M.
AU  - Ali M
AD  - Critical Care Department, Faculty of Medicine - Beni Suef University, Cairo,
      Egypt
FAU - Rageb, D.
AU  - Rageb D
AD  - Critical Care Department, Faculty of Medicine - Cairo University, Cairo, Egypt
FAU - Helmy, M.
AU  - Helmy M
AD  - Critical Care Department, Faculty of Medicine - Beni Suef University, Cairo,
      Egypt
FAU - Marin-Corral, J.
AU  - Marin-Corral J
AD  - Critical Care Department, Hospital Parc de Salut Mar - GREPAC, IMIM, Barcelona,
      Spain
FAU - Vilà, C.
AU  - Vilà C
AD  - Critical Care Department, Hospital Parc de Salut Mar - GREPAC, IMIM, Barcelona,
      Spain
FAU - Masclans, J. R.
AU  - Masclans JR
AD  - Critical Care Department, Hospital Parc de Salut Mar - GREPAC, IMIM, Barcelona,
      Spain
FAU - Vàzquez, A.
AU  - Vàzquez A
AD  - Critical Care Department, Hospital Parc de Salut Mar - GREPAC, IMIM, Barcelona,
      Spain
FAU - Martín-Loeches, I.
AU  - Martín-Loeches I
AD  - Department of Anesthesia and Critical Care, Multidisciplinary Intensive Care
      Research Organization (MICRO). St James’s; University Hospital. Trinity Center
      for Health Sciences, Dublin, Ireland
FAU - Díaz, E.
AU  - Díaz E
AD  - Critical Care Department, Hospital Parc Tauli, Sabadell, Spain
FAU - Yébenes, J. C.
AU  - Yébenes JC
AD  - Critical Care Department, Hospital de Mataró, Mataró, Spain
FAU - Rodriguez, A.
AU  - Rodriguez A
AD  - Critical Care Department, University Hospital Joan XXIII - IISPV-URV, Tarragona, 
      Spain
FAU - Álvarez-Lerma, F.
AU  - Álvarez-Lerma F
AD  - Critical Care Department, Hospital Parc de Salut Mar - GREPAC, IMIM, Barcelona,
      Spain
CN  - H1N1 SEMICYUC/GETGAG Working Group
FAU - Varga, N.
AU  - Varga N
AD  - Hospital Universitari Vall d’Hebron, Critical Care, Barcelona, Spain
FAU - Cortina-Gutiérrez, A.
AU  - Cortina-Gutiérrez A
AD  - Hospital Universitari Vall d’Hebron, Critical Care, Barcelona, Spain
FAU - Dono, L.
AU  - Dono L
AD  - Hospital Universitari Vall d’Hebron, Critical Care, Barcelona, Spain
FAU - Martínez-Martínez, M.
AU  - Martínez-Martínez M
AD  - Hospital Universitari Vall d’Hebron, Critical Care, Barcelona, Spain
FAU - Maldonado, C.
AU  - Maldonado C
AD  - Hospital Universitari Vall d’Hebron, Critical Care, Barcelona, Spain
FAU - Papiol, E.
AU  - Papiol E
AD  - Hospital Universitari Vall d’Hebron, Critical Care, Barcelona, Spain
FAU - Pérez-Carrasco, M.
AU  - Pérez-Carrasco M
AD  - Hospital Universitari Vall d’Hebron, Critical Care, Barcelona, Spain
FAU - Ferrer, R.
AU  - Ferrer R
AD  - Hospital Universitari Vall d’Hebron, Critical Care, Barcelona, Spain
FAU - Nweze, K.
AU  - Nweze K
AD  - University of Liverpool, Institute of Infection and Global Health, Liverpool, UK
FAU - Morton, B.
AU  - Morton B
AD  - Royal Liverpool University Hospital, Intensive Care Unit, Liverpool, UK
FAU - Welters, I.
AU  - Welters I
AD  - Royal Liverpool University Hospital, Intensive Care Unit, Liverpool, UK
FAU - Houard, M.
AU  - Houard M
AD  - Lille University Hospital, ICU, Lille, France
FAU - Voisin, B.
AU  - Voisin B
AD  - Lille University Hospital, ICU, Lille, France
FAU - Ledoux, G.
AU  - Ledoux G
AD  - Lille University Hospital, ICU, Lille, France
FAU - Six, S.
AU  - Six S
AD  - Lille University Hospital, ICU, Lille, France
FAU - Jaillette, E.
AU  - Jaillette E
AD  - Lille University Hospital, ICU, Lille, France
FAU - Nseir, S.
AU  - Nseir S
AD  - Lille University Hospital, ICU, Lille, France
FAU - Romdhani, S.
AU  - Romdhani S
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Bouneb, R.
AU  - Bouneb R
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Loghmari, D.
AU  - Loghmari D
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Aicha, N. Ben
AU  - Aicha NB
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Ayachi, J.
AU  - Ayachi J
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Meddeb, K.
AU  - Meddeb K
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Chouchène, I.
AU  - Chouchène I
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Khedher, A.
AU  - Khedher A
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Boussarsar, M.
AU  - Boussarsar M
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Chan, K. S.
AU  - Chan KS
AD  - Chi Mei Medical Center, Tainan, Taiwan, Province of China
FAU - Yu, W. L.
AU  - Yu WL
AD  - Chi Mei Medical Center, Tainan, Taiwan, Province of China
FAU - Marin-Corral, J.
AU  - Marin-Corral J
AD  - Critical Care Department, Hospital Parc de Salut Mar - GREPAC, IMIM, Barcelona,
      Spain
FAU - Vilà, C.
AU  - Vilà C
AD  - Critical Care Department, Hospital Parc de Salut Mar - GREPAC, IMIM, Barcelona,
      Spain
FAU - Masclans, J. R.
AU  - Masclans JR
AD  - Critical Care Department, Hospital Parc de Salut Mar - GREPAC, IMIM, Barcelona,
      Spain
FAU - Nolla, J.
AU  - Nolla J
AD  - Pompeu Fabra University (UPF) - CEXS, Barcelona, Spain
FAU - Vidaur, L.
AU  - Vidaur L
AD  - Critical care Department, Hospital de Donosti, San Sebastian, Spain
FAU - Bonastre, J.
AU  - Bonastre J
AD  - Critical care Department, Hospital la Fe, Valencia, Spain
FAU - Suberbiola, B.
AU  - Suberbiola B
AD  - Critical care Department, Hospital de Valdecillas, Santander, Spain
FAU - Guerrero, J. E.
AU  - Guerrero JE
AD  - Critical care Department, Hospital Gregorio Marañon, Madrid, Spain
FAU - Rodriguez, A.
AU  - Rodriguez A
AD  - CIBERES. Instituto de Salud Carlos III, Madrid, Spain
CN  - H1N1 SEMICYUC/GETGAG working group
FAU - Coll, N. Ramon
AU  - Coll NR
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - Jiménez, G. Jiménez
AU  - Jiménez GJ
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - Brugger, S. Carvalho
AU  - Brugger SC
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - Calero, J. Codina
AU  - Calero JC
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - Garrido, B. Balsera
AU  - Garrido BB
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - García, M.
AU  - García M
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - Martínez, M. Palomar
AU  - Martínez MP
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - Vidal, M. Vallverdú
AU  - Vidal MV
AD  - Hospital Universitari Arnau de Vilanova, Lleida, Spain
FAU - de la Torre, M. C.
AU  - de la Torre MC
AD  - Consorci Sanitari del Maresme, Intensive Care Unit, Mataró, Spain
FAU - Vendrell, E.
AU  - Vendrell E
AD  - Consorci Sanitari del Maresme, Intensive Care Unit, Mataró, Spain
FAU - Palomera, E.
AU  - Palomera E
AD  - Consorci Sanitari del Maresme, Investigation Unit, Mataró, Spain
FAU - Güell, E.
AU  - Güell E
AD  - Consorci Sanitari del Maresme, Intensive Care Unit, Mataró, Spain
FAU - Yébenes, J. C.
AU  - Yébenes JC
AD  - Consorci Sanitari del Maresme, Intensive Care Unit, Mataró, Spain
FAU - Serra-Prat, M.
AU  - Serra-Prat M
AD  - Consorci Sanitari del Maresme, Investigation Unit, Mataró, Spain
FAU - Bermejo-Martín, J. F.
AU  - Bermejo-Martín JF
AD  - Hospital Clínico Universitario de Valladolid, Unidad de Investigación Médica en
      Infección e Immunidad, Valladolid, Spain
FAU - Almirall, J.
AU  - Almirall J
AD  - Consorci Sanitari del Maresme, Intensive Care Unit, Mataró, Spain
FAU - Tomas, E.
AU  - Tomas E
AD  - Clinica Sagrada Esperança, ICU, Luanda, Angola
FAU - Escoval, A.
AU  - Escoval A
AD  - Escola Nacional de Saude Publica/ UNL, Lisboa, Portugal
FAU - Froe, F.
AU  - Froe F
AD  - Escola Nacional de Saude Publica/ UNL, Lisboa, Portugal
FAU - Pereira, M. H. Vitoria
AU  - Pereira MHV
AD  - Clinica Sagrada Esperança, Infectiology, Luanda, Angola
FAU - Velez, N.
AU  - Velez N
AD  - Clinica Sagrada Esperança, Luanda, Angola
FAU - Viegas, E.
AU  - Viegas E
AD  - Clinica Sagrada Esperança, Luanda, Angola
FAU - Filipe, E.
AU  - Filipe E
AD  - Clinica Sagrada Esperança, ICU, Luanda, Angola
FAU - Groves, C.
AU  - Groves C
AD  - University Hospital, UHCW NHS Trust, General Critical Care, Coventry, UK
FAU - Reay, M.
AU  - Reay M
AD  - Department of Anaesthetics and Intensive Care, Dudley Group of Hospitals NHS
      Foundation Trust, Dudley, UK
FAU - Chiu, L. C.
AU  - Chiu LC
AD  - Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan,
      Province of China
FAU - Hu, H. C.
AU  - Hu HC
AD  - Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan,
      Province of China
FAU - Hung, C. Y.
AU  - Hung CY
AD  - Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan,
      Province of China
FAU - Chang, C. H.
AU  - Chang CH
AD  - Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan,
      Province of China
FAU - Li, S. H.
AU  - Li SH
AD  - Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan,
      Province of China
FAU - Kao, K. C.
AU  - Kao KC
AD  - Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan,
      Province of China
FAU - Ballin, A.
AU  - Ballin A
AD  - Azienda Ospedaliera di Padova, UOC Anesthesia and Intensive Care Unit, Padua,
      Italy
FAU - Facchin, F.
AU  - Facchin F
AD  - Azienda Ospedaliera di Padova, UOC Anesthesia and Intensive Care Unit, Padua,
      Italy
FAU - Sartori, G.
AU  - Sartori G
AD  - Azienda Ospedaliera di Padova, UOC Anesthesia and Intensive Care Unit, Padua,
      Italy
FAU - Zarantonello, F.
AU  - Zarantonello F
AD  - Azienda Ospedaliera di Padova, UOC Anesthesia and Intensive Care Unit, Padua,
      Italy
FAU - Campello, E.
AU  - Campello E
AD  - Department of Medicine, University of Padua, Thrombotic and Hemorrhagic Diseases 
      Unit, Padua, Italy
FAU - Radu, C. M.
AU  - Radu CM
AD  - Department of Medicine, University of Padua, Thrombotic and Hemorrhagic Diseases 
      Unit, Padua, Italy
FAU - Rossi, S.
AU  - Rossi S
AD  - Azienda Ospedaliera di Padova, UOC Anesthesia and Intensive Care Unit, Padua,
      Italy
FAU - Ori, C.
AU  - Ori C
AD  - Department of Medicine-DIMED, Azienda Ospedaliera di Padova, UOC Anesthesia and
      Intensive Care Unit, Padua, Italy
FAU - Simioni, P.
AU  - Simioni P
AD  - Department of Medicine, University of Padua, Thrombotic and Hemorrhagic Diseases 
      Unit, Padua, Italy
FAU - Umei, N.
AU  - Umei N
AD  - Nippon Medical School Hospital, Tokyo, Japan
FAU - Shingo, I.
AU  - Shingo I
AD  - Nippon Medical School Hospital, Tokyo, Japan
FAU - Santos, A. C.
AU  - Santos AC
AD  - Intensive Care Department, University Hospital of Santa Maria, CHLN, Lisbon,
      Portugal
FAU - Candeias, C.
AU  - Candeias C
AD  - Intensive Care Department, University Hospital of Santa Maria, CHLN, Lisbon,
      Portugal
FAU - Moniz, I.
AU  - Moniz I
AD  - Intensive Care Department, University Hospital of Santa Maria, CHLN, Lisbon,
      Portugal
FAU - Marçal, R.
AU  - Marçal R
AD  - Intensive Care Department, University Hospital of Santa Maria, CHLN, Lisbon,
      Portugal
FAU - e Silva, Z. Costa
AU  - e Silva ZC
AD  - Intensive Care Department, University Hospital of Santa Maria, CHLN, Lisbon,
      Portugal
FAU - Ribeiro, J. M.
AU  - Ribeiro JM
AD  - Intensive Care Department, University Hospital of Santa Maria, CHLN, Lisbon,
      Portugal
FAU - Georger, J. F.
AU  - Georger JF
AD  - Centre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond
      AUBRAC, Reanimation Polyvalente - Surveillance Continue, Villeneuve Saint
      Georges, France
FAU - Ponthus, J. P.
AU  - Ponthus JP
AD  - Centre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond
      AUBRAC, Reanimation Polyvalente - Surveillance Continue, Villeneuve Saint
      Georges, France
FAU - Tchir, M.
AU  - Tchir M
AD  - Centre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond
      AUBRAC, Reanimation Polyvalente - Surveillance Continue, Villeneuve Saint
      Georges, France
FAU - Amilien, V.
AU  - Amilien V
AD  - Centre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond
      AUBRAC, Reanimation Polyvalente - Surveillance Continue, Villeneuve Saint
      Georges, France
FAU - Ayoub, M.
AU  - Ayoub M
AD  - Centre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond
      AUBRAC, Reanimation Polyvalente - Surveillance Continue, Villeneuve Saint
      Georges, France
FAU - Barsam, E.
AU  - Barsam E
AD  - Centre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond
      AUBRAC, Reanimation Polyvalente - Surveillance Continue, Villeneuve Saint
      Georges, France
FAU - Martucci, G.
AU  - Martucci G
AD  - Department of Anesthesia and Intensive Care, IRCCS-ISMETT Mediterranean Institute
      for Transplantation and Advanced Therapies, Palermo, Italy
FAU - Panarello, G.
AU  - Panarello G
AD  - Department of Anesthesia and Intensive Care, IRCCS-ISMETT Mediterranean Institute
      for Transplantation and Advanced Therapies, Palermo, Italy
FAU - Tuzzolino, F.
AU  - Tuzzolino F
AD  - IRCCS-ISMETT Mediterranean Institute for Transplantation and Advanced Therapies, 
      Statistics, Research Office, Palermo, Italy
FAU - Capitanio, G.
AU  - Capitanio G
AD  - Department of Anesthesia and Intensive Care, IRCCS-ISMETT Mediterranean Institute
      for Transplantation and Advanced Therapies, Palermo, Italy
FAU - Ferrazza, V.
AU  - Ferrazza V
AD  - Department of Anesthesia and Intensive Care, IRCCS-ISMETT Mediterranean Institute
      for Transplantation and Advanced Therapies, Palermo, Italy
FAU - Carollo, T.
AU  - Carollo T
AD  - Department of Anesthesia and Intensive Care, IRCCS-ISMETT Mediterranean Institute
      for Transplantation and Advanced Therapies, Palermo, Italy
FAU - Giovanni, L.
AU  - Giovanni L
AD  - Department of Anesthesia and Intensive Care, IRCCS-ISMETT Mediterranean Institute
      for Transplantation and Advanced Therapies, Palermo, Italy
FAU - Arcadipane, A.
AU  - Arcadipane A
AD  - Department of Anesthesia and Intensive Care, IRCCS-ISMETT Mediterranean Institute
      for Transplantation and Advanced Therapies, Palermo, Italy
FAU - Sánchez, M. López
AU  - Sánchez ML
AD  - Hospital Universitario Marqués de Valdecilla, Intensive Care Unit, Santander,
      Spain
FAU - González-Gay, M. A.
AU  - González-Gay MA
AD  - Hospital Universitario Marqués de Valdecilla, Rheumathology Service, Santander,
      Spain
FAU - Díaz, F. J. Llorca
AU  - Díaz FJL
AD  - Universidad de Cantabria, Preventive Medicine and Public Health, Santander, Spain
FAU - López, M. I. Rubio
AU  - López MIR
AD  - Hospital Universitario Marqués de Valdecilla, Intensive Care Unit, Santander,
      Spain
FAU - Zogheib, E.
AU  - Zogheib E
AD  - CHU Amiens - Picardie, Cardio Thoracic and Vascular Intensive Care Unit, Amiens, 
      France
FAU - Villeret, L.
AU  - Villeret L
AD  - CHU Amiens - Picardie, Cardio Thoracic and Vascular Intensive Care Unit, Amiens, 
      France
FAU - Nader, J.
AU  - Nader J
AD  - CHU Amiens - Picardie, Cardiac Surgery, Amiens, France
FAU - Bernasinski, M.
AU  - Bernasinski M
AD  - CHU Amiens - Picardie, Cardio Thoracic and Vascular Intensive Care Unit, Amiens, 
      France
FAU - Besserve, P.
AU  - Besserve P
AD  - CHU Amiens - Picardie, Cardio Thoracic and Vascular Intensive Care Unit, Amiens, 
      France
FAU - Caus, T.
AU  - Caus T
AD  - Université de Picardie Jules Verne, CURS, Amiens, France
FAU - Dupont, H.
AU  - Dupont H
AD  - CHU Amiens - Picardie, Cardio Thoracic and Vascular Intensive Care Unit, Amiens, 
      France
FAU - Morimont, P.
AU  - Morimont P
AD  - University Hospital of Liège, Medical and Coronary Intensive Care, Liege, Belgium
FAU - Habran, S.
AU  - Habran S
AD  - University of Liège, GIGA Research, Liège, Belgium
FAU - Hubert, R.
AU  - Hubert R
AD  - University of Liège, GIGA Research, Liège, Belgium
FAU - Desaive, T.
AU  - Desaive T
AD  - University of Liège, GIGA Research, Liège, Belgium
FAU - Blaffart, F.
AU  - Blaffart F
AD  - University Hospital of Liège, Perfusion School, Liege, Belgium
FAU - Janssen, N.
AU  - Janssen N
AD  - University of Liège, GIGA Research, Liège, Belgium
FAU - Guiot, J.
AU  - Guiot J
AD  - University Hospital of Liège, Medical and Coronary Intensive Care, Liege, Belgium
FAU - Pironet, A.
AU  - Pironet A
AD  - University of Liège, GIGA Research, Liège, Belgium
FAU - Dauby, P.
AU  - Dauby P
AD  - University of Liège, GIGA Research, Liège, Belgium
FAU - Lambermont, B.
AU  - Lambermont B
AD  - University Hospital of Liège, Medical and Coronary Intensive Care, Liege, Belgium
FAU - Zarantonello, F.
AU  - Zarantonello F
AD  - Department of Medicine (DIMED), University of Padova, Padova, Italy
FAU - Ballin, A.
AU  - Ballin A
AD  - Department of Medicine (DIMED), University of Padova, Padova, Italy
FAU - Facchin, F.
AU  - Facchin F
AD  - Department of Medicine (DIMED), University of Padova, Padova, Italy
FAU - Sartori, G.
AU  - Sartori G
AD  - Department of Medicine (DIMED), University of Padova, Padova, Italy
FAU - Campello, E.
AU  - Campello E
AD  - Department of Medicine (DIMED), University of Padova, Padova, Italy
FAU - Pettenuzzo, T.
AU  - Pettenuzzo T
AD  - Department of Medicine (DIMED), University of Padova, Padova, Italy
FAU - Citton, G.
AU  - Citton G
AD  - Department of Medicine (DIMED), University of Padova, Padova, Italy
FAU - Rossi, S.
AU  - Rossi S
AD  - Emergency Department, Azienda Ospedaliera di Padova, Padova, Italy
FAU - Simioni, P.
AU  - Simioni P
AD  - Department of Medicine (DIMED), University of Padova, Padova, Italy
FAU - Ori, C.
AU  - Ori C
AD  - Department of Medicine (DIMED), University of Padova, Padova, Italy
FAU - Kirakli, C.
AU  - Kirakli C
AD  - Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit,
      Izmir, Turkey
FAU - Ediboglu, O.
AU  - Ediboglu O
AD  - Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit,
      Izmir, Turkey
FAU - Ataman, S.
AU  - Ataman S
AD  - Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit,
      Izmir, Turkey
FAU - Yarici, M.
AU  - Yarici M
AD  - Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit,
      Izmir, Turkey
FAU - Tuksavul, F.
AU  - Tuksavul F
AD  - Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit,
      Izmir, Turkey
FAU - Keating, S.
AU  - Keating S
AD  - Royal Infirmary of Edinburgh, Ward 118, Edinburgh, UK
FAU - Gibson, A.
AU  - Gibson A
AD  - Royal Infirmary of Edinburgh, Edinburgh, UK
FAU - Gilles, M.
AU  - Gilles M
AD  - Royal Infirmary of Edinburgh, Edinburgh, UK
FAU - Dunn, M.
AU  - Dunn M
AD  - Royal Infirmary of Edinburgh, Edinburgh, UK
FAU - Price, G.
AU  - Price G
AD  - Royal Infirmary of Edinburgh, Edinburgh, UK
FAU - Young, N.
AU  - Young N
AD  - Royal Infirmary of Edinburgh, Edinburgh, UK
FAU - Remeta, P.
AU  - Remeta P
AD  - PAH Harlow, Intensive Care, Harlow, UK
FAU - Bishop, P.
AU  - Bishop P
AD  - Colchester NHSFT, Intensive Care, Colchester, UK
FAU - Zamora, M. D. Fernández
AU  - Zamora MDF
AD  - Hospital Regional Málaga, Intensive Care, Málaga, Spain
FAU - Muñoz-Bono, J.
AU  - Muñoz-Bono J
AD  - Hospital Regional Málaga, Intensive Care, Málaga, Spain
FAU - Curiel-Balsera, E.
AU  - Curiel-Balsera E
AD  - Hospital Regional Málaga, Intensive Care, Málaga, Spain
FAU - Aguilar-Alonso, E.
AU  - Aguilar-Alonso E
AD  - Hospital Infanta Margarita, Intensive Care, Cabra, Spain
FAU - Hinojosa, R.
AU  - Hinojosa R
AD  - Hospital Virgen del Rocio, Intensive Care, Sevilla, Spain
FAU - Gordillo-Brenes, A.
AU  - Gordillo-Brenes A
AD  - Hospital Puerta del Mar, Intensive Care, Cádiz, Spain
FAU - Arboleda-Sánchez, J. A.
AU  - Arboleda-Sánchez JA
AD  - Hospital Regional Málaga, Málaga, Spain
CN  - ARIAM-CARDIAC SURGERY PROJECT AUTHORS
FAU - Skorniakov, I.
AU  - Skorniakov I
AD  - Guy’s & St Thomas’ NHS Foundation Trust, London, UK
FAU - Vikulova, D.
AU  - Vikulova D
AD  - Sverdlovsk Regional Clinical Hospital 1, Ekaterinburg, Russian Federation
FAU - Whiteley, C.
AU  - Whiteley C
AD  - Guy’s & St Thomas’ NHS Foundation Trust, London, UK
FAU - Shaikh, O.
AU  - Shaikh O
AD  - Guy’s & St Thomas’ NHS Foundation Trust, London, UK
FAU - Jones, A.
AU  - Jones A
AD  - Guy’s & St Thomas’ NHS Foundation Trust, London, UK
FAU - Ostermann, M.
AU  - Ostermann M
AD  - Guys and St Thomas’ NHS Foundation Trust, London, UK
FAU - Forni, L.
AU  - Forni L
AD  - Royal Surrey County Hospital, Guildford, UK
FAU - Scott, M.
AU  - Scott M
AD  - Royal Surrey County Hospital, ICU and SPACeR research group, Guildford, UK
FAU - Sahatjian, J.
AU  - Sahatjian J
AD  - Cheetah Medical, Inc., Director of Clinical Operations, Newton Center, USA
FAU - Linde-Zwirble, W.
AU  - Linde-Zwirble W
AD  - Health Economics Trexin, Chief Data Scientist, Chicago, USA
FAU - Hansell, D.
AU  - Hansell D
AD  - Cheetah Medical, Inc., Chief Physician Executive, Newton Center, USA
FAU - Laoveeravat, P.
AU  - Laoveeravat P
AD  - Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial
      Hospital, Thai Red Cross and Faculty of Medicine, Chulalongkorn University,
      Bangkok, Thailand
FAU - Srisawat, N.
AU  - Srisawat N
AD  - Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial
      Hospital, Thai Red Cross and Faculty of Medicine, Chulalongkorn University,
      Bangkok, Thailand
FAU - Kongwibulwut, M.
AU  - Kongwibulwut M
AD  - Department of Anesthesiology, King Chulalongkorn Memorial Hospital, Thai Red
      Cross and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
FAU - Peerapornrattana, S.
AU  - Peerapornrattana S
AD  - Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial
      Hospital, Thai Red Cross and Faculty of Medicine, Chulalongkorn University,
      Bangkok, Thailand
FAU - Suwachittanont, N.
AU  - Suwachittanont N
AD  - Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial
      Hospital, Thai Red Cross and Faculty of Medicine, Chulalongkorn University,
      Bangkok, Thailand
FAU - Wirotwan, T. O.
AU  - Wirotwan TO
AD  - Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial
      Hospital, Thai Red Cross and Faculty of Medicine, Chulalongkorn University,
      Bangkok, Thailand
FAU - Chatkaew, P.
AU  - Chatkaew P
AD  - Department of Anesthesiology, King Chulalongkorn Memorial Hospital, Thai Red
      Cross and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
FAU - Saeyub, P.
AU  - Saeyub P
AD  - Department of Anesthesiology, King Chulalongkorn Memorial Hospital, Thai Red
      Cross and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
FAU - Latthaprecha, K.
AU  - Latthaprecha K
AD  - Department of Anesthesiology, King Chulalongkorn Memorial Hospital, Thai Red
      Cross and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
FAU - Tiranathanagul, K.
AU  - Tiranathanagul K
AD  - Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial
      Hospital, Thai Red Cross and Faculty of Medicine, Chulalongkorn University,
      Bangkok, Thailand
FAU - Eiam-ong, S.
AU  - Eiam-ong S
AD  - Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial
      Hospital, Thai Red Cross and Faculty of Medicine, Chulalongkorn University,
      Bangkok, Thailand
FAU - Kellum, J. A.
AU  - Kellum JA
AD  - Department of Critical Care Medicine, Center for Critical Care Nephrology, CRISMA
      Center, University of Pittsburgh School of Medicine, Pittsburgh, USA
FAU - Berthelsen, R. E.
AU  - Berthelsen RE
AD  - Department of Anaesthesiology and Intensive Care, Nordsjællands Hospital,
      Hillerød, Denmark
FAU - Perner, A.
AU  - Perner A
AD  - Department of Intensive Care, Rigshospitalet, Copenhagen University Hospital,
      Copenhagen, Denmark
FAU - Jensen, A. E. K.
AU  - Jensen AEK
AD  - Department of Biostatistics, University of Copenhagen, Copenhagen, Denmark
FAU - Jensen, J. U.
AU  - Jensen JU
AD  - Department of Infectious Diseases, Rigshospitalet, Copenhagen University
      Hospital, CHIP & PERSIMUNE, Copenhagen, Denmark
FAU - Bestle, M. H.
AU  - Bestle MH
AD  - Department of Anaesthesiology and Intensive Care, Nordsjællands Hospital,
      Hillerød, Denmark
FAU - Gebhard, D. J.
AU  - Gebhard DJ
AD  - University of Texas Health Science Center San Antonio, Pediatric Critical Care
      Medicine, San Antonio, USA
FAU - Price, J.
AU  - Price J
AD  - Baylor College of Medicine, Pediatric Cardiology, Houston, USA
FAU - Kennedy, C. E.
AU  - Kennedy CE
AD  - Baylor College of Medicine, Pediatric Critical Care Medicine, Houston, USA
FAU - Akcan-Arikan, A.
AU  - Akcan-Arikan A
AD  - Baylor College of Medicine, Pediatric Critical Care Medicine, Houston, USA
FAU - Liberatore, A. M. A.
AU  - Liberatore AMA
AD  - Federal University of São Paulo, Surgery, São Paulo, Brazil
FAU - Souza, R. B.
AU  - Souza RB
AD  - Federal University of São Paulo, Morphology and Genetics, São Paulo, Brazil
FAU - Martins, A. M. C. R. P. F.
AU  - Martins AMCRPF
AD  - Biological Institute of São Paulo, Sao Paulo, Brazil
FAU - Vieira, J. C. F.
AU  - Vieira JCF
AD  - Federal University of São Paulo, Surgery, São Paulo, Brazil
FAU - Kang, Y. R.
AU  - Kang YR
AD  - Federal University of São Paulo, Surgery, São Paulo, Brazil
FAU - Nakamae, M. N.
AU  - Nakamae MN
AD  - Federal University of São Paulo, Surgery, São Paulo, Brazil
FAU - Koh, I. H. J.
AU  - Koh IHJ
AD  - Federal University of São Paulo, Surgery, São Paulo, Brazil
FAU - Hamed, K.
AU  - Hamed K
AD  - Faculty of Medicine, Cairo University, Critical Care Medicine, Cairo, Egypt
FAU - Khaled, M. M.
AU  - Khaled MM
AD  - Faculty of Medicine, Cairo University, Critical Care Medicine, Cairo, Egypt
FAU - Soliman, R. Aly
AU  - Soliman RA
AD  - Faculty of Medicine, Cairo University, Critical Care Medicine, Cairo, Egypt
FAU - Mokhtar, M. Sherif
AU  - Mokhtar MS
AD  - Faculty of Medicine, Cairo University, Critical Care Medicine, Cairo, Egypt
FAU - Seller-Pérez, G.
AU  - Seller-Pérez G
AD  - Complejo Universitario Carlos Haya, Málaga, Spain
FAU - Arias-Verdú, D.
AU  - Arias-Verdú D
AD  - Complejo Universitario Carlos Haya, Málaga, Spain
FAU - Llopar-Valdor, E.
AU  - Llopar-Valdor E
AD  - Hospital Parc Tauli, Sabadell, Spain
FAU - De-Diós-Chacón, I.
AU  - De-Diós-Chacón I
AD  - Hospital Son Llatzer, Palma de Mallorca, Spain
FAU - Quesada-García, G.
AU  - Quesada-García G
AD  - Complejo Universitario Carlos Haya, Málaga, Spain
FAU - Herrera-Gutierrez, M. E.
AU  - Herrera-Gutierrez ME
AD  - Complejo Universitario Carlos Haya, Málaga, Spain
FAU - Hafes, R.
AU  - Hafes R
AD  - University of Glasgow, Glasgow, UK
FAU - Carroll, G.
AU  - Carroll G
AD  - Queen Elizabeth Hospital, Critical Care, Glasgow, UK
FAU - Doherty, P.
AU  - Doherty P
AD  - Queen Elizabeth Hospital, Critical Care, Glasgow, UK
FAU - Wright, C.
AU  - Wright C
AD  - Queen Elizabeth Hospital, Critical Care, Glasgow, UK
FAU - Vera, I. G. Guerra
AU  - Vera IGG
AD  - Centro Universitario de La Costa, Puerto Vallarta, Jalisco Mexico
FAU - Ralston, M.
AU  - Ralston M
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Gemmell, M. L.
AU  - Gemmell ML
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - MacKay, A.
AU  - MacKay A
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Black, E.
AU  - Black E
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Wright, C.
AU  - Wright C
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Docking, R. I.
AU  - Docking RI
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Appleton, R.
AU  - Appleton R
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Ralston, M. R.
AU  - Ralston MR
AD  - Queen Elizabeth University Hospital, Intensive Care Unit, Glasgow, UK
FAU - Gemmell, L.
AU  - Gemmell L
AD  - Queen Elizabeth University Hospital, Intensive Care Unit, Glasgow, UK
FAU - Appleton, R.
AU  - Appleton R
AD  - Queen Elizabeth University Hospital, Intensive Care Unit, Glasgow, UK
FAU - Wright, C.
AU  - Wright C
AD  - Queen Elizabeth University Hospital, Intensive Care Unit, Glasgow, UK
FAU - Docking, R. I.
AU  - Docking RI
AD  - Queen Elizabeth University Hospital, Intensive Care Unit, Glasgow, UK
FAU - Black, E.
AU  - Black E
AD  - Queen Elizabeth University Hospital, Intensive Care Unit, Glasgow, UK
FAU - Mackay, A.
AU  - Mackay A
AD  - Queen Elizabeth University Hospital, Intensive Care Unit, Glasgow, UK
FAU - Rozemeijer, S.
AU  - Rozemeijer S
AD  - Department of Intensive Care, VU University Medical Center Amsterdam, Adults,
      Amsterdam, Netherlands
FAU - Mulier, J. L. G. Haitsma
AU  - Mulier JLGH
AD  - Department of Intensive Care, VU University Medical Center Amsterdam, Adults,
      Amsterdam, Netherlands
FAU - Röttgering, J. G.
AU  - Röttgering JG
AD  - Department of Intensive Care, VU University Medical Center Amsterdam, Adults,
      Amsterdam, Netherlands
FAU - Elbers, P. W. G.
AU  - Elbers PWG
AD  - Department of Intensive Care, VU University Medical Center Amsterdam, Adults,
      Amsterdam, Netherlands
FAU - Spoelstra-de Man, A. M. E.
AU  - Spoelstra-de Man AME
AD  - Department of Intensive Care, VU University Medical Center Amsterdam, Adults,
      Amsterdam, Netherlands
FAU - Tuinman, P. R.
AU  - Tuinman PR
AD  - Department of Intensive Care, VU University Medical Center Amsterdam, Adults,
      Amsterdam, Netherlands
FAU - de Waard, M. C.
AU  - de Waard MC
AD  - Department of Intensive Care, VU University Medical Center Amsterdam, Adults,
      Amsterdam, Netherlands
FAU - Oudemans-van Straaten, H. M.
AU  - Oudemans-van Straaten HM
AD  - Department of Intensive Care, VU University Medical Center Amsterdam, Adults,
      Amsterdam, Netherlands
FAU - Mejeni, N.
AU  - Mejeni N
AD  - University of Kinshasa, Anaesthesiology and Intensive Care, Kinshasa, Democratic 
      Republic of the Congo
FAU - Nsiala, J.
AU  - Nsiala J
AD  - University of Kinshasa, Anaesthesiology and Intensive Care, Kinshasa, Democratic 
      Republic of the Congo
FAU - Kilembe, A.
AU  - Kilembe A
AD  - University of Kinshasa, Anaesthesiology and Intensive Care, Kinshasa, Democratic 
      Republic of the Congo
FAU - Akilimali, P.
AU  - Akilimali P
AD  - University of Kinshasa, Public Heath, Kinshasa, Democratic Republic of the Congo
FAU - Thomas, G.
AU  - Thomas G
AD  - Hôpital Nord, Reanimation, Marseille, France
FAU - Egerod, I.
AU  - Egerod I
AD  - Rigshospitalet, Copenhagen University Hospital, Neurointensive Care Unit,
      Copenhagen, Denmark
FAU - Andersson, A. E.
AU  - Andersson AE
AD  - University of Gothenburg, The Sahlgrenska Academy, Gothenburg, Sweden
FAU - Fagerdahl, A. M.
AU  - Fagerdahl AM
AD  - Karolinska Institute, Stockholm, Sweden
FAU - Knudsen, V.
AU  - Knudsen V
AD  - Rigshospitalet, Copenhagen University Hospital, Intensive Care Unit, Copenhagen, 
      Denmark
CN  - P-INFECT
FAU - Meddeb, K.
AU  - Meddeb K
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Cheikh, A. Ben
AU  - Cheikh AB
AD  - Farhat Hached University Hospital, Hospital Hygiene Unit, Sousse, Tunisia
FAU - Hamdaoui, Y.
AU  - Hamdaoui Y
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Ayachi, J.
AU  - Ayachi J
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Guiga, A.
AU  - Guiga A
AD  - Internal Medicine Department, Farhat Hached University Hospital, Sousse, Tunisia
FAU - Fraj, N.
AU  - Fraj N
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Romdhani, S.
AU  - Romdhani S
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Sma, N.
AU  - Sma N
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Bouneb, R.
AU  - Bouneb R
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Chouchene, I.
AU  - Chouchene I
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Khedher, A.
AU  - Khedher A
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Bouafia, N.
AU  - Bouafia N
AD  - Farhat Hached University Hospital, Hospital Hygiene Unit, Sousse, Tunisia
FAU - Boussarsar, M.
AU  - Boussarsar M
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Amirian, A.
AU  - Amirian A
AD  - Department of Surgery, Shiraz University of Medical Sciences, Shiraz, Islamic
      Republic of Iran
FAU - Ziaian, B.
AU  - Ziaian B
AD  - Department of Surgery, Shiraz University of Medical Sciences, Shiraz, Islamic
      Republic of Iran
FAU - Masjedi, M.
AU  - Masjedi M
AD  - Anesthesiology and Critical Care Research Center, Shiraz University of Medical
      Sciences, Shiraz, Islamic Republic of Iran
FAU - Fleischmann, C.
AU  - Fleischmann C
AD  - Department of Anesthesiology and Intensive Care Medicine, Jena University
      Hospital, Jena, Germany
FAU - Thomas-Rueddel, D. O.
AU  - Thomas-Rueddel DO
AD  - Department of Anesthesiology and Intensive Care Medicine, Jena University
      Hospital, Jena, Germany
FAU - Schettler, A.
AU  - Schettler A
AD  - Department of Anesthesiology and Intensive Care Medicine, Jena University
      Hospital, Jena, Germany
FAU - Schwarzkopf, D.
AU  - Schwarzkopf D
AD  - Department of Anesthesiology and Intensive Care Medicine, Jena University
      Hospital, Jena, Germany
FAU - Stacke, A.
AU  - Stacke A
AD  - Department of Anesthesiology and Intensive Care Medicine, Jena University
      Hospital, Jena, Germany
FAU - Reinhart, K.
AU  - Reinhart K
AD  - Department of Anesthesiology and Intensive Care Medicine, Jena University
      Hospital, Jena, Germany
FAU - Filipe, E.
AU  - Filipe E
AD  - Clinica Sagrada Esperança, ICU, Luanda, Angola
FAU - Escoval, A.
AU  - Escoval A
AD  - Escola Nacional de Saude Publica/ UNL, Lisboa, Portugal
FAU - Martins, A.
AU  - Martins A
AD  - Clinica Sagrada Esperança, Luanda, Angola
FAU - Sousa, P.
AU  - Sousa P
AD  - Escola Nacional de Saude Publica/ UNL, Lisboa, Portugal
FAU - Velez, N.
AU  - Velez N
AD  - Clinica Sagrada Esperança, Luanda, Angola
FAU - Viegas, E.
AU  - Viegas E
AD  - Clinica Sagrada Esperança, Luanda, Angola
FAU - Tomas, E.
AU  - Tomas E
AD  - Clinica Sagrada Esperança, Luanda, Angola
FAU - Snell, G.
AU  - Snell G
AD  - Royal Stoke University Hospital, Critical Care, Stoke-on-Trent, UK
FAU - Matsa, R.
AU  - Matsa R
AD  - Royal Stoke University Hospital, Critical Care, Stoke-on-Trent, UK
FAU - Paary, T. T. S.
AU  - Paary TTS
AD  - Apollo Hospitals, Intensive Care Medicine, Bangalore, India
FAU - Kalaiselvan, M. S.
AU  - Kalaiselvan MS
AD  - SRI Ramachindra University, Intensive Care Medicine, Chennai, India
FAU - Cavalheiro, A. M.
AU  - Cavalheiro AM
AD  - Hospital Israelita Albert Einstein, ICU, São Paulo, Brazil
FAU - Rocha, L. L.
AU  - Rocha LL
AD  - Hospital Israelita Albert Einstein, ICU, São Paulo, Brazil
FAU - Vallone, C. S.
AU  - Vallone CS
AD  - Hospital Israelita Albert Einstein, ICU, São Paulo, Brazil
FAU - Tonilo, A.
AU  - Tonilo A
AD  - Hospital Israelita Albert Einstein, ICU, São Paulo, Brazil
FAU - Lobato, M. D. S.
AU  - Lobato MDS
AD  - Hospital Israelita Albert Einstein, ICU, São Paulo, Brazil
FAU - Malheiro, D. T.
AU  - Malheiro DT
AD  - Hospital Israelita Albert Einstein, ICU, São Paulo, Brazil
FAU - Sussumo, G.
AU  - Sussumo G
AD  - Hospital Israelita Albert Einstein, ICU, São Paulo, Brazil
FAU - Lucino, N. M.
AU  - Lucino NM
AD  - Hospital Israelita Albert Einstein, ICU, São Paulo, Brazil
FAU - Zand, F.
AU  - Zand F
AD  - Anesthesiology and Critical Care Research Center, Shiraz University of Medical
      Sciences, Shiraz, Islamic Republic of Iran
FAU - Rosenthal, V. D.
AU  - Rosenthal VD
AD  - International Nosocomial Infection Control Consortium, Buenos Aires, Argentina
FAU - Masjedi, M.
AU  - Masjedi M
AD  - Anesthesiology and Critical Care Research Center, Shiraz University of Medical
      Sciences, Shiraz, Islamic Republic of Iran
FAU - Sabetian, G.
AU  - Sabetian G
AD  - Trauma Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic
      Republic of Iran
FAU - Maghsudi, B.
AU  - Maghsudi B
AD  - Anesthesiology and Critical Care Research Center, Shiraz University of Medical
      Sciences, Shiraz, Islamic Republic of Iran
FAU - Ghorbani, M.
AU  - Ghorbani M
AD  - Anesthesiology and Critical Care Research Center, Shiraz University of Medical
      Sciences, Shiraz, Islamic Republic of Iran
FAU - Dashti, A. Sanaei
AU  - Dashti AS
AD  - Shiraz HIV/AIDS Research Center, Shiraz University of Medical Sciences, Shiraz,
      Islamic Republic of Iran
FAU - Yousefipour, A.
AU  - Yousefipour A
AD  - Anesthesiology and Critical Care Research Center, Shiraz University of Medical
      Sciences, Shiraz, Islamic Republic of Iran
FAU - Goodall, J. R.
AU  - Goodall JR
AD  - Salford Royal NHS Foundation Trust, Critical Care, Salford, UK
FAU - Williamson, M.
AU  - Williamson M
AD  - Salford Royal NHS Foundation Trust, Manchester, UK
FAU - Tant, E.
AU  - Tant E
AD  - Salford Royal NHS Foundation Trust, Manchester, UK
FAU - Thomas, N.
AU  - Thomas N
AD  - Salford Royal NHS Foundation Trust, Manchester, UK
FAU - Balci, C.
AU  - Balci C
AD  - Kocaeli Derince Education and Research Hospital, Kocaeli, Turkey
FAU - Gonen, C.
AU  - Gonen C
AD  - Kocaeli Derince Education and Research Hospital, Kocaeli, Turkey
FAU - Haftacı, E.
AU  - Haftacı E
AD  - Kocaeli Derince Education and Research Hospital, Kocaeli, Turkey
FAU - Gurarda, H.
AU  - Gurarda H
AD  - Kocaeli Derince Education and Research Hospital, Kocaeli, Turkey
FAU - Karaca, E.
AU  - Karaca E
AD  - Kocaeli Derince Education and Research Hospital, Kocaeli, Turkey
FAU - Paldusová, B.
AU  - Paldusová B
AD  - Department of Anesthesia and Intensive Care, Regional Hospital Liberec, Liberec, 
      Czech Republic
FAU - Zýková, I.
AU  - Zýková I
AD  - Department of Anesthesia and Intensive Care, Regional Hospital Liberec, Liberec, 
      Czech Republic
FAU - Šímová, D.
AU  - Šímová D
AD  - Regional Hospital Liberec, Neurocentre, Liberec, Czech Republic
FAU - Houston, S.
AU  - Houston S
AD  - St Mary’s Hospital, Adult Intensive Care Unit, London, UK
FAU - D’Antona, L.
AU  - D’Antona L
AD  - St Mary’s Hospital, Adult Intensive Care Unit, London, UK
FAU - Lloyd, J.
AU  - Lloyd J
AD  - St Mary’s Hospital, Adult Intensive Care Unit, London, UK
FAU - Garnelo-Rey, V.
AU  - Garnelo-Rey V
AD  - St Mary’s Hospital, Adult Intensive Care Unit, London, UK
FAU - Sosic, M.
AU  - Sosic M
AD  - Department of Neurology, Faculty of Medicine, University of Rijeka, Rijeka,
      Croatia
FAU - Sotosek-Tokmazic, V.
AU  - Sotosek-Tokmazic V
AD  - Department of Anesthesiology, Reanimatology and Intensive Care Medicine, Faculty 
      of Medicine, University of Rijeka, Rijeka, Croatia
FAU - Kuharic, J.
AU  - Kuharic J
AD  - Department of Anesthesiology, Reanimatology and Intensive Care Medicine, Faculty 
      of Medicine, University of Rijeka, Rijeka, Croatia
FAU - Antoncic, I.
AU  - Antoncic I
AD  - Department of Neurology, Faculty of Medicine, University of Rijeka, Rijeka,
      Croatia
FAU - Dunatov, S.
AU  - Dunatov S
AD  - Department of Neurology, Faculty of Medicine, University of Rijeka, Rijeka,
      Croatia
FAU - Sustic, A.
AU  - Sustic A
AD  - Department of Anesthesiology, Reanimatology and Intensive Care Medicine, Faculty 
      of Medicine, University of Rijeka, Rijeka, Croatia
FAU - Chong, C. T.
AU  - Chong CT
AD  - Tan Tock Seng Hospital, National Healthcare Group (Singapore), Singapore,
      Singapore
FAU - Sim, M.
AU  - Sim M
AD  - National University of Singapore, Singapore, Singapore
FAU - Lyovarin, T.
AU  - Lyovarin T
AD  - National University of Singapore, Singapore, Singapore
FAU - Díaz, F. M. Acosta
AU  - Díaz FMA
AD  - Hospital Universitario San Cecilio, Granada, Spain
FAU - Galdó, S. Narbona
AU  - Galdó SN
AD  - Hospital Universitario San Cecilio, Granada, Spain
FAU - Garach, M. Muñoz
AU  - Garach MM
AD  - Hospital Universitario San Cecilio, Granada, Spain
FAU - Romero, O. Moreno
AU  - Romero OM
AD  - Hospital Universitario San Cecilio, Granada, Spain
FAU - Bailón, A. M. Pérez
AU  - Bailón AMP
AD  - Hospital Universitario San Cecilio, Granada, Spain
FAU - Pinel, A. Carranza
AU  - Pinel AC
AD  - Hospital Universitario San Cecilio, Granada, Spain
FAU - Colmenero, M.
AU  - Colmenero M
AD  - Hospital Universitario San Cecilio, Granada, Spain
FAU - Gritsan, A.
AU  - Gritsan A
AD  - Krasnoyarsk State Medical University, Krasnoyarsk Regional Hospital,
      Anaesthesiology and Intensive Care, Krasnoyarsk, Russian Federation
FAU - Gazenkampf, A.
AU  - Gazenkampf A
AD  - Krasnoyarsk State Medical University, Krasnoyarsk Regional Hospital,
      Anaesthesiology and Intensive Care, Krasnoyarsk, Russian Federation
FAU - Korchagin, E.
AU  - Korchagin E
AD  - Krasnoyarsk Regional Hospital, Krasnoyarsk, Russian Federation
FAU - Dovbish, N.
AU  - Dovbish N
AD  - Krasnoyarsk Clinical Regional Hospital, Anaesthesiology and Intensive Care,
      Krasnoyarsk, Russian Federation
FAU - Lee, R. M.
AU  - Lee RM
AD  - Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore
FAU - Lim, M. P. P.
AU  - Lim MPP
AD  - Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore
FAU - Chong, C. T.
AU  - Chong CT
AD  - Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore
FAU - Lim, B. C. L.
AU  - Lim BCL
AD  - Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore
FAU - See, J. J.
AU  - See JJ
AD  - Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore
FAU - Assis, R.
AU  - Assis R
AD  - Centro Hospitalar do Médio Tejo, Unidade de Cuidados Intensivos Polivalente,
      Abrantes, Portugal
FAU - Filipe, F.
AU  - Filipe F
AD  - Hospital de Santa Maria/CHLN, Lisboa, Portugal
FAU - Lopes, N.
AU  - Lopes N
AD  - Centro Hospitalar do Médio Tejo, Abrantes, Portugal
FAU - Pessoa, L.
AU  - Pessoa L
AD  - Centro Hospitalar do Médio Tejo, Abrantes, Portugal
FAU - Pereira, T.
AU  - Pereira T
AD  - Centro Hospitalar do Médio Tejo, Abrantes, Portugal
FAU - Catorze, N.
AU  - Catorze N
AD  - Centro Hospitalar do Médio Tejo, Abrantes, Portugal
FAU - Aydogan, M. S.
AU  - Aydogan MS
AD  - Inonu University, Intensive Care, Malatya, Turkey
FAU - Aldasoro, C.
AU  - Aldasoro C
AD  - University of Valencia/School of Medicine, Valencia, Spain
FAU - Marchio, P.
AU  - Marchio P
AD  - University of Valencia/School of Medicine, Valencia, Spain
FAU - Jorda, A.
AU  - Jorda A
AD  - University of Valencia/School of Medicine, Valencia, Spain
FAU - Mauricio, M. D.
AU  - Mauricio MD
AD  - University of Valencia/School of Medicine, Valencia, Spain
FAU - Guerra-Ojeda, S.
AU  - Guerra-Ojeda S
AD  - University of Valencia/School of Medicine, Valencia, Spain
FAU - Gimeno-Raga, M.
AU  - Gimeno-Raga M
AD  - University of Valencia/School of Medicine, Valencia, Spain
FAU - Colque-Cano, M.
AU  - Colque-Cano M
AD  - University of Valencia/School of Medicine, Valencia, Spain
FAU - Bertomeu-Artecero, A.
AU  - Bertomeu-Artecero A
AD  - University of Valencia/School of Medicine, Valencia, Spain
FAU - Aldasoro, M.
AU  - Aldasoro M
AD  - University of Valencia/School of Medicine, Valencia, Spain
FAU - Valles, S. L.
AU  - Valles SL
AD  - University of Valencia/School of Medicine, Valencia, Spain
FAU - Tonon, D.
AU  - Tonon D
AD  - Department of Anaesthesiology & Intensive Care, APHM, CHU Timone, Marseille,
      France
FAU - Triglia, T.
AU  - Triglia T
AD  - Department of Anaesthesiology & Intensive Care, APHM, CHU Timone, Marseille,
      France
FAU - Martin, J. C.
AU  - Martin JC
AD  - University School of Medicine, NORT Laboratory, INSERM 1062 INRA 1260, Marseille,
      France
FAU - Alessi, M. C.
AU  - Alessi MC
AD  - APHM, CHU Timone, Laboratoire NORT INSERM U 1062 INRA U 1260, Marseille, France
FAU - Bruder, N.
AU  - Bruder N
AD  - Department of Anaesthesiology & Intensive Care, APHM, CHU Timone, Marseille,
      France
FAU - Garrigue, P.
AU  - Garrigue P
AD  - APHM, CHU Timone, Vascular Research Center of Marseille INSERM UMRS 1076,
      CERIMED, Marseille, France
FAU - Velly, L.
AU  - Velly L
AD  - Department of Anaesthesiology & Intensive Care, APHM, CHU Timone, Marseille,
      France
FAU - Spina, S.
AU  - Spina S
AD  - University of Milan - Bicocca, School of Medicine and Surgery, Milan, Italy
FAU - Scaravilli, V.
AU  - Scaravilli V
AD  - University of Milan - Bicocca, School of Medicine and Surgery, Milan, Italy
FAU - Marzorati, C.
AU  - Marzorati C
AD  - University of Milan - Bicocca, School of Medicine and Surgery, Milan, Italy
FAU - Colombo, E.
AU  - Colombo E
AD  - Department of Emergency and Intensive Care, San Gerardo Hospital, Neurointensive 
      Care, Monza, Italy
FAU - Savo, D.
AU  - Savo D
AD  - Department of Emergency and Intensive Care, San Gerardo Hospital, Neurointensive 
      Care, Monza, Italy
FAU - Vargiolu, A.
AU  - Vargiolu A
AD  - Department of Emergency and Intensive Care, San Gerardo Hospital, Neurointensive 
      Care, Monza, Italy
FAU - Cavenaghi, G.
AU  - Cavenaghi G
AD  - Department of Otolaryngology, San Gerardo Hospital, Monza, Italy
FAU - Citerio, G.
AU  - Citerio G
AD  - University of Milan - Bicocca, School of Medicine and Surgery, Milan, Italy
FAU - Andrade, A. H. V.
AU  - Andrade AHV
AD  - Hospital municipal Moyses Deutsch, ICU, Sao Paulo, Brazil
FAU - Bulgarelli, P.
AU  - Bulgarelli P
AD  - Hospital municipal Moyses Deutsch, ICU, Sao Paulo, Brazil
FAU - Araujo, J. A. P.
AU  - Araujo JAP
AD  - Hospital municipal Moyses Deutsch, ICU, Sao Paulo, Brazil
FAU - Gonzalez, V.
AU  - Gonzalez V
AD  - Hospital municipal Moyses Deutsch, ICU, Sao Paulo, Brazil
FAU - Souza, V. A.
AU  - Souza VA
AD  - Hospital municipal Moyses Deutsch, ICU, Sao Paulo, Brazil
FAU - Costa, A.
AU  - Costa A
AD  - Hospital Israelita Albert Einstein, Neurology/Telemedicine, Sao Paulo, Brazil
FAU - Massant, C.
AU  - Massant C
AD  - Hospital Israelita Albert Einstein, Neurology/Telemedicine, Sao Paulo, Brazil
FAU - Filho, C. A. C. Abreu
AU  - Filho CACA
AD  - Hospital municipal Moyses Deutsch, ICU, Sao Paulo, Brazil
FAU - Morbeck, R. A.
AU  - Morbeck RA
AD  - Hospital Israelita Albert Einstein, Telemedicine, Sao Paulo, Brazil
FAU - Burgo, L. E.
AU  - Burgo LE
AD  - Hospital municipal Moyses Deutsch, Telemedicine, Sao Paulo, Brazil
FAU - van Groenendael, R.
AU  - van Groenendael R
AD  - Radboud University Medical Center, Intensive Care, Nijmegen, Netherlands
FAU - van Eijk, L. T.
AU  - van Eijk LT
AD  - Radboud University Medical Center, Anesthesiology, Nijmegen, Netherlands
FAU - Leijte, G. P.
AU  - Leijte GP
AD  - Radboud University Medical Center, Intensive Care, Nijmegen, Netherlands
FAU - Koeneman, B.
AU  - Koeneman B
AD  - Radboud University Medical Center, Intensive Care, Nijmegen, Netherlands
FAU - Kox, M.
AU  - Kox M
AD  - Radboud University Medical Center, Intensive Care, Nijmegen, Netherlands
FAU - Pickkers, P.
AU  - Pickkers P
AD  - Radboud University Medical Center, Intensive Care, Nijmegen, Netherlands
FAU - García-de la Torre, A.
AU  - García-de la Torre A
AD  - Clinical Chemistry Department, University Hospital Virgen de la Victoria / IBIMA,
      Málaga, Spain
FAU - de la Torre-Prados, M.
AU  - de la Torre-Prados M
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Fernández-Porcel, A.
AU  - Fernández-Porcel A
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Rueda-Molina, C.
AU  - Rueda-Molina C
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Nuevo-Ortega, P.
AU  - Nuevo-Ortega P
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Tsvetanova-Spasova, T.
AU  - Tsvetanova-Spasova T
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Cámara-Sola, E.
AU  - Cámara-Sola E
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - García-Alcántara, A.
AU  - García-Alcántara A
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Salido-Díaz, L.
AU  - Salido-Díaz L
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Liao, X.
AU  - Liao X
AD  - West China Hospital of Sichuan University, Chengdu, China
FAU - Feng, T.
AU  - Feng T
AD  - West China Second Hospital of Sichuan University, Chengdu, China
FAU - Zhang, J.
AU  - Zhang J
AD  - West China Hospital of Sichuan University, Chengdu, China
FAU - Cao, X.
AU  - Cao X
AD  - West China Hospital of Sichuan University, Chengdu, China
FAU - Wu, Q.
AU  - Wu Q
AD  - West China Second Hospital of Sichuan University, Chengdu, China
FAU - Xie, Z.
AU  - Xie Z
AD  - West China Hospital of Sichuan University, Chengdu, China
FAU - Li, H.
AU  - Li H
AD  - West China Second Hospital of Sichuan University, Chengdu, China
FAU - Kang, Y.
AU  - Kang Y
AD  - West China Hospital of Sichuan University, Chengdu, China
FAU - Winkler, M. S.
AU  - Winkler MS
AD  - Department of Anaesthesiology, University Medical Center Hamburg-Eppendorf,
      Hamburg, Germany
FAU - Nierhaus, A.
AU  - Nierhaus A
AD  - Department of Intensive Care Medicine, University Medical Center
      Hamburg-Eppendorf, Hamburg, Germany
FAU - Mudersbach, E.
AU  - Mudersbach E
AD  - University Medical Center Hamburg-Eppendorf, Institute of Clinical Pharmacology
      and Toxicology, Hamburg, Germany
FAU - Bauer, A.
AU  - Bauer A
AD  - Department of Anaesthesiology, University Medical Center Hamburg-Eppendorf,
      Hamburg, Germany
FAU - Robbe, L.
AU  - Robbe L
AD  - Department of Anaesthesiology, University Medical Center Hamburg-Eppendorf,
      Hamburg, Germany
FAU - Zahrte, C.
AU  - Zahrte C
AD  - Department of Intensive Care Medicine, University Medical Center
      Hamburg-Eppendorf, Hamburg, Germany
FAU - Schwedhelm, E.
AU  - Schwedhelm E
AD  - University Medical Center Hamburg-Eppendorf, Institute of Clinical Pharmacology
      and Toxicology, Hamburg, Germany
FAU - Kluge, S.
AU  - Kluge S
AD  - University Medical Center Hamburg-Eppendorf, Institute of Clinical Pharmacology
      and Toxicology, Hamburg, Germany
FAU - Zöllner, C.
AU  - Zöllner C
AD  - Department of Anaesthesiology, University Medical Center Hamburg-Eppendorf,
      Hamburg, Germany
FAU - Morton, B.
AU  - Morton B
AD  - Liverpool School of Tropical Medicine, Clinical Sciences, Liverpool, UK
FAU - Mitsi, E.
AU  - Mitsi E
AD  - Liverpool School of Tropical Medicine, Clinical Sciences, Liverpool, UK
FAU - Pennington, S. H.
AU  - Pennington SH
AD  - Liverpool School of Tropical Medicine, Clinical Sciences, Liverpool, UK
FAU - Reine, J.
AU  - Reine J
AD  - Liverpool School of Tropical Medicine, Clinical Sciences, Liverpool, UK
FAU - Wright, A. D.
AU  - Wright AD
AD  - Liverpool School of Tropical Medicine, Clinical Sciences, Liverpool, UK
FAU - Parker, R.
AU  - Parker R
AD  - Aintree University Hospital NHS Foundation Trust, Critical Care, Liverpool, UK
FAU - Welters, I. D.
AU  - Welters ID
AD  - University of Liverpool, Institute of Ageing and Chronic Disease, Liverpool, UK
FAU - Blakey, J. D.
AU  - Blakey JD
AD  - Liverpool School of Tropical Medicine, Clinical Sciences, Liverpool, UK
FAU - Rajam, G.
AU  - Rajam G
AD  - Centers for Disease Control, Bacterial Infection, Atlanta, USA
FAU - Ades, E. W.
AU  - Ades EW
AD  - Centers for Disease Control, Bacterial Infection, Atlanta, USA
FAU - Ferreira, D. M.
AU  - Ferreira DM
AD  - Liverpool School of Tropical Medicine, Clinical Sciences, Liverpool, UK
FAU - Wang, D.
AU  - Wang D
AD  - Liverpool School of Tropical Medicine, Clinical Sciences, Liverpool, UK
FAU - Kadioglu, A.
AU  - Kadioglu A
AD  - University of Liverpool, Institute of Infection & Global Health, Liverpool, UK
FAU - Gordon, S. B.
AU  - Gordon SB
AD  - Liverpool School of Tropical Medicine, Clinical Sciences, Liverpool, UK
FAU - Koch, R.
AU  - Koch R
AD  - Radboud University Medical Center, Intensive Care, Nijmegen, Netherlands
FAU - Kox, M.
AU  - Kox M
AD  - Radboud University Medical Center, Intensive Care, Nijmegen, Netherlands
FAU - Rahamat-Langedoen, J.
AU  - Rahamat-Langedoen J
AD  - Radboud University Medical Center, Virology, Nijmegen, Netherlands
FAU - Schloesser, J.
AU  - Schloesser J
AD  - NIZO, Ede, Netherlands
FAU - de Jonge, M.
AU  - de Jonge M
AD  - Radboud University Medical Center, Pediatrics, Nijmegen, Netherlands
FAU - Pickkers, P.
AU  - Pickkers P
AD  - Radboud University Medical Center, Intensive Care, Nijmegen, Netherlands
FAU - Bringue, J.
AU  - Bringue J
AD  - Fundació Parc Taulí, Sabadell, Spain
FAU - Guillamat-Prats, R.
AU  - Guillamat-Prats R
AD  - CIBERES, Grup 33, Sabadell, Spain
FAU - Torrents, E.
AU  - Torrents E
AD  - Corporació Sanitària i Universitaria Parc Taulí, Critical Care Center, Sabadell, 
      Spain
FAU - Martinez, M. L.
AU  - Martinez ML
AD  - Corporació Sanitària i Universitaria Parc Taulí, Critical Care Center, Sabadell, 
      Spain
FAU - Camprubí-Rimblas, M.
AU  - Camprubí-Rimblas M
AD  - Fundació Parc Taulí, Sabadell, Spain
FAU - Artigas, A.
AU  - Artigas A
AD  - CIBERES, Grup 33, Sabadell, Spain
FAU - Blanch, L.
AU  - Blanch L
AD  - Fundació Parc Taulí, Sabadell, Spain
FAU - Park, S. Y.
AU  - Park SY
AD  - Kyung Hee University/Kyung Hee Medical Center, Pulmonary and Critical Care
      Medicine, Seoul, Republic of Korea
FAU - Park, Y. B.
AU  - Park YB
AD  - Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal
      Medicine, Kangdong Sacred Heart Hospital, Seoul, Republic of Korea
FAU - Song, D. K.
AU  - Song DK
AD  - Department of Pharmacology, College of Medicine, Hallym University, Chuncheon,
      Republic of Korea
FAU - Shrestha, S.
AU  - Shrestha S
AD  - Department of Pharmacology, College of Medicine, Hallym University, Chuncheon,
      Republic of Korea
FAU - Park, S. H.
AU  - Park SH
AD  - Kyung Hee University/Kyung Hee University Hospital at Gangdong, Seoul, Republic
      of Korea
FAU - Koh, Y.
AU  - Koh Y
AD  - University of Ulsan College of Medicine/ Asan Medical Center, Seoul, Republic of 
      Korea
FAU - Park, M. J.
AU  - Park MJ
AD  - Kyung Hee University/Kyung Hee University Hospital at Gangdong, Seoul, Republic
      of Korea
FAU - Hong, C. W.
AU  - Hong CW
AD  - Department of Physiology College of Medicine, Kyungpook National University,
      Daegue, Republic of Korea
FAU - Lesur, O.
AU  - Lesur O
AD  - Sherbrooke, ICU/Medicine, Sherbrooke, Canada
FAU - Coquerel, D.
AU  - Coquerel D
AD  - Sherbrooke, ICU/Medicine, Sherbrooke, Canada
FAU - Sainsily, X.
AU  - Sainsily X
AD  - Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada
FAU - Cote, J.
AU  - Cote J
AD  - Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada
FAU - Söllradl, T.
AU  - Söllradl T
AD  - Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada
FAU - Murza, A.
AU  - Murza A
AD  - Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada
FAU - Dumont, L.
AU  - Dumont L
AD  - Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada
FAU - Dumaine, R.
AU  - Dumaine R
AD  - Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada
FAU - Grandbois, M.
AU  - Grandbois M
AD  - Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada
FAU - Sarret, P.
AU  - Sarret P
AD  - Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada
FAU - Marsault, E.
AU  - Marsault E
AD  - Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada
FAU - Salvail, D.
AU  - Salvail D
AD  - IPS Therapeutic Inc, Sherbrooke, Canada
FAU - Auger-Messier, M.
AU  - Auger-Messier M
AD  - Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada
FAU - Chagnon, F.
AU  - Chagnon F
AD  - Sherbrooke, ICU/Medicine, Sherbrooke, Canada
CN  - Apelin Group
FAU - Lauretta, M. P.
AU  - Lauretta MP
AD  - Division of Medicine, Bloomsbury Institute of Intensive Care Medicine, University
      College London, London, UK
FAU - Greco, E.
AU  - Greco E
AD  - Bloomsbury Institute of Intensive Care Medicine, University College London,
      London, UK
FAU - Dyson, A.
AU  - Dyson A
AD  - Bloomsbury Institute of Intensive Care Medicine, University College London,
      London, UK
FAU - Singer, M.
AU  - Singer M
AD  - Bloomsbury Institute of Intensive Care Medicine, University College London,
      London, UK
FAU - Preau, S.
AU  - Preau S
AD  - University College London, Faculty of Medical Sciences, London, UK
FAU - Ambler, M.
AU  - Ambler M
AD  - University College London, Faculty of Medical Sciences, London, UK
FAU - Sigurta, A.
AU  - Sigurta A
AD  - University College London, Faculty of Medical Sciences, London, UK
FAU - Saeed, S.
AU  - Saeed S
AD  - University College London, Faculty of Medical Sciences, London, UK
FAU - Singer, M.
AU  - Singer M
AD  - University College London, Faculty of Medical Sciences, London, UK
FAU - Sarıca, L. Topcu
AU  - Sarıca LT
AD  - Marmara University, Anesthesiology and Reanimation, Istanbul, Turkey
FAU - Zibandeh, N.
AU  - Zibandeh N
AD  - Marmara University, Pediatric Immunology and Alergy, Istanbul, Turkey
FAU - Genc, D.
AU  - Genc D
AD  - Marmara University, Pediatric Immunology and Alergy, Istanbul, Turkey
FAU - Gul, F.
AU  - Gul F
AD  - Marmara University, Anesthesiology and Reanimation, Istanbul, Turkey
FAU - Akkoc, T.
AU  - Akkoc T
AD  - Tubitak Arastırma Merkezi, Gen Engineering, Istanbul, Turkey
FAU - Kombak, E.
AU  - Kombak E
AD  - Marmara University, Pathology, Istanbul, Turkey
FAU - Cinel, L.
AU  - Cinel L
AD  - Marmara University, Pathology, Istanbul, Turkey
FAU - Akkoc, T.
AU  - Akkoc T
AD  - Marmara University, Pediatric Immunology and Alergy, Istanbul, Turkey
FAU - Cinel, I.
AU  - Cinel I
AD  - Marmara University, Anesthesiology and Reanimation, Istanbul, Turkey
FAU - Pollen, S. J.
AU  - Pollen SJ
AD  - UCL, Bloomsbury Institute of Intensive Care Medicine, London, UK
FAU - Arulkumaran, N.
AU  - Arulkumaran N
AD  - UCL, Bloomsbury Institute of Intensive Care Medicine, London, UK
FAU - Singer, M.
AU  - Singer M
AD  - UCL, Bloomsbury Institute of Intensive Care Medicine, London, UK
FAU - Torrance, H. D.
AU  - Torrance HD
AD  - Barts Health NHS Trust, London, UK
FAU - Longbottom, E. R.
AU  - Longbottom ER
AD  - Barts Health NHS Trust, London, UK
FAU - Warnes, G.
AU  - Warnes G
AD  - The Bizard Institute, Barts & the London School of Medicine & Dentistry, London, 
      UK
FAU - Hinds, C. J.
AU  - Hinds CJ
AD  - Barts Health NHS Trust, London, UK
FAU - Pennington, D. J.
AU  - Pennington DJ
AD  - The Bizard Institute, Barts & the London School of Medicine & Dentistry, London, 
      UK
FAU - Brohi, K.
AU  - Brohi K
AD  - Barts Health NHS Trust, London, UK
FAU - O’Dwyer, M. J.
AU  - O’Dwyer MJ
AD  - Barts Health NHS Trust, London, UK
FAU - Kim, H. Y.
AU  - Kim HY
AD  - Yonsei University College of Medicine, Anesthesiology, Seoul, Republic of Korea
FAU - Na, S.
AU  - Na S
AD  - Yonsei University College of Medicine, Anesthesiology, Seoul, Republic of Korea
FAU - Kim, J.
AU  - Kim J
AD  - Yonsei University College of Medicine, Anesthesiology, Seoul, Republic of Korea
FAU - Chang, Y. F.
AU  - Chang YF
AD  - National Yang-Ming University, Institute of Emergency and Critical Care Medicine,
      Taipei, Taiwan, Province of China
FAU - Chao, A.
AU  - Chao A
AD  - Department of Anesthesiology, National Taiwan University Hospital, Taipei,
      Taiwan, Province of China
FAU - Shih, P. Y.
AU  - Shih PY
AD  - Department of Anesthesiology, National Taiwan University Hospital, Taipei,
      Taiwan, Province of China
FAU - Lee, C. T.
AU  - Lee CT
AD  - Department of Anesthesiology, National Taiwan University Hospital, Taipei,
      Taiwan, Province of China
FAU - Yeh, Y. C.
AU  - Yeh YC
AD  - Department of Anesthesiology, National Taiwan University Hospital, Taipei,
      Taiwan, Province of China
FAU - Chen, L. W.
AU  - Chen LW
AD  - National Yang-Ming University, Institute of Emergency and Critical Care Medicine,
      Taipei, Taiwan, Province of China
FAU - Adriaanse, M.
AU  - Adriaanse M
AD  - Department of Intensive Care, Bravis Hospital, Roosendaal, Netherlands
FAU - Trogrlic, Z.
AU  - Trogrlic Z
AD  - Department of Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands
FAU - Ista, E.
AU  - Ista E
AD  - Department of Pediatric Surgery, Intensive Care Unit, Erasmus MC-Sophia
      Children’s Hospital, University Medical Center, Rotterdam, Netherlands
FAU - Lingsma, H.
AU  - Lingsma H
AD  - Department of Public Health, Erasmus Medical Centre, Rotterdam, Netherlands
FAU - Rietdijk, W.
AU  - Rietdijk W
AD  - Department of Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands
FAU - Ponssen, H. H.
AU  - Ponssen HH
AD  - Department of Intensive Care, Albert Schweitzer Hospital, Dordrecht, Netherlands
FAU - Schoonderbeek, J. F.
AU  - Schoonderbeek JF
AD  - Department of Intensive Care, Ikazia Hospital, Rotterdam, Netherlands
FAU - Schreiner, F.
AU  - Schreiner F
AD  - Department of Intensive Care, IJsselland Hospital, Rotterdam, Netherlands
FAU - Verbrugge, S. J.
AU  - Verbrugge SJ
AD  - Department of Intensive Care, Sint Franciscus Gasthuis, Rotterdam, Netherlands
FAU - Duran, S.
AU  - Duran S
AD  - Department of Intensive Care, Maasstad Hospital, Rotterdam, Netherlands
FAU - Gommers, D. A. M. P. J.
AU  - Gommers DAMPJ
AD  - Department of Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands
FAU - van der Jagt, M.
AU  - van der Jagt M
AD  - Department of Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands
FAU - Funcke, S.
AU  - Funcke S
AD  - University Medical Center Hamburg-Eppendorf, Center of Anesthesiology and
      Intensive Care Medicine, Hamburg, Germany
FAU - Sauerlaender, S.
AU  - Sauerlaender S
AD  - University Medical Center Hamburg-Eppendorf, Center of Anesthesiology and
      Intensive Care Medicine, Hamburg, Germany
FAU - Saugel, B.
AU  - Saugel B
AD  - University Medical Center Hamburg-Eppendorf, Center of Anesthesiology and
      Intensive Care Medicine, Hamburg, Germany
FAU - Pinnschmidt, H.
AU  - Pinnschmidt H
AD  - University Medical Center Hamburg-Eppendorf, Institute of Medical Biometry and
      Epidemiology, Hamburg, Germany
FAU - Reuter, D. A.
AU  - Reuter DA
AD  - University Medical Center Hamburg-Eppendorf, Center of Anesthesiology and
      Intensive Care Medicine, Hamburg, Germany
FAU - Nitzschke, R.
AU  - Nitzschke R
AD  - University Medical Center Hamburg-Eppendorf, Center of Anesthesiology and
      Intensive Care Medicine, Hamburg, Germany
FAU - Perbet, S.
AU  - Perbet S
AD  - University Hospital Clermont-Ferrand, ICU, Clermont-Ferrand, France
FAU - Biboulet, C.
AU  - Biboulet C
AD  - University Hospital Clermont-Ferrand, ICU, Clermont-Ferrand, France
FAU - Lenoire, A.
AU  - Lenoire A
AD  - Saint-Louis Hospital, APHP, Burn ICU, Paris, France
FAU - Bourdeaux, D.
AU  - Bourdeaux D
AD  - University Hospital Clermont-Ferrand, Pharmacy, Clermont-Ferrand, France
FAU - Pereira, B.
AU  - Pereira B
AD  - University Hospital Clermont-Ferrand, Biostatistics, Clermont-Ferrand, France
FAU - Plaud, B.
AU  - Plaud B
AD  - Saint-Louis Hospital, APHP, Burn ICU, Paris, France
FAU - Bazin, J. E.
AU  - Bazin JE
AD  - University Hospital Clermont-Ferrand, ICU, Clermont-Ferrand, France
FAU - Sautou, V.
AU  - Sautou V
AD  - University Hospital Clermont-Ferrand, Pharmacy, Clermont-Ferrand, France
FAU - Mebazaa, A.
AU  - Mebazaa A
AD  - Saint-Louis Hospital, APHP, Burn ICU, Paris, France
FAU - Constantin, J. M.
AU  - Constantin JM
AD  - University Hospital Clermont-Ferrand, ICU, Clermont-Ferrand, France
FAU - Legrand, M.
AU  - Legrand M
AD  - Saint-Louis Hospital, APHP, Burn ICU, Paris, France
FAU - Boyko, Y.
AU  - Boyko Y
AD  - Odense University Hospital, University of Southern Denmark, Anaesthesiology and
      Intensive Therapy, Odense, Denmark
FAU - Jennum, P.
AU  - Jennum P
AD  - Danish Center for Sleep Medicine, University of Copenhagen, Copenhagen, Denmark
FAU - Nikolic, M.
AU  - Nikolic M
AD  - Danish Center for Sleep Medicine, University of Copenhagen, Copenhagen, Denmark
FAU - Oerding, H.
AU  - Oerding H
AD  - University of Southern Denmark, Vejle, Denmark
FAU - Holst, R.
AU  - Holst R
AD  - University of Southern Denmark, Odense, Denmark
FAU - Toft, P.
AU  - Toft P
AD  - Odense University Hospital, University of Southern Denmark, Anaesthesiology and
      Intensive Therapy, Odense, Denmark
FAU - Nedergaard, H. K.
AU  - Nedergaard HK
AD  - University of Southern Denmark, Odense, Denmark
FAU - Haberlandt, T.
AU  - Haberlandt T
AD  - Lillebaelt Hospital, Kolding, Denmark
FAU - Jensen, H. I.
AU  - Jensen HI
AD  - University of Southern Denmark, Odense, Denmark
FAU - Toft, P.
AU  - Toft P
AD  - University of Southern Denmark, Odense, Denmark
FAU - Park, S.
AU  - Park S
AD  - Sheikh Khalifa Specialty Hospital, Anesthesiology, Rak, United Arab Emirates
FAU - Kim, S.
AU  - Kim S
AD  - Department of Pulmonology, Sheikh Khalifa Specialty Hospital, Rak, United Arab
      Emirates
FAU - Cho, Y. J.
AU  - Cho YJ
AD  - Seoul National University Bundang Hospital, Seongnam, Republic of Korea
FAU - Lim, Y. J.
AU  - Lim YJ
AD  - Department of Pharmacy, National University of Singapore, Singapore, Singapore
FAU - Chan, A.
AU  - Chan A
AD  - Department of Pharmacy, National University of Singapore, Singapore, Singapore
FAU - Tang, S.
AU  - Tang S
AD  - Department of Pharmacy, National University Hospital, Singapore, Singapore
FAU - Nunes, S. L.
AU  - Nunes SL
AD  - Department of Anesthesiology and Intensive Care, Danderyd Hospital, Stockholm,
      Sweden
FAU - Forsberg, S.
AU  - Forsberg S
AD  - Department of Anesthesiology and Intensive Care, Norrtälje Hospital, Norrtälje,
      Sweden
FAU - Blomqvist, H.
AU  - Blomqvist H
AD  - Department of Anesthesiology and Intensive Care, Karolinska University Hospital, 
      Stockholm, Sweden
FAU - Berggren, L.
AU  - Berggren L
AD  - Department of Anesthesiology and Intensive Care, Örebro University Hospital,
      Örebro, Sweden
FAU - Sörberg, M.
AU  - Sörberg M
AD  - Orion Pharma, Stockholm, Sweden
FAU - Sarapohja, T.
AU  - Sarapohja T
AD  - Orion Pharma, Espoo, Finland
FAU - Wickerts, C. J.
AU  - Wickerts CJ
AD  - Department of Anesthesiology and Intensive Care, Danderyd Hospital, Stockholm,
      Sweden
FAU - Hofhuis, J. G. M.
AU  - Hofhuis JGM
AD  - Gelre Hospitals Apeldoorn, Intensive Care, Apeldoorn, Netherlands
FAU - Rose, L.
AU  - Rose L
AD  - University of Toronto, Toronto, Canada
FAU - Blackwood, B.
AU  - Blackwood B
AD  - University Belfast, Belfast, UK
FAU - Akerman, E.
AU  - Akerman E
AD  - Clinc of Intensive Care, Malmo, Sweden
FAU - Mcgaughey, J.
AU  - Mcgaughey J
AD  - Queens University Belfast, Belfast, UK
FAU - Egerod, I.
AU  - Egerod I
AD  - University of Copenhagen, Copenhagen, Denmark
FAU - Fossum, M.
AU  - Fossum M
AD  - University of Agdar, Grimstad, Norway
FAU - Foss, H.
AU  - Foss H
AD  - Univeristy of Agdar, Grimstad, Norway
FAU - Georgiou, E.
AU  - Georgiou E
AD  - Division of Intensive Care, Cyprus, Cyprus
FAU - Graff, H. J.
AU  - Graff HJ
AD  - University of Copenhagen, Copenhagen, Denmark
FAU - Kalafati, M.
AU  - Kalafati M
AD  - University of Athens, Athens, Greece
FAU - Sperlinga, R.
AU  - Sperlinga R
AD  - University Cattolica del Sacro Cuore, Turino, Italy
FAU - Schafer, A.
AU  - Schafer A
AD  - Division of Intensive Care, ᅟ, Germany
FAU - Wojnicka, A. G.
AU  - Wojnicka AG
AD  - University Warminsko-Mazwski, Olsztyn, Poland
FAU - Spronk, P. E.
AU  - Spronk PE
AD  - Gelre Hospitals Apeldoorn, Intensive Care, Apeldoorn, Netherlands
FAU - Zand, F.
AU  - Zand F
AD  - Anesthesiology and Critical Care Research Center, Shiraz University of Medical
      Sciences, Shiraz, Islamic Republic of Iran
FAU - Khalili, F.
AU  - Khalili F
AD  - Anesthesiology and Critical Care Research Center, Shiraz University of Medical
      Sciences, Shiraz, Islamic Republic of Iran
FAU - Afshari, R.
AU  - Afshari R
AD  - Department of Drug Abuse Control, Shiraz University of Medical Sciences, Shiraz, 
      Islamic Republic of Iran
FAU - Sabetian, G.
AU  - Sabetian G
AD  - Trauma Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic
      Republic of Iran
FAU - Masjedi, M.
AU  - Masjedi M
AD  - Anesthesiology and Critical Care Research Center, Shiraz University of Medical
      Sciences, Shiraz, Islamic Republic of Iran
FAU - Maghsudi, B.
AU  - Maghsudi B
AD  - Anesthesiology and Critical Care Research Center, Shiraz University of Medical
      Sciences, Shiraz, Islamic Republic of Iran
FAU - Khodaei, H. Haddad
AU  - Khodaei HH
AD  - Department of Neurosurgery, Shiraz University of Medical Sciences, Shiraz,
      Islamic Republic of Iran
FAU - Javadpour, S.
AU  - Javadpour S
AD  - Department of Critical Care Nursing, Jahrom University of Medical Sciences,
      Jahrom, Islamic Republic of Iran
FAU - Petramfar, P.
AU  - Petramfar P
AD  - Department of Neurology, Shiraz University Of Medical Sciences, Shiraz, Islamic
      Republic of Iran
FAU - Nasimi, S.
AU  - Nasimi S
AD  - Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Islamic Republic
      of Iran
FAU - Vazin, A.
AU  - Vazin A
AD  - Department of Clinical Pharmacy, Shiraz University of Medical Sciences, Shiraz,
      Islamic Republic of Iran
FAU - Ziaian, B.
AU  - Ziaian B
AD  - Department of Surgery, Shiraz University of Medical Sciences, Shiraz, Islamic
      Republic of Iran
FAU - Tabei, H.
AU  - Tabei H
AD  - Anesthesiology and Critical Care Research Center, Shiraz University of Medical
      Sciences, Shiraz, Islamic Republic of Iran
FAU - Gunther, A.
AU  - Gunther A
AD  - Karolinska University Hospital, Stockholm, Sweden
FAU - Hansen, J. O.
AU  - Hansen JO
AD  - University of Oslo, Oslo, Norway
FAU - Sackey, P.
AU  - Sackey P
AD  - Karolinska University Hospital, Stockholm, Sweden
FAU - Storm, H.
AU  - Storm H
AD  - University of Oslo, Oslo, Norway
FAU - Bernhardsson, J.
AU  - Bernhardsson J
AD  - Mitt Universitetet, Östersund, Sweden
FAU - Sundin, Ø.
AU  - Sundin Ø
AD  - Mitt Universitetet, Östersund, Sweden
FAU - Bjärtå, A.
AU  - Bjärtå A
AD  - Mitt Universitetet, Östersund, Sweden
FAU - Bienert, A.
AU  - Bienert A
AD  - Poznan Unversity of Medical Sciences, Poznan, Poland
FAU - Smuszkiewicz, P.
AU  - Smuszkiewicz P
AD  - Poznan Unversity of Medical Sciences, Poznan, Poland
FAU - Wiczling, P.
AU  - Wiczling P
AD  - Medical University of Gdansk, Gdansk, Poland
FAU - Przybylowski, K.
AU  - Przybylowski K
AD  - Poznan Unversity of Medical Sciences, Poznan, Poland
FAU - Borsuk, A.
AU  - Borsuk A
AD  - Medical University of Gdansk, Gdansk, Poland
FAU - Trojanowska, I.
AU  - Trojanowska I
AD  - Poznan Unversity of Medical Sciences, Poznan, Poland
FAU - Matysiak, J.
AU  - Matysiak J
AD  - Poznan Unversity of Medical Sciences, Poznan, Poland
FAU - Kokot, Z.
AU  - Kokot Z
AD  - Poznan Unversity of Medical Sciences, Poznan, Poland
FAU - Paterska, M.
AU  - Paterska M
AD  - Poznan Unversity of Medical Sciences, Poznan, Poland
FAU - Grzeskowiak, E.
AU  - Grzeskowiak E
AD  - Poznan Unversity of Medical Sciences, Poznan, Poland
FAU - Messina, A.
AU  - Messina A
AD  - AOU Maggiore della Carità, Novara, Italy
FAU - Bonicolini, E.
AU  - Bonicolini E
AD  - Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy
FAU - Colombo, D.
AU  - Colombo D
AD  - AOU Maggiore della Carità, Novara, Italy
FAU - Moro, G.
AU  - Moro G
AD  - AOU Maggiore della Carità, Novara, Italy
FAU - Romagnoli, S.
AU  - Romagnoli S
AD  - Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy
FAU - De Gaudio, A. R.
AU  - De Gaudio AR
AD  - Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy
FAU - Corte, F. Della
AU  - Corte FD
AD  - Azienda Ospedaliero-Universitaria Careggi, Novara, Italy
FAU - Romano, S. M.
AU  - Romano SM
AD  - Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy
FAU - Silversides, J. A.
AU  - Silversides JA
AD  - Belfast Health and Social Care Trust, Critical Care, Belfast, UK
FAU - Major, E.
AU  - Major E
AD  - Belfast Health and Social Care Trust, Critical Care, Belfast, UK
FAU - Mann, E. E.
AU  - Mann EE
AD  - Belfast Health and Social Care Trust, Critical Care, Belfast, UK
FAU - Ferguson, A. J.
AU  - Ferguson AJ
AD  - Southern Health and Social Care Trust, Anaesthetics and Intensive Care,
      Craigavon, UK
FAU - Mcauley, D. F.
AU  - Mcauley DF
AD  - Belfast Health and Social Care Trust, Critical Care, Belfast, UK
FAU - Marshall, J. C.
AU  - Marshall JC
AD  - University of Toronto, Critical Care Medicine, Toronto, Canada
FAU - Blackwood, B.
AU  - Blackwood B
AD  - Queen’s University of Belfast, Centre for Experimental Medicine, Belfast, UK
FAU - Fan, E.
AU  - Fan E
AD  - University of Toronto, Critical Care Medicine, Toronto, Canada
FAU - Diaz-Rodriguez, J. A.
AU  - Diaz-Rodriguez JA
AD  - Instituto Mexicano del Seguro Social, Intensive Care Unit, Leon, Mexico
FAU - Silva-Medina, R.
AU  - Silva-Medina R
AD  - Instituto Mexicano del Seguro Social, Radiology Unit, Leon, Mexico
FAU - Gomez-Sandoval, E.
AU  - Gomez-Sandoval E
AD  - Instituto Mexicano del Seguro Social, Intensive Care Unit, Leon, Mexico
FAU - Gomez-Gonzalez, N.
AU  - Gomez-Gonzalez N
AD  - Instituto Mexicano del Seguro Social, Intensive Care Unit, Leon, Mexico
FAU - Soriano-Orozco, R.
AU  - Soriano-Orozco R
AD  - Instituto Mexicano del Seguro Social, Intensive Care Unit, Leon, Mexico
FAU - Gonzalez-Carrillo, P. L.
AU  - Gonzalez-Carrillo PL
AD  - Instituto Mexicano del Seguro Social, Intensive Care Unit, Leon, Mexico
FAU - Hernández-Flores, M.
AU  - Hernández-Flores M
AD  - Instituto Mexicano del Seguro Social, Intensive Care Unit, Leon, Mexico
FAU - Pilarczyk, K.
AU  - Pilarczyk K
AD  - Department for Intensive Care Medicine, Imland Klinik Rendsburg, Rendsburg,
      Germany
FAU - Lubarksi, J.
AU  - Lubarksi J
AD  - Department for Thoracic and Cardiovascular Surgery, University Hospital Essen,
      Essen, Germany
FAU - Wendt, D.
AU  - Wendt D
AD  - Department for Thoracic and Cardiovascular Surgery, University Hospital Essen,
      Essen, Germany
FAU - Dusse, F.
AU  - Dusse F
AD  - Department for Thoracic and Cardiovascular Surgery, University Hospital Essen,
      Essen, Germany
FAU - Günter, J.
AU  - Günter J
AD  - Department for Thoracic and Cardiovascular Surgery, University Hospital Essen,
      Essen, Germany
FAU - Huschens, B.
AU  - Huschens B
AD  - Department for Thoracic and Cardiovascular Surgery, University Hospital Essen,
      Essen, Germany
FAU - Demircioglu, E.
AU  - Demircioglu E
AD  - Department for Thoracic and Cardiovascular Surgery, University Hospital Essen,
      Essen, Germany
FAU - Jakob, H.
AU  - Jakob H
AD  - Department for Thoracic and Cardiovascular Surgery, University Hospital Essen,
      Essen, Germany
FAU - Palmaccio, A.
AU  - Palmaccio A
AD  - Policlinico Universitario A. Gemelli, Anesthesia and Intensive Care Medicine,
      Roma, Italy
FAU - Dell’Anna, A. M.
AU  - Dell’Anna AM
AD  - Policlinico Universitario A. Gemelli, Anesthesia and Intensive Care Medicine,
      Roma, Italy
FAU - Grieco, D. L.
AU  - Grieco DL
AD  - Policlinico Universitario A. Gemelli, Anesthesia and Intensive Care Medicine,
      Roma, Italy
FAU - Torrini, F.
AU  - Torrini F
AD  - Policlinico Universitario A. Gemelli, Anesthesia and Intensive Care Medicine,
      Roma, Italy
FAU - Iaquaniello, C.
AU  - Iaquaniello C
AD  - Policlinico Universitario A. Gemelli, Anesthesia and Intensive Care Medicine,
      Roma, Italy
FAU - Bongiovanni, F.
AU  - Bongiovanni F
AD  - Policlinico Universitario A. Gemelli, Anesthesia and Intensive Care Medicine,
      Roma, Italy
FAU - Antonelli, M.
AU  - Antonelli M
AD  - Policlinico Universitario A. Gemelli, Anesthesia and Intensive Care Medicine,
      Roma, Italy
FAU - Toscani, L.
AU  - Toscani L
AD  - St George’s University Hospital, London, UK
FAU - Antonakaki, D.
AU  - Antonakaki D
AD  - St George’s University Hospital, London, UK
FAU - Bastoni, D.
AU  - Bastoni D
AD  - St George’s University Hospital, London, UK
FAU - Aya, H. D.
AU  - Aya HD
AD  - St George’s University Hospital, London, UK
FAU - Rhodes, A.
AU  - Rhodes A
AD  - St George’s University Hospital, London, UK
FAU - Cecconi, M.
AU  - Cecconi M
AD  - St George’s University Hospital, London, UK
FAU - Jozwiak, M.
AU  - Jozwiak M
AD  - Hôpital de Bicêtre, Hôpitaux Universitaires Paris-Sud, Université Paris-Sud,
      Service de Réanimation Médicale, Inserm UMR_S999, Le Kremlin Bicêtre, France
FAU - Depret, F.
AU  - Depret F
AD  - Hôpital de Bicêtre, Hôpitaux Universitaires Paris-Sud, Université Paris-Sud,
      Service de Réanimation Médicale, Inserm UMR_S999, Le Kremlin Bicêtre, France
FAU - Teboul, J. L.
AU  - Teboul JL
AD  - Hôpital de Bicêtre, Hôpitaux Universitaires Paris-Sud, Université Paris-Sud,
      Service de Réanimation Médicale, Inserm UMR_S999, Le Kremlin Bicêtre, France
FAU - Alphonsine, J.
AU  - Alphonsine J
AD  - Hôpital de Bicêtre, Hôpitaux Universitaires Paris-Sud, Université Paris-Sud,
      Service de Réanimation Médicale, Inserm UMR_S999, Le Kremlin Bicêtre, France
FAU - Lai, C.
AU  - Lai C
AD  - Hôpital de Bicêtre, Hôpitaux Universitaires Paris-Sud, Université Paris-Sud,
      Service de Réanimation Médicale, Inserm UMR_S999, Le Kremlin Bicêtre, France
FAU - Richard, C.
AU  - Richard C
AD  - Hôpital de Bicêtre, Hôpitaux Universitaires Paris-Sud, Université Paris-Sud,
      Service de Réanimation Médicale, Inserm UMR_S999, Le Kremlin Bicêtre, France
FAU - Monnet, X.
AU  - Monnet X
AD  - Hôpital de Bicêtre, Hôpitaux Universitaires Paris-Sud, Université Paris-Sud,
      Service de Réanimation Médicale, Inserm UMR_S999, Le Kremlin Bicêtre, France
FAU - László, I.
AU  - László I
AD  - Department of Anesthesiology and Intensive Therapy, University of Szeged, Szeged,
      Hungary
FAU - Demeter, G.
AU  - Demeter G
AD  - Department of Anesthesiology and Intensive Therapy, University of Szeged, Szeged,
      Hungary
FAU - Öveges, N.
AU  - Öveges N
AD  - Department of Anesthesiology and Intensive Therapy, University of Szeged, Szeged,
      Hungary
FAU - Tánczos, K.
AU  - Tánczos K
AD  - Department of Anesthesiology and Intensive Therapy, University of Szeged, Szeged,
      Hungary
FAU - Németh, M.
AU  - Németh M
AD  - Department of Anesthesiology and Intensive Therapy, University of Szeged, Szeged,
      Hungary
FAU - Trásy, D.
AU  - Trásy D
AD  - Department of Anesthesiology and Intensive Therapy, University of Szeged, Szeged,
      Hungary
FAU - Kertmegi, I.
AU  - Kertmegi I
AD  - University of Szeged, Institute of Surgical Research, Szeged, Hungary
FAU - Érces, D.
AU  - Érces D
AD  - University of Szeged, Institute of Surgical Research, Szeged, Hungary
FAU - Tudor, B.
AU  - Tudor B
AD  - Department of Anaesthesiology and General Intensive Care Medicine, Medical
      University of Vienna, Vienna, Austria
FAU - Kaszaki, J.
AU  - Kaszaki J
AD  - University of Szeged, Institute of Surgical Research, Szeged, Hungary
FAU - Molnár, Z.
AU  - Molnár Z
AD  - Department of Anesthesiology and Intensive Therapy, University of Szeged, Szeged,
      Hungary
FAU - Hasanin, A.
AU  - Hasanin A
AD  - Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo,
      Egypt
FAU - Lotfy, A.
AU  - Lotfy A
AD  - Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo,
      Egypt
FAU - El-adawy, A.
AU  - El-adawy A
AD  - Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo,
      Egypt
FAU - Nassar, H.
AU  - Nassar H
AD  - Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo,
      Egypt
FAU - Mahmoud, S.
AU  - Mahmoud S
AD  - Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo,
      Egypt
FAU - Abougabal, A.
AU  - Abougabal A
AD  - Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo,
      Egypt
FAU - Mukhtar, A.
AU  - Mukhtar A
AD  - Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo,
      Egypt
FAU - Quinty, F.
AU  - Quinty F
AD  - University of la Reunion, Intensive Care Unit, Saint Pierre de la Reunion, France
FAU - Habchi, S.
AU  - Habchi S
AD  - University of la Reunion, Neurocritical Care Unit, Saint Pierre de la Reunion,
      France
FAU - Luzi, A.
AU  - Luzi A
AD  - Anesthesiology Department, University of la Reunion, Saint Pierre de la Reunion, 
      France
FAU - Antok, E.
AU  - Antok E
AD  - University of la Reunion, Intensive Care Unit, Saint Pierre de la Reunion, France
FAU - Hernandez, G.
AU  - Hernandez G
AD  - Departamento de Medicina Intensiva, Pontificia Universidad Catolica de Chile,
      Facultad de Medicina, Santiago, Chile
FAU - Lara, B.
AU  - Lara B
AD  - Pontificia Universidad Catolica de Chile, Programa de Medicina de Urgencia,
      Facultad de Medicina, Santiago, Chile
FAU - Enberg, L.
AU  - Enberg L
AD  - Pontificia Universidad Catolica de Chile, Programa de Medicina de Urgencia,
      Facultad de Medicina, Santiago, Chile
FAU - Ortega, M.
AU  - Ortega M
AD  - Departamento de Medicina Intensiva, Pontificia Universidad Catolica de Chile,
      Facultad de Medicina, Santiago, Chile
FAU - Leon, P.
AU  - Leon P
AD  - Departamento de Medicina Intensiva, Pontificia Universidad Catolica de Chile,
      Facultad de Medicina, Santiago, Chile
FAU - Kripper, C.
AU  - Kripper C
AD  - Pontificia Universidad Catolica de Chile, Programa de Medicina de Urgencia,
      Facultad de Medicina, Santiago, Chile
FAU - Aguilera, P.
AU  - Aguilera P
AD  - Pontificia Universidad Catolica de Chile, Programa de Medicina de Urgencia,
      Facultad de Medicina, Santiago, Chile
FAU - Kattan, E.
AU  - Kattan E
AD  - Departamento de Medicina Intensiva, Pontificia Universidad Catolica de Chile,
      Facultad de Medicina, Santiago, Chile
FAU - Bakker, J.
AU  - Bakker J
AD  - Departamento de Medicina Intensiva, Pontificia Universidad Catolica de Chile,
      Facultad de Medicina, Santiago, Chile
FAU - Huber, W.
AU  - Huber W
AD  - Technische Universität München, II. Medizinische Klinik, Munich, Germany
FAU - Lehmann, M.
AU  - Lehmann M
AD  - Technische Universität München, II. Medizinische Klinik, Munich, Germany
FAU - Sakka, S.
AU  - Sakka S
AD  - Klinikum Köln-Merheim, Cologne, Germany
FAU - Bein, B.
AU  - Bein B
AD  - Asklepios Klinik St. Georg, Hamburg, Ghana
FAU - Schmid, R. M.
AU  - Schmid RM
AD  - Technische Universität München, II. Medizinische Klinik, Munich, Germany
FAU - Preti, J.
AU  - Preti J
AD  - Université Libre de Bruxelles, Brussels, Belgium
FAU - Creteur, J.
AU  - Creteur J
AD  - Université Libre de Bruxelles, Brussels, Belgium
FAU - Herpain, A.
AU  - Herpain A
AD  - Université Libre de Bruxelles, Brussels, Belgium
FAU - Marc, J.
AU  - Marc J
AD  - Univ. Hospital of Amiens, Amiens, France
FAU - Zogheib, E.
AU  - Zogheib E
AD  - Univ. Hospital of Amiens, Amiens, France
FAU - Trojette, F.
AU  - Trojette F
AD  - Univ. Hospital of Amiens, Amiens, France
FAU - Bar, S.
AU  - Bar S
AD  - Univ. Hospital of Amiens, Amiens, France
FAU - Kontar, L.
AU  - Kontar L
AD  - Univ. Hospital of Amiens, Amiens, France
FAU - Titeca, D.
AU  - Titeca D
AD  - Univ. Hospital of Amiens, Amiens, France
FAU - Richecoeur, J.
AU  - Richecoeur J
AD  - CH Beauvais, Beauvais, France
FAU - Gelee, B.
AU  - Gelee B
AD  - CH Beauvais, Beauvais, France
FAU - Verrier, N.
AU  - Verrier N
AD  - CH Beauvais, Beauvais, France
FAU - Mercier, R.
AU  - Mercier R
AD  - CH Beauvais, Beauvais, France
FAU - Lorne, E.
AU  - Lorne E
AD  - Univ. Hospital of Amiens, Amiens, France
FAU - Maizel, J.
AU  - Maizel J
AD  - Univ. Hospital of Amiens, Amiens, France
FAU - Dupont, H.
AU  - Dupont H
AD  - Univ. Hospital of Amiens, Amiens, France
FAU - Slama, M.
AU  - Slama M
AD  - Univ. Hospital of Amiens, Amiens, France
FAU - Abdelfattah, M. E.
AU  - Abdelfattah ME
AD  - Cairo University, Cairo, Egypt
FAU - Eladawy, A.
AU  - Eladawy A
AD  - Kasr Alainy Medical School, Cairo University, Cairo, Egypt
FAU - Elsayed, M. A. Ali
AU  - Elsayed MAA
AD  - Cairo University, Cairo, Egypt
FAU - Mukhtar, A.
AU  - Mukhtar A
AD  - Cairo University, Cairo, Egypt
FAU - Montenegro, A. Pedraza
AU  - Montenegro AP
AD  - ABC Medical Center, Critical Medicine, Mexico City, Mexico
FAU - Zepeda, E. Monares
AU  - Zepeda EM
AD  - ABC Medical Center, Critical Medicine, Mexico City, Mexico
FAU - Granillo, J. Franco
AU  - Granillo JF
AD  - ABC Medical Center, Critical Medicine, Mexico City, Mexico
FAU - Sánchez, J. S. Aguirre
AU  - Sánchez JSA
AD  - ABC Medical Center, Critical Medicine, Mexico City, Mexico
FAU - Alejo, G. Camarena
AU  - Alejo GC
AD  - ABC Medical Center, Critical Medicine, Mexico City, Mexico
FAU - Cabrera, A. Rugerio
AU  - Cabrera AR
AD  - ABC Medical Center, Critical Medicine, Mexico City, Mexico
FAU - Montoya, A. A. Tanaka
AU  - Montoya AAT
AD  - ABC Medical Center, Critical Medicine, Mexico City, Mexico
FAU - Lee, C.
AU  - Lee C
AD  - Edwards Lifesciences, Critical Care, Irvine, USA
FAU - Hatib, F.
AU  - Hatib F
AD  - Edwards Lifesciences, Critical Care, Irvine, USA
FAU - Cannesson, M.
AU  - Cannesson M
AD  - University of California Los Angeles, Anesthesiology, Los Angeles, USA
FAU - Theerawit, P.
AU  - Theerawit P
AD  - Ramathibodi Hospital, Mahidol University, Medicine, Bangkok, Thailand
FAU - Morasert, T.
AU  - Morasert T
AD  - Ramathibodi Hospital, Mahidol University, Medicine, Bangkok, Thailand
FAU - Sutherasan, Y.
AU  - Sutherasan Y
AD  - Ramathibodi Hospital, Mahidol University, Medicine, Bangkok, Thailand
FAU - Zani, G.
AU  - Zani G
AD  - Santa Maria delle Croci Hospital, Anesthesia and Intensive Care, Ravenna, Italy
FAU - Mescolini, S.
AU  - Mescolini S
AD  - Santa Maria delle Croci Hospital, Anesthesia and Intensive Care, Ravenna, Italy
FAU - Diamanti, M.
AU  - Diamanti M
AD  - Santa Maria delle Croci Hospital, Anesthesia and Intensive Care, Ravenna, Italy
FAU - Righetti, R.
AU  - Righetti R
AD  - Santa Maria delle Croci Hospital, Anesthesia and Intensive Care, Ravenna, Italy
FAU - Scaramuzza, A.
AU  - Scaramuzza A
AD  - Santa Maria delle Croci Hospital, Anesthesia and Intensive Care, Ravenna, Italy
FAU - Papetti, M.
AU  - Papetti M
AD  - Santa Maria delle Croci Hospital, Anesthesia and Intensive Care, Ravenna, Italy
FAU - Terenzoni, M.
AU  - Terenzoni M
AD  - Santa Maria delle Croci Hospital, Anesthesia and Intensive Care, Ravenna, Italy
FAU - Gecele, C.
AU  - Gecele C
AD  - Santa Maria delle Croci Hospital, Anesthesia and Intensive Care, Ravenna, Italy
FAU - Fusari, M.
AU  - Fusari M
AD  - Santa Maria delle Croci Hospital, Anesthesia and Intensive Care, Ravenna, Italy
FAU - Hakim, K. A.
AU  - Hakim KA
AD  - King Hamad University Hospital, Intensive Care, Muharraq, Bahrain
FAU - Chaari, A.
AU  - Chaari A
AD  - King Hamad University Hospital, Intensive Care, Muharraq, Bahrain
FAU - Ismail, M.
AU  - Ismail M
AD  - King Hamad University Hospital, Intensive Care, Muharraq, Bahrain
FAU - Elsaka, A. H.
AU  - Elsaka AH
AD  - King Hamad University Hospital, Intensive Care, Muharraq, Bahrain
FAU - Mahmoud, T. M.
AU  - Mahmoud TM
AD  - King Hamad University Hospital, Intensive Care, Muharraq, Bahrain
FAU - Bousselmi, K.
AU  - Bousselmi K
AD  - King Hamad University Hospital, Intensive Care, Muharraq, Bahrain
FAU - Kauts, V.
AU  - Kauts V
AD  - King Hamad University Hospital, Intensive Care, Muharraq, Bahrain
FAU - Casey, W. F.
AU  - Casey WF
AD  - King Hamad University Hospital, Intensive Care, Muharraq, Bahrain
FAU - Hutchings, S. D.
AU  - Hutchings SD
AD  - Kings College Hospital, London, UK
FAU - Naumann, D.
AU  - Naumann D
AD  - NIHR Surgical Reconstruction and Microbiology Research Centre, Birmingham, UK
FAU - Wendon, J.
AU  - Wendon J
AD  - Kings College Hospital, London, UK
FAU - Watts, S.
AU  - Watts S
AD  - Defence Science and Technology Laboratory, Salisbury, UK
FAU - Kirkman, E.
AU  - Kirkman E
AD  - Defence Science and Technology Laboratory, Salisbury, UK
FAU - Jian, Z.
AU  - Jian Z
AD  - Edwards Lifesciences, Irvine, USA
FAU - Buddi, S.
AU  - Buddi S
AD  - Edwards Lifesciences, Irvine, USA
FAU - Lee, C.
AU  - Lee C
AD  - Edwards Lifesciences, Irvine, USA
FAU - Settels, J.
AU  - Settels J
AD  - Edwards Lifesciences, Amsterdam, Netherlands
FAU - Hatib, F.
AU  - Hatib F
AD  - Edwards Lifesciences, Irvine, USA
FAU - Pinsky, M. R.
AU  - Pinsky MR
AD  - Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, USA
FAU - Bertini, P.
AU  - Bertini P
AD  - Department of Anaesthesia and Critical Care Medicine, Cardiothoracic and Vascular
      Anaesthesia, University Hospital of Pisa, Pisa, Italy
FAU - Guarracino, F.
AU  - Guarracino F
AD  - Department of Anaesthesia and Critical Care Medicine, Cardiothoracic and Vascular
      Anaesthesia, University Hospital of Pisa, Pisa, Italy
FAU - Trepte, C.
AU  - Trepte C
AD  - University Medical Center Hamburg-Eppendorf, Hamburg, Germany
FAU - Richter, P.
AU  - Richter P
AD  - Klinikum Harlaching, München, Germany
FAU - Haas, S. A.
AU  - Haas SA
AD  - University Medical Center Hamburg-Eppendorf, Hamburg, Germany
FAU - Eichhorn, V.
AU  - Eichhorn V
AD  - Dalhousie University, Halifax, Canada
FAU - Kubitz, J. C.
AU  - Kubitz JC
AD  - University Medical Center Hamburg-Eppendorf, Hamburg, Germany
FAU - Reuter, D. A.
AU  - Reuter DA
AD  - University Medical Center Hamburg-Eppendorf, Hamburg, Germany
FAU - Soliman, M. S.
AU  - Soliman MS
AD  - Cairo University, Anaesthesia, Cairo, Egypt
FAU - Hamimy, W. I.
AU  - Hamimy WI
AD  - Cairo University, Cairo, Egypt
FAU - Fouad, A. Z.
AU  - Fouad AZ
AD  - Cairo University, Cairo, Egypt
FAU - Mukhtar, A. M.
AU  - Mukhtar AM
AD  - Cairo University, Cairo, Egypt
FAU - Charlton, M.
AU  - Charlton M
AD  - University Hospitals of Leicester NHS Trust, Anaesthesia, Critical Care and Pain,
      Leicester, UK
FAU - Tonks, L.
AU  - Tonks L
AD  - University of Leicester, Leicester, UK
FAU - Mclelland, L.
AU  - Mclelland L
AD  - University Hospitals of Leicester NHS Trust, Emergency Medicine Academic Group,
      Leicester, UK
FAU - Coats, T. J.
AU  - Coats TJ
AD  - University Hospitals of Leicester NHS Trust, Emergency Medicine Academic Group,
      Leicester, UK
FAU - Thompson, J. P.
AU  - Thompson JP
AD  - University Hospitals of Leicester NHS Trust, Anaesthesia, Critical Care and Pain,
      Leicester, UK
FAU - Sims, M. R.
AU  - Sims MR
AD  - University of Leicester, Leicester, UK
FAU - Williams, D.
AU  - Williams D
AD  - Ysbyty Glan Clwyd, Critical Care, Bodelwyddan, UK
FAU - Roushdy, D. Z.
AU  - Roushdy DZ
AD  - Critical Care Department, Faculty of Medicine, Cairo University, Cairo, Egypt
FAU - Soliman, R. A.
AU  - Soliman RA
AD  - Critical Care Department, Faculty of Medicine, Cairo University, Cairo, Egypt
FAU - Nahas, R. A.
AU  - Nahas RA
AD  - Critical Care Department, Cairo University, Cairo, Egypt
FAU - Arafa, M. Y.
AU  - Arafa MY
AD  - Critical Care Department, Cairo University, Cairo, Egypt
FAU - Hung, W. T.
AU  - Hung WT
AD  - Department of Critical Care Medicine, Kaohsiung Veterans General Hospital,
      Kaohsiung City, Taiwan, Province of China
FAU - Chiang, C. C.
AU  - Chiang CC
AD  - Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City,
      Taiwan, Province of China
FAU - Huang, W. C.
AU  - Huang WC
AD  - Department of Critical Care Medicine, Kaohsiung Veterans General Hospital,
      Kaohsiung City, Taiwan, Province of China
FAU - Lin, K. C.
AU  - Lin KC
AD  - Department of Critical Care Medicine, Kaohsiung Veterans General Hospital,
      Kaohsiung City, Taiwan, Province of China
FAU - Lin, S. C.
AU  - Lin SC
AD  - Department of Critical Care Medicine, Kaohsiung Veterans General Hospital,
      Kaohsiung City, Taiwan, Province of China
FAU - Cheng, C. C.
AU  - Cheng CC
AD  - Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City,
      Taiwan, Province of China
FAU - Kang, P. L.
AU  - Kang PL
AD  - Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City,
      Taiwan, Province of China
FAU - Wann, S. R.
AU  - Wann SR
AD  - Department of Critical Care Medicine, Kaohsiung Veterans General Hospital,
      Kaohsiung City, Taiwan, Province of China
FAU - Mar, G. Y.
AU  - Mar GY
AD  - Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City,
      Taiwan, Province of China
FAU - Liu, C. P.
AU  - Liu CP
AD  - Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City,
      Taiwan, Province of China
FAU - Carranza, M. Lopez
AU  - Carranza ML
AD  - Hospital Universitario V. de Valme, Medicina Intensiva, Sevilla, Spain
FAU - Fernandez, H. Sancho
AU  - Fernandez HS
AD  - Hospital Universitario V. de Valme, Sevilla, Spain
FAU - Roman, J. A. Sanchez
AU  - Roman JAS
AD  - Hospital Universitario V. de Valme, Sevilla, Spain
FAU - Lucena, F.
AU  - Lucena F
AD  - Hospital Universitario V. de Valme, Sevilla, Spain
FAU - Garcia, A. Campanario
AU  - Garcia AC
AD  - Hospital Universitario V. de Valme, Sevilla, Spain
FAU - Vazquez, A. Loza
AU  - Vazquez AL
AD  - Hospital Universitario V. de Valme, Sevilla, Spain
FAU - Serrano, A. Lesmes
AU  - Serrano AL
AD  - Hospital Universitario V. de Valme, Sevilla, Spain
CN  - ARIAM-SEMICYUC Registry Investigators
FAU - Moreira, L. Sayagues
AU  - Moreira LS
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care,
      Santiago de Compostela, Spain
FAU - Vidal-Perez, R.
AU  - Vidal-Perez R
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Cardiology,
      Santiago de Compostela, Spain
FAU - Herranz, U. Anido
AU  - Herranz UA
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care,
      Santiago de Compostela, Spain
FAU - Acuna, J. M. Garcia
AU  - Acuna JMG
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Cardiology,
      Santiago de Compostela, Spain
FAU - Gil, C. Pena
AU  - Gil CP
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Cardiology,
      Santiago de Compostela, Spain
FAU - Allut, J. L. Garcia
AU  - Allut JLG
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care,
      Santiago de Compostela, Spain
FAU - Sedes, P. Rascado
AU  - Sedes PR
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care,
      Santiago de Compostela, Spain
FAU - Lopez, C. Martin
AU  - Lopez CM
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care,
      Santiago de Compostela, Spain
FAU - Paz, E. Saborido
AU  - Paz ES
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care,
      Santiago de Compostela, Spain
FAU - Rodriguez, C. Galban
AU  - Rodriguez CG
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care,
      Santiago de Compostela, Spain
FAU - Gonzalez-Juanatey, J. R.
AU  - Gonzalez-Juanatey JR
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Cardiology,
      Santiago de Compostela, Spain
FAU - Vallejo-Baez, A.
AU  - Vallejo-Baez A
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - de la Torre-Prados, M. V.
AU  - de la Torre-Prados MV
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Nuevo-Ortega, P.
AU  - Nuevo-Ortega P
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Fernández-Porcel, A.
AU  - Fernández-Porcel A
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Cámara-Sola, E.
AU  - Cámara-Sola E
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Tsvetanova-Spasova, T.
AU  - Tsvetanova-Spasova T
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Rueda-Molina, C.
AU  - Rueda-Molina C
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Salido-Díaz, L.
AU  - Salido-Díaz L
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - García-Alcántara, A.
AU  - García-Alcántara A
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
CN  - ARIAM Group
FAU - Aron, J.
AU  - Aron J
AD  - Kings College Hospital, Intensive Care Unit, London, UK
FAU - Marharaj, R.
AU  - Marharaj R
AD  - Kings College Hospital, Intensive Care Unit, London, UK
FAU - Gervasio, K.
AU  - Gervasio K
AD  - Anesthesia and Critical Care Medicine, Cardiothoracic Department ‘A. De
      Gasperis’, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
FAU - Bottiroli, M.
AU  - Bottiroli M
AD  - Anesthesia and Critical Care Medicine, Cardiothoracic Department ‘A. De
      Gasperis’, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
FAU - Mondino, M.
AU  - Mondino M
AD  - Anesthesia and Critical Care Medicine, Cardiothoracic Department ‘A. De
      Gasperis’, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
FAU - De Caria, D.
AU  - De Caria D
AD  - Anesthesia and Critical Care Medicine, Cardiothoracic Department ‘A. De
      Gasperis’, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
FAU - Calini, A.
AU  - Calini A
AD  - Anesthesia and Critical Care Medicine, Cardiothoracic Department ‘A. De
      Gasperis’, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
FAU - Montrasio, E.
AU  - Montrasio E
AD  - Anesthesia and Critical Care Medicine, Cardiothoracic Department ‘A. De
      Gasperis’, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
FAU - Milazzo, F.
AU  - Milazzo F
AD  - Anesthesia and Critical Care Medicine, Cardiothoracic Department ‘A. De
      Gasperis’, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
FAU - Gagliardone, M. P.
AU  - Gagliardone MP
AD  - Anesthesia and Critical Care Medicine, Cardiothoracic Department ‘A. De
      Gasperis’, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
FAU - Vallejo-Báez, A.
AU  - Vallejo-Báez A
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - de la Torre-Prados, M. V.
AU  - de la Torre-Prados MV
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Nuevo-Ortega, P.
AU  - Nuevo-Ortega P
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Fernández-Porcel, A.
AU  - Fernández-Porcel A
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Cámara-Sola, E.
AU  - Cámara-Sola E
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Tsvetanova-Spasova, T.
AU  - Tsvetanova-Spasova T
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Rueda-Molina, C.
AU  - Rueda-Molina C
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Salido-Díaz, L.
AU  - Salido-Díaz L
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - García-Alcántara, A.
AU  - García-Alcántara A
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
CN  - ARIAM group
FAU - Moreira, L. Sayagues
AU  - Moreira LS
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care,
      Santiago de Compostela, Spain
FAU - Vidal-Perez, R.
AU  - Vidal-Perez R
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Cardiology,
      Santiago de Compostela, Spain
FAU - Anido, U.
AU  - Anido U
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care,
      Santiago de Compostela, Spain
FAU - Gil, C. Pena
AU  - Gil CP
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Cardiology,
      Santiago de Compostela, Spain
FAU - Acuna, J. M. Garcia
AU  - Acuna JMG
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Cardiology,
      Santiago de Compostela, Spain
FAU - Sedes, P. Rascado
AU  - Sedes PR
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care,
      Santiago de Compostela, Spain
FAU - Lopez, C. Martin
AU  - Lopez CM
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care,
      Santiago de Compostela, Spain
FAU - Paz, E. Saborido
AU  - Paz ES
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care,
      Santiago de Compostela, Spain
FAU - Allut, J. L. Garcia
AU  - Allut JLG
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care,
      Santiago de Compostela, Spain
FAU - Rodriguez, C. Galban
AU  - Rodriguez CG
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care,
      Santiago de Compostela, Spain
FAU - Gonzalez-Juanatey, J. R.
AU  - Gonzalez-Juanatey JR
AD  - Complexo Hospitalario Universitario de Santiago de Compostela, Cardiology,
      Santiago de Compostela, Spain
FAU - Hamdaoui, Y.
AU  - Hamdaoui Y
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Khedher, A.
AU  - Khedher A
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Cheikh-Bouhlel, M.
AU  - Cheikh-Bouhlel M
AD  - Cardiology Department, Farhat Hached University Hospital, Sousse, Tunisia
FAU - Ayachi, J.
AU  - Ayachi J
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Meddeb, K.
AU  - Meddeb K
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Sma, N.
AU  - Sma N
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Fraj, N.
AU  - Fraj N
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Aicha, N. Ben
AU  - Aicha NB
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Romdhani, S.
AU  - Romdhani S
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Bouneb, R.
AU  - Bouneb R
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Chouchene, I.
AU  - Chouchene I
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Boussarsar, M.
AU  - Boussarsar M
AD  - Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia
FAU - Dela Cruz, M. P. R. D. L.
AU  - Dela Cruz MPRDL
AD  - Makati Medical Center, Internal Medicine, Makati, Philippines
FAU - Bernardo, J. M.
AU  - Bernardo JM
AD  - Makati Medical Center, Internal Medicine, Makati, Philippines
FAU - Galfo, F.
AU  - Galfo F
AD  - University College London, Bloomsbury Institute of Intensive Care Medicine,
      London, UK
FAU - Dyson, A.
AU  - Dyson A
AD  - University College London, Bloomsbury Institute of Intensive Care Medicine,
      London, UK
FAU - Singer, M.
AU  - Singer M
AD  - University College London, Bloomsbury Institute of Intensive Care Medicine,
      London, UK
FAU - Marino, A.
AU  - Marino A
AD  - University College London, Bloomsbury Institute of Intensive Care Medicine,
      London, UK
FAU - Dyson, A.
AU  - Dyson A
AD  - University College London, Bloomsbury Institute of Intensive Care Medicine,
      London, UK
FAU - Singer, M.
AU  - Singer M
AD  - University College London, Bloomsbury Institute of Intensive Care Medicine,
      London, UK
FAU - Chao, C. C.
AU  - Chao CC
AD  - Emergency Department, Taipei Medical University Hospital, Taipei, Taiwan,
      Province of China
FAU - Hou, P.
AU  - Hou P
AD  - Harvard Medical School, Boston, USA
FAU - Huang, W. C.
AU  - Huang WC
AD  - Critical Care Division, Kaohsiung Veterans General Hospital, Kaohsiung City,
      Taiwan, Province of China
FAU - Hung, C. C.
AU  - Hung CC
AD  - Critical Care Division, Kaohsiung Veterans General Hospital, Kaohsiung City,
      Taiwan, Province of China
FAU - Chiang, C. H.
AU  - Chiang CH
AD  - Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City,
      Taiwan, Province of China
FAU - Hung, W. T.
AU  - Hung WT
AD  - Critical Care Division, Kaohsiung Veterans General Hospital, Kaohsiung City,
      Taiwan, Province of China
FAU - Lin, K. C.
AU  - Lin KC
AD  - Critical Care Division, Kaohsiung Veterans General Hospital, Kaohsiung City,
      Taiwan, Province of China
FAU - Lin, S. C.
AU  - Lin SC
AD  - Critical Care Division, Kaohsiung Veterans General Hospital, Kaohsiung City,
      Taiwan, Province of China
FAU - Liou, Y. J.
AU  - Liou YJ
AD  - Kaohsiung City Government, Fire Bureau, Kaohsiung City, Taiwan, Province of China
FAU - Hung, S. M.
AU  - Hung SM
AD  - Kaohsiung City Government, Fire Bureau, Kaohsiung City, Taiwan, Province of China
FAU - Lin, Y. S.
AU  - Lin YS
AD  - Kaohsiung City Government, Fire Bureau, Kaohsiung City, Taiwan, Province of China
FAU - Cheng, C. C.
AU  - Cheng CC
AD  - Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City,
      Taiwan, Province of China
FAU - Kuo, F. Y.
AU  - Kuo FY
AD  - Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City,
      Taiwan, Province of China
FAU - Chiou, K. R.
AU  - Chiou KR
AD  - Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City,
      Taiwan, Province of China
FAU - Chen, C. J.
AU  - Chen CJ
AD  - Department of Health, Kaohsiung City Government, Kaohsiung City, Taiwan, Province
      of China
FAU - Yan, L. S.
AU  - Yan LS
AD  - Department of Health, Kaohsiung City Government, Kaohsiung City, Taiwan, Province
      of China
FAU - Liu, C. Y.
AU  - Liu CY
AD  - Department of Health, Kaohsiung City Government, Kaohsiung City, Taiwan, Province
      of China
FAU - Wang, H. H.
AU  - Wang HH
AD  - Department of Health, Kaohsiung City Government, Kaohsiung City, Taiwan, Province
      of China
FAU - Kang, P. L.
AU  - Kang PL
AD  - Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City,
      Taiwan, Province of China
FAU - Chen, H. L.
AU  - Chen HL
AD  - Kaohsiung City Government, Fire Bureau, Kaohsiung City, Taiwan, Province of China
FAU - Ho, C. K.
AU  - Ho CK
AD  - Department of Health, Kaohsiung City Government, Kaohsiung City, Taiwan, Province
      of China
FAU - Mar, G. Y.
AU  - Mar GY
AD  - Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City,
      Taiwan, Province of China
FAU - Liu, C. P.
AU  - Liu CP
AD  - Department of Health, Kaohsiung City Government, Kaohsiung City, Taiwan, Province
      of China
FAU - Grewal, S.
AU  - Grewal S
AD  - New Cross Hospital, Integrated Critical Care Unit, Wolverhamptom, UK
FAU - Gopal, S.
AU  - Gopal S
AD  - New Cross Hospital, Integrated Critical Care Unit, Wolverhamptom, UK
FAU - Corbett, C.
AU  - Corbett C
AD  - New Cross Hospital, Critical Care Services, Research and Audit Office,
      Wolverhamptom, UK
FAU - Wilson, A.
AU  - Wilson A
AD  - Central Manchester Foundation NHS Trust, Adult Critical Care, Manchester, UK
FAU - Capps, J.
AU  - Capps J
AD  - Central Manchester Foundation NHS Trust, Adult Critical Care, Manchester, UK
FAU - Ayoub, W.
AU  - Ayoub W
AD  - Central Manchester Foundation NHS Trust, Adult Critical Care, Manchester, UK
FAU - Lomas, A.
AU  - Lomas A
AD  - Central Manchester Foundation NHS Trust, Adult Critical Care, Manchester, UK
FAU - Ghani, S.
AU  - Ghani S
AD  - Central Manchester Foundation NHS Trust, Adult Critical Care, Manchester, UK
FAU - Moore, J.
AU  - Moore J
AD  - Central Manchester Foundation NHS Trust, Adult Critical Care, Manchester, UK
FAU - Atkinson, D.
AU  - Atkinson D
AD  - Central Manchester Foundation NHS Trust, Adult Critical Care, Manchester, UK
FAU - Sharman, M.
AU  - Sharman M
AD  - Central Manchester Foundation NHS Trust, Adult Critical Care, Manchester, UK
FAU - Swinnen, W.
AU  - Swinnen W
AD  - az Sint-Blasius, Dendermonde, Belgium
FAU - Pauwels, J.
AU  - Pauwels J
AD  - az Sint-Blasius, Dendermonde, Belgium
FAU - Mignolet, K.
AU  - Mignolet K
AD  - az Sint-Blasius, Dendermonde, Belgium
FAU - Pannier, E.
AU  - Pannier E
AD  - az Sint-Blasius, Dendermonde, Belgium
FAU - Koch, A.
AU  - Koch A
AD  - az Sint-Blasius, Dendermonde, Belgium
FAU - Sarens, T.
AU  - Sarens T
AD  - az Sint-Blasius, Dendermonde, Belgium
FAU - Temmerman, W.
AU  - Temmerman W
AD  - az Sint-Blasius, Dendermonde, Belgium
FAU - Elmenshawy, A. M.
AU  - Elmenshawy AM
AD  - Alexandria University, Critical Care Medicine, Alexandria, Egypt
FAU - Fayed, A. M.
AU  - Fayed AM
AD  - Alexandria University, Critical Care Medicine, Alexandria, Egypt
FAU - Elboriuny, M.
AU  - Elboriuny M
AD  - Alexandria University, Critical Care Medicine, Alexandria, Egypt
FAU - Hamdy, E.
AU  - Hamdy E
AD  - Alexandria University, Critical Care Medicine, Alexandria, Egypt
FAU - Zakaria, E.
AU  - Zakaria E
AD  - Alexandria University, Critical Care Medicine, Alexandria, Egypt
FAU - Falk, A. C.
AU  - Falk AC
AD  - Karolinska University Hospital, CIVA, Stockholm, Sweden
FAU - Petosic, A.
AU  - Petosic A
AD  - Oslo University Hospital, General Intensive Care Unit - Ullevål, Oslo, Norway
FAU - Olafsen, K.
AU  - Olafsen K
AD  - Department of Anaesthesiology, Oslo University Hospital, Oslo, Norway
FAU - Wøien, H.
AU  - Wøien H
AD  - Oslo University Hospital, General Intensive Care Unit 1 -Rikshospitalet, Oslo,
      Norway
FAU - Flaatten, H.
AU  - Flaatten H
AD  - Haukeland University Hospital, General Intensive Care Unit, Bergen, Norway
FAU - Sunde, K.
AU  - Sunde K
AD  - Department of Anaesthesiology, Oslo University Hospital, Oslo, Norway
FAU - Agra, J. J. Cáceres
AU  - Agra JJC
AD  - Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain
FAU - Cabrera, J. L. Santana
AU  - Cabrera JLS
AD  - Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain
FAU - Santana, J. D. Martín
AU  - Santana JDM
AD  - Department of Economy. University of Las Palmas de Gran Canaria, Hospital Insular
      Las Palmas GC, Las Palmas de Gran Canaria, Spain
FAU - Alzola, L. Melián
AU  - Alzola LM
AD  - Department of Economy. University of Las Palmas de Gran Canaria, Hospital Insular
      Las Palmas GC, Las Palmas de Gran Canaria, Spain
FAU - Pérez, H. Rodríguez
AU  - Pérez HR
AD  - Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain
FAU - Pires, T. Castro
AU  - Pires TC
AD  - University of Algarve, Departmant of Biomedical Sciences and Medicine, Faro,
      Portugal
FAU - Calderón, H.
AU  - Calderón H
AD  - Emergency and Intensive Care Departmant, Centro Hospitalar do Algarve, Hospital
      de Faro, Faro, Portugal
FAU - Pereira, A.
AU  - Pereira A
AD  - Centro Hospitalar do Algarve, Hospital de Faro, Faro, Portugal
FAU - Castro, S.
AU  - Castro S
AD  - Emergency and Intensive Care Departmant, Centro Hospitalar do Algarve, Hospital
      de Faro, Faro, Portugal
FAU - Granja, C.
AU  - Granja C
AD  - University of Algarve, Departmant of Biomedical Sciences and Medicine, Faro,
      Portugal
FAU - Norkiene, I.
AU  - Norkiene I
AD  - Vilnius University, Clinic of Anaesthesiology and Intensive care, Vilnius,
      Lithuania
FAU - Urbanaviciute, I.
AU  - Urbanaviciute I
AD  - Vilnius University, Faculty of Medicine, Vilnius, Lithuania
FAU - Kezyte, G.
AU  - Kezyte G
AD  - Vilnius University, Faculty of Medicine, Vilnius, Lithuania
FAU - Ringaitiene, D.
AU  - Ringaitiene D
AD  - Vilnius University, Clinic of Anaesthesiology and Intensive care, Vilnius,
      Lithuania
FAU - Jovaisa, T.
AU  - Jovaisa T
AD  - Lithuanian University of Health Sciences, Clinic of Anaesthesiology, Kaunas,
      Lithuania
FAU - Vogel, G.
AU  - Vogel G
AD  - Department of Clinical Science and Education, Karolinska Institutet,
      Södersjukhuset, Stockholm, Sweden
FAU - Johansson, U. B.
AU  - Johansson UB
AD  - Department of Clinical Science and Education, Karolinska Institutet,
      Södersjukhuset, Stockholm, Sweden
FAU - Sandgren, A.
AU  - Sandgren A
AD  - Linnaeus University, Kalmar/Växjö, Sweden
FAU - Svensen, C.
AU  - Svensen C
AD  - Department of Clinical Science and Education, Karolinska Institutet,
      Södersjukhuset, Stockholm, Sweden
FAU - Joelsson-Alm, E.
AU  - Joelsson-Alm E
AD  - Department of Clinical Science and Education, Karolinska Institutet,
      Södersjukhuset, Stockholm, Sweden
FAU - Leite, M. A.
AU  - Leite MA
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Murbach, L. D.
AU  - Murbach LD
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Osaku, E. F.
AU  - Osaku EF
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Costa, C. R. L. M.
AU  - Costa CRLM
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Pelenz, M.
AU  - Pelenz M
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Neitzke, N. M.
AU  - Neitzke NM
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Moraes, M. M.
AU  - Moraes MM
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Jaskowiak, J. L.
AU  - Jaskowiak JL
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Silva, M. M. M.
AU  - Silva MMM
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Zaponi, R. S.
AU  - Zaponi RS
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Abentroth, L. R. L.
AU  - Abentroth LRL
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Ogasawara, S. M.
AU  - Ogasawara SM
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Jorge, A. C.
AU  - Jorge AC
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Duarte, P. A. D.
AU  - Duarte PAD
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Murbach, L. D.
AU  - Murbach LD
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Leite, M. A.
AU  - Leite MA
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Osaku, E. F.
AU  - Osaku EF
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Barreto, J.
AU  - Barreto J
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Duarte, S. T.
AU  - Duarte ST
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Taba, S.
AU  - Taba S
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Miglioranza, D.
AU  - Miglioranza D
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Gund, D. P.
AU  - Gund DP
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Lordani, C. F.
AU  - Lordani CF
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Costa, C. R. L. M.
AU  - Costa CRLM
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Ogasawara, S. M.
AU  - Ogasawara SM
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Jorge, A. C.
AU  - Jorge AC
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Duarte, P. A. D.
AU  - Duarte PAD
AD  - Western Parana State University Hospital, Cascavel, Brazil
FAU - Vollmer, H.
AU  - Vollmer H
AD  - Royal Berkshire Hospital, Intensive Care Unit, Reading, UK
FAU - Gager, M.
AU  - Gager M
AD  - Royal Berkshire Hospital, Intensive Care Unit, Reading, UK
FAU - Waldmann, C.
AU  - Waldmann C
AD  - Royal Berkshire Hospital, Intensive Care Unit, Reading, UK
FAU - Mazzeo, A. T.
AU  - Mazzeo AT
AD  - University of Turin, Anesthesia and Intensive Care, Turin, Italy
FAU - Tesio, R.
AU  - Tesio R
AD  - University of Turin, Anesthesia and Intensive Care, Turin, Italy
FAU - Filippini, C.
AU  - Filippini C
AD  - University of Turin, Anesthesia and Intensive Care, Turin, Italy
FAU - Vallero, M. E.
AU  - Vallero ME
AD  - University of Turin, Anesthesia and Intensive Care, Turin, Italy
FAU - Giolitti, C.
AU  - Giolitti C
AD  - University of Turin, Anesthesia and Intensive Care, Turin, Italy
FAU - Caccia, S.
AU  - Caccia S
AD  - University of Turin, Anesthesia and Intensive Care, Turin, Italy
FAU - Medugno, M.
AU  - Medugno M
AD  - University of Turin, Anesthesia and Intensive Care, Turin, Italy
FAU - Tenaglia, T.
AU  - Tenaglia T
AD  - University of Turin, Anesthesia and Intensive Care, Turin, Italy
FAU - Rosato, R.
AU  - Rosato R
AD  - University of Turin, Psychology, Torino, Italy
FAU - Mastromauro, I.
AU  - Mastromauro I
AD  - University of Turin, Anesthesia and Intensive Care, Turin, Italy
FAU - Brazzi, L.
AU  - Brazzi L
AD  - University of Turin, Anesthesia and Intensive Care, Turin, Italy
FAU - Terragni, P. P.
AU  - Terragni PP
AD  - University of Turin, Anesthesia and Intensive Care, Turin, Italy
FAU - Urbino, R.
AU  - Urbino R
AD  - University of Turin, Anesthesia and Intensive Care, Turin, Italy
FAU - Fanelli, V.
AU  - Fanelli V
AD  - University of Turin, Anesthesia and Intensive Care, Turin, Italy
FAU - Ranieri, V. M.
AU  - Ranieri VM
AD  - Sapienza University of Rome, Anesthesia and Intensive Care, Rome, Italy
FAU - Mascia, L.
AU  - Mascia L
AD  - Sapienza University of Rome, Scienze e Biotecnologie Medico Chirurgiche, Rome,
      Italy
FAU - Ballantyne, J.
AU  - Ballantyne J
AD  - Queen Elizabeth University Hospital, NHS GG&C, Intensive Care Medicine, Glasgow, 
      UK
FAU - Paton, L.
AU  - Paton L
AD  - Queen Elizabeth University Hospital, NHS GG&C, Intensive Care Medicine, Glasgow, 
      UK
FAU - Mackay, A.
AU  - Mackay A
AD  - Queen Elizabeth University Hospital, NHS GG&C, Intensive Care Medicine, Glasgow, 
      UK
FAU - Perez-Teran, P.
AU  - Perez-Teran P
AD  - Hospital del Mar/CIBERES/UPF, Intensive Care, Barcelona, Spain
FAU - Roca, O.
AU  - Roca O
AD  - Vall d’Hebrón University Hospital, Intensive Care, Barcelona, Spain
FAU - Ruiz-Rodriguez, J. C.
AU  - Ruiz-Rodriguez JC
AD  - Vall d’Hebrón University Hospital, Intensive Care, Barcelona, Spain
FAU - Zapatero, A.
AU  - Zapatero A
AD  - Hospital del Mar/CIBERES/UPF, Intensive Care, Barcelona, Spain
FAU - Serra, J.
AU  - Serra J
AD  - Vall d’Hebrón University Hospital, Intensive Care, Barcelona, Spain
FAU - Masclans, J. R.
AU  - Masclans JR
AD  - Hospital del Mar/CIBERES/UPF, Intensive Care, Barcelona, Spain
FAU - Bianzina, S.
AU  - Bianzina S
AD  - Anesthesia and Intensive Care, Fondazione IRCCS Policlinico S. Matteo, University
      of Pavia, Pavia, Italy
FAU - Cornara, P.
AU  - Cornara P
AD  - Anesthesia and Intensive Care, Fondazione IRCCS Policlinico S. Matteo, University
      of Pavia, Pavia, Italy
FAU - Rodi, G.
AU  - Rodi G
AD  - Anesthesia and Intensive Care, Fondazione IRCCS Policlinico S. Matteo, University
      of Pavia, Pavia, Italy
FAU - Tavazzi, G.
AU  - Tavazzi G
AD  - Anesthesia and Intensive Care, Fondazione IRCCS Policlinico S. Matteo, University
      of Pavia, Pavia, Italy
FAU - Pozzi, M.
AU  - Pozzi M
AD  - Anesthesia and Intensive Care, Fondazione IRCCS Policlinico S. Matteo, University
      of Pavia, Pavia, Italy
FAU - Iotti, G. A.
AU  - Iotti GA
AD  - Anesthesia and Intensive Care, Fondazione IRCCS Policlinico S. Matteo, University
      of Pavia, Pavia, Italy
FAU - Mojoli, F.
AU  - Mojoli F
AD  - Anesthesia and Intensive Care, Fondazione IRCCS Policlinico S. Matteo, University
      of Pavia, Pavia, Italy
FAU - Braschi, A.
AU  - Braschi A
AD  - Anesthesia and Intensive Care, Fondazione IRCCS Policlinico S. Matteo, University
      of Pavia, Pavia, Italy
FAU - Vishnu, A.
AU  - Vishnu A
AD  - Blkapoor Super Speciality Hospital, BLK Centre for Critical Care, New Delhi,
      India
FAU - Buche, D.
AU  - Buche D
AD  - Blkapoor Super Speciality Hospital, BLK Centre for Critical Care, New Delhi,
      India
FAU - Pande, R.
AU  - Pande R
AD  - Blkapoor Super Speciality Hospital, BLK Centre for Critical Care, New Delhi,
      India
FAU - Moolenaar, D. L. J.
AU  - Moolenaar DLJ
AD  - University Medical Center Utrecht, Intensive Care, Utrecht, Netherlands
FAU - Bakhshi-Raiez, F.
AU  - Bakhshi-Raiez F
AD  - Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam,
      Netherlands
FAU - Dongelmans, D. A.
AU  - Dongelmans DA
AD  - Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam,
      Netherlands
FAU - de Keizer, N. F.
AU  - de Keizer NF
AD  - Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam,
      Netherlands
FAU - de Lange, D. W.
AU  - de Lange DW
AD  - University Medical Center Utrecht, Intensive Care, Utrecht, Netherlands
FAU - Fernández, I. Fuentes
AU  - Fernández IF
AD  - Hospital Virgen de la Arrixaca, ICU, El Palmar, Spain
FAU - Baño, D. Martínez
AU  - Baño DM
AD  - Hospital Virgen de la Arrixaca, ICU, El Palmar, Spain
FAU - Moreno, J. L. Buendía
AU  - Moreno JLB
AD  - Hospital Virgen de la Arrixaca, ICU, El Palmar, Spain
FAU - Rubio, R. Jara
AU  - Rubio RJ
AD  - Hospital Virgen de la Arrixaca, ICU, El Palmar, Spain
FAU - Scott, J.
AU  - Scott J
AD  - Mater Misericordiae University Hospital, ICU, Dublin, Ireland
FAU - Phelan, D.
AU  - Phelan D
AD  - Mater Misericordiae University Hospital, Dublin, Ireland
FAU - Morely, D.
AU  - Morely D
AD  - Mater Misericordiae University Hospital, Dublin, Ireland
FAU - O’Flynn, J.
AU  - O’Flynn J
AD  - Mater Misericordiae University Hospital, Dublin, Ireland
FAU - Stapleton, P.
AU  - Stapleton P
AD  - Mater Misericordiae University Hospital, Microbiology, Dublin, Ireland
FAU - Lynch, M.
AU  - Lynch M
AD  - Mater Misericordiae University Hospital, Microbiology, Dublin, Ireland
FAU - Marsh, B.
AU  - Marsh B
AD  - Mater Misericordiae University Hospital, ICU, Dublin, Ireland
FAU - Carton, E.
AU  - Carton E
AD  - Mater Misericordiae University Hospital, ICU, Dublin, Ireland
FAU - O’Loughlin, C.
AU  - O’Loughlin C
AD  - Mater Misericordiae University Hospital, ICU, Dublin, Ireland
FAU - Cheng, K. C.
AU  - Cheng KC
AD  - Chi Mei Medical Center, Internal Medicine, Tainan, Taiwan, Province of China
FAU - Sung, M. I.
AU  - Sung MI
AD  - Chi Mei Medical Center, Internal Medicine, Tainan, Taiwan, Province of China
FAU - Elghonemi, M. O.
AU  - Elghonemi MO
AD  - Critical Care Medicine Department, Kasr Alainy Medical School, Cairo University, 
      Cairo, Egypt
FAU - Saleh, M. H.
AU  - Saleh MH
AD  - Critical Care Medicine Department, Kasr Alainy Medical School, Cairo University, 
      Cairo, Egypt
FAU - Meyhoff, T. S.
AU  - Meyhoff TS
AD  - Department of Intensive Care 4131, Copenhagen University Hospital, Copenhagen,
      Denmark
FAU - Krag, M.
AU  - Krag M
AD  - Department of Intensive Care 4131, Copenhagen University Hospital, Copenhagen,
      Denmark
FAU - Hjortrup, P. B.
AU  - Hjortrup PB
AD  - Department of Intensive Care 4131, Copenhagen University Hospital, Copenhagen,
      Denmark
FAU - Perner, A.
AU  - Perner A
AD  - Department of Intensive Care 4131, Copenhagen University Hospital, Copenhagen,
      Denmark
FAU - Møller, M. H.
AU  - Møller MH
AD  - Department of Intensive Care 4131, Copenhagen University Hospital, Copenhagen,
      Denmark
FAU - Öhman, T.
AU  - Öhman T
AD  - Department of Anaesthesiology, Surgical Services and Intensive Care Medicine,
      Karolinska University Hospital, Stockholm, Sweden
FAU - Sigmundsson, T.
AU  - Sigmundsson T
AD  - Department of Anaesthesiology, Surgical Services and Intensive Care Medicine,
      Karolinska University Hospital, Stockholm, Sweden
FAU - Redondo, E.
AU  - Redondo E
AD  - Department of Intensive Care Medicine, Hospital de Navarra, Pamplona, Spain
FAU - Hallbäck, M.
AU  - Hallbäck M
AD  - Maquet Critical Care AB, Solna, Sweden
FAU - Suarez-Sipmann, F.
AU  - Suarez-Sipmann F
AD  - Department of Surgical Sciences, Uppsala University, Hedenstierna Laboratory,
      Uppsala, Sweden
FAU - Björne, H.
AU  - Björne H
AD  - Department of Anaesthesiology, Surgical Services and Intensive Care Medicine,
      Karolinska University Hospital, Stockholm, Sweden
FAU - Sander, C. Hällsjö
AU  - Sander CH
AD  - Department of Anaesthesiology, Surgical Services and Intensive Care Medicine,
      Karolinska University Hospital, Stockholm, Sweden
CN  - KARISMA
FAU - Cressoni, M.
AU  - Cressoni M
AD  - Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Università
      degli Studi di Milano, Milano, Italy
FAU - Chiumello, D.
AU  - Chiumello D
AD  - Dipartimento di Anestesia, Rianimazione, Urgenza ed Emergenza, Policlinico Di
      Milano, Milano, Italy
FAU - Chiurazzi, C.
AU  - Chiurazzi C
AD  - Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università
      degli Studi di Milano, Milano, Italy
FAU - Brioni, M.
AU  - Brioni M
AD  - Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Università
      degli Studi di Milano, Milano, Italy
FAU - Algieri, I.
AU  - Algieri I
AD  - Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Università
      degli Studi di Milano, Milano, Italy
FAU - Guanziroli, M.
AU  - Guanziroli M
AD  - Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Università
      degli Studi di Milano, Milano, Italy
FAU - Vergani, G.
AU  - Vergani G
AD  - Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Università
      degli Studi di Milano, Milano, Italy
FAU - Tonetti, T.
AU  - Tonetti T
AD  - Georg-August-University Goettingen, Anesthesiology and Intensive Care Medicine,
      Goettingen, Germany
FAU - Tomic, I.
AU  - Tomic I
AD  - Department of Intensive Care Medicine, University of Zagreb, Rebro, Croatia
FAU - Colombo, A.
AU  - Colombo A
AD  - Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Università
      degli Studi di Milano, Milano, Italy
FAU - Crimella, F.
AU  - Crimella F
AD  - Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Università
      degli Studi di Milano, Milano, Italy
FAU - Carlesso, E.
AU  - Carlesso E
AD  - Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Università
      degli Studi di Milano, Milano, Italy
FAU - Colombo, A.
AU  - Colombo A
AD  - Dipartimento di Anestesia, Rianimazione, Urgenza ed Emergenza, Policlinico Di
      Milano, Milano, Italy
FAU - Gasparovic, V.
AU  - Gasparovic V
AD  - Department of Intensive Care Medicine, University of Zagreb, Rebro, Croatia
FAU - Gattinoni, L.
AU  - Gattinoni L
AD  - Georg-August-University Goettingen, Anesthesiology and Intensive Care Medicine,
      Goettingen, Germany
FAU - El-Sherif, R.
AU  - El-Sherif R
AD  - Critical Care Department, Kasr Al-Aini Hospitals, Cairo University, Cairo, Egypt
FAU - Al-Basser, M. Abd
AU  - Al-Basser MA
AD  - Critical Care Department, Kasr Al-Aini Hospitals, Cairo University, Cairo, Egypt
FAU - Raafat, A.
AU  - Raafat A
AD  - Physiotherapy Department, Cairo University, Cairo, Egypt
FAU - El-Sherif, A.
AU  - El-Sherif A
AD  - Critical Care Department, Kasr Al-Aini Hospitals, Cairo University, Cairo, Egypt
FAU - Simonis, F. D.
AU  - Simonis FD
AD  - Academic Medical Center, Amsterdam, Netherlands
FAU - Schouten, L. R. A.
AU  - Schouten LRA
AD  - Academic Medical Center, Amsterdam, Netherlands
FAU - Cremer, O. L.
AU  - Cremer OL
AD  - University Medical Center Utrecht, Utrecht, Netherlands
FAU - Ong, D. S. Y.
AU  - Ong DSY
AD  - University Medical Center Utrecht, Utrecht, Netherlands
FAU - Amoruso, G.
AU  - Amoruso G
AD  - University of Foggia, Foggia, Italy
FAU - Cinnella, G.
AU  - Cinnella G
AD  - University of Foggia, Foggia, Italy
FAU - Schultz, M. J.
AU  - Schultz MJ
AD  - Academic Medical Center, Amsterdam, Netherlands
FAU - Bos, L. D. J.
AU  - Bos LDJ
AD  - Academic Medical Center, Amsterdam, Netherlands
FAU - Huber, W.
AU  - Huber W
AD  - Technische Universität München, II. Medizinische Klinik, Munich, Germany
FAU - Schmidle, P.
AU  - Schmidle P
AD  - Technische Universität München, II. Medizinische Klinik, Munich, Germany
FAU - Findeisen, M.
AU  - Findeisen M
AD  - Städtisches Klinikum München Harlaching, Munich, Germany
FAU - Hoppmann, P.
AU  - Hoppmann P
AD  - Technische Universität München, I. Medizinische Klinik, Munich, Germany
FAU - Jaitner, J.
AU  - Jaitner J
AD  - Technische Universität München, I. Medizinische Klinik, Munich, Germany
FAU - Brettner, F.
AU  - Brettner F
AD  - Krankenhaus Barmherzige Brüder, Munich, Germany
FAU - Schmid, R. M.
AU  - Schmid RM
AD  - Technische Universität München, II. Medizinische Klinik, Munich, Germany
FAU - Lahmer, T.
AU  - Lahmer T
AD  - Technische Universität München, II. Medizinische Klinik, Munich, Germany
CN  - EXODUS-investigators
FAU - Festic, E.
AU  - Festic E
AD  - Mayo Clinic, Jacksonville, FL USA
FAU - Rajagopalan, G.
AU  - Rajagopalan G
AD  - Mayo Clinic, Rochester, NY USA
FAU - Bansal, V.
AU  - Bansal V
AD  - Mayo Clinic, Jacksonville, FL USA
FAU - Frank, R.
AU  - Frank R
AD  - Mayo Clinic, Jacksonville, FL USA
FAU - Hinds, R.
AU  - Hinds R
AD  - Mayo Clinic, Rochester, NY USA
FAU - Levitt, J.
AU  - Levitt J
AD  - Stanford University, Stanford, CA USA
CN  - United States Critical Illness and Injury Trials Group/LIPS-B investigators
FAU - Siddiqui, S.
AU  - Siddiqui S
AD  - Khoo Teck Puat Hospital, Singapore, Singapore
CN  - SICM NICER Group
FAU - Gilbert, J. P.
AU  - Gilbert JP
AD  - Department of Critical Care, Whiston Hospital, Liverpool, UK
FAU - Sim, K.
AU  - Sim K
AD  - Department of Critical Care, Whiston Hospital, Liverpool, UK
FAU - Wang, C. H.
AU  - Wang CH
AD  - Chang Gung University, School of Nursing, College of Medicine, Taoyuan, Taiwan,
      Province of China
FAU - Hu, H. C.
AU  - Hu HC
AD  - Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan,
      Province of China
FAU - Li, I. J.
AU  - Li IJ
AD  - Department of Nursing, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical
      Foundation, New Taipei City, Taiwan, Province of China
FAU - Tang, W. R.
AU  - Tang WR
AD  - Chang Gung University, School of Nursing, College of Medicine, Taoyuan, Taiwan,
      Province of China
FAU - Kao, K. C.
AU  - Kao KC
AD  - Department of Respiratory Therapy, Chang Gung Memorial Hospital, Taoyuan, Taiwan,
      Province of China
FAU - Persona, P.
AU  - Persona P
AD  - Emergency Department, Azienda Ospedaliera di Padova, Padova, Italy
FAU - De Cassai, A.
AU  - De Cassai A
AD  - Medicine Department, University of Padova, Padova, Italy
FAU - Franco, M.
AU  - Franco M
AD  - Medicine Department, University of Padova, Padova, Italy
FAU - Facchin, F.
AU  - Facchin F
AD  - Medicine Department, University of Padova, Padova, Italy
FAU - Ori, C.
AU  - Ori C
AD  - Medicine Department, University of Padova, Padova, Italy
FAU - Rossi, S.
AU  - Rossi S
AD  - Emergency Department, Azienda Ospedaliera di Padova, Padova, Italy
FAU - Goffi, A.
AU  - Goffi A
AD  - Toronto Western Hospital MSNICU, Toronto, Canada
FAU - Li, S. H.
AU  - Li SH
AD  - Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan,
      Province of China
FAU - Hu, H. C.
AU  - Hu HC
AD  - Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan,
      Province of China
FAU - Chiu, L. C.
AU  - Chiu LC
AD  - Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan,
      Province of China
FAU - Hung, C. Y.
AU  - Hung CY
AD  - Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan,
      Province of China
FAU - Chang, C. H.
AU  - Chang CH
AD  - Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan,
      Province of China
FAU - Kao, K. C.
AU  - Kao KC
AD  - Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan,
      Province of China
FAU - Ruiz, B. Llorente
AU  - Ruiz BL
AD  - Hospital Universitario Príncipe de Asturias, Intensive Care Unit, Madrid, Spain
FAU - Varas, J. Lujan
AU  - Varas JL
AD  - Hospital Universitario Príncipe de Asturias, Intensive Care Unit, Madrid, Spain
FAU - Montero, R. Molina
AU  - Montero RM
AD  - Hospital Universitario Príncipe de Asturias, Intensive Care Unit, Madrid, Spain
FAU - Delgado, C. Pintado
AU  - Delgado CP
AD  - Hospital Universitario Príncipe de Asturias, Intensive Care Unit, Madrid, Spain
FAU - Navarrete, O.
AU  - Navarrete O
AD  - Hospital Universitario Príncipe de Asturias, Pneumology, Madrid, Spain
FAU - Mezquita, M. Vazquez
AU  - Mezquita MV
AD  - Hospital Universitario Príncipe de Asturias, Pneumology, Madrid, Spain
FAU - Peces, E. Alonso
AU  - Peces EA
AD  - Hospital Universitario Príncipe de Asturias, Pneumology, Madrid, Spain
FAU - Nakamura, M. A. M.
AU  - Nakamura MAM
AD  - Pulmonology Division, Hospital das Clínicas da Faculdade de Medicina da
      Universidade de São Paulo, Heart Institute, São Paulo, Brazil
FAU - Hajjar, L. A.
AU  - Hajjar LA
AD  - Cardiology Division, Hospital das Clínicas da Faculdade de Medicina da
      Universidade de São Paulo, Heart Institute, São Paulo, Brazil
FAU - Galas, F. R. B. G.
AU  - Galas FRBG
AD  - Anesthesiology Division, Hospital das Clínicas da Faculdade de Medicina da
      Universidade de São Paulo, Heart Institute, São Paulo, Brazil
FAU - Ortiz, T. A.
AU  - Ortiz TA
AD  - Pulmonology Division, Hospital das Clínicas da Faculdade de Medicina da
      Universidade de São Paulo, Heart Institute, São Paulo, Brazil
FAU - Amato, M. B. P.
AU  - Amato MBP
AD  - Pulmonology Division, Hospital das Clínicas da Faculdade de Medicina da
      Universidade de São Paulo, Heart Institute, São Paulo, Brazil
FAU - Bitker, L.
AU  - Bitker L
AD  - Hospices Civils de Lyon, Hôpital de la Croix-Rousse - Service de réanimation
      médicale, Lyon, France
FAU - Costes, N.
AU  - Costes N
AD  - CERMEP, Bron, France
FAU - Le Bars, D.
AU  - Le Bars D
AD  - CERMEP, Bron, France
FAU - Lavenne, F.
AU  - Lavenne F
AD  - CERMEP, Bron, France
FAU - Mojgan, D.
AU  - Mojgan D
AD  - Hospices Civils de Lyon, Hôpital de la Croix-Rousse - Service
      d’anatomopathologie, Lyon, France
FAU - Richard, J. C.
AU  - Richard JC
AD  - Hospices Civils de Lyon, Hôpital de la Croix-Rousse - Service de réanimation
      médicale, Lyon, France
FAU - Chiurazzi, C.
AU  - Chiurazzi C
AD  - Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università
      degli Studi di Milano, Milano, Italy
FAU - Cressoni, M.
AU  - Cressoni M
AD  - Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università
      degli Studi di Milano, Milano, Italy
FAU - Massari, D.
AU  - Massari D
AD  - Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università
      degli Studi di Milano, Milano, Italy
FAU - Guanziroli, M.
AU  - Guanziroli M
AD  - Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università
      degli Studi di Milano, Milano, Italy
FAU - Vergani, G.
AU  - Vergani G
AD  - Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università
      degli Studi di Milano, Milano, Italy
FAU - Gotti, M.
AU  - Gotti M
AD  - Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università
      degli Studi di Milano, Milano, Italy
FAU - Brioni, M.
AU  - Brioni M
AD  - Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università
      degli Studi di Milano, Milano, Italy
FAU - Algieri, I.
AU  - Algieri I
AD  - Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università
      degli Studi di Milano, Milano, Italy
FAU - Cadringher, P.
AU  - Cadringher P
AD  - Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università
      degli Studi di Milano, Milano, Italy
FAU - Tonetti, T.
AU  - Tonetti T
AD  - Georg-August-University Goettingen, Anesthesiology and Intensive Care Medicine,
      Goettingen, Germany
FAU - Chiumello, D.
AU  - Chiumello D
AD  - Dipartimento di Anestesia, Rianimazione, Urgenza ed Emergenza, Policlinico Di
      Milano, Milano, Italy
FAU - Gattinoni, L.
AU  - Gattinoni L
AD  - Georg-August-University Goettingen, Anesthesiology and Intensive Care Medicine,
      Goettingen, Germany
FAU - Zerman, A.
AU  - Zerman A
AD  - Department of Critical Care Medicine, Gazi University Faculty of Medicine,
      Ankara, Turkey
FAU - Türkoğlu, M.
AU  - Türkoğlu M
AD  - Department of Critical Care Medicine, Gazi University Faculty of Medicine,
      Ankara, Turkey
FAU - Arık, G.
AU  - Arık G
AD  - Department of Geriatrics, Gazi University Faculty of Medicine, Ankara, Turkey
FAU - Yıldırım, F.
AU  - Yıldırım F
AD  - Department of Critical Care Medicine, Gazi University Faculty of Medicine,
      Ankara, Turkey
FAU - Güllü, Z.
AU  - Güllü Z
AD  - Department of Critical Care Medicine, Gazi University Faculty of Medicine,
      Ankara, Turkey
FAU - Kara, I.
AU  - Kara I
AD  - Department of Critical Care Medicine, Gazi University Faculty of Medicine,
      Ankara, Turkey
FAU - Boyacı, N.
AU  - Boyacı N
AD  - Department of Critical Care Medicine, Gazi University Faculty of Medicine,
      Ankara, Turkey
FAU - Aydoğan, B. Basarık
AU  - Aydoğan BB
AD  - Department of Critical Care Medicine, Gazi University Faculty of Medicine,
      Ankara, Turkey
FAU - Gaygısız, Ü.
AU  - Gaygısız Ü
AD  - Department of Critical Care Medicine, Gazi University Faculty of Medicine,
      Ankara, Turkey
FAU - Gönderen, K.
AU  - Gönderen K
AD  - Department of Critical Care Medicine, Gazi University Faculty of Medicine,
      Ankara, Turkey
FAU - Aygencel, G.
AU  - Aygencel G
AD  - Department of Critical Care Medicine, Gazi University Faculty of Medicine,
      Ankara, Turkey
FAU - Aydoğdu, M.
AU  - Aydoğdu M
AD  - Department of Critical Care Medicine, Gazi University Faculty of Medicine,
      Ankara, Turkey
FAU - Ülger, Z.
AU  - Ülger Z
AD  - Department of Geriatrics, Gazi University Faculty of Medicine, Ankara, Turkey
FAU - Gürsel, G.
AU  - Gürsel G
AD  - Department of Critical Care Medicine, Gazi University Faculty of Medicine,
      Ankara, Turkey
FAU - Riera, J.
AU  - Riera J
AD  - Critical Care Department, Vall d’Hebron University Hospital, Barcelona, Spain
FAU - Toral, C. Maldonado
AU  - Toral CM
AD  - Critical Care Department, Vall d’Hebron University Hospital, Barcelona, Spain
FAU - Mazo, C.
AU  - Mazo C
AD  - Critical Care Department, Vall d’Hebron University Hospital, Barcelona, Spain
FAU - Martínez, M.
AU  - Martínez M
AD  - Critical Care Department, Vall d’Hebron University Hospital, Barcelona, Spain
FAU - Baldirà, J.
AU  - Baldirà J
AD  - Critical Care Department, Vall d’Hebron University Hospital, Barcelona, Spain
FAU - Lagunes, L.
AU  - Lagunes L
AD  - Critical Care Department, Vall d’Hebron University Hospital, Barcelona, Spain
FAU - Roman, A.
AU  - Roman A
AD  - CIBERES, Instituto de Salud Carlos III, Madrid, Spain
FAU - Deu, M.
AU  - Deu M
AD  - Vall d’Hebrón University Hospital, Thoracic Surgery, Barcelona, Spain
FAU - Rello, J.
AU  - Rello J
AD  - Critical Care Department, Vall d’Hebron University Hospital, Barcelona, Spain
FAU - Levine, D. J.
AU  - Levine DJ
AD  - Department of Medicine, Division of Pulmonary and Critical Care Medicine,
      University of Texas Health Science Center at San Antonio, San Antonio, TX USA
FAU - Mohus, R. M.
AU  - Mohus RM
AD  - Department of Circulation and Medical Imaging, Norwegian University of Science
      and Technology, Trondheim, Norway
FAU - Askim, Å.
AU  - Askim Å
AD  - Department of Circulation and Medical Imaging, Norwegian University of Science
      and Technology, Trondheim, Norway
FAU - Paulsen, J.
AU  - Paulsen J
AD  - Department of Cancer Research and Molecular Medicine, Norwegian University of
      Science and Technology, Centre of Molecular Inflammation Research, Trondheim,
      Norway
FAU - Mehl, A.
AU  - Mehl A
AD  - Department of Cancer Research and Molecular Medicine, Norwegian University of
      Science and Technology, Trondheim, Norway
FAU - Dewan, A. T.
AU  - Dewan AT
AD  - Department of Chronic Disease Epidemiology, Yale University School of Public
      Health, New Haven, CT USA
FAU - Damås, J. K.
AU  - Damås JK
AD  - Department of Circulation and Medical Imaging, Norwegian University of Science
      and Technology, Trondheim, Norway
FAU - Solligård, E.
AU  - Solligård E
AD  - Department of Circulation and Medical Imaging, Norwegian University of Science
      and Technology, Trondheim, Norway
FAU - Åsvold, B. O.
AU  - Åsvold BO
AD  - Department of Public Health and General Practice, Norwegian University of Science
      and Technology, Trondheim, Norway
CN  - Mid-Norway Sepsis Research Center
FAU - Paulsen, J.
AU  - Paulsen J
AD  - Norwegian University of Science and Technology, Centre of Molecular Inflammation 
      Research, Trondheim, Norway
FAU - Askim, Å.
AU  - Askim Å
AD  - Department of Circulation and Medical Imaging, Norwegian University of Science
      and Technology, Trondheim, Norway
FAU - Mohus, R. M.
AU  - Mohus RM
AD  - Department of Circulation and Medical Imaging, Norwegian University of Science
      and Technology, Trondheim, Norway
FAU - Mehl, A.
AU  - Mehl A
AD  - Norwegian University of Science and Technology, Institute of Cancer Research and 
      Molecular Medicine, Trondheim, Norway
FAU - DeWan, A.
AU  - DeWan A
AD  - Yale University School of Public Health, New Haven, CT USA
FAU - Solligård, E.
AU  - Solligård E
AD  - Department of Circulation and Medical Imaging, Norwegian University of Science
      and Technology, Trondheim, Norway
FAU - Damås, J. K.
AU  - Damås JK
AD  - Norwegian University of Science and Technology, Centre of Molecular Inflammation 
      Research, Trondheim, Norway
FAU - Åsvold, B. O.
AU  - Åsvold BO
AD  - Department of Public Health and General Practice, Norwegian University of Science
      and Technology, Trondheim, Norway
FAU - Aktepe, O.
AU  - Aktepe O
AD  - Hacettepe University, Ankara, Turkey
FAU - Kara, A.
AU  - Kara A
AD  - Hacettepe University, Ankara, Turkey
FAU - Yeter, H.
AU  - Yeter H
AD  - Hacettepe University, Ankara, Turkey
FAU - Topeli, A.
AU  - Topeli A
AD  - Hacettepe University, Ankara, Turkey
FAU - Norrenberg, M.
AU  - Norrenberg M
AD  - Erasme, Brussels, Belgium
FAU - Devroey, M.
AU  - Devroey M
AD  - Erasme Hospital, ICU, Brussels, Belgium
FAU - Khader, H.
AU  - Khader H
AD  - Erasme Hospital, ICU, Brussels, Belgium
FAU - Preiser, J. C.
AU  - Preiser JC
AD  - Erasme Hospital, ICU, Brussels, Belgium
FAU - Tang, Z.
AU  - Tang Z
AD  - The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
FAU - Qiu, C.
AU  - Qiu C
AD  - The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
FAU - Tong, L.
AU  - Tong L
AD  - The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
FAU - Cai, C.
AU  - Cai C
AD  - The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
FAU - Theodorakopoulou, M.
AU  - Theodorakopoulou M
AD  - Attikon University Hospital, ICU, Athens, Greece
FAU - Diamantakis, A.
AU  - Diamantakis A
AD  - Attikon University Hospital, ICU, Athens, Greece
FAU - Kontogiorgi, M.
AU  - Kontogiorgi M
AD  - Attikon University Hospital, ICU, Athens, Greece
FAU - Chrysanthopoulou, E.
AU  - Chrysanthopoulou E
AD  - Attikon University Hospital, ICU, Athens, Greece
FAU - Christodoulopoulou, T.
AU  - Christodoulopoulou T
AD  - Attikon University Hospital, ICU, Athens, Greece
FAU - Frantzeskaki, F.
AU  - Frantzeskaki F
AD  - Attikon University Hospital, ICU, Athens, Greece
FAU - Lygnos, M.
AU  - Lygnos M
AD  - Attikon University Hospital, ICU, Athens, Greece
FAU - Apostolopoulou, O.
AU  - Apostolopoulou O
AD  - Attikon University Hospital, ICU, Athens, Greece
FAU - Armaganidis, A.
AU  - Armaganidis A
AD  - Attikon University Hospital, ICU, Athens, Greece
FAU - Moon, J. Y.
AU  - Moon JY
AD  - Department of Internal Medicine, Chungnam National University Hospital, Daejeon, 
      Republic of Korea
FAU - Park, M. R.
AU  - Park MR
AD  - Department of Internal Medicine, Chungnam National University Hospital, Daejeon, 
      Republic of Korea
FAU - Kwon, I. S.
AU  - Kwon IS
AD  - Chungnam National University Hospital, Clinical Trials Center, Daejeon, Republic 
      of Korea
FAU - Chon, G. R.
AU  - Chon GR
AD  - Department of Internal Medicine, Cheongju St. Mary’s Hospital, Cheongju, Republic
      of Korea
FAU - Ahn, J. Y.
AU  - Ahn JY
AD  - Department of Internal Medicine, Chungbuk National University Hospital, Cheongju,
      Republic of Korea
FAU - Kwon, S. J.
AU  - Kwon SJ
AD  - Department of Internal Medicine, Konyang University Hospital, Daejeon, Republic
      of Korea
FAU - Chang, Y. J.
AU  - Chang YJ
AD  - Department of Internal Medicine, Chungbuk National University Hospital, Cheongju,
      Republic of Korea
FAU - Lee, J. Y.
AU  - Lee JY
AD  - Department of Internal Medicine, Konkuk University Chungju Hospital, Chungju,
      Republic of Korea
FAU - Yoon, S. Y.
AU  - Yoon SY
AD  - Department of Internal Medicine, Konkuk University Chungju Hospital, Chungju,
      Republic of Korea
FAU - Lee, J. W.
AU  - Lee JW
AD  - Department of Internal Medicine, Chungnam National University Hospital, Daejeon, 
      Republic of Korea
CN  - The Korean Chungcheong Critical Care Research Group
FAU - Kostalas, M.
AU  - Kostalas M
AD  - Royal Surrey County Hospital, ICU and SPACeR Research Group, Guildford, UK
FAU - Mckinlay, J.
AU  - Mckinlay J
AD  - Royal Surrey County Hospital, ICU and SPACeR Research Group, Guildford, UK
FAU - Kooner, G.
AU  - Kooner G
AD  - Royal Surrey County Hospital, ICU and SPACeR Research Group, Guildford, UK
FAU - Dudas, G.
AU  - Dudas G
AD  - Royal Surrey County Hospital, ICU and SPACeR Research Group, Guildford, UK
FAU - Horton, A.
AU  - Horton A
AD  - Royal Surrey County Hospital, Guildford, UK
FAU - Kerr, C.
AU  - Kerr C
AD  - Royal Surrey County Hospital, Guildford, UK
FAU - Karanjia, N.
AU  - Karanjia N
AD  - University of Surrey, Guildford, UK
FAU - Creagh-Brown, B.
AU  - Creagh-Brown B
AD  - Royal Surrey County Hospital, ICU and SPACeR Research Group, Guildford, UK
FAU - Altintas, N. D.
AU  - Altintas ND
AD  - Department of Internal Medicine, Ankara University Faculty of Medicine, Intensive
      Care, Ankara, Turkey
FAU - Izdes, S.
AU  - Izdes S
AD  - Department of Anesthesiology and Reanimation, Yıldırım Beyazıt University,
      Medical Faculty, Ankara, Turkey
FAU - Keremoglu, O.
AU  - Keremoglu O
AD  - Department of Anesthesiology and Reanimation, Yıldırım Beyazıt University,
      Medical Faculty, Ankara, Turkey
FAU - Alkan, A.
AU  - Alkan A
AD  - Department of Biostatistics and Medical Informatics, Yıldırım Beyazıt University,
      Ankara, Turkey
FAU - Neselioglu, S.
AU  - Neselioglu S
AD  - Department of Biochemistry, Yıldırım Beyazıt University, Medical Faculty, Ankara,
      Turkey
FAU - Erel, O.
AU  - Erel O
AD  - Department of Biochemistry, Yıldırım Beyazıt University, Medical Faculty, Ankara,
      Turkey
FAU - Tardif, N.
AU  - Tardif N
AD  - Karolinska University Hospital / Karolinska Institutet, Stockholm, Sweden
FAU - Gustafsson, T.
AU  - Gustafsson T
AD  - Karolinska University Hospital / Karolinska Institutet, Stockholm, Sweden
FAU - Rooyackers, O.
AU  - Rooyackers O
AD  - Karolinska University Hospital / Karolinska Institutet, Stockholm, Sweden
FAU - MacEachern, K. N.
AU  - MacEachern KN
AD  - Mount Sinai Hospital, Toronto, Canada
FAU - Traille, M.
AU  - Traille M
AD  - Mount Sinai Hospital, Toronto, Canada
FAU - Bromberg, I.
AU  - Bromberg I
AD  - Mount Sinai Hospital, Toronto, Canada
FAU - Lapinsky, S. E.
AU  - Lapinsky SE
AD  - Mount Sinai Hospital, Toronto, Canada
FAU - Moore, M. J.
AU  - Moore MJ
AD  - St Georges NHS Foundation Trust, Critical Care Directorate, London, UK
FAU - Tang, Z.
AU  - Tang Z
AD  - The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
FAU - Cai, C.
AU  - Cai C
AD  - The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
FAU - Tong, L.
AU  - Tong L
AD  - The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
FAU - García-Garmendia, J. L.
AU  - García-Garmendia JL
AD  - Hospital San Juan de Dios del Aljarafe, Intensive Care Unit, Bormujos, Sevilla
      Spain
FAU - Villarrasa-Clemente, F.
AU  - Villarrasa-Clemente F
AD  - Hospital San Juan de Dios del Aljarafe, Intensive Care Unit, Bormujos, Sevilla
      Spain
FAU - Maroto-Monserrat, F.
AU  - Maroto-Monserrat F
AD  - Hospital San Juan de Dios del Aljarafe, Intensive Care Unit, Bormujos, Sevilla
      Spain
FAU - Rufo-Tejeiro, O.
AU  - Rufo-Tejeiro O
AD  - Hospital San Juan de Dios del Aljarafe, Intensive Care Unit, Bormujos, Sevilla
      Spain
FAU - Jorge-Amigo, V.
AU  - Jorge-Amigo V
AD  - Hospital San Juan de Dios del Aljarafe, Intensive Care Unit, Bormujos, Sevilla
      Spain
FAU - Sánchez-Santamaría, M.
AU  - Sánchez-Santamaría M
AD  - Hospital San Juan de Dios del Aljarafe, Intensive Care Unit, Bormujos, Sevilla
      Spain
FAU - Colón-Pallarés, C.
AU  - Colón-Pallarés C
AD  - Hospital San Juan de Dios del Aljarafe, Intensive Care Unit, Bormujos, Sevilla
      Spain
FAU - Barrero-Almodóvar, A.
AU  - Barrero-Almodóvar A
AD  - Hospital San Juan de Dios del Aljarafe, Intensive Care Unit, Bormujos, Sevilla
      Spain
FAU - Gallego-Lara, S.
AU  - Gallego-Lara S
AD  - Hospital San Juan de Dios del Aljarafe, Intensive Care Unit, Bormujos, Sevilla
      Spain
FAU - Anthon, C. T.
AU  - Anthon CT
AD  - Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet,
      Copenhagen, Denmark
FAU - Müller, R. B.
AU  - Müller RB
AD  - Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet,
      Copenhagen, Denmark
FAU - Haase, N.
AU  - Haase N
AD  - Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet,
      Copenhagen, Denmark
FAU - Møller, K.
AU  - Møller K
AD  - Copenhagen University Hospital - Rigshospitalet, Center of Inflammation and
      Metabolism, Copenhagen, Denmark
FAU - Hjortrup, P. B.
AU  - Hjortrup PB
AD  - Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet,
      Copenhagen, Denmark
FAU - Wetterslev, J.
AU  - Wetterslev J
AD  - Copenhagen University Hospital - Rigshospitalet, Centre for Clinical Intervention
      Research - Copenhagen Trial Unit, Copenhagen, Denmark
FAU - Perner, A.
AU  - Perner A
AD  - Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet,
      Copenhagen, Denmark
FAU - Nakanishi, M.
AU  - Nakanishi M
AD  - Department of Emergency Medicine, Kurashiki Central Hospital, Kurashiki, Japan
FAU - Kuriyama, A.
AU  - Kuriyama A
AD  - Department of General Medicine, Kurashiki Central Hospital, Kurashiki, Japan
FAU - Fukuoka, T.
AU  - Fukuoka T
AD  - Department of General Medicine, Kurashiki Central Hospital, Kurashiki, Japan
FAU - Abd el Halim, M. A.
AU  - Abd el Halim MA
AD  - Cairo University/Kasr Alainy Medical School, Anethesia, Cairo, Egypt
FAU - Elsaid hafez, M. H.
AU  - Elsaid hafez MH
AD  - Cairo University/Kasr Alainy Medical School, Anethesia, Cairo, Egypt
FAU - Moktar, A. M.
AU  - Moktar AM
AD  - Cairo University/Kasr Alainy Medical School, Anethesia, Cairo, Egypt
FAU - Eladawy, A.
AU  - Eladawy A
AD  - Cairo University/Kasr Alainy Medical School, Anethesia, Cairo, Egypt
FAU - Elazizy, H. M.
AU  - Elazizy HM
AD  - Cairo University/Kasr Alainy Medical School, Anethesia, Cairo, Egypt
FAU - Hakim, K. Abdel
AU  - Hakim KA
AD  - Intensive Care Department, King Hamad University Hospital, Muharraq, Bahrain
FAU - Chaari, A.
AU  - Chaari A
AD  - Intensive Care Department, King Hamad University Hospital, Muharraq, Bahrain
FAU - Elbahr, M.
AU  - Elbahr M
AD  - Intensive Care Department, King Hamad University Hospital, Muharraq, Bahrain
FAU - Ismail, M.
AU  - Ismail M
AD  - Intensive Care Department, King Hamad University Hospital, Muharraq, Bahrain
FAU - Mahmoud, T.
AU  - Mahmoud T
AD  - Intensive Care Department, King Hamad University Hospital, Muharraq, Bahrain
FAU - Kauts, V.
AU  - Kauts V
AD  - Intensive Care Department, King Hamad University Hospital, Muharraq, Bahrain
FAU - Bousselmi, K.
AU  - Bousselmi K
AD  - Intensive Care Department, King Hamad University Hospital, Muharraq, Bahrain
FAU - Khalil, E.
AU  - Khalil E
AD  - Intensive Care Department, King Hamad University Hospital, Muharraq, Bahrain
FAU - Casey, W.
AU  - Casey W
AD  - Intensive Care Department, King Hamad University Hospital, Muharraq, Bahrain
FAU - Zaky, S. H.
AU  - Zaky SH
AD  - Cairo University, Critical Care, Cairo, Egypt
FAU - Rizk, A.
AU  - Rizk A
AD  - Cairo University, Critical Care, Cairo, Egypt
FAU - Elghonemi, M. O.
AU  - Elghonemi MO
AD  - Cairo University, Critical Care, Cairo, Egypt
FAU - Ahmed, R.
AU  - Ahmed R
AD  - Cairo University, Critical Care, Cairo, Egypt
FAU - Vieira, J. C. F.
AU  - Vieira JCF
AD  - Federal University of São Paulo, Surgery, São Paulo, Brazil
FAU - Souza, R. B.
AU  - Souza RB
AD  - Federal University of São Paulo, Morphology and Genetics, São Paulo, Brazil
FAU - Liberatore, A. M. A.
AU  - Liberatore AMA
AD  - Federal University of São Paulo, Surgery, São Paulo, Brazil
FAU - Koh, I. H. J.
AU  - Koh IHJ
AD  - Federal University of São Paulo, Surgery, São Paulo, Brazil
FAU - Ospina-Tascón, G. A.
AU  - Ospina-Tascón GA
AD  - Department of Intensive Care Medicine, Fundación Valle del Lili - Universidad
      ICESI, Cali, Colombia
FAU - Marin, A. F. Garcia
AU  - Marin AFG
AD  - Department of Intensive Care Medicine, Fundación Valle del Lili - Universidad
      ICESI, Cali, Colombia
FAU - Echeverry, G. J.
AU  - Echeverry GJ
AD  - Department of Intensive Care Medicine, Fundación Valle del Lili - Universidad
      ICESI, Cali, Colombia
FAU - Bermudez, W. F.
AU  - Bermudez WF
AD  - Department of Intensive Care Medicine, Fundación Valle del Lili - Universidad
      ICESI, Cali, Colombia
FAU - Madriñan-Navia, H. J.
AU  - Madriñan-Navia HJ
AD  - Department of Intensive Care Medicine, Fundación Valle del Lili - Universidad
      ICESI, Cali, Colombia
FAU - Valencia, J. D.
AU  - Valencia JD
AD  - Department of Intensive Care Medicine, Fundación Valle del Lili - Universidad
      ICESI, Cali, Colombia
FAU - Quiñonez, E.
AU  - Quiñonez E
AD  - Department of Intensive Care Medicine, Fundación Valle del Lili - Universidad
      ICESI, Cali, Colombia
FAU - Marulanda, A.
AU  - Marulanda A
AD  - Department of Intensive Care Medicine, Fundación Valle del Lili - Universidad
      ICESI, Cali, Colombia
FAU - Arango-Dávila, C. A.
AU  - Arango-Dávila CA
AD  - Department of Intensive Care Medicine, Fundación Valle del Lili - Universidad
      ICESI, Cali, Colombia
FAU - Bruhn, A.
AU  - Bruhn A
AD  - Departamento de Medicina Intensiva, Pontificia Universidad Católica de Chile,
      Facultad de Medicina, Santiago, Chile
FAU - Hernandez, G.
AU  - Hernandez G
AD  - Departamento de Medicina Intensiva, Pontificia Universidad Católica de Chile,
      Facultad de Medicina, Santiago, Chile
FAU - De Backer, D.
AU  - De Backer D
AD  - Department of Intensive Care Medicine, CHIREC Hospitals, Université Libre de
      Bruxelles (ULB), Brussels, Belgium
FAU - Cortes, D. Orbegozo
AU  - Cortes DO
AD  - Erasme University Hospital, Université Libre de Bruxelles, Intensive Care,
      Brussels, Belgium
FAU - Su, F.
AU  - Su F
AD  - Erasme University Hospital, Université Libre de Bruxelles, Intensive Care,
      Brussels, Belgium
FAU - Vincent, J. L.
AU  - Vincent JL
AD  - Erasme University Hospital, Université Libre de Bruxelles, Intensive Care,
      Brussels, Belgium
FAU - Creteur, J.
AU  - Creteur J
AD  - Erasme University Hospital, Université Libre de Bruxelles, Intensive Care,
      Brussels, Belgium
FAU - Tullo, L.
AU  - Tullo L
AD  - University of Foggia, Anaesthesia and Intensive Care, Foggia, Italy
FAU - Mirabella, L.
AU  - Mirabella L
AD  - University of Foggia, Anaesthesia and Intensive Care, Foggia, Italy
FAU - Di Molfetta, P.
AU  - Di Molfetta P
AD  - University of Foggia, Anaesthesia and Intensive Care, Foggia, Italy
FAU - Cinnella, G.
AU  - Cinnella G
AD  - University of Foggia, Anaesthesia and Intensive Care, Foggia, Italy
FAU - Dambrosio, M.
AU  - Dambrosio M
AD  - University of Foggia, Anaesthesia and Intensive Care, Foggia, Italy
FAU - Lujan, C. Villavicencio
AU  - Lujan CV
AD  - Joan XXIII University Hospital, Tarragona, Spain
FAU - irigoyen, J. Leache
AU  - irigoyen JL
AD  - Joan XXIII University Hospital, Tarragona, Spain
FAU - Cartanya ferré, M.
AU  - Cartanya ferré M
AD  - Joan XXIII University Hospital, Tarragona, Spain
FAU - García, R. Carbonell
AU  - García RC
AD  - Joan XXIII University Hospital, Tarragona, Spain
FAU - Mukhtar, A.
AU  - Mukhtar A
AD  - Cairo University, Cairo, Egypt
FAU - Ahmed, M.
AU  - Ahmed M
AD  - Cairo University, Cairo, Egypt
FAU - El Ayashi, M.
AU  - El Ayashi M
AD  - Cairo University Medical School, Cairo, Egypt
FAU - Hasanin, A.
AU  - Hasanin A
AD  - Cairo University, Cairo, Egypt
FAU - Ayman, E.
AU  - Ayman E
AD  - Cairo University, Cairo, Egypt
FAU - Salem, M.
AU  - Salem M
AD  - Cairo University, Cairo, Egypt
FAU - Eladawy, A.
AU  - Eladawy A
AD  - Cairo University, Cairo, Egypt
FAU - Fathy, S.
AU  - Fathy S
AD  - Cairo University, Cairo, Egypt
FAU - Nassar, H.
AU  - Nassar H
AD  - Cairo University, Cairo, Egypt
FAU - Zaghlol, A.
AU  - Zaghlol A
AD  - Cairo University, Cairo, Egypt
FAU - Arzapalo, M. F. Aguilar
AU  - Arzapalo MFA
AD  - SSA UADY, Mérida, Mexico
FAU - Valsø, Å.
AU  - Valsø Å
AD  - Division on Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway
FAU - Sunde, K.
AU  - Sunde K
AD  - Division on Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway
FAU - Rustøen, T.
AU  - Rustøen T
AD  - Division on Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway
FAU - Schou-Bredal, I.
AU  - Schou-Bredal I
AD  - Divison of Cancer, Oslo University Hospital, Oslo, Norway
FAU - Skogstad, L.
AU  - Skogstad L
AD  - Division of Medicine, Oslo University Hospital, Oslo, Norway
FAU - Tøien, K.
AU  - Tøien K
AD  - Division on Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway
FAU - Padilla, C.
AU  - Padilla C
AD  - Hospital Clinico UC - CHRISTUS, Unidad de Paciente Critico, Santiago, Chile
FAU - Palmeiro, Y.
AU  - Palmeiro Y
AD  - Universidad de los Andes, Santiago, Chile
FAU - Egbaria, W.
AU  - Egbaria W
AD  - Tal Hashomer Hospital, General ICU, Umm el Fahem, Israel
FAU - Kigli, R.
AU  - Kigli R
AD  - Tel Aviv University, Ramat Gan, Israel
FAU - Maertens, B.
AU  - Maertens B
AD  - Ghent University, Faculty of Medicine and Health Sciences, Ghent, Belgium
FAU - Blot, K.
AU  - Blot K
AD  - Ghent University, Faculty of Medicine and Health Sciences, Ghent, Belgium
FAU - Blot, S.
AU  - Blot S
AD  - Department of Internal Medicine, Ghent University, Ghent, Belgium
FAU - Santana-Santos, E.
AU  - Santana-Santos E
AD  - Heart Institute (InCor) do Hospital das Clínicas da Faculdades de Medicina da
      Universidade de São Paulo, Nursing Coordination, São Paulo, Brazil
FAU - dos Santos, E. R.
AU  - dos Santos ER
AD  - Instituto Israelita de Ensino e Pesquisa Albert Einstein, School of Nursing, São 
      Paulo, Brazil
FAU - Ferretti-Rebustini, R. E. D. L.
AU  - Ferretti-Rebustini REDL
AD  - Nursing School of University of São Paulo, São Paulo, Brazil
FAU - dos Santos, R. D. C. C. D. O.
AU  - dos Santos RDCCDO
AD  - Heart Institute (InCor) do Hospital das Clínicas da Faculdades de Medicina da
      Universidade de São Paulo, Nursing Coordination, São Paulo, Brazil
FAU - Verardino, R. G. S.
AU  - Verardino RGS
AD  - Heart Institute (InCor) do Hospital das Clínicas da Faculdades de Medicina da
      Universidade de São Paulo, Nursing Coordination, São Paulo, Brazil
FAU - Bortolotto, L. A.
AU  - Bortolotto LA
AD  - Hypertension Department, Heart Institute (InCor) do Hospital das Clínicas da
      Faculdades de Medicina da Universidade de São Paulo, São Paulo, Brazil
FAU - Doyle, A. M.
AU  - Doyle AM
AD  - The Royal Brompton and Harefield NHS Foundation Trust, Critical Care, London, UK
FAU - Naldrett, I.
AU  - Naldrett I
AD  - The Royal Brompton and Harefield NHS Foundation Trust, Critical Care, London, UK
FAU - Tillman, J.
AU  - Tillman J
AD  - The Royal Brompton and Harefield NHS Foundation Trust, Critical Care, London, UK
FAU - Price, S.
AU  - Price S
AD  - The Royal Brompton and Harefield NHS Foundation Trust, Critical Care, London, UK
FAU - Shrestha, S.
AU  - Shrestha S
AD  - Frimley Health NHS Foundation Trust, ICU, Frimley, UK
FAU - Pearson, P.
AU  - Pearson P
AD  - The Royal College of Nursing Critical Care and Inflight Nursing Forum, London, UK
FAU - Greaves, J.
AU  - Greaves J
AD  - Northumbria University, Newcastle, UK
FAU - Goodall, D.
AU  - Goodall D
AD  - Northumbria University, Newcastle, UK
FAU - Berry, A.
AU  - Berry A
AD  - UKCCNA, Manchester, UK
FAU - Richardson, A.
AU  - Richardson A
AD  - BACCN, Newcastle, UK
FAU - Odundo, G. O.
AU  - Odundo GO
AD  - Gertrude’s Children’s Hospital, Nairobi, Kenya
FAU - Omengo, P.
AU  - Omengo P
AD  - Gertrude’s Children’s Hospital, Nairobi, Kenya
FAU - Obonyo, P.
AU  - Obonyo P
AD  - Gertrude’s Children’s Hospital, Nairobi, Kenya
FAU - Chanzu, N. M.
AU  - Chanzu NM
AD  - Gertrude’s Children’s Hospital, Nairobi, Kenya
FAU - Kleinpell, R.
AU  - Kleinpell R
AD  - Rush University Medical Center, Chicago, USA
FAU - Sarris, S. J.
AU  - Sarris SJ
AD  - Rush University Medical Center, Chicago, USA
FAU - Nedved, P.
AU  - Nedved P
AD  - Rush University Medical Center, Chicago, USA
FAU - Heitschmidt, M.
AU  - Heitschmidt M
AD  - Rush University Medical Center, Chicago, USA
FAU - Ben-Ghezala, H.
AU  - Ben-Ghezala H
AD  - Teaching Department of Emergency and Critical Care Medicine, University of Tunis 
      El Manar, Zaghouan, Tunisia
FAU - Snouda, S.
AU  - Snouda S
AD  - Teaching Department of Emergency and Critical Care Medicine, University of Tunis 
      El Manar, Zaghouan, Tunisia
FAU - Djobbi, S.
AU  - Djobbi S
AD  - Teaching Department of Emergency and Critical Care Medicine, University of Tunis 
      El Manar, Zaghouan, Tunisia
FAU - Ben-Ghezala, H.
AU  - Ben-Ghezala H
AD  - Teaching Department of Emergency and Critical Care Medicine, University of Tunis 
      El Manar, Zaghouan, Tunisia
FAU - Snouda, S.
AU  - Snouda S
AD  - Teaching Department of Emergency and Critical Care Medicine, University of Tunis 
      El Manar, Zaghouan, Tunisia
FAU - Rose, L.
AU  - Rose L
AD  - University of Toronto, Toronto, Canada
FAU - Adhikari, N. K. J.
AU  - Adhikari NKJ
AD  - Sunnybrook Health Sciences Centre, Toronto, Canada
FAU - Leasa, D.
AU  - Leasa D
AD  - London Health Sciences Centre, London, Canada
FAU - Fergusson, D.
AU  - Fergusson D
AD  - Ottawa Hospital Research Institute, Ottawa, Canada
FAU - Mckim, D. A.
AU  - Mckim DA
AD  - Ottawa Hospital, Ottawa, Canada
FAU - Weblin, J.
AU  - Weblin J
AD  - University Hospitals Birmingham NHS Foundation Trust, Physiotherapy, Birmingham, 
      UK
FAU - Tucker, O.
AU  - Tucker O
AD  - University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
FAU - McWilliams, D.
AU  - McWilliams D
AD  - University Hospitals Birmingham NHS Foundation Trust, Physiotherapy, Birmingham, 
      UK
FAU - Doesburg, F.
AU  - Doesburg F
AD  - Department of Critical Care, University Medical Center Groningen, Groningen,
      Netherlands
FAU - Cnossen, F.
AU  - Cnossen F
AD  - University of Groningen, Artificial Intelligence, Groningen, Netherlands
FAU - Dieperink, W.
AU  - Dieperink W
AD  - Department of Critical Care, University Medical Center Groningen, Groningen,
      Netherlands
FAU - Bult, W.
AU  - Bult W
AD  - University Medical Center Groningen, Hospital Pharmacy, Groningen, Netherlands
FAU - Nijsten, M. W. N.
AU  - Nijsten MWN
AD  - Department of Critical Care, University Medical Center Groningen, Groningen,
      Netherlands
FAU - Galvez-Blanco, G. A.
AU  - Galvez-Blanco GA
AD  - ABC Medical Center, Intensive Care Unit, Mexico City, Mexico
FAU - Zepeda, E. Monares
AU  - Zepeda EM
AD  - ABC Medical Center, Intensive Care Unit, Mexico City, Mexico
FAU - Guzman, C. I. Olvera
AU  - Guzman CIO
AD  - ABC Medical Center, Intensive Care Unit, Mexico City, Mexico
FAU - Sánchez, J. S. Aguirre
AU  - Sánchez JSA
AD  - ABC Medical Center, Intensive Care Unit, Mexico City, Mexico
FAU - Granillo, J. Franco
AU  - Granillo JF
AD  - ABC Medical Center, Intensive Care Unit, Mexico City, Mexico
FAU - Stroud, J. Santos
AU  - Stroud JS
AD  - St Georges NHS Foundation Trust, Cardiothoracic Intensive Care, London, UK
FAU - Thomson, R.
AU  - Thomson R
AD  - St Georges NHS Trust, London, UK
FAU - Llaurado-Serra, M.
AU  - Llaurado-Serra M
AD  - Nursing Department, Rovira i Virgili University, Tarragona, Spain
FAU - Lobo-Civico, A.
AU  - Lobo-Civico A
AD  - Dr Josep Trueta University Hospital, Intensive Care Unit, Girona, Spain
FAU - Pi-Guerrero, M.
AU  - Pi-Guerrero M
AD  - Hospital de Sant Joan Despí Moissès Broggi, Intensive Care Unit, Barcelona, Spain
FAU - Blanco-Sanchez, I.
AU  - Blanco-Sanchez I
AD  - Quiron Salud-Hospital General de Catalunya, Intensive Care Unit, Barcelona, Spain
FAU - Piñol-Tena, A.
AU  - Piñol-Tena A
AD  - Verge de la Cinta University Hospital, Intensive Care Unit, Tortosa, Spain
FAU - Paños-Espinosa, C.
AU  - Paños-Espinosa C
AD  - Sant Pau I Santa Tecla University Hospital, Intensive Care Unit, Tarragona, Spain
FAU - Alabart-Segura, Y.
AU  - Alabart-Segura Y
AD  - Joan XXIII University Hospital, Intensive Care Unit, Tarragona, Spain
FAU - Coloma-Gomez, B.
AU  - Coloma-Gomez B
AD  - Joan XXIII University Hospital, Intensive Care Unit, Tarragona, Spain
FAU - Fernandez-Blanco, A.
AU  - Fernandez-Blanco A
AD  - Dr Josep Trueta University Hospital, Intensive Care Unit, Girona, Spain
FAU - Braga-Dias, F.
AU  - Braga-Dias F
AD  - Quiron Salud-Hospital General de Catalunya, Intensive Care Unit, Barcelona, Spain
FAU - Treso-Geira, M.
AU  - Treso-Geira M
AD  - Verge de la Cinta University Hospital, Intensive Care Unit, Tarragona, Spain
FAU - Valeiras-Valero, A.
AU  - Valeiras-Valero A
AD  - Hospital de Sant Joan Despí Moissès Broggi, Intensive Care Unit, Barcelona, Spain
FAU - Martinez-Reyes, L.
AU  - Martinez-Reyes L
AD  - Sant Pau I Santa Tecla University Hospital, Intensive Care Unit, Tarragona, Spain
FAU - Sandiumenge, A.
AU  - Sandiumenge A
AD  - Vall d’Hebrón University Hospital, Barcelona, Spain
FAU - Jimenez-Herrera, M. F.
AU  - Jimenez-Herrera MF
AD  - Nursing Department, Rovira i Virgili University, Tarragona, Spain
CN  - CAPCRI Study
FAU - Prada, R.
AU  - Prada R
AD  - Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas de Gran Canaria,
      Spain
FAU - Juárez, P.
AU  - Juárez P
AD  - Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas de Gran Canaria,
      Spain
FAU - Argandoña, R.
AU  - Argandoña R
AD  - Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas de Gran Canaria,
      Spain
FAU - Díaz, J. J.
AU  - Díaz JJ
AD  - Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas de Gran Canaria,
      Spain
FAU - Ramirez, C. Sánchez
AU  - Ramirez CS
AD  - Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas de Gran Canaria,
      Spain
FAU - Saavedra, P.
AU  - Saavedra P
AD  - Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
FAU - Santana, S. Ruiz
AU  - Santana SR
AD  - Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas de Gran Canaria,
      Spain
FAU - Obukhova, O.
AU  - Obukhova O
AD  - N.N. Blokhin Russian Cancer Research Center, Medical ICU, Moscow, Russian
      Federation
FAU - Kashiya, S.
AU  - Kashiya S
AD  - N.N. Blokhin Russian Cancer Research Center, Medical ICU, Moscow, Russian
      Federation
FAU - Kurmukov, I. A.
AU  - Kurmukov IA
AD  - N.N. Blokhin Russian Cancer Research Center, Medical ICU, Moscow, Russian
      Federation
FAU - Pronina, A. M.
AU  - Pronina AM
AD  - N.N. Blokhin Russian Cancer Research Center, Medical ICU, Moscow, Russian
      Federation
FAU - Simeone, P.
AU  - Simeone P
AD  - Department of Anaesthesiology and Critical Care Medicine, Aix Marseille
      University, CHU Timone, Marseille, France
FAU - Puybasset, L.
AU  - Puybasset L
AD  - CHU Pitié-Salpêtrière, Neurosurgical Intensive Care Unit, Paris, France
FAU - Auzias, G.
AU  - Auzias G
AD  - Aix-Marseille University / CNRS, Institut des Neurosciences de la Timone,
      UMR7289, Marseille, France
FAU - Coulon, O.
AU  - Coulon O
AD  - Aix-Marseille University / CNRS, Institut des Neurosciences de la Timone,
      UMR7289, Marseille, France
FAU - Lesimple, B.
AU  - Lesimple B
AD  - CHU Pitié-Salpêtrière, Neurosurgical Intensive Care Unit, Paris, France
FAU - Torkomian, G.
AU  - Torkomian G
AD  - CHU Pitié-Salpêtrière, Neurosurgical Intensive Care Unit, Paris, France
FAU - Velly, L.
AU  - Velly L
AD  - Department of Anaesthesiology and Critical Care Medicine, Aix Marseille
      University, CHU Timone, Marseille, France
FAU - Bienert, A.
AU  - Bienert A
AD  - Poznan Unversity of Medical Sciences, Poznan, Poland
FAU - Bartkowska-Sniatkowska, A.
AU  - Bartkowska-Sniatkowska A
AD  - Poznan Unversity of Medical Sciences, Poznan, Poland
FAU - Wiczling, P.
AU  - Wiczling P
AD  - Medical University of Gdansk, Gdansk, Poland
FAU - Szerkus, O.
AU  - Szerkus O
AD  - Medical University of Gdansk, Gdansk, Poland
FAU - Siluk, D.
AU  - Siluk D
AD  - Medical University of Gdansk, Gdansk, Poland
FAU - Bartkowiak-Wieczorek, J.
AU  - Bartkowiak-Wieczorek J
AD  - Poznan Unversity of Medical Sciences, Poznan, Poland
FAU - Rosada-Kurasinska, J.
AU  - Rosada-Kurasinska J
AD  - Poznan Unversity of Medical Sciences, Poznan, Poland
FAU - Warzybok, J.
AU  - Warzybok J
AD  - Poznan Unversity of Medical Sciences, Poznan, Poland
FAU - Borsuk, A.
AU  - Borsuk A
AD  - Medical University of Gdansk, Gdansk, Poland
FAU - Kaliszan, R.
AU  - Kaliszan R
AD  - Medical University of Gdansk, Gdansk, Poland
FAU - Grzeskowiak, E.
AU  - Grzeskowiak E
AD  - Poznan Unversity of Medical Sciences, Poznan, Poland
FAU - Caballero, C. Hernandez
AU  - Caballero CH
AD  - Royal Brompton and Harefield NHS Foundation Trust, London, UK
FAU - Roberts, S.
AU  - Roberts S
AD  - Royal Brompton and Harefield NHS Foundation Trust, London, UK
FAU - Isgro, G.
AU  - Isgro G
AD  - Royal Brompton and Harefield NHS Foundation Trust, London, UK
FAU - Hall, D.
AU  - Hall D
AD  - Royal Brompton and Harefield NHS Foundation Trust, London, UK
FAU - Guillaume, G.
AU  - Guillaume G
AD  - Cochin Hospital, Medical Intensive Care Unit, Paris, France
FAU - Passouant, O.
AU  - Passouant O
AD  - Cochin Hospital, Medical Intensive Care Unit, Paris, France
FAU - Dumas, F.
AU  - Dumas F
AD  - Paris Descartes University, Paris, France
FAU - Bougouin, W.
AU  - Bougouin W
AD  - Cochin Hospital, Medical Intensive Care Unit, Paris, France
FAU - Champigneulle, B.
AU  - Champigneulle B
AD  - Cochin Hospital, Medical Intensive Care Unit, Paris, France
FAU - Arnaout, M.
AU  - Arnaout M
AD  - Cochin Hospital, Medical Intensive Care Unit, Paris, France
FAU - Chelly, J.
AU  - Chelly J
AD  - Intensive Care Unit of Melun Hospital, Melun, France
FAU - Chiche, J. D.
AU  - Chiche JD
AD  - Cochin Hospital, Medical Intensive Care Unit, Paris, France
FAU - Varenne, O.
AU  - Varenne O
AD  - Paris Descartes University, Paris, France
FAU - Mira, J. P.
AU  - Mira JP
AD  - Cochin Hospital, Medical Intensive Care Unit, Paris, France
FAU - Marijon, E.
AU  - Marijon E
AD  - Paris Descartes University, Paris, France
FAU - Cariou, A.
AU  - Cariou A
AD  - Cochin Hospital, Medical Intensive Care Unit, Paris, France
FAU - Beerepoot, M.
AU  - Beerepoot M
AD  - VU University Medical Center Amsterdam, Intensive Care, Amsterdam, Netherlands
FAU - Touw, H. R.
AU  - Touw HR
AD  - VU University Medical Center Amsterdam, Amsterdam, Netherlands
FAU - Parlevliet, K.
AU  - Parlevliet K
AD  - VU University Medical Center Amsterdam, Amsterdam, Netherlands
FAU - Boer, C.
AU  - Boer C
AD  - VU University Medical Center Amsterdam, Amsterdam, Netherlands
FAU - Elbers, P. W.
AU  - Elbers PW
AD  - VU University Medical Center Amsterdam, Amsterdam, Netherlands
FAU - Tuinman, P. R.
AU  - Tuinman PR
AD  - VU University Medical Center Amsterdam, Amsterdam, Netherlands
FAU - Reina, Á. J. Roldán
AU  - Reina ÁJR
AD  - Hospital Universitario Virgen del Rocío, Sevilla, Spain
FAU - Palomo, Y. Corcia
AU  - Palomo YC
AD  - Hospital Universitario Virgen del Rocío, Sevilla, Spain
FAU - Bermúdez, R. Martín
AU  - Bermúdez RM
AD  - Hospital Universitario Virgen del Rocío, Sevilla, Spain
FAU - Villén, L. Martín
AU  - Villén LM
AD  - Hospital Universitario Virgen del Rocío, Sevilla, Spain
FAU - García, I. Palacios
AU  - García IP
AD  - Hospital Universitario Virgen del Rocío, Sevilla, Spain
FAU - Izurieta, J. R. Naranjo
AU  - Izurieta JRN
AD  - Hospital Universitario Virgen del Rocío, Sevilla, Spain
FAU - Bernal, J. B. Pérez
AU  - Bernal JBP
AD  - Hospital Universitario Virgen del Rocío, Sevilla, Spain
FAU - Jiménez, F. J. Jiménez
AU  - Jiménez FJJ
AD  - Hospital Universitario Virgen del Rocío, Sevilla, Spain
CN  - Cardiac Arrest Group HUVR
FAU - Cota-Delgado, F.
AU  - Cota-Delgado F
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - de la Torre-Prados, M. V.
AU  - de la Torre-Prados MV
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Fernández-Porcel, A.
AU  - Fernández-Porcel A
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Nuevo-Ortega, P.
AU  - Nuevo-Ortega P
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Cámara-Sola, E.
AU  - Cámara-Sola E
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Tsvetanova-Spasova, T.
AU  - Tsvetanova-Spasova T
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Rueda-Molina, C.
AU  - Rueda-Molina C
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Salido-Díaz, L.
AU  - Salido-Díaz L
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - García-Alcántara, A.
AU  - García-Alcántara A
AD  - Department of Intensive Care Unit, University Hospital Virgen de la Victoria /
      IBIMA, Málaga, Spain
FAU - Kaneko, T.
AU  - Kaneko T
AD  - Emergency and General Medicine, Kumamoto University Hospital, Kumamoto, Japan
FAU - Tanaka, H.
AU  - Tanaka H
AD  - Emergency and General Medicine, Kumamoto University Hospital, Kumamoto, Japan
FAU - Kamikawa, M.
AU  - Kamikawa M
AD  - Emergency and General Medicine, Kumamoto University Hospital, Kumamoto, Japan
FAU - Karashima, R.
AU  - Karashima R
AD  - Emergency and General Medicine, Kumamoto University Hospital, Kumamoto, Japan
FAU - Iwashita, S.
AU  - Iwashita S
AD  - Emergency and General Medicine, Kumamoto University Hospital, Kumamoto, Japan
FAU - Irie, H.
AU  - Irie H
AD  - Emergency and General Medicine, Kumamoto University Hospital, Kumamoto, Japan
FAU - Kasaoka, S.
AU  - Kasaoka S
AD  - Emergency and General Medicine, Kumamoto University Hospital, Kumamoto, Japan
FAU - Arola, O.
AU  - Arola O
AD  - Division of Perioperative Services, Intensive Care Medicine and Pain Management, 
      Turku University, Turku University Hospital, Turku, Finland
FAU - Laitio, R.
AU  - Laitio R
AD  - Division of Perioperative Services, Intensive Care Medicine and Pain Management, 
      Turku University, Turku University Hospital, Turku, Finland
FAU - Saraste, A.
AU  - Saraste A
AD  - Turku University, Turku University Hospital, Heart Center, Turku, Finland
FAU - Airaksinen, J.
AU  - Airaksinen J
AD  - Turku University, Turku University Hospital, Heart Center, Turku, Finland
FAU - Pietilä, M.
AU  - Pietilä M
AD  - Turku University, Turku University Hospital, Heart Center, Turku, Finland
FAU - Hynninen, M.
AU  - Hynninen M
AD  - Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive
      Care and Pain Medicine, Helsinki University, Helsinki University Hospital,
      Helsinki, Finland
FAU - Wennervirta, J.
AU  - Wennervirta J
AD  - Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive
      Care and Pain Medicine, Helsinki University, Helsinki University Hospital,
      Helsinki, Finland
FAU - Bäcklund, M.
AU  - Bäcklund M
AD  - Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive
      Care and Pain Medicine, Helsinki University, Helsinki University Hospital,
      Helsinki, Finland
FAU - Ylikoski, E.
AU  - Ylikoski E
AD  - Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive
      Care and Pain Medicine, Helsinki University, Helsinki University Hospital,
      Helsinki, Finland
FAU - Silvasti, P.
AU  - Silvasti P
AD  - Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive
      Care and Pain Medicine, Helsinki University, Helsinki University Hospital,
      Helsinki, Finland
FAU - Nukarinen, E.
AU  - Nukarinen E
AD  - Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive
      Care and Pain Medicine, Helsinki University, Helsinki University Hospital,
      Helsinki, Finland
FAU - Grönlund, J.
AU  - Grönlund J
AD  - Division of Perioperative Services, Intensive Care Medicine and Pain Management, 
      Turku University, Turku University Hospital, Turku, Finland
FAU - Harjola, V. P.
AU  - Harjola VP
AD  - Department of Emergency Medicine and Services, Helsinki University, Helsinki
      University Hospital, Helsinki, Finland
FAU - Niiranen, J.
AU  - Niiranen J
AD  - Department of Cardiology, Helsinki University, Helsinki University Hospital,
      Helsinki, Finland
FAU - Korpi, K.
AU  - Korpi K
AD  - Department of Cardiology, Helsinki University, Helsinki University Hospital,
      Helsinki, Finland
FAU - Varpula, M.
AU  - Varpula M
AD  - Department of Cardiology, Helsinki University, Helsinki University Hospital,
      Helsinki, Finland
FAU - Roine, R. O.
AU  - Roine RO
AD  - Division of Clinical Neurosciences, Turku University, Turku University Hospital, 
      Turku, Finland
FAU - Laitio, T.
AU  - Laitio T
AD  - Division of Perioperative Services, Intensive Care Medicine and Pain Management, 
      Turku University, Turku University Hospital, Turku, Finland
CN  - for the Xe-HYPOTHECA study group
FAU - Salah, S.
AU  - Salah S
AD  - Regional Hospital of Zaghouan, Zaghouan, Tunisia
FAU - Hassen, B. G.
AU  - Hassen BG
AD  - Regional Hospital of Zaghouan, Zaghouan, Tunisia
FAU - Fehmi, A. Mohamed
AU  - Fehmi AM
AD  - Regional Hospital of Zaghouan, Zaghouan, Tunisia
FAU - Kim, S.
AU  - Kim S
AD  - Catholic University of Korea, Seoul, Republic of Korea
FAU - Hsu, Y. C.
AU  - Hsu YC
AD  - National Taiwan University Hospital, Anesthesiology, Taipei, Taiwan, Province of 
      China
FAU - Barea-Mendoza, J.
AU  - Barea-Mendoza J
AD  - Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain
FAU - García-Fuentes, C.
AU  - García-Fuentes C
AD  - Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain
FAU - Castillo-Jaramillo, M.
AU  - Castillo-Jaramillo M
AD  - Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain
FAU - Dominguez-Aguado, H.
AU  - Dominguez-Aguado H
AD  - Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain
FAU - Viejo-Moreno, R.
AU  - Viejo-Moreno R
AD  - Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain
FAU - Terceros-Almanza, L.
AU  - Terceros-Almanza L
AD  - Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain
FAU - Aznárez, S. Bermejo
AU  - Aznárez SB
AD  - Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain
FAU - Mudarra-Reche, C.
AU  - Mudarra-Reche C
AD  - Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain
FAU - Xu, W.
AU  - Xu W
AD  - Bethesda, Maryland USA
FAU - Chico-Fernández, M.
AU  - Chico-Fernández M
AD  - Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain
FAU - Montejo-González, J. C.
AU  - Montejo-González JC
AD  - Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain
FAU - Crewdson, K.
AU  - Crewdson K
AD  - North Bristol NHS Trust, Anaesthetics and Intensive Care Medicine, Bristol, UK
FAU - Thomas, M.
AU  - Thomas M
AD  - North Bristol NHS Trust, Anaesthetics and Intensive Care Medicine, Bristol, UK
FAU - Merghani, M.
AU  - Merghani M
AD  - North Bristol NHS Trust, Anaesthetics and Intensive Care Medicine, Bristol, UK
FAU - Fenner, L.
AU  - Fenner L
AD  - North Bristol NHS Trust, Anaesthetics and Intensive Care Medicine, Bristol, UK
FAU - Morgan, P.
AU  - Morgan P
AD  - North Bristol NHS Trust, Anaesthetics and Intensive Care Medicine, Bristol, UK
FAU - Lockey, D.
AU  - Lockey D
AD  - North Bristol NHS Trust, Anaesthetics and Intensive Care Medicine, Bristol, UK
FAU - van Lieshout, E. J.
AU  - van Lieshout EJ
AD  - Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam,
      Netherlands
FAU - Oomen, B.
AU  - Oomen B
AD  - Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam,
      Netherlands
FAU - Binnekade, J. M.
AU  - Binnekade JM
AD  - Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam,
      Netherlands
FAU - Dongelmans, D. A.
AU  - Dongelmans DA
AD  - Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam,
      Netherlands
FAU - de Haan, R. J.
AU  - de Haan RJ
AD  - Academic Medical Center, University of Amsterdam, Clinical Research Unit,
      Amsterdam, Netherlands
FAU - Juffermans, N. P.
AU  - Juffermans NP
AD  - Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam,
      Netherlands
FAU - Vroom, M. B.
AU  - Vroom MB
AD  - Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam,
      Netherlands
FAU - Algarte, R.
AU  - Algarte R
AD  - Critical Care Department, Hospital Universitari Mutua Terrassa, Terrassa, Spain
FAU - Martínez, L.
AU  - Martínez L
AD  - Critical Care Department, Hospital Universitari Mutua Terrassa, Terrassa, Spain
FAU - Sánchez, B.
AU  - Sánchez B
AD  - Critical Care Department, Hospital Universitari Mutua Terrassa, Terrassa, Spain
FAU - Romero, I.
AU  - Romero I
AD  - Hospital Universitari Mutua Terrassa, Terrassa, Spain
FAU - Martínez, F.
AU  - Martínez F
AD  - Critical Care Department, Hospital Universitari Mutua Terrassa, Terrassa, Spain
FAU - Quintana, S.
AU  - Quintana S
AD  - Critical Care Department, Hospital Universitari Mutua Terrassa, Terrassa, Spain
FAU - Trenado, J.
AU  - Trenado J
AD  - Critical Care Department, Hospital Universitari Mutua Terrassa, Terrassa, Spain
FAU - Sheikh, O.
AU  - Sheikh O
AD  - Queen Alexandra Hospital, Critical Care, Portsmouth, UK
FAU - Pogson, D.
AU  - Pogson D
AD  - Queen Alexandra Hospital, Critical Care, Portsmouth, UK
FAU - Clinton, R.
AU  - Clinton R
AD  - Queen Alexandra Hospital, Critical Care, Portsmouth, UK
FAU - Riccio, F.
AU  - Riccio F
AD  - Queen Alexandra Hospital, Critical Care, Portsmouth, UK
FAU - Gemmell, L.
AU  - Gemmell L
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - MacKay, A.
AU  - MacKay A
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Arthur, A.
AU  - Arthur A
AD  - Golden Jubilee National Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Young, L.
AU  - Young L
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Sinclair, A.
AU  - Sinclair A
AD  - Golden Jubilee National Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Markopoulou, D.
AU  - Markopoulou D
AD  - KAT Hospital, B ICU and Research Center, Kifisia, Greece
FAU - Venetsanou, K.
AU  - Venetsanou K
AD  - KAT Hospital, B ICU and Research Center, Kifisia, Greece
FAU - Filippou, L.
AU  - Filippou L
AD  - KAT Hospital, B ICU and Research Center, Kifisia, Greece
FAU - Salla, E.
AU  - Salla E
AD  - KAT Hospital, B ICU and Research Center, Kifisia, Greece
FAU - Stratouli, S.
AU  - Stratouli S
AD  - KAT Hospital, B ICU and Research Center, Kifisia, Greece
FAU - Alamanos, I.
AU  - Alamanos I
AD  - KAT Hospital, B ICU and Research Center, Kifisia, Greece
FAU - Guirgis, A. H.
AU  - Guirgis AH
AD  - Khoula Hospital, ICU, Muscat, Oman
FAU - Rodriguez, R. Gutiérrez
AU  - Rodriguez RG
AD  - Carlos Haya Hospital, ICU, Malága, Spain
FAU - Lorente, M. J. Furones
AU  - Lorente MJF
AD  - Carlos Haya Hospital, Málaga, Spain
FAU - Guarasa, I. Macias
AU  - Guarasa IM
AD  - Carlos Haya Hospital, ICU, Malága, Spain
FAU - Ukere, A.
AU  - Ukere A
AD  - University Medical Center Hamburg-Eppendorf, Anesthesiology, Hamburg, Germany
FAU - Meisner, S.
AU  - Meisner S
AD  - University Medical Center Hamburg-Eppendorf, Internal Medicine, Hamburg, Germany
FAU - Greiwe, G.
AU  - Greiwe G
AD  - University Medical Center Hamburg-Eppendorf, Anesthesiology, Hamburg, Germany
FAU - Opitz, B.
AU  - Opitz B
AD  - University Medical Center Hamburg-Eppendorf, Anesthesiology, Hamburg, Germany
FAU - Benten, D.
AU  - Benten D
AD  - University Medical Center Hamburg-Eppendorf, Internal Medicine, Hamburg, Germany
FAU - Nashan, B.
AU  - Nashan B
AD  - University Medical Center Hamburg-Eppendorf, Hepatobiliary Surgery and Visceral
      Transplantation, Hamburg, Germany
FAU - Fischer, L.
AU  - Fischer L
AD  - University Medical Center Hamburg-Eppendorf, Hepatobiliary Surgery and Visceral
      Transplantation, Hamburg, Germany
FAU - Trepte, C. J. C.
AU  - Trepte CJC
AD  - University Medical Center Hamburg-Eppendorf, Anesthesiology, Hamburg, Germany
FAU - Reuter, D. A.
AU  - Reuter DA
AD  - University Medical Center Hamburg-Eppendorf, Anesthesiology, Hamburg, Germany
FAU - Haas, S. A.
AU  - Haas SA
AD  - University Medical Center Hamburg-Eppendorf, Anesthesiology, Hamburg, Germany
FAU - Behem, C. R.
AU  - Behem CR
AD  - University Medical Center Hamburg-Eppendorf, Anesthesiology, Hamburg, Germany
FAU - Tavazzi, G.
AU  - Tavazzi G
AD  - University of Pavia, Anaesthesia, Intensive Care and Pain Therapy, Pavia, Italy
FAU - Ana, B.
AU  - Ana B
AD  - Cardiology Department, Universitat Autònoma de Barcelona, Barcelona, Spain
FAU - Vazir, A.
AU  - Vazir A
AD  - Cardiology Department, Royal Brompton and Harefield NHS Foundation Trust, London,
      UK
FAU - Gibson, D.
AU  - Gibson D
AD  - Cardiology Department, Royal Brompton and Harefield NHS Foundation Trust, London,
      UK
FAU - Price, S.
AU  - Price S
AD  - Royal Brompton and Harefield NHS Foundation Trust, London, UK
FAU - Masjedi, M.
AU  - Masjedi M
AD  - Anesthesia and Intensive Care Department, Shiraz University of Medical Sciences, 
      Shiraz, Islamic Republic of Iran
FAU - Hadavi, M. R.
AU  - Hadavi MR
AD  - Anesthesia and Intensive Care Department, Shiraz University of Medical Sciences, 
      Shiraz, Islamic Republic of Iran
FAU - alam, M. Riahi
AU  - alam MR
AD  - Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran
FAU - Sasani, M. R.
AU  - Sasani MR
AD  - Shiraz University of Medical Sciences, Radiology, Shiraz, Islamic Republic of
      Iran
FAU - Parenti, N.
AU  - Parenti N
AD  - University of Modena, Bologna, Italy
FAU - Agrusta, F.
AU  - Agrusta F
AD  - University of Modena, Modena, Italy
FAU - Palazzi, C.
AU  - Palazzi C
AD  - University of Modena, Modena, Italy
FAU - Pifferi, B.
AU  - Pifferi B
AD  - University of Modena, Modena, Italy
FAU - Sganzerla, R.
AU  - Sganzerla R
AD  - University of Modena, Modena, Italy
FAU - Tagliazucchi, F.
AU  - Tagliazucchi F
AD  - University of Modena, Modena, Italy
FAU - Luciani, A.
AU  - Luciani A
AD  - University of Modena, Modena, Italy
FAU - Möller, M.
AU  - Möller M
AD  - Klinikum Kassel, Cardiology and Intensive Care, Kassel, Germany
FAU - Müller-Engelmann, J.
AU  - Müller-Engelmann J
AD  - Klinikum Kassel, Cardiology and Intensive Care, Kassel, Germany
FAU - Montag, G.
AU  - Montag G
AD  - Klinikum Kassel, Cardiology and Intensive Care, Kassel, Germany
FAU - Adams, P.
AU  - Adams P
AD  - Klinikum Kassel, Cardiology and Intensive Care, Kassel, Germany
FAU - Lange, C.
AU  - Lange C
AD  - Klinikum Kassel, Cardiology and Intensive Care, Kassel, Germany
FAU - Neuzner, J.
AU  - Neuzner J
AD  - Klinikum Kassel, Cardiology and Intensive Care, Kassel, Germany
FAU - Gradaus, R.
AU  - Gradaus R
AD  - Klinikum Kassel, Cardiology and Intensive Care, Kassel, Germany
FAU - Wodack, K. H.
AU  - Wodack KH
AD  - Department of Anesthesiology, University Medical Center Hamburg-Eppendorf,
      Hamburg, Germany
FAU - Thürk, F.
AU  - Thürk F
AD  - Vienna University of Technology, Institute of Electrodynamics, Microwave and
      Circuit Engineering, Vienna, Austria
FAU - Waldmann, A. D.
AU  - Waldmann AD
AD  - Swisstom AG, Landquart, Switzerland
FAU - Grässler, M. F.
AU  - Grässler MF
AD  - Department of Anesthesiology, University Medical Center Hamburg-Eppendorf,
      Hamburg, Germany
FAU - Nishimoto, S.
AU  - Nishimoto S
AD  - Department of Anesthesiology, University Medical Center Hamburg-Eppendorf,
      Hamburg, Germany
FAU - Böhm, S. H.
AU  - Böhm SH
AD  - Swisstom AG, Landquart, Switzerland
FAU - Kaniusas, E.
AU  - Kaniusas E
AD  - Vienna University of Technology, Institute of Electrodynamics, Microwave and
      Circuit Engineering, Vienna, Austria
FAU - Reuter, D. A.
AU  - Reuter DA
AD  - Department of Anesthesiology, University Medical Center Hamburg-Eppendorf,
      Hamburg, Germany
FAU - Trepte, C. J.
AU  - Trepte CJ
AD  - Department of Anesthesiology, University Medical Center Hamburg-Eppendorf,
      Hamburg, Germany
FAU - Sigmundsson, T.
AU  - Sigmundsson T
AD  - Department of Anaesthesiology, Surgical Services and Intensive Care Medicine,
      Karolinska University Hospital, Stockholm, Sweden
FAU - Öhman, T.
AU  - Öhman T
AD  - Department of Anaesthesiology, Surgical Services and Intensive Care Medicine,
      Karolinska University Hospital, Stockholm, Sweden
FAU - Redondo, E.
AU  - Redondo E
AD  - Department of Intensive Care Medicine, Hospital de Navarra, Pamplona, Spain
FAU - Hallbäck, M.
AU  - Hallbäck M
AD  - Maquet Critical Care, Stockholm, Sweden
FAU - Wallin, M.
AU  - Wallin M
AD  - Maquet Critical Care, Stockholm, Sweden
FAU - Sipman, F. Suarez
AU  - Sipman FS
AD  - Department of Surgical Sciences, Hedenstierna Laboratory, Uppsala, Sweden
FAU - Oldner, A.
AU  - Oldner A
AD  - Department of Anaesthesiology, Surgical Services and Intensive Care Medicine,
      Karolinska University Hospital, Stockholm, Sweden
FAU - Sander, C. Hällsjö
AU  - Sander CH
AD  - Department of Anaesthesiology, Surgical Services and Intensive Care Medicine,
      Karolinska University Hospital, Stockholm, Sweden
FAU - Björne, H.
AU  - Björne H
AD  - Department of Anaesthesiology, Surgical Services and Intensive Care Medicine,
      Karolinska University Hospital, Stockholm, Sweden
FAU - Colinas, L.
AU  - Colinas L
AD  - Hospital Virgen de la Salud, SESCAM, Intensive Care Medicine, Toledo, Spain
FAU - Hernandez, G.
AU  - Hernandez G
AD  - Hospital Virgen de la Salud, SESCAM, Intensive Care Medicine, Toledo, Spain
FAU - Vicho, R.
AU  - Vicho R
AD  - Hospital Quironsalud Palmaplanas, Intensive Care Medicine, Palma de Mallorca,
      Spain
FAU - Serna, M.
AU  - Serna M
AD  - Hospital Marina Salud Denia, Intensive Care Medicine, Murcia, Spain
FAU - Cuena, R.
AU  - Cuena R
AD  - Hospital Virgen de la Salud, SESCAM, Research Unit, Medical Council, Toledo,
      Spain
FAU - Canabal, A.
AU  - Canabal A
AD  - Hospital Virgen de la Salud, SESCAM, Intensive Care Medicine, Toledo, Spain
CN  - ECOCRITIC group
FAU - Chaari, A.
AU  - Chaari A
AD  - King Hamad University Hospital, Intensive Care, Muharaq, Bahrain
FAU - Hakim, K. Abdel
AU  - Hakim KA
AD  - King Hamad University Hospital, Muharaq, Bahrain
FAU - Etman, M.
AU  - Etman M
AD  - King Hamad University Hospital, Muharaq, Bahrain
FAU - El Bahr, M.
AU  - El Bahr M
AD  - King Hamad University Hospital, Muharaq, Bahrain
FAU - El Sakka, A.
AU  - El Sakka A
AD  - King Hamad University Hospital, Muharaq, Bahrain
FAU - Bousselmi, K.
AU  - Bousselmi K
AD  - King Hamad University Hospital, Muharaq, Bahrain
FAU - Arali, A.
AU  - Arali A
AD  - King Hamad University Hospital, Muharaq, Bahrain
FAU - Kauts, V.
AU  - Kauts V
AD  - King Hamad University Hospital, Muharaq, Bahrain
FAU - Casey, W. F.
AU  - Casey WF
AD  - King Hamad University Hospital, Muharaq, Bahrain
FAU - Bond, O.
AU  - Bond O
AD  - Department of Intensive Care, Hopital Erasme, Université Libre de Bruxelles,
      Brussels, Belgium
FAU - De Santis, P.
AU  - De Santis P
AD  - Department of Intensive Care, Hopital Erasme, Université Libre de Bruxelles,
      Brussels, Belgium
FAU - Iesu, E.
AU  - Iesu E
AD  - Department of Intensive Care, Hopital Erasme, Université Libre de Bruxelles,
      Brussels, Belgium
FAU - Franchi, F.
AU  - Franchi F
AD  - Department of Medical Biotechnologies, University of Siena, Anesthesia and
      Intensive Care Unit, Siena, Italy
FAU - Vincent, J. L.
AU  - Vincent JL
AD  - Department of Intensive Care, Hopital Erasme, Université Libre de Bruxelles,
      Brussels, Belgium
FAU - Creteur, J.
AU  - Creteur J
AD  - Department of Intensive Care, Hopital Erasme, Université Libre de Bruxelles,
      Brussels, Belgium
FAU - Scolletta, S.
AU  - Scolletta S
AD  - Department of Medical Biotechnologies, University of Siena, Anesthesia and
      Intensive Care Unit, Siena, Italy
FAU - Taccone, F. S.
AU  - Taccone FS
AD  - Department of Intensive Care, Hopital Erasme, Université Libre de Bruxelles,
      Brussels, Belgium
FAU - Marutyan, Z.
AU  - Marutyan Z
AD  - N.V. Sklifosovsky Research Institute of Emergency Medicine of the Moscow
      Healthcare Department, Moscow, Russian Federation
FAU - Hamidova, L.
AU  - Hamidova L
AD  - N.V. Sklifosovsky Research Institute of Emergency Medicine of the Moscow
      Healthcare Department, Moscow, Russian Federation
FAU - Shakotko, A.
AU  - Shakotko A
AD  - N.V. Sklifosovsky Research Institute of Emergency Medicine of the Moscow
      Healthcare Department, Moscow, Russian Federation
FAU - Movsisyan, V.
AU  - Movsisyan V
AD  - N.V. Sklifosovsky Research Institute of Emergency Medicine of the Moscow
      Healthcare Department, Moscow, Russian Federation
FAU - Uysupova, I.
AU  - Uysupova I
AD  - N.V. Sklifosovsky Research Institute of Emergency Medicine of the Moscow
      Healthcare Department, Moscow, Russian Federation
FAU - Evdokimov, A.
AU  - Evdokimov A
AD  - N.V. Sklifosovsky Research Institute of Emergency Medicine of the Moscow
      Healthcare Department, Moscow, Russian Federation
FAU - Petrikov, S.
AU  - Petrikov S
AD  - N.V. Sklifosovsky Research Institute of Emergency Medicine of the Moscow
      Healthcare Department, Moscow, Russian Federation
FAU - Gonen, C.
AU  - Gonen C
AD  - Kocaeli Derince Training Hospital, Intensive Care, Kocaeli, Turkey
FAU - Haftacı, E.
AU  - Haftacı E
AD  - Kocaeli Derince Education and Research Hospital, Kocaeli, Turkey
FAU - Balci, C.
AU  - Balci C
AD  - Kocaeli Derince Training Hospital, Intensive Care, Kocaeli, Turkey
FAU - Calvo, F. J. Redondo
AU  - Calvo FJR
AD  - Facultad de Medicina Ciudad Real, Hospital General Universitario de Ciudad Real, 
      Anestesiologia y Reanimacion, Ciudad Real, Spain
FAU - Bejarano, N.
AU  - Bejarano N
AD  - Facultad de Medicina Ciudad Real, Hospital General Universitario Ciudad Real,
      Cuidados Criticos Pediatricos, Ciudad Real, Spain
FAU - Baladron, V.
AU  - Baladron V
AD  - Hospital General Universitario Ciudad Real, Anestesiologia y Reanimacion, Ciudad 
      Real, Spain
FAU - Villazala, R.
AU  - Villazala R
AD  - Hospital General Universitario Ciudad Real, Anestesiologia y Reanimacion, Ciudad 
      Real, Spain
FAU - Redondo, J.
AU  - Redondo J
AD  - Hospital General Universitario Ciudad Real, Anestesiologia y Reanimacion, Ciudad 
      Real, Spain
FAU - Padilla, D.
AU  - Padilla D
AD  - Facultad de Medicina Ciudad Real, Hospital General Universitario Ciudad Real,
      Cirugía Hepatobiliar, Ciudad Real, Spain
FAU - Villarejo, P.
AU  - Villarejo P
AD  - Facultad de Medicina Ciudad Real, Hospital General Universitario Ciudad Real,
      Cirugía Hepatobiliar, Ciudad Real, Spain
FAU - Akcan-Arikan, A.
AU  - Akcan-Arikan A
AD  - Baylor College of Medicine, Pediatric Critical Care, Houston, TX USA
FAU - Kennedy, C. E.
AU  - Kennedy CE
AD  - Baylor College of Medicine, Pediatric Critical Care, Houston, TX USA
FAU - Arzapalo, M. F. Aguilar
AU  - Arzapalo MFA
AD  - SSA UADY, Mérida, Mexico
FAU - Gomez-Gonzalez, C.
AU  - Gomez-Gonzalez C
AD  - Hospital U.V. Rocío, Seville, Spain
FAU - Mas-Font, S.
AU  - Mas-Font S
AD  - Hospital General Universitario de Castellon, Castellon, Spain
FAU - Puppo-Moreno, A.
AU  - Puppo-Moreno A
AD  - Hospital U.V. Rocío, Seville, Spain
FAU - Herrera-Gutierrez, M.
AU  - Herrera-Gutierrez M
AD  - H Carlos Haya, Malaga, Spain
FAU - Garcia-Garcia, M.
AU  - Garcia-Garcia M
AD  - Hospital de Sagunto, Valencia, Spain
FAU - Aldunate-Calvo, S.
AU  - Aldunate-Calvo S
AD  - Complejo Hospitalario de Navarra, Pamplona, Spain
CN  - NEFROCON Investigators
FAU - Plata-Menchaca, E. P.
AU  - Plata-Menchaca EP
AD  - Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Critical
      Care, México, Mexico
FAU - Pérez-Fernández, X. L.
AU  - Pérez-Fernández XL
AD  - Hospital Universitari de Bellvitge, Critical Care, L’Hospitalet, Spain
FAU - Estruch, M.
AU  - Estruch M
AD  - Hospital de la Santa Creu i Sant Pau, Institut de Recerca Cardiovascular,
      Barcelona, Spain
FAU - Betbese-Roig, A.
AU  - Betbese-Roig A
AD  - Hospital de la Santa Creu i Sant Pau, Critical Care, Barcelona, Spain
FAU - Campos, P. Cárdenas
AU  - Campos PC
AD  - Hospital Universitari de Bellvitge, Critical Care, L’Hospitalet, Spain
FAU - Lora, M. Rojas
AU  - Lora MR
AD  - Hospital Universitari de Bellvitge, Critical Care, L’Hospitalet, Spain
FAU - Gaibor, N. D. Toapanta
AU  - Gaibor NDT
AD  - Hospital Universitari de Bellvitge, Critical Care, L’Hospitalet, Spain
FAU - Medina, R. S. Contreras
AU  - Medina RSC
AD  - Hospital Universitari de Bellvitge, Critical Care, L’Hospitalet, Spain
FAU - Sanguino, V. D. Gumucio
AU  - Sanguino VDG
AD  - Hospital Universitari de Bellvitge, Critical Care, L’Hospitalet, Spain
FAU - Casanova, E. J.
AU  - Casanova EJ
AD  - Hospital Universitari de Bellvitge, Critical Care, L’Hospitalet, Spain
FAU - Riera, J. Sabater
AU  - Riera JS
AD  - Hospital Universitari de Bellvitge, Critical Care, L’Hospitalet, Spain
CN  - SIRAKI group
FAU - Kritmetapak, K.
AU  - Kritmetapak K
AD  - Department of Medicine, Division of Nephrology, Chulalongkorn University,
      Bangkok, Thailand
FAU - Peerapornratana, S.
AU  - Peerapornratana S
AD  - Department of Medicine, Division of Nephrology, Chulalongkorn University,
      Bangkok, Thailand
FAU - Kittiskulnam, P.
AU  - Kittiskulnam P
AD  - Department of Medicine, Division of Nephrology, Chulalongkorn University,
      Bangkok, Thailand
FAU - Dissayabutra, T.
AU  - Dissayabutra T
AD  - Department of Biochemistry, Chulalongkorn University, Bangkok, Thailand
FAU - Tiranathanagul, K.
AU  - Tiranathanagul K
AD  - Department of Medicine, Division of Nephrology, Chulalongkorn University,
      Bangkok, Thailand
FAU - Susantithapong, P.
AU  - Susantithapong P
AD  - Department of Medicine, Division of Nephrology, Chulalongkorn University,
      Bangkok, Thailand
FAU - Praditpornsilpa, K.
AU  - Praditpornsilpa K
AD  - Department of Medicine, Division of Nephrology, Chulalongkorn University,
      Bangkok, Thailand
FAU - Tungsanga, K.
AU  - Tungsanga K
AD  - Department of Medicine, Division of Nephrology, Chulalongkorn University,
      Bangkok, Thailand
FAU - Eiam-Ong, S.
AU  - Eiam-Ong S
AD  - Department of Medicine, Division of Nephrology, Chulalongkorn University,
      Bangkok, Thailand
FAU - Srisawat, N.
AU  - Srisawat N
AD  - Department of Medicine, Division of Nephrology, Chulalongkorn University,
      Bangkok, Thailand
FAU - Winkelmann, T.
AU  - Winkelmann T
AD  - University Hospital Leipzig, Anesthesia and Intensive Care, Leipzig, Germany
FAU - Busch, T.
AU  - Busch T
AD  - University Hospital Leipzig, Anesthesia and Intensive Care, Leipzig, Germany
FAU - Meixensberger, J.
AU  - Meixensberger J
AD  - University Hospital Leipzig, Neurosurgery, Leipzig, Germany
FAU - Bercker, S.
AU  - Bercker S
AD  - University Hospital Leipzig, Anesthesia and Intensive Care, Leipzig, Germany
FAU - Cabeza, E. M. Flores
AU  - Cabeza EMF
AD  - Hospital Universitario La Paz, Medicina Intensiva, Madrid, Spain
FAU - Sánchez, M. Sánchez
AU  - Sánchez MS
AD  - Hospital Universitario La Paz, Medicina Intensiva, Madrid, Spain
FAU - Giménez, N. Cáceres
AU  - Giménez NC
AD  - Hospital Universitario La Paz, Medicina Intensiva, Madrid, Spain
FAU - Melón, C. Gutierrez
AU  - Melón CG
AD  - Hospital Universitario La Paz, Medicina Intensiva, Madrid, Spain
FAU - de Lucas, E. Herrero
AU  - de Lucas EH
AD  - Hospital Universitario La Paz, Medicina Intensiva, Madrid, Spain
FAU - Estañ, P. Millán
AU  - Estañ PM
AD  - Hospital Universitario La Paz, Medicina Intensiva, Madrid, Spain
FAU - Bernal, M. Hernández
AU  - Bernal MH
AD  - Hospital Universitario La Paz, Medicina Intensiva, Madrid, Spain
FAU - de Lorenzo y Mateos, A. Garcia
AU  - de Lorenzo y Mateos AG
AD  - Hospital Universitario La Paz, Medicina Intensiva, Madrid, Spain
FAU - Ergin, B.
AU  - Ergin B
AD  - Academic Medical Center, University of Amsterdam, Translational Physiology,
      Amsterdam, Netherlands
FAU - Guerci, P.
AU  - Guerci P
AD  - Academic Medical Center, University of Amsterdam, Translational Physiology,
      Amsterdam, Netherlands
FAU - Specht, P. A. C.
AU  - Specht PAC
AD  - Erasmus Medical Center, Experimental Anesthesiology, Roterdam, Netherlands
FAU - Ince, Y.
AU  - Ince Y
AD  - Academic Medical Center, University of Amsterdam, Translational Physiology,
      Amsterdam, Netherlands
FAU - Ince, C.
AU  - Ince C
AD  - Academic Medical Center, University of Amsterdam, Translational Physiology,
      Amsterdam, Netherlands
FAU - Balik, M.
AU  - Balik M
AD  - 1st Medical Faculty, Charles University, Prague, Czech Republic
FAU - Zakharchenko, M.
AU  - Zakharchenko M
AD  - 1st Medical Faculty, Charles University, Prague, Czech Republic
FAU - Los, F.
AU  - Los F
AD  - 1st Medical Faculty, Charles University, Prague, Czech Republic
FAU - Brodska, H.
AU  - Brodska H
AD  - 1st Medical Faculty, Charles University, Prague, Czech Republic
FAU - de Tymowski, C.
AU  - de Tymowski C
AD  - Hopital Bichat Claude Bernard, Anaesthesiology and Surgical Critical Care, Paris,
      France
FAU - Augustin, P.
AU  - Augustin P
AD  - Hopital Bichat Claude Bernard, Anaesthesiology and Surgical Critical Care, Paris,
      France
FAU - Desmard, M.
AU  - Desmard M
AD  - Centre Hospitalier Sud Francilien, Critical Care Medecine, Corbeil-Essonnes,
      France
FAU - Montravers, P.
AU  - Montravers P
AD  - Hopital Bichat Claude Bernard, Anaesthesiology and Surgical Critical Care, Paris,
      France
FAU - Stapel, S. N.
AU  - Stapel SN
AD  - VU University Medical Center, Intensive Care, Amsterdam, Netherlands
FAU - de Boer, R.
AU  - de Boer R
AD  - VU University Medical Center, Intensive Care, Amsterdam, Netherlands
FAU - Oudemans, H. M.
AU  - Oudemans HM
AD  - VU University Medical Center, Intensive Care, Amsterdam, Netherlands
FAU - Hollinger, A.
AU  - Hollinger A
AD  - University Hospital Basel, Anaesthesia & Intensive Care: Surgical Intensive Care,
      Basel, Switzerland
FAU - Schweingruber, T.
AU  - Schweingruber T
AD  - University Hospital Basel, Anaesthesia & Intensive Care: Surgical Intensive Care,
      Basel, Switzerland
FAU - Jockers, F.
AU  - Jockers F
AD  - University Hospital Basel, Anaesthesia & Intensive Care: Surgical Intensive Care,
      Basel, Switzerland
FAU - Dickenmann, M.
AU  - Dickenmann M
AD  - University Hospital Basel, Nephrology & Transplant Immunology, Basel, Switzerland
FAU - Siegemund, M.
AU  - Siegemund M
AD  - University Hospital Basel, Anaesthesia & Intensive Care: Surgical Intensive Care,
      Basel, Switzerland
CN  - Clinical Intensive Care Research Basel
FAU - Runciman, N.
AU  - Runciman N
AD  - Queen Elizabeth University Hospital, NHS GG&C, Glasgow, UK
FAU - Ralston, M.
AU  - Ralston M
AD  - Queen Elizabeth University Hospital, NHS GG&C, Glasgow, UK
FAU - Appleton, R.
AU  - Appleton R
AD  - Queen Elizabeth University Hospital, NHS GG&C, Glasgow, UK
FAU - Mauri, T.
AU  - Mauri T
AD  - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
FAU - Alban, L.
AU  - Alban L
AD  - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
FAU - Turrini, C.
AU  - Turrini C
AD  - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
FAU - Sasso, T.
AU  - Sasso T
AD  - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
FAU - Langer, T.
AU  - Langer T
AD  - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
FAU - Panigada, M.
AU  - Panigada M
AD  - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
FAU - Taccone, P.
AU  - Taccone P
AD  - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
FAU - Carlesso, E.
AU  - Carlesso E
AD  - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
FAU - Marenghi, C.
AU  - Marenghi C
AD  - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
FAU - Grasselli, G.
AU  - Grasselli G
AD  - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
FAU - Pesenti, A.
AU  - Pesenti A
AD  - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
FAU - Wibart, P.
AU  - Wibart P
AD  - CHU Bordeaux, Réanimation Médicale, Bordeaux, France
FAU - Reginault, T.
AU  - Reginault T
AD  - CHU Bordeaux, Réanimation Médicale, Bordeaux, France
FAU - Garcia, M.
AU  - Garcia M
AD  - CHU Bordeaux, Réanimation Médicale, Bordeaux, France
FAU - Barbrel, B.
AU  - Barbrel B
AD  - CHU Bordeaux, Réanimation Médicale, Bordeaux, France
FAU - Benard, A.
AU  - Benard A
AD  - CHU Bordeaux, Unité d’Épidemiologie Clinique, Bordeaux, France
FAU - Bader, C.
AU  - Bader C
AD  - CHU Bordeaux, Unité d’Épidemiologie Clinique, Bordeaux, France
FAU - Vargas, F.
AU  - Vargas F
AD  - CHU Bordeaux, Réanimation Médicale, Bordeaux, France
FAU - Bui, H. N.
AU  - Bui HN
AD  - CHU Bordeaux, Réanimation Médicale, Bordeaux, France
FAU - Hilbert, G.
AU  - Hilbert G
AD  - CHU Bordeaux, Réanimation Médicale, Bordeaux, France
FAU - Simón, J. M. Serrano
AU  - Simón JMS
AD  - Hospital Universitario Reina Sofia, Intensive Care Unit, Córdoba, Spain
FAU - Sánchez, P. Carmona
AU  - Sánchez PC
AD  - Hospital Universitario Reina Sofia, Intensive Care Unit, Córdoba, Spain
FAU - Ferrón, F. Ruiz
AU  - Ferrón FR
AD  - Complejo Hospitalario de Jaén, Intensive Care Unit, Jaén, Spain
FAU - de Acilu, M. García
AU  - de Acilu MG
AD  - Critical Care Department, Vall d’Hebron University Hospital, Barcelona, Spain
FAU - Marin, J.
AU  - Marin J
AD  - Critical Care Department, Parc de Salut Mar. IMIM (Mar Medical Research
      Institut), Barcelona, Spain
FAU - Antonia, V.
AU  - Antonia V
AD  - Critical Care Department, Parc de Salut Mar. IMIM (Mar Medical Research
      Institut), Barcelona, Spain
FAU - Ruano, L.
AU  - Ruano L
AD  - Critical Care Department, Vall d’Hebron University Hospital, Barcelona, Spain
FAU - Monica, M.
AU  - Monica M
AD  - Critical Care Department, Joan XXIII University Hospital, Tarragona, Spain
FAU - Ferrer, R.
AU  - Ferrer R
AD  - Critical Care Department, Vall d’Hebron University Hospital, Barcelona, Spain
FAU - Masclans, J. R.
AU  - Masclans JR
AD  - Critical Care Department, Parc de Salut Mar. IMIM (Mar Medical Research
      Institut), Barcelona, Spain
FAU - Roca, O.
AU  - Roca O
AD  - Critical Care Department, Vall d’Hebron University Hospital, Barcelona, Spain
FAU - Hong, G.
AU  - Hong G
AD  - Department of Internal Medicine, Dankook University Hospital, Dankook University 
      College of Medicine, Cheonan, Republic of Korea
FAU - Kim, D. H.
AU  - Kim DH
AD  - Department of Internal Medicine, Dankook University Hospital, Dankook University 
      College of Medicine, Cheonan, Republic of Korea
FAU - Kim, Y. S.
AU  - Kim YS
AD  - Department of Internal Medicine, Dankook University Hospital, Dankook University 
      College of Medicine, Cheonan, Republic of Korea
FAU - Park, J. S.
AU  - Park JS
AD  - Department of Internal Medicine, Dankook University Hospital, Dankook University 
      College of Medicine, Cheonan, Republic of Korea
FAU - Jee, Y. K.
AU  - Jee YK
AD  - Department of Internal Medicine, Dankook University Hospital, Dankook University 
      College of Medicine, Cheonan, Republic of Korea
FAU - xiang, Z. Yu
AU  - xiang ZY
AD  - 309th Hospital PLA, Beijing, China
FAU - Jia-xing, W.
AU  - Jia-xing W
AD  - 309th Hospital PLA, Beijing, China
FAU - dan, W. Xiao
AU  - dan WX
AD  - 309th Hospital PLA, Beijing, China
FAU - long, N. Wen
AU  - long NW
AD  - 309th Hospital PLA, Beijing, China
FAU - Yu, W.
AU  - Yu W
AD  - 309th Hospital PLA, Beijing, China
FAU - Yan, Z.
AU  - Yan Z
AD  - 309th Hospital PLA, Beijing, China
FAU - Cheng, X.
AU  - Cheng X
AD  - 309th Hospital PLA, Beijing, China
FAU - Kobayashi, T.
AU  - Kobayashi T
AD  - Yamagata University Faculty of Medicine, Anaesthesiology and Critical Care
      Medicine, Yamagata, Japan
FAU - Onodera, Y.
AU  - Onodera Y
AD  - Yamagata University Faculty of Medicine, Anaesthesiology and Critical Care
      Medicine, Yamagata, Japan
FAU - Akimoto, R.
AU  - Akimoto R
AD  - Yamagata University Faculty of Medicine, Anaesthesiology and Critical Care
      Medicine, Yamagata, Japan
FAU - Sugiura, A.
AU  - Sugiura A
AD  - Yamagata University Faculty of Medicine, Anaesthesiology and Critical Care
      Medicine, Yamagata, Japan
FAU - Suzuki, H.
AU  - Suzuki H
AD  - Yamagata University Faculty of Medicine, Anaesthesiology and Critical Care
      Medicine, Yamagata, Japan
FAU - Iwabuchi, M.
AU  - Iwabuchi M
AD  - Yamagata University Faculty of Medicine, Anaesthesiology and Critical Care
      Medicine, Yamagata, Japan
FAU - Nakane, M.
AU  - Nakane M
AD  - Yamagata University Faculty of Medicine, Anaesthesiology and Critical Care
      Medicine, Yamagata, Japan
FAU - Kawamae, K.
AU  - Kawamae K
AD  - Yamagata University Faculty of Medicine, Anaesthesiology and Critical Care
      Medicine, Yamagata, Japan
FAU - Sanchez, P. Carmona
AU  - Sanchez PC
AD  - Hospital Universitario Reina Sofia, Intensive Care Unit, Córdoba, Spain
FAU - Rodriguez, M. D. Bautista
AU  - Rodriguez MDB
AD  - Hospital Universitario Reina Sofia, Intensive Care Unit, Córdoba, Spain
FAU - Delgado, M. Rodriguez
AU  - Delgado MR
AD  - Hospital Universitario Reina Sofia, Intensive Care Unit, Córdoba, Spain
FAU - Sánchez, V. Martínez de Pinillos
AU  - Sánchez VMde P
AD  - Hospital Universitario Reina Sofia, Intensive Care Unit, Córdoba, Spain
FAU - Gómez, A. Mula
AU  - Gómez AM
AD  - Hospital Universitario Reina Sofia, Intensive Care Unit, Córdoba, Spain
FAU - Simón, J. M. Serrano
AU  - Simón JMS
AD  - Hospital Universitario Reina Sofia, Intensive Care Unit, Córdoba, Spain
FAU - Beuret, P.
AU  - Beuret P
AD  - Centre Hospitalier, Intensive Care Unit, Roanne, France
FAU - Fortes, C.
AU  - Fortes C
AD  - Centre Hospitalier, Intensive Care Unit, Roanne, France
FAU - Lauer, M.
AU  - Lauer M
AD  - Centre Hospitalier, Intensive Care Unit, Roanne, France
FAU - Reboul, M.
AU  - Reboul M
AD  - Centre Hospitalier, Intensive Care Unit, Roanne, France
FAU - Chakarian, J. C.
AU  - Chakarian JC
AD  - Centre Hospitalier, Intensive Care Unit, Roanne, France
FAU - Fabre, X.
AU  - Fabre X
AD  - Centre Hospitalier, Intensive Care Unit, Roanne, France
FAU - Philippon-Jouve, B.
AU  - Philippon-Jouve B
AD  - Centre Hospitalier, Intensive Care Unit, Roanne, France
FAU - Devillez, S.
AU  - Devillez S
AD  - Centre Hospitalier, Intensive Care Unit, Roanne, France
FAU - Clerc, M.
AU  - Clerc M
AD  - Centre Hospitalier, Intensive Care Unit, Roanne, France
FAU - Rittayamai, N.
AU  - Rittayamai N
AD  - Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, 
      Toronto, Canada
FAU - Sklar, M.
AU  - Sklar M
AD  - Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, 
      Toronto, Canada
FAU - Dres, M.
AU  - Dres M
AD  - Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, 
      Toronto, Canada
FAU - Rauseo, M.
AU  - Rauseo M
AD  - Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, 
      Toronto, Canada
FAU - Campbell, C.
AU  - Campbell C
AD  - Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, 
      Toronto, Canada
FAU - West, B.
AU  - West B
AD  - Division of Respirology, St. Michael’s Hospital, Toronto, Canada
FAU - Tullis, D. E.
AU  - Tullis DE
AD  - Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, 
      Toronto, Canada
FAU - Brochard, L.
AU  - Brochard L
AD  - Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, 
      Toronto, Canada
FAU - Onodera, Y.
AU  - Onodera Y
AD  - Department of Anesthesiology, Faculty of Medicine, Yamagata University, Yamagata,
      Japan
FAU - Akimoto, R.
AU  - Akimoto R
AD  - Department of Anesthesiology, Faculty of Medicine, Yamagata University, Yamagata,
      Japan
FAU - Suzuki, H.
AU  - Suzuki H
AD  - Department of Anesthesiology, Faculty of Medicine, Yamagata University, Yamagata,
      Japan
FAU - Okada, M.
AU  - Okada M
AD  - Department of Anesthesiology, Faculty of Medicine, Yamagata University, Yamagata,
      Japan
FAU - Nakane, M.
AU  - Nakane M
AD  - Department of Anesthesiology, Faculty of Medicine, Yamagata University, Yamagata,
      Japan
FAU - Kawamae, K.
AU  - Kawamae K
AD  - Department of Anesthesiology, Faculty of Medicine, Yamagata University, Yamagata,
      Japan
FAU - Ahmad, N.
AU  - Ahmad N
AD  - Northern General Hospital, Sheffield Teaching Hospital NHS Trust, Anaesthesia and
      Critical Care, Sheffield, UK
FAU - Wood, M.
AU  - Wood M
AD  - Northern General Hospital, Sheffield Teaching Hospital NHS Trust, Anaesthesia and
      Critical Care, Sheffield, UK
FAU - Glossop, A.
AU  - Glossop A
AD  - Northern General Hospital, Sheffield Teaching Hospital NHS Trust, Anaesthesia and
      Critical Care, Sheffield, UK
FAU - Lucas, J. Higuera
AU  - Lucas JH
AD  - Hospital Universitario Ramón y Cajal, Unidad de Cuidados Intensivos, Madrid,
      Spain
FAU - Ortiz, A. Blandino
AU  - Ortiz AB
AD  - Hospital Universitario Ramón y Cajal, Unidad de Cuidados Intensivos, Madrid,
      Spain
FAU - Alonso, D. Cabestrero
AU  - Alonso DC
AD  - Hospital Universitario Ramón y Cajal, Unidad de Cuidados Intensivos, Madrid,
      Spain
FAU - De Pablo Sánchez, R.
AU  - De Pablo Sánchez R
AD  - Hospital Universitario Ramón y Cajal, Unidad de Cuidados Intensivos, Madrid,
      Spain
FAU - González, L. Rey
AU  - González LR
AD  - Hospital Universitario Ramón y Cajal, Unidad de Cuidados Intensivos, Madrid,
      Spain
FAU - Costa, R.
AU  - Costa R
AD  - Department of Anesthesia and Intensive Care, Catholic University of Rome, Rome,
      Italy
FAU - Spinazzola, G.
AU  - Spinazzola G
AD  - Department of Anesthesia and Intensive Care, Catholic University of Rome, Rome,
      Italy
FAU - Pizza, A.
AU  - Pizza A
AD  - Department of Anesthesia and Intensive Care, Catholic University of Rome, Rome,
      Italy
FAU - Ferrone, G.
AU  - Ferrone G
AD  - Department of Anesthesia and Intensive Care, Catholic University of Rome, Rome,
      Italy
FAU - Rossi, M.
AU  - Rossi M
AD  - Department of Anesthesia and Intensive Care, Catholic University of Rome, Rome,
      Italy
FAU - Antonelli, M.
AU  - Antonelli M
AD  - Department of Anesthesia and Intensive Care, Catholic University of Rome, Rome,
      Italy
FAU - Conti, G.
AU  - Conti G
AD  - Department of Anesthesia and Intensive Care, Catholic University of Rome, Rome,
      Italy
FAU - Ribeiro, H.
AU  - Ribeiro H
AD  - Centro Hospitalar de Entre o Douro e Vouga, Serviço de Medicina Intensiva
      Polivalente, Santa Maria da Feira, Portugal
FAU - Alves, J.
AU  - Alves J
AD  - Centro Hospitalar de Entre o Douro e Vouga, Serviço de Medicina Intensiva
      Polivalente, Santa Maria da Feira, Portugal
FAU - Sousa, M.
AU  - Sousa M
AD  - Centro Hospitalar de Entre o Douro e Vouga, Serviço de Medicina Intensiva
      Polivalente, Santa Maria da Feira, Portugal
FAU - Reis, P.
AU  - Reis P
AD  - Centro Hospitalar de Entre o Douro e Vouga, Serviço de Medicina Intensiva
      Polivalente, Santa Maria da Feira, Portugal
FAU - Socolovsky, C. S.
AU  - Socolovsky CS
AD  - Department of Medicine, Massachusetts General Hospital, Boston, MA USA
FAU - Cauley, R. P.
AU  - Cauley RP
AD  - Department of Surgery, Massachusetts General Hospital, Boston, MA USA
FAU - Frankel, J. E.
AU  - Frankel JE
AD  - Spaulding Rehabilitation Hospital, Physical Medicine & Rehabilitation, Boston, MA
      USA
FAU - Beam, A. L.
AU  - Beam AL
AD  - Harvard Medical School, Biomedical Informatics, Boston, MA USA
FAU - Olaniran, K. O.
AU  - Olaniran KO
AD  - Massachusetts General Hospital, Renal Division, Boston, MA USA
FAU - Gibbons, F. K.
AU  - Gibbons FK
AD  - Massachusetts General Hospital, Pulmonary and Critical Care Medicine, Boston, MA 
      USA
FAU - Christopher, K. B.
AU  - Christopher KB
AD  - Brigham and Women’s Hospital, Renal Division, Boston, MA USA
FAU - Pennington, J.
AU  - Pennington J
AD  - Barts Health NHS Trust, Adult Critical Care Unit, London, UK
FAU - Zolfaghari, P.
AU  - Zolfaghari P
AD  - Barts Health NHS Trust, Adult Critical Care Unit, London, UK
FAU - King, H. S.
AU  - King HS
AD  - Department of Intensive Care, Pamela Youde Nethersole Eastern Hospital, Hong
      Kong, Hong Kong China
FAU - Kong, H. H. Y.
AU  - Kong HHY
AD  - Department of Intensive Care, Pamela Youde Nethersole Eastern Hospital, Hong
      Kong, Hong Kong China
FAU - Shum, H. P.
AU  - Shum HP
AD  - Department of Intensive Care, Pamela Youde Nethersole Eastern Hospital, Hong
      Kong, Hong Kong China
FAU - Yan, W. W.
AU  - Yan WW
AD  - Department of Intensive Care, Pamela Youde Nethersole Eastern Hospital, Hong
      Kong, Hong Kong China
FAU - Kaymak, C.
AU  - Kaymak C
AD  - Anesthesiology and Reanimation Department, Ministry of Health, Ankara Training
      and Research Hospital, Intensive Care Unit, Ankara, Turkey
FAU - Okumus, N.
AU  - Okumus N
AD  - Ministry of Health, Departmant of Health Services, Ankara, Turkey
FAU - Sari, A.
AU  - Sari A
AD  - Ministry of Health, Departmant of Health Services, Ankara, Turkey
FAU - Erdogdu, B.
AU  - Erdogdu B
AD  - Ministry of Health, Departmant of Health Services, Ankara, Turkey
FAU - Aksun, S.
AU  - Aksun S
AD  - Ministry of Health, Departmant of Health Services, Ankara, Turkey
FAU - Basar, H.
AU  - Basar H
AD  - Anesthesiology and Reanimation Department, Ministry of Health, Ankara Training
      and Research Hospital, Intensive Care Unit, Ankara, Turkey
FAU - Ozcan, A.
AU  - Ozcan A
AD  - Anesthesiology and Reanimation Department, Ministry of Health, Ankara Training
      and Research Hospital, Intensive Care Unit, Ankara, Turkey
FAU - Ozcan, N.
AU  - Ozcan N
AD  - Anesthesiology and Reanimation Department, Ministry of Health, Ankara Training
      and Research Hospital, Intensive Care Unit, Ankara, Turkey
FAU - Oztuna, D.
AU  - Oztuna D
AD  - Medical Biostatistics Department, University of Ankara, Faculty of Medicine,
      Ankara, Turkey
FAU - Malmgren, J. A.
AU  - Malmgren JA
AD  - Department of Anaesthesiology and Intensive Care, Sahlgrenska University
      Hospital, Gothenburg, Sweden
FAU - Lundin, S.
AU  - Lundin S
AD  - Department of Anaesthesiology and Intensive Care, Sahlgrenska University
      Hospital, Gothenburg, Sweden
FAU - Torén, K.
AU  - Torén K
AD  - University of Gothenburg, Gothenburg, Sweden
FAU - Eckerström, M.
AU  - Eckerström M
AD  - University of Gothenburg, Gothenburg, Sweden
FAU - Wallin, A.
AU  - Wallin A
AD  - University of Gothenburg, Gothenburg, Sweden
FAU - Waldenström, A. C.
AU  - Waldenström AC
AD  - University of Gothenburg, Gothenburg, Sweden
CN  - for the Section on Ethics of the ESICM
FAU - Riccio, F. C.
AU  - Riccio FC
AD  - Queen Alexandra Hospital, Critical Care, Portsmouth, UK
FAU - Pogson, D.
AU  - Pogson D
AD  - Queen Alexandra Hospital, Critical Care, Portsmouth, UK
FAU - Antonio, A. C. P.
AU  - Antonio ACP
AD  - Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
FAU - Leivas, A. F.
AU  - Leivas AF
AD  - Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
FAU - Kenji, F.
AU  - Kenji F
AD  - Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
FAU - James, E.
AU  - James E
AD  - East Surrey Hospital, Intensive Care, Redhill, UK
FAU - Morgan, P.
AU  - Morgan P
AD  - East Surrey Hospital, Intensive Care, Redhill, UK
FAU - Carroll, G.
AU  - Carroll G
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Gemmell, L.
AU  - Gemmell L
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - MacKay, A.
AU  - MacKay A
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Wright, C.
AU  - Wright C
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Ballantyne, J.
AU  - Ballantyne J
AD  - Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK
FAU - Jonnada, S.
AU  - Jonnada S
AD  - University of Cambridge, Gonville & Caius College, Cambridge, UK
FAU - Gerrard, C. S.
AU  - Gerrard CS
AD  - Papworth Hospital, Papworth Everard, UK
FAU - Jones, N.
AU  - Jones N
AD  - Papworth Hospital, Papworth Everard, UK
FAU - Salciccioli, J. D.
AU  - Salciccioli JD
AD  - Imperial College London, London, UK
FAU - Marshall, D. C.
AU  - Marshall DC
AD  - Imperial College London, London, UK
FAU - Komorowski, M.
AU  - Komorowski M
AD  - Imperial College London, London, UK
FAU - Hartley, A.
AU  - Hartley A
AD  - Imperial College London, London, UK
FAU - Sykes, M. C.
AU  - Sykes MC
AD  - Imperial College London, London, UK
FAU - Goodson, R.
AU  - Goodson R
AD  - Imperial College London, London, UK
FAU - Shalhoub, J.
AU  - Shalhoub J
AD  - Imperial College London, London, UK
FAU - Villanueva, J. R. Fernández
AU  - Villanueva JRF
AD  - Hospital Clínico Universitario de Santiago de Compostela, Critical Care Unit,
      Santiago de Compostela, Spain
FAU - Garda, R. Fernández
AU  - Garda RF
AD  - Hospital Clínico Universitario de Santiago de Compostela, Critical Care Unit,
      Santiago de Compostela, Spain
FAU - Lago, A. M. López
AU  - Lago AML
AD  - Hospital Clínico Universitario de Santiago de Compostela, Critical Care Unit,
      Santiago de Compostela, Spain
FAU - Ruiz, E. Rodríguez
AU  - Ruiz ER
AD  - Hospital Clínico Universitario de Santiago de Compostela, Critical Care Unit,
      Santiago de Compostela, Spain
FAU - Vaquero, R. Hernández
AU  - Vaquero RH
AD  - Hospital Clínico Universitario de Santiago de Compostela, Critical Care Unit,
      Santiago de Compostela, Spain
FAU - Rodríguez, C. Galbán
AU  - Rodríguez CG
AD  - Hospital Clínico Universitario de Santiago de Compostela, Critical Care Unit,
      Santiago de Compostela, Spain
FAU - Pérez, E. Varo
AU  - Pérez EV
AD  - Hospital Clínico Universitario de Santiago de Compostela, Abdominal Transplant
      Unit, Santiago de Compostela, Spain
FAU - Hilasque, C.
AU  - Hilasque C
AD  - St. George’s Healthcare Trust, Neuro ICU, London, UK
FAU - Oliva, I.
AU  - Oliva I
AD  - Hospital Universitari Joan XXIII, Intensive Care Unit, Tarragona, Spain
FAU - Sirgo, G.
AU  - Sirgo G
AD  - Hospital Universitari Joan XXIII, Intensive Care Unit, Tarragona, Spain
FAU - Martin, M. C.
AU  - Martin MC
AD  - Hospital Universitario de Torrejón, Intensive Care Unit, Madrid, Spain
FAU - Olona, M.
AU  - Olona M
AD  - Department of Preventive Medicine, Hospital Universitari Joan XXIII, Tarragona,
      Spain
FAU - Gilavert, M. C.
AU  - Gilavert MC
AD  - Hospital Universitari Joan XXIII, Intensive Care Unit, Tarragona, Spain
FAU - Bodí, M.
AU  - Bodí M
AD  - Hospital Universitari Joan XXIII, Intensive Care Unit, Tarragona, Spain
FAU - Ebm, C.
AU  - Ebm C
AD  - WPK Hopsital, Vienna, Austria
FAU - Aggarwal, G.
AU  - Aggarwal G
AD  - Royal Surrey County Hospital, Guildford, UK
FAU - Huddart, S.
AU  - Huddart S
AD  - Royal Surrey County Hospital, Guildford, UK
FAU - Quiney, N.
AU  - Quiney N
AD  - Royal Surrey County Hospital, Guildford, UK
FAU - Cecconi, M.
AU  - Cecconi M
AD  - St. George’s Healthcare Trust, London, UK
FAU - Fernandes, S. M.
AU  - Fernandes SM
AD  - Hospital de Santa Maria/CHLN, Serviço de Medicina Intensiva, Lisboa, Portugal
FAU - Silva, J. Santos
AU  - Silva JS
AD  - Hospital de Santa Maria/CHLN, Serviço de Medicina Intensiva, Lisboa, Portugal
FAU - Gouveia, J.
AU  - Gouveia J
AD  - Hospital de Santa Maria/CHLN, Serviço de Medicina Intensiva, Lisboa, Portugal
FAU - Silva, D.
AU  - Silva D
AD  - Hospital de Santa Maria/CHLN, Serviço de Medicina Intensiva, Lisboa, Portugal
FAU - Marques, R.
AU  - Marques R
AD  - Hospital de Santa Maria/CHLN, Serviço de Medicina Intensiva, Lisboa, Portugal
FAU - Bento, H.
AU  - Bento H
AD  - Hospital de Santa Maria/CHLN, Lisboa, Portugal
FAU - Alvarez, A.
AU  - Alvarez A
AD  - Hospital de Santa Maria/CHLN, Serviço de Medicina Intensiva, Lisboa, Portugal
FAU - Silva, Z. Costa
AU  - Silva ZC
AD  - Hospital de Santa Maria/CHLN, Serviço de Medicina Intensiva, Lisboa, Portugal
FAU - Diaz, D. Díaz
AU  - Diaz DD
AD  - Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain
FAU - Martínez, M. Villanova
AU  - Martínez MV
AD  - Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain
FAU - Herrejon, E. Palencia
AU  - Herrejon EP
AD  - Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain
FAU - de la Gandara, A. Martinez
AU  - de la Gandara AM
AD  - Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain
FAU - Gonzalo, G.
AU  - Gonzalo G
AD  - Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain
FAU - Lopez, M. A.
AU  - Lopez MA
AD  - Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain
FAU - de Gopegui Miguelena, P. Ruíz
AU  - de Gopegui Miguelena PR
AD  - Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain
FAU - Matilla, C. I. Bernal
AU  - Matilla CIB
AD  - Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain
FAU - Chueca, P. Sánchez
AU  - Chueca PS
AD  - Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain
FAU - Longares, M. D. C. Rodríguez
AU  - Longares MDCR
AD  - Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain
FAU - Abril, R. Ramos
AU  - Abril RR
AD  - Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain
FAU - Aguilar, A. L. Ruíz
AU  - Aguilar ALR
AD  - Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain
FAU - de Murillas, R. Garrido López
AU  - de Murillas RGL
AD  - Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain
FAU - Fernández, R. Fernández
AU  - Fernández RF
AD  - Hospital Comarcal Santa Ana, UCI, Motril, Spain
FAU - Laborías, P. Morales
AU  - Laborías PM
AD  - Hospital Comarcal Santa Ana, Motril, Spain
FAU - Castellanos, M. A. Díaz
AU  - Castellanos MAD
AD  - Hospital Comarcal Santa Ana, Motril, Spain
FAU - Laborías, M. E. Morales
AU  - Laborías MEM
AD  - Hospital Comarcal Santa Ana, Motril, Spain
FAU - Cho, J.
AU  - Cho J
AD  - Inha University Hospital, Pulmonary and Critical Care, Incheon, Republic of Korea
FAU - Kim, J.
AU  - Kim J
AD  - Inha University Hospital, Pulmonary and Critical Care, Incheon, Republic of Korea
FAU - Park, J.
AU  - Park J
AD  - Inha University Hospital, Pulmonary and Critical Care, Incheon, Republic of Korea
FAU - Woo, S.
AU  - Woo S
AD  - Inha University, Internal Medicine, Incheon, Republic of Korea
FAU - West, T.
AU  - West T
AD  - University Hospital of Wales, Anaesthetics, Cardiff, UK
FAU - Powell, E.
AU  - Powell E
AD  - Royal Gwent Hospital, Newport, UK
FAU - Rimmer, A.
AU  - Rimmer A
AD  - Royal Gwent Hospital, Newport, UK
FAU - Orford, C.
AU  - Orford C
AD  - Royal Gwent Hospital, Newport, UK
FAU - Jones, N.
AU  - Jones N
AD  - Royal Gwent Hospital, Newport, UK
FAU - Williams, J.
AU  - Williams J
AD  - Royal Gwent Hospital, Newport, UK
FAU - Matilla, C. I. Bernal
AU  - Matilla CIB
AD  - Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain
FAU - de Gopegui Miguelena, P. Ruiz
AU  - de Gopegui Miguelena PR
AD  - Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain
FAU - Chueca, P. Sánchez
AU  - Chueca PS
AD  - Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain
FAU - Abril, R. Ramos
AU  - Abril RR
AD  - Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain
FAU - Longares, M. D. C. Rodríguez
AU  - Longares MDCR
AD  - Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain
FAU - Aguilar, A. L. Ruíz
AU  - Aguilar ALR
AD  - Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain
FAU - de Murillas, R. Garrido López
AU  - de Murillas RGL
AD  - Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain
FAU - Bourne, R. S.
AU  - Bourne RS
AD  - Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
FAU - Shulman, R.
AU  - Shulman R
AD  - University College London Hospitals NHS Foundation Trust, London, UK
FAU - Tomlin, M.
AU  - Tomlin M
AD  - Southampton University Hospitals NHS Trust, Southampton, UK
FAU - Mills, G. H.
AU  - Mills GH
AD  - Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
FAU - Borthwick, M.
AU  - Borthwick M
AD  - Oxford University Hospitals NHS Foundation Trust, Oxford, UK
FAU - Berry, W.
AU  - Berry W
AD  - Guy’s and St Thomas’ NHS Foundation Trust, London, UK
FAU - Huertas, D. García
AU  - Huertas DG
AD  - Complejo Hospitalario de Granada, Granada, Spain
FAU - Manzano, F.
AU  - Manzano F
AD  - Complejo Hospitalario de Granada, Granada, Spain
FAU - Villagrán-Ramírez, F.
AU  - Villagrán-Ramírez F
AD  - Complejo Hospitalario de Granada, Granada, Spain
FAU - Ruiz-Perea, A.
AU  - Ruiz-Perea A
AD  - Complejo Hospitalario de Granada, Granada, Spain
FAU - Rodríguez-Mejías, C.
AU  - Rodríguez-Mejías C
AD  - Complejo Hospitalario de Granada, Granada, Spain
FAU - Santiago-Ruiz, F.
AU  - Santiago-Ruiz F
AD  - Complejo Hospitalario de Granada, Granada, Spain
FAU - Colmenero-Ruiz, M.
AU  - Colmenero-Ruiz M
AD  - Complejo Hospitalario de Granada, Granada, Spain
FAU - König, C.
AU  - König C
AD  - Department of Anesthesiology and Intensive Care Medicine, Jena University
      Hospital, Jena, Germany
FAU - Matt, B.
AU  - Matt B
AD  - Department of Anesthesiology and Intensive Care Medicine, Jena University
      Hospital, Jena, Germany
FAU - Kortgen, A.
AU  - Kortgen A
AD  - Department of Anesthesiology and Intensive Care Medicine, Jena University
      Hospital, Jena, Germany
FAU - Hartog, C. S.
AU  - Hartog CS
AD  - Department of Anesthesiology and Intensive Care Medicine, Jena University
      Hospital, Jena, Germany
FAU - Wong, A.
AU  - Wong A
AD  - Oxford University Hospitals NHS Trust, OCCULAR Group, Adult Intensive Care Unit, 
      Oxford, UK
FAU - Balan, C.
AU  - Balan C
AD  - Oxford University Hospitals NHS Trust, OCCULAR Group, Adult Intensive Care Unit, 
      Oxford, UK
FAU - Barker, G.
AU  - Barker G
AD  - Oxford University Hospitals NHS Trust, OCCULAR Group, Adult Intensive Care Unit, 
      Oxford, UK
FAU - Srisawat, N.
AU  - Srisawat N
AD  - Chulalongkorn university, Medicine, Bangkok, Thailand
FAU - Peerapornratana, S.
AU  - Peerapornratana S
AD  - Chulalongkorn university, Medicine, Bangkok, Thailand
FAU - Laoveeravat, P.
AU  - Laoveeravat P
AD  - Chulalongkorn university, Medicine, Bangkok, Thailand
FAU - Tachaboon, S.
AU  - Tachaboon S
AD  - Chulalongkorn university, Medicine, Bangkok, Thailand
FAU - Eiam-ong, S.
AU  - Eiam-ong S
AD  - Chulalongkorn university, Medicine, Bangkok, Thailand
FAU - Paratz, J.
AU  - Paratz J
AD  - University of Queensland, Brisbane, Australia
FAU - Kayambu, G.
AU  - Kayambu G
AD  - University of Queensland, Brisbane, Australia
FAU - Boots, R.
AU  - Boots R
AD  - University of Queensland, Brisbane, Australia
FAU - Arzapalo, M. F. Aguilar
AU  - Arzapalo MFA
AD  - SSA UADY, Mérida, Mexico
FAU - Vlasenko, R.
AU  - Vlasenko R
AD  - NN Blokhin Russisn Cancer Research Center, Moscow, Russian Federation
FAU - Gromova, E.
AU  - Gromova E
AD  - NN Blokhin Russisn Cancer Research Center, Moscow, Russian Federation
FAU - Loginov, S.
AU  - Loginov S
AD  - Moscow Botkin Clinic, Moscow, Russian Federation
FAU - Kiselevskiy, M.
AU  - Kiselevskiy M
AD  - NN Blokhin Russisn Cancer Research Center, Moscow, Russian Federation
FAU - Dolgikova, Y.
AU  - Dolgikova Y
AD  - NN Blokhin Russisn Cancer Research Center, Moscow, Russian Federation
FAU - Tang, K. B.
AU  - Tang KB
AD  - North District Hospital, Hong Kong, Hong Kong China
FAU - Chau, C. M.
AU  - Chau CM
AD  - North District Hospital, Hong Kong, Hong Kong China
FAU - Lam, K. N.
AU  - Lam KN
AD  - North District Hospital, Hong Kong, Hong Kong China
FAU - Gil, E.
AU  - Gil E
AD  - Samsung Medical Center, Critical Care Medicine, Seoul, Republic of Korea
FAU - Suh, G. Y.
AU  - Suh GY
AD  - Samsung Medical Center, Critical Care Medicine, Seoul, Republic of Korea
FAU - Park, C. M.
AU  - Park CM
AD  - Samsung Medical Center, Critical Care Medicine, Seoul, Republic of Korea
FAU - Park, J.
AU  - Park J
AD  - Samsung Medical Center, Critical Care Medicine, Seoul, Republic of Korea
FAU - Chung, C. R.
AU  - Chung CR
AD  - Samsung Medical Center, Critical Care Medicine, Seoul, Republic of Korea
FAU - Lee, C. T.
AU  - Lee CT
AD  - Department of Anesthesiology, National Taiwan University Hospital, Taipei,
      Taiwan, Province of China
FAU - Chao, A.
AU  - Chao A
AD  - Department of Anesthesiology, National Taiwan University Hospital, Taipei,
      Taiwan, Province of China
FAU - Shih, P. Y.
AU  - Shih PY
AD  - Department of Anesthesiology, National Taiwan University Hospital, Taipei,
      Taiwan, Province of China
FAU - Chang, Y. F.
AU  - Chang YF
AD  - Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan,
      Province of China
FAU - Lai, C. H.
AU  - Lai CH
AD  - Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan,
      Province of China
FAU - Hsu, Y. C.
AU  - Hsu YC
AD  - Department of Anesthesiology, National Taiwan University Hospital, Taipei,
      Taiwan, Province of China
FAU - Yeh, Y. C.
AU  - Yeh YC
AD  - Department of Anesthesiology, National Taiwan University Hospital, Taipei,
      Taiwan, Province of China
FAU - Cheng, Y. J.
AU  - Cheng YJ
AD  - Department of Anesthesiology, National Taiwan University Hospital, Taipei,
      Taiwan, Province of China
FAU - Colella, V.
AU  - Colella V
AD  - Ospedale Sant’Anna e San Sebastiano, U.O. di Anestesia e Rianimazione, Caserta,
      Italy
FAU - Zarrillo, N.
AU  - Zarrillo N
AD  - Ospedale Sant’Anna e San Sebastiano, U.O. di Anestesia e Rianimazione, Caserta,
      Italy
FAU - D’Amico, M.
AU  - D’Amico M
AD  - Ospedale S. Maria delle Grazie - ASL Napoli 2 Nord, U.O. di Anestesia e
      Rianimazione, Pozzuoli, Italy
FAU - Forfori, F.
AU  - Forfori F
AD  - AOUP Università degli Studi di Pisa, IV U.O. di Anestesia e Rianimazione, Pisa,
      Italy
FAU - Pezza, B.
AU  - Pezza B
AD  - Ospedale Sant’Anna e San Sebastiano, U.O. di Anestesia e Rianimazione, Caserta,
      Italy
FAU - Laddomada, T.
AU  - Laddomada T
AD  - San Marco Hospital, Anesthesia and Intensive Care, Zingonia, Italy
FAU - Beltramelli, V.
AU  - Beltramelli V
AD  - San Marco Hospital, Anesthesia and Intensive Care, Zingonia, Italy
FAU - Pizzaballa, M. L.
AU  - Pizzaballa ML
AD  - San Marco Hospital, Anesthesia and Intensive Care, Zingonia, Italy
FAU - Doronzio, A.
AU  - Doronzio A
AD  - San Marco Hospital, Anesthesia and Intensive Care, Zingonia, Italy
FAU - Balicco, B.
AU  - Balicco B
AD  - San Marco Hospital, Anesthesia and Intensive Care, Zingonia, Italy
FAU - Kiers, D.
AU  - Kiers D
AD  - Department of Intensive Care Medicine, Radboud University Nijmegen Medical
      Centre, Nijmegen, Netherlands
FAU - van der Heijden, W.
AU  - van der Heijden W
AD  - Department of Internal Medicine, Radboud University Nijmegen Medical Centre,
      Nijmegen, Netherlands
FAU - Gerretsen, J.
AU  - Gerretsen J
AD  - Department of Intensive Care Medicine, Radboud University Nijmegen Medical
      Centre, Nijmegen, Netherlands
FAU - de Mast, Q.
AU  - de Mast Q
AD  - Department of Internal Medicine, Radboud University Nijmegen Medical Centre,
      Nijmegen, Netherlands
FAU - el Messaoudi, S.
AU  - el Messaoudi S
AD  - Department of Pharmacology and Toxicology, Radboud University Nijmegen Medical
      Centre, Nijmegen, Netherlands
FAU - Rongen, G.
AU  - Rongen G
AD  - Department of Pharmacology and Toxicology, Radboud University Nijmegen Medical
      Centre, Nijmegen, Netherlands
FAU - Gomes, M.
AU  - Gomes M
AD  - Department of Cardiology, Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands
FAU - Kox, M.
AU  - Kox M
AD  - Department of Intensive Care Medicine, Radboud University Nijmegen Medical
      Centre, Nijmegen, Netherlands
FAU - Pickkers, P.
AU  - Pickkers P
AD  - Department of Intensive Care Medicine, Radboud University Nijmegen Medical
      Centre, Nijmegen, Netherlands
FAU - Riksen, N. P.
AU  - Riksen NP
AD  - Department of Internal Medicine, Radboud University Nijmegen Medical Centre,
      Nijmegen, Netherlands
FAU - Kashiwagi, Y.
AU  - Kashiwagi Y
AD  - Department of Anesthesiology, Asahikawa Medical University, Asahikawa City,
      Hokkaido Japan
FAU - Okada, M.
AU  - Okada M
AD  - Department of Emergency Medicine, Asahikawa Medical University, Asahikawa City,
      Hokkaido Japan
FAU - Hayashi, K.
AU  - Hayashi K
AD  - Department of Emergency Medicine, Asahikawa Medical University, Asahikawa City,
      Hokkaido Japan
FAU - Inagaki, Y.
AU  - Inagaki Y
AD  - Department of Emergency Medicine, Asahikawa Medical University, Asahikawa City,
      Hokkaido Japan
FAU - Fujita, S.
AU  - Fujita S
AD  - Department of Emergency Medicine, Asahikawa Medical University, Asahikawa City,
      Hokkaido Japan
FAU - Nakamae, M. N.
AU  - Nakamae MN
AD  - Federal University of São Paulo, Surgery, São Paulo, Brazil
FAU - Kang, Y. R.
AU  - Kang YR
AD  - Federal University of São Paulo, Surgery, São Paulo, Brazil
FAU - Souza, R. B.
AU  - Souza RB
AD  - Federal University of São Paulo, Morphology and Genetics, São Paulo, Brazil
FAU - Liberatore, A. M. A.
AU  - Liberatore AMA
AD  - Federal University of São Paulo, Surgery, São Paulo, Brazil
FAU - Koh, I. H. J.
AU  - Koh IHJ
AD  - Federal University of São Paulo, Surgery, São Paulo, Brazil
FAU - Blet, A.
AU  - Blet A
AD  - Inserm, UMR-S 942, Paris, France
FAU - Sadoune, M.
AU  - Sadoune M
AD  - Inserm, UMR-S 942, Paris, France
FAU - Lemarié, J.
AU  - Lemarié J
AD  - CHU Nancy, Hôpital Central, Medical Intensive Care Unit, Nancy, France
FAU - Bihry, N.
AU  - Bihry N
AD  - AP-HP, Cardiology, Paris, France
FAU - Bern, R.
AU  - Bern R
AD  - Inserm, UMR-S 942, Paris, France
FAU - Polidano, E.
AU  - Polidano E
AD  - Inserm, UMR-S 942, Paris, France
FAU - Merval, R.
AU  - Merval R
AD  - Inserm, UMR-S 942, Paris, France
FAU - Launay, J. M.
AU  - Launay JM
AD  - AP-HP, Biochemistry and Molecular Biology, Paris, France
FAU - Lévy, B.
AU  - Lévy B
AD  - CHU Nancy, Hôpital Brabois, Medical Intensive Care Unit, Nancy, France
FAU - Samuel, J. L.
AU  - Samuel JL
AD  - Inserm, UMR-S 942, Paris, France
FAU - Mebazaa, A.
AU  - Mebazaa A
AD  - Inserm, UMR-S 942, Paris, France
FAU - Hartmann, J.
AU  - Hartmann J
AD  - Danube University Krems, Center for Biomedical Technology, Krems, Austria
FAU - Harm, S.
AU  - Harm S
AD  - Danube University Krems, Center for Biomedical Technology, Krems, Austria
FAU - Weber, V.
AU  - Weber V
AD  - Danube University Krems, Center for Biomedical Technology, Krems, Austria
LA  - eng
PT  - Journal Article
DEP - 20160929
TA  - Intensive Care Med Exp
JT  - Intensive Care Medicine Experimental
AID - 98 [pii]
AID - 10.1186/s40635-016-0098-x [doi]
SO  - Intensive Care Med Exp. 2016 Sep 29;4(Suppl 1):. doi:10.1186/s40635-016-0098-x.

PMC - PMC4937986
PMID- 27402994
IS  - 0002-9459 (Print)
IS  - 1553-6467 (Electronic)
VI  - 80
IP  - 5
DP  - 2016 Jun 25
TI  - 117th Annual Meeting of the American Association of Colleges of Pharmacy,
      Anaheim, California, July 23-27, 2016.
LID - S2
LA  - eng
PT  - Journal Article
TA  - Am J Pharm Educ
JT  - American Journal of Pharmaceutical Education
AID - 10.5688/ajpe805S2 [doi]
AID - ajpeS2 [pii]
SO  - Am J Pharm Educ. 2016 Jun 25;80(5):. doi:10.5688/ajpe805S2.

PMC - PMC4912513
PMID- 27316915
IS  - 2110-5820 (Electronic)
VI  - 6
IP  - Suppl 1
DP  - 2016
TI  - French Intensive Care Society, International congress – Réanimation 2016.
LID - 50
AB  - PHYSICIANS ABSTRACTSO1 Impact of tracheal cuff shape on microaspiration of
      gastric contents in intubated critically ill patients: a multicenter randomized
      controlled study (BEST CUFF)Emmanuelle Jaillette, Christophe Girault, Guillaume
      Brunin, Farid Zerimech, Arnaud Chiche, Céline Broucqsault-Dedrie, Cyril Fayolle, 
      Franck Minacori, Isabelle Alves, Stephanie Barrailler, Laurent Robriquet,
      Fabienne Tamion, Emmanuel Delaporte, Damien Thellier, Claire Delcourte, Alain
      Duhamel, Saad NseirO2 Bicarbonate versus saline for contrast-induced acute kidney
      injury prevention in critically ill patientsXavier Valette, Isabelle Desmeulles, 
      Benoit Savary, Romain Masson, Amélie Seguin, Cédric Daubin, Bertrand Sauneuf,
      Jennifer Brunet, Pierre Verrier, Véronique Pottier, Marie Orabona, Désiré Samba, 
      Gérald Viquesnel, Mathilde Lermuzeaux, Pascal Hazera, Jean-Luc Hanouz,
      Jean-Jacques Parienti, Damien Du CheyronO3 Neurally adjusted ventilatory assist
      in the early phase of weaning from mechanical ventilation: a multicenter
      randomized studyAlexandre Demoule, Marc Clavel, Camille Rolland-Debord, Sébastien
      Perbet, Nicolas Terzi, Achille Kouatchet, Florent Wallet, Hadrien Roze, Frédéric 
      Vargas, Claude Guérin, Jean Dellamonica, Samir Jaber, Thomas SimilowskiO4 Very
      high volume hemofiltration with the Cascade system in septic shock
      patientsJean-Pierre Quenot, Christine Binquet, Christophe Vinsonneau,
      Saber-Davide Barbar, Sandrine Vinault,, Valérie Deckert, Stephanie Lemaire, Ali
      Ait Hssain, Rémi Bruyère, Bertrand Souweine, Laurent Lagrost, Christophe AdrieO5 
      Effect of rapid response systems on hospital mortality, a prospective
      interventional study and systematic reviewBoris Jung, Aurelien Daurat, Audrey De 
      Jong, Gérald Chanques, Martin Mahul,, Marion Monnin, Nicolas Molinari, Samir
      JaberO6 Beta-lactams serum concentrations in critically ill cirrhotic patients: a
      matched control studyOlivier Lheureux, Eric Trepo, Maya Hites, Frederic Cotton,
      Fleur Wolff, Rudy Surin, Jacques Créteur, Jean-Louis Vincent, Thierry Gustot,
      Frederique Jacobs, Fabio Silvio TacconeO7 Systematic overdosing of oxa- and
      cloxacillin in severe infections treated in ICU: Risk factors and side
      effectsMathilde Neuville, Jean-François Timsit, Najoua El-Helali, Alban Le
      Monnier, Eric Magalhaes, Aguila Radjou, Roland Smonig, Jean-François Soubirou,
      Guillaume Voiriot, Romain Sonneville, Lila Bouadma, Bruno MourvillierO8 Amikacin 
      peak concentrations in patients receiving extracorporeal membrane oxygenation
      (ECMO) support: a case–control studyElodie Gélisse, Mathilde Neuville, Etienne De
      Montmollin, Guillaume Voiriot, Jean-François Soubirou, Roland Smonig, Aguila
      Radjou, Eric Magalhaes, Lila Bouadma, Bruno Mourvillier, Jean-François Timsit,
      Romain SonnevilleO9 A high aminoglycoside regimen associated with renal
      replacement therapy for the treatment of multi-drug-resistant pathogensAlexandre 
      Brasseur, Maya Hites, Sandrine Roisin, Frederic Cotton, Jean-Louis Vincent,
      Daniel De Backer, Frederique Jacobs, Fabio Silvio TacconeO10 Optimization of
      administration of vancomycin in septic patients: a prospective randomized
      studyValerie Van Ruychevelt, Eric Carlier, Michael Piagnerelli, Michel
      Vanhaeverbeek, Christine Danguy, Patrick BistonO11 Impact of elevated
      intra-abdominal pressure on the ability of dynamic parameters to predict fluid
      responsivenessSiu-Ming Au, Emmanuelle Begot, François Dalmay, Xavier Repessé,
      Gwenael Prat, Koceila Bouferrache, Michel Slama, Philippe Vignon, Antoine
      Vieillard-BaronO12 Passive leg raising for predicting fluid responsiveness: a
      systematic review and meta-analysisXavier Monnet, Paul Marik, Jean-Louis
      TeboulO13 Predicting volume responsiveness by using combined end-expiratory and
      end-inspiratory occlusion tests with echocardiographyMathieu Jozwiak, Jean-Louis 
      Teboul, Christian Richard, Xavier MonnetO14 Early dynamic left intraventricular
      obstruction is associated with hypovolemia and hight mortality in septic shock
      patientsJean-Louis Chauvet, Shari El-Dash, Olivier Delastre, Bernard Bouffandeau,
      Dominique Jusserand, Jean-Baptiste Michot, Fabrice Bauer, Julien Maizel, Michel
      SlamaO15 Predictive factors for poor hemodynamic tolerance to fluid removal in
      ICU: the DepleRea studyFrançois Brazier, Pablo Mercado, Loay Kontar, Dimitri
      Titeca, Bertand De Cagny, Gaelle Bacari-Risal, Antoine Riviere, Michel Slama,
      Julien MaizelO16 High-flow nasal cannula: first-line treatment of noninvasive
      ventilation for infants with bronchiolitis. Applicability and risk factors for
      failureCamille Guillot, Claire Le Reun, Marie Lampin, Ahmed Sadik, Astrid Botte, 
      Alain Duhamel, Stéphane LeteurtreO17 Is high-flow nasal cannula better than nasal
      continuous positive airway pressure for bronchiolitis management in pediatric
      intensive care unit?Aurélie Collins, Céline Kempeneers, Nathalie CajgfingerO18
      Interest and risk of high-flow cannula during acute hypoxemic pneumonia in
      children: a retrospective studyCamille Ohlmann, Robin Pouyau, Fabien Subtil,
      Florent Baudin, Bruno Massenavette, Etienne JavouheyO19 Interest of high-flow
      nasal cannula (HFNC) versus nasal continuous positive airway pressure (nCPAP)
      during the initial management of severe bronchiolitis in infants: a multicenter
      randomized controlled trialChristophe Milesi, Sandrine Essouri, Robin Pouyau,,
      Jean-Michel Liet, Mickael Afanetti, Julien Baleine, Sabine Durand, Philippe
      Durand, Etienne Javouhey, Jean Christophe Roze, Didier Dupont, Gilles CambonieO20
      Outcome of severe cerebral venous thrombosis in intensive care unit: a cohort
      studyBenjamin Soyer, Marco Rusca, Anne-Claire Lukaszewicz, Isabelle Crassard,
      Jean-Pierre Guichard, Damien Bresson, Didier Payen de la GaranderieO21 Brain
      lesion spectrum characterization in an experimental model of infective
      endocarditisMarie Cantier, Candice Sabben, Liliane Louedec, Sandrine Delbosc,
      Clément Journé, Phalla Ou, Isabelle Klein, Françoise Chau, Agnes Lefort,
      Jean-Philippe Desilles, Jean-Baptiste Michel, Romain Sonneville, Mikaël
      MazighiO22 Outcome of patients with Parkinson’s disease admitted in intensive
      care unitOmar Ben Hadj Salem, Sophie Demeret, Alexandre Demoule, Thomas
      Similowski, Francis Bolgert, Tarek Sharshar, David GrabliO23 Cerebrospinal fluid 
      glucose and lactate concentrations after subarachnoid hemorrhageSafa Arib, Ilaria
      Alice Crippa, Jacques Créteur, Jean-Louis Vincent, Fabio Silvio TacconeO24
      Spontaneous angionegative subarachnoidal hemorrhage: neurological outcome based
      on a retrospective study of 68 patientsAlexis Soummer, Nicolas Engrand, Pierre
      Guedin, Grégoire Trebbia, Sorin Aldea, Charles CerfO25 Serious game evaluation of
      a one-hour training basic life support session for secondary school students: new
      tools for future bystandersVictoire Desailly, Pierre Pasquier, Patrick Brun,
      Damien Roux, Jonathan Messika, Gwendoline Latournerie, Laetitia Kasprzyk, Vincent
      Grosjean, Amine Latreche, Pierre Habert, Stephane Huot, Timon Jobin, Antoine
      Tesnière, Didier Dreyfuss, Jean-Damien Ricard, Alexandre Mignon, Stéphane
      GaudryO26 Refractory out-of-hospital refractory cardiac arrest treated by
      veno-arterial extracorporeal membrane oxygenation. A retrospective single-center 
      experience from 2012 to 2015. CARECMO program (Cardiac ARrest Extra Corporeal
      Membrane Oxygenation)François-Xavier Laithier, Antoine Kimmoun, Tahar Chouihed,
      Stéphane Albizzati, Edoardo Camenzind, Fabrice Vanhuyse, Bruno LevyO27 Decreased 
      monocyte HLA-DR expression after out-of-hospital cardiac arrestMartin Cour,
      Fabienne Venet, Romain Hernu, Julie Demaret, Guillaume Monneret, Laurent
      ArgaudO28 Is emergent PCI associated with a clinical benefit in post-cardiac
      arrest patients without ST-segment elevation pattern? Insights from the PROCAT II
      registryFlorence Dumas, Wulfran Bougouin, Guillaume Geri, Lionel Lamhaut, Julien 
      Rosencher, Frédéric Pène, Jean-Daniel Chiche, Olivier Varenne, Pierre Carli,
      Xavier Jouven, Jean-Paul Mira, Christian Spaulding, Alain CariouO29 Predictors of
      long-term quality of life after cardiac arrest: insights from the Parisian
      registryGuillaume Geri, Florence Dumas, Franck Bonnetain,, Wulfran Bougouin,
      Benoit Champigneulle, Michel Arnaout, Pierre Carli, Eloi Marijon, Olivier
      Varenne, Jean-Paul Mira, Jean Philippe Empana, Alain CariouO30 Red blood cell
      transfusions in early resuscitation of severe sepsis and septic shock in patients
      with hematological malignanciesAdrien Mirouse, Matthieu Resche-Rigon, Virginie
      Lemiale, Djamel Mokart, François Vincent, Julien Mayaux, Antoine Rabbat, Martine 
      Nyunga, Anne Pascale Meert, Dominique Benoit, Achille Kouatchet, Michaël Darmon, 
      Fabrice Bruneel, Elie Azoulay, Frédéric PèneO31 Causal effect of transfusion on
      mortality and other adverse events among critically ill septic patients: an
      observational study with a marginal structural modelClaire Dupuis, Michaël
      Darmon, Carole Schwebel, Elie Azoulay, Romain Sonneville, Lila Bouadma, Roland
      Smonig, Yves Cohen, Stéphane Ruckly, Christophe Adrie, Dany Goldgran-Toledano,
      Sébastien Bailly, Guillaume Marcotte, Maïté Garrouste-Orgeas, Jean-François
      TimsitO32 Autoimmune hemolytic anemia in the intensive care unitAntoine Lafarge, 
      Claire Pichereau, Sandrine Valade, Marion Venot, Akli Chermak, Igor Theodose,
      Marion Scotto, Delphine Kemlin, Claire Givel, Leïla Mourtada, Etienne Ghrenassia,
      Emmanuel Canet, Virginie Lemiale, Benoît Schlemmer, Elie Azoulay, Eric
      MariotteO33 Pre-ICU location, lead time bias and outcomes in patients with
      thrombotic microangiopathiesDamien Vimpere, Sandrine Valade, Marion Venot, Claire
      Pichereau, Akli Chermak, Virginie Lemiale, Emmanuel Canet, Lionel Galicier, Elie 
      Azoulay, Eric MariotteO34 Septic shocks with no early etiological diagnosis: a
      multicenter prospective cohort study (the shock 24 study)Damien Contou, Damien
      Roux, Sebastien Jochmans, Remi Coudroy, Emmanuel Guérot, David Grimaldi, Sylvie
      Ricome, Eric Maury, Gaëtan Plantefève, Julien Mayaux, Armand Mekontso Dessap,
      Christian Brun-Buisson, Nicolas de ProstO35 Respective contribution of diaphragm 
      and limbs muscles weakness on weaning from mechanical ventilation
      outcomeAlexandre Demoule, Bruno-Pierre Dubé, Julien Mayaux, Julie Delemazure,
      Thomas Similowski, Martin DresO36 Impact of sleep quality on the duration of
      weaning from mechanical ventilationLudivine Rousseau, Xavier Drouot, Véronique
      Diaz, Yohann Rebollar, Jean-Pierre Frat, Remi Coudroy, René Robert, Arnaud, W
      Thille, Groupe ALIVEO37 Integrative ultrasound assessment of lung, cardiac and
      diaphragm function during a successful weaning trial predicts postextubation
      distressDalinda Ait Aissa, Pierre Coquet, Jean Ruiz, Fabrice Ferre, Lucille
      Hoarau, Béatrice Riu-Poulenc, Benoit Bataille, Stein SilvaO38 ETCO2 improved
      outcome prediction of mechanical ventilation weaningJean-Luc Baudel, Simon
      Bourcier, Claire Pichereau, Naïke Bigé, Jalel Tahiri, Vincent Dubée, Bertrand
      Guidet, Eric Maury, Hafid Ait-OufellaO39 Characteristics of 150 cases of
      weaning-induced pulmonary oedema and effects of diureticsLiu Jinglun, Feng Shen, 
      Jean-Louis Teboul, Christian Richard, Xavier MonnetO40 Antifungal de-escalation
      was not associated with adverse outcome in critically ill patients treated for
      invasive candidiasisSébastien Bailly, Olivier Leroy, Philippe Montravers,
      Jean-Michel Constantin, Hervé Dupont, Didier Guillemot, Olivier Lortholary,
      Jean-Paul Mira, Pierre-François Perrigault, Jean-Pierre Gangneux, Elie Azoulay,
      Jean-François TimsitO41 Intensive care acquired pneumonia due to
      extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE) among
      patients with prior colonization: Frequency, risk factors and prognosisKeyvan
      Razazi, Armand Mekontso-Dessap, Chloe Jansen, Nicolas de Prost, Christian
      Brun-BuissonO42 Epidemiology, characteristics and outcomes of septic critically
      ill patients after the removal of a totally implantable venous-access portsMarie 
      Lecronier, Valade Sandrine, Naïke Bigé, Nicolas de Prost, Damien Roux,
      Jean-Damien Ricard, Eric Maury, Julien Mayaux, Elie Azoulay, Alexandre Demoule,
      Martin DresO43 Genetic risk of Pseudomonas aeruginosa ventilator-associated
      pneumonia: the EXTENSE studyJean-Paul Mira, Sophie Blein, Nathalie Marin,
      Christophe Rousseau, Julien Charpentier, Jean-Daniel Chiche, Alexandre PachotO44 
      Cytomegalovirus reactivation enhances the virulence of a Staphylococcus aureus
      pneumonia in a mouse modelSami Hraiech, Julien Bordes, Samuel Lehingue,
      Lamballerie Xavier De, Jean-Louis Mège, Jean-Marie Forel, Christophe Guervilly,
      Mélanie Adda, Didier Raoult, Laurent PapazianO45 Families looking back:
      meaning-making after a decision to accept or refuse organ donation. A qualitative
      approachNancy Kentish-Barnes, Zoé Cohen-Solal, Elie AzoulayO46 The letter of
      condolence at the heart of family centered care. A qualitative approach of
      relatives’ experienceNancy Kentish-Barnes, Zoé Cohen-Solal, Virginie Souppart,
      Elie AzoulayO47 Use of a children information booklet to support young relatives 
      visiting a critically ill adult: impact on ICU practicesLionel Kerhuel, Carole
      Haubertin, Isabelle Exbrayat, Elodie Rozières, Audrey Argain, Agnès Suc, Michel
      Vignes, Pierre Cougot, Béatrice Riu-Poulenc, Stein Silva, Olivier Fourcade,
      Elodie BrunelO48 Withdrawal of life-support therapies reporting in ICU randomized
      controlled trial: Let us move to a transparent reporting—a systematic
      reviewJonathan Messika, Stéphane Gaudry, Florence Tubach, Emeline Dubief,
      Blandine Pasquet, Sylvie Guillo, Didier Dreyfuss, Jean-Damien RicardO49 Gasp
      during children end-of-life: healthcare providers’ feelings and
      knowledgeCharlotte Pierron, Marion Grimaud, Caroline Farnoux, Amélie MaillardO50 
      Prognosis of malignant primary brain tumors in intensive care unitMaxens
      Decavèle, Nicolas Weiss, Hélène Prodanovic, Julien Mayaux, Ahmed Idbaih, Agusti
      Alentorn, Jean-Yves Delattre, Thomas Similowski, Alexandre DemouleO51 Impact of
      early immunomodulating treatment on outcome of adult patients with
      anti-N-methyl-d-aspartate receptor encephalitis requiring intensive care: a
      multicentre study with prospective long-term follow-upEtienne De Montmollin,
      Sophie Demeret, Noelle Brule, Marie Conrad, Frédéric Dailler, Nicolas Lerolle,
      Jean-Christophe Navellou, Carole Schwebel, Mikael Alves, Martin Cour, Nicolas
      Engrand, Jean-Marie Tonnelier, Stephane Ruckly, Géraldine Picard, Véronique
      Rogemond, Jean-François Timsit, Jérôme Honnorat, Romain Sonneville, ENCEPHALITICA
      study groupO52 Determinants of outcome in critically ill patients with
      hematological malignancy and central neurological failure: data from the TRIAL OH
      studyChiara Marzorati, Virginie Lemiale, Djamel Mokart, Frédéric Pène, Achille
      Kouatchet, Julien Mayaux, François Vincent, Martine Nyunga, Fabrice Bruneel,
      Antoine Rabbat, Christine Lebert, Pierre Perez, Dominique Benoit, Giuseppe
      Citerio, Elie Azoulay, Stéphane LegrielO53 Ammonemia predicts severity and
      outcome in cirrhotic patients with hepatic encephalopathy in ICUSimona Tripon,
      Maxime Mallet, Marika Rudler, Francoise Imbert-Bismut, Dominique Thabut, Nicolas 
      WeissO54 Acute varicella zoster encephalitis admitted to the ICU: a case series
      of 47 patientsEmmanuel Canet, Adrien Mirouse, Romain Sonneville, Laurent Argaud, 
      Stanislas Faguer, Keyvan Razazi, Claude Guérin, Pierre Perez, Anne-Sophie Moreau,
      Claire Pichereau, François Barbier, Sybille Merceron, Amélie Seguin, Julien
      Mayaux, Guillaume Geri, Christophe Guitton, Francois Labadie, Elie AzoulayO55
      High-flow nasal cannula for acute respiratory failure in immunocompromised
      patientsVirginie Lemiale, Matthieu Resche-Rigon, Djamel Mokart, Frédéric Pène,
      Etienne Faucher, Christophe Guitton, Antoine Rabbat, Christophe Girault, Achille 
      Kouatchet, François Vincent, Fabrice Bruneel, Martine Nyunga, Amélie Seguin, Kada
      Klouche, Sylvie Chevret, Elie Azoulay, Groupe de Recherche en Reanimation
      Respiratoire du patient d’Onc-hématologieO56 High-flow oxygen therapy through a
      nasal cannula in immunocompromised patients with acute hypoxemic respiratory
      failureJean-Pierre Frat, Stéphanie Ragot, Christophe Girault, Remi Coudroy, René 
      Robert, Jean-Michel Constantin, Gwenael Prat, Thierry Boulain, Angéline Jamet,,
      Alain Mercat, Laurent Brochard, Arnaud, W. ThilleO57 Prospective validations of
      the PASTEIL score to assess the clinical pretest probability of Pneumocystis
      jirovecii pneumonia (PjP) in patients with hematologic malignancies (HMs) and
      acute respiratory failure (ARF)Elie Azoulay, Sylvie Chevret, Antoine Roux,
      Etienne Faucher, François Vincent, Antoine Rabbat, Achille Kouatchet, Frédéric
      Pène, Julien Mayaux, Pierre Perez, Martine Nyunga, Christophe Guitton, Fabrice
      Bruneel, Kada Klouche, Djamel Mokart, Virginie LemialeO58 Bedside contribution of
      electrical impedance tomography (EIT) to set mechanical ventilation for severe
      acute respiratory distress syndrome (ARDS) on extracorporeal membrane oxygenation
      (ECMO)Guillaume Franchineau, Nicolas Brechot, Guillaume Lebreton, Guillaume
      Hekimian, Ania Nieszkowska, Charles-Edouard Luyt, Pascal Leprince, Jean Louis
      Trouillet, Alain Combes, Matthieu SchmidtO59 Liberal oxygenation versus
      restrictive oxygenation in ICU patients: effects on proinflammatory cytokines,
      sRAGE and organ dysfunctions - results of an ancillary studyLoïc Barrot, Gaël
      Piton, Michael Bailey, Rakshit Panwar, Nicolas Belin, François Belon,, Cyrille
      Patry, Jean-Christophe Navellou, Mathilde Grandperrin, Claire Chaignat, Guylaine 
      Labro, Bérengère Vivet, Gilles CapellierO60 Immature granulocyte level at the
      acute phase of sepsis, a potential prognostic marker of clinical deterioration.
      The Septiflux 2 multicenter trialThomas Daix, Estelle Guérin, Elsa Tavernier,
      Emmanuelle Mercier, Valérie Gissot, Christine Vallejo, Jean-Paul Mira, Christophe
      Guitton, Bruno François, Septiflux trial GroupO61 Analysis of microbiome and
      resistome using next-generation sequencing in urine samples from patients with
      sepsis, severe sepsis or septic shockCéline Ravry, Bruno François, Emmanuelle
      Begot, Nicolas Pichon, Catherine Chapellas, Anne-Laure Fedou, Antoine Galy,
      Marie-Cécile Ploy, Olivier Barraud, Philippe VignonO62 Patients metabolomic
      profiles at intensive care admissionAurelie Thooft, Raphael Conotte, Jean-Marie
      Colet, Patrick Biston, Michael PiagnerelliO63 Lymphocyte phenotype during severe 
      sepsis and septic shockMatthieu Le Dorze, Virginie Tarazona,, Caren Brumpt,,
      Hélène Moins-Teisserenc,, Anne-Claire Lukaszewicz, Didier Payen de la
      GaranderieO64 Myeloid-derived suppressor cells expressing arginase-1 and IDO play
      a major role in immune dysfunction during septic shockFabrice Uhel, Imane
      Azzaoui,, Murielle Gregoire, Céline Pangault, Joëlle Dulong,, Luc Cynober,,
      Jean-Marc Tadié, Mikaël Roussel,, Yves Le Tulzo, Karin TarteO65 Anti-neutrophil
      cytoplasmic antibody (ANCA)-associated vasculitis admitted to the intensive care 
      unit: a multicenter studyJulien Demiselle,, Johann Auchabie,, Julie
      Boisramé-Helms, Pierre François Dequin, Damien Du Cheyron, Michaël Darmon,
      Nicolas Chudeau, Guillaume Geri, René Robert, François Fourrier, Steven Grange,
      Christophe Guitton, Lise Piquilloud, Alexandre Lautrette, Sonia Boyer, Emmanuel
      Guérot, Julien Letheulle, Nicolas LerolleO66 Continuous renal replacement therapy
      versus intermittent hemodialysis: impact on mortality and renal recoveryAnne
      Sophie Truche, Michaël Darmon, Sébastien Bailly, Christophe Clec’h, Claire
      Dupuis, Benoit Misset, Elie Azoulay, Carole Schwebel, Lila Bouadma, Christophe
      Adrie, Guillaume Marcotte, Philippe Zaoui, Virginie Laurent, Dany Goldgran
      Toledano, Romain Sonneville, Bertrand Souweine, Jean-François TimsitO67 Hospital 
      survival and need of renal replacement therapy with respect to AKI duration in
      critically ill patients: results of a multicenter cohort studySophie Perinel
      Ragey, Anne Sophie Truche, Bertrand Souweine, Sébastien Bailly, Elie Azoulay,
      Lila Bouadma, Christophe Clec’h, Maïté Garrouste-Orgeas, Antoine Gros, Carole
      Schwebel, Christophe Adrie, Anne Sylvie Dumenil, Laurent Argaud, Samir Jamali,
      Dany Goldgran Toledano, Guillaume Marcotte, Michaël Darmon, Jean-François Timsit,
      For the OUTCOMEREA study groupO68 Early versus delayed initiation of renal
      replacement therapy in septic acute kidney injury: a retrospective studyMikhael
      Chouraqui, Antoine Dewitte, Brigitte Chastel, Pauline Carles, Catherine Fleureau,
      Olivier Joannes-Boyau, Alexandre OuattaraO69 Renal recovery after severe acute
      kidney injury in critically ill myeloma patientsAdrien Joseph, Marion Venot,
      Sandrine Valade, Eric Mariotte, Claire Pichereau, Akli Chermak, Virginie Lemiale,
      Elie Azoulay, Emmanuel CanetO70 Impact of proactive nurse participation in ICU
      family conferences: a Mixed-Method StudyMaïté Garrouste-Orgeas, Adeline Max,
      Talia Lerin, Charles Grégoire, Stephane Ruckly, Martin Kloeckner, Cédric Bruel,
      Sandie Brochon, Francois Philippart, Emmanuelle Pichot, Clara Simons,
      Jean-François Timsit, Benoit MissetO71 Duration of platelet storage and outcome
      of critically ill patientsAndrew Flint, Cécile Aubron, Michael Bailey, Rinaldo
      Bellomo, David Pilcher, Allen Cheng, Colin Hegarty, Anthony Martinelli, Benjamin 
      Howden, Michael Reade, Zoe McquiltenO72 REA-C-SUR safety culture in intensive
      care in France: is there a link with morbi-mortality conferences?Cédric
      Bretonnière, Daniel Villers, Christophe Guitton, Groupe RMM, Qualité et Sécurité 
      des Soins - CBPR-CFARO73 Survival of critically ill solid cancer patients:
      results of a retrospective multicentre studyM Soares, Virginie Lemiale, Djamel
      Mokart, Frédéric Gonzalez, Fabrice Bruneel, Yves Cohen, Elie Azoulay, Michaël
      Darmon, François Vincent, for the GrrrOH: Groupe de recherche en réanimation
      respiratoire en Onco-Hématologie (Group for Research in Respiratory Intensive
      Care Onco-Hematology)O74 Encouraging results of the French controlled donation
      after circulatory death Maastricht category III ProgramClémence Fauché, Michel
      Muller, Samuel Gay, Olivier Skowron, Albrice Levrat, Didier DorezO75 Clinical
      significance of cardiac troponin I release in severe trauma patientsMaxens
      Decavèle, Arnaud Foucrier, Sebastian Pease, Tobias Gauss, Catherine PaugamO76 The
      modified Glasgow prognostic score is helpful in screening lung cancer patient at 
      risk of hospitalization at the emergency departmentJulie Gorham, Lieveke Ameye,
      Marianne Paesmans, Thierry Berghmans, Jean-Paul Sculier, Anne-Pascale MeertO77
      Relationship between body mass index classes and massive transfusion needs in
      trauma patients and predictive performance of the TASH score in obese and
      non-obese populations: a retrospective study on 910 trauma patientsAudrey De
      Jong, Pauline Deras, Orianne Martinez, Pascal Latry, Samir Jaber, Xavier
      Capdevila, Jonathan CharbitO78 The Eschmann stylet as first tracheal access tool 
      during emergency difficult tracheal intubation: An initial simulation trial
      followed by a clinical studyJaubert J., Celia Etiennar, Lucie Ginoux, Jean-Luc
      Sebbah, Hakim Haouache, Gilles DhonneurO79 Maternal mortality risk factors for
      eclampsiaChaigar Mohammed Cheikh, I. Moussaid, O. Ghazaoui, Kamal Belkadi, S. El 
      Youssoufi, S. SalmiO80 Use of aminoglycosides in cirrhotic patients admitted in
      intensive care for severe sepsis or septic shock: short- and intermediate-term
      impact on renal function and mortalityLaure Pajot, Benjamin Zuber, Carole
      Schwebel, Romain Sonneville, Benoit Misset, Michael Darmon, Guillaume Marcotte,
      Anne Sophie Truche, Dany Goldgran-Toledano, Bertrand Souweine, Samir Jamali,
      Stephane Ruckly, Elie Azoulay, Christophe Clec’h, Jean Pierre Bedos,
      Jean-François Timsit, OutcomeRéaO81 Diagnostic yield and therapeutic impact of
      liver biopsy in the intensive care unitBertrand Sauneuf, Benoit Dupont, Axelle
      Eugène, Jean-Luc Hanouz, Françoise Galateau-Sallé, Nicolas TerziO82 Critically
      ill patients requiring liver transplantation: a 7-year monocentric retrospective 
      experienceBaptiste Michard, Benjamin Lebas, Alexandra Boivin, Max Guillot,
      Jean-Etienne Herbrecht, Marie-Line Harlay, Ralf Janssen-Langenstein, Maleka
      Schenck, Bernard Ellero, Marie-Lorraine Woehl-Jaegle, Camille Besch, Vincent
      Castelain, Philippe Bachellier, Francis SchneiderO83 Hospital survival and access
      to liver transplantation of MARS-treated patients in France, 2004–2008: a
      retrospective multicenter study (RETROMARS)Christophe Camus, Fawzi Saliba,
      Bernard Goubaux, Agnès Bonadona, Laurence Lavayssiere, Catherine Paugam, Alice
      Quinart, Olivier Barbot, Sebastien Dharancy, Bertrand Delafosse, Nicolas Pichon, 
      Helene Barraud, Arnaud Galbois, Benoit Veber, Sophie Cayot, Bruno Souche, Clara
      Locher, RETROMARS Study GroupOlivier Roux, Francesco Figorilli, Antonella
      Putignano, Pauline Houssel, Claire Francoz, Emmanuel Weiss, Catherine Paugam,
      Banwari Agarwal, Rajiv Jalan, François DurandP1 Severe brain injuries:
      epidemiology and outcome in a Tunisian medical intensive care unitHassen Ben
      Ghezala, Salah Snouda, Rebeh Daoudi, Moez KaddourP2 Stroke prognosis in the ICU
      of the regional hospital of Bizerte and withhold and withdrawal treatment
      decisionsHatem Ghadhoune, E. Rachedi, J. Guissouma, A. Ben Slimene, W. Azzeza, H.
      Brahmi, H. ElghordP3 Brain death predictive factors for traumatic brain
      injuryAhmed Youssef Kada, Radia Chikh, Roza Slimani, Kheireddine.a BouyoucefP4
      Guillain–Barré syndrome in intensive care unit: epidemiology and prognostic
      factors: analysis of 30 patientsKais Regaieg, Chtara Kamilia, Najeh Baccouch,
      Olfa Turki, Anis Chaari, Hmida Chokri Ben, Mabrouk Bahloul, Mounir BouazizP5
      Eclampsia: epidemiological and clinical study about 194 casesFatma Kaaniche
      Medhioub, Najeh Baccouch, Manel Zekri, Kais Rgieg, Chokri Bhimada, Bouaziz
      MounirP6 Neuroimagery in eclampsia and preclampsiaChaigar Mohammed Cheikh, I.
      Moussaid, Kamal Belkadi, O. Ghazaoui, S. El Youssoufi, S. SalmiP7 Interest of
      brain oxygen tension measurement (PbrO2) in the diagnosis of cerebral vasospasm
      after aneurismal subarachnoid hemorrhageElodie Lang, Stephane Welschbillig,
      Fabian Roy-Gash, Nicolas EngrandP8 Noninvasive ventilation: an alternative to the
      intubation during myasthenic crisisMathilde Perrin, Fabian Roy-Gash, Stephane
      Welschbillig, Jean-Michel DevysP9 Interest of the transcranial Doppler ultrasound
      in the management of severe traumatic brain injurySoumia Benbernou, Houria
      Mokhtari-Djebli, Sofiane Ilies, Khalida Bouyacoub, Abdelkader AzzaP10 VV-ECMO on 
      ARDS: toward a lower anticoagulation ratio?Elie Zogheib, Joseph Nader, Léonie
      Villeret, Mathieu Guilbart, Patricia Besserve, Thierry Caus, Hervé DupontP11
      Inter-hospital transportation of patients implanted with veno-venous ECMO:
      Experience of the Pitié-Salpêtrière mobile ECMO teamNicolas Brechot, Ciro
      Mastroianni, Matthieu Schmidt, Francesca Santi, Guillaume Lebreton,
      Charles-Edouard Luyt, Jean Louis Trouillet, Ania Nieszkowska, Guillaume Hékimian,
      Leprince Pascal, Jean Chastre, Alain CombesP12 Evolution of tidal volume and
      compliance under pressure-controlled mode during the first 24 hours of ECMO ARDS 
      patients transported to a referral centerHadrien Roze, Benjamin Repusseau,
      Jean-Christophe Richard, Virginie Perrier, Alexandre OuattaraP13 Extracorporeal
      dioxide carbon removal (ECCO2R), a French national surveyBenjamin Deniau,
      Jean-Damien Ricard, Jonathan Messika, Didier Dreyfuss, Stéphane GaudryP14 Levels 
      of microparticles in acute respiratory distress syndrome with veno-venous
      extra-corporeal membrane oxygenationChristophe Guervilly, Fanny Klasen, Sami
      Hraiech, Jean-Marie Forel, Laurent PapazianP15 In patients under extracorporeal
      CO2 removal therapy (ECCO2R) for ARDS can we do prone position? Efficiency,
      stability and safety of the maneuverJean Pierre Ponthus, Polysie Ngasseu,
      Virginie Amilien, Elise Barsam, Pierre Lehericey, Martial Tchir, Jean Francois
      GeorgerP16 Feasibility of the implementation of a technique of extra-corporeal
      CO2 removal (ECCO2R) in an intensive care unit which does not use ECMO and its
      real utilizationVirginie Amilien, Jean Pierre Ponthus, Polysie Ngasseu, Martial
      Tchir, Elise Barsam, Pierre Lehericey, Jean Francois GeorgerP17 Six-hour daily
      session of high-frequency oscillatory ventilation in moderate-to-severe ARDS:
      impact on the end-expiratory lung volume, compliance and oxygenationBérénice
      Puech, David Vandroux, Arnaud Roussiaux, Dominique Belcour, Cyril Ferdynus,
      Olivier Martinet, Julien JabotP18 Can we optimize prescription of laboratory
      tests in surgical intensive care unit (ICU)? Study of appropriateness of
      careMarion Fresco, Gaëlle Demeilliers-Pfister, Véronique Merle, Valéry Brunel,
      Benoit Veber, Bertrand DureuilP19 Impact of the implementation of guidelines for 
      laboratory testing in an intensive care unitSébastien Leydier, Isabelle
      Clerc-Urmes, Jérémie Lemarie, Charles-Henri Maigrat, Marie Conrad, Aurélie
      Cravoisy-Popovic, Damien Barraud, Lionel Nace, Sébastien Gibot, Nelly Agrinier,
      Pierre-Edouard BollaertP20 Identifying useless precaution to reduce costs in
      ICUVincent Peigne, Jean-Louis Daban, Mathieu Boutonnet, Guillaume Dumas,
      Elisabeth Falzone, Patrick Jault, Bernard LenoirP21 The ICU of the teaching
      hospital of KinshasaJoseph Nsiala Makunza, Nathalie MejeniP22 Security culture
      and risk management in intensive care units: risk cartography in a French
      intensive care unitAmélie Mazaud, Sébastien Béague, Anne-Flore Rousselle, Alain
      DurocherP23 Acquiring messages of medical articles according to the reading
      style: the BIBLIOFLASH multicenter studyRomain Sonneville, Benjamin Sztrymf,
      Emmanuel Canet, for the BIBLIOFLASH study groupP24 ICU portrayal in social media 
      channelsPauline Perez, Alexandra Grinea, Nicolas WeissP25 The burnout syndrome in
      a Tunisian intensive care unit: what is the truth?Hassen Ben Ghezala, Naoures
      Bedoui, Salah Snouda, Rebeh Daoudi, Moez KaddourP26 Resistance of endotracheal
      tubes measured after extubation in ICU patientsAlina Stoian, Loredana Baboi,
      Florent Gobert, Hodane Yonis, Romain Tapponier, Jean-Christophe Richard, Claude
      GuérinP27 Length of endotracheal tube, humidification system and airway
      resistance: an experimental bench studyFrédéric Duprez, Arnaud Bruyneel, Thierry 
      Bonus, Grégory Cuvelier, Sharam Machayeckhi, Sandra Olieuz, Alexandre LegrandP28 
      Diagnosis contribution and safety of bronchoalveolar lavage in intensive care
      unitFatma Feki, Amira Jamoussi, Takoua Merhebene, Emna Braham, Asma Ghariani,
      Faouzi El Mezni, Leila Slim, Jalila Ben Khelil, Mohamed BesbesP29 Impact of
      fiberoptic bronchoscopy performed under noninvasive ventilation on the outcome of
      critically ill patients: a cohort study over 11 yearsAntoine Marchalot,
      Christophe Girault, Gaetan Beduneau, Dorothée Carpentier, Steven Grange, Emmanuel
      Besnier, Gioia Gastaldi, Julien Abily, Marion Beuzelin, Fabienne TamionP30 New
      single-use flexible bronchoscope dedicated for the invasive mechanical
      ventilation: a proof of conceptMai-Anh Nay, Adrien Auvet, Julie Mankikian,
      Virginie Hervé, Antoine GuillonP31 Incidence of and risk factors for difficult
      intubation in ICUMarie Soulie, Pierrick Cronier, Elie Kantor, Laura Federici,
      Marion Gilbert, Ilham Mezhari, Gérald Choukroun, Sophie MarqueP32 Endotracheal
      self-extubation in the intensive care unit: a two-year observational studyZ.
      Coppere, Maxens Decavèle, Jean-Pierre Fulgencio, Clarisse Blayau, Tai Pham,
      Muriel Fartoukh, Michel DjibreP33 Criteria to assess extubation readiness and
      prediction of successful weaningMatthieu Reffienna, Michel Arnaout, Sébastien
      Lefort, Anne-Sophie Debue, Fabrice Daviaud, Sarah Cabon, Frédéric Pène, Julien
      Charpentier, Alain Cariou, Jean-Paul Mira, Jean-Daniel Chiche, Working Group on
      Mechanical VentilationP34 Domestic accidents during school holidays in
      childrenNabil Tabet Aoul, Zakaria Addou, Ali Douah, Mohamed Moussati, Kamel
      Belhabiche, Nabil AouffenP35 Pediatric ARDS: interest of prone positioning and
      NAVA ventilation during veno-venous ECMOSylvie Soulier, Philippe Mauriat, Nadir
      Tafer, Alexandre OuattaraP36 Esogastric pressure measurement as a guide for
      noninvasive ventilation in unexplained hypercapnic respiratory failure in
      infantsGuillaume Mortamet, Alessandro Amaddeo, Sonia Khirani, Brigitte FaurouxP37
      Experience Of Antibacterial Treatment Of Bone And Joint Sepsis Of Young
      ChildrenGennadiy Khanes, Olga Liutko, Svitlana BidnenkoP38 Comparison of toxic
      and septic shocks in childrenSolenn Remy, Emilie Doye, Nicolas Voirin, Delphine
      Maucort-Boulch, Karine Kolev-Descamp, Guillaume Monneret, Etienne JavouheyP39
      Pediatric carbon monoxide poisoning in the Ile-de-France Region, Link between
      HbCO level and clinical presentationImane El Aouane, Aben Essid, Wallid Hammami, 
      Isabelle Haegy, Jacques Bataille, Jean BergouniouxP40 Refractory septic shock in 
      children: an ESPNIC definitionLuc Morin, Samiran Ray, Graeme Maclaren, Etienne
      Javouhey, Simon Nadel, Martin Kneyber, Mark Peters, Koos Jansen, Daniele De Luca,
      Clare Wilson, Luregn Schlapbach, Pierre Tissières, The infection, inflammation
      and sepsis section of the ESPNICP41 Impact of the Leonetti law on end-of-life
      practices in a French NICU and PICU, from January 2011 to December
      2014Anne-Claire Girard, Elodie Savajols, Antoine Burguet, Denis Semama, Stephanie
      Litzler-RenaultP42 Mortality risk factors for anticoagulant-related bleedingInes 
      Sedghiani, Hana Fredj, Malek Hassouna, Youssef Zied El Hechmi, Mohamed Ali
      Cherif, Jerbi ZouheirP43 Management of the polytrauma in the emergency department
      of CHUOranHouria Mokhtari-Djebli, Soumia Benbernou, Ahmed Dernane, Fouad
      Bouakkaz, Khalida Bouyacoub, Abdelkader AzzaP44 Realization of a feedback system 
      of respiratory parameters during CPRLhoucine Ben Taleb, Elmaati Essoukaki, A
      Zeddine Mouhsen, Aissam Lyazidi, Jean-Christophe Marie Richard, Ahmed Mouhsen,
      Mohammed Harmouchi, Mourad RattalP45 Burns from French military operations: a
      14-year retrospective observational analysisMatthias Huck, Thomas Leclerc,
      Nicolas Donat, Audrey Cirodde, Jean-Vivien Schaal, Yannick Masson, Clément
      HoffmannP46 Drowning in Martinique—characteristics and infectious
      complicationsDabor Resiere, Laura Cerland, Ruddy Valentino, C Chabartier, Laurent
      Villain-Coquet, Jean-Louis Ferge, Y Brouste, Bruno Megarbane, Hossein MehdaouiP47
      Prevalence, characteristics, and associated factors to physician’s conflicts in
      Emergency Department: A multicentric Moroccan studyJihane Belayachi, Maha Louriz,
      Naoufal Madani, Fatiha Amlaiky, Tarek Dendane, Khalid Abidi, Aicha Zekraoui,
      Amine Ali Zeggwagh, Redouane AbouqalP48 Serious peripartum complications needing 
      admission in obstetrical ICU: retrospective study about 127 casesAffra Brahim,
      Fehmi Ferhi, Hosni Khouadja, Mohamed Amine Bouslama, Khalil Tarmiz, Khaled
      BenjaziaP49 Epidemiology of suicide in emergency departmentNeila Maaroufi, Abid
      Zeineb, Dhaouadi MahassenP50 Beneficial cardiovascular effects of O-GlcNAc
      stimulation in early phase of septic shockJulien Cadiet, Marine Ferron, Valentine
      Prat, Angelique Erraud, Virginie Aillerie, Mathieu Mevel, Amandine Grabherr, John
      C. Chatham, Chantal Gauthier, Benjamin Lauzier, Bertrand RozecP51 MiR-21
      deficiency increases mortality during experimental septic shockJeremie Joffre,
      Xavier Loyer, Jean-Rémi Lavillegrand, Lynda Zeboudj, Ludivine Laurans, Bruno
      Esposito, Alain Tedgui, Ziad Mallat, Hafid Ait-OufellaP52 Isolated heart rate
      reduction by ivabradine does not improve cardiac and vascular function in
      experimental septic shockChaojie Wei, Narimane Al Kattani, Huguette Louis, Sophie
      Orlowski, Bruno Levy, Antoine KimmounP53 Exploration and modulation of the EGF-R 
      during experimental septic shockJean-Rémi Lavillegrand, Lynda Zeboudj, Jeremie
      Joffre,, Ludivine Laurans,, Bruno Esposito, Alain Tedgui, Pierre-Louis Tharaux,
      Hafid Ait-OufellaP54 An intravenous omega-3 bolus at reperfusion time improves
      shock and vascular dysfunction in a myocardial ischemia–reperfusion rat
      modelMélanie Burban, Grégory Meyer, Anne Olland, Blandine Yver, Florence Toti,
      Valérie Schini-Kerth, Alexandra Monnier, Alexandra Boivin, Pierrick Leborgne,
      Ferhat Meziani, Julie Boisramé-HelmsP55 Impact of urantide antagonist of
      urotensinergic system on myocardial function during a murine model of septic
      shockEmmanuel Besnier, Thomas Clavier, Mulder Paulus, Hélène Castel, Vincent
      Richard, Fabienne TamionP56 Association of dexamethasone and antibodies to
      poly-β(1,6)-n-acetyl-glucosamine in prevention and treatment of neonatal
      bacterial meningitis: an experimental studyStéphanie Pons, Bruno Mourvillier,
      David SkurnikP57 Hyperoxemia as a risk factor for ventilator-associated
      pneumoniaSophie Six, Karim Jaffal, Saad NseirP59 Significance of prior digestive 
      colonisation with extended-spectrum beta-lactamase producing Enterobacteriaceae
      in patients with ventilator-associated pneumoniaRémi Bruyère, Clara Vigneron,
      Audrey Large, Julien Bador, Serge Aho, Sebastien Prin, Jean-Pierre Quenot,
      Pierre-Emmanuel CharlesP60 Lower respiratory tract colonization in mechanically
      ventilated patients: Incidence, risk factors and impact on prognosisYosr Touil,
      Soufia Ayed, Habiba Sik Ali, Najla Tilouch, Houda Mateur, I Talik, Rim Gharbi,
      Mohamed Fekih Hassen, Souheil ElatrousP61 Epidemiology of ventilator-associated
      pneumonia in the ICU among patients already hospitalized: early- versus
      late-onset pneumoniaMathilde Grandperrin, Isabelle Patry, Xavier Bertrand,
      Jean-Christophe Navellou, Gaël Piton, Gilles CapellierP62 Systematic review of
      inclusion/exclusion criteria, judgment criteria and statistical hypothesis in
      randomized controlled trials assessing the efficacy of antimicrobials for
      hospital-acquired and ventilator-associated pneumonia treatmentEmmanuel Weiss,
      Jean-Ralph Zahar, Christophe Adrie, Wafa Essaied, Martin Wolkewitz, Jean-François
      TimsitP63 Gram stain identification resulting from blindly inserted telescoping
      plugged catheter material. Does it contribute to diagnosis and treatment of
      ventilator-associated pneumonia?Mickaël Soued, Fabrice Cook, David Lobo, Roman
      Mounier, Aurélie Emirian, Jean Winoc Decousser, Gilles DhonneurP64 Colistin in
      nosocomial pneumonia in intensive careHanane Ezzouine, Mohamed Toufik Slaoui,
      Abdellatif BenslamaP65 Bedside tissue perfusion evaluation predicts intradialytic
      hemodynamic instability in critically ill patientsNaïke Bigé, Claire Pichereau,
      Jean-Rémi Lavillegrand, Arnaud Galbois, Mikael Alves, Jean-Luc Baudel, Simon
      Bourcier, Vincent Dubée, Jalel Tahiri, Eric Maury, Bertrand Guidet, Hafid
      Ait-OufellaP66 Evaluation of electrolytes and acid–base disorders in patients
      undergoing citrate-based anticoagulation for continuous renal replacement therapy
      in intensive care unitBenjamin Delmas, Olivier Joannes-Boyau, Antoine Dewitte,
      Julien Jabot, Dorothée Valance, Nicolas Allou, Jérôme Allyn, Catherine Fleureau,,
      Alexandre OuattaraP67 Continuous venovenous hemofiltration in critically ill
      patients with acute kidney injury: a cost study impact of replacement fluids
      consumptionsElodie Jean-Bart, Floriane Bel., Fabienne Morey, Rémi Bruyère,
      Nicholas SedillotP68 Acute kidney injury in patients receiving liposomal
      amphotericin B in an intensive care unit: register of 104 patients from 2008 to
      2014Marion Venot, Lucie Biard, Sylvie Chevret, Sandrine Valade, Eric Mariotte,
      Claire Pichereau, Virginie Lemiale, Elie Azoulay, Emmanuel CanetP69 Regional
      citrate-based anticoagulation for dummies in continuous venovenous
      hemofiltration: does it work?Dorothée Valance, Richard Galliot, Romain Zunarelli,
      David Vandroux, Cyril Ferdynus, Bernard-Alex Gauzere, Olivier Martinet, Julien
      JabotP70 Incidence of and risk factors for acute kidney injury in early
      postoperative liver transplantation according to AKIN classificationJean-Charles 
      Cartier, Thomas Jouve, Marie-Noëlle Hilleret, Rebecca Hamidfar-Roy, Claire
      Ara-Somohano, Clémence Minet, Agnès Bonadona, Carole SchwebelP71 Metabolic
      acidosis uncompensated by kidney in septic patients: a predictive factor for
      acute kidney injury?Aline Pourcelet, Jean-Michel Hougardy, Pierre Defrance,
      Patrick Biston, Michael PiagnerelliP72 Blood volume monitoring is useful to
      predict intradialytic hypotension during intermittent hemodialysisLouis De
      Laforcade, Alexandre Boyer, Didier Gruson, Benjamin ClouzeauP73 Risk factors for 
      occurrence of acute kidney injury in diabetic ketoacidosisNajah Hajjam, Ines
      Sedghiani, Houda Nasri, Hamdi Doghri, Youssef Zied El Hechmi, Mohamed Ali Cherif,
      Jerbi ZouheirP74 Face-to-face tracheal intubation with the video laryngoscope
      Airtraq in the sitting patients: a report of 3-year experience in patients after 
      failed conventional tracheal intubation techniqueGilles Dhonneur, Nicolas
      Mongardon, Eric Levesque, Hakim HaouacheP75 Ultrasound-guided central venous
      access technique among French intensivistsMarie-Anaïs Bastide, Jack Richecoeur,
      Eric Frenoy, Christian Lemaire, Bertrand Sauneuf, Fabienne Tamion, Saad Nseir,
      Damien Du Cheyron, Hervé Dupont, Julien Maizel, BoReal Study GroupP76
      Ultrasound-guided venous catheter insertion. What do French intensivists really
      do?Hafid Ait-Oufella, Eric Maury, Julien Maizel, Frédérique Schortgen, Cécile
      Aubron, Christophe Clec’h, Christophe Guitton, Kada Klouche, Nicolas Lerolle,
      Frédéric Pène, Sebastien Preau, Carole Schwebel, Nicolas Terzi, Frédéric Vargas, 
      Vincent CastelainP77 Can we trust new connected devices recording heart rate and 
      oxygen saturation? A concordance assessment in intensive care unitFranck Ehooman,
      Yacine Tandjaoui-Lambiotte, Claire Montlahuc, Guillaume Van Der Meersch, Johanna 
      Oziel, Jean Bardon, Matthieu Resche-Rigon, Nicolas Postel-Vinay, Yves CohenP78
      Hemoglobin monitoring with HemoCue©, spectrophotometry and blood cells analyzer: 
      comparison of agreement, completion time and costsMehdi Lafi, Frédéric Jacobs,
      Dominique Prat, Matthieu Le Meur, Olfa Hamzaoui, Anne Sylvie Dumenil, Guy
      Moneger, Nadège Demars, Pierre Trouiller, Benjamin SztrymfP79 Activated partial
      thromboplastin time and anti-Xa measurements in heparin monitoring among critical
      care patientsNoémie Tencé, Inès Zaien, Martine Wolf, Pierre Trouiller, Frédéric
      JacobsP80 Agreement between the Point-Of-Care Siemens RAPIDPoint® 500 Blood gas
      system and central laboratory measurement of hemoglobin, hematocrit, glucose and 
      electrolytes in ICU patientsJérôme Allardet-Servent, Melissa Lebsir, Christian
      Dubroca, Mireille Portugal, Matthias Castanier, Thomas Signouret, Guillemette
      Thomas, Rettinavelou Soundaravelou, Anne Lepidi, Philippe Halfon, Jean-Marie
      SeghboyanP81 Clinical features and prognosis of pesticide poisoningNeila
      Maaroufi, Dhaouadi Mahassen, Abid ZeinebP82 Variability of neurobehavioral
      toxicity of naphyrone, a new synthetic cathinone, according to its acute or binge
      administrationCamille Gamblin, Nadia Benturquia, Olivier Roussel, Lucie
      Chevillard, Patricia Risede, Jacques Callebert, Bruno MegarbaneP83 Acute
      acenocoumarin poisoning: an epidemiological and clinical studyA. M’rad, Hana
      Fredj, Messaouda Khelfa, Youssef Blel, H. Thabet, Nozha Brahmi, M. AmamouP84
      Death by deliberate self-poisoning in Sfax, Tunisia: Victims characteristics and 
      toxic substance profileYoussef Nouma, Wiem Ben Amar, Sami Bardaa, Karama Regaieg,
      Kaouthar Jammeli, Mabrouk Bahloul, Zouheir Hammami, Maatoug SamirP85 Adverse drug
      reactions (ADRs) collected by medical-staffed ambulances: pilot studyA. Lillo-Le 
      Louët, F. Baud, C. Le Beller, B. Vivien, L. Soufir, P. Carli and H. Le LouëtP86
      Prognostic value of plasma concentration of acebutolol in acute poisoningA.
      M’rad, Youssef Blel, Fatma Essafi, Nasreddine Foudhaili, Abdelaziz Ben Slimen,
      Nozha Brahmi, M. AmamouP87 Baseline pharmacologic treatment for patients admitted
      in ICU for AECOPD: trends in use and conformity to the GOLD guidelinesIslem
      Ouanes, Rami Jabla, Hedia Hammed, Mahdi Marzouk, Nesrine Boujelbene, Fahmi
      Dachraoui, Asma Hachani, Saousen Ben Abdallah, Hend Ben Lakhal, Chaima Ghribi,
      Imen Ben Ali, Imen Abdellaoui, Lamia Ouanes-Besbes, Fekri AbrougP88 Blood
      eosinophils levels and acute exacerbations of COPDIslem Ouanes, Asma Hachani,
      Lamia Ouanes-Besbes, Saousen Ben Abdallah, Rami Jabla, Hedia Hammed, Mahdi
      Marzouk, Hend Ben Lakhal, Imen Ben Ali, Imen Abdellaoui, Chaima Ghribi, Fahmi
      Dachraoui, Fekri AbrougP89 POFE: postoperative outcomes of chronic obstructive
      pulmonary disease (COPD) frequent exacerbators after pulmonary resection—a pilot 
      studySuela Demiri, Christine Lorut, Van Lang, Daniel Luu, Antoine Rabbat, Aurélie
      Lefebvre, Marco Alifano, Jean-Francois Reignard, Marc Samama, Daniel Dusser,
      Nicolas RocheP90 Optimal delivery of salbutamol with a pressurized metered-dose
      inhaler within a high-flow nasal therapy circuitFrançois Réminiac, Cassandre
      Landel, Samuel Gensburger, Thomas Bocar, Lydiane Mordier, Marion Philippe,
      Déborah Le Pennec, Laurent Vecellio, Stephan EhrmannP91 Differences in
      perceptions between the various healthcare professionals working at the bedside
      of the risks related to the rehabilitation proceduresLaurent Poiroux, David
      Thevoz, Julien Simons, Cheryl Hickmann, Jean Roeseler, Anthéa Loiez, Stéphanie
      Gérard, Nicolas Dousse, Tai Pham, Nicolas Terzi, Lise PiquilloudP92 Early
      rehabilitation in critically ill patients: a prospective multicenter assessment
      of real-life practiceLorraine Ducroux, Sylvie L’hotellier, Elodie Baumgarten,
      Stéphanie Borschneck, Francis Schneider, Vincent CastelainP93 Extracorporeal
      membrane oxygenation for pheochromocytoma-induced cardiogenic shock: report of
      nine casesGuillaume Hékimian, Nicolas Brechot, Matthieu Schmidt, Fatima Kharcha, 
      Cécile Ghander, Guillaume Lebreton, Christophe Tresallet, Jean Louis Trouillet,
      Pascal Leprince, Alain Combes, Charles-Edouard LuytP94 Mortality related to
      cardiogenic shock in critically ill patients in France, 1997–2012Etienne
      Puymirat, Jean-Yves Fagon, Philippe Aegerter, Florence Boissier, Jean-Luc Diehl, 
      Caroline Hauw-Berlemont, Bertrand Guidet, Gilles Chatellier, Nicolas Danchin,
      Nadia AissaouiP95 Benefits of extracorporeal life support (ECLS) in elderly
      patients with postcardiotomy refractory cardiogenic shockNadia Aissat, R.
      Bernard, Guillaume Lebreton, Dimitri Margetis, Julien Amour, Pascal Leprince,
      Adrien BougléP96 Heart transplantation versus ventricular assist device: which
      therapy for patients with refractory cardiogenic shock?Charles Vidal, Guillaume
      Lebreton, Djavidi Nima, Varnous Shaida, Adrien Bouglé, Pascal Leprince, Julien
      AmourP97 Refractory cardiogenic shock in immunocompromised patients rescued by
      veno-arterial extracorporeal membrane oxygenationAmandine Dorget, Nicolas
      Bréchot, Guillaume Lebreton, Guillaume Hekimian, Ania Nieszkowska,
      Charles-Edouard Luyt, Pascal Leprince, Jean Louis Trouillet, Alain Combes,
      Matthieu SchmidtP98 Which index severity to use in obstetric medium? (Comparison 
      of 4 scores)Rabi Toufiki, Youssef Mouaffak, Ahmed Rhassan El Adib, M. AmineP99
      Maternal mortality in obstetric department of UH IBN ROCHD, Casablanca,
      MoroccoKamal Belkadi, I. Moussaid, Chaigar Mohammed Cheikh, S. Moumine, S. El
      Youssoufi, S. SalmiP100 Disseminated intravascular coagulation in pregnant women:
      evaluation of a new scoreMarie Jonard, Anne Sophie Ducloy-Bouthors, François
      FourrierP101 Validity of severity scores in critically ill obstetric
      patientsFatma Kaaniche Medhioub, Anis Chaari, Olfa Turki, Kais Rgieg, Mabrouk
      Bahloul, Hmida Chokri Ben, Bouaziz MounirP102 Evaluation of a neuromuscular
      blockade with benzylisoquinoliniums: a comparison of a train of four with a
      clinical assessmentPierre Bouju, Nicolas Barbarot, Arnaud Gacouin, Fabrice Uhel, 
      Julien Letheulle, Pierre Fillatre, Guillaume Grillet, Angélique Goepp, Jean-Marc 
      Tadié, Yves Le TulzoP103 The use of enteral route for drug administration in the 
      ICU is dimly rationalAnne-Laure Clairet, Gilles Capellier, Samuel Limat,
      Christian Cornette, Gaël PitonP104 Microcirculatory effects of norepinephrine in 
      septic shock: a muscle microdialysis studyAmira Fatnassi, Zied Hajjej, Chiheb
      Romdhani, Walid Sammoud, Iheb Labbene, Mustapha FerjaniP105 Administration of
      drugs per os by stomach tube for enteral feeding in surgical ICUHind Taibi, Ijlal
      Elatiqi, A Iraqui, Rachid Cherkab, Wafae Haddad, Chafik Elkettani, Lahoucine
      BarrouP106 Implementation of an intensive care follow-up clinicFabien Cave, Alain
      Mercat, Nicolas LerolleP107 Needs assessment of adults post-intensive care
      rehabilitation department in Amiens University HospitalGaelle Bacari-Risal,
      Pierre Louis Doutrellot, Benoit Vaysse, M. Inan, K. Khelfoun, M. Nasserallah,
      Julien Maizel, C. Legrand-Monteil, S. Tasseel-PoncheP108 Factors of degradation
      on independence and quality of life at 3 and 6 months after stay in intensive
      care unitBenjamin Kowalski, Anne Guaguere, Claire Boulle-GeronimiP109 Octavie:
      Epidemiological study of mortality and autonomy 3 and 6 months after ICU stay for
      very elderly patientsJuliette Masse, Clément Vanbaelinghem, Patrick HerbecqP110
      Analysis of burn injuries in the elderlyAmel Mokline, Syrine Draief, Lazhari
      Gharsallah, Imen Rahmani, Bahija Gasri, Sofiene Tlaili, Rym Hammouda, Amen Allah 
      MessadiP111 ICU admission criteria for patients 85 years and olderPhilippe
      Michel, Bruno Gelée, Fouad Fadel, Marie ThuongP112 Facteurs pronostiques chez les
      patients âgés admis en réanimation médicale. Prognostic factors in elderly
      patients admitted in medical intensive careSandra Ait-Aoudia, Salima Laddi,
      Mohamed-Mohcen SahraouiP113 Uncontrolled donation after circulatory determination
      of death: 42 months of experience in a general hospitalClémence Fauché, Samuel
      Gay, Michel Muller, Anna Faucher, Olivier Skowron, Albrice Levrat, Didier
      DorezP114 Epidemiology of long stays in ICUBertrand Hermann, Caroline Hauw
      Berlemont, Alexandra Monnier, Florence Boissier, Nadia Aissaoui, Jean-Yves Fagon,
      Jean-Luc Diehl, Emmanuel GuérotP115 Are daily sedation stops safe in a medical
      ICU?Michel Arnaout, Julien Charpentier, Benoit Champigneulle, Julie Busson,
      Anne-Sophie Debue, Julie Dhumeaux, Guillaume Geri, Wulfran Bougouin, Nicole
      Ericher, Sébastien Lefort, Pierre Lucas, Alain Cariou, Jean-Paul Mira, Frédéric
      Pène, Jean-Daniel Chiche, Groupe de travail sur la ventilationP116 Delay in
      awakening after stopping continuous sedation in critically ill patients:
      incidence, risk factors and impact on ventilator weaningMagalie Dumas, Celine
      Chapelle, Benedicte Philippon-Jouve, Jerome Morel, Pascal BeuretP117 Risk factors
      and prognosis impact of decreased patient–ventilator synchrony in mechanically
      ventilated patients—a prospective studyCôme Bureau, Camille Rolland-Debord,
      Tymothée Poitou, Marc Clavel, Sébastien Perbet, Nicolas Terzi, Achille Kouatchet,
      Thomas Similowski, Alexandre Demoule, Université Paris 6—Pierre et Marie Curie
      and Institut National pour la Santé et la Recherche Médicale, UMRS1158, ParisP118
      High-flow oxygen therapy through a nasal cannula versus noninvasive ventilation
      versus in immunocompromised patients with acute respiratory failureRemi Coudroy, 
      Angéline Jamet, Philippe Petua, René Robert, Jean-Pierre Frat, Arnaud, W.
      ThilleP119 The use of dexmedetomidine in patients with noninvasive ventilation: a
      preliminary studyHassen Ben Ghezala, Salah Snouda, Rebeh Daoudi, Moez KaddourP120
      Comparison of tolerance of 4 interfaces for preventive noninvasive ventilation
      after abdominal surgery in intensive care units assessed by patients and
      caregiversAudrey De Jong, Albert Prades, Marion Monnin, Martin Mahul, Marion
      Basty, Clément Monet, Benjamin Mounet, Emmanuel Futier, Gérald Chanques, Samir
      JaberP121 Dexmedetomidine, new approach in sedation analgesia: a prospective and 
      observational study of mechanically ventilated patients in adults intensive care 
      units in a university hospital during the first year of useAudrey Leroux, Xavier 
      Oudinot, Gaëlle Demeilliers-Pfister, Marc LaurentP122 Pain, confusion, and
      agitation associated with noninvasive ventilationNesrine Boujelbene, Rami Jabla, 
      Fahmi Dachraoui, Islem Ouanes, Saousen Ben Abdallah, Mahdi Marzouk, Asma Hachani,
      Hedia Hammed, Hend Ben Lakhal, Imen Ben Ali, Chaima Ghribi, Imen Abdellaoui,
      Lamia Ouanes-Besbes, Fekri AbrougP123 Impact of metformin on prognosis of ICU
      patientsSebastien Jochmans, Jean-Emmanuel Alphonsine, Ly Van Vong, Nathalie
      Rolin, Oumar Sy, Jean Serbource-Goguel, Jonathan Chelly, Olivier Ellrodt, Mehran 
      Monchi, Christophe VinsonneauP124 Serum cholinesterase activity in the diagnosis 
      of septic shock due to bacterial infections: a new specific biomarker of
      sepsisMabrouk Bahloul, Turki Olfa, Najeh Baccouche, Kais Regaieg, Chtara Kamilia,
      Benhamida Chokri, Hedi Chelly, Mounir BouazizP125 Is hyperoxaemia a rare event
      during septic shock patients management?Amélie Trichot, Gwenhaël Colin,
      Jean-Baptiste Lascarrou, Isabelle Vinatier, Konstantinos Bachoumas, Jean-Claude
      Lacherade, Maud Fiancette, Aurélie Joret, Aihem Yehia, Christine Lebert, Matthieu
      Henry-Laguarrigue, Laurent Martin-LefèvreP126 Myocardial depressant factor during
      human septic shock: screening of twenty-three cytokines and chemokinesKeyvan
      Razazi, Florence Boissier, Mathieu Surenaud, Alexandre Bedet, Nicolas de Prost,
      Aurelien Seemann, Christian Brun-Buisson, Sophie Hüe, Armand Mekontso-DessapP127 
      Plasma of septic shock patients modifies in vitro mitochondrial respiration of
      human PBMC as well as lymphocytes and monocytes cell linesRaphaël Clere-Jehl,
      Julie Boisramé-Helms, Anne-Laure Charles, Pierrick Leborgne, Xavier Delabranche, 
      Bernard Geny, Ferhat Meziani, Pascal BilbaultP128 Assessment of skin endothelial 
      functions during severe infectionsSimon Bourcier, Claire Pichereau, Vincent
      Dubée, Gabriel Lejour, Jean-Luc Baudel, Arnaud Galbois, Jalel Tahiri, Naïke Bigé,
      Eric Maury, Bertrand Guidet, Hafid Ait-OufellaP129 Toe-to-Room temperature
      gradient correlates with tissue perfusion and predicts outcome during septic
      shockSimon Bourcier, Claire Pichereau, Pierre Yves Boêlle, Nemlaghi Safaa,
      Vincent Dubée, Gabriel Lejour, Jean-Luc Baudel, Arnaud Galbois, Jean-Rémi
      Lavillegrand, Naïke Bigé, Jalel Tahiri, Eric Maury, Bertrand Guidet, Hafid
      Ait-OufellaP130 Determination of HLA-DR expression on monocytes in heart
      recipients and clinical outcome correlationSylvie Paulus, Claire Flamens,
      Guillaume Monneret, Julie Demaret, Jean NeideckerP131 Nosocomial infections in
      neonates under ECMOJerome Rambaud, Cecile Allioux, Romain Guedj, Isabelle
      Guellec, Julia Guilbert, Pierre-Louis Leger, Maryne Demoulin, Amélie Durandy,
      Sandrine Jean, Ricardo CarbajalP132 Point-of-care ultrasound in pediatric and
      neonatal intensive care units: prospective, observational transversal
      studyAurélie Morand, Laurent Zieleskiewicz, Olivier Brissaud, Stéphane Le Bel,
      Mickael Afanetti, Zoé Meresse, Astrid Botte, Michel Panuel, Laurent Thomachot,
      Jean-Michel Constantin, Marc Leone, Fabrice MichelP133 Use of continuous infusion
      of clonidine for sedation in critically ill children: indications, efficacy and
      side effectsAnna Deho’, Laïly Sadozai, Stéphane Dauger, Sonia Prot-LabartheP134
      Pharmacokinetic analysis of continuous infusion vancomycin therapy in critically 
      ill childrenMathieu Genuini, Mehdi Oualha, Moulin Florence, Jean-Marc Treluyer,
      Fabrice Lesage, Sylvain RenolleauP135 Incidence of central venous
      catheter-associated bacteraemia in a paediatric intensive care unitEmmanuelle
      Chalavon, Claire Le Reun, Rodrigue Dessein, Bruno Grandbastien, Alain Duhamel,
      Sarah Pesin, François Dubos, Stéphane LeteurtreEmmanuelle Chalavon, Claire Le
      Reun, Rodrigue Dessein, Bruno Grandbastien, Alain Duhamel, Sarah Pesin, François 
      Dubos, Stéphane LeteurtreP136 Outcome at 2 months at the infectious level of the 
      pediatric central venous catheters: prospective evaluation of the guidelines
      optimization impactMarie-Aude Puel, Marie Szulc, Anais Philippe, François
      Severac, Dominique Astruc, Pierre Kuhn, Philippe DesprezMarie-Aude Puel, Marie
      Szulc, Anais Philippe, François Severac, Dominique Astruc, Pierre Kuhn, Philippe 
      DesprezP137 Ten years of intensive care in children hospital in Oran,
      AlgeriaNabil Tabet Aoul, zakaria addou, Ali Douah, Mohamed Moussati, Kamel
      Belhabiche, Nabil AouffenNabil Tabet Aoul, zakaria addou, Ali Douah, Mohamed
      Moussati, Kamel Belhabiche, Nabil AouffenP138 High-frequency percussive
      ventilation during neonatal transportation: a pilot studyBenoît Colomb, Karine
      Kolev-Descamp, Anne Marie Petion, Laurent Queudet, Elodie Savajols, Stephanie
      Litzler-Renault, Denis SemamaP139 Lymphopenia after severe infectious shock in
      children: association with severity and risk for nosocomial infectionEmilie Doye,
      Solenn Remy, Nicolas Voirin, Delphine Maucort-Boulch, Karine Kolev-Descamp,
      Guillaume Monneret, Etienne JavouheyP140 Importance of troponin evaluation in
      scorpion envenomation in pediatric intensive care unitMouaffak YoussefP141
      Hyperosmolar therapy in pediatric traumatic brain injury: a retrospective
      studyNadia Roumeliotis, Christian Dong, Geraldine Pettersen, Louis Crevier,
      Guillaume EmeriaudP142 Cerebral sinovenous thrombosis in children: report of
      seven casesMouaffak YoussefP143 Optimising nurse confidence and skill acquisition
      in paediatric continuous renal replacement therapy (pCRRT) through a training
      programme: result of the first-year experience in a tertiary care centreJérôme
      Naudin, Laetitia Abdallah, Marion Ganier, Karine Frannais, Dylia Douglas, Cecile 
      Flusin, Anna Deho’, Stéphane DaugerP144 From high-quality electronic database to 
      the new concept of perpetual patient. Preliminary resultsDavid Brossier, Redha
      Eltaani, Michaël Sauthier, Guillaume Emeriaud, Bernard Guillois, Philippe
      JouvetP145 Transportation of children on extracorporeal membrane oxygenation:
      1-year experience of a tertiary referral center in the Paris regionJerome
      Rambaud, Pierre-Louis Leger, Michelle Larroquet, Alain Amblard, Noella Lode,
      Julia Guilbert, Sandrine Jean, Isabelle Guellec, Isabelle Casadevall, Katia
      Kessous, Hervé Walti, Ricardo CarbajalP146 Acute neurotoxicity of bath salts
      combining 3,4-methylenedioxypyrovalerone and mephedrone in the ratChristophe
      Poiré, Nadia Benturquia, Olivier Roussel, Lucie Chevillard, Patricia Risede,
      Jacques Callebert, Huixiong Chen, Bruno MegarbaneP147 Acute organophosphate
      poisoning: what about pralidoxime use?A. M’rad, Sahar Habacha, Bassem Chatbri,
      Youssef Blel, H Thabet, Nozha Brahmi, M. AmamouP148 Acute nifedipine poisoning:
      clinical and prognosis aspectsA. M’rad, Fatma Essafi, Nasreddine Foudhaili,
      Youssef Blel, H. Thabet, Nozha Brahmi, M. AmamouP149 Acute behavioral toxicity
      and addictive liability of the new synthetic cathinone
      3,4-methylenedioxypyrovalerone (MDPV) in the ratCyril Masniere, Nadia Benturquia,
      Olivier Roussel, Lucie Chevillard, Patricia Risede, Jacques Callebert, Bruno
      MegarbaneP150 Clinical and therapeutic characteristics of metformin poisoningA.
      M’rad, Messaouda Khelfa, Hana Fredj, Youssef Blel, H. Thabet, Nozha Brahmi, M.
      AmamouP151 Calcium channel blockers poisoningSamar Souissi, Hatem El Ghord, N.
      Kouraichi, N. Brahmi, H. Thabet, M. AmamouP152 Characteristics and outcomes in
      patients with community-acquired pneumonia admitted to intensive care unitTakoua 
      Marhbène, Islam Mejri, Amira Jamoussi, Douha Lakhdar, Asma Ghariani, Leila Slim, 
      Jalila Ben Khelil, Mohamed BesbesP153 Comparison of characteristics and outcomes 
      of pneumococcal community-acquired pneumonia versus other pathogensTakoua T.
      Merhabane, Héla Maamouri, Amira Jamoussi, Asma Ghariani, Leila Slim, Jalila Ben
      Khelil, Mohamed BesbesP154 Outcome of L. pneumophila pneumonia and risk factors
      for ICU admissionOestreicher Charlotte, Helena Wegelius, Caroline Landelle,
      Jacques Schrenzel, Laurent Kaiser, Jérôme PuginP155 The descending necrotizing
      mediastinitis: report of 60 casesHind BelhadjP156 Characteristics, mortality risk
      factors and therapeutic approach of ARDS in patients with severe leptospirosis in
      Reunion IslandPaul Chanareille, Julien Jabot, Benjamin Delmas, Arnaud Roussiaux, 
      Cyril Ferdynus, Bernard-Alex Gauzere, Olivier Martinet, David VandrouxP157
      Characterization of organ dysfunction in severe leptospirosisAdélie Ladureau,
      Alice Sanna, Amélie Rolle, Bertrand Pons, Pascale Piednoir, Fanny Ardisson,
      Frédéric Martino, Thomas Bernos, Khalid Elkoun, Elie Elain, Roland Lawson,
      Matthieu Resh-Rigon, Sophie Belorgey, Guillaume ThieryP158 Report of experience: 
      management of a pre-XDR and XDR-TB population hospitalized in a medical
      ICUCaroline Hauw Berlemont, Cyprian Pricopi, Florence Boissier, Alexandra
      Monnier, Françoise Barthes, Jean-Luc Diehl, Jean-Yves Fagon, Emmanuel GuérotP159 
      Benefit of magnesium sulfate for tetanus management in adults: case of the
      provincial general referral hospital of KinshasaThansya Doddie, Mj Nsiala, Nh
      Situakibanza, Be Amisi, Mj Kazadi, Ma KilembeP160 Ebola fever outbreak:
      questioning the delivery of careChristophe Clement, François LamontagneP161
      Marked decrease in the incidence of ventilator-associated pneumonia using a
      bundle of care containing selective oropharyngeal decontaminationBoyer, Valérie
      Nocquet, Caroline Landelle, Sébastien Naimo, Ronan Raulais, Emilie Genevois,
      Lucie Bouchoud, Filippo Boroli, Nour Abidi, Mohamed Abbas, Stefan Harbarth,
      Jérôme PuginP162 Ventilator-associated pneumonia prevention by oral care
      improvement: a before–after studyPierre-Emmanuel Charles, Caroline Dereux, Audrey
      Large, Rémi Bruyère, Sebastien Prin, Julien Bador, Jean-Pierre QuenotP163 Impact 
      of a multifaceted bundle ventilator-associated pneumonia prevention program in a 
      secondary care medical–surgical intensive care unitStanislas De Guillebon, Eloise
      Morisse, Julie France, Deborah Gasser, Philippe Badia, Walter PicardP164 Daily
      chlorhexidine bathing in a medical intensive care unit: effects on
      healthcare-associated infections and on acquisition of multidrug-resistant
      bacteriaP. Corne, Nicolas Molinari, I. De Boulastel, S. Seguin, A. Blasco, V.
      Ledur, Olivier Jonquet, Kada KloucheP165 Impact of twin bedrooms intensive care
      unit on the epidemiology of extended-spectrum beta-lactamase-producing
      enterobacteriaceaePaktoris-Papine Sophie, Margaux Artiguenave, Faten El Sayed,
      Florence Espinasse, Aurélien Dinh, Cyril Charron, Xavier Repessé, Antoine
      Vieillard-BaronP166 Prophylactic confinement after liver transplant: a necessity 
      or a useless precaution?Benjamin Lebas, Sophie Hatsch, Quentin Maestraggi,
      Anne-Florence Dureau, Vincent Castelain, Bernard Ellero, François Faitot, Max
      Guillot, Francis SchneiderP167 Proteomic response and adaptation mechanisms of E.
      coli 536 to overcome the inhibitory effect of cranberry proanthocyanidinsDimitri 
      Margetis, Odile Bouvet, Didier Chevret, Didier Dreyfuss, Erick Denamur,
      Jean-Damien RicardP168 Is daily measurement of CRP useful to detect earlier
      ventilator-associated pneumonia?Justine Simonet, Mathieu Boutonnet, Jean-Louis
      Daban, Elisabeth Falzone, Guillaume Dumas, Philippe Vest, Vincent PeigneP169
      Clinical and biological features of healthcare-associated coagulase-negative
      Staphylococci meningitis: results of a retrospective studySeverine Couffin, David
      Lobo, Gilles Dhonneur, Roman MounierP170 Prognostic value of electrocardiographic
      abnormalities in patients with acute pulmonary embolismM. Cheikh Bouhlel, Ahmed
      Khedher, Kaoula Meddeb, A. Azouzi, Y. Hamdaoui, Jihene Ayachi, W. Brahim, Rania
      Bouneb, Mohamed BoussarsarP171 Does mean arterial pressure alarm improve the time
      spent within blood pressure target range in septic shock? A before and after
      studyNans Florens, Martin Cour, Julie Varéon, Arnaud Malatray, Romain Hernu,
      Laurent ArgaudP172 Respiratory change of pulse pressure is not indicative of
      preload reserve in cardiac surgery patientsPierre Dupland, Thomas D’humières,
      Romain Vergier, Pauline Issaurat, Philippe Estagnasié, Pierre Squara, Alain
      BrussetP173 Importance of diastolic arterial pressure to optimize pulse pressure 
      variation performances for patients receiving norepinephrineVincent Génin, David 
      Vandroux, Cyril Ferdynus, Arnaud Roussiaux, Jérôme Allyn, Nicolas Allou, Olivier 
      Martinet, Julien JabotP174 Multi-parameter monitoring for tissue perfusion in
      septic shock: correlations between macrohemodynamic and metabolic parameters:
      Preliminary resultsAli Jendoubi, Rifka Jlassi, Bassem Hamrouni, Yahia Marzougui, 
      Jihen Kouka, Salma Ghedira, Mohamed HouissaP175 Correlation between changes in
      levels of N-terminal pro-brain natriuretic peptide (NT-pro-BNP) and weight before
      and after dialysisKaouther Dhifaoui, Zied Hajjej, Walid Sammoud, Iheb Labbene,
      Mustapha FerjaniP176 Impact of colonization with multidrug-resistant bacteria on 
      the outcome of patients with hematological malignancies admitted to the intensive
      care medicineJohanna Oziel, Carole Schwebel, Elie Azoulay, Michaël Darmon,
      Bertrand Souweine, Lila Bouadma, Guillaume Marcotte, Christophe Clec’h, Yves
      Cohen, Outcomerea Study GroupP177 ICU moving followed by a drop of
      imipenem-resistant Pseudomonas aeruginosaAlexy Tran Dinh, Caroline Neulier,
      Marlène Amara, Nicaise Nebot, Gilles Troché, Nelly Breton, Benjamin Zuber,
      Sébastien Cavelot, Béatrice Pangon, Jean Pierre Bedos, Jacques Merrer, David
      GrimaldiP178 Risk factors of carbapenem resistance acquisition in intensive care 
      unitFrançois Labaste, Jean-Marie Conil, Julia Grossac, Stéphanie Ruiz, Marion
      Grare, Olivier Fourcade, Vincent Minville, Bernard GeorgesP179 Risk factors for
      subsequent infection among patients with extended-spectrum
      beta-lactamase-producing enterobacteriaceae colonization: a retrospective
      studyGuillaume Van Der Meersch, Johanna Oziel, Yacine Tandjaoui-Lambiotte,
      Frédéric Gonzalez, Philippe Karoubi, Christophe Huang, Christophe Clec’h, Yves
      CohenP180 Is rectal colonisation predictive of extended-spectrum
      β-lactamase-producing enterobacteriaceae presence in respiratory samples
      performed in the intensive care unit?Helene Carbonne, Matthieu Le Dorze, Rishma
      Amarsy, Joaquim Mateo, Didier Payen de la GaranderieP181 Antibiotic therapy in
      intensive care unit patients: appraisal of medical attitude related to therapy
      appropriateness, severity of infection and outcomeSophie Leloup Von Edelsberg,
      Christelle Vercheval, Monique Nys, Pierre DamasP182 Epidemiology and associated
      factors of ICU-acquired infections in critically ill patients: a prospective
      cohort studyZied Hajjej, Chaker Bouguerra, Noura Naas, Walid Sammoud, Iheb
      Labbene, Mustapha FerjaniP183 The impact of nosocomial infection acquired in
      intensive care units on mortality and length of stay until hospital discharge: a 
      retrospective, monocentric, 10-year studyJoris Muller, François Severac, Mickael 
      Schaeffer, Pierre Tran Ba Loc, Stéphanie Deboscker, Maleka Schenck, Marie-Line
      Harley, Ralf Janssen-Langenstein, Jean-Etienne Herbrecht, Benjamin Lebas, Max
      Guillot, Vincent Castelain, Francis Schneider, Thierry LavigneP184 Incidence and 
      prognosis of catheter-associated urinary tract infections in intensive care unit:
      the IPRIUS studyJennifer Brunet, Bertrand Canoville, Cédric Daubin, Amélie
      Seguin, Nicolas Terzi, Xavier Valette, Pierre Verrier, Damien Du CheyronP185
      Automatic tube compensation during mechanical ventilation in ICU patients.
      Meta-analysis of trials on weaning outcome and physiologic effectsAlina Stoian,
      Claude GuérinP186 Automated oxygen titration during high-flow oxygen therapy.
      Evaluation of the feasibility in healthy subjectsFrançois Lellouche, Erwan L’her,
      Pierre Alexandre Bouchard, Mathieu Delorme, Tamer Elfaramawy, Benoit GosselinP187
      Accuracy of ventilators for intermediate care to deliver tidal volume. A bench
      studyClaude Guérin, Loredana Baboi, Sarah Guegan, Fabien SubtilP188 Efficiency of
      ventilators for intermediate care to deliver adequate FIO2. A bench studyClaude
      Guérin, Loredana Baboi, Fabien Subtil, Sarah GueganP189 In vitro comparison of
      inspiratory-synchronized and continuous nebulization modes during noninvasive
      ventilation: analysis of inhaled and lost dosesJean-Bernard Michotte, Enrico
      Staderini, Jonathan Dugernier, Rares Rusu, Jean Roeseler, Giuseppe Liistro,
      Gregory ReychlerP190 Short-term physiological effects of nasal high flow in
      patients with respiratory distress. Impact of flow rates on the work of
      breathingMathieu Delorme, Pierre Alexandre Bouchard, Mathieu Simon, François
      LelloucheP191 Design and implementation of an active artificial lungElmaati
      Essoukaki, Lhoucine Ben Taleb, Mohammed Harmouchi, Mourad Rattal, Ahmed Mouhsen, 
      Jean-Christophe Marie Richard, A Zeddine Mouhsen, Aissam LyazidiP192 Assessment
      of the accuracy of ventilator simulation softwaresFrédéric Duprez, Jean Bernard
      Michotte, Olivier Contal, Thierry Bonus, Sandra Olieuz, Grégory Cuvelier, Sharam 
      MachayeckhiP193 Outcome and early prognostic factors in neutropenic patients
      admitted to the intensive care unitBecem Trabelsi, Zied Hajjej, Walid Sammoud,
      Hedi Garsallah, Mustapha FerjaniP194 Blood loss and transfusion practice in
      medical surgical intensive care unit: 1-year studyWalid Sammoud, Zied Hajjej,
      Khaoula Harira, Hedi Garsallah, Mustapha FerjaniP195 Atypical hemolytic and
      uremic syndrome in critically ill adult patientsElie Azoulay, Akli Chermak,
      Cédric Rafat, Claire Pichereau, Emmanuel Canet, Virginie Lemiale, Valade
      Sandrine, Marion Venot, Benoît Schlemmer, Eric MariotteP196 Outcome of critically
      ill patients after allogeneic hematopoietic stem cell transplantation: comparison
      of cord blood cells with others cells as hematopoietic stem cells sourceCaroline 
      Le Jeune, Florent Wallet, Pascal Roy, Laurent Argaud, Mauricette MichalletP197
      Outcome of patients with organ failures related to solid malignancies and
      receiving chemotherapy in the intensive care unitYoann Zerbib, Julien Maizel,
      Naïke Bigé, Benoit Misset, Nicolas de Prost, Virginie Lemiale, Sylvie Ricome,
      François Baudin, Muriel Fartoukh, Frédéric Jacobs, François Blot, Matthieu
      Schmidt, Antoine Rabbat, Julien Mayaux, Frédéric Gonzalez, Caroline Bornstain,
      Elie Azoulay, Frédéric PèneP198 Characteristics and outcomes of patients with
      hematological malignancies (HMs) admitted to the intensive care unitStéphanie
      Gelinotte, Dorothée Carpentier, Steven Grange, Julien Abily, Marion Beuzelin,
      Emmanuel Besnier, Gioia Gastaldi, Gaetan Beduneau, Jean-Philippe Rigaud,
      Christophe Girault, Fabienne TamionP199 Influence of neutropenia on mortality of 
      critically ill cancer patients: Results of a systematic review and meta-analysis 
      of available evidencesMarie Bouteloup, Sophie Perinel Ragey, Elie Azoulay, Djamel
      Mokart, Michaël Darmon, Groupe de Recherche en Réanimation Respiratoire et
      Onco-Hematologique (GRRROH)P200 Thrombotic Microangiopathy (TMA) Syndromes in the
      ICU: experience of a Tunisian ICUJihene Ayachi, Ahmed Khedher, Kaoula Meddeb, A. 
      Azouzi, Y Hamdaoui, H. Nouira, Rania Bouneb, Mohamed BoussarsarP201
      “Immunonutrition” failed to improve septic shock-induced vascular dysfunction in 
      a rat modelJulie Boisramé-Helms, Grégory Meyer, Su Degirmenci, Mélanie Burban,
      Valérie Schini-Kerth, Alexandra Boivin, Raphaël Clere-Jehl, Alexandra Monnier,
      Christine Kummerlen, Ferhat MezianiP202 PTP1B gene deletion improves glucose
      metabolism and limits cardiovascular dysfunction in experimental septic
      shockEugénie Delile, Pierre-Alain Thiébaut, Jean-Claude Do Rego, David Coquerel, 
      Rémi Nevière, Vincent Richard, Fabienne TamionP203 Ascitic fluid TREM-1 for the
      diagnosis of spontaneous bacterial peritonitisLaure Ichou, Nicolas Carbonell,
      Pierre-Emmanuel Rautou, Ludivine Laurans, Simon Bourcier, Claire Pichereau,
      Jean-Luc Baudel, Jean-Baptiste Nousbaum, Christophe Renou, Rodolphe Anty, Jacques
      Tankovic, Eric Maury, Bertrand Guidet, Luce Landraud, Hafid Ait-OufellaP204
      Modulation of inflammatory response related to severe peritonitis by polymyxin-B 
      hemoperfusionRemi Coudroy, Jean-Claude Lecron, Didier Payen de la Garanderie,
      René Robert, ABDOMIX GroupP205 Descriptive study of ultrasonographic data inside 
      a surgical intensive care unit for cholestasis diagnosis: dechorea studyMichael
      Helary, Jonathan Paillot, Sebastien Pili-FlouryP206 In-hospital mortality and
      predictive risk factors for patients with cirrhosisSana Khedher, Amira Maoui,
      Asma Ezzamouri, Mohamed SalemP207 CONSTIPREA: evaluation of the management of
      constipation in intensive care—National Survey of French intensivitsLamia
      Kerdjana, Mihaela Dumitrescu, Olivier Mimoz, Bertrand Debaene, Virginie Migeot,
      Claire Dahyot-FizelierP208 Corrosive ingestion in adults: endoscopic findings and
      agents involvedSana Khedher, Asma Ezzamouri, Amira Maoui, Mohamed Salem, Amira A.
      MaouiP209 Hypoxic hepatitis after out-of-hospital cardiac arrest: incidence,
      determinants and prognosisBenoit Champigneulle, Guillaume Geri, Wulfran Bougouin,
      Florence Dumas, Michel Arnaout, Lara Zafrani, Frédéric Pène, Julien Charpentier, 
      Jean-Paul Mira, Alain CariouP210 Aspiration pneumonitis in comatose patients
      treated with invasive mechanical ventilation. The SPIRE prospective
      surveyJean-Baptiste Lascarrou, Floriane Lissonde, Aurélie Le Thuaut, Konstantinos
      Bachoumas, Gwenhaël Colin, Matthieu Henry-Laguarrigue, Maud Fiancette,
      Jean-Claude Lacherade, Christine Lebert, Isabelle Vinatier, Aihem Yehia, Aurélie 
      Joret, Laurent Martin-Lefèvre, Jean ReignierP211 Ventilator-associated pneumonia 
      (VAP) in cancer patients: impact of 1-year survivalLaura Platon, Jerôme Lambert, 
      David Lagier, Jeanpaul Brun, Antoine Sannini, Laurent Chow-Chine, Magali Bisbal, 
      Marion Faucher, Djamel MokartP212 High-resolution computed tomography (HRCT)
      patterns in patients with pneumocystis pneumoniaLeïla Mourtada, Lemiale Virgnie, 
      Claire Givel, Valade Sandrine, Claire Pichereau, Emmanuel Canet, Eric Mariotte,
      Elie AzoulayP213 Plasma endocan predicts the occurrence of acute respiratory
      distress syndrome (ARDS) in severe sepsis and septic shock patientsAlexandre
      Gaudet, Erika Parmentier-Decrucq, Nathalie De Freitas Caires, Sylvain Dubucquoi, 
      Philippe Lassalle, Daniel MathieuP214 Comparison of 3 diagnostic methods to
      identify fluid responsiveness during prone position in ARDSJean-Christophe
      Richard, Hodane Yonis, Florent Gobert, Romain Tapponnier, Claude GuérinP215 Low
      pressure support-high PEEP for early severe acute respiratory distress syndrome: 
      a retrospective analysisLuc Quintin, C. Pichot, F. PetitjeansP216 Neutrophil
      proteases alter the interleukin-22-receptor-dependent lung antimicrobial
      defenceAntoine Guillon, Youenn Jouan, Daborah Breah, Fabien Gueugnon, Emilie
      Dalloneau, Thomas Baranek, Clemence Henry, Eric Morello, Jc Renauld, M Pichavant,
      Philippe Gosset, Y Courty, Patrice Diot, Mustapha Si-TaharP217 Impaired
      phagocytosis of apoptotic neutrophils in human ARDS: beneficial effects of
      metforminFabrice Uhel, Murielle Gregoire, Arnaud Gacouin, Yves Le Tulzo, Karin
      Tarte, Jean-Marc TadiéP218 What are the deteP219 Emergency thoracotomy:
      development and results in a military trauma centerrminants of needle aspiration 
      success in primary spontaneous pneumothorax?Constance Vuillard, Jean-Damien
      Ricard, Béatrice La Combe, Stéphane Gaudry, Didier Dreyfuss, Jonathan MessikaP219
      Emergency thoracotomy: development and results in a military trauma centerPauline
      Ponsin, Jean-Louis Daban, Guillaume Boddaert, Bertrand Grand, Vincent Peigne,
      Yohan Baudoin, Mathieu Boutonnet, Patrick Jault, Stéphane BonnetP220 Management
      of isthmic aortic rupture in polytraumatized patients in ICU: a report of 12
      casesChtara Kamilia, Kais Regaieg, Olfa Turki, Najeh Baccouch, Anis Chaari, Hmida
      Chokri Ben, Mabrouk Bahloul, Mounir BouazizP221 NT-proBNP levels and
      echocardiography findings in the etiologic diagnosis of acute dyspneaSalah
      Snouda, Hassen Ben Ghezala, Mohamed Fehmi Abbes, Rebeh Daoudi, Moez Kaddour, Imen
      BenchiekhP222 Cardiac decompensation in peripartumKamal Belkadi, I. Moussaid,
      Chaigar Mohammed Cheikh, S. El Youssoufi, S. SalmiP223 Peripheral intravenous
      catheter-related complications in an emergency wardInes Sedghiani, Hana Fredj,
      Hamdi Doghri, Youssef Zied El Hechmi, Mohamed Ali Cherif, Jerbi ZouheirP224
      Burnout in the emergency roomNeila Maaroufi, Abid ZeinebP225 Prevalence, and
      characteristics of elderly patient admitted in a Moroccan Medical Unit for the
      Acute CareJihane Belayachi, Leila Debono, Naoufal Madani, Fatiha Amlaiky, Tarek
      Dendane, Khalid Abidi, Aicha Zekraoui, Amine Ali Zeggwagh, Redouane AbouqalP226
      Metabolic phenotyping in bronchoalveolar lavage fluids distinguishes influenza
      and pneumococcal pneumoniaAdrien Auvet, Antoine Guillon, Lydie Nadal-Desbarats,
      Thomas Baranek, Eric Morello, François Réminiac, Mustapha Si-TaharP227
      Microbiological documentation of pneumonia in the ICU by per-bronchoscopic
      bronchial aspiration (PBA) is very similar to that obtained by bronchoalveolar
      lavage (BAL)Jean-Luc Baudel, Jacques Tankovic, Redouane Dahoumane, Arnaud
      Galbois, Hafid Ait Oufella, Georges Offenstadt, Eric Maury, Bertrand GuidetP228
      Compliance with the H3 bundle of the 2012 surviving sepsis campaign according to 
      the chain of care of septic patients: the sepsis CHOC studyAmel Filali, Emmanuel 
      Faure, Nicolas Van Grunderbeeck, Olivier Nigeon, Juliette Masse, H Bazus, Jihad
      Mallat, Didier TheveninP229 CRP ratio as a predictive tool for mortality in ICU
      septic patientsSophie Lempereur-Legros, Didier Ledoux, Monique Nys, Pierre
      DamasP230 Candidemia in ICU: Epidemiology and prognostic factorsZied Hajjej,
      Walid Sammoud, Becem Trabelsi, Iheb Labbene, Mustapha FerjaniP231 Extracorporeal 
      membrane oxygenation cannula-associated infections: implication of virulent
      Escherichia coli phylogroupsJonathan Messika, Olivier Clermont, Matthieu Schmidt,
      Alexandra Aubry, Romain Fernandes, Erick Denamur, Alain Combes, Jean-Damien
      RicardP232 Is diabetes mellitus a risk factor for intensive care unit-acquired
      infections in intensive care unit patients with hematologic malignancies?Marion
      Venot, Sylvie Chevret, Djamel Mokart, Frédéric Pène, Virginie Lemiale, Achille
      Kouatchet, Julien Mayaux, François Vincent, Martine Nyunga, Fabrice Bruneel, Elie
      AzoulayP233 Should we need aerobic–anaerobic or specific blood culture bottles
      for diagnosing candidemia in ICU patients?Sébastien Bailly, Jean-François Timsit,
      Cécile Garnaud, Muriel Cornet, Patricia Pavese, Rebecca Hamidfar-Roy, Luc Foroni,
      Sandrine Boisset, Carole Schwebel, Danièle MaubonP234 Invasive Candida infection 
      in a Tunisian ICU: an observational cohort studyIslem Ouanes, Maha Abid, Hend Ben
      Lakhal, Saousen Ben Abdallah, Fahmi Dachraoui, Hedia Hammed, Rami Jabla, Asma
      Hachani, Mahdi Marzouk, Imen Abdellaoui, Chaima Ghribi, Imen Ben Ali, Lamia
      Ouanes-Besbes, Fekri AbrougP235 Causes of admission in medical intensive care of 
      patients suffering from severe psychiatric disordersHanane Ezzouine, Constant
      Aniolo Edith, Abdellatif BenslamaP236 Unplanned extubation in critical care:
      still to learn from local surveyFrédéric Jacobs, Dominique Prat, Matthieu Le
      Meur, Olfa Hamzaoui, Anne Sylvie Dumenil, Guy Moneger, Nadège Demars, Pierre
      Trouiller, Benjamin SztrymfP237 Mortality associated with nights and weekends
      admission to intensive care unit (ICU): results of a 9-year cohort study
      (2006–2014)Vincent Brunot, Jean-Emmanuel Serre, P. Corne, Nicolas Molinari, L.
      Landreau, Olivier Jonquet, Kada KloucheP238 Determinants and outcomes associated 
      with decisions to deny admission in a Tunisian ICURania Bouneb, Kaoula Meddeb, Y.
      Hamdaoui, H Nouira, A. Azouzi, Jihene Ayachi, Ahmed Khedher, Mohamed
      BoussarsarP239 Characteristics and outcomes of patients not admitted to
      ICUNesrine Boujelbene, Rami Jabla, Fahmi Dachraoui, Islem Ouanes, Mahdi Marzouk, 
      Hedia Hammed, Asma Hachani, Hend Ben Lakhal, Chaima Ghribi, Imen Abdellaoui, Imen
      Ben Ali, Saousen Ben Abdallah, Lamia Ouanes-Besbes, Fekri AbrougP240 Long-term
      outcomes of critically ill patients with severe acute kidney injury requiring
      renal replacement therapyVanessa Jean-Michel, Francis Couturaud, Elizabeth Moore,
      Pierre-Yves Egreteau, Jean-Michel Boles, Cécile AubronP241 Nowadays, SAPSII
      better predicts 1-year mortality than hospital mortalityJean-Etienne Herbrecht,
      Max Guillot, Quentin Maestraggi, Charlotte Kaeuffer, Ralf Janssen-Langenstein,
      Sylvie L’hotellier, Sophie Hatsch, Benjamin Lebas, Alexandra Boivin, Maleka
      Schenck, Marie-Line Harlay, Anne Meyer, Vincent Castelain, Francis SchneiderP242 
      Impact of diabetes on burn injury: preliminary results from retrospective
      studyAmel Mokline, Imen Rahmani, Khaouther Ben Arfi, Lazhari Gharsallah, Sofiene 
      Tlaili, Bahija Gasri, Rym Hammouda, Amen Allah MessadiP243 Withdrawal or
      withholding of life-sustaining treatments decisions: Is there a risk of excessive
      influence of medical imaging?Fabrice Lesage, Sylvie Séguret, Laurent Dupic, Laure
      De Saint Blanquat, Sylvain RenolleauP244 Withholding and withdrawal of
      life-sustaining treatments in intensive care unit patients: predisposing factors 
      and implementationAnne-Sophie Baptiste, Hugues Georges, Pierre-Yves Delannoy,
      Patrick Devos, Olivier LeroyP245 Advanced directives in an old patient with
      suicide attempt: analysis of ICU physicians perceptionDolores Albarracin, A.
      Ducousso-Lacaze, Angéline Jamet,, Julien Dufour, Séverin Cabasson, Anne
      Veinstein, Delphine Chatellier, Jean-Pierre Frat, René RobertP246 Having the talk
      about advance directives in the daily practice: Is a stay in an intensive care
      unit a good opportunity?Vivien Hong Tuan Ha, Nicolas Lau, Lucie Mimoun, Xavier
      ForcevilleP247 Long-term outcome of patients who have withheld life support in
      intensive careAdel Maamar, Stéphanie Chevalier, Vlad Botoc, Yves Le TulzoP248
      Epidemiology of refusals in a polyvalent intensive care unit ad outcome of
      refused patientsStephane Rouleau, David Schnell, Arnaud Desachy, Sylvie Calvat,
      Philippe Petua, Charles Lafon, Christophe CraccoP249 Ten critical sentences you
      have already heard in the Intensive Care Unit and the Emergency Department, their
      real meanings and consequencesNicolas Van Grunderbeeck, J. Temime, Perrine Molmy,
      Stephanie Barrailler, G. Gasan, Olivier Nigeon, Didier TheveninP250 Communication
      with the parents: a challenge in the pediatric intensive care unitAgathe
      Béranger, Charlotte Pierron, Laure De Saint Blanquat, Sandrine Jean, Hélène
      ChappuyP251 End of life in the intensive care unit: between practice and
      knowledgePierre-Marie Bertrand, Alexandra Beurton, Laetitia Bodet-Contentin,
      Julie Boisramé-Helms, Pierre-éRic Danin, Elsa Dubois, Elodie Gélisse, Yasemin
      Karaca, Pierre Mora, Nicolas de Prost, Damien Roux, Alexis Soummer, Dominique
      Vodovar, Committee of young intensivists of the French Society for Intensive Care
      Medicine (FICS)S1 The HICU Score (Hematologic Intensive Care Unit Score): a new
      prognostic score for predicting 30-day and 1-year mortality of patients with
      hematologic malignancies admitted in ICUYohan Desbrosses, Guylaine Labro, Gaël
      Piton, Adrien Chauchet, Etienne Daguindau, François Blot, Eric Deconinck, Gilles 
      CapellierS2 Patients with multiple myeloma in the ICU: trends of use and outcomes
      over timeAkli Chermak, Adrien Joseph, Virginie Lemiale, Claire Pichereau, Marinne
      Baron, Emmanuel Canet, Eric Mariotte, Michaël Darmon, Elie AzoulayS3 Impact of
      bone marrow aspiration on the management of adult critically ill patientsLaure
      Calvet, Anne Françoise Sapin, Bruno Pereira, Alexandre Lautrette, Bertrand
      SouweineS4 Red blood cells transfusion in ICU: descriptive analysis of French
      cohort from “Age BLood Evaluation” clinical trialLucie Vettoretti, Sebastien
      Pili-Floury, Gaël Piton, Jacques Lacroix, Lucy Clayton, Elham Sabri, Laurent
      Bardiaux, Pierre Tiberghien, Paul Hebert, Gilles Capellier, ABLE French
      InvestigatorsS5 Graft-versus-host disease trajectories and mortality in
      critically ill allogeneic stem cell recipientsClaire Pichereau, Etienne Lengliné,
      Anne-Sophie Moreau, Eric Mariotte, Marion Venot, Sandrine Valade, Akli Chermak,
      Virginie Lemiale, Emmanuel Canet, Gérard Socié, Benoît Schlemmer, Elie AzoulayS6 
      Outcome of 544 patients with solid cancer in the intensive care unit: the Oncoréa
      studyEdith Borcoman, Virginie Lemiale, Eric Mariotte, Claire Pichereau, Emmanuel 
      Canet, Adrien Joseph, Akli Chermak, Sandrine Valade, Marion Venot, Benoît
      Schlemmer, Elie AzoulayS7 Assessing the process of ICU admission refusal in
      critically ill patients with hematological malignanciesKaterina Rusinova,
      Virginie Lemiale, Matthieu Resche-Rigon, Djamel Mokart, Antoine Rabbat, Frédéric 
      Pène, Achille Kouatchet, Fabrice Bruneel, Julien Mayaux, François Vincent, Pierre
      Perez, Martine Nyunga, Elie Azoulay, Groupe de Recherche en Réanimation
      Respiratoire en Onco-HématologieS8 Neurologic and hepatic failures at ICU
      admission are associated with worst prognosis for patients with lymphomasAurélien
      Sutra Del Galy, Achille Kouatchet, Mélanie Mercier, Jean-François Hamel, Tommy
      Raveau, Marie-Pierre Moles, Aline Clavert, Mathilde Hunault-Berger, Alain Mercat,
      Norbert Ifrah, Aline Schmidt-TanguyS9 Impact of earplugs and eye mask on sleep in
      critically ill patients: a prospective randomized polysomnographic studyAlexandre
      Demoule, Serge Carreira, Sophie Lavault, Olivier Pallanca, Elise Morawiec, Julien
      Mayaux, Isabelle Arnulf, Thomas SimilowskiS10 Diaphragmatic paralysis after adult
      cardiac surgery: incidence and predicting factorsThomas D’humières, Pierre
      Dupland, Pauline Issaurat, Romain Vergier, Philippe Estagnasié, Alain Brusset,
      Pierre SquaraS11 Ultrasound evaluation of diaphragmatic dysfunction: prognostic
      marker of ICU weaning failureCédric Carrié, Chloé Gisbert-Mora, Eline Bonnardel, 
      Matthieu Biais, Frédéric Vargas, Gilles HilbertS12 A prospective multicentric
      study to evaluate the impact of breathing variability on clinical outcomes in
      mechanically ventilated patientsCôme Bureau, Camille Rolland-Debord, Tymothée
      Poitou, Marc Clavel, Sébastien Perbet, Nicolas Terzi, Achille Kouatchet, Thomas
      Similowski, Alexandre Demoule, Université Paris 6 —Pierre et Marie Curie and
      Institut National pour la Santé et la Recherche Médicale, UMRS1158, ParisS13
      Nurse-driven sedation protocol with sedation vacation and incidence of unplanned 
      extubationsPierre Lucas, Julien Charpentier, Michel Arnaout, Thomas Joannon,,
      Sébastien Lefort, Aude Marincamp, Anne-Sophie Debue, Matthieu Reffienna, Frédéric
      Pène, Jean-Paul Mira, Alain Cariou, Jean-Daniel Chiche, Working Group on
      Mechanical VentilationS14 Lung ultrasound enables to detect weaning-induced
      cardiogenic pulmonary oedemaAlexis Ferre, Max Guillot, Jean-Louis Teboul, Daniel 
      Lichtenstein, Gilbert Meziere, Christian Richard, Xavier MonnetS15 Pleural
      effusion during the weaning from mechanical ventilation: prevalence and
      impactDamien Roux, Tai Pham, Alexandra Beurton, Muriel Fartoukh, Jean-Damien
      Ricard, Alexandre Demoule, Martin DresS16 Prognostic impact of left ventricular
      diastolic dysfunction in patients with septic shockCéline Gonzalez, François
      Dalmay, Emmanuelle Begot, Nicolas Pichon, Bruno François, Anne-Laure Fedou,
      Catherine Chapellas, Antoine Galy, Philippe VignonS17 Norepinephrine exerts an
      inotropic effect at the early phase of human septic shockOlfa Hamzaoui, Mathieu
      Jozwiak, Thomas Geffriaud, Benjamin Sztrymf, Dominique Prat, Frédéric Jacobs,
      Xavier Monnet, Pierre Trouiller, Christian Richard, Jean-Louis TeboulS18 Effect
      of high PEEP after recruitment maneuver on right ventricular function in ARDS: Is
      it good for the lung and for the heart?Shari El-Dash, Loay Kontar, François
      Leleu, Bertand De Cagny, François Brazier, Dimitri Titeca, Gaelle Bacari-Risal,
      Julien Maizel, Michel SlamaS19 Myocardial dysfunction during septic shock:
      prevalence, prognosis and role of loading conditionsFlorence Boissier, Keyvan
      Razazi, Aurelien Seemann, Arnaud, W Thille, Nicolas de Prost, Elise Cuquemelle,, 
      Filippo Boroli,, Alexandre Bedet, Pascal Lim, Christian Brun-Buisson, Armand
      Mekontso DessapS20 Echocardiography for the critically ill: 1-year experience of 
      a noninvasive intensive care unitW Brahim, R Amara, A Azouzi, Ahmed Khedher,
      Jihene Ayachi, Rania Bouneb, Y Hamdaoui, Kaoula Meddeb, Mohamed BoussarsarS21
      Echocardiographic indices to predict fluid responsiveness in ventilated patients 
      with circulatory failure: which threshold for which aim?Emmanuelle Begot, Xavier 
      Repessé, Julie Léger, Gwenael Prat, Cyril Charron, Pierre-Yves Egreteau,
      Christophe Jacob, Koceila Bouferache, Loay Kontar, Julien Maizel, Michel Slama,
      Antoine Vieillard-Baron, Philippe VignonS22 Effects of norepinephrine on the
      right ventricle assessed by transthoracic echocardiography in the ICUClaire
      Ragot, Laure Corradi, Frédéric VargasS23 Effect of recruitment maneuver on left
      ventricular systolic strainPablo Mercado, Julien Maizel, Loay Kontar, Bertand De 
      Cagny, François Brazier, Dimitri Titeca, Gaelle Bacari-Risal, Antoine Riviere,
      Shari El-Dash, Michel SlamaS24 Management of diabetic ketoacidosis in two
      pediatric intensive care units: comparison of two care protocolsLaure Maurice,
      Stéphane Dauger, S Julliand, Anna Deho, Fleur Le BourgeoisS25 NUTRI-REAPED:
      Nutritional status on admission to the pediatric intensive care unit—a French
      multicentric studyAurelien Jacquot, Frederic Valla, Bénédicte Gaillard-Le Roux,
      Flavie Letois, Gilles Cambonie, NutriSIPS26 Apnea test in children for brain
      death diagnosis: efficacy and complicationsAlexandre Salvadori, Gaia Ottonello,
      Stéphane Blanot, Juliette Montmayeur, Gilles OrliaguetS27 Interest of the
      ultrasound in the central venous catheterization in children poses in intensive
      care unitFehmi Ferhi, Hosni Khouadja, Mohamed Amine Bouslama, Affra Brahim,
      Khalil Tarmiz, Khaled BenjaziaS28 Supraclavicular approach to the innominate vein
      in pediatric intensive care unit: interest in the prevention of thrombosis and
      catheter-related blood stream infectionFlora Habas, Julien Baleine, Julia
      Lebouhellec, Christophe Milesi, Clementine Combes, Gilles CambonieS29 EPURE
      Study: Preliminary results on the organization of pediatric acute dialysis in 2
      French-speaking countriesMaryline Chomton, Philippe Jouvet, Bruno Ranchin, Marie 
      Alice Macher, Théophile Gaillot, EPURE Study GroupS30 Hyperglycemia in severe
      scorpion envenomed children: incidence and impact outcomeMabrouk Bahloul, Najeh
      Baccouche, Kais Regaieg, Turki Olfa, Chtara Kamilia, Benhamida Chokri, Hedi
      Chelly, Mounir BouazizS31 Prehospital care and initial hospital care of pediatric
      patients with severe trauma hospitalized in the ICU at Grenoble University
      Hospital, data from the “TRENAU” trauma-systemMurielle Moine, François Xavier
      Ageron, Claire Jannel, Thierry Debillon, Isabelle WroblewskiS32
      Ventilator-associated pneumonia due to multi- or extensively drug-resistant
      Pseudomonas aeruginosa: comparison with susceptible strainsMatthieu Duprey,
      Nicolas Bréchot, Alexandra Aubry, Guillaume Hekimian, Matthieu Schmidt, Ania
      Nieszkowska, Jean Louis Trouillet, Vincent Jarlier, Alain Combes, Jean Chastre,
      Charles-Edouard LuytS33 Can we predict a secondary documented infection in
      patients empirically treated for an invasive candidiasis?Sébastien Bailly,
      Olivier Leroy, Jean-Paul Mira, Hervé Dupont, Jean-Pierre Gangneux, Philippe
      Montravers, Jean-Michel Constantin, Didier Guillemot, Olivier Lortholary,
      Pierre-François Perrigault, Elie Azoulay, Jean-François TimsitS34 Should
      aminoglycosides be administered to hematological patients with septic shock? Data
      from the Groupe de Recherche respiratoire en Réanimation Onco-Hématologique
      (Grrr-OH)Thomas Longval, Sylvie Chevret, Fabrice Bruneel, Djamel Mokart, Frédéric
      Pène, Julien Mayaux, Achille Kouatchet, Martine Nyunga, Antoine Rabbat, Pierre
      Perez, Christine Lebert, Dominique Benoit, François Vincent, Virginie Lemiale,
      Elie AzoulayS35 Is de-escalation of antimicrobial therapy safe in hematology
      patients?David Schnell, Claire Montlahuc, Matthieu Resche-Rigon, Achille
      Kouatchet, Jean-Ralph Zahar, Michaël Darmon, Frédéric Pène, Virginie Lemiale,
      Antoine Rabbat, François Vincent, Fabrice Bruneel, Djamel Mokart, Elie AzoulayS36
      Pharmacokinetics and absolute bioavailability of voriconazole administered
      through a nasogastric tube with continuous enteral feeding to critically ill
      ventilated patientsPhilippe Karoubi, Christophe Huang, Antoine Rabbat, Johanna
      Oziel, Guillaume Van Der Meersch, Yacine Tandjaoui-Lambiotte, Frédéric Gonzalez, 
      Christophe Clec’h, Christophe Padoin, Yves CohenS37 Which optimal daily dose for 
      linezolid in burn patients?Amel Mokline, Lazhari Gharsallah, Imen Rahmani, Emna
      Gaies, Sofiene Tlaili, Bahija Gasri, Rym Hammouda, Sameh Triki, Anis Klouz, Amen 
      Allah MessadiS38 Predictive factors of sub-therapeutic peak concentration after a
      single dose of amikacin in postoperative cardiovascular critically ill
      patientsMouhamed Moussa, Flavie DesrumauxS39 Supra-therapeutic serum levels and
      toxicity of beta-lactam antibiotics in septic ICU patients requiring replacement 
      therapy for acute renal failure: a single-center cohort studyFaten May, Marion
      Perrin, Najoua El-Helali, Jean-Claude Nguyen, Kelly Tiercelet, Stephane Ruckly,
      Julien Fournier, Mélanie Cherin, Cédric Bruel, Francois Philippart, Maïté
      Garrouste-Orgeas, Marie Dominique Kitzis, Alban Le Monnier, Jean-François Timsit,
      Benoit MissetS40 Post-cardiac arrest syndrome: lessons from a monocentric
      retrospective studyCyrille Mathien, Antoine Poidevin, Luis Donatti, Joy Mootien, 
      Luis Pinto, Mathieu Egard, Gokhan Bodur, Guillaume Barberet, Carmen Ionescu,
      Frederique Ganster, Philippe Guiot, Khaldoun KuteifanS41 Out-of-hospital cardiac 
      arrest (OHCA) score for prediction of outcome of in-hospital cardiac arrest:
      results of the OSPICA pilot studyAlain Mpela, Jonathan Chelly, Jennifer Brunet,
      Stéphane Legriel, Laurent Guérin, Romain Persichini, Alexis Soummer, Bertrand
      Sauneuf, Tai Pham, Thomas Hullin, Nicolas Deye, Pierre Aubertein, Mehran
      MonchiS42 Delayed awakening after cardiac arrest: causes and outcome in the
      Parisian registryMarine Paul, Wulfran Bougouin, Guillaume Geri, Florence Dumas,
      Benoit Champigneulle, Stéphane Legriel, Julien Charpentier, Jean-Paul Mira,
      Claudio Sandroni, Alain CariouS43 Incidence and characteristics of sudden
      unexplained cardiac death: insights from the Parisian registryOlivier Passouant, 
      Guillaume Geri, Florence Dumas, Wulfran Bougouin, Benoit Champigneulle, Michel
      Arnaout, Jonathan Chelly, Jean-Daniel Chiche, Olivier Varenne, Jean-Paul Mira,
      Alain CariouS44 Supranormal oxygen tension is not associated with an impaired
      redox balance in patients resuscitated from cardiac arrestJean-François Llitjos, 
      Camille Chenevier-Gobeaux, Julien Charpentier, Florence Dumas, Guillaume Geri,
      Wulfran Bougouin, Benoit Champigneulle, Michel Arnaout, Jean-Paul Mira, Frédéric 
      Pène, Frederic Batteux, Alain CariouS45 Impaired biological response to aspirin
      in comatose patients resuscitated from out-of-hospital cardiac
      arrestJean-François Llitjos, Ludovic Drouet, Sebastian Voicu, Nicolas Deye, Bruno
      Megarbane, Patrick Henry, Jean-Guillaume DillingerS46 Gender differences in
      coronary reperfusion after cardiac arrestWulfran Bougouin, Florence Dumas, Eloi
      Marijon, Guillaume Geri, Benoit Champigneulle, Jean-Daniel Chiche, Olivier
      Varenne, Christian Spaulding, Jean-Paul Mira, Xavier Jouven, Alain CariouS47
      Prognostic factors of out-of-hospital cardiac arrests in Martinique: prospective 
      study over a period of 29 months, about 385 casesDabor Resiere, A. L. Dessoy,
      Ruddy Valentino, C. Chabartier, Laurent Villain-Coquet, Jean-Louis Ferge, Y.
      Brouste, Bruno Megarbane, Hossein MehdaouiS48 Incubation of immune cells in
      septic plasma: effect on glucose utilization and on phenotypic expression on
      monocytes, polymorphonuclears and lymphocytesBenjamin Soyer, Valérie Faivre,
      Charles Damoisel, Anne-Claire Lukaszewicz, Didier Payen de la GaranderieS49 Ex
      vivo effects of hyperglycemia on phenotype and production of reactive oxygen
      species by the NADPH oxidase of human immune cells in acute inflammatory
      responseBenjamin Soyer, Valérie Faivre, Charles Damoisel, Anne-Claire
      Lukaszewicz, Didier Payen de la GaranderieS52 HMGB1 induces neutrophils
      dysfunction after septic shockFabrice Uhel, Murielle Gregoire, Arnaud Gacouin,
      Caroline Piau, Yves Le Tulzo, Karin Tarte, Jean-Marc TadiéS53 Rapid mobilization 
      of myeloid-derived suppressor cells during sepsis and relation with clinical
      courseThomas Daix, Robin Jeannet, Emmanuelle Begot, Nicolas Pichon, Anne-Laure
      Fedou, Estelle Guérin, Philippe Vignon, Jean Feuillard, Bruno FrançoisS54
      Targeted endothelial TREM-1 deletion protects mice during septic shockLucie
      Jolly, Amir Boufenzer, Jérémie Lemarie, Kevin Carrasco, Marc Derive, Sebastien
      GibotS55 Polymicrobial sepsis inhibits tumor growth in cancer miceHamid Merdji,
      Jean-François Llitjos, Christophe Rousseau, Nadia Belaidouni, Julie Toubiana,
      Jean-Paul Mira, Jean-Daniel Chiche, Frédéric PèneS56 Telestroke implementation in
      the biggest French region (12 millions inhabitants): the project ORTIFYann
      L’Hermitte, France Woimant, Catherine Oppenheim, Christophe Couvreur, François
      DolveckS57 Free haemoglobin concentration in patients with sickle cell disease
      referred to the emergency room: Is it useful?Pierre Mora, Magali Devriese, Sophie
      Dupeyrat, Patrick Ray, Guillaume Lefevre, Muriel FartoukhS58 Evaluation of the
      prescription and use of antibiotics in an emergency department of a general
      hospital by Gyssens MethodNicolas Roothaer, Amélie Carpentier, Fabien Vaniet,
      Antoine Maisonneuve, Eric WielS59 High dosages of norepinephrine in trauma
      patientsSébastien Canu, Emmanuelle Hammad, Francois Antonini, Marion Poirier,
      Laurent Zieleskiewicz, Coralie Vigne, Malik Haddam, Julie Alingrin, Marc LeoneS60
      Bleeding risk of pleural procedures in patients taking antiplatelet therapy: a
      multicentric prospective studyLaurence Dangers, Gilles Mangiapan, Mikael Alves,
      Naïke Bigé, Jonathan Messika, Elise Morawiec, Mathilde Neuville, Christophe
      Cracco, Gaetan Beduneau, Nicolas Terzi, Isabelle Huet, Xavier Dhalluin, Nathalie 
      Bautin, Jean Jacques Quiot, Corinne Appere De Vecchi, Thomas Similowski, Cécile
      ChenivesseS61 Interest of the association fibrinogen/tranexamic acid in the
      management of severe postpartum hemorrhageKhalil Tarmiz, Fehmi Ferhi, Hosni
      Khouadja, Affra Brahim, Mohamed Amine Bouslama, Khaled BenjaziaS62 HELLP syndrome
      in ICU: epidemiological, clinical and prognostic study about 112 casesFatma
      Kaaniche Medhioub, Kais Rgieg, Olfa Turki, Mariem Smaoui, Anis Chaari, Benhamida 
      Chokri, Mabrouk Bahloul, Bouaziz MounirS63 Neurological complications in
      eclampsiaChaigar Mohammed Cheikh, I. Moussaid, Kamal Belkadi, E. El Alami, S. El 
      Youssoufi, S. SalmiS64 Brain water contain is dependent on plasmatic ammonemia
      levels in hyperammoniemic encephalopathy, a quantitative CT scan studyNicolas
      Weiss, Fanny Mochel, Damien Galanaud, Louis Puybasset, Dominique Thabut, Brain
      Liver Pitié-Salpêtrière Study Group (BLIPS), Paris, FranceS65 Sodium
      phenylbutyrate administration to avoid neurological worsening in hepatic
      encephalopathy patients in ICUSimona Tripon, Marion Lodey, Elsa Guiller, Maxime
      Mallet, Marika Rudler, Dominique Thabut, Nicolas Weiss, Brain Liver
      Pitié-Salpêtrière Study Group (BLIPS), Paris, FranceS66 Disruption of
      posteromedial large-scale neural communication predicts recovery from comaStein
      Silva, Béatrice Riu-Poulenc, Jean Ruiz, Corine Vuillaume, Francesco De Pasquale, 
      Jean Francois DemonetS67 Loss of sleep elements on continuous EEG monitoring is
      associated with mortality in patients with cardiogenic shock requiring
      veno-arterial extra-corporeal membrane oxygenation (ECMO)Fabrice Sinnah, Marie
      Amelie Dalloz, Eric Magalhaes, Mathilde Neuville, Roland Smonig, Aguila Radjou,
      Bruno Mourvillier, Lila Bouadma, Jean-François Timsit, Marie Pia D’ortho, Anny
      Rouvel-Tallec, Romain SonnevilleS68 Protective effects of high-density
      lipoprotein therapy in a mouse model of ischemic stroke hemorrhagic
      transformation due to acute hyperglycemiaDavid Couret, Aurélie Catan, Brice
      Nativel, Cynthia Planesse, Nicolas Diotel, Olivier MeilhacS69 Glucocorticoids as 
      a “rescue therapy” for delayed intracranial hypertension after acute brain
      injury: a retrospective studyFabian Roy-Gash, Stephane Welschbillig, Elodie Lang,
      Christophe Lebard, Nicolas EngrandS70 Organ donation: early talks (ET) to
      relatives before occurence of brain deathAnne-Gaelle Si Larbi, Virginie Gaudin,
      France Bonnin, Oceane Sultan,, Alexis Soummer, Grégoire Trebbia, Cecile Hoc,
      Emmanuel Mathieu, Bertrand Lapergue, Frederic Bourdain, Charles CerfS71
      Remifentanil target-controlled infusion for procedures generating pain or
      discomfort in the ICU: feasibility, safety and tolerance evaluationMargot Caron, 
      Antoine Parrot, Maxens Decavèle, Clarisse Blayau, Jean-Pierre Fulgencio, Vincent 
      Labbe, Michel Djibre, El Mahdi Hafiani, Christophe Quesnel, Muriel Fartoukh, Tai 
      PhamS72 Minimizing dead-volume infusion devices leads to a reduction in
      hypoglycaemia in surgery patients admitted to a perioperative intensive care
      unitStephanie Genay, Bertrand Décaudin, Sabine Ethgen, Pascal Odou, Gilles
      LebuffeS73 Patient-important outcomes in randomized controlled trials in
      critically ill patientsStéphane Gaudry, Jonathan Messika, Jean-Damien Ricard,
      Blandine Pasquet, Sylvie Guillo, Emeline Dubief, Didier Dreyfuss, Florence
      TubachS74 Epidemiology of platelets transfusion in critically ill patientsCécile 
      Aubron, Andrew Flint, Michael Bailey, Rinaldo Bellomo, David Pilcher, Allen
      Cheng, Colin Hegarty, Anthony Martinelli, Benjamin Howden, Michael Reade, Zoe
      McquiltenS75 Outcome of selected nonagenarians admitted in ICUs: a multicenter
      study from the Outcomerea research groupMaïté Garrouste-Orgeas, Stephane Ruckly, 
      Francois Philippart, Anne Sylvie Dumenil, Dany Goldgran Toledano, Samir Jamali,
      Carole Schwebel, Lilia Soufir, Christophe Clec’h, Michaël Darmon, Bernard
      Allaouchiche, Laurent Argaud, Bruno Verdière, Muriel Fartoukh, Mélanie Cherin,
      Elie Azoulay, Jean-François TimsitS76 A systematic follow-up consultation
      guarantee quality of care in intensive care unitMartine Nyunga, Noémie Banaias,
      Clément Vanbaelinghem, Céline Broucqsault-Dedrie, Delphine Colling, Marie Kauv,
      Erik Blondeau, Patrick HerbecqS77 Change in functional autonomy following ICU
      stayIslem Ouanes, Mahdi Marzouk, Lamia Ouanes-Besbes, Rami Jabla, Chaima Ghribi, 
      Nesrine Boujelbene, Asma Hachani, Saousen Ben Abdallah, Hedia Hammed, Hend Ben
      Lakhal, Imen Ben Ali, Imen Abdellaoui, Fahmi Dachraoui, Fekri AbrougS78 Outcome
      of Intensive Care Unit (ICU) elderly patients admitted with solid tumorEdouard
      Auclin, Emmanuel Guérot, Caroline Haw-Berlemont, Julien Taieb, Stéphane Oudard,
      Jean-Luc Diehl, Jean-Yves Fagon, Nadia AissaouiS79 Risks factors for mortality in
      critically ill children with acute kidney injury requiring renal replacement
      therapyGenevieve Morissette, Wassim Kechaou, Catherine Litalien, Aïcha Merouani, 
      Véronique Phan, Josée Bouchard, Philippe JouvetS80 Epinephrine use in pediatric
      septic shock: a retrospective, single-center study on 117 patientsJulie Starck,
      Mehdi Oualha, Nelly Briand, Jean-Marc Treluyer, Sylvain Renolleau, Laurent
      DupicS81 Sickle cell disease in pediatric intensive care unit: a five-year
      retrospective monocentric study of 74 patientsPhilippe Sachs, S Julliand,
      François Angoulvant, Julie Sommet, L Holvoet, M Benkerrou, Stéphane DaugerS82
      Implementation and evaluation of a paediatric nurse-driven sedation protocol in a
      PICULélia Dreyfus, Fabienne Bordet, Sandrine Touzet, Angélique Denis, Etienne
      JavouheyS83 Diagnostic evaluation and management of new-onset seizures and
      seizures with known epilepsy in children: a retrospective and comparative
      analysisJulien Le Coz, Gérard Chéron, Rima Nabbout, Geraldine Patteau, Claire
      Heilbronner, Philippe Hubert, Sylvain Renolleau, Mehdi OualhaS84 MRI sedation in 
      children in pediatric hospital in Oran, AlgeriaNabil Tabet Aoul, zakaria addou,
      Ali Douah, Mohamed Moussati, Kamel Belhabiche, Nabil AouffenS85 Neurally adjusted
      ventilatory assist in pediatric patients following cardiac surgery: feasibility
      in clinical practice and impact on ventilation pressuresBenjamin Crulli, Baruch
      Toledano, Nancy Poirier, Suzanne Vobecky, Guillaume EmeriaudS86 Percutaneous
      central venous cannulation: a Seldinger technique versus an ultrasound guidance
      technique in a pediatric intensive care unitFehmi Ferhi, Hosni Khouadja, Mohamed 
      Amine Bouslama, Affra Brahim, Khalil Tarmiz, Khaled BenjaziaS87 Effect of remote 
      ischemic preconditioning on renal resistive index in healthy volunteersRené
      Robert, M. Vinet, Angéline Jamet, Remi Coudroy, Arnaud W. ThilleS88 Peak
      concentration of high-dose AMIKACIN does not affect renal recovery at day 90: a
      retrospective study of 93 patients in a single medical Intensive Care UnitCamille
      Vinclair, Romain Sonneville, Bruno Mourvillier, Mathilde Neuville, Roland Smonig,
      Eric Magalhaes, Guillaume Voiriot, Aguila Radjou, Jean-François Soubirou,
      Stephane Ruckly, Lila Bouadma, Jean-François TimsitS89 Resuscitating chronic
      hypertensive patient with a high mean arterial pressure target during septic
      shock protects against acute renal failureJulie Boisramé-Helms, Ferhat Meziani,
      Jean-François Hamel, François Beloncle, Jean-Louis Teboul, Peter Radermacher,
      Pierre AsfarS90 Guidewire exchange vs new-site placement for temporary dialysis
      catheters insertion in ICU patients: Is there a greater risk of colonization or
      dysfunction?Elisabeth Coupez, Jean-François Timsit, Stephane Ruckly, Carole
      Schwebel, Didier Gruson, Emmanuel Canet, Kada Klouche, Laurent Argaud, Julien
      Bohé, Maïté Garrouste-Orgeas, François Vincent, Sophie Cayot, Michaël Darmon,
      Alexandre Boyer, Elie Azoulay, Lila Bouadma, Alexandre Lautrette, Bertrand
      SouweineS92 Assessment of chloride levels on renal function after cardiac
      arrestCláudia Righy Shinotsuka, Pietro Caironi, Paola Villois, Vito Fontana,
      Jean-Louis Vincent, Jacques Creteur, Fabio Silvio TacconeS93 Sustained
      low-efficiency dialysis with regional citrate anticoagulation is safe for
      patients with acute liver failure or cirrhosisFranck Pourcine, Ly Vong, Jonathan 
      Chelly, Sebastien Jochmans, Oumar Sy, Olivier Ellrodt, Nathalie Rolin,
      Jean-Emmanuel Alphonsine,, Claire Marie Weyer, Jean Serbource-Goguel, Benoit
      Akando, Razach Abdallah, Mehran Monchi, Christophe VinsonneauS94 The new
      biomarker Nephrocheck™ can discriminate the population of septic shock patients
      with an AKIN 1 or 2 acute renal failure who will not progress toward the AKIN 3
      levelMorgane Wetzstein, Loay Kontar, Dimitri Titeca, François Brazier, Bertand De
      Cagny, Gaelle Bacari-Risal, Antoine Riviere, Michel Slama, Julien MaizelS95 Is
      thrombocytopenia an early prognostic marker in septic shock?Nadiejda Antier,
      Christine Binquet, Sandrine Vinault, Ferhat Meziani, Julie Boisramé-Helms,
      Jean-Pierre QuenotS96 Assessment of fibrinolysis in critically ill
      patientsYasmina Serroukh, Karim Zouaoui Boudjeltia, Anne Joosten, Alexandre
      Rousseau, Patrick Biston, Michael PiagnerelliS97 Early detection of disseminated 
      intravascular coagulation during septic shock: a multicentre prospective
      studyXavier Delabranche, Jean-Pierre Quenot, Thierry Lavigne, Emmanuelle Mercier,
      Bruno François, François Severac, Lélia Grunebaum, Laure Stiel, Florence Toti,
      Ferhat Meziani, Julie Boisramé-Helms, CRICS NetworkS98 Activation or
      dysregulation of coagulation during septic shock: How to stratify patients in
      2016?Xavier Delabranche, Thierry Lavigne, Laure Stiel, Julie Boisramé-Helms,
      Achille Kouatchet, Maleka Schenck, Lélia Grunebaum, Yoganaden Mootien, Nicolas
      Lerolle, Ferhat MezianiS99 Associated factors to early high blood pressure after 
      weaning vasopressors during septic shockRostane Gaci, Jean-Romain Garric, Damien 
      Barraud, Marie Conrad, Aurélie Cravoisy-Popovic, Jérémie Lemarie, Charles-Henri
      Maigrat, Pierre-Edouard Bollaert, Sébastien GibotS100 Impact of endotracheal
      intubation on septic shock outcome: a post hoc analysis of the SEPSISPAM
      trialAgathe Delbove, Cédric Darreau, Nicolas Lerolle, Pierre Asfar, CNER DESC
      réanimation grand ouestS101 Corporal Contention at the Onset of Septic shock
      (COCOONs): study protocol and preliminary results of a phase II trialAuguste
      Dargent, Audrey Large, Agnès Soudry-Faure, Sebastien Prin, Pierre-Emmanuel
      Charles, Jean-Pierre Quenot, COCOONs Study GroupS102 Veno-arterial ECMO for
      refractory cardiogenic shock following cardiac arrestMarc Pineton De Chambrun,
      Nicolas Bréchot, Guillaume Hekimian, Guillaume Lebreton, Matthieu Schmidt, Pierre
      Demondion, Ania Nieszkowska, Jean Louis Trouillet, Pascal Leprince, Jean Chastre,
      Alain Combes, Charles-Edouard LuytS103 Outcome of patients with pulmonary
      embolism treated by extra-corporeal life support (ECLS)Jean-Christophe Blanchard,
      François Belon, Sydney Chocron, Nicolas Meneveau, Loïc Barrot, Nicolas Belin,
      Bérengère Vivet, Guylaine Labro, Jean-Christophe Navellou, Cyrille Patry, Gaël
      Piton, Gilles CapellierS104 Acute massive pulmonary embolism rescued by
      veno-arterial extracorporeal membrane oxygenationFilippo Corsi, Guillaume
      Lebreton, Nicolas Bréchot, Guillaume Hékimian, Ania Nieszkowska, Charles-Edouard 
      Luyt, Pascal Leprince, Jean Louis Trouillet, Alain Combes, Matthieu SchmidtS105
      Outcome of patient recused for extracorporeal membrane oxygenation for
      ARDSPierre-Emmanuel Meynieu, Benjamin Repusseau, Virginie Perrier, Arnaud
      Germain, Antoine Dewitte, Hadrien Roze, Alexandre OuattaraS106 Refractory
      electrical storm rescued by venoarterial extracorporeal membrane
      oxygenationGuillaume Baudry, Guillaume Lebreton, Guillaume Hekimian, Nicolas
      Brechot, Ania Nieszkowska, Charles-Edouard Luyt, Jean Louis Trouillet, Pascal
      Leprince, Alain Combes, Matthieu SchmidtS107 Incidence and determinants of severe
      bleeding among patients with extra-corporeal membrane oxygenation (ECMO)Lucie
      Hierle, François Belon, Guillaume Besch, Sebastien Pili-Floury, Loïc Barrot,
      Bérengère Vivet, Guylaine Labro, Jean-Christophe Navellou, Cyrille Patry, Nicolas
      Belin, Gaël Piton, Gilles CapellierS108 Venovenous extracorporeal membranous
      oxygenation device-related infections and colonizationsGuillemette Thomas,
      Jean-Marie Forel, Nadim Cassir, Sami Hraiech, Christophe Guervilly, Fanny Klasen,
      Mélanie Adda, Stéphanie Dizier, Antoine Roch, Laurent PapazianS109 High emergency
      lung transplant for end-stage cystic fibrosis: ECMO as a bridge to transplant for
      patients with temporary contraindicationsGrégoire Trebbia, Kiruba Govindaradjou, 
      Alexis Soummer, Jérôme Devaquet, Clément Picard, Antoine Roux, François Parquin, 
      Elise Cuquemelle, Morgan Leguen, Marie-Louise Felten, Edouard Sage, Alain
      Chapelier, Charles CerfS110 Malignant acute respiratory distress syndrome in
      diffuse lepidic adenocarcinoma (DLA): diagnosis and current issuesMaxens
      Decavèle, Antoine Parrot, Michael Duruisseaux, Jocelyne Fleury, Martine Antoine, 
      Marie-France Carette, Marie Wislez, Muriel FartoukhS111 Acute respiratory failure
      from pulmonary leukemic infiltrates: diagnosis contribution of high-resolution
      computed tomography (HRCT)Claire Givel, Virginie Lemiale, Constance De
      Margerie-Mellon, Etienne Lengliné, Leïla Mourtada, François Vincent, Akli
      Chermak, Eric De Kerviler, Elie AzoulayS112 Characteristics and outcome of
      patients with interstitial lung disease admitted to the intensive care unit over 
      a 15-year periodYacine Tandjaoui-Lambiotte, Frédéric Gonzalez, Olivia Freynet,
      Guillaume Van Der Meersch, Johanna Oziel, Christophe Huang, Philippe Karoubi,
      Christophe Clec’h, Yves CohenS113 Outcome of patients admitted in intensive care 
      unit for acute manifestation of small vessel vasculitisAntoine Kimmoun, Elisabeth
      Baux, Vincent Das, Nicolas Terzi, Patrice Talec, Stephan Ehrmann, Guillaume Geri,
      Steven Grange, Nadia Anguel, Alexandre Demoule, Anne-Sophie Moreau, Elie Azoulay,
      Jean-Pierre Quenot, Julie Boisramé-Helms, Guillaume Louis, Romain Sonneville,
      Nicolas Girerd, Bruno LevyS114 A monocenter retrospective study of predictive
      factors of prolonged intensive care unit hospitalization after a whole lung
      lavage procedure for patients with pulmonary alveolar proteinosisPauline Tallon, 
      Alice Hadchouel-Duvergé, Nadège Salvi, Pascale Cairet, Jean-Marc Treluyer, Mehdi 
      Oualha, Fabrice Lesage, Laure De Saint Blanquat, Sylvain Renolleau, Christophe
      Delacourt, Laurent DupicS115 Free fatty acids plasma profile during acute chest
      syndrome in adult patients with sickle cell disease: a pilot studyBlandine
      Lefebvre Blandine, Guillaume Lefevre, Laurence Beraud, Pierre Mora, Zoé Coppere, 
      Antonin Lamaziere, François Lionnet, Muriel FartoukhS116 Extravascular lung water
      and lung ultrasound to predict severe primary graft dysfunction following lung
      transplantationSamuel Lehingue, Christophe Guervilly, Stéphanie Dizier, Laurent
      Zieleskiewicz, Xavier D’journo, Guillemette Thomas, Fanny Klasen, Mélanie Adda,
      Antoine Roch, Forel Jean-Marie, Marc Leone, Laurent PapazianS117 Results of the
      international multicentric prospective observational study Phase Angle Project:
      phase angle measured by bioimpedance analysis at intensive care unit (ICU)
      admission predicts 28-day survivalRonan Thibault, Anne-Marie Makhlouf, Aurélien
      Mulliez, Cristina Gonzalez, Sylvain Dadet, Gintautas Kekstas, Jean-Charles
      Preiser, Kozjek Nada Rotovnik, Isabel Ceniceros Rozalen, Kinga Kupczyk, Zeljko
      Krznaric, Fabienne Tamion, Noël Cano, Claude Pichard, Phase angle project
      InvestigatorsS118 Nutrireaped: a survey of physician nutrition practices and
      knowledge in French-speaking pediatric intensive care unitsBénédicte Gaillard-Le 
      Roux, Aurelien Jacquot, Corinne Jotterand, Shancy Rooze, Clemence Moullet, Flavie
      Letois, Frederic VallaS119 A computerized tool increases compliance to caloric
      and protein targets and may lower mortality in neutropenic hematologic patients
      in the ICU: the NUTCHOCO study: NUTritionnal Care in Hematologic Oncologic
      patients and Critical OutcomeAurélia Henin, Florence Ettori, Christophe Zemmour, 
      Laurent Chow-Chine, Jeanpaul Brun, Antoine Sannini, Magali Bisbal, Marion
      Faucher, Jean Marie Boher, Djamel MokartS120 Systemic evaluation of intakes in
      patients receiving noninvasive ventilation: the STARVE studyMichel Arnaout, Aude 
      Marincamp, Matthieu Reffienna, Anne-Sophie Debue, Pierre Lucas, Audrey Feltry,
      Julien Charpentier, Benoit Champigneulle, Wulfran Bougouin, Guillaume Geri,
      Frédéric Pène, Jean-Paul Mira, Alain Cariou, Jean-Daniel Chiche, Groupe de
      travail sur la ventilationS121 Computerized glucose control in the ICUSalah Adel 
      Ben, Juliette Audibert, Alexandre Conia, Olivier Gontier, Mouldi Hamrouni,
      Thierry Lherm, Abdelkader Ouchenir, Jérôme Rétif, Alain Proudhom, Chantal
      Lagardere, Stéphane Tissot, Pierre KalfonS122 Toxicodynetics in
      mono-intoxications with oxazepam and nordiazepam: an approach to a better
      understanding of drug–drug interactionLynn Sacre, Antoine Villa, Alaywa Khadija, 
      Robert Garnier, Frederic BaudS123 Rapid triage of victims suspected of a chemical
      attack: a one-page sheet allowing identifying the toxidrome: the doctors without 
      borders (MSF) experienceFrederic Baud, Robert Garnier, Brigitte Vasset, Annette
      HeinzelmanS124 Low sensitivity of toxicological analysis in daily practice of
      acute poisonings: an endless rupture in spite of modern technologyFrederic Baud, 
      Alaywa Khadija, Romain Jouffroy, Lionel LamhautS125 Context of the request and
      interest of toxicological screening in a medical intensive care unitElsa Démarest
      Durand, Fabienne Tamion, Christophe Girault, Gaetan Beduneau, Dorothée
      Carpentier, Patricia Compagnon, Steven GrangeS126 Acute poisoning in emergency
      departmentNeila Maaroufi, Dhaouadi MahassenS127 Management of poising: Are there 
      differences between specialised and non-specialised emergencies?A M’rad, Alia
      Jebri, Youssef Blel, Hend Ben Lakhal, Messaouda Khelfa, Nozha Brahmi, H
      ThabetS128 Jusquiame poisoning: report of a family intoxicationHassen Ben
      Ghezala, Salah Snouda, Rebeh Daoudi, Moez KaddourS129 Morbi-mortality of
      poisoning episodes in Paris region: a test for a multisource surveillance
      systemCéline Legout, Robert Garnier, Antoine Villa, Frederic Baud, Philippe
      Aegerter, Anne Castot-VillepeletS130 Atypical pneumonia in the ICU: a
      retrospective multicentric studySandrine Valade, Virginie Lemiale, Laurent
      Argaud, Frédéric Pène, Laurent Papazian, Fabrice Bruneel, Amélie Seguin, Achille 
      Kouatchet, Johanna Oziel, Olivier Lesieur, Florence Boissier, Bruno Megarbane,
      Naïke Bigé, Noelle Brule, Anne-Sophie Moreau, Alexandre Lautrette, Elie
      AzoulayS131 Severe leptospirosis: analysis of mortality and organ failures in 134
      patients hospitalized in intensive care unitBenjamin Delmas, Julien Jabot, Paul
      Chanareille, Jérôme Allyn, Nicolas Allou, Cyril Ferdynus, Bernard-Alex Gauzere,
      Olivier Martinet, David VandrouxS132 In severe pneumonia, respiratory viruses are
      not passengers but pathogensGuillaume Voiriot, Benoit Visseaux, Johana Cohen,
      Liem Binh Luong Nguyen, Mathilde Neuville, Caroline Morbieu, Charles Burdet,
      Aguila Radjou, François-Xavier Lescure, Roland Smonig, Laurence Armand-Lefevre,
      Bruno Mourvillier, Yazdan Yazdanpanah, Jean-François Soubirou, Stephane Ruckly,
      Nadira Houhou-Fidouh, Jean-François TimsitS133 Critical care management of
      patients with HHV8-associated disordersMarine Cazaux, Claire Pichereau, Marion
      Venot, Sandrine Valade, Virginie Lemiale, Akli Chermak, Emmanuel Canet, Le Goff
      Jérôme, Veronique Meignin, David Boutboul, Lionel Galicier, Elie Azoulay, Eric
      MariotteS134 Emerging moulds in critically ill patients: epidemiological trends, 
      clinical features and ICU outcomeLaura Platon, Philippe Rispail, Vincent Brunot, 
      N. Besnard, Patrice Ceballos, Kada KloucheS135 Intensive care unit-associated
      bloodstream infection and ventilator-associated pneumonia in critically ill
      cancer patients: a 12-year retrospective studyAnnabelle Stoclin, Federico Rotolo,
      Muriel Wartelle, Yosr Hicheri, Sylvia Maillet, Elisabeth Chachaty, Jean-Pierre
      Pignon, François BlotS136 Is diabetes mellitus a risk factor for intensive care
      unit-acquired infections?Marion Venot, Stephane Ruckly, Christophe Clec’h,
      Michaël Darmon, Bernard Allaouchiche, Dany Goldgran Toledano, Maïté
      Garrouste-Orgeas, Christophe Adrie, Jean-François Timsit, Elie
      AzoulayPHYSIOTHERAPISTS ABSTRACTSO85 Short-term physiological effects of nasal
      high-flow in healthy subjects. Impact of flow rates on the work of
      breathingMathieu Delorme, Pierre Alexandre Bouchard, Mathieu Simon, François
      LelloucheO86 High-flow therapy allows a decreased workload of accessory
      respiratory musclesEmilie Bialais, Dupuis Julie, Laura Paoloni, Gregory Reychler,
      Xavier WittebolleO87 Patient perception and feasibility of early mobilization in 
      the critically illCheryl Hickmann, Diego Castanares-Zapatero, Emilie Bialais,
      Jonathan Dugernier, Antoine Tordeur, Lise Colmant, Xavier Wittebole, Giuseppe
      Tirone, Jean Roeseler, Pierre-François LaterreP252 Early rehabilitation in
      critically ill patients: a prospective multicenter assessment of real-life
      practiceLorraine Ducroux, Sylvie L’hotellier, Elodie Baumgarten, Stéphanie
      Borschneck, Francis Schneider, Vincent CastelainP253 Motor imagery and functional
      magnetic resonance imagingClaire Kemlin, Eric Moulton, Charlotte RossoP254
      Thoracic ultrasound: potential new tool for physiotherapists in respiratory
      management—a narrative reviewAymeric Le Neindre, Silvia Mongodi, Francois
      Philippart, Béaïd BouhemadP255 In vitro comparison of a vibrating-mesh nebulizer 
      operating in expiratory synchronized and inspiratory nebulization modes during
      noninvasive ventilationJoana Rodrigues, Caroline Botteau, Jonathan Dugernier,
      Giuseppe Liistro, Gregory Reychler, Jean-Bernard MichotteP256 Evaluation of a new
      system of oxygen administration: the Wenoll systemFrédéric Duprez, François
      Waroquier, Karel Christiaens, Grégory Cuvelier, Frank Vantrimpont, Sharam
      MachayeckhiP257 Evaluation of three portable oxyconcentrators in high
      altitudeFrédéric Duprez, François Waroquier, Karel Christiaens, Grégory Cuvelier,
      Charbel Elkhawand, Frank Vantrimpont, Sharam Machayeckhi, Frank Vermeesh
FAU - Jaillette, Emmanuelle
AU  - Jaillette E
AD  - Centre de réanimation, Centre Hospitalier Régional Universitaire de Lille (CHRU),
      Lille, France
FAU - Girault, Christophe
AU  - Girault C
AD  - Réanimation Médicale, Centre Hospitalier Universitaire Rouen, Rouen, France
FAU - Brunin, Guillaume
AU  - Brunin G
AD  - Reanimation, Hospital Center De Boulogne-Sur-Mer, Boulogne-sur-Mer, France
FAU - Zerimech, Farid
AU  - Zerimech F
AD  - Laboratoire de biochimie et biologie moléculaire, C.h.r.u. Lille, Lille, France
FAU - Chiche, Arnaud
AU  - Chiche A
AD  - Réanimation, Centre Hospitalier de Tourcoing, Tourcoing, France
FAU - Broucqsault-Dedrie, Céline
AU  - Broucqsault-Dedrie C
AD  - Réanimation, Hôpital Victor Provo, Roubaix, France
FAU - Fayolle, Cyril
AU  - Fayolle C
AD  - Reanimation, Hospital Center De Dunkerque, Dunkerque, France
FAU - Minacori, Franck
AU  - Minacori F
AD  - Reanimation, Hospital Saint Philibert, Lille, France
FAU - Alves, Isabelle
AU  - Alves I
AD  - Reanimation, Hospital Center De Valenciennes, Valenciennes, France
FAU - Barrailler, Stephanie
AU  - Barrailler S
AD  - Reanimation, C.H. de Lens, Lens, France
FAU - Robriquet, Laurent
AU  - Robriquet L
AD  - Centre de réanimation, Centre Hospitalier Régional Universitaire de Lille (CHRU),
      Lille, France
FAU - Delaporte, Emmanuel
AU  - Delaporte E
AD  - Reanimation, Hospital Center De Boulogne-Sur-Mer, Boulogne-sur-Mer, France
FAU - Thellier, Damien
AU  - Thellier D
AD  - Réanimation, Centre Hospitalier de Tourcoing, Tourcoing, France
FAU - Delcourte, Claire
AU  - Delcourte C
AD  - Centre de réanimation, Centre Hospitalier Régional Universitaire de Lille (CHRU),
      Lille, France
FAU - Duhamel, Alain
AU  - Duhamel A
AD  - Clinique de santé publique, plateforme d’aide méthodologique, C.h.r.u. Lille,
      Lille, France
FAU - Nseir, Saad
AU  - Nseir S
AD  - Centre de réanimation, Centre Hospitalier Régional Universitaire de Lille (CHRU),
      Lille, France
FAU - Valette, Xavier
AU  - Valette X
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Caen (CHU), Caen,
      France
FAU - Desmeulles, Isabelle
AU  - Desmeulles I
AD  - Réanimation chirurgicale, Centre Hospitalier Universitaire de Caen (CHU), Caen,
      France
FAU - Savary, Benoit
AU  - Savary B
AD  - Réanimation polyvalente, C.H. Mémorial France - Etats-Unis (Saint-Lô), Saint-Lô, 
      France
FAU - Masson, Romain
AU  - Masson R
AD  - Réanimation chirurgicale, Centre Hospitalier Universitaire de Caen (CHU), Caen,
      France
FAU - Seguin, Amélie
AU  - Seguin A
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Caen (CHU), Caen,
      France
FAU - Daubin, Cédric
AU  - Daubin C
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Caen (CHU), Caen,
      France
FAU - Sauneuf, Bertrand
AU  - Sauneuf B
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Caen (CHU), Caen,
      France
FAU - Verrier, Pierre
AU  - Verrier P
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Caen (CHU), Caen,
      France
FAU - Pottier, Véronique
AU  - Pottier V
AD  - Réanimation chirurgicale, Centre Hospitalier Universitaire de Caen (CHU), Caen,
      France
FAU - Orabona, Marie
AU  - Orabona M
AD  - Réanimation chirurgicale, Centre Hospitalier Universitaire de Caen (CHU), Caen,
      France
FAU - Samba, Désiré
AU  - Samba D
AD  - Réanimation chirurgicale, Centre Hospitalier Universitaire de Caen (CHU), Caen,
      France
FAU - Viquesnel, Gérald
AU  - Viquesnel G
AD  - Réanimation chirurgicale, Centre Hospitalier Universitaire de Caen (CHU), Caen,
      France
FAU - Lermuzeaux, Mathilde
AU  - Lermuzeaux M
AD  - Réanimation chirurgicale, Centre Hospitalier Universitaire de Caen (CHU), Caen,
      France
FAU - Hazera, Pascal
AU  - Hazera P
AD  - Réanimation polyvalente, C.H. Mémorial France - Etats-Unis (Saint-Lô), Saint-Lô, 
      France
FAU - Hanouz, Jean-Luc
AU  - Hanouz JL
AD  - Réanimation chirurgicale, Centre Hospitalier Universitaire de Caen (CHU), Caen,
      France
FAU - Parienti, Jean-Jacques
AU  - Parienti JJ
AD  - Unité de biostatistique et de recherche clinique, Centre Hospitalier
      Universitaire de Caen (CHU), Caen, France
FAU - Du Cheyron, Damien
AU  - Du Cheyron D
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Caen (CHU), Caen,
      France
FAU - Demoule, Alexandre
AU  - Demoule A
AD  - Intensive Care and Respiratory Division, Pitié-Salpêtrière Hospital, Paris,
      France
FAU - Clavel, Marc
AU  - Clavel M
AD  - Service de réanimation polyvalente, Centre Hospitalier Universitaire de Limoges, 
      Limoges, France
FAU - Rolland-Debord, Camille
AU  - Rolland-Debord C
AD  - Intensive Care and Respiratory Division, Pitié-Salpêtrière Hospital, Paris,
      France
FAU - Perbet, Sébastien
AU  - Perbet S
AD  - Service de réanimation adultes, C.H.U. Estaing, Clermont-Ferrand, France
FAU - Terzi, Nicolas
AU  - Terzi N
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Caen (CHU), Caen,
      France
FAU - Kouatchet, Achille
AU  - Kouatchet A
AD  - Réanimation médicale, Centre Hospitalier Universitaire d’Angers, Angers, France
FAU - Wallet, Florent
AU  - Wallet F
AD  - Réanimation médicale et chirurgicale, CHU Lyon Sud, Lyon, France
FAU - Roze, Hadrien
AU  - Roze H
AD  - Service d’anesthésie réanimation 2, unité réanimation thoracique greffe, CHU de
      Bordeaux, Bordeaux, France
FAU - Vargas, Frédéric
AU  - Vargas F
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux,
      France
FAU - Guérin, Claude
AU  - Guérin C
AD  - Réanimation médicale, Hôpital de la Croix-Rousse, Lyon, France
FAU - Dellamonica, Jean
AU  - Dellamonica J
AD  - Réanimation médicale, Centre Hospitalier Universitaire Archet, Nice, France
FAU - Jaber, Samir
AU  - Jaber S
AD  - DAR B, Hôpital Saint Eloi, Montpellier, France
FAU - Similowski, Thomas
AU  - Similowski T
AD  - Intensive Care and Respiratory Division, Pitié-Salpêtrière Hospital, Paris,
      France
FAU - Quenot, Jean-Pierre
AU  - Quenot JP
AD  - Réanimation médicale, CHU Dijon, Dijon, France
FAU - Binquet, Christine
AU  - Binquet C
AD  - Centre d’investigation clinique, Chu Dijon, Dijon, France
FAU - Vinsonneau, Christophe
AU  - Vinsonneau C
AD  - Réanimation polyvalente, Centre Hospitalier Marc Jacquet, Melun, France
FAU - Barbar, Saber-Davide
AU  - Barbar SD
AD  - 30, Chru De Nîmes, Nîmes, France
FAU - Vinault, Sandrine
AU  - Vinault S
AD  - Centre d’investigation clinique, Chu Dijon, Dijon, France
FAU - Deckert, Valérie
AU  - Deckert V
AD  - 21, Faculté de médecine, Dijon, France
FAU - Lemaire, Stephanie
AU  - Lemaire S
AD  - 21, Faculté de médecine, Dijon, France
FAU - Hssain, Ali Ait
AU  - Hssain AA
AD  - Réanimation médicale, CHU Gabriel-Montpied, Clermont-Ferrand, France
FAU - Bruyère, Rémi
AU  - Bruyère R
AD  - Réanimation médicale, CHU Dijon, Dijon, France
FAU - Souweine, Bertrand
AU  - Souweine B
AD  - Réanimation médicale, CHU Gabriel-Montpied, Clermont-Ferrand, France
FAU - Lagrost, Laurent
AU  - Lagrost L
AD  - 21, Faculté de médecine, Dijon, France
FAU - Adrie, Christophe
AU  - Adrie C
AD  - Physiologie, Hôpital Cochin, Paris, France
FAU - Jung, Boris
AU  - Jung B
AD  - DAR B, Hôpital Saint Eloi, Montpellier, France
FAU - Daurat, Aurelien
AU  - Daurat A
AD  - DAR B, Hôpital Saint Eloi, Montpellier, France
FAU - De Jong, Audrey
AU  - De Jong A
AD  - DAR B, Hôpital Saint Eloi, Montpellier, France
FAU - Chanques, Gérald
AU  - Chanques G
AD  - DAR B, Hôpital Saint Eloi, Montpellier, France
FAU - Mahul, Martin
AU  - Mahul M
AD  - DAR B, Hôpital Saint Eloi, Montpellier, France
FAU - Monnin, Marion
AU  - Monnin M
AD  - DAR B, Hôpital Saint Eloi, Montpellier, France
FAU - Molinari, Nicolas
AU  - Molinari N
AD  - Département de l’information médicale, Hôpital La Colombière, Montpellier, France
FAU - Lheureux, Olivier
AU  - Lheureux O
AD  - Service de soins intensifs, Hospital Erasme, Brussel, Belgium
FAU - Trepo, Eric
AU  - Trepo E
AD  - Service de gastroentérologie, Hospital Erasme, Brussel, Belgium
FAU - Hites, Maya
AU  - Hites M
AD  - Service de maladies infectieuses, Hospital Erasme, Brussel, Belgium
FAU - Cotton, Frederic
AU  - Cotton F
AD  - Service de biochimie médicale, Hospital Erasme, Brussel, Belgium
FAU - Wolff, Fleur
AU  - Wolff F
AD  - Service de biochimie médicale, Hospital Erasme, Brussel, Belgium
FAU - Surin, Rudy
AU  - Surin R
AD  - Service de maladies infectieuses, Hospital Erasme, Brussel, Belgium
FAU - Créteur, Jacques
AU  - Créteur J
AD  - Service de soins intensifs, Hospital Erasme, Brussel, Belgium
FAU - Vincent, Jean-Louis
AU  - Vincent JL
AD  - Service de soins intensifs, Hospital Erasme, Brussel, Belgium
FAU - Gustot, Thierry
AU  - Gustot T
AD  - Service de gastroentérologie, Hospital Erasme, Brussel, Belgium
FAU - Jacobs, Frederique
AU  - Jacobs F
AD  - Service de maladies infectieuses, Hospital Erasme, Brussel, Belgium
FAU - Taccone, Fabio Silvio
AU  - Taccone FS
AD  - Service de soins intensifs, Hospital Erasme, Brussel, Belgium
FAU - Neuville, Mathilde
AU  - Neuville M
AD  - Réanimation médicale et infectieuse, Hôpital Bichat-Claude Bernard, Paris, France
FAU - Timsit, Jean-François
AU  - Timsit JF
AD  - Service de réanimation médicale et infectieuse, Hôpital Bichat-Claude
      Bernard-APHP, Paris, France
FAU - El-Helali, Najoua
AU  - El-Helali N
AD  - Unité de microbiologie clinique et dosages des anti-infectieux, Groupe
      hospitalier Paris Saint-Joseph, Paris, France
FAU - Le Monnier, Alban
AU  - Le Monnier A
AD  - Unité de microbiologie clinique et dosages des anti-infectieux, Groupe
      hospitalier Paris Saint-Joseph, Paris, France
FAU - Magalhaes, Eric
AU  - Magalhaes E
AD  - Réanimation médicale et infectieuse, Hôpital Bichat-Claude Bernard, Paris, France
FAU - Radjou, Aguila
AU  - Radjou A
AD  - Réanimation médicale et infectieuse, Hôpital Bichat-Claude Bernard, Paris, France
FAU - Smonig, Roland
AU  - Smonig R
AD  - Réanimation médicale et infectieuse, Hôpital Bichat-Claude Bernard, Paris, France
FAU - Soubirou, Jean-François
AU  - Soubirou JF
AD  - Réanimation médicale et infectieuse, Hôpital Bichat-Claude Bernard, Paris, France
FAU - Voiriot, Guillaume
AU  - Voiriot G
AD  - Réanimation médicale et infectieuse, Hôpital Bichat-Claude Bernard, Paris, France
FAU - Sonneville, Romain
AU  - Sonneville R
AD  - Réanimation médicale et infectieuse, Hôpital Bichat-Claude Bernard, Paris, France
FAU - Bouadma, Lila
AU  - Bouadma L
AD  - Réanimation médicale et infectieuse, Hôpital Bichat-Claude Bernard, Paris, France
FAU - Mourvillier, Bruno
AU  - Mourvillier B
AD  - Réanimation médicale et infectieuse, Hôpital Bichat-Claude Bernard, Paris, France
FAU - Gélisse, Elodie
AU  - Gélisse E
AD  - Unité de réanimation robert debré, CHU Reims, Reims, France
FAU - Brasseur, Alexandre
AU  - Brasseur A
AD  - Soins Intensifs, Hôpital Erasme, Brussels, Belgium
FAU - Roisin, Sandrine
AU  - Roisin S
AD  - Service de microbiologie clinique, Hospital Erasme, Brussel, Belgium
FAU - De Backer, Daniel
AU  - De Backer D
AD  - Soins intensifs, Hospital Erasme, Brussels, Belgium
FAU - Van Ruychevelt, Valerie
AU  - Van Ruychevelt V
AD  - Intensive Care Unit, Hôpital Civil Marie Curie, Charleroi, Belgium
FAU - Carlier, Eric
AU  - Carlier E
AD  - Intensive Care Unit, Hôpital Civil Marie Curie, Charleroi, Belgium
FAU - Piagnerelli, Michael
AU  - Piagnerelli M
AD  - Intensive Care Unit, Hôpital Civil Marie Curie, Charleroi, Belgium
FAU - Vanhaeverbeek, Michel
AU  - Vanhaeverbeek M
AD  - Internal medicine, Hospital André Vésale, Montigny-le-Tilleul, Belgium
FAU - Danguy, Christine
AU  - Danguy C
AD  - Pharmacy, Hospital André Vésale, Montigny-le-Tilleul, Belgium
FAU - Biston, Patrick
AU  - Biston P
AD  - Intensive Care Unit, Hôpital Civil Marie Curie, Charleroi, Belgium
FAU - Au, Siu-Ming
AU  - Au SM
AD  - Icu, Hospital Ambroise Paré, Boulogne-Billancourt, France
FAU - Begot, Emmanuelle
AU  - Begot E
AD  - Service de réanimation polyvalente, Centre Hospitalier Universitaire de Limoges, 
      Limoges, France
FAU - Dalmay, François
AU  - Dalmay F
AD  - Réanimation Polyvalente, CHU Limoges, Limoges, France
FAU - Repessé, Xavier
AU  - Repessé X
AD  - Réanimation médico-chirurgicale, Assistance Publique - Hôpitaux de Paris, Hôpital
      Ambroise Paré, Boulogne-Billancourt, France
FAU - Prat, Gwenael
AU  - Prat G
AD  - Réanimation médicale, CHRU de Brest, Brest, France
FAU - Bouferrache, Koceila
AU  - Bouferrache K
AD  - Icu, Hospital Foch, Suresnes, France
FAU - Slama, Michel
AU  - Slama M
AD  - Réanimation médicale, Centre Hospitalier Universitaire, Amiens, France
FAU - Vieillard-Baron, Antoine
AU  - Vieillard-Baron A
AD  - Réanimation médico-chirurgicale, Assistance Publique - Hôpitaux de Paris, Hôpital
      Ambroise Paré, Boulogne-Billancourt, France
FAU - Monnet, Xavier
AU  - Monnet X
AD  - Service de réanimation médicale, inserm umr_s 999, Hôpital de Bicêtre, Université
      Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre,
      France
FAU - Marik, Paul
AU  - Marik P
AD  - Department of Medicine, Division of Pulmonary and Critical Care Medicine, Eastern
      Virginia Medical School, Norfolk, USA
FAU - Teboul, Jean-Louis
AU  - Teboul JL
AD  - Service de réanimation médicale, inserm umr_s 999, Hôpital de Bicêtre, Université
      Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre,
      France
FAU - Jozwiak, Mathieu
AU  - Jozwiak M
AD  - Service de réanimation médicale, Hôpital de Bicêtre, Faculté de médecine
      Paris-Sud, université Paris-Sud, Le Kremlin-Bicêtre, France
FAU - Richard, Christian
AU  - Richard C
AD  - Service de réanimation médicale, Hôpital de Bicêtre, Faculté de médecine
      Paris-Sud, université Paris-Sud, Le Kremlin-Bicêtre, France
FAU - Chauvet, Jean-Louis
AU  - Chauvet JL
AD  - Réanimation Polyvalente - USC, Centre Hospitalier Elbeuf Louviers Val de Reuil,
      Elbeuf, France
FAU - El-Dash, Shari
AU  - El-Dash S
AD  - Réanimation médicale, Centre Hospitalier Universitaire, Amiens, France
FAU - Delastre, Olivier
AU  - Delastre O
AD  - Réanimation Polyvalente - USC, Centre Hospitalier Elbeuf Louviers Val de Reuil,
      Elbeuf, France
FAU - Bouffandeau, Bernard
AU  - Bouffandeau B
AD  - Réanimation Polyvalente - USC, Centre Hospitalier Elbeuf Louviers Val de Reuil,
      Elbeuf, France
FAU - Jusserand, Dominique
AU  - Jusserand D
AD  - Réanimation Polyvalente - USC, Centre Hospitalier Elbeuf Louviers Val de Reuil,
      Elbeuf, France
FAU - Michot, Jean-Baptiste
AU  - Michot JB
AD  - Réanimation Polyvalente - USC, Centre Hospitalier Elbeuf Louviers Val de Reuil,
      Elbeuf, France
FAU - Bauer, Fabrice
AU  - Bauer F
AD  - Cardiology, Chu De Rouen, Rouen, France
FAU - Brazier, François
AU  - Brazier F
AD  - Réanimation médicale, Centre Hospitalier Universitaire, Amiens, France
FAU - Mercado, Pablo
AU  - Mercado P
AD  - Réanimation médicale, Centre Hospitalier Universitaire, Amiens, France
FAU - Kontar, Loay
AU  - Kontar L
AD  - Réanimation médicale, Centre Hospitalier Universitaire, Amiens, France
FAU - Titeca, Dimitri
AU  - Titeca D
AD  - Réanimation médicale, Centre Hospitalier Universitaire, Amiens, France
FAU - De Cagny, Bertand
AU  - De Cagny B
AD  - Réanimation médicale, Centre Hospitalier Universitaire, Amiens, France
FAU - Bacari-Risal, Gaelle
AU  - Bacari-Risal G
AD  - Réanimation médicale, Centre Hospitalier Universitaire, Amiens, France
FAU - Riviere, Antoine
AU  - Riviere A
AD  - Réanimation médicale, Centre Hospitalier Universitaire, Amiens, France
FAU - Maizel, Julien
AU  - Maizel J
AD  - Réanimation médicale, Centre Hospitalier Universitaire, Amiens, France
FAU - Guillot, Camille
AU  - Guillot C
AD  - Réanimation et surveillance continue pédiatriques, Centre Hospitalier Régional
      Universitaire de Lille, Lille, France
FAU - Le Reun, Claire
AU  - Le Reun C
AD  - Réanimation et surveillance continue pédiatriques, Centre Hospitalier Régional
      Universitaire de Lille, Lille, France
FAU - Lampin, Marie
AU  - Lampin M
AD  - Réanimation et surveillance continue pédiatriques, Centre Hospitalier Régional
      Universitaire de Lille, Lille, France
FAU - Sadik, Ahmed
AU  - Sadik A
AD  - Réanimation et surveillance continue pédiatriques, Centre Hospitalier Régional
      Universitaire de Lille, Lille, France
FAU - Botte, Astrid
AU  - Botte A
AD  - Réanimation et surveillance continue pédiatriques, Centre Hospitalier Régional
      Universitaire de Lille, Lille, France
FAU - Leteurtre, Stéphane
AU  - Leteurtre S
AD  - Réanimation et surveillance continue pédiatriques, Centre Hospitalier Régional
      Universitaire de Lille, Lille, France
FAU - Collins, Aurélie
AU  - Collins A
AD  - Pediatric departement, CHR de la Citadelle, Liège, Belgium
FAU - Kempeneers, Céline
AU  - Kempeneers C
AD  - Pediatric respirology departement, CHR de la Citadelle, Liège, Belgium
FAU - Cajgfinger, Nathalie
AU  - Cajgfinger N
AD  - Pediatric intensive care unit, CHR de la Citadelle, Liège, Belgium
FAU - Ohlmann, Camille
AU  - Ohlmann C
AD  - Réanimation pédiatrique hfme, Hospices civils de Lyon, Lyon, France
FAU - Pouyau, Robin
AU  - Pouyau R
AD  - Réanimation pédiatrique hfme, Hospices civils de Lyon, Lyon, France
FAU - Subtil, Fabien
AU  - Subtil F
AD  - Service de biostatistiques, Hospices Civils de Lyon, Lyon, France
FAU - Baudin, Florent
AU  - Baudin F
AD  - Réanimation pédiatrique hfme, Hospices civils de Lyon, Lyon, France
FAU - Massenavette, Bruno
AU  - Massenavette B
AD  - Réanimation pédiatrique hfme, Hospices civils de Lyon, Lyon, France
FAU - Javouhey, Etienne
AU  - Javouhey E
AD  - Réanimation pédiatrique hfme, Hospices civils de Lyon, Lyon, France
FAU - Milesi, Christophe
AU  - Milesi C
AD  - Réanimation pédiatrique, Hôpital Arnaud-de-Villeneuve, Montpellier, France
FAU - Essouri, Sandrine
AU  - Essouri S
AD  - Service de réanimation pédiatrique, CHU de Bicêtre, Le Kremlin-Bicêtre, France
FAU - Liet, Jean-Michel
AU  - Liet JM
AD  - Réanimation pédiatrique, CHU de Nantes, Nantes, France
FAU - Afanetti, Mickael
AU  - Afanetti M
AD  - Réanimation pédiatrique, Hôpitaux Pédiatrique CHU-Lenval, Nice, France
FAU - Durand, Sabine
AU  - Durand S
AD  - Réanimation pédiatrique, Hôpital Arnaud-de-Villeneuve, Montpellier, France
FAU - Durand, Philippe
AU  - Durand P
AD  - Service de réanimation pédiatrique, CHU de Bicêtre, Le Kremlin-Bicêtre, France
FAU - Roze, Jean Christophe
AU  - Roze JC
AD  - Réanimation pédiatrique, CHU de Nantes, Nantes, France
FAU - Dupont, Didier
AU  - Dupont D
AD  - Réanimation pédiatrique, Hôpitaux Pédiatrique CHU-Lenval, Nice, France
FAU - Cambonie, Gilles
AU  - Cambonie G
AD  - Réanimation pédiatrique, Hôpital Arnaud-de-Villeneuve, Montpellier, France
FAU - Soyer, Benjamin
AU  - Soyer B
AD  - Réanimation chirurgicale, CHU Lariboisière, Paris, France
FAU - Rusca, Marco
AU  - Rusca M
AD  - Réanimation chirurgicale, CHU Lariboisière, Paris, France
FAU - Lukaszewicz, Anne-Claire
AU  - Lukaszewicz AC
AD  - Réanimation chirurgicale, CHU Lariboisière, Paris, France
FAU - Crassard, Isabelle
AU  - Crassard I
AD  - Neurologie, CHU Lariboisière, Paris, France
FAU - Guichard, Jean-Pierre
AU  - Guichard JP
AD  - Neuroradiologie, CHU Lariboisière, Paris, France
FAU - Bresson, Damien
AU  - Bresson D
AD  - Neurochirurgie, CHU Lariboisière, Paris, France
FAU - de la Garanderie, Didier Payen
AU  - de la Garanderie DP
AD  - Réanimation chirurgicale, CHU Lariboisière, Paris, France
FAU - Cantier, Marie
AU  - Cantier M
AD  - Inserm u1148, laboratory for vascular translational science, Hôpital
      Bichat-Claude Bernard, Paris, France
FAU - Sabben, Candice
AU  - Sabben C
AD  - Inserm u1148, laboratory for vascular translational science, Hôpital
      Bichat-Claude Bernard, Paris, France
FAU - Louedec, Liliane
AU  - Louedec L
AD  - Inserm u1148, laboratory for vascular translational science, Hôpital
      Bichat-Claude Bernard, Paris, France
FAU - Delbosc, Sandrine
AU  - Delbosc S
AD  - Inserm u1148, laboratory for vascular translational science, Hôpital
      Bichat-Claude Bernard, Paris, France
FAU - Journé, Clément
AU  - Journé C
AD  - Inserm u1148, laboratory for vascular translational science, Hôpital
      Bichat-Claude Bernard, Paris, France
FAU - Ou, Phalla
AU  - Ou P
AD  - Inserm u1148, laboratory for vascular translational science, Hôpital
      Bichat-Claude Bernard, Paris, France
FAU - Klein, Isabelle
AU  - Klein I
AD  - Inserm u1148, laboratory for vascular translational science, Hôpital
      Bichat-Claude Bernard, Paris, France
FAU - Chau, Françoise
AU  - Chau F
AD  - Inserm u1137, infection, antimicrobiens, modélisation, evolution, Hôpital
      Bichat-Claude Bernard, Paris, France
FAU - Lefort, Agnes
AU  - Lefort A
AD  - Service de médecine interne, Hospital Beaujon, Clichy, France
FAU - Desilles, Jean-Philippe
AU  - Desilles JP
AD  - Inserm u1148, laboratory for vascular translational science, Hôpital
      Bichat-Claude Bernard, Paris, France
FAU - Michel, Jean-Baptiste
AU  - Michel JB
AD  - Inserm u1148, laboratory for vascular translational science, Hôpital
      Bichat-Claude Bernard, Paris, France
FAU - Mazighi, Mikaël
AU  - Mazighi M
AD  - Inserm u1148, laboratory for vascular translational science, Hôpital
      Bichat-Claude Bernard, Paris, France
FAU - Salem, Omar Ben Hadj
AU  - Salem OBH
AD  - Service de réanimation médicale, Cochin, Paris, France
FAU - Demeret, Sophie
AU  - Demeret S
AD  - Service de réanimation neurologique, Pitié-Salpêtrière Hospital, Paris, France
FAU - Bolgert, Francis
AU  - Bolgert F
AD  - Réanimation neurologique, Pitié-Salpêtrière Hospital, Paris, France
FAU - Sharshar, Tarek
AU  - Sharshar T
AD  - Réanimation, Hôpital Raymond-Poincaré, Garches, France
FAU - Grabli, David
AU  - Grabli D
AD  - Féderation des maladies du système nerveux, Pitié-Salpêtrière Hospital, Paris,
      France
FAU - Arib, Safa
AU  - Arib S
AD  - Service de soins intensifs, Hospital Erasme, Brussels, Belgium
FAU - Crippa, Ilaria Alice
AU  - Crippa IA
AD  - Service de soins intensifs, Hospital Erasme, Brussels, Belgium
FAU - Soummer, Alexis
AU  - Soummer A
AD  - Réanimation, Hospital Foch, Suresnes, France
FAU - Engrand, Nicolas
AU  - Engrand N
AD  - Département d’anesthésie-réanimation, Fondation Ophtalmologique Adolphe de
      Rothschild, Paris, France
FAU - Guedin, Pierre
AU  - Guedin P
AD  - Neuroradiology, Hospital Foch, Suresnes, France
FAU - Aldea, Sorin
AU  - Aldea S
AD  - Neurosurgery, Hospital Foch, Suresnes, France
FAU - Cerf, Charles
AU  - Cerf C
AD  - Réanimation, Hospital Foch, Suresnes, France
FAU - Desailly, Victoire
AU  - Desailly V
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - Pasquier, Pierre
AU  - Pasquier P
AD  - Service de réanimation, Hôpital d’Instruction des Armées Percy, Clamart, France
FAU - Brun, Patrick
AU  - Brun P
AD  - Giga la vie, Institut des Hauts de Seine, Nanterre, France
FAU - Roux, Damien
AU  - Roux D
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - Latournerie, Gwendoline
AU  - Latournerie G
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - Kasprzyk, Laetitia
AU  - Kasprzyk L
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - Grosjean, Vincent
AU  - Grosjean V
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - Latreche, Amine
AU  - Latreche A
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - Habert, Pierre
AU  - Habert P
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - Huot, Stephane
AU  - Huot S
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - Jobin, Timon
AU  - Jobin T
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - Tesnière, Antoine
AU  - Tesnière A
AD  - Laboratoire ilumens, Universisté René Descartes - Paris V, Paris, France
FAU - Dreyfuss, Didier
AU  - Dreyfuss D
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - Ricard, Jean-Damien
AU  - Ricard JD
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - Mignon, Alexandre
AU  - Mignon A
AD  - Laboratoire ilumens, Universisté René Descartes - Paris V, Paris, France
FAU - Gaudry, Stéphane
AU  - Gaudry S
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - Laithier, François-Xavier
AU  - Laithier FX
AD  - Réanimation médicale brabois, Centre Hospitalier Universitaire de Nancy,
      Vandœuvre-lès-Nancy, France
FAU - Kimmoun, Antoine
AU  - Kimmoun A
AD  - Réanimation médicale brabois, Centre Hospitalier Universitaire de Nancy,
      Vandœuvre-lès-Nancy, France
FAU - Chouihed, Tahar
AU  - Chouihed T
AD  - Sau-samu-smur, C.H.U. de Nancy, Nancy, France
FAU - Albizzati, Stéphane
AU  - Albizzati S
AD  - Sau-samu-smur, C.H.U. de Nancy, Nancy, France
FAU - Camenzind, Edoardo
AU  - Camenzind E
AD  - Cardiologie, C.H.U. de Nancy, Nancy, France
FAU - Vanhuyse, Fabrice
AU  - Vanhuyse F
AD  - Chirurgie cardiaque, Centre Hospitalier Universitaire de Nancy,
      Vandœuvre-lès-Nancy, France
FAU - Levy, Bruno
AU  - Levy B
AD  - Réanimation médicale brabois, Centre Hospitalier Universitaire de Nancy,
      Vandœuvre-lès-Nancy, France
FAU - Cour, Martin
AU  - Cour M
AD  - Réanimation Médicale, Hospices Civils de Lyon - Groupement Hospitalier Edouard
      Herriot, Lyon, France
FAU - Venet, Fabienne
AU  - Venet F
AD  - Laboratoire d’immunologie, Hôpital Édouard Herriot, Lyon, France
FAU - Hernu, Romain
AU  - Hernu R
AD  - Réanimation Médicale, Hospices Civils de Lyon - Groupement Hospitalier Edouard
      Herriot, Lyon, France
FAU - Demaret, Julie
AU  - Demaret J
AD  - Laboratoire d’immunologie, Hôpital Édouard Herriot, Lyon, France
FAU - Monneret, Guillaume
AU  - Monneret G
AD  - Laboratoire d’immunologie, Hôpital Édouard Herriot, Lyon, France
FAU - Argaud, Laurent
AU  - Argaud L
AD  - Réanimation Médicale, Hospices Civils de Lyon - Groupement Hospitalier Edouard
      Herriot, Lyon, France
FAU - Dumas, Florence
AU  - Dumas F
AD  - Emergency department, Cochin hospital-APHP, Paris, France
FAU - Lamhaut, Lionel
AU  - Lamhaut L
AD  - Réanimation adulte, Hôpital Necker - Enfants Malades, Paris, France
FAU - Rosencher, Julien
AU  - Rosencher J
AD  - Cardiologie, Hôpital Cochin-Port Royal, Paris, France
FAU - Pène, Frédéric
AU  - Pène F
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Varenne, Olivier
AU  - Varenne O
AD  - Cardiologie, Hôpital Cochin, Paris, France
FAU - Carli, Pierre
AU  - Carli P
AD  - Réanimation adulte - samu, Hôpital Necker - Enfants Malades, Paris, France
FAU - Jouven, Xavier
AU  - Jouven X
AD  - Cardiologie, Hôpital Européen Georges-Pompidou, Paris, France
FAU - Spaulding, Christian
AU  - Spaulding C
AD  - Cardiologie, Hôpital Européen Georges-Pompidou, Paris, France
FAU - Cariou, Alain
AU  - Cariou A
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Geri, Guillaume
AU  - Geri G
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Bonnetain, Franck
AU  - Bonnetain F
AD  - Unité de méthodologie et de qualité de vie en cancérologie, CHRU de Besançon,
      Boulevard Alexandre Fleming, Besançon, France
FAU - Marijon, Eloi
AU  - Marijon E
AD  - Cardiologie, Hôpital Européen Georges-Pompidou, Rue Leblanc, Paris, France
FAU - Empana, Jean Philippe
AU  - Empana JP
AD  - Inserm u970, Paris Centre de recherche Cardio-vasculaire, Paris, France
FAU - Mirouse, Adrien
AU  - Mirouse A
AD  - Réanimation médicale, hôpital Cochin, Assistance Publique - Hôpitaux de Paris,
      Paris, France
FAU - Resche-Rigon, Matthieu
AU  - Resche-Rigon M
AD  - Biostatistiques, Hôpital Saint-Louis, Paris, France
FAU - Mayaux, Julien
AU  - Mayaux J
AD  - Intensive Care and Respiratory Division, Pitié-Salpêtrière Hospital, Paris,
      France
FAU - Rabbat, Antoine
AU  - Rabbat A
AD  - Réanimation pneumologique, Hôpital Cochin, Paris, France
FAU - Meert, Anne Pascale
AU  - Meert AP
AD  - Réanimation, Institut Jules Bordet, Brussels, Belgium
FAU - Benoit, Dominique
AU  - Benoit D
AD  - Réanimation polyvalente, Hopital universitaire, Gand, Belgium
FAU - Bruneel, Fabrice
AU  - Bruneel F
AD  - Réanimation médico-chirurgicale, Centre Hospitalier de Versailles, Le Chesnay,
      France
FAU - Azoulay, Elie
AU  - Azoulay E
AD  - Réanimation médicale, Hôpital Saint-Louis, Paris, France
FAU - Dupuis, Claire
AU  - Dupuis C
AD  - Réanimation médicale, CHU Bichat, Paris, France
FAU - Schwebel, Carole
AU  - Schwebel C
AD  - 38, C.H.U de Grenoble C.H.U, La Tronche, France
FAU - Ruckly, Stéphane
AU  - Ruckly S
AD  - Umr 1137, Inserm iame, Paris, France
FAU - Goldgran-Toledano, Dany
AU  - Goldgran-Toledano D
AD  - Réanimation, CH gonesse, Gonesse, France
FAU - Marcotte, Guillaume
AU  - Marcotte G
AD  - Reanimation medicale, Assistance Publique Hôpitaux de Paris, Paris, France
FAU - Lafarge, Antoine
AU  - Lafarge A
AD  - Réanimation médicale, Hôpital Saint Louis, Paris, France
FAU - Pichereau, Claire
AU  - Pichereau C
AD  - Réanimation médicale, Hôpital Saint Louis, Paris, France
FAU - Theodose, Igor
AU  - Theodose I
AD  - Réanimation médicale, Hôpital Saint Louis, Paris, France
FAU - Scotto, Marion
AU  - Scotto M
AD  - Réanimation médicale, Hôpital Saint Louis, Paris, France
FAU - Kemlin, Delphine
AU  - Kemlin D
AD  - Réanimation médicale, Hôpital Saint Louis, Paris, France
FAU - Ghrenassia, Etienne
AU  - Ghrenassia E
AD  - Réanimation médicale, Hôpital Saint Louis, Paris, France
FAU - Schlemmer, Benoît
AU  - Schlemmer B
AD  - Réanimation médicale, Hôpital Saint Louis, Paris, France
FAU - Vimpere, Damien
AU  - Vimpere D
AD  - Réanimation médicale, Hôpital Saint Louis, Paris, France
FAU - Galicier, Lionel
AU  - Galicier L
AD  - Immuno-hématologie, Assistance Publique Hôpitaux de Paris, Paris, France
FAU - Contou, Damien
AU  - Contou D
AD  - Medical Intensive Care Unit, Hospital Henri Mondor, Créteil, France
FAU - Guérot, Emmanuel
AU  - Guérot E
AD  - Réanimation médicale, Hopital Europeen Georges-Pompidou, Paris, France
FAU - Grimaldi, David
AU  - Grimaldi D
AD  - Service de réanimation polyvalente, Centre Hospitalier de Versailles, Le Chesnay,
      France
FAU - Ricome, Sylvie
AU  - Ricome S
AD  - Service de réanimation polyvalente, Centre hospitalier intercommunal Robert
      Ballanger, Aulnay-sous-Bois, France
FAU - Maury, Eric
AU  - Maury E
AD  - Réanimation Médicale, Hôpital Saint-Antoine, AP-HP, Paris, France
FAU - Plantefève, Gaëtan
AU  - Plantefève G
AD  - Réanimation polyvalente, C.H. Victor Dupouy (Argenteuil), Argenteuil, France
FAU - Dessap, Armand Mekontso
AU  - Dessap AM
AD  - Réanimation Médicale, Hôpital Henri Mondor, Créteil, France
FAU - Brun-Buisson, Christian
AU  - Brun-Buisson C
AD  - Réanimation Médicale, Hôpital Henri Mondor, Créteil, France
FAU - de Prost, Nicolas
AU  - de Prost N
AD  - Réanimation Médicale, Hôpital Henri Mondor, Créteil, France
FAU - Dubé, Bruno-Pierre
AU  - Dubé BP
AD  - Intensive Care and Respiratory Division, Pitié-Salpêtrière Hospital, Paris,
      France
FAU - Delemazure, Julie
AU  - Delemazure J
AD  - Intensive Care and Respiratory Division, Pitié-Salpêtrière Hospital, Paris,
      France
FAU - Dres, Martin
AU  - Dres M
AD  - Intensive Care and Respiratory Division, Pitié-Salpêtrière Hospital, Paris,
      France
FAU - Rousseau, Ludivine
AU  - Rousseau L
AD  - Réanimation médicale, Chu De Poitiers, Poitiers, France
FAU - Drouot, Xavier
AU  - Drouot X
AD  - Neurophysiologie et explorations fonctionnelles, Chu De Poitiers, Poitiers,
      France
FAU - Diaz, Véronique
AU  - Diaz V
AD  - Neurophysiologie et explorations fonctionnelles, Chu De Poitiers, Poitiers,
      France
FAU - Rebollar, Yohann
AU  - Rebollar Y
AD  - Neurophysiologie et explorations fonctionnelles, Chu De Poitiers, Poitiers,
      France
FAU - Frat, Jean-Pierre
AU  - Frat JP
AD  - Réanimation médicale, Chu De Poitiers, Poitiers, France
FAU - Thille, Arnaud W.
AU  - Thille AW
AD  - Réanimation médicale, Chu De Poitiers, Poitiers, France
CN  - Groupe ALIVE
FAU - Aissa, Dalinda Ait
AU  - Aissa DA
AD  - Réanimation, Centre Hospitalier Universitaire Toulouse, Toulouse, France
FAU - Coquet, Pierre
AU  - Coquet P
AD  - Critical care unit, CHR, Narbonne, France
FAU - Ruiz, Jean
AU  - Ruiz J
AD  - Réanimation, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse,
      France
FAU - Ferre, Fabrice
AU  - Ferre F
AD  - Réanimation, Centre Hospitalier Universitaire Toulouse, Toulouse, France
FAU - Hoarau, Lucille
AU  - Hoarau L
AD  - Réanimation, Centre Hospitalier Universitaire Toulouse, Toulouse, France
FAU - Riu-Poulenc, Béatrice
AU  - Riu-Poulenc B
AD  - Réanimation, Centre Hospitalier Universitaire Toulouse, Toulouse, France
FAU - Bataille, Benoit
AU  - Bataille B
AD  - Critical care unit, CHR, Narbonne, France
FAU - Silva, Stein
AU  - Silva S
AD  - Critical care unit/inserm u825, University Teaching Hospital of Purpan, Toulouse,
      France
FAU - Baudel, Jean-Luc
AU  - Baudel JL
AD  - Service de reanimation, Hôpital Saint-Antoine, Paris, France
FAU - Bigé, Naïke
AU  - Bigé N
AD  - Réanimation médicale, Hôpital Saint-Antoine, Paris, France
FAU - Tahiri, Jalel
AU  - Tahiri J
AD  - Service de reanimation, Hôpital Saint-Antoine, Paris, France
FAU - Dubée, Vincent
AU  - Dubée V
AD  - Service de reanimation, Hôpital Saint-Antoine, Paris, France
FAU - Guidet, Bertrand
AU  - Guidet B
AD  - Service de reanimation, Hôpital Saint-Antoine, Paris, France
FAU - Ait-Oufella, Hafid
AU  - Ait-Oufella H
AD  - Service de reanimation, Hôpital Saint-Antoine, Paris, France
FAU - Jinglun, Liu
AU  - Jinglun L
AD  - Service de réanimation médicale, inserm umr_s 999, Hôpital de Bicêtre, Université
      Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre,
      France
FAU - Shen, Feng
AU  - Shen F
AD  - Service de réanimation médicale, inserm umr_s 999, Hôpital de Bicêtre, Université
      Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre,
      France
FAU - Monnet, Xavier
AU  - Monnet X
AD  - Service de réanimation médicale, inserm umr_s 999, Hôpital de Bicêtre, Université
      Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre,
      France
FAU - Bailly, Sébastien
AU  - Bailly S
AD  - Descid - team 5, INSERM U1137, Paris, France
FAU - Leroy, Olivier
AU  - Leroy O
AD  - Réanimation, Centre Hospitalier de Tourcoing, Tourcoing, France
FAU - Montravers, Philippe
AU  - Montravers P
AD  - Anesthésie et soins intensifs, Hôpital Bichat-Claude Bernard, Paris, France
FAU - Constantin, Jean-Michel
AU  - Constantin JM
AD  - Réanimation adulte, C.H.U. Estaing, Clermont-Ferrand, France
FAU - Dupont, Hervé
AU  - Dupont H
AD  - Réanimation cardio thoracique et vasculaire, CHU Amiens-Picardie, Amiens, France
FAU - Guillemot, Didier
AU  - Guillemot D
AD  - Umr 1181, Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious
      Diseases, Inserm, Paris, France
FAU - Lortholary, Olivier
AU  - Lortholary O
AD  - Necker Pasteur Center for Infectious Diseases, Hospital Necker, Paris, France
FAU - Perrigault, Pierre-François
AU  - Perrigault PF
AD  - Réanimation médicale et chirurgicale, C.H.U. De Montpellier, Prades-le-Lez,
      France
FAU - Gangneux, Jean-Pierre
AU  - Gangneux JP
AD  - Mycologie, Hospital Center University De Rennes, Rennes, France
FAU - Razazi, Keyvan
AU  - Razazi K
AD  - Réanimation médicale, Hospital Henri Mondor, Créteil, France
FAU - Mekontso-Dessap, Armand
AU  - Mekontso-Dessap A
AD  - Réanimation Médicale, Hôpital Henri Mondor, Créteil, France
FAU - Jansen, Chloe
AU  - Jansen C
AD  - Cepi, Hospital Henri Mondor, Créteil, France
FAU - Lecronier, Marie
AU  - Lecronier M
AD  - Service de pneumologie et réanimation médicale, Groupe Hospitalier
      Pitié-Salpêtrière - APHP, Paris, France
FAU - Sandrine, Valade
AU  - Sandrine V
AD  - Réanimation médicale, Hôpital Saint-Louis, Paris, France
FAU - Mira, Jean-Paul
AU  - Mira JP
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Blein, Sophie
AU  - Blein S
AD  - Biostatistics/Bioinformatics, Biomérieux, Marcy-l’Étoile, France
FAU - Marin, Nathalie
AU  - Marin N
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Rousseau, Christophe
AU  - Rousseau C
AD  - Unité 1016, institut National de la Santé et de la Recherche Médicale, 22 rue
      méchain, 75014 Paris, France
FAU - Charpentier, Julien
AU  - Charpentier J
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Pachot, Alexandre
AU  - Pachot A
AD  - Recherche diagnostique, Biomerieux, Rue Censier, Paris, France
FAU - Hraiech, Sami
AU  - Hraiech S
AD  - Réanimation DRIS, Hôpital Nord APHM, Marseille, France
FAU - Bordes, Julien
AU  - Bordes J
AD  - Anesthésie, Hôpital d’instruction des Armées Sainte-Anne, Toulon, France
FAU - De, Lamballerie Xavier
AU  - De LX
AD  - Unite des virus emergents umr190 “emergence des pathologies virales” faculte de
      medecine, 27, Aix-Marseille Université, Marseille, France
FAU - Mège, Jean-Louis
AU  - Mège JL
AD  - Ihu méditerranée infection, urmite cnrs ird inserm umr 7278, Aix-Marseille
      Université, Marseille, France
FAU - Forel, Jean-Marie
AU  - Forel JM
AD  - Réanimation détresses respiratoires et infections sévères (DRIS), Hôpital Nord
      APHM, Marseille, France
FAU - Guervilly, Christophe
AU  - Guervilly C
AD  - Réanimation détresses respiratoires et infections sévères (DRIS), Hôpital Nord
      APHM, Marseille, France
FAU - Adda, Mélanie
AU  - Adda M
AD  - Réanimation détresses respiratoires et infections sévères (DRIS), Hôpital Nord
      APHM, Marseille, France
FAU - Raoult, Didier
AU  - Raoult D
AD  - Ihu méditerranée infection, urmite cnrs ird inserm umr 7278, Aix-Marseille
      Université, Marseille, France
FAU - Papazian, Laurent
AU  - Papazian L
AD  - Réanimation détresses respiratoires et infections sévères, Hôpital Nord APHM,
      Marseille, France
FAU - Kentish-Barnes, Nancy
AU  - Kentish-Barnes N
AD  - Réanimation médicale, Assistance Publique Hôpitaux de Paris, Hôpital Saint Louis,
      Paris, France
FAU - Cohen-Solal, Zoé
AU  - Cohen-Solal Z
AD  - Réanimation médicale, Assistance Publique Hôpitaux de Paris, Hôpital Saint Louis,
      Paris, France
FAU - Kentish-Barnes, Nancy
AU  - Kentish-Barnes N
AD  - Réanimation médicale, Assistance Publique Hôpitaux de Paris, Hôpital Saint Louis,
      Paris, France
FAU - Souppart, Virginie
AU  - Souppart V
AD  - Réanimation médicale, Hôpital Saint Louis, Paris, France
FAU - Kerhuel, Lionel
AU  - Kerhuel L
AD  - Critical care unit - purpan hospital, CHU Toulouse, Toulouse, France
FAU - Haubertin, Carole
AU  - Haubertin C
AD  - Critical care unit - purpan hospital, CHU Toulouse, Toulouse, France
FAU - Exbrayat, Isabelle
AU  - Exbrayat I
AD  - Critical care unit - purpan hospital, CHU Toulouse, Toulouse, France
FAU - Rozières, Elodie
AU  - Rozières E
AD  - Critical care unit - purpan hospital, CHU Toulouse, Toulouse, France
FAU - Argain, Audrey
AU  - Argain A
AD  - Critical care unit - purpan hospital, CHU Toulouse, Toulouse, France
FAU - Suc, Agnès
AU  - Suc A
AD  - Pain Management and Palliative Care Unit - Children Hospital, CHU Toulouse,
      Toulouse, France
FAU - Vignes, Michel
AU  - Vignes M
AD  - Child and Adolescent Psychiatry Unit - La Grave Hospital, CHU Toulouse, Toulouse,
      France
FAU - Cougot, Pierre
AU  - Cougot P
AD  - Critical Care Unit - Rangueil Hospital, CHU Toulouse, Toulouse, France
FAU - Fourcade, Olivier
AU  - Fourcade O
AD  - Critical care unit - purpan hospital, CHU Toulouse, Toulouse, France
FAU - Brunel, Elodie
AU  - Brunel E
AD  - Critical care unit - purpan hospital, CHU Toulouse, Toulouse, France
FAU - Messika, Jonathan
AU  - Messika J
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - Tubach, Florence
AU  - Tubach F
AD  - Département d’epidémiologie et recherche clinique, Unité de Recherche Clinique
      Paris Nord, Paris, France
FAU - Dubief, Emeline
AU  - Dubief E
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - Pasquet, Blandine
AU  - Pasquet B
AD  - Département d’epidémiologie et recherche clinique, Unité de Recherche Clinique
      Paris Nord, Paris, France
FAU - Guillo, Sylvie
AU  - Guillo S
AD  - Département d’epidémiologie et recherche clinique, Unité de Recherche Clinique
      Paris Nord, Paris, France
FAU - Pierron, Charlotte
AU  - Pierron C
AD  - Réanimation et surveillance continue pédiatriques, Hospital Robert-Debré, Paris, 
      France
FAU - Grimaud, Marion
AU  - Grimaud M
AD  - Réanimation et surveillance continue médicochirurgicales pédiatriques, Hôpital
      Necker Enfants-Malades, Paris, France
FAU - Farnoux, Caroline
AU  - Farnoux C
AD  - Réanimation néonatale et néonatalogie, Hôpital Robert-Debré, Paris, France
FAU - Maillard, Amélie
AU  - Maillard A
AD  - Réanimation et médecine néonatales, Hôpital Cochin-Port-royal, Paris, France
FAU - Decavèle, Maxens
AU  - Decavèle M
AD  - Réanimation médico-chirurgicale, Hôpital Tenon, Paris, France
FAU - Prodanovic, Hélène
AU  - Prodanovic H
AD  - Service de pneumologie et réanimation médicale, Groupe Hospitalier
      Pitié-Salpêtrière, Paris, France
FAU - Idbaih, Ahmed
AU  - Idbaih A
AD  - Service de neurologie mazarin 2, Pitié-Salpêtrière Hospital, Paris, France
FAU - Alentorn, Agusti
AU  - Alentorn A
AD  - Service de neurologie mazarin 2, Pitié-Salpêtrière Hospital, Paris, France
FAU - Delattre, Jean-Yves
AU  - Delattre JY
AD  - Service de neurologie mazarin 2, Pitié-Salpêtrière Hospital, Paris, France
FAU - De Montmollin, Etienne
AU  - De Montmollin E
AD  - Réanimation, C.H. Général Saint Denis hôpital Delafontaine, Saint-Denis, France
FAU - Brule, Noelle
AU  - Brule N
AD  - Réanimation médicale, CHU, Nantes, France
FAU - Conrad, Marie
AU  - Conrad M
AD  - Réanimation Médicale, Hôpital Central, C.H.U. de Nancy, Nancy, France
FAU - Dailler, Frédéric
AU  - Dailler F
AD  - Réanimation neurologique, Groupement Hospitalier Est, Hospices Civils de Lyon,
      Bron, France
FAU - Navellou, Jean-Christophe
AU  - Navellou JC
AD  - Réanimation Médicale, CHU de Besançon, Besançon, France
FAU - Alves, Mikael
AU  - Alves M
AD  - Réanimation médicale, Hôpital Saint-Antoine, Paris, France
FAU - Tonnelier, Jean-Marie
AU  - Tonnelier JM
AD  - Réanimation médicale, CHU Brest, Brest, France
FAU - Ruckly, Stephane
AU  - Ruckly S
AD  - Réanimation médicale et infectieuse, Hôpital Bichat-Claude Bernard, Paris, France
FAU - Picard, Géraldine
AU  - Picard G
AD  - Centre national de reference des syndromes neurologiques paranéoplasiques,
      Hôpital neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France
FAU - Rogemond, Véronique
AU  - Rogemond V
AD  - Centre national de reference des syndromes neurologiques paranéoplasiques,
      Hôpital neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France
FAU - Honnorat, Jérôme
AU  - Honnorat J
AD  - Centre national de reference des syndromes neurologiques paranéoplasiques,
      Hôpital neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France
CN  - ENCEPHALITICA Study Group
FAU - Marzorati, Chiara
AU  - Marzorati C
AD  - Anaesthesiology and Critical Care Department, San Gerardo Hospital, Monza, Italy
FAU - Lebert, Christine
AU  - Lebert C
AD  - Réanimation, Centre Hospitalier Départemental - site de La Roche-sur-Yon, La
      Roche-sur-Yon, France
FAU - Perez, Pierre
AU  - Perez P
AD  - Réanimation polyvalente, C.H.U. de Nancy, Nancy, France
FAU - Citerio, Giuseppe
AU  - Citerio G
AD  - Anaesthesiology and Critical Care Department, San Gerardo Hospital, Monza, Italy
FAU - Legriel, Stéphane
AU  - Legriel S
AD  - Réanimation médico-chirurgicale, Centre Hospitalier de Versailles, Le Chesnay,
      France
FAU - Tripon, Simona
AU  - Tripon S
AD  - Brain-Liver Pitié-Salpêtrière Study Group (BLIPS), Soins Intensifs d’Hépatologie,
      Pitié-Salpêtrière Hospital, Paris, France
FAU - Mallet, Maxime
AU  - Mallet M
AD  - Brain-Liver Pitié-Salpêtrière Study Group (BLIPS), Soins Intensifs d’Hépatologie,
      Pitié-Salpêtrière Hospital, Paris, France
FAU - Rudler, Marika
AU  - Rudler M
AD  - Brain-Liver Pitié-Salpêtrière Study Group (BLIPS), Soins Intensifs d’Hépatologie,
      Pitié-Salpêtrière Hospital, Paris, France
FAU - Imbert-Bismut, Francoise
AU  - Imbert-Bismut F
AD  - Département de biochimie, Hôpital Pitié-Salpêtrière, Paris, France
FAU - Thabut, Dominique
AU  - Thabut D
AD  - Brain-Liver Pitié-Salpêtrière Study Group (BLIPS), Soins Intensifs d’Hépatologie,
      Pitié-Salpêtrière Hospital, Paris, France
FAU - Canet, Emmanuel
AU  - Canet E
AD  - Réanimation médicale, Hôpital Saint Louis, Paris, France
FAU - Faguer, Stanislas
AU  - Faguer S
AD  - Département de néphrologie et transplantation d’organes, Hopital Rangueil,
      Toulouse, France
FAU - Moreau, Anne-Sophie
AU  - Moreau AS
AD  - Réanimation Médicale, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris,
      Paris, France
FAU - Barbier, François
AU  - Barbier F
AD  - Loiret, Hôpital Régional Orléans La Source, Orléans, France
FAU - Merceron, Sybille
AU  - Merceron S
AD  - Réanimation médico-chirurgicale, Centre Hospitalier de Versailles, Le Chesnay,
      France
FAU - Guitton, Christophe
AU  - Guitton C
AD  - Réanimation médicale, C.H.U. Hôtel Dieu, Nantes, France
FAU - Labadie, Francois
AU  - Labadie F
AD  - Service de réanimation polyvalente, Hôpitaux de Saint-Nazaire, Saint-Nazaire,
      France
FAU - Lemiale, Virginie
AU  - Lemiale V
AD  - Réanimation médicale, Hôpital Saint Louis, Paris, France
FAU - Faucher, Etienne
AU  - Faucher E
AD  - Réanimation Médicale, Hospices Civils de Lyon - Groupement Hospitalier Edouard
      Herriot, Lyon, France
FAU - Klouche, Kada
AU  - Klouche K
AD  - Service de réanimation, CHU Lapeyronie, Montpellier, France
FAU - Chevret, Sylvie
AU  - Chevret S
AD  - Service de biostatistique et information médicale, Hôpital Saint-Louis, Paris,
      France
CN  - Groupe de Recherche en Reanimation Respiratoire du patient d’Onc-hématologie
FAU - Ragot, Stéphanie
AU  - Ragot S
AD  - Département de Biostatistiques et d’Epidémiologie, CHU de Poitiers, Poitiers,
      France
FAU - Coudroy, Remi
AU  - Coudroy R
AD  - Réanimation médicale, Chu De Poitiers, Poitiers, France
FAU - Boulain, Thierry
AU  - Boulain T
AD  - Réanimation médicale polyvalente, Hôpital de La Source, CHR Orléans, Orléans,
      France
FAU - Jamet, Angéline
AU  - Jamet A
AD  - Réanimation médicale, Chu De Poitiers, Poitiers, France
FAU - Mercat, Alain
AU  - Mercat A
AD  - Service de réanimation médicale et médecine hyperbare, Centre Hospitalier
      Universitaire d’Angers, Angers, France
FAU - Brochard, Laurent
AU  - Brochard L
AD  - Interdepartmental Division of Critical Care- University of Toronto, Hospital St. 
      Michael and Keenan Research Center, Toronto, Canada
FAU - Roux, Antoine
AU  - Roux A
AD  - 92151, Hospital Foch, Suresnes, France
FAU - Lemiale, Virginie
AU  - Lemiale V
AD  - Medical ICU, Hôpital Saint Louis, Paris, France
FAU - Franchineau, Guillaume
AU  - Franchineau G
AD  - Paris, Pitié-Salpêtrière Hospital, Paris, France
FAU - Brechot, Nicolas
AU  - Brechot N
AD  - Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition,
      Pitié-Salpêtrière Hospital, Paris, France
FAU - Lebreton, Guillaume
AU  - Lebreton G
AD  - Cardiac and Thoracic Surgery, iCAN, Institute of Cardiometabolism and Nutrition, 
      Groupe Hospitalier Pitié Salpêtrière, Paris, France
FAU - Hekimian, Guillaume
AU  - Hekimian G
AD  - Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition,
      Pitié-Salpêtrière Hospital, Paris, France
FAU - Nieszkowska, Ania
AU  - Nieszkowska A
AD  - Service de réanimation médicale, Groupe Hospitalier Pitié-Salpêtrière, Institut
      de Cardiométabolisme et Nutrition, Paris, France
FAU - Leprince, Pascal
AU  - Leprince P
AD  - Service de chirurgie cardio-vasculaire et thoracique, Groupe Hospitalier
      Pitié-Salpêtrière, Paris, France
FAU - Trouillet, Jean Louis
AU  - Trouillet JL
AD  - Service de réanimation médicale, Groupe Hospitalier Pitié-Salpêtrière, Institut
      de Cardiométabolisme et Nutrition, Paris, France
FAU - Combes, Alain
AU  - Combes A
AD  - Service de réanimation médicale, Groupe Hospitalier Pitié-Salpêtrière, Institut
      de Cardiométabolisme et Nutrition, Paris, France
FAU - Schmidt, Matthieu
AU  - Schmidt M
AD  - Service de pneumologie et réanimation médicale, Groupe Hospitalier
      Pitié-Salpêtrière, Paris, France
FAU - Barrot, Loïc
AU  - Barrot L
AD  - Réanimation Médicale, CHU de Besançon, Besançon, France
FAU - Piton, Gaël
AU  - Piton G
AD  - Réanimation médicale, CHRU de Besançon, Besançon, France
FAU - Bailey, Michael
AU  - Bailey M
AD  - Depm, Monash University, ANZIC-RC, Melbourne, Australia
FAU - Panwar, Rakshit
AU  - Panwar R
AD  - Depm, Monash University, ANZIC-RC, Melbourne, Australia
FAU - Belin, Nicolas
AU  - Belin N
AD  - Réanimation Médicale, CHU de Besançon, Besançon, France
FAU - Belon, François
AU  - Belon F
AD  - Réanimation Médicale, CHU de Besançon, Besançon, France
FAU - Patry, Cyrille
AU  - Patry C
AD  - Réanimation Médicale, CHU de Besançon, Besançon, France
FAU - Grandperrin, Mathilde
AU  - Grandperrin M
AD  - Réanimation Médicale, CHU de Besançon, Besançon, France
FAU - Chaignat, Claire
AU  - Chaignat C
AD  - Réanimation Médicale, CHU de Besançon, Besançon, France
FAU - Labro, Guylaine
AU  - Labro G
AD  - Réanimation médicale, CHRU de Besançon, Besançon, France
FAU - Vivet, Bérengère
AU  - Vivet B
AD  - Réanimation Médicale, CHU de Besançon, Besançon, France
FAU - Capellier, Gilles
AU  - Capellier G
AD  - Réanimation Médicale, CHU de Besançon, Besançon, France
FAU - Daix, Thomas
AU  - Daix T
AD  - Inserm cic 1435/medical-surgical icu, Chu Limoges, Limoges, France
FAU - Guérin, Estelle
AU  - Guérin E
AD  - Hematology Laboratory/umr cnrs 7276, Chu Limoges, Limoges, France
FAU - Tavernier, Elsa
AU  - Tavernier E
AD  - Inserm cic 1415, Chru Hôpitaux De Tours, Tours, France
FAU - Mercier, Emmanuelle
AU  - Mercier E
AD  - Medical icu, Chru Hôpitaux De Tours, Tours, France
FAU - Gissot, Valérie
AU  - Gissot V
AD  - Emergency Department/Inserm cic 1415, Chru Hôpitaux De Tours, Tours, France
FAU - Vallejo, Christine
AU  - Vallejo C
AD  - Emergency Department, Chu Limoges, Limoges, France
FAU - François, Bruno
AU  - François B
AD  - Service de réanimation polyvalente, Centre Hospitalier Universitaire de Limoges, 
      Limoges, France
CN  - Septiflux trial Group
FAU - Ravry, Céline
AU  - Ravry C
AD  - Service de Réanimation Polyvalente/Inserm UMR-S 1092/Faculté de Médecine, Centre 
      Hospitalier Universitaire de Limoges, Limoges, France
FAU - Pichon, Nicolas
AU  - Pichon N
AD  - Service de réanimation polyvalente, Centre Hospitalier Universitaire de Limoges, 
      Limoges, France
FAU - Chapellas, Catherine
AU  - Chapellas C
AD  - Service de réanimation polyvalente, Centre Hospitalier Universitaire de Limoges, 
      Limoges, France
FAU - Fedou, Anne-Laure
AU  - Fedou AL
AD  - Service de réanimation polyvalente, Centre Hospitalier Universitaire de Limoges, 
      Limoges, France
FAU - Galy, Antoine
AU  - Galy A
AD  - Service de réanimation polyvalente, Centre Hospitalier Universitaire de Limoges, 
      Limoges, France
FAU - Ploy, Marie-Cécile
AU  - Ploy MC
AD  - Inserm UMR-S 1092/Faculté de Médecine/Laboratoire de Bactériologie, Centre
      Hospitalier Universitaire de Limoges, Limoges, France
FAU - Barraud, Olivier
AU  - Barraud O
AD  - Inserm UMR-S 1092/Faculté de Médecine/Laboratoire de Bactériologie, Centre
      Hospitalier Universitaire de Limoges, Limoges, France
FAU - Vignon, Philippe
AU  - Vignon P
AD  - Service de réanimation polyvalente, Centre Hospitalier Universitaire de Limoges, 
      Limoges, France
FAU - Thooft, Aurelie
AU  - Thooft A
AD  - Réanimation polyvalente, C.H.U. De Charleroi, Charleroi, Belgium
FAU - Conotte, Raphael
AU  - Conotte R
AD  - Laboratoire de biologie humaine et toxicologie, Université de Mons - Campus
      Plaine de Nimy, Mons, Belgium
FAU - Colet, Jean-Marie
AU  - Colet JM
AD  - Laboratoire de biologie humaine et toxicologie, Université de Mons - Campus
      Plaine de Nimy, Mons, Belgium
FAU - Le Dorze, Matthieu
AU  - Le Dorze M
AD  - Anesthesiology and critical care, Hospital Lariboisière, Paris, France
FAU - Tarazona, Virginie
AU  - Tarazona V
AD  - Anesthesiology and critical care, Hospital Lariboisière, Paris, France
FAU - Brumpt, Caren
AU  - Brumpt C
AD  - Hematology, Hospital Lariboisière, Paris, France
FAU - Moins-Teisserenc, Hélène
AU  - Moins-Teisserenc H
AD  - Immunology, Hôpital Saint Louis, Paris, France
FAU - Uhel, Fabrice
AU  - Uhel F
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Rennes, Rennes, France
FAU - Azzaoui, Imane
AU  - Azzaoui I
AD  - Pôle biologie, Centre Hospitalier Universitaire de Rennes, Rennes, France
FAU - Gregoire, Murielle
AU  - Gregoire M
AD  - Biosit and inserm u917, faculte de medecine, universite rennes i, Centre
      Hospitalier Universitaire de Rennes, Rennes, France
FAU - Pangault, Céline
AU  - Pangault C
AD  - Inserm u917, Faculté de Médecine de Rennes - Université Rennes 1, Rennes, France
FAU - Dulong, Joëlle
AU  - Dulong J
AD  - Inserm u917, Faculté de Médecine de Rennes - Université Rennes 1, Rennes, France
FAU - Cynober, Luc
AU  - Cynober L
AD  - Service de biochimie, AP-HP, Hôpital Cochin, Paris, France
FAU - Roussel, Mikaël
AU  - Roussel M
AD  - Inserm u917, Faculté de Médecine de Rennes - Université Rennes 1, Rennes, France
FAU - Le Tulzo, Yves
AU  - Le Tulzo Y
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Rennes, Rennes, France
FAU - Tarte, Karin
AU  - Tarte K
AD  - Biosit and inserm u917, faculte de medecine, universite rennes i, Centre
      Hospitalier Universitaire de Rennes, Rennes, France
FAU - Demiselle, Julien
AU  - Demiselle J
AD  - Service de néphrologie et transplantation rénale, Centre Hospitalier
      Universitaire d’Angers, Angers, France
FAU - Auchabie, Johann
AU  - Auchabie J
AD  - Département de réanimation médicale et médecine hyperbare, Centre Hospitalier
      Universitaire d’Angers, Angers, France
FAU - Dequin, Pierre François
AU  - Dequin PF
AD  - Réanimation polyvalente, CHRU Hôpitaux de Tours, Tours, France
FAU - Chudeau, Nicolas
AU  - Chudeau N
AD  - Centre hospitalier universitaire d’angers, Service de Réanimation Médicale et
      Médecine Hyperbare, Angers, France
FAU - Fourrier, François
AU  - Fourrier F
AD  - Réanimation, Centre de réanimation, Lille, France
FAU - Grange, Steven
AU  - Grange S
AD  - Réanimation Médicale, Centre Hospitalier Universitaire Rouen, Rouen, France
FAU - Piquilloud, Lise
AU  - Piquilloud L
AD  - Service de médecine intensive adulte et centre des brûlés, CHUV | Centre
      hospitalier universitaire vaudois, Lausanne, Switzerland
FAU - Lautrette, Alexandre
AU  - Lautrette A
AD  - Réanimation médicale, CHU Gabriel-Montpied, Clermont-Ferrand, France
FAU - Boyer, Sonia
AU  - Boyer S
AD  - Service de réanimation médicale, CHU Nice, Nice, France
FAU - Letheulle, Julien
AU  - Letheulle J
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Rennes, Rennes, France
FAU - Lerolle, Nicolas
AU  - Lerolle N
AD  - Réanimation médicale, Centre Hospitalier Universitaire d’Angers, Angers, France
FAU - Truche, Anne Sophie
AU  - Truche AS
AD  - Umr 1137 iame equipe 5 descid, Université Paris Diderot, Paris, France
FAU - Clec’h, Christophe
AU  - Clec’h C
AD  - Réanimation medico-chirurgicale, Hopital avicenne, Bobigny, France
FAU - Zaoui, Philippe
AU  - Zaoui P
AD  - Nephrologie, C.H.U Grenoble, La Tronche, France
FAU - Laurent, Virginie
AU  - Laurent V
AD  - Réanimation médicale, Hospital Center De Versailles, Le Chesnay, France
FAU - Toledano, Dany Goldgran
AU  - Toledano DG
AD  - Réanimation polyvalente, Centre Hospitalier Général, Gonesse, France
FAU - Ragey, Sophie Perinel
AU  - Ragey SP
AD  - Réanimation G, CHU Hôpital Nord, Saint-Priest-en-Jarez, France
FAU - Gros, Antoine
AU  - Gros A
AD  - Réanimation médico-chirurgicale, Centre Hospitalier de Versailles, Le Chesnay,
      France
FAU - Dumenil, Anne Sylvie
AU  - Dumenil AS
AD  - Réanimation chirurgicale, Hôpital Antoine Béclère, Clamart, France
FAU - Jamali, Samir
AU  - Jamali S
AD  - Réanimation médicale, Centre Hospitalier Sud Essonne, Dourdan, France
FAU - Darmon, Michaël
AU  - Darmon M
AD  - Réanimation Médicale, CHU Saint-Etienne - Hôpital Nord, Saint-Étienne, France
CN  - For the OUTCOMEREA Study Group
FAU - Chouraqui, Mikhael
AU  - Chouraqui M
AD  - Réanimation polyvalente, service d’anesthésie-réanimation 2, CHU de Bordeaux,
      Maison du Haut Lévèque, Avenue de Magellan, Pessac, France
FAU - Dewitte, Antoine
AU  - Dewitte A
AD  - Réanimation polyvalente, service d’anesthésie-réanimation 2, CHU de Bordeaux,
      Maison du Haut Lévèque, Avenue de Magellan, Pessac, France
FAU - Chastel, Brigitte
AU  - Chastel B
AD  - Réanimation polyvalente, service d’anesthésie-réanimation 2, CHU de Bordeaux,
      Maison du Haut Lévèque, Avenue de Magellan, Pessac, France
FAU - Carles, Pauline
AU  - Carles P
AD  - Réanimation polyvalente, service d’anesthésie-réanimation 2, CHU de Bordeaux,
      Maison du Haut Lévèque, Avenue de Magellan, Pessac, France
FAU - Fleureau, Catherine
AU  - Fleureau C
AD  - Réanimation polyvalente, service d’anesthésie-réanimation 2, CHU de Bordeaux,
      Maison du Haut Lévèque, Avenue de Magellan, Pessac, France
FAU - Joannes-Boyau, Olivier
AU  - Joannes-Boyau O
AD  - Réanimation polyvalente, service d’anesthésie-réanimation 2, CHU de Bordeaux,
      Maison du Haut Lévèque, Avenue de Magellan, Pessac, France
FAU - Ouattara, Alexandre
AU  - Ouattara A
AD  - Réanimation polyvalente, service d’anesthésie réanimation 2, CHU de Bordeaux,
      Bordeaux, France
FAU - Joseph, Adrien
AU  - Joseph A
AD  - Réanimation médicale, Hôpital Saint Louis, Paris, France
FAU - Garrouste-Orgeas, Maïté
AU  - Garrouste-Orgeas M
AD  - Réanimation, Fondation Hopital Saint Joseph, Paris, France
FAU - Max, Adeline
AU  - Max A
AD  - Réanimation polyvalente, Groupe Hospitalier Paris-Saint-Joseph, Paris, France
FAU - Lerin, Talia
AU  - Lerin T
AD  - Ile de France, Hospital Group Paris Saint-Joseph, Paris, France
FAU - Grégoire, Charles
AU  - Grégoire C
AD  - Réanimation polyvalente, Groupe Hospitalier Paris-Saint-Joseph, Paris, France
FAU - Kloeckner, Martin
AU  - Kloeckner M
AD  - Réanimation polyvalente, Groupe Hospitalier Paris-Saint-Joseph, Paris, France
FAU - Bruel, Cédric
AU  - Bruel C
AD  - Réanimation, Hôpital Paris Saint-Joseph, Paris, France
FAU - Brochon, Sandie
AU  - Brochon S
AD  - Réanimation, Groupe Hospitalier Paris Saint-Joseph, Paris, France
FAU - Philippart, Francois
AU  - Philippart F
AD  - Réanimation polyvalente, Groupe Hospitalier Paris-Saint-Joseph, Paris, France
FAU - Pichot, Emmanuelle
AU  - Pichot E
AD  - Réanimation polyvalente, Groupe Hospitalier Paris-Saint-Joseph, Paris, France
FAU - Simons, Clara
AU  - Simons C
AD  - Réanimation, Hôpital Paris Saint-Joseph, Paris, France
FAU - Flint, Andrew
AU  - Flint A
AD  - Depm, Monash University, ANZIC-RC, Melbourne, Australia
FAU - Aubron, Cécile
AU  - Aubron C
AD  - Réanimation médicale, CHRU de Brest, La Cavale Blanche, Brest, France
FAU - Bellomo, Rinaldo
AU  - Bellomo R
AD  - Depm, Monash University, ANZIC-RC, Melbourne, Australia
FAU - Pilcher, David
AU  - Pilcher D
AD  - Intensive Care Unit, Alfred Hospital, Melbourne, Australia
FAU - Cheng, Allen
AU  - Cheng A
AD  - Depm, Monash University, Melbourne, Australia
FAU - Hegarty, Colin
AU  - Hegarty C
AD  - The Transfusion Service, Austin Hospital, Heidelberg, Australia
FAU - Martinelli, Anthony
AU  - Martinelli A
AD  - The Transfusion Service, Austin Hospital, Heidelberg, Australia
FAU - Howden, Benjamin
AU  - Howden B
AD  - Infectious Diseases Department, Austin Hospital, Heidelberg, Australia
FAU - Reade, Michael
AU  - Reade M
AD  - Infectious Diseases Department, Austin Hospital, Heidelberg, Australia
FAU - Mcquilten, Zoe
AU  - Mcquilten Z
AD  - Depm, Transfusion Research Unit, Monash University, Melbourne, Australia
FAU - Bretonnière, Cédric
AU  - Bretonnière C
AD  - Réanimation médicale polyvalente, C.H.U. Hôtel Dieu, Nantes, France
FAU - Villers, Daniel
AU  - Villers D
AD  - Réanimation médicale polyvalente, C.H.U. Hôtel Dieu, Nantes, France
CN  - Groupe RMM
CN  - Qualité et Sécurité des Soins - CBPR-CFAR
FAU - Soares, M.
AU  - Soares M
AD  - Post-graduation Program, D’Or Institute for Research and Education, Rio de
      Janeiro, Brazil
FAU - Gonzalez, Frédéric
AU  - Gonzalez F
AD  - Réanimation médico-chirurgicale, Hôpital Avicenne, Bobigny, France
FAU - Vincent, François
AU  - Vincent F
AD  - Réanimation médico-chirurgicale, GHIC Le Raincy-Montfermeil, Montfermeil, France
CN  - For the GrrrOH: Groupe de recherche en réanimation respiratoire en
      Onco-Hématologie (Group for Research in Respiratory Intensive Care
      Onco-Hematology
FAU - Fauché, Clémence
AU  - Fauché C
AD  - Haute savoie, Intensive Care Unit, Hospital Center Annecy Genevois, Metz-Tessy,
      France
FAU - Gay, Samuel
AU  - Gay S
AD  - Haute savoie, Intensive Care Unit, Hospital Center Annecy Genevois, Metz-Tessy,
      France
FAU - Skowron, Olivier
AU  - Skowron O
AD  - Haute savoie, Department of Urology, Hospital Center Annecy Genevois, Metz-Tessy,
      France
FAU - Levrat, Albrice
AU  - Levrat A
AD  - Haute savoie, Intensive Care Unit, Hospital Center Annecy Genevois, Metz-Tessy,
      France
FAU - Dorez, Didier
AU  - Dorez D
AD  - Haute savoie, Organ Procurement Coordination, Hospital Center Annecy Genevois,
      Metz-Tessy, France
FAU - Decavèle, Maxens
AU  - Decavèle M
AD  - Réanimation médico-chirurgicale, Hôpital Tenon, Paris, France
FAU - Foucrier, Arnaud
AU  - Foucrier A
AD  - Unité de réanimation chirurgicale polyvalente, service d’anesthésie réanimation, 
      Hospital Beaujon, Clichy, France
FAU - Pease, Sebastian
AU  - Pease S
AD  - Unité de réanimation chirurgicale polyvalente, service d’anesthésie réanimation, 
      Hospital Beaujon, Clichy, France
FAU - Gauss, Tobias
AU  - Gauss T
AD  - Unité de réanimation chirurgicale polyvalente, service d’anesthésie réanimation, 
      Hospital Beaujon, Clichy, France
FAU - Paugam, Catherine
AU  - Paugam C
AD  - Unité de réanimation chirurgicale polyvalente, service d’anesthésie réanimation, 
      Hospital Beaujon, Clichy, France
FAU - Gorham, Julie
AU  - Gorham J
AD  - Intensive Care and Thoracic Oncology, Institute Jules Bordet, Brussels, Belgium
FAU - Ameye, Lieveke
AU  - Ameye L
AD  - Data Centre, Institute Jules Bordet, Brussels, Belgium
FAU - Paesmans, Marianne
AU  - Paesmans M
AD  - Data Centre, Institute Jules Bordet, Brussels, Belgium
FAU - Berghmans, Thierry
AU  - Berghmans T
AD  - Intensive Care and Thoracic Oncology, Institute Jules Bordet, Brussels, Belgium
FAU - Sculier, Jean-Paul
AU  - Sculier JP
AD  - Intensive Care and Thoracic Oncology, Institute Jules Bordet, Brussels, Belgium
FAU - Meert, Anne-Pascale
AU  - Meert AP
AD  - Intensive Care and Thoracic Oncology, Institute Jules Bordet, Brussels, Belgium
FAU - Deras, Pauline
AU  - Deras P
AD  - Dar a centre régional d’accueil des polytraumatisés, Hospital Lapeyronie,
      Montpellier Cedex 5, France
FAU - Martinez, Orianne
AU  - Martinez O
AD  - Dar a centre régional d’accueil des polytraumatisés, Hospital Lapeyronie,
      Montpellier Cedex 5, France
FAU - Latry, Pascal
AU  - Latry P
AD  - Inserm u1046, Hospital Lapeyronie, Montpellier Cedex 5, France
FAU - Capdevila, Xavier
AU  - Capdevila X
AD  - Dar a centre régional d’accueil des polytraumatisés, Hospital Lapeyronie,
      Montpellier Cedex 5, France
FAU - Charbit, Jonathan
AU  - Charbit J
AD  - Dar a centre régional d’accueil des polytraumatisés, Hospital Lapeyronie,
      Montpellier Cedex 5, France
FAU - Jaubert, J.
AU  - Jaubert J
AD  - Anesthesia and Intensive Care Medicine, CHU Henri Mondor, Créteil, France
FAU - Etiennar, Celia
AU  - Etiennar C
AD  - Prehospital Emergency Medicine Unit (smur 95), Centre Hospitalier, Gonesse,
      France
FAU - Ginoux, Lucie
AU  - Ginoux L
AD  - Prehospital Emergency Medicine Unit (smur 95), Centre Hospitalier, Gonesse,
      France
FAU - Sebbah, Jean-Luc
AU  - Sebbah JL
AD  - Prehospital Emergency Medicine Unit (smur 95), Centre Hospitalier, Gonesse,
      France
FAU - Haouache, Hakim
AU  - Haouache H
AD  - Anesthesia and Intensive Care Medicine, CHU Henri Mondor, Créteil, France
FAU - Dhonneur, Gilles
AU  - Dhonneur G
AD  - Anesthesia and Intensive Care Medicine, CHU Henri Mondor, Créteil, France
FAU - Cheikh, Chaigar Mohammed
AU  - Cheikh CM
AD  - Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Moussaid, I.
AU  - Moussaid I
AD  - Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Ghazaoui, O.
AU  - Ghazaoui O
AD  - Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Belkadi, Kamal
AU  - Belkadi K
AD  - Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco
FAU - El Youssoufi, S.
AU  - El Youssoufi S
AD  - Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Salmi, S.
AU  - Salmi S
AD  - Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Pajot, Laure
AU  - Pajot L
AD  - Réanimation médico-chirurgicale, Hospital Center De Versailles, Le Chesnay,
      France
FAU - Zuber, Benjamin
AU  - Zuber B
AD  - Réanimation médico-chirurgicale, Hospital Center De Versailles, Le Chesnay,
      France
FAU - Darmon, Michael
AU  - Darmon M
AD  - Réanimation médicale, CHU Bichat, Paris, France
FAU - Bedos, Jean Pierre
AU  - Bedos JP
AD  - Réanimation médico-chirurgicale, Hospital Center De Versailles, Le Chesnay,
      France
CN  - OutcomeRéa
FAU - Dupont, Benoit
AU  - Dupont B
AD  - Département d’hépato-gastroentérologie et nutrition, C.H.U de Caen, Caen, France
FAU - Eugène, Axelle
AU  - Eugène A
AD  - Laboratoire d’anatomie pathologique, C.H.U de Caen, Caen, France
FAU - Galateau-Sallé, Françoise
AU  - Galateau-Sallé F
AD  - Laboratoire d’anatomie pathologique, C.H.U de Caen, Caen, France
FAU - Michard, Baptiste
AU  - Michard B
AD  - Service de réanimation médicale, Hôpital de Hautepierre, Hôpitaux Universitaires 
      de Strasbourg, Strasbourg, France
FAU - Lebas, Benjamin
AU  - Lebas B
AD  - Service de réanimation médicale, Hôpital de Hautepierre, Hôpitaux Universitaires 
      de Strasbourg, Strasbourg, France
FAU - Boivin, Alexandra
AU  - Boivin A
AD  - Service de réanimation médicale, Hôpital de Hautepierre, Hôpitaux Universitaires 
      de Strasbourg, Strasbourg, France
FAU - Guillot, Max
AU  - Guillot M
AD  - Service de réanimation médicale, inserm umr_s 999, Hôpital de Bicêtre, Université
      Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre,
      France
FAU - Harlay, Marie-Line
AU  - Harlay ML
AD  - Service de réanimation médicale, Hôpital de Hautepierre, Hôpitaux Universitaires 
      de Strasbourg, Strasbourg, France
FAU - Janssen-Langenstein, Ralf
AU  - Janssen-Langenstein R
AD  - Service de réanimation médicale, Hôpital de Hautepierre, Hôpitaux Universitaires 
      de Strasbourg, Strasbourg, France
FAU - Schenck, Maleka
AU  - Schenck M
AD  - Service de réanimation médicale, Hôpital de Hautepierre, Hôpitaux Universitaires 
      de Strasbourg, Strasbourg, France
FAU - Ellero, Bernard
AU  - Ellero B
AD  - Service de chirurgie hépato-biliaire et transplantation, Hôpital de Hautepierre, 
      Hôpitaux Universitaires de Strasbourg, Strasbourg, France
FAU - Woehl-Jaegle, Marie-Lorraine
AU  - Woehl-Jaegle ML
AD  - Service de chirurgie hépato-biliaire et transplantation, Hôpital de Hautepierre, 
      Hôpitaux Universitaires de Strasbourg, Strasbourg, France
FAU - Besch, Camille
AU  - Besch C
AD  - Service de chirurgie hépato-biliaire et transplantation, Hôpital de Hautepierre, 
      Hôpitaux Universitaires de Strasbourg, Strasbourg, France
FAU - Castelain, Vincent
AU  - Castelain V
AD  - Service de réanimation médicale, Hôpital de Hautepierre, Hôpitaux Universitaires 
      de Strasbourg, Strasbourg, France
FAU - Bachellier, Philippe
AU  - Bachellier P
AD  - Service de chirurgie hépato-biliaire et transplantation, Hôpital de Hautepierre, 
      Hôpitaux Universitaires de Strasbourg, Strasbourg, France
FAU - Schneider, Francis
AU  - Schneider F
AD  - Service de réanimation médicale, Hôpital de Hautepierre, Hôpitaux Universitaires 
      de Strasbourg, Strasbourg, France
FAU - Camus, Christophe
AU  - Camus C
AD  - 35033, Hospital Center University De Rennes, Rennes, France
FAU - Saliba, Fawzi
AU  - Saliba F
AD  - Villejuif, Hospital University Paul Brousse, Villejuif, France
FAU - Goubaux, Bernard
AU  - Goubaux B
AD  - 06000, CHU Nice, Nice, France
FAU - Bonadona, Agnès
AU  - Bonadona A
AD  - Réanimation médicale, C.H.U. Grenoble, La Tronche, France
FAU - Lavayssiere, Laurence
AU  - Lavayssiere L
AD  - 31000, CHU Rangueil, Toulouse, France
FAU - Quinart, Alice
AU  - Quinart A
AD  - 33000, CHU, Bordeaux, France
FAU - Barbot, Olivier
AU  - Barbot O
AD  - 25000, CHU, Besançon, France
FAU - Dharancy, Sebastien
AU  - Dharancy S
AD  - 59000, CHRU Huriez, Lille, France
FAU - Delafosse, Bertrand
AU  - Delafosse B
AD  - 69000, Hospices Civils de Lyon, Lyon, France
FAU - Barraud, Helene
AU  - Barraud H
AD  - 54000, Hépatogastroentérologie, CHU Nancy, Nancy, France
FAU - Galbois, Arnaud
AU  - Galbois A
AD  - Réanimation médicale, Hôpital Saint-Antoine, Paris, France
FAU - Veber, Benoit
AU  - Veber B
AD  - Reanimation chirurgicale, Centre Hospitalier Universitaire Rouen, Rouen, France
FAU - Cayot, Sophie
AU  - Cayot S
AD  - 63000, CHU, Clermont-Ferrand, France
FAU - Souche, Bruno
AU  - Souche B
AD  - 34000, CHU Saint-Eloi, Montpellier, France
FAU - Locher, Clara
AU  - Locher C
AD  - 35000, CIC Pontchaillou, Rennes, France
CN  - RETROMARS Study Group
FAU - Roux, Olivier
AU  - Roux O
AD  - Hepatology and Liver Intensive Care Unit, Hôpital Beaujon, Clichy, France
FAU - Figorilli, Francesco
AU  - Figorilli F
AD  - UCL Institute for Liver and Digestive Health, Royal Free Hospital, London, United
      Kingdom
FAU - Putignano, Antonella
AU  - Putignano A
AD  - UCL Institute for Liver and Digestive Health, Royal Free Hospital, London, United
      Kingdom
FAU - Houssel, Pauline
AU  - Houssel P
AD  - Hepatology and Liver Intensive Care Unit, Hospital Beaujon, Clichy, France
FAU - Francoz, Claire
AU  - Francoz C
AD  - Hepatology and Liver Intensive Care Unit, Hospital Beaujon, Clichy, France
FAU - Weiss, Emmanuel
AU  - Weiss E
AD  - Département d’anesthésie-réanimation, Hôpital Beaujon, Boulevard du Général
      Leclerc, Clichy, France
FAU - Agarwal, Banwari
AU  - Agarwal B
AD  - Intensive Care Unit, Royal Free Hospital, London, United Kingdom
FAU - Jalan, Rajiv
AU  - Jalan R
AD  - UCL Institute for Liver and Digestive Health, Royal Free Hospital, London, United
      Kingdom
FAU - Durand, François
AU  - Durand F
AD  - Service d’hépatologie, Hôpital Beaujon, Clichy, France
FAU - Ghezala, Hassen Ben
AU  - Ghezala HB
AD  - Teaching Department of Emergency and Intensive Care, Hospital Zaghouan, Zaghouan,
      Tunisia
FAU - Daoudi, Rebeh
AU  - Daoudi R
AD  - Teaching Department of Emergency and Intensive Care, Hospital Zaghouan, Zaghouan,
      Tunisia
FAU - Kaddour, Moez
AU  - Kaddour M
AD  - Teaching Department of Emergency and Intensive Care, Hospital Zaghouan, Zaghouan,
      Tunisia
FAU - Ghadhoune, Hatem
AU  - Ghadhoune H
AD  - Service de réanimation médicale, Hôpital universitaire de Bizerte, Bizerte,
      Tunisia
FAU - Rachedi, E.
AU  - Rachedi E
AD  - Service de réanimation médicale, Hôpital universitaire de Bizerte, Bizerte,
      Tunisia
FAU - Guissouma, J.
AU  - Guissouma J
AD  - Service de réanimation médicale, Hôpital universitaire de Bizerte, Bizerte,
      Tunisia
FAU - Ben Slimene, A.
AU  - Ben Slimene A
AD  - Service de réanimation médicale, Hôpital universitaire de Bizerte, Bizerte,
      Tunisia
FAU - Azzeza, W.
AU  - Azzeza W
AD  - Service de réanimation médicale, Hôpital universitaire de Bizerte, Bizerte,
      Tunisia
FAU - Brahmi, H.
AU  - Brahmi H
AD  - Service de réanimation médicale, Hôpital universitaire de Bizerte, Bizerte,
      Tunisia
FAU - Elghord, H.
AU  - Elghord H
AD  - Service de réanimation médicale, Hôpital universitaire de Bizerte, Bizerte,
      Tunisia
FAU - Kada, Ahmed Youssef
AU  - Kada AY
AD  - Neurosurgery, CHU de Blida, Blida, Algeria
FAU - Chikh, Radia
AU  - Chikh R
AD  - Neurosurgery, CHU de Blida, Blida, Algeria
FAU - Slimani, Roza
AU  - Slimani R
AD  - Neurosurgery, CHU de Blida, Blida, Algeria
FAU - a Bouyoucef, Kheireddine.
AU  - a Bouyoucef K
AD  - Neurosurgery, CHU de Blida, Blida, Algeria
FAU - Regaieg, Kais
AU  - Regaieg K
AD  - Réanimation polyvalente, Faculté de médecine de Sfax, Sfax, Tunisia
FAU - Kamilia, Chtara
AU  - Kamilia C
AD  - Réanimation polyvalente, Faculté de médecine de Sfax, Sfax, Tunisia
FAU - Baccouche, Najeh
AU  - Baccouche N
AD  - ICU, CHU Habib Bourguiba, Sfax, Tunisia
FAU - Turki, Olfa
AU  - Turki O
AD  - Réanimation polyvalente, Faculté de médecine de Sfax, Sfax, Tunisia
FAU - Chaari, Anis
AU  - Chaari A
AD  - Réanimation polyvalente, Faculté de médecine de Sfax, Sfax, Tunisia
FAU - Ben, Hmida Chokri
AU  - Ben HC
AD  - Réanimation polyvalente, Faculté de médecine de Sfax, Sfax, Tunisia
FAU - Bouaziz, Mounir
AU  - Bouaziz M
AD  - ICU, CHU Habib Bourguiba, Sfax, Tunisia
FAU - Medhioub, Fatma Kaaniche
AU  - Medhioub FK
AD  - Faculté de médecine de Sfax, Sfax, Tunisia
FAU - Zekri, Manel
AU  - Zekri M
AD  - Réanimation polyvalente, CHU Habib Bourguiba, Sfax, Tunisia
FAU - Rgieg, Kais
AU  - Rgieg K
AD  - Réanimation polyvalente, CHU Habib Bourguiba, Sfax, Tunisia
FAU - Bhimada, Chokri
AU  - Bhimada C
AD  - Réanimation polyvalente, Faculté de médecine de Sfax, Sfax, Tunisia
FAU - Mounir, Bouaziz
AU  - Mounir B
AD  - Réanimation polyvalente, Faculté de médecine de Sfax, Sfax, Tunisia
FAU - Cheikh, Chaigar Mohammed
AU  - Cheikh CM
AD  - Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Lang, Elodie
AU  - Lang E
AD  - Département d’anesthésie - réanimation, Fondation Ophtalmologique Adolphe de
      Rothschild, Paris, France
FAU - Welschbillig, Stephane
AU  - Welschbillig S
AD  - Département d’anesthésie - réanimation, Fondation Ophtalmologique Adolphe de
      Rothschild, Paris, France
FAU - Perrin, Mathilde
AU  - Perrin M
AD  - 75019, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France
FAU - Devys, Jean-Michel
AU  - Devys JM
AD  - 75019, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France
FAU - Benbernou, Soumia
AU  - Benbernou S
AD  - Urgences Medicales Chuoran, Faculté de médecine d’Oran, Oran, Algeria
FAU - Mokhtari-Djebli, Houria
AU  - Mokhtari-Djebli H
AD  - Urgences Medicales Chuoran, Faculté de médecine d’Oran, Oran, Algeria
FAU - Ilies, Sofiane
AU  - Ilies S
AD  - Urgences Medicales Chuoran, Faculté de médecine d’Oran, Oran, Algeria
FAU - Bouyacoub, Khalida
AU  - Bouyacoub K
AD  - Urgences Medicales, Chu Oran, Oran, Algeria
FAU - Azza, Abdelkader
AU  - Azza A
AD  - Urgences Medicales, Chu Oran, Oran, Algeria
FAU - Zogheib, Elie
AU  - Zogheib E
AD  - Réanimation cardio thoracique et vasculaire, CHU Amiens-Picardie, Salouel, France
FAU - Nader, Joseph
AU  - Nader J
AD  - Chirurgie cardiaque, CHU Amiens-Picardie, Salouel, France
FAU - Villeret, Léonie
AU  - Villeret L
AD  - Réanimation cardio thoracique et vasculaire, CHU Amiens-Picardie, Salouel, France
FAU - Guilbart, Mathieu
AU  - Guilbart M
AD  - Réanimation cardio thoracique et vasculaire, CHU Amiens-Picardie, Salouel, France
FAU - Besserve, Patricia
AU  - Besserve P
AD  - Réanimation cardio thoracique et vasculaire, CHU Amiens-Picardie, Salouel, France
FAU - Caus, Thierry
AU  - Caus T
AD  - Chirurgie cardiaque, CHU Amiens-Picardie, Salouel, France
FAU - Mastroianni, Ciro
AU  - Mastroianni C
AD  - Service de chirurgie cardio-vasculaire et thoracique, Groupe Hospitalier
      Pitié-Salpêtrière, Paris, France
FAU - Santi, Francesca
AU  - Santi F
AD  - Service de chirurgie cardio-vasculaire et thoracique, Groupe Hospitalier
      Pitié-Salpêtrière, Paris, France
FAU - Hékimian, Guillaume
AU  - Hékimian G
AD  - Service de réanimation médicale, Groupe Hospitalier Pitié-Salpêtrière, Institut
      de Cardiométabolisme et Nutrition, Paris, France
FAU - Pascal, Leprince
AU  - Pascal L
AD  - Service de chirurgie cardio-vasculaire et thoracique, Groupe Hospitalier
      Pitié-Salpêtrière, Paris, France
FAU - Chastre, Jean
AU  - Chastre J
AD  - Service de réanimation médicale, Groupe Hospitalier Pitié-Salpêtrière, Institut
      de Cardiométabolisme et Nutrition, Paris, France
FAU - Perrier, Virginie
AU  - Perrier V
AD  - Réanimation polyvalente, service d’anesthésie réanimation 2, CHU de Bordeaux,
      Bordeaux, France
FAU - Deniau, Benjamin
AU  - Deniau B
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - Klasen, Fanny
AU  - Klasen F
AD  - Réanimation détresses respiratoires et infections sévères, Hôpital Nord APHM,
      Marseille, France
FAU - Ponthus, Jean Pierre
AU  - Ponthus JP
AD  - Réanimation polyvalente - surveillance continue, Ctre Hospitalier Intercommunal
      de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Villeneuve-Saint-Georges,
      France
FAU - Ngasseu, Polysie
AU  - Ngasseu P
AD  - Réanimation polyvalente - surveillance continue, Ctre Hospitalier Intercommunal
      de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Villeneuve-Saint-Georges,
      France
FAU - Amilien, Virginie
AU  - Amilien V
AD  - Réanimation polyvalente - surveillance continue, Ctre Hospitalier Intercommunal
      de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Villeneuve-Saint-Georges,
      France
FAU - Barsam, Elise
AU  - Barsam E
AD  - Réanimation polyvalente - surveillance continue, Ctre Hospitalier Intercommunal
      de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Villeneuve-Saint-Georges,
      France
FAU - Lehericey, Pierre
AU  - Lehericey P
AD  - Réanimation polyvalente - surveillance continue, Ctre Hospitalier Intercommunal
      de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Villeneuve-Saint-Georges,
      France
FAU - Tchir, Martial
AU  - Tchir M
AD  - Réanimation polyvalente - surveillance continue, Ctre Hospitalier Intercommunal
      de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Villeneuve-Saint-Georges,
      France
FAU - Georger, Jean Francois
AU  - Georger JF
AD  - Réanimation polyvalente - surveillance continue, Ctre Hospitalier Intercommunal
      de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Villeneuve-Saint-Georges,
      France
FAU - Puech, Bérénice
AU  - Puech B
AD  - Réanimation Polyvalente, CHU La Réunion, Saint-Denis, France
FAU - Vandroux, David
AU  - Vandroux D
AD  - Réanimation Polyvalente, CHU La Réunion, Saint-Denis, France
FAU - Roussiaux, Arnaud
AU  - Roussiaux A
AD  - Réanimation Polyvalente, CHU La Réunion, Saint-Denis, France
FAU - Belcour, Dominique
AU  - Belcour D
AD  - Réanimation Polyvalente, CHU La Réunion, Saint-Denis, France
FAU - Ferdynus, Cyril
AU  - Ferdynus C
AD  - Unité de soutien méthodologique, CHU La Réunion, Saint-Denis, France
FAU - Martinet, Olivier
AU  - Martinet O
AD  - Réanimation Polyvalente, CHU La Réunion, Saint-Denis, France
FAU - Jabot, Julien
AU  - Jabot J
AD  - Réanimation Polyvalente, CHU La Réunion, Saint-Denis, France
FAU - Fresco, Marion
AU  - Fresco M
AD  - Reanimation chirurgicale, Centre Hospitalier Universitaire Rouen, Rouen, France
FAU - Demeilliers-Pfister, Gaëlle
AU  - Demeilliers-Pfister G
AD  - Reanimation chirurgicale, Centre Hospitalier Universitaire Rouen, Rouen, France
FAU - Merle, Véronique
AU  - Merle V
AD  - Département d’épidémiologie et de santé publique, Centre Hospitalier
      Universitaire Rouen, Rouen, France
FAU - Brunel, Valéry
AU  - Brunel V
AD  - Institut de biologie clinique, Centre Hospitalier Universitaire Rouen, Rouen,
      France
FAU - Dureuil, Bertrand
AU  - Dureuil B
AD  - Anesthésie, Centre Hospitalier Universitaire Rouen, Rouen, France
FAU - Leydier, Sébastien
AU  - Leydier S
AD  - Réanimation Médicale, Hôpital Central, C.H.U. de Nancy, Nancy, France
FAU - Clerc-Urmes, Isabelle
AU  - Clerc-Urmes I
AD  - Epidémiologie et evaluation clinique, C.H.U. de Nancy, Nancy, France
FAU - Lemarie, Jérémie
AU  - Lemarie J
AD  - Réanimation Médicale, Hôpital Central, C.H.U. de Nancy, Nancy, France
FAU - Maigrat, Charles-Henri
AU  - Maigrat CH
AD  - Réanimation Médicale, Hôpital Central, C.H.U. de Nancy, Nancy, France
FAU - Cravoisy-Popovic, Aurélie
AU  - Cravoisy-Popovic A
AD  - Réanimation Médicale, Hôpital Central, C.H.U. de Nancy, Nancy, France
FAU - Barraud, Damien
AU  - Barraud D
AD  - Réanimation Médicale, Hôpital Central, C.H.U. de Nancy, Nancy, France
FAU - Nace, Lionel
AU  - Nace L
AD  - Réanimation Médicale, Hôpital Central, C.H.U. de Nancy, Nancy, France
FAU - Gibot, Sébastien
AU  - Gibot S
AD  - Réanimation Médicale, Hôpital Central, C.H.U. de Nancy, Nancy, France
FAU - Agrinier, Nelly
AU  - Agrinier N
AD  - Epidémiologie et evaluation clinique, C.H.U. de Nancy, Nancy, France
FAU - Bollaert, Pierre-Edouard
AU  - Bollaert PE
AD  - Réanimation Médicale, Hôpital Central, C.H.U. de Nancy, Nancy, France
FAU - Daban, Jean-Louis
AU  - Daban JL
AD  - Réanimation, Hôpital d’Instruction des Armées Percy, Clamart, France
FAU - Boutonnet, Mathieu
AU  - Boutonnet M
AD  - Réanimation, Hôpital d’Instruction des Armées Percy, Clamart, France
FAU - Dumas, Guillaume
AU  - Dumas G
AD  - Réanimation, Hôpital d’Instruction des Armées Percy, Clamart, France
FAU - Falzone, Elisabeth
AU  - Falzone E
AD  - Réanimation, Hôpital d’Instruction des Armées Percy, Clamart, France
FAU - Jault, Patrick
AU  - Jault P
AD  - Département d’Anesthésie-Réanimation, Hôpital d’Instruction des Armées Percy,
      Clamart, France
FAU - Lenoir, Bernard
AU  - Lenoir B
AD  - Département d’Anesthésie-Réanimation, Hôpital d’Instruction des Armées Percy,
      Clamart, France
FAU - Makunza, Joseph Nsiala
AU  - Makunza JN
AD  - Anesthésie-Réanimation, Hôpital Privé d’Athis-Mons - Site Caron, Athis-Mons,
      France
FAU - Mejeni, Nathalie
AU  - Mejeni N
AD  - Anesthésie-réanimation, Clinique universitaire de Kinshasa, Kinshasa, Democratic 
      Republic of the Congo
FAU - Mazaud, Amélie
AU  - Mazaud A
AD  - Service d’anesthésie réanimation, Hôpital Édouard Herriot, Lyon, France
FAU - Béague, Sébastien
AU  - Béague S
AD  - Réanimation polyvalente adulte, Hospital Center De Dunkerque, Dunkerque, France
FAU - Rousselle, Anne-Flore
AU  - Rousselle AF
AD  - Cellule de management de la qualité et de la gestion du risque, Hospital Center
      De Dunkerque, Dunkerque, France
FAU - Durocher, Alain
AU  - Durocher A
AD  - Réanimation médicale, Centre Hospitalier Régional Universitaire de Lille, Lille, 
      France
CN  - For the BIBLIOFLASH Study Group
FAU - Perez, Pauline
AU  - Perez P
AD  - Unité de réanimation neurologique, féderation de neurologie 1, pole des maladies 
      du systeme nerv, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Assistance
      Publique – Hôpitaux de Paris, Paris, France
FAU - Grinea, Alexandra
AU  - Grinea A
AD  - Unité de réanimation neurologique, féderation de neurologie 1, pole des maladies 
      du systeme nerv, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Assistance
      Publique – Hôpitaux de Paris, Paris, France
FAU - Bedoui, Naoures
AU  - Bedoui N
AD  - Teaching Department of Emergency and Intensive Care, Hospital Zaghouan, Zaghouan,
      Tunisia
FAU - Stoian, Alina
AU  - Stoian A
AD  - Réanimation médicale, Hôpital de la Croix-Rousse, Lyon, France
FAU - Baboi, Loredana
AU  - Baboi L
AD  - Réanimation médicale, Hôpital de la Croix-Rousse, Lyon, France
FAU - Gobert, Florent
AU  - Gobert F
AD  - Réanimation médicale, Hôpital de la Croix-Rousse, Lyon, France
FAU - Yonis, Hodane
AU  - Yonis H
AD  - Réanimation médicale, Hôpital de la Croix-Rousse, Lyon, France
FAU - Tapponier, Romain
AU  - Tapponier R
AD  - Réanimation médicale, Hôpital de la Croix-Rousse, Lyon, France
FAU - Bruyneel, Arnaud
AU  - Bruyneel A
AD  - Nursing School, Condorcet, Mons, Belgium
FAU - Bonus, Thierry
AU  - Bonus T
AD  - ICU, C.H. Epicura, Hornu, Belgium
FAU - Cuvelier, Grégory
AU  - Cuvelier G
AD  - Laboratoire de l’effort et du mouvement, Condorcet, Tournai, Belgium
FAU - Machayeckhi, Sharam
AU  - Machayeckhi S
AD  - ICU, C.H. Epicura, Hornu, Belgium
FAU - Olieuz, Sandra
AU  - Olieuz S
AD  - ICU, C.H. Epicura, Hornu, Belgium
FAU - Legrand, Alexandre
AU  - Legrand A
AD  - Physiologie et pharmacologie, Université de Mons - Campus Plaine de Nimy, Mons,
      Belgium
FAU - Feki, Fatma
AU  - Feki F
AD  - Respiratory ICU, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana,
      Tunisia
FAU - Jamoussi, Amira
AU  - Jamoussi A
AD  - Respiratory ICU, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana,
      Tunisia
FAU - Merhebene, Takoua
AU  - Merhebene T
AD  - Respiratory ICU, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana,
      Tunisia
FAU - Braham, Emna
AU  - Braham E
AD  - Pathology, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana, Tunisia
FAU - Ghariani, Asma
AU  - Ghariani A
AD  - Microbiology, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana, Tunisia
FAU - Mezni, Faouzi El
AU  - Mezni FE
AD  - Pathology, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana, Tunisia
FAU - Slim, Leila
AU  - Slim L
AD  - Microbiology, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana, Tunisia
FAU - Khelil, Jalila Ben
AU  - Khelil JB
AD  - Respiratory ICU, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana,
      Tunisia
FAU - Besbes, Mohamed
AU  - Besbes M
AD  - Respiratory ICU, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana,
      Tunisia
FAU - Marchalot, Antoine
AU  - Marchalot A
AD  - Seine-Maritime, CHU Charles Nicolle Rouen, Rouen, France
FAU - Beduneau, Gaetan
AU  - Beduneau G
AD  - Réanimation Médicale, Centre Hospitalier Universitaire Rouen, Rouen, France
FAU - Carpentier, Dorothée
AU  - Carpentier D
AD  - Réanimation Médicale, Centre Hospitalier Universitaire Rouen, Rouen, France
FAU - Besnier, Emmanuel
AU  - Besnier E
AD  - Réanimation Médicale, Centre Hospitalier Universitaire Rouen, Rouen, France
FAU - Gastaldi, Gioia
AU  - Gastaldi G
AD  - Réanimation Médicale, Centre Hospitalier Universitaire Rouen, Rouen, France
FAU - Abily, Julien
AU  - Abily J
AD  - Réanimation Médicale, Centre Hospitalier Universitaire Rouen, Rouen, France
FAU - Beuzelin, Marion
AU  - Beuzelin M
AD  - Réanimation Médicale, Centre Hospitalier Universitaire Rouen, Rouen, France
FAU - Nay, Mai-Anh
AU  - Nay MA
AD  - Réanimation médicale polyvalente, Hôpital de La Source, CHR Orléans, Orléans,
      France
FAU - Mankikian, Julie
AU  - Mankikian J
AD  - Réanimation polyvalente, CHRU Hôpitaux de Tours, Tours, France
FAU - Hervé, Virginie
AU  - Hervé V
AD  - Inserm u1100, centre d’étude des pathologies respiratoires, Université François
      Rabelais, Tours, France
FAU - Soulie, Marie
AU  - Soulie M
AD  - ICU, C.H. Sud Francilien, Corbeil-Essonnes, France
FAU - Cronier, Pierrick
AU  - Cronier P
AD  - ICU, C.H. Sud Francilien, Corbeil-Essonnes, France
FAU - Kantor, Elie
AU  - Kantor E
AD  - ICU, C.H. Sud Francilien, Corbeil-Essonnes, France
FAU - Federici, Laura
AU  - Federici L
AD  - ICU, C.H. Sud Francilien, Corbeil-Essonnes, France
FAU - Gilbert, Marion
AU  - Gilbert M
AD  - ICU, C.H. Sud Francilien, Corbeil-Essonnes, France
FAU - Mezhari, Ilham
AU  - Mezhari I
AD  - ICU, C.H. Sud Francilien, Corbeil-Essonnes, France
FAU - Choukroun, Gérald
AU  - Choukroun G
AD  - ICU, C.H. Sud Francilien, Corbeil-Essonnes, France
FAU - Marque, Sophie
AU  - Marque S
AD  - ICU, C.H. Sud Francilien, Corbeil-Essonnes, France
FAU - Coppere, Z.
AU  - Coppere Z
AD  - Réanimation médico-chirurgicale, Hôpital Tenon, Paris, France
FAU - Fulgencio, Jean-Pierre
AU  - Fulgencio JP
AD  - Réanimation médico-chirurgicale, Hôpital Tenon, Paris, France
FAU - Blayau, Clarisse
AU  - Blayau C
AD  - Réanimation médico-chirurgicale, Hôpital Tenon, Paris, France
FAU - Pham, Tai
AU  - Pham T
AD  - Réanimation médico-chirurgicale, Hôpital Tenon, Paris, France
FAU - Djibre, Michel
AU  - Djibre M
AD  - Réanimation médico-chirurgicale, Hôpital Tenon, Paris, France
FAU - Reffienna, Matthieu
AU  - Reffienna M
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Lefort, Sébastien
AU  - Lefort S
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Debue, Anne-Sophie
AU  - Debue AS
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Daviaud, Fabrice
AU  - Daviaud F
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Cabon, Sarah
AU  - Cabon S
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
CN  - Working Group on Mechanical Ventilation
FAU - Addou, Zakaria
AU  - Addou Z
AD  - Réanimation Pédiatrique de Canastel d’oran, Departement de medecine d’Oran
      Algerie, Oran, Algeria
FAU - Douah, Ali
AU  - Douah A
AD  - Anesthésie Réanimation Pédiatrique, Etablissement Hospitalier Spécialisé en
      Pédiatrie Canastel, Oran, Algeria
FAU - Moussati, Mohamed
AU  - Moussati M
AD  - Anesthésie Réanimation Pédiatrique, Etablissement Hospitalier Spécialisé en
      Pédiatrie Canastel, Oran, Algeria
FAU - Belhabiche, Kamel
AU  - Belhabiche K
AD  - Anesthésie Réanimation Pédiatrique, Etablissement Hospitalier Spécialisé en
      Pédiatrie Canastel, Oran, Algeria
FAU - Aouffen, Nabil
AU  - Aouffen N
AD  - Anesthésie Réanimation Pédiatrique, Etablissement Hospitalier Spécialisé en
      Pédiatrie Canastel, Oran, Algeria
FAU - Soulier, Sylvie
AU  - Soulier S
AD  - Sar 2, Hôpital Haut-Lévèque, Pessac, France
FAU - Mauriat, Philippe
AU  - Mauriat P
AD  - Sar 2, unité cardiopathies congénitales, Hôpital Haut-Lévèque, Pessac, France
FAU - Tafer, Nadir
AU  - Tafer N
AD  - Sar 2, unité cardiopathies congénitales, Hôpital Haut-Lévèque, Pessac, France
FAU - Mortamet, Guillaume
AU  - Mortamet G
AD  - Réanimation médico-chirurgicale pédiatrique, Hôpital Necker, Rue de Sèvres,
      Paris, France
FAU - Amaddeo, Alessandro
AU  - Amaddeo A
AD  - Pediatric Non Invasive Ventilation and Sleep Unit, Hôpital Necker, Rue de Sèvres,
      Paris, France
FAU - Khirani, Sonia
AU  - Khirani S
AD  - Pediatric Non Invasive Ventilation and Sleep Unit, Hôpital Necker, Rue de Sèvres,
      Paris, France
FAU - Fauroux, Brigitte
AU  - Fauroux B
AD  - Pediatric Non Invasive Ventilation and Sleep Unit, Hôpital Necker, Rue de Sèvres,
      Paris, France
FAU - Khanes, Gennadiy
AU  - Khanes G
AD  - Neonatal Surgery, National Ukrainian Pediatric Hospital OkhMatDyt, Kyiv, Ukraine
FAU - Liutko, Olga
AU  - Liutko O
AD  - Microbiology and Chemotherapy, Research Inctitute of Orthopedics of Medical
      Sciences of Ukraine, Kyiv, Ukraine
FAU - Bidnenko, Svitlana
AU  - Bidnenko S
AD  - Microbiology and Chemotherapy, Research Inctitute of Orthopedics of Medical
      Sciences of Ukraine, Kyiv, Ukraine
FAU - Doye, Emilie
AU  - Doye E
AD  - 69, Hôpital Femme Mère Enfant, Bron, France
FAU - Voirin, Nicolas
AU  - Voirin N
AD  - Cnrs umr 5558, Hospices Civils de Lyon, Lyon, France
FAU - Maucort-Boulch, Delphine
AU  - Maucort-Boulch D
AD  - Cnrs umr 5558, Hospices Civils de Lyon, Lyon, France
FAU - Kolev-Descamp, Karine
AU  - Kolev-Descamp K
AD  - Réanimation pédiatrique, Hôpital Femme Mère Enfant, Bron, France
FAU - Aouane, Imane El
AU  - Aouane IE
AD  - 92380, Hopital Raymond Poincare - Medecine Phys, Garches, France
FAU - Essid, Aben
AU  - Essid A
AD  - 92380, Hopital Raymond Poincare - Medecine Phys, Garches, France
FAU - Hammami, Wallid
AU  - Hammami W
AD  - 92380, Hopital Raymond Poincare - Medecine Phys, Boulevard Raymond Poincaré,
      Garches, France
FAU - Haegy, Isabelle
AU  - Haegy I
AD  - 92380, Hopital Raymond Poincare - Medecine Phys, Garches, France
FAU - Bataille, Jacques
AU  - Bataille J
AD  - 92380, Hopital Raymond Poincare - Medecine Phys, Boulevard Raymond Poincaré,
      Garches, France
FAU - Bergounioux, Jean
AU  - Bergounioux J
AD  - Unité de réanimation pédiatrique, Hopital Raymond Poincare - Medecine Phys,
      Garches, France
FAU - Morin, Luc
AU  - Morin L
AD  - Réanimation et surveillance continue pédiatriques, CHU Kremlin Bicêtre, Le
      Kremlin Bicêtre, France
FAU - Ray, Samiran
AU  - Ray S
AD  - Pediatric intensive care unit, Great Ormond Street Hospital, London, United
      Kingdom
FAU - Maclaren, Graeme
AU  - Maclaren G
AD  - Pediatric Intensive Care Unit, The Royal Children’s Hospital, Parkville,
      Australia
FAU - Nadel, Simon
AU  - Nadel S
AD  - Pediatric Intensive Care Unit, Saint Mary’s Hospital, London, United Kingdom
FAU - Kneyber, Martin
AU  - Kneyber M
AD  - Pediatric Intensive Care Unit, Beatrix Children’s Hospital, Groningen,
      Netherlands
FAU - Peters, Mark
AU  - Peters M
AD  - Pediatric intensive care unit, Great Ormond Street Hospital, London, United
      Kingdom
FAU - Jansen, Koos
AU  - Jansen K
AD  - Pediatric Intensive Care Unit, Wihelmina Children’s Hospital, Utrecht,
      Netherlands
FAU - De Luca, Daniele
AU  - De Luca D
AD  - Neonatal Intensive Care Unit, Hospital Antoine Béclère, Clamart, France
FAU - Wilson, Clare
AU  - Wilson C
AD  - Pediatric Intensive Care Unit, Saint Mary’s Hospital, London, United Kingdom
FAU - Schlapbach, Luregn
AU  - Schlapbach L
AD  - Pediatric Intensive Care Unit, Royal Children Hospital, Brisbane, Australia
FAU - Tissières, Pierre
AU  - Tissières P
AD  - Réanimation et surveillance continue pédiatriques, CHU Kremlin Bicêtre, Le
      Kremlin Bicêtre, France
FAU - Girard, Anne-Claire
AU  - Girard AC
AD  - Côte d’or, C.H. Chalon sur Saône William Morey, Chalon-sur-Saône, France
FAU - Savajols, Elodie
AU  - Savajols E
AD  - Pédiatrie 2, Chu Dijon, Dijon, France
FAU - Burguet, Antoine
AU  - Burguet A
AD  - Pédiatrie 2, Chu Dijon, Dijon, France
FAU - Semama, Denis
AU  - Semama D
AD  - Pédiatrie 2, Chu Dijon, Dijon, France
FAU - Litzler-Renault, Stephanie
AU  - Litzler-Renault S
AD  - Réanimation pédiatrique polyvalente, Chu Dijon, Dijon, France
FAU - Fredj, Hana
AU  - Fredj H
AD  - Emergency and Intensive Care Department, Hopital Habib Thameur, Tunis, Tunisia
FAU - Hassouna, Malek
AU  - Hassouna M
AD  - Emergency and Intensive Care Department, Hopital Habib Thameur, Tunis, Tunisia
FAU - Hechmi, Youssef Zied El
AU  - Hechmi YZE
AD  - Emergency and Intensive Care Department, Hopital Habib Thameur, Tunis, Tunisia
FAU - Cherif, Mohamed Ali
AU  - Cherif MA
AD  - Emergency and Intensive Care Department, Hopital Habib Thameur, Tunis, Tunisia
FAU - Zouheir, Jerbi
AU  - Zouheir J
AD  - Emergency and Intensive Care Department, Hopital Habib Thameur, Tunis, Tunisia
FAU - Dernane, Ahmed
AU  - Dernane A
AD  - UMC, Hospital Center and University D’oran, Oran, Algeria
FAU - Bouakkaz, Fouad
AU  - Bouakkaz F
AD  - Urgences Medicales Chuoran, Faculté de médecine d’Oran, Oran, Algeria
FAU - Taleb, Lhoucine Ben
AU  - Taleb LB
AD  - Laboratoire rayonnement-matière et instrumentation, Université hassan 1er,
      Faculté des Sciences et Techniques, Settat, Morocco
FAU - Zeddine Mouhsen, A.
AU  - Zeddine Mouhsen A
AD  - Laboratoire rayonnement-matière et instrumentation, Université hassan 1er,
      Faculté des Sciences et Techniques, Settat, Morocco
FAU - Lyazidi, Aissam
AU  - Lyazidi A
AD  - Institut supérieur des sciences de la santé-laboratoire rayonnement-matière et
      instrumentation, Université hassan 1er, Settat, Morocco
FAU - Richard, Jean-Christophe Marie
AU  - Richard JCM
AD  - Emergency and Intensive Care Department, General Hospital of Annecy, Annecy,
      France
FAU - Mouhsen, Ahmed
AU  - Mouhsen A
AD  - Laboratoire d’ingénierie, management industriel et innovation, Faculté des
      Sciences et Techniques, Settat, Morocco
FAU - Harmouchi, Mohammed
AU  - Harmouchi M
AD  - Laboratoire rayonnement-matière et instrumentation, Université hassan 1er,
      Faculté des Sciences et Techniques, Settat, Morocco
FAU - Rattal, Mourad
AU  - Rattal M
AD  - Institut supérieur des sciences de la santé-laboratoire rayonnement-matière et
      instrumentation, Université hassan 1er, Settat, Morocco
FAU - Huck, Matthias
AU  - Huck M
AD  - Centre de traitement des brûlés, Hôpital d’Instruction des Armées Percy, Clamart,
      France
FAU - Leclerc, Thomas
AU  - Leclerc T
AD  - Centre de traitement des brûlés, Hôpital d’Instruction des Armées Percy, Clamart,
      France
FAU - Donat, Nicolas
AU  - Donat N
AD  - Centre de traitement des brûlés, Hôpital d’Instruction des Armées Percy, Clamart,
      France
FAU - Cirodde, Audrey
AU  - Cirodde A
AD  - Centre de traitement des brûlés, Hôpital d’Instruction des Armées Percy, Clamart,
      France
FAU - Schaal, Jean-Vivien
AU  - Schaal JV
AD  - Centre de traitement des brûlés, Hôpital d’Instruction des Armées Percy, Clamart,
      France
FAU - Masson, Yannick
AU  - Masson Y
AD  - Centre de traitement des brûlés, Hôpital d’Instruction des Armées Percy, Clamart,
      France
FAU - Hoffmann, Clément
AU  - Hoffmann C
AD  - Centre de traitement des brûlés, Hôpital d’Instruction des Armées Percy, Clamart,
      France
FAU - Cerland, Laura
AU  - Cerland L
AD  - Service de réanimation médico-chirurgicale, CHU de Fort de France,
      Fort-de-France, France
FAU - Valentino, Ruddy
AU  - Valentino R
AD  - Service de réanimation médico-chirurgicale, CHU de Fort de France,
      Fort-de-France, France
FAU - Chabartier, C.
AU  - Chabartier C
AD  - Service de réanimation médico-chirurgicale, CHU de Fort de France,
      Fort-de-France, France
FAU - Villain-Coquet, Laurent
AU  - Villain-Coquet L
AD  - Samu 972, CHU de Fort de France, Fort-de-France, France
FAU - Ferge, Jean-Louis
AU  - Ferge JL
AD  - Service de réanimation médico-chirurgicale, CHU de Fort de France,
      Fort-de-France, France
FAU - Brouste, Y.
AU  - Brouste Y
AD  - Samu 972, CHU de Fort de France, Fort-de-France, France
FAU - Mehdaoui, Hossein
AU  - Mehdaoui H
AD  - Service de réanimation médico-chirurgicale, CHU de Fort de France,
      Fort-de-France, France
FAU - Louriz, Maha
AU  - Louriz M
AD  - Medical Emergency Department, Ibn Sina University Hospital, Rabat, Morocco
FAU - Madani, Naoufal
AU  - Madani N
AD  - Medical Emergency Department, Ibn Sina University Hospital, Rabat, Morocco
FAU - Amlaiky, Fatiha
AU  - Amlaiky F
AD  - Medical Emergency Department, Ibn Sina University Hospital, Rabat, Morocco
FAU - Dendane, Tarek
AU  - Dendane T
AD  - Service de réanimation médicale et de toxicologie clinique- chu ibn
      sina-universite mohamed v, Hopital Ibn Sina, Rabat, Morocco
FAU - Abidi, Khalid
AU  - Abidi K
AD  - Service de réanimation médicale et de toxicologie clinique- chu ibn
      sina-universite mohamed v, Hopital Ibn Sina, Rabat, Morocco
FAU - Zekraoui, Aicha
AU  - Zekraoui A
AD  - Medical Emergency Department, Ibn Sina University Hospital, Rabat, Morocco
FAU - Zeggwagh, Amine Ali
AU  - Zeggwagh AA
AD  - Service de réanimation médicale et de toxicologie clinique- chu ibn
      sina-universite mohamed v, Hopital Ibn Sina, Rabat, Morocco
FAU - Abouqal, Redouane
AU  - Abouqal R
AD  - Medical Emergency Department, Ibn Sina University Hospital, Rabat, Morocco
FAU - Brahim, Affra
AU  - Brahim A
AD  - Anesthesia and Intensive Care, Chu Farhat Hached, Sousse, Tunisia
FAU - Ferhi, Fehmi
AU  - Ferhi F
AD  - Anesthesia and Intensive Care, Chu Farhat Hached, Sousse, Tunisia
FAU - Bouslama, Mohamed Amine
AU  - Bouslama MA
AD  - Anesthesia and Intensive Care, Chu Farhat Hached, Sousse, Tunisia
FAU - Benjazia, Khaled
AU  - Benjazia K
AD  - Anesthesia and Intensive Care, Chu Farhat Hached, Sousse, Tunisia
FAU - Zeineb, Abid
AU  - Zeineb A
AD  - Emergency, General Hospital, Tunis, Tunisia
FAU - Mahassen, Dhaouadi
AU  - Mahassen D
AD  - Tunisia, General Hospital, Tunis, Tunisia
FAU - Cadiet, Julien
AU  - Cadiet J
AD  - Department of Anesthesiology and Intensive Care Unit, Centre hospitalier
      universitaire de Nantes, Nantes, France
FAU - Ferron, Marine
AU  - Ferron M
AD  - L’institut du thorax, INSERM UMR 1087, Nantes, France
FAU - Prat, Valentine
AU  - Prat V
AD  - L’institut du thorax, INSERM UMR 1087, Nantes, France
FAU - Erraud, Angelique
AU  - Erraud A
AD  - L’institut du thorax, INSERM UMR 1087, Nantes, France
FAU - Aillerie, Virginie
AU  - Aillerie V
AD  - L’institut du thorax, INSERM UMR 1087, Nantes, France
FAU - Mevel, Mathieu
AU  - Mevel M
AD  - Atlantic Gene Therapies, INSERM UMR 1089, Nantes, France
FAU - Grabherr, Amandine
AU  - Grabherr A
AD  - L’institut du thorax, INSERM UMR 1087, Nantes, France
FAU - Chatham, John C.
AU  - Chatham JC
AD  - Division of Molecular and Cellular Pathology, University of Alabama at
      Birmingham, Birmingham, United States of America
FAU - Gauthier, Chantal
AU  - Gauthier C
AD  - L’institut du thorax, INSERM UMR 1087, Nantes, France
FAU - Lauzier, Benjamin
AU  - Lauzier B
AD  - L’institut du thorax, INSERM UMR 1087, Nantes, France
FAU - Rozec, Bertrand
AU  - Rozec B
AD  - Réanimation CTCV Transplantation thoracique, CHU de Nantes - Hôpital Nord
      Laennec, Saint-Herblain, France
FAU - Joffre, Jeremie
AU  - Joffre J
AD  - Service de reanimation, Hôpital Saint-Antoine, Paris, France
FAU - Loyer, Xavier
AU  - Loyer X
AD  - U970, Inserm, Paris, France
FAU - Lavillegrand, Jean-Rémi
AU  - Lavillegrand JR
AD  - Service de reanimation, Hôpital Saint-Antoine, Paris, France
FAU - Zeboudj, Lynda
AU  - Zeboudj L
AD  - U970, Inserm, Paris, France
FAU - Laurans, Ludivine
AU  - Laurans L
AD  - U970, Inserm, Paris, France
FAU - Esposito, Bruno
AU  - Esposito B
AD  - U970, Inserm, Paris, France
FAU - Tedgui, Alain
AU  - Tedgui A
AD  - U970, Inserm, Paris, France
FAU - Mallat, Ziad
AU  - Mallat Z
AD  - U970, Inserm, Paris, France
FAU - Wei, Chaojie
AU  - Wei C
AD  - Inserm u1116, Université de Lorraine, Vandœuvre-lès-Nancy, France
FAU - Kattani, Narimane Al
AU  - Kattani NA
AD  - Inserm u1116, Université de Lorraine, Vandœuvre-lès-Nancy, France
FAU - Louis, Huguette
AU  - Louis H
AD  - Dcac, Inserm, Vandœuvre-lès-Nancy, France
FAU - Orlowski, Sophie
AU  - Orlowski S
AD  - Service de biochimie, Centre Hospitalier Universitaire de Nancy,
      Vandœuvre-lès-Nancy, France
FAU - Tharaux, Pierre-Louis
AU  - Tharaux PL
AD  - U970, Inserm, Paris, France
FAU - Burban, Mélanie
AU  - Burban M
AD  - Umr7213, Strasbourg University, Strasbourg, France
FAU - Meyer, Grégory
AU  - Meyer G
AD  - Ea 4278, Université d’Avignon, Avignon, France
FAU - Olland, Anne
AU  - Olland A
AD  - Chirurgie thoracique, Nouvel Hôpital Civil, CHU Strasbourg, Strasbourg, France
FAU - Yver, Blandine
AU  - Yver B
AD  - Ea7293, Strasbourg University, Strasbourg, France
FAU - Toti, Florence
AU  - Toti F
AD  - Umr7213, Strasbourg University, Strasbourg, France
FAU - Schini-Kerth, Valérie
AU  - Schini-Kerth V
AD  - Umr7213, Strasbourg University, Strasbourg, France
FAU - Monnier, Alexandra
AU  - Monnier A
AD  - Réanimation médicale, Nouvel Hôpital Civil, CHU Strasbourg, Strasbourg, France
FAU - Leborgne, Pierrick
AU  - Leborgne P
AD  - Service d’accueil des urgences, Nouvel Hôpital Civil, CHU Strasbourg, Strasbourg,
      France
FAU - Meziani, Ferhat
AU  - Meziani F
AD  - Réanimation médicale, Nouvel Hôpital Civil, CHU Strasbourg, Strasbourg, France
FAU - Clavier, Thomas
AU  - Clavier T
AD  - Pôle Réanimations Anesthésie SAMU, Hospital Center University Rouen, Rouen,
      France
FAU - Paulus, Mulder
AU  - Paulus M
AD  - U1096, Inserm, Rouen, France
FAU - Castel, Hélène
AU  - Castel H
AD  - U982, Inserm, Mont-Saint-Aignan, France
FAU - Richard, Vincent
AU  - Richard V
AD  - U1096, Inserm, Rouen, France
FAU - Pons, Stéphanie
AU  - Pons S
AD  - Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, United
      States of America
FAU - Skurnik, David
AU  - Skurnik D
AD  - Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, United
      States of America
FAU - Six, Sophie
AU  - Six S
AD  - Centre de réanimation, Centre Hospitalier Régional Universitaire de Lille (CHRU),
      Lille, France
FAU - Jaffal, Karim
AU  - Jaffal K
AD  - Centre de réanimation, Centre Hospitalier Régional Universitaire de Lille (CHRU),
      Lille, France
FAU - Vigneron, Clara
AU  - Vigneron C
AD  - Réanimation médicale, CHU Dijon, Dijon, France
FAU - Large, Audrey
AU  - Large A
AD  - Réanimation médicale, CHU Dijon, Dijon, France
FAU - Bador, Julien
AU  - Bador J
AD  - 21000, Chu Dijon, Dijon, France
FAU - Aho, Serge
AU  - Aho S
AD  - Service d’epidemiologie et d’hygiène hospitalière, Chu Dijon, Dijon, France
FAU - Prin, Sebastien
AU  - Prin S
AD  - Réanimation médicale, CHU Dijon, Dijon, France
FAU - Touil, Yosr
AU  - Touil Y
AD  - Réanimation médicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia
FAU - Ayed, Soufia
AU  - Ayed S
AD  - Réanimation médicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia
FAU - Ali, Habiba Sik
AU  - Ali HS
AD  - Réanimation médicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia
FAU - Tilouch, Najla
AU  - Tilouch N
AD  - Réanimation médicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia
FAU - Mateur, Houda
AU  - Mateur H
AD  - Réanimation médicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia
FAU - Talik, I.
AU  - Talik I
AD  - Réanimation médicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia
FAU - Gharbi, Rim
AU  - Gharbi R
AD  - Réanimation médicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia
FAU - Hassen, Mohamed Fekih
AU  - Hassen MF
AD  - Réanimation médicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia
FAU - Elatrous, Souheil
AU  - Elatrous S
AD  - Réanimation médicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia
FAU - Patry, Isabelle
AU  - Patry I
AD  - Bactériologie, CHRU de Besançon, Besançon, France
FAU - Bertrand, Xavier
AU  - Bertrand X
AD  - Hygiène hospitalière, Centre Hospitalier Régional Universitaire de Besançon,
      Besançon, France
FAU - Zahar, Jean-Ralph
AU  - Zahar JR
AD  - Unité de prévention et de lutte contre les infections nosocomiales, C.H.U.
      d’Angers, Rue Larrey, Angers, France
FAU - Essaied, Wafa
AU  - Essaied W
AD  - Umr 1137 iame, Université Paris Diderot, Paris, France
FAU - Wolkewitz, Martin
AU  - Wolkewitz M
AD  - Biostatistics, Biostatistical Institute, Freiburg, Germany
FAU - Soued, Mickaël
AU  - Soued M
AD  - Anesthesia and Intensive Care Medicine, Hospital Henri Mondor, Créteil, France
FAU - Cook, Fabrice
AU  - Cook F
AD  - Anesthesia and Intensive Care Medicine, Hospital Henri Mondor, Créteil, France
FAU - Lobo, David
AU  - Lobo D
AD  - Anesthesia and Intensive Care Medicine, Hospital Henri Mondor, Créteil, France
FAU - Mounier, Roman
AU  - Mounier R
AD  - Anesthesia and Intensive Care Medicine, Hospital Henri Mondor, Créteil, France
FAU - Emirian, Aurélie
AU  - Emirian A
AD  - Microbiology, Hospital Henri Mondor, Créteil, France
FAU - Decousser, Jean Winoc
AU  - Decousser JW
AD  - Microbiology, Hospital Henri Mondor, Créteil, France
FAU - Slaoui, Mohamed Toufik
AU  - Slaoui MT
AD  - Anesthesiology and Intensive Care Department, University Teaching Hospital Ibn
      Rushd-Casablanca, Casablanca, Morocco
FAU - Benslama, Abdellatif
AU  - Benslama A
AD  - Anesthesiology and Intensive Care Department, University Teaching Hospital Ibn
      Rushd-Casablanca, Casablanca, Morocco
FAU - Valance, Dorothée
AU  - Valance D
AD  - Réanimation Polyvalente, CHU La Réunion, Saint-Denis, France
FAU - Allou, Nicolas
AU  - Allou N
AD  - Réanimation Polyvalente, CHU La Réunion, Saint-Denis, France
FAU - Allyn, Jérôme
AU  - Allyn J
AD  - Réanimation Polyvalente, CHU La Réunion, Saint-Denis, France
FAU - Jean-Bart, Elodie
AU  - Jean-Bart E
AD  - Pharmacy, Hospital Center Fleyriat, Bourg-en-Bresse, France
FAU - Bel., Floriane
AU  - Bel. F
AD  - Pharmacy, Hospital Center Fleyriat, Bourg-en-Bresse, France
FAU - Morey, Fabienne
AU  - Morey F
AD  - Pharmacy, Hospital Center Fleyriat, Bourg-en-Bresse, France
FAU - Sedillot, Nicholas
AU  - Sedillot N
AD  - Intensive care unit, Hospital Center Fleyriat, Bourg-en-Bresse, France
FAU - Biard, Lucie
AU  - Biard L
AD  - Service de biostatistique et information médicale, Hôpital Saint-Louis, Paris,
      France
FAU - Galliot, Richard
AU  - Galliot R
AD  - Réanimation Polyvalente, CHU La Réunion, Saint-Denis, France
FAU - Zunarelli, Romain
AU  - Zunarelli R
AD  - Réanimation Polyvalente, CHU La Réunion, Saint-Denis, France
FAU - Gauzere, Bernard-Alex
AU  - Gauzere BA
AD  - Réanimation Polyvalente, CHU La Réunion, Saint-Denis, France
FAU - Cartier, Jean-Charles
AU  - Cartier JC
AD  - Réanimation médicale, C.H.U de Grenoble, La Tronche, France
FAU - Jouve, Thomas
AU  - Jouve T
AD  - Néphrologie, hémodialyse, transplantation rénale, C.H.U de Grenoble, La Tronche, 
      France
FAU - Hilleret, Marie-Noëlle
AU  - Hilleret MN
AD  - Hépato-gastro-entérologie, C.H.U de Grenoble, La Tronche, France
FAU - Hamidfar-Roy, Rebecca
AU  - Hamidfar-Roy R
AD  - Réanimation médicale, C.H.U., La Tronche, France
FAU - Ara-Somohano, Claire
AU  - Ara-Somohano C
AD  - Réanimation médicale, C.H.U de Grenoble, La Tronche, France
FAU - Minet, Clémence
AU  - Minet C
AD  - Réanimation médicale, C.H.U. Grenoble, Grenoble, France
FAU - Pourcelet, Aline
AU  - Pourcelet A
AD  - Nephrology, Hospital Erasme, Brussels, Belgium
FAU - Hougardy, Jean-Michel
AU  - Hougardy JM
AD  - Nephrology, Hospital Erasme, Brussels, Belgium
FAU - Defrance, Pierre
AU  - Defrance P
AD  - Intensive care, Hospital Civil Charleroi, Charleroi, Belgium
FAU - De Laforcade, Louis
AU  - De Laforcade L
AD  - C.H. Lyon Sud, Pierre-Bénite, France
FAU - Boyer, Alexandre
AU  - Boyer A
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux,
      France
FAU - Gruson, Didier
AU  - Gruson D
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux,
      France
FAU - Clouzeau, Benjamin
AU  - Clouzeau B
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux,
      France
FAU - Hajjam, Najah
AU  - Hajjam N
AD  - Emergency and Intensive Care Department, Hopital Habib Thameur, Tunis, Tunisia
FAU - Nasri, Houda
AU  - Nasri H
AD  - Emergency and Intensive Care Department, Hopital Habib Thameur, Tunis, Tunisia
FAU - Doghri, Hamdi
AU  - Doghri H
AD  - Emergency and Intensive Care Department, Hopital Habib Thameur, Tunis, Tunisia
FAU - Mongardon, Nicolas
AU  - Mongardon N
AD  - Anesthesia and Intensive Care Medicine, CHU Henri Mondor, Créteil, France
FAU - Levesque, Eric
AU  - Levesque E
AD  - Anesthesia and Intensive Care Medicine, CHU Henri Mondor, Créteil, France
FAU - Bastide, Marie-Anaïs
AU  - Bastide MA
AD  - Réanimation médicale, Centre Hospitalier Universitaire, Amiens, France
FAU - Richecoeur, Jack
AU  - Richecoeur J
AD  - Réanimation polyvalente, C.H. de Beauvais, Beauvais, France
FAU - Frenoy, Eric
AU  - Frenoy E
AD  - Réanimation polyvalente, Hospital Center General Du Havre, Le Havre, France
FAU - Lemaire, Christian
AU  - Lemaire C
AD  - Réanimation polyvalente, Hospital Center De Roubaix, Roubaix, France
CN  - BoReal study group
FAU - Schortgen, Frédérique
AU  - Schortgen F
AD  - Réanimation Médicale, Hôpital Henri Mondor, Créteil, France
FAU - Preau, Sebastien
AU  - Preau S
AD  - Réanimation médicale, Centre Hospitalier Régional Universitaire de Lille, Lille, 
      France
FAU - Ehooman, Franck
AU  - Ehooman F
AD  - Réanimation médico-chirurgicale, Hôpital Avicenne, Bobigny, France
FAU - Montlahuc, Claire
AU  - Montlahuc C
AD  - Service de biostatistique et information médicale, Hôpital Saint Louis, Paris,
      France
FAU - Bardon, Jean
AU  - Bardon J
AD  - Réanimation chirurgicale, Hôpital Henri Mondor, Créteil, France
FAU - Postel-Vinay, Nicolas
AU  - Postel-Vinay N
AD  - Unité d’hypertension artérielle, Hôpital Européen Georges Pompidou, Paris, France
FAU - Lafi, Mehdi
AU  - Lafi M
AD  - Réanimation polyvalente, Hôpital Antoine Béclère, Clamart, France
FAU - Jacobs, Frédéric
AU  - Jacobs F
AD  - Réanimation polyvalente, Hôpital Antoine Béclère, Clamart, France
FAU - Prat, Dominique
AU  - Prat D
AD  - Réanimation polyvalente, Hôpital Antoine Béclère, Clamart, France
FAU - Le Meur, Matthieu
AU  - Le Meur M
AD  - Réanimation polyvalente, Hôpital Antoine Béclère, Clamart, France
FAU - Moneger, Guy
AU  - Moneger G
AD  - Réanimation polyvalente, Hôpital Antoine Béclère, Clamart, France
FAU - Demars, Nadège
AU  - Demars N
AD  - Réanimation polyvalente, Hôpital Antoine Béclère, Clamart, France
FAU - Trouiller, Pierre
AU  - Trouiller P
AD  - Réanimation polyvalente, Hôpital Antoine Béclère, Clamart, France
FAU - Tencé, Noémie
AU  - Tencé N
AD  - Réanimation polyvalente, Hôpital Antoine Béclère, Clamart, France
FAU - Zaien, Inès
AU  - Zaien I
AD  - Réanimation polyvalente, Hôpital Antoine Béclère, Clamart, France
FAU - Wolf, Martine
AU  - Wolf M
AD  - Service d’hématologie biologique, Hôpital Antoine Béclère, Clamart, France
FAU - Allardet-Servent, Jérôme
AU  - Allardet-Servent J
AD  - Réanimation, Hôpital Européen Marseille, Marseille, France
FAU - Lebsir, Melissa
AU  - Lebsir M
AD  - Laboratoire européen, Laboratoire d’analyses de Biologie Médicale Alphabio,
      Marseille, France
FAU - Dubroca, Christian
AU  - Dubroca C
AD  - Laboratoire européen, Laboratoire d’analyses de Biologie Médicale Alphabio,
      Marseille, France
FAU - Portugal, Mireille
AU  - Portugal M
AD  - Laboratoire européen, Laboratoire d’analyses de Biologie Médicale Alphabio,
      Marseille, France
FAU - Castanier, Matthias
AU  - Castanier M
AD  - Réanimation, Hôpital Européen Marseille, Marseille, France
FAU - Signouret, Thomas
AU  - Signouret T
AD  - Réanimation, Hôpital Européen Marseille, Marseille, France
FAU - Soundaravelou, Rettinavelou
AU  - Soundaravelou R
AD  - Réanimation, Hôpital Européen Marseille, Marseille, France
FAU - Lepidi, Anne
AU  - Lepidi A
AD  - Réanimation, Hôpital Européen Marseille, Marseille, France
FAU - Halfon, Philippe
AU  - Halfon P
AD  - Laboratoire européen, Laboratoire d’analyses de Biologie Médicale Alphabio,
      Marseille, France
FAU - Seghboyan, Jean-Marie
AU  - Seghboyan JM
AD  - Réanimation, Hôpital Européen Marseille, Marseille, France
FAU - Gamblin, Camille
AU  - Gamblin C
AD  - Inserm u1144, Université Paris Descartes, Paris, France
FAU - Benturquia, Nadia
AU  - Benturquia N
AD  - Inserm u1144, Université Paris Descartes, Paris, France
FAU - Roussel, Olivier
AU  - Roussel O
AD  - Inserm u1144, Université Paris Descartes, Paris, France
FAU - Chevillard, Lucie
AU  - Chevillard L
AD  - Inserm u1144, Université Paris Descartes, Paris, France
FAU - Risede, Patricia
AU  - Risede P
AD  - Inserm u1144, Université Paris Descartes, Paris, France
FAU - Callebert, Jacques
AU  - Callebert J
AD  - Inserm u1144, Université Paris Descartes, Paris, France
FAU - Khelfa, Messaouda
AU  - Khelfa M
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Blel, Youssef
AU  - Blel Y
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Thabet, H.
AU  - Thabet H
AD  - Department of Emergency, Centre d’Assistance Médicale Urgente, Tunis, Tunisia
FAU - Brahmi, Nozha
AU  - Brahmi N
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Amamou, M.
AU  - Amamou M
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Le Louët, A. Lillo-
AU  - Le Louët
AD  - Centre Régional de Pharmacovigilance (CRPV), Hôpital Européen Georges Pompidou,
      Paris, France
FAU - Baud, F.
AU  - Baud F
AD  - SAMU de Paris, Hôpital Necker EM, Paris, France
FAU - Le Beller, C.
AU  - Le Beller C
AD  - Centre Régional de Pharmacovigilance (CRPV), Hôpital Européen Georges Pompidou,
      Paris, France
FAU - Vivien, B.
AU  - Vivien B
AD  - SAMU de Paris, Hôpital Necker EM, Paris, France
FAU - Soufir, L.
AU  - Soufir L
AD  - Réanimation, Groupe hospitalier Saint-Joseph, Paris, France
FAU - Carli, P.
AU  - Carli P
AD  - SAMU de Paris, Hôpital Necker EM, Paris, France
FAU - Le Louët, H.
AU  - Le Louët H
AD  - CRPV Hôpital Henri Mondor, AP-HP, Paris, France
FAU - Essafi, Fatma
AU  - Essafi F
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Foudhaili, Nasreddine
AU  - Foudhaili N
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Slimen, Abdelaziz Ben
AU  - Slimen AB
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Jabla, Rami
AU  - Jabla R
AD  - Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Hammed, Hedia
AU  - Hammed H
AD  - Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Marzouk, Mahdi
AU  - Marzouk M
AD  - Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Boujelbene, Nesrine
AU  - Boujelbene N
AD  - Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Dachraoui, Fahmi
AU  - Dachraoui F
AD  - Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Hachani, Asma
AU  - Hachani A
AD  - Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Abdallah, Saousen Ben
AU  - Abdallah SB
AD  - Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Lakhal, Hend Ben
AU  - Lakhal HB
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Ghribi, Chaima
AU  - Ghribi C
AD  - Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Ali, Imen Ben
AU  - Ali IB
AD  - Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Abdellaoui, Imen
AU  - Abdellaoui I
AD  - Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Ouanes-Besbes, Lamia
AU  - Ouanes-Besbes L
AD  - Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Abroug, Fekri
AU  - Abroug F
AD  - Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Demiri, Suela
AU  - Demiri S
AD  - Hôpital Cochin, Paris, France
FAU - Lorut, Christine
AU  - Lorut C
AD  - Réanimation pneumologique, Hôpital Cochin, Paris, France
FAU - Van Lang, Daniel Luu
AU  - Van Lang DL
AD  - Anesthésie réanimation, Hôpital Cochin, Paris, France
FAU - Lefebvre, Aurélie
AU  - Lefebvre A
AD  - Réanimation pneumologique, Hôpital Cochin, Paris, France
FAU - Alifano, Marco
AU  - Alifano M
AD  - Chirurgie thoracique, Hôpital Cochin, Paris, France
FAU - Reignard, Jean-Francois
AU  - Reignard JF
AD  - Chirurgie thoracique, Hôpital Cochin, Paris, France
FAU - Samama, Marc
AU  - Samama M
AD  - Anesthésie réanimation, Hôpital Cochin, Paris, France
FAU - Dusser, Daniel
AU  - Dusser D
AD  - Réanimation pneumologique, Hôpital Cochin, Paris, France
FAU - Roche, Nicolas
AU  - Roche N
AD  - Réanimation pneumologique, Hôpital Cochin, Paris, France
FAU - Réminiac, François
AU  - Réminiac F
AD  - Anesthésie-réanimation, CHRU Hôpitaux De Tours, Tours, France
FAU - Landel, Cassandre
AU  - Landel C
AD  - Inserm u1100, aérosolthérapie et biomédicaments à visée respiratoire, Université 
      François Rabelais, Tours, France
FAU - Gensburger, Samuel
AU  - Gensburger S
AD  - Inserm u1100, aérosolthérapie et biomédicaments à visée respiratoire, Université 
      François Rabelais, Tours, France
FAU - Bocar, Thomas
AU  - Bocar T
AD  - Inserm u1100, aérosolthérapie et biomédicaments à visée respiratoire, Université 
      François Rabelais, Tours, France
FAU - Mordier, Lydiane
AU  - Mordier L
AD  - Inserm u1100, aérosolthérapie et biomédicaments à visée respiratoire, Université 
      François Rabelais, Tours, France
FAU - Philippe, Marion
AU  - Philippe M
AD  - Inserm u1100, aérosolthérapie et biomédicaments à visée respiratoire, Université 
      François Rabelais, Tours, France
FAU - Le Pennec, Déborah
AU  - Le Pennec D
AD  - Inserm u1100, aérosolthérapie et biomédicaments à visée respiratoire, Université 
      François Rabelais, Tours, France
FAU - Vecellio, Laurent
AU  - Vecellio L
AD  - Inserm u1100, aérosolthérapie et biomédicaments à visée respiratoire, Université 
      François Rabelais, Tours, France
FAU - Ehrmann, Stephan
AU  - Ehrmann S
AD  - Réanimation polyvalente, CHRU Hôpitaux de Tours, Tours, France
FAU - Poiroux, Laurent
AU  - Poiroux L
AD  - Département de réanimation médicale et médecine hyperbare, CHU d’Angers, Angers, 
      France
FAU - Thevoz, David
AU  - Thevoz D
AD  - Service de physiothérapie cardio-respiratoire, CHUV, Lausanne, Switzerland
FAU - Simons, Julien
AU  - Simons J
AD  - Service de physiothérapie cardio-respiratoire, CHUV, Lausanne, Switzerland
FAU - Roeseler, Jean
AU  - Roeseler J
AD  - Service des soins intensifs, Cliniques Universitaires Saint-Luc, Brussels,
      Belgium
FAU - Loiez, Anthéa
AU  - Loiez A
AD  - Département de réanimation médicale et de médecine hyperbare, C.H.U. d’Angers,
      Angers, France
FAU - Gérard, Stéphanie
AU  - Gérard S
AD  - Service de physiothérapie, Hôpital neuchâtelois, Neuchâtel, Switzerland
FAU - Dousse, Nicolas
AU  - Dousse N
AD  - Service de soins intensifs, Hôpitaux Universitaires de Genève, Genève,
      Switzerland
FAU - L’hotellier, Sylvie
AU  - L’hotellier S
AD  - Réanimation médicale, Hôpitaux Universitaires de Strasbourg (Hôpital de
      Hautepierre), Strasbourg, France
FAU - Baumgarten, Elodie
AU  - Baumgarten E
AD  - 67000, Cabinet libéral de masso kinésithérapie, Strasbourg, France
FAU - Borschneck, Stéphanie
AU  - Borschneck S
AD  - Hautepierre réanimation médicale, C.H.R.U. Hôpitaux Universitaires Strasbourg,
      Strasbourg, France
FAU - Kharcha, Fatima
AU  - Kharcha F
AD  - Endocrinologie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
FAU - Ghander, Cécile
AU  - Ghander C
AD  - Endocrinologie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
FAU - Tresallet, Christophe
AU  - Tresallet C
AD  - Chirurgie Digestive, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
FAU - Puymirat, Etienne
AU  - Puymirat E
AD  - Cardiology, Hôpital Européen Georges-Pompidou, Paris, France
FAU - Fagon, Jean-Yves
AU  - Fagon JY
AD  - Réanimation médicale, Hopital Europeen Georges-Pompidou, Paris, France
FAU - Aegerter, Philippe
AU  - Aegerter P
AD  - URC, Hospital Ambroise Paré, Boulogne-Billancourt, France
FAU - Diehl, Jean-Luc
AU  - Diehl JL
AD  - Réanimation médicale, Hopital Europeen Georges-Pompidou, Paris, France
FAU - Hauw-Berlemont, Caroline
AU  - Hauw-Berlemont C
AD  - Réanimation médicale, Hopital Europeen Georges-Pompidou, Paris, France
FAU - Chatellier, Gilles
AU  - Chatellier G
AD  - Unité de recherche clinique, Hopital Europeen Georges-Pompidou, Paris, France
FAU - Danchin, Nicolas
AU  - Danchin N
AD  - Cardiologie, Hôpital Européen Georges-Pompidou, Paris, France
FAU - Aissaoui, Nadia
AU  - Aissaoui N
AD  - Réanimation médicale, Hopital Europeen Georges-Pompidou, Paris, France
FAU - Aissat, Nadia
AU  - Aissat N
AD  - Ile de France, Pitié-Salpêtrière Hospita, ICAN, Paris, France
FAU - Bernard, R.
AU  - Bernard R
AD  - Ile de France, Pitié-Salpêtrière Hospita, ICAN, Paris, France
FAU - Amour, Julien
AU  - Amour J
AD  - Dar, Groupe Hospitalier Pitié Salpêtrière, Paris, France
FAU - Bouglé, Adrien
AU  - Bouglé A
AD  - Ile de France, Pitié-Salpêtrière Hospita, ICAN, Paris, France
FAU - Vidal, Charles
AU  - Vidal C
AD  - Réanimation chirurgicale cardio-vasculaire et thoracique, Groupe Hospitalier
      Pitié-Salpêtrière, Paris, France
FAU - Nima, Djavidi
AU  - Nima D
AD  - Réanimation chirurgicale cardio-vasculaire et thoracique, Groupe Hospitalier
      Pitié-Salpêtrière, Paris, France
FAU - Shaida, Varnous
AU  - Shaida V
AD  - Service de chirurgie cardio-vasculaire et thoracique, Groupe Hospitalier
      Pitié-Salpêtrière, Paris, France
FAU - Dorget, Amandine
AU  - Dorget A
AD  - Medical Intensive Care Unit, iCAN, Institute of Cardiometobalism and Nutrition,
      Groupe Hospitalier Pitié–Salpêtrière, Paris, France
FAU - Bréchot, Nicolas
AU  - Bréchot N
AD  - Medical Intensive Care Unit, iCAN, Institute of Cardiometobalism and Nutrition,
      Groupe Hospitalier Pitié–Salpêtrière, Paris, France
FAU - Toufiki, Rabi
AU  - Toufiki R
AD  - Service Anaesthesia and Intensive Care Hospital Mother – Child, CHU Marrakech,
      Marrakech, Morocco
FAU - Mouaffak, Youssef
AU  - Mouaffak Y
AD  - Service Anaesthesia and Intensive Care Hospital Mother – Child, CHU Marrakech,
      Marrakech, Morocco
FAU - Adib, Ahmed Rhassan El
AU  - Adib ARE
AD  - Service Anaesthesia and Intensive Care Hospital Mother – Child, CHU Marrakech,
      Marrakech, Morocco
FAU - Amine, M.
AU  - Amine M
AD  - Clinical Laboratory of Epidemiology, CHU Marrakech, Marrakech, Morocco
FAU - Moumine, S.
AU  - Moumine S
AD  - Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Jonard, Marie
AU  - Jonard M
AD  - Nord, Centre de réanimation, Lille, France
FAU - Ducloy-Bouthors, Anne Sophie
AU  - Ducloy-Bouthors AS
AD  - Anesthésie obstétricale, Hospital Jeanne De Flandre, Lille, France
FAU - Bouju, Pierre
AU  - Bouju P
AD  - Service de maladies infectieuses et réanimation médicale, Centre Hospitalier
      Universitaire, Rennes, France
FAU - Barbarot, Nicolas
AU  - Barbarot N
AD  - Service de réanimation polyvalente, Centre hospitalier, Saint Brieuc, France
FAU - Gacouin, Arnaud
AU  - Gacouin A
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Rennes, Rennes, France
FAU - Fillatre, Pierre
AU  - Fillatre P
AD  - Service de maladies infectieuses et réanimation médicale, Centre Hospitalier
      Universitaire, Rennes, France
FAU - Grillet, Guillaume
AU  - Grillet G
AD  - Service de maladies infectieuses et réanimation médicale, Centre Hospitalier
      Universitaire, Rennes, France
FAU - Goepp, Angélique
AU  - Goepp A
AD  - Service de réanimation polyvalente, Centre hospitalier, Saint Brieuc, France
FAU - Clairet, Anne-Laure
AU  - Clairet AL
AD  - Réanimation Médicale, CHU de Besançon, Besançon, France
FAU - Limat, Samuel
AU  - Limat S
AD  - Pôle pharmaceutique, CHU de Besançon, Besançon, France
FAU - Cornette, Christian
AU  - Cornette C
AD  - Pôle pharmaceutique, CHU de Besançon, Besançon, France
FAU - Fatnassi, Amira
AU  - Fatnassi A
AD  - Department of Critical Care Medicine and Anesthesiology, Military Hospital of
      Tunis, Tunisia, Tunis, Tunisia
FAU - Romdhani, Chiheb
AU  - Romdhani C
AD  - Department of Critical Care Medicine and Anesthesiology, Military Hospital of
      Tunis, Tunisia, Tunis, Tunisia
FAU - Sammoud, Walid
AU  - Sammoud W
AD  - Department of Critical Care Medicine and Anesthesiology, Military Hospital of
      Tunis, Tunisia, Tunis, Tunisia
FAU - Labbene, Iheb
AU  - Labbene I
AD  - Department of Critical Care Medicine and Anesthesiology, Military Hospital of
      Tunis, Tunisia, Tunis, Tunisia
FAU - Ferjani, Mustapha
AU  - Ferjani M
AD  - Department of Critical Care Medicine and Anesthesiology, Military Hospital of
      Tunis, Tunisia, Tunis, Tunisia
FAU - Taibi, Hind
AU  - Taibi H
AD  - Anesthésie Réanimation, Chu Ibn Rochd, Casablanca, Morocco
FAU - Elatiqi, Ijlal
AU  - Elatiqi I
AD  - Anesthésie Réanimation, Chu Ibn Rochd, Casablanca, Morocco
FAU - Iraqui, A.
AU  - Iraqui A
AD  - Anesthésie réanimation, CHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Cherkab, Rachid
AU  - Cherkab R
AD  - Anesthésie Réanimation, Chu Ibn Rochd, Casablanca, Morocco
FAU - Haddad, Wafae
AU  - Haddad W
AD  - Anesthésie Réanimation, Chu Ibn Rochd, Casablanca, Morocco
FAU - Elkettani, Chafik
AU  - Elkettani C
AD  - Anesthésie Réanimation, Chu Ibn Rochd, Casablanca, Morocco
FAU - Barrou, Lahoucine
AU  - Barrou L
AD  - Anesthésie Réanimation, Chu Ibn Rochd, Casablanca, Morocco
FAU - Cave, Fabien
AU  - Cave F
AD  - Réanimation médicale, Centre Hospitalier Universitaire d’Angers, Angers, France
FAU - Lerolle, Nicolas
AU  - Lerolle N
AD  - Réanimation médicale, Centre Hospitalier Universitaire d’Angers, Angers, France
FAU - Doutrellot, Pierre Louis
AU  - Doutrellot PL
AD  - Médecine physique et réadaptation neurologique et ufr de médecine upjv, pôle
      santé, Centre Hospitalier Universitaire, Amiens, France
FAU - Vaysse, Benoit
AU  - Vaysse B
AD  - Service d’information médicale, service d’épidémiologie, Centre Hospitalier
      Universitaire, Amiens, France
FAU - Inan, M.
AU  - Inan M
AD  - Soins Service, Service d’hospitalisation à domicile, Rivery, France
FAU - Khelfoun, K.
AU  - Khelfoun K
AD  - Service des urgences, C.H. Compiègne-Noyon, Compiègne, France
FAU - Nasserallah, M.
AU  - Nasserallah M
AD  - Département de médecine générale, Centre Hospitalier Universitaire, Amiens,
      France
FAU - Maizel, Julien
AU  - Maizel J
AD  - Réanimation médicale, Centre Hospitalier Universitaire, Amiens, France
FAU - Legrand-Monteil, C.
AU  - Legrand-Monteil C
AD  - Médecine physique et réadaptation plateau technique et unité mobile de mpr,
      Centre Hospitalier Universitaire, Amiens, France
FAU - Tasseel-Ponche, S.
AU  - Tasseel-Ponche S
AD  - Médecine physique et réadaptation neurologique et ufr de médecine upjv, pôle
      santé, Centre Hospitalier Universitaire, Amiens, France
FAU - Kowalski, Benjamin
AU  - Kowalski B
AD  - Reanimation, Centre Hospitalier de Douai, Douai, France
FAU - Guaguere, Anne
AU  - Guaguere A
AD  - Réanimation polyvalente, Hospital Center De Douai, Douai, France
FAU - Boulle-Geronimi, Claire
AU  - Boulle-Geronimi C
AD  - Réanimation polyvalente, Hôpital de Douai, Douai, France
FAU - Masse, Juliette
AU  - Masse J
AD  - Pôle de réanimation hôpital roger salengro, C.H.R.U. Lille, Lille, France
FAU - Vanbaelinghem, Clément
AU  - Vanbaelinghem C
AD  - Réanimation polyvalente, Centre Hospitalier de Roubaix, Roubaix, France
FAU - Herbecq, Patrick
AU  - Herbecq P
AD  - Réanimation polyvalente, Centre Hospitalier de Roubaix, Roubaix, France
FAU - Mokline, Amel
AU  - Mokline A
AD  - Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia
FAU - Draief, Syrine
AU  - Draief S
AD  - Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia
FAU - Gharsallah, Lazhari
AU  - Gharsallah L
AD  - Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia
FAU - Rahmani, Imen
AU  - Rahmani I
AD  - Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia
FAU - Gasri, Bahija
AU  - Gasri B
AD  - Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia
FAU - Tlaili, Sofiene
AU  - Tlaili S
AD  - Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia
FAU - Hammouda, Rym
AU  - Hammouda R
AD  - Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia
FAU - Messadi, Amen Allah
AU  - Messadi AA
AD  - Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia
FAU - Michel, Philippe
AU  - Michel P
AD  - Réanimation médico-chirurgicale, CH René Dubos, Pontoise, France
FAU - Gelée, Bruno
AU  - Gelée B
AD  - Réanimation polyvalente, C.H. de Beauvais, Beauvais, France
FAU - Fadel, Fouad
AU  - Fadel F
AD  - Réanimation médico-chirurgicale, CH René Dubos, Pontoise, France
FAU - Thuong, Marie
AU  - Thuong M
AD  - Réanimation médico-chirurgicale, CH René Dubos, Pontoise, France
FAU - Ait-Aoudia, Sandra
AU  - Ait-Aoudia S
AD  - Réanimation medicale, Hopital central de l’armee (HCA), Alger, Algeria
FAU - Laddi, Salima
AU  - Laddi S
AD  - Réanimation medicale, Hopital central de l’armee (HCA), Alger, Algeria
FAU - Sahraoui, Mohamed-Mohcen
AU  - Sahraoui MM
AD  - Réanimation medicale, Hopital central de l’armee (HCA), Alger, Algeria
FAU - Muller, Michel
AU  - Muller M
AD  - Haute savoie, Intensive Care Unit, Hospital Center Annecy Genevois, Metz-Tessy,
      France
FAU - Faucher, Anna
AU  - Faucher A
AD  - Coordination des dons d’organe et de tissus, Hospital Center Annecy Genevois,
      Metz-Tessy, France
FAU - Hermann, Bertrand
AU  - Hermann B
AD  - Réanimation médicale, Hopital Europeen Georges-Pompidou, Paris, France
FAU - Berlemont, Caroline Hauw
AU  - Berlemont CH
AD  - Réanimation médicale, Hopital Europeen Georges-Pompidou, Paris, France
FAU - Arnaout, Michel
AU  - Arnaout M
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Busson, Julie
AU  - Busson J
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Dhumeaux, Julie
AU  - Dhumeaux J
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Ericher, Nicole
AU  - Ericher N
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Lucas, Pierre
AU  - Lucas P
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
CN  - Groupe de travail sur la ventilation
FAU - Dumas, Magalie
AU  - Dumas M
AD  - Réanimation polyvalente urgences, Centre Hospitalier Universitaire,
      Saint-Priest-en-Jarez, France
FAU - Chapelle, Celine
AU  - Chapelle C
AD  - Unité de recherche clinique innovation et pharmacologie, Centre Hospitalier
      Universitaire, Saint-Priest-en-Jarez, France
FAU - Philippon-Jouve, Benedicte
AU  - Philippon-Jouve B
AD  - Réanimation polyvalente, Centre Hospitalier, Roanne, France
FAU - Morel, Jerome
AU  - Morel J
AD  - Réanimation polyvalente, Centre Hospitalier Universitaire, Saint-Priest-en-Jarez,
      France
FAU - Beuret, Pascal
AU  - Beuret P
AD  - Réanimation polyvalente, Centre Hospitalier, Roanne, France
FAU - Bureau, Côme
AU  - Bureau C
AD  - Intensive Care and Respiratory Division, Pitié-Salpêtrière Hospital, Paris,
      France
FAU - Poitou, Tymothée
AU  - Poitou T
AD  - Paris, Pierre and Marie Curie University, Paris, France
CN  - Université Paris 6 —Pierre et Marie Curie and Institut National pour la Santé et 
      la Recherche Médicale, UMRS1158, Paris
FAU - Coudroy, Remi
AU  - Coudroy R
AD  - Réanimation médicale, Chu De Poitiers, Poitiers, France
FAU - Petua, Philippe
AU  - Petua P
AD  - Réanimation médicale, Chu De Poitiers, Poitiers, France
FAU - Ghezala, Hassen Ben
AU  - Ghezala HB
AD  - Teaching Department of Emergency and Intensive Care, Hospital Zaghouan, Zaghouan,
      Tunisia
FAU - Prades, Albert
AU  - Prades A
AD  - DAR B, Hôpital Saint Eloi, Montpellier, France
FAU - Basty, Marion
AU  - Basty M
AD  - DAR B, Hôpital Saint Eloi, Montpellier, France
FAU - Monet, Clément
AU  - Monet C
AD  - DAR B, Hôpital Saint Eloi, Montpellier, France
FAU - Mounet, Benjamin
AU  - Mounet B
AD  - DAR B, Hôpital Saint Eloi, Montpellier, France
FAU - Futier, Emmanuel
AU  - Futier E
AD  - Dar, CHU Estaing, Clermont-Ferrand, France
FAU - Leroux, Audrey
AU  - Leroux A
AD  - Pharmacy, CHU - Hôpitaux de Rouen, Rouen, France
FAU - Oudinot, Xavier
AU  - Oudinot X
AD  - Pharmacy, CHU - Hôpitaux de Rouen, Rouen, France
FAU - Laurent, Marc
AU  - Laurent M
AD  - Pharmacy, CHU - Hôpitaux de Rouen, Rouen, France
FAU - Ouanes, Islem
AU  - Ouanes I
AD  - Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Jochmans, Sebastien
AU  - Jochmans S
AD  - Service de Réanimation, Centre Hospitalier Marc Jacquet, Melun, France
FAU - Alphonsine, Jean-Emmanuel
AU  - Alphonsine JE
AD  - Service de Réanimation, Centre Hospitalier Marc Jacquet, Melun, France
FAU - Van Vong, Ly
AU  - Van Vong L
AD  - Service de Réanimation, Centre Hospitalier Marc Jacquet, Melun, France
FAU - Rolin, Nathalie
AU  - Rolin N
AD  - Service de Réanimation, Centre Hospitalier Marc Jacquet, Melun, France
FAU - Sy, Oumar
AU  - Sy O
AD  - Service de Réanimation, Centre Hospitalier Marc Jacquet, Melun, France
FAU - Serbource-Goguel, Jean
AU  - Serbource-Goguel J
AD  - Service de Réanimation, Centre Hospitalier Marc Jacquet, Melun, France
FAU - Ellrodt, Olivier
AU  - Ellrodt O
AD  - Service de Réanimation, Centre Hospitalier Marc Jacquet, Melun, France
FAU - Monchi, Mehran
AU  - Monchi M
AD  - Service de Réanimation, Centre Hospitalier Marc Jacquet, Melun, France
FAU - Bahloul, Mabrouk
AU  - Bahloul M
AD  - Réanimation polyvalente, Faculté de médecine de Sfax, Sfax, Tunisia
FAU - Olfa, Turki
AU  - Olfa T
AD  - Réanimation polyvalente, Faculté de médecine de Sfax, Sfax, Tunisia
FAU - Chokri, Benhamida
AU  - Chokri B
AD  - Réanimation polyvalente, Faculté de médecine de Sfax, Sfax, Tunisia
FAU - Chelly, Hedi
AU  - Chelly H
AD  - ICU, CHU Habib Bourguiba, Sfax, Tunisia
FAU - Trichot, Amélie
AU  - Trichot A
AD  - Réanimation polyvalente, Centre Hospitalier Départemental - site de La
      Roche-sur-Yon, La Roche-sur-Yon, France
FAU - Colin, Gwenhaël
AU  - Colin G
AD  - Réanimation polyvalente, Centre Hospitalier Départemental - site de La
      Roche-sur-Yon, La Roche-sur-Yon, France
FAU - Vinatier, Isabelle
AU  - Vinatier I
AD  - Réanimation, Centre Hospitalier Départemental - site de La Roche-sur-Yon, La
      Roche-sur-Yon, France
FAU - Bachoumas, Konstantinos
AU  - Bachoumas K
AD  - Réanimation, Centre Hospitalier Départemental - site de La Roche-sur-Yon, La
      Roche-sur-Yon, France
FAU - Lacherade, Jean-Claude
AU  - Lacherade JC
AD  - Réanimation, Centre Hospitalier Départemental - site de La Roche-sur-Yon, La
      Roche-sur-Yon, France
FAU - Fiancette, Maud
AU  - Fiancette M
AD  - Réanimation polyvalente, Centre Hospitalier Départemental - site de La
      Roche-sur-Yon, La Roche-sur-Yon, France
FAU - Joret, Aurélie
AU  - Joret A
AD  - Réanimation polyvalente, Centre Hospitalier Départemental - site de La
      Roche-sur-Yon, La Roche-sur-Yon, France
FAU - Yehia, Aihem
AU  - Yehia A
AD  - Réanimation, Centre Hospitalier Départemental - site de La Roche-sur-Yon, La
      Roche-sur-Yon, France
FAU - Henry-Laguarrigue, Matthieu
AU  - Henry-Laguarrigue M
AD  - Réanimation, Centre Hospitalier Départemental - site de La Roche-sur-Yon, La
      Roche-sur-Yon, France
FAU - Martin-Lefèvre, Laurent
AU  - Martin-Lefèvre L
AD  - Réanimation polyvalente, Centre Hospitalier Départemental - site de La
      Roche-sur-Yon, La Roche-sur-Yon, France
FAU - Razazi, Keyvan
AU  - Razazi K
AD  - Réanimation médicale, Hospital Henri Mondor, Créteil, France
FAU - Surenaud, Mathieu
AU  - Surenaud M
AD  - Inserm u955, Hôpital Henri Mondor, Créteil, France
FAU - Bedet, Alexandre
AU  - Bedet A
AD  - Réanimation Médicale, Hôpital Henri Mondor, Créteil, France
FAU - Seemann, Aurelien
AU  - Seemann A
AD  - Réanimation Médicale, Hôpital Henri Mondor, Créteil, France
FAU - Hüe, Sophie
AU  - Hüe S
AD  - Laboratoire d’immunologie, Hôpital Henri Mondor, Créteil, France
FAU - Clere-Jehl, Raphaël
AU  - Clere-Jehl R
AD  - Réanimation médicale, Nouvel Hôpital Civil, CHU Strasbourg, Strasbourg, France
FAU - Charles, Anne-Laure
AU  - Charles AL
AD  - Laboratoire de physiologie, Faculté de Médecine, Equipe d’accueil 3072,
      Strasbourg, France
FAU - Geny, Bernard
AU  - Geny B
AD  - Laboratoire de physiologie, Faculté de Médecine, Equipe d’accueil 3072,
      Strasbourg, France
FAU - Bilbault, Pascal
AU  - Bilbault P
AD  - Service d’accueil des urgences, Nouvel Hôpital Civil, CHU Strasbourg, Strasbourg,
      France
FAU - Bourcier, Simon
AU  - Bourcier S
AD  - Réanimation médicale, Hôpital Saint-Antoine, Paris, France
FAU - Lejour, Gabriel
AU  - Lejour G
AD  - Réanimation médicale, Hôpital Saint-Antoine, Paris, France
FAU - Bourcier, Simon
AU  - Bourcier S
AD  - Service de reanimation, Hôpital Saint-Antoine, Paris, France
FAU - Boêlle, Pierre Yves
AU  - Boêlle PY
AD  - Service de santé publique, Hôpital Saint-Antoine, Paris, France
FAU - Safaa, Nemlaghi
AU  - Safaa N
AD  - Réanimation polyvalente, Hospital Center Private Claude Galien,
      Quincy-sous-Sénart, France
FAU - Paulus, Sylvie
AU  - Paulus S
AD  - Anesthésie-réanimation, Hopital Louis Pradel, Bron, France
FAU - Flamens, Claire
AU  - Flamens C
AD  - Anesthésie-réanimation, Hopital Louis Pradel, Bron, France
FAU - Neidecker, Jean
AU  - Neidecker J
AD  - Anesthésie-réanimation, Groupement Hospitalier Est, Hospices Civils de Lyon,
      Bron, France
FAU - Rambaud, Jerome
AU  - Rambaud J
AD  - Réanimation néonatale et pédiatrique, Hôpital Trousseau, Paris, France
FAU - Allioux, Cecile
AU  - Allioux C
AD  - Réanimation néonatale et pédiatrique, Hôpital Trousseau, Paris, France
FAU - Guedj, Romain
AU  - Guedj R
AD  - Urgences pédiatriques, Hôpital Trousseau, Paris, France
FAU - Guellec, Isabelle
AU  - Guellec I
AD  - Réanimation néonatale et pédiatrique, Hôpital Trousseau, Paris, France
FAU - Guilbert, Julia
AU  - Guilbert J
AD  - Réanimation néonatale et pédiatrique, Hôpital Trousseau, Paris, France
FAU - Leger, Pierre-Louis
AU  - Leger PL
AD  - Réanimation néonatale et pédiatrique, Hôpital Trousseau, Paris, France
FAU - Demoulin, Maryne
AU  - Demoulin M
AD  - Réanimation néonatale et pédiatrique, Hôpital Trousseau, Paris, France
FAU - Durandy, Amélie
AU  - Durandy A
AD  - Réanimation néonatale et pédiatrique, Hôpital Trousseau, Paris, France
FAU - Jean, Sandrine
AU  - Jean S
AD  - Réanimation néonatale et pédiatrique, Hôpital Trousseau, Paris, France
FAU - Carbajal, Ricardo
AU  - Carbajal R
AD  - Réanimation néonatale et pédiatrique, Hôpital Trousseau, Paris, France
FAU - Morand, Aurélie
AU  - Morand A
AD  - Anesthésie-réanimation pédiatrique, Hospital Nord, Marseille, France
FAU - Zieleskiewicz, Laurent
AU  - Zieleskiewicz L
AD  - Bouches du rhône, Hôpital Nord, Chemin des Bourrely, Marseille, France
FAU - Brissaud, Olivier
AU  - Brissaud O
AD  - Service de réanimation pédiatrique et néonatale, Centre Hospitalier Universitaire
      de Bordeaux, Bordeaux, France
FAU - Le Bel, Stéphane
AU  - Le Bel S
AD  - Anesthésie-réanimation pédiatrique, Hospital Timone, Marseille, France
FAU - Meresse, Zoé
AU  - Meresse Z
AD  - Anesthésie-réanimation, Hospital Nord, Marseille, France
FAU - Panuel, Michel
AU  - Panuel M
AD  - Imagerie médicale, Hôpital Nord, Marseille, France
FAU - Thomachot, Laurent
AU  - Thomachot L
AD  - Anesthésie-Réanimation Pédiatrique, Hôpital Nord, Marseille, France
FAU - Leone, Marc
AU  - Leone M
AD  - Département d’anesthésie réanimation, Hôpital Nord, Chemin des Bourrely,
      Marseille, France
FAU - Michel, Fabrice
AU  - Michel F
AD  - Anesthésie-Réanimation Pédiatrique, Hôpital Nord, Marseille, France
FAU - Deho’, Anna
AU  - Deho’ A
AD  - Service de réanimation et surveillance continue pèdiatriques, Hospital
      Robert-Debré, Paris, France
FAU - Sadozai, Laïly
AU  - Sadozai L
AD  - Département de pharmacie, Hospital Robert-Debré, Paris, France
FAU - Dauger, Stéphane
AU  - Dauger S
AD  - Service de réanimation et surveillance continue pèdiatriques, Hospital
      Robert-Debré, Paris, France
FAU - Prot-Labarthe, Sonia
AU  - Prot-Labarthe S
AD  - Département de pharmacie, Hospital Robert-Debré, Paris, France
FAU - Genuini, Mathieu
AU  - Genuini M
AD  - Hospital Necker, Paris, France
FAU - Florence, Moulin
AU  - Florence M
AD  - Réanimation et surveillance continue médico-chirurgicales, Hôpital Necker -
      Enfants Malades, Paris, France
FAU - Treluyer, Jean-Marc
AU  - Treluyer JM
AD  - Centre d’investigation clinique, Institut Imagine, Paris, France
FAU - Renolleau, Sylvain
AU  - Renolleau S
AD  - Réanimation et surveillance continue médico-chirurgicales, Hôpital Necker -
      Enfants Malades, Paris, France
FAU - Chalavon, Emmanuelle
AU  - Chalavon E
AD  - Réanimation pédiatrique, Centre Hospitalier Régional Universitaire de Lille,
      Lille, France
FAU - Dessein, Rodrigue
AU  - Dessein R
AD  - Center for infection and immunity, CHRU de Lille, Lille, France
FAU - Grandbastien, Bruno
AU  - Grandbastien B
AD  - Department of epidemiology and public health, Centre Hospitalier Régional
      Universitaire de Lille, Lille, France
FAU - Pesin, Sarah
AU  - Pesin S
AD  - Department of epidemiology and public health, Centre Hospitalier Régional
      Universitaire de Lille, Lille, France
FAU - Dubos, François
AU  - Dubos F
AD  - Pediatric Emergency Unit and Infectious Diseases, Centre Hospitalier Régional
      Universitaire de Lille, Lille, France
FAU - Leteurtre, Stéphane
AU  - Leteurtre S
AD  - Réanimation pédiatrique, Centre Hospitalier Régional Universitaire de Lille,
      Lille, France
FAU - Puel, Marie-Aude
AU  - Puel MA
AD  - Réanimation néonatale, CHU de Strasbourg, Strasbourg, France
FAU - Szulc, Marie
AU  - Szulc M
AD  - Pédiatrie, CHU de Strasbourg, Strasbourg, France
FAU - Philippe, Anais
AU  - Philippe A
AD  - Pédiatrie, CHU de Strasbourg, Strasbourg, France
FAU - Severac, François
AU  - Severac F
AD  - Laboratoire de biostatistique et d’informatique médicale, CHU de Strasbourg,
      Strasbourg, France
FAU - Astruc, Dominique
AU  - Astruc D
AD  - Réanimation néonatale, CHU de Strasbourg, Strasbourg, France
FAU - Kuhn, Pierre
AU  - Kuhn P
AD  - Réanimation néonatale, CHU de Strasbourg, Strasbourg, France
FAU - Desprez, Philippe
AU  - Desprez P
AD  - Réanimation pédiatrique, CHU de Strasbourg, Strasbourg, France
FAU - Aoul, Nabil Tabet
AU  - Aoul NT
AD  - Réanimation pédiatrique canastel, Faculté de médecine d’Oran, Oran, Algeria
FAU - Colomb, Benoît
AU  - Colomb B
AD  - Réanimation pédiatrique polyvalente, Chu Dijon, Dijon, France
FAU - Petion, Anne Marie
AU  - Petion AM
AD  - Smur pédiatrique, CHU Dijon, Dijon, France
FAU - Queudet, Laurent
AU  - Queudet L
AD  - Smur pédiatrique, CHU Dijon, Dijon, France
FAU - Remy, Solenn
AU  - Remy S
AD  - Réanimation pédiatrique, Hôpital Femme Mère Enfant, Bron, France
FAU - Youssef, Mouaffak
AU  - Youssef M
AD  - Service Anaesthesia and Intensive Care Hospital Mother – Child, CHU Marrakech,
      Marrakech, Morocco
FAU - Roumeliotis, Nadia
AU  - Roumeliotis N
AD  - Soins intensifs pédiatriques, CHU Sainte Justine, Montréal, Canada
FAU - Dong, Christian
AU  - Dong C
AD  - Centre de recherche, CHU Sainte-Justine, Montréal, Canada
FAU - Pettersen, Geraldine
AU  - Pettersen G
AD  - Soins intensifs pédiatriques, CHU Sainte Justine, Montréal, Canada
FAU - Crevier, Louis
AU  - Crevier L
AD  - Neurochirurgie, CHU Sainte-Justine, Montréal, Canada
FAU - Emeriaud, Guillaume
AU  - Emeriaud G
AD  - Soins intensifs pédiatriques, CHU Sainte Justine, Montréal, Canada
FAU - Naudin, Jérôme
AU  - Naudin J
AD  - Réanimation et surveillance continue pédiatriques, CHU Robert Debré, Paris,
      France
FAU - Abdallah, Laetitia
AU  - Abdallah L
AD  - Réanimation et surveillance continue pédiatriques, CHU Robert Debré, Paris,
      France
FAU - Ganier, Marion
AU  - Ganier M
AD  - Réanimation et surveillance continue pédiatriques, CHU Robert Debré, Paris,
      France
FAU - Frannais, Karine
AU  - Frannais K
AD  - Réanimation et surveillance continue pédiatriques, CHU Robert Debré, Paris,
      France
FAU - Douglas, Dylia
AU  - Douglas D
AD  - Réanimation et surveillance continue pédiatriques, CHU Robert Debré, Paris,
      France
FAU - Flusin, Cecile
AU  - Flusin C
AD  - Réanimation et surveillance continue pédiatriques, CHU Robert Debré, Paris,
      France
FAU - Brossier, David
AU  - Brossier D
AD  - Soins intensifs pédiatriques, CHU Sainte-Justine, Montréal, Canada
FAU - Eltaani, Redha
AU  - Eltaani R
AD  - Unité de recherche clinique appliquée, CHU Sainte-Justine, Montréal, Canada
FAU - Sauthier, Michaël
AU  - Sauthier M
AD  - Soins intensifs pédiatriques, CHU Sainte-Justine, Montréal, Canada
FAU - Guillois, Bernard
AU  - Guillois B
AD  - Néonatalogie, CHU, Caen, France
FAU - Rambaud, Jerome
AU  - Rambaud J
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Larroquet, Michelle
AU  - Larroquet M
AD  - Chirugie pédiatrique, Hopital pour enfants Trousseau, Paris, France
FAU - Amblard, Alain
AU  - Amblard A
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Lode, Noella
AU  - Lode N
AD  - Smur pédiatrique, Robert Debré, Paris, France
FAU - Casadevall, Isabelle
AU  - Casadevall I
AD  - Smur pédiatrique, Robert Debré, Paris, France
FAU - Kessous, Katia
AU  - Kessous K
AD  - Smur pédiatrique, Robert Debré, Paris, France
FAU - Walti, Hervé
AU  - Walti H
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Poiré, Christophe
AU  - Poiré C
AD  - Inserm u1144, Université Paris Descartes, Paris, France
FAU - Chen, Huixiong
AU  - Chen H
AD  - CNRS umr8601, Université Paris Descartes, Paris, France
FAU - Megarbane, Bruno
AU  - Megarbane B
AD  - Service de Réanimation Médicale et Toxicologique, CHU Lariboisière, Paris, France
FAU - M’rad, A.
AU  - M’rad A
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Habacha, Sahar
AU  - Habacha S
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Chatbri, Bassem
AU  - Chatbri B
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - M’rad, A.
AU  - M’rad A
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Masniere, Cyril
AU  - Masniere C
AD  - Inserm u1144, Université Paris Descartes, Paris, France
FAU - Megarbane, Bruno
AU  - Megarbane B
AD  - Service de Réanimation Médicale et Toxicologique, CHU Lariboisière, Paris, France
FAU - M’rad, A.
AU  - M’rad A
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Souissi, Samar
AU  - Souissi S
AD  - Service de réanimation, Centre d’assistance médicale-urgente, Tunis, Tunisia
FAU - Ghord, Hatem El
AU  - Ghord HE
AD  - \, Centre d’assistance médicale urgente, Tunis, Tunisia
FAU - Kouraichi, N.
AU  - Kouraichi N
AD  - Service de réanimation, Centre d’assistance médicale-urgente, Tunis, Tunisia
FAU - Brahmi, N.
AU  - Brahmi N
AD  - Service de réanimation médicale, Centre d’assistance médicale-urgente, Tunis,
      Tunisia
FAU - Marhbène, Takoua
AU  - Marhbène T
AD  - Réanimation médicale, Hôpital Abderrahmen Mami, Ariana, Tunisia
FAU - Mejri, Islam
AU  - Mejri I
AD  - Réanimation respiratoire, Hôpital Abderrahmen Mami de pneumo-phtisiologie,
      Ariana, Tunisia
FAU - Lakhdar, Douha
AU  - Lakhdar D
AD  - Réanimation médicale, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana,
      Tunisia
FAU - Merhabane, Takoua T.
AU  - Merhabane TT
AD  - Réanimation respiratoire, Hôpital Abderrahmen Mami de pneumo-phtisiologie,
      Ariana, Tunisia
FAU - la Maamouri, Hé
AU  - la Maamouri H
AD  - Service de réanimation médicale, Centre d’assistance médicale-urgente, Tunis,
      Tunisia
FAU - Charlotte, Oestreicher
AU  - Charlotte O
AD  - Intensive Care, University Hospitals of Geneva, Geneva, Switzerland
FAU - Wegelius, Helena
AU  - Wegelius H
AD  - Intensive Care, University Hospitals of Geneva, Geneva, Switzerland
FAU - Landelle, Caroline
AU  - Landelle C
AD  - Infection Control Programme, University Hospitals of Geneva, Geneva, Switzerland
FAU - Schrenzel, Jacques
AU  - Schrenzel J
AD  - Infectious Diseases, University Hospitals of Geneva, Geneva, Switzerland
FAU - Kaiser, Laurent
AU  - Kaiser L
AD  - Infectious Diseases, University Hospitals of Geneva, Geneva, Switzerland
FAU - Pugin, Jérôme
AU  - Pugin J
AD  - Intensive Care, University Hospitals of Geneva, Geneva, Switzerland
FAU - Belhadj, Hind
AU  - Belhadj H
AD  - Reanimation -anesthesie, CHU Mohamed VI, Marrakesh, Morocco
FAU - Chanareille, Paul
AU  - Chanareille P
AD  - Réanimation Polyvalente, CHU La Réunion, Saint-Denis, France
FAU - Ladureau, Adélie
AU  - Ladureau A
AD  - Réanimation - Grands brulés, CHU Pointe à Pitre - Abymes, Pointe à Pitre, France
FAU - Sanna, Alice
AU  - Sanna A
AD  - Département de biostatistiques, Hôpital Saint Louis, Paris, France
FAU - Rolle, Amélie
AU  - Rolle A
AD  - Réanimation - Grands brulés, CHU Pointe à Pitre - Abymes, Pointe à Pitre, France
FAU - Pons, Bertrand
AU  - Pons B
AD  - Réanimation - Grands brulés, CHU Pointe à Pitre - Abymes, Pointe à Pitre, France
FAU - Piednoir, Pascale
AU  - Piednoir P
AD  - Réanimation - Grands brulés, CHU Pointe à Pitre - Abymes, Pointe à Pitre, France
FAU - Ardisson, Fanny
AU  - Ardisson F
AD  - Réanimation - Grands brulés, CHU Pointe à Pitre - Abymes, Pointe à Pitre, France
FAU - Martino, Frédéric
AU  - Martino F
AD  - Réanimation - Grands brulés, CHU Pointe à Pitre - Abymes, Pointe à Pitre, France
FAU - Bernos, Thomas
AU  - Bernos T
AD  - Réanimation - Grands brulés, CHU Pointe à Pitre - Abymes, Pointe à Pitre, France
FAU - Elkoun, Khalid
AU  - Elkoun K
AD  - Réanimation - Grands brulés, CHU Pointe à Pitre - Abymes, Pointe à Pitre, France
FAU - Elain, Elie
AU  - Elain E
AD  - Réanimation - Grands brulés, CHU Pointe à Pitre - Abymes, Pointe à Pitre, France
FAU - Lawson, Roland
AU  - Lawson R
AD  - Centre de réanimation, Centre Hospitalier Régional Universitaire de Lille (CHRU),
      Lille, France
FAU - Resh-Rigon, Matthieu
AU  - Resh-Rigon M
AD  - Département de biostatistiques, Hôpital Saint Louis, Paris, France
FAU - Belorgey, Sophie
AU  - Belorgey S
AD  - Réanimation, Centre Hospitalier Général de Saint-Denis, Saint-Denis, France
FAU - Thiery, Guillaume
AU  - Thiery G
AD  - Réanimation - Grands brulés, CHU Pointe à Pitre - Abymes, Pointe à Pitre, France
FAU - Berlemont, Caroline Hauw
AU  - Berlemont CH
AD  - Réanimation médicale, Hopital Europeen Georges-Pompidou, Paris, France
FAU - Pricopi, Cyprian
AU  - Pricopi C
AD  - Chirurgie Thoracique, Hopital Europeen Georges-Pompidou, Paris, France
FAU - Barthes, Françoise
AU  - Barthes F
AD  - Chirurgie Thoracique, Hopital Europeen Georges-Pompidou, Paris, France
FAU - Doddie, Thansya
AU  - Doddie T
AD  - Anesthésie-réanimation, Cliniques universitaires de Kinshasa, Kinshasa,
      Democratic Republic of the Congo
FAU - Nsiala, Mj
AU  - Nsiala M
AD  - Anaesthesiology –Reanimation, Cliniques Universitaires, Kinshasa, Democratic
      Republic of the Congo
FAU - Situakibanza, Nh
AU  - Situakibanza N
AD  - Internal Medicine, Tropical Medicine, Infectious and Parasitic Diseases,
      University of Kinshasa, Kinshasa, Democratic Republic of the Congo
FAU - Amisi, Be
AU  - Amisi B
AD  - Anaesthesiology –Reanimation, Cliniques Universitaires, Kinshasa, Democratic
      Republic of the Congo
FAU - Kazadi, Mj
AU  - Kazadi M
AD  - Anaesthesiology-Reanimation, Provincial General Referral Hospital of Kinshasa,
      Kinshasa, Democratic Republic of the Congo
FAU - Kilembe, Ma
AU  - Kilembe M
AD  - Anaesthesiology –Reanimation, Cliniques Universitaires, Kinshasa, Democratic
      Republic of the Congo
FAU - Clement, Christophe
AU  - Clement C
AD  - RMC, Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France
FAU - Lamontagne, François
AU  - Lamontagne F
AD  - Intensive Care Unit, Université de Sherbrooke, Sherbrooke, Canada
FAU - Boyer, Valérie Nocquet
AU  - Boyer VN
AD  - Intensive Care, University Hospitals of Geneva, Geneva, Switzerland
FAU - Naimo, Sébastien
AU  - Naimo S
AD  - Intensive Care, University Hospitals of Geneva, Geneva, Switzerland
FAU - Raulais, Ronan
AU  - Raulais R
AD  - Intensive Care, University Hospitals of Geneva, Geneva, Switzerland
FAU - Genevois, Emilie
AU  - Genevois E
AD  - Intensive Care, University Hospitals of Geneva, Geneva, Switzerland
FAU - Bouchoud, Lucie
AU  - Bouchoud L
AD  - Pharmacy, University Hospitals of Geneva, Geneva, Switzerland
FAU - Boroli, Filippo
AU  - Boroli F
AD  - Réanimation Médicale, Hôpital Henri Mondor, Créteil, France
FAU - Abidi, Nour
AU  - Abidi N
AD  - Intensive Care, University Hospitals of Geneva, Geneva, Switzerland
FAU - Abbas, Mohamed
AU  - Abbas M
AD  - Infectious Diseases, University Hospitals of Geneva, Geneva, Switzerland
FAU - Harbarth, Stefan
AU  - Harbarth S
AD  - Infection Control Programme, University Hospitals of Geneva, Geneva, Switzerland
FAU - Pugin, Jérôme
AU  - Pugin J
AD  - Intensive Care, University Hospitals of Geneva, Geneva, Switzerland
FAU - Charles, Pierre-Emmanuel
AU  - Charles PE
AD  - Réanimation médicale, CHU Dijon, Dijon, France
FAU - Dereux, Caroline
AU  - Dereux C
AD  - 21000, Chu Dijon, Dijon, France
FAU - De Guillebon, Stanislas
AU  - De Guillebon S
AD  - CHU de BORDEAUX, Bordeaux, France
FAU - Morisse, Eloise
AU  - Morisse E
AD  - Pyrenées-atlantiques, Hospital François Mitterrand, Pau, France
FAU - France, Julie
AU  - France J
AD  - Pyrenées-atlantiques, Hospital François Mitterrand, Pau, France
FAU - Gasser, Deborah
AU  - Gasser D
AD  - Pyrenées-atlantiques, Hospital François Mitterrand, Pau, France
FAU - Badia, Philippe
AU  - Badia P
AD  - Pyrenées-atlantiques, Hospital François Mitterrand, Pau, France
FAU - Picard, Walter
AU  - Picard W
AD  - Pyrenées-atlantiques, Hospital François Mitterrand, Pau, France
FAU - Corne, P.
AU  - Corne P
AD  - Réanimation médicale, Hôpital Lapeyronie, Montpellier, France
FAU - De Boulastel, I.
AU  - De Boulastel I
AD  - Réanimation médicale, Hôpital Lapeyronie, Montpellier, France
FAU - Seguin, S.
AU  - Seguin S
AD  - Réanimation médicale, Hôpital Lapeyronie, Montpellier, France
FAU - Blasco, A.
AU  - Blasco A
AD  - Unité d’hygiène hospitalière et de prévention, Hôpital Lapeyronie, Montpellier,
      France
FAU - Ledur, V.
AU  - Ledur V
AD  - Direction des achats et des approvisionnements, Centre André Benech, Montpellier,
      France
FAU - Jonquet, Olivier
AU  - Jonquet O
AD  - Réanimation médicale, Hôpital Lapeyronie, Montpellier, France
FAU - Sophie, Paktoris-Papine
AU  - Sophie PP
AD  - Réanimation médico-chirurgicale, Assistance Publique - Hôpitaux de Paris, Hôpital
      Ambroise Paré, Boulogne-Billancourt, France
FAU - Artiguenave, Margaux
AU  - Artiguenave M
AD  - Réanimation médico-chirurgicale, Assistance Publique - Hôpitaux de Paris, Hôpital
      Ambroise Paré, Boulogne-Billancourt, France
FAU - Sayed, Faten El
AU  - Sayed FE
AD  - Service de microbiologie, Assistance Publique - Hôpitaux de Paris, Hôpital
      Ambroise Paré, Boulogne-Billancourt, France
FAU - Espinasse, Florence
AU  - Espinasse F
AD  - Equipe opérationnelle d’hygiène hospitalière, Assistance Publique - Hôpitaux de
      Paris, Hôpital Ambroise Paré, Boulogne-Billancourt, France
FAU - Dinh, Aurélien
AU  - Dinh A
AD  - Equipe opérationnelle d’hygiène hospitalière, Assistance Publique - Hôpitaux de
      Paris, Hôpital Ambroise Paré, Boulogne-Billancourt, France
FAU - Charron, Cyril
AU  - Charron C
AD  - Réanimation médico-chirurgicale, Assistance Publique - Hôpitaux de Paris, Hôpital
      Ambroise Paré, Boulogne-Billancourt, France
FAU - Lebas, Benjamin
AU  - Lebas B
AD  - Service de réanimation médicale, Hôpital de Hautepierre, Hôpitaux Universitaires 
      de Strasbourg, Strasbourg, France
FAU - Hatsch, Sophie
AU  - Hatsch S
AD  - Service de réanimation médicale, Hôpital de Hautepierre, Hôpitaux Universitaires 
      de Strasbourg, Strasbourg, France
FAU - Maestraggi, Quentin
AU  - Maestraggi Q
AD  - Service de réanimation médicale, Hôpital de Hautepierre, Hôpitaux Universitaires 
      de Strasbourg, Strasbourg, France
FAU - Dureau, Anne-Florence
AU  - Dureau AF
AD  - Service de réanimation médicale, Hôpital de Hautepierre, Hôpitaux Universitaires 
      de Strasbourg, Strasbourg, France
FAU - Faitot, François
AU  - Faitot F
AD  - Service de chirurgie hépato-biliaire et transplantation, Hôpital de Hautepierre, 
      Hôpitaux Universitaires de Strasbourg, Strasbourg, France
FAU - Margetis, Dimitri
AU  - Margetis D
AD  - Ile de France, Pitié-Salpêtrière Hospita, ICAN, Paris, France
FAU - Bouvet, Odile
AU  - Bouvet O
AD  - Iame - inserm umr1137, Université Paris Diderot, Paris, France
FAU - Chevret, Didier
AU  - Chevret D
AD  - 78, I.N.R.A ((Institut National de Recherche Agronomique)), Jouy-en-Josas, France
FAU - Denamur, Erick
AU  - Denamur E
AD  - Iame inserm umr1137, Université Paris Diderot, Paris, France
FAU - Simonet, Justine
AU  - Simonet J
AD  - Réanimation, Hôpital d’Instruction des Armées Percy, Clamart, France
FAU - Vest, Philippe
AU  - Vest P
AD  - Biochimie, Hôpital d’Instruction des Armées Percy, Clamart, France
FAU - Peigne, Vincent
AU  - Peigne V
AD  - Réanimation, Hôpital d’Instruction des Armées Percy, Clamart, France
FAU - Couffin, Severine
AU  - Couffin S
AD  - Surgical Intensive Care, Hospital Henri Mondor, Créteil, France
FAU - Cheikh Bouhlel, M.
AU  - Cheikh Bouhlel M
AD  - Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Khedher, Ahmed
AU  - Khedher A
AD  - Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Meddeb, Kaoula
AU  - Meddeb K
AD  - Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Azouzi, A.
AU  - Azouzi A
AD  - Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Hamdaoui, Y.
AU  - Hamdaoui Y
AD  - Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Ayachi, Jihene
AU  - Ayachi J
AD  - Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Brahim, W.
AU  - Brahim W
AD  - Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Bouneb, Rania
AU  - Bouneb R
AD  - Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Boussarsar, Mohamed
AU  - Boussarsar M
AD  - Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Florens, Nans
AU  - Florens N
AD  - Réanimation Médicale, Hospices Civils de Lyon - Groupement Hospitalier Edouard
      Herriot, Lyon, France
FAU - Varéon, Julie
AU  - Varéon J
AD  - Réanimation Médicale, Hospices Civils de Lyon - Groupement Hospitalier Edouard
      Herriot, Lyon, France
FAU - Malatray, Arnaud
AU  - Malatray A
AD  - Réanimation Médicale, Hospices Civils de Lyon - Groupement Hospitalier Edouard
      Herriot, Lyon, France
FAU - Argaud, Laurent
AU  - Argaud L
AD  - Réanimation Médicale, Hospices Civils de Lyon - Groupement Hospitalier Edouard
      Herriot, Lyon, France
FAU - Dupland, Pierre
AU  - Dupland P
AD  - Reanimation, Clinical Ambroise Paré, Neuilly-sur-Seine, France
FAU - Vergier, Romain
AU  - Vergier R
AD  - ICU, Clinical Ambroise Paré, Neuilly-sur-Seine, France
FAU - Issaurat, Pauline
AU  - Issaurat P
AD  - ICU, Clinical Ambroise Paré, Neuilly-sur-Seine, France
FAU - Estagnasié, Philippe
AU  - Estagnasié P
AD  - Reanimation, Clinical Ambroise Paré, Neuilly-sur-Seine, France
FAU - Squara, Pierre
AU  - Squara P
AD  - Reanimation, Clinical Ambroise Paré, Neuilly-sur-Seine, France
FAU - Brusset, Alain
AU  - Brusset A
AD  - Reanimation, Clinical Ambroise Paré, Neuilly-sur-Seine, France
FAU - Génin, Vincent
AU  - Génin V
AD  - Réanimation Polyvalente, CHU La Réunion, Saint-Denis, France
FAU - Jendoubi, Ali
AU  - Jendoubi A
AD  - Anesthesia and Intensive Care, Charles Nicolle Teaching Hospital, Tunis, Tunisia
FAU - Jlassi, Rifka
AU  - Jlassi R
AD  - Anesthesia and Intensive Care, Charles Nicolle Teaching Hospital, Tunis, Tunisia
FAU - Hamrouni, Bassem
AU  - Hamrouni B
AD  - Anesthesia and Intensive Care, Charles Nicolle Teaching Hospital, Tunis, Tunisia
FAU - Marzougui, Yahia
AU  - Marzougui Y
AD  - Anesthesia and Intensive Care, Charles Nicolle Teaching Hospital, Tunis, Tunisia
FAU - Kouka, Jihen
AU  - Kouka J
AD  - Anesthesia and Intensive Care, Charles Nicolle Teaching Hospital, Tunis, Tunisia
FAU - Ghedira, Salma
AU  - Ghedira S
AD  - Anesthesia and Intensive Care, Charles Nicolle Teaching Hospital, Tunis, Tunisia
FAU - Houissa, Mohamed
AU  - Houissa M
AD  - Anesthesia and Intensive Care, Charles Nicolle Teaching Hospital, Tunis, Tunisia
FAU - Dhifaoui, Kaouther
AU  - Dhifaoui K
AD  - Department of Critical Care Medicine and Anesthesiology, Military Hospital of
      Tunis, Tunisia, Tunis, Tunisia
FAU - Hajjej, Zied
AU  - Hajjej Z
AD  - Department of Critical Care Medicine and Anesthesiology, Military Hospital of
      Tunis, Tunisia, Tunis, Tunisia
FAU - Oziel, Johanna
AU  - Oziel J
AD  - Réanimation pneumologique et soins intensifs respiratoires, Hôpital Cochin,
      Paris, France
CN  - Outcomerea Study Group
FAU - Dinh, Alexy Tran
AU  - Dinh AT
AD  - 78150, Hospital Center De Versailles, Le Chesnay, France
FAU - Neulier, Caroline
AU  - Neulier C
AD  - 78150, Hospital Center De Versailles, Le Chesnay, France
FAU - Amara, Marlène
AU  - Amara M
AD  - 78150, Hospital Center De Versailles, Le Chesnay, France
FAU - Nebot, Nicaise
AU  - Nebot N
AD  - 78150, Hospital Center De Versailles, Le Chesnay, France
FAU - Troché, Gilles
AU  - Troché G
AD  - 78150, Hospital Center De Versailles, Le Chesnay, France
FAU - Breton, Nelly
AU  - Breton N
AD  - 78150, Hospital Center De Versailles, Le Chesnay, France
FAU - Cavelot, Sébastien
AU  - Cavelot S
AD  - 78150, Hospital Center De Versailles, Le Chesnay, France
FAU - Pangon, Béatrice
AU  - Pangon B
AD  - 78150, Hospital Center De Versailles, Le Chesnay, France
FAU - Merrer, Jacques
AU  - Merrer J
AD  - 78150, Hospital Center De Versailles, Le Chesnay, France
FAU - Labaste, François
AU  - Labaste F
AD  - Réanimation polyvalente, CHU Toulouse Rangueil, Avenue du Professeur Jean
      Poulhes, Toulouse, France
FAU - Conil, Jean-Marie
AU  - Conil JM
AD  - Réanimation polyvalente, CHU Toulouse Rangueil, Avenue du Professeur Jean
      Poulhes, Toulouse, France
FAU - Grossac, Julia
AU  - Grossac J
AD  - Réanimation polyvalente, CHU Toulouse Rangueil, Avenue du Professeur Jean
      Poulhes, Toulouse, France
FAU - Ruiz, Stéphanie
AU  - Ruiz S
AD  - Réanimation polyvalente, CHU Toulouse Rangueil, Avenue du Professeur Jean
      Poulhes, Toulouse, France
FAU - Grare, Marion
AU  - Grare M
AD  - Service de bactériologie, Hospital Center University Toulouse - Casselardit
      Ancely, Toulouse, France
FAU - Minville, Vincent
AU  - Minville V
AD  - Réanimation polyvalente, CHU Toulouse Rangueil, Avenue du Professeur Jean
      Poulhes, Toulouse, France
FAU - Georges, Bernard
AU  - Georges B
AD  - Réanimation polyvalente, CHU Toulouse Rangueil, Avenue du Professeur Jean
      Poulhes, Toulouse, France
FAU - Van Der Meersch, Guillaume
AU  - Van Der Meersch G
AD  - Réanimation pneumologique et soins intensifs respiratoires, Hôpital Cochin,
      Paris, France
FAU - Karoubi, Philippe
AU  - Karoubi P
AD  - Réanimation médico-chirurgicale, Hôpital Avicenne, Bobigny, France
FAU - Huang, Christophe
AU  - Huang C
AD  - Réanimation médico-chirurgicale, Hôpital Avicenne, Bobigny, France
FAU - Carbonne, Helene
AU  - Carbonne H
AD  - Hospital Lariboisière, Paris, France
FAU - Amarsy, Rishma
AU  - Amarsy R
AD  - Equipe opérationnelle d’hygiène, Hospital Lariboisière, Paris, France
FAU - Mateo, Joaquim
AU  - Mateo J
AD  - Anesthesiology and critical care, Hospital Lariboisière, Paris, France
FAU - Von Edelsberg, Sophie Leloup
AU  - Von Edelsberg SL
AD  - Intensive Care, CHU Sart-Tilman, Liège, Belgium
FAU - Vercheval, Christelle
AU  - Vercheval C
AD  - Clinical Pharmacy, CHU Sart-Tilman, Liège, Belgium
FAU - Damas, Pierre
AU  - Damas P
AD  - Intensive Care, CHU Sart-Tilman, Liège, Belgium
FAU - Bouguerra, Chaker
AU  - Bouguerra C
AD  - Department of Preventive Medicine, Military Hospital of Tunis, Tunis, Tunisia
FAU - Naas, Noura
AU  - Naas N
AD  - Department of Critical Care Medicine and Anesthesiology, Military Hospital of
      Tunis, Tunisia, Tunis, Tunisia
FAU - Muller, Joris
AU  - Muller J
AD  - Infection Control Unit, Strasbourg University Hospital, Strasbourg, France
FAU - Schaeffer, Mickael
AU  - Schaeffer M
AD  - Public Health Service, Strasbourg University Hospital, Strasbourg, France
FAU - Loc, Pierre Tran Ba
AU  - Loc PTB
AD  - Public Health Service, Strasbourg University Hospital, Strasbourg, France
FAU - Deboscker, Stéphanie
AU  - Deboscker S
AD  - Infection Control Unit, Strasbourg University Hospital, Strasbourg, France
FAU - Harley, Marie-Line
AU  - Harley ML
AD  - Medical Intensive Care Unit, Strasbourg University Hospital, Strasbourg, France
FAU - Lavigne, Thierry
AU  - Lavigne T
AD  - Infection Control Unit, Strasbourg University Hospital, Strasbourg, France
FAU - Brunet, Jennifer
AU  - Brunet J
AD  - Réanimation chirurgicale, Centre Hospitalier Universitaire de Caen (CHU), Caen,
      France
FAU - Canoville, Bertrand
AU  - Canoville B
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Caen, Caen, France
FAU - Lellouche, François
AU  - Lellouche F
AD  - Centre de recherche de l’iucpq, Institut Universitaire de Cardiologie et de
      Pneumologie de Québec, Québec, Canada
FAU - L’her, Erwan
AU  - L’her E
AD  - Réanimation médicale, CHRU de Brest, Brest, France
FAU - Bouchard, Pierre Alexandre
AU  - Bouchard PA
AD  - Centre de recherche de l’iucpq, Institut Universitaire de Cardiologie et de
      Pneumologie de Québec, Québec, Canada
FAU - Delorme, Mathieu
AU  - Delorme M
AD  - 33, Hôpital Haut-Lévêque, Avenue Magellan, Pessac, France
FAU - Elfaramawy, Tamer
AU  - Elfaramawy T
AD  - Département de génie électrique et informatique de l’université laval, Université
      Laval, Québec, Canada
FAU - Gosselin, Benoit
AU  - Gosselin B
AD  - Département de génie électrique et informatique de l’université laval, Université
      Laval, Québec, Canada
FAU - Guegan, Sarah
AU  - Guegan S
AD  - Stagiaire 5ème année, ProG’HEI, Lille, France
FAU - Michotte, Jean-Bernard
AU  - Michotte JB
AD  - Haute école de santé vaud, University of Applied Sciences and Arts Western
      Switzerland (HES-SO), Lausanne, Switzerland
FAU - Staderini, Enrico
AU  - Staderini E
AD  - Haute école d’ingénierie et de gestion du canton de vaud, University of Applied
      Sciences and Arts Western Switzerland, Yverdon-les-Bains, Switzerland
FAU - Dugernier, Jonathan
AU  - Dugernier J
AD  - Intensive Care Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium
FAU - Rusu, Rares
AU  - Rusu R
AD  - Haute école d’ingénierie et de gestion du canton de vaud, University of Applied
      Sciences and Arts Western Switzerland, Yverdon-les-Bains, Switzerland
FAU - Liistro, Giuseppe
AU  - Liistro G
AD  - Service de pneumologie, Cliniques Universitaires Saint-Luc, Brussels, Belgium
FAU - Reychler, Gregory
AU  - Reychler G
AD  - Service de pneumologie, Cliniques Universitaires Saint-Luc, Brussels, Belgium
FAU - Delorme, Mathieu
AU  - Delorme M
AD  - 33, Hôpital Haut-Lévêque, Avenue Magellan, Pessac, France
FAU - Simon, Mathieu
AU  - Simon M
AD  - Centre de recherche de l’iucpq, Institut Universitaire de Cardiologie et de
      Pneumologie de Québec, Québec, Canada
FAU - Essoukaki, Elmaati
AU  - Essoukaki E
AD  - Laboratoire rayonnement-matière et instrumentation, Université hassan 1er,
      Faculté des Sciences et Techniques, Settat, Morocco
FAU - Duprez, Frédéric
AU  - Duprez F
AD  - ICU, C.H. Epicura, Hornu, Belgium
FAU - Michotte, Jean Bernard
AU  - Michotte JB
AD  - Physiotherapy, Haute École de Santé Vaud, Lausanne, Switzerland
FAU - Contal, Olivier
AU  - Contal O
AD  - Physiotherapy, Haute École de Santé Vaud, Lausanne, Switzerland
FAU - Trabelsi, Becem
AU  - Trabelsi B
AD  - Department of Critical Care Medicine and Anesthesiology, Military Hospital of
      Tunis, Tunisia, Tunis, Tunisia
FAU - Hajjej, Zied
AU  - Hajjej Z
AD  - Department of Critical Care Medicine and Anesthesiology, Military Hospital of
      Tunis, Tunisia, Tunis, Tunisia
FAU - Garsallah, Hedi
AU  - Garsallah H
AD  - Department of Critical Care Medicine and Anesthesiology, Military Hospital of
      Tunis, Tunisia, Tunis, Tunisia
FAU - Hajjej, Zied
AU  - Hajjej Z
AD  - Department of Critical Care Medicine and Anesthesiology, Military Hospital of
      Tunis, Tunisia, Tunis, Tunisia
FAU - Harira, Khaoula
AU  - Harira K
AD  - Department of Critical Care Medicine and Anesthesiology, Military Hospital of
      Tunis, Tunisia, Tunis, Tunisia
FAU - Rafat, Cédric
AU  - Rafat C
AD  - Service de réanimation médico-chirurgicale, Hôpital Louis-Mourier - APHP,
      Colombes, France
FAU - Mariotte, Eric
AU  - Mariotte E
AD  - Service de réanimation médicale et infectieuse, Hôpital Bichat-Claude
      Bernard-APHP, Paris, France
FAU - Le Jeune, Caroline
AU  - Le Jeune C
AD  - Hematology, CHU Lyon Sud, Lyon, France
FAU - Roy, Pascal
AU  - Roy P
AD  - Biostatistics, Hospices Civils de Lyon, Lyon, France
FAU - Michallet, Mauricette
AU  - Michallet M
AD  - Hematology, CHU Lyon Sud, Lyon, France
FAU - Zerbib, Yoann
AU  - Zerbib Y
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Baudin, François
AU  - Baudin F
AD  - Réanimation chirurgicale, Cochin Port-Royal, Paris, France
FAU - Blot, François
AU  - Blot F
AD  - Réanimation médicale, Institut Gustave Roussy, Villejuif, France
FAU - Bornstain, Caroline
AU  - Bornstain C
AD  - Réanimation polyvalente, Groupe Hospitalier Intercommunal Le Raincy-Montfermeil, 
      Montfermeil, France
FAU - Gelinotte, Stéphanie
AU  - Gelinotte S
AD  - Reanimation Polyvalente, Centre Hospitalier de Dieppe, Dieppe, France
FAU - Rigaud, Jean-Philippe
AU  - Rigaud JP
AD  - Reanimation Polyvalente, Centre Hospitalier de Dieppe, Dieppe, France
FAU - Tamion, Fabienne
AU  - Tamion F
AD  - Réanimation Médicale, Centre Hospitalier Universitaire Rouen, Rouen, France
FAU - Bouteloup, Marie
AU  - Bouteloup M
AD  - Réanimation médicale, Hospital Center Valence, Valence, France
FAU - Darmon, Michaël
AU  - Darmon M
AD  - Réanimation Médicale, CHU Saint-Etienne - Hôpital Nord, Saint-Étienne, France
CN  - Groupe de Recherche en Réanimation Respiratoire et Onco-Hematologique (GRRROH)
FAU - Nouira, H.
AU  - Nouira H
AD  - Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Boisramé-Helms, Julie
AU  - Boisramé-Helms J
AD  - Réanimation médicale, Nouvel Hôpital Civil, CHU Strasbourg, Strasbourg, France
FAU - Degirmenci, Su
AU  - Degirmenci S
AD  - Umr7213, Strasbourg University, Strasbourg, France
FAU - Kummerlen, Christine
AU  - Kummerlen C
AD  - Réanimation médicale, Nouvel Hôpital Civil, CHU Strasbourg, Strasbourg, France
FAU - Delile, Eugénie
AU  - Delile E
AD  - Inserm u1096, Université de rouen, Rouen, France
FAU - Thiébaut, Pierre-Alain
AU  - Thiébaut PA
AD  - Inserm u1096, Université de rouen, Rouen, France
FAU - Do Rego, Jean-Claude
AU  - Do Rego JC
AD  - Scac-irib, Université de Rouen, Rouen, France
FAU - Coquerel, David
AU  - Coquerel D
AD  - Inserm u1096, Université de rouen, Rouen, France
FAU - Nevière, Rémi
AU  - Nevière R
AD  - Inserm u995 equipe 4, Université Lille 2, Lille, France
FAU - Ichou, Laure
AU  - Ichou L
AD  - Service de reanimation, Hôpital Saint-Antoine, Paris, France
FAU - Carbonell, Nicolas
AU  - Carbonell N
AD  - Service d’hépatologie, Hôpital Saint-Antoine, Paris, France
FAU - Rautou, Pierre-Emmanuel
AU  - Rautou PE
AD  - Service d’hépatologie, Hospital Beaujon, Clichy, France
FAU - Nousbaum, Jean-Baptiste
AU  - Nousbaum JB
AD  - Service d’hépato-gastro-entérologie, CHRU de Brest Hôpital Morvan, Brest, France
FAU - Renou, Christophe
AU  - Renou C
AD  - Service d’hépato-gastro-entérologie, CH, Hyères, France
FAU - Anty, Rodolphe
AU  - Anty R
AD  - Service d’hepato-gastro-enterologie, CHU Nice, Nice, France
FAU - Landraud, Luce
AU  - Landraud L
AD  - Service de microbiologie, CHU Nice, Nice, France
FAU - Ait-Oufella, Hafid
AU  - Ait-Oufella H
AD  - Service de reanimation, Hôpital Saint-Antoine, Paris, France
FAU - Coudroy, Remi
AU  - Coudroy R
AD  - Réanimation médicale, Chu De Poitiers, Poitiers, France
FAU - Lecron, Jean-Claude
AU  - Lecron JC
AD  - Litec ea4331, Chu De Poitiers, Poitiers, France
CN  - ABDOMIX Group
FAU - Helary, Michael
AU  - Helary M
AD  - Anesthésie-Réanimation, Hospital Jean Minjoz, Besançon, France
FAU - Paillot, Jonathan
AU  - Paillot J
AD  - Reanimation chirurgicale, Hospital Jean Minjoz, Besançon, France
FAU - Pili-Floury, Sebastien
AU  - Pili-Floury S
AD  - Réanimation chirurgicale, CHU de Besançon, Besançon, France
FAU - Khedher, Sana
AU  - Khedher S
AD  - Digestif USI, EPS Charles Nicolle, Bardo, Tunisia
FAU - Maoui, Amira
AU  - Maoui A
AD  - Digestif USI, EPS Charles Nicolle, Bardo, Tunisia
FAU - Ezzamouri, Asma
AU  - Ezzamouri A
AD  - Digestif USI, EPS Charles Nicoles, Tunis, Tunisia
FAU - Salem, Mohamed
AU  - Salem M
AD  - Digestif USI, EPS Charles Nicoles, Tunis, Tunisia
FAU - Kerdjana, Lamia
AU  - Kerdjana L
AD  - Réanimation médicale, CHU Lariboisière, Paris, France
FAU - Dumitrescu, Mihaela
AU  - Dumitrescu M
AD  - Service d’épidémiologie clinique, CHU de Poitiers, Poitiers, France
FAU - Mimoz, Olivier
AU  - Mimoz O
AD  - Réanimation chirurgicale, CHU de Poitiers, Poitiers, France
FAU - Debaene, Bertrand
AU  - Debaene B
AD  - Département d’anesthésie-réanimation, CHU de Poitiers, Poitiers, France
FAU - Migeot, Virginie
AU  - Migeot V
AD  - Service d’épidémiologie clinique, CHU de Poitiers, Poitiers, France
FAU - Dahyot-Fizelier, Claire
AU  - Dahyot-Fizelier C
AD  - Réanimation neuro-chirurgicale, CHU de Poitiers, Poitiers, France
FAU - Khedher, Sana
AU  - Khedher S
AD  - Digestif USI, EPS Charles Nicolle, Bardo, Tunisia
FAU - maoui, Amira A.
AU  - maoui AA
AD  - Digestif USI, EPS Charles Nicolles, Tunis, Tunisia
FAU - Champigneulle, Benoit
AU  - Champigneulle B
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Zafrani, Lara
AU  - Zafrani L
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Lascarrou, Jean-Baptiste
AU  - Lascarrou JB
AD  - Réanimation polyvalente, Centre Hospitalier Départemental - site de La
      Roche-sur-Yon, La Roche-sur-Yon, France
FAU - Lissonde, Floriane
AU  - Lissonde F
AD  - Département d’anesthésie, CHU de Nantes, Nantes Cedex 1, France
FAU - Le Thuaut, Aurélie
AU  - Le Thuaut A
AD  - Biostatistiques, C.H.U. Hôtel Dieu, Nantes, France
FAU - Reignier, Jean
AU  - Reignier J
AD  - Réanimation médicale, C.H.U de Nantes, Nantes, France
FAU - Platon, Laura
AU  - Platon L
AD  - Réanimation médicale, CHU lapeyronie, Montpellier, France
FAU - Lambert, Jerôme
AU  - Lambert J
AD  - Sbim, Hôpital Saint-Louis, Paris, France
FAU - Lagier, David
AU  - Lagier D
AD  - Hôpital la timone (Marseille), CHU La Timone (Marseille), Marseille, France
FAU - Brun, Jeanpaul
AU  - Brun J
AD  - Reanimation, Institute Paoli-Calmettes, Marseille, France
FAU - Sannini, Antoine
AU  - Sannini A
AD  - Reanimation, Institute Paoli-Calmettes, Marseille, France
FAU - Chow-Chine, Laurent
AU  - Chow-Chine L
AD  - Réanimation, Institute Paoli-Calmettes, Marseille, France
FAU - Bisbal, Magali
AU  - Bisbal M
AD  - Reanimation, Institute Paoli-Calmettes, Marseille, France
FAU - Faucher, Marion
AU  - Faucher M
AD  - Reanimation, Institute Paoli-Calmettes, Marseille, France
FAU - Mokart, Djamel
AU  - Mokart D
AD  - Réanimation, Institut Paoli-Calmettes, Marseille, France
FAU - la Mourtada, Leï
AU  - la Mourtada L
AD  - Réanimation médicale, Hôpital Saint Louis, Paris, France
FAU - Virgnie, Lemiale
AU  - Virgnie L
AD  - Réanimation médicale, Hôpital Saint Louis, Paris, France
FAU - Gaudet, Alexandre
AU  - Gaudet A
AD  - Pôle de réanimation, hôpital salengro, Centre Hospitalier Régional Universitaire 
      de Lille, Lille, France
FAU - Parmentier-Decrucq, Erika
AU  - Parmentier-Decrucq E
AD  - Pôle de réanimation, hôpital salengro, Centre Hospitalier Régional Universitaire 
      de Lille, Lille, France
FAU - De Freitas Caires, Nathalie
AU  - De Freitas Caires N
AD  - Lunginnov, Institut Pasteur de Lille, Lille, France
FAU - Dubucquoi, Sylvain
AU  - Dubucquoi S
AD  - Institut d’immunologie, Centre de biologie-pathologie génétique, Centre
      Hospitalier Régional Universitaire de Lille, Lille, France
FAU - Lassalle, Philippe
AU  - Lassalle P
AD  - Inserm u1019 e13, Institut Pasteur de Lille, Lille, France
FAU - Mathieu, Daniel
AU  - Mathieu D
AD  - Pôle de réanimation, hôpital salengro, Centre Hospitalier Régional Universitaire 
      de Lille, Lille, France
FAU - Richard, Jean-Christophe
AU  - Richard JC
AD  - Réanimation médicale, Hôpital de la Croix-Rousse, Lyon, France
FAU - Tapponnier, Romain
AU  - Tapponnier R
AD  - Réanimation médicale, Hôpital de la Croix-Rousse, Lyon, France
FAU - Quintin, Luc
AU  - Quintin L
AD  - Physiology, CNRS, Lyon-Villeurbanne, France
FAU - Pichot, C.
AU  - Pichot C
AD  - Physiology, U Lyon1, Lyon, France
FAU - Petitjeans, F.
AU  - Petitjeans F
AD  - Critical Care, Hospital Instruction Armed Desgenettes, Lyon, France
FAU - Guillon, Antoine
AU  - Guillon A
AD  - Réanimation polyvalente, CHRU Hôpitaux de Tours, Tours, France
FAU - Jouan, Youenn
AU  - Jouan Y
AD  - Réanimation polyvalente - u1100 centre d’etude des pathologies respiratoires,
      CHRU Hôpitaux de Tours, Tours, France
FAU - Breah, Daborah
AU  - Breah D
AD  - Inserm u1100, Centre d’étude des pathologies respiratoires, Tours, France
FAU - Gueugnon, Fabien
AU  - Gueugnon F
AD  - Inserm u1100, Centre d’étude des pathologies respiratoires, Tours, France
FAU - Dalloneau, Emilie
AU  - Dalloneau E
AD  - Inserm u1100, Centre d’étude des pathologies respiratoires, Tours, France
FAU - Baranek, Thomas
AU  - Baranek T
AD  - Inserm u1100, Centre d’étude des pathologies respiratoires, Tours, France
FAU - Henry, Clemence
AU  - Henry C
AD  - Inserm u1100, Centre d’étude des pathologies respiratoires, Tours, France
FAU - Morello, Eric
AU  - Morello E
AD  - Inserm u1100, Centre d’étude des pathologies respiratoires, Tours, France
FAU - Renauld, Jc
AU  - Renauld J
AD  - Université catholique de Louvain, De Duve institute, Brussels, Belgium
FAU - Pichavant, M.
AU  - Pichavant M
AD  - Institut pasteur de lille, Centre for infection and immunity, Lille, France
FAU - Gosset, Philippe
AU  - Gosset P
AD  - Institut pasteur de lille, Centre for infection and immunity, Lille, France
FAU - Courty, Y.
AU  - Courty Y
AD  - Inserm u1100, Centre d’étude des pathologies respiratoires, Tours, France
FAU - Diot, Patrice
AU  - Diot P
AD  - Pneumologie, CHRU Hôpitaux de Tours, Tours, France
FAU - Si-Tahar, Mustapha
AU  - Si-Tahar M
AD  - Inserm u1100, Centre d’étude des pathologies respiratoires, Tours, France
FAU - Tadié, Jean-Marc
AU  - Tadié JM
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Rennes, Rennes, France
FAU - Vuillard, Constance
AU  - Vuillard C
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - La Combe, Béatrice
AU  - La Combe B
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - Ponsin, Pauline
AU  - Ponsin P
AD  - Hôpital d’Instruction des Armées Percy, Clamart, France
FAU - Boddaert, Guillaume
AU  - Boddaert G
AD  - Chirurgie thoracique et vasculaire, Hôpital d’Instruction des Armées Percy,
      Avenue Henri Barbusse, Clamart, France
FAU - Grand, Bertrand
AU  - Grand B
AD  - Chirurgie thoracique et vasculaire, Hôpital d’Instruction des Armées Percy,
      Avenue Henri Barbusse, Clamart, France
FAU - Baudoin, Yohan
AU  - Baudoin Y
AD  - Chirurgie viscérale, Hôpital d’Instruction des Armées Percy, Avenue Henri
      Barbusse, Clamart, France
FAU - Bonnet, Stéphane
AU  - Bonnet S
AD  - Chirurgie viscérale, Hôpital d’Instruction des Armées Percy, Avenue Henri
      Barbusse, Clamart, France
FAU - Snouda, Salah
AU  - Snouda S
AD  - Teaching Department of Emergency and Intensive Care, Regional hospital of
      Zaghouan, Zaghouan, Tunisia
FAU - Abbes, Mohamed Fehmi
AU  - Abbes MF
AD  - Cardiology, Regional hospital of Zaghouan, Zaghouan, Tunisia
FAU - Benchiekh, Imen
AU  - Benchiekh I
AD  - Teaching Department of Emergency and Intensive Care, Regional hospital of
      Zaghouan, Zaghouan, Tunisia
FAU - Cheikh, Chaigar Mohammed
AU  - Cheikh CM
AD  - Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Sedghiani, Ines
AU  - Sedghiani I
AD  - Emergency and Intensive Care Department, Hopital Habib Thameur, Tunis, Tunisia
FAU - Maaroufi, Neila
AU  - Maaroufi N
AD  - General Hospital, Tunis, Tunisia
FAU - Belayachi, Jihane
AU  - Belayachi J
AD  - Medical Emergency Department, Ibn Sina University Hospital, Rabat, Morocco
FAU - Debono, Leila
AU  - Debono L
AD  - Medical Emergency Department, Ibn Sina University Hospital, Rabat, Morocco
FAU - Auvet, Adrien
AU  - Auvet A
AD  - Réanimation polyvalente, CHRU Hôpitaux de Tours, Tours, France
FAU - Nadal-Desbarats, Lydie
AU  - Nadal-Desbarats L
AD  - INSERM U930 équipe 2, Université françois Rabelais, Tours, France
FAU - Tankovic, Jacques
AU  - Tankovic J
AD  - Bactériologie, Hôpital Saint-Antoine, Paris, France
FAU - Dahoumane, Redouane
AU  - Dahoumane R
AD  - Bactériologie, Hôpital Saint-Antoine, Paris, France
FAU - Oufella, Hafid Ait
AU  - Oufella HA
AD  - Réanimation médicale, Hôpital Saint-Antoine, Paris, France
FAU - Offenstadt, Georges
AU  - Offenstadt G
AD  - Réanimation médicale, Hôpital Saint-Antoine, Paris, France
FAU - Filali, Amel
AU  - Filali A
AD  - Maladies Infectieuses, C.H.R.U. Lille, Lille, France
FAU - Faure, Emmanuel
AU  - Faure E
AD  - Groupe de recherche translationnelle relation hôte-pathogène, Universite Lille 2 
      - Droit et Santé, Lille, France
FAU - Van Grunderbeeck, Nicolas
AU  - Van Grunderbeeck N
AD  - Réanimation Polyvalente & USC, Centre Hospitalier de Lens, Lens, France
FAU - Nigeon, Olivier
AU  - Nigeon O
AD  - Service d’accueil des urgences & usc, Centre Hospitalier de Lens, Lens, France
FAU - Bazus, H.
AU  - Bazus H
AD  - Maladies Infectieuses, Centre Hospitalier de Lens, Lens, France
FAU - Mallat, Jihad
AU  - Mallat J
AD  - Réanimation Polyvalente & USC, Centre Hospitalier de Lens, Lens, France
FAU - Thevenin, Didier
AU  - Thevenin D
AD  - Réanimation Polyvalente & USC, Centre Hospitalier de Lens, Lens, France
FAU - Lempereur-Legros, Sophie
AU  - Lempereur-Legros S
AD  - ICU, CHR Verviers, Verviers, Belgium
FAU - Ledoux, Didier
AU  - Ledoux D
AD  - Soins intensifs généraux, CHU Sart-Tilman, Liège, Belgium
FAU - Nys, Monique
AU  - Nys M
AD  - Soins intensifs généraux, CHU Sart-Tilman, Liège, Belgium
FAU - Hajjej, Zied
AU  - Hajjej Z
AD  - Department of Critical Care Medicine and Anesthesiology, Military Hospital of
      Tunis, Tunis, Tunisia
FAU - Messika, Jonathan
AU  - Messika J
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - Clermont, Olivier
AU  - Clermont O
AD  - Iame, umr 1137, INSERM, Univ Paris Diderot, Sorbonne Paris Cité, Paris, France
FAU - Aubry, Alexandra
AU  - Aubry A
AD  - Service de microbiologie, Inserm u1135, Immunity and Infectious Diseases Center, 
      Hôpital de la Pitié-salpétrière, Sorbonne Universités, UPMC Univ Paris 06, Paris,
      France
FAU - Fernandes, Romain
AU  - Fernandes R
AD  - Iame, umr 1137, INSERM, Univ Paris Diderot, Sorbonne Paris Cité, Paris, France
FAU - Venot, Marion
AU  - Venot M
AD  - Réanimation médicale, Hôpital Saint-Louis, Paris, France
FAU - Bailly, Sébastien
AU  - Bailly S
AD  - Equipe 11, Institut Albert Bonniot - Inserm U823, La Tronche, France
FAU - Garnaud, Cécile
AU  - Garnaud C
AD  - Laboratoire de parasitologie-mycologie, C.H.U., La Tronche, France
FAU - Cornet, Muriel
AU  - Cornet M
AD  - Laboratoire de parasitologie-mycologie médicale, C.H.U. Grenoble, La Tronche,
      France
FAU - Pavese, Patricia
AU  - Pavese P
AD  - Maladies infectieuses, C.H.U., La Tronche, France
FAU - Foroni, Luc
AU  - Foroni L
AD  - Pharmacie, C.H.U. Grenoble, La Tronche, France
FAU - Boisset, Sandrine
AU  - Boisset S
AD  - Laboiratoire bactériologie-hygiène, C.H.U., La Tronche, France
FAU - le Maubon, Daniè
AU  - le Maubon D
AD  - Parasitologie-mycologie médicale, C.H.U. Grenoble, La Tronche, France
FAU - Ouanes, Islem
AU  - Ouanes I
AD  - Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Abid, Maha
AU  - Abid M
AD  - Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Ezzouine, Hanane
AU  - Ezzouine H
AD  - Anesthesiology and Intensive Care Department, University Teaching Hospital Ibn
      Rushd-Casablanca, Casablanca, Morocco
FAU - Edith, Constant Aniolo
AU  - Edith CA
AD  - Anesthesiology and Intensive Care Department, University Teaching Hospital Ibn
      Rushd-Casablanca, Casablanca, Morocco
FAU - Sztrymf, Benjamin
AU  - Sztrymf B
AD  - Réanimation polyvalente, Hôpital Antoine Béclère, Clamart, France
FAU - Brunot, Vincent
AU  - Brunot V
AD  - Réanimation médicale, CHU lapeyronie, Montpellier, France
FAU - Serre, Jean-Emmanuel
AU  - Serre JE
AD  - Néphrologie, Chu lapeyronie, Montpellier, France
FAU - Landreau, L.
AU  - Landreau L
AD  - Réanimation médicale, CHU lapeyronie, Montpellier, France
FAU - Boussarsar, Mohamed
AU  - Boussarsar M
AD  - Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Ouanes, Islem
AU  - Ouanes I
AD  - Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Jean-Michel, Vanessa
AU  - Jean-Michel V
AD  - Réanimation médicale, CHRU de Brest site La Cavale Blanche - Université de
      Bretagne Occidentale, Brest, France
FAU - Couturaud, Francis
AU  - Couturaud F
AD  - Département de médecine interne et pneumologie, ea 3878, cic inserm 1412, ifr
      148, CHRU de Brest site La Cavale Blanche - Université de Bretagne Occidentale,
      Brest, France
FAU - Moore, Elizabeth
AU  - Moore E
AD  - Department of Epidemiology Preventive Medicine, Monash University, Melbourne,
      Australia
FAU - Egreteau, Pierre-Yves
AU  - Egreteau PY
AD  - Réanimation, Centre Hospitalier des Pays de Morlaix, Morlaix, France
FAU - Boles, Jean-Michel
AU  - Boles JM
AD  - Réanimation médicale, CHRU de Brest site La Cavale Blanche - Université de
      Bretagne Occidentale, Brest, France
FAU - Herbrecht, Jean-Etienne
AU  - Herbrecht JE
AD  - Service de réanimation médicale, Hôpital de Hautepierre, Hôpitaux Universitaires 
      de Strasbourg, Strasbourg, France
FAU - Kaeuffer, Charlotte
AU  - Kaeuffer C
AD  - Réanimation médicale, Hôpitaux Universitaires de Strasbourg (Hôpital de
      Hautepierre), Strasbourg, France
FAU - Meyer, Anne
AU  - Meyer A
AD  - Réanimation médicale, Hôpitaux Universitaires de Strasbourg (Hôpital de
      Hautepierre), Strasbourg, France
FAU - Mokline, Amel
AU  - Mokline A
AD  - Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia
FAU - Arfi, Khaouther Ben
AU  - Arfi KB
AD  - Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia
FAU - Lesage, Fabrice
AU  - Lesage F
AD  - Réanimation et surveillance continue pédiatriques, CHU Necker-Enfants Malades,
      Paris, France
FAU - Séguret, Sylvie
AU  - Séguret S
AD  - Réanimation et surveillance continue pédiatriques, CHU Necker-Enfants Malades,
      Paris, France
FAU - Dupic, Laurent
AU  - Dupic L
AD  - Réanimation et surveillance continue pédiatriques, CHU Necker-Enfants Malades,
      Paris, France
FAU - De Saint Blanquat, Laure
AU  - De Saint Blanquat L
AD  - Réanimation et surveillance continue pédiatriques, CHU Necker-Enfants Malades,
      Paris, France
FAU - Baptiste, Anne-Sophie
AU  - Baptiste AS
AD  - Hospital Center De Tourcoing, Tourcoing, France
FAU - Georges, Hugues
AU  - Georges H
AD  - Réanimation, Centre Hospitalier de Tourcoing, Tourcoing, France
FAU - Delannoy, Pierre-Yves
AU  - Delannoy PY
AD  - Réanimation, Centre Hospitalier de Tourcoing, Tourcoing, France
FAU - Devos, Patrick
AU  - Devos P
AD  - Laboratoire de biostatistiques, Maison régionale de la recherche clinique, Lille,
      France
FAU - Albarracin, Dolores
AU  - Albarracin D
AD  - Departement de psychologie ea 4050 caps, Université de Poitiers, Poitiers, France
FAU - Ducousso-Lacaze, A.
AU  - Ducousso-Lacaze A
AD  - Departement de psychologie ea 4050 caps, Université de Poitiers, Poitiers, France
FAU - Dufour, Julien
AU  - Dufour J
AD  - Service de réanimation médicale, Chu De Poitiers, Poitiers, France
FAU - Cabasson, Séverin
AU  - Cabasson S
AD  - Service de réanimation, Centre Hospitalier La Rochelle, La Rochelle, France
FAU - Veinstein, Anne
AU  - Veinstein A
AD  - Service de réanimation médicale, Chu De Poitiers, Poitiers, France
FAU - Chatellier, Delphine
AU  - Chatellier D
AD  - Service de réanimation médicale, Chu De Poitiers, Poitiers, France
FAU - Robert, René
AU  - Robert R
AD  - Réanimation médicale, Chu De Poitiers, Poitiers, France
FAU - Ha, Vivien Hong Tuan
AU  - Ha VHT
AD  - Intensive Care Unit, Hospital Center De Meaux, Meaux, France
FAU - Lau, Nicolas
AU  - Lau N
AD  - Réanimation, Hôpital de Meaux, Meaux, France
FAU - Mimoun, Lucie
AU  - Mimoun L
AD  - Réanimation, Hôpital de Meaux, Meaux, France
FAU - Forceville, Xavier
AU  - Forceville X
AD  - Réanimation, Hôpital de Meaux, Meaux, France
FAU - Maamar, Adel
AU  - Maamar A
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Rennes, Rennes, France
FAU - Chevalier, Stéphanie
AU  - Chevalier S
AD  - Réanimation polyvalente, C.H. de Saint Malo, Saint-Malo, France
FAU - Botoc, Vlad
AU  - Botoc V
AD  - Réanimation polyvalente, C.H. de Saint Malo, Saint-Malo, France
FAU - Rouleau, Stephane
AU  - Rouleau S
AD  - Service de réanimation polyvalente, CH D’Angoulême, Angoulême, France
FAU - Desachy, Arnaud
AU  - Desachy A
AD  - Service de réanimation polyvalente, CH D’Angoulême, Angoulême, France
FAU - Calvat, Sylvie
AU  - Calvat S
AD  - Service de réanimation polyvalente, CH D’Angoulême, Angoulême, France
FAU - Lafon, Charles
AU  - Lafon C
AD  - Service de réanimation polyvalente, CH D’Angoulême, Angoulême, France
FAU - Cracco, Christophe
AU  - Cracco C
AD  - Service de réanimation polyvalente, CH D’Angoulême, Angoulême, France
FAU - Van Grunderbeeck, Nicolas
AU  - Van Grunderbeeck N
AD  - Réanimation Polyvalente & USC, C.H. de Lens, Lens, France
FAU - Temime, J.
AU  - Temime J
AD  - Réanimation Polyvalente & USC, C.H. de Lens, Lens, France
FAU - Molmy, Perrine
AU  - Molmy P
AD  - Réanimation Polyvalente & USC, C.H. de Lens, Lens, France
FAU - Gasan, G.
AU  - Gasan G
AD  - Réanimation Polyvalente & USC, C.H. de Lens, Lens, France
FAU - Béranger, Agathe
AU  - Béranger A
AD  - Laboratoire d’éthique médicale, Université Paris Descartes, Paris, France
FAU - Chappuy, Hélène
AU  - Chappuy H
AD  - Urgences pédiatriques, Hôpital Trousseau, Paris, France
FAU - Bertrand, Pierre-Marie
AU  - Bertrand PM
AD  - Service de réanimation médico-chirurgicale, Centre Hospitalier, Cannes, France
FAU - Beurton, Alexandra
AU  - Beurton A
AD  - Intensive Care and Respiratory Division, Pitié-Salpêtrière Hospital, Paris,
      France
FAU - Bodet-Contentin, Laetitia
AU  - Bodet-Contentin L
AD  - Réanimation polyvalente, CHRU Hôpitaux de Tours, Tours, France
FAU - Boisramé-Helms, Julie
AU  - Boisramé-Helms J
AD  - Réanimation médicale, Nouvel Hôpital Civil, CHU Strasbourg, Strasbourg, France
FAU - Danin, Pierre-éRic
AU  - Danin Pé
AD  - Réanimation chirurgicale, Hôpital l’Archet 2, Nice, France
FAU - Dubois, Elsa
AU  - Dubois E
AD  - Sau-samu-smur, C.H.U. de Nancy, Nancy, France
FAU - Karaca, Yasemin
AU  - Karaca Y
AD  - Service de réanimation pédiatrique, CHRU de Lille - Hôpital Jeanne de Flandre,
      Lille, France
FAU - Mora, Pierre
AU  - Mora P
AD  - Service de réanimation médicale, CHU Cochin - Saint-Vincent de Paul - Site
      Cochin, Paris, France
FAU - Vodovar, Dominique
AU  - Vodovar D
AD  - Réanimation Médicale et Toxicologique, Hôpital Lariboisière, Paris, France
CN  - Committee of young intensivists of the French Society for Intensive Care Medicine
      (FICS)
FAU - Desbrosses, Yohan
AU  - Desbrosses Y
AD  - Hématologie, CHRU de Besançon, Besançon, France
FAU - Chauchet, Adrien
AU  - Chauchet A
AD  - Hématologie, CHRU de Besançon, Besançon, France
FAU - Daguindau, Etienne
AU  - Daguindau E
AD  - Hématologie, CHRU de Besançon, Besançon, France
FAU - Deconinck, Eric
AU  - Deconinck E
AD  - Hématologie, CHRU de Besançon, Besançon, France
FAU - Chermak, Akli
AU  - Chermak A
AD  - Réanimation médicale, Hôpital Saint-Louis, Paris, France
FAU - Baron, Marinne
AU  - Baron M
AD  - Immuno Hematologie, Hôpital Saint-Louis, Paris, France
FAU - Calvet, Laure
AU  - Calvet L
AD  - Réanimation médicale, CHU Gabriel-Montpied, Clermont-Ferrand, France
FAU - Sapin, Anne Françoise
AU  - Sapin AF
AD  - Laboratoire d’hématologie, CHU Estaing, Clermont-Ferrand, France
FAU - Pereira, Bruno
AU  - Pereira B
AD  - Department of clinical research and innovation (DRCI), CHU Clermont-Ferrand,
      Clermont-Ferrand, France
FAU - Vettoretti, Lucie
AU  - Vettoretti L
AD  - Réanimation médicale, CHRU de Besançon, Besançon, France
FAU - Lacroix, Jacques
AU  - Lacroix J
AD  - Urgences et soins intensifs pédiatriques, CHU Sainte-Justine, Montréal, Canada
FAU - Clayton, Lucy
AU  - Clayton L
AD  - Clinical Research, CHU Sainte-Justine, Montréal, Canada
FAU - Sabri, Elham
AU  - Sabri E
AD  - Centre for Practice-Changing Research, Hospital Research Institute, Ottawa,
      Canada
FAU - Bardiaux, Laurent
AU  - Bardiaux L
AD  - Distribution, Etablissement Français du Sang, Besançon, France
FAU - Tiberghien, Pierre
AU  - Tiberghien P
AD  - Direction de la recherche, Etablissement Français du Sang, Saint-Denis, France
FAU - Hebert, Paul
AU  - Hebert P
AD  - Hospital Research Institute, Ottawa, Canada
CN  - ABLE French Investigators
FAU - Lengliné, Etienne
AU  - Lengliné E
AD  - Hématologie, Hôpital Saint Louis, Paris, France
FAU - Venot, Marion
AU  - Venot M
AD  - Réanimation médicale, Hôpital Saint-Louis, Paris, France
FAU - Socié, Gérard
AU  - Socié G
AD  - Hématologie-greffe de moelle, Hôpital Saint Louis, Paris, France
FAU - Borcoman, Edith
AU  - Borcoman E
AD  - Réanimation médicale, Hôpital Saint Louis, Paris, France
FAU - Rusinova, Katerina
AU  - Rusinova K
AD  - Department of Anesthesiology and Intensive Care, First Faculty of Medicine
      Charles University in Prague and General University Hospital in Prague, Prague,
      Czech Republic
CN  - Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie
FAU - Del Galy, Aurélien Sutra
AU  - Del Galy AS
AD  - Maladies du sang, Centre Hospitalier Universitaire d’Angers, Angers, France
FAU - Mercier, Mélanie
AU  - Mercier M
AD  - Maladies du sang, Centre Hospitalier Universitaire d’Angers, Angers, France
FAU - Hamel, Jean-François
AU  - Hamel JF
AD  - Département de réanimation médicale et de médecine hyperbare, C.H.U. d’Angers,
      Angers, France
FAU - Raveau, Tommy
AU  - Raveau T
AD  - Service de réanimation médicale et médecine hyperbare, Centre Hospitalier
      Universitaire d’Angers, Angers, France
FAU - Moles, Marie-Pierre
AU  - Moles MP
AD  - Maladies du sang, Centre Hospitalier Universitaire d’Angers, Angers, France
FAU - Clavert, Aline
AU  - Clavert A
AD  - Maladies du sang, Centre Hospitalier Universitaire d’Angers, Angers, France
FAU - Hunault-Berger, Mathilde
AU  - Hunault-Berger M
AD  - Maladies du sang, Centre Hospitalier Universitaire d’Angers, Angers, France
FAU - Ifrah, Norbert
AU  - Ifrah N
AD  - Maladies du sang, Centre Hospitalier Universitaire d’Angers, Angers, France
FAU - Schmidt-Tanguy, Aline
AU  - Schmidt-Tanguy A
AD  - Maladies du sang, Centre Hospitalier Universitaire d’Angers, Angers, France
FAU - Carreira, Serge
AU  - Carreira S
AD  - Anesthesia and Intensice Care Unit, Hospital Saint-Camille, Bry-sur-Marne, France
FAU - Lavault, Sophie
AU  - Lavault S
AD  - Sleep disorder unit, Pitié-Salpêtrière Hospital, Paris, France
FAU - Pallanca, Olivier
AU  - Pallanca O
AD  - Sleep disorder unit, Pitié-Salpêtrière Hospital, Paris, France
FAU - Morawiec, Elise
AU  - Morawiec E
AD  - Intensive Care and Respiratory Division, Pitié-Salpêtrière Hospital, Paris,
      France
FAU - Arnulf, Isabelle
AU  - Arnulf I
AD  - Sleep disorder unit, Pitié-Salpêtrière Hospital, Paris, France
FAU - D’humières, Thomas
AU  - D’humières T
AD  - ICU, Clinical Ambroise Paré, Neuilly-sur-Seine, France
FAU - Carrié, Cédric
AU  - Carrié C
AD  - Réanimation des urgences, Centre Hospitalier Universitaire de Bordeaux, Bordeaux,
      France
FAU - Gisbert-Mora, Chloé
AU  - Gisbert-Mora C
AD  - 33, Hospital Pellegrin, Bordeaux, France
FAU - Bonnardel, Eline
AU  - Bonnardel E
AD  - Réanimation des urgences, Centre Hospitalier Universitaire de Bordeaux, Bordeaux,
      France
FAU - Biais, Matthieu
AU  - Biais M
AD  - Réanimation des urgences, Centre Hospitalier Universitaire de Bordeaux, Bordeaux,
      France
FAU - Hilbert, Gilles
AU  - Hilbert G
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux,
      France
FAU - Bureau, Côme
AU  - Bureau C
AD  - Intensive Care and Respiratory Division, Pitié-Salpêtrière Hospital, Paris,
      France
FAU - Joannon, Thomas
AU  - Joannon T
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Marincamp, Aude
AU  - Marincamp A
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Chiche, Jean-Daniel
AU  - Chiche JD
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Ferre, Alexis
AU  - Ferre A
AD  - Service de réanimation médicale, inserm umr_s 999, Hôpital de Bicêtre, Université
      Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre,
      France
FAU - Lichtenstein, Daniel
AU  - Lichtenstein D
AD  - Service de réanimation médicale, AP-HP, Hôpital Ambroise-Paré,
      Boulogne-Billancourt, France
FAU - Meziere, Gilbert
AU  - Meziere G
AD  - Service de réanimation polyvalente, Centre hospitalier de Sens, Sens, France
FAU - Dres, Martin
AU  - Dres M
AD  - Intensive Care and Respiratory Division, Pitié-Salpêtrière Hospital, Paris,
      France
FAU - Gonzalez, Céline
AU  - Gonzalez C
AD  - Réanimation Polyvalente, CHU Limoges, Limoges, France
FAU - Vignon, Philippe
AU  - Vignon P
AD  - Service de réanimation polyvalente, Centre Hospitalier Universitaire de Limoges, 
      Limoges, France
FAU - Hamzaoui, Olfa
AU  - Hamzaoui O
AD  - Réanimation polyvalente, Hôpital Antoine Béclère, Clamart, France
FAU - Geffriaud, Thomas
AU  - Geffriaud T
AD  - Service de réanimation médicale, Hôpital de Bicêtre, Faculté de médecine
      Paris-Sud, université Paris-Sud, Le Kremlin-Bicêtre, France
FAU - Leleu, François
AU  - Leleu F
AD  - Réanimation médicale, Centre Hospitalier Universitaire, Amiens, France
FAU - Maizel, Julien
AU  - Maizel J
AD  - Réanimation médicale, Centre Hospitalier Universitaire, Amiens, France
FAU - Boissier, Florence
AU  - Boissier F
AD  - Réanimation médicale, Hopital Europeen Georges-Pompidou, Paris, France
FAU - Cuquemelle, Elise
AU  - Cuquemelle E
AD  - 92151, Hospital Foch, Suresnes, France
FAU - Lim, Pascal
AU  - Lim P
AD  - Cardiologie, Hôpital Henri Mondor, Créteil, France
FAU - Amara, R.
AU  - Amara R
AD  - Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Boussarsar, Mohamed
AU  - Boussarsar M
AD  - Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Léger, Julie
AU  - Léger J
AD  - Inserm cic 1415, C.H. Régional Universitaire de TOURS, Tours, France
FAU - Jacob, Christophe
AU  - Jacob C
AD  - Réanimation médicale, CHRU de Brest, Brest, France
FAU - Bouferache, Koceila
AU  - Bouferache K
AD  - Réanimation polyvalente, Hôpital Foch, Suresnes, France
FAU - Vignon, Philippe
AU  - Vignon P
AD  - Inserm cic 1435/medical-surgical icu/umr 1092, Medecine University, Chu Limoges, 
      Limoges, France
FAU - Ragot, Claire
AU  - Ragot C
AD  - 33, Hopital Robert Boulin, Libourne, France
FAU - Corradi, Laure
AU  - Corradi L
AD  - 974, Hopital Felix Guyon, Saint-Denis, France
FAU - Maizel, Julien
AU  - Maizel J
AD  - Réanimation médicale, Centre Hospitalier Universitaire, Amiens, France
FAU - Maurice, Laure
AU  - Maurice L
AD  - Hospital Robert-Debré, Paris, France
FAU - Julliand, S.
AU  - Julliand S
AD  - Reanimation Pediatrique, Hospital Robert-Debré, Paris, France
FAU - Deho, Anna
AU  - Deho A
AD  - Réanimation et surveillance continue pédiatriques, CHU Robert Debré, Paris,
      France
FAU - Le Bourgeois, Fleur
AU  - Le Bourgeois F
AD  - Réanimation et surveillance continue pédiatriques, Hôpital Robert Debré, Paris,
      France
FAU - Jacquot, Aurelien
AU  - Jacquot A
AD  - Réanimation pédiatrique, CHU de Montpellier - Hôpital Arnaud de Villeneuve,
      Montpellier, France
FAU - Valla, Frederic
AU  - Valla F
AD  - Réanimation pédiatrique hfme, Hospices civils de Lyon, Lyon, France
FAU - Letois, Flavie
AU  - Letois F
AD  - Inserm cic 1411, CHU de Montpellier, Montpellier, France
CN  - NutriSIP
FAU - Salvadori, Alexandre
AU  - Salvadori A
AD  - HIA Bégin, Paris, France
FAU - Ottonello, Gaia
AU  - Ottonello G
AD  - Intensive Care, Fondazione IRCCS - Policlinico San Matteo, Pavia, Italy
FAU - Blanot, Stéphane
AU  - Blanot S
AD  - Réanimation neurochirurgicale pédiatrique, Hospital Necker, Paris, France
FAU - Montmayeur, Juliette
AU  - Montmayeur J
AD  - Réanimation neurochirurgicale pédiatrique, Hospital Necker, Paris, France
FAU - Orliaguet, Gilles
AU  - Orliaguet G
AD  - Réanimation neurochirurgicale pédiatrique, Hospital Necker, Paris, France
FAU - Tarmiz, Khalil
AU  - Tarmiz K
AD  - Sousse Centre, Chu Farhat Hached, Sousse, Tunisia
FAU - Habas, Flora
AU  - Habas F
AD  - Réanimation pédiatrique, Hôpital Arnaud-de-Villeneuve, Montpellier, France
FAU - Baleine, Julien
AU  - Baleine J
AD  - Réanimation pédiatrique, Hôpital Arnaud-de-Villeneuve, Montpellier, France
FAU - Lebouhellec, Julia
AU  - Lebouhellec J
AD  - Réanimation pédiatrique, Hôpital Arnaud-de-Villeneuve, Montpellier, France
FAU - Combes, Clementine
AU  - Combes C
AD  - Réanimation pédiatrique, Hôpital Arnaud-de-Villeneuve, Montpellier, France
FAU - Chomton, Maryline
AU  - Chomton M
AD  - Soins intensifs pédiatriques, CHU Sainte-Justine, Montréal, Canada
FAU - Jouvet, Philippe
AU  - Jouvet P
AD  - Soins intensifs pédiatriques, CHU Sainte-Justine, Montréal, Canada
FAU - Ranchin, Bruno
AU  - Ranchin B
AD  - Pédiatrie, CHU Lyon, Lyon, France
FAU - Macher, Marie Alice
AU  - Macher MA
AD  - Pédiatrie, CHU Robert Debré, Paris, France
FAU - Gaillot, Théophile
AU  - Gaillot T
AD  - Pédiatrie, Hospital Center University De Rennes, Rennes, France
CN  - EPURE Study Group
FAU - Bahloul, Mabrouk
AU  - Bahloul M
AD  - Réanimation polyvalente, Faculté de médecine de Sfax, Sfax, Tunisia
FAU - Moine, Murielle
AU  - Moine M
AD  - Reanimation Pediatrique, C.H.U., La Tronche, France
FAU - Ageron, François Xavier
AU  - Ageron FX
AD  - Pôle SAU - SAMU 74 - Réanimation, CHANGE, Annecy, France
FAU - Jannel, Claire
AU  - Jannel C
AD  - Reanimation Pediatrique, C.H.U., La Tronche, France
FAU - Debillon, Thierry
AU  - Debillon T
AD  - Reanimation Pediatrique, C.H.U., La Tronche, France
FAU - Wroblewski, Isabelle
AU  - Wroblewski I
AD  - Reanimation Pediatrique, C.H.U., La Tronche, France
FAU - Duprey, Matthieu
AU  - Duprey M
AD  - Service de Réanimation Médicale, Groupe Hospitalier Pitié Salpêtrière, Paris,
      France
FAU - Jarlier, Vincent
AU  - Jarlier V
AD  - Service de microbiologie, Inserm u1135, Immunity and Infectious Diseases Center, 
      Hôpital de la Pitié-salpétrière, Sorbonne Universités, UPMC Univ Paris 06, Paris,
      France
FAU - Luyt, Charles-Edouard
AU  - Luyt CE
AD  - Service de Réanimation Médicale, Groupe Hospitalier Pitié Salpêtrière, Paris,
      France
FAU - Bailly, Sébastien
AU  - Bailly S
AD  - Descid - team 5, INSERM U1137 - IAME, Paris, France
FAU - Longval, Thomas
AU  - Longval T
AD  - Réanimation médicale, Hôpital Saint Louis, Paris, France
FAU - Schnell, David
AU  - Schnell D
AD  - Service de réanimation polyvalente, CH D’Angoulême, Angoulême, France
FAU - Padoin, Christophe
AU  - Padoin C
AD  - Service Pharmacie, Laboratoire de contrôle, Hopital Avicenne, Bobigny, France
FAU - Cohen, Yves
AU  - Cohen Y
AD  - Réanimation médico-chirugicale, Hôpital Avicenne, Université Paris 13, Bobigny,
      France
FAU - Mokline, Amel
AU  - Mokline A
AD  - Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia
FAU - Gaies, Emna
AU  - Gaies E
AD  - Laboratory of pharmacology, Charles Nicolle Hospital, Tunis, Tunisia
FAU - Triki, Sameh
AU  - Triki S
AD  - Laboratory of pharmacology, Charles Nicolle Hospital, Tunis, Tunisia
FAU - Klouz, Anis
AU  - Klouz A
AD  - Laboratory of pharmacology, Charles Nicolle Hospital, Tunis, Tunisia
FAU - Moussa, Mouhamed
AU  - Moussa M
AD  - Nord, C.H.R.U. Lille, Lille, France
FAU - Desrumaux, Flavie
AU  - Desrumaux F
AD  - Nord, C.H.R.U. Lille, Lille, France
FAU - May, Faten
AU  - May F
AD  - Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Perrin, Marion
AU  - Perrin M
AD  - Biostatistics, CHU, Grenoble, France
FAU - Nguyen, Jean-Claude
AU  - Nguyen JC
AD  - Microbiologie, Groupe Hospitalier Paris Saint-Joseph, Paris, France
FAU - Tiercelet, Kelly
AU  - Tiercelet K
AD  - Réanimation polyvalente, Hospital Group Paris Saint-Joseph, Paris, France
FAU - Fournier, Julien
AU  - Fournier J
AD  - Réanimation polyvalente, Hospital Group Paris Saint-Joseph, Paris, France
FAU - Cherin, Mélanie
AU  - Cherin M
AD  - Réanimation polyvalente, Groupe Hospitalier Paris-Saint-Joseph, Paris, France
FAU - Kitzis, Marie Dominique
AU  - Kitzis MD
AD  - Microbiologie clinique, Groupe Hospitalier Paris-Saint-Joseph, Paris, France
FAU - Misset, Benoit
AU  - Misset B
AD  - Réanimation polyvalente, Groupe Hospitalier Paris-Saint-Joseph, Paris, France
FAU - Mathien, Cyrille
AU  - Mathien C
AD  - 68, Hospital Center De Mulhouse, Mulhouse, France
FAU - Poidevin, Antoine
AU  - Poidevin A
AD  - 68, Hospital Center De Mulhouse, Mulhouse, France
FAU - Donatti, Luis
AU  - Donatti L
AD  - 68, Hospital Center De Mulhouse, Mulhouse, France
FAU - Mootien, Joy
AU  - Mootien J
AD  - 68, Hospital Center De Mulhouse, Mulhouse, France
FAU - Pinto, Luis
AU  - Pinto L
AD  - Réanimation médicale, Centre Hospitalier de Mulhouse, Mulhouse, France
FAU - Egard, Mathieu
AU  - Egard M
AD  - Réanimation médicale, Centre Hospitalier de Mulhouse, Mulhouse, France
FAU - Bodur, Gokhan
AU  - Bodur G
AD  - Réanimation médicale, Centre Hospitalier de Mulhouse, Mulhouse, France
FAU - Barberet, Guillaume
AU  - Barberet G
AD  - Réanimation médicale, Centre Hospitalier de Mulhouse, Mulhouse, France
FAU - Ionescu, Carmen
AU  - Ionescu C
AD  - Réanimation médicale, Centre Hospitalier de Mulhouse, Mulhouse, France
FAU - Ganster, Frederique
AU  - Ganster F
AD  - Réanimation médicale, Centre Hospitalier de Mulhouse, Mulhouse, France
FAU - Guiot, Philippe
AU  - Guiot P
AD  - 68, Hospital Center De Mulhouse, Mulhouse, France
FAU - Kuteifan, Khaldoun
AU  - Kuteifan K
AD  - Réanimation médicale, Centre Hospitalier de Mulhouse, Mulhouse, France
FAU - Mpela, Alain
AU  - Mpela A
AD  - Médecine intensive, Centre Hospitalier Marc Jacquet, Melun, France
FAU - Chelly, Jonathan
AU  - Chelly J
AD  - Médecine intensive, Centre Hospitalier Marc Jacquet, Melun, France
FAU - Guérin, Laurent
AU  - Guérin L
AD  - Réanimation, Hospital Ambroise Paré, Boulogne-Billancourt, France
FAU - Persichini, Romain
AU  - Persichini R
AD  - Réanimation médicale, Hospital Bicêtre, Le Kremlin-Bicêtre, France
FAU - Hullin, Thomas
AU  - Hullin T
AD  - Réanimation, Centre Hospitalier d’Etampes, Étampes, France
FAU - Deye, Nicolas
AU  - Deye N
AD  - Réanimation Médicale et Toxicologique, Hôpital Lariboisière, Paris, France
FAU - Aubertein, Pierre
AU  - Aubertein P
AD  - Médecine intensive, Centre Hospitalier Marc Jacquet, Melun, France
FAU - Paul, Marine
AU  - Paul M
AD  - Réanimation médicale, Cochin Port-Royal, Paris, France
FAU - Bougouin, Wulfran
AU  - Bougouin W
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Sandroni, Claudio
AU  - Sandroni C
AD  - Department of Anaesthesiology and Intensive Care, Catholic University School of
      Medicine, Rome, Italy
FAU - Passouant, Olivier
AU  - Passouant O
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Geri, Guillaume
AU  - Geri G
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Llitjos, Jean-François
AU  - Llitjos JF
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Chenevier-Gobeaux, Camille
AU  - Chenevier-Gobeaux C
AD  - Biology, Cochin Port-Royal, Paris, France
FAU - Batteux, Frederic
AU  - Batteux F
AD  - Biology, Cochin Port-Royal, Paris, France
FAU - Llitjos, Jean-François
AU  - Llitjos JF
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Drouet, Ludovic
AU  - Drouet L
AD  - Department of Angio-Hematology, Hospital Lariboisière, Paris, France
FAU - Voicu, Sebastian
AU  - Voicu S
AD  - Intensive Care Unit, Hospital Lariboisière, Paris, France
FAU - Henry, Patrick
AU  - Henry P
AD  - Cardiology, Hospital Lariboisière, Paris, France
FAU - Dillinger, Jean-Guillaume
AU  - Dillinger JG
AD  - Cardiology, Hospital Lariboisière, Paris, France
FAU - Bougouin, Wulfran
AU  - Bougouin W
AD  - Cochin Hospital, Paris, France
FAU - Resiere, Dabor
AU  - Resiere D
AD  - Service de réanimation médico-chirurgicale, CHU de Fort de France,
      Fort-de-France, France
FAU - Dessoy, A. L.
AU  - Dessoy AL
AD  - Service de réanimation médico-chirurgicale, CHU de Fort de France,
      Fort-de-France, France
FAU - Soyer, Benjamin
AU  - Soyer B
AD  - Réanimation chirurgicale, CHU Lariboisière, Paris, France
FAU - Faivre, Valérie
AU  - Faivre V
AD  - Réanimation chirurgicale, CHU Lariboisière, Paris, France
FAU - Damoisel, Charles
AU  - Damoisel C
AD  - Réanimation chirurgicale, CHU Lariboisière, Paris, France
FAU - Soyer, Benjamin
AU  - Soyer B
AD  - Réanimation chirurgicale, CHU Lariboisière, Paris, France
FAU - Stiel, Laure
AU  - Stiel L
AD  - Réanimation Médicale NHC, CHU de Strasbourg, Strasbourg, France
FAU - Galoisy, Anne-Cécile
AU  - Galoisy AC
AD  - Laboratoire d’hématologie, CHU de Strasbourg, Strasbourg, France
FAU - Mauvieux, Laurent
AU  - Mauvieux L
AD  - Laboratoire d’hématologie, CHU de Strasbourg, Strasbourg, France
FAU - Zobairi, Fatiha
AU  - Zobairi F
AD  - Ea7293, Strasbourg University, Strasbourg, France
FAU - Angles-Cano, Eduardo
AU  - Angles-Cano E
AD  - Inserm umr_s1140 “innovative therapies in haemostasis”, Inserm, Paris, France
FAU - Stiel, Laure
AU  - Stiel L
AD  - Réanimation Médicale NHC, CHU de Strasbourg, Strasbourg, France
FAU - Piau, Caroline
AU  - Piau C
AD  - Service de bactériologie et hygiène hospitalière, Centre Hospitalier
      Universitaire de Rennes, Rennes, France
FAU - Tadié, Jean-Marc
AU  - Tadié JM
AD  - Réanimation médicale, Centre Hospitalier Universitaire de Rennes, Rennes, France
FAU - Daix, Thomas
AU  - Daix T
AD  - Inserm cic 1435/medical-surgical icu, Chu Limoges, Limoges, France
FAU - Jeannet, Robin
AU  - Jeannet R
AD  - UMR CNRS 7276, Medecine University, Chu Limoges, Limoges, France
FAU - Feuillard, Jean
AU  - Feuillard J
AD  - Hematology Laboratory/umr cnrs 7276, Medecine university, Chu Limoges, Limoges,
      France
FAU - Jolly, Lucie
AU  - Jolly L
AD  - Inserm u1116, Faculté de Médecine, Vandœuvre-lès-Nancy, France
FAU - Boufenzer, Amir
AU  - Boufenzer A
AD  - Inotrem, Nancy, France
FAU - Carrasco, Kevin
AU  - Carrasco K
AD  - Inserm u1116, Faculté de Médecine, Vandœuvre-lès-Nancy, France
FAU - Derive, Marc
AU  - Derive M
AD  - Inotrem, Nancy, France
FAU - Gibot, Sebastien
AU  - Gibot S
AD  - Réanimation Médicale, Hôpital Central, C.H.U. de Nancy, Nancy, France
FAU - Merdji, Hamid
AU  - Merdji H
AD  - Departement d’anesthésie-réanimation, CHU de Reims, Reims, France
FAU - Belaidouni, Nadia
AU  - Belaidouni N
AD  - U1016, 22 rue méchain, 75014, Paris, Institut National de la Santé et de la
      Recherche Médicale, Paris, France
FAU - Toubiana, Julie
AU  - Toubiana J
AD  - U1016, 22 rue méchain, 75014, Paris, Institut National de la Santé et de la
      Recherche Médicale, Paris, France
FAU - L’Hermitte, Yann
AU  - L’Hermitte Y
AD  - Fédération des urgences, hôpital marc jacquet melun, GCSdSISIF, Paris, Melun,
      France
FAU - Woimant, France
AU  - Woimant F
AD  - Hôpital lariboisière Paris, Agence régionnale de Santé, Paris, France
FAU - Oppenheim, Catherine
AU  - Oppenheim C
AD  - Neuroradiologie, C.H. Sainte Anne, Paris, France
FAU - Couvreur, Christophe
AU  - Couvreur C
AD  - GCSdSISIF, Paris, France
FAU - Dolveck, François
AU  - Dolveck F
AD  - Fédération des urgences, hôpital marc jacquet melun, GCSdSISIF, Paris, Melun,
      France
FAU - Devriese, Magali
AU  - Devriese M
AD  - Service de biochimie et hormonologie, Hôpital Tenon, Sorbonne Universités, UPMC
      Université Paris 06, Paris, France
FAU - Dupeyrat, Sophie
AU  - Dupeyrat S
AD  - Réanimation médico-chirurgicale, Hôpital Tenon, Sorbonne Universités, UPMC
      Université Paris 06, Paris, France
FAU - Ray, Patrick
AU  - Ray P
AD  - Service d’acceuil des urgences, Hôpital Tenon, Sorbonne Universités, UPMC
      Université Paris 06, Paris, France
FAU - Lefevre, Guillaume
AU  - Lefevre G
AD  - Service de biochimie et hormonologie, Hôpital Tenon, Sorbonne Universités, UPMC
      Université Paris 06, Paris, France
FAU - Fartoukh, Muriel
AU  - Fartoukh M
AD  - Réanimation médico-chirurgicale, Hôpital Tenon, Paris, France
FAU - Roothaer, Nicolas
AU  - Roothaer N
AD  - 59, Hospital Center De Valenciennes, Valenciennes, France
FAU - Carpentier, Amélie
AU  - Carpentier A
AD  - 59, Hospital Center De Valenciennes, Valenciennes, France
FAU - Vaniet, Fabien
AU  - Vaniet F
AD  - 59, Hospital Center De Valenciennes, Valenciennes, France
FAU - Maisonneuve, Antoine
AU  - Maisonneuve A
AD  - 59, Hospital Center De Valenciennes, Valenciennes, France
FAU - Wiel, Eric
AU  - Wiel E
AD  - Nord, Pôle de l’Urgence-SAMU du Nord- CHRU de Lille, Lille, France
FAU - Canu, Sébastien
AU  - Canu S
AD  - 13015, Hospital Nord, Marseille, France
FAU - Hammad, Emmanuelle
AU  - Hammad E
AD  - 13015, Hospital Nord, Marseille, France
FAU - Antonini, Francois
AU  - Antonini F
AD  - 13015, Hospital Nord, Marseille, France
FAU - Poirier, Marion
AU  - Poirier M
AD  - 13015, Hospital Nord, Marseille, France
FAU - Vigne, Coralie
AU  - Vigne C
AD  - 13015, Hospital Nord, Marseille, France
FAU - Haddam, Malik
AU  - Haddam M
AD  - 13015, Hospital Nord, Marseille, France
FAU - Alingrin, Julie
AU  - Alingrin J
AD  - Service de réanimation polyvalente, Hôpital Nord, Chemin des Bourrely, Marseille,
      France
FAU - Dangers, Laurence
AU  - Dangers L
AD  - Service de pneumologie et réanimation médicale, Groupe Hospitalier Pitié
      Salpêtrière, Paris, France
FAU - Mangiapan, Gilles
AU  - Mangiapan G
AD  - Service de pneumologie et pathologies professionnelles, Centre Hospitalier
      Intercommunal de Créteil, Créteil, France
FAU - Huet, Isabelle
AU  - Huet I
AD  - Service de pneumologie, Centre hospitalier universitaire de Toulouse, Toulouse,
      France
FAU - Dhalluin, Xavier
AU  - Dhalluin X
AD  - Clinique des maladies respiratoires, Centre Hospitalier Régional Universitaire de
      Lille, Lille, France
FAU - Bautin, Nathalie
AU  - Bautin N
AD  - Service de pneumologie et allergologie, Centre hospitalier de Roubaix, Roubaix,
      France
FAU - Quiot, Jean Jacques
AU  - Quiot JJ
AD  - Département de médecine interne et de pneumologie, Centre Hospitalier Régional
      Universitaire de Brest, Brest, France
FAU - De Vecchi, Corinne Appere
AU  - De Vecchi CA
AD  - Service de pneumologie, Centre Hospitalier Victor Dupouy, Argenteuil, France
FAU - Chenivesse, Cécile
AU  - Chenivesse C
AD  - Service de pneumologie et réanimation médicale, Groupe Hospitalier Pitié
      Salpêtrière, Paris, France
FAU - Tarmiz, Khalil
AU  - Tarmiz K
AD  - Anesthesia and Intensive Care, Chu Farhat Hached, Sousse, Tunisia
FAU - Medhioub, Fatma Kaaniche
AU  - Medhioub FK
AD  - Faculté de médecine de Sfax, Sfax, Tunisia
FAU - Smaoui, Mariem
AU  - Smaoui M
AD  - Réanimation polyvalente, CHU Habib Bourguiba, Sfax, Tunisia
FAU - Cheikh, Chaigar Mohammed
AU  - Cheikh CM
AD  - Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco
FAU - El Alami, E.
AU  - El Alami E
AD  - Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Weiss, Nicolas
AU  - Weiss N
AD  - Unité de réanimation neurologique, Hôpital Pitié-Salpêtrière, Paris, France
FAU - Mochel, Fanny
AU  - Mochel F
AD  - Unité neurométabolique, Pitié-Salpêtrière Hospital, Paris, France
FAU - Galanaud, Damien
AU  - Galanaud D
AD  - Neuroradiologie, Pitié-Salpêtrière Hospital, Paris, France
FAU - Puybasset, Louis
AU  - Puybasset L
AD  - Réanimation neurochirurgicale, Pitié-Salpêtrière Hospital, Paris, France
CN  - Brain Liver Pitié-Salpêtrière Study Group (BLIPS), Paris, France
FAU - Lodey, Marion
AU  - Lodey M
AD  - Pharmacology, Pitié-Salpêtrière Hospital, Paris, France
FAU - Guiller, Elsa
AU  - Guiller E
AD  - Pharmacology, Pitié-Salpêtrière Hospital, Paris, France
FAU - Weiss, Nicolas
AU  - Weiss N
AD  - Unité de réanimation neurologique, Hôpital Pitié-Salpêtrière, Paris, France
FAU - Silva, Stein
AU  - Silva S
AD  - Critical care unit/inserm u825, University Teaching Hospital of Purpan, Toulouse,
      France
FAU - Vuillaume, Corine
AU  - Vuillaume C
AD  - Réanimation, Centre Hospitalier Universitaire Toulouse, Toulouse, France
FAU - De Pasquale, Francesco
AU  - De Pasquale F
AD  - Neuroscience and Neuroimaging, Santa Lucia, Roma, Italy
FAU - Demonet, Jean Francois
AU  - Demonet JF
AD  - Applied Neurosciences, Leeanards Memory Centera, Lausanne, Switzerland
FAU - Sinnah, Fabrice
AU  - Sinnah F
AD  - Service de réanimation médicale et infectieuse, Hôpital Bichat-Claude Bernard,
      Paris, France
FAU - Dalloz, Marie Amelie
AU  - Dalloz MA
AD  - Département de physiologie, Hôpital Bichat Claude Bernard, Paris, France
FAU - D’ortho, Marie Pia
AU  - D’ortho MP
AD  - Département de physiologie, Hôpital Bichat Claude Bernard, Paris, France
FAU - Rouvel-Tallec, Anny
AU  - Rouvel-Tallec A
AD  - Département de physiologie, Hôpital Bichat Claude Bernard, Paris, France
FAU - Couret, David
AU  - Couret D
AD  - Neurocritical Care Unit, CHU de la Réunion, Groupe Hospitalier Sud Réunion,
      Saint-Pierre, Réunion, France
FAU - Catan, Aurélie
AU  - Catan A
AD  - Inserm, UMR 1188 Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI),
      Sainte Clotilde, Réunion, France
FAU - Nativel, Brice
AU  - Nativel B
AD  - Inserm, UMR 1188 Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI),
      Sainte Clotilde, Réunion, France
FAU - Planesse, Cynthia
AU  - Planesse C
AD  - Inserm, UMR 1188 Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI),
      Sainte Clotilde, Réunion, France
FAU - Diotel, Nicolas
AU  - Diotel N
AD  - Inserm, UMR 1188 Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI),
      Sainte Clotilde, Réunion, France
FAU - Meilhac, Olivier
AU  - Meilhac O
AD  - Inserm, UMR 1188 Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI),
      Sainte Clotilde, Réunion, France
FAU - Roy-Gash, Fabian
AU  - Roy-Gash F
AD  - Département d’anesthésie - réanimation, Fondation Ophtalmologique Adolphe de
      Rothschild, Paris, France
FAU - Lebard, Christophe
AU  - Lebard C
AD  - Intensive Care Unit, Fondation Ophtalmologique Adolphe de Rothschild, Paris,
      France
FAU - Larbi, Anne-Gaelle Si
AU  - Larbi AGS
AD  - Réanimation, Hospital Foch, Suresnes, France
FAU - Gaudin, Virginie
AU  - Gaudin V
AD  - Coordination hospitalière, Hospital Foch, Suresnes, France
FAU - Bonnin, France
AU  - Bonnin F
AD  - Coordination hospitalière, Hospital Foch, Suresnes, France
FAU - Sultan, Oceane
AU  - Sultan O
AD  - Réanimation, Hospital Foch, Suresnes, France
FAU - Hoc, Cecile
AU  - Hoc C
AD  - Sau, Hospital Foch, Suresnes, France
FAU - Mathieu, Emmanuel
AU  - Mathieu E
AD  - Sau, Hospital Foch, Suresnes, France
FAU - Lapergue, Bertrand
AU  - Lapergue B
AD  - Neurologie, Hospital Foch, Suresnes, France
FAU - Bourdain, Frederic
AU  - Bourdain F
AD  - Neurologie, Hospital Foch, Suresnes, France
FAU - Caron, Margot
AU  - Caron M
AD  - Réanimation médico-chirurgicale, Hôpital Tenon, Paris, France
FAU - Parrot, Antoine
AU  - Parrot A
AD  - Réanimation médico-chirurgicale, Hôpital Tenon, Paris, France
FAU - Labbe, Vincent
AU  - Labbe V
AD  - Réanimation médico-chirurgicale, Hôpital Tenon, Paris, France
FAU - Hafiani, El Mahdi
AU  - Hafiani EM
AD  - Réanimation médico-chirurgicale, Hôpital Tenon, Paris, France
FAU - Quesnel, Christophe
AU  - Quesnel C
AD  - Réanimation médico-chirurgicale, Hôpital Tenon, Paris, France
FAU - Genay, Stephanie
AU  - Genay S
AD  - Pharmacy Institute, C.H.R.U. Lille, Lille, France
FAU - Décaudin, Bertrand
AU  - Décaudin B
AD  - Pharmacy Institute, C.H.R.U. Lille, Lille, France
FAU - Ethgen, Sabine
AU  - Ethgen S
AD  - Anaesthesia and Resuscitation Department, C.H.R.U. Lille, Lille, France
FAU - Odou, Pascal
AU  - Odou P
AD  - Pharmacy Institute, C.H.R.U. Lille, Lille, France
FAU - Lebuffe, Gilles
AU  - Lebuffe G
AD  - Anaesthesia and Resuscitation Department, C.H.R.U. Lille, Lille, France
FAU - Gaudry, Stéphane
AU  - Gaudry S
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes,
      Colombes, France
FAU - Aubron, Cécile
AU  - Aubron C
AD  - Réanimation médicale, CHRU de Brest, Brest, France
FAU - Mcquilte, Zoe
AU  - Mcquilte Z
AD  - Depm, Transfusion Research Unit, Monash University, Melbourne, Australia
FAU - Garrouste-Orgeas, Maïté
AU  - Garrouste-Orgeas M
AD  - Réanimation, Fondation Hopital Saint Joseph, Paris, France
FAU - Soufir, Lilia
AU  - Soufir L
AD  - Réanimation polyvalente, Groupe Hospitalier Paris-Saint-Joseph, Paris, France
FAU - Allaouchiche, Bernard
AU  - Allaouchiche B
AD  - Réanimation, Hôpital civil de Lyon, Lyon, France
FAU - Verdière, Bruno
AU  - Verdière B
AD  - Réanimation, Centre Hospitalier Général de Saint-Denis, Saint-Denis, France
FAU - Nyunga, Martine
AU  - Nyunga M
AD  - Réanimation polyvalente, Centre Hospitalier de Roubaix, Roubaix, France
FAU - Banaias, Noémie
AU  - Banaias N
AD  - Réanimation polyvalente, Centre Hospitalier de Roubaix, Roubaix, France
FAU - Colling, Delphine
AU  - Colling D
AD  - Réanimation polyvalente, Centre Hospitalier de Roubaix, Roubaix, France
FAU - Kauv, Marie
AU  - Kauv M
AD  - Réanimation polyvalente, Centre Hospitalier de Roubaix, Roubaix, France
FAU - Blondeau, Erik
AU  - Blondeau E
AD  - Réanimation polyvalente, Centre Hospitalier de Roubaix, Roubaix, France
FAU - Ouanes, Islem
AU  - Ouanes I
AD  - Réanimation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Auclin, Edouard
AU  - Auclin E
AD  - Oncologie médicale, Hopital Europeen Georges-Pompidou, Paris, France
FAU - Haw-Berlemont, Caroline
AU  - Haw-Berlemont C
AD  - Réanimation médicale, Hopital Europeen Georges-Pompidou, Paris, France
FAU - Taieb, Julien
AU  - Taieb J
AD  - Oncologie digestive, Hopital Europeen Georges-Pompidou, Paris, France
FAU - Oudard, Stéphane
AU  - Oudard S
AD  - Oncologie médicale, Hopital Europeen Georges-Pompidou, Paris, France
FAU - Morissette, Genevieve
AU  - Morissette G
AD  - Pediatric Critical Care, CHU Sainte-Justine, Montréal, Canada
FAU - Kechaou, Wassim
AU  - Kechaou W
AD  - Pediatric Critical Care, CHU Sainte-Justine, Montréal, Canada
FAU - Litalien, Catherine
AU  - Litalien C
AD  - Pediatric Critical Care, CHU Sainte-Justine, Montréal, Canada
FAU - Merouani, Aïcha
AU  - Merouani A
AD  - Pediatric Nephrology, CHU Sainte-Justine, Montréal, Canada
FAU - Phan, Véronique
AU  - Phan V
AD  - Pediatric Nephrology, CHU Sainte-Justine, Montréal, Canada
FAU - Bouchard, Josée
AU  - Bouchard J
AD  - Nephrology, Sacré-Coeur Hospital, Montréal, Canada
FAU - Starck, Julie
AU  - Starck J
AD  - Réanimation et Surveillance Continue Médico Chirurgicale, Hôpital Necker -
      Enfants Malades, Paris, France
FAU - Briand, Nelly
AU  - Briand N
AD  - Centre d’investigation clinique, Institut Imagine, Paris, France
FAU - Sachs, Philippe
AU  - Sachs P
AD  - Réanimation et surveillance continue pédiatriques, CHU Robert Debré, Paris,
      France
FAU - Angoulvant, François
AU  - Angoulvant F
AD  - Urgences pédiatriques, CHU Necker-Enfants Malades, Paris, France
FAU - Sommet, Julie
AU  - Sommet J
AD  - Réanimation et surveillance continue pédiatriques, CHU Robert Debré, Paris,
      France
FAU - Holvoet, L.
AU  - Holvoet L
AD  - Centre drepanocytose, Hospital Robert-Debré, Paris, France
FAU - Benkerrou, M.
AU  - Benkerrou M
AD  - Centre drepanocytose, Hospital Robert-Debré, Paris, France
FAU - Dreyfus, Lélia
AU  - Dreyfus L
AD  - Réanimation pédiatrique hfme, Hospices civils de Lyon, Lyon, France
FAU - Bordet, Fabienne
AU  - Bordet F
AD  - Réanimation pédiatrique hfme, Hospices civils de Lyon, Lyon, France
FAU - Touzet, Sandrine
AU  - Touzet S
AD  - Pôle information médicale évaluation recherche, Hospices Civils de Lyon, Lyon,
      France
FAU - Denis, Angélique
AU  - Denis A
AD  - Pôle information médicale évaluation recherche, Hospices Civils de Lyon, Lyon,
      France
FAU - Le Coz, Julien
AU  - Le Coz J
AD  - Urgences pédiatriques, Hospital Robert-Debré, Paris, France
FAU - Chéron, Gérard
AU  - Chéron G
AD  - Urgences pédiatriques, Hospital Necker - Enfants Malades, Paris, France
FAU - Nabbout, Rima
AU  - Nabbout R
AD  - Neurologie pédiatrique, Hospital Necker - Enfants Malades, Paris, France
FAU - Patteau, Geraldine
AU  - Patteau G
AD  - Urgences pédiatriques, Hospital Necker - Enfants Malades, Paris, France
FAU - Heilbronner, Claire
AU  - Heilbronner C
AD  - Réanimation et surveillance continue médico-chirurgicales, Hôpital Necker -
      Enfants Malades, Paris, France
FAU - Hubert, Philippe
AU  - Hubert P
AD  - Réanimation et surveillance continue médico-chirurgicales, Hôpital Necker -
      Enfants Malades, Paris, France
FAU - Oualha, Mehdi
AU  - Oualha M
AD  - Réanimation et surveillance continue médico-chirurgicales, Hôpital Necker -
      Enfants Malades, Paris, France
FAU - Aoul, Nabil Tabet
AU  - Aoul NT
AD  - Réanimation pédiatrique canastel, Faculté de médecine d’Oran, Oran, Algeria
FAU - Crulli, Benjamin
AU  - Crulli B
AD  - Soins intensifs pédiatriques, CHU Sainte-Justine, Montréal, Canada
FAU - Toledano, Baruch
AU  - Toledano B
AD  - Soins intensifs pédiatriques, CHU Sainte-Justine, Montréal, Canada
FAU - Poirier, Nancy
AU  - Poirier N
AD  - Chirurgie cardiaque pédiatrique, CHU Sainte-Justine, Montréal, Canada
FAU - Vobecky, Suzanne
AU  - Vobecky S
AD  - Chirurgie cardiaque pédiatrique, CHU Sainte-Justine, Montréal, Canada
FAU - Khouadja, Hosni
AU  - Khouadja H
AD  - Anesthesia and Intensive Care, Chu Farhat Hached, Sousse, Tunisia
FAU - Robert, René
AU  - Robert R
AD  - Service de réanimation médicale, Chu De Poitiers, Poitiers, France
FAU - Vinet, M.
AU  - Vinet M
AD  - Service de réanimation médicale, Chu De Poitiers, Poitiers, France
FAU - Vinclair, Camille
AU  - Vinclair C
AD  - Pyrénées-atlantiques, Hospital Center De La Côte Basque, Bayonne, France
FAU - Boisramé-Helms, Julie
AU  - Boisramé-Helms J
AD  - Réanimation médicale, Nouvel Hôpital Civil, CHU Strasbourg, Strasbourg, France
FAU - Beloncle, François
AU  - Beloncle F
AD  - Département de réanimation médicale et de médecine hyperbare, C.H.U. d’Angers,
      Angers, France
FAU - Radermacher, Peter
AU  - Radermacher P
AD  - Institut für anästhesiologische pathophysiologie und verfahrensentwicklung,
      Universitätsklinikum Ulm, Ulm, Germany
FAU - Asfar, Pierre
AU  - Asfar P
AD  - Réanimation, C.H.U. d’Angers, Angers, France
FAU - Coupez, Elisabeth
AU  - Coupez E
AD  - CHU Gabriel-Montpied, Clermont-Ferrand, France
FAU - Bohé, Julien
AU  - Bohé J
AD  - Service de réanimation, CHU Lyon Sud, Lyon, France
FAU - Shinotsuka, Cláudia Righy
AU  - Shinotsuka CR
AD  - Service de soins intensifs, Hospital Erasme, Brussels, Belgium
FAU - Caironi, Pietro
AU  - Caironi P
AD  - Dipartimento di fisiopatologia medico-chirurgica e dei trapianti, University of
      Milan, Milano, Italy
FAU - Villois, Paola
AU  - Villois P
AD  - Service de soins intensifs, Hospital Erasme, Brussels, Belgium
FAU - Fontana, Vito
AU  - Fontana V
AD  - Service de soins intensifs, Hospital Erasme, Brussels, Belgium
FAU - Creteur, Jacques
AU  - Creteur J
AD  - Service de soins intensifs, Hospital Erasme, Brussels, Belgium
FAU - Pourcine, Franck
AU  - Pourcine F
AD  - Service de Réanimation, Centre Hospitalier Marc Jacquet, Melun, France
FAU - Vong, Ly
AU  - Vong L
AD  - Service de Réanimation, Centre Hospitalier Marc Jacquet, Melun, France
FAU - Weyer, Claire Marie
AU  - Weyer CM
AD  - Service de Réanimation, Centre Hospitalier Marc Jacquet, Melun, France
FAU - Akando, Benoit
AU  - Akando B
AD  - Service de Réanimation, Centre Hospitalier Marc Jacquet, Melun, France
FAU - Abdallah, Razach
AU  - Abdallah R
AD  - Service de Réanimation, Centre Hospitalier Marc Jacquet, Melun, France
FAU - Wetzstein, Morgane
AU  - Wetzstein M
AD  - Réanimation médicale, Centre Hospitalier Universitaire, Amiens, France
FAU - Maizel, Julien
AU  - Maizel J
AD  - Réanimation médicale, Centre Hospitalier Universitaire, Amiens, France
FAU - Antier, Nadiejda
AU  - Antier N
AD  - Réanimation, Ch Alès cévennes, Alès, France
FAU - Serroukh, Yasmina
AU  - Serroukh Y
AD  - Intensive Care Unit, C.H.U. De Charleroi, Charleroi, Belgium
FAU - Boudjeltia, Karim Zouaoui
AU  - Boudjeltia KZ
AD  - Laboratoire de médecine expérimentale - université libre de Brussels, C.H.U. De
      Charleroi, Charleroi, Belgium
FAU - Joosten, Anne
AU  - Joosten A
AD  - Intensive Care Unit, C.H.U. De Charleroi, Charleroi, Belgium
FAU - Rousseau, Alexandre
AU  - Rousseau A
AD  - Laboratoire de médecine expérimentale - université libre de Brussels, C.H.U. De
      Charleroi, Charleroi, Belgium
FAU - Delabranche, Xavier
AU  - Delabranche X
AD  - Réanimation Médicale NHC, CHU de Strasbourg, Strasbourg, France
FAU - Grunebaum, Lélia
AU  - Grunebaum L
AD  - Laboratoire d’hématologie et hémostase, CHU de Strasbourg, Strasbourg, France
CN  - CRICS Network
FAU - Delabranche, Xavier
AU  - Delabranche X
AD  - Réanimation Médicale NHC, CHU de Strasbourg, Strasbourg, France
FAU - Mootien, Yoganaden
AU  - Mootien Y
AD  - Réanimation médicale, Hospital Center De Mulhouse, Mulhouse, France
FAU - Gaci, Rostane
AU  - Gaci R
AD  - Réanimation Médicale, Hôpital Central, C.H.U. de Nancy, Nancy, France
FAU - Garric, Jean-Romain
AU  - Garric JR
AD  - Réanimation Médicale, Hôpital Central, C.H.U. de Nancy, Nancy, France
FAU - Delbove, Agathe
AU  - Delbove A
AD  - Département de soins intensifs de pneumologie, Centre hospitalier universitaire
      de Nantes, Nantes, France
FAU - Darreau, Cédric
AU  - Darreau C
AD  - Département de réanimation médicale et de médecine hyperbare, C.H.U. d’Angers,
      Angers, France
CN  - CNER DESC réanimation grand ouest
FAU - Dargent, Auguste
AU  - Dargent A
AD  - CHU Dijon, Dijon, France
FAU - Soudry-Faure, Agnès
AU  - Soudry-Faure A
AD  - Direction de la recherche clinique et de l’innovation, CHU Dijon, Dijon, France
CN  - COCOONs Study Group
FAU - De Chambrun, Marc Pineton
AU  - De Chambrun MP
AD  - Service de réanimation médicale, Groupe Hospitalier La Pitié-Salpêtrière,
      Institut de Cardiométabolisme et Nutrition, APHP, Paris, France
FAU - Demondion, Pierre
AU  - Demondion P
AD  - Service de chirurgie thoracique et cardiovasculaire, Groupe Hospitalier La Pitié 
      Salpêtrière, Institut de Cardiométabolisme et Nutrition, APHP, Paris, France
FAU - Blanchard, Jean-Christophe
AU  - Blanchard JC
AD  - Réanimation Médicale, CHU de Besançon, Besançon, France
FAU - Chocron, Sydney
AU  - Chocron S
AD  - Chirurgie cardiaque, CHU de Besançon, Besançon, France
FAU - Meneveau, Nicolas
AU  - Meneveau N
AD  - Cardiologie, C.H. Régional Universitaire de Besançon, Besançon, France
FAU - Corsi, Filippo
AU  - Corsi F
AD  - Dipartimento di anestesia e rianimazione, Policlinico Universitario A. Gemelli,
      Università Cattolica Del Sacro Cuore, Rome, Italy
FAU - Meynieu, Pierre-Emmanuel
AU  - Meynieu PE
AD  - Réanimation polyvalente, service d’anesthésie réanimation 2, CHU de Bordeaux,
      Bordeaux, France
FAU - Repusseau, Benjamin
AU  - Repusseau B
AD  - Réanimation polyvalente, service d’anesthésie réanimation 2, CHU de Bordeaux,
      Bordeaux, France
FAU - Germain, Arnaud
AU  - Germain A
AD  - Réanimation polyvalente, service d’anesthésie réanimation 2, CHU de Bordeaux,
      Bordeaux, France
FAU - Baudry, Guillaume
AU  - Baudry G
AD  - Service de Réanimation Médicale, Groupe Hospitalier Pitié Salpêtrière, Paris,
      France
FAU - Hierle, Lucie
AU  - Hierle L
AD  - Réanimation Médicale, CHU de Besançon, Besançon, France
FAU - Besch, Guillaume
AU  - Besch G
AD  - Réanimation chirurgicale, CHU de Besançon, Besançon, France
FAU - Thomas, Guillemette
AU  - Thomas G
AD  - Réanimation détresses respiratoires et infections sévères, Hôpital Nord APHM,
      Marseille, France
FAU - Cassir, Nadim
AU  - Cassir N
AD  - Unité de recherche sur les maladies infectieuses tropicales et émergentes,
      Hôpital Nord APHM, Marseille, France
FAU - Dizier, Stéphanie
AU  - Dizier S
AD  - Réanimation détresses respiratoires et infections sévères, Hôpital Nord APHM,
      Marseille, France
FAU - Roch, Antoine
AU  - Roch A
AD  - Réanimation DRIS, Hôpital Nord APHM, Marseille, France
FAU - Trebbia, Grégoire
AU  - Trebbia G
AD  - Réanimation, Hospital Foch, Suresnes, France
FAU - Govindaradjou, Kiruba
AU  - Govindaradjou K
AD  - 92151, Hospital Foch, Suresnes, France
FAU - Devaquet, Jérôme
AU  - Devaquet J
AD  - 92151, Hospital Foch, Suresnes, France
FAU - Picard, Clément
AU  - Picard C
AD  - 92151, Hospital Foch, Suresnes, France
FAU - Parquin, François
AU  - Parquin F
AD  - 92151, Hospital Foch, Suresnes, France
FAU - Leguen, Morgan
AU  - Leguen M
AD  - 92151, Hospital Foch, Suresnes, France
FAU - Felten, Marie-Louise
AU  - Felten ML
AD  - 92151, Hospital Foch, Suresnes, France
FAU - Sage, Edouard
AU  - Sage E
AD  - 92151, Hospital Foch, Suresnes, France
FAU - Chapelier, Alain
AU  - Chapelier A
AD  - 92151, Hospital Foch, Suresnes, France
FAU - Decavèle, Maxens
AU  - Decavèle M
AD  - Réanimation médico-chirurgicale, Hôpital Tenon, Paris, France
FAU - Duruisseaux, Michael
AU  - Duruisseaux M
AD  - Service de pneumologie, C.H.U de Grenoble C.H.U, La Tronche, France
FAU - Fleury, Jocelyne
AU  - Fleury J
AD  - Département d’anatomie et cytologie pathologiques, Hôpital Tenon, Paris, France
FAU - Antoine, Martine
AU  - Antoine M
AD  - Département d’anatomie et cytologie pathologiques, Hôpital Tenon, Paris, France
FAU - Carette, Marie-France
AU  - Carette MF
AD  - Service de radiologie, Hôpital Tenon, Paris, France
FAU - Wislez, Marie
AU  - Wislez M
AD  - Service de pneumologie, Hôpital Tenon, Paris, France
FAU - Givel, Claire
AU  - Givel C
AD  - Réanimation médicale, Hôpital Saint-Louis, Paris, France
FAU - De Margerie-Mellon, Constance
AU  - De Margerie-Mellon C
AD  - Radiologie, Saint Louis, Paris, France
FAU - De Kerviler, Eric
AU  - De Kerviler E
AD  - Radiologie, Hopital Saint Louis, Paris, France
FAU - Tandjaoui-Lambiotte, Yacine
AU  - Tandjaoui-Lambiotte Y
AD  - Réanimation pneumologique et soins intensifs respiratoires, Hôpital Cochin,
      Paris, France
FAU - Freynet, Olivia
AU  - Freynet O
AD  - Pneumologie, Hôpital Avicenne, Bobigny, France
FAU - Kimmoun, Antoine
AU  - Kimmoun A
AD  - Réanimation médicale brabois, Centre Hospitalier Universitaire de Nancy,
      Vandœuvre-lès-Nancy, France
FAU - Baux, Elisabeth
AU  - Baux E
AD  - Réanimation médicale brabois, Centre Hospitalier Universitaire de Nancy,
      Vandœuvre-lès-Nancy, France
FAU - Das, Vincent
AU  - Das V
AD  - Réanimation polyvalente adulte, Centre Hospitalier Intercommunal André Grégoire, 
      Montreuil, France
FAU - Talec, Patrice
AU  - Talec P
AD  - Réanimation médicale, C.H.U. d’Angers, Angers, France
FAU - Anguel, Nadia
AU  - Anguel N
AD  - Réanimation médicale, CHU de Bicêtre, Le Kremlin Bicêtre, France
FAU - Louis, Guillaume
AU  - Louis G
AD  - Réanimation polyvalente, Hôpital de Mercy, Ars Laquenexy, France
FAU - Girerd, Nicolas
AU  - Girerd N
AD  - Cardiologie - Centre d’investigation clinique pierre Drouin, Centre Hospitalier
      Universitaire de Nancy, Vandœuvre-lès-Nancy, France
FAU - Tallon, Pauline
AU  - Tallon P
AD  - Hospital Necker, Paris, France
FAU - Hadchouel-Duvergé, Alice
AU  - Hadchouel-Duvergé A
AD  - Pneumologie, Hospital Necker, Paris, France
FAU - Salvi, Nadège
AU  - Salvi N
AD  - Anesthésie, Hospital Necker, Paris, France
FAU - Cairet, Pascale
AU  - Cairet P
AD  - Anesthésie, Hospital Necker, Paris, France
FAU - Delacourt, Christophe
AU  - Delacourt C
AD  - Pneumologie, Hospital Necker, Paris, France
FAU - Blandine, Blandine Lefebvre
AU  - Blandine BL
AD  - Réanimation médico-chirurgicale, Hôpital Tenon, Sorbonne Universités, UPMC
      Université Paris 06, Paris, France
FAU - Beraud, Laurence
AU  - Beraud L
AD  - Service de biochimie et hormonologie, Hôpital Tenon, Sorbonne Universités, UPMC
      Université Paris 06, Paris, France
FAU - Coppere, Zoé
AU  - Coppere Z
AD  - Réanimation médico-chirurgicale, Hôpital Tenon, Sorbonne Universités, UPMC
      Université Paris 06, Paris, France
FAU - Lamaziere, Antonin
AU  - Lamaziere A
AD  - Service de spectrométrie de masse, Faculté de Médecine Saint Antoine, Sorbonne
      Universités, UPMC Université Paris 06, Paris, France
FAU - Lionnet, François
AU  - Lionnet F
AD  - Service de médecine interne, Hôpital Tenon, Sorbonne Universités, UPMC Université
      Paris 06, Paris, France
FAU - Fartoukh, Muriel
AU  - Fartoukh M
AD  - Réanimation médico-chirurgicale, Hôpital Tenon, Sorbonne Universités, UPMC
      Université Paris 06, Paris, France
FAU - Lehingue, Samuel
AU  - Lehingue S
AD  - Bouches du rhône, Hôpital Nord, Chemin des Bourrely, Marseille, France
FAU - D’journo, Xavier
AU  - D’journo X
AD  - Bouches du rhône, Hôpital Nord, Chemin des Bourrely, Marseille, France
FAU - Jean-Marie, Forel
AU  - Jean-Marie F
AD  - Réanimation des détresses respiratoires et des infections sévères, Hospital Nord,
      Marseille, France
FAU - Thibault, Ronan
AU  - Thibault R
AD  - Service d’Endocrinologie, Diabétologie, Nutrition, Hospital Center University De 
      Rennes, Rennes, France
FAU - Makhlouf, Anne-Marie
AU  - Makhlouf AM
AD  - Nutrition Unit, Geneva University Hospital, Geneva, Switzerland
FAU - Mulliez, Aurélien
AU  - Mulliez A
AD  - Drci, CHU Gabriel-Montpied, Clermont-Ferrand, France
FAU - Gonzalez, Cristina
AU  - Gonzalez C
AD  - Nutrition, Université de Pelotas, Pelotas, Brazil
FAU - Dadet, Sylvain
AU  - Dadet S
AD  - Service de nutrition clinique, CHU Gabriel-Montpied, Clermont-Ferrand, France
FAU - Kekstas, Gintautas
AU  - Kekstas G
AD  - Department of ICU, Vilnius University Hospital, Vilnius, Lithuania
FAU - Preiser, Jean-Charles
AU  - Preiser JC
AD  - Service de Réanimation Médico-Chirurgicale, Hôpital Erasme, Bruxelles, Belgium
FAU - Rotovnik, Kozjek Nada
AU  - Rotovnik KN
AD  - Department of Clinical Nutrition, Institute of Oncology, Ljubljana, Slovenia
FAU - Rozalen, Isabel Ceniceros
AU  - Rozalen IC
AD  - Department of ICU, Clinic USP Palmaplanas, Palma, Spain
FAU - Kupczyk, Kinga
AU  - Kupczyk K
AD  - Department of ICU, Bydgoszcz Hospital, Bydgoszcz, Poland
FAU - Krznaric, Zeljko
AU  - Krznaric Z
AD  - Departement of Internal Medicine, Univ. Hospital Center Zagreb, Zagreb, Croatia
FAU - Cano, Noël
AU  - Cano N
AD  - Service de nutrition clinique, CHU Gabriel-Montpied, Clermont-Ferrand, France
FAU - Pichard, Claude
AU  - Pichard C
AD  - Nutrition Unit, Geneva University Hospital, Geneva, Switzerland
CN  - Phase Angle Project Investigators
FAU - Le Roux, Bénédicte Gaillard-
AU  - Le Roux
AD  - Pediatric Intensive Care Unit, C.H.U de Nantes, Nantes, France
FAU - Jotterand, Corinne
AU  - Jotterand C
AD  - Pediatric Intensive Care Unit, University of Lausanne, Lausanne, Switzerland
FAU - Rooze, Shancy
AU  - Rooze S
AD  - Pediatric Intensive Care Unit, Brussels University Hospital, Brussels, Belgium
FAU - Moullet, Clemence
AU  - Moullet C
AD  - Pediatric Intensive Care Unit, University of Lausanne, Lausanne, Switzerland
FAU - Henin, Aurélia
AU  - Henin A
AD  - Anesthesie réanimation, Hospital Timone, Marseille, France
FAU - Ettori, Florence
AU  - Ettori F
AD  - Bouches du rhône, Institute Paoli-Calmettes, Marseille, France
FAU - Zemmour, Christophe
AU  - Zemmour C
AD  - Statistics, Institute Paoli-Calmettes, Marseille, France
FAU - Boher, Jean Marie
AU  - Boher JM
AD  - Statistics, Institute Paoli-Calmettes, Marseille, France
FAU - Arnaout, Michel
AU  - Arnaout M
AD  - Réanimation Médicale, Hôpital Cochin, Paris, France
FAU - Feltry, Audrey
AU  - Feltry A
AD  - Equipe mobile de nutrition, Hôpital Cochin, Paris, France
FAU - Ben, Salah Adel
AU  - Ben SA
AD  - Réanimation polyvalente, C.H. de Chartres, Le Coudray, France
FAU - Audibert, Juliette
AU  - Audibert J
AD  - Réanimation polyvalente, C.H. de Chartres, Le Coudray, France
FAU - Conia, Alexandre
AU  - Conia A
AD  - Réanimation polyvalente, C.H. de Chartres, Le Coudray, France
FAU - Gontier, Olivier
AU  - Gontier O
AD  - Réanimation polyvalente, C.H. de Chartres, Le Coudray, France
FAU - Hamrouni, Mouldi
AU  - Hamrouni M
AD  - Réanimation polyvalente, C.H. de Chartres, Le Coudray, France
FAU - Lherm, Thierry
AU  - Lherm T
AD  - Réanimation Polyvalente, Hôpitaux de Chartres, Chartres, France
FAU - Ouchenir, Abdelkader
AU  - Ouchenir A
AD  - Réanimation polyvalente, C.H. de Chartres, Le Coudray, France
FAU - Rétif, Jérôme
AU  - Rétif J
AD  - Réanimation polyvalente, C.H. de Chartres, Le Coudray, France
FAU - Proudhom, Alain
AU  - Proudhom A
AD  - Information Technology, GE Healthcare IT France & BeNeLux, Lyon, France
FAU - Lagardere, Chantal
AU  - Lagardere C
AD  - Information Technology, GE Healthcare IT France & BeNeLux, Lyon, France
FAU - Tissot, Stéphane
AU  - Tissot S
AD  - Information Technology, GE Healthcare IT France & BeNeLux, Lyon, France
FAU - Kalfon, Pierre
AU  - Kalfon P
AD  - Réanimation polyvalente, C.H. de Chartres, Le Coudray, France
FAU - Sacre, Lynn
AU  - Sacre L
AD  - Hôpital Fernand Widal, Centre Antipoison et de Toxicovigilance de Paris, Paris,
      France
FAU - Villa, Antoine
AU  - Villa A
AD  - Hôpital Fernand Widal, Centre Antipoison et de Toxicovigilance de Paris, Paris,
      France
FAU - Khadija, Alaywa
AU  - Khadija A
AD  - Samu de Paris centre antipoison de paris umr-8536, Hospital Necker, Paris, France
FAU - Garnier, Robert
AU  - Garnier R
AD  - Hôpital Fernand Widal, Centre Antipoison et de Toxicovigilance de Paris, Paris,
      France
FAU - Baud, Frederic
AU  - Baud F
AD  - 75014, SAMU de Paris Réanimation polyvalente, Paris, France
FAU - Baud, Frederic
AU  - Baud F
AD  - 75014, SAMU de Paris Réanimation polyvalente, Paris, France
FAU - Vasset, Brigitte
AU  - Vasset B
AD  - 2, rue saint sabin 75012 Paris, Médecins Sans Frontières, Paris, France
FAU - Heinzelman, Annette
AU  - Heinzelman A
AD  - 2, rue saint-sabin 75012, Médecins Sans Frontières, Paris, France
FAU - Baud, Frederic
AU  - Baud F
AD  - 75014, SAMU de Paris Réanimation polyvalente, Paris, France
FAU - Jouffroy, Romain
AU  - Jouffroy R
AD  - Réanimation adulte, Hôpital Necker - Enfants Malades, Paris, France
FAU - Durand, Elsa Démarest
AU  - Durand ED
AD  - 76, Chu Rouen, Rouen, France
FAU - Compagnon, Patricia
AU  - Compagnon P
AD  - 76, Centre Hospitalier Universitaire Rouen, Rouen, France
FAU - Maaroufi, Neila
AU  - Maaroufi N
AD  - General Hospital, Tunis, Tunisia
FAU - M’rad, A.
AU  - M’rad A
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Jebri, Alia
AU  - Jebri A
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Ghezala, Hassen Ben
AU  - Ghezala HB
AD  - Teaching Department of Emergency and Intensive Care, Hospital Zaghouan, Zaghouan,
      Tunisia
FAU - Legout, Céline
AU  - Legout C
AD  - Agence régionale de santé ile-de-france, Cellule de l’InVS en régions (Cire)
      Île-de-France et Champagne-Ardenne, Paris, France
FAU - Baud, Frederic
AU  - Baud F
AD  - 75014, SAMU de Paris Réanimation polyvalente, Paris, France
FAU - Castot-Villepelet, Anne
AU  - Castot-Villepelet A
AD  - Département des vigilances, Agence régionale de santé (ARS) Ile-de-France, Paris,
      France
FAU - Valade, Sandrine
AU  - Valade S
AD  - Réanimation médicale, Hôpital Saint-Louis, Paris, France
FAU - Lesieur, Olivier
AU  - Lesieur O
AD  - Réanimation, Centre Hospitalier la Rochelle, La Rochelle, France
FAU - Delmas, Benjamin
AU  - Delmas B
AD  - Réanimation Polyvalente, CHU La Réunion, Saint-Denis, France
FAU - Visseaux, Benoit
AU  - Visseaux B
AD  - Service de virologie, Hôpital Bichat-Claude Bernard, Paris, France
FAU - Cohen, Johana
AU  - Cohen J
AD  - Service de réanimation médicale et infectieuse, Hôpital Bichat-Claude
      Bernard-APHP, Paris, France
FAU - Nguyen, Liem Binh Luong
AU  - Nguyen LBL
AD  - Service de maladies infectieuses et tropicales, Hôpital Bichat-Claude Bernard,
      Paris, France
FAU - Morbieu, Caroline
AU  - Morbieu C
AD  - Service de maladies infectieuses et tropicales, Hôpital Bichat-Claude Bernard,
      Paris, France
FAU - Burdet, Charles
AU  - Burdet C
AD  - Service de maladies infectieuses et tropicales, Hôpital Bichat-Claude Bernard,
      Paris, France
FAU - Lescure, François-Xavier
AU  - Lescure FX
AD  - Service de maladies infectieuses et tropicales, Hôpital Bichat-Claude Bernard,
      Paris, France
FAU - Armand-Lefevre, Laurence
AU  - Armand-Lefevre L
AD  - Service de microbiologie, Hôpital Bichat-Claude Bernard, Paris, France
FAU - Yazdanpanah, Yazdan
AU  - Yazdanpanah Y
AD  - Service de maladies infectieuses et tropicales, Hôpital Bichat-Claude Bernard,
      Paris, France
FAU - Houhou-Fidouh, Nadira
AU  - Houhou-Fidouh N
AD  - Service de virologie, Hôpital Bichat-Claude Bernard, Paris, France
FAU - Cazaux, Marine
AU  - Cazaux M
AD  - Réanimation médicale, Hôpital Saint Louis, Paris, France
FAU - Goff Jérôme, Le
AU  - Goff Jérôme L
AD  - Virology, Hôpital Saint Louis, Paris, France
FAU - Meignin, Veronique
AU  - Meignin V
AD  - Anatomopathology, Hôpital Saint Louis, Paris, France
FAU - Boutboul, David
AU  - Boutboul D
AD  - Immuno-hématologie, Assistance Publique Hôpitaux de Paris, Paris, France
FAU - Rispail, Philippe
AU  - Rispail P
AD  - Mycologie, Hospital Arnaud-De-Villeneuve, Montpellier, France
FAU - Brunot, Vincent
AU  - Brunot V
AD  - Réanimation médicale, Hôpital Lapeyronie, Montpellier, France
FAU - Besnard, N.
AU  - Besnard N
AD  - Réanimation médicale, Hôpital Lapeyronie, Montpellier, France
FAU - Ceballos, Patrice
AU  - Ceballos P
AD  - Hématologie, CHRU Hôpital Saint Eloi, Montpellier, France
FAU - Stoclin, Annabelle
AU  - Stoclin A
AD  - Réanimation-USCM, Gustave Roussy, Villejuif, France
FAU - Rotolo, Federico
AU  - Rotolo F
AD  - Service de biostatistique et d’épidémiologie, inserm u1018, cesp, Université
      paris-sud, Gustave Roussy, Villejuif, France
FAU - Wartelle, Muriel
AU  - Wartelle M
AD  - Direction du système d’information, Gustave Roussy, Villejuif, France
FAU - Hicheri, Yosr
AU  - Hicheri Y
AD  - Service de réanimation médico-chirurgicale, Gustave Roussy, Villejuif, France
FAU - Maillet, Sylvia
AU  - Maillet S
AD  - Service d’information médicale, Gustave Roussy, Villejuif, France
FAU - Chachaty, Elisabeth
AU  - Chachaty E
AD  - Service de microbiologie médicale, Gustave Roussy, Villejuif, France
FAU - Pignon, Jean-Pierre
AU  - Pignon JP
AD  - Service de biostatistique et d’epidemiologie, inserm u1018, cesp, Université
      paris-sud, Gustave Roussy, Villejuif, France
FAU - Venot, Marion
AU  - Venot M
AD  - Réanimation médicale, Hôpital Saint-Louis, Paris, France
FAU - Delorme, Mathieu
AU  - Delorme M
AD  - 33, Hôpital Haut-Lévêque, Avenue Magellan, Pessac, France
FAU - Bialais, Emilie
AU  - Bialais E
AD  - Intensive Care Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium
FAU - Julie, Dupuis
AU  - Julie D
AD  - Sevice des soins intensifs, Cliniques Universitaires Saint-Luc, Brussels, Belgium
FAU - Paoloni, Laura
AU  - Paoloni L
AD  - Sevice des soins intensifs, Cliniques Universitaires Saint-Luc, Brussels, Belgium
FAU - Wittebolle, Xavier
AU  - Wittebolle X
AD  - Sevice des soins intensifs, Cliniques Universitaires Saint-Luc, Brussels, Belgium
FAU - Hickmann, Cheryl
AU  - Hickmann C
AD  - Service des soins intensifs, Cliniques Universitaires Saint-Luc, Brussels,
      Belgium
FAU - Castanares-Zapatero, Diego
AU  - Castanares-Zapatero D
AD  - Intensive Care Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium
FAU - Tordeur, Antoine
AU  - Tordeur A
AD  - Intensive Care Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium
FAU - Colmant, Lise
AU  - Colmant L
AD  - Intensive Care Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium
FAU - Wittebole, Xavier
AU  - Wittebole X
AD  - Intensive Care Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium
FAU - Tirone, Giuseppe
AU  - Tirone G
AD  - Intensive Care Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium
FAU - Laterre, Pierre-François
AU  - Laterre PF
AD  - Intensive Care Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium
FAU - Ducroux, Lorraine
AU  - Ducroux L
AD  - Hautepierre réanimation médicale, C.H.R.U. Hôpitaux Universitaires Strasbourg,
      Strasbourg, France
FAU - Kemlin, Claire
AU  - Kemlin C
AD  - Service de médecine physique et réadaptation, Hôpital Pitié-Salpêtrière, Paris,
      France
FAU - Moulton, Eric
AU  - Moulton E
AD  - Institut du cerveau et de la moelle, Hôpital Pitié-Salpêtrière, Paris, France
FAU - Rosso, Charlotte
AU  - Rosso C
AD  - Service des urgences cérébro-vasculaires, Hôpital Pitié-Salpêtrière, Paris,
      France
FAU - Le Neindre, Aymeric
AU  - Le Neindre A
AD  - Intensive care unit and department of critical care medicine, Groupe Hospitalier 
      Paris Saint-Joseph, Paris, France
FAU - Mongodi, Silvia
AU  - Mongodi S
AD  - Department of anesthesia and intensive care, Fondazione IRCCS Policlinico S
      Matteo, Pavie, Italy
FAU - Bouhemad, Béaïd
AU  - Bouhemad B
AD  - Department of anesthesia and surgical intensive care unit, CHU Dijon, Dijon,
      France
FAU - Rodrigues, Joana
AU  - Rodrigues J
AD  - Haute école de santé vaud, University of Applied Sciences and Arts Western
      Switzerland (HES-SO), Lausanne, Switzerland
FAU - Botteau, Caroline
AU  - Botteau C
AD  - Haute école de santé vaud, University of Applied Sciences and Arts Western
      Switzerland (HES-SO), Lausanne, Switzerland
FAU - Duprez, Frédéric
AU  - Duprez F
AD  - ICU, C.H. Epicura, Hornu, Belgium
FAU - Waroquier, François
AU  - Waroquier F
AD  - Emergency unit, C.H. Epicura, Hornu, Belgium
FAU - Christiaens, Karel
AU  - Christiaens K
AD  - Emergency unit, C.H. Epicura, Hornu, Belgium
FAU - Vantrimpont, Frank
AU  - Vantrimpont F
AD  - Emergency unit, C.H. Epicura, Hornu, Belgium
FAU - Duprez, Frédéric
AU  - Duprez F
AD  - ICU, C.H. Epicura, Hornu, Belgium
FAU - Elkhawand, Charbel
AU  - Elkhawand C
AD  - Pneumology, C.H. Epicura, Hornu, Belgium
FAU - Vermeesh, Frank
AU  - Vermeesh F
AD  - Emergency unit, C.H. Epicura, Hornu, Belgium
LA  - eng
PT  - Journal Article
DEP - 20160617
TA  - Ann Intensive Care
JT  - Annals of Intensive Care
AID - 114 [pii]
AID - 10.1186/s13613-016-0114-z [doi]
SO  - Ann Intensive Care. 2016 Jun 17;6(Suppl 1):. doi:10.1186/s13613-016-0114-z.

PMC - PMC5053362
PMID- 27228448
IS  - 0012-1649 (Print)
IS  - 1939-0599 (Electronic)
VI  - 52
IP  - 6
DP  - 2016 Jun
TI  - Early Visual Deprivation Severely Compromises the Auditory Sense of Space in
      Congenitally Blind Children.
PG  - 847-53
AB  - A recent study has shown that congenitally blind adults, who have never had
      visual experience, are impaired on an auditory spatial bisection task (Gori,
      Sandini, Martinoli, & Burr, 2014). In this study we investigated how thresholds
      for auditory spatial bisection and auditory discrimination develop with age in
      sighted and congenitally blind children (9 to 14 years old). Children performed 2
      spatial tasks (minimum audible angle and space bisection) and 1 temporal task
      (temporal bisection). There was no impairment in the temporal task for blind
      children but, like adults, they showed severely compromised thresholds for
      spatial bisection. Interestingly, the blind children also showed lower precision 
      in judging minimum audible angle. These results confirm the adult study and go on
      to suggest that even simpler auditory spatial tasks are compromised in children, 
      and that this capacity recovers over time.
FAU - Vercillo, Tiziana
AU  - Vercillo T
AD  - Department of Psychology, University of Nevada
FAU - Burr, David
AU  - Burr D
AD  - Department of Neuroscience, University of Florence and CNR Institute of
      Neuroscience, Pisa, Italy
FAU - Gori, Monica
AU  - Gori M
AD  - U-VIP Unit for Visually Impaired People, Fondazione Istituto Italiano di
      Tecnologia, Genoa, Italy
LA  - eng
PT  - Journal Article
TA  - Dev Psychol
JT  - Developmental psychology
AID - 10.1037/dev0000103 [doi]
MID - EMS70068
SO  - Dev Psychol. 2016 Jun;52(6):847-53. doi:10.1037/dev0000103.

PMC - PMC4721829
PMID- 26703610
IS  - 1424-8220 (Electronic)
VI  - 15
IP  - 12
DP  - 2015 Dec
TI  - Design, Implementation and Evaluation of an Indoor Navigation System for Visually
      Impaired People.
PG  - 32168-87
AB  - Indoor navigation is a challenging task for visually impaired people. Although
      there are guidance systems available for such purposes, they have some drawbacks 
      that hamper their direct application in real-life situations. These systems are
      either too complex, inaccurate, or require very special conditions (i.e., rare in
      everyday life) to operate. In this regard, Ultra-Wideband (UWB) technology has
      been shown to be effective for indoor positioning, providing a high level of
      accuracy and low installation complexity. This paper presents SUGAR, an indoor
      navigation system for visually impaired people which uses UWB for positioning, a 
      spatial database of the environment for pathfinding through the application of
      the A* algorithm, and a guidance module. The interaction with the user takes
      place using acoustic signals and voice commands played through headphones. The
      suitability of the system for indoor navigation has been verified by means of a
      functional and usable prototype through a field test with a blind person. In
      addition, other tests have been conducted in order to show the accuracy of
      different relevant parts of the system.
FAU - Martinez-Sala, Alejandro Santos
AU  - Martinez-Sala AS
FAU - Losilla, Fernando
AU  - Losilla F
FAU - Sánchez-Aarnoutse, Juan Carlos
AU  - Sánchez-Aarnoutse JC
FAU - García-Haro, Joan
AU  - García-Haro J
LA  - eng
PT  - Journal Article
DEP - 20151221
PHST- 2015/10/01 [received]
PHST- 2015/12/17 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s151229912 [doi]
AID - sensors-15-29912 [pii]
SO  - Sensors (Basel). 2015 Dec 21;15(12):32168-87. doi:10.3390/s151229912.

PMC - PMC4672309
PMID- 26632285
IS  - 0893-133X (Print)
IS  - 1740-634X (Electronic)
VI  - 40
IP  - Suppl 1
DP  - 2015 Dec
TI  - Panels, Mini-Panels and Study Groups Monday, December 7, 2015.
PG  - S1-S105
LA  - eng
PT  - Journal Article
DEP - 20151203
PHST- 2015/12/03 [aheadofprint]
TA  - Neuropsychopharmacology
JT  - Neuropsychopharmacology
AID - npp2015324 [pii]
AID - 10.1038/npp.2015.324 [doi]
SO  - Neuropsychopharmacology. 2015 Dec;40(Suppl 1):S1-S105. Epub 2015 Dec 03
      doi:10.1038/npp.2015.324.

PMC - PMC4669990
IS  - 2050-6406 (Print)
IS  - 2050-6414 (Electronic)
VI  - 3
IP  - 5 Suppl
DP  - 2015 Oct
DP  - 2015 Oct
TI  - UEG Week 2015 Oral Presentations.
PG  - 1-145
LA  - eng
PT  - Journal Article
TA  - United European Gastroenterol J
JT  - United European Gastroenterology Journal
AID - 10.1177/2050640615601611 [doi]
AID - 10.1177_2050640615601611 [pii]
SO  - United European Gastroenterol J. 2015 Oct;3(5 Suppl):1-145.
      doi:10.1177/2050640615601611.

PMC - PMC4571044
IS  - 0002-9459 (Print)
IS  - 1553-6467 (Electronic)
VI  - 79
IP  - 5
DP  - 2015 Jun 25
TI  - 116th Annual Meeting of the American Association of Colleges of Pharmacy National
      Harbor, Maryland, July 11-15, 2015.
LID - S4
LA  - eng
PT  - Journal Article
TA  - Am J Pharm Educ
JT  - American Journal of Pharmaceutical Education
AID - ajpeS4 [pii]
AID - 10.5688/ajpe795S4 [doi]
SO  - Am J Pharm Educ. 2015 Jun 25;79(5):. doi:10.5688/ajpe795S4.

PMC - PMC5350766
IS  - 1752-8054 (Print)
IS  - 1752-8062 (Electronic)
VI  - 8
IP  - 3
DP  - 2015 Jun
TI  - ACTS Abstracts.
PG  - 178-258
LA  - eng
PT  - Journal Article
DEP - 20150615
TA  - Clin Transl Sci
JT  - Clinical and Translational Science
AID - 10.1111/cts.12290 [doi]
AID - CTS12290 [pii]
SO  - Clin Transl Sci. 2015 Jun;8(3):178-258. Epub 2015 Jun 15 doi:10.1111/cts.12290.

PMC - PMC4895366
IS  - 0891-6640 (Print)
IS  - 1939-1676 (Electronic)
VI  - 29
IP  - 4
DP  - 2015 Jul-Aug
TI  - 2015 ACVIM Forum Research Abstract Program.
PG  - 1122-256
LA  - eng
PT  - Journal Article
DEP - 20150527
TA  - J Vet Intern Med
JT  - Journal of Veterinary Internal Medicine
AID - 10.1111/jvim.12609 [doi]
AID - JVIM12609 [pii]
SO  - J Vet Intern Med. 2015 Jul-Aug;29(4):1122-256. Epub 2015 May 27
      doi:10.1111/jvim.12609.

PMC - PMC4256376
PMID- 25474036
IS  - 1932-6203 (Electronic)
VI  - 9
IP  - 12
DP  - 2014
TI  - Investigating the Role of Auditory and Tactile Modalities in Violin Quality
      Evaluation.
LID - e112552
AB  - The role of auditory and tactile modalities involved in violin playing and
      evaluation was investigated in an experiment employing a blind violin evaluation 
      task under different conditions: i) normal playing conditions, ii) playing with
      auditory masking, and iii) playing with vibrotactile masking. Under each
      condition, 20 violinists evaluated five violins according to criteria related to 
      violin playing and sound characteristics and rated their overall quality and
      relative preference. Results show that both auditory and vibrotactile feedback
      are important in the violinists’ evaluations but that their relative importance
      depends on the violinist, the violin and the type of evaluation (different
      criteria ratings or preference). In this way, the overall quality ratings were
      found to be accurately predicted by the rating criteria, which also proved to be 
      perceptually relevant to violinists, but were poorly correlated with the
      preference ratings; this suggests that the two types of ratings (overall quality 
      vs preference) may stem from different decision-making strategies. Furthermore,
      the experimental design confirmed that violinists agree more on the importance of
      criteria in their overall evaluation than on their actual ratings for different
      violins. In particular, greater agreement was found on the importance of criteria
      related to the sound of the violin. Nevertheless, this study reveals that there
      are fundamental differences in the way players interpret and evaluate each
      criterion, which may explain why correlating physical properties with perceptual 
      properties has been challenging so far in the field of musical acoustics.
FAU - Wollman, Indiana
AU  - Wollman I
AD  - Sorbonne Universités, UPMC University Paris 06/CNRS, UMR 7190, Institut Jean le
      Rond, d'Alembert, F-75015, Paris, France
FAU - Fritz, Claudia
AU  - Fritz C
AD  - Sorbonne Universités, UPMC University Paris 06/CNRS, UMR 7190, Institut Jean le
      Rond, d'Alembert, F-75015, Paris, France
FAU - Poitevineau, Jacques
AU  - Poitevineau J
AD  - Sorbonne Universités, UPMC University Paris 06/CNRS, UMR 7190, Institut Jean le
      Rond, d'Alembert, F-75015, Paris, France
FAU - McAdams, Stephen
AU  - McAdams S
AD  - Schulich School of Music, McGill University, 555 Sherbrooke Street West,
      Montreal, Quebec, H3A 1E3, Canada
LA  - eng
PT  - Journal Article
DEP - 20141204
PHST- 2014/03/27 [received]
PHST- 2014/10/04 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-14-13416 [pii]
AID - 10.1371/journal.pone.0112552 [doi]
SO  - PLoS One. 2014 Dec 4;9(12):. doi:10.1371/journal.pone.0112552.

PMC - PMC4261147
IS  - 0893-133X (Print)
IS  - 1740-634X (Electronic)
VI  - 39
IP  - Suppl 1
DP  - 2014 Dec
TI  - Poster Session I Monday, December 08, 2014.
PG  - S112-290
LA  - eng
PT  - Journal Article
DEP - 20141203
PHST- 2014/12/03 [aheadofprint]
TA  - Neuropsychopharmacology
JT  - Neuropsychopharmacology
AID - npp2014280 [pii]
AID - 10.1038/npp.2014.280 [doi]
SO  - Neuropsychopharmacology. 2014 Dec;39(Suppl 1):S112-290. Epub 2014 Dec 03
      doi:10.1038/npp.2014.280.

PMC - PMC4261146
PMID- 25466712
IS  - 0893-133X (Print)
IS  - 1740-634X (Electronic)
VI  - 39
IP  - Suppl 1
DP  - 2014 Dec
TI  - Panel, Mini-panel, and Study Group.
PG  - S1-S111
LA  - eng
PT  - Journal Article
DEP - 20141203
PHST- 2014/12/03 [aheadofprint]
TA  - Neuropsychopharmacology
JT  - Neuropsychopharmacology
AID - npp2014279 [pii]
AID - 10.1038/npp.2014.279 [doi]
SO  - Neuropsychopharmacology. 2014 Dec;39(Suppl 1):S1-S111. Epub 2014 Dec 03
      doi:10.1038/npp.2014.279.

PMC - PMC4186340
PMID- 25339872
IS  - 1662-5137 (Electronic)
VI  - 8
DP  - 2014
TI  - Time-interval for integration of stabilizing haptic and visual information in
      subjects balancing under static and dynamic conditions.
LID - 190
AB  - Maintaining equilibrium is basically a sensorimotor integration task. The central
      nervous system (CNS) continually and selectively weights and rapidly integrates
      sensory inputs from multiple sources, and coordinates multiple outputs. The
      weighting process is based on the availability and accuracy of afferent signals
      at a given instant, on the time-period required to process each input, and
      possibly on the plasticity of the relevant pathways. The likelihood that sensory 
      inflow changes while balancing under static or dynamic conditions is high,
      because subjects can pass from a dark to a well-lit environment or from a
      tactile-guided stabilization to loss of haptic inflow. This review article
      presents recent data on the temporal events accompanying sensory transition, on
      which basic information is fragmentary. The processing time from sensory shift to
      reaching a new steady state includes the time to (a) subtract or integrate
      sensory inputs; (b) move from allocentric to egocentric reference or vice versa; 
      and (c) adjust the calibration of motor activity in time and amplitude to the new
      sensory set. We present examples of processes of integration of
      posture-stabilizing information, and of the respective sensorimotor
      time-intervals while allowing or occluding vision or adding or subtracting
      tactile information. These intervals are short, in the order of 1–2 s for
      different postural conditions, modalities and deliberate or passive shift. They
      are just longer for haptic than visual shift, just shorter on withdrawal than on 
      addition of stabilizing input, and on deliberate than unexpected mode. The delays
      are the shortest (for haptic shift) in blind subjects. Since automatic balance
      stabilization may be vulnerable to sensory-integration delays and to interference
      from concurrent cognitive tasks in patients with sensorimotor problems, insight
      into the processing time for balance control represents a critical step in the
      design of new balance- and locomotion training devices.
FAU - Honeine, Jean-Louis
AU  - Honeine JL
AD  - Department of Public Health, Experimental and Forensic Medicine, University of
      PaviaPavia, Italy
FAU - Schieppati, Marco
AU  - Schieppati M
AD  - Department of Public Health, Experimental and Forensic Medicine, University of
      PaviaPavia, Italy
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20141006
PHST- 2014/07/21 [received]
PHST- 2014/09/17 [accepted]
TA  - Front Syst Neurosci
JT  - Frontiers in Systems Neuroscience
AID - 10.3389/fnsys.2014.00190 [doi]
SO  - Front Syst Neurosci. 2014 Oct 06;8:. doi:10.3389/fnsys.2014.00190.

PMC - PMC3792873
PMID- 24116156
IS  - 1932-6203 (Electronic)
VI  - 8
IP  - 10
DP  - 2013
TI  - Indoor Navigation by People with Visual Impairment Using a Digital Sign System.
LID - e76783
AB  - There is a need for adaptive technology to enhance indoor wayfinding by
      visually-impaired people. To address this need, we have developed and tested a
      Digital Sign System. The hardware and software consist of digitally-encoded signs
      widely distributed throughout a building, a handheld sign-reader based on an
      infrared camera, image-processing software, and a talking digital map running on 
      a mobile device. Four groups of subjects—blind, low vision, blindfolded sighted, 
      and normally sighted controls—were evaluated on three navigation tasks. The
      results demonstrate that the technology can be used reliably in retrieving
      information from the signs during active mobility, in finding nearby points of
      interest, and following routes in a building from a starting location to a
      destination. The visually impaired subjects accurately and independently
      completed the navigation tasks, but took substantially longer than normally
      sighted controls. This fully functional prototype system demonstrates the
      feasibility of technology enabling independent indoor navigation by people with
      visual impairment.
FAU - Legge, Gordon E.
AU  - Legge GE
AD  - Minnesota laboratory for Low-Vision Research, University of Minnesota, Twin
      Cities, Minnesota, United States of America
FAU - Beckmann, Paul J.
AU  - Beckmann PJ
AD  - University of St. Thomas, St. Paul, Minnesota, United States of America
FAU - Tjan, Bosco S.
AU  - Tjan BS
AD  - University of Southern California, Los Angeles, California, United States of
      America
FAU - Havey, Gary
AU  - Havey G
AD  - Advanced Medical Electronics Corporation (AME), Maple Grove, Minnesota, United
      States of America
FAU - Kramer, Kevin
AU  - Kramer K
AD  - Advanced Medical Electronics Corporation (AME), Maple Grove, Minnesota, United
      States of America
FAU - Rolkosky, David
AU  - Rolkosky D
AD  - Advanced Medical Electronics Corporation (AME), Maple Grove, Minnesota, United
      States of America
FAU - Gage, Rachel
AU  - Gage R
AD  - Minnesota laboratory for Low-Vision Research, University of Minnesota, Twin
      Cities, Minnesota, United States of America
FAU - Chen, Muzi
AU  - Chen M
AD  - Minnesota laboratory for Low-Vision Research, University of Minnesota, Twin
      Cities, Minnesota, United States of America
FAU - Puchakayala, Sravan
AU  - Puchakayala S
AD  - Minnesota laboratory for Low-Vision Research, University of Minnesota, Twin
      Cities, Minnesota, United States of America
FAU - Rangarajan, Aravindhan
AU  - Rangarajan A
AD  - Minnesota laboratory for Low-Vision Research, University of Minnesota, Twin
      Cities, Minnesota, United States of America
LA  - eng
PT  - Journal Article
DEP - 20131008
PHST- 2013/06/11 [received]
PHST- 2013/09/03 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-13-24318 [pii]
AID - 10.1371/journal.pone.0076783 [doi]
SO  - PLoS One. 2013 Oct 8;8(10):. doi:10.1371/journal.pone.0076783.

PMC - PMC3687120
IS  - 0002-9459 (Print)
IS  - 1553-6467 (Electronic)
VI  - 77
IP  - 5
DP  - 2013 Jun 12
TI  - 114th Annual Meeting of the American Associaton of Colleges of Pharmacy, Chicago,
      IL, July 13-17, 2013.
LID - 109
LA  - eng
PT  - Journal Article
TA  - Am J Pharm Educ
JT  - American Journal of Pharmaceutical Education
AID - ajpe109 [pii]
AID - 10.5688/ajpe775109 [doi]
SO  - Am J Pharm Educ. 2013 Jun 12;77(5):. doi:10.5688/ajpe775109.

PMC - PMC3142979
IS  - 0002-9459 (Print)
IS  - 1553-6467 (Electronic)
VI  - 75
IP  - 5
DP  - 2011 Jun 10
TI  - 112th Annual Meeting of the American Association of Colleges of Pharmacy, San
      Antonio, TX, July 9-13, 2011.
LID - 105
LA  - eng
PT  - Journal Article
TA  - Am J Pharm Educ
JT  - American Journal of Pharmaceutical Education
AID - ajpe105 [pii]
AID - 10.5688/ajpe755105 [doi]
SO  - Am J Pharm Educ. 2011 Jun 10;75(5):. doi:10.5688/ajpe755105.

PMC - PMC3533624
PMID- 23100071
IS  - 1869-4101 (Electronic)
VI  - 2
IP  - Suppl 1
DP  - 2011 Mar
TI  - ECR 2011 Book of Abstracts - B - Scientific Sessions.
PG  - 135-324
LA  - eng
PT  - Journal Article
DEP - 20110301
TA  - Insights Imaging
JT  - Insights into Imaging
AID - 77 [pii]
AID - 10.1007/s13244-011-0077-4 [doi]
SO  - Insights Imaging. 2011 Mar 1;2(Suppl 1):135-324. doi:10.1007/s13244-011-0077-4.

PMC - PMC5467057
PMID- 28616097
IS  - 1866-1947 (Print)
IS  - 1866-1955 (Electronic)
VI  - 9
DP  - 2017
TI  - Updated report on tools to measure outcomes of clinical trials in fragile X
      syndrome.
LID - 14
AB  - Objective: Fragile X syndrome (FXS) has been the neurodevelopmental disorder with
      the most active translation of preclinical breakthroughs into clinical trials.
      This process has led to a critical assessment of outcome measures, which resulted
      in a comprehensive review published in 2013. Nevertheless, the disappointing
      outcome of several recent phase III drug trials in FXS, and parallel efforts at
      evaluating behavioral endpoints for trials in autism spectrum disorder (ASD), has
      emphasized the need for re-assessing outcome measures and revising
      recommendations for FXS. Methods: After performing an extensive database search
      (PubMed, Food and Drug Administration (FDA)/National Institutes of Health (NIH)’s
      www.ClinicalTrials.gov, etc.) to determine progress since 2013, members of the
      Working Groups who published the 2013 Report evaluated the available outcome
      measures for FXS and related neurodevelopmental disorders using the COSMIN
      grading system of levels of evidence. The latter has also been applied to a
      British survey of endpoints for ASD. In addition, we also generated an informal
      classification of outcome measures for use in FXS intervention studies as
      instruments appropriate to detect shorter- or longer-term changes. Results: To
      date, a total of 22 double-blind controlled clinical trials in FXS have been
      identified through www.ClinicalTrials.gov and an extensive literature search. The
      vast majority of these FDA/NIH-registered clinical trials has been completed
      between 2008 and 2015 and has targeted the core excitatory/inhibitory imbalance
      present in FXS and other neurodevelopmental disorders. Limited data exist on
      reliability and validity for most tools used to measure cognitive, behavioral,
      and other problems in FXS in these trials and other studies. Overall, evidence
      for most tools supports a moderate tool quality grading. Data on sensitivity to
      treatment, currently under evaluation, could improve ratings for some cognitive
      and behavioral tools. Some progress has also been made at identifying promising
      biomarkers, mainly on blood-based and neurophysiological measures. Conclusion:
      Despite the tangible progress in implementing clinical trials in FXS, the
      increasing data on measurement properties of endpoints, and the ongoing process
      of new tool development, the vast majority of outcome measures are at the
      moderate quality level with limited information on reliability, validity, and
      sensitivity to treatment. This situation is not unique to FXS, since reviews of
      endpoints for ASD have arrived at similar conclusions. These findings, in
      conjunction with the predominance of parent-based measures particularly in the
      behavioral domain, indicate that endpoint development in FXS needs to continue
      with an emphasis on more objective measures (observational, direct testing,
      biomarkers) that reflect meaningful improvements in quality of life. A major
      continuous challenge is the development of measurement tools concurrently with
      testing drug safety and efficacy in clinical trials.
FAU - Budimirovic, Dejan B.
AU  - Budimirovic DB
AD  - 0000 0001 2171 9311grid.21107.35Departments of Psychiatry and Behavioral
      Sciences, Kennedy Krieger Institute and Child Psychiatry, Johns Hopkins
      University School of Medicine, 716 N. Broadway, Baltimore, MD 21205 USA
FAU - Berry-Kravis, Elizabeth
AU  - Berry-Kravis E
AD  - 0000 0001 0705 3621grid.240684.cDepartments of Pediatrics, Neurological Sciences,
      Biochemistry, Rush University Medical Center, 1725 West Harrison, Suite 718,
      Chicago, IL 60612 USA
FAU - Erickson, Craig A.
AU  - Erickson CA
AD  - 0000 0001 2179 9593grid.24827.3bDivision of Child and Adolescent Psychiatry,
      Cincinnati Children’s Hospital Medical Center and the University of Cincinnati
      College of Medicine, 3333 Burnet Avenue MLC 4002, Cincinnati, OH 45229 USA
FAU - Hall, Scott S.
AU  - Hall SS
AD  - 0000000419368956grid.168010.eDivision of Interdisciplinary Brain Sciences,
      Department of Psychiatry and Behavioral Sciences, Stanford University, 401 Quarry
      Road, Stanford, CA 94305 USA
FAU - Hessl, David
AU  - Hessl D
AD  - 0000 0000 9752 8549grid.413079.8MIND Institute and Department of Psychiatry and
      Behavioral Sciences, University of California Davis Medical Center, 2825 50th
      Street, Sacramento, CA 95817 USA
FAU - Reiss, Allan L.
AU  - Reiss AL
AD  - 0000000419368956grid.168010.eDivision of Interdisciplinary Brain Sciences,
      Departments of Psychiatry and Behavioral Sciences, Radiology and Pediatrics,
      Stanford University, 401 Quarry Road, Stanford, CA 94305 USA
FAU - King, Margaret K.
AU  - King MK
AD  - grid.476963.9Autism & Developmental Medicine Institute, Geisinger Health System, 
      Present address: Novartis Pharmaceuticals Corporation, US Medical, One Health
      Plaza, East Hanover, NJ 07936 USA
FAU - Abbeduto, Leonard
AU  - Abbeduto L
AD  - 0000 0000 9752 8549grid.413079.8MIND Institute and Department of Psychiatry and
      Behavioral Sciences, University of California Davis Medical Center, 2825 50th
      Street, Sacramento, CA 95817 USA
FAU - Kaufmann, Walter E.
AU  - Kaufmann WE
AD  - 0000 0000 8571 0933grid.418307.9Center for Translational Research, Greenwood
      Genetic Center, 113 Gregor Mendel Circle, Greenwood, SC 29646 USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170612
PHST- 2016/07/27 [received]
PHST- 2017/02/22 [accepted]
TA  - J Neurodev Disord
JT  - Journal of Neurodevelopmental Disorders
AID - 9193 [pii]
AID - 10.1186/s11689-017-9193-x [doi]
SO  - J Neurodev Disord. 2017 Jun 12;9:. doi:10.1186/s11689-017-9193-x.

PMC - PMC5374646
IS  - 2050-5736 (Electronic)
VI  - 5
IP  - Suppl 1
DP  - 2017
TI  - International Society for Therapeutic Ultrasound Conference 2016: Tel Aviv,
      Israel. 14-18 March, 2016.
LID - 15
FAU - Fowlkes, Brian
AU  - Fowlkes B
AD  - 0000000086837370grid.214458.eBasic Radiological Sciences Division, Department of 
      Radiology, University of Michigan, Ann Arbor, Michigan USA
FAU - Ghanouni, Pejman
AU  - Ghanouni P
AD  - 0000000419368956grid.168010.eStanford School of Medicine, Stanford, California
      USA
FAU - Sanghvi, Narendra
AU  - Sanghvi N
AD  - grid.421488.3SonaCare Medical, Indianapolis, Indiana USA
FAU - Coussios, Constantin
AU  - Coussios C
AD  - 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of 
      Oxford, Oxford, UK
FAU - Lyon, Paul C.
AU  - Lyon PC
AD  - 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of 
      Oxford, Oxford, UK
FAU - Gray, Michael
AU  - Gray M
AD  - 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of 
      Oxford, Oxford, UK
FAU - Mannaris, Christophoros
AU  - Mannaris C
AD  - 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of 
      Oxford, Oxford, UK
FAU - Victor, Marie de Saint
AU  - Victor Mde S
AD  - 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of 
      Oxford, Oxford, UK
FAU - Stride, Eleanor
AU  - Stride E
AD  - 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of 
      Oxford, Oxford, UK
FAU - Cleveland, Robin
AU  - Cleveland R
AD  - 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of 
      Oxford, Oxford, UK
FAU - Carlisle, Robert
AU  - Carlisle R
AD  - 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of 
      Oxford, Oxford, UK
FAU - Wu, Feng
AU  - Wu F
AD  - 0000 0004 0488 9484grid.415719.fHIFU Unit, Churchill Hospital, Oxford, UK
FAU - Middleton, Mark
AU  - Middleton M
AD  - 0000 0004 1936 8948grid.4991.5Department of Oncology, University of Oxford,
      Oxford, UK
FAU - Gleeson, Fergus
AU  - Gleeson F
AD  - 0000 0004 0488 9484grid.415719.fDepartment of Radiology, Churchill Hospital,
      Oxford, UK
FAU - Aubry, Jean-Franҫois
AU  - Aubry JF
AD  - Institut Langevin, Paris, France
FAU - Pauly, Kim Butts
AU  - Pauly KB
AD  - 0000000419368956grid.168010.eStanford School of Medicine, Stanford, California
      USA
FAU - Moonen, Chrit
AU  - Moonen C
AD  - 0000000090126352grid.7692.aCenter for Imaging Sciences, Imaging Division,
      University Medical Center, Utrecht, The Netherlands
FAU - Vortman, Jacob
AU  - Vortman J
AD  - grid.435375.3InSighTec, Haifa, Israel
FAU - Ghanouni, Pejman
AU  - Ghanouni P
AD  - 0000000419368956grid.168010.eStanford School of Medicine, Stanford, California
      USA
FAU - Sharabi, Shirley
AU  - Sharabi S
AD  - 0000 0001 2107 2845grid.413795.dSheba Medical Center, Ramat-Gan, Israel
FAU - Daniels, Dianne
AU  - Daniels D
AD  - 0000 0001 2107 2845grid.413795.dSheba Medical Center, Ramat-Gan, Israel
FAU - Last, David
AU  - Last D
AD  - 0000 0001 2107 2845grid.413795.dSheba Medical Center, Ramat-Gan, Israel
FAU - Guez, David
AU  - Guez D
AD  - 0000 0001 2107 2845grid.413795.dSheba Medical Center, Ramat-Gan, Israel
FAU - Levy, Yoav
AU  - Levy Y
AD  - grid.435375.3InSighTec, Haifa, Israel
FAU - Volovick, Alexander
AU  - Volovick A
AD  - grid.435375.3InSighTec, Haifa, Israel
FAU - Grinfeld, Javier
AU  - Grinfeld J
AD  - grid.435375.3InSighTec, Haifa, Israel
FAU - Rachmilevich, Itay
AU  - Rachmilevich I
AD  - grid.435375.3InSighTec, Haifa, Israel
FAU - Amar, Talia
AU  - Amar T
AD  - grid.435375.3InSighTec, Haifa, Israel
FAU - Zibly, Zion
AU  - Zibly Z
AD  - 0000 0001 2107 2845grid.413795.dSheba Medical Center, Ramat-Gan, Israel
FAU - Mardor, Yael
AU  - Mardor Y
AD  - 0000 0001 2107 2845grid.413795.dSheba Medical Center, Ramat-Gan, Israel
FAU - Harnof, Sagi
AU  - Harnof S
AD  - 0000 0001 2107 2845grid.413795.dSheba Medical Center, Ramat-Gan, Israel
FAU - Plaksin, Michael
AU  - Plaksin M
AD  - 0000000121102151grid.6451.6Faculty of Biomedical Engineering & Russell Berrie
      Nanotechnology Institute, Technion – Israel Institute of Technology, Haifa,
      Israel
FAU - Weissler, Yoni
AU  - Weissler Y
AD  - 0000000121102151grid.6451.6Faculty of Biomedical Engineering & Russell Berrie
      Nanotechnology Institute, Technion – Israel Institute of Technology, Haifa,
      Israel
FAU - Shoham, Shy
AU  - Shoham S
AD  - 0000000121102151grid.6451.6Faculty of Biomedical Engineering & Russell Berrie
      Nanotechnology Institute, Technion – Israel Institute of Technology, Haifa,
      Israel
FAU - Kimmel, Eitan
AU  - Kimmel E
AD  - 0000000121102151grid.6451.6Faculty of Biomedical Engineering & Russell Berrie
      Nanotechnology Institute, Technion – Israel Institute of Technology, Haifa,
      Israel
FAU - Naor, Omer
AU  - Naor O
AD  - 0000 0004 1937 0538grid.9619.7ELSC Center for Brain Sciences, Hebrew University, 
      Jerusalem, Israel
FAU - Farah, Nairouz
AU  - Farah N
AD  - 0000 0004 1937 0503grid.22098.31Faculty of Life Sciences, Bar Ilan University,
      Ramat Gan, Israel
FAU - Shoham, Shy
AU  - Shoham S
AD  - 0000000121102151grid.6451.6Biomedical Engineering, Technion- Israel Institute of 
      Technology, Haifa, Israel
FAU - Paeng, Dong-Guk
AU  - Paeng DG
AD  - grid.428670.fFocused Ultrasound Foundation, Charlottesville, Virginia USA
FAU - Xu, Zhiyuan
AU  - Xu Z
AD  - 0000 0000 9136 933Xgrid.27755.32Neurosurgery, University of Virginia,
      Charlottesville, Virginia USA
FAU - Snell, John
AU  - Snell J
AD  - grid.428670.fFocused Ultrasound Foundation, Charlottesville, Virginia USA
FAU - Quigg, Anders H.
AU  - Quigg AH
AD  - grid.428670.fFocused Ultrasound Foundation, Charlottesville, Virginia USA
FAU - Eames, Matthew
AU  - Eames M
AD  - grid.428670.fFocused Ultrasound Foundation, Charlottesville, Virginia USA
FAU - Jin, Changzhu
AU  - Jin C
AD  - 0000 0001 0725 5207grid.411277.6Ocean System Engineering, Jeju National
      University, Jeju, Republic of Korea
FAU - Everstine, Ashli C.
AU  - Everstine AC
AD  - 0000 0000 9136 933Xgrid.27755.32Biology, University of Virginia, Charlottesville,
      Virginia USA
FAU - Sheehan, Jason P.
AU  - Sheehan JP
AD  - 0000 0000 9136 933Xgrid.27755.32Neurosurgery, University of Virginia,
      Charlottesville, Virginia USA
FAU - Lopes, Beatriz S.
AU  - Lopes BS
AD  - 0000 0000 9136 933Xgrid.27755.32Pathology, University of Virginia,
      Charlottesville, Virginia USA
FAU - Kassell, Neal
AU  - Kassell N
AD  - grid.428670.fFocused Ultrasound Foundation, Charlottesville, Virginia USA
FAU - Looi, Thomas
AU  - Looi T
AD  - 0000 0004 0473 9646grid.42327.30Hospital for Sick Children, Toronto, Ontario
      Canada
FAU - Khokhlova, Vera
AU  - Khokhlova V
AD  - 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA
FAU - Mougenot, Charles
AU  - Mougenot C
AD  - Philips Healthcare, Markham, Ontario Canada
FAU - Hynynen, Kullervo
AU  - Hynynen K
AD  - grid.17063.33Sunnybrook Research Institute, Toronto, Ontario Canada
FAU - Drake, James
AU  - Drake J
AD  - 0000 0004 0473 9646grid.42327.30Hospital for Sick Children, Toronto, Ontario
      Canada
FAU - Slayton, Michael
AU  - Slayton M
AD  - Guided Therapy Systems, LLC, Mesa, Arizona USA
FAU - Amodei, Richard C.
AU  - Amodei RC
AD  - Guided Therapy Systems, LLC, Mesa, Arizona USA
FAU - Compton, Keegan
AU  - Compton K
AD  - Guided Therapy Systems, LLC, Mesa, Arizona USA
FAU - McNelly, Ashley
AU  - McNelly A
AD  - 0000 0001 2168 186Xgrid.134563.6School of Medicine, University of Arizona,
      Tucson, Arizona USA
FAU - Latt, Daniel
AU  - Latt D
AD  - 0000 0001 2168 186Xgrid.134563.6School of Medicine, University of Arizona,
      Tucson, Arizona USA
FAU - Slayton, Michael
AU  - Slayton M
AD  - Guided Therapy Systems, Mesa, Arizona USA
FAU - Amodei, Richard C.
AU  - Amodei RC
AD  - Guided Therapy Systems, Mesa, Arizona USA
FAU - Compton, Keegan
AU  - Compton K
AD  - Guided Therapy Systems, Mesa, Arizona USA
FAU - Kearney, John
AU  - Kearney J
AD  - The CORE Institute, Phoenix, Arizona USA
FAU - Melodelima, David
AU  - Melodelima D
AD  - LabTAU - U1032, INSERM, Lyon, France
FAU - Dupre, Aurelien
AU  - Dupre A
AD  - 0000 0001 0200 3174grid.418116.bCentre Leon Berard, Lyon, France
FAU - Chen, Yao
AU  - Chen Y
AD  - 0000 0001 0200 3174grid.418116.bCentre Leon Berard, Lyon, France
FAU - Perol, David
AU  - Perol D
AD  - 0000 0001 0200 3174grid.418116.bCentre Leon Berard, Lyon, France
FAU - Vincenot, Jeremy
AU  - Vincenot J
AD  - LabTAU - U1032, INSERM, Lyon, France
FAU - Chapelon, Jean-Yves
AU  - Chapelon JY
AD  - LabTAU - U1032, INSERM, Lyon, France
FAU - Rivoire, Michel
AU  - Rivoire M
AD  - 0000 0001 0200 3174grid.418116.bCentre Leon Berard, Lyon, France
FAU - Guo, Wei
AU  - Guo W
AD  - Department of Oral Maxillofacial and Head Neck Oncology, Shanghai 9th People’s
      Hospital, Shanghai, China
FAU - Ren, Guoxin
AU  - Ren G
AD  - Department of Oral Maxillofacial and Head Neck Oncology, Shanghai 9th People’s
      Hospital, Shanghai, China
FAU - Shen, Guofeng
AU  - Shen G
AD  - Department of Oral Maxillofacial and Head Neck Oncology, Shanghai 9th People’s
      Hospital, Shanghai, China
FAU - Neidrauer, Michael
AU  - Neidrauer M
AD  - 0000 0001 2181 3113grid.166341.7The School of Biomedical Engineering, Science and
      Health Systems, Drexel University, Philadelphia, Pennsylvania USA
FAU - Zubkov, Leonid
AU  - Zubkov L
AD  - 0000 0001 2181 3113grid.166341.7The School of Biomedical Engineering, Science and
      Health Systems, Drexel University, Philadelphia, Pennsylvania USA
FAU - Weingarten, Michael S.
AU  - Weingarten MS
AD  - 0000 0001 2181 3113grid.166341.7Department of Surgery, College of Medicine,
      Drexel University, Philadelphia, Pennsylvania USA
FAU - Margolis, David J.
AU  - Margolis DJ
AD  - 0000 0004 1936 8972grid.25879.31Biostatistics and Epidemiology, University of
      Pennsylvania, Philadelphia, Pennsylvania USA
FAU - Lewin, Peter A.
AU  - Lewin PA
AD  - 0000 0001 2181 3113grid.166341.7The School of Biomedical Engineering, Science and
      Health Systems, Drexel University, Philadelphia, Pennsylvania USA
FAU - McDannold, Nathan
AU  - McDannold N
AD  - 0000 0004 0378 8294grid.62560.37Radiology, Brigham and Women’s Hospital, Boston, 
      Massachusetts USA
FAU - Sutton, Jonathan
AU  - Sutton J
AD  - 0000 0004 0378 8294grid.62560.37Radiology, Brigham and Women’s Hospital, Boston, 
      Massachusetts USA
FAU - Vykhodtseva, Natalia
AU  - Vykhodtseva N
AD  - 0000 0004 0378 8294grid.62560.37Radiology, Brigham and Women’s Hospital, Boston, 
      Massachusetts USA
FAU - Livingstone, Margaret
AU  - Livingstone M
AD  - 000000041936754Xgrid.38142.3cNeurobiology, Harvard Medical School, Boston,
      Massachusetts USA
FAU - Kobus, Thiele
AU  - Kobus T
AD  - 0000 0004 0444 9382grid.10417.33Radiology and Nuclear Medicine, Radboud
      University Medical Center, Nijmegen, Netherlands
FAU - Zhang, Yong-Zhi
AU  - Zhang YZ
AD  - 0000 0004 0378 8294grid.62560.37Radiology, Brigham and Women’s Hospital, Boston, 
      Massachusetts USA
FAU - Vykhodtseva, Natalia
AU  - Vykhodtseva N
AD  - 0000 0004 0378 8294grid.62560.37Radiology, Brigham and Women’s Hospital, Boston, 
      Massachusetts USA
FAU - McDannold, Nathan
AU  - McDannold N
AD  - 0000 0004 0378 8294grid.62560.37Radiology, Brigham and Women’s Hospital, Boston, 
      Massachusetts USA
FAU - Schwartz, Michael
AU  - Schwartz M
AD  - grid.17063.33Surgery (Neurosurgery), University of Toronto, Toronto, Ontario
      Canada
FAU - Huang, Yuexi
AU  - Huang Y
AD  - 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto,
      Ontario Canada
FAU - Lipsman, Nir
AU  - Lipsman N
AD  - grid.17063.33Surgery (Neurosurgery), University of Toronto, Toronto, Ontario
      Canada
FAU - Jain, Jennifer
AU  - Jain J
AD  - 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto,
      Ontario Canada
FAU - Chapman, Martin
AU  - Chapman M
AD  - 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto,
      Ontario Canada
FAU - Sankar, Tejas
AU  - Sankar T
AD  - grid.17089.37Surgery (Neurosurgery), University of Alberta, Edmonton, Alberta
      Canada
FAU - Lozano, Andres
AU  - Lozano A
AD  - grid.17063.33Surgery (Neurosurgery), University of Toronto, Toronto, Ontario
      Canada
FAU - Hynynen, Kullervo
AU  - Hynynen K
AD  - 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto,
      Ontario Canada
FAU - Schwartz, Michael
AU  - Schwartz M
AD  - 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto,
      Ontario Canada
FAU - Yeung, Robert
AU  - Yeung R
AD  - 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto,
      Ontario Canada
FAU - Huang, Yuexi
AU  - Huang Y
AD  - 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto,
      Ontario Canada
FAU - Lipsman, Nir
AU  - Lipsman N
AD  - grid.17063.33Surgery (Neurosurgery), University of Toronto, Toronto, Ontario
      Canada
FAU - Jain, Jennifer
AU  - Jain J
AD  - 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto,
      Ontario Canada
FAU - Chapman, Martin
AU  - Chapman M
AD  - 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto,
      Ontario Canada
FAU - Lozano, Andres
AU  - Lozano A
AD  - grid.17063.33Surgery (Neurosurgery), University of Toronto, Toronto, Ontario
      Canada
FAU - Hynynen, Kullervo
AU  - Hynynen K
AD  - 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto,
      Ontario Canada
FAU - Damianou, Christakis
AU  - Damianou C
AD  - 0000 0000 9995 3899grid.15810.3dCyprus University of Technology, Limassol, Cyprus
FAU - Papadopoulos, Nikolaos
AU  - Papadopoulos N
AD  - 0000 0004 1936 8497grid.28577.3fCity University, London, UK
FAU - Volovick, Alexander
AU  - Volovick A
AD  - grid.435375.3INSIGHTEC, Tirat Carmel, Israel
FAU - Grinfeld, Javier
AU  - Grinfeld J
AD  - grid.435375.3INSIGHTEC, Tirat Carmel, Israel
FAU - Levy, Yoav
AU  - Levy Y
AD  - grid.435375.3INSIGHTEC, Tirat Carmel, Israel
FAU - Brokman, Omer
AU  - Brokman O
AD  - grid.435375.3INSIGHTEC, Tirat Carmel, Israel
FAU - Zadicario, Eyal
AU  - Zadicario E
AD  - grid.435375.3INSIGHTEC, Tirat Carmel, Israel
FAU - Brenner, Ori
AU  - Brenner O
AD  - 0000 0004 0604 7563grid.13992.30Weizmann Institute, Rehovot, Israel
FAU - Castel, David
AU  - Castel D
AD  - 0000 0001 2107 2845grid.413795.dSheba Medical Center, Ramat Gan, Israel
FAU - Wu, Shih-Ying
AU  - Wu SY
AD  - 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New
      York, New York USA
FAU - Grondin, Julien
AU  - Grondin J
AD  - 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New
      York, New York USA
FAU - Zheng, Wenlan
AU  - Zheng W
AD  - 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New
      York, New York USA
FAU - Heidmann, Marc
AU  - Heidmann M
AD  - 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New
      York, New York USA
FAU - Karakatsani, Maria Eleni
AU  - Karakatsani ME
AD  - 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New
      York, New York USA
FAU - Sánchez, Carlos J. Sierra
AU  - Sánchez CJS
AD  - 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New
      York, New York USA
FAU - Ferrera, Vincent
AU  - Ferrera V
AD  - 0000000419368729grid.21729.3fNeuroscience, Columbia University, New York, New
      York USA
FAU - Konofagou, Elisa E.
AU  - Konofagou EE
AD  - 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New
      York, New York USA
FAU - Damianou, Christakis
AU  - Damianou C
AD  - 0000 0000 9995 3899grid.15810.3dCyprus University of Technology, Limassol, Cyprus
FAU - Yiannakou, Marinos
AU  - Yiannakou M
AD  - 0000 0000 9995 3899grid.15810.3dCyprus University of Technology, Limassol, Cyprus
FAU - Cho, HongSeok
AU  - Cho H
AD  - Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea
FAU - Lee, Hwayoun
AU  - Lee H
AD  - Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea
FAU - Han, Mun
AU  - Han M
AD  - 0000 0001 0661 1556grid.258803.4Kyungpook National University, Daegu, Republic of
      Korea
FAU - Choi, Jong-Ryul
AU  - Choi JR
AD  - Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea
FAU - Lee, Taekwan
AU  - Lee T
AD  - Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea
FAU - Ahn, Sanghyun
AU  - Ahn S
AD  - Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea
FAU - Chang, Yongmin
AU  - Chang Y
AD  - 0000 0001 0661 1556grid.258803.4Kyungpook National University, Daegu, Republic of
      Korea
FAU - Park, Juyoung
AU  - Park J
AD  - Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea
FAU - Ellens, Nicholas
AU  - Ellens N
AD  - 0000 0001 2171 9311grid.21107.35Radiology, Johns Hopkins University, Baltimore,
      Maryland USA
FAU - Partanen, Ari
AU  - Partanen A
AD  - 0000 0001 2171 9311grid.21107.35Radiology, Johns Hopkins University, Baltimore,
      Maryland USA
FAU - Farahani, Keyvan
AU  - Farahani K
AD  - 0000 0001 2171 9311grid.21107.35Radiology, Johns Hopkins University, Baltimore,
      Maryland USA
FAU - Airan, Raag
AU  - Airan R
AD  - 0000 0001 2171 9311grid.21107.35Radiology, Johns Hopkins University, Baltimore,
      Maryland USA
FAU - Carpentier, Alexandre
AU  - Carpentier A
AD  - 0000 0001 2150 9058grid.411439.aAssistance Publique Hopitaux de Paris, Hopital de
      la Pitie Salpetriere, Department of Neurosurgery, Paris, France
FAU - Canney, Michael
AU  - Canney M
AD  - CarThera, Lyon, France
FAU - Vignot, Alexandre
AU  - Vignot A
AD  - CarThera, Lyon, France
FAU - Lafon, Cyril
AU  - Lafon C
AD  - INSERM, U1032, LabTau, Lyon, France
FAU - Chapelon, Jean-Yves
AU  - Chapelon JY
AD  - INSERM, U1032, LabTau, Lyon, France
FAU - Delattre, Jean-yves
AU  - Delattre Jy
AD  - 0000 0001 2149 7878grid.410511.0Universite Paris, UPMC, Paris, France
FAU - Idbaih, Ahmed
AU  - Idbaih A
AD  - 0000 0001 2150 9058grid.411439.aAssistance Publique Hopitaux de Paris, Hopital de
      la Pitie Salpetriere, Department of Neuro-Oncology, Paris, France
FAU - Odéen, Henrik
AU  - Odéen H
AD  - Siemens Healthcare, Salt Lake City, Utah USA
FAU - Bolster, Bradley
AU  - Bolster B
AD  - Siemens Healthcare, Salt Lake City, Utah USA
FAU - Jeong, Eun Kee
AU  - Jeong EK
AD  - 0000 0001 2193 0096grid.223827.eRadiology, University of Utah, Salt Lake City,
      Utah USA
FAU - Parker, Dennis L.
AU  - Parker DL
AD  - 0000 0001 2193 0096grid.223827.eRadiology, University of Utah, Salt Lake City,
      Utah USA
FAU - Gaur, Pooja
AU  - Gaur P
AD  - 0000 0001 2264 7217grid.152326.1Vanderbilt University, Nashville, Tennessee USA
FAU - Feng, Xue
AU  - Feng X
AD  - 0000 0000 9136 933Xgrid.27755.32University of Virginia, Charlottesville, Virginia
      USA
FAU - Fielden, Samuel
AU  - Fielden S
AD  - 0000 0000 9136 933Xgrid.27755.32University of Virginia, Charlottesville, Virginia
      USA
FAU - Meyer, Craig
AU  - Meyer C
AD  - 0000 0000 9136 933Xgrid.27755.32University of Virginia, Charlottesville, Virginia
      USA
FAU - Werner, Beat
AU  - Werner B
AD  - 0000 0001 0726 4330grid.412341.1University Children’s Hospital, Zurich,
      Switzerland
FAU - Grissom, William
AU  - Grissom W
AD  - 0000 0001 2264 7217grid.152326.1Vanderbilt University, Nashville, Tennessee USA
FAU - Marx, Michael
AU  - Marx M
AD  - 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California
      USA
FAU - Ghanouni, Pejman
AU  - Ghanouni P
AD  - 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California
      USA
FAU - Pauly, Kim Butts
AU  - Pauly KB
AD  - 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California
      USA
FAU - Weber, Hans
AU  - Weber H
AD  - 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California
      USA
FAU - Taviani, Valentina
AU  - Taviani V
AD  - 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California
      USA
FAU - Pauly, Kim Butts
AU  - Pauly KB
AD  - 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California
      USA
FAU - Ghanouni, Pejman
AU  - Ghanouni P
AD  - 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California
      USA
FAU - Hargreaves, Brian
AU  - Hargreaves B
AD  - 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California
      USA
FAU - Tanaka, Jun
AU  - Tanaka J
AD  - 0000 0001 2151 536Xgrid.26999.3dThe University of Tokyo, Tokyo, Japan
FAU - Kikuchi, Kentaro
AU  - Kikuchi K
AD  - 0000 0001 2151 536Xgrid.26999.3dThe University of Tokyo, Tokyo, Japan
FAU - Ishijima, Ayumu
AU  - Ishijima A
AD  - 0000 0001 2151 536Xgrid.26999.3dThe University of Tokyo, Tokyo, Japan
FAU - Azuma, Takashi
AU  - Azuma T
AD  - 0000 0001 2151 536Xgrid.26999.3dThe University of Tokyo, Tokyo, Japan
FAU - Minamihata, Kosuke
AU  - Minamihata K
AD  - 0000 0001 2151 536Xgrid.26999.3dThe University of Tokyo, Tokyo, Japan
FAU - Yamaguchi, Satoshi
AU  - Yamaguchi S
AD  - 0000 0001 2151 536Xgrid.26999.3dThe University of Tokyo, Tokyo, Japan
FAU - Nagamune, Teruyuki
AU  - Nagamune T
AD  - 0000 0001 2151 536Xgrid.26999.3dThe University of Tokyo, Tokyo, Japan
FAU - Sakuma, Ichiro
AU  - Sakuma I
AD  - 0000 0001 2151 536Xgrid.26999.3dThe University of Tokyo, Tokyo, Japan
FAU - Takagi, Shu
AU  - Takagi S
AD  - 0000 0001 2151 536Xgrid.26999.3dThe University of Tokyo, Tokyo, Japan
FAU - Santin, Mathieu D.
AU  - Santin MD
AD  - Centre de NeuroImagerie de Recherche - CENIR, Paris, France
FAU - Marsac, Laurent
AU  - Marsac L
AD  - Supersonic Imagine, Aix-en-Provence, France
FAU - Maimbourg, Guillaume
AU  - Maimbourg G
AD  - 0000 0001 2217 0017grid.7452.4Institut Langevin, Université Denis Diderot, Paris,
      France
FAU - Monfort, Morgane
AU  - Monfort M
AD  - Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S
      1127, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France
FAU - Larrat, Benoit
AU  - Larrat B
AD  - 0000 0001 2112 9282grid.4444.0Institut Langevin, CNRS, Paris, France
FAU - François, Chantal
AU  - François C
AD  - Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S
      1127, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France
FAU - Lehéricy, Stéphane
AU  - Lehéricy S
AD  - Centre de NeuroImagerie de Recherche - CENIR, Paris, France
FAU - Tanter, Mickael
AU  - Tanter M
AD  - 0000000121866389grid.7429.8Institut Langevin, INSERM, Paris, France
FAU - Aubry, Jean-Franҫois
AU  - Aubry JF
AD  - 0000 0001 2112 9282grid.4444.0Institut Langevin, CNRS, Paris, France
FAU - Karakatsani, Maria Eleni
AU  - Karakatsani ME
AD  - 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New
      York, New York USA
FAU - Samiotaki, Gesthimani
AU  - Samiotaki G
AD  - 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New
      York, New York USA
FAU - Wang, Shutao
AU  - Wang S
AD  - 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New
      York, New York USA
FAU - Acosta, Camilo
AU  - Acosta C
AD  - 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New
      York, New York USA
FAU - Feinberg, Eliza R.
AU  - Feinberg ER
AD  - 0000000419368729grid.21729.3fBiological Sciences, Columbia University, New York, 
      New York USA
FAU - Konofagou, Elisa E.
AU  - Konofagou EE
AD  - 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New
      York, New York USA
FAU - Kovacs, Zsofia I.
AU  - Kovacs ZI
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institute of Health, Bethesda, Maryland USA
FAU - Tu, Tsang-Wei
AU  - Tu TW
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institute of Health, Bethesda, Maryland USA
FAU - Papadakis, Georgios Z.
AU  - Papadakis GZ
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institute of Health, Bethesda, Maryland USA
FAU - Reid, William C.
AU  - Reid WC
AD  - 0000 0001 2297 5165grid.94365.3dCenter for Infectious Disease Imaging (CIDI),
      Radiology and Imaging Sciences, National Institute of Health, Bethesda, Maryland 
      USA
FAU - Hammoud, Dima A.
AU  - Hammoud DA
AD  - 0000 0001 2297 5165grid.94365.3dCenter for Infectious Disease Imaging (CIDI),
      Radiology and Imaging Sciences, National Institute of Health, Bethesda, Maryland 
      USA
FAU - Frank, Joseph A.
AU  - Frank JA
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institute of Health, Bethesda, Maryland USA
FAU - Kovacs, Zsofia i.
AU  - Kovacs Zi
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institute of Health, Bethesda, Maryland USA
FAU - Kim, Saejeong
AU  - Kim S
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institute of Health, Bethesda, Maryland USA
FAU - Jikaria, Neekita
AU  - Jikaria N
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institute of Health, Bethesda, Maryland USA
FAU - Bresler, Michele
AU  - Bresler M
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institute of Health, Bethesda, Maryland USA
FAU - Qureshi, Farhan
AU  - Qureshi F
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institute of Health, Bethesda, Maryland USA
FAU - Frank, Joseph A.
AU  - Frank JA
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institute of Health, Bethesda, Maryland USA
FAU - Xia, Jingjing
AU  - Xia J
AD  - grid.145695.aDepartment of Electrical Engineering, Chang Gung University,
      Taoyuan, Taiwan
FAU - Tsui, Po-Shiang
AU  - Tsui PS
AD  - grid.145695.aDepartment of Medical Imaging and Radiological Sciences, Chang Gung 
      University, Taoyuan, Taiwan
FAU - Liu, Hao-Li
AU  - Liu HL
AD  - grid.145695.aDepartment of Electrical Engineering, Chang Gung University,
      Taoyuan, Taiwan
FAU - Plata, Juan C.
AU  - Plata JC
AD  - 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California
      USA
FAU - Fielden, Samuel
AU  - Fielden S
AD  - 0000 0000 9136 933Xgrid.27755.32Bioengineering, University of Virginia,
      Charlottesville, Virginia USA
FAU - Sveinsson, Bragi
AU  - Sveinsson B
AD  - 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California
      USA
FAU - Hargreaves, Brian
AU  - Hargreaves B
AD  - 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California
      USA
FAU - Meyer, Craig
AU  - Meyer C
AD  - 0000 0000 9136 933Xgrid.27755.32Bioengineering, University of Virginia,
      Charlottesville, Virginia USA
FAU - Pauly, Kim Butts
AU  - Pauly KB
AD  - 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California
      USA
FAU - Plata, Juan C.
AU  - Plata JC
AD  - 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California
      USA
FAU - Salgaonkar, Vasant A.
AU  - Salgaonkar VA
AD  - 0000 0001 2297 6811grid.266102.1Radiation Oncology, University of California San 
      Francisco, San Francisco, California USA
FAU - Adams, Matthew
AU  - Adams M
AD  - 0000 0001 2297 6811grid.266102.1Radiation Oncology, University of California San 
      Francisco, San Francisco, California USA
FAU - Diederich, Chris
AU  - Diederich C
AD  - 0000 0001 2297 6811grid.266102.1Radiation Oncology, University of California San 
      Francisco, San Francisco, California USA
FAU - Ozhinsky, Eugene
AU  - Ozhinsky E
AD  - 0000 0001 2297 6811grid.266102.1Radiology and Biomedical Imaging, University of
      California San Francisco, San Francisco, California USA
FAU - Bucknor, Matthew D.
AU  - Bucknor MD
AD  - 0000 0001 2297 6811grid.266102.1Radiology and Biomedical Imaging, University of
      California San Francisco, San Francisco, California USA
FAU - Rieke, Viola
AU  - Rieke V
AD  - 0000 0001 2297 6811grid.266102.1Radiology and Biomedical Imaging, University of
      California San Francisco, San Francisco, California USA
FAU - Partanen, Ari
AU  - Partanen A
AD  - Clinical Science MR Therapy, Philips, Andover, Massachusetts USA
FAU - Mikhail, Andrew
AU  - Mikhail A
AD  - 0000 0001 2194 5650grid.410305.3Center for Interventional Oncology, Department of
      Radiology and Imaging Sciences, Clinical Center, National Institutes of Health,
      Bethesda, Maryland USA
FAU - Severance, Lauren
AU  - Severance L
AD  - 0000 0001 2194 5650grid.410305.3Center for Interventional Oncology, Department of
      Radiology and Imaging Sciences, Clinical Center, National Institutes of Health,
      Bethesda, Maryland USA
FAU - Negussie, Ayele H.
AU  - Negussie AH
AD  - 0000 0001 2194 5650grid.410305.3Center for Interventional Oncology, Department of
      Radiology and Imaging Sciences, Clinical Center, National Institutes of Health,
      Bethesda, Maryland USA
FAU - Wood, Bradford
AU  - Wood B
AD  - 0000 0001 2194 5650grid.410305.3Center for Interventional Oncology, Department of
      Radiology and Imaging Sciences, Clinical Center, National Institutes of Health,
      Bethesda, Maryland USA
FAU - de Greef, Martijn
AU  - de Greef M
AD  - 0000000090126352grid.7692.aImaging Division, University Medical Center, Utrecht, 
      Netherlands
FAU - Schubert, Gerald
AU  - Schubert G
AD  - Philips Healthcare, Vantaa, Finland
FAU - Moonen, Chrit
AU  - Moonen C
AD  - 0000000090126352grid.7692.aImaging Division, University Medical Center, Utrecht, 
      Netherlands
FAU - Ries, Mario
AU  - Ries M
AD  - 0000000090126352grid.7692.aImaging Division, University Medical Center, Utrecht, 
      Netherlands
FAU - Poorman, Megan E.
AU  - Poorman ME
AD  - 0000 0001 2264 7217grid.152326.1Biomedical Engineering, Vanderbilt University,
      Nashville, Tennessee USA
FAU - Dockery, Mary
AU  - Dockery M
AD  - 0000 0001 2264 7217grid.152326.1Biomedical Engineering, Vanderbilt University,
      Nashville, Tennessee USA
FAU - Chaplin, Vandiver
AU  - Chaplin V
AD  - 0000 0001 2264 7217grid.152326.1Chemical and Physical Biology, Vanderbilt
      University, Nashville, Tennessee USA
FAU - Dudzinski, Stephanie O.
AU  - Dudzinski SO
AD  - 0000 0001 2264 7217grid.152326.1Biomedical Engineering, Vanderbilt University,
      Nashville, Tennessee USA
FAU - Spears, Ryan
AU  - Spears R
AD  - 0000 0001 2264 7217grid.152326.1Biomedical Engineering, Vanderbilt University,
      Nashville, Tennessee USA
FAU - Caskey, Charles
AU  - Caskey C
AD  - 0000 0001 2264 7217grid.152326.1Radiology, Vanderbilt University, Nashville,
      Tennessee USA
FAU - Giorgio, Todd
AU  - Giorgio T
AD  - 0000 0001 2264 7217grid.152326.1Biomedical Engineering, Vanderbilt University,
      Nashville, Tennessee USA
FAU - Grissom, William
AU  - Grissom W
AD  - 0000 0001 2264 7217grid.152326.1Biomedical Engineering, Vanderbilt University,
      Nashville, Tennessee USA
FAU - Costa, Marcia M.
AU  - Costa MM
AD  - The Institute of Cancer Research, Department of Physics, Sutton, UK
FAU - Papaevangelou, Efthymia
AU  - Papaevangelou E
AD  - The Institute of Cancer Research, Department of Physics, Sutton, UK
FAU - Shah, Anant
AU  - Shah A
AD  - The Institute of Cancer Research, Department of Physics, Sutton, UK
FAU - Rivens, Ian
AU  - Rivens I
AD  - The Institute of Cancer Research, Department of Physics, Sutton, UK
FAU - Box, Carol
AU  - Box C
AD  - The Institute of Cancer Research, Department of Physics, Sutton, UK
FAU - Bamber, Jeff
AU  - Bamber J
AD  - The Institute of Cancer Research, Department of Physics, Sutton, UK
FAU - ter Haar, Gail
AU  - ter Haar G
AD  - The Institute of Cancer Research, Department of Physics, Sutton, UK
FAU - Burks, Scott R.
AU  - Burks SR
AD  - 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical
      Center, Bethesda, Maryland USA
FAU - Nagle, Matthew
AU  - Nagle M
AD  - 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical
      Center, Bethesda, Maryland USA
FAU - Nguyen, Ben
AU  - Nguyen B
AD  - 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical
      Center, Bethesda, Maryland USA
FAU - Bresler, Michele
AU  - Bresler M
AD  - 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical
      Center, Bethesda, Maryland USA
FAU - Frank, Joseph A.
AU  - Frank JA
AD  - 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical
      Center, Bethesda, Maryland USA
FAU - Burks, Scott R.
AU  - Burks SR
AD  - 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical
      Center, Bethesda, Maryland USA
FAU - Nagle, Matthew
AU  - Nagle M
AD  - 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical
      Center, Bethesda, Maryland USA
FAU - Nguyen, Ben
AU  - Nguyen B
AD  - 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical
      Center, Bethesda, Maryland USA
FAU - Bresler, Michele
AU  - Bresler M
AD  - 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical
      Center, Bethesda, Maryland USA
FAU - Kim, Saejeong
AU  - Kim S
AD  - 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical
      Center, Bethesda, Maryland USA
FAU - Milo, Blerta
AU  - Milo B
AD  - 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical
      Center, Bethesda, Maryland USA
FAU - Frank, Joseph A.
AU  - Frank JA
AD  - 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical
      Center, Bethesda, Maryland USA
FAU - Le, Nhan M.
AU  - Le NM
AD  - 0000 0004 0397 2876grid.8241.fMechanical Engineering, University of Dundee,
      Dundee, Angus UK
FAU - Song, Shaozhen
AU  - Song S
AD  - 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA
FAU - Zhou, Kanheng
AU  - Zhou K
AD  - 0000 0004 0397 2876grid.8241.fMechanical Engineering, University of Dundee,
      Dundee, Angus UK
FAU - Nabi, Ghulam
AU  - Nabi G
AD  - 0000 0004 0397 2876grid.8241.fUniversity of Dundee, Dundee, UK
FAU - Huang, Zhihong
AU  - Huang Z
AD  - 0000 0004 0397 2876grid.8241.fMechanical Engineering, University of Dundee,
      Dundee, Angus UK
FAU - Ben-Ezra, Shmuel
AU  - Ben-Ezra S
AD  - Action-Physics, Pardes-Hanna, Israel
FAU - Rosen, Shani
AU  - Rosen S
AD  - CByond ltd., Nesher, Israel
FAU - Mihcin, Senay
AU  - Mihcin S
AD  - School of Medicine, IMSaT, Dundee, UK
FAU - Strehlow, Jan
AU  - Strehlow J
AD  - 0000 0000 9261 3939grid.4561.6Fraunhofer, Mevis, Bremen Germany
FAU - Karakitsios, Ioannis
AU  - Karakitsios I
AD  - School of Medicine, IMSaT, Dundee, UK
FAU - Le, Nhan
AU  - Le N
AD  - School of Medicine, IMSaT, Dundee, UK
FAU - Schwenke, Michael
AU  - Schwenke M
AD  - 0000 0000 9261 3939grid.4561.6Fraunhofer, Mevis, Bremen Germany
FAU - Demedts, Daniel
AU  - Demedts D
AD  - 0000 0000 9261 3939grid.4561.6Fraunhofer, Mevis, Bremen Germany
FAU - Prentice, Paul
AU  - Prentice P
AD  - School of Medicine, IMSaT, Dundee, UK
FAU - Haase, Sabrina
AU  - Haase S
AD  - 0000 0000 9261 3939grid.4561.6Fraunhofer, Mevis, Bremen Germany
FAU - Preusser, Tobias
AU  - Preusser T
AD  - 0000 0000 9261 3939grid.4561.6Fraunhofer, Mevis, Bremen Germany
FAU - Melzer, Andreas
AU  - Melzer A
AD  - School of Medicine, IMSaT, Dundee, UK
FAU - Mestas, Jean-Louis
AU  - Mestas JL
AD  - U1032, INSERM, Lyon, Rhone-Alpes France
FAU - Chettab, Kamel
AU  - Chettab K
AD  - 0000 0001 2172 4233grid.25697.3fUniversité de lyon, Lyon, Rhone-Alpes France
FAU - Gomez, Gustavo Stadthagen
AU  - Gomez GS
AD  - Bioaster, Lyon, Rhone-Alpes France
FAU - Dumontet, Charles
AU  - Dumontet C
AD  - U1052, INSERM, Lyon, Rhone-Alpes France
FAU - Werle, Bettina
AU  - Werle B
AD  - Bioaster, Lyon, Rhone-Alpes France
FAU - Lafon, Cyril
AU  - Lafon C
AD  - U1032, INSERM, Lyon, Rhone-Alpes France
FAU - Marquet, Fabrice
AU  - Marquet F
AD  - IHU Institut de Rythmologie et de Modélisation Cardiaque, Bordeaux, France
FAU - Bour, Pierre
AU  - Bour P
AD  - IHU Institut de Rythmologie et de Modélisation Cardiaque, Bordeaux, France
FAU - Vaillant, Fanny
AU  - Vaillant F
AD  - IHU Institut de Rythmologie et de Modélisation Cardiaque, Bordeaux, France
FAU - Amraoui, Sana
AU  - Amraoui S
AD  - IHU Institut de Rythmologie et de Modélisation Cardiaque, Bordeaux, France
FAU - Dubois, Rémi
AU  - Dubois R
AD  - IHU Institut de Rythmologie et de Modélisation Cardiaque, Bordeaux, France
FAU - Ritter, Philippe
AU  - Ritter P
AD  - IHU Institut de Rythmologie et de Modélisation Cardiaque, Bordeaux, France
FAU - Haïssaguerre, Michel
AU  - Haïssaguerre M
AD  - IHU Institut de Rythmologie et de Modélisation Cardiaque, Bordeaux, France
FAU - Hocini, Mélèze
AU  - Hocini M
AD  - IHU Institut de Rythmologie et de Modélisation Cardiaque, Bordeaux, France
FAU - Bernus, Olivier
AU  - Bernus O
AD  - IHU Institut de Rythmologie et de Modélisation Cardiaque, Bordeaux, France
FAU - Quesson, Bruno
AU  - Quesson B
AD  - IHU Institut de Rythmologie et de Modélisation Cardiaque, Bordeaux, France
FAU - Livneh, Amit
AU  - Livneh A
AD  - 0000000121102151grid.6451.6Department of Biomedical Engineering, Technion-Israel 
      Institute of Technology, Haifa, Israel
FAU - Kimmel, Eitan
AU  - Kimmel E
AD  - 0000000121102151grid.6451.6Department of Biomedical Engineering, Technion-Israel 
      Institute of Technology, Haifa, Israel
FAU - Adam, Dan
AU  - Adam D
AD  - 0000000121102151grid.6451.6Department of Biomedical Engineering, Technion-Israel 
      Institute of Technology, Haifa, Israel
FAU - Robin, Justine
AU  - Robin J
AD  - 0000 0001 2217 0017grid.7452.4Institut Langevin, ESPCI ParisTech, CNRS UMR 7587, 
      INSERM U979, Université Paris Diderot, Paris, France
FAU - Arnal, Bastien
AU  - Arnal B
AD  - 0000 0001 2217 0017grid.7452.4Institut Langevin, ESPCI ParisTech, CNRS UMR 7587, 
      INSERM U979, Université Paris Diderot, Paris, France
FAU - Fink, Mathias
AU  - Fink M
AD  - 0000 0001 2217 0017grid.7452.4Institut Langevin, ESPCI ParisTech, CNRS UMR 7587, 
      INSERM U979, Université Paris Diderot, Paris, France
FAU - Tanter, Mickael
AU  - Tanter M
AD  - 0000 0001 2217 0017grid.7452.4Institut Langevin, ESPCI ParisTech, CNRS UMR 7587, 
      INSERM U979, Université Paris Diderot, Paris, France
FAU - Pernot, Mathieu
AU  - Pernot M
AD  - 0000 0001 2217 0017grid.7452.4Institut Langevin, ESPCI ParisTech, CNRS UMR 7587, 
      INSERM U979, Université Paris Diderot, Paris, France
FAU - Khokhlova, Tatiana D.
AU  - Khokhlova TD
AD  - 0000000122986657grid.34477.33Department of Medicine, University of Washington,
      Seattle, Washington USA
FAU - Schade, George R.
AU  - Schade GR
AD  - 0000000122986657grid.34477.33Department of Urology, University of Washington,
      Seattle, Washington USA
FAU - Wang, Yak-Nam
AU  - Wang YN
AD  - 0000000122986657grid.34477.33Applied Physics Laboratory, University of
      Washington, Seattle, Washington USA
FAU - Kreider, Wayne
AU  - Kreider W
AD  - 0000000122986657grid.34477.33Applied Physics Laboratory, University of
      Washington, Seattle, Washington USA
FAU - Simon, Julianna
AU  - Simon J
AD  - 0000000122986657grid.34477.33Applied Physics Laboratory, University of
      Washington, Seattle, Washington USA
FAU - Starr, Frank
AU  - Starr F
AD  - 0000000122986657grid.34477.33Applied Physics Laboratory, University of
      Washington, Seattle, Washington USA
FAU - Karzova, Maria
AU  - Karzova M
AD  - 0000 0001 2342 9668grid.14476.30Physics Department, M.V. Lomonosov Moscow State
      University, Moscow, Russian Federation
FAU - Maxwell, Adam
AU  - Maxwell A
AD  - 0000000122986657grid.34477.33Department of Urology, University of Washington,
      Seattle, Washington USA
FAU - Bailey, Michael R.
AU  - Bailey MR
AD  - 0000000122986657grid.34477.33Applied Physics Laboratory, University of
      Washington, Seattle, Washington USA
FAU - Khokhlova, Vera
AU  - Khokhlova V
AD  - 0000000122986657grid.34477.33Applied Physics Laboratory, University of
      Washington, Seattle, Washington USA
FAU - Lundt, Jonathan E.
AU  - Lundt JE
AD  - 0000000086837370grid.214458.eBiomedical Engineering, University of Michigan, Ann 
      Arbor, Michigan USA
FAU - Allen, Steven P.
AU  - Allen SP
AD  - 0000000086837370grid.214458.eBiomedical Engineering, University of Michigan, Ann 
      Arbor, Michigan USA
FAU - Sukovich, Jonathan R.
AU  - Sukovich JR
AD  - 0000000086837370grid.214458.eBiomedical Engineering, University of Michigan, Ann 
      Arbor, Michigan USA
FAU - Hall, Timothy
AU  - Hall T
AD  - 0000000086837370grid.214458.eBiomedical Engineering, University of Michigan, Ann 
      Arbor, Michigan USA
FAU - Xu, Zhen
AU  - Xu Z
AD  - 0000000086837370grid.214458.eBiomedical Engineering, University of Michigan, Ann 
      Arbor, Michigan USA
FAU - Schade, George R.
AU  - Schade GR
AD  - 0000000122986657grid.34477.33Urology, University of Washington, Seattle,
      Washington USA
FAU - Wang, Yak-Nam
AU  - Wang YN
AD  - 0000000122986657grid.34477.33Appied Physics Lab, University of Washington,
      Seattle, Washington USA
FAU - Khokhlova, Tatiana D.
AU  - Khokhlova TD
AD  - 0000000122986657grid.34477.33Medicine, University of Washington, Seattle,
      Washington USA
FAU - May, Philip
AU  - May P
AD  - 0000000122986657grid.34477.33Urology, University of Washington, Seattle,
      Washington USA
FAU - Lin, Daniel W.
AU  - Lin DW
AD  - 0000000122986657grid.34477.33Urology, University of Washington, Seattle,
      Washington USA
FAU - Bailey, Michael R.
AU  - Bailey MR
AD  - 0000000122986657grid.34477.33Appied Physics Lab, University of Washington,
      Seattle, Washington USA
FAU - Khokhlova, Vera
AU  - Khokhlova V
AD  - 0000 0001 2342 9668grid.14476.30Physics, M.V. Lomonosov Moscow State University, 
      Moscow, Russian Federation
FAU - Constans, Charlotte
AU  - Constans C
AD  - 0000 0001 2217 0017grid.7452.4Institut Langevin, Université Paris Diderot, Paris,
      France
FAU - Deffieux, Thomas
AU  - Deffieux T
AD  - 0000000121866389grid.7429.8Institut Langevin, INSERM, Paris, France
FAU - Tanter, Mickael
AU  - Tanter M
AD  - 0000000121866389grid.7429.8Institut Langevin, INSERM, Paris, France
FAU - Aubry, Jean-Francois
AU  - Aubry JF
AD  - 0000 0001 2112 9282grid.4444.0Institut Langevin, CNRS, Paris, France
FAU - Park, Eun-Joo
AU  - Park EJ
AD  - 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital,
      Seoul, Republic of Korea
FAU - Ahn, Yun Deok
AU  - Ahn YD
AD  - 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital,
      Seoul, Republic of Korea
FAU - Kang, Soo Yeon
AU  - Kang SY
AD  - 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital,
      Seoul, Republic of Korea
FAU - Park, Dong-Hyuk
AU  - Park DH
AD  - 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital,
      Seoul, Republic of Korea
FAU - Lee, Jae Young
AU  - Lee JY
AD  - 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital,
      Seoul, Republic of Korea
FAU - Vidal-Jove, J.
AU  - Vidal-Jove J
AD  - Surgical Oncology, HIFU Unit, Hospital Universitari Mutua Terrassa (HUMT),
      Barcelona, Spain
FAU - Perich, E.
AU  - Perich E
AD  - Interventional Oncology Unit, Institut Khuab, Barcelona, Spain
FAU - Ruiz, A.
AU  - Ruiz A
AD  - Surgical Oncology, HIFU Unit, Hospital Universitari Mutua Terrassa (HUMT),
      Barcelona, Spain
FAU - Jaen, A.
AU  - Jaen A
AD  - Research Unit, Hospital Universitari Mutua Terrassa (HUMT), Barcelona, Spain
FAU - Eres, N.
AU  - Eres N
AD  - Interventional Oncology Unit, Institut Khuab, Barcelona, Spain
FAU - del Castillo, M. Alvarez
AU  - del Castillo MA
AD  - Medical Direction Department, Hospital Universitari Mutua Terrassa (HUMT),
      Barcelona, Spain
FAU - Myers, Rachel
AU  - Myers R
AD  - 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of 
      Oxford, Oxford, UK
FAU - Kwan, James
AU  - Kwan J
AD  - OxSonics Ltd, Oxford, UK
FAU - Coviello, Christian
AU  - Coviello C
AD  - OxSonics Ltd, Oxford, UK
FAU - Rowe, Cliff
AU  - Rowe C
AD  - OxSonics Ltd, Oxford, UK
FAU - Crake, Calum
AU  - Crake C
AD  - 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of 
      Oxford, Oxford, UK
FAU - Finn, Sean
AU  - Finn S
AD  - OxSonics Ltd, Oxford, UK
FAU - Jackson, Edward
AU  - Jackson E
AD  - OxSonics Ltd, Oxford, UK
FAU - Carlisle, Robert
AU  - Carlisle R
AD  - 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of 
      Oxford, Oxford, UK
FAU - Coussios, Constantin
AU  - Coussios C
AD  - 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of 
      Oxford, Oxford, UK
FAU - Pouliopoulos, Antonios
AU  - Pouliopoulos A
AD  - 0000 0001 2113 8111grid.7445.2Bioengineering, Imperial College London, London, UK
FAU - Li, Caiqin
AU  - Li C
AD  - 0000 0001 2113 8111grid.7445.2Bioengineering, Imperial College London, London, UK
FAU - Tinguely, Marc
AU  - Tinguely M
AD  - 0000 0001 2113 8111grid.7445.2Chemical Engineering, Imperial College London,
      London, UK
FAU - Tang, Meng-Xing
AU  - Tang MX
AD  - 0000 0001 2113 8111grid.7445.2Bioengineering, Imperial College London, London, UK
FAU - Garbin, Valeria
AU  - Garbin V
AD  - 0000 0001 2113 8111grid.7445.2Chemical Engineering, Imperial College London,
      London, UK
FAU - Choi, James J.
AU  - Choi JJ
AD  - 0000 0001 2113 8111grid.7445.2Bioengineering, Imperial College London, London, UK
FAU - Lyon, Paul C.
AU  - Lyon PC
AD  - 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University
      Hospitals NHS Foundation Trust, Oxford, UK
FAU - Mannaris, Christophoros
AU  - Mannaris C
AD  - 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University
      Hospitals NHS Foundation Trust, Oxford, UK
FAU - Gray, Michael
AU  - Gray M
AD  - 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University
      Hospitals NHS Foundation Trust, Oxford, UK
FAU - Folkes, Lisa
AU  - Folkes L
AD  - 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University
      Hospitals NHS Foundation Trust, Oxford, UK
FAU - Stratford, Michael
AU  - Stratford M
AD  - 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University
      Hospitals NHS Foundation Trust, Oxford, UK
FAU - Carlisle, Robert
AU  - Carlisle R
AD  - 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University
      Hospitals NHS Foundation Trust, Oxford, UK
FAU - Wu, Feng
AU  - Wu F
AD  - 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University
      Hospitals NHS Foundation Trust, Oxford, UK
FAU - Middleton, Mark
AU  - Middleton M
AD  - 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University
      Hospitals NHS Foundation Trust, Oxford, UK
FAU - Gleeson, Fergus
AU  - Gleeson F
AD  - 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University
      Hospitals NHS Foundation Trust, Oxford, UK
FAU - Coussios, Constantin
AU  - Coussios C
AD  - 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University
      Hospitals NHS Foundation Trust, Oxford, UK
FAU - Nwokeoha, Sandra
AU  - Nwokeoha S
AD  - 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of 
      Oxford, Oxford, UK
FAU - Carlisle, Robert
AU  - Carlisle R
AD  - 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of 
      Oxford, Oxford, UK
FAU - Cleveland, Robin
AU  - Cleveland R
AD  - 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of 
      Oxford, Oxford, UK
FAU - Wang, Yak-Nam
AU  - Wang YN
AD  - 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA
FAU - Khokhlova, Tatiana D.
AU  - Khokhlova TD
AD  - 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA
FAU - Li, Tong
AU  - Li T
AD  - 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA
FAU - Farr, Navid
AU  - Farr N
AD  - 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA
FAU - D’Andrea, Samantha
AU  - D’Andrea S
AD  - 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA
FAU - Starr, Frank
AU  - Starr F
AD  - 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA
FAU - Gravelle, Kayla
AU  - Gravelle K
AD  - 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA
FAU - Chen, Hong
AU  - Chen H
AD  - 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA
FAU - Partanen, Ari
AU  - Partanen A
AD  - Philips, Bethesda, Maryland USA
FAU - Lee, Donghoon
AU  - Lee D
AD  - 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA
FAU - Hwang, Joo Ha
AU  - Hwang JH
AD  - 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA
FAU - Tardoski, Sophie
AU  - Tardoski S
AD  - LabTAU - U1032, INSERM, Lyon, France
FAU - Ngo, Jacqueline
AU  - Ngo J
AD  - LabTAU - U1032, INSERM, Lyon, France
FAU - Gineyts, Evelyne
AU  - Gineyts E
AD  - Lyos - U1033, INSERM, Lyon, France
FAU - Roux, Jean-Pau
AU  - Roux JP
AD  - Lyos - U1033, INSERM, Lyon, France
FAU - Clézardin, Philippe
AU  - Clézardin P
AD  - Lyos - U1033, INSERM, Lyon, France
FAU - Melodelima, David
AU  - Melodelima D
AD  - LabTAU - U1032, INSERM, Lyon, France
FAU - Conti, Allegra
AU  - Conti A
AD  - CEA/DSV/I2BM/NeuroSpin, Gif sur Yvette, France
FAU - Magnin, Rémi
AU  - Magnin R
AD  - CEA/DSV/I2BM/NeuroSpin, Gif sur Yvette, France
FAU - Gerstenmayer, Matthieu
AU  - Gerstenmayer M
AD  - CEA/DSV/I2BM/NeuroSpin, Gif sur Yvette, France
FAU - Lux, François
AU  - Lux F
AD  - 0000 0001 2150 7757grid.7849.2Université Lyon 1, Lyon, France
FAU - Tillement, Olivier
AU  - Tillement O
AD  - 0000 0001 2150 7757grid.7849.2Université Lyon 1, Lyon, France
FAU - Mériaux, Sébastien
AU  - Mériaux S
AD  - CEA/DSV/I2BM/NeuroSpin, Gif sur Yvette, France
FAU - Penna, Stefania Della
AU  - Penna SD
AD  - 0000 0001 2181 4941grid.412451.7Department of Neuroscience, G. D’Annunzio
      University, Chieti, Italy
FAU - Romani, Gian Luca
AU  - Romani GL
AD  - 0000 0001 2181 4941grid.412451.7Department of Neuroscience, G. D’Annunzio
      University, Chieti, Italy
FAU - Dumont, Erik
AU  - Dumont E
AD  - Image Guided Therapy, Pessac, France
FAU - Larrat, Benoit
AU  - Larrat B
AD  - CEA/DSV/I2BM/NeuroSpin, Gif sur Yvette, France
FAU - Sun, Tao
AU  - Sun T
AD  - 0000 0004 0378 8294grid.62560.37Department of Radiology, Brigham and Women’s
      Hospital, Harvard Medical School, Boston, Massachusetts USA
FAU - Power, Chanikarn
AU  - Power C
AD  - 0000 0004 0378 8294grid.62560.37Department of Radiology, Brigham and Women’s
      Hospital, Harvard Medical School, Boston, Massachusetts USA
FAU - Zhang, Yong-Zhi
AU  - Zhang YZ
AD  - 0000 0004 0378 8294grid.62560.37Department of Radiology, Brigham and Women’s
      Hospital, Harvard Medical School, Boston, Massachusetts USA
FAU - Sutton, Jonathan
AU  - Sutton J
AD  - 0000 0004 0378 8294grid.62560.37Department of Radiology, Brigham and Women’s
      Hospital, Harvard Medical School, Boston, Massachusetts USA
FAU - Miller, Eric
AU  - Miller E
AD  - 0000 0004 1936 7531grid.429997.8Department of Electrical and Computer
      Engineering, Tufts University, Medford, Massachusetts USA
FAU - McDannold, Nathan
AU  - McDannold N
AD  - 0000 0004 0378 8294grid.62560.37Department of Radiology, Brigham and Women’s
      Hospital, Harvard Medical School, Boston, Massachusetts USA
FAU - Sapozhnikov, Oleg
AU  - Sapozhnikov O
AD  - 0000 0001 2342 9668grid.14476.30Physics Faculty, Moscow State University, Moscow,
      Russian Federation
FAU - Tsysar, Sergey
AU  - Tsysar S
AD  - 0000 0001 2342 9668grid.14476.30Physics Faculty, Moscow State University, Moscow,
      Russian Federation
FAU - Yuldashev, Petr V.
AU  - Yuldashev PV
AD  - 0000 0001 2342 9668grid.14476.30Physics Faculty, Moscow State University, Moscow,
      Russian Federation
FAU - Khokhlova, Vera
AU  - Khokhlova V
AD  - 0000 0001 2342 9668grid.14476.30Physics Faculty, Moscow State University, Moscow,
      Russian Federation
FAU - Svet, Victor
AU  - Svet V
AD  - N.N. Andreyev Acoustics Institute, Moscow, Russian Federation
FAU - Kreider, Wayne
AU  - Kreider W
AD  - 0000000122986657grid.34477.33Center for Industrial and Medical Ultrasound,
      Applied Physics Laboratory, University of Washington, Seattle, WA USA
FAU - Li, Dongli
AU  - Li D
AD  - 0000 0004 1936 8948grid.4991.5Department of Engineering Science, University of
      Oxford, Oxford, UK
FAU - Pellegrino, Antonio
AU  - Pellegrino A
AD  - 0000 0004 1936 8948grid.4991.5Department of Engineering Science, University of
      Oxford, Oxford, UK
FAU - Petrinic, Nik
AU  - Petrinic N
AD  - 0000 0004 1936 8948grid.4991.5Department of Engineering Science, University of
      Oxford, Oxford, UK
FAU - Siviour, Clive
AU  - Siviour C
AD  - 0000 0004 1936 8948grid.4991.5Department of Engineering Science, University of
      Oxford, Oxford, UK
FAU - Jerusalem, Antoine
AU  - Jerusalem A
AD  - 0000 0004 1936 8948grid.4991.5Department of Engineering Science, University of
      Oxford, Oxford, UK
FAU - Cleveland, Robin
AU  - Cleveland R
AD  - 0000 0004 1936 8948grid.4991.5Department of Engineering Science, University of
      Oxford, Oxford, UK
FAU - Yuldashev, Peter V.
AU  - Yuldashev PV
AD  - 0000 0001 2342 9668grid.14476.30Physics Faculty, Moscow State University, Moscow,
      Russian Federation
FAU - Karzova, Maria
AU  - Karzova M
AD  - 0000 0001 2342 9668grid.14476.30Physics Faculty, Moscow State University, Moscow,
      Russian Federation
FAU - Cunitz, Bryan W.
AU  - Cunitz BW
AD  - 0000000122986657grid.34477.33CIMU, Applied Physics Laboratory, University of
      Washington, Seattle, WA USA
FAU - Dunmire, Barbrina
AU  - Dunmire B
AD  - 0000000122986657grid.34477.33CIMU, Applied Physics Laboratory, University of
      Washington, Seattle, WA USA
FAU - Kreider, Wayne
AU  - Kreider W
AD  - 0000000122986657grid.34477.33CIMU, Applied Physics Laboratory, University of
      Washington, Seattle, WA USA
FAU - Sapozhnikov, Oleg
AU  - Sapozhnikov O
AD  - 0000 0001 2342 9668grid.14476.30Physics Faculty, Moscow State University, Moscow,
      Russian Federation
FAU - Bailey, Michael R.
AU  - Bailey MR
AD  - 0000000122986657grid.34477.33CIMU, Applied Physics Laboratory, University of
      Washington, Seattle, WA USA
FAU - Khokhlova, Vera
AU  - Khokhlova V
AD  - 0000 0001 2342 9668grid.14476.30Physics Faculty, Moscow State University, Moscow,
      Russian Federation
FAU - Inserra, Claude
AU  - Inserra C
AD  - LabTAU Inserm U1032, Lyon, France
FAU - Guedra, Matthieu
AU  - Guedra M
AD  - LabTAU Inserm U1032, Lyon, France
FAU - Mauger, Cyril
AU  - Mauger C
AD  - 0000 0004 1765 5089grid.15399.37INSA de Lyon, Villeurbanne, France
FAU - Gilles, Bruno
AU  - Gilles B
AD  - LabTAU Inserm U1032, Lyon, France
FAU - Solovchuk, Maxim
AU  - Solovchuk M
AD  - 0000000406229172grid.59784.37Institutes of Biomedical Engineering and
      Nanomedicine, National Health Research Institutes, Zhunan, Taiwan
FAU - Sheu, Tony W. H.
AU  - Sheu TWH
AD  - 0000 0004 0546 0241grid.19188.39National Taiwan University, Taipei, Taiwan
FAU - Thiriet, Marc
AU  - Thiriet M
AD  - 0000 0001 1955 3500grid.5805.8Sorbonne Universities, UPMC Univ Paris 06, Paris,
      France
FAU - Zhou, Yufeng
AU  - Zhou Y
AD  - 0000 0001 2224 0361grid.59025.3bNanyang Technological University, Singapore,
      Singapore
FAU - Neufeld, Esra
AU  - Neufeld E
AD  - grid.443853.dIT’IS Foundation for Research on Information Technologies in
      Society, Zurich, Switzerland
FAU - Baumgartner, Christian
AU  - Baumgartner C
AD  - grid.443853.dIT’IS Foundation for Research on Information Technologies in
      Society, Zurich, Switzerland
FAU - Payne, Davnah
AU  - Payne D
AD  - grid.443853.dIT’IS Foundation for Research on Information Technologies in
      Society, Zurich, Switzerland
FAU - Kyriakou, Adamos
AU  - Kyriakou A
AD  - grid.443853.dIT’IS Foundation for Research on Information Technologies in
      Society, Zurich, Switzerland
FAU - Kuster, Niels
AU  - Kuster N
AD  - grid.443853.dIT’IS Foundation for Research on Information Technologies in
      Society, Zurich, Switzerland
FAU - Xiao, Xu
AU  - Xiao X
AD  - Institute for Medical Science and Technology, Dundee, UK
FAU - McLeod, Helen
AU  - McLeod H
AD  - 0000 0000 9009 9462grid.416266.1Ninewells Hospital, Dundee, UK
FAU - Melzer, Andreas
AU  - Melzer A
AD  - Institute for Medical Science and Technology, Dundee, UK
FAU - Dillon, Christopher
AU  - Dillon C
AD  - 0000 0001 2193 0096grid.223827.eRadiology, University of Utah, Salt Lake City, UT
      USA
FAU - Rieke, Viola
AU  - Rieke V
AD  - 0000 0001 2297 6811grid.266102.1Radiology and Biomedical Imaging, University of
      California San Francisco, San Francisco, CA USA
FAU - Ghanouni, Pejman
AU  - Ghanouni P
AD  - 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, CA USA
FAU - Parker, Dennis L.
AU  - Parker DL
AD  - 0000 0001 2193 0096grid.223827.eRadiology, University of Utah, Salt Lake City, UT
      USA
FAU - Payne, Allison
AU  - Payne A
AD  - 0000 0001 2193 0096grid.223827.eRadiology, University of Utah, Salt Lake City, UT
      USA
FAU - Khokhova, Vera A.
AU  - Khokhova VA
AD  - 0000 0001 2342 9668grid.14476.30Physics Faculty, M.V. Lomonosov Moscow State
      University, Moscow, Russian Federation
FAU - Yuldashev, Peter V.
AU  - Yuldashev PV
AD  - 0000 0001 2342 9668grid.14476.30Physics Faculty, M.V. Lomonosov Moscow State
      University, Moscow, Russian Federation
FAU - Sinilshchikov, Ilya
AU  - Sinilshchikov I
AD  - 0000 0001 2342 9668grid.14476.30Physics Faculty, M.V. Lomonosov Moscow State
      University, Moscow, Russian Federation
FAU - Andriyakhina, Yulia
AU  - Andriyakhina Y
AD  - 0000 0001 2342 9668grid.14476.30Physics Faculty, M.V. Lomonosov Moscow State
      University, Moscow, Russian Federation
FAU - Khokhlova, Tatiana D.
AU  - Khokhlova TD
AD  - 0000000122986657grid.34477.33Department of Gastroenterology, School of Medicine, 
      University of Washington, Seattle, WA USA
FAU - Kreider, Wayne
AU  - Kreider W
AD  - 0000000122986657grid.34477.33Center for Industrial and Medical Ultrasound,
      University of Washington, Seattle, WA USA
FAU - Maxwell, Adam
AU  - Maxwell A
AD  - 0000000122986657grid.34477.33Department of Urology, School of Medicine,
      University of Washington, Seattle, WA USA
FAU - Sapozhnikov, Oleg
AU  - Sapozhnikov O
AD  - 0000 0001 2342 9668grid.14476.30Physics Faculty, M.V. Lomonosov Moscow State
      University, Moscow, Russian Federation
FAU - Partanen, Ari
AU  - Partanen A
AD  - Clinical Science MR Therapy, Philips, Andover, MA USA
FAU - Rybyanets, Andrey
AU  - Rybyanets A
AD  - 0000 0001 2172 8170grid.182798.dSouthern Federal University, Rostov on Don,
      Russian Federation
FAU - Shvetsova, Natalia
AU  - Shvetsova N
AD  - 0000 0001 2172 8170grid.182798.dSouthern Federal University, Rostov on Don,
      Russian Federation
FAU - Berkovich, Alex
AU  - Berkovich A
AD  - Saint Petersburg Polytechnical University, Saint Petersburg, Russian Federation
FAU - Shvetsov, Igor
AU  - Shvetsov I
AD  - 0000 0001 2172 8170grid.182798.dSouthern Federal University, Rostov on Don,
      Russian Federation
FAU - Sapozhnikov, Oleg
AU  - Sapozhnikov O
AD  - 0000 0001 2342 9668grid.14476.30Moscow State University, Moscow, Russian
      Federation
FAU - Khokhlova, Vera
AU  - Khokhlova V
AD  - 0000 0001 2342 9668grid.14476.30Moscow State University, Moscow, Russian
      Federation
FAU - Shaw, Caroline J.
AU  - Shaw CJ
AD  - 0000000121885934grid.5335.0Department of Physiology, Development and
      Neuroscience, University of Cambridge, Cambridge, UK
FAU - Rivens, Ian
AU  - Rivens I
AD  - 0000 0001 1271 4623grid.18886.3fJoint Department of Physics, The Institute of
      Cancer Research, London, UK
FAU - Civale, John
AU  - Civale J
AD  - 0000 0001 1271 4623grid.18886.3fJoint Department of Physics, The Institute of
      Cancer Research, London, UK
FAU - Giussani, Dino
AU  - Giussani D
AD  - 0000000121885934grid.5335.0Department of Physiology, Development and
      Neuroscience, University of Cambridge, Cambridge, UK
FAU - ter Haar, Gail
AU  - ter Haar G
AD  - 0000 0001 1271 4623grid.18886.3fJoint Department of Physics, The Institute of
      Cancer Research, London, UK
FAU - Lees, Christoph
AU  - Lees C
AD  - 0000 0001 2113 8111grid.7445.2Institute of Developmental and Reproductive
      Biology, Imperial College London, UK, London, UK
FAU - Bour, Pierre
AU  - Bour P
AD  - IHU-Liryc, Pessac, France
FAU - Marquet, Fabrice
AU  - Marquet F
AD  - IHU-Liryc, Pessac, France
FAU - Ozenne, Valery
AU  - Ozenne V
AD  - IHU-Liryc, Pessac, France
FAU - Toupin, Solenn
AU  - Toupin S
AD  - IHU-Liryc, Pessac, France
FAU - Quesson, Bruno
AU  - Quesson B
AD  - IHU-Liryc, Pessac, France
FAU - Dumont, Erik
AU  - Dumont E
AD  - Image Guided Therapy, Pessac, France
FAU - Ozhinsky, Eugene
AU  - Ozhinsky E
AD  - 0000 0001 2297 6811grid.266102.1Radiology and Biomedical Imaging, University of
      California San Francisco, San Francisco, CA USA
FAU - Salgaonkar, Vasant
AU  - Salgaonkar V
AD  - 0000 0001 2297 6811grid.266102.1Radiation Oncology, University of California San 
      Francisco, San Francisco, CA USA
FAU - Diederich, Chris
AU  - Diederich C
AD  - 0000 0001 2297 6811grid.266102.1Radiation Oncology, University of California San 
      Francisco, San Francisco, CA USA
FAU - Rieke, Viola
AU  - Rieke V
AD  - 0000 0001 2297 6811grid.266102.1Radiology and Biomedical Imaging, University of
      California San Francisco, San Francisco, CA USA
FAU - Kaye, Elena
AU  - Kaye E
AD  - 0000 0001 2171 9952grid.51462.34Memorial Sloan Kettering Cancer Center, New York,
      NY USA
FAU - Monette, Sebastien
AU  - Monette S
AD  - 0000 0001 2171 9952grid.51462.34Memorial Sloan Kettering Cancer Center, New York,
      NY USA
FAU - Maybody, Majid
AU  - Maybody M
AD  - 0000 0001 2171 9952grid.51462.34Memorial Sloan Kettering Cancer Center, New York,
      NY USA
FAU - Srimathveeravalli, Govindarajan
AU  - Srimathveeravalli G
AD  - 0000 0001 2171 9952grid.51462.34Memorial Sloan Kettering Cancer Center, New York,
      NY USA
FAU - Solomon, Stephen
AU  - Solomon S
AD  - 0000 0001 2171 9952grid.51462.34Memorial Sloan Kettering Cancer Center, New York,
      NY USA
FAU - Gulati, Amitabh
AU  - Gulati A
AD  - 0000 0001 2171 9952grid.51462.34Memorial Sloan Kettering Cancer Center, New York,
      NY USA
FAU - Preusser, Tobias
AU  - Preusser T
AD  - 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany
FAU - Haase, Sabrina
AU  - Haase S
AD  - 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany
FAU - Bezzi, Mario
AU  - Bezzi M
AD  - grid.7841.aUniversita Degli Studi Di Roma La Sapienza, Rome, Italy
FAU - Jenne, Jürgen W.
AU  - Jenne JW
AD  - grid.436006.7Mediri GmbH, Heidelberg, Germany
FAU - Lango, Thomas
AU  - Lango T
AD  - 0000 0004 0448 3150grid.4319.fStiftelsen SINTEF, Trondheim, Norway
FAU - Levy, Yoav
AU  - Levy Y
AD  - grid.435375.3InSightec, Haifa, Israel
FAU - Müller, Michael
AU  - Müller M
AD  - grid.435349.cIBSmm, Brno, Czech Republic
FAU - Sat, Giora
AU  - Sat G
AD  - GE Medical Systems, Haifa, Israel
FAU - Tanner, Christine
AU  - Tanner C
AD  - 0000 0001 2156 2780grid.5801.cETH, Zurich, Switzerland
FAU - Zangos, Stephan
AU  - Zangos S
AD  - 0000 0004 1936 9721grid.7839.5Johann Wolfgang Goethe University, Frankfurt,
      Germany
FAU - Günther, Matthias
AU  - Günther M
AD  - 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany
FAU - Melzer, Andreas
AU  - Melzer A
AD  - 0000 0004 0397 2876grid.8241.fIMSat, University of Dundee, Dundee, UK
FAU - Lafon, Cyril
AU  - Lafon C
AD  - LabTAU, INSERM, Lyon, France
FAU - Dinh, Au Hoang
AU  - Dinh AH
AD  - LabTAU, INSERM, Lyon, France
FAU - Niaf, Emilie
AU  - Niaf E
AD  - 0000 0004 0638 0358grid.462859.4CREATIS, Lyon, France
FAU - Bratan, Flavie
AU  - Bratan F
AD  - 0000 0001 2163 3825grid.413852.9Hospices Civils de Lyon, Lyon, France
FAU - Guillen, Nicolas
AU  - Guillen N
AD  - EDAP-TMS, Vaux-en-Velin, France
FAU - Souchon, Rémi
AU  - Souchon R
AD  - LabTAU, INSERM, Lyon, France
FAU - Lartizien, Carole
AU  - Lartizien C
AD  - 0000 0004 0638 0358grid.462859.4CREATIS, Lyon, France
FAU - Crouzet, Sebastien
AU  - Crouzet S
AD  - 0000 0001 2163 3825grid.413852.9Hospices Civils de Lyon, Lyon, France
FAU - Rouviere, Olivier
AU  - Rouviere O
AD  - LabTAU, INSERM, Lyon, France
FAU - Chapelon, Jean-Yves
AU  - Chapelon JY
AD  - LabTAU, INSERM, Lyon, France
FAU - Han, Yang
AU  - Han Y
AD  - 0000000419368729grid.21729.3fDepartment of Biomedical Engineering, Columbia
      University, New York, NY USA
FAU - Wang, Shutao
AU  - Wang S
AD  - 0000000419368729grid.21729.3fDepartment of Biomedical Engineering, Columbia
      University, New York, NY USA
FAU - Konofagou, Elisa E.
AU  - Konofagou EE
AD  - 0000000419368729grid.21729.3fDepartment of Biomedical Engineering, Columbia
      University, New York, NY USA
FAU - Payen, Thomas
AU  - Payen T
AD  - 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New
      York, NY USA
FAU - Palermo, Carmine
AU  - Palermo C
AD  - 0000000419368729grid.21729.3fHerbert Irving Comprehensive, Cancer Center,
      Columbia University, New York, NY USA
FAU - Sastra, Steve
AU  - Sastra S
AD  - 0000000419368729grid.21729.3fHerbert Irving Comprehensive, Cancer Center,
      Columbia University, New York, NY USA
FAU - Chen, Hong
AU  - Chen H
AD  - 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New
      York, NY USA
FAU - Han, Yang
AU  - Han Y
AD  - 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New
      York, NY USA
FAU - Olive, Kenneth
AU  - Olive K
AD  - 0000000419368729grid.21729.3fHerbert Irving Comprehensive, Cancer Center,
      Columbia University, New York, NY USA
FAU - Konofagou, Elisa E.
AU  - Konofagou EE
AD  - 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New
      York, NY USA
FAU - van Breugel, Johanna M.
AU  - van Breugel JM
AD  - 0000000090126352grid.7692.aImaging Department, University Medical Center Utrecht,
      Utrecht, Netherlands
FAU - de Greef, Martijn
AU  - de Greef M
AD  - 0000000090126352grid.7692.aImaging Department, University Medical Center Utrecht,
      Utrecht, Netherlands
FAU - Mougenot, Charles
AU  - Mougenot C
AD  - Philips, Ontario, Ontario, Canada
FAU - van den Bosch, Maurice A.
AU  - van den Bosch MA
AD  - 0000000090126352grid.7692.aRadiology, University Medical Center Utrecht, Utrecht,
      Netherlands
FAU - Moonen, Chrit
AU  - Moonen C
AD  - 0000000090126352grid.7692.aImaging Department, University Medical Center Utrecht,
      Utrecht, Netherlands
FAU - Ries, Mario
AU  - Ries M
AD  - 0000000090126352grid.7692.aImaging Department, University Medical Center Utrecht,
      Utrecht, Netherlands
FAU - Gerstenmayer, Matthieu
AU  - Gerstenmayer M
AD  - grid.457334.2NeuroSpin, CEA Saclay, Gif-sur-Yvette, France
FAU - Magnin, Rémi
AU  - Magnin R
AD  - grid.457334.2NeuroSpin, CEA Saclay, Gif-sur-Yvette, France
FAU - Fellah, Benjamin
AU  - Fellah B
AD  - grid.457334.2NeuroSpin, CEA Saclay, Gif-sur-Yvette, France
FAU - Le Bihan, Denis
AU  - Le Bihan D
AD  - grid.457334.2NeuroSpin, CEA Saclay, Gif-sur-Yvette, France
FAU - Larrat, Benoit
AU  - Larrat B
AD  - grid.457334.2NeuroSpin, CEA Saclay, Gif-sur-Yvette, France
FAU - Gerstenmayer, Matthieu
AU  - Gerstenmayer M
AD  - grid.457334.2NeuroSpin, CEA Saclay, Gif sur Yvette, France
FAU - Magnin, Rémi
AU  - Magnin R
AD  - grid.457334.2NeuroSpin, CEA Saclay, Gif sur Yvette, France
FAU - Mériaux, Sébastien
AU  - Mériaux S
AD  - grid.457334.2NeuroSpin, CEA Saclay, Gif sur Yvette, France
FAU - Le Bihan, Denis
AU  - Le Bihan D
AD  - grid.457334.2NeuroSpin, CEA Saclay, Gif sur Yvette, France
FAU - Larrat, Benoit
AU  - Larrat B
AD  - grid.457334.2NeuroSpin, CEA Saclay, Gif sur Yvette, France
FAU - Allen, Steven P.
AU  - Allen SP
AD  - 0000000086837370grid.214458.eBiomedical Engineering, University of Michigan, Ann 
      Arbor, MI USA
FAU - Hernandez-Garcia, Luis
AU  - Hernandez-Garcia L
AD  - 0000000086837370grid.214458.eFMRI Lab, University of Michigan, Ann Arbor, MI USA
FAU - Cain, Charles A.
AU  - Cain CA
AD  - 0000000086837370grid.214458.eBiomedical Engineering, University of Michigan, Ann 
      Arbor, MI USA
FAU - Hall, Timothy
AU  - Hall T
AD  - 0000000086837370grid.214458.eBiomedical Engineering, University of Michigan, Ann 
      Arbor, MI USA
FAU - Lyka, Erasmia
AU  - Lyka E
AD  - 0000 0004 1936 8948grid.4991.5Engineering Science, University of Oxford, Oxford, 
      UK
FAU - Elbes, Delphine
AU  - Elbes D
AD  - 0000 0004 1936 8948grid.4991.5Engineering Science, University of Oxford, Oxford, 
      UK
FAU - Coviello, Christian
AU  - Coviello C
AD  - 0000 0004 1936 8948grid.4991.5Engineering Science, University of Oxford, Oxford, 
      UK
FAU - Cleveland, Robin
AU  - Cleveland R
AD  - 0000 0004 1936 8948grid.4991.5Engineering Science, University of Oxford, Oxford, 
      UK
FAU - Coussios, Constantin
AU  - Coussios C
AD  - 0000 0004 1936 8948grid.4991.5Engineering Science, University of Oxford, Oxford, 
      UK
FAU - Zhou, Kanheng
AU  - Zhou K
AD  - 0000 0004 0397 2876grid.8241.fUniversity of Dundee, Dundee, UK
FAU - Le, Nhan M.
AU  - Le NM
AD  - 0000 0004 0397 2876grid.8241.fUniversity of Dundee, Dundee, UK
FAU - Li, Chunhui
AU  - Li C
AD  - 0000 0004 0397 2876grid.8241.fUniversity of Dundee, Dundee, UK
FAU - Huang, Zhihong
AU  - Huang Z
AD  - 0000 0004 0397 2876grid.8241.fUniversity of Dundee, Dundee, UK
FAU - Tamano, Satoshi
AU  - Tamano S
AD  - 0000 0001 2248 6943grid.69566.3aGraduate School of Engineering, Tohoku
      University, Sendai, Miyagi Japan
FAU - Jimbo, Hayato
AU  - Jimbo H
AD  - 0000 0001 2248 6943grid.69566.3aGraduate School of Engineering, Tohoku
      University, Sendai, Miyagi Japan
FAU - Azuma, Takashi
AU  - Azuma T
AD  - 0000 0001 2151 536Xgrid.26999.3dDepartment of Mechanical Engineering, The
      University of Tokyo, Bunkyo, Tokyo Japan
FAU - Yoshizawa, Shin
AU  - Yoshizawa S
AD  - 0000 0001 2248 6943grid.69566.3aGraduate School of Engineering, Tohoku
      University, Sendai, Miyagi Japan
FAU - Fujiwara, Keisuke
AU  - Fujiwara K
AD  - Hitachi Aloka Medical, Ltd., Kokubunji, Tokyo Japan
FAU - Itani, Kazunori
AU  - Itani K
AD  - Hitachi Aloka Medical, Ltd., Kokubunji, Tokyo Japan
FAU - Umemura, Shin-ichiro
AU  - Umemura Si
AD  - 0000 0001 2248 6943grid.69566.3aGraduate School of Biomedical Engineering, Tohoku
      University, Sendai, Miyagi Japan
FAU - Damianou, Christakis
AU  - Damianou C
AD  - 0000 0000 9995 3899grid.15810.3dCyprus University of Technology, Limassol, Cyprus
FAU - Yiannakou, Marinos
AU  - Yiannakou M
AD  - 0000 0000 9995 3899grid.15810.3dCyprus University of Technology, Limassol, Cyprus
FAU - Ellens, Nicholas
AU  - Ellens N
AD  - 0000 0001 2171 9311grid.21107.35Radiology, Johns Hopkins University, Baltimore,
      MD USA
FAU - Partanen, Ari
AU  - Partanen A
AD  - 0000 0001 2171 9311grid.21107.35Radiology, Johns Hopkins University, Baltimore,
      MD USA
FAU - Stoianovici, Dan
AU  - Stoianovici D
AD  - 0000 0001 2171 9311grid.21107.35Urology, Johns Hopkins University, Baltimore, MD 
      USA
FAU - Farahani, Keyvan
AU  - Farahani K
AD  - 0000 0001 2171 9311grid.21107.35Radiology, Johns Hopkins University, Baltimore,
      MD USA
FAU - Zaini, Zulfadhli
AU  - Zaini Z
AD  - 0000 0001 2248 6943grid.69566.3aBiomedical Engineering, Tohoku University,
      Sendai, Japan
FAU - Takagi, Ryo
AU  - Takagi R
AD  - 0000 0001 2248 6943grid.69566.3aCommunication Engineering, Tohoku University,
      Sendai, Japan
FAU - Yoshizawa, Shin
AU  - Yoshizawa S
AD  - 0000 0001 2248 6943grid.69566.3aCommunication Engineering, Tohoku University,
      Sendai, Japan
FAU - Umemura, Shin-ichiro
AU  - Umemura Si
AD  - 0000 0001 2248 6943grid.69566.3aBiomedical Engineering, Tohoku University,
      Sendai, Japan
FAU - Zong, Shenyan
AU  - Zong S
AD  - 0000 0004 0368 8293grid.16821.3cSchool of Biomedical Engineering, Shanghai Jiao
      Tong University, Biomedical Instrument Institute, Shanghai, China
FAU - Shen, Guofeng
AU  - Shen G
AD  - 0000 0004 0368 8293grid.16821.3cShanghai Jiao Tong University, Med-X Research
      Institute, Shanghai, China
FAU - Watkins, Ron
AU  - Watkins R
AD  - 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, CA USA
FAU - Pascal-Tenorio, Aurea
AU  - Pascal-Tenorio A
AD  - 0000000419368956grid.168010.eComparative Medicine, Stanford University, Palo
      Alto, CA USA
FAU - Adams, Matthew
AU  - Adams M
AD  - 0000 0001 2297 6811grid.266102.1Thermal Therapy Research Group, UCSF, San
      Francisco, CA USA
FAU - Plata, Juan C.
AU  - Plata JC
AD  - 0000 0004 0450 875Xgrid.414123.1Radiology, Stanford University, Palo Alto, CA USA
FAU - Salgaonkar, Vasant
AU  - Salgaonkar V
AD  - 0000 0001 2297 6811grid.266102.1Thermal Therapy Research Group, UCSF, San
      Francisco, CA USA
FAU - Jones, Peter
AU  - Jones P
AD  - 0000 0001 2297 6811grid.266102.1Thermal Therapy Research Group, UCSF, San
      Francisco, CA USA
FAU - Butts-Pauly, Kim
AU  - Butts-Pauly K
AD  - 0000 0004 0450 875Xgrid.414123.1Radiology, Stanford University, Palo Alto, CA USA
FAU - Diederich, Chris
AU  - Diederich C
AD  - 0000 0001 2297 6811grid.266102.1Thermal Therapy Research Group, UCSF, San
      Francisco, CA USA
FAU - Bouley, Donna
AU  - Bouley D
AD  - 0000 0004 0450 875Xgrid.414123.1Comparative Medicine, Stanford University, Palo
      Alto, CA USA
FAU - Rybyanets, Andrey
AU  - Rybyanets A
AD  - 0000 0001 2172 8170grid.182798.dSouthern Federal University, Rostov on Don,
      Russian Federation
FAU - Ren, Guoxin
AU  - Ren G
AD  - 0000 0004 0368 8293grid.16821.3cShangai Jiao Tong University, Shanghai, China
FAU - Guo, Wei
AU  - Guo W
AD  - 0000 0004 0368 8293grid.16821.3cShangai Jiao Tong University, Shanghai, China
FAU - Shen, Guofeng
AU  - Shen G
AD  - 0000 0004 0368 8293grid.16821.3cShangai Jiao Tong University, Shanghai, China
FAU - Chen, Yazhu
AU  - Chen Y
AD  - 0000 0004 0368 8293grid.16821.3cShangai Jiao Tong University, Shanghai, China
FAU - Lin, Chung-Yin
AU  - Lin CY
AD  - grid.145695.aChang Gung University, Taoyuan, Taiwan
FAU - Hsieh, Han-Yi
AU  - Hsieh HY
AD  - grid.145695.aChang Gung University, Taoyuan, Taiwan
FAU - Wei, Kuo-Chen
AU  - Wei KC
AD  - grid.145695.aChang Gung University, Taoyuan, Taiwan
FAU - Liu, Hao-Li
AU  - Liu HL
AD  - grid.145695.aChang Gung University, Taoyuan, Taiwan
FAU - Garnier, Camille
AU  - Garnier C
AD  - 0000 0001 2217 0017grid.7452.4Université Paris 7, Paris, France
FAU - Renault, Gilles
AU  - Renault G
AD  - 0000 0004 0643 431Xgrid.462098.1Institut Cochin, Paris, France
FAU - Farr, Navid
AU  - Farr N
AD  - 0000 0001 2297 5165grid.94365.3dNational Institutes of Health, Bethesda, MD, USA
FAU - Partanen, Ari
AU  - Partanen A
AD  - Clinical Science MR Therapy, Philips, Andover, MA USA
FAU - Negussie, Ayele H.
AU  - Negussie AH
AD  - 0000 0001 2297 5165grid.94365.3dNational Institutes of Health, Bethesda, MD, USA
FAU - Mikhail, Andrew
AU  - Mikhail A
AD  - 0000 0001 2297 5165grid.94365.3dNational Institutes of Health, Bethesda, MD, USA
FAU - Seifabadi, Reza
AU  - Seifabadi R
AD  - 0000 0001 2297 5165grid.94365.3dNational Institutes of Health, Bethesda, MD, USA
FAU - Wilson, Emmanuel
AU  - Wilson E
AD  - grid.239560.bChildren’s National Medical Center, Washington, DC USA
FAU - Eranki, Avinash
AU  - Eranki A
AD  - grid.239560.bChildren’s National Medical Center, Washington, DC USA
FAU - Kim, Peter
AU  - Kim P
AD  - grid.239560.bChildren’s National Medical Center, Washington, DC USA
FAU - Wood, Bradford
AU  - Wood B
AD  - 0000 0001 2297 5165grid.94365.3dNational Institutes of Health, Bethesda, MD, USA
FAU - Lübke, Dennis
AU  - Lübke D
AD  - 0000 0004 0496 8246grid.428590.2MRI Physics, Fraunhofer MEVIS, Bremen, Germany
FAU - Jenne, Jürgen W.
AU  - Jenne JW
AD  - 0000 0004 0496 8246grid.428590.2MRI Physics, Fraunhofer MEVIS, Bremen, Germany
FAU - Huber, Peter
AU  - Huber P
AD  - 0000 0004 0492 0584grid.7497.dDeutsches Krebsforschungszentrum, Heidelberg,
      Germany
FAU - Günther, Matthias
AU  - Günther M
AD  - 0000 0004 0496 8246grid.428590.2MRI Physics, Fraunhofer MEVIS, Bremen, Germany
FAU - Lübke, Dennis
AU  - Lübke D
AD  - 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany
FAU - Georgii, Joachim
AU  - Georgii J
AD  - 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany
FAU - Schwenke, Michael
AU  - Schwenke M
AD  - 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany
FAU - Dresky, Caroline V.
AU  - Dresky CV
AD  - 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany
FAU - Haller, Julian
AU  - Haller J
AD  - 0000 0001 2186 1887grid.4764.1PTB Braunschweig, Braunschweig, Germany
FAU - Günther, Matthias
AU  - Günther M
AD  - 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany
FAU - Preusser, Tobias
AU  - Preusser T
AD  - 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany
FAU - Jenne, Jürgen W.
AU  - Jenne JW
AD  - 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany
FAU - Eranki, Avinash
AU  - Eranki A
AD  - grid.239560.bChildren’s National Medical Center, Washington, DC USA
FAU - Farr, Navid
AU  - Farr N
AD  - 0000 0001 2297 5165grid.94365.3dNational Institutes of Health, Bethesda, MD USA
FAU - Partanen, Ari
AU  - Partanen A
AD  - Clinical Science MR Therapy, Philips, Andover, MA USA
FAU - Yarmolenko, Pavel
AU  - Yarmolenko P
AD  - grid.239560.bChildren’s National Medical Center, Washington, DC USA
FAU - Negussie, Ayele H.
AU  - Negussie AH
AD  - 0000 0001 2297 5165grid.94365.3dNational Institutes of Health, Bethesda, MD USA
FAU - Sharma, Karun
AU  - Sharma K
AD  - grid.239560.bChildren’s National Medical Center, Washington, DC USA
FAU - Celik, Haydar
AU  - Celik H
AD  - 0000 0001 2297 5165grid.94365.3dNational Institutes of Health, Bethesda, MD USA
FAU - Wood, Bradford
AU  - Wood B
AD  - 0000 0001 2297 5165grid.94365.3dNational Institutes of Health, Bethesda, MD USA
FAU - Kim, Peter
AU  - Kim P
AD  - grid.239560.bChildren’s National Medical Center, Washington, DC USA
FAU - Li, Guofeng
AU  - Li G
AD  - 0000 0001 0483 7922grid.458489.cShenzhen Institutes of Advanced Technology,
      Chinese Academy of Sciences, Shenzhen, China
FAU - Qiu, Weibao
AU  - Qiu W
AD  - 0000 0001 0483 7922grid.458489.cShenzhen Institutes of Advanced Technology,
      Chinese Academy of Sciences, Shenzhen, China
FAU - Zheng, Hairong
AU  - Zheng H
AD  - 0000 0001 0483 7922grid.458489.cShenzhen Institutes of Advanced Technology,
      Chinese Academy of Sciences, Shenzhen, China
FAU - Tsai, Meng-Yen
AU  - Tsai MY
AD  - grid.145695.aDepartment of Electrical Engineering, Chang Gung University,
      Taoyuan, Taiwan
FAU - Chu, Po-Chun
AU  - Chu PC
AD  - grid.145695.aDepartment of Electrical Engineering, Chang Gung University,
      Taoyuan, Taiwan
FAU - Liu, Hao-Li
AU  - Liu HL
AD  - grid.145695.aDepartment of Electrical Engineering, Chang Gung University,
      Taoyuan, Taiwan
FAU - Webb, Taylor
AU  - Webb T
AD  - 0000 0004 0450 875Xgrid.414123.1Electrical Engineering, Stanford University, Palo
      Alto, CA USA
FAU - Vyas, Urvi
AU  - Vyas U
AD  - 0000 0004 0450 875Xgrid.414123.1Radiology, Stanford University, Palo Alto, CA USA
FAU - Pauly, Kim Butts
AU  - Pauly KB
AD  - 0000 0004 0450 875Xgrid.414123.1Electrical Engineering, Stanford University, Palo
      Alto, CA USA
FAU - Walker, Matthew
AU  - Walker M
AD  - grid.17063.33Institute of Medical Science, University of Toronto, Toronto,
      Ontario Canada
FAU - Zhong, Jidan
AU  - Zhong J
AD  - 0000 0004 0474 0428grid.231844.8Krembil Research Institute, University Health
      Network, Toronto, Ontario Canada
FAU - Looi, Thomas
AU  - Looi T
AD  - 0000 0004 0473 9646grid.42327.30Centre for Image Guided Innovation and
      Therapeutic Intervention, Hospital for Sick Children, Toronto, Ontario Canada
FAU - Waspe, Adam C.
AU  - Waspe AC
AD  - 0000 0004 0473 9646grid.42327.30Centre for Image Guided Innovation and
      Therapeutic Intervention, Hospital for Sick Children, Toronto, Ontario Canada
FAU - Drake, James
AU  - Drake J
AD  - 0000 0004 0473 9646grid.42327.30Centre for Image Guided Innovation and
      Therapeutic Intervention, Hospital for Sick Children, Toronto, Ontario Canada
FAU - Hodaie, Mojgan
AU  - Hodaie M
AD  - 0000 0004 0474 0428grid.231844.8Krembil Research Institute, University Health
      Network, Toronto, Ontario Canada
FAU - Yang, Feng-Yi
AU  - Yang FY
AD  - 0000 0001 0425 5914grid.260770.4Department of Biomedical Imaging and Radiological
      Sciences, National Yang-Ming University, Taipei, Taiwan
FAU - Huang, Sin-Luo
AU  - Huang SL
AD  - 0000 0001 0425 5914grid.260770.4Department of Biomedical Imaging and Radiological
      Sciences, National Yang-Ming University, Taipei, Taiwan
FAU - Zur, Yuval
AU  - Zur Y
AD  - General Electric, Tirat Carmel, Israel
FAU - Volovick, Alexander
AU  - Volovick A
AD  - grid.435375.3InSighTec, Tirat Carmel, Israel
FAU - Assif, Benny
AU  - Assif B
AD  - grid.435375.3InSighTec, Tirat Carmel, Israel
FAU - Aurup, Christian
AU  - Aurup C
AD  - 0000000419368729grid.21729.3fColumbia University, New York, NY USA
FAU - Kamimura, Hermes
AU  - Kamimura H
AD  - 0000 0004 1937 0722grid.11899.38Universidade de São Paulo, São Paulo, Brasil
FAU - Wang, Shutao
AU  - Wang S
AD  - 0000000419368729grid.21729.3fColumbia University, New York, NY USA
FAU - Chen, Hong
AU  - Chen H
AD  - 0000000419368729grid.21729.3fColumbia University, New York, NY USA
FAU - Acosta, Camilo
AU  - Acosta C
AD  - 0000000419368729grid.21729.3fColumbia University, New York, NY USA
FAU - Carneiro, Antonio A.
AU  - Carneiro AA
AD  - 0000 0004 1937 0722grid.11899.38Universidade de São Paulo, São Paulo, Brasil
FAU - Konofagou, Elisa E.
AU  - Konofagou EE
AD  - 0000000419368729grid.21729.3fColumbia University, New York, NY USA
FAU - Volovick, Alexander
AU  - Volovick A
AD  - grid.435375.3InSighTec, Tirat Carmel, Israel
FAU - Grinfeld, Javier
AU  - Grinfeld J
AD  - grid.435375.3InSighTec, Tirat Carmel, Israel
FAU - Castel, David
AU  - Castel D
AD  - 0000 0001 2107 2845grid.413795.dSheba Medical Center, Ramat Gan, Israel
FAU - Rothlübbers, Sven
AU  - Rothlübbers S
AD  - grid.436006.7mediri GmbH, Heidelberg, Germany
FAU - Schwaab, Julia
AU  - Schwaab J
AD  - grid.436006.7mediri GmbH, Heidelberg, Germany
FAU - Tanner, Christine
AU  - Tanner C
AD  - 0000 0001 2156 2780grid.5801.cETH Zürich, Zürich, Switzerland
FAU - Mihcin, Senay
AU  - Mihcin S
AD  - IMSAT, Dundee, UK
FAU - Houston, Graeme
AU  - Houston G
AD  - IMSAT, Dundee, UK
FAU - Günther, Matthias
AU  - Günther M
AD  - 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany
FAU - Jenne, Jürgen W.
AU  - Jenne JW
AD  - 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany
FAU - Ozhinsky, Eugene
AU  - Ozhinsky E
AD  - 0000 0001 2297 6811grid.266102.1Radiology and Biomedical Imaging, University of
      California San Francisco, San Francisco, CA USA
FAU - Bucknor, Matthew D.
AU  - Bucknor MD
AD  - 0000 0001 2297 6811grid.266102.1Radiology and Biomedical Imaging, University of
      California San Francisco, San Francisco, CA USA
FAU - Rieke, Viola
AU  - Rieke V
AD  - 0000 0001 2297 6811grid.266102.1Radiology and Biomedical Imaging, University of
      California San Francisco, San Francisco, CA USA
FAU - Azhari, Haim
AU  - Azhari H
AD  - 0000000121102151grid.6451.6Biomedical Engineering, Technion, IIT, Haifa, Israel
FAU - Weiss, Noam
AU  - Weiss N
AD  - 0000000121102151grid.6451.6Biomedical Engineering, Technion, IIT, Haifa, Israel
FAU - Sosna, Jacob
AU  - Sosna J
AD  - 0000 0001 2221 2926grid.17788.31Department of Radiology, Hadassah, Hebrew
      University, Medical Center, Jerusalem, Israel
FAU - Goldberg, S. Nahum
AU  - Goldberg SN
AD  - 0000 0001 2221 2926grid.17788.31Department of Radiology, Hadassah, Hebrew
      University, Medical Center, Jerusalem, Israel
FAU - Barrere, Victor
AU  - Barrere V
AD  - 0000 0004 0450 6033grid.462394.eInserm, Lyon, France
FAU - Melodelima, David
AU  - Melodelima D
AD  - 0000 0004 0450 6033grid.462394.eInserm, Lyon, France
FAU - Jang, Kee W.
AU  - Jang KW
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institutes of Health, Bethesda, MD USA
FAU - Burks, Scott R.
AU  - Burks SR
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institutes of Health, Bethesda, MD USA
FAU - Kovacs, Zsofia I.
AU  - Kovacs ZI
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institutes of Health, Bethesda, MD USA
FAU - Tu, Tsang-Wei
AU  - Tu TW
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institutes of Health, Bethesda, MD USA
FAU - Lewis, Bobbi
AU  - Lewis B
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institutes of Health, Bethesda, MD USA
FAU - Kim, Saejeong
AU  - Kim S
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institutes of Health, Bethesda, MD USA
FAU - Nagle, Matthew
AU  - Nagle M
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institutes of Health, Bethesda, MD USA
FAU - Jikaria, Neekita
AU  - Jikaria N
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institutes of Health, Bethesda, MD USA
FAU - Frank, Joseph A.
AU  - Frank JA
AD  - 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences,
      National Institutes of Health, Bethesda, MD USA
FAU - Zhou, Yufeng
AU  - Zhou Y
AD  - 0000 0001 2224 0361grid.59025.3bNanyang Technological University, Singapore,
      Singapore
FAU - Wang, Xiaotong
AU  - Wang X
AD  - 0000 0001 2224 0361grid.59025.3bNanyang Technological University, Singapore,
      Singapore
FAU - Ahn, Yun Deok
AU  - Ahn YD
AD  - 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital,
      Seoul, Republic of Korea
FAU - Park, Eun-Joo
AU  - Park EJ
AD  - 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital,
      Seoul, Republic of Korea
FAU - Park, Dong-Hyuk
AU  - Park DH
AD  - 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital,
      Seoul, Republic of Korea
FAU - Kang, Soo Yeon
AU  - Kang SY
AD  - 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital,
      Seoul, Republic of Korea
FAU - Lee, Jae Young
AU  - Lee JY
AD  - 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital,
      Seoul, Republic of Korea
FAU - Suomi, Visa
AU  - Suomi V
AD  - 0000 0004 1936 8948grid.4991.5University of Oxford, Oxford, UK
FAU - Konofagou, Elisa E.
AU  - Konofagou EE
AD  - 0000000419368729grid.21729.3fColumbia University, New York City, NY USA
FAU - Edwards, David
AU  - Edwards D
AD  - 0000 0004 1936 8948grid.4991.5University of Oxford, Oxford, UK
FAU - Cleveland, Robin
AU  - Cleveland R
AD  - 0000 0004 1936 8948grid.4991.5University of Oxford, Oxford, UK
FAU - Larrabee, Zahary
AU  - Larrabee Z
AD  - grid.428670.fFocused Ultrasound Foundation, Charlottesville, VA USA
FAU - Eames, Matthew
AU  - Eames M
AD  - grid.428670.fFocused Ultrasound Foundation, Charlottesville, VA USA
FAU - Hananel, Arik
AU  - Hananel A
AD  - grid.428670.fFocused Ultrasound Foundation, Charlottesville, VA USA
FAU - Aubry, Jean-Franҫois
AU  - Aubry JF
AD  - Institut Langevin, Paris, France
FAU - Rafaely, Boaz
AU  - Rafaely B
AD  - 0000 0004 1937 0511grid.7489.2Department of Electrical and Computer Engineering, 
      Ben-Gurion University of the Negev, Beer-Sheva, Israel
FAU - Volovick, Alexander
AU  - Volovick A
AD  - grid.435375.3InSighTec, Tirat Carmel, Israel
FAU - Grinfeld, Javier
AU  - Grinfeld J
AD  - grid.435375.3InSighTec, Tirat Carmel, Israel
FAU - Kimmel, Eitan
AU  - Kimmel E
AD  - 0000000121102151grid.6451.6Biomedical Engineering, Technion – Israel Institute of
      Technology, Haifa, Israel
FAU - Debbiny, Rasha Elaimy
AU  - Debbiny RE
AD  - 0000000121102151grid.6451.6Biomedical Engineering, Technion – Israel Institute of
      Technology, Haifa, Israel
FAU - Dekel, Carmel Zeltser
AU  - Dekel CZ
AD  - Biomedical Engineering, Technion, Haifa, Israel
FAU - Assa, Michael
AU  - Assa M
AD  - Biomedical Engineering, Technion, Haifa, Israel
FAU - Kimmel, Eitan
AU  - Kimmel E
AD  - Biomedical Engineering, Technion, Haifa, Israel
FAU - Menikou, George
AU  - Menikou G
AD  - 0000 0004 1936 8497grid.28577.3fCity University, London, UK
FAU - Damianou, Christakis
AU  - Damianou C
AD  - 0000 0000 9995 3899grid.15810.3dCyprus University of Technology, Limassol, Cyprus
FAU - Mouratidis, Petros
AU  - Mouratidis P
AD  - 0000 0001 1271 4623grid.18886.3fRadiotherapy and Imaging, The Institute of Cancer
      Research, Sutton, London, Surrey UK
FAU - Rivens, Ian
AU  - Rivens I
AD  - 0000 0001 1271 4623grid.18886.3fRadiotherapy and Imaging, The Institute of Cancer
      Research, Sutton, London, Surrey UK
FAU - ter Haar, Gail
AU  - ter Haar G
AD  - 0000 0001 1271 4623grid.18886.3fRadiotherapy and Imaging, The Institute of Cancer
      Research, Sutton, London, Surrey UK
FAU - Pineda-Pardo, José A.
AU  - Pineda-Pardo JA
AD  - HM CINAC. Hospital Puerta del Sur, Móstoles, Spain
FAU - de Pedro, Marta Del Álamo
AU  - de Pedro MDÁ
AD  - HM CINAC. Hospital Puerta del Sur, Móstoles, Spain
FAU - Martinez, Raul
AU  - Martinez R
AD  - HM CINAC. Hospital Puerta del Sur, Móstoles, Spain
FAU - Hernandez, Frida
AU  - Hernandez F
AD  - HM CINAC. Hospital Puerta del Sur, Móstoles, Spain
FAU - Casas, Silvia
AU  - Casas S
AD  - Hospital Puerta del Sur, Móstoles, Spain
FAU - Oliver, Carlos
AU  - Oliver C
AD  - Hospital Puerta del Sur, Móstoles, Spain
FAU - Pastor, Patricia
AU  - Pastor P
AD  - Hospital Puerta del Sur, Móstoles, Spain
FAU - Vela, Lidia
AU  - Vela L
AD  - HM CINAC. Hospital Puerta del Sur, Móstoles, Spain
FAU - Obeso, Jose
AU  - Obeso J
AD  - HM CINAC. Hospital Puerta del Sur, Móstoles, Spain
FAU - Greillier, Paul
AU  - Greillier P
AD  - LabTau - U1032, INSERM, Lyon, France
FAU - Zorgani, Ali
AU  - Zorgani A
AD  - LabTau - U1032, INSERM, Lyon, France
FAU - Souchon, Rémi
AU  - Souchon R
AD  - LabTau - U1032, INSERM, Lyon, France
FAU - Melodelima, David
AU  - Melodelima D
AD  - LabTau - U1032, INSERM, Lyon, France
FAU - Catheline, Stefan
AU  - Catheline S
AD  - LabTau - U1032, INSERM, Lyon, France
FAU - Lafon, Cyril
AU  - Lafon C
AD  - LabTau - U1032, INSERM, Lyon, France
FAU - Solovov, Vyacheslav
AU  - Solovov V
AD  - Samara Oncology Center, Samara, Russian Federation
FAU - Vozdvizhenskiy, Michael O.
AU  - Vozdvizhenskiy MO
AD  - Samara Oncology Center, Samara, Russian Federation
FAU - Orlov, Andrew E.
AU  - Orlov AE
AD  - Samara Oncology Center, Samara, Russian Federation
FAU - Wu, Chueh-Hung
AU  - Wu CH
AD  - 0000 0004 0572 7815grid.412094.aPhysical Medicine & Rehabilitation, National
      Taiwan University Hospital, Taipei, Taiwan
FAU - Sun, Ming-Kuan
AU  - Sun MK
AD  - 0000 0004 0572 7815grid.412094.aPhysical Medicine & Rehabilitation, National
      Taiwan University Hospital, Taipei, Taiwan
FAU - Shih, Tiffany T.
AU  - Shih TT
AD  - 0000 0004 0572 7815grid.412094.aMedical Imaging, National Taiwan University
      Hospital, Taipei, Taiwan
FAU - Chen, Wen-Shiang
AU  - Chen WS
AD  - 0000 0004 0572 7815grid.412094.aPhysical Medicine & Rehabilitation, National
      Taiwan University Hospital, Taipei, Taiwan
FAU - Prieur, Fabrice
AU  - Prieur F
AD  - 0000 0004 1936 8921grid.5510.1University of Oslo, Oslo, Norway
FAU - Pillon, Arnaud
AU  - Pillon A
AD  - Centre de Recherche en Oncologie Experimentale, Institut de Recherche Pierre
      Fabre, Toulouse, France
FAU - Mestas, Jean-Louis
AU  - Mestas JL
AD  - U1032, LabTau, INSERM, Lyon, France
FAU - Cartron, Valerie
AU  - Cartron V
AD  - Centre de Recherche en Oncologie Experimentale, Institut de Recherche Pierre
      Fabre, Toulouse, France
FAU - Cebe, Patrick
AU  - Cebe P
AD  - Centre de Recherche en Oncologie Experimentale, Institut de Recherche Pierre
      Fabre, Toulouse, France
FAU - Chansard, Nathalie
AU  - Chansard N
AD  - Centre de Recherche en Oncologie Experimentale, Institut de Recherche Pierre
      Fabre, Toulouse, France
FAU - Lafond, Maxime
AU  - Lafond M
AD  - U1032, LabTau, INSERM, Lyon, France
FAU - Lafon, Cyril
AU  - Lafon C
AD  - U1032, LabTau, INSERM, Lyon, France
FAU - Inserra, Claude
AU  - Inserra C
AD  - LabTAU Inserm U1032, Lyon, France
FAU - Seya, Pauline Muleki
AU  - Seya PM
AD  - Laboratoire de Mécanique et d’Acoustique CNRS - UPR 7051, Marseille, France
FAU - Chen, Wen-Shiang
AU  - Chen WS
AD  - 0000 0004 0572 7815grid.412094.aNational Taiwan University Hospital, Taipei,
      Taiwan
FAU - Bera, Jean-Christophe
AU  - Bera JC
AD  - LabTAU Inserm U1032, Lyon, France
FAU - Boissenot, Tanguy
AU  - Boissenot T
AD  - Institut Galien Paris-Sud, CNRS, Univ. Paris-Sud, Université Paris Sacla,
      Châtenay-Malabry, France
FAU - Larrat, Benoit
AU  - Larrat B
AD  - CEA, Neurospin, Saclay, France
FAU - Fattal, Elias
AU  - Fattal E
AD  - Institut Galien Paris-Sud, CNRS, Univ. Paris-Sud, Université Paris Sacla,
      Châtenay-Malabry, France
FAU - Bordat, Alexandre
AU  - Bordat A
AD  - Institut Galien Paris-Sud, CNRS, Univ. Paris-Sud, Université Paris Sacla,
      Châtenay-Malabry, France
FAU - Chacun, Helene
AU  - Chacun H
AD  - Institut Galien Paris-Sud, CNRS, Univ. Paris-Sud, Université Paris Sacla,
      Châtenay-Malabry, France
FAU - Guetin, Claire
AU  - Guetin C
AD  - Institut Galien Paris-Sud, CNRS, Univ. Paris-Sud, Université Paris Sacla,
      Châtenay-Malabry, France
FAU - Tsapis, Nicolas
AU  - Tsapis N
AD  - Institut Galien Paris-Sud, CNRS, Univ. Paris-Sud, Université Paris Sacla,
      Châtenay-Malabry, France
FAU - Maruyama, Kazuo
AU  - Maruyama K
AD  - 0000 0000 9239 9995grid.264706.1Department of DDS Research, Teikyo University,
      Tokyo, Japan
FAU - Unga, Johan
AU  - Unga J
AD  - 0000 0000 9239 9995grid.264706.1Department of DDS Research, Teikyo University,
      Tokyo, Japan
FAU - Suzuki, Ryo
AU  - Suzuki R
AD  - 0000 0000 9239 9995grid.264706.1Department of DDS Research, Teikyo University,
      Tokyo, Japan
FAU - Fant, Cécile
AU  - Fant C
AD  - LabTAU, INSERM U1032, Lyon, France
FAU - Lafond, Maxime
AU  - Lafond M
AD  - LabTAU, INSERM U1032, Lyon, France
FAU - Rogez, Bernadette
AU  - Rogez B
AD  - LabTAU, INSERM U1032, Lyon, France
FAU - Ngo, Jacqueline
AU  - Ngo J
AD  - LabTAU, INSERM U1032, Lyon, France
FAU - Lafon, Cyril
AU  - Lafon C
AD  - LabTAU, INSERM U1032, Lyon, France
FAU - Mestas, Jean-Louis
AU  - Mestas JL
AD  - LabTAU, INSERM U1032, Lyon, France
FAU - Afadzi, Mercy
AU  - Afadzi M
AD  - Physics, Norwegian Univeristy of Science and Techonlogy, Trondhiem, Norway
FAU - Myhre, Ola Finneng
AU  - Myhre OF
AD  - Circulation and Medical Imaging, Norwegian Univeristy of Science and Techonlogy, 
      Trondhiem, Norway
FAU - Vea, Siri
AU  - Vea S
AD  - Circulation and Medical Imaging, Norwegian Univeristy of Science and Techonlogy, 
      Trondhiem, Norway
FAU - Bjørkøy, Astrid
AU  - Bjørkøy A
AD  - Physics, Norwegian Univeristy of Science and Techonlogy, Trondhiem, Norway
FAU - Yemane, Petros Tesfamichael
AU  - Yemane PT
AD  - Physics, Norwegian Univeristy of Science and Techonlogy, Trondhiem, Norway
FAU - van Wamel, Annemieke
AU  - van Wamel A
AD  - Physics, Norwegian Univeristy of Science and Techonlogy, Trondhiem, Norway
FAU - Berg, Sigrid
AU  - Berg S
AD  - SINTEF Technology and Society, Trondhiem, Norway
FAU - Hansen, Rune
AU  - Hansen R
AD  - SINTEF Technology and Society, Trondhiem, Norway
FAU - Angelsen, Bjørn
AU  - Angelsen B
AD  - Circulation and Medical Imaging, Norwegian Univeristy of Science and Techonlogy, 
      Trondhiem, Norway
FAU - Davies, Catharina
AU  - Davies C
AD  - Physics, Norwegian Univeristy of Science and Techonlogy, Trondhiem, Norway
LA  - eng
PT  - Journal Article
DEP - 20170317
TA  - J Ther Ultrasound
JT  - Journal of Therapeutic Ultrasound
AID - 79 [pii]
AID - 10.1186/s40349-016-0079-2 [doi]
SO  - J Ther Ultrasound. 2017 Mar 17;5(Suppl 1):. doi:10.1186/s40349-016-0079-2.

PMC - PMC5134466
PMID- 27801834
IS  - 1424-8220 (Electronic)
VI  - 16
IP  - 11
DP  - 2016 Nov
TI  - When Ultrasonic Sensors and Computer Vision Join Forces for Efficient Obstacle
      Detection and Recognition.
LID - 1807
AB  - In the most recent report published by the World Health Organization concerning
      people with visual disabilities it is highlighted that by the year 2020,
      worldwide, the number of completely blind people will reach 75 million, while the
      number of visually impaired (VI) people will rise to 250 million. Within this
      context, the development of dedicated electronic travel aid (ETA) systems, able
      to increase the safe displacement of VI people in indoor/outdoor spaces, while
      providing additional cognition of the environment becomes of outmost importance. 
      This paper introduces a novel wearable assistive device designed to facilitate
      the autonomous navigation of blind and VI people in highly dynamic urban scenes. 
      The system exploits two independent sources of information: ultrasonic sensors
      and the video camera embedded in a regular smartphone. The underlying methodology
      exploits computer vision and machine learning techniques and makes it possible to
      identify accurately both static and highly dynamic objects existent in a scene,
      regardless on their location, size or shape. In addition, the proposed system is 
      able to acquire information about the environment, semantically interpret it and 
      alert users about possible dangerous situations through acoustic feedback. To
      determine the performance of the proposed methodology we have performed an
      extensive objective and subjective experimental evaluation with the help of 21 VI
      subjects from two blind associations. The users pointed out that our prototype is
      highly helpful in increasing the mobility, while being friendly and easy to
      learn.
FAU - Mocanu, Bogdan
AU  - Mocanu B
AD  - ARTEMIS Department, Institut Mines-Télécom/Télécom SudParis, UMR CNRS MAP5 8145, 
      9 rue Charles Fourier, Évry 91000, France; bogdan.mocanu@telecom-sudparis.eu
      (B.M.); titus.zaharia@telecom-sudparis.eu (T.Z.)
FAU - Tapu, Ruxandra
AU  - Tapu R
AD  - ARTEMIS Department, Institut Mines-Télécom/Télécom SudParis, UMR CNRS MAP5 8145, 
      9 rue Charles Fourier, Évry 91000, France; bogdan.mocanu@telecom-sudparis.eu
      (B.M.); titus.zaharia@telecom-sudparis.eu (T.Z.)
FAU - Zaharia, Titus
AU  - Zaharia T
AD  - ARTEMIS Department, Institut Mines-Télécom/Télécom SudParis, UMR CNRS MAP5 8145, 
      9 rue Charles Fourier, Évry 91000, France; bogdan.mocanu@telecom-sudparis.eu
      (B.M.); titus.zaharia@telecom-sudparis.eu (T.Z.)
LA  - eng
PT  - Journal Article
DEP - 20161028
PHST- 2016/08/30 [received]
PHST- 2016/10/25 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s16111807 [doi]
AID - sensors-16-01807 [pii]
SO  - Sensors (Basel). 2016 Oct 28;16(11):. doi:10.3390/s16111807.

PMC - PMC4528297
PMID- 26300772
IS  - 1663-4365 (Electronic)
VI  - 7
DP  - 2015
TI  - Gains in cognition through combined cognitive and physical training: the role of 
      training dosage and severity of neurocognitive disorder.
LID - 152
AB  - Physical as well as cognitive training interventions improve specific cognitive
      functions but effects barely generalize on global cognition. Combined physical
      and cognitive training may overcome this shortcoming as physical training may
      facilitate the neuroplastic potential which, in turn, may be guided by cognitive 
      training. This study aimed at investigating the benefits of combined training on 
      global cognition while assessing the effect of training dosage and exploring the 
      role of several potential effect modifiers. In this multi-center study, 322 older
      adults with or without neurocognitive disorders (NCDs) were allocated to a
      computerized, game-based, combined physical and cognitive training group (n =
      237) or a passive control group (n = 85). Training group participants were
      allocated to different training dosages ranging from 24 to 110 potential
      sessions. In a pre-post-test design, global cognition was assessed by averaging
      standardized performance in working memory, episodic memory and executive
      function tests. The intervention group increased in global cognition compared to 
      the control group, p = 0.002, Cohen’s d = 0.31. Exploratory analysis revealed a
      trend for less benefits in participants with more severe NCD, p = 0.08
      (cognitively healthy: d = 0.54; mild cognitive impairment: d = 0.19; dementia: d 
      = 0.04). In participants without dementia, we found a dose-response effect of the
      potential number and of the completed number of training sessions on global
      cognition, p = 0.008 and p = 0.04, respectively. The results indicate that
      combined physical and cognitive training improves global cognition in a
      dose-responsive manner but these benefits may be less pronounced in older adults 
      with more severe NCD. The long-lasting impact of combined training on the
      incidence and trajectory of NCDs in relation to its severity should be assessed
      in future long-term trials.
FAU - Bamidis, Panagiotis D.
AU  - Bamidis PD
AD  - Laboratory of Medical Physics, Faculty of Health Sciences, Medical School,
      Aristotle University of ThessalonikiThessaloniki, Greece
FAU - Fissler, Patrick
AU  - Fissler P
AD  - Institute of Psychology and Pedagogy, Clinical and Biological Psychology, Ulm
      University, UlmGermany
FAU - Papageorgiou, Sokratis G.
AU  - Papageorgiou SG
AD  - Behavioral Neurology and Neuropsychology Unit, 1st and 2nd Department of
      Neurology, Medical School, National Kapodistrian University of AthensAthens,
      Greece
FAU - Zilidou, Vasiliki
AU  - Zilidou V
AD  - Laboratory of Medical Physics, Faculty of Health Sciences, Medical School,
      Aristotle University of ThessalonikiThessaloniki, Greece
FAU - Konstantinidis, Evdokimos I.
AU  - Konstantinidis EI
AD  - Laboratory of Medical Physics, Faculty of Health Sciences, Medical School,
      Aristotle University of ThessalonikiThessaloniki, Greece
FAU - Billis, Antonis S.
AU  - Billis AS
AD  - Laboratory of Medical Physics, Faculty of Health Sciences, Medical School,
      Aristotle University of ThessalonikiThessaloniki, Greece
FAU - Romanopoulou, Evangelia
AU  - Romanopoulou E
AD  - Laboratory of Medical Physics, Faculty of Health Sciences, Medical School,
      Aristotle University of ThessalonikiThessaloniki, Greece
FAU - Karagianni, Maria
AU  - Karagianni M
AD  - Laboratory of Medical Physics, Faculty of Health Sciences, Medical School,
      Aristotle University of ThessalonikiThessaloniki, Greece
FAU - Beratis, Ion
AU  - Beratis I
AD  - Behavioral Neurology and Neuropsychology Unit, 1st and 2nd Department of
      Neurology, Medical School, National Kapodistrian University of AthensAthens,
      Greece
FAU - Tsapanou, Angeliki
AU  - Tsapanou A
AD  - Behavioral Neurology and Neuropsychology Unit, 1st and 2nd Department of
      Neurology, Medical School, National Kapodistrian University of AthensAthens,
      Greece
FAU - Tsilikopoulou, Georgia
AU  - Tsilikopoulou G
AD  - Behavioral Neurology and Neuropsychology Unit, 1st and 2nd Department of
      Neurology, Medical School, National Kapodistrian University of AthensAthens,
      Greece
FAU - Grigoriadou, Eirini
AU  - Grigoriadou E
AD  - Laboratory of Medical Physics, Faculty of Health Sciences, Medical School,
      Aristotle University of ThessalonikiThessaloniki, Greece
FAU - Ladas, Aristea
AU  - Ladas A
AD  - Laboratory of Medical Physics, Faculty of Health Sciences, Medical School,
      Aristotle University of ThessalonikiThessaloniki, Greece
FAU - Kyrillidou, Athina
AU  - Kyrillidou A
AD  - Laboratory of Medical Physics, Faculty of Health Sciences, Medical School,
      Aristotle University of ThessalonikiThessaloniki, Greece
FAU - Tsolaki, Anthoula
AU  - Tsolaki A
AD  - Laboratory of Medical Physics, Faculty of Health Sciences, Medical School,
      Aristotle University of ThessalonikiThessaloniki, Greece
FAU - Frantzidis, Christos
AU  - Frantzidis C
AD  - Laboratory of Medical Physics, Faculty of Health Sciences, Medical School,
      Aristotle University of ThessalonikiThessaloniki, Greece
FAU - Sidiropoulos, Efstathios
AU  - Sidiropoulos E
AD  - Laboratory of Medical Physics, Faculty of Health Sciences, Medical School,
      Aristotle University of ThessalonikiThessaloniki, Greece
FAU - Siountas, Anastasios
AU  - Siountas A
AD  - Laboratory of Medical Physics, Faculty of Health Sciences, Medical School,
      Aristotle University of ThessalonikiThessaloniki, Greece
FAU - Matsi, Stavroula
AU  - Matsi S
AD  - Behavioral Neurology and Neuropsychology Unit, 1st and 2nd Department of
      Neurology, Medical School, National Kapodistrian University of AthensAthens,
      Greece
FAU - Papatriantafyllou, John
AU  - Papatriantafyllou J
AD  - Behavioral Neurology and Neuropsychology Unit, 1st and 2nd Department of
      Neurology, Medical School, National Kapodistrian University of AthensAthens,
      Greece
FAU - Margioti, Eleni
AU  - Margioti E
AD  - Behavioral Neurology and Neuropsychology Unit, 1st and 2nd Department of
      Neurology, Medical School, National Kapodistrian University of AthensAthens,
      Greece
FAU - Nika, Aspasia
AU  - Nika A
AD  - Behavioral Neurology and Neuropsychology Unit, 1st and 2nd Department of
      Neurology, Medical School, National Kapodistrian University of AthensAthens,
      Greece
FAU - Schlee, Winfried
AU  - Schlee W
AD  - Department of Psychiatry and Psychotherapy, University of RegensburgRegensburg,
      Germany
FAU - Elbert, Thomas
AU  - Elbert T
AD  - Clinical Psychology and Clinical Neuropsychology, University of KonstanzKonstanz,
      Germany
FAU - Tsolaki, Magda
AU  - Tsolaki M
AD  - Greek Association of Alzheimer’s Disease and Related Disorders,
      ThessalonikiGreece
FAU - Vivas, Ana B.
AU  - Vivas AB
AD  - Cognitive Psychology and Neuropsychology Lab, Department of Psychology, City
      College, The University of Sheffield International Faculty, ThessalonikiGreece
FAU - Kolassa, Iris-Tatjana
AU  - Kolassa IT
AD  - Institute of Psychology and Pedagogy, Clinical and Biological Psychology, Ulm
      University, UlmGermany
LA  - eng
PT  - Journal Article
DEP - 20150807
GR  - CIP-ICTPSP.2008.1.4
PHST- 2015/01/14 [received]
PHST- 2015/07/24 [accepted]
TA  - Front Aging Neurosci
JT  - Frontiers in Aging Neuroscience
AID - 10.3389/fnagi.2015.00152 [doi]
SO  - Front Aging Neurosci. 2015 Aug 07;7:. doi:10.3389/fnagi.2015.00152.

PMC - PMC4487932
PMID- 26161000
IS  - 0953-4180 (Print)
IS  - 1875-8584 (Electronic)
VI  - 2015
DP  - 2015
TI  - Effects of Different Types of Cognitive Training on Cognitive Function, Brain
      Structure, and Driving Safety in Senior Daily Drivers: A Pilot Study.
LID - 525901
AB  - Background. Increasing proportion of the elderly in the driving population raises
      the importance of assuring their safety. We explored the effects of three
      different types of cognitive training on the cognitive function, brain structure,
      and driving safety of the elderly. Methods. Thirty-seven healthy elderly daily
      drivers were randomly assigned to one of three training groups: Group V trained
      in a vehicle with a newly developed onboard cognitive training program, Group P
      trained with a similar program but on a personal computer, and Group C trained to
      solve a crossword puzzle. Before and after the 8-week training period, they
      underwent neuropsychological tests, structural brain magnetic resonance imaging, 
      and driving safety tests. Results. For cognitive function, only Group V showed
      significant improvements in processing speed and working memory. For driving
      safety, Group V showed significant improvements both in the driving aptitude test
      and in the on-road evaluations. Group P showed no significant improvements in
      either test, and Group C showed significant improvements in the driving aptitude 
      but not in the on-road evaluations. Conclusion. The results support the
      effectiveness of the onboard training program in enhancing the elderly's
      abilities to drive safely and the potential advantages of a multimodal training
      approach.
FAU - Nozawa, Takayuki
AU  - Nozawa T
AUID- ORCID: 0000-0001-6300-4373
AD  - Smart Ageing International Research Center, Institute of Development, Aging and
      Cancer, Tohoku University, Sendai 980-8575, Japan
FAU - Taki, Yasuyuki
AU  - Taki Y
AD  - Division of Developmental Cognitive Neuroscience, Institute of Development, Aging
      and Cancer, Tohoku University, Sendai 980-8575, Japan
FAU - Kanno, Akitake
AU  - Kanno A
AD  - Department of Functional Brain Imaging, Institute of Development, Aging and
      Cancer, Tohoku University, Sendai 980-8575, Japan
FAU - Akimoto, Yoritaka
AU  - Akimoto Y
AD  - Department of Functional Brain Imaging, Institute of Development, Aging and
      Cancer, Tohoku University, Sendai 980-8575, Japan
FAU - Ihara, Mizuki
AU  - Ihara M
AD  - Smart Ageing International Research Center, Institute of Development, Aging and
      Cancer, Tohoku University, Sendai 980-8575, Japan
FAU - Yokoyama, Ryoichi
AU  - Yokoyama R
AD  - Department of Functional Brain Imaging, Institute of Development, Aging and
      Cancer, Tohoku University, Sendai 980-8575, Japan
FAU - Kotozaki, Yuka
AU  - Kotozaki Y
AD  - Smart Ageing International Research Center, Institute of Development, Aging and
      Cancer, Tohoku University, Sendai 980-8575, Japan
FAU - Nouchi, Rui
AU  - Nouchi R
AUID- ORCID: 0000-0002-2078-9518
AD  - Smart Ageing International Research Center, Institute of Development, Aging and
      Cancer, Tohoku University, Sendai 980-8575, Japan
FAU - Sekiguchi, Atsushi
AU  - Sekiguchi A
AD  - Division of Medical Neuroimage Analysis, Department of Community Medical
      Supports, Tohoku Medical Megabank Organization, Tohoku University, Sendai
      980-8575, Japan
FAU - Takeuchi, Hikaru
AU  - Takeuchi H
AD  - Division of Developmental Cognitive Neuroscience, Institute of Development, Aging
      and Cancer, Tohoku University, Sendai 980-8575, Japan
FAU - Miyauchi, Carlos Makoto
AU  - Miyauchi CM
AD  - Department of Functional Brain Imaging, Institute of Development, Aging and
      Cancer, Tohoku University, Sendai 980-8575, Japan
FAU - Ogawa, Takeshi
AU  - Ogawa T
AD  - Department of Functional Brain Imaging, Institute of Development, Aging and
      Cancer, Tohoku University, Sendai 980-8575, Japan
FAU - Goto, Takakuni
AU  - Goto T
AD  - Department of Functional Brain Imaging, Institute of Development, Aging and
      Cancer, Tohoku University, Sendai 980-8575, Japan
FAU - Sunda, Takashi
AU  - Sunda T
AD  - Research Division 2, Mobility Services Laboratory, Nissan Motor Co., Ltd.,
      Kanagawa 243-0123, Japan
FAU - Shimizu, Toshiyuki
AU  - Shimizu T
AD  - Research Division 2, Mobility Services Laboratory, Nissan Motor Co., Ltd.,
      Kanagawa 243-0123, Japan
FAU - Tozuka, Eiji
AU  - Tozuka E
AD  - CAE and Testing Division 1, Vehicle Test and Measurement Technology Development, 
      Nissan Motor Co., Ltd., Kanagawa 243-0192, Japan
FAU - Hirose, Satoru
AU  - Hirose S
AD  - Research Division 2, Mobility Services Laboratory, Nissan Motor Co., Ltd.,
      Kanagawa 243-0123, Japan
FAU - Nanbu, Tatsuyoshi
AU  - Nanbu T
AD  - Research Division 2, Prototype and Test Department, Nissan Motor Co., Ltd.,
      Kanagawa 243-0123, Japan
FAU - Kawashima, Ryuta
AU  - Kawashima R
AD  - Smart Ageing International Research Center, Institute of Development, Aging and
      Cancer, Tohoku University, Sendai 980-8575, Japan
LA  - eng
PT  - Journal Article
DEP - 20150616
PHST- 2014/11/11 [received]
PHST- 2015/02/21 [accepted]
PHST- 2015/06/16 [aheadofprint]
TA  - Behav Neurol
JT  - Behavioural Neurology
AID - 10.1155/2015/525901 [doi]
SO  - Behav Neurol. 2015;2015:. Epub 2015 Jun 16 doi:10.1155/2015/525901.

PMC - PMC4507650
PMID- 26057043
IS  - 1424-8220 (Electronic)
VI  - 15
IP  - 6
DP  - 2015 Jun
TI  - The Survey on Near Field Communication.
PG  - 13348-405
AB  - Near Field Communication (NFC) is an emerging short-range wireless communication 
      technology that offers great and varied promise in services such as payment,
      ticketing, gaming, crowd sourcing, voting, navigation, and many others. NFC
      technology enables the integration of services from a wide range of applications 
      into one single smartphone. NFC technology has emerged recently, and consequently
      not much academic data are available yet, although the number of academic
      research studies carried out in the past two years has already surpassed the
      total number of the prior works combined. This paper presents the concept of NFC 
      technology in a holistic approach from different perspectives, including hardware
      improvement and optimization, communication essentials and standards,
      applications, secure elements, privacy and security, usability analysis, and
      ecosystem and business issues. Further research opportunities in terms of the
      academic and business points of view are also explored and discussed at the end
      of each section. This comprehensive survey will be a valuable guide for
      researchers and academicians, as well as for business in the NFC technology and
      ecosystem.
FAU - Coskun, Vedat
AU  - Coskun V
FAU - Ozdenizci, Busra
AU  - Ozdenizci B
FAU - Ok, Kerem
AU  - Ok K
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20150605
PHST- 2015/04/14 [received]
PHST- 2015/06/02 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s150613348 [doi]
AID - sensors-15-13348 [pii]
SO  - Sensors (Basel). 2015 Jun 05;15(6):13348-405. doi:10.3390/s150613348.

PMC - PMC4192729
IS  - 2235-0640 (Print)
IS  - 2235-0802 (Electronic)
VI  - 3
IP  - Suppl 1
DP  - 2014 Aug
TI  - 38th Annual Meeting of the European Thyroid Association.
PG  - 73-226
LA  - eng
PT  - Journal Article
DEP - 20140815
PHST- 2014/08/15 [aheadofprint]
TA  - Eur Thyroid J
JT  - European Thyroid Journal
AID - 10.1159/000365244 [doi]
AID - etj-0003-0073 [pii]
SO  - Eur Thyroid J. 2014 Aug;3(Suppl 1):73-226. Epub 2014 Aug 15
      doi:10.1159/000365244.

PMC - PMC4052974
PMID- 24966816
IS  - 1662-5137 (Electronic)
VI  - 8
DP  - 2014
TI  - Augmentation-related brain plasticity.
LID - 109
AB  - Today, the anthropomorphism of the tools and the development of neural interfaces
      require reconsidering the concept of human-tools interaction in the framework of 
      human augmentation. This review analyses the plastic process that the brain
      undergoes when it comes into contact with augmenting artificial sensors and
      effectors and, on the other hand, the changes that the use of external augmenting
      devices produces in the brain. Hitherto, few studies investigated the neural
      correlates of augmentation, but clues on it can be borrowed from
      logically-related paradigms: sensorimotor training, cognitive enhancement,
      cross-modal plasticity, sensorimotor functional substitution, use and embodiment 
      of tools. Augmentation modifies function and structure of a number of areas,
      i.e., primary sensory cortices shape their receptive fields to become sensitive
      to novel inputs. Motor areas adapt the neuroprosthesis representation firing-rate
      to refine kinematics. As for normal motor outputs, the learning process recruits 
      motor and premotor cortices and the acquisition of proficiency decreases
      attentional recruitment, focuses the activity on sensorimotor areas and increases
      the basal ganglia drive on the cortex. Augmentation deeply relies on the
      frontoparietal network. In particular, premotor cortex is involved in learning
      the control of an external effector and owns the tool motor representation, while
      the intraparietal sulcus extracts its visual features. In these areas,
      multisensory integration neurons enlarge their receptive fields to embody
      supernumerary limbs. For operating an anthropomorphic neuroprosthesis, the mirror
      system is required to understand the meaning of the action, the cerebellum for
      the formation of its internal model and the insula for its interoception. In
      conclusion, anthropomorphic sensorized devices can provide the critical sensory
      afferences to evolve the exploitation of tools through their embodiment,
      reshaping the body representation and the sense of the self.
FAU - Di Pino, Giovanni
AU  - Di Pino G
AD  - Institute of Neurology and Fondazione Alberto Sordi - Research Institute for
      Ageing, Campus Bio Medico University of RomeRome, Italy
FAU - Maravita, Angelo
AU  - Maravita A
AD  - Department of Psycology, Università di Milano-BicoccaMilano, Italy
FAU - Zollo, Loredana
AU  - Zollo L
AD  - Laboratory of Biomedical Robotics and Biomicrosystems CIR - Centre for Integrated
      Research, Campus Bio Medico University of RomeRome, Italy
FAU - Guglielmelli, Eugenio
AU  - Guglielmelli E
AD  - Laboratory of Biomedical Robotics and Biomicrosystems CIR - Centre for Integrated
      Research, Campus Bio Medico University of RomeRome, Italy
FAU - Di Lazzaro, Vincenzo
AU  - Di Lazzaro V
AD  - Institute of Neurology and Fondazione Alberto Sordi - Research Institute for
      Ageing, Campus Bio Medico University of RomeRome, Italy
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20140611
PHST- 2014/03/14 [received]
PHST- 2014/05/23 [accepted]
TA  - Front Syst Neurosci
JT  - Frontiers in Systems Neuroscience
AID - 10.3389/fnsys.2014.00109 [doi]
SO  - Front Syst Neurosci. 2014 Jun 11;8:. doi:10.3389/fnsys.2014.00109.

PMC - PMC4013463
PMID- 24822044
IS  - 1662-5161 (Electronic)
VI  - 8
DP  - 2014
TI  - Virtual environments for the transfer of navigation skills in the blind: a
      comparison of directed instruction vs. video game based learning approaches.
LID - 223
AB  - For profoundly blind individuals, navigating in an unfamiliar building can
      represent a significant challenge. We investigated the use of an audio-based,
      virtual environment called Audio-based Environment Simulator (AbES) that can be
      explored for the purposes of learning the layout of an unfamiliar, complex indoor
      environment. Furthermore, we compared two modes of interaction with AbES. In one 
      group, blind participants implicitly learned the layout of a target environment
      while playing an exploratory, goal-directed video game. By comparison, a second
      group was explicitly taught the same layout following a standard route and
      instructions provided by a sighted facilitator. As a control, a third group
      interacted with AbES while playing an exploratory, goal-directed video game
      however, the explored environment did not correspond to the target layout.
      Following interaction with AbES, a series of route navigation tasks were carried 
      out in the virtual and physical building represented in the training environment 
      to assess the transfer of acquired spatial information. We found that
      participants from both modes of interaction were able to transfer the spatial
      knowledge gained as indexed by their successful route navigation performance.
      This transfer was not apparent in the control participants. Most notably, the
      game-based learning strategy was also associated with enhanced performance when
      participants were required to find alternate routes and short cuts within the
      target building suggesting that a ludic-based training approach may provide for a
      more flexible mental representation of the environment. Furthermore, outcome
      comparisons between early and late blind individuals suggested that greater prior
      visual experience did not have a significant effect on overall navigation
      performance following training. Finally, performance did not appear to be
      associated with other factors of interest such as age, gender, and verbal memory 
      recall. We conclude that the highly interactive and immersive exploration of the 
      virtual environment greatly engages a blind user to develop skills akin to
      positive near transfer of learning. Learning through a game play strategy appears
      to confer certain behavioral advantages with respect to how spatial information
      is acquired and ultimately manipulated for navigation.
FAU - Connors, Erin C.
AU  - Connors EC
AD  - The Laboratory for Visual Neuroplasticity, Department of Ophthalmology,
      Massachusetts Eye and Ear Infirmary, Harvard Medical SchoolBoston, MA, USA
FAU - Chrastil, Elizabeth R.
AU  - Chrastil ER
AD  - Department of Psychology, Center for Memory and Brain, Boston UniversityBoston,
      MA, USA
FAU - Sánchez, Jaime
AU  - Sánchez J
AD  - Department of Computer Science, Center for Advanced Research in Education,
      University of ChileSantiago, Chile
FAU - Merabet, Lotfi B.
AU  - Merabet LB
AD  - The Laboratory for Visual Neuroplasticity, Department of Ophthalmology,
      Massachusetts Eye and Ear Infirmary, Harvard Medical SchoolBoston, MA, USA
LA  - eng
PT  - Journal Article
DEP - 20140501
PHST- 2013/08/27 [received]
PHST- 2014/03/30 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2014.00223 [doi]
SO  - Front Hum Neurosci. 2014 May 01;8:. doi:10.3389/fnhum.2014.00223.

PMC - PMC3674474
IS  - 2000-8198 (Print)
IS  - 2000-8066 (Electronic)
VI  - 4
DP  - 2013
TI  - Oral and Posters, June 8.
LID - 10.3402/ejpt.v4i0.21127
LA  - eng
PT  - Journal Article
DEP - 20130604
TA  - Eur J Psychotraumatol
JT  - European Journal of Psychotraumatology
AID - 21127 [pii]
AID - 10.3402/ejpt.v4i0.21127 [doi]
SO  - Eur J Psychotraumatol. 2013 Jun 04;4:. doi:10.3402/ejpt.v4i0.21127.

PMC - PMC3674472
IS  - 2000-8198 (Print)
IS  - 2000-8066 (Electronic)
VI  - 4
DP  - 2013
TI  - Oral and Posters, June 7.
LID - 10.3402/ejpt.v4i0.21098
LA  - eng
PT  - Journal Article
DEP - 20130604
TA  - Eur J Psychotraumatol
JT  - European Journal of Psychotraumatology
AID - 21098 [pii]
AID - 10.3402/ejpt.v4i0.21098 [doi]
SO  - Eur J Psychotraumatol. 2013 Jun 04;4:. doi:10.3402/ejpt.v4i0.21098.

PMC - PMC4599704
PMID- 24203548
IS  - 0748-7711 (Print)
IS  - 1938-1352 (Electronic)
VI  - 50
IP  - 6
DP  - 2013
TI  - Opportunities in rehabilitation research.
PG  - vii-xxxii
FAU - Ommaya, Alexander K.
AU  - Ommaya AK
AD  - VA Office of Research and Development, Washington, DC
FAU - Adams, Kenneth M.
AU  - Adams KM
AD  - Mental Health Service, VA Ann Arbor Healthcare System, Ann Arbor, MI; and
      Department of Psychiatry, University of Michigan, Ann Arbor, MI
FAU - Allman, Richard M.
AU  - Allman RM
AD  - Geriatric Research, Education, and Clinical Center (GRECC) and Division of
      Gerontology and Geriatrics, Birmingham VA Medical Center (VAMC), Birmingham, AL; 
      and Division of Gerontology, Geriatrics, and Palliative Medicine, Department of
      Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, AL
FAU - Collins, Eileen G.
AU  - Collins EG
AD  - Research and Development Service, Edward Hines, Jr. VA Hospital, Hines, IL; and
      College of Nursing, University of Illinois at Chicago, Chicago, IL
FAU - Cooper, Rory A.
AU  - Cooper RA
AD  - Human Engineering Research Laboratories, VA Pittsburgh Healthcare System,
      Pittsburgh, PA
FAU - Dixon, C. Edward
AU  - Dixon CE
AD  - GRECC, VA Pittsburgh Healthcare System, Pittsburg, PA; and University of
      Pittsburgh, Pittsburgh, PA
FAU - Fishman, Paul S.
AU  - Fishman PS
AD  - Neurology Service, Baltimore VAMC, Baltimore, MD; and Department of Neurology,
      University of Maryland School of Medicine, Baltimore, MD
FAU - Henry, James A.
AU  - Henry JA
AD  - National Center for Rehabilitative Auditory Research, Portland VAMC, Portland,
      OR; and Department of Otolaryngology, Head and Neck Surgery, Oregon Health &
      Science University, Portland, OR
FAU - Kardon, Randy
AU  - Kardon R
AD  - Division of Neuro-ophthalmology and VA Research Center for the Prevention and
      Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA; and
      University of Iowa, Iowa City, IA
FAU - Kerns, Robert D.
AU  - Kerns RD
AD  - Pain Research, Informatics, Multi-Morbidity, and Education Center, VA Connecticut
      Healthcare System, New Haven, CT; and Departments of Psychiatry, Neurology, and
      Psychology, Yale University, New Haven, CT
FAU - Kupersmith, Joel
AU  - Kupersmith J
AD  - VA Office of Research and Development, Washington, DC
FAU - Lo, Albert
AU  - Lo A
AD  - Providence VAMC, Providence, RI; and Departments of Neurology and Public Health, 
      Division of Biology and Medicine, Brown University, Providence, RI
FAU - Macko, Richard
AU  - Macko R
AD  - Rehabilitation Research and Development (RR&D) Center of Excellence and GRECC,
      Baltimore VAMC, Baltimore, MD; and Departments of Neurology, Medicine, and
      Physical Therapy and Rehabilitation Science, University of Maryland School of
      Medicine, Baltimore, MD
FAU - McArdle, Rachel
AU  - McArdle R
AD  - Bay Pines VA Healthcare System, Bay Pines, FL; and Department of Communication
      Sciences and Disorders, College of Behavioral and Community Disorders, University
      of South Florida, Tampa, FL
FAU - McGlinchey, Regina E.
AU  - McGlinchey RE
AD  - GRECC and Translational Research Center for TBI and Stress Disorders, VA Boston
      Healthcare System, Boston, MA; and Department of Psychiatry, Harvard Medical
      School, Boston, MA
FAU - McNeil, Malcolm R.
AU  - McNeil MR
AD  - GRECC, VA Pittsburgh Healthcare System, Pittsburg, PA; and Department of
      Communication Science and Disorders, School of Health and Rehabilitation
      Sciences, University of Pittsburgh, Pittsburgh, PA
FAU - O’Toole, Thomas P.
AU  - O’Toole TP
AD  - Providence VAMC, Providence, RI; and Alpert Medical School, Brown University,
      Providence, RI
FAU - Peckham, P. Hunter
AU  - Peckham PH
AD  - Cleveland Functional Electrical Stimulation Center, Louis Stokes Cleveland VAMC, 
      Cleveland, OH; and Department of Biomedical Engineering, Case Western Reserve
      University, Cleveland, OH
FAU - Tuszynski, Mark H.
AU  - Tuszynski MH
AD  - VA San Diego Healthcare System, San Diego, CA; and Department of Neurosciences,
      University of California, San Diego, La Jolla, CA
FAU - Waxman, Stephen G.
AU  - Waxman SG
AD  - Center of Excellence for Restoration of Nervous System Function, VA Connecticut
      Healthcare System, New Haven, CT; and Yale School of Medicine, New Haven, CT
FAU - Wittenberg, George F.
AU  - Wittenberg GF
AD  - GRECC, Baltimore VAMC, Baltimore, MD; and Department of Neurology, University of 
      Maryland School of Medicine, Baltimore, MD
LA  - eng
PT  - Journal Article
TA  - J Rehabil Res Dev
JT  - Journal of rehabilitation research and development
AID - 10.1682/JRRD.2012.09.0167 [doi]
MID - NIHMS726361
SO  - J Rehabil Res Dev. 2013;50(6):vii-xxxii. doi:10.1682/JRRD.2012.09.0167.

PMC - PMC4259253
PMID- 25505797
VI  - 2013
DP  - 2013
TI  - Enhancing Orientation and Mobility Skills in Learners who are Blind through Video
      gaming.
PG  - 353-6
AB  - In this work we present the results of the cognitive impact evaluation regarding 
      the use of Audiopolis, an audio and/or haptic-based videogame. The software has
      been designed, developed and evaluated for the purpose of developing orientation 
      and mobility (O&M) skills in blind users. The videogame was evaluated through
      cognitive tasks performed by a sample of 12 learners. The results demonstrated
      that the use of Audiopolis had a positive impact on the development and use of
      O&M skills in school-aged blind learners.
FAU - Sánchez, Jaime
AU  - Sánchez J
AD  - Department of Computer Science and Center for Advanced Research in Education
      (CARE), University Of Chile Santiago, Chile, jsanchez@dcc.uchile.cl
FAU - Espinoza, Matías
AU  - Espinoza M
AD  - Department of Computer Science and Center for Advanced Research in Education
      (CARE), University Of Chile Santiago, Chile, maespino@dcc.uchile.cl
FAU - de Borba Campos, Marcia
AU  - de Borba Campos M
AD  - Faculty of Informatics, Pontifical Catholic University of Rio Grande do Sul Rio
      Grande do Sul, Brazil, marcia.campos@pucrs.br
FAU - Merabet, Lotfi B.
AU  - Merabet LB
AD  - Dept. Ophthalmology Massachusetts Eye and Ear Infirmary, Harvard Medical School
      Boston, MA, USA, lotfi_merabet@meei.harvard.edu
LA  - eng
PT  - Journal Article
TA  - Creat Cognit
JT  - Creativity & cognition : proceedings of the ... Creativity & Cognition
      Conference. Creativity & Cognition Conference
AID - 10.1145/2466627.2466673 [doi]
MID - NIHMS592624
SO  - Creat Cognit. 2013;2013:353-6. doi:10.1145/2466627.2466673.

PMC - PMC3571849
PMID- 23247413
IS  - 1424-8220 (Electronic)
VI  - 12
IP  - 12
DP  - 2012 Dec
TI  - Assisting the Visually Impaired: Obstacle Detection and Warning System by
      Acoustic Feedback.
PG  - 17476-96
AB  - The aim of this article is focused on the design of an obstacle detection system 
      for assisting visually impaired people. A dense disparity map is computed from
      the images of a stereo camera carried by the user. By using the dense disparity
      map, potential obstacles can be detected in 3D in indoor and outdoor scenarios. A
      ground plane estimation algorithm based on RANSAC plus filtering techniques
      allows the robust detection of the ground in every frame. A polar grid
      representation is proposed to account for the potential obstacles in the scene.
      The design is completed with acoustic feedback to assist visually impaired users 
      while approaching obstacles. Beep sounds with different frequencies and
      repetitions inform the user about the presence of obstacles. Audio bone
      conducting technology is employed to play these sounds without interrupting the
      visually impaired user from hearing other important sounds from its local
      environment. A user study participated by four visually impaired volunteers
      supports the proposed system.
FAU - Rodríguez, Alberto
AU  - Rodríguez A
AD  - Department of Electronics, University of Alcalá, Alcalá de Henares, 28871 Madrid,
      Spain; E-Mails: alberto.rodrguezfernndez@gmail.com (A.R.); bergasa@depeca.uah.es 
      (L.M.B.); javier.almazan@depeca.uah.es (J.A.)
FAU - Yebes, J. Javier
AU  - Yebes JJ
AD  - Department of Electronics, University of Alcalá, Alcalá de Henares, 28871 Madrid,
      Spain; E-Mails: alberto.rodrguezfernndez@gmail.com (A.R.); bergasa@depeca.uah.es 
      (L.M.B.); javier.almazan@depeca.uah.es (J.A.)
FAU - Alcantarilla, Pablo F.
AU  - Alcantarilla PF
AD  - ISIT UMR 6284 CNRS, Université d’Auvergne, 63001 Clermont-Ferrand, France;
      E-Mail: pablofdezalc@gmail.com
FAU - Bergasa, Luis M.
AU  - Bergasa LM
AD  - Department of Electronics, University of Alcalá, Alcalá de Henares, 28871 Madrid,
      Spain; E-Mails: alberto.rodrguezfernndez@gmail.com (A.R.); bergasa@depeca.uah.es 
      (L.M.B.); javier.almazan@depeca.uah.es (J.A.)
FAU - Almazán, Javier
AU  - Almazán J
AD  - Department of Electronics, University of Alcalá, Alcalá de Henares, 28871 Madrid,
      Spain; E-Mails: alberto.rodrguezfernndez@gmail.com (A.R.); bergasa@depeca.uah.es 
      (L.M.B.); javier.almazan@depeca.uah.es (J.A.)
FAU - Cela, Andrés
AU  - Cela A
AD  - Department of Automation and Industrial Control, National Polytechnic, EC170135
      Quito, Ecuador; E-Mail: andres_cela@yahoo.com
LA  - eng
PT  - Journal Article
DEP - 20121217
PHST- 2012/10/12 [received]
PHST- 2012/11/23 [revised]
PHST- 2012/12/10 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s121217476 [doi]
AID - sensors-12-17476 [pii]
SO  - Sensors (Basel). 2012 Dec 17;12(12):17476-96. doi:10.3390/s121217476.

PMC - PMC3481065
PMID- 22696128
IS  - 1869-4101 (Electronic)
VI  - 3
IP  - Suppl 1
DP  - 2012 Mar
TI  - ECR 2012 Book of Abstracts - B - Scientific Sessions.
PG  - 135-363
CN  - European Society of Radiology (ESR)
LA  - eng
PT  - Journal Article
DEP - 20120321
TA  - Insights Imaging
JT  - Insights into Imaging
AID - 158 [pii]
AID - 10.1007/s13244-012-0158-z [doi]
SO  - Insights Imaging. 2012 Mar 21;3(Suppl 1):135-363. doi:10.1007/s13244-012-0158-z.

PMC - PMC2907861
IS  - 0002-9459 (Print)
IS  - 1553-6467 (Electronic)
VI  - 74
IP  - 5
DP  - 2010 Jun 15
TI  - 111th Annual Meeting of the American Association of Colleges of Pharmacy,
      Seattle, Washington, July 10-14, 2010.
LID - 96
LA  - eng
PT  - Journal Article
TA  - Am J Pharm Educ
JT  - American Journal of Pharmaceutical Education
AID - ajpe96 [pii]
SO  - Am J Pharm Educ. 2010 Jun 15;74(5):.

PMC - PMC3534347
PMID- 23099631
IS  - 1869-4101 (Electronic)
VI  - 1
IP  - Suppl 1
DP  - 2010 Mar
TI  - B - Scientific Sessions.
PG  - 127-322
LA  - eng
PT  - Journal Article
DEP - 20100309
TA  - Insights Imaging
JT  - Insights into Imaging
AID - 11 [pii]
AID - 10.1007/s13244-010-0011-1 [doi]
SO  - Insights Imaging. 2010 Mar 9;1(Suppl 1):127-322. doi:10.1007/s13244-010-0011-1.

PMC - PMC2786081
PMID- 19960101
IS  - 0218-2130 (Print)
IS  - 1793-6349 (Electronic)
VI  - 18
IP  - 3
DP  - 2009 Jun 1
TI  - FUNCTIONAL ASSESSMENT OF A CAMERA PHONE-BASED WAYFINDING SYSTEM OPERATED BY BLIND
      AND VISUALLY IMPAIRED USERS.
PG  - 379-97
AB  - We describe a wayfinding system for blind and visually impaired persons that uses
      a camera phone to determine the user's location with respect to color markers,
      posted at locations of interest (such as offices), which are automatically
      detected by the phone. The color marker signs are specially designed to be
      detected in real time in cluttered environments using computer vision software
      running on the phone; a novel segmentation algorithm quickly locates the borders 
      of the color marker in each image, which allows the system to calculate how far
      the marker is from the phone. We present a model of how the user's scanning
      strategy (i.e. how he/she pans the phone left and right to find color markers)
      affects the system's ability to detect color markers given the limitations
      imposed by motion blur, which is always a possibility whenever a camera is in
      motion. Finally, we describe experiments with our system tested by blind and
      visually impaired volunteers, demonstrating their ability to reliably use the
      system to find locations designated by color markers in a variety of indoor and
      outdoor environments, and elucidating which search strategies were most effective
      for users.
FAU - COUGHLAN, JAMES
AU  - COUGHLAN J
AD  - The Smith-Kettlewell Eye Research Institute San Francisco, California 94115, USA 
      coughlan@ski.org
FAU - MANDUCHI, ROBERTO
AU  - MANDUCHI R
AD  - Department of Computer Engineering, University of California Santa Cruz,
      California, 95064 manduchi@soe.ucsc.edu
LA  - eng
PT  - Journal Article
TA  - Int J Artif Intell Tools
JT  - International journal of artificial intelligence tools : architectures,
      languages, algorithms
AID - 10.1142/S0218213009000196 [doi]
MID - NIHMS158895
SO  - Int J Artif Intell Tools. 2009 Jun 1;18(3):379-97. doi:10.1142/S0218213009000196.

PMC - PMC2219573
IS  - 0884-8734 (Print)
IS  - 1525-1497 (Electronic)
VI  - 22
IP  - Suppl 1
DP  - 2007 Apr
TI  - Abtracts from the 30th Annual Meeting of the Society of General Internal
      Medicine.
PG  - 1-276
LA  - eng
PT  - Journal Article
DEP - 20070330
TA  - J Gen Intern Med
JT  - Journal of General Internal Medicine
AID - 176 [pii]
AID - 10.1007/s11606-007-0176-6 [doi]
SO  - J Gen Intern Med. 2007 Apr;22(Suppl 1):1-276. Epub 2007 Mar 30
      doi:10.1007/s11606-007-0176-6.

PMC - PMC2565426
PMID- 14712829
IS  - 2090-5904 (Print)
IS  - 1687-5443 (Electronic)
VI  - 10
IP  - 3
DP  - 2003
TI  - Abstracts of the 12th Annual Meeting of Israel Society for Neuroscience.
PG  - 179-241
LA  - eng
PT  - Journal Article
TA  - Neural Plast
JT  - Neural Plasticity
AID - 10.1155/NP.2003.179 [doi]
SO  - Neural Plast. 2003;10(3):179-241. doi:10.1155/NP.2003.179.

PMC - PMC5461518
IS  - 2397-1789 (Electronic)
VI  - 12
IP  - Suppl 1
DP  - 2017
TI  - 13th International Conference on Conservative Management of Spinal Deformities
      and First Joint Meeting of the International Research Society on Spinal
      Deformities and the Society on Scoliosis Orthopaedic and Rehabilitation Treatment
      – SOSORT-IRSSD 2016 meeting: Banff, Canada. 25-28 May 2016.
LID - 17
FAU - Bagheri, Aria
AU  - Bagheri A
AD  - 0000 0001 2111 8460grid.30760.32Division of Biostatistics, Medical College of
      Wisconsin, Milwaukee, WI USA
FAU - Liu, Xue-Cheng
AU  - Liu XC
AD  - Department of Orthopaedic Surgery, Milwaukee, WI USA
FAU - Tassone, Channing
AU  - Tassone C
AD  - Department of Orthopaedic Surgery, Milwaukee, WI USA
FAU - Thometz, John
AU  - Thometz J
AD  - Department of Orthopaedic Surgery, Milwaukee, WI USA
FAU - Chaloupka, Amie
AU  - Chaloupka A
AD  - Department of Orthopaedic Surgery, Milwaukee, WI USA
FAU - Tarima, Sergey
AU  - Tarima S
AD  - 0000 0001 2111 8460grid.30760.32Division of Biostatistics, Medical College of
      Wisconsin, Milwaukee, WI USA
FAU - Cohen, Larry
AU  - Cohen L
AD  - 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia
FAU - Simic, Milena
AU  - Simic M
AD  - 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia
FAU - Dennis, Sarah
AU  - Dennis S
AD  - 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia
FAU - Refshauge, Kathryn
AU  - Refshauge K
AD  - 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia
FAU - Pappas, Evangelos
AU  - Pappas E
AD  - 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia
FAU - Parent, Eric C.
AU  - Parent EC
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Pietrosanu, Matthew
AU  - Pietrosanu M
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Redford, Emily
AU  - Redford E
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Schmidt, Sheri
AU  - Schmidt S
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Hill, Douglas
AU  - Hill D
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Moreau, Marc
AU  - Moreau M
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Hedden, Douglas
AU  - Hedden D
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Adeeb, Samer
AU  - Adeeb S
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Lou, Edmond
AU  - Lou E
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Brink, Rob C.
AU  - Brink RC
AD  - 0000000090126352grid.7692.aDepartment of Orthopaedic Surgery, University Medical 
      Center Utrecht, Utrcht, The Netherlands
FAU - Schlösser, Tom P. C.
AU  - Schlösser TPC
AD  - 0000000090126352grid.7692.aDepartment of Orthopaedic Surgery, University Medical 
      Center Utrecht, Utrcht, The Netherlands
FAU - Colo, Dino
AU  - Colo D
AD  - 0000000090126352grid.7692.aDepartment of Orthopaedic Surgery, University Medical 
      Center Utrecht, Utrcht, The Netherlands
FAU - Vincken, Koen L.
AU  - Vincken KL
AD  - 0000000090126352grid.7692.aImage Sciences Institute, University Medical Center
      Utrecht, Utrecht, The Netherlands
FAU - van Stralen, Marijn
AU  - van Stralen M
AD  - 0000000090126352grid.7692.aImage Sciences Institute, University Medical Center
      Utrecht, Utrecht, The Netherlands
FAU - Hui, Steve C. N.
AU  - Hui SCN
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Imaging & Interventional Radiology,
      Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong 
      SAR
FAU - Chu, Winnie C. W.
AU  - Chu WCW
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Imaging & Interventional Radiology,
      Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong 
      SAR
FAU - Cheng, Jack C. Y.
AU  - Cheng JCY
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology,
      Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong 
      SAR
FAU - Castelein, René M.
AU  - Castelein RM
AD  - 0000000090126352grid.7692.aDepartment of Orthopaedic Surgery, University Medical 
      Center Utrecht, Utrcht, The Netherlands
FAU - Kechagias, Vasileios
AU  - Kechagias V
AD  - Private practice, Athens, Greece
FAU - Grivas, Theodoros B.
AU  - Grivas TB
AD  - grid.459305.eDepartment of Orthopaedics and Traumatology, Tzaneio General
      Hospital of Piraeus, Piraeus, Greece
FAU - Vlasis, Konstantinos
AU  - Vlasis K
AD  - 0000 0001 2155 0800grid.5216.0Department of Anatomy, Medical School, University
      of Athens, Athens, Greece
FAU - Michas, Konstantinos
AU  - Michas K
AD  - Kimi Health Center, Kimi, Greece
FAU - Grivas, Theodoros B.
AU  - Grivas TB
AD  - grid.459305.eDepartment of Orthopaedics and Traumatology, Tzaneio General
      Hospital of Piraeus, Piraeus, Greece
FAU - Kechagias, Vasileios
AU  - Kechagias V
AD  - Private Practice, Athens, Greece
FAU - Vlasis, Konstantinos
AU  - Vlasis K
AD  - 0000 0001 2155 0800grid.5216.0Department of Anatomy, Medical School, University
      of Athens, Athens, Greece
FAU - Michas, Konstantinos
AU  - Michas K
AD  - Kimi Health Center, Kimi, Greece
FAU - Tam, Elisa M. S.
AU  - Tam EMS
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics & Traumatology, The
      Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Yu, Fiona W. P.
AU  - Yu FWP
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics & Traumatology, The
      Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Hung, Vivian W. Y.
AU  - Hung VWY
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics & Traumatology, The
      Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Shi, Lin
AU  - Shi L
AD  - Department of Medicine and Therapeutics, The Chinese University of Hong Kong,
      Shatin,, Hong Kong SAR
FAU - Qin, Ling
AU  - Qin L
AD  - 0000 0004 1937 0482grid.10784.3aBone Quality and Health Centre, Department of
      Orthopaedics & Traumatology, The Chinese University of Hong Kong, Shatin, Hong
      Kong SAR
FAU - Ng, Bobby K. W.
AU  - Ng BKW
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics & Traumatology, The
      Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Chu, Winnie C. W.
AU  - Chu WCW
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Imaging & Interventional Radiology,
      Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong 
      SAR
FAU - Griffith, James
AU  - Griffith J
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Imaging & Interventional Radiology,
      Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong 
      SAR
FAU - Cheng, Jack C. Y.
AU  - Cheng JCY
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics & Traumatology, The
      Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Lam, Tsz Ping
AU  - Lam TP
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics & Traumatology, The
      Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Xue, Cindy
AU  - Xue C
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Imaging and Interventional
      Radiology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Shi, Lin
AU  - Shi L
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Medicine & Therapeutics, The
      Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Hui, Steve C. N.
AU  - Hui SCN
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Imaging and Interventional
      Radiology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Lam, Tsz Ping
AU  - Lam TP
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopedics & Traumatology, The
      Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Ng, Bobby K. W.
AU  - Ng BKW
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopedics & Traumatology, The
      Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Cheng, Jack C. Y.
AU  - Cheng JCY
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopedics & Traumatology, The
      Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Chu, Winnie C. W.
AU  - Chu WCW
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Imaging and Interventional
      Radiology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Hui, Steve C. N.
AU  - Hui SCN
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Imaging and Interventional
      Radiology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Pialasse, Jean-Philippe
AU  - Pialasse JP
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Imaging and Interventional
      Radiology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Wong, Judy Y. H.
AU  - Wong JYH
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Imaging and Interventional
      Radiology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Lam, Tsz Ping
AU  - Lam TP
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopedics & Traumatology, The
      Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Ng, Bobby K. W.
AU  - Ng BKW
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopedics & Traumatology, The
      Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Cheng, Jack C. Y.
AU  - Cheng JCY
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopedics & Traumatology, The
      Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Chu, Winnie C. W.
AU  - Chu WCW
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Imaging and Interventional
      Radiology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR
FAU - Vo, Quang N.
AU  - Vo QN
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Le, Lawrence H.
AU  - Le LH
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Lou, Edmond H. M.
AU  - Lou EHM
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Zheng, Rui
AU  - Zheng R
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Hill, Douglas L.
AU  - Hill DL
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Moreau, Marc J.
AU  - Moreau MJ
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Hedden, Douglas M.
AU  - Hedden DM
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Mahood, James K.
AU  - Mahood JK
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Southon, Sarah
AU  - Southon S
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Lou, Edmond
AU  - Lou E
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Brignol, Arnaud
AU  - Brignol A
AD  - 0000 0001 2222 4302grid.459234.dÉcole de technologie supérieure, Montréal, Canada
FAU - Cheriet, Farida
AU  - Cheriet F
AD  - Polytechnique Montréal, Montréal, Canada
FAU - Miron, Marie-Claude
AU  - Miron MC
AD  - 0000 0001 2173 6322grid.411418.9CHU Sainte-Justine, Montréal, Québec Canada
FAU - Laporte, Catherine
AU  - Laporte C
AD  - 0000 0001 2222 4302grid.459234.dÉcole de technologie supérieure, Montréal, Canada
FAU - Qiu, Yong
AU  - Qiu Y
AD  - 0000 0004 1800 1685grid.428392.6The Department of Spine Surgery, the Affiliated
      Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
FAU - Liu, Hao
AU  - Liu H
AD  - 0000 0004 1800 1685grid.428392.6The Department of Spine Surgery, the Affiliated
      Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
FAU - Liu, Zhen
AU  - Liu Z
AD  - 0000 0004 1800 1685grid.428392.6The Department of Spine Surgery, the Affiliated
      Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
FAU - Zhu, Ze-zhang
AU  - Zhu Zz
AD  - 0000 0004 1800 1685grid.428392.6The Department of Spine Surgery, the Affiliated
      Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
FAU - Qian, Bang-ping
AU  - Qian Bp
AD  - 0000 0004 1800 1685grid.428392.6The Department of Spine Surgery, the Affiliated
      Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
FAU - Liu, XueCheng
AU  - Liu X
AD  - 0000 0001 2111 8460grid.30760.32Department of Orthopaedic Surgery, Medical
      College of Wisconsin, Milwaukee, WI USA
FAU - Rizza, Robert
AU  - Rizza R
AD  - 0000 0001 0706 8057grid.260064.6Department of Mechanical Engineering, Milwaukee
      School of Engineering, Milwaukee, WI USA
FAU - Thometz, John
AU  - Thometz J
AD  - 0000 0001 2111 8460grid.30760.32Department of Orthopaedic Surgery, Medical
      College of Wisconsin, Milwaukee, WI USA
FAU - Rosol, Derek
AU  - Rosol D
AD  - 0000 0001 2111 8460grid.30760.32Department of Orthopaedic Surgery, Medical
      College of Wisconsin, Milwaukee, WI USA
FAU - Tassone, Channing
AU  - Tassone C
AD  - 0000 0001 2111 8460grid.30760.32Department of Orthopaedic Surgery, Medical
      College of Wisconsin, Milwaukee, WI USA
FAU - Tarima, Sergey
AU  - Tarima S
AD  - 0000 0001 2111 8460grid.30760.32Division of Biostatistics, Medical College of
      Wisconsin, Milwaukee, WI USA
FAU - North, Paula
AU  - North P
AD  - 0000 0001 2111 8460grid.30760.32Department of Pathology, Children’s Hospital of
      Wisconsin, Medical College of Wisconsin, Milwaukee, WI USA
FAU - Zaina, Fabio
AU  - Zaina F
AD  - grid.419440.cISICO, Milan, Italy
FAU - Pesenti, Francesca
AU  - Pesenti F
AD  - 0000 0004 1757 9530grid.418224.9Division of Endocrine & Metabolic Disease,
      Istituto Auxologico Italiano, Milan, Italy
FAU - Negrini, Stefano
AU  - Negrini S
AD  - 0000 0001 1090 9021grid.418563.dDon Gnocchi Foundation, Brescia, Italy
FAU - Persani, Luca
AU  - Persani L
AD  - 0000 0004 1757 9530grid.418224.9Division of Endocrine & Metabolic Disease,
      Istituto Auxologico Italiano, Milan, Italy
FAU - Capodaglio, Paolo
AU  - Capodaglio P
AD  - 0000 0004 1757 9530grid.418224.9Rehabilitation Department, Istituto Auxologico
      Italiano, Verbania, Italy
FAU - Polli, Nicoletta
AU  - Polli N
AD  - 0000 0004 1757 9530grid.418224.9Division of Endocrine & Metabolic Disease,
      Istituto Auxologico Italiano, Milan, Italy
FAU - Yip, Benjamin Hon Kei
AU  - Yip BHK
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology,
      Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong
      Kong, Shatin, Hong Kong SAR
FAU - Yu, Fiona Wai Ping
AU  - Yu FWP
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology,
      Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong
      Kong, Shatin, Hong Kong SAR
FAU - Hung, Vivian Wing Yin
AU  - Hung VWY
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology,
      Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong
      Kong, Shatin, Hong Kong SAR
FAU - Lam, Tsz Ping
AU  - Lam TP
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology,
      Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong
      Kong, Shatin, Hong Kong SAR
FAU - Qin, Ling
AU  - Qin L
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology,
      Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong
      Kong, Shatin, Hong Kong SAR
FAU - Ng, Bobby Kin Wah
AU  - Ng BKW
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology,
      Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong
      Kong, Shatin, Hong Kong SAR
FAU - Cheng, Jack Chun Yiu
AU  - Cheng JCY
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology,
      Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong
      Kong, Shatin, Hong Kong SAR
FAU - Zhang, Jiajun
AU  - Zhang J
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The 
      Chinese University of Hong Kong, Shatin, NT Hong Kong
FAU - Lee, Wayne Yuk Wai
AU  - Lee WYW
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The 
      Chinese University of Hong Kong, Shatin, NT Hong Kong
FAU - Chen, Huanxiong
AU  - Chen H
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The 
      Chinese University of Hong Kong, Shatin, NT Hong Kong
FAU - Tam, Elisa Man Shan
AU  - Tam EMS
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The 
      Chinese University of Hong Kong, Shatin, NT Hong Kong
FAU - Man, Gene Chiwai
AU  - Man GC
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The 
      Chinese University of Hong Kong, Shatin, NT Hong Kong
FAU - Lam, Tsz Ping
AU  - Lam TP
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The 
      Chinese University of Hong Kong, Shatin, NT Hong Kong
FAU - Ng, Bobby Kin Wah
AU  - Ng BKW
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The 
      Chinese University of Hong Kong, Shatin, NT Hong Kong
FAU - Qiu, Yong
AU  - Qiu Y
AD  - Joint Scoliosis Research Center of the Chinese University of Hong Kong and
      Nanjing University, Nanjing and Hong Kong, People’s Republic of China
FAU - Cheng, Jack Chun Yiu
AU  - Cheng JCY
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The 
      Chinese University of Hong Kong, Shatin, NT Hong Kong
FAU - Liu, Hao
AU  - Liu H
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Liu, Zhen
AU  - Liu Z
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Zhu, Zezhang
AU  - Zhu Z
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Qian, Bang Ping
AU  - Qian BP
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Qiu, Yong
AU  - Qiu Y
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Harasymczuk, P.
AU  - Harasymczuk P
AD  - 0000 0001 2205 0971grid.22254.33Department of Pediatric Orthopedics and
      Traumatology, University of Medical Sciences Poznan, Poznan, Poland
FAU - Andrusiewicz, M.
AU  - Andrusiewicz M
AD  - 0000 0001 2205 0971grid.22254.33Department of Cell Biology, University of Medical
      Sciences Poznan, Poznan, Poland
FAU - Janusz, P.
AU  - Janusz P
AD  - 0000 0001 2205 0971grid.22254.33Department of Pediatric Orthopedics and
      Traumatology, University of Medical Sciences Poznan, Poznan, Poland
FAU - Biecek, P.
AU  - Biecek P
AD  - 0000 0004 1937 1290grid.12847.38Department of Medical Statistics, University of
      Warsaw, Warsaw, Poland
FAU - Kotwicki, T.
AU  - Kotwicki T
AD  - 0000 0001 2205 0971grid.22254.33Department of Pediatric Orthopedics and
      Traumatology, University of Medical Sciences Poznan, Poznan, Poland
FAU - Kotwicka, M.
AU  - Kotwicka M
AD  - 0000 0001 2205 0971grid.22254.33Department of Cell Biology, University of Medical
      Sciences Poznan, Poznan, Poland
FAU - Lee, Jung Sub
AU  - Lee JS
AD  - 0000 0001 0719 8572grid.262229.fPusan National University School of Medicine,
      Busan, South Korea
FAU - Shin, Jong Ki
AU  - Shin JK
AD  - 0000 0001 0719 8572grid.262229.fPusan National University School of Medicine,
      Busan, South Korea
FAU - Goh, Tae Sik
AU  - Goh TS
AD  - 0000 0001 0719 8572grid.262229.fPusan National University School of Medicine,
      Busan, South Korea
FAU - Son, Seung Min
AU  - Son SM
AD  - 0000 0001 0719 8572grid.262229.fPusan National University School of Medicine,
      Busan, South Korea
FAU - Chen, Huanxiong
AU  - Chen H
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The 
      Chinese University of Hong Kong, Shatin, NT Hong Kong
FAU - Lee, Wayne Yuk Wai
AU  - Lee WYW
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The 
      Chinese University of Hong Kong, Shatin, NT Hong Kong
FAU - Zhang, Jiajun
AU  - Zhang J
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The 
      Chinese University of Hong Kong, Shatin, NT Hong Kong
FAU - Tam, Elisa Man Shan
AU  - Tam EMS
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The 
      Chinese University of Hong Kong, Shatin, NT Hong Kong
FAU - Man, Gene Chi Wai
AU  - Man GCW
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The 
      Chinese University of Hong Kong, Shatin, NT Hong Kong
FAU - Lam, Tsz Ping
AU  - Lam TP
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The 
      Chinese University of Hong Kong, Shatin, NT Hong Kong
FAU - Ng, Bobby Kin Wah
AU  - Ng BKW
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The 
      Chinese University of Hong Kong, Shatin, NT Hong Kong
FAU - Qiu, Yong
AU  - Qiu Y
AD  - Joint Scoliosis Research Center of the Chinese University of Hong Kong and
      Nanjing University, Nanjing and Hong Kong, People’s Republic of China
FAU - Cheng, Jack Chun Yiu
AU  - Cheng JCY
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The 
      Chinese University of Hong Kong, Shatin, NT Hong Kong
FAU - Schwartz, Mark
AU  - Schwartz M
AD  - 0000 0000 9025 8099grid.239573.9Cincinnati Children’s Hospital Medical Center,
      Cincinnati, OH USA
FAU - Gilday, Sarah
AU  - Gilday S
AD  - 0000 0000 9025 8099grid.239573.9Cincinnati Children’s Hospital Medical Center,
      Cincinnati, OH USA
FAU - Bylski-Austrow, Donita I.
AU  - Bylski-Austrow DI
AD  - 0000 0000 9025 8099grid.239573.9Cincinnati Children’s Hospital Medical Center,
      Cincinnati, OH USA
FAU - Glos, David L.
AU  - Glos DL
AD  - 0000 0000 9025 8099grid.239573.9Cincinnati Children’s Hospital Medical Center,
      Cincinnati, OH USA
FAU - Schultz, Lindsay
AU  - Schultz L
AD  - 0000 0000 9025 8099grid.239573.9Cincinnati Children’s Hospital Medical Center,
      Cincinnati, OH USA
FAU - O’Hara, Sara
AU  - O’Hara S
AD  - 0000 0000 9025 8099grid.239573.9Cincinnati Children’s Hospital Medical Center,
      Cincinnati, OH USA
FAU - Jain, Viral V.
AU  - Jain VV
AD  - 0000 0000 9025 8099grid.239573.9Cincinnati Children’s Hospital Medical Center,
      Cincinnati, OH USA
FAU - Sturm, Peter F.
AU  - Sturm PF
AD  - 0000 0000 9025 8099grid.239573.9Cincinnati Children’s Hospital Medical Center,
      Cincinnati, OH USA
FAU - Wang, Xiaoyu
AU  - Wang X
AD  - Polytechnique Montréal, Montréal, Canada
FAU - Crandall, Dennis G.
AU  - Crandall DG
AD  - Sonoran Spine Center and Research Foundation, Phoenix, AZ USA
FAU - Parent, Stefan
AU  - Parent S
AD  - 0000 0001 2173 6322grid.411418.9Sainte-Justine University Hospital Center,
      Montréal, Canada
FAU - Larson, Noelle
AU  - Larson N
AD  - 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, Rochester, MN USA
FAU - Labelle, Hubert
AU  - Labelle H
AD  - 0000 0001 2173 6322grid.411418.9Sainte-Justine University Hospital Center,
      Montréal, Canada
FAU - Aubin, Carl-Eric
AU  - Aubin CE
AD  - Polytechnique Montréal, Montréal, Canada
FAU - Fard, Negar Behzadi
AU  - Fard NB
AD  - grid.17089.37Department of Mechanical Engineering, University of Alberta,
      Edmonton, Canada
FAU - Southon, Sarah
AU  - Southon S
AD  - 0000 0004 0459 7625grid.241114.3Alberta Health Services, University of Alberta
      Hospital, Edmonton, Canada
FAU - Moreau, Marc
AU  - Moreau M
AD  - grid.17089.37Division of Orthopaedic Surgery, University of Alberta, Edmonton,
      Canada
FAU - Hedden, Douglas
AU  - Hedden D
AD  - grid.17089.37Division of Orthopaedic Surgery, University of Alberta, Edmonton,
      Canada
FAU - Duke, Kajsa
AU  - Duke K
AD  - grid.17089.37Department of Mechanical Engineering, University of Alberta,
      Edmonton, Canada
FAU - Southon, Sarah
AU  - Southon S
AD  - 0000 0004 0633 3703grid.416656.6Stollery Children’s Hospital, Edmonton, Alberta
      Canada
FAU - Lukenchuk, Leeann
AU  - Lukenchuk L
AD  - 0000 0004 0633 3703grid.416656.6Stollery Children’s Hospital, Edmonton, Alberta
      Canada
FAU - Kerslake, Matthew
AU  - Kerslake M
AD  - 0000 0004 0633 3703grid.416656.6Stollery Children’s Hospital, Edmonton, Alberta
      Canada
FAU - Huynh, Geraldine
AU  - Huynh G
AD  - 0000 0004 0633 3703grid.416656.6Stollery Children’s Hospital, Edmonton, Alberta
      Canada
FAU - Chorney, Jill
AU  - Chorney J
AD  - 0000 0001 0351 6983grid.414870.eIWK Health Centre, Halifax, Nova Scotia Canada
FAU - Tsui, Ban
AU  - Tsui B
AD  - 0000 0004 0633 3703grid.416656.6Stollery Children’s Hospital, Edmonton, Alberta
      Canada
FAU - Tobert, Daniel
AU  - Tobert D
AD  - 000000041936754Xgrid.38142.3cHarvard Medical School, Boston, USA
FAU - Bakarania, Prachi
AU  - Bakarania P
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, USA
FAU - Berdishevsky, Hagit
AU  - Berdishevsky H
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, USA
FAU - Grimes, Kelly
AU  - Grimes K
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, USA
FAU - Matsumoto, Hiroko
AU  - Matsumoto H
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, USA
FAU - Hyman, Joshua
AU  - Hyman J
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, USA
FAU - Roye, Benjamin
AU  - Roye B
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, USA
FAU - Roye, David
AU  - Roye D
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, USA
FAU - Vitale, Michael
AU  - Vitale M
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, USA
FAU - Black, Jason
AU  - Black J
AD  - Scoliosis SOS, London, UK
FAU - Bradley, Michael
AU  - Bradley M
AD  - Scoliosis SOS, London, UK
FAU - Drake, Shawn
AU  - Drake S
AD  - 0000 0001 2169 5989grid.252381.fArkansas State University, Jonesboro, AR USA
FAU - Glynn, David
AU  - Glynn D
AD  - Independant, York, UK
FAU - Maude, Erika
AU  - Maude E
AD  - Scoliosis SOS, London, UK
FAU - Berdishevsky, Hagit
AU  - Berdishevsky H
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Lindgren, Amelia
AU  - Lindgren A
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Bakarania, Prachi
AU  - Bakarania P
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Grimes, Kelly
AU  - Grimes K
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Matsumoto, Hiroko
AU  - Matsumoto H
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Feinberg, Nicholas
AU  - Feinberg N
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Bloom, Zachary
AU  - Bloom Z
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Roye, David
AU  - Roye D
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Vitale, Michael
AU  - Vitale M
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Dupuis, Sarah
AU  - Dupuis S
AD  - Polytechnique Montréal, Montréal, Canada
FAU - Fortin, Carole
AU  - Fortin C
AD  - 0000 0001 2173 6322grid.411418.9CHU Sainte-Justine, Montréal, Canada
FAU - Caouette, Christiane
AU  - Caouette C
AD  - Polytechnique Montréal, Montréal, Canada
FAU - Aubin, Carl-Éric
AU  - Aubin CÉ
AD  - Polytechnique Montréal, Montréal, Canada
FAU - Gur, Gozde
AU  - Gur G
AD  - 0000 0001 2342 7339grid.14442.37Hacettepe University, Ankara, Turkey
FAU - Yakut, Yavuz
AU  - Yakut Y
AD  - 0000 0001 2342 7339grid.14442.37Hacettepe University, Ankara, Turkey
FAU - Jevtić, Nikola
AU  - Jevtić N
AD  - 0000 0001 2149 743Xgrid.10822.39University of Novi Sad, Faculty of Sport and
      Physical Education, Novi Sad, Serbia
FAU - Schreiber, Sanja
AU  - Schreiber S
AD  - grid.17089.37Department of Pediatrics, University of Alberta, Edmonton, Canada
FAU - Hennes, Axel
AU  - Hennes A
AD  - MVZ Bad Sobernheim GmbH, Bad Sobernheim, Germany
FAU - Pantović, Milan
AU  - Pantović M
AD  - 0000 0001 2149 743Xgrid.10822.39University of Novi Sad, Faculty of Sport and
      Physical Education, Novi Sad, Serbia
FAU - de Mauroy, Jean-Claude
AU  - de Mauroy JC
AD  - Clinique du parc, Lyon, France
FAU - Barral, Frédéric
AU  - Barral F
AD  - Lecante Group, Lyon, France
FAU - Pourret, Sophie
AU  - Pourret S
AD  - Lecante Group, Lyon, France
FAU - de Mauroy, Jean-Claude
AU  - de Mauroy JC
AD  - Clinique du Parc, Lyon, France
FAU - Barral, Frédéric
AU  - Barral F
AD  - Lecante Group, Lyon, France
FAU - Pourret, Sophie
AU  - Pourret S
AD  - Lecante Group, Lyon, France
FAU - Aulisa, Angelo Gabriele
AU  - Aulisa AG
AD  - U.O.C. of Orthopedics and Traumatology, Children’s Hospital Bambino Gesù,
      Institute of Scientific Research, P.zza S. Onofrio 4, Rome, 00165 Italy
FAU - Guzzanti, Vincenzo
AU  - Guzzanti V
AD  - U.O.C. of Orthopedics and Traumatology, Children’s Hospital Bambino Gesù,
      Institute of Scientific Research, P.zza S. Onofrio 4, Rome, 00165 Italy
FAU - Galli, Marco
AU  - Galli M
AD  - 0000 0004 1760 4193grid.411075.6Department of Orthopedics, University Hospital
      “Agostino Gemelli”, Catholic University of the Sacred Heart School of Medicine,
      Rome, 00168 Italy
FAU - Falciglia, Francesco
AU  - Falciglia F
AD  - U.O.C. of Orthopedics and Traumatology, Children’s Hospital Bambino Gesù,
      Institute of Scientific Research, P.zza S. Onofrio 4, Rome, 00165 Italy
FAU - Aulisa, Lorenzo
AU  - Aulisa L
AD  - 0000 0004 1760 4193grid.411075.6Department of Orthopedics, University Hospital
      “Agostino Gemelli”, Catholic University of the Sacred Heart School of Medicine,
      Rome, 00168 Italy
FAU - Bernard, Jean-Claude
AU  - Bernard JC
AD  - Croix Rouge française-CMCR des Massues, Lyon, France
FAU - Deceuninck, Julie
AU  - Deceuninck J
AD  - 0000 0001 2150 7757grid.7849.2Laboratoire de physiologie de l’exercice,
      Université de Lyon, Saint Étienne, France
FAU - Berthonnaud, Eric
AU  - Berthonnaud E
AD  - Croix Rouge française-CMCR des Massues, Lyon, France
FAU - Rougelot, Adrien
AU  - Rougelot A
AD  - Croix Rouge française-CMCR des Massues, Lyon, France
FAU - Pickering, Marie-Eva
AU  - Pickering ME
AD  - Croix Rouge française-CMCR des Massues, Lyon, France
FAU - Chaleat-Valayer, Emmanuelle
AU  - Chaleat-Valayer E
AD  - Croix Rouge française-CMCR des Massues, Lyon, France
FAU - Webb, Richard
AU  - Webb R
AD  - Teesside University/Peacocks Medical Group, Newcastle, UK
FAU - Bettany-Saltikov, Josette
AU  - Bettany-Saltikov J
AD  - 0000 0001 2325 1783grid.26597.3fTeesside University, Middlesbrough, UK
FAU - Neil, Barbara
AU  - Neil B
AD  - 0000 0001 2325 1783grid.26597.3fTeesside University, Middlesbrough, UK
FAU - Zaina, Fabio
AU  - Zaina F
AD  - grid.419440.cISICO, Milan, Italy
FAU - Poggio, Martina
AU  - Poggio M
AD  - grid.419440.cISICO, Milan, Italy
FAU - Donzelli, Sabrina
AU  - Donzelli S
AD  - grid.419440.cISICO, Milan, Italy
FAU - Lusini, Monia
AU  - Lusini M
AD  - grid.419440.cISICO, Milan, Italy
FAU - Minnella, Salvatore
AU  - Minnella S
AD  - grid.419440.cISICO, Milan, Italy
FAU - Negrini, Stefano
AU  - Negrini S
AD  - 0000 0001 1090 9021grid.418563.dDon Gnocchi Foundation, Brescia, Italy
FAU - de Mauroy, Jean-Claude
AU  - de Mauroy JC
AD  - Clinique du parc, Lyon, France
FAU - Barral, Frédéric
AU  - Barral F
AD  - Lecante group, Lyon, France
FAU - Hoang, Alith
AU  - Hoang A
AD  - Lecante group, Lyon, France
FAU - Mao, Saihu
AU  - Mao S
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Shi, Benlong
AU  - Shi B
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Qian, Bangping
AU  - Qian B
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Zhu, Zezhang
AU  - Zhu Z
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Sun, Xu
AU  - Sun X
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Qiu, Yong
AU  - Qiu Y
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Cobetto, Nikita
AU  - Cobetto N
AD  - Polytechnique Montréal, Montréal, Canada
FAU - Aubin, Carl-Éric
AU  - Aubin CÉ
AD  - Polytechnique Montréal, Montréal, Canada
FAU - Parent, Stefan
AU  - Parent S
AD  - 0000 0001 2173 6322grid.411418.9CHU Sainte-Justine, Montréal, Canada
FAU - Barch, Soraya
AU  - Barch S
AD  - 0000 0001 2173 6322grid.411418.9CHU Sainte-Justine, Montréal, Canada
FAU - Turgeon, Isabelle
AU  - Turgeon I
AD  - 0000 0001 2173 6322grid.411418.9CHU Sainte-Justine, Montréal, Canada
FAU - Labelle, Hubert
AU  - Labelle H
AD  - 0000 0001 2173 6322grid.411418.9CHU Sainte-Justine, Montréal, Canada
FAU - Raihan, Hasan Md Arif
AU  - Raihan HMA
AD  - 0000 0004 1799 577Xgrid.418546.aThe West Bengal University of Health Sciences &
      National Institute for the Orthopaedically Handicapped, Kolkata, India
FAU - Kumar, Datta Tarit
AU  - Kumar DT
AD  - 0000 0004 1799 577Xgrid.418546.aThe West Bengal University of Health Sciences &
      National Institute for the Orthopaedically Handicapped, Kolkata, India
FAU - Khasnabis, Chapal
AU  - Khasnabis C
AD  - 0000000121633745grid.3575.4World Health Organization, Geneva, Switzerland
FAU - Equbal, Ameed
AU  - Equbal A
AD  - 0000 0004 1799 577Xgrid.418546.aThe West Bengal University of Health Sciences &
      National Institute for the Orthopaedically Handicapped, Kolkata, India
FAU - Chakraborty, Ashis Kumar
AU  - Chakraborty AK
AD  - 0000 0001 2157 0617grid.39953.35Indian Statistical Institute, Kolkata, India
FAU - Biswas, Abhishek
AU  - Biswas A
AD  - 0000 0004 1799 577Xgrid.418546.aThe West Bengal University of Health Sciences &
      National Institute for the Orthopaedically Handicapped, Kolkata, India
FAU - Gur, Gozde
AU  - Gur G
AD  - 0000 0001 2342 7339grid.14442.37Department of Physiotherapy and Rehabilitation,
      Faculty of Health Sciences, Hacettepe University, Ankara, Turkey
FAU - Dilek, Burcu
AU  - Dilek B
AD  - 0000 0001 2342 7339grid.14442.37Department of Physiotherapy and Rehabilitation,
      Faculty of Health Sciences, Hacettepe University, Ankara, Turkey
FAU - Ayhan, Cigdem
AU  - Ayhan C
AD  - 0000 0001 2342 7339grid.14442.37Department of Physiotherapy and Rehabilitation,
      Faculty of Health Sciences, Hacettepe University, Ankara, Turkey
FAU - Simsek, Engin
AU  - Simsek E
AD  - School of Physical Therapy and Rehabilitation, Dokuzeylul University, Izmir,
      Turkey
FAU - Aras, Ozgen
AU  - Aras O
AD  - 0000 0004 0595 6407grid.412109.fDepartment of Physiotherapy and Rehabilitation,
      School of Health Sciences, Dumlupinar University, Kutahya, Turkey
FAU - Aksoy, Songul
AU  - Aksoy S
AD  - 0000 0001 2342 7339grid.14442.37Department of Audiology, Voice and Speech
      Disorders, Faculty of Health Sciences, Hacettepe University, Ankara, Turkey
FAU - Yakut, Yavuz
AU  - Yakut Y
AD  - 0000 0001 2342 7339grid.14442.37Department of Physiotherapy and Rehabilitation,
      Faculty of Health Sciences, Hacettepe University, Ankara, Turkey
FAU - Lou, Edmond
AU  - Lou E
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Hill, Doug
AU  - Hill D
AD  - 0000 0001 0693 8815grid.413574.0Alberta Health Services, Edmonton, Canada
FAU - Zheng, Rui
AU  - Zheng R
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Donauer, Andreas
AU  - Donauer A
AD  - 0000 0001 0693 8815grid.413574.0Alberta Health Services, Edmonton, Canada
FAU - Tilburn, Melissa
AU  - Tilburn M
AD  - 0000 0001 0693 8815grid.413574.0Alberta Health Services, Edmonton, Canada
FAU - Raso, Jim
AU  - Raso J
AD  - 0000 0001 0693 8815grid.413574.0Alberta Health Services, Edmonton, Canada
FAU - Morau, Marc
AU  - Morau M
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Hedden, Douglas
AU  - Hedden D
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Chen, He
AU  - Chen H
AD  - 0000 0004 1764 6123grid.16890.36Interdisciplinary Division of Biomedical
      Engineering, The Hong Kong Polytechnic University, Hong Kong, China
FAU - Man-Sang, Wong
AU  - Man-Sang W
AD  - 0000 0004 1764 6123grid.16890.36Interdisciplinary Division of Biomedical
      Engineering, The Hong Kong Polytechnic University, Hong Kong, China
FAU - Cohen, Larry
AU  - Cohen L
AD  - 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia
FAU - Kobayashi, Sarah
AU  - Kobayashi S
AD  - 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia
FAU - Simic, Milena
AU  - Simic M
AD  - 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia
FAU - Dennis, Sarah
AU  - Dennis S
AD  - 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia
FAU - Refshauge, Kathryn
AU  - Refshauge K
AD  - 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia
FAU - Pappas, Evangelos
AU  - Pappas E
AD  - 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia
FAU - Aslanzadeh, Fatemeh
AU  - Aslanzadeh F
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Parent, Eric C.
AU  - Parent EC
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - MacIntosh, Brian
AU  - MacIntosh B
AD  - 0000 0004 1936 7697grid.22072.35University of Calgary, Calgary, Canada
FAU - Maragkoudakis, Emmanouil G.
AU  - Maragkoudakis EG
AD  - Private Practice, Athens, Greece
FAU - Grivas, Theodoros B.
AU  - Grivas TB
AD  - grid.459305.e“Tzaneio” General Hospital of Piraeus, Piraeus, Greece
FAU - Gelalis, Ioannis D.
AU  - Gelalis ID
AD  - 0000 0004 0622 9754grid.411740.7University Hospital of Ioannina, Ioannina, Greece
FAU - Mazioti, Christina
AU  - Mazioti C
AD  - grid.459305.e“Tzaneio” General Hospital of Piraeus, Piraeus, Greece
FAU - Tsilimidos, Gerasimos
AU  - Tsilimidos G
AD  - grid.459305.e“Tzaneio” General Hospital of Piraeus, Piraeus, Greece
FAU - Burwell, R. Geoffrey
AU  - Burwell RG
AD  - 0000 0001 0440 1889grid.240404.6Nottingham University Hospitals Trust,
      Nottingham, UK
FAU - Zheng, Yu
AU  - Zheng Y
AD  - 0000 0004 1764 6123grid.16890.36Interdisciplinary Division of Biomedical
      Engineering, The Hong Kong Polytechnic University, Hong Kong, China
FAU - Wu, Xiao-Jun
AU  - Wu XJ
AD  - Department of Rehabilitation Medicine, Wuxi Rehabilitation Hospital, Wuxi,
      Jiangsu China
FAU - Dang, Yi-Ni
AU  - Dang YN
AD  - 0000 0004 1799 0784grid.412676.0Department of Gastroenterology, The First
      Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu China
FAU - Sun, Ning
AU  - Sun N
AD  - Department of Rehabilitation Medicine, Wuxi Rehabilitation Hospital, Wuxi,
      Jiangsu China
FAU - Yang, Yan
AU  - Yang Y
AD  - Department of Rehabilitation Medicine, Wuxi Rehabilitation Hospital, Wuxi,
      Jiangsu China
FAU - Wang, Tao
AU  - Wang T
AD  - Department of Rehabilitation Medicine, Wuxi Rehabilitation Hospital, Wuxi,
      Jiangsu China
FAU - He, Cheng-Qi
AU  - He CQ
AD  - 0000 0004 1770 1022grid.412901.fDepartment of Rehabilitation Medicine, West China
      Hospital, Sichuan University, Chengdu, Sichuan China
FAU - Wong, Man-Sang
AU  - Wong MS
AD  - 0000 0004 1764 6123grid.16890.36Interdisciplinary Division of Biomedical
      Engineering, The Hong Kong Polytechnic University, Hong Kong, China
FAU - Donzelli, Sabrina
AU  - Donzelli S
AD  - grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy
FAU - Martinez, Gregorio
AU  - Martinez G
AD  - grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy
FAU - Negrini, Alberto
AU  - Negrini A
AD  - grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy
FAU - Zaina, Fabio
AU  - Zaina F
AD  - grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy
FAU - Negrini, Stefano
AU  - Negrini S
AD  - grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy
FAU - Matsumoto, Hiroko
AU  - Matsumoto H
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Feinberg, Nicholas
AU  - Feinberg N
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Shirley, Matthew
AU  - Shirley M
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Swindell, Hasani
AU  - Swindell H
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Bloom, Zachary
AU  - Bloom Z
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Roye, David P.
AU  - Roye DP
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Akbarnia, Behrooz A.
AU  - Akbarnia BA
AD  - 0000 0004 0383 2910grid.286440.cRady Children’s Hospital, San Diego, CA USA
FAU - Garg, Sumeet
AU  - Garg S
AD  - 0000 0001 0690 7621grid.413957.dChildren’s Hospital Colorado, Aurora, CO USA
FAU - Sanders, James O.
AU  - Sanders JO
AD  - 0000 0004 1936 9174grid.16416.34University of Rochester, Rochester, NY USA
FAU - Skaggs, David L.
AU  - Skaggs DL
AD  - 0000 0001 2153 6013grid.239546.fChildren’s Hospital of Los Angeles, Los Angeles, 
      CA USA
FAU - Smith, John T.
AU  - Smith JT
AD  - 0000 0001 2193 0096grid.223827.eUniversity of Utah, Salt Lake City, UT USA
FAU - Vitale, Michael G.
AU  - Vitale MG
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
CN  - Children’s Spine Study Group
AD  - Growing Spine Foundation, San Diego, CA USA
CN  - Growing Spine Study Group
AD  - Children’s Spine Foundation, Valley Forge, PA USA
FAU - Rizza, Robert
AU  - Rizza R
AD  - 0000 0001 0706 8057grid.260064.6Department of Mechanical Engineering, Milwaukee
      School of Engineering, Milwaukee, WI USA
FAU - Liu, XueCheng
AU  - Liu X
AD  - 0000 0001 2111 8460grid.30760.32Department of Orthopaedic Surgery, Medical
      College of Wisconsin, Milwaukee, WI USA
FAU - Thometz, John
AU  - Thometz J
AD  - 0000 0001 2111 8460grid.30760.32Department of Orthopaedic Surgery, Medical
      College of Wisconsin, Milwaukee, WI USA
FAU - Lou, Edmond
AU  - Lou E
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Hill, Doug
AU  - Hill D
AD  - 0000 0001 0693 8815grid.413574.0Alberta Health Services, Edmonton, Canada
FAU - Donauer, Andreas
AU  - Donauer A
AD  - 0000 0001 0693 8815grid.413574.0Alberta Health Services, Edmonton, Canada
FAU - Tilburn, Melissa
AU  - Tilburn M
AD  - 0000 0001 0693 8815grid.413574.0Alberta Health Services, Edmonton, Canada
FAU - Hedden, Douglas
AU  - Hedden D
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Moreau, Marc
AU  - Moreau M
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Healy, Aoife
AU  - Healy A
AD  - 0000000106863366grid.19873.34Faculty of Health Sciences, Staffordshire
      University, Stoke-on-Trent, UK
FAU - Farmer, Sybil
AU  - Farmer S
AD  - 0000000106863366grid.19873.34Faculty of Health Sciences, Staffordshire
      University, Stoke-on-Trent, UK
FAU - Chockalingam, Nachiappan
AU  - Chockalingam N
AD  - 0000000106863366grid.19873.34Faculty of Health Sciences, Staffordshire
      University, Stoke-on-Trent, UK
FAU - Aulisa, Angelo Gabriele
AU  - Aulisa AG
AD  - U.O.C. of Orthopedics and Traumatology, Children’s Hospital Bambino Gesù,
      Institute of Scientific Research, P.zza S. Onofrio 4, Rome, 00165 Italy
FAU - Guzzanti, Vincenzo
AU  - Guzzanti V
AD  - U.O.C. of Orthopedics and Traumatology, Children’s Hospital Bambino Gesù,
      Institute of Scientific Research, P.zza S. Onofrio 4, Rome, 00165 Italy
FAU - Galli, Marco
AU  - Galli M
AD  - 0000 0004 1760 4193grid.411075.6Department of Orthopedics, University Hospital
      “Agostino Gemelli”, Catholic University of the Sacred Heart School of Medicine,
      Rome, 00168 Italy
FAU - Pizzetti, Paolo
AU  - Pizzetti P
AD  - Independent practitioner, Rome, Italy
FAU - Aulisa, Lorenzo
AU  - Aulisa L
AD  - 0000 0004 1760 4193grid.411075.6Department of Orthopedics, University Hospital
      “Agostino Gemelli”, Catholic University of the Sacred Heart School of Medicine,
      Rome, 00168 Italy
FAU - Maruyama, Toru
AU  - Maruyama T
AD  - Saitama Prefectural Rehabilitation Center, Ageo, Japan
FAU - Kobayashi, Yosuke
AU  - Kobayashi Y
AD  - 0000 0001 2216 2631grid.410802.fSaitama Medical Center, Saitama Medical
      University, Moroyama, Japan
FAU - Nakao, Yusuke
AU  - Nakao Y
AD  - 0000 0001 2216 2631grid.410802.fSaitama Medical Center, Saitama Medical
      University, Moroyama, Japan
FAU - Liu, Hao
AU  - Liu H
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Qian, Bang Ping
AU  - Qian BP
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Qiu, Yong
AU  - Qiu Y
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Mao, Sai-hu
AU  - Mao Sh
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Wang, Bin
AU  - Wang B
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Yu, Yang
AU  - Yu Y
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Zhu, Zezhang
AU  - Zhu Z
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Berdishevsky, Hagit
AU  - Berdishevsky H
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Lindgren, Amelia M.
AU  - Lindgren AM
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Bakarania, Prachi
AU  - Bakarania P
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Grimes, Kelly
AU  - Grimes K
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Makhni, Melvin C.
AU  - Makhni MC
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Shillingford, Jamal
AU  - Shillingford J
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Vitale, Michael G.
AU  - Vitale MG
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Black, Jason
AU  - Black J
AD  - Scoliosis SOS, London, UK
FAU - Maude, Erika
AU  - Maude E
AD  - Scoliosis SOS, London, UK
FAU - Turland, Abbie
AU  - Turland A
AD  - Scoliosis SOS, London, UK
FAU - Glynn, David
AU  - Glynn D
AD  - Independant, York, UK
FAU - Caronni, Antonio
AU  - Caronni A
AD  - Department of Neurorehabilitation Sciences, Casa di Cura del Policlinico, Milan, 
      Italy
FAU - Sciumè, Luciana
AU  - Sciumè L
AD  - 0000 0004 1757 2822grid.4708.bUniversity of Milan, Milan, Italy
FAU - Donzelli, Sabrina
AU  - Donzelli S
AD  - grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy
FAU - Zaina, Fabio
AU  - Zaina F
AD  - grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy
FAU - Negrini, Stefano
AU  - Negrini S
AD  - grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy
FAU - Schreiber, Sanja
AU  - Schreiber S
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Parent, Eric C.
AU  - Parent EC
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Moez, Elham Khodayari
AU  - Moez EK
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Hedden, Douglas M.
AU  - Hedden DM
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Hill, Douglas L.
AU  - Hill DL
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Moreau, Marc
AU  - Moreau M
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Lou, Edmond
AU  - Lou E
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Watkins, Elise M.
AU  - Watkins EM
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Southon, Sarah C.
AU  - Southon SC
AD  - 0000 0001 0693 8815grid.413574.0Alberta Health Services, Edmonton, Canada
FAU - Parent, Eric C.
AU  - Parent EC
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Schreiber, Sanja
AU  - Schreiber S
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Moez, Elham Khodayari
AU  - Moez EK
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Sloan, Preston
AU  - Sloan P
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Hedden, Douglass
AU  - Hedden D
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Moreau, Marc
AU  - Moreau M
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Hill, Douglas
AU  - Hill D
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Southon, Sarah
AU  - Southon S
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Watkins, Elise
AU  - Watkins E
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Parent, Eric C.
AU  - Parent EC
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Ghaneei, Maliheh
AU  - Ghaneei M
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Adeeb, Samer
AU  - Adeeb S
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Schreiber, Sanja
AU  - Schreiber S
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Moreau, Marc
AU  - Moreau M
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Hedden, Douglas
AU  - Hedden D
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Hill, Douglas
AU  - Hill D
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Southon, Sarah
AU  - Southon S
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Karavidas, Nikos
AU  - Karavidas N
AD  - Scoliosis Spine Laser Centre, Athens, Greece
FAU - Dritsa, Despoina
AU  - Dritsa D
AD  - 0000 0001 2325 1783grid.26597.3fTeesside University, Middlesbrough, UK
FAU - Bettany-Saltikov, Josette
AU  - Bettany-Saltikov J
AD  - 0000 0001 2325 1783grid.26597.3fTeesside University, Middlesbrough, UK
FAU - Hanchard, Nigel
AU  - Hanchard N
AD  - 0000 0001 2325 1783grid.26597.3fTeesside University, Middlesbrough, UK
FAU - Kim, Donghyun
AU  - Kim D
AD  - Seoul Hyun Rehabilitation Hospital, Seoul, Korea
FAU - Kim, Junlae
AU  - Kim J
AD  - Seoul Hyun Rehabilitation Hospital, Seoul, Korea
FAU - Sbihli, Amy
AU  - Sbihli A
AD  - Spine Academy Physical Therapy, PLLC, Lexington, MA USA
FAU - Parent, Eric
AU  - Parent E
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Levey, Lauren
AU  - Levey L
AD  - 0000 0004 0371 6071grid.428158.2Children’s Healthcare of Atlanta, Atlanta, GA USA
FAU - Holowka, Mark
AU  - Holowka M
AD  - 0000 0004 0371 6071grid.428158.2Children’s Healthcare of Atlanta, Atlanta, GA USA
FAU - Davis, Leigh
AU  - Davis L
AD  - 0000 0004 0371 6071grid.428158.2Children’s Healthcare of Atlanta, Atlanta, GA USA
FAU - Dolan, Lori A
AU  - Dolan LA
AD  - 0000 0004 1936 8294grid.214572.7University of Iowa, Iowa City, IA USA
FAU - Weinstein, Stuart L.
AU  - Weinstein SL
AD  - 0000 0004 1936 8294grid.214572.7University of Iowa, Iowa City, IA USA
CN  - BrAIST Study Group
AD  - 0000 0004 1936 8294grid.214572.7University of Iowa, Iowa City, IA USA
FAU - Larson, Jill E.
AU  - Larson JE
AD  - 0000 0001 2299 3507grid.16753.36Northwestern University, Chicago, IL USA
FAU - Meyer, Maximilian A.
AU  - Meyer MA
AD  - 0000 0001 2299 3507grid.16753.36Northwestern University, Chicago, IL USA
FAU - Boody, Barrett
AU  - Boody B
AD  - 0000 0001 2299 3507grid.16753.36Northwestern University, Chicago, IL USA
FAU - Sarwark, John F.
AU  - Sarwark JF
AD  - 0000 0004 0388 2248grid.413808.6Ann & Robert H. Lurie Children’s Hospital of
      Chicago, Chicago, IL USA
FAU - Schreiber, Sanja
AU  - Schreiber S
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Parent, Eric C.
AU  - Parent EC
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Hedden, Douglas M.
AU  - Hedden DM
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Hill, Douglas L.
AU  - Hill DL
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Thometz, John
AU  - Thometz J
AD  - Children’s Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, WI USA
FAU - Liu, XueCheng
AU  - Liu X
AD  - Children’s Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, WI USA
FAU - Rizza, Robert
AU  - Rizza R
AD  - 0000 0001 0706 8057grid.260064.6Milwaukee School of Engineering, Milwaukee, WI
      USA
FAU - Tassone, Channing
AU  - Tassone C
AD  - 0000 0001 0568 442Xgrid.414086.fDeptartment of Orthopaedic Surgery, Children’s
      Hospital of Wisconsin, Milwaukee, WI USA
FAU - Liu, XueCheng
AU  - Liu X
AD  - 0000 0001 0568 442Xgrid.414086.fDeptartment of Orthopaedic Surgery, Children’s
      Hospital of Wisconsin, Milwaukee, WI USA
FAU - Gundlach, Benjamin
AU  - Gundlach B
AD  - 0000 0001 2111 8460grid.30760.32Medical College of Wisconsin, Milwaukee, WI USA
FAU - Tarima, Sergey
AU  - Tarima S
AD  - 0000 0004 1936 8438grid.266539.dDivision of Biostatistics, Institute for Health
      and Society Education, University of Kentucky, Lexignton, KY USA
FAU - Grant, Alison
AU  - Grant A
AD  - The Spine Corporation, Millennium House, Foxwood Road, Chesterfield, S41 9RF UK
FAU - Kalyan, Raman
AU  - Kalyan R
AD  - James Cook University Hospitals, Marton Road, Middlesbrough, TS4 3BW UK
FAU - Hekal, Waleed
AU  - Hekal W
AD  - James Cook University Hospitals, Marton Road, Middlesbrough, TS4 3BW UK
FAU - Honeyman, Cheryl
AU  - Honeyman C
AD  - James Cook University Hospitals, Marton Road, Middlesbrough, TS4 3BW UK
FAU - Cook, Tim
AU  - Cook T
AD  - The Spine Corporation, Millennium House, Foxwood Road, Chesterfield, S41 9RF UK
FAU - Murray, Scott
AU  - Murray S
AD  - James Cook University Hospitals, Marton Road, Middlesbrough, TS4 3BW UK
FAU - Pitruzzella, Morena
AU  - Pitruzzella M
AD  - grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy
FAU - Donzelli, Sabrina
AU  - Donzelli S
AD  - grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy
FAU - Zaina, Fabio
AU  - Zaina F
AD  - grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy
FAU - Negrini, Stefano
AU  - Negrini S
AD  - grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy
FAU - de Mauroy, Jean-Claude
AU  - de Mauroy JC
AD  - Clinique du Parc, Lyon, France
FAU - Barral, Frédéric
AU  - Barral F
AD  - Lecante Group, Lyon, France
FAU - Pourret, Sophie
AU  - Pourret S
AD  - Lecante Group, Lyon, France
FAU - de Mauroy, Jean-Claude
AU  - de Mauroy JC
AD  - Clinique du Parc, Lyon, France
FAU - Barral, Frédéric
AU  - Barral F
AD  - Lecante Group, Lyon, France
FAU - Pourret, Sophie
AU  - Pourret S
AD  - Lecante Group, Lyon, France
FAU - Grimes, Kelly
AU  - Grimes K
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Feinberg, Nicholas
AU  - Feinberg N
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Hope, Jennifer
AU  - Hope J
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Berdishevsky, Hagit
AU  - Berdishevsky H
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Bakarania, Prachi
AU  - Bakarania P
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Matsumoto, Hiroko
AU  - Matsumoto H
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Swindell, Hasani
AU  - Swindell H
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Yoshimachi, Julie
AU  - Yoshimachi J
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Roye, David
AU  - Roye D
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Vitale, Michael
AU  - Vitale M
AD  - 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley
      Children’s Hospital, New York, NY USA
FAU - Touchette, Julie
AU  - Touchette J
AD  - 0000 0001 2197 8284grid.265703.5Université du Québec à Trois-Rivières,
      Trois-Rivières, Québec Canada
FAU - St-Jean, Anissa
AU  - St-Jean A
AD  - 0000 0001 2197 8284grid.265703.5Université du Québec à Trois-Rivières,
      Trois-Rivières, Québec Canada
FAU - Brousseau, Danica
AU  - Brousseau D
AD  - 0000 0001 2197 8284grid.265703.5Université du Québec à Trois-Rivières,
      Trois-Rivières, Québec Canada
FAU - Marcotte, Louise
AU  - Marcotte L
AD  - Private Practice, Montréal, Canada
FAU - Théroux, Jean
AU  - Théroux J
AD  - 0000 0001 2292 3357grid.14848.31Faculty of Medecine, University of Montreal,
      Montreal, Québec Canada
FAU - Doucet, Chantal
AU  - Doucet C
AD  - 0000 0001 2197 8284grid.265703.5Université du Québec à Trois-Rivières,
      Trois-Rivières, Québec Canada
FAU - Lin, Yangmin
AU  - Lin Y
AD  - 0000 0004 1764 6123grid.16890.36Interdisciplinary Division of Biomedical
      Engineering, The Hong Kong Polytechnic University, Hong Kong, China
FAU - Wong, Man Sang
AU  - Wong MS
AD  - 0000 0004 1764 6123grid.16890.36Interdisciplinary Division of Biomedical
      Engineering, The Hong Kong Polytechnic University, Hong Kong, China
FAU - MacMahon, John
AU  - MacMahon J
AD  - Moyarta 2, LLC, The Plains, VA USA
FAU - MacMahon, Edward
AU  - MacMahon E
AD  - Moyarta 2, LLC, The Plains, VA USA
FAU - Boyette, Jeremy
AU  - Boyette J
AD  - Moyarta 2, LLC, The Plains, VA USA
FAU - Stikeleather, Luke
AU  - Stikeleather L
AD  - National Scoliosis Center, Fairfax, VA USA
FAU - Lebel, Andrea
AU  - Lebel A
AD  - Ottawa & District Physiotherapy Clinic and Scoliosis Physiotherapy and Posture
      Centre, Ottawa, Canada
FAU - Lebel, Victoria Ashley
AU  - Lebel VA
AD  - Saba University School of Medicine, Devens, MA USA
FAU - Pancholi-Parekh, Chintan A.
AU  - Pancholi-Parekh CA
AD  - Pediatric Rehabilitation New York (PRNY), Totowa, NJ USA
FAU - Stolze, Lise
AU  - Stolze L
AD  - Stolze Therapies, Denver, CO USA
FAU - Selthafner, Marissa
AU  - Selthafner M
AD  - 0000 0001 0568 442Xgrid.414086.fDepartment of Physical Therapy, Children’s
      Hospital of Wisconsin, Milwaukee, USA
FAU - Hong, Kaitlin
AU  - Hong K
AD  - 0000 0001 0568 442Xgrid.414086.fDepartment of Physical Therapy, Children’s
      Hospital of Wisconsin, Milwaukee, USA
FAU - Liu, XueCheng
AU  - Liu X
AD  - Department of Orthopaedic Surgery, Children’s Hospital of Wisconsin, Medical
      College of Wisconsin, Milwaukee, USA
FAU - Thometz, John
AU  - Thometz J
AD  - Department of Orthopaedic Surgery, Children’s Hospital of Wisconsin, Medical
      College of Wisconsin, Milwaukee, USA
FAU - Tassone, Channing
AU  - Tassone C
AD  - Department of Orthopaedic Surgery, Children’s Hospital of Wisconsin, Medical
      College of Wisconsin, Milwaukee, USA
FAU - Morrison, Pamela R.
AU  - Morrison PR
AD  - Morrison Physical Therapy, Lake Forest, Illinois USA
FAU - Hanke, Timothy A.
AU  - Hanke TA
AD  - grid.260024.2Midwestern University, Downers Grove, Illinois USA
FAU - Knott, Patrick
AU  - Knott P
AD  - 0000 0004 0388 7807grid.262641.5Rosalind Franklin University, North Chicago,
      Illinois USA
FAU - Krumdick, Nathaniel D.
AU  - Krumdick ND
AD  - grid.260024.2Midwestern University, Downers Grove, Illinois USA
FAU - Chockalingam, Nachiappan
AU  - Chockalingam N
AD  - 0000000106863366grid.19873.34Faculty of Health Sciences, Staffordshire
      University, Stoke-on-Trent, ST4 2DF UK
FAU - Shannon, Thomas
AU  - Shannon T
AD  - 0000000106863366grid.19873.34Faculty of Health Sciences, Staffordshire
      University, Stoke-on-Trent, ST4 2DF UK
FAU - Davenhill, Ryan
AU  - Davenhill R
AD  - 0000000106863366grid.19873.34Faculty of Health Sciences, Staffordshire
      University, Stoke-on-Trent, ST4 2DF UK
FAU - Needham, Robert
AU  - Needham R
AD  - 0000000106863366grid.19873.34Faculty of Health Sciences, Staffordshire
      University, Stoke-on-Trent, ST4 2DF UK
FAU - Jasani, Vinay
AU  - Jasani V
AD  - 0000000106863366grid.19873.34Faculty of Health Sciences, Staffordshire
      University, Stoke-on-Trent, ST4 2DF UK
FAU - Ahmed, El-Nasri
AU  - Ahmed EN
AD  - 0000000106863366grid.19873.34Faculty of Health Sciences, Staffordshire
      University, Stoke-on-Trent, ST4 2DF UK
FAU - St-Jean, Anissa
AU  - St-Jean A
AD  - 0000 0001 2197 8284grid.265703.5Université du Québec à Trois-Rivières,
      Trois-Rivières, Québec Canada
FAU - Touchette, Julie
AU  - Touchette J
AD  - 0000 0001 2197 8284grid.265703.5Université du Québec à Trois-Rivières,
      Trois-Rivières, Québec Canada
FAU - Drake, Shawn
AU  - Drake S
AD  - 0000 0001 2169 5989grid.252381.fArkansas State University, Jonesboro, AR USA
FAU - Brousseau, Danica
AU  - Brousseau D
AD  - 0000 0001 2197 8284grid.265703.5Université du Québec à Trois-Rivières,
      Trois-Rivières, Québec Canada
FAU - Marcotte, Louise
AU  - Marcotte L
AD  - Private Practice, Montréal, Canada
FAU - Théroux, Jean
AU  - Théroux J
AD  - 0000 0001 2292 3357grid.14848.31Faculty of Medecine, University of Montreal,
      Montreal, Québec Canada
FAU - Doucet, Chantal
AU  - Doucet C
AD  - 0000 0001 2197 8284grid.265703.5Université du Québec à Trois-Rivières,
      Trois-Rivières, Québec Canada
FAU - Aulisa, Angelo Gabriele
AU  - Aulisa AG
AD  - U.O.C. of Orthopedics and Traumatology, Children’s Hospital Bambino Gesù,
      Institute of Scientific Research, P.zza S. Onofrio 4, Rome, 00165 Italy
FAU - Guzzanti, Vincenzo
AU  - Guzzanti V
AD  - U.O.C. of Orthopedics and Traumatology, Children’s Hospital Bambino Gesù,
      Institute of Scientific Research, P.zza S. Onofrio 4, Rome, 00165 Italy
FAU - Gordano, Marco
AU  - Gordano M
AD  - U.O.C. of Orthopedics and Traumatology, Children’s Hospital Bambino Gesù,
      Institute of Scientific Research, P.zza S. Onofrio 4, Rome, 00165 Italy
FAU - Mastantuoni, Giuseppe
AU  - Mastantuoni G
AD  - U.O.C. of Orthopedics and Traumatology, Children’s Hospital Bambino Gesù,
      Institute of Scientific Research, P.zza S. Onofrio 4, Rome, 00165 Italy
FAU - Aulisa, Lorenzo
AU  - Aulisa L
AD  - 0000 0004 1760 4193grid.411075.6Department of Orthopedics, University Hospital
      “Agostino Gemelli”, Catholic University of the Sacred Heart School of Medicine,
      Rome, 00168 Italy
FAU - Chandrinos, Michail
AU  - Chandrinos M
AD  - grid.459305.eDepartment of Orthopaedics and Traumatology, “Tzaneio” General
      Hospital of Piraeus, Piraeus, Greece
FAU - Grivas, Theodoros B.
AU  - Grivas TB
AD  - grid.459305.eDepartment of Orthopaedics and Traumatology, “Tzaneio” General
      Hospital of Piraeus, Piraeus, Greece
FAU - Kechagias, Vasileios
AU  - Kechagias V
AD  - Orthopaedic Surgeon, Athens, Greece
FAU - Głowka, Paweł
AU  - Głowka P
AD  - 0000 0001 2205 0971grid.22254.33Spine Disorders and Pediatric Orthopedics
      Department, University of Medical Sciences, Poznan, Poland
FAU - Gaweł, Dominik
AU  - Gaweł D
AD  - Division of Virtual Engineering, University of Technology, Poznan, Poland
FAU - Kasprzak, Bartosz
AU  - Kasprzak B
AD  - 0000 0001 2205 0971grid.22254.33Department of Biophysics, University of Medical
      Sciences, Poznan, Poland
FAU - Nowak, Michał
AU  - Nowak M
AD  - Division of Virtual Engineering, University of Technology, Poznan, Poland
FAU - Morzyński, Marek
AU  - Morzyński M
AD  - Division of Virtual Engineering, University of Technology, Poznan, Poland
FAU - Kotwicki, Tomasz
AU  - Kotwicki T
AD  - 0000 0001 2205 0971grid.22254.33Spine Disorders and Pediatric Orthopedics
      Department, University of Medical Sciences, Poznan, Poland
FAU - Deceuninck, Julie
AU  - Deceuninck J
AD  - 0000 0001 2158 1682grid.6279.aLaboratoire de Physiologie de l’Exercice (EA4338), 
      Université Jean Monnet, Saint-Etienne, France
FAU - Bernard, Jean-Claude
AU  - Bernard JC
AD  - Centre des Massues-Croix Rouge Française, 92 rue Edmond Locard, 69005 Lyon,
      France
FAU - Lecante, Cyril
AU  - Lecante C
AD  - Ets Lecante, 125 rue Bataille, 69008 Lyon, France
FAU - Berthonnaud, Eric
AU  - Berthonnaud E
AD  - 0000 0001 2158 1682grid.6279.aLaboratoire de Physiologie de l’Exercice (EA4338), 
      Université Jean Monnet, Saint-Etienne, France
FAU - Fortin, Carole
AU  - Fortin C
AD  - 0000 0001 2292 3357grid.14848.31Université de Montréal, Montréal, Canada
FAU - Aubin-Fournier, Jean-François
AU  - Aubin-Fournier JF
AD  - 0000 0001 2173 6322grid.411418.9CHU Sainte-Justine, Montréal, Canada
FAU - Bettany-Saltikov, Josette
AU  - Bettany-Saltikov J
AD  - 0000 0001 2325 1783grid.26597.3fTeesside University, Middlesbrough, UK
FAU - Parent, Eric C.
AU  - Parent EC
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Feldman, Debbie Ehrmann
AU  - Feldman DE
AD  - 0000 0001 2292 3357grid.14848.31Université de Montréal, Montréal, Canada
FAU - Bernard, Jean-Claude
AU  - Bernard JC
AD  - Centre Médico-Chirurgical des Massues, Lyon, France
FAU - Liu, Zhen
AU  - Liu Z
AD  - Department of Spine Surgery, Drum Tower Hospital of Nanjing University Medical
      School, Nanjing, China
FAU - Zhang, Wen
AU  - Zhang W
AD  - Department of Spine Surgery, Drum Tower Hospital of Nanjing University Medical
      School, Nanjing, China
FAU - Hu, Zongshan
AU  - Hu Z
AD  - Department of Spine Surgery, Drum Tower Hospital of Nanjing University Medical
      School, Nanjing, China
FAU - Zhu, Weiguo
AU  - Zhu W
AD  - Department of Spine Surgery, Drum Tower Hospital of Nanjing University Medical
      School, Nanjing, China
FAU - Jin, Mengran
AU  - Jin M
AD  - Department of Spine Surgery, Drum Tower Hospital of Nanjing University Medical
      School, Nanjing, China
FAU - Han, Xiao
AU  - Han X
AD  - Department of Spine Surgery, Drum Tower Hospital of Nanjing University Medical
      School, Nanjing, China
FAU - Qiu, Yong
AU  - Qiu Y
AD  - Department of Spine Surgery, Drum Tower Hospital of Nanjing University Medical
      School, Nanjing, China
FAU - Cheng, Jack C. Y.
AU  - Cheng JCY
AD  - Joint Scoliosis Research Center of the Chinese University of Hong Kong and
      Nanjing University, Hong Kong, China
FAU - Zhu, Zezhang
AU  - Zhu Z
AD  - Department of Spine Surgery, Drum Tower Hospital of Nanjing University Medical
      School, Nanjing, China
FAU - Liu, Zhen
AU  - Liu Z
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Guo, Jing
AU  - Guo J
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Wu, Tao
AU  - Wu T
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Qian, Bangping
AU  - Qian B
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Zhu, Zezhang
AU  - Zhu Z
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Zhu, Feng
AU  - Zhu F
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Jiang, Jian
AU  - Jiang J
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Qiu, Yong
AU  - Qiu Y
AD  - 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital
      of Nanjing University Medical School, Nanjing, China
FAU - Han, Xiao
AU  - Han X
AD  - Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing,
      China
FAU - Liu, Zhen
AU  - Liu Z
AD  - Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing,
      China
FAU - Liu, Hao
AU  - Liu H
AD  - Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing,
      China
FAU - Qiu, Yong
AU  - Qiu Y
AD  - Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing,
      China
FAU - Guo, Jing
AU  - Guo J
AD  - Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing,
      China
FAU - Yan, Huang
AU  - Yan H
AD  - Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing,
      China
FAU - Sun, Xu
AU  - Sun X
AD  - Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing,
      China
FAU - Cheng, Jack C. Y.
AU  - Cheng JCY
AD  - The Joint Scoliosis Research Center of Nanjing University and the Chinese
      University of Hong Kong, Nanjing, China
FAU - Zhu, Zezhang
AU  - Zhu Z
AD  - Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing,
      China
FAU - Di Felice, Francesca
AU  - Di Felice F
AD  - grid.419440.cISICO (Italian Scientific Spine Institute), Milan, Italy
FAU - Zaina, Fabio
AU  - Zaina F
AD  - grid.419440.cISICO (Italian Scientific Spine Institute), Milan, Italy
FAU - Pitruzzella, Morena
AU  - Pitruzzella M
AD  - grid.419440.cISICO (Italian Scientific Spine Institute), Milan, Italy
FAU - Donzelli, Sabrina
AU  - Donzelli S
AD  - grid.419440.cISICO (Italian Scientific Spine Institute), Milan, Italy
FAU - Negrini, Stefano
AU  - Negrini S
AD  - 0000000417571846grid.7637.5Department of Clinical and Experimental Sciences,
      University of Brescia, Brescia, Italy
FAU - Needham, Robert A
AU  - Needham RA
AD  - 0000000106863366grid.19873.34Staffordshire University, Stoke-on-Trent, UK
FAU - Chatzistergos, Panagiotis
AU  - Chatzistergos P
AD  - 0000000106863366grid.19873.34Staffordshire University, Stoke-on-Trent, UK
FAU - Chockalingam, Nachiappan
AU  - Chockalingam N
AD  - 0000000106863366grid.19873.34Staffordshire University, Stoke-on-Trent, UK
FAU - Brink, Rob C.
AU  - Brink RC
AD  - 0000000090126352grid.7692.aDepartment of Orthopaedic Surgery, University Medical 
      Center Utrecht, Utrecht, The Netherlands
FAU - Schlösser, Tom P. C.
AU  - Schlösser TPC
AD  - 0000000090126352grid.7692.aDepartment of Orthopaedic Surgery, University Medical 
      Center Utrecht, Utrecht, The Netherlands
FAU - Colo, Dino
AU  - Colo D
AD  - 0000000090126352grid.7692.aDepartment of Orthopaedic Surgery, University Medical 
      Center Utrecht, Utrecht, The Netherlands
FAU - Vincken, Koen L.
AU  - Vincken KL
AD  - 0000000090126352grid.7692.aImage Sciences Institute, University Medical Center
      Utrecht, Utrecht, The Netherlands
FAU - van Stralen, Marijn
AU  - van Stralen M
AD  - 0000000090126352grid.7692.aImage Sciences Institute, University Medical Center
      Utrecht, Utrecht, The Netherlands
FAU - Hui, Steve C. N.
AU  - Hui SCN
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Imaging & Interventional Radiology,
      Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China
FAU - Chu, Winnie C. W.
AU  - Chu WCW
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Imaging & Interventional Radiology,
      Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China
FAU - Cheng, Jack C. Y.
AU  - Cheng JCY
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology,
      Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China
FAU - Castelein, René M.
AU  - Castelein RM
AD  - 0000000090126352grid.7692.aDepartment of Orthopaedic Surgery, University Medical 
      Center Utrecht, Utrecht, The Netherlands
FAU - Bylski-Austrow, Donita I.
AU  - Bylski-Austrow DI
AD  - 0000 0000 9025 8099grid.239573.9Cincinnati Children’s Hospital Medical Center,
      Cincinnati, OH USA
FAU - Glos, David L.
AU  - Glos DL
AD  - 0000 0000 9025 8099grid.239573.9Cincinnati Children’s Hospital Medical Center,
      Cincinnati, OH USA
FAU - Jain, Viral V.
AU  - Jain VV
AD  - 0000 0000 9025 8099grid.239573.9Cincinnati Children’s Hospital Medical Center,
      Cincinnati, OH USA
FAU - Reynolds, Joseph E.
AU  - Reynolds JE
AD  - SpineForm LLC, Cincinnati, OH USA
FAU - Sturm, Peter F.
AU  - Sturm PF
AD  - 0000 0000 9025 8099grid.239573.9Cincinnati Children’s Hospital Medical Center,
      Cincinnati, OH USA
FAU - Wall, Eric J.
AU  - Wall EJ
AD  - 0000 0000 9025 8099grid.239573.9Cincinnati Children’s Hospital Medical Center,
      Cincinnati, OH USA
FAU - Igoumenou, Vasilios G.
AU  - Igoumenou VG
AD  - 0000 0001 2155 0800grid.5216.0First Department of Orthopaedics, Athens University
      Medical School, ATTIKON University Hospital, Athens, Greece
FAU - Megaloikonomos, Panayiotis D.
AU  - Megaloikonomos PD
AD  - 0000 0001 2155 0800grid.5216.0First Department of Orthopaedics, Athens University
      Medical School, ATTIKON University Hospital, Athens, Greece
FAU - Tsiavos, Konstantinos
AU  - Tsiavos K
AD  - 0000 0001 2155 0800grid.5216.0First Department of Orthopaedics, Athens University
      Medical School, ATTIKON University Hospital, Athens, Greece
FAU - Panagopoulos, Georgios N.
AU  - Panagopoulos GN
AD  - 0000 0001 2155 0800grid.5216.0First Department of Orthopaedics, Athens University
      Medical School, ATTIKON University Hospital, Athens, Greece
FAU - Mavrogenis, Andreas F.
AU  - Mavrogenis AF
AD  - 0000 0001 2155 0800grid.5216.0First Department of Orthopaedics, Athens University
      Medical School, ATTIKON University Hospital, Athens, Greece
FAU - Grivas, Theodoros B.
AU  - Grivas TB
AD  - Department of Trauma and Orthopaedics “Tzaneion” General Hospital of Piraeus,
      Piraeus, Greece
FAU - Soultanis, Konstantinos
AU  - Soultanis K
AD  - 0000 0001 2155 0800grid.5216.0First Department of Orthopaedics, Athens University
      Medical School, ATTIKON University Hospital, Athens, Greece
FAU - Papagelopoulos, Panayiotis J.
AU  - Papagelopoulos PJ
AD  - 0000 0001 2155 0800grid.5216.0First Department of Orthopaedics, Athens University
      Medical School, ATTIKON University Hospital, Athens, Greece
FAU - Fard, Negar Behzadi
AU  - Fard NB
AD  - grid.17089.37Department of Mechanical Engineering, University of Alberta,
      Edmonton, Canada
FAU - Duke, Kajsa
AU  - Duke K
AD  - grid.17089.37Department of Mechanical Engineering, University of Alberta,
      Edmonton, Canada
FAU - Chan, Andrew
AU  - Chan A
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Parent, Eric C.
AU  - Parent EC
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Lou, Edmond
AU  - Lou E
AD  - grid.17089.37University of Alberta, Edmonton, Canada
FAU - Lee, Jung Sub
AU  - Lee JS
AD  - 0000 0001 0719 8572grid.262229.fPusan National University School of Medicine,
      Busan, South Korea
FAU - Shin, Jong Ki
AU  - Shin JK
AD  - 0000 0001 0719 8572grid.262229.fPusan National University School of Medicine,
      Busan, South Korea
FAU - Goh, Tae Sik
AU  - Goh TS
AD  - 0000 0001 0719 8572grid.262229.fPusan National University School of Medicine,
      Busan, South Korea
FAU - Son, Seung Min
AU  - Son SM
AD  - 0000 0001 0719 8572grid.262229.fPusan National University School of Medicine,
      Busan, South Korea
FAU - Kobayashi, Sho
AU  - Kobayashi S
AD  - 0000 0004 1762 0759grid.411951.9Hamamatsu University School of Medicine,
      Hamamatsu, Japan
FAU - Togawa, Daisuke
AU  - Togawa D
AD  - 0000 0004 1762 0759grid.411951.9Hamamatsu University School of Medicine,
      Hamamatsu, Japan
FAU - Hasegawa, Tomohiko
AU  - Hasegawa T
AD  - 0000 0004 1762 0759grid.411951.9Hamamatsu University School of Medicine,
      Hamamatsu, Japan
FAU - Yamato, Yu
AU  - Yamato Y
AD  - 0000 0004 1762 0759grid.411951.9Hamamatsu University School of Medicine,
      Hamamatsu, Japan
FAU - Oe, Shin
AU  - Oe S
AD  - 0000 0004 1762 0759grid.411951.9Hamamatsu University School of Medicine,
      Hamamatsu, Japan
FAU - Banno, Tomohiro
AU  - Banno T
AD  - 0000 0004 1762 0759grid.411951.9Hamamatsu University School of Medicine,
      Hamamatsu, Japan
FAU - Mihara, Yuuki
AU  - Mihara Y
AD  - 0000 0004 1762 0759grid.411951.9Hamamatsu University School of Medicine,
      Hamamatsu, Japan
FAU - Matsuyama, Yukihiro
AU  - Matsuyama Y
AD  - 0000 0004 1762 0759grid.411951.9Hamamatsu University School of Medicine,
      Hamamatsu, Japan
LA  - eng
PT  - Journal Article
DEP - 20170530
TA  - Scoliosis Spinal Disord
JT  - Scoliosis and Spinal Disorders
AID - 124 [pii]
AID - 10.1186/s13013-017-0124-0 [doi]
SO  - Scoliosis Spinal Disord. 2017 May 30;12(Suppl 1):. doi:10.1186/s13013-017-0124-0.

PMC - PMC5225387
IS  - 2110-5820 (Electronic)
VI  - 7
IP  - Suppl 1
DP  - 2017
TI  - Proceedings of Réanimation 2017, the French Intensive Care Society International 
      Congress.
LID - 8
FAU - Bougouin, Wulfran
AU  - Bougouin W
AD  - grid.414093.bCardiologie, Hôpital Européen Georges-Pompidou, Rue Leblanc, Paris, 
      France
FAU - Marijon, Eloi
AU  - Marijon E
AD  - grid.414093.bCardiologie, Hôpital Européen Georges-Pompidou, Rue Leblanc, Paris, 
      France
FAU - Planquette, Benjamin
AU  - Planquette B
AD  - grid.414093.bUsip, Hopital Europeen Georges-Pompidou, Paris, France
FAU - Karam, Nicole
AU  - Karam N
AD  - grid.414093.bCardiologie, Hôpital Européen Georges-Pompidou, Rue Leblanc, Paris, 
      France
FAU - Dumas, Florence
AU  - Dumas F
AD  - 0000 0001 0274 3893grid.411784.fService d’accueil des urgences, Hôpital Cochin,
      Paris, France
FAU - Celermajer, David
AU  - Celermajer D
AD  - 0000 0004 1936 834Xgrid.1013.3Cardiology, Sydney Medical School, Sydney,
      Australia
FAU - Jost, Daniel
AU  - Jost D
AD  - Bspp, B.s.p.p., Paris, France
FAU - Lamhaut, Lionel
AU  - Lamhaut L
AD  - 0000 0004 0593 9113grid.412134.1Réanimation adulte, Hôpital Necker - Enfants
      Malades, Paris, France
FAU - Beganton, Frankie
AU  - Beganton F
AD  - 0000 0004 0495 1460grid.462416.3Paris descartes, Inserm U970, Paris, France
FAU - Cariou, Alain
AU  - Cariou A
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Meyer, Guy
AU  - Meyer G
AD  - grid.414093.bService de Pneumologie et Soins Intensifs, Hopital Europeen
      Georges-Pompidou, Paris, France
FAU - Jouven, Xavier
AU  - Jouven X
AD  - grid.414093.bCardiologie, Hôpital Européen Georges-Pompidou, Rue Leblanc, Paris, 
      France
CN  - Sudden Death Expertise Center
FAU - Bureau, Côme
AU  - Bureau C
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Charpentier, Julien
AU  - Charpentier J
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Salem, Omar Ben Hadj
AU  - Salem OBH
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Guillemet, Lucie
AU  - Guillemet L
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Arnaout, Michel
AU  - Arnaout M
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Ferre, Alexis
AU  - Ferre A
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Geri, Guillaume
AU  - Geri G
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Mongardon, Nicolas
AU  - Mongardon N
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Pène, Frédéric
AU  - Pène F
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Chiche, Jean-Daniel
AU  - Chiche JD
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Mira, Jean-Paul
AU  - Mira JP
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Labro, Guylaine
AU  - Labro G
AD  - 0000 0004 0638 9213grid.411158.8Réanimation médicale, CHU de Besançon, Besançon, 
      France
FAU - Belon, François
AU  - Belon F
AD  - 0000 0004 0638 9213grid.411158.8Réanimation médicale, CHU de Besançon, Besançon, 
      France
FAU - Luu, Vinh-Phuc
AU  - Luu VP
AD  - 0000 0004 0638 9213grid.411158.8Centre de méthodologie clinique, CHU de Besançon,
      Besançon, France
FAU - Chenet, Julien
AU  - Chenet J
AD  - 0000 0004 0638 9213grid.411158.8Département d’anesthésie et de réanimation, CHU
      de Besançon, Besançon, France
FAU - Besch, Guillaume
AU  - Besch G
AD  - 0000 0004 0638 9213grid.411158.8Réanimation chirurgicale, CHU de Besançon,
      Besançon, France
FAU - Puyraveau, Marc
AU  - Puyraveau M
AD  - 0000 0004 0638 9213grid.411158.8Centre de méthodologie clinique, CHU de Besançon,
      Besançon, France
FAU - Piton, Gaël
AU  - Piton G
AD  - 0000 0004 0638 9213grid.411158.8Réanimation médicale, CHU de Besançon, Besançon, 
      France
FAU - Capellier, Gilles
AU  - Capellier G
AD  - 0000 0004 0638 9213grid.411158.8Réanimation médicale, CHU de Besançon, Besançon, 
      France
FAU - Martin, Maëlle
AU  - Martin M
AD  - Intensive Care, District Hospital Center, La Roche-Sur-Yon, France
FAU - Lascarrou, Jean-Baptiste
AU  - Lascarrou JB
AD  - Intensive Care, District Hospital Center, La Roche-Sur-Yon, France
FAU - Le Thuaut, Aurélie
AU  - Le Thuaut A
AD  - Clinical Research Unit, District Hospital Center, La Roche-Sur-Yon, France
FAU - Lacherade, Jean-Claude
AU  - Lacherade JC
AD  - Intensive Care, District Hospital Center, La Roche-Sur-Yon, France
FAU - Martin-Lefèvre, Laurent
AU  - Martin-Lefèvre L
AD  - Intensive Care, District Hospital Center, La Roche-Sur-Yon, France
FAU - Fiancette, Maud
AU  - Fiancette M
AD  - Intensive Care, District Hospital Center, La Roche-Sur-Yon, France
FAU - Vinatier, Isabelle
AU  - Vinatier I
AD  - Intensive Care, District Hospital Center, La Roche-Sur-Yon, France
FAU - Lebert, Christine
AU  - Lebert C
AD  - Intensive Care, District Hospital Center, La Roche-Sur-Yon, France
FAU - Bachoumas, Konstantinos
AU  - Bachoumas K
AD  - Intensive Care, District Hospital Center, La Roche-Sur-Yon, France
FAU - Yehia, Aihem
AU  - Yehia A
AD  - Intensive Care, District Hospital Center, La Roche-Sur-Yon, France
FAU - Henry-Laguarrigue, Matthieu
AU  - Henry-Laguarrigue M
AD  - Intensive Care, District Hospital Center, La Roche-Sur-Yon, France
FAU - Colin, Gwenhaël
AU  - Colin G
AD  - Intensive Care, District Hospital Center, La Roche-Sur-Yon, France
FAU - Reignier, Jean
AU  - Reignier J
AD  - grid.31151.37Medical Intensive Care Unit, University Hospital Center, Nantes,
      France
FAU - Privat, Elodie
AU  - Privat E
AD  - 0000 0004 0471 8845grid.410463.4Réanimation pédiatrique, C.H. Régional
      Universitaire de Lille (CHRU de Lille), Lille, France
FAU - Escutnaire, Joséphine
AU  - Escutnaire J
AD  - French National Out-of-Hospital Cardiac Arrest Registry (réac), Lille, France
FAU - Dumont, Cyrielle
AU  - Dumont C
AD  - Public Health Department, Université Lille 2 – Faculté de Médecine Henri
      Warembourg, Loos, France
FAU - Baert, Valentine
AU  - Baert V
AD  - French National Out-of-Hospital Cardiac Arrest Registry (réac), Lille, France
FAU - Vilhelm, Christian
AU  - Vilhelm C
AD  - 0000 0001 2097 7060grid.16780.38Public Health Department, Université Lille 2 –
      Faculté de Médecine Henri Warembourg, Lille, France
FAU - Hubert, Hervé
AU  - Hubert H
AD  - 0000 0001 2097 7060grid.16780.38Public Health Department, Université Lille 2 –
      Faculté de Médecine Henri Warembourg, Lille, France
FAU - Robert-Edan, Vincent
AU  - Robert-Edan V
AD  - 0000 0004 0472 0371grid.277151.7Service de réanimation chirurgicale, Hôpital
      Guillaume et René Laënnec, CHU de Nantes, Nantes, France
FAU - Lakhal, Karim
AU  - Lakhal K
AD  - 0000 0004 0472 0371grid.277151.7Service de réanimation chirurgicale, Hôpital
      Guillaume et René Laënnec, CHU de Nantes, Nantes, France
FAU - Quartin, Andrew
AU  - Quartin A
AD  - 0000 0004 1936 8606grid.26790.3aDivision of pulmonary, Critical Care, Allergy and
      Sleep Medicine, Department of Medicine, University of Miami School of Medicine,
      Miami, USA
FAU - Hobbs, Brian
AU  - Hobbs B
AD  - 0000 0001 2291 4776grid.240145.6Department of Biostatistics, University of Texas 
      M.D. Anderson Cancer Center, Houston, TX USA
FAU - Cely, Cynthia
AU  - Cely C
AD  - 0000 0000 9206 2401grid.267308.8Division of Pediatric Nephrology and
      Hypertension, University of Texas Health Science Center-Houston, Houston, TX USA
FAU - Bell, Cynthia
AU  - Bell C
AD  - 0000 0000 9206 2401grid.267308.8Division of Pediatric Nephrology and
      Hypertension, University of Texas Health Science Center-Houston, Houston, TX USA
FAU - Pham, Tai
AU  - Pham T
AD  - 0000 0001 2259 4338grid.413483.9Réanimation médico-chirurgicale, Hôpital Tenon,
      Paris, France
FAU - Schein, Roland
AU  - Schein R
AD  - 0000 0004 1936 8606grid.26790.3aDivision of pulmonary, Critical Care, Allergy and
      Sleep Medicine, Department of Medicine, University of Miami School of Medicine,
      Miami, USA
FAU - Geng, Yimin
AU  - Geng Y
AD  - 0000 0001 2291 4776grid.240145.6Research Medical Library, University of Texas
      M.D. Anderson Cancer Center, Houston, TX USA
FAU - Ng, Chaan
AU  - Ng C
AD  - 0000 0001 2291 4776grid.240145.6Department of Radiology, University of Texas M.D.
      Anderson Cancer Center, Houston, TX USA
FAU - Ehrmann, Stephan
AU  - Ehrmann S
AD  - Réanimation polyvalenteCHRU Hôpitaux de Tours, Tours, France
FAU - Gandonnière, Charlotte Salmon
AU  - Gandonnière CS
AD  - Réanimation polyvalenteCHRU Hôpitaux de Tours, Tours, France
FAU - Boisramé-Helms, Julie
AU  - Boisramé-Helms J
AD  - Réanimation médicale, Nouvel Hôpital Civil, CHU Strasbourg, Strasbourg, France
FAU - Le Tilly, Olivier
AU  - Le Tilly O
AD  - Biochimie et biologie moléculaire, CHRU Hôpitaux de Tours, Tours, France
FAU - De Bretagne, Isabelle Benz
AU  - De Bretagne IB
AD  - Biochimie et biologie moléculaire, CHRU Hôpitaux de Tours, Tours, France
FAU - Mercier, Emmanuelle
AU  - Mercier E
AD  - Réanimation polyvalenteCHRU Hôpitaux de Tours, Tours, France
FAU - Mankikian, Julie
AU  - Mankikian J
AD  - Réanimation polyvalenteCHRU Hôpitaux de Tours, Tours, France
FAU - Bretagnol, Anne
AU  - Bretagnol A
AD  - 0000 0004 1792 201Xgrid.413932.eRéanimation médicale polyvalente, Hôpital de La
      Source, CHR Orléans, Orléans, France
FAU - Meziani, Ferhat
AU  - Meziani F
AD  - Réanimation médicale, Nouvel Hôpital Civil, CHU Strasbourg, Strasbourg, France
FAU - Halimi, Jean Michel
AU  - Halimi JM
AD  - Néphrologie, transplantation rénale et hémodialyse, CHRU Hôpitaux de Tours,
      Tours, France
FAU - Le Guellec, Chantal Barin
AU  - Le Guellec CB
AD  - Biochimie et biologie moléculaire, CHRU Hôpitaux de Tours, Tours, France
FAU - Gaudry, Stéphane
AU  - Gaudry S
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes, France
FAU - Hajage, David
AU  - Hajage D
AD  - 0000 0001 0273 556Xgrid.414205.6Département d’épidémiologie et de recherche
      clinique, Hôpital Louis-Mourier - APHP, Colombes, France
FAU - Tubach, Florence
AU  - Tubach F
AD  - Département d’epidémiologie et recherche clinique, Unité de Recherche Clinique
      Paris Nord, Paris, France
FAU - Pons, Bertrand
AU  - Pons B
AD  - Réanimation - Grands Brulés, CHU Pointe à Pitre - Abymes, Pointe a Pitre, France
FAU - Boulet, Eric
AU  - Boulet E
AD  - Val d’oise, Hôpital René Dubos, Pontoise, France
FAU - Boyer, Alexandre
AU  - Boyer A
AD  - 0000 0004 0593 7118grid.42399.35Réanimation médicale, Centre Hospitalier
      Universitaire de Bordeaux, Bordeaux, France
FAU - Chevrel, Guillaume
AU  - Chevrel G
AD  - Essonnes, C.H. Sud Francilien, Corbeil-Essonnes, France
FAU - Lerolle, Nicolas
AU  - Lerolle N
AD  - 0000 0004 0472 0283grid.411147.6Réanimation médicale, Centre Hospitalier
      Universitaire d’Angers, Angers, France
FAU - Carpentier, Dorothée
AU  - Carpentier D
AD  - Réanimation médicale, Centre Hospitalier Universitaire Rouen, Rouen, France
FAU - de Prost, Nicolas
AU  - de Prost N
AD  - 0000 0001 2292 1474grid.412116.1Réanimation Médicale, Hôpital Henri Mondor,
      Créteil, France
FAU - Lautrette, Alexandre
AU  - Lautrette A
AD  - 0000 0004 0639 4151grid.411163.0Réanimation médicale, CHU Gabriel-Montpied,
      Clermont-Ferrand, France
FAU - Mayaux, Julien
AU  - Mayaux J
AD  - 0000 0001 2150 9058grid.411439.aService de pneumologie et réanimation médicale,
      Pitié-Salpêtrière Hospital, Paris, France
FAU - Nseir, Saad
AU  - Nseir S
AD  - 0000 0004 0471 8845grid.410463.4Centre de Réanimation, Centre Hospitalier
      Régional Universitaire de Lille, Lille, France
FAU - Ricard, Jean-Damien
AU  - Ricard JD
AD  - Service de Réanimation Médico-Chirurgicale, CHU Louis Mourier, Colombes, France
FAU - Dreyfuss, Didier
AU  - Dreyfuss D
AD  - 0000 0001 2217 0017grid.7452.4Inserm, iame, umr 1137, Université Paris Diderot,
      Sorbonne Paris Cité, Paris, France
CN  - AKIKI Study Group
FAU - Robert, René
AU  - Robert R
AD  - Service de Réanimation médicaleCHU de Poitiers, Poitiers, France
FAU - Garzotto, Franscesco
AU  - Garzotto F
AD  - 0000 0004 1758 2035grid.416303.3International Renal Research Institute of
      Vicenza, San Bortolo Hospital, Vicenza, Italy
FAU - Kipnis, Eric
AU  - Kipnis E
AD  - 0000 0004 0471 8845grid.410463.4Réanimation chirurgicale, Centre Hospitalier
      Régional Universitaire de Lille, Lille, France
FAU - Tetta, Ciro
AU  - Tetta C
AD  - grid.415062.4Research Extracorporeal Therapies, Fresenius Medical Care, Bad
      Homburg Vor Der Höhe, Germany
FAU - Ronco, Claudio
AU  - Ronco C
AD  - 0000 0004 1758 2035grid.416303.3International Renal Research Institute of
      Vicenza, San Bortolo Hospital, Vicenza, Italy
FAU - Schnell, David
AU  - Schnell D
AD  - Service de reanimation, Service de Réanimation polyvalente, Angoulême, France
CN  - DO-RE-MI-FA Group
FAU - Aurelie, Bourmaud
AU  - Aurelie B
AD  - Département de santé publique, Institut de Cancérologie de la Loire Lucien
      Neuwirth, Saint-Priest-En-Jarez, France
FAU - Reynaud, Marie
AU  - Reynaud M
AD  - Réanimation polyvalente b, Hospital Center University De Saint-Étienne,
      Saint-Priest-En-Jarez, France
FAU - Clec’h, Christophe
AU  - Clec’h C
AD  - 0000 0000 8715 2621grid.413780.9Réanimation medico-chirurgicale, Hôpital
      Avicenne, Bobigny, France
FAU - Benyamina, Mourad
AU  - Benyamina M
AD  - 0000 0001 2300 6614grid.413328.fAnesthésie réanimation et traitement chirurgical 
      des grands brûlés, APHP - Hopital Saint-Louis, Paris, France
FAU - Vincent, François
AU  - Vincent F
AD  - 0000 0000 8620 9964grid.420138.cRéanimation polyvalente, Groupe Hospitalier
      Intercommunal Le Raincy-Montfermeil, Montfermeil, France
FAU - Mariat, Christophe
AU  - Mariat C
AD  - 0000 0004 1765 1491grid.412954.fNéphrologie, Centre Hospitalier Universitaire de 
      Saint-Étienne, Saint-Étienne, France
FAU - Bornstain, Caroline
AU  - Bornstain C
AD  - 0000 0000 8620 9964grid.420138.cRéanimation polyvalente, Groupe Hospitalier
      Intercommunal Le Raincy-Montfermeil, Montfermeil, France
FAU - Rouleau, Stephane
AU  - Rouleau S
AD  - Service de réanimation, Hospital Center D’angoulême, Angoulême, France
FAU - Leroy, Christophe
AU  - Leroy C
AD  - 0000 0004 0639 4151grid.411163.0Réanimation médicale, CHU Gabriel-Montpied,
      Clermont-Ferrand, France
FAU - Cohen, Yves
AU  - Cohen Y
AD  - 0000 0000 8715 2621grid.413780.9Réanimation medico-chirurgicale, Hôpital
      Avicenne, Bobigny, France
FAU - Morel, Jerome
AU  - Morel J
AD  - Réanimation polyvalente b, Hospital Center University De Saint-Étienne,
      Saint-Priest-En-Jarez, France
FAU - Legrand, Matthieu
AU  - Legrand M
AD  - 0000 0001 2300 6614grid.413328.fAnesthésie réanimation et traitement chirurgical 
      des grands brûlés, APHP - Hopital Saint-Louis, Paris, France
FAU - Terreaux, Jeremy
AU  - Terreaux J
AD  - 0000 0004 1765 1491grid.412954.fRéanimation médicale, CHU Saint-Etienne - Hôpital
      Nord, Saint-Étienne, France
FAU - Darmon, Michaël
AU  - Darmon M
AD  - 0000 0004 1765 1491grid.412954.fRéanimation médicale, CHU Saint-Etienne - Hôpital
      Nord, Saint-Étienne, France
FAU - Cantier, Marie
AU  - Cantier M
AD  - 0000 0000 8588 831Xgrid.411119.dService de réanimation médicale et infectieuse,
      Hôpital Bichat-Claude Bernard-APHP, Paris, France
FAU - Morisot, Adeline
AU  - Morisot A
AD  - Centre mémoire, clinique rainier iii, Hospital Center Princesse Grace, Monaco,
      Monaco
FAU - Guérot, Emmanuel
AU  - Guérot E
AD  - grid.414093.bRéanimation médicale, Hopital Europeen Georges-Pompidou, Paris,
      France
FAU - Canet, Emmanuel
AU  - Canet E
AD  - 0000 0001 2300 6614grid.413328.fService de réanimation médicale, Hôpital
      Saint-Louis (AP-HP), Paris, France
FAU - De Montmollin, Etienne
AU  - De Montmollin E
AD  - 0000 0004 0443 544Xgrid.413961.8Réanimation, C.H. Général Saint Denis hôpital
      Delafontaine, Saint-Denis, France
FAU - Voiriot, Guillaume
AU  - Voiriot G
AD  - 0000 0001 2259 4338grid.413483.9Service de réanimation médicale, Hôpital Tenon
      (AP-HP), Paris, France
FAU - Neuville, Mathilde
AU  - Neuville M
AD  - 0000 0000 8588 831Xgrid.411119.dService de réanimation médicale et infectieuse,
      Hôpital Bichat-Claude Bernard-APHP, Paris, France
FAU - Timsit, Jean-François
AU  - Timsit JF
AD  - 0000 0000 8588 831Xgrid.411119.dService de réanimation médicale et infectieuse,
      Hôpital Bichat-Claude Bernard (AP-HP), Paris, France
FAU - Sonneville, Romain
AU  - Sonneville R
AD  - 0000 0000 8588 831Xgrid.411119.dService de réanimation médicale et infectieuse,
      Hôpital Bichat-Claude Bernard-APHP, Paris, France
CN  - ENCEPHALITICA Study Group
FAU - Fayssoil, Abdallah
AU  - Fayssoil A
AD  - Neurologie et reanimation polyvalente, Institute De Myologie et CHU Raymond
      Poincaré, Garches, France
FAU - Stojkovic, Tania
AU  - Stojkovic T
AD  - Neurologie, Institute De Myologie, Paris, France
FAU - Behin, Anthony
AU  - Behin A
AD  - Neurologie, Institute De Myologie, Paris, France
FAU - Ogna, Adam
AU  - Ogna A
AD  - Réanimation polyvalente et pole ventilation à domicile, CHU Raymond Poincare,
      Garches, France
FAU - Lofaso, Frédéric
AU  - Lofaso F
AD  - grid.414291.bService d’explorations fonctionnelles respiratoires, Hôpital
      Raymond-Poincaré (AP-HP), Garches, France
FAU - Laforet, Pascal
AU  - Laforet P
AD  - Neurologie, Institute De Myologie, Paris, France
FAU - Wahbi, Karim
AU  - Wahbi K
AD  - Neurologie, Institute De Myologie, Paris, France
FAU - Prigent, Helene
AU  - Prigent H
AD  - grid.414291.bService d’explorations fonctionnelles respiratoires, Hôpital
      Raymond-Poincaré (AP-HP), Garches, France
FAU - Duboc, Denis
AU  - Duboc D
AD  - 0000 0001 0274 3893grid.411784.fCardiologie, Hôpital Cochin, Paris, France
FAU - Orlikowski, David
AU  - Orlikowski D
AD  - Réanimation polyvalente et pole ventilation à domicile, CHU Raymond Poincare,
      Garches, France
FAU - Eymard, Bruno
AU  - Eymard B
AD  - Neurologie, Institute De Myologie, Paris, France
FAU - Annane, Djillali
AU  - Annane D
AD  - grid.414291.bRéanimation médico-chirurgicale, Hôpital Raymond-Poincaré, Garches, 
      France
FAU - Le Guennec, Loic
AU  - Le Guennec L
AD  - Service de réanimation médicaleGroupe Hospitalier Pitié Salpêtrière, Paris,
      France
FAU - Cholet, Clémentine
AU  - Cholet C
AD  - Service de réanimation médicaleGroupe Hospitalier Pitié Salpêtrière, Paris,
      France
FAU - Bréchot, Nicolas
AU  - Bréchot N
AD  - Service de réanimation médicaleGroupe Hospitalier Pitié Salpêtrière, Paris,
      France
FAU - Hekimian, Guillaume
AU  - Hekimian G
AD  - Service de réanimation médicaleGroupe Hospitalier Pitié Salpêtrière, Paris,
      France
FAU - Besset, Sébastien
AU  - Besset S
AD  - Service de réanimation médicaleGroupe Hospitalier Pitié Salpêtrière, Paris,
      France
FAU - Lebreton, Guillaume
AU  - Lebreton G
AD  - Service de réanimation médicaleGroupe Hospitalier Pitié Salpêtrière, Paris,
      France
FAU - Nieszkowska, Ania
AU  - Nieszkowska A
AD  - Service de réanimation médicaleGroupe Hospitalier Pitié Salpêtrière, Paris,
      France
FAU - Trouillet, Jean Louis
AU  - Trouillet JL
AD  - Service de réanimation médicaleGroupe Hospitalier Pitié Salpêtrière, Paris,
      France
FAU - Leprince, Pascal
AU  - Leprince P
AD  - Groupe Hospitalier Pitié Salpêtrière, Paris, France
FAU - Combes, Alain
AU  - Combes A
AD  - Service de réanimation médicaleGroupe Hospitalier Pitié Salpêtrière, Paris,
      France
FAU - Luyt, Charles-Edouard
AU  - Luyt CE
AD  - Service de réanimation médicaleGroupe Hospitalier Pitié Salpêtrière, Paris,
      France
FAU - Griton, Marion
AU  - Griton M
AD  - Neuro ICUCHU – Hôpitaux de Bordeaux, Bordeaux, France
FAU - Sesay, Musa
AU  - Sesay M
AD  - Neuro ICUCHU – Hôpitaux de Bordeaux, Bordeaux, France
FAU - De Panthou, Nadia Sibaï
AU  - De Panthou NS
AD  - Neuro ICUCHU – Hôpitaux de Bordeaux, Bordeaux, France
FAU - Bienvenu, Thomas
AU  - Bienvenu T
AD  - Neuro ICUCHU – Hôpitaux de Bordeaux, Bordeaux, France
FAU - Biais, Matthieu
AU  - Biais M
AD  - Neuro ICUCHU – Hôpitaux de Bordeaux, Bordeaux, France
FAU - Nouette-Gaulain, Karine
AU  - Nouette-Gaulain K
AD  - Neuro ICUCHU – Hôpitaux de Bordeaux, Bordeaux, France
FAU - Fossat, Guillaume
AU  - Fossat G
AD  - 0000 0004 1792 201Xgrid.413932.eRéanimation médicale polyvalente, Hôpital de La
      Source, CHR Orléans, Orléans, France
FAU - Baudin, Florian
AU  - Baudin F
AD  - 0000 0004 1792 201Xgrid.413932.eRéanimation médicale polyvalente, Hôpital de La
      Source, CHR Orléans, Orléans, France
FAU - Coulanges, Cécile
AU  - Coulanges C
AD  - Service de pneumologie, Hôpital de La Source, CHR Orléans, Orléans, France
FAU - Bobet, Sabrine
AU  - Bobet S
AD  - 0000 0004 1792 201Xgrid.413932.eRéanimation médicale polyvalente, Hôpital de La
      Source, CHR Orléans, Orléans, France
FAU - Dupont, Arnaud
AU  - Dupont A
AD  - Service de réanimation chirurgicale, Hôpital de La Source, CHR Orléans, Orléans, 
      France
FAU - Courtes, Léa
AU  - Courtes L
AD  - 0000 0004 1792 201Xgrid.413932.eRéanimation médicale polyvalente, Hôpital de La
      Source, CHR Orléans, Orléans, France
FAU - Benzekri, Dalila
AU  - Benzekri D
AD  - 0000 0004 1792 201Xgrid.413932.eRéanimation médicale polyvalente, Hôpital de La
      Source, CHR Orléans, Orléans, France
FAU - Kamel, Toufik
AU  - Kamel T
AD  - 0000 0004 1792 201Xgrid.413932.eRéanimation médicale polyvalente, Hôpital de La
      Source, CHR Orléans, Orléans, France
FAU - Muller, Grégoire
AU  - Muller G
AD  - 0000 0004 1792 201Xgrid.413932.eRéanimation médicale polyvalente, Hôpital de La
      Source, CHR Orléans, Orléans, France
FAU - Bercault, Nicolas
AU  - Bercault N
AD  - 0000 0004 1792 201Xgrid.413932.eRéanimation médicale polyvalente, Hôpital de La
      Source, CHR Orléans, Orléans, France
FAU - Barbier, François
AU  - Barbier F
AD  - 0000 0004 1792 201Xgrid.413932.eRéanimation médicale polyvalente, Hôpital de La
      Source, CHR Orléans, Orléans, France
FAU - Runge, Isabelle
AU  - Runge I
AD  - 0000 0004 1792 201Xgrid.413932.eRéanimation médicale polyvalente, Hôpital de La
      Source, CHR Orléans, Orléans, France
FAU - Skarzynski, Marie
AU  - Skarzynski M
AD  - 0000 0004 1792 201Xgrid.413932.eRéanimation médicale polyvalente, Hôpital de La
      Source, CHR Orléans, Orléans, France
FAU - Mathonnet, Armelle
AU  - Mathonnet A
AD  - 0000 0004 1792 201Xgrid.413932.eRéanimation médicale polyvalente, Hôpital de La
      Source, CHR Orléans, Orléans, France
FAU - Boulain, Thierry
AU  - Boulain T
AD  - 0000 0004 1792 201Xgrid.413932.eRéanimation médicale polyvalente, Hôpital de La
      Source, CHR Orléans, Orléans, France
FAU - Jouan, Youenn
AU  - Jouan Y
AD  - Réanimation polyvalenteCHRU Hôpitaux de Tours, Tours, France
FAU - Teixera, Noémie
AU  - Teixera N
AD  - Service des urgences, CHRU Hôpitaux de Tours, Tours, France
FAU - Hassen-Khodja, Claire
AU  - Hassen-Khodja C
AD  - Service d’information médicale, épidémiologie et économie de la santé, CHRU
      Hôpitaux de Tours, Tours, France
FAU - Guillon, Antoine
AU  - Guillon A
AD  - Réanimation polyvalenteCHRU Hôpitaux de Tours, Tours, France
FAU - Gaborit, Christophe
AU  - Gaborit C
AD  - Service d’information médicale, épidémiologie et économie de la santé, CHRU
      Hôpitaux de Tours, Tours, France
FAU - Grammatico-Guillon, Leslie
AU  - Grammatico-Guillon L
AD  - Service d’information médicale, épidémiologie et économie de la santé, CHRU
      Hôpitaux de Tours, Tours, France
FAU - Rebière, Cécile
AU  - Rebière C
AD  - 0000 0001 0274 7763grid.414363.7Réanimation, Fondation Hopital Saint Joseph,
      Paris, France
FAU - Azoulay, Elie
AU  - Azoulay E
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Hôpital Saint-Louis
      (AP-HP), Paris, France
FAU - Misset, Benoit
AU  - Misset B
AD  - Réanimation médicale, Hospital Center University, Rouen, France
FAU - Ruckly, Stephane
AU  - Ruckly S
AD  - Statistics Department, Outcomerea research group, Paris, France
FAU - Garrouste-Orgeas, Maïté
AU  - Garrouste-Orgeas M
AD  - 0000 0001 0274 7763grid.414363.7Réanimation, Fondation Hopital Saint Joseph,
      Paris, France
FAU - Kentish-Barnes, Nancy
AU  - Kentish-Barnes N
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Assistance Publique
      Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
FAU - Duranteau, Jacques
AU  - Duranteau J
AD  - 0000 0001 2181 7253grid.413784.dRéanimation chirurgicale, Hôpital Bicêtre, Le
      Kremlin-Bicêtre, France
FAU - Thuong, Marie
AU  - Thuong M
AD  - Val d’oise, CH René Dubos, Pontoise, France
FAU - Joseph, Liliane
AU  - Joseph L
AD  - 0000 0001 2181 7253grid.413784.dRéanimation chirurgicale, Hôpital Bicêtre, Le
      Kremlin-Bicêtre, France
FAU - Renault, Anne
AU  - Renault A
AD  - 0000 0004 0472 3249grid.411169.aRéanimation médicale, CHU Brest, Brest, France
FAU - Lesieur, Olivier
AU  - Lesieur O
AD  - Réanimation, Centre Hospitalier la Rochelle, La Rochelle, France
FAU - Larbi, Anne-Gaelle Si
AU  - Larbi AGS
AD  - Hospital Foch, 92151 Suresnes, France
FAU - Viquesnel, Gérald
AU  - Viquesnel G
AD  - Réanimation chirurgicale, C.H.U de Caen, Caen, France
FAU - Zuber, Benjamin
AU  - Zuber B
AD  - Intensive Care Unit, Hospital Center De Versailles, Le Chesnay, France
FAU - Marque, Sophie
AU  - Marque S
AD  - ICU, C.H. Sud Francilien, Corbeil-Essonnes, France
FAU - Kandelman, Stanislas
AU  - Kandelman S
AD  - 0000 0000 8595 4540grid.411599.1Anesthésie réanimation, Hôpital Beaujon (AP-HP), 
      Clichy, France
FAU - Pichon, Nicolas
AU  - Pichon N
AD  - 0000 0001 1486 4131grid.411178.aService de réanimation polyvalente, Centre
      Hospitalier Universitaire de Limoges, Limoges, France
FAU - Floccard, Bernard
AU  - Floccard B
AD  - 0000 0001 2198 4166grid.412180.eDépartement anesthésie-réanimation, Hôpital
      Édouard Herriot, Lyon, France
FAU - Galon, Marion
AU  - Galon M
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, AP-HP, Hôpital Saint Louis,
      Paris, France
FAU - Chevret, Sylvie
AU  - Chevret S
AD  - 0000 0001 2300 6614grid.413328.fService de biostatistique et information
      médicale, Hôpital Saint-Louis, Paris, France
FAU - Kentish-Barnes, Nancy
AU  - Kentish-Barnes N
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Assistance Publique
      Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
FAU - Seegers, Valérie
AU  - Seegers V
AD  - Umr 669, Inserm, Paris, France
FAU - Legriel, Stéphane
AU  - Legriel S
AD  - 0000 0001 2177 7052grid.418080.5Réanimation, Centre Hospitalier de Versailles, Le
      Chesnay, France
FAU - Jaber, Samir
AU  - Jaber S
AD  - grid.414352.5DAR B, Hôpital Saint Eloi, Montpellier, France
FAU - Lefrant, Jean Yves
AU  - Lefrant JY
AD  - 0000 0004 0593 8241grid.411165.6Réanimation chirurgicale, Hopital Carémeau,
      Nîmes, France
FAU - Reuter, Danielle
AU  - Reuter D
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Hôpital Saint-Louis, Paris,
      France
FAU - Guisset, Olivier
AU  - Guisset O
AD  - 0000 0004 0593 7118grid.42399.35Réanimation médicale-hôpital saint-andré, Centre 
      Hospitalier Universitaire de Bordeaux, Bordeaux, France
FAU - Cracco, Christophe
AU  - Cracco C
AD  - Service de reanimation, Service de Réanimation polyvalente, Angoulême, France
FAU - Seguin, Amélie
AU  - Seguin A
AD  - 0000 0004 0472 0160grid.411149.8Réanimation médicale, Centre Hospitalier
      Universitaire de Caen, Caen, France
FAU - Durand-Gasselin, Jacques
AU  - Durand-Gasselin J
AD  - Réanimation, Hôpital Sainte-Musse, Toulon, France
FAU - Thirion, Marine
AU  - Thirion M
AD  - 0000 0004 0639 3263grid.414474.6Val d’oise, Centre Hospitalier Victor Dupouy
      (Argenteuil), Argenteuil, France
FAU - Cohen-Solal, Zoé
AU  - Cohen-Solal Z
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Assistance Publique
      Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
FAU - Foulgoc, Hélène
AU  - Foulgoc H
AD  - 0000 0004 0593 7118grid.42399.3533, CHU – Hôpitaux de Bordeaux, Bordeaux, France
FAU - Rogier, Julien
AU  - Rogier J
AD  - 0000 0004 0593 7118grid.42399.3533, CHU – Hôpitaux de Bordeaux, Bordeaux, France
FAU - Delobbe, Elsa
AU  - Delobbe E
AD  - 0000 0004 0593 7118grid.42399.3533, CHU – Hôpitaux de Bordeaux, Bordeaux, France
FAU - Schortgen, Frédérique
AU  - Schortgen F
AD  - 0000 0001 2292 1474grid.412116.1Réanimation médicale, Hôpital Henri-Mondor
      (AP-HP), Créteil Cedex, France
FAU - Asfar, Pierre
AU  - Asfar P
AD  - Réanimation, C.H.U. d’Angers, Angers, France
FAU - Julie, Boisramé-Helms
AU  - Julie BH
AD  - Réanimation médicale, Nouvel Hôpital Civil, Hôpitaux Universitaires de
      Strasbourg, Strasbourg, France
FAU - Grimaldi, David
AU  - Grimaldi D
AD  - 0000 0001 2177 7052grid.418080.5Service de réanimation polyvalente, Centre
      Hospitalier de Versailles, Le Chesnay, France
FAU - Fabien, Grelon
AU  - Fabien G
AD  - Réanimation, C.H. – Le Mans, Le Mans, France
FAU - Anguel, Nadia
AU  - Anguel N
AD  - 0000 0001 2181 7253grid.413784.dRéanimation médicale, CHU de Bicêtre, Le Kremlin 
      Bicêtre, France
FAU - Sigismond, Lasocki
AU  - Sigismond L
AD  - Réanimation chirurgicale, C.H.U. d’Angers, Angers, France
FAU - Matthieu, Henry-Lagarrigue
AU  - Matthieu HL
AD  - Réanimation polyvalente, Hospital Center Departmental De Vendée, La
      Roche-Sur-Yon, France
FAU - Gonzalez, Frédéric
AU  - Gonzalez F
AD  - 0000 0000 8715 2621grid.413780.9Réanimation medico-chirurgicale, Hôpital
      Avicenne, Bobigny, France
FAU - François, Legay
AU  - François L
AD  - Réanimation, C.H. de Saint Brieuc, Saint-Brieuc, France
FAU - Guitton, Christophe
AU  - Guitton C
AD  - Réanimation médicale, C.H.U. Hôtel Dieu, Nantes, France
FAU - Schenck, Maleka
AU  - Schenck M
AD  - 0000 0001 2177 138Xgrid.412220.7Réanimation médicale, C.H.R.U. Hôpitaux
      Universitaires Strasbourg, Strasbourg, France
FAU - Jean-Marc, Doise
AU  - Jean-Marc D
AD  - Réanimation, C.H. Chalon sur Saône William Morey, Chalon-Sur-Saône, France
FAU - Radermacher, Peter
AU  - Radermacher P
AD  - grid.410712.1Institut für anästhesiologische pathophysiologie und
      verfahrensentwicklung, Universitätsklinikum Ulm, Ulm, Germany
CN  - for the HYPER2S Investigators and REVA Research Network
FAU - Kentish-Barnes, Nancy
AU  - Kentish-Barnes N
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Assistance Publique
      Hôpitaux de Paris, Hôpital Saint Louis, Paris, France
FAU - Makunza, Joseph Nsiala
AU  - Makunza JN
AD  - 0000 0000 9927 0991grid.9783.5Anesthésie-Réanimation, Cliniques Universitaires de
      Kinshasa, Kinshasa, Democratic Republic of the Congo
FAU - Nathalie, Mejeni Kamdem
AU  - Nathalie MK
AD  - 0000 0000 9927 0991grid.9783.5Anesthésie-Réanimation, Cliniques Universitaires de
      Kinshasa, Kinshasa, Democratic Republic of the Congo
FAU - Pierre, Akilimali
AU  - Pierre A
AD  - Statistics, School of Public Health, Kinshasa, Democratic Republic of the Congo
FAU - Adolphe, Kilembe Manzanza
AU  - Adolphe KM
AD  - 0000 0000 9927 0991grid.9783.5Anesthéthésie-réanimation, Cliniqes Universitaires 
      de Kinshasa, Kinshasa, Democratic Republic of the Congo
FAU - Mahieu, Rafael
AU  - Mahieu R
AD  - 0000 0004 0472 0283grid.411147.6Réanimation médicale, Centre Hospitalier
      Universitaire d’Angers, Angers, France
FAU - Reydel, Thomas
AU  - Reydel T
AD  - 0000 0004 0472 0283grid.411147.6Réanimation médicale, Centre Hospitalier
      Universitaire d’Angers, Angers, France
FAU - Jamet, Angéline
AU  - Jamet A
AD  - Réanimation médicaleCHU de Poitiers, Poitiers, France
FAU - Chudeau, Nicolas
AU  - Chudeau N
AD  - Réanimation médico-chirurgicale, C.H. - Le Mans, Le Mans, France
FAU - Huntzinger, Julien
AU  - Huntzinger J
AD  - grid.440367.2Réanimation médicale, Centre hospitalier Bretagne Atlantique,
      Vannes, France
FAU - Grange, Steven
AU  - Grange S
AD  - Réanimation médicale, Centre Hospitalier Universitaire Rouen, Rouen, France
FAU - Courte, Anne
AU  - Courte A
AD  - Réanimation polyvalente, Centre Hospitalier Yves le Foll, Saint-Brieuc, France
FAU - Lemarie, Jérémie
AU  - Lemarie J
AD  - 0000 0004 1765 1301grid.410527.5Réanimation médicale, Hôpital Central, C.H.U. de 
      Nancy, Nancy, France
FAU - Gibot, Sébastien
AU  - Gibot S
AD  - 0000 0004 1765 1301grid.410527.5Réanimation médicale, Hôpital Central, C.H.U. de 
      Nancy, Nancy, France
FAU - Champey, Julia
AU  - Champey J
AD  - Réanimation médicale, C.H.U. Grenoble, Grenoble, France
FAU - Dellamonica, Jean
AU  - Dellamonica J
AD  - 0000 0001 2322 4179grid.410528.aRéanimation médicale, Centre Hospitalier
      Universitaire Archet, Nice, France
FAU - Du Cheyron, Damien
AU  - Du Cheyron D
AD  - 0000 0004 0472 0160grid.411149.8Réanimation médicale, Centre Hospitalier
      Universitaire de Caen, Caen, France
FAU - Contou, Damien
AU  - Contou D
AD  - 0000 0001 2292 1474grid.412116.1Réanimation Médicale, Hôpital Henri Mondor,
      Créteil, France
FAU - Tadié, Jean-Marc
AU  - Tadié JM
AD  - 0000 0001 2175 0984grid.411154.4Réanimation médicale, Centre Hospitalier
      Universitaire de Rennes, Rennes, France
FAU - Cour, Martin
AU  - Cour M
AD  - 0000 0001 2163 3825grid.413852.9Réanimation Médicale, Hospices Civils de Lyon -
      Groupement Hospitalier Edouard Herriot, Lyon, France
FAU - Beduneau, Gaetan
AU  - Beduneau G
AD  - Réanimation médicale, Centre Hospitalier Universitaire Rouen, Rouen, France
FAU - Marchalot, Antoine
AU  - Marchalot A
AD  - Service de réanimation médicale, Centre Hospitalier de Dieppe, Dieppe, France
FAU - Guérin, Laurent
AU  - Guérin L
AD  - 0000 0000 9982 5352grid.413756.2Réanimation médicale, Hôpital Ambroise Paré
      (AP-HP), Boulogne-Billancourt, France
FAU - Jochmans, Sebastien
AU  - Jochmans S
AD  - Service de Réanimation, Centre Hospitalier Marc Jacquet, Melun, France
FAU - Terzi, Nicolas
AU  - Terzi N
AD  - Service de réanimation médicale, Clinique de Réanimation Médicale, Grenoble,
      France
FAU - Preau, Sebastien
AU  - Preau S
AD  - 0000 0004 0471 8845grid.410463.4Réanimation médicale, Centre Hospitalier Régional
      Universitaire de Lille, Lille, France
FAU - Brun-Buisson, Christian
AU  - Brun-Buisson C
AD  - 0000 0001 2292 1474grid.412116.1Réanimation Médicale, Hôpital Henri Mondor,
      Créteil, France
FAU - Dessap, Armand Mekontso
AU  - Dessap AM
AD  - 0000 0001 2292 1474grid.412116.1Réanimation Médicale, Hôpital Henri Mondor,
      Créteil, France
CN  - for the Purpura Fulminans Study Group
FAU - Vedrenne-Cloquet, Meryl
AU  - Vedrenne-Cloquet M
AD  - Service de réanimation néonatale, C.H. Intercommunal Créteil, Créteil, France
FAU - Breinig, Sophie
AU  - Breinig S
AD  - Service de réanimation néonatale et pédiatrique, Hospital Center University
      Toulouse - Casselardit Ancely, Toulouse, France
FAU - Jung, Camille
AU  - Jung C
AD  - Centre de recherche clinique, C.H. Intercommunal Créteil, Créteil, France
FAU - Brussieux, Maxime
AU  - Brussieux M
AD  - Centre de recherche clinique, C.H. Intercommunal Créteil, Créteil, France
FAU - Marcoux, Marie-Odile
AU  - Marcoux MO
AD  - Service de réanimation néonatale et pédiatrique, Hospital Center University
      Toulouse - Casselardit Ancely, Toulouse, France
FAU - Durrmeyer, Xavier
AU  - Durrmeyer X
AD  - Service de réanimation néonatale, C.H. Intercommunal Créteil, Créteil, France
FAU - Blondé, Renaud
AU  - Blondé R
AD  - Mayotte, CHM, Mamoudzou, France
FAU - Angoulvant, François
AU  - Angoulvant F
AD  - Urgences pédiatriquesCHU Necker-Enfants Malades, Paris, France
FAU - Grasset, Jérôme
AU  - Grasset J
AD  - Iriseo, Iriseo - 3D Supports multimédia Interactifs, Saint-Victurnien, France
FAU - Naudin, Jérôme
AU  - Naudin J
AD  - 0000 0004 0472 3476grid.139510.fRéanimation et surveillance continue
      pédiatriques, CHU Robert Debré, Paris, France
FAU - Dauger, Stéphane
AU  - Dauger S
AD  - 0000 0004 0472 3476grid.139510.fRéanimation et surveillance continue
      pédiatriques, CHU Robert Debré, Paris, France
CN  - GFRUP RMEF
FAU - Remy, Solenn
AU  - Remy S
AD  - grid.414103.3Réanimation pédiatrique, Hôpital Femme Mère Enfant, Bron/Lyon,
      France
FAU - Kolev-Descamp, Karine
AU  - Kolev-Descamp K
AD  - grid.414103.3Réanimation pédiatrique, Hôpital Femme Mère Enfant, Bron/Lyon,
      France
FAU - Demaret, Julie
AU  - Demaret J
AD  - 0000 0001 2163 3825grid.413852.9Laboratoire d’immunologie cellulaire, Hospices
      Civils de Lyon - Groupement Hospitalier Edouard Herriot, Lyon, France
FAU - Monneret, Guillaume
AU  - Monneret G
AD  - 0000 0001 2163 3825grid.413852.9Laboratoire d’immunologie cellulaire, Hospices
      Civils de Lyon - Groupement Hospitalier Edouard Herriot, Lyon, France
FAU - Javouhey, Etienne
AU  - Javouhey E
AD  - grid.414103.3Réanimation pédiatrique, Hôpital Femme Mère Enfant, Bron/Lyon,
      France
FAU - Chomton, Maryline
AU  - Chomton M
AD  - 0000 0001 2173 6322grid.411418.9Soins intensifs pédiatriques, CHU Sainte-Justine,
      Montréal, Canada
FAU - Sauthier, Michaël
AU  - Sauthier M
AD  - 0000 0001 2173 6322grid.411418.9Soins intensifs pédiatriques, CHU Sainte-Justine,
      Montréal, Canada
FAU - Vallieres, Emilie
AU  - Vallieres E
AD  - 0000 0001 2173 6322grid.411418.9Microbiology Department, CHU Sainte-Justine,
      Montréal, Canada
FAU - Jouvet, Philippe
AU  - Jouvet P
AD  - 0000 0001 2173 6322grid.411418.9Soins intensifs pédiatriques, CHU Sainte-Justine,
      Montréal, Canada
FAU - Geslain, Guillaume
AU  - Geslain G
AD  - 0000 0004 1937 0589grid.413235.2Hôpital Robert-Debré (AP-HP), Paris, France
FAU - Guellec, Isabelle
AU  - Guellec I
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Rambaud, Jérôme
AU  - Rambaud J
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Schmidt, Matthieu
AU  - Schmidt M
AD  - Service de réanimation médicale, Groupe Hospitalier Pitié-Salpêtrière, Paris,
      France
FAU - Schellongowski, Peter
AU  - Schellongowski P
AD  - Unit 13i2, Department of Medicine I/intensive care, Vienna, Austria
FAU - Dorget, Amandine
AU  - Dorget A
AD  - Service de réanimation médicale, Groupe Hospitalier Pitié-Salpêtrière, Paris,
      France
FAU - Patroniti, Nicolo
AU  - Patroniti N
AD  - 0000 0004 1756 8604grid.415025.7Anestesia e raiamizione, Ospedale San Gerardo,
      Monza, Italy
FAU - Taccone, Fabio Silvio
AU  - Taccone FS
AD  - 0000 0000 8571 829Xgrid.412157.4Service de Soins Intensifs, Hôpital Erasme,
      Brussels, Belgium
FAU - Miranda, Dinis Reis
AU  - Miranda DR
AD  - 000000040459992Xgrid.5645.2Intensive Care, Erasmus University Medical Center,
      Rotterdam, Netherlands
FAU - Reuter, Jean
AU  - Reuter J
AD  - 0000 0000 8588 831Xgrid.411119.dService de réanimation médicale et infectieuse,
      Hôpital Bichat-Claude Bernard-APHP, Paris, France
FAU - Prodanovic, Hélène
AU  - Prodanovic H
AD  - 0000 0001 2150 9058grid.411439.aUnité de réanimation et de surveillance
      continueservice de pneumologie et réanimation médicale, Pitié-Salpêtrière
      Hospital, Paris, France
FAU - Pierrot, Marc
AU  - Pierrot M
AD  - Service de réanimation medicale, Hopital Universitaire d’Angers, Angers, France
FAU - Balik, Martin
AU  - Balik M
AD  - 0000 0000 9100 9940grid.411798.2Department of Anaesthesia and Intensive Care,
      General University Hospital in Prague, Prague, Czech Republic
FAU - Park, Sunghoon
AU  - Park S
AD  - 0000 0000 9834 782Xgrid.411945.cPulmonaryallergy and Critical Care, Hallym
      University Sacred Heart Hospital, Seoul, Republic of Korea
CN  - REVA ECMOnet
FAU - Guérin, Claude
AU  - Guérin C
AD  - 0000 0004 4685 6736grid.413306.3Réanimation médicale, Hôpital de la Croix-Rousse,
      Lyon, France
FAU - Papazian, Laurent
AU  - Papazian L
AD  - 0000 0004 1773 6284grid.414244.3Service de réanimation-détresses respiratoires et
      infections sévères, Hôpital Nord, Marseille, France
FAU - Jean, Reignier
AU  - Jean R
AD  - 0000 0004 0472 0371grid.277151.7Réanimation médicale, CHU Hôtel-Dieu Nantes,
      Nantes, France
FAU - Ayzac, Louis
AU  - Ayzac L
AD  - C-clin, Hôpital Henry Gabrielle, Saint-Genis-Laval, France
FAU - Loundou, Anderson
AU  - Loundou A
AD  - 0000 0001 2176 4817grid.5399.6Unité de recherche de santé publique, Faculté de
      Médecine secteur Timone (Aix-Marseille Université), Marseille, France
FAU - Forel, Jean-Marie
AU  - Forel JM
AD  - Réanimation médicale, Hospital Nord, Marseille, France
FAU - Mezidi, Mehdi
AU  - Mezidi M
AD  - 0000 0004 4685 6736grid.413306.3Réanimation médicale, Hôpital de la Croix-Rousse,
      Lyon, France
FAU - Aublanc, Mylène
AU  - Aublanc M
AD  - 0000 0004 4685 6736grid.413306.3Réanimation médicale, Hôpital de la Croix-Rousse,
      Lyon, France
FAU - Perinel-Ragey, Sophie
AU  - Perinel-Ragey S
AD  - 0000 0004 4685 6736grid.413306.3Réanimation médicale, Hôpital de la Croix-Rousse,
      Lyon, France
FAU - Lissonde, Floriane
AU  - Lissonde F
AD  - 0000 0004 4685 6736grid.413306.3Réanimation médicale, Hôpital de la Croix-Rousse,
      Lyon, France
FAU - Louf-Durier, Aurore
AU  - Louf-Durier A
AD  - 0000 0004 4685 6736grid.413306.3Réanimation médicale, Hôpital de la Croix-Rousse,
      Lyon, France
FAU - Tapponnier, Romain
AU  - Tapponnier R
AD  - 0000 0004 4685 6736grid.413306.3Réanimation médicale, Hôpital de la Croix-Rousse,
      Lyon, France
FAU - Yonis, Hodane
AU  - Yonis H
AD  - 0000 0004 4685 6736grid.413306.3Réanimation médicale, Hôpital de la Croix-Rousse,
      Lyon, France
FAU - Coudroy, Remi
AU  - Coudroy R
AD  - Réanimation médicaleCHU de Poitiers, Poitiers, France
FAU - Frat, Jean-Pierre
AU  - Frat JP
AD  - Réanimation médicaleCHU de Poitiers, Poitiers, France
FAU - Boissier, Florence
AU  - Boissier F
AD  - 0000 0001 2292 1474grid.412116.1Réanimation Médicale, Hôpital Henri Mondor,
      Créteil, France
FAU - Thille, Arnaud W.
AU  - Thille AW
AD  - Réanimation médicaleCHU de Poitiers, Poitiers, France
FAU - Richard, Flore
AU  - Richard F
AD  - 0000 0004 0472 0283grid.411147.6Service de réanimation médicale et médecine
      hyperbare, Centre Hospitalier Universitaire d’Angers, Angers, France
FAU - Le Gullou-Guillemette, Hélène
AU  - Le Gullou-Guillemette H
AD  - 0000 0004 0472 0283grid.411147.6Département de biologie des agents infectieux et 
      pharmaco-toxicologie, Centre Hospitalier Universitaire d’Angers, Angers, France
FAU - Fahri, Jonathan
AU  - Fahri J
AD  - 0000 0004 0472 0283grid.411147.6Service des maladies du sang, Centre Hospitalier 
      Universitaire d’Angers, Angers, France
FAU - Kouatchet, Achille
AU  - Kouatchet A
AD  - 0000 0004 0472 0283grid.411147.6Service de réanimation médicale et médecine
      hyperbare, Centre Hospitalier Universitaire d’Angers, Angers, France
FAU - Bodet-Contentin, Laetitia
AU  - Bodet-Contentin L
AD  - Réanimation polyvalenteCHRU Hôpitaux de Tours, Tours, France
FAU - Garot, Denis
AU  - Garot D
AD  - Réanimation polyvalenteCHRU Hôpitaux de Tours, Tours, France
FAU - Le Pennec, Déborah
AU  - Le Pennec D
AD  - 0000 0001 2182 6141grid.12366.30CEPR (Inserm U1100/EA 6305), aérosolthérapie et
      biomédicaments à visée respiratoire, Université François Rabelais, Tours, France
FAU - Vecellio, Laurent
AU  - Vecellio L
AD  - 0000 0001 2182 6141grid.12366.30CEPR (Inserm U1100/EA 6305), aérosolthérapie et
      biomédicaments à visée respiratoire, Université François Rabelais, Tours, France
FAU - Tavernier, Elsa
AU  - Tavernier E
AD  - Inserm cic 1415, CHRU Hôpitaux de Tours, Tours, France
FAU - Dequin, Pierre François
AU  - Dequin PF
AD  - Réanimation polyvalenteCHRU Hôpitaux de Tours, Tours, France
FAU - Messika, Jonathan
AU  - Messika J
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes, France
FAU - Martin, Yolaine
AU  - Martin Y
AD  - 0000 0001 0273 556Xgrid.414205.6Réanimation médico-chirurgicale, Hôpital
      Louis-Mourier - APHP, Colombes, France
FAU - Maquigneau, Natacha
AU  - Maquigneau N
AD  - Réanimation, Centre Hospitalier Départemental – site de La Roche-sur-Yon, La
      Roche-Sur-Yon, France
FAU - Puechberty, Christelle
AU  - Puechberty C
AD  - Réanimation-uscm, Gustave Roussy, Villejuif, France
FAU - Stoclin, Annabelle
AU  - Stoclin A
AD  - Réanimation-uscm, Gustave Roussy, Villejuif, France
FAU - Villard, Serge
AU  - Villard S
AD  - 0000 0001 0273 556Xgrid.414205.6Réanimation médico-chirurgicale, Hôpital
      Louis-Mourier - APHP, Colombes, France
FAU - Dechanet, Aline
AU  - Dechanet A
AD  - 0000 0000 8588 831Xgrid.411119.dUnité de recherche clinique, Hôpital
      Bichat-Claude Bernard (AP-HP), Paris, France
FAU - De Jong, Audrey
AU  - De Jong A
AD  - grid.414352.5DAR B, Hôpital Saint Eloi, Montpellier, France
FAU - Monnin, Marion
AU  - Monnin M
AD  - grid.414352.5DAR B, Hôpital Saint Eloi, Montpellier, France
FAU - Girard, Mehdi
AU  - Girard M
AD  - grid.414352.5DAR B, Hôpital Saint Eloi, Montpellier, France
FAU - Chanques, Gérald
AU  - Chanques G
AD  - grid.414352.5DAR B, Hôpital Saint Eloi, Montpellier, France
FAU - Molinari, Nicolas
AU  - Molinari N
AD  - Dim, Hôpital La Colombière, Montpellier, France
FAU - Decavèle, Maxens
AU  - Decavèle M
AD  - 0000 0001 2150 9058grid.411439.aService de pneumologie et réanimation médicale,
      Pitié-Salpêtrière Hospital, Paris, France
FAU - Campion, Sébastien
AU  - Campion S
AD  - 0000 0001 2150 9058grid.411439.aInserm umr_s 1158 “neurophysiologie respiratoire 
      expérimentale et clinique”, Pitié-Salpêtrière Hospital, Paris, France
FAU - Ainsouya, Roukia
AU  - Ainsouya R
AD  - 0000 0001 2150 9058grid.411439.aInserm umr_s 1158 “neurophysiologie respiratoire 
      expérimentale et clinique”, Pitié-Salpêtrière Hospital, Paris, France
FAU - Niérat, Marie-Cécile
AU  - Niérat MC
AD  - 0000 0001 2150 9058grid.411439.aInserm umr_s 1158 “neurophysiologie respiratoire 
      expérimentale et clinique”, Pitié-Salpêtrière Hospital, Paris, France
FAU - Raux, Mathieu
AU  - Raux M
AD  - Département d’anesthésie-réanimation et umr_s 1158, Hôpital Universitaire
      Pitié-Salpêtrière, Paris, France
FAU - Similowski, Thomas
AU  - Similowski T
AD  - 0000 0001 2150 9058grid.411439.aService de pneumologie et réanimation médicale,
      Pitié-Salpêtrière Hospital, Paris, France
FAU - Demoule, Alexandre
AU  - Demoule A
AD  - 0000 0001 2150 9058grid.411439.aService de pneumologie et réanimation médicale,
      Pitié-Salpêtrière Hospital, Paris, France
FAU - Razazi, Keyvan
AU  - Razazi K
AD  - 0000 0001 2292 1474grid.412116.1Réanimation Médicale, Hôpital Henri Mondor,
      Créteil, France
FAU - Tchir, Martial
AU  - Tchir M
AD  - Réanimation polyvalente - surveillance continue, Ctre Hospitalier Intercommunal
      de Villeneuve Saint GeorgesLucie et Raymond AUBRAC, Villeneuve-Saint-Georges,
      France
FAU - May, Faten
AU  - May F
AD  - 0000 0001 2292 1474grid.412116.1Réanimation Médicale, Hôpital Henri Mondor,
      Créteil, France
FAU - Carteaux, Guillaume
AU  - Carteaux G
AD  - 0000 0001 2292 1474grid.412116.1Réanimation Médicale, Hôpital Henri Mondor,
      Créteil, France
FAU - Pauline, Rougevin-Baville
AU  - Pauline RB
AD  - 0000 0000 9454 4367grid.413738.aRéanimation polyvalente, Hôpital Antoine Béclère,
      Clamart, France
FAU - Marc, Andronikof
AU  - Marc A
AD  - 0000 0000 9454 4367grid.413738.aService d’accueil des urgences, Hôpital Antoine
      Béclère, Clamart, France
FAU - Bedos, Jean Pierre
AU  - Bedos JP
AD  - 0000 0001 2177 7052grid.418080.5Réanimation médico-chirurgicale, Centre
      Hospitalier de Versailles, Le Chesnay, France
FAU - Mehrsa, Koukabi
AU  - Mehrsa K
AD  - 0000 0001 2177 7052grid.418080.5Service d’accueil des urgences, Centre
      Hospitalier de Versailles, Le Chesnay, France
FAU - Mauger-Briche, Carole
AU  - Mauger-Briche C
AD  - Service d’accueil des urgences, C.H. Intercommunal de Meulan-Les Mureaux,
      Meulan-En-Yvelines, France
FAU - Mijon, François
AU  - Mijon F
AD  - Réanimation polyvalente, C.H. Intercommunal de Meulan-Les Mureaux,
      Meulan-En-Yvelines, France
FAU - Trouiller, Pierre
AU  - Trouiller P
AD  - 0000 0000 9454 4367grid.413738.aRéanimation polyvalente, Hôpital Antoine Béclère,
      Clamart, France
FAU - Sztrymf, Benjamin
AU  - Sztrymf B
AD  - 0000 0000 9454 4367grid.413738.aRéanimation polyvalente, Hôpital Antoine Béclère,
      Clamart, France
FAU - Cretallaz, Pierre
AU  - Cretallaz P
AD  - Pôle sau - samu 74 - smur - réanimation, C.H. Annecy Genevois, Metz-Tessy, France
FAU - Mermillod-Blondin, Romain
AU  - Mermillod-Blondin R
AD  - Pôle sau - samu 74 - smur - réanimation, C.H. Annecy Genevois, Metz-Tessy, France
FAU - Savary, Dominique
AU  - Savary D
AD  - Pôle sau - samu 74 - smur - réanimation, C.H. Annecy Genevois, Metz-Tessy, France
FAU - Sedghiani, Ines
AU  - Sedghiani I
AD  - Emergency and Intensive Care Department, hôpital habib thameur, Tunis, Tunisia
FAU - Doghri, Hamdi
AU  - Doghri H
AD  - Emergency and Intensive Care Department, hôpital habib thameur, Tunis, Tunisia
FAU - Jendoubi, Asma
AU  - Jendoubi A
AD  - Emergency and Intensive Care Department, hôpital habib thameur, Tunis, Tunisia
FAU - Hamdi, Dhekra
AU  - Hamdi D
AD  - Emergency and Intensive Care Department, hôpital habib thameur, Tunis, Tunisia
FAU - Cherif, Mohamed Ali
AU  - Cherif MA
AD  - Emergency and Intensive Care Department, hôpital habib thameur, Tunis, Tunisia
FAU - Hechmi, Youssef Zied El
AU  - Hechmi YZE
AD  - Emergency and Intensive Care Department, hôpital habib thameur, Tunis, Tunisia
FAU - Zouheir, Jerbi
AU  - Zouheir J
AD  - Emergency and Intensive Care Department, hôpital habib thameur, Tunis, Tunisia
FAU - Persico, Nicolas
AU  - Persico N
AD  - 0000 0004 1773 6284grid.414244.3Service d’accueil des urgences adultes, Hôpital
      Nord APHM, Marseille, France
FAU - Maltese, Francois
AU  - Maltese F
AD  - 0000 0004 1773 6284grid.414244.3Réanimation DRIS, Hôpital Nord APHM, Marseille,
      France
FAU - Ferrigno, Cécile
AU  - Ferrigno C
AD  - 0000 0004 1773 6284grid.414244.3Service d’accueil des urgences adultes, Hôpital
      Nord APHM, Marseille, France
FAU - Bablon, Amandine
AU  - Bablon A
AD  - 0000 0004 1773 6284grid.414244.3Service d’accueil des urgences adultes, Hôpital
      Nord APHM, Marseille, France
FAU - Marmillot, Cécile
AU  - Marmillot C
AD  - 0000 0004 1773 6284grid.414244.3Service d’accueil des urgences adultes, Hôpital
      Nord APHM, Marseille, France
FAU - Roch, Antoine
AU  - Roch A
AD  - 0000 0004 1773 6284grid.414244.3Réanimation DRIS, Hôpital Nord APHM, Marseille,
      France
FAU - Sedghiani, Ines
AU  - Sedghiani I
AD  - Emergency and Intensive Care Department, hôpital habib thameur, Tunis, Tunisia
FAU - Papin, Grégory
AU  - Papin G
AD  - 0000 0001 2217 0017grid.7452.4INSERM U1137 équipe 5, Université Paris Diderot,
      75018 Paris, France
FAU - Gainnier, Marc
AU  - Gainnier M
AD  - grid.411266.6Réanimation des urgences médicales, Hôpital de la Timone, Marseille,
      France
FAU - Argaud, Laurent
AU  - Argaud L
AD  - 0000 0001 2163 3825grid.413852.9Réanimation Médicale, Hospices Civils de Lyon -
      Groupement Hospitalier Edouard Herriot, Lyon, France
FAU - Christophe, Adrie
AU  - Christophe A
AD  - 0000 0001 0274 3893grid.411784.fHôpital Cochin, 75014 Paris, France
FAU - Souweine, Bertrand
AU  - Souweine B
AD  - 0000 0004 0639 4151grid.411163.0Réanimation médicale, CHU Gabriel-Montpied,
      Clermont-Ferrand, France
FAU - Goldgran-Toledano, Dany
AU  - Goldgran-Toledano D
AD  - Réanimation polyvalente, Centre Hospitalier Général, Gonesse, France
FAU - Marcotte, Guillaume
AU  - Marcotte G
AD  - 0000 0001 2175 4109grid.50550.35Reanimation medicale, Assistance Publique
      Hôpitaux de Paris, Paris, France
FAU - Dumenil, Anne Sylvie
AU  - Dumenil AS
AD  - 0000 0000 9454 4367grid.413738.aRéanimation chirurgicale, Hôpital Antoine
      Béclère, Clamart, France
FAU - Carole, Schwebel
AU  - Carole S
AD  - 38, C.H.U de Grenoble, C.H.U, La Tronche, La Tronche, France
FAU - Cecchini, Jerôme
AU  - Cecchini J
AD  - 0000 0001 2292 1474grid.412116.1Réanimation Médicale, Hôpital Henri Mondor,
      Créteil, France
FAU - Tuffet, Samuel
AU  - Tuffet S
AD  - 0000 0001 2292 1474grid.412116.1Réanimation Médicale, Hôpital Henri Mondor,
      Créteil, France
FAU - Fartoukh, Muriel
AU  - Fartoukh M
AD  - 0000 0001 2259 4338grid.413483.9Réanimation médico-chirurgicale, Hôpital Tenon,
      Paris, France
FAU - Roux, Damien
AU  - Roux D
AD  - 0000 0001 0273 556Xgrid.414205.6Réanimation médico-chirurgicale, Hôpital
      Louis-Mourier - APHP, Colombes, France
FAU - Thyrault, Martial
AU  - Thyrault M
AD  - ICU, C.H. de Longjumeau, Longjumeau, France
FAU - Armand, Mekontso Dessap
AU  - Armand MD
AD  - 0000 0001 2292 1474grid.412116.1Réanimation médicale, Hôpital Henri-Mondor
      (AP-HP), Créteil Cedex, France
FAU - Chauveau, Simon
AU  - Chauveau S
AD  - 0000 0004 1937 1100grid.412370.3Réanimation médicale, Hôpital Saint-Antoine,
      Paris, France
FAU - Wesner, Nadège
AU  - Wesner N
AD  - 0000 0004 1937 1100grid.412370.3Réanimation médicale, Hôpital Saint-Antoine,
      Paris, France
FAU - Monnier-Cholley, Laurence
AU  - Monnier-Cholley L
AD  - 0000 0004 1937 1100grid.412370.3Radiologie, Hôpital Saint-Antoine, Paris, France
FAU - Bigé, Naïke
AU  - Bigé N
AD  - 0000 0004 1937 1100grid.412370.3Réanimation médicale, Hôpital Saint-Antoine,
      Paris, France
FAU - Ait-Oufella, Hafid
AU  - Ait-Oufella H
AD  - 0000 0004 1937 1100grid.412370.3Réanimation médicale, Hôpital Saint-Antoine,
      Paris, France
FAU - Guidet, Bertrand
AU  - Guidet B
AD  - 0000 0004 1937 1100grid.412370.3Réanimation médicale, Hôpital Saint-Antoine,
      Paris, France
FAU - Dubée, Vincent
AU  - Dubée V
AD  - 0000 0004 1937 1100grid.412370.3Réanimation médicale, Hôpital Saint-Antoine,
      Paris, France
FAU - Labroca, Pierre
AU  - Labroca P
AD  - 0000 0004 1765 1301grid.410527.5Réanimation médicale, Hôpital Central, C.H.U. de 
      Nancy, Nancy, France
FAU - Lemarié, Jérémie
AU  - Lemarié J
AD  - 0000 0004 1765 1301grid.410527.5Réanimation médicale, Hôpital Central, C.H.U. de 
      Nancy, Nancy, France
FAU - Chiesa, Gérard
AU  - Chiesa G
AD  - Service de rééducation et d’appareillage, Institut Robert Merle d’Aubigné,
      Valenton, France
FAU - Laroyenne, Isabelle
AU  - Laroyenne I
AD  - Service de médecine physique et de réadaptation, Centre Medico-Chirurgical de
      Readaptation des Massues, Lyon, France
FAU - Borrini, Léo
AU  - Borrini L
AD  - 0000 0004 1795 3756grid.414028.bService de médecine physique et de réadaptation, 
      Hôpital d’Instruction des Armées Percy, Clamart, France
FAU - Klotz, Rémi
AU  - Klotz R
AD  - Service de médecine physique et de réadaptation, Centre de médecine physique et
      de réadaptation de la tour de Gassies, Brugge, France
FAU - Sy, Quoc Phan
AU  - Sy QP
AD  - Service de médecine physique et de réadaptation, Hôpital la renaissance
      sanitaire, Villiers-Saint-Denis, France
FAU - Cristina, Marie-Christine
AU  - Cristina MC
AD  - Service de médecine physique et de réadaptation, Pôle Saint Hélier, Rennes,
      France
FAU - Paysant, Jean
AU  - Paysant J
AD  - 0000 0001 0071 9523grid.418570.fCentre louis pierquin, Institut Régional de
      Médecine Physique et de Réadaptation, Nancy, France
FAU - Fillâtre, Pierre
AU  - Fillâtre P
AD  - 0000 0001 2175 0984grid.411154.4Service de maladies infectieuses et réanimation
      médicale, Centre Hospitalier Universitaire, Rennes, France
FAU - Gacouin, Arnaud
AU  - Gacouin A
AD  - 0000 0001 2175 0984grid.411154.4Service de maladies infectieuses et réanimation
      médicale, Centre Hospitalier Universitaire, Rennes, France
FAU - Revest, Matthieu
AU  - Revest M
AD  - 0000 0001 2175 0984grid.411154.4Service de maladies infectieuses et réanimation
      médicale, Centre Hospitalier Universitaire, Rennes, France
FAU - Tattevin, Pierre
AU  - Tattevin P
AD  - 0000 0001 2175 0984grid.411154.4Service de maladies infectieuses et réanimation
      médicale, Centre Hospitalier Universitaire, Rennes, France
FAU - Flecher, Erwan
AU  - Flecher E
AD  - 0000 0001 2175 0984grid.411154.4Service de chirurgie thoracique, cardiaque et
      vasculaire, Centre Hospitalier Universitaire, Rennes, France
FAU - Le Tulzo, Yves
AU  - Le Tulzo Y
AD  - 0000 0001 2175 0984grid.411154.4Service de maladies infectieuses et réanimation
      médicale, Centre Hospitalier Universitaire, Rennes, France
FAU - Jamme, Matthieu
AU  - Jamme M
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Daviaud, Fabrice
AU  - Daviaud F
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Marin, Nathalie
AU  - Marin N
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Thy, Michael
AU  - Thy M
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Duceau, Baptiste
AU  - Duceau B
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Hôpital Saint-Louis
      (AP-HP), Paris, France
FAU - Ardisson, Fanny
AU  - Ardisson F
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Hôpital Saint-Louis
      (AP-HP), Paris, France
FAU - Sandrine, Valade
AU  - Sandrine V
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Hôpital Saint-Louis
      (AP-HP), Paris, France
FAU - Venot, Marion
AU  - Venot M
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Hôpital Saint-Louis
      (AP-HP), Paris, France
FAU - Schlemmer, Benoît
AU  - Schlemmer B
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Hôpital Saint-Louis
      (AP-HP), Paris, France
FAU - Zafrani, Lara
AU  - Zafrani L
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Hôpital Saint-Louis
      (AP-HP), Paris, France
FAU - Pons, Stéphanie
AU  - Pons S
AD  - 0000 0000 8588 831Xgrid.411119.dRéanimation médicale et infectieuse, Hôpital
      Bichat-Claude Bernard (AP-HP), Paris, France
FAU - Styfalova, Lenka
AU  - Styfalova L
AD  - ICUREsearch, Paris, France
FAU - Bouadma, Lila
AU  - Bouadma L
AD  - 0000 0000 8588 831Xgrid.411119.dRéanimation médicale et infectieuse, Hôpital
      Bichat-Claude Bernard (AP-HP), Paris, France
FAU - Radjou, Aguila
AU  - Radjou A
AD  - 0000 0000 8588 831Xgrid.411119.dRéanimation médicale et infectieuse, Hôpital
      Bichat-Claude Bernard (AP-HP), Paris, France
FAU - Lebut, Jordane
AU  - Lebut J
AD  - 0000 0000 8588 831Xgrid.411119.dRéanimation médicale et infectieuse, Hôpital
      Bichat-Claude Bernard (AP-HP), Paris, France
FAU - Mourvillier, Bruno
AU  - Mourvillier B
AD  - 0000 0000 8588 831Xgrid.411119.dRéanimation médicale et infectieuse, Hôpital
      Bichat-Claude Bernard (AP-HP), Paris, France
FAU - Dorent, Richard
AU  - Dorent R
AD  - 0000 0000 8588 831Xgrid.411119.dCardiologie, Hôpital Bichat-Claude Bernard
      (AP-HP), Paris, France
FAU - Dilly, Marie-Pierre
AU  - Dilly MP
AD  - 0000 0000 8588 831Xgrid.411119.dAnesthésie réanimation chirurgie
      cardio-vasculaire, Hôpital Bichat-Claude Bernard (AP-HP), Paris, France
FAU - Nataf, Patrick
AU  - Nataf P
AD  - 0000 0000 8588 831Xgrid.411119.dChirurgie cardiaque et vasculaire, Hôpital
      Bichat-Claude Bernard (AP-HP), Paris, France
FAU - Wolff, Michel
AU  - Wolff M
AD  - 0000 0000 8588 831Xgrid.411119.dRéanimation médicale et infectieuse, Hôpital
      Bichat-Claude Bernard (AP-HP), Paris, France
FAU - Le Gall, Aëlle
AU  - Le Gall A
AD  - 0000 0004 1937 1100grid.412370.3Réanimation médicale, Hôpital Saint-Antoine,
      Paris, France
FAU - Bourcier, Simon
AU  - Bourcier S
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Tandjaoui-Lambiotte, Yacine
AU  - Tandjaoui-Lambiotte Y
AD  - 0000 0000 8715 2621grid.413780.993, Hôpital Avicenne, Bobigny, France
FAU - Das, Vincent
AU  - Das V
AD  - Réanimation polyvalente adulte, Centre Hospitalier Intercommunal André Grégoire, 
      Montreuil, France
FAU - Alves, Mikael
AU  - Alves M
AD  - Réanimation médicale, C.H. Intercommunal Poissy/Saint-Germain-en-Laye, Poissy
      Cedex, France
FAU - Bigé, Naïke
AU  - Bigé N
AD  - 0000 0004 1937 1100grid.412370.3Réanimation médicale, Hôpital Saint-Antoine,
      Paris, France
FAU - Kamilia, Chtara
AU  - Kamilia C
AD  - 0000 0001 2323 5644grid.412124.0Réanimation polyvalente, Faculté de médecine de
      Sfax, Sfax, Tunisia
FAU - Rania, Ammar
AU  - Rania A
AD  - 0000 0001 2323 5644grid.412124.0Réanimation polyvalente, Faculté de médecine de
      Sfax, Sfax, Tunisia
FAU - Baccouch, Najeh
AU  - Baccouch N
AD  - grid.413497.cRéanimation polyvalente, CHU Habib Bourguiba, Sfax, Tunisia
FAU - Turki, Olfa
AU  - Turki O
AD  - 0000 0001 2323 5644grid.412124.0Réanimation polyvalente, Faculté de médecine de
      Sfax, Sfax, Tunisia
FAU - Ben, Hmida Chokri
AU  - Ben HC
AD  - 0000 0001 2323 5644grid.412124.0Réanimation polyvalente, Faculté de médecine de
      Sfax, Sfax, Tunisia
FAU - Bahloul, Mabrouk
AU  - Bahloul M
AD  - 0000 0001 2323 5644grid.412124.0Réanimation polyvalente, Faculté de médecine de
      Sfax, Sfax, Tunisia
FAU - Bouaziz, Mounir
AU  - Bouaziz M
AD  - 0000 0001 2323 5644grid.412124.0Réanimation polyvalente, Faculté de médecine de
      Sfax, Sfax, Tunisia
FAU - Dupuis, Claire
AU  - Dupuis C
AD  - 0000 0000 8588 831Xgrid.411119.dRéanimation médicale, CHU BICHAT, Paris, France
FAU - Perozziello, Anne
AU  - Perozziello A
AD  - 0000 0001 2217 0017grid.7452.4Umr 1137, Faculté de Médecine Xavier Bichat, Paris,
      France
FAU - Letheulle, Julien
AU  - Letheulle J
AD  - Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre,
      Guadeloupe
FAU - Valette, Marc
AU  - Valette M
AD  - Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre,
      Guadeloupe
FAU - Herrmann-Storck, Cécile
AU  - Herrmann-Storck C
AD  - Virology, Hospital Center Regional University, Pointe-a-Pitre, Guadeloupe
FAU - Crosby, Laura
AU  - Crosby L
AD  - Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre,
      Guadeloupe
FAU - Elkoun, Khalid
AU  - Elkoun K
AD  - Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre,
      Guadeloupe
FAU - Madeux, Benjamin
AU  - Madeux B
AD  - Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre,
      Guadeloupe
FAU - Martino, Frédéric
AU  - Martino F
AD  - Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre,
      Guadeloupe
FAU - Migueres, Hélène
AU  - Migueres H
AD  - Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre,
      Guadeloupe
FAU - Piednoir, Pascale
AU  - Piednoir P
AD  - Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre,
      Guadeloupe
FAU - Posch, Matthias
AU  - Posch M
AD  - Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre,
      Guadeloupe
FAU - Thiery, Guillaume
AU  - Thiery G
AD  - Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre,
      Guadeloupe
FAU - Huynh-Ky, Minh-Tu
AU  - Huynh-Ky MT
AD  - 0000 0000 8521 1798grid.421142.0Centre de recherche de l’iucpq, Institut
      Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Canada
FAU - Bouchard, Pierre Alexandre
AU  - Bouchard PA
AD  - 0000 0000 8521 1798grid.421142.0Centre de recherche de l’iucpq, Institut
      Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Canada
FAU - Sarrazin, Jean-François
AU  - Sarrazin JF
AD  - 0000 0000 8521 1798grid.421142.0Centre de recherche de l’iucpq, Institut
      Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Canada
FAU - Lellouche, François
AU  - Lellouche F
AD  - 0000 0000 8521 1798grid.421142.0Centre de recherche de l’iucpq, Institut
      Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Canada
FAU - Nay, Mai-Anh
AU  - Nay MA
AD  - 0000 0004 1792 201Xgrid.413932.eRéanimation médicale polyvalente, Hôpital de La
      Source, CHR Orléans, Orléans, France
FAU - Lortat-Jacob, Brice
AU  - Lortat-Jacob B
AD  - 0000 0000 8588 831Xgrid.411119.dRéanimation chirurgicale polyvalente, Hôpital
      Bichat-Claude Bernard (AP-HP), Paris, France
FAU - Rozec, Bertrand
AU  - Rozec B
AD  - Réanimation CTCV Transplantation thoracique, CHU de Nantes - Hôpital Nord
      Laennec, Saint-Herblain, France
FAU - Colnot, Marion
AU  - Colnot M
AD  - 0000 0004 0638 9213grid.411158.8Réanimation médicale, CHU de Besançon, Besançon, 
      France
FAU - Belin, Nicolas
AU  - Belin N
AD  - 0000 0004 0638 9213grid.411158.8Réanimation médicale, CHU de Besançon, Besançon, 
      France
FAU - Barrot, Loïc
AU  - Barrot L
AD  - 0000 0004 0638 9213grid.411158.8Réanimation médicale, CHU de Besançon, Besançon, 
      France
FAU - Navellou, Jean-Christophe
AU  - Navellou JC
AD  - 0000 0004 0638 9213grid.411158.8Réanimation médicale, CHU de Besançon, Besançon, 
      France
FAU - Patry, Cyrille
AU  - Patry C
AD  - 0000 0004 0638 9213grid.411158.8Réanimation médicale, CHU de Besançon, Besançon, 
      France
FAU - Chaignat, Claire
AU  - Chaignat C
AD  - 0000 0004 0638 9213grid.411158.8Réanimation médicale, CHU de Besançon, Besançon, 
      France
FAU - Claveau, Melanie
AU  - Claveau M
AD  - 0000 0004 0638 9213grid.411158.8Réanimation médicale, CHU de Besançon, Besançon, 
      France
FAU - Claude, Frédéric
AU  - Claude F
AD  - 0000 0004 0638 9213grid.411158.8Réanimation médicale, CHU de Besançon, Besançon, 
      France
FAU - Aubron, Cécile
AU  - Aubron C
AD  - Réanimation médicaleBd Tanguy Prigent, Brest, France
FAU - Mcquilten, Zoe
AU  - Mcquilten Z
AD  - 0000 0004 1936 7857grid.1002.3DEPM, Transfusion Research Unit, Monash University,
      Melbourne, Australia
FAU - Bailey, Michael
AU  - Bailey M
AD  - 0000 0004 1936 7857grid.1002.3DEPM, Monash University, ANZIC-RC, Melbourne,
      Australia
FAU - Board, Jasmin
AU  - Board J
AD  - 0000 0004 0432 511Xgrid.1623.6Intensive Care Unit, Alfred Hospital, Melbourne,
      Australia
FAU - Buhr, Heidi
AU  - Buhr H
AD  - 0000 0004 0385 0051grid.413249.9Intensive Care Unit, Royal Prince Alfred
      Hospital, Sydney, Australia
FAU - Cartwright, Bruce
AU  - Cartwright B
AD  - 0000 0004 0385 0051grid.413249.9Intensive Care Unit, Royal Prince Alfred
      Hospital, Sydney, Australia
FAU - Dennis, Mark
AU  - Dennis M
AD  - 0000 0004 0385 0051grid.413249.9Intensive Care Unit, Royal Prince Alfred
      Hospital, Camperdown, Australia
FAU - Forrest, Paul
AU  - Forrest P
AD  - 0000 0004 0385 0051grid.413249.9Intensive Care Unit, Royal Prince Alfred
      Hospital, Sydney, Australia
FAU - Hodgson, Carol
AU  - Hodgson C
AD  - 0000 0004 0432 511Xgrid.1623.6Intensive Care Unit, Alfred Hospital, Melbourne,
      Australia
FAU - Mcilroy, David
AU  - Mcilroy D
AD  - 0000 0004 0432 511Xgrid.1623.6Anesthesiology, Alfred Hospital, Prahran, Australia
FAU - Murphy, Deirdre
AU  - Murphy D
AD  - 0000 0004 0432 511Xgrid.1623.6Intensive Care Unit, Alfred Hospital, Melbourne,
      Australia
FAU - Murray, Lynnette
AU  - Murray L
AD  - 0000 0004 1936 7857grid.1002.3DEPM, Monash University, ANZIC-RC, Melbourne,
      Australia
FAU - Pellegrino, Vincent
AU  - Pellegrino V
AD  - 0000 0004 0432 511Xgrid.1623.6Intensive Care Unit, Alfred Hospital, Melbourne,
      Australia
FAU - Pilcher, David
AU  - Pilcher D
AD  - 0000 0004 0432 511Xgrid.1623.6Intensive Care Unit, Alfred Hospital, Melbourne,
      Australia
FAU - Sheldrake, Jayne
AU  - Sheldrake J
AD  - 0000 0004 0432 511Xgrid.1623.6Intensive Care Unit, Alfred Hospital, Melbourne,
      Australia
FAU - Tran, Huyen
AU  - Tran H
AD  - 0000 0004 0432 511Xgrid.1623.6Haematology, Alfred Hospital, Prahran, Australia
FAU - Vallance, Shirley
AU  - Vallance S
AD  - 0000 0004 0432 511Xgrid.1623.6Intensive Care Unit, Alfred Hospital, Melbourne,
      Australia
FAU - Cooper, Jamie
AU  - Cooper J
AD  - 0000 0004 1936 7857grid.1002.3DEPM, Monash University, ANZIC-RC, Melbourne,
      Australia
FAU - Bombled, Camille
AU  - Bombled C
AD  - 0000 0001 1955 3500grid.5805.8Département d’anesthésie et de réanimation, UMRS
      INSERM 1166, Hôpital Universitaire La Pitié-Salpêtrière, Université Pierre et
      Marie Curie, IHU ICAN, Paris, France
FAU - Vidal, Charles
AU  - Vidal C
AD  - 0000 0001 1955 3500grid.5805.8Département d’anesthésie et de réanimation, UMRS
      INSERM 1166, Hôpital Universitaire La Pitié-Salpêtrière, Université Pierre et
      Marie Curie, IHU ICAN, Paris, France
FAU - Margetis, Dimitri
AU  - Margetis D
AD  - 0000 0001 1955 3500grid.5805.8Département d’anesthésie et de réanimation, UMRS
      INSERM 1166, Hôpital Universitaire La Pitié-Salpêtrière, Université Pierre et
      Marie Curie, IHU ICAN, Paris, France
FAU - Amour, Julien
AU  - Amour J
AD  - 0000 0001 1955 3500grid.5805.8Département d’anesthésie et de réanimation, UMRS
      INSERM 1166, Hôpital Universitaire La Pitié-Salpêtrière, Université Pierre et
      Marie Curie, IHU ICAN, Paris, France
FAU - Coart, Domien
AU  - Coart D
AD  - 0000 0004 0626 3338grid.410569.fIntensive care medicine, UZ Leuven, Louvain,
      Belgium
FAU - Dubois, Jasperina
AU  - Dubois J
AD  - 0000 0004 0578 1096grid.414977.8Anesthesia & Intensive Care, Jessa Ziekenhuis,
      Campus Virga Jesse, Hasselt, Belgium
FAU - Van Herpe, Tom
AU  - Van Herpe T
AD  - 0000 0004 0626 3338grid.410569.fIntensive care medicine, UZ Leuven, Louvain,
      Belgium
FAU - Mesotten, Dieter
AU  - Mesotten D
AD  - 0000 0004 0612 7379grid.470040.7Anaesthesiology & Intensive Care, Ziekenhuis
      Oost-Limburg a.v., Genk, Belgium
FAU - Bailly, Sébastien
AU  - Bailly S
AD  - 0000000121866389grid.7429.8Iame team 5, INSERM UMR 1137, Paris, France
FAU - Lucet, Jc
AU  - Lucet J
AD  - 0000 0000 8588 831Xgrid.411119.dHygiène hospitalière, Hôpital Bichat-Claude
      Bernard (AP-HP), Paris, France
FAU - Lepape, Alain
AU  - Lepape A
AD  - 0000 0001 2163 3825grid.413852.9Réanimation, Hospices Civils De Lyon, Lyon,
      France
FAU - L’hériteau, François
AU  - L’hériteau F
AD  - 0000 0000 8588 831Xgrid.411119.dMédecine interne, Hôpital Bichat-Claude Bernard
      (AP-HP), Paris, France
FAU - Aupée, Martine
AU  - Aupée M
AD  - Hygiène hospitalière, C.H.U de Rennes, Rennes, France
FAU - Bervas, Caroline
AU  - Bervas C
AD  - 0000 0004 0593 7118grid.42399.35Pharmacie, CHU - Hôpitaux de Bordeaux, Bordeaux, 
      France
FAU - Boussat, Sandrine
AU  - Boussat S
AD  - Réanimation, CHRU Nancy, Nancy, France
FAU - Berger-Carbonne, Anne
AU  - Berger-Carbonne A
AD  - grid.418199.cDGOS, Ministère des Affaires sociales et de la Santé, Paris, France
FAU - Machut, Anaïs
AU  - Machut A
AD  - 0000 0001 2163 3825grid.413852.9Cclin sud est, Hospices Civils De Lyon, Lyon,
      France
FAU - Savey, Anne
AU  - Savey A
AD  - 0000 0001 2163 3825grid.413852.9Cclin, Hospices Civils De Lyon, Lyon, France
CN  - REA-RAISIN Study Group
FAU - Tudesq, Jean-Jacques
AU  - Tudesq JJ
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Hôpital Saint-Louis, Paris,
      France
FAU - Valade, Sandrine
AU  - Valade S
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Hôpital Saint-Louis, Paris,
      France
FAU - Galicier, Lionel
AU  - Galicier L
AD  - 0000 0001 2300 6614grid.413328.fImmuno-hématologie, Hôpital Saint-Louis (AP-HP), 
      Paris, France
FAU - De Bazelaire, Cédric
AU  - De Bazelaire C
AD  - 0000 0001 2300 6614grid.413328.fRadiologie, Hôpital Saint-Louis, Paris, France
FAU - Munoz-Bongrand, Nicolas
AU  - Munoz-Bongrand N
AD  - 0000 0001 2300 6614grid.413328.fChirurgie viscérale, Hôpital Saint-Louis, Paris, 
      France
FAU - Mignard, Xavier
AU  - Mignard X
AD  - 0000 0001 2300 6614grid.413328.fReanimation médicale, Hôpital Saint-Louis
      (AP-HP), Paris, France
FAU - Biard, Lucie
AU  - Biard L
AD  - 0000 0001 2175 4109grid.50550.35Sbim, Assistance Publique Hôpitaux de Paris,
      Paris, France
FAU - Mokart, Djamel
AU  - Mokart D
AD  - 0000 0004 0598 4440grid.418443.eRéanimation, Institut Paoli-Calmettes, Marseille,
      France
FAU - Nyunga, Martine
AU  - Nyunga M
AD  - Réanimation polyvalente, Centre Hospitalier de Roubaix, Roubaix, France
FAU - Bruneel, Fabrice
AU  - Bruneel F
AD  - 0000 0001 2177 7052grid.418080.5Réanimation médico-chirurgicale, Centre
      Hospitalier de Versailles, Le Chesnay, France
FAU - Rabbat, Antoine
AU  - Rabbat A
AD  - 0000 0001 0274 3893grid.411784.fRéanimation pneumologique, Hôpital Cochin, Paris,
      France
FAU - Perez, Pierre
AU  - Perez P
AD  - Réanimation polyvalente, C.H.U. de Nancy, Nancy, France
FAU - Meert, Anne Pascale
AU  - Meert AP
AD  - 0000 0001 0684 291Xgrid.418119.4Réanimation, Institut Jules Bordet, Brussels,
      Belgium
FAU - Benoit, Dominique
AU  - Benoit D
AD  - 0000 0004 0626 3303grid.410566.0Réanimation polyvalente, Hopital universitaire,
      Gand, Belgium
FAU - Mariotte, Eric
AU  - Mariotte E
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Hôpital Saint-Louis
      (AP-HP), Paris, France
FAU - Ehooman, Franck
AU  - Ehooman F
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Hôpital Saint-Louis
      (AP-HP), Paris, France
FAU - Hamidfar-Roy, Rebecca
AU  - Hamidfar-Roy R
AD  - Réanimation médicale, C.H.U., La Tronche, La Tronche, France
FAU - Hourmant, Yannick
AU  - Hourmant Y
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Mailloux, Arnaud
AU  - Mailloux A
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Hôpital Saint-Louis, Paris,
      France
FAU - Beurton, Alexandra
AU  - Beurton A
AD  - 0000 0001 2181 7253grid.413784.dService de réanimation médicale, INSERM UMRS_999,
      université paris-sud, Hôpital de bicêtre, hôpitaux universitaires paris-sud,
      Assistance publique – Hôpitaux de Paris, Le Kremlin-Bicêtre, France
FAU - Teboul, Jean-Louis
AU  - Teboul JL
AD  - 0000 0001 2181 7253grid.413784.dService de réanimation médicale, INSERM UMRS_999,
      université paris-sud, Hôpital de bicêtre, hôpitaux universitaires paris-sud,
      Assistance publique – Hôpitaux de Paris, Le Kremlin-Bicêtre, France
FAU - Girroto, Valentina
AU  - Girroto V
AD  - 0000 0001 2181 7253grid.413784.dService de réanimation médicale, INSERM UMRS_999,
      université paris-sud, Hôpital de bicêtre, hôpitaux universitaires paris-sud,
      Assistance publique – Hôpitaux de Paris, Le Kremlin-Bicêtre, France
FAU - Laura, Galarza
AU  - Laura G
AD  - 0000 0001 2181 7253grid.413784.dService de réanimation médicale, INSERM UMRS_999,
      université paris-sud, Hôpital de bicêtre, hôpitaux universitaires paris-sud,
      Assistance publique – Hôpitaux de Paris, Le Kremlin-Bicêtre, France
FAU - Richard, Christian
AU  - Richard C
AD  - 0000 0001 2181 7253grid.413784.dService de réanimation médicale, INSERM UMRS_999,
      université paris-sud, Hôpital de bicêtre, hôpitaux universitaires paris-sud,
      Assistance publique – Hôpitaux de Paris, Le Kremlin-Bicêtre, France
FAU - Monnet, Xavier
AU  - Monnet X
AD  - 0000 0001 2181 7253grid.413784.dService de réanimation médicale, INSERM UMRS_999,
      université paris-sud, Hôpital de bicêtre, hôpitaux universitaires paris-sud,
      Assistance publique – Hôpitaux de Paris, Le Kremlin-Bicêtre, France
FAU - Dubée, Vincent
AU  - Dubée V
AD  - 0000 0004 1937 1100grid.412370.3Service de Réanimation Médicale, Hôpital
      Saint-Antoine, Paris, France
FAU - Merdji, Hamid
AU  - Merdji H
AD  - 0000 0004 1937 1100grid.412370.3Service de Réanimation Médicale, Hôpital
      Saint-Antoine, Paris, France
FAU - Dang, Julien
AU  - Dang J
AD  - 0000 0004 1937 1100grid.412370.3Service de Réanimation Médicale, Hôpital
      Saint-Antoine, Paris, France
FAU - Preda, Gabriel
AU  - Preda G
AD  - 0000 0004 1937 1100grid.412370.3Réanimation médicale, Hôpital Saint-Antoine,
      Paris, France
FAU - Baudel, Jean-Luc
AU  - Baudel JL
AD  - 0000 0004 1937 1100grid.412370.3Réanimation médicale, Hôpital Saint-Antoine,
      Paris, France
FAU - Desnos, Cyrielle
AU  - Desnos C
AD  - 0000 0001 2259 4338grid.413483.9Réanimation médico-chirurgicale, Hôpital Tenon,
      Paris, France
FAU - Zeitouni, Michel
AU  - Zeitouni M
AD  - 0000 0001 2259 4338grid.413483.9Réanimation médico-chirurgicale, Hôpital Tenon,
      Paris, France
FAU - Belaroussi, Ines
AU  - Belaroussi I
AD  - 0000 0001 2259 4338grid.413483.9Réanimation médico-chirurgicale, Hôpital Tenon,
      Paris, France
FAU - Parrot, Antoine
AU  - Parrot A
AD  - 0000 0001 2259 4338grid.413483.9Réanimation médico-chirurgicale, Hôpital Tenon,
      Paris, France
FAU - Blayau, Clarisse
AU  - Blayau C
AD  - 0000 0001 2259 4338grid.413483.9Réanimation médico-chirurgicale, Hôpital Tenon,
      Paris, France
FAU - Fulgencio, Jean-Pierre
AU  - Fulgencio JP
AD  - 0000 0001 2259 4338grid.413483.9Réanimation médico-chirurgicale, Hôpital Tenon,
      Paris, France
FAU - Quesnel, Christophe
AU  - Quesnel C
AD  - 0000 0001 2259 4338grid.413483.9Réanimation médico-chirurgicale, Hôpital Tenon,
      Paris, France
FAU - Labbe, Vincent
AU  - Labbe V
AD  - 0000 0001 2259 4338grid.413483.9Réanimation médico-chirurgicale, Hôpital Tenon
      -APHP, Paris, France
FAU - De Chambrun, Marc Pineton
AU  - De Chambrun MP
AD  - 0000 0001 2175 4109grid.50550.35Service de réanimation médicale, Groupe
      Hospitalier La Pitié-Salpêtrière, Institut de Cardiométabolisme et Nutrition,
      Assistance Publique Hôpitaux de Paris, Paris, France
FAU - Beloncle, François
AU  - Beloncle F
AD  - Département de réanimation médicale et de médecine hyperbare, C.H.U. d’Angers,
      Angers, France
FAU - Merceron, Sybille
AU  - Merceron S
AD  - 0000 0001 2177 7052grid.418080.5Service de réanimation médico-chirurgicale,
      Centre Hospitalier de Versailles, Le Chesnay, France
FAU - Fedun, Yannick
AU  - Fedun Y
AD  - grid.440367.2Service de réanimation polyvalente, Centre Hospitalier Bretagne
      Atlantique, Vannes, France
FAU - Lecomte, Bernard
AU  - Lecomte B
AD  - Service de réanimation polyvalente, Centre Hospitalier Notre-Dame de la
      Miséricorde, Ajaccio, France
FAU - Devaquet, Jérôme
AU  - Devaquet J
AD  - Service de réanimation polyvalente, Hospital Foch, Suresnes, France
FAU - Puidupin, Marc
AU  - Puidupin M
AD  - 0000 0000 8943 5457grid.414010.0Service de réanimation polyvalente, Hôpital
      d’instruction des armées Desgenettes, Lyon, France
FAU - Verdière, Bruno
AU  - Verdière B
AD  - Service de réanimation polyvalente, Centre Hospitalier Général de Saint-Denis,
      Saint-Denis, France
FAU - Amoura, Zahir
AU  - Amoura Z
AD  - 0000 0001 2175 4109grid.50550.35Service de médecine interne, Groupe Hospitalier
      La Pitié-Salpêtrière, Institut IE3M, Assistance Publique Hôpitaux de Paris,
      Paris, France
CN  - for the EurêClark Study Group
FAU - Vuillard, Constance
AU  - Vuillard C
AD  - 0000 0001 2181 7253grid.413784.dHôpital Bicêtre (AP-HP), Le Kremlin-Bicêtre,
      France
FAU - Xavier, Jais
AU  - Xavier J
AD  - 0000 0001 2181 7253grid.413784.dVal de marne, Hôpital Bicêtre (AP-HP), Le
      Kremlin-Bicêtre, France
FAU - Bourlier, Delphine
AU  - Bourlier D
AD  - 0000 0001 2181 7253grid.413784.dVal de marne, Hôpital Bicêtre (AP-HP), Le
      Kremlin-Bicêtre, France
FAU - David, Amar
AU  - David A
AD  - 0000 0001 2181 7253grid.413784.dVal de marne, Hôpital Bicêtre (AP-HP), Le
      Kremlin-Bicêtre, France
FAU - Caroline, Sattler
AU  - Caroline S
AD  - 0000 0001 2181 7253grid.413784.dVal de marne, Hôpital Bicêtre (AP-HP), Le
      Kremlin-Bicêtre, France
FAU - David, Montani
AU  - David M
AD  - 0000 0001 2181 7253grid.413784.dVal de marne, Hôpital Bicêtre (AP-HP), Le
      Kremlin-Bicêtre, France
FAU - Gerald, Simmoneau
AU  - Gerald S
AD  - 0000 0001 2181 7253grid.413784.dVal de marne, Hôpital Bicêtre (AP-HP), Le
      Kremlin-Bicêtre, France
FAU - Olivier, Sitbon
AU  - Olivier S
AD  - 0000 0001 2181 7253grid.413784.dVal de marne, Hôpital Bicêtre (AP-HP), Le
      Kremlin-Bicêtre, France
FAU - Humbert, Marc
AU  - Humbert M
AD  - 0000 0001 2181 7253grid.413784.dVal de marne, Hôpital Bicêtre (AP-HP), Le
      Kremlin-Bicêtre, France
FAU - Laurent, Savale
AU  - Laurent S
AD  - 0000 0001 2181 7253grid.413784.dVal de marne, Hôpital Bicêtre (AP-HP), Le
      Kremlin-Bicêtre, France
FAU - Dujardin, Olivier
AU  - Dujardin O
AD  - 0000 0001 1955 3500grid.5805.8Département d’anesthésie et de réanimation, UMRS
      INSERM 1166, Hôpital Universitaire La Pitié-Salpêtrière, Université Pierre et
      Marie Curie, IHU ICAN, Paris, France
FAU - Bouglé, Adrien
AU  - Bouglé A
AD  - 0000 0001 1955 3500grid.5805.8Département d’anesthésie et de réanimation, UMRS
      INSERM 1166, Hôpital Universitaire La Pitié-Salpêtrière, Université Pierre et
      Marie Curie, IHU ICAN, Paris, France
FAU - Ait, Hamou Nora
AU  - Ait HN
AD  - 0000 0001 1955 3500grid.5805.8Département d’anesthésie et de réanimation, UMRS
      INSERM 1166, Hôpital Universitaire La Pitié-Salpêtrière, Université Pierre et
      Marie Curie, IHU ICAN, Paris, France
FAU - Salem, Joe Elie
AU  - Salem JE
AD  - 0000 0001 1955 3500grid.5805.8Centre d’investigation clinique paris est 1421,
      département de pharmacologie, Hôpital Universitaire La Pitié-Salpêtrière,
      Université Pierre et Marie Curie, IHU ICAN, Paris, France
FAU - El-Helali, Najoua
AU  - El-Helali N
AD  - 0000 0001 0274 7763grid.414363.7Unité de microbiologie clinique et dosages des
      anti-infectieux, Groupe hospitalier Paris Saint-Joseph, Paris, France
FAU - Coppere, Zoé
AU  - Coppere Z
AD  - 0000 0001 2259 4338grid.413483.9Réanimation médico-chirurgicale, Hôpital Tenon
      -APHP, Paris, France
FAU - Gibelin, Aude
AU  - Gibelin A
AD  - 0000 0001 2259 4338grid.413483.9Réanimation médico-chirurgicale, Hôpital Tenon
      -APHP, Paris, France
FAU - Taconet, Clementine
AU  - Taconet C
AD  - 0000 0001 2259 4338grid.413483.9Réanimation médico-chirurgicale, Hôpital Tenon
      -APHP, Paris, France
FAU - Djibre, Michel
AU  - Djibre M
AD  - 0000 0001 2259 4338grid.413483.9Réanimation médico-chirurgicale, Hôpital Tenon
      -APHP, Paris, France
FAU - Maamar, Adel
AU  - Maamar A
AD  - 0000 0001 2175 0984grid.411154.4Réanimation médicale, Centre Hospitalier
      Universitaire de Rennes, Rennes, France
FAU - Colobert, Elen
AU  - Colobert E
AD  - 0000 0001 2175 0984grid.411154.4Réanimation médicale, Centre Hospitalier
      Universitaire de Rennes, Rennes, France
FAU - Fillatre, Pierre
AU  - Fillatre P
AD  - 0000 0001 2175 0984grid.411154.4Réanimation médicale, Centre Hospitalier
      Universitaire de Rennes, Rennes, France
FAU - Uhel, Fabrice
AU  - Uhel F
AD  - 0000 0001 2175 0984grid.411154.4Réanimation médicale, Centre Hospitalier
      Universitaire de Rennes, Rennes, France
FAU - Camus, Christophe
AU  - Camus C
AD  - 0000 0001 2175 0984grid.411154.4Réanimation médicale, Centre Hospitalier
      Universitaire de Rennes, Rennes, France
FAU - Moraly, Josquin
AU  - Moraly J
AD  - 0000 0004 1937 1100grid.412370.3Réanimation médicale, Hôpital Saint-Antoine,
      Paris, France
FAU - Dahoumane, Redouane
AU  - Dahoumane R
AD  - 0000 0004 1937 1100grid.412370.3Microbiologie, Hôpital Saint-Antoine, Paris,
      France
FAU - Maury, Eric
AU  - Maury E
AD  - 0000 0004 1937 1100grid.412370.3Réanimation Médicale, Hôpital Saint-Antoine,
      AP-HP, Paris, France
FAU - Tan, Boun Kim
AU  - Tan BK
AD  - Réanimation Polyvalente, Hôpital Saint Joseph Saint Luc, Lyon, France
FAU - Emmanuel, Vivier
AU  - Emmanuel V
AD  - Réanimation Polyvalente, Hôpital Saint Joseph Saint Luc, Lyon, France
FAU - Pauline, Misslin
AU  - Pauline M
AD  - Pharmacie, Hôpital Saint Joseph Saint Luc, Lyon, France
FAU - Laurence, Parmeland
AU  - Laurence P
AD  - Biologie, Hôpital Saint Joseph Saint Luc, Lyon, France
FAU - Philippe, Poirié
AU  - Philippe P
AD  - Département d’information médicale, Hôpital Saint Joseph Saint Luc, Lyon, France
FAU - Zahar, Jean-Ralph
AU  - Zahar JR
AD  - 0000 0004 0472 0283grid.411147.6Unité de prévention et lutte contre les
      infections nosocomiales (uplin), CHU Angers, Angers, France
FAU - Catherine, Haond
AU  - Catherine H
AD  - 0000 0001 2163 3825grid.413852.9Hygiène hospitalière, Hospices Civils de Lyon,
      Lyon, France
FAU - Christian, Pommier
AU  - Christian P
AD  - Réanimation Polyvalente, Hôpital Saint Joseph Saint Luc, Lyon, France
FAU - Karim, Ait-Bouziad
AU  - Karim AB
AD  - 0000 0001 2185 090Xgrid.36823.3cLaboratoire mesurs, Conservatoire National des
      Arts et Métiers, Paris, France
FAU - Mounia, Hocine
AU  - Mounia H
AD  - 0000 0001 2185 090Xgrid.36823.3cLaboratoire mesurs, Conservatoire National des
      Arts et Métiers, Paris, France
FAU - Laura, Témime
AU  - Laura T
AD  - 0000 0001 2185 090Xgrid.36823.3cLaboratoire mesurs, Conservatoire National des
      Arts et Métiers, Paris, France
FAU - Rasoldier, Vero Hanitra
AU  - Rasoldier VH
AD  - Réanimation polyvalente, Centre Hospitalier de Dieppe, Dieppe, France
FAU - Mager, Guy
AU  - Mager G
AD  - Microbiologie, Centre Hospitalier de Dieppe, Dieppe, France
FAU - Eraldi, Jean-Pierre
AU  - Eraldi JP
AD  - Réanimation polyvalente, Centre Hospitalier de Dieppe, Dieppe, France
FAU - Gelinotte, Stéphanie
AU  - Gelinotte S
AD  - Réanimation polyvalente, Centre Hospitalier de Dieppe, Dieppe, France
FAU - Bougerol, François
AU  - Bougerol F
AD  - Réanimation polyvalente, Centre Hospitalier de Dieppe, Dieppe, France
FAU - Dehay, Julien
AU  - Dehay J
AD  - Réanimation polyvalente, Centre Hospitalier de Dieppe, Dieppe, France
FAU - Rigaud, Jean-Philippe
AU  - Rigaud JP
AD  - Réanimation polyvalente, Centre Hospitalier de Dieppe, Dieppe, France
FAU - Declercq, Pierre Louis
AU  - Declercq PL
AD  - Réanimation polyvalente, Centre Hospitalier de Dieppe, Dieppe, France
FAU - Michel, Julien
AU  - Michel J
AD  - Service de réanimation médicale brabois, CHRU de Nancy, Vandœuvre-Lès-Nancy,
      France
FAU - Aissa, Nejla
AU  - Aissa N
AD  - Service de microbiologie, CHRU de Nancy, Vandœuvre-Lès-Nancy, France
FAU - Henard, Sandrine
AU  - Henard S
AD  - Service de maladie infectieuse et tropicale, CHRU de Nancy, Vandœuvre-Lès-Nancy, 
      France
FAU - Guerci, Philippe
AU  - Guerci P
AD  - Service de réanimation chirurgicale brabois, CHRU de Nancy, Vandœuvre-Lès-Nancy, 
      France
FAU - Latar, Ichraq
AU  - Latar I
AD  - Centre d’investigation clinique pierre drouin, CHRU de Nancy,
      Vandœuvre-Lès-Nancy, France
FAU - Levy, Bruno
AU  - Levy B
AD  - Service de réanimation médicale brabois, CHRU de Nancy, Vandœuvre-Lès-Nancy,
      France
FAU - Girerd, Nicolas
AU  - Girerd N
AD  - Cardiologie - centre d’investigation clinique pierre drouin, CHRU de Nancy,
      Vandœuvre-Lès-Nancy, France
FAU - Kimmoun, Antoine
AU  - Kimmoun A
AD  - 0000 0004 1765 1301grid.410527.5Réanimation Médicale Brabois, Centre Hospitalier 
      Universitaire de Nancy, Vandœuvre-Lès-Nancy, France
FAU - Abdallah, Saousen Ben
AU  - Abdallah SB
AD  - grid.420157.5Réanimation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Nakaa, Sabrine
AU  - Nakaa S
AD  - grid.420157.5Réanimation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Hraiech, Kmar
AU  - Hraiech K
AD  - grid.420157.5Réanimation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Braiek, Dhouha Ben
AU  - Braiek DB
AD  - grid.420157.5Réanimation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Adhieb, Ali
AU  - Adhieb A
AD  - grid.420157.5Réanimation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - M’ghirbi, Abdelwaheb
AU  - M’ghirbi A
AD  - grid.420157.5Réanimation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Ousji, Ali
AU  - Ousji A
AD  - grid.420157.5Réanimation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Hammouda, Zeineb
AU  - Hammouda Z
AD  - grid.420157.5Réanimation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Abroug, Fekri
AU  - Abroug F
AD  - grid.420157.5Réanimation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Sellami, Walid
AU  - Sellami W
AD  - grid.415617.0Department of Critical Care Medicine and Anesthesiology, Military
      Hospital of Tunis, Tunis, Tunisia
FAU - Hajjej, Zied
AU  - Hajjej Z
AD  - grid.415617.0Department of Critical Care Medicine and Anesthesiology, Military
      Hospital of Tunis, Tunis, Tunisia
FAU - Samoud, Walid
AU  - Samoud W
AD  - grid.415617.0Department of Critical Care Medicine and Anesthesiology, Military
      Hospital of Tunis, Tunis, Tunisia
FAU - Labbene, Iheb
AU  - Labbene I
AD  - grid.415617.0Department of Critical Care Medicine and Anesthesiology, Military
      Hospital of Tunis, Tunis, Tunisia
FAU - Ferjani, Mustapha
AU  - Ferjani M
AD  - grid.415617.0Department of Critical Care Medicine and Anesthesiology, Military
      Hospital of Tunis, Tunis, Tunisia
FAU - Medhioub, Fatma Kaaniche
AU  - Medhioub FK
AD  - 0000 0001 2323 5644grid.412124.0Faculté de médecine de Sfax, Sfax, Tunisia
FAU - Allela, Rania
AU  - Allela R
AD  - 0000 0001 2323 5644grid.412124.0Hopital régional mahres, Faculté de médecine de
      Sfax, Sfax, Tunisia
FAU - Algia, Najla Ben
AU  - Algia NB
AD  - Intensive Care, hopital régional Gafsa, Sfax, Tunisia
FAU - Cherif, Samar
AU  - Cherif S
AD  - Intensive Care, hopital régional mahres, Sfax, Tunisia
FAU - Attia, Delphine
AU  - Attia D
AD  - URGENCES, Centre Hospitalier Général de Longjumeau, Longjumeau, France
FAU - Herinjatovo, Andrianjafy
AU  - Herinjatovo A
AD  - URGENCES, Centre Hospitalier Général de Longjumeau, Longjumeau, France
FAU - Francois, Xavier Laborne
AU  - Francois XL
AD  - Samu, C.H. Sud Francilien, Corbeil-Essonnes, France
FAU - Bouhouri, Med Aziz
AU  - Bouhouri MA
AD  - 0000 0004 0647 7037grid.414346.0Reanimation des urgences chirurgicale, Chu Ibn
      Rochd, Casablanca, Morocco
FAU - Slaoui, Mohamed Taoufik
AU  - Slaoui MT
AD  - 0000 0004 0647 7037grid.414346.0Reanimation des urgences chirurgicale, Chu Ibn
      Rochd, Casablanca, Morocco
FAU - Soufi, A.
AU  - Soufi A
AD  - 0000 0004 0647 7037grid.414346.0Reanimation des urgences chirurgicale, Chu Ibn
      Rochd, Casablanca, Morocco
FAU - Khaleq, K.
AU  - Khaleq K
AD  - 0000 0004 0647 7037grid.414346.0Reanimation des urgences chirurgicale, Chu Ibn
      Rochd, Casablanca, Morocco
FAU - Hamoudi, D.
AU  - Hamoudi D
AD  - 0000 0004 0647 7037grid.414346.0Reanimation des urgences chirurgicale, Chu Ibn
      Rochd, Casablanca, Morocco
FAU - Nsiri, A.
AU  - Nsiri A
AD  - 0000 0004 0647 7037grid.414346.0Reanimation des urgences chirurgicale, Chu Ibn
      Rochd, Casablanca, Morocco
FAU - Harrar, R.
AU  - Harrar R
AD  - 0000 0004 0647 7037grid.414346.0Reanimation des urgences chirurgicale, Chu Ibn
      Rochd, Casablanca, Morocco
FAU - Maury, Eric
AU  - Maury E
AD  - 0000 0004 1937 1100grid.412370.3Réanimation médicale, Hôpital Saint-Antoine,
      Paris, France
FAU - Goursaud, Suzanne
AU  - Goursaud S
AD  - Calvados, Pôle Anesthésie-Réanimation C.H.U de Caen, Caen, France
FAU - Gauberti, Maxime
AU  - Gauberti M
AD  - Calvados, INSERM U919, Cyceron, Caen, France
FAU - Labeyrie, Paul-Emile
AU  - Labeyrie PE
AD  - Calvados, INSERM U919, Cyceron, Caen, France
FAU - Gaberel, Thomas
AU  - Gaberel T
AD  - Calvados, Neurochirurgie, C.H.U de Caen, Caen, France
FAU - Agin, Véronique
AU  - Agin V
AD  - Calvados, INSERM U919, Cyceron, Caen, France
FAU - Maubert, Eric
AU  - Maubert E
AD  - Calvados, INSERM U919, Cyceron, Caen, France
FAU - Vivien, Denis
AU  - Vivien D
AD  - Calvados, INSERM U919, Cyceron, Caen, France
FAU - Gakuba, Clément
AU  - Gakuba C
AD  - Calvados, Pôle Anesthésie-Réanimation C.H.U de Caen, Caen, France
FAU - Armel, Anwar
AU  - Armel A
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Abdou, Rchi
AU  - Abdou R
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Kalouch, Samira
AU  - Kalouch S
AD  - Service de réanimation pédiatriqueChu Ibn Rochd, Casablanca, Morocco
FAU - Yaqini, Khalid
AU  - Yaqini K
AD  - Service de réanimation pédiatriqueChu Ibn Rochd, Casablanca, Morocco
FAU - Chlilek, Aziz
AU  - Chlilek A
AD  - Service de réanimation pédiatriqueChu Ibn Rochd, Casablanca, Morocco
FAU - Sellami, Walid
AU  - Sellami W
AD  - grid.415617.0Department of Critical Care Medicine and Anesthesiology, Military
      Hospital of Tunis, Tunis, Tunisia
FAU - Yedder, Soumaya Ben
AU  - Yedder SB
AD  - grid.415617.0Department of Critical Care Medicine and Anesthesiology, Military
      Hospital of Tunis, Tunis, Tunisia
FAU - Tonnelier, Alexandre
AU  - Tonnelier A
AD  - FinistereC.H. de Cornouaille, Quimper, France
FAU - Hervé, Fabien
AU  - Hervé F
AD  - FinistereC.H. de Cornouaille, Quimper, France
FAU - Halley, Guillaume
AU  - Halley G
AD  - FinistereC.H. de Cornouaille, Quimper, France
FAU - Frances, Jean-Luc
AU  - Frances JL
AD  - FinistereC.H. de Cornouaille, Quimper, France
FAU - Moriconi, Mickael
AU  - Moriconi M
AD  - FinistereC.H. de Cornouaille, Quimper, France
FAU - Saoli, Mathieu
AU  - Saoli M
AD  - VAR, Hospital Sainte Musse, Toulon, France
FAU - Garnero, Aude
AU  - Garnero A
AD  - VAR, Hospital Sainte Musse, Toulon, France
FAU - Demory, Didier
AU  - Demory D
AD  - Réanimation polyvalente, Hôpital Sainte-Musse, Toulon, France
FAU - Arnal, Jean Michel
AU  - Arnal JM
AD  - Réanimation polyvalente, Hôpital Sainte-Musse, Toulon, France
FAU - Canoville, Bertrand
AU  - Canoville B
AD  - 0000 0004 0472 0160grid.411149.8Réanimation médicale, Centre Hospitalier
      Universitaire de Caen, Caen, France
FAU - Daubin, Cédric
AU  - Daubin C
AD  - 0000 0004 0472 0160grid.411149.8Réanimation médicale, Centre Hospitalier
      Universitaire de Caen, Caen, France
FAU - Brunet, Jennifer
AU  - Brunet J
AD  - 0000 0004 0472 0160grid.411149.8Anesthésie, Centre Hospitalier Universitaire de
      Caen, Caen, France
FAU - Ghezala, Hassen Ben
AU  - Ghezala HB
AD  - 0000 0001 2292 1474grid.412116.1Réanimation Médicale, Hôpital Henri Mondor,
      Avenue du Maréchal de Lattre de Tassigny, Créteil, France
FAU - Snouda, Salah
AU  - Snouda S
AD  - Réanimation Médicale, Hopital regional zaghouan, faculté de médecine de Tunis,
      Zaghouan, Tunisia
FAU - Ben, Chiekh Imen
AU  - Ben CI
AD  - Teaching Department of Emergency and Intensive Care, Regional Hospital of
      Zaghouan, Zaghouan, Tunisia
FAU - Kaddour, Moez
AU  - Kaddour M
AD  - Réanimation Médicale, Hopital regional zaghouan, faculté de médecine de Tunis,
      Zaghouan, Tunisia
FAU - Ouanes, Islem
AU  - Ouanes I
AD  - grid.420157.5Réanimation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Marzouk, Mahdi
AU  - Marzouk M
AD  - grid.420157.5Réanimation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Haniez, Françoise
AU  - Haniez F
AD  - 91, C.H. Bligny, Briis-Sous-Forges, France
FAU - Jaillet, Hélène
AU  - Jaillet H
AD  - 91, C.H. Bligny, Briis-Sous-Forges, France
FAU - Maas, Henri
AU  - Maas H
AD  - 91, C.H. Bligny, Briis-Sous-Forges, France
FAU - Andrivet, Pierre
AU  - Andrivet P
AD  - 91, C.H. Bligny, Briis-Sous-Forges, France
FAU - Darné, Christian
AU  - Darné C
AD  - 91, C.H. Bligny, Briis-Sous-Forges, France
FAU - Viau, François
AU  - Viau F
AD  - 91, C.H. Bligny, Briis-Sous-Forges, France
FAU - Ghezala, Hassen Ben
AU  - Ghezala HB
AD  - Réanimation Médicale, Teaching Department of Emergency and Intensive Care,
      Hospital of Zaghouan, Zaghouan, Tunisia
FAU - Ouanes, Islem
AU  - Ouanes I
AD  - grid.420157.5Réanimation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Dangers, Laurence
AU  - Dangers L
AD  - Service de pneumologie et réanimation médicale, Groupe Hospitalier Pitié
      Salpêtrière, Paris, France
FAU - Montlahuc, Claire
AU  - Montlahuc C
AD  - 0000 0001 2300 6614grid.413328.fDepartment of Informatics and Biostatistics,
      Saint Louis Hospital, Paris, France
FAU - Perbet, Sébastien
AU  - Perbet S
AD  - Service de réanimation adultes, C.H.U. Estaing, Clermont-Ferrand, France
FAU - Ouanes, Islem
AU  - Ouanes I
AD  - grid.420157.5Réanimation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Hamouda, Zeineb
AU  - Hamouda Z
AD  - Réanimation Polyvalente, CHU Fatouma Bourguiba, Monastir, Tunisia
FAU - Nakee, Sabrine
AU  - Nakee S
AD  - Réanimation Polyvalente, CHU Fatouma Bourguiba, Monastir, Tunisia
FAU - Ouanes-Besbes, Lamia
AU  - Ouanes-Besbes L
AD  - Réanimation Polyvalente, CHU Fatouma Bourguiba, Monastir, Tunisia
FAU - Meddeb, Khaoula
AU  - Meddeb K
AD  - grid.412791.8Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Khedher, Ahmed
AU  - Khedher A
AD  - grid.412791.8Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Sma, Nesrine
AU  - Sma N
AD  - grid.412791.8Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Ayachi, Jihene
AU  - Ayachi J
AD  - grid.412791.8Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Khelfa, Messaouda
AU  - Khelfa M
AD  - grid.412791.8Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Fraj, Nesrine
AU  - Fraj N
AD  - grid.412791.8Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Lakhal, Hend Ben
AU  - Lakhal HB
AD  - grid.412791.8Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Hammed, Hedia
AU  - Hammed H
AD  - grid.412791.8Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Boukadida, Raja
AU  - Boukadida R
AD  - grid.412791.8Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Hafsa, Hajer
AU  - Hafsa H
AD  - grid.412791.8Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Chouchene, Imed
AU  - Chouchene I
AD  - grid.412791.8Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Boussarsar, Mohamed
AU  - Boussarsar M
AD  - grid.412791.8Réanimation médicale, Research laboratory n° lr14es05, Faculty of
      medicine, CHU Farhat Hached, Sousse, Tunisia
FAU - Ben, Braiek Dhouha
AU  - Ben BD
AD  - Réanimation Polyvalente, CHU Fatouma Bourguiba, Monastir, Tunisia
FAU - Ouanes-Besbes, Lamia
AU  - Ouanes-Besbes L
AD  - Réanimation Polyvalente, CHU Fatouma Bourguiba, Monastir, Tunisia
FAU - Benatti, Kaoutar
AU  - Benatti K
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Dafir, A.
AU  - Dafir A
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Aissaoui, W.
AU  - Aissaoui W
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Elallame, W.
AU  - Elallame W
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Haddad, W.
AU  - Haddad W
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Cherkab, R.
AU  - Cherkab R
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Elkettani, C.
AU  - Elkettani C
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Barrou, L.
AU  - Barrou L
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Hamou, Zakaria Ait
AU  - Hamou ZA
AD  - 0000 0001 2181 7253grid.413784.dRéanimation médicale, CHU de Bicêtre, Le Kremlin 
      Bicêtre, France
FAU - Repessé, Xavier
AU  - Repessé X
AD  - 0000 0000 9982 5352grid.413756.2Réanimation médico-chirurgicale, Assistance
      Publique - Hôpitaux de Paris, Hôpital Ambroise Paré, Boulogne-Billancourt, France
FAU - Charron, Cyril
AU  - Charron C
AD  - 0000 0000 9982 5352grid.413756.2Réanimation médico-chirurgicale, Assistance
      Publique - Hôpitaux de Paris, Hôpital Ambroise Paré, Boulogne-Billancourt, France
FAU - Aubry, Alix
AU  - Aubry A
AD  - 0000 0000 9982 5352grid.413756.2Réanimation médico-chirurgicale, Assistance
      Publique - Hôpitaux de Paris, Hôpital Ambroise Paré, Boulogne-Billancourt, France
FAU - Paternot, Alexis
AU  - Paternot A
AD  - 0000 0000 9982 5352grid.413756.2Réanimation médico-chirurgicale, Assistance
      Publique - Hôpitaux de Paris, Hôpital Ambroise Paré, Boulogne-Billancourt, France
FAU - Maizel, Julien
AU  - Maizel J
AD  - 0000 0004 0593 702Xgrid.134996.0Réanimation médicale, Centre Hospitalier
      Universitaire, Amiens, France
FAU - Slama, Michel
AU  - Slama M
AD  - 0000 0004 0593 702Xgrid.134996.0Réanimation médicale, Centre Hospitalier
      Universitaire, Amiens, France
FAU - Vieillard-Baron, Antoine
AU  - Vieillard-Baron A
AD  - 0000 0000 9982 5352grid.413756.2Réanimation médico-chirurgicale, Assistance
      Publique - Hôpitaux de Paris, Hôpital Ambroise Paré, Boulogne-Billancourt, France
FAU - Trifi, Ahlem
AU  - Trifi A
AD  - Réanimation médicale, Centre hospitalier universitaire la Rabta de Tunis, Tunis, 
      Tunisia
FAU - Abdellatif, Sami
AU  - Abdellatif S
AD  - Réanimation médicale, Centre hospitalier universitaire la Rabta de Tunis, Tunis, 
      Tunisia
FAU - Fatnassi, Meriem
AU  - Fatnassi M
AD  - Réanimation médicale, Centre hospitalier universitaire la Rabta de Tunis, Tunis, 
      Tunisia
FAU - Daly, Foued
AU  - Daly F
AD  - Réanimation médicale, Centre hospitalier universitaire la Rabta de Tunis, Tunis, 
      Tunisia
FAU - Nasri, Rochdi
AU  - Nasri R
AD  - Réanimation médicale, Centre hospitalier universitaire la Rabta de Tunis, Tunis, 
      Tunisia
FAU - Ismail, Khaoula Ben
AU  - Ismail KB
AD  - Réanimation médicale, Centre hospitalier universitaire la Rabta de Tunis, Tunis, 
      Tunisia
FAU - Lakhal, Salah Ben
AU  - Lakhal SB
AD  - Réanimation médicale, Centre hospitalier universitaire la Rabta de Tunis, Tunis, 
      Tunisia
FAU - Bazalgette, Florian
AU  - Bazalgette F
AD  - Réanimation, Chru De Nîmes, Nîmes, France
FAU - Daurat, Aurelien
AU  - Daurat A
AD  - Réanimation, Chru De Nîmes, Nîmes, France
FAU - Roger, Claire
AU  - Roger C
AD  - Réanimation, Chru De Nîmes, Nîmes, France
FAU - Muller, Laurent
AU  - Muller L
AD  - Réanimation, Chru De Nîmes, Nîmes, France
FAU - Doyen, Denis
AU  - Doyen D
AD  - Réanimation médicale, CHU Hôpital l’Archet 1, Route Saint-Antoine de Ginestière, 
      Nice, France
FAU - Plattier, Rémi
AU  - Plattier R
AD  - Réanimation médicale, CHU Hôpital l’Archet 1, Route Saint-Antoine de Ginestière, 
      Nice, France
FAU - Robert, Alexandre
AU  - Robert A
AD  - Réanimation médicale, Hôpitaux de l’Archet 1 et 2, Nice, France
FAU - Hyvernat, Hervé
AU  - Hyvernat H
AD  - Réanimation médicale, CHU Hôpital l’Archet 1, Route Saint-Antoine de Ginestière, 
      Nice, France
FAU - Bernardin, Gilles
AU  - Bernardin G
AD  - grid.413770.6Service de réanimation, Hôpital l’Archet 2, Nice, France
FAU - Jozwiak, Mathieu
AU  - Jozwiak M
AD  - 0000 0001 2181 7253grid.413784.dService de réanimation médicale, INSERM UMRS_999,
      université paris-sud, Hôpital de bicêtre, hôpitaux universitaires paris-sud,
      Assistance publique – Hôpitaux de Paris, Le Kremlin-Bicêtre, France
FAU - Gimenez, Julia
AU  - Gimenez J
AD  - 0000 0001 2181 7253grid.413784.dService de réanimation médicale, INSERM UMRS_999,
      université paris-sud, Hôpital de bicêtre, hôpitaux universitaires paris-sud,
      Assistance publique – Hôpitaux de Paris, Le Kremlin-Bicêtre, France
FAU - Mercado, Pablo
AU  - Mercado P
AD  - 0000 0001 2181 7253grid.413784.dService de réanimation médicale, INSERM UMRS_999,
      université paris-sud, Hôpital de bicêtre, hôpitaux universitaires paris-sud,
      Assistance publique – Hôpitaux de Paris, Le Kremlin-Bicêtre, France
FAU - Depret, François
AU  - Depret F
AD  - 0000 0001 2181 7253grid.413784.dService de réanimation médicale, INSERM UMRS_999,
      université paris-sud, Hôpital de bicêtre, hôpitaux universitaires paris-sud,
      Assistance publique – Hôpitaux de Paris, Le Kremlin-Bicêtre, France
FAU - Tilouch, Najla
AU  - Tilouch N
AD  - Réanimation Médicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia
FAU - Mater, Houda
AU  - Mater H
AD  - Réanimation Médicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia
FAU - Habiba, Ben Sik Ali
AU  - Habiba BSA
AD  - Réanimation Médicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia
FAU - Jaoued, Oussama
AU  - Jaoued O
AD  - Réanimation Médicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia
FAU - Gharbi, Rim
AU  - Gharbi R
AD  - Réanimation Médicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia
FAU - Hassen, Mohamed Fekih
AU  - Hassen MF
AD  - Réanimation Médicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia
FAU - Elatrous, Souheil
AU  - Elatrous S
AD  - Réanimation Médicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia
FAU - Pasquier, Pierre
AU  - Pasquier P
AD  - 0000 0004 1795 3756grid.414028.bService de réanimation, Hôpital d’Instruction des
      Armées Percy, Clamart, France
FAU - Vuillemin, Quentin
AU  - Vuillemin Q
AD  - Antenne médicale, Centre médical des armées, Besançon, France
FAU - Schaal, Jean-Vivien
AU  - Schaal JV
AD  - 0000 0004 1795 3756grid.414028.bCentre de traitement des brûlés, Hôpital
      d’Instruction des Armées Percy, Clamart, France
FAU - Martinez, Thibault
AU  - Martinez T
AD  - 0000 0004 1795 3756grid.414028.bService de réanimation, Hôpital d’Instruction des
      Armées Percy, Clamart, France
FAU - Duron, Sandrine
AU  - Duron S
AD  - Unité de recherche, Centre d’épidémiologie et de santé publique des armées,
      Marseille, France
FAU - Trousselard, Marion
AU  - Trousselard M
AD  - grid.418221.cDépartement de neurosciences et contraintes opérationnelles,
      Institut de Recherche Biomédicale des Armées, Brétigny-Sur-Orge, France
FAU - Schwartzbrod, Pierre-Eric
AU  - Schwartzbrod PE
AD  - Antenne médicale, Centre médical des armées, Besançon, France
FAU - Baugnon, Thomas
AU  - Baugnon T
AD  - 0000 0004 0593 9113grid.412134.1Réanimation neurochirurgicale pédiatrique,
      Hôpital Necker - Enfants Malades, Paris, France
FAU - Dupic, Laurent
AU  - Dupic L
AD  - 0000 0004 0593 9113grid.412134.1Réanimation et surveillance continue
      médico-chirurgicales, Hôpital Necker - Enfants Malades, Paris, France
FAU - Gout, Caroline Duracher
AU  - Gout CD
AD  - 0000 0004 0593 9113grid.412134.1Réanimation neurochirurgicale pédiatrique,
      Hôpital Necker - Enfants Malades, Paris, France
FAU - De Saint Blanquat, Laure
AU  - De Saint Blanquat L
AD  - 0000 0004 0593 9113grid.412134.1Réanimation et surveillance continue
      médico-chirurgicales, Hôpital Necker - Enfants Malades, Paris, France
FAU - Séguret, Sylvie
AU  - Séguret S
AD  - 0000 0004 0593 9113grid.412134.1Réanimation et surveillance continue
      médico-chirurgicales, Hôpital Necker - Enfants Malades, Paris, France
FAU - Le Ficher, Gaelle
AU  - Le Ficher G
AD  - 0000 0004 0593 9113grid.412134.1Réanimation neurochirurgicale pédiatrique,
      Hôpital Necker - Enfants Malades, Paris, France
FAU - Orliaguet, Gilles
AU  - Orliaguet G
AD  - 0000 0004 0593 9113grid.412134.1Réanimation neurochirurgicale pédiatrique,
      Hôpital Necker - Enfants Malades, Paris, France
FAU - Hubert, Philippe
AU  - Hubert P
AD  - 0000 0004 0593 9113grid.412134.1Réanimation et surveillance continue
      médico-chirurgicales, Hôpital Necker - Enfants Malades, Paris, France
CN  - Groupe Communication et Simulation en Pédiatrie
FAU - Bigé, Naïke
AU  - Bigé N
AD  - 0000 0004 1937 1100grid.412370.3Réanimation médicale, Hôpital Saint-Antoine,
      Paris, France
FAU - Leblanc, Guillaume
AU  - Leblanc G
AD  - 0000 0004 1937 1100grid.412370.3Réanimation médicale, Hôpital Saint-Antoine,
      Paris, France
FAU - Briand, Raphael
AU  - Briand R
AD  - 0000 0000 9454 4367grid.413738.aRéanimation polyvalente, Hôpital Antoine Béclère,
      Clamart, France
FAU - Brousse, Lucas
AU  - Brousse L
AD  - 0000 0000 9454 4367grid.413738.aRéanimation polyvalente, Hôpital Antoine Béclère,
      Clamart, France
FAU - Brunet, Valentine
AU  - Brunet V
AD  - 0000 0000 9454 4367grid.413738.aRéanimation polyvalente, Hôpital Antoine Béclère,
      Clamart, France
FAU - Chatelain, Léonard
AU  - Chatelain L
AD  - 0000 0000 9454 4367grid.413738.aRéanimation polyvalente, Hôpital Antoine Béclère,
      Clamart, France
FAU - Prat, Dominique
AU  - Prat D
AD  - 0000 0000 9454 4367grid.413738.aRéanimation polyvalente, Hôpital Antoine Béclère,
      Clamart, France
FAU - Jacobs, Frédéric
AU  - Jacobs F
AD  - 0000 0000 9454 4367grid.413738.aRéanimation polyvalente, Hôpital Antoine Béclère,
      Clamart, France
FAU - Demars, Nadège
AU  - Demars N
AD  - 0000 0000 9454 4367grid.413738.aRéanimation polyvalente, Hôpital Antoine Béclère,
      Clamart, France
FAU - Hamzaoui, Olfa
AU  - Hamzaoui O
AD  - 0000 0000 9454 4367grid.413738.aRéanimation polyvalente, Hôpital Antoine Béclère,
      Clamart, France
FAU - Moneger, Guy
AU  - Moneger G
AD  - 0000 0000 9454 4367grid.413738.aRéanimation polyvalente, Hospital Antoine
      Béclère, Clamart, France
FAU - Sztrymf, Benjamin
AU  - Sztrymf B
AD  - 0000 0000 9454 4367grid.413738.aRéanimation polyvalente, Hôpital Antoine Béclère,
      Clamart, France
FAU - Duburcq-Gury, Emilie
AU  - Duburcq-Gury E
AD  - Pôle de réanimation, hôpital salengro, C.H.R.U. - Lille, Avenue Oscar Lambret,
      Lille, France
FAU - Satre-Buisson, Léa
AU  - Satre-Buisson L
AD  - Pôle de réanimation, hôpital salengro, C.H.R.U. - Lille, Avenue Oscar Lambret,
      Lille, France
FAU - Duburcq, Thibault
AU  - Duburcq T
AD  - Pôle de réanimation, hôpital salengro, C.H.R.U. - Lille, Avenue Oscar Lambret,
      Lille, France
FAU - Poissy, Julien
AU  - Poissy J
AD  - Pôle de réanimation, hôpital salengro, C.H.R.U. - Lille, Avenue Oscar Lambret,
      Lille, France
FAU - Robriquet, Laurent
AU  - Robriquet L
AD  - Pôle de réanimation, hôpital salengro, C.H.R.U. - Lille, Avenue Oscar Lambret,
      Lille, France
FAU - Jourdain, Merce
AU  - Jourdain M
AD  - Pôle de réanimation, hôpital salengro, C.H.R.U. - Lille, Avenue Oscar Lambret,
      Lille, France
FAU - Sécheresse, Thierry
AU  - Sécheresse T
AD  - 73, Centre hospitalier Métropole Savoie, Chambéry, France
FAU - Miquet, Mattéo
AU  - Miquet M
AD  - 73, Centre hospitalier Métropole Savoie, Chambéry, France
FAU - Simond, Alexis
AU  - Simond A
AD  - 73, Centre hospitalier Métropole Savoie, Chambéry, France
FAU - Usseglio, Pascal
AU  - Usseglio P
AD  - 73, Centre hospitalier Métropole Savoie, Chambéry, France
FAU - Hamdaoui, Yamina
AU  - Hamdaoui Y
AD  - grid.412791.8Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia
FAU - Boussarsar, Mohamed
AU  - Boussarsar M
AD  - grid.412791.8Réanimation médicale, Research laboratory n° lr14es05, Faculty of
      medicine, CHU Farhat Hached, Sousse, Tunisia
FAU - Desailly, Victoire
AU  - Desailly V
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes, France
FAU - Brun, Patrick
AU  - Brun P
AD  - Giga la vis, Institut des Hauts de Seine, Nanterre, France
FAU - Iglesias, Pauline
AU  - Iglesias P
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes, France
FAU - Huet, Jérémie
AU  - Huet J
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes, France
FAU - Masseran, Clémence
AU  - Masseran C
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes, France
FAU - Claudon, Antoine
AU  - Claudon A
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes, France
FAU - Ebeyer, Clément
AU  - Ebeyer C
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes, France
FAU - Truong, Thomas
AU  - Truong T
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes, France
FAU - Tesnière, Antoine
AU  - Tesnière A
AD  - 0000 0001 0274 3893grid.411784.fService de pneumologie et réanimation, Hôpital
      Cochin, Paris, France
FAU - Mignon, Alexandre
AU  - Mignon A
AD  - 0000 0001 2188 0914grid.10992.33Laboratoire ilumens, Universisté René Descartes -
      Paris V, Paris, France
FAU - Gaudry, Stéphane
AU  - Gaudry S
AD  - Service de réanimation médico-chirurgicale, CHU Louis Mourier, Colombes, France
FAU - Resiere, Dabor
AU  - Resiere D
AD  - Intensive Care Unit, University Hospital of Martinique, Fort-De-France, France
FAU - Valentino, Ruddy
AU  - Valentino R
AD  - Intensive Care Unit, University Hospital of Martinique, Fort-De-France, France
FAU - Fabre, Julien
AU  - Fabre J
AD  - Cardiology Department, University Hospital of Martinique, Fort-De-France, France
FAU - Roze, Benoit
AU  - Roze B
AD  - Infectious and Tropical Diseases Department, University Hospital of Martinique,
      Fort-De-France, France
FAU - Ferge, Jean-Louis
AU  - Ferge JL
AD  - Intensive Care Unit, University Hospital of Martinique, Fort-De-France, France
FAU - Charbatier, Cyrille
AU  - Charbatier C
AD  - Intensive Care Unit, University Hospital of Martinique, Fort-De-France, France
FAU - Marie, Sabia
AU  - Marie S
AD  - Intensive Care Unit, University Hospital of Martinique, Fort-De-France, France
FAU - Scholsser, Michel
AU  - Scholsser M
AD  - Intensive Care Unit, University Hospital of Martinique, Fort-De-France, France
FAU - Aitsatou, Signate
AU  - Aitsatou S
AD  - Department of Neurology, University Hospital of Martinique, Fort-De-France,
      France
FAU - Raad, Mathieu
AU  - Raad M
AD  - Intensive Care Unit, University Hospital of Martinique, Fort-De-France, France
FAU - Cabie, Andre
AU  - Cabie A
AD  - Infectious and Tropical Diseases Department, University Hospital of Martinique,
      Fort-De-France, France
FAU - Mehdaoui, Hossein
AU  - Mehdaoui H
AD  - Intensive Care Unit, University Hospital of Martinique, Fort-De-France, France
FAU - Cousin, Clement
AU  - Cousin C
AD  - 0000 0001 0274 3893grid.411784.fMedical Intensive Care, Hôpital Cochin, Paris,
      France
FAU - Rousseau, Christophe
AU  - Rousseau C
AD  - 0000000121866389grid.7429.8Unité 1016, 22 rue méchain, Institut National de la
      Santé et de la Recherche Médicale, Paris, France
FAU - Llitjos, Jean-François
AU  - Llitjos JF
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Alby-Laurent, Fanny
AU  - Alby-Laurent F
AD  - 0000000121866389grid.7429.8U1016, Institut National de la Santé et de la
      Recherche Médicale, 22 rue méchain, Paris, France
FAU - Toubiana, Julie
AU  - Toubiana J
AD  - 0000000121866389grid.7429.8U1016, Institut National de la Santé et de la
      Recherche Médicale, 22 rue méchain, Paris, France
FAU - Belaidouni, Nadia
AU  - Belaidouni N
AD  - 0000000121866389grid.7429.8U1016, Institut National de la Santé et de la
      Recherche Médicale, 22 rue méchain, Paris, France
FAU - Cherruault, Marlène
AU  - Cherruault M
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Tamburini, Jérome
AU  - Tamburini J
AD  - 0000 0001 0274 3893grid.411784.fHaematology, Hôpital Cochin, Paris, France
FAU - Bouscary, Didier
AU  - Bouscary D
AD  - 0000 0001 0274 3893grid.411784.fHaematology, Hôpital Cochin, Paris, France
FAU - Fert, Sarah
AU  - Fert S
AD  - 0000 0001 2108 3034grid.10400.35INSERM U1096, Université de rouen, Rouen, France
FAU - Delile, Eugénie
AU  - Delile E
AD  - 0000 0001 2108 3034grid.10400.35INSERM U1096, Université de rouen, Rouen, France
FAU - Besnier, Emmanuel
AU  - Besnier E
AD  - Pôle Réanimations Anesthésie SAMU, Hospital Center University Rouen, Rouen,
      France
FAU - Coquerel, David
AU  - Coquerel D
AD  - U1096, INSERM, Rouen, France
FAU - Nevière, Rémi
AU  - Nevière R
AD  - 0000 0001 2097 7060grid.16780.38Inserm u995 equipe 4, Université Lille 2, Lille, 
      France
FAU - Richard, Vincent
AU  - Richard V
AD  - U1096, INSERM, Rouen, France
FAU - Tamion, Fabienne
AU  - Tamion F
AD  - Réanimation médicale, Hospital Center University Rouen, Rouen, France
FAU - Wei, Chaojie
AU  - Wei C
AD  - 0000 0001 2194 6418grid.29172.3fU1116, Faculté de Médecine de Nancy,
      Vandœuvre-Lès-Nancy, France
FAU - Louis, Huguette
AU  - Louis H
AD  - 0000 0001 2194 6418grid.29172.3fU1116, Faculté de Médecine de Nancy,
      Vandœuvre-Lès-Nancy, France
FAU - Margaux, Schmitt
AU  - Margaux S
AD  - 0000 0001 2194 6418grid.29172.3fU1116, Faculté de Médecine de Nancy,
      Vandœuvre-Lès-Nancy, France
FAU - Eliane, Albuisson
AU  - Eliane A
AD  - Unité espri-biobase, CHRU Nancy, Vandœuvre-Lès-Nancy, France
FAU - Sophie, Orlowski
AU  - Sophie O
AD  - Service de biochimie, CHRU de Nancy, Vandœuvre-Lès-Nancy, France
FAU - Kimmoun, Antoine
AU  - Kimmoun A
AD  - Service de réanimation médicale brabois, CHRU de Nancy, Vandœuvre-Lès-Nancy,
      France
FAU - Riad, Zakaria
AU  - Riad Z
AD  - 0000 0004 4685 6736grid.413306.3Réanimation médicale, Hôpital de la Croix-Rousse,
      Lyon, France
FAU - Coroir, Marine
AU  - Coroir M
AD  - Réanimation chirurgicale cardiovasculaire et thoracique, Groupe Hospitalier
      Pitié-Salpêtrière, Paris, France
FAU - Rémy, Bernard
AU  - Rémy B
AD  - Réanimation chirurgicale cardiovasculaire et thoracique, Groupe Hospitalier
      Pitié-Salpêtrière, Paris, France
FAU - Camille, Bombled
AU  - Camille B
AD  - Réanimation chirurgicale cardiovasculaire et thoracique, Groupe Hospitalier
      Pitié-Salpêtrière, Paris, France
FAU - Joffre, Jeremie
AU  - Joffre J
AD  - 0000 0004 1937 1100grid.412370.3Réanimation médicale, Hôpital Saint-Antoine,
      Paris, France
FAU - Aegerter, Philippe
AU  - Aegerter P
AD  - URC, Hospital Ambroise Paré, Boulogne-Billancourt, France
FAU - Ilic, Dejan
AU  - Ilic D
AD  - 0000 0004 0638 9213grid.411158.8Réanimation chirurgicale, CHU Jean Minjoz,
      Besançon, France
FAU - Ginet, Marc
AU  - Ginet M
AD  - 0000 0004 0638 9213grid.411158.8Réanimation chirurgicale, CHU Jean Minjoz,
      Besançon, France
FAU - Pignard, Caroline
AU  - Pignard C
AD  - 0000 0004 0638 9213grid.411158.8Réanimation chirurgicale, CHU Jean Minjoz,
      Besançon, France
FAU - Nguyen, Philippe
AU  - Nguyen P
AD  - 0000 0004 1937 0589grid.413235.2Laboratoire d’hématologie, Hopital Robert Debré, 
      Reims, France
FAU - Mourey, Guillaume
AU  - Mourey G
AD  - Laboratoire d’hémostase, cytologie et plateforme de biomonitoring, EFS Bourgogne 
      Franche-Comté, Besancon, France
FAU - Samain, Emmanuel
AU  - Samain E
AD  - 0000 0004 0638 9213grid.411158.8Réanimation chirurgicale, CHU Jean Minjoz,
      Besançon, France
FAU - Pili-Floury, Sebastien
AU  - Pili-Floury S
AD  - 0000 0004 0638 9213grid.411158.8Réanimation chirurgicale, CHU Jean Minjoz,
      Besançon, France
FAU - Jouffroy, Romain
AU  - Jouffroy R
AD  - Anesthésie Réanimation SAMUAPHP - CHRU Necker Enfants Malades, Paris, France
FAU - Nicolas, Caill
AU  - Nicolas C
AD  - Service de pharmacologie toxicologie, APHP - Hopital Raymond Poincaré, Paris,
      France
FAU - Alvarez, Jean-Claude
AU  - Alvarez JC
AD  - 0000 0001 2175 4109grid.50550.35Assistance Publique Hôpitaux de Paris, Paris,
      France
FAU - Tomasso, Maraffi
AU  - Tomasso M
AD  - Anesthésie Réanimation SAMUAPHP - CHRU Necker Enfants Malades, Paris, France
FAU - Philippe, Pascal
AU  - Philippe P
AD  - Anesthésie Réanimation SAMUAPHP - CHRU Necker Enfants Malades, Paris, France
FAU - Raphalen, Jean-Herlé
AU  - Raphalen JH
AD  - 0000 0004 0593 9113grid.412134.1Service de réanimation adulte, Hôpital Necker,
      Assistance Publique Hôpitaux de Paris, Paris, France
FAU - Frédéric, J. Baud
AU  - Frédéric JB
AD  - Anesthésie Réanimation SAMUAPHP - CHRU Necker Enfants Malades, Paris, France
FAU - Vivien, Benoit
AU  - Vivien B
AD  - 0000 0004 0593 9113grid.412134.1Réanimation adulte - samu, Hôpital Necker -
      Enfants Malades, Paris, France
FAU - Pierre, Carli
AU  - Pierre C
AD  - Anesthésie Réanimation SAMUAPHP - CHRU Necker Enfants Malades, Paris, France
FAU - Baud, Frederic
AU  - Baud F
AD  - SAMU de ParisRéanimation polyvalente, 75014 Paris, France
FAU - Fredj, Hana
AU  - Fredj H
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Blel, Youssef
AU  - Blel Y
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Brahmi, Nozha
AU  - Brahmi N
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Ghezala, Hassen Ben
AU  - Ghezala HB
AD  - 0000 0001 2292 1474grid.412116.1Réanimation Médicale, Hôpital Henri Mondor,
      Avenue du Maréchal de Lattre de Tassigny, Créteil, France
FAU - Hanak, Anne-Sophie
AU  - Hanak AS
AD  - 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris, 
      France
FAU - Malissin, Isabelle
AU  - Malissin I
AD  - 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical 
      Care, Lariboisière Hospital, Paris, France
FAU - Poupon, Joel
AU  - Poupon J
AD  - 0000 0000 9725 279Xgrid.411296.9Laboratory of Toxicology, Lariboisière Hospital, 
      Paris, France
FAU - Risede, Patricia
AU  - Risede P
AD  - 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris, 
      France
FAU - Chevillard, Lucie
AU  - Chevillard L
AD  - 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris, 
      France
FAU - Megarbane, Bruno
AU  - Megarbane B
AD  - 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical 
      Care, Lariboisière Hospital, Paris, France
FAU - Barghouth, Manel
AU  - Barghouth M
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - M’rad, Aymen
AU  - M’rad A
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Hmida, Marwa Ben
AU  - Hmida MB
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Thabet, Hafedh
AU  - Thabet H
AD  - Department of Emergency, Centre d’Assistance Médicale Urgente, Tunis, Tunisia
FAU - Liang, Hao
AU  - Liang H
AD  - 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris, 
      France
FAU - Callebert, Jacques
AU  - Callebert J
AD  - 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris, 
      France
FAU - Lagard, Camille
AU  - Lagard C
AD  - 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris, 
      France
FAU - Megarbane, Bruno
AU  - Megarbane B
AD  - 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical 
      Care, Lariboisière Hospital, Paris, France
FAU - Habacha, Sahar
AU  - Habacha S
AD  - Departement of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Chatbri, Bassem
AU  - Chatbri B
AD  - Departement of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Camillerapp, Christophe
AU  - Camillerapp C
AD  - 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical 
      Care, Lariboisière Hospital, Paris, France
FAU - Labat, Laurence
AU  - Labat L
AD  - 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris, 
      France
FAU - Soichot, Marion
AU  - Soichot M
AD  - 0000 0000 9725 279Xgrid.411296.9Laboratory of Toxicology, Lariboisière Hospital, 
      Paris, France
FAU - Garçon, Pierre
AU  - Garçon P
AD  - 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical 
      Care, Lariboisière Hospital, Paris, France
FAU - Goury, Antoine
AU  - Goury A
AD  - 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical 
      Care, Lariboisière Hospital, Paris, France
FAU - Kerdjana, Lamia
AU  - Kerdjana L
AD  - 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical 
      Care, Lariboisière Hospital, Paris, France
FAU - Voicu, Sebastian
AU  - Voicu S
AD  - 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical 
      Care, Lariboisière Hospital, Paris, France
FAU - Deye, Nicolas
AU  - Deye N
AD  - 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical 
      Care, Lariboisière Hospital, Paris, France
FAU - Megarbane, Bruno
AU  - Megarbane B
AD  - 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical 
      Care, Lariboisière Hospital, Paris, France
FAU - Armel, Anwar
AU  - Armel A
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Anas, Benqqa
AU  - Anas B
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Othman, Mezgui
AU  - Othman M
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Moumine, S.
AU  - Moumine S
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Kalouch, S.
AU  - Kalouch S
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Yakini, K. K.
AU  - Yakini KK
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Chlilek, A.
AU  - Chlilek A
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Hajji, Ahmed
AU  - Hajji A
AD  - Peadiatric Intensive Care Unit, Children Hospital of Tunis, Tunis, Tunisia
FAU - Louati, Assaad
AU  - Louati A
AD  - Unité de recherche ur12sp10, université tunis el manar, Peadiatric Intensive Care
      Unit, Children Hospital of Tunis, Tunis, Tunisia
FAU - Khaldi, Ammar
AU  - Khaldi A
AD  - Peadiatric Intensive Care Unit, Children Hospital of Tunis, Tunis, Tunisia
FAU - Borgi, Aida
AU  - Borgi A
AD  - Peadiatric Intensive Care Unit, Children Hospital of Tunis, Tunis, Tunisia
FAU - Ghali, Nargess
AU  - Ghali N
AD  - Peadiatric Intensive Care Unit, Children Hospital of Tunis, Tunis, Tunisia
FAU - Bouziri, Asma
AU  - Bouziri A
AD  - Peadiatric Intensive Care Unit, Children Hospital of Tunis, Tunis, Tunisia
FAU - Menif, Khaled
AU  - Menif K
AD  - Peadiatric Intensive Care Unit, Children Hospital of Tunis, Tunis, Tunisia
FAU - Ben, Jaballah Najla
AU  - Ben JN
AD  - Peadiatric Intensive Care Unit, Children Hospital of Tunis, Tunis, Tunisia
FAU - Armel, Anwar
AU  - Armel A
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Brochon, Jeanne
AU  - Brochon J
AD  - 0000 0000 9336 4276grid.411162.1Neonatal and Paediatric Intensive Care, Chu de
      poitiers, Poitiers, France
FAU - Dumitrescu, Mihaela
AU  - Dumitrescu M
AD  - 0000 0000 9336 4276grid.411162.1Infection Prevention Team, Chu de poitiers,
      Poitiers, France
FAU - Thévenot, Sarah
AU  - Thévenot S
AD  - 0000 0000 9336 4276grid.411162.1Infection Prevention Team, Chu de poitiers,
      Poitiers, France
FAU - Saulnier, Jean-Pascal
AU  - Saulnier JP
AD  - 0000 0000 9336 4276grid.411162.1Neonatal and Paediatric Intensive Care, Chu de
      poitiers, Poitiers, France
FAU - Husseini, Khaled
AU  - Husseini K
AD  - 0000 0000 9336 4276grid.411162.1Neonatal and Paediatric Intensive Care, Chu de
      poitiers, Poitiers, France
FAU - Laland, Catherine
AU  - Laland C
AD  - 0000 0000 9336 4276grid.411162.1Infection Prevention Team, Chu de poitiers,
      Poitiers, France
FAU - Cremniter, Julie
AU  - Cremniter J
AD  - 0000 0000 9336 4276grid.411162.1Laboratory of Bacteriology, Chu de poitiers,
      Poitiers, France
FAU - Bousseau, Anne
AU  - Bousseau A
AD  - 0000 0000 9336 4276grid.411162.1Infection Prevention Team, Chu de poitiers,
      Poitiers, France
FAU - Castel, Olivier
AU  - Castel O
AD  - 0000 0000 9336 4276grid.411162.1Infection Prevention Team, Chu de poitiers,
      Poitiers, France
FAU - Brémaud-Csizmadia, Cassandra
AU  - Brémaud-Csizmadia C
AD  - 0000 0000 9336 4276grid.411162.1Neonatal and Paediatric Intensive Care, Chu de
      poitiers, Poitiers, France
FAU - Diss, Margot
AU  - Diss M
AD  - grid.414103.3PEDIATRIE, Hôpital Femme Mère Enfant, Bron, France
FAU - Portefaix, Aurélie
AU  - Portefaix A
AD  - grid.414103.3Réanimation Pédiatrique, Groupement Hospitalier Est-Hôpital Femme
      Mère Enfant, Bron, France
FAU - Berthiller, Julien
AU  - Berthiller J
AD  - 0000 0001 2163 3825grid.413852.9Pôle information médicale evaluation recherche,
      equipe d’accueil 4129, hospices civils de Lyon, Lyon, France
FAU - Gillet, Yves
AU  - Gillet Y
AD  - grid.414103.3Réanimation Pédiatrique, Groupement Hospitalier Est-Hôpital Femme
      Mère Enfant, Bron, France
FAU - Aoul, Nabil Tabet
AU  - Aoul NT
AD  - Réanimation pédiatrique canastel, Faculté de médecine d’Oran, Oran, Algeria
FAU - Douah, Ali
AU  - Douah A
AD  - Anesthésie réanimation pédiatrique, Etablissement hospitalier spécialisé en
      pédiatrie Canastel, Oran, Algeria
FAU - Addou, Zakaria
AU  - Addou Z
AD  - Réanimation pédiatrique de Canastel d’oran, Departement de medecine d’Oran
      Algerie, Oran, Algeria
FAU - Youbi, Houari
AU  - Youbi H
AD  - Anesthésie réanimation pédiatrique, Etablissement hospitalier spécialisé en
      pédiatrie Canastel, Oran, Algeria
FAU - Moussati, Mohamed
AU  - Moussati M
AD  - Anesthésie réanimation pédiatrique, Etablissement hospitalier spécialisé en
      pédiatrie Canastel, Oran, Algeria
FAU - Belhabiche, Kamel
AU  - Belhabiche K
AD  - Anesthésie réanimation pédiatrique, Etablissement hospitalier spécialisé en
      pédiatrie Canastel, Oran, Algeria
FAU - Mir, Souad
AU  - Mir S
AD  - Réanimation pédiatrique canastel, Faculté de médecine d’Oran, Oran, Algeria
FAU - Abada, Sanaa
AU  - Abada S
AD  - Réanimation pédiatrique canastel, Faculté de médecine d’Oran, Oran, Algeria
FAU - Amel, Zerhouni
AU  - Amel Z
AD  - Réanimation pédiatrique, EHS CANASTEL, Oran, Algeria
FAU - Aouffen, Nabil
AU  - Aouffen N
AD  - Anesthésie réanimation pédiatrique, Etablissement hospitalier spécialisé en
      pédiatrie Canastel, Oran, Algeria
FAU - Bouzit, Zina
AU  - Bouzit Z
AD  - 0000 0001 2292 1474grid.412116.1Service d’Anesthésie et des Réanimations
      Chirurgicales, Hôpital Henri Mondor, Créteil, France
FAU - Grati, Ahmed H.
AU  - Grati AH
AD  - 0000 0001 2292 1474grid.412116.1Service d’Anesthésie et des Réanimations
      Chirurgicales, Hôpital Henri Mondor, Créteil, France
FAU - Dhonneur, Gilles F.
AU  - Dhonneur GF
AD  - 0000 0001 2292 1474grid.412116.1Service d’Anesthésie et des Réanimations
      Chirurgicales, Hôpital Henri Mondor, Créteil, France
FAU - Boussarsar, Mohamed
AU  - Boussarsar M
AD  - grid.412791.8Réanimation médicale, Research laboratory n° lr14es05, Faculty of
      medicine, CHU Farhat Hached, Sousse, Tunisia
FAU - Lau, Nicolas
AU  - Lau N
AD  - ICU, C.H. des Deux Vallées - site Longjumeau, Longjumeau, France
FAU - Mezhari, Ilham
AU  - Mezhari I
AD  - ICU, C.H. des Deux Vallées - site Longjumeau, Longjumeau, France
FAU - Roucaud, Nicolas
AU  - Roucaud N
AD  - ICU, C.H. des Deux Vallées - site Longjumeau, Longjumeau, France
FAU - Le Meur, Matthieu
AU  - Le Meur M
AD  - ICU, C.H. des Deux Vallées - site Longjumeau, Longjumeau, France
FAU - Paulet, Rémi
AU  - Paulet R
AD  - ICU, C.H. des Deux Vallées - site Longjumeau, Longjumeau, France
FAU - Coudray, Jean-Michel
AU  - Coudray JM
AD  - ICU, C.H. des Deux Vallées - site Longjumeau, Longjumeau, France
FAU - Ghomari, Wahiba Imène
AU  - Ghomari WI
AD  - Anesthésie-Réanimatiion, CHU Abdelkader Hassani, Sidi Bel Abbès, Algeria
FAU - Boumlik, Reda
AU  - Boumlik R
AD  - Urgences médico-chirurgicales, CHU Abdelkader Hassani, Sidi Bel Abbès, Algeria
FAU - Peigne, Vincent
AU  - Peigne V
AD  - 0000 0004 0639 3482grid.418064.fRéanimation, Centre hospitalier Métropole Savoie,
      Chambéry, France
FAU - Daban, Jean-Louis
AU  - Daban JL
AD  - 0000 0004 1795 3756grid.414028.bRéanimation, Hôpital d’Instruction des Armées
      Percy, Clamart, France
FAU - Boutonnet, Mathieu
AU  - Boutonnet M
AD  - 0000 0004 1795 3756grid.414028.bRéanimation, Hôpital d’Instruction des Armées
      Percy, Clamart, France
FAU - Lenoir, Bernard
AU  - Lenoir B
AD  - 0000 0004 1795 3756grid.414028.bDépartement d’anesthésie-réanimation, Hôpital
      d’Instruction des Armées Percy, Clamart, France
FAU - Yassine, Hafiani
AU  - Yassine H
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Mohamed, Cheikh Chaigar
AU  - Mohamed CC
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Khalid, Allali
AU  - Khalid A
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Ihssan, Moussaid
AU  - Ihssan M
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Said, Elyoussoufi
AU  - Said E
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Said, Salmi
AU  - Said S
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Jazia, Amira Ben
AU  - Jazia AB
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Fatima, Jaziri
AU  - Fatima J
AD  - grid.413207.3Réanimation médicale, Hôpital Abderrahmen Mami, Ariana, Tunisia
FAU - Wafa, Skouri
AU  - Wafa S
AD  - grid.413207.3Réanimation médicale, Hôpital Abderrahmen Mami, Ariana, Tunisia
FAU - Maha, Bennasr
AU  - Maha B
AD  - grid.413207.3Réanimation médicale, Hôpital Abderrahmen Mami, Ariana, Tunisia
FAU - Khaoula, Ben Abdelghni
AU  - Khaoula BA
AD  - grid.413207.3Réanimation médicale, Hôpital Abderrahmen Mami, Ariana, Tunisia
FAU - Sami, Turki
AU  - Sami T
AD  - grid.413207.3Réanimation médicale, Hôpital Abderrahmen Mami, Ariana, Tunisia
FAU - Abdallah Taeib, B.
AU  - Abdallah Taeib B
AD  - grid.413207.3Réanimation médicale, Hôpital Abderrahmen Mami, Ariana, Tunisia
FAU - Medhioub, Fatma Kaaniche
AU  - Medhioub FK
AD  - 0000 0001 2323 5644grid.412124.0Faculté de médecine de Sfax, Sfax, Tunisia
FAU - Rollet-Cohen, Virginie
AU  - Rollet-Cohen V
AD  - 0000 0004 0593 9113grid.412134.1Réanimation et surveillance continue
      pédiatriques, Hôpital Necker, Rue de Sèvres, Paris, France
FAU - Sachs, Philippe
AU  - Sachs P
AD  - 0000 0004 0472 3476grid.139510.fRéanimation et surveillance continue
      pédiatriques, CHU Robert Debré, Paris, France
FAU - Merchaoui, Zied
AU  - Merchaoui Z
AD  - Réanimation néonatale et pédiatrique, CHU Kremlin-bicêtre, Le Kremlin-Bicêtre,
      France
FAU - Renolleau, Sylvain
AU  - Renolleau S
AD  - 0000 0004 0593 9113grid.412134.1Réanimation pédiatrique polyvalente, Hôpital
      Necker - Enfants Malades, Paris, France
FAU - Oualha, Mehdi
AU  - Oualha M
AD  - 0000 0004 0593 9113grid.412134.1Réanimation et surveillance continue
      médico-chirurgicales, Hôpital Necker - Enfants Malades, Paris, France
FAU - Eloi, Maxime
AU  - Eloi M
AD  - 0000 0004 1937 0589grid.413235.2Unité u1141, INSERM-Hôpital Robert Debré, Paris, 
      France
FAU - Jean, Sandrine
AU  - Jean S
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Demoulin, Maryne
AU  - Demoulin M
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Valentin, Cécile
AU  - Valentin C
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Guilbert, Julia
AU  - Guilbert J
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Walti, Hervé
AU  - Walti H
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Carbajal, Ricardo
AU  - Carbajal R
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Leger, Pierre-Louis
AU  - Leger PL
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Karaca-Altintas, Yasemin
AU  - Karaca-Altintas Y
AD  - 0000 0004 0471 8845grid.410463.4Pediatric Intensive Care Unit, CHU Lille, 59000
      Lille, France
FAU - Botte, Astrid
AU  - Botte A
AD  - 0000 0004 0471 8845grid.410463.4Pediatric Intensive Care Unit, CHU Lille, 59000
      Lille, France
FAU - Labreuche, Julien
AU  - Labreuche J
AD  - 0000 0004 0471 8845grid.410463.4Department of Biostatistics, CHU Lille, 59000
      Lille, France
FAU - Drumez, Elodie
AU  - Drumez E
AD  - 0000 0004 0471 8845grid.410463.4Department of Biostatistics, CHU Lille, 59000
      Lille, France
FAU - Devos, Patrick
AU  - Devos P
AD  - 0000 0004 0471 8845grid.410463.4Department of Biostatistics, CHU Lille, 59000
      Lille, France
FAU - Bour, Franck
AU  - Bour F
AD  - Physioflow, Manatec Biomedical, 78300 Poissy, France
FAU - Leclerc, Francis
AU  - Leclerc F
AD  - 0000 0004 0471 8845grid.410463.4Réanimation pédiatrique, C.H. Régional
      Universitaire de Lille (CHRU de Lille), Lille, France
FAU - Ahmed, Ayari
AU  - Ahmed A
AD  - Unité de recherche ur12sp10. université tunis el manar, Service de réanimation
      pédiatrique polyvalente, Hôpital d’enfants Béchir Hamza de Tunis, Tunis, Tunisia
FAU - khaled, Menif
AU  - khaled M
AD  - Unité de recherche ur12sp10. université tunis el manar, Service de réanimation
      pédiatrique polyvalente, Hôpital d’enfants Béchir Hamza de Tunis, Tunis, Tunisia
FAU - Louati, Assaad
AU  - Louati A
AD  - Unité de recherche ur12sp10. université tunis el manar, Service de réanimation
      pédiatrique polyvalente, Hôpital d’enfants Béchir Hamza de Tunis, Tunis, Tunisia
FAU - Aida, Borgi
AU  - Aida B
AD  - Unité de recherche ur12sp10. université tunis el manar, Service de réanimation
      pédiatrique polyvalente, Hôpital d’enfants Béchir Hamza de Tunis, Tunis, Tunisia
FAU - Ammar, Khaldi
AU  - Ammar K
AD  - Unité de recherche ur12sp10. université tunis el manar, Service de réanimation
      pédiatrique polyvalente, Hôpital d’enfants Béchir Hamza de Tunis, Tunis, Tunisia
FAU - Narjess, Ghali
AU  - Narjess G
AD  - Unité de recherche ur12sp10. université tunis el manar, Service de réanimation
      pédiatrique polyvalente, Hôpital d’enfants Béchir Hamza de Tunis, Tunis, Tunisia
FAU - Ahmed, Hajji
AU  - Ahmed H
AD  - Unité de recherche ur12sp10. université tunis el manar, Service de réanimation
      pédiatrique polyvalente, Hôpital d’enfants Béchir Hamza de Tunis, Tunis, Tunisia
FAU - Asma, Bouziri
AU  - Asma B
AD  - Unité de recherche ur12sp10. université tunis el manar, Service de réanimation
      pédiatrique polyvalente, Hôpital d’enfants Béchir Hamza de Tunis, Tunis, Tunisia
FAU - Jaballah, Nejla Ben
AU  - Jaballah NB
AD  - Unité de recherche ur12sp10. université tunis el manar, Service de réanimation
      pédiatrique polyvalente, Hôpital d’enfants Béchir Hamza de Tunis, Tunis, Tunisia
FAU - Leger, Pierre-Louis
AU  - Leger PL
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Pansiot, Julien
AU  - Pansiot J
AD  - 0000 0004 1937 0589grid.413235.2Inserm u1141, Hôpital Robert Debré, Paris, France
FAU - Besson, Valérie
AU  - Besson V
AD  - 0000 0001 2188 0914grid.10992.33Pharmacologie de la circulation cérébrale, INSERM
      EA4475, Faculté de Pharmacie, University Paris Descartes, Paris, France
FAU - Palmier, Bruno
AU  - Palmier B
AD  - 0000 0001 2188 0914grid.10992.33Pharmacologie de la circulation cérébrale, INSERM
      EA4475, Faculté de Pharmacie, University Paris Descartes, Paris, France
FAU - Baud, Olivier
AU  - Baud O
AD  - 0000 0004 1937 0589grid.413235.2Inserm u1141, Hôpital Robert Debré, Paris, France
FAU - Cauli, Bruno
AU  - Cauli B
AD  - 0000 0001 1955 3500grid.5805.8Inserm nps, Université UPMC, Paris, France
FAU - Charriaut-Marlangue, Christiane
AU  - Charriaut-Marlangue C
AD  - 0000 0004 1937 0589grid.413235.2Inserm u1141, Hôpital Robert Debré, Paris, France
FAU - Mansuy, Amélie
AU  - Mansuy A
AD  - grid.411266.6Anesthésie-réanimation pédiatrique, Hopital de la Timone, Marseille,
      France
FAU - Michel, Fabrice
AU  - Michel F
AD  - grid.411266.6Anesthésie-réanimation pédiatrique, Hopital de la Timone, Marseille,
      France
FAU - Le Bel, Stéphane
AU  - Le Bel S
AD  - grid.411266.6Anesthésie-réanimation pédiatrique, Hopital de la Timone, Marseille,
      France
FAU - Boubnova, Julia
AU  - Boubnova J
AD  - grid.411266.6Centre de référence des hernies diaphragmatiques, Hôpital de la
      Timone, Marseille, France
FAU - Ughetto, Fabrice
AU  - Ughetto F
AD  - grid.411266.6Anesthésie-réanimation pédiatrique, Hopital de la Timone, Marseille,
      France
FAU - Ovaert, Caroline
AU  - Ovaert C
AD  - grid.411266.6Cardiologie pédiatrique, Hôpital de la Timone, Marseille, France
FAU - Fouilloux, Virginie
AU  - Fouilloux V
AD  - grid.411266.6Chirurgie cardiaque pédiatrique, Hôpital de la Timone, Marseille,
      France
FAU - Paut, Olivier
AU  - Paut O
AD  - grid.411266.6Anesthésie-réanimation pédiatrique, Hopital de la Timone, Marseille,
      France
FAU - Jacquet-Lagrèze, Matthias
AU  - Jacquet-Lagrèze M
AD  - grid.413858.3Anesthésie réanimation, Hôpital Louis Pradel, Bron, France
FAU - Tiebergien, Nicolas
AU  - Tiebergien N
AD  - grid.413858.3Anesthésie réanimation, Hôpital Louis Pradel, Bron, France
FAU - Hanna, Najib
AU  - Hanna N
AD  - grid.413858.3Anesthésie réanimation, Hôpital Louis Pradel, Bron, France
FAU - Evain, Jean-Noël
AU  - Evain JN
AD  - grid.414103.3Réanimation pédiatrique, Hôpital Femme Mère Enfant, Bron, France
FAU - Baudin, Florent
AU  - Baudin F
AD  - grid.414103.3Réanimation pédiatrique, Hôpital Femme Mère Enfant, Bron, France
FAU - Courtil-Teyssedre, Sonia
AU  - Courtil-Teyssedre S
AD  - grid.414103.3Réanimation pédiatrique, Hôpital Femme Mère Enfant, Bron, France
FAU - Bompard, Dominique
AU  - Bompard D
AD  - grid.413858.3Anesthésie réanimation, Hôpital Louis Pradel, Bron, France
FAU - Lilot, Marc
AU  - Lilot M
AD  - grid.414103.3Anesthésie, Hôpital Femme Mère Enfant, Bron, France
FAU - Chardonal, Laurent
AU  - Chardonal L
AD  - grid.413858.3Anesthésie réanimation, Hôpital Louis Pradel, Bron, France
FAU - Fellahi, Jean-Luc
AU  - Fellahi JL
AD  - grid.413858.3Anesthésie réanimation, Hôpital Louis Pradel, Bron, France
FAU - Claverie, Claire
AU  - Claverie C
AD  - 0000 0004 0471 8845grid.410463.4Réanimation pédiatrique, C.H. Régional
      Universitaire de Lille (CHRU de Lille), Lille, France
FAU - Pouessel, Guillaume
AU  - Pouessel G
AD  - Pédiatrie, Centre Hospitalier de Roubaix, Roubaix, France
FAU - Dorkenoo, Aimée
AU  - Dorkenoo A
AD  - 0000 0004 0471 8845grid.410463.4Réanimation pédiatrique, C.H. Régional
      Universitaire de Lille (CHRU de Lille), Lille, France
FAU - Renaudin, Jean-Marie
AU  - Renaudin JM
AD  - Department of allergology, Emile Durkheim Hospital, Épinal, France
FAU - Eb, Mireille
AU  - Eb M
AD  - Department of epidemiology (cepidc), National Mortality Center, Le
      Kremlin-Bicêtre, France
FAU - Deschildre, Antoine
AU  - Deschildre A
AD  - 0000 0004 0471 8845grid.410463.4Pediatric Pulmonology and Allergy Department,
      C.H. Régional Universitaire de Lille (CHRU de Lille), Lille, France
FAU - Leteurtre, Stéphane
AU  - Leteurtre S
AD  - 0000 0004 0471 8845grid.410463.4Réanimation pédiatrique, C.H. Régional
      Universitaire de Lille (CHRU de Lille), Lille, France
FAU - Yassine, Hafiani
AU  - Yassine H
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Kamal, Belkadi
AU  - Kamal B
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Adil, Oboukhlik
AU  - Adil O
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Ouafa, Aalalam
AU  - Ouafa A
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Mouhamed, Moussaoui
AU  - Mouhamed M
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Rachid, Charkab
AU  - Rachid C
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Lahoucine, Barrou
AU  - Lahoucine B
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Dachraoui, Fahmi
AU  - Dachraoui F
AD  - grid.420157.5Réanimation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia
FAU - Nakkaa, Sabrine
AU  - Nakkaa S
AD  - Réanimation Polyvalente, CHU Fatouma Bourguiba, Monastir, Tunisia
FAU - Zaineb, Hammouda
AU  - Zaineb H
AD  - Réanimation Polyvalente, CHU Fatouma Bourguiba, Monastir, Tunisia
FAU - Mlika, Dorra
AU  - Mlika D
AD  - grid.412791.8Pharmacy Department, CHU Farhat Hached, Sousse, Tunisia
FAU - Gloulou, Olfa
AU  - Gloulou O
AD  - grid.412791.8Pharmacy Department, CHU Farhat Hached, Sousse, Tunisia
FAU - Boussarsar, Mohamed
AU  - Boussarsar M
AD  - grid.412791.8Réanimation médicale, Research laboratory n° lr14es05, Faculty of
      medicine, CHU Farhat Hached, Sousse, Tunisia
FAU - Zelmat, Setti-Aouicha
AU  - Zelmat SA
AD  - Anesthésie réanimation chirurgicale, EHU 1er Novembre, Oran, Algeria
FAU - Batouche, Djamila-Djahida
AU  - Batouche DD
AD  - Réanimation pédiatrique, Centre Hospitalier et Universitaire d’Oran, Oran,
      Algeria
FAU - Chaffi, Belkacem
AU  - Chaffi B
AD  - Service de gynéco-obstétrique, EHS 1er Novembre, Oran, Algeria
FAU - Mazour, Fatima
AU  - Mazour F
AD  - Anesthesie-réanimation chirurgicale, EHS 1ER NOVEMBRE, Oran, Algeria
FAU - Benatta, Nadia
AU  - Benatta N
AD  - Cardiologie, Centre Hospitalier et Universitaire d’Oran, Oran, Algeria
FAU - Fathallah, Ines
AU  - Fathallah I
AD  - Intensive Care Unit, Regional Hospital of Ben Arous, Tunis, Tunisia
FAU - Aloui, Rafaa
AU  - Aloui R
AD  - Intensive Care Unit, Regional Hospital of Ben Arous, Tunis, Tunisia
FAU - Zoubli, Aymen
AU  - Zoubli A
AD  - Intensive Care Unit, Regional Hospital of Ben Arous, Tunis, Tunisia
FAU - Kouraichi, Nadia
AU  - Kouraichi N
AD  - Intensive Care Unit, Regional Hospital of Ben Arous, Tunis, Tunisia
FAU - Fathallah, Ines
AU  - Fathallah I
AD  - Intensive Care Unit, Regional Hospital of Ben Arous, Tunis, Tunisia
FAU - Kouraichi, N.
AU  - Kouraichi N
AD  - Intensive Care Unit, Regional Hospital of Ben Arous, Tunis, Tunisia
FAU - Salem, Shireen
AU  - Salem S
AD  - 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical 
      Care, Lariboisière Hospital, Paris, France
FAU - Vicaut, Eric
AU  - Vicaut E
AD  - 0000 0000 9725 279Xgrid.411296.9Department of Biostatistics, Lariboisière
      Hospital, Paris, France
FAU - Megarbane, Bruno
AU  - Megarbane B
AD  - 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical 
      Care, Lariboisière Hospital, Paris, France
FAU - Ambroise, David
AU  - Ambroise D
AD  - 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical 
      Care, Lariboisière Hospital, Paris, France
FAU - Loriot, Anne-Marie
AU  - Loriot AM
AD  - grid.414093.bLaboratory of Biochemistry, HEGP, Paris, France
FAU - Bourgogne, Emmanuel
AU  - Bourgogne E
AD  - 0000 0000 9725 279Xgrid.411296.9Laboratory of Toxicology, Lariboisière Hospital, 
      Paris, France
FAU - Megarbane, Bruno
AU  - Megarbane B
AD  - 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical 
      Care, Lariboisière Hospital, Paris, France
FAU - Ghadhoune, Hatem
AU  - Ghadhoune H
AD  - 0000000122959819grid.12574.35Réanimation médicale bizerte, Faculté de médecine de
      Tunis, Bizerte, Tunisia
FAU - Jihene, Guissouma
AU  - Jihene G
AD  - 0000000122959819grid.12574.35Réanimation médicale bizerte, Faculté de médecine de
      Tunis, Bizerte, Tunisia
FAU - Trabelsi, Insaf
AU  - Trabelsi I
AD  - 0000000122959819grid.12574.35Réanimation médicale bizerte, Faculté de médecine de
      Tunis, Bizerte, Tunisia
FAU - Allouche, Hend
AU  - Allouche H
AD  - 0000000122959819grid.12574.35Réanimation médicale bizerte, Faculté de médecine de
      Tunis, Bizerte, Tunisia
FAU - Brahmi, Habib
AU  - Brahmi H
AD  - 0000000122959819grid.12574.35Réanimation médicale bizerte, Faculté de médecine de
      Tunis, Bizerte, Tunisia
FAU - Samet, Mohamed
AU  - Samet M
AD  - 0000000122959819grid.12574.35Réanimation médicale bizerte, Faculté de médecine de
      Tunis, Bizerte, Tunisia
FAU - Ghord, Hatem El
AU  - Ghord HE
AD  - 0000000122959819grid.12574.35Réanimation médicale bizerte, Faculté de médecine de
      Tunis, Bizerte, Tunisia
FAU - Lebeau, Rodolphe
AU  - Lebeau R
AD  - 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris, 
      France
FAU - Laplanche, Jean-Louis
AU  - Laplanche JL
AD  - 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris, 
      France
FAU - Benturquia, Nadia
AU  - Benturquia N
AD  - 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris, 
      France
FAU - Megarbane, Bruno
AU  - Megarbane B
AD  - 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical 
      Care, Lariboisière Hospital, Paris, France
FAU - Blel, Youssef
AU  - Blel Y
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - M’rad, A.
AU  - M’rad A
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Essafi, Fatma
AU  - Essafi F
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Benabderrahim, A.
AU  - Benabderrahim A
AD  - Department of Intensive Care and Toxicology, Centre d’Assistance Médicale
      Urgente, Tunis, Tunisia
FAU - Jouffroy, Romain
AU  - Jouffroy R
AD  - Anesthésie Réanimation SAMUAPHP - CHRU Necker Enfants Malades, Paris, France
FAU - Resiere, Dabor
AU  - Resiere D
AD  - Centre Hospitalier Universitaire de Fort de France, Fort-De-France, Martinique
      France
FAU - Sanchez, Bruno
AU  - Sanchez B
AD  - Centre Hospitalier Universitaire de Fort de France, Fort-De-France, Martinique
      France
FAU - Inamo, Jocelyn
AU  - Inamo J
AD  - Centre Hospitalier Universitaire de Fort de France, Fort-De-France, Martinique
      France
FAU - Megarbane, Bruno
AU  - Megarbane B
AD  - 0000 0000 9725 279Xgrid.411296.9Service de Réanimation Médicale et Toxicologique,
      CHU Lariboisière, Paris, France
FAU - Batouche, Djamila-Djahida
AU  - Batouche DD
AD  - Réanimation pédiatrique, Centre Hospitalier et Universitaire d’Oran, Oran,
      Algeria
FAU - Zerhouni, Amel
AU  - Zerhouni A
AD  - Reanimation, EHS CANASTEL, Oran, Algeria
FAU - Tabeliouna, Kheira
AU  - Tabeliouna K
AD  - Réanimation pédiatrique, Centre Hospitalier et Universitaire d’Oran, Oran,
      Algeria
FAU - Negadi, Amine
AU  - Negadi A
AD  - Réanimation pédiatrique, Centre Hospitalier et Universitaire d’Oran, Oran,
      Algeria
FAU - Mentouri, Zahia
AU  - Mentouri Z
AD  - Réanimation pédiatrique, Centre Hospitalier et Universitaire d’Oran, Oran,
      Algeria
FAU - Le Gall, Fanny
AU  - Le Gall F
AD  - 0000 0004 0472 0160grid.411149.8Service d’anesthésie réanimation, Centre
      Hospitalier Universitaire de Caen, Caen, France
FAU - Hanouz, Jean-Luc
AU  - Hanouz JL
AD  - 0000 0004 0472 0160grid.411149.8Service d’anesthésie réanimation, Centre
      Hospitalier Universitaire de Caen, Caen, France
FAU - Normand, Hervé
AU  - Normand H
AD  - 0000 0004 0472 0160grid.411149.8Service d’explorations fonctionnelles
      respiratoire, Centre Hospitalier Universitaire de Caen, Caen, France
FAU - Khoury, Abdo
AU  - Khoury A
AD  - 0000 0004 0638 9213grid.411158.8Emergency Medicine and Critical Care, CHU de
      Besançon, Besançon, France
FAU - Sall, Fatimata Seydou
AU  - Sall FS
AD  - 0000 0004 0638 9213grid.411158.8Inserm cic 1431, CHU de Besançon, Besançon,
      France
FAU - De Luca, Alban
AU  - De Luca A
AD  - 0000 0004 0638 9213grid.411158.8Inserm cic 1431, CHU de Besançon, Besançon,
      France
FAU - Pugin, Aurore
AU  - Pugin A
AD  - 0000 0004 0638 9213grid.411158.8Inserm cic 1431, CHU de Besançon, Besançon,
      France
FAU - Pazart, Lionel
AU  - Pazart L
AD  - 0000 0004 0638 9213grid.411158.8Inserm cic 1431, CHU de Besançon, Besançon,
      France
FAU - Vidal, Chrystelle
AU  - Vidal C
AD  - 0000 0004 0638 9213grid.411158.8Inserm cic 1431, CHU de Besançon, Besançon,
      France
FAU - Leroux, Franck
AU  - Leroux F
AD  - 0000 0004 0638 9213grid.411158.8Inserm cic 1431, CHU de Besançon, Besançon,
      France
FAU - Khoury, Abdo
AU  - Khoury A
AD  - 0000 0004 0638 9213grid.411158.8Emergency Medicine and Critical Care, Hôpital
      jean Minjoz, Besançon, France
FAU - L’Her, Erwan
AU  - L’Her E
AD  - grid.411766.3Réanimation médicale, CHRU de Brest, Brest, France
FAU - Marjanovic, Nicolas
AU  - Marjanovic N
AD  - 0000 0000 9336 4276grid.411162.1Urgences, CHU de Poitiers, Poitiers, France
FAU - Khoury, Abdo
AU  - Khoury A
AD  - 0000 0004 0638 9213grid.411158.8Emergency Medicine and Critical Care, CHU de
      Besançon, Besançon, France
FAU - Desmettre, Thibault
AU  - Desmettre T
AD  - 0000 0004 0638 9213grid.411158.8Réanimation médicale, CHU de Besançon, Besançon, 
      France
FAU - Lambert, Christophe
AU  - Lambert C
AD  - 0000 0004 0638 9213grid.411158.8Emergency Medicine and Critical Care, CHU de
      Besançon, Besançon, France
FAU - Ragey, Sophie Perinel
AU  - Ragey SP
AD  - 0000 0004 4685 6736grid.413306.3Réanimation médicale, Hôpital de la Croix-Rousse,
      Lyon, France
FAU - Baboi, Loredana
AU  - Baboi L
AD  - 0000 0004 4685 6736grid.413306.3Réanimation médicale, Hôpital de la Croix-Rousse,
      Lyon, France
FAU - Bazin, Jean-Etienne
AU  - Bazin JE
AD  - 0000 0004 0639 4151grid.411163.0CHU Gabriel-Montpied, Clermont-Ferrand, France
FAU - Koffel, Catherine
AU  - Koffel C
AD  - Anesthesia and Intensive Care Medicine, Centre Hospitalier Louis Pradel, Lyon,
      France
FAU - Dhonneur, Gilles
AU  - Dhonneur G
AD  - 0000 0004 1799 3934grid.411388.7Anesthesia and Intensive Care Medicine, CHU Henri
      Mondor, Créteil, France
FAU - Bouzit, Zina
AU  - Bouzit Z
AD  - 0000 0001 2292 1474grid.412116.1Service d’Anesthésie et des Réanimations
      Chirurgicales, Hôpital Henri Mondor, Créteil, France
FAU - Bradai, Larbi
AU  - Bradai L
AD  - 0000 0001 2292 1474grid.412116.1Service d’Anesthésie et des Réanimations
      Chirurgicales, Hôpital Henri Mondor, Créteil, France
FAU - Ayed, Issam Ben
AU  - Ayed IB
AD  - 0000 0001 2292 1474grid.412116.1Service d’Anesthésie et des Réanimations
      Chirurgicales, Hôpital Henri Mondor, Créteil, France
FAU - Aissa, Fethi
AU  - Aissa F
AD  - 0000 0001 2292 1474grid.412116.1Service d’Anesthésie et des Réanimations
      Chirurgicales, Hôpital Henri Mondor, Créteil, France
FAU - Haouache, Hakim
AU  - Haouache H
AD  - 0000 0001 2292 1474grid.412116.1Service d’Anesthésie et des Réanimations
      Chirurgicales, Hôpital Henri Mondor, Créteil, France
FAU - Marechal, Yoann
AU  - Marechal Y
AD  - 0000 0001 0124 3248grid.413871.8Reanimation polyvalente, Hôpital Civil Marie
      Curie, Charleroi, Belgium
FAU - Biston, Patrick
AU  - Biston P
AD  - 0000 0001 0124 3248grid.413871.8Reanimation polyvalente, Hôpital Civil Marie
      Curie, Charleroi, Belgium
FAU - Piagnerelli, Michael
AU  - Piagnerelli M
AD  - 0000 0001 0124 3248grid.413871.8Reanimation polyvalente, Hôpital Civil Marie
      Curie, Charleroi, Belgium
FAU - Bortolotti, Perrine
AU  - Bortolotti P
AD  - 0000 0004 0471 8845grid.410463.4Réanimation médicale, Centre Hospitalier Régional
      Universitaire de Lille, Lille, France
FAU - Colling, Delphine
AU  - Colling D
AD  - 0000 0004 0471 8845grid.410463.4Réanimation médicale, Centre Hospitalier Régional
      Universitaire de Lille, Lille, France
FAU - Colas, Vincent
AU  - Colas V
AD  - 0000 0004 0594 4203grid.418063.8Réanimation Polyvalente, Centre Hospitalier De
      Valenciennes, Valenciennes, France
FAU - Voisin, Benoit
AU  - Voisin B
AD  - 0000 0004 0471 8845grid.410463.4Réanimation médicale, Centre Hospitalier Régional
      Universitaire de Lille, Lille, France
FAU - Dewavrin, Florent
AU  - Dewavrin F
AD  - 0000 0004 0594 4203grid.418063.8Réanimation Polyvalente, Centre Hospitalier De
      Valenciennes, Valenciennes, France
FAU - Onimus, Thierry
AU  - Onimus T
AD  - 0000 0004 0471 8845grid.410463.4Réanimation médicale, Centre Hospitalier Régional
      Universitaire de Lille, Lille, France
FAU - Girardie, Patrick
AU  - Girardie P
AD  - 0000 0004 0471 8845grid.410463.4Réanimation médicale, Centre Hospitalier Régional
      Universitaire de Lille, Lille, France
FAU - Saulnier, Fabienne
AU  - Saulnier F
AD  - 0000 0004 0471 8845grid.410463.4Réanimation médicale, Centre Hospitalier Régional
      Universitaire de Lille, Lille, France
FAU - Urbina, Tomas
AU  - Urbina T
AD  - 0000 0004 1937 1100grid.412370.3Réanimation médicale, Hôpital Saint-Antoine,
      Paris, France
FAU - Nguyen, Yann
AU  - Nguyen Y
AD  - 0000 0004 1937 1100grid.412370.3Réanimation médicale, Hôpital Saint-Antoine,
      Paris, France
FAU - Druoton, Anne-Lise
AU  - Druoton AL
AD  - 0000 0004 1765 1301grid.410527.5Réanimation médicale, Hôpital Central, C.H.U. de 
      Nancy, Nancy, France
FAU - Soudant, Marc
AU  - Soudant M
AD  - Cic 1433 épidémiologie et clinique, C.H.U. de Nancy, Nancy, France
FAU - Barraud, Damien
AU  - Barraud D
AD  - 0000 0004 1765 1301grid.410527.5Réanimation médicale, Hôpital Central, C.H.U. de 
      Nancy, Nancy, France
FAU - Conrad, Marie
AU  - Conrad M
AD  - 0000 0004 1765 1301grid.410527.5Réanimation médicale, Hôpital Central, C.H.U. de 
      Nancy, Nancy, France
FAU - Cravoisy-Popovic, Aurélie
AU  - Cravoisy-Popovic A
AD  - 0000 0004 1765 1301grid.410527.5Réanimation médicale, Hôpital Central, C.H.U. de 
      Nancy, Nancy, France
FAU - Nace, Lionel
AU  - Nace L
AD  - 0000 0004 1765 1301grid.410527.5Réanimation médicale, Hôpital Central, C.H.U. de 
      Nancy, Nancy, France
FAU - Bollaert, Pierre-Edouard
AU  - Bollaert PE
AD  - 0000 0004 1765 1301grid.410527.5Réanimation médicale, Hôpital Central, C.H.U. de 
      Nancy, Nancy, France
FAU - Martin, Ruste
AU  - Martin R
AD  - 0000 0004 4685 6736grid.413306.3Réanimation médicale, Hôpital de la Croix-Rousse,
      Lyon, France
FAU - Bitker, Laurent
AU  - Bitker L
AD  - 0000 0004 4685 6736grid.413306.3Réanimation médicale, Hôpital de la Croix-Rousse,
      Lyon, France
FAU - Richard, Jean-Christophe
AU  - Richard JC
AD  - 0000 0004 4685 6736grid.413306.3Réanimation médicale, Hôpital de la Croix-Rousse,
      Lyon, France
FAU - Brossier, David
AU  - Brossier D
AD  - 0000 0001 2173 6322grid.411418.9Soins intensifs pédiatriques, CHU Sainte-Justine,
      Montréal, Canada
FAU - Goyer, Isabelle
AU  - Goyer I
AD  - 0000 0001 2173 6322grid.411418.9Soins intensifs pédiatriques, CHU Sainte-Justine,
      Montréal, Canada
FAU - Marquis, Christopher
AU  - Marquis C
AD  - 0000 0001 2173 6322grid.411418.9Soins intensifs pédiatriques, CHU Sainte-Justine,
      Montréal, Canada
FAU - Lampin, Marie
AU  - Lampin M
AD  - 0000 0004 0471 8845grid.410463.4Réanimation pédiatrique, C.H. Régional
      Universitaire de Lille (CHRU de Lille), Lille, France
FAU - Duhamel, Alain
AU  - Duhamel A
AD  - 0000 0004 0471 8845grid.410463.4Santé publique:épidémiologie et qualité des
      soinsservice de biostatistiques, CHRU de Lille, Lille, France
FAU - Béhal, Hélène
AU  - Béhal H
AD  - 0000 0004 0471 8845grid.410463.4Biostatistiques, C.H. Régional Universitaire de
      Lille (CHRU de Lille), Lille, France
FAU - Dhaoui, Tahar
AU  - Dhaoui T
AD  - Pédiatrie, C.H. de Cambrai, Cambrai, France
FAU - Godeffroy, Véronique
AU  - Godeffroy V
AD  - Pédiatrie, C.H. de Lens, Lens, France
FAU - Devouge, Eve
AU  - Devouge E
AD  - Pédiatrie, C.H. d ‘Arras, Arras, France
FAU - Evrard, Dominique
AU  - Evrard D
AD  - Pédiatrie, C.H. de Boulogne-sur-Mer, Boulogne-Sur-Mer, France
FAU - Delepoulle, Florence
AU  - Delepoulle F
AD  - Pédiatrie, C.H. de Dunkerque, Dunkirk, France
FAU - Racoussot, Sylvie
AU  - Racoussot S
AD  - Pédiatrie, C.H. de Douai, Douai, France
FAU - Grandbastien, Bruno
AU  - Grandbastien B
AD  - 0000 0004 0471 8845grid.410463.4Santé publique:épidémiologie et qualité des
      soinsservice de gestion du risque infectieux, CHRU de Lille, Lille, France
FAU - Lampin, Marie
AU  - Lampin M
AD  - 0000 0004 0471 8845grid.410463.4Réanimation pédiatrique, C.H. Régional
      Universitaire de Lille (CHRU de Lille), Lille, France
FAU - Heilbronner, Claire
AU  - Heilbronner C
AD  - 0000 0004 0593 9113grid.412134.1Service de réanimation et surveillance continue
      médico-chirurgicale pédiatrique, Hôpital Necker - Enfants Malades, Paris, France
FAU - Roy, Emeline
AU  - Roy E
AD  - 0000 0004 0593 9113grid.412134.1Service de pédiatrie générale, Hôpital Necker -
      Enfants Malades, Paris, France
FAU - Masson, Alexandra
AU  - Masson A
AD  - 0000 0004 0593 9113grid.412134.1Service de réanimation et surveillance continue
      médico-chirurgicale pédiatrique, Hôpital Necker - Enfants Malades, Paris, France
FAU - Hadchouel-Duvergé, Alice
AU  - Hadchouel-Duvergé A
AD  - 0000 0004 0593 9113grid.412134.1Pneumology, Hospital Necker, Paris, France
FAU - Rigourd, Virginie
AU  - Rigourd V
AD  - 0000 0004 0593 9113grid.412134.1Réanimation néonatale, Hôpital Necker - Enfants
      Malades, Paris, France
FAU - Delacroix, Elise
AU  - Delacroix E
AD  - Isère, Hôpital couple enfant, Grenoble, France
FAU - Wroblewski, Isabelle
AU  - Wroblewski I
AD  - Reanimation pediatrique, C.h.u., La Tronche, La Tronche, France
FAU - Pin, Isabelle
AU  - Pin I
AD  - Isère, Hôpital couple enfant, Grenoble, France
FAU - Ego, Anne
AU  - Ego A
AD  - Isère, Hôpital couple enfant, Grenoble, France
FAU - Payen, Valerie
AU  - Payen V
AD  - Isère, Hôpital couple enfant, Grenoble, France
FAU - Debillon, Thierry
AU  - Debillon T
AD  - Reanimation pediatrique, C.h.u., La Tronche, La Tronche, France
FAU - Millet, Anne
AU  - Millet A
AD  - Isère, Hôpital couple enfant, Grenoble, France
FAU - Denot, Julien
AU  - Denot J
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Berthelot, Véronique
AU  - Berthelot V
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Thueux, Emilie
AU  - Thueux E
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Reymond, Marie
AU  - Reymond M
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - De Larrard, Alexandra
AU  - De Larrard A
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Amblard, Alain
AU  - Amblard A
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Leger, Pierre-Louis
AU  - Leger PL
AD  - Réanimation pédiatrique et néonatale, Hopital pour enfants Trousseau, Paris,
      France
FAU - Aoul, Nabil Tabet
AU  - Aoul NT
AD  - Réanimation pédiatrique canastel, Faculté de médecine d’Oran, Oran, Algeria
FAU - Lemiale, Virginie
AU  - Lemiale V
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Hôpital Saint-Louis
      (AP-HP), Paris, France
FAU - Oziel, Johanna
AU  - Oziel J
AD  - 0000 0000 8715 2621grid.413780.9Réanimation medico-chirurgicale, Hôpital
      Avicenne, Bobigny, France
FAU - Brule, Noelle
AU  - Brule N
AD  - 0000 0004 0472 0371grid.277151.7Réanimation médicale, CHU, Nantes, France
FAU - Moreau, Anne-Sophie
AU  - Moreau AS
AD  - 0000 0001 2300 6614grid.413328.fRéanimation médicale, Hôpital Saint-Louis
      (AP-HP), Paris, France
FAU - Marhbène, Takoua
AU  - Marhbène T
AD  - grid.413207.3Réanimation médicale, Hôpital Abderrahmen Mami, Ariana, Tunisia
FAU - Sellami, Salma
AU  - Sellami S
AD  - grid.413207.3Réanimation médicale, Hôpital Abderrahmen Mami, Ariana, Tunisia
FAU - Jamoussi, Amira
AU  - Jamoussi A
AD  - grid.413207.3Réanimation médicale, Hôpital Abderrahmen Mami, Ariana, Tunisia
FAU - Ayed, Samia
AU  - Ayed S
AD  - grid.413207.3Réanimation médicale, Hôpital Abderrahmen Mami, Ariana, Tunisia
FAU - Mhiri, Emna
AU  - Mhiri E
AD  - grid.413207.3Microbiologie Laboratory, Hôpital Abderrahmen Mami, Ariana, Tunisia
FAU - Slim, Leila
AU  - Slim L
AD  - grid.413207.3Microbiologie Laboratory, Hôpital Abderrahmen Mami, Ariana, Tunisia
FAU - Khelil, Jalila Ben
AU  - Khelil JB
AD  - grid.413207.3Réanimation médicale, Hôpital Abderrahmen Mami, Ariana, Tunisia
FAU - Besbes, Mohamed
AU  - Besbes M
AD  - grid.413207.3Réanimation médicale, Hôpital Abderrahmen Mami, Ariana, Tunisia
FAU - Chawki, Sylvain
AU  - Chawki S
AD  - Réanimation polyvalente adulte, Centre Hospitalier Intercommunal André Grégoire, 
      Montreuil, France
FAU - Hamdi, Aicha
AU  - Hamdi A
AD  - Réanimation polyvalente adulte, Centre Hospitalier Intercommunal André Grégoire, 
      Montreuil, France
FAU - Ciroldi, Magali
AU  - Ciroldi M
AD  - Réanimation polyvalente adulte, Centre Hospitalier Intercommunal André Grégoire, 
      Montreuil, France
FAU - Cottereau, Alice
AU  - Cottereau A
AD  - Réanimation polyvalente adulte, Centre Hospitalier Intercommunal André Grégoire, 
      Montreuil, France
FAU - Obadia, Edouard
AU  - Obadia E
AD  - Réanimation polyvalente adulte, Centre Hospitalier Intercommunal André Grégoire, 
      Montreuil, France
FAU - Zerbib, Yoann
AU  - Zerbib Y
AD  - 0000 0001 0274 3893grid.411784.fRéanimation médicale, Hôpital Cochin, Paris,
      France
FAU - Andrejak, Claire
AU  - Andrejak C
AD  - 0000 0004 0593 702Xgrid.134996.0Service de Réanimation Pneumologique, CHU Amiens 
      - Hôpital Sud, Amiens, France
FAU - Ricome, Sylvie
AU  - Ricome S
AD  - Service de réanimation polyvalente, Centre hospitalier intercommunal Robert
      Ballanger, Aulnay-Sous-Bois, France
FAU - Dupont, Hervé
AU  - Dupont H
AD  - Réanimation cardio thoracique et vasculaire, CHU Amiens-Picardie, Amiens, France
FAU - Baudin, François
AU  - Baudin F
AD  - Réanimation chirurgicale, Cochin Port-Royal, Paris, France
FAU - Dureau, Pauline
AU  - Dureau P
AD  - 0000 0001 1955 3500grid.5805.8Service d’anesthésie et de réanimation, Institut de
      cardiologiepitié salpetrière hospital, Faculté de Médecine Pierre et Marie Curie,
      Paris, France
FAU - Tanguy, Audrey
AU  - Tanguy A
AD  - 0000 0001 2150 9058grid.411439.aDépartement de biostatistiques, santé publique et
      information médicale, Pitié-Salpêtrière Hospital, Paris, France
FAU - Arbelot, Charlotte
AU  - Arbelot C
AD  - 0000 0001 2150 9058grid.411439.aRéanimation chirurgicale polyvalente, Hôpital de 
      la Pitié-Salpêtrière, Paris, France
FAU - Ben, Hassen Kais
AU  - Ben HK
AD  - 0000 0001 2150 9058grid.411439.aService d’anesthésie et de réanimation, institut 
      de cardiologie, Pitié-Salpêtrière Hospital, Paris, France
FAU - Charfeddine, Ahmed
AU  - Charfeddine A
AD  - 0000 0001 2150 9058grid.411439.aService d’anesthésie et de réanimation, institut 
      de cardiologie, Pitié-Salpêtrière Hospital, Paris, France
FAU - Granger, Benjamin
AU  - Granger B
AD  - 0000 0001 2150 9058grid.411439.aDépartement de biostatistiques, santé publique et
      information médicale, Pitié-Salpêtrière Hospital, Paris, France
FAU - Laporte, Lucile
AU  - Laporte L
AD  - Réanimation polyvalenteCHRU Hôpitaux de Tours, Tours, France
FAU - Hermetet, Coralie
AU  - Hermetet C
AD  - Service d’information médicaled’épidémiologie et d’économie de la santé, CHRU
      Hôpitaux de Tours, Tours, France
FAU - Regaieg, Kais
AU  - Regaieg K
AD  - grid.413497.cICU, CHU Habib Bourguiba, Sfax, Tunisia
FAU - Khemakhem, Rim
AU  - Khemakhem R
AD  - 0000 0001 2323 5644grid.412124.0Réanimation polyvalente, Faculté de médecine de
      Sfax, Sfax, Tunisia
FAU - Chelly, Hedi
AU  - Chelly H
AD  - 0000 0001 2323 5644grid.412124.0Réanimation polyvalente, Faculté de médecine de
      Sfax, Sfax, Tunisia
FAU - Cheikh, Chaigar Mohammed
AU  - Cheikh CM
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Mountij, Hamid
AU  - Mountij H
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Rghioui, Kawtar
AU  - Rghioui K
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Haddad, Wafae
AU  - Haddad W
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Cherkab, Rachid
AU  - Cherkab R
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Barrou, Houcine
AU  - Barrou H
AD  - Anesthésie réanimationCHU Ibn Rochd Casa, Casablanca, Morocco
FAU - Naima, Aitmouden
AU  - Naima A
AD  - 0000 0004 0647 7037grid.414346.0Medical Informatics Laboratory, Chu Ibn Rochd,
      Casablanca, Morocco
FAU - bennani, Othmani M.
AU  - bennani OM
AD  - 0000 0004 0647 7037grid.414346.0Medical Informatics Laboratory, Chu Ibn Rochd,
      Casablanca, Morocco
FAU - Regaieg, Kais
AU  - Regaieg K
AD  - grid.413497.cICU, CHU Habib Bourguiba, Sfax, Tunisia
FAU - Douib, Ahmed
AU  - Douib A
AD  - 0000 0001 2323 5644grid.412124.0Réanimation polyvalente, Faculté de médecine de
      Sfax, Sfax, Tunisia
FAU - Samet, Amal
AU  - Samet A
AD  - grid.413497.cRéanimation polyvalente, CHU Habib Bourguiba, Sfax, Tunisia
FAU - Cungi, Pierre-Julien
AU  - Cungi PJ
AD  - 0000 0000 9759 428Xgrid.414039.bIntensive Care Unit and Anesthesiology, Hôpital
      d’Instruction des Armées Sainte-Anne, Toulon, France
FAU - Nguyen, Cédric
AU  - Nguyen C
AD  - 0000 0000 9759 428Xgrid.414039.bIntensive Care Unit and Anesthesiology, Hôpital
      d’Instruction des Armées Sainte-Anne, Toulon, France
FAU - Cotte, Jean
AU  - Cotte J
AD  - 0000 0000 9759 428Xgrid.414039.bIntensive Care Unit and Anesthesiology, Hôpital
      d’Instruction des Armées Sainte-Anne, Toulon, France
FAU - D’aranda, Erwan
AU  - D’aranda E
AD  - 0000 0000 9759 428Xgrid.414039.bIntensive Care Unit and Anesthesiology, Hôpital
      d’Instruction des Armées Sainte-Anne, Toulon, France
FAU - Meaudre, Eric
AU  - Meaudre E
AD  - 0000 0000 9759 428Xgrid.414039.bIntensive Care Unit and Anesthesiology, Hôpital
      d’Instruction des Armées Sainte-Anne, Toulon, France
FAU - Avaro, Jean-Phillipe
AU  - Avaro JP
AD  - 0000 0000 9759 428Xgrid.414039.bThoracic Surgery Department, Hôpital
      d’Instruction des Armées Sainte-Anne, Toulon, France
FAU - Slaoui, Mohamed Taoufik
AU  - Slaoui MT
AD  - 0000 0004 0647 7037grid.414346.0Reanimation des urgences chirurgicale, Chu Ibn
      Rochd, Casablanca, Morocco
FAU - Mokline, Amel
AU  - Mokline A
AD  - Burn Care Department, Trauma and Burn Center, Tunis, Tunisia
FAU - Rahmani, Imene
AU  - Rahmani I
AD  - Burn Care Department, Trauma and Burn Center, Tunis, Tunisia
FAU - Laajili, Achraf
AU  - Laajili A
AD  - Burn Care Department, Trauma and Burn Center, Tunis, Tunisia
FAU - Amri, Helmi
AU  - Amri H
AD  - Burn Care Department, Trauma and Burn Center, Tunis, Tunisia
FAU - Gharsallah, Lazheri
AU  - Gharsallah L
AD  - Burn Care Department, Trauma and Burn Center, Tunis, Tunisia
FAU - Gasri, Bahija
AU  - Gasri B
AD  - Burn Care Department, Trauma and Burn Center, Tunis, Tunisia
FAU - Tlaili, Sofiene
AU  - Tlaili S
AD  - Burn Care Department, Trauma and Burn Center, Tunis, Tunisia
FAU - Hammouda, Rym
AU  - Hammouda R
AD  - Burn Care Department, Trauma and Burn Center, Tunis, Tunisia
FAU - Messadi, Amen Allah
AU  - Messadi AA
AD  - Burn Care Department, Trauma and Burn Center, Tunis, Tunisia
LA  - eng
PT  - Journal Article
DEP - 20170110
TA  - Ann Intensive Care
JT  - Annals of Intensive Care
AID - 223 [pii]
AID - 10.1186/s13613-016-0223-8 [doi]
SO  - Ann Intensive Care. 2017 Jan 10;7(Suppl 1):. doi:10.1186/s13613-016-0223-8.

PMC - PMC5123388
IS  - 2050-5736 (Electronic)
VI  - 4
IP  - Suppl 1
DP  - 2016
TI  - 5th International Symposium on Focused Ultrasound: North Bethesda, MD, USA. 28
      August- 1 September 2016.
PG  - 1-113
FAU - Zaaroor, Menashe
AU  - Zaaroor M
AD  - Rambam Health Care Campus, Haifa, Israel
FAU - Sinai, Alon
AU  - Sinai A
AD  - Rambam Health Care Campus, Haifa, Israel
FAU - Goldsher, Dorit
AU  - Goldsher D
AD  - Rambam Health Care Campus, Haifa, Israel
FAU - Eran, Ayelet
AU  - Eran A
AD  - Rambam Health Care Campus, Haifa, Israel
FAU - Nassar, Maria
AU  - Nassar M
AD  - Rambam Health Care Campus, Haifa, Israel
FAU - Schlesinger, Ilana
AU  - Schlesinger I
AD  - Rambam Health Care Campus, Haifa, Israel
FAU - Parker, Jonathon
AU  - Parker J
AD  - Stanford University, Stanford, CA USA
FAU - Ravikumar, Vinod
AU  - Ravikumar V
AD  - Stanford University, Stanford, CA USA
FAU - Ghanouni, Pejman
AU  - Ghanouni P
AD  - Stanford University, Stanford, CA USA
FAU - Stein, Sherman
AU  - Stein S
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Halpern, Casey
AU  - Halpern C
AD  - Stanford University, Stanford, CA USA
FAU - Krishna, Vibhor
AU  - Krishna V
AD  - The Ohio State University, Columbus, OH USA
FAU - Hargrove, Amelia
AU  - Hargrove A
AD  - The Ohio State University, Columbus, OH USA
FAU - Agrawal, Punit
AU  - Agrawal P
AD  - The Ohio State University, Columbus, OH USA
FAU - Changizi, Barbara
AU  - Changizi B
AD  - The Ohio State University, Columbus, OH USA
FAU - Bourekas, Eric
AU  - Bourekas E
AD  - The Ohio State University, Columbus, OH USA
FAU - Knopp, Michael
AU  - Knopp M
AD  - The Ohio State University, Columbus, OH USA
FAU - Rezai, Ali
AU  - Rezai A
AD  - The Ohio State University, Columbus, OH USA
FAU - Mead, Brian
AU  - Mead B
AD  - University of Virginia, Charlottesville, VA USA
FAU - Kim, Namho
AU  - Kim N
AD  - Center for Nanomedicine/Wilmer Eye Institute, Johns Hopkins University,
      Baltimore, MD USA
FAU - Mastorakos, Panagiotis
AU  - Mastorakos P
AD  - Center for Nanomedicine/Wilmer Eye Institute, Johns Hopkins University,
      Baltimore, MD USA
FAU - Suk, Jung Soo
AU  - Suk JS
AD  - Center for Nanomedicine/Wilmer Eye Institute, Johns Hopkins University,
      Baltimore, MD USA
FAU - Miller, Wilson
AU  - Miller W
AD  - University of Virginia, Charlottesville, VA USA
FAU - Klibanov, Alexander
AU  - Klibanov A
AD  - University of Virginia, Charlottesville, VA USA
FAU - Hanes, Justin
AU  - Hanes J
AD  - Center for Nanomedicine/Wilmer Eye Institute, Johns Hopkins University,
      Baltimore, MD USA
FAU - Price, Richard
AU  - Price R
AD  - University of Virginia, Charlottesville, VA USA
FAU - Wang, Shutao
AU  - Wang S
AD  - Columbia University, New York, NY USA
FAU - Olumolade, Oluyemi
AU  - Olumolade O
AD  - Columbia University, New York, NY USA
FAU - Kugelman, Tara
AU  - Kugelman T
AD  - Columbia University, New York, NY USA
FAU - Jackson-Lewis, Vernice
AU  - Jackson-Lewis V
AD  - Columbia University, New York, NY USA
FAU - Karakatsani, Maria Eleni (Marilena)
AU  - Karakatsani ME(
AD  - Columbia University, New York, NY USA
FAU - Han, Yang
AU  - Han Y
AD  - Columbia University, New York, NY USA
FAU - Przedborski, Serge
AU  - Przedborski S
AD  - Columbia University, New York, NY USA
FAU - Konofagou, Elisa
AU  - Konofagou E
AD  - Columbia University, New York, NY USA
FAU - Hynynen, Kullervo
AU  - Hynynen K
AD  - Sunnybrook Health Sciences Centre, Toronto, ON Canada
FAU - Aubert, Isabelle
AU  - Aubert I
AD  - Sunnybrook Research Institute, Toronto, ON Canada
FAU - Leinenga, Gerhard
AU  - Leinenga G
AD  - Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The
      University of Queensland, St Lucia, QLD Australia
FAU - Nisbet, Rebecca
AU  - Nisbet R
AD  - The University of Queensland, Brisbane (St Lucia Campus), QLD Australia
FAU - Hatch, Robert
AU  - Hatch R
AD  - Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The
      University of Queensland, St Lucia, QLD Australia
FAU - Van der Jeugd, Anneke
AU  - Van der Jeugd A
AD  - University of Leuven, Leuven, Belgium
FAU - Evans, Harrison
AU  - Evans H
AD  - The University of Queensland, Brisbane (St Lucia Campus), QLD Australia
FAU - Götz, Jürgen
AU  - Götz J
AD  - The University of Queensland, Brisbane (St Lucia Campus), QLD Australia
FAU - Götz, Jürgen
AU  - Götz J
AD  - The University of Queensland, Brisbane (St Lucia Campus), QLD Australia
FAU - Nisbet, Rebecca
AU  - Nisbet R
AD  - The University of Queensland, Brisbane (St Lucia Campus), QLD Australia
FAU - Van der Jeugd, Ann
AU  - Van der Jeugd A
AD  - The University of Queensland, Brisbane (St Lucia Campus), QLD Australia
FAU - Evans, Harrison
AU  - Evans H
AD  - The University of Queensland, Brisbane (St Lucia Campus), QLD Australia
FAU - Leinenga, Gerhard
AU  - Leinenga G
AD  - Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The
      University of Queensland, St Lucia, QLD Australia
FAU - Fishman, Paul
AU  - Fishman P
AD  - University of Maryland School of Medicine/Baltimore VAMC, Baltimore, MD USA
FAU - Yarowsky, Paul
AU  - Yarowsky P
AD  - Research & Development Service, VA Maryland Healthcare System and University of
      Maryland School of Medicine, Baltimore, MD USA
FAU - Frenkel, Victor
AU  - Frenkel V
AD  - University of Maryland School of Medicine, Baltimore, MD USA
FAU - Wei-Bin, Shen
AU  - Wei-Bin S
AD  - University of Maryland School of Medicine, Baltimore, MD USA
FAU - Nguyen, Ben
AU  - Nguyen B
AD  - University of Maryland School of Medicine, Baltimore, MD USA
FAU - Sanchez, Carlos Sierra
AU  - Sanchez CS
AD  - Columbia University, New York, NY USA
FAU - Acosta, Camilo
AU  - Acosta C
AD  - Columbia University, New York, NY USA
FAU - Chen, Cherry
AU  - Chen C
AD  - Columbia University, New York, NY USA
FAU - Wu, Shih-Ying
AU  - Wu SY
AD  - Columbia University, New York, NY USA
FAU - Karakatsani, Maria Eleni (Marilena)
AU  - Karakatsani ME(
AD  - Columbia University, New York, NY USA
FAU - Konofagou, Elisa
AU  - Konofagou E
AD  - Columbia University, New York, NY USA
FAU - Aryal, Muna
AU  - Aryal M
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Papademetriou, Iason T.
AU  - Papademetriou IT
AD  - Boston University, Boston, MA USA
FAU - Zhang, Yong-Zhi
AU  - Zhang YZ
AD  - Harvard Medical School, Boston, MA USA
FAU - Power, Chanikarn
AU  - Power C
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - McDannold, Nathan
AU  - McDannold N
AD  - Rambam Health Care Campus, Haifa, Israel
FAU - Porter, Tyrone
AU  - Porter T
AD  - Boston University, Boston, MA USA
FAU - Kovacs, Zsofia
AU  - Kovacs Z
AD  - National Institutes of Health, Bethesda, MD USA
FAU - Kim, Saejeong
AU  - Kim S
AD  - National Institutes of Health, Bethesda, MD USA
FAU - Jikaria, Neekita
AU  - Jikaria N
AD  - National Institutes of Health, Bethesda, MD USA
FAU - Qureshi, Farhan
AU  - Qureshi F
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Bresler, Michele
AU  - Bresler M
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Frank, Joseph
AU  - Frank J
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Odéen, Henrik
AU  - Odéen H
AD  - University of Utah, Salt Lake City, UT USA
FAU - Chiou, George
AU  - Chiou G
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Snell, John
AU  - Snell J
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Todd, Nick
AU  - Todd N
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Madore, Bruno
AU  - Madore B
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Parker, Dennis
AU  - Parker D
AD  - University of Utah, Salt Lake City, UT USA
FAU - Pauly, Kim Butts
AU  - Pauly KB
AD  - Stanford University, Stanford, CA USA
FAU - Marx, Mike
AU  - Marx M
AD  - Stanford University, Stanford, CA USA
FAU - Ghanouni, Pejman
AU  - Ghanouni P
AD  - Stanford University, Stanford, CA USA
FAU - Jonathan, Sumeeth
AU  - Jonathan S
AD  - Vanderbilt University, Nashville, TN USA
FAU - Grissom, William
AU  - Grissom W
AD  - Vanderbilt University, Nashville, TN USA
FAU - Arvanitis, Costas
AU  - Arvanitis C
AD  - Georgia Institute of Technology, Atlanta, GA USA
FAU - McDannold, Nathan
AU  - McDannold N
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Clement, Gregory
AU  - Clement G
AD  - Cleveland Clinic, Cleveland, OH USA
FAU - Parker, Dennis
AU  - Parker D
AD  - University of Utah, Salt Lake City, UT USA
FAU - de Bever, Joshua
AU  - de Bever J
AD  - University of Utah, Salt Lake City, UT USA
FAU - Odéen, Henrik
AU  - Odéen H
AD  - University of Utah, Salt Lake City, UT USA
FAU - Payne, Allison
AU  - Payne A
AD  - University of Utah, Salt Lake City, UT USA
FAU - Christensen, Douglas
AU  - Christensen D
AD  - University of Utah, Salt Lake City, UT USA
FAU - Maimbourg, Guillaume
AU  - Maimbourg G
AD  - Institut Langevin Ondes et Images, ESPCI ParisTech, CNRS UMR 7587, INSERM U979,
      Paris, France
FAU - Santin, Mathieu David
AU  - Santin MD
AD  - CENIR, ICM, CNRS U7225, INSERM U975, Paris, France
FAU - Houdouin, Alexandre
AU  - Houdouin A
AD  - Institut Langevin Ondes et Images, ESPCI ParisTech, CNRS UMR 7587, INSERM U979,
      Paris, France
FAU - Lehericy, Stéphane
AU  - Lehericy S
AD  - CENIR, ICM, CNRS U7225, INSERM U975, Paris, France
FAU - Tanter, Mickael
AU  - Tanter M
AD  - Institut Langevin Ondes et Images, ESPCI ParisTech, CNRS UMR 7587, INSERM U979,
      Paris, France
FAU - Aubry, Jean Francois
AU  - Aubry JF
AD  - Institut Langevin Ondes et Images, ESPCI ParisTech, CNRS UMR 7587, INSERM U979,
      Paris, France
FAU - Pauly, Kim Butts
AU  - Pauly KB
AD  - Stanford University, Stanford, CA USA
FAU - Federau, Christian
AU  - Federau C
AD  - Stanford University, Stanford, CA USA
FAU - Werner, Beat
AU  - Werner B
AD  - University Children’s Hospital Zurich, Zurich, Switzerland
FAU - Halpern, Casey
AU  - Halpern C
AD  - Stanford University, Stanford, CA USA
FAU - Ghanouni, Pejman
AU  - Ghanouni P
AD  - Stanford University, Stanford, CA USA
FAU - Paeng, Dong-Guk
AU  - Paeng DG
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Xu, Zhiyuan
AU  - Xu Z
AD  - University of Virginia, Charlottesville, VA USA
FAU - Snell, John
AU  - Snell J
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Quigg, Anders
AU  - Quigg A
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Eames, Matt
AU  - Eames M
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Jin, Changzhu
AU  - Jin C
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Everstine, Ashli
AU  - Everstine A
AD  - University of Virginia, Charlottesville, VA USA
FAU - Sheehan, Jason
AU  - Sheehan J
AD  - University of Virginia, Charlottesville, VA USA
FAU - Lopes, M. Beatriz
AU  - Lopes MB
AD  - University of Virginia, Charlottesville, VA USA
FAU - Kassell, Neal
AU  - Kassell N
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Snell, John
AU  - Snell J
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Quigg, Anders
AU  - Quigg A
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Drake, James
AU  - Drake J
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Price, Karl
AU  - Price K
AD  - Centre for Image Guided Innovation and Therapeutic Intervention, Toronto, ON
      Canada
FAU - Lustgarten, Lior
AU  - Lustgarten L
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Sin, Vivian
AU  - Sin V
AD  - Centre for Image Guided Innovation and Therapeutic Intervention, Toronto, ON
      Canada
FAU - Mougenot, Charles
AU  - Mougenot C
AD  - Philips Healthcare Canada, Toronto, ON Canada
FAU - Donner, Elizabeth
AU  - Donner E
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Tam, Emily
AU  - Tam E
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Hodaie, Mojgan
AU  - Hodaie M
AD  - Toronto Western Hospital, Toronto, ON Canada
FAU - Waspe, Adam
AU  - Waspe A
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Looi, Thomas
AU  - Looi T
AD  - Centre for Image Guided Innovation and Therapeutic Intervention, Toronto, ON
      Canada
FAU - Pichardo, Samuel
AU  - Pichardo S
AD  - Thunder Bay Regional Research Institute, Thunder Bay, ON Canada
FAU - Lee, Wonhye
AU  - Lee W
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Chung, Yong An
AU  - Chung YA
AD  - Incheon St. Mary’s Hospital, The Catholic University of Korea, Incheon, Republic 
      of Korea
FAU - Jung, Yujin
AU  - Jung Y
AD  - Incheon St. Mary’s Hospital, The Catholic University of Korea, Incheon, Republic 
      of Korea
FAU - Song, In-Uk
AU  - Song IU
AD  - Incheon St. Mary’s Hospital, The Catholic University of Korea, Incheon, Republic 
      of Korea
FAU - Yoo, Seung-Schik
AU  - Yoo SS
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Lee, Wonhye
AU  - Lee W
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Kim, Hyun-Chul
AU  - Kim HC
AD  - Department of Brain and Cognitive Engineering, Korea University, Seoul, Republic 
      of Korea
FAU - Jung, Yujin
AU  - Jung Y
AD  - Incheon St. Mary’s Hospital, The Catholic University of Korea, Incheon, Republic 
      of Korea
FAU - Chung, Yong An
AU  - Chung YA
AD  - Incheon St. Mary’s Hospital, The Catholic University of Korea, Incheon, Republic 
      of Korea
FAU - Song, In-Uk
AU  - Song IU
AD  - Incheon St. Mary’s Hospital, The Catholic University of Korea, Incheon, Republic 
      of Korea
FAU - Lee, Jong-Hwan
AU  - Lee JH
AD  - Department of Brain and Cognitive Engineering, Korea University, Seoul, Republic 
      of Korea
FAU - Yoo, Seung-Schik
AU  - Yoo SS
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Caskey, Charles
AU  - Caskey C
AD  - Vanderbilt University, Nashville, TN USA
FAU - Zinke, Wolf
AU  - Zinke W
AD  - Vanderbilt University, Nashville, TN USA
FAU - Cosman, Josh
AU  - Cosman J
AD  - Vanderbilt University, Nashville, TN USA
FAU - Shuman, Jillian
AU  - Shuman J
AD  - Vanderbilt University, Nashville, TN USA
FAU - Schall, Jeffrey
AU  - Schall J
AD  - Vanderbilt University, Nashville, TN USA
FAU - Aurup, Christian
AU  - Aurup C
AD  - Columbia University, New York, NY USA
FAU - Wang, Shutao
AU  - Wang S
AD  - Columbia University, New York, NY USA
FAU - Chen, Hong
AU  - Chen H
AD  - Washington University in St. Louis, St. Louis, MO USA
FAU - Acosta, Camilo
AU  - Acosta C
AD  - Washington University in St. Louis, St. Louis, MO USA
FAU - Konofagou, Elisa
AU  - Konofagou E
AD  - Washington University in St. Louis, St. Louis, MO USA
FAU - Kamimura, Hermes
AU  - Kamimura H
AD  - Universidade de Sao Paolo, Sao Paulo, Brazil
FAU - Carneiro, Antonio
AU  - Carneiro A
AD  - Universidade de Sao Paolo, Sao Paulo, Brazil
FAU - Todd, Nick
AU  - Todd N
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Sun, Tao
AU  - Sun T
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Zhang, Yong-Zhi
AU  - Zhang YZ
AD  - Harvard Medical School, Boston, MA USA
FAU - Power, Chanikarn
AU  - Power C
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Nazai, Navid
AU  - Nazai N
AD  - Boston University, Boston, MA USA
FAU - Patz, Sam
AU  - Patz S
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Livingstone, Margaret
AU  - Livingstone M
AD  - Harvard Medical School, Boston, MA USA
FAU - McDannold, Nathan
AU  - McDannold N
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Mainprize, Todd
AU  - Mainprize T
AD  - Sunnybrook Health Sciences Centre, Toronto, ON Canada
FAU - Huang, Yuexi
AU  - Huang Y
AD  - Physical Sciences Platform, Sunnybrook Research Institute, Toronto, ON Canada
FAU - Alkins, Ryan
AU  - Alkins R
AD  - University of Toronto, Toronto, ON Canada
FAU - Chapman, Martin
AU  - Chapman M
AD  - University of Toronto, Toronto, ON Canada
FAU - Perry, James
AU  - Perry J
AD  - Sunnybrook Research Institute, Toronto, ON Canada
FAU - Lipsman, Nir
AU  - Lipsman N
AD  - Sunnybrook Health Sciences Centre, Toronto, ON Canada
FAU - Bethune, Allison
AU  - Bethune A
AD  - Sunnybrook Health Sciences Centre, Toronto, ON Canada
FAU - Sahgal, Arjun
AU  - Sahgal A
AD  - Sunnybrook Research Institute, Toronto, ON Canada
FAU - Trudeau, Maureen
AU  - Trudeau M
AD  - Sunnybrook Research Institute, Toronto, ON Canada
FAU - Hynynen, Kullervo
AU  - Hynynen K
AD  - Sunnybrook Health Sciences Centre, Toronto, ON Canada
FAU - Liu, Hao-Li
AU  - Liu HL
AD  - Chang Gung University, Taoyuan, Taiwan
FAU - Hsu, Po-Hung
AU  - Hsu PH
AD  - Chang Gung University, Taoyuan, Taiwan
FAU - Wei, Kuo-Chen
AU  - Wei KC
AD  - Chang Gung Memorial Hospital, Taoyuan, Taiwan
FAU - Sun, Tao
AU  - Sun T
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Power, Chanikarn
AU  - Power C
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Zhang, Yong-Zhi
AU  - Zhang YZ
AD  - Harvard Medical School, Boston, MA USA
FAU - Sutton, Jonathan
AU  - Sutton J
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Alexander, Phillip
AU  - Alexander P
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Aryal, Muna
AU  - Aryal M
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Miller, Eric
AU  - Miller E
AD  - Tufts University, Medford, MA USA
FAU - McDannold, Nathan
AU  - McDannold N
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Kobus, Thiele
AU  - Kobus T
AD  - Radboud University Medical Center, Nijmegen, Netherlands
FAU - Zhang, Yong-Zhi
AU  - Zhang YZ
AD  - Harvard Medical School, Boston, MA USA
FAU - McDannold, Nathan
AU  - McDannold N
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Carpentier, Alexandre
AU  - Carpentier A
AD  - Hopital de la Pitié-Salpêtrière, Assistance Publique Hopitaux de Paris, Paris,
      France
FAU - Canney, Michael
AU  - Canney M
AD  - CarThera, Denver, CO USA
FAU - Vignot, Alexandre
AU  - Vignot A
AD  - CarThera, Lyon, France
FAU - Beccaria, Kevin
AU  - Beccaria K
AD  - Hopital de la Pitié-Salpêtrière, Assistance Publique Hopitaux de Paris, Paris,
      France
FAU - Leclercq, Delphine
AU  - Leclercq D
AD  - Hopital de la Pitié-Salpêtrière, Assistance Publique Hopitaux de Paris, Paris,
      France
FAU - Lafon, Cyril
AU  - Lafon C
AD  - University of Virginia, Charlottesville, VA USA
FAU - Chapelon, Jean Yves
AU  - Chapelon JY
AD  - INSERM Unit 1032, Lyon, France
FAU - Hoang-Xuan, Khe
AU  - Hoang-Xuan K
AD  - Institut du Cerveau et de la Moelle épinière, ICM, Paris, France
FAU - Delattre, Jean-Yves
AU  - Delattre JY
AD  - Hopital de la Pitié-Salpêtrière, Assistance Publique Hopitaux de Paris, Paris,
      France
FAU - Idbaih, Ahmed
AU  - Idbaih A
AD  - Hopital de la Pitié-Salpêtrière, Assistance Publique Hopitaux de Paris, Paris,
      France
FAU - Xu, Zhiyuan
AU  - Xu Z
AD  - University of Virginia, Charlottesville, VA USA
FAU - Moore, David
AU  - Moore D
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Xu, Alexis
AU  - Xu A
AD  - University of Virginia, Charlottesville, VA USA
FAU - Schmitt, Paul
AU  - Schmitt P
AD  - University of Virginia Health System, Charlottesville, VA USA
FAU - Snell, John
AU  - Snell J
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Foley, Jessica
AU  - Foley J
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Eames, Matt
AU  - Eames M
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Sheehan, Jason
AU  - Sheehan J
AD  - University of Virginia, Charlottesville, VA USA
FAU - Kassell, Neal
AU  - Kassell N
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Sukovich, Jonathan
AU  - Sukovich J
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Cain, Charles
AU  - Cain C
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Xu, Zhiyuan
AU  - Xu Z
AD  - University of Virginia, Charlottesville, VA USA
FAU - Pandey, Aditya
AU  - Pandey A
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Snell, John
AU  - Snell J
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Chaudhary, Neeraj
AU  - Chaudhary N
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Camelo-Piragua, Sandra
AU  - Camelo-Piragua S
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Allen, Steven
AU  - Allen S
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Paeng, Dong-Guk
AU  - Paeng DG
AD  - Jeju National University, Jeju, Republic of Korea
FAU - Cannata, Jon
AU  - Cannata J
AD  - HistoSonics, Inc., Ann Arbor, MI USA
FAU - Teofilovic, Dejan
AU  - Teofilovic D
AD  - HistoSonics, Inc., Ann Arbor, MI USA
FAU - Bertolina, Jim
AU  - Bertolina J
AD  - HistoSonics, Inc., Ann Arbor, MI USA
FAU - Kassell, Neal
AU  - Kassell N
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Hall, Timothy
AU  - Hall T
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Xu, Zhen
AU  - Xu Z
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Wu, Shih-Ying
AU  - Wu SY
AD  - Columbia University, New York, NY USA
FAU - Karakatsani, Maria Eleni (Marilena)
AU  - Karakatsani ME(
AD  - Columbia University, New York, NY USA
FAU - Grondin, Julien
AU  - Grondin J
AD  - Columbia University, New York, NY USA
FAU - Sanchez, Carlos Sierra
AU  - Sanchez CS
AD  - Columbia University, New York, NY USA
FAU - Ferrera, Vincent
AU  - Ferrera V
AD  - Columbia University, New York, NY USA
FAU - Konofagou, Elisa
AU  - Konofagou E
AD  - Columbia University, New York, NY USA
FAU - ter Haar, Gail
AU  - ter Haar G
AD  - The Institute of Cancer Research, Sutton, Surrey, UK
FAU - Mouratidis, Petros
AU  - Mouratidis P
AD  - The Institute of Cancer Research, Sutton, Surrey, UK
FAU - Repasky, Elizabeth
AU  - Repasky E
AD  - Roswell Park Cancer Institute, Buffalo, NY USA
FAU - Timbie, Kelsie
AU  - Timbie K
AD  - University of Virginia, Charlottesville, VA USA
FAU - Badr, Lena
AU  - Badr L
AD  - University of Virginia, Charlottesville, VA USA
FAU - Campbell, Benjamin
AU  - Campbell B
AD  - University of Virginia, Charlottesville, VA USA
FAU - McMichael, John
AU  - McMichael J
AD  - University of Virginia, Charlottesville, VA USA
FAU - Buckner, Andrew
AU  - Buckner A
AD  - University of Virginia, Charlottesville, VA USA
FAU - Prince, Jessica
AU  - Prince J
AD  - University of Virginia, Charlottesville, VA USA
FAU - Stevens, Aaron
AU  - Stevens A
AD  - University of Virginia, Charlottesville, VA USA
FAU - Bullock, Timothy
AU  - Bullock T
AD  - University of Virginia, Charlottesville, VA USA
FAU - Price, Richard
AU  - Price R
AD  - University of Virginia, Charlottesville, VA USA
FAU - Skalina, Karin
AU  - Skalina K
AD  - Albert Einstein College of Medicine, Bronx, NY USA
FAU - Guha, Chandan
AU  - Guha C
AD  - Montefiore Medical Center, Bronx, NY USA
FAU - Orsi, Franco
AU  - Orsi F
FAU - Bonomo, Guido
AU  - Bonomo G
AD  - Istituto Europeo di Oncologia, Milan, Italy
FAU - Vigna, Paolo Della
AU  - Vigna PD
AD  - Istituto Europeo di Oncologia, Milan, Italy
FAU - Mauri, Giovanni
AU  - Mauri G
AD  - Istituto Europeo di Oncologia, Milan, Italy
FAU - Varano, Gianluca
AU  - Varano G
AD  - Istituto Europeo di Oncologia, Milan, Italy
FAU - Schade, George
AU  - Schade G
AD  - University of Washington, Seattle, WA USA
FAU - Wang, Yak-Nam
AU  - Wang YN
AD  - University of Washington, Seattle, WA USA
FAU - Pillarisetty, Venu
AU  - Pillarisetty V
AD  - University of Washington, Seattle, WA USA
FAU - Hwang, Joo Ha
AU  - Hwang JH
AD  - University of Washington, Seattle, WA USA
FAU - Khokhlova, Vera
AU  - Khokhlova V
AD  - University of Washington, Seattle, WA USA
FAU - Bailey, Michael
AU  - Bailey M
AD  - University of Washington, Seattle, WA USA
FAU - Khokhlova, Tatiana
AU  - Khokhlova T
AD  - University of Washington, Seattle, WA USA
FAU - Khokhlova, Vera
AU  - Khokhlova V
AD  - University of Washington, Seattle, WA USA
FAU - Sinilshchikov, Ilya
AU  - Sinilshchikov I
AD  - M.V. Lomonosov Moscow State University, Moscow, Russian Federation
FAU - Yuldashev, Petr
AU  - Yuldashev P
AD  - M.V. Lomonosov Moscow State University, Moscow, Russian Federation
FAU - Andriyakhina, Yulia
AU  - Andriyakhina Y
AD  - M.V. Lomonosov Moscow State University, Moscow, Russian Federation
FAU - Kreider, Wayne
AU  - Kreider W
AD  - University of Washington, Seattle, WA USA
FAU - Maxwell, Adam
AU  - Maxwell A
AD  - University of Washington, Seattle, WA USA
FAU - Khokhlova, Tatiana
AU  - Khokhlova T
AD  - University of Washington, Seattle, WA USA
FAU - Sapozhnikov, Oleg
AU  - Sapozhnikov O
AD  - University of Washington, Seattle, WA USA
FAU - Partanen, Ari
AU  - Partanen A
AD  - Philips, Bethesda, MD USA
FAU - Lundt, Jonathan
AU  - Lundt J
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Allen, Steven
AU  - Allen S
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Sukovich, Jonathan
AU  - Sukovich J
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Hall, Timothy
AU  - Hall T
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Cain, Charles
AU  - Cain C
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Xu, Zhen
AU  - Xu Z
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Preusser, Tobias
AU  - Preusser T
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Haase, Sabrina
AU  - Haase S
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Bezzi, Mario
AU  - Bezzi M
AD  - Universita Degli Studi Di Roma La Sapienza, Rome, Italy
FAU - Jenne, Jürgen
AU  - Jenne J
AD  - mediri GmbH, Heidelberg, Baden-Württemberg Germany
FAU - Langø, Thomas
AU  - Langø T
AD  - Stiftelsen SINTEF, Trondheim, Norway
FAU - Midiri, Massimo
AU  - Midiri M
AD  - University of Palermo, Palermo, Italy
FAU - Mueller, Michael
AU  - Mueller M
AD  - IBSmm Engineering spol. s r.o., Brno, Czech Republic
FAU - Sat, Giora
AU  - Sat G
AD  - GE Medical Systems Israel Ltd, Tirat Carmel, Israel
FAU - Tanner, Christine
AU  - Tanner C
AD  - ETH Zurich, Computer Vision Laboratory, Zurich, Switzerland
FAU - Zangos, Stephan
AU  - Zangos S
AD  - Johann Wolfgang Goethe-Universität, Frankfurt, Germany
FAU - Guenther, Matthias
AU  - Guenther M
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Melzer, Andreas
AU  - Melzer A
AD  - University of Dundee, Dundee, UK
FAU - Menciassi, Arianna
AU  - Menciassi A
AD  - Scuola Superiore Sant’Anna - The BioRobotics Institute, Pontedera, Italy
FAU - Tognarelli, Selene
AU  - Tognarelli S
AD  - Scuola Superiore Sant’Anna - The BioRobotics Institute, Pontedera, Italy
FAU - Cafarelli, Andrea
AU  - Cafarelli A
AD  - Scuola Superiore Sant’Anna - The BioRobotics Institute, Pontedera, Italy
FAU - Diodato, Alessandro
AU  - Diodato A
AD  - Scuola Superiore Sant’Anna - The BioRobotics Institute, Pontedera, Italy
FAU - Ciuti, Gastone
AU  - Ciuti G
AD  - Scuola Superiore Sant’Anna - The BioRobotics Institute, Pontedera, Italy
FAU - Rothluebbers, Sven
AU  - Rothluebbers S
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Schwaab, Julia
AU  - Schwaab J
AD  - mediri GmbH, Heidelberg, Baden-Württemberg Germany
FAU - Strehlow, Jan
AU  - Strehlow J
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Mihcin, Senay
AU  - Mihcin S
AD  - University of Dundee - TRANS-FUSIMO, Dundee, Scotland UK
FAU - Tanner, Christine
AU  - Tanner C
AD  - ETH Zurich, Computer Vision Laboratory, Zurich, Switzerland
FAU - Tretbar, Steffen
AU  - Tretbar S
AD  - Fraunhofer IBMT, St. Ingbert, Germany
FAU - Preusser, Tobias
AU  - Preusser T
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Guenther, Matthias
AU  - Guenther M
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Jenne, Jürgen
AU  - Jenne J
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Payen, Thomas
AU  - Payen T
AD  - Columbia University, New York, NY USA
FAU - Palermo, Carmine
AU  - Palermo C
AD  - Columbia University, New York, NY USA
FAU - Sastra, Steve
AU  - Sastra S
AD  - Columbia University, New York, NY USA
FAU - Chen, Hong
AU  - Chen H
AD  - Washington University in St. Louis, St. Louis, MO USA
FAU - Han, Yang
AU  - Han Y
AD  - Columbia University, New York, NY USA
FAU - Olive, Kenneth
AU  - Olive K
AD  - Columbia University, New York, NY USA
FAU - Konofagou, Elisa
AU  - Konofagou E
AD  - Columbia University, New York, NY USA
FAU - Adams, Matthew
AU  - Adams M
AD  - UCSF Thermal Therapy Research Group, San Francisco, CA USA
FAU - Salgaonkar, Vasant
AU  - Salgaonkar V
AD  - University of California Sunnyvale, Sunnyvale, CA USA
FAU - Scott, Serena
AU  - Scott S
AD  - University of California Sunnyvale, Sunnyvale, CA USA
FAU - Sommer, Graham
AU  - Sommer G
AD  - Stanford University, Stanford, CA USA
FAU - Diederich, Chris
AU  - Diederich C
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Vidal-Jove, Joan
AU  - Vidal-Jove J
AD  - Hospital University Mutua Terrassa, Barcelona, Spain
FAU - Perich, Eloi
AU  - Perich E
AD  - Institut Khuab Barcelona, Barcelona, Spain
FAU - Ruiz, Antonio
AU  - Ruiz A
AD  - Institut Khuab Barcelona, Barcelona, Spain
FAU - Velat, Manuela
AU  - Velat M
AD  - Institut Khuab Barcelona, Barcelona, Spain
FAU - Melodelima, David
AU  - Melodelima D
AD  - LabTAU - INSERM U1032, Lyon, France
FAU - Dupre, Aurelien
AU  - Dupre A
AD  - Centre Leon Berard, Lyon, France
FAU - Vincenot, Jeremy
AU  - Vincenot J
AD  - LabTAU - INSERM U1032, Lyon, France
FAU - Yao, Chen
AU  - Yao C
AD  - Centre Leon Berard, Lyon, France
FAU - Perol, David
AU  - Perol D
AD  - Centre Leon Berard, Lyon, France
FAU - Rivoire, Michel
AU  - Rivoire M
AD  - Centre Leon Berard, Lyon, France
FAU - Tucci, Samantha
AU  - Tucci S
AD  - University of California Davis, Davis, CA USA
FAU - Mahakian, Lisa
AU  - Mahakian L
AD  - University of California Davis, Davis, CA USA
FAU - Fite, Brett
AU  - Fite B
AD  - University of California Davis, Davis, CA USA
FAU - Ingham, Elizabeth
AU  - Ingham E
AD  - University of California Davis, Davis, CA USA
FAU - Tam, Sarah
AU  - Tam S
AD  - University of California Davis, Davis, CA USA
FAU - Hwang, Chang-il
AU  - Hwang Ci
AD  - Cold Spring Harbor Laboratory, Cold Spring Harbor, NY USA
FAU - Tuveson, David
AU  - Tuveson D
AD  - Cold Spring Harbor Laboratory, Cold Spring Harbor, NY USA
FAU - Ferrara, Katherine
AU  - Ferrara K
AD  - University of California Davis, Davis, CA USA
FAU - Scionti, Stephen
AU  - Scionti S
AD  - Scionti Prostate Center, Sarasota, FL USA
FAU - Chen, Lili
AU  - Chen L
AD  - Fox Chase Cancer Center, Philadelphia, PA USA
FAU - Cvetkovic, Dusica
AU  - Cvetkovic D
AD  - Fox Chase Cancer Center, Philadelphia, PA USA
FAU - Chen, Xiaoming
AU  - Chen X
AD  - Fox Chase Cancer Center, Philadelphia, PA USA
FAU - Gupta, Roohi
AU  - Gupta R
AD  - Fox Chase Cancer Center, Philadelphia, PA USA
FAU - Wang, Bin
AU  - Wang B
AD  - Fox Chase Cancer Center, Philadelphia, PA USA
FAU - Ma, Charlie
AU  - Ma C
AD  - Fox Chase Cancer Center, Philadelphia, PA USA
FAU - Bader, Kenneth
AU  - Bader K
AD  - University of Cincinnati, Cincinnati, OH USA
FAU - Haworth, Kevin
AU  - Haworth K
AD  - University of Cincinnati, Cincinnati, OH USA
FAU - Maxwell, Adam
AU  - Maxwell A
AD  - University of Washington, Seattle, WA USA
FAU - Holland, Christy
AU  - Holland C
AD  - University of Cincinnati, Cincinnati, OH USA
FAU - Sanghvi, Narendra
AU  - Sanghvi N
AD  - SonaCare Medical, LLC, Indianapolis, IN USA
FAU - Carlson, Roy
AU  - Carlson R
AD  - SonaCare Medical, LLC, Indianapolis, IN USA
FAU - Chen, Wohsing
AU  - Chen W
AD  - Ulthera, Inc., Mesa, AZ USA
FAU - Chaussy, Christian
AU  - Chaussy C
AD  - Caritas Hospital St. Josef, University of Regensburg, Strasslach-Dingharting,
      Germany
FAU - Thueroff, Stefan
AU  - Thueroff S
AD  - Klinikum Muenchen Harlaching, Munich, Germany
FAU - Cesana, Claudio
AU  - Cesana C
AD  - Clinica Columbus, Milan, Italy
FAU - Bellorofonte, Carlo
AU  - Bellorofonte C
AD  - Clinica Columbus, Milan, Italy
FAU - Wang, Qingguo
AU  - Wang Q
AD  - Shanghai First People’s Hospital, Shanghai, China
FAU - Wang, Han
AU  - Wang H
AD  - Shanghai Cancer Center, Shanghai, China
FAU - Wang, Shengping
AU  - Wang S
FAU - Zhang, Junhai
AU  - Zhang J
AD  - Shanghai Huashan Hospital, Shanghai, China
FAU - Bazzocchi, Alberto
AU  - Bazzocchi A
AD  - The “Rizzoli” Orthopaedic Institute, Bologna, Italy
FAU - Napoli, Alessandro
AU  - Napoli A
AD  - Policlinico Umberto I, University of Rome – La Sapienza, Rome, Italy
FAU - Staruch, Robert
AU  - Staruch R
AD  - Philips Research, Dallas, TX USA
FAU - Bing, Chenchen
AU  - Bing C
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Shaikh, Sumbul
AU  - Shaikh S
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Nofiele, Joris
AU  - Nofiele J
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Szczepanski, Debra
AU  - Szczepanski D
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Staruch, Michelle Wodzak
AU  - Staruch MW
AD  - University of Oklahoma Health Sciences Center, Oklahoma City, OK USA
FAU - Williams, Noelle
AU  - Williams N
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Laetsch, Theodore
AU  - Laetsch T
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Chopra, Rajiv
AU  - Chopra R
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Ghanouni, Pejman
AU  - Ghanouni P
AD  - Stanford University, Stanford, CA USA
FAU - Rosenberg, Jarrett
AU  - Rosenberg J
AD  - Stanford University, Stanford, CA USA
FAU - Bitton, Rachelle
AU  - Bitton R
AD  - Stanford University, Stanford, CA USA
FAU - Napoli, Alessandro
AU  - Napoli A
AD  - University of Rome, Rome, Italy
FAU - LeBlang, Suzanne
AU  - LeBlang S
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Meyer, Joshua
AU  - Meyer J
AD  - Fox Chase Cancer Center, Philadelphia, PA USA
FAU - Hurwitz, Mark
AU  - Hurwitz M
AD  - Jefferson University Hospitals, Philadelphia, PA USA
FAU - Pauly, Kim Butts
AU  - Pauly KB
AD  - Stanford University, Stanford, CA USA
FAU - Partanen, Ari
AU  - Partanen A
AD  - Philips, Bethesda, MD USA
FAU - Yarmolenko, Pavel
AU  - Yarmolenko P
AD  - Sheikh Zayed Institute for Pediatric Surgical Innovation, Children’s National
      Health System, Washington, DC USA
FAU - Partanen, Ari
AU  - Partanen A
AD  - Sheikh Zayed Institute for Pediatric Surgical Innovation, Children’s National
      Health System, Washington, DC USA
FAU - Celik, Haydar
AU  - Celik H
AD  - Sheikh Zayed Institute for Pediatric Surgical Innovation, Children’s National
      Health System, Washington, DC USA
FAU - Eranki, Avinash
AU  - Eranki A
AD  - Children’s National Health System, Washington, DC USA
FAU - Beskin, Viktoriya
AU  - Beskin V
AD  - Children’s National Health System, Washington, DC USA
FAU - Santos, Domiciano
AU  - Santos D
AD  - Children’s National Health System, Washington, DC USA
FAU - Patel, Janish
AU  - Patel J
AD  - Children’s National Health System, Washington, DC USA
FAU - Oetgen, Matthew
AU  - Oetgen M
AD  - Children’s National Health System, Washington, DC USA
FAU - Kim, AeRang
AU  - Kim A
AD  - Children’s National Health System, Washington, DC USA
FAU - Kim, Peter
AU  - Kim P
AD  - Children’s National Health System, Washington, DC USA
FAU - Sharma, Karun
AU  - Sharma K
AD  - Children’s National Health System, Washington, DC USA
FAU - Chisholm, Alexander
AU  - Chisholm A
AD  - University of Toronto, Toronto, ON Canada
FAU - Drake, James
AU  - Drake J
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Aleman, Dionne
AU  - Aleman D
AD  - University of Toronto, Toronto, ON Canada
FAU - Waspe, Adam
AU  - Waspe A
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Looi, Thomas
AU  - Looi T
AD  - Centre for Image Guided Innovation and Therapeutic Intervention, Toronto, ON
      Canada
FAU - Pichardo, Samuel
AU  - Pichardo S
AD  - Thunder Bay Regional Research Institute, Thunder Bay, ON Canada
FAU - Napoli, Alessandro
AU  - Napoli A
AD  - Policlinico Umberto I, University of Rome – La Sapienza, Rome, Italy
FAU - Bazzocchi, Alberto
AU  - Bazzocchi A
AD  - The “Rizzoli” Orthopaedic Institute, Bologna, Italy
FAU - Scipione, Roberto
AU  - Scipione R
AD  - University of Rome – La Sapienza, Rome, Italy
FAU - Temple, Michael
AU  - Temple M
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Waspe, Adam
AU  - Waspe A
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Amaral, Joao Guilherme
AU  - Amaral JG
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Huang, Yuexi
AU  - Huang Y
AD  - Sunnybrook Health Sciences Center, Toronto, ON Canada
FAU - Endre, Ruby
AU  - Endre R
AD  - Sunnybrook Health Sciences Center, Toronto, ON Canada
FAU - Lamberti-Pasculli, Maria
AU  - Lamberti-Pasculli M
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - de Ruiter, Joost
AU  - de Ruiter J
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Campbell, Fiona
AU  - Campbell F
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Stimec, Jennifer
AU  - Stimec J
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Gupta, Samit
AU  - Gupta S
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Singh, Manoj
AU  - Singh M
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Mougenot, Charles
AU  - Mougenot C
AD  - Philips Healthcare Canada, Toronto, ON Canada
FAU - Hopyan, Sevan
AU  - Hopyan S
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Hynynen, Kullervo
AU  - Hynynen K
AD  - Sunnybrook Health Sciences Center, Toronto, ON Canada
FAU - Czarnota, Gregory
AU  - Czarnota G
AD  - Sunnybrook Health Sciences Center, Toronto, ON Canada
FAU - Drake, James
AU  - Drake J
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Brenin, David
AU  - Brenin D
AD  - University of Virginia, Charlottesville, VA USA
FAU - Rochman, Carrie
AU  - Rochman C
AD  - University of Virginia, Charlottesville, VA USA
FAU - Kovatcheva, Roussanka
AU  - Kovatcheva R
AD  - University Hospital of Endocrinology, Sofia, Bulgaria
FAU - Vlahov, Jordan
AU  - Vlahov J
AD  - University Hospital of Endocrinology, Sofia, Bulgaria
FAU - Zaletel, Katja
AU  - Zaletel K
AD  - University Medical Centre Ljubljana, Ljubljana, Slovenia
FAU - Stoinov, Julian
AU  - Stoinov J
AD  - University Hospital of Endocrinology, Sofia, Bulgaria
FAU - Han, Yang
AU  - Han Y
AD  - Columbia University, New York, NY USA
FAU - Wang, Shutao
AU  - Wang S
AD  - Columbia University, New York, NY USA
FAU - Konofagou, Elisa
AU  - Konofagou E
AD  - Columbia University, New York, NY USA
FAU - Bucknor, Matthew
AU  - Bucknor M
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Rieke, Viola
AU  - Rieke V
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Shim, Jenny
AU  - Shim J
AD  - Children’s Health, Decatur, GA USA
FAU - Staruch, Robert
AU  - Staruch R
AD  - Philips Research, Dallas, TX USA
FAU - Koral, Korgun
AU  - Koral K
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Chopra, Rajiv
AU  - Chopra R
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Laetsch, Theodore
AU  - Laetsch T
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Lang, Brian
AU  - Lang B
AD  - University of Hong Kong, Hong Kong, Hong Kong SAR
FAU - Wong, Carlos
AU  - Wong C
AD  - University of Hong Kong, Hong Kong, Hong Kong SAR
FAU - Lam, Heather
AU  - Lam H
AD  - Theraclion Asia Pacific Limited, Hong Kong, Hong Kong SAR
FAU - Kovatcheva, Roussanka
AU  - Kovatcheva R
AD  - University Medical Centre Ljubljana, Ljubljana, Slovenia
FAU - Vlahov, Jordan
AU  - Vlahov J
AD  - University Hospital of Endocrinology, Sofia, Bulgaria
FAU - Zaletel, Katja
AU  - Zaletel K
AD  - University Medical Centre Ljubljana, Ljubljana, Slovenia
FAU - Stoinov, Julian
AU  - Stoinov J
AD  - University Hospital of Endocrinology, Sofia, Bulgaria
FAU - Shinkov, Alexander
AU  - Shinkov A
AD  - Medical University Sofia, Clinical Center of Endocrinology, Sofia, Bulgaria
FAU - Hu, Jim
AU  - Hu J
AD  - Weill Cornell Medicine, New York, NY USA
FAU - Sharma, Karun
AU  - Sharma K
AD  - Children’s National Health System, Washington, DC USA
FAU - Zhang, Xi
AU  - Zhang X
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Macoskey, Jonathan
AU  - Macoskey J
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Ives, Kimberly
AU  - Ives K
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Owens, Gabe
AU  - Owens G
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Gurm, Hitinder
AU  - Gurm H
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Shi, Jiaqi
AU  - Shi J
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Pizzuto, Matthew
AU  - Pizzuto M
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Cain, Charles
AU  - Cain C
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Xu, Zhen
AU  - Xu Z
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Payne, Allison
AU  - Payne A
AD  - University of Utah, Salt Lake City, UT USA
FAU - Dillon, Christopher
AU  - Dillon C
AD  - University of Utah, Salt Lake City, UT USA
FAU - Christofferson, Ivy
AU  - Christofferson I
AD  - University of Utah, Salt Lake City, UT USA
FAU - Hilas, Elaine
AU  - Hilas E
AD  - University of Utah, Salt Lake City, UT USA
FAU - Shea, Jill
AU  - Shea J
AD  - University of Utah, Salt Lake City, UT USA
FAU - Greillier, Paul
AU  - Greillier P
AD  - INSERM / Université de Lyon, Lyon, France
FAU - Ankou, Bénédicte
AU  - Ankou B
AD  - Hospices Civils de Lyon, Lyon, France
FAU - Bessière, Francis
AU  - Bessière F
AD  - Hospices Civils de Lyon, Lyon, France
FAU - Zorgani, Ali
AU  - Zorgani A
AD  - INSERM / Université de Lyon, Lyon, France
FAU - Pioche, Mathieu
AU  - Pioche M
AD  - Hospices Civils de Lyon, Lyon, France
FAU - Kwiecinski, Wojciech
AU  - Kwiecinski W
AD  - Institut Langevin Ondes et Images, ESPCI ParisTech, CNRS UMR 7587, INSERM U979,
      Paris, France
FAU - Magat, Julie
AU  - Magat J
AD  - IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux,
      France
FAU - Melot-Dusseau, Sandrine
AU  - Melot-Dusseau S
AD  - Station de Primatologie-UPS846-CNRS, Rousset sur Arc, France
FAU - Lacoste, Romain
AU  - Lacoste R
AD  - Station de Primatologie-UPS846-CNRS, Rousset sur Arc, France
FAU - Quesson, Bruno
AU  - Quesson B
AD  - IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux,
      France
FAU - Pernot, Mathieu
AU  - Pernot M
AD  - Institut Langevin Ondes et Images, ESPCI ParisTech, CNRS UMR 7587, INSERM U979,
      Paris, France
FAU - Catheline, Stefan
AU  - Catheline S
AD  - INSERM / Université de Lyon, Lyon, France
FAU - Chevalier, Philippe
AU  - Chevalier P
AD  - Hospices Civils de Lyon, Lyon, France
FAU - Lafon, Cyril
AU  - Lafon C
AD  - University of Virginia, Charlottesville, Virginia, United States and INSERM Unit 
      1032, Lyon, France
FAU - Marquet, Fabrice
AU  - Marquet F
AD  - IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux,
      France
FAU - Bour, Pierre
AU  - Bour P
AD  - IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux,
      France
FAU - Vaillant, Fanny
AU  - Vaillant F
AD  - IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux,
      France
FAU - Amraoui, Sana
AU  - Amraoui S
AD  - IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux,
      France
FAU - Dubois, Rémi
AU  - Dubois R
AD  - IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux,
      France
FAU - Ritter, Philippe
AU  - Ritter P
AD  - IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux,
      France
FAU - Haïssaguerre, Michel
AU  - Haïssaguerre M
AD  - IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux,
      France
FAU - Hocini, Mélèze
AU  - Hocini M
AD  - IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux,
      France
FAU - Bernus, Olivier
AU  - Bernus O
AD  - IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux,
      France
FAU - Quesson, Bruno
AU  - Quesson B
AD  - IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux,
      France
FAU - Tebebi, Pamela
AU  - Tebebi P
AD  - National Institutes of Health, Bethesda, MD USA
FAU - Burks, Scott
AU  - Burks S
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Kim, Saejeong
AU  - Kim S
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Milo, Blerta
AU  - Milo B
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Frank, Joseph
AU  - Frank J
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Gertner, Michael
AU  - Gertner M
AD  - Kona Medical, Inc., Bellevue, WA USA
FAU - Zhang, Jimin
AU  - Zhang J
AD  - Kona Medical, Inc., Bellevue, WA USA
FAU - Wong, Andrew
AU  - Wong A
AD  - University of California Davis, Davis, CA USA
FAU - Fite, Brett
AU  - Fite B
AD  - University of California Davis, Davis, CA USA
FAU - Liu, Yu
AU  - Liu Y
AD  - University of California Davis, Davis, CA USA
FAU - Kheirolomoom, Azadeh
AU  - Kheirolomoom A
AD  - University of California Davis, Davis, CA USA
FAU - Seo, Jai
AU  - Seo J
AD  - University of California Davis, Davis, CA USA
FAU - Watson, Katherine
AU  - Watson K
AD  - University of California Davis, Davis, CA USA
FAU - Mahakian, Lisa
AU  - Mahakian L
AD  - University of California Davis, Davis, CA USA
FAU - Tam, Sarah
AU  - Tam S
AD  - University of California Davis, Davis, CA USA
FAU - Zhang, Hua
AU  - Zhang H
AD  - University of California Davis, Davis, CA USA
FAU - Foiret, Josquin
AU  - Foiret J
AD  - University of California Davis, Davis, CA USA
FAU - Borowsky, Alexander
AU  - Borowsky A
AD  - University of California Davis, Davis, CA USA
FAU - Ferrara, Katherine
AU  - Ferrara K
AD  - University of California Davis, Davis, CA USA
FAU - Xu, Doudou
AU  - Xu D
AD  - Chongqing Changlin Science & Technology Ltd., Chongqing, China
FAU - Melzer, Andreas
AU  - Melzer A
AD  - University of Dundee, Dundee, UK
FAU - Thanou, Maya
AU  - Thanou M
AD  - King’s College London, London, UK
FAU - Centelles, Miguell
AU  - Centelles M
AD  - King’s College London, London, UK
FAU - Wright, Mike
AU  - Wright M
AD  - King’s College London, London, UK
FAU - Amrahli, Maral
AU  - Amrahli M
AD  - King’s College London, London, UK
FAU - So, Po-Wah
AU  - So PW
AD  - King’s College London, London, UK
FAU - Gedroyc, Wladyslaw
AU  - Gedroyc W
AD  - Imperial College Healthcare London, London, UK
FAU - Centelles, Miguell
AU  - Centelles M
AD  - King’s College London, London, UK
FAU - Wright, Mike
AU  - Wright M
AD  - King’s College London, London, UK
FAU - Gedroyc, Wladyslaw
AU  - Gedroyc W
AD  - Imperial College Healthcare London, London, UK
FAU - Thanou, Maya
AU  - Thanou M
AD  - King’s College London, London, UK
FAU - Kneepkens, Esther
AU  - Kneepkens E
AD  - Eindhoven University of Technology, Eindhoven, Netherlands
FAU - Heijman, Edwin
AU  - Heijman E
AD  - Philips Research, Eindhoven, Netherlands
FAU - Keupp, Jochen
AU  - Keupp J
AD  - Philips Research, Hamburg, Germany
FAU - Weiss, Steffen
AU  - Weiss S
AD  - Philips Research, Hamburg, Germany
FAU - Nicolay, Klaas
AU  - Nicolay K
AD  - Eindhoven University of Technology, Eindhoven, Netherlands
FAU - Grüll, Holger
AU  - Grüll H
AD  - Philips Research, Eindhoven, Netherlands
FAU - Fite, Brett
AU  - Fite B
AD  - University of California Davis, Davis, CA USA
FAU - Wong, Andrew
AU  - Wong A
AD  - University of California Davis, Davis, CA USA
FAU - Liu, Yu
AU  - Liu Y
AD  - University of California Davis, Davis, CA USA
FAU - Kheirolomoom, Azadeh
AU  - Kheirolomoom A
AD  - University of California Davis, Davis, CA USA
FAU - Mahakian, Lisa
AU  - Mahakian L
AD  - University of California Davis, Davis, CA USA
FAU - Tam, Sarah
AU  - Tam S
AD  - University of California Davis, Davis, CA USA
FAU - Foiret, Josquin
AU  - Foiret J
AD  - University of California Davis, Davis, CA USA
FAU - Ferrara, Katherine
AU  - Ferrara K
AD  - University of California Davis, Davis, CA USA
FAU - Burks, Scott
AU  - Burks S
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Nagle, Matthew
AU  - Nagle M
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Kim, Saejeong
AU  - Kim S
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Milo, Blerta
AU  - Milo B
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Frank, Joseph
AU  - Frank J
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Sapozhnikov, Oleg
AU  - Sapozhnikov O
AD  - University of Washington, Seattle, WA USA
FAU - Nikolaeva, Anastasia V.
AU  - Nikolaeva AV
AD  - Moscow State University, Moscow, Russian Federation
FAU - Terzi, Marina E.
AU  - Terzi ME
AD  - Moscow State University, Moscow, Russian Federation
FAU - Tsysar, Sergey A.
AU  - Tsysar SA
AD  - Moscow State University, Moscow, Russian Federation
FAU - Maxwell, Adam
AU  - Maxwell A
AD  - University of Washington, Seattle, WA USA
FAU - Cunitz, Bryan
AU  - Cunitz B
AD  - University of Washington, Seattle, WA USA
FAU - Bailey, Michael
AU  - Bailey M
AD  - University of Washington, Seattle, WA USA
FAU - Mourad, Pierre
AU  - Mourad P
AD  - University of Washington, Seattle, WA USA
FAU - Downs, Matthew
AU  - Downs M
AD  - Columbia University, New York, NY USA
FAU - Yang, Georgiana
AU  - Yang G
AD  - Columbia University, New York, NY USA
FAU - Wang, Qi
AU  - Wang Q
AD  - Columbia University, New York, NY USA
FAU - Konofagou, Elisa
AU  - Konofagou E
AD  - Columbia University, New York, NY USA
FAU - Burks, Scott
AU  - Burks S
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Nagle, Matthew
AU  - Nagle M
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Nguyen, Ben
AU  - Nguyen B
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Bresler, Michele
AU  - Bresler M
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Kim, Saejeong
AU  - Kim S
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Milo, Blerta
AU  - Milo B
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Frank, Joseph
AU  - Frank J
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Burks, Scott
AU  - Burks S
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Nagle, Matthew
AU  - Nagle M
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Kim, Saejeong
AU  - Kim S
AD  - National Institutes of Health, Bethesda, MD USA
FAU - Milo, Blerta
AU  - Milo B
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Frank, Joseph
AU  - Frank J
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Chen, Johnny
AU  - Chen J
AD  - University of Virginia, Charlottesville, VA USA
FAU - Farry, Justin
AU  - Farry J
AD  - University of Virginia, Charlottesville, VA USA
FAU - Dixon, Adam
AU  - Dixon A
AD  - University of Virginia, Charlottesville, VA USA
FAU - Du, Zhongmin
AU  - Du Z
AD  - University of Virginia, Charlottesville, VA USA
FAU - Dhanaliwala, Ali
AU  - Dhanaliwala A
AD  - University of Virginia, Charlottesville, VA USA
FAU - Hossack, John
AU  - Hossack J
AD  - University of Virginia, Charlottesville, VA USA
FAU - Klibanov, Alexander
AU  - Klibanov A
AD  - University of Virginia, Charlottesville, VA USA
FAU - Ranjan, Ashish
AU  - Ranjan A
AD  - Oklahoma State University, Stillwater, OK USA
FAU - Maples, Danny
AU  - Maples D
AD  - Oklahoma State University, Stillwater, OK USA
FAU - Chopra, Rajiv
AU  - Chopra R
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Bing, Chenchen
AU  - Bing C
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Staruch, Robert
AU  - Staruch R
AD  - Philips Research, Dallas, TX USA
FAU - Wardlow, Rachel
AU  - Wardlow R
AD  - Oklahoma State University, Stillwater, OK USA
FAU - Staruch, Michelle Wodzak
AU  - Staruch MW
AD  - University of Oklahoma Health Sciences Center, Oklahoma City, OK USA
FAU - Malayer, Jerry
AU  - Malayer J
AD  - Oklahoma State University, Stillwater, OK USA
FAU - Ramachandran, Akhilesh
AU  - Ramachandran A
AD  - Oklahoma State University, Stillwater, OK USA
FAU - Nofiele, Joris
AU  - Nofiele J
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Namba, Hirofumi
AU  - Namba H
AD  - Kochi University, Kochi Medical School, Nankoku, Kochi Japan
FAU - Kawasaki, Motohiro
AU  - Kawasaki M
AD  - Kochi University, Kochi Medical School, Nankoku, Kochi Japan
FAU - Izumi, Masashi
AU  - Izumi M
AD  - Kochi University, Kochi Medical School, Nankoku, Kochi Japan
FAU - Kiyasu, Katsuhito
AU  - Kiyasu K
AD  - Kochi University, Kochi Medical School, Nankoku, Kochi Japan
FAU - Takemasa, Ryuichi
AU  - Takemasa R
AD  - Kochi University, Kochi Medical School, Nankoku, Kochi Japan
FAU - Ikeuchi, Masahiko
AU  - Ikeuchi M
AD  - Kochi University, Kochi Medical School, Nankoku, Kochi Japan
FAU - Ushida, Takahiro
AU  - Ushida T
AD  - Multidisciplinary Pain Center, School of Medicine, Aichi Medical University,
      Nagakute, Aichi Japan
FAU - Crake, Calum
AU  - Crake C
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Papademetriou, Iason T.
AU  - Papademetriou IT
AD  - Boston University, Boston, MA USA
FAU - Zhang, Yong-Zhi
AU  - Zhang YZ
AD  - Harvard Medical School, Boston, MA USA
FAU - Porter, Tyrone
AU  - Porter T
AD  - Boston University, Boston, MA USA
FAU - McDannold, Nathan
AU  - McDannold N
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Kothapalli, Satya V. V. N.
AU  - Kothapalli SVVN
AD  - Washington University in Saint Louis, Saint Louis, MO USA
FAU - Leighton, Wan
AU  - Leighton W
AD  - Washington University in Saint Louis, Saint Louis, MO USA
FAU - Wang, Zhaorui
AU  - Wang Z
AD  - Washington University in Saint Louis, Saint Louis, MO USA
FAU - Partanen, Ari
AU  - Partanen A
AD  - Philips, Bethesda, MD USA
FAU - Gach, H. Michael
AU  - Gach HM
AD  - Washington University in Saint Louis, Saint Louis, MO USA
FAU - Straube, William
AU  - Straube W
AD  - Washington University in Saint Louis, Saint Louis, MO USA
FAU - Altman, Michael
AU  - Altman M
AD  - Washington University in Saint Louis, Saint Louis, MO USA
FAU - Chen, Hong
AU  - Chen H
AD  - Washington University in Saint Louis, Saint Louis, MO USA
FAU - Kim, Young-sun
AU  - Kim Ys
AD  - Samsung Medical Center, Seoul, Republic of Korea
FAU - Lim, Hyo Keun
AU  - Lim HK
AD  - Samsung Medical Center, Seoul, Republic of Korea
FAU - Rhim, Hyunchul
AU  - Rhim H
AD  - Samsung Medical Center, Seoul, Republic of Korea
FAU - Kim, Young-sun
AU  - Kim Ys
AD  - Samsung Medical Center, Seoul, Republic of Korea
FAU - Lim, Hyo Keun
AU  - Lim HK
AD  - Samsung Medical Center, Seoul, Republic of Korea
FAU - Rhim, Hyunchul
AU  - Rhim H
AD  - Samsung Medical Center, Seoul, Republic of Korea
FAU - van Breugel, Johanna
AU  - van Breugel J
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Braat, Manon
AU  - Braat M
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Moonen, Chrit
AU  - Moonen C
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - van den Bosch, Maurice
AU  - van den Bosch M
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Ries, Mario
AU  - Ries M
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Marrocchio, Cristina
AU  - Marrocchio C
AD  - University of Rome – La Sapienza, Rome, Italy
FAU - Dababou, Susan
AU  - Dababou S
AD  - University of Rome – La Sapienza, Rome, Italy
FAU - Bitton, Rachelle
AU  - Bitton R
AD  - Stanford University, Stanford, CA USA
FAU - Pauly, Kim Butts
AU  - Pauly KB
AD  - Stanford University, Stanford, CA USA
FAU - Ghanouni, Pejman
AU  - Ghanouni P
AD  - Stanford University, Stanford, CA USA
FAU - Lee, Jae Young
AU  - Lee JY
AD  - Seoul National University Hospital, Seoul, Republic of Korea
FAU - Lee, Jae Young
AU  - Lee JY
AD  - Seoul National University Hospital, Seoul, Republic of Korea
FAU - Chung, Hyun Hoon
AU  - Chung HH
AD  - Seoul National University Hospital, Seoul, Republic of Korea
FAU - Kang, Soo Yeon
AU  - Kang SY
AD  - Seoul National University Hospital, Seoul, Republic of Korea
FAU - Kang, Kook Jin
AU  - Kang KJ
AD  - Alpinion Medical Systems, Seoul, Republic of Korea
FAU - Son, Keon Ho
AU  - Son KH
AD  - Alpinion Medical Systems, Seoul, Republic of Korea
FAU - Zhang, Dandan
AU  - Zhang D
AD  - The First Affiliated Hospital of Harbin Medical University, Harbin, China
FAU - Adams, Matthew
AU  - Adams M
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Salgaonkar, Vasant
AU  - Salgaonkar V
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Plata, Juan
AU  - Plata J
AD  - Stanford University, Stanford, CA USA
FAU - Jones, Peter
AU  - Jones P
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Pascal-Tenorio, Aurea
AU  - Pascal-Tenorio A
AD  - Stanford University, Stanford, CA USA
FAU - Bouley, Donna
AU  - Bouley D
AD  - Stanford University, Stanford, CA USA
FAU - Sommer, Graham
AU  - Sommer G
AD  - Stanford University, Stanford, CA USA
FAU - Pauly, Kim Butts
AU  - Pauly KB
AD  - Stanford University, Stanford, CA USA
FAU - Diederich, Chris
AU  - Diederich C
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Bond, Aaron
AU  - Bond A
AD  - University of Virginia, Charlottesville, VA USA
FAU - Dallapiazza, Robert
AU  - Dallapiazza R
AD  - University of Virginia, Charlottesville, VA USA
FAU - Huss, Diane
AU  - Huss D
AD  - University of Virginia, Charlottesville, VA USA
FAU - Warren, Amy
AU  - Warren A
AD  - University of Virginia, Charlottesville, VA USA
FAU - Sperling, Scott
AU  - Sperling S
AD  - University of Virginia, Charlottesville, VA USA
FAU - Gwinn, Ryder
AU  - Gwinn R
AD  - Swedish Neuroscience Institute, Seattle, WA USA
FAU - Shah, Binit
AU  - Shah B
AD  - University of Virginia, Charlottesville, VA USA
FAU - Elias, W. Jeff
AU  - Elias WJ
AD  - University of Virginia, Charlottesville, VA USA
FAU - Curley, Colleen
AU  - Curley C
AD  - University of Virginia, Charlottesville, VA USA
FAU - Zhang, Ying
AU  - Zhang Y
AD  - University of Virginia, Charlottesville, VA USA
FAU - Negron, Karina
AU  - Negron K
AD  - Johns Hopkins University, Baltimore, MD USA
FAU - Miller, Wilson
AU  - Miller W
AD  - University of Virginia, Charlottesville, VA USA
FAU - Klibanov, Alexander
AU  - Klibanov A
AD  - University of Virginia, Charlottesville, VA USA
FAU - Abounader, Roger
AU  - Abounader R
AD  - University of Virginia, Charlottesville, VA USA
FAU - Suk, Jung Soo
AU  - Suk JS
AD  - Center for Nanomedicine/Wilmer Eye Institute, Johns Hopkins University,
      Baltimore, MD USA
FAU - Hanes, Justin
AU  - Hanes J
AD  - Center for Nanomedicine/Wilmer Eye Institute, Johns Hopkins University,
      Baltimore, MD USA
FAU - Price, Richard
AU  - Price R
AD  - University of Virginia, Charlottesville, VA USA
FAU - Karakatsani, Maria Eleni (Marilena)
AU  - Karakatsani ME(
AD  - Columbia University, New York, NY USA
FAU - Samiotaki, Gesthimani
AU  - Samiotaki G
AD  - Columbia University, New York, NY USA
FAU - Wang, Shutao
AU  - Wang S
AD  - Columbia University, New York, NY USA
FAU - Kugelman, Tara
AU  - Kugelman T
AD  - Columbia University, New York, NY USA
FAU - Acosta, Camilo
AU  - Acosta C
AD  - Columbia University, New York, NY USA
FAU - Konofagou, Elisa
AU  - Konofagou E
AD  - Columbia University, New York, NY USA
FAU - Kovacs, Zsofia
AU  - Kovacs Z
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Tu, Tsang-Wei
AU  - Tu TW
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Papadakis, Georgios
AU  - Papadakis G
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Hammoud, Dima
AU  - Hammoud D
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Frank, Joseph
AU  - Frank J
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Silvestrini, Matthew
AU  - Silvestrini M
AD  - University of California Davis, Davis, CA USA
FAU - Wolfram, Frank
AU  - Wolfram F
AD  - SRH Wald-Klinikum Gera / Clinic of Thoracic Surgery, Gera, Germany
FAU - Güllmar, Daniel
AU  - Güllmar D
AD  - Institute of Diagnostic and Interventional Radiology, University Hospital -
      Friedrich Schiller University, Jena, Germany
FAU - Reichenbach, Juergen
AU  - Reichenbach J
AD  - Institute of Diagnostic and Interventional Radiology, University Hospital -
      Friedrich Schiller University, Jena, Germany
FAU - Hofmann, Denis
AU  - Hofmann D
AD  - SRH Wald-Klinikum Gera, Gera, Germany
FAU - Böttcher, Joachim
AU  - Böttcher J
AD  - SRH Wald-Klinikum Gera, Gera, Germany
FAU - Schubert, Harald
AU  - Schubert H
AD  - Institute of Animal Experimentation, Friedrich Schiller University, Jena, Germany
FAU - Lesser, Thomas G.
AU  - Lesser TG
AD  - SRH Wald-Klinikum Gera, Gera, Germany
FAU - Almquist, Scott
AU  - Almquist S
AD  - University of Utah, Salt Lake City, UT USA
FAU - Parker, Dennis
AU  - Parker D
AD  - University of Utah, Salt Lake City, UT USA
FAU - Christensen, Douglas
AU  - Christensen D
AD  - University of Utah, Salt Lake City, UT USA
FAU - Camarena, Francisco
AU  - Camarena F
AD  - Universitat Politècnica de València, Gandia, Spain
FAU - Jiménez-Gambín, Sergio
AU  - Jiménez-Gambín S
AD  - Universitat Politècnica de València, Gandia, Spain
FAU - Jiménez, Noé
AU  - Jiménez N
AD  - LUNAM Universite. Université du Maine, Le Mans, Spain
FAU - Konofagou, Elisa
AU  - Konofagou E
AD  - Columbia University, New York, NY USA
FAU - Chang, Jin Woo
AU  - Chang JW
AD  - YUMC Severance Hospital, Seoul, Republic of Korea
FAU - Chaplin, Vandiver
AU  - Chaplin V
AD  - Vanderbilt University Institute of Imaging Science, Nashville, TN USA
FAU - Griesenauer, Rebekah
AU  - Griesenauer R
AD  - Vanderbilt University, Nashville, TN USA
FAU - Miga, Michael
AU  - Miga M
AD  - Vanderbilt University, Nashville, TN USA
FAU - Caskey, Charles
AU  - Caskey C
AD  - Vanderbilt University, Nashville, TN USA
FAU - Ellens, Nicholas
AU  - Ellens N
AD  - Johns Hopkins University, Baltimore, MD USA
FAU - Airan, Raag
AU  - Airan R
AD  - Stanford University, Stanford, CA USA
FAU - Quinones-Hinojosa, Alfredo
AU  - Quinones-Hinojosa A
AD  - Johns Hopkins University, Baltimore, MD USA
FAU - Farahani, Keyvan
AU  - Farahani K
AD  - National Cancer Institute, Bethesda, MD USA
FAU - Partanen, Ari
AU  - Partanen A
AD  - Philips, Bethesda, MD USA
FAU - Feng, Xue
AU  - Feng X
AD  - University of Virginia, Charlottesville, VA USA
FAU - Fielden, Samuel
AU  - Fielden S
AD  - University of Virginia, Charlottesville, VA USA
FAU - Zhao, Li
AU  - Zhao L
AD  - University of Virginia, Charlottesville, VA USA
FAU - Miller, Wilson
AU  - Miller W
AD  - University of Virginia, Charlottesville, VA USA
FAU - Wintermark, Max
AU  - Wintermark M
AD  - University of Virginia, Charlottesville, VA USA
FAU - Pauly, Kim Butts
AU  - Pauly KB
AD  - Stanford University, Stanford, CA USA
FAU - Meyer, Craig
AU  - Meyer C
AD  - University of Virginia, Charlottesville, VA USA
FAU - Guo, Sijia
AU  - Guo S
AD  - University of Maryland Baltimore, Baltimore, MD USA
FAU - Lu, Xin
AU  - Lu X
AD  - University of Maryland Baltimore, Baltimore, MD USA
FAU - Zhuo, Jiachen
AU  - Zhuo J
AD  - University of Maryland Baltimore, Baltimore, MD USA
FAU - Xu, Su
AU  - Xu S
AD  - University of Maryland Baltimore, Baltimore, MD USA
FAU - Gullapalli, Rao
AU  - Gullapalli R
AD  - University of Maryland Baltimore, Baltimore, MD USA
FAU - Gandhi, Dheeraj
AU  - Gandhi D
AD  - University of Maryland Baltimore, Baltimore, MD USA
FAU - Jin, Changzhu
AU  - Jin C
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Brokman, Omer
AU  - Brokman O
AD  - InSightec Ltd, Tirat Carmel, Israel
FAU - Eames, Matt
AU  - Eames M
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Snell, John
AU  - Snell J
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Paeng, Dong-Guk
AU  - Paeng DG
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Baek, Hongchae
AU  - Baek H
AD  - Korea Institute of Science and Technology, Seoul, Republic of Korea
FAU - Kim, Hyungmin
AU  - Kim H
AD  - Korea Institute of Science and Technology, Seoul, Republic of Korea
FAU - Leung, Steven
AU  - Leung S
AD  - Stanford University, Stanford, CA USA
FAU - Webb, Taylor
AU  - Webb T
AD  - Stanford University, Stanford, CA USA
FAU - Pauly, Kim Butts
AU  - Pauly KB
AD  - Stanford University, Stanford, CA USA
FAU - McDannold, Nathan
AU  - McDannold N
AD  - Brigham and Women’s Hospital, Harvard Medical School, Boston, MA USA
FAU - Zhang, Yong-Zhi
AU  - Zhang YZ
AD  - Harvard Medical School, Boston, MA USA
FAU - Vykhodtseva, Natalia
AU  - Vykhodtseva N
AD  - Brigham and Women’s Hospital, Harvard Medical School, Boston, MA USA
FAU - Nguyen, Thai-Son
AU  - Nguyen TS
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Sukovich, Jonathan
AU  - Sukovich J
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Hall, Timothy
AU  - Hall T
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Xu, Zhen
AU  - Xu Z
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Cain, Charles
AU  - Cain C
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Park, Chang Kyu
AU  - Park CK
AD  - Severance Hospital, Yonsei University, Seoul, Republic of Korea
FAU - Park, Sang Man
AU  - Park SM
AD  - Severance Hospital, Yonsei University, Seoul, Republic of Korea
FAU - Jung, Na Young
AU  - Jung NY
AD  - Severance Hospital, Yonsei University, Seoul, Republic of Korea
FAU - Kim, Min Soo
AU  - Kim MS
AD  - Severance Hospital, Yonsei University, Seoul, Republic of Korea
FAU - Chang, Won Seok
AU  - Chang WS
AD  - Severance Hospital, Yonsei University, Seoul, Republic of Korea
FAU - Jung, Hyun Ho
AU  - Jung HH
AD  - Severance Hospital, Yonsei University, Seoul, Republic of Korea
FAU - Chang, Jin Woo
AU  - Chang JW
AD  - YUMC Severance Hospital, Seoul, Republic of Korea
FAU - Pichardo, Samuel
AU  - Pichardo S
AD  - Thunder Bay Regional Research Institute, Thunder Bay, ON Canada
FAU - Hynynen, Kullervo
AU  - Hynynen K
AD  - Sunnybrook Health Sciences Centre, Toronto, ON Canada
FAU - Plaksin, Michael
AU  - Plaksin M
AD  - Technion – Israel Institute of Technology, Haifa, Israel
FAU - Weissler, Yoni
AU  - Weissler Y
AD  - Technion – Israel Institute of Technology, Haifa, Israel
FAU - Shoham, Shy
AU  - Shoham S
AD  - Technion – Israel Institute of Technology, Haifa, Israel
FAU - Kimmel, Eitan
AU  - Kimmel E
AD  - Technion – Israel Institute of Technology, Haifa, Israel
FAU - Quigg, Anders
AU  - Quigg A
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Snell, John
AU  - Snell J
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Paeng, Dong-Guk
AU  - Paeng DG
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Eames, Matt
AU  - Eames M
AD  - Focused Ultrasound Foundation, Charlottesville, VA USA
FAU - Sapozhnikov, Oleg
AU  - Sapozhnikov O
AD  - University of Washington, Seattle, WA USA
FAU - Rosnitskiy, Pavel B.
AU  - Rosnitskiy PB
AD  - Moscow State University, Moscow, Russian Federation
FAU - Khokhlova, Vera
AU  - Khokhlova V
AD  - University of Washington, Seattle, WA USA
FAU - Shoham, Shy
AU  - Shoham S
AD  - InSightec Ltd, Tirat Carmel, Israel
FAU - Krupa, Steve
AU  - Krupa S
AD  - Technion - Israel Institute of Technology, Haifa, Israel
FAU - Hazan, Eilon
AU  - Hazan E
AD  - Technion - Israel Institute of Technology, Haifa, Israel
FAU - Naor, Omer
AU  - Naor O
AD  - Technion - Israel Institute of Technology, Haifa, Israel
FAU - Levy, Yoav
AU  - Levy Y
AD  - InSightec Ltd, Tirat Carmel, Israel
FAU - Maimon, Noam
AU  - Maimon N
AD  - InSightec Ltd, Tirat Carmel, Israel
FAU - Brosh, Inbar
AU  - Brosh I
AD  - Technion - Israel Institute of Technology, Haifa, Israel
FAU - Kimmel, Eitan
AU  - Kimmel E
AD  - Technion - Israel Institute of Technology, Haifa, Israel
FAU - Kahn, Itamar
AU  - Kahn I
AD  - Technion - Israel Institute of Technology, Haifa, Israel
FAU - Sukovich, Jonathan
AU  - Sukovich J
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Xu, Zhen
AU  - Xu Z
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Hall, Timothy
AU  - Hall T
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Allen, Steven
AU  - Allen S
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Cain, Charles
AU  - Cain C
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Cahill, Jessica
AU  - Cahill J
AD  - Georgia Institute of Technology, Atlanta, GA USA
FAU - Sun, Tao
AU  - Sun T
AD  - Brigham and Women’s Hospital, Harvard Medical School, Boston, MA USA
FAU - Zhang, Yong-Zhi
AU  - Zhang YZ
AD  - Harvard Medical School, Boston, MA USA
FAU - Power, Chanikarn
AU  - Power C
AD  - Brigham and Women’s Hospital, Harvard Medical School, Boston, MA USA
FAU - Livingstone, Margaret
AU  - Livingstone M
AD  - Harvard Medical School, Boston, MA USA
FAU - McDannold, Nathan
AU  - McDannold N
AD  - Brigham and Women’s Hospital, Harvard Medical School, Boston, MA USA
FAU - Todd, Nick
AU  - Todd N
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Colas, Elodie Constanciel
AU  - Colas EC
AD  - Centre for Image Guided Innovation and Therapeutic Intervention, Toronto, ON
      Canada
FAU - Wydra, Adrian
AU  - Wydra A
AD  - The Institute for Diagnostic Imaging Research, Windsor, ON Canada
FAU - Waspe, Adam
AU  - Waspe A
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Looi, Thomas
AU  - Looi T
AD  - Centre for Image Guided Innovation and Therapeutic Intervention, Toronto, ON
      Canada
FAU - Maev, Roman
AU  - Maev R
AD  - The Institute for Diagnostic Imaging Research, Windsor, ON Canada
FAU - Pichardo, Samuel
AU  - Pichardo S
AD  - Thunder Bay Regional Research Institute, Thunder Bay, ON Canada
FAU - Drake, James
AU  - Drake J
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Aly, Amirah
AU  - Aly A
AD  - Northeastern University, Boston, MA USA
FAU - Sun, Tao
AU  - Sun T
AD  - Brigham and Women’s Hospital, Harvard Medical School, Boston, MA USA
FAU - Zhang, Yong-Zhi
AU  - Zhang YZ
AD  - Harvard Medical School, Boston, MA USA
FAU - Sesenoglu-Laird, Ozge
AU  - Sesenoglu-Laird O
AD  - Coprenicus Therapeutics, Inc., Cleveland, OH USA
FAU - Padegimas, Linas
AU  - Padegimas L
AD  - Coprenicus Therapeutics, Inc., Cleveland, OH USA
FAU - Cooper, Mark
AU  - Cooper M
AD  - Coprenicus Therapeutics, Inc., Cleveland, OH USA
FAU - McDannold, Nathan
AU  - McDannold N
AD  - Brigham and Women’s Hospital, Harvard Medical School, Boston, MA USA
FAU - Waszczak, Barbara
AU  - Waszczak B
AD  - Northeastern University, Boston, MA USA
FAU - Tehrani, Seruz
AU  - Tehrani S
AD  - University of Virginia, Charlottesville, VA USA
FAU - Miller, Wilson
AU  - Miller W
AD  - University of Virginia, Charlottesville, VA USA
FAU - Slingluff, Craig
AU  - Slingluff C
AD  - University of Virginia, Charlottesville, VA USA
FAU - Larner, James
AU  - Larner J
AD  - University of Virginia, Charlottesville, VA USA
FAU - Andarawewa, Kumari
AU  - Andarawewa K
AD  - University of Virginia, Charlottesville, VA USA
FAU - Bucknor, Matthew
AU  - Bucknor M
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Ozhinsky, Eugene
AU  - Ozhinsky E
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Shah, Rutwik
AU  - Shah R
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Krug, Roland
AU  - Krug R
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Rieke, Viola
AU  - Rieke V
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Deckers, Roel
AU  - Deckers R
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Linn, Sabine
AU  - Linn S
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Suelmann, Britt
AU  - Suelmann B
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Braat, Manon
AU  - Braat M
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Witkamp, Arjen
AU  - Witkamp A
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Vaessen, Paul
AU  - Vaessen P
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - van Diest, Paul
AU  - van Diest P
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Bartels, Lambertus W.
AU  - Bartels LW
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Bos, Clemens
AU  - Bos C
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - van den Bosch, Maurice
AU  - van den Bosch M
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Borys, Nicolas
AU  - Borys N
AD  - Celsion Corporation, Lawrenceville, NJ USA
FAU - Storm, Gert
AU  - Storm G
AD  - Utrecht University, Utrecht, Netherlands
FAU - Van der Wall, Elsken
AU  - Van der Wall E
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Moonen, Chrit
AU  - Moonen C
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Farr, Navid
AU  - Farr N
AD  - National Institutes of Health, Bethesda, MD USA
FAU - Alnazeer, Moez
AU  - Alnazeer M
AD  - National Institutes of Health, Bethesda, MD USA
FAU - Yarmolenko, Pavel
AU  - Yarmolenko P
AD  - The Sheikh Zayed Institute for Pediatric Surgical Innovation, Washington, DC USA
FAU - Katti, Prateek
AU  - Katti P
AD  - National Institutes of Health, Bethesda, MD USA
FAU - Partanen, Ari
AU  - Partanen A
AD  - Philips, Bethesda, MD USA
FAU - Eranki, Avinash
AU  - Eranki A
AD  - Children’s National Health System, Washington, DC USA
FAU - Kim, Peter
AU  - Kim P
AD  - Children’s National Health System, Washington, DC USA
FAU - Wood, Bradford
AU  - Wood B
AD  - National Institutes of Health, Bethesda, MD USA
FAU - Farrer, Alexis
AU  - Farrer A
AD  - University of Utah, Salt Lake City, UT USA
FAU - Almquist, Scott
AU  - Almquist S
AD  - University of Utah, Salt Lake City, UT USA
FAU - Dillon, Christopher
AU  - Dillon C
AD  - University of Utah, Salt Lake City, UT USA
FAU - Parker, Dennis
AU  - Parker D
AD  - University of Utah, Salt Lake City, UT USA
FAU - Christensen, Douglas
AU  - Christensen D
AD  - University of Utah, Salt Lake City, UT USA
FAU - Payne, Allison
AU  - Payne A
AD  - University of Utah, Salt Lake City, UT USA
FAU - Ferrer, Cyril
AU  - Ferrer C
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Bartels, Lambertus W.
AU  - Bartels LW
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - de Senneville, Baudouin Denis
AU  - de Senneville BD
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - van Stralen, Marijn
AU  - van Stralen M
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Moonen, Chrit
AU  - Moonen C
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Bos, Clemens
AU  - Bos C
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Liu, Yu
AU  - Liu Y
AD  - University of California Davis, Davis, CA USA
FAU - Liu, Jingfei
AU  - Liu J
AD  - University of California Davis, Davis, CA USA
FAU - Fite, Brett
AU  - Fite B
AD  - University of California Davis, Davis, CA USA
FAU - Foiret, Josquin
AU  - Foiret J
AD  - University of California Davis, Davis, CA USA
FAU - Leach, J. Kent
AU  - Leach JK
AD  - University of California Davis, Davis, CA USA
FAU - Ferrara, Katherine
AU  - Ferrara K
AD  - University of California Davis, Davis, CA USA
FAU - Gupta, Roohi
AU  - Gupta R
AD  - Fox Chase Cancer Center, Philadelphia, PA USA
FAU - Cvetkovic, Dusica
AU  - Cvetkovic D
AD  - Fox Chase Cancer Center, Philadelphia, PA USA
FAU - Ma, Charlie
AU  - Ma C
AD  - Fox Chase Cancer Center, Philadelphia, PA USA
FAU - Chen, Lili
AU  - Chen L
AD  - Fox Chase Cancer Center, Philadelphia, PA USA
FAU - Haase, Sabrina
AU  - Haase S
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Zidowitz, Stephan
AU  - Zidowitz S
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Melzer, Andreas
AU  - Melzer A
AD  - University of Dundee, Dundee, UK
FAU - Preusser, Tobias
AU  - Preusser T
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Lee, Hsin-Lun
AU  - Lee HL
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Hsu, Fang-Chi
AU  - Hsu FC
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Kuo, Chia-Chun
AU  - Kuo CC
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Jeng, Shiu-Chen
AU  - Jeng SC
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Chen, Tung-Ho
AU  - Chen TH
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Yang, Nai-Yi
AU  - Yang NY
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Chiou, Jeng-Fong
AU  - Chiou JF
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Jeng, Shiu-Chen
AU  - Jeng SC
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Kao, Yi-tzu
AU  - Kao Yt
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Pan, Chia-Hsin
AU  - Pan CH
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Wu, Jing-Fu
AU  - Wu JF
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Chen, Tung-Ho
AU  - Chen TH
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Hsu, Fang-Chi
AU  - Hsu FC
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Lee, Hsin-Lun
AU  - Lee HL
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Chiou, Jeng-Fong
AU  - Chiou JF
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Hsu, Fang-Chi
AU  - Hsu FC
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Tsai, Yi-Chieh
AU  - Tsai YC
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Lee, Hsin-Lun
AU  - Lee HL
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Chiou, Jeng-Fong
AU  - Chiou JF
AD  - Taipei Medical University Healthcare System, Taipei, Taiwan
FAU - Johnson, Sara
AU  - Johnson S
AD  - University of Utah, Salt Lake City, UT USA
FAU - Parker, Dennis
AU  - Parker D
AD  - University of Utah, Salt Lake City, UT USA
FAU - Payne, Allison
AU  - Payne A
AD  - University of Utah, Salt Lake City, UT USA
FAU - Li, Dawei
AU  - Li D
AD  - Shanghai A&S Science Technology Development Co., LTD., Shanghai, China
FAU - He, Ye
AU  - He Y
AD  - Shanghai A&S Science Technology Development Co., LTD., Shanghai, China
FAU - Mihcin, Senay
AU  - Mihcin S
AD  - IMSAT, Dundee, UK
FAU - Karakitsios, Ioannis
AU  - Karakitsios I
AD  - University of Dundee, Dundee, UK
FAU - Strehlow, Jan
AU  - Strehlow J
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Schwenke, Michael
AU  - Schwenke M
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Haase, Sabrina
AU  - Haase S
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Demedts, Daniel
AU  - Demedts D
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Levy, Yoav
AU  - Levy Y
AD  - InSightec Ltd, Tirat Carmel, Israel
FAU - Preusser, Tobias
AU  - Preusser T
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Melzer, Andreas
AU  - Melzer A
AD  - University of Dundee, Dundee, UK
FAU - Mihcin, Senay
AU  - Mihcin S
AD  - IMSAT, Dundee, UK
FAU - Rothluebbers, Sven
AU  - Rothluebbers S
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Karakitsios, Ioannis
AU  - Karakitsios I
AD  - University of Dundee, Dundee, UK
FAU - Xiao, Xu
AU  - Xiao X
AD  - University of Dundee - FUTURA, Dundee, UK
FAU - Strehlow, Jan
AU  - Strehlow J
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Demedts, Daniel
AU  - Demedts D
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Cavin, Ian
AU  - Cavin I
AD  - NHS, Dundee, UK
FAU - Sat, Giora
AU  - Sat G
AD  - GE Medical Systems Israel Ltd., Tirat Carmel, Israel
FAU - Preusser, Tobias
AU  - Preusser T
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Melzer, Andreas
AU  - Melzer A
AD  - University of Dundee, Dundee, UK
FAU - Minalga, Emilee
AU  - Minalga E
AD  - University of Utah, Salt Lake City, UT USA
FAU - Payne, Allison
AU  - Payne A
AD  - University of Utah, Salt Lake City, UT USA
FAU - Merrill, Robb
AU  - Merrill R
AD  - University of Utah, Salt Lake City, UT USA
FAU - Parker, Dennis
AU  - Parker D
AD  - University of Utah, Salt Lake City, UT USA
FAU - Hadley, Rock
AU  - Hadley R
AD  - University of Utah, Salt Lake City, UT USA
FAU - Ramaekers, Pascal
AU  - Ramaekers P
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Ries, Mario
AU  - Ries M
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Moonen, Chrit
AU  - Moonen C
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - de Greef, Martijn
AU  - de Greef M
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Shahriari, Kian
AU  - Shahriari K
AD  - Islamic Azad University, Science and Research Branch, Tehran, Iran
FAU - Parvizi, Mohammad Hossein
AU  - Parvizi MH
AD  - Islamic Azad University, Science and Research Branch, Tehran, Iran
FAU - Asadnia, Kiana
AU  - Asadnia K
AD  - Islamic Azad University, Science and Research Branch, Tehran, Iran
FAU - Chamanara, Marzieh
AU  - Chamanara M
AD  - Islamic Azad University, Science and Research Branch, Tehran, Iran
FAU - Kamrava, Seyed Kamran
AU  - Kamrava SK
AD  - Iran University of Medical Sciences, Tehran, Iran
FAU - Chabok, Hamid Reza
AU  - Chabok HR
AD  - University of Southern California Los Angeles, Los Angeles, CA USA
FAU - Schwenke, Michael
AU  - Schwenke M
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Strehlow, Jan
AU  - Strehlow J
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Demedts, Daniel
AU  - Demedts D
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Tanner, Christine
AU  - Tanner C
AD  - ETH Zurich, Computer Vision Laboratory, Zurich, Switzerland
FAU - Rothluebbers, Sven
AU  - Rothluebbers S
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Preusser, Tobias
AU  - Preusser T
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Strehlow, Jan
AU  - Strehlow J
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Stein, Ruben
AU  - Stein R
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Demedts, Daniel
AU  - Demedts D
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Schwenke, Michael
AU  - Schwenke M
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Rothluebbers, Sven
AU  - Rothluebbers S
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Preusser, Tobias
AU  - Preusser T
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Demedts, Daniel
AU  - Demedts D
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Haase, Sabrina
AU  - Haase S
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Muller, Sébastien
AU  - Muller S
AD  - Stiftelsen SINTEF, Trondheim, Norway
FAU - Strehlow, Jan
AU  - Strehlow J
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Langø, Thomas
AU  - Langø T
AD  - Stiftelsen SINTEF, Trondheim, Norway
FAU - Preusser, Tobias
AU  - Preusser T
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Tan, Jeremy
AU  - Tan J
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Zachiu, Cornel
AU  - Zachiu C
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Ramaekers, Pascal
AU  - Ramaekers P
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Moonen, Chrit
AU  - Moonen C
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Ries, Mario
AU  - Ries M
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Wolfram, Frank
AU  - Wolfram F
AD  - SRH Wald-Klinikum Gera, Gera, Germany
FAU - Güllmar, Daniel
AU  - Güllmar D
AD  - Institute of Diagnostic and Interventional Radiology, Friedrich Schiller
      University, Jena, Germany
FAU - Schubert, Harald
AU  - Schubert H
AD  - Institute of Animal Experimentation, Friedrich Schiller University, Jena, Germany
FAU - Lesser, Thomas G.
AU  - Lesser TG
AD  - SRH Wald-Klinikum Gera, Gera, Germany
FAU - Erasmus, Hans-Peter
AU  - Erasmus HP
AD  - University of Rome – La Sapienza, Rome, Italy
FAU - Colas, Elodie Constanciel
AU  - Colas EC
AD  - Centre for Image Guided Innovation and Therapeutic Intervention, Toronto, ON
      Canada
FAU - Waspe, Adam
AU  - Waspe A
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Mougenot, Charles
AU  - Mougenot C
AD  - Philips Healthcare Canada, Toronto, ON Canada
FAU - Looi, Thomas
AU  - Looi T
AD  - Centre for Image Guided Innovation and Therapeutic Intervention, Toronto, ON
      Canada
FAU - Van Arsdell, Glen
AU  - Van Arsdell G
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Benson, Lee
AU  - Benson L
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Drake, James
AU  - Drake J
AD  - Hospital for Sick Children, Toronto, ON Canada
FAU - Jang, Kee W.
AU  - Jang KW
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Tu, Tsang-Wei
AU  - Tu TW
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Jikaria, Neekita
AU  - Jikaria N
AD  - National Institutes of Health, Bethesda, MD USA
FAU - Nagle, Matthew
AU  - Nagle M
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Angstadt, Mary
AU  - Angstadt M
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Lewis, Bobbi
AU  - Lewis B
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Qureshi, Farhan
AU  - Qureshi F
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Burks, Scott
AU  - Burks S
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - Frank, Joseph
AU  - Frank J
AD  - National Institutes of Health Clinical Center, Bethesda, MD USA
FAU - McLean, Hailey
AU  - McLean H
AD  - University of Utah, Salt Lake City, UT USA
FAU - Payne, Allison
AU  - Payne A
AD  - University of Utah, Salt Lake City, UT USA
FAU - Hoogenboom, Martijn
AU  - Hoogenboom M
AD  - Radboud University Medical Center, Nijmegen, Netherlands
FAU - Eikelenboom, Dylan
AU  - Eikelenboom D
AD  - Radboud University Medical Center, Nijmegen, Netherlands
FAU - den Brok, Martijn
AU  - den Brok M
AD  - Radboud University Medical Center, Nijmegen, Netherlands
FAU - Wesseling, Pieter
AU  - Wesseling P
AD  - Radboud University Medical Center, Nijmegen, Netherlands
FAU - Heerschap, Arend
AU  - Heerschap A
AD  - Radboud University Medical Center, Nijmegen, Netherlands
FAU - Fütterer, Jurgen
AU  - Fütterer J
AD  - Radboud University Medical Center, Nijmegen, Netherlands
FAU - Adema, Gosse
AU  - Adema G
AD  - Radboud University Medical Center, Nijmegen, Netherlands
FAU - Wang, Kevin
AU  - Wang K
AD  - Virginia Tech, Blacksburg, VA USA
FAU - Zhang, Ying
AU  - Zhang Y
AD  - Duke University, Durham, NC USA
FAU - Zhong, Pei
AU  - Zhong P
AD  - Duke University, Durham, NC USA
FAU - Xiao, Xu
AU  - Xiao X
AD  - University of Dundee - FUTURA, Dundee, UK
FAU - Joy, Joyce
AU  - Joy J
AD  - University of Dundee, Dundee, UK
FAU - McLeod, Helen
AU  - McLeod H
AD  - University of Dundee, Dundee, UK
FAU - Melzer, Andreas
AU  - Melzer A
AD  - University of Dundee, Dundee, UK
FAU - Bing, Chenchen
AU  - Bing C
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Staruch, Robert
AU  - Staruch R
AD  - Philips Research, Dallas, TX USA
FAU - Nofiele, Joris
AU  - Nofiele J
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Szczepanski, Debra
AU  - Szczepanski D
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Staruch, Michelle Wodzak
AU  - Staruch MW
AD  - University of Oklahoma Health Sciences Center, Oklahoma City, OK USA
FAU - Laetsch, Theodore
AU  - Laetsch T
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Chopra, Rajiv
AU  - Chopra R
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Bing, Chenchen
AU  - Bing C
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Staruch, Robert
AU  - Staruch R
AD  - Philips Research, Dallas, TX USA
FAU - Yarmolenko, Pavel
AU  - Yarmolenko P
AD  - Philips Research, Dallas, TX USA
FAU - Celik, Haydar
AU  - Celik H
AD  - Sheikh Zayed Institute for Pediatric Surgical Innovation, Washington, DC USA
FAU - Nofiele, Joris
AU  - Nofiele J
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Szczepanski, Debra
AU  - Szczepanski D
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Kim, Peter
AU  - Kim P
AD  - Children’s National Health System, Washington, DC USA
FAU - Kim, Harry
AU  - Kim H
AD  - Texas Scottish Rite Hospital for Children, Dallas, TX USA
FAU - Lewis, Matthew
AU  - Lewis M
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Chopra, Rajiv
AU  - Chopra R
AD  - University of Texas Southwestern Medical Center, Dallas, TX USA
FAU - Shah, Rutwik
AU  - Shah R
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Ozhinsky, Eugene
AU  - Ozhinsky E
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Rieke, Viola
AU  - Rieke V
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Bucknor, Matthew
AU  - Bucknor M
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Diederich, Chris
AU  - Diederich C
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Salgaonkar, Vasant
AU  - Salgaonkar V
AD  - University of California San Francisco, Sunnyvale, CA USA
FAU - Jones, Peter
AU  - Jones P
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Adams, Matthew
AU  - Adams M
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Ozilgen, Arda
AU  - Ozilgen A
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Zahos, Peter
AU  - Zahos P
AD  - University of California San Francisco, Napa, CA USA
FAU - Coughlin, Dezba
AU  - Coughlin D
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Tang, Xinyan
AU  - Tang X
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Lotz, Jeff
AU  - Lotz J
AD  - University of California San Francisco, San Francisco, CA USA
FAU - Jedruszczuk, Kathleen
AU  - Jedruszczuk K
AD  - Memorial Sloan-Kettering Cancer Center, New York, NY USA
FAU - Gulati, Amitabh
AU  - Gulati A
FAU - Solomon, Stephen
AU  - Solomon S
AD  - Memorial Sloan-Kettering Cancer Center, New York, NY USA
FAU - Kaye, Elena
AU  - Kaye E
AD  - Memorial Sloan-Kettering Cancer Center, New York, NY USA
FAU - Fielden, Samuel
AU  - Fielden S
AD  - University of Virginia, Charlottesville, VA USA
FAU - Mugler, John
AU  - Mugler J
AD  - University of Virginia, Charlottesville, VA USA
FAU - Miller, Wilson
AU  - Miller W
AD  - University of Virginia, Charlottesville, VA USA
FAU - Pauly, Kim Butts
AU  - Pauly KB
AD  - Stanford University, Stanford, CA USA
FAU - Meyer, Craig
AU  - Meyer C
AD  - University of Virginia, Charlottesville, VA USA
FAU - Barbato, Gaetano
AU  - Barbato G
AD  - Promedica Bioelectronics SRL, Rome, Italy
FAU - Scoarughi, Gian Luca
AU  - Scoarughi GL
AD  - Promedica Bioelectronics SRL, Rome, Italy
FAU - Corso, Cristiano
AU  - Corso C
AD  - Promedica Bioelectronics SRL, Rome, Italy
FAU - Gorgone, Alessandro
AU  - Gorgone A
AD  - Promedica Bioelectronics SRL, Rome, Italy
FAU - Migliore, Ilaria Giuseppina
AU  - Migliore IG
AD  - Promedica Bioelectronics SRL, Rome, Italy
FAU - Larrabee, Zachary
AU  - Larrabee Z
AD  - University of Virginia, Charlottesville, VA USA
FAU - Hananel, Arik
AU  - Hananel A
AD  - FUS Mobile Inc., Alpharetta, GA USA
FAU - Eames, Matt
AU  - Eames M
AD  - University of Virginia, Charlottesville, VA USA
FAU - Aubry, Jean-Francois
AU  - Aubry JF
AD  - Institut Langevin Ondes et Images, ESPCI ParisTech, CNRS UMR 7587, INSERM U979,
      Paris, France
FAU - Eranki, Avinash
AU  - Eranki A
AD  - Children’s National Health System, Washington, DC USA
FAU - Farr, Navid
AU  - Farr N
AD  - National Institutes of Health, Bethesda, MD USA
FAU - Partanen, Ari
AU  - Partanen A
AD  - Philips, Bethesda, MD USA
FAU - Sharma, Karun
AU  - Sharma K
AD  - Children’s National Health System, Washington, DC USA
FAU - Yarmolenko, Pavel
AU  - Yarmolenko P
AD  - The Sheikh Zayed Institute for Pediatric Surgical Innovation, Washington, DC USA
FAU - Wood, Bradford
AU  - Wood B
AD  - National Institutes of Health, Bethesda, MD USA
FAU - Kim, Peter
AU  - Kim P
AD  - Children’s National Health System, Washington, DC USA
FAU - Farr, Navid
AU  - Farr N
AD  - National Institutes of Health, Bethesda, MD USA
FAU - Kothapalli, Satya V. V. N.
AU  - Kothapalli SVVN
AD  - Washington University in Saint Louis, Saint Louis, MO USA
FAU - Eranki, Avinash
AU  - Eranki A
AD  - Children’s National Health System, Washington, DC USA
FAU - Negussie, Ayele
AU  - Negussie A
AD  - National Institutes of Health, Bethesda, MD USA
FAU - Wilson, Emmanuel
AU  - Wilson E
AD  - Children’s National Health System, Washington, DC USA
FAU - Seifabadi, Reza
AU  - Seifabadi R
AD  - National Institutes of Health, Bethesda, MD USA
FAU - Kim, Peter
AU  - Kim P
AD  - Children’s National Health System, Washington, DC USA
FAU - Chen, Hong
AU  - Chen H
AD  - Washington University in Saint Louis, Saint Louis, MO USA
FAU - Wood, Bradford
AU  - Wood B
AD  - National Institutes of Health, Bethesda, MD USA
FAU - Partanen, Ari
AU  - Partanen A
AD  - Philips, Bethesda, MD USA
FAU - Moon, Hyungwon
AU  - Moon H
AD  - Seoul National University Bundang Hospital, Seongnam, Republic of Korea
FAU - Kang, Jeeun
AU  - Kang J
AD  - Sogang University, Seoul, Republic of Korea
FAU - Sim, Changbeom
AU  - Sim C
AD  - Sogang University, Seoul, Republic of Korea
FAU - Chang, Jin Ho
AU  - Chang JH
AD  - Sogang University, Seoul, Republic of Korea
FAU - Kim, Hyuncheol
AU  - Kim H
AD  - Sogang University, Seoul, Republic of Korea
FAU - Lee, Hak Jong
AU  - Lee HJ
AD  - Seoul National University Bundang Hospital, Seongnam, Republic of Korea
FAU - Sasaki, Noboru
AU  - Sasaki N
AD  - Hokkaido University, Sapporo, Hokkaido Japan
FAU - Takiguchi, Mitsuyoshi
AU  - Takiguchi M
AD  - Hokkaido University, Sapporo, Hokkaido Japan
FAU - Sebeke, Lukas
AU  - Sebeke L
AD  - Uniklinik Koeln, Cologne, Germany
FAU - Luo, Xi
AU  - Luo X
AD  - Eindhoven University of Technology, Eindhoven, Netherlands
FAU - de Jager, Bram
AU  - de Jager B
AD  - Eindhoven University of Technology, Eindhoven, Netherlands
FAU - Heemels, Maurice
AU  - Heemels M
AD  - Eindhoven University of Technology, Eindhoven, Netherlands
FAU - Heijman, Edwin
AU  - Heijman E
AD  - Philips Research, Eindhoven, Netherlands
FAU - Grüll, Holger
AU  - Grüll H
AD  - Eindhoven University of Technology, Eindhoven, Netherlands
FAU - Strehlow, Jan
AU  - Strehlow J
AD  - Fraunhofer MEVIS, Bremen, Germany
FAU - Schwenke, Michael
AU  - Schwenke M
AD  - Philips Research, Eindhoven, Netherlands
FAU - Demedts, Daniel
AU  - Demedts D
AD  - Philips Research, Eindhoven, Netherlands
FAU - Preusser, Tobias
AU  - Preusser T
AD  - Philips Research, Eindhoven, Netherlands
FAU - McLeod, Helen
AU  - McLeod H
AD  - Univerisity of Dundee, Dundee, UK
FAU - Abraham, Christopher
AU  - Abraham C
AD  - Thunder Bay Regional Research Institute, Thunder Bay, ON Canada
FAU - Pichardo, Samuel
AU  - Pichardo S
AD  - Thunder Bay Regional Research Institute, Thunder Bay, ON Canada
FAU - Curiel, Laura
AU  - Curiel L
AD  - Thunder Bay Regional Research Institute, Thunder Bay, ON Canada
FAU - Ramaekers, Pascal
AU  - Ramaekers P
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - de Greef, Martijn
AU  - de Greef M
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Berriet, Rémi
AU  - Berriet R
AD  - IMASONIC SAS, Voray sur l’Ognon, France
FAU - Moonen, Chrit
AU  - Moonen C
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Ries, Mario
AU  - Ries M
AD  - University Medical Center – Utrecht, Utrecht, Netherlands
FAU - Dillon, Christopher
AU  - Dillon C
AD  - University of Utah, Salt Lake City, UT USA
FAU - Janát-Amsbury, Margit
AU  - Janát-Amsbury M
AD  - University of Utah, Salt Lake City, UT USA
FAU - Payne, Allison
AU  - Payne A
AD  - University of Utah, Salt Lake City, UT USA
FAU - Corea, Joseph
AU  - Corea J
AD  - University of California Berkeley, Berkeley, CA USA
FAU - Ye, Patrick Peiyong
AU  - Ye PP
AD  - University of California Berkeley, Berkeley, CA USA
FAU - Arias, Ana Clauda
AU  - Arias AC
AD  - University of California Berkeley, Berkeley, CA USA
FAU - Pauly, Kim Butts
AU  - Pauly KB
AD  - Stanford University, Stanford, CA USA
FAU - Lustig, Micheal
AU  - Lustig M
AD  - University of California Berkeley, Berkeley, CA USA
FAU - Svedin, Bryant
AU  - Svedin B
AD  - University of Utah, Salt Lake City, UT USA
FAU - Payne, Allison
AU  - Payne A
AD  - University of Utah, Salt Lake City, UT USA
FAU - Parker, Dennis
AU  - Parker D
AD  - University of Utah, Salt Lake City, UT USA
LA  - eng
PT  - Journal Article
DEP - 20161121
TA  - J Ther Ultrasound
JT  - Journal of Therapeutic Ultrasound
AID - 76 [pii]
AID - 10.1186/s40349-016-0076-5 [doi]
SO  - J Ther Ultrasound. 2016 Nov 21;4(Suppl 1):1-113. doi:10.1186/s40349-016-0076-5.

PMC - PMC4919322
PMID- 27445739
IS  - 1662-5161 (Electronic)
VI  - 10
DP  - 2016
TI  - Does a Combination of Virtual Reality, Neuromodulation and Neuroimaging Provide a
      Comprehensive Platform for Neurorehabilitation? – A Narrative Review of the
      Literature.
LID - 284
AB  - In the last decade, virtual reality (VR) training has been used extensively in
      video games and military training to provide a sense of realism and environmental
      interaction to its users. More recently, VR training has been explored as a
      possible adjunct therapy for people with motor and mental health dysfunctions.
      The concept underlying VR therapy as a treatment for motor and cognitive
      dysfunction is to improve neuroplasticity of the brain by engaging users in
      multisensory training. In this review, we discuss the theoretical framework
      underlying the use of VR as a therapeutic intervention for neurorehabilitation
      and provide evidence for its use in treating motor and mental disorders such as
      cerebral palsy, Parkinson’s disease, stroke, schizophrenia, anxiety disorders,
      and other related clinical areas. While this review provides some insights into
      the efficacy of VR in clinical rehabilitation and its complimentary use with
      neuroimaging (e.g., fNIRS and EEG) and neuromodulation (e.g., tDCS and rTMS),
      more research is needed to understand how different clinical conditions are
      affected by VR therapies (e.g., stimulus presentation, interactivity, control and
      types of VR). Future studies should consider large, longitudinal randomized
      controlled trials to determine the true potential of VR therapies in various
      clinical populations.
FAU - Teo, Wei-Peng
AU  - Teo WP
AD  - Institute for Physical Activity and Nutrition (IPAN), Deakin University,
      BurwoodVIC, Australia
FAU - Muthalib, Makii
AU  - Muthalib M
AD  - EuroMov, University of MontpellierMontpellier, France
FAU - Yamin, Sami
AU  - Yamin S
AD  - Liminal Pty Ltd., MelbourneVIC, Australia
FAU - Hendy, Ashlee M.
AU  - Hendy AM
AD  - School of Exercise and Nutrition Sciences, Deakin University, BurwoodVIC,
      Australia
FAU - Bramstedt, Kelly
AU  - Bramstedt K
AD  - Liminal Pty Ltd., MelbourneVIC, Australia
FAU - Kotsopoulos, Eleftheria
AU  - Kotsopoulos E
AD  - Liminal Pty Ltd., MelbourneVIC, Australia
FAU - Perrey, Stephane
AU  - Perrey S
AD  - EuroMov, University of MontpellierMontpellier, France
FAU - Ayaz, Hasan
AU  - Ayaz H
AD  - School of Biomedical Engineering, Science and Health Systems, Drexel University, 
      PhiladelphiaPA, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20160624
PHST- 2015/12/08 [received]
PHST- 2016/05/25 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2016.00284 [doi]
SO  - Front Hum Neurosci. 2016 Jun 24;10:. doi:10.3389/fnhum.2016.00284.

PMC - PMC4878058
PMID- 27215830
IS  - 1471-244X (Electronic)
VI  - 16
DP  - 2016
TI  - The underlying neurobiology of key functional domains in young people with mood
      and anxiety disorders: a systematic review.
LID - 156
AB  - Background: Mood and anxiety disorders are leading causes of disability and
      mortality, due largely to their onset during adolescence and young adulthood and 
      broader impact on functioning. Key factors that are associated with disability
      and these disorders in young people are social and economic participation (e.g.
      education, employment), physical health, suicide and self-harm behaviours, and
      alcohol and substance use. A better understanding of the objective markers (i.e. 
      neurobiological parameters) associated with these factors is important for the
      development of effective early interventions that reduce the impact of disability
      and illness persistence. Methods: We systematically reviewed the literature for
      neurobiological parameters (i.e. neuropsychology, neuroimaging, sleep-wake and
      circadian biology, neurophysiology and metabolic measures) associated with
      functional domains in young people (12 to 30 years) with mood and/or anxiety
      disorders. Results: Of the one hundred and thirty-four studies selected, 7.6 %
      investigated social and economic participation, 2.1 % physical health, 15.3 %
      suicide and self-harm behaviours, 6.9 % alcohol and substance use, whereas the
      majority (68.1 %) focussed on clinical syndrome. Conclusions: Despite the
      predominance of studies that solely examine the clinical syndrome of young people
      the literature also provides evidence of distinct associations among objective
      measures (indexing various aspects of brain circuitry) and other functional
      domains. We suggest that a shift in focus towards characterising the mechanisms
      that underlie and/or mediate multiple functional domains will optimise
      personalised interventions and improve illness trajectories.
FAU - Iorfino, Frank
AU  - Iorfino F
AD  - Clinical Research Unit, Brain and Mind Centre, University of Sydney, 94 Mallet
      Street, Camperdown, NSW 2050 Australia
FAU - Hickie, Ian B.
AU  - Hickie IB
AD  - Clinical Research Unit, Brain and Mind Centre, University of Sydney, 94 Mallet
      Street, Camperdown, NSW 2050 Australia
FAU - Lee, Rico S. C.
AU  - Lee RSC
AD  - Clinical Research Unit, Brain and Mind Centre, University of Sydney, 94 Mallet
      Street, Camperdown, NSW 2050 Australia
FAU - Lagopoulos, Jim
AU  - Lagopoulos J
AD  - Clinical Research Unit, Brain and Mind Centre, University of Sydney, 94 Mallet
      Street, Camperdown, NSW 2050 Australia
FAU - Hermens, Daniel F.
AU  - Hermens DF
AD  - Clinical Research Unit, Brain and Mind Centre, University of Sydney, 94 Mallet
      Street, Camperdown, NSW 2050 Australia
LA  - eng
PT  - Journal Article
DEP - 20160523
GR  - 1061043
PHST- 2015/10/22 [received]
PHST- 2016/05/08 [accepted]
TA  - BMC Psychiatry
JT  - BMC Psychiatry
AID - 852 [pii]
AID - 10.1186/s12888-016-0852-3 [doi]
SO  - BMC Psychiatry. 2016 May 23;16:. doi:10.1186/s12888-016-0852-3.

PMC - PMC4896262
IS  - 1878-5077 (Print)
IS  - 1878-5085 (Electronic)
VI  - 7
IP  - Suppl 1
DP  - 2016
TI  - EPMA-World Congress 2015: Bonn, Germany. 3-5 September 2015.
LID - 9
AB  - A1 Predictive and prognostic biomarker panel for targeted application of
      radioembolisation improving individual outcomes in hepatocellular
      carcinomaJella-Andrea Abraham, Olga GolubnitschajaA2 Integrated market access
      approach amplifying value of “Rx-CDx”Ildar AkhmetovA3 Disaster response: an
      opportunity to improve global healthcareRussell J. Andrews, Leonidas QuintanaA4
      USA PPPM: proscriptive, profligate, profiteering medicine-good for 1 % wealthy,
      not for 99 % unhealthyRussell J. AndrewsA5 The role of IDO in a murine model of
      gingivitis: predictive and therapeutic potentialsBabak Baban, Jun Yao Liu, Xu
      Qin, Tailing Wang, Mahmood S. MozaffariA6 Specific diets for personalised
      treatment of diabetes type 2Viktoriia V. Bati, Tamara V. Meleshko, Olga B.
      Levchuk, Nadiya V. BoykoA7 Towards personalized physiotherapeutic approachJoanna 
      Bauer, Ewa Boerner, Halina PodbielskaA8 Cells, animal, SHIME and in silico models
      for detection and verification of specific biomarkers of non-communicable chronic
      diseasesAlojz Bomba, Viktor O. Petrov, Volodymyr G. Drobnych, Rostyslav V.
      Bubnov, Oksana M. Bykova, Nadiya V. BoykoA9 INTERACT-chronic care model:
      Self-treatment by patients with decision support e-Health solutionHans-Peter
      Brunner-La Rocca, Lutz Fleischhacker, Olga Golubnitschaja, Frank Heemskerk,
      Thomas Helms, Tiny Jaarsma, Judita Kinkorova, Jan Ramaekers, Peter Ruff, Ivana
      Schnur, Emilio Vanoli, Jose VerduA10 PPPM in cardiovascular medicine in
      2015Hans-Peter Brunner-La RoccaA11 Magnetic resonance imaging of nanoparticles in
      mice, potential for theranostic and contrast media development – pilot
      resultsRostyslav V. Bubnov, Sergiy A. Grabovetskyi, Olena M. Mykhalchenko,
      Natalia O. Tymoshok, Oleksandr B. Shcherbakov, Igor P. Semeniv, Mykola Y.
      SpivakA12 Ultrasound diagnosis for diabetic neuropathy - comparative
      studyRostyslav V. Bubnov, Tetyana V. OstapenkoA13 Ultrasound for stratification
      patients with diabetic foot ulcers for prevention and personalized treatment -
      pilot resultsRostyslav V. Bubnov, Nazarii M. Kobyliak, Nadiya M. Zholobak, Mykola
      Ya. SpivakA14 Project ImaGenX – designing and executing a questionnaire on
      environment and lifestyle risk of breast cancerJohn Paul CauchiA15 Genomics – a
      new structural brand of predictive, preventive and personalized medicine or the
      new driver as well?Dmitrii Cherepakhin, Marina Bakay, Artem Borovikov, Sergey
      SuchkovA16 Survey of questionnaires for evaluation of the quality of life in
      various medical fieldsBarbara Cieślik, Agnieszka Migasiewicz, Maria-Luiza
      Podbielska, Markus Pelleter, Agnieszka Giemza, Halina PodbielskaA17 Personalized 
      molecular treatment for muscular dystrophiesSebahattin CirakA18 Secondary
      mutations in circulating tumour DNA for acquired drug resistance in patients with
      advanced ALK + NSCLCMarzia Del Re, Paola Bordi, Valentina Citi, Marta Palombi,
      Carmine Pinto, Marcello Tiseo, Romano DanesiA19 Recombinant species-specific
      FcεRI alpha proteins for diagnosis of IgE-mediated allergies in dogs, cats and
      horsesLukas Einhorn, Judit Fazekas, Martina Muhr, Alexandra Schoos, Lucia
      Panakova, Ina Herrmann, Krisztina Manzano-Szalai, Kumiko Oida, Edda Fiebiger,
      Josef Singer, Erika Jensen-JarolimA20 Global methodology for developmental
      neurotoxicity testing in humans and animals early and chronically exposed to
      chemical contaminantsArpiné A. Elnar, Nadia Ouamara, Nadiya Boyko, Xavier
      Coumoul, Jean-Philippe Antignac, Bruno Le Bizec, Gauthier Eppe, Jenny Renaut,
      Torsten Bonn, Cédric Guignard, Margherita Ferrante, Maria Liusa Chiusano,
      Salvatore Cuzzocrea, Gerard O'Keeffe, John Cryan, Michelle Bisson, Amina Barakat,
      Ihsane Hmamouchi, Nasser Zawia, Anumantha Kanthasamy, Glen E. Kisby, Rui Alves,
      Oscar Villacañas Pérez, Kim Burgard, Peter Spencer, Norbert Bomba, Martin
      Haranta, Nina Zaitseva, Irina May, Stéphanie Grojean, Mathilde Body-Malapel,
      Florencia Harari, Raul Harari, Kristina Yeghiazaryan, Olga Golubnitschaja,
      Vittorio Calabrese, Christophe Nemos, Rachid SoulimaniA21 Mental indicators at
      young people with attributes hypertension and pre-hypertensionMaria E. Evsevyeva,
      Elena A. Mishenko, Zurida V. Kumukova, Evgeniy V. Chudnovsky, Tatyana A.
      SmirnovaA22 On the approaches to the early diagnosis of stress-induced
      hypertension in young employees of State law enforcement agenciesMaria E.
      Evsevyeva, Ludmila V. Ivanova, Michail V. Eremin, Maria V. RostovtsevaA23 Сentral
      aortic pressure and indexes of augmentation in young persons in view of risk
      factorsMaria E. Evsevyeva, Michail V. Eremin, Vladimir I. Koshel, Oksana V.
      Sergeeva, Nadesgda M. KonovalovaA24 Breast cancer prediction and prevention: Are 
      reliable biomarkers in horizon?Shantanu Girotra, Olga GolubnitschajaA25 Flammer
      Syndrome and potential formation of pre-metastatic niches: A multi-centred study 
      on phenotyping, patient stratification, prediction and potential prevention of
      aggressive breast cancer and metastatic diseaseOlga Golubnitschaja, Manuel
      Debald, Walther Kuhn, Kristina Yeghiazaryan, Rostyslav V. Bubnov, Vadym M.
      Goncharenko, Ulyana Lushchyk, Godfrey Grech, Katarzyna KonieczkaA26 Innovative
      tools for prenatal diagnostics and monitoring: improving individual pregnancy
      outcomes and health-economy in EUOlga Golubnitschaja, Jan Jaap Erwich, Vincenzo
      Costigliola, Kristina Yeghiazaryan, Ulrich GembruchA27 Immunohistochemical
      assessment of APUD cells in endometriosisVadym M. Goncharenko, Vasyl O. Beniuk,
      Olga V. Kalenska, Rostyslav V. BubnovA28 Updating personalized management
      algorithm of endometrial hyperplasia in pre-menopause womenVadym M. Goncharenko, 
      Vasyl O. Beniuk, Rostyslav V. Bubnov, Olga MelnychukA29 The personified treatment
      approach of polimorbid patients with periodontal inflammatory diseasesIrina A.
      Gorbacheva, Lyudmila Y. Orekhova, Vadim V. TachalovA30 Ukrainian experience in
      hybrid war – the challenge to update algorithms for personalized care and early
      prevention of different military injuriesOlena I. Grechanyk, Rizvan Ya.
      Abdullaiev, Rostyslav V. BubnovA31 Tear fluid biomarkers: a comparison of tear
      fluid sampling and storage protocolsSuzanne Hagan, Eilidh Martin, Ian Pearce,
      Katherine OliverA32 The correlation of dietary habits with gingival problems
      during menstruationCenk Haytac, Fariz Salimov, Servin Yoksul, Anatoly A. Kunin,
      Natalia S. MoiseevaA33 Genomic medicine in a contemporary Spanish population of
      prostate cancer: our experienceBernardo Herrera-Imbroda, Sergio del Río-González,
      Maria Fernanda Lara, Antonia Angulo, Francisco Javier Machuca Santa-CruzA34
      Challenges, opportunities and collaborations for personalized medicine
      applicability in uro-oncological diseaseBernardo Herrera-Imbroda, Sergio del
      Río-González, Maria Fernanda LaraA35 Metabolic hallmarks of cancer as targets for
      a personalized therapyJohn IonescuA36 Influence of genetic polymorphism as a
      predictor of the development of periodontal disease in patients with gastric
      ulcer and 12 duodenal ulcerAlfiya Z. Isamulaeva, Anatoly A. Kunin, Shamil Sh.
      Magomedov, Aida I. IsamulaevaA37 Challenges in diabetic macular edemaTatjana
      JosifovaA38 Overview of the EPMA strategies in laboratory medicine relevant for
      PPPMMarko Kapalla, Juraj Kubáň, Olga Golubnitschaja, Vincenzo CostigliolaA39 EPMA
      initiative for effective organization of medical travel: European concepts and
      criteriaVincenzo Costigliola, Marko Kapalla, Juraj Kubáň, Olga GolubnitschajaA40 
      Design and innovation in e-textiles: implications for PPPMAnthony Kent, Tom
      Fisher, Tilak DiasA41 Biobank in Pilsen as a member of national node
      BBMRI_CZJudita Kinkorová, Ondřej TopolčanA42 Big data in personalized medicine:
      hype and hopeMatthias KohlA43 The 3P approach as the platform of the European
      Dentistry Department (DPPPD)Anatoly A. Kunin, Natalia S. MoiseevaA44 The
      endometrium cytokine patterns for predictive diagnosis of proliferation severity 
      and cancer preventionAndrii I. Kurchenko, Vasyl A. Beniuk, Vadym M. Goncharenko, 
      Rostyslav V. Bubnov, Nadiya V. Boyko, Andriy M. StrokanA45 A monocyte-based
      in-vitro system for testing individual responses to the implanted material:
      future for personalized implant constructionJulia Kzhyshkowska, Alexandru Gudima,
      Ksenia S. Stankevich, Victor D. Filimonov4, Harald Klüter, Evgeniya M. Mamontova,
      Sergei I. TverdokhlebovA46 Prediction and prevention of adverse health effects by
      meteorological factors: Biomarker patterns and creation of a device for
      self-monitoring and integrated careUlyana B. Lushchyk, Viktor V. Novytskyy, Igor 
      P. Babii, Nadiya G. Lushchyk, Lyudmyla S. Riabets, Ivanna I. LegkaA47 Targeting
      "disease signatures" towards personalized healthcareMira Marcus-Kalish, Alexis
      Mitelpunkt, Tal Galili, Neta Shachar, Yoav BenjaminiA48 Influence of the skin
      imperfection on the personal quality of life and possible tools for objective
      diagnosisAgnieszka Migasiewicz, Markus Pelleter, Joanna Bauer, Ewelina Dereń,
      Halina PodbielskaA49 The new direction in caries prevention based on the
      ultrastructure of dental hard tissues and filling materialsNatalia S. Moiseeva,
      Anatoly A. Kunin, Dmitry A. KuninA50 The use of LED radiation in prevention of
      dental diseasesNatalia S. Moiseeva, Yury A. Ippolitov, Dmitry A. Kunin, Alexei N.
      Morozov, Natalia V. Chirkova, Nakhid T. AlievA51 Status of endothelial progenitor
      cells in diabetic nephropathy: predictive and preventive potentialsMahmood S.
      Mozaffari, Jun Yao Liu, Babak BabanA52 The status of glucocorticoid-induced
      leucine zipper protein in salivary gland in Sjögren’s syndrome: predictive and
      personalized treatment potentialsMahmood S. Mozaffari, Jun Yao Liu, Rafik
      Abdelsayed, Xing-Ming Shi, Babak BabanA53 Maximal aerobic capacity - important
      quality marker of healthJaroslav Novák, Milan Štork, Václav ZemanA54 The EMPOWER 
      project: laboratory medicine and Horizon 2020Wytze P. Oosterhuis, Elvar
      TheodorssonA55 Personality profile manifestations in patient’s attitude to oral
      care and adherence to doctor’s prescriptionsLyudmila Y. Orekhova, Tatyana V.
      Kudryavtseva, Elena R. Isaeva, Vadim V. Tachalov, Ekaterina S. LobodaA56 Results 
      of an European survey on personalized medicine addressed to directions of
      laboratory medicineMario Pazzagli, Francesca Malentacchi, Irene Mancini, Ivan
      Brandslund, Pieter Vermeersch, Matthias Schwab, Janja Marc, Ron H.N. van Schaik, 
      Gerard Siest, Elvar Theodorsson, Chiara Di RestaA57 MCI or early dementia
      predictive speech based diagnosis techniquesMatus Pleva, Jozef JuharA58
      Personalized speech based mobile application for eHealthMatus Pleva, Jozef
      JuharA59 Circulating tumor cell-free DNA as the biomarker in the management of
      cancer patientsJiří Polívka jr., Filip Janků, Martin Pešta, Jan Doležal, Milena
      Králíčková, Jiří PolívkaA60 Complex stroke care – educational programme in Stroke
      Centre University Hospital PlzenJiří Polívka, Alena Lukešová, Nina Müllerová,
      Petr Ševčík, Vladimír RohanA61 Sleep apnea and sleep fragmentation contribute to 
      brain agingKneginja Richter, Lence Miloseva, Günter NiklewskiA62 Personalised
      approach for sleep disturbances in shift workersKneginja Richter, Jens Acker,
      Guenter NiklewskiA63 Medical travel and innovative PPPM clusters: new concept of 
      integrationOlga Safonicheva, Vincenzo CostigliolaA64 Medical travel and women
      healthOlga SafonichevaA65 Continuity of generations in the training of
      specialists in the field of reconstructive microsurgeryMaxim Sautin, Janna
      Sinelnikova, Sergey SuchkovA66 Telemonitoring of stroke patients – empirical
      evidence of individual risk management results from an observational study in
      GermanySongül Secer, Stephan von BandemerA67 Women’s increasing breast cancer
      risk with n-6 fatty acid intake explained by estrogen-fatty acid interactive
      effect on DNA damage: implications for gender-specific nutrition within
      personalized medicineNiva ShapiraA68 Cytobacterioscopy of the gingival crevicular
      fluid as a method for preventive diagnosis of periodontal diseasesAleksandr
      Shcherbakov, Anatoly A. Kunin, Natalia S. MoiseevaA69 Use of specially treated
      composites in dentistry to avoid violations of aestheticsBogdan R. Shumilovich,
      Zhanna Lipkind, Yulia Vorobieva, Dmitry A. Kunin, Anastasiia V. SudarevaA70
      National eHealth system – platform for preventive, predictive and personalized
      diabetes careIvica Smokovski, Tatjana MilenkovicA72 The common energy levels of
      Prof. Szent-Györgyi, the intrinsic chemistry of melanin, and the muscle
      physiopathology. Implications in the context of Preventive, Predictive, and
      Personalized MedicineArturo Solís-Herrera, María del Carmen Arias-Esparza, Sergey
      SuchkovA73 Plurality and individuality of hepatocellular carcinoma: PPPM
      perspectivesKrishna Chander Sridhar, Olga GolubnitschajaA74 Strategic aspects of 
      higher medical education reforms to secure newer educational platforms for
      getting biopharma professionals maturesMaria Studneva, Sihong Song, James
      Creeden, Мark Мandrik, Sergey SuchkovA75 Overview of the strategies and
      activities of the European Federation of Clinical Chemistry and Laboratory
      Medicine, (EFLM)Elvar Theodorsson, EFLMA76 New spectroscopic techniques for point
      of care label free diagnosticsSyed A. M. TofailA77 Tumor markers for personalized
      medicine and oncology - the role of Laboratory MedicineOndřej Topolčan, Judita
      Kinkorová, Ondřej Fiala, Marie Karlíková, Šárka Svobodová, Radek Kučera, Radka
      Fuchsová, Vladislav Třeška, Václav Šimánek, Ladislav Pecen, Jan Šoupal, Štěpán
      Svačina2A78 Modern medical terminology (MMT) as a driver of the global
      educational reformsEvgeniya Tretyak, Maria Studneva, Sergey SuchkovA79 Juvenile
      hypertension; the relevance of novel predictive, preventive and personalized
      assessment of its determinantsFrancesca M. Trovato, G. Fabio Martines, Daniela
      Brischetto, Daniela Catalano, Giuseppe Musumeci, Guglielmo M. TrovatoA80
      Proteomarkers BiotechGeorge Th. Tsangaris, Athanasios K. AnagnostopoulosA81
      Proteomics and mass spectrometry based non-invasive prenatal testing of fetal
      health and pregnancy complicationsGeorge Th. Tsangaris, Athanasios K.
      AnagnostopoulosA82 Integrated Ecosystem for an Integrated Care model for Heart
      Failure (HF) patients including related comorbidities (ZENITH)José Verdú, German 
      Gutiérrez, Jordi Rovira, Marta Martinez, Lutz Fleischhacker, Donna Green, Arthur 
      Garson, Elena Tamburini, Stefano Cuomo, Juan Martinez-Leon, Teresa Abrisqueta,
      Hans-Peter Brunner-La Rocca, Tiny Jaarsma, Teresa Arredondo, Cecilia Vera,
      Giuseppe Fico, Olga Golubnitschaja, Fernando Arribas, Martina Onderco, Isabel
      Vara, on behalf of ZENITH consortiumA83 Predictive, preventive and personalized
      medicine in diabetes onset and complication (MOSAIC project)José Verdú, Francesco
      Sambo, Barbara Di Camillo, Claudio Cobelli, Andrea Facchinetti, Giuseppe Fico,
      Riccardo Bellazzi, Lucia Sacchi, Arianna Dagliati, Daniele Segnani, Valentina
      Tibollo, Manuel Ottaviano, Rafael Gabriel, Leif Groop, Jacqueline Postma, Antonio
      Martinez, Liisa Hakaste, Tiinamaija Tuomi, Konstantia Zarkogianni, on behalf of
      MOSAIC consortiumA84 Possibilities for personalized therapy of diabetes using in 
      vitro screening of insulin and oral hypoglycemic agentsIgor Volchek, Nina
      Pototskaya, Andrey PetrovA85 The innovative technology for personalized therapy
      of human diseases based on in vitro drug screeningIgor Volchek, Nadezhda
      Pototskaya, Andrey PetrovA86 Bone destruction and temporomandibular joint:
      predictive markers, pathogenetic aspects and quality of lifeÜlle Voog-Oras,
      Oksana Jagur, Edvitar Leibur, Priit Niibo, Triin Jagomägi, Minh Son Nguyen, Chris
      Pruunsild, Dagmar Piikov, Mare SaagA87 Sub-optimal health management – global
      vision for concepts in medical travelWei WangA88 Sub-optimal health management:
      synergic PPPM-TCAM approachWei WangA89 Innovative technologies for minimal
      invasive diagnosticsAndreas Weinhäusel, Walter Pulverer, Matthias Wielscher,
      Manuela Hofner, Christa Noehammer, Regina Soldo, Peter Hettegger, Istvan Gyurjan,
      Ronald Kulovics, Silvia Schönthaler, Gabriel Beikircher, Albert Kriegner, Stephan
      Pabinger, Klemens VierlingerA90 Rare disease diobanks for personalized
      medicineAyşe Yüzbaşıoğlu, Meral Özgüç, Member of EuroBioBank - European Network
      of DNA, Cell and Tissue Banks for Rare Diseases
FAU - Abraham, Jella-Andrea
AU  - Abraham JA
AD  - Department of Radiology, University of Bonn, Sigmund-Freud-Str. 25, 53105, Bonn, 
      Germany
FAU - Golubnitschaja, Olga
AU  - Golubnitschaja O
AD  - Department of Radiology, University of Bonn, Sigmund-Freud-Str. 25, 53105, Bonn, 
      Germany
FAU - Akhmetov, Ildar
AU  - Akhmetov I
AD  - Market Access at Unicorn, P.O.B. 91, Zhytomyr, 10020 Ukraine
FAU - Andrews, Russell J.
AU  - Andrews RJ
AD  - Nanotechnology & Smart Systems, NASA Ames Research Center, Moffett Field, CA USA
FAU - Quintana, Leonidas
AU  - Quintana L
AD  - Department of Neurosurgery, Valparaiso University Medical School, Valparaiso,
      Chile
FAU - Andrews, Russell J.
AU  - Andrews RJ
AD  - Nanotechnology & Smart Systems, NASA Ames Research Center, Moffett Field, CA USA
FAU - Baban, Babak
AU  - Baban B
AD  - Department of Oral Biology, College of Dental Medicine, Georgia Regents
      University, Augusta, Georgia 30912 USA
FAU - Liu, Jun Yao
AU  - Liu JY
AD  - Department of Oral Biology, College of Dental Medicine, Georgia Regents
      University, Augusta, Georgia 30912 USA
FAU - Qin, Xu
AU  - Qin X
AD  - Department of Oral Biology, College of Dental Medicine, Georgia Regents
      University, Augusta, Georgia 30912 USA
FAU - Wang, Tailing
AU  - Wang T
AD  - Department of Oral Biology, College of Dental Medicine, Georgia Regents
      University, Augusta, Georgia 30912 USA
FAU - Mozaffari, Mahmood S.
AU  - Mozaffari MS
AD  - Department of Oral Biology, College of Dental Medicine, Georgia Regents
      University, Augusta, Georgia 30912 USA
FAU - Bati, Viktoriia V.
AU  - Bati VV
AD  - Research, Developing and Training Centre of Molecular Microbiology and Mucosal
      Immunology, Uzhhorod National University, Uzhhorod, Ukraine
FAU - Meleshko, Tamara V.
AU  - Meleshko TV
AD  - Research, Developing and Training Centre of Molecular Microbiology and Mucosal
      Immunology, Uzhhorod National University, Uzhhorod, Ukraine
FAU - Levchuk, Olga B.
AU  - Levchuk OB
AD  - Research, Developing and Training Centre of Molecular Microbiology and Mucosal
      Immunology, Uzhhorod National University, Uzhhorod, Ukraine
FAU - Boyko, Nadiya V.
AU  - Boyko NV
AD  - Research, Developing and Training Centre of Molecular Microbiology and Mucosal
      Immunology, Uzhhorod National University, Uzhhorod, Ukraine
FAU - Bauer, Joanna
AU  - Bauer J
AD  - Department of Biomedical Engineering, Wroclaw University of Technology, Wroclaw, 
      Poland
FAU - Boerner, Ewa
AU  - Boerner E
AD  - Faculty of Physiotherapy, Wrocław University School of Physical Education,
      Wroclaw, Poland
FAU - Podbielska, Halina
AU  - Podbielska H
AD  - Department of Biomedical Engineering, Wroclaw University of Technology, Wroclaw, 
      Poland
FAU - Bomba, Alojz
AU  - Bomba A
AD  - Pavol Jozef Šafárik University, Košice, Slovakia
FAU - Petrov, Viktor O.
AU  - Petrov VO
AD  - Uzhhorod National University, Uzhhorod, Ukraine
FAU - Drobnych, Volodymyr G.
AU  - Drobnych VG
AD  - Uzhhorod National University, Uzhhorod, Ukraine
FAU - Bubnov, Rostyslav V.
AU  - Bubnov RV
AD  - Clinical Hospital “Pheophania” of State Affairs Department, The Centre of
      Ultrasound Diagnostics and Interventional Sonography, Kyiv, Ukraine
FAU - Bykova, Oksana M.
AU  - Bykova OM
AD  - Association “Health and Wealth”, Kyiv, Ukraine
FAU - Boyko, Nadiya V.
AU  - Boyko NV
AD  - Cassovia Life Science, Kysucké Nové Mesto, Slovakia
FAU - Brunner-La Rocca, Hans-Peter
AU  - Brunner-La Rocca HP
AD  - Maastricht University Medical Centre, Maastricht, The Netherlands
FAU - Fleischhacker, Lutz
AU  - Fleischhacker L
AD  - Fleischhacker GmbH, Schwerte, Germany
FAU - Golubnitschaja, Olga
AU  - Golubnitschaja O
AD  - The European Association for Predictive, Preventive and Personalised Medicine,
      Brussels, Belgium
FAU - Heemskerk, Frank
AU  - Heemskerk F
AD  - RIMS bvba, Overijse, Belgium
FAU - Helms, Thomas
AU  - Helms T
AD  - German Foundation For the Chronically Ill, Fürth, Germany
FAU - Jaarsma, Tiny
AU  - Jaarsma T
AD  - Linköping University, Norrköping, Sweden
FAU - Kinkorová, Judita
AU  - Kinkorová J
AD  - Medical Faculty Pilsen, Pilsen, Czech Republic
FAU - Ramaekers, Jan
AU  - Ramaekers J
AD  - Sananet Care BV, Sittard, The Netherlands
FAU - Ruff, Peter
AU  - Ruff P
AD  - Exploris AG, Zürich, Switzerland
FAU - Schnur, Ivana
AU  - Schnur I
AD  - sense.ly, San Francisco, USA
FAU - Vanoli, Emilio
AU  - Vanoli E
AD  - Mulimedica SPA, Milano, Italy
FAU - Verdu, Jose
AU  - Verdu J
AD  - Medtronic Iberica SA, Madrid, Spain
FAU - Brunner-La Rocca, Hans-Peter
AU  - Brunner-La Rocca HP
AD  - Maastricht University Medical Centre, Maastricht, The Netherlands
FAU - Bubnov, Rostyslav V.
AU  - Bubnov RV
AD  - Clinical Hospital “Pheophania” of State Affairs Department, Zabolotny Str., 21,
      Kyiv, 03680 Ukraine
FAU - Grabovetskyi, Sergiy A.
AU  - Grabovetskyi SA
AD  - Clinical Hospital “Pheophania” of State Affairs Department, Zabolotny Str., 21,
      Kyiv, 03680 Ukraine
FAU - Mykhalchenko, Olena M.
AU  - Mykhalchenko OM
AD  - Clinical Hospital “Pheophania” of State Affairs Department, Zabolotny Str., 21,
      Kyiv, 03680 Ukraine
FAU - Tymoshok, Natalia O.
AU  - Tymoshok NO
AD  - Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of
      Ukraine, 154, Zabolotny st., Kyiv, 03680 Ukraine
FAU - Shcherbakov, Oleksandr B.
AU  - Shcherbakov OB
AD  - Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of
      Ukraine, 154, Zabolotny st., Kyiv, 03680 Ukraine
FAU - Semeniv, Igor P.
AU  - Semeniv IP
AD  - Clinical Hospital “Pheophania” of State Affairs Department, Zabolotny Str., 21,
      Kyiv, 03680 Ukraine
FAU - Spivak, Mykola Y.
AU  - Spivak MY
AD  - Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of
      Ukraine, 154, Zabolotny st., Kyiv, 03680 Ukraine
FAU - Bubnov, Rostyslav V.
AU  - Bubnov RV
AD  - Centre of Ultrasound Clinical Hospital “Pheophania” of State Affairs Department, 
      Zabolotny Str., 21, Kyiv, 03680 Ukraine
FAU - Ostapenko, Tetyana V.
AU  - Ostapenko TV
AD  - Endocrinology centre, Clinical Hospital “Pheophania” of State Affairs Department,
      Zabolotny Str., 21, Kyiv, 03680 Ukraine
FAU - Bubnov, Rostyslav V.
AU  - Bubnov RV
AD  - Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of
      Ukraine, Zabolotny Str., 154, Kyiv, 03680 Ukraine
FAU - Kobyliak, Nazarii M.
AU  - Kobyliak NM
AD  - Bogomolets National Medical University, T. Shevchenko boulevard, 13, Kyiv, 01601 
      Ukraine
FAU - Zholobak, Nadiya M.
AU  - Zholobak NM
AD  - Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of
      Ukraine, Zabolotny Str., 154, Kyiv, 03680 Ukraine
FAU - Spivak, Mykola Ya.
AU  - Spivak MY
AD  - Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of
      Ukraine, Zabolotny Str., 154, Kyiv, 03680 Ukraine
FAU - Cauchi, John Paul
AU  - Cauchi JP
AD  - Department of Physiology and Biochemistry, University of Malta, Msida, Malta
FAU - Cherepakhin, Dmitrii
AU  - Cherepakhin D
AD  - First Moscow State Medical University, Moscow, Russia
FAU - Bakay, Marina
AU  - Bakay M
AD  - The Children’s Hospital of Philadelphia, Philadelphia, USA
FAU - Borovikov, Artem
AU  - Borovikov A
AD  - First Moscow State Medical University, Moscow, Russia
FAU - Suchkov, Sergey
AU  - Suchkov S
AD  - First Moscow State Medical University, Moscow, Russia
FAU - Cieślik, Barbara
AU  - Cieślik B
AD  - Faculty of Physiotherapy, Wroclaw University School of Physical Education,
      Wroclaw, Poland
FAU - Migasiewicz, Agnieszka
AU  - Migasiewicz A
AD  - Faculty of Physiotherapy, Wroclaw University School of Physical Education,
      Wroclaw, Poland
FAU - Podbielska, Maria-Luiza
AU  - Podbielska ML
AD  - Inwestasekur, Wroclaw, Poland
FAU - Pelleter, Markus
AU  - Pelleter M
AD  - VIANESSE AG, Research and Development, Engelberg, Switzerland
FAU - Giemza, Agnieszka
AU  - Giemza A
AD  - VIANESSE AG, Research and Development, Engelberg, Switzerland
FAU - Podbielska, Halina
AU  - Podbielska H
AD  - Faculty of Physiotherapy, Wroclaw University School of Physical Education,
      Wroclaw, Poland
FAU - Cirak, Sebahattin
AU  - Cirak S
AD  - Center for Molecular Medicine, University Hospital Cologne, Cologne, Germany
FAU - Del Re, Marzia
AU  - Del Re M
AD  - Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and
      Experimental Medicine, University of Pisa, Pisa, Italy
FAU - Bordi, Paola
AU  - Bordi P
AD  - Medical Oncology Unit, University Hospital of Parma, Parma, Italy
FAU - Citi, Valentina
AU  - Citi V
AD  - Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and
      Experimental Medicine, University of Pisa, Pisa, Italy
FAU - Palombi, Marta
AU  - Palombi M
AD  - Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and
      Experimental Medicine, University of Pisa, Pisa, Italy
FAU - Pinto, Carmine
AU  - Pinto C
AD  - Medical Oncology Unit, University Hospital of Parma, Parma, Italy
FAU - Tiseo, Marcello
AU  - Tiseo M
AD  - Medical Oncology Unit, University Hospital of Parma, Parma, Italy
FAU - Danesi, Romano
AU  - Danesi R
AD  - Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and
      Experimental Medicine, University of Pisa, Pisa, Italy
FAU - Einhorn, Lukas
AU  - Einhorn L
AD  - Comparative Medicine, Messerli Research Institute of the University of Veterinary
      Medicine Vienna, Medical University Vienna and University Vienna, Vienna, Austria
FAU - Fazekas, Judit
AU  - Fazekas J
AD  - Comparative Medicine, Messerli Research Institute of the University of Veterinary
      Medicine Vienna, Medical University Vienna and University Vienna, Vienna, Austria
FAU - Muhr, Martina
AU  - Muhr M
AD  - Comparative Medicine, Messerli Research Institute of the University of Veterinary
      Medicine Vienna, Medical University Vienna and University Vienna, Vienna, Austria
FAU - Schoos, Alexandra
AU  - Schoos A
AD  - Comparative Medicine, Messerli Research Institute of the University of Veterinary
      Medicine Vienna, Medical University Vienna and University Vienna, Vienna, Austria
FAU - Panakova, Lucia
AU  - Panakova L
AD  - Department for Companion Animals and Horses, University of Veterinary Medicine
      Vienna, Vienna, Austria
FAU - Herrmann, Ina
AU  - Herrmann I
AD  - Department for Companion Animals and Horses, University of Veterinary Medicine
      Vienna, Vienna, Austria
FAU - Manzano-Szalai, Krisztina
AU  - Manzano-Szalai K
AD  - Comparative Medicine, Messerli Research Institute of the University of Veterinary
      Medicine Vienna, Medical University Vienna and University Vienna, Vienna, Austria
FAU - Oida, Kumiko
AU  - Oida K
AD  - Comparative Medicine, Messerli Research Institute of the University of Veterinary
      Medicine Vienna, Medical University Vienna and University Vienna, Vienna, Austria
FAU - Fiebiger, Edda
AU  - Fiebiger E
AD  - Division of Gastroenterology and Nutrition, Boston Children’s Hospital and
      Department of Pediatrics, Harvard Medical School, Boston, USA
FAU - Singer, Josef
AU  - Singer J
AD  - Comparative Immunology and Oncology, Institute for Pathophysiology and Allergy
      Research, Center of Pathophysiology, Infectiology and Immunology, Medical
      University of Vienna, Vienna, Austria
FAU - Jensen-Jarolim, Erika
AU  - Jensen-Jarolim E
AD  - Comparative Medicine, Messerli Research Institute of the University of Veterinary
      Medicine Vienna, Medical University Vienna and University Vienna, Vienna, Austria
FAU - Elnar, Arpiné A.
AU  - Elnar AA
AD  - Université de Lorraine, Metz, France
FAU - Ouamara, Nadia
AU  - Ouamara N
AD  - CHR Metz-Thionville, Pôle mère-enfant, Metz, France
FAU - Boyko, Nadiya
AU  - Boyko N
AD  - Cassovia Life Sciences, Research and Innovation, Košice, Slovakia
FAU - Coumoul, Xavier
AU  - Coumoul X
AD  - Université Paris Descartes, Paris, France
FAU - Antignac, Jean-Philippe
AU  - Antignac JP
AD  - Ecole Nationale Vétérinaire, Agroalimentaire et de l’Alimentation, Nantes, France
FAU - Le Bizec, Bruno
AU  - Le Bizec B
AD  - Ecole Nationale Vétérinaire, Agroalimentaire et de l’Alimentation, Nantes, France
FAU - Eppe, Gauthier
AU  - Eppe G
AD  - Université de Liège, Liège, Belgium
FAU - Renaut, Jenny
AU  - Renaut J
AD  - Luxembourg Institute of Sciences and Technology, Belvaux, Luxembourg
FAU - Bonn, Torsten
AU  - Bonn T
AD  - Luxembourg Institute of Sciences and Technology, Belvaux, Luxembourg
FAU - Guignard, Cédric
AU  - Guignard C
AD  - Luxembourg Institute of Sciences and Technology, Belvaux, Luxembourg
FAU - Ferrante, Margherita
AU  - Ferrante M
AD  - University of Catania, Catania, Italy
FAU - Chiusano, Maria Liusa
AU  - Chiusano ML
AD  - University Federico II of Naples, Naples, Italy
FAU - Cuzzocrea, Salvatore
AU  - Cuzzocrea S
AD  - University of Messina, Messina, Italy
FAU - O’Keeffe, Gerard
AU  - O’Keeffe G
AD  - University College Cork, Cork, Ireland
FAU - Cryan, John
AU  - Cryan J
AD  - University College Cork, Cork, Ireland
FAU - Bisson, Michelle
AU  - Bisson M
AD  - Institut National de l’Environnement Industriel et des Risques, Paris, France
FAU - Barakat, Amina
AU  - Barakat A
AD  - University Hospital, Rabat, Morocco
FAU - Hmamouchi, Ihsane
AU  - Hmamouchi I
AD  - University Hospital, Rabat, Morocco
FAU - Zawia, Nasser
AU  - Zawia N
AD  - University of Rhodes Island, Rhodes Island, USA
FAU - Kanthasamy, Anumantha
AU  - Kanthasamy A
AD  - Iowa State University, Ames, IA USA
FAU - Kisby, Glen E.
AU  - Kisby GE
AD  - Western University of Health Sciences, Oregon, USA
FAU - Alves, Rui
AU  - Alves R
AD  - Biomedical Research Institute of Lleida, Lleida, Catalunya Spain
FAU - Pérez, Oscar Villacañas
AU  - Pérez OV
AD  - CEO - Owner at Intelligent Pharma, Barcelona, Spain
FAU - Burgard, Kim
AU  - Burgard K
AD  - Laboratoires Réunis, Luxembourg, Luxembourg
FAU - Spencer, Peter
AU  - Spencer P
AD  - Oregon Health & Science University, Oregon, USA
FAU - Bomba, Norbert
AU  - Bomba N
AD  - PAMIDA International, Kysucké Nové Mesto, Slovakia
FAU - Haranta, Martin
AU  - Haranta M
AD  - PAMIDA International, Kysucké Nové Mesto, Slovakia
FAU - Zaitseva, Nina
AU  - Zaitseva N
AD  - University of Perm, Perm, Russia
FAU - May, Irina
AU  - May I
AD  - University of Perm, Perm, Russia
FAU - Grojean, Stéphanie
AU  - Grojean S
AD  - European Drug Development Hub, Nancy, France
FAU - Body-Malapel, Mathilde
AU  - Body-Malapel M
AD  - Université de Lille II Droit et Santé, Lille, France
FAU - Harari, Florencia
AU  - Harari F
AD  - Institute for Production and Work Environment Development, Quito, Ecuador
FAU - Harari, Raul
AU  - Harari R
AD  - Institute for Production and Work Environment Development, Quito, Ecuador
FAU - Yeghiazaryan, Kristina
AU  - Yeghiazaryan K
AD  - European Association for Predictive and Personalised Medicine, Brussels, Belgium
FAU - Golubnitschaja, Olga
AU  - Golubnitschaja O
AD  - European Association for Predictive and Personalised Medicine, Brussels, Belgium
FAU - Calabrese, Vittorio
AU  - Calabrese V
AD  - University of Catania, Catania, Italy
FAU - Nemos, Christophe
AU  - Nemos C
AD  - Université de Lorraine, Metz, France
FAU - Soulimani, Rachid
AU  - Soulimani R
AD  - Université de Lorraine, Metz, France
FAU - Evsevyeva, Maria E.
AU  - Evsevyeva ME
AD  - Stavropol State Medical University, Stavropol, Russia
FAU - Mishenko, Elena A.
AU  - Mishenko EA
AD  - Stavropol State Medical University, Stavropol, Russia
FAU - Kumukova, Zurida V.
AU  - Kumukova ZV
AD  - Stavropol State Medical University, Stavropol, Russia
FAU - Chudnovsky, Evgeniy V.
AU  - Chudnovsky EV
AD  - Stavropol State Medical University, Stavropol, Russia
FAU - Smirnova, Tatyana A.
AU  - Smirnova TA
AD  - Stavropol State Medical University, Stavropol, Russia
FAU - Evsevyeva, Maria E.
AU  - Evsevyeva ME
AD  - Stavropol State Medical University, Stavropol, Russian Federation
FAU - Ivanova, Ludmila V.
AU  - Ivanova LV
AD  - Stavropol State Medical University, Stavropol, Russian Federation
FAU - Eremin, Michail V.
AU  - Eremin MV
AD  - Stavropol State Medical University, Stavropol, Russian Federation
FAU - Rostovtseva, Maria V.
AU  - Rostovtseva MV
AD  - Stavropol State Medical University, Stavropol, Russian Federation
FAU - Evsevyeva, Maria E.
AU  - Evsevyeva ME
AD  - Stavropol State Medical University, Stavropol, Russian Federation
FAU - Eremin, Michail V.
AU  - Eremin MV
AD  - Stavropol State Medical University, Stavropol, Russian Federation
FAU - Koshel, Vladimir I.
AU  - Koshel VI
AD  - Stavropol State Medical University, Stavropol, Russian Federation
FAU - Sergeeva, Oksana V.
AU  - Sergeeva OV
AD  - Stavropol State Medical University, Stavropol, Russian Federation
FAU - Konovalova, Nadesgda M.
AU  - Konovalova NM
AD  - Stavropol State Medical University, Stavropol, Russian Federation
FAU - Girotra, Shantanu
AU  - Girotra S
AD  - Department of Radiology, University of Bonn, Bonn, Germany
FAU - Golubnitschaja, Olga
AU  - Golubnitschaja O
AD  - Department of Radiology, University of Bonn, Bonn, Germany
FAU - Golubnitschaja, Olga
AU  - Golubnitschaja O
AD  - Breast Cancer Research Centre, University of Bonn, Bonn, Germany
FAU - Debald, Manuel
AU  - Debald M
AD  - Breast Cancer Research Centre, University of Bonn, Bonn, Germany
FAU - Kuhn, Walther
AU  - Kuhn W
AD  - Breast Cancer Research Centre, University of Bonn, Bonn, Germany
FAU - Yeghiazaryan, Kristina
AU  - Yeghiazaryan K
AD  - Breast Cancer Research Centre, University of Bonn, Bonn, Germany
FAU - Bubnov, Rostyslav V.
AU  - Bubnov RV
AD  - Clinical hospital “Pheophania” of State Affairs Department, Kyiv, Ukraine
FAU - Goncharenko, Vadym M.
AU  - Goncharenko VM
AD  - Clinical hospital “Pheophania” of State Affairs Department, Kyiv, Ukraine
FAU - Lushchyk, Ulyana
AU  - Lushchyk U
AD  - Clinical hospital “Pheophania” of State Affairs Department, Kyiv, Ukraine
FAU - Grech, Godfrey
AU  - Grech G
AD  - University of Malta, Msida, Malta
FAU - Konieczka, Katarzyna
AU  - Konieczka K
AD  - Department of Ophthalmology, University of Basel, Basel, Switzerland
FAU - Golubnitschaja, Olga
AU  - Golubnitschaja O
AD  - Department of Radiology, University of Bonn, Bonn, Germany
FAU - Erwich, Jan Jaap
AU  - Erwich JJ
AD  - University Medical Center Groningen, Groningen, The Netherlands
FAU - Costigliola, Vincenzo
AU  - Costigliola V
AD  - European Association for Predictive, Preventive and Personalised Medicine (EPMA),
      Brussels, Belgium
FAU - Yeghiazaryan, Kristina
AU  - Yeghiazaryan K
AD  - Department of Radiology, University of Bonn, Bonn, Germany
FAU - Gembruch, Ulrich
AU  - Gembruch U
AD  - Department of Gynaecology and Obstetrics, University of Bonn, Bonn, Germany
FAU - Goncharenko, Vadym M.
AU  - Goncharenko VM
AD  - Clinical Hospital ‘Pheophania’ of State Affairs Department, Zabolotny str., 21,
      Kyiv, 03680 Ukraine
FAU - Beniuk, Vasyl O.
AU  - Beniuk VO
AD  - Bogomolets National Medical University, Kyiv, 01601 Ukraine
FAU - Kalenska, Olga V.
AU  - Kalenska OV
AD  - Clinical Hospital ‘Pheophania’ of State Affairs Department, Zabolotny str., 21,
      Kyiv, 03680 Ukraine
FAU - Bubnov, Rostyslav V.
AU  - Bubnov RV
AD  - Clinical Hospital ‘Pheophania’ of State Affairs Department, Zabolotny str., 21,
      Kyiv, 03680 Ukraine
FAU - Goncharenko, Vadym M.
AU  - Goncharenko VM
AD  - Bogomolets National Medical University, Kyiv, 01601 Ukraine
FAU - Beniuk, Vasyl O.
AU  - Beniuk VO
AD  - Bogomolets National Medical University, Kyiv, 01601 Ukraine
FAU - Bubnov, Rostyslav V.
AU  - Bubnov RV
AD  - Clinical Hospital ‘Pheophania’ of State Affairs Department, Zabolotny str., 21,
      Kyiv, 03680 Ukraine
FAU - Melnychuk, Olga
AU  - Melnychuk O
AD  - Bogomolets National Medical University, Kyiv, 01601 Ukraine
FAU - Gorbacheva, Irina A.
AU  - Gorbacheva IA
AD  - St. Petersburg Periodontal Center “PAKS”, Pavlov First Saint Petersburg State
      Medical University, Saint Petersburg, Russia
FAU - Orekhova, Lyudmila Y.
AU  - Orekhova LY
AD  - St. Petersburg Periodontal Center “PAKS”, Pavlov First Saint Petersburg State
      Medical University, Saint Petersburg, Russia
FAU - Tachalov, Vadim V.
AU  - Tachalov VV
AD  - St. Petersburg Periodontal Center “PAKS”, Pavlov First Saint Petersburg State
      Medical University, Saint Petersburg, Russia
FAU - Grechanyk, Olena I.
AU  - Grechanyk OI
AD  - Main Ukrainian Military Clinical Hospital #17 in Kyiv, Gospitalna str., 18, Kyiv,
      Ukraine
FAU - Abdullaiev, Rizvan Ya.
AU  - Abdullaiev RY
AD  - Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine
FAU - Bubnov, Rostyslav V.
AU  - Bubnov RV
AD  - Clinical Hospital “Pheophania” of State Affairs Department, Zabolotny Str., 21,
      Kyiv, 03680 Ukraine
FAU - Hagan, Suzanne
AU  - Hagan S
AD  - Vision Sciences, School of Health and Life Sciences, Glasgow Caledonian
      University, Glasgow, Scotland UK
FAU - Martin, Eilidh
AU  - Martin E
AD  - Vision Sciences, School of Health and Life Sciences, Glasgow Caledonian
      University, Glasgow, Scotland UK
FAU - Pearce, Ian
AU  - Pearce I
AD  - Vision Sciences, School of Health and Life Sciences, Glasgow Caledonian
      University, Glasgow, Scotland UK
FAU - Oliver, Katherine
AU  - Oliver K
AD  - Vision Sciences, School of Health and Life Sciences, Glasgow Caledonian
      University, Glasgow, Scotland UK
FAU - Haytac, Cenk
AU  - Haytac C
AD  - Cukurova University, Faculty of Dentistry, Adana, Turkey
FAU - Salimov, Fariz
AU  - Salimov F
AD  - Cukurova University, Faculty of Dentistry, Adana, Turkey
FAU - Yoksul, Servin
AU  - Yoksul S
AD  - Cukurova University, Faculty of Dentistry, Adana, Turkey
FAU - Kunin, Anatoly A.
AU  - Kunin AA
AD  - Voronezh N.N. Burdenko State Medical University, Voronezh, Russia
FAU - Moiseeva, Natalia S.
AU  - Moiseeva NS
AD  - Voronezh N.N. Burdenko State Medical University, Voronezh, Russia
FAU - Herrera-Imbroda, Bernardo
AU  - Herrera-Imbroda B
AD  - Intercenter Urology Unit, Virgen de la Victoria University Hospital, Málaga,
      Spain
FAU - del Río-González, Sergio
AU  - del Río-González S
AD  - Intercenter Urology Unit, Virgen de la Victoria University Hospital, Málaga,
      Spain
FAU - Lara, Maria Fernanda
AU  - Lara MF
AD  - Intercenter Urology Unit, Virgen de la Victoria University Hospital, Málaga,
      Spain
FAU - Angulo, Antonia
AU  - Angulo A
AD  - Myriad Genetics España S.L.U, Madrid, Spain
FAU - Machuca Santa-Cruz, Francisco Javier
AU  - Machuca Santa-Cruz FJ
AD  - Intercenter Urology Unit, Virgen de la Victoria University Hospital, Málaga,
      Spain
FAU - Herrera-Imbroda, Bernardo
AU  - Herrera-Imbroda B
AD  - Intercenter Urology Unit, Virgen de la Victoria University Hospital, Málaga,
      Spain
FAU - del Río-González, Sergio
AU  - del Río-González S
AD  - Intercenter Urology Unit, Virgen de la Victoria University Hospital, Málaga,
      Spain
FAU - Lara, Maria Fernanda
AU  - Lara MF
AD  - Intercenter Urology Unit, Virgen de la Victoria University Hospital, Málaga,
      Spain
FAU - Ionescu, John
AU  - Ionescu J
AD  - Spezialklinik Neukirchen, Neukirchen beim Heiligen Blut, Germany
FAU - Isamulaeva, Alfiya Z.
AU  - Isamulaeva AZ
AD  - Department of Therapeutic Dentistry Medical University “Astrakhan State Medical
      Academy” Russian Ministry of Health, 121 Bakinskaya St., Astrakhan, 414000 Russia
FAU - Kunin, Anatoly A.
AU  - Kunin AA
AD  - Faculty of Dentistry Medical University “Voronezh State Medical Academy” of the
      Ministry of Health of the Russian Federation n.a. N.N. Burdenko, Institute of
      Dentistry at VGMA n.a. N.N. Burdenko, 14 pr. Revolyutsii, Voronezh, 394000 Russia
FAU - Magomedov, Shamil Sh.
AU  - Magomedov SS
AD  - Department of Therapeutic Stomatology, Medical University “Astrakhan State
      Medical University” the Ministry of Health of Russia, 121 Bakinskaya St.,
      Astrakhan, 414000 Russia
FAU - Isamulaeva, Aida I.
AU  - Isamulaeva AI
AD  - Faculty of Dentistry Medical University “Astrakhan State Medical Academy”, the
      Ministry of Health of Russia, Russia, 121 Bakinskaya St., Astrakhan, 414000
      Russia
FAU - Josifova, Tatjana
AU  - Josifova T
AD  - Augenzentrum Fankhauser, Bern, Switzerland
FAU - Kapalla, Marko
AU  - Kapalla M
AD  - European Association for Predictive, Preventive and Personalised Medicine (EPMA),
      Brussels, Belgium
FAU - Kubáň, Juraj
AU  - Kubáň J
AD  - European Association for Predictive, Preventive and Personalised Medicine (EPMA),
      Brussels, Belgium
FAU - Golubnitschaja, Olga
AU  - Golubnitschaja O
AD  - European Association for Predictive, Preventive and Personalised Medicine (EPMA),
      Brussels, Belgium
FAU - Costigliola, Vincenzo
AU  - Costigliola V
AD  - European Association for Predictive, Preventive and Personalised Medicine (EPMA),
      Brussels, Belgium
FAU - Costigliola, Vincenzo
AU  - Costigliola V
AD  - European Association for Predictive, Preventive and Personalised Medicine (EPMA),
      Brussels, Belgium
FAU - Kapalla, Marko
AU  - Kapalla M
AD  - European Association for Predictive, Preventive and Personalised Medicine (EPMA),
      Brussels, Belgium
FAU - Kubáň, Juraj
AU  - Kubáň J
AD  - European Association for Predictive, Preventive and Personalised Medicine (EPMA),
      Brussels, Belgium
FAU - Golubnitschaja, Olga
AU  - Golubnitschaja O
AD  - European Association for Predictive, Preventive and Personalised Medicine (EPMA),
      Brussels, Belgium
FAU - Kent, Anthony
AU  - Kent A
AD  - School of Art and Design, Nottingham Trent University, Nottingham, UK
FAU - Fisher, Tom
AU  - Fisher T
AD  - School of Art and Design, Nottingham Trent University, Nottingham, UK
FAU - Dias, Tilak
AU  - Dias T
AD  - School of Art and Design, Nottingham Trent University, Nottingham, UK
FAU - Kinkorová, Judita
AU  - Kinkorová J
AD  - Faculty Hospital in Pilsen, Charles University Medical Faculty in Pilsen, Pilsen,
      Czech Republic
FAU - Topolčan, Ondřej
AU  - Topolčan O
AD  - Faculty Hospital in Pilsen, Charles University Medical Faculty in Pilsen, Pilsen,
      Czech Republic
FAU - Kohl, Matthias
AU  - Kohl M
AD  - Department of Medical and Life Sciences, Furtwangen University,
      Villingen-Schwenningen, Germany
FAU - Kunin, Anatoly A.
AU  - Kunin AA
AD  - Voronezh N.N. Burdenko State Medical University, Voronezh, Russia
FAU - Moiseeva, Natalia S.
AU  - Moiseeva NS
AD  - Voronezh N.N. Burdenko State Medical University, Voronezh, Russia
FAU - Kurchenko, Andrii I.
AU  - Kurchenko AI
AD  - Bogomolets National Medical University, Kyiv, 01601 Ukraine
FAU - Beniuk, Vasyl A.
AU  - Beniuk VA
AD  - Bogomolets National Medical University, Kyiv, 01601 Ukraine
FAU - Goncharenko, Vadym M.
AU  - Goncharenko VM
AD  - Bogomolets National Medical University, Kyiv, 01601 Ukraine
FAU - Bubnov, Rostyslav V.
AU  - Bubnov RV
AD  - Clinical Hospital ‘Pheophania’ of State Affairs Department, Zabolotny str., 21,
      Kyiv, 03680 Ukraine
FAU - Boyko, Nadiya V.
AU  - Boyko NV
AD  - Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of
      Ukraine, Zabolotny Str., 154, Kyiv, 03680 Ukraine
FAU - Strokan, Andriy M.
AU  - Strokan AM
AD  - Clinical Hospital ‘Pheophania’ of State Affairs Department, Zabolotny str., 21,
      Kyiv, 03680 Ukraine
FAU - Kzhyshkowska, Julia
AU  - Kzhyshkowska J
AD  - Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim,
      Heidelberg University, Mannheim, Germany
FAU - Gudima, Alexandru
AU  - Gudima A
AD  - Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim,
      Heidelberg University, Mannheim, Germany
FAU - Stankevich, Ksenia S.
AU  - Stankevich KS
AD  - Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim,
      Heidelberg University, Mannheim, Germany
FAU - Filimonov, Victor D.
AU  - Filimonov VD
AD  - National Research Tomsk Polytechnic University, Tomsk, Russia
FAU - Klüter, Harald
AU  - Klüter H
AD  - Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim,
      Heidelberg University, Mannheim, Germany
FAU - Mamontova, Evgeniya M.
AU  - Mamontova EM
AD  - National Research Tomsk Polytechnic University, Tomsk, Russia
FAU - Tverdokhlebov, Sergei I.
AU  - Tverdokhlebov SI
AD  - National Research Tomsk Polytechnic University, Tomsk, Russia
FAU - Lushchyk, Ulyana B.
AU  - Lushchyk UB
AD  - Istyna-Veritas Research Center, Kyiv, Ukraine
FAU - Novytskyy, Viktor V.
AU  - Novytskyy VV
AD  - Institute of Mathematics of NAS of Ukraine, Kyiv, Ukraine
FAU - Babii, Igor P.
AU  - Babii IP
AD  - Clinic of Healthy Vessels, Kyiv, Ukraine
FAU - Lushchyk, Nadiya G.
AU  - Lushchyk NG
AD  - Medical center “Ukrainian medical innovations”, Ternopil, Ukraine
FAU - Riabets, Lyudmyla S.
AU  - Riabets LS
AD  - Veritas IT Med Center for Innovative Medical Technologies, 4 Williams Str., Kyiv,
      03191 Ukraine
FAU - Legka, Ivanna I.
AU  - Legka II
AD  - Specialized clinic “Vessels, brain, neurorehabilitation”, Muscat, Oman
FAU - Marcus-Kalish, Mira
AU  - Marcus-Kalish M
AD  - Department of Statistics and Operations Research, the Sackler Faculty of Exact
      Sciences, the Sagol School of Neurosciences, Tel Aviv University, Tel Aviv,
      Israel
FAU - Mitelpunkt, Alexis
AU  - Mitelpunkt A
AD  - Department of Statistics and Operations Research, the Sackler Faculty of Exact
      Sciences, the Sagol School of Neurosciences, Tel Aviv University, Tel Aviv,
      Israel
FAU - Galili, Tal
AU  - Galili T
AD  - Department of Statistics and Operations Research, the Sackler Faculty of Exact
      Sciences, the Sagol School of Neurosciences, Tel Aviv University, Tel Aviv,
      Israel
FAU - Shachar, Neta
AU  - Shachar N
AD  - Department of Statistics and Operations Research, the Sackler Faculty of Exact
      Sciences, the Sagol School of Neurosciences, Tel Aviv University, Tel Aviv,
      Israel
FAU - Benjamini, Yoav
AU  - Benjamini Y
AD  - Department of Statistics and Operations Research, the Sackler Faculty of Exact
      Sciences, the Sagol School of Neurosciences, Tel Aviv University, Tel Aviv,
      Israel
FAU - Migasiewicz, Agnieszka
AU  - Migasiewicz A
AD  - Wroclaw University School of Physical Education, Faculty of Physiotherapy,
      Wroclaw, Poland
FAU - Pelleter, Markus
AU  - Pelleter M
AD  - VIANESSE AG, Research and Development, Engelberg, Switzerland
FAU - Bauer, Joanna
AU  - Bauer J
AD  - Wroclaw University of Technology, Department of Biomedical Engineering, Wroclaw, 
      Poland
FAU - Dereń, Ewelina
AU  - Dereń E
AD  - Wroclaw University of Technology, Department of Biomedical Engineering, Wroclaw, 
      Poland
FAU - Podbielska, Halina
AU  - Podbielska H
AD  - Wroclaw University School of Physical Education, Faculty of Physiotherapy,
      Wroclaw, Poland
FAU - Moiseeva, Natalia S.
AU  - Moiseeva NS
AD  - Voronezh N.N. Burdenko State Medical University, Voronezh, Russia
FAU - Kunin, Anatoly A.
AU  - Kunin AA
AD  - Voronezh N.N. Burdenko State Medical University, Voronezh, Russia
FAU - Kunin, Dmitry A.
AU  - Kunin DA
AD  - Voronezh N.N. Burdenko State Medical University, Voronezh, Russia
FAU - Moiseeva, Natalia S.
AU  - Moiseeva NS
AD  - Voronezh N.N. Burdenko State Medical University, Voronezh, Russia
FAU - Ippolitov, Yury A.
AU  - Ippolitov YA
AD  - Voronezh N.N. Burdenko State Medical University, Voronezh, Russia
FAU - Kunin, Dmitry A.
AU  - Kunin DA
AD  - Voronezh N.N. Burdenko State Medical University, Voronezh, Russia
FAU - Morozov, Alexei N.
AU  - Morozov AN
AD  - Voronezh N.N. Burdenko State Medical University, Voronezh, Russia
FAU - Chirkova, Natalia V.
AU  - Chirkova NV
AD  - Voronezh N.N. Burdenko State Medical University, Voronezh, Russia
FAU - Aliev, Nakhid T.
AU  - Aliev NT
AD  - Voronezh N.N. Burdenko State Medical University, Voronezh, Russia
FAU - Mozaffari, Mahmood S.
AU  - Mozaffari MS
AD  - Department of Oral Biology, Georgia Regents University, Augusta, Georgia 30912
      USA
FAU - Liu, Jun Yao
AU  - Liu JY
AD  - Department of Oral Biology, Georgia Regents University, Augusta, Georgia 30912
      USA
FAU - Baban, Babak
AU  - Baban B
AD  - Department of Oral Biology, Georgia Regents University, Augusta, Georgia 30912
      USA
FAU - Mozaffari, Mahmood S.
AU  - Mozaffari MS
AD  - Department of Oral Biology, College of Dental Medicine, Georgia Regents
      University, Augusta, Georgia 30912 USA
FAU - Liu, Jun Yao
AU  - Liu JY
AD  - Department of Oral Biology, College of Dental Medicine, Georgia Regents
      University, Augusta, Georgia 30912 USA
FAU - Abdelsayed, Rafik
AU  - Abdelsayed R
AD  - Department of Oral Biology, College of Dental Medicine, Georgia Regents
      University, Augusta, Georgia 30912 USA
FAU - Shi, Xing-Ming
AU  - Shi XM
AD  - Department of Oral Biology, College of Dental Medicine, Georgia Regents
      University, Augusta, Georgia 30912 USA
FAU - Baban, Babak
AU  - Baban B
AD  - Department of Oral Biology, College of Dental Medicine, Georgia Regents
      University, Augusta, Georgia 30912 USA
FAU - Novák, Jaroslav
AU  - Novák J
AD  - Institute of Sports Medicine, Medical Faculty of Charles University, Plzeň, Czech
      Republic
FAU - Štork, Milan
AU  - Štork M
AD  - Faculty of Applied Electronics, Western-Bohemian University, Plzeň, Czech
      Republic
FAU - Zeman, Václav
AU  - Zeman V
AD  - Institute of Sports Medicine, Medical Faculty of Charles University, Plzeň, Czech
      Republic
FAU - Oosterhuis, Wytze P.
AU  - Oosterhuis WP
AD  - Atrium-Orbis, Department of Clinical Chemistry and Haematology, Heerlen, The
      Netherlands
FAU - Theodorsson, Elvar
AU  - Theodorsson E
AD  - Department of Clinical Chemistry, University Hospital, SE-581 85 Linköping,
      Sweden
FAU - Orekhova, Lyudmila Y.
AU  - Orekhova LY
AD  - Therapeutic Dentistry Department, Pavlov First Saint Petersburg State Medical
      University of the Ministry of Health of the Russian Federation, Saint Petersburg,
      Russia
FAU - Kudryavtseva, Tatyana V.
AU  - Kudryavtseva TV
AD  - Therapeutic Dentistry Department, Pavlov First Saint Petersburg State Medical
      University of the Ministry of Health of the Russian Federation, Saint Petersburg,
      Russia
FAU - Isaeva, Elena R.
AU  - Isaeva ER
AD  - General and Clinical Psychology Department, Pavlov First Saint Petersburg State
      Medical University of the Ministry of Health of the Russian Federation, Saint
      Petersburg, Russia
FAU - Tachalov, Vadim V.
AU  - Tachalov VV
AD  - Therapeutic Dentistry Department, Pavlov First Saint Petersburg State Medical
      University of the Ministry of Health of the Russian Federation, Saint Petersburg,
      Russia
FAU - Loboda, Ekaterina S.
AU  - Loboda ES
AD  - Therapeutic Dentistry Department, Pavlov First Saint Petersburg State Medical
      University of the Ministry of Health of the Russian Federation, Saint Petersburg,
      Russia
FAU - Pazzagli, Mario
AU  - Pazzagli M
AD  - Department of Clinical and Experimental Biomedical Sciences, University of
      Florence, Viale G. Pieraccini, 6, 50139 Florence, Italy
FAU - Malentacchi, Francesca
AU  - Malentacchi F
AD  - Department of Clinical and Experimental Biomedical Sciences, University of
      Florence, Viale G. Pieraccini, 6, 50139 Florence, Italy
FAU - Mancini, Irene
AU  - Mancini I
AD  - Department of Clinical and Experimental Biomedical Sciences, University of
      Florence, Viale G. Pieraccini, 6, 50139 Florence, Italy
FAU - Brandslund, Ivan
AU  - Brandslund I
AD  - Department of Biochemistry Faculty of Health Sciences, University of Southern
      Denmark, Vejle Hospital, Vejle, Denmark
FAU - Vermeersch, Pieter
AU  - Vermeersch P
AD  - Clinical Department of Laboratory Medicine, University Hospitals Leuven, Leuven, 
      Belgium
FAU - Schwab, Matthias
AU  - Schwab M
AD  - Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen,
      Germany
FAU - Marc, Janja
AU  - Marc J
AD  - Department of Clinical Biochemistry, Faculty of Pharmacy, University of
      Ljubljana, Ljubljana, Slovenia
FAU - van Schaik, Ron H. N.
AU  - van Schaik RHN
AD  - Department of Clinical Chemistry, Erasmus University Medical Centre, Rotterdam,
      The Netherlands
FAU - Siest, Gerard
AU  - Siest G
AD  - University of Lorraine, UMR ISERM U1122; IGE-PCV, Genetique Cardiovasculaire,
      Nancy, France
FAU - Theodorsson, Elvar
AU  - Theodorsson E
AD  - Division of Microbiology and Molecular Medicine, Department of Clinical,
      Experimental Medicine, Faculty of Health Sciences, Linköping University,
      Linköping, Sweden
FAU - Di Resta, Chiara
AU  - Di Resta C
AD  - Genomic Unit for the Diagnosis of Human Pathologies, Vita-Salute San Raffaele
      University, Milan, Italy
FAU - Pleva, Matus
AU  - Pleva M
AD  - Department of Electronics and Multimedia Communications, Faculty of Electrical
      Engineering and Informatics, Technical university of Kosice, Letná 9, Košice,
      Slovakia
FAU - Juhar, Jozef
AU  - Juhar J
AD  - Department of Electronics and Multimedia Communications, Faculty of Electrical
      Engineering and Informatics, Technical university of Kosice, Letná 9, Košice,
      Slovakia
FAU - Pleva, Matus
AU  - Pleva M
AD  - Department of Electronics and Multimedia Communications, Faculty of Electrical
      Engineering and Informatics, Technical university of Kosice, Letná 9, Košice,
      Slovakia
FAU - Juhar, Jozef
AU  - Juhar J
AD  - Department of Electronics and Multimedia Communications, Faculty of Electrical
      Engineering and Informatics, Technical university of Kosice, Letná 9, Košice,
      Slovakia
FAU - Polívka jr., Jiří
AU  - Polívka jr. J
AD  - Department of Histology and Embryology in Plzen, Charles University in Prague,
      Plzen, Czech Republic
FAU - Janků, Filip
AU  - Janků F
AD  - Department of Investigational Cancer Therapeutics, The University of Texas MD
      Anderson Cancer Center, Houston, USA
FAU - Pešta, Martin
AU  - Pešta M
AD  - Department of Biology, Faculty of Medicine in Plzen, Charles University in Prague
      and Faculty Hospital Plzen, Plzen, Czech Republic
FAU - Doležal, Jan
AU  - Doležal J
AD  - Department of Surgery, Faculty of Medicine in Plzen, Charles University in Prague
      and Faculty Hospital Plzen, Plzen, Czech Republic
FAU - Králíčková, Milena
AU  - Králíčková M
AD  - Department of Histology and Embryology in Plzen, Charles University in Prague,
      Plzen, Czech Republic
FAU - Polívka, Jiří
AU  - Polívka J
AD  - Department of Neurology, Faculty of Medicine in Plzen, Charles University in
      Prague and Faculty Hospital Plzen, Plzen, Czech Republic
FAU - Polívka, Jiří
AU  - Polívka J
AD  - University Hospital Plzen and Faculty of Medicine in Plzen, Charles University in
      Prague, Department of Neurology, Plzen, Czech Republic
FAU - Lukešová, Alena
AU  - Lukešová A
AD  - University Hospital Plzen and Faculty of Medicine in Plzen, Charles University in
      Prague, Department of Neurology, Plzen, Czech Republic
FAU - Müllerová, Nina
AU  - Müllerová N
AD  - University Hospital Plzen, Department of Quality Assessment, Plzen, Czech
      Republic
FAU - Ševčík, Petr
AU  - Ševčík P
AD  - University Hospital Plzen and Faculty of Medicine in Plzen, Charles University in
      Prague, Department of Neurology, Plzen, Czech Republic
FAU - Rohan, Vladimír
AU  - Rohan V
AD  - University Hospital Plzen and Faculty of Medicine in Plzen, Charles University in
      Prague, Department of Neurology, Plzen, Czech Republic
FAU - Richter, Kneginja
AU  - Richter K
AD  - University Clinic for Psychiatry and Psychotherapy, Paracelsus Private Medical
      University, Nuremberg, Germany
FAU - Miloseva, Lence
AU  - Miloseva L
AD  - Faculty for Medical Sciences, University Goce Delcev, Stip, Macedonia
FAU - Niklewski, Günter
AU  - Niklewski G
AD  - University Clinic for Psychiatry and Psychotherapy, Paracelsus Private Medical
      University, Nuremberg, Germany
FAU - Richter, Kneginja
AU  - Richter K
AD  - Univesity Clinic for Psychiatry and Psychotherapy, Paracelsus Private Medical
      University, Nuremberg, Germany
FAU - Acker, Jens
AU  - Acker J
AD  - Clinic for Sleep Medicine, Bad Zurzcach, Schwitzerland
FAU - Niklewski, Guenter
AU  - Niklewski G
AD  - Univesity Clinic for Psychiatry and Psychotherapy, Paracelsus Private Medical
      University, Nuremberg, Germany
FAU - Safonicheva, Olga
AU  - Safonicheva O
AD  - First Moscow State Medical University named by Sechenov, Moscow, Russia
FAU - Costigliola, Vincenzo
AU  - Costigliola V
AD  - European Association for Predictive, Preventive and Personalised Medicine,
      Brussels, Belgium
FAU - Safonicheva, Olga
AU  - Safonicheva O
AD  - First Moscow State Medical University by I.M. Sechenov, Moscow, Russia
FAU - Sautin, Maxim
AU  - Sautin M
AD  - European Clinic of Sports Traumatology and Orthopaedics, Moscow, Russia
FAU - Sinelnikova, Janna
AU  - Sinelnikova J
AD  - A.I.Evdokimov Moscow State University of Medicine & Dentistry, Moscow, Russia
FAU - Suchkov, Sergey
AU  - Suchkov S
AD  - A.I.Evdokimov Moscow State University of Medicine & Dentistry, Moscow, Russia
FAU - Secer, Songül
AU  - Secer S
AD  - Westdeutsches Zentrum für angewandte Telemedizin, Duisburg, Germany
FAU - von Bandemer, Stephan
AU  - von Bandemer S
AD  - Institute for Work and Technology, Gelsenkirchen, Germany
FAU - Shapira, Niva
AU  - Shapira N
AD  - Institute for Nutrition Research, Beilinson Hospital, Rabin Medical Center, Petah
      Tikva, Israel
FAU - Shcherbakov, Aleksandr
AU  - Shcherbakov A
AD  - Voronezh N.N. Burdenko State Medical University, Voronezh, Russia
FAU - Kunin, Anatoly A.
AU  - Kunin AA
AD  - Voronezh N.N. Burdenko State Medical University, Voronezh, Russia
FAU - Moiseeva, Natalia S.
AU  - Moiseeva NS
AD  - Voronezh N.N. Burdenko State Medical University, Voronezh, Russia
FAU - Shumilovich, Bogdan R.
AU  - Shumilovich BR
AD  - Voronezh State Medical University named after N.N. Burdenko, Postgraduate
      Dentistry Department, Voronezh, Russia
FAU - Lipkind, Zhanna
AU  - Lipkind Z
AD  - Voronezh State Medical University named after N.N. Burdenko, Postgraduate
      Dentistry Department, Voronezh, Russia
FAU - Vorobieva, Yulia
AU  - Vorobieva Y
AD  - Voronezh State Medical University named after N.N. Burdenko, Postgraduate
      Dentistry Department, Voronezh, Russia
FAU - Kunin, Dmitry A.
AU  - Kunin DA
AD  - Voronezh State Medical University named after N.N. Burdenko, Postgraduate
      Dentistry Department, Voronezh, Russia
FAU - Sudareva, Anastasiia V.
AU  - Sudareva AV
AD  - Voronezh State Medical University named after N.N. Burdenko, Postgraduate
      Dentistry Department, Voronezh, Russia
FAU - Smokovski, Ivica
AU  - Smokovski I
AD  - National Diabetes Committee and University Clinic of Emergency Internal Medicine 
      and Toxicology, Skopje, Republic of Macedonia
FAU - Milenkovic, Tatjana
AU  - Milenkovic T
AD  - National Diabetes Committee and University Clinic of Endocrinology, Diabetes and 
      Metabolic Disorders, Skopje, Republic of Macedonia
FAU - Solís-Herrera, Arturo
AU  - Solís-Herrera A
AD  - Human Photosynthesis Study Center, Av. Aguascalientes Norte 607, Pulgas Pandas
      Sur, Aguascalientes México
FAU - Arias-Esparza, María del Carmen
AU  - Arias-Esparza Mdel C
AD  - Human Photosynthesis Study Center, Av. Aguascalientes Norte 607, Pulgas Pandas
      Sur, Aguascalientes México
FAU - Suchkov, Sergey
AU  - Suchkov S
AD  - I.M. Sechenov Firts Moscow State Medical University and A.I. Konstantinov Moscow 
      State Medical & Dental University, Moscow, Russia
FAU - Sridhar, Krishna Chander
AU  - Sridhar KC
AD  - Department of Radiology, Univeristy of Bonn, Bonn, Germany
FAU - Golubnitschaja, Olga
AU  - Golubnitschaja O
AD  - Department of Radiology, Univeristy of Bonn, Bonn, Germany
FAU - Studneva, Maria
AU  - Studneva M
AD  - I.M. Sechenov First Moscow State Medical University (PMGMU), Moscow, Russia
FAU - Song, Sihong
AU  - Song S
AD  - Department of Pharmaceutics, University of Florida College of Pharmacy,
      Gainesville, FL USA
FAU - Creeden, James
AU  - Creeden J
AD  - Roche Diagnostics Ltd., Rotkreuz, Switzerland, and Roche Diagnostics Division,
      Basel, Switzerland
FAU - Мandrik, Мark
AU  - Мandrik М
AD  - I.M. Sechenov First Moscow State Medical University (PMGMU), Moscow, Russia
FAU - Suchkov, Sergey
AU  - Suchkov S
AD  - I.M. Sechenov First Moscow State Medical University (PMGMU), Moscow, Russia
FAU - Theodorsson, Elvar
AU  - Theodorsson E
AD  - IKE/Klinisk kemi, Lab1, Hus 420, Plan 11, Universitetssjukhuset, SE-581 85,
      Linköping, Sweden
CN  - EFLM
FAU - Tofail, Syed A. M.
AU  - Tofail SAM
AD  - Department of Physics and Energy, and Materials and Surface Science Institute
      (MSSI), University of Limerick, ᅟ, Ireland
FAU - Topolčan, Ondřej
AU  - Topolčan O
AD  - Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University
      Prague, Pilsen, Czech Republic
FAU - Kinkorová, Judita
AU  - Kinkorová J
AD  - Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University
      Prague, Pilsen, Czech Republic
FAU - Fiala, Ondřej
AU  - Fiala O
AD  - Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University
      Prague, Pilsen, Czech Republic
FAU - Karlíková, Marie
AU  - Karlíková M
AD  - Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University
      Prague, Pilsen, Czech Republic
FAU - Svobodová, Šárka
AU  - Svobodová Š
AD  - Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University
      Prague, Pilsen, Czech Republic
FAU - Kučera, Radek
AU  - Kučera R
AD  - Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University
      Prague, Pilsen, Czech Republic
FAU - Fuchsová, Radka
AU  - Fuchsová R
AD  - Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University
      Prague, Pilsen, Czech Republic
FAU - Třeška, Vladislav
AU  - Třeška V
AD  - Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University
      Prague, Pilsen, Czech Republic
FAU - Šimánek, Václav
AU  - Šimánek V
AD  - Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University
      Prague, Pilsen, Czech Republic
FAU - Pecen, Ladislav
AU  - Pecen L
AD  - Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University
      Prague, Pilsen, Czech Republic
FAU - Šoupal, Jan
AU  - Šoupal J
AD  - General Faculty Hospital and 1st Faculty of Medice in Prague, Charles University 
      Prague, Prague, Czech Republic
FAU - Svačina, Štěpán
AU  - Svačina Š
AD  - General Faculty Hospital and 1st Faculty of Medice in Prague, Charles University 
      Prague, Prague, Czech Republic
FAU - Tretyak, Evgeniya
AU  - Tretyak E
AD  - Clinical Hospital 86, Federal Medical Biological Agency of Russia, Moscow, Russia
FAU - Studneva, Maria
AU  - Studneva M
AD  - I.M. Sechenov First Moscow State Medical University, Trubetskaya Str. 8-2,
      Moscow, 119991 Russia
FAU - Suchkov, Sergey
AU  - Suchkov S
AD  - I.M. Sechenov First Moscow State Medical University, Trubetskaya Str. 8-2,
      Moscow, 119991 Russia
FAU - Trovato, Francesca M.
AU  - Trovato FM
AD  - Department of Clinical and Experimental Medicine, University Hospital of Catania,
      Catania, Italy
FAU - Martines, Giuseppe Fabio
AU  - Martines GF
AD  - Department of Clinical and Experimental Medicine, University Hospital of Catania,
      Catania, Italy
FAU - Brischetto, Daniela
AU  - Brischetto D
AD  - Department of Clinical and Experimental Medicine, University Hospital of Catania,
      Catania, Italy
FAU - Catalano, Daniela
AU  - Catalano D
AD  - Department of Clinical and Experimental Medicine, University Hospital of Catania,
      Catania, Italy
FAU - Musumeci, Giuseppe
AU  - Musumeci G
AD  - Department of Bio-Medical Sciences, Human Anatomy and Histology Section, School
      of Medicine, University of Catania, Catania, Italy
FAU - Trovato, Guglielmo M.
AU  - Trovato GM
AD  - Department of Clinical and Experimental Medicine, University Hospital of Catania,
      Catania, Italy
FAU - Tsangaris, George Th.
AU  - Tsangaris GT
AD  - Proteomarkers Biotech P.C., Athens, Greece
FAU - Anagnostopoulos, Athanasios K.
AU  - Anagnostopoulos AK
AD  - Proteomarkers Biotech P.C., Athens, Greece
FAU - Tsangaris, George Th.
AU  - Tsangaris GT
AD  - Proteomarkers Biotech P.C., Athens, Greece
FAU - Anagnostopoulos, Athanasios K.
AU  - Anagnostopoulos AK
AD  - Proteomarkers Biotech P.C., Athens, Greece
FAU - Verdú, José
AU  - Verdú J
AD  - Medtronic Iberica S.A., Madrid, Spain
FAU - Gutiérrez, German
AU  - Gutiérrez G
AD  - Medtronic Iberica S.A., Madrid, Spain
FAU - Rovira, Jordi
AU  - Rovira J
AD  - Telefonica, Madrid, Spain
FAU - Martinez, Marta
AU  - Martinez M
AD  - Telefonica, Madrid, Spain
FAU - Fleischhacker, Lutz
AU  - Fleischhacker L
AD  - Fleischhacker, Schwerte, Germany
FAU - Green, Donna
AU  - Green D
AD  - Grand-Aides, Houston, Texas USA
FAU - Garson, Arthur
AU  - Garson A
AD  - Grand-Aides, Houston, Texas USA
FAU - Tamburini, Elena
AU  - Tamburini E
AD  - I+ SRL, Firenze, Italy
FAU - Cuomo, Stefano
AU  - Cuomo S
AD  - I+ SRL, Firenze, Italy
FAU - Martinez-Leon, Juan
AU  - Martinez-Leon J
AD  - Hospital G.U. Valencia, Valencia, Spain
FAU - Abrisqueta, Teresa
AU  - Abrisqueta T
AD  - Hospital G.U. Valencia, Valencia, Spain
FAU - Brunner-La Rocca, Hans-Peter
AU  - Brunner-La Rocca HP
AD  - Maastricht U. Medical Centre, Maastricht, The Netherlands
FAU - Jaarsma, Tiny
AU  - Jaarsma T
AD  - Linkopings Universitet, Linkopings, Sweden
FAU - Arredondo, Teresa
AU  - Arredondo T
AD  - Universidad Politecnica de Madrid, Madrid, Spain
FAU - Vera, Cecilia
AU  - Vera C
AD  - Universidad Politecnica de Madrid, Madrid, Spain
FAU - Fico, Giuseppe
AU  - Fico G
AD  - Universidad Politecnica de Madrid, Madrid, Spain
FAU - Golubnitschaja, Olga
AU  - Golubnitschaja O
AD  - European Association for Predictive, Preventive and Personalised Medicine,
      Brussels, Belgium
FAU - Arribas, Fernando
AU  - Arribas F
AD  - Hospital U. 12 de Octubre, Madrid, Spain
FAU - Onderco, Martina
AU  - Onderco M
AD  - Elsevier, Amsterdam, The Netherlands
FAU - Vara, Isabel
AU  - Vara I
AD  - Elsevier, Amsterdam, The Netherlands
CN  - on behalf of ZENITH consortium
FAU - Verdú, José
AU  - Verdú J
AD  - Medtronic Iberica S.A., Madrid, Spain
FAU - Sambo, Francesco
AU  - Sambo F
AD  - Universita Degli Studi di Padova, Padova, Italy
FAU - Di Camillo, Barbara
AU  - Di Camillo B
AD  - Universita Degli Studi di Padova, Padova, Italy
FAU - Cobelli, Claudio
AU  - Cobelli C
AD  - Universita Degli Studi di Padova, Padova, Italy
FAU - Facchinetti, Andrea
AU  - Facchinetti A
AD  - Universita Degli Studi di Padova, Padova, Italy
FAU - Fico, Giuseppe
AU  - Fico G
AD  - Universidad Politecnica de Madrid, Madrid, Spain
FAU - Bellazzi, Riccardo
AU  - Bellazzi R
AD  - Universita Degli Studi di Pavia, Pavia, Italy
FAU - Sacchi, Lucia
AU  - Sacchi L
AD  - Universita Degli Studi di Pavia, Pavia, Italy
FAU - Dagliati, Arianna
AU  - Dagliati A
AD  - Universita Degli Studi di Pavia, Pavia, Italy
FAU - Segnani, Daniele
AU  - Segnani D
AD  - Fondazione Salvatore Maugeri Clinica del Lavoro e Della Riabilitazione, Pavia,
      Italy
FAU - Tibollo, Valentina
AU  - Tibollo V
AD  - Fondazione Salvatore Maugeri Clinica del Lavoro e Della Riabilitazione, Pavia,
      Italy
FAU - Ottaviano, Manuel
AU  - Ottaviano M
AD  - Asociacion Espanola para el desarrollo de La Epidemiologia Clinica, Madrid, Spain
FAU - Gabriel, Rafael
AU  - Gabriel R
AD  - Asociacion Espanola para el desarrollo de La Epidemiologia Clinica, Madrid, Spain
FAU - Groop, Leif
AU  - Groop L
AD  - Lunds Universitet, Lund, Sweden
FAU - Postma, Jacqueline
AU  - Postma J
AD  - Lunds Universitet, Lund, Sweden
FAU - Martinez, Antonio
AU  - Martinez A
AD  - Soluciones Tecnologicas para la Salud y el Bienestar (TSB), Valencia, Spain
FAU - Hakaste, Liisa
AU  - Hakaste L
AD  - Samfundet Folkhalsan I Svenska Finland RF, Helsingfors, Finland
FAU - Tuomi, Tiinamaija
AU  - Tuomi T
AD  - Samfundet Folkhalsan I Svenska Finland RF, Helsingfors, Finland
FAU - Zarkogianni, Konstantia
AU  - Zarkogianni K
AD  - National Technical University of Athens, Athens, Greece
CN  - on behalf of MOSAIC consortium
FAU - Volchek, Igor
AU  - Volchek I
AD  - DiscoveryMed Ltd, St. Petersburg, Russia
FAU - Pototskaya, Nina
AU  - Pototskaya N
AD  - Belarus State Medical University, Minsk, Belarus
FAU - Petrov, Andrey
AU  - Petrov A
AD  - DiscoveryMed Ltd, St. Petersburg, Russia
FAU - Volchek, Igor
AU  - Volchek I
AD  - DiscoveryMed Ltd, St. Petersburg, Russia
FAU - Pototskaya, Nadezhda
AU  - Pototskaya N
AD  - Belarus State Medical University, Minsk, Belarus
FAU - Petrov, Andrey
AU  - Petrov A
AD  - DiscoveryMed Ltd, St. Petersburg, Russia
FAU - Voog-Oras, Ülle
AU  - Voog-Oras Ü
AD  - University of Tartu, Department of Stomatology, Tartu, Estonia
FAU - Jagur, Oksana
AU  - Jagur O
AD  - Clinic of Dentistry, Department of Maxillofacial Surgery, Tartu, Estonia
FAU - Leibur, Edvitar
AU  - Leibur E
AD  - University of Tartu, Department of Internal Medicine, Tartu, Estonia
FAU - Niibo, Priit
AU  - Niibo P
AD  - University of Tartu, Department of Stomatology, Tartu, Estonia
FAU - Jagomägi, Triin
AU  - Jagomägi T
AD  - University of Tartu, Department of Stomatology, Tartu, Estonia
FAU - Nguyen, Minh Son
AU  - Nguyen MS
AD  - University of Tartu, Department of Stomatology, Tartu, Estonia
FAU - Pruunsild, Chris
AU  - Pruunsild C
AD  - University of Tartu, Department of Pediatrics, Tartu, Estonia
FAU - Piikov, Dagmar
AU  - Piikov D
AD  - University of Tartu, Department of Stomatology, Tartu, Estonia
FAU - Saag, Mare
AU  - Saag M
AD  - University of Tartu, Department of Stomatology, Tartu, Estonia
FAU - Wang, Wei
AU  - Wang W
AD  - School of Medical Science, Edith Cowan University, Perth, Australia
FAU - Wang, Wei
AU  - Wang W
AD  - School of Medical Science, Edith Cowan University, Perth, Australia
FAU - Weinhäusel, Andreas
AU  - Weinhäusel A
AD  - Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna,
      Austria
FAU - Pulverer, Walter
AU  - Pulverer W
AD  - Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna,
      Austria
FAU - Wielscher, Matthias
AU  - Wielscher M
AD  - Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna,
      Austria
FAU - Hofner, Manuela
AU  - Hofner M
AD  - Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna,
      Austria
FAU - Noehammer, Christa
AU  - Noehammer C
AD  - Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna,
      Austria
FAU - Soldo, Regina
AU  - Soldo R
AD  - Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna,
      Austria
FAU - Hettegger, Peter
AU  - Hettegger P
AD  - Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna,
      Austria
FAU - Gyurjan, Istvan
AU  - Gyurjan I
AD  - Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna,
      Austria
FAU - Kulovics, Ronald
AU  - Kulovics R
AD  - Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna,
      Austria
FAU - Schönthaler, Silvia
AU  - Schönthaler S
AD  - Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna,
      Austria
FAU - Beikircher, Gabriel
AU  - Beikircher G
AD  - Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna,
      Austria
FAU - Kriegner, Albert
AU  - Kriegner A
AD  - Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna,
      Austria
FAU - Pabinger, Stephan
AU  - Pabinger S
AD  - Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna,
      Austria
FAU - Vierlinger, Klemens
AU  - Vierlinger K
AD  - Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna,
      Austria
FAU - Yüzbaşıoğlu, Ayşe
AU  - Yüzbaşıoğlu A
AD  - Hacettepe University Center for Biobanking and Genomics, DNA/Cell Bank for Rare
      Diseases, Ankara, Turkey
FAU - Özgüç, Meral
AU  - Özgüç M
AD  - Hacettepe University Center for Biobanking and Genomics, DNA/Cell Bank for Rare
      Diseases, Ankara, Turkey
LA  - eng
PT  - Journal Article
DEP - 20160509
TA  - EPMA J
JT  - The EPMA Journal
AID - 54 [pii]
AID - 10.1186/s13167-016-0054-6 [doi]
SO  - EPMA J. 2016 May 9;7(Suppl 1):. doi:10.1186/s13167-016-0054-6.

PMC - PMC4813425
PMID- 26841800
IS  - 0031-6997 (Print)
IS  - 1521-0081 (Electronic)
VI  - 68
IP  - 2
DP  - 2016 Apr
TI  - Psychedelics.
PG  - 264-355
AB  - Psychedelics (serotonergic hallucinogens) are powerful psychoactive substances
      that alter perception and mood and affect numerous cognitive processes. They are 
      generally considered physiologically safe and do not lead to dependence or
      addiction. Their origin predates written history, and they were employed by early
      cultures in many sociocultural and ritual contexts. After the virtually
      contemporaneous discovery of (5R,8R)-(+)-lysergic acid-N,N-diethylamide (LSD)-25 
      and the identification of serotonin in the brain, early research focused
      intensively on the possibility that LSD and other psychedelics had a serotonergic
      basis for their action. Today there is a consensus that psychedelics are agonists
      or partial agonists at brain serotonin 5-hydroxytryptamine 2A receptors, with
      particular importance on those expressed on apical dendrites of neocortical
      pyramidal cells in layer V. Several useful rodent models have been developed over
      the years to help unravel the neurochemical correlates of serotonin
      5-hydroxytryptamine 2A receptor activation in the brain, and a variety of imaging
      techniques have been employed to identify key brain areas that are directly
      affected by psychedelics. Recent and exciting developments in the field have
      occurred in clinical research, where several double-blind placebo-controlled
      phase 2 studies of psilocybin-assisted psychotherapy in patients with
      cancer-related psychosocial distress have demonstrated unprecedented positive
      relief of anxiety and depression. Two small pilot studies of psilocybin-assisted 
      psychotherapy also have shown positive benefit in treating both alcohol and
      nicotine addiction. Recently, blood oxygen level–dependent functional magnetic
      resonance imaging and magnetoencephalography have been employed for in vivo brain
      imaging in humans after administration of a psychedelic, and results indicate
      that intravenously administered psilocybin and LSD produce decreases in
      oscillatory power in areas of the brain’s default mode network.
FAU - Nichols, David E.
AU  - Nichols DE
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 201604
PHST- 2016/04 [aheadofprint]
TA  - Pharmacol Rev
JT  - Pharmacological Reviews
AID - PHARMREV_011478 [pii]
AID - 10.1124/pr.115.011478 [doi]
SO  - Pharmacol Rev. 2016 Apr;68(2):264-355. Epub 2016 Apr doi:10.1124/pr.115.011478.

PMC - PMC4801642
PMID- 26907296
IS  - 1424-8220 (Electronic)
VI  - 16
IP  - 2
DP  - 2016 Feb
TI  - Parametric Cognitive Modeling of Information and Computer Technology Usage by
      People with Aging- and Disability-Derived Functional Impairments.
LID - 266
AB  - Despite the speedy evolution of Information and Computer Technology (ICT), and
      the growing recognition of the importance of the concept of universal design in
      all domains of daily living, mainstream ICT-based product designers and
      developers still work without any truly structured tools, guidance or support to 
      effectively adapt their products and services to users’ real needs. This paper
      presents the approach used to define and evaluate parametric cognitive models
      that describe interaction and usage of ICT by people with aging- and
      disability-derived functional impairments. A multisensorial training platform was
      used to train, based on real user measurements in real conditions, the virtual
      parameterized user models that act as subjects of the test-bed during all stages 
      of simulated disabilities-friendly ICT-based products design. An analytical study
      was carried out to identify the relevant cognitive functions involved, together
      with their corresponding parameters as related to aging- and disability-derived
      functional impairments. Evaluation of the final cognitive virtual user models in 
      a real application has confirmed that the use of these models produce concrete
      valuable benefits to the design and testing process of accessible ICT-based
      applications and services. Parameterization of cognitive virtual user models
      allows incorporating cognitive and perceptual aspects during the design process.
FAU - García-Betances, Rebeca I.
AU  - García-Betances RI
FAU - Cabrera-Umpiérrez, María Fernanda
AU  - Cabrera-Umpiérrez MF
FAU - Ottaviano, Manuel
AU  - Ottaviano M
FAU - Pastorino, Matteo
AU  - Pastorino M
FAU - Arredondo, María T.
AU  - Arredondo MT
LA  - eng
PT  - Journal Article
DEP - 20160222
PHST- 2015/10/29 [received]
PHST- 2016/02/18 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s16020266 [doi]
AID - sensors-16-00266 [pii]
SO  - Sensors (Basel). 2016 Feb 22;16(2):. doi:10.3390/s16020266.

PMC - PMC4747791
PMID- 26652115
IS  - 1388-2457 (Print)
IS  - 1872-8952 (Electronic)
VI  - 127
IP  - 2
DP  - 2016 Feb
TI  - A technical guide to tDCS, and related non-invasive brain stimulation tools.
PG  - 1031-48
AB  - Transcranial electrical stimulation (tES), including transcranial direct and
      alternating current stimulation (tDCS, tACS) are non-invasive brain stimulation
      techniques increasingly used for modulation of central nervous system
      excitability in humans. Here we address methodological issues required for tES
      application. This review covers technical aspects of tES, as well as applications
      like exploration of brain physiology, modelling approaches, tES in cognitive
      neurosciences, and interventional approaches. It aims to help the reader to
      appropriately design and conduct studies involving these brain stimulation
      techniques, understand limitations and avoid shortcomings, which might hamper the
      scientific rigor and potential applications in the clinical domain.
FAU - Woods, AJ
AU  - Woods A
AD  - Center for Cognitive Aging and Memory, Institute on Aging, McKnight Brain
      Institute, Department of Aging and Geriatric Research, Department of
      Neuroscience, University of Florida, Gainesville, FL, USA
FAU - Antal, A
AU  - Antal A
AD  - University Medical Center, Dept. Clinical Neurophysiology,
      Georg-August-University, Goettingen, Germany
FAU - Bikson, M
AU  - Bikson M
AD  - Department of Biomedical Engineering, The City College of New York, USA
FAU - Boggio, PS
AU  - Boggio P
AD  - Social and Cognitive Neuroscience Laboratory and Developmental Disorders Program,
      Center for Health and Biological Science, Mackenzie Presbyterian University, São 
      Paulo, SP, Brazil
FAU - Brunoni, AR
AU  - Brunoni A
AD  - Service of Interdisciplinary Neuromodulation, Department and Institute of
      Psychiatry, University of São Paulo, São Paulo, Brazil
FAU - Celnik, P
AU  - Celnik P
AD  - Department of Physical Medicine and Rehabilitation, Johns Hopkins Medical
      Institution, Baltimore, MD, USA
FAU - Cohen, LG
AU  - Cohen L
AD  - Human Cortical Physiology and Neurorehabilitation Section, National Institute of 
      Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD,
      USA
FAU - Fregni, F
AU  - Fregni F
AD  - Laboratory of Neuromodulation, Center for Clinical Research Learning, Department 
      of Physical Medicine and Rehabilitation, Harvard University, USA
FAU - Herrmann, CS
AU  - Herrmann C
AD  - Experimental Psychology Lab, Center of excellence Hearing4all, Department for
      Psychology, Faculty for Medicine and Health Sciences, Carl von Ossietzky
      Universität, Ammerländer Heerstr, Oldenburg, Germany
FAU - Kappenman, ES
AU  - Kappenman E
AD  - Center for Mind & Brain and Department of Psychology, University of California,
      Davis, Davis, CA, USA
FAU - Knotkova, H
AU  - Knotkova H
AD  - MJHS Institute for Innovation in Palliative Care, New York, NY, USA
FAU - Liebetanz, D
AU  - Liebetanz D
AD  - University Medical Center, Dept. Clinical Neurophysiology,
      Georg-August-University, Goettingen, Germany
FAU - Miniussi, C
AU  - Miniussi C
AD  - Neuroscience Section, Department of Clinical and Experimental Sciences,
      University of Brescia & Cognitive Neuroscience Section, IRCCS Centro San Giovanni
      di Dio Fatebenefratelli, Brescia, Italy
FAU - Miranda, PC
AU  - Miranda P
AD  - Institute of Biophysics and Biomedical Engineering (IBEB), Faculdade de Ciências,
      Universidade de Lisboa, Lisbon, Portugal
FAU - Paulus, W
AU  - Paulus W
AD  - University Medical Center, Dept. Clinical Neurophysiology,
      Georg-August-University, Goettingen, Germany
FAU - Priori, A
AU  - Priori A
AD  - Direttore Clinica Neurologica III, Università degli Studi di Milano, Ospedale San
      Paolo, Milan, Italy
FAU - Reato, D
AU  - Reato D
AD  - Department of Biomedical Engineering, The City College of New York, USA
FAU - Stagg, C
AU  - Stagg C
AD  - Centre for Functional MRI of the Brain (FMRIB) Nuffield Department of Clinical
      Neurosciences, University of Oxford, Oxford, UK; Oxford Centre for Human Brain
      Activity (OHBA), Department of Psychiatry, University of Oxford, Oxford, UK
FAU - Wenderoth, N
AU  - Wenderoth N
AD  - Neural Control of Movement Lab, Dept. Health Sciences and Technology, ETH Zürich,
      Switzerland
FAU - Nitsche, MA
AU  - Nitsche M
AD  - University Medical Center, Dept. Clinical Neurophysiology,
      Georg-August-University, Goettingen, Germany
LA  - eng
PT  - Journal Article
DEP - 20151122
TA  - Clin Neurophysiol
JT  - Clinical neurophysiology : official journal of the International Federation of
      Clinical Neurophysiology
AID - 10.1016/j.clinph.2015.11.012 [doi]
MID - NIHMS740431
SO  - Clin Neurophysiol. 2016 Feb;127(2):1031-48. Epub 2015 Nov 22
      doi:10.1016/j.clinph.2015.11.012.

PMC - PMC4670752
IS  - 2190-5991 (Print)
IS  - 2190-6009 (Electronic)
VI  - 6
IP  - 4
DP  - 2015 Dec
TI  - Abstracts of the 8th International Conference on Cachexia, Sarcopenia and Muscle 
      Wasting, Paris, France, 4-6 December 2015.
PG  - 398-509
LA  - eng
PT  - Journal Article
DEP - 20151118
PHST- 2015/11/18 [aheadofprint]
TA  - J Cachexia Sarcopenia Muscle
JT  - Journal of Cachexia, Sarcopenia and Muscle
AID - 10.1002/jcsm.12087 [doi]
SO  - J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):398-509. Epub 2015 Nov 18
      doi:10.1002/jcsm.12087.

PMC - PMC4835043
PMID- 26303396
IS  - 0037-976X (Print)
IS  - 1540-5834 (Electronic)
VI  - 80
IP  - 3
DP  - 2015 Sep
TI  - Studies in Fetal Behavior: Revisited, Renewed, and Reimagined.
PG  - vii-vii94
AB  - Among the earliest volumes of this Monograph series was a report by Lester Sontag
      and colleagues, of the esteemed Fels Institute, on the heart rate of the human
      fetus as an expression of the developing nervous system. Here, some 75 years
      later, we commemorate this work and provide historical and contemporary context
      on knowledge regarding fetal development, as well as results from our own
      research. These are based on synchronized monitoring of maternal and fetal
      parameters assessed between 24 and 36 weeks gestation on 740 maternal-fetal pairs
      compiled from eight separate longitudinal studies, which commenced in the early
      1990s. Data include maternal heart rate, respiratory sinus arrhythmia, and
      electrodermal activity and fetal heart rate, motor activity, and their
      integration. Hierarchical linear modeling of developmental trajectories reveals
      that the fetus develops in predictable ways consistent with advancing
      parasympathetic regulation. Findings also include: within-fetus stability (i.e., 
      preservation of rank ordering over time) for heart rate, motor, and coupling
      measures; a transitional period of decelerating development near 30 weeks
      gestation; sex differences in fetal heart rate measures but not in most fetal
      motor activity measures; modest correspondence in fetal neurodevelopment among
      siblings as compared to unrelated fetuses; and deviations from normative fetal
      development in fetuses affected by intrauterine growth restriction and other
      conditions. Maternal parameters also change during this period of gestation and
      there is evidence that fetal sex and individual variation in fetal neurobehavior 
      influence maternal physiological processes and the local intrauterine context.
      Results are discussed within the framework of neuromaturation, the emergence of
      individual differences, and the bidirectional nature of the maternal-fetal
      relationship. We pose a number of open questions for future research. Although
      the human fetus remains just out of reach, new technologies portend an era of
      accelerated discovery of the earliest period of development.
FAU - DiPietro, Janet A.
AU  - DiPietro JA
AD  - Johns Hopkins Bloomberg School of Public Health
FAU - Costigan, Kathleen A.
AU  - Costigan KA
AD  - The Johns Hopkins Hospital
FAU - Voegtline, Kristin M.
AU  - Voegtline KM
AD  - Johns Hopkins Bloomberg School of Public Health
LA  - eng
PT  - Journal Article
TA  - Monogr Soc Res Child Dev
JT  - Monographs of the Society for Research in Child Development
AID - 10.1111/mono.v80.3 [doi]
MID - NIHMS775451
SO  - Monogr Soc Res Child Dev. 2015 Sep;80(3):vii-vii94. doi:10.1111/mono.v80.3.

PMC - PMC4587627
IS  - 1559-6109 (Print)
VI  - 54
IP  - 5
DP  - 2015 Sep
TI  - Abstracts of Scientific Presentations: 2015 AALAS National Meeting Phoenix,
      Arizona.
PG  - 568-668
LA  - eng
PT  - Journal Article
DEP - 201509
PHST- 2015/09 [aheadofprint]
TA  - J Am Assoc Lab Anim Sci
JT  - Journal of the American Association for Laboratory Animal Science : JAALAS
AID - 2015000568 [pii]
SO  - J Am Assoc Lab Anim Sci. 2015 Sep;54(5):568-668. Epub 2015 Sep

PMC - PMC4212304
IS  - 2050-6406 (Print)
IS  - 2050-6414 (Electronic)
VI  - 2
IP  - 1 Suppl
DP  - 2014 Oct
DP  - 2014 Oct
TI  - UEG Week 2014 Oral Presentations.
PG  - A1-A131
LA  - eng
PT  - Journal Article
TA  - United European Gastroenterol J
JT  - United European Gastroenterology Journal
AID - 10.1177/2050640614548974 [doi]
AID - 10.1177_2050640614548974 [pii]
SO  - United European Gastroenterol J. 2014 Oct;2(1 Suppl):A1-A131.
      doi:10.1177/2050640614548974.

PMC - PMC4146258
PMID- 25206907
IS  - 1673-5374 (Print)
IS  - 1876-7958 (Electronic)
VI  - 9
IP  - 8
DP  - 2014 Apr 15
TI  - Virtual reality interface devices in the reorganization of neural networks in the
      brain of patients with neurological diseases.
PG  - 888-96
AB  - Two key characteristics of all virtual reality applications are interaction and
      immersion. Systemic interaction is achieved through a variety of multisensory
      channels (hearing, sight, touch, and smell), permitting the user to interact with
      the virtual world in real time. Immersion is the degree to which a person can
      feel wrapped in the virtual world through a defined interface. Virtual reality
      interface devices such as the Nintendo® Wii and its peripheral nunchuks-balance
      board, head mounted displays and joystick allow interaction and immersion in
      unreal environments created from computer software. Virtual environments are
      highly interactive, generating great activation of visual, vestibular and
      proprioceptive systems during the execution of a video game. In addition, they
      are entertaining and safe for the user. Recently, incorporating therapeutic
      purposes in virtual reality interface devices has allowed them to be used for the
      rehabilitation of neurological patients, e.g., balance training in older adults
      and dynamic stability in healthy participants. The improvements observed in
      neurological diseases (chronic stroke and cerebral palsy) have been shown by
      changes in the reorganization of neural networks in patients’ brain, along with
      better hand function and other skills, contributing to their quality of life. The
      data generated by such studies could substantially contribute to physical
      rehabilitation strategies.
FAU - Gatica-Rojas, Valeska
AU  - Gatica-Rojas V
AD  - Laboratory of Human Motor Control, Faculty of Health Sciences, University of
      Talca, Talca, Chile
FAU - Méndez-Rebolledo, Guillermo
AU  - Méndez-Rebolledo G
AD  - Laboratory of Human Motor Control, School of Kinesiology, Faculty of Health
      Sciences, University of Talca, Talca, Chile
LA  - eng
PT  - Journal Article
PHST- 2014/01/21 [accepted]
TA  - Neural Regen Res
JT  - Neural Regeneration Research
AID - NRR-9-888 [pii]
AID - 10.4103/1673-5374.131612 [doi]
SO  - Neural Regen Res. 2014 Apr 15;9(8):888-96. doi:10.4103/1673-5374.131612.

PMC - PMC3920854
IS  - 1520-9156 (Print)
IS  - 1557-8593 (Electronic)
VI  - 16
IP  - Suppl 1
DP  - 2014 Feb 01
TI  - Abstracts from ATTD 20147th International Conference on AdvancedTechnologies &
      Treatments for DiabetesVienna, Austria, February 5–8, 2014.
PG  - A-1-A-162
LA  - eng
PT  - Journal Article
TA  - Diabetes Technol Ther
JT  - Diabetes Technology & Therapeutics
AID - 10.1089/dia.2014.1515 [pii]
AID - 10.1089/dia.2014.1515 [doi]
SO  - Diabetes Technol Ther. 2014 Feb 01;16(Suppl 1):A-1-A-162.
      doi:10.1089/dia.2014.1515.

PMC - PMC5350776
IS  - 1752-8054 (Print)
IS  - 1752-8062 (Electronic)
VI  - 6
IP  - 2
DP  - 2013 Apr
TI  - Translational Science 2013 Abstracts.
PG  - 103-64
LA  - eng
PT  - Journal Article
DEP - 20130418
PHST- 2013/04/18 [aheadofprint]
TA  - Clin Transl Sci
JT  - Clinical and Translational Science
AID - 10.1111/cts.12047 [doi]
AID - CTS12047 [pii]
SO  - Clin Transl Sci. 2013 Apr;6(2):103-64. Epub 2013 Apr 18 doi:10.1111/cts.12047.

PMC - PMC3362608
PMID- 22666311
IS  - 1932-6203 (Electronic)
VI  - 7
IP  - 5
DP  - 2012
TI  - Passive Auditory Stimulation Improves Vision in Hemianopia.
LID - e31603
AB  - Techniques employed in rehabilitation of visual field disorders such as
      hemianopia are usually based on either visual or audio-visual stimulation and
      patients have to perform a training task. Here we present results from a
      completely different, novel approach that was based on passive unimodal auditory 
      stimulation. Ten patients with either left or right-sided pure hemianopia
      (without neglect) received one hour of unilateral passive auditory stimulation on
      either their anopic or their intact side by application of repetitive trains of
      sound pulses emitted simultaneously via two loudspeakers. Immediately before and 
      after passive auditory stimulation as well as after a period of recovery,
      patients completed a simple visual task requiring detection of light flashes
      presented along the horizontal plane in total darkness. The results showed that
      one-time passive auditory stimulation on the side of the blind, but not of the
      intact, hemifield of patients with hemianopia induced an improvement in visual
      detections by almost 100% within 30 min after passive auditory stimulation. This 
      enhancement in performance was reversible and was reduced to baseline 1.5 h
      later. A non-significant trend of a shift of the visual field border toward the
      blind hemifield was obtained after passive auditory stimulation. These results
      are compatible with the view that passive auditory stimulation elicited some
      activation of the residual visual pathways, which are known to be multisensory
      and may also be sensitive to unimodal auditory stimuli as were used here.Trial
      Registration: DRKS00003577
FAU - Lewald, Jörg
AU  - Lewald J
AD  - Department of Cognitive Psychology, Faculty of Psychology, Ruhr University
      Bochum, Bochum, Germany
FAU - Tegenthoff, Martin
AU  - Tegenthoff M
AD  - Department of Neurology, BG-Kliniken Bergmannsheil, Ruhr University Bochum,
      Bochum, Germany
FAU - Peters, Sören
AU  - Peters S
AD  - Department of Radiology, BG-Kliniken Bergmannsheil, Ruhr University Bochum,
      Bochum, Germany
FAU - Hausmann, Markus
AU  - Hausmann M
AD  - Department of Psychology, University of Durham, Durham, United Kingdom
LA  - eng
PT  - Journal Article
DEP - 20120529
PHST- 2011/09/15 [received]
PHST- 2012/01/10 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-11-18177 [pii]
AID - 10.1371/journal.pone.0031603 [doi]
SO  - PLoS One. 2012 May 29;7(5):. doi:10.1371/journal.pone.0031603.

PMC - PMC3290767
PMID- 22403535
IS  - 1662-5161 (Electronic)
VI  - 6
DP  - 2012
TI  - Sensory Augmentation for the Blind.
LID - 37
AB  - Common navigational aids used by blind travelers during large-scale navigation
      divert attention away from important cues of the immediate environment (i.e.,
      approaching vehicles). Sensory augmentation devices, relying on principles
      similar to those at work in sensory substitution, can potentially bypass the
      bottleneck of attention through sub-cognitive implementation of a set of rules
      coupling motor actions with sensory stimulation. We provide a late blind subject 
      with a vibrotactile belt that continually signals the direction of magnetic
      north. The subject completed a set of behavioral tests before and after an
      extended training period. The tests were complemented by questionnaires and
      interviews. This newly supplied information improved performance on different
      time scales. In a pointing task we demonstrate an instant improvement of
      performance based on the signal provided by the device. Furthermore, the signal
      was helpful in relevant daily tasks, often complicated for the blind, such as
      keeping a direction over longer distances or taking shortcuts in familiar
      environments. A homing task with an additional attentional load demonstrated a
      significant improvement after training. The subject found the directional
      information highly expedient for the adjustment of his inner maps of familiar
      environments and describes an increase in his feeling of security when exploring 
      unfamiliar environments with the belt. The results give evidence for a firm
      integration of the newly supplied signals into the behavior of this late blind
      subject with better navigational performance and more courageous behavior in
      unfamiliar environments. Most importantly, the complementary information provided
      by the belt lead to a positive emotional impact with enhanced feeling of
      security. The present experimental approach demonstrates the positive potential
      of sensory augmentation devices for the help of handicapped people.
FAU - Kärcher, Silke M.
AU  - Kärcher SM
AD  - Neurobiopsychology, Institute of Cognitive Science, University
      OsnabrückOsnabrück, Germany
FAU - Fenzlaff, Sandra
AU  - Fenzlaff S
AD  - Neurobiopsychology, Institute of Cognitive Science, University
      OsnabrückOsnabrück, Germany
FAU - Hartmann, Daniela
AU  - Hartmann D
AD  - Neurobiopsychology, Institute of Cognitive Science, University
      OsnabrückOsnabrück, Germany
FAU - Nagel, Saskia K.
AU  - Nagel SK
AD  - Neurobiopsychology, Institute of Cognitive Science, University
      OsnabrückOsnabrück, Germany
FAU - König, Peter
AU  - König P
AD  - Neurobiopsychology, Institute of Cognitive Science, University
      OsnabrückOsnabrück, Germany
LA  - eng
PT  - Journal Article
DEP - 20120301
PHST- 2011/09/23 [received]
PHST- 2012/02/15 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2012.00037 [doi]
SO  - Front Hum Neurosci. 2012 Mar 01;6:. doi:10.3389/fnhum.2012.00037.

PMC - PMC5350643
IS  - 1752-8054 (Print)
IS  - 1752-8062 (Electronic)
VI  - 3
IP  - 2
DP  - 2010 Apr
TI  - ACRT‐SCTS Scholar Abstracts.
PG  - S8-S55
LA  - eng
PT  - Journal Article
DEP - 20100325
TA  - Clin Transl Sci
JT  - Clinical and Translational Science
AID - 10.1111/j.1752-8062.2010.00181_2.x [doi]
AID - CTS181_2 [pii]
SO  - Clin Transl Sci. 2010 Apr;3(2):S8-S55. Epub 2010 Mar 25
      doi:10.1111/j.1752-8062.2010.00181_2.x.

PMC - PMC2801896
PMID- 20054426
IS  - 0145-482X (Print)
IS  - 1559-1476 (Electronic)
VI  - 99
IP  - 4
DP  - 2005
TI  - Personal Guidance System for People with Visual Impairment: A Comparison of
      Spatial Displays for Route Guidance.
PG  - 219-32
AB  - This article reports on a study of route guidance using a navigation system that 
      receives location information from a Global Positioning System receiver. Fifteen 
      visually impaired participants traveled along 50-meter (about 164-foot) paths in 
      each of five conditions that were defined by the type of display interface used. 
      One of the virtual displays—virtual speech—led to the shortest travel times and
      the highest subjective ratings, despite concerns about the use of headphones.
FAU - Loomis, Jack M.
AU  - Loomis JM
AD  - Department of Psychology, University of California, Santa Barbara, CA 93106;
      loomis@psych.ucsb.edu.
FAU - Marston, James R.
AU  - Marston JR
AD  - Department of Geography, University of California, Santa Barbara, CA 93106;
      marstonj@geog.ucsb.edu.
FAU - Golledge, Reginald G.
AU  - Golledge RG
AD  - Department of Geography, University of California, Santa Barbara, CA 93106;
      golledge@geog.ucsb.edu.
FAU - Klatzky, Roberta L.
AU  - Klatzky RL
AD  - Department of Psychology, Carnegie Mellon University, Baker Hall 342C,
      Pittsburgh, PA 15213; klatzky@andrew.cmu.edu.
LA  - eng
PT  - Journal Article
TA  - J Vis Impair Blind
JT  - Journal of visual impairment & blindness
MID - NIHMS159056
SO  - J Vis Impair Blind. 2005;99(4):219-32.

PMC - PMC5499100
IS  - 1472-6882 (Electronic)
VI  - 17
IP  - Suppl 1
DP  - 2017
TI  - World Congress Integrative Medicine & Health 2017: part three: Berlin, Germany.
      3-5 May 2017.
LID - 333
FAU - Ortiz, Miriam
AU  - Ortiz M
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité University Hospital, Berlin, Germany
FAU - Schnabel, Katharina
AU  - Schnabel K
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité University Hospital, Berlin, Germany
FAU - Teut, Michael
AU  - Teut M
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité University Hospital, Berlin, Germany
FAU - Rotter, Gabriele
AU  - Rotter G
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité University Hospital, Berlin, Germany
FAU - Binting, Sylvia
AU  - Binting S
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité University Hospital, Berlin, Germany
FAU - Cree, Margit
AU  - Cree M
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité University Hospital, Berlin, Germany
FAU - Lotz, Fabian
AU  - Lotz F
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité University Hospital, Berlin, Germany
FAU - Suhr, Ralf
AU  - Suhr R
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité University Hospital, Berlin, Germany
FAU - Brinkhaus, Benno
AU  - Brinkhaus B
AD  - 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and
      Health Economics, Charité University Hospital, Berlin, Germany
FAU - Parvizi, Mohammad M.
AU  - Parvizi MM
AD  - 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic
      Republic of
FAU - Handjani, Farhad
AU  - Handjani F
AD  - 0000 0001 0745 1259grid.412573.6Molecular Dermatology Research Centre, Shiraz
      University of Medicine, Shiraz, Iran, Islamic Republic of
FAU - Zarshenas, Mohammad M.
AU  - Zarshenas MM
AD  - 0000 0000 8819 4698grid.412571.4Medicinal Plants Processing Research Center,
      Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of
FAU - Moein, Mahmood R.
AU  - Moein MR
AD  - 0000 0000 8819 4698grid.412571.4Medicinal Plants Processing Research Center,
      Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of
FAU - Nimrouzi, Majid
AU  - Nimrouzi M
AD  - 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic
      Republic of
FAU - Hatam, Gholamreza
AU  - Hatam G
AD  - 0000 0000 8819 4698grid.412571.4Basic Sciences in Infectious Diseases Research
      Center, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of
FAU - Hasanzadeh, Jafar
AU  - Hasanzadeh J
AD  - 0000 0000 8819 4698grid.412571.4Department of Epidemiology, Shiraz University of 
      Medical Sciences, Shiraz, Iran, Islamic Republic of
FAU - Hamidizadeh, Nasrin
AU  - Hamidizadeh N
AD  - 0000 0001 0745 1259grid.412573.6Molecular Dermatology Research Centre, Shiraz
      University of Medicine, Shiraz, Iran, Islamic Republic of
FAU - Parvizi, Mohammad M.
AU  - Parvizi MM
AD  - 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic
      Republic of
FAU - Heydari, Mojtaba
AU  - Heydari M
AD  - 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic
      Republic of
FAU - Namazi, Mohammad R.
AU  - Namazi MR
AD  - 0000 0000 8819 4698grid.412571.4Molecular Dermatology Research Center, Shiraz
      University of Medical Sciences, Shiraz, Iran, Islamic Republic of
FAU - Parvizi, Zahra
AU  - Parvizi Z
AD  - 0000 0000 8819 4698grid.412571.4Health Policy Research Center, Shiraz University 
      of Medical Sciences, Shiraz, Iran, Islamic Republic of
FAU - Pasalar, Mehdi
AU  - Pasalar M
AD  - 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic
      Republic of
FAU - Mosaffa-Jahromi, Maryam
AU  - Mosaffa-Jahromi M
AD  - 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic
      Republic of
FAU - Bagheri-Lankarani, Kamran
AU  - Bagheri-Lankarani K
AD  - 0000 0000 8819 4698grid.412571.4Health Policy Research Center, Shiraz University 
      of Medical Sciences, Shiraz, Iran, Islamic Republic of
FAU - Afsharypuor, Suleiman
AU  - Afsharypuor S
AD  - 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic
      Republic of
FAU - Tamaddon, Ali M.
AU  - Tamaddon AM
AD  - 0000 0000 8819 4698grid.412571.4Center for Nanotechnology in Drug Delivery,
      School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic 
      Republic of
FAU - Ostovar, Mohadeseh
AU  - Ostovar M
AD  - 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic
      Republic of
FAU - Peloni, Giuseppe
AU  - Peloni G
AD  - 0000 0004 0478 8536grid.477768.dOspedale Beata Vergine, Mendrisio, 6850
      Switzerland
FAU - Bolliger, Ingo
AU  - Bolliger I
AD  - 0000 0004 0478 8536grid.477768.dOspedale Beata Vergine, Mendrisio, 6850
      Switzerland
FAU - Faria, Rui M. Da Cunha
AU  - Faria RMDC
AD  - 0000 0004 0478 8536grid.477768.dOspedale Beata Vergine, Mendrisio, 6850
      Switzerland
FAU - Quadri, Pierluigi
AU  - Quadri P
AD  - 0000 0004 0478 8536grid.477768.dOspedale Beata Vergine, Mendrisio, 6850
      Switzerland
FAU - Sanzeni, Wilma
AU  - Sanzeni W
AD  - 0000 0004 0478 8536grid.477768.dOspedale Beata Vergine, Mendrisio, 6850
      Switzerland
FAU - Zemp, Damiano
AU  - Zemp D
AD  - 0000 0004 0478 8536grid.477768.dOspedale Beata Vergine, Mendrisio, 6850
      Switzerland
FAU - Risvoll, Hilde
AU  - Risvoll H
AD  - NKS Kløveråsen as, Bodø, 8076 Norway
FAU - Giverhaug, Trude
AU  - Giverhaug T
AD  - 0000 0004 4689 5540grid.412244.5RELIS North Norway, University Hospital North
      Norway, Tromsø, 9037 Norway
FAU - Halvorsen, Kjell H.
AU  - Halvorsen KH
AD  - 0000000122595234grid.10919.30Department of Pharmacy, UiT The Arctic University of
      Norway, Tromsø, Norway
FAU - Waaseth, Marit
AU  - Waaseth M
AD  - 0000000122595234grid.10919.30Department of Pharmacy, UiT The Arctic University of
      Norway, Tromsø, Norway
FAU - Musial, Frauke
AU  - Musial F
AD  - 0000000122595234grid.10919.30National Research Center in Complementary and
      Alternative Medicine (NAFKAM), Department of Community Medicine, The Arctic
      University of Norway UiT, Tromsø, 9037 Norway
FAU - Rossi, Elio
AU  - Rossi E
AD  - Homeopatic Clinic ASL Tuscany North West Lucca, Tuscan network for Integrative
      Medicine, Lucca, 55100 Italy
FAU - Baccetti, Sonia
AU  - Baccetti S
AD  - Tuscan Network of Integrative Medicine, Florence, 50139 Italy
FAU - Picchi, Marco
AU  - Picchi M
AD  - Tuscan Network of Integrative Medicine, Florence, 50139 Italy
FAU - Conti, Tommaso
AU  - Conti T
AD  - Tuscan Network of Integrative Medicine, Florence, 50139 Italy
FAU - Firenzuoli, Fabio
AU  - Firenzuoli F
AD  - Tuscan Network of Integrative Medicine, Florence, 50139 Italy
FAU - Guido, Carmelo
AU  - Guido C
AD  - Tuscan Network of Integrative Medicine, Florence, 50139 Italy
FAU - Bosco, Filippo
AU  - Bosco F
AD  - Tuscan Network of Integrative Medicine, Florence, 50139 Italy
FAU - Guido, Carmelo
AU  - Guido C
AD  - Tuscan Network of Integrative Medicine, Florence, 50139 Italy
FAU - Rossi, Elio
AU  - Rossi E
AD  - Homeopatic Clinic ASL Tuscany North West Lucca, Tuscan network for Integrative
      Medicine, Lucca, 55100 Italy
FAU - Panozzo, Marialessandra
AU  - Panozzo M
AD  - Homeopatic Clinic ASL Tuscany North West Lucca, Tuscan network for Integrative
      Medicine, Lucca, 55100 Italy
FAU - Picchi, Marco
AU  - Picchi M
AD  - Homeopatic Clinic ASL Tuscany North West Lucca, Tuscan network for Integrative
      Medicine, Lucca, 55100 Italy
FAU - Cervino, Chiara
AU  - Cervino C
AD  - Homeopatic Clinic ASL Tuscany North West Lucca, Tuscan network for Integrative
      Medicine, Lucca, 55100 Italy
FAU - Nurra, Linda
AU  - Nurra L
AD  - Homeopatic Clinic ASL Tuscany North West Lucca, Tuscan network for Integrative
      Medicine, Lucca, 55100 Italy
FAU - Rossi, Elio
AU  - Rossi E
AD  - Homeopatic Clinic ASL Tuscany North West Lucca, Tuscan network for Integrative
      Medicine, Florence, Italy
FAU - Picchi, Marco
AU  - Picchi M
AD  - Tuscany Network of Integrative Medicine, Florence, 50139 Italy
FAU - Firenzuoli, Fabio
AU  - Firenzuoli F
AD  - Tuscany Network of Integrative Medicine, Florence, 50139 Italy
FAU - Traversi, Antonella
AU  - Traversi A
AD  - Tuscany Network of Integrative Medicine, Florence, 50139 Italy
FAU - Vuono, Katia
AU  - Vuono K
AD  - Tuscany Network of Integrative Medicine, Florence, 50139 Italy
FAU - Sabatini, Federica
AU  - Sabatini F
AD  - Tuscany Network of Integrative Medicine, Florence, 50139 Italy
FAU - Bellandi, Tommaso
AU  - Bellandi T
AD  - Regional Centre for Clinical Risk Management, Tuscany Region, Florence, 50139
      Italy
FAU - Rutert, Britta
AU  - Rutert B
AD  - 0000 0001 2218 4662grid.6363.0Pediatric Oncology, Charité University Hospital,
      Berlin, 10117 Germany
FAU - Eggert, Angelika
AU  - Eggert A
AD  - 0000 0001 2218 4662grid.6363.0Pediatric Oncology, Charité University Hospital,
      Berlin, 10117 Germany
FAU - Seifert, Georg
AU  - Seifert G
AD  - 0000 0001 2218 4662grid.6363.0Pediatric Oncology, Charité University Hospital,
      Berlin, 10117 Germany
FAU - Stritter, Wiebke
AU  - Stritter W
AD  - 0000 0001 2218 4662grid.6363.0Pediatric Oncology, Charité University Hospital,
      Berlin, 10117 Germany
FAU - Holmberg, Christine
AU  - Holmberg C
AD  - 0000 0001 2218 4662grid.6363.0Institute of Public Health, Charité University
      Hospital, Berlin, 13353 Germany
FAU - Längler, Alfred
AU  - Längler A
AD  - Institute for Integrative Medicine, Community Hospital Herdecke, Herdecke,
      Germany
FAU - Salamonsen, Anita
AU  - Salamonsen A
AD  - 0000000122595234grid.10919.30Department of Community Medicine, National Research 
      Center in Complementary and Alternative Medicine, UiT The Arctic University of
      Norway, Tromsø, 9037 Norway
FAU - Wiesener, Solveig
AU  - Wiesener S
AD  - 0000000122595234grid.10919.30Department of Community Medicine, National Research 
      Center in Complementary and Alternative Medicine, UiT The Arctic University of
      Norway, Tromsø, 9037 Norway
FAU - Schad, Friedemann
AU  - Schad F
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Steele, Megan
AU  - Steele M
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Kröz, Matthias
AU  - Kröz M
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Matthes, Harald
AU  - Matthes H
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Herbstreit, Cornelia
AU  - Herbstreit C
AD  - Hospital Havelhöhe, Berlin, Germany
FAU - Thronicke, Anja
AU  - Thronicke A
AD  - Research Institute Havelhöhe, Berlin, 14089 Germany
FAU - Schlingensiepen, Irene
AU  - Schlingensiepen I
AD  - Institut für wissenschaftliche Homoeopathie, Berlin, 13505 Germany
FAU - von Schoen-Angerer, Tido
AU  - von Schoen-Angerer T
AD  - Department of Pediatrics, Fribourg Hospital HFR, Fribourg, 1708 Switzerland
FAU - Schneider, Romy
AU  - Schneider R
AD  - Department of Pediatrics, Fribourg Hospital HFR, Fribourg, 1708 Switzerland
FAU - Waeber, Livia
AU  - Waeber L
AD  - Department of Pediatrics, Fribourg Hospital HFR, Fribourg, 1708 Switzerland
FAU - Vagedes, Jan
AU  - Vagedes J
AD  - Filderklinik, ARCIM Institute, Filderstadt, Germany
FAU - Kaczala, Gregor
AU  - Kaczala G
AD  - Department of Pediatrics, Fribourg Hospital HFR, Fribourg, 1708 Switzerland
FAU - Pharisa, Cosette
AU  - Pharisa C
AD  - Department of Pediatrics, Fribourg Hospital HFR, Fribourg, 1708 Switzerland
FAU - Wildhaber, Johannes
AU  - Wildhaber J
AD  - Department of Pediatrics, Fribourg Hospital HFR, Fribourg, 1708 Switzerland
FAU - Huber, Benedikt
AU  - Huber B
AD  - Department of Pediatrics, Fribourg Hospital HFR, Fribourg, 1708 Switzerland
FAU - Sidorov, Pavel
AU  - Sidorov P
AD  - 0000 0001 0339 7822grid.412254.4Mental Health, Northern State Medical University,
      Arkhangelsk, Russian Federation
FAU - Sovershaeva, Evgeniya
AU  - Sovershaeva E
AD  - 0000 0001 0339 7822grid.412254.4Mental Health, Northern State Medical University,
      Arkhangelsk, Russian Federation
FAU - Simões-Wüst, Ana P.
AU  - Simões-Wüst AP
AD  - 0000 0004 0478 9977grid.412004.3Obstetrics, University Hospital Zurich, Zurich,
      8091 Switzerland
FAU - Nietlispach, Anna
AU  - Nietlispach A
AD  - 0000 0004 0478 9977grid.412004.3Obstetrics, University Hospital Zurich, Zurich,
      8091 Switzerland
FAU - Mennet, Mónica
AU  - Mennet M
AD  - Weleda AG, Arlesheim, 4144 Switzerland
FAU - Schnelle, Martin
AU  - Schnelle M
AD  - Weleda AG, Arlesheim, 4144 Switzerland
FAU - von Mandach, Ursula
AU  - von Mandach U
AD  - 0000 0004 0478 9977grid.412004.3Obstetrics, University Hospital Zurich, Zurich,
      8091 Switzerland
FAU - Wang, Xia
AU  - Wang X
AD  - grid.464481.bXiyuan Hospital of China Academy of Chinese Medical Sciences,
      Oncology Department, Beijing, China
FAU - Woo, Hye L.
AU  - Woo HL
AD  - 0000 0001 0357 1464grid.411231.4Department of Korean Gynecology, Kyung Hee
      University Hospital at Gangdong, Seoul, 05278 South Korea
FAU - Lee, Jin M.
AU  - Lee JM
AD  - 0000 0001 0357 1464grid.411231.4Department of Korean Gynecology, Kyung Hee
      University Hospital at Gangdong, Seoul, 05278 South Korea
FAU - Wu, Yuhao
AU  - Wu Y
AD  - 0000 0001 0376 205Xgrid.411304.3Chengdu University of Traditional Chinese
      Medicine, School of Acupuncture, Chengdu, China
FAU - Cho, Yumin
AU  - Cho Y
AD  - 0000 0000 9632 6718grid.19006.3eULCA, David Geffen School of Medicine, Center for
      East West Medicine, Los Angeles, CA USA
FAU - Yun, Younghee
AU  - Yun Y
AD  - 0000 0001 0357 1464grid.411231.4Department of Korean Medicine Dermatology, Kyung 
      Hee University Hospital at Gangdong, Seoul, 134-806 South Korea
FAU - Kim, Hyunho
AU  - Kim H
AD  - 0000 0001 2171 7818grid.289247.2Department of Biofunctional Medicine &
      Diagnostics, Kyung Hee University Korean Medicine Hospital, Seoul, South Korea
FAU - Jung, Wonmo
AU  - Jung W
AD  - 0000 0001 2171 7818grid.289247.2Department of Science in Korean Medicine,
      Graduate School, Kyung Hee University, Seoul, South Korea
FAU - Jang, Bo-Hyung
AU  - Jang BH
AD  - 0000 0001 2171 7818grid.289247.2Department of Preventive Medicine, Graduate
      School, Kyung Hee University, Seoul, South Korea
FAU - Ziea, Eric
AU  - Ziea E
AD  - 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority, 
      Hong Kong, Hong Kong
FAU - Hui, Henny
AU  - Hui H
AD  - 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority, 
      Hong Kong, Hong Kong
FAU - Li, Mia
AU  - Li M
AD  - 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority, 
      Hong Kong, Hong Kong
FAU - Tsui, Dora
AU  - Tsui D
AD  - 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority, 
      Hong Kong, Hong Kong
FAU - Lam, Christine
AU  - Lam C
AD  - 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority, 
      Hong Kong, Hong Kong
FAU - Hsieh, Joyce
AU  - Hsieh J
AD  - 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority, 
      Hong Kong, Hong Kong
FAU - Chan, Edith
AU  - Chan E
AD  - 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority, 
      Hong Kong, Hong Kong
FAU - Balneaves, Lynda
AU  - Balneaves L
AD  - 0000 0004 1936 9609grid.21613.37College of Nursing, University of Manitoba,
      Winnipeg, R3T 2N2 Canada
FAU - Burnside, Sandra
AU  - Burnside S
AD  - 0000 0004 0463 0093grid.460766.5The Scarborough Hospital, Toronto, Canada
FAU - Doyle, Ethel
AU  - Doyle E
AD  - 0000 0004 0463 0093grid.460766.5The Scarborough Hospital, Toronto, Canada
FAU - Dorazio, Shelley
AU  - Dorazio S
AD  - 0000 0004 0463 0093grid.460766.5The Scarborough Hospital, Toronto, Canada
FAU - Chan, Pak K.
AU  - Chan PK
AD  - Leslie Dan Faculty of Pharmacy, Toronto, Canada
FAU - Bhagra, Anjali
AU  - Bhagra A
AD  - 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, Rochester, MN USA
FAU - Chen, Po-Hsu
AU  - Chen PH
AD  - 0000 0004 0572 7372grid.413814.bChinese medicine, Changhua Christian Hospital,
      Changhua, 500 Taiwan
FAU - Chung, Vincent C. H.
AU  - Chung VCH
AD  - 0000 0004 1937 0482grid.10784.3aJockey Club School of Public Health and Primary
      Care, The Chinese University of Hong Kong, Shatin, Hong Kong Hong Kong
FAU - Wu, Justin C. Y.
AU  - Wu JCY
AD  - 0000 0004 1937 0482grid.10784.3aThe Chinese University of Hong Kong, Hong Kong
      Institute of Integrative Medicine, Hong Kong, Hong Kong
FAU - Lin, Zhi X.
AU  - Lin ZX
AD  - 0000 0004 1937 0482grid.10784.3aThe Chinese University of Hong Kong, Hong Kong
      Institute of Integrative Medicine, Hong Kong, Hong Kong
FAU - Wong, Wendy
AU  - Wong W
AD  - 0000 0004 1937 0482grid.10784.3aThe Chinese University of Hong Kong, Hong Kong
      Institute of Integrative Medicine, Hong Kong, Hong Kong
FAU - Wu, Xin Y.
AU  - Wu XY
AD  - 0000 0004 1937 0482grid.10784.3aThe Chinese University of Hong Kong, Hong Kong
      Institute of Integrative Medicine, Hong Kong, Hong Kong
FAU - Ho, Robin S. T.
AU  - Ho RST
AD  - 0000 0004 1937 0482grid.10784.3aJockey Club School of Public Health and Primary
      Care, The Chinese University of Hong Kong, Shatin, Hong Kong Hong Kong
FAU - Wong, Charlene H. L.
AU  - Wong CHL
AD  - 0000 0004 1937 0482grid.10784.3aDepartment of Medicine and Therapeutics, The
      Chinese University of Hong Kong, Shatin, Hong Kong Hong Kong
FAU - Chan, Lily
AU  - Chan L
AD  - 0000 0004 1937 0482grid.10784.3aThe Chinese University of Hong Kong, Hong Kong
      Institute of Integrative Medicine, Hong Kong, Hong Kong
FAU - Ziea, Eric T. C.
AU  - Ziea ETC
AD  - 0000 0004 1937 0482grid.10784.3aThe Chinese University of Hong Kong, Hong Kong
      Institute of Integrative Medicine, Hong Kong, Hong Kong
FAU - Elder, William
AU  - Elder W
AD  - 0000 0004 1936 8438grid.266539.dUniversity of Kentucky, Lexington, KY USA
FAU - Cardarelli, Roberto
AU  - Cardarelli R
AD  - 0000 0004 1936 8438grid.266539.dUniversity of Kentucky, Lexington, KY USA
FAU - Kaspar, Cornelia
AU  - Kaspar C
AD  - Simonton Cancer Center, Ulm, 89077 Germany
FAU - Kempenich, Robert
AU  - Kempenich R
AD  - AREMA, Strasbourg, 67000 France
FAU - Kopferschmitt, Jacques
AU  - Kopferschmitt J
AD  - Unistra, Strasbourg, 67000 France
FAU - Marinko, Zulj
AU  - Marinko Z
AD  - Department of Integrative Medicine, Faculty of medicine Osijek, Osijek, 31000
      Croatia
FAU - Damir, Sebo
AU  - Damir S
AD  - Department of Integrative Medicine, Faculty of medicine Osijek, Osijek, 31000
      Croatia
FAU - Vcev, Aleksandar
AU  - Vcev A
AD  - Department of Integrative Medicine, Faculty of medicine Osijek, Osijek, 31000
      Croatia
FAU - Monezi, Ricardo
AU  - Monezi R
AD  - 0000 0001 0514 7202grid.411249.bCampus Avançado de Extensão Santo Amaro, UNIFESP,
      São Paulo, 04753060 Brazil
FAU - Ruggerini, Eny Márcia
AU  - Ruggerini EM
AD  - Setor Espiritualidade e Saúde, Fundação Mokiti Okada, São Paulo, 04015-050 Brazil
FAU - Fuchigami, Ivna M.
AU  - Fuchigami IM
AD  - 0000 0001 2295 1681grid.456932.fReligious Studies, Methodist University of São
      Paulo, São Bernardo do Campo, 09641-000 Brazil
FAU - Mazini, Ana C. Moreno
AU  - Mazini ACM
AD  - 0000 0001 2163 588Xgrid.411247.5Departamento de Ciências Biológicas, Universidade
      Federal de São Carlos, São Carlos, 13565-905 Brazil
FAU - Monezi, Ricardo
AU  - Monezi R
AD  - 0000 0001 0514 7202grid.411249.bUNIFESP, São Paulo, 04753060 Brazil
FAU - Oliveira, Maria Waldenez
AU  - Oliveira MW
AD  - 0000 0001 2163 588Xgrid.411247.5Departamento de Ciências Biológicas, Universidade
      Federal de São Carlos, São Carlos, 13565-905 Brazil
FAU - Papuga, Petar
AU  - Papuga P
AD  - Daofa, Komenda, 1218 Slovenia
FAU - Schloss, Janet
AU  - Schloss J
AD  - 0000 0000 9962 2299grid.459858.dOffice of Research, Endeavour College of Natural 
      Health, Fortitude Valley, 4006 Australia
FAU - Steel, Amie
AU  - Steel A
AD  - 0000 0000 9962 2299grid.459858.dOffice of Research, Endeavour College of Natural 
      Health, Fortitude Valley, 4006 Australia
FAU - Jacobsen, Márcia da Silva
AU  - Jacobsen Mda S
AD  - Curso Técnico em Massoterapia, Escola de Educação Profissional Cecília Meireles –
      SEG, Porto Alegre, Brazil
FAU - Monezi, Ricardo
AU  - Monezi R
AD  - 0000 0001 0514 7202grid.411249.bUNIFESP, São Paulo, 04753060 Brazil
FAU - Jacobsen, Miranda Rodrigo
AU  - Jacobsen MR
AD  - 0000 0004 0520 9866grid.464548.fFisioterapia, Centro Universitário Metodista-IPA,
      Porto Alegre, 90420-004 Brazil
FAU - Mangini, Maria T.
AU  - Mangini MT
AD  - Curso Técnico em Massoterapia, Escola de Educação Profissional Cecília Meireles –
      SEG, Porto Alegre, Brazil
FAU - Trapani, Gianfranco
AU  - Trapani G
AD  - SMB ITALIA, Sanremo, 18038 Italy
FAU - Di Giampietro, Tiziana
AU  - Di Giampietro T
AD  - SIOMI, Integrative Medicine School, Firenze, Italy
FAU - Zanino, Luisella
AU  - Zanino L
AD  - SMB ITALIA, Sanremo, 18038 Italy
FAU - Ciullo, Luigi
AU  - Ciullo L
AD  - Istituto Europeo di Medicina Osteopatica, Osteopathy School, Genova, Italy
FAU - Lanaro, Diego
AU  - Lanaro D
AD  - Istituto Europeo di Medicina Osteopatica, Osteopathy School, Genova, Italy
FAU - Cerritelli, Francesco
AU  - Cerritelli F
AD  - COME Collaboration ONLUS, Fondazione per la Ricerca in Ambito Osteopatico, Vasto,
      Italy
FAU - Macrì, Francesco
AU  - Macrì F
AD  - SIOMI, Integrative Medicine School, Firenze, Italy
FAU - Tsai, Andre
AU  - Tsai A
AD  - Acupuncture Centre of IOTHCFMSUP, São Paulo, 05410001 Brazil
FAU - Lin, Chin
AU  - Lin C
AD  - 0000 0004 1937 0722grid.11899.38Acupuncture Centre of Orthopaedic and
      Traumatology Institute of Hospital das Clinicas, Medical School, São Paulo
      University, São Paulo, Brazil
FAU - Wu, Tu-Hsing
AU  - Wu TH
AD  - 0000 0004 1937 0722grid.11899.38Acupuncture Centre of Orthopaedic and
      Traumatology Institute of Hospital das Clinicas, Medical School, São Paulo
      University, São Paulo, Brazil
FAU - D’Alessandro, Eduardo
AU  - D’Alessandro E
AD  - 0000 0004 1937 0722grid.11899.38Acupuncture Centre of Orthopaedic and
      Traumatology Institute of Hospital das Clinicas, Medical School, São Paulo
      University, São Paulo, Brazil
FAU - Watts, Sam
AU  - Watts S
AD  - 0000 0004 1936 9297grid.5491.9Primary Care, University of Southampton,
      Southhampton, SO16 5ST United Kingdom
FAU - Zhang, Ying
AU  - Zhang Y
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Wu, Xufang
AU  - Wu X
AD  - Changying Community Health Service Center, Beijing, China
FAU - Li, Xun
AU  - Li X
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Fei, Yutong
AU  - Fei Y
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Liu, Jianping
AU  - Liu J
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Zhao, Nanqi
AU  - Zhao N
AD  - 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing
      University of Chinese Medicine, Beijing, China
FAU - Jia, Liyan
AU  - Jia L
AD  - 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing
      University of Chinese Medicine, Beijing, China
FAU - Yan, Xiaoyi
AU  - Yan X
AD  - 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing
      University of Chinese Medicine, Beijing, China
FAU - Zhen, Fei
AU  - Zhen F
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Beijing, China
FAU - Liu, Zhaolan
AU  - Liu Z
AD  - 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing
      University of Chinese Medicine, Beijing, China
FAU - Liu, Jianping
AU  - Liu J
AD  - 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing
      University of Chinese Medicine, Beijing, China
FAU - Ahn, Jinhyang
AU  - Ahn J
AD  - 0000 0001 0357 1464grid.411231.4Kyung Hee University Hospital at Gangdong, Seoul,
      05278 South Korea
FAU - Yun, Younghee
AU  - Yun Y
AD  - 0000 0001 0357 1464grid.411231.4Kyung Hee University Hospital at Gangdong, Seoul,
      05278 South Korea
FAU - AlEidi, Sulaiman
AU  - AlEidi S
AD  - National Center for Complementary and Alternative Medicine, Riyadh, Saudi Arabia
FAU - Mohamed, Ashry Gad
AU  - Mohamed AG
AD  - 0000 0004 1773 5396grid.56302.32Family and Community Medicine Department, King
      Saud University, Riyadh, Saudi Arabia
FAU - Al-Beda, Abdullah M.
AU  - Al-Beda AM
AD  - National Center for Complementary and Alternative Medicine, Riyadh, Saudi Arabia
FAU - Abutalib, Raid A.
AU  - Abutalib RA
AD  - Orthopedic Surgery, King Fahad Hospital, Madinah, Saudi Arabia
FAU - Khalil, Mohemmed K. M.
AU  - Khalil MKM
AD  - National Center for Complementary and Alternative Medicine, Riyadh, Saudi Arabia
FAU - Amri, Hakima
AU  - Amri H
AD  - 0000 0001 2186 0438grid.411667.3Biochemistry and Cellular and Molecular Biology, 
      Georgetown University Medical Center, Washington, D.C, USA
FAU - Badekila, Sathyanarayana
AU  - Badekila S
AD  - Ayurveda, Muniyal Institute of Ayurveda Medical Sciences, Manipal, 576104 India
FAU - Behmanesh, Elham
AU  - Behmanesh E
AD  - 0000 0001 0166 0922grid.411705.6School of Traditional Medicine and History of
      Medical Science Research Center, University of Medical Sciences, Babol, 47176477 
      Iran, Islamic Republic of
FAU - Mozaffarpour, Seyyedali
AU  - Mozaffarpour S
AD  - 0000 0001 0166 0922grid.411705.6School of Traditional Medicine and History of
      Medical Science Research Center, University of Medical Sciences, Babol, 47176477 
      Iran, Islamic Republic of
FAU - Behmanesh, Elham
AU  - Behmanesh E
AD  - Traditional Medicine, University of Medical Science, Babol, 4717647745 Iran,
      Islamic Republic of
FAU - Mozaffarpour, Seyyedali
AU  - Mozaffarpour S
AD  - Traditional Medicine, University of Medical Science, Babol, 4717647745 Iran,
      Islamic Republic of
FAU - Behmanesh, Elham
AU  - Behmanesh E
AD  - Traditional Medicine, University of Medical Science, Babol, 4717647745 Iran,
      Islamic Republic of
FAU - Shirooye, Pantea
AU  - Shirooye P
AD  - Traditional Medicine, Shahid eheshti University of Medical Science, Tehran,
      1516745811 Iran, Islamic Republic of
FAU - Meybodi, Razie N.
AU  - Meybodi RN
AD  - Traditional Medicine, Shahid eheshti University of Medical Science, Tehran,
      1516745811 Iran, Islamic Republic of
FAU - Mokaberinejad, Roshanak
AU  - Mokaberinejad R
AD  - Traditional Medicine, Shahid eheshti University of Medical Science, Tehran,
      1516745811 Iran, Islamic Republic of
FAU - Tansaz, Mojgan
AU  - Tansaz M
AD  - Traditional Medicine, Shahid eheshti University of Medical Science, Tehran,
      1516745811 Iran, Islamic Republic of
FAU - Mozaffarpour, Seyyedali
AU  - Mozaffarpour S
AD  - Traditional Medicine, University of Medical Science, Babol, 4717647745 Iran,
      Islamic Republic of
FAU - Chung, Vincent C. H.
AU  - Chung VCH
AD  - 0000 0004 1937 0482grid.10784.3aJockey Club School of Public Health and Primary
      Care, The Chinese University of Hong Kong, Shatin, Hong Kong Hong Kong
FAU - Wu, Xin Y.
AU  - Wu XY
AD  - 0000 0004 1937 0482grid.10784.3aJockey Club School of Public Health and Primary
      Care, The Chinese University of Hong Kong, Shatin, Hong Kong Hong Kong
FAU - Wu, Justin C. Y.
AU  - Wu JCY
AD  - 0000 0004 1937 0482grid.10784.3aJockey Club School of Public Health and Primary
      Care, The Chinese University of Hong Kong, Shatin, Hong Kong Hong Kong
FAU - Daneshfard, Babak
AU  - Daneshfard B
AD  - 0000 0000 8819 4698grid.412571.4Student Research Committee, Shiraz University of 
      Medical Sciences, Shiraz, Iran, Islamic Republic of
FAU - Hosseinkhani, Ayda
AU  - Hosseinkhani A
AD  - 0000 0000 8819 4698grid.412571.4Research Center for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic
      Republic of
FAU - Tafazoli, Vahid
AU  - Tafazoli V
AD  - 0000 0000 8819 4698grid.412571.4Research Center for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic
      Republic of
FAU - Jaladat, Amir M.
AU  - Jaladat AM
AD  - 0000 0000 8819 4698grid.412571.4Research Center for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic
      Republic of
FAU - Jaladat, Amir M.
AU  - Jaladat AM
AD  - 0000 0000 8819 4698grid.412571.4Shiraz University of Medical Sciences, Shiraz,
      Iran, Islamic Republic of
FAU - Sadeghi, Hasan
AU  - Sadeghi H
AD  - 0000 0000 8819 4698grid.412571.4Shiraz University of Medical Sciences, Shiraz,
      Iran, Islamic Republic of
FAU - Jia, Liyan
AU  - Jia L
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Zhao, Nanqi
AU  - Zhao N
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Yan, Xiaoyi
AU  - Yan X
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Zhou, Li
AU  - Zhou L
AD  - 0000 0001 1431 9176grid.24695.3cDongzhimen hospital, Beijing University of
      Chinese Medicine, Beijing, China
FAU - Zhao, Meng
AU  - Zhao M
AD  - 0000 0001 1431 9176grid.24695.3cDongzhimen hospital, Beijing University of
      Chinese Medicine, Beijing, China
FAU - Li, Weiwei
AU  - Li W
AD  - 0000 0001 1431 9176grid.24695.3cXiyuan hospital, Beijing University of Chinese
      Medicine, Beijing, China
FAU - Liu, Jianping
AU  - Liu J
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Liu, Zhaolan
AU  - Liu Z
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Jia, Liyan
AU  - Jia L
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Zhao, Nanqi
AU  - Zhao N
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Yan, Xiaoyi
AU  - Yan X
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Zhou, Li
AU  - Zhou L
AD  - 0000 0001 1431 9176grid.24695.3cDongzhimen hospital, Beijing University of
      Chinese Medicine, Beijing, China
FAU - Zhao, Meng
AU  - Zhao M
AD  - 0000 0001 1431 9176grid.24695.3cDongzhimen hospital, Beijing University of
      Chinese Medicine, Beijing, China
FAU - Li, Weiwei
AU  - Li W
AD  - 0000 0001 1431 9176grid.24695.3cXiyuan hospital, Beijing University of Chinese
      Medicine, Beijing, China
FAU - Liu, Jianping
AU  - Liu J
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Liu, Zhaolan
AU  - Liu Z
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Larsen, Anette L.
AU  - Larsen AL
AD  - 0000000122595234grid.10919.30Department of Community Medicine, NAFKAM, The Arctic
      University of Norway UiT, Tromsø, 9037 Norway
FAU - Salamonsen, Anita
AU  - Salamonsen A
AD  - 0000000122595234grid.10919.30Department of Community Medicine, NAFKAM, The Arctic
      University of Norway UiT, Tromsø, 9037 Norway
FAU - Kristoffersen, Agnete E.
AU  - Kristoffersen AE
AD  - 0000000122595234grid.10919.30Department of Community Medicine, NAFKAM, The Arctic
      University of Norway UiT, Tromsø, 9037 Norway
FAU - Hamran, Torunn
AU  - Hamran T
AD  - Department of Health and Care Sciences, The Artic University of Norway, Tromsø,
      9037 Norway
FAU - Evjen, Bjørg
AU  - Evjen B
AD  - Centre for Sami studies, The Actic University of Norway, Tromsø, 9037 Norway
FAU - Stub, Trine
AU  - Stub T
AD  - 0000000122595234grid.10919.30Department of Community Medicine, NAFKAM, The Arctic
      University of Norway UiT, Tromsø, 9037 Norway
FAU - Li, Meiling
AU  - Li M
AD  - 0000 0000 8848 7685grid.411866.cGuangzhou University of Chinese Medicine,
      Guangzhou, 510000 China
FAU - Cai, Jianxiong
AU  - Cai J
AD  - 0000 0000 8848 7685grid.411866.cThe Second Affiliated Hospital of Guangzhou
      University of Chinese Medicine, Guangzhou, 510120 China
FAU - Lu, Taoying
AU  - Lu T
AD  - 0000 0000 8848 7685grid.411866.cThe Second Affiliated Hospital of Guangzhou
      University of Chinese Medicine, Guangzhou, 510120 China
FAU - Yin, Lingjia
AU  - Yin L
AD  - 0000 0000 8848 7685grid.411866.cThe Second Affiliated Hospital of Guangzhou
      University of Chinese Medicine, Guangzhou, 510120 China
FAU - Wu, Darong
AU  - Wu D
AD  - 0000 0000 8848 7685grid.411866.cThe Second Affiliated Hospital of Guangzhou
      University of Chinese Medicine, Guangzhou, 510120 China
FAU - Wang, Lixin
AU  - Wang L
AD  - 0000 0004 1757 641Xgrid.440665.5The Affiliated Hospital of Changchun University
      of Chinese Medicine, Changchun, China
FAU - Liew, Siaw M.
AU  - Liew SM
AD  - 0000 0004 0366 8516grid.444452.7Cyberjaya University College of Medical Sciences,
      Cyberjaya, Malaysia
FAU - Liu, Tiegang
AU  - Liu T
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Bai, Chen
AU  - Bai C
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Zheng, Zian
AU  - Zheng Z
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Wan, Yuxiang
AU  - Wan Y
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Xu, Jingnan
AU  - Xu J
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Wang, Xuan
AU  - Wang X
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Yu, He
AU  - Yu H
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Gu, Xiaohong
AU  - Gu X
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing, 
      100029 China
FAU - Liu, Zhaolan
AU  - Liu Z
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Center
      for Evidence-based Chinese Medicine, Beijing, China
FAU - Yan, Xiaoyi
AU  - Yan X
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Center
      for Evidence-based Chinese Medicine, Beijing, China
FAU - Jia, Liyan
AU  - Jia L
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Center
      for Evidence-based Chinese Medicine, Beijing, China
FAU - Zhao, Nanqi
AU  - Zhao N
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Center
      for Evidence-based Chinese Medicine, Beijing, China
FAU - Yang, Guoyan
AU  - Yang G
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Center
      for Evidence-based Chinese Medicine, Beijing, China
FAU - Liu, Jianping
AU  - Liu J
AD  - 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Center
      for Evidence-based Chinese Medicine, Beijing, China
FAU - Mozaffarpour, Seyyedali
AU  - Mozaffarpour S
AD  - Traditional Medicine and Medical history Research Centre, University of Medical
      Science, Babol, Iran, Islamic Republic of
FAU - Behmanesh, Elham
AU  - Behmanesh E
AD  - Traditional Medicine and Medical history Research Centre, University of Medical
      Science, Babol, Iran, Islamic Republic of
FAU - Nimrouzi, Majid
AU  - Nimrouzi M
AD  - 0000 0000 8819 4698grid.412571.4Shiraz University of Medical Sciences, Shiraz,
      Iran, Islamic Republic of
FAU - Tafazoli, Vahid
AU  - Tafazoli V
AD  - 0000 0000 8819 4698grid.412571.4Shiraz University of Medical Sciences, Shiraz,
      Iran, Islamic Republic of
FAU - Daneshfard, Babak
AU  - Daneshfard B
AD  - 0000 0000 8819 4698grid.412571.4Shiraz University of Medical Sciences, Shiraz,
      Iran, Islamic Republic of
FAU - Ostrowski, Deja
AU  - Ostrowski D
AD  - Office of Hawaiian Affairs, Honolulu, 96817 HI USA
FAU - Fox, Kealoha
AU  - Fox K
AD  - Office of Hawaiian Affairs, Honolulu, 96817 HI USA
FAU - Pasalar, Mehdi
AU  - Pasalar M
AD  - 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic
      Republic of
FAU - Tabatabei, Fatemeh
AU  - Tabatabei F
AD  - 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic
      Republic of
FAU - Amini, Fatemeh
AU  - Amini F
AD  - 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic
      Republic of
FAU - Sathasivampillai, Saravanan
AU  - Sathasivampillai S
AD  - 0000000121901201grid.83440.3bSchool of Phramacy, University College London,
      London, WC1N 1AX United Kingdom
FAU - Rajamanoharan, Pholtan
AU  - Rajamanoharan P
AD  - Provincial Department of Indigenous Medicine, Trincomalee, Sri Lanka
FAU - Munday, Michael
AU  - Munday M
AD  - 0000000121901201grid.83440.3bSchool of Phramacy, University College London,
      London, WC1N 1AX United Kingdom
FAU - Heinrich, Michael
AU  - Heinrich M
AD  - 0000000121901201grid.83440.3bSchool of Phramacy, University College London,
      London, WC1N 1AX United Kingdom
FAU - Scherrer, Yvonne M.
AU  - Scherrer YM
AD  - 0000 0004 1937 0642grid.6612.3Sustainability Research Group, University of Basel,
      Basel, 4051 Switzerland
FAU - Heinrich, Michael
AU  - Heinrich M
AD  - 0000 0001 2161 2573grid.4464.2Research Group ‘Pharmacognosy and Phytotherapy’,
      Univ. London, School of Pharmacy, London, WC1N 1AX United Kingdom
FAU - Szuter, Carolyn
AU  - Szuter C
AD  - 0000 0004 0402 6152grid.266820.8Sociology, University of New Brunswick,
      Fredericton, E3B4H7 Canada
FAU - Amini, Fatemeh
AU  - Amini F
AD  - 0000 0001 0745 1259grid.412573.6School of Medicine, Traditional Medicine, Shiraz,
      Iran, Islamic Republic of
FAU - Tabatabaei, Fatemeh
AU  - Tabatabaei F
AD  - 0000 0001 0745 1259grid.412573.6School of Medicine, Traditional Medicine, Shiraz,
      Iran, Islamic Republic of
FAU - Tavakoli, Ali
AU  - Tavakoli A
AD  - 0000 0000 8819 4698grid.412571.4Research Center for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic
      Republic of
FAU - Tavakoli, Fatemeh
AU  - Tavakoli F
AD  - 0000 0000 8819 4698grid.412571.4Research Center for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic
      Republic of
FAU - Pasalar, Mehdi
AU  - Pasalar M
AD  - 0000 0000 8819 4698grid.412571.4Research Center for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic
      Republic of
FAU - rostami, Mahsa
AU  - rostami M
AD  - 0000 0000 8819 4698grid.412571.4Research Center for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic
      Republic of
FAU - Torri, Maria C.
AU  - Torri MC
AD  - 0000 0004 0402 6152grid.266820.8Sociology, University of New Brunswick,
      Fredericton, E3B4H7 Canada
FAU - Szuter, Carolyn
AU  - Szuter C
AD  - 0000 0004 0402 6152grid.266820.8Sociology, University of New Brunswick,
      Fredericton, E3B4H7 Canada
FAU - Walach, Harald
AU  - Walach H
AD  - 0000 0001 2205 0971grid.22254.33Pediatric Gastroenterology, Poznan Medical
      University, Poznan, 60-572 Poland
FAU - Warner, Faith
AU  - Warner F
AD  - 0000 0001 0710 330Xgrid.15822.3cMiddlesex University, London, NW4 4BT United
      Kingdom
FAU - Majumdar, Anne
AU  - Majumdar A
AD  - 0000 0004 5903 394Xgrid.417907.cSHAS, St Mary’s University Twickenham,
      Twickenham, TW1 4SX United Kingdom
FAU - Serasingh, Palitha
AU  - Serasingh P
AD  - 0000 0001 0710 330Xgrid.15822.3cMiddlesex University, London, NW4 4BT United
      Kingdom
FAU - Yan, Xiaoyi
AU  - Yan X
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Jia, Liyan
AU  - Jia L
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Zhao, Nanqi
AU  - Zhao N
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Liu, Zhaolan
AU  - Liu Z
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Liu, Jianping
AU  - Liu J
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Zhao, Nanqi
AU  - Zhao N
AD  - 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing
      University of Chinese Medicine, Beijing, China
FAU - Zhen, Fei
AU  - Zhen F
AD  - 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese 
      Medicine, Beijing, China
FAU - Jia, Liyan
AU  - Jia L
AD  - 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing
      University of Chinese Medicine, Beijing, China
FAU - Yan, Xiaoyi
AU  - Yan X
AD  - 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing
      University of Chinese Medicine, Beijing, China
FAU - Liu, Zhaolan
AU  - Liu Z
AD  - 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing
      University of Chinese Medicine, Beijing, China
FAU - Liu, Jianping
AU  - Liu J
AD  - 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing
      University of Chinese Medicine, Beijing, China
FAU - Abbing, Annemarie
AU  - Abbing A
AD  - 0000000120346234grid.5477.1Anthroposphic Health Care, University of applied
      sciences, Leiden, 2300 AJ Netherlands
FAU - Ponstein, Anne
AU  - Ponstein A
AD  - 0000000120346234grid.5477.1Anthroposphic Health Care, University of applied
      sciences, Leiden, 2300 AJ Netherlands
FAU - Baars, Erik
AU  - Baars E
AD  - 0000000120346234grid.5477.1Anthroposphic Health Care, University of applied
      sciences, Leiden, 2300 AJ Netherlands
FAU - Croke, Sarah
AU  - Croke S
AD  - 0000 0004 1936 8403grid.9909.9School of Heathcare, University of Leeds Alumnus,
      Rochdale, OL12 7RX United Kingdom
FAU - Hanser, Suzanne
AU  - Hanser S
AD  - grid.427946.aMusic Therapy, Berklee College of Music, Boston, 02215 USA
FAU - Heckel, Viola
AU  - Heckel V
AD  - Klinik Arlesheim, Arlesheim, 4144 Switzerland
FAU - Krüerke, Daniel
AU  - Krüerke D
AD  - Klinik Arlesheim, Arlesheim, 4144 Switzerland
FAU - Simões-Wüst, Ana P.
AU  - Simões-Wüst AP
AD  - Klinik Arlesheim, Arlesheim, 4144 Switzerland
FAU - Weiss, Sebastian
AU  - Weiss S
AD  - Klinik Öschelbronn, Niefern-Öschelbronn, Germany
FAU - Metzner, Susanne
AU  - Metzner S
AD  - 0000 0001 2108 9006grid.7307.3University of Augsburg, Augsburg, Germany
FAU - Lee, Jang W.
AU  - Lee JW
AD  - 0000 0001 0671 5021grid.255168.dCollege of Korean Medicine, Dongguk University,
      Goyang, South Korea
FAU - Hyun, Min K.
AU  - Hyun MK
AD  - 0000 0001 0671 5021grid.255168.dPreventive Medicine, College of Korean Medicine, 
      Dongguk University, Gyeongju, South Korea
FAU - Masetti, Morgana
AU  - Masetti M
AD  - 0000 0001 2149 6891grid.412529.9Psychology, Pontificia Universidade Católica de
      Sao Paulo, Rio de Janeiro, 22430 Brazil
FAU - Oepen, Renate
AU  - Oepen R
AD  - grid.448722.fResearch Institute for Creative Arts Therapies (RIArT), Alanus
      University of Arts and Social Sciences, Alfter/Bonn, 53347 Germany
FAU - Gruber, Harald
AU  - Gruber H
AD  - grid.448722.fResearch Institute for Creative Arts Therapies (RIArT), Alanus
      University of Arts and Social Sciences, Alfter/Bonn, 53347 Germany
FAU - Heusser, Peter
AU  - Heusser P
AD  - 0000 0000 9024 6397grid.412581.bTheory of Medicine, Integrative and
      Anthroposophic Medicine, Witten/Herdecke University, Herdecke, 58313 Germany
FAU - Pelz, Holger
AU  - Pelz H
AD  - DGOM e.V./HGMB i.G, Buxtehude, 21614 Germany
FAU - Perlitz, Volker
AU  - Perlitz V
AD  - DGOM e.V./HGMB i.G, Buxtehude, 21614 Germany
FAU - Ponstein, Anne
AU  - Ponstein A
AD  - 0000000120346234grid.5477.1Anthroposphic Health Care, University of applied
      sciences, Leiden, 2300 AJ Netherlands
FAU - Abbing, Annemarie
AU  - Abbing A
AD  - 0000000120346234grid.5477.1Anthroposphic Health Care, University of applied
      sciences, Leiden, 2300 AJ Netherlands
FAU - Baars, Erik
AU  - Baars E
AD  - 0000000120346234grid.5477.1Anthroposphic Health Care, University of applied
      sciences, Leiden, 2300 AJ Netherlands
FAU - Robinson, Nicola
AU  - Robinson N
AD  - 0000 0001 2112 2291grid.4756.0School of Health and Social Care, London South Bank
      University, London, SE1 0AA United Kingdom
FAU - Ronan, Patricia
AU  - Ronan P
AD  - 0000 0001 2112 2291grid.4756.0School of Health and Social Care, London South Bank
      University, London, SE1 0AA United Kingdom
FAU - Mian, Awais
AU  - Mian A
AD  - 0000 0001 2112 2291grid.4756.0School of Health and Social Care, London South Bank
      University, London, SE1 0AA United Kingdom
FAU - Madge, Su
AU  - Madge S
AD  - 0000 0004 0581 2008grid.451052.7Royal Brompton and Harefield NHS Trust, London,
      United Kingdom
FAU - Lorenc, Ava
AU  - Lorenc A
AD  - 0000 0001 2112 2291grid.4756.0School of Health and Social Care, London South Bank
      University, London, SE1 0AA United Kingdom
FAU - Agent, Penny
AU  - Agent P
AD  - 0000 0004 0581 2008grid.451052.7Royal Brompton and Harefield NHS Trust, London,
      United Kingdom
FAU - Carr, Siobhan
AU  - Carr S
AD  - 0000 0004 0581 2008grid.451052.7Royal Brompton and Harefield NHS Trust, London,
      United Kingdom
FAU - Ronan, Patricia
AU  - Ronan P
AD  - 0000 0001 2112 2291grid.4756.0School of Health and Social Care, London South Bank
      University, London, SE1 0AA United Kingdom
FAU - Robinson, Nicola
AU  - Robinson N
AD  - 0000 0001 2112 2291grid.4756.0School of Health and Social Care, London South Bank
      University, London, SE1 0AA United Kingdom
FAU - Carr, Siobhan
AU  - Carr S
AD  - 0000 0004 0581 2008grid.451052.7Royal Brompton and Harefield NHS Trust, London,
      United Kingdom
FAU - Mian, Awais
AU  - Mian A
AD  - 0000 0001 2112 2291grid.4756.0School of Health and Social Care, London South Bank
      University, London, SE1 0AA United Kingdom
FAU - Lorenc, Ava
AU  - Lorenc A
AD  - 0000 0001 2112 2291grid.4756.0School of Health and Social Care, London South Bank
      University, London, SE1 0AA United Kingdom
FAU - Agent, Penny
AU  - Agent P
AD  - 0000 0004 0581 2008grid.451052.7Royal Brompton and Harefield NHS Trust, London,
      United Kingdom
FAU - Madge, Su
AU  - Madge S
AD  - 0000 0004 0581 2008grid.451052.7Royal Brompton and Harefield NHS Trust, London,
      United Kingdom
FAU - Winnubst, Monica E.
AU  - Winnubst ME
AD  - 0000 0001 0514 7202grid.411249.bUNIFESP, Sao Paulo, 04753-060 Brazil
FAU - Monezi, Ricardo
AU  - Monezi R
AD  - 0000 0001 0514 7202grid.411249.bUNIFESP, Sao Paulo, 04753-060 Brazil
FAU - Abolghasemi, Jafar
AU  - Abolghasemi J
AD  - 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, 71348457
      Iran, Islamic Republic of
FAU - Heydari, Mojtaba
AU  - Heydari M
AD  - 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and
      History of Medicine, Shiraz University of Medical Sciences, Shiraz, 71348457
      Iran, Islamic Republic of
FAU - Baccetti, Sonia
AU  - Baccetti S
AD  - Centre of Acupuncture and Traditional Chinese Medicine, Tuscan network for
      Integrative Medicine, Florence, 50133 Italy
FAU - Rossi, Elio
AU  - Rossi E
AD  - Tuscan network for Integrative Medicine, Florence, 50139 Italy
FAU - Fedi, Paolo
AU  - Fedi P
AD  - Tuscan network for Integrative Medicine, Florence, 50139 Italy
FAU - Di Stefano, Mariella
AU  - Di Stefano M
AD  - Tuscan network for Integrative Medicine, Florence, 50139 Italy
FAU - Belvedere, Katia
AU  - Belvedere K
AD  - Health Directorate, Region of Tuscany, Florence, 50139 Italy
FAU - Baccetti, Sonia
AU  - Baccetti S
AD  - Centre of Acupuncture and Traditional Chinese Medicine, Tuscan network for
      Integrative Medicine, Florence, 50133 Italy
FAU - Rossi, Elio
AU  - Rossi E
AD  - Tuscan Network of Integrative Medicine, Florence, 50139 Italy
FAU - Firenzuoli, Fabio
AU  - Firenzuoli F
AD  - Tuscan Network of Integrative Medicine, Florence, 50139 Italy
FAU - Di Stefano, Mariella
AU  - Di Stefano M
AD  - Tuscan Network of Integrative Medicine, Florence, 50139 Italy
FAU - Belvedere, Katia
AU  - Belvedere K
AD  - Health Directorate, Region of Tuscany, Florence, 50139 Italy
FAU - Beaven, Katherine
AU  - Beaven K
AD  - Eurythm Therapy, Raphael Medical Centre, Hildenborough, United Kingdom
FAU - Rose, Anita
AU  - Rose A
AD  - Eurythm Therapy, Raphael Medical Centre, Hildenborough, United Kingdom
FAU - Florschutz, Gerhard
AU  - Florschutz G
AD  - Eurythm Therapy, Raphael Medical Centre, Hildenborough, United Kingdom
FAU - Phil, Nicola Brough
AU  - Phil NB
AD  - 0000 0000 8809 1613grid.7372.1Warwick Medical School, University of Warwick,
      Coventry, CV4 7AL United Kingdom
FAU - Parsons, Helen
AU  - Parsons H
AD  - 0000 0000 8809 1613grid.7372.1Warwick Medical School, University of Warwick,
      Coventry, CV4 7AL United Kingdom
FAU - Stewart-Brown, Sarah
AU  - Stewart-Brown S
AD  - 0000 0000 8809 1613grid.7372.1Warwick Medical School, University of Warwick,
      Coventry, CV4 7AL United Kingdom
FAU - Burke, Katherine
AU  - Burke K
AD  - 0000 0001 2188 0957grid.410445.0Office of Public Health Studies, University of
      Hawaii, Honolulu, HI USA
FAU - Busch, Martine
AU  - Busch M
AD  - Van Praag Instituut, Utrecht, 3511 VH Netherlands
FAU - Heyning, Fenna
AU  - Heyning F
AD  - STZ Association of Teaching Hospitals, Utrecht, Netherlands
FAU - Smit, Jan
AU  - Smit J
AD  - 0000000122931605grid.5590.9Internal Medicine, Radboud University Medical School, 
      Nijmegen, Netherlands
FAU - Jeekel, Hans
AU  - Jeekel H
AD  - 0000000092621349grid.6906.9Surgery, Erasmus University Medical School, Rotterdam,
      Netherlands
FAU - de Goeij, Hans
AU  - de Goeij H
AD  - Ministery of Health, Den Haag, Netherlands
FAU - Guido, Paulo Caceres
AU  - Guido PC
AD  - grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos
      Aires, 1245 Argentina
FAU - Barraza, Norma
AU  - Barraza N
AD  - grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos
      Aires, 1245 Argentina
FAU - Balbarrey, Ziomara
AU  - Balbarrey Z
AD  - grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos
      Aires, 1245 Argentina
FAU - Ribas, Alejandra
AU  - Ribas A
AD  - grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos
      Aires, 1245 Argentina
FAU - Jimenez, Beatriz
AU  - Jimenez B
AD  - grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos
      Aires, 1245 Argentina
FAU - Iachino, Claudia
AU  - Iachino C
AD  - grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos
      Aires, 1245 Argentina
FAU - Quattrone, Fabiana
AU  - Quattrone F
AD  - grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos
      Aires, 1245 Argentina
FAU - Gaioli, Marisa
AU  - Gaioli M
AD  - grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos
      Aires, 1245 Argentina
FAU - Dell’Orso, Marta
AU  - Dell’Orso M
AD  - grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos
      Aires, 1245 Argentina
FAU - Villanueva, Silvia
AU  - Villanueva S
AD  - grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos
      Aires, 1245 Argentina
FAU - Rocha, Carmen
AU  - Rocha C
AD  - grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos
      Aires, 1245 Argentina
FAU - Macchi, Adriana
AU  - Macchi A
AD  - grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos
      Aires, 1245 Argentina
FAU - Cai, Jianxiong
AU  - Cai J
AD  - 0000 0000 8848 7685grid.411866.cThe TCM Clinical Outcome Assessment Team, The
      Second Affiliated Hospital of Guangzhou University of Chinese Medicine,
      Guangzhou, 510120 China
FAU - Chen, Lina
AU  - Chen L
AD  - Science and Technology Division, State Administration of Traditional Chinese
      Medicine of the People of China, Beijing, 100027 China
FAU - Wu, Darong
AU  - Wu D
AD  - 0000 0000 8848 7685grid.411866.cThe TCM Clinical Outcome Assessment Team, The
      Second Affiliated Hospital of Guangzhou University of Chinese Medicine,
      Guangzhou, 510120 China
FAU - Wang, Sicheng
AU  - Wang S
AD  - Science and Technology Division, State Administration of Traditional Chinese
      Medicine of the People of China, Beijing, 100027 China
FAU - Choi, Eunji
AU  - Choi E
AD  - ONBODYCLINIC, Seoul, South Korea
FAU - Go, Namgyeong
AU  - Go N
AD  - ONBODYCLINIC, Seoul, South Korea
FAU - Lee, Yongho
AU  - Lee Y
AD  - ONBODYCLINIC, Seoul, South Korea
FAU - Dahal, Gokarna
AU  - Dahal G
AD  - Department of Ayurveda, Ministry of Health, Kathmandu, Nepal
FAU - Frauenknecht, Xaver
AU  - Frauenknecht X
AD  - 0000 0001 0617 3250grid.419802.6Sozialstiftung Bamberg, Bamberg, 96049 Germany
FAU - Gerhardt, Heike
AU  - Gerhardt H
AD  - 0000 0001 0617 3250grid.419802.6Sozialstiftung Bamberg, Bamberg, 96049 Germany
FAU - Galanti, Mónica
AU  - Galanti M
AD  - grid.415779.9Public Policies, Ministry of Health, Santiago, 8320000 Chile
FAU - Cerda, Carmen J.
AU  - Cerda CJ
AD  - grid.415779.9Public Policies, Ministry of Health, Santiago, 8320000 Chile
FAU - Galanti, Mónica
AU  - Galanti M
AD  - grid.415779.9Ministry of Health, Public Policies, Santiago, Chile
FAU - Galanti, Mónica
AU  - Galanti M
AD  - grid.415779.9Public Policies, Ministry of Health, Santiago, Chile
FAU - Heckersdorf, Daniela Navarrete
AU  - Heckersdorf DN
AD  - Department of Quality of Life and Labor Relations, Chilean Health Ministry,
      Santiago, Chile
FAU - Jorquera, Héctor
AU  - Jorquera H
AD  - Chilean Health Service, Santiago, Chile
FAU - Saldivia, María L. Alcázar
AU  - Saldivia MLA
AD  - Department of health explicit guarantees and High Complexity Networks, Chilean
      Health Ministry, Santiago, Chile
FAU - Jakubonienė, Daiva
AU  - Jakubonienė D
AD  - Natūraliosios terapijos centras, Vilnius, 08119 Lithuania
FAU - McEwen, Bradley
AU  - McEwen B
AD  - 0000 0000 9962 2299grid.459858.dDepartment of Nutritional Medicine, Endeavour
      College of Natural Health, Sydney, 2000 Australia
FAU - Melo, Francislete
AU  - Melo F
AD  - Pharmacy, UPIS, Brasília, 70390-12 Brazil
FAU - Fontana, Fernanda Mulinari
AU  - Fontana FM
AD  - Pharmacy, UPIS, Brasília, 70390-12 Brazil
FAU - Valle, Ana C. Viana
AU  - Valle ACV
AD  - Natural Pet, Brasília, Brazil
FAU - Neres, Maria T. Borges
AU  - Neres MTB
AD  - Pharmacy, UPIS, Brasília, 70390-12 Brazil
FAU - Mohagheghzadeh, Abolali
AU  - Mohagheghzadeh A
AD  - 0000 0000 8819 4698grid.412571.4Museum, Archives and Cultural Studies of Norani
      Vesal, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of
FAU - Zohalinezhad, Mohammad E.
AU  - Zohalinezhad ME
AD  - 0000 0000 8819 4698grid.412571.4Museum, Archives and Cultural Studies of Norani
      Vesal, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of
FAU - Njaradi, Olja
AU  - Njaradi O
AD  - 0000 0000 8819 4698grid.412571.4Museum, Archives and Cultural Studies of Norani
      Vesal, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of
FAU - Dunjic, Momir
AU  - Dunjic M
AD  - BDORT Center, Belgrade, 11000 Serbia
FAU - Njaradi, Olja
AU  - Njaradi O
AD  - BDORT Center, Belgrade, 11000 Serbia
FAU - Dunjic, Momir
AU  - Dunjic M
AD  - BDORT Center, Belgrade, 11000 Serbia
FAU - Ostrowski, Deja
AU  - Ostrowski D
AD  - BDORT Center, Belgrade, 11000 Serbia
FAU - Fox, Kealoha
AU  - Fox K
AD  - Office of Hawaiian Affairs, Honolulu, HI USA
FAU - Pokladnikova, Jitka
AU  - Pokladnikova J
AD  - 0000 0004 1937 116Xgrid.4491.8Charles University, Hradec Kralove, 50005 Czech
      Republic
FAU - Selke-Krulichova, Iva
AU  - Selke-Krulichova I
AD  - 0000 0004 1937 116Xgrid.4491.8Charles University, Hradec Kralove, 50005 Czech
      Republic
FAU - Seo, Jinsoon
AU  - Seo J
AD  - 0000 0004 1937 116Xgrid.4491.8Charles University, Hradec Kralove, 50005 Czech
      Republic
FAU - Jang, Hyunchul
AU  - Jang H
AD  - 0000 0000 8749 5149grid.418980.cKorea Institute of Oriental Medicine, Daejeon,
      South Korea
FAU - Simões-Wüst, Ana P.
AU  - Simões-Wüst AP
AD  - 0000 0004 0478 9977grid.412004.3Obstetrics, University Hospital Zurich, Zurich,
      Switzerland
FAU - Moltó-Puigmartí, Carolina
AU  - Moltó-Puigmartí C
AD  - 0000 0001 0481 6099grid.5012.6Epidemiology,CAPHRI School for Public Health and
      Primary Care, Maastricht University, Maastricht, Netherlands
FAU - van Dongen, Martien
AU  - van Dongen M
AD  - 0000 0001 0481 6099grid.5012.6Epidemiology,CAPHRI School for Public Health and
      Primary Care, Maastricht University, Maastricht, Netherlands
FAU - Dagnelie, Pieter
AU  - Dagnelie P
AD  - 0000 0001 0481 6099grid.5012.6Epidemiology,CAPHRI School for Public Health and
      Primary Care, Maastricht University, Maastricht, Netherlands
FAU - Thijs, Carel
AU  - Thijs C
AD  - 0000 0001 0481 6099grid.5012.6Epidemiology,CAPHRI School for Public Health and
      Primary Care, Maastricht University, Maastricht, Netherlands
FAU - Tihanyi, Eva
AU  - Tihanyi E
AD  - 0000 0001 0663 9479grid.9679.1Faculty of Health Sciences, University of Pecs,
      Pecs, Hungary
FAU - Hegyi, Gabriella
AU  - Hegyi G
AD  - 0000 0001 0663 9479grid.9679.1Confucius Institute of TCM, University of Pecs,
      Pecs, Hungary
FAU - Zhang, Ying
AU  - Zhang Y
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Li, Xun
AU  - Li X
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Fei, Yutong
AU  - Fei Y
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Liu, Jianping
AU  - Liu J
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Zhang, Ying
AU  - Zhang Y
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Liu, Jianping
AU  - Liu J
AD  - 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine,
      Beijing University of Chinese Medicine, Beijing, China
FAU - Tong, Xiaolin
AU  - Tong X
AD  - 0000 0004 0632 3409grid.410318.fChina Academy of Chinese Medical Sciences,
      Guang’anmen Hospital, Beijing, China
LA  - eng
PT  - Journal Article
DEP - 20170630
TA  - BMC Complement Altern Med
JT  - BMC Complementary and Alternative Medicine
AID - 1784 [pii]
AID - 10.1186/s12906-017-1784-2 [doi]
SO  - BMC Complement Altern Med. 2017 Jun 30;17(Suppl 1):.
      doi:10.1186/s12906-017-1784-2.

PMC - PMC5492838
PMID- 28604607
IS  - 1424-8220 (Electronic)
VI  - 17
IP  - 6
DP  - 2017 Jun
TI  - Emotional Self-Regulation of Individuals with Autism Spectrum Disorders:
      Smartwatches for Monitoring and Interaction.
LID - 1359
AB  - In this paper, we analyze the needs of individuals with Autism Spectrum Disorders
      (ASD) to have a pervasive, feasible and non-stigmatizing form of assistance in
      their emotional self-regulation, in order to ease certain behavioral issues that 
      undermine their mental health throughout their life. We argue the potential of
      recent widespread wearables, and more specifically smartwatches, to achieve this 
      goal. Then, a smartwatch system that implements a wide range of self-regulation
      strategies and infers outburst patterns from physiological signals and movement
      is presented, along with an authoring tool for smartphones that is to be used by 
      caregivers or family members to create and edit these strategies, in an adaptive 
      way. We conducted an intensive experiment with two individuals with ASD who
      showed varied, representative behavioral responses to their emotional
      dysregulation. Both users were able to employ effective, customized emotional
      self-regulation strategies by means of the system, recovering from the majority
      of mild stress episodes and temper tantrums experienced in the nine days of
      experiment in their classroom.
FAU - Torrado, Juan C.
AU  - Torrado JC
FAU - Gomez, Javier
AU  - Gomez J
FAU - Montoro, Germán
AU  - Montoro G
LA  - eng
PT  - Journal Article
DEP - 20170611
PHST- 2017/05/01 [received]
PHST- 2017/06/06 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s17061359 [doi]
AID - sensors-17-01359 [pii]
SO  - Sensors (Basel). 2017 Jun 11;17(6):. doi:10.3390/s17061359.

PMC - PMC5319996
PMID- 28275344
IS  - 1662-5161 (Electronic)
VI  - 11
DP  - 2017
TI  - EEG-Neurofeedback as a Tool to Modulate Cognition and Behavior: A Review
      Tutorial.
LID - 51
AB  - Neurofeedback is attracting renewed interest as a method to self-regulate one’s
      own brain activity to directly alter the underlying neural mechanisms of
      cognition and behavior. It not only promises new avenues as a method for
      cognitive enhancement in healthy subjects, but also as a therapeutic tool. In the
      current article, we present a review tutorial discussing key aspects relevant to 
      the development of electroencephalography (EEG) neurofeedback studies. In
      addition, the putative mechanisms underlying neurofeedback learning are
      considered. We highlight both aspects relevant for the practical application of
      neurofeedback as well as rather theoretical considerations related to the
      development of new generation protocols. Important characteristics regarding the 
      set-up of a neurofeedback protocol are outlined in a step-by-step way. All these 
      practical and theoretical considerations are illustrated based on a protocol and 
      results of a frontal-midline theta up-regulation training for the improvement of 
      executive functions. Not least, assessment criteria for the validation of
      neurofeedback studies as well as general guidelines for the evaluation of
      training efficacy are discussed.
FAU - Enriquez-Geppert, Stefanie
AU  - Enriquez-Geppert S
AD  - Department of Clinical and Developmental Neuropsychology, Faculty of Behavioural 
      and Social Sciences, University of GroningenGroningen, Netherlands
FAU - Huster, René J.
AU  - Huster RJ
AD  - Department of Psychology, Faculty of Social Sciences, University of OsloOslo,
      Norway
FAU - Herrmann, Christoph S.
AU  - Herrmann CS
AD  - Experimental Psychology Laboratory, Department of Psychology, Faculty VI Medical 
      and Health Sciences, University of OldenburgOldenburg, Germany
LA  - eng
PT  - Journal Article
DEP - 20170222
PHST- 2016/08/18 [received]
PHST- 2017/01/23 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2017.00051 [doi]
SO  - Front Hum Neurosci. 2017 Feb 22;11:. doi:10.3389/fnhum.2017.00051.

PMC - PMC5029834
IS  - 1559-6109 (Print)
VI  - 55
IP  - 5
DP  - 2016 Sep
TI  - Abstracts of Scientific Presentations: 2016 AALAS National Meeting Charlotte,
      North Carolina.
PG  - 606-710
LA  - eng
PT  - Journal Article
DEP - 201609
PHST- 2016/09 [aheadofprint]
TA  - J Am Assoc Lab Anim Sci
JT  - Journal of the American Association for Laboratory Animal Science : JAALAS
AID - 2016000606 [pii]
SO  - J Am Assoc Lab Anim Sci. 2016 Sep;55(5):606-710. Epub 2016 Sep

PMC - PMC4883358
PMID- 27187388
IS  - 1424-8220 (Electronic)
VI  - 16
IP  - 5
DP  - 2016 May
TI  - A Dual-Field Sensing Scheme for a Guidance System for the Blind.
LID - 667
AB  - An electronic guidance system is very helpful in improving blind people’s
      perceptions in a local environment. In our previous work “Lin, Q.; Han, Y. A
      Context-Aware-Based Audio Guidance System for Blind People Using a Multimodal
      Profile Model. Sensors 2014, 14, 18670–18700”, a context-aware guidance system
      using a combination of a laser scanner and a camera was proposed. By using a
      near-field graphical model, the proposed system could interpret a near-field
      scene in very high resolution. In this paper, our work is extended by adding a
      far-field graphical model. The integration of the near-field and the far-field
      models constitutes a dual-field sensing scheme. In the near-field range, reliable
      inference of the ground and object status is obtained by fusing range data and
      image data using the near-field graphical model. In the far-field range, which
      only the camera can cover, the far-field graphical model is proposed to interpret
      far-field image data based on appearance and spatial prototypes built using the
      near-field interpreted data. The dual-field sensing scheme provides a solution
      for the guidance systems to optimise their scene interpretation capability using 
      simple sensor configurations. Experiments under various local conditions were
      conducted to show the efficiency of the proposed scheme in improving blind
      people’s perceptions in urban environments.
FAU - Lin, Qing
AU  - Lin Q
AD  - Sports-IT Convergence Department, Soongsil University, 511, Sangdo-Dong,
      Dongjak-Gu, Seoul 156-743, Korea; linqing15@ssu.ac.kr
FAU - Han, Youngjoon
AU  - Han Y
AD  - Department of Smart Systems Software, Soongsil University, 511, Sangdo-Dong,
      Dongjak-Gu, Seoul 156-743, Korea
LA  - eng
PT  - Journal Article
DEP - 20160511
PHST- 2016/03/14 [received]
PHST- 2016/04/28 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s16050667 [doi]
AID - sensors-16-00667 [pii]
SO  - Sensors (Basel). 2016 May 11;16(5):. doi:10.3390/s16050667.

PMC - PMC4730549
PMID- 26329308
IS  - 1469-493X (Electronic)
VI  - 8
DP  - 2015
TI  - Telerehabilitation for people with low vision.
PG  - CD011019
AB  - Background: Low vision affects over 300 million people worldwide and can
      compromise both activities of daily living and quality of life. Rehabilitative
      training and vision assistive equipment (VAE) may help, but some visually
      impaired people have limited resources to attend in-person visits at
      rehabilitation clinics. These people may be able to overcome barriers to care
      through remote, Internet-based consultation (i.e., telerehabilitation).
      Objectives: To compare the effects of telerehabilitation with face-to-face (e.g.,
      in-office or inpatient) vision rehabilitation services for improving
      vision-related quality of life and reading speed in people with visual function
      loss due to any ocular condition. Secondary objectives are to evaluate compliance
      with scheduled rehabilitation sessions, abandonment rates for visual assistive
      equipment devices, and patient satisfaction ratings. Search methods: We searched 
      CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (2015
      Issue 5), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, 
      Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1980 to June 2015), EMBASE (January 
      1980 to June 2015), PubMed (1980 to June 2015), ClinicalTrials.gov
      (www.clinicaltrials.gov) and the World Health Organization (WHO) International
      Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did
      not use any language restriction or study design filter in the electronic
      searches; however, we restricted the searches from 1980 onwards because the
      Internet was not introduced to the public until 1982. We last searched the
      electronic databases on 15 June 2015. Selection criteria: We planned to include
      randomized controlled trials (RCTs) or controlled clinical trials (CCTs) in which
      participants were diagnosed with low vision and were undergoing low vision
      rehabilitation using an Internet, web-based technology compared with an approach 
      based on in-person consultations. Data collection and analysis: Two authors
      independently screened titles and abstracts, and then full-text articles against 
      the eligibility criteria. We planned to have two authors independently abstract
      data from included studies. We resolved discrepancies by discussion. Main
      results: We did not find any study that met the inclusion criteria for this
      review and, hence, we did not conduct a quantitative analysis. As a part of the
      background, we discussed review articles on telemedicine for facilitating
      communication with elderly individuals or for providing remote ophthalmological
      care. Authors’ conclusions: We did not find any evidence on whether the use of
      telerehabilitation is feasible or a potentially viable means to remotely deliver 
      rehabilitation services to individuals with low vision. Given the disease burden 
      and the growing interest in telemedicine, there is a need for future pilot
      studies and subsequent clinical trials to explore the potential for
      telerehabilitation as a platform for providing services to people with low
      vision.
FAU - Bittner, Ava K
AU  - Bittner AK
AD  - Nova Southeastern University, College of Optometry, Ft Lauderdale, Florida, USA.
FAU - Wykstra, Stephanie L
AU  - Wykstra SL
AD  - Innovations for Poverty Action, New Haven, Connecticut, USA.
FAU - Yoshinaga, Patrick D
AU  - Yoshinaga PD
AD  - Southern California College of Optometry, Marshall B Ketchum University,
      Fullerton, California, USA.
FAU - Li, Tianjing
AU  - Li T
AD  - Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health,
      Baltimore, Maryland, USA
LA  - eng
PT  - Journal Article
DEP - 20150831
TA  - Cochrane Database Syst Rev
JT  - The Cochrane database of systematic reviews
AID - 10.1002/14651858.CD011019.pub2 [doi]
MID - NIHMS751615
SO  - Cochrane Database Syst Rev. 2015 Aug 31;8:CD011019.
      doi:10.1002/14651858.CD011019.pub2.

PMC - PMC4546863
PMID- 26122301
IS  - 0018-506X (Print)
IS  - 1095-6867 (Electronic)
VI  - 73
DP  - 2015 Jul
TI  - Common and divergent psychobiological mechanisms underlying maternal behaviors in
      non-human and human mammals.
PG  - 156-85
AB  - Maternal interactions with young occupy most of the reproductive period for
      female mammals and are absolutely essential for offspring survival and
      development. The hormonal, sensory, reward-related, emotional, cognitive and
      neurobiological regulators of maternal caregiving behaviors have been well
      studied in numerous subprimate mammalian species, and some of the importance of
      this body of work is thought to be its relevance for understanding similar
      controls in humans. We here review many of the important biopsychological
      influences on maternal behaviors in the two best studied non-human animals,
      laboratory rats and sheep, and directly examine how the conceptual framework
      established by some of the major discoveries in these animal “models” do or do
      not hold for our understanding of human mothering. We also explore some of the
      limits for extrapolating from non-human animals to humans. We conclude that there
      are many similarities between non-human and human mothers in the biological and
      psychological factors influencing their early maternal behavior and that many of 
      the differences are due to species-characteristic features related to the role of
      hormones, the relative importance of each sensory system, flexibility in what
      behaviors are exhibited, the presence or absence of language, and the complexity 
      of cortical function influencing the behavior.
FAU - Lonstein, Joseph S.
AU  - Lonstein JS
AD  - Neuroscience Program and Department of Psychology, 108 Giltner Hall, Michigan
      State University, East Lansing, MI 48824 USA, Lonstein@msu.edu
FAU - Lévy, Frédéric
AU  - Lévy F
AD  - Physiologie de la Reproduction et des Comportements, INRA-CNRS-Université de
      Tours-Haras Nationaux, Nouzilly, 37380 France, Frederic.Levy@tours.inra.fr
FAU - Fleming, Alison S.
AU  - Fleming AS
AD  - Fraser Mustard Institute for Human Development & Department of Psychology,
      University of Toronto at Mississauga, 3359 Mississauga Road, Mississauga, ON L5L 
      1C6 Canada, alison.fleming@utoronto.ca
LA  - eng
PT  - Journal Article
DEP - 20150627
TA  - Horm Behav
JT  - Hormones and behavior
AID - 10.1016/j.yhbeh.2015.06.011 [doi]
MID - NIHMS705712
SO  - Horm Behav. 2015 Jul;73:156-85. Epub 2015 Jun 27 doi:10.1016/j.yhbeh.2015.06.011.

PMC - PMC4604580
IS  - 1932-2968 (Electronic)
VI  - 9
IP  - 2
DP  - 2015 Mar
TI  - 2014 Diabetes Technology Meeting Abstracts.
PG  - 342-485
LA  - eng
PT  - Journal Article
DEP - 20150301
TA  - J Diabetes Sci Technol
JT  - Journal of Diabetes Science and Technology
AID - 10.1177/1932296815570777 [doi]
AID - 10.1177_1932296815570777 [pii]
SO  - J Diabetes Sci Technol. 2015 Mar 1;9(2):342-485. doi:10.1177/1932296815570777.

PMC - PMC4446205
PMID- 25706766
IS  - 0096-1523 (Print)
IS  - 1939-1277 (Electronic)
VI  - 41
IP  - 3
DP  - 2015 Jun
TI  - Spatial learning while navigating with severely degraded viewing: The role of
      attention and mobility monitoring.
PG  - 649-64
AB  - The ability to navigate without getting lost is an important aspect of quality of
      life. In five studies, we evaluated how spatial learning is affected by the
      increased demands of keeping oneself safe while walking with degraded vision
      (mobility monitoring). We proposed that safe low-vision mobility requires
      attentional resources, providing competition for those needed to learn a new
      environment. In Experiments 1 and 2 participants navigated along paths in a
      real-world indoor environment with simulated degraded vision or normal vision.
      Memory for object locations seen along the paths was better with normal compared 
      to degraded vision. With degraded vision, memory was better when participants
      were guided by an experimenter (low monitoring demands) versus unguided (high
      monitoring demands). In Experiments 3 and 4, participants walked while performing
      an auditory task. Auditory task performance was superior with normal compared to 
      degraded vision. With degraded vision, auditory task performance was better when 
      guided compared to unguided. In Experiment 5, participants performed both the
      spatial learning and auditory tasks under degraded vision. Results showed that
      attention mediates the relationship between mobility-monitoring demands and
      spatial learning. These studies suggest that more attention is required and
      spatial learning is impaired when navigating with degraded viewing.
FAU - Rand, Kristina M.
AU  - Rand KM
AD  - Department of Psychology, University of Utah
FAU - Creem-Regehr, Sarah H.
AU  - Creem-Regehr SH
AD  - Department of Psychology, University of Utah
FAU - Thompson, William B.
AU  - Thompson WB
AD  - School of Computing, University of Utah
LA  - eng
PT  - Journal Article
DEP - 20150223
TA  - J Exp Psychol Hum Percept Perform
JT  - Journal of experimental psychology. Human perception and performance
AID - 10.1037/xhp0000040 [doi]
MID - NIHMS662574
SO  - J Exp Psychol Hum Percept Perform. 2015 Jun;41(3):649-64. Epub 2015 Feb 23
      doi:10.1037/xhp0000040.

PMC - PMC4029785
PMID- 24401110
IS  - 1743-0003 (Electronic)
VI  - 11
DP  - 2014
TI  - A survey on robotic devices for upper limb rehabilitation.
PG  - 3
AB  - The existing shortage of therapists and caregivers assisting physically disabled 
      individuals at home is expected to increase and become serious problem in the
      near future. The patient population needing physical rehabilitation of the upper 
      extremity is also constantly increasing. Robotic devices have the potential to
      address this problem as noted by the results of recent research studies. However,
      the availability of these devices in clinical settings is limited, leaving plenty
      of room for improvement. The purpose of this paper is to document a review of
      robotic devices for upper limb rehabilitation including those in developing phase
      in order to provide a comprehensive reference about existing solutions and
      facilitate the development of new and improved devices. In particular the
      following issues are discussed: application field, target group, type of
      assistance, mechanical design, control strategy and clinical evaluation. This
      paper also includes a comprehensive, tabulated comparison of technical solutions 
      implemented in various systems.
FAU - Maciejasz, Paweł
AU  - Maciejasz P
AD  - DEMAR - LIRMM, INRIA, University of Montpellier 2, CNRS, Montpellier, 161 rue
      Ada, 34095 Montpellier, France
FAU - Eschweiler, Jörg
AU  - Eschweiler J
AD  - Chair of Medical Engineering (mediTEC), Helmholtz-Institute for Biomedical
      Engineering, RWTH Aachen University, Pauwelsstraße 20, 52074 Aachen, Germany
FAU - Gerlach-Hahn, Kurt
AU  - Gerlach-Hahn K
AD  - Philips Chair of Medical Information Technology (MedIT), Helmholtz-Institute for 
      Biomedical Engineering, RWTH Aachen University, Pauwelsstraße 20, 52074 Aachen,
      Germany
FAU - Jansen-Troy, Arne
AU  - Jansen-Troy A
AD  - Chair of Medical Engineering (mediTEC), Helmholtz-Institute for Biomedical
      Engineering, RWTH Aachen University, Pauwelsstraße 20, 52074 Aachen, Germany
FAU - Leonhardt, Steffen
AU  - Leonhardt S
AD  - Philips Chair of Medical Information Technology (MedIT), Helmholtz-Institute for 
      Biomedical Engineering, RWTH Aachen University, Pauwelsstraße 20, 52074 Aachen,
      Germany
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20140109
PHST- 2012/10/25 [received]
PHST- 2014/01/03 [accepted]
TA  - J Neuroeng Rehabil
JT  - Journal of NeuroEngineering and Rehabilitation
AID - 1743-0003-11-3 [pii]
AID - 10.1186/1743-0003-11-3 [doi]
SO  - J Neuroeng Rehabil. 2014 Jan 9;11:3. doi:10.1186/1743-0003-11-3.

PMC - PMC4590087
IS  - 2049-4637 (Print)
IS  - 2049-4645 (Electronic)
VI  - 7
IP  - 2 Suppl
DP  - 2013 Apr
DP  - 2013 Apr
TI  - Acute Pain.
PG  - 5-76
LA  - eng
PT  - Journal Article
TA  - Br J Pain
JT  - British Journal of Pain
AID - 10.1177/2049463713481587 [doi]
AID - 10.1177_2049463713481587 [pii]
SO  - Br J Pain. 2013 Apr;7(2 Suppl):5-76. doi:10.1177/2049463713481587.

PMC - PMC5484630
PMID- 24458968
IS  - 0748-7711 (Print)
IS  - 1938-1352 (Electronic)
VI  - 50
IP  - 9
DP  - 2013
TI  - Power Mobility with Collision Avoidance for Older Adults: User, Caregiver and
      Prescriber Perspectives.
PG  - 1287-300
AB  - Collision avoidance technology has the capacity to facilitate safer mobility
      among older power mobility users with physical, sensory and cognitive
      impairments, thus enabling independence for more potential users. However, little
      is known about consumers’ perceptions of collision avoidance. This article draws 
      on interviews with 29 users, five caregivers, and 10 prescribers to examine views
      on the design and utilization of this technology. Data analysis identified three 
      themes: “useful situations or contexts”, “technology design issues and real life 
      application”, and “appropriateness of collision avoidance technology for a
      variety of users”. Findings support the ongoing development of collision
      avoidance for older adult users. The majority of participants were supportive of 
      the technology, and felt that it might benefit current power mobility users and
      users with visual impairments, but might be unsuitable for people with
      significant cognitive impairments. Some participants voiced concerns regarding
      the risk for injury with power mobility use and some identified situations where 
      collision avoidance might be beneficial (driving backwards, avoiding dynamic
      obstacles, negotiating outdoor barriers, and learning power mobility use). Design
      issues include the need for context awareness, reliability, and user interface
      specifications. Furthermore, user desire to maintain driving autonomy indicates
      the need to develop collaboratively-controlled systems. This research lays the
      groundwork for future development by identifying and illustrating consumer needs 
      for this technology.
FAU - Wang, Rosalie H
AU  - Wang RH
AD  - Intelligent Assistive Technology and Systems Lab, Toronto Rehabilitation
      Institute and University of Toronto
FAU - Korotchenko, Alexandra
AU  - Korotchenko A
AD  - School of Kinesiology, The University of British Columbia
FAU - Clarke, Laura Hurd
AU  - Clarke LH
AD  - School of Kinesiology, The University of British Columbia
FAU - Ben Mortenson, W
AU  - Ben Mortenson W
AD  - Gerontology Research Centre, Simon Fraser University
FAU - Mihailidis, Alex
AU  - Mihailidis A
AD  - Intelligent Assistive Technology and Systems Lab, Toronto Rehabilitation
      Institute and University of Toronto
LA  - eng
PT  - Journal Article
TA  - J Rehabil Res Dev
JT  - Journal of rehabilitation research and development
AID - 10.1682/JRRD.2012.10.0181 [doi]
MID - CAMS6703
SO  - J Rehabil Res Dev. 2013;50(9):1287-300. doi:10.1682/JRRD.2012.10.0181.

PMC - PMC3398395
PMID- 22584224
IS  - 1053-8119 (Print)
IS  - 1095-9572 (Electronic)
VI  - 62
IP  - 2
DP  - 2012 Aug 15
TI  - A review and synthesis of the first 20 years of PET and fMRI studies of heard
      speech, spoken language and reading.
PG  - 816-47
AB  - The anatomy of language has been investigated with PET or fMRI for more than
      20 years. Here I attempt to provide an overview of the brain areas associated
      with heard speech, speech production and reading. The conclusions of many
      hundreds of studies were considered, grouped according to the type of processing,
      and reported in the order that they were published. Many findings have been
      replicated time and time again leading to some consistent and undisputable
      conclusions. These are summarised in an anatomical model that indicates the
      location of the language areas and the most consistent functions that have been
      assigned to them. The implications for cognitive models of language processing
      are also considered. In particular, a distinction can be made between processes
      that are localized to specific structures (e.g. sensory and motor processing) and
      processes where specialisation arises in the distributed pattern of activation
      over many different areas that each participate in multiple functions. For
      example, phonological processing of heard speech is supported by the functional
      integration of auditory processing and articulation; and orthographic processing 
      is supported by the functional integration of visual processing, articulation and
      semantics. Future studies will undoubtedly be able to improve the spatial
      precision with which functional regions can be dissociated but the greatest
      challenge will be to understand how different brain regions interact with one
      another in their attempts to comprehend and produce language.
FAU - Price, Cathy J.
AU  - Price CJ
LA  - eng
PT  - Journal Article
PT  - Review
PHST- 2012/04/30 [accepted]
TA  - Neuroimage
JT  - Neuroimage
AID - S1053-8119(12)00470-3 [pii]
AID - 10.1016/j.neuroimage.2012.04.062 [doi]
SO  - Neuroimage. 2012 Aug 15;62(2):816-47. doi:10.1016/j.neuroimage.2012.04.062.

PMC - PMC3338628
PMID- 22558370
IS  - 1932-6203 (Electronic)
VI  - 7
IP  - 4
DP  - 2012
TI  - Using Biofeedback while Immersed in a Stressful Videogame Increases the
      Effectiveness of Stress Management Skills in Soldiers.
LID - e36169
AB  - This study assessed the efficacy of using visual and auditory biofeedback while
      immersed in a tridimensional videogame to practice a stress management skill
      (tactical breathing). All 41 participants were soldiers who had previously
      received basic stress management training and first aid training in combat. On
      the first day, they received a 15-minute refresher briefing and were randomly
      assigned to either: (a) no additional stress management training (SMT) for three 
      days, or (b) 30-minute sessions (one per day for three days) of
      biofeedback-assisted SMT while immersed in a horror/first-person shooter game.
      The training was performed in a dark and enclosed environment using a 50-inch
      television with active stereoscopic display and loudspeakers. On the last day,
      all participants underwent a live simulated ambush with an improvised explosive
      device, where they had to provide first aid to a wounded soldier. Stress levels
      were measured with salivary cortisol collected when waking-up, before and after
      the live simulation. Stress was also measured with heart rate at baseline, during
      an apprehension phase, and during the live simulation. Repeated-measure ANOVAs
      and ANCOVAs confirmed that practicing SMT was effective in reducing stress.
      Results are discussed in terms of the advantages of the proposed program for
      military personnel and the need to practice SMT.
FAU - Bouchard, Stéphane
AU  - Bouchard S
AD  - Université du Québec en Outaouais, Gatineau, Québec, Canada
FAU - Bernier, François
AU  - Bernier F
AD  - Defence Research and Development Canada – ValCartier, Québec, Canada
FAU - Boivin, Éric
AU  - Boivin É
AD  - Defence Research and Development Canada – ValCartier, Québec, Canada
FAU - Morin, Brian
AU  - Morin B
AD  - Clinique de Psychologie Cognitive, Québec, Canada
FAU - Robillard, Geneviève
AU  - Robillard G
AD  - Université du Québec en Outaouais, Gatineau, Québec, Canada
LA  - eng
PT  - Journal Article
DEP - 20120427
PHST- 2011/12/22 [received]
PHST- 2012/04/02 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-12-00740 [pii]
AID - 10.1371/journal.pone.0036169 [doi]
SO  - PLoS One. 2012 Apr 27;7(4):. doi:10.1371/journal.pone.0036169.

PMC - PMC5439753
IS  - 1752-8054 (Print)
IS  - 1752-8062 (Electronic)
VI  - 5
IP  - 2
DP  - 2012 Apr
TI  - translational science 2012 meeting abstracts.
PG  - 141-210
LA  - eng
PT  - Journal Article
DEP - 20120404
PHST- 2012/04/04 [aheadofprint]
TA  - Clin Transl Sci
JT  - Clinical and Translational Science
AID - 10.1111/j.1752-8062.2012.00398.x [doi]
AID - CTS398 [pii]
SO  - Clin Transl Sci. 2012 Apr;5(2):141-210. Epub 2012 Apr 04
      doi:10.1111/j.1752-8062.2012.00398.x.

PMC - PMC3481066
PMID- 22696127
IS  - 1869-4101 (Electronic)
VI  - 3
IP  - Suppl 1
DP  - 2012 Mar
TI  - ECR 2012 Book of Abstracts - A - Postergraduate Educational Programme.
PG  - 1-134
CN  - European Society of Radiology (ESR)
LA  - eng
PT  - Journal Article
DEP - 20120321
TA  - Insights Imaging
JT  - Insights into Imaging
AID - 153 [pii]
AID - 10.1007/s13244-012-0153-4 [doi]
SO  - Insights Imaging. 2012 Mar 21;3(Suppl 1):1-134. doi:10.1007/s13244-012-0153-4.

PMC - PMC4972024
PMID- 19923289
IS  - 0270-6474 (Print)
IS  - 1529-2401 (Electronic)
VI  - 29
IP  - 46
DP  - 2009 Nov 18
TI  - Correlations of neuronal and microvascular densities in murine cortex revealed by
      direct counting and colocalization of nuclei and vessels.
PG  - 14553-70
AB  - It is well known that the density of neurons varies within the adult brain. In
      neocortex, this includes variations in neuronal density between different lamina 
      as well as between different regions. Yet the concomitant variation of the
      microvessels is largely uncharted. Here we present automated histological,
      imaging, and analysis tools to simultaneously map the locations of all neuronal
      and non-neuronal nuclei and the centerlines and diameters of all blood vessels
      within thick slabs of neocortex from mice. Based on total inventory measurements 
      of different cortical regions (~ 107 cells vectorized across brains), these
      methods revealed: (1) In three dimensions, the mean distance of the center of
      neuronal somata to the closest microvessel was 14 μm. (2) Volume samples within
      lamina of a given region show that the density of microvessels does not match the
      strong laminar variation in neuronal density. This holds for both agranular and
      granular cortex. (3) Volume samples in successive radii from the midline to the
      ventral-lateral edge, where each volume summed the number of cells and
      microvessels from the pia to the white matter, show a significant correlation
      between neuronal and microvessel densities. These data show that while neuronal
      and vascular densities do not track each other on the 100 μm scale of cortical
      lamina, they do track each other on the 1 – 10 mm scale of the cortical mantle.
      The absence of a disproportionate density of blood vessels in granular lamina is 
      argued to be consistent with the initial locus of functional brain imaging
      signals.
FAU - Tsai, Philbert S.
AU  - Tsai PS
AD  - Department of Physics, University of California, San Diego
FAU - Kaufhold, John P.
AU  - Kaufhold JP
AD  - SAIC Intelligent Systems Division, Arlington, VA
FAU - Blinder, Pablo
AU  - Blinder P
AD  - Department of Physics, University of California, San Diego
FAU - Friedman, Beth
AU  - Friedman B
AD  - Department of Pharmacology, University of California School of Medicine, San
      Diego
FAU - Drew, Patrick J.
AU  - Drew PJ
AD  - Department of Physics, University of California, San Diego
FAU - Karten, Harvey J.
AU  - Karten HJ
AD  - Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA
FAU - Lyden, Patrick D.
AU  - Lyden PD
AD  - Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA
FAU - Kleinfeld, David
AU  - Kleinfeld D
AD  - Department of Physics, University of California, San Diego
LA  - eng
PT  - Journal Article
TA  - J Neurosci
JT  - The Journal of neuroscience : the official journal of the Society for
      Neuroscience
AID - 10.1523/JNEUROSCI.3287-09.2009 [doi]
MID - NIHMS804228
SO  - J Neurosci. 2009 Nov 18;29(46):14553-70. doi:10.1523/JNEUROSCI.3287-09.2009.

PMC - PMC2670986
PMID- 19350330
IS  - 0884-8734 (Print)
IS  - 1525-1497 (Electronic)
VI  - 24
IP  - Suppl 1
DP  - 2009 Apr
TI  - Scientific Abstracts.
PG  - 1-380
LA  - eng
PT  - Journal Article
DEP - 20090407
TA  - J Gen Intern Med
JT  - Journal of General Internal Medicine
AID - 963 [pii]
AID - 10.1007/s11606-009-0963-3 [doi]
SO  - J Gen Intern Med. 2009 Apr;24(Suppl 1):1-380. Epub 2009 Apr 7
      doi:10.1007/s11606-009-0963-3.

PMC - PMC2688712
PMID- 19269307
IS  - 0163-7258 (Print)
VI  - 122
IP  - 2
DP  - 2009 May
TI  - Using the MATRICS to guide development of a preclinical cognitive test battery
      for research in schizophrenia.
PG  - 150-202
AB  - Cognitive deficits in schizophrenia are among the core symptoms of the disease,
      correlate with functional outcome, and are not well treated with current
      antipsychotic therapies. In order to bring together academic, industrial, and
      governmental bodies to address this great ‘unmet therapeutic need’, the NIMH
      sponsored the Measurement and Treatment Research to Improve Cognition in
      Schizophrenia (MATRICS) initiative. Through careful factor analysis and consensus
      of expert opinion, MATRICS identified seven domains of cognition that are
      deficient in schizophrenia (attention/vigilance, working memory, reasoning and
      problem solving, processing speed, visual learning and memory, verbal learning
      and memory, and social cognition) and recommended a specific neuropsychological
      test battery to probe these domains. In order to move the field forward and
      outline an approach for translational research, there is a need for a
      “preclinical MATRICS” to develop a rodent test battery that is appropriate for
      drug development. In this review, we outline such an approach and review current 
      rodent tasks that target these seven domains of cognition. The rodent tasks are
      discussed in terms of their validity for probing each cognitive domain as well as
      a brief overview of the pharmacology and manipulations relevant to schizophrenia 
      for each task.
FAU - YOUNG, Jared W
AU  - YOUNG JW
FAU - POWELL, Susan
AU  - POWELL S
FAU - RISBROUGH, Victoria
AU  - RISBROUGH V
FAU - MARSTON, Hugh M
AU  - MARSTON HM
FAU - GEYER, Mark A
AU  - GEYER MA
LA  - eng
PT  - Journal Article
DEP - 20090306
TA  - Pharmacol Ther
JT  - Pharmacology & therapeutics
AID - 10.1016/j.pharmthera.2009.02.004 [doi]
MID - NIHMS98330
SO  - Pharmacol Ther. 2009 May;122(2):150-202. Epub 2009 Mar 6
      doi:10.1016/j.pharmthera.2009.02.004.

PMC - PMC2651108
PMID- 19252181
IS  - 0586-7614 (Print)
IS  - 1745-1701 (Electronic)
VI  - 35
IP  - Suppl 1
DP  - 2009 Mar
DP  - 2009 Mar
TI  - Abstracts for the 12th International Congress on Schizophrenia Research (ICOSR).
PG  - 1-377
LA  - eng
PT  - Journal Article
TA  - Schizophr Bull
JT  - Schizophrenia Bulletin
AID - 10.1093/schbul/sbn173 [doi]
SO  - Schizophr Bull. 2009 Mar;35(Suppl 1):1-377. doi:10.1093/schbul/sbn173.

PMC - PMC3304110
PMID- 22438708
IS  - 1424-8220 (Electronic)
VI  - 12
IP  - 2
DP  - 2012
TI  - Brain Computer Interfaces, a Review.
PG  - 1211-79
AB  - A brain-computer interface (BCI) is a hardware and software communications system
      that permits cerebral activity alone to control computers or external devices.
      The immediate goal of BCI research is to provide communications capabilities to
      severely disabled people who are totally paralyzed or ‘locked in’ by neurological
      neuromuscular disorders, such as amyotrophic lateral sclerosis, brain stem
      stroke, or spinal cord injury. Here, we review the state-of-the-art of BCIs,
      looking at the different steps that form a standard BCI: signal acquisition,
      preprocessing or signal enhancement, feature extraction, classification and the
      control interface. We discuss their advantages, drawbacks, and latest advances,
      and we survey the numerous technologies reported in the scientific literature to 
      design each step of a BCI. First, the review examines the neuroimaging modalities
      used in the signal acquisition step, each of which monitors a different
      functional brain activity such as electrical, magnetic or metabolic activity.
      Second, the review discusses different electrophysiological control signals that 
      determine user intentions, which can be detected in brain activity. Third, the
      review includes some techniques used in the signal enhancement step to deal with 
      the artifacts in the control signals and improve the performance. Fourth, the
      review studies some mathematic algorithms used in the feature extraction and
      classification steps which translate the information in the control signals into 
      commands that operate a computer or other device. Finally, the review provides an
      overview of various BCI applications that control a range of devices.
FAU - Nicolas-Alonso, Luis Fernando
AU  - Nicolas-Alonso LF
FAU - Gomez-Gil, Jaime
AU  - Gomez-Gil J
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20120131
PHST- 2011/12/29 [received]
PHST- 2012/01/16 [revised]
PHST- 2012/01/29 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s120201211 [doi]
AID - sensors-12-01211 [pii]
SO  - Sensors (Basel). 2012 Jan 31;12(2):1211-79. doi:10.3390/s120201211.

PMC - PMC2782734
PMID- 18085482
IS  - 1093-7404 (Print)
IS  - 1521-6950 (Electronic)
VI  - 10
IP  - Suppl 1
DP  - 2007
TI  - HUMAN HEALTH RISK ASSESSMENT FOR ALUMINIUM, ALUMINIUM OXIDE, AND ALUMINIUM
      HYDROXIDE.
PG  - 1-269
EIN - J Toxicol Environ Health B Crit Rev 11:147.
FAU - Krewski, Daniel
AU  - Krewski D
AD  - Department of Epidemiology and Community Medicine, Faculty of Medicine,
      University of Ottawa, Ottawa, Ontario, Canada
FAU - Yokel, Robert A
AU  - Yokel RA
AD  - College of Pharmacy and Graduate Center for Toxicology, University of Kentucky
      Medical Center, Kentucky, USA
FAU - Nieboer, Evert
AU  - Nieboer E
AD  - Department of Biochemistry and Biomedical Sciences, McMaster University,
      Hamilton, Ontario, Canada and Institute of Community Medicine, University of
      Tromsø, Norway
FAU - Borchelt, David
AU  - Borchelt D
AD  - SantaFe Health Alzheimer’s Disease Research Center, Department of Neuroscience,
      McKnight Brain Institute, University of Florida, USA
FAU - Cohen, Joshua
AU  - Cohen J
AD  - Institute for Clinical Research and Health Policy Studies, Tufts-New England
      Medical Center, USA
FAU - Harry, Jean
AU  - Harry J
AD  - National Institute of Environmental Health Sciences, NIH, Research Triangle Park,
      NC, USA
FAU - Kacew, Sam
AU  - Kacew S
AD  - McLaughlin Centre for Population Health Risk Assessment, Institute of Population 
      Health, University of Ottawa, Ottawa, Ontario, Canada
FAU - Lindsay, Joan
AU  - Lindsay J
AD  - Aging-Related Diseases Section, Surveillance Division, Public Health Agency of
      Canada, Ottawa, Ontario, Canada
FAU - Mahfouz, Amal M
AU  - Mahfouz AM
AD  - United States Environmental Protection Agency, Washington DC, USA
FAU - Rondeau, Virginie
AU  - Rondeau V
AD  - INSERM E0338 (Biostatistic), Université Victor Segalen Bordeaux 2, Bordeaux,
      France
LA  - eng
PT  - Journal Article
TA  - J Toxicol Environ Health B Crit Rev
JT  - Journal of toxicology and environmental health. Part B, Critical reviews
AID - 10.1080/10937400701597766 [doi]
MID - NIHMS33559
SO  - J Toxicol Environ Health B Crit Rev. 2007;10(Suppl 1):1-269.
      doi:10.1080/10937400701597766.

PMC - PMC5134464
PMID- 27801822
IS  - 1424-8220 (Electronic)
VI  - 16
IP  - 11
DP  - 2016 Nov
TI  - Driver Distraction Using Visual-Based Sensors and Algorithms.
LID - 1805
AB  - Driver distraction, defined as the diversion of attention away from activities
      critical for safe driving toward a competing activity, is increasingly recognized
      as a significant source of injuries and fatalities on the roadway. Additionally, 
      the trend towards increasing the use of in-vehicle information systems is
      critical because they induce visual, biomechanical and cognitive distraction and 
      may affect driving performance in qualitatively different ways. Non-intrusive
      methods are strongly preferred for monitoring distraction, and vision-based
      systems have appeared to be attractive for both drivers and researchers.
      Biomechanical, visual and cognitive distractions are the most commonly detected
      types in video-based algorithms. Many distraction detection systems only use a
      single visual cue and therefore, they may be easily disturbed when occlusion or
      illumination changes appear. Moreover, the combination of these visual cues is a 
      key and challenging aspect in the development of robust distraction detection
      systems. These visual cues can be extracted mainly by using face monitoring
      systems but they should be completed with more visual cues (e.g., hands or body
      information) or even, distraction detection from specific actions (e.g., phone
      usage). Additionally, these algorithms should be included in an embedded device
      or system inside a car. This is not a trivial task and several requirements must 
      be taken into account: reliability, real-time performance, low cost, small size, 
      low power consumption, flexibility and short time-to-market. The key points for
      the development and implementation of sensors to carry out the detection of
      distraction will also be reviewed. This paper shows a review of the role of
      computer vision technology applied to the development of monitoring systems to
      detect distraction. Some key points considered as both future work and challenges
      ahead yet to be solved will also be addressed.
FAU - Fernández, Alberto
AU  - Fernández A
AD  - Grupo TSK, Technological Scientific Park of Gijón, 33203 Gijón, Asturias, Spain; 
      juanluis.carus@grupotsk.com
FAU - Usamentiaga, Rubén
AU  - Usamentiaga R
AD  - Department of Computer Science and Engineering, University of Oviedo, Campus de
      Viesques, 33204 Gijón, Asturias, Spain; rusamentiaga@uniovi.es (R.U.);
      rcasado@lsi.uniovi.es (R.C.)
FAU - Carús, Juan Luis
AU  - Carús JL
AD  - Grupo TSK, Technological Scientific Park of Gijón, 33203 Gijón, Asturias, Spain; 
      juanluis.carus@grupotsk.com
FAU - Casado, Rubén
AU  - Casado R
AD  - Department of Computer Science and Engineering, University of Oviedo, Campus de
      Viesques, 33204 Gijón, Asturias, Spain; rusamentiaga@uniovi.es (R.U.);
      rcasado@lsi.uniovi.es (R.C.)
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20161028
PHST- 2016/07/14 [received]
PHST- 2016/10/24 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s16111805 [doi]
AID - sensors-16-01805 [pii]
SO  - Sensors (Basel). 2016 Oct 28;16(11):. doi:10.3390/s16111805.

PMC - PMC4521440
PMID- 26240749
IS  - 2045-1253 (Print)
IS  - 2045-1261 (Electronic)
VI  - 5
IP  - 2
DP  - 2015 Apr
DP  - 2015 Apr
TI  - Legal highs: staying on top of the flood of novel psychoactive substances.
PG  - 97-132
AB  - There has been growing clinical, public, and media awareness and concern about
      the availability and potential harmfulness of so-called ‘legal highs’, which are 
      more appropriately called new or novel psychoactive substances (NPS). A
      cat-and-mouse process has emerged wherein unknown chemists and laboratories are
      producing new, and as yet nonproscribed, compounds for human consumption; and as 
      soon as they are banned, which they inevitably are, slightly modified analogues
      are produced to circumvent new laws. This rapidly changing environment, 81 new
      substances were identified in 2013 alone, has led to confusion for clinicians,
      psychopharmacologists, and the public at large. Our difficulties in keeping up
      with the process has had a two-fold negative effect: the danger of ignoring what 
      is confusing; and the problem that some of the newer synthesized compounds appear
      ever more potent. This review aims to circumscribe a quick moving and growing
      field, and to categorize NPS into five major groups based upon their ‘parent’
      compounds: stimulants similar to cocaine, amphetamines and ecstasy; cannabinoids;
      benzodiazepine based drugs; dissociatives similar to ketamine and phencyclidine
      (PCP); and those modelled after classic hallucinogens such as LSD and psilocybin.
      Pharmacodynamic actions, subjective and physical effects, harmfulness, risk of
      dependency and, where appropriate, putative clinical potentials are described for
      each class. Clinicians might encounter NPS in various ways: anecdotal reportage; 
      acute intoxication; as part of a substance misuse profile; and as a precipitant
      or perpetuating factor for longer-term physical and psychological ill health.
      Current data are overall limited, and much of our knowledge and treatment
      strategies are based upon those of the ‘parent’ compound. There is a critical
      need for more research in this field, and for professionals to make themselves
      more aware of this growing issue and how it might affect those we see clinically 
      and try to help: a brave new world of so-called ‘psychonauts’ consuming NPS will 
      also need informed ‘psychotherapeutonauts’. The paper should serve as a primer
      for clinicians and interested readers, as well as provide a framework into which 
      to place the new substances that will inevitably be synthesized in the future.
FAU - Baumeister, David
AU  - Baumeister D
AD  - Department of Psychology, Institute of Psychiatry, King’s College, London, UK
FAU - Tojo, Luis M.
AU  - Tojo LM
AD  - Stress, Psychiatry and Immunology Lab, Department of Psychological Medicine,
      Institute of Psychiatry, King's College, London, UK
FAU - Tracy, Derek K.
AU  - Tracy DK
AD  - Consultant Psychiatrist and Associate Clinical Director, Oxleas NHS Foundation
      Trust, Princess Royal University Hospital, and Cognition, Schizophrenia and
      Imaging Laboratory, Department of Psychosis Studies, Institute of Psychiatry,
      King’s College, London BR6 8NY, UK
LA  - eng
PT  - Journal Article
PT  - Review
TA  - Ther Adv Psychopharmacol
JT  - Therapeutic Advances in Psychopharmacology
AID - 10.1177/2045125314559539 [doi]
AID - 10.1177_2045125314559539 [pii]
SO  - Ther Adv Psychopharmacol. 2015 Apr;5(2):97-132. doi:10.1177/2045125314559539.

PMC - PMC2716913
PMID- 19669273
IS  - 1936-0533 (Print)
IS  - 1936-0541 (Electronic)
VI  - 2
IP  - Suppl 3
DP  - 2008 Mar
TI  - APASL Seoul 2008 Meeting.
PG  - 213-552
LA  - eng
PT  - Journal Article
PT  - News
DEP - 20080920
TA  - Hepatol Int
JT  - Hepatology International
AID - 9101 [pii]
AID - 10.1007/s12072-008-9101-2 [doi]
SO  - Hepatol Int. 2008 Mar;2(Suppl 3):213-552. Epub 2008 Sep 20
      doi:10.1007/s12072-008-9101-2.

PMC - PMC4739132
PMID- 26462967
IS  - 1050-7256 (Print)
IS  - 1557-9077 (Electronic)
VI  - 26
IP  - 1
DP  - 2016 Jan 01
TI  - 2015 American Thyroid Association Management Guidelines for Adult Patients with
      Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid
      Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid
      Cancer.
PG  - 1-133
AB  - Background: Thyroid nodules are a common clinical problem, and differentiated
      thyroid cancer is becoming increasingly prevalent. Since the American Thyroid
      Association's (ATA's) guidelines for the management of these disorders were
      revised in 2009, significant scientific advances have occurred in the field. The 
      aim of these guidelines is to inform clinicians, patients, researchers, and
      health policy makers on published evidence relating to the diagnosis and
      management of thyroid nodules and differentiated thyroid cancer.Methods: The
      specific clinical questions addressed in these guidelines were based on prior
      versions of the guidelines, stakeholder input, and input of task force members.
      Task force panel members were educated on knowledge synthesis methods, including 
      electronic database searching, review and selection of relevant citations, and
      critical appraisal of selected studies. Published English language articles on
      adults were eligible for inclusion. The American College of Physicians Guideline 
      Grading System was used for critical appraisal of evidence and grading strength
      of recommendations for therapeutic interventions. We developed a similarly
      formatted system to appraise the quality of such studies and resultant
      recommendations. The guideline panel had complete editorial independence from the
      ATA. Competing interests of guideline task force members were regularly updated, 
      managed, and communicated to the ATA and task force members.Results: The revised 
      guidelines for the management of thyroid nodules include recommendations
      regarding initial evaluation, clinical and ultrasound criteria for fine-needle
      aspiration biopsy, interpretation of fine-needle aspiration biopsy results, use
      of molecular markers, and management of benign thyroid nodules. Recommendations
      regarding the initial management of thyroid cancer include those relating to
      screening for thyroid cancer, staging and risk assessment, surgical management,
      radioiodine remnant ablation and therapy, and thyrotropin suppression therapy
      using levothyroxine. Recommendations related to long-term management of
      differentiated thyroid cancer include those related to surveillance for recurrent
      disease using imaging and serum thyroglobulin, thyroid hormone therapy,
      management of recurrent and metastatic disease, consideration for clinical trials
      and targeted therapy, as well as directions for future research.Conclusions: We
      have developed evidence-based recommendations to inform clinical decision-making 
      in the management of thyroid nodules and differentiated thyroid cancer. They
      represent, in our opinion, contemporary optimal care for patients with these
      disorders.
FAU - Haugen, Bryan R.
AU  - Haugen BR
AD  - University of Colorado School of Medicine, Aurora, Colorado.
FAU - Alexander, Erik K.
AU  - Alexander EK
AD  - Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
FAU - Bible, Keith C.
AU  - Bible KC
AD  - The Mayo Clinic, Rochester, Minnesota.
FAU - Doherty, Gerard M.
AU  - Doherty GM
AD  - Boston Medical Center, Boston, Massachusetts.
FAU - Mandel, Susan J.
AU  - Mandel SJ
AD  - Perelman School of Medicine, University of Pennsylvania, Philadelphia,
      Pennsylvania.
FAU - Nikiforov, Yuri E.
AU  - Nikiforov YE
AD  - University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
FAU - Pacini, Furio
AU  - Pacini F
AD  - The University of Siena, Siena, Italy.
FAU - Randolph, Gregory W.
AU  - Randolph GW
AD  - Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, Harvard
      Medical School, Boston, Massachusetts.
FAU - Sawka, Anna M.
AU  - Sawka AM
AD  - University Health Network, University of Toronto, Toronto, Ontario, Canada.
FAU - Schlumberger, Martin
AU  - Schlumberger M
AD  - Institute Gustave Roussy and University Paris Sud, Villejuif, France.
FAU - Schuff, Kathryn G.
AU  - Schuff KG
AD  - Oregon Health and Science University, Portland, Oregon.
FAU - Sherman, Steven I.
AU  - Sherman SI
AD  - University of Texas M.D. Anderson Cancer Center, Houston, Texas.
FAU - Sosa, Julie Ann
AU  - Sosa JA
AD  - Duke University School of Medicine, Durham, North Carolina.
FAU - Steward, David L.
AU  - Steward DL
AD  - University of Cincinnati Medical Center, Cincinnati, Ohio.
FAU - Tuttle, R. Michael
AU  - Tuttle RM
AD  - Memorial Sloan Kettering Cancer Center, New York, New York.
FAU - Wartofsky, Leonard
AU  - Wartofsky L
AD  - MedStar Washington Hospital Center, Washington, DC.
LA  - eng
PT  - Journal Article
TA  - Thyroid
JT  - Thyroid
AID - 10.1089/thy.2015.0020 [pii]
AID - 10.1089/thy.2015.0020 [doi]
SO  - Thyroid. 2016 Jan 01;26(1):1-133. doi:10.1089/thy.2015.0020.

PMC - PMC5359370
PMID- 28386586
IS  - 2365-7464 (Electronic)
VI  - 2
IP  - 1
DP  - 2017
TI  - Teaching students to think spatially through embodied actions: Design principles 
      for learning environments in science, technology, engineering, and mathematics.
LID - 22
AB  - Spatial thinking is a vital component of the science, technology, engineering,
      and mathematics curriculum. However, to date, broad development of learning
      environments that target domain-specific spatial thinking is incomplete. The
      present article visits the problem of improving spatial thinking by first
      reviewing the evidence that the human mind is embodied: that cognition, memory,
      and knowledge representation maintain traces of sensorimotor impressions from
      acting and perceiving in a physical environment. In particular, we review the
      evidence that spatial cognition and the ways that humans perceive and conceive of
      space are embodied. We then propose a set of design principles to aid
      researchers, designers, and practitioners in creating and evaluating learning
      environments that align principled embodied actions to targets of spatial
      thinking in science, technology, engineering, and mathematics.
FAU - DeSutter, D.
AU  - DeSutter D
AUID- ORCID: 0000-0002-4340-9514
AD  - 0000 0001 2175 0319grid.185648.6Department of the Learning Sciences, University
      of Illinois-Chicago, Chicago, IL 60607 USA
FAU - Stieff, M.
AU  - Stieff M
AD  - 0000 0001 2175 0319grid.185648.6Department of the Learning Sciences, University
      of Illinois-Chicago, Chicago, IL 60607 USA
LA  - eng
PT  - Journal Article
DEP - 20170320
PHST- 2016/07/15 [received]
PHST- 2016/12/08 [accepted]
TA  - Cogn Res Princ Implic
JT  - Cognitive Research
AID - 39 [pii]
AID - 10.1186/s41235-016-0039-y [doi]
SO  - Cogn Res Princ Implic. 2017;2(1):. Epub 2017 Mar 20
      doi:10.1186/s41235-016-0039-y.

PMC - PMC4451244
PMID- 25025658
IS  - 0149-7634 (Print)
IS  - 1873-7528 (Electronic)
VI  - 45
DP  - 2014 Sep
TI  - Adolescent Brain Maturation and Smoking: What We Know and Where We’re Headed.
PG  - 323-42
AB  - Smoking is a leading cause of mortality and morbidity worldwide. Smoking
      initiation often occurs during adolescence. This paper reviews and synthesizes
      adolescent development and nicotine dependence literatures to provide an account 
      of adolescent smoking from onset to compulsive use. We extend neurobiological
      models of adolescent risk-taking, that focus on the interplay between incentive
      processing and cognitive control brain systems, through incorporating
      psychosocial and contextual factors specific to smoking, to suggest that
      adolescents are more vulnerable than adults to cigarette use generally, but that 
      individual differences exist placing some adolescents at increased risk for
      smoking. Upon smoking, adolescents are more likely to continue smoking due to the
      increased positive effects induced by nicotine during this period. Continued use 
      during adolescence, may be best understood as reflecting drug-related changes to 
      neural systems underlying incentive processing and cognitive control, resulting
      in decision-making that is biased towards continued smoking. Persistent changes
      following nicotine exposure that may underlie continued dependence are described.
      We highlight ways that interventions may benefit from a consideration of
      cognitive-neuroscience findings.
FAU - Lydon, David M.
AU  - Lydon DM
AD  - Department of Human Development and Family Studies, College of Health and Human
      Development, The Pennsylvania State University, 315 Health and Human Development 
      – East, University Park, PA 16802
FAU - Wilson, Stephen J.
AU  - Wilson SJ
AD  - Department of Psychology, The College of the Liberal Arts, The Pennsylvania State
      University, 311 Moore Building, University Park, PA 16802
FAU - Child, Amanda
AU  - Child A
AD  - Department of Human Development and Family Studies, College of Health and Human
      Development, The Pennsylvania State University, 315 Health and Human Development 
      – East, University Park, PA 16802
FAU - Geier, Charles F.
AU  - Geier CF
AD  - Department of Human Development and Family Studies, College of Health and Human
      Development, The Pennsylvania State University, 315 Health and Human Development 
      – East, University Park, PA 16802
LA  - eng
PT  - Journal Article
DEP - 20140712
TA  - Neurosci Biobehav Rev
JT  - Neuroscience and biobehavioral reviews
AID - 10.1016/j.neubiorev.2014.07.003 [doi]
MID - NIHMS691864
SO  - Neurosci Biobehav Rev. 2014 Sep;45:323-42. Epub 2014 Jul 12
      doi:10.1016/j.neubiorev.2014.07.003.

PMC - PMC5281667
PMID- 28203635
IS  - 2365-7464 (Electronic)
VI  - 2
IP  - 1
DP  - 2017
TI  - Grounded understanding of abstract concepts: The case of STEM learning.
LID - 7
AB  - Characterizing the neural implementation of abstract conceptual representations
      has long been a contentious topic in cognitive science. At the heart of the
      debate is whether the “sensorimotor” machinery of the brain plays a central role 
      in representing concepts, or whether the involvement of these perceptual and
      motor regions is merely peripheral or epiphenomenal. The domain of science,
      technology, engineering, and mathematics (STEM) learning provides an important
      proving ground for sensorimotor (or grounded) theories of cognition, as concepts 
      in science and engineering courses are often taught through laboratory-based and 
      other hands-on methodologies. In this review of the literature, we examine
      evidence suggesting that sensorimotor processes strengthen learning associated
      with the abstract concepts central to STEM pedagogy. After considering how
      contemporary theories have defined abstraction in the context of semantic
      knowledge, we propose our own explanation for how body-centered information, as
      computed in sensorimotor brain regions and visuomotor association cortex, can
      form a useful foundation upon which to build an understanding of abstract
      scientific concepts, such as mechanical force. Drawing from theories in cognitive
      neuroscience, we then explore models elucidating the neural mechanisms involved
      in grounding intangible concepts, including Hebbian learning, predictive coding, 
      and neuronal recycling. Empirical data on STEM learning through hands-on
      instruction are considered in light of these neural models. We conclude the
      review by proposing three distinct ways in which the field of cognitive
      neuroscience can contribute to STEM learning by bolstering our understanding of
      how the brain instantiates abstract concepts in an embodied fashion.
FAU - Hayes, Justin C.
AU  - Hayes JC
AD  - 0000 0001 2179 2404grid.254880.3Department of Psychological and Brain Sciences,
      Dartmouth College, Moore Hall 3 Maynard St., Hanover, NH 03755 USA
FAU - Kraemer, David J. M.
AU  - Kraemer DJM
AD  - 0000 0001 2179 2404grid.254880.3Department of Education, Dartmouth College, 5
      Maynard St., Hanover, NH 03755 USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170130
PHST- 2016/08/04 [received]
PHST- 2016/12/23 [accepted]
TA  - Cogn Res
JT  - Cognitive Research
AID - 46 [pii]
AID - 10.1186/s41235-016-0046-z [doi]
SO  - Cogn Res. 2017;2(1):. Epub 2017 Jan 30 doi:10.1186/s41235-016-0046-z.

PMC - PMC4836709
PMID- 26141071
IS  - 1081-4159 (Print)
IS  - 1465-7325 (Electronic)
VI  - 20
IP  - 4
DP  - 2015 Oct
TI  - Understanding Language, Hearing Status, and Visual-Spatial Skills.
PG  - 310-30
AB  - It is frequently assumed that deaf individuals have superior visual-spatial
      abilities relative to hearing peers and thus, in educational settings, they are
      often considered visual learners. There is some empirical evidence to support the
      former assumption, although it is inconsistent, and apparently none to support
      the latter. Three experiments examined visual-spatial and related cognitive
      abilities among deaf individuals who varied in their preferred language modality 
      and use of cochlear implants (CIs) and hearing individuals who varied in their
      sign language skills. Sign language and spoken language assessments accompanied
      tasks involving visual-spatial processing, working memory, nonverbal logical
      reasoning, and executive function. Results were consistent with other recent
      studies indicating no generalized visual-spatial advantage for deaf individuals
      and suggested that their performance in that domain may be linked to the strength
      of their preferred language skills regardless of modality. Hearing individuals
      performed more strongly than deaf individuals on several visual-spatial and
      self-reported executive functioning measures, regardless of sign language skills 
      or use of CIs. Findings are inconsistent with assumptions that deaf individuals
      are visual learners or are superior to hearing individuals across a broad range
      of visual-spatial tasks. Further, performance of deaf and hearing individuals on 
      the same visual-spatial tasks was associated with differing cognitive abilities, 
      suggesting that different cognitive processes may be involved in visual-spatial
      processing in these groups.
FAU - Marschark, Marc
AU  - Marschark M
AD  - Rochester Institute of Technology,
FAU - Spencer, Linda J.
AU  - Spencer LJ
AD  - New Mexico State University,
FAU - Durkin, Andreana
AU  - Durkin A
AD  - Rochester Institute of Technology,
FAU - Borgna, Georgianna
AU  - Borgna G
AD  - Rochester Institute of Technology,
FAU - Convertino, Carol
AU  - Convertino C
AD  - Rochester Institute of Technology,
FAU - Machmer, Elizabeth
AU  - Machmer E
AD  - Rochester Institute of Technology,
FAU - Kronenberger, William G.
AU  - Kronenberger WG
AD  - Indiana University School of Medicine, and
FAU - Trani, Alexandra
AU  - Trani A
AD  - Georgia Institute of Technology
LA  - eng
PT  - Journal Article
DEP - 20150703
PHST- 2015/04/06 [received]
PHST- 2015/06/09 [revised]
PHST- 2015/06/12 [accepted]
PHST- 2015/07/03 [aheadofprint]
TA  - J Deaf Stud Deaf Educ
JT  - The Journal of Deaf Studies and Deaf Education
AID - 10.1093/deafed/env025 [doi]
SO  - J Deaf Stud Deaf Educ. 2015 Oct;20(4):310-30. Epub 2015 Jul 3
      doi:10.1093/deafed/env025.

PMC - PMC3570558
PMID- 23424615
IS  - 1932-6203 (Electronic)
VI  - 8
IP  - 2
DP  - 2013
TI  - Does Perceptual-Motor Calibration Generalize across Two Different Forms of
      Locomotion? Investigations of Walking and Wheelchairs.
LID - e54446
AB  - The relationship between biomechanical action and perception of self-motion
      during walking is typically consistent and well-learned but also adaptable. This 
      perceptual-motor coupling can be recalibrated by creating a mismatch between the 
      visual information for self-motion and walking speed. Perceptual-motor
      recalibration of locomotion has been demonstrated through effects on subsequent
      walking without vision, showing that learned perceptual-motor coupling influences
      a dynamic representation of one's spatial position during walking. Our present
      studies test whether recalibration of wheelchair locomotion, a novel form of
      locomotion for typically walking individuals, similarly influences subsequent
      wheelchair locomotion. Furthermore, we test whether adaptation to the pairing of 
      visual information for self-motion during one form of locomotion transfers to a
      different locomotion modality. We find strong effects of perceptual-motor
      recalibration for matched locomotion modalities – walking/walking and
      wheeling/wheeling. Transfer across incongruent locomotion modalities showed weak 
      recalibration effects. The results have implications both for theories of
      perceptual-motor calibration mechanisms and their effects on spatial orientation,
      as well as for practical applications in training and rehabilitation.
FAU - Kunz, Benjamin R.
AU  - Kunz BR
AD  - Department of Psychology, University of Dayton, Dayton, Ohio, United States of
      America
FAU - Creem-Regehr, Sarah H.
AU  - Creem-Regehr SH
AD  - Department of Psychology, University of Utah, Salt Lake City, Utah, United States
      of America
FAU - Thompson, William B.
AU  - Thompson WB
AD  - School of Computing, University of Utah, Salt Lake City, Utah, United States of
      America
LA  - eng
PT  - Journal Article
DEP - 20130212
PHST- 2012/08/02 [received]
PHST- 2012/12/11 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-12-23099 [pii]
AID - 10.1371/journal.pone.0054446 [doi]
SO  - PLoS One. 2013 Feb 12;8(2):. doi:10.1371/journal.pone.0054446.

PMC - PMC3536016
PMID- 22154509
IS  - 0093-934X (Print)
IS  - 1090-2155 (Electronic)
VI  - 122
IP  - 3
DP  - 2012 Sep
TI  - A sensitive period for language in the visual cortex: Distinct patterns of
      plasticity in congenitally versus late blind adults.
PG  - 162-70
AB  - Recent evidence suggests that blindness enables visual circuits to contribute to 
      language processing. We examined whether this dramatic functional plasticity has 
      a sensitive period. BOLD fMRI signal was measured in congenitally blind, late
      blind (blindness onset 9-years-old or later) and sighted participants while they 
      performed a sentence comprehension task. In a control condition, participants
      listened to backwards speech and made match/non-match to sample judgments. In
      both, congenitally and late blind participants BOLD signal increased in bilateral
      foveal-pericalcarine cortex during response preparation, irrespective of whether 
      the stimulus was a sentence or backwards speech. However, only in congenitally
      blind people left occipital areas (pericalcarine, extrastriate, fusiform and
      lateral) responded more to sentences than backwards speech. We conclude that age 
      of blindness onset constrains the non-visual functions of occipital cortex: while
      plasticity is present in both congenitally and late blind individuals,
      recruitment of visual circuits for language depends on blindness during
      childhood.
FAU - Bedny, Marina
AU  - Bedny M
AD  - Massachussetts Institute of Technology, Department of Brain and Cognitive
      Sciences, Cambridge MA, USA.
FAU - Pascual-Leone, Alvaro
AU  - Pascual-Leone A
AD  - Berenson-Allen Center for Noninvasive Brain Stimulation, Division of Cognitive
      Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard
      Medical School, Boston, MA, USA.
FAU - Dravida, Swethasri
AU  - Dravida S
AD  - Massachussetts Institute of Technology, Department of Brain and Cognitive
      Sciences, Cambridge MA, USA.
FAU - Saxe, Rebecca
AU  - Saxe R
AD  - Massachussetts Institute of Technology, Department of Brain and Cognitive
      Sciences, Cambridge MA, USA.
LA  - eng
PT  - Journal Article
DEP - 20111207
GR  - R01 EY012091 || EY
TA  - Brain Lang
JT  - Brain and language
AID - 10.1016/j.bandl.2011.10.005 [doi]
MID - NIHMS337975
SO  - Brain Lang. 2012 Sep;122(3):162-70. Epub 2011 Dec 07
      doi:10.1016/j.bandl.2011.10.005.

PMC - PMC3679720
PMID- 23613005
IS  - 0301-0449 (Print)
IS  - 1432-1998 (Electronic)
VI  - 43
IP  - Suppl 3
DP  - 2013 Jun
TI  - ESPR 2013.
PG  - 459-656
LA  - eng
PT  - Journal Article
DEP - 20130424
TA  - Pediatr Radiol
JT  - Pediatric Radiology
AID - 2675 [pii]
AID - 10.1007/s00247-013-2675-4 [doi]
SO  - Pediatr Radiol. 2013 Jun;43(Suppl 3):459-656. Epub 2013 Apr 24
      doi:10.1007/s00247-013-2675-4.

PMC - PMC4728776
PMID- 26812902
IS  - 1745-6215 (Electronic)
VI  - 17
DP  - 2016
TI  - Working memory and processing speed training in schizophrenia: study protocol for
      a randomized controlled trial.
LID - 49
AB  - Background: In most domains of cognition, individuals with schizophrenia are
      generally found to be one standard deviation below the mean of the controls. As a
      result, examining the impact of cognitive remediation in individuals with
      schizophrenia has been a burgeoning area of research. However, the state of the
      literature remains unclear as to which domains of cognition should be targeted to
      produce the most widespread and durable benefits for individuals with
      schizophrenia. One suggestion is that targeting lower-level cognitive processes
      that are important for higher-level and more complex aspects of cognition may
      produce the most widespread benefits in cognition and everyday functioning.
      Relatively few studies have examined the effects of working memory or processing 
      speed training in schizophrenia, as most studies examine broad-based remediation 
      programs. Thus, a need exists for targeted working memory and processing
      speed training studies to better understand the mechanisms of cognitive
      enhancement in patients. This study aims to 1) investigate near-transfer gains
      (that is, the transfer of learning to related contexts) associated with working
      memory and processing speed training in schizophrenia patients; 2) investigate
      far-transfer gains (that is, the transfer of learning to new contexts) associated
      with working memory and processing speed training (that is, gains in other
      neurocognitive domains and social cognition); and 3) investigate real-world gains
      associated with training (that is, gains in daily functioning). Methods/Design: A
      double-blind randomized controlled trial with a three parallel group design will 
      be conducted. A random sample of 81 patients with schizophrenia or
      schizoaffective disorder will be recruited through outpatient clinics at
      Foothills Hospital and community support programs in Calgary, Alberta.
      Participants will be randomly assigned using a computer-generated program in a
      1:1:1 ratio to a working memory-training group, a processing speed-training
      group, or a no-training control group. Training will be completed at home for
      30 minutes per day, 5 days per week, for a total of 10 weeks. Neurocognitive,
      social cognitive, and daily functioning measures will be administered both pre-
      and post-training to detect training-related gains. The primary outcome measures 
      will include working memory and processing speed (near-transfer measures), as
      well as fluid intelligence (far-transfer measure). Trial registration: Current
      controlled trials NCT02478827 (ClinicalTrials.gov, registered on 15 June 2015).
      Electronic supplementary material: The online version of this article
      (doi:10.1186/s13063-016-1188-5) contains supplementary material, which is
      available to authorized users.
FAU - Cassetta, Briana D.
AU  - Cassetta BD
AD  - Clinical Neuroscience of Schizophrenia Laboratory, Administration Building,
      Department of Psychology, University of Calgary, 2500 University Drive NW,
      Calgary, AB T2N 1N4 Canada
FAU - Goghari, Vina M.
AU  - Goghari VM
AD  - Clinical Neuroscience of Schizophrenia Laboratory, Administration Building,
      Department of Psychology, University of Calgary, 2500 University Drive NW,
      Calgary, AB T2N 1N4 Canada
LA  - eng
PT  - Journal Article
DEP - 20160126
GR  - #S40
PHST- 2015/08/29 [received]
PHST- 2016/01/20 [accepted]
TA  - Trials
JT  - Trials
AID - 1188 [pii]
AID - 10.1186/s13063-016-1188-5 [doi]
SO  - Trials. 2016 Jan 26;17:. doi:10.1186/s13063-016-1188-5.

PMC - PMC5423487
IS  - 0165-8107 (Print)
IS  - 1744-506X (Electronic)
VI  - 37
IP  - sup1
DP  - 2013
TI  - Editors’ Introduction.
PG  - 1-109
LA  - eng
PT  - Journal Article
DEP - 20130226
TA  - Neuroophthalmology
JT  - Neuro-Ophthalmology
AID - 767119 [pii]
AID - 10.3109/01658107.2013.767119 [doi]
SO  - Neuroophthalmology. 2013 Feb 26;37(sup1):1-109. doi:10.3109/01658107.2013.767119.

PMC - PMC4794196
PMID- 26982481
IS  - 1932-6203 (Electronic)
VI  - 11
IP  - 3
DP  - 2016
TI  - Haptic Guidance Needs to Be Intuitive Not Just Informative to Improve Human Motor
      Accuracy.
LID - e0150912
AB  - Humans make both random and systematic errors when reproducing learned movements.
      Intuitive haptic guidance that assists one to make the movements reduces such
      errors. Our study examined whether any additional haptic information about the
      location of the target reduces errors in a position reproduction task, or whether
      the haptic guidance needs to be assistive to do so. Holding a haptic device,
      subjects made reaches to visible targets without time constraints. They did so in
      a no-guidance condition, and in guidance conditions in which the direction of the
      force with respect to the target differed, but the force scaled with the distance
      to the target in the same way. We examined whether guidance forces directed
      towards the target would reduce subjects’ errors in reproducing a prior position 
      to the same extent as do forces rotated by 90 degrees or 180 degrees, as it might
      because the forces provide the same information in all three cases. Without
      vision of the arm, both the accuracy and precision were significantly better with
      guidance directed towards the target than in all other conditions. The errors
      with rotated guidance did not differ from those without guidance. Not
      surprisingly, the movements tended to be faster when guidance forces directed the
      reaches to the target. This study shows that haptic guidance significantly
      improved motor performance when using it was intuitive, while non-intuitively
      presented information did not lead to any improvements and seemed to be ignored
      even in our simple paradigm with static targets and no time constraints.
FAU - Mugge, Winfred
AU  - Mugge W
AD  - MOVE Research Institute Amsterdam, Department of Human Movement Sciences, VU
      University, Amsterdam, Netherlands
FAU - Kuling, Irene A.
AU  - Kuling IA
AD  - MOVE Research Institute Amsterdam, Department of Human Movement Sciences, VU
      University, Amsterdam, Netherlands
FAU - Brenner, Eli
AU  - Brenner E
AD  - MOVE Research Institute Amsterdam, Department of Human Movement Sciences, VU
      University, Amsterdam, Netherlands
FAU - Smeets, Jeroen B. J.
AU  - Smeets JBJ
AD  - MOVE Research Institute Amsterdam, Department of Human Movement Sciences, VU
      University, Amsterdam, Netherlands
LA  - eng
PT  - Journal Article
DEP - 20160316
PHST- 2015/07/31 [received]
PHST- 2016/02/22 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - 10.1371/journal.pone.0150912 [doi]
AID - PONE-D-15-33675 [pii]
SO  - PLoS One. 2016 Mar 16;11(3):. doi:10.1371/journal.pone.0150912.

PMC - PMC5025604
PMID- 27634471
IS  - 1743-0003 (Electronic)
VI  - 13
DP  - 2016
TI  - Technology-assisted stroke rehabilitation in Mexico: a pilot randomized trial
      comparing traditional therapy to circuit training in a Robot/technology-assisted 
      therapy gym.
LID - 83
AB  - Background: Stroke rehabilitation in low- and middle-income countries, such as
      Mexico, is often hampered by lack of clinical resources and funding. To provide a
      cost-effective solution for comprehensive post-stroke rehabilitation that can
      alleviate the need for one-on-one physical or occupational therapy, in lower and 
      upper extremities, we proposed and implemented a technology-assisted
      rehabilitation gymnasium in Chihuahua, Mexico. The Gymnasium for Robotic
      Rehabilitation (Robot Gym) consisted of low- and high-tech systems for upper and 
      lower limb rehabilitation. Our hypothesis is that the Robot Gym can provide a
      cost- and labor-efficient alternative for post-stroke rehabilitation, while being
      more or as effective as traditional physical and occupational therapy approaches.
      Methods: A typical group of stroke patients was randomly allocated to an
      intervention (n = 10) or a control group (n = 10). The intervention group
      received rehabilitation using the devices in the Robot Gym, whereas the control
      group (n = 10) received time-matched standard care. All of the study subjects
      were subjected to 24 two-hour therapy sessions over a period of 6 to 8 weeks.
      Several clinical assessments tests for upper and lower extremities were used to
      evaluate motor function pre- and post-intervention. A cost analysis was done to
      compare the cost effectiveness for both therapies. Results: No significant
      differences were observed when comparing the results of the pre-intervention
      Mini-mental, Brunnstrom Test, and Geriatric Depression Scale Test, showing that
      both groups were functionally similar prior to the intervention. Although, both
      training groups were functionally equivalent, they had a significant age
      difference. The results of all of the upper extremity tests showed an improvement
      in function in both groups with no statistically significant differences between 
      the groups. The Fugl-Meyer and the 10 Meters Walk lower extremity tests showed
      greater improvement in the intervention group compared to the control group. On
      the Time Up and Go Test, no statistically significant differences were observed
      pre- and post-intervention when comparing the control and the intervention
      groups. For the 6 Minute Walk Test, both groups presented a statistically
      significant difference pre- and post-intervention, showing progress in their
      performance. The robot gym therapy was more cost-effective than the traditional
      one-to-one therapy used during this study in that it enabled therapist to train
      up to 1.5 to 6 times more patients for the approximately same cost in the long
      term. Conclusions: The results of this study showed that the patients that
      received therapy using the Robot Gym had enhanced functionality in the upper
      extremity tests similar to patients in the control group. In the lower extremity 
      tests, the intervention patients showed more improvement than those subjected to 
      traditional therapy. These results support that the Robot Gym can be as effective
      as traditional therapy for stroke patients, presenting a more cost- and
      labor-efficient option for countries with scarce clinical resources and funding. 
      Trial registration: ISRCTN98578807.
FAU - Bustamante Valles, Karla
AU  - Bustamante Valles K
AD  - Orthopaedic and Rehabilitation Engineering Center (OREC), Marquette University,
      Milwaukee, WI USA
FAU - Montes, Sandra
AU  - Montes S
AD  - Biomedical Engineering, ITESM, Campus Chihuahua, Chihuahua, Chihuahua Mexico
FAU - Madrigal, Maria de Jesus
AU  - Madrigal Mde J
AD  - Centro de Rehabilitacion y Educacion Especial, DIF, Chihuahua, Chihuahua Mexico
FAU - Burciaga, Adan
AU  - Burciaga A
AD  - Centro de Rehabilitacion y Educacion Especial, DIF, Chihuahua, Chihuahua Mexico
FAU - Martínez, María Elena
AU  - Martínez ME
AD  - Biomedical Engineering, ITESM, Campus Chihuahua, Chihuahua, Chihuahua Mexico
FAU - Johnson, Michelle J.
AU  - Johnson MJ
AUID- ORCID: 0000-0002-7964-0304
AD  - Department of Physical Medicine and Rehabilitation, University of Pennsylvania,
      Philadelphia, PA USA
LA  - eng
PT  - Journal Article
DEP - 20160915
GR  - CHIH-2009-C02-127781
PHST- 2015/11/13 [received]
PHST- 2016/08/26 [accepted]
TA  - J Neuroeng Rehabil
JT  - Journal of NeuroEngineering and Rehabilitation
AID - 190 [pii]
AID - 10.1186/s12984-016-0190-1 [doi]
SO  - J Neuroeng Rehabil. 2016 Sep 15;13:. doi:10.1186/s12984-016-0190-1.

PMC - PMC3533621
PMID- 23100070
IS  - 1869-4101 (Electronic)
VI  - 2
IP  - Suppl 1
DP  - 2011 Mar
TI  - ECR 2011 Book of Abstracts - A - Postgraduate Educational Programme.
PG  - 1-134
LA  - eng
PT  - Journal Article
DEP - 20110301
TA  - Insights Imaging
JT  - Insights into Imaging
AID - 78 [pii]
AID - 10.1007/s13244-011-0078-3 [doi]
SO  - Insights Imaging. 2011 Mar 1;2(Suppl 1):1-134. doi:10.1007/s13244-011-0078-3.

PMC - PMC5423956
PMID- 28539894
IS  - 1664-1078 (Electronic)
VI  - 8
DP  - 2017
TI  - Modulation of Brain Activity with Noninvasive Transcranial Direct Current
      Stimulation (tDCS): Clinical Applications and Safety Concerns.
LID - 685
AB  - Transcranial direct current stimulation (tDCS) is a widely-used tool to induce
      neuroplasticity and modulate cortical function by applying weak direct current
      over the scalp. In this review, we first introduce the underlying mechanism of
      action, the brief history from discovery to clinical scientific research,
      electrode positioning and montages, and parameter setup of tDCS. Then, we review 
      tDCS application in clinical samples including people with drug addiction, major 
      depression disorder, Alzheimer's disease, as well as in children. This review
      covers the typical characteristics and the underlying neural mechanisms of tDCS
      treatment in such studies. This is followed by a discussion of safety, especially
      when the current intensity is increased or the stimulation duration is prolonged.
      Given such concerns, we provide detailed suggestions regarding safety procedures 
      for tDCS operation. Lastly, future research directions are discussed. They
      include foci on the development of multi-tech combination with tDCS such as with 
      TMS and fMRI; long-term behavioral and morphological changes; possible
      applications in other research domains, and more animal research to deepen the
      understanding of the biological and physiological mechanisms of tDCS stimulation.
FAU - Zhao, Haichao
AU  - Zhao H
AD  - Faculty of Psychology, Southwest UniversityChongqing, China
FAU - Qiao, Lei
AU  - Qiao L
AD  - Faculty of Psychology, Southwest UniversityChongqing, China
FAU - Fan, Dongqiong
AU  - Fan D
AD  - Faculty of Psychology, Southwest UniversityChongqing, China
FAU - Zhang, Shuyue
AU  - Zhang S
AD  - School of Education, Guangxi UniversityNanning, China
FAU - Turel, Ofir
AU  - Turel O
AD  - Department of Information systems and Decision Sciences, College of Business and 
      Economics, California State University, FullertonFullerton, CA, USA
FAU - Li, Yonghui
AU  - Li Y
AD  - Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of
      SciencesBeijing, China
FAU - Li, Jun
AU  - Li J
AD  - National Key Laboratory of Cognitive Neuroscience and Learning, IDG/McGovern
      Institute for Brain Research, Beijing Normal UniversityBeijing, China
FAU - Xue, Gui
AU  - Xue G
AD  - National Key Laboratory of Cognitive Neuroscience and Learning, IDG/McGovern
      Institute for Brain Research, Beijing Normal UniversityBeijing, China
FAU - Chen, Antao
AU  - Chen A
AD  - Faculty of Psychology, Southwest UniversityChongqing, China
FAU - He, Qinghua
AU  - He Q
AD  - Faculty of Psychology, Southwest UniversityChongqing, China
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170510
PHST- 2017/02/05 [received]
PHST- 2017/04/19 [accepted]
TA  - Front Psychol
JT  - Frontiers in Psychology
AID - 10.3389/fpsyg.2017.00685 [doi]
SO  - Front Psychol. 2017 May 10;8:. doi:10.3389/fpsyg.2017.00685.

PMC - PMC4763202
PMID- 26900961
IS  - 1932-6203 (Electronic)
VI  - 11
IP  - 2
DP  - 2016
TI  - Perceived Comfort and Blinding Efficacy in Randomised Sham-Controlled
      Transcranial Direct Current Stimulation (tDCS) Trials at 2 mA in Young and Older 
      Healthy Adults.
LID - e0149703
AB  - Background: tDCS studies typically find that: lowest levels of comfort occur at
      stimulation-onset; young adult participants experience less comfort than older
      participants; and participants’ blinding seems effective at low current
      strengths. At 2 mA conflicting results have been reported, questioning the
      effectiveness of blinding in sham-controlled paradigms using higher current
      strengths. Investigator blinding is rarely reported. Objective: Using a protocol 
      with 30 min of 2 mA stimulation we sought to: (a) investigate the level of
      perceived comfort in young and older adults, ranging in age from 19 to 29 years
      and 63 to 76 years, respectively; (b) test investigator and participant blinding;
      (c) assess comfort over a longer stimulation duration; (d) add to the literature 
      on protocols using 2 mA current strength. Methods: A two-session experiment was
      conducted where sham and active stimulation were administered to the frontal
      cortex at the F8/FP1 sites in a within-subjects manner. Levels of perceived
      comfort were measured, using a visual analogue scale, at the start and end of
      stimulation in young and older adults. Post-stimulation, participants and
      investigators judged whether or not active stimulation was used. Results: Comfort
      scores were lower at stimulation onset in both age groups. Older adults reported:
      (i) more comfort than young participants overall; (ii) comparable levels of
      comfort in sham and active stimulation; (iii) significantly more comfort than the
      young participants during active stimulation. Stimulation mode was correctly
      identified above chance in the second of the two sessions; 65% of all
      participants correctly identified the stimulation mode, resulting in a
      statistical trend. Similarly, the experimenter correctly identified stimulation
      mode significantly above chance, with 62% of all investigator judgements correct 
      across 120 judgements. Conclusions: Using 2 mA current strength over 30 minutes, 
      tDCS stimulation comfort is lower at stimulation onset in young and older adults 
      and, overall, lower for young participants. Investigators and participants may be
      able to identify active stimulation at above chance levels, although accuracy
      never exceeded 65% for either participants or the experimenter. Further research 
      into blinding efficacy is recommended.
FAU - Wallace, Denise
AU  - Wallace D
AD  - Department of Psychology and Centre for Brain Science, University of Essex,
      Colchester, Essex, United Kingdom
FAU - Cooper, Nicholas R.
AU  - Cooper NR
AD  - Department of Psychology and Centre for Brain Science, University of Essex,
      Colchester, Essex, United Kingdom
FAU - Paulmann, Silke
AU  - Paulmann S
AD  - Department of Psychology and Centre for Brain Science, University of Essex,
      Colchester, Essex, United Kingdom
FAU - Fitzgerald, Paul B.
AU  - Fitzgerald PB
AD  - Monash Alfred Psychiatry Research Centre, Monash University Central Clinical
      School and The Alfred, Monash University, Melbourne, Australia
FAU - Russo, Riccardo
AU  - Russo R
AD  - Department of Psychology and Centre for Brain Science, University of Essex,
      Colchester, Essex, United Kingdom
LA  - eng
PT  - Journal Article
DEP - 20160222
PHST- 2015/10/08 [received]
PHST- 2016/02/02 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - 10.1371/journal.pone.0149703 [doi]
AID - PONE-D-15-44350 [pii]
SO  - PLoS One. 2016 Feb 22;11(2):. doi:10.1371/journal.pone.0149703.

PMC - PMC3343376
PMID- 21734284
IS  - 0270-6474 (Print)
IS  - 1529-2401 (Electronic)
VI  - 31
IP  - 27
DP  - 2011 Jul 6
TI  - Oscillatory alpha-band mechanisms and the deployment of spatial attention to
      anticipated auditory and visual target locations: Supramodal or sensory-specific 
      control mechanisms?
PG  - 9923-32
AB  - Oscillatory alpha-band activity (8–15 Hz) over parieto-occipital cortex in humans
      plays an important role in suppression of processing for inputs at to-be-ignored 
      regions of space, with increased alpha-band power observed over cortex
      contralateral to locations expected to contain distractors. It is unclear if
      similar processes operate during deployment of spatial attention in other sensory
      modalities. Evidence from lesion patients suggests that parietal regions house
      supramodal representations of space. The parietal lobes are prominent generators 
      of alpha-oscillations; raising the possibility that alpha is a neural signature
      of supramodal spatial attention. Further, when spatial attention is deployed
      within vision, processing of task-irrelevant auditory inputs at attended
      locations is also enhanced, pointing to automatic links between spatial
      deployments across senses. Here, we asked whether lateralized alpha-band activity
      is also evident in a purely auditory spatial-cueing task, and whether it had the 
      same underlying generator configuration as in a purely visuo-spatial task. If
      common to both sensory-systems, this would provide strong support for
      “supramodal” attention theory. Alternately, alpha-band differences between
      auditory and visual tasks would support a sensory-specific account. Lateralized
      shifts in alpha-band activity were indeed observed during a purely
      auditory-spatial task. Crucially, there were clear differences in scalp
      topographies of this alpha-activity depending on the sensory system within which 
      spatial attention was deployed. Findings suggest that parietally-generated
      alpha-band mechanisms are central to attentional deployments across modalities
      but that they are invoked in a sensory-specific manner. The data support an
      interactivity account, whereby a supramodal system interacts with
      sensory-specific control systems during deployment of spatial attention.
FAU - Banerjee, Snigdha
AU  - Banerjee S
AD  - The Cognitive Neurophysiology Laboratory, Children's Evaluation and
      Rehabilitation Center (CERC), Departments of Pediatrics and Neuroscience, Albert 
      Einstein College of Medicine, Van Etten Building – Wing 1C, 1225 Morris Park
      Avenue, Bronx, N.Y. 10461, USA
FAU - Snyder, Adam C.
AU  - Snyder AC
AD  - The Cognitive Neurophysiology Laboratory, Children's Evaluation and
      Rehabilitation Center (CERC), Departments of Pediatrics and Neuroscience, Albert 
      Einstein College of Medicine, Van Etten Building – Wing 1C, 1225 Morris Park
      Avenue, Bronx, N.Y. 10461, USA
FAU - Molholm, Sophie
AU  - Molholm S
AD  - The Cognitive Neurophysiology Laboratory, Children's Evaluation and
      Rehabilitation Center (CERC), Departments of Pediatrics and Neuroscience, Albert 
      Einstein College of Medicine, Van Etten Building – Wing 1C, 1225 Morris Park
      Avenue, Bronx, N.Y. 10461, USA
FAU - Foxe, John J.
AU  - Foxe JJ
AD  - The Cognitive Neurophysiology Laboratory, Children's Evaluation and
      Rehabilitation Center (CERC), Departments of Pediatrics and Neuroscience, Albert 
      Einstein College of Medicine, Van Etten Building – Wing 1C, 1225 Morris Park
      Avenue, Bronx, N.Y. 10461, USA
LA  - eng
PT  - Journal Article
GR  - R01 MH085322-01 || MH
TA  - J Neurosci
JT  - The Journal of Neuroscience
AID - 10.1523/JNEUROSCI.4660-10.2011 [doi]
MID - NIHMS309856
SO  - J Neurosci. 2011 Jul 6;31(27):9923-32. doi:10.1523/JNEUROSCI.4660-10.2011.

PMC - PMC3464940
PMID- 22958744
IS  - 1866-1947 (Print)
IS  - 1866-1955 (Electronic)
VI  - 4
IP  - 1
DP  - 2012
TI  - Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and 
      genetic syndromes: animal models and clinical findings.
PG  - 19
AB  - This review summarizes evidence of dysregulated reward circuitry function in a
      range of neurodevelopmental and psychiatric disorders and genetic syndromes.
      First, the contribution of identifying a core mechanistic process across
      disparate disorders to disease classification is discussed, followed by a review 
      of the neurobiology of reward circuitry. We next consider preclinical animal
      models and clinical evidence of reward-pathway dysfunction in a range of
      disorders, including psychiatric disorders (i.e., substance-use disorders,
      affective disorders, eating disorders, and obsessive compulsive disorders),
      neurodevelopmental disorders (i.e., schizophrenia,
      attention-deficit/hyperactivity disorder, autism spectrum disorders, Tourette’s
      syndrome, conduct disorder/oppositional defiant disorder), and genetic syndromes 
      (i.e., Fragile X syndrome, Prader–Willi syndrome, Williams syndrome, Angelman
      syndrome, and Rett syndrome). We also provide brief overviews of effective
      psychopharmacologic agents that have an effect on the dopamine system in these
      disorders. This review concludes with methodological considerations for future
      research designed to more clearly probe reward-circuitry dysfunction, with the
      ultimate goal of improved intervention strategies.
FAU - Dichter, Gabriel S
AU  - Dichter GS
AD  - Carolina Institute for Developmental Disabilities, University of North Carolina
      at Chapel Hill School of Medicine, Chapel Hill, NC, USA
FAU - Damiano, Cara A
AU  - Damiano CA
AD  - Department of Psychology, University of North Carolina at Chapel Hill, Chapel
      Hill, NC, USA
FAU - Allen, John A
AU  - Allen JA
AD  - Neuroscience Research Unit Pfizer Global Research and Development, Groton, CT
      06340, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20120706
PHST- 2012/02/06 [received]
PHST- 2012/05/02 [accepted]
PHST- 2012/07/06 [aheadofprint]
TA  - J Neurodev Disord
JT  - Journal of Neurodevelopmental Disorders
AID - 1866-1955-4-19 [pii]
AID - 10.1186/1866-1955-4-19 [doi]
SO  - J Neurodev Disord. 2012;4(1):19. Epub 2012 Jul 6 doi:10.1186/1866-1955-4-19.

PMC - PMC3953591
PMID- 24626393
IS  - 1932-6203 (Electronic)
VI  - 9
IP  - 3
DP  - 2014
TI  - A Bidirectional Brain-Machine Interface Algorithm That Approximates Arbitrary
      Force-Fields.
LID - e91677
AB  - We examine bidirectional brain-machine interfaces that control external devices
      in a closed loop by decoding motor cortical activity to command the device and by
      encoding the state of the device by delivering electrical stimuli to sensory
      areas. Although it is possible to design this artificial sensory-motor
      interaction while maintaining two independent channels of communication, here we 
      propose a rule that closes the loop between flows of sensory and motor
      information in a way that approximates a desired dynamical policy expressed as a 
      field of forces acting upon the controlled external device. We previously
      developed a first implementation of this approach based on linear decoding of
      neural activity recorded from the motor cortex into a set of forces (a force
      field) applied to a point mass, and on encoding of position of the point mass
      into patterns of electrical stimuli delivered to somatosensory areas. However,
      this previous algorithm had the limitation that it only worked in situations when
      the position-to-force map to be implemented is invertible. Here we overcome this 
      limitation by developing a new non-linear form of the bidirectional interface
      that can approximate a virtually unlimited family of continuous fields. The new
      algorithm bases both the encoding of position information and the decoding of
      motor cortical activity on an explicit map between spike trains and the state
      space of the device computed with Multi-Dimensional-Scaling. We present a
      detailed computational analysis of the performance of the interface and a
      validation of its robustness by using synthetic neural responses in a simulated
      sensory-motor loop.
FAU - Vato, Alessandro
AU  - Vato A
AD  - Department of Robotics, Brain and Cognitive Sciences, Istituto Italiano di
      Tecnologia, Genova, Italy
FAU - Szymanski, Francois D.
AU  - Szymanski FD
AD  - Department of Robotics, Brain and Cognitive Sciences, Istituto Italiano di
      Tecnologia, Genova, Italy
FAU - Semprini, Marianna
AU  - Semprini M
AD  - Department of Robotics, Brain and Cognitive Sciences, Istituto Italiano di
      Tecnologia, Genova, Italy
FAU - Mussa-Ivaldi, Ferdinando A.
AU  - Mussa-Ivaldi FA
AD  - Department of Physiology, Northwestern University, Chicago, Illinois, United
      States of America
FAU - Panzeri, Stefano
AU  - Panzeri S
AD  - Center for Neuroscience and Cognitive Systems @UniTn, Istituto Italiano di
      Tecnologia, Rovereto, Italy
LA  - eng
PT  - Journal Article
DEP - 20140313
PHST- 2013/07/16 [received]
PHST- 2014/02/14 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-13-29237 [pii]
AID - 10.1371/journal.pone.0091677 [doi]
SO  - PLoS One. 2014 Mar 13;9(3):. doi:10.1371/journal.pone.0091677.

PMC - PMC4945719
PMID- 27114333
IS  - 0022-3751 (Print)
IS  - 1469-7793 (Electronic)
VI  - 594
IP  - 14
DP  - 2016 Jul 15
TI  - Clinical neurocardiology defining the value of neuroscience‐based cardiovascular 
      therapeutics.
PG  - 3911-54
AB  - The autonomic nervous system regulates all aspects of normal cardiac function,
      and is recognized to play a critical role in the pathophysiology of many
      cardiovascular diseases. As such, the value of neuroscience‐based cardiovascular 
      therapeutics is increasingly evident. This White Paper reviews the current state 
      of understanding of human cardiac neuroanatomy, neurophysiology, pathophysiology 
      in specific disease conditions, autonomic testing, risk stratification, and
      neuromodulatory strategies to mitigate the progression of cardiovascular
      diseases.
FAU - Shivkumar, Kalyanam
AU  - Shivkumar K
AD  - UCLA Cardiac Arrhythmia Center and Neurocardiology Research Center of
      ExcellenceLos AngelesCAUSA
FAU - Ajijola, Olujimi A.
AU  - Ajijola OA
AD  - UCLA Cardiac Arrhythmia Center and Neurocardiology Research Center of
      ExcellenceLos AngelesCAUSA
FAU - Anand, Inder
AU  - Anand I
AD  - Department of CardiologyUniversity of Minnesota Medical SchoolMinneapolisMNUSA
FAU - Armour, J. Andrew
AU  - Armour JA
AD  - UCLA Cardiac Arrhythmia Center and Neurocardiology Research Center of
      ExcellenceLos AngelesCAUSA
FAU - Chen, Peng‐Sheng
AU  - Chen P
AD  - Krannert Institute of CardiologyIndiana University School of
      MedicineIndianapolisINUSA
FAU - Esler, Murray
AU  - Esler M
AD  - Baker IDI Heart and Diabetes InstituteMelbourneVictoriaAustralia
FAU - De Ferrari, Gaetano M.
AU  - De Ferrari GM
AD  - Department of Molecular Medicine, University of PaviaPaviaItaly
FAU - Fishbein, Michael C.
AU  - Fishbein MC
AD  - Department of Pathology and Laboratory MedicineDavid Geffen School of Medicine at
      UCLALos AngelesCaliforniaUSA
FAU - Goldberger, Jeffrey J.
AU  - Goldberger JJ
AD  - Division of CardiologyUniversity of Miami Miller School of MedicineMiamiFLUSA
FAU - Harper, Ronald M.
AU  - Harper RM
AD  - Department of Neurobiology and the Brain Research InstituteUniversity of
      CaliforniaLos AngelesCAUSA
FAU - Joyner, Michael J.
AU  - Joyner MJ
AD  - Division of Cardiovascular DiseasesMayo Clinic and Mayo FoundationRochesterMNUSA
FAU - Khalsa, Sahib S.
AU  - Khalsa SS
AD  - Laureate Institute for Brain ResearchTulsaOKUSA
FAU - Kumar, Rajesh
AU  - Kumar R
AD  - Departments of Anesthesiology and Radiological SciencesDavid Geffen School of
      Medicine at UCLALos AngelesCAUSA
FAU - Lane, Richard
AU  - Lane R
AD  - Department of PsychiatryUniversity of Arizona College of MedicineTucsonAZUSA
FAU - Mahajan, Aman
AU  - Mahajan A
AD  - Department of AnesthesiaUCLALos AngelesCAUSA
FAU - Po, Sunny
AU  - Po S
AD  - Heart Rhythm InstituteUniversity of Oklahoma Health Sciences CenterOklahoma
      CityOKUSA
FAU - Schwartz, Peter J.
AU  - Schwartz PJ
AD  - Center for Cardiac Arrhythmias of Genetic OriginIRCCS Instituto Auxologico
      Italianoc/o Centro Diagnostico e di Ricerrca San CarloMilanItaly
FAU - Somers, Virend K.
AU  - Somers VK
AD  - Division of Cardiovascular DiseasesMayo Clinic and Mayo FoundationRochesterMNUSA
FAU - Valderrabano, Miguel
AU  - Valderrabano M
AD  - Methodist DeBakey Heart and Vascular Center and Methodist Hospital Research
      InstituteHouston Methodist HospitalHoustonTXUSA
FAU - Vaseghi, Marmar
AU  - Vaseghi M
AD  - UCLA Cardiac Arrhythmia Center and Neurocardiology Research Center of
      ExcellenceLos AngelesCAUSA
FAU - Zipes, Douglas P.
AU  - Zipes DP
AD  - Indiana University School of MedicineIndianapolisINUSA
LA  - eng
PT  - Journal Article
DEP - 20160614
PHST- 2016/02/06 [received]
PHST- 2016/04/08 [accepted]
TA  - J Physiol
JT  - The Journal of Physiology
AID - 10.1113/JP271870 [doi]
AID - TJP7302 [pii]
SO  - J Physiol. 2016 Jul 15;594(14):3911-54. Epub 2016 Jun 14 doi:10.1113/JP271870.

PMC - PMC3613863
PMID- 23559893
IS  - 1552-5260 (Print)
IS  - 1552-5279 (Electronic)
VI  - 7
IP  - 3
DP  - 2011 May 1
TI  - Assessment of cognition in early dementia.
PG  - e60-76
AB  - Better tools for assessing cognitive impairment in the early stages of
      Alzheimer’s disease (AD) are required to enable diagnosis of the disease before
      substantial neurodegeneration has taken place and to allow detection of subtle
      changes in the early stages of progression of the disease. The National Institute
      on Aging and the Alzheimer’s Association convened a meeting to discuss state of
      the art methods for cognitive assessment, including computerized batteries, as
      well as new approaches in the pipeline. Speakers described research using novel
      tests of object recognition, spatial navigation, attentional control, semantic
      memory, semantic interference, prospective memory, false memory and executive
      function as among the tools that could provide earlier identification of
      individuals with AD. In addition to early detection, there is a need for
      assessments that reflect real-world situations in order to better assess
      functional disability. It is especially important to develop assessment tools
      that are useful in ethnically, culturally and linguistically diverse populations 
      as well as in individuals with neurodegenerative disease other than AD.
FAU - Silverberg, Nina B.
AU  - Silverberg NB
AD  - Division of Neuroscience, National Institute on Aging, National Institutes of
      Health, Bethesda MD
FAU - Ryan, Laurie M.
AU  - Ryan LM
AD  - Division of Neuroscience, National Institute on Aging, National Institutes of
      Health, Bethesda MD
FAU - Carrillo, Maria C.
AU  - Carrillo MC
AD  - Alzheimer’s Association, Chicago, IL
FAU - Sperling, Reisa
AU  - Sperling R
AD  - Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and
      Women’s Hospital, Massachusetts General Hospital, Harvard Medical School, Boston,
      MA
FAU - Petersen, Ronald C.
AU  - Petersen RC
AD  - Department of Neurology, Mayo Clinic, Rochester, MN
FAU - Posner, Holly B.
AU  - Posner HB
FAU - Snyder, Peter J.
AU  - Snyder PJ
AD  - Rhode Island Hospital and Department of Neurology, Alpert Medical School of Brown
      University, Providence, RI
FAU - Hilsabeck, Robin
AU  - Hilsabeck R
AD  - Department of Psychiatry, University of Texas Health Science Center at San
      Antonio and Psychology Service, South Texas Veterans Health Care System
FAU - Gallagher, Michela
AU  - Gallagher M
AD  - Department of Psychological and Brain Sciences, Johns Hopkins University,
      Baltimore, MD
FAU - Raber, Jacob
AU  - Raber J
AD  - Department of Behavioral Neuroscience and Neurology and Division of Neuroscience,
      ONPRC, Oregon Health and Science University
FAU - Rizzo, Albert
AU  - Rizzo A
AD  - University of Southern California, Institute for Creative Technologies, Playa
      Vista, CA
FAU - Possin, Katherine
AU  - Possin K
AD  - Department of Neurology, University of California, San Francisco, CA
FAU - King, Jonathan
AU  - King J
AD  - Division of Behavioral and Social Research, National Institute on Aging, National
      Institutes of Health, Bethesda MD
FAU - Kaye, Jeffrey
AU  - Kaye J
AD  - Departments of Neurology and Biomedical Engineering, Layton Aging & Alzheimer’s
      Disease Center, Oregon Center for Aging & Technology, Oregon Health & Science
      University and Portland Veteran’s Affairs Medical Center, Portland, OR
FAU - Ott, Brian R.
AU  - Ott BR
AD  - Department of Cognitive, Linguistic and Psychological Sciences, Brown University,
      Street, Providence, RI
FAU - Albert, Marilyn S.
AU  - Albert MS
AD  - Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, 
      MD
FAU - Wagster, Molly V.
AU  - Wagster MV
AD  - Division of Neuroscience, National Institute on Aging, National Institutes of
      Health, Bethesda MD
FAU - Schinka, John A.
AU  - Schinka JA
AD  - James A. Haley VA Medical Center and Department of Psychiatry, University of
      South Florida, Tampa, FL
FAU - Cullum, C. Munro
AU  - Cullum CM
AD  - University of Texas Southwestern Medical Center at Dallas, TX
FAU - Farias, Sarah T.
AU  - Farias ST
AD  - Department of Neurology, University of California, Davis, Sacramento, California
FAU - Balota, David
AU  - Balota D
AD  - Department of Psychology, Washington University, St. Louis, Missouri
FAU - Rao, Stephen
AU  - Rao S
AD  - Schey Center for Cognitive Neuroimaging, Neurological Institute, Cleveland
      Clinic, Cleveland, OH
FAU - Loewenstein, David
AU  - Loewenstein D
AD  - Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical
      Center, Miami Beach, FL
FAU - Budson, Andrew E.
AU  - Budson AE
AD  - Department of Neurology, Boston University Alzheimer’s Disease Center, Boston
      University School of Medicine, Bedford, MA and Center for Translational Cognitive
      Neuroscience, Geriatric Research Education Clinical Center, Edith Nourse Rogers
      Memorial Veterans Hospital, Bedford, MA
FAU - Brandt, Jason
AU  - Brandt J
AD  - Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University
      School of Medicine, Baltimore, MD
FAU - Manly, Jennifer J.
AU  - Manly JJ
AD  - Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia 
      University Medical Center, New York, NY
FAU - Barnes, Lisa
AU  - Barnes L
AD  - Rush Alzheimer’s Disease Center, Department of Neurological Sciences, and
      Department of Behavioral Sciences, 4Rush Institute for Healthy Aging, Rush
      University Medical Center, Chicago, IL
FAU - Strutt, Adriana
AU  - Strutt A
AD  - Baylor College of Medicine, Houston, TX
FAU - Gollan, Tamar H.
AU  - Gollan TH
AD  - Department of Psychiatry, University of California, San Diego, CA
FAU - Ganguli, Mary
AU  - Ganguli M
AD  - Departments of Psychiatry and Neurology, School of Medicine, University of
      Pittsburgh; Department of Epidemiology, Graduate School of Public Health,
      University of Pittsburgh, Pittsburgh, PA
FAU - Babcock, Debra
AU  - Babcock D
AD  - National Institute of Neurological Disorders and Stroke, National Institutes of
      Health, Bethesda, MD
FAU - Litvan, Irene
AU  - Litvan I
AD  - Division of Movement Disorders, Department of Neurology, University of
      Louisville, Louisville, KY
FAU - Kramer, Joel H.
AU  - Kramer JH
AD  - Department of Neurology, University of California, San Francisco, CA
FAU - Ferman, Tanis J.
AU  - Ferman TJ
AD  - Department of Psychiatry and Psychology, Mayo Clinic, College of Medicine,
      Jacksonville, FL
LA  - eng
PT  - Journal Article
GR  - Z99 AG999999 || AG
TA  - Alzheimers Dement
JT  - Alzheimer's & dementia : the journal of the Alzheimer's Association
AID - 10.1016/j.jalz.2011.05.001 [doi]
MID - NIHMS294637
SO  - Alzheimers Dement. 2011 May 1;7(3):e60-76. doi:10.1016/j.jalz.2011.05.001.

PMC - PMC2846313
PMID- 19933142
IS  - 0962-8436 (Print)
IS  - 1471-2970 (Electronic)
VI  - 364
IP  - 1536
DP  - 2009 Dec 27
TI  - Neurophysiological mechanisms involved in language learning in adults.
PG  - 3711-35
AB  - Little is known about the brain mechanisms involved in word learning during
      infancy and in second language acquisition and about the way these new words
      become stable representations that sustain language processing. In several
      studies we have adopted the human simulation perspective, studying the effects of
      brain-lesions and combining different neuroimaging techniques such as
      event-related potentials and functional magnetic resonance imaging in order to
      examine the language learning (LL) process. In the present article, we review
      this evidence focusing on how different brain signatures relate to (i) the
      extraction of words from speech, (ii) the discovery of their embedded grammatical
      structure, and (iii) how meaning derived from verbal contexts can inform us about
      the cognitive mechanisms underlying the learning process. We compile these
      findings and frame them into an integrative neurophysiological model that tries
      to delineate the major neural networks that might be involved in the initial
      stages of LL. Finally, we propose that LL simulations can help us to understand
      natural language processing and how the recovery from language disorders in
      infants and adults can be accomplished.
FAU - Rodríguez-Fornells, Antoni
AU  - Rodríguez-Fornells A
AD  - Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
FAU - Cunillera, Toni
AU  - Cunillera T
AD  - Department of Basic Psychology, Faculty of Psychology, University of Barcelona,
      08035 Barcelona, Spain
FAU - Mestres-Missé, Anna
AU  - Mestres-Missé A
AD  - Max Planck Institute for Human Cognitive and Brain Sciences, 04103 Leipzig,
      Germany
FAU - de Diego-Balaguer, Ruth
AU  - de Diego-Balaguer R
AD  - Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
LA  - eng
PT  - Journal Article
PT  - Review
TA  - Philos Trans R Soc Lond B Biol Sci
JT  - Philosophical Transactions of the Royal Society B: Biological Sciences
AID - 10.1098/rstb.2009.0130 [doi]
AID - rstb20090130 [pii]
SO  - Philos Trans R Soc Lond B Biol Sci. 2009 Dec 27;364(1536):3711-35.
      doi:10.1098/rstb.2009.0130.

PMC - PMC4686285
PMID- 26334013
IS  - 0022-3077 (Print)
IS  - 1522-1598 (Electronic)
VI  - 114
IP  - 6
DP  - 2015 Dec 1
TI  - Processing time of addition or withdrawal of single or combined
      balance-stabilizing haptic and visual information.
PG  - 3097-110
AB  - We investigated the integration time of haptic and visual input and their
      interaction during stance stabilization. Eleven subjects performed four
      tandem-stance conditions (60 trials each). Vision, touch, and both vision and
      touch were added and withdrawn. Furthermore, vision was replaced with touch and
      vice versa. Body sway, tibialis anterior, and peroneus longus activity were
      measured. Following addition or withdrawal of vision or touch, an integration
      time period elapsed before the earliest changes in sway were observed.
      Thereafter, sway varied exponentially to a new steady-state while reweighting
      occurred. Latencies of sway changes on sensory addition ranged from 0.6 to 1.5 s 
      across subjects, consistently longer for touch than vision, and were regularly
      preceded by changes in muscle activity. Addition of vision and touch
      simultaneously shortened the latencies with respect to vision or touch
      separately, suggesting cooperation between sensory modalities. Latencies
      following withdrawal of vision or touch or both simultaneously were shorter than 
      following addition. When vision was replaced with touch or vice versa, adding one
      modality did not interfere with the effect of withdrawal of the other, suggesting
      that integration of withdrawal and addition were performed in parallel. The time 
      course of the reweighting process to reach the new steady-state was also shorter 
      on withdrawal than addition. The effects of different sensory inputs on posture
      stabilization illustrate the operation of a time-consuming, possibly supraspinal 
      process that integrates and fuses modalities for accurate balance control. This
      study also shows the facilitatory interaction of visual and haptic inputs in
      integration and reweighting of stance-stabilizing inputs.
FAU - Honeine, Jean-Louis
AU  - Honeine JL
AD  - Department of Public Health, Experimental and Forensic Medicine, University of
      Pavia, Pavia, Italy; and
FAU - Crisafulli, Oscar
AU  - Crisafulli O
AD  - Department of Public Health, Experimental and Forensic Medicine, University of
      Pavia, Pavia, Italy; and
FAU - Sozzi, Stefania
AU  - Sozzi S
AD  - Centro Studi Attività Motorie (CSAM), Fondazione Salvatore Maugeri (IRCSS),
      Pavia, Italy
FAU - Schieppati, Marco
AU  - Schieppati M
AD  - Department of Public Health, Experimental and Forensic Medicine, University of
      Pavia, Pavia, Italy; and
LA  - eng
PT  - Journal Article
DEP - 20150902
GR  - GR-2009-1471033
PHST- 2015/06/22 [received]
PHST- 2015/08/28 [accepted]
TA  - J Neurophysiol
JT  - Journal of Neurophysiology
AID - JN-00618-2015 [pii]
AID - 10.1152/jn.00618.2015 [doi]
SO  - J Neurophysiol. 2015 Dec 1;114(6):3097-110. Epub 2015 Sep 2
      doi:10.1152/jn.00618.2015.

PMC - PMC3858645
PMID- 24376403
IS  - 1662-5145 (Electronic)
VI  - 7
DP  - 2013
TI  - Vestibular activity and cognitive development in children: perspectives.
LID - 92
AB  - Vestibular signals play an essential role in oculomotor and static and dynamic
      posturomotor functions. Increasing attention is now focusing on their impact on
      spatial and non-spatial cognitive functions. Movements of the head in space evoke
      vestibular signals that make important contributions during the development of
      brain representations of body parts relative to one another as well as
      representations of body orientation and position within the environment. A
      central nervous system pathway relays signals from the vestibular nuclei to the
      hippocampal system where this input is indispensable for neuronal responses
      selective for the position and orientation of the head in space. One aspect of
      the hippocampal systems’ processing to create episodic and contextual memories is
      its role in spatial orientation and navigation behaviors that require processing 
      of relations between background cues. These are also impaired in adult patients
      with vestibular deficits. However little is known about the impact of vestibular 
      loss on cognitive development in children. This is investigated here with a
      particular emphasis upon the hypothetical mechanisms and potential impact of
      vestibular loss at critical ages on the development of respective spatial and
      non-spatial cognitive processes and their brain substrates.
FAU - Wiener-Vacher, Sylvette R.
AU  - Wiener-Vacher SR
AD  - Vestibular and Oculomotor Evaluation Unit, Department of Otorhinolaryngology,
      Robert Debré Pediatric HospitalParis, France
FAU - Hamilton, Derek A.
AU  - Hamilton DA
AD  - Department of Psychology, University of New MexicoAlbuquerque, NM, USA
FAU - Wiener, Sidney I.
AU  - Wiener SI
AD  - Laboratoire de Physiologie de la Perception et de l’Action, UMR-7152, Centre
      National de la Recherche Scientifique - Collège de FranceParis, France
LA  - eng
PT  - Journal Article
DEP - 20131211
PHST- 2013/07/31 [received]
PHST- 2013/11/21 [accepted]
TA  - Front Integr Neurosci
JT  - Frontiers in Integrative Neuroscience
AID - 10.3389/fnint.2013.00092 [doi]
SO  - Front Integr Neurosci. 2013 Dec 11;7:. doi:10.3389/fnint.2013.00092.

PMC - PMC4971093
PMID- 27536212
IS  - 1662-4548 (Print)
IS  - 1662-453X (Electronic)
VI  - 10
DP  - 2016
TI  - Neurofeedback Therapy for Enhancing Visual Attention: State-of-the-Art and
      Challenges.
LID - 352
AB  - We have witnessed a rapid development of brain-computer interfaces (BCIs) linking
      the brain to external devices. BCIs can be utilized to treat neurological
      conditions and even to augment brain functions. BCIs offer a promising treatment 
      for mental disorders, including disorders of attention. Here we review the
      current state of the art and challenges of attention-based BCIs, with a focus on 
      visual attention. Attention-based BCIs utilize electroencephalograms (EEGs) or
      other recording techniques to generate neurofeedback, which patients use to
      improve their attention, a complex cognitive function. Although progress has been
      made in the studies of neural mechanisms of attention, extraction of
      attention-related neural signals needed for BCI operations is a difficult
      problem. To attain good BCI performance, it is important to select the features
      of neural activity that represent attentional signals. BCI decoding of
      attention-related activity may be hindered by the presence of different neural
      signals. Therefore, BCI accuracy can be improved by signal processing algorithms 
      that dissociate signals of interest from irrelevant activities. Notwithstanding
      recent progress, optimal processing of attentional neural signals remains a
      fundamental challenge for the development of efficient therapies for disorders of
      attention.
FAU - Ordikhani-Seyedlar, Mehdi
AU  - Ordikhani-Seyedlar M
AD  - Division of Biomedical Engineering, Department of Electrical Engineering,
      Technical University of DenmarkLyngby, Denmark
FAU - Lebedev, Mikhail A.
AU  - Lebedev MA
AD  - Department of Neurobiology, Duke UniversityDurham, NC, USA
FAU - Sorensen, Helge B. D.
AU  - Sorensen HBD
AD  - Division of Biomedical Engineering, Department of Electrical Engineering,
      Technical University of DenmarkLyngby, Denmark
FAU - Puthusserypady, Sadasivan
AU  - Puthusserypady S
AD  - Division of Biomedical Engineering, Department of Electrical Engineering,
      Technical University of DenmarkLyngby, Denmark
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20160803
PHST- 2016/04/19 [received]
PHST- 2016/07/12 [accepted]
TA  - Front Neurosci
JT  - Frontiers in Neuroscience
AID - 10.3389/fnins.2016.00352 [doi]
SO  - Front Neurosci. 2016 Aug 03;10:. doi:10.3389/fnins.2016.00352.

PMC - PMC3721360
PMID- 23898241
IS  - 1662-5145 (Electronic)
VI  - 7
DP  - 2013
TI  - Autism: the micro-movement perspective.
LID - 32
AB  - The current assessment of behaviors in the inventories to diagnose autism
      spectrum disorders (ASD) focus on observation and discrete categorizations.
      Behaviors require movements, yet measurements of physical movements are seldom
      included. Their inclusion however, could provide an objective characterization of
      behavior to help unveil interactions between the peripheral and the central
      nervous systems (CNSs). Such interactions are critical for the development and
      maintenance of spontaneous autonomy, self-regulation, and voluntary control. At
      present, current approaches cannot deal with the heterogeneous, dynamic and
      stochastic nature of development. Accordingly, they leave no avenues for real
      time or longitudinal assessments of change in a coping system continuously
      adapting and developing compensatory mechanisms. We offer a new unifying
      statistical framework to reveal re-afferent kinesthetic features of the
      individual with ASD. The new methodology is based on the non-stationary
      stochastic patterns of minute fluctuations (micro-movements) inherent to our
      natural actions. Such patterns of behavioral variability provide re-entrant
      sensory feedback contributing to the autonomous regulation and coordination of
      the motor output. From an early age, this feedback supports centrally driven
      volitional control and fluid, flexible transitions between intentional and
      spontaneous behaviors. We show that in ASD there is a disruption in the
      maturation of this form of proprioception. Despite this disturbance, each
      individual has unique adaptive compensatory capabilities that we can unveil and
      exploit to evoke faster and more accurate decisions. Measuring the kinesthetic
      re-afference in tandem with stimuli variations we can detect changes in their
      micro-movements indicative of a more predictive and reliable kinesthetic percept.
      Our methods address the heterogeneity of ASD with a personalized approach
      grounded in the inherent sensory-motor abilities that the individual has already 
      developed.
FAU - Torres, Elizabeth B.
AU  - Torres EB
AD  - Psychology Department, Rutgers Center for Cognitive Science, Center for
      Computational Biomedicine Imaging and Modeling (Computer Science), Movement
      Disorders, Neurology, Rutgers University School of Medicine, Rutgers
      UniversityNew Brunswick, NJ, USA
FAU - Brincker, Maria
AU  - Brincker M
AD  - Philosophy Department, University of MassachusettsBoston, MA, USA
FAU - Isenhower, Robert W.
AU  - Isenhower RW
AD  - Psychology Department, Rutgers UniversityPiscataway, NJ, USA
FAU - Yanovich, Polina
AU  - Yanovich P
AD  - Computer Science Department, Rutgers UniversityPiscataway, NJ, USA
FAU - Stigler, Kimberly A.
AU  - Stigler KA
AD  - Department of Psychiatry, Indiana University School of Medicine, Indiana
      UniversityIndianapolis, IN, USA
FAU - Nurnberger, John I.
AU  - Nurnberger JI
AD  - Department of Psychiatry, Christian Sarkine Autism Treatment Center, Riley
      Hospital for Children, Indiana University School of Medicine, Indiana
      UniversityIndianapolis, IN, USA
FAU - Metaxas, Dimitris N.
AU  - Metaxas DN
AD  - Computer Science Department, Center for Computational Biomedicine Imaging and
      Modeling, Rutgers Center for Cognitive Science, Rutgers UniversityPiscataway, NJ,
      USA
FAU - José, Jorge V.
AU  - José JV
AD  - Physics Department Bloomington, Department of Cellular and Integrative
      Physiology, Indiana University School of Medicine, Indiana UniversityBloomington,
      IN, USA
LA  - eng
PT  - Journal Article
DEP - 20130724
PHST- 2013/04/07 [received]
PHST- 2013/04/21 [accepted]
TA  - Front Integr Neurosci
JT  - Frontiers in Integrative Neuroscience
AID - 10.3389/fnint.2013.00032 [doi]
SO  - Front Integr Neurosci. 2013 Jul 24;7:. doi:10.3389/fnint.2013.00032.

PMC - PMC4148063
PMID- 24968105
IS  - 1530-5627 (Print)
IS  - 1556-3669 (Electronic)
VI  - 20
IP  - 9
DP  - 2014 Sep 01
TI  - The Empirical Foundations of Telemedicine Interventions for Chronic Disease
      Management.
PG  - 769-800
AB  - The telemedicine intervention in chronic disease management promises to involve
      patients in their own care, provides continuous monitoring by their healthcare
      providers, identifies early symptoms, and responds promptly to exacerbations in
      their illnesses. This review set out to establish the evidence from the available
      literature on the impact of telemedicine for the management of three chronic
      diseases: congestive heart failure, stroke, and chronic obstructive pulmonary
      disease. By design, the review focuses on a limited set of representative chronic
      diseases because of their current and increasing importance relative to their
      prevalence, associated morbidity, mortality, and cost. Furthermore, these three
      diseases are amenable to timely interventions and secondary prevention through
      telemonitoring. The preponderance of evidence from studies using rigorous
      research methods points to beneficial results from telemonitoring in its various 
      manifestations, albeit with a few exceptions. Generally, the benefits include
      reductions in use of service: hospital admissions/re-admissions, length of
      hospital stay, and emergency department visits typically declined. It is
      important that there often were reductions in mortality. Few studies reported
      neutral or mixed findings.
FAU - Bashshur, Rashid L.
AU  - Bashshur RL
AD  - E-Health Center, University of Michigan Health System, Ann Arbor, Michigan.
FAU - Shannon, Gary W.
AU  - Shannon GW
AD  - Department of Geography, University of Kentucky, Lexington, Kentucky.
FAU - Smith, Brian R.
AU  - Smith BR
AD  - E-Health Center, University of Michigan Health System, Ann Arbor, Michigan.
FAU - Alverson, Dale C.
AU  - Alverson DC
AD  - University of New Mexico, Albuquerque, New Mexico.
FAU - Antoniotti, Nina
AU  - Antoniotti N
AD  - Marshfield Clinic, Marshfield, Wisconsin.
FAU - Barsan, William G.
AU  - Barsan WG
AD  - University of Michigan Health System, Ann Arbor, Michigan.
FAU - Bashshur, Noura
AU  - Bashshur N
AD  - E-Health Center, University of Michigan Health System, Ann Arbor, Michigan.
FAU - Brown, Edward M.
AU  - Brown EM
AD  - Ontario Telemedicine Network, Toronto, Ontario, Canada.
FAU - Coye, Molly J.
AU  - Coye MJ
AD  - University of California at Los Angeles, Los Angeles, California.
FAU - Doarn, Charles R.
AU  - Doarn CR
AD  - Family and Community Medicine, University of Cincinnati, Cincinnati, Ohio.
FAU - Ferguson, Stewart
AU  - Ferguson S
AD  - Alaska Native Tribal Health Consortium, Anchorage, Alaska.
FAU - Grigsby, Jim
AU  - Grigsby J
AD  - University of Colorado Denver, Denver, Colorado.
FAU - Krupinski, Elizabeth A.
AU  - Krupinski EA
AD  - University of Arizona, Tucson, Arizona.
FAU - Kvedar, Joseph C.
AU  - Kvedar JC
AD  - Partners Health Care, Harvard University, Cambridge, Massachusetts.
FAU - Linkous, Jonathan
AU  - Linkous J
AD  - American Telemedicine Association, Washington, D.C.
FAU - Merrell, Ronald C.
AU  - Merrell RC
AD  - Virginia Commonwealth University, Richmond, Virginia.
FAU - Nesbitt, Thomas
AU  - Nesbitt T
AD  - University of California Davis, Sacramento, California.
FAU - Poropatich, Ronald
AU  - Poropatich R
AD  - University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
FAU - Rheuban, Karen S.
AU  - Rheuban KS
AD  - University of Virginia, Charlottesville, Virginia.
FAU - Sanders, Jay H.
AU  - Sanders JH
AD  - The Global Telemedicine Group, McLean, Virginia.
FAU - Watson, Andrew R.
AU  - Watson AR
AD  - University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
FAU - Weinstein, Ronald S.
AU  - Weinstein RS
AD  - University of Arizona, Tucson, Arizona.
FAU - Yellowlees, Peter
AU  - Yellowlees P
AD  - University of California Davis, Sacramento, California.
LA  - eng
PT  - Journal Article
PHST- 2014/05/28 [received]
PHST- 2014/05/28 [accepted]
TA  - Telemed J E Health
JT  - Telemedicine Journal and e-Health
AID - 10.1089/tmj.2014.9981 [pii]
AID - 10.1089/tmj.2014.9981 [doi]
SO  - Telemed J E Health. 2014 Sep 01;20(9):769-800. doi:10.1089/tmj.2014.9981.

PMC - PMC5362618
PMID- 28386211
IS  - 1662-4548 (Print)
IS  - 1662-453X (Electronic)
VI  - 11
DP  - 2017
TI  - On the Auditory-Proprioception Substitution Hypothesis: Movement Sonification in 
      Two Deafferented Subjects Learning to Write New Characters.
LID - 137
AB  - The aim of this study was to evaluate the compensatory effects of real-time
      auditory feedback on two proprioceptively deafferented subjects. The real-time
      auditory feedback was based on a movement sonification approach, consisting of
      translating some movement variables into synthetic sounds to make them audible.
      The two deafferented subjects and 16 age-matched control participants were asked 
      to learn four new characters. The characters were learned under two different
      conditions, one without sonification and one with sonification, respecting a
      within-subject protocol. The results revealed that characters learned with
      sonification were reproduced more quickly and more fluently than characters
      learned without and that the effects of sonification were larger in deafferented 
      than in control subjects. Secondly, whereas control subjects were able to learn
      the characters without sounds the deafferented subjects were able to learn them
      only when they were trained with sonification. Thirdly, although the improvement 
      was still present in controls, the performance of deafferented subjects came back
      to the pre-test level 2 h after the training with sounds. Finally, the two
      deafferented subjects performed differently from each other, highlighting the
      importance of studying at least two subjects to better understand the loss of
      proprioception and its impact on motor control and learning. To conclude,
      movement sonification may compensate for a lack of proprioception, supporting the
      auditory-proprioception substitution hypothesis. However, sonification would act 
      as a “sensory prosthesis” helping deafferented subjects to better feel their
      movements, without permanently modifying their motor performance once the
      prosthesis is removed. Potential clinical applications for motor rehabilitation
      are numerous: people with a limb prosthesis, with a stroke, or with some
      peripheral nerve injury may potentially be interested.
FAU - Danna, Jérémy
AU  - Danna J
FAU - Velay, Jean-Luc
AU  - Velay JL
LA  - eng
PT  - Journal Article
DEP - 20170323
GR  - ANR-11-LABX-0036
PHST- 2016/12/02 [received]
PHST- 2017/03/06 [accepted]
TA  - Front Neurosci
JT  - Frontiers in Neuroscience
AID - 10.3389/fnins.2017.00137 [doi]
SO  - Front Neurosci. 2017 Mar 23;11:. doi:10.3389/fnins.2017.00137.

PMC - PMC3874475
PMID- 24415996
IS  - 1662-4548 (Print)
IS  - 1662-453X (Electronic)
VI  - 7
DP  - 2013
TI  - Decoding of single-trial auditory mismatch responses for online perceptual
      monitoring and neurofeedback.
LID - 265
AB  - Multivariate pattern classification methods are increasingly applied to
      neuroimaging data in the context of both fundamental research and in
      brain-computer interfacing approaches. Such methods provide a framework for
      interpreting measurements made at the single-trial level with respect to a set of
      two or more distinct mental states. Here, we define an approach in which the
      output of a binary classifier trained on data from an auditory mismatch paradigm 
      can be used for online tracking of perception and as a neurofeedback signal. The 
      auditory mismatch paradigm is known to induce distinct perceptual states related 
      to the presentation of high- and low-probability stimuli, which are reflected in 
      event-related potential (ERP) components such as the mismatch negativity (MMN).
      The first part of this paper illustrates how pattern classification methods can
      be applied to data collected in an MMN paradigm, including discussion of the
      optimization of preprocessing steps, the interpretation of features and how the
      performance of these methods generalizes across individual participants and
      measurement sessions. We then go on to show that the output of these decoding
      methods can be used in online settings as a continuous index of single-trial
      brain activation underlying perceptual discrimination. We conclude by discussing 
      several potential domains of application, including neurofeedback, cognitive
      monitoring and passive brain-computer interfaces.
FAU - Brandmeyer, Alex
AU  - Brandmeyer A
AD  - Centre for Cognition, Donders Institute for Brain, Cognition and Behaviour,
      Radboud University NijmegenNijmegen, Netherlands
FAU - Sadakata, Makiko
AU  - Sadakata M
AD  - Centre for Cognition, Donders Institute for Brain, Cognition and Behaviour,
      Radboud University NijmegenNijmegen, Netherlands
FAU - Spyrou, Loukianos
AU  - Spyrou L
AD  - Centre for Cognition, Donders Institute for Brain, Cognition and Behaviour,
      Radboud University NijmegenNijmegen, Netherlands
FAU - McQueen, James M.
AU  - McQueen JM
AD  - Centre for Cognition, Donders Institute for Brain, Cognition and Behaviour,
      Radboud University NijmegenNijmegen, Netherlands
FAU - Desain, Peter
AU  - Desain P
AD  - Centre for Cognition, Donders Institute for Brain, Cognition and Behaviour,
      Radboud University NijmegenNijmegen, Netherlands
LA  - eng
PT  - Journal Article
DEP - 20131230
PHST- 2013/10/18 [received]
PHST- 2013/12/16 [accepted]
TA  - Front Neurosci
JT  - Frontiers in Neuroscience
AID - 10.3389/fnins.2013.00265 [doi]
SO  - Front Neurosci. 2013 Dec 30;7:. doi:10.3389/fnins.2013.00265.

PMC - PMC4326499
PMID- 25558785
IS  - 1743-0003 (Electronic)
VI  - 12
IP  - 1
DP  - 2015
TI  - Real-time modulation of visual feedback on human full-body movements in a virtual
      mirror: development and proof-of-concept.
LID - 2
AB  - Background: Virtual reality (VR) provides interactive multimodal sensory stimuli 
      and biofeedback, and can be a powerful tool for physical and cognitive
      rehabilitation. However, existing systems have generally not implemented
      realistic full-body avatars and/or a scaling of visual movement feedback. We
      developed a “virtual mirror” that displays a realistic full-body avatar that
      responds to full-body movements in all movement planes in real-time, and that
      allows for the scaling of visual feedback on movements in real-time. The primary 
      objective of this proof-of-concept study was to assess the ability of healthy
      subjects to detect scaled feedback on trunk flexion movements. Methods: The
      “virtual mirror” was developed by integrating motion capture, virtual reality and
      projection systems. A protocol was developed to provide both augmented and
      reduced feedback on trunk flexion movements while sitting and standing. The task 
      required reliance on both visual and proprioceptive feedback. The ability to
      detect scaled feedback was assessed in healthy subjects (n = 10) using a
      two-alternative forced choice paradigm. Additionally, immersion in the VR
      environment and task adherence (flexion angles, velocity, and fluency) were
      assessed. Results: The ability to detect scaled feedback could be modelled using 
      a sigmoid curve with a high goodness of fit (R2 range 89-98%). The point of
      subjective equivalence was not significantly different from 0 (i.e. not shifted),
      indicating an unbiased perception. The just noticeable difference was
      0.035 ± 0.007, indicating that subjects were able to discriminate different
      scaling levels consistently. VR immersion was reported to be good, despite some
      perceived delays between movements and VR projections. Movement kinematic
      analysis confirmed task adherence. Conclusions: The new “virtual mirror” extends 
      existing VR systems for motor and pain rehabilitation by enabling the use of
      realistic full-body avatars and scaled feedback. Proof-of-concept was
      demonstrated for the assessment of body perception during active movement in
      healthy controls. The next step will be to apply this system to assessment of
      body perception disturbances in patients with chronic pain.
FAU - Roosink, Meyke
AU  - Roosink M
AD  - Centre Interdisciplinaire de Recherche en Réadaptation et Intégration Sociale
      (CIRRIS), 525 Boul Hamel, Québec, QC G1M 2S8 Canada
FAU - Robitaille, Nicolas
AU  - Robitaille N
AD  - Centre Interdisciplinaire de Recherche en Réadaptation et Intégration Sociale
      (CIRRIS), 525 Boul Hamel, Québec, QC G1M 2S8 Canada
FAU - McFadyen, Bradford J
AU  - McFadyen BJ
AD  - Centre Interdisciplinaire de Recherche en Réadaptation et Intégration Sociale
      (CIRRIS), 525 Boul Hamel, Québec, QC G1M 2S8 Canada
FAU - Hébert, Luc J
AU  - Hébert LJ
AD  - Centre Interdisciplinaire de Recherche en Réadaptation et Intégration Sociale
      (CIRRIS), 525 Boul Hamel, Québec, QC G1M 2S8 Canada
FAU - Jackson, Philip L
AU  - Jackson PL
AD  - Centre Interdisciplinaire de Recherche en Réadaptation et Intégration Sociale
      (CIRRIS), 525 Boul Hamel, Québec, QC G1M 2S8 Canada
FAU - Bouyer, Laurent J
AU  - Bouyer LJ
AD  - Centre Interdisciplinaire de Recherche en Réadaptation et Intégration Sociale
      (CIRRIS), 525 Boul Hamel, Québec, QC G1M 2S8 Canada
FAU - Mercier, Catherine
AU  - Mercier C
AD  - Centre Interdisciplinaire de Recherche en Réadaptation et Intégration Sociale
      (CIRRIS), 525 Boul Hamel, Québec, QC G1M 2S8 Canada
LA  - eng
PT  - Journal Article
DEP - 20150105
PHST- 2014/07/03 [received]
PHST- 2014/12/22 [accepted]
TA  - J Neuroeng Rehabil
JT  - Journal of NeuroEngineering and Rehabilitation
AID - 692 [pii]
AID - 10.1186/1743-0003-12-2 [doi]
SO  - J Neuroeng Rehabil. 2015 Jan 5;12(1):. doi:10.1186/1743-0003-12-2.

PMC - PMC5122822
PMID- 27933009
IS  - 1664-1078 (Electronic)
VI  - 7
DP  - 2016
TI  - Effects of Embodied Learning and Digital Platform on the Retention of Physics
      Content: Centripetal Force.
LID - 1819
AB  - Embodiment theory proposes that knowledge is grounded in sensorimotor systems,
      and that learning can be facilitated to the extent that lessons can be mapped to 
      these systems. This study with 109 college-age participants addresses two
      overarching questions: (a) how are immediate and delayed learning gains affected 
      by the degree to which a lesson is embodied, and (b) how do the affordances of
      three different educational platforms affect immediate and delayed learning? Six 
      50 min-long lessons on centripetal force were created. The first factor was the
      degree of embodiment with two levels: (1) low and (2) high. The second factor was
      platform with three levels: (1) a large scale “mixed reality” immersive
      environment containing both digital and hands-on components called SMALLab, (2)
      an interactive whiteboard system, and (3) a mouse-driven desktop computer.
      Pre-tests, post-tests, and 1-week follow-up (retention or delayed learning gains)
      tests were administered resulting in a 2 × 3 × 3 design. Two knowledge subtests
      were analyzed, one that relied on more declarative knowledge and one that relied 
      on more generative knowledge, e.g., hand-drawing vectors. Regardless of
      condition, participants made significant immediate learning gains from pre-test
      to post-test. There were no significant main effects or interactions due to
      platform or embodiment on immediate learning. However, from post-test to
      follow-up the level of embodiment interacted significantly with time, such that
      participants in the high embodiment conditions performed better on the subtest
      devoted to generative knowledge questions. We posit that better retention of
      certain types of knowledge can be seen over time when more embodiment is present 
      during the encoding phase. This sort of retention may not appear on more
      traditional factual/declarative tests. Educational technology designers should
      consider using more sensorimotor feedback and gestural congruency when designing 
      and opportunities for instructor professional development need to be provided as 
      well.
FAU - Johnson-Glenberg, Mina C.
AU  - Johnson-Glenberg MC
AD  - Department of Psychology, Arizona State University, TempeAZ, USA
FAU - Megowan-Romanowicz, Colleen
AU  - Megowan-Romanowicz C
AD  - American Modeling Teachers Association, SacramentoCA, USA
FAU - Birchfield, David A.
AU  - Birchfield DA
AD  - SMALLab Learning, LLC, North HollywoodCA, USA
FAU - Savio-Ramos, Caroline
AU  - Savio-Ramos C
AD  - Mary Lou Fulton Teachers College, Arizona State University, TempeAZ, USA
LA  - eng
PT  - Journal Article
DEP - 20161125
PHST- 2016/06/07 [received]
PHST- 2016/11/03 [accepted]
TA  - Front Psychol
JT  - Frontiers in Psychology
AID - 10.3389/fpsyg.2016.01819 [doi]
SO  - Front Psychol. 2016 Nov 25;7:. doi:10.3389/fpsyg.2016.01819.

PMC - PMC5541680
PMID- 27652455
IS  - 0278-940X (Print)
IS  - 1943-619X (Electronic)
VI  - 44
IP  - 1-2
DP  - 2016
TI  - The Evolution of Neuroprosthetic Interfaces.
PG  - 123-52
AB  - The ideal neuroprosthetic interface permits high-quality neural recording and
      stimulation of the nervous system while reliably providing clinical benefits over
      chronic periods. Although current technologies have made notable strides in this 
      direction, significant improvements must be made to better achieve these design
      goals and satisfy clinical needs. This article provides an overview of the state 
      of neuroprosthetic interfaces, starting with the design and placement of these
      interfaces before exploring the stimulation and recording platforms yielded from 
      contemporary research. Finally, we outline emerging research trends in an effort 
      to explore the potential next generation of neuroprosthetic interfaces.
FAU - Adewole, Dayo O.
AU  - Adewole DO
AD  - Center for Brain Injury and Repair, Department of Neurosurgery, Perelman School
      of Medicine, University of Pennsylvania, Philadelphia, PA, USA
FAU - Serruya, Mijail D.
AU  - Serruya MD
AD  - Department of Neurology, Jefferson University, Philadelphia, PA, USA
FAU - Harris, James P.
AU  - Harris JP
AD  - Center for Brain Injury and Repair, Department of Neurosurgery, Perelman School
      of Medicine, University of Pennsylvania, Philadelphia, PA, USA
FAU - Burrell, Justin C.
AU  - Burrell JC
AD  - Center for Brain Injury and Repair, Department of Neurosurgery, Perelman School
      of Medicine, University of Pennsylvania, Philadelphia, PA, USA
FAU - Petrov, Dmitriy
AU  - Petrov D
AD  - Center for Brain Injury and Repair, Department of Neurosurgery, Perelman School
      of Medicine, University of Pennsylvania, Philadelphia, PA, USA
FAU - Chen, H. Isaac
AU  - Chen HI
AD  - Center for Brain Injury and Repair, Department of Neurosurgery, Perelman School
      of Medicine, University of Pennsylvania, Philadelphia, PA, USA
FAU - Wolf, John A.
AU  - Wolf JA
AD  - Center for Brain Injury and Repair, Department of Neurosurgery, Perelman School
      of Medicine, University of Pennsylvania, Philadelphia, PA, USA
FAU - Cullen, D. Kacy
AU  - Cullen DK
AD  - Center for Brain Injury and Repair, Department of Neurosurgery, Perelman School
      of Medicine, University of Pennsylvania, Philadelphia, PA, USA
LA  - eng
PT  - Journal Article
TA  - Crit Rev Biomed Eng
JT  - Critical reviews in biomedical engineering
AID - 10.1615/CritRevBiomedEng.2016017198 [doi]
MID - NIHMS881349
SO  - Crit Rev Biomed Eng. 2016;44(1-2):123-52.
      doi:10.1615/CritRevBiomedEng.2016017198.

PMC - PMC3398697
PMID- 22815563
IS  - 0001-0782 (Print)
VI  - 55
IP  - 1
DP  - 2012 Jan
TI  - (Computer) Vision without Sight.
PG  - 96-104
AB  - Computer vision holds great promise for helping persons with blindness or visual 
      impairments (VI) to interpret and explore the visual world. To this end, it is
      worthwhile to assess the situation critically by understanding the actual needs
      of the VI population and which of these needs might be addressed by computer
      vision. This article reviews the types of assistive technology application areas 
      that have already been developed for VI, and the possible roles that computer
      vision can play in facilitating these applications. We discuss how appropriate
      user interfaces are designed to translate the output of computer vision
      algorithms into information that the user can quickly and safely act upon, and
      how system-level characteristics affect the overall usability of an assistive
      technology. Finally, we conclude by highlighting a few novel and intriguing areas
      of application of computer vision to assistive technology.
FAU - Manduchi, Roberto
AU  - Manduchi R
AD  - Department of Computer Engineering, University of California, Santa Cruz, Santa
      Cruz, CA 95064
FAU - Coughlan, James
AU  - Coughlan J
AD  - The Smith-Kettlewell Eye Research Institute, 2318 Fillmore Street, San Francisco,
      CA 94115
LA  - eng
PT  - Journal Article
TA  - Commun ACM
JT  - Communications of the ACM
AID - 10.1145/2063176.2063200 [doi]
MID - NIHMS388393
SO  - Commun ACM. 2012 Jan;55(1):96-104. doi:10.1145/2063176.2063200.

PMC - PMC4473270
PMID- 26110109
IS  - 2213-1582 (Electronic)
VI  - 8
DP  - 2015
TI  - Neuroimaging and neuromodulation approaches to study eating behavior and prevent 
      and treat eating disorders and obesity.
PG  - 1-31
AB  - Functional, molecular and genetic neuroimaging has highlighted the existence of
      brain anomalies and neural vulnerability factors related to obesity and eating
      disorders such as binge eating or anorexia nervosa. In particular, decreased
      basal metabolism in the prefrontal cortex and striatum as well as dopaminergic
      alterations have been described in obese subjects, in parallel with increased
      activation of reward brain areas in response to palatable food cues. Elevated
      reward region responsivity may trigger food craving and predict future weight
      gain. This opens the way to prevention studies using functional and molecular
      neuroimaging to perform early diagnostics and to phenotype subjects at risk by
      exploring different neurobehavioral dimensions of the food choices and motivation
      processes. In the first part of this review, advantages and limitations of
      neuroimaging techniques, such as functional magnetic resonance imaging (fMRI),
      positron emission tomography (PET), single photon emission computed tomography
      (SPECT), pharmacogenetic fMRI and functional near-infrared spectroscopy (fNIRS)
      will be discussed in the context of recent work dealing with eating behavior,
      with a particular focus on obesity. In the second part of the review,
      non-invasive strategies to modulate food-related brain processes and functions
      will be presented. At the leading edge of non-invasive brain-based technologies
      is real-time fMRI (rtfMRI) neurofeedback, which is a powerful tool to better
      understand the complexity of human brain–behavior relationships. rtfMRI, alone or
      when combined with other techniques and tools such as EEG and cognitive therapy, 
      could be used to alter neural plasticity and learned behavior to optimize and/or 
      restore healthy cognition and eating behavior. Other promising non-invasive
      neuromodulation approaches being explored are repetitive transcranial magnetic
      stimulation (rTMS) and transcranial direct-current stimulation (tDCS). Converging
      evidence points at the value of these non-invasive neuromodulation strategies to 
      study basic mechanisms underlying eating behavior and to treat its disorders.
      Both of these approaches will be compared in light of recent work in this field, 
      while addressing technical and practical questions. The third part of this review
      will be dedicated to invasive neuromodulation strategies, such as vagus nerve
      stimulation (VNS) and deep brain stimulation (DBS). In combination with
      neuroimaging approaches, these techniques are promising experimental tools to
      unravel the intricate relationships between homeostatic and hedonic brain
      circuits. Their potential as additional therapeutic tools to combat
      pharmacorefractory morbid obesity or acute eating disorders will be discussed, in
      terms of technical challenges, applicability and ethics. In a general discussion,
      we will put the brain at the core of fundamental research, prevention and therapy
      in the context of obesity and eating disorders. First, we will discuss the
      possibility to identify new biological markers of brain functions. Second, we
      will highlight the potential of neuroimaging and neuromodulation in
      individualized medicine. Third, we will introduce the ethical questions that are 
      concomitant to the emergence of new neuromodulation therapies.
OAB - Publisher: Abstract available from the publisher.
FAU - Val-Laillet, D.
AU  - Val-Laillet D
AD  - INRA, UR1341 ADNC, France
FAU - Aarts, E.
AU  - Aarts E
AD  - Radboud University, Donders Institute for Brain, Cognition and Behaviour,
      Nijmegen, The Netherlands
FAU - Weber, B.
AU  - Weber B
AD  - Department of Epileptology, University Hospital Bonn, Germany
FAU - Ferrari, M.
AU  - Ferrari M
AD  - Department of Life, Health and Environmental Sciences, University of L'Aquila,
      Italy
FAU - Quaresima, V.
AU  - Quaresima V
AD  - Department of Life, Health and Environmental Sciences, University of L'Aquila,
      Italy
FAU - Stoeckel, L.E.
AU  - Stoeckel L
AD  - Massachusetts General Hospital, Harvard Medical School, USA
FAU - Alonso-Alonso, M.
AU  - Alonso-Alonso M
AD  - Beth Israel Deaconess Medical Center, Harvard Medical School, USA
FAU - Audette, M.
AU  - Audette M
AD  - Old Dominion University, USA
FAU - Malbert, C.H.
AU  - Malbert C
AD  - INRA, US1395 Ani-Scans, France
FAU - Stice, E.
AU  - Stice E
AD  - Oregon Research Institute, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20150324
PHST- 2014/12/01 [received]
PHST- 2015/03/18 [revised]
PHST- 2015/03/19 [accepted]
TA  - Neuroimage Clin
JT  - NeuroImage : Clinical
AID - S2213-1582(15)00058-3 [pii]
AID - 10.1016/j.nicl.2015.03.016 [doi]
SO  - Neuroimage Clin. 2015 Mar 24;8:1-31. doi:10.1016/j.nicl.2015.03.016.

PMC - PMC4415417
PMID- 25983676
IS  - 1662-4548 (Print)
IS  - 1662-453X (Electronic)
VI  - 9
DP  - 2015
TI  - Using neurophysiological signals that reflect cognitive or affective state: six
      recommendations to avoid common pitfalls.
LID - 136
AB  - Estimating cognitive or affective state from neurophysiological signals and
      designing applications that make use of this information requires expertise in
      many disciplines such as neurophysiology, machine learning, experimental
      psychology, and human factors. This makes it difficult to perform research that
      is strong in all its aspects as well as to judge a study or application on its
      merits. On the occasion of the special topic “Using neurophysiological signals
      that reflect cognitive or affective state” we here summarize often occurring
      pitfalls and recommendations on how to avoid them, both for authors (researchers)
      and readers. They relate to defining the state of interest, the
      neurophysiological processes that are expected to be involved in the state of
      interest, confounding factors, inadvertently “cheating” with classification
      analyses, insight on what underlies successful state estimation, and finally, the
      added value of neurophysiological measures in the context of an application. We
      hope that this paper will support the community in producing high quality studies
      and well-validated, useful applications.
FAU - Brouwer, Anne-Marie
AU  - Brouwer AM
AD  - Perceptual and Cognitive Systems, Netherlands Organisation for Applied Scientific
      Research TNOSoesterberg, Netherlands
FAU - Zander, Thorsten O.
AU  - Zander TO
AD  - Team PhyPA, Biological Psychology and Neuroergonomics, Technical
      UniversityBerlin, Germany
FAU - van Erp, Jan B. F.
AU  - van Erp JBF
AD  - Perceptual and Cognitive Systems, Netherlands Organisation for Applied Scientific
      Research TNOSoesterberg, Netherlands
FAU - Korteling, Johannes E.
AU  - Korteling JE
AD  - Training Performance Innovations, Netherlands Organisation for Applied Scientific
      Research TNOSoesterberg, Netherlands
FAU - Bronkhorst, Adelbert W.
AU  - Bronkhorst AW
AD  - Perceptual and Cognitive Systems, Netherlands Organisation for Applied Scientific
      Research TNOSoesterberg, Netherlands
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20150430
PHST- 2014/12/24 [received]
PHST- 2015/04/02 [accepted]
TA  - Front Neurosci
JT  - Frontiers in Neuroscience
AID - 10.3389/fnins.2015.00136 [doi]
SO  - Front Neurosci. 2015 Apr 30;9:. doi:10.3389/fnins.2015.00136.

PMC - PMC3870317
PMID- 24391575
IS  - 1662-5161 (Electronic)
VI  - 7
DP  - 2013
TI  - Neuroergonomics: a review of applications to physical and cognitive work.
LID - 889
AB  - Neuroergonomics is an emerging science that is defined as the study of the human 
      brain in relation to performance at work and in everyday settings. This paper
      provides a critical review of the neuroergonomic approach to evaluating physical 
      and cognitive work, particularly in mobile settings. Neuroergonomics research
      employing mobile and immobile brain imaging techniques are discussed in the
      following areas of physical and cognitive work: (1) physical work parameters; (2)
      physical fatigue; (3) vigilance and mental fatigue; (4) training and
      neuroadaptive systems; and (5) assessment of concurrent physical and cognitive
      work. Finally, the integration of brain and body measurements in investigating
      workload and fatigue, in the context of mobile brain/body imaging (“MoBI”), is
      discussed.
FAU - Mehta, Ranjana K.
AU  - Mehta RK
AD  - Department of Environmental and Occupational Health, School of Rural Public
      Healthy, Texas A&M University, College StationTX, USA
FAU - Parasuraman, Raja
AU  - Parasuraman R
AD  - Center of Excellence in Neuroergonomics, Technology, and Cognition, George Mason 
      UniversityFairfax, VA, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20131223
PHST- 2013/08/23 [received]
PHST- 2013/12/05 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2013.00889 [doi]
SO  - Front Hum Neurosci. 2013 Dec 23;7:. doi:10.3389/fnhum.2013.00889.

PMC - PMC5038639
PMID- 27563906
IS  - 1424-8220 (Electronic)
VI  - 16
IP  - 9
DP  - 2016 Sep
TI  - Are We Ready to Build a System for Assisting Blind People in Tactile Exploration 
      of Bas-Reliefs?
LID - 1361
AB  - Nowadays, the creation of methodologies and tools for facilitating the 3D
      reproduction of artworks and, contextually, to make their exploration possible
      and more meaningful for blind users is becoming increasingly relevant in society.
      Accordingly, the creation of integrated systems including both tactile media
      (e.g., bas-reliefs) and interfaces capable of providing the users with an
      experience cognitively comparable to the one originally envisioned by the artist,
      may be considered the next step for enhancing artworks exploration. In light of
      this, the present work provides a description of a first-attempt system designed 
      to aid blind people (BP) in the tactile exploration of bas-reliefs. In detail,
      consistent hardware layout, comprising a hand-tracking system based on Kinect®
      sensor and an audio device, together with a number of methodologies, algorithms
      and information related to physical design are proposed. Moreover, according to
      experimental test on the developed system related to the device position, some
      design alternatives are suggested so as to discuss pros and cons.
FAU - Buonamici, Francesco
AU  - Buonamici F
FAU - Carfagni, Monica
AU  - Carfagni M
FAU - Furferi, Rocco
AU  - Furferi R
FAU - Governi, Lapo
AU  - Governi L
FAU - Volpe, Yary
AU  - Volpe Y
LA  - eng
PT  - Journal Article
DEP - 20160824
PHST- 2016/07/06 [received]
PHST- 2016/08/18 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s16091361 [doi]
AID - sensors-16-01361 [pii]
SO  - Sensors (Basel). 2016 Aug 24;16(9):. doi:10.3390/s16091361.

PMC - PMC3721359
PMID- 23898243
IS  - 1662-5145 (Electronic)
VI  - 7
DP  - 2013
TI  - Give spontaneity and self-discovery a chance in ASD: spontaneous peripheral limb 
      variability as a proxy to evoke centrally driven intentional acts.
LID - 46
AB  - Autism can be conceived as an adaptive biological response to an early unexpected
      developmental change. Under such conceptualization one could think of emerging
      biological compensatory mechanisms with unique manifestations in each individual.
      Within a large group of affected people this would result in a highly
      heterogeneous spectral disorder where it would be difficult to tap into the
      hidden potentials of any given individual. A pressing question is how to treat
      the disorder while harnessing the capabilities and predispositions that the
      individual has already developed. It would indeed be ideal to use such strengths 
      to accelerate the learning of self-sufficiency and independence, important as the
      person transitions into adulthood. In this report, we introduce a new concept for
      therapeutic interventions and basic research in autism. We use visuo-spatial and 
      auditory stimuli to help augment the physical reality of the child and
      sensory-substitute corrupted kinesthetic information quantified in his/her
      movement patterns to help the person develop volitional control over the hand
      motions. We develop a co-adaptive child-computer interface that closes the
      sensory-motor feedback loops by alerting the child of a cause-effect relationship
      between the statistics of his/her real-time hand movement patterns and those of
      external media states. By co-adapting the statistics of the media states and
      those of the child's real-time hand movements, we found that without any
      food/token reward the children naturally remained engaged in the task. Even in
      the absence of practice, the learning gains were retained, transferred and
      improved 2–4 weeks later. This new concept demonstrates that individuals with
      autism do have spontaneous sensory-motor adaptive capabilities. When led to their
      self-discovery, these patterns of spontaneous behavioral variability (SBV) morph 
      into more predictive and reliable intentional actions. These can unlock and
      enhance exploratory behavior and autonomy in the individual with autism spectrum 
      disorders (ASD).
FAU - Torres, Elizabeth B.
AU  - Torres EB
AD  - Rutgers University Psychology Department, Computational Biomedicine Imaging and
      Medicine Center, Rutgers University Center for Cognitive ScienceNew Brunswick,
      NJ, USA
FAU - Yanovich, Polina
AU  - Yanovich P
AD  - Rutgers University Computer Science Department, Rutgers University Center for
      Cognitive Science PiscatawayNJ, USA
FAU - Metaxas, Dimitris N.
AU  - Metaxas DN
AD  - Rutgers University Computer Science Department, Computational Biomedicine Imaging
      and Medicine Center, Rutgers University Center for Cognitive SciencePiscataway,
      NJ, USA
LA  - eng
PT  - Journal Article
DEP - 20130724
PHST- 2013/04/05 [received]
PHST- 2013/05/29 [accepted]
TA  - Front Integr Neurosci
JT  - Frontiers in Integrative Neuroscience
AID - 10.3389/fnint.2013.00046 [doi]
SO  - Front Integr Neurosci. 2013 Jul 24;7:. doi:10.3389/fnint.2013.00046.

PMC - PMC4433028
PMID- 25928870
IS  - 1745-6215 (Electronic)
VI  - 16
DP  - 2015
TI  - Neurofeedback as a nonpharmacological treatment for adults with
      attention-deficit/hyperactivity disorder (ADHD): study protocol for a randomized 
      controlled trial.
LID - 174
AB  - Background: Neurofeedback has been applied effectively in various areas,
      especially in the treatment of children with attention-deficit/hyperactivity
      disorder (ADHD). This study protocol is designed to investigate the effect of
      slow cortical potential (SCP) feedback and a new form of neurofeedback using
      near-infrared spectroscopy (NIRS) on symptomatology and neurophysiological
      parameters in an adult ADHD population. A comparison of SCP and NIRS feedback
      therapy methods has not been previously conducted and may yield valuable findings
      about alternative treatments for adult ADHD. Methods/Design: The outcome of both 
      neurofeedback techniques will be assessed over 30 treatment sessions and after a 
      6-month follow-up period, and then will be compared to a nonspecific biofeedback 
      treatment. Furthermore, to investigate if treatment effects in this
      proof-of-principle study can be predicted by specific neurophysiological baseline
      parameters, regression models will be applied. Finally, a comparison with healthy
      controls will be conducted to evaluate deviant pretraining neurophysiological
      parameters, stability of assessment measures, and treatment outcome. Discussion: 
      To date, an investigation and comparison of SCP and NIRS feedback training to an 
      active control has not been conducted; therefore, we hope to gain valuable
      insights in effects and differences of these types of treatment for ADHD in
      adults. Trial registration: This study is registered with the German Registry of 
      Clinical Trials: DRKS00006767, date of registration: 8 October 2014.
FAU - Mayer, Kerstin
AU  - Mayer K
AD  - Institute for Medical Psychology and Behavioral Neurobiology, University of
      Tübingen, Silcherstrasse 5, 72076 Tübingen, Germany
FAU - Wyckoff, Sarah Nicole
AU  - Wyckoff SN
AD  - Institute for Medical Psychology and Behavioral Neurobiology, University of
      Tübingen, Silcherstrasse 5, 72076 Tübingen, Germany
FAU - Fallgatter, Andreas J
AU  - Fallgatter AJ
AD  - Department for Psychiatry and Psychotherapy, University of Tübingen, Osianderstr.
      24, 72076 Tübingen, Germany
FAU - Ehlis, Ann-Christine
AU  - Ehlis AC
AD  - Department for Psychiatry and Psychotherapy, University of Tübingen, Osianderstr.
      24, 72076 Tübingen, Germany
FAU - Strehl, Ute
AU  - Strehl U
AD  - Institute for Medical Psychology and Behavioral Neurobiology, University of
      Tübingen, Silcherstrasse 5, 72076 Tübingen, Germany
LA  - eng
PT  - Journal Article
DEP - 20150418
PHST- 2014/12/18 [received]
PHST- 2015/03/26 [accepted]
TA  - Trials
JT  - Trials
AID - 683 [pii]
AID - 10.1186/s13063-015-0683-4 [doi]
SO  - Trials. 2015 Apr 18;16:. doi:10.1186/s13063-015-0683-4.

PMC - PMC5186786
PMID- 28082858
IS  - 1662-4548 (Print)
IS  - 1662-453X (Electronic)
VI  - 10
DP  - 2016
TI  - Enhancing Nervous System Recovery through Neurobiologics, Neural Interface
      Training, and Neurorehabilitation.
LID - 584
AB  - After an initial period of recovery, human neurological injury has long been
      thought to be static. In order to improve quality of life for those suffering
      from stroke, spinal cord injury, or traumatic brain injury, researchers have been
      working to restore the nervous system and reduce neurological deficits through a 
      number of mechanisms. For example, neurobiologists have been identifying and
      manipulating components of the intra- and extracellular milieu to alter the
      regenerative potential of neurons, neuro-engineers have been producing
      brain-machine and neural interfaces that circumvent lesions to restore
      functionality, and neurorehabilitation experts have been developing new ways to
      revitalize the nervous system even in chronic disease. While each of these areas 
      holds promise, their individual paths to clinical relevance remain difficult.
      Nonetheless, these methods are now able to synergistically enhance recovery of
      native motor function to levels which were previously believed to be impossible. 
      Furthermore, such recovery can even persist after training, and for the first
      time there is evidence of functional axonal regrowth and rewiring in the central 
      nervous system of animal models. To attain this type of regeneration,
      rehabilitation paradigms that pair cortically-based intent with activation of
      affected circuits and positive neurofeedback appear to be required—a phenomenon
      which raises new and far reaching questions about the underlying relationship
      between conscious action and neural repair. For this reason, we argue that
      multi-modal therapy will be necessary to facilitate a truly robust recovery, and 
      that the success of investigational microscopic techniques may depend on their
      integration into macroscopic frameworks that include task-based
      neurorehabilitation. We further identify critical components of future neural
      repair strategies and explore the most updated knowledge, progress, and
      challenges in the fields of cellular neuronal repair, neural interfacing, and
      neurorehabilitation, all with the goal of better understanding neurological
      injury and how to improve recovery.
FAU - Krucoff, Max O.
AU  - Krucoff MO
AD  - Department of Neurosurgery, Duke University Medical CenterDurham, NC, USA
FAU - Rahimpour, Shervin
AU  - Rahimpour S
AD  - Department of Neurosurgery, Duke University Medical CenterDurham, NC, USA
FAU - Slutzky, Marc W.
AU  - Slutzky MW
AD  - Department of Physiology, Feinberg School of Medicine, Northwestern
      UniversityChicago, IL, USA
FAU - Edgerton, V. Reggie
AU  - Edgerton VR
AD  - Department of Integrative Biology and Physiology, University of California, Los
      AngelesLos Angeles, CA, USA
FAU - Turner, Dennis A.
AU  - Turner DA
AD  - Department of Neurosurgery, Duke University Medical CenterDurham, NC, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20161227
PHST- 2016/03/15 [received]
PHST- 2016/12/06 [accepted]
TA  - Front Neurosci
JT  - Frontiers in Neuroscience
AID - 10.3389/fnins.2016.00584 [doi]
SO  - Front Neurosci. 2016 Dec 27;10:. doi:10.3389/fnins.2016.00584.

PMC - PMC4058366
PMID- 24704580
IS  - 1350-9462 (Print)
IS  - 1873-1635 (Electronic)
VI  - 0
DP  - 2014 Jul
TI  - Cholesterol in the retina: the best is yet to come.
PG  - 64-89
AB  - Historically understudied, cholesterol in the retina is receiving more attention 
      now because of genetic studies showing that several cholesterol-related genes are
      risk factors for age-related macular degeneration (AMD) and because eye pathology
      studies showing high cholesterol content of drusen, aging Bruch's membrane, and
      newly found subretinal lesions. The challenge before us is determining how the
      cholesterol-AMD link is realized. Meeting this challenge will require an
      excellent understanding these genes’ roles in retinal physiology and how
      chorioretinal cholesterol is maintained. In the first half of this review, we
      will succinctly summarize physico-chemical properties of cholesterol, its
      distribution in the human body, general principles of maintenance and metabolism,
      and differences in cholesterol handling in human and mouse that impact on
      experimental approaches. This information will provide a backdrop to the second
      part of the review focusing on unique aspects of chorioretinal cholesterol
      homeostasis, aging in Bruch's membrane, cholesterol in AMD lesions, a model for
      lesion biogenesis, a model for macular vulnerability based on vascular biology,
      and alignment of AMD-related genes and pathobiology using cholesterol and an
      atherosclerosis-like progression as unifying features. We conclude with
      recommendations for the most important research steps we can take towards
      delineating the cholesterol-AMD link.
FAU - Pikuleva, Irina A.
AU  - Pikuleva IA
AD  - Department of Ophthalmology and Visual Sciences, Case Western Reserve University,
      Cleveland, Ohio 44106, United States
FAU - Curcio, Christine A.
AU  - Curcio CA
AD  - Department of Ophthalmology, University of Alabama, Birmingham, AL 35294, United 
      States
LA  - eng
PT  - Journal Article
DEP - 20140404
TA  - Prog Retin Eye Res
JT  - Progress in retinal and eye research
AID - 10.1016/j.preteyeres.2014.03.002 [doi]
MID - NIHMS583144
SO  - Prog Retin Eye Res. 2014 Jul;0:64-89. Epub 2014 Apr 4
      doi:10.1016/j.preteyeres.2014.03.002.

PMC - PMC4003996
PMID- 24643006
IS  - 1424-8220 (Electronic)
VI  - 14
IP  - 3
DP  - 2014 Mar
TI  - Modeling Users, Context and Devices for Ambient Assisted Living Environments.
PG  - 5354-91
AB  - The participation of users within AAL environments is increasing thanks to the
      capabilities of the current wearable devices. Furthermore, the significance of
      considering user's preferences, context conditions and device's capabilities help
      smart environments to personalize services and resources for them. Being aware of
      different characteristics of the entities participating in these situations is
      vital for reaching the main goals of the corresponding systems efficiently. To
      collect different information from these entities, it is necessary to design
      several formal models which help designers to organize and give some meaning to
      the gathered data. In this paper, we analyze several literature solutions for
      modeling users, context and devices considering different approaches in the
      Ambient Assisted Living domain. Besides, we remark different ongoing
      standardization works in this area. We also discuss the used techniques, modeled 
      characteristics and the advantages and drawbacks of each approach to finally draw
      several conclusions about the reviewed works.
FAU - Castillejo, Eduardo
AU  - Castillejo E
AD  - Deusto Institute of Technology—DeustoTech, University of Deusto, Avda.
      Universidades 24, Bilbao 48007, Spain; E-Mails: aitor.almeida@deusto.es (A.A.);
      dipina@deusto.es (D.L.-I.)
FAU - Almeida, Aitor
AU  - Almeida A
AD  - Deusto Institute of Technology—DeustoTech, University of Deusto, Avda.
      Universidades 24, Bilbao 48007, Spain; E-Mails: aitor.almeida@deusto.es (A.A.);
      dipina@deusto.es (D.L.-I.)
FAU - López-de-Ipiña, Diego
AU  - López-de-Ipiña D
AD  - Deusto Institute of Technology—DeustoTech, University of Deusto, Avda.
      Universidades 24, Bilbao 48007, Spain; E-Mails: aitor.almeida@deusto.es (A.A.);
      dipina@deusto.es (D.L.-I.)
FAU - Chen, Liming
AU  - Chen L
AD  - School of Computer Science and Informatics, Faculty of Technology, De Montfort
      University, Gateway House, The Gateway, Leicester, LE1 9BH, UK; E-Mail:
      liming.chen@dmu.ac.uk
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20140317
PHST- 2014/01/23 [received]
PHST- 2014/03/03 [revised]
PHST- 2014/03/11 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s140305354 [doi]
AID - sensors-14-05354 [pii]
SO  - Sensors (Basel). 2014 Mar 17;14(3):5354-91. doi:10.3390/s140305354.

PMC - PMC2964903
PMID- 20716669
IS  - 0031-6997 (Print)
IS  - 1521-0081 (Electronic)
VI  - 62
IP  - 3
DP  - 2010 Sep
TI  - Glutamate Receptor Ion Channels: Structure, Regulation, and Function.
PG  - 405-96
AB  - The mammalian ionotropic glutamate receptor family encodes 18 gene products that 
      coassemble to form ligand-gated ion channels containing an agonist recognition
      site, a transmembrane ion permeation pathway, and gating elements that couple
      agonist-induced conformational changes to the opening or closing of the
      permeation pore. Glutamate receptors mediate fast excitatory synaptic
      transmission in the central nervous system and are localized on neuronal and
      non-neuronal cells. These receptors regulate a broad spectrum of processes in the
      brain, spinal cord, retina, and peripheral nervous system. Glutamate receptors
      are postulated to play important roles in numerous neurological diseases and have
      attracted intense scrutiny. The description of glutamate receptor structure,
      including its transmembrane elements, reveals a complex assembly of multiple
      semiautonomous extracellular domains linked to a pore-forming element with
      striking resemblance to an inverted potassium channel. In this review we discuss 
      International Union of Basic and Clinical Pharmacology glutamate receptor
      nomenclature, structure, assembly, accessory subunits, interacting proteins, gene
      expression and translation, post-translational modifications, agonist and
      antagonist pharmacology, allosteric modulation, mechanisms of gating and
      permeation, roles in normal physiological function, as well as the potential
      therapeutic use of pharmacological agents acting at glutamate receptors.
FAU - Traynelis, Stephen F.
AU  - Traynelis SF
FAU - Wollmuth, Lonnie P.
AU  - Wollmuth LP
FAU - McBain, Chris J.
AU  - McBain CJ
FAU - Menniti, Frank S.
AU  - Menniti FS
FAU - Vance, Katie M.
AU  - Vance KM
FAU - Ogden, Kevin K.
AU  - Ogden KK
FAU - Hansen, Kasper B.
AU  - Hansen KB
FAU - Yuan, Hongjie
AU  - Yuan H
FAU - Myers, Scott J.
AU  - Myers SJ
FAU - Dingledine, Ray
AU  - Dingledine R
LA  - eng
PT  - Journal Article
PT  - Review
GR  - NS065371
TA  - Pharmacol Rev
JT  - Pharmacological Reviews
AID - 3592788 [pii]
AID - 10.1124/pr.109.002451 [doi]
SO  - Pharmacol Rev. 2010 Sep;62(3):405-96. doi:10.1124/pr.109.002451.

PMC - PMC3691350
PMID- 22851346
IS  - 0734-0478 (Print)
IS  - 1098-9056 (Electronic)
VI  - 33
IP  - 3
DP  - 2012 Aug
TI  - Telerehabilitation, Virtual Therapists, and Acquired Neurologic Speech and
      Language Disorders.
PG  - 243-57
AB  - Telerehabilitation (telererehab) offers cost effective services that potentially 
      can improve access to care for those with acquired neurologic communication
      disorders. However, regulatory issues including licensure, reimbursement, and
      threats to privacy and confidentiality hinder the routine implementation of
      telerehab services into the clinical setting. Despite these barriers, rapid
      technological advances and a growing body of research regarding the use of
      telerehab applications support its use. This article reviews the evidence related
      to acquired neurologic speech and language disorders in adults, focusing on
      studies that have been published since 2000. Research studies have used telerehab
      systems to assess and treat disorders including dysarthria, apraxia of speech,
      aphasia, and mild Alzheimer’s disease. They show that telerehab is a valid and
      reliable vehicle for delivering speech and language services. The studies
      represent a progression of technological advances in computing, Internet, and
      mobile technologies. They range on a continuum from working synchronously (in
      real-time) with a speech-language pathologist to working asynchronously (offline)
      with a stand-in virtual therapist. One such system that uses a virtual therapist 
      for the treatment of aphasia, the Web-ORLA™ (Rehabilitation Institute of Chicago,
      Chicago, IL) system, is described in detail. Future directions for the
      advancement of telerehab for clinical practice are discussed.
FAU - Cherney, Leora R.
AU  - Cherney LR
AD  - Center for Aphasia Research and Treatment, Rehabilitation Institute of Chicago,
      Chicago, IL
FAU - van Vuuren, Sarel
AU  - van Vuuren S
AD  - Institute of Cognitive Science, University of Colorado Boulder, Boulder, CO
LA  - eng
PT  - Journal Article
DEP - 20120731
GR  - R01 DC011754 || DC
TA  - Semin Speech Lang
JT  - Seminars in speech and language
AID - 10.1055/s-0032-1320044 [doi]
MID - NIHMS482354
SO  - Semin Speech Lang. 2012 Aug;33(3):243-57. Epub 2012 Jul 31
      doi:10.1055/s-0032-1320044.

PMC - PMC4141981
PMID- 25161891
IS  - 2213-1582 (Electronic)
VI  - 5
DP  - 2014
TI  - Optimizing real time fMRI neurofeedback for therapeutic discovery and
      development.
PG  - 245-55
AB  - While reducing the burden of brain disorders remains a top priority of
      organizations like the World Health Organization and National Institutes of
      Health, the development of novel, safe and effective treatments for brain
      disorders has been slow. In this paper, we describe the state of the science for 
      an emerging technology, real time functional magnetic resonance imaging (rtfMRI) 
      neurofeedback, in clinical neurotherapeutics. We review the scientific potential 
      of rtfMRI and outline research strategies to optimize the development and
      application of rtfMRI neurofeedback as a next generation therapeutic tool. We
      propose that rtfMRI can be used to address a broad range of clinical problems by 
      improving our understanding of brain–behavior relationships in order to develop
      more specific and effective interventions for individuals with brain disorders.
      We focus on the use of rtfMRI neurofeedback as a clinical neurotherapeutic tool
      to drive plasticity in brain function, cognition, and behavior. Our overall goal 
      is for rtfMRI to advance personalized assessment and intervention approaches to
      enhance resilience and reduce morbidity by correcting maladaptive patterns of
      brain function in those with brain disorders.
OAB - Publisher: Abstract available from the publisher.
FAU - Stoeckel, L.E.
AU  - Stoeckel L
AD  - Massachusetts General Hospital, Department of Psychiatry, USA
FAU - Garrison, K.A.
AU  - Garrison K
AD  - Yale University School of Medicine, Department of Psychiatry, USA
FAU - Ghosh, S.
AU  - Ghosh S
AD  - McGovern Institute for Brain Research, Massachusetts Institute of Technology, USA
FAU - Wighton, P.
AU  - Wighton P
AD  - Athinoula A. Martinos Center, USA
FAU - Hanlon, C.A.
AU  - Hanlon C
AD  - Department of Psychiatry, Medical University of South Carolina, USA
FAU - Gilman, J.M.
AU  - Gilman J
AD  - Massachusetts General Hospital, Department of Psychiatry, USA
FAU - Greer, S.
AU  - Greer S
AD  - Department of Neuroscience, University of California, Berkeley, USA
FAU - Turk-Browne, N.B.
AU  - Turk-Browne N
AD  - Department of Psychology, Princeton University, USA
FAU - deBettencourt, M.T.
AU  - deBettencourt M
AD  - Princeton Neuroscience Institute, Princeton University, USA
FAU - Scheinost, D.
AU  - Scheinost D
AD  - Department of Diagnostic Radiology, Yale University School of Medicine, USA
FAU - Craddock, C.
AU  - Craddock C
AD  - Child Mind Institute, USA
FAU - Thompson, T.
AU  - Thompson T
AD  - McGovern Institute for Brain Research, Massachusetts Institute of Technology, USA
FAU - Calderon, V.
AU  - Calderon V
AD  - Massachusetts General Hospital, Department of Psychiatry, USA
FAU - Bauer, C.C.
AU  - Bauer C
AD  - Universidad Nacional Autonoma de Mexico, Instituto de Neurobiologia, Mexico
FAU - George, M.
AU  - George M
AD  - Department of Psychiatry, Medical University of South Carolina, USA
FAU - Breiter, H.C.
AU  - Breiter H
AD  - Massachusetts General Hospital, Department of Psychiatry, USA
FAU - Whitfield-Gabrieli, S.
AU  - Whitfield-Gabrieli S
AD  - McGovern Institute for Brain Research, Massachusetts Institute of Technology, USA
FAU - Gabrieli, J.D.
AU  - Gabrieli J
AD  - McGovern Institute for Brain Research, Massachusetts Institute of Technology, USA
FAU - LaConte, S.M.
AU  - LaConte S
AD  - School of Biomedical Engineering and Sciences, Virginia Tech, USA
FAU - Hirshberg, L.
AU  - Hirshberg L
AD  - Department of Psychiatry and Human Behavior, Alpert Medical School of Brown
      University, USA
FAU - Brewer, J.A.
AU  - Brewer J
AD  - Yale University School of Medicine, Department of Psychiatry, USA
FAU - Hampson, M.
AU  - Hampson M
AD  - Department of Diagnostic Radiology, Yale University School of Medicine, USA
FAU - Van Der Kouwe, A.
AU  - Van Der Kouwe A
AD  - Athinoula A. Martinos Center, USA
FAU - Mackey, S.
AU  - Mackey S
AD  - Department of Anesthesia, Stanford University School of Medicine, USA
FAU - Evins, A.E.
AU  - Evins A
AD  - Massachusetts General Hospital, Department of Psychiatry, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20140710
PHST- 2014/04/24 [received]
PHST- 2014/06/20 [revised]
PHST- 2014/07/05 [accepted]
TA  - Neuroimage Clin
JT  - NeuroImage : Clinical
AID - S2213-1582(14)00092-8 [pii]
AID - 10.1016/j.nicl.2014.07.002 [doi]
SO  - Neuroimage Clin. 2014 Jul 10;5:245-55. doi:10.1016/j.nicl.2014.07.002.

PMC - PMC3494382
PMID- 22780564
IS  - 1467-7881 (Print)
IS  - 1467-789X (Electronic)
VI  - 13
IP  - 10
DP  - 2012 Oct
TI  - Impact of postprandial glycaemia on health and prevention of disease.
PG  - 923-84
AB  - Postprandial glucose, together with related hyperinsulinemia and lipidaemia, has 
      been implicated in the development of chronic metabolic diseases like obesity,
      type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). In this review,
      available evidence is discussed on postprandial glucose in relation to body
      weight control, the development of oxidative stress, T2DM, and CVD and in
      maintaining optimal exercise and cognitive performance. There is mechanistic
      evidence linking postprandial glycaemia or glycaemic variability to the
      development of these conditions or in the impairment in cognitive and exercise
      performance. Nevertheless, postprandial glycaemia is interrelated with many other
      (risk) factors as well as to fasting glucose. In many studies, meal-related
      glycaemic response is not sufficiently characterized, or the methodology with
      respect to the description of food or meal composition, or the duration of the
      measurement of postprandial glycaemia is limited. It is evident that more
      randomized controlled dietary intervention trials using effective low vs. high
      glucose response diets are necessary in order to draw more definite conclusions
      on the role of postprandial glycaemia in relation to health and disease. Also of 
      importance is the evaluation of the potential role of the time course of
      postprandial glycaemia.
FAU - Blaak, E E
AU  - Blaak EE
AD  - Department of Human Biology, School of Nutrition & Toxicology Research and
      Metabolism (NUTRIM), Maastricht UniversityMaastricht, the Netherlands
FAU - Antoine, J-M
AU  - Antoine JM
AD  - Danone Research CenterPalaiseau, France
FAU - Benton, D
AU  - Benton D
AD  - Department of Psychology, University of SwanseaWales, UK
FAU - Björck, I
AU  - Björck I
AD  - Division of Applied Nutrition and Food Chemistry, Department of Food Technology, 
      Engineering and Nutrition, Lund UniversityLund, Sweden
FAU - Bozzetto, L
AU  - Bozzetto L
AD  - Department of Clinical and Experimental Medicine, University Federico IINaples,
      Italy
FAU - Brouns, F
AU  - Brouns F
AD  - Department of Human Biology, School of Nutrition & Toxicology Research and
      Metabolism (NUTRIM), Maastricht UniversityMaastricht, the Netherlands
FAU - Diamant, M
AU  - Diamant M
AD  - Diabetes Center, Department of Internal Medicine, VU University Medical
      CenterAmsterdam, the Netherlands
FAU - Dye, L
AU  - Dye L
AD  - Institute of Psychological Sciences, University of LeedsLeeds, UK
FAU - Hulshof, T
AU  - Hulshof T
AD  - Kellogg EuropeDen Bosch, the Netherlands
FAU - Holst, J J
AU  - Holst JJ
AD  - Department of Biomedical Sciences and Novo Nordisk Foundation Centre of Basic
      Metabolic Research, University of CopenhagenCopenhagen, Denmark
FAU - Lamport, D J
AU  - Lamport DJ
AD  - Institute of Psychological Sciences, University of LeedsLeeds, UK
FAU - Laville, M
AU  - Laville M
AD  - Centre de Recherche en Nutrition Humaine, Rhône-Alpes, Center for European
      Nutrition, Safety and Health, Centre Hospitalier Lyon SudLyon, France
FAU - Lawton, C L
AU  - Lawton CL
AD  - Institute of Psychological Sciences, University of LeedsLeeds, UK
FAU - Meheust, A
AU  - Meheust A
AD  - ILSI EuropeBrussels, Belgium
FAU - Nilson, A
AU  - Nilson A
AD  - Division of Applied Nutrition and Food Chemistry, Department of Food Technology, 
      Engineering and Nutrition, Lund UniversityLund, Sweden
FAU - Normand, S
AU  - Normand S
AD  - Centre de Recherche en Nutrition Humaine, Rhône-Alpes, Center for European
      Nutrition, Safety and Health, Centre Hospitalier Lyon SudLyon, France
FAU - Rivellese, A A
AU  - Rivellese AA
AD  - Department of Clinical and Experimental Medicine, University Federico IINaples,
      Italy
FAU - Theis, S
AU  - Theis S
AD  - Südzucker/BENEO GroupObrigheim, Germany
FAU - Torekov, S S
AU  - Torekov SS
AD  - Department of Biomedical Sciences and Novo Nordisk Foundation Centre of Basic
      Metabolic Research, University of CopenhagenCopenhagen, Denmark
FAU - Vinoy, S
AU  - Vinoy S
AD  - Kraft Foods, R&D Centre, Nutrition DepartmentSaclay, France
LA  - eng
PT  - Journal Article
PHST- 2012/02/06 [received]
PHST- 2012/04/11 [revised]
PHST- 2012/04/27 [accepted]
TA  - Obes Rev
JT  - Obesity Reviews
AID - 10.1111/j.1467-789X.2012.01011.x [doi]
SO  - Obes Rev. 2012 Oct;13(10):923-84. doi:10.1111/j.1467-789X.2012.01011.x.

PMC - PMC5408008
PMID- 28503155
IS  - 1664-0640 (Electronic)
VI  - 8
DP  - 2017
TI  - DJINNI: A Novel Technology Supported Exposure Therapy Paradigm for SAD Combining 
      Virtual Reality and Augmented Reality.
LID - 26
AB  - The present paper explores the benefits and the capabilities of various emerging 
      state-of-the-art interactive 3D and Internet of Things technologies and
      investigates how these technologies can be exploited to develop a more effective 
      technology supported exposure therapy solution for social anxiety disorder.
      “DJINNI” is a conceptual design of an in vivo augmented reality (AR) exposure
      therapy mobile support system that exploits several capturing technologies and
      integrates the patient’s state and situation by vision-based, audio-based, and
      physiology-based analysis as well as by indoor/outdoor localization techniques.
      DJINNI also comprises an innovative virtual reality exposure therapy system that 
      is adaptive and customizable to the demands of the in vivo experience and
      therapeutic progress. DJINNI follows a gamification approach where rewards and
      achievements are utilized to motivate the patient to progress in her/his
      treatment. The current paper reviews the state of the art of technologies needed 
      for such a solution and recommends how these technologies could be integrated in 
      the development of an individually tailored and yet feasible and effective
      AR/virtual reality-based exposure therapy. Finally, the paper outlines how DJINNI
      could be part of classical cognitive behavioral treatment and how to validate
      such a setup.
FAU - Ben-Moussa, Maher
AU  - Ben-Moussa M
AD  - Information Science Institute, Computer Science Centre, University of Geneva,
      Geneva, Switzerland
FAU - Rubo, Marius
AU  - Rubo M
AD  - Experimental Clinical Psychology, Department of Psychology, University of
      Würzburg, Würzburg, Germany
FAU - Debracque, Coralie
AU  - Debracque C
AD  - Neuroscience of Emotion and Affective Dynamics Lab, Swiss Center for Affective
      Sciences, Department of Psychology, University of Geneva, Geneva, Switzerland
FAU - Lange, Wolf-Gero
AU  - Lange WG
AD  - Department of Clinical Psychology, Behavioural Science Institute, Radboud
      University Nijmegen, Nijmegen, Netherlands
LA  - eng
PT  - Journal Article
DEP - 20170428
PHST- 2016/09/20 [received]
PHST- 2017/02/01 [accepted]
TA  - Front Psychiatry
JT  - Frontiers in Psychiatry
AID - 10.3389/fpsyt.2017.00026 [doi]
SO  - Front Psychiatry. 2017 Apr 28;8:. doi:10.3389/fpsyt.2017.00026.

PMC - PMC3192990
PMID- 22016719
IS  - 1662-4548 (Print)
IS  - 1662-453X (Electronic)
VI  - 5
DP  - 2011
TI  - Listen, You are Writing! Speeding up Online Spelling with a Dynamic Auditory BCI.
LID - 112
AB  - Representing an intuitive spelling interface for brain–computer interfaces (BCI) 
      in the auditory domain is not straight-forward. In consequence, all existing
      approaches based on event-related potentials (ERP) rely at least partially on a
      visual representation of the interface. This online study introduces an auditory 
      spelling interface that eliminates the necessity for such a visualization. In up 
      to two sessions, a group of healthy subjects (N = 21) was asked to use a text
      entry application, utilizing the spatial cues of the AMUSE paradigm (Auditory
      Multi-class Spatial ERP). The speller relies on the auditory sense both for
      stimulation and the core feedback. Without prior BCI experience, 76% of the
      participants were able to write a full sentence during the first session. By
      exploiting the advantages of a newly introduced dynamic stopping method, a
      maximum writing speed of 1.41 char/min (7.55 bits/min) could be reached during
      the second session (average: 0.94 char/min, 5.26 bits/min). For the first time,
      the presented work shows that an auditory BCI can reach performances similar to
      state-of-the-art visual BCIs based on covert attention. These results represent
      an important step toward a purely auditory BCI.
FAU - Schreuder, Martijn
AU  - Schreuder M
AD  - Machine Learning Laboratory, Berlin Institute of TechnologyBerlin, Germany
FAU - Rost, Thomas
AU  - Rost T
AD  - Machine Learning Laboratory, Berlin Institute of TechnologyBerlin, Germany
FAU - Tangermann, Michael
AU  - Tangermann M
AD  - Machine Learning Laboratory, Berlin Institute of TechnologyBerlin, Germany
LA  - eng
PT  - Journal Article
DEP - 20111014
PHST- 2011/05/20 [received]
PHST- 2011/09/01 [accepted]
TA  - Front Neurosci
JT  - Frontiers in Neuroscience
AID - 10.3389/fnins.2011.00112 [doi]
SO  - Front Neurosci. 2011 Oct 14;5:. doi:10.3389/fnins.2011.00112.

PMC - PMC5517302
PMID- 26643802
IS  - 1741-2560 (Print)
IS  - 1741-2552 (Electronic)
VI  - 13
IP  - 1
DP  - 2016 Feb
TI  - Sensory feedback by peripheral nerve stimulation improves task performance in
      individuals with upper limb loss using a myoelectric prosthesis.
PG  - 016001
AB  - Objective: Tactile feedback is critical to grip and object manipulation. Its
      absence results in reliance on visual and auditory cues. Our objective was to
      assess the effect of sensory feedback on task performance in individuals with
      limb loss. Approach: Stimulation of the peripheral nerves using implanted cuff
      electrodes provided two subjects with sensory feedback with intensity
      proportional to forces on the thumb, index, and middle fingers of their
      prosthetic hand during object manipulation. Both subjects perceived the sensation
      on their phantom hand at locations corresponding to the locations of the forces
      on the prosthetic hand. A bend sensor measured prosthetic hand span. Hand span
      modulated the intensity of sensory feedback perceived on the thenar eminence for 
      subject 1 and the middle finger for subject 2. We performed three functional
      tests with the blindfolded subjects. First, the subject tried to determine
      whether or not a wooden block had been placed in his prosthetic hand. Second, the
      subject had to locate and remove magnetic blocks from a metal table. Third, the
      subject performed the Southampton Hand Assessment Procedure (SHAP). We also
      measured the subject’s sense of embodiment with a survey and his self-confidence.
      Main results: Blindfolded performance with sensory feedback was similar to
      sighted performance in the wooden block and magnetic block tasks. Performance on 
      the SHAP, a measure of hand mechanical function and control, was similar with and
      without sensory feedback. An embodiment survey showed an improved sense of
      integration of the prosthesis in self body image with sensory feedback.
      Significance: Sensory feedback by peripheral nerve stimulation improved object
      discrimination and manipulation, embodiment, and confidence. With both forms of
      feedback, the blindfolded subjects tended toward results obtained with visual
      feedback.
FAU - Schiefer, Matthew
AU  - Schiefer M
AD  - Case Western Reserve University, Cleveland, OH, USA
FAU - Tan, Daniel
AU  - Tan D
AD  - Case Western Reserve University, Cleveland, OH, USA
FAU - Sidek, Steven M
AU  - Sidek SM
AD  - Case Western Reserve University, Cleveland, OH, USA
FAU - Tyler, Dustin J
AU  - Tyler DJ
AD  - Case Western Reserve University, Cleveland, OH, USA
LA  - eng
PT  - Journal Article
DEP - 20151208
TA  - J Neural Eng
JT  - Journal of neural engineering
AID - 10.1088/1741-2560/13/1/016001 [doi]
MID - VAPA867040
SO  - J Neural Eng. 2016 Feb;13(1):016001. Epub 2015 Dec 08
      doi:10.1088/1741-2560/13/1/016001.

PMC - PMC4609423
PMID- 26504351
IS  - 0953-4180 (Print)
IS  - 1875-8584 (Electronic)
VI  - 2015
DP  - 2015
TI  - Neurophysiological Indicators of Residual Cognitive Capacity in the Minimally
      Conscious State.
LID - 145913
AB  - Background. The diagnostic usefulness of electrophysiological methods in
      assessing disorders of consciousness (DoC) remains to be established on an
      individual patient level, and there is need to determine what constitutes robust 
      experimental paradigm to elicit electrophysiological indices of covert cognitive 
      capacity. Objectives. Two tasks encompassing active and passive conditions were
      explored in an event-related potentials (ERP) study. The task robustness was
      studied in healthy controls, and their utility to detect covert signs of
      command-following on an individual patient level was investigated in patients in 
      a minimally conscious state (MCS). Methods. Twenty healthy controls and 20 MCS
      patients participated. The active tasks included (1) listening for a change of
      pitch in the subject's own name (SON) and (2) counting SON, both contrasted to
      passive conditions. Midline ERPs are reported. Results. A larger P3 response was 
      detected in the counting task compared to active listening to pitch change in the
      healthy controls. On an individual level, the counting task revealed a higher
      rate of responders among both healthy subjects and MCS patients. Conclusion. ERP 
      paradigms involving actively counting SON represent a robust paradigm in probing 
      for volitional cognition in minimally conscious patients and add important
      diagnostic information in some patients.
FAU - Hauger, Solveig L.
AU  - Hauger SL
AD  - Department of Research, Sunnaas Rehabilitation Hospital, 1450 Nesoddtangen,
      Norway
FAU - Schnakers, Caroline
AU  - Schnakers C
AD  - Department of Psychology and Neurosurgery, University of California, Los Angeles,
      CA 90095-1563, USA
FAU - Andersson, Stein
AU  - Andersson S
AD  - Department of Psychology, University of Oslo, Postboks 1094 Blindern, 0317 Oslo, 
      Norway
FAU - Becker, Frank
AU  - Becker F
AD  - Department of Research, Sunnaas Rehabilitation Hospital, 1450 Nesoddtangen,
      Norway
FAU - Moberget, Torgeir
AU  - Moberget T
AD  - Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for
      Psychosis Research, Division of Mental Health and Addiction, Oslo University
      Hospital, Postboks 4953 Nydalen, 0424 Oslo, Norway
FAU - Giacino, Joseph T.
AU  - Giacino JT
AD  - Department of Physical Medicine and Rehabilitation, Harvard Medical School and
      Spaulding Rehabilitation Hospital, 300 First Avenue, Charlestown, MA 02129, USA
FAU - Schanke, Anne-Kristine
AU  - Schanke AK
AD  - Department of Research, Sunnaas Rehabilitation Hospital, 1450 Nesoddtangen,
      Norway
FAU - Løvstad, Marianne
AU  - Løvstad M
AD  - Department of Research, Sunnaas Rehabilitation Hospital, 1450 Nesoddtangen,
      Norway
LA  - eng
PT  - Journal Article
DEP - 20151004
PHST- 2015/07/08 [received]
PHST- 2015/09/07 [revised]
PHST- 2015/09/09 [accepted]
PHST- 2015/10/04 [aheadofprint]
TA  - Behav Neurol
JT  - Behavioural Neurology
AID - 10.1155/2015/145913 [doi]
SO  - Behav Neurol. 2015;2015:. Epub 2015 Oct 4 doi:10.1155/2015/145913.

PMC - PMC5131699
PMID- 27112213
IS  - 1743-4440 (Print)
IS  - 1745-2422 (Electronic)
VI  - 13
IP  - 5
DP  - 2016 May
TI  - A review of the progression and future implications of brain-computer interface
      therapies for restoration of distal upper extremity motor function after stroke.
PG  - 445-54
AB  - Stroke is a leading cause of acquired disability resulting in distal upper
      extremity functional motor impairment. Stroke mortality rates continue to decline
      with advances in healthcare and medical technology. This has led to an increased 
      demand for advanced, personalized rehabilitation. Survivors often experience some
      level of spontaneous recovery shortly after their stroke event; yet reach a
      functional plateau after which there is exiguous motor recovery. Nevertheless,
      studies have demonstrated the potential for recovery beyond this plateau.
      Non-traditional neurorehabilitation techniques, such as those incorporating the
      brain-computer interface (BCI), are being investigated for rehabilitation. BCIs
      may offer a gateway to the brain’s plasticity and revolutionize how humans
      interact with the world. Non-invasive BCIs work by closing the proprioceptive
      feedback loop with real-time, multi-sensory feedback allowing for volitional
      modulation of brain signals to assist hand function. BCI technology potentially
      promotes neuroplasticity and Hebbian-based motor recovery by rewarding cortical
      activity associated with sensory-motor rhythms through use with a variety of
      self-guided and assistive modalities.
FAU - Remsik, Alexander
AU  - Remsik A
FAU - Young, Brittany
AU  - Young B
FAU - Vermilyea, Rebecca
AU  - Vermilyea R
FAU - Kiekoefer, Laura
AU  - Kiekoefer L
FAU - Abrams, Jessica
AU  - Abrams J
FAU - Elmore, Samantha Evander
AU  - Elmore SE
FAU - Schultz, Paige
AU  - Schultz P
FAU - Nair, Veena
AU  - Nair V
FAU - Edwards, Dorothy
AU  - Edwards D
FAU - Williams, Justin
AU  - Williams J
FAU - Prabhakaran, Vivek
AU  - Prabhakaran V
LA  - eng
PT  - Journal Article
TA  - Expert Rev Med Devices
JT  - Expert review of medical devices
AID - 10.1080/17434440.2016.1174572 [doi]
MID - NIHMS828769
SO  - Expert Rev Med Devices. 2016 May;13(5):445-54. doi:10.1080/17434440.2016.1174572.

PMC - PMC5341771
PMID- 27419272
IS  - 1562-2975 (Print)
IS  - 1814-1412 (Electronic)
VI  - 18
IP  - 3
DP  - 2017 Apr
TI  - Biological markers for anxiety disorders, OCD and PTSD: A consensus statement.
      Part II: Neurochemistry, neurophysiology and neurocognition.
PG  - 162-214
AB  - Objective: Biomarkers are defined as anatomical, biochemical or physiological
      traits that are specific to certain disorders or syndromes. The objective of this
      paper is to summarise the current knowledge of biomarkers for anxiety disorders, 
      obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD).
      Methods: Findings in biomarker research were reviewed by a task force of
      international experts in the field, consisting of members of the World Federation
      of Societies for Biological Psychiatry Task Force on Biological Markers and of
      the European College of Neuropsychopharmacology Anxiety Disorders Research
      Network. Results: The present article (Part II) summarises findings on potential 
      biomarkers in neurochemistry (neurotransmitters such as serotonin,
      norepinephrine, dopamine or GABA, neuropeptides such as cholecystokinin,
      neurokinins, atrial natriuretic peptide, or oxytocin, the HPA axis, neurotrophic 
      factors such as NGF and BDNF, immunology and CO2 hypersensitivity),
      neurophysiology (EEG, heart rate variability) and neurocognition. The
      accompanying paper (Part I) focuses on neuroimaging and genetics. Conclusions:
      Although at present, none of the putative biomarkers is sufficient and specific
      as a diagnostic tool, an abundance of high quality research has accumulated that 
      should improve our understanding of the neurobiological causes of anxiety
      disorders, OCD and PTSD.
FAU - Bandelow, Borwin
AU  - Bandelow B
AD  - Department of Psychiatry and Psychotherapy, University of Göttingen, Germany
FAU - Baldwin, David
AU  - Baldwin D
AD  - Faculty of Medicine, University of Southampton, Southampton, UK
FAU - Abelli, Marianna
AU  - Abelli M
AD  - Department of Clinical and Experimental Medicine, Section of Psychiatry,
      University of Pisa, Pisa, Italy
FAU - Bolea-Alamanac, Blanca
AU  - Bolea-Alamanac B
AD  - School of Social and Community Medicine, Academic Unit of Psychiatry, University 
      of Bristol, Bristol, UK
FAU - Bourin, Michel
AU  - Bourin M
AD  - Neurobiology of Anxiety and Mood Disorders, University of Nantes, Nantes, France
FAU - Chamberlain, Samuel R.
AU  - Chamberlain SR
AD  - Hertfordshire Partnership University NHS Foundation Trust and University of
      Hertfordshire, Parkway, UK
FAU - Cinosi, Eduardo
AU  - Cinosi E
AD  - Department of Neuroscience Imaging and Clinical Sciences, Gabriele D’Annunzio
      University, Chieti, Italy
FAU - Davies, Simon
AU  - Davies S
AD  - Centre for Addiction and Mental Health, Geriatric Psychiatry Division, University
      of Toronto, Toronto, Canada
FAU - Domschke, Katharina
AU  - Domschke K
AD  - Department of Psychiatry Psychosomatics and Psychotherapy, University of
      Wuerzburg, Wuerzburg, Germany
FAU - Fineberg, Naomi
AU  - Fineberg N
AD  - Hertfordshire Partnership University NHS Foundation Trust and University of
      Hertfordshire, Parkway, UK
FAU - Grünblatt, Edna
AU  - Grünblatt E
AD  - Department of Psychiatry Psychosomatics and Psychotherapy, University of
      Wuerzburg, Wuerzburg, Germany
FAU - Jarema, Marek
AU  - Jarema M
AD  - Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warszawa, 
      Poland
FAU - Kim, Yong-Ku
AU  - Kim YK
AD  - Department of Psychiatry College of Medicine, Korea University, Seoul, Republic
      of Korea
FAU - Maron, Eduard
AU  - Maron E
AD  - Department of Psychiatry, North Estonia Medical Centre, Tallinn, Estonia
FAU - Masdrakis, Vasileios
AU  - Masdrakis V
AD  - Athens University Medical School, First Department of Psychiatry, Eginition
      Hospital, Athens, Greece
FAU - Mikova, Olya
AU  - Mikova O
AD  - Foundation Biological Psychiatry, Sofia, Bulgaria
FAU - Nutt, David
AU  - Nutt D
AD  - Faculty of Medicine Department of Medicine, Centre for Neuropsychopharmacology,
      Division of Brain Sciences, Imperial College London, UK
FAU - Pallanti, Stefano
AU  - Pallanti S
AD  - UC Davis Department of Psychiatry and Behavioural Sciences, Sacramento, CA, USA
FAU - Pini, Stefano
AU  - Pini S
AD  - Department of Clinical and Experimental Medicine, Section of Psychiatry,
      University of Pisa, Pisa, Italy
FAU - Ströhle, Andreas
AU  - Ströhle A
AD  - Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité –
      University Medica Center Berlin, Berlin, Germany
FAU - Thibaut, Florence
AU  - Thibaut F
AD  - Faculty of Medicine Paris Descartes, University Hospital Cochin, Paris, France
FAU - Vaghix, Matilde M.
AU  - Vaghix MM
AD  - Department of Psychology and Behavioural and Clinical Neuroscience Institute,
      University of Cambridge, UK
FAU - Won, Eunsoo
AU  - Won E
AD  - Department of Psychiatry College of Medicine, Korea University, Seoul, Republic
      of Korea
FAU - Wedekind, Dirk
AU  - Wedekind D
AD  - Department of Psychiatry and Psychotherapy, University of Göttingen, Germany
FAU - Wichniak, Adam
AU  - Wichniak A
AD  - Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warszawa, 
      Poland
FAU - Woolley, Jade
AU  - Woolley J
AD  - Faculty of Medicine, University of Southampton, Southampton, UK
FAU - Zwanzger, Peter
AU  - Zwanzger P
AD  - kbo-Inn-Salzach-Klinikum Wasserburg am Inn, Germany
FAU - Riederer, Peter
AU  - Riederer P
AD  - Department of Psychiatry Psychosomatics and Psychotherapy, University of
      Wuerzburg, Wuerzburg, Germany
LA  - eng
PT  - Journal Article
DEP - 20160715
TA  - World J Biol Psychiatry
JT  - The world journal of biological psychiatry : the official journal of the World
      Federation of Societies of Biological Psychiatry
AID - 10.1080/15622975.2016.1190867 [doi]
MID - EMS71678
SO  - World J Biol Psychiatry. 2017 Apr;18(3):162-214. Epub 2016 Jul 15
      doi:10.1080/15622975.2016.1190867.

PMC - PMC3543349
PMID- 23234491
IS  - 1745-6215 (Electronic)
VI  - 13
DP  - 2012
TI  - Efficacy of a children’s procedural preparation and distraction device on healing
      in acute burn wound care procedures: study protocol for a randomized controlled
      trial.
PG  - 238
AB  - Background: The intense pain and anxiety triggered by burns and their associated 
      wound care procedures are well established in the literature. Non-pharmacological
      intervention is a critical component of total pain management protocols and is
      used as an adjunct to pharmacological analgesia. An example is virtual reality,
      which has been used effectively to dampen pain intensity and unpleasantness.
      Possible links or causal relationships between pain/anxiety/stress and burn wound
      healing have previously not been investigated. The purpose of this study is to
      investigate these relationships, specifically by determining if a newly developed
      multi-modal procedural preparation and distraction device (Ditto™) used during
      acute burn wound care procedures will reduce the pain and anxiety of a child and 
      increase the rate of re-epithelialization. Methods/design: Children (4 to 12
      years) with acute burn injuries presenting for their first dressing change will
      be randomly assigned to either the (1) Control group (standard distraction) or
      (2) Ditto™ intervention group (receiving Ditto™, procedural preparation and
      Ditto™ distraction). It is intended that a minimum of 29 participants will be
      recruited for each treatment group. Repeated measures of pain intensity, anxiety,
      stress and healing will be taken at every dressing change until complete wound
      re-epithelialization. Further data collection will aid in determining patient
      satisfaction and cost effectiveness of the Ditto™ intervention, as well as its
      effect on speed of wound re-epithelialization. Discussion: Results of this study 
      will provide data on whether the disease process can be altered by reducing
      stress, pain and anxiety in the context of acute burn wounds. Trial registration:
      ACTRN12611000913976
FAU - Brown, Nadia J
AU  - Brown NJ
AD  - Centre for Children’s Burns and Trauma Research, Queensland Children’s Medical
      Research Institute, University of Queensland, Royal Children’s Hospital,
      Brisbane, Queensland, Australia
FAU - Rodger, Sylvia
AU  - Rodger S
AD  - Division of Occupational Therapy, The University of Queensland, School of Health 
      & Rehabilitation Sciences, Brisbane, Queensland, Australia
FAU - Ware, Robert S
AU  - Ware RS
AD  - The University of Queensland, Queensland Children’s Medical Research Institute,
      Brisbane, Queensland, Australia
FAU - Kimble, Roy M
AU  - Kimble RM
AD  - Centre for Children’s Burns and Trauma Research, Queensland Children’s Medical
      Research Institute, University of Queensland, Royal Children’s Hospital,
      Brisbane, Queensland, Australia
FAU - Cuttle, Leila
AU  - Cuttle L
AD  - Centre for Children’s Burns and Trauma Research, Queensland Children’s Medical
      Research Institute, University of Queensland, Royal Children’s Hospital,
      Brisbane, Queensland, Australia
LA  - eng
PT  - Journal Article
DEP - 20121212
PHST- 2012/07/23 [received]
PHST- 2012/11/27 [accepted]
TA  - Trials
JT  - Trials
AID - 1745-6215-13-238 [pii]
AID - 10.1186/1745-6215-13-238 [doi]
SO  - Trials. 2012 Dec 12;13:238. doi:10.1186/1745-6215-13-238.

PMC - PMC1859999
PMID- 16531518
IS  - 0017-5749 (Print)
IS  - 1468-3288 (Electronic)
VI  - 55
IP  - Suppl 2
DP  - 2006 Apr
PG  - A1-A119
LA  - eng
PT  - Journal Article
TA  - Gut
JT  - Gut
AID - gtBSG06ab1 [pii]
SO  - Gut. 2006 Apr;55(Suppl 2):A1-A119.

PMC - PMC4060712
PMID- 24912179
IS  - 0027-8424 (Print)
IS  - 1091-6490 (Electronic)
VI  - 111
IP  - 23
DP  - 2014 Jun 10
TI  - Switching brain serotonin with oxytocin.
PG  - 8637-42
AB  - Serotonin (5-HT) and oxytocin (OXT) are two neuromodulators involved in human
      affect and sociality and in disorders like depression and autism. Here we show
      that these chemical messengers interact in areas of the human brain important for
      the regulation of emotion-based behavior. By highlighting the role of OXT in the 
      regulation of 5-HT signaling, our findings can lead to novel therapeutic
      strategies for mental disorders such as social anxiety, depression, and autism.
OAB - Publisher: Abstract available from the publisher.
FAU - Mottolese, Raphaelle
AU  - Mottolese R
AD  - Center for Cognitive Neuroscience, Unité Mixte de Recherche 5229, Centre National
      de la Recherche Scientifique, 69675 Bron, France;
FAU - Redouté, Jérôme
AU  - Redouté J
AD  - University Claude Bernard Lyon 1, 69609 Lyon, France; and
FAU - Costes, Nicolas
AU  - Costes N
AD  - Centre d'Etude et de Recherche Multimodal et Pluridisciplinaire Imagerie du
      Vivant, 69003 Lyon, France
FAU - Le Bars, Didier
AU  - Le Bars D
AD  - University Claude Bernard Lyon 1, 69609 Lyon, France; and
FAU - Sirigu, Angela
AU  - Sirigu A
AD  - Center for Cognitive Neuroscience, Unité Mixte de Recherche 5229, Centre National
      de la Recherche Scientifique, 69675 Bron, France;
LA  - eng
PT  - Journal Article
DEP - 20140527
PHST- 2014/05/27 [aheadofprint]
TA  - Proc Natl Acad Sci U S A
JT  - Proceedings of the National Academy of Sciences of the United States of America
AID - 201319810 [pii]
AID - 10.1073/pnas.1319810111 [doi]
SO  - Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8637-42. Epub 2014 May 27
      doi:10.1073/pnas.1319810111.

PMC - PMC4786042
PMID- 26997897
IS  - 1364-5021 (Print)
IS  - 1471-2946 (Electronic)
VI  - 472
IP  - 2185
DP  - 2016 Jan
TI  - Are some people suffering as a result of increasing mass exposure of the public
      to ultrasound in air?
LID - 20150624
AB  - New measurements indicate that the public are being exposed, without their
      knowledge, to airborne ultrasound. Existing guidelines are insufficient for such 
      exposures; the vast majority refers to occupational exposure only (where workers 
      are aware of the exposure, can be monitored and can wear protection). Existing
      guidelines are based on an insufficient evidence base, most of which was
      collected over 40 years ago by researchers who themselves considered it
      insufficient to finalize guidelines, but which produced preliminary guidelines.
      This warning of inadequacy was lost as nations and organizations issued ‘new’
      guidelines based on these early guidelines, and through such repetition generated
      a false impression of consensus. The evidence base is so slim that few reports
      have progressed far along the sequence from anecdote to case study, to formal
      scientific controlled trials and epidemiological studies. Early studies reported 
      hearing threshold shifts, nausea, headache, fatigue, migraine and tinnitus, but
      there is insufficient research on human subjects, and insufficient measurement of
      fields, to assess what health risk current occupational and public exposures
      might produce. Furthermore, the assumptions underpinning audiology and physical
      measurements at high frequencies must be questioned: simple extrapolation of
      approaches used at lower frequencies does not address current unknowns.
      Recommendations are provided.
FAU - Leighton, T. G.
AU  - Leighton TG
LA  - eng
PT  - Journal Article
PT  - Review
GR  - RP015002
PHST- 2015/09/03 [received]
PHST- 2015/11/03 [accepted]
TA  - Proc Math Phys Eng Sci
JT  - Proceedings. Mathematical, Physical, and Engineering Sciences / The Royal Society
AID - 10.1098/rspa.2015.0624 [doi]
AID - rspa20150624 [pii]
SO  - Proc Math Phys Eng Sci. 2016 Jan;472(2185):. doi:10.1098/rspa.2015.0624.

PMC - PMC3168949
PMID- 21255702
IS  - 0146-0005 (Print)
IS  - 1558-075X (Electronic)
VI  - 35
IP  - 1
DP  - 2011 Feb
TI  - Infant Neurobehavioral Development.
PG  - 8-19
AB  - The trend toward single-room neonatal intensive care units (NICUs) is increasing;
      however scientific evidence is, at this point, mostly anecdotal. This is a
      critical time to assess the impact of the single-room NICU on improving medical
      and neurobehavioral outcomes of the preterm infant. We have developed a
      theoretical model that may be useful in studying how the change from an open-bay 
      NICU to a single-room NICU could affect infant medical and neurobehavioral
      outcome. The model identifies mediating factors that are likely to accompany the 
      change to a single-room NICU. These mediating factors include family centered
      care, developmental care, parenting and family factors, staff behavior and
      attitudes, and medical practices. Medical outcomes that plan to be measured are
      sepsis, length of stay, gestational age at discharge, weight gain, illness
      severity, gestational age at enteral feeding, and necrotizing enterocolitis
      (NEC). Neurobehavioral outcomes include the NICU Network Neurobehavioral Scale
      (NNNS) scores, sleep state organization and sleep physiology, infant mother
      feeding interaction scores, and pain scores. Preliminary findings on the sample
      of 150 patients in the open-bay NICU showed a “baseline” of effects of family
      centered care, developmental care, parent satisfaction, maternal depression, and 
      parenting stress on the neurobehavioral outcomes of the newborn. The single-room 
      NICU has the potential to improve the neurobehavioral status of the infant at
      discharge. Neurobehavioral assessment can assist with early detection and
      therefore preventative intervention to maximize developmental outcome. We also
      present an epigenetic model of the potential effects of maternal care on
      improving infant neurobehavioral status.
FAU - Lester, Barry M.
AU  - Lester BM
AD  - Brown Center for the Study of Children at Risk, Providence, RI.
FAU - Miller, Robin J.
AU  - Miller RJ
AD  - Brown Center for the Study of Children at Risk, Providence, RI.
FAU - Hawes, Katheleen
AU  - Hawes K
AD  - Brown Center for the Study of Children at Risk, Providence, RI.
FAU - Salisbury, Amy
AU  - Salisbury A
AD  - Brown Center for the Study of Children at Risk, Providence, RI.
FAU - Bigsby, Rosemarie
AU  - Bigsby R
AD  - Brown Center for the Study of Children at Risk, Providence, RI.
FAU - Sullivan, Mary C.
AU  - Sullivan MC
AD  - Brown Center for the Study of Children at Risk, Providence, RI.
FAU - Padbury, James F.
AU  - Padbury JF
AD  - Brown, Alpert Medical School, Providence, RI.
LA  - eng
PT  - Journal Article
GR  - R01 MH078033-03 || MH
TA  - Semin Perinatol
JT  - Seminars in perinatology
AID - 10.1053/j.semperi.2010.10.003 [doi]
MID - NIHMS261929
SO  - Semin Perinatol. 2011 Feb;35(1):8-19. doi:10.1053/j.semperi.2010.10.003.

PMC - PMC4092375
PMID- 25071485
IS  - 1662-5153 (Electronic)
VI  - 8
DP  - 2014
TI  - The development and malleability of executive control abilities.
LID - 221
AB  - Executive control (EC) generally refers to the regulation of mental activity. It 
      plays a crucial role in complex cognition, and EC skills predict high-level
      abilities including language processing, memory, and problem solving, as well as 
      practically relevant outcomes such as scholastic achievement. EC develops
      relatively late in ontogeny, and many sub-groups of developmental populations
      demonstrate an exaggeratedly poor ability to control cognition even alongside the
      normal protracted growth of EC skills. Given the value of EC to human
      performance, researchers have sought means to improve it through targeted
      training; indeed, accumulating evidence suggests that regulatory processes are
      malleable through experience and practice. Nonetheless, there is a need to
      understand both whether specific populations might particularly benefit from
      training, and what cortical mechanisms engage during performance of the tasks
      used in the training protocols. This contribution has two parts: in Part I, we
      review EC development and intervention work in select populations. Although
      promising, the mixed results in this early field make it difficult to draw strong
      conclusions. To guide future studies, in Part II, we discuss training studies
      that have included a neuroimaging component – a relatively new enterprise that
      also has not yet yielded a consistent pattern of results post-training,
      preventing broad conclusions. We therefore suggest that recent developments in
      neuroimaging (e.g., multivariate and connectivity approaches) may be useful to
      advance our understanding of the neural mechanisms underlying the malleability of
      EC and brain plasticity. In conjunction with behavioral data, these methods may
      further inform our understanding of the brain–behavior relationship and the
      extent to which EC is dynamic and malleable, guiding the development of future,
      targeted interventions to promote executive functioning in both healthy and
      atypical populations.
FAU - Hsu, Nina S.
AU  - Hsu NS
AD  - Center for Advanced Study of Language, University of MarylandCollege Park, MD,
      USA
FAU - Novick, Jared M.
AU  - Novick JM
AD  - Center for Advanced Study of Language, University of MarylandCollege Park, MD,
      USA
FAU - Jaeggi, Susanne M.
AU  - Jaeggi SM
AD  - School of Education, University of California, IrvineIrvine, CA, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20140624
PHST- 2014/02/21 [received]
PHST- 2014/06/01 [accepted]
TA  - Front Behav Neurosci
JT  - Frontiers in Behavioral Neuroscience
AID - 10.3389/fnbeh.2014.00221 [doi]
SO  - Front Behav Neurosci. 2014 Jun 24;8:. doi:10.3389/fnbeh.2014.00221.

PMC - PMC2799006
IS  - 0342-4642 (Print)
IS  - 1432-1238 (Electronic)
VI  - 34
IP  - Suppl 1
DP  - 2008 Sep
TI  - 21st ESICM Annual Congress.
PG  - 93-180
LA  - eng
PT  - Journal Article
DEP - 20080808
TA  - Intensive Care Med
JT  - Intensive Care Medicine
AID - 1241 [pii]
AID - 10.1007/s00134-008-1241-2 [doi]
SO  - Intensive Care Med. 2008 Sep;34(Suppl 1):93-180. Epub 2008 Aug 8
      doi:10.1007/s00134-008-1241-2.

PMC - PMC3728570
PMID- 23914170
IS  - 1662-5161 (Electronic)
VI  - 7
DP  - 2013
TI  - Brain Mapping in a Patient with Congenital Blindness – A Case for Multimodal
      Approaches.
LID - 431
AB  - Recent advances in basic neuroscience research across a wide range of
      methodologies have contributed significantly to our understanding of human
      cortical electrophysiology and functional brain imaging. Translation of this
      research into clinical neurosurgery has opened doors for advanced mapping of
      functionality that previously was prohibitively difficult, if not impossible.
      Here we present the case of a unique individual with congenital blindness and
      medically refractory epilepsy who underwent neurosurgical treatment of her
      seizures. Pre-operative evaluation presented the challenge of accurately and
      robustly mapping the cerebral cortex for an individual with a high probability of
      significant cortical re-organization. Additionally, a blind individual has unique
      priorities in one’s ability to read Braille by touch and sense the environment
      primarily by sound than the non-vision impaired person. For these reasons we
      employed additional measures to map sensory, motor, speech, language, and
      auditory perception by employing a number of cortical electrophysiologic mapping 
      and functional magnetic resonance imaging methods. Our data show promising
      results in the application of these adjunctive methods in the pre-operative
      mapping of otherwise difficult to localize, and highly variable, functional
      cortical areas.
FAU - Roland, Jarod L.
AU  - Roland JL
AD  - Department of Neurological Surgery, Washington University School of Medicine, St.
      Louis, MO, USA
FAU - Hacker, Carl D.
AU  - Hacker CD
AD  - Department of Biomedical Engineering, Washington University, St. Louis, MO, USA
FAU - Breshears, Jonathan D.
AU  - Breshears JD
AD  - Department of Neurological Surgery, School of Medicine, University of California 
      San Francisco, San Francisco, CA, USA
FAU - Gaona, Charles M.
AU  - Gaona CM
AD  - Department of Biomedical Engineering, Washington University, St. Louis, MO, USA
FAU - Hogan, R. Edward
AU  - Hogan RE
AD  - Department of Neurology, Washington University School of Medicine, St. Louis, MO,
      USA
FAU - Burton, Harold
AU  - Burton H
AD  - Department of Anatomy and Neurobiology, Washington University School of Medicine,
      St. Louis, MO, USA
FAU - Corbetta, Maurizio
AU  - Corbetta M
AD  - Department of Neurology, Washington University School of Medicine, St. Louis, MO,
      USA
FAU - Leuthardt, Eric C.
AU  - Leuthardt EC
AD  - Department of Neurological Surgery, Washington University School of Medicine, St.
      Louis, MO, USA
LA  - eng
PT  - Journal Article
DEP - 20130731
PHST- 2013/04/05 [received]
PHST- 2013/07/15 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2013.00431 [doi]
SO  - Front Hum Neurosci. 2013 Jul 31;7:. doi:10.3389/fnhum.2013.00431.

PMC - PMC4531161
PMID- 26290661
IS  - 1687-5265 (Print)
IS  - 1687-5273 (Electronic)
VI  - 2015
DP  - 2015
TI  - A Link between the Increase in Electroencephalographic Coherence and Performance 
      Improvement in Operating a Brain-Computer Interface.
LID - 824175
AB  - We study the relationship between electroencephalographic (EEG) coherence and
      accuracy in operating a brain-computer interface (BCI). In our case, the BCI is
      controlled through motor imagery. Hence, a number of volunteers were trained
      using different training paradigms: classical visual feedback, auditory
      stimulation, and functional electrical stimulation (FES). After each training
      session, the volunteers' accuracy in operating the BCI was assessed, and the
      event-related coherence (ErCoh) was calculated for all possible combinations of
      pairs of EEG sensors. After at least four training sessions, we searched for
      significant differences in accuracy and ErCoh using one-way analysis of variance 
      (ANOVA) and multiple comparison tests. Our results show that there exists a high 
      correlation between an increase in ErCoh and performance improvement, and this
      effect is mainly localized in the centrofrontal and centroparietal brain regions 
      for the case of our motor imagery task. This result has a direct implication with
      the development of new techniques to evaluate BCI performance and the process of 
      selecting a feedback modality that better enhances the volunteer's capacity to
      operate a BCI system.
FAU - Angulo-Sherman, Irma Nayeli
AU  - Angulo-Sherman IN
AUID- ORCID: 0000-0003-2628-768X
AD  - Centro de Investigación y de Estudios Avanzados (CINVESTAV), Unidad Monterrey,
      66600 Apodaca, NL, Mexico
FAU - Gutiérrez, David
AU  - Gutiérrez D
AUID- ORCID: 0000-0003-0424-3053
AD  - Centro de Investigación y de Estudios Avanzados (CINVESTAV), Unidad Monterrey,
      66600 Apodaca, NL, Mexico
LA  - eng
PT  - Journal Article
DEP - 20150728
PHST- 2015/03/16 [received]
PHST- 2015/06/21 [revised]
PHST- 2015/06/24 [accepted]
PHST- 2015/07/28 [aheadofprint]
TA  - Comput Intell Neurosci
JT  - Computational Intelligence and Neuroscience
AID - 10.1155/2015/824175 [doi]
SO  - Comput Intell Neurosci. 2015;2015:. Epub 2015 Jul 28 doi:10.1155/2015/824175.

PMC - PMC4625082
PMID- 26579069
IS  - 1664-2295 (Electronic)
VI  - 6
DP  - 2015
TI  - A Review of Transcranial Magnetic Stimulation and Multimodal Neuroimaging to
      Characterize Post-Stroke Neuroplasticity.
LID - 226
AB  - Following stroke, the brain undergoes various stages of recovery where the
      central nervous system can reorganize neural circuitry (neuroplasticity) both
      spontaneously and with the aid of behavioral rehabilitation and non-invasive
      brain stimulation. Multiple neuroimaging techniques can characterize common
      structural and functional stroke-related deficits, and importantly, help predict 
      recovery of function. Diffusion tensor imaging (DTI) typically reveals increased 
      overall diffusivity throughout the brain following stroke, and is capable of
      indexing the extent of white matter damage. Magnetic resonance spectroscopy (MRS)
      provides an index of metabolic changes in surviving neural tissue after stroke,
      serving as a marker of brain function. The neural correlates of altered brain
      activity after stroke have been demonstrated by abnormal activation of
      sensorimotor cortices during task performance, and at rest, using functional
      magnetic resonance imaging (fMRI). Electroencephalography (EEG) has been used to 
      characterize motor dysfunction in terms of increased cortical amplitude in the
      sensorimotor regions when performing upper limb movement, indicating abnormally
      increased cognitive effort and planning in individuals with stroke. Transcranial 
      magnetic stimulation (TMS) work reveals changes in ipsilesional and
      contralesional cortical excitability in the sensorimotor cortices. The severity
      of motor deficits indexed using TMS has been linked to the magnitude of activity 
      imbalance between the sensorimotor cortices. In this paper, we will provide a
      narrative review of data from studies utilizing DTI, MRS, fMRI, EEG, and brain
      stimulation techniques focusing on TMS and its combination with uni- and
      multimodal neuroimaging methods to assess recovery after stroke. Approaches that 
      delineate the best measures with which to predict or positively alter outcomes
      will be highlighted.
FAU - Auriat, Angela M.
AU  - Auriat AM
AD  - Department of Physical Therapy, Faculty of Medicine, University of British
      Columbia, Vancouver, BC, Canada
FAU - Neva, Jason L.
AU  - Neva JL
AD  - Department of Physical Therapy, Faculty of Medicine, University of British
      Columbia, Vancouver, BC, Canada
FAU - Peters, Sue
AU  - Peters S
AD  - Department of Physical Therapy, Faculty of Medicine, University of British
      Columbia, Vancouver, BC, Canada
FAU - Ferris, Jennifer K.
AU  - Ferris JK
AD  - Graduate Program in Neuroscience, Faculty of Medicine, University of British
      Columbia, Vancouver, BC, Canada
FAU - Boyd, Lara A.
AU  - Boyd LA
AD  - Department of Physical Therapy, Faculty of Medicine, University of British
      Columbia, Vancouver, BC, Canada
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20151029
PHST- 2015/06/01 [received]
PHST- 2015/10/12 [accepted]
TA  - Front Neurol
JT  - Frontiers in Neurology
AID - 10.3389/fneur.2015.00226 [doi]
SO  - Front Neurol. 2015 Oct 29;6:. doi:10.3389/fneur.2015.00226.

PMC - PMC2565376
PMID- 11783444
IS  - 2090-5904 (Print)
IS  - 1687-5443 (Electronic)
VI  - 8
IP  - 3
DP  - 2001
TI  - Abstracts of the Tenth Annual Meeting of the Israel Society for Neurosciences.
PG  - 157-210
LA  - eng
PT  - Journal Article
TA  - Neural Plast
JT  - Neural Plasticity
AID - 10.1155/NP.2001.157 [doi]
SO  - Neural Plast. 2001;8(3):157-210. doi:10.1155/NP.2001.157.

PMC - PMC4879973
PMID- 20508185
IS  - 0039-2499 (Print)
IS  - 1524-4628 (Electronic)
VI  - 41
IP  - 7
DP  - 2010 Jul
TI  - Effectiveness of Virtual Reality Using Wii Gaming Technology in Stroke
      Rehabilitation: A Pilot Randomized Clinical Trial and Proof of Principle.
PG  - 1477-84
AB  - Background and Purpose: Hemiparesis resulting in functional limitation of an
      upper extremity is common among stroke survivors. Although existing evidence
      suggests that increasing intensity of stroke rehabilitation therapy results in
      better motor recovery, limited evidence is available on the efficacy of virtual
      reality for stroke rehabilitation. Methods: In this pilot, randomized,
      single-blinded clinical trial with 2 parallel groups involving stroke patients
      within 2 months, we compared the feasibility, safety, and efficacy of virtual
      reality using the Nintendo Wii gaming system (VRWii) versus recreational therapy 
      (playing cards, bingo, or “Jenga”) among those receiving standard rehabilitation 
      to evaluate arm motor improvement. The primary feasibility outcome was the total 
      time receiving the intervention. The primary safety outcome was the proportion of
      patients experiencing intervention-related adverse events during the study
      period. Efficacy, a secondary outcome measure, was evaluated with the Wolf Motor 
      Function Test, Box and Block Test, and Stroke Impact Scale at 4 weeks after
      intervention. Results: Overall, 22 of 110 (20%) of screened patients were
      randomized. The mean age (range) was 61.3 (41 to 83) years. Two participants
      dropped out after a training session. The interventions were successfully
      delivered in 9 of 10 participants in the VRWii and 8 of 10 in the recreational
      therapy arm. The mean total session time was 388 minutes in the recreational
      therapy group compared with 364 minutes in the VRWii group (P=0.75). There were
      no serious adverse events in any group. Relative to the recreational therapy
      group, participants in the VRWii arm had a significant improvement in mean motor 
      function of 7 seconds (Wolf Motor Function Test, 7.4 seconds; 95% CI, −14.5,
      −0.2) after adjustment for age, baseline functional status (Wolf Motor Function
      Test), and stroke severity. Conclusions: VRWii gaming technology represents a
      safe, feasible, and potentially effective alternative to facilitate
      rehabilitation therapy and promote motor recovery after stroke.
FAU - Saposnik, Gustavo
AU  - Saposnik G
FAU - Teasell, Robert
AU  - Teasell R
FAU - Mamdani, Muhammad
AU  - Mamdani M
FAU - Hall, Judith
AU  - Hall J
FAU - McIlroy, William
AU  - McIlroy W
FAU - Cheung, Donna
AU  - Cheung D
FAU - Thorpe, Kevin E.
AU  - Thorpe KE
FAU - Cohen, Leonardo G.
AU  - Cohen LG
FAU - Bayley, Mark
AU  - Bayley M
CN  - Stroke Outcome Research Canada (SORCan) Working Group
LA  - eng
PT  - Journal Article
DEP - 20100527
TA  - Stroke
JT  - Stroke; a journal of cerebral circulation
AID - 10.1161/STROKEAHA.110.584979 [doi]
MID - NIHMS787363
SO  - Stroke. 2010 Jul;41(7):1477-84. Epub 2010 May 27
      doi:10.1161/STROKEAHA.110.584979.

PMC - PMC5226959
PMID- 28127283
IS  - 1662-5161 (Electronic)
VI  - 10
DP  - 2016
TI  - Understanding Minds in Real-World Environments: Toward a Mobile Cognition
      Approach.
LID - 694
AB  - There is a growing body of evidence that important aspects of human cognition
      have been marginalized, or overlooked, by traditional cognitive science. In
      particular, the use of laboratory-based experiments in which stimuli are
      artificial, and response options are fixed, inevitably results in findings that
      are less ecologically valid in relation to real-world behavior. In the present
      review we highlight the opportunities provided by a range of new mobile
      technologies that allow traditionally lab-bound measurements to now be collected 
      during natural interactions with the world. We begin by outlining the theoretical
      support that mobile approaches receive from the development of embodied accounts 
      of cognition, and we review the widening evidence that illustrates the importance
      of examining cognitive processes in their context. As we acknowledge, in
      practice, the development of mobile approaches brings with it fresh challenges,
      and will undoubtedly require innovation in paradigm design and analysis. If
      successful, however, the mobile cognition approach will offer novel insights in a
      range of areas, including understanding the cognitive processes underlying
      navigation through space and the role of attention during natural behavior. We
      argue that the development of real-world mobile cognition offers both increased
      ecological validity, and the opportunity to examine the interactions between
      perception, cognition and action—rather than examining each in isolation.
FAU - Ladouce, Simon
AU  - Ladouce S
FAU - Donaldson, David I.
AU  - Donaldson DI
FAU - Dudchenko, Paul A.
AU  - Dudchenko PA
FAU - Ietswaart, Magdalena
AU  - Ietswaart M
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170112
PHST- 2016/09/15 [received]
PHST- 2016/12/29 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2016.00694 [doi]
SO  - Front Hum Neurosci. 2017 Jan 12;10:. doi:10.3389/fnhum.2016.00694.

PMC - PMC4736099
PMID- 26833080
IS  - 1745-6215 (Electronic)
VI  - 17
DP  - 2016
TI  - Perspectives on the design and methodology of periconceptional nutrient
      supplementation trials.
LID - 58
AB  - Periconceptional supplementation could extend the period over which maternal and 
      fetal nutrition is improved, but there are many challenges facing early-life
      intervention studies. Periconceptional trials differ from pregnancy
      supplementation trials, not only because of the very early or pre-gestational
      timing of nutrient exposure but also because they generate subsidiary information
      on participants who remain non-pregnant. The methodological challenges are more
      complex although, if well designed, they provide opportunities to evaluate
      concurrent hypotheses related to the health of non-pregnant women, especially
      nulliparous adolescents. This review examines the framework of published and
      ongoing randomised trial designs. Four cohorts typically arise from the
      periconceptional trial design — two of which are non-pregnant and two are
      pregnant — and this structure provides assessment options related to
      pre-pregnant, maternal, pregnancy and fetal outcomes. Conceptually the initial
      decision for single or micronutrient intervention is central — as is the choice
      of dosage and content — in order to establish a comparative framework across
      trials, improve standardisation, and facilitate interpretation of mechanistic
      hypotheses. Other trial features considered in the review include: measurement
      options for baseline and outcome assessments; adherence to long-term
      supplementation; sample size considerations in relation to duration of nutrient
      supplementation; cohort size for non-pregnant and pregnant cohorts as the latter 
      is influenced by parity selection; integrating qualitative studies and data
      management issues. Emphasis is given to low resource settings where high
      infection rates and the possibility of nutrient-infection interactions may
      require appropriate safety monitoring. The focus is on pragmatic issues that may 
      help investigators planning a periconceptional trial.
FAU - Brabin, Bernard J.
AU  - Brabin BJ
AD  - Clinical Division, Liverpool School of Tropical Medicine, Pembroke Place,
      Liverpool, L35QA UK
FAU - Gies, Sabine
AU  - Gies S
AD  - Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp,
      Belgium
FAU - Owens, Stephen
AU  - Owens S
AD  - Northumbria Healthcare NHS Foundation Trust, North Shields, NE29 8NH UK
FAU - Claeys, Yves
AU  - Claeys Y
AD  - Clinical Sciences Department, Institute of Tropical Medicine, Antwerp, Belgium
FAU - D’Alessandro, Umberto
AU  - D’Alessandro U
AD  - Medical Research Council Unit (MRC), Fajara, The Gambia
FAU - Tinto, Halidou
AU  - Tinto H
AD  - Clinical Research Unit of Nanoro (URCN/IRSS), Nanoro, Burkina Faso
FAU - Brabin, Loretta
AU  - Brabin L
AD  - Institute of Cancer Sciences, University of Manchester, Manchester, UK
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20160130
PHST- 2015/03/20 [received]
PHST- 2015/12/15 [accepted]
TA  - Trials
JT  - Trials
AID - 1124 [pii]
AID - 10.1186/s13063-015-1124-0 [doi]
SO  - Trials. 2016 Jan 30;17:. doi:10.1186/s13063-015-1124-0.

PMC - PMC5452683
PMID- 28035576
IS  - 0065-2598 (Print)
IS  - 2214-8019 (Electronic)
VI  - 957
DP  - 2016
TI  - Toward a Proprioceptive Neural Interface That Mimics Natural Cortical Activity.
PG  - 367-88
AB  - The dramatic advances in efferent neural interfaces over the past decade are
      remarkable, with cortical signals used to allow paralyzed patients to control the
      movement of a prosthetic limb or even their own hand. However, this success has
      thrown into relief, the relative lack of progress in our ability to restore
      somatosensation to these same patients. Somatosensation, including
      proprioception, the sense of limb position and movement, plays a crucial role in 
      even basic motor tasks like reaching and walking. Its loss results in crippling
      deficits. Historical work dating back decades and even centuries has demonstrated
      that modality-specific sensations can be elicited by activating the central
      nervous system electrically. Recent work has focused on the challenge of refining
      these sensations by stimulating the somatosensory cortex (S1) directly. Animals
      are able to detect particular patterns of stimulation and even associate those
      patterns with particular sensory cues. Most of this work has involved areas of
      the somatosensory cortex that mediate the sense of touch. Very little
      corresponding work has been done for proprioception. Here we describe the effort 
      to develop afferent neural interfaces through spatiotemporally precise
      intracortical microstimulation (ICMS). We review what is known of the cortical
      representation of proprioception, and describe recent work in our lab that
      demonstrates for the first time, that sensations like those of natural
      proprioception may be evoked by ICMS in S1. These preliminary findings are an
      important first step to the development of an afferent cortical interface to
      restore proprioception.
FAU - Tomlinson, Tucker
AU  - Tomlinson T
AD  - Department of Physiology, Feinberg School of Medicine, Northwestern University,
      303 E., Chicago Avenue, Chicago, IL 60611, USA
FAU - Miller, Lee E.
AU  - Miller LE
AD  - Department of Physiology, Feinberg School of Medicine, Northwestern University,
      303 E., Chicago Avenue, Chicago, IL 60611, USA
AD  - Department of Physical Medicine and Rehabilitation, Northwestern University, 710 
      North, Lake Shore Drive, Chicago, IL, USA
AD  - Department of Biomedical Engineering, Northwestern University, 2145 Sheridan
      Road, Evanston, IL 60208, USA
LA  - eng
PT  - Journal Article
TA  - Adv Exp Med Biol
JT  - Advances in experimental medicine and biology
AID - 10.1007/978-3-319-47313-0_20 [doi]
MID - NIHMS864720
SO  - Adv Exp Med Biol. 2016;957:367-88. doi:10.1007/978-3-319-47313-0_20.

PMC - PMC4931870
PMID- 27363441
IS  - 0031-6997 (Print)
IS  - 1521-0081 (Electronic)
VI  - 68
IP  - 3
DP  - 2016 Jul
TI  - The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the
      Importance of Glutamate Homeostasis.
PG  - 816-71
AB  - The nucleus accumbens is a major input structure of the basal ganglia and
      integrates information from cortical and limbic structures to mediate
      goal-directed behaviors. Chronic exposure to several classes of drugs of abuse
      disrupts plasticity in this region, allowing drug-associated cues to engender a
      pathologic motivation for drug seeking. A number of alterations in glutamatergic 
      transmission occur within the nucleus accumbens after withdrawal from chronic
      drug exposure. These drug-induced neuroadaptations serve as the molecular basis
      for relapse vulnerability. In this review, we focus on the role that glutamate
      signal transduction in the nucleus accumbens plays in addiction-related
      behaviors. First, we explore the nucleus accumbens, including the cell types and 
      neuronal populations present as well as afferent and efferent connections. Next
      we discuss rodent models of addiction and assess the viability of these models
      for testing candidate pharmacotherapies for the prevention of relapse. Then we
      provide a review of the literature describing how synaptic plasticity in the
      accumbens is altered after exposure to drugs of abuse and withdrawal and also how
      pharmacological manipulation of glutamate systems in the accumbens can inhibit
      drug seeking in the laboratory setting. Finally, we examine results from clinical
      trials in which pharmacotherapies designed to manipulate glutamate systems have
      been effective in treating relapse in human patients. Further elucidation of how 
      drugs of abuse alter glutamatergic plasticity within the accumbens will be
      necessary for the development of new therapeutics for the treatment of addiction 
      across all classes of addictive substances.
FAU - Scofield, M. D.
AU  - Scofield MD
FAU - Heinsbroek, J. A.
AU  - Heinsbroek JA
FAU - Gipson, C. D.
AU  - Gipson CD
FAU - Kupchik, Y. M.
AU  - Kupchik YM
FAU - Spencer, S.
AU  - Spencer S
FAU - Smith, A. C. W.
AU  - Smith ACW
FAU - Roberts-Wolfe, D.
AU  - Roberts-Wolfe D
FAU - Kalivas, P. W.
AU  - Kalivas PW
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 201607
PHST- 2016/07 [aheadofprint]
TA  - Pharmacol Rev
JT  - Pharmacological Reviews
AID - PHARMREV_012484 [pii]
AID - 10.1124/pr.116.012484 [doi]
SO  - Pharmacol Rev. 2016 Jul;68(3):816-71. Epub 2016 Jul doi:10.1124/pr.116.012484.

PMC - PMC5207212
PMID- 24303859
IS  - 0003-2409 (Print)
IS  - 1365-2044 (Electronic)
VI  - 69
IP  - Suppl 1
DP  - 2014 Jan
TI  - Should general anaesthesia be avoided in the elderly?
PG  - 35-44
AB  - Surgery and anaesthesia exert comparatively greater adverse effects on the
      elderly than on the younger brain, manifest by the higher prevalence of
      postoperative delirium and cognitive dysfunction. Postoperative delirium and
      cognitive dysfunction delay rehabilitation, and are associated with increases in 
      morbidity and mortality among elderly surgical patients. We review the aetiology 
      of postoperative delirium and cognitive dysfunction in the elderly with a
      particular focus on anaesthesia and sedation, discuss methods of diagnosing and
      monitoring postoperative cognitive decline, and describe the treatment strategies
      by which such decline may be prevented.
FAU - Strøm, C.
AU  - Strøm C
AD  - Department of Anaesthesia, Centre of Head and Orthopaedics, Rigshospitalet,
      Copenhagen University Hospital, Copenhagen, Denmark
FAU - Rasmussen, L. S.
AU  - Rasmussen LS
AD  - Department of Anaesthesia, Centre of Head and Orthopaedics, Rigshospitalet,
      Copenhagen University Hospital, Copenhagen, Denmark
FAU - Sieber, F. E.
AU  - Sieber FE
AD  - Anaesthesiology, Department of Anaesthesiology/Critical Care Medicine, The Johns 
      Hopkins Medical Institutions, Baltimore, Maryland, USA
LA  - eng
PT  - Journal Article
TA  - Anaesthesia
JT  - Anaesthesia
AID - 10.1111/anae.12493 [doi]
MID - NIHMS568684
SO  - Anaesthesia. 2014 Jan;69(Suppl 1):35-44. doi:10.1111/anae.12493.

PMC - PMC2788507
PMID- 19951784
IS  - 1047-9651 (Print)
IS  - 1558-1381 (Electronic)
VI  - 21
IP  - 1
DP  - 2010 Feb
TI  - Neural Interface Technology for Rehabilitation: Exploiting and Promoting
      Neuroplasticity.
PG  - 157-78
FAU - Wang, Wei
AU  - Wang W
AD  - Department of Physical Medicine and Rehabilitation, University of Pittsburgh,
      Pittsburgh, PA, USA
FAU - Collinger, Jennifer L.
AU  - Collinger JL
AD  - Department of Physical Medicine and Rehabilitation, University of Pittsburgh,
      Pittsburgh, PA, USA
FAU - Perez, Monica A.
AU  - Perez MA
AD  - Department of Physical Medicine and Rehabilitation, University of Pittsburgh,
      Pittsburgh, PA, USA
FAU - Tyler-Kabara, Elizabeth C.
AU  - Tyler-Kabara EC
AD  - Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA
FAU - Cohen, Leonardo G.
AU  - Cohen LG
AD  - Human Cortical Physiology Section and Stroke Neurorehabilitation Section,
      National Institute of Neurological Disorders and Stroke (NINDS), NIH, Bethesda,
      MD, USA
FAU - Birbaumer, Niels
AU  - Birbaumer N
AD  - Institute of Medical Psychology and Behavioral Neurobiology, University of
      Tuebingen, Tuebingen, Germany
FAU - Brose, Steven W.
AU  - Brose SW
AD  - Department of Physical Medicine and Rehabilitation, University of Pittsburgh,
      Pittsburgh, PA, USA
FAU - Schwartz, Andrew B.
AU  - Schwartz AB
AD  - Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA
FAU - Boninger, Michael L.
AU  - Boninger ML
AD  - Department of Physical Medicine and Rehabilitation, University of Pittsburgh,
      Pittsburgh, PA, USA
FAU - Weber, Douglas J.
AU  - Weber DJ
AD  - Department of Physical Medicine and Rehabilitation, University of Pittsburgh,
      Pittsburgh, PA, USA
LA  - eng
PT  - Journal Article
TA  - Phys Med Rehabil Clin N Am
JT  - Physical medicine and rehabilitation clinics of North America
AID - 10.1016/j.pmr.2009.07.003 [doi]
MID - NIHMS136474
SO  - Phys Med Rehabil Clin N Am. 2010 Feb;21(1):157-78. doi:10.1016/j.pmr.2009.07.003.

PMC - PMC3774323
PMID- 18662461
IS  - 0140-525X (Print)
IS  - 1469-1825 (Electronic)
VI  - 31
IP  - 4
DP  - 2008 Aug
TI  - A unified framework for addiction: Vulnerabilities in the decision process.
PG  - 415-87
AB  - The understanding of decision-making systems has come together in recent years to
      form a unified theory of decision-making in the mammalian brain as arising from
      multiple, interacting systems (a planning system, a habit system, and a
      situation-recognition system). This unified decision-making system has multiple
      potential access points through which it can be driven to make maladaptive
      choices, particularly choices that entail seeking of certain drugs or behaviors. 
      We identify 10 key vulnerabilities in the system: (1) moving away from
      homeostasis, (2) changing allostatic set points, (3) euphorigenic “reward-like”
      signals, (4) overvaluation in the planning system, (5) incorrect search of
      situation-action-outcome relationships, (6) misclassification of situations, (7) 
      overvaluation in the habit system, (8) a mismatch in the balance of the two
      decision systems, (9) over-fast discounting processes, and (10) changed learning 
      rates. These vulnerabilities provide a taxonomy of potential problems with
      decision-making systems. Although each vulnerability can drive an agent to return
      to the addictive choice, each vulnerability also implies a characteristic
      symptomology. Different drugs, different behaviors, and different individuals are
      likely to access different vulnerabilities. This has implications for an
      individual’s susceptibility to addiction and the transition to addiction, for the
      potential for relapse, and for the potential for treatment.
FAU - Redish, A. David
AU  - Redish AD
AD  - Department of Neuroscience, University of Minnesota, Minneapolis, MN 55455,
      redish@umn.edu, http://umn.edu/~redish/
FAU - Jensen, Steve
AU  - Jensen S
AD  - Graduate Program in Computer Science, University of Minnesota, Minneapolis, MN
      55455, jens0491@umn.edu
FAU - Johnson, Adam
AU  - Johnson A
AD  - Graduate Program in Neuroscience and Center for Cognitive Sciences, University of
      Minnesota, Minneapolis, MN 55455, john5726@umn.edu
LA  - eng
PT  - Journal Article
GR  - T32 GM008471 || GM
TA  - Behav Brain Sci
JT  - The Behavioral and brain sciences
AID - 10.1017/S0140525X0800472X [doi]
MID - NIHMS490337
SO  - Behav Brain Sci. 2008 Aug;31(4):415-87. doi:10.1017/S0140525X0800472X.

PMC - PMC2748127
PMID- 19484833
IS  - 0002-8614 (Print)
IS  - 1532-5415 (Electronic)
VI  - 57
IP  - 5
DP  - 2009 May
TI  - Evidence-Based Recommendations for the Assessment and Management of Sleep
      Disorders in Older Persons.
PG  - 761-89
FAU - Bloom, Harrison G.
AU  - Bloom HG
AD  - International Longevity Center-USA and Brookdale Department of Geriatrics and
      Adult Development, Mount Sinai Medical School
FAU - Ahmed, Imran
AU  - Ahmed I
AD  - Albert Einstein College of Medicine
FAU - Alessi, Cathy A.
AU  - Alessi CA
AD  - UCLA David Geffen School of Medicine and GRECC, VA Greater Los Angeles Healthcare
      Systems
FAU - Ancoli-Israel, Sonia
AU  - Ancoli-Israel S
AD  - University of California San Diego, School of Medicine and Veterans Affairs San
      Diego Healthcare System
FAU - Buysse, Daniel J.
AU  - Buysse DJ
AD  - Neuroscience Clinical and Translational Center, University of Pittsburgh School
      of Medicine
FAU - Kryger, Meir H.
AU  - Kryger MH
AD  - Gaylord Sleep Center, Gaylord Hospital
FAU - Phillips, Barbara A.
AU  - Phillips BA
AD  - National Sleep Foundation and University of Kentucky College of Medicine
FAU - Thorpy, Michael J.
AU  - Thorpy MJ
AD  - Albert Einstein College of Medicine, Sleep-Wake Disorders Center-Montefiore
      Medical Center
FAU - Vitiello, Michael V.
AU  - Vitiello MV
AD  - NW Geriatric Education Center, University of Washington
FAU - Zee, Phyllis C.
AU  - Zee PC
AD  - Sleep Disorders Center, Northwestern University
LA  - eng
PT  - Journal Article
TA  - J Am Geriatr Soc
JT  - Journal of the American Geriatrics Society
MID - NIHMS138238
SO  - J Am Geriatr Soc. 2009 May;57(5):761-89.

PMC - PMC5054290
PMID- 27774054
IS  - 1662-5110 (Electronic)
VI  - 10
DP  - 2016
TI  - TMSEEG: A MATLAB-Based Graphical User Interface for Processing
      Electrophysiological Signals during Transcranial Magnetic Stimulation.
LID - 78
AB  - Concurrent recording of electroencephalography (EEG) during transcranial magnetic
      stimulation (TMS) is an emerging and powerful tool for studying brain health and 
      function. Despite a growing interest in adaptation of TMS-EEG across neuroscience
      disciplines, its widespread utility is limited by signal processing challenges.
      These challenges arise due to the nature of TMS and the sensitivity of EEG to
      artifacts that often mask TMS-evoked potentials (TEP)s. With an increase in the
      complexity of data processing methods and a growing interest in multi-site data
      integration, analysis of TMS-EEG data requires the development of a standardized 
      method to recover TEPs from various sources of artifacts. This article introduces
      TMSEEG, an open-source MATLAB application comprised of multiple algorithms
      organized to facilitate a step-by-step procedure for TMS-EEG signal processing.
      Using a modular design and interactive graphical user interface (GUI), this
      toolbox aims to streamline TMS-EEG signal processing for both novice and
      experienced users. Specifically, TMSEEG provides: (i) targeted removal of
      TMS-induced and general EEG artifacts; (ii) a step-by-step modular workflow with 
      flexibility to modify existing algorithms and add customized algorithms; (iii) a 
      comprehensive display and quantification of artifacts; (iv) quality control check
      points with visual feedback of TEPs throughout the data processing workflow; and 
      (v) capability to label and store a database of artifacts. In addition to these
      features, the software architecture of TMSEEG ensures minimal user effort in
      initial setup and configuration of parameters for each processing step. This is
      partly accomplished through a close integration with EEGLAB, a widely used
      open-source toolbox for EEG signal processing. In this article, we introduce
      TMSEEG, validate its features and demonstrate its application in extracting TEPs 
      across several single- and multi-pulse TMS protocols. As the first open-source
      GUI-based pipeline for TMS-EEG signal processing, this toolbox intends to promote
      the widespread utility and standardization of an emerging technology in brain
      research.
FAU - Atluri, Sravya
AU  - Atluri S
AD  - Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and
      Mental HealthToronto, ON, Canada
FAU - Frehlich, Matthew
AU  - Frehlich M
AD  - Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and
      Mental HealthToronto, ON, Canada
FAU - Mei, Ye
AU  - Mei Y
AD  - Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and
      Mental HealthToronto, ON, Canada
FAU - Garcia Dominguez, Luis
AU  - Garcia Dominguez L
AD  - Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and
      Mental HealthToronto, ON, Canada
FAU - Rogasch, Nigel C.
AU  - Rogasch NC
AD  - Brain and Mental Health Laboratory, School of Psychological Sciences and Monash
      Biomedical Imaging, Monash Institute of Cognitive and Clinical Neuroscience,
      Monash UniversityMelbourne, VIC, Australia
FAU - Wong, Willy
AU  - Wong W
AD  - Institute of Biomaterials and Biomedical Engineering, University of
      TorontoToronto, ON, Canada
FAU - Daskalakis, Zafiris J.
AU  - Daskalakis ZJ
AD  - Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and
      Mental HealthToronto, ON, Canada
FAU - Farzan, Faranak
AU  - Farzan F
AD  - Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and
      Mental HealthToronto, ON, Canada
LA  - eng
PT  - Journal Article
DEP - 20161007
GR  - RGPIN-2015-05783
PHST- 2016/06/09 [received]
PHST- 2016/09/20 [accepted]
TA  - Front Neural Circuits
JT  - Frontiers in Neural Circuits
AID - 10.3389/fncir.2016.00078 [doi]
SO  - Front Neural Circuits. 2016 Oct 07;10:. doi:10.3389/fncir.2016.00078.

PMC - PMC5259870
PMID- 28118856
IS  - 1745-6215 (Electronic)
VI  - 18
DP  - 2017
TI  - NIRS-based neurofeedback training in a virtual reality classroom for children
      with attention-deficit/hyperactivity disorder: study protocol for a randomized
      controlled trial.
LID - 41
AB  - Background: Children with attention-deficit/hyperactivity disorder (ADHD) suffer 
      from attention deficits, motor hyperactivity, and impulsive behaviour. These
      impairments are experienced at home, at school, and with friends. Functional
      imaging studies show that ADHD behaviour and impairments in executive functions
      (EFs) are mirrored by aberrant neurophysiological functioning. Moreover, several 
      studies show that ADHD behaviour, impairments in EFs, and a lack of self-control 
      contribute to poor school performance. Non-pharmacological interventions such as 
      neurofeedback training (NFT), for instance, aim at improving neurophysiological
      and neuropsychological functioning as well as behaviour. Consequently, NFT is
      expected to improve school performance, EFs, and self-control in children with
      ADHD. Generalization of acquired self-regulation skills from laboratory to real
      life is crucial for a transfer to everyday situations and is hypothesized to be
      facilitated via training using virtual reality (VR) environments. Consequently,
      experiencing NFT in VR is expected to yield greater effects than training in two 
      dimensions (2D). Methods/design: Ninety children with a clinical diagnosis of
      ADHD will be included in the study. Participants may be medicated or unmedicated.
      After random assignation to one of three conditions, all participants receive 15 
      training sessions of either near-infrared spectroscopy (NIRS)-based NFT in VR,
      NIRS-based NFT in 2D, or electromyogram-based biofeedback training in VR. ADHD
      symptoms, self-control, EF, health-related quality of life, school performance,
      and motor activity measured via parent, teacher, and child reports or objectively
      will be assessed before and after the intervention and at a 6 months follow-up.
      Furthermore, we are interested in parents’ expectations about the training’s
      effects. Discussion: This is, to our knowledge, the first study investigating the
      efficacy of NFT for children with ADHD in a VR compared to a 2D environment.
      Furthermore, this study will contribute to the discussion about the efficacy and 
      specific and unspecific effects of NFTs in children with ADHD. In addition to
      commonly assessed variables such as ADHD symptoms, NIRS and behavioural data
      obtained in EF measures, health-related quality of life, and parents’
      expectations about the intervention’s effects, this study will investigate the
      effects on self-control, school performance, and motor activity. Trial
      registration: ClinicalTrials.gov, NCT02572180. Registered on 19 November 2015.
      Electronic supplementary material: The online version of this article
      (doi:10.1186/s13063-016-1769-3) contains supplementary material, which is
      available to authorized users.
FAU - Blume, Friederike
AU  - Blume F
AUID- ORCID: 0000-0003-3334-5366
AD  - 0000 0001 2190 1447grid.10392.39LEAD Graduate School & Research Network,
      University of Tübingen, Gartenstrasse 29, 72074 Tübingen, Germany
FAU - Hudak, Justin
AU  - Hudak J
AD  - 0000 0001 2190 1447grid.10392.39LEAD Graduate School & Research Network,
      University of Tübingen, Gartenstrasse 29, 72074 Tübingen, Germany
FAU - Dresler, Thomas
AU  - Dresler T
AD  - 0000 0001 2190 1447grid.10392.39LEAD Graduate School & Research Network,
      University of Tübingen, Gartenstrasse 29, 72074 Tübingen, Germany
FAU - Ehlis, Ann-Christine
AU  - Ehlis AC
AD  - 0000 0001 2190 1447grid.10392.39Department of Psychiatry and Psychotherapy,
      University of Tübingen, Calwerstrasse 14, 72076 Tübingen, Germany
FAU - Kühnhausen, Jan
AU  - Kühnhausen J
AD  - 0000 0001 2190 1447grid.10392.39LEAD Graduate School & Research Network,
      University of Tübingen, Gartenstrasse 29, 72074 Tübingen, Germany
FAU - Renner, Tobias J.
AU  - Renner TJ
AD  - 0000 0001 2190 1447grid.10392.39LEAD Graduate School & Research Network,
      University of Tübingen, Gartenstrasse 29, 72074 Tübingen, Germany
FAU - Gawrilow, Caterina
AU  - Gawrilow C
AD  - 0000 0001 2190 1447grid.10392.39LEAD Graduate School & Research Network,
      University of Tübingen, Gartenstrasse 29, 72074 Tübingen, Germany
LA  - eng
PT  - Journal Article
DEP - 20170124
GR  - GSC1028
PHST- 2016/06/30 [received]
PHST- 2016/12/21 [accepted]
TA  - Trials
JT  - Trials
AID - 1769 [pii]
AID - 10.1186/s13063-016-1769-3 [doi]
SO  - Trials. 2017 Jan 24;18:. doi:10.1186/s13063-016-1769-3.

PMC - PMC4648295
PMID- 26135716
IS  - 1050-9631 (Print)
IS  - 1098-1063 (Electronic)
VI  - 25
IP  - 10
DP  - 2015 Oct
TI  - Hippocampal sharp wave‐ripple: A cognitive biomarker for episodic memory and
      planning.
PG  - 1073-188
AB  - Sharp wave ripples (SPW‐Rs) represent the most synchronous population pattern in 
      the mammalian brain. Their excitatory output affects a wide area of the cortex
      and several subcortical nuclei. SPW‐Rs occur during “off‐line” states of the
      brain, associated with consummatory behaviors and non‐REM sleep, and are
      influenced by numerous neurotransmitters and neuromodulators. They arise from the
      excitatory recurrent system of the CA3 region and the SPW‐induced excitation
      brings about a fast network oscillation (ripple) in CA1. The spike content of
      SPW‐Rs is temporally and spatially coordinated by a consortium of interneurons to
      replay fragments of waking neuronal sequences in a compressed format. SPW‐Rs
      assist in transferring this compressed hippocampal representation to distributed 
      circuits to support memory consolidation; selective disruption of SPW‐Rs
      interferes with memory. Recently acquired and pre‐existing information are
      combined during SPW‐R replay to influence decisions, plan actions and,
      potentially, allow for creative thoughts. In addition to the widely studied
      contribution to memory, SPW‐Rs may also affect endocrine function via activation 
      of hypothalamic circuits. Alteration of the physiological mechanisms supporting
      SPW‐Rs leads to their pathological conversion, “p‐ripples,” which are a marker of
      epileptogenic tissue and can be observed in rodent models of schizophrenia and
      Alzheimer's Disease. Mechanisms for SPW‐R genesis and function are discussed in
      this review. © 2015 The Authors Hippocampus Published by Wiley Periodicals, Inc.
FAU - Buzsáki, György
AU  - Buzsáki G
AD  - The Neuroscience Institute, School of Medicine and Center for Neural Science, New
      York UniversityNew YorkNew York
LA  - eng
PT  - Journal Article
DEP - 20150926
GR  - NS075015
GR  - SBE 0542013
PHST- 2015/06/26 [received]
PHST- 2015/06/30 [accepted]
TA  - Hippocampus
JT  - Hippocampus
AID - 10.1002/hipo.22488 [doi]
AID - HIPO22488 [pii]
SO  - Hippocampus. 2015 Oct;25(10):1073-188. Epub 2015 Sep 26 doi:10.1002/hipo.22488.

PMC - PMC5102531
PMID- 27867700
IS  - 2156-7085 (Electronic)
VI  - 7
IP  - 10
DP  - 2016 Oct 01
TI  - Mental stress assessment using simultaneous measurement of EEG and fNIRS.
PG  - 3882-98
AB  - Previous studies reported mental stress as one of the major contributing factors 
      leading to various diseases such as heart attack, depression and stroke. An
      accurate stress assessment method may thus be of importance to clinical
      intervention and disease prevention. We propose a joint independent component
      analysis (jICA) based approach to fuse simultaneous measurement of
      electroencephalography (EEG) and functional near-infrared spectroscopy (fNIRS) on
      the prefrontal cortex (PFC) as a means of stress assessment. For the purpose of
      this study, stress was induced by using an established mental arithmetic task
      under time pressure with negative feedback. The induction of mental stress was
      confirmed by salivary alpha amylase test. Experiment results showed that the
      proposed fusion of EEG and fNIRS measurements improves the classification
      accuracy of mental stress by +3.4% compared to EEG alone and +11% compared to
      fNIRS alone. Similar improvements were also observed in sensitivity and
      specificity of proposed approach over unimodal EEG/fNIRS. Our study suggests that
      combination of EEG (frontal alpha rhythm) and fNIRS (concentration change of
      oxygenated hemoglobin) could be a potential means to assess mental stress
      objectively.
FAU - Al-Shargie, Fares
AU  - Al-Shargie F
AD  - Universiti Teknologi PETRONAS, Centre of Intelligent Signal and Imaging Research,
      Department of Electrical and Electronic Engineering, 32610 Bandar Seri Iskandar, 
      Perak, Malaysia
FAU - Kiguchi, Masashi
AU  - Kiguchi M
AD  - Hitachi, Ltd., Research & Development Group, 350-0395, Japan
FAU - Badruddin, Nasreen
AU  - Badruddin N
AD  - Universiti Teknologi PETRONAS, Centre of Intelligent Signal and Imaging Research,
      Department of Electrical and Electronic Engineering, 32610 Bandar Seri Iskandar, 
      Perak, Malaysia
FAU - Dass, Sarat C.
AU  - Dass SC
AD  - Universiti Teknologi PETRONAS, Centre of Intelligent Signal and Imaging Research,
      Department of Electrical and Electronic Engineering, 32610 Bandar Seri Iskandar, 
      Perak, Malaysia
FAU - Hani, Ahmad Fadzil Mohammad
AU  - Hani AFM
AD  - Universiti Teknologi PETRONAS, Centre of Intelligent Signal and Imaging Research,
      Department of Electrical and Electronic Engineering, 32610 Bandar Seri Iskandar, 
      Perak, Malaysia
FAU - Tang, Tong Boon
AU  - Tang TB
AD  - Universiti Teknologi PETRONAS, Centre of Intelligent Signal and Imaging Research,
      Department of Electrical and Electronic Engineering, 32610 Bandar Seri Iskandar, 
      Perak, Malaysia
LA  - eng
PT  - Journal Article
DEP - 20160906
GR  - HiCOE Scheme
PHST- 2016/06/17 [received]
PHST- 2016/08/25 [revised]
PHST- 2016/08/28 [accepted]
TA  - Biomed Opt Express
JT  - Biomedical Optics Express
AID - 268614 [pii]
AID - 10.1364/BOE.7.003882 [doi]
SO  - Biomed Opt Express. 2016 Sep 06;7(10):3882-98. doi:10.1364/BOE.7.003882.

PMC - PMC1933387
PMID- 16890291
IS  - 0149-7634 (Print)
VI  - 30
IP  - 8
DP  - 2006
TI  - Development of structure and function in the infant brain: Implications for
      cognition, language and social behaviour.
PG  - 1087-105
AB  - Recent advances in cognitive neuroscience have allowed us to begin investigating 
      the development of both structure and function in the infant brain. However,
      despite the rapid evolution of technology, surprisingly few studies have examined
      the intersection between brain and behaviour over the first years of life. Even
      fewer have done so in the context of a particular research question. This paper
      aims to provide an overview of four domains that have been studied using
      techniques amenable to elucidating the brain/behaviour interface: language, face 
      processing, object permanence, and joint attention, with particular emphasis on
      studies focusing on early development. The importance of the unique role of
      development and the interplay between structure and function is stressed
      throughout. It is hoped that this review will serve as a catalyst for further
      thinking about the substantial gaps in our understanding of the relationship
      between brain and behaviour across development. Further, our aim is to provide
      ideas about candidate brain areas that are likely to be implicated in particular 
      behaviours or cognitive domains.
FAU - Paterson, Sarah J.
AU  - Paterson SJ
AD  - Child Study Center, Yale University School of Medicine, 230 South Frontage Rd,
      New Haven, CT 06520–7900, USA
FAU - Heim, Sabine
AU  - Heim S
AD  - Department of Psychology, University of Konstanz, Germany
FAU - Friedman, Jennifer Thomas
AU  - Friedman JT
AD  - Infancy Studies Laboratory, Center for Molecular and Behavioral Neuroscience,
      Rutgers University, Newark, NJ, USA
FAU - Choudhury, Naseem
AU  - Choudhury N
AD  - Infancy Studies Laboratory, Center for Molecular and Behavioral Neuroscience,
      Rutgers University, Newark, NJ, USA
FAU - Benasich, April A.
AU  - Benasich AA
AD  - Infancy Studies Laboratory, Center for Molecular and Behavioral Neuroscience,
      Rutgers University, Newark, NJ, USA
LA  - eng
PT  - Journal Article
DEP - 20060804
TA  - Neurosci Biobehav Rev
JT  - Neuroscience and biobehavioral reviews
AID - 10.1016/j.neubiorev.2006.05.001 [doi]
MID - NIHMS22678
SO  - Neurosci Biobehav Rev. 2006;30(8):1087-105. Epub 2006 Aug 4
      doi:10.1016/j.neubiorev.2006.05.001.

PMC - PMC2799007
IS  - 0342-4642 (Print)
IS  - 1432-1238 (Electronic)
VI  - 34
IP  - Suppl 1
DP  - 2008 Sep
TI  - 21st ESICM Annual Congress.
PG  - 181-268
LA  - eng
PT  - Journal Article
DEP - 20080808
TA  - Intensive Care Med
JT  - Intensive Care Medicine
AID - 1240 [pii]
AID - 10.1007/s00134-008-1240-3 [doi]
SO  - Intensive Care Med. 2008 Sep;34(Suppl 1):181-268. Epub 2008 Aug 8
      doi:10.1007/s00134-008-1240-3.

PMC - PMC2949710
PMID- 20860808
IS  - 1743-0003 (Electronic)
VI  - 7
DP  - 2010
TI  - Neurorehabilitation using the virtual reality based Rehabilitation Gaming System:
      methodology, design, psychometrics, usability and validation.
PG  - 48
AB  - Background: Stroke is a frequent cause of adult disability that can lead to
      enduring impairments. However, given the life-long plasticity of the brain one
      could assume that recovery could be facilitated by the harnessing of mechanisms
      underlying neuronal reorganization. Currently it is not clear how this
      reorganization can be mobilized. Novel technology based neurorehabilitation
      techniques hold promise to address this issue. Here we describe a Virtual Reality
      (VR) based system, the Rehabilitation Gaming System (RGS) that is based on a
      number of hypotheses on the neuronal mechanisms underlying recovery, the
      structure of training and the role of individualization. We investigate the
      psychometrics of the RGS in stroke patients and healthy controls. Methods: We
      describe the key components of the RGS and the psychometrics of one
      rehabilitation scenario called Spheroids. We performed trials with 21
      acute/subacute stroke patients and 20 healthy controls to study the effect of the
      training parameters on task performance. This allowed us to develop a
      Personalized Training Module (PTM) for online adjustment of task difficulty. In
      addition, we studied task transfer between physical and virtual environments.
      Finally, we assessed the usability and acceptance of the RGS as a rehabilitation 
      tool. Results: We show that the PTM implemented in RGS allows us to effectively
      adjust the difficulty and the parameters of the task to the user by capturing
      specific features of the movements of the arms. The results reported here also
      show a consistent transfer of movement kinematics between physical and virtual
      tasks. Moreover, our usability assessment shows that the RGS is highly accepted
      by stroke patients as a rehabilitation tool. Conclusions: We introduce a novel VR
      based paradigm for neurorehabilitation, RGS, which combines specific
      rehabilitative principles with a psychometric evaluation to provide a
      personalized and automated training. Our results show that the RGS effectively
      adjusts to the individual features of the user, allowing for an unsupervised
      deployment of individualized rehabilitation protocols.
FAU - Cameirão, Mónica S
AU  - Cameirão MS
AD  - Laboratory of Synthetic Perceptive Emotive and Cognitive Systems (SPECS),
      Department of Technology, Universitat Pompeu Fabra, Edifici la Nau, Roc Boronat
      138, 08018 Barcelona, Spain
FAU - Badia, Sergi Bermúdez i
AU  - Badia SBi
AD  - Laboratory of Synthetic Perceptive Emotive and Cognitive Systems (SPECS),
      Department of Technology, Universitat Pompeu Fabra, Edifici la Nau, Roc Boronat
      138, 08018 Barcelona, Spain
FAU - Oller, Esther Duarte
AU  - Oller ED
AD  - Servei de Medicina Física i Rehabilitació, Hospital de L'Esperança, Barcelona,
      Spain
FAU - Verschure, Paul FMJ
AU  - Verschure PF
AD  - Laboratory of Synthetic Perceptive Emotive and Cognitive Systems (SPECS),
      Department of Technology, Universitat Pompeu Fabra, Edifici la Nau, Roc Boronat
      138, 08018 Barcelona, Spain
LA  - eng
PT  - Journal Article
DEP - 20100922
PHST- 2010/03/16 [received]
PHST- 2010/09/22 [accepted]
TA  - J Neuroeng Rehabil
JT  - Journal of NeuroEngineering and Rehabilitation
AID - 1743-0003-7-48 [pii]
AID - 10.1186/1743-0003-7-48 [doi]
SO  - J Neuroeng Rehabil. 2010 Sep 22;7:48. doi:10.1186/1743-0003-7-48.

PMC - PMC5421260
PMID- 28540125
IS  - 2229-5097 (Print)
IS  - 2152-7806 (Electronic)
VI  - 8
DP  - 2017
TI  - PROJECT HEAVEN: Preoperative Training in Virtual Reality.
LID - 59
AB  - A cephalosomatic anastomosis (CSA; also called HEAVEN: head anastomosis venture) 
      has been proposed as an option for patients with neurological impairments, such
      as spinal cord injury (SCI), and terminal medical illnesses, for which medicine
      is currently powerless. Protocols to prepare a patient for life after CSA do not 
      currently exist. However, methods used in conventional neurorehabilitation can be
      used as a reference for developing preparatory training. Studies on virtual
      reality (VR) technologies have documented VR's ability to enhance rehabilitation 
      and improve the quality of recovery in patients with neurological disabilities.
      VR-augmented rehabilitation resulted in increased motivation towards performing
      functional training and improved the biopsychosocial state of patients. In
      addition, VR experiences coupled with haptic feedback promote neuroplasticity,
      resulting in the recovery of motor functions in neurologically-impaired
      individuals. To prepare the recipient psychologically for life after CSA, the
      development of VR experiences paired with haptic feedback is proposed. This
      proposal aims to innovate techniques in conventional neurorehabilitation to
      implement preoperative psychological training for the recipient of HEAVEN.
      Recipient's familiarity to body movements will prevent unexpected psychological
      reactions from occurring after the HEAVEN procedure.
FAU - Iamsakul, Kiratipath
AU  - Iamsakul K
AD  - Department of Biomedical Engineering, Inventum Bioengineering Technologies, LLC, 
      Chicago, Illinois, USA
FAU - Pavlovcik, Alexander V.
AU  - Pavlovcik AV
AD  - Department of Biomedical Engineering, Inventum Bioengineering Technologies, LLC, 
      Chicago, Illinois, USA
FAU - Calderon, Jesus I.
AU  - Calderon JI
AD  - Department of Biomedical Engineering, Inventum Bioengineering Technologies, LLC, 
      Chicago, Illinois, USA
FAU - Sanderson, Lance M.
AU  - Sanderson LM
AD  - Department of Biomedical Engineering, Inventum Bioengineering Technologies, LLC, 
      Chicago, Illinois, USA
LA  - eng
PT  - Journal Article
DEP - 20170426
PHST- 2016/09/14 [received]
PHST- 2017/01/10 [accepted]
TA  - Surg Neurol Int
JT  - Surgical Neurology International
AID - SNI-8-59 [pii]
AID - 10.4103/sni.sni_371_16 [doi]
SO  - Surg Neurol Int. 2017 Apr 26;8:. doi:10.4103/sni.sni_371_16.

PMC - PMC4777049
PMID- 22980147
IS  - 1916-9736 (Print)
IS  - 1916-9744 (Electronic)
VI  - 4
IP  - 2
DP  - 2012 Mar
TI  - Design Principles to Accommodate Older Adults.
PG  - 2-25
AB  - The global population is aging. In many industrial countries, almost one in five 
      people are over age 65. As people age, gradual changes ensue in vision, hearing, 
      balance, coordination, and memory. Products, communication materials, and the
      physical environment must be thoughtfully designed to meet the needs of people of
      all ages. This article summarizes normal changes in sensory function, mobility,
      balance, memory, and attention that occur with age. It presents practical
      guidelines that allow design professionals to accommodate these changes and
      better meet the needs of older adults. Designing for older adults is inclusive
      design: it accommodates a range of physical and cognitive abilities and promotes 
      simplicity, flexibility, and ease of use for people of any age.
FAU - Farage, Miranda A.
AU  - Farage MA
AD  - Feminine Care Innovation Center, The Procter & Gamble Company 6110 Center Hill
      Rd, Cincinnati, OH 45224, USA Tel: 513-634-5594 E-mail: farage.m@pg.com
FAU - Miller, Kenneth W.
AU  - Miller KW
AD  - The Procter and Gamble Company, Cincinnati, OH USA E-mail: miller.kw@pg.com
FAU - Ajayi, Funmi
AU  - Ajayi F
AD  - The Procter and Gamble Company, Cincinnati, OH USA E-mail: Ajayi.fo@pg.com
FAU - Hutchins, Deborah
AU  - Hutchins D
AD  - Hutchins & Associates LLC, Cincinnati, OH USA E-mail: hutchinsda@fuse.net
LA  - eng
PT  - Journal Article
DEP - 20120301
PHST- 2012/01/11 [received]
PHST- 2012/01/28 [accepted]
PHST- 2012/03/01 [aheadofprint]
TA  - Glob J Health Sci
JT  - Global Journal of Health Science
AID - GJHS-4-2 [pii]
AID - 10.5539/gjhs.v4n2p2 [doi]
SO  - Glob J Health Sci. 2012 Mar;4(2):2-25. Epub 2012 Mar 01 doi:10.5539/gjhs.v4n2p2.

PMC - PMC3776942
PMID- 24065903
IS  - 1662-5161 (Electronic)
VI  - 7
DP  - 2013
TI  - Towards the integration of mental practice in rehabilitation programs. A critical
      review.
LID - 576
AB  - Many clinical studies have investigated the use of mental practice (MP) through
      motor imagery (MI) to enhance functional recovery of patients with diverse
      physical disabilities. Although beneficial effects have been generally reported
      for training motor functions in persons with chronic stroke (e.g., reaching,
      writing, walking), attempts to integrate MP within rehabilitation programs have
      been met with mitigated results. These findings have stirred further questioning 
      about the value of MP in neurological rehabilitation. In fact, despite abundant
      systematic reviews, which customarily focused on the methodological merits of
      selected studies, several questions about factors underlying observed effects
      remain to be addressed. This review discusses these issues in an attempt to
      identify factors likely to hamper the integration of MP within rehabilitation
      programs. First, the rationale underlying the use of MP for training motor
      function is briefly reviewed. Second, three modes of MI delivery are proposed
      based on the analysis of the research protocols from 27 studies in persons with
      stroke and Parkinson's disease. Third, for each mode of MI delivery, a general
      description of MI training is provided. Fourth, the review discusses factors
      influencing MI training outcomes such as: the adherence to MI training, the
      amount of training and the interaction between physical and mental rehearsal; the
      use of relaxation, the selection of reliable, valid and sensitive outcome
      measures, the heterogeneity of the patient groups, the selection of patients and 
      the mental rehearsal procedures. To conclude, the review proposes a framework for
      integrating MP in rehabilitation programs and suggests research targets for
      steering the implementation of MP in the early stages of the rehabilitation
      process. The challenge has now shifted towards the demonstration that MI training
      can enhance the effects of regular therapy in persons with subacute stroke during
      the period of spontaneous recovery.
FAU - Malouin, Francine
AU  - Malouin F
AD  - Département de Réadaptation, Faculté de Médecine, Université LavalQuébec, QC,
      Canada
FAU - Jackson, Philip L.
AU  - Jackson PL
AD  - Centre Interdisciplinaire de Recherche en Réadaptation et Intégration
      SocialeQuébec, QC, Canada
FAU - Richards, Carol L.
AU  - Richards CL
AD  - Département de Réadaptation, Faculté de Médecine, Université LavalQuébec, QC,
      Canada
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20130919
PHST- 2013/05/31 [received]
PHST- 2013/08/28 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2013.00576 [doi]
SO  - Front Hum Neurosci. 2013 Sep 19;7:. doi:10.3389/fnhum.2013.00576.

PMC - PMC4712702
PMID- 26778939
IS  - 1569-1101 (Print)
VI  - 12
IP  - 1
DP  - 2013 Jan 1
TI  - Preliminary evidence for the feasibility of at-home online cognitive training
      with older adults.
PG  - 26-35
AB  - Increased levels of cognitive activity may improve general cognitive function in 
      older adults and potentially increase cognitive reserve, protecting against the
      onset of dementia associated with syndromes like Alzheimer's disease. To test the
      efficacy of cognitive training administered online, 18 participants (11
      cognitively healthy; 7 mild cognitive impairment) were recruited from a clinical 
      population of older adults to complete an online training intervention
      (CogniFit™). Before and after training, participants completed a separate battery
      of assessment measures, including measures of quality of life and competency at
      everyday activities, as well as a series of tests assessing cognitive function.
      Participants generally adhered to the online training protocol and completed a
      computerized assessment battery pre- and post-training. However, participants
      with mild cognitive impairment (MCI) were somewhat less likely to adhere to the
      protocol, suggesting that more direct contact is needed with this population in
      intervention research. Furthermore, participants demonstrated significant
      improvement on a measure of working memory and also in processing speed across
      several assessments, though these data are tentative, as no control data exist.
      These results, along with the generally good adherence observed, suggest that
      online cognitive training is feasible for this population and a potentially
      valuable tool for the wider dissemination of cognitive training.
FAU - Gigler, Kathryn L.
AU  - Gigler KL
AD  - Department of Psychology, Northwestern University, Evanston, IL, USA
FAU - Blomeke, Kelsey
AU  - Blomeke K
AD  - Department of Psychology, University of Notre Dame, South Bend, IN, USA
FAU - Shatil, Evelyn
AU  - Shatil E
AD  - CogniFit™ Research, New York, NY, USA
FAU - Weintraub, Sandra
AU  - Weintraub S
AD  - Department of Psychiatry and Behavioral Sciences, Cognitive Neurology and
      Alzheimer's Disease Center, Northwestern University, Evanston, IL, USA
FAU - Reber, Paul J.
AU  - Reber PJ
AD  - Department of Psychology, Northwestern University, Evanston, IL, USA
LA  - eng
PT  - Journal Article
TA  - Gerontechnology
JT  - Gerontechnology : international journal on the fundamental aspects of technology 
      to serve the ageing society
AID - 10.4017/gt.2013.12.1.007.00 [doi]
MID - NIHMS724044
SO  - Gerontechnology. 2013 Jan 1;12(1):26-35. doi:10.4017/gt.2013.12.1.007.00.

PMC - PMC4280043
PMID- 25495889
IS  - 1743-0003 (Electronic)
VI  - 11
DP  - 2014
TI  - Home-based Computer Assisted Arm Rehabilitation (hCAAR) robotic device for upper 
      limb exercise after stroke: results of a feasibility study in home setting.
LID - 163
AB  - Background: Home-based robotic technologies may offer the possibility of
      self-directed upper limb exercise after stroke as a means of increasing the
      intensity of rehabilitation treatment. The current literature has a paucity of
      robotic devices that have been tested in a home environment. The aim of this
      research project was to evaluate a robotic device Home-based Computer Assisted
      Arm Rehabilitation (hCAAR) that can be used independently at home by stroke
      survivors with upper limb weakness. Methods: hCAAR device comprises of a joystick
      handle moved by the weak upper limb to perform tasks on the computer screen. The 
      device provides assistance to the movements depending on users ability. Nineteen 
      participants (stroke survivors with upper limb weakness) were recruited. Outcome 
      measures performed at baseline (A0), at end of 8-weeks of hCAAR use (A1) and
      1 month after end of hCAAR use (A2) were: Optotrak kinematic variables, Fugl
      Meyer Upper Extremity motor subscale (FM-UE), Action Research Arm Test (ARAT),
      Medical Research Council (MRC) and Modified Ashworth Scale (MAS), Chedoke Arm and
      Hand Activity Inventory (CAHAI) and ABILHAND. Results: Two participants were
      unable to use hCAAR: one due to severe paresis and the other due to personal
      problems. The remaining 17 participants were able to use the device independently
      in their home setting. No serious adverse events were reported. The median usage 
      time was 433 minutes (IQR 250 – 791 min). A statistically significant improvement
      was observed in the kinematic and clinical outcomes at A1. The median gain in the
      scores at A1 were by: movement time 19%, path length 15% and jerk 19%, FM-UE 1
      point, total MAS 1.5 point, total MRC 2 points, ARAT 3 points, CAHAI 5.5 points
      and ABILHAND 3 points. Three participants showed clinically significant
      improvement in all the clinical outcomes. Conclusions: The hCAAR feasibility
      study is the first clinical study of its kind reported in the current literature;
      in this study, 17 participants used the robotic device independently for eight
      weeks in their own homes with minimal supervision from healthcare professionals. 
      Statistically significant improvements were observed in the kinematic and
      clinical outcomes in the study. Electronic supplementary material: The online
      version of this article (doi:10.1186/1743-0003-11-163) contains supplementary
      material, which is available to authorized users.
FAU - Sivan, Manoj
AU  - Sivan M
AD  - Academic Department of Rehabilitation Medicine, University of Leeds, Leeds, LS1
      3EX UK
FAU - Gallagher, Justin
AU  - Gallagher J
AD  - School of Mechanical Engineering, University of Leeds, Leeds, LS1 3EX UK
FAU - Makower, Sophie
AU  - Makower S
AD  - Academic Department of Rehabilitation Medicine, University of Leeds, Leeds, LS1
      3EX UK
FAU - Keeling, David
AU  - Keeling D
AD  - School of Mechanical Engineering, University of Leeds, Leeds, LS1 3EX UK
FAU - Bhakta, Bipin
AU  - Bhakta B
AD  - Academic Department of Rehabilitation Medicine, University of Leeds, Leeds, LS1
      3EX UK
FAU - O’Connor, Rory J
AU  - O’Connor RJ
AD  - Academic Department of Rehabilitation Medicine, University of Leeds, Leeds, LS1
      3EX UK
FAU - Levesley, Martin
AU  - Levesley M
AD  - School of Mechanical Engineering, University of Leeds, Leeds, LS1 3EX UK
LA  - eng
PT  - Journal Article
DEP - 20141212
PHST- 2014/08/26 [received]
PHST- 2014/12/05 [accepted]
TA  - J Neuroeng Rehabil
JT  - Journal of NeuroEngineering and Rehabilitation
AID - 686 [pii]
AID - 10.1186/1743-0003-11-163 [doi]
SO  - J Neuroeng Rehabil. 2014 Dec 12;11:. doi:10.1186/1743-0003-11-163.

PMC - PMC1422600
PMID- 12368674
IS  - 0003-4932 (Print)
IS  - 1528-1140 (Electronic)
VI  - 236
IP  - 4
DP  - 2002 Oct
TI  - Virtual Reality Training Improves Operating Room Performance: Results of a
      Randomized, Double-Blinded Study.
PG  - 458-64
AB  - Objective: To demonstrate that virtual reality (VR) training transfers technical 
      skills to the operating room (OR) environment. Summary Background Data: The use
      of VR surgical simulation to train skills and reduce error risk in the OR has
      never been demonstrated in a prospective, randomized, blinded study. Methods:
      Sixteen surgical residents (PGY 1–4) had baseline psychomotor abilities assessed,
      then were randomized to either VR training (MIST VR simulator diathermy task)
      until expert criterion levels established by experienced laparoscopists were
      achieved (n = 8), or control non-VR-trained (n = 8). All subjects performed
      laparoscopic cholecystectomy with an attending surgeon blinded to training
      status. Videotapes of gallbladder dissection were reviewed independently by two
      investigators blinded to subject identity and training, and scored for eight
      predefined errors for each procedure minute (interrater reliability of error
      assessment r > 0.80). Results: No differences in baseline assessments were found 
      between groups. Gallbladder dissection was 29% faster for VR-trained residents.
      Non-VR-trained residents were nine times more likely to transiently fail to make 
      progress (P < .007, Mann-Whitney test) and five times more likely to injure the
      gallbladder or burn nontarget tissue (chi-square = 4.27, P < .04). Mean errors
      were six times less likely to occur in the VR-trained group (1.19 vs. 7.38 errors
      per case;P < .008, Mann-Whitney test). Conclusions: The use of VR surgical
      simulation to reach specific target criteria significantly improved the OR
      performance of residents during laparoscopic cholecystectomy. This validation of 
      transfer of training skills from VR to OR sets the stage for more sophisticated
      uses of VR in assessment, training, error reduction, and certification of
      surgeons.
FAU - Seymour, Neal E.
AU  - Seymour NE
AD  - From the *Department of Surgery, Yale University School of Medicine, New Haven,
      Connecticut, U.S.A., and the †Department of Psychology, Queens University,
      Belfast, Northern Ireland, U.K.
FAU - Gallagher, Anthony G.
AU  - Gallagher AG
AD  - From the *Department of Surgery, Yale University School of Medicine, New Haven,
      Connecticut, U.S.A., and the †Department of Psychology, Queens University,
      Belfast, Northern Ireland, U.K.
FAU - Roman, Sanziana A.
AU  - Roman SA
AD  - From the *Department of Surgery, Yale University School of Medicine, New Haven,
      Connecticut, U.S.A., and the †Department of Psychology, Queens University,
      Belfast, Northern Ireland, U.K.
FAU - O’Brien, Michael K.
AU  - O’Brien MK
AD  - From the *Department of Surgery, Yale University School of Medicine, New Haven,
      Connecticut, U.S.A., and the †Department of Psychology, Queens University,
      Belfast, Northern Ireland, U.K.
FAU - Bansal, Vipin K.
AU  - Bansal VK
AD  - From the *Department of Surgery, Yale University School of Medicine, New Haven,
      Connecticut, U.S.A., and the †Department of Psychology, Queens University,
      Belfast, Northern Ireland, U.K.
FAU - Andersen, Dana K.
AU  - Andersen DK
AD  - From the *Department of Surgery, Yale University School of Medicine, New Haven,
      Connecticut, U.S.A., and the †Department of Psychology, Queens University,
      Belfast, Northern Ireland, U.K.
FAU - Satava, Richard M.
AU  - Satava RM
AD  - From the *Department of Surgery, Yale University School of Medicine, New Haven,
      Connecticut, U.S.A., and the †Department of Psychology, Queens University,
      Belfast, Northern Ireland, U.K.
LA  - eng
PT  - Journal Article
TA  - Ann Surg
JT  - Annals of Surgery
AID - 0000658-200210000-00008 [pii]
SO  - Ann Surg. 2002 Oct;236(4):458-64.

PMC - PMC5123381
IS  - 2051-1426 (Electronic)
VI  - 4
IP  - Suppl 1
DP  - 2016
TI  - 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of
      Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016.
PG  - 107-221
FAU - Ager, Casey
AU  - Ager C
AD  - Department of Immunology, University of Texas MD Anderson Cancer Center, Houston,
      TX USA
FAU - Reilley, Matthew
AU  - Reilley M
AD  - Department of Cancer Medicine, University of Texas MD Anderson Cancer Center,
      Houston, TX USA
FAU - Nicholas, Courtney
AU  - Nicholas C
AD  - Department of Immunology, University of Texas MD Anderson Cancer Center, Houston,
      TX USA
FAU - Bartkowiak, Todd
AU  - Bartkowiak T
AD  - Department of Immunology, University of Texas MD Anderson Cancer Center, Houston,
      TX USA
FAU - Jaiswal, Ashvin
AU  - Jaiswal A
AD  - Department of Immunology, University of Texas MD Anderson Cancer Center, Houston,
      TX USA
FAU - Curran, Michael
AU  - Curran M
AD  - Department of Immunology, University of Texas MD Anderson Cancer Center, Houston,
      TX USA
FAU - Albershardt, Tina C.
AU  - Albershardt TC
AD  - Immune Design, Seattle, WA USA
FAU - Bajaj, Anshika
AU  - Bajaj A
AD  - Immune Design, Seattle, WA USA
FAU - Archer, Jacob F.
AU  - Archer JF
AD  - Immune Design, Seattle, WA USA
FAU - Reeves, Rebecca S.
AU  - Reeves RS
AD  - Immune Design, Seattle, WA USA
FAU - Ngo, Lisa Y.
AU  - Ngo LY
AD  - Immune Design, Seattle, WA USA
FAU - Berglund, Peter
AU  - Berglund P
AD  - Immune Design, Seattle, WA USA
FAU - ter Meulen, Jan
AU  - ter Meulen J
AD  - Immune Design, Seattle, WA USA
FAU - Denis, Caroline
AU  - Denis C
AD  - Innate Pharma, Marseille, Provence-Alpes-Cote d’Azur France
FAU - Ghadially, Hormas
AU  - Ghadially H
AD  - MedImmune, Cambridge, England UK
FAU - Arnoux, Thomas
AU  - Arnoux T
AD  - Innate Pharma, Marseille, Provence-Alpes-Cote d’Azur France
FAU - Chanuc, Fabien
AU  - Chanuc F
AD  - Innate Pharma, Marseille, Provence-Alpes-Cote d’Azur France
FAU - Fuseri, Nicolas
AU  - Fuseri N
AD  - Innate Pharma, Marseille, Provence-Alpes-Cote d’Azur France
FAU - Wilkinson, Robert W.
AU  - Wilkinson RW
AD  - MedImmune, Cambridge, England UK
FAU - Wagtmann, Nicolai
AU  - Wagtmann N
AD  - Innate Pharma, Marseille, Provence-Alpes-Cote d’Azur France
FAU - Morel, Yannis
AU  - Morel Y
AD  - Innate Pharma, Marseille, Provence-Alpes-Cote d’Azur France
FAU - Andre, Pascale
AU  - Andre P
AD  - Innate Pharma, Marseille, Provence-Alpes-Cote d’Azur France
FAU - Atkins, Michael B.
AU  - Atkins MB
AD  - Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC USA
FAU - Carlino, Matteo S.
AU  - Carlino MS
AD  - Westmead and Blacktown Hospitals, Melanoma Institute Australia, and the
      University of Sydney, Westmead, New South Wales Australia
FAU - Ribas, Antoni
AU  - Ribas A
AD  - University of California, Los Angeles, CA USA
FAU - Thompson, John A.
AU  - Thompson JA
AD  - University of Washington, Seattle, WA USA
FAU - Choueiri, Toni K.
AU  - Choueiri TK
AD  - Dana-Farber Cancer Institute/Brigham and Women’s Hospital, Harvard University,
      Boston, MA USA
FAU - Hodi, F. Stephen
AU  - Hodi FS
AD  - Dana-Farber Cancer Institute/Brigham and Women’s Hospital, Harvard University,
      Boston, MA USA
FAU - Hwu, Wen-Jen
AU  - Hwu WJ
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - McDermott, David F.
AU  - McDermott DF
AD  - Beth Israel Deaconess Medical Center, Boston, MA USA
FAU - Atkinson, Victoria
AU  - Atkinson V
AD  - Gallipoli Medical Research Foundation, Greenslopes Private Hospital, and the
      University of Queensland, Greenslopes, Queensland Australia
FAU - Cebon, Jonathan S.
AU  - Cebon JS
AD  - Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria Australia
FAU - Fitzharris, Bernie
AU  - Fitzharris B
AD  - Canterbury District Health Board, Christchurch Hospital, Christchurch, New
      Zealand
FAU - Jameson, Michael B.
AU  - Jameson MB
AD  - Waikato Hospital Regional Cancer Centre, Hamilton, New Zealand
FAU - McNeil, Catriona
AU  - McNeil C
AD  - Royal Prince Alfred Hospital, Melanoma Institute Australia, the University of
      Sydney, and Chris O’Brien Lifehouse, Camperdown, New South Wales Australia
FAU - Hill, Andrew G.
AU  - Hill AG
AD  - Tasman Oncology Research, Southport Gold Coast, Queensland Australia
FAU - Mangin, Eric
AU  - Mangin E
AD  - Merck & Co., Inc., Kenilworth, NJ USA
FAU - Ahamadi, Malidi
AU  - Ahamadi M
AD  - Merck & Co., Inc., Kenilworth, NJ USA
FAU - van Vugt, Marianne
AU  - van Vugt M
AD  - Quantitative Solutions, A Certara Company, Oss, Netherlands
FAU - van Zutphen, Mariëlle
AU  - van Zutphen M
AD  - Quantitative Solutions, A Certara Company, Oss, Netherlands
FAU - Ibrahim, Nageatte
AU  - Ibrahim N
AD  - Merck & Co., Inc., Kenilworth, NJ USA
FAU - Long, Georgina V.
AU  - Long GV
AD  - Melanoma Institute Australia, the University of Sydney, Mater Hospital, and Royal
      North Shore Hospital, Wollstonecraft, New South Wales Australia
FAU - Gartrell, Robyn
AU  - Gartrell R
AD  - Columbia University Medical Center, New York, NY USA
FAU - Blake, Zoe
AU  - Blake Z
AD  - Columbia University Medical Center, New York, NY USA
FAU - Simoes, Ines
AU  - Simoes I
AD  - Institut d’Investigacions Biomediques August Pi i Sunyer, Barcelona, Catalonia
      Spain
FAU - Fu, Yichun
AU  - Fu Y
AD  - Columbia University Medical Center, New York, NY USA
FAU - Saito, Takuro
AU  - Saito T
AD  - Icahn School of Medicine at Mount Sinai, New York, NY USA
FAU - Qian, Yingzhi
AU  - Qian Y
AD  - Columbia University Medical Center, New York, NY USA
FAU - Lu, Yan
AU  - Lu Y
AD  - Columbia University Medical Center, New York, NY USA
FAU - Saenger, Yvonne M.
AU  - Saenger YM
AD  - New York Presbyterian/Columbia University Medical Center, New York, NY USA
FAU - Budhu, Sadna
AU  - Budhu S
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - De Henau, Olivier
AU  - De Henau O
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Zappasodi, Roberta
AU  - Zappasodi R
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Schlunegger, Kyle
AU  - Schlunegger K
AD  - Peregrine Pharmaceuticals, Inc., Tustin, CA USA
FAU - Freimark, Bruce
AU  - Freimark B
AD  - Peregrine Pharmaceuticals, Inc., Tustin, CA USA
FAU - Hutchins, Jeff
AU  - Hutchins J
AD  - Peregrine Pharmaceuticals, Inc., Tustin, CA USA
FAU - Barker, Christopher A.
AU  - Barker CA
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Wolchok, Jedd D.
AU  - Wolchok JD
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Merghoub, Taha
AU  - Merghoub T
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Burova, Elena
AU  - Burova E
AD  - Regeneron, Tarrytown, NY USA
FAU - Allbritton, Omaira
AU  - Allbritton O
AD  - Regeneron, Tarrytown, NY USA
FAU - Hong, Peter
AU  - Hong P
AD  - Regeneron, Tarrytown, NY USA
FAU - Dai, Jie
AU  - Dai J
AD  - Regeneron, Tarrytown, NY USA
FAU - Pei, Jerry
AU  - Pei J
AD  - Regeneron, Tarrytown, NY USA
FAU - Liu, Matt
AU  - Liu M
AD  - Regeneron, Tarrytown, NY USA
FAU - Kantrowitz, Joel
AU  - Kantrowitz J
AD  - Regeneron, Tarrytown, NY USA
FAU - Lai, Venus
AU  - Lai V
AD  - Regeneron, Tarrytown, NY USA
FAU - Poueymirou, William
AU  - Poueymirou W
AD  - Regeneron, Tarrytown, NY USA
FAU - MacDonald, Douglas
AU  - MacDonald D
AD  - Regeneron, Tarrytown, NY USA
FAU - Ioffe, Ella
AU  - Ioffe E
AD  - Regeneron, Tarrytown, NY USA
FAU - Mohrs, Markus
AU  - Mohrs M
AD  - Regeneron, Tarrytown, NY USA
FAU - Olson, William
AU  - Olson W
AD  - Regeneron, Tarrytown, NY USA
FAU - Thurston, Gavin
AU  - Thurston G
AD  - Regeneron, Tarrytown, NY USA
FAU - Capasso, Cristian
AU  - Capasso C
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Frascaro, Federica
AU  - Frascaro F
AD  - University of Siena, Supersano (LE), Puglia Italy
FAU - Carpi, Sara
AU  - Carpi S
AD  - University of Pisa, Pisa, Toscana Italy
FAU - Tähtinen, Siri
AU  - Tähtinen S
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Feola, Sara
AU  - Feola S
AD  - University of Napoli Federico II, Helsinki, Uusimaa Finland
FAU - Fusciello, Manlio
AU  - Fusciello M
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Peltonen, Karita
AU  - Peltonen K
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Martins, Beatriz
AU  - Martins B
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Sjöberg, Madeleine
AU  - Sjöberg M
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Pesonen, Sari
AU  - Pesonen S
AD  - PeptiCRAd Oy, Helsinki, Uusimaa Finland
FAU - Ranki, Tuuli
AU  - Ranki T
AD  - PeptiCRAd Oy, Helsinki, Uusimaa Finland
FAU - Kyruk, Lukasz
AU  - Kyruk L
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Ylösmäki, Erkko
AU  - Ylösmäki E
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Cerullo, Vincenzo
AU  - Cerullo V
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Cerignoli, Fabio
AU  - Cerignoli F
AD  - ACEA Biosciences Inc., San Diego, CA USA
FAU - Xi, Biao
AU  - Xi B
AD  - ACEA Biosciences Inc., San Diego, CA USA
FAU - Guenther, Garret
AU  - Guenther G
AD  - ACEA Biosciences Inc., San Diego, CA USA
FAU - Yu, Naichen
AU  - Yu N
AD  - ACEA Biosciences Inc., San Diego, CA USA
FAU - Muir, Lincoln
AU  - Muir L
AD  - ACEA Biosciences Inc., San Diego, CA USA
FAU - Zhao, Leyna
AU  - Zhao L
AD  - ACEA Biosciences Inc., San Diego, CA USA
FAU - Abassi, Yama
AU  - Abassi Y
AD  - ACEA Biosciences Inc., San Diego, CA USA
FAU - Cervera-Carrascón, Víctor
AU  - Cervera-Carrascón V
AD  - TILT Biotherapeutics, Helsinki, Uusimaa Finland
FAU - Siurala, Mikko
AU  - Siurala M
AD  - TILT Biotherapeutics, Helsinki, Uusimaa Finland
FAU - Santos, João
AU  - Santos J
AD  - TILT Biotherapeutics, Helsinki, Uusimaa Finland
FAU - Havunen, Riikka
AU  - Havunen R
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Parviainen, Suvi
AU  - Parviainen S
AD  - TILT Biotherapeutics, Helsinki, Uusimaa Finland
FAU - Hemminki, Akseli
AU  - Hemminki A
AD  - TILT Biotherapeutics, Helsinki, Uusimaa Finland
FAU - Dalgleish, Angus
AU  - Dalgleish A
AD  - St George’s University of London, London, UK
FAU - Mudan, Satvinder
AU  - Mudan S
AD  - The Royal Marsden Hospital and Imperial College London, London, UK
FAU - DeBenedette, Mark
AU  - DeBenedette M
AD  - Argos Therapeutics Inc., Durham, NC USA
FAU - Plachco, Ana
AU  - Plachco A
AD  - Argos Therapeutics Inc., Durham, NC USA
FAU - Gamble, Alicia
AU  - Gamble A
AD  - Argos Therapeutics Inc., Durham, NC USA
FAU - Grogan, Elizabeth W.
AU  - Grogan EW
AD  - Argos Therapeutics Inc., Durham, NC USA
FAU - Krisko, John
AU  - Krisko J
AD  - Argos Therapeutics Inc., Durham, NC USA
FAU - Tcherepanova, Irina
AU  - Tcherepanova I
AD  - Argos Therapeutics Inc., Durham, NC USA
FAU - Nicolette, Charles
AU  - Nicolette C
AD  - Argos Therapeutics Inc., Durham, NC USA
FAU - Dhupkar, Pooja
AU  - Dhupkar P
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Yu, Ling
AU  - Yu L
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Kleinerman, Eugenie S.
AU  - Kleinerman ES
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Gordon, Nancy
AU  - Gordon N
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Grenga, Italia
AU  - Grenga I
AD  - Laboratory of Tumor Immunology and Biology, National Cancer Institute, National
      Institutes of Health, Bethesda, MD USA
FAU - Lepone, Lauren
AU  - Lepone L
AD  - Laboratory of Tumor Immunology and Biology, National Cancer Institute, National
      Institutes of Health, Bethesda, MD USA
FAU - Gameiro, Sofia
AU  - Gameiro S
AD  - Laboratory of Tumor Immunology and Biology, National Cancer Institute, National
      Institutes of Health, Bethesda, MD USA
FAU - Knudson, Karin M.
AU  - Knudson KM
AD  - Laboratory of Tumor Immunology and Biology, National Cancer Institute, National
      Institutes of Health, Bethesda, MD USA
FAU - Fantini, Massimo
AU  - Fantini M
AD  - Laboratory of Tumor Immunology and Biology, National Cancer Institute, National
      Institutes of Health, Bethesda, MD USA
FAU - Tsang, Kwong
AU  - Tsang K
AD  - Laboratory of Tumor Immunology and Biology, National Cancer Institute, National
      Institutes of Health, Bethesda, MD USA
FAU - Hodge, James
AU  - Hodge J
AD  - Laboratory of Tumor Immunology and Biology, National Cancer Institute, National
      Institutes of Health, Bethesda, MD USA
FAU - Donahue, Renee
AU  - Donahue R
AD  - Laboratory of Tumor Immunology and Biology, National Cancer Institute, National
      Institutes of Health, Bethesda, MD USA
FAU - Schlom, Jeffrey
AU  - Schlom J
AD  - Laboratory of Tumor Immunology and Biology, National Cancer Institute, National
      Institutes of Health, Bethesda, MD USA
FAU - Evans, Elizabeth
AU  - Evans E
AD  - Vaccinex, Rochester, NY USA
FAU - Bussler, Holm
AU  - Bussler H
AD  - Vaccinex, Rochester, NY USA
FAU - Mallow, Crystal
AU  - Mallow C
AD  - Vaccinex, Rochester, NY USA
FAU - Reilly, Christine
AU  - Reilly C
AD  - Vaccinex, Rochester, NY USA
FAU - Torno, Sebold
AU  - Torno S
AD  - Vaccinex, Rochester, NY USA
FAU - Scrivens, Maria
AU  - Scrivens M
AD  - Vaccinex, Rochester, NY USA
FAU - Foster, Cathie
AU  - Foster C
AD  - Vaccinex, Rochester, NY USA
FAU - Howell, Alan
AU  - Howell A
AD  - Vaccinex, Rochester, NY USA
FAU - Balch, Leslie
AU  - Balch L
AD  - Vaccinex, Rochester, NY USA
FAU - Knapp, Alyssa
AU  - Knapp A
AD  - Vaccinex, Rochester, NY USA
FAU - Leonard, John E.
AU  - Leonard JE
AD  - Vaccinex, Rochester, NY USA
FAU - Paris, Mark
AU  - Paris M
AD  - Vaccinex, Rochester, NY USA
FAU - Fisher, Terry
AU  - Fisher T
AD  - Vaccinex, Rochester, NY USA
FAU - Hu-Lieskovan, Siwen
AU  - Hu-Lieskovan S
AD  - University of California, Los Angeles, CA USA
FAU - Ribas, Antoni
AU  - Ribas A
AD  - University of California, Los Angeles, CA USA
FAU - Smith, Ernest
AU  - Smith E
AD  - Vaccinex, Rochester, NY USA
FAU - Zauderer, Maurice
AU  - Zauderer M
AD  - Vaccinex, Rochester, NY USA
FAU - Fogler, William
AU  - Fogler W
AD  - GlycoMimetics, Inc., Rockville, MD USA
FAU - Franklin, Marilyn
AU  - Franklin M
AD  - MI Bioresearch, Ann Arbor, MI USA
FAU - Thayer, Matt
AU  - Thayer M
AD  - MI Bioresearch, Ann Arbor, MI USA
FAU - Saims, Dan
AU  - Saims D
AD  - MI Bioresearch, Ann Arbor, MI USA
FAU - Magnani, John L.
AU  - Magnani JL
AD  - GlycoMimetics, Inc., Rockville, MD USA
FAU - Gong, Jian
AU  - Gong J
AD  - Peregrine Pharmaceuticals, Tustin, CA USA
FAU - Gray, Michael
AU  - Gray M
AD  - Peregrine Pharmaceuticals, Tustin, CA USA
FAU - Hutchins, Jeff
AU  - Hutchins J
AD  - Peregrine Pharmaceuticals, Tustin, CA USA
FAU - Freimark, Bruce
AU  - Freimark B
AD  - Peregrine Pharmaceuticals, Tustin, CA USA
FAU - Fromm, George
AU  - Fromm G
AD  - Heat Biologics, Inc., Durham, NC USA
FAU - de Silva, Suresh
AU  - de Silva S
AD  - Heat Biologics, Inc., Durham, NC USA
FAU - Giffin, Louise
AU  - Giffin L
AD  - Heat Biologics, Inc., Durham, NC USA
FAU - Xu, Xin
AU  - Xu X
AD  - Heat Biologics, Inc., Durham, NC USA
FAU - Rose, Jason
AU  - Rose J
AD  - Heat Biologics, Inc., Durham, NC USA
FAU - Schreiber, Taylor H.
AU  - Schreiber TH
AD  - Heat Biologics, Inc., Durham, NC USA
FAU - Fantini, Massimo
AU  - Fantini M
AD  - National Cancer Institute, National Institutes of Health, Bethesda, MD USA
FAU - Gameiro, Sofia R.
AU  - Gameiro SR
AD  - National Cancer Institute, National Institutes of Health, Bethesda, MD USA
FAU - Knudson, Karin M.
AU  - Knudson KM
AD  - National Cancer Institute, National Institutes of Health, Bethesda, MD USA
FAU - Clavijo, Paul E.
AU  - Clavijo PE
AD  - National Institute on Deafness and Other Communication Disorders, National
      Institutes of Health, Bethesda, MD USA
FAU - Allen, Clint T.
AU  - Allen CT
AD  - National Institute on Deafness and Other Communication Disorders, National
      Institutes of Health, Bethesda, MD USA
FAU - Donahue, Renee
AU  - Donahue R
AD  - National Cancer Institute, National Institutes of Health, Bethesda, MD USA
FAU - Lepone, Lauren
AU  - Lepone L
AD  - National Cancer Institute, National Institutes of Health, Bethesda, MD USA
FAU - Grenga, Italia
AU  - Grenga I
AD  - National Cancer Institute, National Institutes of Health, Bethesda, MD USA
FAU - Hodge, James W.
AU  - Hodge JW
AD  - National Cancer Institute, National Institutes of Health, Bethesda, MD USA
FAU - Tsang, Kwong Y.
AU  - Tsang KY
AD  - National Cancer Institute, National Institutes of Health, Bethesda, MD USA
FAU - Schlom, Jeffrey
AU  - Schlom J
AD  - National Cancer Institute, National Institutes of Health, Bethesda, MD USA
FAU - Gray, Michael
AU  - Gray M
AD  - Peregrine Pharmaceuticals, Tustin, CA USA
FAU - Gong, Jian
AU  - Gong J
AD  - Peregrine Pharmaceuticals, Tustin, CA USA
FAU - Hutchins, Jeff
AU  - Hutchins J
AD  - Peregrine Pharmaceuticals, Tustin, CA USA
FAU - Freimark, Bruce
AU  - Freimark B
AD  - Peregrine Pharmaceuticals, Tustin, CA USA
FAU - Grogan, Jane
AU  - Grogan J
AD  - Genentech, South San Francisco, CA USA
FAU - Manieri, Nicholas
AU  - Manieri N
AD  - Genentech, South San Francisco, CA USA
FAU - Chiang, Eugene
AU  - Chiang E
AD  - Genentech, South San Francisco, CA USA
FAU - Caplazi, Patrick
AU  - Caplazi P
AD  - Genentech, South San Francisco, CA USA
FAU - Yadav, Mahesh
AU  - Yadav M
AD  - Genentech, South San Francisco, CA USA
FAU - Hagner, Patrick
AU  - Hagner P
AD  - Celgene Corporation, Summit, NJ USA
FAU - Chiu, Hsiling
AU  - Chiu H
AD  - Celgene Corporation, Summit, NJ USA
FAU - Waldman, Michelle
AU  - Waldman M
AD  - Celgene Corporation, Summit, NJ USA
FAU - Klippel, Anke
AU  - Klippel A
AD  - Celgene Corporation, Summit, NJ USA
FAU - Thakurta, Anjan
AU  - Thakurta A
AD  - Celgene Corporation, Summit, NJ USA
FAU - Pourdehnad, Michael
AU  - Pourdehnad M
AD  - Celgene Corporation, San Francisco, CA USA
FAU - Gandhi, Anita
AU  - Gandhi A
AD  - Celgene Corporation, Summit, NJ USA
FAU - Henrich, Ian
AU  - Henrich I
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Quick, Laura
AU  - Quick L
AD  - Children’s Hospital of Pennsylvania, Philadelphia, PA USA
FAU - Young, Rob
AU  - Young R
AD  - Children’s Hospital of Pennsylvania, Philadelphia, PA USA
FAU - Chou, Margaret
AU  - Chou M
AD  - Children’s Hospital of Pennsylvania, Philadelphia, PA USA
FAU - Hotson, Andrew
AU  - Hotson A
AD  - Corvus Pharmaceuticals, Burlingame, CA USA
FAU - Willingham, Stephen
AU  - Willingham S
AD  - Corvus Pharmaceuticals, Burlingame, CA USA
FAU - Ho, Po
AU  - Ho P
AD  - Corvus Pharmaceuticals, Burlingame, CA USA
FAU - Choy, Carmen
AU  - Choy C
AD  - Corvus Pharmaceuticals, Burlingame, CA USA
FAU - Laport, Ginna
AU  - Laport G
AD  - Corvus Pharmaceuticals, Burlingame, CA USA
FAU - McCaffery, Ian
AU  - McCaffery I
AD  - Corvus Pharmaceuticals, Burlingame, CA USA
FAU - Miller, Richard
AU  - Miller R
AD  - Corvus Pharmaceuticals, Burlingame, CA USA
FAU - Tipton, Kimberly A.
AU  - Tipton KA
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Wong, Kenneth R.
AU  - Wong KR
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Singson, Victoria
AU  - Singson V
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Wong, Chihunt
AU  - Wong C
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Chan, Chanty
AU  - Chan C
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Huang, Yuanhiu
AU  - Huang Y
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Liu, Shouchun
AU  - Liu S
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Richardson, Jennifer H.
AU  - Richardson JH
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Kavanaugh, W. Michael
AU  - Kavanaugh WM
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - West, James
AU  - West J
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Irving, Bryan A.
AU  - Irving BA
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Tipton, Kimberly A.
AU  - Tipton KA
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Wong, Kenneth R.
AU  - Wong KR
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Singson, Victoria
AU  - Singson V
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Wong, Chihunt
AU  - Wong C
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Chan, Chanty
AU  - Chan C
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Huang, Yuanhiu
AU  - Huang Y
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Liu, Shouchun
AU  - Liu S
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Richardson, Jennifer H.
AU  - Richardson JH
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Kavanaugh, W. Michael
AU  - Kavanaugh WM
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - West, James
AU  - West J
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Irving, Bryan A.
AU  - Irving BA
AD  - CytomX Therapeutics, Inc, South San Francisco, CA USA
FAU - Jaini, Ritika
AU  - Jaini R
AD  - Lerner Research Institute, Cleveland Clinic, Cleveland, OH USA
FAU - Loya, Matthew
AU  - Loya M
AD  - Lerner Research Institute, Cleveland Clinic, Cleveland, OH USA
FAU - Eng, Charis
AU  - Eng C
AD  - Lerner Research Institute, Cleveland Clinic, Cleveland, OH USA
FAU - Johnson, Melissa L.
AU  - Johnson ML
AD  - Sarah Cannon Research Institute, Nashville, TN USA
FAU - Adjei, Alex A.
AU  - Adjei AA
AD  - Mayo Clinic, Rochester, MN USA
FAU - Opyrchal, Mateusz
AU  - Opyrchal M
AD  - Roswell Park Cancer Institute, Buffalo, NY USA
FAU - Ramalingam, Suresh
AU  - Ramalingam S
AD  - Emory University, Atlanta, GA USA
FAU - Janne, Pasi A.
AU  - Janne PA
AD  - Dana-Farber Cancer Institute, Boston, MA USA
FAU - Dominguez, George
AU  - Dominguez G
AD  - The Wistar Institute, Philadelphia, PA USA
FAU - Gabrilovich, Dmitry
AU  - Gabrilovich D
AD  - The Wistar Institute, Philadelphia, PA USA
FAU - de Leon, Laura
AU  - de Leon L
AD  - Syndax Pharmaceuticals, Inc, Waltham, MA USA
FAU - Hasapidis, Jeannette
AU  - Hasapidis J
AD  - Syndax Pharmaceuticals, Inc, Waltham, MA USA
FAU - Diede, Scott J.
AU  - Diede SJ
AD  - Merck Research Laboratories, North Wales, PA USA
FAU - Ordentlich, Peter
AU  - Ordentlich P
AD  - Syndax Pharmaceuticals, Inc, Waltham, MA USA
FAU - Cruickshank, Scott
AU  - Cruickshank S
AD  - Syndax Pharmaceuticals, Inc, Waltham, MA USA
FAU - Meyers, Michael L.
AU  - Meyers ML
AD  - Syndax Pharmaceuticals, Inc, New York, NY USA
FAU - Hellmann, Matthew D.
AU  - Hellmann MD
AD  - Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Kalinski, Pawel
AU  - Kalinski P
AD  - Department of Surgery, University of Pittsburgh Cancer Institute, Pittsburgh, PA 
      USA
FAU - Zureikat, Amer
AU  - Zureikat A
AD  - University of Pittsburgh Cancer Institute, Pittsburgh, PA USA
FAU - Edwards, Robert
AU  - Edwards R
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Muthuswamy, Ravi
AU  - Muthuswamy R
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Obermajer, Nataša
AU  - Obermajer N
AD  - Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA
FAU - Urban, Julie
AU  - Urban J
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Butterfield, Lisa H.
AU  - Butterfield LH
AD  - University of Pittsburgh Cancer Institute, Pittsburgh, PA USA
FAU - Gooding, William
AU  - Gooding W
AD  - University of Pittsburgh Cancer Institute, Pittsburgh, PA USA
FAU - Zeh, Herbert
AU  - Zeh H
AD  - University of Pittsburgh Cancer Institute, Pittsburgh, PA USA
FAU - Bartlett, David
AU  - Bartlett D
AD  - Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA
FAU - Zubkova, Olga
AU  - Zubkova O
AD  - LLC Cellthera Pharm, Volginsky, Vladimir Russia
FAU - Agapova, Larissa
AU  - Agapova L
AD  - LLC Cellthera Pharm, Volginsky, Vladimir Russia
FAU - Kapralova, Marina
AU  - Kapralova M
AD  - LLC Cellthera Pharm, Volginsky, Vladimir Russia
FAU - Krasovskaia, Liudmila
AU  - Krasovskaia L
AD  - LLC Cellthera Pharm, Volginsky, Vladimir Russia
FAU - Ovsepyan, Armen
AU  - Ovsepyan A
AD  - LLC IBC Generium, Volginsky, Vladimir Russia
FAU - Lykov, Maxim
AU  - Lykov M
AD  - LLC IBC Generium, Volginsky, Vladimir Russia
FAU - Eremeev, Artem
AU  - Eremeev A
AD  - LLC Cellthera Pharm, Volginsky, Vladimir Russia
FAU - Bokovanov, Vladimir
AU  - Bokovanov V
AD  - LLC Cellthera Pharm, Volginsky, Vladimir Russia
FAU - Grigoryeva, Olga
AU  - Grigoryeva O
AD  - LLC Cellthera Pharm, Volginsky, Vladimir Russia
FAU - Karpov, Andrey
AU  - Karpov A
AD  - LLC Cellthera Pharm, Volginsky, Vladimir Russia
FAU - Ruchko, Sergey
AU  - Ruchko S
AD  - LLC Cellthera Pharm, Volginsky, Vladimir Russia
FAU - Nicolette, Charles
AU  - Nicolette C
AD  - Argos Therapeutics Inc., Durham, NC USA
FAU - Shuster, Alexandr
AU  - Shuster A
AD  - LLC IBC Generium, Volginsky, Vladimir Russia
FAU - Khalil, Danny N.
AU  - Khalil DN
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Campesato, Luis Felipe
AU  - Campesato LF
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Li, Yanyun
AU  - Li Y
AD  - Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New
      York, NY USA
FAU - Merghoub, Taha
AU  - Merghoub T
AD  - Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New
      York, NY USA
FAU - Wolchok, Jedd D.
AU  - Wolchok JD
AD  - Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Lazorchak, Adam S.
AU  - Lazorchak AS
AD  - Curis, Inc., Lexington, MA USA
FAU - Patterson, Troy D.
AU  - Patterson TD
AD  - Curis, Inc., Lexington, MA USA
FAU - Ding, Yueyun
AU  - Ding Y
AD  - Curis, Inc., Lexington, MA USA
FAU - Sasikumar, Pottayil
AU  - Sasikumar P
AD  - Aurigene Discovery Technologies Limited, Bangalore, Karnataka India
FAU - Sudarshan, Naremaddepalli
AU  - Sudarshan N
AD  - Aurigene Discovery Technologies Limited, Bangalore, Karnataka India
FAU - Gowda, Nagaraj
AU  - Gowda N
AD  - Aurigene Discovery Technologies Limited, Bangalore, Karnataka India
FAU - Ramachandra, Raghuveer
AU  - Ramachandra R
AD  - Aurigene Discovery Technologies Limited, Bangalore, Karnataka India
FAU - Samiulla, Dodheri
AU  - Samiulla D
AD  - Aurigene Discovery Technologies Limited, Bangalore, Karnataka India
FAU - Giri, Sanjeev
AU  - Giri S
AD  - Aurigene Discovery Technologies Limited, Bangalore, Karnataka India
FAU - Eswarappa, Rajesh
AU  - Eswarappa R
AD  - Aurigene Discovery Technologies Limited, Bangalore, Karnataka India
FAU - Ramachandra, Murali
AU  - Ramachandra M
AD  - Aurigene Discovery Technologies Limited, Bangalore, Karnataka India
FAU - Tuck, David
AU  - Tuck D
AD  - Curis, Inc., Lexington, MA USA
FAU - Wyant, Timothy
AU  - Wyant T
AD  - Curis, Inc., Lexington, MA USA
FAU - Leshem, Jasmin
AU  - Leshem J
AD  - National Cancer Institute, NIH, Bethesda, MD USA
FAU - Liu, Xiu-fen
AU  - Liu Xf
AD  - National Cancer Institute, NIH, Bethesda, MD USA
FAU - Bera, Tapan
AU  - Bera T
AD  - National Cancer Institute, NIH, Bethesda, MD USA
FAU - Terabe, Masaki
AU  - Terabe M
AD  - National Cancer Institute, NIH, Bethesda, MD USA
FAU - Bossenmaier, Birgit
AU  - Bossenmaier B
AD  - Roche Pharmaceutical Research &Early Development, Discovery Oncology, Innovation 
      Center Penzberg, Roche Diagnostics GmbH, Penzberg, Germany
FAU - Niederfellner, Gerhard
AU  - Niederfellner G
AD  - Roche Pharmaceutical Research &Early Development, Discovery Oncology, Innovation 
      Center Penzberg, Roche Diagnostics GmbH, Penzberg, Germany
FAU - Reiter, Yoram
AU  - Reiter Y
AD  - Technion Institute, Haifa, Iceland
FAU - Pastan, Ira
AU  - Pastan I
AD  - National Cancer Institute, NIH, Bethesda, MD USA
FAU - Xia, Leiming
AU  - Xia L
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Xia, Yang
AU  - Xia Y
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Hu, Yangyang
AU  - Hu Y
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Wang, Yi
AU  - Wang Y
AD  - The No.1 People’s Hospital of Hefei, Hefei, Anhui People’s Republic of China
FAU - Bao, Yangyi
AU  - Bao Y
AD  - The No.1 People’s Hospital of Hefei, Hefei, Anhui People’s Republic of China
FAU - Dai, Fu
AU  - Dai F
AD  - The No.1 People’s Hospital of Hefei, Hefei, Anhui People’s Republic of China
FAU - Huang, Shiang
AU  - Huang S
AD  - Union Hospital, Tongji Medical College, Huazhong University of Science and
      Technology, Wuhan, Hubei People’s Republic of China
FAU - Hurt, Elaine
AU  - Hurt E
AD  - MedImmune Inc, Gaithersburg, MD USA
FAU - Hollingsworth, Robert E.
AU  - Hollingsworth RE
AD  - MedImmune Inc, Gaithersburg, MD USA
FAU - Lum, Lawrence G.
AU  - Lum LG
AD  - University of Virginia Cancer Center, Charlottesville, VA USA
FAU - Chang, Alfred E.
AU  - Chang AE
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Wicha, Max S.
AU  - Wicha MS
AD  - University of Michigan Medical School, Ann Arbor, MI USA
FAU - Li, Qiao
AU  - Li Q
AD  - University of Michigan Medical Center, Ann Arbor, MI USA
FAU - Mace, Thomas
AU  - Mace T
AD  - The Ohio State University, Columbus, OH USA
FAU - Makhijani, Neil
AU  - Makhijani N
AD  - The Ohio State University, Columbus, OH USA
FAU - Talbert, Erin
AU  - Talbert E
AD  - The Ohio State University, Columbus, OH USA
FAU - Young, Gregory
AU  - Young G
AD  - The Ohio State University, Columbus, OH USA
FAU - Guttridge, Denis
AU  - Guttridge D
AD  - The Ohio State University, Columbus, OH USA
FAU - Conwell, Darwin
AU  - Conwell D
AD  - The Ohio State University, Columbus, OH USA
FAU - Lesinski, Gregory B.
AU  - Lesinski GB
AD  - The Ohio State University, Columbus, OH USA
FAU - Gonzales, Rodney JM Macedo
AU  - Gonzales RJM
AD  - Columbia Center for Translational Immunology, Columbia University Medical Center,
      New York, NY USA
FAU - Huffman, Austin P.
AU  - Huffman AP
AD  - Columbia Center for Translational Immunology, Columbia University Medical Center,
      New York, NY USA
FAU - Wang, Ximi K.
AU  - Wang XK
AD  - Columbia Center for Translational Immunology, Columbia University Medical Center,
      New York, NY USA
FAU - Reshef, Ran
AU  - Reshef R
AD  - Columbia Center for Translational Immunology, Columbia University Medical Center,
      New York, NY USA
FAU - MacKinnon, Andy
AU  - MacKinnon A
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Chen, Jason
AU  - Chen J
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Gross, Matt
AU  - Gross M
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Marguier, Gisele
AU  - Marguier G
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Shwonek, Peter
AU  - Shwonek P
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Sotirovska, Natalija
AU  - Sotirovska N
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Steggerda, Susanne
AU  - Steggerda S
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Parlati, Francesco
AU  - Parlati F
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Makkouk, Amani
AU  - Makkouk A
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Bennett, Mark K.
AU  - Bennett MK
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Chen, Jason
AU  - Chen J
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Emberley, Ethan
AU  - Emberley E
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Gross, Matt
AU  - Gross M
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Huang, Tony
AU  - Huang T
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Li, Weiqun
AU  - Li W
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - MacKinnon, Andy
AU  - MacKinnon A
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Marguier, Gisele
AU  - Marguier G
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Neou, Silinda
AU  - Neou S
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Pan, Alison
AU  - Pan A
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Zhang, Jing
AU  - Zhang J
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Zhang, Winter
AU  - Zhang W
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Parlati, Francesco
AU  - Parlati F
AD  - Calithera Biosciences, South San Francisco, CA USA
FAU - Marshall, Netonia
AU  - Marshall N
AD  - Icahn School of Medicine at Mount Sinai, New York, NY USA
FAU - Marron, Thomas U.
AU  - Marron TU
AD  - Icahn School of Medicine at Mount Sinai, New York, NY USA
FAU - Agudo, Judith
AU  - Agudo J
AD  - Icahn School of Medicine at Mount Sinai, New York, NY USA
FAU - Brown, Brian
AU  - Brown B
AD  - Icahn School of Medicine at Mount Sinai, New York, NY USA
FAU - Brody, Joshua
AU  - Brody J
AD  - Icahn School of Medicine at Mount Sinai, New York, NY USA
FAU - McQuinn, Christopher
AU  - McQuinn C
AD  - The Ohio State University, Columbus, OH USA
FAU - Mace, Thomas
AU  - Mace T
AD  - The Ohio State University, Columbus, OH USA
FAU - Farren, Matthew
AU  - Farren M
AD  - The Ohio State University, Columbus, OH USA
FAU - Komar, Hannah
AU  - Komar H
AD  - The Ohio State University, Columbus, OH USA
FAU - Shakya, Reena
AU  - Shakya R
AD  - The Ohio State University, Columbus, OH USA
FAU - Young, Gregory
AU  - Young G
AD  - The Ohio State University, Columbus, OH USA
FAU - Ludwug, Thomas
AU  - Ludwug T
AD  - The Ohio State University, Columbus, OH USA
FAU - Lesinski, Gregory B.
AU  - Lesinski GB
AD  - The Ohio State University, Columbus, OH USA
FAU - Morillon, Y. Maurice
AU  - Morillon YM
AD  - Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National 
      Cancer Institute, Bethesda, MD USA
FAU - Hammond, Scott A.
AU  - Hammond SA
AD  - MedImmune LLC, Gaithersburg, MD USA
FAU - Schlom, Jeffrey
AU  - Schlom J
AD  - Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National 
      Cancer Institute, Bethesda, MD USA
FAU - Greiner, John W.
AU  - Greiner JW
AD  - Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National 
      Cancer Institute, Bethesda, MD USA
FAU - Nath, Pulak R.
AU  - Nath PR
AD  - National Cancer Institute, National Institutes of Health, Bethesda, MD USA
FAU - Schwartz, Anthony L.
AU  - Schwartz AL
AD  - National Cancer Institute, National Institutes of Health, Bethesda, MD USA
FAU - Maric, Dragan
AU  - Maric D
AD  - National Institute of Neurological Disorders and Stroke, National Institutes of
      Health, Bethesda, MD USA
FAU - Roberts, David D.
AU  - Roberts DD
AD  - National Cancer Institute, National Institutes of Health, Bethesda, MD USA
FAU - Obermajer, Nataša
AU  - Obermajer N
AD  - Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA
FAU - Bartlett, David
AU  - Bartlett D
AD  - Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA
FAU - Kalinski, Pawel
AU  - Kalinski P
AD  - Department of Surgery, University of Pittsburgh Cancer Institute, Pittsburgh, PA 
      USA
FAU - Naing, Aung
AU  - Naing A
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Papadopoulos, Kyriakos P.
AU  - Papadopoulos KP
AD  - South Texas Accelerated Research Therapeutics, LLC, San Antonio, TX USA
FAU - Autio, Karen A.
AU  - Autio KA
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Wong, Deborah J.
AU  - Wong DJ
AD  - UCLA, Los Angeles, CA USA
FAU - Patel, Manish
AU  - Patel M
AD  - Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL USA
FAU - Falchook, Gerald
AU  - Falchook G
AD  - SCRI at HealthONE, Denver, CO USA
FAU - Pant, Shubham
AU  - Pant S
AD  - Oklahoma University, Oklahoma City, OK USA
FAU - Ott, Patrick A.
AU  - Ott PA
AD  - Dana-Farber Cancer Institute, Boston, MA USA
FAU - Whiteside, Melinda
AU  - Whiteside M
AD  - ARMO BioSciences, Redwood City, CA USA
FAU - Patnaik, Amita
AU  - Patnaik A
AD  - South Texas Accelerated Research Therapeutics, LLC, San Antonio, TX USA
FAU - Mumm, John
AU  - Mumm J
AD  - ARMO BioSciences, Redwood City, CA USA
FAU - Janku, Filip
AU  - Janku F
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Chan, Ivan
AU  - Chan I
AD  - ARMO BioSciences, Redwood City, CA USA
FAU - Bauer, Todd
AU  - Bauer T
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Colen, Rivka
AU  - Colen R
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - VanVlasselaer, Peter
AU  - VanVlasselaer P
AD  - ARMO BioSciences, Redwood City, CA USA
FAU - Brown, Gail L.
AU  - Brown GL
AD  - ARMO BioSciences, Redwood City, CA USA
FAU - Tannir, Nizar M.
AU  - Tannir NM
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Oft, Martin
AU  - Oft M
AD  - ARMO BioSciences, Redwood City, CA USA
FAU - Infante, Jeffrey
AU  - Infante J
AD  - Sarah Cannon Research Institute, Nashville, TN USA
FAU - Lipson, Evan
AU  - Lipson E
AD  - Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of
      Medicine, Baltimore, MD USA
FAU - Gopal, Ajay
AU  - Gopal A
AD  - Seattle Cancer Care Alliance, University of Washington, Seattle, WA USA
FAU - Neelapu, Sattva S.
AU  - Neelapu SS
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Armand, Philippe
AU  - Armand P
AD  - Dana-Farber Cancer Institute, Harvard University, Boston, MA USA
FAU - Spurgeon, Stephen
AU  - Spurgeon S
AD  - Center for Hematologic Malignancies, Oregon Health and Sciences University,
      Portland, OR USA
FAU - Leonard, John P.
AU  - Leonard JP
AD  - New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY USA
FAU - Hodi, F. Stephen
AU  - Hodi FS
AD  - Dana-Farber Cancer Institute, Harvard University, Boston, MA USA
FAU - Sanborn, Rachel E.
AU  - Sanborn RE
AD  - Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute,
      Providence Cancer Center, Portland, OR USA
FAU - Melero, Ignacio
AU  - Melero I
AD  - Center for Applied Medical Research (CIMA), University of Navarra, Pamplona,
      Navarra Spain
FAU - Gajewski, Thomas F.
AU  - Gajewski TF
AD  - University of Chicago Medical Center, Chicago, IL USA
FAU - Maurer, Matthew
AU  - Maurer M
AD  - Bristol-Myers Squibb, Princeton, NJ USA
FAU - Perna, Serena
AU  - Perna S
AD  - Bristol-Myers Squibb, Lawrence Township, NJ USA
FAU - Gutierrez, Andres A.
AU  - Gutierrez AA
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Clynes, Raphael
AU  - Clynes R
AD  - Bristol-Myers Squibb, Lawrence Township, NJ USA
FAU - Mitra, Priyam
AU  - Mitra P
AD  - Bristol-Myers Squibb, Lawrence Township, NJ USA
FAU - Suryawanshi, Satyendra
AU  - Suryawanshi S
AD  - Bristol-Myers Squibb, Lawrence Township, NJ USA
FAU - Gladstone, Douglas
AU  - Gladstone D
AD  - Center for Applied Medical Research (CIMA), University of Navarra, Pamplona,
      Navarra Spain
FAU - Callahan, Margaret K.
AU  - Callahan MK
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Crooks, James
AU  - Crooks J
AD  - MCCIR, University of Manchester, Manchester, England UK
FAU - Brown, Sheila
AU  - Brown S
AD  - MCCIR, University of Manchester, Manchester, England UK
FAU - Gauthier, Audrey
AU  - Gauthier A
AD  - Oncodesign, Dijon, Bourgogne France
FAU - de Boisferon, Marc Hillairet
AU  - de Boisferon MH
AD  - Oncodesign, Dijon, Bourgogne France
FAU - MacDonald, Andrew
AU  - MacDonald A
AD  - MCCIR, University of Manchester, Manchester, England UK
FAU - Brunet, Laura Rosa
AU  - Brunet LR
AD  - Immodulon Therapeutics Ltd, Uxbridge, England UK
FAU - Rothwell, William T.
AU  - Rothwell WT
AD  - University of Pennsylvania Perelman School of Medicine, Philadelphia, PA USA
FAU - Bell, Peter
AU  - Bell P
AD  - University of Pennsylvania Perelman School of Medicine, Philadelphia, PA USA
FAU - Wilson, James M.
AU  - Wilson JM
AD  - University of Pennsylvania Perelman School of Medicine, Philadelphia, PA USA
FAU - Sato-Kaneko, Fumi
AU  - Sato-Kaneko F
AD  - Moores Cancer Center, University of California, San Diego, La Jolla, CA USA
FAU - Yao, Shiyin
AU  - Yao S
AD  - Moores Cancer Center, University of California, San Diego, La Jolla, CA USA
FAU - Zhang, Shannon S.
AU  - Zhang SS
AD  - Dynavax Technologies, Berkeley, CA USA
FAU - Carson, Dennis A.
AU  - Carson DA
AD  - Moores Cancer Center, University of California, San Diego, La Jolla, CA USA
FAU - Guiducci, Cristina
AU  - Guiducci C
AD  - Dynavax Technologies, Berkeley, CA USA
FAU - Coffman, Robert L.
AU  - Coffman RL
AD  - Dynavax Technologies, Berkeley, CA USA
FAU - Kitaura, Kazutaka
AU  - Kitaura K
AD  - Repertoire Genesis Incorporation, Ibaraki, Osaka Japan
FAU - Matsutani, Takaji
AU  - Matsutani T
AD  - Repertoire Genesis Incorporation, Ibaraki, Osaka Japan
FAU - Suzuki, Ryuji
AU  - Suzuki R
AD  - Repertoire Genesis Incorporation, Ibaraki, Osaka Japan
FAU - Hayashi, Tomoko
AU  - Hayashi T
AD  - Moores Cancer Center, University of California, San Diego, La Jolla, CA USA
FAU - Cohen, Ezra E. W.
AU  - Cohen EEW
AD  - Moores Cancer Center, University of California, San Diego, La Jolla, CA USA
FAU - Schaer, David
AU  - Schaer D
AD  - Eli Lilly and Company, New York, NY USA
FAU - Li, Yanxia
AU  - Li Y
AD  - Eli Lilly and Company, New York, NY USA
FAU - Dobkin, Julie
AU  - Dobkin J
AD  - Eli Lilly and Company, New York, NY USA
FAU - Amatulli, Michael
AU  - Amatulli M
AD  - Eli Lilly and Company, New York, NY USA
FAU - Hall, Gerald
AU  - Hall G
AD  - Eli Lilly and Company, New York, NY USA
FAU - Doman, Thompson
AU  - Doman T
AD  - Eli Lilly and Company, Indianapolis, IN USA
FAU - Manro, Jason
AU  - Manro J
AD  - Eli Lilly and Company, Indianapolis, IN USA
FAU - Dorsey, Frank Charles
AU  - Dorsey FC
AD  - Eli Lilly and Company, Indianapolis, IN USA
FAU - Sams, Lillian
AU  - Sams L
AD  - Eli Lilly and Company, Indianapolis, IN USA
FAU - Holmgaard, Rikke
AU  - Holmgaard R
AD  - Eli Lilly and Company, New York, NY USA
FAU - Persaud, Krishnadatt
AU  - Persaud K
AD  - Eli Lilly and Company, New York, NY USA
FAU - Ludwig, Dale
AU  - Ludwig D
AD  - Eli Lilly and Company, New York, NY USA
FAU - Surguladze, David
AU  - Surguladze D
AD  - Eli Lilly and Company, New York, NY USA
FAU - Kauh, John S.
AU  - Kauh JS
AD  - Eli Lilly and Company, Bridgewater, NJ USA
FAU - Novosiadly, Ruslan
AU  - Novosiadly R
AD  - Eli Lilly and Company, New York, NY USA
FAU - Kalos, Michael
AU  - Kalos M
AD  - Eli Lilly and Company, New York, NY USA
FAU - Driscoll, Kyla
AU  - Driscoll K
AD  - Eli Lilly and Company, New York, NY USA
FAU - Pandha, Hardev
AU  - Pandha H
AD  - University of Surrey, Guildford, England UK
FAU - Ralph, Christy
AU  - Ralph C
AD  - St James University Hospital, Leeds, England UK
FAU - Harrington, Kevin
AU  - Harrington K
AD  - Institute for Cancer Research, London, England UK
FAU - Curti, Brendan
AU  - Curti B
AD  - Providence Cancer Center, Portland, OR USA
FAU - Sanborn, Rachel E.
AU  - Sanborn RE
AD  - Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute,
      Providence Cancer Center, Portland, Oregon USA
FAU - Akerley, Wallace
AU  - Akerley W
AD  - Huntsman Cancer Institute, Salt Lake City, UT USA
FAU - Gupta, Sumati
AU  - Gupta S
AD  - Huntsman Cancer Institute, Salt Lake City, UT USA
FAU - Melcher, Alan
AU  - Melcher A
AD  - Institute for Cancer Research, London, England UK
FAU - Mansfield, David
AU  - Mansfield D
AD  - Institute for Cancer Research, London, England UK
FAU - Kaufman, David R.
AU  - Kaufman DR
AD  - Merck & Co., Inc., Kenilworth, NJ USA
FAU - Schmidt, Emmett
AU  - Schmidt E
AD  - Merck & Co., Inc., Kenilworth, NJ USA
FAU - Grose, Mark
AU  - Grose M
AD  - Merck & Co., Inc., Kenilworth, NJ USA
FAU - Davies, Bronwyn
AU  - Davies B
AD  - Viralytics Ltd., Sydney, New South Wales Australia
FAU - Karpathy, Roberta
AU  - Karpathy R
AD  - Viralytics Ltd., Sydney, New South Wales Australia
FAU - Shafren, Darren
AU  - Shafren D
AD  - Viralytics Ltd., Sydney, New South Wales Australia
FAU - Shamalov, Katerina
AU  - Shamalov K
AD  - Bar Ilan University, Ramat Gan, HaMerkaz, Iceland
FAU - Cohen, Cyrille
AU  - Cohen C
AD  - Bar Ilan University, Ramat Gan, HaMerkaz, Iceland
FAU - Sharma, Naveen
AU  - Sharma N
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Allison, James
AU  - Allison J
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Shekarian, Tala
AU  - Shekarian T
AD  - Université Claude Bernard Lyon 1, Centre Leon Berard, Lyon, Rhone-Alpes France
FAU - Valsesia-Wittmann, Sandrine
AU  - Valsesia-Wittmann S
AD  - Centre Leon Berard, Innovations in Immunotherapy Platform, Lyon, Rhone-Alpes
      France
FAU - Caux, Christophe
AU  - Caux C
AD  - Université Claude Bernard Lyon 1, Centre Leon Berard, Lyon, Rhone-Alpes France
FAU - Marabelle, Aurelien
AU  - Marabelle A
AD  - Institue Goustave Roussy, Université Claude Bernard Lyon 1, Centre Leon Berard,
      Villejuif, Ile-de-France France
FAU - Slomovitz, Brian M.
AU  - Slomovitz BM
AD  - Sylvester Comprehensive Cancer Center/University of Miami, Miami, FL USA
FAU - Moore, Kathleen M.
AU  - Moore KM
AD  - Stephenson Oklahoma Cancer Center, Oklahoma City, OK USA
FAU - Youssoufian, Hagop
AU  - Youssoufian H
AD  - Advaxis Immunotherapies, Princeton, NJ USA
FAU - Posner, Marshall
AU  - Posner M
AD  - Icahn School of Medicine at Mount Sinai, Mount Sinai Medical Center, New York, NY
      USA
FAU - Tewary, Poonam
AU  - Tewary P
AD  - CIP, Center for Cancer Research, BSP, Leidos Biomed Research Inc, National Cancer
      Institute-Frederick, Frederick, MD USA
FAU - Brooks, Alan D.
AU  - Brooks AD
AD  - CIP, Center for Cancer Research, Leidos Biomed Research Inc, National Cancer
      Institute-Frederick, Frederick, MD USA
FAU - Xu, Ya-Ming
AU  - Xu YM
AD  - University of Arizona, Southwest Center for Natural Products Research and
      Commercialization, Tucson, AZ USA
FAU - Wijeratne, Kithsiri
AU  - Wijeratne K
AD  - University of Arizona, Southwest Center for Natural Products Research and
      Commercialization, Tucson, AZ USA
FAU - Gunatilaka, Leslie A. A.
AU  - Gunatilaka LAA
AD  - University of Arizona, Tucson, AZ USA
FAU - Sayers, Thomas J.
AU  - Sayers TJ
AD  - CIP, Center for Cancer Research, BSP, Leidos Biomed Research Inc, National Cancer
      Institute-Frederick, Frederick, MD USA
FAU - Vasilakos, John P.
AU  - Vasilakos JP
AD  - 3M Company, St. Paul, MN USA
FAU - Alston, Tesha
AU  - Alston T
AD  - 3M Company, St. Paul, MN USA
FAU - Dovedi, Simon
AU  - Dovedi S
AD  - Medimmune, Cambridge, England UK
FAU - Elvecrog, James
AU  - Elvecrog J
AD  - 3M Company, St. Paul, MN USA
FAU - Grigsby, Iwen
AU  - Grigsby I
AD  - 3M Company, St. Paul, MN USA
FAU - Herbst, Ronald
AU  - Herbst R
AD  - Medimmune, Gaithersburg, MD USA
FAU - Johnson, Karen
AU  - Johnson K
AD  - 3M Company, St. Paul, MN USA
FAU - Moeckly, Craig
AU  - Moeckly C
AD  - 3M Company, St. Paul, MN USA
FAU - Mullins, Stefanie
AU  - Mullins S
AD  - Medimmune, Cambridge, England UK
FAU - Siebenaler, Kristen
AU  - Siebenaler K
AD  - 3M Company, St. Paul, MN USA
FAU - SternJohn, Julius
AU  - SternJohn J
AD  - 3M Company, St. Paul, MN USA
FAU - Tilahun, Ashenafi
AU  - Tilahun A
AD  - 3M Company, St. Paul, MN USA
FAU - Tomai, Mark A.
AU  - Tomai MA
AD  - 3M Company, St. Paul, MN USA
FAU - Vogel, Katharina
AU  - Vogel K
AD  - Medimmune, Cambridge, England UK
FAU - Wilkinson, Robert W.
AU  - Wilkinson RW
AD  - Medimmune, Cambridge, England UK
FAU - Vietsch, Eveline E.
AU  - Vietsch EE
AD  - Georgetown University/Medical School/Lombardi Cancer Center, Washington, DC USA
FAU - Wellstein, Anton
AU  - Wellstein A
AD  - Georgetown University/Medical School/Lombardi Cancer Center, Washington, DC USA
FAU - Wythes, Martin
AU  - Wythes M
AD  - Pfizer, San Diego, CA USA
FAU - Crosignani, Stefano
AU  - Crosignani S
AD  - iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium
FAU - Tumang, Joseph
AU  - Tumang J
AD  - Pfizer, San Diego, CA USA
FAU - Alekar, Shilpa
AU  - Alekar S
AD  - Pfizer, San Diego, CA USA
FAU - Bingham, Patrick
AU  - Bingham P
AD  - Pfizer, San Diego, CA USA
FAU - Cauwenberghs, Sandra
AU  - Cauwenberghs S
AD  - iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium
FAU - Chaplin, Jenny
AU  - Chaplin J
AD  - Pfizer, San Diego, CA USA
FAU - Dalvie, Deepak
AU  - Dalvie D
AD  - Pfizer, San Diego, CA USA
FAU - Denies, Sofie
AU  - Denies S
AD  - iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium
FAU - De Maeseneire, Coraline
AU  - De Maeseneire C
AD  - iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium
FAU - Feng, JunLi
AU  - Feng J
AD  - Pfizer, San Diego, CA USA
FAU - Frederix, Kim
AU  - Frederix K
AD  - iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium
FAU - Greasley, Samantha
AU  - Greasley S
AD  - Pfizer, San Diego, CA USA
FAU - Guo, Jie
AU  - Guo J
AD  - Pfizer, San Diego, CA USA
FAU - Hardwick, James
AU  - Hardwick J
AD  - Pfizer, San Diego, CA USA
FAU - Kaiser, Stephen
AU  - Kaiser S
AD  - Pfizer, San Diego, CA USA
FAU - Jessen, Katti
AU  - Jessen K
AD  - Pfizer, San Diego, CA USA
FAU - Kindt, Erick
AU  - Kindt E
AD  - Pfizer, San Diego, CA USA
FAU - Letellier, Marie-Claire
AU  - Letellier MC
AD  - iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium
FAU - Li, Wenlin
AU  - Li W
AD  - Pfizer, San Diego, CA USA
FAU - Maegley, Karen
AU  - Maegley K
AD  - Pfizer, San Diego, CA USA
FAU - Marillier, Reece
AU  - Marillier R
AD  - iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium
FAU - Miller, Nichol
AU  - Miller N
AD  - Pfizer, San Diego, CA USA
FAU - Murray, Brion
AU  - Murray B
AD  - Pfizer, San Diego, CA USA
FAU - Pirson, Romain
AU  - Pirson R
AD  - iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium
FAU - Preillon, Julie
AU  - Preillon J
AD  - iTeos, Rue Auguste Piccard 48, Brussels, Hoofdstedelijk Gewest Belgium
FAU - Rabolli, Virginie
AU  - Rabolli V
AD  - iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium
FAU - Ray, Chad
AU  - Ray C
AD  - Pfizer, San Diego, CA USA
FAU - Ryan, Kevin
AU  - Ryan K
AD  - Pfizer, San Diego, CA USA
FAU - Scales, Stephanie
AU  - Scales S
AD  - Pfizer, San Diego, CA USA
FAU - Srirangam, Jay
AU  - Srirangam J
AD  - Pfizer, San Diego, CA USA
FAU - Solowiej, Jim
AU  - Solowiej J
AD  - Pfizer, San Diego, CA USA
FAU - Stewart, Al
AU  - Stewart A
AD  - Pfizer, San Diego, CA USA
FAU - Streiner, Nicole
AU  - Streiner N
AD  - Pfizer, San Diego, CA USA
FAU - Torti, Vince
AU  - Torti V
AD  - Pfizer, San Diego, CA USA
FAU - Tsaparikos, Konstantinos
AU  - Tsaparikos K
AD  - Pfizer, San Diego, CA USA
FAU - Zheng, Xianxian
AU  - Zheng X
AD  - Pfizer, San Diego, CA USA
FAU - Driessens, Gregory
AU  - Driessens G
AD  - iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium
FAU - Gomes, Bruno
AU  - Gomes B
AD  - iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium
FAU - Kraus, Manfred
AU  - Kraus M
AD  - Pfizer, San Diego, CA USA
FAU - Xu, Chunxiao
AU  - Xu C
AD  - EMD Serono, Belmont, MA USA
FAU - Zhang, Yanping
AU  - Zhang Y
AD  - EMD Serono, Billerica, MA USA
FAU - Kradjian, Giorgio
AU  - Kradjian G
AD  - EMD Serono, Billerica, MA USA
FAU - Qin, Guozhong
AU  - Qin G
AD  - EMD Serono, Billerica, MA USA
FAU - Qi, Jin
AU  - Qi J
AD  - EMD Serono, Billerica, MA USA
FAU - Xu, Xiaomei
AU  - Xu X
AD  - EMD Serono, Billerica, MA USA
FAU - Marelli, Bo
AU  - Marelli B
AD  - EMD Serono, Billerica, MA USA
FAU - Yu, Huakui
AU  - Yu H
AD  - EMD Serono, Billerica, MA USA
FAU - Guzman, Wilson
AU  - Guzman W
AD  - EMD Serono, Billerica, MA USA
FAU - Tighe, Rober
AU  - Tighe R
AD  - EMD Serono, Billerica, MA USA
FAU - Salazar, Rachel
AU  - Salazar R
AD  - EMD Serono, Billerica, MA USA
FAU - Lo, Kin-Ming
AU  - Lo KM
AD  - EMD Serono, Billerica, MA USA
FAU - English, Jessie
AU  - English J
AD  - EMD Serono, Billerica, MA USA
FAU - Radvanyi, Laszlo
AU  - Radvanyi L
AD  - EMD Serono, Billerica, MA USA
FAU - Lan, Yan
AU  - Lan Y
AD  - EMD Serono, Billerica, MA USA
FAU - Zappasodi, Roberta
AU  - Zappasodi R
AD  - Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New
      York, NY USA
FAU - Budhu, Sadna
AU  - Budhu S
AD  - Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New
      York, NY USA
FAU - Hellmann, Matthew D.
AU  - Hellmann MD
AD  - Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Postow, Michael
AU  - Postow M
AD  - Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Senbabaoglu, Yasin
AU  - Senbabaoglu Y
AD  - Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New
      York, NY USA
FAU - Gasmi, Billel
AU  - Gasmi B
AD  - Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New
      York, NY USA
FAU - Zhong, Hong
AU  - Zhong H
AD  - Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New
      York, NY USA
FAU - Li, Yanyun
AU  - Li Y
AD  - Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New
      York, NY USA
FAU - Liu, Cailian
AU  - Liu C
AD  - Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New
      York, NY USA
FAU - Hirschhorhn-Cymerman, Daniel
AU  - Hirschhorhn-Cymerman D
AD  - Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New
      York, NY USA
FAU - Wolchok, Jedd D.
AU  - Wolchok JD
AD  - Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Merghoub, Taha
AU  - Merghoub T
AD  - Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New
      York, NY USA
FAU - Zha, Yuanyuan
AU  - Zha Y
AD  - University of Chicago, OSRF-HIM, Chicago, IL USA
FAU - Malnassy, Gregory
AU  - Malnassy G
AD  - University of Chicago, Chicago, IL USA
FAU - Fulton, Noreen
AU  - Fulton N
AD  - University of Chicago, Chicago, IL USA
FAU - Park, Jae-Hyun
AU  - Park JH
AD  - University of Chicago, Chicago, IL USA
FAU - Stock, Wendy
AU  - Stock W
AD  - Section of Hematology/Oncology, University of Chicago, Chicago, IL USA
FAU - Nakamura, Yusuke
AU  - Nakamura Y
AD  - University of Chicago, Chicago, IL USA
FAU - Gajewski, Thomas F.
AU  - Gajewski TF
AD  - University of Chicago Medical Center, Chicago, IL USA
FAU - Liu, Hongtao
AU  - Liu H
AD  - University of Chicago Medical Center, Chicago, IL USA
FAU - Ju, Xiaoming
AU  - Ju X
AD  - Advaxis Immunotherapies, Princeton, NJ USA
FAU - Kosoff, Rachelle
AU  - Kosoff R
AD  - Advaxis Immunotherapies, Princeton, NJ USA
FAU - Ramos, Kimberly
AU  - Ramos K
AD  - Advaxis Immunotherapies, Princeton, NJ USA
FAU - Coder, Brandon
AU  - Coder B
AD  - Advaxis Immunotherapies, Princeton, NJ USA
FAU - Petit, Robert
AU  - Petit R
AD  - Advaxis Immunotherapies, Princeton, NJ USA
FAU - Princiotta, Michael
AU  - Princiotta M
AD  - Advaxis Immunotherapies, Princeton, NJ USA
FAU - Perry, Kyle
AU  - Perry K
AD  - Advaxis Immunotherapies, Princeton, NJ USA
FAU - Zou, Jun
AU  - Zou J
AD  - Advaxis Immunotherapies, Princeton, NJ USA
FAU - Arina, Ainhoa
AU  - Arina A
AD  - The University of Chicago, Chicago, IL USA
FAU - Fernandez, Christian
AU  - Fernandez C
AD  - The University of Chicago, Chicago, IL USA
FAU - Zheng, Wenxin
AU  - Zheng W
AD  - The University of Chicago, Chicago, IL USA
FAU - Beckett, Michael A.
AU  - Beckett MA
AD  - The University of Chicago, Chicago, IL USA
FAU - Mauceri, Helena J.
AU  - Mauceri HJ
AD  - The University of Chicago, Chicago, IL USA
FAU - Fu, Yang-Xin
AU  - Fu YX
AD  - UT Southwestern, Dallas, TX USA
FAU - Weichselbaum, Ralph R.
AU  - Weichselbaum RR
AD  - The University of Chicago, Chicago, IL USA
FAU - DeBenedette, Mark
AU  - DeBenedette M
AD  - Argos Therapeutics, Durham, NC USA
FAU - Lewis, Whitney
AU  - Lewis W
AD  - Argos Therapeutics, Durham, NC USA
FAU - Gamble, Alicia
AU  - Gamble A
AD  - Argos Therapeutics, Durham, NC USA
FAU - Nicolette, Charles
AU  - Nicolette C
AD  - Argos Therapeutics, Durham, NC USA
FAU - Han, Yanyan
AU  - Han Y
AD  - R&D Department, HRYZ Biotech Co., Shenzhen, Guangdong People’s Republic of China
FAU - Wu, Yeting
AU  - Wu Y
AD  - Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital,
      Guangzhou, Guangdong People’s Republic of China
FAU - Yang, Chou
AU  - Yang C
AD  - Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital,
      Guangzhou, Guangdong People’s Republic of China
FAU - Huang, Jing
AU  - Huang J
AD  - Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital,
      Guangzhou, Guangdong People’s Republic of China
FAU - Wu, Dongyun
AU  - Wu D
AD  - HRYZ Biotech Co., Shenzhen, Guangdong People’s Republic of China
FAU - Li, Jin
AU  - Li J
AD  - HRYZ Biotech Co., Shenzhen, Guangdong People’s Republic of China
FAU - Liang, Xiaoling
AU  - Liang X
AD  - R&D Department, HRYZ Biotech Co., Shenzhen, Guangdong People’s Republic of China
FAU - Zhou, Xiangjun
AU  - Zhou X
AD  - HRYZ Biotech Co., Shenzhen, Guangdong People’s Republic of China
FAU - Hou, Jinlin
AU  - Hou J
AD  - Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital,
      Guangzhou, Guangdong People’s Republic of China
FAU - Hassan, Raffit
AU  - Hassan R
AD  - Thoracic and GI Oncology Branch, National Cancer Institute, Bethesda, MD USA
FAU - Jahan, Thierry
AU  - Jahan T
AD  - Department of Medicine, Division of Hematology Oncology, UCSF, San Francisco, CA 
      USA
FAU - Antonia, Scott J.
AU  - Antonia SJ
AD  - H. Lee Moffitt Cancer Center, Tampa, FL USA
FAU - Kindler, Hedy L.
AU  - Kindler HL
AD  - Gastrointestinal Oncology and Mesothelioma Programs, Section of
      Hematology/Oncology, University of Chicago, Chicago, IL USA
FAU - Alley, Evan W.
AU  - Alley EW
AD  - Penn Prebyterian Medical Center, University of Pennsylvania, Philadelphia, PA USA
FAU - Honarmand, Somayeh
AU  - Honarmand S
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Liu, Weiqun
AU  - Liu W
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Leong, Meredith L.
AU  - Leong ML
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Whiting, Chan C.
AU  - Whiting CC
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Nair, Nitya
AU  - Nair N
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Enstrom, Amanda
AU  - Enstrom A
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Lemmens, Edward E.
AU  - Lemmens EE
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Tsujikawa, Takahiro
AU  - Tsujikawa T
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Kumar, Sushil
AU  - Kumar S
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Coussens, Lisa M.
AU  - Coussens LM
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Murphy, Aimee L.
AU  - Murphy AL
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Brockstedt, Dirk G.
AU  - Brockstedt DG
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Koch, Sven D.
AU  - Koch SD
AD  - CureVac AG, Tubingen, Baden-Wurttemberg Germany
FAU - Sebastian, Martin
AU  - Sebastian M
AD  - University Hospital Frankfurt, Medical Clinic II, Goethe University, Frankfurt,
      Hessen Germany
FAU - Weiss, Christian
AU  - Weiss C
AD  - Klinikum Darmstadt GmbH, Darmstadt, Hessen Germany
FAU - Früh, Martin
AU  - Früh M
AD  - Kantonsspital St. Gallen, St. Gallen, Switzerland
FAU - Pless, Miklos
AU  - Pless M
AD  - Kantonsspital Winterthur, Winterthur, Zurich Switzerland
FAU - Cathomas, Richard
AU  - Cathomas R
AD  - Kantonsspital Graubünden, Chur, Graubunden Switzerland
FAU - Hilbe, Wolfgang
AU  - Hilbe W
AD  - Wilhelminenspital Wien, Wien, Austria
FAU - Pall, Georg
AU  - Pall G
AD  - Fachkliniken Wangen, Wangen (Allgäu), Baden-Wurttemberg Germany
FAU - Wehler, Thomas
AU  - Wehler T
AD  - J. Gutenberg University Hospital Mainz, Mainz, Rheinland-Pfalz Germany
FAU - Alt, Jürgen
AU  - Alt J
AD  - J. Gutenberg University Hospital Mainz, Mainz, Rheinland-Pfalz Germany
FAU - Bischoff, Helge
AU  - Bischoff H
AD  - Thoraxklinik Heidelberg gGmbH, Heidelberg, Baden-Wurttemberg Germany
FAU - Geissler, Michael
AU  - Geissler M
AD  - Klinikum Esslingen GmbH, Esslingen, Baden-Wurttemberg Germany
FAU - Griesinger, Frank
AU  - Griesinger F
AD  - Pius Hospital Oldenburg, Oldenburg, Niedersachsen Germany
FAU - Kollmeier, Jens
AU  - Kollmeier J
AD  - Heckeshorn Lung Clinic, Berlin, Germany
FAU - Papachristofilou, Alexandros
AU  - Papachristofilou A
AD  - University Hospital Basel, Basel-Stadt, Switzerland
FAU - Doener, Fatma
AU  - Doener F
AD  - CureVac AG, Tubingen, Baden-Wurttemberg Germany
FAU - Fotin-Mleczek, Mariola
AU  - Fotin-Mleczek M
AD  - CureVac AG, Tubingen, Baden-Wurttemberg Germany
FAU - Hipp, Madeleine
AU  - Hipp M
AD  - CureVac AG, Tubingen, Baden-Wurttemberg Germany
FAU - Hong, Henoch S.
AU  - Hong HS
AD  - CureVac AG, Tubingen, Baden-Wurttemberg Germany
FAU - Kallen, Karl-Josef
AU  - Kallen KJ
AD  - CureVac AG, Tubingen, Baden-Wurttemberg Germany
FAU - Klinkhardt, Ute
AU  - Klinkhardt U
AD  - CureVac AG, Frankfurt am Main, Hessen Germany
FAU - Stosnach, Claudia
AU  - Stosnach C
AD  - CureVac AG, Frankfurt am Main, Hessen Germany
FAU - Scheel, Birgit
AU  - Scheel B
AD  - CureVac AG, Tubingen, Baden-Wurttemberg Germany
FAU - Schroeder, Andreas
AU  - Schroeder A
AD  - CureVac AG, Frankfurt am Main, Hessen Germany
FAU - Seibel, Tobias
AU  - Seibel T
AD  - CureVac AG, Frankfurt am Main, Hessen Germany
FAU - Gnad-Vogt, Ulrike
AU  - Gnad-Vogt U
AD  - CureVac AG, Frankfurt am Main, Hessen Germany
FAU - Zippelius, Alfred
AU  - Zippelius A
AD  - University Hospital Basel, Basel-Stadt, Switzerland
FAU - Park, Ha-Ram
AU  - Park HR
AD  - SNU Cancer Research Institute, Seoul, Republic of Korea
FAU - Ahn, Yong-Oon
AU  - Ahn YO
AD  - SNU Cancer Research Institute, Seoul, Republic of Korea
FAU - Kim, Tae Min
AU  - Kim TM
AD  - Seoul National University Hospital, SNU Cancer Research Institute, Seoul,
      Republic of Korea
FAU - Kim, Soyeon
AU  - Kim S
AD  - SNU Cancer Research Institute, Seoul, Republic of Korea
FAU - Kim, Seulki
AU  - Kim S
AD  - SNU Cancer Research Institute, Seoul, Republic of Korea
FAU - Lee, Yu Soo
AU  - Lee YS
AD  - SNU Cancer Research Institute, Seoul, Republic of Korea
FAU - Keam, Bhumsuk
AU  - Keam B
AD  - Seoul National University Hospital, SNU Cancer Research Institute, Seoul,
      Republic of Korea
FAU - Kim, Dong-Wan
AU  - Kim DW
AD  - Seoul National University Hospital, SNU Cancer Research Institute, Seoul,
      Republic of Korea
FAU - Heo, Dae Seog
AU  - Heo DS
AD  - Seoul National University Hospital, SNU Cancer Research Institute, Seoul,
      Republic of Korea
FAU - Pilon-Thomas, Shari
AU  - Pilon-Thomas S
AD  - H. Lee Moffitt Cancer Center, Tampa, FL USA
FAU - Weber, Amy
AU  - Weber A
AD  - H. Lee Moffitt Cancer Center, Tampa, FL USA
FAU - Morse, Jennifer
AU  - Morse J
AD  - H. Lee Moffitt Cancer Center, Tampa, FL USA
FAU - Kodumudi, Krithika
AU  - Kodumudi K
AD  - H. Lee Moffitt Cancer Center, Tampa, FL USA
FAU - Liu, Hao
AU  - Liu H
AD  - H. Lee Moffitt Cancer Center, Tampa, FL USA
FAU - Mullinax, John
AU  - Mullinax J
AD  - H. Lee Moffitt Cancer Center, Tampa, FL USA
FAU - Sarnaik, Amod A.
AU  - Sarnaik AA
AD  - H. Lee Moffitt Cancer Center, Tampa, FL USA
FAU - Pike, Luke
AU  - Pike L
AD  - Brigham and Women’s/Dana-Farber Cancer Center, Harvard University, Boston, MA USA
FAU - Bang, Andrew
AU  - Bang A
AD  - Harvard Radiation Oncology Program, Boston, MA USA
FAU - Ott, Patrick A.
AU  - Ott PA
AD  - Dana-Farber Cancer Institute, Harvard University, Boston, MA USA
FAU - Balboni, Tracy
AU  - Balboni T
AD  - Brigham and Women’s/Dana-Farber Cancer Center, Harvard University, Boston, MA USA
FAU - Taylor, Allison
AU  - Taylor A
AD  - Brigham and Women’s/Dana-Farber Cancer Center, Harvard University, Boston, MA USA
FAU - Spektor, Alexander
AU  - Spektor A
AD  - Brigham and Women’s/Dana-Farber Cancer Center, Harvard University, Boston, MA USA
FAU - Wilhite, Tyler
AU  - Wilhite T
AD  - Brigham and Women’s/Dana-Farber Cancer Center, Harvard University, Boston, MA USA
FAU - Krishnan, Monica
AU  - Krishnan M
AD  - Brigham and Women’s/Dana-Farber Cancer Center, Harvard University, Boston, MA USA
FAU - Cagney, Daniel
AU  - Cagney D
AD  - Brigham and Women’s/Dana-Farber Cancer Center, Harvard University, Boston, MA USA
FAU - Alexander, Brian
AU  - Alexander B
AD  - Brigham and Women’s/Dana-Farber Cancer Center, Harvard University, Boston, MA USA
FAU - Aizer, Ayal
AU  - Aizer A
AD  - Brigham and Women’s/Dana-Farber Cancer Center, Harvard University, Boston, MA USA
FAU - Buchbinder, Elizabeth
AU  - Buchbinder E
AD  - Brigham and Women’s/Dana-Farber Cancer Center, Harvard University, Boston, MA USA
FAU - Awad, Mark
AU  - Awad M
AD  - Brigham and Women’s/Dana-Farber Cancer Center, Harvard University, Boston, MA USA
FAU - Ghandi, Leena
AU  - Ghandi L
AD  - Brigham and Women’s/Dana-Farber Cancer Center, Harvard University, Boston, MA USA
FAU - Hodi, F. Stephen
AU  - Hodi FS
AD  - Dana-Farber Cancer Institute, Harvard University, Boston, MA USA
FAU - Schoenfeld, Jonathan
AU  - Schoenfeld J
AD  - Brigham and Women’s/Dana-Farber Cancer Center, Harvard University, Boston, MA USA
FAU - Schwartz, Anthony L.
AU  - Schwartz AL
AD  - National Cancer Institute, Bethesda, MD USA
FAU - Nath, Pulak R.
AU  - Nath PR
AD  - National Cancer Institute, Bethesda, MD USA
FAU - Lessey-Morillon, Elizabeth
AU  - Lessey-Morillon E
AD  - National Cancer Institute, Bethesda, MD USA
FAU - Ridnour, Lisa
AU  - Ridnour L
AD  - National Cancer Institute, Frederick, MD USA
FAU - Roberts, David D.
AU  - Roberts DD
AD  - Department of Pathology, National Cancer Institute, Bethesda, MD USA
FAU - Segal, Neil H.
AU  - Segal NH
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Sharma, Manish
AU  - Sharma M
AD  - University of Chicago Medicine, Chicago, IL USA
FAU - Le, Dung T.
AU  - Le DT
AD  - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore,
      MD USA
FAU - Ott, Patrick A.
AU  - Ott PA
AD  - Dana-Farber Cancer Institute, Boston, MA USA
FAU - Ferris, Robert L.
AU  - Ferris RL
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Zelenetz, Andrew D.
AU  - Zelenetz AD
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Neelapu, Sattva S.
AU  - Neelapu SS
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Levy, Ronald
AU  - Levy R
AD  - Stanford University School of Medicine, Stanford, CA USA
FAU - Lossos, Izidore S.
AU  - Lossos IS
AD  - University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer
      Center, Miami, FL USA
FAU - Jacobson, Caron
AU  - Jacobson C
AD  - Dana-Farber Cancer Institute, Boston, MA USA
FAU - Ramchandren, Radhakrishnan
AU  - Ramchandren R
AD  - Karmanos Cancer Institute, Detroit, MI USA
FAU - Godwin, John
AU  - Godwin J
AD  - Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR USA
FAU - Colevas, A. Dimitrios
AU  - Colevas AD
AD  - Stanford University School of Medicine, Stanford, CA USA
FAU - Meier, Roland
AU  - Meier R
AD  - Bristol-Myers Squibb, Princeton, NJ USA
FAU - Krishnan, Suba
AU  - Krishnan S
AD  - Bristol-Myers Squibb, Princeton, NJ USA
FAU - Gu, Xuemin
AU  - Gu X
AD  - Bristol-Myers Squibb, Princeton, NJ USA
FAU - Neely, Jaclyn
AU  - Neely J
AD  - Bristol-Myers Squibb, Princeton, NJ USA
FAU - Suryawanshi, Satyendra
AU  - Suryawanshi S
AD  - Bristol-Myers Squibb, Princeton, NJ USA
FAU - Timmerman, John
AU  - Timmerman J
AD  - UCLA Medical Center, Los Angeles, CA USA
FAU - Vanpouille-Box, Claire I.
AU  - Vanpouille-Box CI
AD  - Department of Radiation Oncology, Weill Cornell Medicine, New York, NY USA
FAU - Formenti, Silvia C.
AU  - Formenti SC
AD  - Department of Radiation Oncology, Weill Cornell Medicine, New York, NY USA
FAU - Demaria, Sandra
AU  - Demaria S
AD  - Department of Radiation Oncology, Weill Cornell Medicine, New York, NY USA
FAU - Wennerberg, Erik
AU  - Wennerberg E
AD  - Weill Cornell Medical College, New York, NY USA
FAU - Mediero, Aranzazu
AU  - Mediero A
AD  - New York University Langone Medical Center, New York, NY USA
FAU - Cronstein, Bruce N.
AU  - Cronstein BN
AD  - Weill Cornell Medical College, New York, NY USA
FAU - Formenti, Silvia C.
AU  - Formenti SC
AD  - Department of Radiation Oncology, Weill Cornell Medicine, New York, NY USA
FAU - Demaria, Sandra
AU  - Demaria S
AD  - Department of Radiation Oncology, Weill Cornell Medicine, New York, NY USA
FAU - Gustafson, Michael P.
AU  - Gustafson MP
AD  - Mayo Clinic, Rochester, MN USA
FAU - DiCostanzo, AriCeli
AU  - DiCostanzo A
AD  - Mayo Clinic, Rochester, MN USA
FAU - Wheatley, Courtney
AU  - Wheatley C
AD  - Mayo Clinic, Rochester, MN USA
FAU - Kim, Chul-Ho
AU  - Kim CH
AD  - Mayo Clinic, Rochester, MN USA
FAU - Bornschlegl, Svetlana
AU  - Bornschlegl S
AD  - Mayo Clinic, Rochester, MN USA
FAU - Gastineau, Dennis A.
AU  - Gastineau DA
AD  - Mayo Clinic, Rochester, MN USA
FAU - Johnson, Bruce D.
AU  - Johnson BD
AD  - Mayo Clinic, Rochester, MN USA
FAU - Dietz, Allan B.
AU  - Dietz AB
AD  - Mayo Clinic, Rochester, MN USA
FAU - MacDonald, Cameron
AU  - MacDonald C
AD  - Roswell Park Cancer Institute, Buffalo, NY USA
FAU - Bucsek, Mark
AU  - Bucsek M
AD  - Roswell Park Cancer Institute, Buffalo, NY USA
FAU - Qiao, Guanxi
AU  - Qiao G
AD  - Roswell Park Cancer Institute, Buffalo, NY USA
FAU - Hylander, Bonnie
AU  - Hylander B
AD  - Roswell Park Cancer Institute, Buffalo, NY USA
FAU - Repasky, Elizabeth
AU  - Repasky E
AD  - Roswell Park Cancer Institute, Buffalo, NY USA
FAU - Turbitt, William J.
AU  - Turbitt WJ
AD  - Pennsylvania State University, University Park, PA USA
FAU - Xu, Yitong
AU  - Xu Y
AD  - Pennsylvania State University, University Park, PA USA
FAU - Mastro, Andrea
AU  - Mastro A
AD  - Pennsylvania State University, University Park, PA USA
FAU - Rogers, Connie J.
AU  - Rogers CJ
AD  - Pennsylvania State University, University Park, PA USA
FAU - Withers, Sita
AU  - Withers S
AD  - University of California, Davis, Sacramento, CA USA
FAU - Wang, Ziming
AU  - Wang Z
AD  - University of California, Davis, Sacramento, CA USA
FAU - Khuat, Lam T.
AU  - Khuat LT
AD  - University of California, Davis, Sacramento, CA USA
FAU - Dunai, Cordelia
AU  - Dunai C
AD  - University of California, Davis, Sacramento, CA USA
FAU - Blazar, Bruce R.
AU  - Blazar BR
AD  - University of Minnesota, Minneapolis, MN USA
FAU - Longo, Dan
AU  - Longo D
AD  - Dana-Farber Cancer Institute, Boston, MA USA
FAU - Rebhun, Robert
AU  - Rebhun R
AD  - University of California, Davis, Sacramento, CA USA
FAU - Grossenbacher, Steven K.
AU  - Grossenbacher SK
AD  - University of California, Davis, Sacramento, CA USA
FAU - Monjazeb, Arta
AU  - Monjazeb A
AD  - University of California, Davis, Sacramento, CA USA
FAU - Murphy, William J.
AU  - Murphy WJ
AD  - University of California, Davis, Sacramento, CA USA
FAU - Rowlinson, Scott
AU  - Rowlinson S
AD  - Aeglea BioTherapeutics, Austin, TX USA
FAU - Agnello, Giulia
AU  - Agnello G
AD  - Aeglea BioTherapeutics, Austin, TX USA
FAU - Alters, Susan
AU  - Alters S
AD  - Aeglea BioTherapeutics, Austin, TX USA
FAU - Lowe, David
AU  - Lowe D
AD  - Aeglea BioTherapeutics, Austin, TX USA
FAU - Scharping, Nicole
AU  - Scharping N
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Menk, Ashley V.
AU  - Menk AV
AD  - University of Pittsburgh Cancer Institute, Pittsburgh, PA USA
FAU - Whetstone, Ryan
AU  - Whetstone R
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Zeng, Xue
AU  - Zeng X
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Delgoffe, Greg M.
AU  - Delgoffe GM
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Santos, Patricia M.
AU  - Santos PM
AD  - University of Pittsburgh Cancer Institute, Pittsburgh, PA USA
FAU - Menk, Ashley V.
AU  - Menk AV
AD  - University of Pittsburgh Cancer Institute, Pittsburgh, PA USA
FAU - Shi, Jian
AU  - Shi J
AD  - University of Pittsburgh Cancer Institute, Pittsburgh, PA USA
FAU - Delgoffe, Greg M.
AU  - Delgoffe GM
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Butterfield, Lisa H.
AU  - Butterfield LH
AD  - University of Pittsburgh Cancer Institute, Pittsburgh, PA USA
FAU - Whetstone, Ryan
AU  - Whetstone R
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Menk, Ashley V.
AU  - Menk AV
AD  - University of Pittsburgh Cancer Institute, Pittsburgh, PA USA
FAU - Scharping, Nicole
AU  - Scharping N
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Delgoffe, Greg
AU  - Delgoffe G
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Nagasaka, Misako
AU  - Nagasaka M
AD  - Karmanos Cancer Institute, Detroit, MI USA
FAU - Sukari, Ammar
AU  - Sukari A
AD  - Karmanos Cancer Institute, Detroit, MI USA
FAU - Byrne-Steele, Miranda
AU  - Byrne-Steele M
AD  - iRepertoire, Inc, Huntsville, AL USA
FAU - Pan, Wenjing
AU  - Pan W
AD  - iRepertoire, Inc, Huntsville, AL USA
FAU - Hou, Xiaohong
AU  - Hou X
AD  - iRepertoire, Inc, Huntsville, AL USA
FAU - Brown, Brittany
AU  - Brown B
AD  - iRepertoire, Inc, Huntsville, AL USA
FAU - Eisenhower, Mary
AU  - Eisenhower M
AD  - iRepertoire, Inc, Huntsville, AL USA
FAU - Han, Jian
AU  - Han J
AD  - iRepertoire, Inc, Huntsville, AL USA
FAU - Collins, Natalie
AU  - Collins N
AD  - Dana-Farber Cancer Institute, Boston, MA USA
FAU - Manguso, Robert
AU  - Manguso R
AD  - Dana-Farber Cancer Institute, Boston, MA USA
FAU - Pope, Hans
AU  - Pope H
AD  - Dana-Farber Cancer Institute, Boston, MA USA
FAU - Shrestha, Yashaswi
AU  - Shrestha Y
AD  - Broad Institute, Cambridge, MA USA
FAU - Boehm, Jesse
AU  - Boehm J
AD  - Broad Institute, Cambridge, MA USA
FAU - Haining, W. Nicholas
AU  - Haining WN
AD  - Dana-Farber Cancer Institute, Boston, MA USA
FAU - Cron, Kyle R.
AU  - Cron KR
AD  - University of Chicago, Chicago, IL USA
FAU - Sivan, Ayelet
AU  - Sivan A
AD  - University of Chicago, Chicago, IL USA
FAU - Aquino-Michaels, Keston
AU  - Aquino-Michaels K
AD  - University of Chicago, Chicago, IL USA
FAU - Gajewski, Thomas F.
AU  - Gajewski TF
AD  - University of Chicago Medical Center, Chicago, IL USA
FAU - Orecchioni, Marco
AU  - Orecchioni M
AD  - University of Sassari, Sassari, Sardegna Italy
FAU - Bedognetti, Davide
AU  - Bedognetti D
AD  - Sidra Medical and Research Center, Doha, Ad Dawhah Qatar
FAU - Hendrickx, Wouter
AU  - Hendrickx W
AD  - Sidra Medical and Research Center, Doha, Ad Dawhah Qatar
FAU - Fuoco, Claudia
AU  - Fuoco C
AD  - Bristol-Myers Squibb, Lawrence Township, NJ USA
FAU - Spada, Filomena
AU  - Spada F
AD  - University of Roma Tor Vergata, Roma, Lazio Italy
FAU - Sgarrella, Francesco
AU  - Sgarrella F
AD  - University of Sassari, Sassari, Sardegna Italy
FAU - Cesareni, Gianni
AU  - Cesareni G
AD  - University of Roma Tor Vergata, Roma, Lazio Italy
FAU - Marincola, Francesco
AU  - Marincola F
AD  - Research Branch, Sidra Medical and Research Center, Doha, Ad Dawhah Qatar
FAU - Kostarelos, Kostas
AU  - Kostarelos K
AD  - Faculty of Medical & Human Sciences, University of Manchester, Manchester,
      England UK
FAU - Bianco, Alberto
AU  - Bianco A
AD  - CNRS, Institute de Biologie Moléculaire et Cellulaire, Strasbourg, Alsace France
FAU - Delogu, Lucia
AU  - Delogu L
AD  - University of Sassari, Sassari, Sardegna Italy
FAU - Hendrickx, Wouter
AU  - Hendrickx W
AD  - Sidra Medical and Research Center, Doha, Ad Dawhah Qatar
FAU - Roelands, Jessica
AU  - Roelands J
AD  - Sidra Medical and Research Center, Doha, Ad Dawhah Qatar
FAU - Boughorbel, Sabri
AU  - Boughorbel S
AD  - Sidra Medical and Research Center, Doha, Ad Dawhah Qatar
FAU - Decock, Julie
AU  - Decock J
AD  - Qatar Biomedical Research Institute (QBRI), Doha, Ar Rayyan Qatar
FAU - Presnell, Scott
AU  - Presnell S
AD  - Benaroya Research Institute, Seattle, WA USA
FAU - Wang, Ena
AU  - Wang E
AD  - Qatar Computing Research Institute, Doha, Ad Dawhah Qatar
FAU - Marincola, Franco M.
AU  - Marincola FM
AD  - Sidra Medical and Research Center, Doha, Ad Dawhah Qatar
FAU - Kuppen, Peter
AU  - Kuppen P
AD  - Leiden University Medical Center, Leiden, Zuid-Holland Netherlands
FAU - Ceccarelli, Michele
AU  - Ceccarelli M
AD  - Qatar Computing Research Institute, Doha, Ad Dawhah Qatar
FAU - Rinchai, Darawan
AU  - Rinchai D
AD  - Sidra Medical and Research Center, Doha, Ad Dawhah Qatar
FAU - Chaussabel, Damien
AU  - Chaussabel D
AD  - Sidra Medical and Research Center, Doha, Ad Dawhah Qatar
FAU - Miller, Lance
AU  - Miller L
AD  - Wake Forest School of Medicine, Winston-Salem, NC USA
FAU - Bedognetti, Davide
AU  - Bedognetti D
AD  - Sidra Medical and Research Center, Doha, Ad Dawhah Qatar
FAU - Nguyen, Andrew
AU  - Nguyen A
AD  - NantOmics, San Jose, CA USA
FAU - Sanborn, J. Zachary
AU  - Sanborn JZ
AD  - NantOmics, Santa Cruz, CA USA
FAU - Vaske, Charles
AU  - Vaske C
AD  - NantOmics, Santa Cruz, CA USA
FAU - Rabizadeh, Shahrooz
AU  - Rabizadeh S
AD  - NantOmics, Santa Cruz, CA USA
FAU - Niazi, Kayvan
AU  - Niazi K
AD  - NantOmics, Santa Cruz, CA USA
FAU - Benz, Steven
AU  - Benz S
AD  - NantOmics, Santa Cruz, CA USA
FAU - Patel, Shashank
AU  - Patel S
AD  - National Cancer Institute, Bethesda, MD USA
FAU - Restifo, Nicholas
AU  - Restifo N
AD  - National Cancer Institute, Bethesda, MD USA
FAU - White, James
AU  - White J
AD  - Personal Genome Diagnostics, Baltimore, MD USA
FAU - Angiuoli, Sam
AU  - Angiuoli S
AD  - Personal Genome Diagnostics, Baltimore, MD USA
FAU - Sausen, Mark
AU  - Sausen M
AD  - Personal Genome Diagnostics, Baltimore, MD USA
FAU - Jones, Sian
AU  - Jones S
AD  - Personal Genome Diagnostics, Baltimore, MD USA
FAU - Sevdali, Maria
AU  - Sevdali M
AD  - Personal Genome Diagnostics, Baltimore, MD USA
FAU - Simmons, John
AU  - Simmons J
AD  - Personal Genome Diagnostics, Baltimore, MD USA
FAU - Velculescu, Victor
AU  - Velculescu V
AD  - Personal Genome Diagnostics, Baltimore, MD USA
FAU - Diaz, Luis
AU  - Diaz L
AD  - Personal Genome Diagnostics, Baltimore, MD USA
FAU - Zhang, Theresa
AU  - Zhang T
AD  - Personal Genome Diagnostics, Baltimore, MD USA
FAU - Sims, Jennifer S.
AU  - Sims JS
AD  - Columbia University Medical Center, New York, NY USA
FAU - Barton, Sunjay M.
AU  - Barton SM
AD  - Columbia University Medical Center, New York, NY USA
FAU - Gartrell, Robyn
AU  - Gartrell R
AD  - Columbia University Medical Center, New York, NY USA
FAU - Kadenhe-Chiweshe, Angela
AU  - Kadenhe-Chiweshe A
AD  - Columbia University Medical Center, New York, NY USA
FAU - Dela Cruz, Filemon
AU  - Dela Cruz F
AD  - Columbia University Medical Center, New York, NY USA
FAU - Turk, Andrew T.
AU  - Turk AT
AD  - Columbia University Medical Center, New York, NY USA
FAU - Lu, Yan
AU  - Lu Y
AD  - Columbia University Medical Center, New York, NY USA
FAU - Mazzeo, Christopher F.
AU  - Mazzeo CF
AD  - Fordham University, New York, NY USA
FAU - Kung, Andrew L.
AU  - Kung AL
AD  - Columbia University Medical Center, New York, NY USA
FAU - Bruce, Jeffrey N.
AU  - Bruce JN
AD  - Columbia University Medical Center, New York, NY USA
FAU - Saenger, Yvonne M.
AU  - Saenger YM
AD  - New York Presbyterian/Columbia University Medical Center, New York, NY USA
FAU - Yamashiro, Darrell J.
AU  - Yamashiro DJ
AD  - Columbia University Medical Center, New York, NY USA
FAU - Connolly, Eileen P.
AU  - Connolly EP
AD  - Columbia University Medical Center, New York, NY USA
FAU - Baird, Jason
AU  - Baird J
AD  - Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence
      Portland Medical Center, Portland, OR USA
FAU - Crittenden, Marka
AU  - Crittenden M
AD  - Earle A. Chile Research Institute, Portland, OR USA
FAU - Friedman, David
AU  - Friedman D
AD  - Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence
      Portland Medical Center, Portland, OR USA
FAU - Xiao, Hong
AU  - Xiao H
AD  - Providence Portland Medical Center, Portland, OR USA
FAU - Leidner, Rom
AU  - Leidner R
AD  - Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence
      Portland Medical Center, Portland, OR USA
FAU - Bell, Bryan
AU  - Bell B
AD  - Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence
      Portland Medical Center, Portland, OR USA
FAU - Young, Kristina
AU  - Young K
AD  - Earle A. Chile Research Institute, Portland, OR USA
FAU - Gough, Michael
AU  - Gough M
AD  - Earle A. Chile Research Institute, Portland, OR USA
FAU - Bian, Zhen
AU  - Bian Z
AD  - Georgia State University, Atlanta, GA USA
FAU - Kidder, Koby
AU  - Kidder K
AD  - Georgia State University, Atlanta, GA USA
FAU - Liu, Yuan
AU  - Liu Y
AD  - Georgia State University, Atlanta, GA USA
FAU - Curran, Emily
AU  - Curran E
AD  - University of Chicago, Chicago, IL USA
FAU - Chen, Xiufen
AU  - Chen X
AD  - Department of Medicine, University of Chicago, Chicago, IL USA
FAU - Corrales, Leticia P.
AU  - Corrales LP
AD  - University of Chicago, Chicago, IL USA
FAU - Kline, Justin
AU  - Kline J
AD  - Committee on Immunology and Department of Medicine, University of Chicago,
      Chicago, IL USA
FAU - Dunai, Cordelia
AU  - Dunai C
AD  - University of California, Davis, Sacramento, CA USA
FAU - Aguilar, Ethan G.
AU  - Aguilar EG
AD  - University of California, Davis, Sacramento, CA USA
FAU - Khuat, Lam T.
AU  - Khuat LT
AD  - University of California, Davis, Sacramento, CA USA
FAU - Murphy, William J.
AU  - Murphy WJ
AD  - University of California, Davis, Sacramento, CA USA
FAU - Guerriero, Jennifer
AU  - Guerriero J
AD  - Dana-Farber Cancer Institute, Boston, MA USA
FAU - Sotayo, Alaba
AU  - Sotayo A
AD  - Dana-Farber Cancer Institute, Boston, MA USA
FAU - Ponichtera, Holly
AU  - Ponichtera H
AD  - Evelo Biosciences, Cambridge, MA USA
FAU - Pourzia, Alexandra
AU  - Pourzia A
AD  - Dana-Farber Cancer Institute, Boston, MA USA
FAU - Schad, Sara
AU  - Schad S
AD  - Dana-Farber Cancer Institute, Boston, MA USA
FAU - Carrasco, Ruben
AU  - Carrasco R
AD  - Dana-Farber Cancer Institute, Boston, MA USA
FAU - Lazo, Suzan
AU  - Lazo S
AD  - Dana-Farber Cancer Institute, Boston, MA USA
FAU - Bronson, Roderick
AU  - Bronson R
AD  - Harvard Medical School, Boston, MA USA
FAU - Letai, Anthony
AU  - Letai A
AD  - Dana-Farber Cancer Institute, Boston, MA USA
FAU - Kornbluth, Richard S.
AU  - Kornbluth RS
AD  - Receptome, LLC, La Jolla, CA USA
FAU - Gupta, Sachin
AU  - Gupta S
AD  - Miller School of Medicine, University of Miami, Miami, FL USA
FAU - Termini, James
AU  - Termini J
AD  - Miller School of Medicine, University of Miami, Miami, FL USA
FAU - Guirado, Elizabeth
AU  - Guirado E
AD  - Miller School of Medicine, University of Miami, Miami, FL USA
FAU - Stone, Geoffrey W.
AU  - Stone GW
AD  - Miller School of Medicine, University of Miami, Miami, FL USA
FAU - Meyer, Christina
AU  - Meyer C
AD  - EMD Serono, Billerica, MA USA
FAU - Helming, Laura
AU  - Helming L
AD  - Merck KGaA, Darmstadt, Hessen Germany
FAU - Tumang, Joseph
AU  - Tumang J
AD  - Compass Therapeutics, Cambridge, MA USA
FAU - Wilson, Nicholas
AU  - Wilson N
AD  - Agenus Inc., Lexington, MA USA
FAU - Hofmeister, Robert
AU  - Hofmeister R
AD  - TCR2 Therapeutics, Cambridge, MA USA
FAU - Radvanyi, Laszlo
AU  - Radvanyi L
AD  - EMD Serono, Billerica, MA USA
FAU - Neubert, Natalie J.
AU  - Neubert NJ
AD  - University of Lausanne, Ludwig Cancer Research, Epalinges, Vaud Switzerland
FAU - Tillé, Laure
AU  - Tillé L
AD  - University of Lausanne, Ludwig Cancer Research, Epalinges, Vaud Switzerland
FAU - Barras, David
AU  - Barras D
AD  - SIB Swiss Institute of Bioinformatics, Lausanne, Vaud Switzerland
FAU - Soneson, Charlotte
AU  - Soneson C
AD  - SIB Swiss Institute of Bioinformatics, Lausanne, Vaud Switzerland
FAU - Baumgaertner, Petra
AU  - Baumgaertner P
AD  - University of Lausanne, Ludwig Cancer Research, Epalinges, Vaud Switzerland
FAU - Rimoldi, Donata
AU  - Rimoldi D
AD  - University of Lausanne, Ludwig Cancer Research, Epalinges, Vaud Switzerland
FAU - Gfeller, David
AU  - Gfeller D
AD  - University of Lausanne, Ludwig Cancer Research, Epalinges, Vaud Switzerland
FAU - Delorenzi, Mauro
AU  - Delorenzi M
AD  - SIB Swiss Institute of Bioinformatics, Lausanne, Vaud Switzerland
FAU - Fuertes Marraco, Silvia A.
AU  - Fuertes Marraco SA
AD  - University of Lausanne, Ludwig Cancer Research, Epalinges, Vaud Switzerland
FAU - Speiser, Daniel E.
AU  - Speiser DE
AD  - University of Lausanne, Ludwig Cancer Research, Epalinges, Vaud Switzerland
FAU - Abraham, Tara S.
AU  - Abraham TS
AD  - Thomas Jefferson University, Philadelphia, PA USA
FAU - Xiang, Bo
AU  - Xiang B
AD  - Thomas Jefferson University, Philadelphia, PA USA
FAU - Magee, Michael S.
AU  - Magee MS
AD  - Thomas Jefferson University, Philadelphia, PA USA
FAU - Waldman, Scott A.
AU  - Waldman SA
AD  - Thomas Jefferson University, Philadelphia, PA USA
FAU - Snook, Adam E.
AU  - Snook AE
AD  - Thomas Jefferson University, Philadelphia, PA USA
FAU - Blogowski, Wojciech
AU  - Blogowski W
AD  - Department of Internal Medicine, University of Zielona Gora, Zielona Gora,
      Lubuskie Poland
FAU - Zuba-Surma, Ewa
AU  - Zuba-Surma E
AD  - Department of Medical Biotechnology, Jagiellonian University, Krakow, Malopolskie
      Poland
FAU - Budkowska, Marta
AU  - Budkowska M
AD  - Department of Medical Analytics, Pomeranian Medical University, Szczecin,
      Zachodniopomorskie Poland
FAU - Salata, Daria
AU  - Salata D
AD  - Department of Medical Analytics, Pomeranian Medical University, Szczecin,
      Zachodniopomorskie Poland
FAU - Dolegowska, Barbara
AU  - Dolegowska B
AD  - Department of Microbiology and Immune Diagnostics, Pomeranian Medical University,
      Szczecin, Zachodniopomorskie Poland
FAU - Starzynska, Teresa
AU  - Starzynska T
AD  - Department of Gastroenterology, Pomeranian Medical University, Szczecin,
      Zachodniopomorskie Poland
FAU - Chan, Leo
AU  - Chan L
AD  - Nexcelom Bioscience, Lawrence, MA USA
FAU - Somanchi, Srinivas
AU  - Somanchi S
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - McCulley, Kelsey
AU  - McCulley K
AD  - Nexcelom Bioscience, Lawrence, MA USA
FAU - Lee, Dean
AU  - Lee D
AD  - Nexcelom Bioscience, Houston, MA USA
FAU - Buettner, Nico
AU  - Buettner N
AD  - Universitätsklinikum Freiburg, Freiburg, Germany
FAU - Shi, Feng
AU  - Shi F
AD  - Massachusetts General Hospital Cancer Center, Boston, MA USA
FAU - Myers, Paisley T.
AU  - Myers PT
AD  - University of Virginia, Charlottesville, VA USA
FAU - Curbishley, Stuart
AU  - Curbishley S
AD  - University of Birmingham, Birmingham, England UK
FAU - Penny, Sarah A.
AU  - Penny SA
AD  - University of Birmingham, Birmingham, England UK
FAU - Steadman, Lora
AU  - Steadman L
AD  - University of Birmingham, Birmingham, England UK
FAU - Millar, David
AU  - Millar D
AD  - Massachusetts General Hospital Cancer Center, Boston, MA USA
FAU - Speers, Ellen
AU  - Speers E
AD  - University of Virginia, Charlottesville, VA USA
FAU - Ruth, Nicola
AU  - Ruth N
AD  - University of Birmingham, Birmingham, England UK
FAU - Wong, Gabriel
AU  - Wong G
AD  - University of Birmingham, Birmingham, England UK
FAU - Thimme, Robert
AU  - Thimme R
AD  - Universitätsklinikum Freiburg, Freiburg, Germany
FAU - Adams, David
AU  - Adams D
AD  - University of Birmingham, Birmingham, England UK
FAU - Cobbold, Mark
AU  - Cobbold M
AD  - Massachusetts General Hospital Cancer Center, Boston, MA USA
FAU - Thomas, Remy
AU  - Thomas R
AD  - Qatar Biomedical Research Instititute (QBRI), Doha, Ar Rayyan Qatar
FAU - Hendrickx, Wouter
AU  - Hendrickx W
AD  - Sidra Medical and Research Center, Doha, Ad Dawhah Qatar
FAU - Al-Muftah, Mariam
AU  - Al-Muftah M
AD  - Qatar Biomedical Research Instititute (QBRI), Doha, Ar Rayyan Qatar
FAU - Decock, Julie
AU  - Decock J
AD  - Qatar Biomedical Research Instititute (QBRI), Doha, Ar Rayyan Qatar
FAU - Wong, Michael KK
AU  - Wong MK
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Morse, Michael
AU  - Morse M
AD  - Duke University Medical Center, Durham, NC USA
FAU - McDermott, David F.
AU  - McDermott DF
AD  - Beth Israel Deaconess Medical Center, Boston, MA USA
FAU - Clark, Joseph I.
AU  - Clark JI
AD  - Loyola University Medical Center, Maywood, IL USA
FAU - Kaufman, Howard L.
AU  - Kaufman HL
AD  - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
FAU - Daniels, Gregory A.
AU  - Daniels GA
AD  - UC San Diego Moores Cancer Center, La Jolla, CA USA
FAU - Hua, Hong
AU  - Hua H
AD  - Prometheus Laboratories Inc., San Diego, CA USA
FAU - Rao, Tharak
AU  - Rao T
AD  - Prometheus Laboratories Inc., San Diego, CA USA
FAU - Dutcher, Janice P.
AU  - Dutcher JP
AD  - Cancer Research Foundation, Chappaqua, NY USA
FAU - Kang, Kai
AU  - Kang K
AD  - Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH USA
FAU - Saunthararajah, Yogen
AU  - Saunthararajah Y
AD  - Cleveland Clinic, Cleveland, OH USA
FAU - Velcheti, Vamsidhar
AU  - Velcheti V
AD  - Cleveland Clinic, Cleveland, OH USA
FAU - Kumar, Vikas
AU  - Kumar V
AD  - Sam Higginbotham Institute of Agriculture, Technology & Sciences, Allahabad,
      Uttar Pradesh India
FAU - Anwar, Firoz
AU  - Anwar F
AD  - King Abdulaziz University, Jeddah, Afghanistan
FAU - Verma, Amita
AU  - Verma A
AD  - Sam Higginbotham Institute of Agriculture, Technology & Sciences, Allahabad,
      Uttar Pradesh India
FAU - Chheda, Zinal
AU  - Chheda Z
AD  - University of California, San Francisco, San Francisco, CA USA
FAU - Kohanbash, Gary
AU  - Kohanbash G
AD  - University of California, San Francisco, San Francisco, CA USA
FAU - Sidney, John
AU  - Sidney J
AD  - La Jolla Institute for Allergy and Immunology, La Jolla, CA USA
FAU - Okada, Kaori
AU  - Okada K
AD  - University of California, San Francisco, San Francisco, CA USA
FAU - Shrivastav, Shruti
AU  - Shrivastav S
AD  - University of California, San Francisco, San Francisco, CA USA
FAU - Carrera, Diego A.
AU  - Carrera DA
AD  - University of California, San Francisco, San Francisco, CA USA
FAU - Liu, Shuming
AU  - Liu S
AD  - University of California, San Francisco, San Francisco, CA USA
FAU - Jahan, Naznin
AU  - Jahan N
AD  - University of California, San Francisco, San Francisco, CA USA
FAU - Mueller, Sabine
AU  - Mueller S
AD  - University of California, San Francisco, San Francisco, CA USA
FAU - Pollack, Ian F.
AU  - Pollack IF
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Carcaboso, Angel M.
AU  - Carcaboso AM
AD  - Hospital Sant Joan de Déu Barcelona, Barcelona, Spain
FAU - Sette, Alessandro
AU  - Sette A
AD  - La Jolla Institute for Allergy and Immunology, La Jolla, CA USA
FAU - Hou, Yafei
AU  - Hou Y
AD  - University of California, San Francisco, San Francisco, CA USA
FAU - Okada, Hideho
AU  - Okada H
AD  - University of California, San Francisco, San Francisco, CA USA
FAU - Field, Jessica J.
AU  - Field JJ
AD  - Seattle Genetics, Inc., Bothell, WA USA
FAU - Zeng, Weiping
AU  - Zeng W
AD  - Seattle Genetics, Inc., Bothell, WA USA
FAU - Shih, Vincent FS
AU  - Shih VF
AD  - Seattle Genetics, Inc., Bothell, WA USA
FAU - Law, Che-Leung
AU  - Law CL
AD  - Seattle Genetics, Inc., Bothell, WA USA
FAU - Senter, Peter D.
AU  - Senter PD
AD  - Seattle Genetics, Inc., Bothell, WA USA
FAU - Gardai, Shyra J.
AU  - Gardai SJ
AD  - Seattle Genetics, Inc., Bothell, WA USA
FAU - Okeley, Nicole M.
AU  - Okeley NM
AD  - Seattle Genetics, Inc., Bothell, WA USA
FAU - Penny, Sarah A.
AU  - Penny SA
AD  - University of Birmingham, Birmingham, England UK
FAU - Abelin, Jennifer G.
AU  - Abelin JG
AD  - University of Virginia, Charlottesville, VA USA
FAU - Saeed, Abu Z.
AU  - Saeed AZ
AD  - University of Birmingham, Birmingham, England UK
FAU - Malaker, Stacy A.
AU  - Malaker SA
AD  - Stanford University, Stanford, CA USA
FAU - Myers, Paisley T.
AU  - Myers PT
AD  - University of Virginia, Charlottesville, VA USA
FAU - Shabanowitz, Jeffrey
AU  - Shabanowitz J
AD  - University of Virginia, Charlottesville, VA USA
FAU - Ward, Stephen T.
AU  - Ward ST
AD  - University of Birmingham, Birmingham, England UK
FAU - Hunt, Donald F.
AU  - Hunt DF
AD  - University of Virginia, Charlottesville, VA USA
FAU - Cobbold, Mark
AU  - Cobbold M
AD  - Massachusetts General Hospital Cancer Center, Boston, MA USA
FAU - Profusek, Pam
AU  - Profusek P
AD  - Cleveland Clinic, Cleveland, OH USA
FAU - Wood, Laura
AU  - Wood L
AD  - Cleveland Clinic, Cleveland, OH USA
FAU - Shepard, Dale
AU  - Shepard D
AD  - Cleveland Clinic, Cleveland, OH USA
FAU - Grivas, Petros
AU  - Grivas P
AD  - Cleveland Clinic, Cleveland, OH USA
FAU - Kapp, Kerstin
AU  - Kapp K
AD  - Mologen AG, Berlin, Germany
FAU - Volz, Barbara
AU  - Volz B
AD  - Mologen AG, Berlin, Germany
FAU - Oswald, Detlef
AU  - Oswald D
AD  - Mologen AG, Berlin, Germany
FAU - Wittig, Burghardt
AU  - Wittig B
AD  - Foundation Institute Molecular Biology and Bioinformatics, Freie Universitaet
      Berlin, Berlin, Germany
FAU - Schmidt, Manuel
AU  - Schmidt M
AD  - Mologen AG, Berlin, Germany
FAU - Sefrin, Julian P.
AU  - Sefrin JP
AD  - Roche Diagnostics GmbH, Penzberg, Bayern Germany
FAU - Hillringhaus, Lars
AU  - Hillringhaus L
AD  - Roche Diagnostics GmbH, Penzberg, Bayern Germany
FAU - Lifke, Valeria
AU  - Lifke V
AD  - Roche Diagnostics GmbH, Penzberg, Bayern Germany
FAU - Lifke, Alexander
AU  - Lifke A
AD  - Roche Diagnostics GmbH, Penzberg, Bayern Germany
FAU - Skaletskaya, Anna
AU  - Skaletskaya A
AD  - ImmunoGen, Inc., Waltham, MA USA
FAU - Ponte, Jose
AU  - Ponte J
AD  - ImmunoGen, Inc., Waltham, MA USA
FAU - Chittenden, Thomas
AU  - Chittenden T
AD  - ImmunoGen, Inc., Waltham, MA USA
FAU - Setiady, Yulius
AU  - Setiady Y
AD  - ImmunoGen, Inc., Waltham, MA USA
FAU - Valsesia-Wittmann, Sandrine
AU  - Valsesia-Wittmann S
AD  - Centre Léon Bérard, Innovations in immunotherapy platform, Lyon, Rhone-Alpes
      France
FAU - Sivado, Eva
AU  - Sivado E
AD  - Centre Léon Bérard, Innovations in immunotherapy platform, Lyon, Rhone-Alpes
      France
FAU - Thomas, Vincent
AU  - Thomas V
AD  - Covalab, Villeurbanne, Rhone-Alpes France
FAU - El Alaoui, Meddy
AU  - El Alaoui M
AD  - Centre Léon Bérard, Innovations in immunotherapy platform, Lyon, Rhone-Alpes
      France
FAU - Papot, Sébastien
AU  - Papot S
AD  - IC2MP, Poitiers, Limousin France
FAU - Dumontet, Charles
AU  - Dumontet C
AD  - CRCL, Lyon, Rhone-Alpes France
FAU - Dyson, Mike
AU  - Dyson M
AD  - IONTAS, Cambridge, England UK
FAU - McCafferty, John
AU  - McCafferty J
AD  - IONTAS, Cambridge, England UK
FAU - El Alaoui, Said
AU  - El Alaoui S
AD  - Covalab, Villeurbanne, Rhone-Alpes France
FAU - Verma, Amita
AU  - Verma A
AD  - Sam Higginbotham Institute of Agriculture, Technology & Sciences, Allahabad,
      Uttar Pradesh India
FAU - Kumar, Vikas
AU  - Kumar V
AD  - Sam Higginbotham Institute of Agriculture, Technology & Sciences, Allahabad,
      Uttar Pradesh India
FAU - Bommareddy, Praveen K.
AU  - Bommareddy PK
AD  - Rutgers University, New Brunswick, NJ USA
FAU - Kaufman, Howard L.
AU  - Kaufman HL
AD  - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
FAU - Zloza, Andrew
AU  - Zloza A
AD  - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
FAU - Kohlhapp, Frederick
AU  - Kohlhapp F
AD  - Rutgers University, New Brunswick, NJ USA
FAU - Silk, Ann W.
AU  - Silk AW
AD  - Rutgers University, New Brunswick, NJ USA
FAU - Jhawar, Sachin
AU  - Jhawar S
AD  - Rutgers University, New Brunswick, NJ USA
FAU - Paneque, Tomas
AU  - Paneque T
AD  - Rutgers Robert Wood Johnson Medical School, Somerset, NJ USA
FAU - Bommareddy, Praveen K.
AU  - Bommareddy PK
AD  - Rutgers University, New Brunswick, NJ USA
FAU - Kohlhapp, Frederick
AU  - Kohlhapp F
AD  - Rutgers University, New Brunswick, NJ USA
FAU - Newman, Jenna
AU  - Newman J
AD  - Rutgers University, New Brunswick, NJ USA
FAU - Beltran, Pedro
AU  - Beltran P
AD  - Rutgers University, New Brunswick, NJ USA
FAU - Zloza, Andrew
AU  - Zloza A
AD  - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
FAU - Kaufman, Howard L.
AU  - Kaufman HL
AD  - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
FAU - Cao, Felicia
AU  - Cao F
AD  - Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist,
      Baylor College of Medicine, Houston, TX USA
FAU - Hong, Bang-Xing
AU  - Hong BX
AD  - Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist,
      Baylor College of Medicine, Houston, TX USA
FAU - Rodriguez-Cruz, Tania
AU  - Rodriguez-Cruz T
AD  - Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist,
      Baylor College of Medicine, Houston, TX USA
FAU - Song, Xiao-Tong
AU  - Song XT
AD  - Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist,
      Baylor College of Medicine, Houston, TX USA
FAU - Gottschalk, Stephen
AU  - Gottschalk S
AD  - Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist,
      Baylor College of Medicine, Houston, TX USA
FAU - Calderon, Hugo
AU  - Calderon H
AD  - PsiOxus Therapeutics Ltd, Abingdon, England UK
FAU - Illingworth, Sam
AU  - Illingworth S
AD  - PsiOxus Therapeutics Ltd, Abingdon, England UK
FAU - Brown, Alice
AU  - Brown A
AD  - PsiOxus Therapeutics Ltd, Abingdon, England UK
FAU - Fisher, Kerry
AU  - Fisher K
AD  - PsiOxus Therapeutics Ltd, Abingdon, England UK
FAU - Seymour, Len
AU  - Seymour L
AD  - Oxford University, Oxford, England UK
FAU - Champion, Brian
AU  - Champion B
AD  - PsiOxus Therapeutics Ltd, Abingdon, England UK
FAU - Eriksson, Emma
AU  - Eriksson E
AD  - Uppsala University, Uppsala, Sweden
FAU - Wenthe, Jessica
AU  - Wenthe J
AD  - Uppsala University, Uppsala, Sweden
FAU - Hellström, Ann-Charlotte
AU  - Hellström AC
AD  - Uppsala University, Uppsala, Sweden
FAU - Paul-Wetterberg, Gabriella
AU  - Paul-Wetterberg G
AD  - Uppsala University, Uppsala, Sweden
FAU - Loskog, Angelica
AU  - Loskog A
AD  - Uppsala University, Lokon Pharma AB, Uppsala, Sweden
FAU - Eriksson, Emma
AU  - Eriksson E
AD  - Uppsala University, Uppsala, Sweden
FAU - Milenova, Ioanna
AU  - Milenova I
AD  - Uppsala University, Amsterdam, Netherlands
FAU - Wenthe, Jessica
AU  - Wenthe J
AD  - Uppsala University, Uppsala, Sweden
FAU - Ståhle, Magnus
AU  - Ståhle M
AD  - Uppsala University, Uppsala, Sweden
FAU - Jarblad-Leja, Justyna
AU  - Jarblad-Leja J
AD  - Uppsala University, Immuneed AB, Uppsala, Sweden
FAU - Ullenhag, Gustav
AU  - Ullenhag G
AD  - Uppsala University, Uppsala University Hospital, Uppsala, Sweden
FAU - Dimberg, Anna
AU  - Dimberg A
AD  - Uppsala University, Uppsala, Sweden
FAU - Moreno, Rafael
AU  - Moreno R
AD  - Institut Catalá d’Oncologia, Barcelona, Spain
FAU - Alemany, Ramon
AU  - Alemany R
AD  - Institut Catalá d’Oncologia, Barcelona, Spain
FAU - Loskog, Angelica
AU  - Loskog A
AD  - Uppsala University, Lokon Pharma AB, Uppsala, Sweden
FAU - Eriksson, Emma
AU  - Eriksson E
AD  - Uppsala University, Uppsala, Sweden
FAU - Milenova, Ioanna
AU  - Milenova I
AD  - Uppsala University, Amsterdam, Netherlands
FAU - Moreno, Rafael
AU  - Moreno R
AD  - Institut Catalá d’Oncologia, Barcelona, Spain
FAU - Alemany, Ramon
AU  - Alemany R
AD  - Institut Catalá d’Oncologia, Barcelona, Spain
FAU - Loskog, Angelica
AU  - Loskog A
AD  - Uppsala University, Lokon Pharma AB, Uppsala, Sweden
FAU - Jhawar, Sachin
AU  - Jhawar S
AD  - Rutgers University, New Brunswick, NJ USA
FAU - Goyal, Sharad
AU  - Goyal S
AD  - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
FAU - Bommareddy, Praveen K.
AU  - Bommareddy PK
AD  - Rutgers University, New Brunswick, NJ USA
FAU - Paneque, Tomas
AU  - Paneque T
AD  - Rutgers Robert Wood Johnson Medical School, Somerset, NJ USA
FAU - Kaufman, Howard L.
AU  - Kaufman HL
AD  - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
FAU - Zloza, Andrew
AU  - Zloza A
AD  - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
FAU - Kaufman, Howard L.
AU  - Kaufman HL
AD  - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
FAU - Silk, Ann
AU  - Silk A
AD  - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
FAU - Mehnert, Janice
AU  - Mehnert J
AD  - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
FAU - Gabrail, Nashat
AU  - Gabrail N
AD  - Gabrail Cancer Center, Canton, OH USA
FAU - Bryan, Jennifer
AU  - Bryan J
AD  - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
FAU - Medina, Daniel
AU  - Medina D
AD  - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
FAU - Bommareddy, Praveen K.
AU  - Bommareddy PK
AD  - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
FAU - Shafren, Darren
AU  - Shafren D
AD  - Viralytics Limited, Sydney, New South Wales Australia
FAU - Grose, Mark
AU  - Grose M
AD  - Viralytics Limited, Sydney, New South Wales Australia
FAU - Zloza, Andrew
AU  - Zloza A
AD  - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
FAU - Mitchell, Leah
AU  - Mitchell L
AD  - Tocagen Inc, San Diego, CA USA
FAU - Yagiz, Kader
AU  - Yagiz K
AD  - Tocagen Inc, San Diego, CA USA
FAU - Lopez, Fernando
AU  - Lopez F
AD  - Tocagen Inc, San Diego, CA USA
FAU - Mendoza, Daniel
AU  - Mendoza D
AD  - Tocagen Inc, San Diego, CA USA
FAU - Munday, Anthony
AU  - Munday A
AD  - Tocagen Inc, San Diego, CA USA
FAU - Gruber, Harry
AU  - Gruber H
AD  - Tocagen Inc, San Diego, CA USA
FAU - Jolly, Douglas
AU  - Jolly D
AD  - Tocagen Inc, San Diego, CA USA
FAU - Fuhrmann, Steven
AU  - Fuhrmann S
AD  - BeneVir Biopharm, Inc, Gaithersburg, MD USA
FAU - Radoja, Sasa
AU  - Radoja S
AD  - BeneVir Biopharm, Inc, Gaithersburg, MD USA
FAU - Tan, Wei
AU  - Tan W
AD  - BeneVir Biopharm, Inc, Gaithersburg, MD USA
FAU - Pourchet, Aldo
AU  - Pourchet A
AD  - New York University Langone School of Medicine, New York, NY USA
FAU - Frey, Alan
AU  - Frey A
AD  - New York University Langone School of Medicine, New York, NY USA
FAU - Mohr, Ian
AU  - Mohr I
AD  - New York University Langone School of Medicine, New York, NY USA
FAU - Mulvey, Matthew
AU  - Mulvey M
AD  - BeneVir Biopharm, Inc, Gaithersburg, MD USA
FAU - Ranki, Tuuli
AU  - Ranki T
AD  - PeptiCRAd Oy, Helsinki, Uusimaa Finland
FAU - Pesonen, Sari
AU  - Pesonen S
AD  - PeptiCRAd Oy, Helsinki, Uusimaa Finland
FAU - Capasso, Cristian
AU  - Capasso C
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Ylösmäki, Erkko
AU  - Ylösmäki E
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Cerullo, Vincenzo
AU  - Cerullo V
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Andtbacka, Robert H. I.
AU  - Andtbacka RHI
AD  - University of Utah, Huntsman Cancer Institute, Salt Lake City, UT USA
FAU - Ross, Merrick
AU  - Ross M
AD  - Univesity of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Agarwala, Sanjiv
AU  - Agarwala S
AD  - St. Luke’s Hospital, Easton, PA USA
FAU - Grossmann, Kenneth
AU  - Grossmann K
AD  - University of Utah, Huntsman Cancer Institute, Salt Lake City, UT USA
FAU - Taylor, Matthew
AU  - Taylor M
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Vetto, John
AU  - Vetto J
AD  - Knight Cancer Institute, Oregon Health and Science University, Portland, OR USA
FAU - Neves, Rogerio
AU  - Neves R
AD  - Pennsylvania State University, Hershey Cancer Institute, Hershey, PA USA
FAU - Daud, Adil
AU  - Daud A
AD  - UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA USA
FAU - Khong, Hung
AU  - Khong H
AD  - University of Utah, Huntsman Cancer Institute, Salt Lake City, UT USA
FAU - Meek, Stephanie M.
AU  - Meek SM
AD  - University of Utah School of Medicine, Salt Lake City, UT USA
FAU - Ungerleider, Richard
AU  - Ungerleider R
AD  - Theradex, Princeton, NJ USA
FAU - Welden, Scott
AU  - Welden S
AD  - Theradex, Princeton, NJ USA
FAU - Tanaka, Maki
AU  - Tanaka M
AD  - Takara Bio, Inc, Otsu, Shiga Japan
FAU - Williams, Matthew
AU  - Williams M
AD  - University of Utah, Salt Lake City, UT USA
FAU - Andtbacka, Robert H. I.
AU  - Andtbacka RHI
AD  - University of Utah, Huntsman Cancer Institute, Salt Lake City, UT USA
FAU - Curti, Brendan
AU  - Curti B
AD  - Providence Cancer Center, Portland, OR USA
FAU - Hallmeyer, Sigrun
AU  - Hallmeyer S
AD  - Oncology Specialists, Chicago, IL USA
FAU - Fox, Bernard
AU  - Fox B
AD  - Innate Pharma, Marseille, Provence-Alpes-Cote d’Azur France
FAU - Feng, Zipei
AU  - Feng Z
AD  - Providence Cancer Center, Portland, OR USA
FAU - Paustian, Christopher
AU  - Paustian C
AD  - Providence Cancer Center, Portland, OR USA
FAU - Bifulco, Carlo
AU  - Bifulco C
AD  - Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute,
      Providence Cancer Center, Portland, OR USA
FAU - Grose, Mark
AU  - Grose M
AD  - Viralytics Limited, Sydney, New South Wales Australia
FAU - Shafren, Darren
AU  - Shafren D
AD  - Viralytics Limited, Sydney, New South Wales Australia
FAU - Zafar, Sadia
AU  - Zafar S
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Parviainen, Suvi
AU  - Parviainen S
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Siurala, Mikko
AU  - Siurala M
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Hemminki, Otto
AU  - Hemminki O
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Havunen, Riikka
AU  - Havunen R
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Tähtinen, Siri
AU  - Tähtinen S
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Bramante, Simona
AU  - Bramante S
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Vassilev, Lotta
AU  - Vassilev L
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Wang, Hongjie
AU  - Wang H
AD  - University of Washington, Seattle, WA USA
FAU - Lieber, Andre
AU  - Lieber A
AD  - University of Washington, Seattle, WA USA
FAU - Hemmi, Silvio
AU  - Hemmi S
AD  - University of Zurich, Zurich, Switzerland
FAU - de Gruijl, Tanja
AU  - de Gruijl T
AD  - VU University Medical Center, Amsterdam, Netherlands
FAU - Kanerva, Anna
AU  - Kanerva A
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Hemminki, Akseli
AU  - Hemminki A
AD  - University of Helsinki, Helsinki, Uusimaa Finland
FAU - Ansari, Tameem
AU  - Ansari T
AD  - Cellular Technology Ltd, Shaker Hts, OH USA
FAU - Sundararaman, Srividya
AU  - Sundararaman S
AD  - Cellular Technology Ltd, Shaker Hts, OH USA
FAU - Roen, Diana
AU  - Roen D
AD  - Cellular Technology Ltd, Shaker Hts, OH USA
FAU - Lehmann, Paul
AU  - Lehmann P
AD  - Cellular Technology Ltd, Shaker Hts, OH USA
FAU - Bloom, Anja C.
AU  - Bloom AC
AD  - National Cancer Institute, Bethesda, MD USA
FAU - Bender, Lewis H.
AU  - Bender LH
AD  - Intensity Therapeutics, Inc., Westport, CT USA
FAU - Walters, Ian B.
AU  - Walters IB
AD  - Intensity Therapeutics, Inc., Westport, CT USA
FAU - Terabe, Masaki
AU  - Terabe M
AD  - National Cancer Institute, Bethesda, MD USA
FAU - Berzofsky, Jay A.
AU  - Berzofsky JA
AD  - National Cancer Institute, Bethesda, MD USA
FAU - Chapelin, Fanny
AU  - Chapelin F
AD  - University of California, San Diego, La Jolla, CA USA
FAU - Okada, Hideho
AU  - Okada H
AD  - University of California, San Francisco, San Francisco, CA USA
FAU - Ahrens, Eric T.
AU  - Ahrens ET
AD  - University of California, San Diego, La Jolla, CA USA
FAU - DeFalco, Jeff
AU  - DeFalco J
AD  - Atreca, Redwood City, CA USA
FAU - Harbell, Michael
AU  - Harbell M
AD  - Atreca, Redwood City, CA USA
FAU - Manning-Bog, Amy
AU  - Manning-Bog A
AD  - Atreca, Redwood City, CA USA
FAU - Scholz, Alexander
AU  - Scholz A
AD  - Atreca, Redwood City, CA USA
FAU - Zhang, Danhui
AU  - Zhang D
AD  - Atreca, Redwood City, CA USA
FAU - Baia, Gilson
AU  - Baia G
AD  - Atreca, Redwood City, CA USA
FAU - Tan, Yann Chong
AU  - Tan YC
AD  - Atreca, Redwood City, CA USA
FAU - Sokolove, Jeremy
AU  - Sokolove J
AD  - Stanford University School of Medicine, Stanford, CA USA
FAU - Kim, Dongkyoon
AU  - Kim D
AD  - Atreca, Redwood City, CA USA
FAU - Williamson, Kevin
AU  - Williamson K
AD  - Atreca, Redwood City, CA USA
FAU - Chen, Xiaomu
AU  - Chen X
AD  - Atreca, Redwood City, CA USA
FAU - Colrain, Jillian
AU  - Colrain J
AD  - Atreca, Redwood City, CA USA
FAU - Santo, Gregg Espiritu
AU  - Santo GE
AD  - Atreca, Redwood City, CA USA
FAU - Nguyen, Ngan
AU  - Nguyen N
AD  - Atreca, Redwood City, CA USA
FAU - Volkmuth, Wayne
AU  - Volkmuth W
AD  - Atreca, Redwood City, CA USA
FAU - Greenberg, Norman
AU  - Greenberg N
AD  - Atreca, Redwood City, CA USA
FAU - Robinson, William
AU  - Robinson W
AD  - Department of Cancer Medicine, University of Texas MD Anderson Cancer Center,
      Houston, TX USA
FAU - Emerling, Daniel
AU  - Emerling D
AD  - Atreca, Redwood City, CA USA
FAU - Drake, Charles G.
AU  - Drake CG
AD  - Johns Hopkins University Cancer Center, Baltimore, MD USA
FAU - Petrylak, Daniel P.
AU  - Petrylak DP
AD  - Yale School of Medicine, New Haven, CT USA
FAU - Antonarakis, Emmanuel S.
AU  - Antonarakis ES
AD  - Johns Hopkins University Cancer Center, Baltimore, MD USA
FAU - Kibel, Adam S.
AU  - Kibel AS
AD  - Johns Hopkins University, Sidney Kimmel Cancer Center, Baltimore, MD USA
FAU - Chang, Nancy N.
AU  - Chang NN
AD  - Harvard Medical School, Dana-Farber Cancer Center, and Brigham and Women’s
      Hospital, Boston, MA USA
FAU - Vu, Tuyen
AU  - Vu T
AD  - Harvard Medical School, Dana-Farber Cancer Center, and Brigham and Women’s
      Hospital, Boston, MA USA
FAU - Campogan, Dwayne
AU  - Campogan D
AD  - Harvard Medical School, Dana-Farber Cancer Center, and Brigham and Women’s
      Hospital, Boston, MA USA
FAU - Haynes, Heather
AU  - Haynes H
AD  - Harvard Medical School, Dana-Farber Cancer Center, and Brigham and Women’s
      Hospital, Boston, MA USA
FAU - Trager, James B.
AU  - Trager JB
AD  - Harvard Medical School, Dana-Farber Cancer Center, and Brigham and Women’s
      Hospital, Boston, MA USA
FAU - Sheikh, Nadeem A.
AU  - Sheikh NA
AD  - Harvard Medical School, Dana-Farber Cancer Center, and Brigham and Women’s
      Hospital, Boston, MA USA
FAU - Quinn, David I.
AU  - Quinn DI
AD  - Dendreon Pharmaceuticals, Inc, Seattle, WA USA
FAU - Kirk, Peter
AU  - Kirk P
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Addepalli, Murali
AU  - Addepalli M
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Chang, Thomas
AU  - Chang T
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Zhang, Ping
AU  - Zhang P
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Konakova, Marina
AU  - Konakova M
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Hagihara, Katsunobu
AU  - Hagihara K
AD  - University of California, San Francisco School of Medicine, San Francisco, CA USA
FAU - Pai, Steven
AU  - Pai S
AD  - Hellen Diller Family Comprehensive Cancer Center, San Francisco, CA USA
FAU - VanderVeen, Laurie
AU  - VanderVeen L
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Obalapur, Palakshi
AU  - Obalapur P
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Kuo, Peiwen
AU  - Kuo P
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Quach, Phi
AU  - Quach P
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Fong, Lawrence
AU  - Fong L
AD  - Hellen Diller Family Comprehensive Cancer Center, San Francisco, CA USA
FAU - Charych, Deborah H.
AU  - Charych DH
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Zalevsky, Jonathan
AU  - Zalevsky J
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Langowski, John L.
AU  - Langowski JL
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Addepalli, Murali
AU  - Addepalli M
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Kirksey, Yolanda
AU  - Kirksey Y
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Nutakki, Ravi
AU  - Nutakki R
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Kolarkar, Shalini
AU  - Kolarkar S
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Pena, Rhoneil
AU  - Pena R
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Hoch, Ute
AU  - Hoch U
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Zalevsky, Jonathan
AU  - Zalevsky J
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Doberstein, Stephen K.
AU  - Doberstein SK
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Charych, Deborah H.
AU  - Charych DH
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Cha, John
AU  - Cha J
AD  - Pulse Biosciences, Burlingame, CA USA
FAU - Mallon, Zach
AU  - Mallon Z
AD  - Pulse Biosciences, Burlingame, CA USA
FAU - Perez, Myra
AU  - Perez M
AD  - Pulse Biosciences, Burlingame, CA USA
FAU - McDaniel, Amanda
AU  - McDaniel A
AD  - Pulse Biosciences, Burlingame, CA USA
FAU - Anand, Snjezana
AU  - Anand S
AD  - Pulse Biosciences, Burlingame, CA USA
FAU - Uecker, Darrin
AU  - Uecker D
AD  - Pulse Biosciences, Burlingame, CA USA
FAU - Nuccitelli, Richard
AU  - Nuccitelli R
AD  - Pulse Biosciences, Burlingame, CA USA
FAU - McDaniel, Amanda
AU  - McDaniel A
AD  - Pulse Biosciences, Burlingame, CA USA
FAU - Anand, Snjezana
AU  - Anand S
AD  - Pulse Biosciences, Burlingame, CA USA
FAU - Cha, John
AU  - Cha J
AD  - Pulse Biosciences, Burlingame, CA USA
FAU - Uecker, Darrin
AU  - Uecker D
AD  - Pulse Biosciences, Burlingame, CA USA
FAU - Nuccitelli, Richard
AU  - Nuccitelli R
AD  - Pulse Biosciences, Burlingame, CA USA
FAU - Obermajer, Nataša
AU  - Obermajer N
AD  - Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA
FAU - Urban, Julie
AU  - Urban J
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Wieckowski, Eva
AU  - Wieckowski E
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Muthuswamy, Ravikumar
AU  - Muthuswamy R
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Ravindranathan, Roshni
AU  - Ravindranathan R
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Bartlett, David
AU  - Bartlett D
AD  - Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA
FAU - Kalinski, Pawel
AU  - Kalinski P
AD  - Department of Surgery, University of Pittsburgh Cancer Institute, Pittsburgh, USA
FAU - Renrick, Ariana N.
AU  - Renrick AN
AD  - Meharry Medical College, Nashville, TN USA
FAU - Thounaojam, Menaka
AU  - Thounaojam M
AD  - Medical College of Georgia, Augusta, GA USA
FAU - Thomas, Portia
AU  - Thomas P
AD  - Meharry Medical College, Nashville, TN USA
FAU - Pellom, Samuel
AU  - Pellom S
AD  - Meharry Medical College, Nashville, TN USA
FAU - Shanker, Anil
AU  - Shanker A
AD  - Meharry Medical College School of Medicine, Nashville, TN USA
FAU - Pellom, Samuel
AU  - Pellom S
AD  - Meharry Medical College, Nashville, TN USA
FAU - Thounaojam, Menaka
AU  - Thounaojam M
AD  - Medical College of Georgia, Augusta, GA USA
FAU - Dudimah, Duafalia
AU  - Dudimah D
AD  - Meharry Medical College School of Medicine, Nashville, TN USA
FAU - Brooks, Alan
AU  - Brooks A
AD  - National Cancer Institute-Frederick, Frederick, MD USA
FAU - Sayers, Thomas J.
AU  - Sayers TJ
AD  - CIP, Center for Cancer Research, BSP, Leidos Biomed Research Inc, National Cancer
      Institute-Frederick, Frederick, MD USA
FAU - Shanker, Anil
AU  - Shanker A
AD  - Meharry Medical College School of Medicine, Nashville, TN USA
FAU - Su, Yu-Lin
AU  - Su YL
AD  - Beckman Research Institute/City of Hope, Monrovia, CA USA
FAU - Adamus, Tomasz
AU  - Adamus T
AD  - City of Hope, Duarte, CA USA
FAU - Zhang, Qifang
AU  - Zhang Q
AD  - City of Hope, Duarte, CA USA
FAU - Nechaev, Sergey
AU  - Nechaev S
AD  - City of Hope, Duarte, CA USA
FAU - Kortylewski, Marcin
AU  - Kortylewski M
AD  - City of Hope, Duarte, CA USA
FAU - Wei, Spencer
AU  - Wei S
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Allison, James
AU  - Allison J
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Anderson, Clark
AU  - Anderson C
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Tang, Chad
AU  - Tang C
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Schoenhals, Jonathan
AU  - Schoenhals J
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Tsouko, Efrosini
AU  - Tsouko E
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Heymach, John
AU  - Heymach J
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - de Groot, Patricia
AU  - de Groot P
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Chang, Joe
AU  - Chang J
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Hess, Kenneth R.
AU  - Hess KR
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Diab, Adi
AU  - Diab A
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Sharma, Padmanee
AU  - Sharma P
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Allison, James
AU  - Allison J
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Naing, Aung
AU  - Naing A
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Hong, David
AU  - Hong D
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Welsh, James
AU  - Welsh J
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Albershardt, Tina C.
AU  - Albershardt TC
AD  - Immune Design, Seattle, WA USA
FAU - Parsons, Andrea J.
AU  - Parsons AJ
AD  - Immune Design, Seattle, WA USA
FAU - Leleux, Jardin
AU  - Leleux J
AD  - Immune Design, Seattle, WA USA
FAU - Reeves, Rebecca S.
AU  - Reeves RS
AD  - Immune Design, Seattle, WA USA
FAU - ter Meulen, Jan
AU  - ter Meulen J
AD  - Immune Design, Seattle, WA USA
FAU - Berglund, Peter
AU  - Berglund P
AD  - Immune Design, Seattle, WA USA
FAU - Ascarateil, Stephane
AU  - Ascarateil S
AD  - Seppic, Puteaux, Ile-de-France France
FAU - Koziol, Marie Eve
AU  - Koziol ME
AD  - Seppic Inc., Fairfield, NJ USA
FAU - Penny, Sarah A.
AU  - Penny SA
AD  - University of Birmingham, Birmingham, England UK
FAU - Malaker, Stacy A.
AU  - Malaker SA
AD  - Stanford University, Stanford, CA USA
FAU - Steadman, Lora
AU  - Steadman L
AD  - University of Birmingham, Birmingham, England UK
FAU - Myers, Paisley T.
AU  - Myers PT
AD  - University of Virginia, Charlottesville, VA USA
FAU - Bai, Dina
AU  - Bai D
AD  - University of Virginia, Charlottesville, VA USA
FAU - Shabanowitz, Jeffrey
AU  - Shabanowitz J
AD  - University of Virginia, Charlottesville, VA USA
FAU - Hunt, Donald F.
AU  - Hunt DF
AD  - University of Virginia, Charlottesville, VA USA
FAU - Cobbold, Mark
AU  - Cobbold M
AD  - Massachusetts General Hospital Cancer Center, Boston, MA USA
FAU - Dai, Peihong
AU  - Dai P
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Wang, Weiyi
AU  - Wang W
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Yang, Ning
AU  - Yang N
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Shuman, Stewart
AU  - Shuman S
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Merghoub, Taha
AU  - Merghoub T
AD  - Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New
      York, NY USA
FAU - Wolchok, Jedd D.
AU  - Wolchok JD
AD  - Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Deng, Liang
AU  - Deng L
AD  - Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Dillon, Patrick
AU  - Dillon P
AD  - University of Virginia, Charlottesville, VA USA
FAU - Petroni, Gina
AU  - Petroni G
AD  - University of Virginia, Charlottesville, VA USA
FAU - Brenin, David
AU  - Brenin D
AD  - University of Virginia, Charlottesville, VA USA
FAU - Bullock, Kim
AU  - Bullock K
AD  - University of Virginia, Charlottesville, VA USA
FAU - Olson, Walter
AU  - Olson W
AD  - University of Virginia, Charlottesville, VA USA
FAU - Smolkin, Mark E.
AU  - Smolkin ME
AD  - Department of Public Health Sciences, University of Virginia, Charlottesville, VA
      USA
FAU - Smith, Kelly
AU  - Smith K
AD  - University of Virginia, Charlottesville, VA USA
FAU - Nail, Carmel
AU  - Nail C
AD  - University of Virginia, Charlottesville, VA USA
FAU - Slingluff, Craig L.
AU  - Slingluff CL
AD  - Division of Surgical Oncology, University of Virginia, Charlottesville, VA USA
FAU - Sharma, Meenu
AU  - Sharma M
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Fa’ak, Faisal
AU  - Fa’ak F
AD  - Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer
      Center, Houston, TX USA
FAU - Janssen, Louise
AU  - Janssen L
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Khong, Hiep
AU  - Khong H
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Xiao, Zhilan
AU  - Xiao Z
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Hailemichael, Yared
AU  - Hailemichael Y
AD  - Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer
      Center, Houston, TX USA
FAU - Singh, Manisha
AU  - Singh M
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Vianden, Christina
AU  - Vianden C
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Diab, Adi
AU  - Diab A
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Zalevsky, Jonathan
AU  - Zalevsky J
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Hoch, Ute
AU  - Hoch U
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Overwijk, Willem W.
AU  - Overwijk WW
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Facciabene, Andrea
AU  - Facciabene A
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Stefano, Pierini
AU  - Stefano P
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Chongyung, Fang
AU  - Chongyung F
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Rafail, Stavros
AU  - Rafail S
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Hailemichael, Yared
AU  - Hailemichael Y
AD  - Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer
      Center, Houston, TX USA
FAU - Nielsen, Michael
AU  - Nielsen M
AD  - Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer
      Center, Houston, TX USA
FAU - Fa’ak, Faisal
AU  - Fa’ak F
AD  - Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer
      Center, Houston, TX USA
FAU - Vanderslice, Peter
AU  - Vanderslice P
AD  - Texas Heart Institute, Houston, TX USA
FAU - Woodside, Darren G.
AU  - Woodside DG
AD  - Department of Molecular Cardiology, Texas Heart Institute, Houston, TX USA
FAU - Market, Robert V.
AU  - Market RV
AD  - Department of Molecular Cardiology, Texas Heart Institute, Houston, TX USA
FAU - Biediger, Ronald J.
AU  - Biediger RJ
AD  - Department of Molecular Cardiology, Texas Heart Institute, Houston, TX USA
FAU - Marathi, Upendra K.
AU  - Marathi UK
AD  - 7 Hills Pharma LLC, Houston, TX USA
FAU - Overwijk, Willem W.
AU  - Overwijk WW
AD  - Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer
      Center, Houston, TX USA
FAU - Hollevoet, Kevin
AU  - Hollevoet K
AD  - KU Leuven, Leuven, Vlaams-Brabant Belgium
FAU - Geukens, Nick
AU  - Geukens N
AD  - KU Leuven, Leuven, Vlaams-Brabant Belgium
FAU - Declerck, Paul
AU  - Declerck P
AD  - KU Leuven, Leuven, Vlaams-Brabant Belgium
FAU - Joly, Nathalie
AU  - Joly N
AD  - Caprion Biosciences Inc., Montreal, PQ Canada
FAU - McIntosh, Laura
AU  - McIntosh L
AD  - Caprion Biosciences Inc., Montreal, PQ Canada
FAU - Paramithiotis, Eustache
AU  - Paramithiotis E
AD  - Caprion Biosciences Inc., Montreal, PQ Canada
FAU - Rizell, Magnus
AU  - Rizell M
AD  - Transplant Institute, Sahlgrenska Academy at University of Gothenburg,
      Gothenburg, Sweden
FAU - Sternby, Malin
AU  - Sternby M
AD  - Transplant Institute, Sahlgrenska Academy at University of Gothenburg,
      Gothenburg, Sweden
FAU - Andersson, Bengt
AU  - Andersson B
AD  - Department of Clinical Immunology, Gothenburg University, Gothenburg, Sweden
FAU - Karlsson-Parra, Alex
AU  - Karlsson-Parra A
AD  - Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala,
      Sweden
FAU - Kuai, Rui
AU  - Kuai R
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Ochyl, Lukasz
AU  - Ochyl L
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Schwendeman, Anna
AU  - Schwendeman A
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Moon, James
AU  - Moon J
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Deng, Weiwen
AU  - Deng W
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Hudson, Thomas E.
AU  - Hudson TE
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Lemmens, Edward E.
AU  - Lemmens EE
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Hanson, Bill
AU  - Hanson B
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Rae, Chris S.
AU  - Rae CS
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Burrill, Joel
AU  - Burrill J
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Skoble, Justin
AU  - Skoble J
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Katibah, George
AU  - Katibah G
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Murphy, Aimee L.
AU  - Murphy AL
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - deVries, Michele
AU  - deVries M
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Brockstedt, Dirk G.
AU  - Brockstedt DG
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Leong, Meredith L.
AU  - Leong ML
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Lauer, Peter
AU  - Lauer P
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Dubensky, Thomas W.
AU  - Dubensky TW
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Whiting, Chan C.
AU  - Whiting CC
AD  - Aduro Biotech, Inc., Berkeley, CA USA
FAU - Chen, Xin
AU  - Chen X
AD  - University of Michigan Cancer Center, Ann Arbor, MI USA
FAU - Hu, Yangyang
AU  - Hu Y
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Xia, Yang
AU  - Xia Y
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Zhou, Li
AU  - Zhou L
AD  - University of Michigan Cancer Center, Ann Arbor, MI USA
FAU - Bao, Yangyi
AU  - Bao Y
AD  - The Third Affiliated Hospital of Anhui Medical University, Heifei, Anhui People’s
      Republic of China
FAU - Huang, Shiang
AU  - Huang S
AD  - Union Hospital, Tongji Medical College, Huazhong University of Science and
      Technology, Wuhan, Hubei People’s Republic of China
FAU - Ren, Xiubao
AU  - Ren X
AD  - Tianjin University Cancer Institute and Hospital, Tianjin, Hebei People’s
      Republic of China
FAU - Hurt, Elaine
AU  - Hurt E
AD  - MedImmune Inc, Gaithersburg, MD USA
FAU - Hollingsworth, Robert E.
AU  - Hollingsworth RE
AD  - MedImmune Inc, Gaithersburg, MD USA
FAU - Chang, Alfred E.
AU  - Chang AE
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Wicha, Max S.
AU  - Wicha MS
AD  - University of Michigan Medical School, Ann Arbor, MI USA
FAU - Li, Qiao
AU  - Li Q
AD  - University of Michigan Medical Center, 1150 W. Medical Center Dr, Ann Arbor, MI
      USA
FAU - Aggarwal, Charu
AU  - Aggarwal C
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Mangrolia, Drishty
AU  - Mangrolia D
AD  - Inovio Pharmaceuticals, Plymouth Meeting, PA USA
FAU - Cohen, Roger
AU  - Cohen R
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Weinstein, Gregory
AU  - Weinstein G
AD  - Inovio Pharmaceuticals, Philadelphia, PA USA
FAU - Morrow, Matthew
AU  - Morrow M
AD  - Inovio Pharmaceuticals, Plymouth Meeting, PA USA
FAU - Bauml, Joshua
AU  - Bauml J
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Kraynyak, Kim
AU  - Kraynyak K
AD  - Inovio Pharmaceuticals, Plymouth Meeting, PA USA
FAU - Boyer, Jean
AU  - Boyer J
AD  - Inovio Pharmaceuticals, San Diego, CA USA
FAU - Yan, Jian
AU  - Yan J
AD  - Inovio Pharmaceuticals, Plymouth Meeting, PA USA
FAU - Lee, Jessica
AU  - Lee J
AD  - Inovio Pharmaceuticals, Plymouth Meeting, PA USA
FAU - Humeau, Laurent
AU  - Humeau L
AD  - University of Michigan, Ann Arbor, MI USA
FAU - Oyola, Sandra
AU  - Oyola S
AD  - Inovio Pharmaceuticals, Plymouth Meeting, PA USA
FAU - Duff, Susan
AU  - Duff S
AD  - Inovio Pharmaceuticals, Plymouth Meeting, PA USA
FAU - Weiner, David
AU  - Weiner D
AD  - The Wistar Institute, Philadelphia, PA USA
FAU - Yang, Zane
AU  - Yang Z
AD  - Inovio Pharmaceuticals, Plymouth Meeting, PA USA
FAU - Bagarazzi, Mark
AU  - Bagarazzi M
AD  - Inovio Pharmaceuticals, Plymouth Meeting, PA USA
FAU - McNeel, Douglas G.
AU  - McNeel DG
AD  - University of Wisconsin Carbone Cancer Center, Madison, WI USA
FAU - Eickhoff, Jens
AU  - Eickhoff J
AD  - University of Wisconsin, Madison, WI USA
FAU - Jeraj, Robert
AU  - Jeraj R
AD  - University of Wisconsin, Madison, WI USA
FAU - Staab, Mary Jane
AU  - Staab MJ
AD  - University of Wisconsin Carbone Cancer Center, Madison, WI USA
FAU - Straus, Jane
AU  - Straus J
AD  - University of Wisconsin Carbone Cancer Center, Madison, WI USA
FAU - Rekoske, Brian
AU  - Rekoske B
AD  - University of Wisconsin, Madison, WI USA
FAU - Liu, Glenn
AU  - Liu G
AD  - University of Wisconsin Carbone Cancer Center, Madison, WI USA
FAU - Melssen, Marit
AU  - Melssen M
AD  - University of Virginia, Charlottesville, VA USA
FAU - Petroni, Gina
AU  - Petroni G
AD  - University of Virginia, Charlottesville, VA USA
FAU - Grosh, William
AU  - Grosh W
AD  - University of Virginia, Charlottesville, VA USA
FAU - Varhegyi, Nikole
AU  - Varhegyi N
AD  - University of Virginia, Charlottesville, VA USA
FAU - Bullock, Kim
AU  - Bullock K
AD  - University of Virginia, Charlottesville, VA USA
FAU - Smolkin, Mark E.
AU  - Smolkin ME
AD  - University of Virginia, Charlottesville, VA USA
FAU - Smith, Kelly
AU  - Smith K
AD  - University of Virginia, Charlottesville, VA USA
FAU - Galeassi, Nadejda
AU  - Galeassi N
AD  - University of Virginia, Charlottesville, VA USA
FAU - Deacon, Donna H.
AU  - Deacon DH
AD  - Department of Surgery, University of Virginia, Charlottesville, VA USA
FAU - Gaughan, Elizabeth
AU  - Gaughan E
AD  - University of Virginia, Charlottesville, VA USA
FAU - Slingluff, Craig L.
AU  - Slingluff CL
AD  - Division of Surgical Oncology, University of Virginia, Charlottesville, VA USA
FAU - Ghisoli, Maurizio
AU  - Ghisoli M
AD  - Mary Crowley Cancer Research Centers, Texas Oncology, P.A, Dallas, TX USA
FAU - Barve, Minal
AU  - Barve M
AD  - Mary Crowley Cancer Research Centers, Texas Oncology, P.A, Dallas, TX USA
FAU - Mennel, Robert
AU  - Mennel R
AD  - Texas Oncology, P.A, Baylor University Medical Center, Dallas, TX USA
FAU - Wallraven, Gladice
AU  - Wallraven G
AD  - Gradalis, Inc, Carrollton, TX USA
FAU - Manning, Luisa
AU  - Manning L
AD  - Gradalis, Inc., Dallas, TX USA
FAU - Senzer, Neil
AU  - Senzer N
AD  - Mary Crowley Cancer Research Centers, Gradalis, Inc, Dallas, TX USA
FAU - Nemunaitis, John
AU  - Nemunaitis J
AD  - Mary Crowley Cancer Research Centers, Gradalis, Inc, Dallas, TX USA
FAU - Ogasawara, Masahiro
AU  - Ogasawara M
AD  - Sapporo Hokuyu Hospital, Sapporo, Hokkaido Japan
FAU - Ota, Shuichi
AU  - Ota S
AD  - Sapporo Hokuyu Hospital, Sapporo, Hokkaido Japan
FAU - Peace, Kaitlin M.
AU  - Peace KM
AD  - Brooke Army Medical Center, San Antonio, TX USA
FAU - Hale, Diane F.
AU  - Hale DF
AD  - Brooke Army Medical Center, San Antonio, TX USA
FAU - Vreeland, Timothy J.
AU  - Vreeland TJ
AD  - Womack Army Medical Center, Fayetteville, NC USA
FAU - Jackson, Doreen O.
AU  - Jackson DO
AD  - Brooke Army Medical Center, San Antonio, TX USA
FAU - Berry, John S.
AU  - Berry JS
AD  - Department of Colon and Rectal Surgery, Washington University, St Louis, MO USA
FAU - Trappey, Alfred F.
AU  - Trappey AF
AD  - Brooke Army Medical Center, San Antonio, TX USA
FAU - Herbert, Garth S.
AU  - Herbert GS
AD  - Brooke Army Medical Center, San Antonio, TX USA
FAU - Clifton, Guy T.
AU  - Clifton GT
AD  - Brooke Army Medical Center, San Antonio, TX USA
FAU - Hardin, Mark O.
AU  - Hardin MO
AD  - Madigan Army Medical Center, Tacoma, WA USA
FAU - Toms, Anne
AU  - Toms A
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Qiao, Na
AU  - Qiao N
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Litton, Jennifer
AU  - Litton J
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Peoples, George E.
AU  - Peoples GE
AD  - Cancer Vaccine Development Program, San Antonio, TX USA
FAU - Mittendorf, Elizabeth A.
AU  - Mittendorf EA
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Ghamsari, Lila
AU  - Ghamsari L
AD  - Genocea Biosciences, Cambridge, MA USA
FAU - Flano, Emilio
AU  - Flano E
AD  - Genocea Biosciences, Cambridge, MA USA
FAU - Jacques, Judy
AU  - Jacques J
AD  - Genocea Biosciences, Cambridge, MA USA
FAU - Liu, Biao
AU  - Liu B
AD  - Genocea Biosciences, Cambridge, MA USA
FAU - Havel, Jonathan
AU  - Havel J
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Makarov, Vladimir
AU  - Makarov V
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Merghoub, Taha
AU  - Merghoub T
AD  - Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New
      York, NY USA
FAU - Wolchok, Jedd D.
AU  - Wolchok JD
AD  - Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Hellmann, Matthew D.
AU  - Hellmann MD
AD  - Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Chan, Timothy A.
AU  - Chan TA
AD  - Memorial Sloan Kettering Cancer Center, New York, NY USA
FAU - Flechtner, Jessica B.
AU  - Flechtner JB
AD  - Genocea Biosciences, Cambridge, MA USA
FAU - Stefano, Pierini
AU  - Stefano P
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Facciabene, Andrea
AU  - Facciabene A
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Facciponte, John
AU  - Facciponte J
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Ugel, Stefano
AU  - Ugel S
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - De Sanctis, Francesco
AU  - De Sanctis F
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Coukos, George
AU  - Coukos G
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Paris, Sébastien
AU  - Paris S
AD  - Nanobiotix, Paris, Ile-de-France France
FAU - Pottier, Agnes
AU  - Pottier A
AD  - Nanobiotix, Paris, Ile-de-France France
FAU - Levy, Laurent
AU  - Levy L
AD  - Nanobiotix, Paris, Ile-de-France France
FAU - Lu, Bo
AU  - Lu B
AD  - Thomas Jefferson University, Philadelphia, PA USA
FAU - Cappuccini, Federica
AU  - Cappuccini F
AD  - The Jenner Institute, University of Oxford, Oxford, England UK
FAU - Pollock, Emily
AU  - Pollock E
AD  - The Jenner Institute, University of Oxford, Oxford, England UK
FAU - Bryant, Richard
AU  - Bryant R
AD  - Nuffield Department of Surgical Sciences, University of Oxford, Oxford, England
      UK
FAU - Hamdy, Freddie
AU  - Hamdy F
AD  - Nuffield Department of Surgical Sciences, University of Oxford, Oxford, England
      UK
FAU - Hill, Adrian
AU  - Hill A
AD  - The Jenner Institute, University of Oxford, Oxford, England UK
FAU - Redchenko, Irina
AU  - Redchenko I
AD  - The Jenner Institute, University of Oxford, Oxford, England UK
FAU - Sultan, Hussein
AU  - Sultan H
AD  - Augusta University, Georgia Cancer Center, Augusta, GA USA
FAU - Kumai, Takumi
AU  - Kumai T
AD  - Augusta University, Georgia Cancer Center, Augusta, GA USA
FAU - Fesenkova, Valentyna
AU  - Fesenkova V
AD  - Augusta University, Georgia Cancer Center, Augusta, GA USA
FAU - Celis, Esteban
AU  - Celis E
AD  - Augusta University, Georgia Cancer Center, Augusta, GA USA
FAU - Tsang, Kwong
AU  - Tsang K
AD  - Laboratory of Tumor Immunology and Biology, National Cancer Institute, National
      Institutes of Health, Bethesda, MD USA
FAU - Fantini, Massimo
AU  - Fantini M
AD  - Laboratory of Tumor Immunology and Biology, National Cancer Institute, National
      Institutes of Health, Bethesda, MD USA
FAU - Fernando, Ingrid
AU  - Fernando I
AD  - Laboratory of Tumor Immunology and Biology, National Cancer Institute, National
      Institutes of Health, Bethesda, MD USA
FAU - Palena, Claudia
AU  - Palena C
AD  - Laboratory of Tumor Immunology and Biology, National Cancer Institute, National
      Institutes of Health, Bethesda, MD USA
FAU - David, Justin M.
AU  - David JM
AD  - Laboratory of Tumor Immunology and Biology, National Cancer Institute, National
      Institutes of Health, Bethesda, MD USA
FAU - Hodge, James
AU  - Hodge J
AD  - Laboratory of Tumor Immunology and Biology, National Cancer Institute, National
      Institutes of Health, Bethesda, MD USA
FAU - Gabitzsch, Elizabeth
AU  - Gabitzsch E
AD  - Etubics Corporation, Seattle, WA USA
FAU - Jones, Frank
AU  - Jones F
AD  - Etubics Corporation, Seattle, WA USA
FAU - Gulley, James L.
AU  - Gulley JL
AD  - Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer
      Institute, National Institutes of Health, Bethesda, MD USA
FAU - Schlom, Jeffrey
AU  - Schlom J
AD  - Center for Cancer Research, National Cancer Institute, National Institutes of
      Health, Bethesda, MD USA
FAU - Herranz, Mireia Uribe
AU  - Herranz MU
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Rafail, Stavros
AU  - Rafail S
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Ugel, Stefano
AU  - Ugel S
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Facciponte, John
AU  - Facciponte J
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Stefano, Pierini
AU  - Stefano P
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Facciabene, Andrea
AU  - Facciabene A
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Wada, Hiroshi
AU  - Wada H
AD  - Taiho Pharmaceutical Co., Ltd, Tsukuba, Ibaraki Japan
FAU - Shimizu, Atsushi
AU  - Shimizu A
AD  - Taiho Pharmaceutical Co., Ltd, Tsukuba, Ibaraki Japan
FAU - Osada, Toshihiro
AU  - Osada T
AD  - Taiho Pharmaceutical Co., Ltd, Tsukuba, Ibaraki Japan
FAU - Fukaya, Satoshi
AU  - Fukaya S
AD  - Taiho Pharmaceutical Co., Ltd, Tsukuba, Ibaraki Japan
FAU - Sasaki, Eiji
AU  - Sasaki E
AD  - Taiho Pharmaceutical Co., Ltd, Tsukuba, Ibaraki Japan
FAU - Abolhalaj, Milad
AU  - Abolhalaj M
AD  - Department of Immunotechnology, Lund University, Lund, Skane Lan Sweden
FAU - Askmyr, David
AU  - Askmyr D
AD  - ENT Department, Lund University Hospital, Lund, Skane Lan Sweden
FAU - Lundberg, Kristina
AU  - Lundberg K
AD  - Department of Immunotechnology, Lund University, Lund, Skane Lan Sweden
FAU - Albrekt, Ann-Sofie
AU  - Albrekt AS
AD  - Department of Immunotechnology, Lund University, Lund, Skane Lan Sweden
FAU - Greiff, Lennart
AU  - Greiff L
AD  - ENT Department, Lund University Hospital, Lund, Skane Lan Sweden
FAU - Lindstedt, Malin
AU  - Lindstedt M
AD  - Department of Immunotechnology, Lund University, Lund, Skane Lan Sweden
FAU - Flies, Dallas B.
AU  - Flies DB
AD  - NextCure, Beltsville, MD USA
FAU - Higuchi, Tomoe
AU  - Higuchi T
AD  - University of New Mexico Comprehensive Cancer Center, Beltsville, MD USA
FAU - Ornatowski, Wojciech
AU  - Ornatowski W
AD  - University of New Mexico Comprehensive Cancer Center, Albuquerque, NM USA
FAU - Harris, Jaryse
AU  - Harris J
AD  - University of New Mexico, Albuquerque, NM USA
FAU - Adams, Sarah F.
AU  - Adams SF
AD  - University of New Mexico Comprehensive Cancer Center, Albuquerque, NM USA
FAU - Aguilera, Todd
AU  - Aguilera T
AD  - Stanford Department of Radiation Oncology, Stanford University School of
      Medicine, Stanford, CA USA
FAU - Rafat, Marjan
AU  - Rafat M
AD  - Stanford Department of Radiation Oncology, Stanford University School of
      Medicine, Stanford, CA USA
FAU - Castellini, Laura
AU  - Castellini L
AD  - Stanford Department of Radiation Oncology, Stanford University School of
      Medicine, Stanford, CA USA
FAU - Shehade, Hussein
AU  - Shehade H
AD  - Stanford Department of Radiation Oncology, Stanford University School of
      Medicine, Stanford, CA USA
FAU - Kariolis, Mihalis
AU  - Kariolis M
AD  - Stanford Department of Radiation Oncology, Stanford University School of
      Medicine, Stanford, CA USA
FAU - Jang, Dadi
AU  - Jang D
AD  - Stanford Department of Radiation Oncology, Stanford University School of
      Medicine, Stanford, CA USA
FAU - vonEbyen, Rie
AU  - vonEbyen R
AD  - Stanford Department of Radiation Oncology, Stanford University School of
      Medicine, Stanford, CA USA
FAU - Graves, Edward
AU  - Graves E
AD  - Stanford Department of Radiation Oncology, Stanford University School of
      Medicine, Stanford, CA USA
FAU - Ellies, Lesley
AU  - Ellies L
AD  - Department of Pathology, University of California, San Diego, La Jolla, CA USA
FAU - Rankin, Erinn
AU  - Rankin E
AD  - Stanford Department of Radiation Oncology, Stanford University School of
      Medicine, Stanford, CA USA
FAU - Koong, Albert
AU  - Koong A
AD  - Stanford Department of Radiation Oncology, Stanford University School of
      Medicine, Stanford, CA USA
FAU - Giaccia, Amato
AU  - Giaccia A
AD  - Stanford Department of Radiation Oncology, Stanford University School of
      Medicine, Stanford, CA USA
FAU - Ajina, Reham
AU  - Ajina R
AD  - Georgetown Lombardi Comprehensive Cancer Center, Washington, DC USA
FAU - Wang, Shangzi
AU  - Wang S
AD  - Georgetown Lombardi Comprehensive Cancer Center, Washington, DC USA
FAU - Smith, Jill
AU  - Smith J
AD  - Georgetown Lombardi Comprehensive Cancer Center, Washington, DC USA
FAU - Pierobon, Mariaelena
AU  - Pierobon M
AD  - Georgetown Lombardi Comprehensive Cancer Center, Washington, DC USA
FAU - Jablonski, Sandra
AU  - Jablonski S
AD  - Georgetown Lombardi Comprehensive Cancer Center, Washington, DC USA
FAU - Petricoin, Emanuel
AU  - Petricoin E
AD  - George Mason University, Manassas, VA USA
FAU - Weiner, Louis M.
AU  - Weiner LM
AD  - Georgetown Lombardi Comprehensive Cancer Center, Washington, DC USA
FAU - Sherry, Lorcan
AU  - Sherry L
AD  - OracleBio, Newhouse, Scotland UK
FAU - Waller, John
AU  - Waller J
AD  - OracleBio, Newhouse, Scotland UK
FAU - Anderson, Mark
AU  - Anderson M
AD  - OracleBio, Newhouse, Scotland UK
FAU - Bigley, Alison
AU  - Bigley A
AD  - OracleBio, Newhouse, Scotland UK
FAU - Bernatchez, Chantale
AU  - Bernatchez C
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Haymaker, Cara
AU  - Haymaker C
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Tannir, Nizar M.
AU  - Tannir NM
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Kluger, Harriet
AU  - Kluger H
AD  - Yale Medical Oncology, New Haven, CT USA
FAU - Tetzlaff, Michael
AU  - Tetzlaff M
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Jackson, Natalie
AU  - Jackson N
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Gergel, Ivan
AU  - Gergel I
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Tagliaferri, Mary
AU  - Tagliaferri M
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Zalevsky, Jonathan
AU  - Zalevsky J
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Hoch, Ute
AU  - Hoch U
AD  - Nektar Therapeutics, San Francisco, CA USA
FAU - Hwu, Patrick
AU  - Hwu P
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Snzol, Mario
AU  - Snzol M
AD  - Yale Medical Oncology, New Haven, CT USA
FAU - Hurwitz, Michael
AU  - Hurwitz M
AD  - Yale Medical Oncology, New Haven, CT USA
FAU - Diab, Adi
AU  - Diab A
AD  - University of Texas MD Anderson Cancer Center, Houston, TX USA
FAU - Barberi, Theresa
AU  - Barberi T
AD  - Johns Hopkins University, Baltimore, MD USA
FAU - Martin, Allison
AU  - Martin A
AD  - Johns Hopkins University, Baltimore, MD USA
FAU - Suresh, Rahul
AU  - Suresh R
AD  - Johns Hopkins University, Baltimore, MD USA
FAU - Barakat, David
AU  - Barakat D
AD  - Johns Hopkins University, Baltimore, MD USA
FAU - Harris-Bookman, Sarah
AU  - Harris-Bookman S
AD  - Johns Hopkins University, Baltimore, MD USA
FAU - Drake, Charles
AU  - Drake C
AD  - Johns Hopkins University, Baltimore, MD USA
FAU - Friedman, Alan
AU  - Friedman A
AD  - Johns Hopkins University, Baltimore, MD USA
FAU - Berkey, Sara
AU  - Berkey S
AD  - Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA
FAU - Downs-Canner, Stephanie
AU  - Downs-Canner S
AD  - Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA
FAU - Delgoffe, Greg M.
AU  - Delgoffe GM
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Edwards, Robert P.
AU  - Edwards RP
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Curiel, Tyler
AU  - Curiel T
AD  - University of Texas Health Science Center at San Antonio, San Antonio, TX USA
FAU - Odunsi, Kunle
AU  - Odunsi K
AD  - Roswell Park Cancer Institute, Buffalo, NY USA
FAU - Bartlett, David
AU  - Bartlett D
AD  - Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA
FAU - Obermajer, Nataša
AU  - Obermajer N
AD  - Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA
FAU - Bruno, Tullia C.
AU  - Bruno TC
AD  - Department of Immunology, University of Pittsburgh, Pittsburgh, PA USA
FAU - Moore, Brandon
AU  - Moore B
AD  - Department of Immunology and Microbiology, University of Colorado, Aurora, CO USA
FAU - Squalls, Olivia
AU  - Squalls O
AD  - Department of Immunology and Microbiology, University of Colorado, Aurora, CO USA
FAU - Ebner, Peggy
AU  - Ebner P
AD  - Department of Immunology and Microbiology, University of Colorado, Aurora, CO USA
FAU - Waugh, Katherine
AU  - Waugh K
AD  - Department of Immunology and Microbiology, University of Colorado, Aurora, CO USA
FAU - Mitchell, John
AU  - Mitchell J
AD  - Department of Cardiothoracic Surgery, University of Colorado, Aurora, CO USA
FAU - Franklin, Wilbur
AU  - Franklin W
AD  - Department of Pathology, University of Colorado, Aurora, CO USA
FAU - Merrick, Daniel
AU  - Merrick D
AD  - Department of Pathology, University of Colorado, Aurora, CO USA
FAU - McCarter, Martin
AU  - McCarter M
AD  - Department of Surgery, University of Colorado, Aurora, CO USA
FAU - Palmer, Brent
AU  - Palmer B
AD  - Department of Medicine, University of Colorado, Aurora, CO USA
FAU - Kern, Jeffrey
AU  - Kern J
AD  - National Jewish Health, Denver, CO USA
FAU - Vignali, Dario
AU  - Vignali D
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Slansky, Jill
AU  - Slansky J
AD  - Department of Immunology and Microbiology, University of Colorado, Aurora, CO USA
FAU - Chan, Anissa S. H.
AU  - Chan ASH
AD  - Biothera Pharmaceuticals Inc, Eagan, MN USA
FAU - Qiu, Xiaohong
AU  - Qiu X
AD  - Biothera Pharmaceuticals Inc, Eagan, MN USA
FAU - Fraser, Kathryn
AU  - Fraser K
AD  - Biothera Pharmaceuticals Inc, Eagan, MN USA
FAU - Jonas, Adria
AU  - Jonas A
AD  - Biothera Pharmaceuticals Inc, Eagan, MN USA
FAU - Ottoson, Nadine
AU  - Ottoson N
AD  - Biothera Pharmaceuticals Inc, Eagan, MN USA
FAU - Gordon, Keith
AU  - Gordon K
AD  - Biothera Pharmaceuticals Inc, Eagan, MN USA
FAU - Kangas, Takashi O.
AU  - Kangas TO
AD  - Biothera Pharmaceuticals Inc, Eagan, MN USA
FAU - Leonardo, Steven
AU  - Leonardo S
AD  - Biothera Pharmaceuticals Inc, Eagan, MN USA
FAU - Ertelt, Kathleen
AU  - Ertelt K
AD  - Biothera Pharmaceuticals Inc, Eagan, MN USA
FAU - Walsh, Richard
AU  - Walsh R
AD  - Biothera Pharmaceuticals Inc, Eagan, MN USA
FAU - Uhlik, Mark
AU  - Uhlik M
AD  - Biothera Pharmaceuticals Inc, Eagan, MN USA
FAU - Graff, Jeremy
AU  - Graff J
AD  - Biothera Pharmaceuticals Inc, Eagan, MN USA
FAU - Bose, Nandita
AU  - Bose N
AD  - Biothera Pharmaceuticals Inc, Eagan, MN USA
FAU - Gupta, Ravi
AU  - Gupta R
AD  - MedGenome Inc, Foster City, CA USA
FAU - Mandloi, Nitin
AU  - Mandloi N
AD  - MedGenome Inc, Foster City, CA USA
FAU - Paul, Kiran
AU  - Paul K
AD  - MedGenome Inc, Foster City, CA USA
FAU - Patil, Ashwini
AU  - Patil A
AD  - MedGenome Inc, Foster City, CA USA
FAU - Sathian, Rekha
AU  - Sathian R
AD  - MedGenome Inc, Foster City, CA USA
FAU - Mohan, Aparna
AU  - Mohan A
AD  - MedGenome Inc, Foster City, CA USA
FAU - Manoharan, Malini
AU  - Manoharan M
AD  - MedGenome Inc, Foster City, CA USA
FAU - Chaudhuri, Amitabha
AU  - Chaudhuri A
AD  - MedGenome Inc, Foster City, CA USA
FAU - Chen, Yu
AU  - Chen Y
AD  - Fujian Provincial Cancer Hospital, Fuzhou, Fujian People’s Republic of China
FAU - Lin, Jing
AU  - Lin J
AD  - Fujian Provincial Cancer Hospital, Fuzhou, Fujian People’s Republic of China
FAU - Ye, Yun-bin
AU  - Ye Yb
AD  - Fujian Provincial Cancer Hospital, Fuzhou, Fujian People’s Republic of China
FAU - Xu, Chun-wei
AU  - Xu Cw
AD  - Fujian Provincial Cancer Hospital, Fuzhou, Fujian People’s Republic of China
FAU - Chen, Gang
AU  - Chen G
AD  - Fujian Provincial Cancer Hospital, Fuzhou, Fujian People’s Republic of China
FAU - Guo, Zeng-qing
AU  - Guo Zq
AD  - Fujian Provincial Cancer Hospital, Fuzhou, Fujian People’s Republic of China
FAU - Komarov, Andrey
AU  - Komarov A
AD  - Cellecta, Inc, Mountain View, CA USA
FAU - Chenchik, Alex
AU  - Chenchik A
AD  - Cellecta, Inc, Mountain View, CA USA
FAU - Makhanov, Michael
AU  - Makhanov M
AD  - Cellecta, Inc, Mountain View, CA USA
FAU - Frangou, Costa
AU  - Frangou C
AD  - Cellecta, Inc, Mountain View, CA USA
FAU - Zheng, Yi
AU  - Zheng Y
AD  - PerkinElmer, Hopkinton, MA USA
FAU - Coltharp, Carla
AU  - Coltharp C
AD  - PerkinElmer, Hopkinton, MA USA
FAU - Unfricht, Darryn
AU  - Unfricht D
AD  - PerkinElmer, Hopkinton, MA USA
FAU - Dilworth, Ryan
AU  - Dilworth R
AD  - PerkinElmer, Hopkinton, MA USA
FAU - Fridman, Leticia
AU  - Fridman L
AD  - PerkinElmer, Hopkinton, MA USA
FAU - Liu, Linying
AU  - Liu L
AD  - PerkinElmer, Hopkinton, MA USA
FAU - Rajopadhye, Milind
AU  - Rajopadhye M
AD  - PerkinElmer, Hopkinton, MA USA
FAU - Miller, Peter
AU  - Miller P
AD  - PerkinElmer, Hopkinton, MA USA
FAU - Concha-Benavente, Fernando
AU  - Concha-Benavente F
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Bauman, Julie
AU  - Bauman J
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Trivedi, Sumita
AU  - Trivedi S
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Srivastava, Raghvendra
AU  - Srivastava R
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Ohr, James
AU  - Ohr J
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Heron, Dwight
AU  - Heron D
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Duvvuri, Uma
AU  - Duvvuri U
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Kim, Seungwon
AU  - Kim S
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Gooding, William
AU  - Gooding W
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Ferris, Robert L.
AU  - Ferris RL
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Torrey, Heather
AU  - Torrey H
AD  - Massachusetts General Hospital, Harvard Medical, Boston, MA USA
FAU - Mera, Toshi
AU  - Mera T
AD  - Massachusetts General Hospital, Harvard Medical, Boston, MA USA
FAU - Okubo, Yoshiaki
AU  - Okubo Y
AD  - Massachusetts General Hospital, Harvard Medical, Boston, MA USA
FAU - Vanamee, Eva
AU  - Vanamee E
AD  - Massachusetts General Hospital, Harvard Medical, Boston, MA USA
FAU - Foster, Rosemary
AU  - Foster R
AD  - Massachusetts General Hospital, Harvard Medical, Boston, MA USA
FAU - Faustman, Denise
AU  - Faustman D
AD  - Massachusetts General Hospital, Harvard Medical, Boston, MA USA
FAU - Gartrell, Robyn
AU  - Gartrell R
AD  - Columbia University Medical Center, New York, NY USA
FAU - Stack, Edward
AU  - Stack E
AD  - Perkin Elmer, Hopkinton, MA USA
FAU - Lu, Yan
AU  - Lu Y
AD  - Columbia University Medical Center, New York, NY USA
FAU - Izaki, Daisuke
AU  - Izaki D
AD  - Columbia University, New York, NY USA
FAU - Beck, Kristen
AU  - Beck K
AD  - Columbia University College of Physicians and Surgeons, New York, NY USA
FAU - Jia, Dan Tong
AU  - Jia DT
AD  - Columbia University College of Physicians and Surgeons, New York, NY USA
FAU - Armenta, Paul
AU  - Armenta P
AD  - Columbia University College of Physicians and Surgeons, New York, NY USA
FAU - White-Stern, Ashley
AU  - White-Stern A
AD  - Columbia University College of Physicians and Surgeons, New York, NY USA
FAU - Fu, Yichun
AU  - Fu Y
AD  - Columbia University College of Physicians and Surgeons, New York, NY USA
FAU - Blake, Zoe
AU  - Blake Z
AD  - Columbia University Medical Center, New York, NY USA
FAU - Marks, Douglas
AU  - Marks D
AD  - Columbia University Medical Center, New York, NY USA
FAU - Kaufman, Howard L.
AU  - Kaufman HL
AD  - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
FAU - Taback, Bret
AU  - Taback B
AD  - Columbia University Medical Center, New York, NY USA
FAU - Horst, Basil
AU  - Horst B
AD  - Columbia University Medical Center, New York, NY USA
FAU - Saenger, Yvonne M.
AU  - Saenger YM
AD  - New York Presbyterian, Columbia University Medical Center, New York, NY USA
FAU - Glickman, Laura Hix
AU  - Glickman LH
AD  - Aduro Biotech, Berkeley, CA USA
FAU - Kanne, David B.
AU  - Kanne DB
AD  - Aduro Biotech, Berkeley, CA USA
FAU - Gauthier, Kelsey S.
AU  - Gauthier KS
AD  - Aduro Biotech, Berkeley, CA USA
FAU - Desbien, Anthony L.
AU  - Desbien AL
AD  - Aduro Biotech, Berkeley, CA USA
FAU - Francica, Brian
AU  - Francica B
AD  - Johns Hopkins University School of Medicine, Baltimore, MD USA
FAU - Katibah, George
AU  - Katibah G
AD  - Aduro Biotech, Berkeley, CA USA
FAU - Corrales, Leticia P.
AU  - Corrales LP
AD  - The University of Chicago, Chicago, IL USA
FAU - Leong, Justin L.
AU  - Leong JL
AD  - Aduro Biotech, Berkeley, CA USA
FAU - Sung, Leonard
AU  - Sung L
AD  - Aduro Biotech, Berkeley, CA USA
FAU - Metchette, Ken
AU  - Metchette K
AD  - Aduro Biotech, Berkeley, CA USA
FAU - Kasibhatla, Shailaja
AU  - Kasibhatla S
AD  - Genomics Institute of the Novartis Research Foundation (GNF), San Diego, CA USA
FAU - Pferdekamper, Anne Marie
AU  - Pferdekamper AM
AD  - Genomics Institute of the Novartis Research Foundation (GNF), San Diego, CA USA
FAU - Zheng, Lianxing
AU  - Zheng L
AD  - Novartis Institutes for BioMedical Research, Inc., Cambridge, MA USA
FAU - Cho, Charles
AU  - Cho C
AD  - Genomics Institute of the Novartis Research Foundation (GNF), San Diego, CA USA
FAU - Feng, Yan
AU  - Feng Y
AD  - Novartis Institutes for BioMedical Research, Inc., Cambridge, MA USA
FAU - McKenna, Jeffery M.
AU  - McKenna JM
AD  - Novartis Institutes for BioMedical Research, Inc., Cambridge, MA USA
FAU - Tallarico, John
AU  - Tallarico J
AD  - Novartis Institutes for BioMedical Research, Inc., Cambridge, MA USA
FAU - Bender, Steven
AU  - Bender S
AD  - Genomics Institute of the Novartis Research Foundation (GNF), San Diego, CA USA
FAU - Ndubaku, Chudi
AU  - Ndubaku C
AD  - Aduro Biotech, Berkeley, CA USA
FAU - McWhirter, Sarah M.
AU  - McWhirter SM
AD  - Aduro Biotech, Berkeley, CA USA
FAU - Drake, Charles G.
AU  - Drake CG
AD  - Johns Hopkins University Cancer Center, Baltimore, MD USA
FAU - Gajewski, Thomas F.
AU  - Gajewski TF
AD  - University of Chicago Medical Center, Chicago, IL USA
FAU - Dubensky, Thomas W.
AU  - Dubensky TW
AD  - Aduro Biotech, Berkeley, CA USA
FAU - Gugel, Elena Gonzalez
AU  - Gugel EG
AD  - Tish Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
FAU - Bell, Charles J. M.
AU  - Bell CJM
AD  - Murray Edwards College and School of Clinical Medicine, University of Cambridge, 
      Cambridge, England UK
FAU - Munk, Adiel
AU  - Munk A
AD  - Tish Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
FAU - Muniz, Luciana
AU  - Muniz L
AD  - Tish Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
FAU - Bhardwaj, Nina
AU  - Bhardwaj N
AD  - Tish Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
FAU - Zhao, Fei
AU  - Zhao F
AD  - Duke University Medical Center, Durham, NC USA
FAU - Evans, Kathy
AU  - Evans K
AD  - Duke University Medical Center, Durham, NC USA
FAU - Xiao, Christine
AU  - Xiao C
AD  - Duke University Medical Center, Durham, NC USA
FAU - Holtzhausen, Alisha
AU  - Holtzhausen A
AD  - Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel
      Hill, NC USA
FAU - Hanks, Brent A.
AU  - Hanks BA
AD  - Duke University Medical Center, Durham, NC USA
FAU - Scholler, Nathalie
AU  - Scholler N
AD  - Stanford Research Institute, Menlo Park, CA USA
FAU - Yin, Catherine
AU  - Yin C
AD  - Stanford Research Institute, Menlo Park, CA USA
FAU - Van der Meijs, Pien
AU  - Van der Meijs P
AD  - Rijksuniversiteit Groningen, Amsterdam, Groningen Netherlands
FAU - Prantner, Andrew M.
AU  - Prantner AM
AD  - University of Pennsylvania, Philadelphia, PA USA
FAU - Krejsa, Cecile M.
AU  - Krejsa CM
AD  - Acerta Pharma, Bellevue, WA USA
FAU - Smith, Leia
AU  - Smith L
AD  - Acerta Pharma, Bellevue, WA USA
FAU - Johnson, Brian
AU  - Johnson B
AD  - University of Washington, Seattle, WA USA
FAU - Branstetter, Daniel
AU  - Branstetter D
AD  - Cynosure Clinical Research LLC, North Bend, WA USA
FAU - Stein, Paul L.
AU  - Stein PL
AD  - Stanford Research Institute, Menlo Park, CA USA
FAU - Jaen, Juan C.
AU  - Jaen JC
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Tan, Joanne BL
AU  - Tan JB
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Chen, Ada
AU  - Chen A
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Chen, Yu
AU  - Chen Y
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Park, Timothy
AU  - Park T
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Powers, Jay P.
AU  - Powers JP
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Sexton, Holly
AU  - Sexton H
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Xu, Guifen
AU  - Xu G
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Young, Steve W.
AU  - Young SW
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Schindler, Ulrike
AU  - Schindler U
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Deng, Wentao
AU  - Deng W
AD  - West Virginia University, Morgantown, WV USA
FAU - Klinke, David John
AU  - Klinke DJ
AD  - West Virginia University, Morgantown, WV USA
FAU - Komar, Hannah M.
AU  - Komar HM
AD  - The Ohio State University, Columbus, OH USA
FAU - Mace, Thomas
AU  - Mace T
AD  - The Ohio State University, Columbus, OH USA
FAU - Serpa, Gregory
AU  - Serpa G
AD  - The Ohio State University, Columbus, OH USA
FAU - Elnaggar, Omar
AU  - Elnaggar O
AD  - The Ohio State University, Columbus, OH USA
FAU - Conwell, Darwin
AU  - Conwell D
AD  - The Ohio State University, Columbus, OH USA
FAU - Hart, Philip
AU  - Hart P
AD  - The Ohio State University Wexner Medical Center, Columbus, OH USA
FAU - Schmidt, Carl
AU  - Schmidt C
AD  - The Ohio State University Wexner Medical Center, Columbus, OH USA
FAU - Dillhoff, Mary
AU  - Dillhoff M
AD  - The Ohio State University Wexner Medical Center, Columbus, OH USA
FAU - Jin, Ming
AU  - Jin M
AD  - The Ohio State University Wexner Medical Center, Columbus, OH USA
FAU - Ostrowski, Michael C.
AU  - Ostrowski MC
AD  - The Ohio State University, Columbus, OH USA
FAU - Lesinski, Gregory B.
AU  - Lesinski GB
AD  - The Ohio State University, Columbus, OH USA
FAU - Koti, Madhuri
AU  - Koti M
AD  - Queen’s University, Kingston, ON Canada
FAU - Au, Katrina
AU  - Au K
AD  - Queen’s University, Kingston, ON Canada
FAU - Peterson, Nichole
AU  - Peterson N
AD  - Queen’s University, Kingston, ON Canada
FAU - Truesdell, Peter
AU  - Truesdell P
AD  - Queen’s University, Kingston, ON Canada
FAU - Reid-Schachter, Gillian
AU  - Reid-Schachter G
AD  - Queen’s University, Kingston, ON Canada
FAU - Graham, Charles
AU  - Graham C
AD  - Queen’s University, Kingston, ON Canada
FAU - Craig, Andrew
AU  - Craig A
AD  - Queen’s University, Kingston, ON Canada
FAU - Francis, Julie-Ann
AU  - Francis JA
AD  - Queen’s University, Kingston, ON Canada
FAU - Kotlan, Beatrix
AU  - Kotlan B
AD  - National Institute of Oncology, Budapest, Hungary
FAU - Balatoni, Timea
AU  - Balatoni T
AD  - National Institute of Oncology, Budapest, Hungary
FAU - Farkas, Emil
AU  - Farkas E
AD  - National Institute of Oncology, Budapest, Hungary
FAU - Toth, Laszlo
AU  - Toth L
AD  - National Institute of Oncology, Budapest, Hungary
FAU - Ujhelyi, Mihaly
AU  - Ujhelyi M
AD  - National Institute of Oncology, Budapest, Hungary
FAU - Savolt, Akos
AU  - Savolt A
AD  - National Institute of Oncology, Budapest, Hungary
FAU - Doleschall, Zoltan
AU  - Doleschall Z
AD  - National Institute of Oncology, Budapest, Hungary
FAU - Horvath, Szabolcs
AU  - Horvath S
AD  - National Institute of Oncology, Budapest, Hungary
FAU - Eles, Klara
AU  - Eles K
AD  - National Institute of Oncology, Budapest, Hungary
FAU - Olasz, Judit
AU  - Olasz J
AD  - National Institute of Oncology, Budapest, Hungary
FAU - Csuka, Orsolya
AU  - Csuka O
AD  - National Institute of Oncology, Budapest, Hungary
FAU - Kasler, Miklos
AU  - Kasler M
AD  - National Institute of Oncology, Budapest, Hungary
FAU - Liszkay, Gabriella
AU  - Liszkay G
AD  - National Institute of Oncology, Budapest, Hungary
FAU - Barnea, Eytan
AU  - Barnea E
AD  - BioIncept, Cherry Hill, NJ USA
FAU - Kumar, Sushil
AU  - Kumar S
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Tsujikawa, Takahiro
AU  - Tsujikawa T
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Blakely, Collin
AU  - Blakely C
AD  - University of California, San Francisco School of Medicine, San Francisco, CA USA
FAU - Flynn, Patrick
AU  - Flynn P
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Goodman, Reid
AU  - Goodman R
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Bueno, Raphael
AU  - Bueno R
AD  - Brigham and Women’s Hospital, Boston, MA USA
FAU - Sugarbaker, David
AU  - Sugarbaker D
AD  - Baylor Clinic, Houston, TX USA
FAU - Jablons, David
AU  - Jablons D
AD  - UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA USA
FAU - Broaddus, V. Courtney
AU  - Broaddus VC
AD  - University of California, San Francisco School of Medicine, San Francisco, CA USA
FAU - West, Brian
AU  - West B
AD  - Plexxikon Inc., Berkeley, CA USA
FAU - Coussens, Lisa M.
AU  - Coussens LM
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Kunk, Paul R.
AU  - Kunk PR
AD  - University of Virginia, Charlottesville, VA USA
FAU - Obeid, Joseph M.
AU  - Obeid JM
AD  - University of Virginia, Charlottesville, VA USA
FAU - Winters, Kevin
AU  - Winters K
AD  - University of Virginia, Charlottesville, VA USA
FAU - Pramoonjago, Patcharin
AU  - Pramoonjago P
AD  - University of Virginia, Charlottesville, VA USA
FAU - Smolkin, Mark E.
AU  - Smolkin ME
AD  - Department of Public Health Sciences, University of Virginia, Charlottesville, VA
      USA
FAU - Stelow, Edward B.
AU  - Stelow EB
AD  - University of Virginia, Charlottesville, VA USA
FAU - Bauer, Todd W.
AU  - Bauer TW
AD  - University of Virginia, Charlottesville, VA USA
FAU - Slingluff, Craig L.
AU  - Slingluff CL
AD  - Division of Surgical Oncology, University of Virginia, Charlottesville, VA USA
FAU - Rahma, Osama E.
AU  - Rahma OE
AD  - Dana Farber Cancer Institute, Harvard University, Boston, MA USA
FAU - Lamble, Adam
AU  - Lamble A
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Kosaka, Yoko
AU  - Kosaka Y
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Huang, Fei
AU  - Huang F
AD  - Janssen Pharmaceutical R&D, Spring House, PA USA
FAU - Saser, Kate A.
AU  - Saser KA
AD  - Janssen Pharmaceutical R&D, Spring House, PA USA
FAU - Adams, Homer
AU  - Adams H
AD  - Janssen Pharmaceutical R&D, Spring House, PA USA
FAU - Tognon, Christina E.
AU  - Tognon CE
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Laderas, Ted
AU  - Laderas T
AD  - Oregon Health & Science University, Portland, OR USA
FAU - McWeeney, Shannon
AU  - McWeeney S
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Loriaux, Marc
AU  - Loriaux M
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Tyner, Jeffery W.
AU  - Tyner JW
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Druker, Brian J.
AU  - Druker BJ
AD  - Knight Cancer Institute, Howard Hughes Medical Institute, Portland, OR USA
FAU - Lind, Evan F.
AU  - Lind EF
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Liu, Zhuqing
AU  - Liu Z
AD  - University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA
      USA
FAU - Lu, Shanhong
AU  - Lu S
AD  - University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA
      USA
FAU - Kane, Lawrence P.
AU  - Kane LP
AD  - Department of Immunology, University of Pittsburgh, Pittsburgh, PA USA
FAU - Ferris, Robert L.
AU  - Ferris RL
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Liu, Zhuqing
AU  - Liu Z
AD  - University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA
      USA
FAU - Shayan, Gulidanna
AU  - Shayan G
AD  - University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA
      USA
FAU - Lu, Shanhong
AU  - Lu S
AD  - University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA
      USA
FAU - Ferris, Robert L.
AU  - Ferris RL
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Femel, Julia
AU  - Femel J
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Tsujikawa, Takahiro
AU  - Tsujikawa T
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Lane, Ryan
AU  - Lane R
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Booth, Jamie
AU  - Booth J
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Lund, Amanda W.
AU  - Lund AW
AD  - Oregon Health & Science University, Portland, OR USA
FAU - Melssen, Marit
AU  - Melssen M
AD  - University of Virginia, Charlottesville, VA USA
FAU - Rodriguez, Anthony
AU  - Rodriguez A
AD  - University of Virginia, Charlottesville, VA USA
FAU - Slingluff, Craig L.
AU  - Slingluff CL
AD  - Division of Surgical Oncology, University of Virginia, Charlottesville, VA USA
FAU - Engelhard, Victor H.
AU  - Engelhard VH
AD  - University of Virginia, Charlottesville, VA USA
FAU - Metelli, Alessandra
AU  - Metelli A
AD  - Medical University of South Carolina, Charleston, SC USA
FAU - Wu, Bill X.
AU  - Wu BX
AD  - Medical University of South Carolina, Charleston, SC USA
FAU - Fugle, Caroline W.
AU  - Fugle CW
AD  - Medical University of South Carolina, Charleston, SC USA
FAU - Saleh, Rachidi
AU  - Saleh R
AD  - Medical University of South Carolina, Charleston, SC USA
FAU - Sun, Shaoli
AU  - Sun S
AD  - Medical University of South Carolina, Charleston, SC USA
FAU - Wu, Jennifer
AU  - Wu J
AD  - Medical University of South Carolina, Charleston, SC USA
FAU - Liu, Bei
AU  - Liu B
AD  - Medical University of South Carolina, Charleston, SC USA
FAU - Li, Zihai
AU  - Li Z
AD  - Medical University of South Carolina, Charleston, SC USA
FAU - Morris, Zachary S.
AU  - Morris ZS
AD  - University of Wisconsin School of Medicine and Public Health, Madison, WI USA
FAU - Guy, Emily I.
AU  - Guy EI
AD  - University of Wisconsin School of Medicine and Public Health, Madison, WI USA
FAU - Heinze, Clinton
AU  - Heinze C
AD  - University of Wisconsin School of Medicine and Public Health, Madison, WI USA
FAU - Kler, Jasdeep
AU  - Kler J
AD  - University of Wisconsin School of Medicine and Public Health, Madison, WI USA
FAU - Gressett, Monica M.
AU  - Gressett MM
AD  - University of Wisconsin School of Medicine and Public Health, Madison, WI USA
FAU - Werner, Lauryn R.
AU  - Werner LR
AD  - University of Wisconsin School of Medicine and Public Health, Madison, WI USA
FAU - Gillies, Stephen D.
AU  - Gillies SD
AD  - Provenance Biopharmaceuticals Corp., Carlisle, MA USA
FAU - Korman, Alan J.
AU  - Korman AJ
AD  - Bristol-Myers Squibb, Princeton, NJ USA
FAU - Loibner, Hans
AU  - Loibner H
AD  - Apeiron Biologics, Vienna, Austria
FAU - Hank, Jacquelyn A.
AU  - Hank JA
AD  - University of Wisconsin School of Medicine and Public Health, Madison, WI USA
FAU - Rakhmilevich, Alexander L.
AU  - Rakhmilevich AL
AD  - University of Wisconsin School of Medicine and Public Health, Madison, WI USA
FAU - Harari, Paul M.
AU  - Harari PM
AD  - University of Wisconsin School of Medicine and Public Health, Madison, WI USA
FAU - Sondel, Paul M.
AU  - Sondel PM
AD  - University of Wisconsin School of Medicine and Public Health, Madison, WI USA
FAU - Newman, Jenna
AU  - Newman J
AD  - Rutgers University, New Brunswick, NJ USA
FAU - Zloza, Andrew
AU  - Zloza A
AD  - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
FAU - Huelsmann, Erica
AU  - Huelsmann E
AD  - Rush University, Chicago, IL USA
FAU - Broucek, Joseph
AU  - Broucek J
AD  - Rush University, Chicago, IL USA
FAU - Kaufman, Howard L.
AU  - Kaufman HL
AD  - Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA
FAU - Brech, Dorothee
AU  - Brech D
AD  - Helmholtz Zentrum München, Immunoanalytics- Tissue Control of Immunocytes,
      Munich, Bayern Germany
FAU - Straub, Tobias
AU  - Straub T
AD  - Bioinformatics Core Unit, Biomedical Center, Ludwig-Maximilians-University,
      Planegg-Martinsried Munich, Munich, Bayern Germany
FAU - Irmler, Martin
AU  - Irmler M
AD  - Helmholtz Zentrum München, Institute of Experimental Genetics, Neuherberg, Bayern
      Germany
FAU - Beckers, Johannes
AU  - Beckers J
AD  - Helmholtz Zentrum München, Institute of Experimental Genetics, Neuherberg, Bayern
      Germany
FAU - Buettner, Florian
AU  - Buettner F
AD  - Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart,
      Baden-Wurttemberg Germany
FAU - Schaeffeler, Elke
AU  - Schaeffeler E
AD  - Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart,
      Baden-Wurttemberg Germany
FAU - Schwab, Matthias
AU  - Schwab M
AD  - Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart,
      University of Tuebingen, Stuttgart, Baden-Wurttemberg Germany
FAU - Noessner, Elfriede
AU  - Noessner E
AD  - Helmholtz Zentrum München, Immunoanalytics-Tissue Control of Immunocytes, Munich,
      Bayern Germany
FAU - Anand, Snjezana
AU  - Anand S
AD  - Pulse Biosciences, Burlingame, CA USA
FAU - McDaniel, Amanda
AU  - McDaniel A
AD  - Pulse Biosciences, Burlingame, CA USA
FAU - Cha, John
AU  - Cha J
AD  - Pulse Biosciences, Burlingame, CA USA
FAU - Uecker, Darrin
AU  - Uecker D
AD  - Pulse Biosciences, Burlingame, CA USA
FAU - Nuccitelli, Richard
AU  - Nuccitelli R
AD  - Pulse Biosciences, Burlingame, CA USA
FAU - Ordentlich, Peter
AU  - Ordentlich P
AD  - Syndax Pharmaceuticals, Inc, Waltham, MA USA
FAU - Wolfreys, Alison
AU  - Wolfreys A
AD  - UCB Biopharma, Slough, England UK
FAU - Da Costa, Andre
AU  - Da Costa A
AD  - UCB Biopharma, Braine-l’Alleud, Brabant Wallon Belgium
FAU - Silva, John
AU  - Silva J
AD  - UCB Biopharma, Slough, England UK
FAU - Crosby, Andrea
AU  - Crosby A
AD  - UCB Biopharma, Slough, England UK
FAU - Staelens, Ludovicus
AU  - Staelens L
AD  - UCB Biopharma, Braine-l’Alleud, Brabant Wallon Belgium
FAU - Craggs, Graham
AU  - Craggs G
AD  - UCB Biopharma, Slough, England UK
FAU - Cauvin, Annick
AU  - Cauvin A
AD  - UCB Biopharma, Braine-l’Alleud, Brabant Wallon Belgium
FAU - Mason, Sean
AU  - Mason S
AD  - UCB Biopharma, Slough, England UK
FAU - Paterson, Alison M.
AU  - Paterson AM
AD  - Surface Oncology, Cambridge, MA USA
FAU - Lake, Andrew C.
AU  - Lake AC
AD  - Surface Oncology, Cambridge, MA USA
FAU - Armet, Caroline M.
AU  - Armet CM
AD  - Surface Oncology, Cambridge, MA USA
FAU - O’Connor, Rachel W.
AU  - O’Connor RW
AD  - Surface Oncology, Cambridge, MA USA
FAU - Hill, Jonathan A.
AU  - Hill JA
AD  - Surface Oncology, Cambridge, MA USA
FAU - Normant, Emmanuel
AU  - Normant E
AD  - Surface Oncology, Cambridge, MA USA
FAU - Adam, Ammar
AU  - Adam A
AD  - Surface Oncology, Cambridge, MA USA
FAU - Biniszkiewicz, Detlev M.
AU  - Biniszkiewicz DM
AD  - Surface Oncology, Cambridge, MA USA
FAU - Chappel, Scott C.
AU  - Chappel SC
AD  - Surface Oncology, Cambridge, MA USA
FAU - Palombella, Vito J.
AU  - Palombella VJ
AD  - Surface Oncology, Cambridge, MA USA
FAU - Holland, Pamela M.
AU  - Holland PM
AD  - Surface Oncology, Cambridge, MA USA
FAU - Powers, Jay P.
AU  - Powers JP
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Becker, Annette
AU  - Becker A
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Chen, Ada
AU  - Chen A
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Leleti, Manmohan R.
AU  - Leleti MR
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Newcomb, Eric
AU  - Newcomb E
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Sexton, Holly
AU  - Sexton H
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Schindler, Ulrike
AU  - Schindler U
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Tan, Joanne B. L.
AU  - Tan JBL
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Young, Steve W.
AU  - Young SW
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Jaen, Juan C.
AU  - Jaen JC
AD  - Arcus Biosciences, Hayward, CA USA
FAU - Rapisuwon, Suthee
AU  - Rapisuwon S
AD  - Georgetown Lombardi Comprehensive Cancer Center, Washington, DC USA
FAU - Radfar, Arash
AU  - Radfar A
AD  - Washington Hospital Center, Washington, DC USA
FAU - Gardner, Kellie
AU  - Gardner K
AD  - Lombardi Comprehensive Cancer Center, Washington, DC USA
FAU - Gibney, Geoffrey
AU  - Gibney G
AD  - Lombardi Comprehensive Cancer Center, Washington, DC USA
FAU - Atkins, Michael
AU  - Atkins M
AD  - Lombardi Comprehensive Cancer Center, Washington, DC USA
FAU - Rennier, Keith R.
AU  - Rennier KR
AD  - Washington University School of Medicine in St. Louis, St. Louis, MO USA
FAU - Crowder, Robert
AU  - Crowder R
AD  - Washington University School of Medicine in St. Louis, St. Louis, MO USA
FAU - Wang, Ping
AU  - Wang P
AD  - Washington University School of Medicine in St. Louis, St. Louis, MO USA
FAU - Pachynski, Russell K.
AU  - Pachynski RK
AD  - Washington University School of Medicine in St. Louis, St. Louis, MO USA
FAU - Carrero, Rosa M. Santana
AU  - Carrero RMS
AD  - The University of Texas Graduate School of Biomedical Sciences at Houston,
      Houston, TX USA
FAU - Rivas, Sarai
AU  - Rivas S
AD  - Department of Immunology, University of Texas MD Anderson Cancer Center, Houston,
      TX USA
FAU - Beceren-Braun, Figen
AU  - Beceren-Braun F
AD  - Department of Immunology, University of Texas MD Anderson Cancer Center, Houston,
      TX USA
FAU - Anthony, Scott
AU  - Anthony S
AD  - Department of Microbiology, University of Iowa, Iowa City, IA USA
FAU - Schluns, Kimberly S.
AU  - Schluns KS
AD  - Department of Immunology, University of Texas MD Anderson Cancer Center, Houston,
      TX USA
FAU - Sawant, Deepali
AU  - Sawant D
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Chikina, Maria
AU  - Chikina M
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Yano, Hiroshi
AU  - Yano H
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Workman, Creg
AU  - Workman C
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Vignali, Dario
AU  - Vignali D
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Salerno, Elise
AU  - Salerno E
AD  - University of Alabama, Birmingham, AL USA
FAU - Bedognetti, Davide
AU  - Bedognetti D
AD  - Sidra Medical and Research Center, Doha, Ad Dawhah Qatar
FAU - Mauldin, Ileana
AU  - Mauldin I
AD  - University of Virginia, Charlottesville, VA USA
FAU - Deacon, Donna
AU  - Deacon D
AD  - University of Virginia, Charlottesville, VA USA
FAU - Shea, Sofia
AU  - Shea S
AD  - Hunter Holmes McGuire Veterans Administration Medical Center, Richmond, VA USA
FAU - Pinczewski, Joel
AU  - Pinczewski J
AD  - Dorevitch Pathology, Heidelberg West, Victoria Australia
FAU - Obeid, Joseph M.
AU  - Obeid JM
AD  - Department of Surgery, University of Virginia, Charlottesville, VA USA
FAU - Coukos, George
AU  - Coukos G
AD  - Ludwig Institute for Cancer Research, Epalinges, Vaud Switzerland
FAU - Wang, Ena
AU  - Wang E
AD  - Sidra Medical and Research Center, Doha, Ad Dawhah Qatar
FAU - Gajewski, Thomas
AU  - Gajewski T
AD  - The University of Chicago, Chicago, IL USA
FAU - Marincola, Franco M.
AU  - Marincola FM
AD  - Sidra Medical and Research Center, Doha, Ad Dawhah Qatar
FAU - Slingluff, Craig L.
AU  - Slingluff CL
AD  - University of Virginia, Charlottesville, VA USA
FAU - Spranger, Stefani
AU  - Spranger S
AD  - Department of Pathology, The University of Chicago, Chicago, IL USA
FAU - Horton, Brendan
AU  - Horton B
AD  - Department of Pathology, The University of Chicago, Chicago, IL USA
FAU - Gajewski, Thomas F.
AU  - Gajewski TF
AD  - University of Chicago Medical Center, Chicago, IL USA
FAU - Suzuki, Akiko
AU  - Suzuki A
AD  - Center for Biologics Evaluation and Research, Food and Drug Administration,
      Silver Spring, MD USA
FAU - Leland, Pamela
AU  - Leland P
AD  - Center for Biologics Evaluation and Research, Food and Drug Administration,
      Silver Spring, MD USA
FAU - Joshi, Bharat H.
AU  - Joshi BH
AD  - Center for Biologics Evaluation and Research, Food and Drug Administration,
      Silver Spring, MD USA
FAU - Puri, Raj K.
AU  - Puri RK
AD  - Center for Biologics Evaluation and Research, Food and Drug Administration,
      Silver Spring, MD USA
FAU - Sweis, Randy F.
AU  - Sweis RF
AD  - University of Chicago, Chicago, IL USA
FAU - Bao, Riyue
AU  - Bao R
AD  - University of Chicago, Chicago, IL USA
FAU - Luke, Jason
AU  - Luke J
AD  - University of Chicago, Chicago, IL USA
FAU - Gajewski, Thomas F.
AU  - Gajewski TF
AD  - University of Chicago Medical Center, Chicago, IL USA
FAU - Theodoraki, Marie-Nicole
AU  - Theodoraki MN
AD  - University of Pittsburgh, Pittsburgh, PA USA
FAU - Mogundo, Frances-Mary
AU  - Mogundo FM
AD  - Magee-Womens Research Institute, Ovarian Cancer Center of Excellence, and
      Peritoneal/Ovarian Cancer Specialty Care Center, Hillman Cancer Center,
      University of Pittsburgh, Pittsburgh, PA USA
FAU - Edwards, Robert P.
AU  - Edwards RP
AD  - Magee-Womens Research Institute, Ovarian Cancer Center of Excellence, and
      Peritoneal/Ovarian Cancer Specialty Care Center, Hillman Cancer Center,
      University of Pittsburgh, Pittsburgh, PA USA
FAU - Kalinski, Pawel
AU  - Kalinski P
AD  - Department of Surgery, University of Pittsburgh Cancer Institute, Pittsburgh, PA 
      USA
FAU - Won, Haejung
AU  - Won H
AD  - City of Hope, Duarte, CA USA
FAU - Moreira, Dayson
AU  - Moreira D
AD  - City of Hope, Duarte, CA USA
FAU - Gao, Chan
AU  - Gao C
AD  - City of Hope, Duarte, CA USA
FAU - Zhao, Xingli
AU  - Zhao X
AD  - City of Hope, Duarte, CA USA
FAU - Duttagupta, Priyanka
AU  - Duttagupta P
AD  - City of Hope, Duarte, CA USA
FAU - Jones, Jeremy
AU  - Jones J
AD  - City of Hope, Duarte, CA USA
FAU - D’Apuzzo, Massimo
AU  - D’Apuzzo M
AD  - City of Hope, Duarte, CA USA
FAU - Pal, Sumanta
AU  - Pal S
AD  - City of Hope, Duarte, CA USA
FAU - Kortylewski, Marcin
AU  - Kortylewski M
AD  - City of Hope, Duarte, CA USA
LA  - eng
PT  - Journal Article
DEP - 20161116
TA  - J Immunother Cancer
JT  - Journal for Immunotherapy of Cancer
AID - 173 [pii]
AID - 10.1186/s40425-016-0173-6 [doi]
SO  - J Immunother Cancer. 2016 Nov 16;4(Suppl 1):107-221.
      doi:10.1186/s40425-016-0173-6.

PMC - PMC2730465
PMID- 19107582
IS  - 0165-005X (Print)
IS  - 1573-076X (Electronic)
VI  - 33
IP  - 1
DP  - 2009 Mar
TI  - Reconsidering the Placebo Response from a Broad Anthropological Perspective.
PG  - 112-52
AB  - This paper considers how the full range of human experience may catalyze a
      placebo response. The placebo effect has been characterized as something to
      control in clinical research, something to cultivate in clinical practice, and
      something present in all healing encounters. We examine domains in which the term
      ‘placebo’ is used in discourse: clinical research, clinical practice, media
      representations of treatment efficacy, and lay interpretations of placebo—an
      under-researched topic. We briefly review major theoretical frameworks proposed
      to explain the placebo effect: classical conditioning, expectancy, the
      therapeutic relationship, and sociocultural ‘meaning.’ As a corrective to what we
      see as an over-emphasis on conscious cognitive approaches to understanding
      placebo, we reorient the discussion to argue that direct embodied experience may 
      take precedence over meaning-making in the healing encounter. As an example, we
      examine the neurobiology of rehearsing or visualizing wellness as a mode of
      directly (performatively) producing an outcome often dismissed as a ‘placebo
      response.’ Given body/mind/emotional resonance, we suggest that the placebo
      response is an evolutionarily adaptive trait and part of healing mechanisms
      operating across many levels—from genetic and cellular to social and cultural.
FAU - Thompson, Jennifer Jo
AU  - Thompson JJ
AD  - Department of Anthropology, University of Arizona
FAU - Ritenbaugh, Cheryl
AU  - Ritenbaugh C
AD  - Department of Family and Community Medicine and Department of Anthropology,
      University of Arizona
FAU - Nichter, Mark
AU  - Nichter M
AD  - Department of Anthropology and Department of Family and Community Medicine,
      University of Arizona
LA  - eng
PT  - Journal Article
TA  - Cult Med Psychiatry
JT  - Culture, medicine and psychiatry
AID - 10.1007/s11013-008-9122-2 [doi]
MID - NIHMS132239
SO  - Cult Med Psychiatry. 2009 Mar;33(1):112-52. doi:10.1007/s11013-008-9122-2.

PMC - PMC4034607
PMID- 24904405
IS  - 1662-6443 (Electronic)
VI  - 7
DP  - 2014
TI  - Organic electrode coatings for next-generation neural interfaces.
LID - 15
AB  - Traditional neuronal interfaces utilize metallic electrodes which in recent years
      have reached a plateau in terms of the ability to provide safe stimulation at
      high resolution or rather with high densities of microelectrodes with improved
      spatial selectivity. To achieve higher resolution it has become clear that
      reducing the size of electrodes is required to enable higher electrode counts
      from the implant device. The limitations of interfacing electrodes including low 
      charge injection limits, mechanical mismatch and foreign body response can be
      addressed through the use of organic electrode coatings which typically provide a
      softer, more roughened surface to enable both improved charge transfer and lower 
      mechanical mismatch with neural tissue. Coating electrodes with conductive
      polymers or carbon nanotubes offers a substantial increase in charge transfer
      area compared to conventional platinum electrodes. These organic conductors
      provide safe electrical stimulation of tissue while avoiding undesirable chemical
      reactions and cell damage. However, the mechanical properties of conductive
      polymers are not ideal, as they are quite brittle. Hydrogel polymers present a
      versatile coating option for electrodes as they can be chemically modified to
      provide a soft and conductive scaffold. However, the in vivo chronic inflammatory
      response of these conductive hydrogels remains unknown. A more recent approach
      proposes tissue engineering the electrode interface through the use of
      encapsulated neurons within hydrogel coatings. This approach may provide a method
      for activating tissue at the cellular scale, however, several technological
      challenges must be addressed to demonstrate feasibility of this innovative idea. 
      The review focuses on the various organic coatings which have been investigated
      to improve neural interface electrodes.
FAU - Aregueta-Robles, Ulises A.
AU  - Aregueta-Robles UA
AD  - Graduate School of Biomedical Engineering, University of New South WalesSydney,
      NSW, Australia
FAU - Woolley, Andrew J.
AU  - Woolley AJ
AD  - Graduate School of Biomedical Engineering, University of New South WalesSydney,
      NSW, Australia
FAU - Poole-Warren, Laura A.
AU  - Poole-Warren LA
AD  - Graduate School of Biomedical Engineering, University of New South WalesSydney,
      NSW, Australia
FAU - Lovell, Nigel H.
AU  - Lovell NH
AD  - Graduate School of Biomedical Engineering, University of New South WalesSydney,
      NSW, Australia
FAU - Green, Rylie A.
AU  - Green RA
AD  - Graduate School of Biomedical Engineering, University of New South WalesSydney,
      NSW, Australia
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20140527
PHST- 2014/01/31 [received]
PHST- 2014/05/06 [accepted]
TA  - Front Neuroeng
JT  - Frontiers in Neuroengineering
AID - 10.3389/fneng.2014.00015 [doi]
SO  - Front Neuroeng. 2014 May 27;7:. doi:10.3389/fneng.2014.00015.

PMC - PMC4865510
PMID- 27242483
IS  - 1662-5161 (Electronic)
VI  - 10
DP  - 2016
TI  - Exploring Neuro-Physiological Correlates of Drivers' Mental Fatigue Caused by
      Sleep Deprivation Using Simultaneous EEG, ECG, and fNIRS Data.
LID - 219
AB  - Investigations of the neuro-physiological correlates of mental loads, or states, 
      have attracted significant attention recently, as it is particularly important to
      evaluate mental fatigue in drivers operating a motor vehicle. In this research,
      we collected multimodal EEG/ECG/EOG and fNIRS data simultaneously to develop
      algorithms to explore neuro-physiological correlates of drivers' mental states.
      Each subject performed simulated driving under two different conditions
      (well-rested and sleep-deprived) on different days. During the experiment, we
      used 68 electrodes for EEG/ECG/EOG and 8 channels for fNIRS recordings. We
      extracted the prominent features of each modality to distinguish between the
      well-rested and sleep-deprived conditions, and all multimodal features, except
      EOG, were combined to quantify mental fatigue during driving. Finally, a novel
      driving condition level (DCL) was proposed that distinguished clearly between the
      features of well-rested and sleep-deprived conditions. This proposed DCL measure 
      may be applicable to real-time monitoring of the mental states of vehicle
      drivers. Further, the combination of methods based on each classifier yielded
      substantial improvements in the classification accuracy between these two
      conditions.
FAU - Ahn, Sangtae
AU  - Ahn S
AD  - School of Electrical Engineering and Computer Science, Gwangju Institute of
      Science and TechnologyGwangju, South Korea
FAU - Nguyen, Thien
AU  - Nguyen T
AD  - Department of Biomedical Science and Engineering, Gwangju Institute of Science
      and TechnologyGwangju, South Korea
FAU - Jang, Hyojung
AU  - Jang H
AD  - School of Electrical Engineering and Computer Science, Gwangju Institute of
      Science and TechnologyGwangju, South Korea
FAU - Kim, Jae G.
AU  - Kim JG
AD  - Department of Biomedical Science and Engineering, Gwangju Institute of Science
      and TechnologyGwangju, South Korea
FAU - Jun, Sung C.
AU  - Jun SC
AD  - School of Electrical Engineering and Computer Science, Gwangju Institute of
      Science and TechnologyGwangju, South Korea
LA  - eng
PT  - Journal Article
DEP - 20160513
GR  - 2013R1A1A2009029
PHST- 2015/11/05 [received]
PHST- 2016/04/27 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2016.00219 [doi]
SO  - Front Hum Neurosci. 2016 May 13;10:. doi:10.3389/fnhum.2016.00219.

PMC - PMC5397096
PMID- 28422639
IS  - 0272-9490 (Print)
IS  - 1943-7676 (Electronic)
VI  - 71
IP  - 3
DP  - 2017 May-Jun
TI  - Rehabilitation Research at the National Institutes of Health: Moving the Field
      Forward (Executive Summary).
PG  - 7103320010P1-7103320010P12
AB  - The authors summarize the discussions and proposals from a recent NIH conference,
      Rehabilitation Research at NIH: Moving the Field Forward, that will help guide
      rehabilitation research at NIH in the near future
OAB - Publisher: Abstract available from the publisher.
FAU - Frontera, Walter R.
AU  - Frontera WR
AD  - Walter R. Frontera, MD, PhD, Department of Physical Medicine and Rehabilitation, 
      Vanderbilt University Medical Center, Nashville, TN, and Department of Physical
      Medicine, Rehabilitation and Sports Medicine, University of Puerto Rico School of
      Medicine, San Juan, PR. Address correspondence to Walter R. Frontera, MD, PhD,
      Vanderbilt University School of Medicine, Vanderbilt University Medical Center,
      2201 Children’s Way, Suite 1318, Nashville, TN 37212;
      walter.frontera@vanderbilt.edu.
FAU - Bean, Jonathan F.
AU  - Bean JF
AD  - Jonathan F. Bean, MD, MS, MPH, Department of Physical Medicine and
      Rehabilitation, Harvard Medical School, Boston, MA, and New England GRECC, VA
      Boston Healthcare System, Boston, MA
FAU - Damiano, Diane
AU  - Damiano D
AD  - Diane Damiano, PT, PhD, Department of Rehabilitation Medicine, Clinical Center,
      National Institutes of Health, Bethesda, MD
FAU - Ehrlich-Jones, Linda
AU  - Ehrlich-Jones L
AD  - Linda Ehrlich-Jones, PhD, RN, Department of Physical Medicine and Rehabilitation,
      Northwestern Feinberg Medical School and Rehabilitation Institute of Chicago,
      Chicago, IL
FAU - Fried-Oken, Melanie
AU  - Fried-Oken M
AD  - Melanie Fried-Oken, PhD, CCC/Sp, Departments of Neurology, Pediatrics, BME, ENT, 
      Oregon Health and Science University, Portland
FAU - Jette, Alan
AU  - Jette A
AD  - Alan Jette, PT, PhD, Health and Disability Research Institute, School of Public
      Health, Boston University, Boston, MA
FAU - Jung, Ranu
AU  - Jung R
AD  - Ranu Jung, PhD, Department of Biomedical Engineering, Florida International
      University, Miami
FAU - Lieber, Rick L.
AU  - Lieber RL
AD  - Rick L. Lieber, PhD, Department of Physical Medicine and Rehabilitation,
      Northwestern Feinberg Medical School and Rehabilitation Institute of Chicago,
      Chicago, IL
FAU - Malec, James F.
AU  - Malec JF
AD  - James F. Malec, PhD, ABPP-Cn, Rp, Department of Physical Medicine and
      Rehabilitation, Indiana University School of Medicine and Rehabilitation Hospital
      of Indiana, Indianapolis
FAU - Mueller, Michael J.
AU  - Mueller MJ
AD  - Michael J. Mueller, PT, PhD, Program in Physical Therapy and Department of
      Radiology, Washington University School of Medicine, St. Louis, MO
FAU - Ottenbacher, Kenneth J.
AU  - Ottenbacher KJ
AD  - Kenneth J. Ottenbacher, PhD, OTR, Division of Rehabilitation Sciences, School of 
      Health Professions, University of Texas Medical Branch, Galveston
FAU - Tansey, Keith E.
AU  - Tansey KE
AD  - Keith E. Tansey, MD, PhD, Methodist Rehabilitation Center, University of
      Mississippi Medical Center, Jackson Veterans Administration Medical Center,
      Jackson, MS
FAU - Thompson, Aiko
AU  - Thompson A
AD  - Aiko Thompson, PhD, Department of Health Science and Research, College of Health 
      Professions, Medical University of South Carolina, Charleston
LA  - eng
PT  - Journal Article
DEP - 20170407
PHST- 2017/04/07 [aheadofprint]
TA  - Am J Occup Ther
JT  - The American Journal of Occupational Therapy
AID - 713003 [pii]
AID - 10.5014/ajot.2017.713003 [doi]
SO  - Am J Occup Ther. 2017 May-Jun;71(3):7103320010P1-7103320010P12. Epub 2017 Apr 07 
      doi:10.5014/ajot.2017.713003.

PMC - PMC4951791
IS  - 1742-271X (Print)
IS  - 1743-1344 (Electronic)
VI  - 24
IP  - 2
DP  - 2016 May
TI  - Proceedings of the British Medical Ultrasound Society 47th Annual Scientific
      Meeting 9–11 December 2015, City Hall, Cardiff, UK.
PG  - NP1-NP54
LA  - eng
PT  - Journal Article
DEP - 20160505
TA  - Ultrasound
JT  - Ultrasound: Journal of the British Medical Ultrasound Society
AID - 10.1177/1742271X16642108 [doi]
AID - 10.1177_1742271X16642108 [pii]
SO  - Ultrasound. 2016 May;24(2):NP1-NP54. Epub 2016 May 5
      doi:10.1177/1742271X16642108.

PMC - PMC4037495
PMID- 24578237
IS  - 1530-9932 (Electronic)
VI  - 15
IP  - 3
DP  - 2014 Jun
TI  - Best Practices for the Development, Scale-up, and Post-approval Change Control of
      IR and MR Dosage Forms in the Current Quality-by-Design Paradigm.
PG  - 665-93
AB  - In this whitepaper, the Manufacturing Technical Committee of the Product Quality 
      Research Institute provides information on the common, best practices in use
      today in the development of high-quality chemistry, manufacturing and controls
      documentation. Important topics reviewed include International Conference on
      Harmonization, in vitro–in vivo correlation considerations, quality-by-design
      approaches, process analytical technologies and current scale-up, and process
      control and validation practices. It is the hope and intent that this whitepaper 
      will engender expanded dialog on this important subject by the pharmaceutical
      industry and its regulatory bodies.
FAU - Van Buskirk, Glenn A.
AU  - Van Buskirk GA
AD  - Nonclinical Drug Development Consulting Services, LLC, Basking Ridge, New Jersey 
      07920 USA
FAU - Asotra, Satish
AU  - Asotra S
AD  - AHI Inc., Brampton, Ontario Canada L6W 4K4
FAU - Balducci, Christopher
AU  - Balducci C
AD  - Novartis Pharmaceuticals, East Hanover, New Jersey 07936 USA
FAU - Basu, Prabir
AU  - Basu P
AD  - National Institute of Pharmaceutical Technology and Engineering (NIPTE),
      Prospect, Illinois 60056 USA
FAU - DiDonato, Gerald
AU  - DiDonato G
AD  - Bristol-Myers Squibb Co., Pennington, New Jersey 08534 USA
FAU - Dorantes, Angelica
AU  - Dorantes A
AD  - Food & Drug Administration, Silver Spring, Maryland 20993 USA
FAU - Eickhoff, W. Mark
AU  - Eickhoff WM
AD  - Merck & Co., West Point, Pennsylvania 19486 USA
FAU - Ghosh, Tapash
AU  - Ghosh T
AD  - Food & Drug Administration, Silver Spring, Maryland 20993 USA
FAU - González, Mario A.
AU  - González MA
AD  - P’Kinetics International, Inc., Pembroke Pines, Florida 33027 USA
FAU - Henry, Theresa
AU  - Henry T
AD  - Old Greenwich, Connecticut 06870 USA
FAU - Howard, Matthew
AU  - Howard M
AD  - McNeil Consumer Healthcare, Ft. Washington, Pennsylvania USA
FAU - Kamm, Jason
AU  - Kamm J
AD  - Summit Pharma Solutions, LLC, South Windsor, Connecticut USA
FAU - Laurenz, Steven
AU  - Laurenz S
AD  - AbbVie, North Chicago, Illinois 60064 USA
FAU - MacKenzie, Ryan
AU  - MacKenzie R
AD  - Janssen Research & Development, LLC, Spring House, Pennsylvania 19477 USA
FAU - Mannion, Richard
AU  - Mannion R
AD  - Purdue Pharma LP, Cranbury, New Jersey 08512 USA
FAU - Noonan, Patrick K.
AU  - Noonan PK
AD  - PK Noonan & Associates, LLC, Williamsburg, Virginia 23188 USA
FAU - Ocheltree, Terrance
AU  - Ocheltree T
AD  - Food & Drug Administration, Silver Spring, Maryland 20993 USA
FAU - Pai, Umesh
AU  - Pai U
AD  - Sun Pharma USA, Cranbury, New Jersey 08512 USA
FAU - Poska, Richard P.
AU  - Poska RP
AD  - AbbVie, North Chicago, Illinois 60064 USA
FAU - Putnam, Michael L.
AU  - Putnam ML
AD  - Boehringer-Ingelheim VetMedica, Inc., Saint Joseph, Missouri 64506 USA
FAU - Raghavan, Ramani R.
AU  - Raghavan RR
AD  - Genentech, South San Francisco, California 94080 USA
FAU - Ruegger, Colleen
AU  - Ruegger C
AD  - Novartis Pharmaceuticals, East Hanover, New Jersey 07936 USA
FAU - Sánchez, Eric
AU  - Sánchez E
AD  - Janssen Ortho, LLC., Gurabo, 00778 Puerto Rico
FAU - Shah, Vinod P.
AU  - Shah VP
AD  - North Potomac, Maryland 20878 USA
FAU - Shao, Zezhi Jesse
AU  - Shao ZJ
AD  - Arena Pharmaceuticals, San Diego, California 92121 USA
FAU - Somma, Russell
AU  - Somma R
AD  - Somma Tech Consulting, Somerset, New Jersey 08873 USA
FAU - Tammara, Vijay
AU  - Tammara V
AD  - Nuron Biotech Inc., Exton, Pennsylvania 19341 USA
FAU - Thombre, Avinash G.
AU  - Thombre AG
AD  - Pfizer Inc., Groton, Connecticut 06340 USA
FAU - Thompson, Bruce
AU  - Thompson B
AD  - Merck & Co., West Point, Pennsylvania 19486 USA
FAU - Timko, Robert J.
AU  - Timko RJ
AD  - AstraZeneca LP, Wilmington, Delaware 19850 USA
FAU - Upadrashta, Satyam
AU  - Upadrashta S
AD  - Millennium Pharmaceuticals, Cambridge, Massachusetts 02139 USA
FAU - Vaithiyalingam, Sivakumar
AU  - Vaithiyalingam S
AD  - Teva Pharmaceuticals, Pomona, New York 10970 USA
LA  - eng
PT  - Journal Article
DEP - 20140301
PHST- 2013/10/14 [received]
PHST- 2014/01/17 [accepted]
TA  - AAPS PharmSciTech
JT  - AAPS PharmSciTech
AID - 87 [pii]
AID - 10.1208/s12249-014-0087-x [doi]
SO  - AAPS PharmSciTech. 2014 Mar 1;15(3):665-93. doi:10.1208/s12249-014-0087-x.

PMC - PMC4890597
PMID- 27313548
IS  - 1664-1078 (Electronic)
VI  - 7
DP  - 2016
TI  - Emotional Experience and Awareness of Self: Functional MRI Studies of
      Depersonalization Disorder.
LID - 432
AB  - This paper presents functional MRI work on emotional processing in
      depersonalization disorder (DPD). This relatively neglected disorder is
      hallmarked by a disturbing change in the quality of first-person experience,
      almost invariably encompassing a diminished sense of self and an alteration in
      emotional experience such that the sufferer feels less emotionally reactive, with
      emotions experienced as decreased or “damped down,” so that emotional life seems 
      to lack spontaneity and subjective validity. Here we explored responses to
      emotive visual stimuli to examine the functional neuroanatomy of emotional
      processing in DPD before and after pharmacological treatment. We also employed
      concurrent skin conductance measurement as an index of autonomic arousal. In
      common with previous studies we demonstrated that in DPD, there is attenuated
      psychophysiological response to emotional material, reflected in altered patterns
      of (i) regional brain response, (ii) autonomic responses. By scanning
      participants before and after treatment we were able to build on previous
      findings by examining the changes in functional MRI response in patients whose
      symptoms had improved at time 2. The attenuation of emotional experience was
      associated with reduced activity of the insula, whereas clinical improvement in
      DPD symptoms was associated with increased insula activity. The insula is known
      to be implicated in interoceptive awareness and the generation of feeling states.
      In addition an area of right ventrolateral prefrontal cortex emerged as
      particularly implicated in what may be “top-down” inhibition of emotional
      responses. The relevance of these findings to the wider study of emotion,
      self-related processes, and interoception is discussed.
FAU - Medford, Nick
AU  - Medford N
AD  - Department of Psychiatry, Brighton and Sussex Medical SchoolBrighton, UK
FAU - Sierra, Mauricio
AU  - Sierra M
AD  - Institute of Psychiatry, Psychology, and NeuroscienceLondon, UK
FAU - Stringaris, Argyris
AU  - Stringaris A
AD  - Institute of Psychiatry, Psychology, and NeuroscienceLondon, UK
FAU - Giampietro, Vincent
AU  - Giampietro V
AD  - Institute of Psychiatry, Psychology, and NeuroscienceLondon, UK
FAU - Brammer, Michael J.
AU  - Brammer MJ
AD  - Institute of Psychiatry, Psychology, and NeuroscienceLondon, UK
FAU - David, Anthony S.
AU  - David AS
AD  - Institute of Psychiatry, Psychology, and NeuroscienceLondon, UK
LA  - eng
PT  - Journal Article
DEP - 20160602
PHST- 2015/10/23 [received]
PHST- 2016/03/10 [accepted]
TA  - Front Psychol
JT  - Frontiers in Psychology
AID - 10.3389/fpsyg.2016.00432 [doi]
SO  - Front Psychol. 2016 Jun 02;7:. doi:10.3389/fpsyg.2016.00432.

PMC - PMC3316474
PMID- 21674392
IS  - 0748-7711 (Print)
IS  - 1938-1352 (Electronic)
VI  - 48
IP  - 4
DP  - 2011
TI  - Pilot study to test effectiveness of video game on reaching performance in
      stroke.
PG  - 431-44
AB  - Robotic systems currently used in upper-limb rehabilitation following stroke rely
      on some form of visual feedback as part of the intervention program. We evaluated
      the effect of a video game environment (air hockey) on reaching in stroke with
      various levels of arm support. We used the Arm Coordination Training 3D system to
      provide variable arm support and to control the hockey stick. We instructed seven
      subjects to reach to one of three targets covering the workspace of the impaired 
      arm during the reaching task and to reach as far as possible while playing the
      video game. The results from this study showed that across subjects, support
      levels, and targets, the reaching distances achieved with the reaching task were 
      greater than those covered with the video game. This held even after further
      restricting the mapped workspace of the arm to the area most affected by the
      flexion synergy (effectively forcing subjects to fight the synergy to reach the
      hockey puck). The results from this study highlight the importance of designing
      video games that include specific reaching targets in the workspace compromised
      by the expression of the flexion synergy. Such video games would also adapt the
      target location online as a subject’s success rate increases.
FAU - Acosta, Ana Maria
AU  - Acosta AM
AD  - Department of Physical Therapy and Human Movement Sciences, Feinberg School of
      Medicine, Northwestern University, Chicago, IL
FAU - Dewald, Hendrik A.
AU  - Dewald HA
AD  - Illinois Mathematics and Science Academy, Aurora, IL
FAU - Dewald, Jules P. A.
AU  - Dewald JPA
AD  - Department of Physical Therapy and Human Movement Sciences, Feinberg School of
      Medicine, Northwestern University, Chicago, IL
LA  - eng
PT  - Journal Article
GR  - R42 HD049923-02 || HD
TA  - J Rehabil Res Dev
JT  - Journal of Rehabilitation Research and Development
MID - NIHMS363556
SO  - J Rehabil Res Dev. 2011;48(4):431-44.

PMC - PMC4606159
PMID- 26473169
IS  - 2373-2822 (Electronic)
VI  - 2
IP  - 5
DP  - 2015 Sep-Oct
TI  - Cognitive Deficits, Changes in Synaptic Function, and Brain Pathology in a Mouse 
      Model of Normal Aging.
LID - ENEURO.0047-15.2015
AB  - Age is the main risk factor for sporadic Alzheimer’s disease. Yet, cognitive
      decline in aged rodents has been less well studied, possibly due to concomitant
      changes in sensory or locomotor function that can complicate cognitive tests. We 
      tested mice that were 3, 11, and 23 months old in cognitive, sensory, and motor
      measures, and postmortem measures of gliosis and neural activity (c-Fos).
      Hippocampal synaptic function was also examined. While age-related impairments
      were detectable in tests of spatial memory, greater age-dependent effects were
      observed in tests of associative learning [active avoidance (AA)]. Gross visual
      function was largely normal, but startle responses to acoustic stimuli decreased 
      with increased age, possibly due to hearing impairments. Therefore, a novel AA
      variant in which light alone served as the conditioning stimuli was used.
      Age-related deficits were again observed. Mild changes in vision, as measured by 
      optokinetic responses, were detected in 19- versus 4-month-old mice, but these
      were not correlated to AA performance. Thus, deficits in hearing or vision are
      unlikely to account for the observed deficits in cognitive measures. Increased
      gliosis was observed in the hippocampal formation at older ages. Age-related
      changes in neural function and plasticity were observed with decreased c-Fos in
      the dentate gyrus, and decreased synaptic strength and paired-pulse facilitation 
      in CA1 slices. This work, which carefully outlines age-dependent impairments in
      cognitive and synaptic function, c-Fos activity, and gliosis during normal aging 
      in the mouse, suggests robust translational measures that will facilitate further
      study of the biology of aging.
FAU - Weber, Martin
AU  - Weber M
AD  - Department of Neuroscience, Genentech, South San Francisco, California 94080
FAU - Wu, Tiffany
AU  - Wu T
AD  - Department of Neuroscience, Genentech, South San Francisco, California 94080
FAU - Hanson, Jesse E.
AU  - Hanson JE
AD  - Department of Neuroscience, Genentech, South San Francisco, California 94080
FAU - Alam, Nazia M.
AU  - Alam NM
AD  - Burke Medical Research Institute, White Plains, New York, 10605
FAU - Solanoy, Hilda
AU  - Solanoy H
AUID- ORCID: 0000-0001-7855-6445
AD  - Department of Neuroscience, Genentech, South San Francisco, California 94080
FAU - Ngu, Hai
AU  - Ngu H
AD  - Department of Pathology, Genentech, South San Francisco, California 94080
FAU - Lauffer, Benjamin E.
AU  - Lauffer BE
AD  - Department of Neuroscience, Genentech, South San Francisco, California 94080
FAU - Lin, Han H.
AU  - Lin HH
AD  - Department of Neuroscience, Genentech, South San Francisco, California 94080
FAU - Dominguez, Sara L.
AU  - Dominguez SL
AD  - Department of Neuroscience, Genentech, South San Francisco, California 94080
FAU - Reeder, Jens
AU  - Reeder J
AD  - Department of Bioinformatics, Genentech, South San Francisco, California 94080
FAU - Tom, Jennifer
AU  - Tom J
AD  - Department of Bioinformatics, Genentech, South San Francisco, California 94080
FAU - Steiner, Pascal
AU  - Steiner P
AD  - Department of Neuroscience, Genentech, South San Francisco, California 94080
FAU - Foreman, Oded
AU  - Foreman O
AD  - Department of Pathology, Genentech, South San Francisco, California 94080
FAU - Prusky, Glen T.
AU  - Prusky GT
AD  - Department of Physiology and Biophysics, Weill Cornell Medical College, Burke
      Medical Research Institute, White Plains, New York 10605
FAU - Scearce-Levie, Kimberly
AU  - Scearce-Levie K
AD  - Department of Neuroscience, Genentech, South San Francisco, California 94080
LA  - eng
PT  - Journal Article
DEP - 20151015
PHST- 2015/05/04 [received]
PHST- 2015/09/09 [revised]
PHST- 2015/09/21 [accepted]
TA  - eNeuro
JT  - eNeuro
AID - 10.1523/ENEURO.0047-15.2015 [doi]
AID - eN-NWR-0047-15 [pii]
SO  - eNeuro. 2015 Oct 15;2(5):. doi:10.1523/ENEURO.0047-15.2015.

PMC - PMC3167184
PMID- 21904685
IS  - 2090-5904 (Print)
IS  - 1687-5443 (Electronic)
VI  - 2011
DP  - 2011
TI  - GABA Neuron Alterations, Cortical Circuit Dysfunction and Cognitive Deficits in
      Schizophrenia.
LID - 723184
AB  - Schizophrenia is a brain disorder associated with cognitive deficits that
      severely affect the patients' capacity for daily functioning. Whereas our
      understanding of its pathophysiology is limited, postmortem studies suggest that 
      schizophrenia is associated with deficits of GABA-mediated synaptic transmission.
      A major role of GABA-mediated transmission may be producing synchronized network 
      oscillations which are currently hypothesized to be essential for normal
      cognitive function. Therefore, cognitive deficits in schizophrenia may result
      from a GABA synapse dysfunction that disturbs neural synchrony. Here, we
      highlight recent studies further suggesting alterations of GABA transmission and 
      network oscillations in schizophrenia. We also review current models for the
      mechanisms of GABA-mediated synchronization of neural activity, focusing on
      parvalbumin-positive GABA neurons, which are altered in schizophrenia and whose
      function has been strongly linked to the production of neural synchrony.
      Alterations of GABA signaling that impair gamma oscillations and, as a result,
      cognitive function suggest paths for novel therapeutic interventions.
FAU - Gonzalez-Burgos, Guillermo
AU  - Gonzalez-Burgos G
AD  - Translational Neuroscience Program, Department of Psychiatry, University of
      Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA
FAU - Fish, Kenneth N.
AU  - Fish KN
AD  - Translational Neuroscience Program, Department of Psychiatry, University of
      Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA
FAU - Lewis, David A.
AU  - Lewis DA
AD  - Translational Neuroscience Program, Department of Psychiatry, University of
      Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20110905
PHST- 2011/02/16 [received]
PHST- 2011/05/01 [accepted]
PHST- 2011/09/05 [aheadofprint]
TA  - Neural Plast
JT  - Neural Plasticity
AID - 10.1155/2011/723184 [doi]
SO  - Neural Plast. 2011;2011:. Epub 2011 Sep 5 doi:10.1155/2011/723184.

PMC - PMC5442198
PMID- 28603770
IS  - 2365-7464 (Electronic)
VI  - 2
IP  - 1
DP  - 2017
TI  - Embodied science and mixed reality: How gesture and motion capture affect physics
      education.
LID - 24
AB  - A mixed design was created using text and game-like multimedia to instruct in the
      content of physics. The study assessed which variables predicted learning gains
      after a 1-h lesson on the electric field. The three manipulated variables were:
      (1) level of embodiment; (2) level of active generativity; and (3) presence of
      story narrative. Two types of tests were administered: (1) a traditional
      text-based physics test answered with a keyboard; and (2) a more embodied,
      transfer test using the Wacom large tablet where learners could use gestures
      (long swipes) to create vectors and answers. The 166 participants were randomly
      assigned to four conditions: (1) symbols and text; (2) low embodied; (3) high
      embodied/active; or (4) high embodied/active with narrative. The last two
      conditions were active because the on-screen content could be manipulated with
      gross body gestures gathered via the Kinect sensor. Results demonstrated that the
      three groups that included embodiment learned significantly more than the symbols
      and text group on the traditional keyboard post-test. When knowledge was assessed
      with the Wacom tablet format that facilitated gestures, the two active
      gesture-based groups scored significantly higher. In addition, engagement scores 
      were significantly higher for the two active embodied groups. The Wacom results
      suggest test sensitivity issues; the more embodied test revealed greater gains in
      learning for the more embodied conditions. We recommend that as more embodied
      learning comes to the fore, more sensitive tests that incorporate gesture be used
      to accurately assess learning. The predicted differences in engagement and
      learning for the condition with the graphically rich story narrative were not
      supported. We hypothesize that a narrative effect for motivation and learning may
      be difficult to uncover in a lab experiment where participants are primarily
      motivated by course credit. Several design principles for mediated and embodied
      science education are proposed.Electronic supplementary material: The online
      version of this article (doi:10.1186/s41235-017-0060-9) contains supplementary
      material, which is available to authorized users.
FAU - Johnson-Glenberg, Mina C.
AU  - Johnson-Glenberg MC
AD  - 0000 0001 2151 2636grid.215654.1Department of Psychology, Arizona State
      University, Tempe, AZ USA
FAU - Megowan-Romanowicz, Colleen
AU  - Megowan-Romanowicz C
AD  - Modeling Instruction Institute, Sacramento, CA USA
LA  - eng
PT  - Journal Article
DEP - 20170524
GR  - 102067
PHST- 2016/09/10 [received]
PHST- 2017/03/09 [accepted]
TA  - Cogn Res Princ Implic
JT  - Cognitive Research
AID - 60 [pii]
AID - 10.1186/s41235-017-0060-9 [doi]
SO  - Cogn Res Princ Implic. 2017;2(1):. Epub 2017 May 24
      doi:10.1186/s41235-017-0060-9.

PMC - PMC5142356
PMID- 27927218
IS  - 1479-5868 (Electronic)
VI  - 13
DP  - 2016
TI  - Efficacy of interventions that use apps to improve diet, physical activity and
      sedentary behaviour: a systematic review.
LID - 127
AB  - Background: Health and fitness applications (apps) have gained popularity in
      interventions to improve diet, physical activity and sedentary behaviours but
      their efficacy is unclear. This systematic review examined the efficacy of
      interventions that use apps to improve diet, physical activity and sedentary
      behaviour in children and adults. Methods: Systematic literature searches were
      conducted in five databases to identify papers published between 2006 and 2016.
      Studies were included if they used a smartphone app in an intervention to improve
      diet, physical activity and/or sedentary behaviour for prevention. Interventions 
      could be stand-alone interventions using an app only, or multi-component
      interventions including an app as one of several intervention components.
      Outcomes measured were changes in the health behaviours and related health
      outcomes (i.e., fitness, body weight, blood pressure, glucose, cholesterol,
      quality of life). Study inclusion and methodological quality were independently
      assessed by two reviewers. Results: Twenty-seven studies were included, most were
      randomised controlled trials (n = 19; 70%). Twenty-three studies targeted adults 
      (17 showed significant health improvements) and four studies targeted children
      (two demonstrated significant health improvements). Twenty-one studies targeted
      physical activity (14 showed significant health improvements), 13 studies
      targeted diet (seven showed significant health improvements) and five studies
      targeted sedentary behaviour (two showed significant health improvements). More
      studies (n = 12; 63%) of those reporting significant effects detected
      between-group improvements in the health behaviour or related health outcomes,
      whilst fewer studies (n = 8; 42%) reported significant within-group improvements.
      A larger proportion of multi-component interventions (8 out of 13; 62%) showed
      significant between-group improvements compared to stand-alone app interventions 
      (5 out of 14; 36%). Eleven studies reported app usage statistics, and three of
      them demonstrated that higher app usage was associated with improved health
      outcomes. Conclusions: This review provided modest evidence that app-based
      interventions to improve diet, physical activity and sedentary behaviours can be 
      effective. Multi-component interventions appear to be more effective than
      stand-alone app interventions, however, this remains to be confirmed in
      controlled trials. Future research is needed on the optimal number and
      combination of app features, behaviour change techniques, and level of
      participant contact needed to maximise user engagement and intervention efficacy.
      Electronic supplementary material: The online version of this article
      (doi:10.1186/s12966-016-0454-y) contains supplementary material, which is
      available to authorized users.
FAU - Schoeppe, Stephanie
AU  - Schoeppe S
AD  - Central Queensland University, School of Health, Medical and Applied Sciences,
      Physical Activity Research Group, Building 77, Bruce Highway, Rockhampton, QLD
      4702 Australia
FAU - Alley, Stephanie
AU  - Alley S
AD  - Central Queensland University, School of Health, Medical and Applied Sciences,
      Physical Activity Research Group, Building 77, Bruce Highway, Rockhampton, QLD
      4702 Australia
FAU - Van Lippevelde, Wendy
AU  - Van Lippevelde W
AD  - Ghent University, Department of Public Health, De Pintelaan 185-4 K3 room 036,
      9000 Ghent, Belgium
FAU - Bray, Nicola A.
AU  - Bray NA
AD  - Central Queensland University, School of Health, Medical and Applied Sciences,
      Physical Activity Research Group, Building 77, Bruce Highway, Rockhampton, QLD
      4702 Australia
FAU - Williams, Susan L.
AU  - Williams SL
AD  - Central Queensland University, School of Health, Medical and Applied Sciences,
      Building 6, Bruce Highway, Rockhampton, QLD 4702 Australia
FAU - Duncan, Mitch J.
AU  - Duncan MJ
AD  - The University of Newcastle, School of Medicine & Public Health, Priority
      Research Centre for Physical Activity and Nutrition, University Drive, Callaghan,
      NSW 2308 Australia
FAU - Vandelanotte, Corneel
AU  - Vandelanotte C
AD  - Central Queensland University, School of Health, Medical and Applied Sciences,
      Physical Activity Research Group, Building 77, Bruce Highway, Rockhampton, QLD
      4702 Australia
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20161207
GR  - ID 100427
PHST- 2016/07/06 [received]
PHST- 2016/11/24 [accepted]
TA  - Int J Behav Nutr Phys Act
JT  - The International Journal of Behavioral Nutrition and Physical Activity
AID - 454 [pii]
AID - 10.1186/s12966-016-0454-y [doi]
SO  - Int J Behav Nutr Phys Act. 2016 Dec 7;13:. doi:10.1186/s12966-016-0454-y.

PMC - PMC5531764
PMID- 28757907
IS  - 1936-7228 (Print)
IS  - 1936-7236 (Electronic)
VI  - 9
IP  - 4
DP  - 2017 Apr
TI  - Mind your crossings: Mining GIS imagery for crosswalk localization.
LID - 11
AB  - For blind travelers, finding crosswalks and remaining within their borders while 
      traversing them is a crucial part of any trip involving street crossings. While
      standard Orientation & Mobility (O&M) techniques allow blind travelers to safely 
      negotiate street crossings, additional information about crosswalks and other
      important features at intersections would be helpful in many situations,
      resulting in greater safety and/or comfort during independent travel. For
      instance, in planning a trip a blind pedestrian may wish to be informed of the
      presence of all marked crossings near a desired route.We have conducted a survey 
      of several O&M experts from the United States and Italy to determine the role
      that crosswalks play in travel by blind pedestrians. The results show stark
      differences between survey respondents from the U.S. compared with Italy: the
      former group emphasized the importance of following standard O&M techniques at
      all legal crossings (marked or unmarked), while the latter group strongly
      recommended crossing at marked crossings whenever possible. These contrasting
      opinions reflect differences in the traffic regulations of the two countries and 
      highlight the diversity of needs that travelers in different regions may have.To 
      address the challenges faced by blind pedestrians in negotiating street
      crossings, we devised a computer vision-based technique that mines existing
      spatial image databases for discovery of zebra crosswalks in urban settings. Our 
      algorithm first searches for zebra crosswalks in satellite images; all candidates
      thus found are validated against spatially registered Google Street View images. 
      This cascaded approach enables fast and reliable discovery and localization of
      zebra crosswalks in large image datasets. While fully automatic, our algorithm
      can be improved by a final crowdsourcing validation. To this end, we developed a 
      Pedestrian Crossing Human Validation (PCHV) web service, which supports
      crowdsourcing to rule out false positives and identify false negatives.
FAU - Ahmetovic, Dragan
AU  - Ahmetovic D
AD  - Carnegie Mellon University
FAU - Manduchi, Roberto
AU  - Manduchi R
AD  - University of California Santa Cruz
FAU - Coughlan, James M.
AU  - Coughlan JM
AD  - The Smith-Kettlewell Eye Research Institute
FAU - Mascetti, Sergio
AU  - Mascetti S
AD  - Università degli Studi di Milano
LA  - eng
PT  - Journal Article
TA  - ACM Trans Access Comput
JT  - ACM transactions on accessible computing
AID - 10.1145/3046790 [doi]
MID - NIHMS876879
SO  - ACM Trans Access Comput. 2017 Apr;9(4):. doi:10.1145/3046790.

PMC - PMC3476596
PMID- 15095072
IS  - 0940-6719 (Print)
IS  - 1432-0932 (Electronic)
VI  - 13
IP  - 6
DP  - 2004 Oct
TI  - Comparison of a high-intensity and a low-intensity lumbar extensor training
      program as minimal intervention treatment in low back pain: a randomized trial.
PG  - 537-47
AB  - In a randomized, observer-blinded trial, the effectiveness of 3-month
      high-intensity training (HIT) of the isolated lumbar extensors was compared to
      low-intensity training (LIT). Eighty-one workers with nonspecific low back pain
      longer than 12 weeks were randomly assigned to either of the two training
      programs.Training sessions were performed on a modified training device that
      isolated the lower back extensors. Total intervention time was limited to
      5–10 min (one or two training sessions) per week. Training effects were assessed 
      in terms of changes in self-rated degree of back complaints, functional
      disability, and general, physical and mental health. Secondary outcomes in this
      study were muscle strength and fear of moving the back (kinesiophobia). Outcomes 
      were evaluated at 1,2, 3, 6, and 9 months after randomization.The results showed 
      that the two treatment programs led to comparable improvements in all outcome
      measures, except for mean isometric strength at 1, 2, 3, 6, and 9 months and
      kinesiophobia score at 2 and 9 months of follow-up. The high-intensity training
      group showed a higher strength gain (24 to 48 Nm) but a smaller decline in
      kinesiophobia (2.5 and 3.4 points, respectively), compared to the low-intensity
      training group.It can be concluded that high-intensity training of the isolated
      back extensors was not superior to a non-progressive, low-intensity variant in
      restoring back function in nonspecific (chronic) low back pain. In further
      research, emphasis should be put on identifying subgroups of patients that will
      have the highest success rate with either of these training approaches.
FAU - Helmhout, P. H.
AU  - Helmhout PH
AD  - Department of Training Medicine and Training Physiology, Occupational Health and 
      Safety Service Royal Netherlands Army, LGen Knoopkazerne, Mineurslaan 500, 3521
      AG Utrecht, The Netherlands
FAU - Harts, C. C.
AU  - Harts CC
AD  - Department of Training Medicine and Training Physiology, Occupational Health and 
      Safety Service Royal Netherlands Army, LGen Knoopkazerne, Mineurslaan 500, 3521
      AG Utrecht, The Netherlands
FAU - Staal, J. B.
AU  - Staal JB
AD  - Department of Epidemiology, Maastricht University, Maastricht, The Netherlands
FAU - Candel, M. J. J. M.
AU  - Candel MJJM
AD  - Department of Methodology and Statistics, Maastricht University, Maastricht, The 
      Netherlands
FAU - de Bie, R. A.
AU  - de Bie RA
AD  - Department of Epidemiology, Maastricht University, Maastricht, The Netherlands
LA  - eng
PT  - Journal Article
DEP - 20040417
PHST- 2003/03/06 [received]
PHST- 2003/12/31 [revised]
PHST- 2004/01/05 [accepted]
TA  - Eur Spine J
JT  - European Spine Journal
AID - 671 [pii]
AID - 10.1007/s00586-004-0671-y [doi]
SO  - Eur Spine J. 2004 Oct;13(6):537-47. Epub 2004 Apr 17
      doi:10.1007/s00586-004-0671-y.

PMC - PMC2858557
PMID- 20582284
IS  - 1662-4548 (Print)
IS  - 1662-453X (Electronic)
VI  - 3
DP  - 2009
TI  - P300-Based Brain–Computer Interface Communication: Evaluation and Follow-up in
      Amyotrophic Lateral Sclerosis.
LID - 60
AB  - To describe results of training and 1-year follow-up of brain-communication in a 
      larger group of early and middle stage amyotrophic lateral sclerosis (ALS)
      patients using a P300-based brain–computer interface (BCI), and to investigate
      the relationship between clinical status, age and BCI performance. A group of 21 
      ALS patients were tested with a BCI-system using two-dimensional cursor
      movements. A four choice visual paradigm was employed to training and test the
      brain-communication abilities. The task consisted of reaching with the cursor one
      out of four icons representing four basic needs. Five patients performed a
      follow-up test 1 year later. The clinical severity in all patients were assessed 
      with a battery of clinical tests. A comparable control group of nine healthy
      subjects was employed to investigate performance differences. Nineteen patients
      and nine healthy subjects were able to achieve good and excellent cursor
      movements' control, acquiring at least communication abilities above chance
      level; during follow-up the patients maintained their BCI-skill. We found mild
      cognitive impairments in the ALS group which may be attributed to motor
      deficiencies, while no relevant correlation has been found between clinical data 
      and BCI performance. A positive correlation between age and the BCI-skill in
      patients was found. Time since training acquisition and clinical status did not
      affect the patients brain-communication skill at early and middle stage of the
      disease. A brain-communication tool can be used in most ALS patients at early and
      middle stage of the disease before entering the locked-in stage.
FAU - Silvoni, Stefano
AU  - Silvoni S
AD  - I.R.C.C.S. San Camillo HospitalVenice, Italy
FAU - Volpato, Chiara
AU  - Volpato C
AD  - I.R.C.C.S. San Camillo HospitalVenice, Italy
FAU - Cavinato, Marianna
AU  - Cavinato M
AD  - I.R.C.C.S. San Camillo HospitalVenice, Italy
FAU - Marchetti, Mauro
AU  - Marchetti M
AD  - Department of General Psychology, University of PaduaPadua, Italy
FAU - Priftis, Konstantinos
AU  - Priftis K
AD  - I.R.C.C.S. San Camillo HospitalVenice, Italy
FAU - Merico, Antonio
AU  - Merico A
AD  - I.R.C.C.S. San Camillo HospitalVenice, Italy
FAU - Tonin, Paolo
AU  - Tonin P
AD  - I.R.C.C.S. San Camillo HospitalVenice, Italy
FAU - Koutsikos, Konstantinos
AU  - Koutsikos K
AD  - I.R.C.C.S. San Camillo HospitalVenice, Italy
FAU - Beverina, Fabrizio
AU  - Beverina F
AD  - I.R.C.C.S. San Camillo HospitalVenice, Italy
FAU - Piccione, Francesco
AU  - Piccione F
AD  - I.R.C.C.S. San Camillo HospitalVenice, Italy
LA  - eng
PT  - Journal Article
DEP - 20090619
PHST- 2009/03/13 [received]
PHST- 2009/06/02 [accepted]
TA  - Front Neurosci
JT  - Frontiers in Neuroscience
AID - 10.3389/neuro.20.001.2009 [doi]
SO  - Front Neurosci. 2009 Jun 19;3:. doi:10.3389/neuro.20.001.2009.

PMC - PMC4439475
PMID- 26064157
IS  - 1741-427X (Print)
IS  - 1741-4288 (Electronic)
VI  - 2015
DP  - 2015
TI  - Complementary and Alternative Therapies for Autism Spectrum Disorder.
LID - 258589
AB  - Background. Complementary and alternative medicine (CAM) represents a popular
      therapeutic option for patients with autism spectrum disorder (ASD).
      Unfortunately, there is a paucity of data regarding the efficacy of CAM in ASD.
      The aim of the present systematic review is to investigate trials of CAM in ASD. 
      Material and Methods. We searched the following databases: MEDLINE, EMBASE,
      Cochrane Database of Systematic Reviews, CINAHL, Psychology and Behavioral
      Sciences Collection, Agricola, and Food Science Source. Results. Our literature
      search identified 2687 clinical publications. After the title/abstract screening,
      139 publications were obtained for detailed evaluation. After detailed evaluation
      67 studies were included, from hand search of references we retrieved 13
      additional studies for a total of 80. Conclusion. There is no conclusive evidence
      supporting the efficacy of CAM therapies in ASD. Promising results are reported
      for music therapy, sensory integration therapy, acupuncture, and massage.
FAU - Brondino, Natascia
AU  - Brondino N
AUID- ORCID: 0000-0002-3128-1592
AD  - Department of Brain and Behavioral Sciences, Section of Psychiatry, University of
      Pavia, Via Bassi 21, 27100 Pavia, Italy
FAU - Fusar-Poli, Laura
AU  - Fusar-Poli L
AD  - Department of Brain and Behavioral Sciences, Section of Psychiatry, University of
      Pavia, Via Bassi 21, 27100 Pavia, Italy
FAU - Rocchetti, Matteo
AU  - Rocchetti M
AD  - Department of Brain and Behavioral Sciences, Section of Psychiatry, University of
      Pavia, Via Bassi 21, 27100 Pavia, Italy
FAU - Provenzani, Umberto
AU  - Provenzani U
AD  - Department of Brain and Behavioral Sciences, Section of Psychiatry, University of
      Pavia, Via Bassi 21, 27100 Pavia, Italy
FAU - Barale, Francesco
AU  - Barale F
AD  - Department of Brain and Behavioral Sciences, Section of Psychiatry, University of
      Pavia, Via Bassi 21, 27100 Pavia, Italy
FAU - Politi, Pierluigi
AU  - Politi P
AUID- ORCID: 0000-0002-4602-2032
AD  - Department of Brain and Behavioral Sciences, Section of Psychiatry, University of
      Pavia, Via Bassi 21, 27100 Pavia, Italy
LA  - eng
PT  - Journal Article
DEP - 20150507
PHST- 2015/01/13 [received]
PHST- 2015/03/23 [revised]
PHST- 2015/03/30 [accepted]
PHST- 2015/05/07 [aheadofprint]
TA  - Evid Based Complement Alternat Med
JT  - Evidence-based Complementary and Alternative Medicine : eCAM
AID - 10.1155/2015/258589 [doi]
SO  - Evid Based Complement Alternat Med. 2015;2015:. Epub 2015 May 7
      doi:10.1155/2015/258589.

PMC - PMC3454542
PMID- 16550448
IS  - 0940-6719 (Print)
IS  - 1432-0932 (Electronic)
VI  - 15
IP  - Suppl 2
DP  - 2006 Mar
TI  - Chapter 4 European guidelines for the management of chronic nonspecific low back 
      pain.
PG  - s192-300
FAU - Airaksinen, O.
AU  - Airaksinen O
FAU - Brox, J. I.
AU  - Brox JI
FAU - Cedraschi, C.
AU  - Cedraschi C
FAU - Hildebrandt, J.
AU  - Hildebrandt J
FAU - Klaber-Moffett, J.
AU  - Klaber-Moffett J
FAU - Kovacs, F.
AU  - Kovacs F
FAU - Mannion, A. F.
AU  - Mannion AF
FAU - Reis, S.
AU  - Reis S
FAU - Staal, J. B.
AU  - Staal JB
FAU - Ursin, H.
AU  - Ursin H
FAU - Zanoli, G.
AU  - Zanoli G
CN  - On behalf of the COST B13 Working Group on Guidelines for Chronic Low Back Pain
LA  - eng
PT  - Journal Article
TA  - Eur Spine J
JT  - European Spine Journal
AID - 1072 [pii]
AID - 10.1007/s00586-006-1072-1 [doi]
SO  - Eur Spine J. 2006 Mar;15(Suppl 2): s192-300. doi:10.1007/s00586-006-1072-1.

PMC - PMC2855180
PMID- 20170128
IS  - 0009-2665 (Print)
IS  - 1520-6890 (Electronic)
VI  - 110
IP  - 4
DP  - 2010 Apr 14
TI  - Molecular Gastronomy: A New Emerging Scientific Discipline.
PG  - 2313-65
FAU - Barham, Peter
AU  - Barham P
FAU - Skibsted, Leif H.
AU  - Skibsted LH
FAU - Bredie, Wender L. P.
AU  - Bredie WLP
FAU - Bom Frøst, Michael
AU  - Bom Frøst M
FAU - Møller, Per
AU  - Møller P
FAU - Risbo, Jens
AU  - Risbo J
FAU - Snitkjær, Pia
AU  - Snitkjær P
FAU - Mortensen, Louise Mørch
AU  - Mortensen LM
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20100219
PHST- 2009/03/18 [received]
TA  - Chem Rev
JT  - Chemical Reviews
AID - 10.1021/cr900105w [doi]
SO  - Chem Rev. 2010 Apr 14;110(4):2313-65. Epub 2010 Feb 19 doi:10.1021/cr900105w.

PMC - PMC4661181
PMID- 25339066
IS  - 1931-7557 (Print)
IS  - 1931-7565 (Electronic)
VI  - 9
IP  - 4
DP  - 2015
TI  - Effective connectivity during visual processing is affected by emotional state.
PG  - 717-28
AB  - The limitations of our cognitive resources necessitate the selection of relevant 
      information from the incoming visual stream. This selection and prioritizing of
      stimuli allows the organism to adapt to the current conditions. However, the
      characteristics of this process vary with time and depend on numerous external
      and internal factors. The present study was aimed at determining how the
      emotional state affects effective connectivity between visual, attentional and
      control brain areas during the perception of affective visual stimuli. The
      Directed Transfer Function was applied on a 32-electrode EEG recording to
      quantify the direction and intensity of the information flow during two sessions:
      positive and negative. These data were correlated with a self-report of the
      emotional state. We demonstrated that the current mood, as measured by
      self-report, is a factor which affects the patterns of effective cortical
      connectivity. An increase in prefrontal top-down control over the visual and
      attentional areas was revealed in a state of tension. It was accompanied by
      increased outflow within and from the areas recognized as the ventral attentional
      network. By contrast, a positive emotional state was associated with heightened
      flow from the parietal to the occipital area. The functional significance of the 
      revealed effects is discussed.
FAU - Wyczesany, Miroslaw
AU  - Wyczesany M
AD  - Psychophysiology Laboratory, Institute of Psychology, Jagiellonian University,
      Ingardena 6, PL-30060 Kraków, Poland
FAU - Ligeza, Tomasz S.
AU  - Ligeza TS
AD  - Psychophysiology Laboratory, Institute of Psychology, Jagiellonian University,
      Ingardena 6, PL-30060 Kraków, Poland
FAU - Grzybowski, Szczepan J.
AU  - Grzybowski SJ
AD  - Psychophysiology Laboratory, Institute of Psychology, Jagiellonian University,
      Ingardena 6, PL-30060 Kraków, Poland
LA  - eng
PT  - Journal Article
DEP - 20141023
TA  - Brain Imaging Behav
JT  - Brain Imaging and Behavior
AID - 9326 [pii]
AID - 10.1007/s11682-014-9326-8 [doi]
SO  - Brain Imaging Behav. 2015;9(4):717-28. Epub 2014 Oct 23
      doi:10.1007/s11682-014-9326-8.

PMC - PMC4602875
PMID- 25997044
IS  - 0025-7974 (Print)
IS  - 1536-5964 (Electronic)
VI  - 94
IP  - 20
DP  - 2015 May
TI  - Virtual Reality Training Versus Blended Learning of Laparoscopic Cholecystectomy:
      A Randomized Controlled Trial With Laparoscopic Novices.
LID - e764
AB  - This study compared virtual reality (VR) training with low cost-blended learning 
      (BL) in a structured training program.Training of laparoscopic skills outside the
      operating room is mandatory to reduce operative times and risks.Laparoscopy-naïve
      medical students were randomized in 2 groups stratified for sex. The BL group
      (n = 42) used E-learning for laparoscopic cholecystectomy (LC) and practiced
      basic skills with box trainers. The VR group (n = 42) trained basic skills and LC
      on the LAP Mentor II (Simbionix, Cleveland, OH). Each group trained 3 × 4 hours
      followed by a knowledge test concerning LC. Blinded raters assessed the operative
      performance of cadaveric porcine LC using the Objective Structured Assessment of 
      Technical Skills (OSATS). The LC was discontinued when it was not completed
      within 80 min. Students evaluated their training modality with questionnaires.The
      VR group completed the LC significantly faster and more often within 80 min than 
      BL (45% v 21%, P = .02). The BL group scored higher than the VR group in the
      knowledge test (13.3 ± 1.3 vs 11.0 ± 1.7, P < 0.001). Both groups showed equal
      operative performance of LC in the OSATS score (49.4 ± 10.5 vs 49.7 ± 12.0,
      P = 0.90). Students generally liked training and felt well prepared for assisting
      in laparoscopic surgery. The efficiency of the training was judged higher by the 
      VR group than by the BL group.VR and BL can both be applied for training the
      basics of LC. Multimodality training programs should be developed that combine
      the advantages of both approaches.
FAU - Nickel, Felix
AU  - Nickel F
FAU - Brzoska, Julia A.
AU  - Brzoska JA
FAU - Gondan, Matthias
AU  - Gondan M
FAU - Rangnick, Henriette M.
AU  - Rangnick HM
FAU - Chu, Jackson
AU  - Chu J
FAU - Kenngott, Hannes G.
AU  - Kenngott HG
FAU - Linke, Georg R.
AU  - Linke GR
FAU - Kadmon, Martina
AU  - Kadmon M
FAU - Fischer, Lars
AU  - Fischer L
FAU - Müller-Stich, Beat P.
AU  - Müller-Stich BP
LA  - eng
PT  - Journal Article
DEP - 20150522
PHST- 2014/11/18 [received]
PHST- 2015/02/20 [revised]
PHST- 2015/03/23 [accepted]
TA  - Medicine (Baltimore)
JT  - Medicine
AID - 10.1097/MD.0000000000000764 [doi]
SO  - Medicine (Baltimore). 2015 May 22;94(20):. doi:10.1097/MD.0000000000000764.

PMC - PMC5352696
PMID- 28360842
IS  - 1662-5102 (Electronic)
VI  - 11
DP  - 2017
TI  - Neuroplastic Changes Following Brain Ischemia and their Contribution to Stroke
      Recovery: Novel Approaches in Neurorehabilitation.
LID - 76
AB  - Ischemic damage to the brain triggers substantial reorganization of spared areas 
      and pathways, which is associated with limited, spontaneous restoration of
      function. A better understanding of this plastic remodeling is crucial to develop
      more effective strategies for stroke rehabilitation. In this review article, we
      discuss advances in the comprehension of post-stroke network reorganization in
      patients and animal models. We first focus on rodent studies that have shed light
      on the mechanisms underlying neuronal remodeling in the perilesional area and
      contralesional hemisphere after motor cortex infarcts. Analysis of
      electrophysiological data has demonstrated brain-wide alterations in functional
      connectivity in both hemispheres, well beyond the infarcted area. We then
      illustrate the potential use of non-invasive brain stimulation (NIBS) techniques 
      to boost recovery. We finally discuss rehabilitative protocols based on robotic
      devices as a tool to promote endogenous plasticity and functional restoration.
FAU - Alia, Claudia
AU  - Alia C
AD  - CNR Neuroscience Institute, National Research Council (CNR)Pisa, Italy
FAU - Spalletti, Cristina
AU  - Spalletti C
AD  - CNR Neuroscience Institute, National Research Council (CNR)Pisa, Italy
FAU - Lai, Stefano
AU  - Lai S
AD  - Translational Neural Engineering Area, The BioRobotics Institute, Scuola
      Superiore Sant’AnnaPontedera, Italy
FAU - Panarese, Alessandro
AU  - Panarese A
AD  - Translational Neural Engineering Area, The BioRobotics Institute, Scuola
      Superiore Sant’AnnaPontedera, Italy
FAU - Lamola, Giuseppe
AU  - Lamola G
AD  - Department of Neuroscience, Unit of Neurorehabilitation—University Hospital of
      PisaPisa, Italy
FAU - Bertolucci, Federica
AU  - Bertolucci F
AD  - Department of Neuroscience, Unit of Neurorehabilitation—University Hospital of
      PisaPisa, Italy
FAU - Vallone, Fabio
AU  - Vallone F
AD  - Translational Neural Engineering Area, The BioRobotics Institute, Scuola
      Superiore Sant’AnnaPontedera, Italy
FAU - Di Garbo, Angelo
AU  - Di Garbo A
AD  - CNR Biophysics Institute, National Research Council (CNR)Pisa, Italy
FAU - Chisari, Carmelo
AU  - Chisari C
AD  - Department of Neuroscience, Unit of Neurorehabilitation—University Hospital of
      PisaPisa, Italy
FAU - Micera, Silvestro
AU  - Micera S
AD  - Translational Neural Engineering Area, The BioRobotics Institute, Scuola
      Superiore Sant’AnnaPontedera, Italy
FAU - Caleo, Matteo
AU  - Caleo M
AD  - CNR Neuroscience Institute, National Research Council (CNR)Pisa, Italy
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170316
GR  - Project 158/2011
PHST- 2016/12/05 [received]
PHST- 2017/03/03 [accepted]
TA  - Front Cell Neurosci
JT  - Frontiers in Cellular Neuroscience
AID - 10.3389/fncel.2017.00076 [doi]
SO  - Front Cell Neurosci. 2017 Mar 16;11:. doi:10.3389/fncel.2017.00076.

PMC - PMC3261106
PMID- 22165907
IS  - 1743-0003 (Electronic)
VI  - 8
DP  - 2011
TI  - Rehabilitation of gait after stroke: a review towards a top-down approach.
PG  - 66
AB  - This document provides a review of the techniques and therapies used in gait
      rehabilitation after stroke. It also examines the possible benefits of including 
      assistive robotic devices and brain-computer interfaces in this field, according 
      to a top-down approach, in which rehabilitation is driven by neural
      plasticity.The methods reviewed comprise classical gait rehabilitation techniques
      (neurophysiological and motor learning approaches), functional electrical
      stimulation (FES), robotic devices, and brain-computer interfaces (BCI).From the 
      analysis of these approaches, we can draw the following conclusions. Regarding
      classical rehabilitation techniques, there is insufficient evidence to state that
      a particular approach is more effective in promoting gait recovery than other.
      Combination of different rehabilitation strategies seems to be more effective
      than over-ground gait training alone. Robotic devices need further research to
      show their suitability for walking training and their effects on over-ground
      gait. The use of FES combined with different walking retraining strategies has
      shown to result in improvements in hemiplegic gait. Reports on non-invasive BCIs 
      for stroke recovery are limited to the rehabilitation of upper limbs; however,
      some works suggest that there might be a common mechanism which influences upper 
      and lower limb recovery simultaneously, independently of the limb chosen for the 
      rehabilitation therapy. Functional near infrared spectroscopy (fNIRS) enables
      researchers to detect signals from specific regions of the cortex during
      performance of motor activities for the development of future BCIs. Future
      research would make possible to analyze the impact of rehabilitation on brain
      plasticity, in order to adapt treatment resources to meet the needs of each
      patient and to optimize the recovery process.
FAU - Belda-Lois, Juan-Manuel
AU  - Belda-Lois JM
AD  - Instituto de Biomecánica de Valencia, Universitat Politécnica de Valencia, Camino
      de Vera, s/n ed. 9C, E46022 Valencia, Spain
FAU - Mena-del Horno, Silvia
AU  - Mena-del Horno S
AD  - Instituto de Biomecánica de Valencia, Universitat Politécnica de Valencia, Camino
      de Vera, s/n ed. 9C, E46022 Valencia, Spain
FAU - Bermejo-Bosch, Ignacio
AU  - Bermejo-Bosch I
AD  - Instituto de Biomecánica de Valencia, Universitat Politécnica de Valencia, Camino
      de Vera, s/n ed. 9C, E46022 Valencia, Spain
FAU - Moreno, Juan C
AU  - Moreno JC
AD  - Bioengineering Group, Center for Automation and Robotics, Spanish National
      Research Council (CSIC). Madrid, Spain
FAU - Pons, José L
AU  - Pons JL
AD  - Bioengineering Group, Center for Automation and Robotics, Spanish National
      Research Council (CSIC). Madrid, Spain
FAU - Farina, Dario
AU  - Farina D
AD  - Department of Neurorehabilitation Engineering, Bernstein Center for Computational
      Neuroscience University Medical Center Göttingen Georg-August University.
      Göttingen, Germany
FAU - Iosa, Marco
AU  - Iosa M
AD  - Fondazione Santa Lucia. Roma, Italy
FAU - Molinari, Marco
AU  - Molinari M
AD  - Fondazione Santa Lucia. Roma, Italy
FAU - Tamburella, Federica
AU  - Tamburella F
AD  - Fondazione Santa Lucia. Roma, Italy
FAU - Ramos, Ander
AU  - Ramos A
AD  - University of Tübingen. Tübingen, Germany
FAU - Caria, Andrea
AU  - Caria A
AD  - University of Tübingen. Tübingen, Germany
FAU - Solis-Escalante, Teodoro
AU  - Solis-Escalante T
AD  - Graz University of Technology. Austria
FAU - Brunner, Clemens
AU  - Brunner C
AD  - Graz University of Technology. Austria
FAU - Rea, Massimiliano
AU  - Rea M
AD  - University of Tübingen. Tübingen, Germany
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20111213
PHST- 2011/04/04 [received]
PHST- 2011/12/13 [accepted]
TA  - J Neuroeng Rehabil
JT  - Journal of NeuroEngineering and Rehabilitation
AID - 1743-0003-8-66 [pii]
AID - 10.1186/1743-0003-8-66 [doi]
SO  - J Neuroeng Rehabil. 2011 Dec 13;8:66. doi:10.1186/1743-0003-8-66.

PMC - PMC3986515
PMID- 24782756
IS  - 1662-6443 (Electronic)
VI  - 7
DP  - 2014
TI  - A new dynamic tactile display for reconfigurable braille: implementation and
      tests.
LID - 6
AB  - Different tactile interfaces have been proposed to represent either text
      (braille) or, in a few cases, tactile large-area screens as replacements for
      visual displays. None of the implementations so far can be customized to match
      users' preferences, perceptual differences and skills. Optimal choices in these
      respects are still debated; we approach a solution by designing a flexible device
      allowing the user to choose key parameters of tactile transduction. We present
      here a new dynamic tactile display, a 8 × 8 matrix of plastic pins based on
      well-established and reliable piezoelectric technology to offer high resolution
      (pin gap 0.7mm) as well as tunable strength of the pins displacement, and refresh
      rate up to 50s−1. It can reproduce arbitrary patterns, allowing it to serve the
      dual purpose of providing, depending on contingent user needs, tactile rendering 
      of non-character information, and reconfigurable braille rendering. Given the
      relevance of the latter functionality for the expected average user, we
      considered testing braille encoding by volunteers a benchmark of primary
      importance. Tests were performed to assess the acceptance and usability with
      minimal training, and to check whether the offered flexibility was indeed
      perceived by the subject as an added value compared to conventional braille
      devices. Different mappings between braille dots and actual tactile pins were
      implemented to match user needs. Performances of eight experienced braille
      readers were defined as the fraction of correct identifications of rendered
      content. Different information contents were tested (median performance on random
      strings, words, sentences identification was about 75%, 85%, 98%, respectively,
      with a significant increase, p < 0.01), obtaining statistically significant
      improvements in performance during the tests (p < 0.05). Experimental results,
      together with qualitative ratings provided by the subjects, show a good
      acceptance and the effectiveness of the proposed solution.
FAU - Motto Ros, Paolo
AU  - Motto Ros P
AD  - Center for Space Human Robotic, Istituto Italiano di Tecnologia (IIT@PoliTO),
      with Dipartimento di Elettronica e Telecomunicazioni of Politecnico di Torino,
      and with Istituto Nazionale Fisica Nuclearesezione di Torino, Torino, Italy
FAU - Dante, Vittorio
AU  - Dante V
AD  - Istituto Superiore di Sanità di Roma and with Istituto Nazionale Fisica
      NucleareSezione di Roma, Italy
FAU - Mesin, Luca
AU  - Mesin L
AD  - Dipartimento di Elettronica e Telecomunicazioni of Politecnico di TorinoTorino,
      Italy
FAU - Petetti, Erminio
AU  - Petetti E
AD  - Istituto Superiore di Sanità di Roma and with Istituto Nazionale Fisica
      NucleareSezione di Roma, Italy
FAU - Del Giudice, Paolo
AU  - Del Giudice P
AD  - Istituto Superiore di Sanità di Roma and with Istituto Nazionale Fisica
      NucleareSezione di Roma, Italy
FAU - Pasero, Eros
AU  - Pasero E
AD  - Dipartimento di Elettronica e Telecomunicazioni of Politecnico di Torino and with
      Istituto Nazionale Fisica NucleareSezione di Torino, Torino, Italy
LA  - eng
PT  - Journal Article
DEP - 20140408
PHST- 2013/12/05 [received]
PHST- 2014/03/06 [accepted]
TA  - Front Neuroeng
JT  - Frontiers in Neuroengineering
AID - 10.3389/fneng.2014.00006 [doi]
SO  - Front Neuroeng. 2014 Apr 08;7:. doi:10.3389/fneng.2014.00006.

PMC - PMC2782849
PMID- 19946565
IS  - 1937-3333 (Print)
IS  - 1941-1189 (Electronic)
VI  - 1
DP  - 2008 Jan 1
TI  - Cochlear Implants:System Design, Integration and Evaluation.
PG  - 115-42
AB  - As the most successful neural prosthesis, cochlear implants have provided partial
      hearing to more than 120,000 persons worldwide; half of which being pediatric
      users who are able to develop nearly normal language. Biomedical engineers have
      played a central role in the design, integration and evaluation of the cochlear
      implant system, but the overall success is a result of collaborative work with
      physiologists, psychologists, physicians, educators, and entrepreneurs. This
      review presents broad yet in-depth academic and industrial perspectives on the
      underlying research and ongoing development of cochlear implants. The
      introduction accounts for major events and advances in cochlear implants,
      including dynamic interplays among engineers, scientists, physicians, and policy 
      makers. The review takes a system approach to address critical issues from design
      and specifications to integration and evaluation. First, the cochlear implant
      system design and specifications are laid out. Second, the design goals,
      principles, and methods of the subsystem components are identified from the
      external speech processor and radio frequency transmission link to the internal
      receiver, stimulator and electrode arrays. Third, system integration and
      functional evaluation are presented with respect to safety, reliability, and
      challenges facing the present and future cochlear implant designers and users.
      Finally, issues beyond cochlear implants are discussed to address treatment
      options for the entire spectrum of hearing impairment as well as to use the
      cochlear implant as a model to design and evaluate other similar neural
      prostheses such as vestibular and retinal implants.
FAU - Zeng, Fan-Gang
AU  - Zeng FG
AD  - Departments of Anatomy and Neurobiology, Biomedical Engineering, Cognitive
      Sciences and Otolaryngology - Head and Neck Surgery, University of California,
      364 Med Surg II, Irvine, CA 92697, USA (fzeng@uci.edu)
FAU - Rebscher, Stephen
AU  - Rebscher S
AD  - Department of Otolaryngology - Head and Neck Surgery, University of California,
      San Francisco, CA 94143, USA
FAU - Harrison, William V.
AU  - Harrison WV
AD  - Silere Medical Technology, Inc., Kirkland, WA 98034, USA
FAU - Sun, Xiaoan
AU  - Sun X
AD  - Nurotron Biotechnology Inc., Irvine, CA 92618, USA
FAU - Feng, Haihong
AU  - Feng H
AD  - Institute of Acoustics, Academia Sinica, Beijing 100190, China
LA  - eng
PT  - Journal Article
TA  - IEEE Rev Biomed Eng
JT  - IEEE reviews in biomedical engineering
AID - 10.1109/RBME.2008.2008250 [doi]
MID - NIHMS75190
SO  - IEEE Rev Biomed Eng. 2008 Jan 1;1:115-42. doi:10.1109/RBME.2008.2008250.

PMC - PMC4195274
PMID- 25352773
IS  - 1662-4548 (Print)
IS  - 1662-453X (Electronic)
VI  - 8
DP  - 2014
TI  - Developing an EEG-based on-line closed-loop lapse detection and mitigation
      system.
LID - 321
AB  - In America, 60% of adults reported that they have driven a motor vehicle while
      feeling drowsy, and at least 15–20% of fatal car accidents are fatigue-related.
      This study translates previous laboratory-oriented neurophysiological research to
      design, develop, and test an On-line Closed-loop Lapse Detection and Mitigation
      (OCLDM) System featuring a mobile wireless dry-sensor EEG headgear and a
      cell-phone based real-time EEG processing platform. Eleven subjects participated 
      in an event-related lane-keeping task, in which they were instructed to
      manipulate a randomly deviated, fixed-speed cruising car on a 4-lane highway.
      This was simulated in a 1st person view with an 8-screen and 8-projector
      immersive virtual-reality environment. When the subjects experienced lapses or
      failed to respond to events during the experiment, auditory warning was delivered
      to rectify the performance decrements. However, the arousing auditory signals
      were not always effective. The EEG spectra exhibited statistically significant
      differences between effective and ineffective arousing signals, suggesting that
      EEG spectra could be used as a countermeasure of the efficacy of arousing
      signals. In this on-line pilot study, the proposed OCLDM System was able to
      continuously detect EEG signatures of fatigue, deliver arousing warning to
      subjects suffering momentary cognitive lapses, and assess the efficacy of the
      warning in near real-time to rectify cognitive lapses. The on-line testing
      results of the OCLDM System validated the efficacy of the arousing signals in
      improving subjects' response times to the subsequent lane-departure events. This 
      study may lead to a practical on-line lapse detection and mitigation system in
      real-world environments.
FAU - Wang, Yu-Te
AU  - Wang YT
AD  - Department of Computer Science and Engineering, Jacobs School of Engineering,
      University of California San DiegoLa Jolla, CA, USA
FAU - Huang, Kuan-Chih
AU  - Huang KC
AD  - Department of Electrical Engineering, National Chiao-Tung UniversityHsinchu,
      Taiwan
FAU - Wei, Chun-Shu
AU  - Wei CS
AD  - Swartz Center for Computational Neuroscience, Institute for Neural Computation,
      University of California San DiegoLa Jolla, CA, USA
FAU - Huang, Teng-Yi
AU  - Huang TY
AD  - Department of Electrical Engineering, National Chiao-Tung UniversityHsinchu,
      Taiwan
FAU - Ko, Li-Wei
AU  - Ko LW
AD  - Department of Biological Science and Technology, National Chiao-Tung
      UniversityHsinchu, Taiwan
FAU - Lin, Chin-Teng
AU  - Lin CT
AD  - Department of Electrical Engineering, National Chiao-Tung UniversityHsinchu,
      Taiwan
FAU - Cheng, Chung-Kuan
AU  - Cheng CK
AD  - Department of Computer Science and Engineering, Jacobs School of Engineering,
      University of California San DiegoLa Jolla, CA, USA
FAU - Jung, Tzyy-Ping
AU  - Jung TP
AD  - Swartz Center for Computational Neuroscience, Institute for Neural Computation,
      University of California San DiegoLa Jolla, CA, USA
LA  - eng
PT  - Journal Article
DEP - 20141013
PHST- 2014/02/15 [received]
PHST- 2014/09/24 [accepted]
TA  - Front Neurosci
JT  - Frontiers in Neuroscience
AID - 10.3389/fnins.2014.00321 [doi]
SO  - Front Neurosci. 2014 Oct 13;8:. doi:10.3389/fnins.2014.00321.

PMC - PMC4408443
PMID- 25967741
IS  - 2001-3078 (Electronic)
VI  - 4
DP  - 2015
TI  - Abstracts from the Fourth International Meeting of ISEV, ISEV2015, Washington,
      D.C., USA, 23-26 April 2015.
LID - 10.3402/jev.v4.27783
LA  - eng
PT  - Journal Article
DEP - 20150421
TA  - J Extracell Vesicles
JT  - Journal of Extracellular Vesicles
AID - 27783 [pii]
AID - 10.3402/jev.v4.27783 [doi]
SO  - J Extracell Vesicles. 2015 Apr 21;4:. doi:10.3402/jev.v4.27783.

PMC - PMC4614280
PMID- 26557098
IS  - 1664-0640 (Electronic)
VI  - 6
DP  - 2015
TI  - ADHD Rehabilitation through Video Gaming: A Systematic Review Using PRISMA
      Guidelines of the Current Findings and the Associated Risk of Bias.
LID - 151
AB  - Empirical research studies have highlighted the need to investigate whether video
      game can be useful as a tool within a neuropsychological rehabilitation program
      for attention deficit hyperactivity disorder (ADHD) patients. However, little is 
      known about the possible gains that this kind of video game-based interventions
      can produce and even if these gains can be transferred to real life abilities.
      The present paper aims to uncover key information related to the use of video
      game in ADHD neuropsychological rehabilitation/intervention by focusing on its
      gains and its capability to transfer/generalize these gains to real life
      situation via a systematic review of the empirical literature. The PRISMA
      guidelines were adopted. Internet-based bibliographic searches were conducted via
      seven major electronic databases (i.e., PsycARTICLES, PsycINFO, Web of Science,
      Core Collection BIOSIS Citation Index, MEDLINE, SciELO Citation Index, and
      PubMed) to access studies examining the association between video game
      interventions in ADHD patients and behavioral and cognitive outcomes. A total of 
      14 empirical studies meeting the inclusion criteria were identified. The studies 
      reported the attention, working memory, and the behavioral aspects as the main
      target of the intervention. Cognitive and behavioral gains were reported after
      the video game training (VGT). However, many bias related to the choice of
      outcome instruments, sampling and blindness of assessors, weaken the results
      power. Additional researches are important to clarify the effects and stability
      of the VGT programs, and an important effort should be made to construct better
      methods to assess improvements on everyday cognitive abilities and real world
      functioning.
FAU - Strahler Rivero, Thiago
AU  - Strahler Rivero T
AD  - Grupo de Investigação em Memória Humana, Departamento de Psicobiologia,
      Universidade Federal de São Paulo, São Paulo, Brazil
FAU - Herrera Nuñez, Lina Maria
AU  - Herrera Nuñez LM
AD  - Departamento de Psicologia, Universidad Libre, Cali, Colombia
FAU - Uehara Pires, Emmy
AU  - Uehara Pires E
AD  - Departamento de Psicologia, Universidade Federal Rural do Rio de Janeiro,
      Seropédica, Brazil
FAU - Amodeo Bueno, Orlando Francisco
AU  - Amodeo Bueno OF
AD  - Grupo de Investigação em Memória Humana, Departamento de Psicobiologia,
      Universidade Federal de São Paulo, São Paulo, Brazil
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20151022
PHST- 2015/05/12 [received]
PHST- 2015/10/09 [accepted]
TA  - Front Psychiatry
JT  - Frontiers in Psychiatry
AID - 10.3389/fpsyt.2015.00151 [doi]
SO  - Front Psychiatry. 2015 Oct 22;6:. doi:10.3389/fpsyt.2015.00151.

PMC - PMC2846084
PMID- 20331653
IS  - 0009-3920 (Print)
IS  - 1467-8624 (Electronic)
VI  - 81
IP  - 1
DP  - 2010 Jan-Feb
TI  - How the Timing and Quality of Early Experiences Influence the Development of
      Brain Architecture.
PG  - 28-40
AB  - Early life events can exert a powerful influence on both the pattern of brain
      architecture and behavioral development. In this paper a conceptual framework is 
      provided for considering how the structure of early experience gets “under the
      skin.” The paper begins with a description of the genetic framework that lays the
      foundation for brain development, and then to the ways experience interacts with 
      and modifies the structures and functions of the developing brain. Much of the
      attention is focused on early experience and sensitive periods, although it is
      made clear that later experience also plays an important role in maintaining and 
      elaborating this early wiring diagram, which is critical to establishing a solid 
      footing for development beyond the early years.
FAU - Fox, Sharon E.
AU  - Fox SE
AD  - Harvard-MIT Division of Health Sciences and Technology
FAU - Levitt, Pat
AU  - Levitt P
AD  - Vanderbilt University
FAU - Nelson, Charles A.
AU  - Nelson CA
AD  - Children’s Hospital Boston, Harvard Medical School
LA  - eng
PT  - Journal Article
TA  - Child Dev
JT  - Child development
AID - 10.1111/j.1467-8624.2009.01380.x [doi]
MID - NIHMS157389
SO  - Child Dev. 2010 Jan-Feb;81(1):28-40. doi:10.1111/j.1467-8624.2009.01380.x.

PMC - PMC2096525
PMID- 18404494
IS  - 1573-9538 (Print)
IS  - 1573-9546 (Electronic)
VI  - 2
IP  - 1
DP  - 2006 May
TI  - Invited Lectures: Overviews Purinergic signalling: past, present and future.
PG  - 1-324
LA  - eng
PT  - Journal Article
DEP - 20060515
PHST- 2006/03/02 [accepted]
TA  - Purinergic Signal
JT  - Purinergic Signalling
AID - 9006 [pii]
AID - 10.1007/s11302-006-9006-2 [doi]
SO  - Purinergic Signal. 2006 May;2(1):1-324. Epub 2006 May 15
      doi:10.1007/s11302-006-9006-2.

PMC - PMC4417513
PMID- 25909465
IS  - 1745-6215 (Electronic)
VI  - 16
DP  - 2015
TI  - The effect of an information and communication technology (ICT) on older adults’ 
      quality of life: study protocol for a randomized control trial.
LID - 191
AB  - Background: This study investigates the use of an information and communication
      technology (Elder Tree) designed for older adults and their informal caregivers
      to improve older adult quality of life and address challenges older adults face
      in maintaining their independence (for example, loneliness and isolation,
      falling, managing medications, driving and transportation). Methods/Design: This 
      study, an unblinded randomized controlled trial, will evaluate the effectiveness 
      and cost of Elder Tree. Older adults who are at risk for losing their
      independence - along with their informal caregivers, if they name them - are
      randomized to two groups. The intervention group has access to their usual
      sources of information and communication as well as to Elder Tree for 18 months
      while the control group uses only their usual sources of information and
      communication. The primary outcome of the study is older adult quality of life.
      Secondary outcomes are cost per Quality-Adjusted Life Year and the impact of the 
      technology on independence, loneliness, falls, medication management, driving and
      transportation, and caregiver appraisal and mastery. We will also examine the
      mediating effect of self-determination theory. We will evaluate the effectiveness
      of Elder Tree by comparing intervention- and control-group participants at
      baseline and months 6, 12, and 18. We will use mixed-effect models to evaluate
      the primary and secondary outcomes, where pretest score functions as a covariate,
      treatment condition is a between-subjects factor, and the multivariate outcome
      reflects scores for a given assessment at the three time points. Separate
      analyses will be conducted for each outcome. Cost per Quality-Adjusted Life Year 
      will be compared between the intervention and control groups. Additional analyses
      will examine the mediating effect of self-determination theory on each outcome.
      Discussion: Elder Tree is a multifaceted intervention, making it a challenge to
      assess which services or combinations of services account for outcomes in which
      subsets of older adults. If Elder Tree can improve quality of life and reduce
      healthcare costs among older adults, it could suggest a promising way to ease the
      burden that advancing age can place on older adults, their families, and the
      healthcare system. Trial registration: ClinicalTrials.govNCT02128789. Registered 
      on 26 March 2014. Electronic supplementary material: The online version of this
      article (doi:10.1186/s13063-015-0713-2) contains supplementary material, which is
      available to authorized users.
FAU - Gustafson, David H
AU  - Gustafson DH
AD  - Center for Health Enhancement Systems Studies, University of Wisconsin-Madison,
      Madison, WI 53706 USA
FAU - McTavish, Fiona
AU  - McTavish F
AD  - Center for Health Enhancement Systems Studies, University of Wisconsin-Madison,
      Madison, WI 53706 USA
FAU - Gustafson, David H
AU  - Gustafson DH
AD  - Center for Health Enhancement Systems Studies, University of Wisconsin-Madison,
      Madison, WI 53706 USA
FAU - Mahoney, Jane E
AU  - Mahoney JE
AD  - Division of Geriatrics, Department of Medicine, University of Wisconsin School of
      Medicine and Public Health and Executive Director, Wisconsin Institute for Health
      Aging, Madison, WI 53792 USA
FAU - Johnson, Roberta A
AU  - Johnson RA
AD  - Center for Health Enhancement Systems Studies, University of Wisconsin-Madison,
      Madison, WI 53706 USA
FAU - Lee, John D
AU  - Lee JD
AD  - Department of Industrial and Systems Engineering, University of
      Wisconsin-Madison, Madison, WI 53705 USA
FAU - Quanbeck, Andrew
AU  - Quanbeck A
AD  - Center for Health Enhancement Systems Studies, University of Wisconsin-Madison,
      Madison, WI 53706 USA
FAU - Atwood, Amy K
AU  - Atwood AK
AD  - Center for Health Enhancement Systems Studies, University of Wisconsin-Madison,
      Madison, WI 53706 USA
FAU - Isham, Andrew
AU  - Isham A
AD  - Center for Health Enhancement Systems Studies, University of Wisconsin-Madison,
      Madison, WI 53706 USA
FAU - Veeramani, Raj
AU  - Veeramani R
AD  - College of Engineering and School of Business and Executive Director, University 
      of Wisconsin E-Business Institute, University of Wisconsin-Madison, Madison, WI
      53706 USA
FAU - Clemson, Lindy
AU  - Clemson L
AD  - Aging, Work & Health Research Group, Faculty of Health Sciences, University of
      Sydney, Sydney, Australia
FAU - Shah, Dhavan
AU  - Shah D
AD  - Mass Communication Research Center, School of Journalism and Mass Communication, 
      University of Wisconsin-Madison, Madison, WI 53706 USA
LA  - eng
PT  - Journal Article
DEP - 20150425
PHST- 2015/02/12 [received]
PHST- 2015/04/08 [accepted]
TA  - Trials
JT  - Trials
AID - 713 [pii]
AID - 10.1186/s13063-015-0713-2 [doi]
SO  - Trials. 2015 Apr 25;16:. doi:10.1186/s13063-015-0713-2.

PMC - PMC4391208
PMID- 25893012
IS  - 1874-1207 (Electronic)
VI  - 9
DP  - 2015
TI  - Auditory Evoked Potential Response and Hearing Loss: A Review.
PG  - 17-24
AB  - Hypoacusis is the most prevalent sensory disability in the world and
      consequently, it can lead to impede speech in human beings. One best approach to 
      tackle this issue is to conduct early and effective hearing screening test using 
      Electroencephalogram (EEG). EEG based hearing threshold level determination is
      most suitable for persons who lack verbal communication and behavioral response
      to sound stimulation. Auditory evoked potential (AEP) is a type of EEG signal
      emanated from the brain scalp by an acoustical stimulus. The goal of this review 
      is to assess the current state of knowledge in estimating the hearing threshold
      levels based on AEP response. AEP response reflects the auditory ability level of
      an individual. An intelligent hearing perception level system enables to examine 
      and determine the functional integrity of the auditory system. Systematic
      evaluation of EEG based hearing perception level system predicting the hearing
      loss in newborns, infants and multiple handicaps will be a priority of interest
      for future research.
FAU - Paulraj, M. P
AU  - Paulraj MP
AD  - Department of Mechatronic Engineering, Universiti Malaysia Perlis, Malaysia
FAU - Subramaniam, Kamalraj
AU  - Subramaniam K
AD  - Department of Mechatronic Engineering, Universiti Malaysia Perlis, Malaysia
FAU - Yaccob, Sazali Bin
AU  - Yaccob SB
AD  - Department of Mechatronic Engineering, Universiti Malaysia Perlis, Malaysia
FAU - Adom, Abdul H. Bin
AU  - Adom AHB
AD  - Department of Mechatronic Engineering, Universiti Malaysia Perlis, Malaysia
FAU - Hema, C. R
AU  - Hema CR
AD  - Faculty of Engineering, Karpagam University, India
LA  - eng
PT  - Journal Article
DEP - 20150227
PHST- 2014/07/12 [received]
PHST- 2014/09/13 [revised]
PHST- 2014/09/18 [accepted]
TA  - Open Biomed Eng J
JT  - The Open Biomedical Engineering Journal
AID - TOBEJ-9-17 [pii]
AID - 10.2174/1874120701509010017 [doi]
SO  - Open Biomed Eng J. 2015 Feb 27 ;9:17-24. doi:10.2174/1874120701509010017.

PMC - PMC4518813
PMID- 25205047
IS  - 1352-4585 (Print)
IS  - 1477-0970 (Electronic)
VI  - 20
IP  - 1 Suppl
DP  - 2014 Sep
DP  - 2014 Sep
TI  - 2014 Joint ACTRIMS-ECTRIMS Meeting (MSBoston 2014): Oral Presentations.
PG  - 14-66
LA  - eng
PT  - Journal Article
TA  - Mult Scler
JT  - Multiple Sclerosis (Houndmills, Basingstoke, England)
AID - 10.1177/1352458514546076 [doi]
AID - 10.1177_1352458514546076 [pii]
SO  - Mult Scler. 2014 Sep;20(1 Suppl):14-66. doi:10.1177/1352458514546076.

PMC - PMC3690007
PMID- 23615581
IS  - 1424-8220 (Electronic)
VI  - 13
IP  - 5
DP  - 2013 May
TI  - A Survey of Body Sensor Networks.
PG  - 5406-47
AB  - The technology of sensor, pervasive computing, and intelligent information
      processing is widely used in Body Sensor Networks (BSNs), which are a branch of
      wireless sensor networks (WSNs). BSNs are playing an increasingly important role 
      in the fields of medical treatment, social welfare and sports, and are changing
      the way humans use computers. Existing surveys have placed emphasis on the
      concept and architecture of BSNs, signal acquisition, context-aware sensing, and 
      system technology, while this paper will focus on sensor, data fusion, and
      network communication. And we will introduce the research status of BSNs, the
      analysis of hotspots, and future development trends, the discussion of major
      challenges and technical problems facing currently. The typical research projects
      and practical application of BSNs are introduced as well. BSNs are progressing
      along the direction of multi-technology integration and intelligence. Although
      there are still many problems, the future of BSNs is fundamentally promising,
      profoundly changing the human-machine relationships and improving the quality of 
      people's lives.
FAU - Lai, Xiaochen
AU  - Lai X
AD  - Faculty of Electronic Information and Electrical Engineering, Dalian University
      of Technology, No. 2 Linggong Road, Ganjingzi District, Dalian 116024, China;
      E-Mails: weixin@mail.dlut.edu.cn (X.W.); wangwei@dlut.edu.cn (W.W.)
FAU - Liu, Quanli
AU  - Liu Q
AD  - Faculty of Electronic Information and Electrical Engineering, Dalian University
      of Technology, No. 2 Linggong Road, Ganjingzi District, Dalian 116024, China;
      E-Mails: weixin@mail.dlut.edu.cn (X.W.); wangwei@dlut.edu.cn (W.W.)
FAU - Wei, Xin
AU  - Wei X
AD  - Faculty of Electronic Information and Electrical Engineering, Dalian University
      of Technology, No. 2 Linggong Road, Ganjingzi District, Dalian 116024, China;
      E-Mails: weixin@mail.dlut.edu.cn (X.W.); wangwei@dlut.edu.cn (W.W.)
FAU - Wang, Wei
AU  - Wang W
AD  - Faculty of Electronic Information and Electrical Engineering, Dalian University
      of Technology, No. 2 Linggong Road, Ganjingzi District, Dalian 116024, China;
      E-Mails: weixin@mail.dlut.edu.cn (X.W.); wangwei@dlut.edu.cn (W.W.)
FAU - Zhou, Guoqiao
AU  - Zhou G
AD  - School of Software, Dalian University of Technology, Economy and Technology
      Development Area, Dalian 116620, China; E-Mails: zhou.guo.qiao@mail.dlut.edu.cn
      (G.Z.); hanguangyi@mail.dlut.edu.cn (G.H.)
FAU - Han, Guangyi
AU  - Han G
AD  - School of Software, Dalian University of Technology, Economy and Technology
      Development Area, Dalian 116620, China; E-Mails: zhou.guo.qiao@mail.dlut.edu.cn
      (G.Z.); hanguangyi@mail.dlut.edu.cn (G.H.)
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20130424
PHST- 2012/12/19 [received]
PHST- 2013/04/12 [revised]
PHST- 2013/04/19 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s130505406 [doi]
AID - sensors-13-05406 [pii]
SO  - Sensors (Basel). 2013 Apr 24;13(5):5406-47. doi:10.3390/s130505406.

PMC - PMC5062470
PMID- 27734956
IS  - 2045-2322 (Electronic)
VI  - 6
DP  - 2016
TI  - The mGluR2 positive allosteric modulator, SAR218645, improves memory and
      attention deficits in translational models of cognitive symptoms associated with 
      schizophrenia.
LID - 35320
AB  - Normalization of altered glutamate neurotransmission through activation of the
      mGluR2 has emerged as a new approach to treat schizophrenia. These studies
      describe a potent brain penetrant mGluR2 positive allosteric modulator (PAM),
      SAR218645. The compound behaves as a selective PAM of mGluR2 in recombinant and
      native receptor expression systems, increasing the affinity of glutamate at
      mGluR2 as inferred by competition and GTPγ35S binding assays. SAR218645 augmented
      the mGluR2-mediated response to glutamate in a rat recombinant mGluR2
      forced-coupled Ca2+ mobilization assay. SAR218645 potentiated mGluR2
      agonist-induced contralateral turning. When SAR218645 was tested in models of the
      positive symptoms of schizophrenia, it reduced head twitch behavior induced by
      DOI, but it failed to inhibit conditioned avoidance and hyperactivity using
      pharmacological and transgenic models. Results from experiments in models of the 
      cognitive symptoms associated with schizophrenia showed that SAR218645 improved
      MK-801-induced episodic memory deficits in rats and attenuated working memory
      impairment in NMDA Nr1neo−/− mice. The drug reversed disrupted latent inhibition 
      and auditory-evoked potential in mice and rats, respectively, two endophenotypes 
      of schizophrenia. This profile positions SAR218645 as a promising candidate for
      the treatment of cognitive symptoms of patients with schizophrenia, in particular
      those with abnormal attention and sensory gating abilities.
FAU - Griebel, Guy
AU  - Griebel G
AD  - Sanofi R&D, Strategy, Science Policy & External Innovation, Chilly-Mazarin,
      France
FAU - Pichat, Philippe
AU  - Pichat P
AD  - Sanofi R&D, Translational Sciences Unit, Chilly-Mazarin, France
FAU - Boulay, Denis
AU  - Boulay D
AD  - Sanofi R&D, Translational Sciences Unit, Chilly-Mazarin, France
FAU - Naimoli, Vanessa
AU  - Naimoli V
AD  - Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA
FAU - Potestio, Lisa
AU  - Potestio L
AD  - Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA
FAU - Featherstone, Robert
AU  - Featherstone R
AD  - Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA
FAU - Sahni, Sukhveen
AU  - Sahni S
AD  - Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA
FAU - Defex, Henry
AU  - Defex H
AD  - Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA
FAU - Desvignes, Christophe
AU  - Desvignes C
AD  - Sanofi R&D, Analytical Sciences, Montpellier, France
FAU - Slowinski, Franck
AU  - Slowinski F
AD  - Sanofi R&D, Lead Generation, Chilly-Mazarin, France
FAU - Vigé, Xavier
AU  - Vigé X
AD  - Sanofi R&D, Translational Sciences Unit, Chilly-Mazarin, France
FAU - Bergis, Olivier E.
AU  - Bergis OE
AD  - Sanofi R&D, Translational Sciences Unit, Chilly-Mazarin, France
FAU - Sher, Rosy
AU  - Sher R
AD  - Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA
FAU - Kosley, Raymond
AU  - Kosley R
AD  - Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA
FAU - Kongsamut, Sathapana
AU  - Kongsamut S
AD  - Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA
FAU - Black, Mark D.
AU  - Black MD
AD  - Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA
FAU - Varty, Geoffrey B.
AU  - Varty GB
AD  - Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA
LA  - eng
PT  - Journal Article
DEP - 20161013
PHST- 2016/06/13 [received]
PHST- 2016/09/28 [accepted]
TA  - Sci Rep
JT  - Scientific Reports
AID - srep35320 [pii]
AID - 10.1038/srep35320 [doi]
SO  - Sci Rep. 2016 Oct 13;6:. doi:10.1038/srep35320.

PMC - PMC2094729
IS  - 0040-6376 (Print)
IS  - 1468-3296 (Electronic)
VI  - 62
IP  - Suppl 3
DP  - 2007 Dec
PG  - A64-A149
LA  - eng
PT  - Journal Article
TA  - Thorax
JT  - Thorax
AID - txbtsabs6 [pii]
SO  - Thorax. 2007 Dec;62(Suppl 3):A64-A149.

PMC - PMC5414058
PMID- 28440792
IS  - 2041-1723 (Electronic)
VI  - 8
DP  - 2017
TI  - An extra-uterine system to physiologically support the extreme premature lamb.
LID - 15112
AB  - In the developed world, extreme prematurity is the leading cause of neonatal
      mortality and morbidity due to a combination of organ immaturity and iatrogenic
      injury. Until now, efforts to extend gestation using extracorporeal systems have 
      achieved limited success. Here we report the development of a system that
      incorporates a pumpless oxygenator circuit connected to the fetus of a lamb via
      an umbilical cord interface that is maintained within a closed ‘amniotic fluid'
      circuit that closely reproduces the environment of the womb. We show that fetal
      lambs that are developmentally equivalent to the extreme premature human infant
      can be physiologically supported in this extra-uterine device for up to 4 weeks. 
      Lambs on support maintain stable haemodynamics, have normal blood gas and
      oxygenation parameters and maintain patency of the fetal circulation. With
      appropriate nutritional support, lambs on the system demonstrate normal somatic
      growth, lung maturation and brain growth and myelination.
OAB - Publisher: Abstract available from the publisher.
FAU - Partridge, Emily A.
AU  - Partridge EA
AD  - Center for Fetal Research, Department of Surgery, The Children's Hospital of
      Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard,
      Philadelphia, Pennsylvania 19104, USA
FAU - Davey, Marcus G.
AU  - Davey MG
AD  - Center for Fetal Research, Department of Surgery, The Children's Hospital of
      Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard,
      Philadelphia, Pennsylvania 19104, USA
FAU - Hornick, Matthew A.
AU  - Hornick MA
AD  - Center for Fetal Research, Department of Surgery, The Children's Hospital of
      Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard,
      Philadelphia, Pennsylvania 19104, USA
FAU - McGovern, Patrick E.
AU  - McGovern PE
AD  - Center for Fetal Research, Department of Surgery, The Children's Hospital of
      Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard,
      Philadelphia, Pennsylvania 19104, USA
FAU - Mejaddam, Ali Y.
AU  - Mejaddam AY
AD  - Center for Fetal Research, Department of Surgery, The Children's Hospital of
      Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard,
      Philadelphia, Pennsylvania 19104, USA
FAU - Vrecenak, Jesse D.
AU  - Vrecenak JD
AD  - Center for Fetal Research, Department of Surgery, The Children's Hospital of
      Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard,
      Philadelphia, Pennsylvania 19104, USA
FAU - Mesas-Burgos, Carmen
AU  - Mesas-Burgos C
AD  - Center for Fetal Research, Department of Surgery, The Children's Hospital of
      Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard,
      Philadelphia, Pennsylvania 19104, USA
FAU - Olive, Aliza
AU  - Olive A
AUID- ORCID: 0000-0003-1725-0981
AD  - Center for Fetal Research, Department of Surgery, The Children's Hospital of
      Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard,
      Philadelphia, Pennsylvania 19104, USA
FAU - Caskey, Robert C.
AU  - Caskey RC
AD  - Center for Fetal Research, Department of Surgery, The Children's Hospital of
      Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard,
      Philadelphia, Pennsylvania 19104, USA
FAU - Weiland, Theodore R.
AU  - Weiland TR
AUID- ORCID: 0000-0002-0170-1795
AD  - Center for Fetal Research, Department of Surgery, The Children's Hospital of
      Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard,
      Philadelphia, Pennsylvania 19104, USA
FAU - Han, Jiancheng
AU  - Han J
AD  - Center for Fetal Research, Department of Surgery, The Children's Hospital of
      Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard,
      Philadelphia, Pennsylvania 19104, USA
FAU - Schupper, Alexander J.
AU  - Schupper AJ
AD  - Center for Fetal Research, Department of Surgery, The Children's Hospital of
      Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard,
      Philadelphia, Pennsylvania 19104, USA
FAU - Connelly, James T.
AU  - Connelly JT
AD  - Center for Fetal Research, Department of Surgery, The Children's Hospital of
      Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard,
      Philadelphia, Pennsylvania 19104, USA
FAU - Dysart, Kevin C.
AU  - Dysart KC
AD  - Division of Neonatology, Department of Pediatrics, The Children's Hospital of
      Philadelphia, 3401 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA
FAU - Rychik, Jack
AU  - Rychik J
AD  - Division of Cardiology, Department of Pediatrics, The Children's Hospital of
      Philadelphia, 3401 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA
FAU - Hedrick, Holly L.
AU  - Hedrick HL
AD  - Center for Fetal Research, Department of Surgery, The Children's Hospital of
      Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard,
      Philadelphia, Pennsylvania 19104, USA
FAU - Peranteau, William H.
AU  - Peranteau WH
AD  - Center for Fetal Research, Department of Surgery, The Children's Hospital of
      Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard,
      Philadelphia, Pennsylvania 19104, USA
FAU - Flake, Alan W.
AU  - Flake AW
AUID- ORCID: 0000-0003-4913-7588
AD  - Center for Fetal Research, Department of Surgery, The Children's Hospital of
      Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard,
      Philadelphia, Pennsylvania 19104, USA
LA  - eng
PT  - Journal Article
DEP - 20170425
PHST- 2016/04/25 [received]
PHST- 2017/03/02 [accepted]
TA  - Nat Commun
JT  - Nature Communications
AID - ncomms15112 [pii]
AID - 10.1038/ncomms15112 [doi]
SO  - Nat Commun. 2017 Apr 25;8:. doi:10.1038/ncomms15112.

PMC - PMC3807567
PMID- 24187539
IS  - 1662-5188 (Electronic)
VI  - 7
DP  - 2013
TI  - Physical principles for scalable neural recording.
LID - 137
AB  - Simultaneously measuring the activities of all neurons in a mammalian brain at
      millisecond resolution is a challenge beyond the limits of existing techniques in
      neuroscience. Entirely new approaches may be required, motivating an analysis of 
      the fundamental physical constraints on the problem. We outline the physical
      principles governing brain activity mapping using optical, electrical, magnetic
      resonance, and molecular modalities of neural recording. Focusing on the mouse
      brain, we analyze the scalability of each method, concentrating on the
      limitations imposed by spatiotemporal resolution, energy dissipation, and volume 
      displacement. Based on this analysis, all existing approaches require orders of
      magnitude improvement in key parameters. Electrical recording is limited by the
      low multiplexing capacity of electrodes and their lack of intrinsic spatial
      resolution, optical methods are constrained by the scattering of visible light in
      brain tissue, magnetic resonance is hindered by the diffusion and relaxation
      timescales of water protons, and the implementation of molecular recording is
      complicated by the stochastic kinetics of enzymes. Understanding the physical
      limits of brain activity mapping may provide insight into opportunities for novel
      solutions. For example, unconventional methods for delivering electrodes may
      enable unprecedented numbers of recording sites, embedded optical devices could
      allow optical detectors to be placed within a few scattering lengths of the
      measured neurons, and new classes of molecularly engineered sensors might obviate
      cumbersome hardware architectures. We also study the physics of powering and
      communicating with microscale devices embedded in brain tissue and find that,
      while radio-frequency electromagnetic data transmission suffers from a severe
      power–bandwidth tradeoff, communication via infrared light or ultrasound may
      allow high data rates due to the possibility of spatial multiplexing. The use of 
      embedded local recording and wireless data transmission would only be viable,
      however, given major improvements to the power efficiency of microelectronic
      devices.
FAU - Marblestone, Adam H.
AU  - Marblestone AH
AD  - Biophysics Program, Harvard UniversityBoston, MA, USA
FAU - Zamft, Bradley M.
AU  - Zamft BM
AD  - Department of Genetics, Harvard Medical SchoolBoston, MA, USA
FAU - Maguire, Yael G.
AU  - Maguire YG
AD  - Department of Genetics, Harvard Medical SchoolBoston, MA, USA
FAU - Shapiro, Mikhail G.
AU  - Shapiro MG
AD  - Division of Chemistry and Chemical Engineering, California Institute of
      TechnologyPasadena, CA, USA
FAU - Cybulski, Thaddeus R.
AU  - Cybulski TR
AD  - Interdepartmental Neuroscience Program, Northwestern UniversityChicago, IL, USA
FAU - Glaser, Joshua I.
AU  - Glaser JI
AD  - Interdepartmental Neuroscience Program, Northwestern UniversityChicago, IL, USA
FAU - Amodei, Dario
AU  - Amodei D
AD  - Department of Radiology, Stanford UniversityPalo Alto, CA, USA
FAU - Stranges, P. Benjamin
AU  - Stranges PB
AD  - Department of Genetics, Harvard Medical SchoolBoston, MA, USA
FAU - Kalhor, Reza
AU  - Kalhor R
AD  - Department of Genetics, Harvard Medical SchoolBoston, MA, USA
FAU - Dalrymple, David A.
AU  - Dalrymple DA
AD  - Biophysics Program, Harvard UniversityBoston, MA, USA
FAU - Seo, Dongjin
AU  - Seo D
AD  - Department of Electrical Engineering and Computer Sciences, University of
      California at BerkeleyBerkeley, CA, USA
FAU - Alon, Elad
AU  - Alon E
AD  - Department of Electrical Engineering and Computer Sciences, University of
      California at BerkeleyBerkeley, CA, USA
FAU - Maharbiz, Michel M.
AU  - Maharbiz MM
AD  - Department of Electrical Engineering and Computer Sciences, University of
      California at BerkeleyBerkeley, CA, USA
FAU - Carmena, Jose M.
AU  - Carmena JM
AD  - Department of Electrical Engineering and Computer Sciences, University of
      California at BerkeleyBerkeley, CA, USA
FAU - Rabaey, Jan M.
AU  - Rabaey JM
AD  - Department of Electrical Engineering and Computer Sciences, University of
      California at BerkeleyBerkeley, CA, USA
FAU - Boyden, Edward S.
AU  - Boyden ES
AD  - Media Laboratory, Massachusetts Institute of TechnologyCambridge, MA, USA
FAU - Church, George M.
AU  - Church GM
AD  - Biophysics Program, Harvard UniversityBoston, MA, USA
FAU - Kording, Konrad P.
AU  - Kording KP
AD  - Departments of Physical Medicine and Rehabilitation and of Physiology,
      Northwestern University Feinberg School of MedicineChicago, IL, USA
LA  - eng
PT  - Journal Article
DEP - 20131021
PHST- 2013/07/07 [received]
PHST- 2013/09/23 [accepted]
TA  - Front Comput Neurosci
JT  - Frontiers in Computational Neuroscience
AID - 10.3389/fncom.2013.00137 [doi]
SO  - Front Comput Neurosci. 2013 Oct 21;7:. doi:10.3389/fncom.2013.00137.

PMC - PMC5089577
IS  - 0891-6640 (Print)
IS  - 1939-1676 (Electronic)
VI  - 30
IP  - 4
DP  - 2016 Jul-Aug
TI  - 2016 ACVIM Forum Research Report Program.
PG  - 1520-51
LA  - eng
PT  - Journal Article
DEP - 20160604
TA  - J Vet Intern Med
JT  - Journal of Veterinary Internal Medicine
AID - 10.1111/jvim.13963 [doi]
AID - JVIM13963 [pii]
SO  - J Vet Intern Med. 2016 Jul-Aug;30(4):1520-51. Epub 2016 Jun 04
      doi:10.1111/jvim.13963.

PMC - PMC4380664
PMID- 25550231
IS  - 0163-7258 (Print)
IS  - 1879-016X (Electronic)
VI  - 149
DP  - 2015 May
TI  - Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety
      and trauma-related disorders.
PG  - 150-90
AB  - Pathological fear and anxiety are highly debilitating and, despite considerable
      advances in psychotherapy and pharmacotherapy they remain insufficiently treated 
      in many patients with PTSD, phobias, panic and other anxiety disorders.
      Increasing preclinical and clinical evidence indicates that pharmacological
      treatments including cognitive enhancers, when given as adjuncts to
      psychotherapeutic approaches [cognitive behavioral therapy including
      extinction-based exposure therapy] enhance treatment efficacy, while using
      anxiolytics such as benzodiazepines as adjuncts can undermine long-term treatment
      success. The purpose of this review is to outline the literature showing how
      pharmacological interventions targeting neurotransmitter systems including
      serotonin, dopamine, noradrenaline, histamine, glutamate, GABA, cannabinoids,
      neuropeptides (oxytocin, neuropeptides Y and S, opioids) and other targets
      (neurotrophins BDNF and FGF2, glucocorticoids, L-type-calcium channels,
      epigenetic modifications) as well as their downstream signaling pathways, can
      augment fear extinction and strengthen extinction memory persistently in
      preclinical models. Particularly promising approaches are discussed in regard to 
      their effects on specific aspects of fear extinction namely, acquisition,
      consolidation and retrieval, including long-term protection from return of fear
      (relapse) phenomena like spontaneous recovery, reinstatement and renewal of fear.
      We also highlight the promising translational value of the preclinial research
      and the clinical potential of targeting certain neurochemical systems with, for
      example d-cycloserine, yohimbine, cortisol, and L-DOPA. The current body of
      research reveals important new insights into the neurobiology and neurochemistry 
      of fear extinction and holds significant promise for pharmacologically-augmented 
      psychotherapy as an improved approach to treat trauma and anxiety-related
      disorders in a more efficient and persistent way promoting enhanced symptom
      remission and recovery.
FAU - Singewald, N.
AU  - Singewald N
AD  - Department of Pharmacology and Toxicology, Institute of Pharmacy and CMBI,
      Leopold-Franzens University of Innsbruck, Innrain 80-82, A-6020 Innsbruck,
      Austria
FAU - Schmuckermair, C.
AU  - Schmuckermair C
AD  - Department of Pharmacology and Toxicology, Institute of Pharmacy and CMBI,
      Leopold-Franzens University of Innsbruck, Innrain 80-82, A-6020 Innsbruck,
      Austria
FAU - Whittle, N.
AU  - Whittle N
AD  - Department of Pharmacology and Toxicology, Institute of Pharmacy and CMBI,
      Leopold-Franzens University of Innsbruck, Innrain 80-82, A-6020 Innsbruck,
      Austria
FAU - Holmes, A.
AU  - Holmes A
AD  - Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol 
      Abuse and Alcoholism, NIH, Bethesda, MD, USA
FAU - Ressler, K.J.
AU  - Ressler K
AD  - Department of Psychiatry and Behavioral Sciences, Emory University School of
      Medicine, Atlanta, GA, USA
LA  - eng
PT  - Journal Article
DEP - 20141227
TA  - Pharmacol Ther
JT  - Pharmacology & therapeutics
AID - 10.1016/j.pharmthera.2014.12.004 [doi]
MID - NIHMS670509
SO  - Pharmacol Ther. 2015 May;149:150-90. Epub 2014 Dec 27
      doi:10.1016/j.pharmthera.2014.12.004.

PMC - PMC3784686
PMID- 24098278
IS  - 1662-5161 (Electronic)
VI  - 7
DP  - 2013
TI  - Altered neural connectivity in excitatory and inhibitory cortical circuits in
      autism.
LID - 609
AB  - Converging evidence from diverse studies suggests that atypical brain
      connectivity in autism affects in distinct ways short- and long-range cortical
      pathways, disrupting neural communication and the balance of excitation and
      inhibition. This hypothesis is based mostly on functional non-invasive studies
      that show atypical synchronization and connectivity patterns between cortical
      areas in children and adults with autism. Indirect methods to study the course
      and integrity of major brain pathways at low resolution show changes in
      fractional anisotropy (FA) or diffusivity of the white matter in autism. Findings
      in post-mortem brains of adults with autism provide evidence of changes in the
      fine structure of axons below prefrontal cortices, which communicate over short- 
      or long-range pathways with other cortices and subcortical structures. Here we
      focus on evidence of cellular and axon features that likely underlie the changes 
      in short- and long-range communication in autism. We review recent findings of
      changes in the shape, thickness, and volume of brain areas, cytoarchitecture,
      neuronal morphology, cellular elements, and structural and neurochemical features
      of individual axons in the white matter, where pathology is evident even in gross
      images. We relate cellular and molecular features to imaging and genetic studies 
      that highlight a variety of polymorphisms and epigenetic factors that primarily
      affect neurite growth and synapse formation and function in autism. We report
      preliminary findings of changes in autism in the ratio of distinct types of
      inhibitory neurons in prefrontal cortex, known to shape network dynamics and the 
      balance of excitation and inhibition. Finally we present a model that synthesizes
      diverse findings by relating them to developmental events, with a goal to
      identify common processes that perturb development in autism and affect neural
      communication, reflected in altered patterns of attention, social interactions,
      and language.
FAU - Zikopoulos, Basilis
AU  - Zikopoulos B
FAU - Barbas, Helen
AU  - Barbas H
LA  - eng
PT  - Journal Article
DEP - 20130927
PHST- 2013/05/01 [received]
PHST- 2013/09/06 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2013.00609 [doi]
SO  - Front Hum Neurosci. 2013 Sep 27;7:. doi:10.3389/fnhum.2013.00609.

PMC - PMC4623224
PMID- 26511236
IS  - 0270-6474 (Print)
IS  - 1529-2401 (Electronic)
VI  - 35
IP  - 43
DP  - 2015 Oct 28
TI  - Attention Modulates TMS-Locked Alpha Oscillations in the Visual Cortex.
PG  - 14435-47
AB  - Cortical oscillations, such as 8–12 Hz alpha-band activity, are thought to
      subserve gating of information processing in the human brain. While most of the
      supporting evidence is correlational, causal evidence comes from attempts to
      externally drive (“entrain”) these oscillations by transcranial magnetic
      stimulation (TMS). Indeed, the frequency profile of TMS-evoked potentials (TEPs) 
      closely resembles that of oscillations spontaneously emerging in the same brain
      region. However, it is unclear whether TMS-locked and spontaneous oscillations
      are produced by the same neuronal mechanisms. If so, they should react in a
      similar manner to top-down modulation by endogenous attention. To test this
      prediction, we assessed the alpha-like EEG response to TMS of the visual cortex
      during periods of high and low visual attention while participants attended to
      either the visual or auditory modality in a cross-modal attention task. We
      observed a TMS-locked local oscillatory alpha response lasting several cycles
      after TMS (but not after sham stimulation). Importantly, TMS-locked alpha power
      was suppressed during deployment of visual relative to auditory attention,
      mirroring spontaneous alpha amplitudes. In addition, the early N40 TEP component,
      located at the stimulation site, was amplified by visual attention. The extent of
      attentional modulation for both TMS-locked alpha power and N40 amplitude did
      depend, with opposite sign, on the individual ability to modulate spontaneous
      alpha power at the stimulation site. We therefore argue that TMS-locked and
      spontaneous oscillations are of common neurophysiological origin, whereas the N40
      TEP component may serve as an index of current cortical excitability at the time 
      of stimulation.SIGNIFICANCE STATEMENT Rhythmic transcranial magnetic stimulation 
      (TMS) is a promising tool to experimentally “entrain” cortical activity. If
      TMS-locked oscillatory responses actually recruit the same neuronal mechanisms as
      spontaneous cortical oscillations, they qualify as a valid tool to study the
      causal role of neuronal oscillations in cognition but also to enable new
      treatments targeting aberrant oscillatory activity in, for example, neurological 
      conditions. Here, we provide first-time evidence that TMS-locked and spontaneous 
      oscillations are indeed tightly related and are likely to rely on the same
      neuronal generators. In addition, we demonstrate that an early local component of
      the TMS-evoked potential (the N40) may serve as a new objective and noninvasive
      probe of visual cortex excitability, which so far was only accessible via
      subjective phosphene reports.
FAU - Herring, Jim D.
AU  - Herring JD
AUID- ORCID: 0000-0002-2247-9206
AD  - Donders Institute for Brain, Cognition and Behaviour, Radboud University
      Nijmegen, 6525 EN Nijmegen, The Netherlands,
FAU - Thut, Gregor
AU  - Thut G
AD  - Centre for Cognitive Neuroimaging, Institute of Neuroscience and Psychology,
      University of Glasgow, Glasgow G12 8QQ, United Kingdom
FAU - Jensen, Ole
AU  - Jensen O
AUID- ORCID: 0000-0003-0324-605X
AD  - Donders Institute for Brain, Cognition and Behaviour, Radboud University
      Nijmegen, 6525 EN Nijmegen, The Netherlands,
FAU - Bergmann, Til O.
AU  - Bergmann TO
AUID- ORCID: 0000-0002-2282-6618
AD  - Donders Institute for Brain, Cognition and Behaviour, Radboud University
      Nijmegen, 6525 EN Nijmegen, The Netherlands,
LA  - eng
PT  - Journal Article
PHST- 2015/05/01 [received]
PHST- 2015/08/29 [revised]
PHST- 2015/09/02 [accepted]
TA  - J Neurosci
JT  - The Journal of Neuroscience
AID - 1833-15 [pii]
AID - 10.1523/JNEUROSCI.1833-15.2015 [doi]
SO  - J Neurosci. 2015 Oct 28;35(43):14435-47. doi:10.1523/JNEUROSCI.1833-15.2015.

PMC - PMC3674470
IS  - 2000-8198 (Print)
IS  - 2000-8066 (Electronic)
VI  - 4
DP  - 2013
TI  - Oral, June 9.
LID - 10.3402/ejpt.v4i0.21227
LA  - eng
PT  - Journal Article
DEP - 20130604
TA  - Eur J Psychotraumatol
JT  - European Journal of Psychotraumatology
AID - 21227 [pii]
AID - 10.3402/ejpt.v4i0.21227 [doi]
SO  - Eur J Psychotraumatol. 2013 Jun 04;4:. doi:10.3402/ejpt.v4i0.21227.

PMC - PMC2946295
PMID- 20840786
IS  - 1743-0003 (Electronic)
VI  - 7
DP  - 2010
TI  - Autonomous indoor wayfinding for individuals with cognitive impairments.
PG  - 45
AB  - Background: A challenge to individuals with cognitive impairments in wayfinding
      is how to remain oriented, recall routines, and travel in unfamiliar areas in a
      way relying on limited cognitive capacity. While people without disabilities
      often use maps or written directions as navigation tools or for remaining
      oriented, this cognitively-impaired population is very sensitive to issues of
      abstraction (e.g. icons on maps or signage) and presents the designer with a
      challenge to tailor navigation information specific to each user and context.
      Methods: This paper describes an approach to providing distributed cognition
      support of travel guidance for persons with cognitive disabilities. A solution is
      proposed based on passive near-field RFID tags and scanning PDAs. A prototype is 
      built and tested in field experiments with real subjects. The unique strength of 
      the system is the ability to provide unique-to-the-user prompts that are
      triggered by context. The key to the approach is to spread the context awareness 
      across the system, with the context being flagged by the RFID tags and the
      appropriate response being evoked by displaying the appropriate path guidance
      images indexed by the intersection of specific end-user and context ID embedded
      in RFID tags. Results: We found that passive RFIDs generally served as good
      context for triggering navigation prompts, although individual differences in
      effectiveness varied. The results of controlled experiments provided more
      evidence with regard to applicabilities of the proposed autonomous indoor
      wayfinding method. Conclusions: Our findings suggest that the ability to adapt
      indoor wayfinding devices for appropriate timing of directions and standing
      orientation will be particularly important.
FAU - Chang, Yao-Jen
AU  - Chang YJ
AD  - Department of Electronic Engineering, Chung Yuan Christian University, Taiwan
FAU - Peng, Shu-Ming
AU  - Peng SM
AD  - Department of Electronic Engineering, Chung Yuan Christian University, Taiwan
FAU - Wang, Tsen-Yung
AU  - Wang TY
AD  - Institute of Health and Welfare Policy, National Yang Ming University, Taiwan
FAU - Chen, Shu-Fang
AU  - Chen SF
AD  - Center for Occupational Therapy, Taipei Municipal Hospital, Taiwan
FAU - Chen, Yan-Ru
AU  - Chen YR
AD  - Department of Electronic Engineering, Chung Yuan Christian University, Taiwan
FAU - Chen, Hung-Chi
AU  - Chen HC
AD  - Department of Electronic Engineering, Chung Yuan Christian University, Taiwan
LA  - eng
PT  - Journal Article
DEP - 20100914
PHST- 2010/03/28 [received]
PHST- 2010/09/14 [accepted]
TA  - J Neuroeng Rehabil
JT  - Journal of NeuroEngineering and Rehabilitation
AID - 1743-0003-7-45 [pii]
AID - 10.1186/1743-0003-7-45 [doi]
SO  - J Neuroeng Rehabil. 2010 Sep 14;7:45. doi:10.1186/1743-0003-7-45.

PMC - PMC2897097
PMID- 20196291
IS  - 0018-7208 (Print)
VI  - 51
IP  - 5
DP  - 2009 Oct
TI  - The Effect of Active Versus Passive Training Strategies on Improving Older
      Drivers’ Scanning in Intersections.
PG  - 652-68
AB  - Objective: This study aimed (a) to determine whether older drivers looked less
      often for potential threats while turning than younger drivers and (b) to compare
      the effectiveness of active and passive training on older drivers’ performance
      and evaluation of their driving skills in intersections. Background: Age-related 
      declines in vision, physical abilities, psychomotor coordination, and cognition
      combine to make it less likely that older drivers will look for potential threats
      during a turn. Research suggests that active training should be an effective
      means of improving older drivers’ performance and self-awareness. Method: In
      Experiment 1, younger and older participants drove a series of virtual
      intersection scenarios, were shown video replays, and were provided feedback. In 
      Experiment 2, older drivers were assigned to one of three cohorts: active
      simulator training, passive classroom training, or no training. Pre- and
      posttraining simulator and field drives assessed training effectiveness. Results:
      In Experiment 1, older drivers looked less often during turns than younger
      drivers. Customized feedback was successful in altering drivers’ perception of
      their abilities. In Experiment 2, active training increased a driver’s
      probability of looking for a threat during a turn by nearly 100% in both
      posttraining simulator and field drives. Those receiving passive training or no
      training showed no improvement. Conclusion: Compared with passive training,
      active training is a more effective strategy for increasing older drivers’
      likelihood of looking for threats during a turn. Application: The results of this
      research can guide the development of programs that could reduce intersection
      crashes among older drivers.
FAU - Romoser, Matthew R. E.
AU  - Romoser MRE
FAU - Fisher, Donald L.
AU  - Fisher DL
LA  - eng
PT  - Journal Article
TA  - Hum Factors
JT  - Human factors
MID - NIHMS212430
SO  - Hum Factors. 2009 Oct;51(5):652-68.

PMC - PMC3031991
PMID- 21441977
IS  - 1662-5161 (Electronic)
VI  - 5
DP  - 2011
TI  - Functional Imaging Reveals Movement Preparatory Activity in the Vegetative State.
LID - 5
AB  - The vegetative state (VS) is characterized by the absence of awareness of self or
      the environment and preserved autonomic functions. The diagnosis relies
      critically on the lack of consistent signs of purposeful behavior in response to 
      external stimulation. Yet, given that patients with disorders of consciousness
      often exhibit fragmented movement patterns, voluntary actions may go unnoticed.
      Here we designed a simple motor paradigm that could potentially detect signs of
      purposeful behavior in VS patients with mild to severe brain damage by examining 
      the neural correlates of motor preparation in response to verbal commands.
      Twenty-four patients who met the diagnostic criteria for VS were recruited for
      this study. Eleven of these patients showing preserved auditory evoked potentials
      underwent functional magnetic resonance imaging (fMRI) to test for basic speech
      processing. Five of these patients, who showed word related activity, were
      included in a second fMRI study aimed at detecting functional changes in premotor
      cortex elicited by specific verbal instructions to move either their left or
      their right hand. Despite the lack of overt muscle activity, two patients out of 
      five activated the dorsal premotor cortex contralateral to the instructed hand,
      consistent with movement preparation. Our results may reflect residual voluntary 
      processing in these two patients. We believe that the identification of positive 
      results with fMRI using this simple task, may complement the clinical assessment 
      by helping attain a more precise diagnosis in patients with disorders of
      consciousness.
FAU - Bekinschtein, Tristan Andres
AU  - Bekinschtein TA
AD  - Institute of Cognitive NeurologyBuenos Aires, Argentina
FAU - Manes, Facundo Francisco
AU  - Manes FF
AD  - Institute of Cognitive NeurologyBuenos Aires, Argentina
FAU - Villarreal, Mirta
AU  - Villarreal M
AD  - Raúl Carrea Institute for Neurological ResearchBuenos Aires, Argentina
FAU - Owen, Adrian Mark
AU  - Owen AM
AD  - Impaired Consciousness Research Group, Addenbrooke's Hospital, University of
      CambridgeCambridge, UK
FAU - Della-Maggiore, Valeria
AU  - Della-Maggiore V
AD  - Department of Physiology, School of Medicine, University of Buenos AiresBuenos
      Aires, Argentina
LA  - eng
PT  - Journal Article
DEP - 20110127
PHST- 2009/11/23 [received]
PHST- 2011/01/08 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2011.00005 [doi]
SO  - Front Hum Neurosci. 2011 Jan 27;5:. doi:10.3389/fnhum.2011.00005.

PMC - PMC2798987
IS  - 0342-4642 (Print)
IS  - 1432-1238 (Electronic)
VI  - 34
IP  - Suppl 1
DP  - 2008 Sep
TI  - 21st ESICM Annual Congress.
PG  - 5-92
LA  - eng
PT  - Journal Article
DEP - 20080808
TA  - Intensive Care Med
JT  - Intensive Care Medicine
AID - 1239 [pii]
AID - 10.1007/s00134-008-1239-9 [doi]
SO  - Intensive Care Med. 2008 Sep;34(Suppl 1):5-92. Epub 2008 Aug 8
      doi:10.1007/s00134-008-1239-9.

PMC - PMC5165015
PMID- 27868168
IS  - 2197-1714 (Electronic)
VI  - 3
DP  - 2016 Dec
TI  - Use, perceptions, and benefits of automotive technologies among aging drivers.
LID - 28
AB  - Advanced in-vehicle technologies have been proposed as a potential way to keep
      older adults driving for as long as they can safely do so, by taking into account
      the common declines in functional abilities experienced by older adults. The
      purpose of this report was to synthesize the knowledge about older drivers and
      advanced in-vehicle technologies, focusing on three areas: use (how older drivers
      use these technologies), perception (what they think about the technologies), and
      outcomes (the safety and/or comfort benefits of the technologies). Twelve
      technologies were selected for review and grouped into three categories: crash
      avoidance systems (lane departure warning, curve speed warning, forward collision
      warning, blind spot warning, parking assistance); in-vehicle information systems 
      (navigation assistance, intelligent speed adaptation); and other systems
      (adaptive cruise control, automatic crash notification, night vision enhancement,
      adaptive headlight, voice activated control). A comprehensive and systematic
      search was conducted for each technology to collect related publications. 271
      articles were included into the final review. Research findings for each of the
      12 technologies are synthesized in relation to how older adults use and think
      about the technologies as well as potential benefits. These results are presented
      separately for each technology. Can advanced in-vehicle technologies help extend 
      the period over which an older adult can drive safely? This report answers this
      question with an optimistic “yes.” Some of the technologies reviewed in this
      report have been shown to help older drivers avoid crashes, improve the ease and 
      comfort of driving, and travel to places and at times that they might normally
      avoid.
FAU - Eby, David W.
AU  - Eby DW
AD  - University of Michigan Transportation Research Institute (UMTRI), 2901 Baxter
      Rd., Ann Arbor, MI 48109 USA
FAU - Molnar, Lisa J.
AU  - Molnar LJ
AD  - University of Michigan Transportation Research Institute (UMTRI), 2901 Baxter
      Rd., Ann Arbor, MI 48109 USA
FAU - Zhang, Liang
AU  - Zhang L
AD  - University of Michigan Transportation Research Institute (UMTRI), 2901 Baxter
      Rd., Ann Arbor, MI 48109 USA
FAU - St. Louis, Renée M.
AU  - St. Louis RM
AD  - University of Michigan Transportation Research Institute (UMTRI), 2901 Baxter
      Rd., Ann Arbor, MI 48109 USA
FAU - Zanier, Nicole
AU  - Zanier N
AD  - University of Michigan Transportation Research Institute (UMTRI), 2901 Baxter
      Rd., Ann Arbor, MI 48109 USA
FAU - Kostyniuk, Lidia P.
AU  - Kostyniuk LP
AD  - University of Michigan Transportation Research Institute (UMTRI), 2901 Baxter
      Rd., Ann Arbor, MI 48109 USA
FAU - Stanciu, Sergiu
AU  - Stanciu S
AD  - University of Michigan Transportation Research Institute (UMTRI), 2901 Baxter
      Rd., Ann Arbor, MI 48109 USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20161219
PHST- 2016/08/25 [received]
PHST- 2016/11/02 [accepted]
TA  - Inj Epidemiol
JT  - Injury Epidemiology
AID - 93 [pii]
AID - 10.1186/s40621-016-0093-4 [doi]
SO  - Inj Epidemiol. 2016 Dec 19;3:. doi:10.1186/s40621-016-0093-4.

PMC - PMC1892584
PMID- 16216535
IS  - 1053-8119 (Print)
VI  - 29
IP  - 4
DP  - 2006 Feb 15
TI  - Mapping Cerebral Blood Flow Changes During Auditory-Cued Conditioned Fear in the 
      Nontethered, Nonrestrained Rat.
PG  - 1344-58
AB  - Conditioned fear (CF) is one of the most frequently used behavioral paradigms;
      however, little work has mapped changes in cerebral perfusion during CF in the
      rat—the species which has dominated CF research. Adult rats carrying an implanted
      minipump were exposed to a tone (controls, n = 8) or a tone conditioned in
      association with footshocks (CS group, n = 9). During reexposure to the tone 24 h
      later, animals were injected intravenously by remote activation with
      [14C]-iodoantipyrine using the pump. Significant group differences in regional
      CBF-related tissue radioactivity (CBF-TR) were determined by region-of-interest
      analysis of brain autoradiographs, as well as in the reconstructed,
      three-dimensional brain by statistical parametric mapping (SPM). CS animals
      demonstrated significantly greater, fear-enhanced increases in CBF-TR in auditory
      cortex than controls. The lateral amygdala was activated, whereas the
      basolateral/basomedial and central amygdala were deactivated. In the hippocampus 
      and medial prefrontal cortex, CBF-TR increased significantly ventrally but not
      dorsally. Significant activations were noted in medial striatum and the thalamic 
      midline and intralaminar nuclei. However, the ventrolateral/dorsolateral striatum
      and its afferents from motor and somatosensory cortex were deactivated,
      consistent with the behavioral immobility seen during CF. Significant activations
      were also noted in the lateral septum, periaqueductal gray, and deep
      mesencephalic nucleus/tegmental tract. Our results show that auditory stimuli
      endowed with aversive properties through conditioning result in significant
      redistribution of cerebral perfusion. SPM is a useful tool in the brain mapping
      of complex rodent behaviors, in particular the changes in activation patterns in 
      limbic, thalamic, motor, and cortical circuits during CF.
FAU - Holschneider, D.P.
AU  - Holschneider D
AD  - Department of Psychiatry and the Behavioral Sciences, University of Southern
      California, Keck School of Medicine, Los Angeles, CA 90089-9112, USA
FAU - Yang, J.
AU  - Yang J
AD  - Department of Psychiatry and the Behavioral Sciences, University of Southern
      California, Keck School of Medicine, Los Angeles, CA 90089-9112, USA
FAU - Sadler, T.R.
AU  - Sadler T
AD  - Department of Pathology, University of Southern California, Keck School of
      Medicine, Los Angeles, CA 90089-9112, USA
FAU - Nguyen, P.T.
AU  - Nguyen P
AD  - Department of Psychiatry and the Behavioral Sciences, University of Southern
      California, Keck School of Medicine, Los Angeles, CA 90089-9112, USA
FAU - Givrad, T.K.
AU  - Givrad T
AD  - Department of Biomedical Engineering, University of Southern California School of
      Engineering, Los Angeles, CA 90089-9112, USA
FAU - Maarek, J.-M.I.
AU  - Maarek JM
AD  - Department of Biomedical Engineering, University of Southern California School of
      Engineering, Los Angeles, CA 90089-9112, USA
LA  - eng
PT  - Journal Article
DEP - 20051010
TA  - Neuroimage
JT  - NeuroImage
AID - 10.1016/j.neuroimage.2005.08.038 [doi]
MID - NIHMS22314
SO  - Neuroimage. 2006 Feb 15;29(4):1344-58. Epub 2005 Oct 10
      doi:10.1016/j.neuroimage.2005.08.038.

PMC - PMC3437523
PMID- 22973218
IS  - 1662-5161 (Electronic)
VI  - 6
DP  - 2012
TI  - Intensive training induces longitudinal changes in meditation state-related EEG
      oscillatory activity.
LID - 256
AB  - The capacity to focus one's attention for an extended period of time can be
      increased through training in contemplative practices. However, the cognitive
      processes engaged during meditation that support trait changes in cognition are
      not well characterized. We conducted a longitudinal wait-list controlled study of
      intensive meditation training. Retreat participants practiced focused attention
      (FA) meditation techniques for three months during an initial retreat. Wait-list 
      participants later undertook formally identical training during a second retreat.
      Dense-array scalp-recorded electroencephalogram (EEG) data were collected during 
      6 min of mindfulness of breathing meditation at three assessment points during
      each retreat. Second-order blind source separation, along with a novel
      semi-automatic artifact removal tool (SMART), was used for data preprocessing. We
      observed replicable reductions in meditative state-related beta-band power
      bilaterally over anteriocentral and posterior scalp regions. In addition,
      individual alpha frequency (IAF) decreased across both retreats and in direct
      relation to the amount of meditative practice. These findings provide evidence
      for replicable longitudinal changes in brain oscillatory activity during
      meditation and increase our understanding of the cortical processes engaged
      during meditation that may support long-term improvements in cognition.
FAU - Saggar, Manish
AU  - Saggar M
AD  - Department of Psychiatry and Behavioral Sciences, Stanford UniversityStanford,
      CA, USA
FAU - King, Brandon G.
AU  - King BG
AD  - Department of Psychology, University of CaliforniaDavis, CA, USA
FAU - Zanesco, Anthony P.
AU  - Zanesco AP
AD  - Department of Psychology, University of CaliforniaDavis, CA, USA
FAU - MacLean, Katherine A.
AU  - MacLean KA
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins
      UniversityBaltimore, MD, USA
FAU - Aichele, Stephen R.
AU  - Aichele SR
AD  - Department of Psychology, University of CaliforniaDavis, CA, USA
FAU - Jacobs, Tonya L.
AU  - Jacobs TL
AD  - Center for Mind and Brain, University of CaliforniaDavis, CA, USA
FAU - Bridwell, David A.
AU  - Bridwell DA
AD  - Mind Research NetworkAlbuquerque, NM, USA
FAU - Shaver, Phillip R.
AU  - Shaver PR
AD  - Department of Psychology, University of CaliforniaDavis, CA, USA
FAU - Rosenberg, Erika L.
AU  - Rosenberg EL
AD  - Center for Mind and Brain, University of CaliforniaDavis, CA, USA
FAU - Sahdra, Baljinder K.
AU  - Sahdra BK
AD  - School of Social Sciences and Psychology, University of Western SydneySydney,
      NSW, Australia
FAU - Ferrer, Emilio
AU  - Ferrer E
AD  - Department of Psychology, University of CaliforniaDavis, CA, USA
FAU - Tang, Akaysha C.
AU  - Tang AC
AD  - Department of Psychology, University of New MexicoAlbuquerque, NM, USA
FAU - Mangun, George R.
AU  - Mangun GR
AD  - Department of Psychology, University of CaliforniaDavis, CA, USA
FAU - Wallace, B. Alan
AU  - Wallace BA
AD  - Santa Barbara Institute for Consciousness StudiesSanta Barbara, CA, USA
FAU - Miikkulainen, Risto
AU  - Miikkulainen R
AD  - Department of Computer Science, University of Texas at AustinTX, USA
FAU - Saron, Clifford D.
AU  - Saron CD
AD  - Center for Mind and Brain, University of CaliforniaDavis, CA, USA
LA  - eng
PT  - Journal Article
DEP - 20120910
PHST- 2012/05/17 [received]
PHST- 2012/08/23 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2012.00256 [doi]
SO  - Front Hum Neurosci. 2012 Sep 10;6:. doi:10.3389/fnhum.2012.00256.

PMC - PMC3728850
PMID- 23905030
IS  - 2239-9747 (Print)
IS  - 2239-9747 (Electronic)
VI  - 1
DP  - 2011 Sep-Dec
TI  - Optical Tecnology Developments in Biomedicine: History, Current and Future.
PG  - 51-150
AB  - Biomedical optics is a rapidly emerging field for medical imaging and
      diagnostics. This paper reviews several biomedical optical technologies that have
      been developed and translated for either clinical or pre-clinical applications.
      Specifically, we focus on the following technologies: 1) near-infrared
      spectroscopy and tomography, 2) optical coherence tomography, 3) fluorescence
      spectroscopy and imaging, and 4) optical molecular imaging. There representative 
      biomedical applications are also discussed here.
FAU - Nioka, Shoko
AU  - Nioka S
AD  - Department of Biochemistry and Biophysics, Perelman School of Medicine,
      University of Pennsylvania, Philadelphia, PA 19104 USA - shoko@nioka.net
FAU - Chen, Yu
AU  - Chen Y
AD  - Fischell Department of Bioengineering, University of Maryland, College Park, MD
      20742 USA - yuchen@umd.edu
LA  - eng
PT  - Journal Article
DEP - 20111017
TA  - Transl Med UniSa
JT  - Translational Medicine @ UniSa
AID - tm-01-51 [pii]
SO  - Transl Med UniSa. 2011 Oct 17;1:51-150.

PMC - PMC3436123
PMID- 22885073
IS  - 0001-6918 (Print)
IS  - 1873-6297 (Electronic)
VI  - 141
IP  - 1
DP  - 2012 Sep
TI  - The Role of Spatial Memory and Frames of Reference in the Precision of Angular
      Path Integration.
PG  - 112-21
AB  - Angular path integration refers to the ability to maintain an estimate of
      self-location after a rotational displacement by integrating internally-generated
      (idiothetic) self-motion signals over time. Previous work has found that
      non-sensory inputs, namely spatial memory, can play a powerful role in angular
      path integration (Arthur et al., 2007, 2009). Here we investigated the conditions
      under which spatial memory facilitates angular path integration. We hypothesized 
      that the benefit of spatial memory is particularly likely in spatial updating
      tasks in which one’s self-location estimate is referenced to external space. To
      test this idea, we administered passive, nonvisual body rotations (ranging 40° – 
      140°) about the yaw axis and asked participants to use verbal reports or
      open-loop manual pointing to indicate the magnitude of the rotation. Prior to
      some trials, previews of the surrounding environment were given. We found that
      when participants adopted an egocentric frame of reference, the
      previously-observed benefit of previews on within-subject response precision was 
      not manifested, regardless of whether remembered spatial frameworks were derived 
      from vision or spatial language. We conclude that the powerful effect of spatial 
      memory is dependent on one’s frame of reference during self-motion updating.
FAU - Arthur, Joeanna C.
AU  - Arthur JC
AD  - Department of Psychology, The George Washington University, Department of
      Psychology, Washington, DC 20052
FAU - Philbeck, John W.
AU  - Philbeck JW
AD  - Department of Psychology, The George Washington University, Department of
      Psychology, Washington, DC 20052
FAU - Kleene, Nicholas J.
AU  - Kleene NJ
AD  - Department of Psychology, The George Washington University, Department of
      Psychology, Washington, DC 20052
FAU - Chichka, David
AU  - Chichka D
AD  - Department of Mechanical and Aerospace Engineering, The George Washington
      University, Department of Psychology, Washington, DC 20052
LA  - eng
PT  - Journal Article
DEP - 20120809
TA  - Acta Psychol (Amst)
JT  - Acta psychologica
AID - 10.1016/j.actpsy.2012.07.003 [doi]
MID - NIHMS400031
SO  - Acta Psychol (Amst). 2012 Sep;141(1):112-21. Epub 2012 Aug 09
      doi:10.1016/j.actpsy.2012.07.003.

PMC - PMC3799852
PMID- 24204597
IS  - 1932-6203 (Electronic)
VI  - 8
IP  - 10
DP  - 2013
TI  - Prediction of P300 BCI Aptitude in Severe Motor Impairment.
LID - e76148
AB  - Brain-computer interfaces (BCIs) provide a non-muscular communication channel for
      persons with severe motor impairments. Previous studies have shown that the
      aptitude with which a BCI can be controlled varies from person to person. A
      reliable predictor of performance could facilitate selection of a suitable BCI
      paradigm. Eleven severely motor impaired participants performed three sessions of
      a P300 BCI web browsing task. Before each session auditory oddball data were
      collected to predict the BCI aptitude of the participants exhibited in the
      current session. We found a strong relationship of early positive and negative
      potentials around 200 ms (elicited with the auditory oddball task) with
      performance. The amplitude of the P2 (r  =  −0.77) and of the N2 (r  =  −0.86)
      had the strongest correlations. Aptitude prediction using an auditory oddball was
      successful. The finding that the N2 amplitude is a stronger predictor of
      performance than P3 amplitude was reproduced after initially showing this effect 
      with a healthy sample of BCI users. This will reduce strain on the end-users by
      minimizing the time needed to find suitable paradigms and inspire new approaches 
      to improve performance.
FAU - Halder, Sebastian
AU  - Halder S
AD  - Institute of Psychology, University of Würzburg, Würzburg, Germany
FAU - Ruf, Carolin Anne
AU  - Ruf CA
AD  - Institute of Medical Psychology and Behavioral Neurobiology, University of
      Tübingen, Tübingen, Germany
FAU - Furdea, Adrian
AU  - Furdea A
AD  - Institute of Medical Psychology and Behavioral Neurobiology, University of
      Tübingen, Tübingen, Germany
FAU - Pasqualotto, Emanuele
AU  - Pasqualotto E
AD  - Psychological Sciences Research Institute, Université catholique de Louvain,
      Louvain-la-neuve, Belgium
FAU - De Massari, Daniele
AU  - De Massari D
AD  - Institute of Medical Psychology and Behavioral Neurobiology, University of
      Tübingen, Tübingen, Germany
FAU - van der Heiden, Linda
AU  - van der Heiden L
AD  - Institute of Medical Psychology and Behavioral Neurobiology, University of
      Tübingen, Tübingen, Germany
FAU - Bogdan, Martin
AU  - Bogdan M
AD  - Department of Computer Engineering, University of Tübingen, Tübingen, Germany
FAU - Rosenstiel, Wolfgang
AU  - Rosenstiel W
AD  - Department of Computer Engineering, University of Tübingen, Tübingen, Germany
FAU - Birbaumer, Niels
AU  - Birbaumer N
AD  - Institute of Medical Psychology and Behavioral Neurobiology, University of
      Tübingen, Tübingen, Germany
FAU - Kübler, Andrea
AU  - Kübler A
AD  - Institute of Psychology, University of Würzburg, Würzburg, Germany
FAU - Matuz, Tamara
AU  - Matuz T
AD  - Institute of Medical Psychology and Behavioral Neurobiology, University of
      Tübingen, Tübingen, Germany
LA  - eng
PT  - Journal Article
DEP - 20131018
PHST- 2013/06/17 [received]
PHST- 2013/08/20 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-13-25090 [pii]
AID - 10.1371/journal.pone.0076148 [doi]
SO  - PLoS One. 2013 Oct 18;8(10):. doi:10.1371/journal.pone.0076148.

PMC - PMC3073348
PMID- 18573323
IS  - 0378-5955 (Print)
IS  - 1878-5891 (Electronic)
VI  - 242
IP  - 1-2
DP  - 2008 Aug
TI  - Localized Cell and Drug Delivery for Auditory Prostheses.
PG  - 117-31
AB  - Localized cell and drug delivery to the cochlea and central auditory pathway can 
      improve the safety and performance of implanted auditory prostheses (APs). While 
      generally successful, these devices have a number of limitations and adverse
      effects including limited tonal and dynamic ranges, channel interactions,
      unwanted stimulation of non-auditory nerves, immune rejection, and infections
      including meningitis. Many of these limitations are associated with the tissue
      reactions to implanted auditory prosthetic devices and the gradual degeneration
      of the auditory system following deafness. Strategies to reduce the insertion
      trauma, degeneration of target neurons, fibrous and bony tissue encapsulation,
      and immune activation can improve the viability of tissue required for AP
      function as well as improve the resolution of stimulation for reduced channel
      interaction and improved place-pitch and level discrimination. Many
      pharmaceutical compounds have been identified that promote the viability of
      auditory tissue and prevent inflammation and infection. Cell delivery and gene
      therapy have provided promising results for treating hearing loss and reversing
      degeneration. Currently, many clinical and experimental methods can produce
      extremely localized and sustained drug delivery to address AP limitations. These 
      methods provide better control over drug concentrations while eliminating the
      adverse effects of systemic delivery. Many of these drug delivery techniques can 
      be integrated into modern auditory prosthetic devices to optimize the tissue
      response to the implanted device and reduce the risk of infection or rejection.
      Together, these methods and pharmaceutical agents can be used to optimize the
      tissue-device interface for improved AP safety and effectiveness.
FAU - Hendricks, Jeffrey L.
AU  - Hendricks JL
AD  - Department of Biomedical Engineering, The University of Michigan, 1107 Gerstacker
      Bldg., 2200 Bonisteel Blvd., Ann Arbor, MI, 48109-2099 USA
FAU - Chikar, Jennifer A.
AU  - Chikar JA
AD  - Neuroscience Program, The University of Michigan, 4137 Undergraduate Research
      Bldg., 204 Washtenaw Ave., Ann Arbor, MI, 48109-2215 USA
FAU - Crumling, Mark A.
AU  - Crumling MA
AD  - Department of Otolaryngology, Kresge Hearing Research Institute, The University
      of Michigan Medical School, MSRB-3 Rm. 9301, Ann Arbor, MI, 48109-5648 USA
FAU - Raphael, Yehoash
AU  - Raphael Y
AD  - Neuroscience Program, The University of Michigan, 4137 Undergraduate Research
      Bldg., 204 Washtenaw Ave., Ann Arbor, MI, 48109-2215 USA
FAU - Martin, David C.
AU  - Martin DC
AD  - Department of Biomedical Engineering, The University of Michigan, 1107 Gerstacker
      Bldg., 2200 Bonisteel Blvd., Ann Arbor, MI, 48109-2099 USA
LA  - eng
PT  - Journal Article
DEP - 20080607
TA  - Hear Res
JT  - Hearing research
AID - 10.1016/j.heares.2008.06.003 [doi]
MID - NIHMS66686
SO  - Hear Res. 2008 Aug;242(1-2):117-31. Epub 2008 Jun 7
      doi:10.1016/j.heares.2008.06.003.

PMC - PMC5119052
PMID- 27920671
IS  - 1662-5145 (Electronic)
VI  - 10
DP  - 2016
TI  - Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: A Review of
      Emerging Issues and Technologies.
LID - 38
AB  - This paper provides an overview of current progress in the technological advances
      and the use of deep brain stimulation (DBS) to treat neurological and
      neuropsychiatric disorders, as presented by participants of the Fourth Annual DBS
      Think Tank, which was convened in March 2016 in conjunction with the Center for
      Movement Disorders and Neurorestoration at the University of Florida,
      Gainesveille FL, USA. The Think Tank discussions first focused on policy and
      advocacy in DBS research and clinical practice, formation of registries, and
      issues involving the use of DBS in the treatment of Tourette Syndrome. Next,
      advances in the use of neuroimaging and electrochemical markers to enhance DBS
      specificity were addressed. Updates on ongoing use and developments of DBS for
      the treatment of Parkinson's disease, essential tremor, Alzheimer's disease,
      depression, post-traumatic stress disorder, obesity, addiction were presented,
      and progress toward innovation(s) in closed-loop applications were discussed.
      Each section of these proceedings provides updates and highlights of new
      information as presented at this year's international Think Tank, with a view
      toward current and near future advancement of the field.
FAU - Deeb, Wissam
AU  - Deeb W
AD  - Department of Neurology, Center for Movement Disorders and Neurorestoration,
      University of FloridaGainesville, FL, USA
FAU - Giordano, James J.
AU  - Giordano JJ
AD  - Department of Neurology, and Neuroethics Studies Program, Pellegrino Center for
      Clinical Bioethics, Georgetown University Medical CenterWashington, DC, USA
FAU - Rossi, Peter J.
AU  - Rossi PJ
AD  - Department of Neurology, Center for Movement Disorders and Neurorestoration,
      University of FloridaGainesville, FL, USA
FAU - Mogilner, Alon Y.
AU  - Mogilner AY
AD  - Department of Neurosurgery, Center for Neuromodulation, New York University
      Langone Medical CenterNew York, NY, USA
FAU - Gunduz, Aysegul
AU  - Gunduz A
AD  - Department of Neurology, Center for Movement Disorders and Neurorestoration,
      University of FloridaGainesville, FL, USA
FAU - Judy, Jack W.
AU  - Judy JW
AD  - Department of Neurology, Center for Movement Disorders and Neurorestoration,
      University of FloridaGainesville, FL, USA
FAU - Klassen, Bryan T.
AU  - Klassen BT
AD  - Department of Neurology, Mayo ClinicRochester, MN, USA
FAU - Butson, Christopher R.
AU  - Butson CR
AD  - Department of Bioengineering, Scientific Computing and Imaging Institute,
      University of UtahSalt Lake City, UT, USA
FAU - Van Horne, Craig
AU  - Van Horne C
AD  - Department of Neurosurgery, University of Kentucky Chandler Medical
      CenterLexington, KY, USA
FAU - Deny, Damiaan
AU  - Deny D
AD  - Department of Psychiatry, Academic Medical Center, University of
      AmsterdamAmsterdam, Netherlands
FAU - Dougherty, Darin D.
AU  - Dougherty DD
AD  - Department of Psychiatry, Massachusetts General HospitalBoston, MA, USA
FAU - Rowell, David
AU  - Rowell D
AD  - Asia Pacific Centre for Neuromodulation, Queensland Brain Institute, The
      University of QueenslandBrisbane, QLD, Australia
FAU - Gerhardt, Greg A.
AU  - Gerhardt GA
AD  - Department of Anatomy and Neurobiology, University of Kentucky Chandler Medical
      CenterLexington, KY, USA
FAU - Smith, Gwenn S.
AU  - Smith GS
AD  - Departments of Psychiatry and Behavioral Sciences and Radiology and Radiological 
      Sciences, Johns Hopkins University School of MedicineBaltimore, MD, USA
FAU - Ponce, Francisco A.
AU  - Ponce FA
AD  - Division of Neurological Surgery, Barrow Neurological Institute, St. Joseph's
      Hospital and Medical Center PhoenixArizona, AZ, USA
FAU - Walker, Harrison C.
AU  - Walker HC
AD  - Department of Neurology and Department of Biomedical Engineering, University of
      Alabama at BirminghamBirmingham, AL, USA
FAU - Bronte-Stewart, Helen M.
AU  - Bronte-Stewart HM
AD  - Departments of Neurology and Neurological Sciences and Neurosurgery, Stanford
      UniversityStanford, CA, USA
FAU - Mayberg, Helen S.
AU  - Mayberg HS
AD  - Department of Psychiatry, Emory University School of MedicineAtlanta, GA, USA
FAU - Chizeck, Howard J.
AU  - Chizeck HJ
AD  - Electrical Engineering Department, University of WashingtonSeattle, WA, USA
FAU - Langevin, Jean-Philippe
AU  - Langevin JP
AD  - Department of Neurosurgery, VA Greater Los Angeles Healthcare SystemLos Angeles, 
      CA, USA
FAU - Volkmann, Jens
AU  - Volkmann J
AD  - Department of Neurology, University Clinic of WürzburgWürzburg, Germany
FAU - Ostrem, Jill L.
AU  - Ostrem JL
AD  - Department of Neurology, University of California San FranciscoSan Francisco, CA,
      USA
FAU - Shute, Jonathan B.
AU  - Shute JB
AD  - J. Crayton Pruitt Family Department of Biomedical Engineering, University of
      FloridaGainesville, FL, USA
FAU - Jimenez-Shahed, Joohi
AU  - Jimenez-Shahed J
AD  - Department of Neurology, Baylor College of MedicineHouston, TX, USA
FAU - Foote, Kelly D.
AU  - Foote KD
AD  - Department of Neurology, Center for Movement Disorders and Neurorestoration,
      University of FloridaGainesville, FL, USA
FAU - Wagle Shukla, Aparna
AU  - Wagle Shukla A
AD  - Department of Neurology, Center for Movement Disorders and Neurorestoration,
      University of FloridaGainesville, FL, USA
FAU - Rossi, Marvin A.
AU  - Rossi MA
AD  - Departments of Neurological Sciences, Diagnostic Radiology, and Nuclear Medicine,
      Rush University Medical CenterChicago, IL, USA
FAU - Oh, Michael
AU  - Oh M
AD  - Division of Functional Neurosurgery, Department of Neurosurgery, Allegheny
      General HospitalPittsburgh, PA, USA
FAU - Pourfar, Michael
AU  - Pourfar M
AD  - Department of Neurology, New York University Langone Medical CenterNew York, NY, 
      USA
FAU - Rosenberg, Paul B.
AU  - Rosenberg PB
AD  - Psychiatry and Behavioral Sciences, Johns Hopkins Bayview Medical Center, Johns
      Hopkins School of MedicineBaltimore, MD, USA
FAU - Silburn, Peter A.
AU  - Silburn PA
AD  - Asia Pacific Centre for Neuromodulation, Queensland Brain Institute, The
      University of QueenslandBrisbane, QLD, Australia
FAU - de Hemptine, Coralie
AU  - de Hemptine C
AD  - Graduate Program in Neuroscience, Department of Neurological Surgery, Kavli
      Institute for Fundamental Neuroscience, University of California, San
      FranciscoSan Francisco, CA, USA
FAU - Starr, Philip A.
AU  - Starr PA
AD  - Graduate Program in Neuroscience, Department of Neurological Surgery, Kavli
      Institute for Fundamental Neuroscience, University of California, San
      FranciscoSan Francisco, CA, USA
FAU - Denison, Timothy
AU  - Denison T
AD  - Medtronic ModulationMinneapolis, MN, USA
FAU - Akbar, Umer
AU  - Akbar U
AD  - Movement Disorders Program, Department of Neurology, Alpert Medical School, Rhode
      Island Hospital, Brown UniversityProvidence, RI, USA
FAU - Grill, Warren M.
AU  - Grill WM
AD  - Department of Biomedical Engineering, Duke UniversityDurham, NC, USA
FAU - Okun, Michael S.
AU  - Okun MS
AD  - Department of Neurology, Center for Movement Disorders and Neurorestoration,
      University of FloridaGainesville, FL, USA
LA  - eng
PT  - Journal Article
DEP - 20161122
GR  - R01 NR014852
PHST- 2016/05/23 [received]
PHST- 2016/11/01 [accepted]
TA  - Front Integr Neurosci
JT  - Frontiers in Integrative Neuroscience
AID - 10.3389/fnint.2016.00038 [doi]
SO  - Front Integr Neurosci. 2016 Nov 22;10:. doi:10.3389/fnint.2016.00038.

PMC - PMC2882655
PMID- 20543997
IS  - 0268-7038 (Print)
VI  - 24
IP  - 4
DP  - 2010
TI  - IMITATE: An intensive computer-based treatment for aphasia based on action
      observation and imitation.
PG  - 449-65
AB  - Background: Neurophysiological evidence from primates has demonstrated the
      presence of mirror neurons, with visual and motor properties, that discharge both
      when an action is performed and during observation of the same action. A similar 
      system for observation-execution matching may also exist in humans. We postulate 
      that behavioral stimulation of this parietal-frontal system may play an important
      role in motor learning for speech and thereby aid language recovery after stroke.
      Aims: The purpose of this article is to describe the development of IMITATE, a
      computer-assisted system for aphasia therapy based on action observation and
      imitation. We also describe briefly the randomized controlled clinical trial that
      is currently underway to evaluate its efficacy and mechanism of action. Methods
      and Procedures: IMITATE therapy consists of silent observation of audio-visually 
      presented words and phrases spoken aloud by six different speakers, followed by a
      period during which the participant orally repeats the stimuli. We describe the
      rationale for the therapeutic features, stimulus selection, and delineation of
      treatment levels.The clinical trial is a randomized single blind controlled trial
      in which participants receive two pre-treatment baseline assessments, six weeks
      apart, followed by either IMITATE or a control therapy. Both treatments are
      provided intensively (90 minutes per day). Treatment is followed by a
      post-treatment assessment, and a six-week follow-up assessment. Outcomes &
      Results: Thus far, five participants have completed IMITATE. We expect the
      results of the randomized controlled trial to be available by late 2010.
      Conclusions: IMITATE is a novel computer-assisted treatment for aphasia that is
      supported by theoretical rationales and previous human and primate data from
      neurobiology. The treatment is feasible, and preliminary behavioral data are
      emerging. However, the results will not be known until the clinical trial data
      are available to evaluate fully the efficacy of IMITATE and to inform
      theoretically about the mechanism of action and the role of a human mirror system
      in aphasia treatment.
FAU - Lee, Jaime
AU  - Lee J
AD  - Center for Aphasia Research and Treatment, Rehabilitation Institute of Chicago
FAU - Fowler, Robert
AU  - Fowler R
AD  - Department of Neurology, The University of Chicago
FAU - Rodney, Daniel
AU  - Rodney D
AD  - Department of Neurology, The University of Chicago
FAU - Cherney, Leora
AU  - Cherney L
AD  - Center for Aphasia Research and Treatment, Rehabilitation Institute of Chicago
FAU - Small, Steven L.
AU  - Small SL
AD  - Department of Neurology, The University of Chicago
LA  - eng
PT  - Journal Article
TA  - Aphasiology
JT  - Aphasiology
AID - 10.1080/02687030802714157 [doi]
MID - NIHMS107202
SO  - Aphasiology. 2010;24(4):449-65. doi:10.1080/02687030802714157.

PMC - PMC5447290
PMID- 28611610
IS  - 1662-5161 (Electronic)
VI  - 11
DP  - 2017
TI  - Music Games: Potential Application and Considerations for Rhythmic Training.
LID - 273
AB  - Rhythmic skills are natural and widespread in the general population. The
      majority can track the beat of music and move along with it. These abilities are 
      meaningful from a cognitive standpoint given their tight links with prominent
      motor and cognitive functions such as language and memory. When rhythmic skills
      are challenged by brain damage or neurodevelopmental disorders, remediation
      strategies based on rhythm can be considered. For example, rhythmic training can 
      be used to improve motor performance (e.g., gait) as well as cognitive and
      language skills. Here, we review the games readily available in the market and
      assess whether they are well-suited for rhythmic training. Games that train
      rhythm skills may serve as useful tools for retraining motor and cognitive
      functions in patients with motor or neurodevelopmental disorders (e.g.,
      Parkinson’s disease, dyslexia, or ADHD). Our criteria were the peripheral used to
      capture and record the response, the type of response and the output measure.
      None of the existing games provides sufficient temporal precision in stimulus
      presentation and/or data acquisition. In addition, games do not train selectively
      rhythmic skills. Hence, the available music games, in their present form, are not
      satisfying for training rhythmic skills. Yet, some features such as the device
      used, the interface or the game scenario provide good indications for devising
      efficient training protocols. Guidelines are provided for devising serious music 
      games targeting rhythmic training in the future.
FAU - Bégel, Valentin
AU  - Bégel V
AD  - Euromov Laboratory, University of MontpellierMontpellier, France
FAU - Di Loreto, Ines
AU  - Di Loreto I
AD  - Homme, Environnement et Technologies de l’Information, Université de Technologie 
      de TroyesTroyes, France
FAU - Seilles, Antoine
AU  - Seilles A
AD  - NaturalPadMontpellier, France
FAU - Dalla Bella, Simone
AU  - Dalla Bella S
AD  - Euromov Laboratory, University of MontpellierMontpellier, France
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170529
PHST- 2016/10/15 [received]
PHST- 2017/05/08 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2017.00273 [doi]
SO  - Front Hum Neurosci. 2017 May 29;11:. doi:10.3389/fnhum.2017.00273.

PMC - PMC4380878
PMID- 25708374
IS  - 2040-2295 (Print)
IS  - 2040-2309 (Electronic)
VI  - 6
IP  - 1
DP  - 2015
TI  - An Exploratory Study on a Chest-Worn Computer for Evaluation of Diet, Physical
      Activity and Lifestyle.
PG  - 1-22
AB  - Recently, wearable computers have become new members in the family of mobile
      electronic devices, adding new functions to those provided by smartphones and
      tablets. As “always-on” miniature computers in the personal space, they will play
      increasing roles in the field of healthcare. In this work, we present our
      development of eButton, a wearable computer designed as a personalized,
      attractive, and convenient chest pin in a circular shape. It contains a powerful 
      microprocessor, numerous electronic sensors, and wireless communication links. We
      describe its design concepts, electronic hardware, data processing algorithms,
      and its applications to the evaluation of diet, physical activity and lifestyle
      in the study of obesity and other chronic diseases.
FAU - Sun, Mingui
AU  - Sun M
AD  - Department of Neurosurgery, University of Pittsburgh, Pittsburgh, PA, USA
FAU - Burke, Lora E.
AU  - Burke LE
AD  - Department of Health and Community Systems, University of Pittsburgh, Pittsburgh,
      PA, USA
FAU - Baranowski, Thomas
AU  - Baranowski T
AD  - Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
FAU - Fernstrom, John D.
AU  - Fernstrom JD
AD  - Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
FAU - Zhang, Hong
AU  - Zhang H
AD  - Center for Image Processing, Beihang University, Beijing, China
FAU - Chen, Hsin-Chen
AU  - Chen HC
AD  - Department of Neurosurgery, University of Pittsburgh, Pittsburgh, PA, USA
FAU - Bai, Yicheng
AU  - Bai Y
AD  - Department of Electrical and Computer Engineering, University of Pittsburgh,
      Pittsburgh, PA, USA
FAU - Li, Yuecheng
AU  - Li Y
AD  - Department of Neurosurgery, University of Pittsburgh, Pittsburgh, PA, USA
FAU - Li, Chengliu
AU  - Li C
AD  - Department of Electrical and Computer Engineering, University of Pittsburgh,
      Pittsburgh, PA, USA
FAU - Yue, Yaofeng
AU  - Yue Y
AD  - Department of Electrical and Computer Engineering, University of Pittsburgh,
      Pittsburgh, PA, USA
FAU - Li, Zhen
AU  - Li Z
AD  - Department of Neurosurgery, University of Pittsburgh, Pittsburgh, PA, USA
FAU - Nie, Jie
AU  - Nie J
AD  - Department of Neurosurgery, University of Pittsburgh, Pittsburgh, PA, USA
FAU - Sclabassi, Robert J.
AU  - Sclabassi RJ
AD  - Computational Diagnostics, Inc., Pittsburgh, PA, USA
FAU - Mao, Zhi-Hong
AU  - Mao ZH
AD  - Department of Electrical and Computer Engineering, University of Pittsburgh,
      Pittsburgh, PA, USA
FAU - Jia, Wenyan
AU  - Jia W
AD  - Department of Neurosurgery, University of Pittsburgh, Pittsburgh, PA, USA
LA  - eng
PT  - Journal Article
TA  - J Healthc Eng
JT  - Journal of healthcare engineering
AID - 10.1260/2040-2295.6.1.1 [doi]
MID - NIHMS673609
SO  - J Healthc Eng. 2015;6(1):1-22. doi:10.1260/2040-2295.6.1.1.

PMC - PMC3696923
PMID- 23442172
IS  - 2158-0014 (Print)
IS  - 2158-0022 (Electronic)
VI  - 3
IP  - 2
DP  - 2013 Apr
TI  - The Virtual Brain Integrates Computational Modeling and Multimodal Neuroimaging.
PG  - 121-45
AB  - Brain function is thought to emerge from the interactions among neuronal
      populations. Apart from traditional efforts to reproduce brain dynamics from the 
      micro- to macroscopic scales, complementary approaches develop phenomenological
      models of lower complexity. Such macroscopic models typically generate only a few
      selected—ideally functionally relevant—aspects of the brain dynamics.
      Importantly, they often allow an understanding of the underlying mechanisms
      beyond computational reproduction. Adding detail to these models will widen their
      ability to reproduce a broader range of dynamic features of the brain. For
      instance, such models allow for the exploration of consequences of focal and
      distributed pathological changes in the system, enabling us to identify and
      develop approaches to counteract those unfavorable processes. Toward this end,
      The Virtual Brain (TVB) (www.thevirtualbrain.org), a neuroinformatics platform
      with a brain simulator that incorporates a range of neuronal models and dynamics 
      at its core, has been developed. This integrated framework allows the model-based
      simulation, analysis, and inference of neurophysiological mechanisms over several
      brain scales that underlie the generation of macroscopic neuroimaging signals. In
      this article, we describe how TVB works, and we present the first proof of
      concept.
FAU - Ritter, Petra
AU  - Ritter P
AD  - Minerva Research Group Brain Modes, Max Planck Institute for Human Cognitive and 
      Brain Sciences, Leipzig, Germany.
FAU - Schirner, Michael
AU  - Schirner M
AD  - Bernstein Focus State Dependencies of Learning & Bernstein Center for
      Computational Neuroscience, Berlin, Germany.
FAU - McIntosh, Anthony R.
AU  - McIntosh AR
AD  - Rotman Research Institute of Baycrest Centre, University of Toronto, Toronto,
      Canada.
FAU - Jirsa, Viktor K.
AU  - Jirsa VK
AD  - Institut de Neurosciences des Systèmes UMR INSERM 1106, Aix-Marseille Université 
      Faculté de Médecine, Marseille, France.
LA  - eng
PT  - Journal Article
TA  - Brain Connect
JT  - Brain Connectivity
AID - 10.1089/brain.2012.0120 [pii]
AID - 10.1089/brain.2012.0120 [doi]
SO  - Brain Connect. 2013 Apr;3(2):121-45. doi:10.1089/brain.2012.0120.

PMC - PMC1872004
IS  - 1522-8517 (Print)
IS  - 1523-5866 (Electronic)
VI  - 6
IP  - 4
DP  - 2004 Oct
TI  - Abstracts from the Ninth Annual Meeting of the Society for Neuro-Oncology:
      November 18–21, 2004.
PG  - 307-87
LA  - eng
PT  - Journal Article
TA  - Neuro-oncol
JT  - Neuro-Oncology
AID - 10.1215/S1152851704100148 [doi]
AID - neu0604p307 [pii]
SO  - Neuro-oncol. 2004 Oct;6(4):307-87. doi:10.1215/S1152851704100148.

PMC - PMC5014342
PMID- 27603211
IS  - 1932-6203 (Electronic)
VI  - 11
IP  - 9
DP  - 2016
TI  - Use of an Enactive Insole for Reducing the Risk of Falling on Different Types of 
      Soil Using Vibrotactile Cueing for the Elderly.
LID - e0162107
AB  - Background: Our daily activities imply displacements on various types of soil.
      For persons with gait disorder or losing functional autonomy, walking on some
      types of soil could be challenging because of the risk of falling it represents. 
      Methods: In this paper, we present, in a first part, the use of an enactive shoe 
      for an automatic differentiation of several types of soil. In a second part,
      using a second improved prototype (an enactive insole), twelve participants with 
      Parkinson’s disease (PD) and nine age-matched controls have performed the Timed
      Up and Go (TUG) test on six types of soil with and without cueing. The frequency 
      of the cueing was set at 10% above the cadence computed at the lower risk of
      falling (walking over the concrete). Depending on the cadence computed at the
      lower risk, the enactive insole activates a vibrotactile cueing aiming to improve
      gait and balance control. Finally, a risk index is computed using gait parameters
      in relation to given type of soil. Results: The frequency analysis of the heel
      strike vibration allows the differentiation of various types of soil. The risk
      computed is associated to an appropriate rhythmic cueing in order to improve
      balance and gait impairment. The results show that a vibrotactile cueing could
      help to reduce the risk of falling. Conclusions: Firstly, this paper demonstrates
      the feasibility of reducing the risk of falling while walking on different types 
      of soil using vibrotactile cueing. We found a significant difference and a
      significant decrease in the computed risks of falling for most of types of soil
      especially for deformable soils which can lead to fall. Secondly, heel strike
      provides an approximation of the impulse response of the soil that can be
      analyzed with time and frequency-domain modeling. From these analyses, an index
      is computed enabling differentiation the types of soil.
FAU - Otis, Martin J. -D.
AU  - Otis MJ-D
AD  - Department of Applied Sciences, University of Quebec at Chicoutimi (UQAC),
      REPARTI centre, Chicoutimi, Quebec, Canada
FAU - Ayena, Johannes C.
AU  - Ayena JC
AD  - Department of Applied Sciences, University of Quebec at Chicoutimi (UQAC),
      REPARTI centre, Chicoutimi, Quebec, Canada
FAU - Tremblay, Louis E.
AU  - Tremblay LE
AD  - Department of Health Sciences, University of Quebec at Chicoutimi, Chicoutimi,
      Quebec, Canada
FAU - Fortin, Pascal E.
AU  - Fortin PE
AD  - Department of Electrical Engineering and Computer at the Center for intelligent
      machine, McGill University, Montreal, Quebec, Canada
FAU - Ménélas, Bob-Antoine J.
AU  - Ménélas BAJ
AD  - Department of Mathematics and Computer Sciences, University of Quebec at
      Chicoutimi, Chicoutimi, Quebec, Canada
LA  - eng
PT  - Journal Article
DEP - 20160907
GR  - 418235-2012
PHST- 2016/03/24 [received]
PHST- 2016/08/17 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - 10.1371/journal.pone.0162107 [doi]
AID - PONE-D-16-12271 [pii]
SO  - PLoS One. 2016 Sep 7;11(9):. doi:10.1371/journal.pone.0162107.

PMC - PMC5414896
PMID- 28332437
IS  - 1545-9683 (Print)
IS  - 1552-6844 (Electronic)
VI  - 31
IP  - 4
DP  - 2017 Apr
TI  - Rehabilitation Research at the National Institutes of Health: Moving the Field
      Forward (Executive Summary).
PG  - 304-14
FAU - Frontera, Walter R.
AU  - Frontera WR
AD  - Department of Physical Medicine and Rehabilitation, Vanderbilt University Medical
      Center, Nashville, TN, USA
FAU - Bean, Jonathan F.
AU  - Bean JF
AD  - Harvard Medical School, Boston, MA, USA
FAU - Damiano, Diane
AU  - Damiano D
AD  - National Institutes of Health, Bethesda, MD, USA
FAU - Ehrlich-Jones, Linda
AU  - Ehrlich-Jones L
AD  - Northwestern Feinberg Medical School and Rehabilitation Institute of Chicago, IL,
      USA
FAU - Fried-Oken, Melanie
AU  - Fried-Oken M
AD  - Oregon Health & Science University, Portland, OR, USA
FAU - Jette, Alan
AU  - Jette A
AD  - Boston University, MA, USA
FAU - Jung, Ranu
AU  - Jung R
AD  - Florida International University, Miami, FL, USA
FAU - Lieber, Rick L.
AU  - Lieber RL
AD  - Northwestern Feinberg Medical School and Rehabilitation Institute of Chicago, IL,
      USA
FAU - Malec, James F.
AU  - Malec JF
AD  - Indiana University School of Medicine and Rehabilitation Hospital of Indiana,
      Indianapolis, IN, USA
FAU - Mueller, Michael J.
AU  - Mueller MJ
AD  - Washington University School of Medicine, St Louis, MO, USA
FAU - Ottenbacher, Kenneth J.
AU  - Ottenbacher KJ
AD  - University of Texas Medical Branch, Galveston, TX, USA
FAU - Tansey, Keith E.
AU  - Tansey KE
AD  - Jackson Veteran’s Administration Medical Center, MS, USA
FAU - Thompson, Aiko
AU  - Thompson A
AD  - Medical University of South Carolina, Charleston, SC, USA
LA  - eng
PT  - Journal Article
DEP - 20170323
TA  - Neurorehabil Neural Repair
JT  - Neurorehabilitation and Neural Repair
AID - 10.1177/1545968317698875 [doi]
AID - 10.1177_1545968317698875 [pii]
SO  - Neurorehabil Neural Repair. 2017 Apr;31(4):304-14. Epub 2017 Mar 23
      doi:10.1177/1545968317698875.

PMC - PMC5126079
PMID- 27965553
IS  - 1662-5161 (Electronic)
VI  - 10
DP  - 2016
TI  - The Effects of Transcranial Direct Current Stimulation (tDCS) on Multitasking
      Throughput Capacity.
LID - 589
AB  - Background: Multitasking has become an integral attribute associated with
      military operations within the past several decades. As the amount of information
      that needs to be processed during these high level multitasking environments
      exceeds the human operators' capabilities, the information throughput capacity
      reaches an asymptotic limit. At this point, the human operator can no longer
      effectively process and respond to the incoming information resulting in a
      plateau or decline in performance. The objective of the study was to evaluate the
      efficacy of a non-invasive brain stimulation technique known as transcranial
      direct current stimulation (tDCS) applied to a scalp location over the left
      dorsolateral prefrontal cortex (lDLPFC) to improve information processing
      capabilities during a multitasking environment.Methods: The study consisted of 20
      participants from Wright-Patterson Air Force Base (16 male and 4 female) with an 
      average age of 31.1 (SD = 4.5). Participants were randomly assigned into two
      groups, each consisting of eight males and two females. Group one received 2 mA
      of anodal tDCS and group two received sham tDCS over the lDLPFC on their testing 
      day.Results: The findings indicate that anodal tDCS significantly improves the
      participants' information processing capability resulting in improved performance
      compared to sham tDCS. For example, the multitasking throughput capacity for the 
      sham tDCS group plateaued near 1.0 bits/s at the higher baud input (2.0 bits/s)
      whereas the anodal tDCS group plateaued near 1.3 bits/s.Conclusion: The findings 
      provided new evidence that tDCS has the ability to augment and enhance
      multitasking capability in a human operator. Future research should be conducted 
      to determine the longevity of the enhancement of transcranial direct current
      stimulation on multitasking performance, which has yet to be accomplished.
FAU - Nelson, Justin
AU  - Nelson J
AD  - Air Force Research Laboratory, Wright-Patterson Air Force BaseOH, USA
FAU - McKinley, Richard A.
AU  - McKinley RA
AD  - Air Force Research Laboratory, Wright-Patterson Air Force BaseOH, USA
FAU - Phillips, Chandler
AU  - Phillips C
AD  - Department of Biomedical, Industrial, and Human Factors Engineering, Wright State
      UniversityDayton, OH, USA
FAU - McIntire, Lindsey
AU  - McIntire L
AD  - Air Force Research Laboratory, Wright-Patterson Air Force BaseOH, USA
FAU - Goodyear, Chuck
AU  - Goodyear C
AD  - Air Force Research Laboratory, Wright-Patterson Air Force BaseOH, USA
FAU - Kreiner, Aerial
AU  - Kreiner A
AD  - Air Force Research Laboratory, Wright-Patterson Air Force BaseOH, USA
FAU - Monforton, Lanie
AU  - Monforton L
AD  - Department of Biomedical, Industrial, and Human Factors Engineering, Wright State
      UniversityDayton, OH, USA
LA  - eng
PT  - Journal Article
DEP - 20161129
PHST- 2016/08/04 [received]
PHST- 2016/11/04 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2016.00589 [doi]
SO  - Front Hum Neurosci. 2016 Nov 29;10:. doi:10.3389/fnhum.2016.00589.

PMC - PMC4090379
PMID- 24943277
IS  - 1929-0748 (Electronic)
VI  - 3
IP  - 2
DP  - 2014 Apr-Jun
TI  - The Cost Effectiveness of a Tailored, Web-Based Care Program to Enhance
      Postoperative Recovery in Gynecologic Patients in Comparison With Usual Care:
      Protocol of a Stepped Wedge Cluster Randomized Controlled Trial.
LID - e30
AB  - Background: The length of recovery after benign gynecological surgery and return 
      to work frequently exceeds the period that is recommended or expected by
      specialists. A prolonged recovery is associated with a poorer quality of life. In
      addition, costs due to prolonged sick leave following gynecological surgery cause
      a significant financial burden on society. Objective: The objective of our study 
      was to present the protocol of a stepped wedge cluster randomized controlled
      trial to evaluate the cost effectiveness of a new care program for patients
      undergoing hysterectomy and/or adnexal surgery for benign disease, compared to
      the usual care. Methods: The care program under study, designed to improve
      convalescence and to prevent delayed return to work, targets two levels. At the
      hospital level, guidelines will be distributed among clinical staff in order to
      stimulate evidence-based patient education. At the patient level, additional
      perioperative guidance is provided by means of an eHealth intervention, equipping
      patients with tailored convalescence advice, and an occupational intervention is 
      available for those patients at risk of prolonged sick leave. Due to the stepped 
      wedge design of the trial, the care program will be sequentially rolled out among
      the 9 participating hospitals, from which the patients are recruited. Eligible
      for this study are employed women, 18-65 years of age, who are scheduled for
      hysterectomy and/or laparoscopic adnexal surgery. The primary outcome is full
      sustainable return to work. The secondary outcomes include general recovery,
      quality of life, self-efficacy, coping, and pain. The data will be collected by
      means of self-reported electronic questionnaires before surgery and at 2, 6, 12, 
      26, and 52 weeks after surgery. Sick leave and cost data are measured by monthly 
      sick leave calendars, and cost diaries during the 12 month follow-up period. The 
      economic evaluation will be performed from the societal perspective. All
      statistical analyses will be conducted according to the intention-to-treat
      principle. Results: The enrollment of the patients started October 2011. The
      follow-up period will be completed in August 2014. Data cleaning or analysis has 
      not begun as of this article’s submission. Conclusions: We hypothesize the care
      program to be effective by means of improving convalescence and reducing costs
      associated with productivity losses following gynecological surgery. The results 
      of this study will enable health care policy makers to decide about future
      implementation of this care program on a broad scale. Trial Registration:
      Netherlands Trial Register: NTR2933;
      http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=2933 (Archived by
      WebCite at http://www.webcitation.org/6Q7exPG84).
FAU - Kok, Gerjo
AU  - Kok G
FAU - Bouwsma, Esther VA
AU  - Bouwsma EV
AD  - Department of Obstetrics and GynecologyVU University Medical
      CenterAmsterdamNetherlands
FAU - Anema, Johannes R
AU  - Anema JR
AD  - Department of Public and Occupational HealthVU University Medical
      CenterAmsterdamNetherlands
FAU - Vonk Noordegraaf, Antonie
AU  - Vonk Noordegraaf A
AD  - Department of Obstetrics and GynecologyVU University Medical
      CenterAmsterdamNetherlands
FAU - Knol, Dirk L
AU  - Knol DL
AD  - Department of Epidemiology and StatisticsVU University Medical
      CenterAmsterdamNetherlands
FAU - Bosmans, Judith E
AU  - Bosmans JE
AD  - EMGO Institute for Health and Care ResearchAmsterdamNetherlands
FAU - Schraffordt Koops, Steven E
AU  - Schraffordt Koops SE
AD  - Department of Obstetrics and GynecologyMeander Medical
      CenterAmersfoortNetherlands
FAU - van Kesteren, Paul JM
AU  - van Kesteren PJ
AD  - Department of Obstetrics and GynecologyOnze Lieve Vrouwe
      GasthuisAmsterdamNetherlands
FAU - van Baal, W Marchien
AU  - van Baal WM
AD  - Department of Obstetrics and GynecologyFlevo HospitalAlmereNetherlands
FAU - Lips, Jos P
AU  - Lips JP
AD  - Department of Obstetrics and GynecologyKennemer GasthuisHaarlemNetherlands
FAU - Emanuel, Mark H
AU  - Emanuel MH
AD  - Department of Obstetrics and GynaecologySpaarne HospitalHoofddorpNetherlands
FAU - Scholten, Petrus C
AU  - Scholten PC
AD  - Department of Obstetrics and GynaecologyDiakonessenhuisUtrechtNetherlands
FAU - Mozes, Alexander
AU  - Mozes A
AD  - Department of Obstetrics and GynecologyAmstelland HospitalAmstelveenNetherlands
FAU - Adriaanse, Albert H
AU  - Adriaanse AH
AD  - Department of Obstetrics and GynecologyMedical Center AlkmaarAlkmaarNetherlands
FAU - Brölmann, Hans AM
AU  - Brölmann HA
AD  - Department of Obstetrics and GynecologyVU University Medical
      CenterAmsterdamNetherlands
FAU - Huirne, Judith AF
AU  - Huirne JA
AD  - Department of Obstetrics and GynecologyVU University Medical
      CenterAmsterdamNetherlands
LA  - eng
PT  - Journal Article
DEP - 20140618
PHST- 2014/04/01 [received]
PHST- 2014/05/21 [accepted]
TA  - JMIR Res Protoc
JT  - JMIR Research Protocols
AID - v3i2e30 [pii]
AID - 10.2196/resprot.3236 [doi]
SO  - JMIR Res Protoc. 2014 Jun 18;3(2):. doi:10.2196/resprot.3236.

PMC - PMC3728181
PMID- 23914344
IS  - 2192-6662 (Print)
IS  - 2192-6670 (Electronic)
VI  - 2
IP  - 2
DP  - 2013 Jul 1
TI  - Monitoring Activity of Taking Medicine by Incorporating RFID and Video Analysis.
PG  - 61-70
AB  - In this paper, we present a new framework to monitor medication intake for
      elderly individuals by incorporating a video camera and Radio Frequency
      Identification (RFID) sensors. The proposed framework can provide a key function 
      for monitoring activities of daily living (ADLs) of elderly people at their own
      home. In an assistive environment, RFID tags are applied on medicine bottles
      located in a medicine cabinet so that each medicine bottle will have a unique ID.
      The description of the medicine data for each tag is manually input to a
      database. RFID readers will detect if any of these bottles are taken away from
      the medicine cabinet and identify the tag attached on the medicine bottle. A
      video camera is installed to continue monitoring the activity of taking medicine 
      by integrating face detection and tracking, mouth detection, background
      subtraction, and activity detection. The preliminary results demonstrate that
      100% detection accuracy for identifying medicine bottles and promising results
      for monitoring activity of taking medicine.
FAU - Hasanuzzaman, Faiz M.
AU  - Hasanuzzaman FM
FAU - Yang, Xiaodong
AU  - Yang X
FAU - Tian, YingLi
AU  - Tian Y
FAU - Liu, Qingshan
AU  - Liu Q
AD  - School of Information & Control Engineering, Nanjing University of Information
      Science and Technology, China qsliu@nuist.edu.cn
FAU - Capezuti, Elizabeth
AU  - Capezuti E
AD  - College of Nursing, New York University, New York, NY USA ec65@nyu.edu
LA  - eng
PT  - Journal Article
DEP - 20130207
GR  - R21 EY020990 || EY
TA  - Netw Modeling Anal Health Inform Bioinforma
JT  - Network modeling and analysis in health informatics and bioinformatics
AID - 10.1007/s13721-013-0025-y [doi]
MID - NIHMS443507
SO  - Netw Modeling Anal Health Inform Bioinforma. 2013 Jul 1;2(2):61-70. Epub 2013 Feb
      7 doi:10.1007/s13721-013-0025-y.

PMC - PMC3969942
PMID- 24407111
IS  - 0301-0082 (Print)
IS  - 1873-5118 (Electronic)
VI  - 0
DP  - 2014 Apr
TI  - Non-pharmaceutical therapies for stroke: Mechanisms and clinical implications.
PG  - 246-69
AB  - Stroke is deemed a worldwide leading cause of neurological disability and death, 
      however, there is currently no promising pharmacotherapy for acute ischemic
      stroke aside from intravenous or intra-arterial thrombolysis. Yet because of the 
      narrow therapeutic time window involved, thrombolytic application is very
      restricted in clinical settings. Accumulating data suggest that
      non-pharmaceutical therapies for stroke might provide new opportunities for
      stroke treatment. Here we review recent research progress in the mechanisms and
      clinical implications of non-pharmaceutical therapies, mainly including
      neuroprotective approaches such as hypothermia, ischemic/hypoxic conditioning,
      acupuncture, medical gases, transcranial laser therapy, etc. In addition, we
      briefly summarize mechanical endovascular recanalization devices and recovery
      devices for the treatment of the chronic phase of stroke and discuss the relative
      merits of these devices.
FAU - Chen, Fan
AU  - Chen F
AD  - Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical
      University, Beijing, Beijing 100053, China
FAU - Qi, Zhifeng
AU  - Qi Z
AD  - Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical
      University, Beijing, Beijing 100053, China
FAU - Luo, Yuming
AU  - Luo Y
AD  - Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical
      University, Beijing, Beijing 100053, China
FAU - Hinchliffe, Taylor
AU  - Hinchliffe T
AD  - The Vivian L Smith Department of Neurosurgery, The University of Texas Medical
      School at Houston, Houston, TX 77030, USA
FAU - Ding, Guanghong
AU  - Ding G
AD  - Shanghai research center for Acupuncture and Meridiam, Shanghai 201203, China
FAU - Xia, Ying
AU  - Xia Y
AD  - The Vivian L Smith Department of Neurosurgery, The University of Texas Medical
      School at Houston, Houston, TX 77030, USA
FAU - Ji, Xunming
AU  - Ji X
AD  - Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical
      University, Beijing, Beijing 100053, China
LA  - eng
PT  - Journal Article
DEP - 20140107
TA  - Prog Neurobiol
JT  - Progress in neurobiology
AID - 10.1016/j.pneurobio.2013.12.007 [doi]
MID - NIHMS562108
SO  - Prog Neurobiol. 2014 Apr;0:246-69. Epub 2014 Jan 7
      doi:10.1016/j.pneurobio.2013.12.007.

PMC - PMC1872006
IS  - 1522-8517 (Print)
IS  - 1523-5866 (Electronic)
VI  - 6
IP  - 4
DP  - 2004 Oct
TI  - Abstracts from the Eleventh International Symposium on Pediatric Neuro-Oncology: 
      June 13–16.
PG  - 401-70
LA  - eng
PT  - Journal Article
TA  - Neuro-oncol
JT  - Neuro-Oncology
AID - 10.1215/S115285170410015X [doi]
AID - neu0604p401 [pii]
SO  - Neuro-oncol. 2004 Oct;6(4):401-70. doi:10.1215/S115285170410015X.

PMC - PMC3656915
PMID- 23690677
IS  - 1177-5467 (Print)
IS  - 1177-5483 (Electronic)
VI  - 7
DP  - 2013
DP  - 2013
TI  - Developmental dyslexia and vision.
PG  - 869-81
AB  - Developmental dyslexia affects almost 10% of school-aged children and represents 
      a significant public health problem. Its etiology is unknown. The consistent
      presence of phonological difficulties combined with an inability to manipulate
      language sounds and the grapheme–phoneme conversion is widely acknowledged.
      Numerous scientific studies have also documented the presence of eye movement
      anomalies and deficits of perception of low contrast, low spatial frequency, and 
      high frequency temporal visual information in dyslexics. Anomalies of visual
      attention with short visual attention spans have also been demonstrated in a
      large number of cases. Spatial orientation is also affected in dyslexics who
      manifest a preference for spatial attention to the right. This asymmetry may be
      so pronounced that it leads to a veritable neglect of space on the left side. The
      evaluation of treatments proposed to dyslexics whether speech or oriented towards
      the visual anomalies remains fragmentary. The advent of new explanatory theories,
      notably cerebellar, magnocellular, or proprioceptive, is an incentive for
      ophthalmologists to enter the world of multimodal cognition given the importance 
      of the eye’s visual input.
FAU - Quercia, Patrick
AU  - Quercia P
AD  - Department of Ophthalmology, University Hospital, Dijon, France
FAU - Feiss, Léonard
AU  - Feiss L
AD  - Office of Ophthalmology, Beaune, France
FAU - Michel, Carine
AU  - Michel C
AD  - University of Burgundy, Dijon, INSERM U1093, Cognition, Action et Plasticité
      Sensorimotrice, Dijon, France
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20130514
PHST- 2013/05/14 [aheadofprint]
TA  - Clin Ophthalmol
JT  - Clinical Ophthalmology (Auckland, N.Z.)
AID - 10.2147/OPTH.S41607 [doi]
AID - opth-7-869 [pii]
SO  - Clin Ophthalmol. 2013;7:869-81. Epub 2013 May 14 doi:10.2147/OPTH.S41607.

PMC - PMC3033009
PMID- 20464803
IS  - 0279-1072 (Print)
VI  - 42
IP  - 1
DP  - 2010 Mar
TI  - Sex Differences in the Effects of Marijuana on Simulated Driving Performance†.
PG  - 19-30
AB  - In the United States, one in six teenagers has driven under the influence of
      marijuana. Driving under the influence of marijuana and alcohol is equally
      prevalent, despite the fact that marijuana use is less common than alcohol use.
      Much of the research examining the effects of marijuana on driving performance
      was conducted in the 1970s and led to equivocal findings. During that time, few
      studies included women and driving simulators were rudimentary. Further, the
      potency of marijuana commonly used recreationally has increased. This study
      examined sex differences in the acute effects of marijuana on driving performance
      using a realistic, validated driving simulator. Eighty-five subjects (n = 50
      males, 35 females) participated in this between-subjects, double-blind, placebo
      controlled study. In addition to an uneventful, baseline segment of driving,
      participants were challenged with collision avoidance and distracted driving
      scenarios. Under the influence of marijuana, participants decreased their speed
      and failed to show expected practice effects during a distracted drive. No
      differences were found during the baseline driving segment or collision avoidance
      scenarios. No differences attributable to sex were observed. This study enhances 
      the current literature by identifying distracted driving and the integration of
      prior experience as particularly problematic under the influence of marijuana.
FAU - Anderson, Beth M.
AU  - Anderson BM
AD  - Postdoctoral Fellow Olin Neuropsychiatry Research Center, Hartford Hospital,
      Hartford, CT
FAU - Rizzo, Matthew
AU  - Rizzo M
AD  - Professor University of Iowa Carver College of Medicine, Iowa City, IA
FAU - Block, Robert I.
AU  - Block RI
AD  - Professor University of Iowa Carver College of Medicine, Iowa City, IA
FAU - Pearlson, Godfrey D.
AU  - Pearlson GD
AD  - Director Olin Neuropsychiatry Research Center, Hartford Hospital, Hartford, CT;
      Professor Yale University, New Haven, CT
FAU - O'Leary, Daniel S.
AU  - O'Leary DS
AD  - Professor University of Iowa Carver College of Medicine, Iowa City, IA
LA  - eng
PT  - Journal Article
TA  - J Psychoactive Drugs
JT  - Journal of psychoactive drugs
MID - NIHMS262579
SO  - J Psychoactive Drugs. 2010 Mar;42(1):19-30.

PMC - PMC5333171
IS  - 2052-1847 (Electronic)
VI  - 9
IP  - Suppl 1
DP  - 2017
TI  - International Conference on Technology and Innovation in Sports, Health and
      Wellbeing (TISHW): Vila Real, Portugal. 01-03 December 2016.
LID - 5
FAU - Muñoz, Idoia
AU  - Muñoz I
AD  - GAIA, Association of Electronic and Information Technologies in the Basque
      Country, Bilbao, Spain
FAU - Garatea, Jokin
AU  - Garatea J
AD  - GAIA, Association of Electronic and Information Technologies in the Basque
      Country, Bilbao, Spain
FAU - Garatea, Jokin
AU  - Garatea J
AD  - GAIA, Association of Electronic and Information Technologies in the Basque
      Country, Bilbao, Spain
FAU - Muñoz, Idoia
AU  - Muñoz I
AD  - GAIA, Association of Electronic and Information Technologies in the Basque
      Country, Bilbao, Spain
FAU - Ala, Silvia
AU  - Ala S
AD  - 0000000121821287grid.12341.35Universidade de Trás-os-Montes e Alto Douro, Vila
      Real, Portugal
FAU - Cardoso, Francisco
AU  - Cardoso F
AD  - 0000000121821287grid.12341.35Universidade de Trás-os-Montes e Alto Douro, Vila
      Real, Portugal
FAU - Paredes, Hugo
AU  - Paredes H
AD  - 0000000121821287grid.12341.35INESC TEC and Universidade de Trás-os-Montes e Alto 
      Douro, Vila Real, Portugal
FAU - Gelautz, Margrit
AU  - Gelautz M
AD  - 0000 0001 2348 4034grid.5329.dVienna University of Technology, Vienna, Austria
FAU - Seitner, Florian
AU  - Seitner F
AD  - emotion3D GmbH, Vienna, Austria
FAU - Kapeller, Christian
AU  - Kapeller C
AD  - 0000 0001 2348 4034grid.5329.dVienna University of Technology, Vienna, Austria
FAU - Brosch, Nicole
AU  - Brosch N
AD  - 0000 0001 2348 4034grid.5329.dVienna University of Technology, Vienna, Austria
FAU - Frydrychova, Zuzana
AU  - Frydrychova Z
AD  - 0000 0001 2194 0956grid.10267.32Department of Psychology, Masaryk University,
      Faculty of Arts, Brno, Czech Republic
FAU - Buresova, Iva
AU  - Buresova I
AD  - 0000 0001 2194 0956grid.10267.32Department of Psychology, Masaryk University,
      Faculty of Arts, Brno, Czech Republic
FAU - Bartosova, Katerina
AU  - Bartosova K
AD  - 0000 0001 2194 0956grid.10267.32Department of Psychology, Masaryk University,
      Faculty of Arts, Brno, Czech Republic
FAU - Huteckova, Sara
AU  - Huteckova S
AD  - 0000 0001 2194 0956grid.10267.32Department of Psychology, Masaryk University,
      Faculty of Arts, Brno, Czech Republic
FAU - Huteckova, Sara
AU  - Huteckova S
AD  - 0000 0001 2194 0956grid.10267.32Department of Psychology, Masaryk University,
      Faculty of Arts, Brno, Czech Republic
FAU - Buresová, Iva
AU  - Buresová I
AD  - 0000 0001 2194 0956grid.10267.32Department of Psychology, Masaryk University,
      Faculty of Arts, Brno, Czech Republic
FAU - Bartosova, Katerina
AU  - Bartosova K
AD  - 0000 0001 2194 0956grid.10267.32Department of Psychology, Masaryk University,
      Faculty of Arts, Brno, Czech Republic
FAU - Frydrychova, Zuzana
AU  - Frydrychova Z
AD  - 0000 0001 2194 0956grid.10267.32Department of Psychology, Masaryk University,
      Faculty of Arts, Brno, Czech Republic
FAU - Pires, Marcelo
AU  - Pires M
AD  - 0000000121511713grid.10772.33Universidade Nova de Lisboa, NOVA IMS, Lisboa,
      Portugal
FAU - Santos, Vítor
AU  - Santos V
AD  - 0000000121511713grid.10772.33Universidade Nova de Lisboa, NOVA IMS, Lisboa,
      Portugal
FAU - Almeida, Luís
AU  - Almeida L
AD  - NOVA IMS, Lisboa, Portugal
FAU - Santos, Vitor
AU  - Santos V
AD  - NOVA IMS, Lisboa, Portugal
FAU - Neiva, Henrique
AU  - Neiva H
AD  - 0000 0001 2220 7094grid.7427.6Department of Sport Sciences and CIDESD, University
      of Beira Interior, Covilhã, Portugal
FAU - Marques, Mário
AU  - Marques M
AD  - 0000 0001 2220 7094grid.7427.6Department of Sport Sciences and CIDESD, University
      of Beira Interior, Covilhã, Portugal
FAU - Travassos, Bruno
AU  - Travassos B
AD  - 0000 0001 2220 7094grid.7427.6Department of Sport Sciences and CIDESD, University
      of Beira Interior, Covilhã, Portugal
FAU - Marinho, Daniel
AU  - Marinho D
AD  - 0000 0001 2220 7094grid.7427.6Department of Sport Sciences and CIDESD, University
      of Beira Interior, Covilhã, Portugal
FAU - Gil, Maria Helena
AU  - Gil MH
AD  - Department of Sport Sciences, University of Beira Interior and Research Centre in
      Sports Sciences, Health Sciences and Human Development, Covilhã, Portugal
FAU - Marques, Mário Cardoso
AU  - Marques MC
AD  - Department of Sport Sciences, University of Beira Interior and Research Centre in
      Sports Sciences, Health Sciences and Human Development, Covilhã, Portugal
FAU - Neiva, Henrique Pereira
AU  - Neiva HP
AD  - Department of Sport Sciences, University of Beira Interior and Research Centre in
      Sports Sciences, Health Sciences and Human Development, Covilhã, Portugal
FAU - Sousa, António Carlos
AU  - Sousa AC
AD  - Department of Sport Sciences, University of Beira Interior and Research Centre in
      Sports Sciences, Health Sciences and Human Development, Covilhã, Portugal
FAU - Marinho, Daniel Almeida
AU  - Marinho DA
AD  - Department of Sport Sciences, University of Beira Interior and Research Centre in
      Sports Sciences, Health Sciences and Human Development, Covilhã, Portugal
FAU - Sousa, António Carlos
AU  - Sousa AC
AD  - 0000 0001 2220 7094grid.7427.6Department of Sport Sciences, University of Beira
      Interior, Research Centre in Sports Sciences, Health Sciences and Human
      Development, Covilhã, Portugal
FAU - Travassos, Bruno Filipe
AU  - Travassos BF
AD  - 0000 0001 2220 7094grid.7427.6Department of Sport Sciences, University of Beira
      Interior, Research Centre in Sports Sciences, Health Sciences and Human
      Development, Covilhã, Portugal
FAU - Gil, Maria Helena
AU  - Gil MH
AD  - 0000 0001 2220 7094grid.7427.6Department of Sport Sciences, University of Beira
      Interior, Research Centre in Sports Sciences, Health Sciences and Human
      Development, Covilhã, Portugal
FAU - Neiva, Henrique Pereira
AU  - Neiva HP
AD  - 0000 0001 2220 7094grid.7427.6Department of Sport Sciences, University of Beira
      Interior, Research Centre in Sports Sciences, Health Sciences and Human
      Development, Covilhã, Portugal
FAU - Marinho, Daniel Almeida
AU  - Marinho DA
AD  - 0000 0001 2220 7094grid.7427.6Department of Sport Sciences, University of Beira
      Interior, Research Centre in Sports Sciences, Health Sciences and Human
      Development, Covilhã, Portugal
FAU - Marques, Mário Cardoso
AU  - Marques MC
AD  - 0000 0001 2220 7094grid.7427.6Department of Sport Sciences, University of Beira
      Interior, Research Centre in Sports Sciences, Health Sciences and Human
      Development, Covilhã, Portugal
FAU - Rocha, Tânia
AU  - Rocha T
AD  - 0000000121821287grid.12341.35INESC TEC and University of Trás-os-Montes and Alto 
      Douro, Vila Real, Portugal
FAU - Reis, Arsénio
AU  - Reis A
AD  - 0000000121821287grid.12341.35INESC TEC and University of Trás-os-Montes and Alto 
      Douro, Vila Real, Portugal
FAU - Paredes, Hugo
AU  - Paredes H
AD  - 0000000121821287grid.12341.35INESC TEC and University of Trás-os-Montes and Alto 
      Douro, Vila Real, Portugal
FAU - Barroso, João
AU  - Barroso J
AD  - 0000000121821287grid.12341.35INESC TEC and University of Trás-os-Montes and Alto 
      Douro, Vila Real, Portugal
FAU - Saffoury, Rimon
AU  - Saffoury R
AD  - 0000 0001 2107 3311grid.5330.5Digital Sports Group, Pattern Recognition Lab,
      Department of Computer Science, Friedrich-Alexander University Erlangen-Nuremberg
      (FAU), Erlangen, Germany
FAU - Blank, Peter
AU  - Blank P
AD  - 0000 0001 2107 3311grid.5330.5Digital Sports Group, Pattern Recognition Lab,
      Department of Computer Science, Friedrich-Alexander University Erlangen-Nuremberg
      (FAU), Erlangen, Germany
FAU - Sessner, Julian
AU  - Sessner J
AD  - 0000 0001 2107 3311grid.5330.5Institute for Factory Automation and Production
      Systems, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen,
      Germany
FAU - Groh, Benjamin
AU  - Groh B
AD  - 0000 0001 2107 3311grid.5330.5Digital Sports Group, Pattern Recognition Lab,
      Department of Computer Science, Friedrich-Alexander University Erlangen-Nuremberg
      (FAU), Erlangen, Germany
FAU - Martindale, Christine
AU  - Martindale C
AD  - 0000 0001 2107 3311grid.5330.5Digital Sports Group, Pattern Recognition Lab,
      Department of Computer Science, Friedrich-Alexander University Erlangen-Nuremberg
      (FAU), Erlangen, Germany
FAU - Dorschky, Eva
AU  - Dorschky E
AD  - 0000 0001 2107 3311grid.5330.5Digital Sports Group, Pattern Recognition Lab,
      Department of Computer Science, Friedrich-Alexander University Erlangen-Nuremberg
      (FAU), Erlangen, Germany
FAU - Franke, Joerg
AU  - Franke J
AD  - 0000 0001 2107 3311grid.5330.5Institute for Factory Automation and Production
      Systems, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen,
      Germany
FAU - Eskofier, Bjoern
AU  - Eskofier B
AD  - 0000 0001 2107 3311grid.5330.5Digital Sports Group, Pattern Recognition Lab,
      Department of Computer Science, Friedrich-Alexander University Erlangen-Nuremberg
      (FAU), Erlangen, Germany
FAU - Barros, Graça
AU  - Barros G
AD  - Fisio Lógic Centro de Fisioterapia, Lisboa, Portugal
FAU - Melo, Filipe
AU  - Melo F
AD  - Faculdade de Motricidade Humana, Universidade de Lisboa, Laboratório de
      Comportamento Motor, Estrada da Costa, 1499-002 Cruz Quebrada, Portugal
FAU - Oliveira, Raul
AU  - Oliveira R
AD  - Faculdade de Motricidade Humana, Universidade de Lisboa, Laboratório de
      Comportamento Motor, Estrada da Costa, 1499-002 Cruz Quebrada, Portugal
FAU - Borges, Jorge
AU  - Borges J
AD  - 0000000121821287grid.12341.35Universidade de Trás-os-Montes e Alto Douro (UTAD), 
      Vila Real, Portugal
FAU - Reis, Arsénio
AU  - Reis A
AD  - 0000000121821287grid.12341.35Universidade de Trás-os-Montes e Alto Douro (UTAD)
      and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência
      (INESC TEC), Vila Real, Portugal
FAU - Santos, Vitor
AU  - Santos V
AD  - 0000000121511713grid.10772.33Universidade Nova de Lisboa, NOVA IMS, Lisboa,
      Portugal
FAU - Barroso, João
AU  - Barroso J
AD  - 0000000121821287grid.12341.35Universidade de Trás-os-Montes e Alto Douro (UTAD)
      and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência
      (INESC TEC), Vila Real, Portugal
FAU - Reis, Arsénio
AU  - Reis A
AD  - 0000000121821287grid.12341.35Universidade de Trás-os-Montes e Alto Douro (UTAD)
      and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência
      (INESC TEC), Vila Real, Portugal
FAU - Paulino, Dennis
AU  - Paulino D
AD  - 0000000121821287grid.12341.35Universidade de Trás-os-Montes e Alto Douro (UTAD)
      and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência
      (INESC TEC), Vila Real, Portugal
FAU - Paredes, Hugo
AU  - Paredes H
AD  - 0000000121821287grid.12341.35Universidade de Trás-os-Montes e Alto Douro (UTAD)
      and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência
      (INESC TEC), Vila Real, Portugal
FAU - Filipe, Vitor
AU  - Filipe V
AD  - 0000000121821287grid.12341.35Universidade de Trás-os-Montes e Alto Douro (UTAD)
      and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência
      (INESC TEC), Vila Real, Portugal
FAU - Barroso, João
AU  - Barroso J
AD  - 0000000121821287grid.12341.35Universidade de Trás-os-Montes e Alto Douro (UTAD)
      and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência
      (INESC TEC), Vila Real, Portugal
FAU - Reis, Arsénio
AU  - Reis A
AD  - 0000000121821287grid.12341.35Universidade de Trás-os-Montes e Alto Douro (UTAD)
      and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência
      (INESC TEC), Vila Real, Portugal
FAU - Santos, Vitor
AU  - Santos V
AD  - 0000000121511713grid.10772.33Universidade Nova de Lisboa, NOVA IMS, Lisboa,
      Portugal
FAU - Paredes, Hugo
AU  - Paredes H
AD  - 0000000121821287grid.12341.35Universidade de Trás-os-Montes e Alto Douro (UTAD)
      and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência
      (INESC TEC), Vila Real, Portugal
FAU - Filipe, Vitor
AU  - Filipe V
AD  - 0000000121821287grid.12341.35Universidade de Trás-os-Montes e Alto Douro (UTAD)
      and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência
      (INESC TEC), Vila Real, Portugal
FAU - Barroso, João
AU  - Barroso J
AD  - 0000000121821287grid.12341.35Universidade de Trás-os-Montes e Alto Douro (UTAD)
      and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência
      (INESC TEC), Vila Real, Portugal
FAU - Ribeiro, João
AU  - Ribeiro J
AD  - 0000000121821287grid.12341.35Universidade de Trás-os-Montes e Alto Douro (UTAD), 
      Vila Real, Portugal
FAU - Reis, Arsénio
AU  - Reis A
AD  - 0000000121821287grid.12341.35Universidade de Trás-os-Montes e Alto Douro (UTAD)
      and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência
      (INESC TEC), Vila Real, Portugal
FAU - Justino, Elsa
AU  - Justino E
AD  - 0000000121821287grid.12341.35Universidade de Trás-os-Montes e Alto Douro (UTAD), 
      Vila Real, Portugal
FAU - Santos, Vitor
AU  - Santos V
AD  - 0000000121511713grid.10772.33Universidade Nova de Lisboa, NOVA IMS, Lisboa,
      Portugal
FAU - Reis, Arsénio
AU  - Reis A
AD  - 0000000121821287grid.12341.35INESC TEC and Universidade de Trás-os-Montes e Alto 
      Douro, Vila Real, Portugal
FAU - Barroso, João
AU  - Barroso J
AD  - 0000000121821287grid.12341.35INESC TEC and Universidade de Trás-os-Montes e Alto 
      Douro, Vila Real, Portugal
FAU - Amorim, Vasco
AU  - Amorim V
AD  - 0000000121821287grid.12341.35INESC TEC and University of Trás-os-Montes e Alto
      Douro, Vila Real, Portugal
FAU - Filipe, Vitor
AU  - Filipe V
AD  - 0000000121821287grid.12341.35INESC TEC and University of Trás-os-Montes e Alto
      Douro, Vila Real, Portugal
FAU - Paulino, Dennis
AU  - Paulino D
AD  - 0000000121821287grid.12341.35INESC TEC and University of Trás-os-Montes e Alto
      Douro, Vila Real, Portugal
FAU - Reis, Arsénio
AU  - Reis A
AD  - 0000000121821287grid.12341.35INESC TEC and University of Trás-os-Montes e Alto
      Douro, Vila Real, Portugal
FAU - Paredes, Hugo
AU  - Paredes H
AD  - 0000000121821287grid.12341.35INESC TEC and University of Trás-os-Montes e Alto
      Douro, Vila Real, Portugal
FAU - Barroso, João
AU  - Barroso J
AD  - 0000000121821287grid.12341.35INESC TEC and University of Trás-os-Montes e Alto
      Douro, Vila Real, Portugal
LA  - eng
PT  - Journal Article
DEP - 20170224
TA  - BMC Sports Sci Med Rehabil
JT  - BMC Sports Science, Medicine and Rehabilitation
AID - 68 [pii]
AID - 10.1186/s13102-017-0068-y [doi]
SO  - BMC Sports Sci Med Rehabil. 2017 Feb 24;9(Suppl 1):.
      doi:10.1186/s13102-017-0068-y.

PMC - PMC4930530
PMID- 27317506
IS  - 1439-4456 (Print)
IS  - 1438-8871 (Electronic)
VI  - 18
IP  - 6
DP  - 2016 Jun
TI  - Changing Behavioral Lifestyle Risk Factors Related to Cognitive Decline in Later 
      Life Using a Self-Motivated eHealth Intervention in Dutch Adults.
LID - e171
AB  - Background: Our labor force is aging, but aged workers are not yet coached on how
      to stay cognitively fit for the job. Objective: In this study, we tested whether 
      a self-motivated, complex eHealth intervention could improve multiple
      health-related behaviors that are associated with cognitive aging among working
      Dutch adults. Methods: This quasi-experimental prospective study with a pre-post 
      design was conducted with employees of Dutch medium to large companies. All
      employees with Internet access, a good understanding of the Dutch language, and
      who provided digital informed consent were eligible to participate. In total,
      2972 participants (2110/2972, 71.11% females) with a mean (standard deviation,
      SD) age of 51.8 (SD 12.9) years were recruited; 2305 became active users of the
      intervention, and 173 completed the 1-year follow-up. This self-motivated eHealth
      lifestyle intervention stimulates participants to set personally relevant,
      monthly health behavior change goals using Goal Attainment Scaling and to realize
      these goals by implementing behavior change techniques grounded in behavior
      change theory. The primary outcomes were the goal-setting success rate and the
      change in overall lifestyle score from baseline to the 1-year follow-up; the
      score was based on physical activity, diet, smoking, alcohol, sleep, and stress
      scores. The secondary outcomes were the changes in body weight, body mass index, 
      specific lifestyle characteristics, and website usage. Results: A total of 1212
      participants set 2620 behavior change goals; 392 participants assessed 1089
      (1089/2288, 47.59%) goals and successfully achieved 422 (422/1089, 38.75%) of
      these goals. Among the goal-setting participants in follow-up, this led to a
      +0.81-point improvement (95% CI 0.49-1.13, P<.001) in overall lifestyle (d=0.32) 
      and weight loss of 0.62 kg (95% CI −1.16 to −0.07, P=.03). These participants
      also showed significant improvement in 8 out of 11 specific lifestyle components.
      Conclusions: Among an adult Dutch population, this eHealth intervention resulted 
      in lifestyle changes in behavioral risk factors associated with cognitive
      decline, and these improvements lasted over the period of 1 year. Given the
      general aging of our workforce, this eHealth intervention opens new avenues for
      the widespread use of cost-effective self-motivated prevention programs aimed at 
      prevention of early-stage cognitive decline and more self-management of their
      risk factors. Trial Registration: Nederlands Trial Register: NTR4144;
      http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=4144 (Archived by
      WebCite at http://www.webcitation.org/6cZzwZSg3).
FAU - De Marco, Matteo
AU  - De Marco M
FAU - Hawkins, Robert
AU  - Hawkins R
FAU - Aalbers, Teun
AU  - Aalbers T
AUID- ORCID: 0000-0002-1002-5485
AD  - Radboud University Medical CenterDepartment of Geriatric
      MedicineNijmegenNetherlands
FAU - Qin, Li
AU  - Qin L
AUID- ORCID: 0000-0001-5002-3372
AD  - Radboud University Medical CenterDepartment of Geriatric
      MedicineNijmegenNetherlands
FAU - Baars, Maria AE
AU  - Baars MA
AUID- ORCID: 0000-0002-1582-9300
AD  - HAN University of Applied SciencesInstitute of Social SciencesNijmegenNetherlands
FAU - de Lange, Annet
AU  - de Lange A
AUID- ORCID: 0000-0002-9122-7387
AD  - HAN University of Applied SciencesFaculty of Human Resource
      ManagementNijmegenNetherlands
FAU - Kessels, Roy PC
AU  - Kessels RP
AUID- ORCID: 0000-0002-7107-8900
AD  - Radboud University NijmegenDonders Institute for Brain, Cognition and
      BehaviourNijmegenNetherlands
FAU - Olde Rikkert, Marcel GM
AU  - Olde Rikkert MG
AUID- ORCID: 0000-0003-1397-1677
AD  - Radboud University Medical CenterDepartment of Geriatric
      MedicineNijmegenNetherlands
LA  - eng
PT  - Journal Article
DEP - 20160617
PHST- 2015/10/28 [received]
PHST- 2016/02/23 [revised]
PHST- 2016/05/04 [accepted]
TA  - J Med Internet Res
JT  - Journal of Medical Internet Research
AID - v18i6e171 [pii]
AID - 10.2196/jmir.5269 [doi]
SO  - J Med Internet Res. 2016 Jun 17;18(6):. doi:10.2196/jmir.5269.

PMC - PMC4468745
PMID- 26137465
IS  - 2296-875X (Electronic)
VI  - 2
DP  - 2015
TI  - Emerging Applications of Bedside 3D Printing in Plastic Surgery.
LID - 25
AB  - Modern imaging techniques are an essential component of preoperative planning in 
      plastic and reconstructive surgery. However, conventional modalities, including
      three-dimensional (3D) reconstructions, are limited by their representation on 2D
      workstations. 3D printing, also known as rapid prototyping or additive
      manufacturing, was once the province of industry to fabricate models from a
      computer-aided design (CAD) in a layer-by-layer manner. The early adopters in
      clinical practice have embraced the medical imaging-guided 3D-printed biomodels
      for their ability to provide tactile feedback and a superior appreciation of
      visuospatial relationship between anatomical structures. With increasing
      accessibility, investigators are able to convert standard imaging data into a CAD
      file using various 3D reconstruction softwares and ultimately fabricate 3D models
      using 3D printing techniques, such as stereolithography, multijet modeling,
      selective laser sintering, binder jet technique, and fused deposition modeling.
      However, many clinicians have questioned whether the cost-to-benefit ratio
      justifies its ongoing use. The cost and size of 3D printers have rapidly
      decreased over the past decade in parallel with the expiration of key 3D printing
      patents. Significant improvements in clinical imaging and user-friendly 3D
      software have permitted computer-aided 3D modeling of anatomical structures and
      implants without outsourcing in many cases. These developments offer immense
      potential for the application of 3D printing at the bedside for a variety of
      clinical applications. In this review, existing uses of 3D printing in plastic
      surgery practice spanning the spectrum from templates for facial transplantation 
      surgery through to the formation of bespoke craniofacial implants to optimize
      post-operative esthetics are described. Furthermore, we discuss the potential of 
      3D printing to become an essential office-based tool in plastic surgery to assist
      in preoperative planning, developing intraoperative guidance tools, teaching
      patients and surgical trainees, and producing patient-specific prosthetics in
      everyday surgical practice.
FAU - Chae, Michael P.
AU  - Chae MP
AD  - 3D PRINT Laboratory, Department of Surgery, Peninsula Health, Frankston, VIC,
      Australia
FAU - Rozen, Warren M.
AU  - Rozen WM
AD  - 3D PRINT Laboratory, Department of Surgery, Peninsula Health, Frankston, VIC,
      Australia
FAU - McMenamin, Paul G.
AU  - McMenamin PG
AD  - Department of Anatomy and Developmental Biology, Centre for Human Anatomy
      Education, School of Biomedical Sciences, Faculty of Medicine, Nursing and Health
      Sciences, Monash University, Clayton, VIC, Australia
FAU - Findlay, Michael W.
AU  - Findlay MW
AD  - 3D PRINT Laboratory, Department of Surgery, Peninsula Health, Frankston, VIC,
      Australia
FAU - Spychal, Robert T.
AU  - Spychal RT
AD  - 3D PRINT Laboratory, Department of Surgery, Peninsula Health, Frankston, VIC,
      Australia
FAU - Hunter-Smith, David J.
AU  - Hunter-Smith DJ
AD  - 3D PRINT Laboratory, Department of Surgery, Peninsula Health, Frankston, VIC,
      Australia
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20150616
PHST- 2015/04/14 [received]
PHST- 2015/06/02 [accepted]
TA  - Front Surg
JT  - Frontiers in Surgery
AID - 10.3389/fsurg.2015.00025 [doi]
SO  - Front Surg. 2015 Jun 16;2:. doi:10.3389/fsurg.2015.00025.

PMC - PMC3199798
PMID- 22073048
IS  - 1865-1011 (Electronic)
VI  - 3
DP  - 2004
TI  - Current aspects of hearing loss from occupational and leisure noise.
LID - Doc06
AB  - Hearing loss from occupational and leisure noise numbers amongst the most
      frequent causes of an acquired sensorineural hearing loss. Here we present a
      review of up-to-date findings on the pathophysiology of acoustic injury to the
      inner ear, with special attention being paid to its molecular-biological and
      genetic aspects. Epidemiological aspects shall also be dealt with, as shall the
      roles of lacking recovery from occupational noise due to additional exposure by
      leisure noise and the combined exposure of noise and chemicals. Based on the
      epidemiological and pathophysiological findings and against the background of
      published animal-experimental, pre-clinical and clinical findings, the various
      approaches for prevention, protection and therapeutic intervention with acoustic 
      trauma are discussed. Pharmacological strategies involving anti-oxidative,
      anti-excitotoxic and anti-apoptotic substances as well as non-pharmacological
      strategies like "sound conditioning" are given attention. Furthermore, systemic
      and local substance application as well as the therapy of acute acoustic trauma
      and chronic hearing problems (including modern therapy forms for comorbidities
      such as tinnitus) shall be delved into.
FAU - Plontke, S.
AU  - Plontke S
AD  - Department of Otorhinolaryngology, Head and Neck Surgery, University of Tübingen,
      Germany
FAU - Zenner, H.-P.
AU  - Zenner HP
AD  - Tübingen Hearing Research Centre (THRC), Germany
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20041228
TA  - GMS Curr Top Otorhinolaryngol Head Neck Surg
JT  - GMS Current Topics in Otorhinolaryngology, Head and Neck Surgery
AID - cto000006 [pii]
SO  - GMS Curr Top Otorhinolaryngol Head Neck Surg. 2004 Dec 28;3:.

PMC - PMC3699140
PMID- 24436648
IS  - 1531-0043 (Print)
IS  - 1530-9681 (Electronic)
VI  - 26
IP  - 1
DP  - 2013 Mar
TI  - Simulation and Its Role in Training.
PG  - 47-55
AB  - Despite its short history, surgical simulation has been successfully introduced
      into surgical residency programs in an effort to augment training. A wide range
      of simulator types and levels of complexity have proven an effective teaching
      method for surgical trainees. They have been used for training in areas such as
      general surgery, urology, gynecology, and ophthalmology among others. Coincident 
      with the introduction of simulators is the need for objective evaluation of
      skills learned on them, which has led to the development and validation of
      multiple evaluation tools. This article evaluates the drivers for simulation,
      types of simulators, training, and evaluation of them especially as it pertains
      to laparoscopic colorectal surgery.
FAU - Samia, Hoda
AU  - Samia H
AD  - Division of Colorectal Surgery, University Hospitals Case Medical Center,
      Cleveland, Ohio
FAU - Khan, Sadaf
AU  - Khan S
AD  - Division of Colorectal Surgery, University Hospitals Case Medical Center,
      Cleveland, Ohio
FAU - Lawrence, Justin
AU  - Lawrence J
AD  - Division of Colorectal Surgery, University Hospitals Case Medical Center,
      Cleveland, Ohio
FAU - Delaney, Conor P.
AU  - Delaney CP
AD  - Division of Colorectal Surgery, University Hospitals Case Medical Center,
      Cleveland, Ohio
LA  - eng
PT  - Journal Article
PT  - Review
TA  - Clin Colon Rectal Surg
JT  - Clinics in Colon and Rectal Surgery
AID - 10.1055/s-0033-1333661 [doi]
AID - 26047 [pii]
SO  - Clin Colon Rectal Surg. 2013 Mar;26(1):47-55. doi:10.1055/s-0033-1333661.

PMC - PMC5011930
PMID- 27596569
IS  - 1471-2261 (Electronic)
VI  - 16
IP  - 1
DP  - 2016
TI  - SMARTphone-based, early cardiac REHABilitation in patients with acute coronary
      syndromes [SMART-REHAB Trial]: a randomized controlled trial protocol.
LID - 170
AB  - Background: There are well-documented treatment gaps in secondary prevention of
      coronary heart disease and no clear guidelines to assist early physical activity 
      after acute coronary syndromes (ACS). Smartphone technology may provide an
      innovative platform to close these gaps. This paper describes the study design of
      a randomized controlled trial assessing whether a smartphone-based secondary
      prevention program can facilitate early physical activity and improve
      cardiovascular health in patients with ACS. Methods: We have developed a
      multi-faceted, patient-centred smartphone-based secondary prevention program
      emphasizing early physical activity with a graduated walking program initiated on
      discharge from ACS admission. The program incorporates; physical activity
      tracking through the smartphone’s accelerometer with interactive feedback and
      goal setting; a dynamic dashboard to review and optimize cardiovascular risk
      factors; educational messages delivered twice weekly; a photographic food diary; 
      pharmacotherapy review; and support through a short message service. The primary 
      endpoint of the trial is change in exercise capacity, as measured by the change
      in six-minute walk test distance at 8-weeks when compared to baseline. Secondary 
      endpoints include improvements in cardiovascular risk factor status,
      psychological well-being and quality of life, medication adherence, uptake of
      cardiac rehabilitation and re-hospitalizations. Discussion: This randomized
      controlled trial will use a smartphone-phone based secondary prevention program
      to emphasize early physical activity post-ACS. It will provide evidence regarding
      the feasibility and utility of this innovative platform in closing the treatment 
      gaps in secondary prevention. Trial registration: The trial was retrospectively
      registered in the Australian New Zealand Clinical Trials Registry (ANZCTR) on
      April 4, 2016. The registration number is ACTRN12616000426482.
FAU - Yudi, Matias B.
AU  - Yudi MB
AD  - Department of Cardiology, Austin Health, Melbourne, Australia
FAU - Clark, David J.
AU  - Clark DJ
AD  - Department of Cardiology, Austin Health, Melbourne, Australia
FAU - Tsang, David
AU  - Tsang D
AD  - Department of Cardiology, Western Health, Melbourne, Australia
FAU - Jelinek, Michael
AU  - Jelinek M
AD  - Department of Medicine, University of Melbourne, Melbourne, Australia
FAU - Kalten, Katie
AU  - Kalten K
AD  - Department of Cardiology, Austin Health, Melbourne, Australia
FAU - Joshi, Subodh
AU  - Joshi S
AD  - Monash Heart, Monash Health, Melbourne, Australia
FAU - Phan, Khoa
AU  - Phan K
AD  - Monash Heart, Monash Health, Melbourne, Australia
FAU - Nasis, Arthur
AU  - Nasis A
AD  - Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia
FAU - Amerena, John
AU  - Amerena J
AD  - Department of Cardiology, Barwon Health, Geelong, Australia
FAU - Arunothayaraj, Sandeep
AU  - Arunothayaraj S
AD  - Department of Cardiology, St Vincent’s Hospital, Melbourne, Australia
FAU - Reid, Chris
AU  - Reid C
AD  - School of Public Health, Curtin University, Perth, Western Australia Australia
FAU - Farouque, Omar
AU  - Farouque O
AD  - Department of Cardiology, Austin Health, Melbourne, Australia
LA  - eng
PT  - Journal Article
DEP - 20160905
GR  - 101130
PHST- 2016/07/14 [received]
PHST- 2016/08/26 [accepted]
TA  - BMC Cardiovasc Disord
JT  - BMC Cardiovascular Disorders
AID - 356 [pii]
AID - 10.1186/s12872-016-0356-6 [doi]
SO  - BMC Cardiovasc Disord. 2016 Sep 5;16(1):. doi:10.1186/s12872-016-0356-6.

PMC - PMC2630170
PMID- 19526048
IS  - 0899-9457 (Print)
VI  - 18
IP  - 1
DP  - 2008 Jun 13
TI  - Neurofeedback fMRI-mediated learning and consolidation of regional brain
      activation during motor imagery.
PG  - 69-78
AB  - We report the long-term effect of real-time functional MRI (rtfMRI) training on
      voluntary regulation of the level of activation from a hand motor area. During
      the performance of a motor imagery task of a right hand,
      blood-oxygenation-level-dependent (BOLD) signal originating from a primary motor 
      area was presented back to the subject in real-time. Demographically matched
      individuals also received the same procedure without valid feedback information. 
      Followed by the initial rtfMRI sessions, both groups underwent two-week long,
      daily-practice of the task. Off-line data analysis revealed that the individuals 
      in the experimental group were able to increase the level of BOLD signal from the
      regulatory target to a greater degree compared to the control group. Furthermore,
      the learned level of activation was maintained after the two-week period, with
      the recruitment of additional neural circuitries such as the hippocampus and the 
      limbo-thalamo-cortical pathway. The activation obtained from the control group,
      in the absence of proper feedback, was indifferent across the training
      conditions. The level of BOLD activity from the target regulatory region was
      positively correlated with a self evaluative score within the experimental group,
      while the majority of control subjects had difficulty adopting a strategy to
      attain the desired level of functional regulation. Our results suggest that
      rtfMRI helped individuals learn how to increase region-specific cortical activity
      associated with a motor imagery task, and the level of increased activation in
      motor areas was consolidated after the two-week self-practice period, with the
      involvement of neural circuitries implicated in motor skill learning.
FAU - Yoo, Seung-Schik
AU  - Yoo SS
FAU - Lee, Jong-Hwan
AU  - Lee JH
FAU - O’Leary, Heather
AU  - O’Leary H
FAU - Panych, Lawrence P.
AU  - Panych LP
FAU - Jolesz, Ferenc A.
AU  - Jolesz FA
LA  - eng
PT  - Journal Article
TA  - Int J Imaging Syst Technol
JT  - International journal of imaging systems and technology
AID - 10.1002/ima.20139 [doi]
MID - NIHMS65722
SO  - Int J Imaging Syst Technol. 2008 Jun 13;18(1):69-78. doi:10.1002/ima.20139.

PMC - PMC4905905
PMID- 27313366
IS  - 0915-5287 (Print)
IS  - 2187-5626 (Electronic)
VI  - 28
IP  - 5
DP  - 2016 May
TI  - Rhythmic auditory stimulation using a portable smart device: short-term effects
      on gait in chronic hemiplegic stroke patients.
PG  - 1538-43
AB  - [Purpose] The effects of various rhythmic auditory stimulation tempos on stroke
      gait pattern changes when training patients with a smartphone-based rhythmic
      auditory stimulation application were investigated. [Subjects and Methods]
      Fifteen patients with chronic stroke were included. Cadence during comfortable
      walking was measured (baseline). After the baseline findings were recorded,
      rhythmic auditory stimulation with five different tempos (i.e., −10%, −5%, 0%,
      +5%, and +10% change from baseline) was randomly applied. Finally, comfortable
      walking without rhythmic auditory stimulation was initiated to evaluate gait
      pattern changes. [Results] As the tempo increased, the spatiotemporal gait
      parameters of the stroke patients changed significantly. Gait speed, cadence, and
      gait cycle duration showed the greatest improvement in the +10% rhythmic auditory
      stimulation condition compared to baseline. After gait training with rhythmic
      auditory stimulation, gait speed, cadence, stride length, gait cycle duration,
      and step length of the affected and unaffected sides improved significantly
      compared to baseline. [Conclusion] Significant changes in the gait pattern of
      stroke patients were noted for various tempos after training with rhythmic
      auditory stimulation. These findings could be used to customize rehabilitative
      gait training for patients who experience stroke with hemiplegia.
FAU - Ko, Byung-Woo
AU  - Ko BW
AD  - Department of Rehabilitation and Assistive Technology, National Rehabilitation
      Research Institute, National Rehabilitation Center, Republic of Korea
FAU - Lee, Hwi-Young
AU  - Lee HY
AD  - Department of Rehabilitation and Assistive Technology, National Rehabilitation
      Research Institute, National Rehabilitation Center, Republic of Korea
FAU - Song, Won-Kyung
AU  - Song WK
AD  - Department of Rehabilitation and Assistive Technology, National Rehabilitation
      Research Institute, National Rehabilitation Center, Republic of Korea
LA  - eng
PT  - Journal Article
DEP - 20160531
PHST- 2015/12/14 [received]
PHST- 2016/02/02 [accepted]
TA  - J Phys Ther Sci
JT  - Journal of Physical Therapy Science
AID - jpts-2015-1079 [pii]
AID - 10.1589/jpts.28.1538 [doi]
SO  - J Phys Ther Sci. 2016 May;28(5):1538-43. Epub 2016 May 31
      doi:10.1589/jpts.28.1538.

PMC - PMC3427766
PMID- 21954988
IS  - 0929-7049 (Print)
IS  - 1744-4136 (Electronic)
VI  - 18
IP  - 4
DP  - 2012 Jul
TI  - A Brief Primer on Sleep for Pediatric and Child Clinical Neuropsychologists.
PG  - 313-38
AB  - Sleep problems are common in the children seen by pediatric and child clinical
      neuropsychologists, and these problems have the potential to significantly impact
      the child and his or her family. All are treatable to some degree, and some
      respond extremely well to existing treatments. This paper provides a brief
      overview of the impact, nature, screening, and treatment for childhood sleep
      problems, with a particular emphasis on issues relevant to practicing
      neuropsychologists.
FAU - Beebe, Dean W.
AU  - Beebe DW
AD  - Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio. Department of
      Pediatrics, University of Cincinnati College of Medicine, Cincinnati Ohio
LA  - eng
PT  - Journal Article
DEP - 20110928
TA  - Child Neuropsychol
JT  - Child neuropsychology : a journal on normal and abnormal development in childhood
      and adolescence
AID - 10.1080/09297049.2011.602014 [doi]
MID - NIHMS388101
SO  - Child Neuropsychol. 2012 Jul;18(4):313-38. Epub 2011 Sep 28
      doi:10.1080/09297049.2011.602014.

PMC - PMC2703263
PMID- 19675738
IS  - 1612-3174 (Electronic)
VI  - 6
DP  - 2008
TI  - Improvement of wound healing by water-filtered infrared-A (wIRA) in patients with
      chronic venous stasis ulcers of the lower legs including evaluation using
      infrared thermography.
LID - Doc11
AB  - Background: Water-filtered infrared-A (wIRA) is a special form of heat radiation 
      with a high tissue-penetration and with a low thermal burden to the surface of
      the skin. wIRA is able to improve essential and energetically meaningful factors 
      of wound healing by thermal and non-thermal effects. Aim of the study:
      prospective study (primarily planned randomised, controlled, blinded, de facto
      with one exception only one cohort possible) using wIRA in the treatment of
      patients with recalcitrant chronic venous stasis ulcers of the lower legs with
      thermographic follow-up. Methods: 10 patients (5 males, 5 females, median age 62 
      years) with 11 recalcitrant chronic venous stasis ulcers of the lower legs were
      treated with water-filtered infrared-A and visible light irradiation (wIRA(+VIS),
      Hydrosun® radiator type 501, 10 mm water cuvette, water-filtered spectrum
      550–1400 nm) or visible light irradiation (VIS; only possible in one patient).
      The uncovered wounds of the patients were irradiated two to five times per week
      for 30 minutes at a standard distance of 25 cm (approximately 140 mW/cm2 wIRA and
      approximately 45 mW/cm2 VIS). Treatment continued for a period of up to 2 months 
      (typically until closure or nearly closure of the ulcer). The main variable of
      interest was “percent change of ulcer size over time” including complete wound
      closure. Additional variables of interest were thermographic image analysis,
      patient’s feeling of pain in the wound, amount of pain medication, assessment of 
      the effect of the irradiation (by patient and by clinical investigator),
      assessment of feeling of the wound area (by patient), assessment of wound healing
      (by clinical investigator) and assessment of the cosmetic state (by patient and
      by clinical investigator). For these assessments visual analogue scales (VAS)
      were used. Results: The study showed a complete or nearly complete healing of
      lower leg ulcers in 7 patients and a clear reduction of ulcer size in another 2
      of 10 patients, a clear reduction of pain and pain medication consumption (e.g.
      from 15 to 0 pain tablets per day), and a normalization of the thermographic
      image (before the beginning of the therapy typically hyperthermic rim of the
      ulcer with relative hypothermic ulcer base, up to 4.5°C temperature difference). 
      In one patient the therapy of an ulcer of one leg was performed with the fully
      active radiator (wIRA(+VIS)), while the therapy of an ulcer of the other leg was 
      made with a control group radiator (only VIS without wIRA), showing a clear
      difference in favour of the wIRA treatment. All mentioned VAS ratings improved
      remarkably during the period of irradiation treatment, representing an increased 
      quality of life. Failures of complete or nearly complete wound healing were seen 
      only in patients with arterial insufficiency, in smokers or in patients who did
      not have venous compression garment therapy. Discussion and conclusions: wIRA can
      alleviate pain considerably (with an impressive decrease of the consumption of
      analgesics) and accelerate wound healing or improve a stagnating wound healing
      process and diminish an elevated wound exudation and inflammation both in acute
      and in chronic wounds (in this study shown in chronic venous stasis ulcers of the
      lower legs) and in problem wounds including infected wounds. In chronic
      recalcitrant wounds complete healing is achieved, which was not reached before.
      Other studies have shown that even without a disturbance of wound healing an
      acute wound healing process can be improved (e.g. reduced pain) by wIRA. wIRA is 
      a contact-free, easily used and pleasantly felt procedure without consumption of 
      material with a good penetration effect, which is similar to solar heat radiation
      on the surface of the earth in moderate climatic zones. Wound healing and
      infection defence (e.g. granulocyte function including antibacterial oxygen
      radical formation of the granulocytes) are critically dependent on a sufficient
      energy supply (and on sufficient oxygen). The good clinical effect of wIRA on
      wounds and also on problem wounds and wound infections can be explained by the
      improvement of both the energy supply and the oxygen supply (e.g. for the
      granulocyte function). wIRA causes as a thermal effect in the tissue an
      improvement in three decisive factors: tissue oxygen partial pressure, tissue
      temperature and tissue blood flow. Besides this non-thermal effects of infrared-A
      by direct stimulation of cells and cellular structures with reactions of the
      cells have also been described. It is concluded that wIRA can be used to improve 
      wound healing, to reduce pain, exudation, and inflammation and to increase
      quality of life.
OAB - Publisher: Abstract available from the publisher.
OABL- ger
FAU - Mercer, James B.
AU  - Mercer JB
AD  - Department of Medical Physiology, Faculty of Medicine, University of Tromsø,
      Norway
FAU - Nielsen, Stig Pors
AU  - Nielsen SP
AD  - Department of Clinical Physiology, Hillerød Hospital, Hillerød, Denmark
FAU - Hoffmann, Gerd
AU  - Hoffmann G
AD  - Institute of Sports Sciences, Johann Wolfgang Goethe University, Frankfurt/Main, 
      Germany
LA  - eng
PT  - Journal Article
DEP - 20081021
PHST- 2008/04/17 [received]
PHST- 2008/07/02 [revised]
TA  - Ger Med Sci
JT  - GMS German Medical Science
AID - 000056 [pii]
SO  - Ger Med Sci. 2008 Oct 21;6:.

PMC - PMC4992723
PMID- 27597821
IS  - 1662-5161 (Electronic)
VI  - 10
DP  - 2016
TI  - Structural and Functional MRI Differences in Master Sommeliers: A Pilot Study on 
      Expertise in the Brain.
LID - 414
AB  - Our experiences, even as adults, shape our brains. Regional differences have been
      found in experts, with the regions associated with their particular skill-set.
      Functional differences have also been noted in brain activation patterns in some 
      experts. This study uses multimodal techniques to assess structural and
      functional patterns that differ between experts and non-experts. Sommeliers are
      experts in wine and thus in olfaction. We assessed differences in Master
      Sommeliers’ brains, compared with controls, in structure and also in functional
      response to olfactory and visual judgment tasks. MRI data were analyzed using
      voxel-based morphometry as well as automated parcellation to assess structural
      properties, and group differences between tasks were calculated. Results indicate
      enhanced volume in the right insula and entorhinal cortex, with the cortical
      thickness of the entorhinal correlating with experience. There were regional
      activation differences in a large area involving the right olfactory and memory
      regions, with heightened activation specifically for sommeliers during an
      olfactory task. Our results indicate that sommeliers’ brains show specialization 
      in the expected regions of the olfactory and memory networks, and also in regions
      important in integration of internal sensory stimuli and external cues. Overall, 
      these differences suggest that specialized expertise and training might result in
      enhancements in the brain well into adulthood. This is particularly important
      given the regions involved, which are the first to be impacted by many
      neurodegenerative diseases.
FAU - Banks, Sarah J.
AU  - Banks SJ
AD  - Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA
FAU - Sreenivasan, Karthik R.
AU  - Sreenivasan KR
AD  - Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA
FAU - Weintraub, David M.
AU  - Weintraub DM
AD  - Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA
FAU - Baldock, Deanna
AU  - Baldock D
AD  - Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA
FAU - Noback, Michael
AU  - Noback M
AD  - Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA
FAU - Pierce, Meghan E.
AU  - Pierce ME
AD  - Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA
FAU - Frasnelli, Johannes
AU  - Frasnelli J
AD  - Université du Québec à Trois-Rivières, Trois-RivièresQC, Canada
FAU - James, Jay
AU  - James J
AD  - Chappellet Vineyard, NapaCA, USA
FAU - Beall, Erik
AU  - Beall E
AD  - Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA
FAU - Zhuang, Xiaowei
AU  - Zhuang X
AD  - Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA
FAU - Cordes, Dietmar
AU  - Cordes D
AD  - Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA
FAU - Leger, Gabriel C.
AU  - Leger GC
AD  - Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA
LA  - eng
PT  - Journal Article
DEP - 20160822
PHST- 2015/09/29 [received]
PHST- 2016/08/04 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2016.00414 [doi]
SO  - Front Hum Neurosci. 2016 Aug 22;10:. doi:10.3389/fnhum.2016.00414.

PMC - PMC4477170
PMID- 26157374
IS  - 1662-5161 (Electronic)
VI  - 9
DP  - 2015
TI  - Combinations of stroke neurorehabilitation to facilitate motor recovery:
      perspectives on Hebbian plasticity and homeostatic metaplasticity.
LID - 349
AB  - Motor recovery after stroke involves developing new neural connections, acquiring
      new functions, and compensating for impairments. These processes are related to
      neural plasticity. Various novel stroke rehabilitation techniques based on basic 
      science and clinical studies of neural plasticity have been developed to aid
      motor recovery. Current research aims to determine whether using combinations of 
      these techniques can synergistically improve motor recovery. When different
      stroke neurorehabilitation therapies are combined, the timing of each therapeutic
      program must be considered to enable optimal neural plasticity. Synchronizing
      stroke rehabilitation with voluntary neural and/or muscle activity can lead to
      motor recovery by targeting Hebbian plasticity. This reinforces the neural
      connections between paretic muscles and the residual motor area. Homeostatic
      metaplasticity, which stabilizes the activity of neurons and neural circuits, can
      either augment or reduce the synergic effect depending on the timing of
      combination therapy and types of neurorehabilitation that are used. Moreover, the
      possibility that the threshold and degree of induced plasticity can be altered
      after stroke should be noted. This review focuses on the mechanisms underlying
      combinations of neurorehabilitation approaches and their future clinical
      applications. We suggest therapeutic approaches for cortical reorganization and
      maximal functional gain in patients with stroke, based on the processes of
      Hebbian plasticity and homeostatic metaplasticity. Few of the possible
      combinations of stroke neurorehabilitation have been tested experimentally;
      therefore, further studies are required to determine the appropriate combination 
      for motor recovery.
FAU - Takeuchi, Naoyuki
AU  - Takeuchi N
FAU - Izumi, Shin-Ichi
AU  - Izumi SI
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20150623
GR  - 25242054
PHST- 2014/12/30 [received]
PHST- 2015/05/31 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2015.00349 [doi]
SO  - Front Hum Neurosci. 2015 Jun 23;9:. doi:10.3389/fnhum.2015.00349.

PMC - PMC3009617
PMID- 21092187
IS  - 1750-1172 (Electronic)
VI  - 5
DP  - 2010
TI  - Fabry disease.
PG  - 30
AB  - Fabry disease (FD) is a progressive, X-linked inherited disorder of
      glycosphingolipid metabolism due to deficient or absent lysosomal α-galactosidase
      A activity. FD is pan-ethnic and the reported annual incidence of 1 in 100,000
      may underestimate the true prevalence of the disease. Classically affected
      hemizygous males, with no residual α-galactosidase A activity may display all the
      characteristic neurological (pain), cutaneous (angiokeratoma), renal
      (proteinuria, kidney failure), cardiovascular (cardiomyopathy, arrhythmia),
      cochleo-vestibular and cerebrovascular (transient ischemic attacks, strokes)
      signs of the disease while heterozygous females have symptoms ranging from very
      mild to severe. Deficient activity of lysosomal α-galactosidase A results in
      progressive accumulation of globotriaosylceramide within lysosomes, believed to
      trigger a cascade of cellular events. Demonstration of marked α-galactosidase A
      deficiency is the definitive method for the diagnosis of hemizygous males. Enzyme
      analysis may occasionnally help to detect heterozygotes but is often inconclusive
      due to random X-chromosomal inactivation so that molecular testing (genotyping)
      of females is mandatory. In childhood, other possible causes of pain such as
      rheumatoid arthritis and 'growing pains' must be ruled out. In adulthood,
      multiple sclerosis is sometimes considered. Prenatal diagnosis, available by
      determination of enzyme activity or DNA testing in chorionic villi or cultured
      amniotic cells is, for ethical reasons, only considered in male fetuses.
      Pre-implantation diagnosis is possible. The existence of atypical variants and
      the availability of a specific therapy singularly complicate genetic counseling. 
      A disease-specific therapeutic option - enzyme replacement therapy using
      recombinant human α-galactosidase A - has been recently introduced and its long
      term outcome is currently still being investigated. Conventional management
      consists of pain relief with analgesic drugs, nephroprotection (angiotensin
      converting enzyme inhibitors and angiotensin receptors blockers) and
      antiarrhythmic agents, whereas dialysis or renal transplantation are available
      for patients experiencing end-stage renal failure. With age, progressive damage
      to vital organ systems develops and at some point, organs may start to fail in
      functioning. End-stage renal disease and life-threatening cardiovascular or
      cerebrovascular complications limit life-expectancy of untreated males and
      females with reductions of 20 and 10 years, respectively, as compared to the
      general population. While there is increasing evidence that long-term enzyme
      therapy can halt disease progression, the importance of adjunctive therapies
      should be emphasized and the possibility of developing an oral therapy drives
      research forward into active site specific chaperones.
FAU - Germain, Dominique P
AU  - Germain DP
AD  - University of Versailles - St Quentin en Yvelines (UVSQ), Faculté de Médecine
      Paris - Ile de France Ouest (PIFO), 78035 Versailles, France
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20101122
PHST- 2009/04/01 [received]
PHST- 2010/11/22 [accepted]
TA  - Orphanet J Rare Dis
JT  - Orphanet Journal of Rare Diseases
AID - 1750-1172-5-30 [pii]
AID - 10.1186/1750-1172-5-30 [doi]
SO  - Orphanet J Rare Dis. 2010 Nov 22;5:30. doi:10.1186/1750-1172-5-30.

PMC - PMC5499776
PMID- 28713549
IS  - 2046-1402 (Electronic)
VI  - 6
DP  - 2017
TI  - Where are aphasia theory and management “headed”?
LID - F1000 Faculty Rev-1038
AB  - The sequelae of post-stroke aphasia are considerable, necessitating an
      understanding of the functional neuroanatomy of language, cognitive processes
      underlying various language tasks, and the mechanisms of recovery after stroke.
      This knowledge is vital in providing optimal care of individuals with aphasia and
      counseling to their families and caregivers. The standard of care in the
      rehabilitation of aphasia dictates that treatment be evidence-based and
      person-centered. Promising techniques, such as cortical stimulation as an adjunct
      to behavioral therapy, are just beginning to be explored. These topics are
      discussed in this review.
FAU - Tippett, Donna C.
AU  - Tippett DC
AUID- ORCID: 0000-0001-9485-9745
AD  - Department of Neurology, Johns Hopkins University School of Medicine, Phipps 446,
      600 N. Wolfe Street, Baltimore, MD, 21287, USA
FAU - Hillis, Argye E.
AU  - Hillis AE
AD  - Department of Neurology, Johns Hopkins University School of Medicine, Phipps 446,
      600 N. Wolfe Street, Baltimore, MD, 21287, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170703
GR  - P50 DC014664
PHST- 2017/06/30 [accepted]
TA  - F1000Res
JT  - F1000Research
AID - 10.12688/f1000research.11122.1 [doi]
SO  - F1000Res. 2017 Jul 3;6:. doi:10.12688/f1000research.11122.1.

PMC - PMC4232317
PMID- 25147224
IS  - 1049-7323 (Print)
IS  - 1552-7557 (Electronic)
VI  - 24
IP  - 11
DP  - 2014 Nov
DP  - 2014 Nov
TI  - Assistive Technology Provision Within the Navajo Nation: User and Provider
      Perceptions.
PG  - 1501-17
AB  - In this study we explored the factors that affect assistive technology (AT)
      provision within the Navajo Nation using a qualitative approach to inquiry. Focus
      groups were held in which AT users discussed their awareness of AT and their need
      for, use of, and satisfaction with AT devices and services. Twenty-eight
      individuals who used wheelchairs, orthotics or prosthetics, hearing aids,
      communication aids, vision aids, and other AT participated in one of seven focus 
      groups. Seven AT providers discussed the facilitators and barriers that affect AT
      provision. The findings revealed six themes common to both stakeholder groups and
      two additional themes for AT users. The central theme for AT users centered on
      (not) feeling understood; the central theme for AT providers revolved around the 
      processes, activities, and roles the providers engaged in at times for different 
      clients. Activities to increase awareness and to promote successful AT provision 
      and satisfaction with AT devices were proposed.
FAU - Reisinger, Kim D.
AU  - Reisinger KD
AD  - San Francisco State University, San Francisco, California, USA
FAU - Ripat, Jacquie D.
AU  - Ripat JD
AD  - University of Manitoba, Winnipeg, Manitoba, Canada
LA  - eng
PT  - Journal Article
TA  - Qual Health Res
JT  - Qualitative Health Research
AID - 10.1177/1049732314546755 [doi]
AID - 10.1177_1049732314546755 [pii]
SO  - Qual Health Res. 2014 Nov;24(11):1501-17. doi:10.1177/1049732314546755.

PMC - PMC5406691
PMID- 28350371
IS  - 2076-3425 (Electronic)
VI  - 7
IP  - 4
DP  - 2017 Apr
TI  - A Neurophysiological Perspective on a Preventive Treatment against Schizophrenia 
      Using Transcranial Electric Stimulation of the Corticothalamic Pathway.
LID - 34
AB  - Schizophrenia patients are waiting for a treatment free of detrimental effects.
      Psychotic disorders are devastating mental illnesses associated with
      dysfunctional brain networks. Ongoing brain network gamma frequency (30–80 Hz)
      oscillations, naturally implicated in integrative function, are excessively
      amplified during hallucinations, in at-risk mental states for psychosis and
      first-episode psychosis. So, gamma oscillations represent a bioelectrical marker 
      for cerebral network disorders with prognostic and therapeutic potential. They
      accompany sensorimotor and cognitive deficits already present in prodromal
      schizophrenia. Abnormally amplified gamma oscillations are reproduced in the
      corticothalamic systems of healthy humans and rodents after a single systemic
      administration, at a psychotomimetic dose, of the glutamate N-methyl-d-aspartate 
      receptor antagonist ketamine. These translational ketamine models of prodromal
      schizophrenia are thus promising to work out a preventive noninvasive treatment
      against first-episode psychosis and chronic schizophrenia. In the present essay, 
      transcranial electric stimulation (TES) is considered an appropriate preventive
      therapeutic modality because it can influence cognitive performance and neural
      oscillations. Here, I highlight clinical and experimental findings showing that, 
      together, the corticothalamic pathway, the thalamus, and the glutamatergic
      synaptic transmission form an etiopathophysiological backbone for schizophrenia
      and represent a potential therapeutic target for preventive TES of dysfunctional 
      brain networks in at-risk mental state patients against psychotic disorders.
FAU - Pinault, Didier
AU  - Pinault D
AD  - INSERM U1114, Neuropsychologie Cognitive et Physiopathologie de la Schizophrénie,
      Strasbourg F-67085, France; pinault@unistra.fr; Tel.: +33-(0)3-6885-3245
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170328
PHST- 2016/12/01 [received]
PHST- 2017/03/24 [accepted]
TA  - Brain Sci
JT  - Brain Sciences
AID - 10.3390/brainsci7040034 [doi]
AID - brainsci-07-00034 [pii]
SO  - Brain Sci. 2017 Mar 28;7(4):. doi:10.3390/brainsci7040034.

PMC - PMC5031704
PMID- 27713691
IS  - 1662-5110 (Electronic)
VI  - 10
DP  - 2016
TI  - Characterizing and Modulating Brain Circuitry through Transcranial Magnetic
      Stimulation Combined with Electroencephalography.
LID - 73
AB  - The concurrent combination of transcranial magnetic stimulation (TMS) with
      electroencephalography (TMS-EEG) is a powerful technology for characterizing and 
      modulating brain networks across developmental, behavioral, and disease states.
      Given the global initiatives in mapping the human brain, recognition of the
      utility of this technique is growing across neuroscience disciplines.
      Importantly, TMS-EEG offers translational biomarkers that can be applied in
      health and disease, across the lifespan, and in humans and animals, bridging the 
      gap between animal models and human studies. However, to utilize the full
      potential of TMS-EEG methodology, standardization of TMS-EEG study protocols is
      needed. In this article, we review the principles of TMS-EEG methodology, factors
      impacting TMS-EEG outcome measures, and the techniques for preventing and
      correcting artifacts in TMS-EEG data. To promote the standardization of this
      technique, we provide comprehensive guides for designing TMS-EEG studies and
      conducting TMS-EEG experiments. We conclude by reviewing the application of
      TMS-EEG in basic, cognitive and clinical neurosciences, and evaluate the
      potential of this emerging technology in brain research.
FAU - Farzan, Faranak
AU  - Farzan F
AD  - Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and
      Mental Health, University of TorontoToronto, ON, Canada
FAU - Vernet, Marine
AU  - Vernet M
AD  - Berenson-Allen Center for Non-invasive Brain Stimulation, Beth Israel Deaconess
      Medical Center, Harvard Medical SchoolBoston, MA, USA
FAU - Shafi, Mouhsin M. D.
AU  - Shafi MMD
AD  - Berenson-Allen Center for Non-invasive Brain Stimulation, Beth Israel Deaconess
      Medical Center, Harvard Medical SchoolBoston, MA, USA
FAU - Rotenberg, Alexander
AU  - Rotenberg A
AD  - Berenson-Allen Center for Non-invasive Brain Stimulation, Beth Israel Deaconess
      Medical Center, Harvard Medical SchoolBoston, MA, USA
FAU - Daskalakis, Zafiris J.
AU  - Daskalakis ZJ
AD  - Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and
      Mental Health, University of TorontoToronto, ON, Canada
FAU - Pascual-Leone, Alvaro
AU  - Pascual-Leone A
AD  - Berenson-Allen Center for Non-invasive Brain Stimulation, Beth Israel Deaconess
      Medical Center, Harvard Medical SchoolBoston, MA, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20160922
PHST- 2016/06/20 [received]
PHST- 2016/09/07 [accepted]
TA  - Front Neural Circuits
JT  - Frontiers in Neural Circuits
AID - 10.3389/fncir.2016.00073 [doi]
SO  - Front Neural Circuits. 2016 Sep 22;10:. doi:10.3389/fncir.2016.00073.

PMC - PMC4833014
PMID- 26445375
IS  - 0148-396X (Print)
IS  - 1524-4040 (Electronic)
VI  - 78
IP  - 2
DP  - 2016 Feb
TI  - Examining Recovery Trajectories Following Sport-related Concussion Using a
      Multi-Modal Clinical Assessment Approach.
PG  - 232-41
AB  - Background: Previous research estimates that the majority of athletes with
      sport-related concussion (SRC) will recover between 7–10 days following injury.
      This short, temporal window of recovery is predominately based on symptom
      resolution and cognitive improvement, and does not accurately reflect recent
      advances to the clinical assessment model. Objective: To characterize SRC
      recovery at 1-week post-injury time intervals on symptom, neurocognitive, and
      vestibular-oculomotor outcomes, and examine gender differences on SRC recovery
      time. Methods: A prospective, repeated measures design was used to examine the
      temporal resolution of neurocognitive, symptom, and vestibular-oculomotor
      impairment in 66 subjects (16.5 ± 1.9 years, range 14–23, 64% male) with SRC.
      Results: Recovery time across all outcomes was between 21–28 days post SRC for
      most athletes. Symptoms demonstrated the greatest improvement in the first 2
      weeks, while neurocognitive impairment lingered across various domains up to 28
      days post SRC. Vestibular-oculomotor decrements also resolved between one to
      three weeks post injury. There were no gender differences in neurocognitive
      recovery. Males were more likely to be asymptomatic by the fourth week and
      reported less vestibular-oculomotor impairment than females at weeks 1 and 2.
      Conclusion: When utilizing the recommended “comprehensive” approach for
      concussion assessment, recovery time for SRC is approximately three to four
      weeks, which is longer than the commonly reported 7–14 days. Sports medicine
      clinicians should use a variety of complementing assessment tools to capture the 
      heterogeneity of SRC.
FAU - Henry, Luke C.
AU  - Henry LC
AD  - Department of Orthopaedic Surgery/UPMC Sports Medicine Concussion Program-
      University of Pittsburgh
FAU - Elbin, RJ
AU  - Elbin R
AD  - Department of Health, Human Performance and Recreation/Office for Sport
      Concussion Research- University of Arkansas
FAU - Collins, Michael W.
AU  - Collins MW
AD  - Department of Orthopaedic Surgery/UPMC Sports Medicine Concussion Program-
      University of Pittsburgh
FAU - Marchetti, Gregory
AU  - Marchetti G
AD  - Department of Physical Therapy, Rangos School of Health Sciences- Duquesne
      University
FAU - Kontos, Anthony P.
AU  - Kontos AP
AD  - Department of Orthopaedic Surgery/UPMC Sports Medicine Concussion Program-
      University of Pittsburgh
LA  - eng
PT  - Journal Article
TA  - Neurosurgery
JT  - Neurosurgery
AID - 10.1227/NEU.0000000000001041 [doi]
MID - NIHMS775857
SO  - Neurosurgery. 2016 Feb;78(2):232-41. doi:10.1227/NEU.0000000000001041.

PMC - PMC5087358
PMID- 27669260
IS  - 1424-8220 (Electronic)
VI  - 16
IP  - 10
DP  - 2016 Oct
TI  - Sensor Fusion and Smart Sensor in Sports and Biomedical Applications.
LID - 1569
AB  - The following work presents an overview of smart sensors and sensor fusion
      targeted at biomedical applications and sports areas. In this work, the
      integration of these areas is demonstrated, promoting a reflection about
      techniques and applications to collect, quantify and qualify some physical
      variables associated with the human body. These techniques are presented in
      various biomedical and sports applications, which cover areas related to
      diagnostics, rehabilitation, physical monitoring, and the development of
      performance in athletes, among others. Although some applications are described
      in only one of two fields of study (biomedicine and sports), it is very likely
      that the same application fits in both, with small peculiarities or adaptations. 
      To illustrate the contemporaneity of applications, an analysis of specialized
      papers published in the last six years has been made. In this context, the main
      characteristic of this review is to present the largest quantity of relevant
      examples of sensor fusion and smart sensors focusing on their utilization and
      proposals, without deeply addressing one specific system or technique, to the
      detriment of the others.
FAU - Mendes, José Jair Alves
AU  - Mendes JJA
AD  - Department of Electronic Engineering, Federal University of Technology of Parana 
      (UTFPR), Ponta Grossa (PR) 84016-210, Brazil; josej@alunos.utfpr.edu.br
      (J.J.A.M.J.); mariovieira@alunos.utfpr.edu.br (M.E.M.V.);
      mpires@alunos.utfpr.edu.br (M.B.P.)
FAU - Vieira, Mário Elias Marinho
AU  - Vieira MEM
AD  - Department of Electronic Engineering, Federal University of Technology of Parana 
      (UTFPR), Ponta Grossa (PR) 84016-210, Brazil; josej@alunos.utfpr.edu.br
      (J.J.A.M.J.); mariovieira@alunos.utfpr.edu.br (M.E.M.V.);
      mpires@alunos.utfpr.edu.br (M.B.P.)
FAU - Pires, Marcelo Bissi
AU  - Pires MB
AD  - Department of Electronic Engineering, Federal University of Technology of Parana 
      (UTFPR), Ponta Grossa (PR) 84016-210, Brazil; josej@alunos.utfpr.edu.br
      (J.J.A.M.J.); mariovieira@alunos.utfpr.edu.br (M.E.M.V.);
      mpires@alunos.utfpr.edu.br (M.B.P.)
FAU - Stevan, Sergio Luiz
AU  - Stevan SL
AD  - Department of Electronic Engineering, Federal University of Technology of Parana 
      (UTFPR), Ponta Grossa (PR) 84016-210, Brazil; josej@alunos.utfpr.edu.br
      (J.J.A.M.J.); mariovieira@alunos.utfpr.edu.br (M.E.M.V.);
      mpires@alunos.utfpr.edu.br (M.B.P.)
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20160923
PHST- 2016/06/28 [received]
PHST- 2016/09/13 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s16101569 [doi]
AID - sensors-16-01569 [pii]
SO  - Sensors (Basel). 2016 Sep 23;16(10):. doi:10.3390/s16101569.

PMC - PMC5018694
PMID- 27615029
IS  - 2045-2322 (Electronic)
VI  - 6
DP  - 2016
TI  - Cognitive Priming and Cognitive Training: Immediate and Far Transfer to Academic 
      Skills in Children.
LID - 32859
AB  - Cognitive operations are supported by dynamically reconfiguring neural systems
      that integrate processing components widely distributed throughout the brain. The
      inter-neuronal connections that constitute these systems are powerfully shaped by
      environmental input. We evaluated the ability of computer-presented brain
      training games done in school to harness this neuroplastic potential and improve 
      learning in an overall study sample of 583 second-grade children. Doing a
      5-minute brain-training game immediately before math or reading curricular
      content games increased performance on the curricular content games. Doing three 
      20-minute brain training sessions per week for four months increased gains on
      school-administered math and reading achievement tests compared to control
      classes tested at the same times without intervening brain training. These
      results provide evidence of cognitive priming with immediate effects on learning,
      and longer-term brain training with far-transfer or generalized effects on
      academic achievement.
FAU - Wexler, Bruce E
AU  - Wexler BE
AD  - Department of Psychiatry Yale University School of Medicine, 34 Park St, New
      Haven, CT 05619, USA
FAU - Iseli, Markus
AU  - Iseli M
AD  - National Center for Research on Evaluation, Standards, and Student Testing,
      CRESST/UCLA, 300 Charles E. Young Drive North, Los Angeles, CA, 90095USA
FAU - Leon, Seth
AU  - Leon S
AD  - National Center for Research on Evaluation, Standards, and Student Testing,
      CRESST/UCLA, 300 Charles E. Young Drive North, Los Angeles, CA, 90095USA
FAU - Zaggle, William
AU  - Zaggle W
AD  - C8 Sciences, 5 Science Park, New Haven, CT 06511, 970-371-1795, USA
FAU - Rush, Cynthia
AU  - Rush C
AD  - Department of Statistics, Yale University, 24 Hilhouse Ave, New Haven CT, 06511, 
      USA.
FAU - Goodman, Annette
AU  - Goodman A
AD  - New Initiatives, 6 Cedar Lane, Cedarhurst, NY 11516, 917-584-0137, USA.
FAU - Esat Imal, A.
AU  - Esat Imal A
AD  - Department of Psychiatry Yale University School of Medicine, 34 Park St, New
      Haven, CT 05619, USA
FAU - Bo, Emily
AU  - Bo E
AD  - National Center for Research on Evaluation, Standards, and Student Testing,
      CRESST/UCLA, 300 Charles E. Young Drive North, Los Angeles, CA, 90095USA
LA  - eng
PT  - Journal Article
DEP - 20160912
PHST- 2016/04/21 [received]
PHST- 2016/08/11 [accepted]
TA  - Sci Rep
JT  - Scientific Reports
AID - srep32859 [pii]
AID - 10.1038/srep32859 [doi]
SO  - Sci Rep. 2016 Sep 12;6:. doi:10.1038/srep32859.

PMC - PMC3893035
PMID- 24045579
IS  - 1741-2560 (Print)
IS  - 1741-2552 (Electronic)
VI  - 10
IP  - 5
DP  - 2013 Oct
TI  - Holographic display system for restoration of sight to the blind.
PG  - 056021
AB  - Objective: We present a holographic near-the-eye display system enabling optical 
      approaches for sight restoration to the blind, such as photovoltaic retinal
      prosthesis, optogenetic and other photoactivation techniques. We compare it with 
      conventional LCD or DLP-based displays in terms of image quality, field of view, 
      optical efficiency and safety. Approach: We detail the optical configuration of
      the holographic display system and its characterization using a phase-only
      spatial light modulator. Main results: We describe approaches to controlling the 
      zero diffraction order and speckle related issues in holographic display systems 
      and assess the image quality of such systems. We show that holographic techniques
      offer significant advantages in terms of peak irradiance and power efficiency,
      and enable designs that are inherently safer than LCD or DLP-based systems. We
      demonstrate the performance of our holographic display system in the assessment
      of cortical response to alternating gratings projected onto the retinas of rats. 
      Significance: We address the issues associated with the design of high
      brightness, near-the-eye display systems and propose solutions to the efficiency 
      and safety challenges with an optical design which could be miniaturized and
      mounted onto goggles.
FAU - Goetz, G A
AU  - Goetz GA
AD  - Hansen Experimental Physics Laboratory, Stanford University, Stanford, CA 94305, 
      USA
FAU - Mandel, Y
AU  - Mandel Y
AD  - Hansen Experimental Physics Laboratory, Stanford University, Stanford, CA 94305, 
      USA
FAU - Manivanh, R
AU  - Manivanh R
AD  - Department of Ophthalmology, Stanford University, Stanford, CA 94305, USA
FAU - Palanker, D V
AU  - Palanker DV
AD  - Hansen Experimental Physics Laboratory, Stanford University, Stanford, CA 94305, 
      USA
FAU - Čižmár, T
AU  - Čižmár T
AD  - School of Medicine, University of St Andrews, North Haugh, KY16 9TF, UK
LA  - eng
PT  - Journal Article
DEP - 20130918
GR  - R01 EY018608 || EY
TA  - J Neural Eng
JT  - Journal of neural engineering
AID - 10.1088/1741-2560/10/5/056021 [doi]
MID - NIHMS528913
SO  - J Neural Eng. 2013 Oct;10(5):056021. Epub 2013 Sep 18
      doi:10.1088/1741-2560/10/5/056021.

PMC - PMC1766006
IS  - 0040-6376 (Print)
IS  - 1468-3296 (Electronic)
VI  - 57
IP  - Suppl 3
DP  - 2002 Dec
TI  - Poster presentations.
PG  - iii48-94
LA  - eng
PT  - Journal Article
TA  - Thorax
JT  - Thorax
AID - 10.1136/thorax.57.suppl_3.iii48 [doi]
SO  - Thorax. 2002 Dec;57(Suppl 3):iii48-94. doi:10.1136/thorax.57.suppl_3.iii48.

PMC - PMC3529482
PMID- 23304507
IS  - 2090-2204 (Print)
IS  - 2090-2212 (Electronic)
VI  - 2012
DP  - 2012
TI  - Robotics to Enable Older Adults to Remain Living at Home.
LID - 538169
AB  - Given the rapidly ageing population, interest is growing in robots to enable
      older people to remain living at home. We conducted a systematic review and
      critical evaluation of the scientific literature, from 1990 to the present, on
      the use of robots in aged care. The key research questions were as follows: (1)
      what is the range of robotic devices available to enable older people to remain
      mobile, independent, and safe? and, (2) what is the evidence demonstrating that
      robotic devices are effective in enabling independent living in community
      dwelling older people? Following database searches for relevant literature an
      initial yield of 161 articles was obtained. Titles and abstracts of articles were
      then reviewed by 2 independent people to determine suitability for inclusion.
      Forty-two articles met the criteria for question 1. Of these, 4 articles met the 
      criteria for question 2. Results showed that robotics is currently available to
      assist older healthy people and people with disabilities to remain independent
      and to monitor their safety and social connectedness. Most studies were conducted
      in laboratories and hospital clinics. Currently limited evidence demonstrates
      that robots can be used to enable people to remain living at home, although this 
      is an emerging smart technology that is rapidly evolving.
FAU - Pearce, Alan J.
AU  - Pearce AJ
AD  - Cognitive and Exercise Neuroscience Unit, School of Psychology, Deakin
      University, Melbourne, VIC, Australia
FAU - Adair, Brooke
AU  - Adair B
AD  - Department of Physiotherapy, The University of Melbourne, Melbourne, VIC,
      Australia
FAU - Miller, Kimberly
AU  - Miller K
AUID- ORCID: 0000-0002-9826-7269
AD  - Department of Physiotherapy, The University of Melbourne, Melbourne, VIC,
      Australia
FAU - Ozanne, Elizabeth
AU  - Ozanne E
AD  - Department of Social Work, The University of Melbourne, Melbourne, VIC, Australia
FAU - Said, Catherine
AU  - Said C
AD  - Department of Physiotherapy, The University of Melbourne, Melbourne, VIC,
      Australia
FAU - Santamaria, Nick
AU  - Santamaria N
AD  - Department of Nursing, The University of Melbourne and Royal Melbourne Hospital, 
      Melbourne, VIC, Australia
FAU - Morris, Meg E.
AU  - Morris ME
AD  - Department of Physiotherapy, The University of Melbourne, Melbourne, VIC,
      Australia
LA  - eng
PT  - Journal Article
DEP - 20121204
PHST- 2012/04/30 [received]
PHST- 2012/09/24 [revised]
PHST- 2012/10/01 [accepted]
PHST- 2012/12/04 [aheadofprint]
TA  - J Aging Res
JT  - Journal of Aging Research
AID - 10.1155/2012/538169 [doi]
SO  - J Aging Res. 2012;2012:. Epub 2012 Dec 4 doi:10.1155/2012/538169.

PMC - PMC5480499
PMID- 28663892
IS  - 2156-7085 (Electronic)
VI  - 8
IP  - 5
DP  - 2017 May 01
TI  - Assessment of mental stress effects on prefrontal cortical activities using
      canonical correlation analysis: an fNIRS-EEG study.
PG  - 2583-98
AB  - This paper presents an investigation about the effects of mental stress on
      prefrontal cortex (PFC) subregions using simultaneous measurement of functional
      Near-Infrared Spectroscopy (fNIRS) and Electroencephalography (EEG) signals. The 
      aim is to explore canonical correlation analysis (CCA) technique to study the
      relationship among the bi-modality signals in mental stress assessment, and how
      we could fuse the signals for better accuracy in stress detection. Twenty-five
      male healthy subjects participated in the study while performing mental
      arithmetic task under control and stress (under time pressure with negative
      feedback) conditions. The fusion of brain signals acquired by fNIRS-EEG was
      performed at feature-level using CCA by maximizing the inter-subject covariance
      across modalities. The CCA result discovered the associations across the
      modalities and estimated the components responsible for these associations. The
      experiment results showed that mental stress experienced by this cohort of
      subjects is subregion specific and localized to the right ventrolateral PFC
      subregion. These suggest the right ventrolateral PFC as a suitable candidate
      region to extract biomarkers as performance indicators of neurofeedback training 
      in stress coping.
FAU - Al-Shargie, Fares
AU  - Al-Shargie F
AD  - Universiti Teknologi PETRONAS, Centre of Intelligent Signal and Imaging Research,
      Department of Electrical and Electronic Engineering, 32610 Bandar Seri Iskandar, 
      Perak, Malaysia
FAU - Tang, Tong Boon
AU  - Tang TB
AD  - Universiti Teknologi PETRONAS, Centre of Intelligent Signal and Imaging Research,
      Department of Electrical and Electronic Engineering, 32610 Bandar Seri Iskandar, 
      Perak, Malaysia
FAU - Kiguchi, Masashi
AU  - Kiguchi M
AD  - Hitachi, Ltd., Research & Development Group, 350-0395, Japan
LA  - eng
PT  - Journal Article
DEP - 20170419
GR  - HiCOE Scheme
PHST- 2016/12/21 [received]
PHST- 2017/03/11 [revised]
PHST- 2017/03/31 [accepted]
TA  - Biomed Opt Express
JT  - Biomedical Optics Express
AID - 283330 [pii]
AID - 10.1364/BOE.8.002583 [doi]
SO  - Biomed Opt Express. 2017 Apr 19;8(5):2583-98. doi:10.1364/BOE.8.002583.

PMC - PMC4570422
PMID- 26295234
IS  - 1424-8220 (Electronic)
VI  - 15
IP  - 8
DP  - 2015 Aug
TI  - An Intelligent System Proposal for Improving the Safety and Accessibility of
      Public Transit by Highway.
PG  - 20279-304
AB  - The development of public transit systems that are accessible and safe for
      everyone, including people with special needs, is an objective that is justified 
      from the civic and economic points of view. Unfortunately, public transit
      services are conceived for people who do not have reduced physical or cognitive
      abilities. In this paper, we present an intelligent public transit system by
      highway with the goal of facilitating access and improving the safety of public
      transit for persons with special needs. The system is deployed using components
      that are commonly available in transport infrastructure, e.g., sensors, mobile
      communications systems, and positioning systems. In addition, the system can
      operate in non-urban transport contexts, e.g., isolated rural areas, where the
      availability of basic infrastructure, such as electricity and communications
      infrastructures, is not always guaranteed. To construct the system, the
      principles and techniques of Ubiquitous Computing and Ambient Intelligence have
      been employed. To illustrate the utility of the system, two cases of services
      rendered by the system are described: the first case involves a surveillance
      system to guarantee accessibility at bus stops; the second case involves a route 
      assistant for blind people.
FAU - García, Carmelo R.
AU  - García CR
FAU - Quesada-Arencibia, Alexis
AU  - Quesada-Arencibia A
FAU - Cristóbal, Teresa
AU  - Cristóbal T
FAU - Padrón, Gabino
AU  - Padrón G
FAU - Pérez, Ricardo
AU  - Pérez R
FAU - Alayón, Francisco
AU  - Alayón F
LA  - eng
PT  - Journal Article
DEP - 20150818
PHST- 2015/03/26 [received]
PHST- 2015/08/12 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s150820279 [doi]
AID - sensors-15-20279 [pii]
SO  - Sensors (Basel). 2015 Aug 18;15(8):20279-304. doi:10.3390/s150820279.

PMC - PMC4625061
PMID- 26112255
IS  - 0031-9023 (Print)
IS  - 1538-6724 (Electronic)
VI  - 95
IP  - 11
DP  - 2015 Nov
TI  - Virtual Sensorimotor Balance Training for Children With Fetal Alcohol Spectrum
      Disorders: Feasibility Study.
PG  - 1569-81
AB  - Background: Diminished sensory adaptation has been associated with poor balance
      control for children with fetal alcohol spectrum disorders (FASD). A virtual
      reality system, Sensorimotor Training to Affect Balance, Engagement and Learning 
      (STABEL), was developed to train sensory control for balance. Objectives: The
      purpose of this study was to examine the STABEL system in children with FASD and 
      children with typical development (TD) to (1) determine the feasibility of the
      STABEL system and (2) explore the immediate effects of the STABEL system on
      sensory attention and postural control. Design: This is a technical report with
      observational study data. Methods: Eleven children with FASD and 11 children with
      TD, aged 8 to 16 years, completed 30 minutes of STABEL training. The children
      answered questions about their experience using STABEL. Sensory attention and
      postural control were measured pre- and post-STABEL training with the Multimodal 
      Balance Entrainment Response system and compared using repeated-measures analysis
      of variance. Results: All children engaged in game play and tolerated controlled 
      sensory input during the STABEL protocol. Immediate effects post-STABEL training 
      in both groups were increased postural sway velocity and some changes in
      entrainment gain. Children with FASD showed higher entrainment gain to vestibular
      stimuli. There were no significant changes in sensory attention fractions.
      Limitations: The small sample size, dose of STABEL training, and exploratory
      statistical analyses are study limitations, but findings warrant larger
      systematic study to examine therapeutic effects. Conclusions: Children completed 
      the training protocol, demonstrating the feasibility of the STABEL system.
      Differences in postural sway velocity post-STABEL training may have been affected
      by fatigue, warranting further investigation. Limited immediate effects suggest
      more practice is needed to affect sensory attention; however, entrainment gain
      changes suggest the STABEL system provoked vestibular responses during balance
      practice.
FAU - McCoy, Sarah Westcott
AU  - McCoy SW
AD  - S.W. McCoy, PT, PhD, FAPTA, Department of Rehabilitation Medicine, University of 
      Washington, Box 356490, Seattle, WA 98195 (USA).
FAU - Jirikowic, Tracy
AU  - Jirikowic T
AD  - T. Jirikowic, PhD, OTR/L, FAOTA, Department of Rehabilitation Medicine,
      University of Washington.
FAU - Price, Robert
AU  - Price R
AD  - R. Price, MSME, Department of Rehabilitation Medicine, University of Washington.
FAU - Ciol, Marcia A.
AU  - Ciol MA
AD  - M.A. Ciol, PhD, Department of Rehabilitation Medicine, University of Washington.
FAU - Hsu, Lin-Ya
AU  - Hsu LY
AD  - L-Y. Hsu, PT, PhD, Department of Rehabilitation Medicine, University of
      Washington.
FAU - Dellon, Brian
AU  - Dellon B
AD  - B. Dellon, PhD, MSME, Boston Dynamics, Waltham, Massachusetts.
FAU - Kartin, Deborah
AU  - Kartin D
AD  - D. Kartin, PT, PhD, Department of Rehabilitation Medicine, University of
      Washington.
LA  - eng
PT  - Journal Article
DEP - 20150625
PHST- 2015/03/05 [received]
PHST- 2015/06/11 [accepted]
PHST- 2015/06/25 [aheadofprint]
TA  - Phys Ther
JT  - Physical Therapy
AID - 2015-0124 [pii]
AID - 10.2522/ptj.20150124 [doi]
SO  - Phys Ther. 2015 Nov;95(11):1569-81. Epub 2015 Jun 25 doi:10.2522/ptj.20150124.

PMC - PMC5404919
PMID- 28440221
IS  - 2050-084X (Electronic)
VI  - 6
DP  - 2017
TI  - NPTX2 and cognitive dysfunction in Alzheimer’s Disease.
LID - e23798
AB  - Memory loss in Alzheimer’s disease (AD) is attributed to pervasive weakening and 
      loss of synapses. Here, we present findings supporting a special role for
      excitatory synapses connecting pyramidal neurons of the hippocampus and cortex
      with fast-spiking parvalbumin (PV) interneurons that control network excitability
      and rhythmicity. Excitatory synapses on PV interneurons are dependent on the AMPA
      receptor subunit GluA4, which is regulated by presynaptic expression of the
      synaptogenic immediate early gene NPTX2 by pyramidal neurons. In a mouse model of
      AD amyloidosis, Nptx2-/- results in reduced GluA4 expression, disrupted
      rhythmicity, and increased pyramidal neuron excitability. Postmortem human AD
      cortex shows profound reductions of NPTX2 and coordinate reductions of GluA4.
      NPTX2 in human CSF is reduced in subjects with AD and shows robust correlations
      with cognitive performance and hippocampal volume. These findings implicate
      failure of adaptive control of pyramidal neuron-PV circuits as a
      pathophysiological mechanism contributing to cognitive failure in
      AD.DOI:http://dx.doi.org/10.7554/eLife.23798.001
FAU - Xiao, Mei-Fang
AU  - Xiao MF
AD  - Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of 
      Medicine, Baltimore, United States
FAU - Xu, Desheng
AU  - Xu D
AD  - Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of 
      Medicine, Baltimore, United States
FAU - Craig, Michael T
AU  - Craig MT
AUID- ORCID: 0000-0001-8481-6709
AD  - Program in Developmental Neurobiology, Eunice Kennedy-Shriver National Institute 
      of Child Health and Human Development, Bethesda, United States
FAU - Pelkey, Kenneth A
AU  - Pelkey KA
AD  - Program in Developmental Neurobiology, Eunice Kennedy-Shriver National Institute 
      of Child Health and Human Development, Bethesda, United States
FAU - Chien, Chun-Che
AU  - Chien CC
AD  - Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of 
      Medicine, Baltimore, United States
FAU - Shi, Yang
AU  - Shi Y
AD  - Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of 
      Medicine, Baltimore, United States
FAU - Zhang, Juhong
AU  - Zhang J
AD  - Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of 
      Medicine, Baltimore, United States
FAU - Resnick, Susan
AU  - Resnick S
AD  - Laboratory of Behavioral Neuroscience, National Institute on Aging, Intramural
      Research Program, Baltimore, United States
FAU - Pletnikova, Olga
AU  - Pletnikova O
AD  - Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, 
      United States
FAU - Salmon, David
AU  - Salmon D
AD  - Department of Neurosciences, University of California San Diego Medical Center,
      San Diego, United States
FAU - Brewer, James
AU  - Brewer J
AD  - Department of Neurosciences, University of California San Diego Medical Center,
      San Diego, United States
FAU - Edland, Steven
AU  - Edland S
AUID- ORCID: 0000-0002-1153-7335
AD  - Shiley-Marcos Alzheimer's Disease Research Center, University of California San
      Diego Medical Center, San Diego, United States
FAU - Wegiel, Jerzy
AU  - Wegiel J
AD  - Institute for Basic Research, New York City, United States
FAU - Tycko, Benjamin
AU  - Tycko B
AD  - Taub Institute for Research on Alzheimer’s disease and the Aging Brain, Columbia 
      University, New York City, United States
FAU - Savonenko, Alena
AU  - Savonenko A
AD  - Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, 
      United States
FAU - Reeves, Roger H
AU  - Reeves RH
AD  - Department of Physiology, Johns Hopkins University School of Medicine, Baltimore,
      United States
FAU - Troncoso, Juan C
AU  - Troncoso JC
AD  - Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, 
      United States
FAU - McBain, Chris J
AU  - McBain CJ
AD  - Program in Developmental Neurobiology, Eunice Kennedy-Shriver National Institute 
      of Child Health and Human Development, Bethesda, United States
FAU - Galasko, Douglas
AU  - Galasko D
AD  - Department of Neurosciences, University of California San Diego Medical Center,
      San Diego, United States
FAU - Worley, Paul F
AU  - Worley PF
AUID- ORCID: 0000-0002-5086-614X
AD  - Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of 
      Medicine, Baltimore, United States
LA  - eng
PT  - Journal Article
GR  - AG05131
PHST- 2016/12/01 [received]
PHST- 2017/03/15 [accepted]
TA  - eLife
JT  - eLife
AID - 23798 [pii]
AID - 10.7554/eLife.23798 [doi]
SO  - eLife. 2017;6:. doi:10.7554/eLife.23798.

PMC - PMC4114288
PMID- 25120466
IS  - 1662-6443 (Electronic)
VI  - 7
DP  - 2014
TI  - Characterizing relationships of DTI, fMRI, and motor recovery in stroke
      rehabilitation utilizing brain-computer interface technology.
LID - 31
AB  - The relationship of the structural integrity of white matter tracts and cortical 
      activity to motor functional outcomes in stroke patients is of particular
      interest in understanding mechanisms of brain structural and functional changes
      while recovering from stroke. This study aims to probe these underlying
      mechanisms using diffusion tensor imaging (DTI) and fMRI measures. We examined
      the structural integrity of the posterior limb of the internal capsule (PLIC)
      using DTI and corticomotor activity using motor-task fMRI in stroke patients who 
      completed up to 15 sessions of rehabilitation therapy using Brain-Computer
      Interface (BCI) technology. We hypothesized that (1) the structural integrity of 
      PLIC and corticomotor activity are affected by stroke; (2) changes in structural 
      integrity and corticomotor activity following BCI intervention are related to
      motor recovery; (3) there is a potential relationship between structural
      integrity and corticomotor activity. We found that (1) the ipsilesional PLIC
      showed significantly decreased fractional anisotropy (FA) values when compared to
      the contralesional PLIC; (2) lower ipsilesional PLIC-FA values were significantly
      associated with worse motor outcomes (i.e., ipsilesional PLIC-FA and motor
      outcomes were positively correlated.); (3) lower ipsilesional PLIC-FA values were
      significantly associated with greater ipsilesional corticomotor activity during
      impaired-finger-tapping-task fMRI (i.e., ipsilesional PLIC-FA and ipsilesional
      corticomotor activity were negatively correlated), with an overall bilateral
      pattern of corticomotor activity observed; and (4) baseline FA values predicted
      motor recovery assessed after BCI intervention. These findings suggest that (1)
      greater vs. lesser microstructural integrity of the ipsilesional PLIC may
      contribute toward better vs. poor motor recovery respectively in the
      stroke-affected limb and demand lesser vs. greater cortical activity respectively
      from the ipsilesional motor cortex; and that (2) PLIC-FA is a promising biomarker
      in tracking and predicting motor functional recovery in stroke patients receiving
      BCI intervention.
FAU - Song, Jie
AU  - Song J
AD  - Department of Radiology, University of Wisconsin - MadisonMadison, WI, USA
FAU - Young, Brittany M.
AU  - Young BM
AD  - Department of Radiology, University of Wisconsin - MadisonMadison, WI, USA
FAU - Nigogosyan, Zack
AU  - Nigogosyan Z
AD  - Department of Radiology, University of Wisconsin - MadisonMadison, WI, USA
FAU - Walton, Leo M.
AU  - Walton LM
AD  - Department of Biomedical Engineering, University of Wisconsin - MadisonMadison,
      WI, USA
FAU - Nair, Veena A.
AU  - Nair VA
AD  - Department of Radiology, University of Wisconsin - MadisonMadison, WI, USA
FAU - Grogan, Scott W.
AU  - Grogan SW
AD  - Department of Radiology, University of Wisconsin - MadisonMadison, WI, USA
FAU - Tyler, Mitchell E.
AU  - Tyler ME
AD  - Department of Biomedical Engineering, University of Wisconsin - MadisonMadison,
      WI, USA
FAU - Farrar-Edwards, Dorothy
AU  - Farrar-Edwards D
AD  - Department of Kinesiology, University of Wisconsin - MadisonMadison, WI, USA
FAU - Caldera, Kristin E.
AU  - Caldera KE
AD  - Departments of Orthopedics and Rehabilitation, University of Wisconsin -
      MadisonMadison, WI, USA
FAU - Sattin, Justin A.
AU  - Sattin JA
AD  - Department of Neurology, University of Wisconsin - MadisonMadison, WI, USA
FAU - Williams, Justin C.
AU  - Williams JC
AD  - Department of Biomedical Engineering, University of Wisconsin - MadisonMadison,
      WI, USA
FAU - Prabhakaran, Vivek
AU  - Prabhakaran V
AD  - Department of Radiology, University of Wisconsin - MadisonMadison, WI, USA
LA  - eng
PT  - Journal Article
DEP - 20140729
PHST- 2014/04/16 [received]
PHST- 2014/07/08 [accepted]
TA  - Front Neuroeng
JT  - Frontiers in Neuroengineering
AID - 10.3389/fneng.2014.00031 [doi]
SO  - Front Neuroeng. 2014 Jul 29;7:. doi:10.3389/fneng.2014.00031.

PMC - PMC5406619
PMID- 28404541
IS  - 2369-2960 (Electronic)
VI  - 3
IP  - 2
DP  - 2017 Apr-Jun
TI  - Making Air Pollution Visible: A Tool for Promoting Environmental Health Literacy.
LID - e16
AB  - Background: Digital maps are instrumental in conveying information about
      environmental hazards geographically. For laypersons, computer-based maps can
      serve as tools to promote environmental health literacy about invisible
      traffic-related air pollution and ultrafine particles. Concentrations of these
      pollutants are higher near major roadways and increasingly linked to adverse
      health effects. Interactive computer maps provide visualizations that can allow
      users to build mental models of the spatial distribution of ultrafine particles
      in a community and learn about the risk of exposure in a geographic context.
      Objective: The objective of this work was to develop a new software tool
      appropriate for educating members of the Boston Chinatown community (Boston, MA, 
      USA) about the nature and potential health risks of traffic-related air
      pollution. The tool, the Interactive Map of Chinatown Traffic Pollution (“Air
      Pollution Map” hereafter), is a prototype that can be adapted for the purpose of 
      educating community members across a range of socioeconomic contexts. Methods: We
      built the educational visualization tool on the open source Weave software
      platform. We designed the tool as the centerpiece of a multimodal and
      intergenerational educational intervention about the health risk of
      traffic-related air pollution. We used a previously published fine resolution (20
      m) hourly land-use regression model of ultrafine particles as the algorithm for
      predicting pollution levels and applied it to one neighborhood, Boston Chinatown.
      In designing the map, we consulted community experts to help customize the user
      interface to communication styles prevalent in the target community. Results: The
      product is a map that displays ultrafine particulate concentrations averaged
      across census blocks using a color gradation from white to dark red. The
      interactive features allow users to explore and learn how changing meteorological
      conditions and traffic volume influence ultrafine particle concentrations. Users 
      can also select from multiple map layers, such as a street map or satellite view.
      The map legends and labels are available in both Chinese and English, and are
      thus accessible to immigrants and residents with proficiency in either language. 
      The map can be either Web or desktop based. Conclusions: The Air Pollution Map
      incorporates relevant language and landmarks to make complex scientific
      information about ultrafine particles accessible to members of the Boston
      Chinatown community. In future work, we will test the map in an educational
      intervention that features intergenerational colearning and the use of
      supplementary multimedia presentations.
FAU - Finn, Symma
AU  - Finn S
FAU - Shafie, Farah Ayuni
AU  - Shafie FA
FAU - Cleary, Ekaterina Galkina
AU  - Cleary EG
AUID- ORCID: 0000-0002-9384-4020
AD  - Center for Integration of Science and IndustryBentley UniversityWaltham, MAUnited
      States
FAU - Patton, Allison P
AU  - Patton AP
AUID- ORCID: 0000-0002-8334-3580
AD  - Environmental and Occupational Health Sciences InstituteRutgers
      UniversityPiscataway, NJUnited States
FAU - Wu, Hsin-Ching
AU  - Wu HC
AUID- ORCID: 0000-0001-9556-456X
AD  - Department of Public Policy and Public AffairsUniversity of Massachusetts
      BostonBoston, MAUnited States
FAU - Xie, Alan
AU  - Xie A
AUID- ORCID: 0000-0002-4416-4889
AD  - Institute for Asian American StudiesUniversity of Massachusetts BostonBoston,
      MAUnited States
FAU - Stubblefield, Joseph
AU  - Stubblefield J
AUID- ORCID: 0000-0003-3603-802X
AD  - Computer Science DepartmentUniversity of Massachusetts LowellLowell, MAUnited
      States
FAU - Mass, William
AU  - Mass W
AUID- ORCID: 0000-0003-4671-0924
AD  - Computer Science DepartmentUniversity of Massachusetts LowellLowell, MAUnited
      States
FAU - Grinstein, Georges
AU  - Grinstein G
AUID- ORCID: 0000-0003-2388-6601
AD  - Computer Science DepartmentUniversity of Massachusetts LowellLowell, MAUnited
      States
FAU - Koch-Weser, Susan
AU  - Koch-Weser S
AUID- ORCID: 0000-0003-1871-1516
AD  - Department of Public Health and Community MedicineTufts University School of
      MedicineBoston, MAUnited States
FAU - Brugge, Doug
AU  - Brugge D
AUID- ORCID: 0000-0002-6812-2720
AD  - Department of Public Health and Community MedicineTufts University School of
      MedicineBoston, MAUnited States
FAU - Wong, Carolyn
AU  - Wong C
AUID- ORCID: 0000-0003-1873-7142
AD  - Institute for Asian American StudiesUniversity of Massachusetts BostonBoston,
      MAUnited States
LA  - eng
PT  - Journal Article
DEP - 20170412
PHST- 2017/02/12 [received]
PHST- 2017/03/07 [revised]
PHST- 2017/03/07 [accepted]
TA  - JMIR Public Health Surveill
JT  - JMIR Public Health and Surveillance
AID - v3i2e16 [pii]
AID - 10.2196/publichealth.7492 [doi]
SO  - JMIR Public Health Surveill. 2017 Apr 12;3(2):. doi:10.2196/publichealth.7492.

PMC - PMC2225522
IS  - 1365-182X (Print)
IS  - 1477-2574 (Electronic)
VI  - 10
IP  - Suppl 1
DP  - 2008
TI  - Abstracts.
PG  - 7-228
LA  - eng
PT  - Journal Article
TA  - HPB (Oxford)
JT  - HPB : The Official Journal of the International Hepato Pancreato Biliary
      Association
AID - 10.1080/13651820701867935 [doi]
AID - 10-007S [pii]
SO  - HPB (Oxford). 2008;10(Suppl 1):7-228. doi:10.1080/13651820701867935.

PMC - PMC4517966
PMID- 26244107
IS  - 2167-8359 (Electronic)
VI  - 3
DP  - 2015
TI  - Conducting perception research over the internet: a tutorial review.
LID - e1058
AB  - This article provides an overview of the recent literature on the use of
      internet-based testing to address important questions in perception research. Our
      goal is to provide a starting point for the perception researcher who is keen on 
      assessing this tool for their own research goals. Internet-based testing has
      several advantages over in-lab research, including the ability to reach a
      relatively broad set of participants and to quickly and inexpensively collect
      large amounts of empirical data, via services such as Amazon’s Mechanical Turk or
      Prolific Academic. In many cases, the quality of online data appears to match
      that collected in lab research. Generally-speaking, online participants tend to
      be more representative of the population at large than those recruited for lab
      based research. There are, though, some important caveats, when it comes to
      collecting data online. It is obviously much more difficult to control the exact 
      parameters of stimulus presentation (such as display characteristics) with online
      research. There are also some thorny ethical elements that need to be considered 
      by experimenters. Strengths and weaknesses of the online approach, relative to
      others, are highlighted, and recommendations made for those researchers who might
      be thinking about conducting their own studies using this increasingly-popular
      approach to research in the psychological sciences.
FAU - Woods, Andy T.
AU  - Woods AT
AD  - Crossmodal Research Laboratory, Department of Experimental Psychology, University
      of Oxford, United Kingdom
FAU - Velasco, Carlos
AU  - Velasco C
AD  - Crossmodal Research Laboratory, Department of Experimental Psychology, University
      of Oxford, United Kingdom
FAU - Levitan, Carmel A.
AU  - Levitan CA
AD  - Department of Cognitive Science, Occidental College, Los Angeles, USA
FAU - Wan, Xiaoang
AU  - Wan X
AD  - Tsinghua University, Beijing, China
FAU - Spence, Charles
AU  - Spence C
AD  - Crossmodal Research Laboratory, Department of Experimental Psychology, University
      of Oxford, United Kingdom
LA  - eng
PT  - Journal Article
DEP - 20150723
GR  - AH/L007053/1
PHST- 2015/03/26 [received]
PHST- 2015/06/07 [accepted]
TA  - PeerJ
JT  - PeerJ
AID - 1058 [pii]
AID - 10.7717/peerj.1058 [doi]
SO  - PeerJ. 2015 Jul 23;3:. doi:10.7717/peerj.1058.

PMC - PMC5497950
PMID- 28678855
IS  - 1932-6203 (Electronic)
VI  - 12
IP  - 7
DP  - 2017
TI  - Does a presentation’s medium affect its message? PowerPoint, Prezi, and oral
      presentations.
LID - e0178774
AB  - Despite the prevalence of PowerPoint in professional and educational
      presentations, surprisingly little is known about how effective such
      presentations are. All else being equal, are PowerPoint presentations better than
      purely oral presentations or those that use alternative software tools? To
      address this question we recreated a real-world business scenario in which
      individuals presented to a corporate board. Participants (playing the role of the
      presenter) were randomly assigned to create PowerPoint, Prezi, or oral
      presentations, and then actually delivered the presentation live to other
      participants (playing the role of corporate executives). Across two experiments
      and on a variety of dimensions, participants evaluated PowerPoint presentations
      comparably to oral presentations, but evaluated Prezi presentations more
      favorably than both PowerPoint and oral presentations. There was some evidence
      that participants who viewed different types of presentations came to different
      conclusions about the business scenario, but no evidence that they remembered or 
      comprehended the scenario differently. We conclude that the observed effects of
      presentation format are not merely the result of novelty, bias, experimenter-, or
      software-specific characteristics, but instead reveal a communication preference 
      for using the panning-and-zooming animations that characterize Prezi
      presentations.
FAU - Moulton, Samuel T.
AU  - Moulton ST
AUID- ORCID: 0000-0002-7837-6564
AD  - Department of Psychology, Harvard University, Cambridge, Massachusetts, United
      States of America
FAU - Türkay, Selen
AU  - Türkay S
AD  - Harvard Initiative for Learning and Teaching, Harvard University, Cambridge,
      Massachusetts, United States of America
FAU - Kosslyn, Stephen M.
AU  - Kosslyn SM
AD  - Minerva Schools at the Keck Graduate Institute, San Francisco, California, United
      States of America
LA  - eng
PT  - Journal Article
DEP - 20170705
PHST- 2016/11/02 [received]
PHST- 2017/05/18 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - 10.1371/journal.pone.0178774 [doi]
AID - PONE-D-16-43683 [pii]
SO  - PLoS One. 2017 Jul 5;12(7):. doi:10.1371/journal.pone.0178774.

PMC - PMC3975244
PMID- 24234359
IS  - 0271-8235 (Print)
IS  - 1098-9021 (Electronic)
VI  - 33
IP  - 4
DP  - 2013 Sep
TI  - Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia.
PG  - 386-416
AB  - Neurodegenerative disorders leading to dementia are common diseases that affect
      many older and some young adults. Neuroimaging methods are important tools for
      assessing and monitoring pathological brain changes associated with progressive
      neurodegenerative conditions. In this review, the authors describe key findings
      from neuroimaging studies (magnetic resonance imaging and radionucleotide
      imaging) in neurodegenerative disorders, including Alzheimer’s disease (AD) and
      prodromal stages, familial and atypical AD syndromes, frontotemporal dementia,
      amyotrophic lateral sclerosis with and without dementia, Parkinson’s disease with
      and without dementia, dementia with Lewy bodies, Huntington’s disease, multiple
      sclerosis, HIV-associated neurocognitive disorder, and prion protein associated
      diseases (i.e., Creutzfeldt-Jakob disease). The authors focus on neuroimaging
      findings of in vivo pathology in these disorders, as well as the potential for
      neuroimaging to provide useful information for differential diagnosis of
      neurodegenerative disorders.
FAU - Risacher, Shannon L.
AU  - Risacher SL
AD  - Center for Neuroimaging, Department of Radiology and Imaging Sciences, and
      Indiana Alzheimer Disease Center Indiana University School of Medicine,
      Indianapolis, Indiana
FAU - Saykin, Andrew J.
AU  - Saykin AJ
AD  - Center for Neuroimaging, Department of Radiology and Imaging Sciences, and
      Indiana Alzheimer Disease Center Indiana University School of Medicine,
      Indianapolis, Indiana
LA  - eng
PT  - Journal Article
DEP - 20131114
TA  - Semin Neurol
JT  - Seminars in neurology
AID - 10.1055/s-0033-1359312 [doi]
MID - NIHMS562687
SO  - Semin Neurol. 2013 Sep;33(4):386-416. Epub 2013 Nov 14
      doi:10.1055/s-0033-1359312.

PMC - PMC4570297
PMID- 26213928
IS  - 1424-8220 (Electronic)
VI  - 15
IP  - 8
DP  - 2015 Aug
TI  - Analysis of Android Device-Based Solutions for Fall Detection.
PG  - 17827-94
AB  - Falls are a major cause of health and psychological problems as well as
      hospitalization costs among older adults. Thus, the investigation on automatic
      Fall Detection Systems (FDSs) has received special attention from the research
      community during the last decade. In this area, the widespread popularity,
      decreasing price, computing capabilities, built-in sensors and multiplicity of
      wireless interfaces of Android-based devices (especially smartphones) have
      fostered the adoption of this technology to deploy wearable and inexpensive
      architectures for fall detection. This paper presents a critical and thorough
      analysis of those existing fall detection systems that are based on Android
      devices. The review systematically classifies and compares the proposals of the
      literature taking into account different criteria such as the system
      architecture, the employed sensors, the detection algorithm or the response in
      case of a fall alarms. The study emphasizes the analysis of the evaluation
      methods that are employed to assess the effectiveness of the detection process.
      The review reveals the complete lack of a reference framework to validate and
      compare the proposals. In addition, the study also shows that most research works
      do not evaluate the actual applicability of the Android devices (with limited
      battery and computing resources) to fall detection solutions.
FAU - Casilari, Eduardo
AU  - Casilari E
FAU - Luque, Rafael
AU  - Luque R
FAU - Morón, María-José
AU  - Morón MJ
LA  - eng
PT  - Journal Article
DEP - 20150723
PHST- 2015/06/15 [received]
PHST- 2015/07/17 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s150817827 [doi]
AID - sensors-15-17827 [pii]
SO  - Sensors (Basel). 2015 Jul 23;15(8):17827-94. doi:10.3390/s150817827.

PMC - PMC4355335
PMID- 25810927
IS  - 2090-5904 (Print)
IS  - 1687-5443 (Electronic)
VI  - 2015
DP  - 2015
TI  - Combined Cognitive-Psychological-Physical Intervention Induces Reorganization of 
      Intrinsic Functional Brain Architecture in Older Adults.
LID - 713104
AB  - Mounting evidence suggests that enriched mental, physical, and socially
      stimulating activities are beneficial for counteracting age-related decreases in 
      brain function and cognition in older adults. Here, we used functional magnetic
      resonance imaging (fMRI) to demonstrate the functional plasticity of brain
      activity in response to a combined cognitive-psychological-physical intervention 
      and investigated the contribution of the intervention-related brain changes to
      individual performance in healthy older adults. The intervention was composed of 
      a 6-week program of combined activities including cognitive training, Tai Chi
      exercise, and group counseling. The results showed improved cognitive performance
      and reorganized regional homogeneity of spontaneous fluctuations in the blood
      oxygen level-dependent (BOLD) signals in the superior and middle temporal gyri,
      and the posterior lobe of the cerebellum, in the participants who attended the
      intervention. Intriguingly, the intervention-induced changes in the coherence of 
      local spontaneous activity correlated with the improvements in individual
      cognitive performance. Taken together with our previous findings of enhanced
      resting-state functional connectivity between the medial prefrontal cortex and
      medial temporal lobe regions following a combined intervention program in older
      adults, we conclude that the functional plasticity of the aging brain is a rather
      complex process, and an effective cognitive-psychological-physical intervention
      is helpful for maintaining a healthy brain and comprehensive cognition during old
      age.
FAU - Zheng, Zhiwei
AU  - Zheng Z
AD  - Center on Aging Psychology, Key Laboratory of Mental Health, Institute of
      Psychology, Chinese Academy of Sciences, Beijing 100101, China
FAU - Zhu, Xinyi
AU  - Zhu X
AD  - Center on Aging Psychology, Key Laboratory of Mental Health, Institute of
      Psychology, Chinese Academy of Sciences, Beijing 100101, China
FAU - Yin, Shufei
AU  - Yin S
AD  - Center on Aging Psychology, Key Laboratory of Mental Health, Institute of
      Psychology, Chinese Academy of Sciences, Beijing 100101, China
FAU - Wang, Baoxi
AU  - Wang B
AD  - Center on Aging Psychology, Key Laboratory of Mental Health, Institute of
      Psychology, Chinese Academy of Sciences, Beijing 100101, China
FAU - Niu, Yanan
AU  - Niu Y
AD  - Center on Aging Psychology, Key Laboratory of Mental Health, Institute of
      Psychology, Chinese Academy of Sciences, Beijing 100101, China
FAU - Huang, Xin
AU  - Huang X
AD  - Center on Aging Psychology, Key Laboratory of Mental Health, Institute of
      Psychology, Chinese Academy of Sciences, Beijing 100101, China
FAU - Li, Rui
AU  - Li R
AD  - Center on Aging Psychology, Key Laboratory of Mental Health, Institute of
      Psychology, Chinese Academy of Sciences, Beijing 100101, China
FAU - Li, Juan
AU  - Li J
AD  - Center on Aging Psychology, Key Laboratory of Mental Health, Institute of
      Psychology, Chinese Academy of Sciences, Beijing 100101, China
LA  - eng
PT  - Journal Article
DEP - 20150224
PHST- 2014/10/13 [received]
PHST- 2015/02/10 [revised]
PHST- 2015/02/10 [accepted]
PHST- 2015/02/24 [aheadofprint]
TA  - Neural Plast
JT  - Neural Plasticity
AID - 10.1155/2015/713104 [doi]
SO  - Neural Plast. 2015;2015:. Epub 2015 Feb 24 doi:10.1155/2015/713104.

PMC - PMC4341560
PMID- 25767445
IS  - 1662-5188 (Electronic)
VI  - 9
DP  - 2015
TI  - State-dependencies of learning across brain scales.
LID - 1
AB  - Learning is a complex brain function operating on different time scales, from
      milliseconds to years, which induces enduring changes in brain dynamics. The
      brain also undergoes continuous “spontaneous” shifts in states, which, amongst
      others, are characterized by rhythmic activity of various frequencies. Besides
      the most obvious distinct modes of waking and sleep, wake-associated brain states
      comprise modulations of vigilance and attention. Recent findings show that
      certain brain states, particularly during sleep, are essential for learning and
      memory consolidation. Oscillatory activity plays a crucial role on several
      spatial scales, for example in plasticity at a synaptic level or in communication
      across brain areas. However, the underlying mechanisms and computational rules
      linking brain states and rhythms to learning, though relevant for our
      understanding of brain function and therapeutic approaches in brain disease, have
      not yet been elucidated. Here we review known mechanisms of how brain states
      mediate and modulate learning by their characteristic rhythmic signatures. To
      understand the critical interplay between brain states, brain rhythms, and
      learning processes, a wide range of experimental and theoretical work in animal
      models and human subjects from the single synapse to the large-scale cortical
      level needs to be integrated. By discussing results from experiments and
      theoretical approaches, we illuminate new avenues for utilizing neuronal learning
      mechanisms in developing tools and therapies, e.g., for stroke patients and to
      devise memory enhancement strategies for the elderly.
FAU - Ritter, Petra
AU  - Ritter P
AD  - Minerva Research Group BrainModes, Max Planck Institute for Human Cognitive and
      Brain SciencesLeipzig, Germany
FAU - Born, Jan
AU  - Born J
AD  - Department of Medical Psychology and Behavioral Neurobiology & Center for
      Integrative Neuroscience (CIN), University of TübingenTübingen, Germany
FAU - Brecht, Michael
AU  - Brecht M
AD  - Bernstein Center for Computational Neuroscience, Humboldt-Universität zu
      BerlinBerlin, Germany
FAU - Dinse, Hubert R.
AU  - Dinse HR
AD  - Neural Plasticity Lab, Institute for Neuroinformatics, Ruhr-University
      BochumBochum, Germany
FAU - Heinemann, Uwe
AU  - Heinemann U
AD  - Bernstein Center for Computational Neuroscience, Humboldt-Universität zu
      BerlinBerlin, Germany
FAU - Pleger, Burkhard
AU  - Pleger B
AD  - Clinic for Cognitive Neurology, University Hospital LeipzigLeipzig, Germany
FAU - Schmitz, Dietmar
AU  - Schmitz D
AD  - Bernstein Center for Computational Neuroscience, Humboldt-Universität zu
      BerlinBerlin, Germany
FAU - Schreiber, Susanne
AU  - Schreiber S
AD  - Bernstein Center for Computational Neuroscience, Humboldt-Universität zu
      BerlinBerlin, Germany
FAU - Villringer, Arno
AU  - Villringer A
AD  - Berlin School of Mind and Brain & Mind and Brain Institute, Humboldt-Universität 
      zu BerlinBerlin, Germany
FAU - Kempter, Richard
AU  - Kempter R
AD  - Bernstein Center for Computational Neuroscience, Humboldt-Universität zu
      BerlinBerlin, Germany
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20150226
PHST- 2014/11/03 [received]
PHST- 2015/01/06 [accepted]
TA  - Front Comput Neurosci
JT  - Frontiers in Computational Neuroscience
AID - 10.3389/fncom.2015.00001 [doi]
SO  - Front Comput Neurosci. 2015 Feb 26;9:. doi:10.3389/fncom.2015.00001.

PMC - PMC4110630
PMID- 25120419
IS  - 1662-4548 (Print)
IS  - 1662-453X (Electronic)
VI  - 8
DP  - 2014
TI  - Origin and function of short-latency inputs to the neural substrates underlying
      the acoustic startle reflex.
LID - 216
AB  - The acoustic startle reflex (ASR) is a survival mechanism of alarm, which rapidly
      alerts the organism to a sudden loud auditory stimulus. In rats, the primary ASR 
      circuit encompasses three serially connected structures: cochlear root neurons
      (CRNs), neurons in the caudal pontine reticular nucleus (PnC), and motoneurons in
      the medulla and spinal cord. It is well-established that both CRNs and PnC
      neurons receive short-latency auditory inputs to mediate the ASR. Here, we
      investigated the anatomical origin and functional role of these inputs using a
      multidisciplinary approach that combines morphological, electrophysiological and 
      behavioral techniques. Anterograde tracer injections into the cochlea suggest
      that CRNs somata and dendrites receive inputs depending, respectively, on their
      basal or apical cochlear origin. Confocal colocalization experiments demonstrated
      that these cochlear inputs are immunopositive for the vesicular glutamate
      transporter 1 (VGLUT1). Using extracellular recordings in vivo followed by
      subsequent tracer injections, we investigated the response of PnC neurons after
      contra-, ipsi-, and bilateral acoustic stimulation and identified the source of
      their auditory afferents. Our results showed that the binaural firing rate of PnC
      neurons was higher than the monaural, exhibiting higher spike discharges with
      contralateral than ipsilateral acoustic stimulations. Our histological analysis
      confirmed the CRNs as the principal source of short-latency acoustic inputs, and 
      indicated that other areas of the cochlear nucleus complex are not likely to
      innervate PnC. Behaviorally, we observed a strong reduction of ASR amplitude in
      monaural earplugged rats that corresponds with the binaural summation process
      shown in our electrophysiological findings. Our study contributes to understand
      better the role of neuronal mechanisms in auditory alerting behaviors and
      provides strong evidence that the CRNs-PnC pathway mediates fast
      neurotransmission and binaural summation of the ASR.
FAU - Gómez-Nieto, Ricardo
AU  - Gómez-Nieto R
AD  - Neuroscience Institute of Castilla y León, University of SalamancaSalamanca,
      Spain
FAU - Horta-Júnior, José de Anchieta C.
AU  - Horta-Júnior Jde AC
AD  - Neuroscience Institute of Castilla y León, University of SalamancaSalamanca,
      Spain
FAU - Castellano, Orlando
AU  - Castellano O
AD  - Neuroscience Institute of Castilla y León, University of SalamancaSalamanca,
      Spain
FAU - Millian-Morell, Lymarie
AU  - Millian-Morell L
AD  - Neuroscience Institute of Castilla y León, University of SalamancaSalamanca,
      Spain
FAU - Rubio, Maria E.
AU  - Rubio ME
AD  - Department of Otolaryngology, University of PittsburghPittsburgh, PA, USA
FAU - López, Dolores E.
AU  - López DE
AD  - Neuroscience Institute of Castilla y León, University of SalamancaSalamanca,
      Spain
LA  - eng
PT  - Journal Article
DEP - 20140725
PHST- 2014/03/01 [received]
PHST- 2014/07/03 [accepted]
TA  - Front Neurosci
JT  - Frontiers in Neuroscience
AID - 10.3389/fnins.2014.00216 [doi]
SO  - Front Neurosci. 2014 Jul 25;8:. doi:10.3389/fnins.2014.00216.

PMC - PMC4843670
PMID- 26962030
IS  - 1742-5689 (Print)
IS  - 1742-5662 (Electronic)
VI  - 13
IP  - 116
DP  - 2016 Mar
TI  - Resilience in social insect infrastructure systems.
LID - 20151022
AB  - Both human and insect societies depend on complex and highly coordinated
      infrastructure systems, such as communication networks, supply chains and
      transportation networks. Like human-designed infrastructure systems, those of
      social insects are regularly subject to disruptions such as natural disasters,
      blockages or breaks in the transportation network, fluctuations in supply and/or 
      demand, outbreaks of disease and loss of individuals. Unlike human-designed
      systems, there is no deliberate planning or centralized control system; rather,
      individual insects make simple decisions based on local information. How do these
      highly decentralized, leaderless systems deal with disruption? What factors make 
      a social insect system resilient, and which factors lead to its collapse? In this
      review, we bring together literature on resilience in three key social insect
      infrastructure systems: transportation networks, supply chains and communication 
      networks. We describe how systems differentially invest in three pathways to
      resilience: resistance, redirection or reconstruction. We suggest that investment
      in particular resistance pathways is related to the severity and frequency of
      disturbance. In the final section, we lay out a prospectus for future research.
      Human infrastructure networks are rapidly becoming decentralized and
      interconnected; indeed, more like social insect infrastructures. Human
      infrastructure management might therefore learn from social insect researchers,
      who can in turn make use of the mature analytical and simulation tools developed 
      for the study of human infrastructure resilience.
FAU - Middleton, Eliza J. T.
AU  - Middleton EJT
AUID- ORCID: 0000-0003-2500-3016
FAU - Latty, Tanya
AU  - Latty T
AUID- ORCID: 0000-0002-7469-8590
LA  - eng
PT  - Journal Article
PT  - Review
GR  - DP140103643
PHST- 2015/11/26 [received]
PHST- 2016/02/17 [accepted]
TA  - J R Soc Interface
JT  - Journal of the Royal Society Interface
AID - 10.1098/rsif.2015.1022 [doi]
AID - rsif20151022 [pii]
SO  - J R Soc Interface. 2016 Mar;13(116):. doi:10.1098/rsif.2015.1022.

PMC - PMC4764713
PMID- 26941708
IS  - 1664-2295 (Electronic)
VI  - 7
DP  - 2016
TI  - Opportunities for Guided Multichannel Non-invasive Transcranial Current
      Stimulation in Poststroke Rehabilitation.
LID - 21
AB  - Stroke is a leading cause of serious long-term disability worldwide. Functional
      outcome depends on stroke location, severity, and early intervention.
      Conventional rehabilitation strategies have limited effectiveness, and new
      treatments still fail to keep pace, in part due to a lack of understanding of the
      different stages in brain recovery and the vast heterogeneity in the poststroke
      population. Innovative methodologies for restorative neurorehabilitation are
      required to reduce long-term disability and socioeconomic burden. Neuroplasticity
      is involved in poststroke functional disturbances and also during rehabilitation.
      Tackling poststroke neuroplasticity by non-invasive brain stimulation is regarded
      as promising, but efficacy might be limited because of rather uniform application
      across patients despite individual heterogeneity of lesions, symptoms, and other 
      factors. Transcranial direct current stimulation (tDCS) induces and modulates
      neuroplasticity, and has been shown to be able to improve motor and cognitive
      functions. tDCS is suited to improve poststroke rehabilitation outcomes, but
      effect sizes are often moderate and suffer from variability. Indeed, the
      location, extent, and pattern of functional network connectivity disruption
      should be considered when determining the optimal location sites for tDCS
      therapies. Here, we present potential opportunities for neuroimaging-guided
      tDCS-based rehabilitation strategies after stroke that could be personalized. We 
      introduce innovative multimodal intervention protocols based on multichannel tDCS
      montages, neuroimaging methods, and real-time closed-loop systems to guide
      therapy. This might help to overcome current treatment limitations in poststroke 
      rehabilitation and increase our general understanding of adaptive neuroplasticity
      leading to neural reorganization after stroke.
FAU - Otal, Begonya
AU  - Otal B
AD  - Neuroelectrics Barcelona, Barcelona, Spain
FAU - Dutta, Anirban
AU  - Dutta A
AD  - INRIA (Sophia Antipolis), Université Montpellier, Montpellier, France
FAU - Foerster, Águida
AU  - Foerster Á
AD  - University of Medicine Göttingen, Göttingen, Germany
FAU - Ripolles, Oscar
AU  - Ripolles O
AD  - Neuroelectrics Barcelona, Barcelona, Spain
FAU - Kuceyeski, Amy
AU  - Kuceyeski A
AD  - Department of Radiology, Brain and Mind Research Institute, Weill Cornell Medical
      College, New York, NY, USA
FAU - Miranda, Pedro C.
AU  - Miranda PC
AD  - Institute of Biophysics and Biomedical Engineering (IBEB), Faculdade de Ciências,
      Universidade de Lisboa, Lisboa, Portugal
FAU - Edwards, Dylan J.
AU  - Edwards DJ
AD  - Non-Invasive Brain Stimulation and Human Motor Control Laboratory, Burke-Cornell 
      Medical Research Institute, White Plains, NY, USA
FAU - Ilić, Tihomir V.
AU  - Ilić TV
AD  - Department of Clinical Neurophysiology, Medical Faculty of Military Medical
      Academy, University of Defense, Belgrade, Serbia
FAU - Nitsche, Michael A.
AU  - Nitsche MA
AD  - Leibniz Research Centre for Working Environment and Human Factors, Technical
      University of Dortmund, Dortmund, Germany
FAU - Ruffini, Giulio
AU  - Ruffini G
AD  - Neuroelectrics Barcelona, Barcelona, Spain
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20160224
PHST- 2015/12/24 [received]
PHST- 2016/02/09 [accepted]
TA  - Front Neurol
JT  - Frontiers in Neurology
AID - 10.3389/fneur.2016.00021 [doi]
SO  - Front Neurol. 2016 Feb 24;7:. doi:10.3389/fneur.2016.00021.

PMC - PMC4098112
PMID- 24787074
IS  - 1073-449X (Print)
IS  - 1535-4970 (Electronic)
VI  - 189
IP  - 9
DP  - 2014 May 1
DP  - 2014 May 1
TI  - An Official American Thoracic Society/European Respiratory Society Statement:
      Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease.
PG  - e15-62
AB  - Background: Limb muscle dysfunction is prevalent in chronic obstructive pulmonary
      disease (COPD) and it has important clinical implications, such as reduced
      exercise tolerance, quality of life, and even survival. Since the previous
      American Thoracic Society/European Respiratory Society (ATS/ERS) statement on
      limb muscle dysfunction, important progress has been made on the characterization
      of this problem and on our understanding of its pathophysiology and clinical
      implications.Purpose: The purpose of this document is to update the 1999 ATS/ERS 
      statement on limb muscle dysfunction in COPD.Methods: An interdisciplinary
      committee of experts from the ATS and ERS Pulmonary Rehabilitation and Clinical
      Problems assemblies determined that the scope of this document should be limited 
      to limb muscles. Committee members conducted focused reviews of the literature on
      several topics. A librarian also performed a literature search. An ATS
      methodologist provided advice to the committee, ensuring that the methodological 
      approach was consistent with ATS standards.Results: We identified important
      advances in our understanding of the extent and nature of the structural
      alterations in limb muscles in patients with COPD. Since the last update,
      landmark studies were published on the mechanisms of development of limb muscle
      dysfunction in COPD and on the treatment of this condition. We now have a better 
      understanding of the clinical implications of limb muscle dysfunction. Although
      exercise training is the most potent intervention to address this condition,
      other therapies, such as neuromuscular electrical stimulation, are emerging.
      Assessment of limb muscle function can identify patients who are at increased
      risk of poor clinical outcomes, such as exercise intolerance and premature
      mortality.Conclusions: Limb muscle dysfunction is a key systemic consequence of
      COPD. However, there are still important gaps in our knowledge about the
      mechanisms of development of this problem. Strategies for early detection and
      specific treatments for this condition are also needed.
FAU - Maltais, François
AU  - Maltais F
FAU - Decramer, Marc
AU  - Decramer M
FAU - Casaburi, Richard
AU  - Casaburi R
FAU - Barreiro, Esther
AU  - Barreiro E
FAU - Burelle, Yan
AU  - Burelle Y
FAU - Debigaré, Richard
AU  - Debigaré R
FAU - Dekhuijzen, P. N. Richard
AU  - Dekhuijzen PNR
FAU - Franssen, Frits
AU  - Franssen F
FAU - Gayan-Ramirez, Ghislaine
AU  - Gayan-Ramirez G
FAU - Gea, Joaquim
AU  - Gea J
FAU - Gosker, Harry R.
AU  - Gosker HR
FAU - Gosselink, Rik
AU  - Gosselink R
FAU - Hayot, Maurice
AU  - Hayot M
FAU - Hussain, Sabah N. A.
AU  - Hussain SNA
FAU - Janssens, Wim
AU  - Janssens W
FAU - Polkey, Micheal I.
AU  - Polkey MI
FAU - Roca, Josep
AU  - Roca J
FAU - Saey, Didier
AU  - Saey D
FAU - Schols, Annemie M. W. J.
AU  - Schols AMWJ
FAU - Spruit, Martijn A.
AU  - Spruit MA
FAU - Steiner, Michael
AU  - Steiner M
FAU - Taivassalo, Tanja
AU  - Taivassalo T
FAU - Troosters, Thierry
AU  - Troosters T
FAU - Vogiatzis, Ioannis
AU  - Vogiatzis I
FAU - Wagner, Peter D.
AU  - Wagner PD
LA  - eng
PT  - Journal Article
DEP - 20140501
TA  - Am J Respir Crit Care Med
JT  - American Journal of Respiratory and Critical Care Medicine
AID - 10.1164/rccm.201402-0373ST [doi]
SO  - Am J Respir Crit Care Med. 2014 May 1;189(9):e15-62. Epub 2014 May 1
      doi:10.1164/rccm.201402-0373ST.

PMC - PMC3884078
PMID- 24416638
IS  - 2161-783X (Print)
IS  - 2161-7856 (Electronic)
VI  - 1
IP  - 2
DP  - 2012 Apr
TI  - A Scoping Review of Health Game Research: Past, Present, and Future.
PG  - 153-64
AB  - Health game research has flourished over the last decade. The number of
      peer-reviewed scientific publications has surged as the clinical application of
      health games has diversified. In response to this growth, several past literature
      reviews have assessed the effectiveness of health games in specific clinical
      subdomains. The past literature reviews, however, have not provided a general
      scope of health games independent of clinical context. The present systematic
      review identified 149 publications. All sources were published before 2011 in a
      peer-reviewed venue. To be included in this review, publications were required
      (1) to be an original research, (2) to focus on health, (3) to utilize a sound
      research design, (4) to report quantitative health outcomes, and (5) to target
      healthcare receivers. Initial findings showed certain trends in health game
      publications: Focus on younger male demographics, relatively low number of study 
      participants, increased number of controlled trials, short duration of
      intervention periods, short duration and frequency of user–game interaction,
      dominance of exercise and rehab games, lack of underlying theoretical frameworks,
      and concentration on clinical contexts such as physical activity and nutrition.
      The review concludes that future research should (1) widen the demographics to
      include females and elderly, (2) increase the number of participants in
      controlled trials, (3) lengthen both the intervention period and user–game
      interaction duration, and (4) expand the application of health games in new
      clinical contexts.
FAU - Kharrazi, Hadi
AU  - Kharrazi H
FAU - Lu, Amy Shirong
AU  - Lu AS
FAU - Gharghabi, Fardad
AU  - Gharghabi F
FAU - Coleman, Whitney
AU  - Coleman W
LA  - eng
PT  - Journal Article
PT  - Review
TA  - Games Health J
JT  - Games For Health Journal
AID - 10.1089/g4h.2012.0011 [pii]
AID - 10.1089/g4h.2012.0011 [doi]
SO  - Games Health J. 2012 Apr;1(2):153-64. doi:10.1089/g4h.2012.0011.

PMC - PMC5476943
PMID- 28649464
IS  - 2157-846X (Electronic)
VI  - 1
DP  - 2017
TI  - Light in diagnosis, therapy and surgery.
LID - 0008
AB  - Light and optical techniques have made profound impacts on modern medicine, with 
      numerous lasers and optical devices being currently used in clinical practice to 
      assess health and treat disease. Recent advances in biomedical optics have
      enabled increasingly sophisticated technologies — in particular those that
      integrate photonics with nanotechnology, biomaterials and genetic engineering. In
      this Review, we revisit the fundamentals of light–matter interactions, describe
      the applications of light in imaging, diagnosis, therapy and surgery, overview
      their clinical use, and discuss the promise of emerging light-based technologies.
FAU - Yun, Seok Hyun
AU  - Yun SH
AD  - Wellman Center for Photomedicine, Massachusetts General Hospital, 65 Landsdowne
      Street, Cambridge, MA 02139, USA
FAU - Kwok, Sheldon J. J.
AU  - Kwok SJJ
AD  - Wellman Center for Photomedicine, Massachusetts General Hospital, 65 Landsdowne
      Street, Cambridge, MA 02139, USA
LA  - eng
PT  - Journal Article
DEP - 20170110
TA  - Nat Biomed Eng
JT  - Nature biomedical engineering
AID - 10.1038/s41551-016-0008 [doi]
MID - NIHMS832709
SO  - Nat Biomed Eng. 2017;1:. Epub 2017 Jan 10 doi:10.1038/s41551-016-0008.

PMC - PMC3441929
PMID- 22930416
IS  - 1933-7213 (Print)
IS  - 1878-7479 (Electronic)
VI  - 9
IP  - 3
DP  - 2012 Jul
TI  - Evidence-Based Information on the Clinical Use of Neurofeedback for ADHD.
PG  - 588-98
AB  - Neurofeedback (NF) is a training to enhance self-regulatory capacity over brain
      activity patterns and consequently over brain mental states. Recent findings
      suggest that NF is a promising alternative for the treatment of
      attention-deficit/hyperactivity disorder (ADHD). We comprehensively reviewed
      literature searching for studies on the effectiveness and specificity of NF for
      the treatment of ADHD. In addition, clinically informative evidence-based data
      are discussed. We found 3 systematic review on the use of NF for ADHD and 6
      randomized controlled trials that have not been included in these reviews. Most
      nonrandomized controlled trials found positive results with medium-to-large
      effect sizes, but the evidence for effectiveness are less robust when only
      randomized controlled studies are considered. The direct comparison of NF and
      sham-NF in 3 published studies have found no group differences, nevertheless
      methodological caveats, such as the quality of the training protocol used, sample
      size, and sample selection may have contributed to the negative results. Further 
      data on specificity comes from electrophysiological studies reporting that NF
      effectively changes brain activity patterns. No safety issues have emerged from
      clinical trials and NF seems to be well tolerated and accepted. Follow-up studies
      support long-term effects of NF. Currently there is no available data to guide
      clinicians on the predictors of response to NF and on optimal treatment protocol.
      In conclusion, NF is a valid option for the treatment for ADHD, but further
      evidence is required to guide its use.Electronic supplementary material: The
      online version of this article (doi:10.1007/s13311-012-0136-7) contains
      supplementary material, which is available to authorized users.
FAU - Moriyama, Tais S.
AU  - Moriyama TS
AD  - National Institute of Developmental Psychiatry for Children and Adolescents,
      (INCT-CNPq), São Paulo, Brazil
FAU - Polanczyk, Guilherme
AU  - Polanczyk G
AD  - National Institute of Developmental Psychiatry for Children and Adolescents,
      (INCT-CNPq), São Paulo, Brazil
FAU - Caye, Arthur
AU  - Caye A
AD  - Child Psychiatric Division, Hospital de Clínicas de Porto Alegre, Federal
      University of Rio Grande do Sul, Porto Alegre, Brazil
FAU - Banaschewski, Tobias
AU  - Banaschewski T
AD  - Department of Child and Adolescent Psychiatry and Psychotherapy, Central
      Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University,
      Mannheim, Germany
FAU - Brandeis, Daniel
AU  - Brandeis D
AD  - Department of Child and Adolescent Psychiatry and Psychotherapy, Central
      Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University,
      Mannheim, Germany
FAU - Rohde, Luis A.
AU  - Rohde LA
AD  - National Institute of Developmental Psychiatry for Children and Adolescents,
      (INCT-CNPq), São Paulo, Brazil
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20120825
TA  - Neurotherapeutics
JT  - Neurotherapeutics
AID - 136 [pii]
AID - 10.1007/s13311-012-0136-7 [doi]
SO  - Neurotherapeutics. 2012 Jul;9(3):588-98. Epub 2012 Aug 25
      doi:10.1007/s13311-012-0136-7.

PMC - PMC4417666
PMID- 25448710
IS  - 0042-6989 (Print)
IS  - 1878-5646 (Electronic)
VI  - 111
IP  - 0 0
DP  - 2015 Jun
TI  - Active confocal imaging for visual prostheses.
PG  - 182-96
AB  - There are encouraging advances in prosthetic vision for the blind, including
      retinal and cortical implants, and other “sensory substitution devices” that use 
      tactile or electrical stimulation. However, they all have low resolution, limited
      visual field, and can display only few gray levels (limited dynamic range),
      severely restricting their utility. To overcome these limitations, image
      processing or the imaging system could emphasize objects of interest and suppress
      the background clutter. We propose an active confocal imaging system based on
      light-field technology that will enable a blind user of any visual prosthesis to 
      efficiently scan, focus on, and “see” only an object of interest while
      suppressing interference from background clutter. The system captures
      three-dimensional scene information using a light-field sensor and displays only 
      an in-focused plane with objects in it. After capturing a confocal image, a
      de-cluttering process removes the clutter based on blur difference. In
      preliminary experiments we verified the positive impact of confocal-based
      background clutter removal on recognition of objects in low resolution and
      limited dynamic range simulated phosphene images. Using a custom-made
      multiple-camera system, we confirmed that the concept of a confocal de-cluttered 
      image can be realized effectively using light field imaging.
FAU - Jung, Jae-Hyun
AU  - Jung JH
AD  - Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical
      School, Boston, MA, USA
FAU - Aloni, Doron
AU  - Aloni D
AD  - Department of Electro-Optics Engineering, Ben-Gurion University of the Negev,
      Beer Sheva, Israel
FAU - Yitzhaky, Yitzhak
AU  - Yitzhaky Y
AD  - Department of Electro-Optics Engineering, Ben-Gurion University of the Negev,
      Beer Sheva, Israel
FAU - Peli, Eli
AU  - Peli E
AD  - Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical
      School, Boston, MA, USA
LA  - eng
PT  - Journal Article
DEP - 20141103
TA  - Vision Res
JT  - Vision research
AID - 10.1016/j.visres.2014.10.023 [doi]
MID - NIHMS641366
SO  - Vision Res. 2015 Jun;111(0 0):182-96. Epub 2014 Nov 03
      doi:10.1016/j.visres.2014.10.023.

PMC - PMC4815903
PMID- 27065338
IS  - 1664-2295 (Electronic)
VI  - 7
DP  - 2016
TI  - Magnetoencephalography in Stroke Recovery and Rehabilitation.
LID - 35
AB  - Magnetoencephalography (MEG) is a non-invasive neurophysiological technique used 
      to study the cerebral cortex. Currently, MEG is mainly used clinically to
      localize epileptic foci and eloquent brain areas in order to avoid damage during 
      neurosurgery. MEG might, however, also be of help in monitoring stroke recovery
      and rehabilitation. This review focuses on experimental use of MEG in
      neurorehabilitation. MEG has been employed to detect early modifications in
      neuroplasticity and connectivity, but there is insufficient evidence as to
      whether these methods are sensitive enough to be used as a clinical diagnostic
      test. MEG has also been exploited to derive the relationship between brain
      activity and movement kinematics for a motor-based brain–computer interface. In
      the current body of experimental research, MEG appears to be a powerful tool in
      neurorehabilitation, but it is necessary to produce new data to confirm its
      clinical utility.
FAU - Paggiaro, Andrea
AU  - Paggiaro A
AD  - Laboratory of Neurophysiology and Magnetoencephalography, Department of
      Neurophysiology, Institute of Care and Research, S.Camillo Hospital Foundation,
      Venice, Italy
FAU - Birbaumer, Niels
AU  - Birbaumer N
AD  - Laboratory of Neurophysiology and Magnetoencephalography, Department of
      Neurophysiology, Institute of Care and Research, S.Camillo Hospital Foundation,
      Venice, Italy
FAU - Cavinato, Marianna
AU  - Cavinato M
AD  - Laboratory of Neurophysiology and Magnetoencephalography, Department of
      Neurophysiology, Institute of Care and Research, S.Camillo Hospital Foundation,
      Venice, Italy
FAU - Turco, Cristina
AU  - Turco C
AD  - Laboratory of Neurophysiology and Magnetoencephalography, Department of
      Neurophysiology, Institute of Care and Research, S.Camillo Hospital Foundation,
      Venice, Italy
FAU - Formaggio, Emanuela
AU  - Formaggio E
AD  - Laboratory of Neurophysiology and Magnetoencephalography, Department of
      Neurophysiology, Institute of Care and Research, S.Camillo Hospital Foundation,
      Venice, Italy
FAU - Del Felice, Alessandra
AU  - Del Felice A
AD  - Section of Rehabilitation, Department of Neuroscience, University of Padova,
      Padova, Italy
FAU - Masiero, Stefano
AU  - Masiero S
AD  - Section of Rehabilitation, Department of Neuroscience, University of Padova,
      Padova, Italy
FAU - Piccione, Francesco
AU  - Piccione F
AD  - Laboratory of Neurophysiology and Magnetoencephalography, Department of
      Neurophysiology, Institute of Care and Research, S.Camillo Hospital Foundation,
      Venice, Italy
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20160331
PHST- 2015/12/02 [received]
PHST- 2016/03/04 [accepted]
TA  - Front Neurol
JT  - Frontiers in Neurology
AID - 10.3389/fneur.2016.00035 [doi]
SO  - Front Neurol. 2016 Mar 31;7:. doi:10.3389/fneur.2016.00035.

PMC - PMC4111532
PMID- 18003865
IS  - 1084-7138 (Print)
IS  - 1940-5588 (Electronic)
VI  - 11
IP  - 4
DP  - 2007 Dec
DP  - 2007 Dec
TI  - Dual Sensory Loss: Overview of Problems, Visual Assessment, and Rehabilitation.
PG  - 219-26
AB  - This article provides an overview of some of the problems and possible solutions 
      surrounding the neglected issue of combined vision and hearing deficits. The
      subject is treated by considering each subpopulation, ranging from those who have
      no residual vision or hearing to those with mild coexisting vision and hearing
      losses. An attempt is made to relate the different types of visual deficit to the
      likely problems encountered in real-life activities, such as communication and
      travel, among individuals who also have a hearing impairment. The assessment and 
      appropriate referral of patients with these combined deficits is discussed,
      including the interpretation of visual test results and the importance of factors
      other than standard visual acuity. Speculation is offered on potential strategies
      and solutions for rehabilitation as well as the need for future research and
      improvements in service delivery.
FAU - Brabyn, John A.
AU  - Brabyn JA
AD  - From The Smith-Kettlewell Eye Research Institute, San Francisco, California (JAB,
      MES, GH-P, LAL) and School of Optometry, University of California, Berkeley,
      California (GH-P).
FAU - Schneck, Marilyn E.
AU  - Schneck ME
AD  - From The Smith-Kettlewell Eye Research Institute, San Francisco, California (JAB,
      MES, GH-P, LAL) and School of Optometry, University of California, Berkeley,
      California (GH-P).
FAU - Haegerstrom-Portnoy, Gunilla
AU  - Haegerstrom-Portnoy G
AD  - From The Smith-Kettlewell Eye Research Institute, San Francisco, California (JAB,
      MES, GH-P, LAL) and School of Optometry, University of California, Berkeley,
      California (GH-P).
FAU - Lott, Lori A.
AU  - Lott LA
AD  - From The Smith-Kettlewell Eye Research Institute, San Francisco, California (JAB,
      MES, GH-P, LAL) and School of Optometry, University of California, Berkeley,
      California (GH-P).
LA  - eng
PT  - Journal Article
TA  - Trends Amplif
JT  - Trends in Amplification
AID - 10.1177/1084713807307410 [doi]
AID - 10.1177_1084713807307410 [pii]
SO  - Trends Amplif. 2007 Dec;11(4):219-26. doi:10.1177/1084713807307410.

PMC - PMC3951257
PMID- 24598397
IS  - 0393-5264 (Print)
IS  - 1971-3274 (Electronic)
VI  - 28
IP  - 4
DP  - 2013 Oct-Dec
TI  - New trends in visual rehabilitation with MP-1 microperimeter biofeedback: optic
      neural dysfunction.
PG  - 285-91
AB  - The aim of this study was to evaluate the efficacy of visual rehabilitation with 
      MP-1 microperimeter biofeedback in advanced optic neural dysfunction due to
      glaucoma, and to precisely characterize fixation stability and location in
      affected patients. Ten patients (18 eyes) with advanced glaucoma were submitted
      to a rehabilitation protocol that consisted of: a 25-item questionnaire (National
      Eye Institute Visual Functioning Que stionnaire); measurement of visual acuity; a
      reading speed test; microperimetry with fixation study, retinal sensitivity and
      the bivariate contour ellipse area (BCEA). The rehabilitation program consisted
      of 10 training sessions of 10 minutes per eye performed over a period of one week
      and was repeated at four months, eight months, and one year. Statistical analysis
      was performed using the Student’s t-test and Spearman correlation; p values less 
      than 0.05 were considered statistically significant. In 13 eyes fixation changed 
      from unstable to relatively unstable while its location changed from
      predominantly eccentric to predominantly central. In five eyes, fixation changed 
      from relatively unstable to stable with a change of location from poor central
      fixation to predominantly central fixation. Mean retinal sensitivity changed from
      7.43±8.28 dB to 8.33±9.04 dB (p<0.05); the mean best corrected visual acuity was 
      0.98±0.66 logMAR at the baseline assessment, and 0.75±0.6 logMAR at the end of
      rehabilitation (p>0.05); reading speed improved from a mean value of 31.4±4.3
      words/minute to 55.6±3.2 words/minute at the end of the training (p<0.05). The
      BCEA changed from 0.94±0.39 deg2 to 0.86±0.46 deg2 (p=0.76). Rehabilitation with 
      MP-1 biofeedback in patients with advanced glaucoma is a useful means of
      improving these patients’ fixation stability, reading speed and quality of life.
FAU - Verboschi, Francesca
AU  - Verboschi F
AD  - Department of Ophthalmology, A. Fiorini Hospital, Terracina (LT), Italy
FAU - Domanico, Daniela
AU  - Domanico D
AD  - Department of Ophthalmology, S.M. Goretti Hospital, Latina, Italy
FAU - Nebbioso, Marcella
AU  - Nebbioso M
AD  - Sapienza University of Rome, Rome, Italy
FAU - Corradetti, Giulia
AU  - Corradetti G
AD  - San Raffaele Scientific Institute Hospital, Milan, Italy
FAU - Scalinci, Sergio Zaccaria
AU  - Scalinci SZ
AD  - Department of Medical and Surgical Sciences, University of Bologna, Italy
FAU - Vingolo, Enzo Maria
AU  - Vingolo EM
AD  - Department of Ophthalmology, A. Fiorini Hospital, Terracina (LT), Italy
LA  - eng
PT  - Journal Article
DEP - 20140305
TA  - Funct Neurol
JT  - Functional Neurology
AID - 285-291 [pii]
SO  - Funct Neurol. 2014 Mar 5;28(4):285-91.

PMC - PMC4824757
PMID- 27092041
IS  - 1662-4548 (Print)
IS  - 1662-453X (Electronic)
VI  - 10
DP  - 2016
TI  - Control of Prosthetic Hands via the Peripheral Nervous System.
LID - 116
AB  - This paper intends to provide a critical review of the literature on the
      technological issues on control and sensorization of hand prostheses interfacing 
      with the Peripheral Nervous System (i.e., PNS), and their experimental validation
      on amputees. The study opens with an in-depth analysis of control solutions and
      sensorization features of research and commercially available prosthetic hands.
      Pros and cons of adopted technologies, signal processing techniques and motion
      control solutions are investigated. Special emphasis is then dedicated to the
      recent studies on the restoration of tactile perception in amputees through
      neural interfaces. The paper finally proposes a number of suggestions for
      designing the prosthetic system able to re-establish a bidirectional
      communication with the PNS and foster the prosthesis natural control.
FAU - Ciancio, Anna Lisa
AU  - Ciancio AL
AD  - Unit of Biomedical Robotics and Biomicrosystems, Department of Engineering,
      Università Campus Bio-Medico di RomaRoma, Italy
FAU - Cordella, Francesca
AU  - Cordella F
AD  - Unit of Biomedical Robotics and Biomicrosystems, Department of Engineering,
      Università Campus Bio-Medico di RomaRoma, Italy
FAU - Barone, Roberto
AU  - Barone R
AD  - Unit of Biomedical Robotics and Biomicrosystems, Department of Engineering,
      Università Campus Bio-Medico di RomaRoma, Italy
FAU - Romeo, Rocco Antonio
AU  - Romeo RA
AD  - Unit of Biomedical Robotics and Biomicrosystems, Department of Engineering,
      Università Campus Bio-Medico di RomaRoma, Italy
FAU - Bellingegni, Alberto Dellacasa
AU  - Bellingegni AD
AD  - Unit of Biomedical Robotics and Biomicrosystems, Department of Engineering,
      Università Campus Bio-Medico di RomaRoma, Italy
FAU - Sacchetti, Rinaldo
AU  - Sacchetti R
AD  - INAIL Centro ProtesiVigorso di Budrio, Italy
FAU - Davalli, Angelo
AU  - Davalli A
AD  - INAIL Centro ProtesiVigorso di Budrio, Italy
FAU - Di Pino, Giovanni
AU  - Di Pino G
AD  - Institute of Neurology, Università Campus Bio-Medico di RomaRoma, Italy
FAU - Ranieri, Federico
AU  - Ranieri F
AD  - Institute of Neurology, Università Campus Bio-Medico di RomaRoma, Italy
FAU - Di Lazzaro, Vincenzo
AU  - Di Lazzaro V
AD  - Institute of Neurology, Università Campus Bio-Medico di RomaRoma, Italy
FAU - Guglielmelli, Eugenio
AU  - Guglielmelli E
AD  - Unit of Biomedical Robotics and Biomicrosystems, Department of Engineering,
      Università Campus Bio-Medico di RomaRoma, Italy
FAU - Zollo, Loredana
AU  - Zollo L
AD  - Unit of Biomedical Robotics and Biomicrosystems, Department of Engineering,
      Università Campus Bio-Medico di RomaRoma, Italy
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20160408
PHST- 2015/11/03 [received]
PHST- 2016/03/08 [accepted]
TA  - Front Neurosci
JT  - Frontiers in Neuroscience
AID - 10.3389/fnins.2016.00116 [doi]
SO  - Front Neurosci. 2016 Apr 08;10:. doi:10.3389/fnins.2016.00116.

PMC - PMC3466244
PMID- 23056557
IS  - 1932-6203 (Electronic)
VI  - 7
IP  - 10
DP  - 2012
TI  - Optical Biomarkers of Serous and Mucinous Human Ovarian Tumor Assessed with
      Nonlinear Optics Microscopies.
LID - e47007
AB  - Background: Nonlinear optical (NLO) microscopy techniques have potential to
      improve the early detection of epithelial ovarian cancer. In this study we showed
      that multimodal NLO microscopies, including two-photon excitation fluorescence
      (TPEF), second-harmonic generation (SHG), third-harmonic generation (THG) and
      fluorescence lifetime imaging microscopy (FLIM) can detect morphological and
      metabolic changes associated with ovarian cancer progression.
      Methodology/Principal Findings: We obtained strong TPEF + SHG + THG signals from 
      fixed samples stained with Hematoxylin & Eosin (H&E) and robust FLIM signal from 
      fixed unstained samples. Particularly, we imaged 34 ovarian biopsies from
      different patients (median age, 49 years) including 5 normal ovarian tissue, 18
      serous tumors and 11 mucinous tumors with the multimodal NLO platform developed
      in our laboratory. We have been able to distinguish adenomas, borderline, and
      adenocarcinomas specimens. Using a complete set of scoring methods we found
      significant differences in the content, distribution and organization of collagen
      fibrils in the stroma as well as in the morphology and fluorescence lifetime from
      epithelial ovarian cells. Conclusions/Significance: NLO microscopes provide
      complementary information about tissue microstructure, showing distinctive
      patterns for serous and mucinous ovarian tumors. The results provide a basis to
      interpret future NLO images of ovarian tissue and lay the foundation for future
      in vivo optical evaluation of premature ovarian lesions.
FAU - Adur, Javier
AU  - Adur J
AD  - Biophotonic Group, Optics and Photonics Research Center (CEPOF), Institute of
      Physics “Gleb Wataghin”, State University of Campinas – UNICAMP, Campinas, São
      Paulo, Brazil
FAU - Pelegati, Vitor B.
AU  - Pelegati VB
AD  - Biophotonic Group, Optics and Photonics Research Center (CEPOF), Institute of
      Physics “Gleb Wataghin”, State University of Campinas – UNICAMP, Campinas, São
      Paulo, Brazil
FAU - de Thomaz, Andre A.
AU  - de Thomaz AA
AD  - Biophotonic Group, Optics and Photonics Research Center (CEPOF), Institute of
      Physics “Gleb Wataghin”, State University of Campinas – UNICAMP, Campinas, São
      Paulo, Brazil
FAU - Baratti, Mariana O.
AU  - Baratti MO
AD  - INFABiC - National Institute of Science and Technology on Photonics Applied to
      Cell Biology, Campinas, São Paulo, Brazil
FAU - Almeida, Diogo B.
AU  - Almeida DB
AD  - Biophotonic Group, Optics and Photonics Research Center (CEPOF), Institute of
      Physics “Gleb Wataghin”, State University of Campinas – UNICAMP, Campinas, São
      Paulo, Brazil
FAU - Andrade, L. A. L. A.
AU  - Andrade LALA
AD  - Department of Pathological Anatomy, Faculty of Medical Sciences, State University
      of Campinas – UNICAMP, Campinas, São Paulo, Brazil
FAU - Bottcher-Luiz, Fátima
AU  - Bottcher-Luiz F
AD  - Department of Obstetrics and Gynecology, Faculty of Medical Sciences, State
      University of Campinas – UNICAMP, Campinas, São Paulo, Brazil
FAU - Carvalho, Hernandes F.
AU  - Carvalho HF
AD  - Department of Anatomy, Cell Biology, Physiology and Biophysics, Institute of
      Biology, State University of Campinas – UNICAMP, Campinas, São Paulo, Brazil
FAU - Cesar, Carlos L.
AU  - Cesar CL
AD  - Biophotonic Group, Optics and Photonics Research Center (CEPOF), Institute of
      Physics “Gleb Wataghin”, State University of Campinas – UNICAMP, Campinas, São
      Paulo, Brazil
LA  - eng
PT  - Journal Article
DEP - 20121008
PHST- 2012/03/30 [received]
PHST- 2012/09/11 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-12-09170 [pii]
AID - 10.1371/journal.pone.0047007 [doi]
SO  - PLoS One. 2012 Oct 8;7(10):. doi:10.1371/journal.pone.0047007.

PMC - PMC3915350
PMID- 24533016
IS  - 1570-159X (Print)
IS  - 1875-6190 (Electronic)
VI  - 12
IP  - 1
DP  - 2014 Jan
TI  - Ketamine as Antidepressant? Current State and Future Perspectives.
PG  - 57-70
AB  - Major depressive disorder (MDD) is a serious mental disorder that ranks among the
      major causes of disease burden. Standard medical treatment targeting cerebral
      monoamines often provides only insufficient symptom relief and fails in
      approximately every fifth patient. The complexity of MDD therefore, reflects more
      than monoaminergic dysregulation. Initial research argues the case for excessive 
      glutamate levels, suggesting that antiglutamatergic drugs might be useful in
      treating MDD. Ketamine is a non-selective, high-affinity N-methyl-D-aspartate
      receptor (NMDAR) antagonist most commonly used in pediatric and animal surgery.
      In the past, ketamine has gained popularity because of its ability to rapidly
      elevate mood, even in treatment-resistant and bipolar depression. However, there 
      are still many obstacles before widespread clinical approval of ketamine
      treatment could become reality. In this review, ketamine’s powerful
      antidepressant effects are discussed and further research necessary for
      therapeutic application is outlined. NMDAR antagonists provide an entirely new
      way of treating the manifold appearances of depression that should not be left
      unused.
FAU - Hasselmann, H. W.W.
AU  - Hasselmann HW
LA  - eng
PT  - Journal Article
DEP - 201401
PHST- 2013/05/07 [received]
PHST- 2013/07/01 [revised]
PHST- 2013/07/09 [accepted]
PHST- 2014/01 [aheadofprint]
TA  - Curr Neuropharmacol
JT  - Current Neuropharmacology
AID - CN-12-57 [pii]
AID - 10.2174/1570159X113119990043 [doi]
SO  - Curr Neuropharmacol. 2014 Jan;12(1):57-70. Epub 2014 Jan
      doi:10.2174/1570159X113119990043.

PMC - PMC4140242
PMID- 25152693
IS  - 1469-493X (Electronic)
VI  - 2014
DP  - 2014 Mar 10
TI  - Telerehabilitation for people with low vision.
LID - 10.1002/14651858.CD011019
AB  - This is the protocol for a review and there is no abstract. The objectives are as
      follows:Our goal is to systematically review the literature on
      telerehabilitation’s effectiveness for improving vision-related quality of life
      and/ or reading speed compared to face-to-face (e.g., in-office or inpatient) low
      vision rehabilitation services in patients with low vision or visual function
      loss due to any ocular condition. Secondary objectives are to evaluate compliance
      with scheduled rehabilitation sessions, VAE device abandonment rates, and/or
      patient satisfaction ratings in the same studies.
FAU - Bittner, Ava K
AU  - Bittner AK
AD  - Nova Southeastern University, College of Optometry, Ft. Lauderdale, Florida, USA
FAU - Wykstra, Stephanie L
AU  - Wykstra SL
AD  - New York, USA
FAU - Yoshinaga, Patrick D
AU  - Yoshinaga PD
AD  - Southern California College of Optometry, Marshall B. Ketchum University,
      Fullerton, California, USA
FAU - Li, Tianjing
AU  - Li T
AD  - Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health,
      Baltimore, Maryland, USA
LA  - eng
PT  - Journal Article
TA  - Cochrane Database Syst Rev
JT  - The Cochrane database of systematic reviews
AID - 10.1002/14651858.CD011019 [doi]
MID - NIHMS574828
SO  - Cochrane Database Syst Rev. 2014 Mar 10;2014:. doi:10.1002/14651858.CD011019.

PMC - PMC4138173
PMID- 25136793
IS  - 1932-6203 (Electronic)
VI  - 9
IP  - 8
DP  - 2014
TI  - The Perception of Materials through Oral Sensation.
LID - e105035
AB  - This paper presents the results of a multimodal study of oral perception
      conducted with a set of material samples made from metals, polymers and woods, in
      which both the somatosensory and taste factors were examined. A multidimensional 
      scaling analysis coupled with subjective attribute ratings was performed to
      assess these factors both qualitatively and quantitatively. The perceptual
      somatosensory factors of warmth, hardness and roughness dominated over the basic 
      taste factors, and roughness was observed to be a less significant sensation
      compared to touch-only experiments. The perceptual somatosensory ratings were
      compared directly with physical property data in order to assess the correlation 
      between the perceived properties and measured physical properties. In each case, 
      a strong correlation was observed, suggesting that physical properties may be
      useful in industrial design for predicting oral perception.
FAU - Howes, Philip D.
AU  - Howes PD
AD  - Materials Department, Imperial College London, London, United Kingdom
FAU - Wongsriruksa, Supinya
AU  - Wongsriruksa S
AD  - Physics Department, King's College London, London, United Kingdom
FAU - Laughlin, Zoe
AU  - Laughlin Z
AD  - Institute of Making, University College London, London, United Kingdom
FAU - Witchel, Harry J.
AU  - Witchel HJ
AD  - Brighton and Sussex Medical School, University of Sussex Campus, Brighton, United
      Kingdom
FAU - Miodownik, Mark
AU  - Miodownik M
AD  - Institute of Making, University College London, London, United Kingdom
LA  - eng
PT  - Journal Article
DEP - 20140819
PHST- 2013/12/13 [received]
PHST- 2014/07/20 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-13-52587 [pii]
AID - 10.1371/journal.pone.0105035 [doi]
SO  - PLoS One. 2014 Aug 19;9(8):. doi:10.1371/journal.pone.0105035.

PMC - PMC4156317
PMID- 25028989
IS  - 1741-2560 (Print)
IS  - 1741-2552 (Electronic)
VI  - 11
IP  - 4
DP  - 2014 Aug
TI  - Comparing temporal aspects of visual, tactile, and microstimulation feedback for 
      motor control.
PG  - 046025
AB  - Objectives: Current brain-computer interfaces (BCIs) rely on visual feedback,
      requiring sustained visual attention to use the device. Improvements to BCIs may 
      stem from the development of an effective way to provide quick feedback
      independent of vision. Tactile stimuli, either delivered on the skin surface, or 
      directly to the brain via microstimulation in somatosensory cortex, could serve
      that purpose. We examined the effectiveness of vibrotactile stimuli and
      microstimulation as a means of non-visual feedback by using a fundamental element
      of feedback: the ability to react to a stimulus while already in motion.
      Approach: Human and monkey subjects performed a center-out reach task which was, 
      on occasion, interrupted with a stimulus cue that instructed a change in reach
      target. Main results: Subjects generally responded faster to tactile cues than to
      visual cues. However, when we delivered cues via microstimuation in a monkey, its
      average response was slower than that for both tactile and visual cues.
      Significance: Tactile and microstimulation feedback can be used to rapidly adjust
      movements mid-flight. The relatively slow speed of microstimulation raises some
      interesting questions and warrants further investigation. Overall, these results 
      highlight the importance of considering temporal aspects of feedback when
      designing alternative forms of feedback for brain-computer interfaces.
FAU - Godlove, Jason
AU  - Godlove J
FAU - O’Brien, Erin
AU  - O’Brien E
FAU - Batista, Aaron
AU  - Batista A
LA  - eng
PT  - Journal Article
DEP - 20140716
TA  - J Neural Eng
JT  - Journal of neural engineering
AID - 10.1088/1741-2560/11/4/046025 [doi]
MID - NIHMS615720
SO  - J Neural Eng. 2014 Aug;11(4):046025. Epub 2014 Jul 16
      doi:10.1088/1741-2560/11/4/046025.

PMC - PMC4870471
PMID- 27242461
IS  - 1662-5153 (Electronic)
VI  - 10
DP  - 2016
TI  - Walking while Performing Working Memory Tasks Changes the Prefrontal Cortex
      Hemodynamic Activations and Gait Kinematics.
LID - 92
AB  - Background: Increasing evidence suggests that walking while performing a
      concurrent task negatively influences gait performance. However, it remains
      unclear how higher-level cognitive processes and coordination of limb movements
      are altered in challenging walking environments. This study investigated the
      influence of cognitive task complexity and walking road condition on the neutral 
      correlates of executive function and postural control in dual-task
      walking.Methods: Twenty-four healthy young adults completed a series of
      overground walks with three walking road conditions (wide, narrow, with
      obstacles) with and without the concurrent n-back working memory tasks of two
      complexity levels (1-back and 3-back). Prefrontal brain activation was assessed
      by functional near-infrared spectroscopy. A three-dimensional motion analysis
      system was used simultaneously to measure gait performance and lower-extremity
      kinematics. Repeated measures analysis of variance were performed to examine the 
      differences between the conditions.Results: In comparison with standing still,
      participants showed lower n-back task accuracy while walking, with the worst
      performance from the road with obstacles. Spatiotemporal gait parameters,
      lower-extremity joint movements, and the relative changes in oxygenated
      hemoglobin (HbO) concentration levels were all significantly different across the
      task complexity and walking path conditions. While dual-tasking participants were
      found to flex their hips and knees less, leading to a slower gait speed, longer
      stride time, shorter step length, and greater gait variability than during normal
      walking. For narrow-road walking, smaller ankle dorsiflexion and larger hip
      flexion were observed, along with a reduced gait speed. Obstacle negotiation was 
      mainly characterized by increased gait variability than other conditions. HbO
      levels appeared to be lower during dual-task walking than normal walking.
      Compared to wide and obstacle conditions, walking on the narrow road was found to
      elicit a smaller decrement in HbO levels.Conclusion: The current study provided
      direct evidence that, in young adults, neural correlates of executive function
      and dynamic postural control tend to be altered in response to the cognitive load
      imposed by the walking environment and the concurrent task during ambulation. A
      shift of brain activation patterns between functionally connected networks may
      occur when facing challenging cognitive–motor interaction.
FAU - Lin, Ming-I B.
AU  - Lin MIB
FAU - Lin, Kuan-Hung
AU  - Lin KH
LA  - eng
PT  - Journal Article
DEP - 20160518
GR  - MOST 103-2221-E-006 –199 -
PHST- 2016/01/29 [received]
PHST- 2016/04/29 [accepted]
TA  - Front Behav Neurosci
JT  - Frontiers in Behavioral Neuroscience
AID - 10.3389/fnbeh.2016.00092 [doi]
SO  - Front Behav Neurosci. 2016 May 18;10:. doi:10.3389/fnbeh.2016.00092.

PMC - PMC1819386
PMID- 17309791
IS  - 1743-0003 (Electronic)
VI  - 4
DP  - 2007
TI  - Multivariate analysis of the Fugl-Meyer outcome measures assessing the
      effectiveness of GENTLE/S robot-mediated stroke therapy.
PG  - 4
AB  - Background: Robot-mediated therapies offer entirely new approaches to
      neurorehabilitation. In this paper we present the results obtained from trialling
      the GENTLE/S neurorehabilitation system assessed using the upper limb section of 
      the Fugl-Meyer (FM) outcome measure. Methods: We demonstrate the design of our
      clinical trial and its results analysed using a novel statistical approach based 
      on a multivariate analytical model. This paper provides the rational for using
      multivariate models in robot-mediated clinical trials and draws conclusions from 
      the clinical data gathered during the GENTLE/S study. Results: The FM outcome
      measures recorded during the baseline (8 sessions), robot-mediated therapy (9
      sessions) and sling-suspension (9 sessions) was analysed using a multiple
      regression model. The results indicate positive but modest recovery trends
      favouring both interventions used in GENTLE/S clinical trial. The modest recovery
      shown occurred at a time late after stroke when changes are not clinically
      anticipated. Conclusion: This study has applied a new method for analysing
      clinical data obtained from rehabilitation robotics studies. While the data
      obtained during the clinical trial is of multivariate nature, having multipoint
      and progressive nature, the multiple regression model used showed great potential
      for drawing conclusions from this study.An important conclusion to draw from this
      paper is that this study has shown that the intervention and control phase both
      caused changes over a period of 9 sessions in comparison to the baseline. This
      might indicate that use of new challenging and motivational therapies can
      influence the outcome of therapies at a point when clinical changes are not
      expected.Further work is required to investigate the effects arising from early
      intervention, longer exposure and intensity of the therapies. Finally, more
      function-oriented robot-mediated therapies or sling-suspension therapies are
      needed to clarify the effects resulting from each intervention for stroke
      recovery.
FAU - Amirabdollahian, Farshid
AU  - Amirabdollahian F
AD  - Think Lab, The University of Salford, Maxwell Building, Salford, M5 4WT, UK
FAU - Loureiro, Rui
AU  - Loureiro R
AD  - Department of Cybernetics, University of Reading, Reading, RG6 6AY, UK
FAU - Gradwell, Elizabeth
AU  - Gradwell E
AD  - Community Therapy Team Florence Desmond Day Hospital, Royal Surrey County
      Hospital, Guildford, Surrey, GU2 7XX, UK
FAU - Collin, Christine
AU  - Collin C
AD  - Department of Neurorehabilitation, South Block Annexe, Royal Berkshire Hospital, 
      London Road, Reading, RG1 5AN, UK
FAU - Harwin, William
AU  - Harwin W
AD  - Department of Cybernetics, University of Reading, Reading, RG6 6AY, UK
FAU - Johnson, Garth
AU  - Johnson G
AD  - Centre for Rehabilitation and Engineering Studies, School of Mechanical and
      Systems Engineering, University of Newcastle upon Tyne, Newcastle, NE1 7RU, UK
LA  - eng
PT  - Journal Article
DEP - 20070219
PHST- 2006/04/21 [received]
PHST- 2007/02/19 [accepted]
TA  - J Neuroengineering Rehabil
JT  - Journal of NeuroEngineering and Rehabilitation
AID - 1743-0003-4-4 [pii]
AID - 10.1186/1743-0003-4-4 [doi]
SO  - J Neuroengineering Rehabil. 2007 Feb 19;4:4. doi:10.1186/1743-0003-4-4.

PMC - PMC2266825
PMID- 18350129
IS  - 1687-5265 (Print)
IS  - 1687-5273 (Electronic)
VI  - 2007
DP  - 2007
TI  - A Concept for Extending the Applicability of Constraint-Induced Movement Therapy 
      through Motor Cortex Activity Feedback Using a Neural Prosthesis.
LID - 51363
AB  - This paper describes a concept for the extension of constraint-induced movement
      therapy (CIMT) through the use of feedback of primary motor cortex activity. CIMT
      requires residual movement to act as a source of feedback to the patient, thus
      preventing its application to those with no perceptible movement. It is proposed 
      in this paper that it is possible to provide feedback of the motor cortex effort 
      to the patient by measurement with near infrared spectroscopy (NIRS). Significant
      changes in such effort may be used to drive rehabilitative robotic actuators, for
      example. This may provide a possible avenue for extending CIMT to patients
      hitherto excluded as a result of severity of condition. In support of such a
      paradigm, this paper details the current status of CIMT and related attempts to
      extend rehabilitation therapy through the application of technology. An
      introduction to the relevant haemodynamics is given including a description of
      the basic technology behind a suitable NIRS system. An illustration of the
      proposed therapy is described using a simple NIRS system driving a robotic arm
      during simple upper-limb unilateral isometric contraction exercises with healthy 
      subjects.
FAU - Ward, Tomas E.
AU  - Ward TE
AD  - Department of Electronic Engineering, National University of Ireland, Maynooth,
      County Kildare, Ireland
FAU - Soraghan, Christopher J.
AU  - Soraghan CJ
AD  - Department of Computer Science and Department of Experimental Physics, National
      University of Ireland, Maynooth, County Kildare, Ireland
FAU - Matthews, Fiachra
AU  - Matthews F
AD  - Hamilton Institute, National University of Ireland, Maynooth, County Kildare,
      Ireland
FAU - Markham, Charles
AU  - Markham C
AD  - Department of Computer Science, National University of Ireland, Maynooth, County 
      Kildare, Ireland
LA  - eng
PT  - Journal Article
DEP - 20070923
PHST- 2007/02/17 [received]
PHST- 2007/05/11 [revised]
PHST- 2007/07/14 [accepted]
PHST- 2007/09/23 [aheadofprint]
TA  - Comput Intell Neurosci
JT  - Computational Intelligence and Neuroscience
AID - 10.1155/2007/51363 [doi]
SO  - Comput Intell Neurosci. 2007;2007:. Epub 2007 Sep 23 doi:10.1155/2007/51363.

PMC - PMC5111169
PMID- 26841263
IS  - 1549-3296 (Print)
IS  - 1552-4965 (Electronic)
VI  - 104
IP  - 6
DP  - 2016 Jun
TI  - Persistence, Distribution, and Impact of Distinctly Segmented Microparticles on
      Cochlear Health following In Vivo Infusion3*.
PG  - 1510-22
AB  - Delivery of pharmaceuticals to the cochleae of patients with auditory dysfunction
      could potentially have many benefits from enhancing auditory nerve survival to
      protecting remaining sensory cells and their neuronal connections. Treatment
      would require platforms to enable drug delivery directly to the cochlea and
      increase the potential efficacy of intervention. Cochlear implant recipients are 
      a specific patient subset that could benefit from local drug delivery as more
      candidates have residual hearing; and since residual hearing directly contributes
      to post-implantation hearing outcomes, it requires protection from implant
      insertion-induced trauma. This study assessed the feasibility of utilizing
      microparticles for drug delivery into cochlear fluids, testing persistence,
      distribution, biocompatibility, and drug release characteristics. To allow for
      delivery of multiple therapeutics, particles were composed of two distinct
      compartments; one containing polylactide-co-glycolide (PLGA), and one composed of
      acetal-modified dextran and PLGA. Following in vivo infusion, image analysis
      revealed microparticle persistence in the cochlea for at least 7 days
      post-infusion, primarily in the first and second turns. The majority of subjects 
      maintained or had only slight elevation in auditory brainstem response thresholds
      at 7 days post-infusion compared to pre-infusion baselines. There was only minor 
      to limited loss of cochlear hair cells and negligible immune response based on
      CD45+ immunolabling. When Piribedil-loaded microparticles were infused, Piribedil
      was detectable within the cochlear fluids at 7 days post-infusion. These results 
      indicate that segmented microparticles are relatively inert, can persist, release
      their contents, and be functionally and biologically compatible with cochlear
      function and therefore are promising vehicles for cochlear drug delivery.
FAU - Ross, Astin M.
AU  - Ross AM
AD  - Department of Biomedical Engineering, University of Michigan, Ann Arbor 48109,
      USA
FAU - Rahmani, Sahar
AU  - Rahmani S
AD  - Department of Biomedical Engineering, University of Michigan, Ann Arbor 48109,
      USA
FAU - Prieskorn, Diane M.
AU  - Prieskorn DM
AD  - Kresge Hearing Research Institute, University of Michigan, Ann Arbor 48109, USA
FAU - Dishman, Acacia F
AU  - Dishman AF
AD  - Department of Biophysics, University of Michigan, Ann Arbor 48109, USA
FAU - Miller, Josef M.
AU  - Miller JM
AD  - Kresge Hearing Research Institute, University of Michigan, Ann Arbor 48109, USA
FAU - Lahann, Joerg
AU  - Lahann J
AD  - Department of Biomedical Engineering, University of Michigan, Ann Arbor 48109,
      USA
FAU - Altschuler, Richard A.
AU  - Altschuler RA
AD  - Kresge Hearing Research Institute, University of Michigan, Ann Arbor 48109, USA
LA  - eng
PT  - Journal Article
DEP - 20160302
TA  - J Biomed Mater Res A
JT  - Journal of biomedical materials research. Part A
AID - 10.1002/jbm.a.35675 [doi]
MID - NIHMS757124
SO  - J Biomed Mater Res A. 2016 Jun;104(6):1510-22. Epub 2016 Mar 02
      doi:10.1002/jbm.a.35675.

PMC - PMC3530851
PMID- 23304640
IS  - 2090-8105 (Print)
IS  - 2042-0056 (Electronic)
VI  - 2012
DP  - 2012
TI  - Seven Capital Devices for the Future of Stroke Rehabilitation.
LID - 187965
AB  - Stroke is the leading cause of long-term disability for adults in industrialized 
      societies. Rehabilitation's efforts are tended to avoid long-term impairments,
      but, actually, the rehabilitative outcomes are still poor. Novel tools based on
      new technologies have been developed to improve the motor recovery. In this
      paper, we have taken into account seven promising technologies that can improve
      rehabilitation of patients with stroke in the early future: (1) robotic devices
      for lower and upper limb recovery, (2) brain computer interfaces, (3) noninvasive
      brain stimulators, (4) neuroprostheses, (5) wearable devices for quantitative
      human movement analysis, (6) virtual reality, and (7) tablet-pc used for
      neurorehabilitation.
FAU - Iosa, M.
AU  - Iosa M
AD  - Clinical Laboratory of Experimental Neurorehabilitation, Santa Lucia Foundation
      I.R.C.C.S., Via Ardeatina 306, 00179 Rome, Italy
FAU - Morone, G.
AU  - Morone G
AD  - Clinical Laboratory of Experimental Neurorehabilitation, Santa Lucia Foundation
      I.R.C.C.S., Via Ardeatina 306, 00179 Rome, Italy
FAU - Fusco, A.
AU  - Fusco A
AD  - Clinical Laboratory of Experimental Neurorehabilitation, Santa Lucia Foundation
      I.R.C.C.S., Via Ardeatina 306, 00179 Rome, Italy
FAU - Bragoni, M.
AU  - Bragoni M
AD  - Operative Unit F, Santa Lucia Foundation I.R.C.C.S., Via Ardeatina 306, 00179
      Rome, Italy
FAU - Coiro, P.
AU  - Coiro P
AD  - Operative Unit F, Santa Lucia Foundation I.R.C.C.S., Via Ardeatina 306, 00179
      Rome, Italy
FAU - Multari, M.
AU  - Multari M
AD  - Operative Unit F, Santa Lucia Foundation I.R.C.C.S., Via Ardeatina 306, 00179
      Rome, Italy
FAU - Venturiero, V.
AU  - Venturiero V
AD  - Operative Unit F, Santa Lucia Foundation I.R.C.C.S., Via Ardeatina 306, 00179
      Rome, Italy
FAU - De Angelis, D.
AU  - De Angelis D
AD  - Operative Unit F, Santa Lucia Foundation I.R.C.C.S., Via Ardeatina 306, 00179
      Rome, Italy
FAU - Pratesi, L.
AU  - Pratesi L
AD  - Operative Unit F, Santa Lucia Foundation I.R.C.C.S., Via Ardeatina 306, 00179
      Rome, Italy
FAU - Paolucci, S.
AU  - Paolucci S
AD  - Clinical Laboratory of Experimental Neurorehabilitation, Santa Lucia Foundation
      I.R.C.C.S., Via Ardeatina 306, 00179 Rome, Italy
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20121213
PHST- 2012/09/26 [received]
PHST- 2012/11/12 [accepted]
PHST- 2012/12/13 [aheadofprint]
TA  - Stroke Res Treat
JT  - Stroke Research and Treatment
AID - 10.1155/2012/187965 [doi]
SO  - Stroke Res Treat. 2012;2012:. Epub 2012 Dec 13 doi:10.1155/2012/187965.

PMC - PMC1359018
PMID- 11797315
IS  - 0065-9533 (Print)
IS  - 1545-6110 (Electronic)
VI  - 99
DP  - 2001
TI  - Intraocular retinal prosthesis.
PG  - 271-300
AB  - PURPOSE: An electronic implant that can bypass the damaged photoreceptors and
      electrically stimulate the remaining retinal neurons to restore useful vision has
      been proposed. A number of key questions remain to make this approach feasible.
      The goal of this thesis is to address the following 2 specific null hypotheses:
      (1) Stimulus parameters make no difference in the electrically elicited retinal
      responses. (2) Just as we have millions of photoreceptors, so it will take a
      device that can generate millions of pixels/light points to create useful vision.
      METHODS: For electrophysiologic experiments, 2 different setups were used. In the
      first setup, charge-balanced pulses were delivered to the retinal surface via
      electrodes inserted through an open sky approach in normal or blind retinal
      degenerate (rd) mice. In the second setup, the rabbit retina was removed under
      red light conditions from an enucleated eye and then maintained in a chamber
      while being superfused with oxygenated, heated Ames media. In both setups,
      stimulating electrodes and recording electrodes were positioned on the retinal
      surface to evaluate the effect of varying stimulation parameters on the
      orthodromic retinal responses (i.e., recording electrode placed between
      stimulating electrodes and optic nerve head). For psychophysical experiments,
      visual images were divided into pixels of light that could be projected in a
      pattern on the retina in up to 8 sighted volunteers. Subjects were asked to
      perform various tasks ranging from reading and face recognition to various
      activities of daily living. RESULTS: Electrophysiologic experiments: In a normal 
      mouse, a single cycle of a 1-kHz sine wave was significantly more efficient than 
      a 1-kHz square wave (P < .05), but no such difference was noted in either of the 
      8- or 16-week-old rd mouse groups (8-week-old, P = .426; 16-week-old, P = .078). 
      Charge threshold was significantly higher in 16-week-old rd mouse versus both
      8-week-old rd and normal mouse for every stimulus duration (P < .05). In all
      groups, short duration pulses (40, 80, and 120 microseconds) were more efficient 
      in terms of total charge (the product of pulse amplitude and pulse duration) than
      longer (500 and 1,000 microseconds) pulses (P < .05). In all groups, applying a
      pulse train did not lead to more efficient charge usage (P < .05). Psychophysical
      experiments: In high-contrast tests, facial recognition rates of over 75% were
      achieved for all subjects with dot sizes of up to 31.5 minutes of arc when using 
      a 25 x 25 grid with 4.5 arc minute gaps, a 30% dropout rate, and 6 gray levels.
      Even with a 4 x 4 array of pixels, some subjects were able to accurately describe
      2 of the objects. Subjects who were able to read the 4-pixel letter height
      sentences (on the 6 x 10 and 16 x 16 array) seemed to have a good scanning
      technique. Scanning at the proper velocity tends to bring out more contrast in
      the lettering. The reading speed for the 72-point font is a bit slower than for
      the next smaller font. This may be due to the limited number of letters (3)
      visible in the window with this large font. CONCLUSIONS: Specific parameters
      needed to stimulate the retina were identified. Delineating the optimum
      parameters will decrease the current requirements. Psychophysical tests show that
      with limited pixels and image processing, useful vision is possible. Both these
      findings should greatly simplify the engineering of an electronic retinal
      prosthesis.
FAU - Humayun, M S
AU  - Humayun MS
LA  - eng
PT  - Journal Article
TA  - Trans Am Ophthalmol Soc
JT  - Transactions of the American Ophthalmological Society
SO  - Trans Am Ophthalmol Soc. 2001;99:271-300.

PMC - PMC2241751
PMID- 16968947
IS  - 0031-6997 (Print)
IS  - 1521-0081 (Electronic)
VI  - 58
IP  - 3
DP  - 2006 Sep
TI  - The Endocannabinoid System as an Emerging Target of Pharmacotherapy.
PG  - 389-462
AB  - The recent identification of cannabinoid receptors and their endogenous lipid
      ligands has triggered an exponential growth of studies exploring the
      endocannabinoid system and its regulatory functions in health and disease. Such
      studies have been greatly facilitated by the introduction of selective
      cannabinoid receptor antagonists and inhibitors of endocannabinoid metabolism and
      transport, as well as mice deficient in cannabinoid receptors or the
      endocannabinoid-degrading enzyme fatty acid amidohydrolase. In the past decade,
      the endocannabinoid system has been implicated in a growing number of
      physiological functions, both in the central and peripheral nervous systems and
      in peripheral organs. More importantly, modulating the activity of the
      endocannabinoid system turned out to hold therapeutic promise in a wide range of 
      disparate diseases and pathological conditions, ranging from mood and anxiety
      disorders, movement disorders such as Parkinson’s and Huntington’s disease,
      neuropathic pain, multiple sclerosis and spinal cord injury, to cancer,
      atherosclerosis, myocardial infarction, stroke, hypertension, glaucoma,
      obesity/metabolic syndrome, and osteoporosis, to name just a few. An impediment
      to the development of cannabinoid medications has been the socially unacceptable 
      psychoactive properties of plant-derived or synthetic agonists, mediated by CB1
      receptors. However, this problem does not arise when the therapeutic aim is
      achieved by treatment with a CB1 receptor antagonist, such as in obesity, and may
      also be absent when the action of endocannabinoids is enhanced indirectly through
      blocking their metabolism or transport. The use of selective CB2 receptor
      agonists, which lack psychoactive properties, could represent another promising
      avenue for certain conditions. The abuse potential of plant-derived cannabinoids 
      may also be limited through the use of preparations with controlled composition
      and the careful selection of dose and route of administration. The growing number
      of preclinical studies and clinical trials with compounds that modulate the
      endocannabinoid system will probably result in novel therapeutic approaches in a 
      number of diseases for which current treatments do not fully address the
      patients’ need. Here, we provide a comprehensive overview on the current state of
      knowledge of the endocannabinoid system as a target of pharmacotherapy.
FAU - PACHER, PÁL
AU  - PACHER P
FAU - BÁTKAI, SÁNDOR
AU  - BÁTKAI S
FAU - KUNOS, GEORGE
AU  - KUNOS G
LA  - eng
PT  - Journal Article
TA  - Pharmacol Rev
JT  - Pharmacological reviews
AID - 10.1124/pr.58.3.2 [doi]
MID - NIHMS38123
SO  - Pharmacol Rev. 2006 Sep;58(3):389-462. doi:10.1124/pr.58.3.2.

PMC - PMC2908743
IS  - 1573-9538 (Print)
IS  - 1573-9546 (Electronic)
VI  - 6
IP  - Suppl 1
DP  - 2010 Jun
TI  - Purines 2010: Adenine Nucleosides and Nucleotides in Biomedicine.
PG  - 1-162
LA  - eng
PT  - Journal Article
DEP - 20100617
TA  - Purinergic Signal
JT  - Purinergic Signalling
AID - 9187 [pii]
AID - 10.1007/s11302-010-9187-6 [doi]
SO  - Purinergic Signal. 2010 Jun;6(Suppl 1):1-162. Epub 2010 Jun 17
      doi:10.1007/s11302-010-9187-6.

PMC - PMC4702293
PMID- 26778962
IS  - 1662-5102 (Electronic)
VI  - 9
DP  - 2015
TI  - Current Challenges Facing the Translation of Brain Computer Interfaces from
      Preclinical Trials to Use in Human Patients.
LID - 497
AB  - Current research in brain computer interface (BCI) technology is advancing beyond
      preclinical studies, with trials beginning in human patients. To date, these
      trials have been carried out with several different types of recording
      interfaces. The success of these devices has varied widely, but different factors
      such as the level of invasiveness, timescale of recorded information, and ability
      to maintain stable functionality of the device over a long period of time all
      must be considered in addition to accuracy in decoding intent when assessing the 
      most practical type of device moving forward. Here, we discuss various approaches
      to BCIs, distinguishing between devices focusing on control of operations
      extrinsic to the subject (e.g., prosthetic limbs, computer cursors) and those
      focusing on control of operations intrinsic to the brain (e.g., using stimulation
      or external feedback), including closed-loop or adaptive devices. In this
      discussion, we consider the current challenges facing the translation of various 
      types of BCI technology to eventual human application.
FAU - Murphy, Maxwell D.
AU  - Murphy MD
AD  - Bioengineering Graduate Program, University of KansasLawrence, KS, USA
FAU - Guggenmos, David J.
AU  - Guggenmos DJ
AD  - Department of Rehabilitation Medicine, University of Kansas Medical CenterKansas 
      City, KS, USA
FAU - Bundy, David T.
AU  - Bundy DT
AD  - Department of Rehabilitation Medicine, University of Kansas Medical CenterKansas 
      City, KS, USA
FAU - Nudo, Randolph J.
AU  - Nudo RJ
AD  - Department of Rehabilitation Medicine, University of Kansas Medical CenterKansas 
      City, KS, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20160106
GR  - PT090167P1
PHST- 2015/07/24 [received]
PHST- 2015/12/10 [accepted]
TA  - Front Cell Neurosci
JT  - Frontiers in Cellular Neuroscience
AID - 10.3389/fncel.2015.00497 [doi]
SO  - Front Cell Neurosci. 2016 Jan 06;9:. doi:10.3389/fncel.2015.00497.

PMC - PMC4719576
PMID- 26791569
IS  - 1471-2393 (Electronic)
VI  - 16
DP  - 2016
TI  - A study of an intelligent system to support decision making in the management of 
      labour using the cardiotocograph – the INFANT study protocol.
LID - 10
AB  - Background: Continuous electronic fetal heart rate monitoring in labour is widely
      used but its potential for improving fetal and neonatal outcomes has not been
      realised. The most likely reason is the difficulty of interpreting the fetal
      heart rate trace correctly during labour. Computerised interpretation of the
      fetal heart rate and intelligent decision-support has the potential to deliver
      this improvement in care.This trial will test whether the addition of decision
      support software to aid the interpretation of the cardiotocogram (CTG) during
      labour will reduce the number of ‘poor neonatal outcomes’ in those women judged
      to require continuous electronic fetal heart rate monitoring. Methods and design:
      An individually randomised controlled trial of 46,000 women who are judged to
      require continuous electronic fetal monitoring in labour.Eligibility criteria:
      Women admitted to a participating labour ward who are judged to require
      continuous electronic fetal monitoring, have a singleton or twin pregnancy,
      are ≥ 35 weeks’ gestation, have no known gross fetal abnormality and
      are ≥ 16 years of age.Exclusion criteria: Triplets or higher order pregnancy,
      elective caesarean section prior to the onset of labour, planned admission to
      NICU.Trial interventions: Computerised interpretation of the CTG with
      decision-support.Primary outcomes: Short term: A composite of ‘poor neonatal
      outcome’ including stillbirth after trial entry, early neonatal death except
      deaths due to congenital anomalies, significant morbidity: neonatal
      encephalopathy, admissions to the neonatal unit with 48 h for > 48 h with
      evidence of feeding difficulties, respiratory illness or encephalopathy where
      there is evidence of compromise at birth. Long term: Developmental assessment at 
      the age of 2 years in a subset of 7000 surviving babies.Data Collection: For all 
      participating women and babies, labour variables and outcomes will be stored
      automatically and contemporaneously onto the Guardian® system. Discussion: The
      results of this trial will have importance for pregnant women and for health
      professionals who provide care for them. Trial registration: Current Controlled
      Trials ISRCTN98680152 assigned 30.09.2008
FAU - Brocklehurst, Peter
AU  - Brocklehurst P
AD  - UCL EGA Institute for Women’s Health, 74 Huntley Street, WC1E 6 AU London, UK
CN  - on behalf of The INFANT Collaborative Group
LA  - eng
PT  - Journal Article
DEP - 20160120
PHST- 2014/10/30 [received]
PHST- 2015/12/08 [accepted]
TA  - BMC Pregnancy Childbirth
JT  - BMC Pregnancy and Childbirth
AID - 780 [pii]
AID - 10.1186/s12884-015-0780-0 [doi]
SO  - BMC Pregnancy Childbirth. 2016 Jan 20;16:. doi:10.1186/s12884-015-0780-0.

PMC - PMC5370129
PMID- 28350887
IS  - 1932-6203 (Electronic)
VI  - 12
IP  - 3
DP  - 2017
TI  - Auditory steady state responses and cochlear implants: Modeling the
      artifact-response mixture in the perspective of denoising.
LID - e0174462
AB  - Auditory steady state responses (ASSRs) in cochlear implant (CI) patients are
      contaminated by the spread of a continuous CI electrical stimulation artifact.
      The aim of this work was to model the electrophysiological mixture of the CI
      artifact and the corresponding evoked potentials on scalp electrodes in order to 
      evaluate the performance of denoising algorithms in eliminating the CI artifact
      in a controlled environment. The basis of the proposed computational framework is
      a neural mass model representing the nodes of the auditory pathways. Six main
      contributors to auditory evoked potentials from the cochlear level and up to the 
      auditory cortex were taken into consideration. The simulated dynamics were then
      projected into a 3-layer realistic head model. 32-channel scalp recordings of the
      CI artifact-response were then generated by solving the electromagnetic forward
      problem. As an application, the framework’s simulated 32-channel datasets were
      used to compare the performance of 4 commonly used Independent Component Analysis
      (ICA) algorithms: infomax, extended infomax, jade and fastICA in eliminating the 
      CI artifact. As expected, two major components were detectable in the simulated
      datasets, a low frequency component at the modulation frequency and a pulsatile
      high frequency component related to the stimulation frequency. The first can be
      attributed to the phase-locked ASSR and the second to the stimulation artifact.
      Among the ICA algorithms tested, simulations showed that infomax was the most
      efficient and reliable in denoising the CI artifact-response mixture. Denoising
      algorithms can induce undesirable deformation of the signal of interest in real
      CI patient recordings. The proposed framework is a valuable tool for evaluating
      these algorithms in a controllable environment ahead of experimental or clinical 
      applications.
FAU - Mina, Faten
AU  - Mina F
AD  - Claude Bernard Lyon 1 University, Lyon, France
FAU - Attina, Virginie
AU  - Attina V
AD  - Claude Bernard Lyon 1 University, Lyon, France
FAU - Duroc, Yvan
AU  - Duroc Y
AD  - Claude Bernard Lyon 1 University, Lyon, France
FAU - Veuillet, Evelyne
AU  - Veuillet E
AD  - Claude Bernard Lyon 1 University, Lyon, France
FAU - Truy, Eric
AU  - Truy E
AD  - Claude Bernard Lyon 1 University, Lyon, France
FAU - Thai-Van, Hung
AU  - Thai-Van H
AD  - Claude Bernard Lyon 1 University, Lyon, France
LA  - eng
PT  - Journal Article
DEP - 20170328
GR  - Neurosyllabic
PHST- 2016/08/05 [received]
PHST- 2017/03/09 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - 10.1371/journal.pone.0174462 [doi]
AID - PONE-D-16-31426 [pii]
SO  - PLoS One. 2017 Mar 28;12(3):. doi:10.1371/journal.pone.0174462.

PMC - PMC2672098
PMID- 19133145
IS  - 1755-8794 (Electronic)
VI  - 2
DP  - 2009
TI  - Iron behaving badly: inappropriate iron chelation as a major contributor to the
      aetiology of vascular and other progressive inflammatory and degenerative
      diseases.
PG  - 2
AB  - Background: The production of peroxide and superoxide is an inevitable
      consequence of aerobic metabolism, and while these particular 'reactive oxygen
      species' (ROSs) can exhibit a number of biological effects, they are not of
      themselves excessively reactive and thus they are not especially damaging at
      physiological concentrations. However, their reactions with poorly liganded iron 
      species can lead to the catalytic production of the very reactive and dangerous
      hydroxyl radical, which is exceptionally damaging, and a major cause of chronic
      inflammation. Review: We review the considerable and wide-ranging evidence for
      the involvement of this combination of (su)peroxide and poorly liganded iron in a
      large number of physiological and indeed pathological processes and inflammatory 
      disorders, especially those involving the progressive degradation of cellular and
      organismal performance. These diseases share a great many similarities and thus
      might be considered to have a common cause (i.e. iron-catalysed free radical and 
      especially hydroxyl radical generation).The studies reviewed include those
      focused on a series of cardiovascular, metabolic and neurological diseases, where
      iron can be found at the sites of plaques and lesions, as well as studies showing
      the significance of iron to aging and longevity. The effective chelation of iron 
      by natural or synthetic ligands is thus of major physiological (and potentially
      therapeutic) importance. As systems properties, we need to recognise that
      physiological observables have multiple molecular causes, and studying them in
      isolation leads to inconsistent patterns of apparent causality when it is the
      simultaneous combination of multiple factors that is responsible.This explains,
      for instance, the decidedly mixed effects of antioxidants that have been
      observed, since in some circumstances (especially the presence of poorly liganded
      iron) molecules that are nominally antioxidants can actually act as pro-oxidants.
      The reduction of redox stress thus requires suitable levels of both antioxidants 
      and effective iron chelators. Some polyphenolic antioxidants may serve both
      roles.Understanding the exact speciation and liganding of iron in all its states 
      is thus crucial to separating its various pro- and anti-inflammatory activities. 
      Redox stress, innate immunity and pro- (and some anti-)inflammatory cytokines are
      linked in particular via signalling pathways involving NF-kappaB and p38, with
      the oxidative roles of iron here seemingly involved upstream of the IkappaB
      kinase (IKK) reaction. In a number of cases it is possible to identify mechanisms
      by which ROSs and poorly liganded iron act synergistically and autocatalytically,
      leading to 'runaway' reactions that are hard to control unless one tackles
      multiple sites of action simultaneously. Some molecules such as statins and
      erythropoietin, not traditionally associated with anti-inflammatory activity, do 
      indeed have 'pleiotropic' anti-inflammatory effects that may be of benefit here. 
      Conclusion: Overall we argue, by synthesising a widely dispersed literature, that
      the role of poorly liganded iron has been rather underappreciated in the past,
      and that in combination with peroxide and superoxide its activity underpins the
      behaviour of a great many physiological processes that degrade over time.
      Understanding these requires an integrative, systems-level approach that may lead
      to novel therapeutic targets.
FAU - Kell, Douglas B
AU  - Kell DB
AD  - School of Chemistry and Manchester Interdisciplinary Biocentre, The University of
      Manchester, 131 Princess St, Manchester, M1 7DN, UK
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20090108
PHST- 2008/09/02 [received]
PHST- 2009/01/08 [accepted]
TA  - BMC Med Genomics
JT  - BMC Medical Genomics
AID - 1755-8794-2-2 [pii]
AID - 10.1186/1755-8794-2-2 [doi]
SO  - BMC Med Genomics. 2009 Jan 8;2:2. doi:10.1186/1755-8794-2-2.

PMC - PMC5327363
PMID- 28255345
IS  - 1838-7640 (Electronic)
VI  - 7
IP  - 2
DP  - 2017
TI  - A specific dietary intervention to restore brain structure and function after
      ischemic stroke.
PG  - 493-512
AB  - Occlusion of the middle cerebral artery (MCAo) is among the most common causes of
      ischemic stroke in humans. Cerebral ischemia leads to brain lesions existing of
      an irreversibly injured core and an ischemic boundary zone, the penumbra,
      containing damaged but potentially salvageable tissue. Using a transient
      occlusion (30 min) of the middle cerebral artery (tMCAo) mouse model in this
      cross-institutional study we investigated the neurorestorative efficacy of a
      dietary approach (Fortasyn) comprising docosahexaenoic acid, eicosapentaenoic
      acid, uridine, choline, phospholipids, folic acid, vitamins B12, B6, C, and E,
      and selenium as therapeutic approach to counteract neuroinflammation and
      impairments of cerebral (structural+functional) connectivity, cerebral blood flow
      (CBF), and motor function. Male adult C57BL/6j mice were subjected to right tMCAo
      using the intraluminal filament model. Following tMCAo, animals were either
      maintained on Control diet or switched to the multicomponent Fortasyn diet. At
      several time points after tMCAo, behavioral tests, and MRI and PET scanning were 
      conducted to identify the impact of the multicomponent diet on the elicited
      neuroinflammatory response, loss of cerebral connectivity, and the resulting
      impairment of motor function after experimental stroke. Mice on the
      multicomponent diet showed decreased neuroinflammation, improved functional and
      structural connectivity, beneficial effect on CBF, and also improved motor
      function after tMCAo. Our present data show that this specific dietary
      intervention may have beneficial effects on structural and functional recovery
      and therefore therapeutic potential after ischemic stroke.
FAU - Wiesmann, Maximilian
AU  - Wiesmann M
AD  - Department of Anatomy, Radboud university medical center, Donders Institute for
      Brain, Cognition & Behaviour, Nijmegen, The Netherlands
FAU - Zinnhardt, Bastian
AU  - Zinnhardt B
AD  - European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms University
      Münster, Münster, Germany
FAU - Reinhardt, Dirk
AU  - Reinhardt D
AD  - European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms University
      Münster, Münster, Germany
FAU - Eligehausen, Sarah
AU  - Eligehausen S
AD  - European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms University
      Münster, Münster, Germany
FAU - Wachsmuth, Lydia
AU  - Wachsmuth L
AD  - Department of Clinical Radiology of the University Hospital, Westfälische
      Wilhelms University Münster, Münster, Germany
FAU - Hermann, Sven
AU  - Hermann S
AD  - European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms University
      Münster, Münster, Germany
FAU - Dederen, Pieter J
AU  - Dederen PJ
AD  - Department of Anatomy, Radboud university medical center, Donders Institute for
      Brain, Cognition & Behaviour, Nijmegen, The Netherlands
FAU - Hellwich, Marloes
AU  - Hellwich M
AD  - Department of Anatomy, Radboud university medical center, Donders Institute for
      Brain, Cognition & Behaviour, Nijmegen, The Netherlands
FAU - Kuhlmann, Michael T
AU  - Kuhlmann MT
AD  - European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms University
      Münster, Münster, Germany
FAU - Broersen, Laus M
AU  - Broersen LM
AD  - Advanced Medical Nutrition, Nutricia Research, Utrecht, The Netherlands
FAU - Heerschap, Arend
AU  - Heerschap A
AD  - Department of Radiology & Nuclear Medicine, Radboud university medical center,
      Nijmegen, The Netherlands
FAU - Jacobs, Andreas H
AU  - Jacobs AH
AD  - European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms University
      Münster, Münster, Germany
FAU - Kiliaan, Amanda J
AU  - Kiliaan AJ
AD  - Department of Anatomy, Radboud university medical center, Donders Institute for
      Brain, Cognition & Behaviour, Nijmegen, The Netherlands
LA  - eng
PT  - Journal Article
DEP - 20170106
PHST- 2016/09/13 [received]
PHST- 2016/10/06 [accepted]
TA  - Theranostics
JT  - Theranostics
AID - 10.7150/thno.17559 [doi]
AID - thnov07p0493 [pii]
SO  - Theranostics. 2017 Jan 6;7(2):493-512. doi:10.7150/thno.17559.

PMC - PMC5394920
PMID- 28351863
IS  - 0031-6997 (Print)
IS  - 1521-0081 (Electronic)
VI  - 69
IP  - 2
DP  - 2017 Apr
TI  - Systems Chronotherapeutics.
PG  - 161-99
AB  - Chronotherapeutics aim at treating illnesses according to the endogenous biologic
      rhythms, which moderate xenobiotic metabolism and cellular drug response. The
      molecular clocks present in individual cells involve approximately fifteen clock 
      genes interconnected in regulatory feedback loops. They are coordinated by the
      suprachiasmatic nuclei, a hypothalamic pacemaker, which also adjusts the
      circadian rhythms to environmental cycles. As a result, many mechanisms of
      diseases and drug effects are controlled by the circadian timing system. Thus,
      the tolerability of nearly 500 medications varies by up to fivefold according to 
      circadian scheduling, both in experimental models and/or patients. Moreover,
      treatment itself disrupted, maintained, or improved the circadian timing system
      as a function of drug timing. Improved patient outcomes on circadian-based
      treatments (chronotherapy) have been demonstrated in randomized clinical trials, 
      especially for cancer and inflammatory diseases. However, recent technological
      advances have highlighted large interpatient differences in circadian functions
      resulting in significant variability in chronotherapy response. Such findings
      advocate for the advancement of personalized chronotherapeutics through
      interdisciplinary systems approaches. Thus, the combination of mathematical,
      statistical, technological, experimental, and clinical expertise is now shaping
      the development of dedicated devices and diagnostic and delivery algorithms
      enabling treatment individualization. In particular, multiscale systems
      chronopharmacology approaches currently combine mathematical modeling based on
      cellular and whole-body physiology to preclinical and clinical investigations
      toward the design of patient-tailored chronotherapies. We review recent systems
      research works aiming to the individualization of disease treatment, with
      emphasis on both cancer management and circadian timing system–resetting
      strategies for improving chronic disease control and patient outcomes.
OAB - Publisher: Abstract available from the publisher.
FAU - Ballesta, Annabelle
AU  - Ballesta A
FAU - Innominato, Pasquale F.
AU  - Innominato PF
FAU - Dallmann, Robert
AU  - Dallmann R
FAU - Rand, David A.
AU  - Rand DA
FAU - Lévi, Francis A.
AU  - Lévi FA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 201704
PHST- 2017/04 [aheadofprint]
TA  - Pharmacol Rev
JT  - Pharmacological Reviews
AID - PHARMREV_013441 [pii]
AID - 10.1124/pr.116.013441 [doi]
SO  - Pharmacol Rev. 2017 Apr;69(2):161-99. Epub 2017 Apr doi:10.1124/pr.116.013441.

PMC - PMC1808273
PMID- 16869091
IS  - 1079-0268 (Print)
VI  - 28
IP  - 5
DP  - 2005
TI  - Preservation of Upper Limb Function Following Spinal Cord Injury: A Clinical
      Practice Guideline for Health-Care Professionals.
PG  - 434-70
CN  - Paralyzed Veterans of America Consortium for Spinal Cord Medicine
LA  - eng
PT  - Journal Article
TA  - J Spinal Cord Med
JT  - The Journal of Spinal Cord Medicine
SO  - J Spinal Cord Med. 2005;28(5):434-70.

PMC - PMC5408969
PMID- 27815414
IS  - 1461-1457 (Print)
IS  - 1469-5111 (Electronic)
VI  - 20
IP  - 2
DP  - 2017 Feb 01
TI  - The International College of Neuropsychopharmacology (CINP) Treatment Guidelines 
      for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of 
      the Development of Guidelines.
PG  - 98-120
AB  - Background:: This paper includes a short description of the important clinical
      aspects of Bipolar Disorder with emphasis on issues that are important for the
      therapeutic considerations, including mixed and psychotic features, predominant
      polarity, and rapid cycling as well as comorbidity. Methods:: The workgroup
      performed a review and critical analysis of the literature concerning grading
      methods and methods for the development of guidelines. Results:: The workgroup
      arrived at a consensus to base the development of the guideline on randomized
      controlled trials and related meta-analyses alone in order to follow a strict
      evidence-based approach. A critical analysis of the existing methods for the
      grading of treatment options was followed by the development of a new grading
      method to arrive at efficacy and recommendation levels after the analysis of 32
      distinct scenarios of available data for a given treatment option. Conclusion::
      The current paper reports details on the design, method, and process for the
      development of CINP guidelines for the treatment of Bipolar Disorder. The
      rationale and the method with which all data and opinions are combined in order
      to produce an evidence-based operationalized but also user-friendly guideline and
      a specific algorithm are described in detail in this paper.
FAU - Fountoulakis, Konstantinos N.
AU  - Fountoulakis KN
AD  - 3rd Department of Psychiatry, School of Medicine, Aristotle University of
      Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); Centre for Affective
      Disorders, Institute of Psychiatry, Psychology and Neuroscience, King’s College, 
      London, UK (Dr Young); Department of Psychiatry, University of British Columbia, 
      Mood Disorders Centre of Excellence, Djavad Mowafaghian Centre for Brain Health, 
      Vancouver, Canada (Dr Yatham); Paracelsus Medical University, Salzburg, Austria
      (Dr Grunze); Hospital Clinic, Institute of Neuroscience, University of Barcelona,
      IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta); The Royal Institute of
      Mental Health Research, Department of Psychiatry, University of Ottawa, Ottawa,
      Canada (Dr Blier); Psychiatric Department, Ludwig Maximilians University, Munich,
      Germany (Dr Moeller); Department of Psychiatry and Psychotherapy, Medical
      University Vienna, MUV, AKH, Vienna, Austria (Dr Kasper).
FAU - Young, Allan
AU  - Young A
AD  - 3rd Department of Psychiatry, School of Medicine, Aristotle University of
      Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); Centre for Affective
      Disorders, Institute of Psychiatry, Psychology and Neuroscience, King’s College, 
      London, UK (Dr Young); Department of Psychiatry, University of British Columbia, 
      Mood Disorders Centre of Excellence, Djavad Mowafaghian Centre for Brain Health, 
      Vancouver, Canada (Dr Yatham); Paracelsus Medical University, Salzburg, Austria
      (Dr Grunze); Hospital Clinic, Institute of Neuroscience, University of Barcelona,
      IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta); The Royal Institute of
      Mental Health Research, Department of Psychiatry, University of Ottawa, Ottawa,
      Canada (Dr Blier); Psychiatric Department, Ludwig Maximilians University, Munich,
      Germany (Dr Moeller); Department of Psychiatry and Psychotherapy, Medical
      University Vienna, MUV, AKH, Vienna, Austria (Dr Kasper).
FAU - Yatham, Lakshmi
AU  - Yatham L
AD  - 3rd Department of Psychiatry, School of Medicine, Aristotle University of
      Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); Centre for Affective
      Disorders, Institute of Psychiatry, Psychology and Neuroscience, King’s College, 
      London, UK (Dr Young); Department of Psychiatry, University of British Columbia, 
      Mood Disorders Centre of Excellence, Djavad Mowafaghian Centre for Brain Health, 
      Vancouver, Canada (Dr Yatham); Paracelsus Medical University, Salzburg, Austria
      (Dr Grunze); Hospital Clinic, Institute of Neuroscience, University of Barcelona,
      IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta); The Royal Institute of
      Mental Health Research, Department of Psychiatry, University of Ottawa, Ottawa,
      Canada (Dr Blier); Psychiatric Department, Ludwig Maximilians University, Munich,
      Germany (Dr Moeller); Department of Psychiatry and Psychotherapy, Medical
      University Vienna, MUV, AKH, Vienna, Austria (Dr Kasper).
FAU - Grunze, Heinz
AU  - Grunze H
AD  - 3rd Department of Psychiatry, School of Medicine, Aristotle University of
      Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); Centre for Affective
      Disorders, Institute of Psychiatry, Psychology and Neuroscience, King’s College, 
      London, UK (Dr Young); Department of Psychiatry, University of British Columbia, 
      Mood Disorders Centre of Excellence, Djavad Mowafaghian Centre for Brain Health, 
      Vancouver, Canada (Dr Yatham); Paracelsus Medical University, Salzburg, Austria
      (Dr Grunze); Hospital Clinic, Institute of Neuroscience, University of Barcelona,
      IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta); The Royal Institute of
      Mental Health Research, Department of Psychiatry, University of Ottawa, Ottawa,
      Canada (Dr Blier); Psychiatric Department, Ludwig Maximilians University, Munich,
      Germany (Dr Moeller); Department of Psychiatry and Psychotherapy, Medical
      University Vienna, MUV, AKH, Vienna, Austria (Dr Kasper).
FAU - Vieta, Eduard
AU  - Vieta E
AD  - 3rd Department of Psychiatry, School of Medicine, Aristotle University of
      Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); Centre for Affective
      Disorders, Institute of Psychiatry, Psychology and Neuroscience, King’s College, 
      London, UK (Dr Young); Department of Psychiatry, University of British Columbia, 
      Mood Disorders Centre of Excellence, Djavad Mowafaghian Centre for Brain Health, 
      Vancouver, Canada (Dr Yatham); Paracelsus Medical University, Salzburg, Austria
      (Dr Grunze); Hospital Clinic, Institute of Neuroscience, University of Barcelona,
      IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta); The Royal Institute of
      Mental Health Research, Department of Psychiatry, University of Ottawa, Ottawa,
      Canada (Dr Blier); Psychiatric Department, Ludwig Maximilians University, Munich,
      Germany (Dr Moeller); Department of Psychiatry and Psychotherapy, Medical
      University Vienna, MUV, AKH, Vienna, Austria (Dr Kasper).
FAU - Blier, Pierre
AU  - Blier P
AD  - 3rd Department of Psychiatry, School of Medicine, Aristotle University of
      Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); Centre for Affective
      Disorders, Institute of Psychiatry, Psychology and Neuroscience, King’s College, 
      London, UK (Dr Young); Department of Psychiatry, University of British Columbia, 
      Mood Disorders Centre of Excellence, Djavad Mowafaghian Centre for Brain Health, 
      Vancouver, Canada (Dr Yatham); Paracelsus Medical University, Salzburg, Austria
      (Dr Grunze); Hospital Clinic, Institute of Neuroscience, University of Barcelona,
      IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta); The Royal Institute of
      Mental Health Research, Department of Psychiatry, University of Ottawa, Ottawa,
      Canada (Dr Blier); Psychiatric Department, Ludwig Maximilians University, Munich,
      Germany (Dr Moeller); Department of Psychiatry and Psychotherapy, Medical
      University Vienna, MUV, AKH, Vienna, Austria (Dr Kasper).
FAU - Moeller, Hans Jurgen
AU  - Moeller HJ
AD  - 3rd Department of Psychiatry, School of Medicine, Aristotle University of
      Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); Centre for Affective
      Disorders, Institute of Psychiatry, Psychology and Neuroscience, King’s College, 
      London, UK (Dr Young); Department of Psychiatry, University of British Columbia, 
      Mood Disorders Centre of Excellence, Djavad Mowafaghian Centre for Brain Health, 
      Vancouver, Canada (Dr Yatham); Paracelsus Medical University, Salzburg, Austria
      (Dr Grunze); Hospital Clinic, Institute of Neuroscience, University of Barcelona,
      IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta); The Royal Institute of
      Mental Health Research, Department of Psychiatry, University of Ottawa, Ottawa,
      Canada (Dr Blier); Psychiatric Department, Ludwig Maximilians University, Munich,
      Germany (Dr Moeller); Department of Psychiatry and Psychotherapy, Medical
      University Vienna, MUV, AKH, Vienna, Austria (Dr Kasper).
FAU - Kasper, Siegfried
AU  - Kasper S
AD  - 3rd Department of Psychiatry, School of Medicine, Aristotle University of
      Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); Centre for Affective
      Disorders, Institute of Psychiatry, Psychology and Neuroscience, King’s College, 
      London, UK (Dr Young); Department of Psychiatry, University of British Columbia, 
      Mood Disorders Centre of Excellence, Djavad Mowafaghian Centre for Brain Health, 
      Vancouver, Canada (Dr Yatham); Paracelsus Medical University, Salzburg, Austria
      (Dr Grunze); Hospital Clinic, Institute of Neuroscience, University of Barcelona,
      IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta); The Royal Institute of
      Mental Health Research, Department of Psychiatry, University of Ottawa, Ottawa,
      Canada (Dr Blier); Psychiatric Department, Ludwig Maximilians University, Munich,
      Germany (Dr Moeller); Department of Psychiatry and Psychotherapy, Medical
      University Vienna, MUV, AKH, Vienna, Austria (Dr Kasper).
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20161104
PHST- 2016/06/29 [received]
PHST- 2016/10/20 [accepted]
TA  - Int J Neuropsychopharmacol
JT  - International Journal of Neuropsychopharmacology
AID - 10.1093/ijnp/pyw091 [doi]
AID - pyw091 [pii]
SO  - Int J Neuropsychopharmacol. 2016 Nov 04;20(2):98-120. doi:10.1093/ijnp/pyw091.

PMC - PMC4058859
PMID- 24262909
IS  - 1042-3680 (Print)
IS  - 1558-1349 (Electronic)
VI  - 25
IP  - 1
DP  - 2014 Jan
TI  - Creating the feedback loop: Closed Loop Neurostimulation.
PG  - 187-204
FAU - Hebb, Adam O.
AU  - Hebb AO
FAU - Zhang, Jun Jason
AU  - Zhang JJ
FAU - Mahoor, Mohammad H.
AU  - Mahoor MH
FAU - Tsiokos, Christos
AU  - Tsiokos C
FAU - Matlack, Charles
AU  - Matlack C
FAU - Chizeck, Howard Jay
AU  - Chizeck HJ
FAU - Pouratian, Nader
AU  - Pouratian N
LA  - eng
PT  - Journal Article
DEP - 20131023
TA  - Neurosurg Clin N Am
JT  - Neurosurgery clinics of North America
AID - 10.1016/j.nec.2013.08.006 [doi]
MID - NIHMS534613
SO  - Neurosurg Clin N Am. 2014 Jan;25(1):187-204. Epub 2013 Oct 23
      doi:10.1016/j.nec.2013.08.006.

PMC - PMC2632222
PMID- 16397202
IS  - 0586-7614 (Print)
VI  - 32
IP  - 2
DP  - 2006 Apr
TI  - Real-World Cognitive—and Metacognitive—Dysfunction in Schizophrenia: A New
      Approach for Measuring (and Remediating) More “Right Stuff”.
PG  - 310-26
AB  - While the role of impaired cognition in accounting for functional outcome in
      schizophrenia is generally established by now, the overlap is far from complete. 
      Moreover, little is known about the potential mechanisms that bridge between
      cognition and functional outcome. The aim of this article is to aid in closing
      this gap by presenting a novel, more ecologically valid approach for
      neuropsychological assessment. The new approach is motivated by the view that
      metacognitive processes of self-monitoring and self-regulation are fundamental
      determinants of competent functioning in the real world. The new approach
      incorporates experimental psychological concepts and paradigms used to study
      metacognition into current standard neuropsychological assessment procedures.
      Preliminary empirical data that support and demonstrate the utility of the new
      approach for assessment, as well as remediation efforts, in schizophrenia are
      presented and discussed.
FAU - Koren, Danny
AU  - Koren D
FAU - Seidman, Larry J
AU  - Seidman LJ
AD  - Department of Psychiatry, Harvard Medical School, Boston, MA
FAU - Goldsmith, Morris
AU  - Goldsmith M
AD  - Department of Psychology, University of Haifa, Haifa, Israel
FAU - Harvey, Phillip D
AU  - Harvey PD
AD  - Department of Psychiatry, Mt. Sinai School of Medicine, New York, NY
LA  - eng
PT  - Journal Article
DEP - 20060105
PHST- 2006/01/05 [aheadofprint]
TA  - Schizophr Bull
JT  - Schizophrenia Bulletin
AID - 10.1093/schbul/sbj035 [doi]
SO  - Schizophr Bull. 2006 Apr;32(2):310-26. Epub 2006 Jan 5 doi:10.1093/schbul/sbj035.

PMC - PMC3590023
PMID- 23040900
IS  - 1056-4993 (Print)
IS  - 1558-0490 (Electronic)
VI  - 21
IP  - 4
DP  - 2012 Oct
TI  - The Neural Effects of Psychotropic Medications in Children and Adolescents.
PG  - 753-71
FAU - Singh, Manpreet K.
AU  - Singh MK
FAU - Chang, Kiki D.
AU  - Chang KD
LA  - eng
PT  - Journal Article
GR  - K23 MH085919 || MH
TA  - Child Adolesc Psychiatr Clin N Am
JT  - Child and adolescent psychiatric clinics of North America
AID - 10.1016/j.chc.2012.07.010 [doi]
MID - NIHMS398562
SO  - Child Adolesc Psychiatr Clin N Am. 2012 Oct;21(4):753-71.
      doi:10.1016/j.chc.2012.07.010.

PMC - PMC4976746
PMID- 26661182
IS  - 0271-678X (Print)
IS  - 1559-7016 (Electronic)
VI  - 36
IP  - 8
DP  - 2016 Aug
TI  - Microvascular basis for growth of small infarcts following occlusion of single
      penetrating arterioles in mouse cortex.
PG  - 1357-73
AB  - Small cerebral infarcts, i.e. microinfarcts, are common in the aging brain and
      linked to vascular cognitive impairment. However, little is known about the acute
      growth of these minute lesions and their effect on blood flow in surrounding
      tissues. We modeled microinfarcts in the mouse cortex by inducing photothrombotic
      clots in single penetrating arterioles. The resultant hemodynamic changes in
      tissues surrounding the occluded vessel were then studied using in vivo
      two-photon microscopy. We were able to generate a spectrum of infarct volumes by 
      occluding arterioles that carried a range of blood fluxes. Those resulting from
      occlusion of high-flux penetrating arterioles (flux of 2 nL/s or higher)
      exhibited a radial outgrowth that encompassed unusually large tissue volumes. The
      gradual expansion of these infarcts was propagated by an evolving insufficiency
      in capillary flow that encroached on territories of neighboring penetrating
      arterioles, leading to the stagnation and recruitment of their perfusion domains 
      into the final infarct volume. Our results suggest that local collapse of
      microvascular function contributes to tissue damage incurred by single
      penetrating arteriole occlusions in mice, and that a similar mechanism may add to
      pathophysiology induced by microinfarcts of the human brain.
FAU - Taylor, Zachary J
AU  - Taylor ZJ
AD  - Department of Neurosciences, Medical University of South Carolina, Charleston,
      SC, USA
FAU - Hui, Edward S
AU  - Hui ES
AD  - Department of Diagnostic Radiology, The University of Hong Kong, Hong Kong
FAU - Watson, Ashley N
AU  - Watson AN
AD  - Department of Neurosciences, Medical University of South Carolina, Charleston,
      SC, USA
FAU - Nie, Xingju
AU  - Nie X
AD  - Department of Radiology and Radiological Science, Medical University of South
      Carolina, Charleston, SC, USA
FAU - Deardorff, Rachael L
AU  - Deardorff RL
AD  - Department of Radiology and Radiological Science, Medical University of South
      Carolina, Charleston, SC, USA
FAU - Jensen, Jens H
AU  - Jensen JH
AD  - Department of Radiology and Radiological Science, Medical University of South
      Carolina, Charleston, SC, USA
FAU - Helpern, Joseph A
AU  - Helpern JA
AD  - Department of Neurosciences, Medical University of South Carolina, Charleston,
      SC, USA
FAU - Shih, Andy Y
AU  - Shih AY
AD  - Department of Neurosciences, Medical University of South Carolina, Charleston,
      SC, USA
LA  - eng
PT  - Journal Article
DEP - 20151013
PHST- 2015/01/12 [received]
PHST- 2015/06/30 [revised]
PHST- 2015/07/02 [accepted]
TA  - J Cereb Blood Flow Metab
JT  - Journal of Cerebral Blood Flow & Metabolism
AID - 10.1177/0271678X15608388 [doi]
AID - 10.1177_0271678X15608388 [pii]
SO  - J Cereb Blood Flow Metab. 2016 Aug;36(8):1357-73. Epub 2015 Oct 13
      doi:10.1177/0271678X15608388.

PMC - PMC4072086
PMID- 25018706
IS  - 1662-5137 (Electronic)
VI  - 8
DP  - 2014
TI  - Hypothesis-driven methods to augment human cognition by optimizing cortical
      oscillations.
LID - 119
AB  - Cortical oscillations have been shown to represent fundamental functions of a
      working brain, e.g., communication, stimulus binding, error monitoring, and
      inhibition, and are directly linked to behavior. Recent studies intervening with 
      these oscillations have demonstrated effective modulation of both the
      oscillations and behavior. In this review, we collect evidence in favor of how
      hypothesis-driven methods can be used to augment cognition by optimizing cortical
      oscillations. We elaborate their potential usefulness for three target groups:
      healthy elderly, patients with attention deficit/hyperactivity disorder, and
      healthy young adults. We discuss the relevance of neuronal oscillations in each
      group and show how each of them can benefit from the manipulation of
      functionally-related oscillations. Further, we describe methods for manipulation 
      of neuronal oscillations including direct brain stimulation as well as indirect
      task alterations. We also discuss practical considerations about the proposed
      techniques. In conclusion, we propose that insights from neuroscience should
      guide techniques to augment human cognition, which in turn can provide a better
      understanding of how the human brain works.
FAU - Horschig, Jörn M.
AU  - Horschig JM
AD  - Radboud University Nijmegen, Donders Institute for Brain, Behaviour and
      CognitionNijmegen, Netherlands
FAU - Zumer, Johanna M.
AU  - Zumer JM
AD  - Radboud University Nijmegen, Donders Institute for Brain, Behaviour and
      CognitionNijmegen, Netherlands
FAU - Bahramisharif, Ali
AU  - Bahramisharif A
AD  - Radboud University Nijmegen, Donders Institute for Brain, Behaviour and
      CognitionNijmegen, Netherlands
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20140626
PHST- 2014/04/08 [received]
PHST- 2014/06/03 [accepted]
TA  - Front Syst Neurosci
JT  - Frontiers in Systems Neuroscience
AID - 10.3389/fnsys.2014.00119 [doi]
SO  - Front Syst Neurosci. 2014 Jun 26;8:. doi:10.3389/fnsys.2014.00119.

PMC - PMC3659508
PMID- 23738231
IS  - 2090-8105 (Print)
IS  - 2042-0056 (Electronic)
VI  - 2013
DP  - 2013
TI  - Rehabilitation with Poststroke Motor Recovery: A Review with a Focus on Neural
      Plasticity.
LID - 128641
AB  - Motor recovery after stroke is related to neural plasticity, which involves
      developing new neuronal interconnections, acquiring new functions, and
      compensating for impairment. However, neural plasticity is impaired in the
      stroke-affected hemisphere. Therefore, it is important that motor recovery
      therapies facilitate neural plasticity to compensate for functional loss. Stroke 
      rehabilitation programs should include meaningful, repetitive, intensive, and
      task-specific movement training in an enriched environment to promote neural
      plasticity and motor recovery. Various novel stroke rehabilitation techniques for
      motor recovery have been developed based on basic science and clinical studies of
      neural plasticity. However, the effectiveness of rehabilitative interventions
      among patients with stroke varies widely because the mechanisms underlying motor 
      recovery are heterogeneous. Neurophysiological and neuroimaging studies have been
      developed to evaluate the heterogeneity of mechanisms underlying motor recovery
      for effective rehabilitation interventions after stroke. Here, we review novel
      stroke rehabilitation techniques associated with neural plasticity and discuss
      individualized strategies to identify appropriate therapeutic goals, prevent
      maladaptive plasticity, and maximize functional gain in patients with stroke.
FAU - Takeuchi, Naoyuki
AU  - Takeuchi N
AD  - Department of Physical Medicine and Rehabilitation, Tohoku University Graduate
      School of Medicine, 2-1 Seiryo-cho, Aoba-ku, Sendai 980-8575, Japan
FAU - Izumi, Shin-Ichi
AU  - Izumi SI
AD  - Department of Physical Medicine and Rehabilitation, Tohoku University Graduate
      School of Medicine, 2-1 Seiryo-cho, Aoba-ku, Sendai 980-8575, Japan
LA  - eng
PT  - Journal Article
DEP - 20130430
PHST- 2013/02/08 [received]
PHST- 2013/04/09 [revised]
PHST- 2013/04/10 [accepted]
PHST- 2013/04/30 [aheadofprint]
TA  - Stroke Res Treat
JT  - Stroke Research and Treatment
AID - 10.1155/2013/128641 [doi]
SO  - Stroke Res Treat. 2013;2013:. Epub 2013 Apr 30 doi:10.1155/2013/128641.

PMC - PMC4765099
PMID- 26911438
IS  - 1743-0003 (Electronic)
VI  - 13
DP  - 2016
TI  - Effects of virtual reality-based rehabilitation on distal upper extremity
      function and health-related quality of life: a single-blinded, randomized
      controlled trial.
LID - 17
AB  - Background: Virtual reality (VR)-based rehabilitation has been reported to have
      beneficial effects on upper extremity function in stroke survivors; however,
      there is limited information about its effects on distal upper extremity function
      and health-related quality of life (HRQoL). The purpose of the present study was 
      to examine the effects of VR-based rehabilitation combined with standard
      occupational therapy on distal upper extremity function and HRQoL, and compare
      the findings to those of amount-matched conventional rehabilitation in stroke
      survivors. Methods: The present study was a single-blinded, randomized controlled
      trial. The study included 46 stroke survivors who were randomized to a Smart
      Glove (SG) group or a conventional intervention (CON) group. In both groups, the 
      interventions were targeted to the distal upper extremity and standard
      occupational therapy was administered. The primary outcome was the change in the 
      Fugl–Meyer assessment (FM) scores, and the secondary outcomes were the changes in
      the Jebsen–Taylor hand function test (JTT), Purdue pegboard test, and Stroke
      Impact Scale (SIS) version 3.0 scores. The outcomes were assessed before the
      intervention, in the middle of the intervention, immediately after the
      intervention, and 1 month after the intervention. Results: The improvements in
      the FM (FM-total, FM-prox, and FM-dist), JTT (JTT-total and JTT-gross), and SIS
      (composite and overall SIS, SIS-social participation, and SIS-mobility) scores
      were significantly greater in the SG group than in the CON group. Conclusions:
      VR-based rehabilitation combined with standard occupational therapy might be more
      effective than amount-matched conventional rehabilitation for improving distal
      upper extremity function and HRQoL. Trial registration: This study is registered 
      under the title “Effects of Novel Game Rehabilitation System on Upper Extremity
      Function of Patients With Stroke” and can be located in
      https://clinicaltrials.gov with the study identifier NCT02029651.
FAU - Shin, Joon-Ho
AU  - Shin JH
AD  - National Rehabilitation Center, Ministry of Health and Welfare, Seoul, Korea
FAU - Kim, Mi-Young
AU  - Kim MY
AD  - National Rehabilitation Center, Ministry of Health and Welfare, Seoul, Korea
FAU - Lee, Ji-Yeong
AU  - Lee JY
AD  - National Rehabilitation Center, Ministry of Health and Welfare, Seoul, Korea
FAU - Jeon, Yu-Jin
AU  - Jeon YJ
AD  - National Rehabilitation Center, Ministry of Health and Welfare, Seoul, Korea
FAU - Kim, Suyoung
AU  - Kim S
AD  - Department of Law, Hanyang University, Seoul, Korea
FAU - Lee, Soobin
AU  - Lee S
AD  - Neofect, Yong-in, Korea
FAU - Seo, Beomjoo
AU  - Seo B
AD  - School of Games, Hongik University, Seoul, Korea
FAU - Choi, Younggeun
AU  - Choi Y
AD  - Neofect, Yong-in, Korea
LA  - eng
PT  - Journal Article
DEP - 20160224
GR  - 2014-050-005-064
PHST- 2015/10/26 [received]
PHST- 2016/02/12 [accepted]
TA  - J Neuroeng Rehabil
JT  - Journal of NeuroEngineering and Rehabilitation
AID - 125 [pii]
AID - 10.1186/s12984-016-0125-x [doi]
SO  - J Neuroeng Rehabil. 2016 Feb 24;13:. doi:10.1186/s12984-016-0125-x.

PMC - PMC4380642
PMID- 25686750
IS  - 0006-8993 (Print)
IS  - 1872-6240 (Electronic)
VI  - 1605
DP  - 2015 Apr 24
TI  - Auditory nerve synapses persist in ventral cochlear nucleus long after loss of
      acoustic input in mice with early-onset progressive hearing loss.
PG  - 22-30
AB  - Perceptual performance in persons with hearing loss, especially those using
      devices to restore hearing, is not fully predicted by traditional audiometric
      measurements designed to evaluate the status of peripheral function. The
      integrity of auditory brainstem synapses may vary with different forms of hearing
      loss, and differential effects on the auditory nerve-brain interface may have
      particularly profound consequences for the transfer of sound from ear to brain.
      Loss of auditory nerve synapses in ventral cochlear nucleus (VCN) has been
      reported after acoustic trauma, ablation of the organ of Corti, and
      administration of ototoxic compounds. The effects of gradually acquired forms
      deafness on these synapses are less well understood. We investigated VCN gross
      morphology and auditory nerve synapse integrity in DBA/2J mice with early-onset
      progressive sensorineural hearing loss. Hearing status was confirmed using
      auditory brainstem response audiometry and acoustic startle responses. We found
      no change in VCN volume, number of macroneurons, or number of VGLUT1-positive
      auditory nerve terminals between young adult and older, deaf DBA/2J. Cell-type
      specific analysis revealed no difference in the number of VGLUT1 puncta
      contacting bushy and multipolar cell body profiles, but the terminals were
      smaller in deaf DBA/2J mice. Transmission electron microscopy confirmed the
      presence of numerous healthy, vesicle-filled auditory nerve synapses in older,
      deaf DBA/2J mice. The present results suggest that synapses can be preserved over
      a relatively long time-course in gradually acquired deafness. Elucidating the
      mechanisms supporting survival of central auditory nerve synapses in models of
      acquired deafness may reveal new opportunities for therapeutic intervention.
FAU - McGuire, Brian
AU  - McGuire B
AD  - Center for Hearing and Balance and Department of Otolaryngology-HNS, Johns
      Hopkins University, Baltimore, MD, 21205 USA
FAU - Fiorillo, Benjamin
AU  - Fiorillo B
AD  - Center for Hearing and Balance and Department of Otolaryngology-HNS, Johns
      Hopkins University, Baltimore, MD, 21205 USA
FAU - Ryugo, David K.
AU  - Ryugo DK
AD  - Hearing Research Unit, Garvan Institute of Medical Research, Darlinghurst, New
      South Wales, 2010 Australia
FAU - Lauer, Amanda M.
AU  - Lauer AM
AD  - Center for Hearing and Balance and Department of Otolaryngology-HNS, Johns
      Hopkins University, Baltimore, MD, 21205 USA
LA  - eng
PT  - Journal Article
DEP - 20150214
TA  - Brain Res
JT  - Brain research
AID - 10.1016/j.brainres.2015.02.012 [doi]
MID - NIHMS664625
SO  - Brain Res. 2015 Apr 24;1605:22-30. Epub 2015 Feb 14
      doi:10.1016/j.brainres.2015.02.012.

PMC - PMC3542397
PMID- 23326394
IS  - 1932-6203 (Electronic)
VI  - 8
IP  - 1
DP  - 2013
TI  - Psychoacoustic Tinnitus Loudness and Tinnitus-Related Distress Show Different
      Associations with Oscillatory Brain Activity.
LID - e53180
AB  - Background: The phantom auditory perception of subjective tinnitus is associated 
      with aberrant brain activity as evidenced by magneto- and electroencephalographic
      studies. We tested the hypotheses (1) that psychoacoustically measured tinnitus
      loudness is related to gamma oscillatory band power, and (2) that tinnitus
      loudness and tinnitus-related distress are related to distinct brain activity
      patterns as suggested by the distinction between loudness and distress
      experienced by tinnitus patients. Furthermore, we explored (3) how hearing
      impairment, minimum masking level, and (4) psychological comorbidities are
      related to spontaneous oscillatory brain activity in tinnitus patients. Methods
      and Findings: Resting state oscillatory brain activity recorded
      electroencephalographically from 46 male tinnitus patients showed a positive
      correlation between gamma band oscillations and psychoacoustic tinnitus loudness 
      determined with the reconstructed tinnitus sound, but not with the other
      psychoacoustic loudness measures that were used. Tinnitus-related distress did
      also correlate with delta band activity, but at electrode positions different
      from those associated with tinnitus loudness. Furthermore, highly distressed
      tinnitus patients exhibited a higher level of theta band activity. Moreover, mean
      hearing loss between 0.125 kHz and 16 kHz was associated with a decrease in gamma
      activity, whereas minimum masking levels correlated positively with delta band
      power. In contrast, psychological comorbidities did not express significant
      correlations with oscillatory brain activity. Conclusion: Different clinically
      relevant tinnitus characteristics show distinctive associations with spontaneous 
      brain oscillatory power. Results support hypothesis (1), but exclusively for the 
      tinnitus loudness derived from matching to the reconstructed tinnitus sound. This
      suggests to preferably use the reconstructed tinnitus spectrum to determine
      psychoacoustic tinnitus loudness. Results also support hypothesis (2). Moreover, 
      hearing loss and minimum masking level correlate with oscillatory power in
      distinctive frequency bands. The lack of an association between psychological
      comorbidities and oscillatory power may be attributed to the overall low level of
      mental health problems in the present sample.
FAU - Balkenhol, Tobias
AU  - Balkenhol T
AD  - Department of Phoniatrics and Audiology, Medical Faculty Mannheim, Heidelberg
      University, Mannheim, Germany
FAU - Wallhäusser-Franke, Elisabeth
AU  - Wallhäusser-Franke E
AD  - Department of Phoniatrics and Audiology, Medical Faculty Mannheim, Heidelberg
      University, Mannheim, Germany
FAU - Delb, Wolfgang
AU  - Delb W
AD  - Department of Phoniatrics and Audiology, Medical Faculty Mannheim, Heidelberg
      University, Mannheim, Germany
LA  - eng
PT  - Journal Article
DEP - 20130110
PHST- 2012/08/22 [received]
PHST- 2012/11/26 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-12-25303 [pii]
AID - 10.1371/journal.pone.0053180 [doi]
SO  - PLoS One. 2013 Jan 10;8(1):. doi:10.1371/journal.pone.0053180.

PMC - PMC4880149
PMID- 27194795
IS  - 1072-0502 (Print)
IS  - 1549-5485 (Electronic)
VI  - 23
IP  - 6
TI  - Retrosplenial cortex is required for the retrieval of remote memory for auditory 
      cues.
PG  - 278-88
AB  - The restrosplenial cortex (RSC) has a well-established role in contextual and
      spatial learning and memory, consistent with its known connectivity with
      visuo-spatial association areas. In contrast, RSC appears to have little
      involvement with delay fear conditioning to an auditory cue. However, all
      previous studies have examined the contribution of the RSC to recently acquired
      auditory fear memories. Since neocortical regions have been implicated in the
      permanent storage of remote memories, we examined the contribution of the RSC to 
      remotely acquired auditory fear memories. In Experiment 1, retrieval of a
      remotely acquired auditory fear memory was impaired when permanent lesions
      (either electrolytic or neurotoxic) were made several weeks after initial
      conditioning. In Experiment 2, using a chemogenetic approach, we observed
      impairments in the retrieval of remote memory for an auditory cue when the RSC
      was temporarily inactivated during testing. In Experiment 3, after injection of a
      retrograde tracer into the RSC, we observed labeled cells in primary and
      secondary auditory cortices, as well as the claustrum, indicating that the RSC
      receives direct projections from auditory regions. Overall our results indicate
      the RSC has a critical role in the retrieval of remotely acquired auditory fear
      memories, and we suggest this is related to the quality of the memory, with less 
      precise memories being RSC dependent.
FAU - Todd, Travis P.
AU  - Todd TP
AD  - Department of Psychological and Brain Sciences, Dartmouth College, Hanover, New
      Hampshire 03755, USA
FAU - Mehlman, Max L.
AU  - Mehlman ML
AD  - Department of Psychological and Brain Sciences, Dartmouth College, Hanover, New
      Hampshire 03755, USA
FAU - Keene, Christopher S.
AU  - Keene CS
AD  - Department of Psychological and Brain Sciences, Dartmouth College, Hanover, New
      Hampshire 03755, USA
FAU - DeAngeli, Nicole E.
AU  - DeAngeli NE
AD  - Department of Psychological and Brain Sciences, Dartmouth College, Hanover, New
      Hampshire 03755, USA
FAU - Bucci, David J.
AU  - Bucci DJ
AD  - Department of Psychological and Brain Sciences, Dartmouth College, Hanover, New
      Hampshire 03755, USA
LA  - eng
PT  - Journal Article
DEP - 201606
GR  - IOS 00441934
PHST- 2016/01/26 [received]
PHST- 2016/03/07 [accepted]
TA  - Learn Mem
JT  - Learning & Memory
AID - 10.1101/lm.041822.116 [doi]
AID - ToddLM041822 [pii]
SO  - Learn Mem. ;23(6):278-88. doi:10.1101/lm.041822.116.

PMC - PMC3875836
PMID- 23177599
IS  - 0749-0690 (Print)
IS  - 1879-8853 (Electronic)
VI  - 29
IP  - 1
DP  - 2013 Feb
TI  - Evolving Prehospital, Emergency Department, and “Inpatient” Management Models for
      Geriatric Emergencies.
LID - 10.1016/j.cger.2012.09.003
AB  - Alternative management methods are essential to ensure high quality and efficient
      emergency care for the growing number of geriatric adults worldwide. Protocols
      for case-finding and rapid diagnosis to support early condition-specific
      treatment for older adults with acute severe illness and injury are needed.
      Improved emergency department care for older adults will require providers to
      look beyond the diagnosis to address the influence of other factors on the
      patient's health: isolation and depression; finances and transportation; and
      chronic medical conditions and polypharmacy. This review article describes recent
      and ongoing efforts to enhance the quality of emergency care for older adults
      using alternative management approaches spanning the spectrum from prehospital
      care, through the emergency department, and into evolving inpatient or outpatient
      processes of care.
FAU - Carpenter, Christopher R.
AU  - Carpenter CR
FAU - Platts-Mills, Timothy F.
AU  - Platts-Mills TF
LA  - eng
PT  - Journal Article
GR  - KM1 CA156708 || CA
TA  - Clin Geriatr Med
JT  - Clinics in geriatric medicine
AID - 10.1016/j.cger.2012.09.003 [doi]
MID - NIHMS542545
SO  - Clin Geriatr Med. 2013 Feb;29(1):. doi:10.1016/j.cger.2012.09.003.

PMC - PMC3528994
PMID- 22966161
IS  - 0022-3751 (Print)
IS  - 1469-7793 (Electronic)
VI  - 590
IP  - Pt 22
DP  - 2012 Nov 15
TI  - Reduced corticomotor excitability and motor skills development in children born
      preterm.
PG  - 5827-44
AB  - The mechanisms underlying the altered neurodevelopment commonly experienced by
      children born preterm, but without brain lesions, remain unknown. While
      individuals born the earliest are at most risk, late preterm children also
      experience significant motor, cognitive and behavioural dysfunction from school
      age, and reduced income and educational attainment in adulthood. We used
      transcranial magnetic stimulation and functional assessments to examine
      corticomotor development in 151 children without cerebral palsy, aged 10–13 years
      and born after gestations of 25–41 completed weeks. We hypothesized that motor
      cortex and corticospinal development are altered in preterm children, which
      underpins at least some of their motor dysfunction. We report for the first time 
      that every week of reduced gestation is associated with a reduction in
      corticomotor excitability that remains evident in late childhood. This reduced
      excitability was associated with poorer motor skill development, particularly
      manual dexterity. However, child adiposity, sex and socio-economic factors
      regarding the child's home environment soon after birth were also powerful
      influences on development of motor skills. Preterm birth was also associated with
      reduced left hemisphere lateralization, but without increasing the likelihood of 
      being left handed per se. These corticomotor findings have implications for
      normal motor development, but also raise questions regarding possible longer term
      consequences of preterm birth on motor function.
FAU - Pitcher, Julia B
AU  - Pitcher JB
AD  - Research Centre for Early Origins of Health and Disease, Robinson Institute,
      School of Paediatrics & Reproductive Health, University of AdelaideSA 5005,
      Australia
FAU - Schneider, Luke A
AU  - Schneider LA
AD  - Research Centre for Early Origins of Health and Disease, Robinson Institute,
      School of Paediatrics & Reproductive Health, University of AdelaideSA 5005,
      Australia
FAU - Burns, Nicholas R
AU  - Burns NR
AD  - School of Psychology, University of AdelaideSA 5005, Australia
FAU - Drysdale, John L
AU  - Drysdale JL
AD  - Research Centre for Early Origins of Health and Disease, Robinson Institute,
      School of Paediatrics & Reproductive Health, University of AdelaideSA 5005,
      Australia
FAU - Higgins, Ryan D
AU  - Higgins RD
AD  - Research Centre for Early Origins of Health and Disease, Robinson Institute,
      School of Paediatrics & Reproductive Health, University of AdelaideSA 5005,
      Australia
FAU - Ridding, Michael C
AU  - Ridding MC
AD  - Research Centre for Early Origins of Health and Disease, Robinson Institute,
      School of Paediatrics & Reproductive Health, University of AdelaideSA 5005,
      Australia
FAU - Nettelbeck, Theodore J
AU  - Nettelbeck TJ
AD  - School of Psychology, University of AdelaideSA 5005, Australia
FAU - Haslam, Ross R
AU  - Haslam RR
AD  - Department of Perinatal Medicine, Women's and Children's HospitalNorth Adelaide, 
      SA 5006, Australia
FAU - Robinson, Jeffrey S
AU  - Robinson JS
AD  - Research Centre for Early Origins of Health and Disease, Robinson Institute,
      School of Paediatrics & Reproductive Health, University of AdelaideSA 5005,
      Australia
LA  - eng
PT  - Journal Article
DEP - 20120910
PHST- 2012/06/19 [received]
PHST- 2012/09/03 [accepted]
PHST- 2012/09/10 [aheadofprint]
TA  - J Physiol
JT  - The Journal of Physiology
AID - 10.1113/jphysiol.2012.239269 [doi]
SO  - J Physiol. 2012 Nov 15;590(Pt 22):5827-44. Epub 2012 Sep 10
      doi:10.1113/jphysiol.2012.239269.

PMC - PMC3261172
PMID- 22279559
IS  - 1932-6203 (Electronic)
VI  - 7
IP  - 1
DP  - 2012
TI  - Virtual Reality as a Tool for Evaluation of Repetitive Rhythmic Movements in the 
      Elderly and Parkinson's Disease Patients.
LID - e30021
AB  - This work presents an immersive Virtual Reality (VR) system to evaluate, and
      potentially treat, the alterations in rhythmic hand movements seen in Parkinson's
      disease (PD) and the elderly (EC), by comparison with healthy young controls
      (YC). The system integrates the subjects into a VR environment by means of a Head
      Mounted Display, such that subjects perceive themselves in a virtual world
      consisting of a table within a room. In this experiment, subjects are presented
      in 1st person perspective, so that the avatar reproduces finger tapping movements
      performed by the subjects. The task, known as the finger tapping test (FT), was
      performed by all three subject groups, PD, EC and YC. FT was carried out by each 
      subject on two different days (sessions), one week apart. In each FT session all 
      subjects performed FT in the real world (FTREAL) and in the VR (FTVR); each mode 
      was repeated three times in randomized order. During FT both the tapping
      frequency and the coefficient of variation of inter-tap interval were registered.
      FTVR was a valid test to detect differences in rhythm formation between the three
      groups. Intra-class correlation coefficients (ICC) and mean difference between
      days for FTVR (for each group) showed reliable results. Finally, the analysis of 
      ICC and mean difference between FTVR vs FTREAL, for each variable and group, also
      showed high reliability. This shows that FT evaluation in VR environments is
      valid as real world alternative, as VR evaluation did not distort movement
      execution and detects alteration in rhythm formation. These results support the
      use of VR as a promising tool to study alterations and the control of movement in
      different subject groups in unusual environments, such as during fMRI or other
      imaging studies.
FAU - Arias, Pablo
AU  - Arias P
AD  - Neuroscience and Motor Control Group (NEUROcom), Department of Medicine-INEF
      Galicia, University of A Coruña, A Coruña, Spain
FAU - Robles-García, Verónica
AU  - Robles-García V
AD  - Neuroscience and Motor Control Group (NEUROcom), Department of Medicine-INEF
      Galicia, University of A Coruña, A Coruña, Spain
FAU - Sanmartín, Gabriel
AU  - Sanmartín G
AD  - Instituto de Investigacións Tecnolóxicas, University of Santiago de Compostela,
      Santiago de Compostela, Spain
FAU - Flores, Julian
AU  - Flores J
AD  - Instituto de Investigacións Tecnolóxicas, University of Santiago de Compostela,
      Santiago de Compostela, Spain
FAU - Cudeiro, Javier
AU  - Cudeiro J
AD  - Neuroscience and Motor Control Group (NEUROcom), Department of Medicine-INEF
      Galicia, University of A Coruña, A Coruña, Spain
LA  - eng
PT  - Journal Article
DEP - 20120118
PHST- 2011/06/16 [received]
PHST- 2011/12/12 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-11-10422 [pii]
AID - 10.1371/journal.pone.0030021 [doi]
SO  - PLoS One. 2012 Jan 18;7(1):. doi:10.1371/journal.pone.0030021.

PMC - PMC5506510
PMID- 28757679
IS  - 0340-5443 (Print)
VI  - 71
IP  - 8
DP  - 2017
TI  - Acoustic ranging in poison frogs—it is not about signal amplitude alone.
LID - 114
AB  - Abstract: Acoustic ranging allows identifying the distance of a sound source and 
      mediates inter-individual spacing and aggression in territorial species. Birds
      and mammals are known to use more complex cues than only sound pressure level
      (SPL), which can be influenced by the signaller and signal transmission in
      non-predictable ways and thus is not reliable by itself. For frogs, only SPL is
      currently known to mediate inter-individual distances, but we hypothesise that
      the strong territoriality of Dendrobatids could make the use of complex cues for 
      ranging highly beneficial for this family. Therefore, we tested the ranging
      abilities of territorial males of Allobates femoralis (Dendrobatidae,
      Aromobatinae) in playback trials, using amplitude-normalized signals that were
      naturally degraded over distance, and synthetic signals that were masked with
      different levels of noise. Frogs responded significantly less to signals recorded
      from larger distances, regardless of SPL and signal-to-noise ratio (SNR), but
      showed no differential response to natural minimum and maximum SNRs across the
      typical communication range in wild populations. This indicates that frogs used
      signal amplitude and SNR only as ancillary cues when assessing the distance of
      sound sources and relied instead mainly on more complex cues, such as spectral
      degradation or reverberation. We suggest that this ability mediates territorial
      spacing and mate choice in A. femoralis. Good ranging abilities might also play a
      role in the remarkable orientation performance of this species, probably by
      enabling the establishment of a mental acoustic map of the habitat. Significance 
      statement: Acoustic ranging allows the distance of vocalizing competitors and
      mates to be identified. While birds and mammals are known to use complex cues
      such as temporal degradation, frequency-dependent attenuation and reverberation
      for ranging, previous research indicated that frogs rely only on signal amplitude
      (sound pressure level) to assess the distance of other callers. The present study
      shows for the first time that also poison frogs can make use of more complex
      cues, an ability which is likely to be highly beneficial in their territorial
      social organization and probably can also be used for orientation. Electronic
      supplementary material: The online version of this article
      (doi:10.1007/s00265-017-2340-2) contains supplementary material, which is
      available to authorized users.
FAU - Ringler, Max
AU  - Ringler M
AUID- ORCID: 0000-0002-4530-4919
AD  - 0000 0000 9632 6718grid.19006.3eDepartment of Ecology and Evolutionary Biology,
      University of California Los Angeles, 621 Charles E. Young Drive South, Los
      Angeles, CA 90095-1606 USA
FAU - Szipl, Georgine
AU  - Szipl G
AD  - 0000 0001 2286 1424grid.10420.37Department of Cognitive Biology, University of
      Vienna, Althanstrasse 14, 1090 Vienna, Austria
FAU - Hödl, Walter
AU  - Hödl W
AD  - 0000 0001 2286 1424grid.10420.37Department of Integrative Zoology, University of 
      Vienna, Althanstrasse 14, 1090 Vienna, Austria
FAU - Khil, Leander
AU  - Khil L
AD  - 0000 0001 2286 1424grid.10420.37Department of Integrative Zoology, University of 
      Vienna, Althanstrasse 14, 1090 Vienna, Austria
FAU - Kofler, Barbara
AU  - Kofler B
AD  - 0000 0001 2286 1424grid.10420.37Department of Integrative Zoology, University of 
      Vienna, Althanstrasse 14, 1090 Vienna, Austria
FAU - Lonauer, Michael
AU  - Lonauer M
AD  - 0000 0001 2286 1424grid.10420.37Department of Integrative Zoology, University of 
      Vienna, Althanstrasse 14, 1090 Vienna, Austria
FAU - Provin, Christina
AU  - Provin C
AD  - 0000 0001 2286 1424grid.10420.37Department of Integrative Zoology, University of 
      Vienna, Althanstrasse 14, 1090 Vienna, Austria
FAU - Ringler, Eva
AU  - Ringler E
AD  - 0000 0000 9632 6718grid.19006.3eDepartment of Ecology and Evolutionary Biology,
      University of California Los Angeles, 621 Charles E. Young Drive South, Los
      Angeles, CA 90095-1606 USA
LA  - eng
PT  - Journal Article
DEP - 20170712
GR  - FWF P24788-B22
PHST- 2016/12/14 [received]
PHST- 2017/06/20 [revised]
PHST- 2017/06/21 [accepted]
TA  - Behav Ecol Sociobiol
JT  - Behavioral Ecology and Sociobiology
AID - 2340 [pii]
AID - 10.1007/s00265-017-2340-2 [doi]
SO  - Behav Ecol Sociobiol. 2017;71(8):. Epub 2017 Jul 12
      doi:10.1007/s00265-017-2340-2.

PMC - PMC5298703
PMID- 28085085
IS  - 1424-8220 (Electronic)
VI  - 17
IP  - 1
DP  - 2017 Jan
TI  - Wearable Sensors for Remote Health Monitoring.
LID - 130
AB  - Life expectancy in most countries has been increasing continually over the
      several few decades thanks to significant improvements in medicine, public
      health, as well as personal and environmental hygiene. However, increased life
      expectancy combined with falling birth rates are expected to engender a large
      aging demographic in the near future that would impose significant  burdens on
      the socio-economic structure of these countries. Therefore, it is essential to
      develop cost-effective, easy-to-use systems for the sake of elderly healthcare
      and well-being. Remote health monitoring, based on non-invasive and wearable
      sensors, actuators and modern communication and information technologies offers
      an efficient and cost-effective solution that allows the elderly to continue to
      live in their comfortable home environment instead of expensive healthcare
      facilities. These systems will also allow healthcare personnel to monitor
      important physiological signs of their patients in real time, assess health
      conditions and provide feedback from distant facilities. In this paper, we have
      presented and compared several low-cost and non-invasive health and activity
      monitoring systems that were reported in recent years. A survey on textile-based 
      sensors that can potentially be used in wearable systems is also presented.
      Finally, compatibility of several communication technologies as well as future
      perspectives and research challenges in remote monitoring systems will be
      discussed.
FAU - Majumder, Sumit
AU  - Majumder S
AD  - Department of Electrical and Computer Engineering, McMaster University, Hamilton,
      ON L8S 4L8, Canada; majums3@mcmaster.ca
FAU - Mondal, Tapas
AU  - Mondal T
AD  - Department of Pediatrics, McMaster University, Hamilton, ON L8S 4L8, Canada;
      mondalt@mcmaster.ca
FAU - Deen, M. Jamal
AU  - Deen MJ
AD  - Department of Electrical and Computer Engineering, McMaster University, Hamilton,
      ON L8S 4L8, Canada; majums3@mcmaster.ca
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170112
PHST- 2016/09/30 [received]
PHST- 2016/12/21 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s17010130 [doi]
AID - sensors-17-00130 [pii]
SO  - Sensors (Basel). 2017 Jan 12;17(1):. doi:10.3390/s17010130.

PMC - PMC4004137
PMID- 24705022
IS  - 1439-4456 (Print)
IS  - 1438-8871 (Electronic)
VI  - 16
IP  - 4
DP  - 2014 Apr
TI  - A Spanish Pillbox App for Elderly Patients Taking Multiple Medications:
      Randomized Controlled Trial.
LID - e99
AB  - Background: Nonadherence and medication errors are common among patients with
      complex drug regimens. Apps for smartphones and tablets are effective for
      improving adherence, but they have not been tested in elderly patients with
      complex chronic conditions and who typically have less experience with this type 
      of technology. Objective: The objective of this study was to design, implement,
      and evaluate a medication self-management app (called ALICE) for elderly patients
      taking multiple medications with the intention of improving adherence and safe
      medication use. Methods: A single-blind randomized controlled trial was conducted
      with a control and an experimental group (N=99) in Spain in 2013. The
      characteristics of ALICE were specified based on the suggestions of 3 nominal
      groups with a total of 23 patients and a focus group with 7 professionals. ALICE 
      was designed for Android and iOS to allow for the personalization of
      prescriptions and medical advice, showing images of each of the medications (the 
      packaging and the medication itself) together with alerts and multiple reminders 
      for each alert. The randomly assigned patients in the control group received oral
      and written information on the safe use of their medications and the patients in 
      the experimental group used ALICE for 3 months. Pre and post measures included
      rate of missed doses and medication errors reported by patients, scores from the 
      4-item Morisky Medication Adherence Scale (MMAS-4), level of independence,
      self-perceived health status, and biochemical test results. In the experimental
      group, data were collected on their previous experience with information and
      communication technologies, their rating of ALICE, and their perception of the
      level of independence they had achieved. The intergroup intervention effects were
      calculated by univariate linear models and ANOVA, with the pre to post
      intervention differences as the dependent variables. Results: Data were obtained 
      from 99 patients (48 and 51 in the control and experimental groups,
      respectively). Patients in the experimental group obtained better MMAS-4 scores
      (P<.001) and reported fewer missed doses of medication (P=.02). ALICE only helped
      to significantly reduce medication errors in patients with an initially higher
      rate of errors (P<.001). Patients with no experience with information and
      communication technologies reported better adherence (P<.001), fewer missed doses
      (P<.001), and fewer medication errors (P=.02). The mean satisfaction score for
      ALICE was 8.5 out of 10. In all, 45 of 51 patients (88%) felt that ALICE improved
      their independence in managing their medications. Conclusions: The ALICE app
      improves adherence, helps reduce rates of forgetting and of medication errors,
      and increases perceived independence in managing medication. Elderly patients
      with no previous experience with information and communication technologies are
      capable of effectively using an app designed to help them take their medicine
      more safely. Trial Registration: Clinicaltrials.gov NCT02071498;
      http://clinicaltrials.gov/ct2/show/NCT02071498 (Archived by WebCite at
      http://www.webcitation.org/6OJjdHVhD).
FAU - Bacigalupe, Gonzalo
AU  - Bacigalupe G
FAU - Fernandez-Luque, Luis
AU  - Fernandez-Luque L
FAU - Mira, José Joaquín
AU  - Mira JJ
AD  - Sant Joan-Alicante Health DistrictConsellería SanidadAlicanteSpain
FAU - Navarro, Isabel
AU  - Navarro I
AD  - Health Psychology DepartmentMiguel Hernández UniversityElcheSpain
FAU - Botella, Federico
AU  - Botella F
AD  - Center of Operations Research University InstituteMiguel Hernández
      UniversityElcheSpain
FAU - Borrás, Fernando
AU  - Borrás F
AD  - Statistics, Mathematics and Informatics DepartmentMiguel Hernández
      UniversityElcheSpain
FAU - Nuño-Solinís, Roberto
AU  - Nuño-Solinís R
AD  - Basque Institute for Healthcare Innovation (O+berri)BarakaldoSpain
FAU - Orozco, Domingo
AU  - Orozco D
AD  - Department of Family MedicineFaculty of MedicineMiguel Hernández
      UniversityAlicanteSpain
FAU - Iglesias-Alonso, Fuencisla
AU  - Iglesias-Alonso F
AD  - Castilla La Mancha Health Service (SESCAM)ToledoSpain
FAU - Pérez-Pérez, Pastora
AU  - Pérez-Pérez P
AD  - Andalusian Patient Safety ObservatoryAndalusian Agency for Health Care
      QualitySevilleSpain
FAU - Lorenzo, Susana
AU  - Lorenzo S
AD  - Hospital Universitario Fundación AlcorcónMadridSpain
FAU - Toro, Nuria
AU  - Toro N
AD  - Basque Institute for Healthcare Innovation (O+berri)BarakaldoSpain
LA  - eng
PT  - Journal Article
DEP - 20140404
PHST- 2014/01/22 [received]
PHST- 2014/03/04 [revised]
PHST- 2014/03/13 [accepted]
TA  - J Med Internet Res
JT  - Journal of Medical Internet Research
AID - v16i4e99 [pii]
AID - 10.2196/jmir.3269 [doi]
SO  - J Med Internet Res. 2014 Apr 04;16(4):. doi:10.2196/jmir.3269.

PMC - PMC3578115
PMID- 23149040
IS  - 0165-1781 (Print)
IS  - 1872-7123 (Electronic)
VI  - 211
IP  - 3
DP  - 2013 Mar 30
TI  - Visual event-related potentials as markers of hyperarousal in Gulf War Illness:
      evidence against a stress-related etiology.
PG  - 257-67
AB  - An exaggerated response to emotional stimuli is among the many symptoms widely
      reported by veterans of the 1991 Persian Gulf War. These symptomologies have been
      attributed to damage and dysfunction associated with deployment-related
      exposures. We collected event-related potential data from 22 veterans meeting
      Haley criteria for Gulf War (GW) Syndromes 1-3 and from 8 matched GW veteran
      controls, who were deployed but not symptomatic, while they performed a visual
      three-condition oddball task where images authenticated to be associated with the
      1991 Persian Gulf War were the distractor stimuli. Hyperarousal reported by ill
      veterans was significantly greater than that by control veterans, but this was
      not paralleled by higher amplitude P3a in their ERP responses to GW-related
      distractor stimuli. Whereas previous studies of PTSD patients have shown higher
      amplitude P3b responses to target stimuli that are placed amid trauma-related
      nontarget stimuli, ill veterans in this study showed P3b amplitudes to target
      stimuli—placed amid GW-related nontarget stimuli—that were significantly lower
      than those of the control group. Hyperarousal scores reliably predicted P3b, but 
      not P3a, amplitudes. Although many factors may contribute to P3b amplitude
      differences—most notably depression and poor sleep quality, symptoms that are
      prevalent in the GW syndrome groups—our findings in context of previous studies
      on this population are consistent with the contention that dysfunction in
      cholinergic and dopaminergic neurotransmitter systems, and in white matter and
      basal ganglia may be contributing to impairments in GW veterans.
FAU - Tillman, Gail D.
AU  - Tillman GD
AD  - Center for BrainHealth, The University of Texas at Dallas, Dallas, TX
FAU - Calley, Clifford S.
AU  - Calley CS
AD  - Center for BrainHealth, The University of Texas at Dallas, Dallas, TX
FAU - Green, Timothy A.
AU  - Green TA
AD  - Center for BrainHealth, The University of Texas at Dallas, Dallas, TX
FAU - Buhl, Virginia I.
AU  - Buhl VI
AD  - Center for BrainHealth, The University of Texas at Dallas, Dallas, TX
FAU - Biggs, Melanie M.
AU  - Biggs MM
AD  - VA North Texas Health Care System, Dallas, TX
FAU - Spence, Jeffrey S.
AU  - Spence JS
AD  - Department of Internal Medicine, University of Texas Southwestern Medical Center 
      Dallas, TX, USA
FAU - Briggs, Richard W.
AU  - Briggs RW
AD  - Department of Radiology, University of Texas Southwestern Medical Center Dallas, 
      TX, USA
FAU - Haley, Robert W.
AU  - Haley RW
AD  - Department of Internal Medicine, University of Texas Southwestern Medical Center 
      Dallas, TX, USA
FAU - Kraut, Michael A.
AU  - Kraut MA
AD  - Center for BrainHealth, The University of Texas at Dallas, Dallas, TX
FAU - Hart, John
AU  - Hart J
AD  - Center for BrainHealth, The University of Texas at Dallas, Dallas, TX
LA  - eng
PT  - Journal Article
DEP - 20121111
GR  - UL1 RR024982 || RR
TA  - Psychiatry Res
JT  - Psychiatry research
AID - 10.1016/j.pscychresns.2012.08.004 [doi]
MID - NIHMS404069
SO  - Psychiatry Res. 2013 Mar 30;211(3):257-67. Epub 2012 Nov 11
      doi:10.1016/j.pscychresns.2012.08.004.

PMC - PMC4916840
PMID- 27132523
IS  - 1092-0684 (Electronic)
VI  - 40
IP  - 5
DP  - 2016 May
TI  - Neurorestoration after stroke.
PG  - E2
AB  - Recent advancements in stem cell biology and neuromodulation have ushered in a
      battery of new neurorestorative therapies for ischemic stroke. While the
      understanding of stroke pathophysiology has matured, the ability to restore
      patients’ quality of life remains inadequate. New therapeutic approaches,
      including cell transplantation and neurostimulation, focus on reestablishing the 
      circuits disrupted by ischemia through multidimensional mechanisms to improve
      neuroplasticity and remodeling. The authors provide a broad overview of stroke
      pathophysiology and existing therapies to highlight the scientifc and clinical
      implications of neurorestorative therapies for stroke.
FAU - Azad, Tej D.
AU  - Azad TD
FAU - Veeravagu, Anand
AU  - Veeravagu A
FAU - Steinberg, Gary K.
AU  - Steinberg GK
LA  - eng
PT  - Journal Article
TA  - Neurosurg Focus
JT  - Neurosurgical focus
AID - 10.3171/2016.2.FOCUS15637 [doi]
MID - NIHMS793756
SO  - Neurosurg Focus. 2016 May;40(5):E2. doi:10.3171/2016.2.FOCUS15637.

PMC - PMC4066236
PMID- 24961699
IS  - 2076-3425 (Electronic)
VI  - 4
IP  - 1
DP  - 2014 Mar
TI  - Towards Effective Non-Invasive Brain-Computer Interfaces Dedicated to Gait
      Rehabilitation Systems.
PG  - 1-48
AB  - In the last few years, significant progress has been made in the field of walk
      rehabilitation. Motor cortex signals in bipedal monkeys have been interpreted to 
      predict walk kinematics. Epidural electrical stimulation in rats and in one young
      paraplegic has been realized to partially restore motor control after spinal cord
      injury. However, these experimental trials are far from being applicable to all
      patients suffering from motor impairments. Therefore, it is thought that more
      simple rehabilitation systems are desirable in the meanwhile. The goal of this
      review is to describe and summarize the progress made in the development of
      non-invasive brain-computer interfaces dedicated to motor rehabilitation systems.
      In the first part, the main principles of human locomotion control are presented.
      The paper then focuses on the mechanisms of supra-spinal centers active during
      gait, including results from electroencephalography, functional brain imaging
      technologies [near-infrared spectroscopy (NIRS), functional magnetic resonance
      imaging (fMRI), positron-emission tomography (PET), single-photon
      emission-computed tomography (SPECT)] and invasive studies. The first
      brain-computer interface (BCI) applications to gait rehabilitation are then
      presented, with a discussion about the different strategies developed in the
      field. The challenges to raise for future systems are identified and discussed.
      Finally, we present some proposals to address these challenges, in order to
      contribute to the improvement of BCI for gait rehabilitation.
FAU - Castermans, Thierry
AU  - Castermans T
AD  - TCTS lab, Université de Mons, Place du Parc 20, Mons 7000, Belgium; E-Mails:
      matthieu.duvinage@gmail.com (M.D.); Thierry.Dutoit@umons.ac.be (T.D.)
FAU - Duvinage, Matthieu
AU  - Duvinage M
AD  - TCTS lab, Université de Mons, Place du Parc 20, Mons 7000, Belgium; E-Mails:
      matthieu.duvinage@gmail.com (M.D.); Thierry.Dutoit@umons.ac.be (T.D.)
FAU - Cheron, Guy
AU  - Cheron G
AD  - LNMB lab, Université Libre de Bruxelles, Avenue Franklin Roosevelt 50, Bruxelles 
      1050, Belgium; E-Mail: gcheron@ulb.ac.be
FAU - Dutoit, Thierry
AU  - Dutoit T
AD  - TCTS lab, Université de Mons, Place du Parc 20, Mons 7000, Belgium; E-Mails:
      matthieu.duvinage@gmail.com (M.D.); Thierry.Dutoit@umons.ac.be (T.D.)
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20131231
PHST- 2013/10/02 [received]
PHST- 2013/11/05 [revised]
PHST- 2013/12/12 [accepted]
TA  - Brain Sci
JT  - Brain Sciences
AID - 10.3390/brainsci4010001 [doi]
AID - brainsci-04-00001 [pii]
SO  - Brain Sci. 2013 Dec 31;4(1):1-48. doi:10.3390/brainsci4010001.

PMC - PMC5223402
PMID- 28119594
IS  - 1662-5161 (Electronic)
VI  - 10
DP  - 2016
TI  - Combined Action Observation and Motor Imagery Neurofeedback for Modulation of
      Brain Activity.
LID - 692
AB  - Motor imagery (MI) and action observation have proven to be efficacious adjuncts 
      to traditional physiotherapy for enhancing motor recovery following stroke.
      Recently, researchers have used a combined approach called imagined imitation
      (II), where an individual watches a motor task being performed, while
      simultaneously imagining they are performing the movement. While neurofeedback
      (NFB) has been used extensively with MI to improve patients' ability to modulate 
      sensorimotor activity and enhance motor recovery, the effectiveness of using NFB 
      with II to modulate brain activity is unknown. This project tested the ability of
      participants to modulate sensorimotor activity during
      electroencephalography-based II-NFB of a complex, multi-part unilateral
      handshake, and whether this ability transferred to a subsequent bout of MI.
      Moreover, given the goal of translating findings from NFB research into practical
      applications, such as rehabilitation, the II-NFB system was designed with several
      user interface and user experience features, in an attempt to both drive user
      engagement and match the level of challenge to the abilities of the subjects. In 
      particular, at easy difficulty levels the II-NFB system incentivized
      contralateral sensorimotor up-regulation (via event related desynchronization of 
      the mu rhythm), while at higher difficulty levels the II-NFB system incentivized 
      sensorimotor lateralization (i.e., both contralateral up-regulation and
      ipsilateral down-regulation). Thirty-two subjects, receiving real or sham NFB
      attended four sessions where they engaged in II-NFB training and subsequent MI.
      Results showed the NFB group demonstrated more bilateral sensorimotor activity
      during sessions 2–4 during II-NFB and subsequent MI, indicating mixed success for
      the implementation of this particular II-NFB system. Here we discuss our findings
      in the context of the design features included in the II-NFB system, highlighting
      limitations that should be considered in future designs.
FAU - Friesen, Christopher L.
AU  - Friesen CL
AD  - Laboratory for Brain Recovery and Function, Dalhousie UniversityHalifax, NS,
      Canada
FAU - Bardouille, Timothy
AU  - Bardouille T
AD  - Department of Psychology and Neuroscience, Dalhousie UniversityHalifax, NS,
      Canada
FAU - Neyedli, Heather F.
AU  - Neyedli HF
AD  - Department of Psychology and Neuroscience, Dalhousie UniversityHalifax, NS,
      Canada
FAU - Boe, Shaun G.
AU  - Boe SG
AD  - Laboratory for Brain Recovery and Function, Dalhousie UniversityHalifax, NS,
      Canada
LA  - eng
PT  - Journal Article
DEP - 20170110
PHST- 2016/09/17 [received]
PHST- 2016/12/26 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2016.00692 [doi]
SO  - Front Hum Neurosci. 2017 Jan 10;10:. doi:10.3389/fnhum.2016.00692.

PMC - PMC5454217
PMID- 28526673
IS  - 1929-0748 (Electronic)
VI  - 6
IP  - 5
DP  - 2017 May
TI  - The Effectiveness of a Computer Game-Based Rehabilitation Platform for Children
      With Cerebral Palsy: Protocol for a Randomized Clinical Trial.
LID - e93
AB  - Background: It is difficult to engage young children with cerebral palsy (CP) in 
      repetitive, tedious therapy. As such, there is a need for innovative approaches
      and tools to motivate these children. We developed the low-cost, computer
      game-based rehabilitation platform CGR that combines fine manipulation and gross 
      movement exercises with attention and planning game activities appropriate for
      young children with CP. Objective: The objective of this study is to provide
      evidence of the therapeutic value of CGR to improve upper extremity (UE) motor
      function for children with CP. Methods: This randomized controlled, single-blind,
      clinical trial with an active control arm will be conducted at 4 sites. Children 
      diagnosed with CP between the ages of 4 and 10 years old with moderate UE
      impairments and fine motor control abnormalities will be recruited. Results: We
      will test the difference between experimental and control groups using the
      Quality of Upper Extremity Skills Test (QUEST) and Peabody Developmental Motor
      Scales, Second Edition (PDMS-2) outcome measures. The parents of the children and
      the therapist experiences with the interventions and tools will be explored using
      semi-structured interviews using the qualitative description approach.
      Conclusions: This research protocol, if effective, will provide evidence for the 
      therapeutic value and feasibility of CGR in the pediatric rehabilitation of UE
      function. Trial Registration: Clinicaltrials.gov NCT02728375;
      http:https://clinicaltrials.gov/ct2/show/NCT02728375 (Archived by WebCite at
      http://www.webcitation.org/6qDjvszvh)
FAU - Karlsson, Dr Petra
AU  - Karlsson DP
FAU - DeLuca, Stephanie
AU  - DeLuca S
FAU - Kanitkar, Anuprita
AU  - Kanitkar A
AUID- ORCID: 0000-0001-9678-1152
AD  - Applied Health SciencesUniversity of ManitobaWinnipeg, MBCanada
FAU - Szturm, Tony
AU  - Szturm T
AUID- ORCID: 0000-0002-1450-0693
AD  - College of Rehabilitation SciencesUniversity of ManitobaWinnipeg, MBCanada
FAU - Parmar, Sanjay
AU  - Parmar S
AUID- ORCID: 0000-0001-7186-0532
AD  - SDM College of Medical Sciences and HospitalRajiv Gandhi University of Health
      SciencesDharwadIndia
FAU - Gandhi, Dorcas BC
AU  - Gandhi DB
AUID- ORCID: 0000-0002-9616-7870
AD  - Christian Medical College and HospitalDepartment of NeurologyBaba Farid
      University of Health SciencesLudhianaIndia
FAU - Rempel, Gina Ruth
AU  - Rempel GR
AUID- ORCID: 0000-0001-8632-3406
AD  - Max Rady College of Medicine, Rady Faculty of Health SciencesDepartment of
      Pediatrics and Child HealthUniversity of ManitobaWinnipeg, MBCanada
FAU - Restall, Gayle
AU  - Restall G
AUID- ORCID: 0000-0002-8656-6261
AD  - College of Rehabilitation SciencesUniversity of ManitobaWinnipeg, MBCanada
FAU - Sharma, Monika
AU  - Sharma M
AUID- ORCID: 0000-0003-0756-0740
AD  - Christian Medical College and HospitalDepartment of PediatricsBaba Farid
      University of Health SciencesLudhianaIndia
FAU - Narayan, Amitesh
AU  - Narayan A
AUID- ORCID: 0000-0001-7587-8414
AD  - Kasturba Medical CollegeDepartment of PhysiotherapyManipal
      UniversityMangaloreIndia
FAU - Pandian, Jeyaraj
AU  - Pandian J
AUID- ORCID: 0000-0003-0028-1968
AD  - Christian Medical College and HospitalDepartment of NeurologyBaba Farid
      University of Health SciencesLudhianaIndia
FAU - Naik, Nilashri
AU  - Naik N
AUID- ORCID: 0000-0001-6616-7629
AD  - Department of PhysiotherapyUshas School for Exceptional ChildrenHubliIndia
FAU - Savadatti, Ravi R
AU  - Savadatti RR
AUID- ORCID: 0000-0001-6372-3968
AD  - SDM College of PhysiotherapyRajiv Gandhi University of Health
      SciencesDharwadIndia
FAU - Kamate, Mahesh Appasaheb
AU  - Kamate MA
AUID- ORCID: 0000-0003-1703-2474
AD  - JN Medical College and HospitalDepartment of PediatricsKLE UniversityBelgaumIndia
LA  - eng
PT  - Journal Article
DEP - 20170518
PHST- 2016/10/21 [received]
PHST- 2017/02/03 [revised]
PHST- 2017/02/03 [accepted]
TA  - JMIR Res Protoc
JT  - JMIR Research Protocols
AID - v6i5e93 [pii]
AID - 10.2196/resprot.6846 [doi]
SO  - JMIR Res Protoc. 2017 May 18;6(5):. doi:10.2196/resprot.6846.

PMC - PMC3349420
PMID- 22343140
IS  - 0964-6906 (Print)
IS  - 1460-2083 (Electronic)
VI  - 21
IP  - 11
DP  - 2012 Jun 1
TI  - Long-lived epigenetic interactions between perinatal PBDE exposure and Mecp2308
      mutation.
PG  - 2399-411
AB  - The widespread use of persistent organic polybrominated diphenyl ethers (PBDEs)
      as commercial flame retardants has raised concern about potential long-lived
      effects on human health. Epigenetic mechanisms, such as DNA methylation, are
      responsive to environmental influences and have long-lasting consequences. Autism
      spectrum disorders (ASDs) have complex neurodevelopmental origins whereby both
      genetic and environmental factors are implicated. Rett syndrome is an X-linked
      ASD caused by mutations in the epigenetic factor methyl-CpG binding protein 2
      (MECP2). In this study, an Mecp2 truncation mutant mouse (Mecp2308) with social
      behavioral defects was used to explore the long-lasting effects of PBDE exposure 
      in a genetically and epigenetically susceptible model. Mecp2308/+ dams were
      perinatally exposed daily to 2,2′,4,4′-tetrabromodiphenyl ether 47 (BDE-47) and
      bred to wild-type C57BL/6J males, and the offspring of each sex and genotype were
      examined for developmental, behavioral and epigenetic outcomes. Perinatal BDE-47 
      exposure negatively impacted fertility of Mecp2308/+ dams and preweaning weights 
      of females. Global hypomethylation of adult brain DNA was observed specifically
      in female offspring perinatally exposed to BDE-47 and it coincided with reduced
      sociability in a genotype-independent manner. A reversing interaction of Mecp2
      genotype on BDE-47 exposure was observed in a short-term memory test of social
      novelty that corresponded to increased Dnmt3a levels specifically in
      BDE-47-exposed Mecp2308/+ offspring. In contrast, learning and long-term memory
      in the Morris water maze was impaired by BDE-47 exposure in female Mecp2308/+
      offspring. These results demonstrate that a genetic and environmental interaction
      relevant to social and cognitive behaviors shows sexual dimorphism, epigenetic
      dysregulation, compensatory molecular mechanisms and specific behavioral
      deficits.
FAU - Woods, Rima
AU  - Woods R
AD  - Medical Microbiology and Immunology and Rowe Program in Human Genetics,
FAU - Vallero, Roxanne O.
AU  - Vallero RO
AD  - Medical Microbiology and Immunology and Rowe Program in Human Genetics,
FAU - Golub, Mari S.
AU  - Golub MS
AD  - Environmental Toxicology,
FAU - Suarez, Joanne K.
AU  - Suarez JK
AD  - Medical Microbiology and Immunology and Rowe Program in Human Genetics,
FAU - Ta, Tram Anh
AU  - Ta TA
AD  - Center for Children's Environmental Health,
FAU - Yasui, Dag H.
AU  - Yasui DH
AD  - Medical Microbiology and Immunology and Rowe Program in Human Genetics,
FAU - Chi, Lai-Har
AU  - Chi LH
AD  - Toxicology Research Center, University at Buffalo, The State University of New
      York, Buffalo, NY 14214-3015, USA
FAU - Kostyniak, Paul J.
AU  - Kostyniak PJ
AD  - Toxicology Research Center, University at Buffalo, The State University of New
      York, Buffalo, NY 14214-3015, USA
FAU - Pessah, Isaac N.
AU  - Pessah IN
AD  - M.I.N.D. Institute,
FAU - Berman, Robert F.
AU  - Berman RF
AD  - M.I.N.D. Institute,
FAU - LaSalle, Janine M.
AU  - LaSalle JM
AD  - Medical Microbiology and Immunology and Rowe Program in Human Genetics,
LA  - eng
PT  - Journal Article
DEP - 20120215
PHST- 2011/10/26 [received]
PHST- 2012/02/10 [accepted]
PHST- 2012/02/15 [aheadofprint]
TA  - Hum Mol Genet
JT  - Human Molecular Genetics
AID - 10.1093/hmg/dds046 [doi]
AID - dds046 [pii]
SO  - Hum Mol Genet. 2012 Jun 1;21(11):2399-411. Epub 2012 Feb 15
      doi:10.1093/hmg/dds046.

PMC - PMC4654784
PMID- 26665041
IS  - 2164-957X (Print)
IS  - 2164-9561 (Electronic)
VI  - 4
IP  - Suppl
DP  - 2015 Nov
TI  - An Overview of Biofield Devices.
PG  - 42-51
AB  - Advances in biophysics, biology, functional genomics, neuroscience, psychology,
      psychoneuroimmunology, and other fields suggest the existence of a subtle system 
      of “biofield” interactions that organize biological processes from the subatomic,
      atomic, molecular, cellular, and organismic to the interpersonal and cosmic
      levels. Biofield interactions may bring about regulation of biochemical,
      cellular, and neurological processes through means related to electromagnetism,
      quantum fields, and perhaps other means of modulating biological activity and
      information flow. The biofield paradigm, in contrast to a reductionist,
      chemistry-centered viewpoint, emphasizes the informational content of biological 
      processes; biofield interactions are thought to operate in part via low-energy or
      “subtle” processes such as weak, nonthermal electromagnetic fields (EMFs) or
      processes potentially related to consciousness and nonlocality. Biofield
      interactions may also operate through or be reflected in more well-understood
      informational processes found in electroencephalographic (EEG) and
      electrocardiographic (ECG) data. Recent advances have led to the development of a
      wide variety of therapeutic and diagnostic biofield devices, defined as physical 
      instruments best understood from the viewpoint of a biofield paradigm. Here, we
      provide a broad overview of biofield devices, with emphasis on those devices for 
      which solid, peer-reviewed evidence exists. A subset of these devices, such as
      those based upon EEG- and ECG-based heart rate variability, function via
      mechanisms that are well understood and are widely employed in clinical settings.
      Other device modalities, such a gas discharge visualization and biophoton
      emission, appear to operate through incompletely understood mechanisms and have
      unclear clinical significance. Device modes of operation include EMF-light,
      EMF-heat, EMF-nonthermal, electrical current, vibration and sound, physical and
      mechanical, intentionality and nonlocality, gas and plasma, and other (mode of
      operation not well-understood). Methodological issues in device development and
      interfaces for future interdisciplinary research are discussed. Devices play
      prominent cultural and scientific roles in our society, and it is likely that
      device technologies will be one of the most influential access points for the
      furthering of biofield research and the dissemination of biofield concepts. This 
      developing field of study presents new areas of research that have many important
      implications for both basic science and clinical medicine.
FAU - Muehsam, David
AU  - Muehsam D
AD  - Visual Institute of Developmental Arts and Sciences, National Institute of
      Biostructures and Biosystems, Bologna, Italy; and Consciousness and Healing
      Initiative, San Diego, California (Dr Muehsam)
FAU - Chevalier, Gaétan
AU  - Chevalier G
AD  - Developmental and Cell Biology Department, University of California Irvine,
      Irvine (Dr Chevalier)
FAU - Barsotti, Tiffany
AU  - Barsotti T
AD  - California Institute for Human Science, Encinitas, California (Ms Barsotti)
FAU - Gurfein, Blake T.
AU  - Gurfein BT
AD  - Osher Center for Integrative Medicine, University of California, San Francisco,
      (Dr Gurfein)
LA  - eng
PT  - Journal Article
DEP - 20151101
PHST- 2015/11/01 [aheadofprint]
TA  - Glob Adv Health Med
JT  - Global Advances in Health and Medicine
AID - gahmj.2015.022.suppl [pii]
AID - 10.7453/gahmj.2015.022.suppl [doi]
SO  - Glob Adv Health Med. 2015 Nov;4(Suppl):42-51. Epub 2015 Nov 01
      doi:10.7453/gahmj.2015.022.suppl.

PMC - PMC2859719
PMID- 19909802
IS  - 0378-5955 (Print)
IS  - 1878-5891 (Electronic)
VI  - 260
IP  - 1-2
DP  - 2010 Feb
TI  - A System to Simulate and Reproduce Audio-Visual Environments for Spatial Hearing 
      Research.
PG  - 1-10
AB  - The article reports the experience gained from two implementations of the
      “Simulated Open-Field Environment” (SOFE), a setup that allows sounds to be
      played at calibrated levels over a wide frequency range from multiple
      loudspeakers in an anechoic chamber. Playing sounds from loudspeakers in the
      free-field has the advantage that each participant listens with their own ears,
      and individual characteristics of the ears are captured in the sound they hear.
      This makes an easy and accurate comparison between various listeners with and
      without hearing devices possible. The SOFE uses custom calibration software to
      assure individual equalization of each loudspeaker. Room simulation software
      creates the spatio-temporal reflection pattern of sound sources in rooms which is
      played via the SOFE loudspeakers. The sound playback system is complemented by a 
      video projection facility which can be used to collect or give feedback or to
      study auditory-visual interaction. The article discusses acoustical and technical
      requirements for accurate sound playback against the specific needs in hearing
      research. An introduction to software concepts is given which allow easy,
      high-level control of the setup and thus fast experimental development, turning
      the SOFE into a “Swiss army knife” tool for auditory, spatial hearing and
      audio-visual research.
FAU - Seeber, Bernhard U.
AU  - Seeber BU
AD  - Audiory Perception Lab, Department of Psychology, University of California at
      Berkeley, Berkeley, CA 94530-1650, USA
FAU - Kerber, Stefan
AU  - Kerber S
AD  - MRC Institute of Hearing Research, University Park, Nottingham, NG7 2RD, United
      Kingdom
FAU - Hafter, Ervin R.
AU  - Hafter ER
AD  - Audiory Perception Lab, Department of Psychology, University of California at
      Berkeley, Berkeley, CA 94530-1650, USA
LA  - eng
PT  - Journal Article
DEP - 20091110
TA  - Hear Res
JT  - Hearing research
AID - 10.1016/j.heares.2009.11.004 [doi]
MID - NIHMS164490
SO  - Hear Res. 2010 Feb;260(1-2):1-10. Epub 2009 Nov 10
      doi:10.1016/j.heares.2009.11.004.

PMC - PMC3829384
PMID- 19646070
IS  - 1350-1925 (Print)
IS  - 1365-2982 (Electronic)
VI  - 21
IP  - 6
DP  - 2009 Jun
TI  - BRAIN IMAGING APPROACHES TO THE STUDY OF FUNCTIONAL GI DISORDERS: A Rome Working 
      Team Report.
LID - 10.1111/j.1365-2982.2009.01304.x
FAU - Mayer, Emeran A
AU  - Mayer EA
AD  - Center for Neurobiology of Stress, Departments of Medicine, Physiology and
      Psychiatry, UCLA, CURE Digestive Diseases Research Center, UCLA Division of
      Digestive Diseases, Los Angeles, CA
FAU - Aziz, Qasim
AU  - Aziz Q
AD  - Wingate Institute for Neurogastroenterology, Neurogastroenterology Group, School 
      of Medicine and Dentistry, Queen Mary University of London, UK
FAU - Coen, Steven
AU  - Coen S
AD  - Wingate Institute for Neurogastroenterology, Neurogastroenterology Group, School 
      of Medicine and Dentistry, Queen Mary University of London, UK
FAU - Kern, Mark
AU  - Kern M
AD  - Department of Medicine, Division of Gastroenterology and Hepatology, Medical
      College of Wisconsin Milwaukee, WI
FAU - Labus, Jennifer
AU  - Labus J
AD  - Center for Neurobiology of Stress, Departments of Medicine, Physiology and
      Psychiatry, UCLA, CURE Digestive Diseases Research Center, UCLA Division of
      Digestive Diseases, Los Angeles, CA
FAU - Lane, Richard
AU  - Lane R
AD  - Departments of Psychiatry, Psychology and Neuroscience, University of Arizona, AZ
FAU - Kuo, Brad
AU  - Kuo B
AD  - Gastro Intestinal Unit, Massachusetts General Hospital, Harvard Medical School,
      Boston, MA
FAU - Naliboff, Bruce
AU  - Naliboff B
AD  - Center for Neurobiology of Stress, Departments of Medicine, Physiology and
      Psychiatry, UCLA, CURE Digestive Diseases Research Center, UCLA Division of
      Digestive Diseases, Los Angeles, CA
FAU - Tracey, Irene
AU  - Tracey I
AD  - Oxford Centre for Functional Magnetic Resonance Imaging of the Brain, FMRIB
      Centre, Oxford University Department of Clinical Neurology, John Radcliffe
      Hospital Oxford, UK
LA  - eng
PT  - Journal Article
GR  - R24 AT002681 || AT
TA  - Neurogastroenterol Motil
JT  - Neurogastroenterology and motility : the official journal of the European
      Gastrointestinal Motility Society
AID - 10.1111/j.1365-2982.2009.01304.x [doi]
MID - NIHMS120425
SO  - Neurogastroenterol Motil. 2009 Jun;21(6):. doi:10.1111/j.1365-2982.2009.01304.x.

PMC - PMC3587686
PMID- 23053600
IS  - 0896-0267 (Print)
IS  - 1573-6792 (Electronic)
VI  - 26
IP  - 2
DP  - 2013
TI  - Assessing the Effects of Electroconvulsive Therapy on Cortical Excitability by
      Means of Transcranial Magnetic Stimulation and Electroencephalography.
PG  - 326-37
AB  - Electroconvulsive therapy (ECT) has significant short-term antidepressant effects
      on drug-resistant patients with severe major depression. Animal studies have
      demonstrated that electroconvulsive seizures produce potentiation-like synaptic
      remodeling in both sub-cortical and frontal cortical circuits. However, the
      electrophysiological effects of ECT in the human brain are not known. In this
      work, we evaluated whether ECT induces a measurable change in the excitability of
      frontal cortical circuits in humans. Electroencephalographic (EEG) potentials
      evoked by transcranial magnetic stimulation (TMS) were collected before and after
      a course of ECT in eight patients with severe major depression. Cortical
      excitability was measured from the early and local EEG response to TMS. Clinical 
      assessment confirmed the beneficial effects of ECT on depressive symptoms at the 
      group level. TMS/EEG measurements revealed a clear-cut increase of frontal
      cortical excitability after ECT as compared to baseline, that was significant in 
      each and every patient. The present findings corroborate in humans the idea that 
      ECT may produce synaptic potentiation, as previously observed in animal studies. 
      Moreover, results suggest that TMS/EEG may be employed in depressed patients to
      monitor longitudinally the electrophysiological effects of different therapeutic 
      neuromodulators, e.g. ECT, repetitive TMS, and sleep deprivation. To the extent
      that depression involves an alteration of frontal cortical excitability, these
      measurements may be used to guide and evaluate treatment progression over time at
      the single-patient level.Electronic supplementary material: The online version of
      this article (doi:10.1007/s10548-012-0256-8) contains supplementary material,
      which is available to authorized users.
FAU - Casarotto, Silvia
AU  - Casarotto S
AD  - Department of Biomedical and Clinical Sciences “L. Sacco”, Università degli Studi
      di Milano, Via G.B. Grassi, 74, 20157 Milan, Italy
FAU - Canali, Paola
AU  - Canali P
AD  - Department of Clinical Neurosciences, Scientific Institute and University
      Vita-Salute San Raffaele, Milan, Italy
FAU - Rosanova, Mario
AU  - Rosanova M
AD  - Department of Biomedical and Clinical Sciences “L. Sacco”, Università degli Studi
      di Milano, Via G.B. Grassi, 74, 20157 Milan, Italy
FAU - Pigorini, Andrea
AU  - Pigorini A
AD  - Department of Biomedical and Clinical Sciences “L. Sacco”, Università degli Studi
      di Milano, Via G.B. Grassi, 74, 20157 Milan, Italy
FAU - Fecchio, Matteo
AU  - Fecchio M
AD  - Department of Biomedical and Clinical Sciences “L. Sacco”, Università degli Studi
      di Milano, Via G.B. Grassi, 74, 20157 Milan, Italy
FAU - Mariotti, Maurizio
AU  - Mariotti M
AD  - Department of Biomedical and Clinical Sciences “L. Sacco”, Università degli Studi
      di Milano, Via G.B. Grassi, 74, 20157 Milan, Italy
FAU - Lucca, Adelio
AU  - Lucca A
AD  - Department of Clinical Neurosciences, Scientific Institute and University
      Vita-Salute San Raffaele, Milan, Italy
FAU - Colombo, Cristina
AU  - Colombo C
AD  - Department of Clinical Neurosciences, Scientific Institute and University
      Vita-Salute San Raffaele, Milan, Italy
FAU - Benedetti, Francesco
AU  - Benedetti F
AD  - Department of Clinical Neurosciences, Scientific Institute and University
      Vita-Salute San Raffaele, Milan, Italy
FAU - Massimini, Marcello
AU  - Massimini M
AD  - Department of Biomedical and Clinical Sciences “L. Sacco”, Università degli Studi
      di Milano, Via G.B. Grassi, 74, 20157 Milan, Italy
LA  - eng
PT  - Journal Article
DEP - 20121009
PHST- 2012/04/26 [received]
PHST- 2012/09/01 [accepted]
TA  - Brain Topogr
JT  - Brain Topography
AID - 256 [pii]
AID - 10.1007/s10548-012-0256-8 [doi]
SO  - Brain Topogr. 2013;26(2):326-37. Epub 2012 Oct 9 doi:10.1007/s10548-012-0256-8.

PMC - PMC4702051
PMID- 26770276
IS  - 1865-1011 (Electronic)
VI  - 14
DP  - 2015
TI  - Comprehensive review on rhino-neurosurgery.
LID - Doc01
AB  - In the past 2 decades, an innovative and active field of surgical collaboration
      has been evolved and established combining the expertise of neurosurgery and
      rhinosurgery in the endonasal treatment of different lesions affecting the
      anterior skull base together with the adjacent intranasal and intradural areas.
      Important prerequisites for this development were improvements of technical
      devices, definitions of transnasal surgical corridors, and approvements in
      endonasal reconstructions, e.g. by use of pedicled nasal mucosal flaps. Due to
      these improvements, the rate of perioperative infectious complications remained
      acceptable. Interdisciplinary surgical teams (4-hands-2-minds) have been
      established constituting specialized centers of “rhino-neurosurgery”. With
      growing expertise of these groups, it could be shown that oncological results and
      perioperative complications were comparable to traditional surgery while at the
      same time the patients’ morbidity could be reduced.The present review encompasses
      the recent literature focusing on the development, technical details, results,
      and complications of “rhino-neurosurgery”.
FAU - Hosemann, Werner
AU  - Hosemann W
AD  - Department of Otolaryngology, Head & Neck Surgery, University Medicine
      Greifswald, Germany
FAU - Schroeder, Henry W.S.
AU  - Schroeder HW
AD  - Department of Neurosurgery, University Medicine Greifswald, Germany
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20151222
TA  - GMS Curr Top Otorhinolaryngol Head Neck Surg
JT  - GMS Current Topics in Otorhinolaryngology, Head and Neck Surgery
AID - cto000116 [pii]
AID - 10.3205/cto000116 [doi]
AID - Doc01 [pii]
SO  - GMS Curr Top Otorhinolaryngol Head Neck Surg. 2015 Dec 22;14:.
      doi:10.3205/cto000116.

PMC - PMC3458247
PMID- 23019518
IS  - 2045-2322 (Electronic)
VI  - 2
DP  - 2012
TI  - The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is
      important for cognitive functions.
LID - 697
AB  - We recently reported expression of hematopoietic growth factor GM-CSF and its
      receptor (GM-CSFR) in CNS neurons. Here we evaluated this system in learning and 
      memory formation using GM-CSF deficient mice. In complementation, GM-CSF
      signalling was manipulated specifically in adult murine hippocampus by
      adeno-associated virus (AAV)-mediated GM-CSFR alpha overexpression or knock-down.
      GM-CSF ablation caused various hippocampus and amygdala-dependent deficits in
      spatial and fear memory while rendering intact basic parameters like motor
      function, inherent anxiety, and pain threshold levels. Corroborating these data, 
      spatial memory of AAV-injected mice was positively correlated with GM-CSFRα
      expression levels. Hippocampal neurons of knock-out mice showed markedly pruned
      dendritic trees, reduced spine densities, and lower percentages of mature spines.
      Despite such morphological alterations, long-term potentiation (LTP) was
      unimpaired in the knock-out hippocampus. Collectively, these results suggest that
      GM-CSF signalling plays a major role in structural plasticity relevant to
      learning and memory.
FAU - Krieger, Markus
AU  - Krieger M
AD  - SYGNIS Bioscience, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany
FAU - Both, Martin
AU  - Both M
AD  - Institute for Physiology, University of Heidelberg, Im Neuenheimer Feld 346,
      69120 Heidelberg, Germany
FAU - Kranig, Simon A.
AU  - Kranig SA
AD  - Institute for Physiology, University of Heidelberg, Im Neuenheimer Feld 346,
      69120 Heidelberg, Germany
FAU - Pitzer, Claudia
AU  - Pitzer C
AD  - SYGNIS Bioscience, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany
FAU - Klugmann, Matthias
AU  - Klugmann M
AD  - Translational Neuroscience Facility, Department of Physiology, School of Medical 
      Sciences, University of New South Wales, UNSW Kensington Campus, Sydney, NSW,
      2052, Australia
FAU - Vogt, Gerhard
AU  - Vogt G
AD  - SYGNIS Bioscience, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany
FAU - Draguhn, Andreas
AU  - Draguhn A
AD  - Institute for Physiology, University of Heidelberg, Im Neuenheimer Feld 346,
      69120 Heidelberg, Germany
FAU - Schneider, Armin
AU  - Schneider A
AD  - SYGNIS Bioscience, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany
LA  - eng
PT  - Journal Article
DEP - 20120926
PHST- 2012/07/17 [received]
PHST- 2012/09/12 [accepted]
TA  - Sci Rep
JT  - Scientific Reports
AID - srep00697 [pii]
AID - 10.1038/srep00697 [doi]
SO  - Sci Rep. 2012 Sep 26;2:. doi:10.1038/srep00697.

PMC - PMC3382677
PMID- 22870477
IS  - 1759-720X (Print)
IS  - 1759-7218 (Electronic)
VI  - 3
IP  - 4
DP  - 2011 Aug
DP  - 2011 Aug
TI  - Management of Chronic Pain in the Rheumatic Diseases with Insights for the
      Clinician.
PG  - 179-90
AB  - Pain that accompanies musculoskeletal conditions should be regarded as an illness
      entity in its own right and deserves treatment in parallel with the management of
      the underlying condition. Recent understanding of the pathophysiology of
      rheumatic pain invokes interplay of the nociceptive mechanisms driven by local
      tissue factors and the neurogenic responses that sustain chronic pain. In line
      with other pain conditions, ideal treatment of rheumatic pain should be through a
      multimodal approach, integrating nonpharmacologic as well as pharmacologic
      treatments. In the light of this new concept of pain mechanisms, future
      pharmacologic treatment options may encompass a wider scope than the use of
      traditional analgesics and nonsteroidal anti-inflammatory drugs. There is
      currently limited experience for use of pharmacologic treatments that act
      primarily on neurogenic mechanisms in rheumatic conditions. Drug combination
      studies are lacking, but this strategy seems clinically reasonable to allow for
      an approach to treating pain from different mechanistic perspectives. An added
      advantage would be the opportunity to use lower doses of individual drugs and
      thereby reduce the side effect profile. Ideal pain management must also include
      attention to the important co-associates of pain such as effects on sleep, mood
      and energy, which all have an impact on the global burden of suffering. Although 
      complete relief of pain is still an unrealistic objective, reasonable outcome
      goals for symptom relief should be accompanied with an improvement in function.
FAU - Fitzcharles, Mary-Ann
AU  - Fitzcharles MA
FAU - Shir, Yoram
AU  - Shir Y
AD  - Montreal General Hospital Pain Centre, Montreal General Hospital, McGill
      University, Montreal, Quebec, Canada
LA  - eng
PT  - Journal Article
PT  - Review
TA  - Ther Adv Musculoskelet Dis
JT  - Therapeutic Advances in Musculoskeletal Disease
AID - 10.1177/1759720X11408999 [doi]
AID - 10.1177_1759720X11408999 [pii]
SO  - Ther Adv Musculoskelet Dis. 2011 Aug;3(4):179-90. doi:10.1177/1759720X11408999.

PMC - PMC2898155
PMID- 20588096
IS  - 1557-0576 (Print)
IS  - 1557-0584 (Electronic)
VI  - 34
IP  - 2
DP  - 2010 Jun
TI  - Application of vibrotactile feedback of body motion to improve rehabilitation in 
      individuals with imbalance.
PG  - 98-104
AB  - Background and Purpose: Balance rehabilitation and vestibular/balance prostheses 
      are both emerging fields that have a potential for synergistic interaction. This 
      paper reviews vibrotactile prosthetic devices that have been developed to date
      and ongoing work related to the application of vibrotactile feedback for enhanced
      postural control. A vibrotactile feedback device developed in the author’s
      laboratory is described. Methods: Twelve subjects with vestibular hypofunction
      were tested on a platform that moved randomly in a plane, while receiving
      vibrotactile feedback in the anterio-posterior direction. The feedback allowed
      subjects to significantly decrease their anterio-posterior body tilt, but did not
      change mediolateral tilt. A tandem walking task using subjects with
      vestibulopathies demonstrated a reduction in their medio-lateral sway due to
      vibrotactile feedback of medio-lateral body tilt, after controlling for the
      effects of task learning. The findings from two additional experiments conducted 
      in the laboratories of collaborating physical therapists are summarized. Results:
      The Dynamic Gait Index scores in community-dwelling elderly individuals who were 
      prone-to-fall were significantly improved with the use of medio-lateral body tilt
      feedback. Discussion and Conclusions: While more work is needed, these results
      suggest that vibrotactile tilt feedback of subjects’ body motion can be used
      effectively by physical therapists for balance rehabilitation. A preliminary
      description of the 3rd generation device that has been reduced from a vest format
      to a belt format is described to demonstrate the progressive evolution from
      research to clinical application.
FAU - Wall, Conrad
AU  - Wall C
AD  - Professor of Otolology and Laryngology, Harvard Medical School Director, Jenks
      Vestibular Diagnostic Laboratory, Massachusetts Eye & Ear Infirmary
LA  - eng
PT  - Journal Article
TA  - J Neurol Phys Ther
JT  - Journal of neurologic physical therapy : JNPT
AID - 10.1097/NPT.0b013e3181dde6f0 [doi]
MID - NIHMS201727
SO  - J Neurol Phys Ther. 2010 Jun;34(2):98-104. doi:10.1097/NPT.0b013e3181dde6f0.

PMC - PMC4676943
PMID- 25000373
IS  - 0269-9206 (Print)
IS  - 1464-5076 (Electronic)
VI  - 28
IP  - 0
DP  - 2014 Jul-Aug
TI  - How to Meet the Neighbors: Modality Effects on Phonological Generalization.
PG  - 477-92
AB  - Long-term auditory priming of words from dense neighborhoods has been posited as 
      a learning mechanism that affects change in the phonological structure of
      children’s lexical representations. An apparent confound associated with the
      modality of priming responsible for structural change has been introduced in the 
      literature, which challenges this proposal. Thus, our purpose was to evaluate
      prime modality in treatment of children with phonological delay. Nine children
      were assigned to auditory-visual, auditory or visual priming of words from dense 
      neighborhoods prior to treatment of production as the independent variable. The
      dependent variable was phonological generalization. Results showed that auditory 
      priming (with or without visual input) promoted greater generalization on an
      order of magnitude of 3:1. Findings support the theoretical significance of
      auditory priming for phonological learning and demonstrate the applied utility of
      priming in clinical treatment.
FAU - Gierut, Judith A.
AU  - Gierut JA
FAU - Morrisette, Michele L.
AU  - Morrisette ML
LA  - eng
PT  - Journal Article
TA  - Clin Linguist Phon
JT  - Clinical linguistics & phonetics
AID - 10.3109/02699206.2014.926992 [doi]
MID - NIHMS742652
SO  - Clin Linguist Phon. 2014 Jul-Aug;28(0):477-92. doi:10.3109/02699206.2014.926992.

PMC - PMC2886806
PMID- 20045055
IS  - 1043-6618 (Print)
IS  - 1096-1186 (Electronic)
VI  - 62
IP  - 2
DP  - 2010 Aug
TI  - Enabling individualized therapy through nanotechnology.
PG  - 57-89
AB  - Individualized medicine is the healthcare strategy that rebukes the idiomatic
      dogma of ‘losing sight of the forest for the trees’. We are entering a new era of
      healthcare where it is no longer acceptable to develop and market a drug that is 
      effective for only 80% of the patient population. The emergence of “-omic”
      technologies (e.g. genomics, transcriptomics, proteomics, metabolomics) and
      advances in systems biology are magnifying the deficiencies of standardized
      therapy, which often provide little treatment latitude for accommodating patient 
      physiologic idiosyncrasies. A personalized approach to medicine is not a novel
      concept. Ever since the scientific community began unraveling the mysteries of
      the genome, the promise of discarding generic treatment regimens in favor of
      patient-specific therapies became more feasible and realistic. One of the major
      scientific impediments of this movement towards personalized medicine has been
      the need for technological enablement. Nanotechnology is projected to play a
      critical role in patient-specific therapy; however, this transition will depend
      heavily upon the evolutionary development of a systems biology approach to
      clinical medicine based upon “-omic” technology analysis and integration. This
      manuscript provides a forward looking assessment of the promise of nanomedicine
      as it pertains to individualized medicine and establishes a technology “snapshot”
      of the current state of nano-based products over a vast array of clinical
      indications and range of patient specificity. Other issues such as market driven 
      hurdles and regulatory compliance reform are anticipated to “self-correct” in
      accordance to scientific advancement and healthcare demand. These peripheral,
      non-scientific concerns are not addressed at length in this manuscript; however
      they do exist, and their impact to the paradigm shifting healthcare
      transformation towards individualized medicine will be critical for its success.
FAU - Sakamoto, Jason H.
AU  - Sakamoto JH
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - van de Ven, Anne L.
AU  - van de Ven AL
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Godin, Biana
AU  - Godin B
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Blanco, Elvin
AU  - Blanco E
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Serda, Rita E.
AU  - Serda RE
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Grattoni, Alessandro
AU  - Grattoni A
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Ziemys, Arturas
AU  - Ziemys A
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Bouamrani, Ali
AU  - Bouamrani A
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Hu, Tony
AU  - Hu T
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Ranganathan, Shivakumar I.
AU  - Ranganathan SI
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - De Rosa, Enrica
AU  - De Rosa E
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Martinez, Jonathan O.
AU  - Martinez JO
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Smid, Christine A.
AU  - Smid CA
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Buchanan, Rachel M.
AU  - Buchanan RM
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Lee, Sei-Young
AU  - Lee SY
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Srinivasan, Srimeenakshi
AU  - Srinivasan S
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Landry, Matthew
AU  - Landry M
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Meyn, Anne
AU  - Meyn A
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Tasciotti, Ennio
AU  - Tasciotti E
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Liu, Xuewu
AU  - Liu X
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Decuzzi, Paolo
AU  - Decuzzi P
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
FAU - Ferrari, Mauro
AU  - Ferrari M
AD  - The University of Texas Health Science Center, Department of Nanomedicine and
      Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA
LA  - eng
PT  - Journal Article
DEP - 20100105
TA  - Pharmacol Res
JT  - Pharmacological research : the official journal of the Italian Pharmacological
      Society
AID - 10.1016/j.phrs.2009.12.011 [doi]
MID - NIHMS201484
SO  - Pharmacol Res. 2010 Aug;62(2):57-89. Epub 2010 Jan 5
      doi:10.1016/j.phrs.2009.12.011.

PMC - PMC2082146
PMID- 18037993
IS  - 0021-9738 (Print)
VI  - 117
IP  - 12
DP  - 2007 Dec 3
TI  - Visual phenotype in Williams-Beuren syndrome challenges magnocellular theories
      explaining human neurodevelopmental visual cortical disorders.
PG  - 3720-9
AB  - Williams-Beuren syndrome (WBS), a neurodevelopmental genetic disorder whose
      manifestations include visuospatial impairment, provides a unique model to link
      genetically determined loss of neural cell populations at different levels of the
      nervous system with neural circuits and visual behavior. Given that several of
      the genes deleted in WBS are also involved in eye development and the
      differentiation of retinal layers, we examined the retinal phenotype in WBS
      patients and its functional relation to global motion perception. We discovered a
      low-level visual phenotype characterized by decreased retinal thickness, abnormal
      optic disk concavity, and impaired visual responses in WBS patients compared with
      age-matched controls by using electrophysiology, confocal and coherence in vivo
      imaging with cellular resolution, and psychophysics. These mechanisms of
      impairment are related to the magnocellular pathway, which is involved in the
      detection of temporal changes in the visual scene. Low-level magnocellular
      performance did not predict high-level deficits in the integration of motion and 
      3D information at higher levels, thereby demonstrating independent mechanisms of 
      dysfunction in WBS that will require remediation strategies different from those 
      used in other visuospatial disorders. These findings challenge neurodevelopmental
      theories that explain cortical deficits based on low-level magnocellular
      impairment, such as regarding dyslexia.
FAU - Castelo-Branco, Miguel
AU  - Castelo-Branco M
AD  - Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal.
      CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children’s Hospital,
      Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra,
      Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital
      Universitari Vall d’Hebron, Barcelona, Spain. Centre for Hereditary Eye Diseases,
      Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal.
FAU - Mendes, Mafalda
AU  - Mendes M
AD  - Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal.
      CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children’s Hospital,
      Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra,
      Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital
      Universitari Vall d’Hebron, Barcelona, Spain. Centre for Hereditary Eye Diseases,
      Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal.
FAU - Sebastião, Ana Raquel
AU  - Sebastião AR
AD  - Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal.
      CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children’s Hospital,
      Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra,
      Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital
      Universitari Vall d’Hebron, Barcelona, Spain. Centre for Hereditary Eye Diseases,
      Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal.
FAU - Reis, Aldina
AU  - Reis A
AD  - Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal.
      CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children’s Hospital,
      Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra,
      Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital
      Universitari Vall d’Hebron, Barcelona, Spain. Centre for Hereditary Eye Diseases,
      Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal.
FAU - Soares, Mário
AU  - Soares M
AD  - Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal.
      CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children’s Hospital,
      Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra,
      Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital
      Universitari Vall d’Hebron, Barcelona, Spain. Centre for Hereditary Eye Diseases,
      Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal.
FAU - Saraiva, Jorge
AU  - Saraiva J
AD  - Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal.
      CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children’s Hospital,
      Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra,
      Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital
      Universitari Vall d’Hebron, Barcelona, Spain. Centre for Hereditary Eye Diseases,
      Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal.
FAU - Bernardes, Rui
AU  - Bernardes R
AD  - Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal.
      CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children’s Hospital,
      Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra,
      Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital
      Universitari Vall d’Hebron, Barcelona, Spain. Centre for Hereditary Eye Diseases,
      Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal.
FAU - Flores, Raquel
AU  - Flores R
AD  - Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal.
      CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children’s Hospital,
      Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra,
      Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital
      Universitari Vall d’Hebron, Barcelona, Spain. Centre for Hereditary Eye Diseases,
      Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal.
FAU - Pérez-Jurado, Luis
AU  - Pérez-Jurado L
AD  - Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal.
      CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children’s Hospital,
      Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra,
      Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital
      Universitari Vall d’Hebron, Barcelona, Spain. Centre for Hereditary Eye Diseases,
      Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal.
FAU - Silva, Eduardo
AU  - Silva E
AD  - Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal.
      CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children’s Hospital,
      Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra,
      Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital
      Universitari Vall d’Hebron, Barcelona, Spain. Centre for Hereditary Eye Diseases,
      Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal.
LA  - eng
PT  - Journal Article
DEP - 20071121
PHST- 2007/05/01 [received]
PHST- 2007/09/19 [accepted]
TA  - J Clin Invest
JT  - The Journal of Clinical Investigation
AID - 32556 [pii]
AID - 10.1172/JCI32556 [doi]
SO  - J Clin Invest. 2007 Dec 3;117(12):3720-9. Epub 2007 Nov 21 doi:10.1172/JCI32556.

PMC - PMC4652844
PMID- 26436490
IS  - 1053-8119 (Print)
IS  - 1095-9572 (Electronic)
VI  - 124
IP  - 0 0
DP  - 2016 Jan 1
TI  - Robust decoding of selective auditory attention from MEG in a competing-speaker
      environment via state-space modeling✩.
PG  - 906-17
AB  - The underlying mechanism of how the human brain solves the cocktail party problem
      is largely unknown. Recent neuroimaging studies, however, suggest salient
      temporal correlations between the auditory neural response and the attended
      auditory object. Using magnetoencephalography (MEG) recordings of the neural
      responses of human subjects, we propose a decoding approach for tracking the
      attentional state while subjects are selectively listening to one of the two
      speech streams embedded in a competing-speaker environment. We develop a
      biophysically-inspired state-space model to account for the modulation of the
      neural response with respect to the attentional state of the listener. The
      constructed decoder is based on a maximum a posteriori (MAP) estimate of the
      state parameters via the Expectation Maximization (EM) algorithm. Using only the 
      envelope of the two speech streams as covariates, the proposed decoder enables us
      to track the attentional state of the listener with a temporal resolution of the 
      order of seconds, together with statistical confidence intervals. We evaluate the
      performance of the proposed model using numerical simulations and experimentally 
      measured evoked MEG responses from the human brain. Our analysis reveals
      considerable performance gains provided by the state-space model in terms of
      temporal resolution, computational complexity and decoding accuracy.
FAU - Akram, Sahar
AU  - Akram S
AD  - Department of Electrical and Computer Engineering, University of Maryland,
      College Park, MD 20742, USA
FAU - Presacco, Alessandro
AU  - Presacco A
AD  - Department of Hearing and Speech Science, University of Maryland, College Park MD
      20742, USA
FAU - Simon, Jonathan Z.
AU  - Simon JZ
AD  - Department of Electrical and Computer Engineering, University of Maryland,
      College Park, MD 20742, USA
FAU - Shamma, Shihab A.
AU  - Shamma SA
AD  - Department of Electrical and Computer Engineering, University of Maryland,
      College Park, MD 20742, USA
FAU - Babadi, Behtash
AU  - Babadi B
AD  - Department of Electrical and Computer Engineering, University of Maryland,
      College Park, MD 20742, USA
LA  - eng
PT  - Journal Article
DEP - 20151004
TA  - Neuroimage
JT  - NeuroImage
AID - 10.1016/j.neuroimage.2015.09.048 [doi]
MID - NIHMS733658
SO  - Neuroimage. 2016 Jan 1;124(0 0):906-17. Epub 2015 Oct 4
      doi:10.1016/j.neuroimage.2015.09.048.

PMC - PMC4698241
PMID- 26541886
IS  - 1350-9462 (Print)
IS  - 1873-1635 (Electronic)
VI  - 50
DP  - 2016 Jan
TI  - Lutein, Zeaxanthin, and meso-Zeaxanthin: The Basic and Clinical Science
      Underlying Carotenoid-based Nutritional Interventions against Ocular Disease.
PG  - 34-66
AB  - The human macula uniquely concentrates three carotenoids: lutein, zeaxanthin, and
      meso-zeaxanthin. Lutein and zeaxanthin must be obtained from dietary sources such
      as green leafy vegetables and orange and yellow fruits and vegetables, while
      meso-zeaxanthin is rarely found in diet and is believed to be formed at the
      macula by metabolic transformations of ingested carotenoids. Epidemiological
      studies and large-scale clinical trials such as AREDS2 have brought attention to 
      the potential ocular health and functional benefits of these three xanthophyll
      carotenoids consumed through the diet or supplements, but the basic science and
      clinical research underlying recommendations for nutritional interventions
      against age-related macular degeneration and other eye diseases are
      underappreciated by clinicians and vision researchers alike. In this review
      article, we first examine the chemistry, biophysics, and physiology of these
      yellow pigments that are specifically concentrated in the macula lutea through
      the means of high-affinity binding proteins and specialized transport and
      metabolic proteins where they play important roles as short-wavelength (blue)
      light-absorbers and localized, efficient antioxidants in a region at high risk
      for light-induced oxidative stress. Next, we turn to clinical evidence supporting
      functional benefits of these carotenoids in normal eyes and for their potential
      protective actions against ocular disease from infancy to old age.
FAU - Bernstein, Paul S.
AU  - Bernstein PS
AD  - Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of 
      Utah School of Medicine, 65 Mario Capecchi Drive, Salt Lake City, Utah, 84132,
      USA
FAU - Li, Binxing
AU  - Li B
AD  - Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of 
      Utah School of Medicine, 65 Mario Capecchi Drive, Salt Lake City, Utah, 84132,
      USA
FAU - Vachali, Preejith P.
AU  - Vachali PP
AD  - Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of 
      Utah School of Medicine, 65 Mario Capecchi Drive, Salt Lake City, Utah, 84132,
      USA
FAU - Gorusupudi, Aruna
AU  - Gorusupudi A
AD  - Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of 
      Utah School of Medicine, 65 Mario Capecchi Drive, Salt Lake City, Utah, 84132,
      USA
FAU - Shyam, Rajalekshmy
AU  - Shyam R
AD  - Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of 
      Utah School of Medicine, 65 Mario Capecchi Drive, Salt Lake City, Utah, 84132,
      USA
FAU - Henriksen, Bradley S.
AU  - Henriksen BS
AD  - Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of 
      Utah School of Medicine, 65 Mario Capecchi Drive, Salt Lake City, Utah, 84132,
      USA
FAU - Nolan, John M.
AU  - Nolan JM
AD  - Macular Pigment Research Group, Vision Research Centre, Carriganore House,
      Waterford Institute of Technology, West Campus, Carriganore, Waterford, Ireland
LA  - eng
PT  - Journal Article
DEP - 20151102
TA  - Prog Retin Eye Res
JT  - Progress in retinal and eye research
AID - 10.1016/j.preteyeres.2015.10.003 [doi]
MID - NIHMS735886
SO  - Prog Retin Eye Res. 2016 Jan;50:34-66. Epub 2015 Nov 02
      doi:10.1016/j.preteyeres.2015.10.003.

PMC - PMC3498928
PMID- 23155479
IS  - 2045-2322 (Electronic)
VI  - 2
DP  - 2012
TI  - Neural Correlates of Lyrical Improvisation: An fMRI Study of Freestyle Rap.
LID - 834
AB  - The neural correlates of creativity are poorly understood. Freestyle rap provides
      a unique opportunity to study spontaneous lyrical improvisation, a
      multidimensional form of creativity at the interface of music and language. Here 
      we use functional magnetic resonance imaging to characterize this process. Task
      contrast analyses indicate that improvised performance is characterized by
      dissociated activity in medial and dorsolateral prefrontal cortices, providing a 
      context in which stimulus-independent behaviors may unfold in the absence of
      conscious monitoring and volitional control. Connectivity analyses reveal
      widespread improvisation-related correlations between medial prefrontal,
      cingulate motor, perisylvian cortices and amygdala, suggesting the emergence of a
      network linking motivation, language, affect and movement. Lyrical improvisation 
      appears to be characterized by altered relationships between regions coupling
      intention and action, in which conventional executive control may be bypassed and
      motor control directed by cingulate motor mechanisms. These functional
      reorganizations may facilitate the initial improvisatory phase of creative
      behavior.
FAU - Liu, Siyuan
AU  - Liu S
AD  - National Institute on Deafness and Other Communication Disorders, National
      Institutes of Health
FAU - Chow, Ho Ming
AU  - Chow HM
AD  - National Institute on Deafness and Other Communication Disorders, National
      Institutes of Health
FAU - Xu, Yisheng
AU  - Xu Y
AD  - National Institute on Deafness and Other Communication Disorders, National
      Institutes of Health
FAU - Erkkinen, Michael G.
AU  - Erkkinen MG
AD  - National Institute on Deafness and Other Communication Disorders, National
      Institutes of Health
FAU - Swett, Katherine E.
AU  - Swett KE
AD  - National Institute on Deafness and Other Communication Disorders, National
      Institutes of Health
FAU - Eagle, Michael W.
AU  - Eagle MW
AD  - Justice by Uniting Creative Energy
FAU - Rizik-Baer, Daniel A.
AU  - Rizik-Baer DA
AD  - Justice by Uniting Creative Energy
FAU - Braun, Allen R.
AU  - Braun AR
AD  - National Institute on Deafness and Other Communication Disorders, National
      Institutes of Health
LA  - eng
PT  - Journal Article
DEP - 20121115
PHST- 2012/06/20 [received]
PHST- 2012/10/19 [accepted]
TA  - Sci Rep
JT  - Scientific Reports
AID - srep00834 [pii]
AID - 10.1038/srep00834 [doi]
SO  - Sci Rep. 2012 Nov 15;2:. doi:10.1038/srep00834.

PMC - PMC5134626
PMID- 27886087
IS  - 1424-8220 (Electronic)
VI  - 16
IP  - 11
DP  - 2016 Nov
TI  - State of the Art, Trends and Future of Bluetooth Low Energy, Near Field
      Communication and Visible Light Communication in the Development of Smart Cities.
LID - 1968
AB  - The current social impact of new technologies has produced major changes in all
      areas of society, creating the concept of a smart city supported by an electronic
      infrastructure, telecommunications and information technology. This paper
      presents a review of Bluetooth Low Energy (BLE), Near Field Communication (NFC)
      and Visible Light Communication (VLC) and their use and influence within
      different areas of the development of the smart city. The document also presents 
      a review of Big Data Solutions for the management of information and the
      extraction of knowledge in an environment where things are connected by an
      “Internet of Things” (IoT) network. Lastly, we present how these technologies can
      be combined together to benefit the development of the smart city.
FAU - Cerruela García, Gonzalo
AU  - Cerruela García G
FAU - Luque Ruiz, Irene
AU  - Luque Ruiz I
FAU - Gómez-Nieto, Miguel Ángel
AU  - Gómez-Nieto MÁ
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20161123
PHST- 2016/08/06 [received]
PHST- 2016/11/14 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s16111968 [doi]
AID - sensors-16-01968 [pii]
SO  - Sensors (Basel). 2016 Nov 23;16(11):. doi:10.3390/s16111968.

PMC - PMC2386957
PMID- 18497872
IS  - 1687-5265 (Print)
IS  - 1687-5273 (Electronic)
VI  - 2008
DP  - 2008
TI  - Performance of a Self-Paced Brain Computer Interface on Data Contaminated with
      Eye-Movement Artifacts and on Data Recorded in a Subsequent Session.
LID - 749204
AB  - The performance of a specific self-paced BCI (SBCI) is investigated using two
      different datasets to determine its suitability for using online: (1) data
      contaminated with large-amplitude eye movements, and (2) data recorded in a
      session subsequent to the original sessions used to design the system. No part of
      the data was rejected in the subsequent session. Therefore, this dataset can be
      regarded as a “pseudo-online” test set. The SBCI under investigation uses
      features extracted from three specific neurological phenomena. Each of these
      neurological phenomena belongs to a different frequency band. Since many
      prominent artifacts are either of mostly low-frequency (e.g., eye movements) or
      mostly high-frequency nature (e.g., muscle movements), it is expected that the
      system shows a fairly robust performance over artifact-contaminated data.
      Analysis of the data of four participants using epochs contaminated with
      large-amplitude eye-movement artifacts shows that the system's performance
      deteriorates only slightly. Furthermore, the system's performance during the
      session subsequent to the original sessions remained largely the same as in the
      original sessions for three out of the four participants. This moderate drop in
      performance can be considered tolerable, since allowing artifact-contaminated
      data to be used as inputs makes the system available for users at ALL times.
FAU - Fatourechi, Mehrdad
AU  - Fatourechi M
AD  - Image and Signal Processing Laboratory, Department of Electrical and Computer
      Engineering, University of British Columbia, Vancouver, BC, Canada V6T 1Z4
FAU - Ward, Rabab K.
AU  - Ward RK
AD  - Image and Signal Processing Laboratory, Department of Electrical and Computer
      Engineering, University of British Columbia, Vancouver, BC, Canada V6T 1Z4
FAU - Birch, Gary E.
AU  - Birch GE
AD  - Image and Signal Processing Laboratory, Department of Electrical and Computer
      Engineering, University of British Columbia, Vancouver, BC, Canada V6T 1Z4
LA  - eng
PT  - Journal Article
DEP - 20080511
PHST- 2007/08/07 [received]
PHST- 2007/12/20 [revised]
PHST- 2008/02/27 [accepted]
PHST- 2008/05/11 [aheadofprint]
TA  - Comput Intell Neurosci
JT  - Computational Intelligence and Neuroscience
AID - 10.1155/2008/749204 [doi]
SO  - Comput Intell Neurosci. 2008;2008:. Epub 2008 May 11 doi:10.1155/2008/749204.

PMC - PMC4287730
PMID- 25620918
IS  - 1662-5137 (Electronic)
VI  - 8
DP  - 2014
TI  - Control of humanoid robot via motion-onset visual evoked potentials.
LID - 247
AB  - This paper investigates controlling humanoid robot behavior via motion-onset
      specific N200 potentials. In this study, N200 potentials are induced by moving a 
      blue bar through robot images intuitively representing robot behaviors to be
      controlled with mind. We present the individual impact of each subject on N200
      potentials and discuss how to deal with individuality to obtain a high accuracy. 
      The study results document the off-line average accuracy of 93% for hitting
      targets across over five subjects, so we use this major component of the
      motion-onset visual evoked potential (mVEP) to code people's mental activities
      and to perform two types of on-line operation tasks: navigating a humanoid robot 
      in an office environment with an obstacle and picking-up an object. We discuss
      the factors that affect the on-line control success rate and the total time for
      completing an on-line operation task.
FAU - Li, Wei
AU  - Li W
AD  - Department of Computer and Electrical Engineering and Computer Science,
      California State UniversityBakersfield, CA, USA
FAU - Li, Mengfan
AU  - Li M
AD  - School of Electrical Engineering and Automation, Tianjin UniversityTianjin, China
FAU - Zhao, Jing
AU  - Zhao J
AD  - School of Electrical Engineering and Automation, Tianjin UniversityTianjin, China
LA  - eng
PT  - Journal Article
DEP - 20150109
PHST- 2014/10/25 [received]
PHST- 2014/12/17 [accepted]
TA  - Front Syst Neurosci
JT  - Frontiers in Systems Neuroscience
AID - 10.3389/fnsys.2014.00247 [doi]
SO  - Front Syst Neurosci. 2015 Jan 09;8:. doi:10.3389/fnsys.2014.00247.

PMC - PMC4869785
PMID- 27274252
IS  - 1176-6328 (Print)
IS  - 1178-2021 (Electronic)
VI  - 12
DP  - 2016
TI  - Clinical usefulness of hemoencephalography beyond the neurofeedback.
PG  - 1173-80
AB  - Aim: Hemoencephalography (HEG) is an emerging procedure for clinical application 
      in attention-deficit hyperactivity disorder and other disorders, regardless of
      age. It is available to any research group for its relative simplicity and low
      cost and is a useful tool for assessing prefrontal-dependent functions. Older
      teenagers pose peculiarities in the prefrontal maturation, and we aim to
      establish HEG patterns that might have clinical applicability. Methods: The HEG
      patterns of 70 university students (56 women and 14 men, 21–48 years old, mean
      31.84, SD 10.65, standard error of mean 0.31) were compared with those of 59
      adolescents – 13–14-year-old secondary education students, 28 females and 31
      males. The HEG patterns were obtained in response to the observation of shocking,
      unpleasant, and pleasant pictures. We use one-way and two-way analysis of
      variance to disentangle the differences between groups. All effects were analyzed
      with F-tests. Results: In all cases, university students and adolescents showed a
      decrease in prefrontal activity, indicative of differences in the emotional inner
      networks between groups, which are responsible for security–insecurity
      processing. Compared with university students, adolescents showed statistically
      significant differences in decreased activity in very unpleasant (shocking) tests
      that demand increased security–insecurity processing. Adolescents showed lower
      decrease. In addition, adolescents, compared with university subjects, did not
      show statistically significantly decreased HEG activity compared with the
      baseline in very unpleasant tests. Conclusion: Teens showed distinguishable
      patterns of HEG, which were consistent with the cognitive emotional dysregulation
      in cognition and emotion interaction, that is, exterior network versus internal
      network interactions. Disability in regulation (modulation) of emotional response
      to negative emotional stimuli (fear of insecurity) in adolescence is an indicator
      of possible future clinical and psychiatric disorders such as depression and
      anxiety with high incidence of onset at this critical age and frequent
      comorbidity in attention-deficit hyperactivity disorder. HEG pattern might be a
      useful marker to define maturation and future possible mental dysfunctions.
FAU - Serra-Sala, Mireia
AU  - Serra-Sala M
AD  - Fundació Carme Vidal NeuroPsicoPedagogia, Spain
FAU - Timoneda-Gallart, Carme
AU  - Timoneda-Gallart C
AD  - Fundació Carme Vidal NeuroPsicoPedagogia, Spain
FAU - Pérez-Álvarez, Frederic
AU  - Pérez-Álvarez F
AD  - Fundació Carme Vidal NeuroPsicoPedagogia, Spain
LA  - eng
PT  - Journal Article
DEP - 20160511
TA  - Neuropsychiatr Dis Treat
JT  - Neuropsychiatric Disease and Treatment
AID - 10.2147/NDT.S105476 [doi]
AID - ndt-12-1173 [pii]
SO  - Neuropsychiatr Dis Treat. 2016 May 11;12:1173-80. doi:10.2147/NDT.S105476.

PMC - PMC3314673
PMID- 22470483
IS  - 1932-6203 (Electronic)
VI  - 7
IP  - 3
DP  - 2012
TI  - The Feasibility and Impact of Delivering a Mind-Body Intervention in a Virtual
      World.
LID - e33843
AB  - Introduction: Mind-body medical approaches may ameliorate chronic disease. Stress
      reduction is particularly helpful, but face-to-face delivery systems cannot reach
      all those who might benefit. An online, 3-dimensional virtual world may be able
      to support the rich interpersonal interactions required of this approach. In this
      pilot study, we explore the feasibility of translating a face-to-face stress
      reduction program into an online virtual setting and estimate the effect size of 
      the intervention. Methods and Findings: Domain experts in virtual world
      technology joined with mind body practitioners to translate an existing 8 week
      relaxation response-based resiliency program into an 8-week virtual world-based
      program in Second Life™ (SL). Twenty-four healthy volunteers with at least one
      month's experience in SL completed the program. Each subject filled out the
      Perceived Stress Scale (PSS) and the Symptom Checklist 90- Revised (SCL-90-R)
      before and after taking part. Participants took part in one of 3 groups of about 
      10 subjects. The participants found the program to be helpful and enjoyable. Many
      reported that the virtual environment was an excellent substitute for the
      preferred face-to-face approach. On quantitative measures, there was a general
      trend toward decreased perceived stress, (15.7 to 15.0), symptoms of depression, 
      (57.6 to 57.0) and anxiety (56.8 to 54.8). There was a significant decrease of
      2.8 points on the SCL-90-R Global Severity Index (p<0.05). Conclusions: This
      pilot project showed that it is feasible to deliver a typical mind-body medical
      intervention through a virtual environment and that it is well received.
      Moreover, the small reduction in psychological distress suggests further research
      is warranted. Based on the data collected for this project, a randomized trial
      with less than 50 subjects would be appropriately powered if perceived stress is 
      the primary outcome.
FAU - Hoch, Daniel B.
AU  - Hoch DB
AD  - The Benson-Henry Institute for Mind Body Medicine, Boston, Massachusetts, United 
      States of America
FAU - Watson, Alice J.
AU  - Watson AJ
AD  - Dermatology, Massachusetts General Hospital, Boston, Massachusetts, United States
      of America
FAU - Linton, Deborah A.
AU  - Linton DA
AD  - Health 2.0, San Francisco, California, United States of America
FAU - Bello, Heather E.
AU  - Bello HE
AD  - Harvard School of Public Health, Massachusetts, United States of America
FAU - Senelly, Marco
AU  - Senelly M
AD  - OneVision Solutions Inc., Austin, Texas, United States of America
FAU - Milik, Mariola T.
AU  - Milik MT
AD  - The Benson-Henry Institute for Mind Body Medicine, Boston, Massachusetts, United 
      States of America
FAU - Baim, Margaret A.
AU  - Baim MA
AD  - The Benson-Henry Institute for Mind Body Medicine, Boston, Massachusetts, United 
      States of America
FAU - Jethwani, Kamal
AU  - Jethwani K
AD  - Center for Connected Health, Partners Healthcare, Boston, Massachusetts, United
      States of America
FAU - Fricchione, Gregory L.
AU  - Fricchione GL
AD  - The Benson-Henry Institute for Mind Body Medicine, Boston, Massachusetts, United 
      States of America
FAU - Benson, Herbert
AU  - Benson H
AD  - The Benson-Henry Institute for Mind Body Medicine, Boston, Massachusetts, United 
      States of America
FAU - Kvedar, Joseph C.
AU  - Kvedar JC
AD  - Center for Connected Health, Partners Healthcare, Boston, Massachusetts, United
      States of America
LA  - eng
PT  - Journal Article
DEP - 20120328
PHST- 2011/06/30 [received]
PHST- 2012/02/17 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-11-11891 [pii]
AID - 10.1371/journal.pone.0033843 [doi]
SO  - PLoS One. 2012 Mar 28;7(3):. doi:10.1371/journal.pone.0033843.

PMC - PMC4806294
PMID- 27034849
IS  - 2090-5904 (Print)
IS  - 1687-5443 (Electronic)
VI  - 2016
DP  - 2016
TI  - A Dietary Treatment Improves Cerebral Blood Flow and Brain Connectivity in Aging 
      apoE4 Mice.
LID - 6846721
AB  - APOE ε4 (apoE4) polymorphism is the main genetic determinant of sporadic
      Alzheimer's disease (AD). A dietary approach (Fortasyn) including docosahexaenoic
      acid, eicosapentaenoic acid, uridine, choline, phospholipids, folic acid,
      vitamins B12, B6, C, and E, and selenium has been proposed for dietary management
      of AD. We hypothesize that the diet could inhibit AD-like pathologies in apoE4
      mice, specifically cerebrovascular and connectivity impairment. Moreover, we
      evaluated the diet effect on cerebral blood flow (CBF), functional connectivity
      (FC), gray/white matter integrity, and postsynaptic density in aging apoE4 mice. 
      At 10–12 months, apoE4 mice did not display prominent pathological differences
      compared to wild-type (WT) mice. However, 16–18-month-old apoE4 mice revealed
      reduced CBF and accelerated synaptic loss. The diet increased cortical CBF and
      amount of synapses and improved white matter integrity and FC in both aging apoE4
      and WT mice. We demonstrated that protective mechanisms on vascular and synapse
      health are enhanced by Fortasyn, independent of apoE genotype. We further showed 
      the efficacy of a multimodal translational approach, including advanced MR
      neuroimaging, to study dietary intervention on brain structure and function in
      aging.
FAU - Wiesmann, Maximilian
AU  - Wiesmann M
AD  - Department of Anatomy, Donders Institute for Brain, Cognition & Behaviour,
      Radboud University Medical Center, 6525 EZ Nijmegen, Netherlands
FAU - Zerbi, Valerio
AU  - Zerbi V
AD  - Department of Anatomy, Donders Institute for Brain, Cognition & Behaviour,
      Radboud University Medical Center, 6525 EZ Nijmegen, Netherlands
FAU - Jansen, Diane
AU  - Jansen D
AD  - Department of Anatomy, Donders Institute for Brain, Cognition & Behaviour,
      Radboud University Medical Center, 6525 EZ Nijmegen, Netherlands
FAU - Haast, Roy
AU  - Haast R
AD  - Department of Anatomy, Donders Institute for Brain, Cognition & Behaviour,
      Radboud University Medical Center, 6525 EZ Nijmegen, Netherlands
FAU - Lütjohann, Dieter
AU  - Lütjohann D
AD  - Institute for Clinical Chemistry and Clinical Pharmacology, University of Bonn,
      Bonn, Germany
FAU - Broersen, Laus M.
AU  - Broersen LM
AD  - Nutricia Research, Advanced Medical Nutrition, Utrecht, Netherlands
FAU - Heerschap, Arend
AU  - Heerschap A
AD  - Department of Radiology and Nuclear Medicine, Radboud University Medical Center, 
      6525 EZ Nijmegen, Netherlands
FAU - Kiliaan, Amanda J.
AU  - Kiliaan AJ
AUID- ORCID: 0000-0002-2158-6210
AD  - Department of Anatomy, Donders Institute for Brain, Cognition & Behaviour,
      Radboud University Medical Center, 6525 EZ Nijmegen, Netherlands
LA  - eng
PT  - Journal Article
DEP - 20160310
PHST- 2016/01/08 [received]
PHST- 2016/02/22 [accepted]
PHST- 2016/03/10 [aheadofprint]
TA  - Neural Plast
JT  - Neural Plasticity
AID - 10.1155/2016/6846721 [doi]
SO  - Neural Plast. 2016;2016:. Epub 2016 Mar 10 doi:10.1155/2016/6846721.

PMC - PMC5087009
PMID- 27791017
IS  - 0027-8424 (Print)
IS  - 1091-6490 (Electronic)
VI  - 113
IP  - 43
DP  - 2016 Oct 25
TI  - Functional connectivity with the retrosplenial cortex predicts cognitive aging in
      rats.
PG  - 12286-91
AB  - Neural network dynamics thought to play a key role in cognition are substantially
      disrupted in both normal and pathological aging. Using a rat model, here we aimed
      to define the effects of aging on the integrity of cortical resting state
      functional connectivity distinct from the potential contribution of
      neurodegenerative disease. The findings highlight that disrupted circuit
      connectivity with the retrosplenial/posterior cingulate cortex is coupled with
      variability in memory function during aging, and that adaptive plasticity in the 
      aged brain appears to contribute to successful cognitive aging. The development
      of interventions that promote neuroadaptive network plasticity is a potentially
      valuable alternative to strategies currently under investigation, toward bending 
      the trajectory of aging away from neurodegeneration.
OAB - Publisher: Abstract available from the publisher.
FAU - Ash, Jessica A.
AU  - Ash JA
AD  - Laboratory of Behavioral Neuroscience, National Institute on Aging, Biomedical
      Research Center, National Institutes of Health (NIH), Baltimore, MD 21224;
FAU - Lu, Hanbing
AU  - Lu H
AD  - Neuroimaging Research Branch, National Institute on Drug Abuse, Biomedical
      Research Center, NIH, Baltimore, MD 21224
FAU - Taxier, Lisa R.
AU  - Taxier LR
AD  - Laboratory of Behavioral Neuroscience, National Institute on Aging, Biomedical
      Research Center, National Institutes of Health (NIH), Baltimore, MD 21224;
FAU - Long, Jeffrey M.
AU  - Long JM
AD  - Laboratory of Behavioral Neuroscience, National Institute on Aging, Biomedical
      Research Center, National Institutes of Health (NIH), Baltimore, MD 21224;
FAU - Yang, Yihong
AU  - Yang Y
AD  - Neuroimaging Research Branch, National Institute on Drug Abuse, Biomedical
      Research Center, NIH, Baltimore, MD 21224
FAU - Stein, Elliot A.
AU  - Stein EA
AD  - Neuroimaging Research Branch, National Institute on Drug Abuse, Biomedical
      Research Center, NIH, Baltimore, MD 21224
FAU - Rapp, Peter R.
AU  - Rapp PR
AD  - Laboratory of Behavioral Neuroscience, National Institute on Aging, Biomedical
      Research Center, National Institutes of Health (NIH), Baltimore, MD 21224;
LA  - eng
PT  - Journal Article
DEP - 20161010
GR  - 000000000
PHST- 2016/10/10 [aheadofprint]
TA  - Proc Natl Acad Sci U S A
JT  - Proceedings of the National Academy of Sciences of the United States of America
AID - 201525309 [pii]
AID - 10.1073/pnas.1525309113 [doi]
SO  - Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12286-91. Epub 2016 Oct 10
      doi:10.1073/pnas.1525309113.

PMC - PMC3707231
PMID- 23864962
IS  - 2090-5904 (Print)
IS  - 1687-5443 (Electronic)
VI  - 2013
DP  - 2013
TI  - Noninvasive Strategies to Promote Functional Recovery after Stroke.
LID - 854597
AB  - Stroke is a common and disabling global health-care problem, which is the third
      most common cause of death and one of the main causes of acquired adult
      disability in many countries. Rehabilitation interventions are a major component 
      of patient care. In the last few years, brain stimulation, mirror therapy, action
      observation, or mental practice with motor imagery has emerged as interesting
      options as add-on interventions to standard physical therapies. The neural bases 
      for poststroke recovery rely on the concept of plasticity, namely, the ability of
      central nervous system cells to modify their structure and function in response
      to external stimuli. In this review, we will discuss recent noninvasive
      strategies employed to enhance functional recovery in stroke patients and we will
      provide an overview of neural plastic events associated with rehabilitation in
      preclinical models of stroke.
FAU - Faralli, Alessio
AU  - Faralli A
AUID- ORCID: 0000-0002-9487-1530
AD  - Department of Neuroscience, Neuroscience Institute of Turin, University of Turin,
      Regione Gonzole 10, 10043 Orbassano (Turin), Italy
FAU - Bigoni, Matteo
AU  - Bigoni M
AUID- ORCID: 0000-0001-5902-657X
AD  - IRCCS Istituto Auxologico Italiano, Corso Goffredo Mameli 197, 28921 Verbania,
      Italy
FAU - Mauro, Alessandro
AU  - Mauro A
AD  - IRCCS Istituto Auxologico Italiano, Corso Goffredo Mameli 197, 28921 Verbania,
      Italy
FAU - Rossi, Ferdinando
AU  - Rossi F
AD  - Department of Neuroscience, Neuroscience Institute of Turin, University of Turin,
      Regione Gonzole 10, 10043 Orbassano (Turin), Italy
FAU - Carulli, Daniela
AU  - Carulli D
AD  - Department of Neuroscience, Neuroscience Institute of Turin, University of Turin,
      Regione Gonzole 10, 10043 Orbassano (Turin), Italy
LA  - eng
PT  - Journal Article
DEP - 20130624
PHST- 2013/04/05 [received]
PHST- 2013/06/02 [accepted]
PHST- 2013/06/24 [aheadofprint]
TA  - Neural Plast
JT  - Neural Plasticity
AID - 10.1155/2013/854597 [doi]
SO  - Neural Plast. 2013;2013:. Epub 2013 Jun 24 doi:10.1155/2013/854597.

PMC - PMC4668058
PMID- 26630392
IS  - 1932-6203 (Electronic)
VI  - 10
IP  - 12
DP  - 2015
TI  - "Rate My Therapist": Automated Detection of Empathy in Drug and Alcohol
      Counseling via Speech and Language Processing.
LID - e0143055
AB  - The technology for evaluating patient-provider interactions in
      psychotherapy–observational coding–has not changed in 70 years. It is
      labor-intensive, error prone, and expensive, limiting its use in evaluating
      psychotherapy in the real world. Engineering solutions from speech and language
      processing provide new methods for the automatic evaluation of provider ratings
      from session recordings. The primary data are 200 Motivational Interviewing (MI) 
      sessions from a study on MI training methods with observer ratings of counselor
      empathy. Automatic Speech Recognition (ASR) was used to transcribe sessions, and 
      the resulting words were used in a text-based predictive model of empathy. Two
      supporting datasets trained the speech processing tasks including ASR (1200
      transcripts from heterogeneous psychotherapy sessions and 153 transcripts and
      session recordings from 5 MI clinical trials). The accuracy of
      computationally-derived empathy ratings were evaluated against human ratings for 
      each provider. Computationally-derived empathy scores and classifications (high
      vs. low) were highly accurate against human-based codes and classifications, with
      a correlation of 0.65 and F-score (a weighted average of sensitivity and
      specificity) of 0.86, respectively. Empathy prediction using human transcription 
      as input (as opposed to ASR) resulted in a slight increase in prediction
      accuracies, suggesting that the fully automatic system with ASR is relatively
      robust. Using speech and language processing methods, it is possible to generate 
      accurate predictions of provider performance in psychotherapy from audio
      recordings alone. This technology can support large-scale evaluation of
      psychotherapy for dissemination and process studies.
FAU - Xiao, Bo
AU  - Xiao B
AD  - Department of Electrical Engineering, University of Southern California, Los
      Angeles, United States of America
FAU - Imel, Zac E.
AU  - Imel ZE
AD  - Department of Educational Psychology, University of Utah, Salt Lake City, United 
      States of America
FAU - Georgiou, Panayiotis G.
AU  - Georgiou PG
AD  - Department of Electrical Engineering, University of Southern California, Los
      Angeles, United States of America
FAU - Atkins, David C.
AU  - Atkins DC
AD  - Department of Psychiatry and Behavioral Sciences, University of Washington,
      Seattle, United States of America
FAU - Narayanan, Shrikanth S.
AU  - Narayanan SS
AD  - Department of Electrical Engineering, University of Southern California, Los
      Angeles, United States of America
LA  - eng
PT  - Journal Article
DEP - 20151202
PHST- 2015/02/04 [received]
PHST- 2015/10/30 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - 10.1371/journal.pone.0143055 [doi]
AID - PONE-D-15-02488 [pii]
SO  - PLoS One. 2015 Dec 2;10(12):. doi:10.1371/journal.pone.0143055.

PMC - PMC4111503
PMID- 17301336
IS  - 1084-7138 (Print)
IS  - 1940-5588 (Electronic)
VI  - 11
IP  - 1
DP  - 2007 Mar
DP  - 2007 Mar
TI  - The Future of Hearing Aid Technology.
PG  - 31-45
AB  - Hearing aids have advanced significantly over the past decade, primarily due to
      the maturing of digital technology. The next decade should see an even greater
      number of innovations to hearing aid technology, and this article attempts to
      predict in which areas the new developments will occur. Both incremental and
      radical innovations in digital hearing aids will be driven by research advances
      in the following fields: (1) wireless technology, (2) digital chip technology,
      (3) hearing science, and (4) cognitive science. The opportunities and limitations
      for each of these areas will be discussed. Additionally, emerging trends such as 
      connectivity and individualization will also drive new technology, and these are 
      discussed within the context of the areas given here.
FAU - Edwards, Brent
AU  - Edwards B
AD  - From Starkey Hearing Research Center, Berkeley, California.
LA  - eng
PT  - Journal Article
TA  - Trends Amplif
JT  - Trends in Amplification
AID - 10.1177/1084713806298004 [doi]
AID - 10.1177_1084713806298004 [pii]
SO  - Trends Amplif. 2007 Mar;11(1):31-45. doi:10.1177/1084713806298004.

PMC - PMC3318209
PMID- 22536230
IS  - 1687-7063 (Print)
IS  - 1687-7071 (Electronic)
VI  - 2012
DP  - 2012
TI  - Gerontechnology: Providing a Helping Hand When Caring for Cognitively Impaired
      Older Adults—Intermediate Results from a Controlled Study on the Satisfaction and
      Acceptance of Informal Caregivers.
LID - 401705
AB  - The incidence of cognitive impairment in older age is increasing, as is the
      number of cognitively impaired older adults living in their own homes. Due to
      lack of social care resources for these adults and their desires to remain in
      their own homes and live as independently as possible, research shows that the
      current standard care provisions are inadequate. Promising opportunities exist in
      using home assistive technology services to foster healthy aging and to realize
      the unmet needs of these groups of citizens in a user-centered manner. ISISEMD
      project has designed, implemented, verified, and assessed an assistive technology
      platform of personalized home care (telecare) for the elderly with cognitive
      impairments and their caregivers by offering intelligent home support services.
      Regions from four European countries have carried out long-term pilot-controlled 
      study in real-life conditions. This paper presents the outcomes from intermediate
      evaluations pertaining to user satisfaction with the system, acceptance of the
      technology and the services, and quality of life outcomes as a result of
      utilizing the services.
FAU - Mitseva, Anelia
AU  - Mitseva A
AD  - North Denmark EU-Office, Aalborg Municipality, Boulevarden 13, 9000 Aalborg,
      Denmark
FAU - Peterson, Carrie Beth
AU  - Peterson CB
AD  - Center for TeleInFrastruktur (CTiF), Aalborg University, Niels Jernes Vej 12,
      9220 Aalborg, Denmark
FAU - Karamberi, Christina
AU  - Karamberi C
AD  - Municipal Enterprise for Social Development (DEKA) of Trikala, European Projects 
      Department, Valkanou 6, 42100 Trikala, Greece
FAU - Oikonomou, Lamprini Ch.
AU  - Oikonomou LC
AD  - Municipal Enterprise for Social Development (DEKA) of Trikala, European Projects 
      Department, Valkanou 6, 42100 Trikala, Greece
FAU - Ballis, Athanasios V.
AU  - Ballis AV
AD  - e-Trikala SA, e-Health Department and R&D Department, Street Sarafi 44, 42100
      Trikala, Greece
FAU - Giannakakos, Charalampos
AU  - Giannakakos C
AD  - Hellenic Statistical Authority, Census Department, Piraeus 46 & Eponiton, 18510
      Piraeus, Greece
FAU - Dafoulas, George E.
AU  - Dafoulas GE
AD  - e-Trikala SA, e-Health Department and R&D Department, Street Sarafi 44, 42100
      Trikala, Greece
LA  - eng
PT  - Journal Article
DEP - 20120322
PHST- 2011/05/31 [received]
PHST- 2011/11/05 [revised]
PHST- 2011/11/17 [accepted]
PHST- 2012/03/22 [aheadofprint]
TA  - Curr Gerontol Geriatr Res
JT  - Current Gerontology and Geriatrics Research
AID - 10.1155/2012/401705 [doi]
SO  - Curr Gerontol Geriatr Res. 2012;2012:. Epub 2012 Mar 22 doi:10.1155/2012/401705.

PMC - PMC3872730
PMID- 24421765
IS  - 1662-5161 (Electronic)
VI  - 7
DP  - 2013
TI  - Neural substrates of cognitive control under the belief of getting neurofeedback 
      training.
LID - 914
AB  - Learning to modulate one's own brain activity is the fundament of neurofeedback
      (NF) applications. Besides the neural networks directly involved in the
      generation and modulation of the neurophysiological parameter being specifically 
      trained, more general determinants of NF efficacy such as self-referential
      processes and cognitive control have been frequently disregarded. Nonetheless,
      deeper insight into these cognitive mechanisms and their neuronal underpinnings
      sheds light on various open NF related questions concerning individual
      differences, brain-computer interface (BCI) illiteracy as well as a more general 
      model of NF learning. In this context, we investigated the neuronal substrate of 
      these more general regulatory mechanisms that are engaged when participants
      believe that they are receiving NF. Twenty healthy participants (40–63 years, 10 
      female) performed a sham NF paradigm during fMRI scanning. All participants were 
      novices to NF-experiments and were instructed to voluntarily modulate their own
      brain activity based on a visual display of moving color bars. However, the bar
      depicted a recording and not the actual brain activity of participants. Reports
      collected at the end of the experiment indicate that participants were unaware of
      the sham feedback. In comparison to a passive watching condition, bilateral
      insula, anterior cingulate cortex and supplementary motor and dorsomedial and
      lateral prefrontal areas were activated when participants actively tried to
      control the bar. In contrast, when merely watching moving bars, increased
      activation in the left angular gyrus was observed. These results show that the
      intention to control a moving bar is sufficient to engage a broad frontoparietal 
      and cingulo-opercular network involved in cognitive control. The results of the
      present study indicate that tasks such as those generally employed in NF training
      recruit the neuronal correlates of cognitive control even when only sham NF is
      presented.
FAU - Ninaus, Manuel
AU  - Ninaus M
AD  - Department of Psychology, University of GrazGraz, Austria
FAU - Kober, Silvia E.
AU  - Kober SE
AD  - Department of Psychology, University of GrazGraz, Austria
FAU - Witte, Matthias
AU  - Witte M
AD  - Department of Psychology, University of GrazGraz, Austria
FAU - Koschutnig, Karl
AU  - Koschutnig K
AD  - Department of Psychology, University of GrazGraz, Austria
FAU - Stangl, Matthias
AU  - Stangl M
AD  - Aging and Cognition Research Group, German Center for Neurodegenerative Diseases 
      (DZNE)Magdeburg, Germany
FAU - Neuper, Christa
AU  - Neuper C
AD  - Department of Psychology, University of GrazGraz, Austria
FAU - Wood, Guilherme
AU  - Wood G
AD  - Department of Psychology, University of GrazGraz, Austria
LA  - eng
PT  - Journal Article
DEP - 20131226
PHST- 2013/05/09 [received]
PHST- 2013/12/13 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2013.00914 [doi]
SO  - Front Hum Neurosci. 2013 Dec 26;7:. doi:10.3389/fnhum.2013.00914.

PMC - PMC5480568
PMID- 28663853
IS  - 2156-7085 (Electronic)
VI  - 8
IP  - 3
DP  - 2017 Mar 01
TI  - Review of intraoperative optical coherence tomography: technology and
      applications [Invited].
PG  - 1607-37
AB  - During microsurgery, en face imaging of the surgical field through the operating 
      microscope limits the surgeon’s depth perception and visualization of instruments
      and sub-surface anatomy. Surgical procedures outside microsurgery, such as breast
      tumor resections, may also benefit from visualization of the sub-surface tissue
      structures. The widespread clinical adoption of optical coherence tomography
      (OCT) in ophthalmology and its growing prominence in other fields, such as cancer
      imaging, has motivated the development of intraoperative OCT for real-time
      tomographic visualization of surgical interventions. This article reviews key
      technological developments in intraoperative OCT and their applications in human 
      surgery. We focus on handheld OCT probes, microscope-integrated OCT systems, and 
      OCT-guided laser treatment platforms designed for intraoperative use. Moreover,
      we discuss intraoperative OCT adjuncts and processing techniques currently under 
      development to optimize the surgical feedback derivable from OCT data. Lastly, we
      survey salient clinical studies of intraoperative OCT for human surgery.
FAU - Carrasco-Zevallos, Oscar M.
AU  - Carrasco-Zevallos OM
AD  - Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA
FAU - Viehland, Christian
AU  - Viehland C
AD  - Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA
FAU - Keller, Brenton
AU  - Keller B
AD  - Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA
FAU - Draelos, Mark
AU  - Draelos M
AD  - Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA
FAU - Kuo, Anthony N.
AU  - Kuo AN
AD  - Department of Ophthalmology, Duke University Medical Center, NC 27710, USA
FAU - Toth, Cynthia A.
AU  - Toth CA
AD  - Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA
FAU - Izatt, Joseph A.
AU  - Izatt JA
AD  - Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA
LA  - eng
PT  - Journal Article
DEP - 20170221
GR  - R01-EY023039
PHST- 2016/11/30 [received]
PHST- 2017/02/09 [revised]
PHST- 2017/02/09 [accepted]
TA  - Biomed Opt Express
JT  - Biomedical Optics Express
AID - 281779 [pii]
AID - 10.1364/BOE.8.001607 [doi]
SO  - Biomed Opt Express. 2017 Feb 21;8(3):1607-37. doi:10.1364/BOE.8.001607.

PMC - PMC4024977
PMID- 24872704
IS  - 1176-9114 (Print)
IS  - 1178-2013 (Electronic)
VI  - 9
IP  - Suppl 1
DP  - 2014
TI  - Novel interfaces for light directed neuronal stimulation: advances and
      challenges.
PG  - 65-83
AB  - Light activation of neurons is a growing field with applications ranging from
      basic investigation of neuronal systems to the development of new therapeutic
      methods such as artificial retina. Many recent studies currently explore novel
      methods for optical stimulation with temporal and spatial precision. Novel
      materials in particular provide an opportunity to enhance contemporary
      approaches. Here we review recent advances towards light directed interfaces for 
      neuronal stimulation, focusing on state-of-the-art nanoengineered devices. In
      particular, we highlight challenges and prospects towards improved retinal
      prostheses.
FAU - Bareket-Keren, Lilach
AU  - Bareket-Keren L
AD  - School of Electrical Engineering, Tel-Aviv University, Tel-Aviv University,
      Tel-Aviv, Israel
FAU - Hanein, Yael
AU  - Hanein Y
AD  - School of Electrical Engineering, Tel-Aviv University, Tel-Aviv University,
      Tel-Aviv, Israel
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20140506
TA  - Int J Nanomedicine
JT  - International Journal of Nanomedicine
AID - 10.2147/IJN.S51193 [doi]
AID - ijn-9-065 [pii]
SO  - Int J Nanomedicine. 2014 May 06;9(Suppl 1):65-83. doi:10.2147/IJN.S51193.

PMC - PMC3376604
PMID- 22737008
IS  - 1424-8220 (Electronic)
VI  - 12
IP  - 3
DP  - 2012
TI  - Consolidation of a WSN and Minimax Method to Rapidly Neutralise Intruders in
      Strategic Installations.
PG  - 3281-301
AB  - Due to the sensitive international situation caused by still-recent terrorist
      attacks, there is a common need to protect the safety of large spaces such as
      government buildings, airports and power stations. To address this problem,
      developments in several research fields, such as video and cognitive audio,
      decision support systems, human interface, computer architecture, communications 
      networks and communications security, should be integrated with the goal of
      achieving advanced security systems capable of checking all of the specified
      requirements and spanning the gap that presently exists in the current market.
      This paper describes the implementation of a decision system for crisis
      management in infrastructural building security. Specifically, it describes the
      implementation of a decision system in the management of building intrusions. The
      positions of the unidentified persons are reported with the help of a Wireless
      Sensor Network (WSN). The goal is to achieve an intelligent system capable of
      making the best decision in real time in order to quickly neutralise one or more 
      intruders who threaten strategic installations. It is assumed that the intruders’
      behaviour is inferred through sequences of sensors’ activations and their fusion.
      This article presents a general approach to selecting the optimum operation from 
      the available neutralisation strategies based on a Minimax algorithm. The
      distances among different scenario elements will be used to measure the risk of
      the scene, so a path planning technique will be integrated in order to attain a
      good performance. Different actions to be executed over the elements of the scene
      such as moving a guard, blocking a door or turning on an alarm will be used to
      neutralise the crisis. This set of actions executed to stop the crisis is known
      as the neutralisation strategy. Finally, the system has been tested in
      simulations of real situations, and the results have been evaluated according to 
      the final state of the intruders. In 86.5% of the cases, the system achieved the 
      capture of the intruders, and in 59.25% of the cases, they were intercepted
      before they reached their objective.
FAU - Conesa-Muñoz, Jesus
AU  - Conesa-Muñoz J
FAU - Ribeiro, Angela
AU  - Ribeiro A
LA  - eng
PT  - Journal Article
DEP - 20120307
PHST- 2012/02/02 [received]
PHST- 2012/03/03 [revised]
PHST- 2012/03/04 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s120303281 [doi]
AID - sensors-12-03281 [pii]
SO  - Sensors (Basel). 2012 Mar 7;12(3):3281-301. doi:10.3390/s120303281.

PMC - PMC4653846
PMID- 26584856
IS  - 1471-2458 (Electronic)
VI  - 15
DP  - 2015
TI  - Evaluation of sit-stand workstations in an office setting: a randomised
      controlled trial.
LID - 1145
AB  - Background: Excessive sitting time is a risk factor for cardiovascular disease
      mortality and morbidity independent of physical activity. This aim of this study 
      was to evaluate the impact of a sit-stand workstation on sitting time, and
      vascular, metabolic and musculoskeletal outcomes in office workers, and to
      investigate workstation acceptability and feasibility. Methods: A two-arm,
      parallel-group, individually randomised controlled trial was conducted in one
      organisation. Participants were asymptomatic full-time office workers aged
      ≥18 years. Each participant in the intervention arm had a sit-stand workstation
      installed on their workplace desk for 8 weeks. Participants in the control arm
      received no intervention. The primary outcome was workplace sitting time,
      assessed at 0, 4 and 8 weeks by an ecological momentary assessment diary.
      Secondary behavioural, cardiometabolic and musculoskeletal outcomes were
      assessed. Acceptability and feasibility were assessed via questionnaire and
      interview. ANCOVA and magnitude-based inferences examined intervention effects
      relative to controls at 4 and 8 weeks. Participants and researchers were not
      blind to group allocation. Results: Forty-seven participants were randomised
      (intervention n = 26; control n = 21). Relative to the control group at 8 weeks, 
      the intervention group had a beneficial decrease in sitting time (−80.2 min/8-h
      workday (95 % CI = −129.0, −31.4); p = 0.002), increase in standing time
      (72.9 min/8-h workday (21.2, 124.6); p = 0.007) and decrease in total cholesterol
      (−0.40 mmol/L  (−0.79, −0.003); p = 0.049). No harmful changes in musculoskeletal
      discomfort/pain were observed relative to controls, and beneficial changes in
      flow-mediated dilation and diastolic blood pressure were observed. Most
      participants self-reported that the workstation was easy to use and their
      work-related productivity did not decrease when using the device. Factors that
      negatively influenced workstation use were workstation design, the social
      environment, work tasks and habits. Conclusion: Short-term use of a feasible
      sit-stand workstation reduced daily sitting time and led to beneficial
      improvements in cardiometabolic risk parameters in asymptomatic office workers.
      These findings imply that if the observed use of the sit-stand workstations
      continued over a longer duration, sit-stand workstations may have important
      ramifications for the prevention and reduction of cardiometabolic risk in a large
      proportion of the working population. Trial registration: ClinicalTrials.gov
      NCT02496507.
FAU - E. F. Graves, Lee
AU  - E. F. Graves L
AD  - Research Institute for Sport and Exercise Science, Liverpool John Moores
      University, Liverpool, UK
FAU - C. Murphy, Rebecca
AU  - C. Murphy R
AD  - Research Institute for Sport and Exercise Science, Liverpool John Moores
      University, Liverpool, UK
FAU - Shepherd, Sam O.
AU  - Shepherd SO
AD  - Research Institute for Sport and Exercise Science, Liverpool John Moores
      University, Liverpool, UK
FAU - Cabot, Josephine
AU  - Cabot J
AD  - Research Institute for Sport and Exercise Science, Liverpool John Moores
      University, Liverpool, UK
FAU - Hopkins, Nicola D.
AU  - Hopkins ND
AD  - Research Institute for Sport and Exercise Science, Liverpool John Moores
      University, Liverpool, UK
LA  - eng
PT  - Journal Article
DEP - 20151119
PHST- 2015/06/23 [received]
PHST- 2015/11/03 [accepted]
TA  - BMC Public Health
JT  - BMC Public Health
AID - 2469 [pii]
AID - 10.1186/s12889-015-2469-8 [doi]
SO  - BMC Public Health. 2015 Nov 19;15:. doi:10.1186/s12889-015-2469-8.

PMC - PMC3049630
PMID- 20559765
IS  - 0009-921X (Print)
IS  - 1528-1132 (Electronic)
VI  - 468
IP  - 10
DP  - 2010 Oct
TI  - Virtual Reality in Orthopaedics: Is It a Reality?
PG  - 2586-91
AB  - Background: Virtual reality (VR) simulation has been a requirement for airline
      and military pilots for decades and is only now being integrated into surgical
      training programs. Thus far, orthopaedic training programs have been slow to
      adopt VR training. Questions/purposes: We therefore asked (1) how VR has worked
      for other surgical specialties; (2) what VR solutions are available for
      orthopaedics; and (3) should VR simulation become part of the orthopaedic
      curriculum? Methods: An informal literature review was performed, searching for
      orthopaedically-oriented VR surgical simulators and comparing this to the number 
      of programs available for general surgery teaching programs. An in-depth review
      of a VR simulator for knee arthroscopy is also presented. Where are we now?The
      number of papers specific to orthopaedics and VR is limited. VR is used
      effectively in other specialties, especially general surgery. VR simulators are
      readily available for shoulder and knee arthroscopy but not as well incorporated 
      into training curricula. Where do we need to go?VR technology is available today 
      for training programs. Integration of VR into the orthopaedic curriculum will
      save time in the OR, reduce operative errors, and improve the resident’s overall 
      educational experience. The public will expect their surgeons to train on these
      simulators. How do we get there?Orthopaedic training programs should take
      advantage of the commercially available VR simulators for orthopaedic procedures 
      and incorporate them into their training curricula. This effort could be led by
      the American Academy of Orthopaedic Surgeons (AAOS) and the American Board of
      Orthopaedic Surgery (ABOS), two of the primary sponsors of a major study in the
      effectiveness of VR simulators for knee arthroscopy.
FAU - Mabrey, Jay D.
AU  - Mabrey JD
AD  - Department of Orthopaedics, Baylor University Medical Center, 3500 Gaston Ave., 6
      Hoblitzelle, Dallas, TX 75246 USA
FAU - Reinig, Karl D.
AU  - Reinig KD
AD  - Touch of Life Technologies, Aurora, CO USA
FAU - Cannon, W. Dilworth
AU  - Cannon WD
AD  - Department of Orthopaedics, University of California, San Francisco, CA USA
LA  - eng
PT  - Journal Article
DEP - 20100618
TA  - Clin Orthop Relat Res
JT  - Clinical Orthopaedics and Related Research
AID - 1426 [pii]
AID - 10.1007/s11999-010-1426-1 [doi]
SO  - Clin Orthop Relat Res. 2010 Oct;468(10):2586-91. Epub 2010 Jun 18
      doi:10.1007/s11999-010-1426-1.

PMC - PMC5405923
PMID- 28445527
IS  - 1932-6203 (Electronic)
VI  - 12
IP  - 4
DP  - 2017
TI  - Enhanced functional connectivity and volume between cognitive and reward centers 
      of naïve rodent brain produced by pro-dopaminergic agent KB220Z.
LID - e0174774
AB  - Dopaminergic reward dysfunction in addictive behaviors is well supported in the
      literature. There is evidence that alterations in synchronous neural activity
      between brain regions subserving reward and various cognitive functions may
      significantly contribute to substance-related disorders. This study presents the 
      first evidence showing that a pro-dopaminergic nutraceutical (KB220Z)
      significantly enhances, above placebo, functional connectivity between reward and
      cognitive brain areas in the rat. These include the nucleus accumbens, anterior
      cingulate gyrus, anterior thalamic nuclei, hippocampus, prelimbic and infralimbic
      loci. Significant functional connectivity, increased brain connectivity volume
      recruitment (potentially neuroplasticity), and dopaminergic functionality were
      found across the brain reward circuitry. Increases in functional connectivity
      were specific to these regions and were not broadly distributed across the brain.
      While these initial findings have been observed in drug naïve rodents, this
      robust, yet selective response implies clinical relevance for addicted
      individuals at risk for relapse, who show reductions in functional connectivity
      after protracted withdrawal. Future studies will evaluate KB220Z in animal models
      of addiction.
FAU - Febo, Marcelo
AU  - Febo M
AD  - Department of Psychiatry & McKnight Brain Institute, University of Florida
      College of Medicine, Gainesville, Florida, United States of America
FAU - Blum, Kenneth
AU  - Blum K
AUID- ORCID: 0000-0001-6727-803X
AD  - Department of Psychiatry & McKnight Brain Institute, University of Florida
      College of Medicine, Gainesville, Florida, United States of America
FAU - Badgaiyan, Rajendra D.
AU  - Badgaiyan RD
AD  - Department of Psychiatry, Wright State University, Boonshoft School of Medicine, 
      Dayton, Ohio, United States of America
FAU - Perez, Pablo D.
AU  - Perez PD
AD  - Department of Psychiatry & McKnight Brain Institute, University of Florida
      College of Medicine, Gainesville, Florida, United States of America
FAU - Colon-Perez, Luis M.
AU  - Colon-Perez LM
AD  - Department of Psychiatry & McKnight Brain Institute, University of Florida
      College of Medicine, Gainesville, Florida, United States of America
FAU - Thanos, Panayotis K.
AU  - Thanos PK
AD  - Research Institute on Addictions, University at Buffalo, Buffalo, New York,
      United States of America
FAU - Ferris, Craig F.
AU  - Ferris CF
AD  - Center for Translational Neuroimaging, Department of Psychology and
      Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, United
      States of America
FAU - Kulkarni, Praveen
AU  - Kulkarni P
AD  - Center for Translational Neuroimaging, Department of Psychology and
      Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, United
      States of America
FAU - Giordano, John
AU  - Giordano J
AD  - Department of Holistic Medicine, National Institute for Holistic Addiction
      Studies, North Miami Beach, Florida, United States of America
FAU - Baron, David
AU  - Baron D
AD  - Department of Psychiatry, Keck Medicine University of Southern California, Los
      Angeles, California, United States of America
FAU - Gold, Mark S.
AU  - Gold MS
AD  - Department of Psychiatry & McKnight Brain Institute, University of Florida
      College of Medicine, Gainesville, Florida, United States of America
LA  - eng
PT  - Journal Article
DEP - 20170426
GR  - R01DA019946 and R21 DA038009.
PHST- 2016/02/01 [received]
PHST- 2017/03/15 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - 10.1371/journal.pone.0174774 [doi]
AID - PONE-D-16-04478 [pii]
SO  - PLoS One. 2017 Apr 26;12(4):. doi:10.1371/journal.pone.0174774.

PMC - PMC4707068
PMID- 26510407
IS  - 0301-0082 (Print)
IS  - 1873-5118 (Electronic)
VI  - 136
DP  - 2016 Jan
TI  - Animal models of gene-environment interaction in schizophrenia: a dimensional
      perspective.
PG  - 1-27
AB  - Schizophrenia has long been considered as a disorder with multifactorial origins.
      Recent discoveries have advanced our understanding of the genetic architecture of
      the disease. However, even with the increase of identified risk variants,
      heritability estimates suggest an important contribution of non-genetic factors. 
      Various environmental risk factors have been proposed to play a role in the
      etiopathogenesis of schizophrenia. These include season of birth, maternal
      infections, obstetric complications, adverse events at early childhood, and drug 
      abuse. Despite the progress in identification of genetic and environmental risk
      factors, we still have a limited understanding of the mechanisms whereby
      gene-environment interactions (GxE) operate in schizophrenia and psychoses at
      large. In this review we provide a critical analysis of current animal models of 
      GxE relevant to psychotic disorders and propose that dimensional perspective will
      advance our understanding of the complex mechanisms of these disorders.
FAU - Ayhan, Yavuz
AU  - Ayhan Y
AD  - Departmant of Psychiatry and Behavioral Sciences, Johns Hopkins University School
      of Medicine
FAU - McFarland, Ross
AU  - McFarland R
AD  - Departmant of Psychiatry and Behavioral Sciences, Johns Hopkins University School
      of Medicine
FAU - Pletnikov, Mikhail V.
AU  - Pletnikov MV
AD  - Departmant of Psychiatry and Behavioral Sciences, Johns Hopkins University School
      of Medicine
LA  - eng
PT  - Journal Article
DEP - 20151025
TA  - Prog Neurobiol
JT  - Progress in neurobiology
AID - 10.1016/j.pneurobio.2015.10.002 [doi]
MID - NIHMS741598
SO  - Prog Neurobiol. 2016 Jan;136:1-27. Epub 2015 Oct 25
      doi:10.1016/j.pneurobio.2015.10.002.

PMC - PMC3557763
PMID- 23190025
IS  - 0022-3042 (Print)
IS  - 1471-4159 (Electronic)
VI  - 124
IP  - 4
DP  - 2013 Feb
TI  - Neuromodulation: Selected approaches and challenges.
PG  - 436-53
AB  - The brain operates through complex interactions in the flow of information and
      signal processing within neural networks. The “wiring” of such networks, being
      neuronal or glial, can physically and/or functionally go rogue in various
      pathological states. Neuromodulation, as a multidisciplinary venture, attempts to
      correct such faulty nets. In this review, selected approaches and challenges in
      neuromoduation are discussed. The use of water-dispersible carbon nanotubes have 
      proven effective in modulation of neurite outgrowth in culture as well as in
      aiding regeneration after spinal cord injury in vivo. Studying neural circuits
      using computational biology and analytical engineering approaches brings to light
      geometrical mapping of dynamics within neural networks, much needed information
      for stimulation interventions in medical practice. Indeed, sophisticated
      desynchronization approaches used for brain stimulation have been successful in
      coaxing “misfiring” neuronal circuits to resume productive firing patterns in
      various human disorders. Devices have been developed for the real time
      measurement of various neurotransmitters as well as electrical activity in the
      human brain during electrical deep brain stimulation. Such devices can establish 
      the dynamics of electrochemical changes in the brain during stimulation. With
      increasing application of nanomaterials in devices for electrical and chemical
      recording and stimulating in the brain, the era of cellular, and even
      intracellular, precision neuromodulation will soon be upon us.
FAU - Parpura, Vladimir
AU  - Parpura V
AD  - Department of Neurobiology, Center for Glial Biology in Medicine, Atomic Force
      Microscopy and Nanotechnology Laboratories, Civitan International Research
      Center, Evelyn F. McKnight Brain Institute, University of Alabama, Birmingham,
      Alabama, USA
FAU - Silva, Gabriel A.
AU  - Silva GA
AD  - Department of Bioengineering, Department of Ophthalmology, and Neurosciences
      Program, University of California, San Diego, USA
FAU - Tass, Peter A.
AU  - Tass PA
AD  - Institute of Neuroscience and Medicine – Neuromodulation, Research Center Jülich,
      Jülich, Germany
FAU - Bennet, Kevin E.
AU  - Bennet KE
AD  - Divison of Engineering, Mayo Clinic Rochester, Rochester, MN, USA
FAU - Meyyappan, Meyya
AU  - Meyyappan M
AD  - Center for Nanotechnology, NASA Ames Research Center, Moffett Field, CA, USA
FAU - Koehne, Jessica
AU  - Koehne J
AD  - Center for Nanotechnology, NASA Ames Research Center, Moffett Field, CA, USA
FAU - Lee, Kendall H.
AU  - Lee KH
AD  - Department of Neurosurgery, Mayo Clinic Rochester, Rochester, MN, USA
FAU - Andrews, Russell J.
AU  - Andrews RJ
AD  - Center for Nanotechnology, NASA Ames Research Center, Moffett Field, CA, USA
LA  - eng
PT  - Journal Article
DEP - 20121226
GR  - R01 NS075013 || NS
TA  - J Neurochem
JT  - Journal of neurochemistry
AID - 10.1111/jnc.12105 [doi]
MID - NIHMS424668
SO  - J Neurochem. 2013 Feb;124(4):436-53. Epub 2012 Dec 26 doi:10.1111/jnc.12105.

PMC - PMC4759206
PMID- 25802982
IS  - 1359-4184 (Print)
IS  - 1476-5578 (Electronic)
VI  - 21
IP  - 3
DP  - 2016 Mar
TI  - Arc expression identifies the lateral amygdala fear memory trace.
PG  - 364-75
AB  - Memories are encoded within sparsely distributed neuronal ensembles. However, the
      defining cellular properties of neurons within a memory trace remain incompletely
      understood. Using a fluorescence-based Arc reporter, we were able to visually
      identify the distinct subset of lateral amygdala (LA) neurons activated during
      auditory fear conditioning. We found that Arc-expressing neurons have enhanced
      intrinsic excitability and are preferentially recruited into newly encoded memory
      traces. Furthermore, synaptic potentiation of thalamic inputs to the LA during
      fear conditioning is learning-specific, postsynaptically mediated and highly
      localized to Arc-expressing neurons. Taken together, our findings validate the
      immediate-early gene Arc as a molecular marker for the LA neuronal ensemble
      recruited during fear learning. Moreover, these results establish a model of fear
      memory formation in which intrinsic excitability determines neuronal selection,
      whereas learning-related encoding is governed by synaptic plasticity.
FAU - Gouty-Colomer, L A
AU  - Gouty-Colomer LA
AD  - Department of Psychiatry, Erasmus University Medical Center, Rotterdam, The
      Netherlands
FAU - Hosseini, B
AU  - Hosseini B
AD  - Department of Psychiatry, Erasmus University Medical Center, Rotterdam, The
      Netherlands
FAU - Marcelo, I M
AU  - Marcelo IM
AD  - Department of Psychiatry, Erasmus University Medical Center, Rotterdam, The
      Netherlands
FAU - Schreiber, J
AU  - Schreiber J
AD  - Department of Neuroscience, Erasmus Medical Centre, Rotterdam, The Netherlands
FAU - Slump, D E
AU  - Slump DE
AD  - Department of Psychiatry, Erasmus University Medical Center, Rotterdam, The
      Netherlands
FAU - Yamaguchi, S
AU  - Yamaguchi S
AD  - Division of Morphological Neuroscience, Gifu University Graduate School of
      Medicine, Gifu, Japan
FAU - Houweling, A R
AU  - Houweling AR
AD  - Department of Neuroscience, Erasmus Medical Centre, Rotterdam, The Netherlands
FAU - Jaarsma, D
AU  - Jaarsma D
AD  - Department of Neuroscience, Erasmus Medical Centre, Rotterdam, The Netherlands
FAU - Elgersma, Y
AU  - Elgersma Y
AD  - Department of Neuroscience, Erasmus Medical Centre, Rotterdam, The Netherlands
FAU - Kushner, S A
AU  - Kushner SA
AD  - Department of Psychiatry, Erasmus University Medical Center, Rotterdam, The
      Netherlands
LA  - eng
PT  - Journal Article
DEP - 20150324
PHST- 2014/07/28 [received]
PHST- 2014/11/28 [revised]
PHST- 2015/01/08 [accepted]
PHST- 2015/03/24 [aheadofprint]
TA  - Mol Psychiatry
JT  - Molecular Psychiatry
AID - mp201518 [pii]
AID - 10.1038/mp.2015.18 [doi]
SO  - Mol Psychiatry. 2016 Mar;21(3):364-75. Epub 2015 Mar 24 doi:10.1038/mp.2015.18.

PMC - PMC4292811
PMID- 25542201
IS  - 1743-0003 (Electronic)
VI  - 11
DP  - 2014
TI  - Training finger individuation with a mechatronic-virtual reality system leads to 
      improved fine motor control post-stroke.
LID - 171
AB  - Background: Dexterous manipulation of the hand, one of the features of human
      motor control, is often compromised after stroke, to the detriment of basic
      functions. Despite the importance of independent movement of the digits to
      activities of daily living, relatively few studies have assessed the impact of
      specifically targeting individuated movements of the digits on hand
      rehabilitation. The purpose of this study was to investigate the impact of such
      finger individuation training, by means of a novel mechatronic-virtual reality
      system, on fine motor control after stroke. Methods: An actuated virtual keypad
      (AVK) system was developed in which the impaired hand controls a virtual hand
      playing a set of keys. Creation of individuated digit movements is assisted by a 
      pneumatically actuated glove, the PneuGlove. A study examining efficacy of the
      AVK system was subsequently performed. Participants had chronic, moderate hand
      impairment resulting from a single stroke incurred at least 6 months prior. Each 
      subject underwent 18 hour-long sessions of extensive therapy (3x per week for
      6 weeks) targeted at finger individuation. Subjects were randomly divided into
      two groups: the first group (Keypad: N = 7) utilized the AVK system while the
      other group (OT: N = 7) received a similarly intensive dose of occupational
      therapy; both groups worked directly with a licensed occupational therapist.
      Outcome measures such as the Jebsen-Taylor Hand Function Test (JTHFT), Action
      research Arm Test (ARAT), Fugl-Meyer Upper Extremity Motor Assessment/Hand
      subcomponent (FMUE/FMH), grip and pinch strengths were collected at baseline,
      post-treatment and one-month post-treatment. Results: While both groups exhibited
      some signs of change after the training sessions, only the Keypad group displayed
      statistically significant improvement both for measures of impairment (FMH:
      p = 0.048) and measures of task performance (JTHFT: p = 0.021). Additionally, the
      finger individuation index – a measure of finger independence – improved only for
      the Keypad group after training (p = 0.05) in the subset (Keypad: N = 4; OT:
      N = 5) of these participants for which it was measured. Conclusions: Actively
      assisted individuation therapy comprised of non task-specific modalities, such as
      can be achieved with virtual platforms like the AVK described here, may prove to 
      be valuable clinical tools for increasing the effectiveness and efficiency of
      therapy following stroke. Electronic supplementary material: The online version
      of this article (doi:10.1186/1743-0003-11-171) contains supplementary material,
      which is available to authorized users.
FAU - Thielbar, Kelly O
AU  - Thielbar KO
AD  - Sensory Motor Performance Program, Rehabilitation Institute of Chicago, 345 E
      Superior Street,Suite 1406, Chicago, IL 60611 USA
FAU - Lord, Thomas J
AU  - Lord TJ
AD  - Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, 
      IL 60616 USA
FAU - Fischer, Heidi C
AU  - Fischer HC
AD  - Sensory Motor Performance Program, Rehabilitation Institute of Chicago, 345 E
      Superior Street,Suite 1406, Chicago, IL 60611 USA
FAU - Lazzaro, Emily C
AU  - Lazzaro EC
AD  - Sensory Motor Performance Program, Rehabilitation Institute of Chicago, 345 E
      Superior Street,Suite 1406, Chicago, IL 60611 USA
FAU - Barth, Kristin C
AU  - Barth KC
AD  - Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37235 
      USA
FAU - Stoykov, Mary E
AU  - Stoykov ME
AD  - Occupational Therapy College of Health Sciences, Rush University, Chicago, IL
      60612 USA
FAU - Triandafilou, Kristen M
AU  - Triandafilou KM
AD  - Sensory Motor Performance Program, Rehabilitation Institute of Chicago, 345 E
      Superior Street,Suite 1406, Chicago, IL 60611 USA
FAU - Kamper, Derek G
AU  - Kamper DG
AD  - Sensory Motor Performance Program, Rehabilitation Institute of Chicago, 345 E
      Superior Street,Suite 1406, Chicago, IL 60611 USA
LA  - eng
PT  - Journal Article
DEP - 20141226
PHST- 2014/07/03 [received]
PHST- 2014/12/05 [accepted]
TA  - J Neuroeng Rehabil
JT  - Journal of NeuroEngineering and Rehabilitation
AID - 690 [pii]
AID - 10.1186/1743-0003-11-171 [doi]
SO  - J Neuroeng Rehabil. 2014 Dec 26;11:. doi:10.1186/1743-0003-11-171.

PMC - PMC3390800
PMID- 22293983
IS  - 0271-678X (Print)
IS  - 1559-7016 (Electronic)
VI  - 32
IP  - 7
DP  - 2012 Jul
TI  - Two-photon microscopy as a tool to study blood flow and neurovascular coupling in
      the rodent brain.
PG  - 1277-309
AB  - The cerebral vascular system services the constant demand for energy during
      neuronal activity in the brain. Attempts to delineate the logic of neurovascular 
      coupling have been greatly aided by the advent of two-photon laser scanning
      microscopy to image both blood flow and the activity of individual cells below
      the surface of the brain. Here we provide a technical guide to imaging cerebral
      blood flow in rodents. We describe in detail the surgical procedures required to 
      generate cranial windows for optical access to the cortex of both rats and mice
      and the use of two-photon microscopy to accurately measure blood flow in
      individual cortical vessels concurrent with local cellular activity. We further
      provide examples on how these techniques can be applied to the study of local
      blood flow regulation and vascular pathologies such as small-scale stroke.
FAU - Shih, Andy Y
AU  - Shih AY
AD  - Department of Physics, University of California at San Diego, La Jolla,
      California, USA
FAU - Driscoll, Jonathan D
AU  - Driscoll JD
AD  - Department of Physics, University of California at San Diego, La Jolla,
      California, USA
FAU - Drew, Patrick J
AU  - Drew PJ
AD  - Department of Engineering Science and Mechanics, Pennsylvania State University,
      University Park, Pennsylvania, USA
FAU - Nishimura, Nozomi
AU  - Nishimura N
AD  - Department of Biomedical Engineering, Cornell University, Ithaca, New York, USA
FAU - Schaffer, Chris B
AU  - Schaffer CB
AD  - Department of Biomedical Engineering, Cornell University, Ithaca, New York, USA
FAU - Kleinfeld, David
AU  - Kleinfeld D
AD  - Department of Physics, University of California at San Diego, La Jolla,
      California, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20120201
PHST- 2011/06/23 [received]
PHST- 2011/10/18 [revised]
PHST- 2011/11/13 [accepted]
PHST- 2012/02/01 [aheadofprint]
TA  - J Cereb Blood Flow Metab
JT  - Journal of Cerebral Blood Flow & Metabolism
AID - jcbfm2011196 [pii]
AID - 10.1038/jcbfm.2011.196 [doi]
SO  - J Cereb Blood Flow Metab. 2012 Jul;32(7):1277-309. Epub 2012 Feb 01
      doi:10.1038/jcbfm.2011.196.

PMC - PMC3369738
PMID- 22778862
IS  - 1948-7193 (Print)
IS  - 1948-7193 (Electronic)
VI  - 2
IP  - 3
DP  - 2011 Mar 16
TI  - Superparamagnetic Iron Oxide Nanoparticles: Promises for Diagnosis and Treatment 
      of Multiple Sclerosis.
PG  - 118-40
AB  - Smart superparamagnetic iron oxide nanoparticles (SPIONs) are the most promising 
      candidate for theragnosis (i.e., diagnosis and treatment) of multiple sclerosis. 
      A deep understanding of the dynamics of the in vivo neuropathology of multiple
      sclerosis can be achieved by improving the efficiency of various medical
      techniques (e.g., positron emission tomography and magnetic resonance imaging)
      using multimodal SPIONs. In this Review, recent advances and challenges in the
      development of smart SPIONs for theragnostic applications are comprehensively
      described. In addition, critical outlines of emerging developments are provided
      from the points of view of both clinicians and nanotechnologists.
FAU - Mahmoudi, Morteza
AU  - Mahmoudi M
AD  - National Cell Bank, Pasteur Institute of Iran, Tehran, 11365-8639, Iran
FAU - Sahraian, Mohammad A.
AU  - Sahraian MA
AD  - Department of Neurology
FAU - Shokrgozar, Mohammad A.
AU  - Shokrgozar MA
AD  - National Cell Bank, Pasteur Institute of Iran, Tehran, 11365-8639, Iran
FAU - Laurent, Sophie
AU  - Laurent S
AD  - Department of General, Organic, and Biomedical Chemistry, NMR and Molecular
      Imaging Laboratory, University of Mons, Avenue Maistriau, 19, B-7000 Mons,
      Belgium
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20110204
PHST- 2010/11/03 [received]
PHST- 2010/12/08 [revised]
TA  - ACS Chem Neurosci
JT  - ACS Chemical Neuroscience
AID - 10.1021/cn100100e [doi]
SO  - ACS Chem Neurosci. 2011 Feb 04;2(3):118-40. doi:10.1021/cn100100e.

PMC - PMC4067954
PMID- 25009491
IS  - 1662-6443 (Electronic)
VI  - 7
DP  - 2014
TI  - Case report: post-stroke interventional BCI rehabilitation in an individual with 
      preexisting sensorineural disability.
LID - 18
AB  - Therapies involving new technologies such as brain-computer interfaces (BCI) are 
      being studied to determine their potential for interventional rehabilitation
      after acute events such as stroke produce lasting impairments. While studies have
      examined the use of BCI devices by individuals with disabilities, many such
      devices are intended to address a specific limitation and have been studied when 
      this limitation or disability is present in isolation. Little is known about the 
      therapeutic potential of these devices for individuals with multiple disabilities
      with an acquired impairment overlaid on a secondary long-standing disability. We 
      describe a case in which a male patient with congenital deafness suffered a right
      pontine ischemic stroke, resulting in persistent weakness of his left hand and
      arm. This patient volunteer completed four baseline assessments beginning at 4
      months after stroke onset and subsequently underwent 6 weeks of interventional
      rehabilitation therapy using a closed-loop neurofeedback BCI device with visual, 
      functional electrical stimulation, and tongue stimulation feedback modalities.
      Additional assessments were conducted at the midpoint of therapy, upon completion
      of therapy, and 1 month after completing all BCI therapy. Anatomical and
      functional MRI scans were obtained at each assessment, along with behavioral
      measures including the Stroke Impact Scale (SIS) and the Action Research Arm Test
      (ARAT). Clinically significant improvements in behavioral measures were noted
      over the course of BCI therapy, with more than 10 point gains in both the ARAT
      scores and scores for the SIS hand function domain. Neuroimaging during finger
      tapping of the impaired hand also showed changes in brain activation patterns
      associated with BCI therapy. This case study demonstrates the potential for
      individuals who have preexisting disability or possible atypical brain
      organization to learn to use a BCI system that may confer some rehabilitative
      benefit.
FAU - Young, Brittany M.
AU  - Young BM
AD  - Department of Radiology, University of Wisconsin-MadisonMadison, WI, USA
FAU - Nigogosyan, Zack
AU  - Nigogosyan Z
AD  - Department of Radiology, University of Wisconsin-MadisonMadison, WI, USA
FAU - Nair, Veena A.
AU  - Nair VA
AD  - Department of Radiology, University of Wisconsin-MadisonMadison, WI, USA
FAU - Walton, Léo M.
AU  - Walton LM
AD  - Department of Biomedical Engineering, University of Wisconsin-MadisonMadison, WI,
      USA
FAU - Song, Jie
AU  - Song J
AD  - Department of Radiology, University of Wisconsin-MadisonMadison, WI, USA
FAU - Tyler, Mitchell E.
AU  - Tyler ME
AD  - Department of Biomedical Engineering, University of Wisconsin-MadisonMadison, WI,
      USA
FAU - Edwards, Dorothy F.
AU  - Edwards DF
AD  - Departments of Kinesiology and Medicine, University of Wisconsin-MadisonMadison, 
      WI, USA
FAU - Caldera, Kristin
AU  - Caldera K
AD  - Department of Orthopedics and Rehabilitation, University of
      Wisconsin-MadisonMadison, WI, USA
FAU - Sattin, Justin A.
AU  - Sattin JA
AD  - Department of Neurology, University of Wisconsin-MadisonMadison, WI, USA
FAU - Williams, Justin C.
AU  - Williams JC
AD  - Neuroscience Training Program, University of Wisconsin-MadisonMadison, WI, USA
FAU - Prabhakaran, Vivek
AU  - Prabhakaran V
AD  - Department of Radiology, University of Wisconsin-MadisonMadison, WI, USA
LA  - eng
PT  - Journal Article
DEP - 20140624
PHST- 2014/03/07 [received]
PHST- 2014/06/03 [accepted]
TA  - Front Neuroeng
JT  - Frontiers in Neuroengineering
AID - 10.3389/fneng.2014.00018 [doi]
SO  - Front Neuroeng. 2014 Jun 24;7:. doi:10.3389/fneng.2014.00018.

PMC - PMC4193388
PMID- 25313266
IS  - 0278-3649 (Print)
IS  - 1741-3176 (Electronic)
VI  - 33
IP  - 4
DP  - 2014 Apr
TI  - Design, Development, and Evaluation of a Master-Slave Surgical System for Breast 
      Biopsy under Continuous MRI*.
PG  - 616-30
AB  - Magnetic Resonance Imaging (MRI) provides superior soft-tissue contrast in cancer
      diagnosis compared to other imaging modalities. However, the strong magnetic
      field inside the MRI bore along with limited scanner bore size poses significant 
      challenges. Since current approaches in breast biopsy using MR images is
      primarily a blind targeting approach, it is necessary to develop a MRI-compatible
      robot that can avoid multiple needle insertions into the breast tissue. This
      MRI-compatible robotic system could potentially lead to improvement in the
      targeting accuracy and reduce sampling errors. A master-slave surgical system has
      been developed comprising of a MRI-compatible slave robot which consists of one
      piezo motor and five pneumatic cylinders connected by long pneumatic transmission
      lines. The slave robot follows the configuration of the master robot, which
      provides an intuitive manipulation interface for the physician and operates
      inside the MRI bore to adjust the needle position and orientation and perform
      needle insertion task. Based on the MRI experiments using the slave robot, there 
      was no significant distortion in the images and hence the slave robot can be
      safely operated inside the MRI with minimal loss in signal-to-noise ratio (SNR). 
      Ex vivo and in vivo experiments have been conducted to evaluate the performance
      of the master-slave surgical system.
FAU - Yang, Bo
AU  - Yang B
AD  - Robotics, Automation, and Medical Systems (RAMS) Laboratory, Maryland Robotics
      Center, Institute for System Research, University of Maryland, College Park, MD, 
      USA
FAU - Roys, Steven
AU  - Roys S
AD  - University of Maryland School of Medicine, Baltimore, MD, USA
FAU - Tan, U-Xuan
AU  - Tan UX
AD  - Singapore University of Technology and Design, Singapore
FAU - Philip, Mathew
AU  - Philip M
AD  - University of Maryland School of Medicine, Baltimore, MD, USA
FAU - Richard, Howard
AU  - Richard H
AD  - University of Maryland School of Medicine, Baltimore, MD, USA
FAU - Gullapalli, Rao
AU  - Gullapalli R
AD  - University of Maryland School of Medicine, Baltimore, MD, USA
FAU - Desai, Jaydev P.
AU  - Desai JP
AD  - Robotics, Automation, and Medical Systems (RAMS) Laboratory, Maryland Robotics
      Center, Institute for System Research, University of Maryland, College Park, MD, 
      USA
LA  - eng
PT  - Journal Article
TA  - Int J Rob Res
JT  - The International journal of robotics research
AID - 10.1177/0278364913500365 [doi]
MID - NIHMS506189
SO  - Int J Rob Res. 2014 Apr;33(4):616-30. doi:10.1177/0278364913500365.

PMC - PMC3847909
PMID- 22036287
IS  - 1525-5050 (Print)
IS  - 1525-5069 (Electronic)
VI  - 22
IP  - 4
DP  - 2011 Dec
TI  - Proceedings of the Second International Workshop on Advances in
      Electrocorticography.
LID - 10.1016/j.yebeh.2011.09.028
AB  - The Second International Workshop on Advances in Electrocorticography (ECoG) was 
      convened in San Diego, CA, USA, on November 11–12, 2010. Between this meeting and
      the inaugural 2009 event, a much clearer picture has been emerging of cortical
      ECoG physiology and its relationship to local field potentials and single-cell
      recordings. Innovations in material engineering are advancing the goal of a
      stable long-term recording interface. Continued evolution of ECoG-driven
      brain–computer interface technology is determining innovation in
      neuroprosthetics. Improvements in instrumentation and statistical methodologies
      continue to elucidate ECoG correlates of normal human function as well as the
      ictal state. This proceedings document summarizes the current status of this
      rapidly evolving field.
FAU - Ritaccio, Anthony
AU  - Ritaccio A
AD  - Albany Medical College, Albany, NY, USA
FAU - Boatman-Reich, Dana
AU  - Boatman-Reich D
AD  - The Johns Hopkins Hospital, Baltimore, MD, USA
FAU - Brunner, Peter
AU  - Brunner P
AD  - Albany Medical College, Albany, NY, USA
FAU - Cervenka, Mackenzie C.
AU  - Cervenka MC
AD  - The Johns Hopkins Hospital, Baltimore, MD, USA
FAU - Cole, Andrew J.
AU  - Cole AJ
AD  - Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
FAU - Crone, Nathan
AU  - Crone N
AD  - The Johns Hopkins Hospital, Baltimore, MD, USA
FAU - Duckrow, Robert
AU  - Duckrow R
AD  - Yale University, New Haven, CT, USA
FAU - Korzeniewska, Anna
AU  - Korzeniewska A
AD  - The Johns Hopkins Hospital, Baltimore, MD, USA
FAU - Litt, Brian
AU  - Litt B
AD  - University of Pennsylvania, Pittsburgh, PA, USA
FAU - Miller, Kai J.
AU  - Miller KJ
AD  - Stanford University, Stanford, CA, USA
FAU - Moran, Daniel W.
AU  - Moran DW
AD  - Washington University, St. Louis, MO, USA
FAU - Parvizi, Josef
AU  - Parvizi J
AD  - Stanford University, Stanford, CA, USA
FAU - Viventi, Jonathan
AU  - Viventi J
AD  - Polytechnic Institute of New York University, Brooklyn, NY, USA
FAU - Williams, Justin
AU  - Williams J
AD  - University of Wisconsin—Madison, Madison, WI, USA
FAU - Schalk, Gerwin
AU  - Schalk G
AD  - Albany Medical College, Albany, NY, USA
LA  - eng
PT  - Journal Article
DEP - 20111028
GR  - K24 DC010028 || DC
TA  - Epilepsy Behav
JT  - Epilepsy & behavior : E&B
AID - 10.1016/j.yebeh.2011.09.028 [doi]
MID - NIHMS533993
SO  - Epilepsy Behav. 2011 Dec;22(4):. Epub 2011 Oct 28
      doi:10.1016/j.yebeh.2011.09.028.

PMC - PMC3637024
PMID- 22373830
IS  - 0946-1965 (Print)
VI  - 50
IP  - 3
DP  - 2012 Mar
TI  - Electroencephalogram-based pharmacodynamic measures: a review .
PG  - 162-84
AB  - Pharmacokinetics and pharmacodynamics can provide a useful modeling framework for
      predicting drug activity and can serve as a basis for dose optimization.
      Determining a suitable biomarker or surrogate measure of drug effect for
      pharmacodynamic models can be challenging. The electroencephalograph is a
      widely-available and non-invasive tool for recording brain-wave activity
      simultaneously from multiple brain regions. Certain drug classes (such as drugs
      that act on the central nervous system) also generate a reproducible
      electroencephalogram (EEG) effect. Characterization of such a drug-induced EEG
      effect can produce pharmacokinetic/pharmacodynamic models useful for titrating
      drug levels and expediting development of chemically-similar drug analogs. This
      paper reviews the relevant concepts involved in pharmacokinetic/pharmacodynamic
      modeling using EEG-based pharmacodynamic measures. In addition, examples of such 
      models for various drugs are organized by drug activity as well as chemical
      structure and presented.
FAU - Bewernitz, Michael
AU  - Bewernitz M
FAU - Derendorf, Hartmut
AU  - Derendorf H
LA  - eng
PT  - Journal Article
DEP - 20120203
PHST- 2010/07/19 [received]
PHST- 2011/10/24 [accepted]
PHST- 2012/02/03 [aheadofprint]
TA  - Int J Clin Pharmacol Ther
JT  - International Journal of Clinical Pharmacology and Therapeutics
AID - 10.5414/CP201484 [doi]
SO  - Int J Clin Pharmacol Ther. 2012 Mar;50(3):162-84. Epub 2012 Feb 3
      doi:10.5414/CP201484.

PMC - PMC4824539
PMID- 26577932
IS  - 0306-4522 (Print)
IS  - 1873-7544 (Electronic)
VI  - 321
DP  - 2016 May 3
TI  - The serotonin system in autism spectrum disorder: from biomarker to animal
      models.
PG  - 24-41
AB  - Elevated whole blood serotonin, or hyperserotonemia, was the first biomarker
      identified in autism spectrum disorder (ASD) and is present in more than 25% of
      affected children. The serotonin system is a logical candidate for involvement in
      ASD due to its pleiotropic role across multiple brain systems both dynamically
      and across development. Tantalizing clues connect this peripheral biomarker with 
      changes in brain and behavior in ASD, but the contribution of the serotonin
      system to ASD pathophysiology remains incompletely understood. Studies of whole
      blood serotonin levels in ASD and in a large founder population indicate greater 
      heritability than for the disorder itself and suggest an association with
      recurrence risk. Emerging data from both neuroimaging and postmortem samples also
      indicate changes in the brain serotonin system in ASD. Genetic linkage and
      association studies of both whole blood serotonin levels and of ASD risk point to
      the chromosomal region containing the serotonin transporter (SERT) gene in males 
      but not in females. In ASD families with evidence of linkage to this region,
      multiple rare SERT amino acid variants lead to a convergent increase in serotonin
      uptake in cell models. A knock-in mouse model of one of these variants, SERT
      Gly56Ala, recapitulates the hyperserotonemia biomarker and shows increased brain 
      serotonin clearance, increased serotonin receptor sensitivity, and altered
      social, communication, and repetitive behaviors. Data from other rodent models
      also suggest an important role for the serotonin system in social behavior, in
      cognitive flexibility, and in sensory development. Recent work indicates that
      reciprocal interactions between serotonin and other systems, such as oxytocin,
      may be particularly important for social behavior. Collectively, these data point
      to the serotonin system as a prime candidate for treatment development in a
      subgroup of children defined by a robust, heritable biomarker.
FAU - Muller, Christopher L.
AU  - Muller CL
AD  - Vanderbilt Brain Institute, Vanderbilt University, 465 21 Ave S, Nashville, TN,
      37232, USA
FAU - Anacker, Allison M.J.
AU  - Anacker AM
AD  - Department of Psychiatry, Columbia University, and New York State Psychiatric
      Institute, 1051 Riverside Drive, Mail Unit 78, New York, NY, 10032, USA
FAU - Veenstra-VanderWeele, Jeremy
AU  - Veenstra-VanderWeele J
AD  - Department of Psychiatry, Columbia University, and New York State Psychiatric
      Institute, 1051 Riverside Drive, Mail Unit 78, New York, NY, 10032, USA
LA  - eng
PT  - Journal Article
DEP - 20151111
TA  - Neuroscience
JT  - Neuroscience
AID - 10.1016/j.neuroscience.2015.11.010 [doi]
MID - NIHMS742578
SO  - Neuroscience. 2016 May 3;321:24-41. Epub 2015 Nov 11
      doi:10.1016/j.neuroscience.2015.11.010.

PMC - PMC4406552
PMID- 25902061
IS  - 1932-6203 (Electronic)
VI  - 10
IP  - 4
DP  - 2015
TI  - Hands-Free Image Capture, Data Tagging and Transfer Using Google Glass: A Pilot
      Study for Improved Wound Care Management.
LID - e0121179
AB  - Chronic wounds, including pressure ulcers, compromise the health of 6.5 million
      Americans and pose an annual estimated burden of $25 billion to the U.S. health
      care system. When treating chronic wounds, clinicians must use meticulous
      documentation to determine wound severity and to monitor healing progress over
      time. Yet, current wound documentation practices using digital photography are
      often cumbersome and labor intensive. The process of transferring photos into
      Electronic Medical Records (EMRs) requires many steps and can take several days. 
      Newer smartphone and tablet-based solutions, such as Epic Haiku, have reduced EMR
      upload time. However, issues still exist involving patient positioning,
      image-capture technique, and patient identification. In this paper, we present
      the development and assessment of the SnapCap System for chronic wound
      photography. Through leveraging the sensor capabilities of Google Glass, SnapCap 
      enables hands-free digital image capture, and the tagging and transfer of images 
      to a patient’s EMR. In a pilot study with wound care nurses at Stanford Hospital 
      (n=16), we (i) examined feature preferences for hands-free digital image capture 
      and documentation, and (ii) compared SnapCap to the state of the art in digital
      wound care photography, the Epic Haiku application. We used the Wilcoxon
      Signed-ranks test to evaluate differences in mean ranks between preference
      options. Preferred hands-free navigation features include barcode scanning for
      patient identification, Z(15) = -3.873, p < 0.001, r = 0.71, and double-blinking 
      to take photographs, Z(13) = -3.606, p < 0.001, r = 0.71. In the comparison
      between SnapCap and Epic Haiku, the SnapCap System was preferred for sterile
      image-capture technique, Z(16) = -3.873, p < 0.001, r = 0.68. Responses were
      divided with respect to image quality and overall ease of use. The study’s
      results have contributed to the future implementation of new features aimed at
      enhancing mobile hands-free digital photography for chronic wound care.
FAU - Aldaz, Gabriel
AU  - Aldaz G
AD  - Center for Design Research, Stanford University, Stanford, CA, United States of
      America
FAU - Shluzas, Lauren Aquino
AU  - Shluzas LA
AD  - Center for Design Research, Stanford University, Stanford, CA, United States of
      America
FAU - Pickham, David
AU  - Pickham D
AD  - Stanford Health Care, Stanford, CA, United States of America
FAU - Eris, Ozgur
AU  - Eris O
AD  - Delft University of Technology, Delft, The Netherlands
FAU - Sadler, Joel
AU  - Sadler J
AD  - Center for Design Research, Stanford University, Stanford, CA, United States of
      America
FAU - Joshi, Shantanu
AU  - Joshi S
AD  - Center for Design Research, Stanford University, Stanford, CA, United States of
      America
FAU - Leifer, Larry
AU  - Leifer L
AD  - Center for Design Research, Stanford University, Stanford, CA, United States of
      America
LA  - eng
PT  - Journal Article
DEP - 20150422
PHST- 2014/08/14 [received]
PHST- 2015/01/28 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - 10.1371/journal.pone.0121179 [doi]
AID - PONE-D-14-36746 [pii]
SO  - PLoS One. 2015 Apr 22;10(4):. doi:10.1371/journal.pone.0121179.

PMC - PMC5148213
PMID- 27957537
IS  - 2375-2548 (Electronic)
VI  - 2
IP  - 12
DP  - 2016 Dec
TI  - Implantable microcoils for intracortical magnetic stimulation.
LID - e1600889
AB  - Magnetic stimulation from cortically implantable microcoils can activate neuronal
      circuits with high selectivity and reliability.
OAB - Publisher: Abstract available from the publisher.
FAU - Lee, Seung Woo
AU  - Lee SW
AUID- ORCID: 0000-0003-4070-809X
AD  - Boston Veterans Affairs Healthcare System, Boston, MA 02130, USA.
FAU - Fallegger, Florian
AU  - Fallegger F
AUID- ORCID: 0000-0003-0626-5264
AD  - Palo Alto Research Center, a Xerox company, Palo Alto, CA 94304, USA.
FAU - Casse, Bernard D. F.
AU  - Casse BDF
AUID- ORCID: 0000-0001-7705-1082
AD  - Palo Alto Research Center, a Xerox company, Palo Alto, CA 94304, USA.
FAU - Fried, Shelley I.
AU  - Fried SI
AD  - Boston Veterans Affairs Healthcare System, Boston, MA 02130, USA.
LA  - eng
PT  - Journal Article
DEP - 20161209
GR  - ID0EWIAI12648
PHST- 2016/04/25 [received]
PHST- 2016/11/03 [accepted]
TA  - Sci Adv
JT  - Science Advances
AID - 1600889 [pii]
AID - 10.1126/sciadv.1600889 [doi]
SO  - Sci Adv. 2016 Dec 09;2(12):. doi:10.1126/sciadv.1600889.

PMC - PMC4193337
PMID- 25346683
IS  - 1662-6443 (Electronic)
VI  - 7
DP  - 2014
TI  - A CMOS IC-based multisite measuring system for stimulation and recording in
      neural preparations in vitro.
LID - 39
AB  - In this report, we describe the system integration of a complementary metal oxide
      semiconductor (CMOS) integrated circuit (IC) chip, capable of both stimulation
      and recording of neurons or neural tissues, to investigate electrical signal
      propagation within cellular networks in vitro. The overall system consisted of
      three major subunits: a 5.0 × 5.0 mm CMOS IC chip, a reconfigurable logic device 
      (field-programmable gate array, FPGA), and a PC. To test the system,
      microelectrode arrays (MEAs) were used to extracellularly measure the activity of
      cultured rat cortical neurons and mouse cortical slices. The MEA had 64
      bidirectional (stimulation and recording) electrodes. In addition, the CMOS IC
      chip was equipped with dedicated analog filters, amplification stages, and a
      stimulation buffer. Signals from the electrodes were sampled at 15.6 kHz with
      16-bit resolution. The measured input-referred circuitry noise was 10.1 μ V root 
      mean square (10 Hz to 100 kHz), which allowed reliable detection of neural
      signals ranging from several millivolts down to approximately 33 μ Vpp.
      Experiments were performed involving the stimulation of neurons with several
      spatiotemporal patterns and the recording of the triggered activity. An advantage
      over current MEAs, as demonstrated by our experiments, includes the ability to
      stimulate (voltage stimulation, 5-bit resolution) spatiotemporal patterns in
      arbitrary subsets of electrodes. Furthermore, the fast stimulation reset
      mechanism allowed us to record neuronal signals from a stimulating electrode
      around 3 ms after stimulation. We demonstrate that the system can be directly
      applied to, for example, auditory neural prostheses in conjunction with an
      acoustic sensor and a sound processing system.
FAU - Tateno, Takashi
AU  - Tateno T
AD  - Special Research Promotion Group, Graduate School of Frontier Biosciences, Osaka 
      UniversityOsaka, Japan
FAU - Nishikawa, Jun
AU  - Nishikawa J
AD  - Bioengineering and Bioinformatics, Graduate School of Information Science and
      Technology, Hokkaido UniversitySapporo, Japan
LA  - eng
PT  - Journal Article
DEP - 20141010
PHST- 2014/07/29 [received]
PHST- 2014/09/15 [accepted]
TA  - Front Neuroeng
JT  - Frontiers in Neuroengineering
AID - 10.3389/fneng.2014.00039 [doi]
SO  - Front Neuroeng. 2014 Oct 10;7:. doi:10.3389/fneng.2014.00039.

PMC - PMC4766198
PMID- 26910535
IS  - 1932-6203 (Electronic)
VI  - 11
IP  - 2
DP  - 2016
TI  - Prediction of Fitness to Drive in Patients with Alzheimer's Dementia.
LID - e0149566
AB  - The number of patients with Alzheimer’s disease (AD) is increasing and so is the 
      number of patients driving a car. To enable patients to retain their mobility
      while at the same time not endangering public safety, each patient should be
      assessed for fitness to drive. The aim of this study is to develop a method to
      assess fitness to drive in a clinical setting, using three types of assessments, 
      i.e. clinical interviews, neuropsychological assessment and driving simulator
      rides. The goals are (1) to determine for each type of assessment which
      combination of measures is most predictive for on-road driving performance, (2)
      to compare the predictive value of clinical interviews, neuropsychological
      assessment and driving simulator evaluation and (3) to determine which
      combination of these assessments provides the best prediction of fitness to
      drive. Eighty-one patients with AD and 45 healthy individuals participated. All
      participated in a clinical interview, and were administered a neuropsychological 
      test battery and a driving simulator ride (predictors). The criterion fitness to 
      drive was determined in an on-road driving assessment by experts of the CBR Dutch
      driving test organisation according to their official protocol. The validity of
      the predictors to determine fitness to drive was explored by means of logistic
      regression analyses, discriminant function analyses, as well as receiver
      operating curve analyses. We found that all three types of assessments are
      predictive of on-road driving performance. Neuropsychological assessment had the 
      highest classification accuracy followed by driving simulator rides and clinical 
      interviews. However, combining all three types of assessments yielded the best
      prediction for fitness to drive in patients with AD with an overall accuracy of
      92.7%, which makes this method highly valid for assessing fitness to drive in AD.
      This method may be used to advise patients with AD and their family members about
      fitness to drive.
FAU - Piersma, Dafne
AU  - Piersma D
AD  - Department of Clinical and Developmental Neuropsychology, University of
      Groningen, Groningen, the Netherlands
FAU - Fuermaier, Anselm B. M.
AU  - Fuermaier ABM
AD  - Department of Clinical and Developmental Neuropsychology, University of
      Groningen, Groningen, the Netherlands
FAU - de Waard, Dick
AU  - de Waard D
AD  - Department of Clinical and Developmental Neuropsychology, University of
      Groningen, Groningen, the Netherlands
FAU - Davidse, Ragnhild J.
AU  - Davidse RJ
AD  - SWOV Institute for Road Safety Research, The Hague, the Netherlands
FAU - de Groot, Jolieke
AU  - de Groot J
AD  - SWOV Institute for Road Safety Research, The Hague, the Netherlands
FAU - Doumen, Michelle J. A.
AU  - Doumen MJA
AD  - Department of Clinical and Developmental Neuropsychology, University of
      Groningen, Groningen, the Netherlands
FAU - Bredewoud, Ruud A.
AU  - Bredewoud RA
AD  - CBR Dutch driving test organisation, Rijswijk, the Netherlands
FAU - Claesen, René
AU  - Claesen R
AD  - CBR Dutch driving test organisation, Rijswijk, the Netherlands
FAU - Lemstra, Afina W.
AU  - Lemstra AW
AD  - Department of Neurology, Alzheimer Center, VU University Medical Center,
      Amsterdam, the Netherlands
FAU - Vermeeren, Annemiek
AU  - Vermeeren A
AD  - Department of Neuropsychology & Psychopharmacology, Maastricht University,
      Maastricht, the Netherlands
FAU - Ponds, Rudolf
AU  - Ponds R
AD  - Department of Psychiatry and Neuropsychology, School of Mental Health and
      Neurosciences (MHeNS), Maastricht University, Maastricht, the Netherlands
FAU - Verhey, Frans
AU  - Verhey F
AD  - Department of Psychiatry and Neuropsychology, School of Mental Health and
      Neurosciences (MHeNS), Maastricht University, Maastricht, the Netherlands
FAU - Brouwer, Wiebo H.
AU  - Brouwer WH
AD  - Department of Clinical and Developmental Neuropsychology, University of
      Groningen, Groningen, the Netherlands
FAU - Tucha, Oliver
AU  - Tucha O
AD  - Department of Clinical and Developmental Neuropsychology, University of
      Groningen, Groningen, the Netherlands
LA  - eng
PT  - Journal Article
DEP - 20160224
PHST- 2015/12/08 [received]
PHST- 2016/02/02 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - 10.1371/journal.pone.0149566 [doi]
AID - PONE-D-15-53060 [pii]
SO  - PLoS One. 2016 Feb 24;11(2):. doi:10.1371/journal.pone.0149566.

PMC - PMC4782059
PMID- 27014048
IS  - 1662-5196 (Electronic)
VI  - 10
DP  - 2016
TI  - Preparing Laboratory and Real-World EEG Data for Large-Scale Analysis: A
      Containerized Approach.
LID - 7
AB  - Large-scale analysis of EEG and other physiological measures promises new
      insights into brain processes and more accurate and robust brain–computer
      interface models. However, the absence of standardized vocabularies for
      annotating events in a machine understandable manner, the welter of
      collection-specific data organizations, the difficulty in moving data across
      processing platforms, and the unavailability of agreed-upon standards for
      preprocessing have prevented large-scale analyses of EEG. Here we describe a
      “containerized” approach and freely available tools we have developed to
      facilitate the process of annotating, packaging, and preprocessing EEG data
      collections to enable data sharing, archiving, large-scale machine learning/data 
      mining and (meta-)analysis. The EEG Study Schema (ESS) comprises three data
      “Levels,” each with its own XML-document schema and file/folder convention, plus 
      a standardized (PREP) pipeline to move raw (Data Level 1) data to a basic
      preprocessed state (Data Level 2) suitable for application of a large class of
      EEG analysis methods. Researchers can ship a study as a single unit and operate
      on its data using a standardized interface. ESS does not require a central
      database and provides all the metadata data necessary to execute a wide variety
      of EEG processing pipelines. The primary focus of ESS is automated in-depth
      analysis and meta-analysis EEG studies. However, ESS can also encapsulate
      meta-information for the other modalities such as eye tracking, that are
      increasingly used in both laboratory and real-world neuroimaging. ESS schema and 
      tools are freely available at www.eegstudy.org and a central catalog of over 850 
      GB of existing data in ESS format is available at studycatalog.org. These tools
      and resources are part of a larger effort to enable data sharing at sufficient
      scale for researchers to engage in truly large-scale EEG analysis and data mining
      (BigEEG.org).
FAU - Bigdely-Shamlo, Nima
AU  - Bigdely-Shamlo N
AD  - Qusp Labs, Qusp, San DiegoCA, USA
FAU - Makeig, Scott
AU  - Makeig S
AD  - Swartz Center for Computational Neuroscience, University of California, San
      Diego, San DiegoCA, USA
FAU - Robbins, Kay A.
AU  - Robbins KA
AD  - Department of Computer Science, University of Texas at San Antonio, San
      AntonioTX, USA
LA  - eng
PT  - Journal Article
DEP - 20160308
GR  - W911NF-10-2-0022
PHST- 2015/11/13 [received]
PHST- 2016/02/19 [accepted]
TA  - Front Neuroinform
JT  - Frontiers in Neuroinformatics
AID - 10.3389/fninf.2016.00007 [doi]
SO  - Front Neuroinform. 2016 Mar 08;10:. doi:10.3389/fninf.2016.00007.

PMC - PMC5468377
PMID- 28659788
IS  - 1663-4365 (Electronic)
VI  - 9
DP  - 2017
TI  - Oscillatory Activities in Neurological Disorders of Elderly: Biomarkers to Target
      for Neuromodulation.
LID - 189
AB  - Non-invasive brain stimulation (NIBS) has been under investigation as adjunct
      treatment of various neurological disorders with variable success. One challenge 
      is the limited knowledge on what would be effective neuronal targets for an
      intervention, combined with limited knowledge on the neuronal mechanisms of NIBS.
      Motivated on the one hand by recent evidence that oscillatory activities in
      neural systems play a role in orchestrating brain functions and dysfunctions, in 
      particular those of neurological disorders specific of elderly patients, and on
      the other hand that NIBS techniques may be used to interact with these brain
      oscillations in a controlled way, we here explore the potential of modulating
      brain oscillations as an effective strategy for clinical NIBS interventions. We
      first review the evidence for abnormal oscillatory profiles to be associated with
      a range of neurological disorders of elderly (e.g., Parkinson’s disease (PD),
      Alzheimer’s disease (AD), stroke, epilepsy), and for these signals of abnormal
      network activity to normalize with treatment, and/or to be predictive of disease 
      progression or recovery. We then ask the question to what extent existing NIBS
      protocols have been tailored to interact with these oscillations and possibly
      associated dysfunctions. Our review shows that, despite evidence for both
      reliable neurophysiological markers of specific oscillatory dis-functionalities
      in neurological disorders and NIBS protocols potentially able to interact with
      them, there are few applications of NIBS aiming to explore clinical outcomes of
      this interaction. Our review article aims to point out oscillatory markers of
      neurological, which are also suitable targets for modification by NIBS, in order 
      to facilitate in future studies the matching of technical application to clinical
      targets.
FAU - Assenza, Giovanni
AU  - Assenza G
AD  - Clinical Neurology, Campus Biomedico University of RomeRome, Italy
FAU - Capone, Fioravante
AU  - Capone F
AD  - Clinical Neurology, Campus Biomedico University of RomeRome, Italy
FAU - di Biase, Lazzaro
AU  - di Biase L
AD  - Clinical Neurology, Campus Biomedico University of RomeRome, Italy
FAU - Ferreri, Florinda
AU  - Ferreri F
AD  - Clinical Neurology, Campus Biomedico University of RomeRome, Italy
FAU - Florio, Lucia
AU  - Florio L
AD  - Clinical Neurology, Campus Biomedico University of RomeRome, Italy
FAU - Guerra, Andrea
AU  - Guerra A
AD  - Clinical Neurology, Campus Biomedico University of RomeRome, Italy
FAU - Marano, Massimo
AU  - Marano M
AD  - Clinical Neurology, Campus Biomedico University of RomeRome, Italy
FAU - Paolucci, Matteo
AU  - Paolucci M
AD  - Clinical Neurology, Campus Biomedico University of RomeRome, Italy
FAU - Ranieri, Federico
AU  - Ranieri F
AD  - Clinical Neurology, Campus Biomedico University of RomeRome, Italy
FAU - Salomone, Gaetano
AU  - Salomone G
AD  - Clinical Neurology, Campus Biomedico University of RomeRome, Italy
FAU - Tombini, Mario
AU  - Tombini M
AD  - Clinical Neurology, Campus Biomedico University of RomeRome, Italy
FAU - Thut, Gregor
AU  - Thut G
AD  - Centre for Cognitive Neuroimaging (CCNi), Institute of Neuroscience and
      Psychology, University of GlasgowGlasgow, United Kingdom
FAU - Di Lazzaro, Vincenzo
AU  - Di Lazzaro V
AD  - Clinical Neurology, Campus Biomedico University of RomeRome, Italy
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170613
PHST- 2016/12/14 [received]
PHST- 2017/05/26 [accepted]
TA  - Front Aging Neurosci
JT  - Frontiers in Aging Neuroscience
AID - 10.3389/fnagi.2017.00189 [doi]
SO  - Front Aging Neurosci. 2017 Jun 13;9:. doi:10.3389/fnagi.2017.00189.

PMC - PMC2620634
PMID- 19136436
IS  - 0893-8512 (Print)
IS  - 1098-6618 (Electronic)
VI  - 22
IP  - 1
DP  - 2009 Jan
TI  - Neuropathogenesis of Congenital Cytomegalovirus Infection: Disease Mechanisms and
      Prospects for Intervention.
PG  - 99-126
AB  - Congenital cytomegalovirus (CMV) infection is the leading infectious cause of
      mental retardation and hearing loss in the developed world. In recent years,
      there has been an improved understanding of the epidemiology, pathogenesis, and
      long-term disabilities associated with CMV infection. In this review, current
      concepts regarding the pathogenesis of neurological injury caused by CMV
      infections acquired by the developing fetus are summarized. The pathogenesis of
      CMV-induced disabilities is considered in the context of the epidemiology of CMV 
      infection in pregnant women and newborn infants, and the clinical manifestations 
      of brain injury are reviewed. The prospects for intervention, including antiviral
      therapies and vaccines, are summarized. Priorities for future research are
      suggested to improve the understanding of this common and disabling illness of
      infancy.
FAU - Cheeran, Maxim C.-J.
AU  - Cheeran MCJ
AD  - Center for Infectious Diseases and Microbiology Translational Research,
      Departments of Medicine, Pediatrics, University of Minnesota Medical School,
      Minneapolis, Minnesota
FAU - Lokensgard, James R.
AU  - Lokensgard JR
AD  - Center for Infectious Diseases and Microbiology Translational Research,
      Departments of Medicine, Pediatrics, University of Minnesota Medical School,
      Minneapolis, Minnesota
FAU - Schleiss, Mark R.
AU  - Schleiss MR
AD  - Center for Infectious Diseases and Microbiology Translational Research,
      Departments of Medicine, Pediatrics, University of Minnesota Medical School,
      Minneapolis, Minnesota
LA  - eng
PT  - Journal Article
TA  - Clin Microbiol Rev
JT  - Clinical Microbiology Reviews
AID - 0023-08 [pii]
AID - 10.1128/CMR.00023-08 [doi]
SO  - Clin Microbiol Rev. 2009 Jan;22(1):99-126. doi:10.1128/CMR.00023-08.

PMC - PMC4580470
PMID- 26397109
IS  - 1932-6203 (Electronic)
VI  - 10
IP  - 9
DP  - 2015
TI  - Working Memory Training in Post-Secondary Students with ADHD: A Randomized
      Controlled Study.
LID - e0137173
AB  - Objectives: To determine whether standard-length computerized training enhances
      working memory (WM), transfers to other cognitive domains and shows sustained
      effects, when controlling for motivation, engagement, and expectancy. Methods: 97
      post-secondary students (59.8% female) aged 18–35 years with
      Attention-Deficit/Hyperactivity Disorder, were randomized into standard-length
      adaptive Cogmed WM training (CWMT; 45-min/session), a shortened-length adaptive
      version of CWMT (15 min/session) that controlled for motivation, engagement and
      expectancy of change, or into a no training group (waitlist-control group). All
      three groups received weekly telephone calls from trained coaches, who supervised
      the CWMT and were independent from the research team. All were evaluated before
      and 3 weeks post-training; those in the two CWMT groups were also assessed 3
      months post-training. Untrained outcome measures of WM included the WAIS-IV Digit
      Span (auditory-verbal WM), CANTAB Spatial Span (visual-spatial WM) and WRAML
      Finger Windows (visual-spatial WM). Transfer-of-training effects included
      measures of short-term memory, cognitive speed, math and reading fluency, complex
      reasoning, and ADHD symptoms. Results: Performance on 5/7 criterion measures
      indicated that shortened-length CWMT conferred as much benefit on WM performance 
      as did standard-length training, with both CWMT groups improving more than the
      waitlist-control group. Only 2 of these findings remained robust after correcting
      for multiple comparisons. Follow-up analyses revealed that post-training
      improvements on WM performance were maintained for at least three months. There
      was no evidence of any transfer effects but the standard-length group showed
      improvement in task-specific strategy use. Conclusions: This study failed to find
      robust evidence of benefits of standard-length CWMT for improving WM in college
      students with ADHD and the overall pattern of findings raise questions about the 
      specificity of training effects. Trial Registration: ClinicalTrials.gov
      NCT01657721
FAU - Mawjee, Karizma
AU  - Mawjee K
AD  - University of Toronto, Toronto, Ontario, Canada
FAU - Woltering, Steven
AU  - Woltering S
AD  - University of Toronto, Toronto, Ontario, Canada
FAU - Tannock, Rosemary
AU  - Tannock R
AD  - University of Toronto, Toronto, Ontario, Canada
LA  - eng
PT  - Journal Article
DEP - 20150923
PHST- 2015/01/31 [received]
PHST- 2015/08/12 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - 10.1371/journal.pone.0137173 [doi]
AID - PONE-D-14-58572 [pii]
SO  - PLoS One. 2015 Sep 23;10(9):. doi:10.1371/journal.pone.0137173.

PMC - PMC2669069
PMID- 19331675
IS  - 1745-6215 (Electronic)
VI  - 10
DP  - 2009
TI  - The second Symptom Management Research Trial in Oncology (SMaRT Oncology-2): a
      randomised trial to determine the effectiveness and cost-effectiveness of adding 
      a complex intervention for major depressive disorder to usual care for cancer
      patients.
PG  - 18
AB  - Background: Depression Care for People with Cancer is a complex intervention
      delivered by specially trained cancer nurses, under the supervision of a
      psychiatrist. It is given as a supplement to the usual care for depression, which
      patients receive from their general practitioner and cancer service. In a 'proof 
      of concept' trial (Symptom Management Research Trials in Oncology-1) Depression
      Care for People with Cancer improved depression more than usual care alone. The
      second Symptom Management Research Trial in Oncology (SMaRT Oncology-2 Trial)
      will test its effectiveness and cost-effectiveness in a 'real world' setting.
      Design: A two arm parallel group multi-centre randomised controlled trial. Trial 
      Procedures: 500 patients will be recruited through established systematic Symptom
      Monitoring Services, which screen patients for depression. Patients will have: a 
      diagnosis of cancer (of various types); an estimated life expectancy of twelve
      months or more and a diagnosis of Major Depressive Disorder. Patients will be
      randomised to usual care or usual care plus Depression Care for People with
      Cancer. Randomisation will be carried out by telephoning a secure computerised
      central randomisation system or by using a secure web interface. The primary
      outcome measure is 'treatment response' measured at 24 week outcome data
      collection. 'Treatment response' will be defined as a reduction of 50% or more in
      the patient's baseline depression score, measured using the 20-item Symptom
      Checklist (SCL-20D). Secondary outcomes include remission of major depressive
      disorder, depression severity and patients' self-rated improvement of depression.
      Trial Registration: Current controlled trials ISRCTN40568538 Trial Hypotheses:
      (1) Depression Care for People with Cancer as a supplement to usual care will be 
      more effective than usual care alone in achieving a 50% reduction in baseline
      SCL-20D score at 24 weeks. (2) Depression Care for People with Cancer as a
      supplement to usual care will cost more than usual care alone but will be more
      cost effective in achieving improvements in patients' depression and quality of
      life.
FAU - Walker, Jane
AU  - Walker J
AD  - Cancer Research UK Clinical Research Training Fellow, University of Edinburgh
      Cancer Research Centre, Western General Hospital, Crewe Road, Edinburgh, EH4 2XR,
      Scotland
FAU - Cassidy, Jim
AU  - Cassidy J
AD  - Professor of Oncology, Cancer Research UK, Department of Medical Oncology,
      University of Glasgow, Garscube Estate, Switchback Road, Glasgow, G61 1BD,
      Scotland
FAU - Sharpe, Michael
AU  - Sharpe M
AD  - Professor of Psychological Medicine Psychological Medicine Research School of
      Molecular and Clinical Medicine, University of Edinburgh, Kennedy Tower, Royal
      Edinburgh Hospital, Morningside Park, Edinburgh, EH10 5HF, Scotland
CN  - the SMaRT Oncology-2 Trialists*
LA  - eng
PT  - Journal Article
DEP - 20090330
PHST- 2008/11/12 [received]
PHST- 2009/03/30 [accepted]
TA  - Trials
JT  - Trials
AID - 1745-6215-10-18 [pii]
AID - 10.1186/1745-6215-10-18 [doi]
SO  - Trials. 2009 Mar 30;10:18. doi:10.1186/1745-6215-10-18.

PMC - PMC4315838
PMID- 25653369
IS  - 0270-6474 (Print)
IS  - 1529-2401 (Electronic)
VI  - 35
IP  - 5
DP  - 2015 Feb 4
TI  - B-Lymphocyte-Mediated Delayed Cognitive Impairment following Stroke.
PG  - 2133-45
AB  - Each year, 10 million people worldwide survive the neurologic injury associated
      with a stroke. Importantly, stroke survivors have more than twice the risk of
      subsequently developing dementia compared with people who have never had a
      stroke. The link between stroke and the later development of dementia is not
      understood. There are reports of oligoclonal bands in the CSF of stroke patients,
      suggesting that in some people a B-lymphocyte response to stroke may occur in the
      CNS. Therefore, we tested the hypothesis that a B-lymphocyte response to stroke
      could contribute to the onset of dementia. We discovered that, in mouse models,
      activated B-lymphocytes infiltrate infarcted tissue in the weeks after stroke.
      B-lymphocytes undergo isotype switching, and IgM, IgG, and IgA antibodies are
      found in the neuropil adjacent to the lesion. Concurrently, mice develop delayed 
      deficits in LTP and cognition. Genetic deficiency, and the pharmacologic ablation
      of B-lymphocytes using an anti-CD20 antibody, prevents the appearance of delayed 
      cognitive deficits. Furthermore, immunostaining of human postmortem tissue
      revealed that a B-lymphocyte response to stroke also occurs in the brain of some 
      people with stroke and dementia. These data suggest that some stroke patients may
      develop a B-lymphocyte response to stroke that contributes to dementia, and is
      potentially treatable with FDA-approved drugs that target B cells.
FAU - Doyle, Kristian P.
AU  - Doyle KP
AD  - Department of Neurology and Neurological Sciences, Stanford University School of 
      Medicine, Stanford, California 94305,
FAU - Quach, Lisa N.
AU  - Quach LN
AD  - Department of Neurology and Neurological Sciences, Stanford University School of 
      Medicine, Stanford, California 94305,
FAU - Solé, Montse
AU  - Solé M
AUID- ORCID: 0000-0003-4240-6562
AD  - Department of Neurology and Neurological Sciences, Stanford University School of 
      Medicine, Stanford, California 94305,
FAU - Axtell, Robert C.
AU  - Axtell RC
AD  - Department of Neurology and Neurological Sciences, Stanford University School of 
      Medicine, Stanford, California 94305,
FAU - Nguyen, Thuy-Vi V.
AU  - Nguyen TVV
AD  - Department of Neurology and Neurological Sciences, Stanford University School of 
      Medicine, Stanford, California 94305,
FAU - Soler-Llavina, Gilberto J.
AU  - Soler-Llavina GJ
AUID- ORCID: 0000-0002-1838-401X
AD  - Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences,
      Stanford University School of Medicine, Stanford, California 94305,
FAU - Jurado, Sandra
AU  - Jurado S
AD  - Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences,
      Stanford University School of Medicine, Stanford, California 94305,
FAU - Han, Jullet
AU  - Han J
AD  - Department of Neurology and Neurological Sciences, Stanford University School of 
      Medicine, Stanford, California 94305,
FAU - Steinman, Lawrence
AU  - Steinman L
AUID- ORCID: 0000-0002-2437-2250
AD  - Department of Neurology and Neurological Sciences, Stanford University School of 
      Medicine, Stanford, California 94305,
FAU - Longo, Frank M.
AU  - Longo FM
AD  - Department of Neurology and Neurological Sciences, Stanford University School of 
      Medicine, Stanford, California 94305,
FAU - Schneider, Julie A.
AU  - Schneider JA
AD  - Department of Pathology and Neurological Sciences, Rush Alzheimer's Disease
      Center Rush University Medical Center, Chicago, Illinois 60612, and
FAU - Malenka, Robert C.
AU  - Malenka RC
AD  - Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences,
      Stanford University School of Medicine, Stanford, California 94305,
FAU - Buckwalter, Marion S.
AU  - Buckwalter MS
AUID- ORCID: 0000-0003-2807-2447
AD  - Department of Neurology and Neurological Sciences, Stanford University School of 
      Medicine, Stanford, California 94305,
LA  - eng
PT  - Journal Article
PHST- 2014/10/02 [received]
PHST- 2014/12/08 [revised]
PHST- 2014/12/18 [accepted]
TA  - J Neurosci
JT  - The Journal of Neuroscience
AID - 4098-14 [pii]
AID - 10.1523/JNEUROSCI.4098-14.2015 [doi]
SO  - J Neurosci. 2015 Feb 4;35(5):2133-45. doi:10.1523/JNEUROSCI.4098-14.2015.

PMC - PMC1087865
PMID- 15847703
IS  - 1477-7525 (Electronic)
VI  - 3
DP  - 2005
TI  - Prevalence and burden of self-reported blindness and low vision for individuals
      living in institutions: a nationwide survey.
PG  - 27
AB  - Background: The prevalence of self-reported low vision (LV) and blindness, and
      their associated disabilities, handicaps and socio-economic consequences for
      individuals living in institutions are poorly documented. Methods: 2,075
      institutions were selected at random and eight individuals were picked at random 
      from the list of residents. Three groups of individuals were defined: blind, LV, 
      and a control group (CG). These were compared after adjustment for age and
      co-morbidities. Of the 15,403 individuals, 14,603 interviews (94.9%) were
      completed. Results: The prevalence of blindness was 1.6% and the LV 13.4%. Blind 
      individuals needed assistance more often (OR: 2.65 to 11.35) than CG members
      while the assistance required by LV individuals was similar to that for the CG.
      Blind individuals required institution adaptation (building and furniture
      changes) more often than the CG. Blind (57.9%) and LV individuals (35.4%) were
      more often registered for social allowances. Monthly social allowances were EUR
      86 higher for blind than LV individuals. Monthly family incomes were found to be 
      similar between the three groups (from EUR 782 to 797). Social and demographic
      data, institution description, income, handicaps, disabilities, social allowances
      and details of daily activities were collected interviews Conclusion: The results
      demonstrate the impact of self-reported blindness and LV on daily life for
      patients living in institutions.
FAU - Brézin, Antoine Pierre
AU  - Brézin AP
AD  - Hôpital Cochin – Service d'ophtalmologie – Université Paris 5 – 27 rue du
      Faubourg Saint-Jacques F-75679 Paris cedex 14, France
FAU - Lafuma, Antoine
AU  - Lafuma A
AD  - Cemka, 43, Boulevard du Maréchal Joffre, F-92340 Bourg-la-Reine, France
FAU - Fagnani, Francis
AU  - Fagnani F
AD  - Cemka, 43, Boulevard du Maréchal Joffre, F-92340 Bourg-la-Reine, France
FAU - Mesbah, Mounir
AU  - Mesbah M
AD  - Université Pierre et marie Curie, 175, rue du Chevaleret, F-75013 Paris France
FAU - Berdeaux, Gilles
AU  - Berdeaux G
AD  - Gilles Berdeaux, Alcon France, 4 Rue Henri Sainte Claire Deville, F-92563
      Rueil-Malmaison Cedex, France
LA  - eng
PT  - Journal Article
DEP - 20050425
PHST- 2005/03/23 [received]
PHST- 2005/04/25 [accepted]
TA  - Health Qual Life Outcomes
JT  - Health and Quality of Life Outcomes
AID - 1477-7525-3-27 [pii]
AID - 10.1186/1477-7525-3-27 [doi]
SO  - Health Qual Life Outcomes. 2005 Apr 25;3:27. doi:10.1186/1477-7525-3-27.

PMC - PMC5432136
PMID- 28516175
VI  - 2017
DP  - 2017 May 2
TI  - TummyTrials: A Feasibility Study of Using Self-Experimentation to Detect
      Individualized Food Triggers.
PG  - 6850-63
AB  - Diagnostic self-tracking, the recording of personal information to diagnose or
      manage a health condition, is a common practice, especially for people with
      chronic conditions. Unfortunately, many who attempt diagnostic self-tracking have
      trouble accomplishing their goals. People often lack knowledge and skills needed 
      to design and conduct scientifically rigorous experiments, and current tools
      provide little support. To address these shortcomings and explore opportunities
      for diagnostic self-tracking, we designed, developed, and evaluated a mobile app 
      that applies a self-experimentation framework to support patients suffering from 
      irritable bowel syndrome (IBS) in identifying their personal food triggers.
      TummyTrials aids a person in designing, executing, and analyzing self-experiments
      to evaluate whether a specific food triggers their symptoms. We examined the
      feasibility of this approach in a field study with 15 IBS patients, finding that 
      participants could use the tool to reliably undergo a self-experiment. However,
      we also discovered an underlying tension between scientific validity and the
      lived experience of self-experimentation. We discuss challenges of applying
      clinical research methods in everyday life, motivating a need for the design of
      self-experimentation systems to balance rigor with the uncertainties of everyday 
      life.
FAU - Karkar, Ravi
AU  - Karkar R
AD  - Computer Science & Engineering, DUB Group, University of Washington, Seattle, WA,
      United States
FAU - Schroeder, Jessica
AU  - Schroeder J
AD  - Computer Science & Engineering, DUB Group, University of Washington, Seattle, WA,
      United States
FAU - Epstein, Daniel A.
AU  - Epstein DA
AD  - Computer Science & Engineering, DUB Group, University of Washington, Seattle, WA,
      United States
FAU - Pina, Laura R.
AU  - Pina LR
AD  - Computer Science & Engineering, DUB Group, University of Washington, Seattle, WA,
      United States
FAU - Scofield, Jeffrey
AU  - Scofield J
AD  - Computer Science & Engineering, DUB Group, University of Washington, Seattle, WA,
      United States
FAU - Fogarty, James
AU  - Fogarty J
AD  - Computer Science & Engineering, DUB Group, University of Washington, Seattle, WA,
      United States
FAU - Kientz, Julie A.
AU  - Kientz JA
AD  - Human Centered Design & Engineering, DUB Group, University of Washington,
      Seattle, WA, United States
FAU - Munson, Sean A.
AU  - Munson SA
AD  - Human Centered Design & Engineering, DUB Group, University of Washington,
      Seattle, WA, United States
FAU - Vilardaga, Roger
AU  - Vilardaga R
AD  - Center for Addiction Science and Technology, Duke University, Durham, NC, United 
      States
FAU - Zia, Jasmine
AU  - Zia J
AD  - Division of Gastroenterology, DUB Group, University of Washington, Seattle, WA,
      United States
LA  - eng
PT  - Journal Article
TA  - Proc SIGCHI Conf Hum Factor Comput Syst
JT  - Proceedings of the SIGCHI conference on human factors in computing systems . CHI 
      Conference
AID - 10.1145/3025453.3025480 [doi]
MID - HHSPA855301
SO  - Proc SIGCHI Conf Hum Factor Comput Syst. 2017 May 2;2017:6850-63.
      doi:10.1145/3025453.3025480.

PMC - PMC2728092
PMID- 19617456
IS  - 1079-5014 (Print)
IS  - 1758-5368 (Electronic)
VI  - 64B
IP  - 5
DP  - 2009 Sep
TI  - The ACTIVE Cognitive Training Interventions and the Onset of and Recovery from
      Suspected Clinical Depression.
PG  - 577-85
AB  - We evaluated the effects of the 3 cognitive interventions fielded in the Advanced
      Cognitive Training for Independent and Vital Elderly study on 2 subsets of
      participants—1,606 without and 424 with suspected clinical depression at
      baseline. In the former group, only the speed of processing (vs. no-contact
      control) intervention had a significant effect, with its participants being 38%
      less likely to develop suspected clinical depression at 1 year (adjusted odds
      ratio = 0.62; p < .01). None of the interventions had a significant effect on
      recovery from suspected clinical depression in the latter group. Although the
      etiological mechanism of the speed of processing’s protective effect was not
      isolated, it may result from successful adaptation to age-related changes through
      selective optimization with compensation.
FAU - Wolinsky, Fredric D.
AU  - Wolinsky FD
AD  - Center for Research in the Implementation of Innovative Strategies into Practice,
      Iowa City VAMC, Iowa
FAU - Mahncke, Henry W.
AU  - Mahncke HW
AD  - Department of Research and Outcomes, Posit Science Corporation, San Francisco,
      California
FAU - Weg, Mark W. Vander
AU  - Weg MWV
AD  - Center for Research in the Implementation of Innovative Strategies into Practice,
      Iowa City VAMC, Iowa
FAU - Martin, Rene
AU  - Martin R
AD  - Center for Research in the Implementation of Innovative Strategies into Practice,
      Iowa City VAMC, Iowa
FAU - Unverzagt, Frederick W.
AU  - Unverzagt FW
AD  - Department of Psychiatry, Indiana University School of Medicine, Indianapolis
FAU - Ball, Karlene K.
AU  - Ball KK
AD  - Department of Psychology, University of Alabama at Birmingham
FAU - Jones, Richard N.
AU  - Jones RN
AD  - Institute for Aging Research, Hebrew Senior-Life, Boston, Massachusetts
FAU - Tennstedt, Sharon L.
AU  - Tennstedt SL
AD  - Department of Behavioral and Social Science Research, New England Research
      Institutes, Boston, Massachusetts
LA  - eng
PT  - Journal Article
DEP - 20090717
PHST- 2008/06/18 [received]
PHST- 2009/05/27 [accepted]
PHST- 2009/07/17 [aheadofprint]
TA  - J Gerontol B Psychol Sci Soc Sci
JT  - The Journals of Gerontology Series B: Psychological Sciences and Social Sciences
AID - 10.1093/geronb/gbp061 [doi]
SO  - J Gerontol B Psychol Sci Soc Sci. 2009 Sep;64B(5):577-85. Epub 2009 Jul 17
      doi:10.1093/geronb/gbp061.

PMC - PMC4961759
PMID- 27075539
IS  - 0022-3077 (Print)
IS  - 1522-1598 (Electronic)
VI  - 116
IP  - 1
DP  - 2016 Jul 1
TI  - Voltage imaging to understand connections and functions of neuronal circuits.
PG  - 135-52
AB  - Understanding of the cellular mechanisms underlying brain functions such as
      cognition and emotions requires monitoring of membrane voltage at the cellular,
      circuit, and system levels. Seminal voltage-sensitive dye and calcium-sensitive
      dye imaging studies have demonstrated parallel detection of electrical activity
      across populations of interconnected neurons in a variety of preparations. A
      game-changing advance made in recent years has been the conceptualization and
      development of optogenetic tools, including genetically encoded indicators of
      voltage (GEVIs) or calcium (GECIs) and genetically encoded light-gated ion
      channels (actuators, e.g., channelrhodopsin2). Compared with low-molecular-weight
      calcium and voltage indicators (dyes), the optogenetic imaging approaches are 1) 
      cell type specific, 2) less invasive, 3) able to relate activity and anatomy, and
      4) facilitate long-term recordings of individual cells' activities over weeks,
      thereby allowing direct monitoring of the emergence of learned behaviors and
      underlying circuit mechanisms. We highlight the potential of novel approaches
      based on GEVIs and compare those to calcium imaging approaches. We also discuss
      how novel approaches based on GEVIs (and GECIs) coupled with genetically encoded 
      actuators will promote progress in our knowledge of brain circuits and systems.
FAU - Antic, Srdjan D.
AU  - Antic SD
AD  - Stem Cell Institute, Institute for Systems Genomics, UConn Health, Farmington,
      Connecticut;
FAU - Empson, Ruth M.
AU  - Empson RM
AD  - Department of Physiology, Brain Research New Zealand, Otago School of Medical
      Sciences, University of Otago, Dunedin, New Zealand; and
FAU - Knöpfel, Thomas
AU  - Knöpfel T
AD  - Division of Brain Sciences, Department of Medicine and Centre for
      Neurotechnology, Institute of Biomedical Engineering, Imperial College London,
      London, United Kingdom
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20160413
GR  - 1U01MH109091-01
PHST- 2016/03/15 [received]
PHST- 2016/04/11 [accepted]
TA  - J Neurophysiol
JT  - Journal of Neurophysiology
AID - JN-00226-2016 [pii]
AID - 10.1152/jn.00226.2016 [doi]
SO  - J Neurophysiol. 2016 Jul 1;116(1):135-52. Epub 2016 Apr 13
      doi:10.1152/jn.00226.2016.

PMC - PMC3711589
PMID- 23407934
IS  - 0270-6474 (Print)
IS  - 1529-2401 (Electronic)
VI  - 33
IP  - 7
DP  - 2013 Feb 13
TI  - The Disruption of Celf6, a Gene Identified by Translational Profiling of
      Serotonergic Neurons, Results in Autism-Related Behaviors.
PG  - 2732-53
AB  - The immense molecular diversity of neurons challenges our ability to understand
      the genetic and cellular etiology of neuropsychiatric disorders. Leveraging
      knowledge from neurobiology may help parse the genetic complexity: identifying
      genes important for a circuit that mediates a particular symptom of a disease may
      help identify polymorphisms that contribute to risk for the disease as a whole.
      The serotonergic system has long been suspected in disorders that have symptoms
      of repetitive behaviors and resistance to change, including autism. We generated 
      a bacTRAP mouse line to permit translational profiling of serotonergic neurons.
      From this, we identified several thousand serotonergic-cell expressed
      transcripts, of which 174 were highly enriched, including all known markers of
      these cells. Analysis of common variants near the corresponding genes in the AGRE
      collection implicated the RNA binding protein CELF6 in autism risk. Screening for
      rare variants in CELF6 identified an inherited premature stop codon in one of the
      probands. Subsequent disruption of Celf6 in mice resulted in animals exhibiting
      resistance to change and decreased ultrasonic vocalization as well as abnormal
      levels of serotonin in the brain. This work provides a reproducible and accurate 
      method to profile serotonergic neurons under a variety of conditions and suggests
      a novel paradigm for gaining information on the etiology of psychiatric
      disorders.
FAU - Dougherty, Joseph D.
AU  - Dougherty JD
AD  - Department of Genetics, Washington University School of Medicine, St. Louis,
      Missouri 63110
FAU - Maloney, Susan E.
AU  - Maloney SE
AD  - Department of Genetics, Washington University School of Medicine, St. Louis,
      Missouri 63110
FAU - Wozniak, David F.
AU  - Wozniak DF
AD  - Department of Psychiatry, Washington University School of Medicine, St. Louis,
      Missouri 63110
FAU - Rieger, Michael A.
AU  - Rieger MA
AD  - Department of Genetics, Washington University School of Medicine, St. Louis,
      Missouri 63110
FAU - Sonnenblick, Lisa
AU  - Sonnenblick L
AD  - UCLA Center for Autism Research and Treatment, Semel Institute for Neuroscience
      and Behavior, Los Angeles, California 90095
FAU - Coppola, Giovanni
AU  - Coppola G
AD  - Program in Neurogenetics, Department of Neurology, Los Angeles, California 90095
FAU - Mahieu, Nathaniel G.
AU  - Mahieu NG
AD  - Department of Genetics, Washington University School of Medicine, St. Louis,
      Missouri 63110
FAU - Zhang, Juliet
AU  - Zhang J
AD  - Laboratory of Molecular Biology, Howard Hughes Medical Institute, New York, New
      York 10065
FAU - Cai, Jinlu
AU  - Cai J
AD  - Departments of Genetics and Neuroscience, Albert Einstein College of Medicine,
      New York, New York 10461
FAU - Patti, Gary J.
AU  - Patti GJ
AD  - Department of Genetics, Washington University School of Medicine, St. Louis,
      Missouri 63110
FAU - Abrahams, Brett S.
AU  - Abrahams BS
AD  - Departments of Genetics and Neuroscience, Albert Einstein College of Medicine,
      New York, New York 10461
FAU - Geschwind, Daniel H.
AU  - Geschwind DH
AD  - UCLA Center for Autism Research and Treatment, Semel Institute for Neuroscience
      and Behavior, Los Angeles, California 90095
FAU - Heintz, Nathaniel
AU  - Heintz N
AD  - Laboratory of Molecular Biology, Howard Hughes Medical Institute, New York, New
      York 10065
LA  - eng
PT  - Journal Article
GR  - R00 NS067239 || NS
TA  - J Neurosci
JT  - The Journal of neuroscience : the official journal of the Society for
      Neuroscience
AID - 10.1523/JNEUROSCI.4762-12.2013 [doi]
MID - NIHMS445869
SO  - J Neurosci. 2013 Feb 13;33(7):2732-53. doi:10.1523/JNEUROSCI.4762-12.2013.

PMC - PMC3505632
PMID- 23213493
IS  - 2090-1321 (Print)
IS  - 2090-133X (Electronic)
VI  - 2012
DP  - 2012
TI  - Using Self-Guided Treatment Software (ePST) to Teach Clinicians How to Deliver
      Problem-Solving Treatment for Depression.
LID - 309094
AB  - Problem-solving treatment (PST) offers a promising approach to the depression
      care; however, few PST training opportunities exist. A computer-guided,
      interactive media program has been developed to deliver PST electronically
      (ePST), directly to patients. The program is a six-session, weekly intervention
      modeled on an evidence-based PST protocol. Users are guided through each session 
      by a clinician who is presented via hundreds of branching audio and video clips. 
      Because expert clinician behaviors are modeled in the program, not only does the 
      ePST program have the potential to deliver PST to patients but it may also serve 
      as a training tool to teach clinicians how to deliver PST. Thirteen social
      workers and trainees used ePST self-instructionally and subsequently attended a
      day-long workshop on PST. Participants' PST knowledge level increased
      significantly from baseline to post-ePST (P = .001) and did not increase
      significantly further after attending the subsequent workshop. Additionally,
      attending the workshop did not significantly increase the participants' skill at 
      performing PST beyond the use of the ePST program. Using the ePST program appears
      to train novices to a sufficient level of competence to begin practicing PST
      under supervision. This self-instructional training method could enable PST for
      depression to be widely disseminated, although follow-up supervision is still
      required.
FAU - Cartreine, James A.
AU  - Cartreine JA
AD  - Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School,
      1249 Boylston Avenue 3rd floor, Boston, MA 02215, USA
FAU - Chang, Trina E.
AU  - Chang TE
AD  - Harvard Medical School, Boston, MA 02215, USA
FAU - Seville, Janette L.
AU  - Seville JL
AD  - Department of Psychiatry, Dartmouth-Hitchcock Medical Center, Dartmouth Medical
      School, Lebanon, NH 03756, USA
FAU - Sandoval, Luis
AU  - Sandoval L
AD  - Department of Educational Psychology, University of Texas at Austin, Austin, TX
      72705, USA
FAU - Moore, John B.
AU  - Moore JB
AD  - Harvard Medical School, Boston, MA 02215, USA
FAU - Xu, Shuai
AU  - Xu S
AD  - Harvard Medical School, Boston, MA 02215, USA
FAU - Hegel, Mark T.
AU  - Hegel MT
AD  - Department of Psychiatry, Dartmouth-Hitchcock Medical Center, Dartmouth Medical
      School, Lebanon, NH 03756, USA
LA  - eng
PT  - Journal Article
DEP - 20121114
PHST- 2012/04/02 [received]
PHST- 2012/08/19 [revised]
PHST- 2012/08/26 [accepted]
PHST- 2012/11/14 [aheadofprint]
TA  - Depress Res Treat
JT  - Depression Research and Treatment
AID - 10.1155/2012/309094 [doi]
SO  - Depress Res Treat. 2012;2012:. Epub 2012 Nov 14 doi:10.1155/2012/309094.

PMC - PMC2848996
PMID- 19569894
IS  - 1092-0684 (Electronic)
VI  - 27
IP  - 1
DP  - 2009 Jul
TI  - Getting signals into the brain: visual prosthetics through thalamic
      microstimulation.
PG  - E6
AB  - Common causes of blindness are diseases that affect the ocular structures, such
      as glaucoma, retinitis pigmentosa, and macular degeneration, rendering the eyes
      no longer sensitive to light. The visual pathway, however, as a predominantly
      central structure, is largely spared in these cases. It is thus widely thought
      that a device-based prosthetic approach to restoration of visual function will be
      effective and will enjoy similar success as cochlear implants have for
      restoration of auditory function. In this article the authors review the
      potential locations for stimulation electrode placement for visual prostheses,
      assessing the anatomical and functional advantages and disadvantages of each. Of 
      particular interest to the neurosurgical community is placement of deep brain
      stimulating electrodes in thalamic structures that has shown substantial promise 
      in an animal model. The theory of operation of visual prostheses is discussed,
      along with a review of the current state of knowledge. Finally, the visual
      prosthesis is proposed as a model for a general high-fidelity machine-brain
      interface.
FAU - Pezaris, John S.
AU  - Pezaris JS
FAU - Eskandar, Emad N.
AU  - Eskandar EN
LA  - eng
PT  - Journal Article
TA  - Neurosurg Focus
JT  - Neurosurgical focus
AID - 10.3171/2009.4.FOCUS0986 [doi]
MID - NIHMS178343
SO  - Neurosurg Focus. 2009 Jul;27(1):E6. doi:10.3171/2009.4.FOCUS0986.

PMC - PMC1867799
PMID- 15764805
IS  - 0017-5749 (Print)
IS  - 1458-3288 (Electronic)
VI  - 54
IP  - Suppl 2
DP  - 2005 Apr
TI  - Abstracts.
PG  - a1-a117
LA  - eng
PT  - Journal Article
TA  - Gut
JT  - Gut
SO  - Gut. 2005 Apr;54(Suppl 2):a1-a117.

PMC - PMC3459596
PMID- 23028266
IS  - 1552-3098 (Print)
IS  - 1941-0468 (Electronic)
VI  - 28
IP  - 1
DP  - 2012 Feb 1
TI  - Micron: an Actively Stabilized Handheld Tool for Microsurgery.
PG  - 195-212
AB  - We describe the design and performance of a hand-held actively stabilized tool to
      increase accuracy in micro-surgery or other precision manipulation. It removes
      involuntary motion such as tremor by actuating the tip to counteract the effect
      of the undesired handle motion. The key components are a three-degree-of-freedom 
      piezoelectric manipulator that has 400 μm range of motion, 1 N force capability, 
      and bandwidth over 100 Hz, and an optical position measurement subsystem that
      acquires the tool pose with 4 μm resolution at 2000 samples/s. A control system
      using these components attenuates hand motion by at least 15 dB (a fivefold
      reduction). By considering the effect of the frequency response of Micron on the 
      human visual feedback loop, we have developed a filter that reduces unintentional
      motion, yet preserves intuitive eye-hand coordination. We evaluated the
      effectiveness of Micron by measuring the accuracy of the human/machine system in 
      three simple manipulation tasks. Handheld testing by three eye surgeons and three
      non-surgeons showed a reduction in position error of between 32% and 52%,
      depending on the error metric.
FAU - MacLachlan, Robert A.
AU  - MacLachlan RA
AD  - Robotics Institute, Carnegie Mellon University, Pittsburgh, PA 15213 USA
FAU - Becker, Brian C.
AU  - Becker BC
AD  - Robotics Institute, Carnegie Mellon University, Pittsburgh, PA 15213 USA
FAU - Tabarés, Jaime Cuevas
AU  - Tabarés JC
AD  - University of Valladolid, Spain
FAU - Podnar, Gregg W.
AU  - Podnar GW
AD  - Robotics Institute, Carnegie Mellon University, Pittsburgh, PA 15213 USA
FAU - Lobes, Louis A.
AU  - Lobes LA
AD  - Dept. of Ophthalmology, University of Pittsburgh Medical Center, Pittsburgh, PA
      15213 USA
FAU - Riviere, Cameron N.
AU  - Riviere CN
AD  - Robotics Institute, Carnegie Mellon University, Pittsburgh, PA 15213 USA
LA  - eng
PT  - Journal Article
DEP - 20111118
GR  - R01 EB007969-04 || EB
TA  - IEEE Trans Robot
JT  - IEEE transactions on robotics : a publication of the IEEE Robotics and Automation
      Society
AID - 10.1109/TRO.2011.2169634 [doi]
MID - NIHMS345015
SO  - IEEE Trans Robot. 2012 Feb 1;28(1):195-212. Epub 2011 Nov 18
      doi:10.1109/TRO.2011.2169634.

PMC - PMC4116281
PMID- 25133052
IS  - 2155-7772 (Print)
IS  - 2155-7780 (Electronic)
VI  - 16
IP  - 2
DP  - 2014
TI  - Psychotic Disorders in Children and Adolescents: A Primer on Contemporary
      Evaluation and Management.
LID - PCC.13f01514
FAU - Stevens, Jonathan R.
AU  - Stevens JR
FAU - Prince, Jefferson B.
AU  - Prince JB
FAU - Prager, Laura M.
AU  - Prager LM
FAU - Stern, Theodore A.
AU  - Stern TA
LA  - eng
PT  - Journal Article
DEP - 20140313
PHST- 2013/03/08 [received]
PHST- 2013/11/26 [accepted]
PHST- 2014/03/13 [aheadofprint]
TA  - Prim Care Companion CNS Disord
JT  - The Primary Care Companion for CNS Disorders
AID - 13f01514 [pii]
AID - 10.4088/PCC.13f01514 [doi]
SO  - Prim Care Companion CNS Disord. 2014;16(2):. Epub 2014 Mar 13
      doi:10.4088/PCC.13f01514.

PMC - PMC2783198
PMID- 19590458
IS  - 1072-3714 (Print)
IS  - 1530-0374 (Electronic)
VI  - 16
IP  - 6
DP  - 2009 Nov–Dec
TI  - Effects of Botanicals and Combined Hormone Therapy on Cognition in Postmenopausal
      Women.
PG  - 1167-77
AB  - Objective: To characterize the effects of red clover, black cohosh, and combined 
      hormone therapy on cognitive function in comparison to placebo in women with
      moderate to severe vasomotor symptoms. Design: In a Phase II randomized,
      double-blind, placebo-controlled study, 66 midlife women (out of 89 from a parent
      study; mean age=53 y) with ≥ 35 weekly hot flashes were randomized to receive red
      clover (120 mg), black cohosh (128 mg), CEE/MPA (0.625 mg conjugated equine
      estrogens plus 2.5 mg medroxyprogesterone acetate), or placebo. Participants
      completed measures of verbal memory (primary outcome) and other cognitive
      measures (secondary outcomes) before and during the 12th treatment month. A
      subset of 19 women completed objective, physiological measures of hot flashes
      using ambulatory skin conductance monitors. Results: There was no impact of
      either of the botanical treatments on any cognitive measure. Compared to placebo,
      CEE/MPA led to greater decline in verbal learning (one of five verbal memory
      measures). This effect just missed statistical significance (p=0.057) in
      unadjusted analyses, but reached significance (p=.02) after adjusting for
      vasomotor symptoms. Neither botanical treatment group showed a change in verbal
      memory that differed from the placebo group (ps>0.28), even after controlling for
      improvements in hot flashes. In secondary outcomes, CEE/MPA led to a decrease in 
      immediate digit recall and an improvement in letter fluency. Only CEE/MPA
      significantly reduced objective hot flashes. Conclusions: Results indicate no
      effects of a red clover (phytoestrogen) supplement or black cohosh on cognitive
      function. CEE/MPA reduces objective hot flashes but worsens some aspects of
      verbal memory.
FAU - Maki, Pauline M.
AU  - Maki PM
AD  - Department of Psychiatry, University of Illinois at Chicago
FAU - Rubin, Leah H.
AU  - Rubin LH
AD  - Department of Psychiatry, University of Illinois at Chicago
FAU - Fornelli, Deanne
AU  - Fornelli D
AD  - Department of Psychiatry, University of Illinois at Chicago
FAU - Drogos, Lauren
AU  - Drogos L
AD  - Department of Psychiatry, University of Illinois at Chicago
FAU - Banuvar, Suzanne
AU  - Banuvar S
AD  - Department of Obstetrics and Gynecology, Feinberg School of Medicine,
      Northwestern University
FAU - Shulman, Lee P.
AU  - Shulman LP
AD  - Department of Obstetrics and Gynecology, Feinberg School of Medicine,
      Northwestern University
FAU - Geller, Stacie E.
AU  - Geller SE
AD  - Department of Obstetrics and Gynecology, University of Illinois at Chicago
LA  - eng
PT  - Journal Article
TA  - Menopause
JT  - Menopause (New York, N.Y.)
AID - 10.1097/gme.0b013e3181ace484 [doi]
MID - NIHMS139478
SO  - Menopause. 2009 Nov–Dec;16(6):1167-77. doi:10.1097/gme.0b013e3181ace484.

PMC - PMC2634811
PMID- 18986237
IS  - 1473-7175 (Print)
IS  - 1744-8360 (Electronic)
VI  - 8
IP  - 11
DP  - 2008 Nov
TI  - Applications of virtual reality for pain management in burn-injured patients.
PG  - 1667-74
AB  - The pain associated with burn injuries is intense, unremitting and often
      exacerbated by anxiety, depression and other complicating patient factors. On top
      of this, modern burn care involves the repetitive performance – often on a daily 
      basis for weeks to months – of painful and anxiety-provoking procedures that
      create additional treatment-related pain, such as wound care, dressing changes
      and rehabilitation activities. Pain management in burn patients is primarily
      achieved by potent pharmacologic analgesics (e.g., opioids), but is necessarily
      complemented by nonpharmacologic techniques, including distraction or hypnosis.
      Immersive virtual reality provides a particularly intense form of cognitive
      distraction during such brief, painful procedures, and has undergone preliminary 
      study by several research groups treating burn patients over the past decade.
      Initial reports from these groups are consistent in suggesting that immersive
      virtual reality is logistically feasible, safe and effective in ameliorating the 
      pain and anxiety experienced in various settings of post-burn pain. Furthermore, 
      the technique appears applicable to a wide age range of patients and may be
      particularly well-adapted for use in children, one of the most challenging
      populations of burn victims to treat. However, confirmation and extension of
      these results in larger numbers of patients in various types of burn-related pain
      is necessary to more clearly define the specific benefits and limitations of
      virtual reality analgesia in the burn care setting.
FAU - Sharar, Sam R
AU  - Sharar SR
AD  - Professor, Department of Anesthesiology, Harborview Medical Center, #359724, 325 
      Ninth Avenue, Seattle, WA 98104, USA, Tel.: +1 206 744 5765, Fax: +1 206 744
      8090, sharar@u.washington.edu
FAU - Miller, William
AU  - Miller W
AD  - Research Assistant, Department of, Rehabilitation Medicine, Harborview, Medical
      Center, #359796, 325 Ninth, Avenue, Seattle, WA 98104, USA, Tel.: +1 206 744
      4811, Fax: +1 206 744 8580, ano327@u.washington.edu
FAU - Teeley, Aubriana
AU  - Teeley A
AD  - Research Coordinator, Department of, Rehabilitation Medicine, Harborview, Medical
      Center, #359796, 325 Ninth, Avenue, Seattle, WA 98104, USA, Tel.: +1 206 744
      4811, Fax: +1 206 744 8580, aubriana@u.washington.edu
FAU - Soltani, Maryam
AU  - Soltani M
AD  - Research Coordinator, Department of, Rehabilitation Medicine, Harborview, Medical
      Center, #359796, 325 Ninth, Avenue, Seattle, WA 98104, USA, Tel.: +1 206 744
      2172, Fax: +1 206 744 8580, soltani@u.washington.edu
FAU - Hoffman, Hunter G
AU  - Hoffman HG
AD  - Research Scientist, Human Interface, Technology Laboratory, University of
      Washington, #352142, Seattle, WA 98195, USA Tel.: +1 206 616 1496 Fax: +1 206 543
      5380 hunter@hitl.washington.edu
FAU - Jensen, Mark P
AU  - Jensen MP
AD  - Professor, Department of Rehabilitation, Medicine, University of Washington,
      #356490, Seattle, WA 98195, USA, Tel.: +1 206 543 3185, Fax: +1 206 685 3244,
      mjensen@u.washington.edu
FAU - Patterson, David R
AU  - Patterson DR
AD  - Professor, Department of Rehabilitation, Medicine, Harborview Medical Center,
      #359740, 325 Ninth Avenue, Seattle, WA 98104, USA, Tel.: +1 206 744 3418, Fax: +1
      206 744 8580, davepatt@u.washington.edu
LA  - eng
PT  - Journal Article
TA  - Expert Rev Neurother
JT  - Expert review of neurotherapeutics
AID - 10.1586/14737175.8.11.1667 [doi]
MID - NIHMS87525
SO  - Expert Rev Neurother. 2008 Nov;8(11):1667-74. doi:10.1586/14737175.8.11.1667.

PMC - PMC3015958
PMID- 19793463
IS  - 1086-8089 (Print)
IS  - 1938-3797 (Electronic)
VI  - 13
IP  - 3
DP  - 2009 Jul-Sep
TI  - Virtual Reality Simulators in Gynecological Endoscopy: a Surging New Wave.
PG  - 279-86
FAU - Mettler, Liselotte L.
AU  - Mettler LL
AD  - Department of Obstetrics and Gynecology, University Hospitals Schleswig-Holstein,
      Campus Kiel, Germany.
FAU - Dewan, Puja
AU  - Dewan P
LA  - eng
PT  - Journal Article
TA  - JSLS
JT  - JSLS : Journal of the Society of Laparoendoscopic Surgeons
SO  - JSLS. 2009 Jul-Sep;13(3):279-86.

PMC - PMC3533836
PMID- 22650320
IS  - 1743-0003 (Electronic)
VI  - 9
DP  - 2012
TI  - Feasibility and effects of patient-cooperative robot-aided gait training applied 
      in a 4-week pilot trial.
PG  - 31
AB  - Background: Functional training is becoming the state-of-the-art therapy approach
      for rehabilitation of individuals after stroke and spinal cord injury.
      Robot-aided treadmill training reduces personnel effort, especially when treating
      severely affected patients. Improving rehabilitation robots towards more
      patient-cooperative behavior may further increase the effects of robot-aided
      training. This pilot study aims at investigating the feasibility of applying
      patient-cooperative robot-aided gait rehabilitation to stroke and incomplete
      spinal cord injury during a therapy period of four weeks. Short-term effects
      within one training session as well as the effects of the training on walking
      function are evaluated. Methods: Two individuals with chronic incomplete spinal
      cord injury and two with chronic stroke trained with the Lokomat gait
      rehabilitation robot which was operated in a new, patient-cooperative mode for a 
      period of four weeks with four training sessions of 45 min per week. At baseline,
      after two and after four weeks, walking function was assessed with the ten meter 
      walking test. Additionally, muscle activity of the major leg muscles, heart rate 
      and the Borg scale were measured under different walking conditions including a
      non-cooperative position control mode to investigate the short-term effects of
      patient-cooperative versus non-cooperative robot-aided gait training. Results:
      Patient-cooperative robot-aided gait training was tolerated well by all subjects 
      and performed without difficulties. The subjects trained more actively and with
      more physiological muscle activity than in a non-cooperative position-control
      mode. One subject showed a significant and relevant increase of gait speed after 
      the therapy, the three remaining subjects did not show significant changes.
      Conclusions: Patient-cooperative robot-aided gait training is feasible in
      clinical practice and overcomes the main points of criticism against robot-aided 
      gait training: It enables patients to train in an active, variable and more
      natural way. The limited number of subjects in this pilot trial does not permit
      valid conclusions on the effect of patient-cooperative robot-aided gait training 
      on walking function. A large, possibly multi-center randomized controlled
      clinical trial is required to shed more light on this question.
FAU - Schück, Alex
AU  - Schück A
AD  - Spinal Cord Injury Center, University Hospital Balgrist, University of Zurich,
      Zurich, Switzerland
FAU - Labruyère, Rob
AU  - Labruyère R
AD  - Spinal Cord Injury Center, University Hospital Balgrist, University of Zurich,
      Zurich, Switzerland
FAU - Vallery, Heike
AU  - Vallery H
AD  - Sensory-Motor Systems Lab, Institute of Robotics and Intelligent Systems,
      Department of Mechanical and Process Engineering,, ETH Zurich, Zurich,
      Switzerland
FAU - Riener, Robert
AU  - Riener R
AD  - Sensory-Motor Systems Lab, Institute of Robotics and Intelligent Systems,
      Department of Mechanical and Process Engineering,, ETH Zurich, Zurich,
      Switzerland
FAU - Duschau-Wicke, Alexander
AU  - Duschau-Wicke A
AD  - Sensory-Motor Systems Lab, Institute of Robotics and Intelligent Systems,
      Department of Mechanical and Process Engineering,, ETH Zurich, Zurich,
      Switzerland
LA  - eng
PT  - Journal Article
DEP - 20120531
PHST- 2011/08/02 [received]
PHST- 2012/04/20 [accepted]
TA  - J Neuroeng Rehabil
JT  - Journal of NeuroEngineering and Rehabilitation
AID - 1743-0003-9-31 [pii]
AID - 10.1186/1743-0003-9-31 [doi]
SO  - J Neuroeng Rehabil. 2012 May 31;9:31. doi:10.1186/1743-0003-9-31.

PMC - PMC2657346
PMID- 19384627
IS  - 1590-9921 (Print)
IS  - 1590-9999 (Electronic)
VI  - 9
IP  - Suppl 1
DP  - 2008 Nov
TI  - Abstract Book - 93rd National Congress of the Italian Society of Orthopaedics and
      Traumatology.
PG  - 1-94
LA  - eng
PT  - Journal Article
DEP - 20081202
TA  - J Orthop Traumatol
JT  - Journal of Orthopaedics and Traumatology : Official Journal of the Italian
      Society of Orthopaedics and Traumatology
AID - 30 [pii]
AID - 10.1007/s10195-008-0030-6 [doi]
SO  - J Orthop Traumatol. 2008 Nov;9(Suppl 1):1-94. Epub 2008 Dec 2
      doi:10.1007/s10195-008-0030-6.

PMC - PMC3015005
PMID- 20830707
IS  - 0020-7136 (Print)
IS  - 1097-0215 (Electronic)
VI  - 128
IP  - 5
DP  - 2011 Mar 1
TI  - Accuracy of optical spectroscopy for the detection of cervical intraepithelial
      neoplasia: testing a device as an adjunct to colposcopy.
PG  - 1151-68
AB  - Testing emerging technologies involves the evaluation of biologic plausibility,
      technical efficacy, clinical effectiveness, patient satisfaction, and
      cost-effectiveness. The objective of this study was to select an effective
      classification algorithm for optical spectroscopy as an adjunct to colposcopy and
      obtain preliminary estimates of its accuracy for the detection of CIN 2 or worse.
      We recruited 1000 patients from screening and prevention clinics and 850 patients
      from colposcopy clinics at two comprehensive cancer centers and a community
      hospital. Optical spectroscopy was performed and 4864 biopsies were obtained from
      the sites measured, including abnormal and normal colposcopic areas. The gold
      standard was the histologic report of biopsies, read 2–3 times by
      histopathologists blinded to the cytologic, histopathologic, and spectroscopic
      results. We calculated sensitivities, specificities, receiver operating
      characteristic (ROC) curves, and areas under the ROC curves. We identified a
      cutpoint for an algorithm based on optical spectroscopy that yielded an estimated
      sensitivity of 1.00 [95% confidence interval (CI) = 0.92 – 1.00] and an estimated
      specificity of 0.71 [95% CI = 0.62 – 0.79] in a combined screening and diagnostic
      population. The positive and negative predictive values were 0.58 and 1.00,
      respectively. The area under the ROC curve was 0.85 (95% CI 0.81 – 0.89). The
      per-patient and per-site performance were similar in the diagnostic and poorer in
      the screening settings. Like colposcopy, the device performs best in a diagnostic
      population. Alternative statistical approaches demonstrate that the analysis is
      robust and that spectroscopy works as well as or slightly better than colposcopy 
      for the detection of CIN 2 to cancer.
FAU - Cantor, Scott B.
AU  - Cantor SB
AD  - Department of Biostatistics, The University of Texas MD Anderson Cancer Center,
      Houston, Texas
FAU - Yamal, Jose-Miguel
AU  - Yamal JM
AD  - Division of Biostatistics, The University of Texas School of Public Health,
      Houston, Texas
FAU - Guillaud, Martial
AU  - Guillaud M
AD  - Department of Cancer Imaging, British Columbia Cancer Research Centre, Vancouver,
      British Columbia, Canada
FAU - Cox, Dennis D.
AU  - Cox DD
AD  - Department of Statistics, Rice University, Houston, Texas
FAU - Atkinson, E. Neely
AU  - Atkinson EN
AD  - Department of Biostatistics, The University of Texas MD Anderson Cancer Center,
      Houston, Texas
FAU - Benedet, J. L.
AU  - Benedet JL
AD  - Department of Cancer Imaging, British Columbia Cancer Research Centre, Vancouver,
      British Columbia, Canada
FAU - Miller, Dianne
AU  - Miller D
AD  - Division of Gynecologic Oncology, Department of Obstetrics and Gynecology,
      University of British Columbia, Vancouver, British Columbia, Canada
FAU - Ehlen, Thomas
AU  - Ehlen T
AD  - Division of Gynecologic Oncology, Department of Obstetrics and Gynecology,
      University of British Columbia, Vancouver, British Columbia, Canada
FAU - Matisic, Jasenka
AU  - Matisic J
AD  - Department of Pathology, University of British Columbia, Vancouver, British
      Columbia, Canada
FAU - van Niekerk, Dirk
AU  - van Niekerk D
AD  - Department of Pathology, University of British Columbia, Vancouver, British
      Columbia, Canada
FAU - Bertrand, Monique
AU  - Bertrand M
AD  - Division of Gynecologic Oncology, Department of Obstetrics and Gynecology,
      University of British Columbia, Vancouver, British Columbia, Canada
FAU - Milbourne, Andrea
AU  - Milbourne A
AD  - Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer
      Center, Houston, Texas
FAU - Rhodes, Helen
AU  - Rhodes H
AD  - Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer
      Center, Houston, Texas
FAU - Malpica, Anais
AU  - Malpica A
AD  - Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer
      Center, Houston, Texas
FAU - Staerkel, Gregg
AU  - Staerkel G
AD  - Department of Pathology, The University of Texas MD Anderson Cancer Center,
      Houston, Texas
FAU - Nader-Eftekhari, Shahla
AU  - Nader-Eftekhari S
AD  - Department of Obstetrics, Gynecology, and Reproductive Sciences, The University
      of Texas Health Science Center at Houston, Houston, Texas
FAU - Adler-Storthz, Karen
AU  - Adler-Storthz K
AD  - The University of Texas Health Science Center at Houston Dental Branch, Houston, 
      Texas
FAU - Scheurer, Michael E.
AU  - Scheurer ME
AD  - Department of Pediatrics and Dan L. Duncan Cancer Center, Baylor College of
      Medicine, Houston, Texas
FAU - Basen-Engquist, Karen
AU  - Basen-Engquist K
AD  - Department of Behavioral Science, The University of Texas MD Anderson Cancer
      Center, Houston, Texas
FAU - Shinn, Eileen
AU  - Shinn E
AD  - Department of Behavioral Science, The University of Texas MD Anderson Cancer
      Center, Houston, Texas
FAU - West, Loyd A.
AU  - West LA
AD  - Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer
      Center, Houston, Texas
FAU - Vlastos, Anne-Therese
AU  - Vlastos AT
AD  - Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer
      Center, Houston, Texas
FAU - Tao, Xia
AU  - Tao X
AD  - Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer
      Center, Houston, Texas
FAU - Beck, J. Robert
AU  - Beck JR
AD  - Fox Chase Cancer Center, Philadelphia, Pennsylvania
FAU - MacAulay, Calum
AU  - MacAulay C
AD  - Department of Cancer Imaging, British Columbia Cancer Research Centre, Vancouver,
      British Columbia, Canada
FAU - Follen, Michele
AU  - Follen M
AD  - Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer
      Center, Houston, Texas
LA  - eng
PT  - Journal Article
DEP - 20101109
TA  - Int J Cancer
JT  - International journal of cancer. Journal international du cancer
AID - 10.1002/ijc.25667 [doi]
MID - NIHMS236083
SO  - Int J Cancer. 2011 Mar 1;128(5):1151-68. Epub 2010 Nov 9 doi:10.1002/ijc.25667.

PMC - PMC3580200
PMID- 23299824
IS  - 1528-4042 (Print)
IS  - 1534-6293 (Electronic)
VI  - 13
IP  - 2
DP  - 2013 Feb
TI  - Biomarkers and predictors of restorative therapy effects after stroke.
PG  - 329
AB  - Many restorative therapies that promote brain repair are under development.
      Stroke is very heterogeneous, highlighting the need to identify target
      populations and to understand inter-subject differences in treatment response.
      Several neuroimaging measures have shown promise as biomarkers and predictors,
      including measures of structure and function, in gray matter and white matter.
      Choice of biomarker and predictor can vary with the content of therapy and with
      the population under study, for example, contralesional hemisphere measures may
      be of particular importance in patients with more severe injury. Studies of
      training effects in healthy subjects provide insights useful to brain repair.
      Limitations of published studies include a focus on chronic stroke, however the
      brain is most galvanized to respond to restorative therapies in the early days
      post-stroke. Multimodal approaches might be the most robust approach for
      stratifying patients and so for optimizing prescription of restorative therapies 
      after stroke.
FAU - Burke, Erin
AU  - Burke E
AD  - Department of Anatomy & Neurobiology, University of California, Irvine
FAU - Cramer, Steven C.
AU  - Cramer SC
AD  - Department of Anatomy & Neurobiology, University of California, Irvine
LA  - eng
PT  - Journal Article
GR  - UL1 RR031985 || RR
TA  - Curr Neurol Neurosci Rep
JT  - Current neurology and neuroscience reports
AID - 10.1007/s11910-012-0329-9 [doi]
MID - NIHMS434915
SO  - Curr Neurol Neurosci Rep. 2013 Feb;13(2):329. doi:10.1007/s11910-012-0329-9.

PMC - PMC4759282
PMID- 26924976
IS  - 1662-5161 (Electronic)
VI  - 10
DP  - 2016
TI  - Functional Connectivity in the Left Dorsal Stream Facilitates Simultaneous
      Language Translation: An EEG Study.
LID - 60
AB  - Cortical speech processing is dependent on the mutual interdependence of two
      distinctive processing streams supporting sound-to-meaning (i.e., ventral stream)
      and sound-to-articulation (i.e., dorsal stream) mapping. Here, we compared the
      strengths of intracranial functional connectivity between two main hubs of the
      dorsal stream, namely the left auditory-related cortex (ARC) and Broca’s region, 
      in a sample of simultaneous interpreters (SIs) and multilingual control subjects 
      while the participants performed a mixed and unmixed auditory semantic decision
      task. Under normal listening conditions such kind of tasks are known to initiate 
      a spread of activation along the ventral stream. However, due to extensive and
      specific training, here we predicted that SIs will more strongly recruit the
      dorsal pathway in order to pre-activate the speech codes of the corresponding
      translation. In line with this reasoning, EEG results demonstrate increased
      left-hemispheric theta phase synchronization in SLI compared to multilingual
      control participants during early task-related processing stages. In addition,
      within the SI group functional connectivity strength in the left dorsal pathway
      was positively related to the cumulative number of training hours across
      lifespan, and inversely correlated with the age of training commencement. Hence, 
      we propose that the alignment of neuronal oscillations between brain regions
      involved in “hearing” and “speaking” results from an intertwining of training,
      sensitive period, and predisposition.
FAU - Elmer, Stefan
AU  - Elmer S
AD  - Auditory Research Group Zurich (ARGZ), Division Neuropsychology, Institute of
      Psychology, University of ZurichZurich, Switzerland
FAU - Kühnis, Jürg
AU  - Kühnis J
AD  - Auditory Research Group Zurich (ARGZ), Division Neuropsychology, Institute of
      Psychology, University of ZurichZurich, Switzerland
LA  - eng
PT  - Journal Article
DEP - 20160219
GR  - 320030-120661
PHST- 2015/11/13 [received]
PHST- 2016/02/08 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2016.00060 [doi]
SO  - Front Hum Neurosci. 2016 Feb 19;10:. doi:10.3389/fnhum.2016.00060.

PMC - PMC5017638
PMID- 27611328
IS  - 1553-734X (Print)
IS  - 1553-7358 (Electronic)
VI  - 12
IP  - 9
DP  - 2016 Sep
TI  - Stimulation-Based Control of Dynamic Brain Networks.
LID - e1005076
AB  - The ability to modulate brain states using targeted stimulation is increasingly
      being employed to treat neurological disorders and to enhance human performance. 
      Despite the growing interest in brain stimulation as a form of neuromodulation,
      much remains unknown about the network-level impact of these focal perturbations.
      To study the system wide impact of regional stimulation, we employ a data-driven 
      computational model of nonlinear brain dynamics to systematically explore the
      effects of targeted stimulation. Validating predictions from network control
      theory, we uncover the relationship between regional controllability and the
      focal versus global impact of stimulation, and we relate these findings to
      differences in the underlying network architecture. Finally, by mapping brain
      regions to cognitive systems, we observe that the default mode system imparts
      large global change despite being highly constrained by structural connectivity. 
      This work forms an important step towards the development of personalized
      stimulation protocols for medical treatment or performance enhancement.
OAB - Publisher: Abstract available from the publisher.
FAU - Muldoon, Sarah Feldt
AU  - Muldoon SF
AUID- ORCID: 0000-0002-2830-9291
AD  - Department of Bioengineering, University of Pennsylvania, Philadelphia,
      Pennsylvania, United States of America
FAU - Pasqualetti, Fabio
AU  - Pasqualetti F
AD  - Department of Mechanical Engineering, University of California, Riverside,
      Riverside, California, United States of America
FAU - Gu, Shi
AU  - Gu S
AD  - Department of Bioengineering, University of Pennsylvania, Philadelphia,
      Pennsylvania, United States of America
FAU - Cieslak, Matthew
AU  - Cieslak M
AD  - Department of Psychological and Brain Sciences, University of California, Santa
      Barbara, Santa Barbara, California, United States of America
FAU - Grafton, Scott T.
AU  - Grafton ST
AUID- ORCID: 0000-0003-4015-3151
AD  - Department of Psychological and Brain Sciences, University of California, Santa
      Barbara, Santa Barbara, California, United States of America
FAU - Vettel, Jean M.
AU  - Vettel JM
AUID- ORCID: 0000-0001-5336-2986
AD  - US Army Research Laboratory, Aberdeen Proving Ground, Maryland, United States of 
      America
FAU - Bassett, Danielle S.
AU  - Bassett DS
AUID- ORCID: 0000-0002-6183-4493
AD  - Department of Bioengineering, University of Pennsylvania, Philadelphia,
      Pennsylvania, United States of America
LA  - eng
PT  - Journal Article
DEP - 20160909
GR  - W911NF-10-2-0022
PHST- 2016/01/24 [received]
PHST- 2016/07/23 [accepted]
TA  - PLoS Comput Biol
JT  - PLoS Computational Biology
AID - PCOMPBIOL-D-16-00120 [pii]
AID - 10.1371/journal.pcbi.1005076 [doi]
SO  - PLoS Comput Biol. 2016 Sep 9;12(9):. doi:10.1371/journal.pcbi.1005076.

PMC - PMC4304489
PMID- 25546652
IS  - 1948-7193 (Print)
IS  - 1948-7193 (Electronic)
VI  - 6
IP  - 1
DP  - 2015 Jan 21
TI  - Brain Tissue Responses to Neural Implants Impact Signal Sensitivity and
      Intervention Strategies.
PG  - 48-67
AB  - Implantable biosensors are valuable scientific tools for basic neuroscience
      research and clinical applications. Neurotechnologies provide direct readouts of 
      neurological signal and neurochemical processes. These tools are generally most
      valuable when performance capacities extend over months and years to facilitate
      the study of memory, plasticity, and behavior or to monitor patients’ conditions.
      These needs have generated a variety of device designs from microelectrodes for
      fast scan cyclic voltammetry (FSCV) and electrophysiology to microdialysis probes
      for sampling and detecting various neurochemicals. Regardless of the technology
      used, the breaching of the blood–brain barrier (BBB) to insert devices triggers a
      cascade of biochemical pathways resulting in complex molecular and cellular
      responses to implanted devices. Molecular and cellular changes in the
      microenvironment surrounding an implant include the introduction of mechanical
      strain, activation of glial cells, loss of perfusion, secondary metabolic injury,
      and neuronal degeneration. Changes to the tissue microenvironment surrounding the
      device can dramatically impact electrochemical and electrophysiological signal
      sensitivity and stability over time. This review summarizes the magnitude,
      variability, and time course of the dynamic molecular and cellular level neural
      tissue responses induced by state-of-the-art implantable devices. Studies show
      that insertion injuries and foreign body response can impact signal quality
      across all implanted central nervous system (CNS) sensors to varying degrees over
      both acute (seconds to minutes) and chronic periods (weeks to months).
      Understanding the underlying biological processes behind the brain tissue
      response to the devices at the cellular and molecular level leads to a variety of
      intervention strategies for improving signal sensitivity and longevity.
FAU - Kozai, Takashi D. Y.
AU  - Kozai TDY
AD  - Department of Bioengineering, Center for the Neural Basis of Cognition, McGowan
      Institute for Regenerative Medicine, Department of Chemistry, and Department of
      Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United
      States
FAU - Jaquins-Gerstl, Andrea S.
AU  - Jaquins-Gerstl AS
AD  - Department of Bioengineering, Center for the Neural Basis of Cognition, McGowan
      Institute for Regenerative Medicine, Department of Chemistry, and Department of
      Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United
      States
FAU - Vazquez, Alberto L.
AU  - Vazquez AL
AD  - Department of Bioengineering, Center for the Neural Basis of Cognition, McGowan
      Institute for Regenerative Medicine, Department of Chemistry, and Department of
      Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United
      States
FAU - Michael, Adrian C.
AU  - Michael AC
AD  - Department of Bioengineering, Center for the Neural Basis of Cognition, McGowan
      Institute for Regenerative Medicine, Department of Chemistry, and Department of
      Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United
      States
FAU - Cui, X. Tracy
AU  - Cui XT
AD  - Department of Bioengineering, Center for the Neural Basis of Cognition, McGowan
      Institute for Regenerative Medicine, Department of Chemistry, and Department of
      Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United
      States
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20141229
PHST- 2014/10/15 [received]
PHST- 2014/12/29 [accepted]
TA  - ACS Chem Neurosci
JT  - ACS Chemical Neuroscience
AID - 10.1021/cn500256e [doi]
SO  - ACS Chem Neurosci. 2014 Dec 29;6(1):48-67. doi:10.1021/cn500256e.

PMC - PMC2772366
PMID- 19822895
IS  - 0893-8512 (Print)
IS  - 1098-6618 (Electronic)
VI  - 22
IP  - 4
DP  - 2009 Oct
TI  - Delusional Infestation.
PG  - 690-732
AB  - Summary: This papers aims at familiarizing psychiatric and nonpsychiatric readers
      with delusional infestation (DI), also known as delusional parasitosis. It is
      characterized by the fixed belief of being infested with pathogens against all
      medical evidence. DI is no single disorder but can occur as a delusional disorder
      of the somatic type (primary DI) or secondary to numerous other conditions. A set
      of minimal diagnostic criteria and a classification are provided. Patients with
      DI pose a truly interdisciplinary problem to the medical system. They avoid
      psychiatrists and consult dermatologists, microbiologists, or general
      practitioners but often lose faith in professional medicine. Epidemiology and
      history suggest that the imaginary pathogens change constantly, while the
      delusional theme “infestation” is stable and ubiquitous. Patients with
      self-diagnosed “Morgellons disease” can be seen as a variation of this delusional
      theme. For clinicians, clinical pathways for efficient diagnostics and
      etiology-specific treatment are provided. Specialized outpatient clinics in
      dermatology with a liaison psychiatrist are theoretically best placed to provide 
      care. The most intricate problem is to engage patients in psychiatric therapy. In
      primary DI, antipsychotics are the treatment of choice, according to limited but 
      sufficient evidence. Pimozide is no longer the treatment of choice for reasons of
      drug safety. Future research should focus on pathophysiology and the neural basis
      of DI, as well as on conclusive clinical trials, which are widely lacking.
      Innovative approaches will be needed, since otherwise patients are unlikely to
      adhere to any study protocol.
FAU - Freudenmann, Roland W.
AU  - Freudenmann RW
AD  - Department of Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany,
      North Wales NHS Trust, Wrexham Academic Unit, Wrexham, Wales, United Kingdom
FAU - Lepping, Peter
AU  - Lepping P
AD  - Department of Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany,
      North Wales NHS Trust, Wrexham Academic Unit, Wrexham, Wales, United Kingdom
LA  - eng
PT  - Journal Article
TA  - Clin Microbiol Rev
JT  - Clinical Microbiology Reviews
AID - 0018-09 [pii]
AID - 10.1128/CMR.00018-09 [doi]
SO  - Clin Microbiol Rev. 2009 Oct;22(4):690-732. doi:10.1128/CMR.00018-09.

PMC - PMC2713585
PMID- 19126755
IS  - 0031-9333 (Print)
IS  - 1522-1210 (Electronic)
VI  - 89
IP  - 1
DP  - 2009 Jan
TI  - Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function.
PG  - 73-120
AB  - The classical studies of nicotine by Langley at the turn of the 20th century
      introduced the concept of a “receptive substance,” from which the idea of a
      “receptor” came to light. Subsequent studies aided by the Torpedo electric organ,
      a rich source of muscle-type nicotinic receptors (nAChRs), and the discovery of
      α-bungarotoxin, a snake toxin that binds pseudo-irreversibly to the muscle nAChR,
      resulted in the muscle nAChR being the best characterized ligand-gated ion
      channel hitherto. With the advancement of functional and genetic studies in the
      late 1980s, the existence of nAChRs in the mammalian brain was confirmed and the 
      realization that the numerous nAChR subtypes contribute to the psychoactive
      properties of nicotine and other drugs of abuse and to the neuropathology of
      various diseases, including Alzheimer’s, Parkinson’s, and schizophrenia, has
      since emerged. This review provides a comprehensive overview of these findings
      and the more recent revelations of the impact that the rich diversity in function
      and expression of this receptor family has on neuronal and nonneuronal cells
      throughout the body. Despite these numerous developments, our understanding of
      the contributions of specific neuronal nAChR subtypes to the many facets of
      physiology throughout the body remains in its infancy.
FAU - Albuquerque, Edson X.
AU  - Albuquerque EX
FAU - Pereira, Edna F. R.
AU  - Pereira EFR
FAU - Alkondon, Manickavasagom
AU  - Alkondon M
FAU - Rogers, Scott W.
AU  - Rogers SW
LA  - eng
PT  - Journal Article
TA  - Physiol Rev
JT  - Physiological reviews
MID - NIHMS106860
AID - 10.1152/physrev.00015.2008 [doi]
SO  - Physiol Rev. 2009 Jan;89(1):73-120. doi:10.1152/physrev.00015.2008.

PMC - PMC2605268
PMID- 18077465
IS  - 0006-8950 (Print)
IS  - 1460-2156 (Electronic)
VI  - 131
IP  - Pt 2
DP  - 2008 Feb
TI  - Cholinergic modulation of visual and attentional brain responses in Alzheimer's
      disease and in health.
PG  - 409-24
AB  - Visuo-attentional deficits occur early in Alzheimer's disease (AD) and are
      considered more responsive to pro-cholinergic therapy than characteristic memory 
      disturbances. We hypothesised that neural responses in AD during visual
      attentional processing would be impaired relative to controls, yet partially
      susceptible to improvement with cholinesterase inhibition. We studied 16 mild AD 
      patients and 17 age-matched healthy controls, using fMRI-scanning to enable
      within-subject placebo-controlled comparisons of the effects of physostigmine on 
      stimulus- and attention-related brain activations, and to allow between-group
      comparisons for these. Subjects viewed stimuli comprising faces or buildings
      while performing a shallow judgement (colour of image) or a deep judgement
      (young/old age of depicted face or building). Behaviourally, AD subjects
      performed poorer than controls in both tasks, while physostigmine benefited AD
      patients for the more demanding age-judgement task. Stimulus-selective (face
      minus building, and vice versa) BOLD signals in precuneus and posterior
      parahippocampal cortex were attenuated in AD relative to controls but increased
      following physostigmine. By contrast, face-selective responses in fusiform cortex
      were not impaired in AD and showed decreases following physostigmine for both
      groups. Task-dependent responses in right parietal and prefrontal cortices were
      diminished in AD but improved following physostigmine. A similar pattern of group
      and treatment effects was observed in two extrastriate cortical regions that
      showed enhanced stimulus-selectivity for the deep versus shallow task. Finally,
      for the healthy group, physostigmine decreased task-dependent effects, partly due
      to an exaggeration of selectivity during the shallow relative to deep task. Our
      results demonstrate cholinergic-mediated improvements for both stimulus- and
      attention-dependent responses in functionally affected extrastriate and
      frontoparietal regions for AD. We also show that normal stimulus- and
      task-dependent activity patterns can be perturbed in the healthy brain by
      cholinergic stimulation.
FAU - Bentley, P.
AU  - Bentley P
AD  - Wellcome Centre for Neuroimaging at UCL, 12 Queen Square, London WC1N 3BG, UK
FAU - Driver, J.
AU  - Driver J
AD  - Wellcome Centre for Neuroimaging at UCL, 12 Queen Square, London WC1N 3BG, UK
FAU - Dolan, R.J.
AU  - Dolan R
AD  - Wellcome Centre for Neuroimaging at UCL, 12 Queen Square, London WC1N 3BG, UK
LA  - eng
PT  - Journal Article
DEP - 20071212
GR  - 066097 || WT
TA  - Brain
JT  - Brain : a journal of neurology
AID - 10.1093/brain/awm299 [doi]
MID - UKMS3286
SO  - Brain. 2008 Feb;131(Pt 2):409-24. Epub 2007 Dec 12 doi:10.1093/brain/awm299.

PMC - PMC1716227
IS  - 0002-9459 (Print)
IS  - 1553-6467 (Electronic)
VI  - 70
IP  - 3
DP  - 2006 Jun 15
TI  - 107TH Annual Meeting of the American Association of Colleges of Pharmacy, San
      Diego, California, July 9–12.
LID - 65
LA  - eng
PT  - Journal Article
TA  - Am J Pharm Educ
JT  - American Journal of Pharmaceutical Education
AID - ajpe65 [pii]
SO  - Am J Pharm Educ. 2006 Jun 15;70(3):.

PMC - PMC2042573
PMID- 17359612
IS  - 0960-1643 (Print)
VI  - 57
IP  - 536
DP  - 2007 Mar 01
TI  - Headache: a ‘suitable case’ for behavioural treatment in primary care?
PG  - 231-7
AB  - Headache is a health problem with considerable impact at personal, social, and
      financial levels in terms of distress, disability, and cost. In the past, many
      studies have investigated the use of various behavioural treatment modalities for
      headache. Literature reviews consistently support the effectiveness of
      behavioural therapeutic approaches for the treatment of the most common primary
      headaches, namely migraine and tension-type headache. This article recommends
      that behavioural headache therapies should be developed, tested, and integrated
      into primary care practice, where most patients with headache are seen and
      treated. The large population seen in general practice, most of whom have
      uncomplicated primary headaches, could represent the ideal target for testing
      behavioural therapies.
FAU - Symvoulakis, Emmanouil K
AU  - Symvoulakis EK
FAU - Clark, Lucy V
AU  - Clark LV
FAU - Dowson, Andrew J
AU  - Dowson AJ
FAU - Jones, Roger
AU  - Jones R
FAU - Ridsdale, Leone
AU  - Ridsdale L
LA  - eng
PT  - Journal Article
PHST- 2006/04/11 [received]
PHST- 2006/05/12 [revised]
PHST- 2006/07/27 [accepted]
TA  - Br J Gen Pract
JT  - The British Journal of General Practice
SO  - Br J Gen Pract. 2007 Mar 01;57(536):231-7.

PMC - PMC4995098
PMID- 27549126
IS  - 2050-084X (Electronic)
VI  - 5
DP  - 2016
TI  - Probing the functional impact of sub-retinal prosthesis.
LID - e12687
AB  - Retinal prostheses are promising tools for recovering visual functions in blind
      patients but, unfortunately, with still poor gains in visual acuity. Improving
      their resolution is thus a key challenge that warrants understanding its origin
      through appropriate animal models. Here, we provide a systematic comparison
      between visual and prosthetic activations of the rat primary visual cortex (V1). 
      We established a precise V1 mapping as a functional benchmark to demonstrate that
      sub-retinal implants activate V1 at the appropriate position, scalable to a wide 
      range of visual luminance, but with an aspect-ratio and an extent much larger
      than expected. Such distorted activation profile can be accounted for by the
      existence of two sources of diffusion, passive diffusion and activation of
      ganglion cells’ axons en passant. Reverse-engineered electrical pulses based on
      impedance spectroscopy is the only solution we tested that decreases the extent
      and aspect-ratio, providing a promising solution for clinical
      applications.DOI:http://dx.doi.org/10.7554/eLife.12687.001
OAB - Publisher: Abstract available from the publisher.
FAU - Roux, Sébastien
AU  - Roux S
AUID- ORCID: 0000-0003-2366-6430
AD  - Institut de Neurosciences de la Timone, CNRS, Aix-Marseille Université,
      Marseille, France
FAU - Matonti, Frédéric
AU  - Matonti F
AD  - Institut de Neurosciences de la Timone, CNRS, Aix-Marseille Université,
      Marseille, France
FAU - Dupont, Florent
AU  - Dupont F
AD  - CEA-LETI, Grenoble, France
FAU - Hoffart, Louis
AU  - Hoffart L
AD  - Institut de Neurosciences de la Timone, CNRS, Aix-Marseille Université,
      Marseille, France
FAU - Takerkart, Sylvain
AU  - Takerkart S
AD  - Institut de Neurosciences de la Timone, CNRS, Aix-Marseille Université,
      Marseille, France
FAU - Picaud, Serge
AU  - Picaud S
AD  - Inserm, UMRS-986, Institut de la vision, Paris, France
FAU - Pham, Pascale
AU  - Pham P
AD  - CEA-LETI, Grenoble, France
FAU - Chavane, Frédéric
AU  - Chavane F
AD  - Institut de Neurosciences de la Timone, CNRS, Aix-Marseille Université,
      Marseille, France
LA  - eng
PT  - Journal Article
GR  - ANR08-TECS-018
PHST- 2015/11/02 [received]
PHST- 2016/07/07 [accepted]
TA  - eLife
JT  - eLife
AID - 12687 [pii]
AID - 10.7554/eLife.12687 [doi]
SO  - eLife. 2016;5:. doi:10.7554/eLife.12687.

PMC - PMC3342413
PMID- 21691215
IS  - 0885-9701 (Print)
IS  - 1550-509X (Electronic)
VI  - 27
IP  - 4
DP  - 2012 Jul
TI  - NONINVASIVE BRAIN STIMULATION IN TRAUMATIC BRAIN INJURY.
PG  - 274-92
AB  - Brain stimulation techniques have evolved in the last few decades with more novel
      methods capable of painless, noninvasive brain stimulation. While the number of
      clinical trials employing noninvasive brain stimulation continues to increase in 
      a variety of medication-resistant neurological and psychiatric diseases, studies 
      evaluating their diagnostic and therapeutic potential in traumatic brain injury
      (TBI) are largely lacking. This review introduces different techniques of
      noninvasive brain stimulation, which may find potential use in TBI. We cover
      transcranial magnetic stimulation (TMS), transcranial direct current stimulation 
      (tDCS), low-level laser therapy (LLLT) and transcranial doppler sonography (TCD) 
      techniques. We provide a brief overview of studies to date, discuss possible
      mechanisms of action, and raise a number of considerations when thinking about
      translating these methods to clinical use.
FAU - Demirtas-Tatlidede, Asli
AU  - Demirtas-Tatlidede A
AD  - Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess
      Medical Center, Harvard Medical School, Boston, MA
FAU - Vahabzadeh-Hagh, Andrew M.
AU  - Vahabzadeh-Hagh AM
AD  - Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess
      Medical Center, Harvard Medical School, Boston, MA
FAU - Bernabeu, Montserrat
AU  - Bernabeu M
AD  - Guttmann University Institute for Neurorehabilitation, Universitat Autonoma de
      Barcelona, Badalona, Spain
FAU - Tormos, Jose M.
AU  - Tormos JM
AD  - Guttmann University Institute for Neurorehabilitation, Universitat Autonoma de
      Barcelona, Badalona, Spain
FAU - Pascual-Leone, Alvaro
AU  - Pascual-Leone A
AD  - Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess
      Medical Center, Harvard Medical School, Boston, MA
LA  - eng
PT  - Journal Article
GR  - K24 RR018875-05 || RR
TA  - J Head Trauma Rehabil
JT  - The Journal of Head Trauma Rehabilitation
AID - 10.1097/HTR.0b013e318217df55 [doi]
MID - NIHMS289018
SO  - J Head Trauma Rehabil. 2012 Jul;27(4):274-92. doi:10.1097/HTR.0b013e318217df55.

PMC - PMC5338692
PMID- 26300010
IS  - 1069-6563 (Print)
IS  - 1553-2712 (Electronic)
VI  - 22
IP  - 9
DP  - 2015 Sep
TI  - Designing Real-time Decision Support for Trauma Resuscitations.
PG  - 1076-84
AB  - Background: Use of electronic clinical decision support (eCDS) has been
      recommended to improve implementation of clinical decision rules. Many eCDS
      tools, however, are designed and implemented without taking into account the
      context in which clinical work is performed. Implementation of the pediatric
      traumatic brain injury (TBI) clinical decision rule at one Level I pediatric
      emergency department includes an electronic questionnaire triggered when ordering
      a head computed tomography using computerized physician order entry (CPOE).
      Providers use this CPOE tool in less than 20% of trauma resuscitation cases. A
      human factors engineering approach could identify the implementation barriers
      that are limiting the use of this tool. Objectives: The objective was to design a
      pediatric TBI eCDS tool for trauma resuscitation using a human factors approach. 
      The hypothesis was that clinical experts will rate a usability-enhanced eCDS tool
      better than the existing CPOE tool for user interface design and suitability for 
      clinical use. Methods: This mixed-methods study followed usability evaluation
      principles. Pediatric emergency physicians were surveyed to identify barriers to 
      using the existing eCDS tool. Using standard trauma resuscitation protocols, a
      hierarchical task analysis of pediatric TBI evaluation was developed. Five
      clinical experts, all board-certified pediatric emergency medicine faculty
      members, then iteratively modified the hierarchical task analysis until reaching 
      consensus. The software team developed a prototype eCDS display using the
      hierarchical task analysis. Three human factors engineers provided feedback on
      the prototype through a heuristic evaluation, and the software team refined the
      eCDS tool using a rapid prototyping process. The eCDS tool then underwent
      iterative usability evaluations by the five clinical experts using video review
      of 50 trauma resuscitation cases. A final eCDS tool was created based on their
      feedback, with content analysis of the evaluations performed to ensure all
      concerns were identified and addressed. Results: Among 26 EPs (76% response
      rate), the main barriers to using the existing tool were that the information
      displayed is redundant and does not fit clinical workflow. After the prototype
      eCDS tool was developed based on the trauma resuscitation hierarchical task
      analysis, the human factors engineers rated it to be better than the CPOE tool
      for nine of 10 standard user interface design heuristics on a three-point scale. 
      The eCDS tool was also rated better for clinical use on the same scale, in 84% of
      50 expert–video pairs, and was rated equivalent in the remainder. Clinical
      experts also rated barriers to use of the eCDS tool as being low. Conclusions: An
      eCDS tool for diagnostic imaging designed using human factors engineering methods
      has improved perceived usability among pediatric emergency physicians.
FAU - Yadav, Kabir
AU  - Yadav K
FAU - Chamberlain, James M.
AU  - Chamberlain JM
FAU - Lewis, Vicki R.
AU  - Lewis VR
FAU - Abts, Natalie
AU  - Abts N
FAU - Chawla, Shawn
AU  - Chawla S
FAU - Hernandez, Angie
AU  - Hernandez A
FAU - Johnson, Justin
AU  - Johnson J
FAU - Tuveson, Genevieve
AU  - Tuveson G
FAU - Burd, Randall S.
AU  - Burd RS
LA  - eng
PT  - Journal Article
DEP - 20150824
TA  - Acad Emerg Med
JT  - Academic emergency medicine : official journal of the Society for Academic
      Emergency Medicine
AID - 10.1111/acem.12747 [doi]
MID - NIHMS753078
SO  - Acad Emerg Med. 2015 Sep;22(9):1076-84. Epub 2015 Aug 24 doi:10.1111/acem.12747.

PMC - PMC4780626
PMID- 26884153
IS  - 0027-8424 (Print)
IS  - 1091-6490 (Electronic)
VI  - 113
IP  - 9
DP  - 2016 Mar 1
TI  - Tailoring nanoparticle designs to target cancer based on tumor pathophysiology.
PG  - E1142-51
AB  - Nanotechnology is a promising approach for improving cancer diagnosis and
      treatment with reduced side effects. A key question that has emerged is: What is 
      the ideal nanoparticle size, shape, or surface chemistry for targeting tumors?
      Here, we show that tumor pathophysiology and volume can significantly impact
      nanoparticle targeting. This finding presents a paradigm shift in nanomedicine
      away from identifying and using a universal nanoparticle design for cancer
      detection and treatment. Rather, our results suggest that future clinicians will 
      be capable of tailoring nanoparticle designs according to the patient's tumor
      characteristics. This concept of “personalized nanomedicine” was tested for
      detection of prostate tumors and was successfully demonstrated to improve
      nanoparticle targeting by over 50%.
OAB - Publisher: Abstract available from the publisher.
FAU - Sykes, Edward A.
AU  - Sykes EA
AD  - Institute of Biomaterials and Biomedical Engineering, University of Toronto,
      Toronto, ON, Canada M5S 3G9;
FAU - Dai, Qin
AU  - Dai Q
AD  - Institute of Biomaterials and Biomedical Engineering, University of Toronto,
      Toronto, ON, Canada M5S 3G9;
FAU - Sarsons, Christopher D.
AU  - Sarsons CD
AD  - Biomedical Engineering, University of Calgary, Calgary, AB, Canada T2N 1N4;
FAU - Chen, Juan
AU  - Chen J
AD  - Department of Medical Biophysics, Princess Margaret Cancer Centre, University of 
      Toronto, Toronto, ON, Canada M5G 1L7;
FAU - Rocheleau, Jonathan V.
AU  - Rocheleau JV
AD  - Institute of Biomaterials and Biomedical Engineering, University of Toronto,
      Toronto, ON, Canada M5S 3G9;
FAU - Hwang, David M.
AU  - Hwang DM
AD  - Department of Pathology, University Health Network, Toronto, ON, Canada M5G 2C4;
FAU - Zheng, Gang
AU  - Zheng G
AD  - Department of Medical Biophysics, Princess Margaret Cancer Centre, University of 
      Toronto, Toronto, ON, Canada M5G 1L7;
FAU - Cramb, David T.
AU  - Cramb DT
AD  - Department of Chemistry, University of Calgary, Calgary, AB, Canada T2N 1N4;
FAU - Rinker, Kristina D.
AU  - Rinker KD
AD  - Biomedical Engineering, University of Calgary, Calgary, AB, Canada T2N 1N4;
FAU - Chan, Warren C. W.
AU  - Chan WCW
AD  - Institute of Biomaterials and Biomedical Engineering, University of Toronto,
      Toronto, ON, Canada M5S 3G9;
LA  - eng
PT  - Journal Article
DEP - 20160216
GR  - MOP130143; COP126588
PHST- 2016/02/16 [aheadofprint]
TA  - Proc Natl Acad Sci U S A
JT  - Proceedings of the National Academy of Sciences of the United States of America
AID - 201521265 [pii]
AID - 10.1073/pnas.1521265113 [doi]
SO  - Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):E1142-51. Epub 2016 Feb 16
      doi:10.1073/pnas.1521265113.

PMC - PMC4997005
PMID- 27511437
IS  - 1439-4456 (Print)
IS  - 1438-8871 (Electronic)
VI  - 18
IP  - 8
DP  - 2016 Aug
TI  - Spanish-Language Consumer Health Information Technology Interventions: A
      Systematic Review.
LID - e214
AB  - Background: As consumer health information technology (IT) becomes more
      thoroughly integrated into patient care, it is critical that these tools are
      appropriate for the diverse patient populations whom they are intended to serve. 
      Cultural differences associated with ethnicity are one aspect of diversity that
      may play a role in user-technology interactions. Objective: Our aim was to
      evaluate the current scope of consumer health IT interventions targeted to the US
      Spanish-speaking Latino population and to characterize these interventions in
      terms of technological attributes, health domains, cultural tailoring, and
      evaluation metrics. Methods: A narrative synthesis was conducted of existing
      Spanish-language consumer health IT interventions indexed within health and
      computer science databases. Database searches were limited to English-language
      articles published between January 1990 and September 2015. Studies were included
      if they detailed an assessment of a patient-centered electronic technology
      intervention targeting health within the US Spanish-speaking Latino population.
      Included studies were required to have a majority Latino population sample. The
      following were extracted from articles: first author’s last name, publication
      year, population characteristics, journal domain, health domain, technology
      platform and functionality, available languages of intervention, US region,
      cultural tailoring, intervention delivery location, study design, and evaluation 
      metrics. Results: We included 42 studies in the review. Most of the studies were 
      published between 2009 and 2015 and had a majority percentage of female study
      participants. The mean age of participants ranged from 15 to 68. Interventions
      most commonly focused on urban population centers and within the western region
      of the United States. Of articles specifying a technology domain, computer was
      found to be most common; however, a fairly even distribution across all
      technologies was noted. Cancer, diabetes, and child, infant, or maternal health
      were the most common health domains targeted by consumer health IT interventions.
      More than half of the interventions were culturally tailored. The most frequently
      used evaluation metric was behavior/attitude change, followed by usability and
      knowledge retention. Conclusions: This study characterizes the existing body of
      research exploring consumer health IT interventions for the US Spanish-speaking
      Latino population. In doing so, it reveals three primary needs within the field. 
      First, while the increase in studies targeting the Latino population in the last 
      decade is a promising advancement, future research is needed that focuses on
      Latino subpopulations previously overlooked. Second, preliminary steps have been 
      taken to culturally tailor consumer health IT interventions for the US
      Spanish-speaking Latino population; however, focus must expand beyond
      intervention content. Finally, the field should work to promote long-term
      evaluation of technology efficacy, moving beyond intermediary measures toward
      measures of health outcomes.
FAU - Tao, Da
AU  - Tao D
FAU - Or, Calvin
AU  - Or C
FAU - Veinot, Tiffany
AU  - Veinot T
FAU - Vandenberg, Neeltje
AU  - Vandenberg N
FAU - Chaet, Alexis V
AU  - Chaet AV
AUID- ORCID: 0000-0002-0583-1220
AD  - Department of Public Health SciencesUniversity of VirginiaCharlottesville,
      VAUnited States
FAU - Morshedi, Bijan
AU  - Morshedi B
AUID- ORCID: 0000-0001-6826-5337
AD  - Department of Public Health SciencesUniversity of VirginiaCharlottesville,
      VAUnited States
FAU - Wells, Kristen J
AU  - Wells KJ
AUID- ORCID: 0000-0003-1616-7772
AD  - Department of PsychologySan Diego State UniversitySan Diego, CAUnited States
FAU - Barnes, Laura E
AU  - Barnes LE
AUID- ORCID: 0000-0001-8224-5164
AD  - Department of Systems and Information EngineeringUniversity of
      VirginiaCharlottesville, VAUnited States
FAU - Valdez, Rupa
AU  - Valdez R
AUID- ORCID: 0000-0002-5125-0793
AD  - Department of Public Health SciencesUniversity of VirginiaCharlottesville,
      VAUnited States
LA  - eng
PT  - Journal Article
DEP - 20160810
PHST- 2016/04/20 [received]
PHST- 2016/06/22 [revised]
PHST- 2016/07/08 [accepted]
TA  - J Med Internet Res
JT  - Journal of Medical Internet Research
AID - v18i8e214 [pii]
AID - 10.2196/jmir.5794 [doi]
SO  - J Med Internet Res. 2016 Aug 10;18(8):. doi:10.2196/jmir.5794.

PMC - PMC3783488
PMID- 24086758
IS  - 1932-6203 (Electronic)
VI  - 8
IP  - 9
DP  - 2013
TI  - Alcohol Affects Neuronal Substrates of Response Inhibition but Not of Perceptual 
      Processing of Stimuli Signalling a Stop Response.
LID - e76649
AB  - Alcohol impairs inhibitory control, including the ability to terminate an
      initiated action. While there is increasing knowledge about neural mechanisms
      involved in response inhibition, the level at which alcohol impairs such
      mechanisms remains poorly understood. Thirty-nine healthy social drinkers
      received either 0.4g/kg or 0.8g/kg of alcohol, or placebo, and performed two
      variants of a Visual Stop-signal task during acquisition of functional magnetic
      resonance imaging (fMRI) data. The two task variants differed only in their
      instructions: in the classic variant (VSST), participants inhibited their
      response to a “Go-stimulus” when it was followed by a “Stop-stimulus”. In the
      control variant (VSST_C), participants responded to the “Go-stimulus” even if it 
      was followed by a “Stop-stimulus”. Comparison of successful Stop-trials
      (Sstop)>Go, and unsuccessful Stop-trials (Ustop)>Sstop between the three beverage
      groups enabled the identification of alcohol effects on functional neural
      circuits supporting inhibitory behaviour and error processing. Alcohol impaired
      inhibitory control as measured by the Stop-signal reaction time, but did not
      affect other aspects of VSST performance, nor performance on the VSST_C. The low 
      alcohol dose evoked changes in neural activity within prefrontal, temporal,
      occipital and motor cortices. The high alcohol dose evoked changes in activity in
      areas affected by the low dose but importantly induced changes in activity within
      subcortical centres including the globus pallidus and thalamus. Alcohol did not
      affect neural correlates of perceptual processing of infrequent cues, as revealed
      by conjunction analyses of VSST and VSST_C tasks. Alcohol ingestion compromises
      the inhibitory control of action by modulating cortical regions supporting
      attentional, sensorimotor and action-planning processes. At higher doses the
      impact of alcohol also extends to affect subcortical nodes of fronto-basal
      ganglia- thalamo-cortical motor circuits. In contrast, alcohol appears to have
      little impact on the early visual processing of infrequent perceptual cues. These
      observations clarify clinically-important effects of alcohol on behaviour.
FAU - Nikolaou, Kyriaki
AU  - Nikolaou K
AD  - Behavioural and Clinical Neuroscience, School of Psychology, University of
      Sussex, Brighton, United Kingdom
FAU - Critchley, Hugo
AU  - Critchley H
AD  - Behavioural and Clinical Neuroscience, School of Psychology, University of
      Sussex, Brighton, United Kingdom
FAU - Duka, Theodora
AU  - Duka T
AD  - Behavioural and Clinical Neuroscience, School of Psychology, University of
      Sussex, Brighton, United Kingdom
LA  - eng
PT  - Journal Article
DEP - 20130925
PHST- 2013/05/16 [received]
PHST- 2013/08/27 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-13-20231 [pii]
AID - 10.1371/journal.pone.0076649 [doi]
SO  - PLoS One. 2013 Sep 25;8(9):. doi:10.1371/journal.pone.0076649.

PMC - PMC4494620
PMID- 26170670
IS  - 1176-6328 (Print)
IS  - 1178-2021 (Electronic)
VI  - 11
DP  - 2015
TI  - Clinical utility of brain stimulation modalities following traumatic brain
      injury: current evidence.
PG  - 1573-86
AB  - Traumatic brain injury (TBI) remains the main cause of disability and a major
      public health problem worldwide. This review focuses on the neurophysiology of
      TBI, and the rationale and current state of evidence of clinical application of
      brain stimulation to promote TBI recovery, particularly on consciousness,
      cognitive function, motor impairments, and psychiatric conditions. We discuss the
      mechanisms of different brain stimulation techniques including major noninvasive 
      and invasive stimulations. Thus far, most noninvasive brain stimulation
      interventions have been nontargeted and focused on the chronic phase of recovery 
      after TBI. In the acute stages, there is limited available evidence of the
      efficacy and safety of brain stimulation to improve functional outcomes.
      Comparing the studies across different techniques, transcranial direct current
      stimulation is the intervention that currently has the higher number of properly 
      designed clinical trials, though total number is still small. We recognize the
      need for larger studies with target neuroplasticity modulation to fully explore
      the benefits of brain stimulation to effect TBI recovery during different stages 
      of recovery.
FAU - Li, Shasha
AU  - Li S
AD  - Department of Rehabilitation Medicine, West China Hospital, Sichuan University,
      Chengdu, Sichuan, People’s Republic of China
FAU - Zaninotto, Ana Luiza
AU  - Zaninotto AL
AD  - Spaulding Neuromodulation Center, Harvard Medical School, Boston, MA, USA
FAU - Neville, Iuri Santana
AU  - Neville IS
AD  - Division of Neurosurgery, University of São Paulo Medical School, São Paulo, São 
      Paulo, Brazil
FAU - Paiva, Wellingson Silva
AU  - Paiva WS
AD  - Division of Neurosurgery, University of São Paulo Medical School, São Paulo, São 
      Paulo, Brazil
FAU - Nunn, Danuza
AU  - Nunn D
AD  - Spaulding Neuromodulation Center, Harvard Medical School, Boston, MA, USA
FAU - Fregni, Felipe
AU  - Fregni F
AD  - Spaulding Neuromodulation Center, Harvard Medical School, Boston, MA, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20150630
TA  - Neuropsychiatr Dis Treat
JT  - Neuropsychiatric Disease and Treatment
AID - 10.2147/NDT.S65816 [doi]
AID - ndt-11-1573 [pii]
SO  - Neuropsychiatr Dis Treat. 2015 Jun 30;11:1573-86. doi:10.2147/NDT.S65816.

PMC - PMC3776952
PMID- 24065911
IS  - 1662-5161 (Electronic)
VI  - 7
DP  - 2013
TI  - Concurrent application of TMS and near-infrared optical imaging: methodological
      considerations and potential artifacts.
LID - 592
AB  - The simultaneous application of transcranial magnetic stimulation (TMS) with
      non-invasive neuroimaging provides a powerful method for investigating functional
      connectivity in the human brain and the causal relationships between areas in
      distributed brain networks. TMS has been combined with numerous neuroimaging
      techniques including, electroencephalography (EEG), functional magnetic resonance
      imaging (fMRI), and positron emission tomography (PET). Recent work has also
      demonstrated the feasibility and utility of combining TMS with non-invasive
      near-infrared optical imaging techniques, functional near-infrared spectroscopy
      (fNIRS) and the event-related optical signal (EROS). Simultaneous TMS and optical
      imaging affords a number of advantages over other neuroimaging methods but also
      involves a unique set of methodological challenges and considerations. This paper
      describes the methodology of concurrently performing optical imaging during the
      administration of TMS, focusing on experimental design, potential artifacts, and 
      approaches to controlling for these artifacts.
FAU - Parks, Nathan A.
AU  - Parks NA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20130919
PHST- 2013/07/01 [received]
PHST- 2013/09/03 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2013.00592 [doi]
SO  - Front Hum Neurosci. 2013 Sep 19;7:. doi:10.3389/fnhum.2013.00592.

PMC - PMC4721742
PMID- 26690164
IS  - 1424-8220 (Electronic)
VI  - 15
IP  - 12
DP  - 2015 Dec
TI  - A Review of Intelligent Driving Style Analysis Systems and Related Artificial
      Intelligence Algorithms.
PG  - 30653-82
AB  - In this paper the various driving style analysis solutions are investigated. An
      in-depth investigation is performed to identify the relevant machine learning and
      artificial intelligence algorithms utilised in current driver behaviour and
      driving style analysis systems. This review therefore serves as a trove of
      information, and will inform the specialist and the student regarding the current
      state of the art in driver style analysis systems, the application of these
      systems and the underlying artificial intelligence algorithms applied to these
      applications. The aim of the investigation is to evaluate the possibilities for
      unique driver identification utilizing the approaches identified in other driver 
      behaviour studies. It was found that Fuzzy Logic inference systems, Hidden Markov
      Models and Support Vector Machines consist of promising capabilities to address
      unique driver identification algorithms if model complexity can be reduced.
FAU - Meiring, Gys Albertus Marthinus
AU  - Meiring GAM
FAU - Myburgh, Hermanus Carel
AU  - Myburgh HC
LA  - eng
PT  - Journal Article
DEP - 20151204
PHST- 2015/07/14 [received]
PHST- 2015/11/16 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s151229822 [doi]
AID - sensors-15-29822 [pii]
SO  - Sensors (Basel). 2015 Dec 04;15(12):30653-82. doi:10.3390/s151229822.

PMC - PMC5524935
PMID- 28722024
IS  - 2041-1723 (Electronic)
VI  - 8
DP  - 2017
TI  - Multifunctional nanoparticles as a tissue adhesive and an injectable marker for
      image-guided procedures.
LID - 15807
AB  - Tissue adhesives have emerged as an alternative to sutures and staples for wound 
      closure and reconnection of injured tissues after surgery or trauma. Owing to
      their convenience and effectiveness, these adhesives have received growing
      attention particularly in minimally invasive procedures. For safe and accurate
      applications, tissue adhesives should be detectable via clinical imaging
      modalities and be highly biocompatible for intracorporeal procedures. However,
      few adhesives meet all these requirements. Herein, we show that biocompatible
      tantalum oxide/silica core/shell nanoparticles (TSNs) exhibit not only high
      contrast effects for real-time imaging but also strong adhesive properties.
      Furthermore, the biocompatible TSNs cause much less cellular toxicity and less
      inflammation than a clinically used, imageable tissue adhesive (that is, a
      mixture of cyanoacrylate and Lipiodol). Because of their multifunctional imaging 
      and adhesive property, the TSNs are successfully applied as a hemostatic adhesive
      for minimally invasive procedures and as an immobilized marker for image-guided
      procedures.
OAB - Publisher: Abstract available from the publisher.
FAU - Shin, Kwangsoo
AU  - Shin K
AD  - Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826,
      Republic of Korea
FAU - Choi, Jin Woo
AU  - Choi JW
AD  - Department of Radiology, Seoul National University Hospital, Seoul National
      University College of Medicine, Seoul 03080, Republic of Korea
FAU - Ko, Giho
AU  - Ko G
AD  - Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826,
      Republic of Korea
FAU - Baik, Seungmin
AU  - Baik S
AD  - Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826,
      Republic of Korea
FAU - Kim, Dokyoon
AU  - Kim D
AD  - Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826,
      Republic of Korea
FAU - Park, Ok Kyu
AU  - Park OK
AD  - Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826,
      Republic of Korea
FAU - Lee, Kyoungbun
AU  - Lee K
AD  - Department of Pathology, Seoul National University Hospital, Seoul 03080,
      Republic of Korea
FAU - Cho, Hye Rim
AU  - Cho HR
AD  - Department of Radiology, Seoul National University Hospital, Seoul National
      University College of Medicine, Seoul 03080, Republic of Korea
FAU - Han, Sang Ihn
AU  - Han SI
AD  - Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826,
      Republic of Korea
FAU - Lee, Soo Hong
AU  - Lee SH
AD  - Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826,
      Republic of Korea
FAU - Lee, Dong Jun
AU  - Lee DJ
AD  - Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826,
      Republic of Korea
FAU - Lee, Nohyun
AU  - Lee N
AD  - School of Advanced Materials Engineering, Kookmin University, Seoul 02707,
      Republic of Korea
FAU - Kim, Hyo-Cheol
AU  - Kim HC
AD  - Department of Radiology, Seoul National University Hospital, Seoul National
      University College of Medicine, Seoul 03080, Republic of Korea
FAU - Hyeon, Taeghwan
AU  - Hyeon T
AD  - Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826,
      Republic of Korea
LA  - eng
PT  - Journal Article
DEP - 20170719
PHST- 2016/10/07 [received]
PHST- 2017/05/02 [accepted]
TA  - Nat Commun
JT  - Nature Communications
AID - ncomms15807 [pii]
AID - 10.1038/ncomms15807 [doi]
SO  - Nat Commun. 2017 Jul 19;8:. doi:10.1038/ncomms15807.

PMC - PMC3406761
PMID- 22645276
IS  - 0964-6906 (Print)
IS  - 1460-2083 (Electronic)
VI  - 21
IP  - 16
DP  - 2012 Aug 15
TI  - ATOH7 mutations cause autosomal recessive persistent hyperplasia of the primary
      vitreous.
PG  - 3681-94
AB  - The vertebrate basic helix–loop–helix (bHLH) transcription factor ATOH7 (Math5)
      is specifically expressed in the embryonic neural retina and is required for the 
      genesis of retinal ganglion cells (RGCs) and optic nerves. In Atoh7 mutant mice, 
      the absence of trophic factors secreted by RGCs prevents the development of the
      intrinsic retinal vasculature and the regression of fetal blood vessels, causing 
      persistent hyperplasia of the primary vitreous (PHPV). We therefore screened
      patients with hereditary PHPV, as well as bilateral optic nerve aplasia (ONA) or 
      hypoplasia (ONH), for mutations in ATOH7. We identified a homozygous ATOH7
      mutation (N46H) in a large family with an autosomal recessive PHPV disease trait 
      linked to 10q21, and a heterozygous variant (R65G, p.Arg65Gly) in one of five
      sporadic ONA patients. High-density single-nucleotide polymorphism analysis also 
      revealed a CNTN4 duplication and an OTX2 deletion in the ONA cohort. Functional
      analysis of ATOH7 bHLH domain substitutions, by electrophoretic mobility shift
      and luciferase cotransfection assays, revealed that the N46H variant cannot bind 
      DNA or activate transcription, consistent with structural modeling. The N46H
      variant also failed to rescue RGC development in mouse Atoh7−/− retinal explants.
      The R65G variant retains all of these activities, similar to wild-type human
      ATOH7. Our results strongly suggest that autosomal recessive persistent
      hyperplastic primary vitreous is caused by N46H and is etiologically related to
      nonsyndromic congenital retinal nonattachment. The R65G allele, however, cannot
      explain the ONA phenotype. Our study firmly establishes ATOH7 as a retinal
      disease gene and provides a functional basis to analyze new coding variants.
FAU - Prasov, Lev
AU  - Prasov L
AD  - Department of Human Genetics and
FAU - Masud, Tehmina
AU  - Masud T
AD  - Department of Human Genetics and
FAU - Khaliq, Shagufta
AU  - Khaliq S
AD  - Department of Human Genetics and Molecular Biology, University of Health
      Sciences, Lahore, Pakistan,
FAU - Mehdi, S. Qasim
AU  - Mehdi SQ
AD  - Centre for Human Genetics, Sindh Institute of Urology and Transplantation,
      Karachi 74200, Pakistan,
FAU - Abid, Aiysha
AU  - Abid A
AD  - Centre for Human Genetics, Sindh Institute of Urology and Transplantation,
      Karachi 74200, Pakistan,
FAU - Oliver, Edward R.
AU  - Oliver ER
AD  - Department of Radiology, Hospital of the University of Pennsylvania,
      Philadelphia, PA 19104, USA,
FAU - Silva, Eduardo D.
AU  - Silva ED
AD  - Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, University of
      Coimbra, Portugal,
FAU - Lewanda, Amy
AU  - Lewanda A
AD  - Department of Pediatrics, Inova Fairfax Hospital for Children, Falls Church, VA, 
      22031, USA,
FAU - Brodsky, Michael C.
AU  - Brodsky MC
AD  - Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN 55905, USA,
FAU - Borchert, Mark
AU  - Borchert M
AD  - The Vision Center, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA,
FAU - Kelberman, Daniel
AU  - Kelberman D
AD  - Ulverscroft Vision Research Group, Developmental Biology Unit, UCL Institute of
      Child Health, London, UK and
FAU - Sowden, Jane C.
AU  - Sowden JC
AD  - Ulverscroft Vision Research Group, Developmental Biology Unit, UCL Institute of
      Child Health, London, UK and
FAU - Dattani, Mehul T.
AU  - Dattani MT
AD  - Developmental Endocrine Research Unit, UCL Institute of Child Health and Great
      Ormond Street Hospital for Children, London, UK
FAU - Glaser, Tom
AU  - Glaser T
AD  - Department of Human Genetics and
LA  - eng
PT  - Journal Article
DEP - 20120529
PHST- 2012/03/09 [received]
PHST- 2012/04/27 [revised]
PHST- 2012/05/18 [accepted]
PHST- 2012/05/29 [aheadofprint]
TA  - Hum Mol Genet
JT  - Human Molecular Genetics
AID - 10.1093/hmg/dds197 [doi]
AID - dds197 [pii]
SO  - Hum Mol Genet. 2012 Aug 15;21(16):3681-94. Epub 2012 May 29
      doi:10.1093/hmg/dds197.

PMC - PMC5116625
PMID- 27869190
IS  - 2045-2322 (Electronic)
VI  - 6
DP  - 2016
TI  - Embodied neurofeedback with an anthropomorphic robotic hand.
LID - 37696
AB  - Neurofeedback-guided motor imagery training (NF-MIT) has been suggested as a
      promising therapy for stroke-induced motor impairment. Whereas much NF-MIT
      research has aimed at signal processing optimization, the type of sensory
      feedback given to the participant has received less attention. Often the feedback
      signal is highly abstract and not inherently coupled to the mental act performed.
      In this study, we asked whether an embodied feedback signal is more efficient for
      neurofeedback operation than a non-embodiable feedback signal. Inspired by the
      rubber hand illusion, demonstrating that an artificial hand can be incorporated
      into one’s own body scheme, we used an anthropomorphic robotic hand to visually
      guide the participants’ motor imagery act and to deliver neurofeedback. Using two
      experimental manipulations, we investigated how a participant’s neurofeedback
      performance and subjective experience were influenced by the embodiability of the
      robotic hand, and by the neurofeedback signal’s validity. As pertains to
      embodiment, we found a promoting effect of robotic-hand embodiment in subjective,
      behavioral, electrophysiological and electrodermal measures. Regarding
      neurofeedback signal validity, we found some differences between real and sham
      neurofeedback in terms of subjective and electrodermal measures, but not in terms
      of behavioral and electrophysiological measures. This study motivates the further
      development of embodied feedback signals for NF-MIT.
FAU - Braun, Niclas
AU  - Braun N
AD  - Neuropsychology Lab, Department of Psychology, University of Oldenburg,
      Oldenburg, Germany
FAU - Emkes, Reiner
AU  - Emkes R
AD  - Neuropsychology Lab, Department of Psychology, University of Oldenburg,
      Oldenburg, Germany
FAU - Thorne, Jeremy D.
AU  - Thorne JD
AD  - Neuropsychology Lab, Department of Psychology, University of Oldenburg,
      Oldenburg, Germany
FAU - Debener, Stefan
AU  - Debener S
AD  - Neuropsychology Lab, Department of Psychology, University of Oldenburg,
      Oldenburg, Germany
LA  - eng
PT  - Journal Article
DEP - 20161121
PHST- 2016/07/08 [received]
PHST- 2016/11/02 [accepted]
TA  - Sci Rep
JT  - Scientific Reports
AID - srep37696 [pii]
AID - 10.1038/srep37696 [doi]
SO  - Sci Rep. 2016 Nov 21;6:. doi:10.1038/srep37696.

PMC - PMC4307396
PMID- 25060262
IS  - 1940-6207 (Print)
IS  - 1940-6215 (Electronic)
VI  - 7
IP  - 10
DP  - 2014 Oct
TI  - Convergence of Nanotechnology and Cancer Prevention: Are We There Yet?
PG  - 973-92
AB  - Nanotechnology is emerging as a promising modality for cancer treatment; however,
      in the realm of cancer prevention, its full utility has yet to be determined.
      Here, we discuss the potential of integrating nanotechnology in cancer prevention
      to augment early diagnosis, precision targeting and controlled release of
      chemopreventive agents, reduced toxicity, risk/response assessment, and
      personalized point-of-care monitoring. Cancer is a multistep, progressive
      disease; the functional and acquired characteristics of the early precancer
      phenotype are intrinsically different from those of a more advanced anaplastic or
      invasive malignancy. Therefore, applying nanotechnology to precancers is likely
      to be far more challenging than applying it to established disease. Frank cancers
      are more readily identifiable through imaging and biomarker and histopathologic
      assessment than their precancerous precursors. In addition, prevention subjects
      routinely have more rigorous intervention criteria than therapy subjects. Any
      nanopreventive agent developed to prevent sporadic cancers found in the general
      population must exhibit a very low risk of serious side effects. In contrast, a
      greater risk of side effects might be more acceptable in subjects at high risk
      for cancer. Using nanotechnology to prevent cancer is an aspirational goal, but
      clearly identifying the intermediate objectives and potential barriers is an
      essential first step in this exciting journey.
FAU - Menter, David G.
AU  - Menter DG
AD  - Department of Gastrointestinal Medical Oncology, The University of Texas MD
      Anderson Cancer Center, Houston, Texas 77030
FAU - Patterson, Sherri L.
AU  - Patterson SL
AD  - Division of Cancer Prevention & Population Sciences, The University of Texas MD
      Anderson Cancer Center, Houston, Texas 77030
FAU - Logsdon, Craig D.
AU  - Logsdon CD
AD  - Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, 
      Houston, Texas 77030
FAU - Kopetz, Scott
AU  - Kopetz S
AD  - Department of Gastrointestinal Medical Oncology, The University of Texas MD
      Anderson Cancer Center, Houston, Texas 77030
FAU - Sood, Anil K.
AU  - Sood AK
AD  - Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson
      Cancer Center, Houston, Texas 77030
FAU - Hawk, Ernest T.
AU  - Hawk ET
AD  - Division of Cancer Prevention & Population Sciences, The University of Texas MD
      Anderson Cancer Center, Houston, Texas 77030
LA  - eng
PT  - Journal Article
DEP - 20140724
TA  - Cancer Prev Res (Phila)
JT  - Cancer prevention research (Philadelphia, Pa.)
AID - 10.1158/1940-6207.CAPR-14-0079 [doi]
MID - NIHMS617204
SO  - Cancer Prev Res (Phila). 2014 Oct;7(10):973-92. Epub 2014 Jul 24
      doi:10.1158/1940-6207.CAPR-14-0079.

PMC - PMC4849799
PMID- 27124275
IS  - 1553-734X (Print)
IS  - 1553-7358 (Electronic)
VI  - 12
IP  - 4
DP  - 2016 Apr
TI  - Principles and Overview of Sampling Methods for Modeling Macromolecular Structure
      and Dynamics.
LID - e1004619
AB  - Investigation of macromolecular structure and dynamics is fundamental to
      understanding how macromolecules carry out their functions in the cell.
      Significant advances have been made toward this end in silico, with a growing
      number of computational methods proposed yearly to study and simulate various
      aspects of macromolecular structure and dynamics. This review aims to provide an 
      overview of recent advances, focusing primarily on methods proposed for exploring
      the structure space of macromolecules in isolation and in assemblies for the
      purpose of characterizing equilibrium structure and dynamics. In addition to
      surveying recent applications that showcase current capabilities of computational
      methods, this review highlights state-of-the-art algorithmic techniques proposed 
      to overcome challenges posed in silico by the disparate spatial and time scales
      accessed by dynamic macromolecules. This review is not meant to be exhaustive, as
      such an endeavor is impossible, but rather aims to balance breadth and depth of
      strategies for modeling macromolecular structure and dynamics for a broad
      audience of novices and experts.
OAB - Publisher: Abstract available from the publisher.
FAU - Maximova, Tatiana
AU  - Maximova T
AUID- ORCID: 0000-0002-5605-0678
AD  - Department of Computer Science, George Mason University, Fairfax, Virginia,
      United States of America
FAU - Moffatt, Ryan
AU  - Moffatt R
AD  - Department of Computer Science, George Mason University, Fairfax, Virginia,
      United States of America
FAU - Ma, Buyong
AU  - Ma B
AD  - Basic Science Program, Leidos Biomedical Research, Inc. Cancer and Inflammation
      Program, National Cancer Institute, Frederick, Maryland, United States of America
FAU - Nussinov, Ruth
AU  - Nussinov R
AD  - Basic Science Program, Leidos Biomedical Research, Inc. Cancer and Inflammation
      Program, National Cancer Institute, Frederick, Maryland, United States of America
FAU - Shehu, Amarda
AU  - Shehu A
AUID- ORCID: 0000-0001-5230-4610
AD  - Department of Computer Science, George Mason University, Fairfax, Virginia,
      United States of America
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20160428
TA  - PLoS Comput Biol
JT  - PLoS Computational Biology
AID - 10.1371/journal.pcbi.1004619 [doi]
AID - PCOMPBIOL-D-15-00493 [pii]
SO  - PLoS Comput Biol. 2016 Apr 28;12(4):. doi:10.1371/journal.pcbi.1004619.

PMC - PMC5405963
PMID- 28445551
IS  - 1932-6203 (Electronic)
VI  - 12
IP  - 4
DP  - 2017
TI  - Pattern classification of EEG signals reveals perceptual and attentional states.
LID - e0176349
AB  - Pattern classification techniques have been widely used to differentiate neural
      activity associated with different perceptual, attentional, or other cognitive
      states, often using fMRI, but more recently with EEG as well. Although these
      methods have identified EEG patterns (i.e., scalp topographies of EEG signals
      occurring at certain latencies) that decode perceptual and attentional states on 
      a trial-by-trial basis, they have yet to be applied to the spatial scope of
      attention toward global or local features of the display. Here, we initially used
      pattern classification to replicate and extend the findings that perceptual
      states could be reliably decoded from EEG. We found that visual perceptual
      states, including stimulus location and object category, could be decoded with
      high accuracy peaking between 125–250 ms, and that the discriminative
      spatiotemporal patterns mirrored and extended our (and other well-established)
      ERP results. Next, we used pattern classification to investigate whether
      spatiotemporal EEG signals could reliably predict attentional states, and
      particularly, the scope of attention. The EEG data were reliably differentiated
      for local versus global attention on a trial-by-trial basis, emerging as a
      specific spatiotemporal activation pattern over posterior electrode sites during 
      the 250–750 ms interval after stimulus onset. In sum, we demonstrate that
      multivariate pattern analysis of EEG, which reveals unique spatiotemporal
      patterns of neural activity distinguishing between behavioral states, is a
      sensitive tool for characterizing the neural correlates of perception and
      attention.
FAU - List, Alexandra
AU  - List A
AD  - Department of Psychology and Neuroscience Program, Hamilton College, Clinton, New
      York, United States of America
FAU - Rosenberg, Monica D.
AU  - Rosenberg MD
AD  - Department of Psychology, Yale University, New Haven, Connecticut, United States 
      of America
FAU - Sherman, Aleksandra
AU  - Sherman A
AD  - Department of Cognitive Science, Occidental College, Los Angeles, California,
      United States of America
FAU - Esterman, Michael
AU  - Esterman M
AD  - Research Service, VA Boston Healthcare System, Boston, Massachusetts, United
      States of America
LA  - eng
PT  - Journal Article
DEP - 20170426
PHST- 2016/11/03 [received]
PHST- 2017/04/10 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - 10.1371/journal.pone.0176349 [doi]
AID - PONE-D-16-43788 [pii]
SO  - PLoS One. 2017 Apr 26;12(4):. doi:10.1371/journal.pone.0176349.

PMC - PMC2023963
IS  - 1365-182X (Print)
IS  - 1477-2574 (Electronic)
VI  - 9
IP  - Suppl 1
DP  - 2007
TI  - Abstracts.
PG  - 36-110
LA  - eng
PT  - Journal Article
TA  - HPB (Oxford)
JT  - HPB : The Official Journal of the International Hepato Pancreato Biliary
      Association
AID - 10.1080/16515320701258846 [doi]
AID - 09-036S [pii]
SO  - HPB (Oxford). 2007;9(Suppl 1):36-110. doi:10.1080/16515320701258846.

PMC - PMC1692699
PMID- 10670023
IS  - 0962-8436 (Print)
IS  - 1471-2970 (Electronic)
VI  - 354
IP  - 1392
DP  - 1999 Dec 29
TI  - The past, the future and the biology of memory storage.
PG  - 2027-52
AB  - We here briefly review a century of accomplishments in studying memory storage
      and delineate the two major questions that have dominated thinking in this area: 
      the systems question of memory, which concerns where in the brain storage occurs;
      and the molecular question of memory, which concerns the mechanisms whereby
      memories are stored and maintained. We go on to consider the themes that memory
      research may be able to address in the 21st century. Finally, we reflect on the
      clinical and societal import of our increasing understanding of the mechanisms of
      memory, discussing possible therapeutic approaches to diseases that manifest with
      disruptions of learning and possible ethical implication of the ability, which is
      on the horizon, to ameliorate or even enhance human memory.
FAU - Kandel, E R
AU  - Kandel ER
FAU - Pittenger, C
AU  - Pittenger C
LA  - eng
PT  - Journal Article
PT  - Review
TA  - Philos Trans R Soc Lond B Biol Sci
JT  - Philosophical Transactions of the Royal Society B: Biological Sciences
SO  - Philos Trans R Soc Lond B Biol Sci. 1999 Dec 29;354(1392):2027-52.

PMC - PMC3717099
PMID- 23837908
IS  - 1743-0003 (Electronic)
VI  - 10
DP  - 2013
TI  - Mirror versus parallel bimanual reaching.
PG  - 71
AB  - Background: In spite of their importance to everyday function, tasks that require
      both hands to work together such as lifting and carrying large objects have not
      been well studied and the full potential of how new technology might facilitate
      recovery remains unknown. Methods: To help identify the best modes for
      self-teleoperated bimanual training, we used an advanced haptic/graphic
      environment to compare several modes of practice. In a 2-by-2 study, we compared 
      mirror vs. parallel reaching movements, and also compared veridical display to
      one that transforms the right hand’s cursor to the opposite side, reducing the
      area that the visual system has to monitor. Twenty healthy, right-handed subjects
      (5 in each group) practiced 200 movements. We hypothesized that parallel reaching
      movements would be the best performing, and attending to one visual area would
      reduce the task difficulty. Results: The two-way comparison revealed that mirror 
      movement times took an average 1.24 s longer to complete than parallel.
      Surprisingly, subjects’ movement times moving to one target (attending to one
      visual area) also took an average of 1.66 s longer than subjects moving to two
      targets. For both hands, there was also a significant interaction effect,
      revealing the lowest errors for parallel movements moving to two targets
      (p < 0.001). This was the only group that began and maintained low errors
      throughout training. Conclusion: Combined with other evidence, these results
      suggest that the most intuitive reaching performance can be observed with
      parallel movements with a veridical display (moving to two separate targets).
      These results point to the expected levels of challenge for these bimanual
      training modes, which could be used to advise therapy choices in
      self-neurorehabilitation.
FAU - Abdollahi, Farnaz
AU  - Abdollahi F
AD  - Rehabilitation Institute of Chicago, Sensory Motor Performance Program (SMPP),
      Suite: 1406, 345 E. Superior Street, Chicago, IL 60611, USA
FAU - Kenyon, Robert V
AU  - Kenyon RV
AD  - Rehabilitation Institute of Chicago, Sensory Motor Performance Program (SMPP),
      Suite: 1406, 345 E. Superior Street, Chicago, IL 60611, USA
FAU - Patton, James L
AU  - Patton JL
AD  - Rehabilitation Institute of Chicago, Sensory Motor Performance Program (SMPP),
      Suite: 1406, 345 E. Superior Street, Chicago, IL 60611, USA
LA  - eng
PT  - Journal Article
DEP - 20130709
PHST- 2012/07/05 [received]
PHST- 2013/06/14 [accepted]
TA  - J Neuroeng Rehabil
JT  - Journal of NeuroEngineering and Rehabilitation
AID - 1743-0003-10-71 [pii]
AID - 10.1186/1743-0003-10-71 [doi]
SO  - J Neuroeng Rehabil. 2013 Jul 9;10:71. doi:10.1186/1743-0003-10-71.

PMC - PMC5154059
PMID- 27965859
IS  - 2055-5784 (Electronic)
VI  - 2
DP  - 2016
TI  - The iBRA (implant breast reconstruction evaluation) study: protocol for a
      prospective multi-centre cohort study to inform the feasibility, design and
      conduct of a pragmatic randomised clinical trial comparing new techniques of
      implant-based breast reconstruction.
LID - 41
AB  - Background: Implant-based breast reconstruction (IBBR) is the most commonly
      performed reconstructive procedure in the UK. The introduction of techniques to
      augment the subpectoral pocket has revolutionised the procedure, but there is a
      lack of high-quality outcome data to describe the safety or effectiveness of
      these techniques. Randomised controlled trials (RCTs) are the best way of
      comparing treatments, but surgical RCTs are challenging. The iBRA (implant breast
      reconstruction evaluation) study aims to determine the feasibility, design and
      conduct of a pragmatic RCT to examine the effectiveness of approaches to IBBR.
      Methods/design: The iBRA study is a trainee-led research collaborative project
      with four phases:Phase 1 – a national practice questionnaire (NPQ) to survey
      current practicePhase 2 – a multi-centre prospective cohort study of patients
      undergoing IBBR to evaluate the clinical and patient-reported outcomesPhase 3– an
      IBBR-RCT acceptability survey and qualitative work to explore patients’ and
      surgeons’ views of proposed trial designs and candidate outcomes.Phase 4 – phases
      1 to 3 will inform the design and conduct of the future RCTAll centres offering
      IBBR will be encouraged to participate by the breast and plastic surgical
      professional associations (Association of Breast Surgery and British Association 
      of Plastic Reconstructive and Aesthetic Surgeons).Data collected will inform the 
      feasibility of undertaking an RCT by defining current practice and exploring
      issues surrounding recruitment, selection of comparator arms, choice of primary
      outcome, sample size, selection criteria, trial conduct, methods of data
      collection and feasibility of using the trainee collaborative model to recruit
      patients and collect data. Discussion: The preliminary work undertaken within the
      iBRA study will determine the feasibility, design and conduct of a definitive RCT
      in IBBR. It will work with the trainee collaborative to build capacity by
      creating an infrastructure of research-active breast and plastic surgeons which
      will facilitate future high-quality research that will ultimately improve
      outcomes for all women seeking reconstructive surgery. Trial registration:
      ISRCTN37664281
FAU - Potter, Shelley
AU  - Potter S
AUID- ORCID: 0000-0002-6977-312X
AD  - Bristol Centre for Surgical Research, School of Social and Community Medicine,
      University of Bristol, Room 3.12 Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS 
      UK
FAU - Conroy, Elizabeth J.
AU  - Conroy EJ
AD  - MRC North West Hub for Trials Methodology Research, Department of Biostatistics, 
      Clinical Trials Research Centre, University of Liverpool, Liverpool, L69 3GS UK
FAU - Williamson, Paula R.
AU  - Williamson PR
AD  - MRC North West Hub for Trials Methodology Research, Department of Biostatistics, 
      Clinical Trials Research Centre, University of Liverpool, Liverpool, L69 3GS UK
FAU - Thrush, Steven
AU  - Thrush S
AD  - Breast Unit, Worcester Royal Hospital. Charles Hastings Way, Worcester, WR5 1DD
      UK
FAU - Whisker, Lisa J.
AU  - Whisker LJ
AD  - Breast Institute, Nottingham University Hospitals NHS Trust, Hucknall Road,
      Nottingham, NG5 1PB UK
FAU - Skillman, Joanna M
AU  - Skillman JM
AD  - Department of Plastic Surgery, University Hospitals Coventry and Warwickshire NHS
      Trust, Clifford Bridge Road, Coventry, CV2 2DX UK
FAU - Barnes, Nicola L. P.
AU  - Barnes NLP
AD  - The Nightingale Centre Breast Unit, University Hospital of South Manchester NHS
      Foundation Trust, Southmoor Road, Manchester, M23 9LT UK
FAU - Cutress, Ramsey I.
AU  - Cutress RI
AD  - Breast Unit, University Hospital Southampton, Tremona Road, Southampton,
      Hampshire SO16 6YD UK
FAU - Teasdale, Elizabeth M.
AU  - Teasdale EM
AD  - Linda McCartney Centre, Royal Liverpool and Broadgreen University Hospital,
      Prescot Street, Liverpool, L7 8XP UK
FAU - Mills, Nicola
AU  - Mills N
AD  - Bristol Centre for Surgical Research, School of Social and Community Medicine,
      University of Bristol, Room 3.12 Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS 
      UK
FAU - Mylvaganam, Senthurun
AU  - Mylvaganam S
AD  - New Cross Hospital, Royal Wolverhampton Hospitals NHS Trust, Wednesfield Way,
      Wolverhampton, WV10 0QP UK
FAU - Branford, Olivier A.
AU  - Branford OA
AD  - Department of Plastic Surgery, The Royal Marsden NHS Foundation Trust, Fulham
      Road, London, SW3 6JJ UK
FAU - McEvoy, Katherina
AU  - McEvoy K
AD  - City Hospital, Dudley Road, West Midlands, B18 7QH UK
FAU - Jain, Abhilash
AU  - Jain A
AD  - Imperial College London NHS Trust, London, SW7 2AZ UK
FAU - Gardiner, Matthew D.
AU  - Gardiner MD
AD  - Imperial College London NHS Trust, London, SW7 2AZ UK
FAU - Blazeby, Jane M.
AU  - Blazeby JM
AD  - Bristol Centre for Surgical Research, School of Social and Community Medicine,
      University of Bristol, Room 3.12 Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS 
      UK
FAU - Holcombe, Christopher
AU  - Holcombe C
AD  - Linda McCartney Centre, Royal Liverpool and Broadgreen University Hospital,
      Prescot Street, Liverpool, L7 8XP UK
CN  - on behalf of the Breast Reconstruction Research Collaborative
LA  - eng
PT  - Journal Article
DEP - 20160804
GR  - RfPB 0214-33065
PHST- 2016/03/19 [received]
PHST- 2016/06/10 [accepted]
TA  - Pilot Feasibility Stud
JT  - Pilot and Feasibility Studies
AID - 85 [pii]
AID - 10.1186/s40814-016-0085-8 [doi]
SO  - Pilot Feasibility Stud. 2016 Aug 4;2:. doi:10.1186/s40814-016-0085-8.

PMC - PMC4068273
PMID- 24956454
IS  - 1098-7339 (Print)
IS  - 1532-8651 (Electronic)
VI  - 39
IP  - 4
DP  - 2014 Jul-Aug
TI  - Adherence to Guidelines for the Management of Local Anesthetic Systemic Toxicity 
      Is Improved by an Electronic Decision Support Tool and Designated ‘Reader’.
PG  - 299-305
AB  - Background and Objectives: A hardcopy or paper cognitive aid has been shown to
      improve performance during the management of simulated local anesthetic systemic 
      toxicity (LAST) when given to the team leader. However, there remains room for
      improvement in order to ensure a system that can achieve perfect adherence to the
      published guidelines for LAST management. Recent research has shown that
      implementing a checklist via a designated reader may be of benefit. Accordingly, 
      we sought to investigate the effect of an electronic decision support tool (DST) 
      and designated ‘Reader’ role on team performance during an in-situ simulation of 
      LAST. Methods: Participants were randomized to Reader+DST (N = 16, rDST) and
      Control (N = 15, memory alone). The rDST group received the assistance of a
      dedicated Reader on the response team who was equipped with an electronic DST.
      The primary outcome measure was adherence to guidelines. Results: For overall and
      critical percent correct scores, the rDST group scored higher than Control (99.3%
      vs 72.2%, P < 0.0001; 99.5% vs 70%, P < 0.0001, respectively). In the LAST
      scenario, 0 of 15 (0%) in the control group performed 100% of critical management
      steps, while 15 of 16 (93.8%) in the rDST group did so (P < 0.0001). Conclusions:
      In a prospective, randomized single-blinded study, a designated Reader with an
      electronic DST improved adherence to guidelines in the management of an in-situ
      simulation of LAST. Such tools are promising in the future of medicine, but
      further research is needed to ensure the best methods for implementing them in
      the clinical arena.
FAU - McEvoy, Matthew D.
AU  - McEvoy MD
AD  - Department of Anesthesiology, Vanderbilt University School of Medicine,
      Nashville, TN
FAU - Hand, William R.
AU  - Hand WR
AD  - Department of Anesthesia and Perioperative Medicine, and ‡Department of Medicine,
      Division of Biostatistics and Epidemiology, Medical University of South Carolina,
      Charleston, SC
FAU - Stoll, W. David
AU  - Stoll WD
AD  - Department of Anesthesia and Perioperative Medicine, and ‡Department of Medicine,
      Division of Biostatistics and Epidemiology, Medical University of South Carolina,
      Charleston, SC
FAU - Furse, Cory M.
AU  - Furse CM
AD  - Department of Anesthesia and Perioperative Medicine, and ‡Department of Medicine,
      Division of Biostatistics and Epidemiology, Medical University of South Carolina,
      Charleston, SC
FAU - Nietert, Paul J.
AU  - Nietert PJ
AD  - Department of Anesthesia and Perioperative Medicine, and ‡Department of Medicine,
      Division of Biostatistics and Epidemiology, Medical University of South Carolina,
      Charleston, SC
LA  - eng
PT  - Journal Article
TA  - Reg Anesth Pain Med
JT  - Regional anesthesia and pain medicine
AID - 10.1097/AAP.0000000000000097 [doi]
MID - NIHMS581653
SO  - Reg Anesth Pain Med. 2014 Jul-Aug;39(4):299-305.
      doi:10.1097/AAP.0000000000000097.

PMC - PMC3690072
PMID- 23686141
IS  - 1424-8220 (Electronic)
VI  - 13
IP  - 5
DP  - 2013 May
TI  - Evolution of Electroencephalogram Signal Analysis Techniques during Anesthesia.
PG  - 6605-35
AB  - Biosignal analysis is one of the most important topics that researchers have
      tried to develop during the last century to understand numerous human diseases.
      Electroencephalograms (EEGs) are one of the techniques which provides an
      electrical representation of biosignals that reflect changes in the activity of
      the human brain. Monitoring the levels of anesthesia is a very important subject,
      which has been proposed to avoid both patient awareness caused by inadequate
      dosage of anesthetic drugs and excessive use of anesthesia during surgery. This
      article reviews the bases of these techniques and their development within the
      last decades and provides a synopsis of the relevant methodologies and algorithms
      that are used to analyze EEG signals. In addition, it aims to present some of the
      physiological background of the EEG signal, developments in EEG signal
      processing, and the effective methods used to remove various types of noise. This
      review will hopefully increase efforts to develop methods that use EEG signals
      for determining and classifying the depth of anesthesia with a high data rate to 
      produce a flexible and reliable detection device.
FAU - Al-Kadi, Mahmoud I.
AU  - Al-Kadi MI
AD  - Department of Electrical, Electronic & Systems Engineering, Faculty of
      Engineering and Built Environment, Universiti Kebangsaan Malaysia, UKM Bangi
      Selangor 43600, Malaysia; E-Mails: mamun.reaz@gmail.com (M.B.I.R.);
      mama@eng.ukm.my (M.A.M.A.)
FAU - Reaz, Mamun Bin Ibne
AU  - Reaz MBI
AD  - Department of Electrical, Electronic & Systems Engineering, Faculty of
      Engineering and Built Environment, Universiti Kebangsaan Malaysia, UKM Bangi
      Selangor 43600, Malaysia; E-Mails: mamun.reaz@gmail.com (M.B.I.R.);
      mama@eng.ukm.my (M.A.M.A.)
FAU - Ali, Mohd Alauddin Mohd
AU  - Ali MAM
AD  - Department of Electrical, Electronic & Systems Engineering, Faculty of
      Engineering and Built Environment, Universiti Kebangsaan Malaysia, UKM Bangi
      Selangor 43600, Malaysia; E-Mails: mamun.reaz@gmail.com (M.B.I.R.);
      mama@eng.ukm.my (M.A.M.A.)
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20130517
PHST- 2013/03/26 [received]
PHST- 2013/05/06 [revised]
PHST- 2013/05/07 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s130506605 [doi]
AID - sensors-13-06605 [pii]
SO  - Sensors (Basel). 2013 May 17;13(5):6605-35. doi:10.3390/s130506605.

PMC - PMC3931437
PMID- 24117343
IS  - 2158-0014 (Print)
IS  - 2158-0022 (Electronic)
VI  - 4
IP  - 1
DP  - 2014 Feb 01
TI  - Effects of Severing the Corpus Callosum on Electrical and BOLD Functional
      Connectivity and Spontaneous Dynamic Activity in the Rat Brain.
PG  - 15-29
AB  - Functional networks, defined by synchronous spontaneous blood oxygenation
      level-dependent (BOLD) oscillations between spatially distinct brain regions,
      appear to be essential to brain function and have been implicated in disease
      states, cognitive capacity, and sensing and motor processes. While the
      topographical extent and behavioral function of these networks has been
      extensively investigated, the neural functions that create and maintain these
      synchronizations remain mysterious. In this work callosotomized rodents are
      examined, providing a unique platform for evaluating the influence of structural 
      connectivity via the corpus callosum on bilateral resting state functional
      connectivity. Two experimental groups were assessed, a full callosotomy group, in
      which the corpus callosum was completely sectioned, and a sham callosotomy group,
      in which the gray matter was sectioned but the corpus callosum remained intact.
      Results indicated a significant reduction in interhemispheric connectivity in the
      full callosotomy group as compared with the sham group in primary somatosensory
      cortex and caudate-putamen regions. Similarly, electrophysiology revealed
      significantly reduced bilateral correlation in band limited power. Bilateral
      gamma Band-limited power connectivity was most strongly affected by the full
      callosotomy procedure. This work represents a robust finding indicating the
      corpus callosum's influence on maintaining integrity in bilateral functional
      networks; further, functional magnetic resonance imaging (fMRI) and
      electrophysiological connectivity share a similar decrease in connectivity as a
      result of the callosotomy, suggesting that fMRI-measured functional connectivity 
      reflects underlying changes in large-scale coordinated electrical activity.
      Finally, spatiotemporal dynamic patterns were evaluated in both groups; the full 
      callosotomy rodents displayed a striking loss of bilaterally synchronous
      propagating waves of cortical activity.
FAU - Magnuson, Matthew E.
AU  - Magnuson ME
FAU - Thompson, Garth J.
AU  - Thompson GJ
FAU - Pan, Wen-Ju
AU  - Pan WJ
FAU - Keilholz, Shella D.
AU  - Keilholz SD
LA  - eng
PT  - Journal Article
TA  - Brain Connect
JT  - Brain Connectivity
AID - 10.1089/brain.2013.0167 [pii]
AID - 10.1089/brain.2013.0167 [doi]
SO  - Brain Connect. 2014 Feb 01;4(1):15-29. doi:10.1089/brain.2013.0167.

PMC - PMC4901081
PMID- 27375470
IS  - 1662-5188 (Electronic)
VI  - 10
DP  - 2016
TI  - Model-Based Comparison of Deep Brain Stimulation Array Functionality with Varying
      Number of Radial Electrodes and Machine Learning Feature Sets.
LID - 58
AB  - Deep brain stimulation (DBS) leads with radially distributed electrodes have
      potential to improve clinical outcomes through more selective targeting of
      pathways and networks within the brain. However, increasing the number of
      electrodes on clinical DBS leads by replacing conventional cylindrical shell
      electrodes with radially distributed electrodes raises practical design and
      stimulation programming challenges. We used computational modeling to
      investigate: (1) how the number of radial electrodes impact the ability to steer,
      shift, and sculpt a region of neural activation (RoA), and (2) which RoA features
      are best used in combination with machine learning classifiers to predict
      programming settings to target a particular area near the lead. Stimulation
      configurations were modeled using 27 lead designs with one to nine radially
      distributed electrodes. The computational modeling framework consisted of a
      three-dimensional finite element tissue conductance model in combination with a
      multi-compartment biophysical axon model. For each lead design, two-dimensional
      threshold-dependent RoAs were calculated from the computational modeling results.
      The models showed more radial electrodes enabled finer resolution RoA steering;
      however, stimulation amplitude, and therefore spatial extent of the RoA, was
      limited by charge injection and charge storage capacity constraints due to the
      small electrode surface area for leads with more than four radially distributed
      electrodes. RoA shifting resolution was improved by the addition of radial
      electrodes when using uniform multi-cathode stimulation, but non-uniform
      multi-cathode stimulation produced equivalent or better resolution shifting
      without increasing the number of radial electrodes. Robust machine learning
      classification of 15 monopolar stimulation configurations was achieved using as
      few as three geometric features describing a RoA. The results of this study
      indicate that, for a clinical-scale DBS lead, more than four radial electrodes
      minimally improved in the ability to steer, shift, and sculpt axonal activation
      around a DBS lead and a simple feature set consisting of the RoA center of mass
      and orientation enabled robust machine learning classification. These results
      provide important design constraints for future development of high-density DBS
      arrays.
FAU - Teplitzky, Benjamin A.
AU  - Teplitzky BA
AD  - Department of Biomedical Engineering, University of MinnesotaMinneapolis, MN, USA
FAU - Zitella, Laura M.
AU  - Zitella LM
AD  - Department of Biomedical Engineering, University of MinnesotaMinneapolis, MN, USA
FAU - Xiao, YiZi
AU  - Xiao Y
AD  - Department of Biomedical Engineering, University of MinnesotaMinneapolis, MN, USA
FAU - Johnson, Matthew D.
AU  - Johnson MD
AD  - Department of Biomedical Engineering, University of MinnesotaMinneapolis, MN, USA
LA  - eng
PT  - Journal Article
DEP - 20160610
GR  - R01-NS081118
PHST- 2016/03/20 [received]
PHST- 2016/05/27 [accepted]
TA  - Front Comput Neurosci
JT  - Frontiers in Computational Neuroscience
AID - 10.3389/fncom.2016.00058 [doi]
SO  - Front Comput Neurosci. 2016 Jun 10;10:. doi:10.3389/fncom.2016.00058.

PMC - PMC4441220
PMID- 14999174
IS  - 1092-8529 (Print)
VI  - 9
IP  - 1
DP  - 2004 Jan
TI  - Outcome Measures for Clinical Drug Trials in Autism.
PG  - 36-47
AB  - This paper identifies instruments and measures that may be appropriate for
      randomized clinical trials in participants with autism spectrum disorders (ASDs).
      The Clinical Global Impressions scale was recommended for all randomized clinical
      trials. At this point, however, there is no “perfect” choice of outcome measure
      for core features of autism, although we will discuss five measures of potential 
      utility. Several communication instruments are recommended, based in part on
      suitability across the age range. In trials where the intention is to alter core 
      features of ASDs, adaptive behavior scales are also worthy of consideration.
      Several “behavior complexes” common to ASDs are identified, and instruments are
      recommended for assessment of these. Given the prevalence of cognitive impairment
      in ASDs, it is important to assess any cognitive effects, although cognitive data
      from ASD randomized clinical trials, thus far, are minimal. Guidance from trials 
      in related pharmacologic areas and behavioral pharmacology may be helpful. We
      recommend routine elicitation of side effects, height and weight, vital signs,
      and (in the case of antipsychotics) extrapyramidal side-effects assessment. It is
      often appropriate to include laboratory tests and assessments for continence and 
      sleep pattern.
FAU - Aman, Michael G.
AU  - Aman MG
AD  - professor of psychology and psychiatry in the Departments of Psychology and
      Psychiatry at the Nisonger Center at Ohio University in Columbus
FAU - Novotny, Sherie
AU  - Novotny S
AD  - assistant professor of psychiatry in the Department of Psychiatry at the
      University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Campus
FAU - Samango-Sprouse, Carole
AU  - Samango-Sprouse C
AD  - associate clinical professor in the Department of Pediatrics at the George
      Washington University in Washington, D.C
FAU - Lecavalier, Luc
AU  - Lecavalier L
AD  - assistant professor of psychology in the Department of Psychology at Ohio State
      University
FAU - Leonard, Elizabeth
AU  - Leonard E
AD  - lecturer on psychology in the Department of Psychiatry at Harvard Medical School 
      in Boston, Massachusetts
FAU - Gadow, Kenneth D.
AU  - Gadow KD
AD  - professor of psychiatry in the Department of Psychiatry at the State University
      of New York at Stony Brook
FAU - King, Bryan H.
AU  - King BH
AD  - the director of Child and Adolescent Psychiatry in the Department of Psychiatry
      at Dartmouth Medical School in Hanover, New Hampshire
FAU - Pearson, Deborah A.
AU  - Pearson DA
AD  - associate professor of psychiatry and behavioral sciences in the Department of
      Psychiatry and Behavioral Sciences at the University of Texas Medical School in
      Houston
FAU - Gernsbacher, Morton Ann
AU  - Gernsbacher MA
AD  - Sir Frederic C. Bartlett Professor of Psychology in the Department of Psychology 
      at the University of Wisconsin, Madison
FAU - Chez, Michael
AU  - Chez M
AD  - assistant professor of Neurology and Pediatrics at the Rush Medical School and
      Lecturer at the Chicago Medical School, both in Chicago, IL
LA  - eng
PT  - Journal Article
TA  - CNS Spectr
JT  - CNS spectrums
MID - NIHMS685505
SO  - CNS Spectr. 2004 Jan;9(1):36-47.

PMC - PMC4459719
PMID- 25499471
IS  - 1935-861X (Print)
VI  - 8
IP  - 1
DP  - 2015 Jan-Feb
TI  - Safety of Noninvasive Brain Stimulation in Children and Adolescents.
PG  - 76-87
AB  - Background: Noninvasive brain stimulation (NIBS) techniques such as transcranial 
      magnetic stimulation (TMS) and transcranial current stimulation (tCS) have the
      potential to mitigate a variety of symptoms associated with neurological and
      psychiatric conditions, including stroke, cerebral palsy, autism, depression, and
      Tourette syndrome. While the safety of these modalities has been established in
      adults, there is a paucity of research assessing the safety of NIBS among
      children. Objective: To examine the existing literature regarding the safety of
      NIBS techniques in children and adolescents with neurologic and neuropsychiatric 
      disorders. Methods: An electronic search was performed on online databases for
      studies using NIBS in individuals less than 18 years of age. Non-English
      publications, diagnostic studies, electroconvulsive therapy, single/dual pulse
      TMS studies, and reviews were excluded. Adverse events reported in the studies
      were carefully examined and synthesized to understand the safety and tolerability
      of NIBS among children and adolescents. Results: The data from 48 studies
      involving more than 513 children/adolescents (2.5–17.8 years of age) indicate
      that the side-effects of NIBS were, in general, mild and transient [TMS: headache
      (11.5%), scalp discomfort (2.5%), twitching (1.2%), mood changes (1.2%), fatigue 
      (0.9%), tinnitus (0.6%); tCS: tingling (11.5%), itching (5.8%), redness (4.7%),
      scalp discomfort (3.1%)] with relatively few serious adverse events. Conclusion: 
      Our findings indicate that both repetitive TMS and tCS are safe modalities in
      children and adolescents with various neurological conditions, especially when
      safety guidelines are followed. The incidence of adverse events appears to be
      similar to that observed in adults; however, further studies with longer
      treatment and follow-up periods are needed to better understand the benefits and 
      tolerance of long-term use of NIBS in children.
FAU - Krishnan, Chandramouli
AU  - Krishnan C
AD  - Department of Physical Medicine and Rehabilitation, University of Michigan
      Medical School, Ann Arbor, MI, USA
FAU - Santos, Luciana
AU  - Santos L
AD  - Department of Physical Medicine and Rehabilitation, University of Michigan
      Medical School, Ann Arbor, MI, USA
FAU - Peterson, Mark D.
AU  - Peterson MD
AD  - Department of Physical Medicine and Rehabilitation, University of Michigan
      Medical School, Ann Arbor, MI, USA
FAU - Ehinger, Margaret
AU  - Ehinger M
AD  - Department of Physical Medicine and Rehabilitation, University of Michigan
      Medical School, Ann Arbor, MI, USA
LA  - eng
PT  - Journal Article
DEP - 20141028
TA  - Brain Stimul
JT  - Brain stimulation
AID - 10.1016/j.brs.2014.10.012 [doi]
MID - NIHMS690696
SO  - Brain Stimul. 2015 Jan-Feb;8(1):76-87. Epub 2014 Oct 28
      doi:10.1016/j.brs.2014.10.012.

PMC - PMC3771698
PMID- 19924522
IS  - 0162-3257 (Print)
IS  - 1573-3432 (Electronic)
VI  - 40
IP  - 3
DP  - 2010 Mar
TI  - Cerebellum, Language, and Cognition in Autism and Specific Language Impairment.
PG  - 300-16
AB  - We performed cerebellum segmentation and parcellation on magnetic resonance
      images from right-handed boys, aged 6–13 years, including 22 boys with autism (16
      with language impairment (ALI)), 9 boys with Specific Language Impairment (SLI), 
      and 11 normal controls. Language-impaired groups had reversed asymmetry relative 
      to unimpaired groups in posterior-lateral cerebellar lobule VIIIA (right side
      larger in unimpaired groups, left side larger in ALI and SLI), contralateral to
      previous findings in inferior frontal cortex language areas. Lobule VIIA Crus I
      was smaller in SLI than in ALI. Vermis volume, particularly anterior I-V, was
      decreased in language-impaired groups. Language performance test scores
      correlated with lobule VIIIA asymmetry and with anterior vermis volume. These
      findings suggest ALI and SLI subjects show abnormalities in neurodevelopment of
      fronto-corticocerebellar circuits that manage motor control and the processing of
      language, cognition, working memory, and attention.
FAU - Hodge, Steven M.
AU  - Hodge SM
AD  - Center for Morphometric Analysis, Massachusetts General Hospital, Boston, MA
FAU - Makris, Nikos
AU  - Makris N
AD  - Center for Morphometric Analysis, Massachusetts General Hospital, Boston, MA
FAU - Kennedy, David N.
AU  - Kennedy DN
AD  - Center for Morphometric Analysis, Massachusetts General Hospital, Boston, MA
FAU - Caviness, Verne S.
AU  - Caviness VS
AD  - Center for Morphometric Analysis, Massachusetts General Hospital, Boston, MA
FAU - Howard, James
AU  - Howard J
AD  - Center for Morphometric Analysis, Massachusetts General Hospital, Boston, MA
FAU - McGrath, Lauren
AU  - McGrath L
AD  - Boston University School of Medicine, Lab of Cognitive Neuroscience, Boston, MA
FAU - Steele, Shelly
AU  - Steele S
AD  - Boston University School of Medicine, Lab of Cognitive Neuroscience, Boston, MA
FAU - Frazier, Jean A.
AU  - Frazier JA
AD  - Department of Psychiatry, Harvard Medical School, Boston, MA
FAU - Tager-Flusberg, Helen
AU  - Tager-Flusberg H
AD  - Boston University School of Medicine, Lab of Cognitive Neuroscience, Boston, MA
FAU - Harris, Gordon J.
AU  - Harris GJ
AD  - Radiology Computer Aided Diagnostics Laboratory, Massachusetts General Hospital, 
      Boston, MA
LA  - eng
PT  - Journal Article
GR  - U19 DC003610 || DC
TA  - J Autism Dev Disord
JT  - Journal of autism and developmental disorders
AID - 10.1007/s10803-009-0872-7 [doi]
MID - NIHMS486118
SO  - J Autism Dev Disord. 2010 Mar;40(3):300-16. doi:10.1007/s10803-009-0872-7.

PMC - PMC4270734
PMID- 25521292
IS  - 1932-6203 (Electronic)
VI  - 9
IP  - 12
DP  - 2014
TI  - First-in-Human Trial of a Novel Suprachoroidal Retinal Prosthesis.
LID - e115239
AB  - : Retinal visual prostheses (“bionic eyes”) have the potential to restore vision 
      to blind or profoundly vision-impaired patients. The medical bionic technology
      used to design, manufacture and implant such prostheses is still in its relative 
      infancy, with various technologies and surgical approaches being evaluated. We
      hypothesised that a suprachoroidal implant location (between the sclera and
      choroid of the eye) would provide significant surgical and safety benefits for
      patients, allowing them to maintain preoperative residual vision as well as
      gaining prosthetic vision input from the device. This report details the
      first-in-human Phase 1 trial to investigate the use of retinal implants in the
      suprachoroidal space in three human subjects with end-stage retinitis pigmentosa.
      The success of the suprachoroidal surgical approach and its associated safety
      benefits, coupled with twelve-month post-operative efficacy data, holds promise
      for the field of vision restoration. Trial Registration: Clinicaltrials.gov
      NCT01603576
FAU - Ayton, Lauren N.
AU  - Ayton LN
AD  - Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye
      and Ear Hospital, East Melbourne, Australia
FAU - Blamey, Peter J.
AU  - Blamey PJ
AD  - Bionics Institute, East Melbourne, Australia
FAU - Guymer, Robyn H.
AU  - Guymer RH
AD  - Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye
      and Ear Hospital, East Melbourne, Australia
FAU - Luu, Chi D.
AU  - Luu CD
AD  - Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye
      and Ear Hospital, East Melbourne, Australia
FAU - Nayagam, David A. X.
AU  - Nayagam DAX
AD  - Bionics Institute, East Melbourne, Australia
FAU - Sinclair, Nicholas C.
AU  - Sinclair NC
AD  - Bionics Institute, East Melbourne, Australia
FAU - Shivdasani, Mohit N.
AU  - Shivdasani MN
AD  - Bionics Institute, East Melbourne, Australia
FAU - Yeoh, Jonathan
AU  - Yeoh J
AD  - Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye
      and Ear Hospital, East Melbourne, Australia
FAU - McCombe, Mark F.
AU  - McCombe MF
AD  - Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye
      and Ear Hospital, East Melbourne, Australia
FAU - Briggs, Robert J.
AU  - Briggs RJ
AD  - Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye
      and Ear Hospital, East Melbourne, Australia
FAU - Opie, Nicholas L.
AU  - Opie NL
AD  - Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye
      and Ear Hospital, East Melbourne, Australia
FAU - Villalobos, Joel
AU  - Villalobos J
AD  - Bionics Institute, East Melbourne, Australia
FAU - Dimitrov, Peter N.
AU  - Dimitrov PN
AD  - Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye
      and Ear Hospital, East Melbourne, Australia
FAU - Varsamidis, Mary
AU  - Varsamidis M
AD  - Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye
      and Ear Hospital, East Melbourne, Australia
FAU - Petoe, Matthew A.
AU  - Petoe MA
AD  - Bionics Institute, East Melbourne, Australia
FAU - McCarthy, Chris D.
AU  - McCarthy CD
AD  - NICTA, Computer Vision Research Group, Canberra, Australia
FAU - Walker, Janine G.
AU  - Walker JG
AD  - NICTA, Computer Vision Research Group, Canberra, Australia
FAU - Barnes, Nick
AU  - Barnes N
AD  - NICTA, Computer Vision Research Group, Canberra, Australia
FAU - Burkitt, Anthony N.
AU  - Burkitt AN
AD  - Bionics Institute, East Melbourne, Australia
FAU - Williams, Chris E.
AU  - Williams CE
AD  - Bionics Institute, East Melbourne, Australia
FAU - Shepherd, Robert K.
AU  - Shepherd RK
AD  - Bionics Institute, East Melbourne, Australia
FAU - Allen, Penelope J.
AU  - Allen PJ
AD  - Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye
      and Ear Hospital, East Melbourne, Australia
CN  - for the Bionic Vision Australia Research Consortium
LA  - eng
PT  - Journal Article
DEP - 20141218
PHST- 2014/07/08 [received]
PHST- 2014/11/18 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-14-27869 [pii]
AID - 10.1371/journal.pone.0115239 [doi]
SO  - PLoS One. 2014 Dec 18;9(12):. doi:10.1371/journal.pone.0115239.

PMC - PMC3996943
PMID- 24294909
IS  - 0897-7151 (Print)
IS  - 1557-9042 (Electronic)
VI  - 31
IP  - 9
DP  - 2014 May 01
TI  - Novel Multi-System Functional Gains via Task Specific Training in Spinal Cord
      Injured Male Rats.
PG  - 819-33
AB  - Locomotor training (LT) after spinal cord injury (SCI) is a rehabilitative
      therapy used to enhance locomotor recovery. There is evidence, primarily
      anecdotal, also associating LT with improvements in bladder function and
      reduction in some types of SCI-related pain. In the present study, we determined 
      if a step training paradigm could improve outcome measures of locomotion, bladder
      function, and pain/allodynia. After a T10 contusive SCI trained animals (adult
      male Wistar rats), trained animals began quadrupedal step training beginning 2
      weeks post-SCI for 1 h/day. End of study experiments (3 months of training)
      revealed significant changes in limb kinematics, gait, and hindlimb
      flexor-extensor bursting patterns relative to non-trained controls. Importantly, 
      micturition function, evaluated with terminal transvesical cystometry, was
      significantly improved in the step trained group (increased voiding efficiency,
      intercontraction interval, and contraction amplitude). Because both SCI and LT
      affect neurotrophin signaling, and neurotrophins are involved with post-SCI
      plasticity in micturition pathways, we measured bladder neurotrophin mRNA.
      Training regulated the expression of nerve growth factor (NGF) but not BDNF or
      NT3. Bladder NGF mRNA levels were inversely related to bladder function in the
      trained group. Monitoring of overground locomotion and neuropathic pain
      throughout the study revealed significant improvements, beginning after 3 weeks
      of training, which in both cases remained consistent for the study duration.
      These novel findings, improving non-locomotor in addition to locomotor functions,
      demonstrate that step training post-SCI could contribute to multiple quality of
      life gains, targeting patient-centered high priority deficits.
FAU - Ward, Patricia J.
AU  - Ward PJ
AD  - Department of Anatomical Sciences and Neurobiology, University of Louisville,
      Louisville, Kentucky
FAU - Herrity, April N.
AU  - Herrity AN
AD  - Department of Anatomical Sciences and Neurobiology, University of Louisville,
      Louisville, Kentucky
FAU - Smith, Rebecca R.
AU  - Smith RR
AD  - Kentucky Spinal Cord Injury Research Center, University of Louisville,
      Louisville, Kentucky
FAU - Willhite, Andrea
AU  - Willhite A
AD  - Kentucky Spinal Cord Injury Research Center, University of Louisville,
      Louisville, Kentucky
FAU - Harrison, Benjamin J.
AU  - Harrison BJ
AD  - Department of Anatomical Sciences and Neurobiology, University of Louisville,
      Louisville, Kentucky
FAU - Petruska, Jeffrey C.
AU  - Petruska JC
AD  - Department of Anatomical Sciences and Neurobiology, University of Louisville,
      Louisville, Kentucky
FAU - Harkema, Susan J.
AU  - Harkema SJ
AD  - Kentucky Spinal Cord Injury Research Center, University of Louisville,
      Louisville, Kentucky
FAU - Hubscher, Charles H.
AU  - Hubscher CH
AD  - Department of Anatomical Sciences and Neurobiology, University of Louisville,
      Louisville, Kentucky
LA  - eng
PT  - Journal Article
TA  - J Neurotrauma
JT  - Journal of Neurotrauma
AID - 10.1089/neu.2013.3082 [pii]
AID - 10.1089/neu.2013.3082 [doi]
SO  - J Neurotrauma. 2014 May 01;31(9):819-33. doi:10.1089/neu.2013.3082.

PMC - PMC5469353
PMID- 28659784
IS  - 1662-5218 (Electronic)
VI  - 11
DP  - 2017
TI  - Effects of Assist-As-Needed Upper Extremity Robotic Therapy after Incomplete
      Spinal Cord Injury: A Parallel-Group Controlled Trial.
LID - 26
AB  - Background: Robotic rehabilitation of the upper limb following neurological
      injury has been supported through several large clinical studies for individuals 
      with chronic stroke. The application of robotic rehabilitation to the treatment
      of other neurological injuries is less developed, despite indications that
      strategies successful for restoration of motor capability following stroke may
      benefit individuals with incomplete spinal cord injury (SCI) as well. Although
      recent studies suggest that robot-aided rehabilitation might be beneficial after 
      incomplete SCI, it is still unclear what type of robot-aided intervention
      contributes to motor recovery. Methods: We developed a novel assist-as-needed
      (AAN) robotic controller to adjust challenge and robotic assistance continuously 
      during rehabilitation therapy delivered via an upper extremity exoskeleton, the
      MAHI Exo-II, to train independent elbow and wrist joint movements. We further
      enrolled seventeen patients with incomplete spinal cord injury (AIS C and D
      levels) in a parallel-group balanced controlled trial to test the efficacy of the
      AAN controller, compared to a subject-triggered (ST) controller that does not
      adjust assistance or challenge levels continuously during therapy. The conducted 
      study is a stage two, development-of-concept pilot study. Results: We validated
      the AAN controller in its capability of modulating assistance and challenge
      during therapy via analysis of longitudinal robotic metrics. For the selected
      primary outcome measure, the pre–post difference in ARAT score, no statistically 
      significant change was measured in either group of subjects. Ancillary analysis
      of secondary outcome measures obtained via robotic testing indicates gradual
      improvement in movement quality during the therapy program in both groups, with
      the AAN controller affording greater increases in movement quality over the ST
      controller. Conclusion: The present study demonstrates feasibility of
      subject-adaptive robotic therapy after incomplete spinal cord injury, but does
      not demonstrate gains in arm function occurring as a result of the robot-assisted
      rehabilitation program, nor differential gains obtained as a result of the
      developed AAN controller. Further research is warranted to better quantify the
      recovery potential provided by AAN control strategies for robotic rehabilitation 
      of the upper limb following incomplete SCI.ClinicalTrials.gov registration
      number: NCT02803255.
FAU - Frullo, John Michael
AU  - Frullo JM
AD  - Department of Mechanical Engineering, Rice University, Houston, TX, United States
FAU - Elinger, Jared
AU  - Elinger J
AD  - Department of Mechanical Engineering, Rice University, Houston, TX, United States
FAU - Pehlivan, Ali Utku
AU  - Pehlivan AU
AD  - Department of Mechanical Engineering, Rice University, Houston, TX, United States
FAU - Fitle, Kyle
AU  - Fitle K
AD  - Department of Mechanical Engineering, Rice University, Houston, TX, United States
FAU - Nedley, Kathryn
AU  - Nedley K
AD  - TIRR Memorial Hermann, Houston, TX, United States
FAU - Francisco, Gerard E.
AU  - Francisco GE
AD  - TIRR Memorial Hermann, Houston, TX, United States
FAU - Sergi, Fabrizio
AU  - Sergi F
AD  - Department of Biomedical Engineering, University of Delaware, Newark, DE, United 
      States
FAU - O’Malley, Marcia K.
AU  - O’Malley MK
AD  - Department of Mechanical Engineering, Rice University, Houston, TX, United States
LA  - eng
PT  - Journal Article
DEP - 20170613
PHST- 2017/03/14 [received]
PHST- 2017/05/18 [accepted]
TA  - Front Neurorobot
JT  - Frontiers in Neurorobotics
AID - 10.3389/fnbot.2017.00026 [doi]
SO  - Front Neurorobot. 2017 Jun 13;11:. doi:10.3389/fnbot.2017.00026.

PMC - PMC4064702
PMID- 24999327
IS  - 1662-5161 (Electronic)
VI  - 8
DP  - 2014
TI  - Focal dystonia and the Sensory-Motor Integrative Loop for Enacting (SMILE).
LID - 458
AB  - Performing accurate movements requires preparation, execution, and monitoring
      mechanisms. The first two are coded by the motor system, the latter by the
      sensory system. To provide an adaptive neural basis to overt behaviors, motor and
      sensory information has to be properly integrated in a reciprocal feedback loop. 
      Abnormalities in this sensory-motor loop are involved in movement disorders such 
      as focal dystonia, a hyperkinetic alteration affecting only a specific body part 
      and characterized by sensory and motor deficits in the absence of basic motor
      impairments. Despite the fundamental impact of sensory-motor integration
      mechanisms on daily life, the general principles of healthy and pathological
      anatomic–functional organization of sensory-motor integration remain to be
      clarified. Based on the available data from experimental psychology,
      neurophysiology, and neuroimaging, we propose a bio-computational model of
      sensory-motor integration: the Sensory-Motor Integrative Loop for Enacting
      (SMILE). Aiming at direct therapeutic implementations and with the final target
      of implementing novel intervention protocols for motor rehabilitation, our main
      goal is to provide the information necessary for further validating the SMILE
      model. By translating neuroscientific hypotheses into empirical investigations
      and clinically relevant questions, the prediction based on the SMILE model can be
      further extended to other pathological conditions characterized by impaired
      sensory-motor integration.
FAU - Perruchoud, David
AU  - Perruchoud D
AD  - Laboratory for Investigative Neurophysiology, Department of Radiology and
      Department of Clinical Neurosciences, University Hospital Center and University
      of LausanneLausanne, Switzerland
FAU - Murray, Micah M.
AU  - Murray MM
AD  - Laboratory for Investigative Neurophysiology, Department of Radiology and
      Department of Clinical Neurosciences, University Hospital Center and University
      of LausanneLausanne, Switzerland
FAU - Lefebvre, Jeremie
AU  - Lefebvre J
AD  - Laboratory for Investigative Neurophysiology, Department of Radiology and
      Department of Clinical Neurosciences, University Hospital Center and University
      of LausanneLausanne, Switzerland
FAU - Ionta, Silvio
AU  - Ionta S
AD  - Laboratory for Investigative Neurophysiology, Department of Radiology and
      Department of Clinical Neurosciences, University Hospital Center and University
      of LausanneLausanne, Switzerland
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20140620
PHST- 2014/03/17 [received]
PHST- 2014/06/04 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2014.00458 [doi]
SO  - Front Hum Neurosci. 2014 Jun 20;8:. doi:10.3389/fnhum.2014.00458.

PMC - PMC4642598
PMID- 26092658
IS  - 1861-6410 (Print)
IS  - 1861-6429 (Electronic)
VI  - 10
IP  - 12
DP  - 2015
TI  - Locally rigid, vessel-based registration for laparoscopic liver surgery.
PG  - 1951-61
AB  - Purpose: Laparoscopic liver resection has significant advantages over open
      surgery due to less patient trauma and faster recovery times, yet is difficult
      for most lesions due to the restricted field of view and lack of haptic feedback.
      Image guidance provides a potential solution but is challenging in a soft
      deforming organ such as the liver. In this paper, we therefore propose a
      laparoscopic ultrasound (LUS) image guidance system and study the feasibility of 
      a locally rigid registration for laparoscopic liver surgery. Methods: We
      developed a real-time segmentation method to extract vessel centre points from
      calibrated, freehand, electromagnetically tracked, 2D LUS images. Using
      landmark-based initial registration and an optional iterative closest point (ICP)
      point-to-line registration, a vessel centre-line model extracted from
      preoperative computed tomography (CT) is registered to the ultrasound data during
      surgery. Results: Using the locally rigid ICP method, the RMS residual error when
      registering to a phantom was 0.7 mm, and the mean target registration error (TRE)
      for two in vivo porcine studies was 3.58 and 2.99 mm, respectively. Using the
      locally rigid landmark-based registration method gave a mean TRE of 4.23 mm using
      vessel centre lines derived from CT scans taken with pneumoperitoneum and 6.57 mm
      without pneumoperitoneum. Conclusion: In this paper we propose a practical
      image-guided surgery system based on locally rigid registration of a CT-derived
      model to vascular structures located with LUS. In a physical phantom and during
      porcine laparoscopic liver resection, we demonstrate accuracy of target location 
      commensurate with surgical requirements. We conclude that locally rigid
      registration could be sufficient for practically useful image guidance in the
      near future.
FAU - Song, Yi
AU  - Song Y
AD  - Centre For Medical Image Computing, Engineering Front Building, University
      College London, Malet Place, London, UK
FAU - Totz, Johannes
AU  - Totz J
AD  - Centre For Medical Image Computing, Engineering Front Building, University
      College London, Malet Place, London, UK
FAU - Thompson, Steve
AU  - Thompson S
AD  - Centre For Medical Image Computing, Engineering Front Building, University
      College London, Malet Place, London, UK
FAU - Johnsen, Stian
AU  - Johnsen S
AD  - Centre For Medical Image Computing, Engineering Front Building, University
      College London, Malet Place, London, UK
FAU - Barratt, Dean
AU  - Barratt D
AD  - Centre For Medical Image Computing, Engineering Front Building, University
      College London, Malet Place, London, UK
FAU - Schneider, Crispin
AU  - Schneider C
AD  - Royal Free Campus, 9th Floor, Royal Free Hospital, UCL Medical School, Rowland
      Hill Street, London, UK
FAU - Gurusamy, Kurinchi
AU  - Gurusamy K
AD  - Royal Free Campus, 9th Floor, Royal Free Hospital, UCL Medical School, Rowland
      Hill Street, London, UK
FAU - Davidson, Brian
AU  - Davidson B
AD  - Royal Free Campus, 9th Floor, Royal Free Hospital, UCL Medical School, Rowland
      Hill Street, London, UK
FAU - Ourselin, Sébastien
AU  - Ourselin S
AD  - Centre For Medical Image Computing, Engineering Front Building, University
      College London, Malet Place, London, UK
FAU - Hawkes, David
AU  - Hawkes D
AD  - Centre For Medical Image Computing, Engineering Front Building, University
      College London, Malet Place, London, UK
FAU - Clarkson, Matthew J.
AU  - Clarkson MJ
AD  - Centre For Medical Image Computing, Engineering Front Building, University
      College London, Malet Place, London, UK
LA  - eng
PT  - Journal Article
DEP - 20150620
PHST- 2015/03/24 [received]
PHST- 2015/05/30 [accepted]
TA  - Int J Comput Assist Radiol Surg
JT  - International Journal of Computer Assisted Radiology and Surgery
AID - 1236 [pii]
AID - 10.1007/s11548-015-1236-8 [doi]
SO  - Int J Comput Assist Radiol Surg. 2015;10(12):1951-61. Epub 2015 Jun 20
      doi:10.1007/s11548-015-1236-8.

PMC - PMC4038779
PMID- 24022474
IS  - 0006-8950 (Print)
IS  - 1460-2156 (Electronic)
VI  - 136
IP  - 10
DP  - 2013 Oct
TI  - Asymmetry of planum temporale constrains interhemispheric language plasticity in 
      children with focal epilepsy.
PG  - 3163-75
AB  - Reorganization of eloquent cortex enables rescue of language functions in
      patients who sustain brain injury. Individuals with left-sided, early-onset focal
      epilepsy often show atypical (i.e. bilateral or right-sided) language dominance. 
      Surprisingly, many patients fail to show such interhemispheric shift of language 
      despite having major epileptogenic lesions in close proximity to eloquent cortex.
      Although a number of epilepsy-related factors may promote interhemispheric
      plasticity, it has remained unexplored if neuroanatomical asymmetries linked to
      human language dominance modify the likelihood of atypical lateralization. Here
      we examined the asymmetry of the planum temporale, one of the most striking
      asymmetries in the human brain, in relation to language lateralization in
      children with left-sided focal epilepsy. Language functional magnetic resonance
      imaging was performed in 51 children with focal epilepsy and left-sided lesions
      and 36 healthy control subjects. We examined the association of language
      laterality with a range of potential clinical predictors and the asymmetry of the
      length of the planum temporale. Using voxel-based methods, we sought to determine
      the effect of lesion location (in the affected left hemisphere) and grey matter
      density (in the unaffected right hemisphere) on language laterality. Atypical
      language lateralization was observed in 19 patients (38%) and in four controls
      (11%). Language laterality was increasingly right-sided in patients who showed
      atypical handedness, a left perisylvian ictal electroencephalographic focus, and 
      a lesion in left anterior superior temporal or inferior frontal regions. Most
      striking was the relationship between rightward asymmetry of the planum temporale
      and atypical language (R = 0.70, P < 0.0001); patients with a longer planum
      temporale in the right (unaffected) hemisphere were more likely to have atypical 
      language dominance. Voxel-based regression analysis confirmed that increased grey
      matter density in the right temporo-parietal junction was correlated with right
      hemisphere lateralization of language. The length of the planum temporale in the 
      right hemisphere was the main predictor of language lateralization in the
      epilepsy group, accounting for 48% of variance, with handedness accounting for
      only a further 5%. There was no correlation between language lateralization and
      planum temporale asymmetry in the control group. We conclude that asymmetry of
      the planum temporale may be unrelated to language lateralization in healthy
      individuals, but the size of the right, contra-lesional planum temporale region
      may reflect a ‘reserve capacity’ for interhemispheric language reorganization in 
      the presence of a seizure focus and lesions within left perisylvian regions.
FAU - Pahs, Gerald
AU  - Pahs G
AD  - 1 Developmental Cognitive Neuroscience Unit, Institute of Child Health,
      University College London, London, WC1N 1EH, UK
FAU - Rankin, Peter
AU  - Rankin P
AD  - 1 Developmental Cognitive Neuroscience Unit, Institute of Child Health,
      University College London, London, WC1N 1EH, UK
FAU - Helen Cross, J.
AU  - Helen Cross J
AD  - 2 Neurosciences Unit, Institute of Child Health, University College London,
      London, WC1N 1EH, UK
FAU - Croft, Louise
AU  - Croft L
AD  - 1 Developmental Cognitive Neuroscience Unit, Institute of Child Health,
      University College London, London, WC1N 1EH, UK
FAU - Northam, Gemma B.
AU  - Northam GB
AD  - 1 Developmental Cognitive Neuroscience Unit, Institute of Child Health,
      University College London, London, WC1N 1EH, UK
FAU - Liegeois, Frederique
AU  - Liegeois F
AD  - 1 Developmental Cognitive Neuroscience Unit, Institute of Child Health,
      University College London, London, WC1N 1EH, UK
FAU - Greenway, Sarah
AU  - Greenway S
AD  - 1 Developmental Cognitive Neuroscience Unit, Institute of Child Health,
      University College London, London, WC1N 1EH, UK
FAU - Harrison, Sue
AU  - Harrison S
AD  - 1 Developmental Cognitive Neuroscience Unit, Institute of Child Health,
      University College London, London, WC1N 1EH, UK
FAU - Vargha-Khadem, Faraneh
AU  - Vargha-Khadem F
AD  - 1 Developmental Cognitive Neuroscience Unit, Institute of Child Health,
      University College London, London, WC1N 1EH, UK
FAU - Baldeweg, Torsten
AU  - Baldeweg T
AD  - 1 Developmental Cognitive Neuroscience Unit, Institute of Child Health,
      University College London, London, WC1N 1EH, UK
LA  - eng
PT  - Journal Article
PHST- 2013/03/01 [received]
PHST- 2013/06/03 [revised]
PHST- 2013/06/17 [accepted]
TA  - Brain
JT  - Brain
AID - 10.1093/brain/awt225 [doi]
AID - awt225 [pii]
SO  - Brain. 2013 Oct;136(10):3163-75. doi:10.1093/brain/awt225.

PMC - PMC4348021
PMID- 24680869
IS  - 1053-8119 (Print)
IS  - 1095-9572 (Electronic)
VI  - 96
DP  - 2014 Aug 1
TI  - Restricted Boltzmann Machines for Neuroimaging: an Application in Identifying
      Intrinsic Networks.
PG  - 245-60
AB  - Matrix factorization models are the current dominant approach for resolving
      meaningful data-driven features in neuroimaging data. Among them, independent
      component analysis (ICA) is arguably the most widely used for identifying
      functional networks, and its success has led to a number of versatile extensions 
      to group and multimodal data. However there are indications that ICA may have
      reached a limit in flexibility and representational capacity, as the majority of 
      such extensions are case-driven, custom-made solutions that are still contained
      within the class of mixture models. In this work, we seek out a principled and
      naturally extensible approach and consider a probabilistic model known as a
      restricted Boltzmann machine (RBM). An RBM separates linear factors from
      functional brain imaging data by fitting a probability distribution model to the 
      data. Importantly, the solution can be used as a building block for more complex 
      (deep) models, making it naturally suitable for hierarchical and multimodal
      extensions that are not easily captured when using linear factorizations alone.
      We investigate the capability of RBMs to identify intrinsic networks and compare 
      its performance to that of well-known linear mixture models, in particular ICA.
      Using synthetic and real task fMRI data, we show that RBMs can be used to
      identify networks and their temporal activations with accuracy that is equal or
      greater than that of factorization models. The demonstrated effectiveness of RBMs
      supports its use as a building block for deeper models, a significant prospect
      for future neuroimaging research.
FAU - Hjelm, R. Devon
AU  - Hjelm RD
AD  - Department of Computer Science, University of New Mexico, Albuquerque, New Mexico
      87131, USA
FAU - Calhoun, Vince D.
AU  - Calhoun VD
AD  - Department of Computer Science, University of New Mexico, Albuquerque, New Mexico
      87131, USA
FAU - Salakhutdinov, Ruslan
AU  - Salakhutdinov R
AD  - Department of Computer Science, University of Toronto, Toronto, Ontario M5S 2J7, 
      Canada
FAU - Allen, Elena A.
AU  - Allen EA
AD  - Mind Research Network, Albuquerque, New Mexico 87106, USA
FAU - Adali, Tulay
AU  - Adali T
AD  - University of Maryland Baltimore County, Baltimore, Maryland 21250, USA
FAU - Plis, Sergey M.
AU  - Plis SM
AD  - Mind Research Network, Albuquerque, New Mexico 87106, USA
LA  - eng
PT  - Journal Article
DEP - 20140328
TA  - Neuroimage
JT  - NeuroImage
AID - 10.1016/j.neuroimage.2014.03.048 [doi]
MID - NIHMS579987
SO  - Neuroimage. 2014 Aug 1;96:245-60. Epub 2014 Mar 28
      doi:10.1016/j.neuroimage.2014.03.048.

PMC - PMC4712849
PMID- 25321384
IS  - 1092-4388 (Print)
IS  - 1558-9102 (Electronic)
VI  - 58
IP  - 1
DP  - 2015 Feb
TI  - Children's Acquisition of English Onset and Coda /l/: Articulatory Evidence.
PG  - 13-27
AB  - Purpose: The goal of this study was to better understand how and when onset /l/
      (leap) and coda /l/ (peel) are acquired by children by examining both the
      articulations involved and adults' perceptions of the produced segments. Method: 
      Twenty-five typically developing Australian English–speaking children aged 3;0
      (years;months) to 7;11 participated in an elicited imitation task, during which
      audio, video, and lingual ultrasound images were collected. Transcribers
      perceptually rated audio, whereas video and ultrasound images were visually
      examined for the presence of adult-like articulations. Results: Data from this
      study establish that for Australian English–learning children, coda /l/s are
      acquired later than onset /l/s, and older children produce greater proportions of
      adultlike /l/s in both onset and coda positions, roughly following established
      norms for American English–speaking children. However, although perceptibility of
      coda /l/s was correlated with their articulations, onset /l/s were nearly
      uniformly perceived as adultlike despite substantial variation in the
      articulations used to produce them. Conclusions: The disparity in the production 
      and perception of children's singleton onset /l/s is linked to both physiological
      and phonological development. Suggestions are made for future research to tease
      these factors apart.
FAU - Lin, Susan
AU  - Lin S
AD  - University of California, Berkeley
FAU - Demuth, Katherine
AU  - Demuth K
AD  - ARC Centre of Excellence in Cognition and Its Disorders, Macquarie University,
      Sydney, New South Wales, Australia
LA  - eng
PT  - Journal Article
PHST- 2014/02/10 [received]
PHST- 2014/08/15 [revised]
PHST- 2014/09/19 [accepted]
TA  - J Speech Lang Hear Res
JT  - Journal of Speech, Language, and Hearing Research : JSLHR
AID - 10924388005800010013 [pii]
AID - 10.1044/2014_JSLHR-S-14-0041 [doi]
SO  - J Speech Lang Hear Res. 2015 Feb;58(1):13-27. doi:10.1044/2014_JSLHR-S-14-0041.

PMC - PMC4096147
PMID- 24746946
IS  - 0028-3932 (Print)
IS  - 1873-3514 (Electronic)
VI  - 59
DP  - 2014 Jul
TI  - Abnormal dynamics of activation of object use information in apraxia: evidence
      from eyetracking.
PG  - 13-26
AB  - Action representations associated with object use may be incidentally activated
      during visual object processing, and the time course of such activations may be
      influenced by lexical-semantic context (e.g., Lee, Middleton, Mirman, Kalénine, &
      Buxbaum, 2012). In this study we used the “visual world” eye-tracking paradigm to
      examine whether a deficit in producing skilled object-use actions (apraxia) is
      associated with abnormalities in incidental activation of action information, and
      assessed the neuroanatomical substrates of any such deficits. Twenty left
      hemisphere stroke patients, ten of whom were apraxic, performed a task requiring 
      identification of a named object in a visual display containing
      manipulation-related and unrelated distractor objects. Manipulation relationships
      among objects were not relevant to the identification task. Objects were cued
      with neutral (“S/he saw the….”), or action-relevant (“S/he used the….”)
      sentences. Non-apraxic participants looked at use-related non-target objects
      significantly more than at unrelated non-target objects when cued both by neutral
      and action-relevant sentences, indicating that action information is incidentally
      activated. In contrast, apraxic participants showed delayed activation of
      manipulation-based action information during object identification when cued by
      neutral sentences. The magnitude of delayed activation in the neutral sentence
      condition was reliably predicted by lower scores on a test of gesture production 
      to viewed objects, as well as by lesion loci in the inferior parietal and
      posterior temporal lobes. However, when cued by a sentence containing an action
      verb, apraxic participants showed fixation patterns that were statistically
      indistinguishable from non-apraxic controls. In support of grounded theories of
      cognition, these results suggest that apraxia and temporal-parietal lesions may
      be associated with abnormalities in incidental activation of action information
      from objects. Further, they suggest that the previously-observed facilitative
      role of action verbs in the retrieval of object-related action information
      extends to participants with apraxia.
FAU - Lee, Chia-lin
AU  - Lee Cl
AD  - Graduate Institute of Linguistics, Department of Psychology, Graduate Institute
      of Brain and Mind Sciences, and Neurobiology and Cognitive Neuroscience Center,
      National Taiwan University, Taipei, Taiwan
FAU - Mirman, Daniel
AU  - Mirman D
AD  - Moss Rehabilitation Research Institute, Philadelphia, Pennsylvania, USA
FAU - Buxbaum, Laurel J.
AU  - Buxbaum LJ
AD  - Moss Rehabilitation Research Institute, Philadelphia, Pennsylvania, USA
LA  - eng
PT  - Journal Article
DEP - 20140416
TA  - Neuropsychologia
JT  - Neuropsychologia
AID - 10.1016/j.neuropsychologia.2014.04.004 [doi]
MID - NIHMS593256
SO  - Neuropsychologia. 2014 Jul;59:13-26. Epub 2014 Apr 16
      doi:10.1016/j.neuropsychologia.2014.04.004.

PMC - PMC3900228
PMID- 24551387
IS  - 1942-597X (Electronic)
VI  - 2013
DP  - 2013
TI  - Adapting Comparative Effectiveness Research Summaries for Delivery to Patients
      and Providers through a Patient Portal.
PG  - 959-68
AB  - Despite increases in the scientific evidence for a variety of medical treatments,
      a gap remains in the adoption of best medical practices. This manuscript
      describes a process for adapting published summary guides from comparative
      effectiveness research to render them concise, targeted to audience, and easily
      actionable; and a strategy for disseminating such evidence to patients and their 
      physicians through a web-based portal and linked electronic health record. This
      project adapted summary guides about oral medications for adults with type 2
      diabetes to a fifth-grade literacy level and modified the resulting materials
      based on evaluations with the Suitability Assessment of Materials instrument.
      Focus groups and individual interviews with patients, diabetes providers, and
      health literacy experts were employed to evaluate and enhance the adapted summary
      guide. We present the lessons learned as general guidelines for the creation of
      concise, targeted, and actionable evidence and its delivery to both patients and 
      providers through increasingly prevalent health information technologies.
FAU - McDougald Scott, Amanda M.
AU  - McDougald Scott AM
FAU - Jackson, Gretchen Purcell
AU  - Jackson GP
FAU - Ho, Yun-Xian
AU  - Ho YX
FAU - Yan, Zhou
AU  - Yan Z
FAU - Davison, Coda
AU  - Davison C
FAU - Rosenbloom, S. Trent
AU  - Rosenbloom ST
LA  - eng
PT  - Journal Article
DEP - 20131116
TA  - AMIA Annu Symp Proc
JT  - AMIA Annual Symposium Proceedings
AID - amia_2013_symposium_959 [pii]
SO  - AMIA Annu Symp Proc. 2013 Nov 16;2013:959-68.

PMC - PMC4416646
PMID- 24732411
IS  - 0031-9384 (Print)
IS  - 1873-507X (Electronic)
VI  - 130
DP  - 2014 May 10
TI  - Novel mechanistic insights into treadmill exercise based rescue of social
      defeat-induced anxiety-like behavior and memory impairment in rats.
PG  - 135-44
AB  - Social defeat (SD) induced stress causes physiological and behavioral deficits in
      rodents, including depression and anxiety-like behaviors, as well as memory
      impairment. Anxiolytic and mood elevating effects of physical exercise are also
      known. However, rescue effect of physical exercise in social defeat-induced
      anxiety, depression or memory impairment has not been addressed. Role of
      epigenetic mechanisms that potentially contribute to these rescue or protective
      effects are also not known. Present study investigated the effect of moderate
      treadmill exercise on anxiety-like behavior and memory function in rats subjected
      to SD using a modified version of the resident-intruder model for social stress
      (defeat). Changes in histone acetylation and histone-modifying enzymes were
      examined in hippocampus, amygdala and frontal cortex which are considered
      critical for anxiety, depression and cognition. Sprague Dawley rats were randomly
      assigned in four groups; control, exercised, social defeat, social defeat and
      exercise. At the end of the SD or control exposure lasting 30 min daily for 7
      days, one group of SD rats was subjected to treadmill exercise for 2 weeks,
      whereas the other SD group was handled without exercise. Anxiety-like behavior
      tests and radial arm water maze test suggested that moderate treadmill exercise
      rescued social defeat induced anxiety-like behavior and memory impairment.
      Moreover, exercise normalized SD-induced increase in oxidative stress, most
      likely by adjusting antioxidant response. Our data suggests involvement of
      epigenetic mechanisms including histone acetylation of H3 and modulation of
      methyl-CpG-binding in the hippocampus that might contribute to the rescue effects
      of exercise in SD-induced behavioral deficits in rats.
FAU - Patki, Gaurav
AU  - Patki G
AD  - Department of Pharmacological and Pharmaceutical Sciences, University of Houston,
      Texas, USA
FAU - Solanki, Naimesh
AU  - Solanki N
AD  - Department of Pharmacological and Pharmaceutical Sciences, University of Houston,
      Texas, USA
FAU - Atrooz, Fatin
AU  - Atrooz F
AD  - Department of Pharmacological and Pharmaceutical Sciences, University of Houston,
      Texas, USA
FAU - Ansari, Amber
AU  - Ansari A
AD  - Department of Pharmacological and Pharmaceutical Sciences, University of Houston,
      Texas, USA
FAU - Allam, Farida
AU  - Allam F
AD  - Department of Pharmacological and Pharmaceutical Sciences, University of Houston,
      Texas, USA
FAU - Jannise, Brittany
AU  - Jannise B
AD  - Department of Pharmacological and Pharmaceutical Sciences, University of Houston,
      Texas, USA
FAU - Maturi, Jaganmohan
AU  - Maturi J
AD  - Department of Pharmacological and Pharmaceutical Sciences, University of Houston,
      Texas, USA
FAU - Salim, Samina
AU  - Salim S
AD  - Department of Pharmacological and Pharmaceutical Sciences, University of Houston,
      Texas, USA
LA  - eng
PT  - Journal Article
DEP - 20140413
TA  - Physiol Behav
JT  - Physiology & behavior
AID - 10.1016/j.physbeh.2014.04.011 [doi]
MID - NIHMS585661
SO  - Physiol Behav. 2014 May 10;130:135-44. Epub 2014 Apr 13
      doi:10.1016/j.physbeh.2014.04.011.

PMC - PMC5006088
PMID- 27630556
IS  - 1662-5188 (Electronic)
VI  - 10
DP  - 2016
TI  - Modeling of Cerebral Oxygen Transport Based on In vivo Microscopic Imaging of
      Microvascular Network Structure, Blood Flow, and Oxygenation.
LID - 82
AB  - Oxygen is delivered to brain tissue by a dense network of microvessels, which
      actively control cerebral blood flow (CBF) through vasodilation and contraction
      in response to changing levels of neural activity. Understanding these
      network-level processes is immediately relevant for (1) interpretation of
      functional Magnetic Resonance Imaging (fMRI) signals, and (2) investigation of
      neurological diseases in which a deterioration of neurovascular and
      neuro-metabolic physiology contributes to motor and cognitive decline.
      Experimental data on the structure, flow and oxygen levels of microvascular
      networks are needed, together with theoretical methods to integrate this
      information and predict physiologically relevant properties that are not directly
      measurable. Recent progress in optical imaging technologies for high-resolution
      in vivo measurement of the cerebral microvascular architecture, blood flow, and
      oxygenation enables construction of detailed computational models of cerebral
      hemodynamics and oxygen transport based on realistic three-dimensional
      microvascular networks. In this article, we review state-of-the-art optical
      microscopy technologies for quantitative in vivo imaging of cerebral
      microvascular structure, blood flow and oxygenation, and theoretical methods that
      utilize such data to generate spatially resolved models for blood flow and oxygen
      transport. These “bottom-up” models are essential for the understanding of the
      processes governing brain oxygenation in normal and disease states and for
      eventual translation of the lessons learned from animal studies to humans.
FAU - Gagnon, Louis
AU  - Gagnon L
AD  - Optics Division, Department of Radiology, MHG/MIT/HMS Athinoula A. Martinos
      Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical
      SchoolCharlestown, MA, USA
FAU - Smith, Amy F.
AU  - Smith AF
AD  - Institut de Mécanique des Fluides de ToulouseToulouse, France
FAU - Boas, David A.
AU  - Boas DA
AD  - Optics Division, Department of Radiology, MHG/MIT/HMS Athinoula A. Martinos
      Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical
      SchoolCharlestown, MA, USA
FAU - Devor, Anna
AU  - Devor A
AD  - Optics Division, Department of Radiology, MHG/MIT/HMS Athinoula A. Martinos
      Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical
      SchoolCharlestown, MA, USA
FAU - Secomb, Timothy W.
AU  - Secomb TW
AD  - Department of Physiology, University of ArizonaTucson, AZ, USA
FAU - Sakadžić, Sava
AU  - Sakadžić S
AD  - Optics Division, Department of Radiology, MHG/MIT/HMS Athinoula A. Martinos
      Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical
      SchoolCharlestown, MA, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20160831
GR  - NS091230
PHST- 2016/03/03 [received]
PHST- 2016/07/25 [accepted]
TA  - Front Comput Neurosci
JT  - Frontiers in Computational Neuroscience
AID - 10.3389/fncom.2016.00082 [doi]
SO  - Front Comput Neurosci. 2016 Aug 31;10:. doi:10.3389/fncom.2016.00082.

PMC - PMC3716612
PMID- 23894517
IS  - 1932-6203 (Electronic)
VI  - 8
IP  - 7
DP  - 2013
TI  - i3Drefine Software for Protein 3D Structure Refinement and Its Assessment in
      CASP10.
LID - e69648
AB  - Protein structure refinement refers to the process of improving the qualities of 
      protein structures during structure modeling processes to bring them closer to
      their native states. Structure refinement has been drawing increasing attention
      in the community-wide Critical Assessment of techniques for Protein Structure
      prediction (CASP) experiments since its addition in 8th CASP experiment. During
      the 9th and recently concluded 10th CASP experiments, a consistent growth in
      number of refinement targets and participating groups has been witnessed. Yet,
      protein structure refinement still remains a largely unsolved problem with
      majority of participating groups in CASP refinement category failed to
      consistently improve the quality of structures issued for refinement. In order to
      alleviate this need, we developed a completely automated and computationally
      efficient protein 3D structure refinement method, i3Drefine, based on an
      iterative and highly convergent energy minimization algorithm with a powerful
      all-atom composite physics and knowledge-based force fields and hydrogen bonding 
      (HB) network optimization technique. In the recent community-wide blind
      experiment, CASP10, i3Drefine (as ‘MULTICOM-CONSTRUCT’) was ranked as the best
      method in the server section as per the official assessment of CASP10 experiment.
      Here we provide the community with free access to i3Drefine software and
      systematically analyse the performance of i3Drefine in strict blind mode on the
      refinement targets issued in CASP10 refinement category and compare with other
      state-of-the-art refinement methods participating in CASP10. Our analysis
      demonstrates that i3Drefine is only fully-automated server participating in
      CASP10 exhibiting consistent improvement over the initial structures in both
      global and local structural quality metrics. Executable version of i3Drefine is
      freely available at http://protein.rnet.missouri.edu/i3drefine/.
FAU - Bhattacharya, Debswapna
AU  - Bhattacharya D
AD  - Department of Computer Science, University of Missouri, Columbia, Missouri,
      United States of America
FAU - Cheng, Jianlin
AU  - Cheng J
AD  - Department of Computer Science, Informatics Institute, Bond Life Science Center, 
      University of Missouri, Columbia, Missouri, United States of America
LA  - eng
PT  - Journal Article
DEP - 20130719
PHST- 2013/04/25 [received]
PHST- 2013/06/13 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-13-16614 [pii]
AID - 10.1371/journal.pone.0069648 [doi]
SO  - PLoS One. 2013 Jul 19;8(7):. doi:10.1371/journal.pone.0069648.

PMC - PMC3197797
PMID- 21718791
IS  - 1053-8119 (Print)
IS  - 1095-9572 (Electronic)
VI  - 59
IP  - 1
DP  - 2012 Jan 2
TI  - A Selective Review of Simulated Driving Studies: Combining Naturalistic and
      Hybrid Paradigms, Analysis Approaches, and Future Directions.
PG  - 25-35
AB  - Naturalistic paradigms such as movie watching or simulated driving that mimic
      closely real-world complex activities are becoming more widely used in functional
      magnetic resonance imaging (fMRI) studies both because of their ability to
      robustly stimulate brain connectivity and the availability of analysis methods
      which are able to capitalize on connectivity within and among intrinsic brain
      networks identified both during a task and in resting fMRI data. In this paper we
      review over a decade of work from our group and others on the use of simulated
      driving paradigms to study both the healthy brain as well as the effects of acute
      alcohol administration on functional connectivity during such paradigms. We
      briefly review our initial work focused on the configuration of the driving
      simulator and the analysis strategies. We then describe in more detail several
      recent studies from our group including a hybrid study examining distracted
      driving and compare resulting data with those from a separate visual oddball
      task.The analysis of these data were performed primarily using a combination of
      group independent component analysis (ICA) and the general linear model (GLM) and
      in the various studies we highlight novel findings which result from an analysis 
      of either 1) within-network connectivity, 2) inter-network connectivity, also
      called functional network connectivity, or 3) the degree to which the modulation 
      of the various intrinsic networks were associated with the alcohol administration
      and the task context.Despite the fact that the behavioral effects of alcohol
      intoxication are relatively well known, there is still much to discover on how
      acute alcohol exposure modulates brain function in a selective manner, associated
      with behavioral alterations. Through the above studies, we have learned more
      regarding the impact of acute alcohol intoxication on organization of the brain’s
      intrinsic connectivity networks during performance of a complex, real-world
      cognitive operation. Lessons learned from the above studies have broader
      applicability to designing ecologically valid, complex, functional MRI cognitive 
      paradigms and incorporating pharmacologic challenges into such studies. Overall, 
      the use of hybrid driving studies is a particularly promising area of
      neuroscience investigation.
FAU - Calhoun, V. D.
AU  - Calhoun VD
AD  - The Mind Research Network, Albuquerque, NM 87106
FAU - Pearlson, G. D.
AU  - Pearlson GD
AD  - Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT 06106
LA  - eng
PT  - Journal Article
DEP - 20110621
GR  - R01 EB000840-09 || EB
TA  - Neuroimage
JT  - NeuroImage
AID - 10.1016/j.neuroimage.2011.06.037 [doi]
MID - NIHMS304243
SO  - Neuroimage. 2012 Jan 2;59(1):25-35. Epub 2011 Jun 21
      doi:10.1016/j.neuroimage.2011.06.037.

PMC - PMC5383730
PMID- 28439233
IS  - 1662-5161 (Electronic)
VI  - 11
DP  - 2017
TI  - Concealed, Unobtrusive Ear-Centered EEG Acquisition: cEEGrids for Transparent
      EEG.
LID - 163
AB  - Electroencephalography (EEG) is an important clinical tool and frequently used to
      study the brain-behavior relationship in humans noninvasively. Traditionally, EEG
      signals are recorded by positioning electrodes on the scalp and keeping them in
      place with glue, rubber bands, or elastic caps. This setup provides good coverage
      of the head, but is impractical for EEG acquisition in natural daily-life
      situations. Here, we propose the transparent EEG concept. Transparent EEG aims
      for motion tolerant, highly portable, unobtrusive, and near invisible data
      acquisition with minimum disturbance of a user's daily activities. In recent
      years several ear-centered EEG solutions that are compatible with the transparent
      EEG concept have been presented. We discuss work showing that miniature
      electrodes placed in and around the human ear are a feasible solution, as they
      are sensitive enough to pick up electrical signals stemming from various brain
      and non-brain sources. We also describe the cEEGrid flex-printed sensor array,
      which enables unobtrusive multi-channel EEG acquisition from around the ear. In a
      number of validation studies we found that the cEEGrid enables the recording of
      meaningful continuous EEG, event-related potentials and neural oscillations.
      Here, we explain the rationale underlying the cEEGrid ear-EEG solution, present
      possible use cases and identify open issues that need to be solved on the way
      toward transparent EEG.
FAU - Bleichner, Martin G.
AU  - Bleichner MG
AD  - Neuropsychology Lab, Department of Psychology, European Medical School,
      University of OldenburgOldenburg, Germany
FAU - Debener, Stefan
AU  - Debener S
AD  - Neuropsychology Lab, Department of Psychology, European Medical School,
      University of OldenburgOldenburg, Germany
LA  - eng
PT  - Journal Article
DEP - 20170407
PHST- 2017/01/15 [received]
PHST- 2017/03/17 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2017.00163 [doi]
SO  - Front Hum Neurosci. 2017 Apr 07;11:. doi:10.3389/fnhum.2017.00163.

PMC - PMC5352287
PMID- 28190035
IS  - 1940-087X (Electronic)
IP  - 119
DP  - 2017
TI  - How to Use the H1 Deep Transcranial Magnetic Stimulation Coil for Conditions
      Other than Depression.
LID - 55100
AB  - Deep transcranial magnetic stimulation (dTMS) is a relatively new technique that 
      uses different coils for the treatment of different neuropathologies. The coils
      are made of soft copper windings in multiple planes that lie adjacent to the
      skull. They are located within a special helmet so that their magnetic fields
      combine and improve depth penetration. The H1 dTMS coil is designed to stimulate 
      bilateral prefrontal cortices with greater effective stimulation over the left
      than the right. By positioning the left side of the coil close to the left
      dorsolateral prefrontal cortex (DLPFC), the H1 coil was used in a multisite
      study, leading to FDA approval for treatment-resistant depression. In this same
      position, the H1 coil was also explored as a possible treatment for negative
      symptoms of schizophrenia, bipolar depression, and migraine. When moved to
      different positions over the subject's skull, the H1 coil was also explored as a 
      possible treatment for other conditions. Such manipulation of the H1 coil was
      demonstrated for PTSD and alcohol dependence by positioning it over the medial
      prefrontal cortex (mPFC), for anxiety by positioning it over the right prefrontal
      cortex (rPFC), for auditory hallucinations and tinnitus by positioning it over
      the temporoparietal junction (TPJ), and for Parkinson's and fatigue from multiple
      sclerosis (MS) by positioning it over the motor cortex (MC) and PFC.
      Corresponding electrical field diagrams measured with an oscilloscope through a
      saline-filled head are included.
FAU - Tendler, Aron
AU  - Tendler A
AD  - Brainsway LTD
FAU - Roth, Yiftach
AU  - Roth Y
AD  - Brainsway LTD
FAU - Barnea-Ygael, Noam
AU  - Barnea-Ygael N
AD  - Department of Life Sciences, Ben Gurion University of the Negev
FAU - Zangen, Abraham
AU  - Zangen A
AD  - Department of Life Sciences, Ben Gurion University of the Negev
LA  - eng
PT  - Journal Article
DEP - 20170123
TA  - J Vis Exp
JT  - Journal of Visualized Experiments : JoVE
AID - 55100 [pii]
AID - 10.3791/55100 [doi]
SO  - J Vis Exp. 2017 Jan 23;(119):. doi:10.3791/55100.

PMC - PMC5057425
PMID- 27724952
IS  - 1475-9276 (Electronic)
VI  - 15
DP  - 2016
TI  - Organizational interventions improving access to community-based primary health
      care for vulnerable populations: a scoping review.
LID - 168
AB  - Access to community-based primary health care (hereafter, ‘primary care’) is a
      priority in many countries. Health care systems have emphasized policies that
      help the community ‘get the right service in the right place at the right time’. 
      However, little is known about organizational interventions in primary care that 
      are aimed to improve access for populations in situations of vulnerability (e.g.,
      socioeconomically disadvantaged) and how successful they are. The purpose of this
      scoping review was to map the existing evidence on organizational interventions
      that improve access to primary care services for vulnerable populations. Scoping 
      review followed an iterative process. Eligibility criteria: organizational
      interventions in Organisation for Economic Cooperation and Development (OECD)
      countries; aiming to improve access to primary care for vulnerable populations;
      all study designs; published from 2000 in English or French; reporting at least
      one outcome (avoidable hospitalization, emergency department admission, or unmet 
      health care needs). Sources: Main bibliographic databases (Medline, Embase,
      CINAHL) and team members’ personal files. Study selection: One researcher
      selected relevant abstracts and full text papers. Theory-driven synthesis: The
      researcher classified included studies using (i) the ‘Patient Centered Access to 
      Healthcare’ conceptual framework (dimensions and outcomes of access to primary
      care), and (ii) the classification of interventions of the Cochrane Effective
      Practice and Organization of Care. Using pattern analysis, interventions were
      mapped in accordance with the presence/absence of ‘dimension-outcome’ patterns.
      Out of 8,694 records (title/abstract), 39 studies with varying designs were
      included. The analysis revealed the following pattern. Results of 10 studies on
      interventions classified as ‘Formal integration of services’ suggested that these
      interventions were associated with three dimensions of access (approachability,
      availability and affordability) and reduction of hospitalizations (four/four
      studies), emergency department admissions (six/six studies), and unmet healthcare
      needs (five/six studies). These 10 studies included seven non-randomized studies,
      one randomized controlled trial, one quantitative descriptive study, and one
      mixed methods study. Our results suggest the limited breadth of research in this 
      area, and that it will be feasible to conduct a full systematic review of studies
      on the effectiveness of the formal integration of services to improve access to
      primary care services for vulnerable populations.
FAU - Khanassov, Vladimir
AU  - Khanassov V
AUID- ORCID: 0000-0003-2609-241X
AD  - Department of Family Medicine, McGill University, 5858 Côte-des-neiges, 3rd
      Floor, Suite 300, Montreal, QC H3S 1Z1 Canada
FAU - Pluye, Pierre
AU  - Pluye P
AD  - Department of Family Medicine, McGill University, 5858 Côte-des-neiges, 3rd
      Floor, Suite 300, Montreal, QC H3S 1Z1 Canada
FAU - Descoteaux, Sarah
AU  - Descoteaux S
AD  - St. Mary’s Hospital Research Centre, 3830 Lacombe Ave, Montréal, QC H3T1M5 Canada
FAU - Haggerty, Jeannie L.
AU  - Haggerty JL
AD  - Department of Family Medicine, McGill University, St. Mary’s Hospital Research
      Centre, 3830 Lacombe Ave, Montréal, QC H3T1M5 Canada
FAU - Russell, Grant
AU  - Russell G
AD  - Southern Academic Primary Care Research Unit, Department of General Practice,
      School of Primary Health Care, Monash University, Building 1, 270 Ferntree Gully 
      Rd, Notting Hill, VIC 3168 Australia
FAU - Gunn, Jane
AU  - Gunn J
AD  - University of Melbourne, 200 Berkeley Street, Melbourne, VIC 3053 Australia
FAU - Levesque, Jean-Frederic
AU  - Levesque JF
AD  - Centre for Primary Health Care and Equity, University of New South Wales, Bureau 
      of Health Information, 67 Albert Avenue, Chatswood, Sydney, NSW 2067 Australia
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20161010
GR  - TTF-130729
PHST- 2016/04/05 [received]
PHST- 2016/10/03 [accepted]
TA  - Int J Equity Health
JT  - International Journal for Equity in Health
AID - 459 [pii]
AID - 10.1186/s12939-016-0459-9 [doi]
SO  - Int J Equity Health. 2016 Oct 10;15:. doi:10.1186/s12939-016-0459-9.

PMC - PMC3055772
PMID- 20671269
IS  - 0146-0404 (Print)
IS  - 1552-5783 (Electronic)
VI  - 51
IP  - 12
DP  - 2010 Dec
TI  - Driving with Hemianopia, II: Lane Position and Steering in a Driving Simulator.
PG  - 6605-13
AB  - Drivers with hemianopia took a lane position that increased their safety margin
      on the blind side. Although their steering control appeared commensurate with
      safe driving, their poor blind-side detection did not seem compatible with safe
      driving.
OAB - Publisher: Abstract available from the publisher.
FAU - Bowers, Alex R.
AU  - Bowers AR
AD  - From The Schepens Eye Research Institute, Department of Ophthalmology, Harvard
      Medical School, Boston, Massachusetts.
FAU - Mandel, Aaron J.
AU  - Mandel AJ
AD  - From The Schepens Eye Research Institute, Department of Ophthalmology, Harvard
      Medical School, Boston, Massachusetts.
FAU - Goldstein, Robert B.
AU  - Goldstein RB
AD  - From The Schepens Eye Research Institute, Department of Ophthalmology, Harvard
      Medical School, Boston, Massachusetts.
FAU - Peli, Eli
AU  - Peli E
AD  - From The Schepens Eye Research Institute, Department of Ophthalmology, Harvard
      Medical School, Boston, Massachusetts.
LA  - eng
PT  - Journal Article
GR  - EY12890
PHST- 2010/02/02 [received]
PHST- 2010/05/18 [revised]
PHST- 2010/07/02 [revised]
PHST- 2010/07/09 [accepted]
TA  - Invest Ophthalmol Vis Sci
JT  - Investigative Ophthalmology & Visual Science
AID - 10-5310 [pii]
AID - 10.1167/iovs.10-5310 [doi]
SO  - Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6605-13. doi:10.1167/iovs.10-5310.

PMC - PMC3186078
PMID- 21969327
IS  - 0031-6997 (Print)
IS  - 1521-0081 (Electronic)
VI  - 63
IP  - 4
DP  - 2011 Dec
TI  - α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's
      Disease.
PG  - 938-66
AB  - Parkinson's disease is a debilitating movement disorder characterized by a
      generalized dysfunction of the nervous system, with a particularly prominent
      decline in the nigrostriatal dopaminergic pathway. Although there is currently no
      cure, drugs targeting the dopaminergic system provide major symptomatic relief.
      As well, agents directed to other neurotransmitter systems are of therapeutic
      benefit. Such drugs may act by directly improving functional deficits in these
      other systems, or they may restore aberrant motor activity that arises as a
      result of a dopaminergic imbalance. Recent research attention has focused on a
      role for drugs targeting the nicotinic cholinergic systems. The rationale for
      such work stems from basic research findings that there is an extensive overlap
      in the organization and function of the nicotinic cholinergic and dopaminergic
      systems in the basal ganglia. In addition, nicotinic acetylcholine receptor
      (nAChR) drugs could have clinical potential for Parkinson's disease. Evidence for
      this proposition stems from studies with experimental animal models showing that 
      nicotine protects against neurotoxin-induced nigrostriatal damage and improves
      motor complications associated with l-DOPA, the “gold standard” for Parkinson's
      disease treatment. Nicotine interacts with multiple central nervous system
      receptors to generate therapeutic responses but also produces side effects. It is
      important therefore to identify the nAChR subtypes most beneficial for treating
      Parkinson's disease. Here we review nAChRs with particular emphasis on the
      subtypes that contribute to basal ganglia function. Accumulating evidence
      suggests that drugs targeting α6β2* and α4β2* nAChR may prove useful in the
      management of Parkinson's disease.
FAU - Quik, Maryka
AU  - Quik M
FAU - Wonnacott, Susan
AU  - Wonnacott S
LA  - eng
PT  - Journal Article
PT  - Review
GR  - NS42091
TA  - Pharmacol Rev
JT  - Pharmacological Reviews
AID - 3709258 [pii]
AID - 10.1124/pr.110.003269 [doi]
SO  - Pharmacol Rev. 2011 Dec;63(4):938-66. doi:10.1124/pr.110.003269.

PMC - PMC3970813
PMID- 24441739
IS  - 0196-0202 (Print)
IS  - 1538-4667 (Electronic)
VI  - 35
IP  - 2
DP  - 2014 Mar-Apr
TI  - Effects of Age on Melody and Timbre Perception in Simulations of Electro-Acoustic
      and Cochlear-Implant Hearing.
PG  - 195-202
AB  - Objectives: Recent evidence suggests that age might affect the ability of
      listeners to process fundamental frequency cues in speech, and that this
      difficulty might impact the ability of older listeners to use and combine
      envelope and fine structure cues available in simulations of electro-acoustic and
      cochlear-implant hearing. The purpose of this paper is to examine whether this
      difficulty extends to music. Specially, this study focuses on whether older
      listeners have a decreased ability to utilize and combine different types of cues
      in the perception of melody and timbre. Design: A group of older listeners with
      normal to near-normal hearing and a group of younger listeners with normal
      hearing participated in the melody and timbre recognition tasks of the University
      of Washington Clinical Assessment of Music Perception (CAMP) test. The
      recognition tasks were completed for five different processing conditions: 1) an 
      unprocessed condition; 2) an eight-channel vocoding condition that simulated a
      traditional cochlear implant and contained temporal envelope cues; 3) a
      simulation of electro-acoustic stimulation (sEAS) that included a low-pass
      acoustic component and high-pass vocoded portion, and which provided fine
      structure and envelope cues; 4) a condition that included only the low-pass
      acoustic portion of the sEAS and 5) a condition that included only the
      high-frequency vocoded portion of the sEAS stimulus. Results: Melody recognition 
      was excellent for both younger and older listeners in the conditions containing
      the unprocessed stimuli, the full sEAS stimuli, and the low-pass sEAS stimuli.
      Melody recognition was significantly worse in the cochlear-implant simulation
      condition, especially for the older group of listeners. Performance on the timbre
      task was highest for the unprocessed condition, and progressively decreased for
      the sEAS and cochlear-implant simulation conditions. Compared to younger
      listeners, older listeners had significantly poorer timbre recognition for all
      processing conditions. For melody recognition, the unprocessed low-frequency
      portion of the sEAS stimulus was the primary factor determining improved
      performance in the sEAS condition compared to the cochlear-implant simulation.
      For timbre recognition, both the unprocessed low-frequency and high-frequency
      vocoded portions of the sEAS stimulus contributed to sEAS improvement in the
      younger group. In contrast, most listeners in the older group were not able to
      take advantage of the high-frequency vocoded portion of the sEAS stimulus for
      timbre recognition. Conclusions: The results of this simulation study support the
      idea that older listeners will have diminished timbre and melody perception in
      traditional cochlear-implant listening due to degraded envelope processing. The
      findings also suggest that music perception by older listeners with cochlear
      implants will be improved with the addition of low-frequency residual hearing.
      However, these improvements might not be comparable for all dimensions of music
      perception. That is, more improvement might be evident for tasks that rely
      primarily on the low-frequency portion of the electro-acoustic stimulus (e.g.,
      melody recognition) and less improvement might be evident in situations that
      require across-frequency integration of cues (e.g., timbre perception).
FAU - Arehart, Kathryn H.
AU  - Arehart KH
AD  - Department of Speech, Language, Hearing Sciences, University of Colorado
FAU - Croghan, Naomi B.H.
AU  - Croghan NB
AD  - Department of Speech, Language, Hearing Sciences, University of Colorado
FAU - Muralimanohar, Ramesh Kumar
AU  - Muralimanohar RK
AD  - Department of Speech, Language, Hearing Sciences, University of Colorado
LA  - eng
PT  - Journal Article
TA  - Ear Hear
JT  - Ear and hearing
AID - 10.1097/AUD.0b013e3182a69a5c [doi]
MID - NIHMS518814
SO  - Ear Hear. 2014 Mar-Apr;35(2):195-202. doi:10.1097/AUD.0b013e3182a69a5c.

PMC - PMC3387772
PMID- 23074440
IS  - 1915-7398 (Electronic)
VI  - 2
IP  - 3
DP  - 2002
TI  - Bone Anchored Hearing Aid: An Evidence-Based Analysis.
PG  - 1-47
AB  - Objective: The objective of this health technology policy assessment was to
      determine the effectiveness and cost-effectiveness of bone-anchored hearing aid
      (BAHA) in improving the hearing of people with conduction or mixed hearing
      loss.The Technology: The (BAHA) is a bone conduction hearing device that includes
      a titanium fixture permanently implanted into the mastoid bone of the skull and
      an external percutaneous sound processor. The sound processor is attached to the 
      fixture by means of a skin penetrating abutment. Because the device bypasses the 
      middle ear and directly stimulates the cochlea, it has been recommended for
      individuals with conduction hearing loss or discharging middle ear infection.The 
      titanium implant is expected to last a lifetime while the external sound
      processor is expected to last 5 years. The total initial device cost is
      approximately $5,300 and the external sound processor costs approximately $3,500.
      Review of BAHA by the Medical Advisory Secretariat: The Medical Advisory
      Secretariat’s review is a descriptive synthesis of findings from 36 research
      articles published between January 1990 and May 2002.Summary of Findings: No
      randomized controlled studies were found. The evidence was derived from level 4
      case series with relative small sample sizes (ranging from 30-188). The majority 
      of the studies have follow-up periods of eight years or longer. All except one
      study were based on monaural BAHA implant on the side with the best bone
      conduction threshold. Safety: Level 4 evidence showed that BAHA has been be
      implanted safely in adults and children with success rates of 90% or higher in
      most studies. No mortality or life threatening morbidity has been reported.
      Revision rates for tissue reduction or resiting were generally under 10% for
      adults but have been reported to be as high as 25% in pediatric studies.Adverse
      skin reaction around the skin penetration site was the most common complication
      reported. Most of these conditions were successfully treated with antibiotics,
      and only 1% to 2% required surgical revision. Less than 1% required removal of
      the fixture.Other complications included failure to osseointegrate and loss of
      fixture and/or abutment due to trauma or infection. Effectiveness: Studies showed
      that BAHAs were implanted in people who have conduction or mixed hearing loss,
      congenital atresia or suppurative otitis media who were not candidates for
      surgical repair, and who cannot use conventional bone conduction hearing aids.
      The need for BAHA is not age- related. Objective audiometric measures and
      subjective patient satisfaction surveys showed that BAHA significantly improved
      the unaided and aided free field and sound field thresholds as well as speech
      discrimination in quiet and in noise for former users of conventional bone
      conduction hearing aids. The outcomes were ambiguous for former users of air
      conduction hearing aids.BAHA has been shown to reduce the frequency of ear
      infection and reduce the discharge particularly among patients with suppurative
      otitis media.Patients have reported that BAHA improved their quality of life.
      Reported benefits were improved speech intelligibility, better sound comfort,
      less pressure on the head, less skin irritation, greater cosmetic acceptance and 
      increase in confidence. Main reported shortcomings were wind noise, feedback and 
      difficulty in using the telephone.Experts and the BAHA manufacturer recommended
      that recipients of a BAHA implant be at least 5 years old. Challenges associated 
      with the implantation of BAHA in pediatric patients include thin bone, soft bone,
      higher rates of fixture loss due to trauma, psychological problems, and higher
      revision rates due to rapid bone growth. The overall outcomes are comparable to
      adult BAHA. The benefits of pediatric BAHA (e.g. on speech development) appear to
      outweigh the disadvantages.Screening according to strict eligibility criteria,
      preoperative counselling, close monitoring by a physician with BAHA expertise and
      on-going follow-up were identified as critical factors for long-term implant
      survival. Examples of eligibility criteria were provided. Cost-effectiveness: No 
      literature on cost-effectiveness of BAHA was found.
CN  - Health Quality Ontario
LA  - eng
PT  - Journal Article
DEP - 20020901
TA  - Ont Health Technol Assess Ser
JT  - Ontario Health Technology Assessment Series
SO  - Ont Health Technol Assess Ser. 2002 Sep 1;2(3):1-47.

PMC - PMC2790121
PMID- 20057958
IS  - 1422-0067 (Electronic)
VI  - 10
IP  - 10
DP  - 2009 Oct
TI  - Electromagnetic Biostimulation of Living Cultures for Biotechnology, Biofuel and 
      Bioenergy Applications.
PG  - 4515-58
AB  - The surge of interest in bioenergy has been marked with increasing efforts in
      research and development to identify new sources of biomass and to incorporate
      cutting-edge biotechnology to improve efficiency and increase yields. It is
      evident that various microorganisms will play an integral role in the development
      of this newly emerging industry, such as yeast for ethanol and Escherichia coli
      for fine chemical fermentation. However, it appears that microalgae have become
      the most promising prospect for biomass production due to their ability to grow
      fast, produce large quantities of lipids, carbohydrates and proteins, thrive in
      poor quality waters, sequester and recycle carbon dioxide from industrial flue
      gases and remove pollutants from industrial, agricultural and municipal
      wastewaters. In an attempt to better understand and manipulate microorganisms for
      optimum production capacity, many researchers have investigated alternative
      methods for stimulating their growth and metabolic behavior. One such novel
      approach is the use of electromagnetic fields for the stimulation of growth and
      metabolic cascades and controlling biochemical pathways. An effort has been made 
      in this review to consolidate the information on the current status of
      biostimulation research to enhance microbial growth and metabolism using
      electromagnetic fields. It summarizes information on the biostimulatory effects
      on growth and other biological processes to obtain insight regarding factors and 
      dosages that lead to the stimulation and also what kind of processes have been
      reportedly affected. Diverse mechanistic theories and explanations for biological
      effects of electromagnetic fields on intra and extracellular environment have
      been discussed. The foundations of biophysical interactions such as
      bioelectromagnetic and biophotonic communication and organization within living
      systems are expounded with special consideration for spatiotemporal aspects of
      electromagnetic topology, leading to the potential of multipolar electromagnetic 
      systems. The future direction for the use of biostimulation using
      bioelectromagnetic, biophotonic and electrochemical methods have been proposed
      for biotechnology industries in general with emphasis on an holistic biofuel
      system encompassing production of algal biomass, its processing and conversion to
      biofuel.
FAU - Hunt, Ryan W.
AU  - Hunt RW
AD  - Department of Biological and Agricultural Engineering, The University of Georgia,
      Athens, GA 30602, USA; E-Mails: bhatnagarashis@gmail.com (A.B.);
      csenthil@engr.uga.edu (S.C.); kdas@engr.uga.edu (K.C.D.)
FAU - Zavalin, Andrey
AU  - Zavalin A
AD  - Mass Spectrometry Research Center, Vanderbilt University Medical Center,
      Nashville, TN 37232, USA; E-Mail: andrey.zavalin@vanderbilt.edu (A.Z.)
FAU - Bhatnagar, Ashish
AU  - Bhatnagar A
AD  - Department of Biological and Agricultural Engineering, The University of Georgia,
      Athens, GA 30602, USA; E-Mails: bhatnagarashis@gmail.com (A.B.);
      csenthil@engr.uga.edu (S.C.); kdas@engr.uga.edu (K.C.D.)
FAU - Chinnasamy, Senthil
AU  - Chinnasamy S
AD  - Department of Biological and Agricultural Engineering, The University of Georgia,
      Athens, GA 30602, USA; E-Mails: bhatnagarashis@gmail.com (A.B.);
      csenthil@engr.uga.edu (S.C.); kdas@engr.uga.edu (K.C.D.)
FAU - Das, Keshav C.
AU  - Das KC
AD  - Department of Biological and Agricultural Engineering, The University of Georgia,
      Athens, GA 30602, USA; E-Mails: bhatnagarashis@gmail.com (A.B.);
      csenthil@engr.uga.edu (S.C.); kdas@engr.uga.edu (K.C.D.)
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20091120
PHST- 2009/08/08 [received]
PHST- 2009/09/17 [revised]
PHST- 2009/10/19 [accepted]
TA  - Int J Mol Sci
JT  - International Journal of Molecular Sciences
AID - 10.3390/ijms10104515 [doi]
AID - ijms-10-04515 [pii]
SO  - Int J Mol Sci. 2009 Nov 20;10(10):4515-58. doi:10.3390/ijms10104515.

PMC - PMC3312458
PMID- 22454598
IS  - 1424-8220 (Electronic)
VI  - 9
IP  - 8
DP  - 2009
TI  - A Unified Multi-Functional Dynamic Spectrum Access Framework: Tutorial, Theory
      and Multi-GHz Wideband Testbed.
PG  - 6530-603
AB  - Dynamic spectrum access is a must-have ingredient for future sensors that are
      ideally cognitive. The goal of this paper is a tutorial treatment of wideband
      cognitive radio and radar—a convergence of (1) algorithms survey, (2) hardware
      platforms survey, (3) challenges for multi-function (radar/communications)
      multi-GHz front end, (4) compressed sensing for multi-GHz waveforms—revolutionary
      A/D, (5) machine learning for cognitive radio/radar, (6) quickest detection, and 
      (7) overlay/underlay cognitive radio waveforms. One focus of this paper is to
      address the multi-GHz front end, which is the challenge for the next-generation
      cognitive sensors. The unifying theme of this paper is to spell out the
      convergence for cognitive radio, radar, and anti-jamming. Moore’s law drives the 
      system functions into digital parts. From a system viewpoint, this paper gives
      the first comprehensive treatment for the functions and the challenges of this
      multi-function (wideband) system. This paper brings together the
      inter-disciplinary knowledge.
FAU - Qiu, Robert
AU  - Qiu R
AD  - Department of Electrical and Computer Engineering, Center for Manufacturing
      Research, Tennessee Technological University, Cookeville, TN 38505, USA; E-Mails:
      nguo@tntech.edu (N.G.); ysong21@tntech.edu (Y.S.); Vasu.Chakravarthy@wpafb.af.mil
      (V.C.); zhu21@tntech.edu (Z.H.); pzhang21@tntech.edu (P.Z.); zchen42@tntech.edu
      (Z.C.)
FAU - Guo, Nan
AU  - Guo N
AD  - Department of Electrical and Computer Engineering, Center for Manufacturing
      Research, Tennessee Technological University, Cookeville, TN 38505, USA; E-Mails:
      nguo@tntech.edu (N.G.); ysong21@tntech.edu (Y.S.); Vasu.Chakravarthy@wpafb.af.mil
      (V.C.); zhu21@tntech.edu (Z.H.); pzhang21@tntech.edu (P.Z.); zchen42@tntech.edu
      (Z.C.)
FAU - Li, Husheng
AU  - Li H
AD  - Department of Electrical Engineering and Computer Science, The University of
      Tennessee Knoxville, TN 37996-2100, USA; E-Mail: husheng@eecs.utk.edu
FAU - Wu, Zhiqiang
AU  - Wu Z
AD  - Department of Electrical Engineering, Wright State University, 3640 Colonel Glenn
      Highway, Dayton, OH 45435-0001, USA; E-Mail: zhiqiang.wu@wright.edu
FAU - Chakravarthy, Vasu
AU  - Chakravarthy V
AD  - Department of Electrical and Computer Engineering, Center for Manufacturing
      Research, Tennessee Technological University, Cookeville, TN 38505, USA; E-Mails:
      nguo@tntech.edu (N.G.); ysong21@tntech.edu (Y.S.); Vasu.Chakravarthy@wpafb.af.mil
      (V.C.); zhu21@tntech.edu (Z.H.); pzhang21@tntech.edu (P.Z.); zchen42@tntech.edu
      (Z.C.)
FAU - Song, Yu
AU  - Song Y
AD  - Department of Electrical and Computer Engineering, Center for Manufacturing
      Research, Tennessee Technological University, Cookeville, TN 38505, USA; E-Mails:
      nguo@tntech.edu (N.G.); ysong21@tntech.edu (Y.S.); Vasu.Chakravarthy@wpafb.af.mil
      (V.C.); zhu21@tntech.edu (Z.H.); pzhang21@tntech.edu (P.Z.); zchen42@tntech.edu
      (Z.C.)
FAU - Hu, Zhen
AU  - Hu Z
AD  - Department of Electrical and Computer Engineering, Center for Manufacturing
      Research, Tennessee Technological University, Cookeville, TN 38505, USA; E-Mails:
      nguo@tntech.edu (N.G.); ysong21@tntech.edu (Y.S.); Vasu.Chakravarthy@wpafb.af.mil
      (V.C.); zhu21@tntech.edu (Z.H.); pzhang21@tntech.edu (P.Z.); zchen42@tntech.edu
      (Z.C.)
FAU - Zhang, Peng
AU  - Zhang P
AD  - Department of Electrical and Computer Engineering, Center for Manufacturing
      Research, Tennessee Technological University, Cookeville, TN 38505, USA; E-Mails:
      nguo@tntech.edu (N.G.); ysong21@tntech.edu (Y.S.); Vasu.Chakravarthy@wpafb.af.mil
      (V.C.); zhu21@tntech.edu (Z.H.); pzhang21@tntech.edu (P.Z.); zchen42@tntech.edu
      (Z.C.)
FAU - Chen, Zhe
AU  - Chen Z
AD  - Department of Electrical and Computer Engineering, Center for Manufacturing
      Research, Tennessee Technological University, Cookeville, TN 38505, USA; E-Mails:
      nguo@tntech.edu (N.G.); ysong21@tntech.edu (Y.S.); Vasu.Chakravarthy@wpafb.af.mil
      (V.C.); zhu21@tntech.edu (Z.H.); pzhang21@tntech.edu (P.Z.); zchen42@tntech.edu
      (Z.C.)
LA  - eng
PT  - Journal Article
DEP - 20090821
PHST- 2009/04/20 [received]
PHST- 2009/07/14 [revised]
PHST- 2009/08/04 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s90806530 [doi]
AID - sensors-09-06530 [pii]
SO  - Sensors (Basel). 2009 Aug 21;9(8):6530-603. doi:10.3390/s90806530.

PMC - PMC3826627
PMID- 24129341
IS  - 2041-1723 (Electronic)
VI  - 4
TI  - Numerical processing in the human parietal cortex during experimental and natural
      conditions.
LID - 2528
AB  - Human cognition is traditionally studied in experimental conditions wherein
      confounding complexities of the natural environment are intentionally eliminated.
      Thus, it remains unknown how a brain region involved in a particular experimental
      condition is engaged in natural conditions. Here we use electrocorticography to
      address this uncertainty in three participants implanted with intracranial
      electrodes and identify activations of neuronal populations within the
      intraparietal sulcus region during an experimental arithmetic condition. In a
      subsequent analysis, we report that the same intraparietal sulcus neural
      populations are activated when participants, engaged in social conversations,
      refer to objects with numerical content. Our prototype approach provides a means 
      for both exploring human brain dynamics as they unfold in complex social settings
      and reconstructing natural experiences from recorded brain signals.
OAB - Publisher: Abstract available from the publisher.
FAU - Dastjerdi, Mohammad
AU  - Dastjerdi M
AD  - Laboratory of Behavioral and Cognitive Neurology (LBCN), Department of Neurology 
      and Neurological Sciences, Stanford Human Intracranial Cognitive
      Electrophysiology Program (SHICEP), Stanford University, 300 Pasteur Drive, Room 
      A343, Stanford, California 94305, USA
FAU - Ozker, Muge
AU  - Ozker M
AD  - Laboratory of Behavioral and Cognitive Neurology (LBCN), Department of Neurology 
      and Neurological Sciences, Stanford Human Intracranial Cognitive
      Electrophysiology Program (SHICEP), Stanford University, 300 Pasteur Drive, Room 
      A343, Stanford, California 94305, USA
FAU - Foster, Brett L.
AU  - Foster BL
AD  - Laboratory of Behavioral and Cognitive Neurology (LBCN), Department of Neurology 
      and Neurological Sciences, Stanford Human Intracranial Cognitive
      Electrophysiology Program (SHICEP), Stanford University, 300 Pasteur Drive, Room 
      A343, Stanford, California 94305, USA
FAU - Rangarajan, Vinitha
AU  - Rangarajan V
AD  - Laboratory of Behavioral and Cognitive Neurology (LBCN), Department of Neurology 
      and Neurological Sciences, Stanford Human Intracranial Cognitive
      Electrophysiology Program (SHICEP), Stanford University, 300 Pasteur Drive, Room 
      A343, Stanford, California 94305, USA
FAU - Parvizi, Josef
AU  - Parvizi J
AD  - Laboratory of Behavioral and Cognitive Neurology (LBCN), Department of Neurology 
      and Neurological Sciences, Stanford Human Intracranial Cognitive
      Electrophysiology Program (SHICEP), Stanford University, 300 Pasteur Drive, Room 
      A343, Stanford, California 94305, USA
LA  - eng
PT  - Journal Article
DEP - 20131015
PHST- 2013/03/06 [received]
PHST- 2013/08/30 [accepted]
TA  - Nat Commun
JT  - Nature Communications
AID - ncomms3528 [pii]
AID - 10.1038/ncomms3528 [doi]
SO  - Nat Commun. ;4:. doi:10.1038/ncomms3528.

PMC - PMC4069835
PMID- 25009463
IS  - 1662-4548 (Print)
IS  - 1662-453X (Electronic)
VI  - 8
DP  - 2014
TI  - Computationally efficient modeling of proprioceptive signals in the upper limb
      for prostheses: a simulation study.
LID - 181
AB  - Accurate models of proprioceptive neural patterns could 1 day play an important
      role in the creation of an intuitive proprioceptive neural prosthesis for
      amputees. This paper looks at combining efficient implementations of
      biomechanical and proprioceptor models in order to generate signals that mimic
      human muscular proprioceptive patterns for future experimental work in prosthesis
      feedback. A neuro-musculoskeletal model of the upper limb with 7 degrees of
      freedom and 17 muscles is presented and generates real time estimates of muscle
      spindle and Golgi Tendon Organ neural firing patterns. Unlike previous
      neuro-musculoskeletal models, muscle activation and excitation levels are
      unknowns in this application and an inverse dynamics tool (static optimization)
      is integrated to estimate these variables. A proprioceptive prosthesis will need 
      to be portable and this is incompatible with the computationally demanding nature
      of standard biomechanical and proprioceptor modeling. This paper uses and
      proposes a number of approximations and optimizations to make real time operation
      on portable hardware feasible. Finally technical obstacles to mimicking natural
      feedback for an intuitive proprioceptive prosthesis, as well as issues and
      limitations with existing models, are identified and discussed.
FAU - Williams, Ian
AU  - Williams I
AD  - Department of Electrical and Electronic Engineering, Imperial College
      LondonLondon, UK
FAU - Constandinou, Timothy G.
AU  - Constandinou TG
AD  - Department of Electrical and Electronic Engineering, Imperial College
      LondonLondon, UK
LA  - eng
PT  - Journal Article
DEP - 20140625
PHST- 2014/03/05 [received]
PHST- 2014/06/09 [accepted]
TA  - Front Neurosci
JT  - Frontiers in Neuroscience
AID - 10.3389/fnins.2014.00181 [doi]
SO  - Front Neurosci. 2014 Jun 25;8:. doi:10.3389/fnins.2014.00181.

PMC - PMC3484478
PMID- 23118709
IS  - 1555-1741 (Print)
IS  - 1555-175X (Electronic)
VI  - 7
DP  - 2012
DP  - 2012
TI  - Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma:
      evidence for role in era of standard adjuvant temozolomide.
PG  - 115-30
AB  - The Polifeprosan 20 with carmustine (BCNU, bis-chloroethylnitrosourea, Gliadel®) 
      polymer implant wafer is a biodegradable compound containing 3.85% carmustine
      which slowly degrades to release carmustine and protects it from exposure to
      water with resultant hydrolysis until the time of release. The carmustine implant
      wafer was demonstrated to improve survival in blinded placebo-controlled trials
      in selected patients with newly diagnosed or recurrent malignant glioma, with
      little increased risk of adverse events. Based on these trials and other
      supporting data, US and European regulatory authorities granted approval for its 
      use in recurrent and newly diagnosed malignant glioma, and it remains the only
      approved local treatment. The preclinical and clinical data suggest that it is
      optimally utilized primarily in the proportion of patients who may have total or 
      near total removal of gross tumor. The aim of this work was to review the
      evidence for the use of carmustine implants in the management of malignant
      astrocytoma (World Health Organization grades III and IV), including newly
      diagnosed and recurrent disease, especially in the setting of a standard of care 
      that has changed since the randomized trials were completed. Therapy has evolved 
      such that patients now generally receive temozolomide chemotherapy during and
      after radiotherapy treatment. For patients undergoing repeat resection for
      malignant glioma, a randomized, blinded, placebo-controlled trial demonstrated a 
      median survival for 110 patients who received carmustine polymers of 31 weeks
      compared with 23 weeks for 122 patients who only received placebo polymers. The
      benefit achieved statistical significance only on analysis adjusting for
      prognostic factors rather than for the randomized groups as a whole (hazard ratio
      = 0.67, P = 0.006). A blinded, placebo-controlled trial has also been performed
      for carmustine implant placement in newly diagnosed patients prior to standard
      radiotherapy. Median survival was improved from 11.6 to 13.9 months (P = 0.03),
      with a 29% reduction in the risk of death. When patients with glioblastoma
      multiforme alone were analyzed, the median survival improved from 11.4 to 13.5
      months, but this improvement was not statistically significant. When a Cox’s
      proportional hazard model was utilized to account for other potential prognostic 
      factors, there was a significant 31% reduction in the risk of death (P = 0.04) in
      this subgroup. Data from other small reports support these results and confirm
      that the incidence of adverse events does not appear to be increased
      meaningfully. Given the poor prognosis without possibility of cure, these
      benefits from a treatment with a favorable safety profile were considered
      meaningful. There is randomized evidence to support the use of carmustine wafers 
      placed during resection of recurrent disease. Therefore, although there is
      limited specific evidence, this treatment is likely to be efficacious in an
      environment when nearly all patients receive temozolomide as part of initial
      management. Given that half of the patients in the randomized trial assessing the
      value of carmustine implants in recurrent disease had received prior
      chemotherapy, it is likely that this remains a valuable treatment at the time of 
      repeat resection, even after temozolomide. There are data from multiple reports
      to support safety. Although there is randomized evidence to support the use of
      this therapy in newly diagnosed patients who will receive radiotherapy alone, it 
      is now standard to administer both adjuvant temozolomide and radiotherapy. There 
      are survival outcome reports for small cohorts of patients receiving temozolomide
      with radiotherapy, but this information is not sufficient to support firm
      recommendations. Based on the rationale and evidence of safety, this approach
      appears to be a reasonable option as more information is acquired. Available data
      support the safety of using carmustine wafers in this circumstance, although
      special attention to surgical guidelines for implanting the wafers is warranted.
FAU - Kleinberg, Lawrence
AU  - Kleinberg L
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20121026
PHST- 2012/10/25 [received]
PHST- 2012/10/26 [aheadofprint]
TA  - Core Evid
JT  - Core Evidence
AID - 10.2147/CE.S23244 [doi]
AID - ce-7-115 [pii]
SO  - Core Evid. 2012;7:115-30. Epub 2012 Oct 26 doi:10.2147/CE.S23244.

PMC - PMC4455045
PMID- 26035672
IS  - 0736-0258 (Print)
IS  - 1537-1603 (Electronic)
VI  - 32
IP  - 3
DP  - 2015 Jun
TI  - The Future of Seizure Prediction and Intervention: Closing the loop.
PG  - 194-206
AB  - The ultimate goal of epilepsy therapies is to provide seizure control for all
      patients while eliminating side effects. Improved specificity of intervention
      through on-demand approaches may overcome many of the limitations of current
      intervention strategies. This article reviews progress in seizure prediction and 
      detection, potential new therapies to provide improved specificity, and devices
      to achieve these ends. Specifically, we discuss 1) potential signal modalities
      and algorithms for seizure detection and prediction, 2) closed-loop intervention 
      approaches, and 3) hardware for implementing these algorithms and interventions. 
      Seizure prediction and therapies maximize efficacy while minimizing side-effects 
      through improved specificity may represent the future of epilepsy treatments.
FAU - Nagaraj, Vivek
AU  - Nagaraj V
AD  - Graduate Program in Neuroscience, University of Minnesota
FAU - Lee, Steven
AU  - Lee S
AD  - Weldon School of Biomedical Engineering, Purdue University
FAU - Krook-Magnuson, Esther
AU  - Krook-Magnuson E
AD  - Department of Anatomy & Neurobiology, University of California, Irvine
FAU - Soltesz, Ivan
AU  - Soltesz I
AD  - Department of Anatomy & Neurobiology, University of California, Irvine
FAU - Benquet, Pascal
AU  - Benquet P
AD  - INSERM U1099 LTSI University of Rennes 1, France
FAU - Irazoqui, Pedro
AU  - Irazoqui P
AD  - Weldon School of Biomedical Engineering, Purdue University
FAU - Netoff, Theoden
AU  - Netoff T
AD  - Graduate Program in Neuroscience, University of Minnesota
LA  - eng
PT  - Journal Article
TA  - J Clin Neurophysiol
JT  - Journal of clinical neurophysiology : official publication of the American
      Electroencephalographic Society
AID - 10.1097/WNP.0000000000000139 [doi]
MID - NIHMS628082
SO  - J Clin Neurophysiol. 2015 Jun;32(3):194-206. doi:10.1097/WNP.0000000000000139.

PMC - PMC5102276
PMID- 27676697
IS  - 0196-206X (Print)
IS  - 1536-7312 (Electronic)
VI  - 37
IP  - 8
DP  - 2016 Oct
TI  - Phenotyping, Etiological Factors, and Biomarkers: Toward Precision Medicine in
      Autism Spectrum Disorders.
PG  - 659-73
AB  - Despite the progress made in understanding the biology of autism spectrum
      disorder (ASD), effective biological interventions for the core symptoms remain
      elusive. Because of the etiological heterogeneity of ASD, identification of a
      “one-size-fits-all” treatment approach will likely continue to be challenging. A 
      meeting was convened at the University of Missouri and the Thompson Center to
      discuss strategies for stratifying patients with ASD for the purpose of moving
      toward precision medicine. The “white paper” presented here articulates the
      challenges involved and provides suggestions for future solutions.
FAU - Beversdorf, David Q.
AU  - Beversdorf DQ
CN  - MISSOURI AUTISM SUMMIT CONSORTIUM*
LA  - eng
PT  - Journal Article
DEP - 20161030
PHST- 2016/03 [received]
PHST- 2016/07 [accepted]
PHST- 2016/10/30 [aheadofprint]
TA  - J Dev Behav Pediatr
JT  - Journal of Developmental and Behavioral Pediatrics
AID - JDBP16-68 [pii]
AID - 10.1097/DBP.0000000000000351 [doi]
SO  - J Dev Behav Pediatr. 2016 Oct;37(8):659-73. Epub 2016 Oct 30
      doi:10.1097/DBP.0000000000000351.

PMC - PMC3400835
PMID- 22759795
IS  - 0031-6997 (Print)
IS  - 1521-0081 (Electronic)
VI  - 64
IP  - 3
DP  - 2012 Jul
TI  - Thinking Outside the Cleft to Understand Synaptic Activity: Contribution of the
      Cystine-Glutamate Antiporter (System xc−) to Normal and Pathological
      Glutamatergic Signaling.
PG  - 780-802
AB  - System xc− represents an intriguing target in attempts to understand the
      pathological states of the central nervous system. Also called a
      cystine-glutamate antiporter, system xc− typically functions by exchanging one
      molecule of extracellular cystine for one molecule of intracellular glutamate.
      Nonvesicular glutamate released during cystine-glutamate exchange activates
      extrasynaptic glutamate receptors in a manner that shapes synaptic activity and
      plasticity. These findings contribute to the intriguing possibility that
      extracellular glutamate is regulated by a complex network of release and reuptake
      mechanisms, many of which are unique to glutamate and rarely depicted in models
      of excitatory signaling. Because system xc− is often expressed on non-neuronal
      cells, the study of cystine-glutamate exchange may advance the emerging viewpoint
      that glia are active contributors to information processing in the brain. It is
      noteworthy that system xc− is at the interface between excitatory signaling and
      oxidative stress, because the uptake of cystine that results from
      cystine-glutamate exchange is critical in maintaining the levels of glutathione, 
      a critical antioxidant. As a result of these dual functions, system xc− has been 
      implicated in a wide array of central nervous system diseases ranging from
      addiction to neurodegenerative disorders to schizophrenia. In the current review,
      we briefly discuss the major cellular components that regulate glutamate
      homeostasis, including glutamate release by system xc−. This is followed by an
      in-depth discussion of system xc− as it relates to glutamate release, cystine
      transport, and glutathione synthesis. Finally, the role of system xc− is surveyed
      across a number of psychiatric and neurodegenerative disorders.
FAU - Bridges, Richard
AU  - Bridges R
FAU - Lutgen, Victoria
AU  - Lutgen V
FAU - Lobner, Doug
AU  - Lobner D
FAU - Baker, David A.
AU  - Baker DA
LA  - eng
PT  - Journal Article
PT  - Review
GR  - DA025617
TA  - Pharmacol Rev
JT  - Pharmacological Reviews
AID - 3781574 [pii]
AID - 10.1124/pr.110.003889 [doi]
SO  - Pharmacol Rev. 2012 Jul;64(3):780-802. doi:10.1124/pr.110.003889.

PMC - PMC3041010
PMID- 20624842
IS  - 1047-3211 (Print)
IS  - 1460-2199 (Electronic)
VI  - 21
IP  - 3
DP  - 2011 Mar
TI  - Blocking Early GABA Depolarization with Bumetanide Results in Permanent
      Alterations in Cortical Circuits and Sensorimotor Gating Deficits.
PG  - 574-87
AB  - A high incidence of seizures occurs during the neonatal period when immature
      networks are hyperexcitable and susceptible to hypersyncrhonous activity. During 
      development, γ-aminobutyric acid (GABA), the primary inhibitory neurotransmitter 
      in adults, typically excites neurons due to high expression of the Na+-K+-2Cl−
      cotransporter (NKCC1). NKCC1 facilitates seizures because it renders GABA
      activity excitatory through intracellular Cl− accumulation, while blocking NKCC1 
      with bumetanide suppresses seizures. Bumetanide is currently being tested in
      clinical trials for treatment of neonatal seizures. By blocking NKCC1 with
      bumetanide during cortical development, we found a critical period for the
      development of α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate synapses.
      Disruption of GABA signaling during this window resulted in permanent decreases
      in excitatory synaptic transmission and sensorimotor gating deficits, a common
      feature in schizophrenia. Our study identifies an essential role for
      GABA-mediated depolarization in regulating the balance between cortical
      excitation and inhibition during a critical period and suggests a cautionary
      approach for using bumetanide in treating neonatal seizures.
FAU - Wang, Doris D.
AU  - Wang DD
AD  - Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research,
      University of California, San Francisco CA 94143, USA
FAU - Kriegstein, Arnold R.
AU  - Kriegstein AR
AD  - Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research,
      University of California, San Francisco CA 94143, USA
LA  - eng
PT  - Journal Article
DEP - 20100712
PHST- 2010/07/12 [aheadofprint]
TA  - Cereb Cortex
JT  - Cerebral Cortex (New York, NY)
AID - 10.1093/cercor/bhq124 [doi]
SO  - Cereb Cortex. 2011 Mar;21(3):574-87. Epub 2010 Jul 12 doi:10.1093/cercor/bhq124.

PMC - PMC4709786
PMID- 26839568
IS  - 1687-966X (Print)
IS  - 1687-9678 (Electronic)
VI  - 2016
DP  - 2016
TI  - Stem Cell Tracking with Nanoparticles for Regenerative Medicine Purposes: An
      Overview.
LID - 7920358
AB  - Accurate and noninvasive stem cell tracking is one of the most important needs in
      regenerative medicine to determine both stem cell destinations and final
      differentiation fates, thus allowing a more detailed picture of the mechanisms
      involved in these therapies. Given the great importance and advances in the field
      of nanotechnology for stem cell imaging, currently, several nanoparticles have
      become standardized products and have been undergoing fast commercialization.
      This review has been intended to summarize the current use of different
      engineered nanoparticles in stem cell tracking for regenerative medicine
      purposes, in particular by detailing their main features and exploring their
      biosafety aspects, the first step for clinical application. Moreover, this review
      has summarized the advantages and applications of stem cell tracking with
      nanoparticles in experimental and preclinical studies and investigated present
      limitations for their employment in the clinical setting.
FAU - Accomasso, Lisa
AU  - Accomasso L
AD  - Department of Clinical and Biological Sciences, University of Turin, Regione
      Gonzole 10, Orbassano, 10043 Turin, Italy
FAU - Gallina, Clara
AU  - Gallina C
AD  - Department of Clinical and Biological Sciences, University of Turin, Regione
      Gonzole 10, Orbassano, 10043 Turin, Italy
FAU - Turinetto, Valentina
AU  - Turinetto V
AD  - Department of Clinical and Biological Sciences, University of Turin, Regione
      Gonzole 10, Orbassano, 10043 Turin, Italy
FAU - Giachino, Claudia
AU  - Giachino C
AD  - Department of Clinical and Biological Sciences, University of Turin, Regione
      Gonzole 10, Orbassano, 10043 Turin, Italy
LA  - eng
PT  - Journal Article
DEP - 20151229
PHST- 2015/07/01 [received]
PHST- 2015/10/07 [revised]
PHST- 2015/10/11 [accepted]
PHST- 2015/12/29 [aheadofprint]
TA  - Stem Cells Int
JT  - Stem Cells International
AID - 10.1155/2016/7920358 [doi]
SO  - Stem Cells Int. 2016;2016:. Epub 2015 Dec 29 doi:10.1155/2016/7920358.

PMC - PMC5507210
PMID- 26280330
IS  - 1548-7091 (Print)
IS  - 1548-7105 (Electronic)
VI  - 12
IP  - 10
DP  - 2015 Oct
TI  - Wirelessly powered, fully internal optogenetics for brain, spinal and peripheral 
      circuits in mice.
PG  - 969-74
AB  - To enable sophisticated optogenetic manipulation of neural circuits throughout
      the nervous system with limited disruption of animal behavior, light-delivery
      systems beyond fiber optic tethering and large, head-mounted wireless receivers
      are desirable. We report the development of an easy-to-construct, implantable
      wireless optogenetic device. Our smallest version (20 mg, 10 mm3) is two orders
      of magnitude smaller than previously reported wireless optogenetic systems,
      allowing the entire device to be implanted subcutaneously. With a radio-frequency
      (RF) power source and controller, this implant produces sufficient light power
      for optogenetic stimulation with minimal tissue heating (<1 °C). We show how
      three adaptations of the implant allow for untethered optogenetic control
      throughout the nervous system (brain, spinal cord and peripheral nerve endings)
      of behaving mice. This technology opens the door for optogenetic experiments in
      which animals are able to behave naturally with optogenetic manipulation of both 
      central and peripheral targets.
FAU - Montgomery, Kate L
AU  - Montgomery KL
AD  - Department of Bioengineering, Stanford University, Stanford, California, USA
FAU - Yeh, Alexander J
AU  - Yeh AJ
AD  - Department of Electrical Engineering, Stanford University, Stanford, California, 
      USA
FAU - Ho, John S
AU  - Ho JS
AD  - Department of Electrical Engineering, Stanford University, Stanford, California, 
      USA
FAU - Tsao, Vivien
AU  - Tsao V
AD  - Department of Electrical Engineering, Stanford University, Stanford, California, 
      USA
FAU - Iyer, Shrivats Mohan
AU  - Iyer SM
AD  - Department of Bioengineering, Stanford University, Stanford, California, USA
FAU - Grosenick, Logan
AU  - Grosenick L
AD  - Department of Bioengineering, Stanford University, Stanford, California, USA
FAU - Ferenczi, Emily A
AU  - Ferenczi EA
AD  - Department of Bioengineering, Stanford University, Stanford, California, USA
FAU - Tanabe, Yuji
AU  - Tanabe Y
AD  - Department of Electrical Engineering, Stanford University, Stanford, California, 
      USA
FAU - Deisseroth, Karl
AU  - Deisseroth K
AD  - Department of Bioengineering, Stanford University, Stanford, California, USA
FAU - Delp, Scott L
AU  - Delp SL
AD  - Department of Bioengineering, Stanford University, Stanford, California, USA
FAU - Poon, Ada S Y
AU  - Poon ASY
AD  - Department of Electrical Engineering, Stanford University, Stanford, California, 
      USA
LA  - eng
PT  - Journal Article
DEP - 20150817
TA  - Nat Methods
JT  - Nature methods
AID - 10.1038/nmeth.3536 [doi]
MID - NIHMS769767
SO  - Nat Methods. 2015 Oct;12(10):969-74. Epub 2015 Aug 17 doi:10.1038/nmeth.3536.

PMC - PMC1737326
IS  - 0022-3050 (Print)
IS  - 1468-330X (Electronic)
VI  - 70
IP  - 5
DP  - 2001 May
TI  - Normal and pathologic development of the human brain and spinal cord.
PG  - 709
FAU - REVESZ, T.
AU  - REVESZ T
LA  - eng
PT  - Journal Article
TA  - J Neurol Neurosurg Psychiatry
JT  - Journal of Neurology, Neurosurgery, and Psychiatry
AID - 10.1136/jnnp.70.5.709a [doi]
SO  - J Neurol Neurosurg Psychiatry. 2001 May;70(5):709. doi:10.1136/jnnp.70.5.709a.

PMC - PMC3060777
PMID- 21423816
IS  - 0018-6694 (Print)
VI  - 46
IP  - 4
DP  - 2009 Jan 31
TI  - INTELLECTUAL PROPERTY IN THE TWENTY-FIRST CENTURY: WILL THE DEVELOPING COUNTRIES 
      LEAD OR FOLLOW?
PG  - 1115-85
AB  - Developing countries, particularly the BRIC countries of Brazil, Russia, India,
      and China, should accommodate their national systems of innovation to the
      worldwide intellectual property (IP) regime emerging after the adoption of the
      Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) in a
      way that maximizes global economic welfare in the foreseeable future. As many
      developed countries’ experience demonstrates, badly configured,
      over-protectionist IP regimes stifle innovation by making inputs to future
      innovation too costly and too cumbersome to sustain over time. More carefully
      considered IP regimes, however, are an important way to protect innovative small-
      and medium-sized firms from predatory, larger competitors. The challenge is for
      emerging economies to capture the benefits of IP without importing the serious
      problems that developed countries have themselves failed to solve. Emerging
      economies can attain this balance by pursuing a policy of counter-harmonization
      in which they take advantage of existing exemptions in international agreements
      governing IP to establish regional, local, and international practices that
      promote more innovative, flexible uses of IP. Such practices include a research
      exemption for experimental uses of IP, government imposed nonexclusive licensing,
      anti-blocking provisions, an essential facilities doctrine, and compulsory
      licenses. Additional tools include an ex ante regime of compensatory liability
      rules for small scale innovation and sensible exceptions, particularly for
      science as well as general fair use provisions, to the exclusive rights of
      domestic copyright laws. Emerging economies will have to overcome strong economic
      pressure to accept more restrictive IP regimes as part of free trade agreements
      as well as a lack of technical expertise and internal government coordination.
      However, emerging economies have already accrued enough experience to be aware of
      the strengths and weaknesses of various IP schemes and their own ability to
      tailor IP to local needs. Developing countries will need to take advantage of
      that experience and defend innovative practices at international dispute
      resolution forums. Through creative, determined efforts, the developing countries
      can avoid other countries’ IP excesses while establishing the kind of IP norms
      that address the real conditions of creativity and innovation in today’s
      digitally empowered universe of scientific discourse.
FAU - Reichman, Jerome H.
AU  - Reichman JH
AD  - Bunyan S. Womble Professor of Law, Duke University School of Law, Durham, N.C
LA  - eng
PT  - Journal Article
TA  - Houst Law Rev
JT  - Houston law review / University of Houston
MID - NIHMS199705
SO  - Houst Law Rev. 2009 Jan 31;46(4):1115-85.

PMC - PMC4419720
PMID- 25999839
IS  - 1662-5161 (Electronic)
VI  - 9
DP  - 2015
TI  - Opportunities for concurrent transcranial magnetic stimulation and
      electroencephalography to characterize cortical activity in stroke.
LID - 250
AB  - Stroke is the leading cause of disability in the United States. Despite the high 
      incidence and mortality of stroke, sensitive and specific brain-based biomarkers 
      predicting persisting disabilities are lacking. Both neuroimaging techniques like
      electroencephalography (EEG) and non-invasive brain stimulation (NIBS) techniques
      such as transcranial magnetic stimulation (TMS) have proven useful in predicting 
      prognosis, recovery trajectories and response to rehabilitation in individuals
      with stroke. We propose, however, that additional synergetic effects can be
      achieved by simultaneously combining both approaches. Combined TMS-EEG is able to
      activate discrete cortical regions and directly assess local cortical reactivity 
      and effective connectivity within the network independent of the integrity of
      descending fiber pathways and also outside the motor system. Studying cortical
      reactivity and connectivity in patients with stroke TMS-EEG may identify salient 
      neural mechanisms underlying motor disabilities and lead to novel biomarkers of
      stroke pathophysiology which can then be used to assess, monitor, and refine
      rehabilitation approaches for individuals with significant disability to improve 
      outcomes and quality of life after stroke.
FAU - Sato, Sumire
AU  - Sato S
AD  - Division of Physical Therapy, Department of Rehabilitation Medicine, Emory
      University School of MedicineAtlanta, GA, USA
FAU - Bergmann, Til Ole
AU  - Bergmann TO
AD  - Institute of Psychology, Christian-Albrechts University KielKiel, Germany
FAU - Borich, Michael R.
AU  - Borich MR
AD  - Division of Physical Therapy, Department of Rehabilitation Medicine, Emory
      University School of MedicineAtlanta, GA, USA
LA  - eng
PT  - Journal Article
DEP - 20150505
PHST- 2015/01/31 [received]
PHST- 2015/04/17 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2015.00250 [doi]
SO  - Front Hum Neurosci. 2015 May 05;9:. doi:10.3389/fnhum.2015.00250.

PMC - PMC4832008
PMID- 26404843
IS  - 0893-133X (Print)
IS  - 1740-634X (Electronic)
VI  - 41
IP  - 6
DP  - 2016 May
TI  - Differential Effects of an NR2B NAM and Ketamine on Synaptic Potentiation and
      Gamma Synchrony: Relevance to Rapid-Onset Antidepressant Efficacy.
PG  - 1486-94
AB  - Ketamine, a pan-NMDA receptor channel blocker, and CP-101,606, an NR2B-selective 
      negative allosteric modulator, have antidepressant effects in humans that develop
      rapidly after the drugs are cleared from the body. It has been proposed that the 
      antidepressant effect of ketamine results from delayed synaptic potentiation. To 
      further investigate this hypothesis and potential mechanistic underpinnings we
      compared the effects of ketamine and CP-101,606 on neurophysiological biomarkers 
      in rats immediately after drug administration and after the drugs had been
      eliminated. Local field and auditory-evoked potentials (AEPs) were recorded from 
      primary auditory cortex and hippocampus in freely moving rats. Effects of
      different doses of ketamine or CP-101,606 were evaluated on amplitude of AEPs,
      auditory gating, and absolute power of delta and gamma oscillations 5–30 min
      (drug-on) and 5–6 h (drug-off) after systemic administration. Both ketamine and
      CP-101,606 significantly enhanced AEPs in cortex and hippocampus in the drug-off 
      phase. In contrast, ketamine but not CP-101,606 disrupted auditory gating and
      increased gamma-band power during the drug-on period. Although both drugs
      affected delta power, these changes did not correlate with increase in AEPs in
      the drug-off phase. Our findings show that both ketamine and CP-101,606 augment
      AEPs after drug elimination, consistent with synaptic potentiation as a mechanism
      for antidepressant efficacy. However, these drugs had different acute effects on 
      neurophysiological parameters. These results have implications for understanding 
      the underlying mechanisms for the rapid-onset antidepressant effects of NMDA
      receptor inhibition and for the use of electrophysiological measures as
      translatable biomarkers.
FAU - Nagy, Dávid
AU  - Nagy D
AD  - Laboratory of Translational Neuropharmacology, Section of Comparative Medicine,
      Yale School of Medicine, New Haven, CT, USA
FAU - Stoiljkovic, Milan
AU  - Stoiljkovic M
AD  - Laboratory of Translational Neuropharmacology, Section of Comparative Medicine,
      Yale School of Medicine, New Haven, CT, USA
FAU - Menniti, Frank S
AU  - Menniti FS
AD  - Mnemosyne Pharmaceuticals Inc., Providence, RI, USA
FAU - Hajós, Mihály
AU  - Hajós M
AD  - Laboratory of Translational Neuropharmacology, Section of Comparative Medicine,
      Yale School of Medicine, New Haven, CT, USA
LA  - eng
PT  - Journal Article
DEP - 20151021
PHST- 2015/07/08 [received]
PHST- 2015/08/26 [revised]
PHST- 2015/09/19 [accepted]
PHST- 2015/10/21 [aheadofprint]
TA  - Neuropsychopharmacology
JT  - Neuropsychopharmacology
AID - npp2015298 [pii]
AID - 10.1038/npp.2015.298 [doi]
SO  - Neuropsychopharmacology. 2016 May;41(6):1486-94. Epub 2015 Oct 21
      doi:10.1038/npp.2015.298.

PMC - PMC3903602
PMID- 24475225
IS  - 1932-6203 (Electronic)
VI  - 9
IP  - 1
DP  - 2014
TI  - A Comparison of Different Informative Vibrotactile Forward Collision Warnings:
      Does the Warning Need to Be Linked to the Collision Event?
LID - e87070
AB  - Recent research demonstrates that auditory and vibrotactile forward collision
      warnings presenting a motion signal (e.g., looming or apparent motion across the 
      body surface) can facilitate speeded braking reaction times (BRTs). The purpose
      of the present study was to expand on this work by directly comparing warning
      signals in which the motion conveyed was constant across all collision events
      with signals in which the speed of motion was dependent on the closing velocity
      (CV). Two experiments were conducted using a simulated car-following task and
      BRTs were measured. In Experiment 1, increasing intensity (looming) vibrotactile 
      signals were presented from a single tactor attached to the driver's waist. When 
      the increase in intensity was CV-linked, BRTs were significantly faster as
      compared to a no-warning condition, however, they were not significantly
      different from constant intensity and CV-independent looming warnings. In
      Experiment 2, a vertical array of three tactors was used to create motion either 
      towards (upwards) or away (downwards) from the driver's head. When the warning
      signal presented upwards motion that was CV-linked, BRTs were significantly
      faster than all other warning types. Downwards warnings led to a significantly
      higher number of brake activations in false alarm situations as compared to
      upwards moving warnings. The effectiveness of dynamic tactile collision warnings 
      would therefore appear to depend on both the link between the warning and
      collision event and on the directionality of the warning signal.
FAU - Gray, Rob
AU  - Gray R
AD  - School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, 
      Birmingham, United Kingdom
FAU - Ho, Cristy
AU  - Ho C
AD  - Department of Experimental Psychology, University of Oxford, Oxford, United
      Kingdom
FAU - Spence, Charles
AU  - Spence C
AD  - Department of Experimental Psychology, University of Oxford, Oxford, United
      Kingdom
LA  - eng
PT  - Journal Article
DEP - 20140127
PHST- 2013/09/27 [received]
PHST- 2013/12/21 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-13-39632 [pii]
AID - 10.1371/journal.pone.0087070 [doi]
SO  - PLoS One. 2014 Jan 27;9(1):. doi:10.1371/journal.pone.0087070.

PMC - PMC4339469
PMID- 25479050
IS  - 0165-0327 (Print)
IS  - 1573-2517 (Electronic)
VI  - 174
DP  - 2015 Mar 15
TI  - Augmenting Psychoeducation with a Mobile Intervention for Bipolar Disorder: A
      Randomized Controlled Trial.
PG  - 23-30
AB  - Background: Psychosocial interventions for bipolar disorder are frequently
      unavailable and resource intensive. Mobile technology may improve access to
      evidence-based interventions and may increase their efficacy. We evaluated the
      feasibility, acceptability and efficacy of an augmentative mobile ecological
      momentary intervention targeting self-management of mood symptoms. Methods: This 
      was a randomized single-blind controlled trial with 82 consumers diagnosed with
      bipolar disorder who completed a four-session psychoeducational intervention and 
      were assigned to 10 weeks of either: 1) mobile device delivered interactive
      intervention linking patient-reported mood states with personalized
      self-management strategies, or 2) paper-and-pencil mood monitoring. Participants 
      were assessed at baseline, 6 weeks (mid-point), 12 weeks (post-treatment), and 24
      weeks (follow up) with clinician-rated depression and mania scales and
      self-reported functioning. Results: Retention at 12 weeks was 93% and both
      conditions were associated with high satisfaction. Compared to the
      paper-and-pencil condition, participants in the augmented mobile intervention
      condition showed significantly greater reductions in depressive symptoms at 6 and
      12 weeks (Cohen's d for both were d=0.48). However, these effects were not
      maintained at 24-week follow up. Conditions did not differ significantly in the
      impact on manic symptoms or functional impairment. Limitations: This was not a
      definitive trial and was not powered to detect moderators and mediators.
      Conclusions: Automated mobile-phone intervention is feasible, acceptable, and may
      enhance the impact of brief psychoeducation on depressive symptoms in bipolar
      disorder. However, sustainment of gains from symptom self-management mobile
      interventions, once stopped, may be limited.
FAU - Depp, Colin A
AU  - Depp CA
AD  - Department of Psychiatry, UC San Diego
FAU - Ceglowski, Jenni
AU  - Ceglowski J
AD  - Department of Psychiatry, UC San Diego
FAU - Wang, Vicki C
AU  - Wang VC
AD  - Department of Psychiatry, UC San Diego
FAU - Yaghouti, Faraz
AU  - Yaghouti F
AD  - Department of Psychiatry, UC San Diego
FAU - Mausbach, Brent T
AU  - Mausbach BT
AD  - Department of Psychiatry, UC San Diego
FAU - Thompson, Wesley K
AU  - Thompson WK
AD  - Department of Psychiatry, UC San Diego
FAU - Granholm, Eric L
AU  - Granholm EL
AD  - Department of Psychiatry, UC San Diego
LA  - eng
PT  - Journal Article
DEP - 20141108
TA  - J Affect Disord
JT  - Journal of affective disorders
AID - 10.1016/j.jad.2014.10.053 [doi]
MID - NIHMS646535
SO  - J Affect Disord. 2015 Mar 15;174:23-30. Epub 2014 Nov 08
      doi:10.1016/j.jad.2014.10.053.

PMC - PMC5530996
PMID- 28750690
IS  - 1758-9193 (Electronic)
VI  - 9
DP  - 2017
TI  - Increased Aβ42-α7-like nicotinic acetylcholine receptor complex level in
      lymphocytes is associated with apolipoprotein E4-driven Alzheimer’s disease
      pathogenesis.
LID - 54
AB  - Background: The apolipoprotein E ε4 (APOE4) genotype is a prominent late-onset
      Alzheimer’s disease (AD) risk factor. ApoE4 disrupts memory function in rodents
      and may contribute to both plaque and tangle formation. Methods:
      Coimmunoprecipitation and Western blot detection were used to determine: 1) the
      effects of select fragments from the apoE low-density lipoprotein (LDL) binding
      domain and recombinant apoE subtypes on amyloid beta (Aβ)42-α7 nicotinic
      acetylcholine receptor (α7nAChR) interaction and tau phosphorylation in rodent
      brain synaptosomes; and 2) the level of Aβ42-α7nAChR complexes in matched
      controls and patients with mild cognitive impairment (MCI) and dementia due to AD
      with known APOE genotypes. Results: In an ex vivo study using rodent
      synaptosomes, apoE141–148 of the apoE promotes Aβ42-α7nAChR association and
      Aβ42-induced α7nAChR-dependent tau phosphorylation. In a single-blind study, we
      examined lymphocytes isolated from control subjects, patients with MCI and
      dementia due to AD with known APOE genotypes, sampled at two time points (1 year 
      apart). APOE ε4 genotype was closely correlated with heightened Aβ42-α7nAChR
      complex levels and with blunted exogenous Aβ42 effects in lymphocytes derived
      from AD and MCI due to AD cases. Similarly, plasma from APOE ε4 carriers enhanced
      the Aβ42-induced Aβ42-α7nAChR association in rat cortical synaptosomes. The
      progression of cognitive decline in APOE ε4 carriers correlated with higher
      levels of Aβ42-α7nAChR complexes in lymphocytes and greater enhancement by their 
      plasma of Aβ42-induced Aβ42-α7nAChR association in rat cortical synaptosomes.
      Conclusions: Our data suggest that increased lymphocyte Aβ42-α7nAChR-like
      complexes may indicate the presence of AD pathology especially in APOE ε4
      carriers. We show that apoE, especially apoE4, promotes Aβ42-α7nAChR interaction 
      and Aβ42-induced α7nAChR-dependent tau phosphorylation via its apoE141–148
      domain. These apoE-mediated effects may contribute to the APOE ε4-driven
      neurodysfunction and AD pathologies.
FAU - Wang, Hoau-Yan
AU  - Wang HY
AUID- ORCID: 0000-0001-5005-7564
AD  - 0000 0004 1936 8753grid.137628.9Department of Physiology, Pharmacology and
      Neuroscience, CUNY School of Medicine, 160 Convent Avenue, New York, NY 10031 USA
FAU - Trocmé-Thibierge, Caryn
AU  - Trocmé-Thibierge C
AD  - 0000 0001 2163 3905grid.418301.fInstitut de Recherches Internationales Servier,
      50 Rue Carnot, 92284 Suresnes, France
FAU - Stucky, Andres
AU  - Stucky A
AD  - 0000 0004 1936 8753grid.137628.9Department of Physiology, Pharmacology and
      Neuroscience, CUNY School of Medicine, 160 Convent Avenue, New York, NY 10031 USA
FAU - Shah, Sanket M.
AU  - Shah SM
AD  - 0000 0004 1936 8753grid.137628.9Department of Physiology, Pharmacology and
      Neuroscience, CUNY School of Medicine, 160 Convent Avenue, New York, NY 10031 USA
FAU - Kvasic, Jessica
AU  - Kvasic J
AD  - 0000 0004 1936 8753grid.137628.9Department of Physiology, Pharmacology and
      Neuroscience, CUNY School of Medicine, 160 Convent Avenue, New York, NY 10031 USA
FAU - Khan, Amber
AU  - Khan A
AD  - 0000 0004 1936 8753grid.137628.9Department of Physiology, Pharmacology and
      Neuroscience, CUNY School of Medicine, 160 Convent Avenue, New York, NY 10031 USA
FAU - Morain, Philippe
AU  - Morain P
AD  - 0000 0001 2163 3905grid.418301.fInstitut de Recherches Internationales Servier,
      50 Rue Carnot, 92284 Suresnes, France
FAU - Guignot, Isabelle
AU  - Guignot I
AD  - 0000 0001 2163 3905grid.418301.fInstitut de Recherches Internationales Servier,
      50 Rue Carnot, 92284 Suresnes, France
FAU - Bouguen, Eva
AU  - Bouguen E
AD  - 0000 0001 2163 3905grid.418301.fInstitut de Recherches Internationales Servier,
      50 Rue Carnot, 92284 Suresnes, France
FAU - Deschet, Karine
AU  - Deschet K
AD  - 0000 0001 2163 3905grid.418301.fInstitut de Recherches Internationales Servier,
      50 Rue Carnot, 92284 Suresnes, France
FAU - Pueyo, Maria
AU  - Pueyo M
AD  - 0000 0001 2163 3905grid.418301.fInstitut de Recherches Internationales Servier,
      50 Rue Carnot, 92284 Suresnes, France
FAU - Mocaer, Elisabeth
AU  - Mocaer E
AD  - 0000 0001 2163 3905grid.418301.fInstitut de Recherches Internationales Servier,
      50 Rue Carnot, 92284 Suresnes, France
FAU - Ousset, Pierre-Jean
AU  - Ousset PJ
AD  - 0000 0001 1457 2980grid.411175.7Alzheimer’s Disease Research and Clinical Center,
      Inserm U1027, Toulouse University Hospital, Toulouse, France
FAU - Vellas, Bruno
AU  - Vellas B
AD  - 0000 0001 1457 2980grid.411175.7Alzheimer’s Disease Research and Clinical Center,
      Inserm U1027, Toulouse University Hospital, Toulouse, France
FAU - Kiyasova, Vera
AU  - Kiyasova V
AD  - 0000 0001 2163 3905grid.418301.fInstitut de Recherches Internationales Servier,
      50 Rue Carnot, 92284 Suresnes, France
LA  - eng
PT  - Journal Article
DEP - 20170727
PHST- 2017/02/10 [received]
PHST- 2017/06/21 [accepted]
TA  - Alzheimers Res Ther
JT  - Alzheimer's Research & Therapy
AID - 280 [pii]
AID - 10.1186/s13195-017-0280-8 [doi]
SO  - Alzheimers Res Ther. 2017 Jul 27;9:. doi:10.1186/s13195-017-0280-8.

PMC - PMC4729290
PMID- 26810536
IS  - 0022-510X (Print)
IS  - 1878-5883 (Electronic)
VI  - 361
DP  - 2016 Feb 15
TI  - Manual therapy as an effective treatment for fibrosis in a rat model of upper
      extremity overuse injury.
PG  - 168-80
AB  - Key clinical features of carpal tunnel syndrome and other types of cumulative
      trauma disorders of the hand and wrist include pain and functional disabilities. 
      Mechanistic details remain under investigation but may involve tissue
      inflammation and/or fibrosis. We examined the effectiveness of modeled manual
      therapy (MMT) as a treatment for sensorimotor behavior declines and increased
      fibrogenic processes occurring in forearm tissues of rats performing an high
      repetition high force (HRHF) reaching and grasping task for 12 weeks. Young
      adult, female rats were examined: food restricted control rats (FRC, n=12); rats 
      that were trained for 6 weeks before performing the HRHF task for 12 weeks with
      no treatment (HRHF-CON, n=11); and HRHF task rats received modeled manual therapy
      (HRHF-MMT, n=5) for 5 days/week for the duration of the 12-week of task. Rats
      receiving the MMT expressed fewer discomfort-related behaviors, and performed
      progressively better in the HRHF task. Grip strength, while decreased after
      training, improved following MMT. Fibrotic nerve and connective tissue changes
      (increased collagen and TGF-β1 deposition) present in 12-week HRHF-CON rats were 
      significantly decreased in 12-week HRHF-MMT rats. These observations support the 
      investigation of manual therapy as a preventative for repetitive motion
      disorders.
FAU - Bove, Geoffrey M.
AU  - Bove GM
AD  - Department of Biomedical Sciences, University of New England College of
      Osteopathic Medicine, 11 Hills Beach Rd, Biddeford, ME 04005
FAU - Harris, Michele Y
AU  - Harris MY
AD  - Department of Anatomy and Cell Biology, Temple University School of Medicine,
      Philadelphia, PA, USA
FAU - Zhao, Huaqing
AU  - Zhao H
AD  - Department of Clinical Sciences and Biostatistical Consulting Center, Temple
      University School of Medicine, Philadelphia, PA, USA
FAU - Barbe, Mary F.
AU  - Barbe MF
AD  - Department of Anatomy and Cell Biology, Temple University School of Medicine,
      Philadelphia, PA, USA
LA  - eng
PT  - Journal Article
DEP - 20151224
TA  - J Neurol Sci
JT  - Journal of the neurological sciences
AID - 10.1016/j.jns.2015.12.029 [doi]
MID - NIHMS749932
SO  - J Neurol Sci. 2016 Feb 15;361:168-80. Epub 2015 Dec 24
      doi:10.1016/j.jns.2015.12.029.

PMC - PMC3758523
PMID- 23820142
IS  - 1079-0268 (Print)
IS  - 2045-7723 (Electronic)
VI  - 36
IP  - 4
DP  - 2013 Jul
TI  - Neuroprosthetic technology for individuals with spinal cord injury.
PG  - 258-72
AB  - Context: Spinal cord injury (SCI) results in a loss of function and sensation
      below the level of the lesion. Neuroprosthetic technology has been developed to
      help restore motor and autonomic functions as well as to provide sensory
      feedback. Findings: This paper provides an overview of neuroprosthetic technology
      that aims to address the priorities for functional restoration as defined by
      individuals with SCI. We describe neuroprostheses that are in various stages of
      preclinical development, clinical testing, and commercialization including
      functional electrical stimulators, epidural and intraspinal microstimulation,
      bladder neuroprosthesis, and cortical stimulation for restoring sensation. We
      also discuss neural recording technologies that may provide command or feedback
      signals for neuroprosthetic devices. Conclusion/clinical relevance:
      Neuroprostheses have begun to address the priorities of individuals with SCI,
      although there remains room for improvement. In addition to continued
      technological improvements, closing the loop between the technology and the user 
      may help provide intuitive device control with high levels of performance.
FAU - Collinger, Jennifer L.
AU  - Collinger JL
AD  - Department of Veterans Affairs, Pittsburgh, PA, USA; Department of Physical
      Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA; and
      Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA
FAU - Foldes, Stephen
AU  - Foldes S
AD  - Department of Veterans Affairs, Pittsburgh, PA, USA; Department of Physical
      Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA; and
      Center for the Neural Basis of Cognition, Pittsburgh, PA, USA
FAU - Bruns, Tim M.
AU  - Bruns TM
AD  - Department of Physical Medicine and Rehabilitation, University of Pittsburgh,
      Pittsburgh, PA, USA
FAU - Wodlinger, Brian
AU  - Wodlinger B
AD  - Department of Physical Medicine and Rehabilitation, University of Pittsburgh,
      Pittsburgh, PA, USA; and Center for the Neural Basis of Cognition, Pittsburgh,
      PA, USA
FAU - Gaunt, Robert
AU  - Gaunt R
AD  - Department of Physical Medicine and Rehabilitation, University of Pittsburgh,
      Pittsburgh, PA, USA; and Department of Bioengineering, University of Pittsburgh, 
      Pittsburgh, PA, USA
FAU - Weber, Douglas J.
AU  - Weber DJ
AD  - Department of Veterans Affairs, Pittsburgh, PA, USA; Department of Physical
      Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA;
      Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA; and 
      Center for the Neural Basis of Cognition, Pittsburgh, PA, USA
LA  - eng
PT  - Journal Article
PT  - Review
TA  - J Spinal Cord Med
JT  - The Journal of Spinal Cord Medicine
AID - 10.1179/2045772313Y.0000000128 [doi]
AID - scm-36-258 [pii]
SO  - J Spinal Cord Med. 2013 Jul;36(4):258-72. doi:10.1179/2045772313Y.0000000128.

PMC - PMC3426815
PMID- 22951439
IS  - 2157-1422 (Electronic)
VI  - 2
IP  - 9
DP  - 2012 Sep
TI  - Treatment Strategies Targeting Amyloid β-Protein.
LID - a006387
AB  - With the advent of the key discovery in the mid-1980s that the amyloid β-protein 
      (Aβ) is the core constituent of the amyloid plaque pathology found in Alzheimer
      disease (AD), an intensive effort has been underway to attempt to mitigate its
      role in the hope of treating the disease. This effort fully matured when it was
      clarified that the Aβ is a normal product of cleavage of the amyloid precursor
      protein, and well-defined proteases for this process were identified. Further
      therapeutic options have been developed around the concept of anti-Aβ aggregation
      inhibitors and the surprising finding that immunization with Aβ itself leads to
      reduction of pathology in animal models of the disease. Here we review the
      progress in this field toward the goal of targeting Aβ for treatment and
      prevention of AD and identify some of the major challenges for the future of this
      area of medicine.
OAB - Publisher: Abstract available from the publisher.
FAU - Schenk, Dale
AU  - Schenk D
AD  - Netotope Biosciences Inc., San Francisco, California 94080
FAU - Basi, Guriqbal S.
AU  - Basi GS
AD  - Netotope Biosciences Inc., San Francisco, California 94080
FAU - Pangalos, Menelas N.
AU  - Pangalos MN
AD  - AstraZeneca, Mereside, Alderley Park SK10 4TG, United Kingdom
LA  - eng
PT  - Journal Article
PT  - Review
TA  - Cold Spring Harb Perspect Med
JT  - Cold Spring Harbor Perspectives in Medicine
AID - 10.1101/cshperspect.a006387 [doi]
AID - a006387 [pii]
SO  - Cold Spring Harb Perspect Med. 2012 Sep;2(9):. doi:10.1101/cshperspect.a006387.

PMC - PMC4137227
PMID- 25191214
IS  - 1662-4548 (Print)
IS  - 1662-453X (Electronic)
VI  - 8
DP  - 2014
TI  - Contributions and complexities from the use of in vivo animal models to improve
      understanding of human neuroimaging signals.
LID - 211
AB  - Many of the major advances in our understanding of how functional brain imaging
      signals relate to neuronal activity over the previous two decades have arisen
      from physiological research studies involving experimental animal models. This
      approach has been successful partly because it provides opportunities to measure 
      both the hemodynamic changes that underpin many human functional brain imaging
      techniques and the neuronal activity about which we wish to make inferences.
      Although research into the coupling of neuronal and hemodynamic responses using
      animal models has provided a general validation of the correspondence of
      neuroimaging signals to specific types of neuronal activity, it is also
      highlighting the key complexities and uncertainties in estimating neural signals 
      from hemodynamic markers. This review will detail how research in animal models
      is contributing to our rapidly evolving understanding of what human neuroimaging 
      techniques tell us about neuronal activity. It will highlight emerging issues in 
      the interpretation of neuroimaging data that arise from in vivo research studies,
      for example spatial and temporal constraints to neuroimaging signal
      interpretation, or the effects of disease and modulatory neurotransmitters upon
      neurovascular coupling. We will also give critical consideration to the
      limitations and possible complexities of translating data acquired in the typical
      animals models used in this area to the arena of human fMRI. These include the
      commonplace use of anesthesia in animal research studies and the fact that many
      neuropsychological questions that are being actively explored in humans have
      limited homologs within current animal models for neuroimaging research. Finally 
      we will highlighting approaches, both in experimental animals models (e.g.
      imaging in conscious, behaving animals) and human studies (e.g. combined
      fMRI-EEG), that mitigate against these challenges.
FAU - Martin, Chris
AU  - Martin C
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20140819
PHST- 2014/03/15 [received]
PHST- 2014/07/01 [accepted]
TA  - Front Neurosci
JT  - Frontiers in Neuroscience
AID - 10.3389/fnins.2014.00211 [doi]
SO  - Front Neurosci. 2014 Aug 19;8:. doi:10.3389/fnins.2014.00211.

PMC - PMC2432466
PMID- 18553155
IS  - 1573-9538 (Print)
IS  - 1573-9546 (Electronic)
VI  - 4
IP  - Suppl 1
DP  - 2008 May
TI  - Purines 2008 Meeting 29 June – 2 July 2008, Copenhagen, Denmark.
PG  - 1-210
LA  - eng
PT  - Journal Article
DEP - 20080614
TA  - Purinergic Signal
JT  - Purinergic Signalling
AID - 9116 [pii]
AID - 10.1007/s11302-008-9116-0 [doi]
SO  - Purinergic Signal. 2008 May;4(Suppl 1):1-210. Epub 2008 Jun 14
      doi:10.1007/s11302-008-9116-0.

PMC - PMC4640495
PMID- 26557803
IS  - 1544-2896 (Electronic)
VI  - 14
IP  - 1
DP  - 2015 Fall
TI  - An Instructor’s Guide to (Some of) the Most Amazing Papers in Neuroscience.
PG  - R3-R14
AB  - Although textbooks are still assigned in many undergraduate science courses, it
      is now not uncommon, even in some of the earliest courses in the curriculum, to
      supplement texts with primary source readings from the scientific literature. Not
      only does reading these articles help students develop an understanding of
      specific course content, it also helps foster an ability to engage with the
      discipline the way its practitioners do. One challenge with this approach,
      however, is that it can be difficult for instructors to select appropriate
      readings on topics outside of their areas of expertise as would be required in a 
      survey course, for example. Here we present a subset of the papers that were
      offered in response to a request for the “most amazing papers in neuroscience”
      that appeared on the listserv of the Faculty for Undergraduate Neuroscience
      (FUN). Each contributor was subsequently asked to describe briefly the content of
      their recommended papers, their pedagogical value, and the audiences for which
      these papers are best suited. Our goal is to provide readers with sufficient
      information to decide whether such articles might be useful in their own classes.
      It is not our intention that any article within this collection will provide the 
      final word on an area of investigation, nor that this collection will provide the
      final word for the discipline as a whole. Rather, this article is a collection of
      papers that have proven themselves valuable in the hands of these particular
      educators. Indeed, it is our hope that this collection represents the inaugural
      offering of what will become a regular feature in this journal, so that we can
      continue to benefit from the diverse expertise of the FUN community.
FAU - Harrington, Ian A.
AU  - Harrington IA
AD  - Augustana College, Rock Island, IL 61201;
FAU - Grisham, William
AU  - Grisham W
AD  - University of California, Los Angeles, Los Angeles CA 90095;
FAU - Brasier, D. J.
AU  - Brasier DJ
AD  - Carnegie Mellon University, Pittsburgh, PA 15213;
FAU - Gallagher, Shawn P.
AU  - Gallagher SP
AD  - Millersville University, Millersville, PA 17551;
FAU - Gizerian, Samantha S.
AU  - Gizerian SS
AD  - Washington State University, Pullman, WA 99164;
FAU - Gordon, Rupa G.
AU  - Gordon RG
AD  - Augustana College, Rock Island, IL 61201;
FAU - Hagenauer, Megan H.
AU  - Hagenauer MH
AD  - University of Michigan, Ann Arbor, MI 48106;
FAU - Linden, Monica L.
AU  - Linden ML
AD  - Brown University, Providence, RI 02912;
FAU - Lom, Barbara
AU  - Lom B
AD  - Davidson College, Davidson, NC 28035;
FAU - Olivo, Richard
AU  - Olivo R
AD  - Smith College, Northampton, MA 01063;
FAU - Sandstrom, Noah J.
AU  - Sandstrom NJ
AD  - Williams College, Williamstown, MA 01267;
FAU - Stough, Shara
AU  - Stough S
AD  - Augustana College, Rock Island, IL 61201;
FAU - Vilinsky, Ilya
AU  - Vilinsky I
AD  - University of Cincinnati, Cincinnati, OH 45221;
FAU - Wiest, Michael C.
AU  - Wiest MC
AD  - Wellesley College, Wellesley, MA 02481.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20151015
PHST- 2015/08/13 [received]
PHST- 2015/08/22 [accepted]
TA  - J Undergrad Neurosci Educ
JT  - Journal of Undergraduate Neuroscience Education
AID - june-14-r3 [pii]
SO  - J Undergrad Neurosci Educ. 2015 Oct 15;14(1):R3-R14.

PMC - PMC4463029
PMID- 25272066
IS  - 0898-4921 (Print)
IS  - 1537-1921 (Electronic)
VI  - 27
IP  - 3
DP  - 2015 Jul
TI  - Aneurysmal Subarachnoid Hemorrhage.
PG  - 222-40
AB  - Aneurysmal subarachnoid hemorrhage (SAH) is a worldwide health burden with high
      fatality and permanent disability rates. The overall prognosis depends on the
      volume of the initial bleed, rebleeding, and degree of delayed cerebral ischemia 
      (DCI). Cardiac manifestations and neurogenic pulmonary edema indicate the
      severity of SAH. The International Subarachnoid Aneurysm Trial (ISAT) reported a 
      favorable neurological outcome with the endovascular coiling procedure compared
      with surgical clipping at the end of 1 year. The ISAT trial recruits were
      primarily neurologically good grade patients with smaller anterior circulation
      aneurysms, and therefore the results cannot be reliably extrapolated to larger
      aneurysms, posterior circulation aneurysms, patients presenting with complex
      aneurysm morphology, and poor neurological grades. The role of hypothermia is not
      proven to be neuroprotective according to a large randomized controlled trial,
      Intraoperative Hypothermia for Aneurysms Surgery Trial (IHAST II), which
      recruited patients with good neurological grades. Patients in this trial were
      subjected to slow cooling and inadequate cooling time and were rewarmed rapidly. 
      This methodology would have reduced the beneficial effects of hypothermia.
      Adenosine is found to be beneficial for transient induced hypotension in 2
      retrospective analyses, without increasing the risk for cardiac and neurological 
      morbidity. The neurological benefit of pharmacological neuroprotection and
      neuromonitoring is not proven in patients undergoing clipping of aneurysms. DCI
      is an important cause of morbidity and mortality following SAH, and the
      pathophysiology is likely multifactorial and not yet understood. At present, oral
      nimodipine has an established role in the management of DCI, along with
      maintenance of euvolemia and induced hypertension. Following SAH, hypernatremia, 
      although less common than hyponatremia, is a predictor of poor neurological
      outcome.
FAU - D’Souza, Stanlies
AU  - D’Souza S
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20150611
PHST- 2014/03/02 [received]
PHST- 2014/08/19 [accepted]
PHST- 2015/06/11 [aheadofprint]
TA  - J Neurosurg Anesthesiol
JT  - Journal of Neurosurgical Anesthesiology
AID - 10.1097/ANA.0000000000000130 [doi]
SO  - J Neurosurg Anesthesiol. 2015 Jul;27(3):222-40. Epub 2015 Jun 11
      doi:10.1097/ANA.0000000000000130.

PMC - PMC3820437
PMID- 24278731
IS  - 2090-908X (Electronic)
VI  - 2012
DP  - 2012
TI  - The Neuropathology of Autism.
LID - 703675
AB  - Autism is a behaviorally defined neurodevelopmental disorder that affects over 1%
      of new births in the United States and about 2% of boys. The etiologies are
      unknown and they are genetically complex. There may be epigenetic effects,
      environmental influences, and other factors that contribute to the mechanisms and
      affected neural pathway(s). The underlying neuropathology of the disorder has
      been evolving in the literature to include specific brain areas in the
      cerebellum, limbic system, and cortex. Part(s) of structures appear to be
      affected most rather than the entire structure, for example, select nuclei of the
      amygdala, the fusiform face area, and so forth. Altered cortical organization
      characterized by more frequent and narrower minicolumns and early overgrowth of
      the frontal portion of the brain, affects connectivity. Abnormalities include
      cytoarchitectonic laminar differences, excess white matter neurons, decreased
      numbers of GABAergic cerebellar Purkinje cells, and other events that can be
      traced developmentally and cause anomalies in circuitry. Problems with
      neurotransmission are evident by recent receptor and binding site studies
      especially in the inhibitory GABA system likely contributing to an imbalance of
      excitatory/inhibitory transmission. As postmortem findings are related to core
      behavior symptoms, and technology improves, researchers are gaining a much better
      perspective of contributing factors to the disorder.
FAU - Blatt, Gene J.
AU  - Blatt GJ
AD  - Department of Anatomy & Neurobiology, School of Medicine, Boston University, 72
      East Concord Street L 1004, Boston, MA 02118, USA
LA  - eng
PT  - Journal Article
DEP - 20121219
PHST- 2012/10/02 [received]
PHST- 2012/11/07 [accepted]
PHST- 2012/12/19 [aheadofprint]
TA  - Scientifica (Cairo)
JT  - Scientifica
AID - 10.6064/2012/703675 [doi]
SO  - Scientifica (Cairo). 2012;2012:. Epub 2012 Dec 19 doi:10.6064/2012/703675.

PMC - PMC2766804
PMID- 12405545
IS  - 1355-6177 (Print)
IS  - 1469-7661 (Electronic)
VI  - 8
IP  - 7
DP  - 2002 Nov
TI  - 1H Magnetic Resonance Spectroscopy, Cognitive Function, and Apolipoprotein E
      Genotype in Normal Aging, Mild Cognitive Impairment and Alzheimer’s Disease.
PG  - 934-42
AB  - The aim of this study was to examine the associations of Apolipoprotein E (APOE) 
      genotype, metabolic changes in the posterior cingulate detected by 1H magnetic
      resonance spectroscopy (MRS), and neuropsychologic measures of memory and
      cognition both in normally aging elderly, and in patients with mild cognitive
      impairment (MCI) and AD. We studied 67 controls, 18 MCI and 33 AD patients. We
      used the Dementia Rating Scale total score (DRSTOT) as a measure of general
      cognitive function and the total learning from the Auditory Verbal Learning Test 
      (AVTOT) as a measure of memory performance. No differences were noted on 1H MRS
      metabolite ratios or cognitive measures across APOE genotype within control and
      patient groups.. In controls, age was a significant predictor of both cognitive
      test scores, and NAA/Cr was a univariate associate of DRSTOT. All three 1H MRS
      metabolite ratios, N-acetylaspartate (NAA)/Creatine (Cr), myoinositol (MI)/Cr,
      and NAA/MI, were univariate associates of AVTOT and DRSTOT scores in the combined
      MCI and AD group. In stepwise regression analyses in the combined patient group
      only NAA/MI entered the model. These data suggest NAA/Cr could be a modest
      predictor of general cognitive function in both healthy elderly and impaired
      patients, while MI/Cr is a more specific marker for neuropsychologic dysfunction 
      associated with neurodegenerative disease. Among 1H MRS measurements, the NAA/MI 
      ratio maybe the most efficient predictor of memory and cognitive function in
      patients with MCI and AD.
FAU - Kantarci, Kejal
AU  - Kantarci K
AD  - Department of Diagnostic Radiology
FAU - Smith, Glenn E.
AU  - Smith GE
AD  - Department of Psychiatry and Psychology
FAU - Ivnik, Robert J.
AU  - Ivnik RJ
AD  - Department of Psychiatry and Psychology
FAU - Petersen, Ronald C.
AU  - Petersen RC
AD  - Alzheimer’s Disease Research Center
FAU - Boeve, Bradley F.
AU  - Boeve BF
AD  - Alzheimer’s Disease Research Center
FAU - Knopman, David S.
AU  - Knopman DS
AD  - Alzheimer’s Disease Research Center
FAU - Tangalos, Eric G.
AU  - Tangalos EG
AD  - Alzheimer’s Disease Research Center
FAU - Jack, Clifford R.
AU  - Jack CR
AD  - Department of Diagnostic Radiology
LA  - eng
PT  - Journal Article
TA  - J Int Neuropsychol Soc
JT  - Journal of the International Neuropsychological Society : JINS
MID - NIHMS151014
SO  - J Int Neuropsychol Soc. 2002 Nov;8(7):934-42.

PMC - PMC4323635
PMID- 25555928
IS  - 0306-4522 (Print)
IS  - 1873-7544 (Electronic)
VI  - 288
DP  - 2015 Mar 12
TI  - Age-dependent long-term structural and functional effects of early life seizures:
      evidence for a hippocampal critical period influencing plasticity in adulthood.
PG  - 120-34
AB  - Neural activity promotes circuit formation in developing systems and during
      critical periods permanently modifies circuit organization and functional
      properties. These observations suggest that excessive neural activity, as occurs 
      during seizures, might influence developing neural circuitry with long-term
      outcomes that depend on age at the time of seizures. We systematically examined
      long-term structural and functional consequences of seizures induced in rats by
      kainic acid, pentylenetetrazol, and hyperthermia across postnatal ages from birth
      through postnatal day 90 in adulthood (P90). Magnetic resonance imaging (MRI),
      diffusion tensor imaging (DTI), and electrophysiological methods at ≥P95
      following seizures induced from P1 to P90 demonstrated consistent patterns of
      gross atrophy, microstructural abnormalities in the corpus callosum and
      hippocampus, and functional alterations in hippocampal circuitry at ≥P95 that
      were independent of the method of seizure induction and varied systematically as 
      a function of age at the time of seizures. Three distinct epochs were observed in
      which seizures resulted in distinct long-term structural and functional outcomes 
      at ≥P95. Seizures prior to P20 resulted in DTI abnormalities in corpus callosum
      and hippocampus in the absence of gross cerebral atrophy, and increased paired
      pulse inhibition (PPI) in the dentate gyrus at ≥P95. Seizures after P30 induced a
      different pattern of DTI abnormalities in the fimbria and hippocampus accompanied
      by gross cerebral atrophy with increases in lateral ventricular volume, as well
      as increased PPI in the dentate gyrus at ≥P95. In contrast, seizures between
      P20-P30 did not result in cerebral atrophy or significant imaging abnormalities
      in the hippocampus or white matter, but irreversibly decreased PPI in the dentate
      gyrus compared to normal adult controls. These age-specific long-term structural 
      and functional outcomes identify P20-P30 as a potential critical period in
      hippocampal development defined by distinctive long-term structural and
      functional properties in adult hippocampal circuitry, including loss of capacity 
      for seizure-induced plasticity in adulthood that could influence epileptogenesis 
      and other hippocampal – dependent behaviors and functional properties.
FAU - Sayin, U.
AU  - Sayin U
AD  - Department of Neurology, University of Wisconsin UW Medical Foundation Centennial
      Building 1685 Highland Ave Madison, WI 53705, USA
FAU - Hutchinson, E.
AU  - Hutchinson E
AD  - Department of Neurology, University of Wisconsin UW Medical Foundation Centennial
      Building 1685 Highland Ave Madison, WI 53705, USA
FAU - Meyerand, M.E.
AU  - Meyerand M
AD  - Department of Medical Physics, University of Wisconsin Wisconsin Institutes
      Medical Research 1111 Highland Avenue Madison, WI 53705, USA
FAU - Sutula, T.
AU  - Sutula T
AD  - Department of Neurology, University of Wisconsin UW Medical Foundation Centennial
      Building 1685 Highland Ave Madison, WI 53705, USA
LA  - eng
PT  - Journal Article
DEP - 20141230
TA  - Neuroscience
JT  - Neuroscience
AID - 10.1016/j.neuroscience.2014.12.017 [doi]
MID - NIHMS652709
SO  - Neuroscience. 2015 Mar 12;288:120-34. Epub 2014 Dec 30
      doi:10.1016/j.neuroscience.2014.12.017.

PMC - PMC4251767
PMID- 24486757
IS  - 1067-151X (Print)
VI  - 22
IP  - 2
DP  - 2014 Feb
TI  - Composite Bone Models in Orthopaedic Surgery Research and Education.
PG  - 111-20
AB  - Composite bone models are increasingly used in orthopaedic biomechanics research 
      and surgical education—applications that traditionally relied on cadavers.
      Cadaver bones are suboptimal for myriad reasons, including issues of cost,
      availability, preservation, and inconsistency between specimens. Further, cadaver
      samples disproportionately represent the elderly, whose bone quality may not be
      representative of the greater orthopaedic population. The current
      fourth-generation composite bone models provide an accurate reproduction of the
      biomechanical properties of human bone when placed under bending, axial, and
      torsional loads. The combination of glass fiber and epoxy resin components into a
      single phase has enabled manufacturing by injection molding. The high anatomic
      fidelity of the cadaver-based molds and negligible shrinkage properties of the
      epoxy resin results in a process that allows for excellent definition of anatomic
      detail in the cortical wall and optimized consistency of features between models.
      Recent biomechanical studies of composites have validated their use as a suitable
      substitute for cadaver specimens.
FAU - Elfar, John
AU  - Elfar J
FAU - Stanbury, Spencer
AU  - Stanbury S
FAU - Menorca, Ron Martin Garcia
AU  - Menorca RMG
FAU - Reed, Jeffrey Douglas
AU  - Reed JD
LA  - eng
PT  - Journal Article
TA  - J Am Acad Orthop Surg
JT  - The Journal of the American Academy of Orthopaedic Surgeons
AID - 10.5435/JAAOS-22-02-111 [doi]
MID - NIHMS641244
SO  - J Am Acad Orthop Surg. 2014 Feb;22(2):111-20. doi:10.5435/JAAOS-22-02-111.

PMC - PMC4219440
PMID- 25408641
IS  - 1662-5161 (Electronic)
VI  - 8
DP  - 2014
TI  - Simulation of thalamic prosthetic vision: reading accuracy, speed, and acuity in 
      sighted humans.
LID - 816
AB  - The psychophysics of reading with artificial sight has received increasing
      attention as visual prostheses are becoming a real possibility to restore useful 
      function to the blind through the coarse, pseudo-pixelized vision they generate. 
      Studies to date have focused on simulating retinal and cortical prostheses; here 
      we extend that work to report on thalamic designs. This study examined the
      reading performance of normally sighted human subjects using a simulation of
      three thalamic visual prostheses that varied in phosphene count, to help
      understand the level of functional ability afforded by thalamic designs in a task
      of daily living. Reading accuracy, reading speed, and reading acuity of 20
      subjects were measured as a function of letter size, using a task based on the
      MNREAD chart. Results showed that fluid reading was feasible with appropriate
      combinations of letter size and phosphene count, and performance degraded
      smoothly as font size was decreased, with an approximate doubling of phosphene
      count resulting in an increase of 0.2 logMAR in acuity. Results here were
      consistent with previous results from our laboratory. Results were also
      consistent with those from the literature, despite using naive subjects who were 
      not trained on the simulator, in contrast to other reports.
FAU - Vurro, Milena
AU  - Vurro M
FAU - Crowell, Anne Marie
AU  - Crowell AM
FAU - Pezaris, John S.
AU  - Pezaris JS
LA  - eng
PT  - Journal Article
DEP - 20141104
PHST- 2014/05/26 [received]
PHST- 2014/09/24 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2014.00816 [doi]
SO  - Front Hum Neurosci. 2014 Nov 04;8:. doi:10.3389/fnhum.2014.00816.

PMC - PMC4642575
PMID- 26323965
IS  - 2045-2322 (Electronic)
VI  - 5
DP  - 2015
TI  - Infrared video tracking of Anopheles gambiae at insecticide-treated bed nets
      reveals rapid decisive impact after brief localised net contact.
LID - 13392
AB  - Long-lasting insecticidal bed nets (LLINs) protect humans from malaria
      transmission and are fundamental to malaria control worldwide, but little is
      known of how mosquitoes interact with nets. Elucidating LLIN mode of action is
      essential to maintain or improve efficacy, an urgent need as emerging insecticide
      resistance threatens their future. Tracking multiple free-flying Anopheles
      gambiae responding to human-occupied bed nets in a novel large-scale system, we
      characterised key behaviours and events. Four behavioural modes with different
      levels of net contact were defined: swooping, visiting, bouncing and resting.
      Approximately 75% of all activity occurred at the bed net roof where multiple
      brief contacts were focussed above the occupant’s torso. Total flight and net
      contact times were lower at LLINs than untreated nets but the essential character
      of the response was unaltered. LLINs did not repel mosquitoes but impacted
      rapidly: LLIN contact of less than 1 minute per mosquito during the first ten
      minutes reduced subsequent activity; after thirty minutes, activity at LLINs was 
      negligible. Velocity measurements showed that mosquitoes detected nets, including
      unbaited untreated nets, prior to contact. This is the most complete
      characterisation of mosquito-LLIN interactions to date, and reveals many aspects 
      of LLIN mode of action, important for developing the next generation of LLINs.
FAU - Parker, Josephine E.A.
AU  - Parker JE
AD  - Vector Biology Department, Liverpool School of Tropical Medicine, Pembroke Place,
      Liverpool L3 5QA, UK
FAU - Angarita-Jaimes, Natalia
AU  - Angarita-Jaimes N
AD  - Optical Engineering Group, School of Engineering, University of Warwick,
      Coventry, CV4 7AL, UK
FAU - Abe, Mayumi
AU  - Abe M
AD  - Vector Biology Department, Liverpool School of Tropical Medicine, Pembroke Place,
      Liverpool L3 5QA, UK
FAU - Towers, Catherine E.
AU  - Towers CE
AD  - Optical Engineering Group, School of Engineering, University of Warwick,
      Coventry, CV4 7AL, UK
FAU - Towers, David
AU  - Towers D
AD  - Optical Engineering Group, School of Engineering, University of Warwick,
      Coventry, CV4 7AL, UK
FAU - McCall, Philip J.
AU  - McCall PJ
AD  - Vector Biology Department, Liverpool School of Tropical Medicine, Pembroke Place,
      Liverpool L3 5QA, UK
LA  - eng
PT  - Journal Article
DEP - 20150901
PHST- 2015/03/11 [received]
PHST- 2015/07/24 [accepted]
TA  - Sci Rep
JT  - Scientific Reports
AID - srep13392 [pii]
AID - 10.1038/srep13392 [doi]
SO  - Sci Rep. 2015 Sep 01;5:. doi:10.1038/srep13392.

PMC - PMC4898144
PMID- 27028625
IS  - 0955-3002 (Print)
IS  - 1362-3095 (Electronic)
VI  - 92
IP  - 6
DP  - 2016 Jun 2
TI  - Analysis of gene expression in mouse brain regions after exposure to 1.9 GHz
      radiofrequency fields.
PG  - 338-50
AB  - Purpose: To assess 1.9 GHz radiofrequency (RF) field exposure on gene expression 
      within a variety of discrete mouse brain regions using whole genome microarray
      analysis. Materials and methods: Adult male C57BL/6 mice were exposed to 1.9 GHz 
      pulse-modulated or continuous-wave RF fields for 4 h/day for 5 consecutive days
      at whole body average (WBA) specific absorption rates of 0 (sham), ∼0.2 W/kg and 
      ∼1.4 W/kg. Total RNA was isolated from the auditory cortex, amygdala, caudate,
      cerebellum, hippocampus, hypothalamus, and medial prefrontal cortex and
      differential gene expression was assessed using Illumina MouseWG-6 (v2) BeadChip 
      arrays. Validation of potentially responding genes was conducted by RT-PCR.
      Results: When analysis of gene expression was conducted within individual brain
      regions when controlling the false discovery rate (FDR), no differentially
      expressed genes were identified relative to the sham control. However, it must be
      noted that most fold changes among groups were observed to be less than 1.5-fold 
      and this study had limited ability to detect such small changes. While some genes
      were differentially expressed without correction for multiple-comparisons
      testing, no consistent pattern of response was observed among different
      RF-exposure levels or among different RF-modulations. Conclusions: The current
      study provides the most comprehensive analysis of potential gene expression
      changes in the rodent brain in response to RF field exposure conducted to date.
      Within the exposure conditions and limitations of this study, no convincing
      evidence of consistent changes in gene expression was found in response to
      1.9 GHz RF field exposure.
FAU - McNamee, James P.
AU  - McNamee JP
AD  - Health Canada, Environmental and Radiation Health Sciences Directorate, Consumer 
      and Clinical Radiation Protection Bureau, Ottawa
FAU - Bellier, Pascale V.
AU  - Bellier PV
AD  - Health Canada, Environmental and Radiation Health Sciences Directorate, Consumer 
      and Clinical Radiation Protection Bureau, Ottawa
FAU - Konkle, Anne T. M.
AU  - Konkle ATM
AD  - Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON,
      Canada
FAU - Thomas, Reuben
AU  - Thomas R
AD  - Gladstone Institutes, San Francisco, CA, USA
FAU - Wasoontarajaroen, Siriwat
AU  - Wasoontarajaroen S
AD  - Faculty of Engineering, Rajamangala University of Technology, Isan, Khon Kaen,
      Thailand
FAU - Lemay, Eric
AU  - Lemay E
AD  - Health Canada, Environmental and Radiation Health Sciences Directorate, Consumer 
      and Clinical Radiation Protection Bureau, Ottawa
FAU - Gajda, Greg B.
AU  - Gajda GB
AD  - Health Canada, Environmental and Radiation Health Sciences Directorate, Consumer 
      and Clinical Radiation Protection Bureau, Ottawa
LA  - eng
PT  - Journal Article
DEP - 20160330
PHST- 2015/12/23 [received]
PHST- 2016/02/15 [revised]
PHST- 2016/02/20 [accepted]
PHST- 2016/03/30 [aheadofprint]
TA  - Int J Radiat Biol
JT  - International Journal of Radiation Biology
AID - 10.3109/09553002.2016.1159353 [doi]
AID - 1159353 [pii]
SO  - Int J Radiat Biol. 2016 Jun 2;92(6):338-50. Epub 2016 Mar 30
      doi:10.3109/09553002.2016.1159353.

PMC - PMC4707267
PMID- 26793118
IS  - 1664-042X (Electronic)
VI  - 6
DP  - 2015
TI  - Monitoring Local Regional Hemodynamic Signal Changes during Motor Execution and
      Motor Imagery Using Near-Infrared Spectroscopy.
LID - 416
AB  - The aim of this study was to clarify the topographical localization of
      motor-related regional hemodynamic signal changes during motor execution (ME) and
      motor imagery (MI) by using near-infrared spectroscopy (NIRS), as this technique 
      is more clinically expedient than established methods (e.g., fMRI). Twenty
      right-handed healthy subjects participated in this study. The experimental
      protocol was a blocked design consisting of 3 cycles of 20 s of task performance 
      and 30 s of rest. The tapping sequence task was performed with their fingers
      under 4 conditions: ME and MI with the right or left hand. Hemodynamic brain
      activity was measured with NIRS to monitor changes in oxygenated hemoglobin
      (oxy-Hb) concentration. Oxy-Hb in the somatosensory motor cortex (SMC) increased 
      significantly only during contralateral ME and showed a significant interaction
      between task and hand. There was a main effect of hand in the left SMC. Although 
      there were no significant main effects or interactions in the supplemental motor 
      area (SMA) and premotor area (PMA), oxy-Hb increased substantially under all
      conditions. These results clarified the topographical localization by
      motor-related regional hemodynamic signal changes during ME and MI by using NIRS.
FAU - Iso, Naoki
AU  - Iso N
AD  - Unit of Rehabilitation Sciences, Nagasaki University Graduate School of
      Biomedical SciencesNagasaki, Japan
FAU - Moriuchi, Takefumi
AU  - Moriuchi T
AD  - Unit of Rehabilitation Sciences, Nagasaki University Graduate School of
      Biomedical SciencesNagasaki, Japan
FAU - Sagari, Akira
AU  - Sagari A
AD  - Unit of Rehabilitation Sciences, Nagasaki University Graduate School of
      Biomedical SciencesNagasaki, Japan
FAU - Kitajima, Eiji
AU  - Kitajima E
AD  - Center for Industry, University and Government Cooperation, Nagasaki
      UniversityNagasaki, Japan
FAU - Iso, Fumiko
AU  - Iso F
AD  - Unit of Physical and Occupational Therapy, Nagasaki University Graduate School of
      Biomedical SciencesNagasaki, Japan
FAU - Tanaka, Koji
AU  - Tanaka K
AD  - Unit of Physical and Occupational Therapy, Nagasaki University Graduate School of
      Biomedical SciencesNagasaki, Japan
FAU - Kikuchi, Yasuki
AU  - Kikuchi Y
AD  - Unit of Physical and Occupational Therapy, Nagasaki University Graduate School of
      Biomedical SciencesNagasaki, Japan
FAU - Tabira, Takayuki
AU  - Tabira T
AD  - Department of Occupational Therapy, Faculty of Rehabilitation Sciences,
      Nishikyushu UniversitySaga, Japan
FAU - Higashi, Toshio
AU  - Higashi T
AD  - Unit of Rehabilitation Sciences, Nagasaki University Graduate School of
      Biomedical SciencesNagasaki, Japan
LA  - eng
PT  - Journal Article
DEP - 20160111
PHST- 2015/10/05 [received]
PHST- 2015/12/18 [accepted]
TA  - Front Physiol
JT  - Frontiers in Physiology
AID - 10.3389/fphys.2015.00416 [doi]
SO  - Front Physiol. 2016 Jan 11;6:. doi:10.3389/fphys.2015.00416.

PMC - PMC4140948
PMID- 24916419
IS  - 0196-8092 (Print)
IS  - 1096-9101 (Electronic)
VI  - 46
IP  - 7
DP  - 2014 Sep
TI  - Multimodality Imaging of the Effects of a Novel Dentifrice on Oral Biofilm.
PG  - 546-52
AB  - Objective: Oral biofilm formation and progression on the surface of the tooth can
      lead to advanced oral disease such as gingivitis. The purpose of this randomized,
      controlled, double-blinded study was to evaluate the effects of a novel dental
      gel on oral plaque biofilm using multimodal imaging techniques. Materials and
      Methods: Twenty-five subjects with moderate gingival inflammation (Löe and
      Silness Gingival Index ≥ 2) and pocket depths <4 were randomly assigned to brush 
      twice daily for 21 days with the test or the control dental gel. In vivo
      multimodality in situ imaging was performed over a 3-week period using in vivo
      Optical Coherence Tomography (OCT) and Non-Linear Optical microscopy (NLOM).
      Plaque levels, gingival inflammation and gingival bleeding were also charted on
      days 0, 7, 14, and 21 using standard clinical indices. Results: After 3 weeks,
      OCT and NLOM images showed a macroscopic break-up of the plaque layer and
      smaller, fragmented residual deposits in the test group with no apparent changes 
      in the pellicle. Biofilm was also reduced in the control group, but to a lesser
      degree with regard to thickness, continuity and surface area. Paralleling these
      imaging results, clinical indices were significantly improved in both groups (P
      <0.05) and significantly lower in the test group (P <0.05). Conclusion: Both
      dental gels reduced oral biofilm with the test gel showing greater efficacy (P
      <0.05) as determined by clinical and imaging parameters.
FAU - Ajdaharian, Janet
AU  - Ajdaharian J
AD  - Beckman Laser Institute, University of California, Irvine, California 92612
FAU - Dadkhah, Mohammad
AU  - Dadkhah M
AD  - Beckman Laser Institute, University of California, Irvine, California 92612
FAU - Sabokpey, Sara
AU  - Sabokpey S
AD  - Beckman Laser Institute, University of California, Irvine, California 92612
FAU - Biren-Fetz, John
AU  - Biren-Fetz J
AD  - Beckman Laser Institute, University of California, Irvine, California 92612
FAU - Chung, Na Eun
AU  - Chung NE
AD  - Beckman Laser Institute, University of California, Irvine, California 92612
FAU - Wink, Cherie
AU  - Wink C
AD  - Beckman Laser Institute, University of California, Irvine, California 92612
FAU - Wilder-Smith, Petra
AU  - Wilder-Smith P
AD  - Beckman Laser Institute, University of California, Irvine, California 92612
LA  - eng
PT  - Journal Article
DEP - 20140610
TA  - Lasers Surg Med
JT  - Lasers in surgery and medicine
AID - 10.1002/lsm.22265 [doi]
MID - NIHMS609501
SO  - Lasers Surg Med. 2014 Sep;46(7):546-52. Epub 2014 Jun 10 doi:10.1002/lsm.22265.

PMC - PMC4777896
PMID- 25664566
IS  - 0735-7044 (Print)
IS  - 1939-0084 (Electronic)
VI  - 129
IP  - 2
DP  - 2015 Apr
TI  - Neural Correlates of Impulsive Aggressive Behavior in Subjects With a History of 
      Alcohol Dependence.
PG  - 183-96
AB  - Alcohol-related aggression is a complex and problematic phenomenon with profound 
      public health consequences. We examined neural correlates potentially moderating 
      the relationship between human aggressive behavior and chronic alcohol use.
      Thirteen subjects meeting DSM–IV criteria for past alcohol-dependence in
      remission (AD) and 13 matched healthy controls (CONT) participated in an fMRI
      study adapted from a laboratory model of human aggressive behavior (Point
      Subtraction Aggression Paradigm, or PSAP). Blood oxygen level dependent (BOLD)
      activation was measured during bouts of operationally defined aggressive
      behavior, during postprovocation periods, and during monetary-reinforced
      behavior. Whole brain voxelwise random-effects analyses found group differences
      in brain regions relevant to chronic alcohol use and aggressive behavior (e.g.,
      emotional and behavioral control). Behaviorally, AD subjects responded on both
      the aggressive response and monetary response options at significantly higher
      rates than CONT. Whole brain voxelwise random-effects analyses revealed
      significant group differences in response to provocation (monetary subtractions),
      with CONT subjects showing greater activation in frontal and prefrontal cortex,
      thalamus, and hippocampus. Collapsing data across all subjects, regression
      analyses of postprovocation brain activation on aggressive response rate revealed
      significant positive regression slopes in precentral gyrus and parietal cortex;
      and significant negative regression slopes in orbitofrontal cortex, prefrontal
      cortex, caudate, thalamus, and middle temporal gyrus. In these collapsed
      analyses, response to provocation and aggressive behavior were associated with
      activation in brain regions subserving inhibitory and emotional control,
      sensorimotor integration, and goal directed motor activity.
FAU - Kose, Samet
AU  - Kose S
AD  - University of Texas Medical School at Houston and Center for Neurobehavioral
      Research on Addictions (CNRA), Houston, Texas
FAU - Steinberg, Joel L.
AU  - Steinberg JL
AD  - Virginia Commonwealth University School of Medicine
FAU - Moeller, F. Gerard
AU  - Moeller FG
AD  - Virginia Commonwealth University School of Medicine
FAU - Gowin, Joshua L.
AU  - Gowin JL
AD  - National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland
FAU - Zuniga, Edward
AU  - Zuniga E
AD  - Virginia Commonwealth University School of Medicine
FAU - Kamdar, Zahra N.
AU  - Kamdar ZN
AD  - Center for Neurobehavioral Research on Addictions (CNRA), Houston, Texas
FAU - Schmitz, Joy M.
AU  - Schmitz JM
AD  - University of Texas Medical School at Houston and Center for Neurobehavioral
      Research on Addictions (CNRA), Houston, Texas
FAU - Lane, Scott D.
AU  - Lane SD
AD  - University of Texas Medical School at Houston and Center for Neurobehavioral
      Research on Addictions (CNRA), Houston, Texas
LA  - eng
PT  - Journal Article
DEP - 20150209
TA  - Behav Neurosci
JT  - Behavioral neuroscience
AID - 10.1037/bne0000038 [doi]
MID - NIHMS691861
SO  - Behav Neurosci. 2015 Apr;129(2):183-96. Epub 2015 Feb 09 doi:10.1037/bne0000038.

PMC - PMC4468351
PMID- 26077825
IS  - 2050-084X (Print)
IS  - 2050-084X (Electronic)
VI  - 4
DP  - 2015
TI  - Dynamical feature extraction at the sensory periphery guides chemotaxis.
LID - e06694
AB  - Behavioral strategies employed for chemotaxis have been described across phyla,
      but the sensorimotor basis of this phenomenon has seldom been studied in
      naturalistic contexts. Here, we examine how signals experienced during free
      olfactory behaviors are processed by first-order olfactory sensory neurons (OSNs)
      of the Drosophila larva. We find that OSNs can act as differentiators that
      transiently normalize stimulus intensity—a property potentially derived from a
      combination of integral feedback and feed-forward regulation of olfactory
      transduction. In olfactory virtual reality experiments, we report that high
      activity levels of the OSN suppress turning, whereas low activity levels
      facilitate turning. Using a generalized linear model, we explain how peripheral
      encoding of olfactory stimuli modulates the probability of switching from a run
      to a turn. Our work clarifies the link between computations carried out at the
      sensory periphery and action selection underlying navigation in odor
      gradients.DOI:http://dx.doi.org/10.7554/eLife.06694.001
OAB - Publisher: Abstract available from the publisher.
FAU - Schulze, Aljoscha
AU  - Schulze A
AD  - EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain
FAU - Gomez-Marin, Alex
AU  - Gomez-Marin A
AD  - EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain
FAU - Rajendran, Vani G
AU  - Rajendran VG
AD  - EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain
FAU - Lott, Gus
AU  - Lott G
AD  - Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
FAU - Musy, Marco
AU  - Musy M
AD  - EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain
FAU - Ahammad, Parvez
AU  - Ahammad P
AD  - Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
FAU - Deogade, Ajinkya
AU  - Deogade A
AD  - EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain
FAU - Sharpe, James
AU  - Sharpe J
AD  - EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain
FAU - Riedl, Julia
AU  - Riedl J
AD  - EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain
FAU - Jarriault, David
AU  - Jarriault D
AD  - EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain
FAU - Trautman, Eric T
AU  - Trautman ET
AD  - Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
FAU - Werner, Christopher
AU  - Werner C
AD  - Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
FAU - Venkadesan, Madhusudhan
AU  - Venkadesan M
AD  - Department of Mechanical Engineering and Materials Science, Yale University, New 
      Haven, United States
FAU - Druckmann, Shaul
AU  - Druckmann S
AD  - Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
FAU - Jayaraman, Vivek
AU  - Jayaraman V
AD  - Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
FAU - Louis, Matthieu
AU  - Louis M
AUID- ORCID: 0000-0002-2267-0262
AD  - EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain
LA  - eng
PT  - Journal Article
GR  - BFU2008-00362
PHST- 2015/01/26 [received]
PHST- 2015/05/30 [accepted]
TA  - eLife
JT  - eLife
AID - 06694 [pii]
AID - 10.7554/eLife.06694 [doi]
SO  - eLife. 2015;4:. doi:10.7554/eLife.06694.

PMC - PMC2811085
PMID- 19516252
IS  - 0893-133X (Print)
IS  - 1740-634X (Electronic)
VI  - 34
IP  - 10
DP  - 2009 Sep
TI  - Glutaminase-Deficient Mice Display Hippocampal Hypoactivity, Insensitivity to
      Pro-Psychotic Drugs and Potentiated Latent Inhibition: Relevance to
      Schizophrenia.
PG  - 2305-22
AB  - Dysregulated glutamatergic neurotransmission has been strongly implicated in the 
      pathophysiology of schizophrenia (SCZ). Recently, presynaptic modulation of
      glutamate transmission has been shown to have therapeutic promise. We asked
      whether genetic knockdown of glutaminase (gene GLS1) to reduce glutamatergic
      transmission presynaptically by slowing the recycling of glutamine to glutamate, 
      would produce a phenotype relevant to SCZ and its treatment. GLS1 heterozygous
      (GLS1 het) mice showed about a 50% global reduction in glutaminase activity, and 
      a modest reduction in glutamate levels in brain regions relevant to SCZ
      pathophysiology, but displayed neither general behavioral abnormalities nor
      SCZ-associated phenotypes. Functional imaging, measuring regional cerebral blood 
      volume, showed hippocampal hypometabolism mainly in the CA1 subregion and
      subiculum, the inverse of recent clinical imaging findings in prodromal and SCZ
      patients. GLS1 het mice were less sensitive to the behavioral stimulating effects
      of amphetamine, showed a reduction in amphetamine-induced striatal dopamine
      release and in ketamine-induced frontal cortical activation, suggesting that GLS1
      het mice are resistant to the effects of these pro-psychotic challenges.
      Moreover, GLS1 het mice showed clozapine-like potentiation of latent inhibition, 
      suggesting that reduction in glutaminase has antipsychotic-like properties. These
      observations provide further support for the pivotal role of altered
      glutamatergic synaptic transmission in the pathophysiology of SCZ, and suggest
      that presynaptic modulation of the glutamine–glutamate pathway through
      glutaminase inhibition may provide a new direction for the pharmacotherapy of
      SCZ.
FAU - Gaisler-Salomon, Inna
AU  - Gaisler-Salomon I
AD  - Department of Psychiatry, Columbia University, New York, NY, USA
FAU - Miller, Gretchen M
AU  - Miller GM
AD  - Department of Psychiatry, Columbia University, New York, NY, USA
FAU - Chuhma, Nao
AU  - Chuhma N
AD  - Department of Psychiatry, Columbia University, New York, NY, USA
FAU - Lee, Sooyeon
AU  - Lee S
AD  - Department of Psychiatry, Columbia University, New York, NY, USA
FAU - Zhang, Hong
AU  - Zhang H
AD  - Department of Pathology, Columbia University, New York, NY, USA
FAU - Ghoddoussi, Farhad
AU  - Ghoddoussi F
AD  - Departments of Psychiatry and Behavioral Neurosciences and Anesthesiology, Wayne 
      State University School of Medicine, Detroit, MI, USA
FAU - Lewandowski, Nicole
AU  - Lewandowski N
AD  - Department of Neurology, Columbia University, New York, NY, USA
FAU - Fairhurst, Stephen
AU  - Fairhurst S
AD  - Department of Cognitive Neuroscience, New York State Psychiatric Institute, New
      York, NY, USA
FAU - Wang, Yvonne
AU  - Wang Y
AD  - Department of Psychiatry, Columbia University, New York, NY, USA
FAU - Conjard-Duplany, Agnès
AU  - Conjard-Duplany A
AD  - INSERM U820, Centre de Métabolomique et Maladies Métaboliques, Faculté de
      Médecine Laennec, Lyon, France
FAU - Masson, Justine
AU  - Masson J
AD  - INSERM U894, Centre de Psychiatrie et Neuroscience, Faculté de Médecine,
      Université Paris Descartes—Paris 5, Paris, France
FAU - Balsam, Peter
AU  - Balsam P
AD  - Department of Psychiatry, Columbia University, New York, NY, USA
FAU - Hen, René
AU  - Hen R
AD  - Department of Pharmacology, Columbia University, New York, NY, USA
FAU - Arancio, Ottavio
AU  - Arancio O
AD  - Department of Pathology, Columbia University, New York, NY, USA
FAU - Galloway, Matthew P
AU  - Galloway MP
AD  - Departments of Psychiatry and Behavioral Neurosciences and Anesthesiology, Wayne 
      State University School of Medicine, Detroit, MI, USA
FAU - Moore, Holly M
AU  - Moore HM
AD  - Department of Psychiatry, Columbia University, New York, NY, USA
FAU - Small, Scott A
AU  - Small SA
AD  - Department of Neurology, Columbia University, New York, NY, USA
FAU - Rayport, Stephen
AU  - Rayport S
AD  - Department of Psychiatry, Columbia University, New York, NY, USA
LA  - eng
PT  - Journal Article
DEP - 20090610
TA  - Neuropsychopharmacology
JT  - Neuropsychopharmacology : official publication of the American College of
      Neuropsychopharmacology
AID - 10.1038/npp.2009.58 [doi]
MID - NIHMS163251
SO  - Neuropsychopharmacology. 2009 Sep;34(10):2305-22. Epub 2009 Jun 10
      doi:10.1038/npp.2009.58.

PMC - PMC3201011
PMID- 22073051
IS  - 1865-1011 (Electronic)
VI  - 4
DP  - 2005
TI  - Restoration of hearing by hearing aids: conventional hearing aids – implantable
      hearing aids – cochlear implants – auditory brainstem implants.
LID - Doc03
AB  - Aim of this report is to explain the current concept of hearing restoration using
      hearing aids. At present the main issues of conventional hearing aids are the
      relative benefits of analogue versus digital devices and different strategies for
      the improvement of hearing in noise. Implantable hearing aids provide a better
      sound quality and less distortion. The lack of directional microphones is the
      major disadvantage of the partially implantable hearing aids commercially
      available. Two different clinical studies about fully implantable hearing aids
      have been started in 2004. One of the most-promising developments seems to be the
      electric-acoustic stimulation.
FAU - Leuwer, R.
AU  - Leuwer R
AD  - Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde, Universitätsklinikum 
      Hamburg-Eppendorf
FAU - Müller, J.
AU  - Müller J
AD  - Klinik und Poliklinik für Hals-, Nasen- und Ohrenkranke, Universität Würzburg
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20050928
TA  - GMS Curr Top Otorhinolaryngol Head Neck Surg
JT  - GMS Current Topics in Otorhinolaryngology, Head and Neck Surgery
AID - cto000009 [pii]
SO  - GMS Curr Top Otorhinolaryngol Head Neck Surg. 2005 Sep 28;4:.

PMC - PMC2395517
PMID- 18521376
IS  - 1357-714X (Print)
IS  - 1369-1643 (Electronic)
VI  - 7
IP  - 2
DP  - 2003 Jun
TI  - 16th Annual Meeting of the European Musculo-Skeletal Oncology Society & 4th
      Symposium of the EMSOS Nurse Group, 7–9 May 2003, Budapest: Abstracts.
PG  - 93-129
LA  - eng
PT  - Journal Article
TA  - Sarcoma
JT  - Sarcoma
AID - S1357714X0300015X [pii]
AID - 10.1080/13577140310001607338 [doi]
SO  - Sarcoma. 2003 Jun;7(2):93-129. doi:10.1080/13577140310001607338.

PMC - PMC3785979
PMID- 24004475
IS  - 1439-4456 (Print)
IS  - 1438-8871 (Electronic)
VI  - 15
IP  - 9
DP  - 2013 Sep
TI  - Effects of a Web-Based Patient Activation Intervention to Overcome Clinical
      Inertia on Blood Pressure Control: Cluster Randomized Controlled Trial.
LID - e158
AB  - Background: Only approximately half of patients with hypertension have their
      blood pressure controlled, due in large part to the tendency of primary care
      providers (PCPs) not to intensify treatment when blood pressure values are
      elevated. Objective: This study tested the effect of an intervention designed to 
      help patients ask questions at the point of care to encourage PCPs to
      appropriately intensify blood pressure treatment. Methods: PCPs and their
      patients with hypertension (N=500) were recruited by letter and randomized into 2
      study groups: (1) intervention condition in which patients used a fully automated
      website each month to receive tailored messages suggesting questions to ask their
      PCP to improve blood pressure control, and (2) control condition in which a
      similar tool suggested questions to ask about preventive services (eg, cancer
      screening). The Web-based tool was designed to be used during each of the 12
      study months and before scheduled visits with PCPs. The primary outcome was the
      percentage of patients in both conditions with controlled blood pressure.
      Results: Of 500 enrolled patients (intervention condition: n=282; control
      condition: n=218), 418 (83.6%) completed the 12-month follow-up visit. At
      baseline, 289 (61.5%) of participants had controlled blood pressure. Most
      (411/500, 82.2%) participants used the intervention during at least 6 of 12
      months and 222 (62.5%) reported asking questions directly from the Web-based
      tool. There were no group differences in asking about medication intensification 
      and there were no differences in blood pressure control after 12 months between
      the intervention condition (201/282, 71.3%) and control condition (143/218,
      65.6%; P=.27) groups. More intervention condition participants discussed having a
      creatinine test (92, 52.6% vs 49, 35.5%; P=.02) and urine protein test (81, 44.8%
      vs 21, 14.6%; P<.001), but no group differences were observed in the rate of
      testing. The control condition participants reported more frequent discussions
      about tetanus and pneumonia vaccines and reported more tetanus (30, 13.8% vs 15, 
      5.3%; P=.02) and pneumonia (25, 11.5% vs 16, 5.7%; P=.02) vaccinations after 12
      months. Conclusions: The use of an interactive website designed to overcome
      clinical inertia for hypertension care did not lead to improvements in blood
      pressure control. Participant adherence to the intervention was high. The control
      intervention led to positive changes in the use of preventive services (eg,
      tetanus immunization) and the intervention condition led to more discussions of
      hypertension-relevant tests (eg, serum creatinine and urine protein). By
      providing patients with individually tailored questions to ask during PCP visits,
      this study demonstrated that participants were likely to discuss the questions
      with PCPs. These discussions did not, however, lead to improvements in blood
      pressure control. Trial Registration: ClinicalTrials.gov NCT00377208;
      http://clinicaltrials.gov/ct2/show/NCT00377208 (Archived by WebCite at
      http://www.webcitation.org/6IqWiPLon).
FAU - Kok, Robin
AU  - Kok R
FAU - Allen, Nancy
AU  - Allen N
FAU - Nolan, Rob
AU  - Nolan R
FAU - Green, Beverly
AU  - Green B
FAU - Thiboutot, Jeffrey
AU  - Thiboutot J
AD  - Mount Sinai School of MedicineNew York, NYUnited States
FAU - Sciamanna, Christopher N
AU  - Sciamanna CN
AD  - Pennsylvania State University College of MedicineMS Hershey Medical
      CenterHershey, PAUnited States
FAU - Falkner, Bonita
AU  - Falkner B
AD  - Jefferson Medical CollegeThomas Jefferson UniversityPhiladelphia, PAUnited States
FAU - Kephart, Donna K
AU  - Kephart DK
AD  - Pennsylvania State University College of MedicineMS Hershey Medical
      CenterHershey, PAUnited States
FAU - Stuckey, Heather L
AU  - Stuckey HL
AD  - Pennsylvania State University College of MedicineMS Hershey Medical
      CenterHershey, PAUnited States
FAU - Adelman, Alan M
AU  - Adelman AM
AD  - Pennsylvania State University College of MedicineMS Hershey Medical
      CenterHershey, PAUnited States
FAU - Curry, William J
AU  - Curry WJ
AD  - Pennsylvania State University College of MedicineMS Hershey Medical
      CenterHershey, PAUnited States
FAU - Lehman, Erik B
AU  - Lehman EB
AD  - Pennsylvania State University College of MedicineMS Hershey Medical
      CenterHershey, PAUnited States
LA  - eng
PT  - Journal Article
DEP - 20130904
PHST- 2012/08/08 [received]
PHST- 2013/02/22 [revised]
PHST- 2013/05/11 [accepted]
TA  - J Med Internet Res
JT  - Journal of Medical Internet Research
AID - v15i9e158 [pii]
AID - 10.2196/jmir.2298 [doi]
SO  - J Med Internet Res. 2013 Sep 04;15(9):. doi:10.2196/jmir.2298.

PMC - PMC3293614
PMID- 22186795
IS  - 1525-0016 (Print)
IS  - 1525-0024 (Electronic)
VI  - 20
IP  - 3
DP  - 2012 Mar
TI  - Progress Toward In Vivo Use of siRNAs-II.
PG  - 483-512
AB  - RNA interference (RNAi) has been extensively employed for in vivo research since 
      its use was first demonstrated in mammalian cells 10 years ago. Design rules have
      improved, and it is now routinely possible to obtain reagents that suppress
      expression of any gene desired. At the same time, increased understanding of the 
      molecular basis of unwanted side effects has led to the development of chemical
      modification strategies that mitigate these concerns. Delivery remains the single
      greatest hurdle to widespread adoption of in vivo RNAi methods. However, exciting
      advances have been made and new delivery systems under development may help to
      overcome these barriers. This review discusses advances in RNAi biochemistry and 
      biology that impact in vivo use and provides an overview of select publications
      that demonstrate interesting applications of these principles. Emphasis is placed
      on work with synthetic, small interfering RNAs (siRNAs) published since the first
      installment of this review which appeared in 2006.
FAU - Rettig, Garrett R
AU  - Rettig GR
AD  - Integrated DNA Technologies, Inc., Coralville, Iowa, USA
FAU - Behlke, Mark A
AU  - Behlke MA
AD  - Integrated DNA Technologies, Inc., Coralville, Iowa, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20111220
PHST- 2011/09/02 [received]
PHST- 2011/11/08 [accepted]
PHST- 2011/12/20 [aheadofprint]
TA  - Mol Ther
JT  - Molecular Therapy
AID - mt2011263 [pii]
AID - 10.1038/mt.2011.263 [doi]
SO  - Mol Ther. 2012 Mar;20(3):483-512. Epub 2011 Dec 20 doi:10.1038/mt.2011.263.

PMC - PMC4373832
PMID- 25759148
IS  - 2291-9279 (Electronic)
VI  - 3
IP  - 1
DP  - 2015 Jan-Jun
TI  - Therapists’ Perceptions of Social Media and Video Game Technologies in Upper Limb
      Rehabilitation.
LID - e2
AB  - Background: The application of technologies, such as video gaming and social
      media for rehabilitation, is garnering interest in the medical field. However,
      little research has examined clinicians’ perspectives regarding technology
      adoption by their clients. Objective: The objective of our study was to explore
      therapists’ perceptions of how young people and adults with hemiplegia use gaming
      and social media technologies in daily life and in rehabilitation, and to
      identify barriers to using these technologies in rehabilitation. Methods: We
      conducted two focus groups comprised of ten occupational
      therapists/physiotherapists who provide neurorehabilitation to individuals with
      hemiplegia secondary to stroke or cerebral palsy. Data was analyzed using
      inductive thematic analysis. The diffusion of innovations theory provided a
      framework to interpret emerging themes. Results: Therapists were using technology
      in a limited capacity. They identified barriers to using social media and gaming 
      technology with their clients, including a lack of age appropriateness, privacy
      issues with social media, limited transfer of training, and a lack of
      accessibility of current systems. Therapists also questioned their role in the
      context of technology-based interventions. The opportunity for social interaction
      was perceived as a major benefit of integrated gaming and social media.
      Conclusions: This study reveals the complexities associated with adopting new
      technologies in clinical practice, including the need to consider both client and
      clinician factors. Despite reporting several challenges with applying gaming and 
      social media technology with clinical populations, therapists identified
      opportunities for increased social interactions and were willing to help shape
      the development of an upper limb training system that could more readily meet the
      needs of clients with hemiplegia. By considering the needs of both therapists and
      clients, technology developers may increase the likelihood that clinicians will
      adopt innovative technologies.
FAU - Meldrum, Dara
AU  - Meldrum D
FAU - Deutsch, Judith
AU  - Deutsch J
FAU - Turolla, Andrea
AU  - Turolla A
FAU - Tatla, Sandy K
AU  - Tatla SK
AUID- ORCID: 0000-0001-5708-2666
AD  - Sunny Hill Health Centre for ChildrenVancouver, BCCanada
FAU - Shirzad, Navid
AU  - Shirzad N
AUID- ORCID: 0000-0003-3839-2583
AD  - Biomedical Engineering Graduate ProgramUniversity of British ColumbiaVancouver,
      BCCanada
FAU - Lohse, Keith R
AU  - Lohse KR
AUID- ORCID: 0000-0002-7643-3887
AD  - School of KinesiologyAuburn UniversityAuburn, ALUnited States
FAU - Virji-Babul, Naznin
AU  - Virji-Babul N
AUID- ORCID: 0000-0002-8984-5848
AD  - Department of Physical TherapyUniversity of British ColumbiaVancouver, BCCanada
FAU - Hoens, Alison M
AU  - Hoens AM
AUID- ORCID: 0000-0002-9533-9079
AD  - Department of Physical TherapyUniversity of British ColumbiaVancouver, BCCanada
FAU - Holsti, Liisa
AU  - Holsti L
AUID- ORCID: 0000-0003-0315-0330
AD  - The Department of Occupational Science and Occupational TherapyUniversity of
      British ColumbiaVancouver, BCCanada
FAU - Li, Linda C
AU  - Li LC
AUID- ORCID: 0000-0001-6280-0511
AD  - Department of Physical TherapyUniversity of British ColumbiaVancouver, BCCanada
FAU - Miller, Kimberly J
AU  - Miller KJ
AUID- ORCID: 0000-0002-9826-7269
AD  - Department of Physical TherapyUniversity of British ColumbiaVancouver, BCCanada
FAU - Lam, Melanie Y
AU  - Lam MY
AUID- ORCID: 0000-0003-4420-9124
AD  - Department of Human KineticsSt Francis Xavier UniversityAntigonish, NSCanada
FAU - Van der Loos, HF Machiel
AU  - Van der Loos HM
AUID- ORCID: 0000-0003-1355-980X
AD  - Department of Mechanical EngineeringUniversity of British ColumbiaVancouver,
      BCCanada
LA  - eng
PT  - Journal Article
DEP - 20150310
PHST- 2014/06/21 [received]
PHST- 2014/10/10 [revised]
PHST- 2014/11/06 [accepted]
TA  - JMIR Serious Games
JT  - JMIR Serious Games
AID - v3i1e2 [pii]
AID - 10.2196/games.3401 [doi]
SO  - JMIR Serious Games. 2015 Mar 10;3(1):. doi:10.2196/games.3401.

PMC - PMC3205820
PMID- 21819259
IS  - 0271-3683 (Print)
IS  - 1460-2202 (Electronic)
VI  - 36
IP  - 10
DP  - 2011 Oct
TI  - Breast Cancer Medications and Vision: Effects of Treatments for Early-stage
      Disease.
PG  - 867-85
AB  - This review concerns the effects on vision and the eye of medications prescribed 
      at three phases of treatment for women with early-stage breast cancer (BC): (1)
      adjuvant cytotoxic chemotherapy, (2) adjuvant endocrine therapy, and (3)
      symptomatic relief. The most common side effects of cytotoxic chemotherapy are
      epiphora and ocular surface irritation, which can be caused by any of several
      different regimens. Most notably, the taxane docetaxel can lead to epiphora by
      inducing canalicular stenosis. The selective-estrogen-receptor-modulator (SERM)
      tamoxifen, long the gold-standard adjuvant-endocrine-therapy for women with
      hormone-receptor-positive BC, increases the risk of posterior subcapsular
      cataract. Tamoxifen also affects the optic nerve head more often than previously 
      thought, apparently by causing subclinical swelling within the first 2 years of
      use for women older than ∼50 years. Tamoxifen retinopathy is rare, but it can
      cause foveal cystoid spaces that are revealed with spectral-domain optical
      coherence tomography (OCT) and that may increase the risk for macular holes.
      Tamoxifen often alters the perceived color of flashed lights detected via
      short-wavelength-sensitive (SWS) cone response isolated psychophysically; these
      altered perceptions may reflect a neural-response sluggishness that becomes
      evident at ∼2 years of use. The aromatase inhibitor (AI) anastrozole affects
      perception similarly, but in an age-dependent manner suggesting that the change
      of estrogen activity towards lower levels is more important than the low estrogen
      activity itself. Based on analysis of OCT retinal thickness data, it is likely
      that anastrozole increases the tractional force between the vitreous and retina. 
      Consequently, AI users, myopic AI users particularly, might be at increased risk 
      for traction-related vision loss. Because bisphosphonates are sometimes
      prescribed to redress AI-induced bone loss, clinicians should be aware of their
      potential to cause scleritis and uveitis occasionally. We conclude by suggesting 
      some avenues for future research into the visual and ocular effects of AIs,
      particularly as relates to assessment of cognitive function.
FAU - Eisner, Alvin
AU  - Eisner A
AD  - Women's Health Research Unit, Department of Obstetrics & Gynecology, Oregon
      Health & Science University, Portland, Oregon, USA
FAU - Luoh, Shiuh-Wen
AU  - Luoh SW
AD  - Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon
      Health & Science University, Portland, Oregon, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20110805
PHST- 2011/02/25 [received]
PHST- 2011/05/26 [revised]
PHST- 2011/05/31 [accepted]
PHST- 2011/08/05 [aheadofprint]
TA  - Curr Eye Res
JT  - Current Eye Research
AID - 10.3109/02713683.2011.594202 [doi]
SO  - Curr Eye Res. 2011 Oct;36(10):867-85. Epub 2011 Aug 05
      doi:10.3109/02713683.2011.594202.

PMC - PMC5419256
PMID- 28529704
IS  - 2046-1402 (Electronic)
VI  - 6
DP  - 2017
TI  - Towards a systems approach for chronic diseases, based on health state modeling.
LID - 309
AB  - Rising pressure from chronic diseases means that we need to learn how to deal
      with challenges at a different level, including the use of systems approaches
      that better connect across fragments, such as disciplines, stakeholders,
      institutions, and technologies. By learning from progress in leading areas of
      health innovation (including oncology and AIDS), as well as complementary
      indications (Alzheimer’s disease), I try to extract the most enabling innovation 
      paradigms, and discuss their extension to additional areas of application within 
      a systems approach. To facilitate such work, a Precision, P4 or Systems Medicine 
      platform is proposed, which is centered on the representation of health states
      that enable the definition of time in the vision to provide the right
      intervention for the right patient at the right time and dose. Modeling of such
      health states should allow iterative optimization, as longitudinal human data
      accumulate. This platform is designed to facilitate the discovery of links
      between opportunities related to a) the modernization of diagnosis, including the
      increased use of omics profiling, b) patient-centric approaches enabled by
      technology convergence, including digital health and connected devices, c)
      increasing understanding of the pathobiological, clinical and health economic
      aspects of disease progression stages, d) design of new interventions, including 
      therapies as well as preventive measures, including sequential intervention
      approaches. Probabilistic Markov models of health states, e.g. those used for
      health economic analysis, are discussed as a simple starting point for the
      platform. A path towards extension into other indications, data types and uses is
      discussed, with a focus on regenerative medicine and relevant pathobiology.
FAU - Rebhan, Michael
AU  - Rebhan M
AUID- ORCID: 0000-0002-0890-9492
AD  - Novartis Institutes for Biomedical Research, Basel, 4056, Switzerland
LA  - eng
PT  - Journal Article
DEP - 20170323
PHST- 2017/03/21 [accepted]
TA  - F1000Res
JT  - F1000Research
AID - 10.12688/f1000research.11085.1 [doi]
SO  - F1000Res. 2017 Mar 23;6:. doi:10.12688/f1000research.11085.1.

PMC - PMC5434828
PMID- 28342214
IS  - 1065-9471 (Print)
IS  - 1097-0193 (Electronic)
VI  - 38
IP  - 6
DP  - 2017 Jun
TI  - Real‐time fMRI neurofeedback in adolescents with attention deficit hyperactivity 
      disorder.
PG  - 3190-209
AB  - Attention Deficit Hyperactivity Disorder (ADHD) is associated with poor
      self‐control, underpinned by inferior fronto‐striatal deficits. Real‐time
      functional magnetic resonance neurofeedback (rtfMRI‐NF) allows participants to
      gain self‐control over dysregulated brain regions. Despite evidence for
      beneficial effects of electrophysiological‐NF on ADHD symptoms, no study has
      applied the spatially superior rtfMRI‐NF neurotherapy to ADHD. A randomized
      controlled trial tested the efficacy of rtfMRI‐NF of right inferior prefrontal
      cortex (rIFG), a key region that is compromised in ADHD and upregulated with
      psychostimulants, on improvement of ADHD symptoms, cognition, and inhibitory fMRI
      activation. To control for region‐specificity, an active control group received
      rtfMRI‐NF of the left parahippocampal gyrus (lPHG). Thirty‐one ADHD boys were
      randomly allocated and had to learn to upregulate their target brain region in an
      average of 11 rtfMRI‐NF runs over 2 weeks. Feedback was provided through a
      video‐clip of a rocket that had to be moved up into space. A transfer session
      without feedback tested learning retention as a proximal measure of transfer to
      everyday life. Both NF groups showed significant linear activation increases with
      increasing number of runs in their respective target regions and significant
      reduction in ADHD symptoms after neurotherapy and at 11‐month follow‐up. Only the
      group targeting rIFG, however, showed a transfer effect, which correlated with
      ADHD symptom reductions, improved at trend level in sustained attention, and
      showed increased IFG activation during an inhibitory fMRI task. This
      proof‐of‐concept study demonstrates for the first time feasibility, safety, and
      shorter‐ and longer‐term efficacy of rtfMRI‐NF of rIFG in adolescents with ADHD. 
      Hum Brain Mapp 38:3190–3209, 2017. © 2017 The Authors Human Brain Mapping
      Published by Wiley Periodicals, Inc.
FAU - Alegria, Analucia A.
AU  - Alegria AA
AD  - Department of Child and Adolescent PsychiatryInstitute of Psychiatry, Psychology 
      and Neuroscience, King's College LondonLondonUnited Kingdom
FAU - Wulff, Melanie
AU  - Wulff M
AD  - Department of Child and Adolescent PsychiatryInstitute of Psychiatry, Psychology 
      and Neuroscience, King's College LondonLondonUnited Kingdom
FAU - Brinson, Helen
AU  - Brinson H
AD  - Department of Child and Adolescent PsychiatryInstitute of Psychiatry, Psychology 
      and Neuroscience, King's College LondonLondonUnited Kingdom
FAU - Barker, Gareth J.
AU  - Barker GJ
AD  - Centre for Neuroimaging Science, Institute of Psychiatry, Psychology and
      Neuroscience, King's College LondonLondonUnited Kingdom
FAU - Norman, Luke J.
AU  - Norman LJ
AD  - Department of Child and Adolescent PsychiatryInstitute of Psychiatry, Psychology 
      and Neuroscience, King's College LondonLondonUnited Kingdom
FAU - Brandeis, Daniel
AU  - Brandeis D
AD  - Department of Child and Adolescent Psychiatry and PsychotherapyCentral Institute 
      of Mental Health, Medical Faculty Mannheim/Heidelberg UniversityMannheimGermany
FAU - Stahl, Daniel
AU  - Stahl D
AD  - Department of BiostatisticsKing's College LondonLondonUnited Kingdom
FAU - David, Anthony S.
AU  - David AS
AD  - Department of Psychosis StudiesInstitute of Psychiatry, Psychology and
      Neuroscience King's College LondonLondonUnited Kingdom
FAU - Taylor, Eric
AU  - Taylor E
AD  - Department of Child and Adolescent PsychiatryInstitute of Psychiatry, Psychology 
      and Neuroscience, King's College LondonLondonUnited Kingdom
FAU - Giampietro, Vincent
AU  - Giampietro V
AD  - Centre for Neuroimaging Science, Institute of Psychiatry, Psychology and
      Neuroscience, King's College LondonLondonUnited Kingdom
FAU - Rubia, Katya
AU  - Rubia K
AUID- ORCID: 0000-0002-1410-7701
AD  - Department of Child and Adolescent PsychiatryInstitute of Psychiatry, Psychology 
      and Neuroscience, King's College LondonLondonUnited Kingdom
LA  - eng
PT  - Journal Article
DEP - 20170325
GR  - 1890 (KR)
PHST- 2016/12/16 [received]
PHST- 2017/03/06 [revised]
PHST- 2017/03/13 [accepted]
TA  - Hum Brain Mapp
JT  - Human Brain Mapping
AID - 10.1002/hbm.23584 [doi]
AID - HBM23584 [pii]
SO  - Hum Brain Mapp. 2017 Jun;38(6):3190-209. Epub 2017 Mar 25 doi:10.1002/hbm.23584.

PMC - PMC4448140
PMID- 25951836
IS  - 0031-9155 (Print)
IS  - 1361-6560 (Electronic)
VI  - 60
IP  - 10
DP  - 2015 May 21
TI  - Functional Optical Coherence Tomography: Principles and Progress.
PG  - R211-37
AB  - In the past decade, several functional extensions of optical coherence tomography
      (OCT) have emerged, and this review highlights key advances in instrumentation,
      theoretical analysis, signal processing and clinical application of these
      extensions. We review five principal extensions: Doppler OCT (DOCT),
      polarization-sensitive OCT (PS-OCT), optical coherence elastography (OCE),
      spectroscopic OCT (SOCT), and molecular imaging OCT. The former three have been
      further developed with studies in both ex vivo and in vivo human tissues. This
      review emphasizes the newer techniques of SOCT and molecular imaging OCT, which
      show excellent potential for clinical application but have yet to be well
      reviewed in the literature. SOCT elucidates tissue characteristics, such as
      oxygenation and carcinogenesis, by detecting wavelength-dependent absorption and 
      scattering of light in tissues. While SOCT measures endogenous biochemical
      distributions, molecular imaging OCT detects exogenous molecular contrast agents.
      These newer advances in functional OCT broaden the potential clinical application
      of OCT by providing novel ways to understand tissue activity that cannot be
      accomplished by other current imaging methodologies.
FAU - Kim, Jina
AU  - Kim J
AD  - Department of Surgery, Duke University, Durham, NC 27710
FAU - Brown, William
AU  - Brown W
AD  - Department of Biomedical Engineering, Duke University, Durham, NC 27708
FAU - Maher, Jason R.
AU  - Maher JR
AD  - Department of Biomedical Engineering, Duke University, Durham, NC 27708
FAU - Levinson, Howard
AU  - Levinson H
AD  - Department of Surgery, Duke University, Durham, NC 27710
FAU - Wax, Adam
AU  - Wax A
AD  - Department of Biomedical Engineering, Duke University, Durham, NC 27708
LA  - eng
PT  - Journal Article
DEP - 20150508
TA  - Phys Med Biol
JT  - Physics in medicine and biology
AID - 10.1088/0031-9155/60/10/R211 [doi]
MID - NIHMS691500
SO  - Phys Med Biol. 2015 May 21;60(10):R211-37. Epub 2015 May 08
      doi:10.1088/0031-9155/60/10/R211.

PMC - PMC1737332
IS  - 0022-3050 (Print)
IS  - 1468-330X (Electronic)
VI  - 70
IP  - 5
DP  - 2001 May
TI  - The Volitional Brain: towards a neuroscience of free will.
PG  - 709
FAU - STONE, J.
AU  - STONE J
LA  - eng
PT  - Journal Article
TA  - J Neurol Neurosurg Psychiatry
JT  - Journal of Neurology, Neurosurgery, and Psychiatry
AID - 10.1136/jnnp.70.5.709c [doi]
SO  - J Neurol Neurosurg Psychiatry. 2001 May;70(5):709. doi:10.1136/jnnp.70.5.709c.

PMC - PMC1737342
IS  - 0022-3050 (Print)
IS  - 1468-330X (Electronic)
VI  - 70
IP  - 5
DP  - 2001 May
TI  - Botulinum toxin type A in pain management.
PG  - 709
FAU - SCHOTT, G
AU  - SCHOTT G
LA  - eng
PT  - Journal Article
TA  - J Neurol Neurosurg Psychiatry
JT  - Journal of Neurology, Neurosurgery, and Psychiatry
AID - 10.1136/jnnp.70.5.709e [doi]
SO  - J Neurol Neurosurg Psychiatry. 2001 May;70(5):709. doi:10.1136/jnnp.70.5.709e.

PMC - PMC2834963
PMID- 18724191
IS  - 1525-4135 (Print)
IS  - 1944-7884 (Electronic)
VI  - 49
IP  - Suppl 1
DP  - 2008 Sep 1
TI  - Designing an Audio Computer-Assisted Self-Interview System in a Multisite Trial: 
      A Brief Report.
PG  - S52-8
AB  - Objective: To describe the advantages and limitations of an ACASI system in a
      multisite trial with African American couples and to present the steps in
      designing, testing, and implementing a system. Methods: The ACASI system evolved 
      from a paper and pencil interview (PAPI) that was pilot tested. Based on this
      initial work, the PAPI was translated into story boards that were the basis of
      the development of ACASI system. Story Boards consisted of one page per question 
      and provided the programmers with the test of the question, valid responses, and 
      any instructions that were to be read to the participants. Story boards were
      further translated into flow diagrams representing each module of the survey and 
      illustrating the skip patterns used to navigate a participant through the survey.
      Provisions were also made to insert a face-to-face interview, into the ACASI
      assessment process, to elicit sexual abuse history data which typically requires 
      specially trained data collectors with active listening skills in order to help
      participants reframe and coordinate times, places and emotionally difficult
      memories. Results: The ACASI was successfully developed and implemented in the
      main trial. During an exit interview, respondents indicated that they liked using
      the ACASI and indicating that they favored it as the method to answer questions. 
      Conclusions: It is feasible to implement an ACASI system in a multisite study in 
      a timely and efficient way.
CN  - NIMH Multisite HIV/STD Prevention Trial for African American Couples Group
AD  - NIMH Multisite HIV/STD Prevention Trial for African American Couples, Center for 
      Mental Health Research on AIDS, Division of AIDS and Health and Behavior
      Research, National Institiutes of Mental Health, National Institutes of Health,
      6001 Executive Boulevard, Room 6219B, Bethesda, MD 20892 (wpequegn@mail.nih.gov).
LA  - eng
PT  - Journal Article
TA  - J Acquir Immune Defic Syndr
JT  - Journal of acquired immune deficiency syndromes (1999)
AID - 10.1097/QAI.0b013e318184481a [doi]
MID - NIHMS170518
SO  - J Acquir Immune Defic Syndr. 2008 Sep 1;49(Suppl 1):S52-8.
      doi:10.1097/QAI.0b013e318184481a.

PMC - PMC4840059
PMID- 26689309
IS  - 0096-1523 (Print)
IS  - 1939-1277 (Electronic)
VI  - 42
IP  - 5
DP  - 2016 May
TI  - Effective Scheduling of Looking and Talking During Rapid Automatized Naming.
PG  - 742-60
AB  - Rapid Automatized Naming (RAN) is strongly related to literacy gains in
      developing readers, reading disabilities and reading ability in children and
      adults. Because successful RAN performance depends on the close coordination of a
      number of abilities, it is unclear what specific skills drive this RAN-reading
      relationship. The current study used concurrent recordings of young adult
      participants’ vocalizations and eye movements during the RAN task to assess how
      individual variation in RAN performance depends on the coordination of visual and
      vocal processes. Results showed that fast RAN times are facilitated by having the
      eyes one or more items ahead of the current vocalization, as long as the eyes do 
      not get so far ahead of the voice as to require a regressive eye movement to an
      earlier item. These data suggest that optimizing RAN performance is a problem of 
      scheduling eye movements and vocalization given memory constraints and the
      efficiency of encoding and articulatory control. Both RAN completion time
      (conventionally used to indicate RAN performance) and eye-voice relations
      predicted some aspects of participants’ eye movements on a separate sentence
      reading task. However, eye-voice relations predicted additional features of
      first-pass reading that were not predicted by RAN completion time. This shows
      that measurement of eye-voice patterns can identify important aspects of
      individual variation in reading that are not identified by the standard measure
      of RAN performance. We argue that RAN performance predicts reading ability
      because both tasks entail challenges of scheduling cognitive and linguistic
      processes that operate simultaneously on multiple linguistic inputs.
FAU - Gordon, Peter C.
AU  - Gordon PC
FAU - Hoedemaker, Renske S.
AU  - Hoedemaker RS
LA  - eng
PT  - Journal Article
DEP - 20151221
TA  - J Exp Psychol Hum Percept Perform
JT  - Journal of experimental psychology. Human perception and performance
AID - 10.1037/xhp0000171 [doi]
MID - NIHMS734423
SO  - J Exp Psychol Hum Percept Perform. 2016 May;42(5):742-60. Epub 2015 Dec 21
      doi:10.1037/xhp0000171.

PMC - PMC1737329
IS  - 0022-3050 (Print)
IS  - 1468-330X (Electronic)
VI  - 70
IP  - 5
DP  - 2001 May
TI  - Multiple sclerosis.
PG  - 709
FAU - HAWKINS, C.
AU  - HAWKINS C
LA  - eng
PT  - Journal Article
TA  - J Neurol Neurosurg Psychiatry
JT  - Journal of Neurology, Neurosurgery, and Psychiatry
AID - 10.1136/jnnp.70.5.709b [doi]
SO  - J Neurol Neurosurg Psychiatry. 2001 May;70(5):709. doi:10.1136/jnnp.70.5.709b.

PMC - PMC1737337
IS  - 0022-3050 (Print)
IS  - 1468-330X (Electronic)
VI  - 70
IP  - 5
DP  - 2001 May
TI  - Neuromuscular diseases: from basic mechanisms to clinical management. Monographs 
      in clinical neurosciences. Volume 18.
PG  - 709
FAU - HANNA, M.
AU  - HANNA M
LA  - eng
PT  - Journal Article
TA  - J Neurol Neurosurg Psychiatry
JT  - Journal of Neurology, Neurosurgery, and Psychiatry
AID - 10.1136/jnnp.70.5.709d [doi]
SO  - J Neurol Neurosurg Psychiatry. 2001 May;70(5):709. doi:10.1136/jnnp.70.5.709d.

PMC - PMC4605037
PMID- 26504628
IS  - 2156-7085 (Electronic)
VI  - 6
IP  - 10
DP  - 2015 Oct 01
TI  - Review of fluorescence guided surgery visualization and overlay techniques.
PG  - 3765-82
AB  - In fluorescence guided surgery, data visualization represents a critical step
      between signal capture and display needed for clinical decisions informed by that
      signal. The diversity of methods for displaying surgical images are reviewed, and
      a particular focus is placed on electronically detected and visualized signals,
      as required for near-infrared or low concentration tracers. Factors driving the
      choices such as human perception, the need for rapid decision making in a
      surgical environment, and biases induced by display choices are outlined. Five
      practical suggestions are outlined for optimal display orientation, color map,
      transparency/alpha function, dynamic range compression, and color perception
      check.
FAU - Elliott, Jonathan T.
AU  - Elliott JT
AD  - Thayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover,
      NH 03755, USA
FAU - Dsouza, Alisha V.
AU  - Dsouza AV
AD  - Thayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover,
      NH 03755, USA
FAU - Davis, Scott C.
AU  - Davis SC
AD  - Thayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover,
      NH 03755, USA
FAU - Olson, Jonathan D.
AU  - Olson JD
AD  - Neurosurgery Section, Dartmouth-Hitchcock Medical Center, 1 Medical Center Drive,
      Lebanon, NH 03766, USA
FAU - Paulsen, Keith D.
AU  - Paulsen KD
AD  - Thayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover,
      NH 03755, USA
FAU - Roberts, David W.
AU  - Roberts DW
AD  - Neurosurgery Section, Dartmouth-Hitchcock Medical Center, 1 Medical Center Drive,
      Lebanon, NH 03766, USA
FAU - Pogue, Brian W.
AU  - Pogue BW
AD  - Thayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover,
      NH 03755, USA
LA  - eng
PT  - Journal Article
DEP - 20150903
GR  - R01CA109558
PHST- 2015/06/30 [received]
PHST- 2015/08/26 [revised]
PHST- 2015/09/01 [accepted]
TA  - Biomed Opt Express
JT  - Biomedical Optics Express
AID - 243885 [pii]
AID - 10.1364/BOE.6.003765 [doi]
SO  - Biomed Opt Express. 2015 Sep 03;6(10):3765-82. doi:10.1364/BOE.6.003765.

PMC - PMC3943174
PMID- 24600516
IS  - 2000-5121 (Electronic)
VI  - 5
DP  - 2014
TI  - An emerging interface between life science and nanotechnology: present status and
      prospects of reproductive healthcare aided by nano-biotechnology.
LID - 10.3402/nano.v5.22762
AB  - Among the various applications of nano-biotechnology, healthcare is considered
      one of the most significant domains. For that possibility to synthesize various
      kind of nanoparticles (NPs) and the ever-increasing ability to control their size
      as well as structure, to improve surface characteristics and binding NPs with
      other desired curing agents has played an important role. In this paper, a brief 
      sketch of various kinds of nanomaterials and their biomedical applications is
      given. Despite claims of bio-nanotechnology about to touch all areas of medical
      science, information pertaining to the role of nanotechnology for the betterment 
      of reproductive healthcare is indeed limited. Therefore, the various achievements
      of nano-biotechnology for healthcare in general have been illustrated while
      giving special insight into the role of nano-biotechnology for the future of
      reproductive healthcare betterment as well as current achievements of nanoscience
      and nanotechnology in this arena.
FAU - Jha, Rakhi K.
AU  - Jha RK
AD  - School of Medical Science and Technology, Indian Institute of Technology
      Kharagpur, India
FAU - Jha, Pradeep K.
AU  - Jha PK
AD  - School of Medical Science and Technology, Indian Institute of Technology
      Kharagpur, India
FAU - Chaudhury, Koel
AU  - Chaudhury K
AD  - School of Medical Science and Technology, Indian Institute of Technology
      Kharagpur, India
FAU - Rana, Suresh V.S.
AU  - Rana SV
AD  - Toxicology Laboratory, CCS University, Meerut, India
FAU - Guha, Sujoy K.
AU  - Guha SK
AD  - School of Medical Science and Technology, Indian Institute of Technology
      Kharagpur, India
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20140226
PHST- 2013/09/05 [received]
PHST- 2014/01/14 [revised]
PHST- 2014/01/19 [accepted]
TA  - Nano Rev
JT  - Nano Reviews
AID - 22762 [pii]
AID - 10.3402/nano.v5.22762 [doi]
SO  - Nano Rev. 2014 Feb 26;5:. doi:10.3402/nano.v5.22762.

PMC - PMC2020607
PMID- 18333003
IS  - 1365-182X (Print)
IS  - 1477-2574 (Electronic)
VI  - 5
IP  - Suppl 1
DP  - 2003
TI  - Free Papers.
PG  - 23-87
LA  - eng
PT  - Journal Article
TA  - HPB (Oxford)
JT  - HPB : The Official Journal of the International Hepato Pancreato Biliary
      Association
AID - 05-023S [pii]
SO  - HPB (Oxford). 2003;5(Suppl 1):23-87.

PMC - PMC4763338
PMID- 26019171
IS  - 1078-0432 (Print)
VI  - 21
IP  - 17
DP  - 2015 Sep 1
TI  - MR-Guided Near-Infrared Spectral Tomography Increases Diagnostic Performance of
      Breast MRI.
PG  - 3906-12
AB  - Purpose: The purpose of this study was to determine the diagnostically most
      important molecular biomarkers quantified by magnetic resonance-guided (MR)
      near-infrared spectral tomography (NIRST) that distinguish malignant breast
      lesions from benign abnormalities when combined with outcomes from clinical
      breast MRI. Experimental Design: The study was HIPAA compliant and approved by
      the Dartmouth Institutional Review Board, the NIH, the United States State
      Department, and Xijing Hospital. MR-guided NIRST evaluated hemoglobin, water, and
      lipid content in regions of interest defined by concurrent dynamic
      contrast-enhanced MRI (DCE-MRI) in the breast. MRI plus NIRST was performed in 44
      subjects (median age, 46, age range, 20–81 years), 28 of whom had subsequent
      malignant pathologic diagnoses, and 16 had benign conditions. A subset of 30
      subject examinations yielded optical data that met minimum sensitivity
      requirements to the suspicious lesion and were included in the analyses of
      diagnostic performance. Results: In the subset of 30 subject examinations meeting
      minimum optical data sensitivity criterion, the MR-guided NIRST separated
      malignant from benign lesions using total hemoglobin (HbT; P < 0.01) and tissue
      optical index (TOI; P < 0.001). Combined MRI plus TOI data caused one false
      positive and 1 false negative, and produced the best diagnostic performance,
      yielding an AUC of 0.95, sensitivity of 95%, specificity of 89%, positive
      predictive value of 95%, and negative predictive value of 89%, respectively.
      Conclusions: MRI plus NIRST results correlated well with histopathologic
      diagnoses and could provide additional information to reduce the number of
      MRI-directed biopsies.
FAU - Mastanduno, Michael A.
AU  - Mastanduno MA
AD  - Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire
FAU - Xu, Junqing
AU  - Xu J
AD  - Department of Radiology, Xijing Hospital, Xi’an, China
FAU - El-Ghussein, Fadi
AU  - El-Ghussein F
AD  - Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire
FAU - Jiang, Shudong
AU  - Jiang S
AD  - Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire
FAU - Yin, Hong
AU  - Yin H
AD  - Department of Radiology, Xijing Hospital, Xi’an, China
FAU - Zhao, Yan
AU  - Zhao Y
AD  - Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire
FAU - Wang, Ke
AU  - Wang K
AD  - Department of Radiology, Xijing Hospital, Xi’an, China
FAU - Ren, Fang
AU  - Ren F
AD  - Department of Radiology, Xijing Hospital, Xi’an, China
FAU - Gui, Jiang
AU  - Gui J
AD  - Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth
      College, Hanover, New Hampshire
FAU - Pogue, Brian W.
AU  - Pogue BW
AD  - Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire
FAU - Paulsen, Keith D.
AU  - Paulsen KD
AD  - Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire
LA  - eng
PT  - Journal Article
DEP - 20150527
TA  - Clin Cancer Res
JT  - Clinical cancer research : an official journal of the American Association for
      Cancer Research
AID - 10.1158/1078-0432.CCR-14-2546 [doi]
MID - NIHMS715744
SO  - Clin Cancer Res. 2015 Sep 1;21(17):3906-12. Epub 2015 May 27
      doi:10.1158/1078-0432.CCR-14-2546.

PMC - PMC4679002
PMID- 26504211
IS  - 0027-8424 (Print)
IS  - 1091-6490 (Electronic)
VI  - 112
IP  - 49
DP  - 2015 Dec 8
TI  - Behavioral assessment of sensitivity to intracortical microstimulation of primate
      somatosensory cortex.
PG  - 15202-7
AB  - Electrical stimulation of sensory structures in the brain is a powerful tool to
      investigate neural circuits and may provide a means to restore sensation for
      patients for whom stimulation of the nerve is not an option. For both purposes,
      however, it is critical to understand how the design of the stimulation shapes
      the evoked sensory experience. With this in mind, we investigate the ability of
      monkeys to detect and discriminate trains of electrical pulses delivered to their
      somatosensory cortex through chronically implanted electrode arrays. We show that
      artificial touch is highly dependent on various features of the electrical
      stimuli and discuss the implications of our results for the use of electrical
      stimulation in neuroscience and neural engineering.
OAB - Publisher: Abstract available from the publisher.
FAU - Kim, Sungshin
AU  - Kim S
AD  - Department of Organismal Biology and Anatomy, University of Chicago, Chicago, IL 
      60637;
FAU - Callier, Thierri
AU  - Callier T
AD  - Department of Organismal Biology and Anatomy, University of Chicago, Chicago, IL 
      60637;
FAU - Tabot, Gregg A.
AU  - Tabot GA
AD  - Committee on Computational Neuroscience, University of Chicago, Chicago, IL
      60637;
FAU - Gaunt, Robert A.
AU  - Gaunt RA
AD  - Department of Physical Medicine and Rehabilitation, University of Pittsburgh,
      Pittsburgh, PA 15213;
FAU - Tenore, Francesco V.
AU  - Tenore FV
AD  - Research and Exploratory Development Department, Applied Physics Laboratory,
      Johns Hopkins University, Laurel, MD 20723
FAU - Bensmaia, Sliman J.
AU  - Bensmaia SJ
AD  - Department of Organismal Biology and Anatomy, University of Chicago, Chicago, IL 
      60637;
LA  - eng
PT  - Journal Article
DEP - 20151026
GR  - N66001-10-C-4056
PHST- 2015/10/26 [aheadofprint]
TA  - Proc Natl Acad Sci U S A
JT  - Proceedings of the National Academy of Sciences of the United States of America
AID - 201509265 [pii]
AID - 10.1073/pnas.1509265112 [doi]
SO  - Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):15202-7. Epub 2015 Oct 26
      doi:10.1073/pnas.1509265112.

PMC - PMC4732705
PMID- 26554491
IS  - 1050-0545 (Print)
IS  - 2157-3107 (Electronic)
VI  - 26
IP  - 10
DP  - 2015 Nov-Dec
TI  - Construct Validity of the Ecological Momentary Assessment in Audiology Research.
PG  - 872-84
AB  - Background: Ecological momentary assessment (EMA) is a methodology involving
      repeated assessments/surveys to collect data describing respondents’ current or
      very recent experiences and related contexts in their natural environments. The
      use of EMA in audiology research is growing. Purpose: This study examined the
      construct validity (i.e., the degree to which a measurement reflects what it is
      intended to measure) of EMA in terms of measuring speech understanding and
      related listening context. Experiment 1 investigated the extent to which
      individuals can accurately report their speech recognition performance and
      characterize the listening context in controlled environments. Experiment 2
      investigated whether the data aggregated across multiple EMA surveys conducted in
      uncontrolled, real-world environments would reveal a valid pattern that was
      consistent with the established relationships between speech understanding,
      hearing aid use, listening context, and lifestyle. Research Design: This is an
      observational study. Study Sample: Twelve and twenty-seven adults with hearing
      impairment participated in Experiments 1 and 2, respectively. Data Collection and
      Analysis: In the laboratory testing of Experiment 1, participants estimated their
      speech recognition performance in settings wherein the signal-to-noise ratio was 
      fixed or constantly varied across sentences. In the field testing the
      participants reported the listening context (e.g., noisiness level) of several
      semicontrolled real-world conversations. Their reports were compared to (1) the
      context described by normal-hearing observers and (2) the background noise level 
      measured using a sound level meter. In Experiment 2, participants repeatedly
      reported the degree of speech understanding, hearing aid use, and listening
      context using paper-and-pencil journals in their natural environments for 1 week.
      They also carried noise dosimeters to measure the sound level. The associations
      between (1) speech understanding, hearing aid use, and listening context, (2)
      dosimeter sound level and self-reported noisiness level, and (3) dosimeter data
      and lifestyle quantified using the journals were examined. Results: For
      Experiment 1, the reported and measured speech recognition scores were highly
      correlated across all test conditions (r = 0.94 to 0.97). The field testing
      results revealed that most listening context properties reported by the
      participants were highly consistent with those described by the observers (74–95%
      consistency), except for noisiness rating (58%). Nevertheless, higher noisiness
      rating was associated with higher background noise level. For Experiment 2, the
      EMA results revealed several associations: better speech understanding was
      associated with the use of hearing aids, front-located speech, and lower
      dosimeter sound level; higher noisiness rating was associated with higher
      dosimeter sound level; listeners with more diverse lifestyles tended to have
      higher dosimeter sound levels. Conclusions: Adults with hearing impairment were
      able to report their listening experiences, such as speech understanding, and
      characterize listening context in controlled environments with reasonable
      accuracy. The pattern of the data aggregated across multiple EMA surveys
      conducted in a wide range of uncontrolled real-world environment was consistent
      with the established knowledge in audiology. The two experiments suggested that, 
      regarding speech understanding and related listening contexts, EMA reflects what 
      it is intended to measure, supporting its construct validity in audiology
      research.
FAU - Wu, Yu-Hsiang
AU  - Wu YH
AD  - Department of Communication Sciences and Disorders, The University of Iowa, Iowa 
      City, IA 52242
FAU - Stangl, Elizabeth
AU  - Stangl E
AD  - Department of Communication Sciences and Disorders, The University of Iowa, Iowa 
      City, IA 52242
FAU - Zhang, Xuyang
AU  - Zhang X
AD  - Department of Communication Sciences and Disorders, The University of Iowa, Iowa 
      City, IA 52242
FAU - Bentler, Ruth A.
AU  - Bentler RA
AD  - Department of Communication Sciences and Disorders, The University of Iowa, Iowa 
      City, IA 52242
LA  - eng
PT  - Journal Article
TA  - J Am Acad Audiol
JT  - Journal of the American Academy of Audiology
AID - 10.3766/jaaa.15034 [doi]
MID - NIHMS754203
SO  - J Am Acad Audiol. 2015 Nov-Dec;26(10):872-84. doi:10.3766/jaaa.15034.

PMC - PMC2557557
IS  - 0007-0920 (Print)
IS  - 1532-1827 (Electronic)
VI  - 85
IP  - Suppl 1
DP  - 2001
TI  - Poster presentations.
PG  - 33-109
LA  - eng
PT  - Journal Article
TA  - Br J Cancer
JT  - British Journal of Cancer
AID - 6691918 [pii]
AID - 10.1054/bjoc.2001.1918 [doi]
SO  - Br J Cancer. 2001;85(Suppl 1):33-109. doi:10.1054/bjoc.2001.1918.

PMC - PMC2020689
IS  - 1365-182X (Print)
IS  - 1477-2574 (Electronic)
VI  - 6
IP  - Suppl 1
DP  - 2004
TI  - IHPBA World Congress abstracts – Free Papers and Videos.
PG  - 1-64
LA  - eng
PT  - Journal Article
TA  - HPB (Oxford)
JT  - HPB : The Official Journal of the International Hepato Pancreato Biliary
      Association
AID - 10.1080/16515320410032700 [doi]
AID - 06-001S [pii]
SO  - HPB (Oxford). 2004;6(Suppl 1):1-64. doi:10.1080/16515320410032700.

PMC - PMC4734754
PMID- 26843894
IS  - 1810-6838 (Print)
IS  - 2073-4735 (Electronic)
VI  - 10
IP  - 3
DP  - 2014 Sep
TI  - Delivering telemedicine interventions in chronic respiratory disease.
PG  - 198-212
FAU - Hernandez, Carme
AU  - Hernandez C
AD  - Integrated Care Unit, Hospital Clinic, Barcelona Spain
FAU - Mallow, Jennifer
AU  - Mallow J
AD  - School of Nursing and West Virginia Clinical Translational Science Institute
      (WVCTSI), West Virginia University (WVU), Morgantown, WV, USA
FAU - Narsavage, Georgia L.
AU  - Narsavage GL
AD  - Robert C. Byrd Health Sciences Center, Mary Babb Randolph Cancer Center, and
      WVCTSI, West Virginia University, Morgantown, WV, USA
LA  - eng
PT  - Journal Article
TA  - Breathe (Sheff)
JT  - Breathe (Sheffield, England)
AID - 10.1183/20734735.008314 [doi]
MID - NIHMS692903
SO  - Breathe (Sheff). 2014 Sep;10(3):198-212. doi:10.1183/20734735.008314.

PMC - PMC3990041
PMID- 24782745
IS  - 1662-5161 (Electronic)
VI  - 8
DP  - 2014
TI  - Harnessing the neuroplastic potential of the human brain & the future of
      cognitive rehabilitation.
LID - 218
FAU - Mishra, Jyoti
AU  - Mishra J
FAU - Gazzaley, Adam
AU  - Gazzaley A
LA  - eng
PT  - Journal Article
PT  - Editorial
DEP - 20140411
PHST- 2013/12/30 [received]
PHST- 2014/03/27 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2014.00218 [doi]
SO  - Front Hum Neurosci. 2014 Apr 11;8:. doi:10.3389/fnhum.2014.00218.

PMC - PMC3623275
PMID- 22015921
IS  - 1474-1776 (Print)
IS  - 1474-1784 (Electronic)
VI  - 10
IP  - 11
TI  - Perspectives and opportunities for nanomedicine in the management of
      atherosclerosis.
PG  - 835-52
AB  - The use of nanotechnology for medical purposes — nanomedicine — has grown
      exponentially over the past few decades. This is exemplified by the US Food and
      Drug Administration’s approval of several nanotherapies for various conditions,
      as well as the funding of nanomedical programmes worldwide. Although originally
      the domain of anticancer therapy, recent advances have illustrated the
      considerable potential of nanomedicine in the diagnosis and treatment of
      atherosclerosis. This Review elaborates on nanoparticle-targeting concepts in
      atherosclerotic disease, provides an overview of the use of nanomedicine in
      atherosclerosis, and discusses potential future applications and clinical
      benefits.
FAU - Lobatto, Mark E.
AU  - Lobatto ME
AD  - Translational and Molecular Imaging Institute, Mount Sinai School of Medicine,
      One Gustave L. Levy Place, BOX 1234, New York 10029, USA.
FAU - Fuster, Valentin
AU  - Fuster V
AD  - Department of Cardiology, Zena and Michael A. Weiner Cardiovascular Institute and
      Marie-Josée and Henry R. Kravis Cardiovascular Health Center, Mount Sinai School 
      of Medicine, One Gustave L. Levy Place, New York 10029, USA.
FAU - Fayad, Zahi A.
AU  - Fayad ZA
AD  - Translational and Molecular Imaging Institute, Mount Sinai School of Medicine,
      One Gustave L. Levy Place, BOX 1234, New York 10029, USA.
FAU - Mulder, Willem J. M.
AU  - Mulder WJM
AD  - Translational and Molecular Imaging Institute, Mount Sinai School of Medicine,
      One Gustave L. Levy Place, BOX 1234, New York 10029, USA.
LA  - eng
PT  - Journal Article
DEP - 20111021
GR  - R01 EB009638 || EB
TA  - Nat Rev Drug Discov
JT  - Nature reviews. Drug discovery
AID - 10.1038/nrd3578 [doi]
MID - NIHMS454555
SO  - Nat Rev Drug Discov. ;10(11):835-52. doi:10.1038/nrd3578.

PMC - PMC4582438
PMID- 26233020
IS  - 0001-4966 (Print)
IS  - 1520-8524 (Electronic)
VI  - 138
IP  - 1
DP  - 2015 Jul
TI  - Numerical calculation of listener-specific head-related transfer functions and
      sound localization: Microphone model and mesh discretization.
PG  - 208
AB  - Head-related transfer functions (HRTFs) can be numerically calculated by applying
      the boundary element method on the geometry of a listener’s head and pinnae. The 
      calculation results are defined by geometrical, numerical, and acoustical
      parameters like the microphone used in acoustic measurements. The scope of this
      study was to estimate requirements on the size and position of the microphone
      model and on the discretization of the boundary geometry as triangular polygon
      mesh for accurate sound localization. The evaluation involved the analysis of
      localization errors predicted by a sagittal-plane localization model, the
      comparison of equivalent head radii estimated by a time-of-arrival model, and the
      analysis of actual localization errors obtained in a sound-localization
      experiment. While the average edge length (AEL) of the mesh had a negligible
      effect on localization performance in the lateral dimension, the localization
      performance in sagittal planes, however, degraded for larger AELs with the
      geometrical error as dominant factor. A microphone position at an arbitrary
      position at the entrance of the ear canal, a microphone size of 1 mm radius, and 
      a mesh with 1 mm AEL yielded a localization performance similar to or better than
      observed with acoustically measured HRTFs.
FAU - Ziegelwanger, Harald
AU  - Ziegelwanger H
FAU - Majdak, Piotr
AU  - Majdak P
FAU - Kreuzer, Wolfgang
AU  - Kreuzer W
LA  - eng
PT  - Journal Article
TA  - J Acoust Soc Am
JT  - The Journal of the Acoustical Society of America
AID - 10.1121/1.4922518 [doi]
MID - EMS65195
SO  - J Acoust Soc Am. 2015 Jul;138(1):208. doi:10.1121/1.4922518.

PMC - PMC5116592
PMID- 27920469
IS  - 1007-9327 (Print)
IS  - 2219-2840 (Electronic)
VI  - 22
IP  - 43
DP  - 2016 Nov 21
TI  - Role of ultrasound in colorectal diseases.
PG  - 9477-87
AB  - Ultrasound is an undervalued non-invasive examination in the diagnosis of colonic
      diseases. It has been replaced by the considerably more expensive magnetic
      resonance imaging and computed tomography, despite the fact that, as first
      examination, it can usefully supplement the diagnostic process. Transabdominal
      ultrasound can provide quick information about bowel status and help in the
      choice of adequate further examinations and treatment. Ultrasonography, as a
      screening imaging modality in asymptomatic patients can identify several colonic 
      diseases such as diverticulosis, inflammatory bowel disease or cancer. In
      addition, it is widely available, cheap, non-invasive technique without the use
      of ionizing radiation, therefore it is safe to use in childhood or during
      pregnancy, and can be repeated at any time. New ultrasound techniques such as
      elastography, contrast enhanced and Doppler ultrasound, mini-probes rectal and
      transperineal ultrasonography have broadened the indication. It gives an overview
      of the methodology of various ultrasound examinations, presents the morphology of
      normal bowel wall and the typical changes in different colonic diseases. We will 
      pay particular attention to rectal and transperineal ultrasound because of their 
      outstanding significance in the diagnosis of rectal and perineal disorders. This 
      article seeks to overview the diagnostic impact and correct indications of bowel 
      ultrasound.
FAU - Bor, Renáta
AU  - Bor R
FAU - Fábián, Anna
AU  - Fábián A
FAU - Szepes, Zoltán
AU  - Szepes Z
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20161121
PHST- 2016/06/28 [received]
PHST- 2016/09/11 [revised]
PHST- 2016/10/19 [accepted]
PHST- 2016/11/21 [aheadofprint]
TA  - World J Gastroenterol
JT  - World Journal of Gastroenterology
AID - 10.3748/wjg.v22.i43.9477 [doi]
SO  - World J Gastroenterol. 2016 Nov 21;22(43):9477-87. Epub 2016 Nov 21
      doi:10.3748/wjg.v22.i43.9477.

PMC - PMC4346507
PMID- 25578293
IS  - 0021-9924 (Print)
IS  - 1873-7994 (Electronic)
VI  - 53
DP  - 2015 Jan-Feb
TI  - Online crowdsourcing for efficient rating of speech: A validation study.
PG  - 70-83
AB  - Blinded listener ratings are essential for valid assessment of interventions for 
      speech disorders, but collecting these ratings can be time-intensive and costly. 
      This study evaluated the validity of speech ratings obtained through online
      crowdsourcing, a potentially more efficient approach. 100 words from children
      with /r/ misarticulation were electronically presented for binary rating by 35
      phonetically trained listeners and 205 naïve listeners recruited through the
      Amazon Mechanical Turk (AMT) crowdsourcing platform. Bootstrapping was used to
      compare different-sized samples of AMT listeners against a “gold standard” (mode 
      across all trained listeners) and an “industry standard” (mode across
      bootstrapped samples of 3 trained listeners). There was strong overall agreement 
      between trained and AMT listeners. The “industry standard” level of performance
      was matched by bootstrapped samples with n = 9 AMT listeners. These results
      support the hypothesis that valid ratings of speech data can be obtained in an
      efficient manner through AMT. Researchers in communication disorders could
      benefit from increased awareness of this method.
FAU - Byun, Tara McAllister
AU  - Byun TM
FAU - Halpin, Peter F.
AU  - Halpin PF
FAU - Szeredi, Daniel
AU  - Szeredi D
LA  - eng
PT  - Journal Article
DEP - 20141215
TA  - J Commun Disord
JT  - Journal of communication disorders
AID - 10.1016/j.jcomdis.2014.11.003 [doi]
MID - NIHMS654904
SO  - J Commun Disord. 2015 Jan-Feb;53:70-83. Epub 2014 Dec 15
      doi:10.1016/j.jcomdis.2014.11.003.

PMC - PMC3558669
PMID- 23001156
IS  - 0028-1298 (Print)
IS  - 1432-1912 (Electronic)
VI  - 386
IP  - 2
DP  - 2013 Feb
TI  - Direct and indirect interactions of the dopamine D3 receptor with glutamate
      pathways: implications for the treatment of schizophrenia.
PG  - 107-24
AB  - This article, based on original data as well as on previously reported
      preclinical and clinical data that are reviewed, describes direct and indirect
      interactions of the D3 receptor with N-methyl-d-aspartate receptor (NMDA)
      signaling and their functional consequences and therapeutic implications for
      schizophrenia. D3 receptor immunoreactivity at ultrastructural level with
      electron microscopy was identified at presumably glutamatergic, asymmetric
      synapses of the medium-sized spiny neurons of the nucleus accumbens. This finding
      supports the existence of a direct interaction of the D3 receptor with glutamate,
      in line with previously described interactions with NMDA signaling involving
      Ca2+/calmodulin-dependent protein kinase II at post-synaptic densities (Liu et
      al. 2009). Indirect interactions of the D3 receptor with glutamate could involve 
      a negative control exerted by the D3 receptor on mesocortical dopamine neurons
      and the complex regulation of the glutamatergic pyramidal cells by dopamine in
      the prefrontal cortex. This could be exemplified here by the regulation of
      pyramidal cell activity in conditions of chronic NMDA receptor blockade with
      dizocilpine (MK-801). BP897, a D3 receptor-selective partial agonist, reversed
      the dysregulation of cortical c-fos mRNA expression and pyramidal cell
      hyperexcitability, as measured by paired-pulse electrophysiology. At the
      behavioral level, blockade of the D3 receptor, by known D3 receptor antagonists
      or the novel D3 receptor-selective antagonist F17141, produces antipsychotic-like
      effects in reversing hyperactivity and social interaction deficits induced by
      NMDA receptor blockade by MK-801 in mice. The glutamate–D3 receptor interactions 
      described here offer a conceptual framework for developing new D3
      receptor-selective drugs, which may appear as an original, efficacious, and safe 
      way to potentially indirectly target glutamate in schizophrenia.
FAU - Sokoloff, Pierre
AU  - Sokoloff P
AD  - Pierre Fabre Research Center, Castres, 81100 France
FAU - Leriche, Ludovic
AU  - Leriche L
AD  - Pierre Fabre Research Center, Castres, 81100 France
FAU - Diaz, Jorge
AU  - Diaz J
AD  - Neurobiology and Pharmacology (INSERM U573), Paris, 74014 France
FAU - Louvel, Jacques
AU  - Louvel J
AD  - Neurobiology and Pharmacology (INSERM U573), Paris, 74014 France
FAU - Pumain, René
AU  - Pumain R
AD  - Neurobiology and Pharmacology (INSERM U573), Paris, 74014 France
LA  - eng
PT  - Journal Article
DEP - 20120922
PHST- 2012/05/31 [received]
PHST- 2012/09/03 [accepted]
TA  - Naunyn Schmiedebergs Arch Pharmacol
JT  - Naunyn-Schmiedeberg's Archives of Pharmacology
AID - 797 [pii]
AID - 10.1007/s00210-012-0797-0 [doi]
SO  - Naunyn Schmiedebergs Arch Pharmacol. 2013 Feb;386(2):107-24. Epub 2012 Sep 22
      doi:10.1007/s00210-012-0797-0.

PMC - PMC3105334
PMID- 21643436
IS  - 1938-7989 (Print)
IS  - 1938-7997 (Electronic)
VI  - 3
IP  - 1
DP  - 2010
TI  - Evaluating Functional Autocorrelation within Spatially Distributed Neural
      Processing Networks*.
PG  - 45-58
AB  - Data-driven statistical approaches, such as cluster analysis or independent
      component analysis, applied to in vivo functional neuroimaging data help to
      identify neural processing networks that exhibit similar task-related or
      restingstate patterns of activity. Ideally, the measured brain activity for
      voxels within such networks should exhibit high autocorrelation. An important
      limitation is that the algorithms do not typically quantify or statistically test
      the strength or nature of the within-network relatedness between voxels. To
      extend the results given by such data-driven analyses, we propose the use of
      Moran’s I statistic to measure the degree of functional autocorrelation within
      identified neural processing networks and to evaluate the statistical
      significance of the observed associations. We adapt the conventional definition
      of Moran’s I, for applicability to neuroimaging analyses, by defining the global 
      autocorrelation index using network-based neighborhoods. Also, we compute
      network-specific contributions to the overall autocorrelation. We present results
      from a bootstrap analysis that provide empirical support for the use of our
      hypothesis testing framework. We illustrate our methodology using positron
      emission tomography (PET) data from a study that examines the neural
      representation of working memory among individuals with schizophrenia and
      functional magnetic resonance imaging (fMRI) data from a study of depression.
FAU - Derado, Gordana
AU  - Derado G
AD  - Department of Biostatistics and Bioinformatics, The Rollins School of Public
      Health, Emory University, gderado@emory.edu
FAU - Bowman, F. Dubois
AU  - Bowman FD
AD  - Department of Biostatistics and Bioinformatics, The Rollins School of Public
      Health, Emory University, dbowma3@sph.emory.edu
FAU - Ely, Timothy D.
AU  - Ely TD
AD  - Department of Psychiatry and Behavioral Sciences, School of Medicine, Emory
      University, tely01@emory.edu
FAU - Kilts, Clinton D.
AU  - Kilts CD
AD  - Department of Psychiatry and Behavioral Sciences, School of Medicine, Emory
      University, sdpcdk@emory.edu
LA  - eng
PT  - Journal Article
TA  - Stat Interface
JT  - Statistics and its interface
MID - NIHMS204664
SO  - Stat Interface. 2010;3(1):45-58.

PMC - PMC4689673
PMID- 26099166
IS  - 0021-9630 (Print)
IS  - 1469-7610 (Electronic)
TI  - Use of EEG biomarkers in child psychiatry research: current state and future
      directions.
LID - 10.1111/jcpp.12435
AB  - Background: Electroencephalography (EEG) and related measures have a long and
      productive history in child psychopathology research and are currently
      experiencing a renaissance in interest, particularly for use as putative
      biomarkers. Method and Scope: First, the recent history leading to the use of EEG
      measures as endophenotypes and biomarkers for disease and treatment response are 
      reviewed. Two key controversies within the area of non-invasive human
      electrophysiology research are discussed, and problems that currently either
      function as barriers or provide gateways to progress. First, the differences
      between the main types of EEG measurements (event related potentials,
      quantitative EEG, and time-frequency measures) and how they can contribute
      collectively to better understanding of cortical dynamics underlying cognition
      and behavior are highlighted. Second, we focus on the ongoing shift in analytic
      focus to specific cortical sources and source networks whose dynamics are
      relevant to the clinical and experimental focus of the study, and the effective
      increase in source signal-to-noise ratio (SNR) that may be obtained in the
      process. Conclusions: Understanding of these issues informs any discussion of
      current trends in EEG research. We highlight possible ways to evolve our
      understanding of brain dynamics beyond the apparent contradictions in
      understanding and modeling EEG activity highlighted by these controversies.
      Finally, we summarize some promising future directions of EEG biomarker research 
      in child psychopathology.
FAU - Loo, Sandra K.
AU  - Loo SK
AD  - Semel Neuropsychiatric Institute, David Geffen School of Medicine, UCLA, CA, USA
FAU - Lenartowicz, Agatha
AU  - Lenartowicz A
AD  - Semel Neuropsychiatric Institute, David Geffen School of Medicine, UCLA, CA, USA
FAU - Makeig, Scott
AU  - Makeig S
AD  - Swartz Center for Computational Neuroscience, UCSD, CA, USA
LA  - eng
PT  - Journal Article
DEP - 20150623
TA  - J Child Psychol Psychiatry
JT  - Journal of child psychology and psychiatry, and allied disciplines
AID - 10.1111/jcpp.12435 [doi]
MID - NIHMS694187
SO  - J Child Psychol Psychiatry. ;:. doi:10.1111/jcpp.12435.

PMC - PMC3848790
PMID- 19214804
IS  - 0893-7648 (Print)
IS  - 1559-1182 (Electronic)
VI  - 39
IP  - 2
DP  - 2009 Apr
TI  - The Fragile X Mental Retardation Protein in Circadian Rhythmicity and Memory
      Consolidation.
LID - 10.1007/s12035-009-8057-0
AB  - The control of new protein synthesis provides a means to locally regulate the
      availability of synaptic components necessary for dynamic neuronal processes. The
      Fragile X Mental Retardation Protein (FMRP), an RNA-binding translational
      regulator, is a key player mediating appropriate synaptic protein synthesis in
      response to neuronal activity levels. Loss of FMRP causes Fragile X Syndrome
      (FraX), the most commonly inherited form of mental retardation and autism
      spectrum disorders. FraX-associated translational dysregulation causes
      wide-ranging neurological deficits including severe impairments of biological
      rhythms, learning processes and memory consolidation. Dysfunction in cytoskeletal
      regulation and synaptic scaffolding disrupts neuronal architecture and functional
      synaptic connectivity. The understanding of this devastating disease and the
      implementation of meaningful treatment strategies require a thorough exploration 
      of the temporal and spatial requirements for FMRP in establishing and maintaining
      neural circuit function.
FAU - Gatto, Cheryl L.
AU  - Gatto CL
FAU - Broadie, Kendal
AU  - Broadie K
LA  - eng
PT  - Journal Article
DEP - 20090212
GR  - R01 GM054544 || GM
TA  - Mol Neurobiol
JT  - Molecular neurobiology
AID - 10.1007/s12035-009-8057-0 [doi]
MID - NIHMS531408
SO  - Mol Neurobiol. 2009 Apr;39(2):. Epub 2009 Feb 12 doi:10.1007/s12035-009-8057-0.

PMC - PMC3859007
PMID- 24396807
IS  - 2287-6391 (Print)
IS  - 2287-6405 (Electronic)
VI  - 15
IP  - 3
DP  - 2013 Sep
TI  - Facilitating Stroke Management using Modern Information Technology.
PG  - 135-43
AB  - Background and Purpose: Information technology and mobile devices may be
      beneficial and useful in many aspects of stroke management, including recognition
      of stroke, transport and triage of patients, emergent stroke evaluation at the
      hospital, and rehabilitation. In this review, we address the contributions of
      information technology and mobile health to stroke management. Summary of Issues:
      Rapid detection and triage are essential for effective thrombolytic treatment.
      Awareness of stroke warning signs and responses to stroke could be enhanced by
      using mobile applications. Furthermore, prehospital assessment and notification
      could be streamlined for use in telemedicine and teleradiology. A mobile
      telemedicine system for assessing the National Institutes of Health Stroke Scale 
      scores has shown higher correlation and fast assessment comparing with
      face-to-face method. Because the benefits of thrombolytic treatment are
      time-dependent, treatment should be initiated as quickly as possible. In-hospital
      communication between multidisciplinary team members can be enhanced using
      information technology. A computerized in-hospital alert system using
      computerized physician-order entry was shown to be effective in reducing the time
      intervals from hospital arrival to medical evaluations and thrombolytic
      treatment. Mobile devices can also be used as supplementary tools for neurologic 
      examination and clinical decision-making. In post-stroke rehabilitation, virtual 
      reality and telerehabilitation are helpful. Mobile applications might be useful
      for public awareness, lifestyle modification, and education/training of
      healthcare professionals. Conclusions: Information technology and mobile health
      are useful tools for management of stroke patients from the acute period to
      rehabilitation. Further improvement of technology will change and enhance stroke 
      prevention and treatment.
FAU - Nam, Hyo Suk
AU  - Nam HS
AD  - Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
FAU - Park, Eunjeong
AU  - Park E
AD  - Wireless Health Institute, University of California Los Angeles (UCLA), Los
      Angeles, United States.
FAU - Heo, Ji Hoe
AU  - Heo JH
AD  - Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20130927
GR  - HI10C2020
PHST- 2013/07/25 [received]
PHST- 2013/09/08 [revised]
PHST- 2013/09/09 [accepted]
PHST- 2013/09/27 [aheadofprint]
TA  - J Stroke
JT  - Journal of Stroke
AID - 10.5853/jos.2013.15.3.135 [doi]
SO  - J Stroke. 2013 Sep;15(3):135-43. Epub 2013 Sep 27 doi:10.5853/jos.2013.15.3.135.

PMC - PMC3243744
PMID- 21987461
IS  - 1096-6080 (Print)
IS  - 1096-0929 (Electronic)
VI  - 125
IP  - 1
DP  - 2012 Jan
TI  - PAH Particles Perturb Prenatal Processes and Phenotypes: Protection from Deficits
      in Object Discrimination Afforded by Dampening of Brain Oxidoreductase Following 
      In Utero Exposure to Inhaled Benzo(a)pyrene.
PG  - 233-47
AB  - The wild-type (WT) Cprlox/lox (cytochrome P450 oxidoreductase, Cpr) mouse is an
      ideal model to assess the contribution of P450 enzymes to the metabolic
      activation and disposition of environmental xenobiotics. In the present study, we
      examined the effect of in utero exposure to benzo(a)pyrene [B(a)P] aerosol on Sp4
      and N-methyl-D-aspartate (NMDA)–dependent systems as well as a resulting
      behavioral phenotype (object discrimination) in Cpr offspring. Results from in
      utero exposure of WT Cprlox/lox mice were compared with in utero exposed
      brain-Cpr-null offspring mice. Null mice were used as they do not express brain
      cytochrome P4501B1–associated NADPH oxidoreductase (CYP1B1-associated NADPH
      oxidoreductase), thus reducing their capacity to produce neural B(a)P
      metabolites. Subsequent to in utero (E14–E17) exposure to B(a)P (100 μg/m3),
      Cprlox/lox offspring exhibited: (1) elevated B(a)P metabolite and F2-isoprostane 
      neocortical tissue burdens, (2) elevated concentrations of cortical glutamate,
      (3) premature developmental expression of Sp4, (4) decreased subunit ratios of
      NR2B:NR2A, and (5) deficits in a novelty discrimination phenotype monitored to in
      utero exposed brain-Cpr-null offspring. Collectively, these findings suggest that
      in situ generation of metabolites by CYP1B1-associated NADPH oxidoreductase
      promotes negative effects on NMDA-mediated signaling processes during the period 
      when synapses are first forming as well as effects on a subsequent behavioral
      phenotype.
FAU - Li, Zhu
AU  - Li Z
AD  - Department of Neuroscience and Pharmacology, Center for Molecular and Behavioral 
      Neuroscience, Meharry Medical College, Nashville, Tennessee 37208
FAU - Chadalapaka, Gayathri
AU  - Chadalapaka G
AD  - Department of Veterinary Physiology and Pharmacology, Texas A&M University,
      College Station, Texas 77843-4466
FAU - Ramesh, Aramandla
AU  - Ramesh A
AD  - Department of Biochemistry and Cancer Biology
FAU - Khoshbouei, Habibeh
AU  - Khoshbouei H
AD  - Department of Physiology, Meharry Medical College, Nashville, Tennessee 37208
FAU - Maguire, Mark
AU  - Maguire M
AD  - Department of Neuroscience and Pharmacology, Center for Molecular and Behavioral 
      Neuroscience, Meharry Medical College, Nashville, Tennessee 37208
FAU - Safe, Stephen
AU  - Safe S
AD  - Department of Veterinary Physiology and Pharmacology, Texas A&M University,
      College Station, Texas 77843-4466
FAU - Rhoades, Raina E.
AU  - Rhoades RE
AD  - Department of Neuroscience and Pharmacology, Center for Molecular and Behavioral 
      Neuroscience, Meharry Medical College, Nashville, Tennessee 37208
FAU - Clark, Ryan
AU  - Clark R
AD  - Department of Neuroscience and Pharmacology, Center for Molecular and Behavioral 
      Neuroscience, Meharry Medical College, Nashville, Tennessee 37208
FAU - Jules, George
AU  - Jules G
AD  - Department of Neuroscience and Pharmacology, Center for Molecular and Behavioral 
      Neuroscience, Meharry Medical College, Nashville, Tennessee 37208
FAU - McCallister, Monique
AU  - McCallister M
FAU - Aschner, Michael
AU  - Aschner M
AD  - Department of Pediatrics
FAU - Hood, Darryl B.
AU  - Hood DB
AD  - Department of Neuroscience and Pharmacology, Center for Molecular and Behavioral 
      Neuroscience, Meharry Medical College, Nashville, Tennessee 37208
LA  - eng
PT  - Journal Article
DEP - 20111010
PHST- 2011/07/22 [received]
PHST- 2011/09/22 [accepted]
PHST- 2011/10/10 [aheadofprint]
TA  - Toxicol Sci
JT  - Toxicological Sciences
AID - 10.1093/toxsci/kfr261 [doi]
SO  - Toxicol Sci. 2012 Jan;125(1):233-47. Epub 2011 Oct 10 doi:10.1093/toxsci/kfr261.

PMC - PMC3726112
PMID- 23983878
IS  - 1941-8744 (Print)
IS  - 1941-8752 (Electronic)
VI  - 2
IP  - 4
DP  - 2012 Oct
DP  - 2012 Oct
TI  - Future Neurohospitalist: Teleneurohospitalist.
PG  - 132-43
AB  - Despite the growing demand for emergency neurological evaluations and
      neurohospitalists, the supply of neurologists remains relatively fixed over
      time.  Telemedicine is a unique tool that has the ability to put a medical
      specialist like a neurologist in 2 places in a relatively short period of time,
      expanding expertise in many rural and in some underserved urban facilities that
      would ordinarily be devoid of such expertise. Teleneurology is a branch of
      telemedicine that consults and practices through remote neurological evaluation. 
      Telestroke is defined as remote stroke evaluation. The demand for timely
      neurological evaluation, especially acute stroke evaluation and treatment with
      intravenous recombinant tissue plasminogen activator (IV rtPA), continues to fuel
      the growth of neurohospitalists, telestroke, and teleneurology services.  Remote,
      rural, or underserved urban emergency departments and hospitals which are unable 
      to successfully recruit a neurologist or neurohospitalist to provide this service
      are uniquely suited to a teleneurology option.  The number of private practices
      and academic centers providing telestroke services has grown significantly in the
      past decade with continued growth expected.  We describe the benefits and
      drawbacks of teleneurology/telestroke, as well as other practical aspects for the
      teleneurohospitalist.
FAU - Freeman, William David
AU  - Freeman WD
AD  - Department of Neurology, Mayo Clinic, Jacksonville, FL, USA
FAU - Barrett, Kevin M.
AU  - Barrett KM
AD  - Department of Neurology, Mayo Clinic, Jacksonville, FL, USA
FAU - Vatz, Kenneth A.
AU  - Vatz KA
AD  - CommunityHealth, Chicago, IL, USA
FAU - Demaerschalk, Bart M.
AU  - Demaerschalk BM
AD  - Department of Neurology, Mayo Clinic, Phoenix, AZ, USA
LA  - eng
PT  - Journal Article
TA  - Neurohospitalist
JT  - The Neurohospitalist
AID - 10.1177/1941874412450714 [doi]
AID - 10.1177_1941874412450714 [pii]
SO  - Neurohospitalist. 2012 Oct;2(4):132-43. doi:10.1177/1941874412450714.

PMC - PMC3975848
PMID- 24594233
IS  - 1743-0003 (Electronic)
VI  - 11
DP  - 2014
TI  - Predicting motor learning performance from Electroencephalographic data.
PG  - 24
AB  - Background: Research on the neurophysiological correlates of visuomotor
      integration and learning (VMIL) has largely focused on identifying
      learning-induced activity changes in cortical areas during motor execution. While
      such studies have generated valuable insights into the neural basis of VMIL,
      little is known about the processes that represent the current state of VMIL
      independently of motor execution. Here, we present empirical evidence that a
      subject’s performance in a 3D reaching task can be predicted on a trial-to-trial 
      basis from pre-trial electroencephalographic (EEG) data. This evidence provides
      novel insights into the brain states that support successful VMIL. Methods: Six
      healthy subjects, attached to a seven degrees-of-freedom (DoF) robot with their
      right arm, practiced 3D reaching movements in a virtual space, while an EEG
      recorded their brain’s electromagnetic field. A random forest ensemble classifier
      was used to predict the next trial’s performance, as measured by the time needed 
      to reach the goal, from pre-trial data using a leave-one-subject-out
      cross-validation procedure. Results: The learned models successfully generalized 
      to novel subjects. An analysis of the brain regions, on which the models based
      their predictions, revealed areas matching prevalent motor learning models. In
      these brain areas, the α/μ frequency band (8–14 Hz) was found to be most relevant
      for performance prediction. Conclusions: VMIL induces changes in cortical
      processes that extend beyond motor execution, indicating a more complex role of
      these processes than previously assumed. Our results further suggest that the
      capability of subjects to modulate their α/μ bandpower in brain regions
      associated with motor learning may be related to performance in VMIL.
      Accordingly, training subjects in α/μ-modulation, e.g., by means of a
      brain-computer interface (BCI), may have a beneficial impact on VMIL.
FAU - Meyer, Timm
AU  - Meyer T
AD  - Department Empirical Inference, Max Planck Institute for Intelligent Systems,
      Tübingen, Germany
FAU - Peters, Jan
AU  - Peters J
AD  - Department Empirical Inference, Max Planck Institute for Intelligent Systems,
      Tübingen, Germany
FAU - Zander, Thorsten O
AU  - Zander TO
AD  - Department Empirical Inference, Max Planck Institute for Intelligent Systems,
      Tübingen, Germany
FAU - Schölkopf, Bernhard
AU  - Schölkopf B
AD  - Department Empirical Inference, Max Planck Institute for Intelligent Systems,
      Tübingen, Germany
FAU - Grosse-Wentrup, Moritz
AU  - Grosse-Wentrup M
AD  - Department Empirical Inference, Max Planck Institute for Intelligent Systems,
      Tübingen, Germany
LA  - eng
PT  - Journal Article
DEP - 20140304
PHST- 2013/03/01 [received]
PHST- 2014/02/08 [accepted]
TA  - J Neuroeng Rehabil
JT  - Journal of NeuroEngineering and Rehabilitation
AID - 1743-0003-11-24 [pii]
AID - 10.1186/1743-0003-11-24 [doi]
SO  - J Neuroeng Rehabil. 2014 Mar 4;11:24. doi:10.1186/1743-0003-11-24.

PMC - PMC3046088
PMID- 21324931
IS  - 1754-8403 (Print)
IS  - 1754-8411 (Electronic)
VI  - 4
IP  - 2
DP  - 2011 Mar
TI  - Remodeling and homeostasis of the extracellular matrix: implications for fibrotic
      diseases and cancer.
PG  - 165-78
AB  - Dynamic remodeling of the extracellular matrix (ECM) is essential for
      development, wound healing and normal organ homeostasis. Life-threatening
      pathological conditions arise when ECM remodeling becomes excessive or
      uncontrolled. In this Perspective, we focus on how ECM remodeling contributes to 
      fibrotic diseases and cancer, which both present challenging obstacles with
      respect to clinical treatment, to illustrate the importance and complexity of
      cell-ECM interactions in the pathogenesis of these conditions. Fibrotic diseases,
      which include pulmonary fibrosis, systemic sclerosis, liver cirrhosis and
      cardiovascular disease, account for over 45% of deaths in the developed world.
      ECM remodeling is also crucial for tumor malignancy and metastatic progression,
      which ultimately cause over 90% of deaths from cancer. Here, we discuss current
      methodologies and models for understanding and quantifying the impact of
      environmental cues provided by the ECM on disease progression, and how improving 
      our understanding of ECM remodeling in these pathological conditions is crucial
      for uncovering novel therapeutic targets and treatment strategies. This can only 
      be achieved through the use of appropriate in vitro and in vivo models to mimic
      disease, and with technologies that enable accurate monitoring, imaging and
      quantification of the ECM.
FAU - Cox, Thomas R.
AU  - Cox TR
AD  - Cancer Research UK Tumour Cell Signalling Unit, Section of Cell and Molecular
      Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK
FAU - Erler, Janine T.
AU  - Erler JT
AD  - Cancer Research UK Tumour Cell Signalling Unit, Section of Cell and Molecular
      Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK
LA  - eng
PT  - Journal Article
PT  - Review
TA  - Dis Model Mech
JT  - Disease Models & Mechanisms
AID - 10.1242/dmm.004077 [doi]
AID - 0040165 [pii]
SO  - Dis Model Mech. 2011 Mar;4(2):165-78. doi:10.1242/dmm.004077.

PMC - PMC5386002
PMID- 26792176
IS  - 1741-2560 (Print)
IS  - 1741-2552 (Electronic)
VI  - 13
IP  - 2
DP  - 2016 Apr
TI  - Tissue damage thresholds during therapeutic electrical stimulation.
PG  - 021001
AB  - Objective: Recent initiatives in bioelectronic modulation of the nervous system
      by the NIH (SPARC), DARPA (ElectRx, SUBNETS) and the GlaxoSmithKline
      Bioelectronic Medicines effort are ushering in a new era of therapeutic
      electrical stimulation. These novel therapies are prompting a re-evaluation of
      established electrical thresholds for stimulation-induced tissue damage.
      Approach: In this review, we explore what is known and unknown in published
      literature regarding tissue damage from electrical stimulation. Main results: For
      macroelectrodes, the potential for tissue damage is often assessed by comparing
      the intensity of stimulation, characterized by the charge density and charge per 
      phase of a stimulus pulse, with a damage threshold identified through
      histological evidence from in vivo experiments as described by the Shannon
      equation. While the Shannon equation has proved useful in assessing the likely
      occurrence of tissue damage, the analysis is limited by the experimental
      parameters of the original studies. Tissue damage is influenced by factors not
      explicitly incorporated into the Shannon equation, including pulse frequency,
      duty cycle, current density, and electrode size. Microelectrodes in particular do
      not follow the charge per phase and charge density co-dependence reflected in the
      Shannon equation. The relevance of these factors to tissue damage is framed in
      the context of available reports from modeling and in vivo studies. Significance:
      It is apparent that emerging applications, especially with microelectrodes, will 
      require clinical charge densities that exceed traditional damage thresholds.
      Experimental data show that stimulation at higher charge densities can be
      achieved without causing tissue damage, suggesting that safety parameters for
      microelectrodes might be distinct from those defined for macroelectrodes.
      However, these increased charge densities may need to be justified by bench,
      non-clinical or clinical testing to provide evidence of device safety.
FAU - Cogan, Stuart F
AU  - Cogan SF
AD  - The Department of Bioengineering, The University of Texas at Dallas, Richardson, 
      TX, USA
FAU - Ludwig, Kip A
AU  - Ludwig KA
AD  - Department of Neurological Surgery, Mayo Clinic, Rochester, MD, USA
FAU - Welle, Cristin G
AU  - Welle CG
AD  - FDA/CDRH/OSEL/DBP, Silver Spring, MD, USA
FAU - Takmakov, Pavel
AU  - Takmakov P
AD  - FDA/CDRH/OSEL/DBCMS, Silver Spring, MD, USA
LA  - eng
PT  - Journal Article
DEP - 20160120
TA  - J Neural Eng
JT  - Journal of neural engineering
AID - 10.1088/1741-2560/13/2/021001 [doi]
MID - NIHMS854736
SO  - J Neural Eng. 2016 Apr;13(2):021001. Epub 2016 Jan 20
      doi:10.1088/1741-2560/13/2/021001.

PMC - PMC4321112
PMID- 25474098
IS  - 0148-0731 (Print)
IS  - 1528-8951 (Electronic)
VI  - 137
IP  - 2
DP  - 2015 Feb
TI  - Is My Model Good Enough? Best Practices for Verification and Validation of
      Musculoskeletal Models and Simulations of Movement.
PG  - 0209051-02090524
AB  - Computational modeling and simulation of neuromusculoskeletal (NMS) systems
      enables researchers and clinicians to study the complex dynamics underlying human
      and animal movement. NMS models use equations derived from physical laws and
      biology to help solve challenging real-world problems, from designing prosthetics
      that maximize running speed to developing exoskeletal devices that enable walking
      after a stroke. NMS modeling and simulation has proliferated in the biomechanics 
      research community over the past 25 years, but the lack of verification and
      validation standards remains a major barrier to wider adoption and impact. The
      goal of this paper is to establish practical guidelines for verification and
      validation of NMS models and simulations that researchers, clinicians, reviewers,
      and others can adopt to evaluate the accuracy and credibility of modeling
      studies. In particular, we review a general process for verification and
      validation applied to NMS models and simulations, including careful formulation
      of a research question and methods, traditional verification and validation
      steps, and documentation and sharing of results for use and testing by other
      researchers. Modeling the NMS system and simulating its motion involves methods
      to represent neural control, musculoskeletal geometry, muscle–tendon dynamics,
      contact forces, and multibody dynamics. For each of these components, we review
      modeling choices and software verification guidelines; discuss variability,
      errors, uncertainty, and sensitivity relationships; and provide recommendations
      for verification and validation by comparing experimental data and testing
      robustness. We present a series of case studies to illustrate key principles. In 
      closing, we discuss challenges the community must overcome to ensure that
      modeling and simulation are successfully used to solve the broad spectrum of
      problems that limit human mobility.
FAU - Hicks, Jennifer L.
AU  - Hicks JL
AD  - Department of Bioengineering, Stanford University, Stanford, CA
      94305e-mail: jenhicks@stanford.edu
FAU - Uchida, Thomas K.
AU  - Uchida TK
AD  - Department of Bioengineering, Stanford University, Stanford, CA 94305
FAU - Seth, Ajay
AU  - Seth A
AD  - Department of Bioengineering, Stanford University, Stanford, CA 94305
FAU - Rajagopal, Apoorva
AU  - Rajagopal A
AD  - Department of Mechanical Engineering, Stanford University, Stanford, CA 94305
FAU - Delp, Scott L.
AU  - Delp SL
AD  - Department of Bioengineering and the Department of Mechanical Engineering,
      Stanford University, Stanford, CA 94305
LA  - eng
PT  - Journal Article
PHST- 2014/09/10 [received]
PHST- 2014/12/02 [revised]
TA  - J Biomech Eng
JT  - Journal of Biomechanical Engineering
AID - 10.1115/1.4029304 [doi]
AID - BIO-14-1452 [pii]
SO  - J Biomech Eng. 2015 Feb;137(2):0209051-02090524. doi:10.1115/1.4029304.

PMC - PMC3118435
PMID- 21779718
IS  - 1807-5932 (Print)
IS  - 1980-5322 (Electronic)
VI  - 66
IP  - Suppl 1
DP  - 2011 Jun
TI  - Long-term potentiation and long-term depression: a clinical perspective.
PG  - 3-17
AB  - Long-term potentiation and long-term depression are enduring changes in synaptic 
      strength, induced by specific patterns of synaptic activity, that have received
      much attention as cellular models of information storage in the central nervous
      system. Work in a number of brain regions, from the spinal cord to the cerebral
      cortex, and in many animal species, ranging from invertebrates to humans, has
      demonstrated a reliable capacity for chemical synapses to undergo lasting changes
      in efficacy in response to a variety of induction protocols. In addition to their
      physiological relevance, long-term potentiation and depression may have important
      clinical applications. A growing insight into the molecular mechanisms underlying
      these processes, and technological advances in non-invasive manipulation of brain
      activity, now puts us at the threshold of harnessing long-term potentiation and
      depression and other forms of synaptic, cellular and circuit plasticity to
      manipulate synaptic strength in the human nervous system. Drugs may be used to
      erase or treat pathological synaptic states and non-invasive stimulation devices 
      may be used to artificially induce synaptic plasticity to ameliorate conditions
      arising from disrupted synaptic drive. These approaches hold promise for the
      treatment of a variety of neurological conditions, including neuropathic pain,
      epilepsy, depression, amblyopia, tinnitus and stroke.
FAU - Bliss, Timothy V.P.
AU  - Bliss TV
AD  - National Institute for Medical Research, Ridgeway, Mill Hill, London, U.K.
FAU - Cooke, Sam F
AU  - Cooke SF
AD  - Picower Institute for Learning and Memory, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, U.S.
LA  - eng
PT  - Journal Article
PHST- 2011/03/31 [received]
PHST- 2011/04/01 [accepted]
TA  - Clinics (Sao Paulo)
JT  - Clinics
AID - 10.1590/S1807-59322011001300002 [doi]
AID - cln_66p3 [pii]
SO  - Clinics (Sao Paulo). 2011 Jun;66(Suppl 1):3-17.
      doi:10.1590/S1807-59322011001300002.

PMC - PMC2668610
PMID- 18725213
IS  - 0006-8993 (Print)
IS  - 1872-6240 (Electronic)
VI  - 1236
DP  - 2008 Oct 21
TI  - Event-related fast optical signal in a rapid object recognition task: improving
      detection by the Independent Component Analysis.
PG  - 145-58
AB  - Noninvasive recording of fast optical signals presumably reflecting neuronal
      activity is a challenging task because of a relatively low signal-to-noise ratio.
      To improve detection of those signals in rapid object recognition tasks, we used 
      the Independent Component Analysis (ICA) to reduce “global interference”
      (heartbeat and contribution of superficial layers). We recorded optical signals
      from the left prefrontal cortex in 10 right-handed participants with a
      continuous-wave instrument (DYNOT, NIRx, Brooklyn, NY). Visual stimuli were
      pictures of urban, landscape and seashore scenes with various vehicles as targets
      (target-to-non-target ratio 1:6) presented at ISI = 166 ms or 250 ms. Subjects
      mentally counted targets. Data were filtered at 2–30 Hz and artifactual
      components were identified visually (for heartbeat) and using the ICA weight
      matrix (for superficial layers). Optical signals were restored from the ICA
      components with artifactual components removed and then averaged over target and 
      non-target epochs. After ICA processing, the event-related response was detected 
      in 70–100% of subjects. The refined signal showed a significant decrease from
      baseline within 200–300 ms after targets and a slight increase after non-targets.
      The temporal profile of the optical signal corresponded well to the profile of a 
      “differential ERP response”, the difference between targets and non-targets which
      peaks at 200 ms in similar object detection tasks. These results demonstrate that
      the detection of fast optical responses with continuous-wave instruments can be
      improved through the ICA method capable to remove noise, global interference and 
      the activity of superficial layers. Fast optical signals may provide further
      information on brain processing during higher-order cognitive tasks such as rapid
      categorization of objects.
FAU - Medvedev, Andrei V.
AU  - Medvedev AV
AD  - Center for Functional and Molecular Imaging, Department of Neurology, Georgetown 
      University Medical Center, Washington, DC 20057, USA
FAU - Kainerstorfer, Jana
AU  - Kainerstorfer J
AD  - Department of Physics, University of Vienna, Vienna, Austria
FAU - Borisov, Sergey V.
AU  - Borisov SV
AD  - Center for Functional and Molecular Imaging, Department of Neurology, Georgetown 
      University Medical Center, Washington, DC 20057, USA
FAU - Barbour, Randall L.
AU  - Barbour RL
AD  - Department of Pathology, State University of New York Downstate Medical Center,
      New York 11203, USA
FAU - VanMeter, John
AU  - VanMeter J
AD  - Center for Functional and Molecular Imaging, Department of Neurology, Georgetown 
      University Medical Center, Washington, DC 20057, USA
LA  - eng
PT  - Journal Article
DEP - 20080812
TA  - Brain Res
JT  - Brain research
MID - NIHMS74728
AID - 10.1016/j.brainres.2008.07.122 [doi]
SO  - Brain Res. 2008 Oct 21;1236:145-58. Epub 2008 Aug 12
      doi:10.1016/j.brainres.2008.07.122.

PMC - PMC3652731
PMID- 23433089
IS  - 1743-0003 (Electronic)
VI  - 10
DP  - 2013
TI  - Effect on signal-to-noise ratio of splitting the continuous contacts of cuff
      electrodes into smaller recording areas.
PG  - 22
AB  - Background: Cuff electrodes have been widely used chronically in different
      clinical applications. This neural interface has been dominantly used for nerve
      stimulation while interfering noise is the major issue when employed for
      recording purposes. Advancements have been made in rejecting extra-neural
      interference by using continuous ring contacts in tripolar topologies. Ring
      contacts provide an average of the neural activity, and thus reduce the
      information retrieved. Splitting these contacts into smaller recording areas
      could potentially increase the information content. In this study, we investigate
      the impact of such discretization on the Signal-to-Noise Ratio (SNR). The effect 
      of contacts positioning and an additional short circuited pair of electrodes were
      also addressed. Methods: Different recording configurations using ring, dot, and 
      a mixed of both contacts were studied in vitro in a frog model. An interfering
      signal was induced in the medium to simulate myoelectric noise. The experimental 
      setup was design in such a way that the only difference between recordings was
      the configuration used. The inter-session experimental differences were taken
      care of by a common configuration that allowed normalization between electrode
      designs. Results: It was found that splitting all contacts into small recording
      areas had negative effects on noise rejection. However, if this is only applied
      to the central contact creating a mixed tripole configuration, a considerable and
      statistically significant improvement was observed. Moreover, the signal to noise
      ratio was equal or larger than what can be achieved with the best known
      configuration, namely the short circuited tripole. This suggests that for
      recording purposes, any tripole topology would benefit from splitting the central
      contact into one or more discrete contacts. Conclusions: Our results showed that 
      a mixed tripole configuration performs better than the configuration including
      only ring contacts. Therefore, splitting the central ring contact of a cuff
      electrode into a number of dot contacts not only provides additional information 
      but also an improved SNR. In addition, the effect of an additional pair of short 
      circuited electrodes and the “end effect” observed with the presented method are 
      in line with previous findings by other authors.
FAU - Ortiz-Catalan, Max
AU  - Ortiz-Catalan M
AD  - Department of Signals and Systems, Biomedical Engineering Division, Chalmers,
      University of Technology, Gothenburg, Sweden
FAU - Marin-Millan, Jorge
AU  - Marin-Millan J
AD  - School of Medicine (MD), Institute of Neuroscience (SSS/IoNS/COSY), Université
      Catholique de Louvain, Brussels, Belgium
FAU - Delbeke, Jean
AU  - Delbeke J
AD  - School of Medicine (MD), Institute of Neuroscience (SSS/IoNS/COSY), Université
      Catholique de Louvain, Brussels, Belgium
FAU - Håkansson, Bo
AU  - Håkansson B
AD  - Department of Signals and Systems, Biomedical Engineering Division, Chalmers,
      University of Technology, Gothenburg, Sweden
FAU - Brånemark, Rickard
AU  - Brånemark R
AD  - Centre of Orthopaedic Osseointegration, Department of Orthopaedics, Sahlgrenska
      University Hospital, Gothenburg, Sweden
LA  - eng
PT  - Journal Article
DEP - 20130221
PHST- 2012/02/22 [received]
PHST- 2013/02/05 [accepted]
TA  - J Neuroeng Rehabil
JT  - Journal of NeuroEngineering and Rehabilitation
AID - 1743-0003-10-22 [pii]
AID - 10.1186/1743-0003-10-22 [doi]
SO  - J Neuroeng Rehabil. 2013 Feb 21;10:22. doi:10.1186/1743-0003-10-22.

PMC - PMC3159417
PMID- 21684526
IS  - 0006-3223 (Print)
IS  - 1873-2402 (Electronic)
VI  - 70
IP  - 5
DP  - 2011 Sep 1
TI  - Safety signals mitigate the consequences of uncontrollable stress via a circuit
      involving the sensory insular cortex and bed nucleus of the stria terminalis.
PG  - 458-64
AB  - BACKGROUND: Safety signals exert a powerful buffering effect when provided during
      exposure to uncontrollable stressors. We evaluated the role of the sensory
      insular cortex (Si) and the extend amygdala in this “safety signal effect.”
      METHODS: Rats were implanted with microinjection cannula, exposed to inescapable 
      tailshocks either with or without a safety signal and later tested for
      anxiety-like behavior or neuronal Fos expression. RESULTS: Exposure to the
      uncontrollable stressor reduced later social exploration, but not when safety
      signals were present. Temporary inhibition of Si during stressor exposure, but
      not during later behavioral testing, blocked the safety signal effect on social
      exploration. The stressor induced Fos in all regions of the amygdala, but safety 
      signals significantly reduced the number of Fos immunoreactive cells in the
      basolateral amygdala and ventrolateral region of the bed nucleus of the stria
      terminalis (BNSTlv). Inhibition of BNSTlv neuronal activity during uncontrollable
      stressor exposure prevented the later reduction in social exploration. Finally,
      safety signals reduced the time spent freezing during uncontrollable stress.
      CONCLUSIONS: These data suggest that safety signals inhibit the neural fear or
      anxiety response that normally occurs during uncontrollable stressors and that
      inhibition of the BNSTlv is sufficient to prevent later anxiety. These data lend 
      support to a growing body of evidence that chronic fear is mediated in the
      basolateral amygdala and BNSTlv and that environmental factors that modulate fear
      during stress will alter the long-term consequences of the stressor.
FAU - Christianson, JP
AU  - Christianson J
FAU - Jennings, J. H.
AU  - Jennings JH
FAU - Ragole, T.
AU  - Ragole T
FAU - Flyer, J.
AU  - Flyer J
FAU - Benison, A. M.
AU  - Benison AM
FAU - Barth, D.
AU  - Barth D
FAU - Watkins, L.R.
AU  - Watkins L
FAU - Maier, S.F.
AU  - Maier S
LA  - eng
PT  - Journal Article
GR  - R01 MH050479-15 || MH
TA  - Biol Psychiatry
JT  - Biological psychiatry
AID - 10.1016/j.biopsych.2011.04.004 [doi]
MID - NIHMS305840
SO  - Biol Psychiatry. 2011 Sep 1;70(5):458-64. doi:10.1016/j.biopsych.2011.04.004.

PMC - PMC2714729
PMID- 19477959
IS  - 0964-6906 (Print)
IS  - 1460-2083 (Electronic)
VI  - 18
IP  - 16
DP  - 2009 Aug 15
TI  - In vivo and in vitro effects of two novel gamma-actin (ACTG1) mutations that
      cause DFNA20/26 hearing impairment.
PG  - 3075-89
AB  - Here we report the functional assessment of two novel deafness-associated γ-actin
      mutants, K118N and E241K, in a spectrum of different situations with increasing
      biological complexity by combining biochemical and cell biological analysis in
      yeast and mammalian cells. Our in vivo experiments showed that while the K118N
      had a very mild effect on yeast behaviour, the phenotype caused by the E241K
      mutation was very severe and characterized by a highly compromised ability to
      grow on glycerol as a carbon source, an aberrant multi-vacuolar pattern and the
      deposition of thick F-actin bundles randomly in the cell. The latter feature is
      consistent with the highly unusual spontaneous tendency of the E241K mutant to
      form bundles in vitro, although this propensity to bundle was neutralized by
      tropomyosin and the E241K filament bundles were hypersensitive to severing in the
      presence of cofilin. In transiently transfected NIH3T3 cells both mutant actins
      were normally incorporated into cytoskeleton structures, although cytoplasmic
      aggregates were also observed indicating an element of abnormality caused by the 
      mutations in vivo. Interestingly, gene-gun mediated expression of these mutants
      in cochlear hair cells results in no gross alteration in cytoskeletal structures 
      or the morphology of stereocilia. Our results provide a more complete picture of 
      the biological consequences of deafness-associated γ-actin mutants and support
      the hypothesis that the post-lingual and progressive nature of the DFNA20/26
      hearing loss is the result of a progressive deterioration of the hair cell
      cytoskeleton over time.
FAU - Morín, Matías
AU  - Morín M
AD  - Unidad de Genética Molecular, Hospital Ramón y Cajal, 28034 Madrid, Spain
FAU - Bryan, Keith E.
AU  - Bryan KE
AD  - Department of Biochemistry, University of Iowa Carver College of Medicine, Iowa
      City, IA 52242, USA
FAU - Mayo-Merino, Fernando
AU  - Mayo-Merino F
AD  - Unidad de Genética Molecular, Hospital Ramón y Cajal, 28034 Madrid, Spain
FAU - Goodyear, Richard
AU  - Goodyear R
AD  - School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9QG, UK
FAU - Mencía, Ángeles
AU  - Mencía Á
AD  - Unidad de Genética Molecular, Hospital Ramón y Cajal, 28034 Madrid, Spain
FAU - Modamio-Høybjør, Silvia
AU  - Modamio-Høybjør S
AD  - Unidad de Genética Molecular, Hospital Ramón y Cajal, 28034 Madrid, Spain
FAU - del Castillo, Ignacio
AU  - del Castillo I
AD  - Unidad de Genética Molecular, Hospital Ramón y Cajal, 28034 Madrid, Spain
FAU - Cabalka, Jessica M.
AU  - Cabalka JM
AD  - Department of Biochemistry, University of Iowa Carver College of Medicine, Iowa
      City, IA 52242, USA
FAU - Richardson, Guy
AU  - Richardson G
AD  - School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9QG, UK
FAU - Moreno, Felipe
AU  - Moreno F
AD  - Unidad de Genética Molecular, Hospital Ramón y Cajal, 28034 Madrid, Spain
FAU - Rubenstein, Peter A.
AU  - Rubenstein PA
AD  - Department of Biochemistry, University of Iowa Carver College of Medicine, Iowa
      City, IA 52242, USA
FAU - Moreno-Pelayo, Miguel Ángel
AU  - Moreno-Pelayo MÁ
AD  - Unidad de Genética Molecular, Hospital Ramón y Cajal, 28034 Madrid, Spain
LA  - eng
PT  - Journal Article
DEP - 20090528
PHST- 2009/03/18 [received]
PHST- 2009/05/21 [accepted]
PHST- 2009/05/28 [aheadofprint]
TA  - Hum Mol Genet
JT  - Human Molecular Genetics
AID - 10.1093/hmg/ddp249 [doi]
AID - ddp249 [pii]
SO  - Hum Mol Genet. 2009 Aug 15;18(16):3075-89. Epub 2009 May 28
      doi:10.1093/hmg/ddp249.

PMC - PMC2839388
PMID- 19697262
IS  - 0899-0220 (Print)
IS  - 1369-1651 (Electronic)
VI  - 26
IP  - 2
DP  - 2009 Jun
TI  - Electrotactile stimulation on the tongue: intensity perception, discrimination
      and cross-modality estimation.
PG  - 50-63
AB  - Due to its high sensitivity and conductivity, electrotactile stimulation (ETS) on
      the tongue has proven to be a useful and technically convenient tool to
      substitute and/or augment sensory capabilities. However, most of its applications
      have only provided spatial attributes and little is known about (a) the ability
      of the tongue's sensory system to process electrical stimuli of varying
      magnitudes and (b) how modulation of ETS intensity affects subjects' ability to
      decode stimulus intensity. We addressed these questions by quantifying: (1) the
      magnitude of the dynamic range (DR; maximal comfortable intensity/perception
      threshold) and its sensitivity to prolonged exposure; (2) subjects' ability to
      perceive intensity changes; and (3) subjects' ability to associate intensity with
      angular excursions of a protractor's handle. We found that the average DR (17 dB)
      was generally large in comparison with other tactile loci and of a relatively
      constant magnitude among subjects, even after prolonged exposure, despite a
      slight but significant upward drift (P < 0.001). Additionally, our results showed
      that as stimulus intensity increased, subjects' ability to discriminate ETS
      stimuli of different intensities improved (P < 0.05) while estimation accuracy,
      in general, slightly decreased (increasing underestimation). These results
      suggest that higher ETS intensity may increase recruitment of rapidly adapting
      mechanoreceptor fibers, as these are specialized for coding stimulus differences 
      rather than absolute intensities. Furthermore, our study revealed that the
      tongue's sensory system can effectively convey electrical stimuli despite minimal
      practice and when information transfer is limited by memory and DR drift.
FAU - Lozano, Cecil A.
AU  - Lozano CA
AD  - Department of Kinesiology, Arizona State University, Tempe, AZ 85287. USA
FAU - Kaczmarek, Kurt A.
AU  - Kaczmarek KA
AD  - Department of Orthopedics and Rehabilitation Medicine and Department of
      Biomedical Engineering, University of Wisconsin, Madison, WI 53706, USA
FAU - Santello, Marco
AU  - Santello M
AD  - Department of Kinesiology, Arizona State University, Tempe, AZ 85287. USA
LA  - eng
PT  - Journal Article
TA  - Somatosens Mot Res
JT  - Somatosensory & motor research
AID - 10.1080/08990220903158797 [doi]
MID - NIHMS176205
SO  - Somatosens Mot Res. 2009 Jun;26(2):50-63. doi:10.1080/08990220903158797.

PMC - PMC2761912
PMID- 19793390
IS  - 1745-6215 (Electronic)
VI  - 10
DP  - 2009
TI  - The third Symptom Management Research Trial in Oncology (SMaRT Oncology-3): a
      randomised trial to determine the efficacy of adding a complex intervention for
      major depressive disorder (Depression Care for People with Lung Cancer) to usual 
      care, compared to usual care alone in patients with lung cancer.
PG  - 92
AB  - Background: Depression Care for People with Lung Cancer is a complex intervention
      delivered by specially trained cancer nurses, under the supervision of a
      psychiatrist. It is given as a supplement to the usual care for depression, which
      patients receive from their general practitioner and cancer service. The third
      Symptom Management Research Trial in Oncology (SMaRT Oncology-3 Trial) will test 
      its efficacy when compared to usual care alone. Design: A two arm parallel group 
      multi-centre randomised controlled trial. 200 patients will be recruited through 
      established systematic Symptom Monitoring Services, which screen patients for
      depression. Patients will have: a diagnosis of lung cancer; an estimated life
      expectancy of three months or more and a diagnosis of Major Depressive Disorder. 
      Patients will be randomised to usual care or usual care plus Depression Care for 
      People with Lung Cancer. Randomisation will be carried out by telephoning a
      secure computerised central randomisation system or by using a secure web
      interface. The primary outcome measure is average depression severity. This will 
      be assessed using scores on the 20-item Symptom Hopkins Checklist (SCL-20D),
      collected every four weeks over 32 weeks. Secondary outcomes include severity of 
      anxiety, pain and fatigue; self-rated improvement of depression; quality of life 
      and satisfaction with depression care. Trial Registration: Current controlled
      trials ISRCTN75905964
FAU - Walker, Jane
AU  - Walker J
AD  - Cancer Research UK, The University of Edinburgh Cancer Research Centre, Western
      General Hospital, Crewe Road, Edinburgh, UK
FAU - Cassidy, Jim
AU  - Cassidy J
AD  - Cancer Research UK, Department of Medical Oncology, University of Glasgow,
      Garscube Estate, Switchback Road, Glasgow, UK
FAU - Sharpe, Michael
AU  - Sharpe M
AD  - Psychological Medicine Research, School of Molecular and Clinical Medicine, the
      University of Edinburgh, Kennedy Tower, Royal Edinburgh Hospital, Morningside
      Park, Edinburgh, UK
CN  - SMaRT Oncology-3 Trialists
LA  - eng
PT  - Journal Article
DEP - 20090930
PHST- 2009/05/08 [received]
PHST- 2009/09/30 [accepted]
TA  - Trials
JT  - Trials
AID - 1745-6215-10-92 [pii]
AID - 10.1186/1745-6215-10-92 [doi]
SO  - Trials. 2009 Sep 30;10:92. doi:10.1186/1745-6215-10-92.

PMC - PMC5461526
IS  - 2045-7022 (Electronic)
VI  - 7
IP  - Suppl 2
DP  - 2017
TI  - Abstracts from the 3rd International Severe Asthma Forum (ISAF).
LID - 14
FAU - Ketelaar, M. E.
AU  - Ketelaar ME
AD  - 0000 0000 9558 4598grid.4494.dBeatrix Children’s Hospital, Groningen Research
      Institute for Asthma and COPD (GRIAC), University Medical Center Groningen,
      Groningen, The Netherlands
FAU - Van De Kant, K.
AU  - Van De Kant K
AD  - grid.412966.eDepartment of Pediatric Pulmonology, School for Public Health and
      Primary Care (CAPHRI), Maastricht University Medical Center (MUMC+), Maastricht, 
      The Netherlands
FAU - Dijk, F. N.
AU  - Dijk FN
AD  - 0000 0000 9558 4598grid.4494.dBeatrix Children’s Hospital, Groningen Research
      Institute for Asthma and COPD (GRIAC), University Medical Center Groningen,
      Groningen, The Netherlands
FAU - Klaassen, E. M. M.
AU  - Klaassen EMM
AD  - grid.412966.eDepartment of General Practice, School for Public Health and Primary
      Care (CAPHRI), Maastricht University Medical Center (MUMC+), Maastricht, The
      Netherlands
FAU - Grotenboer, N.
AU  - Grotenboer N
AD  - 0000 0000 9558 4598grid.4494.dDepartment of Pathology and Medical Biology,
      Laboratory of Experimental Pulmonology and Inflammation Research (EXPIRE),
      Groningen Research Institute for Asthma and COPD (GRIAC), University Medical
      Center Groningen, Groningen, The Netherlands
FAU - Nawijn, M. C.
AU  - Nawijn MC
AD  - 0000 0000 9558 4598grid.4494.dDepartment of Pathology and Medical Biology,
      Laboratory of Experimental Pulmonology and Inflammation Research (EXPIRE),
      Groningen Research Institute for Asthma and COPD (GRIAC), University Medical
      Center Groningen, Groningen, The Netherlands
FAU - Dompeling, E.
AU  - Dompeling E
AD  - grid.412966.eDepartment of Pediatric Pulmonology, School for Public Health and
      Primary Care (CAPHRI), Maastricht University Medical Center (MUMC+), Maastricht, 
      The Netherlands
FAU - Koppelman, G. H.
AU  - Koppelman GH
AD  - 0000 0000 9558 4598grid.4494.dBeatrix Children’s Hospital, Groningen Research
      Institute for Asthma and COPD (GRIAC), University Medical Center Groningen,
      Groningen, The Netherlands
FAU - Murray, Clare
AU  - Murray C
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Foden, Philip
AU  - Foden P
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Lowe, Lesley
AU  - Lowe L
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Durrington, Hannah
AU  - Durrington H
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Custovic, Adnan
AU  - Custovic A
AD  - 0000 0001 2113 8111grid.7445.2Imperial College, London, UK
FAU - Simpson, Angela
AU  - Simpson A
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Simpson, Andrew J.
AU  - Simpson AJ
AD  - 0000 0004 0430 9363grid.5465.2Division of Infection, Immunity and Respiratory
      Medicine, School of Biological Sciences, The University of Manchester and
      University Hospital of South Manchester, NHS Foundation Trust, Manchester, UK
FAU - Shaw, Dominick E.
AU  - Shaw DE
AD  - 0000 0004 1936 8868grid.4563.4Respiratory Research Unit, University of
      Nottingham, Nottingham, UK
FAU - Sousa, Ana R.
AU  - Sousa AR
AD  - 0000 0001 2162 0389grid.418236.aRespiratory Therapeutic Unit, GSK, Stockley Park,
      London, UK
FAU - Fleming, Louise J.
AU  - Fleming LJ
AD  - 0000 0001 2113 8111grid.7445.2National Heart and Lung Institute, Imperial
      College, London, UK
FAU - Roberts, Graham
AU  - Roberts G
AD  - grid.454385.bBiomedical Research Unit, Clinical and Experimental Sciences and
      Human Development and Health, NIHR Southampton Respiratory, Southampton, UK
FAU - Pandis, Ioannis
AU  - Pandis I
AD  - 0000 0001 2113 8111grid.7445.2Data Science Institute, South Kensington Campus,
      Imperial College London, London, UK
FAU - Bansal, Aruna T.
AU  - Bansal AT
AD  - 0000000121885934grid.5335.0Acclarogen Ltd, St John’s Innovation Centre,
      Cambridge, UK
FAU - Corfield, Julie
AU  - Corfield J
AD  - 0000 0001 1519 6403grid.418151.8AstraZeneca R&D, Mölndal, Sweden
FAU - Wagers, Scott
AU  - Wagers S
AD  - BioSci Consulting, Maasmechelen, Belgium
FAU - Djukanovic, Ratko
AU  - Djukanovic R
AD  - grid.454385.bBiomedical Research Unit, Clinical and Experimental Sciences and
      Human Development and Health, NIHR Southampton Respiratory, Southampton, UK
FAU - Chung, Kian Fan
AU  - Chung KF
AD  - 0000 0001 2113 8111grid.7445.2National Heart and Lung Institute, Imperial
      College, London, UK
FAU - Sterk, Peter J.
AU  - Sterk PJ
AD  - 0000000084992262grid.7177.6Dept of Respiratory Medicine, Academic Medical Centre,
      University of Amsterdam, Amsterdam, The Netherlands
FAU - Vestbo, Jorgen
AU  - Vestbo J
AD  - 0000 0004 0430 9363grid.5465.2Division of Infection, Immunity and Respiratory
      Medicine, School of Biological Sciences, The University of Manchester and
      University Hospital of South Manchester, NHS Foundation Trust, Manchester, UK
FAU - Fowler, Stephen J.
AU  - Fowler SJ
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Tebbutt, S. J.
AU  - Tebbutt SJ
AD  - 0000 0001 2288 9830grid.17091.3eUniversity of British Columbia, Vancouver, Canada
FAU - Singh, A.
AU  - Singh A
AD  - 0000 0001 2288 9830grid.17091.3eUniversity of British Columbia, Vancouver, Canada
FAU - Shannon, C. P.
AU  - Shannon CP
AD  - grid.460559.bPROOF Centre of Excellence, Vancouver, Canada
FAU - Kim, Y. W.
AU  - Kim YW
AD  - 0000 0001 2288 9830grid.17091.3eUniversity of British Columbia, Vancouver, Canada
FAU - Yang, C. X.
AU  - Yang CX
AD  - 0000 0001 2288 9830grid.17091.3eUniversity of British Columbia, Vancouver, Canada
FAU - Gauvreau, G. M.
AU  - Gauvreau GM
AD  - 0000 0004 1936 8227grid.25073.33McMaster University, Hamilton, Canada
FAU - Fitzgerald, J. M.
AU  - Fitzgerald JM
AD  - 0000 0001 2288 9830grid.17091.3eUniversity of British Columbia, Vancouver, Canada
FAU - Boulet, L. P.
AU  - Boulet LP
AD  - 0000 0004 1936 8390grid.23856.3aUniversité Laval, Québec City, Canada
FAU - O’Byrne, P. M.
AU  - O’Byrne PM
AD  - 0000 0004 1936 8227grid.25073.33McMaster University, Hamilton, Canada
FAU - Begley, N.
AU  - Begley N
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Loudon, A.
AU  - Loudon A
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Ray, D. W.
AU  - Ray DW
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Baos, Selene
AU  - Baos S
AD  - grid.419651.eIIS-Fundación Jiménez Díaz-UAM, Madrid, Spain
FAU - Cremades, Lucía
AU  - Cremades L
AD  - grid.419651.eIIS-Fundación Jiménez Díaz-UAM, Madrid, Spain
FAU - Calzada, David
AU  - Calzada D
AD  - grid.419651.eIIS-Fundación Jiménez Díaz-UAM, Madrid, Spain
FAU - Lahoz, Carlos
AU  - Lahoz C
AD  - grid.419651.eIIS-Fundación Jiménez Díaz-UAM, Madrid, Spain
FAU - Cárdaba, Blanca
AU  - Cárdaba B
AD  - grid.419651.eIIS-Fundación Jiménez Díaz-UAM, Madrid, Spain
FAU - Asosingh, Kewal
AU  - Asosingh K
AD  - 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA
FAU - Lauruschkat, Chris
AU  - Lauruschkat C
AD  - 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA
FAU - Queisser, Kimberly
AU  - Queisser K
AD  - 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA
FAU - Wanner, Nicholas
AU  - Wanner N
AD  - 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA
FAU - Weiss, Kelly
AU  - Weiss K
AD  - 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA
FAU - Xu, Weiling
AU  - Xu W
AD  - 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA
FAU - Erzurum, Serpil
AU  - Erzurum S
AD  - 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA
FAU - Sokolowska, Milena
AU  - Sokolowska M
AD  - 0000 0001 2297 5165grid.94365.3dCritical Care Medicine Department, Clinical
      Center, NIH, Bethesda, MD USA
FAU - Chen, Li-Yuan
AU  - Chen LY
AD  - 0000 0001 2297 5165grid.94365.3dCritical Care Medicine Department, Clinical
      Center, NIH, Bethesda, MD USA
FAU - Liu, Yueqin
AU  - Liu Y
AD  - 0000 0001 2297 5165grid.94365.3dCritical Care Medicine Department, Clinical
      Center, NIH, Bethesda, MD USA
FAU - Martinez-Anton, Asuncion
AU  - Martinez-Anton A
AD  - 0000 0001 2297 5165grid.94365.3dCritical Care Medicine Department, Clinical
      Center, NIH, Bethesda, MD USA
FAU - Logun, Carolea
AU  - Logun C
AD  - 0000 0001 2297 5165grid.94365.3dCritical Care Medicine Department, Clinical
      Center, NIH, Bethesda, MD USA
FAU - Alsaaty, Sara
AU  - Alsaaty S
AD  - 0000 0001 2297 5165grid.94365.3dCritical Care Medicine Department, Clinical
      Center, NIH, Bethesda, MD USA
FAU - Cuento, Rosemarie
AU  - Cuento R
AD  - 0000 0001 2297 5165grid.94365.3dLaboratory of Asthma and Lung Inflammation,
      Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute,
      NIH, Bethesda, MD USA
FAU - Cai, Rongman
AU  - Cai R
AD  - 0000 0001 2297 5165grid.94365.3dCritical Care Medicine Department, Clinical
      Center, NIH, Bethesda, MD USA
FAU - Sun, Junfeng
AU  - Sun J
AD  - 0000 0001 2297 5165grid.94365.3dCritical Care Medicine Department, Clinical
      Center, NIH, Bethesda, MD USA
FAU - Quehenberger, Oswald
AU  - Quehenberger O
AD  - Department of Medicine, Department of Pharmacology, San Diego, CA USA
FAU - Armando, Aaron
AU  - Armando A
AD  - 0000 0001 2107 4242grid.266100.3Department of Chemistry and Biochemistry, San
      Diego, CA USA
FAU - Dennis, Edward
AU  - Dennis E
AD  - 0000 0001 2107 4242grid.266100.3Department of Chemistry and Biochemistry, San
      Diego, CA USA
FAU - Levine, Stewart
AU  - Levine S
AD  - 0000 0001 2297 5165grid.94365.3dLaboratory of Asthma and Lung Inflammation,
      Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute,
      NIH, Bethesda, MD USA
FAU - Shelhamer, James
AU  - Shelhamer J
AD  - 0000 0001 2297 5165grid.94365.3dCritical Care Medicine Department, Clinical
      Center, NIH, Bethesda, MD USA
FAU - Choi, Kilyong
AU  - Choi K
AD  - 0000 0004 0642 340Xgrid.415520.7Seoul Medical Center, Seoul, South Korea
FAU - Lazova, Snezhina
AU  - Lazova S
AD  - 0000 0004 0621 0092grid.410563.5Medical University, Pediatric Clinic, UMHAT
      Alexandrovska, Sofia, Bulgaria
FAU - Perenovska, Penka
AU  - Perenovska P
AD  - 0000 0004 0621 0092grid.410563.5Medical University, Pediatric Clinic, UMHAT
      Alexandrovska, Sofia, Bulgaria
FAU - Miteva, Dimitrinka
AU  - Miteva D
AD  - 0000 0004 0621 0092grid.410563.5Medical University, Pediatric Clinic, UMHAT
      Alexandrovska, Sofia, Bulgaria
FAU - Priftis, Stamatios
AU  - Priftis S
AD  - 0000 0004 0621 0092grid.410563.5Medical University, Sofia, Bulgaria
FAU - Petrova, Guergana
AU  - Petrova G
AD  - 0000 0004 0621 0092grid.410563.5Medical University, Pediatric Clinic, UMHAT
      Alexandrovska, Sofia, Bulgaria
FAU - Yablanski, Vassil
AU  - Yablanski V
AD  - grid.479663.9Orthopedics Department, Tokuda Hospital, Sofia, Bulgaria
FAU - Vlaev, Evgeni
AU  - Vlaev E
AD  - grid.479663.9Orthopedics Department, Tokuda Hospital, Sofia, Bulgaria
FAU - Rafailova, Hristina
AU  - Rafailova H
AD  - 0000 0004 0621 0092grid.410563.5Medical University, Pediatric Clinic, UMHAT
      Alexandrovska, Sofia, Bulgaria
FAU - Kumae, Takashi
AU  - Kumae T
AD  - grid.410772.7Research Institute, Tokyo University of Agriculture, Tokyo, Japan
FAU - Holmes, L. J.
AU  - Holmes LJ
AD  - 0000 0004 0430 9363grid.5465.2University Hospital of South Manchester &
      University of Manchester, Manchester, UK
FAU - Yorke, J.
AU  - Yorke J
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Ryan, D. M.
AU  - Ryan DM
AD  - 0000 0004 0430 9363grid.5465.2University Hospital of South Manchester,
      Manchester, UK
FAU - Chinratanapisit, Sasawan
AU  - Chinratanapisit S
AD  - 0000 0004 0617 6015grid.414501.5Division of Allergy and Immunology, Department of
      Pediatrics, Bhumibol Adulyadej Hospital, Bangkok, Thailand
FAU - Matchimmadamrong, Khlongtip
AU  - Matchimmadamrong K
AD  - Saraburi Hospital, Saraburi, Thailand
FAU - Deerojanawong, Jitladda
AU  - Deerojanawong J
AD  - 0000 0001 0244 7875grid.7922.eDivision of Respiratory Disease and Intensive Care,
      Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok,
      Thailand
FAU - Karoonboonyanan, Wissaroot
AU  - Karoonboonyanan W
AD  - 0000 0004 0617 6015grid.414501.5Department of Pediatrics, Bhumibol Adulyadej
      Hospital, Bangkok, Thailand
FAU - Sritipsukho, Paskorn
AU  - Sritipsukho P
AD  - 0000 0004 1937 1127grid.412434.4Center of Excellence in Applied Epidemiology,
      Thammasat University, Bangkok, Thailand
FAU - Youroukova, Vania
AU  - Youroukova V
AD  - 0000 0004 0621 0092grid.410563.5Clinical Center of Pulmonary Diseases; SHATPD
      “St. Sofia”, Medical Faculty of Medical University of Sofia, Sofia, Bulgaria
FAU - Dimitrova, Denitsa
AU  - Dimitrova D
AD  - 0000 0004 0621 0092grid.410563.5Clinical Center of Pulmonary Diseases; SHATPD
      “St. Sofia”, Medical Faculty of Medical University of Sofia, Sofia, Bulgaria
FAU - Slavova, Yanina
AU  - Slavova Y
AD  - 0000 0004 0621 0092grid.410563.5Clinical Center of Pulmonary Diseases; SHATPD
      “St. Sofia”, Medical Faculty of Medical University of Sofia, Sofia, Bulgaria
FAU - Lesichkova, Spaska
AU  - Lesichkova S
AD  - grid.107984.3Department of Clinical Immunology, Medical Faculty of Medical
      University of Sofia, University Hospital Alexandrovska, Sofia, Bulgaria
FAU - Tzocheva, Iren
AU  - Tzocheva I
AD  - 0000 0004 0621 0092grid.410563.5Pediatric Clinic, University Hospital
      Alexandrovska, Medical University, Sofia, Bulgaria
FAU - Parina, Snezhana
AU  - Parina S
AD  - 0000 0004 0621 0092grid.410563.5Pediatric Clinic, University Hospital
      Alexandrovska, Medical University, Sofia, Bulgaria
FAU - Angelova, Svetla
AU  - Angelova S
AD  - National Centre of Infectious and Parasitic Diseases, National Laboratory
      Influenza and ARD, Sofia, Bulgaria
FAU - Korsun, Neli
AU  - Korsun N
AD  - National Centre of Infectious and Parasitic Diseases, National Laboratory
      Influenza and ARD, Sofia, Bulgaria
FAU - Craiu, Mihai
AU  - Craiu M
AD  - INSMC Alessandrescu-Rusescu, Bucharest, Romania
FAU - Stan, Iustina Violeta
AU  - Stan IV
AD  - INSMC Alessandrescu-Rusescu, Bucharest, Romania
FAU - Deliu, Matea
AU  - Deliu M
AD  - 0000000121662407grid.5379.8Institute of Population Health, Health e-Research
      Centre, University of Manchester, Manchester, UK
FAU - Yavuz, Tolga
AU  - Yavuz T
AD  - 0000000109409118grid.7256.6Division of Pediatric Allergy, GATA Military School of
      Medicine, Ankara, Turkey
FAU - Sperrin, Matthew
AU  - Sperrin M
AD  - 0000000121662407grid.5379.8Centre for Health Informatics, Institute of Population
      Health, University of Manchester, Manchester, UK
FAU - Sahiner, Umit M.
AU  - Sahiner UM
AD  - 0000 0001 2342 7339grid.14442.37Division of Pediatric Allergy, Hacettepe
      University School of Medicine, Ankara, Turkey
FAU - Belgrave, Danielle
AU  - Belgrave D
AD  - 0000 0001 2113 8111grid.7445.2Faculty of Medicine, Department of Medicine,
      Imperial College London, London, UK
FAU - Sackesen, Cansin Sackesen
AU  - Sackesen CS
AD  - 0000000106887552grid.15876.3dKoç University Hospital, Istanbul, Turkey
FAU - Kalayci, Ömer
AU  - Kalayci Ö
AD  - 0000 0001 2342 7339grid.14442.37Pediatric Allergy and Asthma Unit, Hacettepe
      University School of Medicine, Ankara, Turkey
FAU - Velikov, Petar
AU  - Velikov P
AD  - 0000 0004 0621 0092grid.410563.5Medical University, Sofia, Bulgaria
FAU - Velikova, Tsvetelina
AU  - Velikova T
AD  - 0000 0004 0621 0092grid.410563.5Laboratory of Clinical Immunology, University
      Hospital St. Ivan Rilski, Medical University, Sofia, Bulgaria
FAU - Ivanova-Todorova, Ekaterina
AU  - Ivanova-Todorova E
AD  - 0000 0004 0621 0092grid.410563.5Laboratory of Clinical Immunology, University
      Hospital St. Ivan Rilski, Medical University, Sofia, Bulgaria
FAU - Tumangelova-Yuzeir, Kalina
AU  - Tumangelova-Yuzeir K
AD  - 0000 0004 0621 0092grid.410563.5Laboratory of Clinical Immunology, University
      Hospital St. Ivan Rilski, Medical University, Sofia, Bulgaria
FAU - Kyurkchiev, Dobroslav
AU  - Kyurkchiev D
AD  - 0000 0004 0621 0092grid.410563.5Laboratory of Clinical Immunology, University
      Hospital St. Ivan Rilski, Medical University, Sofia, Bulgaria
FAU - Megremis, Spyridon
AU  - Megremis S
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Constantinides, Bede
AU  - Constantinides B
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Sotiropoulos, Alexandros Georgios
AU  - Sotiropoulos AG
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Xepapadaki, Paraskevi
AU  - Xepapadaki P
AD  - 0000 0001 2155 0800grid.5216.0University of Athens, Athens, Greece
FAU - Robertson, David
AU  - Robertson D
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Papadopoulos, Nikolaos
AU  - Papadopoulos N
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Wilkinson, Maxim
AU  - Wilkinson M
AD  - 0000000121662407grid.5379.8Division of Infection, Immunity and Respiratory
      Medicine, Faculty of Biology, Medicine and Health, University of Manchester,
      Manchester, UK
FAU - Portsmouth, Craig
AU  - Portsmouth C
AD  - 0000000121662407grid.5379.8Division of Infection, Immunity and Respiratory
      Medicine, Faculty of Biology, Medicine and Health, University of Manchester,
      Manchester, UK
FAU - Ray, David
AU  - Ray D
AD  - 0000000121662407grid.5379.8Division of Metabolism and Gastroenterology, Faculty
      of Biology, Medicine and Health, University of Manchester, Manchester, UK
FAU - Goodacre, Royston
AU  - Goodacre R
AD  - 0000000121662407grid.5379.8School of Chemistry, Manchester Institute of
      Biotechnology, University of Manchester, Manchester, UK
FAU - Valerieva, Anna
AU  - Valerieva A
AD  - 0000 0004 0621 0092grid.410563.5Clinic of Allergy and Asthma, University Hospital
      Alexandrovska, Medical Faculty of Medical University of Sofia, Sofia, Bulgaria
FAU - Bobolea, Irina
AU  - Bobolea I
AD  - 0000 0001 1945 5329grid.144756.5Hospital 12 de octubre, i+12 Research Institute, 
      Madrid, Spain
FAU - Vera, Daiana Guillén
AU  - Vera DG
AD  - 0000 0001 1945 5329grid.144756.5Hospital 12 de octubre, i+12 Research Institute, 
      Madrid, Spain
FAU - Gonzalez-Salazar, Gabriel
AU  - Gonzalez-Salazar G
AD  - 0000 0001 1945 5329grid.144756.5Hospital 12 de octubre, i+12 Research Institute, 
      Madrid, Spain
FAU - Moreno, Carlos Melero
AU  - Moreno CM
AD  - 0000 0001 1945 5329grid.144756.5Hospital 12 de octubre, i+12 Research Institute, 
      Madrid, Spain
FAU - Rodriguez, Consuelo Fernandez
AU  - Rodriguez CF
AD  - 0000 0001 1945 5329grid.144756.5Hospital 12 de octubre, i+12 Research Institute, 
      Madrid, Spain
FAU - De Las Cuevas Moreno, Natividad
AU  - De Las Cuevas Moreno N
AD  - 0000 0001 1945 5329grid.144756.5Hospital 12 de octubre, i+12 Research Institute, 
      Madrid, Spain
FAU - Wang, R.
AU  - Wang R
AD  - 0000 0004 0430 9363grid.5465.2University Hospital of South Manchester,
      Manchester, UK
FAU - Satia, I.
AU  - Satia I
AD  - 0000 0004 0430 9363grid.5465.2University Hospital of South Manchester,
      Manchester, UK
FAU - Niven, R.
AU  - Niven R
AD  - 0000 0004 0430 9363grid.5465.2University Hospital of South Manchester,
      Manchester, UK
FAU - Smith, J. A.
AU  - Smith JA
AD  - 0000 0004 0430 9363grid.5465.2University Hospital of South Manchester,
      Manchester, UK
FAU - Southworth, T.
AU  - Southworth T
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Plumb, J.
AU  - Plumb J
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Gupta, V.
AU  - Gupta V
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Pearson, J.
AU  - Pearson J
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Ramis, I.
AU  - Ramis I
AD  - grid.474012.4Almirall S. A., Barcelona, Spain
FAU - Lehner, M. D.
AU  - Lehner MD
AD  - grid.474012.4Almirall S. A., Barcelona, Spain
FAU - Miralpeix, M.
AU  - Miralpeix M
AD  - grid.474012.4Almirall S. A., Barcelona, Spain
FAU - Singh, D.
AU  - Singh D
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Satia, Imran
AU  - Satia I
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Woodhead, Mark
AU  - Woodhead M
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - O’Byrne, Paul
AU  - O’Byrne P
AD  - 0000 0004 1936 8227grid.25073.33McMaster University, Hamilton, Canada
FAU - Smith, Jaclyn Ann
AU  - Smith JA
AD  - 0000000121662407grid.5379.8University of Manchester, Manchester, UK
FAU - Forss, Cecilia
AU  - Forss C
AD  - Manchester Collaborative Centre for Inflammation Research, Manchester, UK
FAU - Cook, Peter
AU  - Cook P
AD  - Manchester Collaborative Centre for Inflammation Research, Manchester, UK
FAU - Brown, Sheila
AU  - Brown S
AD  - Manchester Collaborative Centre for Inflammation Research, Manchester, UK
FAU - Svedberg, Freya
AU  - Svedberg F
AD  - Manchester Collaborative Centre for Inflammation Research, Manchester, UK
FAU - Stephenson, Katherine
AU  - Stephenson K
AD  - Manchester Collaborative Centre for Inflammation Research, Manchester, UK
FAU - Bertuzzi, Margherita
AU  - Bertuzzi M
AD  - Manchester Fungal Infection Group, Manchester, UK
FAU - Bignell, Elaine
AU  - Bignell E
AD  - Manchester Fungal Infection Group, Manchester, UK
FAU - Enerbäck, Malin
AU  - Enerbäck M
AD  - 0000 0001 1519 6403grid.418151.8AstraZeneca R&D, Mölndal, Sweden
FAU - Cunoosamy, Danen
AU  - Cunoosamy D
AD  - 0000 0001 1519 6403grid.418151.8AstraZeneca R&D, Mölndal, Sweden
FAU - Macdonald, Andrew
AU  - Macdonald A
AD  - Manchester Collaborative Centre for Inflammation Research, Manchester, UK
FAU - Liu, Caini
AU  - Liu C
AD  - 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA
FAU - Zhu, Liang
AU  - Zhu L
AD  - 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA
FAU - Fukuda, Kiochi
AU  - Fukuda K
AD  - 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA
FAU - Zhang, Cunjin
AU  - Zhang C
AD  - 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA
FAU - Ouyang, Suidong
AU  - Ouyang S
AD  - 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA
FAU - Chen, Xing
AU  - Chen X
AD  - 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA
FAU - Qin, Luke
AU  - Qin L
AD  - 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA
FAU - Rachakonda, Suguna
AU  - Rachakonda S
AD  - 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA
FAU - Aronica, Mark
AU  - Aronica M
AD  - 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA
FAU - Qin, Jun
AU  - Qin J
AD  - 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA
FAU - Li, Xiaoxia
AU  - Li X
AD  - 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA
FAU - Larose, Marie-Chantal
AU  - Larose MC
AD  - CRIUCPQ, Québec, Canada
FAU - Archambault, Anne-Sophie
AU  - Archambault AS
AD  - CRIUCPQ, Québec, Canada
FAU - Provost, Véronique
AU  - Provost V
AD  - CRIUCPQ, Québec, Canada
FAU - Chakir, Jamila
AU  - Chakir J
AD  - CRIUCPQ, Québec, Canada
FAU - Laviolette, Michel
AU  - Laviolette M
AD  - CRIUCPQ, Québec, Canada
FAU - Flamand, Nicolas
AU  - Flamand N
AD  - CRIUCPQ, Québec, Canada
FAU - Logan, Nicola
AU  - Logan N
AD  - 0000 0004 1936 7988grid.4305.2Institute of Immunology and Infection Research,
      University of Edinburgh, Edinburgh, UK
FAU - Ruckerl, Dominik
AU  - Ruckerl D
AD  - 0000000121662407grid.5379.8Faculty of Biology, Medicine & Health, University of
      Manchester, Manchester, UK
FAU - Allen, Judith E.
AU  - Allen JE
AD  - 0000000121662407grid.5379.8Faculty of Biology, Medicine & Health, University of
      Manchester, Manchester, UK
FAU - Sutherland, Tara E.
AU  - Sutherland TE
AD  - 0000000121662407grid.5379.8Manchester Collaborative Centre for Inflammation
      Research, University of Manchester, Manchester, UK
FAU - Hamelmann, E.
AU  - Hamelmann E
AD  - 0000 0004 0490 981Xgrid.5570.7Children’s Center, Evangelisches Krankenhaus
      Bielefeld, and Allergy Center, Ruhr University, Bochum, Germany
FAU - Vogelberg, C.
AU  - Vogelberg C
AD  - 0000 0001 2111 7257grid.4488.0University Hospital Carl Gustav Carus, Technical
      University of Dresden, Dresden, Germany
FAU - Goldstein, S.
AU  - Goldstein S
AD  - Island Medical Research, Rockville Centre, New York City, NY USA
FAU - Azzi, G. E.
AU  - Azzi GE
AD  - 0000 0001 2171 7500grid.420061.1Boehringer Ingelheim Pharma GmbH & Co. KG,
      Ingelheim Am Rhein, Germany
FAU - Engel, M.
AU  - Engel M
AD  - 0000 0001 2171 7500grid.420061.1Boehringer Ingelheim Pharma GmbH & Co. KG,
      Ingelheim Am Rhein, Germany
FAU - Sigmund, R.
AU  - Sigmund R
AD  - 0000 0001 2171 7500grid.420061.1Boehringer Ingelheim Pharma GmbH & Co. KG,
      Biberach An Der Riss, Germany
FAU - Szefler, S. J.
AU  - Szefler SJ
AD  - Children’s Hospital of Colorado, University of Colorado School of Medicine,
      Aurora City, CO USA
FAU - Mesquita, Raquel
AU  - Mesquita R
AD  - 0000 0000 9375 4688grid.414556.7Internal Medicine Department, Centro Hospitalar
      de São João, Porto, Portugal
FAU - Coentrão, Luis
AU  - Coentrão L
AD  - 0000 0000 9375 4688grid.414556.7Emergency and Intensive Care Medicine Department,
      Centro Hospitalar de São João, Porto, Portugal
FAU - Veiga, Rui
AU  - Veiga R
AD  - 0000 0000 9375 4688grid.414556.7Emergency and Intensive Care Medicine Department,
      Centro Hospitalar de São João, Porto, Portugal
FAU - Paiva, José-Artur
AU  - Paiva JA
AD  - 0000 0000 9375 4688grid.414556.7Emergency and Intensive Care Medicine Department,
      Centro Hospitalar de São João, Porto, Portugal
FAU - Roncon-Albuquerque, Roberto
AU  - Roncon-Albuquerque R
AD  - 0000 0000 9375 4688grid.414556.7Emergency and Intensive Care Medicine Department,
      Centro Hospitalar de São João, Porto, Portugal
FAU - Porras, Wendy Vargas
AU  - Porras WV
AD  - 0000 0004 0425 3881grid.411171.3University Hospital Foundation Alcorcón, Madrid, 
      Spain
FAU - Moreno, Ana González
AU  - Moreno AG
AD  - 0000 0004 0425 3881grid.411171.3University Hospital Foundation Alcorcón, Madrid, 
      Spain
FAU - Iglesias, Jesus Macías
AU  - Iglesias JM
AD  - 0000 0004 0425 3881grid.411171.3University Hospital Foundation Alcorcón, Madrid, 
      Spain
FAU - Ramos, Gustavo Córdova
AU  - Ramos GC
AD  - 0000 0004 0425 3881grid.411171.3University Hospital Foundation Alcorcón, Madrid, 
      Spain
FAU - Acevedo, Yesenia Peña
AU  - Acevedo YP
AD  - 0000 0004 0425 3881grid.411171.3University Hospital Foundation Alcorcón, Madrid, 
      Spain
FAU - Alonso, Miguel Angel Tejedor
AU  - Alonso MAT
AD  - 0000 0004 0425 3881grid.411171.3University Hospital Foundation Alcorcón, Madrid, 
      Spain
FAU - Del Mar Moro Moro, Maria
AU  - Del Mar Moro Moro M
AD  - 0000 0004 0425 3881grid.411171.3University Hospital Foundation Alcorcón, Madrid, 
      Spain
FAU - Krcmova, Irena
AU  - Krcmova I
AD  - 0000 0004 0609 2284grid.412539.8Institute of Clinical Immunology and Allergy,
      University Hospital, Hradec Kralove, Czechia
FAU - Novosad, Jakub
AU  - Novosad J
AD  - 0000 0004 0609 2284grid.412539.8Institute of Clinical Immunology and Allergy,
      University Hospital, Hradec Kralove, Czechia
FAU - Hanania, Nicola Alexander
AU  - Hanania NA
AD  - 0000 0001 2160 926Xgrid.39382.33Baylor College of Medicine, Houston, TX USA
FAU - Massanari, Marc
AU  - Massanari M
AD  - Circassia, Raleigh, NC USA
FAU - Hecker, Heike
AU  - Hecker H
AD  - Circassia, Raleigh, NC USA
FAU - Kassel, Eric
AU  - Kassel E
AD  - Circassia, Raleigh, NC USA
FAU - Laforce, Craig
AU  - Laforce C
AD  - grid.477632.3North Carolina Clinical Research, Raleigh, NC USA
FAU - Rickard, Kathy
AU  - Rickard K
AD  - Circassia, Raleigh, NC USA
FAU - Snelder, Sanne
AU  - Snelder S
AD  - 0000 0004 0459 9858grid.461048.fSint Franciscus Gasthuis, Rotterdam, The
      Netherlands
FAU - Braunstahl, Gert-Jan
AU  - Braunstahl GJ
AD  - 0000 0004 0459 9858grid.461048.fSint Franciscus Gasthuis, Rotterdam, The
      Netherlands
FAU - Jones, T. L.
AU  - Jones TL
AD  - 0000 0004 0456 1761grid.418709.3Portsmouth Hospitals NHS Trust, Portsmouth, UK
FAU - Neville, D.
AU  - Neville D
AD  - 0000 0004 0456 1761grid.418709.3Portsmouth Hospitals NHS Trust, Portsmouth, UK
FAU - Heiden, E. R.
AU  - Heiden ER
AD  - 0000 0004 0456 1761grid.418709.3Portsmouth Hospitals NHS Trust, Portsmouth, UK
FAU - Lanning, E.
AU  - Lanning E
AD  - 0000 0004 0456 1761grid.418709.3Portsmouth Hospitals NHS Trust, Portsmouth, UK
FAU - Brown, T.
AU  - Brown T
AD  - 0000 0004 0456 1761grid.418709.3Portsmouth Hospitals NHS Trust, Portsmouth, UK
FAU - Rupani, H.
AU  - Rupani H
AD  - 0000 0004 0456 1761grid.418709.3Portsmouth Hospitals NHS Trust, Portsmouth, UK
FAU - Babu, K. S.
AU  - Babu KS
AD  - 0000 0004 0456 1761grid.418709.3Portsmouth Hospitals NHS Trust, Portsmouth, UK
FAU - Chauhan, A. J.
AU  - Chauhan AJ
AD  - 0000 0004 0456 1761grid.418709.3Portsmouth Hospitals NHS Trust, Portsmouth, UK
FAU - Eldegeir, M. Y.
AU  - Eldegeir MY
AD  - National Guard Hospital, Dammam, Saudi Arabia
FAU - Chapman, A. A.
AU  - Chapman AA
AD  - 0000 0001 2113 8111grid.7445.2Imperial College, London, UK
FAU - Ferwana, M.
AU  - Ferwana M
AD  - 0000 0004 1773 5396grid.56302.32King Saud University, Riyadh, Saudi Arabia
FAU - Caldron, M.
AU  - Caldron M
AD  - 0000 0001 2113 8111grid.7445.2Imperial College, London, UK
LA  - eng
PT  - Journal Article
DEP - 20170524
TA  - Clin Transl Allergy
JT  - Clinical and Translational Allergy
AID - 149 [pii]
AID - 10.1186/s13601-017-0149-8 [doi]
SO  - Clin Transl Allergy. 2017 May 24;7(Suppl 2):. doi:10.1186/s13601-017-0149-8.

PMC - PMC3065324
PMID- 20660250
IS  - 0270-6474 (Print)
IS  - 1529-2401 (Electronic)
VI  - 30
IP  - 29
DP  - 2010 Jul 21
TI  - Rapid Structural Remodeling of Thalamocortical Synapses Parallels
      Experience-Dependent Functional Plasticity in Mouse Primary Visual Cortex.
PG  - 9670-82
AB  - Monocular lid closure (MC) causes a profound shift in the ocular dominance (OD)
      of neurons in primary visual cortex (V1). Anatomical studies in both cat and
      mouse V1 suggest that large-scale structural rearrangements of eye-specific
      thalamocortical (TC) axons in response to MC occur much more slowly than the
      shift in OD. Consequently, there has been considerable debate as to whether the
      plasticity of TC synapses, which transmit competing visual information from each 
      eye to V1, contributes to the early functional consequences of MC or is simply a 
      feature of long-term deprivation. Here, we used quantitative immuno-electron
      microscopy to examine the possibility that alterations of TC synapses occur
      rapidly enough to impact OD after brief MC. The effect of short-term deprivation 
      on TC synaptic structure was examined in male C57BL/6 mice that underwent 3 and 7
      d of MC or monocular retinal inactivation (MI) with tetrodotoxin. The data show
      that 3 d of MC is sufficient to induce substantial remodeling of TC synapses. In 
      contrast, 3 d of MI, which alters TC activity but does not shift OD, does not
      significantly affect the structure of TC synapses. Our results support the
      hypothesis that the rapid plasticity of TC synapses is a key step in the sequence
      of events that shift OD in visual cortex.
FAU - Coleman, Jason E.
AU  - Coleman JE
AD  - Howard Hughes Medical Institute, The Picower Institute for Learning and Memory,
      Cambridge, Massachusetts 02142
FAU - Nahmani, Marc
AU  - Nahmani M
AD  - Department of Psychology, University of Virginia, Charlottesville, Virginia
      22904-4400
FAU - Gavornik, Jeffrey P.
AU  - Gavornik JP
AD  - Howard Hughes Medical Institute, The Picower Institute for Learning and Memory,
      Cambridge, Massachusetts 02142
FAU - Haslinger, Robert
AU  - Haslinger R
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, Massachusetts 02142
FAU - Heynen, Arnold J.
AU  - Heynen AJ
AD  - Howard Hughes Medical Institute, The Picower Institute for Learning and Memory,
      Cambridge, Massachusetts 02142
FAU - Erisir, Alev
AU  - Erisir A
AD  - Department of Psychology, University of Virginia, Charlottesville, Virginia
      22904-4400
FAU - Bear, Mark F.
AU  - Bear MF
AD  - Howard Hughes Medical Institute, The Picower Institute for Learning and Memory,
      Cambridge, Massachusetts 02142
LA  - eng
PT  - Journal Article
GR  - R01 EY012309-12S1 || EY
TA  - J Neurosci
JT  - The Journal of neuroscience : the official journal of the Society for
      Neuroscience
AID - 10.1523/JNEUROSCI.1248-10.2010 [doi]
MID - NIHMS278827
SO  - J Neurosci. 2010 Jul 21;30(29):9670-82. doi:10.1523/JNEUROSCI.1248-10.2010.

PMC - PMC3776058
PMID- 24048836
IS  - 0270-6474 (Print)
IS  - 1529-2401 (Electronic)
VI  - 33
IP  - 38
DP  - 2013 Sep 18
TI  - Human Cortical θ during Free Exploration Encodes Space and Predicts Subsequent
      Memory.
PG  - 15056-68
AB  - Spatial representations and walking speed in rodents are consistently related to 
      the phase, frequency, and/or amplitude of θ rhythms in hippocampal local field
      potentials. However, neuropsychological studies in humans have emphasized the
      importance of parietal cortex for spatial navigation, and efforts to identify the
      electrophysiological signs of spatial navigation in humans have been stymied by
      the difficulty of recording during free exploration of complex environments. We
      resolved the recording problem and experimentally probed brain activity of human 
      participants who were fully ambulant. On each of 2 d, electroencephalography was 
      synchronized with head and body movement in 13 subjects freely navigating an
      extended virtual environment containing numerous unique objects. θ phase and
      amplitude recorded over parietal cortex were consistent when subjects walked
      through a particular spatial separation at widely separated times. This spatial
      displacement θ autocorrelation (STAcc) was quantified and found to be significant
      from 2 to 8 Hz within the environment. Similar autocorrelation analyses performed
      on an electrooculographic channel, used to measure eye movements, showed no
      significant spatial autocorrelations, ruling out eye movements as the source of
      STAcc. Strikingly, the strength of an individual's STAcc maps from day 1
      significantly predicted object location recall success on day 2. θ was also
      significantly correlated with walking speed; however, this correlation appeared
      unrelated to STAcc and did not predict memory performance. This is the first
      demonstration of memory-related, spatial maps in humans generated during active
      spatial exploration.
FAU - Snider, Joseph
AU  - Snider J
AD  - Institute for Neural Computation, University of California, San Diego, La Jolla, 
      California 92093,
FAU - Plank, Markus
AU  - Plank M
AD  - Institute for Neural Computation, University of California, San Diego, La Jolla, 
      California 92093,
FAU - Lynch, Gary
AU  - Lynch G
AD  - Departments of Psychiatry and Human Behavior and Anatomy and Neurobiology,
      University of California, Irvine, Irvine, California 92697,
FAU - Halgren, Eric
AU  - Halgren E
AD  - Departments of Radiology, Neuroscience, and Psychiatry, University of California,
      San Diego, La Jolla, California 92093, and
FAU - Poizner, Howard
AU  - Poizner H
AD  - Institute for Neural Computation, University of California, San Diego, La Jolla, 
      California 92093,
LA  - eng
PT  - Journal Article
PHST- 2013/01/20 [received]
PHST- 2013/08/13 [revised]
PHST- 2013/08/15 [accepted]
TA  - J Neurosci
JT  - The Journal of Neuroscience
AID - 0268-13 [pii]
AID - 10.1523/JNEUROSCI.0268-13.2013 [doi]
SO  - J Neurosci. 2013 Sep 18;33(38):15056-68. doi:10.1523/JNEUROSCI.0268-13.2013.

PMC - PMC2878373
PMID- 19794098
IS  - 0883-0738 (Print)
IS  - 1708-8283 (Electronic)
VI  - 25
IP  - 6
DP  - 2010 Jun
TI  - Increasing viscosity and inertia using a robotically-controlled pen improves
      handwriting in children.
PG  - 674-80
AB  - The aim of this study was to determine the effect of mechanical properties of the
      pen on the quality of handwriting in children.Twenty two school aged children,
      ages 8–14 years wrote in cursive using a pen attached to a robot. The robot was
      programmed to increase the effective weight (inertia) and stiffness (viscosity)
      of the pen. Speed, frequency, variability, and quality of the two handwriting
      samples were compared.Increased inertia and viscosity improved handwriting
      quality in 85% of children (p<0.05). Handwriting quality did not correlate with
      changes in speed, suggesting that improvement was not due to reduced speed.
      Measures of movement variability remained unchanged, suggesting that improvement 
      was not due to mechanical smoothing of pen movement by the robot. Since
      improvement was not explained by reduced speed or mechanical smoothing, we
      conclude that children alter handwriting movements in response to pen mechanics. 
      Altered movement could be caused by changes in proprioceptive sensory feedback.
FAU - Ben-Pazi, Hilla
AU  - Ben-Pazi H
AD  - Neuropediatric Unit, Shaare Zedek Medical Center, Jerusalem, Israel and
      Department of Child Neurology, Stanford Medical Center, Stanford CA, USA
FAU - Ishihara, Abraham
AU  - Ishihara A
AD  - Department of Child Neurology, Stanford Medical Center, Stanford CA, USA
FAU - Kukke, Sahana
AU  - Kukke S
AD  - Department of Child Neurology, Stanford Medical Center, Stanford CA, USA
FAU - Sanger, Terence D
AU  - Sanger TD
AD  - Department of Child Neurology, Stanford Medical Center, Stanford CA, USA
LA  - eng
PT  - Journal Article
DEP - 20090930
TA  - J Child Neurol
JT  - Journal of child neurology
AID - 10.1177/0883073809342592 [doi]
MID - NIHMS179704
SO  - J Child Neurol. 2010 Jun;25(6):674-80. Epub 2009 Sep 30
      doi:10.1177/0883073809342592.

PMC - PMC2958453
PMID- 20807062
IS  - 1044-5463 (Print)
IS  - 1557-8992 (Electronic)
VI  - 20
IP  - 4
DP  - 2010 Aug
TI  - Neurobiological Substrates of Tourette's Disorder.
PG  - 237-47
AB  - Objective: This article reviews the available scientific literature concerning
      the neurobiological substrates of Tourette's disorder (TD). Methods: The
      electronic databases of PubMed, ScienceDirect, and PsycINFO were searched for
      relevant studies using relevant search terms. Results: Neuropathological as well 
      as structural and functional neuroimaging studies of TD implicate not only the
      sensorimotor corticostriatal circuit, but also the limbic and associative
      circuits as well. Preliminary evidence also points to abnormalities in the
      frontoparietal network that is thought to maintain adaptive online control.
      Evidence supporting abnormalities in dopaminergic and noradrenergic
      neurotransmission remains strong, although the precise mechanisms remain the
      subject of speculation. Conclusion: Structural and functional abnormalities in
      multiple parallel corticostriatal circuits may underlie the behavioral
      manifestations of TD and related neuropsychiatric disorders over the course of
      development. Further longitudinal research is needed to elucidate these
      neurobiological substrates.
FAU - Leckman, James F.
AU  - Leckman JF
AD  - Child Study Center, Yale University, New Haven, Connecticut.
FAU - Bloch, Michael H.
AU  - Bloch MH
AD  - Child Study Center, Yale University, New Haven, Connecticut.
FAU - Smith, Megan E.
AU  - Smith ME
AD  - Child Study Center, Yale University, New Haven, Connecticut.
FAU - Larabi, Daouia
AU  - Larabi D
AD  - University Medical Center Groningen, University of Groningen, Groningen, The
      Netherlands.
FAU - Hampson, Michelle
AU  - Hampson M
AD  - Department of Diagnostic Radiology, Yale University, New Haven, Connecticut.
LA  - eng
PT  - Journal Article
TA  - J Child Adolesc Psychopharmacol
JT  - Journal of Child and Adolescent Psychopharmacology
AID - 10.1089/cap.2009.0118 [pii]
AID - 10.1089/cap.2009.0118 [doi]
SO  - J Child Adolesc Psychopharmacol. 2010 Aug;20(4):237-47.
      doi:10.1089/cap.2009.0118.

PMC - PMC5135376
PMID- 27803317
IS  - 0027-8424 (Print)
IS  - 1091-6490 (Electronic)
VI  - 113
IP  - 46
DP  - 2016 Nov 15
TI  - Jointly reduced inhibition and excitation underlies circuit-wide changes in
      cortical processing in Rett syndrome.
PG  - E7287-96
AB  - Understanding neurophysiological correlates of neurodevelopmental disorders is
      one of the pressing challenges of neuroscience. By analyzing a mouse model of
      Rett syndrome (RTT), we show that cortical pyramidal neurons in methyl-CpG
      binding protein 2 (MeCP2) mutant mice have reduced excitatory as well as
      inhibitory synaptic drive. Thus, neuronal response reliability and selectivity,
      features that arise from excitatory/inhibitory processing circuits within cortex,
      are reduced. MeCP2 deletion crucially regulates inhibition via two complementary 
      mechanisms: reducing responses of parvalbumin-expressing (PV+) inhibitory neurons
      and altering the polarity of GABAergic inhibition in pyramidal neurons. Treating 
      mutant mice with recombinant human insulin-like growth factor-1 (rhIGF1) restores
      GABAergic polarity along with PV+ and pyramidal neuron responses, thus providing 
      a mechanistic basis of action of rhIGF1 in RTT.
OAB - Publisher: Abstract available from the publisher.
FAU - Banerjee, Abhishek
AU  - Banerjee A
AD  - The Picower Institute for Learning and Memory, Department of Brain and Cognitive 
      Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139;
FAU - Rikhye, Rajeev V.
AU  - Rikhye RV
AD  - The Picower Institute for Learning and Memory, Department of Brain and Cognitive 
      Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139;
FAU - Breton-Provencher, Vincent
AU  - Breton-Provencher V
AD  - The Picower Institute for Learning and Memory, Department of Brain and Cognitive 
      Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139;
FAU - Tang, Xin
AU  - Tang X
AD  - The Whitehead Institute for Biomedical Research, Cambridge, MA 02142;
FAU - Li, Chenchen
AU  - Li C
AD  - Broad Institute of MIT and Harvard, Cambridge, MA 02142
FAU - Li, Keji
AU  - Li K
AD  - The Picower Institute for Learning and Memory, Department of Brain and Cognitive 
      Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139;
FAU - Runyan, Caroline A.
AU  - Runyan CA
AD  - The Picower Institute for Learning and Memory, Department of Brain and Cognitive 
      Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139;
FAU - Fu, Zhanyan
AU  - Fu Z
AD  - Broad Institute of MIT and Harvard, Cambridge, MA 02142
FAU - Jaenisch, Rudolf
AU  - Jaenisch R
AD  - The Whitehead Institute for Biomedical Research, Cambridge, MA 02142;
FAU - Sur, Mriganka
AU  - Sur M
AD  - The Picower Institute for Learning and Memory, Department of Brain and Cognitive 
      Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139;
LA  - eng
PT  - Journal Article
DEP - 20161101
GR  - HD 045022
PHST- 2016/11/01 [aheadofprint]
TA  - Proc Natl Acad Sci U S A
JT  - Proceedings of the National Academy of Sciences of the United States of America
AID - 201615330 [pii]
AID - 10.1073/pnas.1615330113 [doi]
SO  - Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):E7287-96. Epub 2016 Nov 1
      doi:10.1073/pnas.1615330113.

PMC - PMC4096778
PMID- 23859354
IS  - 0902-0063 (Print)
IS  - 1399-0012 (Electronic)
VI  - 27
IP  - 4
DP  - 2013 Jul-Aug
TI  - Computerized Assessment of Competence-Related Abilities in Living Liver Donors:
      The Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL).
PG  - 633-45
AB  - Background: Despite its importance, determination of competence to consent to
      organ donation varies widely based on local standards. We piloted a new tool to
      aid transplant centers in donor assessment. Methods: We assessed
      competence-related abilities among potential living liver donors (LDs) in the
      9-center A2ALL study. Prospective LDs viewed an educational video, and were
      queried to assess Understanding, Appreciation, Reasoning, and ability to express 
      a Final Choice using the MacArthur Competence Assessment Tool for Clinical
      Research, adapted for computerized administration in LDs (“MacLiver”). Videotaped
      responses were scored by a clinical neuropsychologist (JF). Results: Ninety-three
      LDs were assessed. Mean (standard deviation; domain maximum) scores were:
      Understanding: 18.1 (2.6; max=22), Appreciation: 5.1 (1.0; max=6), Reasoning: 3.1
      (0.8; max=4), and Final Choice: 3.8 (0.5; max=4). Scores did not differ by
      demographics, relationship to the recipient, eligibility to donate, or eventual
      donation (p>0.4). Higher education was associated with greater Understanding
      (p=0.004) and Reasoning (p=0.03). Conclusion: Standardized, computerized
      education with independent ratings of responses may (1) alert the clinical staff 
      to potential donors who may not be competent to donate, and (2) highlight areas
      needing further assessment and education, leading to better informed
      decision-making.
FAU - Freeman, Jason
AU  - Freeman J
AD  - Department of Psychiatry and Neurobehavioral Sciences, University of Virginia,
      Charlottesville, VA
FAU - Emond, Jean
AU  - Emond J
AD  - Department of Surgery, Columbia University Medical Center, New York, NY
FAU - Gillespie, Brenda W.
AU  - Gillespie BW
AD  - Department of Biostatistics, University of Michigan, Ann Arbor, MI
FAU - Appelbaum, Paul S.
AU  - Appelbaum PS
AD  - Department of Psychiatry, Columbia University Medical Center, New York, NY
FAU - Weinrieb, Robert
AU  - Weinrieb R
AD  - Department of Psychiatry, University of Pennsylvania, Philadelphia, PA
FAU - Hill-Callahan, Peg
AU  - Hill-Callahan P
AD  - Arbor Research Collaborative for Health, Ann Arbor, MI
FAU - Gordon, Elisa J.
AU  - Gordon EJ
AD  - Center for Healthcare Studies and Comprehensive Transplant Center, Northwestern
      University, Chicago, IL
FAU - Terrault, Norah
AU  - Terrault N
AD  - Department of Medicine, University of California at San Francisco, San Francisco,
      CA
FAU - Trotter, James
AU  - Trotter J
AD  - Department of Surgery, University of Colorado, Aurora, CO (Current affiliation = 
      Department of Medicine, Baylor University Medical Center, Dallas, TX)
FAU - Ashworth, April
AU  - Ashworth A
AD  - Department of Transplant Surgery, Virginia Commonwealth University Medical
      Center, Richmond, VA
FAU - Dew, Mary Amanda
AU  - Dew MA
AD  - Department of Psychiatry, Univ. of Pittsburgh School of Medicine and Medical
      Center, Pittsburgh, PA
FAU - Pruett, Timothy
AU  - Pruett T
AD  - Department of Transplant Surgery, University of Minnesota, Minneapolis, MN
CN  - the A2ALL Study Group
LA  - eng
PT  - Journal Article
DEP - 20130716
TA  - Clin Transplant
JT  - Clinical transplantation
AID - 10.1111/ctr.12184 [doi]
MID - NIHMS593802
SO  - Clin Transplant. 2013 Jul-Aug;27(4):633-45. Epub 2013 Jul 16
      doi:10.1111/ctr.12184.

PMC - PMC311321
PMID- 10706603
IS  - 1072-0502 (Print)
VI  - 7
IP  - 1
DP  - 2000 Jan
TI  - Computer-Assisted Behavioral Assessment of Pavlovian Fear Conditioning in Mice.
PG  - 58-72
AB  - In Pavlovian fear conditioning, a conditional stimulus (CS, usually a tone) is
      paired with an aversive unconditional stimulus (US, usually a foot shock) in a
      novel context. After even a single pairing, the animal comes to exhibit a
      long-lasting fear to the CS and the conditioning context, which can be measured
      as freezing, an adaptive defense reaction in mice. Both context and tone
      conditioning depend on the integrity of the amygdala, and context conditioning
      further depends on the hippocampus. The reliability and efficiency of the fear
      conditioning assay makes it an excellent candidate for the screening of learning 
      and memory deficits in mutant mice. One obstacle is that freezing in mice has
      been accurately quantified only by human observers, using a tedious method that
      can be subject to bias. In the present study we generated a simple, high-speed,
      and highly accurate algorithm that scores freezing of four mice simultaneously
      using NIH Image on an ordinary Macintosh computer. The algorithm yielded a high
      correlation and excellent linear fit between computer and human scores across a
      broad range of conditions. This included the ability to score low pretraining
      baseline scores and accurately mimic the effects of two independent variables
      (shock intensity and test modality) on fear. Because we used a computer and
      digital video, we were able to acquire a secondary index of fear, activity
      suppression, as well as baseline activity scores. Moreover, we measured the
      unconditional response to shock. These additional measures can enhance the
      sensitivity of the assay to detect interesting memory phenotypes and control for 
      possible confounds. Thus, this computer-assisted system for measuring behavior
      during fear conditioning allows for the standardized and carefully controlled
      assessment of multiple aspects of the fear conditioning experience.
FAU - Anagnostaras, Stephan G.
AU  - Anagnostaras SG
FAU - Josselyn, Sheena A.
AU  - Josselyn SA
FAU - Frankland, Paul W.
AU  - Frankland PW
FAU - Silva, Alcino J.
AU  - Silva AJ
LA  - eng
PT  - Journal Article
PHST- 1999/08/25 [received]
PHST- 1999/11/17 [accepted]
TA  - Learn Mem
JT  - Learning & Memory
SO  - Learn Mem. 2000 Jan;7(1):58-72.

PMC - PMC5490089
PMID- 28659159
IS  - 1748-5908 (Electronic)
VI  - 12
DP  - 2017
TI  - Searching for management approaches to reduce HAI transmission (SMART): a study
      protocol.
LID - 82
AB  - Background: Healthcare-associated infections (HAIs) impact patients’ lives
      through prolonged hospitalization, morbidity, and death, resulting in significant
      costs to both health systems and society. Central line-associated bloodstream
      infections (CLABSIs) and catheter-associated urinary tract infections (CAUTIs)
      are two of the most preventable HAIs. As a result, these HAIs have been the focus
      of significant efforts to identify evidence-based clinical strategies to reduce
      infection rates. The Comprehensive Unit-based Safety Program (CUSP) provides a
      formal model for translating CLABSI-reduction evidence into practice. Yet, a
      national demonstration project found organizations experienced variable levels of
      success using CUSP to reduce CLABSIs. In addition, in Fiscal year 2019, Medicare 
      will expand use of CLABSI and CAUTI metrics beyond ICUs to the entire hospital
      for reimbursement purposes. As a result, hospitals need guidance about how to
      successfully translate HAI-reduction efforts such as CUSP to non-ICU settings
      (clinical practice), and how to shape context (management practice)—including
      culture and management strategies—to proactively support clinical teams. Methods:
      Using a mixed-methods approach to evaluate the contribution of management factors
      to successful HAI-reduction efforts, our study aims to: (1) Develop valid and
      reliable measures of structural management practices associated with the
      recommended CLABSI Management Strategies for use as a survey (HAI Management
      Practice Guideline Survey) to support HAI-reduction efforts in both
      medical/surgical units and ICUs; (2) Develop, validate, and then deploy the HAI
      Management Practice Guideline Survey, first across Ohio hospitals, then
      nationwide, to determine the positive predictive value of the measurement
      instrument as it relates to CLABSI- and CAUTI-prevention; and (3) Integrate
      findings into a Management Practices Toolkit for HAI reduction that includes an
      organization-specific data dashboard for monitoring progress and an
      implementation program for toolkit use, and disseminate that Toolkit nationwide. 
      Discussion: Providing hospitals with the tools they need to successfully measure 
      management structures that support clinical care provides a powerful approach
      that can be leveraged to reduce the incidence of HAIs experienced by patients.
      This study is critical to providing the information necessary to successfully
      “make health care safer” by providing guidance on how contextual factors within a
      healthcare setting can improve patient safety across hospitals.
FAU - McAlearney, Ann Scheck
AU  - McAlearney AS
AUID- ORCID: 0000-0001-9107-5419
AD  - 0000 0001 2285 7943grid.261331.4Department of Family Medicine, College of
      Medicine, The Ohio State University, 2231 North High Street, Suite 273, Columbus,
      OH 43201 USA
FAU - Hefner, Jennifer L.
AU  - Hefner JL
AD  - 0000 0001 2285 7943grid.261331.4Department of Family Medicine, College of
      Medicine, The Ohio State University, 2231 North High Street, Suite 273, Columbus,
      OH 43201 USA
FAU - Sieck, Cynthia J.
AU  - Sieck CJ
AD  - 0000 0001 2285 7943grid.261331.4Department of Family Medicine, College of
      Medicine, The Ohio State University, 2231 North High Street, Suite 273, Columbus,
      OH 43201 USA
FAU - Walker, Daniel M.
AU  - Walker DM
AD  - 0000 0001 2285 7943grid.261331.4Department of Family Medicine, College of
      Medicine, The Ohio State University, 2231 North High Street, Suite 273, Columbus,
      OH 43201 USA
FAU - Aldrich, Alison M.
AU  - Aldrich AM
AD  - 0000 0001 2285 7943grid.261331.4Department of Family Medicine, College of
      Medicine, The Ohio State University, 2231 North High Street, Suite 273, Columbus,
      OH 43201 USA
FAU - Sova, Lindsey N.
AU  - Sova LN
AD  - 0000 0001 2285 7943grid.261331.4Department of Family Medicine, College of
      Medicine, The Ohio State University, 2231 North High Street, Suite 273, Columbus,
      OH 43201 USA
FAU - Gaughan, Alice A.
AU  - Gaughan AA
AD  - 0000 0001 2285 7943grid.261331.4Department of Family Medicine, College of
      Medicine, The Ohio State University, 2231 North High Street, Suite 273, Columbus,
      OH 43201 USA
FAU - Slevin, Caitlin M.
AU  - Slevin CM
AD  - 0000 0001 2285 7943grid.261331.4Department of Family Medicine, College of
      Medicine, The Ohio State University, 2231 North High Street, Suite 273, Columbus,
      OH 43201 USA
FAU - Hebert, Courtney
AU  - Hebert C
AD  - 0000 0001 2285 7943grid.261331.4Division of Health Services Management and
      Policy, College of Public Health, The Ohio State University, Columbus, OH 43201
      USA
FAU - Hade, Erinn
AU  - Hade E
AD  - 0000 0001 2285 7943grid.261331.4Center for Biostatistics, College of Medicine,
      The Ohio State University, 320G Lincoln Tower, 1800 Cannon Drive, Columbus, OH
      43201 USA
FAU - Buck, Jacalyn
AU  - Buck J
AD  - 0000 0001 1545 0811grid.412332.5The Ohio State University Wexner Medical Center, 
      134 Doan Hall, 410 W. 10th Ave, Columbus, OH 43210 USA
FAU - Grove, Michele
AU  - Grove M
AD  - 0000 0001 1545 0811grid.412332.5The Ohio State University Wexner Medical Center, 
      134 Doan Hall, 410 W. 10th Ave, Columbus, OH 43210 USA
FAU - Huerta, Timothy R.
AU  - Huerta TR
AD  - 0000 0001 2285 7943grid.261331.4Department of Family Medicine, College of
      Medicine, The Ohio State University, 2231 North High Street, Suite 273, Columbus,
      OH 43201 USA
LA  - eng
PT  - Journal Article
DEP - 20170628
GR  - R01HS024958
PHST- 2017/05/15 [received]
PHST- 2017/06/14 [accepted]
TA  - Implement Sci
JT  - Implementation Science : IS
AID - 610 [pii]
AID - 10.1186/s13012-017-0610-z [doi]
SO  - Implement Sci. 2017 Jun 28;12:. doi:10.1186/s13012-017-0610-z.

PMC - PMC4239945
PMID- 25299953
IS  - 1424-8220 (Electronic)
VI  - 14
IP  - 10
DP  - 2014 Oct
TI  - Comparison and Characterization of Android-Based Fall Detection Systems.
PG  - 18543-74
AB  - Falls are a foremost source of injuries and hospitalization for seniors. The
      adoption of automatic fall detection mechanisms can noticeably reduce the
      response time of the medical staff or caregivers when a fall takes place.
      Smartphones are being increasingly proposed as wearable, cost-effective and
      not-intrusive systems for fall detection. The exploitation of smartphones'
      potential (and in particular, the Android Operating System) can benefit from the 
      wide implantation, the growing computational capabilities and the diversity of
      communication interfaces and embedded sensors of these personal devices. After
      revising the state-of-the-art on this matter, this study develops an experimental
      testbed to assess the performance of different fall detection algorithms that
      ground their decisions on the analysis of the inertial data registered by the
      accelerometer of the smartphone. Results obtained in a real testbed with diverse 
      individuals indicate that the accuracy of the accelerometry-based techniques to
      identify the falls depends strongly on the fall pattern. The performed tests also
      show the difficulty to set detection acceleration thresholds that allow achieving
      a good trade-off between false negatives (falls that remain unnoticed) and false 
      positives (conventional movements that are erroneously classified as falls). In
      any case, the study of the evolution of the battery drain reveals that the extra 
      power consumption introduced by the Android monitoring applications cannot be
      neglected when evaluating the autonomy and even the viability of fall detection
      systems.
FAU - Luque, Rafael
AU  - Luque R
FAU - Casilari, Eduardo
AU  - Casilari E
FAU - Morón, María-José
AU  - Morón MJ
FAU - Redondo, Gema
AU  - Redondo G
LA  - eng
PT  - Journal Article
DEP - 20141008
PHST- 2014/06/25 [received]
PHST- 2014/09/22 [revised]
PHST- 2014/09/23 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s141018543 [doi]
AID - sensors-14-18543 [pii]
SO  - Sensors (Basel). 2014 Oct 08;14(10):18543-74. doi:10.3390/s141018543.

PMC - PMC3534480
PMID- 23146079
IS  - 1477-9560 (Electronic)
VI  - 10
DP  - 2012
TI  - Diastolic timed Vibro-Percussion at 50 Hz delivered across a chest wall sized
      meat barrier enhances clot dissolution and remotely administered Streptokinase
      effectiveness in an in-vitro model of acute coronary thrombosis.
PG  - 23
AB  - Background: Low Frequency Vibro-Percussion (LFVP) assists clearance of thrombi in
      catheter systems and when applied to the heart and timed to diastole is known to 
      enhance coronary flow. However LFVP on a clotted coronary like vessel given
      engagement over a chest wall sized barrier (to resemble non-invasive heart attack
      therapy) requires study. Methods: One hour old clots (n=16) were dispensed within
      a flexible segment of Soft-Flo catheter (4 mm lumen), weighted, interfaced with
      Heparinized Saline (HS), secured atop a curved dampening base, and photographed. 
      A ~4 cm meat slab was placed over the segment and randomized to receive
      intermittent LFVP (engaged, - disengaged at 1 second intervals), or no LFVP for
      20 minutes. HS was pulsed (~120/80 mmHg), with the diastolic phase coordinated to
      match LFVP delivery. The segment was then re-photographed and aspirated of fluid 
      to determine post clot weight. The trial was then repeated with 0.5 mls of
      Streptokinase (15,000 IU/100 microlitre) delivered ~ 2 cm upstream from the clot.
      Results: LFVP - HS only samples (vs. controls) showed; a) development of clot
      length fluid channels absent in the control group (p < 0.0002); b) enhanced
      dissolved clot mixing scores ( 5.0 vs. 0.8, p < 2.8 E – 6); and c) increased
      percent clot dissolution (23.0% vs. 1.8% respectively, p < 8.5 E-6). LFVP - SK
      samples had a similar comparative clot disruptive profile, however fluid channels
      developed faster and percent clot dissolution more than doubled (51.0% vs. 3.0%, 
      p< 9.8 E- 6). Conclusion: Diastolic timed LFVP (50 Hz) engaged across a chest
      wall sized barrier enhances clot disruptive effects to an underlying coronary
      like system.
FAU - Hoffmann, Andrew
AU  - Hoffmann A
AD  - Ahof Biophysical Systems Inc, 3858 Regent St, Burnaby, BC, Canada , V5C4G8
FAU - Gill, Harjit
AU  - Gill H
AD  - In-Vitro Labs, 5407 Canada Way, Burnaby, BC, Canada , V5E 3N5
LA  - eng
PT  - Journal Article
DEP - 20121112
PHST- 2012/09/09 [received]
PHST- 2012/10/31 [accepted]
TA  - Thromb J
JT  - Thrombosis Journal
AID - 1477-9560-10-23 [pii]
AID - 10.1186/1477-9560-10-23 [doi]
SO  - Thromb J. 2012 Nov 12;10:23. doi:10.1186/1477-9560-10-23.

PMC - PMC2746660
PMID- 19768136
IS  - 1573-4056 (Print)
VI  - 5
IP  - 1
DP  - 2009 Feb 1
TI  - In Vivo Cellular Imaging for Translational Medical Research.
PG  - 19-38
AB  - Personalized treatment using stem, modified or genetically engineered, cells is
      becoming a reality in the field of medicine, in which allogenic or autologous
      cells can be used for treatment and possibly for early diagnosis of diseases.
      Hematopoietic, stromal and organ specific stem cells are under evaluation for
      cell-based therapies for cardiac, neurological, autoimmune and other disorders.
      Cytotoxic or genetically altered T-cells are under clinical trial for the
      treatment of hematopoietic or other malignant diseases. Before using stem cells
      in clinical trials, translational research in experimental animal models are
      essential, with a critical emphasis on developing noninvasive methods for
      tracking the temporal and spatial homing of these cells to target tissues.
      Moreover, it is necessary to determine the transplanted cell’s engraftment
      efficiency and functional capability. Various in vivo imaging modalities are in
      use to track the movement and incorporation of administered cells. Tagging cells 
      with reporter genes, fluorescent dyes or different contrast agents transforms
      them into cellular probes or imaging agents. Recent reports have shown that
      magnetically labeled cells can be used as cellular magnetic resonance imaging
      (MRI) probes, demonstrating the cell trafficking to target tissues. In this
      review, we will discuss the methods to transform cells into probes for in vivo
      imaging, along with their advantages and disadvantages as well as the future
      clinical applicability of cellular imaging method and corresponding imaging
      modality.
FAU - Arbab, Ali S
AU  - Arbab AS
AD  - Cellular and Molecular Imaging Laboratory, Department of Radiology, Henry Ford
      Hospital, Detroit, MI
FAU - Janic, Branislava
AU  - Janic B
AD  - Cellular and Molecular Imaging Laboratory, Department of Radiology, Henry Ford
      Hospital, Detroit, MI
FAU - Haller, Jodi
AU  - Haller J
AD  - Frank Laboratory, Radiology and Imaging Sciences, Clinical Center, National
      Institutes of Health, Bethesda, MD
FAU - Pawelczyk, Edyta
AU  - Pawelczyk E
AD  - Frank Laboratory, Radiology and Imaging Sciences, Clinical Center, National
      Institutes of Health, Bethesda, MD
FAU - Liu, Wei
AU  - Liu W
AD  - Frank Laboratory, Radiology and Imaging Sciences, Clinical Center, National
      Institutes of Health, Bethesda, MD
FAU - Frank, Joseph A
AU  - Frank JA
AD  - Frank Laboratory, Radiology and Imaging Sciences, Clinical Center, National
      Institutes of Health, Bethesda, MD
LA  - eng
PT  - Journal Article
TA  - Curr Med Imaging Rev
JT  - Current medical imaging reviews
AID - 10.2174/157340509787354697 [doi]
MID - NIHMS96806
SO  - Curr Med Imaging Rev. 2009 Feb 1;5(1):19-38. doi:10.2174/157340509787354697.

PMC - PMC3140594
PMID- 21397519
IS  - 1053-8100 (Print)
IS  - 1090-2376 (Electronic)
VI  - 20
IP  - 3
DP  - 2011 Sep
TI  - Placebo acupuncture as a form of ritual touch healing: a neurophenomenological
      model.
PG  - 784-91
AB  - Evidence that placebo acupuncture is an effective treatment for chronic pain
      presents a puzzle: how do placebo needles appearing to patients to penetrate the 
      body, but instead sitting on the skin’s surface in the manner of a tactile
      stimulus, evoke a healing response? Previous accounts of ritual touch healing in 
      which patients often described enhanced touch sensations (including warmth,
      tingling or flowing sensations) suggest an embodied healing mechanism. In this
      qualitative study, we asked a subset of patients in a randomized trial in
      irritable bowel syndrome to describe treatment experiences. Analysis focused on
      patients’ unprompted descriptions of any enhanced touch sensations (e.g., warmth,
      tingling) and any significance patients assigned to the sensations. We found in
      5/6 cases, patients associated sensations including “warmth” and “tingling” with 
      treatment efficacy. The conclusion offers a “neurophenomenological” account of
      the placebo effect by considering dynamic effects of attentional filtering on
      early sensory cortices, possibly underlying the phenomenology of placebo
      acupuncture.
FAU - Kerr, Catherine E.
AU  - Kerr CE
AD  - Osher Research Center, Harvard Medical School, Boston, MA
FAU - Shaw, Jessica R
AU  - Shaw JR
AD  - Osher Research Center, Harvard Medical School, Boston, MA
FAU - Conboy, Lisa
AU  - Conboy L
AD  - Osher Research Center, Harvard Medical School, Boston, MA
FAU - Kelley, John M.
AU  - Kelley JM
AD  - Endicott College, Beverly, MA
FAU - Jacobson, Eric
AU  - Jacobson E
AD  - Osher Research Center, Harvard Medical School, Boston, MA
FAU - Kaptchuk, Ted
AU  - Kaptchuk T
AD  - Osher Research Center, Harvard Medical School, Boston, MA
LA  - eng
PT  - Journal Article
DEP - 20110311
TA  - Conscious Cogn
JT  - Consciousness and cognition
AID - 10.1016/j.concog.2010.12.009 [doi]
MID - NIHMS260548
SO  - Conscious Cogn. 2011 Sep;20(3):784-91. Epub 2011 Mar 11
      doi:10.1016/j.concog.2010.12.009.

PMC - PMC2951849
PMID- 20181623
IS  - 1047-3211 (Print)
IS  - 1460-2199 (Electronic)
VI  - 20
IP  - 11
DP  - 2010 Nov
TI  - Unique Contributions of Distinct Cholinergic Projections to Motor Cortical
      Plasticity and Learning.
PG  - 2739-48
AB  - The cholinergic basal forebrain projects throughout the neocortex, exerting a
      critical role in modulating plasticity associated with normal learning.
      Cholinergic modulation of cortical plasticity could arise from 3 distinct
      mechanisms by 1) “direct” modulation via cholinergic inputs to regions undergoing
      plasticity, 2) “indirect” modulation via cholinergic projections to anterior,
      prefrontal attentional systems, or 3) modulating more global aspects of
      processing via distributed inputs throughout the cortex. To segregate these
      potential mechanisms, we investigated cholinergic-dependent reorganization of
      cortical motor representations in rats undergoing skilled motor learning.
      Behavioral and electrophysiological consequences of depleting cholinergic inputs 
      to either motor cortex, prefrontal cortex, or globally, were compared. We find
      that local depletion of cholinergic afferents to motor cortex significantly
      disrupts map plasticity and skilled motor behavior, whereas prefrontal
      cholinergic depletion has no effect on these measures. Global cholinergic
      depletion perturbs map plasticity comparable with motor cortex depletions but
      results in significantly greater impairments in skilled motor acquisition. These 
      findings indicate that local cholinergic activation within motor cortex, as
      opposed to indirect regulation of prefrontal systems, modulate cortical map
      plasticity and motor learning. More globally acting cholinergic mechanisms
      provide additional support for the acquisition of skilled motor behaviors, beyond
      those associated with cortical map reorganization.
FAU - Conner, J.M.
AU  - Conner J
AD  - Department of Neurosciences, University of California-San Diego, La Jolla, CA
      92093-0626, USA
FAU - Kulczycki, M.
AU  - Kulczycki M
AD  - Department of Neurosciences, University of California-San Diego, La Jolla, CA
      92093-0626, USA
FAU - Tuszynski, M.H.
AU  - Tuszynski M
AD  - Department of Neurosciences, University of California-San Diego, La Jolla, CA
      92093-0626, USA
LA  - eng
PT  - Journal Article
DEP - 20100224
PHST- 2010/02/24 [aheadofprint]
TA  - Cereb Cortex
JT  - Cerebral Cortex (New York, NY)
AID - 10.1093/cercor/bhq022 [doi]
SO  - Cereb Cortex. 2010 Nov;20(11):2739-48. Epub 2010 Feb 24
      doi:10.1093/cercor/bhq022.

PMC - PMC2889745
PMID- 20216530
IS  - 1525-0016 (Print)
IS  - 1525-0024 (Electronic)
VI  - 18
IP  - 6
DP  - 2010 Jun
TI  - Effects of Localized Neurotrophin Gene Expression on Spiral Ganglion Neuron
      Resprouting in the Deafened Cochlea.
PG  - 1111-22
AB  - A cochlear implant may be used to electrically stimulate spiral ganglion neurons 
      (SGNs) in people with severe sensorineural hearing loss (SNHL). However, these
      neurons progressively degenerate after SNHL due to loss of neurotrophins normally
      supplied by sensory hair cells (HCs). Experimentally, exogenous neurotrophin
      administration prevents SGN degeneration but can also result in abnormal
      resprouting of their peripheral fibers. This study aimed to create a
      target-derived neurotrophin source to increase neuron survival and redirect fiber
      resprouting following SNHL. Adenoviral (Ad) vectors expressing green fluorescent 
      protein (GFP) alone or in combination with brain-derived neurotrophic factor
      (BDNF) or neurotrophin-3 (NT3) were injected into the cochlear scala tympani or
      scala media of guinea-pigs (GPs) deafened via aminoglycosides for 1 week. After 3
      weeks, cochleae were examined for gene expression, neuron survival, and the
      projection of peripheral fibers in response to gene expression. Injection of
      vectors into the scala media resulted in more localized gene expression than
      scala tympani injection with gene expression consistently observed within the
      partially degenerated organ of Corti. There was also greater neuron survival and 
      evidence of localized fiber responses to neurotrophin-expressing cells within the
      organ of Corti from scala media injections (P < 0.05), a first step in promoting 
      organized resprouting of auditory peripheral fibers via gene therapy.
FAU - Wise, Andrew K
AU  - Wise AK
AD  - Bionic Ear Institute East Melbourne, Victoria, Australia
FAU - Hume, Clifford R
AU  - Hume CR
AD  - Department of Otolaryngology–Head and Neck Surgery, University of Washington
      Seattle, Washington, USA
FAU - Flynn, Brianna O
AU  - Flynn BO
AD  - Bionic Ear Institute East Melbourne, Victoria, Australia
FAU - Jeelall, Yogesh S
AU  - Jeelall YS
AD  - Bionic Ear Institute East Melbourne, Victoria, Australia
FAU - Suhr, Courtney L
AU  - Suhr CL
AD  - Bionic Ear Institute East Melbourne, Victoria, Australia
FAU - Sgro, Beatrice E
AU  - Sgro BE
AD  - Bionic Ear Institute East Melbourne, Victoria, Australia
FAU - O'Leary, Stephen J
AU  - O'Leary SJ
AD  - Bionic Ear Institute East Melbourne, Victoria, Australia
FAU - Shepherd, Robert K
AU  - Shepherd RK
AD  - Bionic Ear Institute East Melbourne, Victoria, Australia
FAU - Richardson, Rachael T
AU  - Richardson RT
AD  - Bionic Ear Institute East Melbourne, Victoria, Australia
LA  - eng
PT  - Journal Article
DEP - 20100309
PHST- 2009/09/01 [received]
PHST- 2010/01/30 [accepted]
TA  - Mol Ther
JT  - Molecular Therapy
AID - mt201028 [pii]
AID - 10.1038/mt.2010.28 [doi]
SO  - Mol Ther. 2010 Jun;18(6):1111-22. Epub 2010 Mar 09 doi:10.1038/mt.2010.28.

PMC - PMC2867585
PMID- 20130042
IS  - 0022-3077 (Print)
IS  - 1522-1598 (Electronic)
VI  - 103
IP  - 5
DP  - 2010 May
TI  - Optimal Control of a Hybrid Rhythmic-Discrete Task: The Bouncing Ball Revisited.
PG  - 2482-93
AB  - Rhythmically bouncing a ball with a racket is a hybrid task that combines
      continuous rhythmic actuation of the racket with the control of discrete impact
      events between racket and ball. This study presents experimental data and a
      two-layered modeling framework that explicitly addresses the hybrid nature of
      control: a first discrete layer calculates the state to reach at impact and the
      second continuous layer smoothly drives the racket to this desired state, based
      on optimality principles. The testbed for this hybrid model is task performance
      at a range of increasingly slower tempos. When slowing the rhythm of the bouncing
      actions, the continuous cycles become separated into a sequence of discrete
      movements interspersed by dwell times and directed to achieve the desired impact.
      Analyses of human performance show increasing variability of performance measures
      with slower tempi, associated with a change in racket trajectories from
      approximately sinusoidal to less symmetrical velocity profiles. Matching results 
      of model simulations give support to a hybrid control model based on optimality, 
      and therefore suggest that optimality principles are applicable to the
      sensorimotor control of complex movements such as ball bouncing.
FAU - Ronsse, Renaud
AU  - Ronsse R
AD  - Department of Electrical Engineering and Computer Science, Montefiore Institute, 
      Université de Liège, Liège, Belgium;
FAU - Wei, Kunlin
AU  - Wei K
AD  - Rehabilitation Institute of Chicago, Northwestern University, Chicago, Illinois;
FAU - Sternad, Dagmar
AU  - Sternad D
AD  - Departments of Biology, Electrical and Computer Engineering, and Physics,
      Northeastern University, Boston, Massachusetts
LA  - eng
PT  - Journal Article
DEP - 20100203
PHST- 2009/07/14 [received]
PHST- 2010/01/30 [accepted]
PHST- 2010/02/03 [aheadofprint]
TA  - J Neurophysiol
JT  - Journal of Neurophysiology
AID - J00600-9 [pii]
AID - 10.1152/jn.00600.2009 [doi]
SO  - J Neurophysiol. 2010 May;103(5):2482-93. Epub 2010 Feb 3
      doi:10.1152/jn.00600.2009.

PMC - PMC3250292
PMID- 21904788
IS  - 1933-7213 (Print)
IS  - 1878-7479 (Electronic)
VI  - 8
IP  - 4
DP  - 2011 Oct
TI  - Combining Cell-Based Therapies and Neural Prostheses to Promote Neural Survival.
PG  - 774-87
AB  - Cochlear implants provide partial restoration of hearing for profoundly deaf
      patients by electrically stimulating spiral ganglion neurons (SGNs); however,
      these neurons gradually degenerate following the onset of deafness. Although the 
      exogenous application of neurotrophins (NTs) can prevent SGN loss, current
      techniques to administer NTs for long periods of time have limited clinical
      applicability. We have used encapsulated choroid plexus cells (NTCells; Living
      Cell Technologies, Auckland, New Zealand) to provide NTs in a clinically viable
      manner that can be combined with a cochlear implant. Neonatal cats were deafened 
      and unilaterally implanted with NTCells and a cochlear implant. Animals received 
      chronic electrical stimulation (ES) alone, NTs alone, or combined NTs and ES (ES 
      + NT) for a period of as much as 8 months. The opposite ear served as a deafened 
      unimplanted control. Chronic ES alone did not result in increased survival of
      SGNs or their peripheral processes. NT treatment alone resulted in greater SGN
      survival restricted to the upper basal cochlear region and an increased density
      of SGN peripheral processes. Importantly, chronic ES in combination with NTs
      provided significant SGN survival throughout a wider extent of the cochlea, in
      addition to an increased peripheral process density. Re-sprouting peripheral
      processes were observed in the scala media and scala tympani, raising the
      possibility of direct contact between peripheral processes and a cochlear implant
      electrode array. We conclude that cell-based therapy is clinically viable and
      effective in promoting SGN survival for extended durations of cochlear implant
      use. These findings have important implications for the safe delivery of
      therapeutic drugs to the cochlea.Electronic supplementary material: The online
      version of this article (doi:10.1007/s13311-011-0070-0) contains supplementary
      material, which is available to authorized users.
FAU - Wise, Andrew K.
AU  - Wise AK
AD  - The Bionics Institute, 384-388 Albert Street, East Melbourne, 3002 Australia
FAU - Fallon, James B.
AU  - Fallon JB
AD  - The Bionics Institute, 384-388 Albert Street, East Melbourne, 3002 Australia
FAU - Neil, Alison J.
AU  - Neil AJ
AD  - The Bionics Institute, 384-388 Albert Street, East Melbourne, 3002 Australia
FAU - Pettingill, Lisa N.
AU  - Pettingill LN
AD  - The Bionics Institute, 384-388 Albert Street, East Melbourne, 3002 Australia
FAU - Geaney, Marilyn S.
AU  - Geaney MS
AD  - Living Cell Technologies Limited, Manukau, 2025 New Zealand
FAU - Skinner, Stephen J.
AU  - Skinner SJ
AD  - Living Cell Technologies Limited, Manukau, 2025 New Zealand
FAU - Shepherd, Robert K.
AU  - Shepherd RK
AD  - The Bionics Institute, 384-388 Albert Street, East Melbourne, 3002 Australia
LA  - eng
PT  - Journal Article
DEP - 20110909
TA  - Neurotherapeutics
JT  - Neurotherapeutics
AID - 70 [pii]
AID - 10.1007/s13311-011-0070-0 [doi]
SO  - Neurotherapeutics. 2011 Oct;8(4):774-87. Epub 2011 Sep 9
      doi:10.1007/s13311-011-0070-0.

PMC - PMC3768104
PMID- 23589833
IS  - 0031-9333 (Print)
IS  - 1522-1210 (Electronic)
VI  - 93
IP  - 2
DP  - 2013 Apr
TI  - The Divergence, Actions, Roles, and Relatives of Sodium-Coupled Bicarbonate
      Transporters.
PG  - 803-959
AB  - The mammalian Slc4 (Solute carrier 4) family of transporters is a functionally
      diverse group of 10 multi-spanning membrane proteins that includes three Cl-HCO3 
      exchangers (AE1–3), five Na+-coupled HCO3− transporters (NCBTs), and two other
      unusual members (AE4, BTR1). In this review, we mainly focus on the five
      mammalian NCBTs-NBCe1, NBCe2, NBCn1, NDCBE, and NBCn2. Each plays a specialized
      role in maintaining intracellular pH and, by contributing to the movement of
      HCO3− across epithelia, in maintaining whole-body pH and otherwise contributing
      to epithelial transport. Disruptions involving NCBT genes are linked to
      blindness, deafness, proximal renal tubular acidosis, mental retardation, and
      epilepsy. We also review AE1–3, AE4, and BTR1, addressing their relevance to the 
      study of NCBTs. This review draws together recent advances in our understanding
      of the phylogenetic origins and physiological relevance of NCBTs and their
      progenitors. Underlying these advances is progress in such diverse disciplines as
      physiology, molecular biology, genetics, immunocytochemistry, proteomics, and
      structural biology. This review highlights the key similarities and differences
      between individual NCBTs and the genes that encode them and also clarifies the
      sometimes confusing NCBT nomenclature.
FAU - Parker, Mark D.
AU  - Parker MD
FAU - Boron, Walter F.
AU  - Boron WF
LA  - eng
PT  - Journal Article
PT  - Review
GR  - EY021646
TA  - Physiol Rev
JT  - Physiological Reviews
AID - PRV-00023-2012 [pii]
AID - 10.1152/physrev.00023.2012 [doi]
SO  - Physiol Rev. 2013 Apr;93(2):803-959. doi:10.1152/physrev.00023.2012.

PMC - PMC4932612
PMID- 27408795
IS  - 2213-1582 (Electronic)
VI  - 12
DP  - 2016
TI  - Connectome-scale assessment of structural and functional connectivity in mild
      traumatic brain injury at the acute stage.
PG  - 100-15
AB  - Mild traumatic brain injury (mTBI) accounts for over one million emergency visits
      each year in the United States. The large-scale structural and functional network
      connectivity changes of mTBI are still unknown. This study was designed to
      determine the connectome-scale brain network connectivity changes in mTBI at both
      structural and functional levels. 40 mTBI patients at the acute stage and 50
      healthy controls were recruited. A novel approach called Dense Individualized and
      Common Connectivity-based Cortical Landmarks (DICCCOLs) was applied for
      connectome-scale analysis of both diffusion tensor imaging and resting state
      functional MRI data. Among 358 networks identified on DICCCOL analysis, 41
      networks were identified as structurally discrepant between patient and control
      groups. The involved major white matter tracts include the corpus callosum, and
      superior and inferior longitudinal fasciculi. Functional connectivity analysis
      identified 60 connectomic signatures that differentiate patients from controls
      with 93.75% sensitivity and 100% specificity. Analysis of functional domains
      showed decreased intra-network connectivity within the emotion network and among 
      emotion-cognition interactions, and increased interactions among action-emotion
      and action-cognition as well as within perception networks. This work suggests
      that mTBI may result in changes of structural and functional connectivity on a
      connectome scale at the acute stage.
FAU - Iraji, Armin
AU  - Iraji A
AD  - Department of Biomedical Engineering, Wayne State University, Detroit, MI, USA
FAU - Chen, Hanbo
AU  - Chen H
AD  - Department of Computer Science, University of Georgia, Athens, GA, USA
FAU - Wiseman, Natalie
AU  - Wiseman N
AD  - Department of Psychiatry and Behavioral Neurosciences, Wayne State University,
      Detroit, MI, USA
FAU - Zhang, Tuo
AU  - Zhang T
AD  - Department of Computer Science, University of Georgia, Athens, GA, USA
FAU - Welch, Robert
AU  - Welch R
AD  - Department of Emergency Medicine, Wayne State University, Detroit, MI, USA
FAU - O'Neil, Brian
AU  - O'Neil B
AD  - Department of Emergency Medicine, Wayne State University, Detroit, MI, USA
FAU - Kulek, Andrew
AU  - Kulek A
AD  - Department of Emergency Medicine, Wayne State University, Detroit, MI, USA
FAU - Ayaz, Syed Imran
AU  - Ayaz SI
AD  - Department of Emergency Medicine, Wayne State University, Detroit, MI, USA
FAU - Wang, Xiao
AU  - Wang X
AD  - Department of Radiology, Wayne State University, Detroit, MI, USA
FAU - Zuk, Conor
AU  - Zuk C
AD  - Department of Radiology, Wayne State University, Detroit, MI, USA
FAU - Haacke, E. Mark
AU  - Haacke EM
AD  - Department of Biomedical Engineering, Wayne State University, Detroit, MI, USA
FAU - Liu, Tianming
AU  - Liu T
AD  - Department of Computer Science, University of Georgia, Athens, GA, USA
FAU - Kou, Zhifeng
AU  - Kou Z
AD  - Department of Biomedical Engineering, Wayne State University, Detroit, MI, USA
LA  - eng
PT  - Journal Article
DEP - 20160616
PHST- 2015/12/02 [received]
PHST- 2016/06/08 [revised]
PHST- 2016/06/14 [accepted]
TA  - Neuroimage Clin
JT  - NeuroImage : Clinical
AID - S2213-1582(16)30110-3 [pii]
AID - 10.1016/j.nicl.2016.06.012 [doi]
SO  - Neuroimage Clin. 2016 Jun 16;12:100-15. doi:10.1016/j.nicl.2016.06.012.

PMC - PMC3661448
PMID- 23717588
IS  - 1932-6203 (Electronic)
VI  - 8
IP  - 5
DP  - 2013
TI  - NeuroChip: A Microfluidic Electrophysiological Device for Genetic and Chemical
      Biology Screening of Caenorhabditis elegans Adult and Larvae.
LID - e64297
AB  - Genetic and chemical biology screens of C. elegans have been of enormous benefit 
      in providing fundamental insight into neural function and neuroactive drugs.
      Recently the exploitation of microfluidic devices has added greater power to this
      experimental approach providing more discrete and higher throughput phenotypic
      analysis of neural systems. Here we make a significant addition to this
      repertoire through the design of a semi-automated microfluidic device, NeuroChip,
      which has been optimised for selecting worms based on the electrophysiological
      features of the pharyngeal neural network. We demonstrate this device has the
      capability to sort mutant from wild-type worms based on high definition
      extracellular electrophysiological recordings. NeuroChip resolves discrete
      differences in excitatory, inhibitory and neuromodulatory components of the
      neural network from individual animals. Worms may be fed into the device
      consecutively from a reservoir and recovered unharmed. It combines microfluidics 
      with integrated electrode recording for sequential trapping, restraining,
      recording, releasing and recovering of C. elegans. Thus mutant worms may be
      selected, recovered and propagated enabling mutagenesis screens based on an
      electrophysiological phenotype. Drugs may be rapidly applied during the recording
      thus permitting compound screening. For toxicology, this analysis can provide a
      precise description of sub-lethal effects on neural function. The chamber has
      been modified to accommodate L2 larval stages showing applicability for small
      size nematodes including parasitic species which otherwise are not tractable to
      this experimental approach. We also combine NeuroChip with optogenetics for
      targeted interrogation of the function of the neural circuit. NeuroChip thus adds
      a new tool for exploitation of C. elegans and has applications in neurogenetics, 
      drug discovery and neurotoxicology.
FAU - Hu, Chunxiao
AU  - Hu C
AD  - Hybrid Biodevices Group, Electronics and Computer Science, University of
      Southampton, Southampton, United Kingdom
FAU - Dillon, James
AU  - Dillon J
AD  - Centre for Biological Sciences, Institute for Life Sciences, University of
      Southampton, Southampton, United Kingdom
FAU - Kearn, James
AU  - Kearn J
AD  - Centre for Biological Sciences, Institute for Life Sciences, University of
      Southampton, Southampton, United Kingdom
FAU - Murray, Caitriona
AU  - Murray C
AD  - Centre for Biological Sciences, Institute for Life Sciences, University of
      Southampton, Southampton, United Kingdom
FAU - O’Connor, Vincent
AU  - O’Connor V
AD  - Centre for Biological Sciences, Institute for Life Sciences, University of
      Southampton, Southampton, United Kingdom
FAU - Holden-Dye, Lindy
AU  - Holden-Dye L
AD  - Centre for Biological Sciences, Institute for Life Sciences, University of
      Southampton, Southampton, United Kingdom
FAU - Morgan, Hywel
AU  - Morgan H
AD  - Hybrid Biodevices Group, Electronics and Computer Science, University of
      Southampton, Southampton, United Kingdom
LA  - eng
PT  - Journal Article
DEP - 20130522
PHST- 2013/01/16 [received]
PHST- 2013/04/11 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-13-02727 [pii]
AID - 10.1371/journal.pone.0064297 [doi]
SO  - PLoS One. 2013 May 22;8(5):. doi:10.1371/journal.pone.0064297.

PMC - PMC4723314
PMID- 26799938
IS  - 1932-6203 (Electronic)
VI  - 11
IP  - 1
DP  - 2016
TI  - Gradient Index Microlens Implanted in Prefrontal Cortex of Mouse Does Not Affect 
      Behavioral Test Performance over Time.
LID - e0146533
AB  - Implanted gradient index lenses have extended the reach of standard multiphoton
      microscopy from the upper layers of the mouse cortex to the lower cortical layers
      and even subcortical regions. These lenses have the clarity to visualize dynamic 
      activities, such as calcium transients, with subcellular and millisecond
      resolution and the stability to facilitate repeated imaging over weeks and
      months. In addition, behavioral tests can be used to correlate performance with
      observed changes in network function and structure that occur over time. Yet,
      this raises the questions, does an implanted microlens have an effect on
      behavioral tests, and if so, what is the extent of the effect? To answer these
      questions, we compared the performance of three groups of mice in three common
      behavioral tests. A gradient index lens was implanted in the prefrontal cortex of
      experimental mice. We compared their performance with mice that had either a
      cranial window or a sham surgery. Three presurgical and five postsurgical sets of
      behavioral tests were performed over seven weeks. Behavioral tests included
      rotarod, foot fault, and Morris water maze. No significant differences were found
      between the three groups, suggesting that microlens implantation did not affect
      performance. The results for the current study clear the way for combining
      behavioral studies with gradient index lens imaging in the prefrontal cortex, and
      potentially other regions of the mouse brain, to study structural, functional,
      and behavioral relationships in the brain.
FAU - Lee, Seon A.
AU  - Lee SA
AD  - Center for Biomedical Research and Rehabilitation Sciences, Louisiana Tech
      University, Ruston, Louisiana, United States of America
FAU - Holly, Kevin S.
AU  - Holly KS
AD  - Center for Biomedical Research and Rehabilitation Sciences, Louisiana Tech
      University, Ruston, Louisiana, United States of America
FAU - Voziyanov, Vladislav
AU  - Voziyanov V
AD  - Center for Biomedical Research and Rehabilitation Sciences, Louisiana Tech
      University, Ruston, Louisiana, United States of America
FAU - Villalba, Stephanie L.
AU  - Villalba SL
AD  - Department of Cellular Biology and Anatomy, Louisiana State University Health
      Sciences Center, Shreveport, LA, United States of America
FAU - Tong, Rudi
AU  - Tong R
AD  - Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford,
      United Kingdom
FAU - Grigsby, Holly E.
AU  - Grigsby HE
AD  - Center for Biomedical Research and Rehabilitation Sciences, Louisiana Tech
      University, Ruston, Louisiana, United States of America
FAU - Glasscock, Edward
AU  - Glasscock E
AD  - Department of Cellular Biology and Anatomy, Louisiana State University Health
      Sciences Center, Shreveport, LA, United States of America
FAU - Szele, Francis G.
AU  - Szele FG
AD  - Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford,
      United Kingdom
FAU - Vlachos, Ioannis
AU  - Vlachos I
AD  - Center for Biomedical Research and Rehabilitation Sciences, Louisiana Tech
      University, Ruston, Louisiana, United States of America
FAU - Murray, Teresa A.
AU  - Murray TA
AD  - Center for Biomedical Research and Rehabilitation Sciences, Louisiana Tech
      University, Ruston, Louisiana, United States of America
LA  - eng
PT  - Journal Article
DEP - 20160122
PHST- 2015/04/15 [received]
PHST- 2015/12/19 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - 10.1371/journal.pone.0146533 [doi]
AID - PONE-D-15-16258 [pii]
SO  - PLoS One. 2016 Jan 22;11(1):. doi:10.1371/journal.pone.0146533.

PMC - PMC3958238
PMID- 24463431
IS  - 1424-8220 (Electronic)
VI  - 14
IP  - 2
DP  - 2014 Feb
TI  - SoundCompass: A Distributed MEMS Microphone Array-Based Sensor for Sound Source
      Localization.
PG  - 1918-49
AB  - Sound source localization is a well-researched subject with applications ranging 
      from localizing sniper fire in urban battlefields to cataloging wildlife in rural
      areas. One critical application is the localization of noise pollution sources in
      urban environments, due to an increasing body of evidence linking noise pollution
      to adverse effects on human health. Current noise mapping techniques often fail
      to accurately identify noise pollution sources, because they rely on the
      interpolation of a limited number of scattered sound sensors. Aiming to produce
      accurate noise pollution maps, we developed the SoundCompass, a low-cost sound
      sensor capable of measuring local noise levels and sound field directionality.
      Our first prototype is composed of a sensor array of 52 Microelectromechanical
      systems (MEMS) microphones, an inertial measuring unit and a low-power
      field-programmable gate array (FPGA). This article presents the SoundCompass’s
      hardware and firmware design together with a data fusion technique that exploits 
      the sensing capabilities of the SoundCompass in a wireless sensor network to
      localize noise pollution sources. Live tests produced a sound source localization
      accuracy of a few centimeters in a 25-m2 anechoic chamber, while simulation
      results accurately located up to five broadband sound sources in a 10,000-m2 open
      field.
FAU - Tiete, Jelmer
AU  - Tiete J
AD  - Department of Electronics and Informatics (ETRO), Vrije Universiteit Brussel,
      Pleinlaan 2, Elsene 1050, Belgium; E-Mails: fedoming@vub.ac.be (F.D.);
      ksteenha@etro.vub.ac.be (K.S.); abdellah.touhafi@vub.ac.be (A.T.)
FAU - Domínguez, Federico
AU  - Domínguez F
AD  - Department of Electronics and Informatics (ETRO), Vrije Universiteit Brussel,
      Pleinlaan 2, Elsene 1050, Belgium; E-Mails: fedoming@vub.ac.be (F.D.);
      ksteenha@etro.vub.ac.be (K.S.); abdellah.touhafi@vub.ac.be (A.T.)
FAU - da Silva, Bruno
AU  - da Silva B
AD  - Department of Industrial Sciences and Technology (INDI), Vrije Universiteit
      Brussel, Pleinlaan 2, Elsene 1050, Belgium; E-Mails:
      BrunoTiago.Da.Silva.Gomes@ehb.be (B.S.); lasegers@vub.ac.be (L.S.)
FAU - Segers, Laurent
AU  - Segers L
AD  - Department of Industrial Sciences and Technology (INDI), Vrije Universiteit
      Brussel, Pleinlaan 2, Elsene 1050, Belgium; E-Mails:
      BrunoTiago.Da.Silva.Gomes@ehb.be (B.S.); lasegers@vub.ac.be (L.S.)
FAU - Steenhaut, Kris
AU  - Steenhaut K
AD  - Department of Electronics and Informatics (ETRO), Vrije Universiteit Brussel,
      Pleinlaan 2, Elsene 1050, Belgium; E-Mails: fedoming@vub.ac.be (F.D.);
      ksteenha@etro.vub.ac.be (K.S.); abdellah.touhafi@vub.ac.be (A.T.)
FAU - Touhafi, Abdellah
AU  - Touhafi A
AD  - Department of Electronics and Informatics (ETRO), Vrije Universiteit Brussel,
      Pleinlaan 2, Elsene 1050, Belgium; E-Mails: fedoming@vub.ac.be (F.D.);
      ksteenha@etro.vub.ac.be (K.S.); abdellah.touhafi@vub.ac.be (A.T.)
LA  - eng
PT  - Journal Article
DEP - 20140123
PHST- 2013/10/28 [received]
PHST- 2013/12/11 [revised]
PHST- 2014/01/20 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s140201918 [doi]
AID - sensors-14-01918 [pii]
SO  - Sensors (Basel). 2014 Jan 23;14(2):1918-49. doi:10.3390/s140201918.

PMC - PMC4358961
PMID- 25768023
IS  - 1932-6203 (Electronic)
VI  - 10
IP  - 3
DP  - 2015
TI  - Telecare for Diabetes, CHF or COPD: Effect on Quality of Life, Hospital Use and
      Costs. A Randomised Controlled Trial and Qualitative Evaluation.
LID - e0116188
AB  - Objectives: To assess the effect of telecare on health related quality of life,
      self-care, hospital use, costs and the experiences of patients, informal carers
      and health care professionals. Methods: Patients were randomly assigned either to
      usual care or to additionally entering their data into a commercially-available
      electronic device that uploaded data once a day to a nurse-led monitoring
      station. Patients had congestive heart failure (Site A), chronic obstructive
      pulmonary disease (Site B), or any long-term condition, mostly diabetes (Site C).
      Site C contributed only intervention patients – they considered a usual care
      option to be unethical. The study took place in New Zealand between September
      2010 and February 2012, and lasted 3 to 6 months for each patient. The primary
      outcome was health-related quality of life (SF36). Data on experiences were
      collected by individual and group interviews and by questionnaire. Results: There
      were 171 patients (98 intervention, 73 control). Quality of life, self-efficacy
      and disease-specific measures did not change significantly, while anxiety and
      depression both decreased significantly with the intervention. Hospital
      admissions, days in hospital, emergency department visits, outpatient visits and 
      costs did not differ significantly between the groups. Patients at all sites were
      universally positive. Many felt safer and more cared-for, and said that they and 
      their family had learned more about managing their condition. Staff could all see
      potential benefits of telecare, and, after some initial technical problems, many 
      staff felt that telecare enabled them to effectively monitor more patients.
      Conclusions: Strongly positive patient and staff experiences and attitudes
      complement and contrast with small or non-significant quantitative changes.
      Telecare led to patients and families taking a more active role in
      self-management. It is likely that subgroups of patients benefitted in ways that 
      were not measured or visible within the quantitative data, especially feelings of
      safety and being cared-for. Trial Registration: Australian New Zealand Clinical
      Trials Registry ACTRN12610000269033
FAU - Kenealy, Timothy W.
AU  - Kenealy TW
AD  - Department of General Practice and Primary Health Care, University of Auckland,
      Auckland, New Zealand
FAU - Parsons, Matthew J. G.
AU  - Parsons MJG
AD  - Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New
      Zealand, in partnership with Waikato District Health Board, Waikato, New Zealand
FAU - Rouse, A. Paul B.
AU  - Rouse APB
AD  - Department of Accounting and Finance, The University of Auckland Business School,
      The University of Auckland, Auckland, New Zealand
FAU - Doughty, Robert N.
AU  - Doughty RN
AD  - Department of Medicine, University of Auckland and Greenlane Cardiovascular
      Service, Auckland City Hospital, Auckland, New Zealand
FAU - Sheridan, Nicolette F.
AU  - Sheridan NF
AD  - School of Nursing, Faculty of Medical and Health Sciences, University of
      Auckland, Auckland, New Zealand
FAU - Hindmarsh, Jennifer K. Harré
AU  - Hindmarsh JKH
AD  - Ngati Porou Hauora Charitable Trust, Te Puia Springs, Tairawhiti/East Coast, New 
      Zealand
FAU - Masson, Sarah C.
AU  - Masson SC
AD  - School of Nursing, Faculty of Medical and Health Sciences, University of
      Auckland, Auckland, New Zealand
FAU - Rea, Harry H.
AU  - Rea HH
AD  - Department of Medicine, University of Auckland, Auckland, New Zealand
LA  - eng
PT  - Journal Article
DEP - 20150313
PHST- 2014/05/31 [received]
PHST- 2014/11/30 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - 10.1371/journal.pone.0116188 [doi]
AID - PONE-D-14-16859 [pii]
SO  - PLoS One. 2015 Mar 13;10(3):. doi:10.1371/journal.pone.0116188.

PMC - PMC2672316
PMID- 19190358
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Electronic)
VI  - 5
IP  - 4
DP  - 2008 Dec
TI  - Web 3D for Public, Environmental and Occupational Health: Early Examples from
      Second Life®.
PG  - 290-317
AB  - Over the past three years (2006–2008), the medical/health and public health
      communities have shown a growing interest in using online 3D virtual worlds like 
      Second Life® (http://secondlife.com/) for health education, community outreach,
      training and simulations purposes. 3D virtual worlds are seen as the precursors
      of ‘Web 3D’, the next major iteration of the Internet that will follow in the
      coming years. This paper provides a tour of several flagship Web 3D experiences
      in Second Life®, including Play2Train Islands (emergency preparedness training), 
      the US Centers for Disease Control and Prevention—CDC Island (public health),
      Karuna Island (AIDS support and information), Tox Town at Virtual NLM Island (US 
      National Library of Medicine - environmental health), and Jefferson’s
      Occupational Therapy Center. We also discuss the potential and future of Web 3D. 
      These are still early days of 3D virtual worlds, and there are still many more
      untapped potentials and affordances of 3D virtual worlds that are yet to be
      explored, as the technology matures further and improves over the coming months
      and years.
FAU - Kamel Boulos, Maged N.
AU  - Kamel Boulos MN
AD  - Faculty of Health and Social Work, University of Plymouth, Drake Circus,
      Plymouth, Devon, PL4 8AA, UK; E-Mails: mnkamelboulos@plymouth.ac.uk (M. N. K.
      B.); ray.jones@plymouth.ac.uk (R. J.)
FAU - Ramloll, Rameshsharma
AU  - Ramloll R
AD  - Idaho State University, Pocatello, USA; E-Mail: r.ramloll@gmail.com (R. R.)
FAU - Jones, Ray
AU  - Jones R
AD  - Faculty of Health and Social Work, University of Plymouth, Drake Circus,
      Plymouth, Devon, PL4 8AA, UK; E-Mails: mnkamelboulos@plymouth.ac.uk (M. N. K.
      B.); ray.jones@plymouth.ac.uk (R. J.)
FAU - Toth-Cohen, Susan
AU  - Toth-Cohen S
AD  - Department of Occupational Therapy, Jefferson College of Health Professions,
      Thomas Jefferson University, USA; E-Mail: Susan.Toth-Cohen@jefferson.edu (S. T.
      C.)
LA  - eng
PT  - Journal Article
DEP - 20081218
PHST- 2008/12/04 [received]
PHST- 2008/12/17 [accepted]
PHST- 2008/12/18 [aheadofprint]
TA  - Int J Environ Res Public Health
JT  - International Journal of Environmental Research and Public Health
AID - 10.3390/ijerph5040290 [doi]
AID - ijerph-05-00290 [pii]
SO  - Int J Environ Res Public Health. 2008 Dec;5(4):290-317. Epub 2008 Dec 18
      doi:10.3390/ijerph5040290.

PMC - PMC3714902
PMID- 23869286
IS  - 2229-5089 (Print)
IS  - 2153-3539 (Electronic)
VI  - 4
DP  - 2013
TI  - The history of pathology informatics: A global perspective.
LID - 7
AB  - Pathology informatics has evolved to varying levels around the world. The history
      of pathology informatics in different countries is a tale with many dimensions.
      At first glance, it is the familiar story of individuals solving problems that
      arise in their clinical practice to enhance efficiency, better manage (e.g.,
      digitize) laboratory information, as well as exploit emerging information
      technologies. Under the surface, however, lie powerful resource, regulatory, and 
      societal forces that helped shape our discipline into what it is today. In this
      monograph, for the first time in the history of our discipline, we collectively
      perform a global review of the field of pathology informatics. In doing so, we
      illustrate how general far-reaching trends such as the advent of computers, the
      Internet and digital imaging have affected pathology informatics in the world at 
      large. Major drivers in the field included the need for pathologists to comply
      with national standards for health information technology and telepathology
      applications to meet the scarcity of pathology services and trained people in
      certain countries. Following trials by a multitude of investigators, not all of
      them successful, it is apparent that innovation alone did not assure the success 
      of many informatics tools and solutions. Common, ongoing barriers to the
      widespread adoption of informatics devices include poor information technology
      infrastructure in undeveloped areas, the cost of technology, and regulatory
      issues. This review offers a deeper understanding of how pathology informatics
      historically developed and provides insights into what the promising future might
      hold.
FAU - Park, Seung
AU  - Park S
AD  - Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA,
      USA
FAU - Parwani, Anil V.
AU  - Parwani AV
AD  - Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA,
      USA
FAU - Aller, Raymond D.
AU  - Aller RD
AD  - Department of Pathology, Keck School of Medicine, University of Southern
      California, Los Angeles, CA, USA
FAU - Banach, Lech
AU  - Banach L
AD  - Department of Anatomical Pathology, and National Health Laboratory Service
      (NHLS), Walter Sisulu University, Mthatha, South Africa
FAU - Becich, Michael J.
AU  - Becich MJ
AD  - Department of Biomedical Informatics, University of Pittsburgh School of
      Medicine, Pittsburgh, PA, USA
FAU - Borkenfeld, Stephan
AU  - Borkenfeld S
AD  - International Academy of Telepathology, Heidelberg, Germany
FAU - Carter, Alexis B.
AU  - Carter AB
AD  - Department of Pathology and Laboratory Medicine, Biomedical Informatics, Emory
      University School of Medicine, Atlanta, GA, USA
FAU - Friedman, Bruce A.
AU  - Friedman BA
AD  - Department of Pathology, University of Michigan Medical School, Ann Arbor, MI,
      USA
FAU - Rojo, Marcial Garcia
AU  - Rojo MG
AD  - Hospital General de Ciudad Real, Ciudad Real, Spain
FAU - Georgiou, Andrew
AU  - Georgiou A
AD  - Centre for Health Systems and Safety Research, Australian Institute of Health
      Innovation, Faculty of Medicine, University of New South Wales, NSW, Australia
FAU - Kayser, Gian
AU  - Kayser G
AD  - Institute of Pathology, University Freiburg, Freiburg, Germany
FAU - Kayser, Klaus
AU  - Kayser K
AD  - Institute of Pathology, Charite, Berlin, Germany
FAU - Legg, Michael
AU  - Legg M
AD  - Centre for Health Informatics and e-Health Research, University of Wollongong,
      Wollongong, NSW, Australia
FAU - Naugler, Christopher
AU  - Naugler C
AD  - Department of Pathology and Laboratory Medicine, University of Calgary, and
      Calgary Laboratory Services, Calgary, Alberta, Canada
FAU - Sawai, Takashi
AU  - Sawai T
AD  - Department of Pathology, School of Medicine, Iwate Medical University, Iwate
      Prefecture, Japan
FAU - Weiner, Hal
AU  - Weiner H
AD  - Weiner Consulting Services, Florence, OR, USA
FAU - Winsten, Dennis
AU  - Winsten D
AD  - Dennis Winsten and Associates, Inc., Healthcare Systems Consultants, Tucson, AZ, 
      USA
FAU - Pantanowitz, Liron
AU  - Pantanowitz L
AD  - Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA,
      USA
LA  - eng
PT  - Journal Article
DEP - 20130530
PHST- 2013/01/02 [received]
PHST- 2013/03/09 [accepted]
TA  - J Pathol Inform
JT  - Journal of Pathology Informatics
AID - JPI-4-7 [pii]
AID - 10.4103/2153-3539.112689 [doi]
SO  - J Pathol Inform. 2013 May 30;4:. doi:10.4103/2153-3539.112689.

PMC - PMC4492822
PMID- 25820276
IS  - 1757-4676 (Print)
IS  - 1757-4684 (Electronic)
VI  - 7
IP  - 5
DP  - 2015 May
TI  - Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
PG  - 648-69
AB  - Lung cancer is the most common malignancy worldwide and is a focus for developing
      targeted therapies due to its refractory nature to current treatment. We
      identified a RNA helicase, DDX3, which is overexpressed in many cancer types
      including lung cancer and is associated with lower survival in lung cancer
      patients. We designed a first-in-class small molecule inhibitor, RK-33, which
      binds to DDX3 and abrogates its activity. Inhibition of DDX3 by RK-33 caused G1
      cell cycle arrest, induced apoptosis, and promoted radiation sensitization in
      DDX3-overexpressing cells. Importantly, RK-33 in combination with radiation
      induced tumor regression in multiple mouse models of lung cancer.
      Mechanistically, loss of DDX3 function either by shRNA or by RK-33 impaired Wnt
      signaling through disruption of the DDX3–β-catenin axis and inhibited
      non-homologous end joining—the major DNA repair pathway in mammalian somatic
      cells. Overall, inhibition of DDX3 by RK-33 promotes tumor regression, thus
      providing a compelling argument to develop DDX3 inhibitors for lung cancer
      therapy.
FAU - Bol, Guus M
AU  - Bol GM
AD  - Department of Radiology and Radiological Science, Johns Hopkins University School
      of MedicineBaltimore, MD, USA
FAU - Vesuna, Farhad
AU  - Vesuna F
AD  - Department of Radiology and Radiological Science, Johns Hopkins University School
      of MedicineBaltimore, MD, USA
FAU - Xie, Min
AU  - Xie M
AD  - Department of Radiology and Radiological Science, Johns Hopkins University School
      of MedicineBaltimore, MD, USA
FAU - Zeng, Jing
AU  - Zeng J
AD  - Department of Radiation Oncology, Johns Hopkins University School of
      MedicineBaltimore, MD, USA
FAU - Aziz, Khaled
AU  - Aziz K
AD  - Department of Radiation Oncology, Johns Hopkins University School of
      MedicineBaltimore, MD, USA
FAU - Gandhi, Nishant
AU  - Gandhi N
AD  - Department of Radiation Oncology, Johns Hopkins University School of
      MedicineBaltimore, MD, USA
FAU - Levine, Anne
AU  - Levine A
AD  - Department of Radiology and Radiological Science, Johns Hopkins University School
      of MedicineBaltimore, MD, USA
FAU - Irving, Ashley
AU  - Irving A
AD  - Department of Radiology and Radiological Science, Johns Hopkins University School
      of MedicineBaltimore, MD, USA
FAU - Korz, Dorian
AU  - Korz D
AD  - Department of Radiology and Radiological Science, Johns Hopkins University School
      of MedicineBaltimore, MD, USA
FAU - Tantravedi, Saritha
AU  - Tantravedi S
AD  - Department of Radiology and Radiological Science, Johns Hopkins University School
      of MedicineBaltimore, MD, USA
FAU - Heerma van Voss, Marise R
AU  - Heerma van Voss MR
AD  - Department of Radiology and Radiological Science, Johns Hopkins University School
      of MedicineBaltimore, MD, USA
FAU - Gabrielson, Kathleen
AU  - Gabrielson K
AD  - Department of Molecular and Comparative Pathobiology, Johns Hopkins University
      School of MedicineBaltimore, MD, USA
FAU - Bordt, Evan A
AU  - Bordt EA
AD  - Department of Anesthesiology, University of Maryland School of MedicineBaltimore,
      MD, USA
FAU - Polster, Brian M
AU  - Polster BM
AD  - Department of Anesthesiology, University of Maryland School of MedicineBaltimore,
      MD, USA
FAU - Cope, Leslie
AU  - Cope L
AD  - Department of Oncology, Johns Hopkins University School of MedicineBaltimore, MD,
      USA
FAU - van der Groep, Petra
AU  - van der Groep P
AD  - Department of Pathology, University Medical Center UtrechtUtrecht, The
      Netherlands
FAU - Kondaskar, Atul
AU  - Kondaskar A
AD  - Department of Chemistry & Biochemistry, University of MarylandBaltimore County,
      MD, USA
FAU - Rudek, Michelle A
AU  - Rudek MA
AD  - Department of Oncology, Johns Hopkins University School of MedicineBaltimore, MD,
      USA
FAU - Hosmane, Ramachandra S
AU  - Hosmane RS
AD  - Department of Chemistry & Biochemistry, University of MarylandBaltimore County,
      MD, USA
FAU - van der Wall, Elsken
AU  - van der Wall E
AD  - Department of Internal Medicine, University Medical Center UtrechtUtrecht, The
      Netherlands
FAU - van Diest, Paul J
AU  - van Diest PJ
AD  - Department of Pathology, University Medical Center UtrechtUtrecht, The
      Netherlands
FAU - Tran, Phuoc T
AU  - Tran PT
AD  - Department of Radiation Oncology, Johns Hopkins University School of
      MedicineBaltimore, MD, USA
FAU - Raman, Venu
AU  - Raman V
AD  - Department of Radiology and Radiological Science, Johns Hopkins University School
      of MedicineBaltimore, MD, USA
LA  - eng
PT  - Journal Article
DEP - 20150327
PHST- 2014/06/25 [received]
PHST- 2015/02/09 [revised]
PHST- 2015/02/12 [accepted]
PHST- 2015/03/27 [aheadofprint]
TA  - EMBO Mol Med
JT  - EMBO Molecular Medicine
AID - 10.15252/emmm.201404368 [doi]
SO  - EMBO Mol Med. 2015 May;7(5):648-69. Epub 2015 Mar 27 doi:10.15252/emmm.201404368.

PMC - PMC3821924
PMID- 23985904
IS  - 1741-2560 (Print)
IS  - 1741-2552 (Electronic)
VI  - 10
IP  - 5
DP  - 2013 Oct
TI  - Multi-electrode stimulation in somatosensory cortex increases probability of
      detection.
LID - 10.1088/1741-2560/10/5/056013
AB  - Brain machine interfaces (BMIs) that decode control signals from motor cortex
      have developed tremendously in the past decade, but virtually all rely
      exclusively on vision to provide feedback. There is now increasing interest in
      developing an afferent interface to replace natural somatosensation, much as the 
      cochlear implant has done for the sense of hearing. Preliminary experiments
      toward a somatosensory neuroprosthesis have mostly addressed the sense of touch, 
      but proprioception, the sense of limb position and movement, is also critical for
      the control of movement. However, proprioceptive areas of cortex lack the precise
      somatotopy of tactile areas. We showed previously that there is only a weak
      tendency for neighboring neurons in area 2 to signal similar directions of hand
      movement. Consequently, stimulation with the relatively large currents used in
      many studies is likely to activate a rather heterogeneous set of neurons. Here,
      we have compared the effect of single-electrode stimulation at sub-threshold
      levels to the effect of stimulating as many as seven electrodes in combination.
      We found a mean enhancement in the sensitivity to the stimulus (d′) of 0.17 for
      pairs compared to individual electrodes (an increase of roughly 30%), and an
      increase of 2.5 for groups of seven electrodes (260%). We propose that a
      proprioceptive interface made up of several hundred electrodes may yield safer,
      more effective sensation than a BMI using fewer electrodes and larger currents.
FAU - Zaaimi, Boubker
AU  - Zaaimi B
AD  - Department of Physiology, Northwestern University, Chicago, IL, 60611, USA
FAU - Ruiz-Torres, Ricardo
AU  - Ruiz-Torres R
AD  - Department of Physiology, Northwestern University, Chicago, IL, 60611, USA
FAU - Solla, Sara A.
AU  - Solla SA
AD  - Department of Physiology, Northwestern University, Chicago, IL, 60611, USA
FAU - Miller, Lee E
AU  - Miller LE
AD  - Department of Physiology, Northwestern University, Chicago, IL, 60611, USA
LA  - eng
PT  - Journal Article
DEP - 20130828
GR  - R01 NS048845 || NS
TA  - J Neural Eng
JT  - Journal of neural engineering
AID - 10.1088/1741-2560/10/5/056013 [doi]
MID - NIHMS520785
SO  - J Neural Eng. 2013 Oct;10(5):. Epub 2013 Aug 28
      doi:10.1088/1741-2560/10/5/056013.

PMC - PMC2571960
PMID- 18024534
IS  - 0040-6376 (Print)
IS  - 1468-3296 (Electronic)
VI  - 63
IP  - 6
DP  - 2008
DP  - 2008 Jun
TI  - Reproducibility of dynamically represented acoustic lung images from healthy
      individuals.
PG  - 542-8
AB  - Background and aim:: Acoustic lung imaging offers a unique method for visualising
      the lung. This study was designed to demonstrate reproducibility of acoustic lung
      images recorded from healthy individuals at different time points and to assess
      intra- and inter-rater agreement in the assessment of dynamically represented
      acoustic lung images. Methods:: Recordings from 29 healthy volunteers were made
      on three separate occasions using vibration response imaging. Reproducibility was
      measured using quantitative, computerised assessment of vibration energy.
      Dynamically represented acoustic lung images were scored by six blinded raters.
      Results:: Quantitative measurement of acoustic recordings was highly reproducible
      with an intraclass correlation score of 0.86 (very good agreement). Intraclass
      correlations for inter-rater agreement and reproducibility were 0.61 (good
      agreement) and 0.86 (very good agreement), respectively. There was no significant
      difference found between the six raters at any time point. Raters ranged from 88%
      to 95% in their ability to identically evaluate the different features of the
      same image presented to them blinded on two separate occasions. Conclusion::
      Acoustic lung imaging is reproducible in healthy individuals. Graphic
      representation of lung images can be interpreted with a high degree of accuracy
      by the same and by different reviewers.
FAU - Maher, T M
AU  - Maher TM
AD  - Department of Respiratory Medicine, The Royal Brompton Hospital, London, UK
FAU - Gat, M
AU  - Gat M
AD  - Deep Breeze Ltd, North Industrial Park, Or Akiva, Israel
FAU - Allen, D
AU  - Allen D
AD  - Department of Radiology, The Royal Brompton Hospital, London, UK
FAU - Devaraj, A
AU  - Devaraj A
AD  - Department of Radiology, The Royal Brompton Hospital, London, UK
FAU - Wells, A U
AU  - Wells AU
AD  - Department of Respiratory Medicine, The Royal Brompton Hospital, London, UK
FAU - Geddes, D M
AU  - Geddes DM
AD  - Department of Respiratory Medicine, The Royal Brompton Hospital, London, UK
LA  - eng
PT  - Journal Article
DEP - 20071116
PHST- 2007/07/02 [received]
PHST- 2007/10/08 [accepted]
PHST- 2007/11/16 [aheadofprint]
TA  - Thorax
JT  - Thorax
AID - tx86405 [pii]
AID - 10.1136/thx.2007.086405 [doi]
SO  - Thorax. 2008 Jun;63(6):542-8. Epub 2007 Nov 16 doi:10.1136/thx.2007.086405.

PMC - PMC4233183
PMID- 25156067
IS  - 1420-682X (Print)
IS  - 1420-9071 (Electronic)
VI  - 71
IP  - 23
DP  - 2014 Dec
TI  - Emerging roles for nuclear receptors in the pathogenesis of age-related macular
      degeneration.
PG  - 4617-36
AB  - Age-related macular degeneration (AMD) is the leading cause of vision loss in the
      elderly in the Western world. Over the last 30 years, our understanding of the
      pathogenesis of the disease has grown exponentially thanks to the results of
      countless epidemiology, genetic, histo-logical, and biochemical studies. This
      information, in turn, has led to the identification of multiple biologic pathways
      potentially involved in development and progression of AMD, including but not
      limited to inflammation, lipid and extracellular matrix dysregulation, and
      angiogenesis. Nuclear receptors are a superfamily of transcription factors that
      have been shown to regulate many of the pathogenic pathways linked with AMD and
      as such they are emerging as promising targets for therapeutic intervention. In
      this review, we will present the fundamental phenotypic features of AMD and
      discuss our current understanding of the pathobiological disease mechanisms. We
      will introduce the nuclear receptor superfamily and discuss the current
      literature on their effects on AMD-related pathophysiology.
FAU - Malek, Goldis
AU  - Malek G
AD  - Department of Ophthalmology, Duke University School of Medicine, 2351 Erwin Road,
      AERI Room 4006, Durham, NC 27710, USA
AD  - Department of Pathology, Duke University School of Medicine, Durham, NC, USA
FAU - Lad, Eleonora M.
AU  - Lad EM
AD  - Department of Ophthalmology, Duke University School of Medicine, 2351 Erwin Road,
      AERI Room 4006, Durham, NC 27710, USA
LA  - eng
PT  - Journal Article
DEP - 20140826
TA  - Cell Mol Life Sci
JT  - Cellular and molecular life sciences : CMLS
AID - 10.1007/s00018-014-1709-x [doi]
MID - NIHMS623664
SO  - Cell Mol Life Sci. 2014 Dec;71(23):4617-36. Epub 2014 Aug 26
      doi:10.1007/s00018-014-1709-x.

PMC - PMC5523951
PMID- 28748231
VI  - 18
IP  - 6
DP  - 2011 Dec
TI  - The tongue display unit (TDU) for electrotactile spatiotemporal pattern
      presentation.
PG  - 1476-85
AB  - The Tongue Display Unit (TDU) is a 144-channel programmable pulse generator that 
      delivers dc-balanced voltage pulses suitable for electrotactile
      (electrocutaneous) stimulation of the anterior-dorsal tongue, through a matrix of
      surface electrodes. This article reviews the theory of operation and a design
      overview of the TDU, as well as selected applications. These include sensory
      substitution, tactile information display and neurorehabilitation via induced
      neuroplasticity.
FAU - Kaczmarek, K.A.
AU  - Kaczmarek K
AD  - Department of Orthopedics and Rehabilitation, University of Wisconsin-Madison,
      1300 University Ave., Madison, WI 53711, USA
LA  - eng
PT  - Journal Article
TA  - Sci Iran D Comput Sci Eng Electr Eng
JT  - Scientia Iranica. Transactions D, Computer science & engineering, electrical
      engineering
AID - 10.1016/j.scient.2011.08.020 [doi]
MID - NIHMS879080
SO  - Sci Iran D Comput Sci Eng Electr Eng. 2011 Dec;18(6):1476-85.
      doi:10.1016/j.scient.2011.08.020.

PMC - PMC3347473
PMID- 21901381
IS  - 1619-7070 (Print)
IS  - 1619-7089 (Electronic)
VI  - 39
IP  - 1
DP  - 2012 Jan
TI  - Emerging roles for integrated imaging modalities in cardiovascular cell-based
      therapeutics: a clinical perspective.
PG  - 165-81
AB  - Despite preclinical promise, the progress of cell-based therapy to clinical
      cardiovascular practice has been slowed by several challenges and uncertainties
      that have been highlighted by the conflicting results of human trials. Most
      telling has been the revelation that current strategies fall short of achieving
      sufficient retention and engraftment of cells to meet the ambitious objective of 
      myocardial regeneration. This has sparked novel research into the refinement of
      cell biology and delivery to overcome these shortcomings. Within this context,
      molecular imaging has emerged as a valuable tool for providing noninvasive
      surveillance of cell fate in vivo. Direct and indirect labelling of cells can be 
      coupled with clinically relevant imaging modalities, such as radionuclide single 
      photon emission computed tomography and positron emission tomography, and
      magnetic resonance imaging, to assess their short- and long-term distributions,
      along with their viability, proliferation and functional interaction with the
      host myocardium. This review details the strengths and limitations of the
      different cell labelling and imaging techniques and their potential application
      to the clinical realm. We also consider the broader, multifaceted utility of
      imaging throughout the cell therapy process, providing a discussion of its
      considerable value during cell delivery and its importance during the evaluation 
      of cardiac outcomes in clinical studies.
FAU - Psaltis, Peter J.
AU  - Psaltis PJ
FAU - Simari, Robert D.
AU  - Simari RD
FAU - Rodriguez-Porcel, Martin
AU  - Rodriguez-Porcel M
LA  - eng
PT  - Journal Article
DEP - 20110908
GR  - R00 HL088048-05 || HL
TA  - Eur J Nucl Med Mol Imaging
JT  - European Journal of Nuclear Medicine and Molecular Imaging
AID - 10.1007/s00259-011-1925-7 [doi]
MID - NIHMS371650
SO  - Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):165-81. Epub 2011 Sep 08
      doi:10.1007/s00259-011-1925-7.

PMC - PMC3981645
PMID- 22426741
IS  - 1107-3756 (Print)
IS  - 1791-244X (Electronic)
VI  - 29
IP  - 6
DP  - 2012 Jun
TI  - Functional MRI using robotic MRI compatible devices for monitoring rehabilitation
      from chronic stroke in the molecular medicine era (Review).
PG  - 963-73
AB  - The number of individuals suffering from stroke is increasing daily, and its
      consequences are a major contributor to invalidity in today’s society. Stroke
      rehabilitation is relatively new, having been hampered from the longstanding view
      that lost functions were not recoverable. Nowadays, robotic devices, which aid by
      stimulating brain plasticity, can assist in restoring movement compromised by
      stroke-induced pathological changes in the brain which can be monitored by MRI.
      Multiparametric magnetic resonance imaging (MRI) of stroke patients participating
      in a training program with a novel Magnetic Resonance Compatible Hand-Induced
      Robotic Device (MR_CHIROD) could yield a promising biomarker that, ultimately,
      will enhance our ability to advance hand motor recovery following chronic stroke.
      Using state-of-the art MRI in conjunction with MR_CHIROD-assisted therapy can
      provide novel biomarkers for stroke patient rehabilitation extracted by a
      meta-analysis of data. Successful completion of such studies may provide a ground
      breaking method for the future evaluation of stroke rehabilitation therapies.
      Their results will attest to the effectiveness of using MR-compatible hand
      devices with MRI to provide accurate monitoring during rehabilitative therapy.
      Furthermore, such results may identify biomarkers of brain plasticity that can be
      monitored during stroke patient rehabilitation. The potential benefit for chronic
      stroke patients is that rehabilitation may become possible for a longer period of
      time after stroke than previously thought, unveiling motor skill improvements
      possible even after six months due to retained brain plasticity.
FAU - ASTRAKAS, LOUKAS G.
AU  - ASTRAKAS LG
AD  - Department of Surgery, NMR Surgical Laboratory, Massachusetts General Hospital
      and Shriners Burn Institute, Harvard Medical School, Boston, MA 02114, USA
FAU - NAQVI, SYED HASSAN ABBAS
AU  - NAQVI SHA
AD  - Department of Surgery, NMR Surgical Laboratory, Massachusetts General Hospital
      and Shriners Burn Institute, Harvard Medical School, Boston, MA 02114, USA
FAU - KATEB, BABAK
AU  - KATEB B
AD  - Brain Mapping Foundation, West Hollywood, CA 90046, USA
FAU - TZIKA, A. ARIA
AU  - TZIKA AA
AD  - Department of Surgery, NMR Surgical Laboratory, Massachusetts General Hospital
      and Shriners Burn Institute, Harvard Medical School, Boston, MA 02114, USA
LA  - eng
PT  - Journal Article
DEP - 20120315
PHST- 2011/11/16 [received]
PHST- 2011/12/27 [accepted]
PHST- 2012/03/15 [aheadofprint]
TA  - Int J Mol Med
JT  - International Journal of Molecular Medicine
AID - 10.3892/ijmm.2012.942 [doi]
AID - ijmm-29-06-0963 [pii]
SO  - Int J Mol Med. 2012 Jun;29(6):963-73. Epub 2012 Mar 15 doi:10.3892/ijmm.2012.942.

PMC - PMC3488562
PMID- 22828128
IS  - 1743-0003 (Electronic)
VI  - 9
DP  - 2012
TI  - Weighted phase lag index stability as an artifact resistant measure to detect
      cognitive EEG activity during locomotion.
PG  - 47
AB  - Background: High-density electroencephalography (EEG) with active electrodes
      allows for monitoring of electrocortical dynamics during human walking but
      movement artifacts have the potential to dominate the signal. One potential
      method for recovering cognitive brain dynamics in the presence of gait-related
      artifact is the Weighted Phase Lag Index. Methods: We tested the ability of
      Weighted Phase Lag Index to recover event-related potentials during locomotion.
      Weighted Phase Lag Index is a functional connectivity measure that quantified how
      consistently 90° (or 270°) phase ‘lagging’ one EEG signal was compared to
      another. 248-channel EEG was recorded as eight subjects performed a visual
      oddball discrimination and response task during standing and walking (0.8 or
      1.2 m/s) on a treadmill. Results: Applying Weighted Phase Lag Index across
      channels we were able to recover a p300-like cognitive response during walking.
      This response was similar to the classic amplitude-based p300 we also recovered
      during standing. We also showed that the Weighted Phase Lag Index detects more
      complex and variable activity patterns than traditional voltage-amplitude
      measures. This variability makes it challenging to compare brain activity over
      time and across subjects. In contrast, a statistical metric of the index’s
      variability, calculated over a moving time window, provided a more generalized
      measure of behavior. Weighted Phase Lag Index Stability returned a peak change of
      1.8% + −0.5% from baseline for the walking case and 3.9% + −1.3% for the standing
      case. Conclusions: These findings suggest that both Weighted Phase Lag Index and 
      Weighted Phase Lag Index Stability have potential for the on-line analysis of
      cognitive dynamics within EEG during human movement. The latter may be more
      useful from extracting general principles of neural behavior across subjects and 
      conditions.
FAU - Lau, Troy M
AU  - Lau TM
AD  - Human Neuromechanics Laboratory, School of Kinesiology, University of Michigan,
      Ann Arbor, MI 48109-2214, USA
FAU - Gwin, Joseph T
AU  - Gwin JT
AD  - Human Neuromechanics Laboratory, School of Kinesiology, University of Michigan,
      Ann Arbor, MI 48109-2214, USA
FAU - McDowell, Kaleb G
AU  - McDowell KG
AD  - US Army Research Laboratory, Human Research and Engineering Directorate,
      Translational Neuroscience Branch, Aberdeen Proving Ground, Aberdeen, MD 21005,
      USA
FAU - Ferris, Daniel P
AU  - Ferris DP
AD  - Human Neuromechanics Laboratory, School of Kinesiology, University of Michigan,
      Ann Arbor, MI 48109-2214, USA
LA  - eng
PT  - Journal Article
DEP - 20120724
PHST- 2011/10/20 [received]
PHST- 2012/07/05 [accepted]
TA  - J Neuroeng Rehabil
JT  - Journal of NeuroEngineering and Rehabilitation
AID - 1743-0003-9-47 [pii]
AID - 10.1186/1743-0003-9-47 [doi]
SO  - J Neuroeng Rehabil. 2012 Jul 24;9:47. doi:10.1186/1743-0003-9-47.

PMC - PMC4902297
PMID- 27298575
IS  - 1083-4435 (Print)
VI  - 21
IP  - 3
DP  - 2016 Jun
TI  - Design and Development of a Smart Exercise Bike for Motor Rehabilitation in
      Individuals with Parkinson’s Disease.
PG  - 1650-8
AB  - Recent studies in rehabilitation of Parkinson’s disease (PD) have shown that
      cycling on a tandem bike at a high pedaling rate can reduce the symptoms of the
      disease. In this research, a smart motorized bicycle has been designed and built 
      for assisting Parkinson’s patients with exercise to improve motor function. The
      exercise bike can accurately control the rider’s experience at an accelerated
      pedaling rate while capturing real-time test data. Here, the design and
      development of the electronics and hardware as well as the software and control
      algorithms are presented. Two control algorithms have been developed for the
      bike; one that implements an inertia load (static mode) and one that implements a
      speed reference (dynamic mode). In static mode the bike operates as a regular
      exercise bike with programmable resistance (load) that captures and records the
      required signals such as heart rate, cadence and power. In dynamic mode the bike 
      operates at a user-selected speed (cadence) with programmable variability in
      speed that has been shown to be essential to achieving the desired motor
      performance benefits for PD patients. In addition, the flexible and extensible
      design of the bike permits readily changing the control algorithm and
      incorporating additional I/O as needed to provide a wide range of riding
      experiences. Furthermore, the network-enabled controller provides remote access
      to bike data during a riding session.
FAU - Mohammadi-Abdar, Hassan
AU  - Mohammadi-Abdar H
AD  - EECS Department, Case Western Reserve University, Cleveland, Ohio, 44106, USA
      (hmabdar@case.edu)
FAU - Ridgel, Angela L.
AU  - Ridgel AL
AD  - Department of Exercise Science, Kent State University, Kent, OH, USA
      (aridgel@kent.edu)
FAU - Discenzo, Fred M.
AU  - Discenzo FM
AD  - Advanced Technology Laboratory, Rockwell Automation, Mayfield Heights, OH, USA
      (fmdiscenzo@ra.rockwell.com)
FAU - Loparo, Kenneth A.
AU  - Loparo KA
AD  - EECS Department Case Western Reserve University, Cleveland, Ohio, 44106, USA
      (kal4@case.edu)
LA  - eng
PT  - Journal Article
DEP - 20151211
TA  - IEEE ASME Trans Mechatron
JT  - IEEE/ASME transactions on mechatronics : a joint publication of the IEEE
      Industrial Electronics Society and the ASME Dynamic Systems and Control Division
AID - 10.1109/TMECH.2015.2508030 [doi]
MID - NIHMS785983
SO  - IEEE ASME Trans Mechatron. 2016 Jun;21(3):1650-8. Epub 2015 Dec 11
      doi:10.1109/TMECH.2015.2508030.

PMC - PMC3280242
PMID- 22355308
IS  - 1932-6203 (Electronic)
VI  - 7
IP  - 2
DP  - 2012
TI  - Independent EEG Sources Are Dipolar.
LID - e30135
AB  - Independent component analysis (ICA) and blind source separation (BSS) methods
      are increasingly used to separate individual brain and non-brain source signals
      mixed by volume conduction in electroencephalographic (EEG) and other
      electrophysiological recordings. We compared results of decomposing thirteen
      71-channel human scalp EEG datasets by 22 ICA and BSS algorithms, assessing the
      pairwise mutual information (PMI) in scalp channel pairs, the remaining PMI in
      component pairs, the overall mutual information reduction (MIR) effected by each 
      decomposition, and decomposition ‘dipolarity’ defined as the number of component 
      scalp maps matching the projection of a single equivalent dipole with less than a
      given residual variance. The least well-performing algorithm was principal
      component analysis (PCA); best performing were AMICA and other likelihood/mutual 
      information based ICA methods. Though these and other commonly-used decomposition
      methods returned many similar components, across 18 ICA/BSS algorithms mean
      dipolarity varied linearly with both MIR and with PMI remaining between the
      resulting component time courses, a result compatible with an interpretation of
      many maximally independent EEG components as being volume-conducted projections
      of partially-synchronous local cortical field activity within single compact
      cortical domains. To encourage further method comparisons, the data and software 
      used to prepare the results have been made available
      (http://sccn.ucsd.edu/wiki/BSSComparison).
FAU - Delorme, Arnaud
AU  - Delorme A
AD  - Swartz Center for Computational Neuroscience, University of California San Diego,
      La Jolla, California, United States of America
FAU - Palmer, Jason
AU  - Palmer J
AD  - Swartz Center for Computational Neuroscience, University of California San Diego,
      La Jolla, California, United States of America
FAU - Onton, Julie
AU  - Onton J
AD  - Swartz Center for Computational Neuroscience, University of California San Diego,
      La Jolla, California, United States of America
FAU - Oostenveld, Robert
AU  - Oostenveld R
AD  - Donders Institute for Brain, Cognition and Behaviour, Radboud University,
      Nijmegen, The Netherlands
FAU - Makeig, Scott
AU  - Makeig S
AD  - Swartz Center for Computational Neuroscience, University of California San Diego,
      La Jolla, California, United States of America
LA  - eng
PT  - Journal Article
DEP - 20120215
PHST- 2011/07/29 [received]
PHST- 2011/12/09 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-11-14790 [pii]
AID - 10.1371/journal.pone.0030135 [doi]
SO  - PLoS One. 2012 Feb 15;7(2):. doi:10.1371/journal.pone.0030135.

PMC - PMC2854557
PMID- 20384404
IS  - 0097-7403 (Print)
IS  - 1939-2184 (Electronic)
VI  - 36
IP  - 2
DP  - 2010 Apr
TI  - Vibratory sources as compound stimuli for the octavolateralis systems: Dissection
      of specific stimulation channels using multiple behavioral approaches.
PG  - 243-57
AB  - An underwater vibratory source simultaneously presents acoustic and hydrodynamic 
      disturbances. Because vibratory dipole sources are poor sonic projectors, most
      researchers have assumed that such sources are of greatest relevance to the
      lateral line system (LL). Both hydroacoustic principles and empirical studies
      have shown that vibratory dipole sources are also a potent stimulus to the inner 
      ear of fishes. Responses to vibratory sources in mottled sculpin (Cottus bairdi) 
      were assessed using unconditioned orienting, differential and
      non-differential-classical conditioning. Orienting responses are dominated by LL 
      inputs and eliminated by LL pharmacological inactivation. Simple conditioning
      depends on inputs from other systems and was not affected by LL inactivation.
      Differential conditioning alters behavioral control, and sculpin could be
      conditioned to ignore substrate borne vibrations and respond only to
      hydroacoustic stimulation of the ear. The lateral line and inner ear of mottled
      sculpin do not necessarily exhibit range fractionation, as both systems operate
      over a similar distance from the animal (within 1.5 body lengths) and respond to 
      many of the same sources. Vibratory dipole sources generate compound stimuli that
      simultaneously activate multiple octavolateralis systems, and animals make use of
      the channels differentially under different behavioral tasks.
FAU - Braun, Christopher B.
AU  - Braun CB
AD  - Department of Psychology, Hunter College; & Psychology, The Graduate Center, City
      University of New York, 695 Park Ave, New York, NY 10021
FAU - Coombs, Sheryl
AU  - Coombs S
AD  - Department of Biological Sciences, JP Scott Center for Neuroscience, Mind and
      Behavior, Bowling Green State University, Bowling Green, Oh 43402
LA  - eng
PT  - Journal Article
TA  - J Exp Psychol Anim Behav Process
JT  - Journal of experimental psychology. Animal behavior processes
AID - 10.1037/a0016747 [doi]
MID - NIHMS186757
SO  - J Exp Psychol Anim Behav Process. 2010 Apr;36(2):243-57. doi:10.1037/a0016747.

PMC - PMC2867772
PMID- 20409347
IS  - 1758-3284 (Electronic)
VI  - 2
DP  - 2010
TI  - Evaluation of a low-cost, portable imaging system for early detection of oral
      cancer.
PG  - 10
AB  - Background: There is an important global need to improve early detection of oral 
      cancer. Recent reports suggest that optical imaging technologies can aid in the
      identification of neoplastic lesions in the oral cavity; however, there is little
      data evaluating the use of optical imaging modalities in resource limited
      settings where oral cancer impacts patients disproportionately. In this article, 
      we evaluate a simple, low-cost optical imaging system that is designed for early 
      detection of oral cancer in resource limited settings. We report results of a
      clinical study conducted at Tata Memorial Hospital (TMH) in Mumbai, India using
      this system as a tool to improve detection of oral cancer and its precursors.
      Methods: Reflectance images with white light illumination and fluorescence images
      with 455 nm excitation were obtained from 261 sites in the oral cavity from 76
      patients and 90 sites in the oral cavity from 33 normal volunteers. Quantitative 
      image features were used to develop classification algorithms to identify
      neoplastic tissue, using clinical diagnosis of expert observers as the gold
      standard. Results: Using the ratio of red to green autofluorescence, the
      algorithm identified tissues judged clinically to be cancer or clinically
      suspicious for neoplasia with a sensitivity of 90% and a specificity of 87%.
      Conclusions: Results suggest that the performance of this simple, objective
      low-cost system has potential to improve oral screening efforts, especially in
      low-resource settings.
FAU - Rahman, Mohammed S
AU  - Rahman MS
AD  - Department of Bioengineering, Rice University, Houston, 77005, USA
FAU - Ingole, Nilesh
AU  - Ingole N
AD  - Head and Neck Surgery, Tata Memorial Hospital, Mumbai, 400012, India
FAU - Roblyer, Darren
AU  - Roblyer D
AD  - Department of Bioengineering, Rice University, Houston, 77005, USA
FAU - Stepanek, Vanda
AU  - Stepanek V
AD  - Department of Bioengineering, Rice University, Houston, 77005, USA
FAU - Richards-Kortum, Rebecca
AU  - Richards-Kortum R
AD  - Department of Bioengineering, Rice University, Houston, 77005, USA
FAU - Gillenwater, Ann
AU  - Gillenwater A
AD  - Department of Bioengineering, Rice University, Houston, 77005, USA
FAU - Shastri, Surendra
AU  - Shastri S
AD  - Head and Neck Surgery, Tata Memorial Hospital, Mumbai, 400012, India
FAU - Chaturvedi, Pankaj
AU  - Chaturvedi P
AD  - Head and Neck Surgery, Tata Memorial Hospital, Mumbai, 400012, India
LA  - eng
PT  - Journal Article
DEP - 20100422
PHST- 2010/03/29 [received]
PHST- 2010/04/22 [accepted]
TA  - Head Neck Oncol
JT  - Head & Neck Oncology
AID - 1758-3284-2-10 [pii]
AID - 10.1186/1758-3284-2-10 [doi]
SO  - Head Neck Oncol. 2010 Apr 22;2:10. doi:10.1186/1758-3284-2-10.

PMC - PMC4947535
PMID- 27213774
IS  - 1350-7540 (Print)
IS  - 1473-6551 (Electronic)
VI  - 29
IP  - 4
DP  - 2016 Aug
TI  - Real-time functional magnetic resonance imaging neurofeedback in motor
      neurorehabilitation.
PG  - 412-8
AB  - Purpose of review: Recent developments in functional magnetic resonance imaging
      (fMRI) have catalyzed a new field of translational neuroscience. Using fMRI to
      monitor the aspects of task-related changes in neural activation or brain
      connectivity, investigators can offer feedback of simple or complex neural
      signals/patterns back to the participant on a quasireal-time basis
      [real-time-fMRI-based neurofeedback (rt-fMRI-NF)]. Here, we introduce some
      background methodology of the new developments in this field and give a
      perspective on how they may be used in neurorehabilitation in the future. Recent 
      findings: The development of rt-fMRI-NF has been used to promote self-regulation 
      of activity in several brain regions and networks. In addition, and unlike other 
      noninvasive techniques, rt-fMRI-NF can access specific subcortical regions and in
      principle any region that can be monitored using fMRI including the cerebellum,
      brainstem and spinal cord. In Parkinson's disease and stroke, rt-fMRI-NF has been
      demonstrated to alter neural activity after the self-regulation training was
      completed and to modify specific behaviours. Summary: Future exploitation of
      rt-fMRI-NF could be used to induce neuroplasticity in brain networks that are
      involved in certain neurological conditions. However, currently, the use of
      rt-fMRI-NF in randomized, controlled clinical trials is in its infancy.
FAU - Linden, David E.J.
AU  - Linden DE
AD  - MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School 
      of Medicine, and Cardiff University Brain Imaging Centre, Cardiff
FAU - Turner, Duncan L.
AU  - Turner DL
AD  - Neurorehabilitation Unit, School of Health, Sport and Bioscience, University of
      East London, London, UK
LA  - eng
PT  - Journal Article
DEP - 20160519
PHST- 2016/05/19 [aheadofprint]
TA  - Curr Opin Neurol
JT  - Current Opinion in Neurology
AID - 10.1097/WCO.0000000000000340 [doi]
SO  - Curr Opin Neurol. 2016 Aug;29(4):412-8. Epub 2016 May 19
      doi:10.1097/WCO.0000000000000340.

PMC - PMC3765989
PMID- 23987126
IS  - 1745-6215 (Electronic)
VI  - 14
DP  - 2013
TI  - HIV prevention in favour of the choice-disabled in southern Africa: study
      protocol for a randomised controlled trial.
PG  - 274
AB  - Background: Most HIV prevention strategies assume beneficiaries can act on their 
      prevention decisions. But some people are unable to do so. They are
      ‘choice-disabled’. Economic and educational interventions can reduce sexual
      violence, but there is less evidence that they can reduce HIV. There is little
      research on complex interventions in HIV prevention, yet all countries in
      southern Africa implement combination prevention programmes. Methods/Design: The 
      primary objective is to reduce HIV infections among women aged 15 to 29 years.
      Secondary objectives are reduction in gender violence and improvement in
      HIV-related knowledge, attitudes and practices among youth aged 15 to 29 years.A 
      random sample of 77 census enumeration areas in three countries (Botswana,
      Namibia and Swaziland) was allocated randomly to three interventions, alone or in
      combination, in a factorial design stratified by country, HIV rates (above or
      below average for country), and urban/rural location. A baseline survey of youth 
      aged 15 to 29 years provided cluster specific rates of HIV. All clusters continue
      existing prevention efforts and have a baseline and follow-up survey. Cluster is 
      the unit of allocation, intervention and analysis, using generalised estimating
      equations, on an intention-to-treat basis.One intervention discusses evidence
      about choice disability with local HIV prevention services, to help them to serve
      the choice-disabled. Another discusses an eight-episode audio-docudrama with
      community groups, of all ages and both sexes, to generate endogenous strategies
      to reduce gender violence and develop an enabling environment. A third supports
      groups of women aged 18 to 25 years to build self-esteem and life skills and to
      set up small enterprises to generate income.A survey in all clusters after 3
      years will measure outcomes, with interviewers unaware of group assignment of the
      clusters. The primary outcome is HIV infection in women aged 15 to 29 years.
      Secondary outcomes in youth aged 15 to 29 years are gender violence and
      protective knowledge, attitudes, subjective norms, intention to change, agency,
      discussion of prevention and practices related to HIV and gender violence. Trial 
      registration: Trial registration number: ISRCTN28557578
FAU - Andersson, Neil
AU  - Andersson N
AD  - Centro de Investigación de Enfermedades Tropicales (CIET), Universidad Autónoma
      de Guerrero, Calle Pino, El Roble, Acapulco, Mexico
FAU - Cockcroft, Anne
AU  - Cockcroft A
AD  - CIET Trust Botswana, P.O. Box 1240, Gaborone, Botswana
FAU - Thabane, Lehana
AU  - Thabane L
AD  - McMaster University, Hamilton, ON, Canada
FAU - Marokoane, Nobantu
AU  - Marokoane N
AD  - CIET Trust, 71 Oxford Road, Johannesburg 2196, South Africa
FAU - Laetsang, Ditiro
AU  - Laetsang D
AD  - CIET Trust Botswana, P.O. Box 1240, Gaborone, Botswana
FAU - Masisi, Mokgweetsi
AU  - Masisi M
AD  - Minister for Presidential Affairs and Public Administration, Office of the
      President, Private Bag 001, Gaborone, Botswana
LA  - eng
PT  - Journal Article
DEP - 20130829
PHST- 2013/02/13 [received]
PHST- 2013/08/12 [accepted]
TA  - Trials
JT  - Trials
AID - 1745-6215-14-274 [pii]
AID - 10.1186/1745-6215-14-274 [doi]
SO  - Trials. 2013 Aug 29;14:274. doi:10.1186/1745-6215-14-274.

PMC - PMC4853938
PMID- 27195007
IS  - 1687-7063 (Print)
IS  - 1687-7071 (Electronic)
VI  - 2016
DP  - 2016
TI  - Do Aging and Tactile Noise Stimulation Affect Responses to Support Surface
      Translations in Healthy Adults?
LID - 2941964
AB  - Appropriate neuromuscular responses to support surface perturbations are crucial 
      to prevent falls, but aging-related anatomical and physiological changes affect
      the appropriateness and efficiency of such responses. Low-level noise application
      to sensory receptors has shown to be effective for postural improvement in a
      variety of different balance tasks, but it is unknown whether this intervention
      may have value for improvement of corrective postural responses. Ten healthy
      younger and ten healthy older adults were exposed to sudden backward translations
      of the support surface. Low-level noise (mechanical vibration) to the foot soles 
      was added during random trials and temporal (response latency) and spatial
      characteristics (maximum center-of-pressure excursion and anterior-posterior path
      length) of postural responses were assessed. Mixed-model ANOVA was applied for
      analysis of postural response differences based on age and vibration condition.
      Age affected postural response characteristics, but older adults were well able
      to maintain balance when exposed to a postural perturbation. Low-level noise
      application did not affect any postural outcomes. Healthy aging affects some
      specific measures of postural stability, and in high-functioning older
      individuals, a low-level noise intervention may not be valuable. More research is
      needed to investigate if recurring fallers and neuropathy patients could benefit 
      from the intervention in postural perturbation tasks.
FAU - Dettmer, Marius
AU  - Dettmer M
AUID- ORCID: 0000-0002-0497-5943
AD  - Memorial Bone & Joint Research Foundation, 1140 Business Center Drive Suite 101, 
      Houston, TX 77043, USA
FAU - Pourmoghaddam, Amir
AU  - Pourmoghaddam A
AD  - Memorial Bone & Joint Research Foundation, 1140 Business Center Drive Suite 101, 
      Houston, TX 77043, USA
FAU - Lee, Beom-Chan
AU  - Lee BC
AD  - Health and Human Performance Department, University of Houston, 3855 Holman
      Street, Houston, TX 77204-6015, USA
FAU - Layne, Charles S.
AU  - Layne CS
AD  - Health and Human Performance Department, University of Houston, 3855 Holman
      Street, Houston, TX 77204-6015, USA
LA  - eng
PT  - Journal Article
DEP - 20160419
PHST- 2015/10/10 [received]
PHST- 2016/02/23 [revised]
PHST- 2016/04/04 [accepted]
PHST- 2016/04/19 [aheadofprint]
TA  - Curr Gerontol Geriatr Res
JT  - Current Gerontology and Geriatrics Research
AID - 10.1155/2016/2941964 [doi]
SO  - Curr Gerontol Geriatr Res. 2016;2016:. Epub 2016 Apr 19 doi:10.1155/2016/2941964.

PMC - PMC3113542
PMID- 21497198
IS  - 1053-8119 (Print)
IS  - 1095-9572 (Electronic)
VI  - 56
IP  - 4
DP  - 2011 Jun 15
TI  - Covariance Modeling of MRI Brain Volumes in Memory Circuitry in Schizophrenia:
      Sex Differences are Critical.
PG  - 1865-74
AB  - Women have consistently demonstrated better verbal memory on tests that evaluate 
      immediate and delayed free recall. In patients with schizophrenia, these verbal
      memory processes are relatively more preserved in women than men. However an
      understanding of the brain anatomy of the female advantage for verbal memory is
      still unclear.29 females and 59 males with schizophrenia made comparable to 21
      female and 27 male healthy volunteers were scanned using structural magnetic
      resonance imaging (sMRI) in order to assess volumes of regions across the entire 
      brain. Sex differences within and between groups in the covariance structure of
      memory circuitry regions were evaluated using a novel approach to covariance
      analysis (the Box M Test). Brain areas of interest included prefrontal cortex
      (PFC), inferior parietal lobule (iPAR), anterior cingulate gyrus (ACG),
      parahippocampus, and hippocampus (HIPP).Results showed significant differences in
      the covariance matrices of females and males with schizophrenia compared with
      their healthy counterparts, in particular the relationships between iPAR-PFC,
      iPAR-ACG, and HIPP-PFC. Sex differences in the iPAR-PFC relationship were
      significantly associated with sex differences in verbal memory performance. In
      control women, but not in men ACG volume correlated strongly with memory
      performance. In schizophrenia, ACG volume was reduced in females, but not in men,
      relative to controls.Findings suggest that the relationship between iPAR and PFC 
      is particularly important for understanding the relative preservation of verbal
      memory processing in females with schizophrenia and may compensate for ACG volume
      reductions. These results illustrate the utility of a unique covariance structure
      modeling approach that yields important new knowledge for understanding the
      nature of schizophrenia.
FAU - Abbs, Brandon
AU  - Abbs B
AD  - Harvard Medical School (HMS), Departments of Psychiatry and Medicine Brigham and 
      Women's Hospital, Connors Center for Women's Health and Gender Biology 1620
      Tremont St. BC 3-34, Boston, MA 02120 USA
FAU - Liang, Lichen
AU  - Liang L
AD  - Department of Neurology, Massachusetts General Hospital (MGH) 149 13 St.,
      Charlestown, MA 02129 USA
FAU - Makris, Nikos
AU  - Makris N
AD  - Department of Neurology, Massachusetts General Hospital (MGH) 149 13 St.,
      Charlestown, MA 02129 USA
FAU - Tsuang, Ming
AU  - Tsuang M
AD  - Center for Behavioral Genomics, Institute for Genomic Medicine, Department of
      Psychiatry, University of California, San Diego
FAU - Seidman, Larry J.
AU  - Seidman LJ
AD  - MGH & MIT Athinoula Martinos Center for Biomedical Imaging & MGH Center for
      Morphometric Analysis 149 13 St., Charlestown, MA 02129 USA
FAU - Goldstein, Jill M.
AU  - Goldstein JM
AD  - Harvard Medical School (HMS), Departments of Psychiatry and Medicine Brigham and 
      Women's Hospital, Connors Center for Women's Health and Gender Biology 1620
      Tremont St. BC 3-34, Boston, MA 02120 USA
LA  - eng
PT  - Journal Article
DEP - 20110408
GR  - R01 MH056956-15 || MH
TA  - Neuroimage
JT  - NeuroImage
AID - 10.1016/j.neuroimage.2011.03.079 [doi]
MID - NIHMS292333
SO  - Neuroimage. 2011 Jun 15;56(4):1865-74. Epub 2011 Apr 8
      doi:10.1016/j.neuroimage.2011.03.079.

PMC - PMC3696943
PMID- 23216339
IS  - 1520-9156 (Print)
IS  - 1557-8593 (Electronic)
VI  - 14
IP  - 12
DP  - 2012 Dec
TI  - 5th Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) Applications and 
      Beyond, May 3–5, 2012, Dublin, Ireland.
PG  - 1155-73
FAU - Hoey, Hilary
AU  - Hoey H
AD  - Diabetes Ireland, Dublin, Ireland.
FAU - Mlinac, Anita
AU  - Mlinac A
AD  - Adecco Human Resources GmbH, Mannheim, Germany.
FAU - Tran, Cam-Tuan
AU  - Tran CT
AD  - Roche Diagnostics GmbH, Mannheim, Germany.
FAU - Schlaeger, Christof
AU  - Schlaeger C
AD  - Roche Diagnostics GmbH, Mannheim, Germany.
LA  - eng
PT  - Journal Article
TA  - Diabetes Technol Ther
JT  - Diabetes Technology & Therapeutics
AID - 10.1089/dia.2012.0230 [pii]
AID - 10.1089/dia.2012.0230 [doi]
SO  - Diabetes Technol Ther. 2012 Dec;14(12):1155-73. doi:10.1089/dia.2012.0230.

PMC - PMC3929854
PMID- 24554670
IS  - 1072-0502 (Print)
IS  - 1549-5485 (Electronic)
VI  - 21
IP  - 3
TI  - Learning enhances intrinsic excitability in a subset of lateral amygdala neurons.
PG  - 161-70
AB  - Learning-induced modulation of neuronal intrinsic excitability is a
      metaplasticity mechanism that can impact the acquisition of new memories.
      Although the amygdala is important for emotional learning and other behaviors,
      including fear and anxiety, whether learning alters intrinsic excitability within
      the amygdala has received very little attention. Fear conditioning was combined
      with intracellular recordings to investigate the effects of learning on the
      intrinsic excitability of lateral amygdala (LA) neurons. To assess time-dependent
      changes, brain slices were prepared either immediately or 24-h post-conditioning.
      Fear conditioning significantly enhanced excitability of LA neurons, as evidenced
      by both decreased afterhyperpolarization (AHP) and increased neuronal firing.
      These changes were time-dependent such that reduced AHPs were evident at both
      time points whereas increased neuronal firing was only observed at the later
      (24-h) time point. Moreover, these changes occurred within a subset (32%) of LA
      neurons. Previous work also demonstrated that learning-related changes in
      synaptic plasticity are also evident in less than one-third of amygdala neurons, 
      suggesting that the neurons undergoing intrinsic plasticity may be critical for
      fear memory. These data may be clinically relevant as enhanced LA excitability
      following fear learning could influence future amygdala-dependent behaviors.
FAU - Sehgal, Megha
AU  - Sehgal M
AD  - Department of Psychology, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin
      53201, USA
FAU - Ehlers, Vanessa L.
AU  - Ehlers VL
AD  - Department of Psychology, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin
      53201, USA
FAU - Moyer, James R.
AU  - Moyer JR
AD  - Department of Psychology, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin
      53201, USA
LA  - eng
PT  - Journal Article
DEP - 201403
PHST- 2013/08/06 [received]
PHST- 2013/12/17 [accepted]
TA  - Learn Mem
JT  - Learning & Memory
AID - 10.1101/lm.032730.113 [doi]
AID - SehgalLM032730 [pii]
SO  - Learn Mem. ;21(3):161-70. doi:10.1101/lm.032730.113.

PMC - PMC3600193
PMID- 23533955
IS  - 2090-8105 (Print)
IS  - 2042-0056 (Electronic)
VI  - 2013
DP  - 2013
TI  - Transcranial Direct Current Stimulation in Stroke Rehabilitation: A Review of
      Recent Advancements.
LID - 170256
AB  - Transcranial direct current stimulation (tDCS) is a promising technique to treat 
      a wide range of neurological conditions including stroke. The pathological
      processes following stroke may provide an exemplary system to investigate how
      tDCS promotes neuronal plasticity and functional recovery. Changes in synaptic
      function after stroke, such as reduced excitability, formation of aberrant
      connections, and deregulated plastic modifications, have been postulated to
      impede recovery from stroke. However, if tDCS could counteract these negative
      changes by influencing the system's neurophysiology, it would contribute to the
      formation of functionally meaningful connections and the maintenance of existing 
      pathways. This paper is aimed at providing a review of underlying mechanisms of
      tDCS and its application to stroke. In addition, to maximize the effectiveness of
      tDCS in stroke rehabilitation, future research needs to determine the optimal
      stimulation protocols and parameters. We discuss how stimulation parameters could
      be optimized based on electrophysiological activity. In particular, we propose
      that cortical synchrony may represent a biomarker of tDCS efficacy to indicate
      communication between affected areas. Understanding the mechanisms by which tDCS 
      affects the neural substrate after stroke and finding ways to optimize tDCS for
      each patient are key to effective rehabilitation approaches.
FAU - Gomez Palacio Schjetnan, Andrea
AU  - Gomez Palacio Schjetnan A
FAU - Faraji, Jamshid
AU  - Faraji J
FAU - Metz, Gerlinde A.
AU  - Metz GA
FAU - Tatsuno, Masami
AU  - Tatsuno M
FAU - Luczak, Artur
AU  - Luczak A
LA  - eng
PT  - Journal Article
DEP - 20130227
PHST- 2012/10/10 [received]
PHST- 2012/12/17 [revised]
PHST- 2013/01/14 [accepted]
PHST- 2013/02/27 [aheadofprint]
TA  - Stroke Res Treat
JT  - Stroke Research and Treatment
AID - 10.1155/2013/170256 [doi]
SO  - Stroke Res Treat. 2013;2013:. Epub 2013 Feb 27 doi:10.1155/2013/170256.

PMC - PMC3739027
PMID- 23950741
IS  - 1662-5161 (Electronic)
VI  - 7
DP  - 2013
TI  - The morphology of midcingulate cortex predicts frontal-midline theta
      neurofeedback success.
LID - 453
AB  - Humans differ in their ability to learn how to control their own brain activity
      by neurofeedback. However, neural mechanisms underlying these inter-individual
      differences, which may determine training success and associated cognitive
      enhancement, are not well-understood. Here, it is asked whether neurofeedback
      success of frontal-midline (fm) theta, an oscillation related to higher cognitive
      functions, could be predicted by the morphology of brain structures known to be
      critically involved in fm-theta generation. Nineteen young, right-handed
      participants underwent magnetic resonance imaging of T1-weighted brain images,
      and took part in an individualized, eight-session neurofeedback training in order
      to learn how to enhance activity in their fm-theta frequency band. Initial
      training success, measured at the second training session, was correlated with
      the final outcome measure. We found that the inferior, superior, and middle
      frontal cortices were not associated with training success. However, volume of
      the midcingulate cortex as well as volume and concentration of the underlying
      white matter structures act as predictor variables for the general responsiveness
      to training. These findings suggest a neuroanatomical foundation for the ability 
      to learn to control one's own brain activity.
FAU - Enriquez-Geppert, Stefanie
AU  - Enriquez-Geppert S
AD  - Department of Psychology, European Medical School, Carl von Ossietzky
      UniversityOldenburg, Germany
FAU - Huster, René J.
AU  - Huster RJ
AD  - Department of Psychology, European Medical School, Carl von Ossietzky
      UniversityOldenburg, Germany
FAU - Scharfenort, Robert
AU  - Scharfenort R
AD  - Department of Psychology, European Medical School, Carl von Ossietzky
      UniversityOldenburg, Germany
FAU - Mokom, Zacharais N.
AU  - Mokom ZN
AD  - Department of Psychology, European Medical School, Carl von Ossietzky
      UniversityOldenburg, Germany
FAU - Vosskuhl, Johannes
AU  - Vosskuhl J
AD  - Department of Psychology, European Medical School, Carl von Ossietzky
      UniversityOldenburg, Germany
FAU - Figge, Christian
AU  - Figge C
AD  - Karl-Jaspers Clinic, European Medical School, Carl von Ossietzky
      UniversityOldenburg, Germany
FAU - Zimmermann, Jörg
AU  - Zimmermann J
AD  - Karl-Jaspers Clinic, European Medical School, Carl von Ossietzky
      UniversityOldenburg, Germany
FAU - Herrmann, Christoph S.
AU  - Herrmann CS
AD  - Department of Psychology, European Medical School, Carl von Ossietzky
      UniversityOldenburg, Germany
LA  - eng
PT  - Journal Article
DEP - 20130809
PHST- 2013/04/12 [received]
PHST- 2013/07/22 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2013.00453 [doi]
SO  - Front Hum Neurosci. 2013 Aug 09;7:. doi:10.3389/fnhum.2013.00453.

PMC - PMC4005474
PMID- 24129553
IS  - 0031-3998 (Print)
IS  - 1530-0447 (Electronic)
VI  - 75
IP  - 0
DP  - 2014 Jan
TI  - Modulation of EEG spectral edge frequency during patterned pneumatic oral
      stimulation in preterm infants.
PG  - 85-92
AB  - Background: Stimulation of the nervous system plays a central role in brain
      development and neurodevelopmental outcome. Thalamocortical and corticocortical
      development is diminished in premature infants and correlated to
      electroencephalography (EEG) progression. The purpose of this study was to
      determine the effects of orocutaneous stimulation on the modulation of spectral
      edge frequency, fc=90% (SEF-90) derived from EEG recordings in preterm infants.
      Methods: Twenty two preterm infants were randomized to experimental and control
      conditions. Pulsed orocutaneous stimulation was presented during gavage feedings 
      begun at around 32 weeks postmenstrual age (PMA). The SEF-90 was derived from
      2-channel EEG recordings. Results: Compared to the control condition, the pulsed 
      orocutaneous stimulation produced a significant reorganization of SEF-90 in the
      left (p = 0.005) and right (p < 0.0001) hemispheres. Notably, the left and right 
      hemisphere showed a reversal in the polarity of frequency shift, demonstrating
      hemispheric asymmetry in the frequency domain. Pulsed orocutaneous stimulation
      also produced a significant pattern of short term cortical adaptation and a long 
      term neural adaptation manifest as a 0.5 Hz elevation in SEF-90 after repeated
      stimulation sessions. Conclusion: This is the first study to demonstrate the
      modulating effects of a servo-controlled oral somatosensory input on the spectral
      features of EEG activity in preterm infants.
FAU - Song, Dongli
AU  - Song D
AD  - Division of Neonatology, Department of Pediatrics, Santa Clara Valley Medical
      Center, San Jose, California
FAU - Jegatheesan, Priya
AU  - Jegatheesan P
AD  - Division of Neonatology, Department of Pediatrics, Santa Clara Valley Medical
      Center, San Jose, California
FAU - Weiss, Sunshine
AU  - Weiss S
AD  - Division of Neonatology, Department of Pediatrics, Santa Clara Valley Medical
      Center, San Jose, California
FAU - Govindaswami, Balaji
AU  - Govindaswami B
AD  - Division of Neonatology, Department of Pediatrics, Santa Clara Valley Medical
      Center, San Jose, California
FAU - Wang, Jingyan
AU  - Wang J
AD  - Department of Speech-Language-Hearing: Sciences and Disorders, Neuroscience and
      Bioengineering, University of Kansas, Lawrence, Kansas
FAU - Lee, Jaehoon
AU  - Lee J
AD  - Center for Research Methods and Data Analysis, University of Kansas, Lawrence,
      Kansas
FAU - Oder, Austin
AU  - Oder A
AD  - Department of Speech-Language-Hearing: Sciences and Disorders, Neuroscience and
      Bioengineering, University of Kansas, Lawrence, Kansas
FAU - Barlow, Steven M
AU  - Barlow SM
AD  - Department of Speech-Language-Hearing: Sciences and Disorders, Neuroscience and
      Bioengineering, University of Kansas, Lawrence, Kansas
LA  - eng
PT  - Journal Article
DEP - 20131015
TA  - Pediatr Res
JT  - Pediatric research
AID - 10.1038/pr.2013.179 [doi]
MID - NIHMS560245
SO  - Pediatr Res. 2014 Jan;75(0):85-92. Epub 2013 Oct 15 doi:10.1038/pr.2013.179.

PMC - PMC2904716
PMID- 20565964
IS  - 1743-8454 (Electronic)
VI  - 7
DP  - 2010
TI  - The function and structure of the cerebrospinal fluid outflow system.
PG  - 9
AB  - This review traces the development of our understanding of the anatomy and
      physiological properties of the two systems responsible for the drainage of
      cerebrospinal fluid (CSF) into the systemic circulation. The roles of the cranial
      and spinal arachnoid villi (AV) and the lymphatic outflow systems are evaluated
      as to the dominance of one over the other in various species and degree of animal
      maturation. The functional capabilities of the total CSF drainage system are
      presented, with evidence that the duality of the system is supported by the
      changes in fluid outflow dynamics in human and sub-human primates in
      hydrocephalus. The review also reconciles the relative importance and alterations
      of each of the outflow systems in a variety of clinical pathological conditions.
FAU - Pollay, Michael
AU  - Pollay M
AD  - 14205 W Via Tercero, Sun City West, AZ 85375, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20100621
PHST- 2010/04/06 [received]
PHST- 2010/06/21 [accepted]
TA  - Cerebrospinal Fluid Res
JT  - Cerebrospinal Fluid Research
AID - 1743-8454-7-9 [pii]
AID - 10.1186/1743-8454-7-9 [doi]
SO  - Cerebrospinal Fluid Res. 2010 Jun 21;7:9. doi:10.1186/1743-8454-7-9.

PMC - PMC2527422
PMID- 18677518
IS  - 0940-6719 (Print)
IS  - 1432-0932 (Electronic)
VI  - 17
IP  - 9
DP  - 2008 Sep
TI  - Role of electrical stimulation for rehabilitation and regeneration after spinal
      cord injury: an overview.
PG  - 1256-69
AB  - Structural discontinuity in the spinal cord after injury results in a disruption 
      in the impulse conduction resulting in loss of various bodily functions depending
      upon the level of injury. This article presents a summary of the scientific
      research employing electrical stimulation as a means for anatomical or functional
      recovery for patients suffering from spinal cord injury. Electrical stimulation
      in the form of functional electrical stimulation (FES) can help facilitate and
      improve upper/lower limb mobility along with other body functions lost due to
      injury e.g. respiratory, sexual, bladder or bowel functions by applying a
      controlled electrical stimulus to generate contractions and functional movement
      in the paralysed muscles. The available rehabilitative techniques based on FES
      technology and various Food and Drug Administration, USA approved neuroprosthetic
      devices that are in use are discussed. The second part of the article summarises 
      the experimental work done in the past 2 decades to study the effects of weakly
      applied direct current fields in promoting regeneration of neurites towards the
      cathode and the new emerging technique of oscillating field stimulation which has
      shown to promote bidirectional regeneration in the injured nerve fibres. The
      present article is not intended to be an exhaustive review but rather a summary
      aiming to highlight these two applications of electrical stimulation and the
      degree of anatomical/functional recovery associated with these in the field of
      spinal cord injury research.
FAU - Hamid, Samar
AU  - Hamid S
AD  - Environmental and Life Sciences, Macquarie University, Sydney, NSW Australia
FAU - Hayek, Ray
AU  - Hayek R
AD  - Environmental and Life Sciences, Macquarie University, Sydney, NSW Australia
LA  - eng
PT  - Journal Article
DEP - 20080802
PHST- 2008/02/12 [received]
PHST- 2008/07/15 [accepted]
TA  - Eur Spine J
JT  - European Spine Journal
AID - 729 [pii]
AID - 10.1007/s00586-008-0729-3 [doi]
SO  - Eur Spine J. 2008 Sep;17(9):1256-69. Epub 2008 Aug 2
      doi:10.1007/s00586-008-0729-3.

PMC - PMC3440437
PMID- 22984404
IS  - 1932-6203 (Electronic)
VI  - 7
IP  - 9
DP  - 2012
TI  - Efficient Universal Computing Architectures for Decoding Neural Activity.
LID - e42492
AB  - The ability to decode neural activity into meaningful control signals for
      prosthetic devices is critical to the development of clinically useful brain–
      machine interfaces (BMIs). Such systems require input from tens to hundreds of
      brain-implanted recording electrodes in order to deliver robust and accurate
      performance; in serving that primary function they should also minimize power
      dissipation in order to avoid damaging neural tissue; and they should transmit
      data wirelessly in order to minimize the risk of infection associated with
      chronic, transcutaneous implants. Electronic architectures for brain– machine
      interfaces must therefore minimize size and power consumption, while maximizing
      the ability to compress data to be transmitted over limited-bandwidth wireless
      channels. Here we present a system of extremely low computational complexity,
      designed for real-time decoding of neural signals, and suited for highly scalable
      implantable systems. Our programmable architecture is an explicit implementation 
      of a universal computing machine emulating the dynamics of a network of
      integrate-and-fire neurons; it requires no arithmetic operations except for
      counting, and decodes neural signals using only computationally inexpensive logic
      operations. The simplicity of this architecture does not compromise its ability
      to compress raw neural data by factors greater than . We describe a set of
      decoding algorithms based on this computational architecture, one designed to
      operate within an implanted system, minimizing its power consumption and data
      transmission bandwidth; and a complementary set of algorithms for learning,
      programming the decoder, and postprocessing the decoded output, designed to
      operate in an external, nonimplanted unit. The implementation of the implantable 
      portion is estimated to require fewer than 5000 operations per second. A
      proof-of-concept, 32-channel field-programmable gate array (FPGA) implementation 
      of this portion is consequently energy efficient. We validate the performance of 
      our overall system by decoding electrophysiologic data from a behaving rodent.
FAU - Rapoport, Benjamin I.
AU  - Rapoport BI
AD  - M.D.–Ph.D. Program, Harvard Medical School, Boston, Massachusetts, United States 
      of America
FAU - Turicchia, Lorenzo
AU  - Turicchia L
AD  - Department of Electrical Engineering and Computer Science, Massachusetts
      Institute of Technology, Cambridge, Massachusetts, United States of America
FAU - Wattanapanitch, Woradorn
AU  - Wattanapanitch W
AD  - Department of Electrical Engineering and Computer Science, Massachusetts
      Institute of Technology, Cambridge, Massachusetts, United States of America
FAU - Davidson, Thomas J.
AU  - Davidson TJ
AD  - Department of Bioengineering, Stanford University School of Medicine, Stanford,
      California, United States of America
FAU - Sarpeshkar, Rahul
AU  - Sarpeshkar R
AD  - Department of Electrical Engineering and Computer Science, Massachusetts
      Institute of Technology, Cambridge, Massachusetts, United States of America
LA  - eng
PT  - Journal Article
DEP - 20120912
PHST- 2011/06/25 [received]
PHST- 2012/07/09 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-11-11745 [pii]
AID - 10.1371/journal.pone.0042492 [doi]
SO  - PLoS One. 2012 Sep 12;7(9):. doi:10.1371/journal.pone.0042492.

PMC - PMC3315222
PMID- 22366161
IS  - 1040-4651 (Print)
IS  - 1532-298X (Electronic)
VI  - 24
IP  - 2
DP  - 2012 Feb
TI  - New Technologies for 21st Century Plant Science.
PG  - 374-94
AB  - Plants are one of the most fascinating and important groups of organisms living
      on Earth. They serve as the conduit of energy into the biosphere, provide food,
      and shape our environment. If we want to make headway in understanding how these 
      essential organisms function and build the foundation for a more sustainable
      future, then we need to apply the most advanced technologies available to the
      study of plant life. In 2009, a committee of the National Academy highlighted the
      “understanding of plant growth” as one of the big challenges for society and part
      of a new era which they termed “new biology.” The aim of this article is to
      identify how new technologies can and will transform plant science to address the
      challenges of new biology. We assess where we stand today regarding current
      technologies, with an emphasis on molecular and imaging technologies, and we try 
      to address questions about where we may go in the future and whether we can get
      an idea of what is at and beyond the horizon.
FAU - Ehrhardt, David W.
AU  - Ehrhardt DW
FAU - Frommer, Wolf B.
AU  - Frommer WB
LA  - eng
PT  - Journal Article
DEP - 20120224
PHST- 2011/10/30 [received]
PHST- 2011/12/16 [revised]
PHST- 2012/02/01 [accepted]
PHST- 2012/02/24 [aheadofprint]
TA  - Plant Cell
JT  - The Plant Cell
AID - 093302 [pii]
AID - 10.1105/tpc.111.093302 [doi]
SO  - Plant Cell. 2012 Feb;24(2):374-94. Epub 2012 Feb 24 doi:10.1105/tpc.111.093302.

PMC - PMC4608105
PMID- 26474979
IS  - 1471-2458 (Electronic)
VI  - 15
DP  - 2015
TI  - Activation of persons living with HIV for treatment, the great study.
LID - 1056
AB  - Background: Patient empowerment represents a potent tool for addressing racial,
      ethnic and socioeconomic disparities in health care, particularly for chronic
      conditions such as HIV infection that require active patient engagement. This
      multimodal intervention, developed in concert with HIV patients and clinicians,
      aims to provide HIV patients with the knowledge, skills, attitudes and tools to
      become more activated patients. Methods/Design: Randomized controlled trial of a 
      multimodal intervention designed to activate persons living with HIV. The
      intervention includes four components: 1) use of a web-enabled hand-held device
      (Apple iPod Touch) loaded with a Personal Health Record (ePHR) customized for HIV
      patients; 2) six 90-minute group-based training sessions in use of the device,
      internet and the ePHR; 3) a pre-visit coaching session; and 4) clinician
      education regarding how they can support activated patients. Outcome measures
      include pre- post changes in patient activation measure score (primary outcome), 
      eHealth literacy, patient involvement in decision-making and care, medication
      adherence, preventive care, and HIV Viral Load. Discussion: We hypothesize that
      participants receiving the intervention will show greater improvement in
      empowerment and the intervention will reduce disparities in study outcomes.
      Disparities in these measures will be smaller than those in the usual care group.
      Findings have implications for activating persons living with HIV and for other
      marginalized groups living with chronic illness. Trial registration:
      ClinicalTrials.gov Identifier: NCT02165735, 6/13/2014.
FAU - Fiscella, Kevin
AU  - Fiscella K
AD  - Public Health Sciences and Community Health, Department of Family Medicine,
      University of Rochester Medical Center, 1381 South Ave, Rochester, NY 14620 USA
FAU - Boyd, Michele
AU  - Boyd M
AD  - Public Health Sciences and Community Health, Department of Family Medicine,
      University of Rochester Medical Center, 1381 South Ave, Rochester, NY 14620 USA
FAU - Brown, Julian
AU  - Brown J
AD  - Trillium Health, Rochester, USA
FAU - Carroll, Jennifer
AU  - Carroll J
AD  - Department of Family Medicine, University of Colorado, Denver, USA
FAU - Cassells, Andrea
AU  - Cassells A
AD  - Clinical Directors Network, New York, USA
FAU - Corales, Roberto
AU  - Corales R
AD  - Trillium Health, Rochester, USA
FAU - Cross, Wendi
AU  - Cross W
AD  - Department of Psychiatry, University of Rochester Medical Center, Rochester, USA
FAU - El’Daher, Nayef
AU  - El’Daher N
AD  - Rochester Regional Health System, Unity Family Medicine at St. Mary’s and Unity
      Infectious Disease, Rochester, USA
FAU - Farah, Subrina
AU  - Farah S
AD  - Public Health Sciences and Community Health, Department of Family Medicine,
      University of Rochester Medical Center, 1381 South Ave, Rochester, NY 14620 USA
FAU - Fine, Steven
AU  - Fine S
AD  - Department of Medicine, Infectious Diseases (SMD), University of Rochester,
      Rochester, USA
FAU - Fowler, Richard
AU  - Fowler R
AD  - Trillium Health, Rochester, USA
FAU - Hann, Ashley
AU  - Hann A
AD  - Rochester Regional Health System, Unity Family Medicine at St. Mary’s and Unity
      Infectious Disease, Rochester, USA
FAU - Luque, Amneris
AU  - Luque A
AD  - Department of Medicine, Infectious Diseases (SMD), University of Rochester,
      Rochester, USA
FAU - Rodriquez, Jennifer
AU  - Rodriquez J
AD  - Clinical Directors Network, New York, USA
FAU - Sanders, Mechelle
AU  - Sanders M
AD  - Public Health Sciences and Community Health, Department of Family Medicine,
      University of Rochester Medical Center, 1381 South Ave, Rochester, NY 14620 USA
FAU - Tobin, Jonathan
AU  - Tobin J
AD  - Clinical Directors Network, New York, USA
LA  - eng
PT  - Journal Article
DEP - 20151016
PHST- 2015/08/04 [received]
PHST- 2015/09/29 [accepted]
TA  - BMC Public Health
JT  - BMC Public Health
AID - 2382 [pii]
AID - 10.1186/s12889-015-2382-1 [doi]
SO  - BMC Public Health. 2015 Oct 16;15:. doi:10.1186/s12889-015-2382-1.

PMC - PMC5143356
PMID- 28018026
IS  - 0340-5443 (Print)
VI  - 71
IP  - 1
DP  - 2017
TI  - Harnessing learning biases is essential for applying social learning in
      conservation.
LID - 16
AB  - Social learning can influence how animals respond to anthropogenic changes in the
      environment, determining whether animals survive novel threats and exploit novel 
      resources or produce maladaptive behaviour and contribute to human-wildlife
      conflict. Predicting where social learning will occur and manipulating its use
      are, therefore, important in conservation, but doing so is not straightforward.
      Learning is an inherently biased process that has been shaped by natural
      selection to prioritize important information and facilitate its efficient
      uptake. In this regard, social learning is no different from other learning
      processes because it too is shaped by perceptual filters, attentional biases and 
      learning constraints that can differ between habitats, species, individuals and
      contexts. The biases that constrain social learning are not understood well
      enough to accurately predict whether or not social learning will occur in many
      situations, which limits the effective use of social learning in conservation
      practice. Nevertheless, we argue that by tapping into the biases that guide the
      social transmission of information, the conservation applications of social
      learning could be improved. We explore the conservation areas where social
      learning is highly relevant and link them to biases in the cues and contexts that
      shape social information use. The resulting synthesis highlights many promising
      areas for collaboration between the fields and stresses the importance of
      systematic reviews of the evidence surrounding social learning practices.
FAU - Greggor, Alison L.
AU  - Greggor AL
AD  - 0000000121885934grid.5335.0Department of Psychology, University of Cambridge,
      Cambridge, UK
FAU - Thornton, Alex
AU  - Thornton A
AD  - 0000 0004 1936 8024grid.8391.3Centre for Ecology and Conservation, University of 
      Exeter, Penryn, UK
FAU - Clayton, Nicola S.
AU  - Clayton NS
AD  - 0000000121885934grid.5335.0Department of Psychology, University of Cambridge,
      Cambridge, UK
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20161207
GR  - BB/H021817/1
PHST- 2016/08/30 [received]
PHST- 2016/11/10 [revised]
PHST- 2016/11/14 [accepted]
TA  - Behav Ecol Sociobiol
JT  - Behavioral Ecology and Sociobiology
AID - 2238 [pii]
AID - 10.1007/s00265-016-2238-4 [doi]
SO  - Behav Ecol Sociobiol. 2017;71(1):. Epub 2016 Dec 7 doi:10.1007/s00265-016-2238-4.

PMC - PMC4762423
PMID- 26883357
IS  - 0890-9369 (Print)
IS  - 1549-5477 (Electronic)
VI  - 30
IP  - 4
DP  - 2016 Feb 15
TI  - Genetics and biology of pancreatic ductal adenocarcinoma.
PG  - 355-85
AB  - Ying et al. review pancreatic ductal adenocarcinoma (PDAC) genetics and biology, 
      particularly altered cancer cell metabolism, the complexity of immune regulation 
      in the tumor microenvironment, and impaired DNA repair processes.
OAB - Publisher: Abstract available from the publisher.
FAU - Ying, Haoqiang
AU  - Ying H
AD  - Department of Molecular and Cellular Oncology, University of Texas MD Anderson
      Cancer Center, Houston, Texas 77030, USA;
FAU - Dey, Prasenjit
AU  - Dey P
AD  - Department of Cancer Biology, University of Texas MD Anderson Cancer Center,
      Houston, Texas 77030, USA;
FAU - Yao, Wantong
AU  - Yao W
AD  - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center,
      Houston, Texas 77030, USA;
FAU - Kimmelman, Alec C.
AU  - Kimmelman AC
AD  - Division of Genomic Stability and DNA Repair, Department of Radiation Oncology,
      Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA;
FAU - Draetta, Giulio F.
AU  - Draetta GF
AD  - Department of Molecular and Cellular Oncology, University of Texas MD Anderson
      Cancer Center, Houston, Texas 77030, USA;
FAU - Maitra, Anirban
AU  - Maitra A
AD  - Department of Pathology and Translational Molecular Pathology, University of
      Texas MD Anderson Cancer Center, Houston, Texas 77030, USA;
FAU - DePinho, Ronald A.
AU  - DePinho RA
AD  - Department of Cancer Biology, University of Texas MD Anderson Cancer Center,
      Houston, Texas 77030, USA;
LA  - eng
PT  - Journal Article
PT  - Review
GR  - W81XWH-14-1-0429
TA  - Genes Dev
JT  - Genes & Development
AID - 10.1101/gad.275776.115 [doi]
SO  - Genes Dev. 2016 Feb 15;30(4):355-85. doi:10.1101/gad.275776.115.

PMC - PMC3903509
PMID- 21248385
IS  - 1741-2560 (Print)
IS  - 1741-2552 (Electronic)
VI  - 8
IP  - 1
DP  - 2011 Feb
TI  - Electric field strength and focality in electroconvulsive therapy and magnetic
      seizure therapy: A finite element simulation study.
PG  - 016007
AB  - We present the first computational study comparing the electric field induced by 
      various electroconvulsive therapy (ECT) and magnetic seizure therapy (MST)
      paradigms. Four ECT electrode configurations (bilateral, bifrontal, right
      unilateral, and focal electrically administered seizure therapy) and three MST
      coil configurations (circular, cap, and double cone) were modeled. The model
      incorporated a modality-specific neural activation threshold. ECT (0.3 ms pulse
      width) and MST induced maximum electric field in the brain of 2.1–2.5 V/cm and
      1.1–2.2 V/cm, corresponding to 6.2–7.2 times and 1.2–2.3 times the neural
      activation threshold, respectively. The MST electric field is more confined to
      the superficial cortex compared to ECT. The brain volume stimulated was much
      higher with ECT (up to 100%) than MST (up to 8.2%). MST with the double cone coil
      was the most focal and bilateral ECT was the least focal. Our results suggest a
      possible biophysical explanation of the reduced side effects of MST compared to
      ECT. Our results also indicate that the conventional ECT pulse amplitude (800–900
      mA) is much higher than necessary for seizure induction. Reducing the ECT pulse
      amplitude should be explored as a potential means of diminishing side effects.
FAU - Deng, Zhi-De
AU  - Deng ZD
AD  - Division of Brain Stimulation and Therapeutic Modulation, Department of
      Psychiatry, ColumbiaUniversity/New York State Psychiatric Institute, 1051
      Riverside Drive, Unit 21, New York, NY 10032, USA
FAU - Lisanby, Sarah H.
AU  - Lisanby SH
AD  - Department of Psychiatry and Behavioral Sciences, Duke University, Box 3950 DUMC,
      Durham, NC27710, USA
FAU - Peterchev, Angel V.
AU  - Peterchev AV
AD  - Division of Brain Stimulation and Therapeutic Modulation, Department of
      Psychiatry, ColumbiaUniversity/New York State Psychiatric Institute, 1051
      Riverside Drive, Unit 21, New York, NY 10032, USA
LA  - eng
PT  - Journal Article
DEP - 20110119
GR  - TL1 RR024158-03 || RR
TA  - J Neural Eng
JT  - Journal of neural engineering
AID - 10.1088/1741-2560/8/1/016007 [doi]
MID - NIHMS269945
SO  - J Neural Eng. 2011 Feb;8(1):016007. Epub 2011 Jan 19
      doi:10.1088/1741-2560/8/1/016007.

PMC - PMC5227703
PMID- 28067224
IS  - 2041-1723 (Electronic)
VI  - 8
DP  - 2017
TI  - Updating temporal expectancy of an aversive event engages striatal plasticity
      under amygdala control.
LID - 13920
AB  - Pavlovian aversive conditioning requires learning of the association between a
      conditioned stimulus (CS) and an unconditioned, aversive stimulus (US) but also
      involves encoding the time interval between the two stimuli. The neurobiological 
      bases of this time interval learning are unknown. Here, we show that in rats, the
      dorsal striatum and basal amygdala belong to a common functional network
      underlying temporal expectancy and learning of a CS–US interval. Importantly,
      changes in coherence between striatum and amygdala local field potentials (LFPs) 
      were found to couple these structures during interval estimation within the lower
      range of the theta rhythm (3–6 Hz). Strikingly, we also show that a change to the
      CS–US time interval results in long-term changes in cortico-striatal synaptic
      efficacy under the control of the amygdala. Collectively, this study reveals
      physiological correlates of plasticity mechanisms of interval timing that take
      place in the striatum and are regulated by the amygdala.
OAB - Publisher: Abstract available from the publisher.
FAU - Dallérac, Glenn
AU  - Dallérac G
AD  - Institut des Neurosciences Paris-Saclay (Neuro-PSI), Cognition and Behaviour
      Department, UMR 9197, Université Paris Sud, CNRS, Université Paris Saclay, Orsay 
      F-91405, France
FAU - Graupner, Michael
AU  - Graupner M
AD  - Center for Neural Science, New York University, New York, New York 10003, USA
FAU - Knippenberg, Jeroen
AU  - Knippenberg J
AD  - Institut des Neurosciences Paris-Saclay (Neuro-PSI), Cognition and Behaviour
      Department, UMR 9197, Université Paris Sud, CNRS, Université Paris Saclay, Orsay 
      F-91405, France
FAU - Martinez, Raquel Chacon Ruiz
AU  - Martinez RCR
AD  - Laboratory of Neuromodulation, Teaching and Research Institute, Hospital Sirio
      Libanes, Rua Professor Daher Cutait, 69, Sao Paulo 01308-060, Brazil
FAU - Tavares, Tatiane Ferreira
AU  - Tavares TF
AD  - Institut des Neurosciences Paris-Saclay (Neuro-PSI), Cognition and Behaviour
      Department, UMR 9197, Université Paris Sud, CNRS, Université Paris Saclay, Orsay 
      F-91405, France
FAU - Tallot, Lucille
AU  - Tallot L
AD  - Institut des Neurosciences Paris-Saclay (Neuro-PSI), Cognition and Behaviour
      Department, UMR 9197, Université Paris Sud, CNRS, Université Paris Saclay, Orsay 
      F-91405, France
FAU - El Massioui, Nicole
AU  - El Massioui N
AD  - Institut des Neurosciences Paris-Saclay (Neuro-PSI), Cognition and Behaviour
      Department, UMR 9197, Université Paris Sud, CNRS, Université Paris Saclay, Orsay 
      F-91405, France
FAU - Verschueren, Anna
AU  - Verschueren A
AD  - Institut des Neurosciences Paris-Saclay (Neuro-PSI), Cognition and Behaviour
      Department, UMR 9197, Université Paris Sud, CNRS, Université Paris Saclay, Orsay 
      F-91405, France
FAU - Höhn, Sophie
AU  - Höhn S
AD  - Institut des Neurosciences Paris-Saclay (Neuro-PSI), Cognition and Behaviour
      Department, UMR 9197, Université Paris Sud, CNRS, Université Paris Saclay, Orsay 
      F-91405, France
FAU - Bertolus, Julie Boulanger
AU  - Bertolus JB
AUID- ORCID: 0000-0001-9213-1814
AD  - Institut des Neurosciences Paris-Saclay (Neuro-PSI), Cognition and Behaviour
      Department, UMR 9197, Université Paris Sud, CNRS, Université Paris Saclay, Orsay 
      F-91405, France
FAU - Reyes, Alex
AU  - Reyes A
AD  - Center for Neural Science, New York University, New York, New York 10003, USA
FAU - LeDoux, Joseph E.
AU  - LeDoux JE
AD  - Center for Neural Science, New York University, New York, New York 10003, USA
FAU - Schafe, Glenn E.
AU  - Schafe GE
AD  - Department of Psychology, Hunter College, New York, New York 10065, USA
FAU - Diaz-Mataix, Lorenzo
AU  - Diaz-Mataix L
AUID- ORCID: 0000-0001-6766-9479
AD  - Center for Neural Science, New York University, New York, New York 10003, USA
FAU - Doyère, Valérie
AU  - Doyère V
AD  - Institut des Neurosciences Paris-Saclay (Neuro-PSI), Cognition and Behaviour
      Department, UMR 9197, Université Paris Sud, CNRS, Université Paris Saclay, Orsay 
      F-91405, France
LA  - eng
PT  - Journal Article
DEP - 20170109
PHST- 2016/07/08 [received]
PHST- 2016/11/11 [accepted]
TA  - Nat Commun
JT  - Nature Communications
AID - ncomms13920 [pii]
AID - 10.1038/ncomms13920 [doi]
SO  - Nat Commun. 2017 Jan 09;8:. doi:10.1038/ncomms13920.

PMC - PMC4384075
PMID- 25806622
IS  - 2076-0817 (Electronic)
VI  - 4
IP  - 1
DP  - 2015 Mar
TI  - Biofilms in Infections of the Eye.
PG  - 111-36
AB  - The ability to form biofilms in a variety of environments is a common trait of
      bacteria, and may represent one of the earliest defenses against predation.
      Biofilms are multicellular communities usually held together by a polymeric
      matrix, ranging from capsular material to cell lysate. In a structure that
      imposes diffusion limits, environmental microgradients arise to which individual 
      bacteria adapt their physiologies, resulting in the gamut of physiological
      diversity. Additionally, the proximity of cells within the biofilm creates the
      opportunity for coordinated behaviors through cell–cell communication using
      diffusible signals, the most well documented being quorum sensing. Biofilms form 
      on abiotic or biotic surfaces, and because of that are associated with a large
      proportion of human infections. Biofilm formation imposes a limitation on the
      uses and design of ocular devices, such as intraocular lenses, posterior contact 
      lenses, scleral buckles, conjunctival plugs, lacrimal intubation devices and
      orbital implants. In the absence of abiotic materials, biofilms have been
      observed on the capsule, and in the corneal stroma. As the evidence for the
      involvement of microbial biofilms in many ocular infections has become
      compelling, developing new strategies to prevent their formation or to eradicate 
      them at the site of infection, has become a priority.
FAU - Bispo, Paulo J. M.
AU  - Bispo PJM
FAU - Haas, Wolfgang
AU  - Haas W
FAU - Gilmore, Michael S.
AU  - Gilmore MS
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20150323
PHST- 2015/01/21 [received]
PHST- 2015/03/13 [accepted]
TA  - Pathogens
JT  - Pathogens
AID - 10.3390/pathogens4010111 [doi]
AID - pathogens-04-00111 [pii]
SO  - Pathogens. 2015 Mar 23;4(1):111-36. doi:10.3390/pathogens4010111.

PMC - PMC3875903
PMID- 24356329
IS  - 1439-4456 (Print)
IS  - 1438-8871 (Electronic)
VI  - 15
IP  - 12
DP  - 2013 Dec
TI  - Use of a Text Message Program to Raise Type 2 Diabetes Risk Awareness and Promote
      Health Behavior Change (Part I): Assessment of Participant Reach and Adoption.
LID - e281
AB  - Background: There are an estimated 25.8 million American children and adults,
      equivalent to 8.3% of the US population, living with diabetes. Diabetes is
      particularly burdensome on minority populations. The use of mobile technologies
      for reaching broad populations is a promising approach, given its wide footprint 
      and ability to deliver inexpensive personalized messages, to increase awareness
      of type 2 diabetes and promote behavior changes targeting risk factors associated
      with type 2 diabetes. As a part of the Beacon Community Cooperative Agreement
      Program, txt4health, a public-facing mobile health information service, was
      launched in 3 Beacon Communities: the Southeast Michigan Beacon Community in
      Detroit, MI, the Greater Cincinnati Beacon Community in Cincinnati, OH, and the
      Crescent City Beacon Community in New Orleans, LA. Txt4health is a mobile health 
      information service designed to help people understand their risk for type 2
      diabetes and become more informed about the steps they can take to lead healthy
      lives. Objective: The purpose of this investigation was to use the RE-AIM
      framework to document txt4health reach and adoption by focusing on enrollment and
      participant engagement in program pilots in Southeast Michigan and Greater
      Cincinnati. Methods: We conducted a retrospective records analysis of
      individual-level txt4health system data from participants in Southeast Michigan
      and Greater Cincinnati to determine participant usage of txt4health and
      engagement with the program. Results: Results from the retrospective records
      analysis revealed that 5570 participants initiated the 2-step enrollment process 
      via 1 of 3 enrollment strategies: text message, website, or directly with Beacon 
      staff who signed participants up via the website. In total, 33.00% (1838/5570) of
      participants completed the 2-step enrollment process and were fully enrolled in
      the program. All participants (100.00%, 1620/1620) who enrolled via text message 
      completed the entire 2-step enrollment process versus 5.52% (218/3950) of
      participants who enrolled via website or a Beacon staff member. Of those who
      fully enrolled, 71.00% (1305/1838) completed the diabetes risk assessment and
      74.27% (1365/1838) set an initial weight loss goal. Overall, 39.06% (718/1838) of
      participants completed all 14 weeks of the program and 56.26% (1034/1838) dropped
      out before completing all 14 weeks, with the bulk of dropouts occurring in the
      first 4 weeks. Length of participation varied greatly, ranging from 0-48.7 weeks 
      (median 8.6, mean 15.8, SD 15.8). Wide variability of participant engagement in
      regards to weekly weight and physical activity was documented. Conclusions:
      Although broadly focused public health text message interventions may have the
      potential to reach large populations and show high levels of engagement among
      some users, the level of individual engagement among participants varies widely, 
      suggesting that this type of approach may not be appropriate for all.
FAU - Whittaker, Robyn
AU  - Whittaker R
FAU - Furberg, Robert
AU  - Furberg R
FAU - McKinley, Michelle
AU  - McKinley M
FAU - Buis, Lorraine R
AU  - Buis LR
AUID- ORCID: 0000-0001-5855-9972
AD  - University of MichiganDepartment of Family MedicineAnn Arbor, MIUnited States
FAU - Hirzel, Lindsey
AU  - Hirzel L
AD  - Wayne State UniversityCollege of NursingDetroit, MIUnited States
FAU - Turske, Scott A
AU  - Turske SA
AD  - Southeast Michigan Beacon CommunityDetroit, MIUnited States
FAU - Des Jardins, Terrisca R
AU  - Des Jardins TR
AD  - Southeast Michigan Beacon CommunityDetroit, MIUnited States
FAU - Yarandi, Hossein
AU  - Yarandi H
AD  - Wayne State UniversityCollege of NursingDetroit, MIUnited States
FAU - Bondurant, Patricia
AU  - Bondurant P
AD  - Greater Cincinnati Beacon CollaborativeCincinnati, OHUnited States
LA  - eng
PT  - Journal Article
DEP - 20131219
PHST- 2013/08/30 [received]
PHST- 2013/10/30 [revised]
PHST- 2013/11/12 [accepted]
TA  - J Med Internet Res
JT  - Journal of Medical Internet Research
AID - v15i12e281 [pii]
AID - 10.2196/jmir.2928 [doi]
SO  - J Med Internet Res. 2013 Dec 19;15(12):. doi:10.2196/jmir.2928.

PMC - PMC5266477
PMID- 28138549
IS  - 2375-2548 (Electronic)
VI  - 3
IP  - 1
DP  - 2017 Jan
TI  - Semiconducting polymers are light nanotransducers in eyeless animals.
LID - e1601699
AB  - Light polymer nanotransducers control cell functions in vivo.
OAB - Publisher: Abstract available from the publisher.
FAU - Tortiglione, Claudia
AU  - Tortiglione C
AD  - Istituto di Scienze Applicate e Sistemi Intelligenti “Eduardo Caianiello,”
      Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, 80078 Pozzuoli, Italy.
FAU - Antognazza, Maria Rosa
AU  - Antognazza MR
AD  - Center for Nano Science and Technology @PoliMi, Istituto Italiano di Tecnologia, 
      Via Pascoli 70/3, 20133 Milano, Italy.
FAU - Tino, Angela
AU  - Tino A
AD  - Istituto di Scienze Applicate e Sistemi Intelligenti “Eduardo Caianiello,”
      Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, 80078 Pozzuoli, Italy.
FAU - Bossio, Caterina
AU  - Bossio C
AD  - Center for Nano Science and Technology @PoliMi, Istituto Italiano di Tecnologia, 
      Via Pascoli 70/3, 20133 Milano, Italy.
FAU - Marchesano, Valentina
AU  - Marchesano V
AD  - Istituto di Scienze Applicate e Sistemi Intelligenti “Eduardo Caianiello,”
      Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, 80078 Pozzuoli, Italy.
FAU - Bauduin, Antonella
AU  - Bauduin A
AD  - Istituto di Scienze Applicate e Sistemi Intelligenti “Eduardo Caianiello,”
      Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, 80078 Pozzuoli, Italy.
FAU - Zangoli, Mattia
AU  - Zangoli M
AD  - Istituto per la Sintesi Organica e la Fotoreattività, Consiglio Nazionale delle
      Ricerche, Via P. Gobetti 101, 40129 Bologna, Italy.
FAU - Morata, Susana Vaquero
AU  - Morata SV
AD  - Center for Nano Science and Technology @PoliMi, Istituto Italiano di Tecnologia, 
      Via Pascoli 70/3, 20133 Milano, Italy.
FAU - Lanzani, Guglielmo
AU  - Lanzani G
AD  - Center for Nano Science and Technology @PoliMi, Istituto Italiano di Tecnologia, 
      Via Pascoli 70/3, 20133 Milano, Italy.
LA  - eng
PT  - Journal Article
DEP - 20170125
GR  - ID0E1BDI13976
PHST- 2016/07/22 [received]
PHST- 2016/12/08 [accepted]
TA  - Sci Adv
JT  - Science Advances
AID - 1601699 [pii]
AID - 10.1126/sciadv.1601699 [doi]
SO  - Sci Adv. 2017 Jan 25;3(1):. doi:10.1126/sciadv.1601699.

PMC - PMC3270064
PMID- 21756683
IS  - 1467-0100 (Print)
IS  - 1754-7628 (Electronic)
VI  - 11
IP  - Suppl 2
DP  - 2010 Sep
TI  - Current and Future Management of Bilateral Loss of Vestibular Sensation – An
      update on the Johns Hopkins Multichannel Vestibular Prosthesis Project.
PG  - 2-11
AB  - Bilateral loss of vestibular sensation can disable individuals whose vestibular
      hair cells are injured by ototoxic medications, infection, Ménière’s disease or
      other insults to the labyrinth including surgical trauma during cochlear
      implantation. Without input to vestibulo-ocular and vestibulo-spinal reflexes
      that normally stabilize the eyes and body, affected patients suffer blurred
      vision during head movement, postural instability, and chronic disequilibrium.
      While individuals with some residual sensation often compensate for their loss
      through rehabilitation exercises, those who fail to do so are left with no
      adequate treatment options. An implantable neuroelectronic vestibular prosthesis 
      that emulates the normal labyrinth by sensing head movement and modulating
      activity on appropriate branches of the vestibular nerve could significantly
      improve quality of life for these otherwise chronically dizzy patients.This brief
      review describes the impact and current management of bilateral loss of
      vestibular sensation, animal studies supporting the feasibility of prosthetic
      vestibular stimulation, and a vestibular prosthesis designed to restore sensation
      of head rotation in all directions. Similar to a cochlear implant in concept and 
      size, the Johns Hopkins Multichannel Vestibular Prosthesis (MVP) includes
      miniature gyroscopes to sense head rotation, a microcontroller to process inputs 
      and control stimulus timing, and current sources switched between pairs of
      electrodes implanted within the vestibular labyrinth. In rodents and rhesus
      monkeys rendered bilaterally vestibular-deficient via treatment with gentamicin
      and/or plugging of semicircular canals, the MVP partially restores the
      vestibulo-ocular reflex for head rotations about any axis of rotation in
      3-dimensional space. Our efforts now focus on addressing issues prerequisite to
      human implantation, including refinement of electrode designs and surgical
      technique to enhance stimulus selectivity and preserve cochlear function,
      optimization of stimulus protocols, and reduction of device size and power
      consumption.
FAU - Della Santina, Charles C.
AU  - Della Santina CC
FAU - Migliaccio, Americo A.
AU  - Migliaccio AA
FAU - Hayden, Russell
AU  - Hayden R
FAU - Melvin, Thuy-Anh
AU  - Melvin TA
FAU - Fridman, Gene Y.
AU  - Fridman GY
FAU - Chiang, Bryce
AU  - Chiang B
FAU - Davidovics, Natan S.
AU  - Davidovics NS
FAU - Dai, Chenkai
AU  - Dai C
FAU - Carey, John P.
AU  - Carey JP
FAU - Minor, Lloyd B.
AU  - Minor LB
FAU - Anderson, Iee-Ching
AU  - Anderson IC
FAU - Park, HongJu
AU  - Park H
FAU - Lyford-Pike, Sofia
AU  - Lyford-Pike S
FAU - Tang, Shan
AU  - Tang S
LA  - eng
PT  - Journal Article
GR  - R01 DC009255-03 || DC
TA  - Cochlear Implants Int
JT  - Cochlear Implants International
AID - 10.1179/146701010X12726366068454 [doi]
MID - NIHMS349295
SO  - Cochlear Implants Int. 2010 Sep;11(Suppl 2):2-11.
      doi:10.1179/146701010X12726366068454.

PMC - PMC3153076
PMID- 21742216
IS  - 0749-0704 (Print)
IS  - 1557-8232 (Electronic)
VI  - 27
IP  - 3
DP  - 2011 Jul 1
TI  - Surfactant Therapy of ALI and ARDS.
PG  - 525-59
AB  - This article examines exogenous lung surfactant replacement therapy and its
      utility in mitigating clinical acute lung injury (ALI) and the acute respiratory 
      distress syndrome (ARDS). Biophysical research has documented that lung
      surfactant dysfunction can be reversed or mitigated by increasing surfactant
      concentration, and multiple studies in animals with ALI/ARDS have shown that
      respiratory function and pulmonary mechanics in vivo can be improved by exogenous
      surfactant administration. Exogenous surfactant therapy is a routine intervention
      in neonatal intensive care, and is life-saving in preventing or treating the
      neonatal respiratory distress syndrome (NRDS) in premature infants. In
      applications relevant for lung injury-related respiratory failure and ALI/ARDS,
      surfactant therapy has been shown to be beneficial in term infants with pneumonia
      and meconium aspiration lung injury, and in children up to age 21 with direct
      pulmonary forms of ALI/ARDS. However, extension of exogenous surfactant therapy
      to adults with respiratory failure and clinical ALI/ARDS remains a challenge.
      Coverage here reviews clinical studies of surfactant therapy in pediatric and
      adult patients with ALI/ARDS, particularly focusing on its potential advantages
      in patients with direct pulmonary forms of these syndromes. Also discussed is the
      rationale for mechanism-based therapies utilizing exogenous surfactant in
      combination with agents targeting other aspects of the multifaceted
      pathophysiology of inflammatory lung injury. Additional factors affecting the
      efficacy of exogenous surfactant therapy in ALI/ARDS are also described,
      including the difficulty of effectively delivering surfactants to injured lungs
      and the existence of activity differences between clinical surfactant drugs.
FAU - Raghavendran, K
AU  - Raghavendran K
AD  - Department of Surgery, University of Michigan, Ann Arbor, MI
FAU - Willson, D
AU  - Willson D
AD  - Department of Pediatrics and Anesthesiology, University of Virginia,
      Charlottesville, VA
FAU - Notter, RH
AU  - Notter R
AD  - Department of Pediatrics, University of Rochester, Rochester, NY
LA  - eng
PT  - Journal Article
TA  - Crit Care Clin
JT  - Critical care clinics
AID - 10.1016/j.ccc.2011.04.005 [doi]
MID - NIHMS292566
SO  - Crit Care Clin. 2011 Jul 1;27(3):525-59. doi:10.1016/j.ccc.2011.04.005.

PMC - PMC2818482
PMID- 20082461
IS  - 1552-4825 (Print)
IS  - 1552-4833 (Electronic)
VI  - 152A
IP  - 2
DP  - 2010 Feb
TI  - What’s New in Neurofibromatosis? Proceedings From The 2009 NF Conference: New
      Frontiers.
PG  - 269-83
AB  - The NF Conference is the largest annual gathering of researchers and clinicians
      focused on neurofibromatosis and has been convened by the Children’s Tumor
      Foundation for over 20 years. The 2009 NF Conference was held in Portland, Oregon
      from June 13th – June 16th, 2009 and co-chaired by Kathryn North from the
      University of Sydney and The Children’s Hospital at Westmead, Sydney, Australia; 
      and Joseph Kissil from the Wistar Institute, Philadelphia. The Conference
      included 80 platform presentations in 9 sessions over 4 days; over 100 abstracts 
      presented as posters; and three Keynote presentations. To date, there have been
      tremendous advances in basic research in the pathogenesis of neurofibromatosis,
      and more recently in progress toward identifying effective drug therapies and the
      commencement of neurofibromatosis clinical trials. The NF Conference attendees
      have significantly increased (doubling from 140 in 2005 to 280 attending in 2009)
      with a significant increase in attendance of physicians and clinical researchers.
      Correspondingly the NF Conference scope has expanded to include translational
      research, clinical trials and clinical management issues while retaining a core
      of basic research. These themes are reflected in the highlights from the 2009 NF 
      Conference presented here.
FAU - Kissil, Joseph
AU  - Kissil J
AD  - The Wistar Institute, Philadelphia, PA
FAU - Blakeley, Jaishri
AU  - Blakeley J
AD  - Johns Hopkins University
FAU - Ferner, Rosalie
AU  - Ferner R
AD  - Guy’s and St Thomas’ NHS Trust, London, United Kingdom
FAU - Huson, Susan
AU  - Huson S
AD  - St. Mary’s Hospital, University of Manchester, United Kingdom
FAU - Kalamarides, Michel
AU  - Kalamarides M
AD  - Hopital Beaujon, Clichy, France
FAU - Mautner, Victor-Felix
AU  - Mautner VF
AD  - University Eppendorf, Hamburg, Germany
FAU - McCormick, Frank
AU  - McCormick F
AD  - University of California, San Francisco
FAU - Morrison, Helen
AU  - Morrison H
AD  - Leibniz Institute for Age Research, Germany
FAU - Packer, Roger
AU  - Packer R
AD  - Children’s National Medical Center, Washington, DC
FAU - Ramesh, Vijaya
AU  - Ramesh V
AD  - Massachusetts General Hospital, Harvard Medical School, Boston, MA
FAU - Ratner, Nancy
AU  - Ratner N
AD  - Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
FAU - Rauen, Katherine A.
AU  - Rauen KA
AD  - University of California, San Francisco
FAU - Stevenson, David
AU  - Stevenson D
AD  - University of Utah, Salt Lake City, UT
FAU - Hunter-Schaedle, Kim
AU  - Hunter-Schaedle K
AD  - Children’s Tumor Foundation, New York, NY
FAU - North, Kathryn
AU  - North K
AD  - University of Sydney and The Children’s Hospital at Westmead, Sydney, Australia
LA  - eng
PT  - Journal Article
TA  - Am J Med Genet A
JT  - American journal of medical genetics. Part A
AID - 10.1002/ajmg.a.33189 [doi]
MID - NIHMS158966
SO  - Am J Med Genet A. 2010 Feb;152A(2):269-83. doi:10.1002/ajmg.a.33189.

PMC - PMC4977506
PMID- 27503239
IS  - 2045-2322 (Electronic)
VI  - 6
DP  - 2016
TI  - MATSAP: An automated analysis of stretch-attend posture in rodent behavioral
      experiments.
LID - 31286
AB  - Stretch-attend posture (SAP) occurs during risk assessment and is prevalent in
      common rodent behavioral tests. Measuring this behavior can enhance behavioral
      tests. For example, stretch-attend posture is a more sensitive measure of the
      effects of anxiolytics than traditional spatiotemporal indices. However,
      quantifying stretch-attend posture using human observers is time consuming,
      somewhat subjective, and prone to errors. We have developed MATLAB-based
      software, MATSAP, which is a quick, consistent, and open source program that
      provides objective automated analysis of stretch-attend posture in rodent
      behavioral experiments. Unlike human observers, MATSAP is not susceptible to
      fatigue or subjectivity. We assessed MATSAP performance with videos of male Swiss
      mice moving in an open field box and in an elevated plus maze. MATSAP reliably
      detected stretch-attend posture on par with human observers. This
      freely-available program can be broadly used by biologists and psychologists to
      accelerate neurological, pharmacological, and behavioral studies.
FAU - Holly, Kevin S.
AU  - Holly KS
AD  - Department of Biomedical Engineering, Louisiana Tech University, Ruston,
      Louisiana, United States of America
FAU - Orndorff, Casey O.
AU  - Orndorff CO
AD  - Department of Mathematics and Statistics, Louisiana Tech University, Ruston,
      Louisiana, United States of America
FAU - Murray, Teresa A.
AU  - Murray TA
AD  - Department of Biomedical Engineering, Louisiana Tech University, Ruston,
      Louisiana, United States of America
LA  - eng
PT  - Journal Article
DEP - 20160809
PHST- 2016/04/06 [received]
PHST- 2016/07/15 [accepted]
TA  - Sci Rep
JT  - Scientific Reports
AID - srep31286 [pii]
AID - 10.1038/srep31286 [doi]
SO  - Sci Rep. 2016 Aug 09;6:. doi:10.1038/srep31286.

PMC - PMC5095979
PMID- 27867351
IS  - 1662-5161 (Electronic)
VI  - 10
DP  - 2016
TI  - Advice Taking from Humans and Machines: An fMRI and Effective Connectivity Study.
LID - 542
AB  - With new technological advances, advice can come from different sources such as
      machines or humans, but how individuals respond to such advice and the neural
      correlates involved need to be better understood. We combined functional MRI and 
      multivariate Granger causality analysis with an X-ray luggage-screening task to
      investigate the neural basis and corresponding effective connectivity involved
      with advice utilization from agents framed as experts. Participants were asked to
      accept or reject good or bad advice from a human or machine agent with low
      reliability (high false alarm rate). We showed that unreliable advice decreased
      performance overall and participants interacting with the human agent had a
      greater depreciation of advice utilization during bad advice compared to the
      machine agent. These differences in advice utilization can be perceivably due to 
      reevaluation of expectations arising from association of dispositional
      credibility for each agent. We demonstrated that differences in advice
      utilization engaged brain regions that may be associated with evaluation of
      personal characteristics and traits (precuneus, posterior cingulate cortex,
      temporoparietal junction) and interoception (posterior insula). We found that the
      right posterior insula and left precuneus were the drivers of the advice
      utilization network that were reciprocally connected to each other and also
      projected to all other regions. Our behavioral and neuroimaging results have
      significant implications for society because of progressions in technology and
      increased interactions with machines.
FAU - Goodyear, Kimberly
AU  - Goodyear K
AD  - Center for Alcohol and Addiction Studies, Department of Behavioral and Social
      Sciences, Brown University, ProvidenceRI, USA
FAU - Parasuraman, Raja
AU  - Parasuraman R
AD  - Department of Psychology, George Mason University, FairfaxVA, USA
FAU - Chernyak, Sergey
AU  - Chernyak S
AD  - Molecular Neuroscience Department, George Mason University, FairfaxVA, USA
FAU - Madhavan, Poornima
AU  - Madhavan P
AD  - Institute for Defense Analyses, AlexandriaVA, USA
FAU - Deshpande, Gopikrishna
AU  - Deshpande G
AD  - Auburn University MRI Research Center, Department of Electrical & Computer
      Engineering, Auburn University, AuburnAL, USA
FAU - Krueger, Frank
AU  - Krueger F
AD  - Department of Psychology, George Mason University, FairfaxVA, USA
LA  - eng
PT  - Journal Article
DEP - 20161104
GR  - 202857
PHST- 2016/01/15 [received]
PHST- 2016/10/12 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2016.00542 [doi]
SO  - Front Hum Neurosci. 2016 Nov 04;10:. doi:10.3389/fnhum.2016.00542.

PMC - PMC1410005
IS  - 0960-1643 (Print)
VI  - 48
IP  - 428
DP  - 1998 Mar
TI  - The Back Pages.
PG  - 1105-22
AB  - Images: p1108-ap1109-a
LA  - eng
PT  - Journal Article
TA  - Br J Gen Pract
JT  - The British Journal of General Practice
SO  - Br J Gen Pract. 1998 Mar;48(428):1105-22.

PMC - PMC3677696
PMID- 23009122
IS  - 1354-3776 (Print)
IS  - 1744-7674 (Electronic)
VI  - 22
IP  - 11
DP  - 2012 Nov
TI  - Novel NMDA Receptor Modulators: An Update.
PG  - 1337-52
AB  - Introduction: The NMDA receptor is a ligand-gated ion channel that plays a
      critical role in higher level brain processes and has been implicated in a range 
      of neurological and psychiatric conditions. Although initial studies for the use 
      of NMDA receptor antagonists in neuroprotection were unsuccessful, more recently,
      NMDA receptor antagonists have shown clinical promise in other indications such
      as Alzheimer’s disease, Parkinson’s disease, pain and depression. Based on the
      clinical observations and more recent insights into receptor pharmacology, new
      modulatory approaches are beginning to emerge, with potential therapeutic
      benefit. Areas Covered: The article covers the known pharmacology and important
      features regarding NMDA receptors and their function. A discussion of
      pre-clinical and clinical relevance is included, as well. The subsequent patent
      literature review highlights the current state of the art targeting the receptor 
      since the last review in 2010. Expert Opinion: The complex nature of the NMDA
      receptor structure and function is becoming better understood. As knowledge about
      this receptor increases, it opens up new opportunities for targeting the receptor
      for many therapeutic indications. New strategies and advances in older
      technologies will need to be further developed before clinical success can be
      achieved. First-in-class potentiators and subunit-selective agents form the basis
      for most new strategies, complemented by efforts to limit off-target liability
      and fine-tune on-target properties.
FAU - Santangelo, Rose M.
AU  - Santangelo RM
AD  - Department of Chemistry, Emory University, Atlanta, GA 30322
FAU - Acker, Timothy M.
AU  - Acker TM
AD  - Department of Chemistry, Emory University, Atlanta, GA 30322
FAU - Zimmerman, Sommer S.
AU  - Zimmerman SS
AD  - Department of Chemistry, Emory University, Atlanta, GA 30322
FAU - Katzman, Brooke M.
AU  - Katzman BM
AD  - Department of Chemistry, Emory University, Atlanta, GA 30322
FAU - Strong, Katie L.
AU  - Strong KL
AD  - Department of Chemistry, Emory University, Atlanta, GA 30322
FAU - Traynelis, Stephen F.
AU  - Traynelis SF
AD  - Department of Pharmacology, Emory University School of Medicine, Atlanta, GA
      30322
FAU - Liotta, Dennis C.
AU  - Liotta DC
AD  - Department of Chemistry, Emory University, Atlanta, GA 30322
LA  - eng
PT  - Journal Article
DEP - 20120926
GR  - T32 GM008602 || GM
TA  - Expert Opin Ther Pat
JT  - Expert opinion on therapeutic patents
AID - 10.1517/13543776.2012.728587 [doi]
MID - NIHMS466280
SO  - Expert Opin Ther Pat. 2012 Nov;22(11):1337-52. Epub 2012 Sep 26
      doi:10.1517/13543776.2012.728587.

PMC - PMC4704898
PMID- 26690917
IS  - 2291-5222 (Electronic)
VI  - 3
IP  - 4
DP  - 2015 Oct-Dec
TI  - Developing and Pretesting a Text Messaging Program for Health Behavior Change:
      Recommended Steps.
LID - e107
AB  - Background: A growing body of evidence demonstrates that text messaging-based
      programs (short message service [SMS]) on mobile phones can help people modify
      health behaviors. Most of these programs have consisted of automated and
      sometimes interactive text messages that guide a person through the process of
      behavior change. Objective: This paper provides guidance on how to develop text
      messaging programs aimed at changing health behaviors. Methods: Based on their
      collective experience in designing, developing, and evaluating text messaging
      programs and a review of the literature, the authors drafted the guide. One
      author initially drafted the guide and the others provided input and review.
      Results: Steps for developing a text messaging program include conducting
      formative research for insights into the target audience and health behavior,
      designing the text messaging program, pretesting the text messaging program
      concept and messages, and revising the text messaging program. Conclusions: The
      steps outlined in this guide may help in the development of SMS-based behavior
      change programs.
FAU - Moynihan, Victoria
AU  - Moynihan V
FAU - Chen, Juliana
AU  - Chen J
FAU - Aicken, Catherine
AU  - Aicken C
FAU - Abroms, Lorien C
AU  - Abroms LC
AUID- ORCID: 0000-0001-6859-283X
AD  - The Milken Institute School of Public HealthThe George Washington
      UniversityWashington, DCUnited States
FAU - Whittaker, Robyn
AU  - Whittaker R
AUID- ORCID: 0000-0003-0901-9149
AD  - National Institute for Health InnovationThe University of AucklandAucklandNew
      Zealand
FAU - Free, Caroline
AU  - Free C
AUID- ORCID: 0000-0003-1711-0006
AD  - Clinical Trials Research UnitLondon School of Hygiene and Tropical
      MedicineLondonUnited Kingdom
FAU - Mendel Van Alstyne, Judith
AU  - Mendel Van Alstyne J
AUID- ORCID: 0000-0002-6112-2904
AD  - The Milken Institute School of Public HealthThe George Washington
      UniversityWashington, DCUnited States
FAU - Schindler-Ruwisch, Jennifer M
AU  - Schindler-Ruwisch JM
AUID- ORCID: 0000-0002-4805-8231
AD  - The Milken Institute School of Public HealthThe George Washington
      UniversityWashington, DCUnited States
LA  - eng
PT  - Journal Article
DEP - 20151221
PHST- 2015/07/08 [received]
PHST- 2015/09/15 [revised]
PHST- 2015/09/30 [accepted]
TA  - JMIR Mhealth Uhealth
JT  - JMIR mHealth and uHealth
AID - v3i4e107 [pii]
AID - 10.2196/mhealth.4917 [doi]
SO  - JMIR Mhealth Uhealth. 2015 Dec 21;3(4):. doi:10.2196/mhealth.4917.

PMC - PMC5125766
PMID- 27920506
IS  - 1177-889X (Electronic)
VI  - 10
DP  - 2016
TI  - Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient
      selection and perspectives on a low-burden therapy.
PG  - 2397-406
AB  - Polifeprosan 20 with carmustine (GLIADEL®) polymer implant wafer is a
      biodegradable compound containing 3.85% carmustine (BCNU,
      bischloroethylnitrosourea) implanted in the brain at the time of planned tumor
      surgery, which then slowly degrades to release the BCNU chemotherapy directly
      into the brain thereby bypassing the blood–brain barrier. Carmustine implant
      wafers were demonstrated to improve survival in randomized placebo-controlled
      trials in patients undergoing a near total resection of newly diagnosed or
      recurrent malignant glioma. Based on these trials and other supporting data,
      carmustine wafer therapy was approved for use for newly diagnosed and recurrent
      malignant glioma in the United States and the European Union. Adverse events are 
      uncommon, and as this therapy is placed at the time of surgery, it does not add
      to patient treatment burden. Nevertheless, this therapy appears to be
      underutilized. This article reviews the evidence for a favorable therapeutic
      ratio for the patient and the potential barriers. Consideration of these issues
      is important for optimal use of this therapeutic approach and may be important as
      this technology and other local therapies are further developed in the future.
FAU - Kleinberg, Lawrence
AU  - Kleinberg L
AD  - Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins 
      University, Baltimore, MD, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20161124
TA  - Patient Prefer Adherence
JT  - Patient preference and adherence
AID - 10.2147/PPA.S93020 [doi]
AID - ppa-10-2397 [pii]
SO  - Patient Prefer Adherence. 2016 Nov 24;10:2397-406. doi:10.2147/PPA.S93020.

PMC - PMC5487063
PMID- 28654676
IS  - 1932-6203 (Electronic)
VI  - 12
IP  - 6
DP  - 2017
TI  - Silver, bighead, and common carp orient to acoustic particle motion when avoiding
      a complex sound.
LID - e0180110
AB  - Behavioral responses of silver carp (Hypopthalmichthys molitrix), bighead carp
      (H. nobilis), and common carp (Cyprinus carpio) to a complex, broadband sound
      were tested in the absence of visual cues to determine whether these species are 
      negatively phonotaxic and the roles that sound pressure and particle motion might
      play mediating this response. In a dark featureless square enclosure, groups of 3
      fish were tracked and the distance of each fish from speakers and their swimming 
      trajectories relative to sound pressure and particle acceleration were analyzed
      before, and then while an outboard motor sound was played. All three species
      exhibited negative phonotaxis during the first two exposures after which they
      ceased responding. The median percent time fish spent near the active speaker for
      the first two trials decreased from 7.0% to 1.3% for silver carp, 7.9% to 1.1%
      for bighead carp, and 9.5% to 3% for common carp. Notably, when close to the
      active speaker fish swam away from the source and maintained a nearly perfect 0° 
      orientation to the axes of particle acceleration. Fish did not enter sound fields
      greater than 140 dB (ref. 1 μPa). These results demonstrate that carp avoid
      complex sounds in darkness and while initial responses may be informed by sound
      pressure, sustained oriented avoidance behavior is likely mediated by particle
      motion. This understanding of how invasive carp use particle motion to guide
      avoidance could be used to design new acoustic deterrents to divert them in dark,
      turbid river waters.
FAU - Zielinski, Daniel P.
AU  - Zielinski DP
AUID- ORCID: 0000-0002-2433-4705
AD  - Department of Fisheries, Wildlife, and Conservation Biology, University of
      Minnesota, St. Paul, Minnesota, United States of America
FAU - Sorensen, Peter W.
AU  - Sorensen PW
AD  - Department of Fisheries, Wildlife, and Conservation Biology, University of
      Minnesota, St. Paul, Minnesota, United States of America
LA  - eng
PT  - Journal Article
DEP - 20170627
GR  - M.L. 2013, Chp. 52, Sec. 2, Subd. 06a
PHST- 2017/02/16 [received]
PHST- 2017/06/11 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - 10.1371/journal.pone.0180110 [doi]
AID - PONE-D-17-06461 [pii]
SO  - PLoS One. 2017 Jun 27;12(6):. doi:10.1371/journal.pone.0180110.

PMC - PMC4511276
PMID- 26213659
IS  - 2168-2291 (Print)
IS  - 2168-2305 (Electronic)
VI  - 45
IP  - 4
DP  - 2015 Aug
TI  - Dysphagia Screening: Contributions of Cervical Auscultation Signals and Modern
      Signal-Processing Techniques.
PG  - 465-77
AB  - Cervical auscultation is the recording of sounds and vibrations caused by the
      human body from the throat during swallowing. While traditionally done by a
      trained clinician with a stethoscope, much work has been put towards developing
      more sensitive and clinically useful methods to characterize the data obtained
      with this technique. The eventual goal of the field is to improve the
      effectiveness of screening algorithms designed to predict the risk that
      swallowing disorders pose to individual patients’ health and safety. This paper
      provides an overview of these signal processing techniques and summarizes recent 
      advances made with digital transducers in hopes of organizing the highly varied
      research on cervical auscultation. It investigates where on the body these
      transducers are placed in order to record a signal as well as the collection of
      analog and digital filtering techniques used to further improve the signal
      quality. It also presents the wide array of methods and features used to
      characterize these signals, ranging from simply counting the number of swallows
      that occur over a period of time to calculating various descriptive features in
      the time, frequency, and phase space domains. Finally, this paper presents the
      algorithms that have been used to classify this data into ‘normal’ and ‘abnormal’
      categories. Both linear as well as non-linear techniques are presented in this
      regard.
FAU - Dudik, Joshua M.
AU  - Dudik JM
AD  - Department of Electrical and Computer Engineering, Swanson School of Enginering, 
      University of Pittsburgh, Pittsburgh, PA, USA
FAU - Coyle, James L.
AU  - Coyle JL
AD  - Department of Communication Science and Disorders, School of Health and
      Rehabilitation Sciences, University of Pittsburgh, Pittsburgh, PA, USA
FAU - Sejdić, Ervin
AU  - Sejdić E
AD  - Department of Electrical and Computer Engineering, Swanson School of Enginering, 
      University of Pittsburgh, Pittsburgh, PA, USA
LA  - eng
PT  - Journal Article
TA  - IEEE Trans Hum Mach Syst
JT  - IEEE transactions on human-machine systems
AID - 10.1109/THMS.2015.2408615 [doi]
MID - NIHMS678910
SO  - IEEE Trans Hum Mach Syst. 2015 Aug;45(4):465-77. doi:10.1109/THMS.2015.2408615.

PMC - PMC3981479
PMID- 24737930
IS  - 1176-9351 (Electronic)
VI  - 13
DP  - 2014
TI  - Nonlinear Optical Microscopy Signal Processing Strategies in Cancer.
PG  - 67-76
AB  - This work reviews the most relevant present-day processing methods used to
      improve the accuracy of multimodal nonlinear images in the detection of
      epithelial cancer and the supporting stroma. Special emphasis has been placed on 
      methods of non linear optical (NLO) microscopy image processing such as: second
      harmonic to autofluorescence ageing index of dermis (SAAID), tumor-associated
      collagen signatures (TACS), fast Fourier transform (FFT) analysis, and gray level
      co-occurrence matrix (GLCM)-based methods. These strategies are presented as a
      set of potential valuable diagnostic tools for early cancer detection. It may be 
      proposed that the combination of NLO microscopy and informatics based image
      analysis approaches described in this review (all carried out on free software)
      may represent a powerful tool to investigate collagen organization and remodeling
      of extracellular matrix in carcinogenesis processes.
FAU - Adur, Javier
AU  - Adur J
AD  - Microscopy Laboratory Applied to Molecular and Cellular Studies, Bioengineering
      School, National University of Entre Rios, Oro Verde, Entre Rios, Argentina.
FAU - Carvalho, Hernandes F
AU  - Carvalho HF
AD  - INFABiC—National Institute of Science and Technology on Photonics Applied to Cell
      Biology, Campinas, São Paulo, Brazil.
FAU - Cesar, Carlos L
AU  - Cesar CL
AD  - INFABiC—National Institute of Science and Technology on Photonics Applied to Cell
      Biology, Campinas, São Paulo, Brazil.
FAU - Casco, Víctor H
AU  - Casco VH
AD  - Microscopy Laboratory Applied to Molecular and Cellular Studies, Bioengineering
      School, National University of Entre Rios, Oro Verde, Entre Rios, Argentina.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20140402
PHST- 2013/12/18 [received]
PHST- 2014/03/02 [revised]
PHST- 2014/03/03 [accepted]
TA  - Cancer Inform
JT  - Cancer Informatics
AID - 10.4137/CIN.S12419 [doi]
AID - cin-13-2014-067 [pii]
SO  - Cancer Inform. 2014 Apr 02;13:67-76. doi:10.4137/CIN.S12419.

PMC - PMC3618170
PMID- 23564897
IS  - 0141-0768 (Print)
IS  - 1758-1095 (Electronic)
VI  - 106
IP  - 4
DP  - 2013 Apr
TI  - Mobile health use in low- and high-income countries: an overview of the
      peer-reviewed literature.
PG  - 130-42
AB  - The evolution of mobile phone technology has introduced new possibilities to the 
      field of medicine. Combining technological advances with medical expertise has
      led to the use of mobile phones in all healthcare areas including diagnostics,
      telemedicine, research, reference libraries and interventions. This article
      provides an overview of the peer-reviewed literature, published between 1 August 
      2006 and 1 August 2011, for the application of mobile/cell phones (from basic
      text-messaging systems to smartphones) in healthcare in both resource-poor and
      high-income countries. Smartphone use is paving the way in high-income countries,
      while basic text-messaging systems of standard mobile phones are proving to be of
      value in low- and middle-income countries. Ranging from infection outbreak
      reporting, anti-HIV therapy adherence to gait analysis, resuscitation training
      and radiological imaging, the current uses and future possibilities of mobile
      phone technology in healthcare are endless. Multiple mobile phone based
      applications are available for healthcare workers and healthcare consumers;
      however, the absolute majority lack an evidence base. Therefore, more rigorous
      research is required to ensure that healthcare is not flooded with non-evidence
      based applications and is maximized for patient benefit.
FAU - Bastawrous, Andrew
AU  - Bastawrous A
AD  - International Centre for Eye Health, Clinical Research Department, London School 
      of Hygiene & Tropical Medicine, London WC1E 7HT, UK
FAU - Armstrong, Matthew J
AU  - Armstrong MJ
AD  - Centre for Liver Research and NIHR Liver Biomedical Research Unit, University of 
      Birmingham, Birmingham B15 2TT, UK
LA  - eng
PT  - Journal Article
PT  - Review
TA  - J R Soc Med
JT  - Journal of the Royal Society of Medicine
AID - 10.1177/0141076812472620 [doi]
AID - JRSM-472620 [pii]
SO  - J R Soc Med. 2013 Apr;106(4):130-42. doi:10.1177/0141076812472620.

PMC - PMC4507624
PMID- 26102494
IS  - 1424-8220 (Electronic)
VI  - 15
IP  - 6
DP  - 2015 Jun
TI  - Gaze-Assisted User Intention Prediction for Initial Delay Reduction in Web Video 
      Access.
PG  - 14679-700
AB  - Despite the remarkable improvement of hardware and network technology, the
      inevitable delay from a user's command action to a system response is still one
      of the most crucial influence factors in user experiences (UXs). Especially for a
      web video service, an initial delay from click action to video start has
      significant influences on the quality of experience (QoE). The initial delay of a
      system can be minimized by preparing execution based on predicted user's
      intention prior to actual command action. The introduction of the sequential and 
      concurrent flow of resources in human cognition and behavior can significantly
      improve the accuracy and preparation time for intention prediction. This paper
      introduces a threaded interaction model and applies it to user intention
      prediction for initial delay reduction in web video access. The proposed
      technique consists of a candidate selection module, a decision module and a
      preparation module that prefetches and preloads the web video data before a
      user's click action. The candidate selection module selects candidates in the web
      page using proximity calculation around a cursor. Meanwhile, the decision module 
      computes the possibility of actual click action based on the cursor-gaze
      relationship. The preparation activates the prefetching for the selected
      candidates when the click possibility exceeds a certain limit in the decision
      module. Experimental results show a 92% hit-ratio, 0.5-s initial delay on average
      and 1.5-s worst initial delay, which is much less than a user's tolerable limit
      in web video access, demonstrating significant improvement of accuracy and
      advance time in intention prediction by introducing the proposed threaded
      interaction model.
FAU - Lee, Seungyup
AU  - Lee S
AD  - School of Integrated Technology, Yonsei University, Incheon 406-840, Korea;
      E-Mails: youb007@yonsei.ac.kr (S.L.); j.y@yonsei.ac.kr (J.Y.)
FAU - Yoo, Juwan
AU  - Yoo J
AD  - School of Integrated Technology, Yonsei University, Incheon 406-840, Korea;
      E-Mails: youb007@yonsei.ac.kr (S.L.); j.y@yonsei.ac.kr (J.Y.)
FAU - Han, Gunhee
AU  - Han G
AD  - School of Integrated Technology, Yonsei University, Incheon 406-840, Korea;
      E-Mails: youb007@yonsei.ac.kr (S.L.); j.y@yonsei.ac.kr (J.Y.)
LA  - eng
PT  - Journal Article
DEP - 20150619
PHST- 2015/02/25 [received]
PHST- 2015/06/16 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s150614679 [doi]
AID - sensors-15-14679 [pii]
SO  - Sensors (Basel). 2015 Jun 19;15(6):14679-700. doi:10.3390/s150614679.

PMC - PMC4537057
PMID- 25566763
IS  - 1090-7165 (Print)
IS  - 1573-3254 (Electronic)
VI  - 19
IP  - 0 2
DP  - 2015 Jun
TI  - Enhancing Lay Counselor Capacity to Improve Patient Outcomes with Multimedia
      Technology.
PG  - 163-76
AB  - Multimedia technologies offer powerful tools to increase capacity of health
      workers to deliver standardized, effective, and engaging antiretroviral
      medication adherence counseling. Masivukeni is an innovative multimedia-based,
      computer-driven, lay counselor-delivered intervention designed to help people
      living with HIV in resource-limited settings achieve optimal adherence. This
      pilot study examined medication adherence and key psychosocial outcomes among 55 
      non-adherent South African HIV+ patients, on ART for at least 6 months, who were 
      randomized to receive either Masivukeni or standard of care (SOC) counseling for 
      ART non-adherence. At baseline, there were no significant differences between the
      SOC and Masivukeni groups on any outcome variables. At post-intervention
      (approximately 5–6 weeks after baseline), clinic-based pill count adherence data 
      available for 20 participants (10 per intervention arm) showed a 10% improvement 
      for Masivukeni participants and a decrease of 8% for SOC participants. Masivukeni
      participants reported significantly more positive attitudes towards disclosure
      and medication social support, less social rejection, and better clinic-patient
      relationships than did SOC participants. Masivukeni shows promise to promote
      optimal adherence and provides preliminary evidence that multimedia,
      computer-based technology can help lay counselors offer better adherence
      counseling than standard approaches.
FAU - Robbins, Reuben N.
AU  - Robbins RN
AD  - HIV Center for Clinical and Behavioral Studies, New York State Psychiatric
      Institute and Columbia University, New York, New York
FAU - Mellins, Claude A.
AU  - Mellins CA
AD  - HIV Center for Clinical and Behavioral Studies, New York State Psychiatric
      Institute and Columbia University, New York, New York
FAU - Leu, Cheng-Shiun
AU  - Leu CS
AD  - HIV Center for Clinical and Behavioral Studies, New York State Psychiatric
      Institute and Columbia University, New York, New York
FAU - Rowe, Jessica
AU  - Rowe J
AD  - The Columbia Center for New Media Teaching and Learning, Columbia University, New
      York, New York
FAU - Warne, Patricia
AU  - Warne P
AD  - HIV Center for Clinical and Behavioral Studies, New York State Psychiatric
      Institute and Columbia University, New York, New York
FAU - Abrams, Elaine J.
AU  - Abrams EJ
AD  - ICAP, Mailman School of Public Health and College of Physicians & Surgeons,
      Columbia University, New York, New York
FAU - Witte, Susan
AU  - Witte S
AD  - Social Intervention Group, School of Social Work, Columbia University, New York, 
      New York
FAU - Stein, Dan J.
AU  - Stein DJ
AD  - Department of Psychiatry and Mental Health, University of Cape Town, Cape Town,
      South Africa
FAU - Remien, Robert H.
AU  - Remien RH
AD  - HIV Center for Clinical and Behavioral Studies, New York State Psychiatric
      Institute and Columbia University, New York, New York
LA  - eng
PT  - Journal Article
TA  - AIDS Behav
JT  - AIDS and behavior
AID - 10.1007/s10461-014-0988-4 [doi]
MID - NIHMS713593
SO  - AIDS Behav. 2015 Jun;19(0 2):163-76. doi:10.1007/s10461-014-0988-4.

PMC - PMC3545163
PMID- 23034363
IS  - 0022-3077 (Print)
IS  - 1522-1598 (Electronic)
VI  - 109
IP  - 1
DP  - 2013 Jan 1
TI  - High-performance execution of psychophysical tasks with complex visual stimuli in
      MATLAB.
PG  - 249-60
AB  - Behavioral, psychological, and physiological experiments often require the
      ability to present sensory stimuli, monitor and record subjects' responses,
      interface with a wide range of devices, and precisely control the timing of
      events within a behavioral task. Here, we describe our recent progress developing
      an accessible and full-featured software system for controlling such studies
      using the MATLAB environment. Compared with earlier reports on this software, key
      new features have been implemented to allow the presentation of more complex
      visual stimuli, increase temporal precision, and enhance user interaction. These 
      features greatly improve the performance of the system and broaden its
      applicability to a wider range of possible experiments. This report describes
      these new features and improvements, current limitations, and quantifies the
      performance of the system in a real-world experimental setting.
FAU - Asaad, Wael F.
AU  - Asaad WF
AD  - Brown Institute for Brain Science, Norman Prince Neurosciences Institute and the 
      Department of Neurosurgery, Alpert Medical School, Brown University and Rhode
      Island Hospital, Providence, Rhode Island
FAU - Santhanam, Navaneethan
AU  - Santhanam N
AD  - Department of Neurobiology, The University of Chicago, Chicago, Illinois; and
FAU - McClellan, Steven
AU  - McClellan S
AD  - Department of Neurobiology, The University of Chicago, Chicago, Illinois; and
FAU - Freedman, David J.
AU  - Freedman DJ
AD  - Department of Neurobiology, The University of Chicago, Chicago, Illinois; and
LA  - eng
PT  - Journal Article
DEP - 20121003
PHST- 2012/06/19 [received]
PHST- 2012/10/02 [accepted]
PHST- 2012/10/03 [aheadofprint]
TA  - J Neurophysiol
JT  - Journal of Neurophysiology
AID - JN-00527-2012 [pii]
AID - 10.1152/jn.00527.2012 [doi]
SO  - J Neurophysiol. 2013 Jan 1;109(1):249-60. Epub 2012 Oct 3
      doi:10.1152/jn.00527.2012.

PMC - PMC3806518
PMID- 24128406
IS  - 1439-4456 (Print)
IS  - 1438-8871 (Electronic)
VI  - 15
IP  - 10
DP  - 2013 Oct
TI  - Considerations for Community-Based mHealth Initiatives: Insights From Three
      Beacon Communities.
LID - e221
AB  - Mobile health (mHealth) is gaining widespread attention for its potential to
      engage patients in their health and health care in their daily lives. Emerging
      evidence suggests that mHealth interventions can be used effectively to support
      behavior change, but numerous challenges remain when implementing these programs 
      at the community level. This paper provides an overview of considerations when
      implementing community-based mHealth initiatives, based on the experiences of
      three Beacon Communities across the United States that have launched text
      messaging (short message service, SMS) pilot programs aimed at diabetes risk
      reduction and disease management. The paper addresses lessons learned and
      suggests strategies to overcome challenges related to developing text message
      content, conducting marketing and outreach, enrolling participants, engaging
      providers, evaluating program effectiveness, and sustaining and scaling the
      programs.
FAU - Whittaker, Robyn
AU  - Whittaker R
FAU - Furberg, Robert
AU  - Furberg R
FAU - McKinley, Michelle
AU  - McKinley M
FAU - Abebe, Nebeyou A
AU  - Abebe NA
AD  - Louisiana Public Health InstituteCrescent City Beacon CommunityNew Orleans,
      LAUnited States
FAU - Capozza, Korey L
AU  - Capozza KL
AD  - HealthInsightUtah Beacon CommunitySalt Lake City, UTUnited States
FAU - Des Jardins, Terrisca R
AU  - Des Jardins TR
AD  - Southeast Michigan Beacon CommunityDetroit, MIUnited States
FAU - Kulick, David A
AU  - Kulick DA
AD  - Louisiana Public Health InstituteCrescent City Beacon CommunityNew Orleans,
      LAUnited States
FAU - Rein, Alison L
AU  - Rein AL
AD  - AcademyHealthWashington, DCUnited States
FAU - Schachter, Abigail A
AU  - Schachter AA
AD  - AcademyHealthWashington, DCUnited States
FAU - Turske, Scott A
AU  - Turske SA
AD  - Southeast Michigan Beacon CommunityDetroit, MIUnited States
LA  - eng
PT  - Journal Article
DEP - 20131015
PHST- 2013/06/28 [received]
PHST- 2013/08/30 [revised]
PHST- 2013/09/06 [accepted]
TA  - J Med Internet Res
JT  - Journal of Medical Internet Research
AID - v15i10e221 [pii]
AID - 10.2196/jmir.2803 [doi]
SO  - J Med Internet Res. 2013 Oct 15;15(10):. doi:10.2196/jmir.2803.

PMC - PMC4843706
PMID- 27199701
IS  - 1662-5161 (Electronic)
VI  - 10
DP  - 2016
TI  - Pre-Trial EEG-Based Single-Trial Motor Performance Prediction to Enhance
      Neuroergonomics for a Hand Force Task.
LID - 170
AB  - We propose a framework for building electrophysiological predictors of
      single-trial motor performance variations, exemplified for SVIPT, a sequential
      isometric force control task suitable for hand motor rehabilitation after stroke.
      Electroencephalogram (EEG) data of 20 subjects with mean age of 53 years was
      recorded prior to and during 400 trials of SVIPT. They were executed within a
      single session with the non-dominant left hand, while receiving continuous visual
      feedback of the produced force trajectories. The behavioral data showed strong
      trial-by-trial performance variations for five clinically relevant metrics, which
      accounted for reaction time as well as for the smoothness and precision of the
      produced force trajectory. 18 out of 20 tested subjects remained after
      preprocessing and entered offline analysis. Source Power Comodulation (SPoC) was 
      applied on EEG data of a short time interval prior to the start of each SVIPT
      trial. For 11 subjects, SPoC revealed robust oscillatory EEG subspace components,
      whose bandpower activity are predictive for the performance of the upcoming
      trial. Since SPoC may overfit to non-informative subspaces, we propose to apply
      three selection criteria accounting for the meaningfulness of the features.
      Across all subjects, the obtained components were spread along the frequency
      spectrum and showed a variety of spatial activity patterns. Those containing the 
      highest level of predictive information resided in and close to the alpha band.
      Their spatial patterns resemble topologies reported for visual attention
      processes as well as those of imagined or executed hand motor tasks. In summary, 
      we identified subject-specific single predictors that explain up to 36% of the
      performance fluctuations and may serve for enhancing neuroergonomics of motor
      rehabilitation scenarios.
FAU - Meinel, Andreas
AU  - Meinel A
AD  - Brain State Decoding Lab, Cluster of Excellence BrainLinks-BrainTools, Department
      of Computer Science, Albert-Ludwigs-UniversityFreiburg, Germany
FAU - Castaño-Candamil, Sebastián
AU  - Castaño-Candamil S
AD  - Brain State Decoding Lab, Cluster of Excellence BrainLinks-BrainTools, Department
      of Computer Science, Albert-Ludwigs-UniversityFreiburg, Germany
FAU - Reis, Janine
AU  - Reis J
AD  - Department of Neurology, Albert-Ludwigs-UniversityFreiburg, Germany
FAU - Tangermann, Michael
AU  - Tangermann M
AD  - Brain State Decoding Lab, Cluster of Excellence BrainLinks-BrainTools, Department
      of Computer Science, Albert-Ludwigs-UniversityFreiburg, Germany
LA  - eng
PT  - Journal Article
DEP - 20160425
GR  - EXC 1086
PHST- 2015/12/15 [received]
PHST- 2016/04/04 [accepted]
TA  - Front Hum Neurosci
JT  - Frontiers in Human Neuroscience
AID - 10.3389/fnhum.2016.00170 [doi]
SO  - Front Hum Neurosci. 2016 Apr 25;10:. doi:10.3389/fnhum.2016.00170.

PMC - PMC2039885
PMID- 17346930
IS  - 0920-9964 (Print)
VI  - 92
IP  - 1-3
DP  - 2007 May
TI  - Multi-site studies of acoustic startle and prepulse inhibition in humans: Initial
      experience and methodological considerations based on studies by the Consortium
      on the Genetics of Schizophrenia.
PG  - 237-51
AB  - Background:: Startle and its inhibition by weak lead stimuli (“prepulse
      inhibition”: PPI) are studied to understand the neurobiology of information
      processing in patients and community comparison subjects (CCS). PPI has a strong 
      genetic basis in infrahumans, and there is evidence for its heritability,
      stability and reliability in humans. PPI has gained increasing use as an
      endophenotype to identify vulnerability genes for brain disorders, including
      schizophrenia. Genetic studies now often employ multiple, geographically
      dispersed test sites to accommodate the need for large and complex study samples.
      Here, we assessed the feasibility of using PPI in multi-site studies. Methods::
      Within a 7-site investigation with multiple measures, the Consortium on the
      Genetics of Schizophrenia conducted a methodological study of acoustic startle
      and PPI in CCS. Methods were manualized, videotaped and standardized across sites
      with intensive in-person training sessions. Equipment was acquired and programmed
      at the “PPI site” (UCSD), and stringent quality assurance (QA) procedures were
      used. Testing was completed on 196 CCS over 2.5 years, with 5 primary startle
      dependent measures: eyeblink startle magnitude, habituation, peak latency,
      latency facilitation and PPI. Results:: Analyses identified significant
      variability across sites in some but not all primary measures, and determined
      factors both within the testing process and subject characteristics that
      influenced a number of test measures. QA procedures also identified
      non-standardized practices with respect to testing methods and procedural
      “drift”, which may be particularly relevant to multi-site studies using these
      measures. Conclusion:: With thorough oversight and QA procedures, measures of
      acoustic startle PPI can be acquired reliably across multiple testing sites.
      Nonetheless, even among sites with substantial expertise in utilizing
      psychophysiological measures, multi-site studies using startle and PPI as
      dependent measures require careful attention to methodological procedures.
FAU - Swerdlow, Neal R.
AU  - Swerdlow NR
AD  - Department of Psychiatry, University of California San Diego, San Diego,
      California, USA.
FAU - Sprock, Joyce
AU  - Sprock J
AD  - Department of Psychiatry, University of California San Diego, San Diego,
      California, USA.
FAU - Light, Gregory A.
AU  - Light GA
AD  - Department of Psychiatry, University of California San Diego, San Diego,
      California, USA.
FAU - Cadenhead, Kristin
AU  - Cadenhead K
AD  - Department of Psychiatry, University of California San Diego, San Diego,
      California, USA.
FAU - Calkins, Monica E.
AU  - Calkins ME
AD  - Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania,
      USA.
FAU - Dobie, Dorcas J.
AU  - Dobie DJ
AD  - Department of Psychiatry and Behavioral Sciences, University of Washington,
      Seattle, Washington, and VA Puget Sound Health Care System, Seattle, Washington, 
      USA, and VISN20 MIRECC.
FAU - Freedman, Robert
AU  - Freedman R
AD  - Department of Psychiatry, University of Colorado Health Sciences Center, Denver, 
      Colorado, USA.
FAU - Green, Michael F.
AU  - Green MF
AD  - Department of Psychiatry and Biobehavioral Sciences, Geffen School of Medicine at
      University of California Los Angeles, Los Angeles, California, USA.
FAU - Greenwood, Tiffany A.
AU  - Greenwood TA
AD  - Department of Psychiatry, University of California San Diego, San Diego,
      California, USA.
FAU - Gur, Raquel E.
AU  - Gur RE
AD  - Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania,
      USA.
FAU - Mintz, Jim
AU  - Mintz J
AD  - Department of Psychiatry and Biobehavioral Sciences, Geffen School of Medicine at
      University of California Los Angeles, Los Angeles, California, USA.
FAU - Olincy, Ann
AU  - Olincy A
AD  - Department of Psychiatry, University of Colorado Health Sciences Center, Denver, 
      Colorado, USA.
FAU - Nuechterlein, Keith H.
AU  - Nuechterlein KH
AD  - Department of Psychiatry and Biobehavioral Sciences, Geffen School of Medicine at
      University of California Los Angeles, Los Angeles, California, USA.
FAU - Radant, Allen D.
AU  - Radant AD
AD  - Department of Psychiatry and Behavioral Sciences, University of Washington,
      Seattle, Washington, and VA Puget Sound Health Care System, Seattle, Washington, 
      USA, and VISN20 MIRECC.
FAU - Schork, Nicholas J.
AU  - Schork NJ
AD  - Department of Psychiatry, University of California San Diego, San Diego,
      California, USA.
FAU - Seidman, Larry J.
AU  - Seidman LJ
AD  - Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel 
      Deaconess Medical Center, Harvard Medical School Department of Psychiatry,
      Boston, Massachusetts, and Harvard Institute of Psychiatric Epidemiology and
      Genetics, Boston, Massachusetts, USA.
FAU - Siever, Larry J.
AU  - Siever LJ
AD  - Department of Psychiatry, The Mount Sinai School of Medicine, New York, New York,
      USA, and James J. Peters VA Medical Center and VISN3 MIRECC.
FAU - Silverman, Jeremy M.
AU  - Silverman JM
AD  - Department of Psychiatry, The Mount Sinai School of Medicine, New York, New York,
      USA, and James J. Peters VA Medical Center and VISN3 MIRECC.
FAU - Stone, William S.
AU  - Stone WS
AD  - Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel 
      Deaconess Medical Center, Harvard Medical School Department of Psychiatry,
      Boston, Massachusetts, and Harvard Institute of Psychiatric Epidemiology and
      Genetics, Boston, Massachusetts, USA.
FAU - Tsuang, Debbie W.
AU  - Tsuang DW
AD  - Department of Psychiatry and Behavioral Sciences, University of Washington,
      Seattle, Washington, and VA Puget Sound Health Care System, Seattle, Washington, 
      USA, and VISN20 MIRECC.
FAU - Tsuang, Ming T.
AU  - Tsuang MT
AD  - Department of Psychiatry, University of California San Diego, San Diego,
      California, USA.
FAU - Turetsky, Bruce I.
AU  - Turetsky BI
AD  - Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania,
      USA.
FAU - Braff, David L.
AU  - Braff DL
AD  - Department of Psychiatry, University of California San Diego, San Diego,
      California, USA.
LA  - eng
PT  - Journal Article
DEP - 20070308
TA  - Schizophr Res
JT  - Schizophrenia research
AID - 10.1016/j.schres.2007.01.012 [doi]
MID - NIHMS22860
SO  - Schizophr Res. 2007 May;92(1-3):237-51. Epub 2007 Mar 8
      doi:10.1016/j.schres.2007.01.012.

PMC - PMC3263788
PMID- 22006910
IS  - 1364-503X (Print)
IS  - 1471-2962 (Electronic)
VI  - 369
IP  - 1955
DP  - 2011 Nov 28
TI  - In vivo optical imaging and dynamic contrast methods for biomedical research.
PG  - 4620-43
AB  - This paper provides an overview of optical imaging methods commonly applied to
      basic research applications. Optical imaging is well suited for non-clinical use,
      since it can exploit an enormous range of endogenous and exogenous forms of
      contrast that provide information about the structure and function of tissues
      ranging from single cells to entire organisms. An additional benefit of optical
      imaging that is often under-exploited is its ability to acquire data at high
      speeds; a feature that enables it to not only observe static distributions of
      contrast, but to probe and characterize dynamic events related to physiology,
      disease progression and acute interventions in real time. The benefits and
      limitations of in vivo optical imaging for biomedical research applications are
      described, followed by a perspective on future applications of optical imaging
      for basic research centred on a recently introduced real-time imaging technique
      called dynamic contrast-enhanced small animal molecular imaging (DyCE).
FAU - Hillman, Elizabeth M. C.
AU  - Hillman EMC
AD  - Laboratory for Functional Optical Imaging, Department of Biomedical Engineering, 
      and Columbia University in the City of New York, New York, NY 10027, USA
FAU - Amoozegar, Cyrus B.
AU  - Amoozegar CB
AD  - Laboratory for Functional Optical Imaging, Department of Biomedical Engineering, 
      and Columbia University in the City of New York, New York, NY 10027, USA
FAU - Wang, Tracy
AU  - Wang T
AD  - Laboratory for Functional Optical Imaging, Department of Biomedical Engineering, 
      and Columbia University in the City of New York, New York, NY 10027, USA
FAU - McCaslin, Addason F. H.
AU  - McCaslin AFH
AD  - Laboratory for Functional Optical Imaging, Department of Biomedical Engineering, 
      and Columbia University in the City of New York, New York, NY 10027, USA
FAU - Bouchard, Matthew B.
AU  - Bouchard MB
AD  - Laboratory for Functional Optical Imaging, Department of Biomedical Engineering, 
      and Columbia University in the City of New York, New York, NY 10027, USA
FAU - Mansfield, James
AU  - Mansfield J
AD  - Caliper Life Sciences Inc., Hopkinton, MA 01748, USA
FAU - Levenson, Richard M.
AU  - Levenson RM
AD  - Brighton Consulting Group, Brighton, MA 02135, USA
LA  - eng
PT  - Journal Article
PT  - Review
TA  - Philos Trans A Math Phys Eng Sci
JT  - Philosophical transactions. Series A, Mathematical, physical, and engineering
      sciences
AID - 10.1098/rsta.2011.0264 [doi]
AID - rsta20110264 [pii]
SO  - Philos Trans A Math Phys Eng Sci. 2011 Nov 28;369(1955):4620-43.
      doi:10.1098/rsta.2011.0264.

PMC - PMC2643949
PMID- 19023127
IS  - 0586-7614 (Print)
IS  - 1745-1701 (Electronic)
VI  - 35
IP  - 1
DP  - 2009 Jan
TI  - Brain-Performance Correlates of Working Memory Retrieval in Schizophrenia: A
      Cognitive Modeling Approach.
PG  - 32-46
AB  - Correlations of cognitive functioning with brain activation during a sternberg
      item recognition paradigm (SIRP) were investigated in patients with schizophrenia
      and in healthy controls studied at 8 sites. To measure memory scanning times, 4
      response time models were fit to SIRP data. The best fitting model assumed
      exhaustive serial memory scanning followed by self-terminating memory search and 
      involved one intercept parameter to represent SIRP processes not contributing
      directly to memory scanning. Patients displayed significantly longer response
      times with increasing memory load and differed on the memory scanning, memory
      search, and intercept parameters of the best fitting probability model. Groups
      differed in the correlation between the memory scanning parameter and linear
      brain response to increasing memory load within left inferior and left middle
      frontal gyrus, bilateral caudate, and right precuneus. The pattern of findings in
      these regions indicated that high scanning capacity was associated with high
      neural capacity among healthy subjects but that scanning speed was uncoupled from
      brain response to increasing memory load among schizophrenia patients. Group
      differences in correlation of the best fitting model's scanning parameter with a 
      quadratic trend in brain response to increasing memory load suggested inefficient
      or disordered patterns of neural inhibition among individuals with schizophrenia,
      especially in the left perirhinal and entorhinal cortices. The results show at
      both cognitive and neural levels that disordered memory scanning contributes to
      deficient SIRP performance among schizophrenia patients.
FAU - Brown, Gregory G.
AU  - Brown GG
AD  - Department of Psychiatry, University of California San Diego; Psychology Service,
      VA San Diego Healthcare System
FAU - McCarthy, Gregory
AU  - McCarthy G
AD  - Department of Psychiatry, Yale University
FAU - Bischoff-Grethe, Amanda
AU  - Bischoff-Grethe A
AD  - Department of Psychiatry, University of California San Diego
FAU - Ozyurt, Burak
AU  - Ozyurt B
AD  - Department of Psychiatry, University of California San Diego
FAU - Greve, Doug
AU  - Greve D
AD  - Department of Psychiatry, Massachusetts General Hospital
FAU - Potkin, Steven G.
AU  - Potkin SG
AD  - Department of Psychiatry, University of California Irvine
FAU - Turner, Jessica A.
AU  - Turner JA
AD  - Department of Psychiatry, University of California Irvine
FAU - Notestine, Randy
AU  - Notestine R
AD  - Department of Psychiatry, University of California San Diego
FAU - Calhoun, Vince D.
AU  - Calhoun VD
AD  - Electrical and Computer Engineering; The Mind Research Network, University of New
      Mexico, Albuquerque, NM 87131
FAU - Ford, Judy M.
AU  - Ford JM
AD  - Department of Psychiatry, University of California San Francisco
FAU - Mathalon, Daniel
AU  - Mathalon D
AD  - Department of Psychiatry, University of California San Francisco
FAU - Manoach, Dara S.
AU  - Manoach DS
AD  - Department of Psychiatry, Massachusetts General Hospital
FAU - Gadde, Syam
AU  - Gadde S
AD  - Department of Psychiatry, Duke University
FAU - Glover, Gary H.
AU  - Glover GH
AD  - Radiological Sciences Laboratory, Stanford University
FAU - Wible, Cynthia G.
AU  - Wible CG
AD  - Department of Psychiatry, Harward Medical School and Brockton VAMC
FAU - Belger, Aysenil
AU  - Belger A
AD  - Department of Psychiatry, University of North Carolina—Chapel Hill
FAU - Gollub, Randy L.
AU  - Gollub RL
AD  - Department of Psychiatry, Massachusetts General Hospital
FAU - Lauriello, John
AU  - Lauriello J
AD  - Department of Psychiatry, University of New Mexico
FAU - O'Leary, Daniel
AU  - O'Leary D
AD  - Department of Psychiatry, University of Iowa
FAU - Lim, Kelvin O.
AU  - Lim KO
LA  - eng
PT  - Journal Article
DEP - 20081120
PHST- 2008/11/20 [aheadofprint]
TA  - Schizophr Bull
JT  - Schizophrenia Bulletin
AID - 10.1093/schbul/sbn149 [doi]
SO  - Schizophr Bull. 2009 Jan;35(1):32-46. Epub 2008 Nov 20 doi:10.1093/schbul/sbn149.

PMC - PMC3945519
PMID- 24639646
IS  - 1662-5196 (Electronic)
VI  - 8
DP  - 2014
TI  - Software and hardware infrastructure for research in electrophysiology.
LID - 20
AB  - As in other areas of experimental science, operation of electrophysiological
      laboratory, design and performance of electrophysiological experiments,
      collection, storage and sharing of experimental data and metadata, analysis and
      interpretation of these data, and publication of results are time consuming
      activities. If these activities are well organized and supported by a suitable
      infrastructure, work efficiency of researchers increases significantly. This
      article deals with the main concepts, design, and development of software and
      hardware infrastructure for research in electrophysiology. The described
      infrastructure has been primarily developed for the needs of neuroinformatics
      laboratory at the University of West Bohemia, the Czech Republic. However, from
      the beginning it has been also designed and developed to be open and applicable
      in laboratories that do similar research. After introducing the laboratory and
      the whole architectural concept the individual parts of the infrastructure are
      described. The central element of the software infrastructure is a web-based
      portal that enables community researchers to store, share, download and search
      data and metadata from electrophysiological experiments. The data model, domain
      ontology and usage of semantic web languages and technologies are described.
      Current data publication policy used in the portal is briefly introduced. The
      registration of the portal within Neuroscience Information Framework is
      described. Then the methods used for processing of electrophysiological signals
      are presented. The specific modifications of these methods introduced by
      laboratory researches are summarized; the methods are organized into a laboratory
      workflow. Other parts of the software infrastructure include mobile and offline
      solutions for data/metadata storing and a hardware stimulator communicating with 
      an EEG amplifier and recording software.
FAU - Mouček, Roman
AU  - Mouček R
AD  - Department of Computer Science and Engineering, Faculty of Applied Sciences,
      University of West BohemiaPlzeň, Czech Republic
FAU - Ježek, Petr
AU  - Ježek P
AD  - Department of Computer Science and Engineering, Faculty of Applied Sciences,
      University of West BohemiaPlzeň, Czech Republic
FAU - Vařeka, Lukáš
AU  - Vařeka L
AD  - Department of Computer Science and Engineering, Faculty of Applied Sciences,
      University of West BohemiaPlzeň, Czech Republic
FAU - Řondík, Tomáš
AU  - Řondík T
AD  - Department of Computer Science and Engineering, Faculty of Applied Sciences,
      University of West BohemiaPlzeň, Czech Republic
FAU - Brůha, Petr
AU  - Brůha P
AD  - Department of Computer Science and Engineering, Faculty of Applied Sciences,
      University of West BohemiaPlzeň, Czech Republic
FAU - Papež, Václav
AU  - Papež V
AD  - Department of Computer Science and Engineering, Faculty of Applied Sciences,
      University of West BohemiaPlzeň, Czech Republic
FAU - Mautner, Pavel
AU  - Mautner P
AD  - Department of Computer Science and Engineering, Faculty of Applied Sciences,
      University of West BohemiaPlzeň, Czech Republic
FAU - Novotný, Jiří
AU  - Novotný J
AD  - Department of Computer Science and Engineering, Faculty of Applied Sciences,
      University of West BohemiaPlzeň, Czech Republic
FAU - Prokop, Tomáš
AU  - Prokop T
AD  - Department of Computer Science and Engineering, Faculty of Applied Sciences,
      University of West BohemiaPlzeň, Czech Republic
FAU - Štěbeták, Jan
AU  - Štěbeták J
AD  - Department of Computer Science and Engineering, Faculty of Applied Sciences,
      University of West BohemiaPlzeň, Czech Republic
LA  - eng
PT  - Journal Article
DEP - 20140307
PHST- 2013/12/30 [received]
PHST- 2014/02/19 [accepted]
TA  - Front Neuroinform
JT  - Frontiers in Neuroinformatics
AID - 10.3389/fninf.2014.00020 [doi]
SO  - Front Neuroinform. 2014 Mar 07;8:. doi:10.3389/fninf.2014.00020.

PMC - PMC2882856
PMID- 19327570
IS  - 0889-8553 (Print)
IS  - 1558-1942 (Electronic)
VI  - 38
IP  - 1
DP  - 2009 Mar
TI  - The Role of FDG-PET and Staging Laparoscopy in the Management of Patients with
      Cancer of the Esophagus or Gastroesophageal Junction.
PG  - 105-ix
FAU - Yoon, Harry H.
AU  - Yoon HH
AD  - Division of Medical Oncology, Department of Oncology, Mayo Clinic, 200 First
      Street SW, Rochester, MN 55905, USA
FAU - Lowe, Val J.
AU  - Lowe VJ
AD  - Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, MN
      55906, USA
FAU - Cassivi, Stephen D.
AU  - Cassivi SD
AD  - Division of General Thoracic Surgery, Department of Surgery, Mayo Clinic, 200
      First Street SW, Rochester, MN 55905, USA
FAU - Romero, Yvonne
AU  - Romero Y
AD  - Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic,
      200 First Street SW, Rochester, MN 55905, USA
LA  - eng
PT  - Journal Article
TA  - Gastroenterol Clin North Am
JT  - Gastroenterology clinics of North America
AID - 10.1016/j.gtc.2009.01.007 [doi]
MID - NIHMS201518
SO  - Gastroenterol Clin North Am. 2009 Mar;38(1):105-ix.
      doi:10.1016/j.gtc.2009.01.007.

PMC - PMC4781989
PMID- 27006833
IS  - 2090-5904 (Print)
IS  - 1687-5443 (Electronic)
VI  - 2016
DP  - 2016
TI  - Models to Tailor Brain Stimulation Therapies in Stroke.
LID - 4071620
AB  - A great challenge facing stroke rehabilitation is the lack of information on how 
      to derive targeted therapies. As such, techniques once considered promising, such
      as brain stimulation, have demonstrated mixed efficacy across heterogeneous
      samples in clinical studies. Here, we explain reasons, citing its
      one-type-suits-all approach as the primary cause of variable efficacy. We present
      evidence supporting the role of alternate substrates, which can be targeted
      instead in patients with greater damage and deficit. Building on this groundwork,
      this review will also discuss different frameworks on how to tailor brain
      stimulation therapies. To the best of our knowledge, our report is the first
      instance that enumerates and compares across theoretical models from upper limb
      recovery and conditions like aphasia and depression. Here, we explain how
      different models capture heterogeneity across patients and how they can be used
      to predict which patients would best respond to what treatments to develop
      targeted, individualized brain stimulation therapies. Our intent is to weigh pros
      and cons of testing each type of model so brain stimulation is successfully
      tailored to maximize upper limb recovery in stroke.
FAU - Plow, E. B.
AU  - Plow EB
AD  - Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic
      Foundation, Cleveland, OH 44195, USA
FAU - Sankarasubramanian, V.
AU  - Sankarasubramanian V
AD  - Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic
      Foundation, Cleveland, OH 44195, USA
FAU - Cunningham, D. A.
AU  - Cunningham DA
AD  - Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic
      Foundation, Cleveland, OH 44195, USA
FAU - Potter-Baker, K.
AU  - Potter-Baker K
AD  - Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic
      Foundation, Cleveland, OH 44195, USA
FAU - Varnerin, N.
AU  - Varnerin N
AD  - Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic
      Foundation, Cleveland, OH 44195, USA
FAU - Cohen, L. G.
AU  - Cohen LG
AD  - Human Cortical Physiology and Stroke Neurorehabilitation Section, National
      Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892, USA
FAU - Sterr, A.
AU  - Sterr A
AD  - University of Surrey, Guildford, Surrey GU2 7XH, UK
FAU - Conforto, A. B.
AU  - Conforto AB
AD  - Neurology Clinical Division, Neurology Department, Hospital das Clinicas, Sao
      Paulo University, 05508-090 Sao Paulo, SP, Brazil
FAU - Machado, A. G.
AU  - Machado AG
AD  - Center for Neurological Restoration, Neurosurgery, Neurological Institute,
      Cleveland Clinic Foundation, Cleveland Clinic, Cleveland, OH 44195, USA
LA  - eng
PT  - Journal Article
DEP - 20160223
PHST- 2015/08/01 [received]
PHST- 2015/12/30 [revised]
PHST- 2016/01/04 [accepted]
PHST- 2016/02/23 [aheadofprint]
TA  - Neural Plast
JT  - Neural Plasticity
AID - 10.1155/2016/4071620 [doi]
SO  - Neural Plast. 2016;2016:. Epub 2016 Feb 23 doi:10.1155/2016/4071620.

PMC - PMC4269754
PMID- 25160670
IS  - 0271-678X (Print)
IS  - 1559-7016 (Electronic)
VI  - 34
IP  - 11
DP  - 2014 Nov
TI  - Insights from neuroenergetics into the interpretation of functional neuroimaging:
      an alternative empirical model for studying the brain's support of behavior.
PG  - 1721-35
AB  - Functional neuroimaging measures quantitative changes in neurophysiological
      parameters coupled to neuronal activity during observable behavior. These results
      have usually been interpreted by assuming that mental causation of behavior
      arises from the simultaneous actions of distinct psychological mechanisms or
      modules. However, reproducible localization of these modules in the brain using
      functional magnetic resonance imaging (MRI) and positron emission tomography
      (PET) imaging has been elusive other than for sensory systems. In this paper, we 
      show that neuroenergetic studies using PET, calibrated functional magnetic
      resonance imaging (fMRI), 13C magnetic resonance spectroscopy, and electrical
      recordings do not support the standard approach, which identifies the location of
      mental modules from changes in brain activity. Of importance in reaching this
      conclusion is that changes in neuronal activities underlying the fMRI signal are 
      many times smaller than the high ubiquitous, baseline neuronal activity, or
      energy in resting, awake humans. Furthermore, the incremental signal depends on
      the baseline activity contradicting theoretical assumptions about linearity and
      insertion of mental modules. To avoid these problems, while making use of these
      valuable results, we propose that neuroimaging should be used to identify
      observable brain activities that are necessary for a person's observable behavior
      rather than being used to seek hypothesized mental processes.
FAU - Shulman, Robert G
AU  - Shulman RG
AD  - Magnetic Resonance Research Center, Yale University, New Haven, Connecticut, USA
FAU - Hyder, Fahmeed
AU  - Hyder F
AD  - Magnetic Resonance Research Center, Yale University, New Haven, Connecticut, USA
FAU - Rothman, Douglas L
AU  - Rothman DL
AD  - Magnetic Resonance Research Center, Yale University, New Haven, Connecticut, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20140827
PHST- 2014/03/12 [received]
PHST- 2014/06/12 [revised]
PHST- 2014/07/21 [accepted]
PHST- 2014/08/27 [aheadofprint]
TA  - J Cereb Blood Flow Metab
JT  - Journal of Cerebral Blood Flow & Metabolism
AID - jcbfm2014145 [pii]
AID - 10.1038/jcbfm.2014.145 [doi]
SO  - J Cereb Blood Flow Metab. 2014 Nov;34(11):1721-35. Epub 2014 Aug 27
      doi:10.1038/jcbfm.2014.145.

PMC - PMC3587383
PMID- 23447666
IS  - 0022-0949 (Print)
IS  - 1477-9145 (Electronic)
VI  - 216
IP  - 6
DP  - 2013 Mar 15
TI  - Ectopic eyes outside the head in Xenopus tadpoles provide sensory data for
      light-mediated learning.
PG  - 1031-40
AB  - A major roadblock in the biomedical treatment of human sensory disorders,
      including blindness, has been an incomplete understanding of the nervous system
      and its ability to adapt to changes in sensory modality. Likewise, fundamental
      insight into the evolvability of complex functional anatomies requires
      understanding brain plasticity and the interaction between the nervous system and
      body architecture. While advances have been made in the generation of artificial 
      and biological replacement components, the brain's ability to interpret sensory
      information arising from ectopic locations is not well understood. We report the 
      use of eye primordia grafts to create ectopic eyes along the body axis of Xenopus
      tadpoles. These eyes are morphologically identical to native eyes and can be
      induced at caudal locations. Cell labeling studies reveal that eyes created in
      the tail send projections to the stomach and trunk. To assess function we
      performed light-mediated learning assays using an automated machine vision and
      environmental control system. The results demonstrate that ectopic eyes in the
      tail of Xenopus tadpoles could confer vision to the host. Thus ectopic visual
      organs were functional even when present at posterior locations. These data and
      protocols demonstrate the ability of vertebrate brains to interpret sensory input
      from ectopic structures and incorporate them into adaptive behavioral programs.
      This tractable new model for understanding the robust plasticity of the central
      nervous system has significant implications for regenerative medicine and sensory
      augmentation technology.
FAU - Blackiston, Douglas J.
AU  - Blackiston DJ
FAU - Levin, Michael
AU  - Levin M
LA  - eng
PT  - Journal Article
PHST- 2012/06/25 [received]
PHST- 2012/11/14 [accepted]
TA  - J Exp Biol
JT  - The Journal of Experimental Biology
AID - 10.1242/jeb.074963 [doi]
SO  - J Exp Biol. 2013 Mar 15;216(6):1031-40. doi:10.1242/jeb.074963.

PMC - PMC3055800
PMID- 19495912
IS  - 1480-9222 (Electronic)
VI  - 11
DP  - 2009
TI  - Detection and Processing Techniques of FECG Signal for Fetal Monitoring.
PG  - 263-95
AB  - Fetal electrocardiogram (FECG) signal contains potentially precise information
      that could assist clinicians in making more appropriate and timely decisions
      during labor. The ultimate reason for the interest in FECG signal analysis is in 
      clinical diagnosis and biomedical applications. The extraction and detection of
      the FECG signal from composite abdominal signals with powerful and advance
      methodologies are becoming very important requirements in fetal monitoring. The
      purpose of this review paper is to illustrate the various methodologies and
      developed algorithms on FECG signal detection and analysis to provide efficient
      and effective ways of understanding the FECG signal and its nature for fetal
      monitoring. A comparative study has been carried out to show the performance and 
      accuracy of various methods of FECG signal analysis for fetal monitoring.
      Finally, this paper further focused some of the hardware implementations using
      electrical signals for monitoring the fetal heart rate. This paper opens up a
      passage for researchers, physicians, and end users to advocate an excellent
      understanding of FECG signal and its analysis procedures for fetal heart rate
      monitoring system.
FAU - Hasan, MA
AU  - Hasan M
AD  - Department of Electrical and Computer Engineering, International Islamic
      University Malaysia, Gombak, 53100, Kuala Lumpur, Malaysia
FAU - Reaz, MBI
AU  - Reaz M
AD  - Department of Electrical, Electronic and Systems Engineering, Universiti
      Kebangsaan Malaysia, 43600 UKM, Bangi, Selangor, Malaysia
FAU - Ibrahimy, MI
AU  - Ibrahimy M
AD  - Department of Electrical and Computer Engineering, International Islamic
      University Malaysia, Gombak, 53100, Kuala Lumpur, Malaysia
FAU - Hussain, MS
AU  - Hussain M
AD  - Department of Electrical and Computer Engineering, International Islamic
      University Malaysia, Gombak, 53100, Kuala Lumpur, Malaysia
FAU - Uddin, J
AU  - Uddin J
AD  - Department of Electrical and Computer Engineering, International Islamic
      University Malaysia, Gombak, 53100, Kuala Lumpur, Malaysia
LA  - eng
PT  - Journal Article
DEP - 20090327
PHST- 2009/01/23 [received]
PHST- 2009/03/05 [accepted]
TA  - Biol Proced Online
JT  - Biological Procedures Online
AID - 1480-9222-11-1-9006 [pii]
AID - 10.1007/s12575-009-9006-z [doi]
SO  - Biol Proced Online. 2009 Mar 27;11:263-95. doi:10.1007/s12575-009-9006-z.

PMC - PMC4126458
PMID- 25152887
IS  - 2296-4185 (Electronic)
VI  - 2
DP  - 2014
TI  - A Cerebellar Neuroprosthetic System: Computational Architecture and in vivo Test.
LID - 14
AB  - Emulating the input–output functions performed by a brain structure opens the
      possibility for developing neuroprosthetic systems that replace damaged neuronal 
      circuits. Here, we demonstrate the feasibility of this approach by replacing the 
      cerebellar circuit responsible for the acquisition and extinction of motor
      memories. Specifically, we show that a rat can undergo acquisition, retention,
      and extinction of the eye-blink reflex even though the biological circuit
      responsible for this task has been chemically inactivated via anesthesia. This is
      achieved by first developing a computational model of the cerebellar microcircuit
      involved in the acquisition of conditioned reflexes and training it with
      synthetic data generated based on physiological recordings. Secondly, the
      cerebellar model is interfaced with the brain of an anesthetized rat, connecting 
      the model’s inputs and outputs to afferent and efferent cerebellar structures. As
      a result, we show that the anesthetized rat, equipped with our neuroprosthetic
      system, can be classically conditioned to the acquisition of an eye-blink
      response. However, non-stationarities in the recorded biological signals limit
      the performance of the cerebellar model. Thus, we introduce an updated cerebellar
      model and validate it with physiological recordings showing that learning becomes
      stable and reliable. The resulting system represents an important step toward
      replacing lost functions of the central nervous system via neuroprosthetics,
      obtained by integrating a synthetic circuit with the afferent and efferent
      pathways of a damaged brain region. These results also embody an early example of
      science-based medicine, where on the one hand the neuroprosthetic system directly
      validates a theory of cerebellar learning that informed the design of the system,
      and on the other one it takes a step toward the development of neuro-prostheses
      that could recover lost learning functions in animals and, in the longer term,
      humans.
FAU - Herreros, Ivan
AU  - Herreros I
AD  - Synthetic Perceptive, Emotive and Cognitive Systems group (SPECS), Universitat
      Pompeu Fabra, Barcelona, Spain
FAU - Giovannucci, Andrea
AU  - Giovannucci A
AD  - Synthetic Perceptive, Emotive and Cognitive Systems group (SPECS), Universitat
      Pompeu Fabra, Barcelona, Spain
FAU - Taub, Aryeh H.
AU  - Taub AH
AD  - Psychobiology Research Unit, Tel Aviv University, Tel Aviv, Israel
FAU - Hogri, Roni
AU  - Hogri R
AD  - Psychobiology Research Unit, Tel Aviv University, Tel Aviv, Israel
FAU - Magal, Ari
AU  - Magal A
AD  - Psychobiology Research Unit, Tel Aviv University, Tel Aviv, Israel
FAU - Bamford, Sim
AU  - Bamford S
AD  - Physics Laboratory, Istituto Superiore di Sanità, Rome, Italy
FAU - Prueckl, Robert
AU  - Prueckl R
AD  - Guger Technologies OG, Graz, Austria
FAU - Verschure, Paul F. M. J.
AU  - Verschure PFMJ
AD  - Synthetic Perceptive, Emotive and Cognitive Systems group (SPECS), Universitat
      Pompeu Fabra, Barcelona, Spain
LA  - eng
PT  - Journal Article
DEP - 20140521
PHST- 2013/11/22 [received]
PHST- 2014/05/04 [accepted]
TA  - Front Bioeng Biotechnol
JT  - Frontiers in Bioengineering and Biotechnology
AID - 10.3389/fbioe.2014.00014 [doi]
SO  - Front Bioeng Biotechnol. 2014 May 21;2:. doi:10.3389/fbioe.2014.00014.

PMC - PMC5287710
PMID- 26852702
IS  - 0306-4522 (Print)
IS  - 1873-7544 (Electronic)
VI  - 320
DP  - 2016 Apr 21
TI  - TRANSPLANTATION OF NEURAL PROGENITOR CELLS IN CHRONIC SPINAL CORD INJURY.
PG  - 69-82
AB  - Previous studies demonstrated that neural progenitor cells (NPCs) transplanted
      into a subacute contusion injury improve motor, sensory, and bladder function. In
      this study we tested whether transplanted NPCs can also improve functional
      recovery after chronic spinal cord injury (SCI) alone or in combination with the 
      reduction of glial scar and neurotrophic support. Adult rats received a T10
      moderate contusion. Thirteen weeks after the injury they were divided into four
      groups and received either: 1. Medium (control), 2. NPC transplants, 3. NPC +
      lentivirus vector expressing chondroitinase, or 4. NPC + lentivirus vectors
      expressing chondroitinase and neurotrophic factors. During the 8 weeks
      post-transplantation the animals were tested for functional recovery and
      eventually analyzed by anatomical and immunohistochemical assays. The behavioral 
      tests for motor and sensory function were performed before and after injury, and 
      weekly after transplantation, with some animals also tested for bladder function 
      at the end of the experiment. Transplant survival in the chronic injury model was
      variable and showed NPCs at the injury site in 60% of the animals in all
      transplantation groups. The NPC transplants comprised less than 40% of the injury
      site, without significant anatomical or histological differences among the
      groups. All groups also showed similar patterns of functional deficits and
      recovery in the 12 weeks after injury and in the 8 weeks after transplantation
      using the Basso, Beattie, and Bresnahan rating score, the grid test, and the Von 
      Frey test for mechanical allodynia. A notable exception was group 4 (NPC together
      with chondroitinase and neurotrophins), which showed a significant improvement in
      bladder function. This study underscores the therapeutic challenges facing
      transplantation strategies in a chronic SCI in which even the inclusion of
      treatments designed to reduce scarring and increase neurotrophic support produce 
      only modest functional improvements. Further studies will have to identify the
      combination of acute and chronic interventions that will augment the survival and
      efficacy of neural cell transplants.
FAU - Jin, Y.
AU  - Jin Y
FAU - Bouyer, J.
AU  - Bouyer J
FAU - Shumsky, J. S.
AU  - Shumsky JS
FAU - Haas, C.
AU  - Haas C
FAU - Fischer, I.
AU  - Fischer I
LA  - eng
PT  - Journal Article
DEP - 20160204
TA  - Neuroscience
JT  - Neuroscience
AID - 10.1016/j.neuroscience.2016.01.066 [doi]
MID - NIHMS842860
SO  - Neuroscience. 2016 Apr 21;320:69-82. Epub 2016 Feb 04
      doi:10.1016/j.neuroscience.2016.01.066.

PMC - PMC3878823
PMID- 22154931
IS  - 0168-3659 (Print)
IS  - 1873-4995 (Electronic)
VI  - 159
IP  - 1
DP  - 2012 Apr 10
TI  - Local Drug Delivery Strategies for Cancer Treatment: Gels, Nanoparticles,
      Polymeric Films, Rods, and Wafers.
LID - 10.1016/j.jconrel.2011.11.031
FAU - Wolinsky, Jesse B.
AU  - Wolinsky JB
AD  - Departments of Biomedical Engineering and Chemistry, Boston University, Boston,
      Massachusetts
FAU - Colson, Yolonda L.
AU  - Colson YL
AD  - Division of Thoracic Surgery, Department of Surgery, Brigham and Women's
      Hospital, Boston, Massachusetts
FAU - Grinstaff, Mark W.
AU  - Grinstaff MW
AD  - Departments of Biomedical Engineering and Chemistry, Boston University, Boston,
      Massachusetts
LA  - eng
PT  - Journal Article
DEP - 20111201
GR  - R25 CA153955 || CA
TA  - J Control Release
JT  - Journal of controlled release : official journal of the Controlled Release
      Society
AID - 10.1016/j.jconrel.2011.11.031 [doi]
MID - NIHMS349384
SO  - J Control Release. 2012 Apr 10;159(1):. Epub 2011 Dec 01
      doi:10.1016/j.jconrel.2011.11.031.

PMC - PMC3203799
PMID- 21987821
IS  - 0027-8424 (Print)
IS  - 1091-6490 (Electronic)
VI  - 108
IP  - 43
DP  - 2011 Oct 25
TI  - New methods devised specify the size and color of the spots monkeys see when
      striate cortex (area V1) is electrically stimulated.
PG  - 17809-14
AB  - Creating a prosthetic device for the blind is a central future task. Our research
      examines the feasibility of producing a prosthetic device based on electrical
      stimulation of primary visual cortex (area V1), an area that remains intact for
      many years after loss of vision attributable to damage to the eyes. As an initial
      step in this effort, we believe that the research should be carried out in
      animals, as it has been in the creation of the highly successful cochlear
      implant. We chose the rhesus monkey, whose visual system is similar to that of
      man. We trained monkeys on two tasks to assess the size, contrast, and color of
      the percepts created when single sites in area V1 are stimulated through
      microelectrodes. Here, we report that electrical stimulation within the central
      5° of the visual field representation creates a small spot that is between 9 and 
      26 min of arc in diameter and has a contrast ranging between 2.6% and 10%. The
      dot generated by the stimulation in the majority of cases was darker than the
      background viewed by the animal and was composed of a variety of low-contrast
      colors. These findings can be used as inputs to models of electrical stimulation 
      in area V1. On the basis of these findings, we derive what kinds of images would 
      be expected when implanted arrays of electrodes are stimulated through a camera
      attached to the head whose images are converted into electrical stimulation using
      appropriate algorithms.
FAU - Schiller, Peter H.
AU  - Schiller PH
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, MA 02139; and
FAU - Slocum, Warren M.
AU  - Slocum WM
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, MA 02139; and
FAU - Kwak, Michelle C.
AU  - Kwak MC
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, MA 02139; and
FAU - Kendall, Geoffrey L.
AU  - Kendall GL
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, MA 02139; and
FAU - Tehovnik, Edward J.
AU  - Tehovnik EJ
AD  - The Edmond and Lily Safra International Institute of Neuroscience of Natal
      (ELS-IINN), Macaiba, 59280, Rio Grande do Norte, Brazil
LA  - eng
PT  - Journal Article
DEP - 20111010
PHST- 2011/10/10 [aheadofprint]
TA  - Proc Natl Acad Sci U S A
JT  - Proceedings of the National Academy of Sciences of the United States of America
AID - 201108337 [pii]
AID - 10.1073/pnas.1108337108 [doi]
SO  - Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17809-14. Epub 2011 Oct 10
      doi:10.1073/pnas.1108337108.

PMC - PMC3981936
PMID- 24681598
IS  - 1078-8956 (Print)
IS  - 1546-170X (Electronic)
VI  - 20
IP  - 4
DP  - 2014 Apr
TI  - Label-free in vivo imaging of myelinated axons in health and disease with
      spectral confocal reflectance microscopy.
PG  - 443-9
AB  - We report a new technique for high-resolution in vivo imaging of myelinated axons
      in the brain, spinal cord and peripheral nerve that requires no fluorescent
      labeling. This method, based on spectral confocal reflectance microscopy (SCoRe),
      uses a conventional laser scanning confocal system to generate images by merging 
      the simultaneously reflected signals from multiple lasers of different
      wavelengths. Striking color patterns unique to individual myelinated fibers are
      generated that facilitate their tracing in dense axonal areas. These patterns
      highlight nodes of Ranvier and Schmidt-Lanterman incisures and can be used to
      detect various myelin pathologies. Using SCoRe we performed chronic brain imaging
      up to 400 μm deep, capturing for the first time de novo myelination of mouse
      cortical axons in vivo. We also established the feasibility of imaging myelinated
      axons in the human cerebral cortex. SCoRe adds a powerful component to the
      evolving toolbox for imaging myelination in living animals and potentially in
      humans.
FAU - Schain, Aaron J.
AU  - Schain AJ
AD  - Yale University School of Medicine, Department of Neurology, 300 George St. Suite
      8201, New Haven, CT 06511
FAU - Hill, Robert A.
AU  - Hill RA
AD  - Yale University School of Medicine, Department of Neurology, 300 George St. Suite
      8201, New Haven, CT 06511
FAU - Grutzendler, Jaime
AU  - Grutzendler J
AD  - Yale University School of Medicine, Department of Neurology, 300 George St. Suite
      8201, New Haven, CT 06511
LA  - eng
PT  - Journal Article
DEP - 20140330
TA  - Nat Med
JT  - Nature medicine
AID - 10.1038/nm.3495 [doi]
MID - NIHMS501672
SO  - Nat Med. 2014 Apr;20(4):443-9. Epub 2014 Mar 30 doi:10.1038/nm.3495.

PMC - PMC3307166
PMID- 22457650
IS  - 1664-042X (Electronic)
VI  - 3
DP  - 2012
TI  - Generation and Applications of Human Pluripotent Stem Cells Induced into Neural
      Lineages and Neural Tissues.
LID - 47
AB  - Human pluripotent stem cells (hPSCs) represent a new and exciting field in modern
      medicine, now the focus of many researchers and media outlets. The hype is
      well-earned because of the potential of stem cells to contribute to disease
      modeling, drug screening, and even therapeutic approaches. In this review, we
      focus first on neural differentiation of these cells. In a second part we compare
      the various cell types available and their advantages for in vitro modeling. Then
      we provide a “state-of-the-art” report about two major biomedical applications:
      (1) the drug and toxicity screening and (2) the neural tissue replacement.
      Finally, we made an overview about current biomedical research using
      differentiated hPSCs.
FAU - Martinez, Y.
AU  - Martinez Y
FAU - Dubois-Dauphin, M.
AU  - Dubois-Dauphin M
AD  - Department of Pathology and Immunology, Faculty of Medicine, University of
      GenevaGeneva, Switzerland
FAU - Krause, K.-H.
AU  - Krause KH
AD  - Department of Pathology and Immunology, Faculty of Medicine, University of
      GenevaGeneva, Switzerland
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20120319
PHST- 2011/12/15 [received]
PHST- 2012/02/21 [accepted]
TA  - Front Physiol
JT  - Frontiers in Physiology
AID - 10.3389/fphys.2012.00047 [doi]
SO  - Front Physiol. 2012 Mar 19;3:. doi:10.3389/fphys.2012.00047.

PMC - PMC2950743
PMID- 20941369
IS  - 1662-5137 (Electronic)
VI  - 4
DP  - 2010
TI  - Transcranial Magnetic Stimulation and Connectivity Mapping: Tools for Studying
      the Neural Bases of Brain Disorders.
LID - 40
AB  - There has been an increasing emphasis on characterizing pathophysiology
      underlying psychiatric and neurological disorders in terms of altered neural
      connectivity and network dynamics. Transcranial magnetic stimulation (TMS)
      provides a unique opportunity for investigating connectivity in the human brain. 
      TMS allows researchers and clinicians to directly stimulate cortical regions
      accessible to electromagnetic coils positioned on the scalp. The induced
      activation can then propagate through long-range connections to other brain
      areas. Thus, by identifying distal regions activated during TMS, researchers can 
      infer connectivity patterns in the healthy human brain and can examine how those 
      patterns may be disrupted in patients with different brain disorders. Conversely,
      connectivity maps derived using neuroimaging methods can identify components of a
      dysfunctional network. Nodes in this dysfunctional network accessible as targets 
      for TMS by virtue of their proximity to the scalp may then permit TMS-induced
      alterations of components of the network not directly accessible to TMS via
      propagated effects. Thus TMS can provide a portal for accessing and altering
      neural dynamics in networks that are widely distributed anatomically. Finally,
      when long-term modulation of network dynamics is induced by trains of repetitive 
      TMS, changes in functional connectivity patterns can be studied in parallel with 
      changes in patient symptoms. These correlational data can elucidate neural
      mechanisms underlying illness and recovery. In this review, we focus on the
      application of these approaches to the study of psychiatric and neurological
      illnesses.
FAU - Hampson, M.
AU  - Hampson M
AD  - Department of Diagnostic Radiology, Yale University School of MedicineNew Haven, 
      CT, USA
FAU - Hoffman, R. E.
AU  - Hoffman RE
AD  - Department of Psychiatry, Yale University School of MedicineNew Haven, CT, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20100812
PHST- 2010/05/18 [received]
PHST- 2010/07/23 [accepted]
TA  - Front Syst Neurosci
JT  - Frontiers in Systems Neuroscience
AID - 10.3389/fnsys.2010.00040 [doi]
SO  - Front Syst Neurosci. 2010 Aug 12;4:. doi:10.3389/fnsys.2010.00040.

PMC - PMC3226920
PMID- 21807120
IS  - 1532-0464 (Print)
IS  - 1532-0480 (Electronic)
VI  - 44
IP  - 6
DP  - 2011 Dec
TI  - Scenario-based design: A method for connecting information system design with
      public health operations and emergency management.
PG  - 978-88
AB  - Responding to public health emergencies requires rapid and accurate assessment of
      workforce availability under adverse and changing circumstances. However, public 
      health information systems to support resource management during both routine and
      emergency operations are currently lacking. We applied scenario-based design as
      an approach to engage public health practitioners in the creation and validation 
      of an information design to support routine and emergency public health
      activities. Methods: Using semi-structured interviews we identified the
      information needs and activities of senior public health managers of a large
      municipal health department during routine and emergency operations. Results:
      Interview analysis identified twenty-five information needs for public health
      operations management. The identified information needs were used in conjunction 
      with scenario-based design to create twenty-five scenarios of use and a public
      health manager persona. Scenarios of use and persona were validated and modified 
      based on follow-up surveys with study participants. Scenarios were used to test
      and gain feedback on a pilot information system. Conclusion: The method of
      scenario-based design was applied to represent the resource management needs of
      senior-level public health managers under routine and disaster settings.
      Scenario-based design can be a useful tool for engaging public health
      practitioners in the design process and to validate an information system design.
FAU - Reeder, Blaine
AU  - Reeder B
AD  - Biobehavioral Nursing and Health Systems, School of Nursing, Box 359442,
      University of Washington, Seattle, WA 98195, USA
FAU - Turner, Anne M
AU  - Turner AM
AD  - Department of Health Services, School of Public Health, Box 354943, University of
      Washington, Seattle, WA 98195, USA
LA  - eng
PT  - Journal Article
DEP - 20110723
TA  - J Biomed Inform
JT  - Journal of biomedical informatics
AID - 10.1016/j.jbi.2011.07.004 [doi]
MID - NIHMS319613
SO  - J Biomed Inform. 2011 Dec;44(6):978-88. Epub 2011 Jul 23
      doi:10.1016/j.jbi.2011.07.004.

PMC - PMC4556825
PMID- 26328881
IS  - 1548-9213 (Print)
IS  - 1548-9221 (Electronic)
VI  - 30
IP  - 5
DP  - 2015 Sep
TI  - Motor System Reorganization After Stroke: Stimulating and Training Toward
      Perfection.
PG  - 358-70
AB  - Stroke instigates regenerative responses that reorganize connectivity patterns
      among surviving neurons. The new connectivity patterns can be suboptimal for
      behavioral function. This review summarizes current knowledge on post-stroke
      motor system reorganization and emerging strategies for shaping it with
      manipulations of behavior and cortical activity to improve functional outcome.
FAU - Jones, Theresa A.
AU  - Jones TA
AD  - Psychology Department, Neuroscience Institute, University of Texas at Austin,
      Austin, Texas; and
FAU - Adkins, DeAnna L.
AU  - Adkins DL
AD  - Neurosciences Department, and Health Sciences & Research Department, Colleges of 
      Medicine & Health Professions, Medical University of South Carolina, Charleston, 
      South Carolina
LA  - eng
PT  - Journal Article
PT  - Review
GR  - NS056839
TA  - Physiology (Bethesda)
JT  - Physiology
AID - Y-00014-2015 [pii]
AID - 10.1152/physiol.00014.2015 [doi]
SO  - Physiology (Bethesda). 2015 Sep;30(5):358-70. doi:10.1152/physiol.00014.2015.

PMC - PMC4327117
PMID- 25608213
IS  - 1424-8220 (Electronic)
VI  - 15
IP  - 1
DP  - 2015 Jan
TI  - A Survey of Online Activity Recognition Using Mobile Phones.
PG  - 2059-85
AB  - Physical activity recognition using embedded sensors has enabled many
      context-aware applications in different areas, such as healthcare. Initially, one
      or more dedicated wearable sensors were used for such applications. However,
      recently, many researchers started using mobile phones for this purpose, since
      these ubiquitous devices are equipped with various sensors, ranging from
      accelerometers to magnetic field sensors. In most of the current studies, sensor 
      data collected for activity recognition are analyzed offline using machine
      learning tools. However, there is now a trend towards implementing activity
      recognition systems on these devices in an online manner, since modern mobile
      phones have become more powerful in terms of available resources, such as CPU,
      memory and battery. The research on offline activity recognition has been
      reviewed in several earlier studies in detail. However, work done on online
      activity recognition is still in its infancy and is yet to be reviewed. In this
      paper, we review the studies done so far that implement activity recognition
      systems on mobile phones and use only their on-board sensors. We discuss various 
      aspects of these studies. Moreover, we discuss their limitations and present
      various recommendations for future research.
FAU - Shoaib, Muhammad
AU  - Shoaib M
AD  - Pervasive Systems Group, Department of Computer Science, Zilverling Building,
      PO-Box 217, 7500 AE Enschede, The Netherlands; E-Mails:
      stephan@inertia-technology.com (S.B.); hans.scholten@utwente.nl (H.S.);
      p.j.m.havinga@utwente.nl (P.J.M.H.)
FAU - Bosch, Stephan
AU  - Bosch S
AD  - Pervasive Systems Group, Department of Computer Science, Zilverling Building,
      PO-Box 217, 7500 AE Enschede, The Netherlands; E-Mails:
      stephan@inertia-technology.com (S.B.); hans.scholten@utwente.nl (H.S.);
      p.j.m.havinga@utwente.nl (P.J.M.H.)
FAU - Incel, Ozlem Durmaz
AU  - Incel OD
AD  - Department of Computer Engineering, Galatasaray University, Ortakoy, Istanbul
      34349, Turkey; E-Mail: odincel@gsu.edu.tr
FAU - Scholten, Hans
AU  - Scholten H
AD  - Pervasive Systems Group, Department of Computer Science, Zilverling Building,
      PO-Box 217, 7500 AE Enschede, The Netherlands; E-Mails:
      stephan@inertia-technology.com (S.B.); hans.scholten@utwente.nl (H.S.);
      p.j.m.havinga@utwente.nl (P.J.M.H.)
FAU - Havinga, Paul J.M.
AU  - Havinga PJ
AD  - Pervasive Systems Group, Department of Computer Science, Zilverling Building,
      PO-Box 217, 7500 AE Enschede, The Netherlands; E-Mails:
      stephan@inertia-technology.com (S.B.); hans.scholten@utwente.nl (H.S.);
      p.j.m.havinga@utwente.nl (P.J.M.H.)
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20150119
PHST- 2014/11/04 [received]
PHST- 2015/01/08 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s150102059 [doi]
AID - sensors-15-02059 [pii]
SO  - Sensors (Basel). 2015 Jan 19;15(1):2059-85. doi:10.3390/s150102059.

PMC - PMC4388933
PMID- 25855189
IS  - 0270-6474 (Print)
IS  - 1529-2401 (Electronic)
VI  - 35
IP  - 14
DP  - 2015 Apr 8
TI  - Mapping Synapses by Conjugate Light-Electron Array Tomography.
PG  - 5792-807
AB  - Synapses of the mammalian CNS are diverse in size, structure, molecular
      composition, and function. Synapses in their myriad variations are fundamental to
      neural circuit development, homeostasis, plasticity, and memory storage.
      Unfortunately, quantitative analysis and mapping of the brain's heterogeneous
      synapse populations has been limited by the lack of adequate single-synapse
      measurement methods. Electron microscopy (EM) is the definitive means to
      recognize and measure individual synaptic contacts, but EM has only limited
      abilities to measure the molecular composition of synapses. This report describes
      conjugate array tomography (AT), a volumetric imaging method that integrates
      immunofluorescence and EM imaging modalities in voxel-conjugate fashion. We
      illustrate the use of conjugate AT to advance the proteometric measurement of
      EM-validated single-synapse analysis in a study of mouse cortex.
FAU - Collman, Forrest
AU  - Collman F
AUID- ORCID: 0000-0002-0280-7022
AD  - Department of Molecular and Cellular Physiology, Stanford School of Medicine,
      Stanford University, Stanford California 94305,
FAU - Buchanan, JoAnn
AU  - Buchanan J
AD  - Department of Molecular and Cellular Physiology, Stanford School of Medicine,
      Stanford University, Stanford California 94305,
FAU - Phend, Kristen D.
AU  - Phend KD
AD  - Department of Cell Biology and Physiology, University of North Carolina School of
      Medicine, University of North Carolina, Chapel Hill, North Carolina 27599,
FAU - Micheva, Kristina D.
AU  - Micheva KD
AD  - Department of Molecular and Cellular Physiology, Stanford School of Medicine,
      Stanford University, Stanford California 94305,
FAU - Weinberg, Richard J.
AU  - Weinberg RJ
AD  - Department of Cell Biology and Physiology, University of North Carolina School of
      Medicine, University of North Carolina, Chapel Hill, North Carolina 27599,
FAU - Smith, Stephen J
AU  - Smith SJ
AD  - Department of Molecular and Cellular Physiology, Stanford School of Medicine,
      Stanford University, Stanford California 94305,
LA  - eng
PT  - Journal Article
PHST- 2014/10/14 [received]
PHST- 2015/01/21 [revised]
PHST- 2015/02/16 [accepted]
TA  - J Neurosci
JT  - The Journal of Neuroscience
AID - 4274-14 [pii]
AID - 10.1523/JNEUROSCI.4274-14.2015 [doi]
SO  - J Neurosci. 2015 Apr 8;35(14):5792-807. doi:10.1523/JNEUROSCI.4274-14.2015.

PMC - PMC5130227
PMID- 26469737
IS  - 1741-2560 (Print)
IS  - 1741-2552 (Electronic)
VI  - 12
IP  - 6
DP  - 2015 Dec
TI  - Local field potential recordings in a non-human primate model of Parkinsons
      disease using the Activa PC + S neurostimulator.
PG  - 066012
AB  - Objective: Using the Medtronic Activa® PC + S system, this study investigated how
      passive joint manipulation, reaching behavior, and deep brain stimulation (DBS)
      modulate local field potential (LFP) activity in the subthalamic nucleus (STN)
      and globus pallidus (GP). Approach: Five non-human primates were implanted
      unilaterally with one or more DBS leads. LFPs were collected in montage
      recordings during resting state conditions and during motor tasks that facilitate
      the expression of parkinsonian motor signs. These recordings were made in the
      naïve state in one subject, in the parkinsonian state in two subjects, and in
      both naïve and parkinsonian states in two subjects. Main results: LFPs measured
      at rest were consistent over time for a given recording location and parkinsonian
      state in a given subject; however, LFPs were highly variable between subjects,
      between and within recording locations, and across parkinsonian states. LFPs in
      both naïve and parkinsonian states across all recorded nuclei contained a
      spectral peak in the beta band (10–30 Hz). Moreover, the spectral content of
      recorded LFPs was modulated by passive and active movement of the subjects’
      limbs. LFPs recorded during a cued-reaching task displayed task-related beta
      desynchronization in STN and GP. The bidirectional capabilities of the Activa® PC
      + S also allowed for recording LFPs while delivering DBS. The therapeutic effect 
      of STN DBS on parkinsonian rigidity outlasted stimulation for 30–60 s, but there 
      was no correlation with beta band power. Significance: This study emphasizes (1) 
      the variability in spontaneous LFPs amongst subjects and (2) the value of using
      the Activa® PC + S system to record neural data in the context of behavioral
      tasks that allow one to evaluate a subject’s symptomatology.
FAU - Connolly, Allison T
AU  - Connolly AT
AD  - Department of Biomedical Engineering, University of Minnesota, USA
FAU - Muralidharan, Abirami
AU  - Muralidharan A
AD  - Department of Neurology, University of Minnesota, USA
FAU - Hendrix, Claudia
AU  - Hendrix C
AD  - Department of Neurology, University of Minnesota, USA
FAU - Johnson, Luke
AU  - Johnson L
AD  - Department of Neurology, University of Minnesota, USA
FAU - Gupta, Rahul
AU  - Gupta R
AD  - Global Research, Medtronic Neuromodulation, USA
FAU - Stanslaski, Scott
AU  - Stanslaski S
AD  - Core Technologies, Medtronic Neuromodulation, USA
FAU - Denison, Tim
AU  - Denison T
AD  - Core Technologies, Medtronic Neuromodulation, USA
FAU - Baker, Kenneth B
AU  - Baker KB
AD  - Department of Neurology, University of Minnesota, USA
FAU - Vitek, Jerrold L
AU  - Vitek JL
AD  - Department of Neurology, University of Minnesota, USA
FAU - Johnson, Matthew D
AU  - Johnson MD
AD  - Department of Biomedical Engineering, University of Minnesota, USA
LA  - eng
PT  - Journal Article
DEP - 20151015
TA  - J Neural Eng
JT  - Journal of neural engineering
AID - 10.1088/1741-2560/12/6/066012 [doi]
MID - NIHMS830233
SO  - J Neural Eng. 2015 Dec;12(6):066012. Epub 2015 Oct 15
      doi:10.1088/1741-2560/12/6/066012.

PMC - PMC1955743
PMID- 17355583
IS  - 0017-9124 (Print)
VI  - 42
IP  - 1 Pt 1
DP  - 2007 Feb
TI  - Clinical Practice Guideline Implementation Strategy Patterns in Veterans Affairs 
      Primary Care Clinics.
PG  - 84-103
AB  - Background: The Department of Veterans Affairs (VA) mandated the system-wide
      implementation of clinical practice guidelines (CPGs) in the mid-1990s, arming
      all facilities with basic resources to facilitate implementation; despite this
      resource allocation, significant variability still exists across VA facilities in
      implementation success. Objective: This study compares CPG implementation
      strategy patterns used by high and low performing primary care clinics in the VA.
      Research Design: Descriptive, cross-sectional study of a purposeful sample of six
      Veterans Affairs Medical Centers (VAMCs) with high and low performance on six
      CPGs. Subjects: One hundred and two employees (management, quality improvement,
      clinic personnel) involved with guideline implementation at each VAMC primary
      care clinic. Measures: Participants reported specific strategies used by their
      facility to implement guidelines in 1-hour semi-structured interviews. Facilities
      were classified as high or low performers based on their guideline adherence
      scores calculated through independently conducted chart reviews. Findings: High
      performing facilities (HPFs) (a) invested significantly in the implementation of 
      the electronic medical record and locally adapting it to provider needs, (b)
      invested dedicated resources to guideline-related initiatives, and (c) exhibited 
      a clear direction in their strategy choices. Low performing facilities exhibited 
      (a) earlier stages of development for their electronic medical record, (b)
      reliance on preexisting resources for guideline implementation, with little local
      adaptation, and (c) no clear direction in their strategy choices. Conclusion: A
      multifaceted, yet targeted, strategic approach to guideline implementation
      emphasizing dedicated resources and local adaptation may result in more
      successful implementation and higher guideline adherence than relying on
      standardized resources and taxing preexisting channels.
FAU - Hysong, Sylvia J
AU  - Hysong SJ
FAU - Best, Richard G
AU  - Best RG
FAU - Pugh, Jacqueline A
AU  - Pugh JA
LA  - eng
PT  - Journal Article
TA  - Health Serv Res
JT  - Health Services Research
AID - 10.1111/j.1475-6773.2006.00610.x [doi]
SO  - Health Serv Res. 2007 Feb;42(1 Pt 1):84-103.
      doi:10.1111/j.1475-6773.2006.00610.x.

PMC - PMC3925174
PMID- 24551193
IS  - 1932-6203 (Electronic)
VI  - 9
IP  - 2
DP  - 2014
TI  - Fast Dynamics of Cortical Functional and Effective Connectivity during Word
      Reading.
LID - e88940
AB  - We describe for the first time the fast dynamics of functional and effective
      (causal) connectivity during word reading. Independent component analysis of
      high-density EEG recorded during a word reading task recovered multiple sources
      of electrical brain activity previously identified by fMRI and PET. Results
      confirmed the ventral occipito-temporal cortex (vOT) as a central hub for word
      reading, showing a progression of theta-band (3–7 Hz) and gamma-band (30–50 Hz)
      phase synchronization and directed theta-band and gamma-band information flow
      with both early visual areas and high-level language-processing areas. These
      results highlight the interplay between local and long-distance neural dynamics
      involved at each stage of the reading process. Moreover, these measures of
      functional and causal connectivity dynamics may be used as a benchmark for
      comparison with clinical populations (e.g. individuals with developmental
      dyslexia), such that disturbances in connectivity dynamics may provide insight as
      to underlying neurological problems with language processing, and their potential
      remediation.
FAU - Bedo, Nicolas
AU  - Bedo N
AD  - Department of Psychology, University of British Columbia, Vancouver, British
      Columbia, Canada
FAU - Ribary, Urs
AU  - Ribary U
AD  - Behavioral and Cognitive Neuroscience Institute, Simon Fraser University,
      Burnaby, British Columbia, Canada
FAU - Ward, Lawrence M.
AU  - Ward LM
AD  - Department of Psychology, University of British Columbia, Vancouver, British
      Columbia, Canada
LA  - eng
PT  - Journal Article
DEP - 20140214
PHST- 2013/09/18 [received]
PHST- 2014/01/13 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-13-38565 [pii]
AID - 10.1371/journal.pone.0088940 [doi]
SO  - PLoS One. 2014 Feb 14;9(2):. doi:10.1371/journal.pone.0088940.

PMC - PMC4858848
IS  - 2047-2994 (Electronic)
VI  - 5
DP  - 2016
TI  - The 2014–2015 Ebola outbreak in West Africa: Hands On.
LID - 17
AB  - The International Consortium for Prevention and Infection Control (ICPIC)
      organises a biannual conference (ICPIC) on various subjects related to infection 
      prevention, treatment and control. During ICPIC 2015, held in Geneva in June
      2015, a full one-day session focused on the 2014–2015 Ebola virus disease (EVD)
      outbreak in West Africa. This article is a non-exhaustive compilation of these
      discussions. It concentrates on lessons learned and imagining a way forward for
      the communities most affected by the epidemic. The reader can access video
      recordings of all lectures delivered during this one-day session, as referenced. 
      Topics include the timeline of the international response, linkages between the
      dynamics of the epidemic and infection prevention and control, the importance of 
      community engagement, and updates on virology, diagnosis, treatment and
      vaccination issues. The paper also includes discussions from public health,
      infectious diseases, critical care and infection control experts who cared for
      patients with EVD in Africa, in Europe, and in the United Sates and were involved
      in Ebola preparedness in both high- and low-resource settings and countries. This
      review concludes that too little is known about the pathogenesis and treatment of
      EVD, therefore basic and applied research in this area are urgently required.
      Furthermore, it is clear that epidemic preparedness needs to improve globally, in
      particular through the strengthening of health systems at local and national
      levels. There is a strong need for culturally sensitive approaches to public
      health which could be designed and delivered by social scientists and medical
      professionals working together. As of December 2015, this epidemic killed more
      than 11,000 people and infected more than 28,000; it has also generated more than
      17,000 survivors and orphans, many of whom face somatic and psychological
      complications. The continued treatment and rehabilitation of these people is a
      public health priority, which also requires an integration of specific medical
      and social science approaches, not always available in West Africa.
FAU - Vetter, Pauline
AU  - Vetter P
AD  - Infection Control Programme and WHO Collaborating Centre on Patient Safety,
      University Hospitals and University of Geneva Medical School, Geneva, Switzerland
FAU - Dayer, Julie-Anne
AU  - Dayer JA
AD  - Division of Infectious Diseases, Laboratory of Virology and Swiss Reference
      Centre for Emerging Viral Diseases, University of Geneva Hospitals, Geneva,
      Switzerland
FAU - Schibler, Manuel
AU  - Schibler M
AD  - Division of Infectious Diseases, Laboratory of Virology and Swiss Reference
      Centre for Emerging Viral Diseases, University of Geneva Hospitals, Geneva,
      Switzerland
FAU - Allegranzi, Benedetta
AU  - Allegranzi B
AD  - World Health Organization, Geneva, Switzerland
FAU - Brown, Donal
AU  - Brown D
AD  - UK Department for International Development, London, UK
FAU - Calmy, Alexandra
AU  - Calmy A
AD  - HIV unit, Division of Infectious Diseases, University of Geneva Hospitals,
      Geneva, Switzerland
FAU - Christie, Derek
AU  - Christie D
AD  - Institute of Global Health, University of Geneva, Geneva, Switzerland
FAU - Eremin, Sergey
AU  - Eremin S
AD  - World Health Organization, Geneva, Switzerland
FAU - Hagon, Olivier
AU  - Hagon O
AD  - Division of Tropical and Humanitarian Medicine, Geneva University Hospitals,
      Geneva, Switzerland
FAU - Henderson, David
AU  - Henderson D
AD  - National Institutes of Health (NIH) Clinical Center, Washington DC, USA
FAU - Iten, Anne
AU  - Iten A
AD  - Infection Control Programme and WHO Collaborating Centre on Patient Safety,
      University Hospitals and University of Geneva Medical School, Geneva, Switzerland
FAU - Kelley, Edward
AU  - Kelley E
AD  - World Health Organization, Geneva, Switzerland
FAU - Marais, Frederick
AU  - Marais F
AD  - Western Cape Government and Stellenbosch University, Cape Town, South Africa
FAU - Ndoye, Babacar
AU  - Ndoye B
AD  - Expert-consultant and trainer in hospital hygiene, infection control and patient 
      safety for WHO and UNDP, Dakar, Senegal
FAU - Pugin, Jérôme
AU  - Pugin J
AD  - Intensive Care Unit, University of Geneva Hospitals, Geneva, Switzerland
FAU - Robert-Nicoud, Hugues
AU  - Robert-Nicoud H
AD  - Médecins sans Frontières, Geneva Operational Centre, Geneva, Switzerland
FAU - Sterk, Esther
AU  - Sterk E
AD  - Médecins sans Frontières, Geneva Operational Centre, Geneva, Switzerland
FAU - Tapper, Michael
AU  - Tapper M
AD  - Division of Infectious Diseases, Lenox Hill Hospital, New York, USA
FAU - Siegrist, Claire-Anne
AU  - Siegrist CA
AD  - Departments of Pathology, Immunology and Paediatrics, WHO Collaborating Centre
      for Vaccine Immunology, University of Geneva Hospitals, Geneva, Switzerland
FAU - Kaiser, Laurent
AU  - Kaiser L
AD  - Division of Infectious Diseases, Laboratory of Virology and Swiss Reference
      Centre for Emerging Viral Diseases, University of Geneva Hospitals, Geneva,
      Switzerland
FAU - Pittet, Didier
AU  - Pittet D
AD  - Infection Control Programme and WHO Collaborating Centre on Patient Safety,
      University Hospitals and University of Geneva Medical School, Geneva, Switzerland
LA  - eng
PT  - Journal Article
PT  - Case Report
DEP - 20160505
PHST- 2016/02/10 [received]
PHST- 2016/03/24 [accepted]
TA  - Antimicrob Resist Infect Control
JT  - Antimicrobial Resistance and Infection Control
AID - 112 [pii]
AID - 10.1186/s13756-016-0112-9 [doi]
SO  - Antimicrob Resist Infect Control. 2016 May 5;5:. doi:10.1186/s13756-016-0112-9.

PMC - PMC5491840
PMID- 28713251
IS  - 1662-5137 (Electronic)
VI  - 11
DP  - 2017
TI  - Age-related Changes in Lateral Entorhinal and CA3 Neuron Allocation Predict Poor 
      Performance on Object Discrimination.
LID - 49
AB  - Age-related memory deficits correlate with dysfunction in the CA3 subregion of
      the hippocampus, which includes both hyperactivity and overly rigid activity
      patterns. While changes in intrinsic membrane currents and interneuron
      alterations are involved in this process, it is not known whether alterations in 
      afferent input to CA3 also contribute. Neurons in layer II of the lateral
      entorhinal cortex (LEC) project directly to CA3 through the perforant path, but
      no data are available regarding the effects of advanced age on LEC activity and
      whether these activity patterns update in response to environmental change.
      Furthermore, it is not known the extent to which age-related deficits in sensory 
      discrimination relate to the inability of aged CA3 neurons to update in response 
      to new environments. Young and aged rats were pre-characterized on a LEGO© object
      discrimination task, comparable to behavioral tests in humans in which CA3
      hyperactivity has been linked to impairments. The cellular compartment analysis
      of temporal activity with fluorescence in situ hybridization for the
      immediate-early gene Arc was then used to identify the principal cell populations
      that were active during two distinct epochs of random foraging in different
      environments. This approach enabled the extent to which rats could discriminate
      two similar objects to be related to the ability of CA3 neurons to update across 
      different environments. In both young and aged rats, there were animals that
      performed poorly on the LEGO object discrimination task. In the aged rats only,
      however, the poor performers had a higher percent of CA3 neurons that were active
      during random foraging in a novel environment, but this is not related to the
      ability of CA3 neurons to remap when the environment changed. Afferent neurons to
      CA3 in LEC, as identified with the retrograde tracer choleratoxin B (CTB), also
      showed a higher percentage of cells that were positive for Arc mRNA in aged poor 
      performing rats. This suggests that LEC contributes to the hyperactivity seen in 
      CA3 of aged animals with object discrimination deficits and age-related cognitive
      decline may be the consequence of dysfunction endemic to the larger network.
FAU - Maurer, Andrew P.
AU  - Maurer AP
AD  - Department of Neuroscience, McKnight Brain Institute, University of
      FloridaGainesville, FL, United States
FAU - Johnson, Sarah A.
AU  - Johnson SA
AD  - Department of Neuroscience, McKnight Brain Institute, University of
      FloridaGainesville, FL, United States
FAU - Hernandez, Abbi R.
AU  - Hernandez AR
AD  - Department of Neuroscience, McKnight Brain Institute, University of
      FloridaGainesville, FL, United States
FAU - Reasor, Jordan
AU  - Reasor J
AD  - Department of Neuroscience, McKnight Brain Institute, University of
      FloridaGainesville, FL, United States
FAU - Cossio, Daniela M.
AU  - Cossio DM
AD  - Department of Neuroscience, McKnight Brain Institute, University of
      FloridaGainesville, FL, United States
FAU - Fertal, Kaeli E.
AU  - Fertal KE
AD  - Department of Neuroscience, McKnight Brain Institute, University of
      FloridaGainesville, FL, United States
FAU - Mizell, Jack M.
AU  - Mizell JM
AD  - Department of Neuroscience, McKnight Brain Institute, University of
      FloridaGainesville, FL, United States
FAU - Lubke, Katelyn N.
AU  - Lubke KN
AD  - Department of Neuroscience, McKnight Brain Institute, University of
      FloridaGainesville, FL, United States
FAU - Clark, Benjamin J.
AU  - Clark BJ
AD  - Department of Psychology, University of New MexicoAlburquerque, NM, United States
FAU - Burke, Sara N.
AU  - Burke SN
AD  - Department of Neuroscience, McKnight Brain Institute, University of
      FloridaGainesville, FL, United States
LA  - eng
PT  - Journal Article
DEP - 20170630
GR  - R01AG049722
PHST- 2017/03/30 [received]
PHST- 2017/06/19 [accepted]
TA  - Front Syst Neurosci
JT  - Frontiers in Systems Neuroscience
AID - 10.3389/fnsys.2017.00049 [doi]
SO  - Front Syst Neurosci. 2017 Jun 30;11:. doi:10.3389/fnsys.2017.00049.

PMC - PMC4732145
PMID- 26797610
IS  - 1424-8220 (Electronic)
VI  - 16
IP  - 1
DP  - 2016 Jan
TI  - A Time-Aware Routing Map for Indoor Evacuation †.
LID - 112
AB  - Knowledge of dynamic environments expires over time. Thus, using static maps of
      the environment for decision making is problematic, especially in emergency
      situations, such as evacuations. This paper suggests a fading memory model for
      mapping dynamic environments: a mechanism to put less trust on older knowledge in
      decision making. The model has been assessed by simulating indoor evacuations,
      adopting and comparing various strategies in decision making. Results suggest
      that fading memory generally improves this decision making.
FAU - Zhao, Haifeng
AU  - Zhao H
FAU - Winter, Stephan
AU  - Winter S
LA  - eng
PT  - Journal Article
DEP - 20160118
PHST- 2015/09/30 [received]
PHST- 2016/01/13 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s16010112 [doi]
AID - sensors-16-00112 [pii]
SO  - Sensors (Basel). 2016 Jan 18;16(1):. doi:10.3390/s16010112.

PMC - PMC2464864
PMID- 17142614
IS  - 1475-3898 (Print)
IS  - 1475-3901 (Electronic)
VI  - 15
IP  - Suppl 1
DP  - 2006 Dec
TI  - Why did that happen? Exploring the proliferation of barely usable software in
      healthcare systems.
PG  - i76-81
AB  - Clinicians and support staff are faced with increasingly complex computer
      applications. This complexity stems partly from the integration of heterogeneous 
      systems ranging from computerized patient records to theatre management and
      dosage planning applications, and also from the increased functionality offered
      by the new generation of IT systems. Many members of clinical staff are
      bewildered by the vast array of configuration options and operating modes
      supported by computer based systems, while manufacturers often feel compelled to 
      offer more and more software features to retain market position. These factors
      combine to create “usability” problems that have had a direct impact on patient
      outcomes as well as a number of indirect effects—for example, the costs of
      replacing and upgrading inadequate computer systems carry significant opportunity
      costs in terms of services that might otherwise have been funded. In the future
      we need to educate staff to reject substandard computer interfaces early in the
      acquisition process; encourage the use of human computer interaction techniques
      in health care; and train staff to recognize the dangers of “working around” poor
      interface design.
FAU - Johnson, C W
AU  - Johnson CW
LA  - eng
PT  - Journal Article
PT  - Review
PHST- 2006/08/10 [accepted]
TA  - Qual Saf Health Care
JT  - Quality & Safety in Health Care
AID - qc16105 [pii]
AID - 10.1136/qshc.2005.016105 [doi]
SO  - Qual Saf Health Care. 2006 Dec;15(Suppl 1):i76-81. doi:10.1136/qshc.2005.016105.

PMC - PMC3464450
PMID- 23060684
IS  - 0268-7038 (Print)
IS  - 1464-5041 (Electronic)
VI  - 26
IP  - 9
DP  - 2012 Sep
TI  - Can tDCS enhance treatment of aphasia after stroke?
PG  - 1169-91
AB  - Background: Recent advances in the application of transcranial direct current
      stimulation (tDCS) in healthy populations have led to the exploration of the
      technique as an adjuvant method to traditional speech therapies in patients with 
      post-stroke aphasia. Aims: The purpose of the review is: (i) to review the
      features of tDCS that make it an attractive tool for research and potential
      future use in clinical contexts; (ii) to describe recent studies exploring the
      facilitation of language performance using tDCS in post-stroke aphasia; (iii) to 
      explore methodological considerations of tDCS that may be key to understanding
      tDCS in treatment of aphasia post stroke; and (iv) to highlight several caveats
      and outstanding questions that need to be addressed in future work. Main
      Contribution: This review aims to highlight our current understanding of the
      methodological and theoretical issues surrounding the use of tDCS as an adjuvant 
      tool in the treatment of language difficulties after stroke. Conclusions:
      Preliminary evidence shows that tDCS may be a useful tool to complement treatment
      of aphasia, particularly for speech production in chronic stroke patients. To
      build on this exciting work, further systematic research is needed to understand 
      the mechanisms of tDCS-induced effects, its application to current models of
      aphasia recovery, and the complex interactions between different stimulation
      parameters and language rehabilitation techniques. The potential of tDCS is to
      optimise language rehabilitation techniques and promote long-term recovery of
      language. A stimulating future for aphasia rehabilitation!
FAU - Holland, Rachel
AU  - Holland R
AD  - Institute of Cognitive Neuroscience, University College London, London, UK
FAU - Crinion, Jenny
AU  - Crinion J
AD  - Institute of Cognitive Neuroscience, University College London, London, UK
LA  - eng
PT  - Journal Article
DEP - 20111103
TA  - Aphasiology
JT  - Aphasiology
AID - 10.1080/02687038.2011.616925 [doi]
SO  - Aphasiology. 2012 Sep;26(9):1169-91. Epub 2011 Nov 3
      doi:10.1080/02687038.2011.616925.

PMC - PMC4472032
PMID- 26106260
IS  - 1177-2719 (Electronic)
VI  - 10
IP  - Suppl 1
DP  - 2015
TI  - Synthetic Extracellular Microenvironment for Modulating Stem Cell Behaviors.
PG  - 105-16
AB  - The innate ability of stem cells to self-renew and differentiate into multiple
      cell types makes them a promising source for tissue engineering and regenerative 
      medicine applications. Their capacity for self-renewal and differentiation is
      largely influenced by the combination of physical, chemical, and biological
      signals found in the stem cell niche, both temporally and spatially. Embryonic
      and adult stem cells are potentially useful for cell-based approaches; however,
      regulating stem cell behavior remains a major challenge in their clinical use.
      Most of the current approaches for controlling stem cell fate do not fully
      address all of the complex signaling pathways that drive stem cell behaviors in
      their natural microenvironments. To overcome this limitation, a new generation of
      biomaterials is being developed for use as three-dimensional synthetic
      microenvironments that can mimic the regulatory characteristics of natural
      extracellular matrix (ECM) proteins and ECM-bound growth factors. These synthetic
      microenvironments are currently being investigated as a substrate with surface
      immobilization and controlled release of bioactive molecules to direct the stem
      cell fate in vitro, as a tissue template to guide and improve the neo-tissue
      formation both in vitro and in vivo, and as a delivery vehicle for cell therapy
      in vivo. The continued advancement of such an intelligent biomaterial system as
      the synthetic extracellular microenvironment holds the promise of improved
      therapies for numerous debilitating medical conditions for which no satisfactory 
      cure exists today.
FAU - Chandra, Prafulla
AU  - Chandra P
FAU - Lee, Sang Jin
AU  - Lee SJ
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20150617
PHST- 2015/02/04 [received]
PHST- 2015/04/12 [revised]
PHST- 2015/04/13 [accepted]
TA  - Biomark Insights
JT  - Biomarker Insights
AID - 10.4137/BMI.S20057 [doi]
AID - bmi-suppl.1-2015-105 [pii]
SO  - Biomark Insights. 2015 Jun 17;10(Suppl 1):105-16. doi:10.4137/BMI.S20057.

PMC - PMC5028010
PMID- 27522077
IS  - 1047-3211 (Print)
IS  - 1460-2199 (Electronic)
VI  - 26
IP  - 10
DP  - 2016 Oct
TI  - Phase Dependency of the Human Primary Motor Cortex and Cholinergic Inhibition
      Cancelation During Beta tACS.
PG  - 3977-90
AB  - The human motor cortex has a tendency to resonant activity at about 20 Hz so
      stimulation should more readily entrain neuronal populations at this frequency.
      We investigated whether and how different interneuronal circuits contribute to
      such resonance by using transcranial magnetic stimulation (TMS) during
      transcranial alternating current stimulation (tACS) at motor (20 Hz) and a
      nonmotor resonance frequency (7 Hz). We tested different TMS interneuronal
      protocols and triggered TMS pulses at different tACS phases. The effect of
      cholinergic short-latency afferent inhibition (SAI) was abolished by 20 Hz tACS, 
      linking cortical beta activity to sensorimotor integration. However, this effect 
      occurred regardless of the tACS phase. In contrast, 20 Hz tACS selectively
      modulated MEP size according to the phase of tACS during single pulse, GABAAergic
      short-interval intracortical inhibition (SICI) and glutamatergic intracortical
      facilitation (ICF). For SICI this phase effect was more marked during 20 Hz
      stimulation. Phase modulation of SICI also depended on whether or not spontaneous
      beta activity occurred at ~20 Hz, supporting an interaction effect between tACS
      and underlying circuit resonances. The present study provides in vivo evidence
      linking cortical beta activity to sensorimotor integration, and for beta
      oscillations in motor cortex being promoted by resonance in GABAAergic
      interneuronal circuits.
FAU - Guerra, Andrea
AU  - Guerra A
AD  - Unit of Neurology, Neurophysiology, Neurobiology, Department of Medicine,
      University Campus Bio-Medico, 00128 Rome, Italy
FAU - Pogosyan, Alek
AU  - Pogosyan A
AD  - Medical Research Council Brain Network Dynamics Unit, Nuffield Department of
      Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK
FAU - Nowak, Magdalena
AU  - Nowak M
AD  - Medical Research Council Brain Network Dynamics Unit, Nuffield Department of
      Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK
FAU - Tan, Huiling
AU  - Tan H
AD  - Medical Research Council Brain Network Dynamics Unit, Nuffield Department of
      Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK
FAU - Ferreri, Florinda
AU  - Ferreri F
AD  - Unit of Neurology, Neurophysiology, Neurobiology, Department of Medicine,
      University Campus Bio-Medico, 00128 Rome, Italy
FAU - Di Lazzaro, Vincenzo
AU  - Di Lazzaro V
AD  - Unit of Neurology, Neurophysiology, Neurobiology, Department of Medicine,
      University Campus Bio-Medico, 00128 Rome, Italy
FAU - Brown, Peter
AU  - Brown P
AD  - Medical Research Council Brain Network Dynamics Unit, Nuffield Department of
      Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK
LA  - eng
PT  - Journal Article
DEP - 20160919
PHST- 2016/07/16 [received]
PHST- 2016/06/14 [revised]
PHST- 2016/07/13 [accepted]
PHST- 2016/09/19 [aheadofprint]
TA  - Cereb Cortex
JT  - Cerebral Cortex (New York, NY)
AID - 10.1093/cercor/bhw245 [doi]
AID - bhw245 [pii]
SO  - Cereb Cortex. 2016 Oct;26(10):3977-90. Epub 2016 Sep 19
      doi:10.1093/cercor/bhw245.

PMC - PMC4154143
PMID- 20358364
IS  - 0033-3158 (Print)
IS  - 1432-2072 (Electronic)
VI  - 210
IP  - 1
DP  - 2010 May
TI  - REINFORCING EFFECTS OF NICOTINE AND NON-NICOTINE COMPONENTS OF CIGARETTE SMOKE.
PG  - 1-12
AB  - We assessed the reinforcing effects of nicotine and non-nicotine components of
      cigarette smoke, by presenting a concurrent choice paradigm in which participants
      had access to intravenous (IV) nicotine infusions vs. saline (placebo) infusions 
      and puffs from denicotinized (“denic”) cigarettes vs. air (sham puffs). We also
      measured the effects on self-administration of prior satiation with each
      component. Sixteen smokers participated in 7 sessions, consisting of: 1) a
      baseline smoking assessment, which was used to tailor the nicotine dose per
      infusion to that of puffs from subjects’ preferred brands of cigarettes; 2) two
      sessions in which participants were trained to discriminate IV nicotine vs.
      saline infusions and denic smoke vs. sham (air) puffs; and 3) four sessions
      assessing choice behavior after different satiation conditions. Results showed
      that subjects self-administered more puffs of denic smoke than any other
      alternative, including IV nicotine. IV nicotine, however, was preferred over IV
      saline and sham puffs. Preference for denic smoke vs. IV nicotine was highly
      correlated with subjective ratings of “comfort” associated with the two
      alternatives. Satiation with smoke diminished the number of denic puffs taken
      during choice periods, while prior administration of nicotine did not affect the 
      number of puffs taken. Smoking withdrawal symptoms were alleviated both by
      nicotine administration and by denic smoke. These results show that in
      established smokers, non-nicotine aspects of cigarette smoking have potent
      reinforcing effects. While current smoking cessation pharmacotherapies primarily 
      address the nicotine component of cigarette addiction, future cessation
      strategies should also be designed to target non-nicotine factors.
FAU - Rose, Jed E.
AU  - Rose JE
AD  - Department of Psychiatry, Duke University Medical Center, Durham, NC USA
FAU - Salley, Al
AU  - Salley A
AD  - Department of Psychiatry, Duke University Medical Center, Durham, NC USA
FAU - Behm, Frederique M.
AU  - Behm FM
AD  - Department of Psychiatry, Duke University Medical Center, Durham, NC USA
FAU - Bates, James E.
AU  - Bates JE
AD  - Department of Psychiatry, Duke University Medical Center, Durham, NC USA
FAU - Westman, Eric C.
AU  - Westman EC
AD  - Department of Medicine, Duke University Medical Center, Durham, NC USA
LA  - eng
PT  - Journal Article
DEP - 20100401
TA  - Psychopharmacology (Berl)
JT  - Psychopharmacology
AID - 10.1007/s00213-010-1810-2 [doi]
MID - NIHMS621050
SO  - Psychopharmacology (Berl). 2010 May;210(1):1-12. Epub 2010 Apr 01
      doi:10.1007/s00213-010-1810-2.

PMC - PMC3299198
PMID- 20381530
IS  - 0165-0270 (Print)
IS  - 1872-678X (Electronic)
VI  - 189
IP  - 2
DP  - 2010 Jun 15
TI  - Visual inspection of independent components: Defining a procedure for artifact
      removal from fMRI data.
PG  - 233-45
AB  - Artifacts in fMRI data, primarily those related to motion and physiological
      sources, negatively impact the functional signal-to-noise ratio in fMRI studies, 
      even after conventional fMRI preprocessing. Independent component analysis’
      demonstrated capacity to separate sources of neural signal, structured noise, and
      random noise into separate components might be utilized in improved procedures to
      remove artifacts from fMRI data. Such procedures require a method for labeling
      independent components (ICs) as representing artifacts to be removed or neural
      signals of interest to be spared. Visual inspection is often considered an
      accurate method for such labeling as well as a standard to which automated
      labeling methods are compared. However, detailed descriptions of methods for
      visual inspection of ICs are lacking in the literature. Here we describe the
      details of, and the rationale for, an operationalized fMRI data denoising
      procedure that involves visual inspection of ICs (96% inter-rater agreement). We 
      estimate that dozens of subjects/sessions can be processed within a few hours
      using the described method of visual inspection. Our hope is that continued
      scientific discussion of and testing of visual inspection methods will lead to
      the development of improved, cost-effective fMRI denoising procedures.
FAU - Kelly, Robert E.
AU  - Kelly RE
AD  - Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College
FAU - Alexopoulos, George S.
AU  - Alexopoulos GS
AD  - Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College
FAU - Wang, Zhishun
AU  - Wang Z
AD  - The MRI Unit and The Division of Child and Adolescent Psychiatry, Columbia
      University and New York State Psychiatric Institute (NYSPI), New York, New York
FAU - Gunning, Faith M.
AU  - Gunning FM
AD  - Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College
FAU - Murphy, Christopher F.
AU  - Murphy CF
AD  - Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College
FAU - Morimoto, Sarah Shizuko
AU  - Morimoto SS
AD  - Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College
FAU - Kanellopoulos, Dora
AU  - Kanellopoulos D
AD  - Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College
FAU - Jia, Zhiru
AU  - Jia Z
AD  - Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College
FAU - Lim, Kelvin O.
AU  - Lim KO
AD  - Department of Psychiatry, University of Minnesota
FAU - Hoptman, Matthew J.
AU  - Hoptman MJ
AD  - Division of Clinical Research, Nathan S. Kline Institute for Psychiatric Research
LA  - eng
PT  - Journal Article
DEP - 20100408
TA  - J Neurosci Methods
JT  - Journal of Neuroscience Methods
AID - 10.1016/j.jneumeth.2010.03.028 [doi]
MID - NIHMS194291
SO  - J Neurosci Methods. 2010 Jun 15;189(2):233-45. Epub 2010 Apr 8
      doi:10.1016/j.jneumeth.2010.03.028.

PMC - PMC4710558
PMID- 26720746
IS  - 1069-6563 (Print)
IS  - 1553-2712 (Electronic)
VI  - 23
IP  - 1
DP  - 2016 Jan
TI  - Monte Carlo Simulation Modeling of a Regional Stroke Team’s Use of Telemedicine.
PG  - 55-62
AB  - Objectives: The objective of this study was to evaluate operational policies that
      may improve the proportion of eligible stroke patients within a population who
      would receive intravenous recombinant tissue plasminogen activator (rt-PA), and
      minimize time to treatment in eligible patients. Methods: In the context of a
      regional stroke team, the authors examined the effects of staff location and
      telemedicine deployment policies on the timeliness of thrombolytic treatment, and
      estimated the efficacy and cost-effectiveness of six different policies. A
      process map comprising the steps from recognition of stroke symptoms to
      intravenous administration of rt-PA was constructed using data from published
      literature combined with expert opinion. Six scenarios were investigated:
      telemedicine deployment (none, all, or outer-ring hospitals only); and, staff
      location (center of region or anywhere in region). Physician locations were
      randomly generated based on their zip codes of residence and work. The outcomes
      of interest were onset-to-treatment (OTT) time, door-to-needle (DTN) time, and
      the proportion of patients treated within three hours. A Monte Carlo simulation
      of the stroke team care-delivery system was constructed based on a primary
      dataset of 121 ischemic stroke patients who were potentially eligible for
      treatment with rt-PA. Results: With the physician located randomly in the region,
      deploying telemedicine at all hospitals in the region (compared with partial or
      no telemedicine) would result in the highest rates of treatment within three
      hours (80% vs. 75% vs. 70%) and the shortest OTT (148 vs. 164 vs. 176 minutes),
      and DTN (45 vs. 61 vs. 73 minutes) times. However, locating the on-call physician
      centrally coupled with partial telemedicine deployment (five of the 17 hospitals)
      would be most cost-effective with comparable eligibility and treatment times.
      Conclusions: Given the potential societal benefits, continued efforts to deploy
      telemedicine appear warranted. Aligning the incentives between those who would
      have to fund the up-front technology investments and those who will benefit over 
      time from reduced ongoing health care expenses will be necessary to fully realize
      the benefits of telemedicine for stroke care.
FAU - Torabi, Elham
AU  - Torabi E
FAU - Froehle, Craig M.
AU  - Froehle CM
FAU - Lindsell, Chris J.
AU  - Lindsell CJ
FAU - Moomaw, Charles J.
AU  - Moomaw CJ
FAU - Kanter, Daniel
AU  - Kanter D
FAU - Kleindorfer, Dawn
AU  - Kleindorfer D
FAU - Adeoye, Opeolu
AU  - Adeoye O
LA  - eng
PT  - Journal Article
DEP - 20151231
TA  - Acad Emerg Med
JT  - Academic emergency medicine : official journal of the Society for Academic
      Emergency Medicine
AID - 10.1111/acem.12839 [doi]
MID - NIHMS735497
SO  - Acad Emerg Med. 2016 Jan;23(1):55-62. Epub 2015 Dec 31 doi:10.1111/acem.12839.

PMC - PMC4803679
PMID- 26951279
IS  - 0884-8734 (Print)
IS  - 1525-1497 (Electronic)
VI  - 31
IP  - Suppl 1
DP  - 2016 Apr
TI  - Opportunities to Enhance Value-Related Research in the U.S. Department of
      Veterans Affairs.
PG  - 78-83
FAU - Wagner, Todd H.
AU  - Wagner TH
AD  - Health Economics Resource Center, VA Palo Alto, 795 Willow Rd, 152-MPD, Menlo
      Park, CA 94025 USA
FAU - Burstin, Helen
AU  - Burstin H
AD  - grid.422331.50000000094192138National Quality Forum, Washington, DC USA
FAU - Frakt, Austin B.
AU  - Frakt AB
AD  - grid.410370.10000000446571992Health Care Financing & Economics, VA Boston Health 
      Care System, Boston, MA USA
FAU - Krein, Sarah L.
AU  - Krein SL
AD  - VA Ann Arbor Center for Clinical Management Research, Ann Arbor, MI USA
FAU - Lorenz, Karl
AU  - Lorenz K
AD  - Center for Innovation to Implementation, Palo Alto VA, Menlo Park, CA USA
FAU - Maciejewski, Matthew L.
AU  - Maciejewski ML
AD  - grid.410332.70000000404199846Center for Innovation, Durham VA Medical Center,
      Durham, NC USA
FAU - Pizer, Steven D.
AU  - Pizer SD
AD  - grid.410370.10000000446571992Health Care Financing & Economics, VA Boston Health 
      Care System, Boston, MA USA
FAU - Weiner, Michael
AU  - Weiner M
AD  - VA Center for Health Information and Communication, Indianapolis, IN USA
FAU - Yoon, Jean
AU  - Yoon J
AD  - Health Economics Resource Center, VA Palo Alto, 795 Willow Rd, 152-MPD, Menlo
      Park, CA 94025 USA
FAU - Zulman, Donna M.
AU  - Zulman DM
AD  - Center for Innovation to Implementation, Palo Alto VA, Menlo Park, CA USA
FAU - Asch, Steven M.
AU  - Asch SM
AD  - Center for Innovation to Implementation, Palo Alto VA, Menlo Park, CA USA
LA  - eng
PT  - Journal Article
DEP - 20160307
TA  - J Gen Intern Med
JT  - Journal of General Internal Medicine
AID - 3538 [pii]
AID - 10.1007/s11606-015-3538-5 [doi]
SO  - J Gen Intern Med. 2016 Apr;31(Suppl 1):78-83. Epub 2016 Mar 7
      doi:10.1007/s11606-015-3538-5.

PMC - PMC3825002
PMID- 23340916
IS  - 0161-9152 (Print)
IS  - 1574-4647 (Electronic)
VI  - 35
IP  - 6
DP  - 2013 Dec
TI  - Voluntary exercise can strengthen the circadian system in aged mice.
PG  - 2137-52
AB  - Consistent daily rhythms are important to healthy aging according to studies
      linking disrupted circadian rhythms with negative health impacts. We studied the 
      effects of age and exercise on baseline circadian rhythms and on the circadian
      system's ability to respond to the perturbation induced by an 8 h advance of the 
      light:dark (LD) cycle as a test of the system's robustness. Mice (male,
      mPer2luc/C57BL/6) were studied at one of two ages: 3.5 months (n = 39) and
      >18 months (n = 72). We examined activity records of these mice under entrained
      and shifted conditions as well as mPER2::LUC measures ex vivo to assess circadian
      function in the suprachiasmatic nuclei (SCN) and important target organs. Age was
      associated with reduced running wheel use, fragmentation of activity, and slowed 
      resetting in both behavioral and molecular measures. Furthermore, we observed
      that for aged mice, the presence of a running wheel altered the amplitude of the 
      spontaneous firing rate rhythm in the SCN in vitro. Following a shift of the LD
      cycle, both young and aged mice showed a change in rhythmicity properties of the 
      mPER2::LUC oscillation of the SCN in vitro, and aged mice exhibited longer
      lasting internal desynchrony. Access to a running wheel alleviated some
      age-related changes in the circadian system. In an additional experiment, we
      replicated the effect of the running wheel, comparing behavioral and in vitro
      results from aged mice housed with or without a running wheel (>21 months, n = 8 
      per group, all examined 4 days after the shift). The impact of voluntary exercise
      on circadian rhythm properties in an aged animal is a novel finding and has
      implications for the health of older people living with environmentally induced
      circadian disruption.Electronic supplementary material: The online version of
      this article (doi:10.1007/s11357-012-9502-y) contains supplementary material,
      which is available to authorized users.
FAU - Leise, T. L.
AU  - Leise TL
AD  - Mathematics Department, Amherst College, Amherst, MA 01002 USA
FAU - Harrington, M. E.
AU  - Harrington ME
AD  - Neuroscience Program, Smith College, Northampton, MA 01063 USA
FAU - Molyneux, P. C.
AU  - Molyneux PC
AD  - Neuroscience Program, Smith College, Northampton, MA 01063 USA
FAU - Song, I.
AU  - Song I
AD  - Neuroscience Program, Smith College, Northampton, MA 01063 USA
FAU - Queenan, H.
AU  - Queenan H
AD  - Neuroscience Program, Smith College, Northampton, MA 01063 USA
FAU - Zimmerman, E.
AU  - Zimmerman E
AD  - Neuroscience Program, Smith College, Northampton, MA 01063 USA
FAU - Lall, G. S.
AU  - Lall GS
AD  - Medway School of Pharmacy, University of Kent, Central Avenue, Chatham, Kent, ME4
      4TB UK
FAU - Biello, S. M.
AU  - Biello SM
AD  - School of Psychology, University of Glasgow, Glasgow, G12 8QB Scotland UK
LA  - eng
PT  - Journal Article
DEP - 20130123
PHST- 2012/07/02 [received]
PHST- 2012/12/05 [accepted]
TA  - Age (Dordr)
JT  - Age
AID - 9502 [pii]
AID - 10.1007/s11357-012-9502-y [doi]
SO  - Age (Dordr). 2013 Dec;35(6):2137-52. Epub 2013 Jan 23
      doi:10.1007/s11357-012-9502-y.

PMC - PMC5136731
PMID- 27995127
IS  - 2296-875X (Electronic)
VI  - 3
DP  - 2016
TI  - Stereotactic Laser Ablation for Medically Intractable Epilepsy: The Next
      Generation of Minimally Invasive Epilepsy Surgery.
LID - 64
AB  - Epilepsy is a common, disabling illness that is refractory to medical treatment
      in approximately one-third of patients, particularly among those with mesial
      temporal lobe epilepsy. While standard open mesial temporal resection is
      effective, achieving seizure freedom in most patients, efforts to develop safer, 
      minimally invasive techniques have been underway for over half a century.
      Stereotactic ablative techniques, in particular, radiofrequency (RF) ablation,
      were first developed in the 1960s, with refinements in the 1990s with the advent 
      of modern computed tomography and magnetic resonance-based imaging. In the past
      5 years, the most recent techniques have used MRI-guided laser interstitial
      thermotherapy (LITT), the development of which began in the 1980s, saw
      refinements in MRI thermal imaging through the 1990s, and was initially used
      primarily for the treatment of intracranial and extracranial tumors. The present 
      review describes the original stereotactic ablation trials, followed by modern
      imaging-guided RF ablation series for mesial temporal lobe epilepsy. The
      developments of LITT and MRI thermometry are then discussed. Finally, the two
      currently available MRI-guided LITT systems are reviewed for their role in the
      treatment of mesial temporal lobe and other medically refractory epilepsies.
FAU - LaRiviere, Michael J.
AU  - LaRiviere MJ
AD  - Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA,
      USA
FAU - Gross, Robert E.
AU  - Gross RE
AD  - Departments of Neurosurgery and Neurology, Emory University School of Medicine,
      Atlanta, GA, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20161205
PHST- 2016/10/06 [received]
PHST- 2016/11/21 [accepted]
TA  - Front Surg
JT  - Frontiers in Surgery
AID - 10.3389/fsurg.2016.00064 [doi]
SO  - Front Surg. 2016 Dec 05;3:. doi:10.3389/fsurg.2016.00064.

PMC - PMC3437545
PMID- 21973003
IS  - 0014-0139 (Print)
IS  - 1366-5847 (Electronic)
VI  - 54
IP  - 10
DP  - 2011 Oct
TI  - The effects of focused attention training (FOCAL) on the duration of novice
      drivers' glances inside the vehicle.
PG  - 917-31
AB  - Several studies have documented that the failure of drivers to attend to the
      forward roadway for a period lasting longer than 2-3 seconds is a major cause of 
      highway crashes. Moreover, several studies have demonstrated that novice drivers 
      are more likely to glance away from the roadway than experienced drivers for
      extended periods when attempting to do a task inside the vehicle. The present
      study examines the efficacy of a PC-based training program (FOCAL) designed to
      teach novice drivers not to glance away for these extended periods of time. A
      FOCAL-trained group was compared to a placebo-trained group in an on-road test,
      and the FOCAL-trained group made significantly fewer glances away from the
      roadway that were more than 2 seconds than the placebo-trained group. Other
      measures indicated an advantage for the FOCAL-trained group as well.
FAU - Pradhan, A.K.
AU  - Pradhan A
AD  - Department of Mechanical and Industrial Engineering, University of Massachusetts,
      Elab 110, Amherst MA 01003, USA
FAU - Divekar, G.
AU  - Divekar G
AD  - Department of Mechanical and Industrial Engineering, University of Massachusetts,
      Elab 110, Amherst MA 01003, USA
FAU - Masserang, K.
AU  - Masserang K
AD  - Department of Psychology, University of Massachusetts, Tobin Hall, Amherst MA
      01003, USA
FAU - Romoser, M.
AU  - Romoser M
AD  - Department of Mechanical and Industrial Engineering, University of Massachusetts,
      Elab 110, Amherst MA 01003, USA
FAU - Zafian, T.
AU  - Zafian T
AD  - Department of Mechanical and Industrial Engineering, University of Massachusetts,
      Elab 110, Amherst MA 01003, USA
FAU - Blomberg, R.D.
AU  - Blomberg R
AD  - Dunlap and Associates, Inc, Stamford, CT 06906, USA
FAU - Thomas, F.D.
AU  - Thomas F
AD  - Dunlap and Associates, Inc, Stamford, CT 06906, USA
FAU - Reagan, I.
AU  - Reagan I
AD  - National Highway Traffic Safety Administration, 1200 New Jersey Ave., SE.
      Washington, DC., 20590
FAU - Knodler, M.
AU  - Knodler M
AD  - Department of Civil and Environmental Engineering, University of Massachusetts,
      216 Marston Hall, Amherst MA 01003, USA
FAU - Pollatsek, A.
AU  - Pollatsek A
AD  - Department of Psychology, University of Massachusetts, Tobin Hall, Amherst MA
      01003, USA
FAU - Fisher, D.L.
AU  - Fisher D
AD  - Department of Mechanical and Industrial Engineering, University of Massachusetts,
      210D Marston Hall, Amherst MA 01003, USA
LA  - eng
PT  - Journal Article
TA  - Ergonomics
JT  - Ergonomics
AID - 10.1080/00140139.2011.607245 [doi]
MID - NIHMS333401
SO  - Ergonomics. 2011 Oct;54(10):917-31. doi:10.1080/00140139.2011.607245.

PMC - PMC5423772
PMID- 28483040
IS  - 2050-084X (Electronic)
VI  - 6
DP  - 2017
TI  - The age of Homo naledi and associated sediments in the Rising Star Cave,
      South Africa.
LID - e24231
AB  - New ages for flowstone, sediments and fossil bones from the Dinaledi Chamber are 
      presented. We combined optically stimulated luminescence dating of sediments with
      U-Th and palaeomagnetic analyses of flowstones to establish that all sediments
      containing Homo naledi fossils can be allocated to a single stratigraphic entity 
      (sub-unit 3b), interpreted to be deposited between 236 ka and 414 ka. This result
      has been confirmed independently by dating three H. naledi teeth with combined
      U-series and electron spin resonance (US-ESR) dating. Two dating scenarios for
      the fossils were tested by varying the assumed levels of 222Rn loss in the
      encasing sediments: a maximum age scenario provides an average age for the two
      least altered fossil teeth of 253 +82/–70 ka, whilst a minimum age scenario
      yields an average age of 200 +70/–61 ka. We consider the maximum age scenario to 
      more closely reflect conditions in the cave, and therefore, the true age of the
      fossils. By combining the US-ESR maximum age estimate obtained from the teeth,
      with the U-Th age for the oldest flowstone overlying Homo naledi fossils, we have
      constrained the depositional age of Homo naledi to a period between 236 ka and
      335 ka. These age results demonstrate that a morphologically primitive hominin,
      Homo naledi, survived into the later parts of the Pleistocene in Africa, and
      indicate a much younger age for the Homo naledi fossils than have previously been
      hypothesized based on their
      morphology.DOI:http://dx.doi.org/10.7554/eLife.24231.001
OAB - Publisher: Abstract available from the publisher.
FAU - Dirks, Paul HGM
AU  - Dirks PH
AUID- ORCID: 0000-0002-1582-1405
AD  - Department of Geoscience, James Cook University, Townsville, Australia
FAU - Roberts, Eric M
AU  - Roberts EM
AD  - Department of Geoscience, James Cook University, Townsville, Australia
FAU - Hilbert-Wolf, Hannah
AU  - Hilbert-Wolf H
AD  - Department of Geoscience, James Cook University, Townsville, Australia
FAU - Kramers, Jan D
AU  - Kramers JD
AD  - Department of Geology, University of Johannesburg, Johannesburg, South Africa
FAU - Hawks, John
AU  - Hawks J
AD  - Evolutionary Studies Institute and the National Centre for Excellence in
      PalaeoSciences, University of the Witwatersrand, Wits, South Africa
FAU - Dosseto, Anthony
AU  - Dosseto A
AD  - School of Earth and Environmental Sciences, University of Wollongong, Wollongong,
      Australia
FAU - Duval, Mathieu
AU  - Duval M
AD  - Australian Research Centre for Human Evolution, Environmental Futures Research
      Institute, Griffith University, Nathan, Australia
FAU - Elliott, Marina
AU  - Elliott M
AD  - Evolutionary Studies Institute and the National Centre for Excellence in
      PalaeoSciences, University of the Witwatersrand, Wits, South Africa
FAU - Evans, Mary
AU  - Evans M
AD  - School of Geosciences, University of the Witwatersrand, Wits, South Africa
FAU - Grün, Rainer
AU  - Grün R
AD  - Australian Research Centre for Human Evolution, Environmental Futures Research
      Institute, Griffith University, Nathan, Australia
FAU - Hellstrom, John
AU  - Hellstrom J
AD  - School of Earth Sciences, The University of Melbourne, Parkville, Australia
FAU - Herries, Andy IR
AU  - Herries AI
AD  - The Australian Archaeomagnetism Laboratory, Department of Archaeology and
      History, La Trobe University, Melbourne, Australia
FAU - Joannes-Boyau, Renaud
AU  - Joannes-Boyau R
AUID- ORCID: 0000-0002-0452-486X
AD  - Geoarchaeology and Archaeometry Research Group, Department of GeoScience,
      Southern Cross University, Lismore, Australia
FAU - Makhubela, Tebogo V
AU  - Makhubela TV
AD  - Department of Geology, University of Johannesburg, Johannesburg, South Africa
FAU - Placzek, Christa J
AU  - Placzek CJ
AD  - Department of Geoscience, James Cook University, Townsville, Australia
FAU - Robbins, Jessie
AU  - Robbins J
AD  - Department of Geoscience, James Cook University, Townsville, Australia
FAU - Spandler, Carl
AU  - Spandler C
AD  - Department of Geoscience, James Cook University, Townsville, Australia
FAU - Wiersma, Jelle
AU  - Wiersma J
AD  - Department of Geoscience, James Cook University, Townsville, Australia
FAU - Woodhead, Jon
AU  - Woodhead J
AD  - School of Earth Sciences, The University of Melbourne, Parkville, Australia
FAU - Berger, Lee R
AU  - Berger LR
AUID- ORCID: 0000-0002-0367-7629
AD  - Evolutionary Studies Institute and the National Centre for Excellence in
      PalaeoSciences, University of the Witwatersrand, Wits, South Africa
LA  - eng
PT  - Journal Article
GR  - DP140104282
PHST- 2016/12/13 [received]
PHST- 2017/04/25 [accepted]
TA  - eLife
JT  - eLife
AID - 24231 [pii]
AID - 10.7554/eLife.24231 [doi]
SO  - eLife. 2017;6:. doi:10.7554/eLife.24231.

PMC - PMC4354349
PMID- 25756808
IS  - 2158-3188 (Electronic)
VI  - 5
IP  - 3
DP  - 2015 Mar
TI  - Lack of parvalbumin in mice leads to behavioral deficits relevant to all human
      autism core symptoms and related neural morphofunctional abnormalities.
PG  - e525-
AB  - Gene mutations and gene copy number variants are associated with autism spectrum 
      disorders (ASDs). Affected gene products are often part of signaling networks
      implicated in synapse formation and/or function leading to alterations in the
      excitation/inhibition (E/I) balance. Although the network of parvalbumin
      (PV)-expressing interneurons has gained particular attention in ASD, little is
      known on PV's putative role with respect to ASD. Genetic mouse models represent
      powerful translational tools for studying the role of genetic and neurobiological
      factors underlying ASD. Here, we report that PV knockout mice (PV−/−) display
      behavioral phenotypes with relevance to all three core symptoms present in human 
      ASD patients: abnormal reciprocal social interactions, impairments in
      communication and repetitive and stereotyped patterns of behavior. PV-depleted
      mice also showed several signs of ASD-associated comorbidities, such as reduced
      pain sensitivity and startle responses yet increased seizure susceptibility,
      whereas no evidence for behavioral phenotypes with relevance to anxiety,
      depression and schizophrenia was obtained. Reduced social interactions and
      communication were also observed in heterozygous (PV+/−) mice characterized by
      lower PV expression levels, indicating that merely a decrease in PV levels might 
      be sufficient to elicit core ASD-like deficits. Structural magnetic resonance
      imaging measurements in PV−/− and PV+/− mice further revealed ASD-associated
      developmental neuroanatomical changes, including transient cortical hypertrophy
      and cerebellar hypoplasia. Electrophysiological experiments finally demonstrated 
      that the E/I balance in these mice is altered by modification of both inhibitory 
      and excitatory synaptic transmission. On the basis of the reported changes in PV 
      expression patterns in several, mostly genetic rodent models of ASD, we propose
      that in these models downregulation of PV might represent one of the points of
      convergence, thus providing a common link between apparently unrelated
      ASD-associated synapse structure/function phenotypes.
FAU - Wöhr, M
AU  - Wöhr M
AD  - Department of Behavioral Neuroscience, Faculty of Psychology, Philipps-University
      of Marburg, Marburg, Germany
FAU - Orduz, D
AU  - Orduz D
AD  - Laboratory of Neurophysiology, ULB Neuroscience Institute (UNI), Université Libre
      de Bruxelles (ULB), Brussels, Belgium
FAU - Gregory, P
AU  - Gregory P
AD  - Anatomy Unit, Department of Medicine, University of Fribourg, Fribourg,
      Switzerland
FAU - Moreno, H
AU  - Moreno H
AD  - Department of Neurology, SUNY Downstate Medical Center, The Robert F Furchgott
      Center for Neural and Behavioral Science, Brooklyn, NY, USA
FAU - Khan, U
AU  - Khan U
AD  - Department of Neurology, SUNY Downstate Medical Center, The Robert F Furchgott
      Center for Neural and Behavioral Science, Brooklyn, NY, USA
FAU - Vörckel, K J
AU  - Vörckel KJ
AD  - Department of Behavioral Neuroscience, Faculty of Psychology, Philipps-University
      of Marburg, Marburg, Germany
FAU - Wolfer, D P
AU  - Wolfer DP
AD  - Institute of Anatomy, Faculty of Medicine, University of Zürich, Zürich,
      Switzerland
FAU - Welzl, H
AU  - Welzl H
AD  - Institute of Anatomy, Faculty of Medicine, University of Zürich, Zürich,
      Switzerland
FAU - Gall, D
AU  - Gall D
AD  - Laboratory of Neurophysiology, ULB Neuroscience Institute (UNI), Université Libre
      de Bruxelles (ULB), Brussels, Belgium
FAU - Schiffmann, S N
AU  - Schiffmann SN
AD  - Laboratory of Neurophysiology, ULB Neuroscience Institute (UNI), Université Libre
      de Bruxelles (ULB), Brussels, Belgium
FAU - Schwaller, B
AU  - Schwaller B
AD  - Anatomy Unit, Department of Medicine, University of Fribourg, Fribourg,
      Switzerland
LA  - eng
PT  - Journal Article
DEP - 20150310
PHST- 2014/01/21 [received]
PHST- 2014/12/29 [revised]
PHST- 2015/01/12 [accepted]
PHST- 2015/03/10 [aheadofprint]
TA  - Transl Psychiatry
JT  - Translational Psychiatry
AID - tp201519 [pii]
AID - 10.1038/tp.2015.19 [doi]
SO  - Transl Psychiatry. 2015 Mar;5(3):e525-. Epub 2015 Mar 10 doi:10.1038/tp.2015.19.

PMC - PMC3419303
PMID- 22575858
IS  - 0169-409X (Print)
IS  - 1872-8294 (Electronic)
VI  - 64
IP  - 14
DP  - 2012 Nov
TI  - Microneedles for drug and vaccine delivery.
PG  - 1547-68
AB  - Microneedles were first conceptualized for drug delivery many decades ago, but
      only became the subject of significant research starting in the mid-1990’s when
      microfabrication technology enabled their manufacture as (i) solid microneedles
      for skin pretreatment to increase skin permeability, (ii) microneedles coated
      with drug that dissolves off in the skin, (iii) polymer microneedles that
      encapsulate drug and fully dissolve in the skin and (iv) hollow microneedles for 
      drug infusion into the skin. As shown in more than 350 papers now published in
      the field, microneedles have been used to deliver a broad range of different low 
      molecular weight drugs, biotherapeutics and vaccines, including published human
      studies with a number of small-molecule and protein drugs and vaccines. Influenza
      vaccination using a hollow microneedle is in widespread clinical use and a number
      of solid microneedle products are sold for cosmetic purposes. In addition to
      applications in the skin, microneedles have also been adapted for delivery of
      bioactives into the eye and into cells. Successful application of microneedles
      depends on device function that facilitates microneedle insertion and possible
      infusion into skin, skin recovery after microneedle removal, and drug stability
      during manufacturing, storage and delivery, and on patient outcomes, including
      lack of pain, skin irritation and skin infection, in addition to drug efficacy
      and safety. Building off a strong technology base and multiple demonstrations of 
      successful drug delivery, microneedles are poised to advance further into
      clinical practice to enable better pharmaceutical therapies, vaccination and
      other applications.
FAU - Kim, Yeu-Chun
AU  - Kim YC
AD  - Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of 
      Science and Technology (KAIST), Daejeon, Republic of Korea
FAU - Park, Jung-Hwan
AU  - Park JH
AD  - Department of BioNano Technology and Gachon BioNano Research Institute, Gachon
      University, Seongnam, Gyeonggi-Do, Republic of Korea
FAU - Prausnitz, Mark R.
AU  - Prausnitz MR
AD  - School of Chemical and Biomolecular Engineering, Georgia Institute of Technology,
      Atlanta, GA 30332 USA
LA  - eng
PT  - Journal Article
DEP - 20120501
GR  - U01 EB012495 || EB
TA  - Adv Drug Deliv Rev
JT  - Advanced drug delivery reviews
AID - 10.1016/j.addr.2012.04.005 [doi]
MID - NIHMS374493
SO  - Adv Drug Deliv Rev. 2012 Nov;64(14):1547-68. Epub 2012 May 01
      doi:10.1016/j.addr.2012.04.005.

PMC - PMC3522982
PMID- 23202229
IS  - 1424-8220 (Electronic)
VI  - 12
IP  - 11
DP  - 2012
TI  - The Swipe Card Model of Odorant Recognition.
PG  - 15709-49
AB  - Just how we discriminate between the different odours we encounter is not
      completely understood yet. While obviously a matter involving biology, the core
      issue is a matter for physics: what microscopic interactions enable the receptors
      in our noses-small protein switches—to distinguish scent molecules? We survey
      what is and is not known about the physical processes that take place when we
      smell things, highlighting the difficulties in developing a full understanding of
      the mechanics of odorant recognition. The main current theories, discussed here, 
      fall into two major groups. One class emphasises the scent molecule's shape, and 
      is described informally as a “lock and key” mechanism. But there is another
      category, which we focus on and which we call “swipe card” theories: the
      molecular shape must be good enough, but the information that identifies the
      smell involves other factors. One clearly-defined “swipe card” mechanism that we 
      discuss here is Turin's theory, in which inelastic electron tunnelling is used to
      discern olfactant vibration frequencies. This theory is explicitly quantal, since
      it requires the molecular vibrations to take in or give out energy only in
      discrete quanta. These ideas lead to obvious experimental tests and challenges.
      We describe the current theory in a form that takes into account molecular shape 
      as well as olfactant vibrations. It emerges that this theory can explain many
      observations hard to reconcile in other ways. There are still some important gaps
      in a comprehensive physics-based description of the central steps in odorant
      recognition. We also discuss how far these ideas carry over to analogous
      processes involving other small biomolecules, like hormones, steroids and
      neurotransmitters. We conclude with a discussion of possible quantum behaviours
      in biology more generally, the case of olfaction being just one example. This
      paper is presented in honour of Prof. Marshall Stoneham who passed away
      unexpectedly during its writing.
FAU - Brookes, Jennifer C.
AU  - Brookes JC
AD  - Department of Chemistry and Chemical Biology, Harvard University, Oxford Street, 
      Cambridge, MA 02138, USA
FAU - Horsfield, Andrew P.
AU  - Horsfield AP
AD  - Department of Materials, Imperial College London, South Kensington Campus, London
      SW7 2AZ, UK
FAU - Stoneham, A. Marshall
AU  - Stoneham AM
AD  - London Centre for Nanotechnology, 17-19 Gordon Street, London WC1H 0AH, UK;
      E-Mail: a.stoneham@ucl.ac.uk
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20121112
PHST- 2012/08/31 [received]
PHST- 2012/10/31 [revised]
PHST- 2012/11/02 [accepted]
TA  - Sensors (Basel)
JT  - Sensors (Basel, Switzerland)
AID - 10.3390/s121115709 [doi]
AID - sensors-12-15709 [pii]
SO  - Sensors (Basel). 2012 Nov 12;12(11):15709-49. doi:10.3390/s121115709.

PMC - PMC3886682
PMID- 18929146
IS  - 0093-7754 (Print)
IS  - 1532-8708 (Electronic)
VI  - 35
IP  - 5
DP  - 2008 Oct
TI  - Tomorrow’s Cancer Treatments Today: The First 50 Years of the Cancer and Leukemia
      Group B.
LID - 10.1053/j.seminoncol.2008.07.002
AB  - Members of the Cancer and Leukemia Group B have been striving to improve cancer
      therapies for more than 50 years. The organization began in the mid 1950s as a
      multi-institutional collaboration between investigators at the National Cancer
      Institute, Roswell Park Memorial Institute, and the Children’s Hospital in
      Buffalo New York. In 1956 it was officially designated as the Acute Leukemia
      Group B (ALGB) and for most of its first decade focused largely on leukemia
      research. Reflecting an expansion of its research portfolio during the 1960s and 
      70s, the name was changed in 1976 to Cancer and Leukemia Group B (CALGB).
      Currently the organization has hundreds of members including nurses, clinical
      research associates, statisticians, physicians, translational scientists, and an 
      administrative staff from a nationwide network of academic and community based
      organizations and medical practices. Disease areas within the scope of CALGB
      research include hematologic malignancies, as well as breast, gastro-intestinal, 
      genito-urinary, and respiratory cancers. Modality expertise includes quality of
      life, medical oncology, surgery, radiation oncology, pathology, imaging, oncology
      nursing, health outcomes, geriatrics, biostatistics, data management, and an
      extensive array of correlative sciences. Some of the major accomplishments of
      CALGB investigators and the patients participating in CALGB research as critical 
      and committed partners will be reviewed in this manuscript.
FAU - Green, Mark R.
AU  - Green MR
AD  - Medical University of South Carolina, Charleston, South Carolina
FAU - George, Stephen L.
AU  - George SL
AD  - CALGB Statistical Center, Duke University Medical Center, Durham, North Carolina
FAU - Schilsky, Richard L.
AU  - Schilsky RL
AD  - Cancer and Leukemia Group B, Central Office of the Chairman and University of
      Chicago, Chicago, Illinois
CN  - Cancer and Leukemia Group B
LA  - eng
PT  - Journal Article
GR  - U10 CA033601 || CA
TA  - Semin Oncol
JT  - Seminars in oncology
AID - 10.1053/j.seminoncol.2008.07.002 [doi]
MID - NIHMS73610
SO  - Semin Oncol. 2008 Oct;35(5):. doi:10.1053/j.seminoncol.2008.07.002.

PMC - PMC4146289
PMID- 25206786
IS  - 1673-5374 (Print)
IS  - 1876-7958 (Electronic)
VI  - 9
IP  - 12
DP  - 2014 Jun 15
TI  - Diffuse axonal injury after traumatic cerebral microbleeds: an evaluation of
      imaging techniques.
PG  - 1222-30
AB  - Previous neuropathological studies regarding traumatic brain injury have
      primarily focused on changes in large structures, for example, the clinical
      prognosis after cerebral contusion, intracerebral hematoma, and epidural and
      subdural hematoma. In fact, many smaller injuries can also lead to severe
      neurological disorders. For example, cerebral microbleeds result in the
      dysfunction of adjacent neurons and the disassociation between cortex and
      subcortical structures. These tiny changes cannot be adequately visualized on CT 
      or conventional MRI. In contrast, gradient echo sequence-based
      susceptibility-weighted imaging is very sensitive to blood metabolites and
      microbleeds, and can be used to evaluate traumatic cerebral microbleeds with high
      sensitivity and accuracy. Cerebral microbleed can be considered as an important
      imaging marker for diffuse axonal injury with potential relevance for prognosis. 
      For this reason, based on experimental and clinical studies, this study reviews
      the role of imaging data showing traumatic cerebral microbleeds in the evaluation
      of cerebral neuronal injury and neurofunctional loss.
FAU - Liu, Jun
AU  - Liu J
AD  - Department of Radiology, Second Xiangya Hospital, Central South University,
      Changsha, Hunan Province, China
FAU - Kou, Zhifeng
AU  - Kou Z
AD  - Department of Biomedical Engineering and Radiology, School of Medicine, Wayne
      State University, 3990 John R St, Detroit, MI, USA
FAU - Tian, Yongquan
AU  - Tian Y
AD  - School of Public Administration, Central South University, Changsha, Hunan
      Province, China
LA  - eng
PT  - Journal Article
PT  - Review
PHST- 2014/04/01 [accepted]
TA  - Neural Regen Res
JT  - Neural Regeneration Research
AID - NRR-9-1222 [pii]
AID - 10.4103/1673-5374.135330 [doi]
SO  - Neural Regen Res. 2014 Jun 15;9(12):1222-30. doi:10.4103/1673-5374.135330.

PMC - PMC2630513
PMID- 18706928
IS  - 0165-0270 (Print)
VI  - 174
IP  - 2
DP  - 2008 Sep 30
TI  - A flexible software tool for temporally-precise behavioral control in Matlab.
PG  - 245-58
AB  - Systems and cognitive neuroscience depend on carefully designed and precisely
      implemented behavioral tasks to elicit the neural phenomena of interest. To
      facilitate this process, we have developed a software system that allows for the 
      straightforward coding and temporally-reliable execution of these tasks in
      Matlab. We find that, in most cases, millisecond accuracy is attainable, and
      those instances in which it is not are usually related to predictable, programmed
      events. In this report, we describe the design of our system, benchmark its
      performance in a real-world setting, and describe some key features.
FAU - Asaad, Wael F.
AU  - Asaad WF
AD  - Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, 02114,
      USA
FAU - Eskandar, Emad N.
AU  - Eskandar EN
AD  - Program in Neuroscience, Harvard Medical School, Boston, MA, 02115, USA
LA  - eng
PT  - Journal Article
DEP - 20080725
TA  - J Neurosci Methods
JT  - Journal of neuroscience methods
MID - NIHMS71283
AID - 10.1016/j.jneumeth.2008.07.014 [doi]
SO  - J Neurosci Methods. 2008 Sep 30;174(2):245-58. Epub 2008 Jul 25
      doi:10.1016/j.jneumeth.2008.07.014.

PMC - PMC4649015
PMID- 26635516
IS  - 1662-4548 (Print)
IS  - 1662-453X (Electronic)
VI  - 9
DP  - 2015
TI  - Non-invasive Central and Peripheral Stimulation: New Hope for Essential Tremor?
LID - 440
AB  - Essential tremor (ET) is among the most frequent movement disorders. It usually
      manifests as a postural and kinematic tremor of the arms, but may also involve
      the head, voice, lower limbs, and trunk. An oscillatory network has been proposed
      as a neural correlate of ET, and is mainly composed of the olivocerebellar
      system, thalamus, and motor cortex. Since pharmacological agents have limited
      benefits, surgical interventions like deep brain stimulation are the last-line
      treatment options for the most severe cases. Non-invasive brain stimulation
      techniques, particularly transcranial magnetic or direct current stimulation, are
      used to ameliorate ET. Their non-invasiveness, along with their side effects
      profile, makes them an appealing treatment option. In addition, peripheral
      stimulation has been applied in the same perspective. Hence, the aim of the
      present review is to shed light on the emergent use of non-invasive central and
      peripheral stimulation techniques in this interesting context.
FAU - Chalah, Moussa A.
AU  - Chalah MA
AD  - EA 4391, Excitabilité Nerveuse et Thérapeutique, Université
      Paris-Est-CréteilCréteil, France
FAU - Lefaucheur, Jean-Pascal
AU  - Lefaucheur JP
AD  - EA 4391, Excitabilité Nerveuse et Thérapeutique, Université
      Paris-Est-CréteilCréteil, France
FAU - Ayache, Samar S.
AU  - Ayache SS
AD  - EA 4391, Excitabilité Nerveuse et Thérapeutique, Université
      Paris-Est-CréteilCréteil, France
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20151118
PHST- 2015/07/17 [received]
PHST- 2015/11/01 [accepted]
TA  - Front Neurosci
JT  - Frontiers in Neuroscience
AID - 10.3389/fnins.2015.00440 [doi]
SO  - Front Neurosci. 2015 Nov 18;9:. doi:10.3389/fnins.2015.00440.

PMC - PMC4854300
PMID- 27158228
IS  - 1179-5972 (Electronic)
VI  - 7
IP  - Suppl 1
DP  - 2016
TI  - Fluorescent Cell Imaging in Regenerative Medicine.
PG  - 29-33
AB  - Fluorescent protein imaging, a promising tool in biological research,
      incorporates numerous applications that can be of specific use in the field of
      regenerative medicine. To enhance tissue regeneration efforts, scientists have
      been developing new ways to monitor tissue development and maturation in vitro
      and in vivo. To that end, new imaging tools and novel fluorescent proteins have
      been developed for the purpose of performing deep-tissue high-resolution imaging.
      These new methods, such as intra-vital microscopy and Förster resonance energy
      transfer, are providing new insights into cellular behavior, including cell
      migration, morphology, and phenotypic changes in a dynamic environment. Such
      applications, combined with multimodal imaging, significantly expand the utility 
      of fluorescent protein imaging in research and clinical applications of
      regenerative medicine.
FAU - Sapoznik, Etai
AU  - Sapoznik E
AD  - Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA.
FAU - Niu, Guoguang
AU  - Niu G
AD  - Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA.
FAU - Zhou, Yu
AU  - Zhou Y
AD  - Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA.
FAU - Murphy, Sean V.
AU  - Murphy SV
AD  - Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA.
FAU - Soker, Shay
AU  - Soker S
AD  - Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20160502
PHST- 2016/02/15 [received]
PHST- 2016/04/03 [accepted]
PHST- 2016/04/05 [revised]
TA  - Biomed Eng Comput Biol
JT  - Biomedical Engineering and Computational Biology
AID - 10.4137/BECB.S39045 [doi]
AID - becb-suppl.1-2016-029 [pii]
SO  - Biomed Eng Comput Biol. 2016 May 02;7(Suppl 1):29-33. doi:10.4137/BECB.S39045.

PMC - PMC3793904
PMID- 24018288
IS  - 1741-2560 (Print)
IS  - 1741-2552 (Electronic)
VI  - 10
IP  - 5
DP  - 2013 Oct
TI  - Burst suppression probability algorithms: state-space methods for tracking EEG
      burst suppression.
PG  - 056017
AB  - Objective: Burst suppression is an electroencephalogram pattern in which bursts
      of electrical activity alternate with an isoelectric state. This pattern is
      commonly seen in states of severely reduced brain activity such as profound
      general anesthesia, anoxic brain injuries, hypothermia and certain developmental 
      disorders. Devising accurate, reliable ways to quantify burst suppression is an
      important clinical and research problem. Although thresholding and segmentation
      algorithms readily identify burst suppression periods, analysis algorithms
      require long intervals of data to characterize burst suppression at a given time 
      and provide no framework for statistical inference. Approach: We introduce the
      concept of the burst suppression probability (BSP) to define the brain’s
      instantaneous propensity of being in the suppressed state. To conduct dynamic
      analyses of burst suppression we propose a state-space model in which the
      observation process is a binomial model and the state equation is a Gaussian
      random walk. We estimate the model using an approximate expectation maximization 
      algorithm and illustrate its application in the analysis of rodent burst
      suppression recordings under general anesthesia and a patient during induction of
      controlled hypothermia. Main result: The BSP algorithms track burst suppression
      on a second-to-second time scale, and make possible formal statistical
      comparisons of burst suppression at different times. Significance: The
      state-space approach suggests a principled and informative way to analyze burst
      suppression that can be used to monitor, and eventually to control, the brain
      states of patients in the operating room and in the intensive care unit.
FAU - Chemali, Jessica
AU  - Chemali J
AD  - Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General 
      Hospital, Boston, MA, USA
FAU - Ching, ShiNung
AU  - Ching S
AD  - Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General 
      Hospital, Boston, MA, USA
FAU - Purdon, Patrick L
AU  - Purdon PL
AD  - Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General 
      Hospital, Boston, MA, USA
FAU - Solt, Ken
AU  - Solt K
AD  - Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General 
      Hospital, Boston, MA, USA
FAU - Brown, Emery N
AU  - Brown EN
AD  - Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General 
      Hospital, Boston, MA, USA
LA  - eng
PT  - Journal Article
DEP - 20130910
GR  - DP1 OD003646 || OD
TA  - J Neural Eng
JT  - Journal of neural engineering
AID - 10.1088/1741-2560/10/5/056017 [doi]
MID - NIHMS523716
SO  - J Neural Eng. 2013 Oct;10(5):056017. Epub 2013 Sep 10
      doi:10.1088/1741-2560/10/5/056017.

PMC - PMC3563342
PMID- 22414771
IS  - 1047-3211 (Print)
IS  - 1460-2199 (Electronic)
VI  - 23
IP  - 3
DP  - 2013 Mar
TI  - Ependymal Ciliary Dysfunction and Reactive Astrocytosis in a Reorganized
      Subventricular Zone after Stroke.
PG  - 647-59
AB  - Subventricular zone (SVZ) astrocytes and ependymal cells are both derived from
      radial glia and may have similar gliotic reactions after stroke. Diminishing SVZ 
      neurogenesis worsens outcomes in mice, yet the effects of stroke on SVZ
      astrocytes and ependymal cells are poorly understood. We used mouse experimental 
      stroke to determine if SVZ astrocytes and ependymal cells assume similar
      phenotypes and if stroke impacts their functions. Using lateral ventricular wall 
      whole mount preparations, we show that stroke caused SVZ reactive astrocytosis,
      disrupting the neuroblast migratory scaffold. Also, SVZ vascular density and
      neural proliferation increased but apoptosis did not. In contrast to other
      reports, ependymal denudation and cell division was never observed. Remarkably,
      however, ependymal cells assumed features of reactive astrocytes post stroke,
      robustly expressing de novo glial fibrillary acidic protein, enlargening and
      extending long processes. Unexpectedly, stroke disrupted motile cilia planar cell
      polarity in ependymal cells. This suggested ciliary function was affected and
      indeed ventricular surface flow was slower and more turbulent post stroke.
      Together, these results demonstrate that in response to stroke there is
      significant SVZ reorganization with implications for both pathophysiology and
      therapeutic strategies.
FAU - Young, Christopher C.
AU  - Young CC
AD  - Department of Physiology, Anatomy and Genetics
FAU - van der Harg, Judith M.
AU  - van der Harg JM
AD  - Department of Physiology, Anatomy and Genetics
FAU - Lewis, Nicola J.
AU  - Lewis NJ
AD  - Department of Physiology, Anatomy and Genetics
FAU - Brooks, Keith J.
AU  - Brooks KJ
AD  - Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX13QX, UK
FAU - Buchan, Alastair M.
AU  - Buchan AM
AD  - Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX13QX, UK
FAU - Szele, Francis G.
AU  - Szele FG
AD  - Department of Physiology, Anatomy and Genetics
LA  - eng
PT  - Journal Article
DEP - 20120313
PHST- 2012/03/13 [aheadofprint]
TA  - Cereb Cortex
JT  - Cerebral Cortex (New York, NY)
AID - 10.1093/cercor/bhs049 [doi]
SO  - Cereb Cortex. 2013 Mar;23(3):647-59. Epub 2012 Mar 13 doi:10.1093/cercor/bhs049.

PMC - PMC2637847
PMID- 19114017
IS  - 1097-6647 (Print)
IS  - 1532-429X (Electronic)
VI  - 10
IP  - 1
DP  - 2008
TI  - Interventional cardiovascular magnetic resonance: still tantalizing.
PG  - 62
AB  - The often touted advantages of MR guidance remain largely unrealized for
      cardiovascular interventional procedures in patients. Many procedures have been
      simulated in animal models. We argue these opportunities for clinical
      interventional MR will be met in the near future. This paper reviews technical
      and clinical considerations and offers advice on how to implement a
      clinical-grade interventional cardiovascular MR (iCMR) laboratory. We caution
      that this reflects our personal view of the "state of the art."
FAU - Ratnayaka, Kanishka
AU  - Ratnayaka K
AD  - Translational Medicine Branch, Division of Intramural Research, National Heart
      Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA
FAU - Faranesh, Anthony Z
AU  - Faranesh AZ
AD  - Translational Medicine Branch, Division of Intramural Research, National Heart
      Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA
FAU - Guttman, Michael A
AU  - Guttman MA
AD  - Translational Medicine Branch, Division of Intramural Research, National Heart
      Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA
FAU - Kocaturk, Ozgur
AU  - Kocaturk O
AD  - Translational Medicine Branch, Division of Intramural Research, National Heart
      Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA
FAU - Saikus, Christina E
AU  - Saikus CE
AD  - Translational Medicine Branch, Division of Intramural Research, National Heart
      Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA
FAU - Lederman, Robert J
AU  - Lederman RJ
AD  - Translational Medicine Branch, Division of Intramural Research, National Heart
      Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20081229
PHST- 2008/09/09 [received]
PHST- 2008/12/29 [accepted]
TA  - J Cardiovasc Magn Reson
JT  - Journal of Cardiovascular Magnetic Resonance
AID - 1532-429X-10-62 [pii]
AID - 10.1186/1532-429X-10-62 [doi]
SO  - J Cardiovasc Magn Reson. 2008 Dec 29;10(1):62. doi:10.1186/1532-429X-10-62.

PMC - PMC4293328
PMID- 25377280
IS  - 0894-1491 (Print)
IS  - 1098-1136 (Electronic)
VI  - 63
IP  - 3
DP  - 2015 Mar
TI  - Transplanted Glial Restricted Precursor Cells Improve Neurobehavioral and
      Neuropathological Outcomes in a Mouse Model of Neonatal White Matter Injury
      Despite Limited Cell Survival.
PG  - 452-65
AB  - Objective: Neonatal White Matter Injury (NWMI) is the leading cause of cerebral
      palsy and other neurocognitive deficits in prematurely-born children, and no
      restorative therapies exist. Our objective was to determine the fate and effect
      of glial restricted precursor cell (GRP) transplantation in an ischemic mouse
      model of NWMI. Methods: Neonatal CD-1 mice underwent unilateral carotid artery
      ligation on postnatal-day 5 (P5). At P22, intracallosal injections of either
      eGFP+ GRPs or saline were performed in control and ligated mice. Neurobehavioral 
      and postmortem studies were performed at four and eight weeks
      post-transplantation. Results: GRP survival was comparable at one month but
      significantly lower at two months post-transplantation in NWMI mice compared to
      unligated controls. Surviving cells showed better migration capability in
      controls; however, the differentiation capacity of transplanted cells was similar
      in control and NWMI. Saline-treated NWMI mice showed significantly altered
      response in startle amplitude and pre-pulse inhibition paradigms compared to
      unligated controls, while these behavioral tests were completely normal in
      GRP-transplanted animals. Similarly, there was significant increase in
      hemispheric myelin basic protein density, along with significant decrease in
      pathologic axonal staining in cell-treated NWMI mice compared to saline-treated
      NWMI animals. Interpretation: The Reduced long-term survival and migration of
      transplanted GRPs in an ischemia-induced NWMI model suggests that neonatal
      ischemia leads to long-lasting detrimental effects on oligodendroglia even months
      after the initial insult. Despite limited GRP-survival, behavioral and
      neuropathological outcomes were improved after GRP-transplantation. Our results
      suggest that exogenous GRPs improve myelination through trophic effects in
      addition to differentiation into mature oligodendrocytes.
FAU - Porambo, Michael
AU  - Porambo M
AD  - Kennedy Krieger Institute, Johns Hopkins University
FAU - Phillips, Andre W.
AU  - Phillips AW
AD  - Kennedy Krieger Institute, Johns Hopkins University
FAU - Marx, Joel
AU  - Marx J
AD  - Kennedy Krieger Institute, Johns Hopkins University
FAU - Ternes, Kylie
AU  - Ternes K
AD  - Kennedy Krieger Institute, Johns Hopkins University
FAU - Arauz, Edwin
AU  - Arauz E
FAU - Pletnikov, Mikhail
AU  - Pletnikov M
AD  - Department of Psychiatry, Johns Hopkins University
FAU - Wilson, Mary Ann
AU  - Wilson MA
AD  - Kennedy Krieger Institute, Johns Hopkins University
FAU - Rothstein, Jeffery D.
AU  - Rothstein JD
AD  - Department of Neurology, Johns Hopkins University
FAU - Johnston, Michael V.
AU  - Johnston MV
AD  - Kennedy Krieger Institute, Johns Hopkins University
FAU - Fatemi, Ali
AU  - Fatemi A
AD  - Kennedy Krieger Institute, Johns Hopkins University
LA  - eng
PT  - Journal Article
DEP - 20141106
TA  - Glia
JT  - Glia
AID - 10.1002/glia.22764 [doi]
MID - NIHMS637485
SO  - Glia. 2015 Mar;63(3):452-65. Epub 2014 Nov 06 doi:10.1002/glia.22764.

PMC - PMC1740860
PMID- 15613602
IS  - 1351-0711 (Print)
IS  - 1470-7926 (Electronic)
VI  - 62
IP  - 1
DP  - 2005 Jan
TI  - Eye complaints in the office environment: precorneal tear film integrity
      influenced by eye blinking efficiency.
PG  - 4-12
AB  - To achieve a common base for understanding work related eye complaints in the
      office environment, it is necessary to merge approaches from indoor air science, 
      occupational health, and ophthalmology. Based on database searches, it is
      concluded that precorneal tear film (PTF) alteration leads to eye complaints that
      may be caused by: (1) thermal factors (low relative humidity; high room
      temperature); (2) demanding task content (attention decreases blinking and widens
      the exposed ocular surface area); and (3) individual characteristics (for
      example, tear film alterations, blinking anomalies, gland dysfunctions, and use
      of contact lenses). These factors and conditions are able to progressively
      increase water evaporation and faster thinning of the PTF, which causes dryness
      and dry spot formation on the cornea, possibly followed by corneal and
      conjunctiva epithelial alterations and eye complaints. Another possible cause of 
      eye complaints is certain irritating chemical compounds, in addition to oxidation
      mixtures that are formed in reactions between ozone and unsaturated organic
      compounds (alkenes). The effect may be exacerbated by low relative humidity.
FAU - Wolkoff, P
AU  - Wolkoff P
FAU - Nojgaard, J
AU  - Nojgaard J
FAU - Troiano, P
AU  - Troiano P
FAU - Piccoli, B
AU  - Piccoli B
LA  - eng
PT  - Journal Article
PT  - Review
TA  - Occup Environ Med
JT  - Occupational and Environmental Medicine
AID - 10.1136/oem.2004.016030 [doi]
SO  - Occup Environ Med. 2005 Jan;62(1):4-12. doi:10.1136/oem.2004.016030.

PMC - PMC4972431
PMID- 27487011
IS  - 1932-6203 (Electronic)
VI  - 11
IP  - 8
DP  - 2016
TI  - Surface-Based fMRI-Driven Diffusion Tractography in the Presence of Significant
      Brain Pathology: A Study Linking Structure and Function in Cerebral Palsy.
LID - e0159540
AB  - Diffusion MRI (dMRI) tractography analyses are difficult to perform in the
      presence of brain pathology. Automated methods that rely on cortical parcellation
      for structural connectivity studies often fail, while manually defining regions
      is extremely time consuming and can introduce human error. Both methods also make
      assumptions about structure-function relationships that may not hold after
      cortical reorganisation. Seeding tractography with functional-MRI (fMRI)
      activation is an emerging method that reduces these confounds, but inherent
      smoothing of fMRI signal may result in the inclusion of irrelevant pathways. This
      paper describes a novel fMRI-seeded dMRI-analysis pipeline based on
      surface-meshes that reduces these issues and utilises machine-learning to
      generate task specific white matter pathways, minimising the requirement for
      manually-drawn ROIs. We directly compared this new strategy to a standard
      voxelwise fMRI-dMRI approach, by investigating correlations between clinical
      scores and dMRI metrics of thalamocortical and corticomotor tracts in 31 children
      with unilateral cerebral palsy. The surface-based approach successfully processed
      more participants (87%) than the voxel-based approach (65%), and provided
      significantly more-coherent tractography. Significant correlations between dMRI
      metrics and five clinical scores of function were found for the more superior
      regions of these tracts. These significant correlations were stronger and more
      frequently found with the surface-based method (15/20 investigated were
      significant; R2 = 0.43–0.73) than the voxelwise analysis (2 sig. correlations;
      0.38 & 0.49). More restricted fMRI signal, better-constrained tractography, and
      the novel track-classification method all appeared to contribute toward these
      differences.
FAU - Reid, Lee B.
AU  - Reid LB
AUID- ORCID: 0000-0002-3585-8141
AD  - The Australian e-Health Research Centre, CSIRO, Brisbane, Australia
FAU - Cunnington, Ross
AU  - Cunnington R
AD  - School of Psychology and Queensland Brain Institute, The University of
      Queensland, St Lucia, Brisbane, Australia
FAU - Boyd, Roslyn N.
AU  - Boyd RN
AD  - Level 6, Queensland Cerebral Palsy and Rehabilitation Research Centre, Children’s
      Health Research Centre, School of Medicine, The University of Queensland,
      Brisbane, Australia
FAU - Rose, Stephen E.
AU  - Rose SE
AD  - The Australian e-Health Research Centre, CSIRO, Brisbane, Australia
LA  - eng
PT  - Journal Article
DEP - 20160803
PHST- 2016/03/14 [received]
PHST- 2016/07/04 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - 10.1371/journal.pone.0159540 [doi]
AID - PONE-D-16-10594 [pii]
SO  - PLoS One. 2016 Aug 3;11(8):. doi:10.1371/journal.pone.0159540.

PMC - PMC4195810
PMID- 24726574
IS  - 0149-7634 (Print)
IS  - 1873-7528 (Electronic)
VI  - 46 Pt 3
DP  - 2014 Oct
TI  - Lifelong opioidergic vulnerability through early life separation: A recent
      extension of the false suffocation alarm theory of panic disorder.
PG  - 345-51
FAU - Preter, Maurice
AU  - Preter M
AD  - Department of Psychiatry, College of Physicians and Surgeons, Columbia
      University, New York, NY, USA
FAU - Klein, Donald F.
AU  - Klein DF
AD  - Phyllis Green and Randolph Cowen Institute for Pediatric Neuroscience, Department
      of Child and Adolescent Psychiatry, New York University Langone Medical Center
      550 1st Ave, New York, NY 10016, USA. donaldk737@aol.com
LA  - eng
PT  - Journal Article
DEP - 20140413
TA  - Neurosci Biobehav Rev
JT  - Neuroscience and biobehavioral reviews
AID - 10.1016/j.neubiorev.2014.03.025 [doi]
MID - NIHMS585187
SO  - Neurosci Biobehav Rev. 2014 Oct;46 Pt 3:345-51. Epub 2014 Apr 13
      doi:10.1016/j.neubiorev.2014.03.025.

PMC - PMC3321017
PMID- 22493695
IS  - 1932-6203 (Electronic)
VI  - 7
IP  - 4
DP  - 2012
TI  - The Digital Fish Library: Using MRI to Digitize, Database, and Document the
      Morphological Diversity of Fish.
LID - e34499
AB  - Museum fish collections possess a wealth of anatomical and morphological data
      that are essential for documenting and understanding biodiversity. Obtaining
      access to specimens for research, however, is not always practical and frequently
      conflicts with the need to maintain the physical integrity of specimens and the
      collection as a whole. Non-invasive three-dimensional (3D) digital imaging
      therefore serves a critical role in facilitating the digitization of these
      specimens for anatomical and morphological analysis as well as facilitating an
      efficient method for online storage and sharing of this imaging data. Here we
      describe the development of the Digital Fish Library (DFL,
      http://www.digitalfishlibrary.org), an online digital archive of high-resolution,
      high-contrast, magnetic resonance imaging (MRI) scans of the soft tissue anatomy 
      of an array of fishes preserved in the Marine Vertebrate Collection of Scripps
      Institution of Oceanography. We have imaged and uploaded MRI data for over 300
      marine and freshwater species, developed a data archival and retrieval system
      with a web-based image analysis and visualization tool, and integrated these into
      the public DFL website to disseminate data and associated metadata freely over
      the web. We show that MRI is a rapid and powerful method for accurately depicting
      the in-situ soft-tissue anatomy of preserved fishes in sufficient detail for
      large-scale comparative digital morphology. However these 3D volumetric data
      require a sophisticated computational and archival infrastructure in order to be 
      broadly accessible to researchers and educators.
FAU - Berquist, Rachel M.
AU  - Berquist RM
AD  - Center for Scientific Computation in Imaging, University of California San Diego,
      La Jolla, California, United States of America
FAU - Gledhill, Kristen M.
AU  - Gledhill KM
AD  - Center for Scientific Computation in Imaging, University of California San Diego,
      La Jolla, California, United States of America
FAU - Peterson, Matthew W.
AU  - Peterson MW
AD  - Center for Scientific Computation in Imaging, University of California San Diego,
      La Jolla, California, United States of America
FAU - Doan, Allyson H.
AU  - Doan AH
AD  - Center for Scientific Computation in Imaging, University of California San Diego,
      La Jolla, California, United States of America
FAU - Baxter, Gregory T.
AU  - Baxter GT
AD  - Center for Scientific Computation in Imaging, University of California San Diego,
      La Jolla, California, United States of America
FAU - Yopak, Kara E.
AU  - Yopak KE
AD  - Center for Scientific Computation in Imaging, University of California San Diego,
      La Jolla, California, United States of America
FAU - Kang, Ning
AU  - Kang N
AD  - Center for Scientific Computation in Imaging, University of California San Diego,
      La Jolla, California, United States of America
FAU - Walker, H. J.
AU  - Walker HJ
AD  - Marine Vertebrate Collection and Marine Biology Research Division, Scripps
      Institution of Oceanography, University of California San Diego, La Jolla,
      California, United States of America
FAU - Hastings, Philip A.
AU  - Hastings PA
AD  - Marine Vertebrate Collection and Marine Biology Research Division, Scripps
      Institution of Oceanography, University of California San Diego, La Jolla,
      California, United States of America
FAU - Frank, Lawrence R.
AU  - Frank LR
AD  - Center for Scientific Computation in Imaging, University of California San Diego,
      La Jolla, California, United States of America
LA  - eng
PT  - Journal Article
DEP - 20120406
PHST- 2011/08/30 [received]
PHST- 2012/03/02 [accepted]
TA  - PLoS One
JT  - PLoS ONE
AID - PONE-D-11-17097 [pii]
AID - 10.1371/journal.pone.0034499 [doi]
SO  - PLoS One. 2012 Apr 6;7(4):. doi:10.1371/journal.pone.0034499.

PMC - PMC3817418
PMID- 24204377
IS  - 1664-8021 (Electronic)
VI  - 4
DP  - 2013
TI  - Channelopathy pathogenesis in autism spectrum disorders.
LID - 222
AB  - Autism spectrum disorder (ASD) is a syndrome that affects normal brain
      development and is characterized by impaired social interaction as well as verbal
      and non-verbal communication and by repetitive, stereotypic behavior. ASD is a
      complex disorder arising from a combination of multiple genetic and environmental
      factors that are independent from racial, ethnic and socioeconomical status. The 
      high heritability of ASD suggests a strong genetic basis for the disorder.
      Furthermore, a mounting body of evidence implies a role of various ion channel
      gene defects (channelopathies) in the pathogenesis of autism. Indeed, recent
      genome-wide association, and whole exome- and whole-genome resequencing studies
      linked polymorphisms and rare variants in calcium, sodium and potassium channels 
      and their subunits with susceptibility to ASD, much as they do with bipolar
      disorder, schizophrenia and other neuropsychiatric disorders. Moreover, animal
      models with these genetic variations recapitulate endophenotypes considered to be
      correlates of autistic behavior seen in patients. An ion flux across the membrane
      regulates a variety of cell functions, from generation of action potentials to
      gene expression and cell morphology, thus it is not surprising that
      channelopathies have profound effects on brain functions. In the present work, we
      summarize existing evidence for the role of ion channel gene defects in the
      pathogenesis of autism with a focus on calcium signaling and its downstream
      effects.
FAU - Schmunk, Galina
AU  - Schmunk G
AD  - Department of Physiology and Biophysics, University of CaliforniaIrvine, CA, USA
FAU - Gargus, J. Jay
AU  - Gargus JJ
AD  - Department of Physiology and Biophysics, University of CaliforniaIrvine, CA, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20131105
PHST- 2013/07/06 [received]
PHST- 2013/10/09 [accepted]
TA  - Front Genet
JT  - Frontiers in Genetics
AID - 10.3389/fgene.2013.00222 [doi]
SO  - Front Genet. 2013 Nov 05;4:. doi:10.3389/fgene.2013.00222.

PMC - PMC4428494
PMID- 25988147
IS  - 2296-889X (Electronic)
VI  - 1
DP  - 2014
TI  - Wrecked regulation of intrinsically disordered proteins in diseases:
      pathogenicity of deregulated regulators.
LID - 6
AB  - Biologically active proteins without stable tertiary structure are common in all 
      known proteomes. Functions of these intrinsically disordered proteins (IDPs) are 
      typically related to regulation, signaling, and control. Cellular levels of these
      important regulators are tightly regulated by a variety mechanisms ranging from
      firmly controlled expression to precisely targeted degradation. Functions of IDPs
      are controlled by binding to specific partners, alternative splicing, and
      posttranslational modifications among other means. In the norm, right amounts of 
      precisely activated IDPs have to be present in right time at right places.
      Wrecked regulation brings havoc to the ordered world of disordered proteins,
      leading to protein misfolding, misidentification, and missignaling that give rise
      to numerous human diseases, such as cancer, cardiovascular disease,
      neurodegenerative diseases, and diabetes. Among factors inducing pathogenic
      transformations of IDPs are various cellular mechanisms, such as chromosomal
      translocations, damaged splicing, altered expression, frustrated
      posttranslational modifications, aberrant proteolytic degradation, and defective 
      trafficking. This review presents some of the aspects of deregulated regulation
      of IDPs leading to human diseases.
FAU - Uversky, Vladimir N.
AU  - Uversky VN
AD  - Department of Molecular Medicine and USF Health Byrd Alzheimer's Research
      Institute, Morsani College of Medicine, University of South FloridaTampa, FL, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20140725
PHST- 2014/06/06 [received]
PHST- 2014/07/06 [accepted]
TA  - Front Mol Biosci
JT  - Frontiers in Molecular Biosciences
AID - 10.3389/fmolb.2014.00006 [doi]
SO  - Front Mol Biosci. 2014 Jul 25;1:. doi:10.3389/fmolb.2014.00006.

PMC - PMC2753830
PMID- 18801115
IS  - 1755-5930 (Print)
IS  - 1755-5949 (Electronic)
VI  - 14
IP  - 3
DP  - 2008 Fall
TI  - A Review of the Discovery, Pharmacological Characterization, and Behavioral
      Effects of the Dopamine D2-Like Receptor Antagonist Eticlopride.
PG  - 248-62
AB  - Eticlopride is a substituted benzamide analog with high affinity and selectivity 
      for dopamine (DA) D2-like receptors that was initially developed as a potential
      antipsychotic agent. A great deal of research has utilized this drug to better
      understand central DA receptor function, the role of D2-like receptors in
      behavior, and the influence of blockade of these receptors on several preclinical
      animal models. This review highlights research utilizing this drug and compares
      it to typical and atypical antipsychotics used clinically. First, we describe
      structure–activity relationships as it relates to binding at DA receptors and the
      consequences on behavior. This is followed by a discussion of several imaging
      strategies including the use of eticlopride for in vivo, in vitro, and ex vivo
      examination of DA D2-like receptor densities and function. Finally, we discuss
      the use of eticlopride in several behavioral models predictive of antipsychotic
      activity, extrapyramidal side effects (EPS), and learning and memory. While
      eticlopride is not used clinically, it remains a viable research tool for
      understanding DA receptor function and behavior.
FAU - Martelle, Jennifer L.
AU  - Martelle JL
FAU - Nader, Michael A.
AU  - Nader MA
LA  - eng
PT  - Journal Article
TA  - CNS Neurosci Ther
JT  - CNS neuroscience & therapeutics
AID - 10.1111/j.1755-5949.2008.00047.x [doi]
MID - NIHMS134729
SO  - CNS Neurosci Ther. 2008 Fall;14(3):248-62. doi:10.1111/j.1755-5949.2008.00047.x.

PMC - PMC4633118
PMID- 26587699
IS  - 1534-7362 (Electronic)
VI  - 15
IP  - 14
DP  - 2015 Oct
TI  - Knowing what the brain is seeing in three dimensions: A novel, noninvasive,
      sensitive, accurate, and low-noise technique for measuring ocular torsion.
LID - 11
AB  - Torsional eye movements are rotations of the eye around the line of sight.
      Measuring torsion is essential to understanding how the brain controls eye
      position and how it creates a veridical perception of object orientation in three
      dimensions. Torsion is also important for diagnosis of many vestibular,
      neurological, and ophthalmological disorders. Currently, there are multiple
      devices and methods that produce reliable measurements of horizontal and vertical
      eye movements. Measuring torsion, however, noninvasively and reliably has been a 
      longstanding challenge, with previous methods lacking real-time capabilities or
      suffering from intrusive artifacts. We propose a novel method for measuring eye
      movements in three dimensions using modern computer vision software (OpenCV) and 
      concepts of iris recognition. To measure torsion, we use template matching of the
      entire iris and automatically account for occlusion of the iris and pupil by the 
      eyelids. The current setup operates binocularly at 100 Hz with noise <0.1° and is
      accurate within 20° of gaze to the left, to the right, and up and 10° of gaze
      down. This new method can be widely applicable and fill a gap in many scientific 
      and clinical disciplines.
FAU - Otero-Millan, Jorge
AU  - Otero-Millan J
AD  - jotero@jhu.edu
AD  - Department of Neurology The Johns Hopkins University, Baltimore, MD, US,
FAU - Roberts, Dale C.
AU  - Roberts DC
AD  - dale.roberts@jhu.edu
AD  - Department of Neurology The Johns Hopkins University, Baltimore, MD, US,
FAU - Lasker, Adrian
AU  - Lasker A
AD  - alasker@jhu.edu
AD  - Department of Neurology The Johns Hopkins University, Baltimore, MD, US,
FAU - Zee, David S.
AU  - Zee DS
AD  - dzee@jhu.edu
AD  - Department of Neurology The Johns Hopkins University, Baltimore, MD, US,
FAU - Kheradmand, Amir
AU  - Kheradmand A
AD  - akherad@jhu.edu
AD  - Department of Neurology The Johns Hopkins University, Baltimore, MD, US,
LA  - eng
PT  - Journal Article
DEP - 20151022
PHST- 2015/05/20 [received]
PHST- 2015/08/07 [accepted]
TA  - J Vis
JT  - Journal of Vision
AID - 10.1167/15.14.11 [doi]
AID - MS#: JOV-04842-2015 [pii]
SO  - J Vis. 2015 Oct 22;15(14):. doi:10.1167/15.14.11.

PMC - PMC5503494
PMID- 28740385
IS  - 1176-9114 (Print)
IS  - 1178-2013 (Electronic)
VI  - 12
DP  - 2017
TI  - Application of nanodiagnostics in point-of-care tests for infectious diseases.
PG  - 4789-803
AB  - Although tremendous efforts have been put into the treatment of infectious
      diseases to prevent epidemics and mortality, it is still one of the major health 
      care issues that have a profound impact on humankind. Therefore, the development 
      of specific, sensitive, accurate, rapid, low-cost, and easy-to-use diagnostic
      tools is still in urgent demand. Nanodiagnostics, defined as the application of
      nanotechnology to medical diagnostics, can offer many unique opportunities for
      more successful and efficient diagnosis and treatment for infectious diseases. In
      this review, we provide an overview of the nanodiagnostics for infectious
      diseases from nanoparticle-based, nanodevice-based, and point-of-care test (POCT)
      platforms. Most importantly, emphasis focused on the recent trends in the
      nanotechnology-based POCT system. The current state-of-the-art and most promising
      point-of-care nanodiagnostic technologies, including miniaturized diagnostic
      magnetic resonance platform, magnetic barcode assay system, cell phone-based
      polarized light microscopy platform, cell phone-based dongle platform, and
      paper-based POCT platform, for infectious diseases were fully examined. The
      limitations, challenges, and future trends of the nanodiagnostics in POCTs for
      infectious diseases are also discussed.
FAU - Wang, Yongzhong
AU  - Wang Y
AD  - Anhui Key Laboratory of Modern Biomanufacturing, School of Life Sciences, Anhui
      University, Hefei, Anhui, People’s Republic of China
FAU - Yu, Li
AU  - Yu L
AD  - Department of Microbiology and Parasitology, Anhui Provincial Laboratory of
      Microbiology and Parasitology, Anhui Key Laboratory of Zoonoses, Anhui Medical
      University, Hefei, Anhui, People’s Republic of China
FAU - Kong, Xiaowei
AU  - Kong X
AD  - Anhui Key Laboratory of Modern Biomanufacturing, School of Life Sciences, Anhui
      University, Hefei, Anhui, People’s Republic of China
FAU - Sun, Leming
AU  - Sun L
AD  - Department of Biomedical Engineering, The Ohio State University, Columbus, OH,
      USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170704
TA  - Int J Nanomedicine
JT  - International Journal of Nanomedicine
AID - 10.2147/IJN.S137338 [doi]
AID - ijn-12-4789 [pii]
SO  - Int J Nanomedicine. 2017 Jul 04;12:4789-803. doi:10.2147/IJN.S137338.

PMC - PMC3980496
PMID- 24709603
IS  - 0959-4388 (Print)
IS  - 1873-6882 (Electronic)
VI  - 0
DP  - 2014 Apr
TI  - Brain-computer interfaces: a powerful tool for scientific inquiry.
PG  - 70-5
AB  - Brain-computer interfaces (BCIs) are devices that record from the nervous system,
      provide input directly to the nervous system, or do both. Sensory BCIs such as
      cochlear implants have already had notable clinical success and motor BCIs have
      shown great promise for helping patients with severe motor deficits. Clinical and
      engineering outcomes aside, BCIs can also be tremendously powerful tools for
      scientific inquiry into the workings of the nervous system. They allow
      researchers to inject and record information at various stages of the system,
      permitting investigation of the brain in vivo and facilitating the reverse
      engineering of brain function. Most notably, BCIs are emerging as a novel
      experimental tool for investigating the tremendous adaptive capacity of the
      nervous system.
FAU - Wander, Jeremiah D
AU  - Wander JD
AD  - Center for Sensorimotor Neural Engineering and Department of Bioengineering,
      University of Washington, William H. Foege Building, Box 355061, 4000 15 Ave NE, 
      Seattle, WA 98195
FAU - Rao, Rajesh P N
AU  - Rao RPN
AD  - Center for Sensorimotor Neural Engineering and Department of Computer Science and
      Engineering, University of Washington, AC101 Paul G. Allen Center, Box 352350,
      185 Stevens Way, Seattle, WA 98195
LA  - eng
PT  - Journal Article
DEP - 20131227
TA  - Curr Opin Neurobiol
JT  - Current opinion in neurobiology
AID - 10.1016/j.conb.2013.11.013 [doi]
MID - NIHMS552133
SO  - Curr Opin Neurobiol. 2014 Apr;0:70-5. Epub 2013 Dec 27
      doi:10.1016/j.conb.2013.11.013.

PMC - PMC2812675
PMID- 19883643
IS  - 0014-4886 (Print)
IS  - 1090-2430 (Electronic)
VI  - 221
IP  - 1
DP  - 2010 Jan
TI  - Sigma receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates neuronal
      nitric oxide synthase/postsynaptic density-95 coupling mechanisms and protects
      against neonatal ischemic degeneration of striatal neurons.
PG  - 166-74
AB  - In adult stroke models, 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP), a sigma
      receptor agonist, attenuates activity of neuronal nitric oxide synthase (nNOS),
      blunts ischemia-induced nitric oxide production, and provides neuroprotection.
      Here, we tested the hypothesis that PPBP attenuates neuronal damage in a model of
      global hypoxia-ischemia (H–I) in newborn piglets. Piglets subjected to hypoxia
      followed by asphyxic cardiac arrest were treated with saline or two dosing
      regimens of PPBP after resuscitation. Sigma-1 receptors were found in striatal
      neurons. PPBP dose-dependently protected neurons in putamen at 4 days of recovery
      from H–I. Immunoblots of putamen extracts at 3 h of recovery showed that PPBP
      decreased H–I-induced recruitment of nNOS in the membrane fraction and reduced
      the association of nNOS with NMDA receptor NR2 subunit. The latter effect was
      associated with changes in the coupling of nNOS to postsynaptic density-95
      (PSD-95), but not NR2-PSD-95 interactions. Moreover, PPBP suppressed NOS activity
      in the membrane fraction and reduced H–I–induced nitrative and oxidative damage
      to proteins and nucleic acids. These findings indicate that PPBP protects
      striatal neurons in a large animal model of neonatal H–I and that the protection 
      is associated with decreased coupling of nNOS to PSD-95.
FAU - Yang, Zeng-Jin
AU  - Yang ZJ
AD  - Department of Anesthesiology/Critical Care Medicine, Johns Hopkins University,
      Baltimore, Maryland, USA
FAU - Carter, Erin L.
AU  - Carter EL
AD  - Department of Anesthesiology/Critical Care Medicine, Johns Hopkins University,
      Baltimore, Maryland, USA
FAU - Torbey, Michel T.
AU  - Torbey MT
AD  - Department of Anesthesiology/Critical Care Medicine, Johns Hopkins University,
      Baltimore, Maryland, USA
FAU - Martin, Lee J.
AU  - Martin LJ
AD  - Division of Neuropathology, Department of Pathology, Johns Hopkins University,
      Baltimore, Maryland, USA
FAU - Koehler, Raymond C.
AU  - Koehler RC
AD  - Department of Anesthesiology/Critical Care Medicine, Johns Hopkins University,
      Baltimore, Maryland, USA
LA  - eng
PT  - Journal Article
DEP - 20091031
TA  - Exp Neurol
JT  - Experimental neurology
AID - 10.1016/j.expneurol.2009.10.019 [doi]
MID - NIHMS157643
SO  - Exp Neurol. 2010 Jan;221(1):166-74. Epub 2009 Oct 31
      doi:10.1016/j.expneurol.2009.10.019.

PMC - PMC3100186
PMID- 21220676
IS  - 0003-9942 (Print)
IS  - 1538-3687 (Electronic)
VI  - 68
IP  - 1
DP  - 2011 Jan
TI  - Deficits in Functional Connectivity of Hippocampal and Frontal Lobe Circuits
      after Traumatic Axonal Injury.
PG  - 74-84
AB  - Objective: To examine the functional connectivity (fc) of hippocampal and
      selected frontal lobe circuits among patients with traumatic axonal injury (TAI).
      Design: Echo-planar and high-resolution T1-weighted images were acquired using 3 
      Tesla scanners. Regions of interest (ROI) were drawn bilaterally for the
      hippocampus, anterior cingulate cortex (ACC), and dorsolateral prefrontal cortex 
      (DLPFC), and were used to extract time series data. BOLD data from each ROI were 
      used as reference functions for correlating with all other brain voxels.
      Interhermispheric fc was assessed for each participant by correlating homologous 
      regions using a Pearson correlation coefficient. Patient functional and
      neurocognitive outcomes were assessed approximately 6 months post-injury.
      Setting: Patients were recruited within days of their injury while in an
      inpatient traumatic brain injury unit. Imaging and neurocognitive assessments
      were conducted in an outpatient research facility. Participants: 25 consecutive
      patients with brain injuries consistent with TAI and acute subcortical white
      matter abnormalities were studied. Sixteen healthy volunteers of similar age and 
      gender were recruited. Main Outcome Measures: Interhemispheric fc for each ROI
      was compared between patients and controls. Spatial patterns of fc were examined 
      for each of the three ROIs. Connectivity measures were examined for associations 
      with functional and neurocognitive outcomes. Results: Patients showed
      significantly lower interhemispheric fc for the hippocampus and ACC. Healthy
      controls demonstrate stronger and more focused fc for hippocampi and ACC, and a
      more focused recruitment of the default mode network for the DLPFC ROI. The
      interhemispheric fc for the hippocampus was correlated to delayed recall of
      verbal information. Conclusions: Our findings suggest that traumatic axonal
      injury impacts interhemispheric neural activity, as patients with TAI show
      disrupted interhemipsheric fc. These results suggest more careful investigation
      of interhemisheric connectivity is warranted, as it demonstrated a modest
      association with outcome in chronic TBI.
FAU - Marquez de la Plata, Carlos D.
AU  - Marquez de la Plata CD
AD  - Center for Brain Health, The University of Texas at Dallas, Richardson, TX, USA
FAU - Garces, Juanita
AU  - Garces J
AD  - Department of Neurology, University of Texas Southwestern Medical Center, Dallas,
      TX, USA
FAU - Kojori, Ehsan Shokri
AU  - Kojori ES
AD  - Department of Psychiatry, University of Texas Southwestern Medical Center,
      Dallas, TX, USA
FAU - Grinnan, Jack
AU  - Grinnan J
AD  - Department of Psychiatry, University of Texas Southwestern Medical Center,
      Dallas, TX, USA
FAU - Krishnan, Kamini
AU  - Krishnan K
AD  - Department of Psychiatry, University of Texas Southwestern Medical Center,
      Dallas, TX, USA
FAU - Pidikiti, Rajesh
AU  - Pidikiti R
AD  - Department of Neurology, University of Texas Southwestern Medical Center, Dallas,
      TX, USA
FAU - Spence, Jeffrey
AU  - Spence J
AD  - Department of Clinical Sciences, University of Texas Southwestern Medical Center,
      Dallas, TX, USA
FAU - Devous, Michael D.
AU  - Devous MD
AD  - Department of Radiology (Neuroradiology), University of Texas Southwestern
      Medical Center, Dallas, TX, USA
FAU - Moore, Carol
AU  - Moore C
AD  - Department of Neurology, University of Texas Southwestern Medical Center, Dallas,
      TX, USA
FAU - McColl, Rodderick
AU  - McColl R
AD  - Department of Radiology (Neuroradiology), University of Texas Southwestern
      Medical Center, Dallas, TX, USA
FAU - Madden, Christopher
AU  - Madden C
AD  - Department of Neurological Surgery, University of Texas Southwestern Medical
      Center, Dallas, TX, USA
FAU - Diaz-Arrastia, Ramon
AU  - Diaz-Arrastia R
AD  - Department of Neurology, University of Texas Southwestern Medical Center, Dallas,
      TX, USA
LA  - eng
PT  - Journal Article
GR  - K23 NS060827-04 || NS
TA  - Arch Neurol
JT  - Archives of neurology
AID - 10.1001/archneurol.2010.342 [doi]
MID - NIHMS292879
SO  - Arch Neurol. 2011 Jan;68(1):74-84. doi:10.1001/archneurol.2010.342.

PMC - PMC4137968
PMID- 24418598
IS  - 1361-8415 (Print)
IS  - 1361-8423 (Electronic)
VI  - 18
IP  - 2
DP  - 2014 Feb
TI  - Evaluation of prostate segmentation algorithms for MRI: the PROMISE12 challenge.
PG  - 359-73
AB  - Prostate MRI image segmentation has been an area of intense research due to the
      increased use of MRI as a modality for the clinical workup of prostate cancer.
      Segmentation is useful for various tasks, e.g. to accurately localize prostate
      boundaries for radiotherapy or to initialize multi-modal registration algorithms.
      In the past, it has been difficult for research groups to evaluate prostate
      segmentation algorithms on multi-center, multi-vendor and multi-protocol data.
      Especially because we are dealing with MR images, image appearance, resolution
      and the presence of artifacts are affected by differences in scanners and/or
      protocols, which in turn can have a large influence on algorithm accuracy. The
      Prostate MR Image Segmentation (PROMISE12) challenge was setup to allow a fair
      and meaningful comparison of segmentation methods on the basis of performance and
      robustness. In this work we will discuss the initial results of the online
      PROMISE12 challenge, and the results obtained in the live challenge workshop
      hosted by the MICCAI2012 conference. In the challenge, 100 prostate MR cases from
      4 different centers were included, with differences in scanner manufacturer,
      field strength and protocol. A total of 11 teams from academic research groups
      and industry participated. Algorithms showed a wide variety in methods and
      implementation, including active appearance models, atlas registration and level 
      sets. Evaluation was performed using boundary and volume based metrics which were
      combined into a single score relating the metrics to human expert performance.
      The winners of the challenge where the algorithms by teams Imorphics and
      ScrAutoProstate, with scores of 85.72 and 84.29 overall. Both algorithms where
      significantly better than all other algorithms in the challenge (p < 0.05) and
      had an efficient implementation with a run time of 8 minutes and 3 second per
      case respectively. Overall, active appearance model based approaches seemed to
      outperform other approaches like multi-atlas registration, both on accuracy and
      computation time. Although average algorithm performance was good to excellent
      and the Imorphics algorithm outperformed the second observer on average, we
      showed that algorithm combination might lead to further improvement, indicating
      that optimal performance for prostate segmentation is not yet obtained. All
      results are available online at http://promise12.grand-challenge.org/.
FAU - Litjens, Geert
AU  - Litjens G
AD  - Radboud University Nijmegen Medical Centre, The Netherlands
FAU - Toth, Robert
AU  - Toth R
AD  - Case Western Reserve University, USA
FAU - van de Ven, Wendy
AU  - van de Ven W
AD  - Radboud University Nijmegen Medical Centre, The Netherlands
FAU - Hoeks, Caroline
AU  - Hoeks C
AD  - Radboud University Nijmegen Medical Centre, The Netherlands
FAU - Kerkstra, Sjoerd
AU  - Kerkstra S
AD  - Radboud University Nijmegen Medical Centre, The Netherlands
FAU - van Ginneken, Bram
AU  - van Ginneken B
AD  - Radboud University Nijmegen Medical Centre, The Netherlands
FAU - Vincent, Graham
AU  - Vincent G
AD  - Imorphics, England
FAU - Guillard, Gwenael
AU  - Guillard G
AD  - Imorphics, England
FAU - Birbeck, Neil
AU  - Birbeck N
AD  - Siemens Corporate Research, USA
FAU - Zhang, Jindang
AU  - Zhang J
AD  - Siemens Corporate Research, USA
FAU - Strand, Robin
AU  - Strand R
AD  - Uppsala University, Sweden
FAU - Malmberg, Filip
AU  - Malmberg F
AD  - Uppsala University, Sweden
FAU - Ou, Yangming
AU  - Ou Y
AD  - University of Pennsylvania, USA
FAU - Davatzikos, Christos
AU  - Davatzikos C
AD  - University of Pennsylvania, USA
FAU - Kirschner, Matthias
AU  - Kirschner M
AD  - Technische Universitat Darmstadt, Germany
FAU - Jung, Florian
AU  - Jung F
AD  - Technische Universitat Darmstadt, Germany
FAU - Yuan, Jing
AU  - Yuan J
AD  - Robarts Research Institute, Canada
FAU - Qiu, Wu
AU  - Qiu W
AD  - Robarts Research Institute, Canada
FAU - Gao, Qinquan
AU  - Gao Q
AD  - Imperial College London, England
FAU - Edwards, Philip “Eddie”
AU  - Edwards P“
AD  - Imperial College London, England
FAU - Maan, Bianca
AU  - Maan B
AD  - University of Twente, The Netherlands
FAU - van der Heijden, Ferdinand
AU  - van der Heijden F
AD  - University of Twente, The Netherlands
FAU - Ghose, Soumya
AU  - Ghose S
AD  - Commonwealth Scientific and Industrial Research Organisation, Australia
FAU - Mitra, Jhimli
AU  - Mitra J
AD  - Commonwealth Scientific and Industrial Research Organisation, Australia
FAU - Dowling, Jason
AU  - Dowling J
AD  - Commonwealth Scientific and Industrial Research Organisation, Australia
FAU - Barratt, Dean
AU  - Barratt D
AD  - University College London, England
FAU - Huisman, Henkjan
AU  - Huisman H
AD  - Radboud University Nijmegen Medical Centre, The Netherlands
FAU - Madabhushi, Anant
AU  - Madabhushi A
AD  - Case Western Reserve University, USA
LA  - eng
PT  - Journal Article
DEP - 20131225
TA  - Med Image Anal
JT  - Medical image analysis
AID - 10.1016/j.media.2013.12.002 [doi]
MID - NIHMS604768
SO  - Med Image Anal. 2014 Feb;18(2):359-73. Epub 2013 Dec 25
      doi:10.1016/j.media.2013.12.002.

PMC - PMC4189373
PMID- 25339859
IS  - 1662-4548 (Print)
IS  - 1662-453X (Electronic)
VI  - 8
DP  - 2014
TI  - Brain temperature and its fundamental properties: a review for clinical
      neuroscientists.
LID - 307
AB  - Brain temperature, as an independent therapeutic target variable, has received
      increasingly intense clinical attention. To date, brain hypothermia represents
      the most potent neuroprotectant in laboratory studies. Although the impact of
      brain temperature is prevalent in a number of common human diseases including:
      head trauma, stroke, multiple sclerosis, epilepsy, mood disorders, headaches, and
      neurodegenerative disorders, it is evident and well recognized that the
      therapeutic application of induced hypothermia is limited to a few highly
      selected clinical conditions such as cardiac arrest and hypoxic ischemic neonatal
      encephalopathy. Efforts to understand the fundamental aspects of brain
      temperature regulation are therefore critical for the development of safe,
      effective, and pragmatic clinical treatments for patients with brain injuries.
      Although centrally-mediated mechanisms to maintain a stable body temperature are 
      relatively well established, very little is clinically known about brain
      temperature's spatial and temporal distribution, its physiological and
      pathological fluctuations, and the mechanism underlying brain thermal
      homeostasis. The human brain, a metabolically “expensive” organ with intense heat
      production, is sensitive to fluctuations in temperature with regards to its
      functional activity and energy efficiency. In this review, we discuss several
      critical aspects concerning the fundamental properties of brain temperature from 
      a clinical perspective.
FAU - Wang, Huan
AU  - Wang H
AD  - Department of Neurosurgery, Carle Foundation Hospital, University of Illinois
      College of Medicine at Urbana-ChampaignUrbana, IL, USA
FAU - Wang, Bonnie
AU  - Wang B
AD  - Department of Internal Medicine, Carle Foundation Hospital, University of
      Illinois College of Medicine at Urbana-ChampaignUrbana, IL, USA
FAU - Normoyle, Kieran P.
AU  - Normoyle KP
AD  - Department of Internal Medicine, College of Medicine at Urbana-Champaign,
      University of IllinoisChampaign, Urbana, IL, USA
FAU - Jackson, Kevin
AU  - Jackson K
AD  - Thermal Neuroscience Laboratory, Beckman Institute, University of Illinois at
      Urbana-ChampaignUrbana, IL, USA
FAU - Spitler, Kevin
AU  - Spitler K
AD  - Department of Internal Medicine, Carle Foundation Hospital, University of
      Illinois College of Medicine at Urbana-ChampaignUrbana, IL, USA
FAU - Sharrock, Matthew F.
AU  - Sharrock MF
AD  - Department of Internal Medicine, College of Medicine at Urbana-Champaign,
      University of IllinoisChampaign, Urbana, IL, USA
FAU - Miller, Claire M.
AU  - Miller CM
AD  - Department of Internal Medicine, College of Medicine at Urbana-Champaign,
      University of IllinoisChampaign, Urbana, IL, USA
FAU - Best, Catherine
AU  - Best C
AD  - Molecular and Cellular Biology, University of Illinois at Urbana-ChampaignUrbana,
      IL, USA
FAU - Llano, Daniel
AU  - Llano D
AD  - Thermal Neuroscience Laboratory, Beckman Institute, University of Illinois at
      Urbana-ChampaignUrbana, IL, USA
FAU - Du, Rose
AU  - Du R
AD  - Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical
      SchoolBoston, MA, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20141008
PHST- 2014/03/03 [received]
PHST- 2014/09/12 [accepted]
TA  - Front Neurosci
JT  - Frontiers in Neuroscience
AID - 10.3389/fnins.2014.00307 [doi]
SO  - Front Neurosci. 2014 Oct 08;8:. doi:10.3389/fnins.2014.00307.

PMC - PMC4713729
PMID- 26572244
IS  - 0022-3751 (Print)
IS  - 1469-7793 (Electronic)
VI  - 594
IP  - 2
DP  - 2016 Jan 15
TI  - Myocardial infarction induces structural and functional remodelling of the
      intrinsic cardiac nervous system.
PG  - 321-41
AB  - Key points: Intrinsic cardiac (IC) neurons undergo differential morphological and
      phenotypic remodelling that reflects the site of myocardial infarction
      (MI).Afferent neural signals from the infarcted region to IC neurons are
      attenuated, while those from border and remote regions are preserved post‐MI,
      giving rise to a ‘neural sensory border zone’.Convergent IC local circuit
      (processing) neurons have enhanced transduction capacity following MI.Functional 
      network connectivity within the intrinsic cardiac nervous system is reduced
      post‐MI.MI reduces the response and alters the characteristics of IC neurons to
      ventricular pacing. Abstract: Autonomic dysregulation following myocardial
      infarction (MI) is an important pathogenic event. The intrinsic cardiac nervous
      system (ICNS) is a neural network located on the heart that is critically
      involved in autonomic regulation. The aims of this study were to characterize
      structural and functional remodelling of the ICNS post‐MI in a porcine model
      (control (n = 16) vs. healed anteroapical MI (n = 16)). In vivo microelectrode
      recordings of basal activity, as well as responses to afferent and efferent
      stimuli, were recorded from intrinsic cardiac neurons. From control 118 neurons
      and from MI animals 102 neurons were functionally classified as afferent,
      efferent, or convergent (receiving both afferent and efferent inputs). In control
      and MI, convergent neurons represented the largest subpopulation (47% and 48%,
      respectively) and had enhanced transduction capacity following MI. Efferent
      inputs to neurons were maintained post‐MI. Afferent inputs were attenuated from
      the infarcted region (19% in control vs. 7% in MI; P = 0.03), creating a ‘neural 
      sensory border zone’, or heterogeneity in afferent information. MI reduced
      transduction of changes in preload (54% in control vs. 41% in MI; P = 0.05). The 
      overall functional network connectivity, or the ability of neurons to respond to 
      independent pairs of stimuli, within the ICNS was reduced following MI. The
      neuronal response was differentially decreased to ventricular vs. atrial pacing
      post‐MI (63% in control vs. 44% in MI to ventricular pacing; P < 0.01). MI
      induced morphological and phenotypic changes within the ICNS. The alteration of
      afferent neural signals, and remodelling of convergent neurons, represents a
      ‘neural signature’ of ischaemic heart disease.
OAB - Publisher: Abstract available from the publisher.
FAU - Rajendran, Pradeep S.
AU  - Rajendran PS
AD  - University of California – Los Angeles (UCLA) Cardiac Arrhythmia CenterDavid
      Geffen School of MedicineLos AngelesCAUSA
FAU - Nakamura, Keijiro
AU  - Nakamura K
AD  - University of California – Los Angeles (UCLA) Cardiac Arrhythmia CenterDavid
      Geffen School of MedicineLos AngelesCAUSA
FAU - Ajijola, Olujimi A.
AU  - Ajijola OA
AD  - University of California – Los Angeles (UCLA) Cardiac Arrhythmia CenterDavid
      Geffen School of MedicineLos AngelesCAUSA
FAU - Vaseghi, Marmar
AU  - Vaseghi M
AD  - University of California – Los Angeles (UCLA) Cardiac Arrhythmia CenterDavid
      Geffen School of MedicineLos AngelesCAUSA
FAU - Armour, J. Andrew
AU  - Armour JA
AD  - University of California – Los Angeles (UCLA) Cardiac Arrhythmia CenterDavid
      Geffen School of MedicineLos AngelesCAUSA
FAU - Ardell, Jeffrey L.
AU  - Ardell JL
AD  - University of California – Los Angeles (UCLA) Cardiac Arrhythmia CenterDavid
      Geffen School of MedicineLos AngelesCAUSA
FAU - Shivkumar, Kalyanam
AU  - Shivkumar K
AD  - University of California – Los Angeles (UCLA) Cardiac Arrhythmia CenterDavid
      Geffen School of MedicineLos AngelesCAUSA
LA  - eng
PT  - Journal Article
DEP - 20151215
PHST- 2015/08/09 [received]
PHST- 2015/11/12 [accepted]
TA  - J Physiol
JT  - The Journal of Physiology
AID - 10.1113/JP271165 [doi]
AID - TJP6965 [pii]
SO  - J Physiol. 2016 Jan 15;594(2):321-41. Epub 2015 Dec 15 doi:10.1113/JP271165.

PMC - PMC5460756
PMID- 27732573
IS  - 0028-0836 (Print)
IS  - 1476-4687 (Electronic)
VI  - 538
IP  - 7625
DP  - 2016 Oct 20
TI  - Cortico-fugal output from visual cortex promotes plasticity of innate motor
      behaviour.
PG  - 383-7
AB  - The mammalian visual cortex massively innervates the brainstem, a
      phylogenetically older structure, via cortico-fugal axonal projections1. Many
      cortico-fugal projections target brainstem nuclei that mediate innate motor
      behaviours, but the function of these projections remains poorly understood1–4. A
      prime example of such behaviours is the optokinetic reflex (OKR), an innate eye
      movement mediated by the brainstem accessory optic system3,5,6, that stabilizes
      images on the retina as the animal moves through the environment and is thus
      crucial for vision5. The OKR is plastic, allowing the amplitude of this reflex to
      be adaptively adjusted relative to other oculomotor reflexes and thereby ensuring
      image stability throughout life7–11. Although the plasticity of the OKR is
      thought to involve subcortical structures such as the cerebellum and vestibular
      nuclei10–13, cortical lesions have suggested that the visual cortex might also be
      involved9,14,15. Here we show that projections from the mouse visual cortex to
      the accessory optic system promote the adaptive plasticity of the OKR. OKR
      potentiation, a compensatory plastic increase in the amplitude of the OKR in
      response to vestibular impairment11,16–18, is diminished by silencing visual
      cortex. Furthermore, targeted ablation of a sparse population of cortico-fugal
      neurons that specifically project to the accessory optic system severely impairs 
      OKR potentiation. Finally, OKR potentiation results from an enhanced drive
      exerted by the visual cortex onto the accessory optic system. Thus, cortico-fugal
      projections to the brainstem enable the visual cortex, an area that has been
      principally studied for its sensory processing function19, to plastically adapt
      the execution of innate motor behaviours.
FAU - Liu, Bao-hua
AU  - Liu Bh
AD  - Howard Hughes Medical Institute and Center for Neural Circuits and Behavior,
      University of California San Diego, La Jolla, California 92093-0634, USA
FAU - Huberman, Andrew D.
AU  - Huberman AD
AD  - Department of Neurobiology, Stanford University School of Medicine, Palo Alto,
      California 94305, USA
FAU - Scanziani, Massimo
AU  - Scanziani M
AD  - Howard Hughes Medical Institute and Center for Neural Circuits and Behavior,
      University of California San Diego, La Jolla, California 92093-0634, USA
LA  - eng
PT  - Journal Article
DEP - 20161012
TA  - Nature
JT  - Nature
AID - 10.1038/nature19818 [doi]
MID - NIHMS861887
SO  - Nature. 2016 Oct 20;538(7625):383-7. Epub 2016 Oct 12 doi:10.1038/nature19818.

PMC - PMC3045877
PMID- 21314935
IS  - 1754-9493 (Electronic)
VI  - 5
DP  - 2011
TI  - Patterns of unexpected in-hospital deaths: a root cause analysis.
PG  - 3
AB  - Background: Respiratory alarm monitoring and rapid response team alerts on
      hospital general floors are based on detection of simple numeric threshold
      breaches. Although some uncontrolled observation trials in select patient
      populations have been encouraging, randomized controlled trials suggest that this
      simplistic approach may not reduce the unexpected death rate in this complex
      environment. The purpose of this review is to examine the history and scientific 
      basis for threshold alarms and to compare thresholds with the actual
      pathophysiologic patterns of evolving death which must be timely detected.
      Methods: The Pubmed database was searched for articles relating to methods for
      triggering rapid response teams and respiratory alarms and these were contrasted 
      with the fundamental timed pathophysiologic patterns of death which evolve due to
      sepsis, congestive heart failure, pulmonary embolism, hypoventilation, narcotic
      overdose, and sleep apnea. Results: In contrast to the simplicity of the numeric 
      threshold breach method of generating alerts, the actual patterns of evolving
      death are complex and do not share common features until near death. On hospital 
      general floors, unexpected clinical instability leading to death often progresses
      along three distinct patterns which can be designated as Types I, II and III.
      Type I is a pattern comprised of hyperventilation compensated respiratory failure
      typical of congestive heart failure and sepsis. Here, early hyperventilation and 
      respiratory alkalosis can conceal the onset of instability. Type II is the
      pattern of classic CO2 narcosis. Type III occurs only during sleep and is a
      pattern of ventilation and SPO2 cycling caused by instability of ventilation
      and/or upper airway control followed by precipitous and fatal oxygen desaturation
      if arousal failure is induced by narcotics and/or sedation. Conclusion: The
      traditional threshold breach method of detecting instability on hospital wards
      was not scientifically derived; explaining the failure of threshold based
      monitoring and rapid response team activation in randomized trials. Furthermore, 
      the thresholds themselves are arbitrary and capricious. There are three common
      fundamental pathophysiologic patterns of unexpected hospital death. These
      patterns are too complex for early detection by any unifying numeric threshold.
      New methods and technologies which detect and identify the actual patterns of
      evolving death should be investigated.
FAU - Lynn, Lawrence A
AU  - Lynn LA
AD  - The Sleep and Breathing Research Institute, Columbus, Ohio USA
FAU - Curry, J Paul
AU  - Curry JP
AD  - Department of Anesthesiology and Perioperative Care, Hoag Memorial Hospital
      Presbyterian, Newport Beach, CA 92658 USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20110211
PHST- 2010/04/07 [received]
PHST- 2011/02/11 [accepted]
TA  - Patient Saf Surg
JT  - Patient Safety in Surgery
AID - 1754-9493-5-3 [pii]
AID - 10.1186/1754-9493-5-3 [doi]
SO  - Patient Saf Surg. 2011 Feb 11;5:3. doi:10.1186/1754-9493-5-3.

PMC - PMC3633640
PMID- 23035940
IS  - 0009-2665 (Print)
IS  - 1520-6890 (Electronic)
VI  - 112
IP  - 12
DP  - 2012 Dec 12
TI  - Modeling and Simulation of Ion Channels.
PG  - 6250-84
FAU - Maffeo, Christopher
AU  - Maffeo C
FAU - Bhattacharya, Swati
AU  - Bhattacharya S
FAU - Yoo, Jejoong
AU  - Yoo J
FAU - Wells, David
AU  - Wells D
FAU - Aksimentiev, Aleksei
AU  - Aksimentiev A
LA  - eng
PT  - Journal Article
DEP - 20121004
GR  - R01 HG005115 || HG
TA  - Chem Rev
JT  - Chemical reviews
AID - 10.1021/cr3002609 [doi]
MID - NIHMS412822
SO  - Chem Rev. 2012 Dec 12;112(12):6250-84. Epub 2012 Oct 04 doi:10.1021/cr3002609.

PMC - PMC4344924
PMID- 25313656
IS  - 0898-929X (Print)
IS  - 1530-8898 (Electronic)
VI  - 27
IP  - 4
DP  - 2015 Apr
TI  - The neural correlates of speech motor sequence learning.
PG  - 819-31
AB  - Speech is perhaps the most sophisticated example of a species-wide movement
      capability in the animal kingdom, requiring split-second sequencing of
      approximately 100 muscles in the respiratory, laryngeal, and oral movement
      systems. Despite the unique role speech plays in human interaction and the
      debilitating impact of its disruption, little is known about the neural
      mechanisms underlying speech motor learning. Here, we studied the behavioral and 
      neural correlates of learning new speech motor sequences. Subjects repeatedly
      produced novel, meaningless syllables comprising illegal consonant clusters (e.g.
      GVAZF) over two days of practice. Following practice, subjects produced the
      sequences with fewer errors and shorter durations, indicative of motor learning. 
      Using functional magnetic resonance imaging, we compared brain activity during
      production of the learned illegal sequences and novel illegal sequences. Greater 
      activity was noted during production of novel sequences in brain regions linked
      to non-speech motor sequence learning, including the basal ganglia and
      pre-supplementary motor area. Activity during novel sequence production was also 
      greater in brain regions associated with learning and maintaining speech motor
      programs, including lateral premotor cortex, frontal operculum, and posterior
      superior temporal cortex. Measures of learning success correlated positively with
      activity in left frontal operculum and white matter integrity under left
      posterior superior temporal sulcus. These findings indicate speech motor sequence
      learning relies not only on brain areas involved generally in motor sequencing
      learning but also those associated with feedback-based speech motor learning.
      Furthermore, learning success is modulated by the integrity of structural
      connectivity between these motor and sensory brain regions.
FAU - Segawa, Jennifer A.
AU  - Segawa JA
AD  - Boston University, Department of Speech, Language and Hearing Sciences, Boston,
      MA 02215
FAU - Tourville, Jason A.
AU  - Tourville JA
AD  - Boston University, Department of Speech, Language and Hearing Sciences, Boston,
      MA 02215
FAU - Beal, Deryk S.
AU  - Beal DS
AD  - Boston University, Department of Speech, Language and Hearing Sciences, Boston,
      MA 02215
FAU - Guenther, Frank H.
AU  - Guenther FH
AD  - Boston University, Department of Speech, Language and Hearing Sciences, Boston,
      MA 02215
LA  - eng
PT  - Journal Article
DEP - 20141014
TA  - J Cogn Neurosci
JT  - Journal of cognitive neuroscience
AID - 10.1162/jocn_a_00737 [doi]
MID - NIHMS631304
SO  - J Cogn Neurosci. 2015 Apr;27(4):819-31. Epub 2014 Oct 14
      doi:10.1162/jocn_a_00737.

PMC - PMC2970617
PMID- 20614202
IS  - 1931-7557 (Print)
IS  - 1931-7565 (Electronic)
VI  - 4
IP  - 3-4
DP  - 2010 Dec
TI  - Sustained cortical and subcortical neuromodulation induced by electrical tongue
      stimulation.
PG  - 199-211
AB  - This pilot study aimed to show that information-free stimulation of the tongue
      can improve behavioral measures and induce sustained neuromodulation of the
      balance-processing network in individuals with balance dysfunction. Twelve
      balance-impaired subjects received one week of cranial nerve non-invasive
      neuromodulation (CN-NINM). Before and after the week of stimulation, postural
      sway and fMRI activation were measured to monitor susceptibility to optic flow.
      Nine normal controls also underwent the postural sway and fMRI tests but did not 
      receive CN-NINM. Results showed that before CN-NINM balance-impaired subjects
      swayed more than normal controls as expected (p≤0.05), and that overall sway and 
      susceptibility to optic flow decreased after CN-NINM (p≤0.005 & p≤0.05). fMRI
      showed upregulation of visual sensitivity to optic flow in balance-impaired
      subjects that decreased after CN-NINM. A region of interest analysis indicated
      that CN-NINM may induce neuromodulation by increasing activity within the dorsal 
      pons (p≤0.01).
FAU - Wildenberg, Joseph C.
AU  - Wildenberg JC
AD  - Neuroscience Training Program, University of Wisconsin-Madison, Madison, WI
      53705, USA
AD  - Medical Scientist Training Program, University of Wisconsin-Madison, Madison, WI 
      53705, USA
AD  - 1122o Wisconsin Institutes for Medical Research, 1111 Highland Ave., Madison, WI 
      53705, USA
FAU - Tyler, Mitchell E.
AU  - Tyler ME
AD  - Department of Orthopedics and Rehabilitation, University of Wisconsin-Madison,
      Madison, WI 53705, USA
FAU - Danilov, Yuri P.
AU  - Danilov YP
AD  - Department of Orthopedics and Rehabilitation, University of Wisconsin-Madison,
      Madison, WI 53705, USA
FAU - Kaczmarek, Kurt A.
AU  - Kaczmarek KA
AD  - Department of Orthopedics and Rehabilitation, University of Wisconsin-Madison,
      Madison, WI 53705, USA
FAU - Meyerand, Mary E.
AU  - Meyerand ME
AD  - Neuroscience Training Program, University of Wisconsin-Madison, Madison, WI
      53705, USA
AD  - Department of Medical Physics, University of Wisconsin-Madison, Madison, WI
      53705, USA
LA  - eng
PT  - Journal Article
TA  - Brain Imaging Behav
JT  - Brain imaging and behavior
AID - 10.1007/s11682-010-9099-7 [doi]
MID - NIHMS223384
SO  - Brain Imaging Behav. 2010 Dec;4(3-4):199-211. doi:10.1007/s11682-010-9099-7.

PMC - PMC4291321
PMID- 24047323
IS  - 0899-7667 (Print)
IS  - 1530-888X (Electronic)
VI  - 25
IP  - 12
DP  - 2013 Dec
TI  - Reinforcement Learning of Two-Joint Virtual Arm Reaching in a Computer Model of
      Sensorimotor Cortex.
PG  - 3263-93
AB  - Neocortical mechanisms of learning sensorimotor control involve a complex series 
      of interactions at multiple levels, from synaptic mechanisms to cellular dynamics
      to network connectomics. We developed a model of sensory and motor neocortex
      consisting of 704 spiking model neurons. Sensory and motor populations included
      excitatory cells and two types of interneurons. Neurons were interconnected with 
      AMPA/NMDA and GABAA synapses. We trained our model using spike-timing-dependent
      reinforcement learning to control a two-joint virtual arm to reach to a fixed
      target. For each of 125 trained networks, we used 200 training sessions, each
      involving 15 s reaches to the target from 16 starting positions. Learning altered
      network dynamics, with enhancements to neuronal synchrony and behaviorally
      relevant information flow between neurons. After learning, networks demonstrated 
      retention of behaviorally relevant memories by using proprioceptive information
      to perform reach-to-target from multiple starting positions. Networks dynamically
      controlled which joint rotations to use to reach a target, depending on current
      arm position. Learning-dependent network reorganization was evident in both
      sensory and motor populations: learned synaptic weights showed target-specific
      patterning optimized for particular reach movements. Our model embodies an
      integrative hypothesis of sensorimotor cortical learning that could be used to
      interpret future electrophysiological data recorded in vivo from sensorimotor
      learning experiments. We used our model to make the following predictions:
      learning enhances synchrony in neuronal populations and behaviorally relevant
      information flow across neuronal populations, enhanced sensory processing aids
      task-relevant motor performance and the relative ease of a particular movement in
      vivo depends on the amount of sensory information required to complete the
      movement.
FAU - Neymotin, Samuel A.
AU  - Neymotin SA
AD  - samuel.neymotin@yale.edu, Department of Neurobiology, Yale University School of
      Medicine, New Haven, CT 06510, U.S.A., and Department of Physiology and
      Pharmacology, SUNY Downstate, Brooklyn, NY 11203, U.S.A.
FAU - Chadderdon, George L.
AU  - Chadderdon GL
AD  - georgec@neurosim.downstate.edu, Department of Physiology and Pharmacology, SUNY
      Downstate, Brooklyn, NY 11203, U.S.A.
FAU - Kerr, Cliff C.
AU  - Kerr CC
AD  - cliffk@neurosim.downstate.edu, Department of Physiology and Pharmacology, SUNY
      Downstate, Brooklyn, NY 11203, U.S.A., and School of Physics, University of
      Sydney, Sydney 2050, Australia
FAU - Francis, Joseph T.
AU  - Francis JT
AD  - Joe.francis@downstate.edu, Department of Physiology and Pharmacology, Program in 
      Neural and Behavioral Science, and Robert F. Furchgott Center for Neural and
      Behavioral Science, SUNY Downstate, Brooklyn, NY 11203, U.S.A., and Joint Program
      in Biomedical Engineering, NYU Poly and SUNY Downstate, Brooklyn, NY 11203,
      U.S.A.
FAU - Lytton, William W.
AU  - Lytton WW
AD  - billl@neurosim.downstate.edu, Department of Physiology and Pharmacology,
      Department of Neurology, Program in Neural and Behavioral Science, and Robert F. 
      Furchgott Center for Neural and Behavioral Science, SUNY Downstate, Brooklyn, NY 
      11203, U.S.A.; Joint Program in Biomedical Engineering, NYU Poly and SUNY
      Downstate, Brooklyn, NY 11203, U.S.A.; and Department of Neurology, Kings County 
      Hospital, Brooklyn, NY 11203, U.S.A.
LA  - eng
PT  - Journal Article
DEP - 20130918
TA  - Neural Comput
JT  - Neural computation
AID - 10.1162/NECO_a_00521 [doi]
MID - NIHMS559874
SO  - Neural Comput. 2013 Dec;25(12):3263-93. Epub 2013 Sep 18
      doi:10.1162/NECO_a_00521.

PMC - PMC4614049
PMID- 26516605
IS  - 2162-3279 (Electronic)
VI  - 5
IP  - 10
DP  - 2015 Oct
TI  - Delineation of somatosensory finger areas using vibrotactile stimulation, an ECoG
      study.
LID - e00369
AB  - Background: In surgical planning for epileptic focus resection, functional
      mapping of eloquent cortex is attained through direct electrical stimulation of
      the brain. This procedure is uncomfortable, can trigger seizures or nausea, and
      relies on subjective evaluation. We hypothesize that a method combining
      vibrotactile stimulation and statistical clustering may provide improved
      somatosensory mapping. Methods: Seven pediatric candidates for surgical resection
      underwent a task in which their fingers were independently stimulated using a
      custom designed finger pad, during electrocorticographic monitoring. A
      cluster‐based statistical analysis was then performed to localize the elicited
      activity on the recording grids. Results: Mid‐Gamma clusters (65–115 Hz) arose in
      areas consistent with anatomical predictions as well as clinical findings, with
      five subjects presenting a somatotopic organization of the fingers. This process 
      allowed us to delineate finger representation even in patients who were sleeping,
      with strong interictal activity, or when electrical stimulation did not
      successfully locate eloquent areas. Conclusions: We suggest that this scheme,
      relying on the endogenous neural response rather than exogenous electrical
      activation, could eventually be extended to map other sensory areas and provide a
      faster and more objective map to better anticipate outcomes of surgical
      resection.
FAU - Wahnoun, Rémy
AU  - Wahnoun R
AD  - Barrow Neurological Institute at Phoenix Children's HospitalChildren's
      Neuroscience ResearchPhoenixArizona
FAU - Benson, Michelle
AU  - Benson M
AD  - Barrow Neurological Institute at Phoenix Children's HospitalChildren's
      Neuroscience ResearchPhoenixArizona
FAU - Helms‐Tillery, Stephen
AU  - Helms‐Tillery S
AD  - School of Biological and Health Systems EngineeringArizona State
      UniversityTempeArizona
FAU - Adelson, P. David
AU  - Adelson PD
AD  - Barrow Neurological Institute at Phoenix Children's HospitalChildren's
      Neuroscience ResearchPhoenixArizona
LA  - eng
PT  - Journal Article
DEP - 20150920
PHST- 2015/03/10 [received]
PHST- 2015/06/15 [revised]
PHST- 2015/06/21 [accepted]
TA  - Brain Behav
JT  - Brain and Behavior
AID - 10.1002/brb3.369 [doi]
AID - BRB3369 [pii]
SO  - Brain Behav. 2015 Sep 20;5(10):. doi:10.1002/brb3.369.

PMC - PMC3713954
PMID- 23770578
IS  - 1439-4456 (Print)
IS  - 1438-8871 (Electronic)
VI  - 15
IP  - 6
DP  - 2013 Jun
TI  - Mobile Health Applications for the Most Prevalent Conditions by the World Health 
      Organization: Review and Analysis.
LID - e120
AB  - Background: New possibilities for mHealth have arisen by means of the latest
      advances in mobile communications and technologies. With more than 1 billion
      smartphones and 100 million tablets around the world, these devices can be a
      valuable tool in health care management. Every aid for health care is welcome and
      necessary as shown by the more than 50 million estimated deaths caused by
      illnesses or health conditions in 2008. Some of these conditions have additional 
      importance depending on their prevalence. Objective: To study the existing
      applications for mobile devices exclusively dedicated to the eight most prevalent
      health conditions by the latest update (2004) of the Global Burden of Disease
      (GBD) of the World Health Organization (WHO): iron-deficiency anemia, hearing
      loss, migraine, low vision, asthma, diabetes mellitus, osteoarthritis (OA), and
      unipolar depressive disorders. Methods: Two reviews have been carried out. The
      first one is a review of mobile applications in published articles retrieved from
      the following systems: IEEE Xplore, Scopus, ScienceDirect, Web of Knowledge, and 
      PubMed. The second review is carried out by searching the most important
      commercial app stores: Google play, iTunes, BlackBerry World, Windows Phone
      Apps+Games, and Nokia's Ovi store. Finally, two applications for each condition, 
      one for each review, were selected for an in-depth analysis. Results: Search
      queries up to April 2013 located 247 papers and more than 3673 apps related to
      the most prevalent conditions. The conditions in descending order by the number
      of applications found in literature are diabetes, asthma, depression, hearing
      loss, low vision, OA, anemia, and migraine. However when ordered by the number of
      commercial apps found, the list is diabetes, depression, migraine, asthma, low
      vision, hearing loss, OA, and anemia. Excluding OA from the former list, the four
      most prevalent conditions have fewer apps and research than the final four.
      Several results are extracted from the in-depth analysis: most of the apps are
      designed for monitoring, assisting, or informing about the condition. Typically
      an Internet connection is not required, and most of the apps are aimed for the
      general public and for nonclinical use. The preferred type of data visualization 
      is text followed by charts and pictures. Assistive and monitoring apps are shown 
      to be frequently used, whereas informative and educational apps are only
      occasionally used. Conclusions: Distribution of work on mobile applications is
      not equal for the eight most prevalent conditions. Whereas some conditions such
      as diabetes and depression have an overwhelming number of apps and research,
      there is a lack of apps related to other conditions, such as anemia, hearing
      loss, or low vision, which must be filled.
FAU - Lin, Kai
AU  - Lin K
FAU - Wang Gao, Xiaohong
AU  - Wang Gao X
FAU - Herreros, Jesús
AU  - Herreros J
FAU - Chomutare, Taridzo
AU  - Chomutare T
FAU - Gao, Junfeng
AU  - Gao J
FAU - Martínez-Pérez, Borja
AU  - Martínez-Pérez B
AD  - University of ValladolidDepartment of Signal Theory and Communications, and
      Telematics Engineering.University of ValladolidValladolidSpain
FAU - de la Torre-Díez, Isabel
AU  - de la Torre-Díez I
AD  - University of ValladolidDepartment of Signal Theory and Communications, and
      Telematics Engineering.University of ValladolidValladolidSpain
FAU - López-Coronado, Miguel
AU  - López-Coronado M
AD  - University of ValladolidDepartment of Signal Theory and Communications, and
      Telematics Engineering.University of ValladolidValladolidSpain
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20130614
PHST- 2013/03/13 [received]
PHST- 2013/04/30 [revised]
PHST- 2013/05/08 [accepted]
TA  - J Med Internet Res
JT  - Journal of Medical Internet Research
AID - v15i6e120 [pii]
AID - 10.2196/jmir.2600 [doi]
SO  - J Med Internet Res. 2013 Jun 14;15(6):. doi:10.2196/jmir.2600.

PMC - PMC4745097
PMID- 26854041
IS  - 2045-2322 (Electronic)
VI  - 6
DP  - 2016
TI  - An integrative approach for analyzing hundreds of neurons in task performing mice
      using wide-field calcium imaging.
LID - 20986
AB  - Advances in neurotechnology have been integral to the investigation of neural
      circuit function in systems neuroscience. Recent improvements in high performance
      fluorescent sensors and scientific CMOS cameras enables optical imaging of neural
      networks at a much larger scale. While exciting technical advances demonstrate
      the potential of this technique, further improvement in data acquisition and
      analysis, especially those that allow effective processing of increasingly larger
      datasets, would greatly promote the application of optical imaging in systems
      neuroscience. Here we demonstrate the ability of wide-field imaging to capture
      the concurrent dynamic activity from hundreds to thousands of neurons over
      millimeters of brain tissue in behaving mice. This system allows the
      visualization of morphological details at a higher spatial resolution than has
      been previously achieved using similar functional imaging modalities. To analyze 
      the expansive data sets, we developed software to facilitate rapid downstream
      data processing. Using this system, we show that a large fraction of anatomically
      distinct hippocampal neurons respond to discrete environmental stimuli associated
      with classical conditioning, and that the observed temporal dynamics of transient
      calcium signals are sufficient for exploring certain spatiotemporal features of
      large neural networks.
FAU - Mohammed, Ali I.
AU  - Mohammed AI
AD  - Boston University, Department of Biomedical Engineering, Boston, MA 02215.
FAU - Gritton, Howard J.
AU  - Gritton HJ
AD  - Boston University, Department of Biomedical Engineering, Boston, MA 02215.
FAU - Tseng, Hua-an
AU  - Tseng Ha
AD  - Boston University, Department of Biomedical Engineering, Boston, MA 02215.
FAU - Bucklin, Mark E.
AU  - Bucklin ME
AD  - Boston University, Department of Biomedical Engineering, Boston, MA 02215.
FAU - Yao, Zhaojie
AU  - Yao Z
AD  - Boston University, Department of Biomedical Engineering, Boston, MA 02215.
FAU - Han, Xue
AU  - Han X
AD  - Boston University, Department of Biomedical Engineering, Boston, MA 02215.
LA  - eng
PT  - Journal Article
DEP - 20160208
PHST- 2015/08/17 [received]
PHST- 2016/01/14 [accepted]
TA  - Sci Rep
JT  - Scientific Reports
AID - srep20986 [pii]
AID - 10.1038/srep20986 [doi]
SO  - Sci Rep. 2016 Feb 08;6:. doi:10.1038/srep20986.

PMC - PMC5056270
PMID- 27747108
IS  - 2090-5904 (Print)
IS  - 1687-5443 (Electronic)
VI  - 2016
DP  - 2016
TI  - MRI Biomarkers for Hand-Motor Outcome Prediction and Therapy Monitoring following
      Stroke.
LID - 9265621
AB  - Several biomarkers have been identified which enable a considerable prediction of
      hand-motor outcome after cerebral damage already in the subacute stage after
      stroke. We here review the value of MRI biomarkers in the evaluation of
      corticospinal integrity and functional recruitment of motor resources. Many of
      the functional imaging parameters are not feasible early after stroke or for
      patients with high impairment and low compliance. Whereas functional connectivity
      parameters have demonstrated varying results on their predictive value for
      hand-motor outcome, corticospinal integrity evaluation using structural imaging
      showed robust and high predictive power for patients with different levels of
      impairment. Although this is indicative of an overall higher value of structural 
      imaging for prediction, we suggest that this variation be explained by structure 
      and function relationships. To gain more insight into the recovering brain, not
      only one biomarker is needed. We rather argue for a combination of different
      measures in an algorithm to classify fine-graded subgroups of patients.
      Approaches to determining biomarkers have to take into account the established
      markers to provide further information on certain subgroups. Assessing the best
      therapy approaches for individual patients will become more feasible as these
      subgroups become specified in more detail. This procedure will help to
      considerably save resources and optimize neurorehabilitative therapy.
FAU - Horn, U.
AU  - Horn U
AD  - Functional Imaging Unit, Department of Diagnostic Radiology and Neuroradiology,
      University Medicine, University of Greifswald, Greifswald, Germany
FAU - Grothe, M.
AU  - Grothe M
AD  - Department of Neurology, University Medicine, University of Greifswald,
      Greifswald, Germany
FAU - Lotze, M.
AU  - Lotze M
AUID- ORCID: 0000-0003-4519-4956
AD  - Functional Imaging Unit, Department of Diagnostic Radiology and Neuroradiology,
      University Medicine, University of Greifswald, Greifswald, Germany
LA  - eng
PT  - Journal Article
DEP - 20160926
GR  - DFG Lo795/7-1
PHST- 2016/07/12 [received]
PHST- 2016/08/23 [accepted]
PHST- 2016/09/26 [aheadofprint]
TA  - Neural Plast
JT  - Neural Plasticity
AID - 10.1155/2016/9265621 [doi]
SO  - Neural Plast. 2016;2016:. Epub 2016 Sep 26 doi:10.1155/2016/9265621.

PMC - PMC3951710
PMID- 24023376
IS  - 1092-4388 (Print)
IS  - 1558-9102 (Electronic)
VI  - 56
IP  - 6
DP  - 2013 Dec 1
TI  - Why Words are Hard for Adults with Developmental Language Impairments.
PG  - 1845-56
AB  - PURPOSE:: To determine whether word learning problems associated with
      developmental language impairment (LI) reflect deficits in encoding or subsequent
      remembering of forms and meanings. METHOD:: Sixty-nine 18-25-year-olds with LI or
      without (ND) took tests to measure learning of 16 word forms and meanings
      immediately after training (encoding) and 12-hours, 24-hours, and 1-week later
      (remembering). Half of the participants trained in the morning and half in the
      evening. RESULTS:: At immediate posttest, those with LI performed more poorly on 
      form and meaning than those with ND. Poor performance was more likely among those
      with more severe LI. The LI and ND groups demonstrated no difference in
      remembering word meanings over one week. In both groups, participants who trained
      in the evening, and therefore slept shortly after training, demonstrated greater 
      gains in meaning recall than those who trained in the morning. In contrast, the
      LI-ND gap for word form recall widened over the week. CONCLUSIONS:: Some adults
      with LI have encoding deficits that limit the addition of word forms and meanings
      to the lexicon. Similarities and differences in patterns of remembering in the LI
      and ND groups motivate the hypothesis that consolidation of declarative memory is
      a strength for adults with LI.
FAU - McGregor, Karla K.
AU  - McGregor KK
FAU - Licandro, Ulla
AU  - Licandro U
FAU - Arenas, Richard
AU  - Arenas R
FAU - Eden, Nichole
AU  - Eden N
FAU - Stiles, Derek
AU  - Stiles D
FAU - Bean, Allison
AU  - Bean A
FAU - Walker, Elizabeth
AU  - Walker E
LA  - eng
PT  - Journal Article
TA  - J Speech Lang Hear Res
JT  - Journal of speech, language, and hearing research : JSLHR
AID - 10.1044/1092-4388(2013/12-0233) [doi]
MID - NIHMS530324
SO  - J Speech Lang Hear Res. 2013 Dec 1;56(6):1845-56.
      doi:10.1044/1092-4388(2013/12-0233).

PMC - PMC4760884
PMID- 26333017
IS  - 1050-9631 (Print)
IS  - 1098-1063 (Electronic)
VI  - 26
IP  - 3
DP  - 2016 Mar
TI  - Mapping the electrophysiological and morphological properties of CA1 pyramidal
      neurons along the longitudinal hippocampal axis.
PG  - 341-61
AB  - Differences in behavioral roles, anatomical connectivity and gene expression
      patterns in the dorsal, intermediate and ventral regions of the hippocampus are
      well characterized. Relatively fewer studies have, however, focused on comparing 
      the physiological properties of neurons located at different dorsoventral extents
      of the hippocampus. Recently we reported that dorsal CA1 neurons are less
      excitable than ventral neurons. There is little or no information for how neurons
      in the intermediate hippocampus compare to those from the dorsal and ventral
      ends. Also, it is not known whether the transition of properties along the
      dorsoventral axis is gradual or segmented. In this study, we developed a
      statistical model to predict the dorsoventral position of transverse hippocampal 
      slices. Using current clamp recordings combined with this model, we found that
      CA1 neurons in dorsal, intermediate and ventral hippocampus have distinct
      electrophysiological and morphological properties and that the transition in most
      (but not all) of these properties from the ventral to dorsal end is gradual.
      Using linear and segmented regression analyses, we found that input resistance
      and resting membrane potential changed linearly along the V–D axis.
      Interestingly, the transition in resonance frequency, rebound slope, dendritic
      branching in stratum radiatum and action potential properties was segmented along
      the V–D axis. Together, the findings from this study highlight the heterogeneity 
      in CA1 neuronal properties along the entire longitudinal axis of hippocampus.
FAU - Ruchi, Malik
AU  - Ruchi M
AD  - Center for Learning and Memory, The University of Texas at Austin, 100 E 24 St,
      Austin, TX 78712
FAU - Ann, Dougherty Kelly
AU  - Ann DK
AD  - Center for Learning and Memory, The University of Texas at Austin, 100 E 24 St,
      Austin, TX 78712
FAU - Komal, Parikh
AU  - Komal P
AD  - Center for Learning and Memory, The University of Texas at Austin, 100 E 24 St,
      Austin, TX 78712
FAU - Connor, Byrne
AU  - Connor B
AD  - Center for Learning and Memory, The University of Texas at Austin, 100 E 24 St,
      Austin, TX 78712
FAU - Daniel, Johnston
AU  - Daniel J
AD  - Center for Learning and Memory, The University of Texas at Austin, 100 E 24 St,
      Austin, TX 78712
LA  - eng
PT  - Journal Article
DEP - 20151010
TA  - Hippocampus
JT  - Hippocampus
AID - 10.1002/hipo.22526 [doi]
MID - NIHMS720572
SO  - Hippocampus. 2016 Mar;26(3):341-61. Epub 2015 Oct 10 doi:10.1002/hipo.22526.

PMC - PMC3517805
PMID- 23239934
IS  - 1388-0764 (Print)
IS  - 1572-896X (Electronic)
VI  - 14
IP  - 12
DP  - 2012 Dec
TI  - Validity range of centrifuges for the regulation of nanomaterials: from
      classification to as-tested coronas.
LID - 1300
AB  - Granulometry is the regulatory category where the differences between traditional
      materials and nanomaterials culminate. Reported herein is a careful validation of
      methods for the quantification of dispersability and size distribution in
      relevant media, and for the classification according to the EC nanodefinition
      recommendation. Suspension-based techniques can assess the nanodefinition only if
      the material in question is reasonably well dispersed. Using dispersed material
      of several chemical compositions (organic, metal, metal-oxide) as test cases we
      benchmark analytical ultracentrifugation (AUC), dynamic light scattering (DLS),
      hydrodynamic chromatography, nanoparticle tracking analysis (NTA) against the
      known content of bimodal suspensions in the commercially relevant range between
      20 nm and a few microns. The results validate fractionating techniques,
      especially AUC, which successfully identifies any dispersed nanoparticle content 
      from 14 to 99.9 nb% with less than 5 nb% deviation. In contrast, our screening
      casts severe doubt over the reliability of ensemble (scattering) techniques and
      highlights the potential of NTA to develop into a counting upgrade of DLS. The
      unique asset of centrifuges with interference, X-ray or absorption detectors—to
      quantify the dispersed solid content for each size interval from proteins over
      individualized nanoparticles up to agglomerates, while accounting for their loose
      packing—addresses also the adsorption/depletion of proteins and
      (de-)agglomeration of nanomaterials under cell culture conditions as tested for
      toxicological endpoints.
FAU - Wohlleben, Wendel
AU  - Wohlleben W
AD  - BASF SE, Material Physics GMC/R, 67056 Ludwigshafen, Germany
LA  - eng
PT  - Journal Article
DEP - 20121124
PHST- 2012/01/13 [received]
PHST- 2012/11/09 [accepted]
TA  - J Nanopart Res
JT  - Journal of Nanoparticle Research
AID - 1300 [pii]
AID - 10.1007/s11051-012-1300-z [doi]
SO  - J Nanopart Res. 2012 Dec;14(12):. Epub 2012 Nov 24 doi:10.1007/s11051-012-1300-z.

PMC - PMC1560501
PMID- 16779092
IS  - 1942-597X (Electronic)
VI  - 2005
DP  - 2005
TI  - RealityFlythrough: Enhancing Situational Awareness for Medical Response to
      Disasters Using Ubiquitous Video.
PG  - 510-4
AB  - The first moments at a disater scene are chaotic. The command center initially
      operates with little knowledge of hazards, geography and casualties, building up 
      knowledge of the event slowly as information trickles in by voice radio channels.
      RealityFlythrough is a tele-presence system that stitches together live video
      feeds in real-time, using the principle of visual closure, to give command center
      personnel the illusion of being able to explore the scene interactively by moving
      smoothly between the video feeds. Using RealityFlythrough, medical, fire, law
      enforcement, hazardous materials, and engineering experts may be able to achieve 
      situational awareness earlier, and better manage scarce resources. The
      RealityFlythrough system is composed of camera units with off-the-shelf GPS and
      orientation systems and a server/viewing station that offers access to images
      collected by the camera units in real time by position/orientation. In initial
      field testing using an experimental mesh 802.11 wireless network, two camera unit
      operators were able to create an interactive image of a simulated disaster scene 
      in about five minutes.
FAU - McCurdy, Neil J.
AU  - McCurdy NJ
AD  - California Institute for Telecommunications and Information Technology,
      University of California, San Diego, La Jolla, CA
FAU - Griswold, William G
AU  - Griswold WG
FAU - Lenert, Leslie A.
AU  - Lenert LA
AD  - California Institute for Telecommunications and Information Technology,
      University of California, San Diego, La Jolla, CA
LA  - eng
PT  - Journal Article
TA  - AMIA Annu Symp Proc
JT  - AMIA Annual Symposium Proceedings
AID - amia2005_0510 [pii]
SO  - AMIA Annu Symp Proc. 2005;2005:510-4.

PMC - PMC4317347
PMID- 22060037
IS  - 0003-2700 (Print)
IS  - 1520-6882 (Electronic)
VI  - 84
IP  - 2
DP  - 2012 Jan 17
TI  - Interferometric Methods for Label-Free Molecular Interaction Studies.
PG  - 779-92
FAU - Kussrow, Amanda
AU  - Kussrow A
FAU - Enders, Carolyn S.
AU  - Enders CS
FAU - Bornhop, Darryl J.
AU  - Bornhop DJ
LA  - eng
PT  - Journal Article
DEP - 20111107
TA  - Anal Chem
JT  - Analytical chemistry
AID - 10.1021/ac202812h [doi]
MID - NIHMS589085
SO  - Anal Chem. 2012 Jan 17;84(2):779-92. Epub 2011 Nov 07 doi:10.1021/ac202812h.

PMC - PMC1284846
PMID- 11831782
IS  - 0022-5002 (Print)
VI  - 77
IP  - 1
DP  - 2002 Jan
TI  - Linear modeling of steady-state behavioral dynamics.
PG  - 3-27
AB  - The observed steady-state behavioral dynamics supported by unsignaled periods of 
      reinforcement within repeating 2,000-s trials were modeled with a linear transfer
      function. These experiments employed improved schedule forms and analytical
      methods to improve the precision of the measured transfer function, compared to
      previous work. The refinements include both the use of multiple reinforcement
      periods that improve spectral coverage and averaging of independently determined 
      transfer functions. A linear analysis was then used to predict behavior observed 
      for three different test schedules. The fidelity of these predictions was
      determined.
FAU - Palya, William L
AU  - Palya WL
FAU - Walter, Donald
AU  - Walter D
FAU - Kessel, Robert
AU  - Kessel R
FAU - Lucke, Robert
AU  - Lucke R
LA  - eng
PT  - Journal Article
TA  - J Exp Anal Behav
JT  - Journal of the Experimental Analysis of Behavior
AID - 10.1901/jeab.2002.77-3 [doi]
SO  - J Exp Anal Behav. 2002 Jan;77(1):3-27. doi:10.1901/jeab.2002.77-3.

PMC - PMC3925252
PMID- 24406054
IS  - 1097-6647 (Print)
IS  - 1532-429X (Electronic)
VI  - 16
IP  - 1
DP  - 2014
TI  - Tracking of stem cells in vivo for cardiovascular applications.
PG  - 7
AB  - In the past ten years, the concept of injecting stem and progenitor cells to
      assist with rebuilding damaged blood vessels and myocardial tissue after injury
      in the heart and peripheral vasculature has moved from bench to bedside.
      Non-invasive imaging can not only provide a means to assess cardiac repair and,
      thereby, cellular therapy efficacy but also a means to confirm cell delivery and 
      engraftment after administration. In this first of a two-part review, we will
      review the different types of cellular labeling techniques and the application of
      these techniques in cardiovascular magnetic resonance and ultrasound. In
      addition, we provide a synopsis of the cardiac cellular clinical trials that have
      been performed to-date.
FAU - Azene, Nicole
AU  - Azene N
AD  - Russell H. Morgan Department of Radiology and Radiological Science, The Johns
      Hopkins University, Baltimore, MD, USA
FAU - Fu, Yingli
AU  - Fu Y
AD  - Russell H. Morgan Department of Radiology and Radiological Science, The Johns
      Hopkins University, Baltimore, MD, USA
FAU - Maurer, Jeremy
AU  - Maurer J
AD  - Russell H. Morgan Department of Radiology and Radiological Science, The Johns
      Hopkins University, Baltimore, MD, USA
FAU - Kraitchman, Dara L
AU  - Kraitchman DL
AD  - Russell H. Morgan Department of Radiology and Radiological Science, The Johns
      Hopkins University, Baltimore, MD, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20140110
PHST- 2012/12/16 [received]
PHST- 2013/12/11 [accepted]
TA  - J Cardiovasc Magn Reson
JT  - Journal of Cardiovascular Magnetic Resonance
AID - 1532-429X-16-7 [pii]
AID - 10.1186/1532-429X-16-7 [doi]
SO  - J Cardiovasc Magn Reson. 2014 Jan 10;16(1):7. doi:10.1186/1532-429X-16-7.

PMC - PMC4441594
PMID- 25418857
IS  - 1389-4501 (Print)
IS  - 1873-5592 (Electronic)
VI  - 16
IP  - 6
DP  - 2015
TI  - Biomedical Imaging in Implantable Drug Delivery Systems.
PG  - 672-82
AB  - Implantable drug delivery systems (DDS) provide a platform for sustained release 
      of therapeutic agents over a period of weeks to months and sometimes years. Such 
      strategies are typically used clinically to increase patient compliance by
      replacing frequent administration of drugs such as contraceptives and hormones to
      maintain plasma concentration within the therapeutic window. Implantable or
      injectable systems have also been investigated as a means of local drug
      administration which favors high drug concentration at a site of interest, such
      as a tumor, while reducing systemic drug exposure to minimize unwanted side
      effects. Significant advances in the field of local DDS have led to increasingly 
      sophisticated technology with new challenges including quantification of local
      and systemic pharmacokinetics and implant-body interactions. Because many of
      these sought-after parameters are highly dependent on the tissue properties at
      the implantation site, and rarely represented adequately with in vitro models,
      new nondestructive techniques that can be used to study implants in situ are
      highly desirable. Versatile imaging tools can meet this need and provide
      quantitative data on morphological and functional aspects of implantable systems.
      The focus of this review article is an overview of current biomedical imaging
      techniques, including magnetic resonance imaging (MRI), ultrasound imaging,
      optical imaging, X-ray and computed tomography (CT), and their application in
      evaluation of implantable DDS.
FAU - Zhou, Haoyan
AU  - Zhou H
AD  - Department of Biomedical Engineering, Case Western Reserve University, 11100
      Euclid Ave, Cleveland, OH, 44106, USA
FAU - Hernandez, Christopher
AU  - Hernandez C
AD  - Department of Biomedical Engineering, Case Western Reserve University, 11100
      Euclid Ave, Cleveland, OH, 44106, USA
FAU - Goss, Monika
AU  - Goss M
AD  - Department of Biomedical Engineering, Case Western Reserve University, 11100
      Euclid Ave, Cleveland, OH, 44106, USA
FAU - Gawlik, Anna
AU  - Gawlik A
AD  - Department of Biomedical Engineering, Case Western Reserve University, 11100
      Euclid Ave, Cleveland, OH, 44106, USA
FAU - Exner, Agata A.
AU  - Exner AA
AD  - Department of Biomedical Engineering, Case Western Reserve University, 11100
      Euclid Ave, Cleveland, OH, 44106, USA
LA  - eng
PT  - Journal Article
TA  - Curr Drug Targets
JT  - Current drug targets
MID - NIHMS670289
SO  - Curr Drug Targets. 2015;16(6):672-82.

PMC - PMC2678859
PMID- 19430590
IS  - 0911-6044 (Print)
VI  - 22
IP  - 3
DP  - 2009 May
TI  - Language effects in second language learners and proficient bilinguals
      investigated with event-related potentials☆.
PG  - 281-300
AB  - The present study examines language effects in second language learners. In three
      experiments participants monitored a stream of words for occasional probes from
      one semantic category and ERPs were recorded to non-probe critical items. In
      Experiment 1 L1 English participants who were university learners of French saw
      two lists of words blocked by language, one in French and one in English. We
      observed a large effect of language that mostly affected amplitudes of the N400
      component, but starting as early as 150 ms post-stimulus onset. A similar pattern
      was found in Experiment 2 with L1 French and L2 English, showing that the effect 
      is due to language dominance and not language per se. Experiment 3 found that
      proficient French/English bilinguals exhibited a different pattern of language
      effects showing that these effects are modulated by proficiency. These results
      lend further support to the hypothesis that word recognition during the early
      phases of L2 acquisition in late learners of L2 involves a specific set of
      mechanisms compared with recognition of L1 words.
FAU - Midgley, Katherine J.
AU  - Midgley KJ
AD  - Department of Psychology, Tufts University, Medford, MA, USA
FAU - Holcomb, Phillip J.
AU  - Holcomb PJ
AD  - Department of Psychology, Tufts University, Medford, MA, USA
FAU - Grainger, Jonathan
AU  - Grainger J
AD  - CNRS, Marseille, France
LA  - eng
PT  - Journal Article
TA  - J Neurolinguistics
JT  - Journal of neurolinguistics
AID - 10.1016/j.jneuroling.2008.08.001 [doi]
MID - NIHMS106052
SO  - J Neurolinguistics. 2009 May;22(3):281-300. doi:10.1016/j.jneuroling.2008.08.001.

PMC - PMC3944133
PMID- 24345389
IS  - 1053-8119 (Print)
IS  - 1095-9572 (Electronic)
VI  - 89
DP  - 2014 Apr 1
TI  - Optimization of multifocal transcranial current stimulation for weighted cortical
      pattern targeting from realistic modeling of electric fields.
PG  - 216-25
AB  - Recently, multifocal transcranial current stimulation (tCS) devices using several
      relatively small electrodes have been used to achieve more focal stimulation of
      specific cortical targets. However, it is becoming increasingly recognized that
      many behavioral manifestations of neurological and psychiatric disease are not
      solely the result of abnormality in one isolated brain region but represent
      alterations in brain networks. In this paper we describe a method for optimizing 
      the configuration of multifocal tCS for stimulation of brain networks,
      represented by spatially extended cortical targets. We show how, based on fMRI,
      PET, EEG or other data specifying a target map on the cortical surface for
      excitatory, inhibitory or neutral stimulation and a constraint of the maximal
      number of electrodes, a solution can be produced with the optimal currents and
      locations of the electrodes. The method described here relies on a fast
      calculation of multifocal tCS electric fields (including components normal and
      tangential to the cortical boundaries) using a five layer finite element model of
      a realistic head. Based on the hypothesis that the effects of current stimulation
      are to first order due to the interaction of electric fields with populations of 
      elongated cortical neurons, it is argued that the optimization problem for tCS
      stimulation can be defined in terms of the component of the electric field normal
      to the cortical surface. Solutions are found using constrained least squares to
      optimize current intensities, while electrode number and their locations are
      selected using a genetic algorithm. For direct current tCS (tDCS) applications,
      we provide some examples of this technique using an available tCS system
      providing 8 small Ag/AgCl stimulation electrodes. We demonstrate the approach
      both for localized and spatially extended targets defined using rs-fcMRI and PET 
      data, with clinical applications in stroke and depression. Finally, we extend
      these ideas to more general stimulation protocols, such as alternating current
      tCS (tACS).
FAU - Ruffini, Giulio
AU  - Ruffini G
AD  - Starlab Barcelona, C. Teodor Roviralta 45, 08022 Barcelona, Spain
FAU - Fox, Michael D.
AU  - Fox MD
AD  - Massachusetts General Hospital, Brigham and Women’s Hospital, Harvard Medical
      School, Boston, MA, USA
FAU - Ripolles, Oscar
AU  - Ripolles O
AD  - Neuroelectrics Barcelona, C. Teodor Roviralta 45, 08022 Barcelona, Spain
FAU - Miranda, Pedro Cavaleiro
AU  - Miranda PC
AD  - Neuroelectrics Barcelona, C. Teodor Roviralta 45, 08022 Barcelona, Spain
FAU - Pascual-Leone, Alvaro
AU  - Pascual-Leone A
AD  - Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess
      Medical Center and Harvard Medical School, Boston, MA, USA
LA  - eng
PT  - Journal Article
DEP - 20131215
TA  - Neuroimage
JT  - NeuroImage
AID - 10.1016/j.neuroimage.2013.12.002 [doi]
MID - NIHMS548232
SO  - Neuroimage. 2014 Apr 1;89:216-25. Epub 2013 Dec 15
      doi:10.1016/j.neuroimage.2013.12.002.